PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Tsutsuyama, M; Nakanishi, H; Yoshimura, M; Oshiro, T; Kinoshita, T; Komori, K; Shimizu, Y; Ichinosawa, Y; Kinuta, S; Wajima, K; Sakakibara, Y; Yatabe, Y; Ito, S; Kodera, Y				Tsutsuyama, Masayuki; Nakanishi, Hayao; Yoshimura, Mayumi; Oshiro, Taihei; Kinoshita, Takashi; Komori, Koji; Shimizu, Yasuhiro; Ichinosawa, Yoshiyuki; Kinuta, Seichin; Wajima, Kentaro; Sakakibara, Yasufumi; Yatabe, Yasushi; Ito, Seiji; Kodera, Yasuhiro			Detection of circulating tumor cells in drainage venous blood from colorectal cancer patients using a new filtration and cytology-based automated platform	PLOS ONE			English	Article							SIZE	Numerous technologies exist to detect circulating tumor cells (CTCs), although reports on cytological detection of CTCs remain limited. We recently developed a cytology-based CTC detection device using glass slides and light microscopy. In this study, we automated this previously manual device to improve its efficiency and cost effectiveness for clinical applications. We conducted a pilot study using this device to compare CTCs in peripheral blood (PB) and draining venous blood (DVB) from patients with colorectal cancer (CRC). The cytology-based automated CTC detection platform consisted of a disposable filtration device with a three-dimensional (3D) metal filter and multichannel automated CTC enrichment device. This platform allowed rapid and gentle filtration of CTCs and their efficient transfer from the filter to glass slides for subsequent Papanicolaou (Pap) and immunocytochemical (ICC) staining. Cytological diagnosis of CTCs was performed by observing permanent glass slide specimens by light microscopy. The current pilot clinical study enrolled CRC patients (n = 26) with stage I-IV tumors, who underwent surgery. PB was collected before surgery, and DVB was obtained from the mesenteric vein immediately after resection. Based on the CTC morphology obtained from PB and DVB samples, we proposed the following cytological criteria for the diagnosis of CTCs: pan-cytokeratin-positive, atypical cells with malignant morphological features identified by Pap staining. The numbers of CTCs defined by these criteria were significantly higher in DVB than PB from CRC patients (p<0.01), and the number of CTCs in DVB was increased significantly with stage progression (p<0.05). These results suggest that DVB may be another potential source of CTCs other than PB for liquid biopsies including downstream analysis. This automated cytology-based CTC detection device therefore provides a unique and powerful tool to investigate the significance of CTCs in CRC patients in a clinical setting.	[Tsutsuyama, Masayuki; Oshiro, Taihei; Kinoshita, Takashi; Komori, Koji; Shimizu, Yasuhiro; Ito, Seiji] Cent Hosp, Aichi Canc Ctr, Dept Surg Gastroenterol, Chikusa Ku, Nagoya, Aichi, Japan; [Tsutsuyama, Masayuki; Kodera, Yasuhiro] Nagoya Univ, Grad Sch Med, Dept Surg Gastroenterol, Showa Ku, Nagoya, Aichi, Japan; [Nakanishi, Hayao; Yoshimura, Mayumi; Yatabe, Yasushi] Cent Hosp, Aichi Canc Ctr, Dept Pathol & Mol Diagnost, Chikusa Ku, Nagoya, Aichi, Japan; [Nakanishi, Hayao] Aichi Hosp, Aichi Canc Ctr, Lab Pathol & Clin Res, Okazaki, Aichi, Japan; [Ichinosawa, Yoshiyuki; Kinuta, Seichin] Optn Precis Co Ltd, Ashikaga, Tochigi, Japan; [Wajima, Kentaro; Sakakibara, Yasufumi] Maruyasu Ind Co Ltd, Okazaki, Aichi, Japan	Aichi Cancer Center; Nagoya University; Aichi Cancer Center; Aichi Cancer Center	Nakanishi, H (corresponding author), Cent Hosp, Aichi Canc Ctr, Dept Pathol & Mol Diagnost, Chikusa Ku, Nagoya, Aichi, Japan.; Nakanishi, H (corresponding author), Aichi Hosp, Aichi Canc Ctr, Lab Pathol & Clin Res, Okazaki, Aichi, Japan.	hnakanis@aichi-cc.jp	YATABE, Yasushi/J-6461-2014	YATABE, Yasushi/0000-0003-1788-559X; Kodera, Yasuhiro/0000-0002-6173-7474	Ministry of Education, Science, Sports, Culture and Technology, Japan [16K10524]; Aichi Science & Technology Foundation, Japan [H30-1]	Ministry of Education, Science, Sports, Culture and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Aichi Science & Technology Foundation, Japan	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, Culture and Technology, Japan (16K10524) to SI of Aichi Cancer Center and by a Grant-in-Aid for Ikusei Program from Aichi Science & Technology Foundation, Japan (H30-1) to YS of Maruyasu Industries. SK and YI are employees (staffs) of Optnics Precision Comments Co., Ltd, and YS and KW are employees (staffs) of Maruyasu Industries Co., Ltd. SK/YI and YS/KW contributed to the development and provided prototype products such as filtration device containing the 3D filter and an automated CTC enrichment platform, respectively. The funders do not alter the authors' adherence to all PLOS ONE policies and had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2018, BREAST CANCER RES TR, V167, P439, DOI 10.1007/s10549-017-4532-x; Adams DL, 2016, RSC ADV, V6, P6405, DOI 10.1039/c5ra21524b; Adams DL, 2014, RSC ADV, V4, P4334, DOI 10.1039/c3ra46839a; Bahrami A, 2008, MODERN PATHOL, V21, P795, DOI 10.1038/modpathol.2008.86; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; De Giorgi V, 2010, J INVEST DERMATOL, V130, P2440, DOI 10.1038/jid.2010.141; Desitter I, 2011, ANTICANCER RES, V31, P427; Galera P, 2016, APPL IMMUNOHISTO M M, V24, P622, DOI 10.1097/PAI.0000000000000230; Hardingham JE, 2015, MOL MED, V21, pS25, DOI 10.2119/molmed.2015.00149; Hofman VJ, 2011, AM J CLIN PATHOL, V135, P146, DOI 10.1309/AJCP9X8OZBEIQVVI; Ignatiadis M, 2015, CLIN CANCER RES, V21, P4786, DOI 10.1158/1078-0432.CCR-14-1190; Ito Y, 2010, CANCER SCI, V101, P1853, DOI 10.1111/j.1349-7006.2010.01607.x; Kaifi JT, 2015, CANCER BIOL THER, V16, P690, DOI 10.1080/15384047.2015.1026508; Katsuno H, 2008, ANN SURG ONCOL, V15, P3083, DOI 10.1245/s10434-008-0131-8; Kondo Y, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3305-6; Krebs MG, 2015, CLIN COLORECTAL CANC, V14, P115, DOI 10.1016/j.clcc.2014.12.006; McGuire S, 2016, ADV NUTR, V7, P418, DOI 10.3945/an.116.012211; Pailler E, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2461-4; Riethdorf S, 2018, ADV DRUG DELIVER REV, V125, P102, DOI 10.1016/j.addr.2018.01.011; Shimada R, 2012, ONCOL REP, V27, P947, DOI 10.3892/or.2012.1649; Tan Y, 2018, CURR PROB CANCER, V42, P95, DOI 10.1016/j.currproblcancer.2017.11.002; Vona G, 2000, AM J PATHOL, V156, P57, DOI 10.1016/S0002-9440(10)64706-2; Weitz J, 2005, LANCET, V365, P153, DOI 10.1016/S0140-6736(05)17706-X; Werner S, 2017, ADV EXP MED BIOL, V994, P205, DOI 10.1007/978-3-319-55947-6_11; Xu L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138032; Yusa A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088821	26	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0212221	10.1371/journal.pone.0212221	http://dx.doi.org/10.1371/journal.pone.0212221			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811434	Green Published, gold, Green Submitted			2022-12-27	WOS:000459806400062
J	Chen, LX; Gu, WP; Liu, CX; Wang, WG; Li, N; Chen, Y; Lu, CX; Sun, XM; Han, YY; Kuang, DX; Tong, PF; Dai, JJ				Chen, Linxia; Gu, Wenpeng; Liu, Chenxiu; Wang, Wenguang; Li, Na; Chen, Yang; Lu, Caixia; Sun, Xiaomei; Han, Yuanyuan; Kuang, Dexuan; Tong, Pinfen; Dai, Jiejie			Characteristics of the tree shrew gut virome	PLOS ONE			English	Article							METAGENOMICS; VIRUSES; CLASSIFICATION; INFECTION; ACLAME; MODEL	The tree shrew (Tupaia belangeri) has been proposed as an alternative laboratory animal to primates in biomedical research in recent years. However, characteristics of the tree shrew gut virome remain unclear. In this study, the metagenomic analysis method was used to identify the features of gut virome from fecal samples of this animal. Results showed that 5.80% of sequence reads in the libraries exhibited significant similarity to sequences deposited in the viral reference database (NCBI non-redundant nucleotide databases, viral protein databases and ACLAME database), and these reads were further classified into three major orders: Caudovirales (58.0%), Picornavirales (16.0%), and Herpesvirales (6.0%). Siphoviridae (46.0%), Myoviridae (45.0%), and Podoviridae (8.0%) comprised most Caudovirales. Picornaviridae (99.9%) and Herpesviridae (99.0%) were the primary families of Picornavirales and Herpesvirales, respectively. According to the host types and nucleic acid classifications, all of the related viruses in this study were divided into bacterial phage (61.83%), animal-specific virus (34.50%), plant-specific virus (0.09%), insect-specific virus (0.08%) and other viruses (3.50%). The dsDNA virus accounted for 51.13% of the total, followed by ssRNA (33.51%) and ssDNA virus (15.36%). This study provides an initial understanding of the community structure of the gut virome of tree shrew and a baseline for future tree shrew virus investigation.	[Chen, Linxia; Gu, Wenpeng; Liu, Chenxiu; Wang, Wenguang; Li, Na; Lu, Caixia; Sun, Xiaomei; Han, Yuanyuan; Kuang, Dexuan; Tong, Pinfen; Dai, Jiejie] Chinese Acad Med Sci, Inst Med Biol, Ctr Tree Shrew Germplasm Resources, Kunming, Yunnan, Peoples R China; [Chen, Linxia; Gu, Wenpeng; Liu, Chenxiu; Wang, Wenguang; Li, Na; Lu, Caixia; Sun, Xiaomei; Han, Yuanyuan; Kuang, Dexuan; Tong, Pinfen; Dai, Jiejie] Peking Union Med Coll, Yunnan Key Lab Vaccine Res & Dev Severe Infect Di, Yunnan Innovat Team Standardizat & Applicat Res T, Kunming, Yunnan, Peoples R China; [Chen, Linxia] Gannan Med Univ, Sch Basic Med Sci, Dept Pathogen Biol, Ganzhou, Peoples R China; [Gu, Wenpeng] Yunnan Prov Ctr Dis Control & Prevent, Dept Acute Infect Dis Control & Prevent, Kunming, Yunnan, Peoples R China; [Chen, Yang] Tsinghua Univ, Dept Automat, Ctr Synthet & Syst Biol, MOE Key Lab Bioinformat,TNLIST, Beijing, Peoples R China; [Chen, Yang] Tsinghua Univ, TNLIST Dept Automat, Ctr Synthet & Syst Biol, Bioinformat Div, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Yunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Diseases; Peking Union Medical College; Gannan Medical University; Tsinghua University; Tsinghua University	Dai, JJ (corresponding author), Chinese Acad Med Sci, Inst Med Biol, Ctr Tree Shrew Germplasm Resources, Kunming, Yunnan, Peoples R China.; Dai, JJ (corresponding author), Peking Union Med Coll, Yunnan Key Lab Vaccine Res & Dev Severe Infect Di, Yunnan Innovat Team Standardizat & Applicat Res T, Kunming, Yunnan, Peoples R China.	djj@imbcams.com.cn	Gu, Wenpeng/U-5367-2017; Wang, WenGuang/AAW-2800-2020		Yunnan Science and Technology Talent and Platform Program [2017HC019]; Yunnan province major science and technology project [2017ZF007]	Yunnan Science and Technology Talent and Platform Program; Yunnan province major science and technology project	This work was supported by Yunnan Science and Technology Talent and Platform Program (2017HC019). Yunnan province major science and technology project (2017ZF007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso PP, 2012, J VIROL, V86, P5039, DOI 10.1128/JVI.07162-11; Belak S, 2013, VET MICROBIOL, V165, P95, DOI 10.1016/j.vetmic.2013.01.022; Calvignac-Spencer S, 2016, ARCH VIROL, V161, P1739, DOI 10.1007/s00705-016-2794-y; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carding SR, 2017, ALIMENT PHARM THER, V46, P800, DOI 10.1111/apt.14280; Caspermeyer J, 2018, MOL BIOL EVOL, V35, P1558, DOI 10.1093/molbev/msy098; Chen H, 2010, J VIROL, V84, P10522, DOI 10.1128/JVI.00450-10; Chinchar VG, 2017, J GEN VIROL, V98, P890, DOI 10.1099/jgv.0.000818; Conceicao-Neto N, 2017, ECOL EVOL, V7, P4135, DOI 10.1002/ece3.2991; Coutinho FH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15955; D'arc M, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-018-0402-9; DARAI G, 1983, J VIROL METHODS, V7, P305, DOI 10.1016/0166-0934(83)90083-6; Delwart EL, 2007, REV MED VIROL, V17, P115, DOI 10.1002/rmv.532; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Endo H, 2000, J VET MED SCI, V62, P517, DOI 10.1292/jvms.62.517; Fan Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2416; Feng Y, 2017, J GEN VIROL, V98, P2069, DOI 10.1099/jgv.0.000869; Hofer U, 2013, NAT REV MICROBIOL, V11, P595, DOI 10.1038/nrmicro3092; Krishnamurthy SR, 2017, VIRUS RES, V239, P136, DOI 10.1016/j.virusres.2017.02.002; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leplae R, 2004, NUCLEIC ACIDS RES, V32, pD45, DOI 10.1093/nar/gkh084; Leplae R, 2010, NUCLEIC ACIDS RES, V38, pD57, DOI 10.1093/nar/gkp938; Liu W., 2016, ADV MATER, P1, DOI DOI 10.1016/J.PACS.2016.05.001; Lukashev AN, 2017, J GEN VIROL, V98, P955, DOI 10.1099/jgv.0.000760; LVOV SD, 1988, VOP VIRUSOL+, P92; Minot S, 2013, P NATL ACAD SCI USA, V110, P12450, DOI 10.1073/pnas.1300833110; Mokili JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058404; Ng TFF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020579; Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385; Phan TG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002218; Romer S, 2018, FRONT NEUROANAT, V12, DOI 10.3389/fnana.2018.00029; Shen Pei-Qing, 2011, Zoological Research, V32, P109, DOI 10.3724/SP.J.1141.2011.01109; Shi M, 2016, NATURE, V540, P539, DOI 10.1038/nature20167; Sullivan MB, 2015, J VIROL, V89, P2459, DOI 10.1128/JVI.03289-14; Tong YH, 2017, ONCOTARGET, V8, P17897, DOI 10.18632/oncotarget.15225; Walker A, 2010, NAT REV MICROBIOL, V8, P841, DOI 10.1038/nrmicro2476; Yang ZF, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-111; Yao YG, 2017, ZOOL RES, V38, P118, DOI 10.24272/j.issn.2095-8137.2017.032; Zhang D, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5152-5	40	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0212774	10.1371/journal.pone.0212774	http://dx.doi.org/10.1371/journal.pone.0212774			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807598	Green Submitted, Green Published, gold			2022-12-27	WOS:000459712100023
J	Kim, I; Eom, JS; Kim, AR; Lee, CH; Lee, G; Jo, EJ; Kim, MH; Mok, JH; Lee, K; Kim, KU; Park, HK; Lee, MK				Kim, Insu; Eom, Jung Seop; Kim, Ah Rong; Lee, Chang Hun; Lee, Geewon; Jo, Eun Jung; Kim, Mi-Hyun; Mok, Jeong Ha; Lee, Kwangha; Kim, Ki Uk; Park, Hye-Kyung; Lee, Min Ki			Molecular analysis of small tissue samples obtained via transbronchial lung biopsy using radial probe endobronchial ultrasound	PLOS ONE			English	Article							PERIPHERAL PULMONARY-LESIONS; FACTOR-RECEPTOR MUTATIONS; CORE-NEEDLE BIOPSY; BRUSH-TIP WASHINGS; GUIDE-SHEATH; INTERNATIONAL-ASSOCIATION; CLINICAL-PRACTICE; CELL BLOCKS; CANCER; DIAGNOSIS	Background Radial probe endobronchial ultrasound using a guide sheath (EBUS-GS) is used to diagnose peripheral lung cancer. The aim was to identify the accuracy of molecular analysis that were performed with EBUS-GS specimens in patients with non-small cell lung cancer (NSCLC). Method From December 2015 to September 2017, we retrospectively studied 91 patients with peripheral NSCLC who underwent surgery after EBUS-GS. Epidermal growth factor receptor (EGFR) mutational and anaplastic lymphoma kinase (ALK) translocation status obtained from surgical specimens served as the references. Results Compared to the reference data, EGFR mutational testing of EBUS-GS specimens was in 97% agreement, and the. coefficient was 0.931 (P<0.001). In addition, on ALK translocation testing, the results of all 91 patients were in agreement with the reference data (concordance rate of 100%,. coefficient 1.000; P<0.001). Conclusion We found that EBUS-GS could be used for molecular diagnosis, such as EGFR mutational and ALK translocation status, in patients with peripheral NSCLC.	[Kim, Insu; Eom, Jung Seop; Jo, Eun Jung; Kim, Mi-Hyun; Mok, Jeong Ha; Lee, Kwangha; Kim, Ki Uk; Park, Hye-Kyung; Lee, Min Ki] Pusan Natl Univ, Sch Med, Dept Internal Med, Busan, South Korea; [Eom, Jung Seop] Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea; [Kim, Ah Rong; Lee, Chang Hun] Pusan Natl Univ, Sch Med, Dept Pathol, Busan, South Korea; [Lee, Geewon] Pusan Natl Univ, Sch Med, Dept Radiol, Busan, South Korea	Pusan National University; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University	Eom, JS (corresponding author), Pusan Natl Univ, Sch Med, Dept Internal Med, Busan, South Korea.; Eom, JS (corresponding author), Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea.	ejspulm@gmail.com						Bonney A, 2016, J THORAC DIS, V8, P2551, DOI 10.21037/jtd.2016.08.85; Bonney A, 2016, ACTA CYTOL, V60, P74, DOI 10.1159/000444044; Chen CM, 2008, ACTA RADIOL, V49, P991, DOI 10.1080/02841850802294410; Eberhard DA, 2008, J CLIN ONCOL, V26, P983, DOI 10.1200/JCO.2007.12.9858; Eberhardt R, 2007, AM J RESP CRIT CARE, V176, P36, DOI 10.1164/rccm.200612-1866OC; Eom JS, RADIAL PROBE E UNPUB; Gould MK, 2013, CHEST, V143, pE93, DOI 10.1378/chest.12-2351; Han YX, 2017, CLIN CHEM LAB MED, V55, P1817, DOI 10.1515/cclm-2017-0112; Hayama M, 2015, RESPIRATION, V90, P129, DOI 10.1159/000431383; Ishida T, 2011, THORAX, V66, P1072, DOI 10.1136/thx.2010.145490; Jing CW, 2018, MOL MED REP, V18, P2191, DOI 10.3892/mmr.2018.9210; Kikuchi E, 2004, EUR RESPIR J, V24, P533, DOI 10.1183/09031936.04.00138603; Kim HR, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-50; Kurimoto N, 2004, CHEST, V126, P959, DOI 10.1378/chest.126.3.959; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lindeman NI, 2018, J MOL DIAGN, V20, P129, DOI 10.1016/j.jmoldx.2017.11.004; Lu CH, 2012, J THORAC ONCOL, V7, P143, DOI 10.1097/JTO.0b013e318233d7dd; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Moreira AL, 2014, CHEST, V146, P1649, DOI 10.1378/chest.14-0713; Reck M, 2013, LANCET, V382, P709, DOI 10.1016/S0140-6736(13)61502-0; Reck M, 2011, LUNG CANCER, V74, P1, DOI 10.1016/j.lungcan.2011.05.002; Rivera MP, 2013, CHEST, V143, pE142, DOI 10.1378/chest.12-2353; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Scagliotti GV, 2009, CURR OPIN ONCOL, V21, P99, DOI 10.1097/CCO.0b013e328321049e; Shigematsu H, 2006, INT J CANCER, V118, P257, DOI 10.1002/ijc.21496; Shinagawa N, 2009, J BRONCHOL INTERN PU, V16, P261, DOI 10.1097/LBR.0b013e3181bb8058; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Solomon BJ, 2014, NEW ENGL J MED, V371, P2167, DOI [10.1056/NEJMoa1408440, 10.1056/NEJMx150034]; Steinfort DP, 2011, EUR RESPIR J, V37, P902, DOI 10.1183/09031936.00075310; Steinfort DP, 2011, RESP MED, V105, P1704, DOI 10.1016/j.rmed.2011.08.008; Sun YH, 2010, J CLIN ONCOL, V28, P4616, DOI 10.1200/JCO.2010.29.6038; Tam AL, 2013, J THORAC ONCOL, V8, P436, DOI 10.1097/JTO.0b013e318287c91e; Tanaka T, 2007, CANCER SCI, V98, P246, DOI 10.1111/j.1349-7006.2006.00377.x; Travis WD, 2013, ARCH PATHOL LAB MED, V137, P668, DOI 10.5858/arpa.2012-0263-RA; VanderLaan PA, 2014, LUNG CANCER, V84, P39, DOI 10.1016/j.lungcan.2014.01.013; Wu YL, 2017, LUNG CANCER, V104, P119, DOI 10.1016/j.lungcan.2016.11.022; Xu XN, 2016, SCAND J CLIN LAB INV, V76, P386, DOI 10.1080/00365513.2016.1183813; Yang F, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-474; Yang JCH, 2015, LANCET ONCOL, V16, P141, DOI 10.1016/S1470-2045(14)71173-8; Yatabe Y, 2007, PATHOL INT, V57, P233, DOI 10.1111/j.1440-1827.2007.02098.x; Yeo CD, 2013, LUNG CANCER, V81, P207, DOI 10.1016/j.lungcan.2013.04.023; Yi ES, 2011, J THORAC ONCOL, V6, P459, DOI 10.1097/JTO.0b013e318209edb9	44	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0212672	10.1371/journal.pone.0212672	http://dx.doi.org/10.1371/journal.pone.0212672			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807604	gold, Green Published			2022-12-27	WOS:000459712100021
J	Ding, XH; Charnigo, RJ; Schmitt, FA; Kryscio, RJ; Abner, EL; Weiner, MW; Aisen, P; Weiner, M; Petersen, R; Jack, CR; Jagust, W; Trojanowki, JQ; Toga, AW; Beckett, L; Green, RC; Morris, J; Khachaturian, Z; Sorensen, G; Carrillo, M; Kuller, L; Raichle, M; Paul, S; Davies, P; Fillit, H; Hefti, F; Holtzman, D; Mesulam, MM; Snyder, P; Lilly, E; Logovinsky, V; Montine, T; Jimenez, G; Hergesheimer, L; Fox, N; Thompson, P; Schuff, N; Vemuri, P; Jones, D; Mathis, C; Franklin, E; Taylor-Reinwald, L; Thal, L; Thal, L; Buckholtz, N; Snyder, PJ; Potter, W; Frank, R; Hsiao, J; Quinn, J; Silbert, LC; Lind, B; Kaye, JA; Carter, R; Dolen, S; Teodoro, L; Spann, BM; Fleisher, A; Ziolkowski, J; Heidebrink, JL; Lord, JL; Mason, SS; Albers, CS; Knopman, D; Johnson, K; Villanueva-Meyer, J; Pavlik, V; Pacini, N; Lamb, A; Kass, JS; Doody, RS; Shibley, V; Chowdhury, M; Rountree, S; Dang, MM; Yeh, R; Ances, B; Winkfield, D; Carroll, M; Oliver, A; Creech, ML; Mintun, MA; Schneider, S; Marson, D; Geldmacher, D; Love, MN; Griffith, R; Clark, D; Brockington, J; Grossman, H; Mitsis, E; Lamar, M; Samuels, P; Greig-Custo, MT; Rodriguez, R; Albert, M; Onyike, C; D'Agostino, D; Kielb, S; Sadowski, M; Sheikh, MO; Singleton-Garvin, J; Ulysse, A; Gaikwad, M; Borges-Neto, S; Wong, TZ; Coleman, E; Karlawish, JH; Wolk, DA; Vaishnavi, S; Clark, CM; Arnold Steven, E; Smith, CD; Jicha, G; Hardy, P; El Khouli, R; Oates, E; Conrad, G; Lopez, OL; Oakley, M; Simpson, DM; Martin, K; Kowalksi, N; Keltz, M; Makino, KM; Ismail, MS; Brand, C; Thai, G; Pierce, A; Yanez, B; Sosa, E; Witbracht, M; Womack, K; Mathews, D; Quiceno, M; Levey, AI; Lah, JJ; Cellar, JS; Burns, JM; Swerdlow, RH; Brooks, WM; Woo, E; Silverman, DHS; Teng, E; Kremen, S; Apostolova, L; Tingus, K; Lu, PH; Bartzokis, G; Graff-Radford, NR; Parfitt, F; Poki-Walker, K; Farlow, MR; Hake, AM; Matthews, BR; Brosch, JR; Herring, S; van Dyck, CH; Carson, RE; Varma, P; Chertkow, H; Bergman, H; Hosein, C; Black, S; Stefanovic, B; Heyn, C; Hsiung, GYR; Mudge, B; Sossi, V; Feldman, H; Assaly, M; Pasternack, S; Pavlosky, W; Kertesz, A; Bernick, C; Munic, D; Mesulam, MM; Rogalski, E; Lipowski, K; Weintraub, S; Bonakdarpour, B; Kerwin, D; Wu, CK; Johnson, N; Johnson, K; Yesavage, J; Taylor, JL; Chao, S; Lane, B; Rosen, A; Tinklenberg, J; Zamrini, E; Belden, CM; Kowall, N; Killiany, R; Budson, AE; Norbash, A; Johnson, PL; Oyonumo, NE; Ogunlana, O; Lerner, A; Ogrocki, P; Tatsuoka, C; Fatica, P; Fletcher, E; Carmichael, O; Kittur, S; Borrie, M; Lee, TY; Bartha, R; Johnson, S; Asthana, S; Carlsson, CM; Tariot, P; Burke, A; Hetelle, J; DeMarco, K; Trncic, N; Fleisher, A; Reeder, S; Bates, V; Capot, H; Rainka, M; Scharre, DW; Kataki, M; Tarawneh, R; Zimmerman, EA; Celmins, D; Hart, D; Pearlson, GD; Blank, K; Anderson, K; Flashman, LA; Seltzer, M; Hynes, ML; Santulli, RB; Sink, KM; Yang, M; Mintz, A; Ott, BR; Tremont, G; Daiello, LA; Bodge, C; Salloway, S; Malloy, P; Correia, S; Lee, A; Rosen, HJ; Miller, BL; Spicer, K; Bachman, D; Finger, E; Pasternak, S; Rachinsky, I; Rogers, J; Kertesz, A; Drost, D; Pomara, N; Hernando, R; Sarrael, A; Miller, DD; Smith, KE; Koleva, H; Nam, KW; Shim, H; Schultz, SK; Relkin, N; Chiang, G; Lin, M; Ravdin, L; Smith, A; Leach, C; Raj, BA; Fargher, K; Grafman, J; Donohue, M; Neylan, T; Hayes, J; Finley, S; Foster, N; Reiman, EM; Chen, KW; Morris, JC; Cairns, NJ; Householder, E; Shaw, LM; Lee, V; Korecka, M; Figurski, M; Saykin, AJ; Potkin, S; Shen, L; Kim, S; Friedl, K; Schneider, LS; Pawluczyk, S; Becerra, M; Brewer, J; Vanderswag, H; Stern, Y; Honig, LS; Bell, KL; Fleischman, D; Arfanakis, K; Shah, RC; Duara, R; Varon, D; Greig, MT; Doraiswamy, PM; Petrella, JR; James, O; Porsteinsson, AP; Goldstein, B; Martin, KS; Potkin, SG; Preda, A; Nguyen, D; Mintzer, J; Massoglia, D; Brawman-Mintzer, O; Sadowsky, C; Martinez, W; Villena, T; Jagust, W; Rosen, H; Perry, D; Turner, RS; Behan, K; Reynolds, B; Sperling, RA; Johnson, KA; Marshall, G; Sabbagh, MN; Jacobson, SA; Sirrel, SA; Obisesan, TO; Wolday, S; Allard, J; Johnson, SC; Fruehling, JJ; Harding, S; Peskind, ER; Petrie, EC; Li, G; DeCarli, C; Drake, E; Raman, R; Donohue, M; Gessert, D; Harless, K; Cabrera, Y; Walter, S; Hergesheimer, L; Shaffer, E; Nelson, C; Bernstein, M; Borowski, B; Gunter, J; Senjem, M; Kantarci, K; Ward, C; Koeppe, RA; Landau, S; Crawford, K; Neu, S; Foroud, TM; Faber, KM; Nho, K; Nudelman, KN; Mackin, S; Rosen, H; Nelson, C; Bickford, D; Au, YH; Scherer, K; Stark, S; Ong, E; Fernandez, D; Butters, M; Zmuda, M				Ding, Xiuhua; Charnigo, Richard J.; Schmitt, Frederick A.; Kryscio, Richard J.; Abner, Erin L.; Weiner, Michael W.; Aisen, Paul; Weiner, Michael; Petersen, Ronald; Jack, Clifford R., Jr.; Jagust, William; Trojanowki, John Q.; Toga, Arthur W.; Beckett, Laurel; Green, Robert C.; Morris, John; Khachaturian, Zaven; Sorensen, Greg; Carrillo, Maria; Kuller, Lew; Raichle, Marc; Paul, Steven; Davies, Peter; Fillit, Howard; Hefti, Franz; Holtzman, David; Mesulam, M. Marcel; Snyder, Peter; Lilly, Eli; Logovinsky, Veronika; Montine, Tom; Jimenez, Gustavo; Hergesheimer, Lindsey; Fox, Nick; Thompson, Paul; Schuff, Norbert; Vemuri, Prashanthi; Jones, David; Mathis, Chet; Franklin, Erin; Taylor-Reinwald, Lisa; Thal, Lean; Thal, Leon; Buckholtz, Neil; Snyder, Peter J.; Potter, William; Frank, Richard; Hsiao, John; Quinn, Joseph; Silbert, Lisa C.; Lind, Betty; Kaye, Jeffrey A.; Carter, Raina; Dolen, Sara; Teodoro, Liberty; Spann, Bryan M.; Fleisher, Adam; Ziolkowski, Jaimie; Heidebrink, Judith L.; Lord, Joanne L.; Mason, Sara S.; Albers, Colleen S.; Knopman, David; Johnson, Kris; Villanueva-Meyer, Javier; Pavlik, Valory; Pacini, Nathaniel; Lamb, Ashley; Kass, Joseph S.; Doody, Rachelle S.; Shibley, Victoria; Chowdhury, Munir; Rountree, Susan; Dang, Mimi; Yeh, Randy; Ances, Beau; Winkfield, David; Carroll, Maria; Oliver, Angela; Creech, Mary L.; Mintun, Mark A.; Schneider, Stacy; Marson, Daniel; Geldmacher, David; Love, Marissa Natelson; Griffith, Randall; Clark, David; Brockington, John; Grossman, Hillel; Mitsis, Effie; Lamar, Melissa; Samuels, Patricia; Greig-Custo, Maria T.; Rodriguez, Rosemarie; Albert, Marilyn; Onyike, Chiadi; D'Agostino, Daniel, II; Kielb, Stephanie; Sadowski, Martin; Sheikh, Mohammed O.; Singleton-Garvin, Jamika; Ulysse, Anaztasia; Gaikwad, Mrunalini; Borges-Neto, Salvador; Wong, Terence Z.; Coleman, Edward; Karlawish, Jason H.; Wolk, David A.; Vaishnavi, Sanjeev; Clark, Christopher M.; Arnold, Steven E.; Smith, Charles D.; Jicha, Greg; Hardy, Peter; El Khouli, Riham; Oates, Elizabeth; Conrad, Gary; Lopez, Oscar L.; Oakley, MaryAnn; Simpson, Donna M.; Martin, Kim; Kowalksi, Nancy; Keltz, Melanie; Makino, Kelly M.; Ismail, M. Saleem; Brand, Connie; Thai, Gaby; Pierce, Aimee; Yanez, Beatriz; Sosa, Elizabeth; Witbracht, Megan; Womack, Kyle; Mathews, Dana; Quiceno, Mary; Levey, Allan I.; Lah, James J.; Cellar, Janet S.; Burns, Jeffrey M.; Swerdlow, Russell H.; Brooks, William M.; Woo, Ellen; Silverman, Daniel H. S.; Teng, Edmond; Kremen, Sarah; Apostolova, Liana; Tingus, Kathleen; Lu, Po H.; Bartzokis, George; Graff-Radford, Neill R.; Parfitt, Francine; Poki-Walker, Kim; Farlow, Martin R.; Hake, Ann Marie; Matthews, Brandy R.; Brosch, Jared R.; Herring, Scott; van Dyck, Christopher H.; Carson, Richard E.; Varma, Pradeep; Chertkow, Howard; Bergman, Howard; Hosein, Chris; Black, Sandra; Stefanovic, Bojana; Heyn, Chris (Chinthaka); Hsiung, Ging-Yuek Robin; Mudge, Benita; Sossi, Vesna; Feldman, Howard; Assaly, Michele; Pasternack, Stephen; Pavlosky, William; Kertesz, Andrew; Bernick, Charles; Munic, Donna; Mesulam, Marek-Marsel; Rogalski, Emily; Lipowski, Kristine; Weintraub, Sandra; Bonakdarpour, Borna; Kerwin, Diana; Wu, Chuang-Kuo; Johnson, Nancy; Johnson, Kathleen; Yesavage, Jerome; Taylor, Joy L.; Chao, Steven; Lane, Barton; Rosen, Allyson; Tinklenberg, Jared; Zamrini, Edward; Belden, Christine M.; Kowall, Neil; Killiany, Ronald; Budson, Andrew E.; Norbash, Alexander; Johnson, Patricia Lynn; Oyonumo, Ntekim E.; Ogunlana, Olu; Lerner, Alan; Ogrocki, Paula; Tatsuoka, Curtis; Fatica, Parianne; Fletcher, Evan; Carmichael, Owen; Kittur, Smita; Borrie, Michael; Lee, T-Y; Bartha, Rob; Johnson, Sterling; Asthana, Sanjay; Carlsson, Cynthia M.; Tariot, Pierre; Burke, Anna; Hetelle, Joel; DeMarco, Kathryn; Trncic, Nadira; Fleisher, Adam; Reeder, Stephanie; Bates, Vernice; Capote, Horacio; Rainka, Michelle; Scharre, Douglas W.; Kataki, Maria; Tarawneh, Rawan; Zimmerman, Earl A.; Celmins, Dzintra; Hart, David; Pearlson, Godfrey D.; Blank, Karen; Anderson, Karen; Flashman, Laura A.; Seltzer, Marc; Hynes, Mary L.; Santulli, Robert B.; Sink, Kaycee M.; Yang, Mia; Mintz, Akiva; Ott, Brian R.; Tremont, Geoffrey; Daiello, Lori A.; Bodge, Courtney; Salloway, Stephen; Malloy, Paul; Correia, Stephen; Lee, Athena; Rosen, Howard J.; Miller, Bruce L.; Spicer, Kenneth; Bachman, David; Finger, Elizabeth; Pasternak, Stephen; Rachinsky, Irina; Rogers, John; Kertesz, Andrew; Drost, Dick; Pomara, Nunzio; Hernando, Raymundo; Sarrael, Antero; Miller, Delwyn D.; Smith, Karen Ekstam; Koleva, Hristina; Nam, Ki Won; Shim, Hyungsub; Schultz, Susan K.; Relkin, Norman; Chiang, Gloria; Lin, Michael; Ravdin, Lisa; Smith, Amanda; Leach, Christi; Raj, Balebail Ashok; Fargher, Kristin; Grafman, Jordan; Donohue, Michael; Neylan, Thomas; Hayes, Jacqueline; Finley, Shannon; Foster, Norm; Reiman, Eric M.; Chen, Kewei; Morris, John C.; Cairns, Nigel J.; Householder, Erin; Shaw, Leslie M.; Lee, Virginia; Korecka, Magdalena; Figurski, Michal; Saykin, Andrew J.; Potkin, Steven; Shen, Li; Kim, Sungeun; Friedl, Karl; Schneider, Lon S.; Pawluczyk, Sonia; Becerra, Mauricio; Brewer, James; Vanderswag, Helen; Stern, Yaakov; Honig, Lawrence S.; Bell, Karen L.; Fleischman, Debra; Arfanakis, Konstantinos; Shah, Raj C.; Duara, Ranjan; Varon, Daniel; Greig, Maria T.; Doraiswamy, P. Murali; Petrella, Jeffrey R.; James, Olga; Porsteinsson, Anton P.; Goldstein, Bonnie; Martin, Kimberly S.; Potkin, Steven G.; Preda, Adrian; Nguyen, Dana; Mintzer, Jacobo; Massoglia, Dino; Brawman-Mintzer, Olga; Sadowsky, Carl; Martinez, Walter; Villena, Teresa; Jagust, William; Rosen, Howard; Perry, David; Turner, Raymond Scott; Behan, Kelly; Reynolds, Brigid; Sperling, Reisa A.; Johnson, Keith A.; Marshall, Gad; Sabbagh, Marwan N.; Jacobson, Sandra A.; Sirrel, Sherye A.; Obisesan, Thomas O.; Wolday, Saba; Allard, Joanne; Johnson, Sterling C.; Fruehling, J. Jay; Harding, Sandra; Peskind, Elaine R.; Petrie, Eric C.; Li, Gail; DeCarli, Charles; Drake, Erin; Raman, Rema; Donohue, Mike; Gessert, Devon; Harless, Kelly; Cabrera, Yuliana; Walter, Sarah; Hergesheimer, Lindsey; Shaffer, Elizabeth; Nelson, Craig; Bernstein, Matthew; Borowski, Bret; Gunter, Jeff; Senjem, Matt; Kantarci, Kejal; Ward, Chad; Koeppe, Robert A.; Landau, Susan; Crawford, Karen; Neu, Scott; Foroud, Tatiana M.; Faber, Kelley M.; Nho, Kwangsik; Nudelman, Kelly N.; Mackin, Scott; Rosen, Howard; Nelson, Craig; Bickford, David; Au, Yiu Ho; Scherer, Kelly; Stark, Samuel; Ong, Elise; Fernandez, Dariella; Butters, Meryl; Zmuda, Michelle		Alzheimer's Dis Neuroimaging Initi	Evaluating trajectories of episodic memory in normal cognition and mild cognitive impairment: Results from ADNI	PLOS ONE			English	Article							VERBAL-LEARNING TEST; ALZHEIMERS-DISEASE; DIAGNOSIS; DEMENTIA; DECLINE; PROGRESSION	Background Memory assessment is a key factor for the diagnosis of cognitive impairment. However, memory performance over time may be quite heterogeneous within diagnostic groups. Method To identify latent trajectories in memory performance and their associated risk factors, we analyzed data from Alzheimer's Disease Neuroimaging Initiative (ADNI) participants who were classified either as cognitively normal or as Mild Cognitive Impairment (MCI) at baseline and were administered the Rey Auditory Verbal Learning test (RAVLT) for up to 9 years. Group-based trajectory modeling on the 30-minute RAVLT delayed recall score was applied separately to the two baseline diagnostic groups. Results There were 219 normal subjects with mean age 75.9 (range from 59.9 to 89.6) and 52.5% male participants, and 372 MCI subjects with mean age 74.8 (range from 55.1 to 89.3) and 63.7% male participants included in the analysis. For normal subjects, six trajectories were identified. Trajectories were classified into three types, determined by the shape, each of which may comprise more than one trajectory: stable (similar to 30% of subjects), curvilinear decline (similar to 28%), and linear decline (similar to 42%). Notably, none of the normal subjects assigned to the stable stratum progressed to dementia during the study period. In contrast, all trajectories identified for the MCI group tended to decline, although some participants were later re-diagnosed with normal cognition. Age, sex, and education were significantly associated with trajectory membership for both diagnostic groups, while APOE epsilon 4 was only significantly associated with trajectories among MCI participants. Conclusion Memory trajectory is a strong indicator of dementia risk. If likely trajectory of memory performance can be identified early, such work may allow clinicians to monitor or predict progression of individual patient cognition. This work also shows the importance of longitudinal cognitive testing and monitoring.	[Ding, Xiuhua] Western Kentucky Univ, Dept Publ Hlth, Bowling Green, KY 42101 USA; [Charnigo, Richard J.; Kryscio, Richard J.] Univ Kentucky, Dept Stat, Lexington, KY USA; [Charnigo, Richard J.; Kryscio, Richard J.; Abner, Erin L.] Univ Kentucky, Dept Biostat, Lexington, KY USA; [Schmitt, Frederick A.; Kryscio, Richard J.; Abner, Erin L.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Schmitt, Frederick A.] Univ Kentucky, Dept Neurol, Lexington, KY 40536 USA; [Abner, Erin L.] Univ Kentucky, Dept Epidemiol, Lexington, KY USA; [Weiner, Michael W.; Weiner, Michael; Rosen, Howard J.; Miller, Delwyn D.; Hayes, Jacqueline; Finley, Shannon; Nelson, Craig] UC San Francisco, San Francisco, CA USA; [Aisen, Paul; Toga, Arthur W.; Teodoro, Liberty; Spann, Bryan M.; Donohue, Mike] Univ Southern Calif, Los Angeles, CA 90089 USA; [Petersen, Ronald; Jack, Clifford R., Jr.; Vemuri, Prashanthi; Jones, David; Mason, Sara S.; Albers, Colleen S.; Knopman, David; Johnson, Kris] Mayo Clin, Rochester, MN USA; [Jagust, William] Univ Calif Berkeley, Berkeley, CA USA; [Trojanowki, John Q.; Clark, David; Karlawish, Jason H.; Wolk, David A.; Vaishnavi, Sanjeev; Arnold, Steven E.] Univ Penn, Philadelphia, PA 19104 USA; [Toga, Arthur W.; Jimenez, Gustavo; Hergesheimer, Lindsey; Shaffer, Elizabeth] USC, Los Angeles, CA USA; [Beckett, Laurel] Univ Calif Davis, Davis, CA USA; [Green, Robert C.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA; [Farlow, Martin R.; Hake, Ann Marie; Matthews, Brandy R.; Brosch, Jared R.; Herring, Scott] Indiana Univ, Bloomington, IN 47405 USA; [Morris, John; Raichle, Marc; Holtzman, David; Montine, Tom; Franklin, Erin; Taylor-Reinwald, Lisa; Ances, Beau; Winkfield, David; Carroll, Maria; Oliver, Angela; Creech, Mary L.; Mintun, Mark A.; Schneider, Stacy; Householder, Erin] Washington Univ, St Louis, MO 63130 USA; [Khachaturian, Zaven] Prevent Alzheimers Dis 2020, Rockville, MD USA; [Sorensen, Greg] Siemens, Munich, Germany; [Carrillo, Maria] Alzheimers Assoc, Chicago, IL USA; [Kuller, Lew; Mathis, Chet; Lopez, Oscar L.; Oakley, MaryAnn; Simpson, Donna M.] Univ Pittsburgh, Pittsburgh, PA 15260 USA; [Paul, Steven; Relkin, Norman; Chiang, Gloria; Lin, Michael; Ravdin, Lisa] Cornell Univ, Ithaca, NY 14853 USA; [Davies, Peter] Yeshiva Univ, Albert Einstein Col Med, New York, NY 10033 USA; [Fillit, Howard] AD Drug Discovery Fdn, New York, NY USA; [Hefti, Franz] Acumen Pharmceut, Livermore, CA USA; [Mesulam, M. Marcel; Mesulam, Marek-Marsel; Rogalski, Emily; Lipowski, Kristine; Weintraub, Sandra] Northwestern Univ, Evanston, IL 60208 USA; NIMH, Rockville, MD 20852 USA; [Snyder, Peter; Snyder, Peter J.] Brown Univ, Providence, RI 02912 USA; [Green, Robert C.; Drake, Erin] HMS, BWH, Boston, MA USA; [Montine, Tom; Peskind, Elaine R.; Petrie, Eric C.; Li, Gail] Univ Washington, Seattle, WA 98195 USA; [Thal, Lean; Thal, Leon] Univ Calif San Diego, La Jolla, CA USA; [Fox, Nick] Univ London, London, England; [Thompson, Paul] Univ Calif Los Angeles, Sch Med, Los Angeles, CA 90024 USA; [Schuff, Norbert] UCSF, MRI, San Francisco, CA USA; [Ziolkowski, Jaimie; Heidebrink, Judith L.; Lord, Joanne L.] Univ Michigan, Ann Arbor, MI 48109 USA; Univ Utah, Salt Lake City, UT 84112 USA; [Fleisher, Adam; Tingus, Kathleen; Burke, Anna; Hetelle, Joel; Trncic, Nadira; Reeder, Stephanie] Banner Alzheimers Inst, Phoenix, AZ USA; [Trojanowki, John Q.] UPenn Sch Med, Philadelphia, PA USA; UC Irvine, Irvine, CA USA; [Buckholtz, Neil; Hsiao, John] NIA, Bethesda, MD 20892 USA; [Onyike, Chiadi; D'Agostino, Daniel, II; Kielb, Stephanie] Johns Hopkins Univ, Baltimore, MD 21218 USA; [Frank, Richard] Richard Frank Consulting, Sacramento, CA USA; [Quinn, Joseph; Silbert, Lisa C.; Lind, Betty; Kaye, Jeffrey A.; Carter, Raina; Dolen, Sara] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Ziolkowski, Jaimie; Heidebrink, Judith L.; Lord, Joanne L.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Villanueva-Meyer, Javier; Pavlik, Valory; Pacini, Nathaniel; Lamb, Ashley; Kass, Joseph S.; Doody, Rachelle S.; Shibley, Victoria; Chowdhury, Munir; Rountree, Susan; Dang, Mimi] Baylor Coll Med, Houston, TX 77030 USA; [Yeh, Randy] Columbia Univ, Med Ctr, New York, NY 10027 USA; [Marson, Daniel; Geldmacher, David; Love, Marissa Natelson; Griffith, Randall; Clark, David] Univ Alabama Birmingham, Birmingham, AL USA; [Grossman, Hillel; Mitsis, Effie] Mt Sinai Sch Med, New York, NY USA; [Lamar, Melissa; Samuels, Patricia; Fleischman, Debra; Arfanakis, Konstantinos] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Greig-Custo, Maria T.; Rodriguez, Rosemarie; Varon, Daniel; Greig, Maria T.] Wien Ctr, Vienna, Austria; [Sadowski, Martin; Sheikh, Mohammed O.; Singleton-Garvin, Jamika; Ulysse, Anaztasia; Gaikwad, Mrunalini] NYU, New York, NY 10003 USA; [Borges-Neto, Salvador; Wong, Terence Z.; Coleman, Edward] Duke Univ, Med Ctr, Durham, NC 27706 USA; [Smith, Charles D.; Jicha, Greg; Hardy, Peter; El Khouli, Riham; Oates, Elizabeth; Conrad, Gary] Univ Kentucky, Lexington, KY 40506 USA; [Martin, Kim; Kowalksi, Nancy; Keltz, Melanie] Univ Rochester, Med Ctr, Rochester, NY 14627 USA; [Thai, Gaby; Pierce, Aimee; Yanez, Beatriz; Sosa, Elizabeth; Witbracht, Megan] Univ Calif Irvine, IMIND, Irvine, CA 92717 USA; [Womack, Kyle; Mathews, Dana; Quiceno, Mary] Univ Texas Southwestern Med Sch, Dallas, TX USA; [Levey, Allan I.; Lah, James J.; Cellar, Janet S.] Emory Univ, Atlanta, GA 30322 USA; [Burns, Jeffrey M.; Swerdlow, Russell H.; Brooks, William M.] Univ Kansas, Med Ctr, Lawrence, KS 66045 USA; [Woo, Ellen; Silverman, Daniel H. S.; Teng, Edmond; Kremen, Sarah; Apostolova, Liana; Tingus, Kathleen; Bartzokis, George] Univ Calif Los Angeles, Los Angeles, CA 90024 USA; [Graff-Radford, Neill R.; Parfitt, Francine; Poki-Walker, Kim] Mayo Clin, Jacksonville, AL USA; [van Dyck, Christopher H.; Carson, Richard E.; Varma, Pradeep] Yale Univ, Sch Med, New Haven, CT 06520 USA; [Chertkow, Howard; Bergman, Howard; Hosein, Chris] McGill Univ, Montreal Jewish Gen Hosp, Montreal, PQ, Canada; [Black, Sandra; Stefanovic, Bojana; Heyn, Chris (Chinthaka)] Sunnybrook Hlth Sci, Toronto, ON, Canada; [Hsiung, Ging-Yuek Robin; Mudge, Benita; Sossi, Vesna; Feldman, Howard; Assaly, Michele] UBC Clin AD & Related Disorders, Vancouver, BC, Canada; [Pasternack, Stephen; Pavlosky, William; Kertesz, Andrew] Cognit Neurol St Josephs, London, ON, Canada; [Bernick, Charles; Munic, Donna] Cleveland Clin, Lou Ruvo Ctr Brain Hlth, Cleveland, OH 44106 USA; [Martinez, Walter] Premiere Res Inst, Palm Beac Neurol, W Palm Beach, FL USA; [Johnson, Kathleen] Georgetown Univ, Med Ctr, Washington, DC 20057 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; [Yesavage, Jerome; Taylor, Joy L.; Chao, Steven; Lane, Barton; Rosen, Allyson; Tinklenberg, Jared; Relkin, Norman; Chiang, Gloria; Ravdin, Lisa] Stanford Univ, Stanford, CA 94305 USA; [Zamrini, Edward; Belden, Christine M.; Sabbagh, Marwan N.; Jacobson, Sandra A.] Banner Sun Hlth Res Inst, Sun City, AZ USA; [Kowall, Neil; Killiany, Ronald; Budson, Andrew E.; Norbash, Alexander; Johnson, Patricia Lynn] Boston Univ, Boston, MA 02215 USA; [Oyonumo, Ntekim E.; Ogunlana, Olu; Wolday, Saba] Howard Univ, Washington, DC 20059 USA; [Lerner, Alan; Ogrocki, Paula; Tatsuoka, Curtis; Fatica, Parianne] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Ogrocki, Paula; Tatsuoka, Curtis; Fatica, Parianne; Fletcher, Evan] Univ Calif Davis, Sacramento, CA 95817 USA; [Kittur, Smita] Neurol Care CNY, Liverpool, Merseyside, England; [Borrie, Michael; Lee, T-Y; Bartha, Rob] Parkwood Inst, London, ON, Canada; [Johnson, Patricia Lynn; Carlsson, Cynthia M.; Fruehling, J. Jay; Harding, Sandra] Univ Wisconsin, Madison, WI 53706 USA; [Bates, Vernice; Capote, Horacio; Rainka, Michelle] DENT Neurol Inst, Amherst, NY USA; [Scharre, Douglas W.; Kataki, Maria; Tarawneh, Rawan] Ohio State Univ, Columbus, OH 43210 USA; [Zimmerman, Earl A.; Celmins, Dzintra; Hart, David] Albany Med Coll, Albany, NY 12208 USA; [Pearlson, Godfrey D.; Blank, Karen; Anderson, Karen] Hartford Hosp, Olin Neuropsychiat Res Ctr, Hartford, CT 06115 USA; [Flashman, Laura A.; Seltzer, Marc; Hynes, Mary L.; Santulli, Robert B.] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA; [Sink, Kaycee M.; Yang, Mia; Mintz, Akiva] Wakr Forest Univ Hlth Sci, Winston Salem, NC USA; [Ott, Brian R.; Tremont, Geoffrey; Daiello, Lori A.] Rhode Isl Hosp, Providence, RI 02903 USA; [Bodge, Courtney; Salloway, Stephen; Malloy, Paul; Correia, Stephen; Lee, Athena] Butler Hosp, Providence, RI 02906 USA; [Spicer, Kenneth; Bachman, David; Massoglia, Dino; Brawman-Mintzer, Olga] Med Univ South Carolina, Charleston, SC 29425 USA; [Kertesz, Andrew; Pasternak, Stephen; Rogers, John] St Josephs Hlth Care, Toronto, ON, Canada; [Pomara, Nunzio; Hernando, Raymundo; Sarrael, Antero] Nathan S Kline Inst Psychiat Res, Orangeburg, NY USA; [Miller, Delwyn D.; Smith, Karen Ekstam; Koleva, Hristina; Nam, Ki Won; Shim, Hyungsub; Schultz, Susan K.] Univ Iowa, Coll Med, Iowa City, IA 52242 USA; [Smith, Amanda; Leach, Christi; Raj, Balebail Ashok; Fargher, Kristin] Univ S Florida, USF Hlth Byrd Alzheimers Inst, Tampa, FL 33620 USA; [Weiner, Michael W.; Jagust, William; Rosen, Howard; Behan, Kelly; Nelson, Craig; Au, Yiu Ho; Scherer, Kelly; Stark, Samuel; Ong, Elise; Fernandez, Dariella] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Trojanowki, John Q.] UPenn, Perelman Sch Med, Philadelphia, PA USA; [Trojanowki, John Q.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Grafman, Jordan] Northwestern Univ, Feinberg Sch Med, Rehabil Inst Chicago, Evanston, IL 60208 USA; [Friedl, Karl] Dept Def, Evanston, IL USA; [Potkin, Steven G.; Preda, Adrian; Nguyen, Dana] Univ Calif Irvine, Irvine, CA 92717 USA	Western Kentucky University; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of California System; University of California San Francisco; University of Southern California; Mayo Clinic; University of California System; University of California Berkeley; University of Pennsylvania; University of Southern California; University of California System; University of California Davis; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Indiana University System; Indiana University Bloomington; Washington University (WUSTL); Siemens AG; Siemens Germany; Alzheimer's Association; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cornell University; Yeshiva University; Northwestern University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Brown University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Washington; University of Washington Seattle; University of California System; University of California San Diego; University of London; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Francisco; University of Michigan System; University of Michigan; Utah System of Higher Education; University of Utah; Banner Research; Banner Health; Banner Alzheimer's Institute; University of California System; University of California Irvine; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University; Oregon Health & Science University; University of California System; University of California San Diego; Baylor College of Medicine; Columbia University; University of Alabama System; University of Alabama Birmingham; Icahn School of Medicine at Mount Sinai; Rush University; New York University; Duke University; University of Kentucky; University of Rochester; University of California System; University of California Irvine; Emory University; University of Kansas; University of Kansas Medical Center; University of California System; University of California Los Angeles; Mayo Clinic; Yale University; McGill University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of British Columbia; Cleveland Clinic Foundation; Georgetown University; Harvard University; Brigham & Women's Hospital; Stanford University; Banner Research; Banner Health; Banner Sun Health Research Institute; Boston University; Howard University; Case Western Reserve University; University of California System; University of California Davis; University of Wisconsin System; University of Wisconsin Madison; University System of Ohio; Ohio State University; Albany Medical College; Hartford Hospital; Dartmouth College; Lifespan Health Rhode Island; Rhode Island Hospital; Butler Hospital Rhode Island; Medical University of South Carolina; University of Toronto; University Toronto Affiliates; Saint Joseph's Health Centre, Toronto; Nathan Kline Institute for Psychiatric Research; University of Iowa; State University System of Florida; University of South Florida; University of California System; University of California San Francisco; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Northwestern University; Feinberg School of Medicine; Shirley Ryan AbilityLab; United States Department of Defense; University of California System; University of California Irvine	Ding, XH (corresponding author), Western Kentucky Univ, Dept Publ Hlth, Bowling Green, KY 42101 USA.	xiuhua.ding@wku.edu	Cairns, Nigel/AAB-9713-2020; Jack, Clifford R/F-2508-2010; Jagust, William/ABE-6426-2020; Shah, Raj/AAS-2210-2021; Paul, Steve/ABE-5400-2020; DeCarli, Charles/B-5541-2009; Thompson, Paul M/C-4194-2018; Vaishnavi, Sanjeev/AGU-9275-2022; Preda, Adrian/K-8889-2013; Nudelman, Kelly/AFM-1022-2022; Killiany, Ronald/Y-7251-2019; Jimenez-Maggiora, Gustavo A/V-6341-2019; Fox, Nick C/B-1319-2009; Levey, Allan/F-2104-2011; Snyder, Peter J./W-2609-2019; Butters, Meryl/AAR-2863-2021; Kass, Joseph/AAM-7392-2020	Cairns, Nigel/0000-0001-9858-3344; Jack, Clifford R/0000-0001-7916-622X; Shah, Raj/0000-0001-9706-9730; Thompson, Paul M/0000-0002-4720-8867; Vaishnavi, Sanjeev/0000-0002-6288-250X; Preda, Adrian/0000-0003-3373-2438; Killiany, Ronald/0000-0003-4740-2181; Jimenez-Maggiora, Gustavo A/0000-0001-9745-5121; Fox, Nick C/0000-0002-6660-657X; Levey, Allan/0000-0002-3153-502X; 	Alzheimer's Disease Neuroimaging Initiative (ADNI) (NIH) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on Aging (NIA) [NIA P30 AG028383]; NATIONAL INSTITUTE ON AGING [R01AG038651, P30AG028383] Funding Source: NIH RePORTER	Alzheimer's Disease Neuroimaging Initiative (ADNI) (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD ADNI (Department of Defense); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Data collection and sharing for this project were funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (NIH Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). This study was also supported by National Institute on Aging (NIA) NIA P30 AG028383.	Abner EL, 2017, ANN NEUROL, V81, P549, DOI 10.1002/ana.24903; [Anonymous], 2005, GROUP BASED MODELING; Barzotti T, 2004, ARCH GERONTOL GERIAT, P57; Carcaillon L, 2007, DEMENT GERIATR COGN, V23, P439, DOI 10.1159/000102017; Chang YL, 2010, NEUROPSYCHOLOGIA, V48, P1237, DOI 10.1016/j.neuropsychologia.2009.12.024; Eckerstrom C, 2013, J ALZHEIMERS DIS, V36, P421, DOI 10.3233/JAD-122440; Ferman TJ, 2006, CLIN NEUROPSYCHOL, V20, P623, DOI 10.1080/13854040500376831; Gauthier S, 2006, LANCET, V367, P1262, DOI 10.1016/S0140-6736(06)68542-5; Gauthier Serge, 2006, Alzheimers Dement, V2, P210, DOI 10.1016/j.jalz.2006.03.002; Hamdan S.S.M.a.A.C, 2010, PSYCHOL NEUROSCI, V3, P7; Hui JS, 2003, NEUROLOGY, V61, P1356, DOI 10.1212/01.WNL.0000094327.68399.59; John DeLuca, ENCY CLIN NEUROPSYCH, P2174; Jones BL, 2001, SOCIOL METHOD RES, V29; Klekociuk SZ, 2014, EUR J NEUROL, V21, P470, DOI 10.1111/ene.12333; Levin A. P. A. S. J, 2012, PSYCHOL NEUROSCI, V5; Lin Katherine A, 2015, Alzheimers Dement (N Y), V1, P103; Loring D. W, 2004, NEUROPSYCHOLIGICAL A; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Messinis L, 2016, J CLIN EXP NEUROPSYC, V38, P23, DOI 10.1080/13803395.2015.1085496; Mitchell AJ, 2009, ACTA PSYCHIAT SCAND, V119, P252, DOI 10.1111/j.1600-0447.2008.01326.x; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; Nagin DS, 2005, GROUP BASED MODELING; Palmer K, 2003, ACTA NEUROL SCAND, V107, P14, DOI 10.1034/j.1600-0404.107.s179.2.x; Pietrzak RH, 2015, NEUROBIOL AGING, V36, P1231, DOI 10.1016/j.neurobiolaging.2014.12.015; Roeder B. L. J. D. S. N. K, 2001, SOCIOLOGICAL METHODS, V29, P10; Roeder Kathryn L. K. G, 1999, J AM STAT ASSOC, V94, P11; Schmidt M., 1996, W PSYCHOL SERVICES; Soto ME, 2008, J NUTR HEALTH AGING, V12, P703; Tierney MC, 2010, J ALZHEIMERS DIS, V22, P1231, DOI 10.3233/JAD-2010-100516; Weiner MW, 2010, ALZHEIMERS DEMENT, V6, P202, DOI 10.1016/j.jalz.2010.03.007; Wolf H, 1998, J NEURAL TRANSM-SUPP, P31; Xie HQ, 2011, DEMENT GERIATR COGN, V31, P165, DOI 10.1159/000323568; Zahodne LB, 2016, J ALZHEIMERS DIS, V52, P1013, DOI 10.3233/JAD-151114; Zhao QH, 2015, CURR ALZHEIMER RES, V12, P520, DOI 10.2174/1567205012666150530202729	34	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2019	14	2							e0212435	10.1371/journal.pone.0212435	http://dx.doi.org/10.1371/journal.pone.0212435			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8EH	30802256	Green Published, gold, Green Submitted			2022-12-27	WOS:000459710700013
J	Steinke, J; Mgimiloko, MG; Graef, F; Hammond, J; van Wijk, MT; van Etten, J				Steinke, Jonathan; Mgimiloko, Majuto Gaspar; Graef, Frieder; Hammond, James; van Wijk, Mark T.; van Etten, Jacob			Prioritizing options for multi-objective agricultural development through the Positive Deviance approach	PLOS ONE			English	Article							CLIMATE-SMART AGRICULTURE; SUSTAINABLE INTENSIFICATION; SYSTEMS; FOOD; AFRICA; ADOPTION; INFORMATION; INNOVATION; NUTRITION; SCIENCE	Agricultural development must integrate multiple objectives at the same time, including food security, income, and environmental sustainability. To help achieve these objectives, development practitioners need to prioritize concrete livelihood practices to promote to rural households. But trade-offs between objectives can lead to dilemmas in selecting practices. In addition, heterogeneity among farming households requires targeting different strategies to different types of households. Existing diversity of household resources and activities, however, may also bear solutions. We explored a new, empirical research method that identifies promising options for multi-objective development by focusing on existing cases of strong multi-dimensional household performance. The "Positive Deviance" approach signifies identifying locally viable livelihood practices from diverse households that achieve stronger performance than comparable households in the same area. These practices are promising for other local households in comparable resource contexts. The approach has been used in other domains, such as child nutrition, but has not yet been fully implemented for agricultural development with a focus on the simultaneous achievement of multiple objectives. To test our adapted version of the Positive Deviance approach, we used a quantitative survey of over 500 rural households in South-Eastern Tanzania. We identified 54 households with outstanding relative performance regarding five key development dimensions (food security, income, nutrition, environmental sustainability, and social equity). We found that, compared to other households with similar resource levels, these "positive deviants" performed strongest for food security, but only slightly better for social equity. We then re-visited a diverse sub-sample for qualitative interviews, and identified 14 uncommon, "deviant" practices that plausibly contributed to the households' superior outcomes. We illustrate how these practices can inform specific recommendations of practices for other local households in comparable resource contexts. The study demonstrates how, with the Positive Deviance approach, empirical observations of individual, outstanding households can inform discussions about locally viable agricultural development solutions in diverse household context.	[Steinke, Jonathan; van Etten, Jacob] CGIAR Res Program Roots Tubers & Bananas, Biovers Int, Turrialba, Costa Rica; [Steinke, Jonathan] Humboldt Univ, Hort Econ, Berlin, Germany; [Steinke, Jonathan; Graef, Frieder] Leibniz Ctr Agr Landscape Res ZALF, Sustainable Land Use Dev Countries, Muncheberg, Germany; [Mgimiloko, Majuto Gaspar] Tanzania Agr Res Inst, Naliendele, Tanzania; [Hammond, James; van Wijk, Mark T.] Int Livestock Res Inst, Livestock Syst & Environm, Nairobi, Kenya	Alliance; Bioversity International; CGIAR; Humboldt University of Berlin; Leibniz Zentrum fur Agrarlandschaftsforschung (ZALF); CGIAR; International Livestock Research Institute (ILRI)	Steinke, J (corresponding author), CGIAR Res Program Roots Tubers & Bananas, Biovers Int, Turrialba, Costa Rica.; Steinke, J (corresponding author), Humboldt Univ, Hort Econ, Berlin, Germany.; Steinke, J (corresponding author), Leibniz Ctr Agr Landscape Res ZALF, Sustainable Land Use Dev Countries, Muncheberg, Germany.	j.steinke@cgiar.org		Steinke, Jonathan/0000-0001-5742-702X; van Etten, Jacob/0000-0001-7554-2558	UK aid from the UK government through the Sustainable Agricultural Intensification Research and Learning in Africa programme (SAIRLA)	UK aid from the UK government through the Sustainable Agricultural Intensification Research and Learning in Africa programme (SAIRLA)	This research was undertaken as part of the CGIAR Research Program on Roots, Tubers and Bananas (RTB). This research has been funded by UK aid from the UK government through the Sustainable Agricultural Intensification Research and Learning in Africa programme (SAIRLA); however the views expressed do not necessarily reflect the UK government's official policies. See sairla.nri.org for more information. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2006, IPCC GUIDELINES NATL; Berre D, 2019, EXP AGR, V55, P191, DOI 10.1017/S0014479716000727; Biggs S, 2008, EXP AGR, V44, P37, DOI 10.1017/S0014479707005959; Brookfield H., 2003, AGRODIVERSITY LEARNI; Bullen PAB, 2011, TROP MED INT HEALTH, V16, P1354, DOI 10.1111/j.1365-3156.2011.02839.x; Carberry P., 2004, ACIAR P, V114, P32; Corbeels M, 2014, AGR ECOSYST ENVIRON, V187, P155, DOI 10.1016/j.agee.2013.10.011; Cornwall A, 2003, WORLD DEV, V31, P1325, DOI 10.1016/S0305-750X(03)00086-X; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Desiere S, 2018, J DEV ECON, V130, P84, DOI 10.1016/j.jdeveco.2017.10.002; Frelat R, 2016, P NATL ACAD SCI USA, V113, P458, DOI 10.1073/pnas.1518384112; Garnett T, 2013, SCIENCE, V341, P33, DOI 10.1126/science.1234485; Genius M, 2014, AM J AGR ECON, V96, P328, DOI 10.1093/ajae/aat054; Gladwin CH, 2002, WORLD DEV, V30, P523, DOI 10.1016/S0305-750X(02)00002-5; Godfray HCJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0273; Graef F, 2015, OUTLOOK AGR, V44, P159, DOI 10.5367/oa.2015.0206; Groot JCJ, 2012, AGR SYST, V110, P63, DOI 10.1016/j.agsy.2012.03.012; Hammond J, 2017, AGR SYST, V151, P225, DOI 10.1016/j.agsy.2016.05.003; Hammond RA, 2012, P NATL ACAD SCI USA, V109, P12356, DOI 10.1073/pnas.0913003109; Hartung C., 2010, OPEN DATA KIT TOOLS; Humphreys M, 2006, WORLD POLIT, V58, P583, DOI 10.1353/wp.2007.0008; Khatri-Chhetri A, 2017, AGR SYST, V151, P184, DOI 10.1016/j.agsy.2016.10.005; Klapwijk CJ, 2014, CURR OPIN ENV SUST, V6, P110, DOI 10.1016/j.cosust.2013.11.012; Knight J, 2003, J DEV STUD, V39, P1, DOI 10.1080/00220380312331293567; Lipper L, 2014, NAT CLIM CHANGE, V4, P1068, DOI [10.1038/NCLIMATE2437, 10.1038/nclimate2437]; Marsh DR, 2002, FOOD NUTR B S, V23, P34; Megersa B, 2014, FOOD SECUR, V6, P15, DOI 10.1007/s12571-013-0314-4; Modernel P, 2018, ECOL INDIC, V89, P755, DOI 10.1016/j.ecolind.2018.01.038; Murdock LL, 2014, J STORED PROD RES, V58, P3, DOI 10.1016/j.jspr.2014.02.006; Mwongera C, 2017, AGR SYST, V151, P192, DOI 10.1016/j.agsy.2016.05.009; Nelson R, 2019, EXP AGR, V55, P125, DOI 10.1017/S0014479716000454; Noltze M, 2012, AGR SYST, V108, P64, DOI 10.1016/j.agsy.2012.01.003; Ochieng CMO, 2007, WORLD DEV, V35, P454, DOI 10.1016/j.worlddev.2006.04.003; Panel Montpellier, 2013, SUST INT NEW PAR AFR; Pant LP., 2009, KNOWLEDGE MANAGEMENT, V5, P160, DOI DOI 10.1080/18716340903201504; Pauw K, 2011, FOOD POLICY, V36, P795, DOI 10.1016/j.foodpol.2011.09.002; Perfect J., 2010, LIVELIHOOD ZONES ANA; Peterman A, 2010, 1111 ESA FAO; Pretty J, 2008, PHILOS T R SOC B, V363, P447, DOI 10.1098/rstb.2007.2163; Pretty J, 2011, INT J AGR SUSTAIN, V9, P5, DOI 10.3763/ijas.2010.0583; R Core Team, 2018, R LANG ENV STAT COMP; Rockstrom J, 2017, AMBIO, V46, P4, DOI 10.1007/s13280-016-0793-6; Schindler J, 2016, AGR SYST, V148, P38, DOI 10.1016/j.agsy.2016.07.002; Schreinemachers P, 2011, ENVIRON MODELL SOFTW, V26, P845, DOI 10.1016/j.envsoft.2011.02.004; Smith A, 2017, GLOB FOOD SECUR-AGR, V12, P127, DOI 10.1016/j.gfs.2016.11.002; Smith P, 2008, PHILOS T R SOC B, V363, P789, DOI 10.1098/rstb.2007.2184; Snapp SS, 2018, AGR SYST, V162, P77, DOI 10.1016/j.agsy.2018.01.012; STASSER G, 1985, J PERS SOC PSYCHOL, V48, P1467, DOI 10.1037/0022-3514.48.6.1467; Sternin M., 1998, DESIGNING COMMUNITY; Sumberg J, 2003, AGR SYST, V76, P739, DOI 10.1016/S0308-521X(02)00153-1; Swindale A., 2006, FHI 360FANTA; Tavenner K, 2019, FRONT SUSTAIN FOOD S; Van Etten J, 2019, EXP AGR, V55, P275, DOI 10.1017/S0014479716000739; van Ginkel M, 2013, FOOD SECUR, V5, P751, DOI 10.1007/s12571-013-0305-5; WATSON I, 1994, KNOWL ENG REV, V9, P327, DOI 10.1017/S0269888900007098; Weisell R, 2012, FOOD NUTR BULL, V33, pS157, DOI 10.1177/15648265120333S203; Woodward SJR, 2008, NEW ZEAL J AGR RES, V51, P235, DOI 10.1080/00288230809510452	58	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2019	14	2							e0212926	10.1371/journal.pone.0212926	http://dx.doi.org/10.1371/journal.pone.0212926			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8EH	30802269	Green Submitted, Green Published, gold			2022-12-27	WOS:000459710700026
J	Aasvold, LO; Ettema, G; Skovereng, K				Aasvold, Lorents Ola; Ettema, Gertjan; Skovereng, Knut			Joint specific power production in cycling: The effect of cadence and intensity	PLOS ONE			English	Article							MUSCLE; GASTROCNEMIUS; VELOCITY; FORCE	Background The effect of cadence and work rate on the joint specific power production in cycling has previously been studied, but research has primarily focused on cadences above 60 rpm, without examining the effect of low cadence on joint contribution to power. Purpose Our purpose was to investigate joint specific power production in recreational and elite cyclists during low-and moderate cycling at a range of different cadences. Methods 18 male cyclists (30.9 +/- 2.7 years with a work rate in watt at lactate threshold of 282.3 +/- 9.3 W) performed cycling bouts at seven different pedalling rates and three intensities. Joint specific power was calculated from kinematic measurements and pedal forces using inverse dynamics at a total of 21 different stages. Results A main effect of cadence on the relative to the total joint power for hip-, knee-and ankle joint power was found (all p < 0.05). Increasing cadence led to increasing knee joint power and decreasing hip joint power (all p < 0.05), with the exception at low cadence (< 60 rpm), where there was no effect of cadence. The elite cyclists had higher relative hip joint power compared to the recreational group (p < 0.05). The hip joint power at moderate intensity with a freely chosen cadence (FCC) was lower than the hip joint power at low intensity with a low cadence (< 60 rpm) (p < 0.05). Conclusion This study demonstrates that there is an effect of cadence on the hip-and knee joint contribution in cycling, however, the effect only occurs from 60 rpm and upward. It also demonstrates that there is a difference in joint contribution between elite-and recreational cyclists, and provide evidence for the possibility of achieving higher relative hip joint power at low intensity than moderate intensity by altering the cadence.	[Aasvold, Lorents Ola; Ettema, Gertjan; Skovereng, Knut] Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, Dept Neuromed & Movement Sci INB, Ctr Elite Sports Res, Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Aasvold, LO (corresponding author), Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, Dept Neuromed & Movement Sci INB, Ctr Elite Sports Res, Trondheim, Norway.	loraa@trondelagfylke.no	Ettema, Gertjan/C-2104-2018	Aasvold, Lorents Ola/0000-0002-8364-2396; Skovereng, Knut/0000-0002-4392-9704				BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Chapman AR, 2008, J ELECTROMYOGR KINES, V18, P359, DOI 10.1016/j.jelekin.2005.12.007; Elmer SJ, 2011, MED SCI SPORT EXER, V43, P1940, DOI 10.1249/MSS.0b013e31821b00c5; Ettema G, 2009, J ELECTROMYOGR KINES, V19, pE94, DOI 10.1016/j.jelekin.2007.11.009; Ettema G, 2009, EUR J APPL PHYSIOL, V106, P1, DOI 10.1007/s00421-009-1008-7; Farina D, 2004, J APPL PHYSIOL, V97, P2035, DOI 10.1152/japplphysiol.00606.2004; Hansen EA, 2017, INT J SPORT PHYSIOL, V12, P1127, DOI 10.1123/ijspp.2016-0574; Hug F, 2009, J ELECTROMYOGR KINES, V19, P182, DOI 10.1016/j.jelekin.2007.10.010; HULL ML, 1985, J BIOMECH, V18, P631, DOI 10.1016/0021-9290(85)90019-3; Jeukendrup A E, 2000, J Sci Med Sport, V3, P414, DOI 10.1016/S1440-2440(00)80008-0; Kristoffersen M, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00034; Leirdal S, 2011, EUR J APPL PHYSIOL, V111, P2885, DOI 10.1007/s00421-011-1914-3; Ludyga S, 2016, J SCI MED SPORT, V19, P342, DOI 10.1016/j.jsams.2015.04.003; MacIntosh BR, 2000, MED SCI SPORT EXER, V32, P1281, DOI 10.1097/00005768-200007000-00015; Martin JC, 2009, J BIOMECH, V42, P474, DOI 10.1016/j.jbiomech.2008.11.015; McDaniel J, 2014, J APPL BIOMECH, V30, P423, DOI 10.1123/jab.2013-0246; McGhie D, 2011, J ELECTROMYOGR KINES, V21, P18, DOI 10.1016/j.jelekin.2010.04.007; Mornieux G, 2007, EUR J APPL PHYSIOL, V102, P11, DOI 10.1007/s00421-007-0555-z; Osu R, 2002, J NEUROPHYSIOL, V88, P991, DOI 10.1152/jn.2002.88.2.991; Sanderson DJ, 2006, J ELECTROMYOGR KINES, V16, P642, DOI 10.1016/j.jelekin.2005.11.003; SCHNEIDER K, 1989, J BIOMECH, V22, P805, DOI 10.1016/0021-9290(89)90064-X; Skovereng K, 2016, EUR J APPL PHYSIOL, V116, P1207, DOI 10.1007/s00421-016-3379-x; Skovereng K, 2016, HUM MOVEMENT SCI, V45, P161, DOI 10.1016/j.humov.2015.11.009; VANSOEST AJ, 1993, J BIOMECH, V26, P1, DOI 10.1016/0021-9290(93)90608-H	24	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212781	10.1371/journal.pone.0212781	http://dx.doi.org/10.1371/journal.pone.0212781			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794700	Green Published, Green Submitted, gold			2022-12-27	WOS:000459709100136
J	Illan, GA; Stuber, H; Friedl, KE; Summers, IR; Peer, A				Illan, Gloria Araiza; Stueber, Heiko; Friedl, Ken E.; Summers, Ian R.; Peer, Angelika			A simulation environment for studying transcutaneous electrotactile stimulation	PLOS ONE			English	Article							TENS; RELIEF; PATTERN; FIBERS; HAND; PAIN	Transcutaneous electrical nerve stimulation (TENS) allows the artificial excitation of nerve fibres by applying electric-current pulses through electrodes on the skin's surface. This work involves the development of a simulation environment that can be used for studying transcutaneous electrotactile stimulation and its dependence on electrode layout and excitation patterns. Using an eight-electrode array implementation, it is shown how nerves located at different depths and with different orientations respond to specific injected currents, allowing the replication of already reported experimental findings and the creation of new hypotheses about the tactile sensations associated with certain stimulation patterns. The simulation consists of a finite element model of a human finger used to calculate the distribution of the electric potential in the finger tissues neglecting capacitive effects, and a cable model to calculate the excitation/inhibition of action potentials in each nerve.	[Illan, Gloria Araiza] Univ Bristol, Bristol Robot Lab, EPSRC Ctr Doctoral Training Future Autonomous & R, Bristol, Avon, England; [Illan, Gloria Araiza; Summers, Ian R.] Univ West England, Bristol Robot Lab, Bristol, Avon, England; [Stueber, Heiko] Tech Univ Munich, Dept Elect & Comp Engn, Chair Informat Oriented Control, Munich, Germany; [Friedl, Ken E.] Tech Univ Munich, Dept Elect & Comp Engn, Chair Automat Control Engn, Munich, Germany; [Peer, Angelika] Free Univ Bozen Bolzano, Fac Sci & Technol, Bruneck Brunico, Italy	UK Research & Innovation (UKRI); Engineering & Physical Sciences Research Council (EPSRC); University of Bristol; University of West England; University of Bristol; University of West England; Technical University of Munich; Technical University of Munich; Free University of Bozen-Bolzano	Illan, GA (corresponding author), Univ Bristol, Bristol Robot Lab, EPSRC Ctr Doctoral Training Future Autonomous & R, Bristol, Avon, England.; Illan, GA (corresponding author), Univ West England, Bristol Robot Lab, Bristol, Avon, England.	ga13414@bristol.ac.uk	Peer, Angelika/E-5806-2013; Peer, Angelika/A-4315-2019	Peer, Angelika/0000-0002-2896-9011; Araiza Illan, Gloria/0000-0001-7539-5324	ReMeDi project within the 7th environment Programme of the European Union [610902]; EPSRC Centre for Doctoral Training in Future Autonomous and Robotic Systems (FARSCOPE) at the Bristol Robotics Laboratory	ReMeDi project within the 7th environment Programme of the European Union; EPSRC Centre for Doctoral Training in Future Autonomous and Robotic Systems (FARSCOPE) at the Bristol Robotics Laboratory(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work is supported in part by the ReMeDi project within the 7th environment Programme of the European Union, under the grant agreement n. 610902 to AP, and partially supported by the EPSRC Centre for Doctoral Training in Future Autonomous and Robotic Systems (FARSCOPE) at the Bristol Robotics Laboratory to GAI. The URLs for the funders are: http://ec.europa.eu/environment/action-programme/and https://www.epsrc.ac.uk/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander B, 2010, INT J MORPHOL, V28, P755, DOI 10.4067/S0717-95022010000300015; BUCHHOLZ B, 1992, ERGONOMICS, V35, P261, DOI 10.1080/00140139208967812; Buschart RJ, 2012, ELECT INSTRUMENTATIO; CARABELLI RA, 1985, ARCH PHYS MED REHAB, V66, P466; CAUNA N, 1961, J COMP NEUROL, V117, P309, DOI 10.1002/cne.901170304; CAUNA N, 1956, AM J ANAT, V99, P315, DOI 10.1002/aja.1000990206; Delmas P, 2011, NAT REV NEUROSCI, V12, P139, DOI 10.1038/nrn2993; FRIEDLANDER GD, 1971, IEEE SPECTRUM, V8, P40, DOI 10.1109/MSPEC.1971.5218422; Germani M, 2013, INT J ADV MANUF TECH, V68, P2185, DOI 10.1007/s00170-013-4832-1; Halata Z, 2003, ANAT REC PART A, V271A, P225, DOI 10.1002/ar.a.10029; HANSSON P, 1983, PAIN, V15, P157, DOI 10.1016/0304-3959(83)90015-5; Hasgall PA, 2018, ITIS DATABASE THERMA, DOI [10.13099/VIP21000-04-0, DOI 10.13099/VIP21000-04-1]; He B, 2010, MODELING IMAGING BIO, P308; Herraiz C, 2007, PROG BRAIN RES, V166, P389, DOI 10.1016/S0079-6123(07)66037-3; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; JOHANSSON RS, 1979, J PHYSIOL-LONDON, V286, P283, DOI 10.1113/jphysiol.1979.sp012619; Kaczmarek KA, 2011, SCI IRAN, V18, P1476, DOI 10.1016/j.scient.2011.08.020; Kaczmarek KA, 2000, IEEE T REHABIL ENG, V8, P268, DOI 10.1109/86.847828; Kajimoto H, 2002, 10TH SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P303, DOI 10.1109/HAPTIC.2002.998973; Kajimoto H., 2004, ELECTROTACTILE DISPL; Kajimoto H., 1999, P 1999 ICAT, P133; Kaplan B, 1998, INT J GYNECOL OBSTET, V60, P251, DOI 10.1016/S0020-7292(97)00275-0; Kruger L, 1996, HDB PERCEPTION COGNI; Kuhn A, 2008, THESIS; Kuhn A, 2010, IEEE T NEUR SYS REH, V18, P255, DOI 10.1109/TNSRE.2009.2039807; Kuhn A, 2009, MED BIOL ENG COMPUT, V47, P279, DOI 10.1007/s11517-008-0422-z; MCNEAL DR, 1976, SCIENCE, V23, P329; Medina LE, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/6/066012; Peters MJ, 2001, ELECTROMAGNETICS, V21, P545, DOI 10.1080/027263401752246199; Philpott M, 2015, IEEE T HAPTICS, V8, P240, DOI 10.1109/TOH.2015.2412551; Provitera V, 2007, MUSCLE NERVE, V35, P767, DOI 10.1002/mus.20771; RANCK JB, 1975, BRAIN RES, V98, P417, DOI 10.1016/0006-8993(75)90364-9; RATTAY F, 1988, IEEE T BIO-MED ENG, V35, P199, DOI 10.1109/10.1362; Rattay F, 1990, ELECT NERVE STIMULAT; Smit JE, 2008, S AFR J SCI, V104, P284; Snell RS., 2011, CLIN ANATOMY REGIONS; STRONG RM, 1970, IEEE T MAN MACHINE, VMM11, P72, DOI 10.1109/TMMS.1970.299965; Stuber H, 2014, ELECT FIELD MODEL TR; Summers IR, 2002, J ACOUST SOC AM, V112, P2118, DOI 10.1121/1.1510140; Willis WD, 2004, SENSORY MECH SPINAL, V1; Wolfson AB, 2012, HARWOOD NUSS CLIN PR; Yem V, 2017, IEEE T HAPTICS, V10, P130, DOI 10.1109/TOH.2016.2605084; Zelena J, 1994, NERVES MECHANORECEPT; Zenker W, 2012, PRIMARY AFFERENT NEU	44	5	5	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212479	10.1371/journal.pone.0212479	http://dx.doi.org/10.1371/journal.pone.0212479			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794630	Green Published, Green Submitted, gold			2022-12-27	WOS:000459709100075
J	Memiah, P; Opanga, Y; Bond, T; Cook, C; Mwangi, M; Fried, J; Joseph, MA; Owuor, K; Mochache, V; Machira, YW				Memiah, Peter; Opanga, Yvonne; Bond, Tristi; Cook, Courtney; Mwangi, Michelle; Fried, Jenna; Joseph, Marie A.; Owuor, Kevin; Mochache, Vernon; Machira, Yvonne Wangui			Is sexual autonomy a protective factor for neonatal, child, and infant mortality? A multi-country analysis	PLOS ONE			English	Article							REPRODUCTIVE HEALTH; WOMEN; DETERMINANTS; VIOLENCE	Background Sexual autonomy empowers women to set boundaries, take control of their bodies, prevent sexually transmitted diseases and avoid unplanned pregnancy. A woman's ability to negotiate safer sex is crucial for her survival and that of her child. Sexual autonomy among East African women is vital to the elimination of the deaths of neonates, infants, and children. The aim of our study was to explore the association of sexual autonomy on neonatal, infant, and child mortality. Methodology This was a secondary analysis of demographic health survey (DHS) data on women of reproductive age (15-49 years) in five East African countries: Burundi, Kenya, Rwanda, Tanzania, and Uganda. Data on our outcome variables neonatal, infant, and under-five mortality which were in binary form was extracted from the database. Sexual autonomy was classified as a composite variable of "respondent can refuse sex," "respondent can ask partner to use condom," and "if spouse is justified in asking husband to use condom." Other sociodemographic, maternal, health system and paternal variables were included in the analysis. STATA version 14 was used for analysis. Proportions and frequencies were used to describe the three outcome variables and sociodemographic characteristics. Chi-square tests were used to compare associations between sexual autonomy and categorical variables. Adjusted hazard ratios were used to determine the association between sexual autonomy and independent variables. Results The sampled women were predominantly urban (75%; n = 5758) and poor (48.7%; n = 3702). A majority of those that experienced mortality (neonatal mortality 53.5%, infant mortality 54.3%, under-five mortality 55.7%) were young (under 20) at the time of their first child's birth while their male partners were older. The multivariate analysis supports the beneficial effects of women's sexual autonomy in East Africa. Women who exercised sexual autonomy experienced significantly lower rates of child mortality at all three stages: neonatal (NHR = 0.80, 95% CI: 0.68-0.94, p = 0.006), infant (IHR = 0.82, 95% CI: 0.72-0.93, p = 0.003), and under-five (UHR = 0.84, 95% CI: 0.75-0.94, p = 0.002), net of all other factors. Receiving antenatal care and using contraceptives also contributed significantly to lower child mortality rates. Conclusion Our findings suggest that sexual autonomy among East African women is an urgent priority that is crucial to the survival of neonates, infants, and children in East Africa. Women should be informed, empowered, and autonomous concerning their reproductive and sexual health.	[Memiah, Peter; Bond, Tristi; Joseph, Marie A.] Univ West Florida, Usha Kundu Coll Hlth, Dept Publ Hlth, Pensacola, FL 32514 USA; [Opanga, Yvonne] Amref Hlth Africa, Nairobi, Kenya; [Cook, Courtney] Univ West Florida, Dept Biol, Pensacola, FL 32514 USA; [Mwangi, Michelle] Univ Nairobi, Dept Econ, Nairobi, Kenya; [Fried, Jenna] Univ West Florida, Dept Psychol, Pensacola, FL 32514 USA; [Owuor, Kevin] Ctr Hlth Solut, Nairobi, Kenya; [Mochache, Vernon] Kenya Natl AIDS Control Council, Nairobi, Kenya; [Machira, Yvonne Wangui] Tafiti Res Grp, Nairobi, Kenya	State University System of Florida; University of West Florida; African Medical & Research Foundation (AMREF); State University System of Florida; University of West Florida; University of Nairobi; State University System of Florida; University of West Florida	Memiah, P (corresponding author), Univ West Florida, Usha Kundu Coll Hlth, Dept Publ Hlth, Pensacola, FL 32514 USA.	pmemiah@uwf.edu	Mochache, Vernon/AAF-1164-2020; Mochache, Vernon/AGR-7032-2022; Bond, Tristi/GVT-2746-2022	Mochache, Vernon/0000-0001-7413-0252; Mochache, Vernon/0000-0001-7413-0252; Owuor, Kevin/0000-0003-0712-3209	Askew Institute for Multidisciplinary Studies (AIMS)	Askew Institute for Multidisciplinary Studies (AIMS)	We acknowledge the Askew Institute for Multidisciplinary Studies (AIMS) for providing the support and time for this research. We thank MEASURE DHS for providing the full data set to conduct this imperative study.	Asling-Monemi K, 2003, B WORLD HEALTH ORGAN, V81, P10; Barmon C, 2016, J GERONTOL B PSSS, V72; Baumeister RF, 2004, PERSONALITY SOCIAL P, V8; Bin Nisar Y, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-663; Chai XN, 2017, SEX REPROD HEALTHC, V14, P79, DOI 10.1016/j.srhc.2017.09.003; Ejembi CL, 2015, 120 ICF; Ezeh OK, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-521; Guilbert N, 2013, NON TRADITIONAL REF; Luke N, 2003, STUD FAMILY PLANN, V34, P67, DOI 10.1111/j.1728-4465.2003.00067.x; Maticka-Tyndale E, 2012, CONDOMS SUB SAHARAN; Memiah P, 2021, J INTERPERS VIOLENCE, V36, P5297, DOI 10.1177/0886260518804177; Montgomery CM, 2008, AIDS CARE PSYCHOL SO; Morokoff PJ, 1997, J PERS SOC PSYCHOL, V73, P790, DOI 10.1037/0022-3514.73.4.790; Moss NE, 2002, GENDER EQUITY SOCIOE; Nour NM, 2006, EMERG INFECT DIS, V12, P1644, DOI 10.3201/eid1211.060510; Sarkar NN, 2008, J OBSTET GYNAECOL, V28, P266, DOI 10.1080/01443610802042415; Svanemyr J, 2015, J ADOLESCENT HEALTH, V56, pS7, DOI 10.1016/j.jadohealth.2014.09.011; Tarekegn SM, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-161; Titaley CR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-232; Tsui AO, 2009, REPROD HLTH J HOPKIN; USAID, 2013, STAND REC MAN DHS 6, P1; WHO, 2016, CONS EV CHILDH OB CO, P1; Woldemicael G, 2010, HEALTH CARE WOMEN IN, V31, P599, DOI 10.1080/07399331003599555; World Health Organization London School of Hygiene and Tropical Medicine, 2010, INJ PREV; Zimmer-Gembeck MJ, 2013, SEX HEALTH, V10, P204, DOI 10.1071/SH12139	25	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212413	10.1371/journal.pone.0212413	http://dx.doi.org/10.1371/journal.pone.0212413			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794592	Green Submitted, Green Published, gold			2022-12-27	WOS:000459709100062
J	Park, SB; Sung, DJ; Kim, B; Kim, S; Han, JK				Park, Seung-Bo; Sung, Dong Jun; Kim, Bokyung; Kim, SoJung; Han, Joung-Kyue			Transcranial Direct Current Stimulation of motor cortex enhances running performance	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; EXERCISE PERFORMANCE; BRAIN-STIMULATION; COGNITIVE CONTROL; MUSCLE AFFERENTS; DC-STIMULATION; PERCEPTION; PAIN; MODULATION; ENDURANCE	Transcranial direct current stimulation (tDCS) is a technique used to modulate neuronal excitability through non-invasive brain stimulation that can enhance exercise performance. We hypothesize that tDCS would improve submaximal running time to exhaustion (TTE) and delay the increase in the rating of perceived exertion (RPE) over time. We also hypothesize that tDCS would not lead to difference in cardiorespiratory responses. We employed a randomized, single-blinded, and counterbalanced design in which 10 trained men participated. After receiving either 20 min of 1.98 mA anodal tDCS applied over the primary motor cortex (M1) or sham-operated control on separate days, participants completed a constant-load test involving running at a speed equivalent to 80% of their own maximum oxygen consumption (VO(2)max). During this constant-load test, RPE, heart rate (HR), VO2, pulmonary ventilation (VE), respiratory exchange ratio (RER), and ventilatory threshold (VT) were continuously monitored. TTE was recorded at the end of the test. TTEs were significantly longer in the tDCS than in the sham conditions (21.18 +/- 7.13 min; 18.44 +/- 6.32 min; p = 0.011). For TTE, no significant differences were found in RPE between conditions at isotime. In addition, no significant differences in HR, VO2, VE, RER, and VT were found during TTE between the two stimulation conditions at any time point. These results indicate that the application of tDCS does not induce a change of the exercise performance-related index; however, it can affect the increase of the exercise duration due to the stimuli in the M1 area.	[Park, Seung-Bo; Kim, Bokyung] Konkuk Univ, Dept Physiol, KU Open Innovat Ctr, Res Inst Med Sci,Sch Med, Chungju, Chungbuk, South Korea; [Sung, Dong Jun] Konkuk Univ, Div Sport & Hlth Sci, Coll Biomed & Hlth Sci, Chungju, Chungbuk, South Korea; [Kim, SoJung] Univ Massachusetts, Dept Phys Therapy & Kinesiol, Coll Hlth Sci, Lowell, MA USA; [Han, Joung-Kyue] Chung Ang Univ, Coll Sport Sci, Anseong, Gyoenggi, South Korea	Konkuk University; Konkuk University Medical Center; Konkuk University; University of Massachusetts System; University of Massachusetts Lowell; Chung Ang University	Han, JK (corresponding author), Chung Ang Univ, Coll Sport Sci, Anseong, Gyoenggi, South Korea.	jkhan@cau.ac.kr		sung, dongjun/0000-0001-6390-454X				Abdelmoula A, 2016, NEUROSCIENCE, V322, P94, DOI 10.1016/j.neuroscience.2016.02.025; Amann M, 2011, J PHYSIOL-LONDON, V589, P5299, DOI 10.1113/jphysiol.2011.213769; Amann M, 2009, J PHYSIOL-LONDON, V587, P271, DOI 10.1113/jphysiol.2008.163303; American College of Sports Medicine, 2017, ACSMS EX TEST PRESCR; Angius L., 2016, P PHYSL SOC, V35, pC03, DOI DOI 10.1016/J.BRS.2017.09.017; Angius L, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00090; Angius L, 2015, EUR J APPL PHYSIOL, V115, P2311, DOI 10.1007/s00421-015-3212-y; Barwood MJ, 2016, BRAIN STIMUL, V9, P842, DOI 10.1016/j.brs.2016.07.006; Boggio PS, 2008, EUR J NEUROL, V15, P1124, DOI 10.1111/j.1468-1331.2008.02270.x; Boggio PS, 2009, J NEUROL NEUROSUR PS, V80, P444, DOI 10.1136/jnnp.2007.141853; Boggio PS, 2008, INT J NEUROPSYCHOPH, V11, P249, DOI 10.1017/S1461145707007833; Boggio PS, 2009, NEUROPSYCHOLOGIA, V47, P212, DOI 10.1016/j.neuropsychologia.2008.07.022; Cogiamanian F, 2007, EUR J NEUROSCI, V26, P242, DOI 10.1111/j.1460-9568.2007.05633.x; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; de Morree HM, 2014, J APPL PHYSIOL, V117, P1514, DOI 10.1152/japplphysiol.00898.2013; de Morree HM, 2012, PSYCHOPHYSIOLOGY, V49, P1242, DOI 10.1111/j.1469-8986.2012.01399.x; Edwards DJ, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00243; Feeser M, 2014, BRAIN STIMUL, V7, P105, DOI 10.1016/j.brs.2013.08.006; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; George MS, 2010, NEUROPSYCHOPHARMACOL, V35, P301, DOI 10.1038/npp.2009.87; Glass S., 2007, ACSMS METABOLIC CALC, P111; Hopkins WG., NEW VIEW STAT; Jatupaiboon N, 2013, SCI WORLD J, DOI 10.1155/2013/618649; Jurcak V, 2007, NEUROIMAGE, V34, P1600, DOI 10.1016/j.neuroimage.2006.09.024; Lang N, 2005, EUR J NEUROSCI, V22, P495, DOI 10.1111/j.1460-9568.2005.04233.x; Liebetanz D, 2002, BRAIN, V125, P2238, DOI 10.1093/brain/awf238; Lorenz J, 2003, BRAIN, V126, P1079, DOI 10.1093/brain/awg102; Mauger AR, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00104; McMorris T, 2018, NEUROSCI BIOBEHAV R, V93, P93, DOI 10.1016/j.neubiorev.2018.03.024; Meinzer M, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00253; Montenegro RA, 2011, NEUROSCI LETT, V497, P32, DOI 10.1016/j.neulet.2011.04.019; Nitsche M A, 2012, Front Psychiatry, V3, P58, DOI 10.3389/fpsyt.2012.00058; Nitsche MA, 2003, SUPPL CLIN NEUROPHYS, V56, P255; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Ohuchi H, 1996, PEDIATR CARDIOL, V17, P7, DOI 10.1007/s002469900002; Okano AH, 2017, INT J SPORTS MED, V38, P493, DOI 10.1055/s-0042-121897; Okano AH, 2015, BRIT J SPORT MED, V49, P1213, DOI 10.1136/bjsports-2012-091658; Pena-Gomez C, 2012, BRAIN STIMUL, V5, P252, DOI 10.1016/j.brs.2011.08.006; Polania R, 2012, HUM BRAIN MAPP, V33, P2499, DOI 10.1002/hbm.21380; Reardon S, 2016, NATURE, V531, P283, DOI 10.1038/nature.2016.19534; Rosenkranz K, 2000, NEUROSCI LETT, V296, P61, DOI 10.1016/S0304-3940(00)01621-9; Rosenthal R, 1994, HDB RES SYNTHESIS, P231; Salehinejad MA, 2017, J AFFECT DISORDERS, V210, P241, DOI 10.1016/j.jad.2016.12.036; Tanaka S, 2011, NEUROREHAB NEURAL RE, V25, P565, DOI 10.1177/1545968311402091; Tanaka S, 2009, EXP BRAIN RES, V196, P459, DOI 10.1007/s00221-009-1863-9; Vitor-Costa M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144916; Williams PS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081418; Zandieh A, 2013, NEUROMODULATION, V16, P345, DOI 10.1111/ner.12009	48	21	22	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0211902	10.1371/journal.pone.0211902	http://dx.doi.org/10.1371/journal.pone.0211902			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794568	Green Published, gold, Green Submitted			2022-12-27	WOS:000459709100026
J	Vet, S; Vandervelde, A; Gelens, L				Vet, Stefan; Vandervelde, Alexandra; Gelens, Lendert			Excitable dynamics through toxin-induced mRNA cleavage in bacteria	PLOS ONE			English	Article							ESCHERICHIA-COLI; ANTITOXIN SYSTEMS; PROTEIN; NOISE; PERSISTER; MODEL; RATES; LOCI	Toxin-antitoxin ( TA) systems in bacteria and archaea are small genetic elements consisting of the genes coding for an intracellular toxin and an antitoxin that can neutralize this toxin. In various cases, the toxins cleave the mRNA. In this theoretical work we use deterministic and stochastic modeling to explain how toxin-induced cleavage of mRNA in TA systems can lead to excitability, allowing large transient spikes in toxin levels to be triggered. By using a simplified network where secondary complex formation and transcriptional regulation are not included, we show that a two-dimensional, deterministic model captures the origin of such toxin excitations. Moreover, it allows to increase our understanding by examining the dynamics in the phase plane. By systematically comparing the deterministic results with Gillespie simulations we demonstrate that even though the real TA system is intrinsically stochastic, toxin excitations can be accurately described deterministically. A bifurcation analysis of the system shows that the excitable behavior is due to a nearby Hopf bifurcation in the parameter space, where the system becomes oscillatory. The influence of stress is modeled by varying the degradation rate of the antitoxin and the translation rate of the toxin. We find that stress increases the frequency of toxin excitations. The inclusion of secondary complex formation and transcriptional regulation does not fundamentally change the mechanism of toxin excitations. Finally, we show that including growth rate suppression and translational inhibition can lead to longer excitations, and even cause excitations in cases when the system would otherwise be non-excitable. To conclude, the deterministic model used in this work provides a simple and intuitive explanation of toxin excitations in TA systems.	[Vet, Stefan; Gelens, Lendert] VUB, Appl Phys Res Grp, Brussels, Belgium; [Vandervelde, Alexandra; Gelens, Lendert] Katholieke Univ Leuven, Lab Dynam Biol Syst, Leuven, Belgium; [Vet, Stefan] VUB ULB, Interuniv Inst Bioinformat Brussels IB2, Brussels, Belgium; [Vet, Stefan] ULB, Unite Chronobiol Theor, Brussels, Belgium	Vrije Universiteit Brussel; KU Leuven; Universite Libre de Bruxelles	Gelens, L (corresponding author), VUB, Appl Phys Res Grp, Brussels, Belgium.; Gelens, L (corresponding author), Katholieke Univ Leuven, Lab Dynam Biol Syst, Leuven, Belgium.	lendert.gelens@kuleuven.be	Gelens, Lendert/E-6348-2010	Gelens, Lendert/0000-0001-7290-9561; Vet, Stefan/0000-0001-7427-4459	Research Council of the Vrije Universiteit Brussel (SRP31 project); KU Leuven; Interuniversity Institute of Bioinformatics in Brussels (IB2)	Research Council of the Vrije Universiteit Brussel (SRP31 project); KU Leuven(KU Leuven); Interuniversity Institute of Bioinformatics in Brussels (IB2)	This work was financially supported by the Research Council of the Vrije Universiteit Brussel (SRP31 project) and internal funds of KU Leuven (to LG and AV). SV received a one-year fellowship from the Interuniversity Institute of Bioinformatics in Brussels (IB2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENISRAEL A, 1966, J MATH ANAL APPL, V15, P243, DOI 10.1016/0022-247X(66)90115-6; Berglund N., 2006, PROB APPL S, DOI 10.1007/1-84628-186-5; BERNARD P, 1992, J MOL BIOL, V226, P735, DOI 10.1016/0022-2836(92)90629-X; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Cataudella I, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003174; Christensen SK, 2003, J MOL BIOL, V332, P809, DOI 10.1016/S0022-2836(03)00922-7; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Culviner PH, 2018, MOL CELL, V70, P868, DOI 10.1016/j.molcel.2018.04.026; Dumortier F, 1996, MEM AM MATH SOC, V121, P1; Feng JC, 2014, P NATL ACAD SCI USA, V111, P544, DOI 10.1073/pnas.1320396110; Gelens L, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003190; Gerdes K, 2012, ANNU REV MICROBIOL, V66, P103, DOI 10.1146/annurev-micro-092611-150159; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gong CC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169703; Goormaghtigh F, 2018, MBIO, V9, DOI 10.1128/mBio.00640-18; Guisoni N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151086; Harms A, 2018, MOL CELL, V70, P768, DOI 10.1016/j.molcel.2018.01.003; Himeoka Y, 2019, PHYS BIOL, V16, DOI 10.1088/1478-3975/aaf3e3; Jones E., 2001, SCIPY OPEN SOURCE SC; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; KUBITSCHEK HE, 1990, J BACTERIOL, V172, P94, DOI 10.1128/JB.172.1.94-101.1990; Leplae R, 2011, NUCLEIC ACIDS RES, V39, P5513, DOI 10.1093/nar/gkr131; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Lindner B, 2004, PHYS REP, V392, P321, DOI 10.1016/j.physrep.2003.10.015; Lou CB, 2008, J THEOR BIOL, V255, P205, DOI 10.1016/j.jtbi.2008.07.035; McKane AJ, 2007, J STAT PHYS, V128, P165, DOI 10.1007/s10955-006-9221-9; Nikolic N, 2019, CURR GENET, V65, P133, DOI 10.1007/s00294-018-0879-8; Nikolic N, 2018, NUCLEIC ACIDS RES, V46, P2918, DOI 10.1093/nar/gky079; Page R, 2016, NAT CHEM BIOL, V12, P208, DOI [10.1038/NCHEMBIO.2044, 10.1038/nchembio.2044]; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Rue P, 2011, MATH BIOSCI, V231, P90, DOI 10.1016/j.mbs.2011.02.013; Santillan M, 2001, P NATL ACAD SCI USA, V98, P1364, DOI 10.1073/pnas.98.4.1364; Schlosshauer M, 2004, PROTEIN SCI, V13, P1660, DOI 10.1110/ps.03517304; Schreiber G, 2009, CHEM REV, V109, P839, DOI 10.1021/cr800373w; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Thomas P, 2013, J THEOR BIOL, V335, P222, DOI 10.1016/j.jtbi.2013.06.021; Thomas P, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-39; Thomas P, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3661156; Tian C, 2017, NUCLEIC ACIDS RES, V45, P8180, DOI 10.1093/nar/gkx552; Van Melderen L, 2010, CURR OPIN MICROBIOL, V13, P781, DOI 10.1016/j.mib.2010.10.006; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7; Zorzini V, 2015, NUCLEIC ACIDS RES, V43, P1241, DOI 10.1093/nar/gku1352	45	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212288	10.1371/journal.pone.0212288	http://dx.doi.org/10.1371/journal.pone.0212288			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794601	Green Published, Green Submitted, gold			2022-12-27	WOS:000459709100052
J	Wirtz, KW				Wirtz, Kai W.			Physics or biology? Persistent chlorophyll accumulation in a shallow coastal sea explained by pathogens and carnivorous grazing	PLOS ONE			English	Article							SOUTHERN NORTH-SEA; PHYTOPLANKTON SPRING BLOOM; MUSSELS MYTILUS-EDULIS; BIOGEOCHEMICAL MODEL; COMMUNITY STRUCTURE; NUTRIENT GRADIENTS; SEASONAL PATTERNS; MARINE VIRUSES; SHELF-SEA; ZOOPLANKTON	One of the most striking patterns at the land-ocean interface is the massive increase of chlorophyll-a (CHL) from continental shelves towards the coast, a phenomenon that is classically linked to physical features. Here I propose that the coastal-offshore CHL gradient in a shallow sea has biological origins related to phytoplankton mortality that are neglected in state-of-the-art biogeochemical models. I integrate a trait-based ecosystem model into a modular coupling framework that is applied to the southern North Sea (SNS). The coupled model very well reproduces daily, seasonal and inter-annual (2000-2014) dynamics and meso-scale patterns in macronutrients, zooplankton biomass, and CHL as observed in situ and by remote sensors. Numerical experiments reveal that coast-offshore CHL gradients may predominantly arise from a trophic effect as resolved by an increase in carnivorous grazing towards shallow waters. This carnivory gradient reflects higher near-coast abundance of juvenile fish and benthic filter feeders. Furthermore, the temporal evolution of CHL can be much affected by viral infection as a fast-responding loss process at intermediate to high phytoplankton concentrations. Viral control in the model also prevents excessive and unrealistic blooms during late spring. Herbivores as often only ecological factor considered for explaining the spatio-temporal phytoplankton distribution are in this study supplemented by pathogens as well as pelagic and benthic carnivores as powerful agents, which are barely represented in current modeling but can mediate physical drivers of coastal ecosystems.	[Wirtz, Kai W.] Helmholtz Zentrum Geesthacht, Inst Coastal Res, Geesthacht, Germany	Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung	Wirtz, KW (corresponding author), Helmholtz Zentrum Geesthacht, Inst Coastal Res, Geesthacht, Germany.	kai.wirtz@hzg.de	Wirtz, Kai/GRY-5339-2022		Helmholtz society via the program PACES; German Federal Ministry of Research and Education in the framework project MOSSCO	Helmholtz society via the program PACES; German Federal Ministry of Research and Education in the framework project MOSSCO	The work was supported by the Helmholtz society via the program PACES and by the German Federal Ministry of Research and Education in the framework project MOSSCO.	Albaina A, 2004, MAR ECOL PROG SER, V284, P65, DOI 10.3354/meps284065; Arndt S, 2009, J MARINE SYST, V78, P42, DOI 10.1016/j.jmarsys.2009.02.008; Banas N, 2009, J GEOPHYS RES, V114, P1; Baschek B, 2017, OCEAN SCI, V13, P379, DOI 10.5194/os-13-379-2017; Behrenfeld MJ, 2014, NAT CLIM CHANGE, V4, P880, DOI 10.1038/NCLIMATE2349; Behrenfeld MJ, 2014, ANNU REV MAR SCI, V6, P167, DOI 10.1146/annurev-marine-052913-021325; Benfield MC, 1996, ENVIRON BIOL FISH, V46, P211, DOI 10.1007/BF00005223; Benoit-Bird KJ, 2012, BIOL LETTERS, V8, P813, DOI 10.1098/rsbl.2012.0232; Bialonski S, 2016, J PLANKTON RES, V38, P1077, DOI 10.1093/plankt/fbv122; BLABER SJM, 1980, J FISH BIOL, V17, P143, DOI 10.1111/j.1095-8649.1980.tb02749.x; Brandt G, 2010, BIOGEOSCIENCES, V7, P371, DOI 10.5194/bg-7-371-2010; Brown CC, 1978, PRINCIPLES ECOTOXICO, P115; Bruggeman J, 2014, ENVIRON MODELL SOFTW, V61, P249, DOI 10.1016/j.envsoft.2014.04.002; Brussaard CPD, 2004, J EUKARYOT MICROBIOL, V51, P125, DOI 10.1111/j.1550-7408.2004.tb00537.x; Burchard H, 2008, J PHYS OCEANOGR, V38, P566, DOI 10.1175/2007JPO3796.1; Byron CJ, 2014, REV FISH BIOL FISHER, V24, P737, DOI 10.1007/s11160-014-9343-0; Capet A, 2013, BIOGEOSCIENCES, V10, P3943, DOI 10.5194/bg-10-3943-2013; Carstensen J, 2015, ESTUAR COAST SHELF S, V162, P98, DOI 10.1016/j.ecss.2015.05.005; Chavez FP, 2011, ANNU REV MAR SCI, V3, P227, DOI 10.1146/annurev.marine.010908.163917; Chen MR, 2011, CONT SHELF RES, V31, P1075, DOI 10.1016/j.csr.2011.03.011; Ciavatta S, 2016, J GEOPHYS RES-OCEANS, V121, P1824, DOI 10.1002/2015JC011496; Cloern JE, 2014, BIOGEOSCIENCES, V11, P2477, DOI 10.5194/bg-11-2477-2014; Cloern JE, 2010, ESTUAR COAST, V33, P230, DOI 10.1007/s12237-009-9195-3; Compton TJ, 2013, J SEA RES, V82, P103, DOI 10.1016/j.seares.2013.02.002; CYRUS DP, 1987, J EXP MAR BIOL ECOL, V109, P71, DOI 10.1016/0022-0981(87)90186-9; Dahnke K, 2008, LIMNOL OCEANOGR, V53, P1504, DOI 10.4319/lo.2008.53.4.1504; Daewel U, 2015, MAR ECOL PROG SER, V534, P199, DOI 10.3354/meps11367; Davenport J, 2000, MAR ECOL PROG SER, V198, P131, DOI 10.3354/meps198131; de Leeuw G, 2003, ATMOS ENVIRON, V37, pS145, DOI 10.1016/S1352-2310(03)00246-2; De Robertis A, 2003, CAN J FISH AQUAT SCI, V60, P1517, DOI 10.1139/F03-123; Ebenhoh W, 2004, ECOL MODEL, V174, P241, DOI 10.1016/j.ecolmodel.2003.07.011; Eisele A, 2018, LONG TERM CHANGES RE; Ford DA, 2017, BIOGEOSCIENCES, V14, P1419, DOI 10.5194/bg-14-1419-2017; Frenken T, 2016, GLOBAL CHANGE BIOL, V22, P299, DOI 10.1111/gcb.13095; Friedrichs MAM, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003852; Fuhrman JA, 1995, LIMNOL OCEANOGR, V40, P1236, DOI 10.4319/lo.1995.40.7.1236; GLIBERT PM, 1995, MAR ECOL PROG SER, V122, P27, DOI 10.3354/meps122027; Grawe U, 2015, OCEAN MODEL, V92, P56, DOI 10.1016/j.ocemod.2015.05.008; Greve W, 2004, HELGOLAND MAR RES, V58, P274, DOI 10.1007/s10152-004-0191-5; Grosse F, 2016, BIOGEOSCIENCES, V13, P2511, DOI 10.5194/bg-13-2511-2016; Grunwald M, 2010, J SEA RES, V64, P199, DOI 10.1016/j.seares.2010.02.008; Guinder VA, 2010, MAR BIOL, V157, P2703, DOI 10.1007/s00227-010-1530-5; Hantzsche F, 2010, EVALUATION EFFECT FO; Hill C, 2004, COMPUT SCI ENG, V6, P18, DOI 10.1109/MCISE.2004.1255817; Hofmeister R, 2017, GEO-MAR LETT, V37, P179, DOI 10.1007/s00367-016-0469-z; Hydes DJ, 1999, MAR CHEM, V68, P117, DOI 10.1016/S0304-4203(99)00069-9; Irigoien X, 2004, MAR ECOL PROG SER, V267, P85, DOI 10.3354/meps267085; Kerimoglu O, 2017, BIOGEOSCIENCES, V14, P4499, DOI 10.5194/bg-14-4499-2017; KRAUSE M, 1995, PROG OCEANOGR, V35, P81, DOI 10.1016/0079-6611(95)00006-3; Kwiatkowski L, 2014, BIOGEOSCIENCES, V11, P7291, DOI 10.5194/bg-11-7291-2014; Lacroix G, 2007, J MARINE SYST, V64, P66, DOI 10.1016/j.jmarsys.2006.01.010; Le Fouest V, 2006, J MARINE SYST, V60, P30, DOI 10.1016/j.jmarsys.2005.11.008; Lehahn Y, 2014, CURR BIOL, V24, P2041, DOI 10.1016/j.cub.2014.07.046; Lehane C, 2006, ESTUAR COAST SHELF S, V67, P645, DOI 10.1016/j.ecss.2005.12.015; Lemmen C, 2018, WATER-SUI, V10, DOI 10.3390/w10111527; Lemmen C, 2018, GEOSCI MODEL DEV, V11, P915, DOI 10.5194/gmd-11-915-2018; Liu FF, 2014, J MARINE SYST, V129, P303, DOI 10.1016/j.jmarsys.2013.07.007; Loder MGJ, 2012, HELGOLAND MAR RES, V66, P11, DOI 10.1007/s10152-010-0242-z; Los FJ, 2008, J MARINE SYST, V74, P259, DOI 10.1016/j.jmarsys.2008.01.002; Maar M, 2007, MAR ECOL PROG SER, V339, P199, DOI 10.3354/meps339199; Maar M, 2014, PROG OCEANOGR, V124, P78, DOI 10.1016/j.pocean.2014.03.002; Maar M, 2011, ECOL MODEL, V222, P1696, DOI 10.1016/j.ecolmodel.2011.03.006; Maerz J, 2016, BIOGEOSCIENCES, V13, P4863, DOI 10.5194/bg-13-4863-2016; Mateus MD, 2017, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00284; Moller KO, 2012, MAR ECOL PROG SER, V468, P57, DOI 10.3354/meps09984; Mojica KDA, 2016, ISME J, V10, P500, DOI 10.1038/ismej.2015.130; Muller D, 2015, REMOTE SENS ENVIRON, V162, P242, DOI 10.1016/j.rse.2013.11.026; Nasermoaddeli MH, 2018, ESTUAR COAST SHELF S, V211, P62, DOI 10.1016/j.ecss.2017.11.002; Nezlin NP, 2012, J GEOPHYS RES O, P117; Nicolas D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088447; Nielsen TG, 2007, MAR ECOL PROG SER, V339, P185, DOI 10.3354/meps339185; Purkiani K, 2015, J GEOPHYS RES-OCEANS, V120, P225, DOI 10.1002/2014JC010325; Raven, 2007, PHOTOSYNTHESIS PRIMA; Renz J, 2008, J PLANKTON RES, V30, P511, DOI 10.1093/plankt/fbn016; Rhodes CJ, 2008, J MARINE SYST, V74, P216, DOI 10.1016/j.jmarsys.2008.01.005; Ribalet F, 2010, P NATL ACAD SCI USA, V107, P16571, DOI 10.1073/pnas.1005638107; RILEY GA, 1946, J MAR RES, V6, P54; Rolff C, 2008, BIOGEOSCIENCES, V5, P1657, DOI 10.5194/bg-5-1657-2008; Ruardij P, 2005, HARMFUL ALGAE, V4, P941, DOI 10.1016/j.hal.2004.12.011; Salihoglu B, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00339; Slavik K, 2019, HYDROBIOLOGIA, V845, P35, DOI 10.1007/s10750-018-3653-5; SOETAERT K, 1994, J PLANKTON RES, V16, P1277, DOI 10.1093/plankt/16.10.1277; Soetaert K, 1996, GEOCHIM COSMOCHIM AC, V60, P1019, DOI 10.1016/0016-7037(96)00013-0; Staaterman E, 2014, ICES J MAR SCI, V71, P918, DOI 10.1093/icesjms/fst103; Stanev EV, 2009, OCEAN DYNAM, V59, P183, DOI 10.1007/s10236-008-0171-4; SUTTLE CA, 1990, NATURE, V347, P467, DOI 10.1038/347467a0; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Tan YH, 2004, CONT SHELF RES, V24, P1949, DOI 10.1016/j.csr.2004.06.018; Thingstad TF, 2000, LIMNOL OCEANOGR, V45, P1320, DOI 10.4319/lo.2000.45.6.1320; Tian T, 2009, J SEA RES, V62, P214, DOI 10.1016/j.seares.2009.04.001; Travers M, 2009, ECOL MODEL, V220, P3089, DOI 10.1016/j.ecolmodel.2009.08.016; van Gennip S, 2016, J GEOPHYS RES-OCEANS, V121, P4149, DOI 10.1002/2016JC011789; van Leeuwen SM, 2013, BIOGEOCHEMISTRY, V113, P137, DOI 10.1007/s10533-012-9704-5; Weitz JS, 2015, ISME J, V9, P1352, DOI 10.1038/ismej.2014.220; Wiltshire KH, 2008, LIMNOL OCEANOGR, V53, P1294, DOI 10.4319/lo.2008.53.4.1294; Wiltshire KH, 2010, ESTUAR COAST, V33, P295, DOI 10.1007/s12237-009-9228-y; Winder M, 2010, PHILOS T R SOC B, V365, P3215, DOI 10.1098/rstb.2010.0125; Wirtz KW, 2016, FRONT ECOL EVOL, V4, DOI 10.3389/fevo.2016.00131; Wirtz KW, 2013, MAR BIOL, V160, P2319, DOI 10.1007/s00227-012-2163-7; Wirtz KW, 2005, J MARINE SYST, V56, P262, DOI 10.1016/j.jmarsys.2004.11.002; Wirtz KW, 1996, ECOL MODEL, V92, P33, DOI 10.1016/0304-3800(95)00196-4	101	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212143	10.1371/journal.pone.0212143	http://dx.doi.org/10.1371/journal.pone.0212143			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794602	gold, Green Published, Green Submitted			2022-12-27	WOS:000459709100041
J	Ferraris, L; Couturier, J; Eckert, C; Delannoy, J; Barbut, F; Butel, MJ; Aires, J				Ferraris, Laurent; Couturier, Jeanne; Eckert, Catherine; Delannoy, Johanne; Barbut, Frederic; Butel, Marie-Jose; Aires, Julio			Carriage and colonization of C-difficile in preterm neonates: A longitudinal prospective study	PLOS ONE			English	Article							INFANTS; INFECTION; TOXIN; EPIDEMIOLOGY; CHILDREN; STRAINS; DISEASE; LOCUS; GUT	Background Premature neonates (PN) present multiple risk factors for high frequencies and high levels of colonization by C. difficile, yet data is missing about this specific pediatric population. Here, we investigated PN C. difficile carriage and colonization dynamics, analyzed the impact of perinatal determinants on colonization, and characterized the isolates. Methods A one year longitudinal monocentric prospective cohort study was performed on 121 PN. C. difficile strains isolated from fecal samples on selective medium were identified and characterized by PCR (tpi housekeeping gene; tcdA and tcdB, and binary toxin genes), capillary gel-based electrophoresis PCR-ribotyping, and Multi-Locus Variable-number tandem repeat Analysis (MLVA). Results Of the 379 samples analyzed, 199 (52%) were C. difficile culture positive with the mean levels of C. difficile colonization decreasing significantly (P = .027) over time. During hospitalization, C. difficile colonization frequency increased up to 61% with 95% of the strains belonging to both non-toxigenic PCR-ribotypes (RTs) FR082 (35%) and 032 (60%). After hospital discharge, if a higher diversity in RTs was observed, RTs FR082 and 032 remained predominant (respectively 40% and 28%). MLVA showed clonal relationship within each FR082 and 032 RTs. Ten toxigenic strains (5%) were isolated, all tcdA(+)/tcdB(+) except for one tcdA(-)/tcdB(+), and all being acquired after hospitalization. At 1 week, the only factors found to be linked with a higher frequency of C. difficile colonization were a higher gestational age (P = 0.006) and a higher birth weight (P = 0.016). Conclusion The dynamics of C. difficile colonization in PN followed a specific pattern. C. difficile colonization rapidly occurred after birth with a low diversity of non-toxigenic RTs. After hospitalization, non-toxigenic RTs diversity increased. Sporadic carriage of toxigenic strains was observed after hospitalization.	[Ferraris, Laurent; Couturier, Jeanne; Delannoy, Johanne; Barbut, Frederic; Butel, Marie-Jose; Aires, Julio] Paris Descartes Univ, Hosp Univ Dept Risks Pregnancy, Sorbonne Paris Cite, EA 4065,Fac Pharm, Paris, France; [Couturier, Jeanne; Barbut, Frederic] CHU St Antoine, French Natl Reference Lab C Difficile, Paris, France; [Eckert, Catherine] GH Est Parisien, AP HP, Dept Bacteriol, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP)	Aires, J (corresponding author), Paris Descartes Univ, Hosp Univ Dept Risks Pregnancy, Sorbonne Paris Cite, EA 4065,Fac Pharm, Paris, France.	julio.aires@parisdescartes.fr	Barbut, frederic/AAF-4952-2021; Eckert, Catherine/O-9808-2017	Eckert, Catherine/0000-0003-2773-7064; Aires, Julio/0000-0002-8090-4565; Delannoy, Johanne/0000-0001-5138-5877	French Research Agency [ANR-07-PNRA-0028]	French Research Agency(French National Research Agency (ANR))	This work was funded by the French Research Agency [grant number ANR-07-PNRA-0028]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlerberth I, 2014, J CLIN MICROBIOL, V52, P173, DOI 10.1128/JCM.01701-13; [Anonymous], 2016, Nat Rev Dis Primers, V2, P16021, DOI 10.1038/nrdp.2016.21; Azad MB, 2013, CAN MED ASSOC J, V185, P385, DOI 10.1503/cmaj.121189; Belmares J, 2009, CLIN INFECT DIS, V49, P1141, DOI 10.1086/605638; Bidet P, 1999, FEMS MICROBIOL LETT, V175, P261, DOI 10.1016/S0378-1097(99)00204-9; Bouwknegt M, 2015, NEW ENGL J MED, V372, P2368, DOI 10.1056/NEJMc1505190; Braun V, 1996, GENE, V181, P29, DOI 10.1016/S0378-1119(96)00398-8; Clayton JA, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0603-8; Cotten CM, 2016, CURR OPIN PEDIATR, V28, P141, DOI 10.1097/MOP.0000000000000338; DELMEE M, 1988, EUR J PEDIATR, V147, P36, DOI 10.1007/BF00442608; Deshpande A, 2013, PEDIATR INFECT DIS J, V32, P1138, DOI 10.1097/INF.0b013e3182948518; Fawley WN, 2008, J CLIN MICROBIOL, V46, P954, DOI 10.1128/JCM.01764-07; Ferraris L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030594; Freeman J, 2010, CLIN MICROBIOL REV, V23, P529, DOI 10.1128/CMR.00082-09; Hall IC, 1935, AM J DIS CHILD, V49, P390, DOI 10.1001/archpedi.1935.01970020105010; He M, 2013, NAT GENET, V45, P109, DOI 10.1038/ng.2478; Jangi S, 2010, J PEDIATR GASTR NUTR, V51, P2, DOI 10.1097/MPG.0b013e3181d29767; KATO H, 1994, J CLIN MICROBIOL, V32, P2067, DOI 10.1128/JCM.32.9.2067-2070.1994; Kuntz JL, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-194; Kutty PK, 2010, EMERG INFECT DIS, V16, P197, DOI 10.3201/eid1602.090953; Lees EA, 2016, EUR J CLIN MICROBIOL, V35, P1047, DOI 10.1007/s10096-016-2639-3; Lemee L, 2004, J CLIN MICROBIOL, V42, P5710, DOI 10.1128/JCM.42.12.5710-5714.2004; MARDH PA, 1982, ACTA PAEDIATR SCAND, V71, P275, DOI 10.1111/j.1651-2227.1982.tb09414.x; Matsuki S, 2005, INT MICROBIOL, V8, P43; Rodriguez-Palacios A, 2013, ANIM HEALTH RES REV, V14, P11, DOI 10.1017/S1466252312000229; Rousseau C, 2011, J MED MICROBIOL, V60, P1112, DOI 10.1099/jmm.0.029736-0; Rousseau C, 2011, J CLIN MICROBIOL, V49, P858, DOI 10.1128/JCM.01507-10; Stoesser N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182307; TULLUS K, 1989, EUR J CLIN MICROBIOL, V8, P390, DOI 10.1007/BF01964052; van den Berg RJ, 2007, J CLIN MICROBIOL, V45, P1024, DOI 10.1128/JCM.02023-06; Zaiss NH, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-6	31	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212568	10.1371/journal.pone.0212568	http://dx.doi.org/10.1371/journal.pone.0212568			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785934	Green Published, Green Submitted, gold			2022-12-27	WOS:000459307000070
J	Paine, OCC; Leichliter, JN; Avenant, N; Codron, D; Lawrence, A; Sponheimer, M				Paine, Oliver C. C.; Leichliter, Jennifer N.; Avenant, Nico; Codron, Daryl; Lawrence, Austin; Sponheimer, Matt			The ecomorphology of southern African rodent incisors: Potential applications to the hominin fossil record	PLOS ONE			English	Article							SMALL MAMMALS; STERKFONTEIN; EXTANT; MORPHOLOGY; VEGETATION; EVOLUTION; BOVIDS; SITE; DIET	The taxonomic identification of mammalian fauna within fossil assemblages is a well-established component of paleoenvironmental reconstructions. However, many fragmentary specimens recovered from fossil sites are often disregarded as they can be difficult to identify with the precision required for taxonomic methods. For this reason, the large numbers of isolated rodent incisors that are often recovered from hominin fossil bearing sites are generally regarded as offering little interpretive value. Ecomorphological analysis, often referred to as a "taxon-free" method, can potentially circumvent this problem by focusing on the adaptive, rather than the taxonomic significance of rodent incisor morphology. Here, we determine if the morphology of the upper incisors of modern southern African rodents reflects dietary behavior using discriminant function analysis. Our model suggests that a strong ecomorphological signal exists in our modern sample and we apply these results to two samples of isolated incisors from the hominin fossil bearing sites, Sterkfontein and Swartkrans.	[Paine, Oliver C. C.; Sponheimer, Matt] Univ Colorado, Dept Anthropol, Boulder, CO 80309 USA; [Leichliter, Jennifer N.] Johannes Gutenberg Univ Mainz, AG Angew & Analyt Palaontol, Inst Geowissensch, Mainz, Germany; [Avenant, Nico; Codron, Daryl] Natl Museum, Mammol Dept, Bloemfontein, South Africa; [Codron, Daryl] Natl Museum, Florisbad Quaternary Res Dept, Bloemfontein, South Africa; [Lawrence, Austin] Univ Missouri, Dept Integrat Anat, Columbia, MO USA	University of Colorado System; University of Colorado Boulder; Johannes Gutenberg University of Mainz; University of Missouri System; University of Missouri Columbia	Paine, OCC (corresponding author), Univ Colorado, Dept Anthropol, Boulder, CO 80309 USA.	oliver.paine@colorado.edu	Codron, Daryl/B-8867-2008; Sponheimer, Matt/A-6075-2013	Codron, Daryl/0000-0001-5223-9513; Avenant, Nico/0000-0002-5390-9010; Lawrence, Austin/0000-0001-5988-8495; Sponheimer, Matt/0000-0002-8743-1123; Paine, Oliver/0000-0001-7993-6319				Arregoitia LDV, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160957; Avery DM, 2003, PALAEOGEOGR PALAEOCL, V189, P55, DOI 10.1016/S0031-0182(02)00593-X; Avery DM, 2001, J HUM EVOL, V41, P113, DOI 10.1006/jhev.2001.0483; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Blomberg SP, 2002, J EVOLUTION BIOL, V15, P899, DOI 10.1046/j.1420-9101.2002.00472.x; Brain CK, 1993, SWARTKRANS CAVES CHR, V8, P23; Croft DA, 2011, J MAMMAL, V92, P871, DOI 10.1644/10-MAMM-A-226.1; Damuth John D., 1992, P183; de Lumley MA, 1982, P 1 INT C HUM PAL, P707; de Ruiter DJ, 2008, J HUM EVOL, V55, P1015, DOI 10.1016/j.jhevol.2008.06.003; DEGRAAFF G, 1981, RODENTS SO AFRICA NO; Denys C., 1987, P118; Denys C, 1987, PALAEGEOGR PALAEOCLI, V152, P77; Faurby S, 2015, MOL PHYLOGENET EVOL, V84, P14, DOI 10.1016/j.ympev.2014.11.001; Geraads D, 2013, QUATERNARY RES, V80, P552, DOI 10.1016/j.yqres.2013.08.003; Grine FE., 2000, ENCY HUMAN EVOLUTION, P681; Happold D.C.D., 2013, MAMMALS AFRICA, VIII; Kappelman J, 1997, J HUM EVOL, V32, P229, DOI 10.1006/jhev.1996.0105; KERLEY GIH, 1990, S AFR J WILDL RES, V20, P123; Kovarovic K, 2007, J HUM EVOL, V52, P663, DOI 10.1016/j.jhevol.2007.01.001; Kuman K, 2000, J HUM EVOL, V38, P827, DOI 10.1006/jhev.1999.0392; Leichliter J, 2017, PALAEOGEOGR PALAEOCL, V485, P57, DOI 10.1016/j.palaeo.2017.06.003; Leichliter JN, 2016, J ARCHAEOL SCI-REP, V8, P335, DOI 10.1016/j.jasrep.2016.05.013; Matthews T, 2011, PALAEOGEOGR PALAEOCL, V302, P213, DOI 10.1016/j.palaeo.2011.01.014; MCKEE JK, 1995, AM J PHYS ANTHROPOL, V96, P235, DOI 10.1002/ajpa.1330960303; Monadjem A., 2015, RODENTS SUB SAHARAN; Munkemuller T, 2012, METHODS ECOL EVOL, V3, P743, DOI 10.1111/j.2041-210X.2012.00196.x; Ohazama A, 2010, P NATL ACAD SCI USA, V107, P92, DOI 10.1073/pnas.0907236107; Plummer TW, 2008, J ARCHAEOL SCI, V35, P3016, DOI 10.1016/j.jas.2008.06.015; PLUMMER TW, 1994, J HUM EVOL, V27, P47, DOI 10.1006/jhev.1994.1035; Reed DN, 2007, VERTEBR PALEOBIOL PA, P217, DOI 10.1007/978-1-4020-3098-7_9; Reed DN, 2011, VERTEBR PALEOBIOL PA, P265, DOI 10.1007/978-90-481-9956-3_13; Reed KE, 2008, J HUM EVOL, V54, P743, DOI 10.1016/j.jhevol.2007.08.013; Reed KE, 2013, EARLY HOMININ PALEOECOLOGY, P3, DOI 10.5876/9781607322252:C01; Reed KE, 1998, PALEOBIOLOGY, V24, P384; Ricklefs Robert E., 1994, P13; ROWEROWE DT, 1986, S AFR J WILDL RES, V16, P32; Simpson G.G., 1944, TEMPO MODE EVOLUTION, DOI DOI 10.1073/pnas.1821292116; Skinner J.D., 2005, MAMMALS SO AFRICAN S, DOI DOI 10.1017/CBO9781107340992; Sponheimer M, 1999, J HUM EVOL, V36, P705, DOI 10.1006/jhev.1999.0300; Ungar P.S., 2010, MAMMAL TEETH ORIGIN; VRBA ES, 1985, ENV HOMINIDES PLIO P, P345; Wainwright P.C., 1994, ECOLOGICAL MORPHOLOG; Wake M.H., 1992, Oxford Surveys in Evolutionary Biology, V8, P289; Watson CR, 1987, THESIS	45	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0205476	10.1371/journal.pone.0205476	http://dx.doi.org/10.1371/journal.pone.0205476			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM2OT	30785886	Green Published, Green Submitted, gold			2022-12-27	WOS:000459307000004
J	Westrupp, EM; D'Esposito, F; Freemantle, J; Mensah, FK; Nicholson, JM				Westrupp, Elizabeth M.; D'Esposito, Fabrizio; Freemantle, Jane; Mensah, Fiona K.; Nicholson, Jan M.			Health outcomes for Australian Aboriginal and Torres Strait Islander children born preterm, low birthweight or small for gestational age: A nationwide cohort study	PLOS ONE			English	Article							ALCOHOL; PROGRESS; DISEASE; WOMEN; RISK; SIZE; CARE	Objective To examine health outcomes in Australian Aboriginal and Torres Strait Islander children experiencing perinatal risk and identify protective factors in the antenatal period. Methods Baby/Child cohorts of the Longitudinal Study of Indigenous Children, born 2001-2008, across four annual surveys (aged 0-8 years, N = 1483). Children with 'mild' and 'moderate-to-high' perinatal risk were compared to children born normal weight at term for maternal rated global health and disability, and body-mass-index measured by the interviewer. Results Almost one third of children had experienced mild (22%) or moderate-to-high perinatal risk (8%). Perinatal risk was associated with lower body-mass-index z-scores (regression coefficients adjusted for pregnancy and environment factors: mild = -0.21, 95% CI = -0.34, -0.07; moderate-to-high = -0.42, 95% CI = -0.63, -0.21). Moderate-to-high perinatal risk was associated with poorer global health, with associations becoming less evident in models adjusted for pregnancy and environment factors; but not evident for disability. A range of protective factors, including cultural-based resilience and smoking cessation, were associated with lower risk of adverse outcomes. Conclusions Perinatal risks are associated with Australian Aboriginal and Torres Strait children experiencing adverse health particularly lower body weight. Cultural-based resilience and smoking cessation may be two modifiable pathways to ameliorating health problems associated with perinatal risk.	[Westrupp, Elizabeth M.; Nicholson, Jan M.] La Trobe Univ, Judith Lumley Ctr, Melbourne, Vic, Australia; [Westrupp, Elizabeth M.] Deakin Univ, Sch Psychol, Melbourne, Vic, Australia; [Westrupp, Elizabeth M.; D'Esposito, Fabrizio; Freemantle, Jane; Mensah, Fiona K.] Univ Melbourne, Melbourne, Vic, Australia; [Mensah, Fiona K.; Nicholson, Jan M.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Mensah, Fiona K.] Royal Childrens Hosp, Melbourne, Vic, Australia	La Trobe University; Deakin University; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Westrupp, EM (corresponding author), La Trobe Univ, Judith Lumley Ctr, Melbourne, Vic, Australia.; Westrupp, EM (corresponding author), Deakin Univ, Sch Psychol, Melbourne, Vic, Australia.; Westrupp, EM (corresponding author), Univ Melbourne, Melbourne, Vic, Australia.	elizabeth.westrupp@deakin.edu.au	Mensah, Fiona K/G-3382-2018	Mensah, Fiona K/0000-0002-6951-9949; /0000-0001-6517-6064; Nicholson, Jan/0000-0002-0305-0017	Centre of Research Excellence in Child Language (Australian National Health and Medical Research Council NHMRC) [1023493]; Australian Communities Foundation; NHMRC [1037449, 1111160]; ARC [DP0880637]; Victorian Government's Operational Infrastructure Support Program	Centre of Research Excellence in Child Language (Australian National Health and Medical Research Council NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Communities Foundation; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); ARC(Australian Research Council); Victorian Government's Operational Infrastructure Support Program	EMW was supported by the Centre of Research Excellence in Child Language (Australian National Health and Medical Research Council NHMRC grant 1023493). EMW and JN were supported by the Australian Communities Foundation through the Roberta Holmes Transition to Contemporary Parenthood Program (Coronella sub-fund). FM was supported by an NHMRC Early Career Fellowship 1037449 and Career Development Fellowship 1111160. JF was supported by an ARC Australian Research Fellowship DP0880637. Research at MCRI is supported by the Victorian Government's Operational Infrastructure Support Program. Authors have no other relevant disclosures. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This paper uses unit record data from Footprints in Time, the Longitudinal Study of Indigenous Children. The study is conducted and managed by the Australian Government Department of Social Services (DSS, formerly the Australian Government Department of Families, Housing, Community Services and Indigenous Affairs).	Angus S, 1998, AUST NZ J PUBL HEAL, V22, P636, DOI 10.1111/j.1467-842X.1998.tb01458.x; Australian Government Department of Social Services, 2018, FOOTPR TIM LONG STUD; Australian Institute of Health and Welfare, 2021, ALC OTH DRUG TREATM; Boyle J, 2016, AUST NZ J OBSTET GYN, V56, P223, DOI 10.1111/ajo.12470; Chamberlain C, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0520-9; Coory M, 2000, AUST NZ J PUBL HEAL, V24, P60, DOI 10.1111/j.1467-842X.2000.tb00724.x; Crengle S, 2009, INDIGENOUS CHILDRENS; D'Aprano A, 2016, QUAL HEALTH RES, V26, P613, DOI 10.1177/1049732314562891; Day A, 2013, AUST NZ J PUBL HEAL, V37, P350, DOI 10.1111/1753-6405.12083; de Onis M., 2004, FOOD NUTR B S1, V25, P1; Department of Families Housing Community Services and Indigenous Affairs, 2009, FOOTPR TIM LONG STUD; Department of Health and Aged Care (DoHAC), 2001, MEAS REM ACC REN IND; Dobbins TA, 2012, MED J AUSTRALIA, V197, P291, DOI 10.5694/mja11.11331; Durey A, 2010, AUST NZ J PUBL HEAL, V34, pS87, DOI 10.1111/j.1753-6405.2010.00560.x; Government Australian, 2013, NAT AB TORR STRAIT I; Hoy WE, 1999, KIDNEY INT, V56, P1072, DOI 10.1046/j.1523-1755.1999.00633.x; Hoy WE, 2010, MED J AUSTRALIA, V192, P14, DOI 10.5694/j.1326-5377.2010.tb03394.x; Jenkinson C, 1997, J Health Serv Res Policy, V2, P14; Korda RJ, 2009, AUST NZ J PUBL HEAL, V33, P458, DOI 10.1111/j.1753-6405.2009.00430.x; Lee KSK, 2014, DRUG ALCOHOL REV, V33, P473, DOI 10.1111/dar.12127; Leeder SR, 1998, AUST NZ J PUBL HEAL, V22, P635, DOI 10.1111/j.1467-842X.1998.tb01457.x; Lotz-Sisitka H, 2013, FUNDISA CHANGE IMPLE; Mackerras D, 2000, AUST NZ J PUBL HEAL, V24, P287, DOI 10.1111/j.1467-842X.2000.tb01570.x; McDonald JL, 2012, J PAEDIATR CHILD H, V48, P114, DOI 10.1111/j.1440-1754.2011.02067.x; McNamara BJ, 2012, INT J EPIDEMIOL, V41, P1661, DOI 10.1093/ije/dys190; O'Leary C, 2013, DEV MED CHILD NEUROL, V55, P271, DOI 10.1111/dmcn.12029; O'Leary CM, 2013, BIRTH DEFECTS RES A, V97, P497, DOI 10.1002/bdra.23142; Panaretto K, 2006, AUST NZ J PUBL HEAL, V30, P163, DOI 10.1111/j.1467-842X.2006.tb00111.x; Sayers SM, 2004, DIABETES RES CLIN PR, V65, P151, DOI 10.1016/j.diabres.2003.12.006; Sayers S, 2007, PAEDIATR PERINAT EP, V21, P411, DOI 10.1111/j.1365-3016.2007.00852.x; Sayers S, 2011, AM J HUM BIOL, V23, P417, DOI 10.1002/ajhb.21133; Sayers S, 2009, PAEDIATR PERINAT EP, V23, P548, DOI 10.1111/j.1365-3016.2009.01071.x; Schellong K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047776; Thomas A, 2010, AUST NZ J PSYCHIAT, V44, P40, DOI 10.3109/00048670903393589; Wake M, 2013, INT J OBESITY, V37, P86, DOI 10.1038/ijo.2012.86; World Health Organization Multicenter Growth Reference Study Group, WHO CHILD GROWTH STA; Wright A, 2018, AUST HEALTH REV, V42, P348, DOI 10.1071/AH16269; Zubrick S., 2004, W AUSTR ABORIGINAL C	38	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212130	10.1371/journal.pone.0212130	http://dx.doi.org/10.1371/journal.pone.0212130			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM2OT	30785929	Green Published, gold			2022-12-27	WOS:000459307000049
J	Chembrammel, P; Kesavadas, T				Chembrammel, Pramod; Kesavadas, Thenkurussi			A new implementation for online calculation of manipulator Jacobian	PLOS ONE			English	Article							ROBOT MANIPULATORS	This paper describes a new implementation for calculating Jacobian and its time derivative for robot manipulators in real-time. The estimation of Jacobian is the key in the real-time implementation of kinematics and dynamics of complex planar or spatial robots with fixed as well as floating axes in which the Jacobian form changes with the structure. The proposed method is suitable for such implementations. The new method is based on matrix differential calculus. Unlike the conventional methods, which are based on screw theory, the Jacobian calculation in the proposed approach has been reduced to the inner product of two matrices. Use of the new method to derive linear and angular velocity parts of Jacobian and its time derivative is described in detail. We have demonstrated the method using a two-DOF spatial robot and a hyper-redundant spatial robot.	[Chembrammel, Pramod; Kesavadas, Thenkurussi] Univ Illinois, Hlth Care Engn Syst Ctr, Urbana, IL 61820 USA; [Kesavadas, Thenkurussi] Univ Illinois, Ind & Enterprise Syst Engn Dept, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Chembrammel, P (corresponding author), Univ Illinois, Hlth Care Engn Syst Ctr, Urbana, IL 61820 USA.	pramodch@illinois.edu						Bogacki P., 1989, APPL MATH LETT, V2, P321, DOI [10.1016/0893-9659(89)90079-7, DOI 10.1016/0893-9659(89)90079-7]; Bruyninckx H, 1996, MECH MACH THEORY, V31, P135, DOI 10.1016/0094-114X(95)00069-B; Chembrammel P, 2013, THESIS; Chembrammel P, 2014, PROCEEDINGS OF THE ASME INTERNATIONAL MECHANICAL ENGINEERING CONGRESS AND EXPOSITION, 2013, VOL 4A; Chen C., 1999, LINEAR SYSTEM THEORY; Chen DC, 2018, IEEE T IND INFORM, V14, P3044, DOI 10.1109/TII.2017.2766455; Chitta S, 2007, IEEE INT CONF ROBOT, P4582, DOI 10.1109/ROBOT.2007.364185; Craig J. J, 2005, INTRO ROBOTICS MECH, V3; Ghoshal A, 2006, ROBOTICS FUNDAMENTAL; Gorner M, 2013, AUTON ROBOT, V34, P311, DOI 10.1007/s10514-013-9326-3; GREENWOOD DT, 1965, PRINCIPLES DYNAMICS; GROOD ES, 1983, J BIOMECH ENG-T ASME, V105, P136, DOI 10.1115/1.3138397; KIM SW, 1994, IEEE INT CONF ROBOT, P683, DOI 10.1109/ROBOT.1994.351407; Komsuoglu H, 2001, IEEE INT CONF ROBOT, P3650, DOI 10.1109/ROBOT.2001.933184; Mallik AK., 1994, KINEMATIC ANAL SYNTH; Orin D. E., 1984, International Journal of Robotics Research, V3, P66, DOI 10.1177/027836498400300404; Petersen K. B., 2008, MATRIX COOKBOOK; Renaud M, 1981, P 11 INT S IND ROB; Schilling R. J., 1990, FUNDAMENTALS ROBOTIC; Selig J. M., 1992, INTRDUCTORY ROBOTICS; Spong M. W., 1970, ROBOT MODELLING CONT; Tsai L.-W., 1999, ROBOT ANAL MECH SERI; Zhang Y., 2015, ZEROING DYNAMICS GRA	23	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0212018	10.1371/journal.pone.0212018	http://dx.doi.org/10.1371/journal.pone.0212018			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807576	Green Submitted, gold, Green Published			2022-12-27	WOS:000459712100010
J	Song, YH; Grimaldi, S; Santaniello, F; Cohen, DJ; Shi, JM; Bar-Yosef, O				Song, Yanhua; Grimaldi, Stefano; Santaniello, Fabio; Cohen, David J.; Shi, Jinming; Bar-Yosef, Ofer			Re-thinking the evolution of microblade technology in East Asia: Techno-functional understanding of the lithic assemblage from Shizitan 29 (Shanxi, China)	PLOS ONE			English	Article							NORTHERN CHINA; PROVINCE; SITE	The lithic assemblage from Shizitan 29, a late Upper Paleolithic open-air site in Shanxi, China, provides evidence for the earliest, well-dated microblade production in East Asia, ca. 26/24 Ka cal BP. To pursue a behavioral rather than traditional typological understanding of this key adaptive technology, we apply a techno-functional approach that enables us to reconstruct the entire operational sequence in behavioral terms through the derivation of technical objectives. This methodology can serve as a model to be applied to other assemblages for greater understanding of the origins and spread of the broadly distributed eastern Asian Late Pleistocene microblade industries. Within the eight cultural layers at Shizitan 29, microblade production abruptly appears at the top of Layer 7 following earlier core-and-flake production, supporting hypotheses of microblade technology arising within adaptive strategies to worsening Late Glacial Maximum environments. Significantly, reconstruction of the operational sequence supports microblade technology being introduced into the North China Loess Plateau from regions further north. It also allows us to re-think microblades' relationship in behavioral terms with earlier limited examples of East Asian blade production and the evolution and spread of microblade technology, providing new insights into the adaptive relationships between subsequent microblade productions.	[Song, Yanhua] Shanxi Univ, Dept Archaeol, Taiyuan, Shanxi, Peoples R China; [Grimaldi, Stefano; Santaniello, Fabio] Univ Trento, Dipartimento Lettere & Filosofia, Trento, Italy; [Grimaldi, Stefano; Santaniello, Fabio] Ist Italiano Paleontol Umana, Anagni, Italy; [Santaniello, Fabio] Progetto Did Ct, Trento, Italy; [Cohen, David J.] Natl Taiwan Univ, Dept Anthropol, Taipei, Taiwan; [Shi, Jinming] Shanxi Museum, Taiyuan, Shanxi, Peoples R China; [Bar-Yosef, Ofer] Harvard Univ, Dept Anthropol, Cambridge, MA 02138 USA	Shanxi University; University of Trento; National Taiwan University; Harvard University	Grimaldi, S (corresponding author), Univ Trento, Dipartimento Lettere & Filosofia, Trento, Italy.; Grimaldi, S (corresponding author), Ist Italiano Paleontol Umana, Anagni, Italy.	stefano.grimaldi@unitn.it	Cohen, David J/A-7526-2015	Cohen, David J/0000-0002-5973-8566; Grimaldi, Stefano/0000-0002-9145-8011	Sanjin Scholar Program of Shanxi Province; Short-Term Foreign Program Shanxi University [S20181400007]; American School of Prehistoric Research	Sanjin Scholar Program of Shanxi Province; Short-Term Foreign Program Shanxi University; American School of Prehistoric Research	Y.S. received award from Sanjin Scholar Program of Shanxi Province and the Short-Term Foreign Program Shanxi University (S20181400007). O.B.-Y. received award from American School of Prehistoric Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	and Shanxi Institute of Archaeology, 2017, KAOGU ARCHAEOLOGY, V2, P35; Bae CJ, 2017, SCIENCE, V358, DOI 10.1126/science.aai9067; Bahn P., 2001, PENGUIN ARCHAEOLOGY, P428; Bar-Yosef O, 1998, CAMB ARCHAEOL J, V8, P141, DOI 10.1017/S0959774300001815; Bar-Yosef O, 2002, ANNU REV ANTHROPOL, V31, P363, DOI 10.1146/annurev.anthro.31.040402.085416; Bar-Yosef O, 1999, AM ANTHROPOL, V101, P322, DOI 10.1525/aa.1999.101.2.322; Bar-Yosef O, 2015, ANTHROPOL-INT J HUM, V53, P77; Bar-Yosef O, 2012, ANNU REV ANTHROPOL, V41, P319, DOI 10.1146/annurev-anthro-092611-145832; Barton L, 2007, DEV QUATER SCI, V9, P105, DOI 10.1016/S1571-0866(07)09009-4; Boeda E., 1994, CONCEPT LEVALLOIS VA; Bordaz J., 1970, TOOLS OLD NEW STONE; BORDES F, 1968, OLD STONE AGE; Bordes F., 1961, TYPOLOGIE PALEOLITHI; Brezillon M. N., 1971, DENOMINATION OBJETS; Chen C., 1983, ACTA ANTHROPOL SIN, V2, P331; Chen H, 2013, QUATERN INT, V295, P253, DOI 10.1016/j.quaint.2012.12.008; Chen Y, 2018, KAOGU, V10, P76; Darvill T., 2008, CONCISE OXFORD DICT; Du SS, 2007, ACTA ARCHAEOLOGICA S, V2, P127; Elston R.G., 2008, ARCHAEOLOGICAL PAPER, V12, P103; [高星 Gao Xing], 2006, [第四纪研究, Quaternary Sciences], V26, P504; Geneste JM, 1992, APPROVISIONNEMNET MA, P1; Goebel T., 2002, ARCHAEOLOGICAL PAPER, V12, P117, DOI 10.1525/ap3a.2002.12.1.117; Grimaldi S, 2014, QUARTAR, V61, P113, DOI DOI 10.7485/QU61_; Grimaldi S, 2014, QUATERN INT, V350, P116, DOI 10.1016/j.quaint.2014.03.057; Hirasawa Y, 2017, QUATERN INT, V442, P104, DOI 10.1016/j.quaint.2016.07.021; Ikawa-Smith F., 2007, ORIGIN SPREAD MICROB, P189; Kato S., 2015, HUAXIA KAOGU, V2, P56; Kato S, 2014, QUATERN INT, V347, P105, DOI 10.1016/j.quaint.2014.07.013; Keates S.G., 2007, ORIGIN SPREAD MICROB, P125; Kuzmin Varoslav., 2007, ORIGIN SPREAD MICROB; Kuzmin YV, 2007, RADIOCARBON, V49, P757, DOI 10.1017/S0033822200042636; Li F, 2016, SCI CHINA EARTH SCI, V59, P1540, DOI 10.1007/s11430-016-5305-9; Li F, 2013, J HUM EVOL, V64, P161, DOI 10.1016/j.jhevol.2012.11.001; [李锋 Li Feng], 2012, [人类学学报, Acta Anthropologica Sinica], V31, P41; Liu L, 2018, ANTIQUITY, V92, P603, DOI 10.15184/aqy.2018.36; MORLAN RE, 1970, ARCTIC ANTHROPOL, V7, P17; Nian XM, 2014, QUATERN INT, V347, P113, DOI 10.1016/j.quaint.2014.05.053; Odell GH, 2004, LITHIC ANAL; Pelegrin J., 2000, MEMOIRES PREHISTOIRE, P73; Pelegrin J., 2012, EMERGENCE PRESSURE B, P465; Peng F, 2014, QUATERN INT, V347, P12, DOI 10.1016/j.quaint.2014.04.041; Qu TL, 2013, J ARCHAEOL RES, V21, P1, DOI 10.1007/s10814-012-9059-4; Sato Hiroyuki., 2007, ORIGIN SPREAD MICROB, P53; Seong C., 2015, ASIAN PERSPECT, P91; Shi J.M., 2013, ARCHAEOLOGY, V8, P46; Shi J.M., 2013, CULTURAL RELICS CENT, V1, P17; Song Y. H., 2015, QUATERN INT, V400, P140; Song YH, 2017, J ARCHAEOL SCI, V79, P19, DOI 10.1016/j.jas.2017.01.007; [宋艳花 SONG Yanhua], 2011, [人类学学报, Acta Anthropologica Sinica], V30, P115; SUN CW, 2017, ADV MECH ENG, V9; Tixier J, 1980, PREHISTOIRE PIERRE T; Wang Y., 2005, ROOTS PLEISTOCENE HO; Wang Y. R., 1991, ACTA ARCHAEOLOGICA S, V10, P1; Yi MJ, 2016, QUATERN INT, V400, P130, DOI 10.1016/j.quaint.2015.07.009; Yi MJ, 2013, J ANTHROPOL ARCHAEOL, V32, P212, DOI 10.1016/j.jaa.2013.02.001; Zhang JF, 2011, J ARCHAEOL SCI, V38, P1537, DOI 10.1016/j.jas.2011.02.019; 李锋, 2016, [中国科学. 地球科学, Scientia Sinica Terrae], V46, P891	58	10	10	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2019	14	2							e0212643	10.1371/journal.pone.0212643	http://dx.doi.org/10.1371/journal.pone.0212643			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8EH	30802253	gold, Green Published, Green Submitted			2022-12-27	WOS:000459710700016
J	Felten, R; Perrin, P; Caillard, S; Moulin, B; Javier, RM				Felten, Renaud; Perrin, Peggy; Caillard, Sophie; Moulin, Bruno; Javier, Rose-Marie			Avascular osteonecrosis in kidney transplant recipients: Risk factors in a recent cohort study and evaluation of the role of secondary hyperparathyroidism	PLOS ONE			English	Article							FEMORAL-HEAD; RENAL-TRANSPLANTATION; NONTRAUMATIC OSTEONECROSIS; ASEPTIC NECROSIS; BONE NECROSIS; ASSOCIATION; POPULATION; PREVALENCE; PREDNISONE; FAT	Avascular osteonecrosis (AVN) is a bone complication that indicates poor functional prognosis. Modern immunosuppressive and steroid-sparing drugs have significantly lowered the occurrence of AVN after kidney transplantation (KT). However, recent data on its incidence rates and risk factors are lacking. Using a large, recent cohort, we sought to investigate AVN incidence and risk factors, with a special focus on mineral and bone disorders. We conducted a cohort study in 805 patients who underwent KT between 2004 and 2014. AVN was identified in 32 patients (4%): before KT in 15 (1.8%) and after KT in 18 (2.2%) cases, including one patient with both. In the group with post-KT AVN, the median time intervals from KT to 1) first symptoms and 2) AVN diagnosis were 12 months [1-99] and 20 months [4-100], respectively. Being overweight/obese, having pre-transplant diabetes or hyperparathyroidism at transplantation, developing acute rejection, and receiving higher cumulative corticosteroid doses were associated with AVN occurrence. Multivariate analysis revealed that BMI. 26 kg/m(2) and higher cumulative corticosteroid doses were predictive of AVN. In conclusion, overweight/obesity is a strong risk factor for AVN. Despite a low maintenance dose, the use of corticosteroids-mostly for treatment of acute rejection-remains an independent risk factor.	[Felten, Renaud; Javier, Rose-Marie] Univ Hosp, Dept Rheumatol, Strasbourg, France; [Felten, Renaud; Perrin, Peggy; Caillard, Sophie; Moulin, Bruno; Javier, Rose-Marie] Federat Med Translat FMTS, Strasbourg, France; [Perrin, Peggy; Caillard, Sophie; Moulin, Bruno] Univ Hosp Strasbourg, Dept Nephrol Transplantat, Strasbourg, France	CHU Strasbourg; CHU Strasbourg	Perrin, P (corresponding author), Federat Med Translat FMTS, Strasbourg, France.; Perrin, P (corresponding author), Univ Hosp Strasbourg, Dept Nephrol Transplantat, Strasbourg, France.	peggy.perrin@chru-strasbourg.fr	Caillard, Sophie/AAG-3790-2019; Felten, Renaud/ABC-4204-2020	Felten, Renaud/0000-0002-4951-4032; caillard, sophie/0000-0002-0525-4291; MOULIN, Bruno/0000-0001-6772-7165; Perrin, Peggy/0000-0001-7343-5943				Agarwala S, 2011, J ARTHROPLASTY, V26, P1128, DOI 10.1016/j.arth.2010.11.010; Ajmal M, 2009, ORTHOP CLIN N AM, V40, P235, DOI 10.1016/j.ocl.2009.01.004; ALEXEEVA L, 1994, WHO TECH REP SER, V843, P1; ARLET J, 1972, REV RHUM, V39, P717; Asano Takeshi, 2003, Pharmacogenetics, V13, P675, DOI 10.1097/00008571-200311000-00003; Atallah AM, 2009, RHEUMATOL INT, V30, P75, DOI 10.1007/s00296-009-0918-3; Bredella MA, 2011, OBESITY, V19, P49, DOI 10.1038/oby.2010.106; Celik A, 2006, TRANSPL P, V38, P512, DOI 10.1016/j.transproceed.2005.12.062; CRUESS RL, 1968, J BONE JOINT SURG AM, VA 50, P1577, DOI 10.2106/00004623-196850080-00006; Ekberg H, 2007, NEW ENGL J MED, V357, P2562, DOI 10.1056/NEJMoa067411; Ekmekci Y, 2006, NEPHROL DIAL TRANSPL, V21, P3555, DOI 10.1093/ndt/gfl400; Ferrari P, 2002, TRANSPLANTATION, V74, P1147, DOI 10.1097/00007890-200210270-00016; HARRINGTON KD, 1971, J BONE JOINT SURG AM, VA 53, P203, DOI 10.2106/00004623-197153020-00001; Hedri H, 2007, TRANSPL P, V39, P1036, DOI 10.1016/j.transproceed.2007.02.031; Hirata T, 2007, J ORTHOP SCI, V12, P199, DOI 10.1007/s00776-007-1110-9; Hirata T, 2007, J RHEUMATOL, V34, P516; JACOBS B, 1992, NEW YORK STATE J MED, V92, P334; Khwaja K, 2004, AM J TRANSPLANT, V4, P980, DOI 10.1111/j.1600-6143.2004.00443.x; Lai KA, 2005, J BONE JOINT SURG AM, V87A, P2155, DOI 10.2106/JBJS.D.02959; LAUSTEN GS, 1988, ACTA ORTHOP SCAND, V59, P650, DOI 10.3109/17453678809149417; Lopez-Ben R, 2004, CLIN RADIOL, V59, P431, DOI 10.1016/j.crad.2003.11.001; Moya-Angeler J, 2015, WORLD J ORTHOP, V6, P590, DOI 10.5312/wjo.v6.i8.590; NAIKER IP, 1993, S AFR MED J, V83, P646; NEHME D, 1989, NEPHROL DIAL TRANSPL, V4, P123; PATTON PR, 1988, SURGERY, V103, P63; Paydas S, 2011, TRANSPL P, V43, P863, DOI 10.1016/j.transproceed.2011.02.072; Perrin P, 2013, AM J TRANSPLANT, V13, P2653, DOI 10.1111/ajt.12425; PIERIDES AM, 1975, Q J MED, V44, P459; Potluri K, 2010, AM J KIDNEY DIS, V56, P143, DOI 10.1053/j.ajkd.2010.01.017; Pritchett JW, 2001, CLIN ORTHOP RELAT R, P173; RAO DS, 1993, NEW ENGL J MED, V328, P171, DOI 10.1056/NEJM199301213280304; Saito M, 2014, ACTA ORTHOP, V85, P266, DOI 10.3109/17453674.2014.916490; Schachtner T, 2018, NEPHROL DIAL TRANSPL, V33, P2060, DOI 10.1093/ndt/gfy148; Serrano OK, 2017, TRANSPLANTATION, V101, P2590, DOI 10.1097/TP.0000000000001756; Shibatani M, 2008, ACTA ORTHOP, V79, P631, DOI 10.1080/17453670810016641; Sprague SM, 2016, AM J KIDNEY DIS, V67, P559, DOI 10.1053/j.ajkd.2015.06.023; Takao M, 2011, RHEUMATOL INT, V31, P165, DOI 10.1007/s00296-009-1241-8; Tang S, 1999, INT J ARTIF ORGANS, V22, P131, DOI 10.1177/039139889902200304; Tang S, 2000, TRANSPLANT P, V32, P1873, DOI 10.1016/S0041-1345(00)01471-8; TERVONEN O, 1992, RADIOLOGY, V182, P845, DOI 10.1148/radiology.182.3.1535906; Yuan HF, 2016, OSTEOPOROSIS INT, V27, P295, DOI 10.1007/s00198-015-3317-5; Zhao DW, 2015, CHINESE MED J-PEKING, V128, P2843, DOI 10.4103/0366-6999.168017; Zhou L, 2015, SCI REP-UK, V5, DOI 10.1038/srep09397	43	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212931	10.1371/journal.pone.0212931	http://dx.doi.org/10.1371/journal.pone.0212931			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794689	Green Published, gold, Green Submitted			2022-12-27	WOS:000459709100159
J	Haruma, T; Yamaji, K; Ogawa, K; Masuya, H; Sekine, Y; Kozai, N				Haruma, Toshikatsu; Yamaji, Keiko; Ogawa, Kazuyoshi; Masuya, Hayato; Sekine, Yurina; Kozai, Naofumi			Root-endophytic Chaetomium cupreum chemically enhances aluminium tolerance in Miscanthus sinensis via increasing the aluminium detoxicants, chlorogenic acid and oosporein	PLOS ONE			English	Article							TOXICITY; SIDEROPHORES; GROWTH; FUNGUS; PLANT; RESISTANCE; TRANSPORT; ROLES; PB	Miscanthus sinensis Andersson is a pioneer plant species that grows naturally at mining sites. Miscanthus sinensis can detoxify aluminium (Al) by producing phytosiderophores, such as chlorogenic acid, citric acid, and malic acid, and localizing Al in cell walls. Rootendophytic Chaetomium cupreum, which produces microbial siderophores, enhances Al tolerance in M. sinensis. However, we could not determine whether the siderophores produced by C. cupreum actually enhance Al tolerance in M. sinensis, because the microbial siderophores have not yet been identified in previous research. The purpose of this study was to clarify how C. cupreum chemically increases Al tolerance in M. sinensis under acidic mining site conditions, especially considering siderophores. Using instrumental analyses, the siderophore produced by C. cupreum was identified as oosporein. Comparison of the stability constant between Al and phytosiderophores and oosporein indicated that oosporein could detoxify Al similarly to chlorogenic acid, which shows higher stability constant than citric acid and malic acid. Inoculation test of C. cupreum onto M. sinensis in acidic mine soil showed that C. cupreum promoted seedling growth, and enhanced Al tolerance via inducing chlorogenic-acid production and producing oosporein. These results suggested that C. cupreum could chemically enhance Al tolerance and might promote growth via reducing excessive Al in cell walls, the main site of Al accumulation. In addition, the chemical enhancement of Al tolerance by C. cupreum might be important for M. sinensis to adapt to acidic mining sites.	[Haruma, Toshikatsu; Yamaji, Keiko; Ogawa, Kazuyoshi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Masuya, Hayato] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki, Japan; [Sekine, Yurina] Japan Atom Energy Agcy, Mat Sci Res Ctr, Tokai, Ibaraki, Japan; [Kozai, Naofumi] Japan Atom Energy Agcy, Adv Sci Res Ctr, Tokai, Ibaraki, Japan	University of Tsukuba; Forestry & Forest Products Research Institute - Japan; Japan Atomic Energy Agency; Japan Atomic Energy Agency	Yamaji, K (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.	yamaji.keiko.fp@u.tsukuba.ac.jp	Masuya, Hayato/AAN-8998-2021	Sekine, Yurina/0000-0002-8971-2498	Sasakawa Scientific Research Grant of The Japan Science Society [28-530]; JSPS KAKENHI [25292080]	Sasakawa Scientific Research Grant of The Japan Science Society; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	TH received award from the Sasakawa Scientific Research Grant of The Japan Science Society (grant number: 28-530, https://www.jss.or.jp/ikusei/sasakawa/).KY received award from the JSPS KAKENHI (grant number: 25292080, https://www.jsps.go.jp/j-grantsinaid/).The funders played roles in data collection and analysis.	Adams ML, 2002, J CHEM ENG DATA, V47, P289, DOI 10.1021/je010279e; Ahmed E, 2014, MICROB BIOTECHNOL, V7, P196, DOI 10.1111/1751-7915.12117; ALEXANDER DB, 1991, BIOL FERT SOILS, V12, P39, DOI 10.1007/BF00369386; [Anonymous], 1974, JPN J HUMANIT NAT SC; Barcelo J, 2002, ENVIRON EXP BOT, V48, P75, DOI 10.1016/S0098-8472(02)00013-8; Bjerrum J., 1941, METAL AMMINE FORMATI, P123; Braud A, 2009, CHEMOSPHERE, V74, P280, DOI 10.1016/j.chemosphere.2008.09.013; CHENERY EM, 1948, ANN BOT-LONDON, V12, P121, DOI 10.1093/oxfordjournals.aob.a083177; Das A, 2012, PLANT SIGNAL BEHAV, V7, P103, DOI 10.4161/psb.7.1.18472; Day RA Jr, 1982, ACID BASE EQUILIBRIA, P166; DELHAIZE E, 1995, PLANT PHYSIOL, V107, P315, DOI 10.1104/pp.107.2.315; Deng ZJ, 2014, ENVIRON SCI POLLUT R, V21, P2346, DOI 10.1007/s11356-013-2163-2; GADD GM, 1993, NEW PHYTOL, V124, P25, DOI 10.1111/j.1469-8137.1993.tb03796.x; Haruma T, 2018, PLANT SPEC BIOL, V33, P109, DOI 10.1111/1442-1984.12197; He G, 2012, ACTA CRYSTALLOGR E, V68, pO1231, DOI 10.1107/S1600536812012950; HUTCHINSON GE, 1945, SOIL SCI, V60, P29, DOI 10.1097/00010694-194507000-00004; Izumi F, 2007, SOLID STATE PHENOMEN, V130, P15, DOI 10.4028/www.scientific.net/SSP.130.15; Jentschke G, 2000, PHYSIOL PLANTARUM, V109, P107, DOI 10.1034/j.1399-3054.2000.100201.x; KINRAIDE TB, 1991, PLANT SOIL, V134, P167, DOI 10.1007/BF00010729; Kochian LV, 2005, PLANT SOIL, V274, P175, DOI 10.1007/s11104-004-1158-7; Larcher W, 2003, PHYSL PLANT ECOLOGY; Li T, 2011, SCI TOTAL ENVIRON, V409, P1069, DOI 10.1016/j.scitotenv.2010.12.012; Ma JF, 1997, NATURE, V390, P569, DOI 10.1038/37518; Ma JF, 2001, TRENDS PLANT SCI, V6, P273, DOI 10.1016/S1360-1385(01)01961-6; Mao BZ, 2010, AFR J BIOTECHNOL, V9, P5955; Nagaoka T, 2004, Z NATURFORSCH C, V59, P302; Nagata S, 2015, PLANT SPEC BIOL, V30, P116, DOI 10.1111/1442-1984.12039; NAGATA T, 1992, PHYTOCHEMISTRY, V31, P1215, DOI 10.1016/0031-9422(92)80263-E; NEILANDS JB, 1952, J AM CHEM SOC, V74, P4846, DOI 10.1021/ja01139a033; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; Rajkumar M, 2012, BIOTECHNOL ADV, V30, P1562, DOI 10.1016/j.biotechadv.2012.04.011; ROBINSON WO, 1945, SOIL SCI, V60, P15, DOI 10.1097/00010694-194507000-00003; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Rogers NJ, 2001, BIOMETALS, V14, P59, DOI 10.1023/A:1016691301330; Schalk IJ, 2011, ENVIRON MICROBIOL, V13, P2844, DOI 10.1111/j.1462-2920.2011.02556.x; SCHINDLER DW, 1988, SCIENCE, V239, P149, DOI 10.1126/science.239.4836.149; Schulz B, 1999, MYCOL RES, V103, P1275, DOI 10.1017/S0953756299008540; Seguel A, 2013, MYCORRHIZA, V23, P167, DOI 10.1007/s00572-013-0479-x; Tabuchi A, 2001, PHYSIOL PLANTARUM, V112, P353, DOI 10.1034/j.1399-3054.2001.1120308.x; TAKEMOTO T, 1978, P JPN ACAD B-PHYS, V54, P469, DOI 10.2183/pjab.54.469; TOMSETT AB, 1988, PLANT CELL ENVIRON, V11, P383, DOI 10.1111/j.1365-3040.1988.tb01362.x; VINING LC, 1962, CAN J MICROBIOL, V8, P931, DOI 10.1139/m62-122; Wang J, 2016, SCI REP-UK, V6, DOI 10.1038/srep20728; Xiao X, 2010, BIORESOURCE TECHNOL, V101, P1668, DOI 10.1016/j.biortech.2009.09.083; Yamaji K, 2012, FOREST PATHOL, V42, P1, DOI 10.1111/j.1439-0329.2010.00709.x; Yamaji K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0169089; YOSHII Y, 1937, BOT MAG, V51, P262, DOI DOI 10.15281/JPLANTRES1887.51.262	47	15	15	6	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212644	10.1371/journal.pone.0212644	http://dx.doi.org/10.1371/journal.pone.0212644			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794662	Green Published, gold, Green Submitted			2022-12-27	WOS:000459709100102
J	Savasi, V; Parisi, F; Oneta, M; Laoreti, A; Parrilla, B; Duca, P; Cetin, I				Savasi, Valeria; Parisi, Francesca; Oneta, Monica; Laoreti, Arianna; Parrilla, Bina; Duca, Piergiorgio; Cetin, Irene			Effects of highly active antiretroviral therapy on semen parameters of a cohort of 770 HIV-1 infected men	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-INFECTED MEN; SPERM MOTILITY; DECREASE	Background HIV-1 infected patients show impaired semen parameters. Currently, it is not clear whether HIV-1 infection itself or antiretroviral therapy have an effect on semen parameters. We aim evaluate semen quality in a large cohort of fertile HIV-1 infected men under stable highly active antiretroviral therapy (HAART) and to assess the effect of HAART type and duration on semen parameters. Materials and methods Between January 2010 and June 2014, we enrolled in a retrospective case-control study 770 HIV-1 patients under stable HAART asking a reproductive counselling with their HIV negative partner. Co-infections with HBV or HCV, genital tract infections and known causes of infertility represented exclusion criteria. Semen samples were analysed and compared with the WHO reference values. A multivariate analysis including HAART type and duration, age, viral load and CD4 count, was performed on 600 patients out of 770. Results The median values of all semen parameters were significantly lower among HIV-1 infected patients compared to the WHO reference group, with a significant proportion of patients having values below the 5th percentile of the WHO reference value. In a multivariate analysis, only age and viral load negatively impacted progressive motility (beta -0.3 (95% CI: -0.5; -0.0)%, p<0.05) and semen morphology (beta -0.00 (95% CI: -0.00; -0.00) %, p <= 0.01), while no associations were detected as regards HAART type and duration. Conclusions HIV-1 infected patients showed a significant impairment of semen parameters compared to the reference values. HAART type and duration showed no associations with semen quality. Further research is needed to investigate implications for clinical care of HIV infected men desiring a child.	[Savasi, Valeria; Parisi, Francesca; Oneta, Monica; Laoreti, Arianna; Parrilla, Bina; Cetin, Irene] Univ Milan, Unit Obstet & Gynecol, Dept Biomed & Clin Sci, ASST Fatebenefratelli Sacco,Hosp L Sacco, Milan, Italy; [Savasi, Valeria; Parisi, Francesca; Laoreti, Arianna; Cetin, Irene] Univ Milan, Ctr Fetal Res Giorgio Pardi, Milan, Italy; [Duca, Piergiorgio] Univ Milan, Hosp L Sacco, Dept Biomed & Clin Sci, Stat & Biometry Unit, Milan, Italy	University of Milan; Luigi Sacco Hospital; University of Milan; University of Milan; Luigi Sacco Hospital	Savasi, V (corresponding author), Univ Milan, Unit Obstet & Gynecol, Dept Biomed & Clin Sci, ASST Fatebenefratelli Sacco,Hosp L Sacco, Milan, Italy.; Savasi, V (corresponding author), Univ Milan, Ctr Fetal Res Giorgio Pardi, Milan, Italy.	valeria.savasi@unimi.it	Laoreti, Arianna/AAC-2137-2019; cetin, irene/K-6112-2016; Parisi, Francesca/AAB-7065-2019; SAVASI, VALERIA MARIA/K-8433-2016	cetin, irene/0000-0002-9217-3034; Parisi, Francesca/0000-0003-2017-7869; SAVASI, VALERIA MARIA/0000-0002-1476-7689	Giorgio Pardi Foundation	Giorgio Pardi Foundation	We thank Giorgio Pardi Foundation for its support to our research.	Bujan L, 2007, J ANDROL, V28, P444, DOI 10.2164/jandrol.106.001529; CRITTENDEN JA, 1992, FERTIL STERIL, V57, P1294; Dejucq-Rainsford N, 2004, CURR PHARM DESIGN, V10, P557, DOI 10.2174/1381612043453225; Dondero F., 1996, HUMAN REPROD, V17, P2112; Dulioust E, 2002, HUM REPROD, V17, P2112, DOI 10.1093/humrep/17.8.2112; Dulioust E, 2010, AIDS, V24, P1595, DOI 10.1097/QAD.0b013e32833b47fc; Frapsauce C, 2015, HUM REPROD, V30, P1797, DOI 10.1093/humrep/dev141; Garrido N, 2005, HUM REPROD, V20, P1028, DOI 10.1093/humrep/deh699; Gunthard HF, 2016, JAMA-J AM MED ASSOC, V316, P191, DOI 10.1001/jama.2016.8900; Jeronimo A, 2017, HUM REPROD, V32, P265, DOI 10.1093/humrep/dew321; Kehl S, 2011, ARCH GYNECOL OBSTET, V284, P229, DOI 10.1007/s00404-011-1898-6; KOVALSKI NN, 1992, FERTIL STERIL, V58, P809; Krisfalusi M, 2006, BIOL REPROD, V75, P270, DOI 10.1095/biolreprod.105.049684; Leandri RD, 2003, INT J ANDROL, V26, P305; Leruez-Ville M, 2002, AIDS, V16, P486, DOI 10.1097/00002030-200202150-00023; Mueller NJ, 2010, AIDS, V24, P1127, DOI 10.1097/QAD.0b013e328337b161; Muller CH, 1998, ANDROLOGIA, V30, P15; Nazmara Z, 2018, UROL J; Nicopoullos JDM, 2004, HUM REPROD, V19, P2289, DOI 10.1093/humrep/deh426; Pavili L, 2010, FERTIL STERIL, V94, P2151, DOI 10.1016/j.fertnstert.2009.12.080; Pilatz A, 2014, AIDS, V28, P875, DOI 10.1097/QAD.0000000000000161; Price TO, 2005, BRAIN RES, V1045, P57, DOI 10.1016/j.brainres.2005.03.031; Savasi V, 2013, HUM REPROD UPDATE, V19, P136, DOI 10.1093/humupd/dms046; Sturmer M, 2008, ANTIVIR THER, V13, P729; Taylor S, 2001, J ANTIMICROB CHEMOTH, V48, P351, DOI 10.1093/jac/48.3.351; Viard JP, 2004, AIDS, V18, P45, DOI 10.1097/00002030-200401020-00005; White DJ, 2001, AIDS, V15, P1061, DOI 10.1097/00002030-200105250-00017; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_	28	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212194	10.1371/journal.pone.0212194	http://dx.doi.org/10.1371/journal.pone.0212194			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789923	Green Published, gold, Green Submitted			2022-12-27	WOS:000459330800019
J	Davis, EO; Crudge, B; Lim, T; O'Connor, D; Roth, V; Hunt, M; Glikman, JA				Davis, Elizabeth Oneita; Crudge, Brian; Lim, Thona; O'Connor, David; Roth, Vichet; Hunt, Matt; Glikman, Jenny Anne			Understanding the prevalence of bear part consumption in Cambodia: A comparison of specialised questioning techniques	PLOS ONE			English	Article							SENSITIVE QUESTIONS; CONSERVATION; BIODIVERSITY; ATTITUDES; EXAMPLE	The trade in bear parts for medicine and for status is a conservation challenge throughout Asia. The Asiatic black bear (Ursus thibetanus) and the sun bear (Helarctos malayanus) are endemic to this region, and populations are estimated to have declined throughout their ranges due to widespread illegal killing of bears and trade in parts, combined with loss of habitat. Previous studies have indicated that legislation alone is insufficient to prevent illegal hunting and trade, indicating instead a need to address demand for bear parts and products. We conducted mixed-method surveys in Cambodia to understand the key motivators for individuals to consume bear parts, and to understand whether specialised questioning techniques are applicable in this context. Bear part use is illegal in Cambodia and may therefore be considered a sensitive behaviour, in that individuals may be reluctant to admit to it. To counteract possible biases, four specialised questioning techniques were used in this study: randomised response technique (RRT), unmatched count technique (UCT), nominative technique (NT), and false consensus bias (FCB). All four methods serve to shield a respondent's admittance of a sensitive behaviour from the interviewer. The results presented here show that great variability exists in anonymous methods' efficacy in certain contexts. However, the results overall indicate that individuals in Cambodia are under-reporting their consumption of bear parts when directly asked, and that the prevalence of bear part use in Cambodia may be as high as 15% of the population, representing a significant conservation challenge.	[Davis, Elizabeth Oneita; O'Connor, David; Glikman, Jenny Anne] San Diego Zoo Inst Conservat Res, Escondido, CA 92027 USA; [Davis, Elizabeth Oneita] Univ Bristol, Dept Archaeol & Anthropol, Bristol, Avon, England; [Crudge, Brian; Lim, Thona; Roth, Vichet; Hunt, Matt] Free Bears, Phnom Penh, Cambodia; [O'Connor, David] Natl Geog Partners NW, Washington, DC USA; [O'Connor, David] Goethe Univ, Fac Biol Sci, Frankfurt, Germany	Zoological Society of San Diego; University of Bristol; Goethe University Frankfurt	Davis, EO (corresponding author), San Diego Zoo Inst Conservat Res, Escondido, CA 92027 USA.; Davis, EO (corresponding author), Univ Bristol, Dept Archaeol & Anthropol, Bristol, Avon, England.	eoneitadavis@gmail.com	Gilkman, Jenny/AAA-2814-2020	O'Connor, David/0000-0001-8604-1812; Crudge, Brian/0000-0001-9578-6592; Davis, Elizabeth/0000-0003-3446-4471; Lim, Thona/0000-0003-4044-2236; Glikman, Jenny Anne/0000-0002-0208-5488	United States Fish and Wildlife Service (USFWS) [F17AP00830]; Perth Zoo	United States Fish and Wildlife Service (USFWS)(US Fish & Wildlife Service); Perth Zoo	Funded by United States Fish and Wildlife Service (USFWS): https://www.fws.gov/.Grant Number: F17AP00830. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Cambodian Ministry of Environment for providing permission to conduct this research. We thank Perth Zoo for co-funding, and the Royal University of Phnom Penh, particularly Dr Saveng Ith, for facilitating research conducted in the Cardamom Mountains study site. We also thank every member of the research team who assisted with data collection. We also would like to thank Jillian Knox for the creation of Fig 1, and Dr. M. Gibson for her helpful comments. We would also like to thank Drs F. St. John, A. Nuno, and A. Hinsley for their advice and assistance, as well as the three reviewers of this manuscript for their invaluable suggestions.	Alves R. R. N., 2018, Ethnozoology: animals in our lives, P481; Alves RNN, 2013, ANIMALS TRADITIONAL, P25, DOI DOI 10.1007/978-3-642-29026-8_3; Alves RRN, 2007, J ETHNOBIOL ETHNOMED, V3, DOI 10.1186/1746-4269-3-14; [Anonymous], 2006, TRADE NATURAL RESOUR; [Anonymous], 2018, WORLD FACTBOOK; Barnett Julie, 1998, J MANAGERIAL PSYCHOL, V13, P63, DOI DOI 10.1108/02683949810369138; Burgess E.A., 2014, BROUGHT BEAR ANAL SE; Burke A, 2003, AM J PUBLIC HEALTH, V93, P1082, DOI 10.2105/AJPH.93.7.1082; Corlett RT, 2007, BIOTROPICA, V39, P292, DOI 10.1111/j.1744-7429.2007.00271.x; Coudrat CNZ, 2011, ORYX, V45, P427, DOI 10.1017/S0030605310001080; Coutts E, 2011, SOCIOL METHOD RES, V40, P169, DOI 10.1177/0049124110390768; Crudge B., 2016, International Zoo Yearbook, V50, P34, DOI 10.1111/izy.12120; Crudge B, 2020, ORYX, V54, P252, DOI 10.1017/S0030605317001752; Davis EO, 2016, BIOL CONSERV, V203, P282, DOI 10.1016/j.biocon.2016.09.009; DAWES RM, 1989, J EXP SOC PSYCHOL, V25, P1, DOI 10.1016/0022-1031(89)90036-X; Duffy R, 2015, ENVIRON CONSERV, V42, P345, DOI 10.1017/S0376892915000119; Dutton AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021243; Feng YB, 2009, J ETHNOBIOL ETHNOMED, V5, DOI 10.1186/1746-4269-5-2; Galobardes B, 2003, SOZ PRAVENTIV MED, V48, P70, DOI 10.1007/s000380300008; Garshelis D., 2016, IUCN RED LIST THREAT, DOI [DOI 10.1037/a0029314, 10.2305/IUCN.UK.2016-3.RLTS.T22824A45034242.en, DOI 10.2305/IUCN.UK.2016-3.RLTS.T22824A45034242.EN]; Gellman M, 2010, DEV PRACT, V20, P85, DOI 10.1080/09614520903436984; Gray Thomas N.E., 2017, Cambodian Journal of Natural History, V1, P38; Gray TNE, 2018, BIODIVERS CONSERV, V27, P1031, DOI 10.1007/s10531-017-1450-5; Harrison RD, 2016, CONSERV BIOL, V30, P972, DOI 10.1111/cobi.12785; Hinsley A, 2017, CONSERV LETT, V10, P602, DOI 10.1111/conl.12316; Ibbett H, 2017, ORYX, P1; Janmejay Sethy, 2011, International Journal of Bio-resource and Stress Management, V2, P409; John FAVS, 2010, BIOL CONSERV, V143, P1025, DOI 10.1016/j.biocon.2010.01.018; Johnson T.P., 2002, CROSS CULTURAL SURVE, P193; Kemmerer L, 2015, BEAR NECESSITIES: RESCUE, REHABILITATION, SANCTUARY, AND ADVOCACY, P17, DOI 10.1163/9789004293090_003; KNECHTGES DR, 1986, J AM ORIENTAL SOC, V106, P49, DOI 10.2307/602363; Lee Tien Ming, 2014, HARVEST WILDLIFE BUS; Lensvelt-Mulders GJLM, 2005, QUAL QUANT, V39, P253, DOI 10.1007/s11135-004-0432-3; Liu F, 2011, BIOL CONSERV, V144, P538, DOI 10.1016/j.biocon.2010.10.009; Livingstone E, 2018, GLOB ECOL CONSERV, V13, DOI 10.1016/j.gecco.2018.e00380; Mainka SA, 1995, J ZOO WILDLIFE MED, V26, P193; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Mendenhall CD, 2012, BIOL CONSERV, V151, P32, DOI 10.1016/j.biocon.2012.01.069; Miller J D, 1985, NIDA Res Monogr, V57, P104; Newing H., 2010, CONDUCTING RES CONSE; Nicholas J, 2016, CAMBODIAN J NATURAL, V1; Alves RRN, 2010, HUM ECOL REV, V17, P11; Nuno A, 2015, BIOL CONSERV, V189, P5, DOI 10.1016/j.biocon.2014.09.047; Nuno A, 2013, CONSERV BIOL, V27, P1355, DOI 10.1111/cobi.12124; Ogada D, 2016, CONSERV LETT, V9, P89, DOI 10.1111/conl.12182; SBJ (Statistics Bureau of Japan), 2008, REV 2008 GEN POPULAT; Shatkin G, 1998, INT J URBAN REGIONAL, V22, P378, DOI 10.1111/1468-2427.00147; Shepherd CR, 2008, BIODIVERS CONSERV, P17; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; St John FAV, 2015, BIOL CONSERV, V189, P86, DOI 10.1016/j.biocon.2014.08.019; St John FAV, 2012, P ROY SOC B-BIOL SCI, V279, P804, DOI 10.1098/rspb.2011.1228; Team R. Core, 2016, R LANG ENV STAT COMP; Tsuchiya T, 2007, PUBLIC OPIN QUART, V71, P253, DOI 10.1093/poq/nfm012; Van Vliet N, 2017, ETHNOBIOL CONSERV, V6, DOI 10.15451/ec2017-04-6.3-1-45; Wai-Ming W., 2017, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2017-3.RLTS.T9760A45033547; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	56	25	25	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211544	10.1371/journal.pone.0211544	http://dx.doi.org/10.1371/journal.pone.0211544			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM2OT	30785903	Green Published, Green Submitted, gold			2022-12-27	WOS:000459307000030
J	Jara-Figueroa, C; Yu, AZ; Hidalgo, CA				Jara-Figueroa, C.; Yu, Amy Z.; Hidalgo, Cesar A.			How the medium shapes the message: Printing and the rise of the arts and sciences	PLOS ONE			English	Article							TECHNOLOGY; NETWORK; FAME	Communication technologies, from printing to social media, affect our historical records by changing the way ideas are spread and recorded. Yet, finding statistical evidence of this fact has been challenging. Here we combine a common causal inference technique (instrumental variable estimation) with a dataset on nearly forty thousand biographies from Wikipedia (Pantheon 2.0), to study the effect of the introduction of printing in European cities on Wikipedia's digital biographical records. By using a city's distance to Mainz as an instrument for the adoption of the movable type press, we show that European cities that adopted printing earlier were more likely to become the birthplace of a famous scientist or artist during the years following the invention of printing. We bring these findings to recent communication technologies by showing that the number of radios and televisions in a country correlates with the number of globally famous performing artists and sports players born in that country, even after controlling for GDP, population, and including country and year fixed effects. These findings support the hypothesis that the introduction of communication technologies can bias historical records in the direction of the content that is best suited for each technology.	[Jara-Figueroa, C.; Yu, Amy Z.; Hidalgo, Cesar A.] MIT, Media Lab, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Hidalgo, CA (corresponding author), MIT, Media Lab, Cambridge, MA 02139 USA.	hidalgo@mit.edu	Jara-Figueroa, Cristian/W-2643-2019; Hidalgo, Cesar A./B-5155-2009	Hidalgo, Cesar A./0000-0002-6977-9492; Jara Figueroa, Cristian/0000-0003-0890-5536				Adorno T. W., 1997, DIALEKTIK AUFKLARUNG; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; Carlyle T., 1993, HEROES HERO WORSHIP, V1; Carter B, 2014, DO FOOTBALLERS REACH; CHANT C, 1996, DOES TECHNOLOGY DRIV; Clark G, 2004, C GLOB HIST PRIC WAG; Comin D, 2004, J MONETARY ECON, V51, P39, DOI 10.1016/j.jmoneco.2003.07.003; CROWLEY D, 2015, COMMUNICATION HIST T; Dittmar JE, 2011, Q J ECON, V126, P1133, DOI 10.1093/qje/qjr035; Dodds PS, 2015, P NATL ACAD SCI USA, V112, P2389, DOI 10.1073/pnas.1411678112; Eisenstein Elizabeth, 1979, PRINTING PRESS AGENT, V1; Eisenstein Elizabeth, 2005, PRINTING REVOLUTION; Ferron M., 2011, P 7 INT S WIK OP COL, P114, DOI DOI 10.1145/2038558.2038578; Fortunato S, 2018, SCIENCE, V359, DOI 10.1126/science.aao0185; Fowles J., 1999, COMMUNICATION HIST T, V3; Fussel S, 2005, GUTENBERG IMPACT PRI, V9; Gilmore MP, 1952, WORLD HUMANISM, P1453; Goody Jack, 1977, DOMESTICATION SAVAGE; Havelock Eric, 1963, PREFACE PLATO, V1; Heaberlin B, 2016, FUTURE INTERNET, V8, DOI 10.3390/fi8020014; Heilbroner R. L., 1967, TECHNOL CULT, V8, P335, DOI [DOI 10.2307/3101719, 10.2307/3101719]; Herman E.S., 2010, MANUFACTURING CONSEN; HITT Michael A., 2007, LONG TAIL WHY FUTURE; Innis Harold, 1951, BIAS COMMUNICATION; ISTC, 1998, INC SHORT TITL CAT; Karimi F, 2015, ARXIV150305522; Killick R, 2014, J STAT SOFTW, V58, P1; Marcuse H., 2013, ONE DIMENSIONAL MAN; McLuhan M., 1994, UNDERSTANDING MEDIA; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; Mitchell Stephen, 2000, SINGER TALES, V24; Mokyr J, 2005, HANDB ECON, V22, P1113; Mokyr J, 1995, PUB EGON SOHMEN FDN, V5, P3; MORAN TP, 1984, ET CETERA, V41, P117; Murray C., 2003, HUMAN ACCOMPLISHMENT; Ong W.J., 2013, ORALITY LITERACY; Ong WJR, 1958, METHOD DECAY DIALOGU; parry milman, 1987, MAKING HOMERIC VERSE, P191; Pentzold C, 2009, MEM STUD, V2, P255, DOI 10.1177/1750698008102055; Peters JD, 2014, HAROLD INNISS HIST C; Poe M. T., 2010, HIST COMMUNICATIONS; Postman Neil, 1985, AMUSING OURSELVES DE; Reba M, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.34; Ronen S, 2014, P NATL ACAD SCI USA, V111, pE5616, DOI 10.1073/pnas.1410931111; Rubin J, 2014, REV ECON STAT, V96, P270, DOI 10.1162/REST_a_00368; Schich M, 2014, SCIENCE, V345, P558, DOI 10.1126/science.1240064; Sinatra R, 2016, SCIENCE, V354, DOI 10.1126/science.aaf5239; Skiena S. S., 2013, WHOS BIGGER HIST FIG; Spinney L, 2012, NATURE, V488, P24, DOI 10.1038/488024a; Stephens M., 1991, COMMUNICATION HIST T, P237; STRATE L, 1985, ET CETERA, V42, P47; Strate L, 1995, NEW JERSEY J COMMUNI, V3, P26; Turchin P, 2008, NATURE, V454, P34, DOI 10.1038/454034a; van de Rijt A, 2013, AM SOCIOL REV, V78, P266, DOI 10.1177/0003122413480362; Van Zanden J. L., 2004, GEHN C US KNOWL LEID; Wick M., 2012, GEONAMES GEOGRAPHICA; Wikipedia, 2011, WIK SYST BIAS; Wikipedia, 2005, WIK NOT PEOPL; Williams R., 1994, DOES TECHNOLOGY DRIV; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099; Yu AZ, 2016, SCI DATA, V3, DOI 10.1038/sdata.2015.75	62	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0205771	10.1371/journal.pone.0205771	http://dx.doi.org/10.1371/journal.pone.0205771			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM2OT	30785879	gold, Green Published, Green Submitted			2022-12-27	WOS:000459307000005
J	Wang, B; Bian, BT; Wang, CL; Li, CX; Fang, H; Zhang, J; Huang, DJ; Huo, JQ; Liao, WB				Wang, Bo; Bian, Biting; Wang, Chunlei; Li, Changxia; Fang, Hua; Zhang, Jing; Huang, Dengjing; Huo, Jianqiang; Liao, Weibiao			Hydrogen gas promotes the adventitious rooting in cucumber under cadmium stress	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; NITRIC-OXIDE; PLANT TOLERANCE; CELL-DEATH; RESPONSES; TOXICITY; ENZYMES; RICE; SATIVA	Hydrogen gas (H-2) plays an important role in plant development and stress responses. Here, cucumber (Cucumis sativus L.) explants were used to investigate the roles of H2 in adventitious root development under cadmium (Cd) stress and its physiological mechanism. The results showed that hydrogen-rich water (HRW) promoted adventitious rooting under Cd stress and 50% HRW obtained the maximal biological response. Compared with Cd treatment, HRW + Cd treatment significantly reduced the content of malondialdehyde (MDA), hydrogen peroxide (H2O2), superoxide radical (O-2(-)), thiobarbituric acid reactive substances (TBARS), ascorbic acid (AsA) and reduced glutathione (GSH), as well as relative electrical conductivity (REC), lipoxygenase (LOX) activity, AsA/docosahexaenoic acid (DHA) ratio, and GSH/oxidized glutathione (GSSG) ratio, while increasing DHA and GSSG content. HRW + Cd treatment also significantly increased in the activity and related gene expression of ascorbate peroxidase (APX), dehydroascorbate reductase (DHAR), monodehydroascorbate reductase (MDHAR) and glutathione reductase (GR). Additionally, HRW + Cd treatment increased the contents of osmotic adjustment substances, as well as the activities of peroxidase (POD) and polyphenol oxidase (PPO), while significantly decreasing indoleacetic acid oxidase (IAAO) activity. In summary, H-2 could induce adventitious rooting under Cd stress by decreasing the oxidative damage, increasing osmotic adjustment substance content and regulating rooting-related enzyme activity.	[Wang, Bo; Bian, Biting; Wang, Chunlei; Li, Changxia; Fang, Hua; Zhang, Jing; Huang, Dengjing; Huo, Jianqiang; Liao, Weibiao] Gansu Agr Univ, Coll Hort, Lanzhou, Gansu, Peoples R China	Gansu Agricultural University	Liao, WB (corresponding author), Gansu Agr Univ, Coll Hort, Lanzhou, Gansu, Peoples R China.	liaowb@gsau.edu.cn	Liao, Weibiao/AAE-7770-2020		Discipline construction fund project of Gansu Agriculture University [GAU-XKJS-2018-223]; National Natural Science Foundation of China [31860568, 31560563, 31160398]; National Key Research and Development Program [2018YFD1000800]; Research Fund of Higher Education of Gansu, China [2018C-14]; Post-Doctoral Foundation of China [20100470887, 2012T50828]; Natural Science Foundation of Gansu Province, China [1606RJZA073, 1606RJZA077]	Discipline construction fund project of Gansu Agriculture University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program; Research Fund of Higher Education of Gansu, China; Post-Doctoral Foundation of China(China Postdoctoral Science Foundation); Natural Science Foundation of Gansu Province, China	This work was supported by the Discipline construction fund project of Gansu Agriculture University grant number GAU-XKJS-2018-223 (http://www.gsau.edu.cn/), the National Natural Science Foundation of China grant numbers (31860568, 31560563 and 31160398) (http://www.nsfc.gov.cn/), the National Key Research and Development Program grant number 2018YFD1000800 (http://program.most.gov.cn/), the Research Fund of Higher Education of Gansu, China grant number 2018C-14 (http://www.gsedu.gov.cn/), the Post-Doctoral Foundation of China grant numbers (20100470887 and 2012T50828) (http://jj.chinapostdoctor.org.cn/V1/Program3/Default.aspx) and the Natural Science Foundation of Gansu Province, China grant numbers (1606RJZA073 and 1606RJZA077) (http://www.gsstc.gov.cn/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad P, 2011, S AFR J BOT, V77, P36, DOI 10.1016/j.sajb.2010.05.003; Anjum NA, 2016, ENVIRON SCI POLLUT R, V23, P19002, DOI 10.1007/s11356-016-7309-6; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUYSSE J, 1993, J EXP BOT, V44, P1627, DOI 10.1093/jxb/44.10.1627; Chen QH, 2017, PLANT GROWTH REGUL, V83, P69, DOI 10.1007/s10725-017-0284-1; Chen Y, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00128; Chew O, 2003, J BIOL CHEM, V278, P46869, DOI 10.1074/jbc.M307525200; Cui WT, 2014, ECOTOX ENVIRON SAFE, V105, P103, DOI 10.1016/j.ecoenv.2014.04.009; Cui WT, 2013, J HAZARD MATER, V260, P715, DOI 10.1016/j.jhazmat.2013.06.032; de Araujo RP, 2017, ECOTOX ENVIRON SAFE, V144, P148, DOI 10.1016/j.ecoenv.2017.06.006; De Michele R, 2009, PLANT PHYSIOL, V150, P217, DOI 10.1104/pp.108.133397; EDWARDS EA, 1990, PLANTA, V180, P278, DOI 10.1007/BF00194008; Golding AL, 2010, ENVIRON CHEM LETT, V8, P101, DOI 10.1007/s10311-010-0278-y; Hasanuzzaman M, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01061; Hasanuzzaman M, 2012, BIOL TRACE ELEM RES, V149, P248, DOI 10.1007/s12011-012-9419-4; He SY, 2017, PEDOSPHERE, V27, P421, DOI [10.1016/S1002-0160(17)60339-4, 10.1016/s1002-0160(17)60339-4]; Hu HL, 2014, FOOD CHEM, V156, P100, DOI 10.1016/j.foodchem.2014.01.067; Huang CS, 2010, FREE RADICAL RES, V44, P971, DOI 10.3109/10715762.2010.500328; Jabs T, 1996, SCIENCE, V273, P1853, DOI 10.1126/science.273.5283.1853; Jin QJ, 2016, J PLANT GROWTH REGUL, V35, P565, DOI 10.1007/s00344-015-9561-2; Jin QJ, 2013, PLANT CELL ENVIRON, V36, P956, DOI 10.1111/pce.12029; Kovacik J, 2009, J PLANT PHYSIOL, V166, P1460, DOI 10.1016/j.jplph.2009.03.002; Li CX, 2018, FUNCT PLANT BIOL, V45, P783, DOI 10.1071/FP17301; Li Ming, 2000, Forest Research, V13, P493; Liao WB, 2010, J PLANT GROWTH REGUL, V29, P338, DOI 10.1007/s00344-010-9140-5; Lin YT, 2014, J PLANT PHYSIOL, V171, P1, DOI 10.1016/j.jplph.2013.08.009; Lu P, 2008, J INTEGR PLANT BIOL, V50, P393, DOI 10.1111/j.1744-7909.2007.00583.x; Lux A, 2011, J EXP BOT, V62, P21, DOI 10.1093/jxb/erq281; Matsumoto R, 2009, INT J HYDROGEN ENERG, V34, P9576, DOI 10.1016/j.ijhydene.2009.09.052; Meng DK, 2011, J HAZARD MATER, V186, P1823, DOI 10.1016/j.jhazmat.2010.12.062; Moreno JL, 1999, BIOL FERT SOILS, V28, P230, DOI 10.1007/s003740050487; Nahar K, 2016, ECOTOX ENVIRON SAFE, V126, P245, DOI 10.1016/j.ecoenv.2015.12.026; POLLE A, 1990, PLANT PHYSIOL, V94, P312, DOI 10.1104/pp.94.1.312; RENWICK GM, 1964, PLANT PHYSIOL, V39, P303, DOI 10.1104/pp.39.3.303; Rizwan M, 2018, SCI TOTAL ENVIRON, V631-632, P1175, DOI 10.1016/j.scitotenv.2018.03.104; Srivastava RK, 2014, PROTOPLASMA, V251, P1047, DOI 10.1007/s00709-014-0614-3; Su NN, 2014, J AGR FOOD CHEM, V62, P6454, DOI 10.1021/jf5019593; Sung CH, 2010, PLANT BIOTECHNOL REP, V4, P243, DOI 10.1007/s11816-010-0138-z; TORRES V, 1984, ANN NY ACAD SCI, V434, P296, DOI 10.1111/j.1749-6632.1984.tb29849.x; Wu Q, 2015, J PLANT PHYSIOL, V175, P174, DOI 10.1016/j.jplph.2014.09.017; Xie PP, 2015, ECOTOX ENVIRON SAFE, V122, P392, DOI 10.1016/j.ecoenv.2015.09.007; Xu S, 2013, PLANT SOIL, V370, P47, DOI 10.1007/s11104-013-1614-3; Zeng JQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071038; Zhang H, 2003, ACTA BOT SIN, V45, P901; Zhao XQ, 2017, ECOTOX ENVIRON SAFE, V144, P369, DOI 10.1016/j.ecoenv.2017.06.045; Zhu YC, 2016, PLANT SIGNAL BEHAV, V11, P50; Zhu YC, 2017, THEOR EXP PLANT PHYS, V29, P77, DOI 10.1007/s40626-017-0085-y; Zhu YC, 2016, J PLANT PHYSIOL, V195, P50, DOI 10.1016/j.jplph.2016.02.018	49	14	17	5	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2								10.1371/journal.pone.0212639	http://dx.doi.org/10.1371/journal.pone.0212639			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785953	Green Published, gold, Green Submitted			2022-12-27	WOS:000459307000078
J	Haque, MA; Janson, S; Moniruzzaman, S; Rahman, AKMF; Islam, SS; Mashreky, SR; Eriksson, UB				Haque, M. Atiqul; Janson, Staffan; Moniruzzaman, Syed; Rahman, A. K. M. Fazlur; Islam, Syed Shariful; Mashreky, Saidur Rahman; Eriksson, Ulla-Britt			Children's exposure to physical abuse from a child perspective: A population-based study in rural Bangladesh	PLOS ONE			English	Article							RISK-FACTORS; ICAST-CH; MALTREATMENT; PREVALENCE; METAANALYSIS; VIOLENCE; FAMILY; HOME	Background Although child physical abuse (CPA) is considered as a major global public health problem, it has not yet been recognized as such in Bangladesh. Very few studies have assessed the prevalence and victims' characteristics of multiple forms of CPA. Objective This population-based study assessed the prevalence of CPA committed by adults in a rural area of Bangladesh and examined its association with demographic and socio-contextual factors. Methods Data were obtained using ISPCAN Child Abuse Screening Tool for Children (ICAST-C) in a random sample of 1416 children (49% girls, 51% boys) aged 11 to 17 years by face-to-face interviews during March-April 2017. The response rate was 91.5%. To estimate predictors of CPA, physical abuse was categorized into frequent and less frequent groups. Results The prevalence of at least one form (>= 1), two forms (>= 2) and three or more forms (>= 3) of CPA were estimated approximately to 99%, 95% and 83% in their lifetime and 93%, 79%, and 57% in the past year respectively. Hitting (except on buttocks), standing/kneeling and slapping were the most common physical abuse whereas given drugs or alcohol, pinched, burned or scalded, beaten-up and locked up were less reported. Female children were faced severe forms of CPA more than that of males. Male children, younger age groups, witnessing adults using weapons at home, bullied by siblings and low level of maternal education were found to be significant risk factors for both >= 1 form and >= 2 forms of frequent CPA whereas adding also adult shouting in a frightening way was found as a significant risk factor for >= 2 forms of frequent CPA. Conclusion Self-reported prevalence of CPA is extremely common in the Bangladeshi rural society. The prevalence was associated with demographic and socio-contextual characteristics of the children such as being younger, witnessing domestic violence and maternal low education. The findings provide evidence to support parents and policy-makers to take effective measures to implement policy and programme on alternative up-bringing methods and creating awareness of negative effects of CM which in turn help Bangladesh to line up with UN Convention on the Rights of the Child, which the country signed in 1990.	[Haque, M. Atiqul; Eriksson, Ulla-Britt] Karlstad Univ, Dept Hlth Sci, Publ Hlth Sci, Karlstad, Sweden; [Janson, Staffan] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Moniruzzaman, Syed] Karlstad Univ, Dept Environm & Life Sci, Risk & Environm Studies, Karlstad, Sweden; [Rahman, A. K. M. Fazlur; Mashreky, Saidur Rahman] New DOHS, Ctr Injury Prevent & Res, Dhaka, Bangladesh; [Rahman, A. K. M. Fazlur; Mashreky, Saidur Rahman] Bangladesh Univ Hlth Sci, Dhaka, Bangladesh; [Islam, Syed Shariful] Bangabandhu Sheikh Mujib Med Univ, Dept Publ Hlth & Informat, Dhaka, Bangladesh	Karlstad University; Uppsala University; Karlstad University; Bangladesh University of Health Sciences (BUHS); Bangabandhu Sheikh Mujib Medical University (BSMMU)	Haque, MA (corresponding author), Karlstad Univ, Dept Hlth Sci, Publ Hlth Sci, Karlstad, Sweden.	atiqulm26@bsmmu.edu.bd	Mashreky, Saidur Rahman/N-9113-2017; Haque, Atiqul/ACD-5508-2022	Mashreky, Saidur Rahman/0000-0001-7892-798X; Haque, Atiqul/0000-0002-7598-2550	Center for Injury Prevention and Research, Bangladesh	Center for Injury Prevention and Research, Bangladesh	This study has been partially funded by the Center for Injury Prevention and Research, Bangladesh. www.ciprb.org.	Akmatov MK, 2011, INT J EPIDEMIOL, V40, P219, DOI 10.1093/ije/dyq168; Al-Eissa MA, 2016, CHILD CARE HLTH DEV, V42, P565, DOI 10.1111/cch.12325; Al-Eissa MA, 2015, CHILD ABUSE NEGLECT, V42, P174, DOI 10.1016/j.chiabu.2014.08.016; Bangladesh Bureau of Statistics and Unicef Bangladesh, 2016, CHILD WELL BEING SUR, DOI [10.1037//0003-066x.35.4.320, DOI 10.1037//0003-066X.35.4.320]; Bangladesh Bureau of Statistics Statistics division Ministry of Planning, 2011, REP HOUS INC EXP SUR; BELSKY J, 1980, AM PSYCHOL, V35, P320, DOI 10.1037/0003-066X.35.4.320; Benbenishty R, 2002, CHILD ABUSE NEGLECT, V26, P763, DOI 10.1016/S0145-2134(02)00350-2; Biswas A, 2010, RURAL REMOTE HEALTH, V10; Bureau of Statistics Punjab Planning & Development Department; Government of the Punjab UNICEF Punjab. Multiple Indicator Cluster Survey Punjab, 2014, MULT IND CLUST SURV; Cappa C, 2014, J INTERPERS VIOLENCE, V29, P497, DOI 10.1177/0886260513505215; Chang HY, 2013, CHILD YOUTH SERV REV, V35, P2135, DOI 10.1016/j.childyouth.2013.10.020; Chen JK, 2011, CHILD ABUSE NEGLECT, V35, P382, DOI 10.1016/j.chiabu.2011.01.009; Cicchetti D, 2000, HDB DEV PSYCHOPATHOL, P697; Crosson-Tower C., 2014, UNDERSTANDING CHILD; Daral S, 2016, J TROP PEDIATRICS, V62, P227, DOI 10.1093/tropej/fmv106; de Zoysa P, 2013, STUDY PARENTAL DISCI; Deb Sibnath, 2010, J Inj Violence Res, V2, P5, DOI 10.5249/jivr.v2i1.31; Doidge JC, 2017, CHILD ABUSE NEGLECT, V64, P47, DOI 10.1016/j.chiabu.2016.12.002; Fang XM, 2015, B WORLD HEALTH ORGAN, V93, P176, DOI 10.2471/BLT.14.140970; Fergusson DM, 2011, INT J METH PSYCH RES, V20, P93, DOI 10.1002/mpr.337; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Flynn-O'Brien KT, 2016, CHILD ABUSE NEGLECT, V51, P154, DOI 10.1016/j.chiabu.2015.10.021; Global Initiative to End All Corporal Punishment of Children, 2018, COUNTD UN PROH 2018; Gorjian Z, 2017, J FUNDAM APPL SCI, V9, P1735, DOI 10.4314/jfas.v9i3.31; Hadi A, 2000, PUBLIC HEALTH, V114, P380; Haque MA, 2017, CHILD CARE HLTH DEV, V43, P876, DOI 10.1111/cch.12508; Haque MA, 2018, CHILD MALTREAT UNPUB; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hein IM, 2015, BMC MED ETHICS, V16, DOI 10.1186/s12910-015-0067-z; Huda T., 2017, DAILY STAR; Hunter WM, 2000, J PEDIATR PSYCHOL, V25, P435, DOI 10.1093/jpepsy/25.6.435; Irfan S., 2004, J MUSLIM MINOR AFF, V24, P89, DOI DOI 10.1080/1360200042000212151; Janson S., 2017, VIOLENCE CHILDREN SW; Ji K, 2015, CHILD ABUSE NEGLECT, V43, P61, DOI 10.1016/j.chiabu.2014.11.011; Jud A, 2016, CHILD ADOL PSYCH MEN, V10, DOI 10.1186/s13034-016-0105-8; Kabir M., 2001, 123 CTR STUD HUM RIG; Korbin JE, 1983, CHILD ABUSE NEGLECT; Kumar MT, 2017, CHILD ABUSE NEGLECT, V70, P356, DOI 10.1016/j.chiabu.2017.06.025; Lakhdir MPA, 2021, J INTERPERS VIOLENCE, V36, P297, DOI 10.1177/0886260517726973; Lwanga SK, 1991, SAMPLE SIZE DETERMIN; Malik F, 2010, INT J BUSINESS SOCIA, V1, P67; Middlebrooks JS., 2008, EFFECTS CHILDHOOD ST; Mookherjee N, 2006, J ROY ANTHROPOL INST, V12, P433, DOI 10.1111/j.1467-9655.2006.00299.x; Nguyen HCD., 2014, EUR J SOC SCI, V43, P305; Nikolaidis G, 2018, CHILD ADOL PSYCH MEN, V12, DOI 10.1186/s13034-017-0208-x; Ribeiro IMP, 2015, ACTA PAUL ENFERM, V28, P54, DOI 10.1590/1982-0194201500010; Pinheiro P.S., 2006, WORLD REPORT VIOLENC; Rumm PD, 2000, CHILD ABUSE NEGLECT, V24, P1375, DOI 10.1016/S0145-2134(00)00192-7; Runyan D., 2015, MANUAL ADM ISPCAN CH; Schapper A, 2017, HUM RIGHTS QUART, V39, P104, DOI 10.1353/hrq.2017.0003; Slep AMS, 2001, CLIN CHILD FAM PSYCH, V4, P87; Sofuoglu Z, 2014, TURK PEDIATR ARSIVI, V49, P47, DOI 10.5152/tpa.2014.838; Stith SM, 2009, AGGRESS VIOLENT BEH, V14, P13, DOI 10.1016/j.avb.2006.03.006; Stoltenborgh M, 2013, INT J PSYCHOL, V48, P81, DOI 10.1080/00207594.2012.697165; Theoklitou D, 2012, CHILD ABUSE NEGLECT, V36, P64, DOI 10.1016/j.chiabu.2011.05.007; UBS Optimus Foundation, 2012, PROM RES PREV CHILD; Unicef, 2014, 4 UN; Unicef, 2010, BAS STUD CHILDR BANG; Unicef, 2008, OP CHILDR BANGL CORP; Waterson R., 2006, WHAT CHILDREN SAY RE; World Health Organization, 2002, WORLD REPORT VIOLENC; Zolotor A. J., 2007, BRIEF TREATMENT CRIS, V7, P305, DOI [DOI 10.1093/BRIEF-TREATMENT/MHM021, 10.1093/brief-treatment/mhm021]	62	9	10	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212428	10.1371/journal.pone.0212428	http://dx.doi.org/10.1371/journal.pone.0212428			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL9KY	30779784	Green Published, Green Submitted, gold			2022-12-27	WOS:000459062900055
J	Dylewski, J; Dobrinskikh, E; Lewis, L; Tonsawan, P; Miyazaki, M; Jat, PS; Blaine, J				Dylewski, James; Dobrinskikh, Evgenia; Lewis, Linda; Tonsawan, Pantipa; Miyazaki, Makoto; Jat, Parmjit S.; Blaine, Judith			Differential trafficking of albumin and IgG facilitated by the neonatal Fc receptor in podocytes in vitro and in vivo	PLOS ONE			English	Article							GLOMERULAR-FILTRATION; DEGRADATION; PROTEINURIA; HOMEOSTASIS; NEPHRITIS; TRANSPORT; REVEALS; PASSAGE; CELLS; GENE	Proteinuria is strongly associated with kidney disease progression but the mechanisms underlying podocyte handling of serum proteins such as albumin and IgG remain to be elucidated. We have previously shown that albumin and IgG are transcytosed by podocytes in vitro. In other epithelial cells, the neonatal Fc receptor (FcRn) is required to salvage albumin and IgG from the degradative pathway thereby allowing these proteins to be transcytosed or recycled. Here we directly examine the role of FcRn in albumin and IgG trafficking in podocytes by studying handling of these proteins in FcRn knockout (KO) podocytes in vitro and in a podocyte-specific FcRn knockout mice in vivo. In vitro, we find that knockout of FcRn leads to IgG accumulation in podocytes but does not alter albumin trafficking. Similarly, in vivo, podocyte-specific knockout of FcRn does not result in albumin accumulation in podocytes in vivo as measured by mean albumin fluorescence intensity whereas these mice demonstrate significant intraglomerular accumulation of IgG over time. In addition we find that podocyte-specific FcRn KO mice demonstrate mesangial expansion as they age and activation of mesangial cells as demonstrated by increased expression of a-smooth muscle actin. Taken together, these results suggest that trafficking pathways for albumin and IgG differ in podocytes and that sustained disruption of trafficking of plasma proteins alters glomerular structure.	[Dylewski, James; Lewis, Linda; Miyazaki, Makoto; Blaine, Judith] Univ Colorado Denver, Div Renal Dis & Hypertens, Aurora, CO 80045 USA; [Dylewski, James] Denver Hlth Med Ctr, Div Nephrol, Denver, CO USA; [Dobrinskikh, Evgenia] Univ Colorado Denver, Div Pulm, Aurora, CO USA; [Tonsawan, Pantipa] Khon Kaen Univ, Dept Med, Div Nephrol, Khon Kaen, Thailand; [Jat, Parmjit S.] UCL, MRC Prion Unit, Inst Prion Dis, London, England	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Denver Health Medical Center; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Khon Kaen University; University of London; University College London	Blaine, J (corresponding author), Univ Colorado Denver, Div Renal Dis & Hypertens, Aurora, CO 80045 USA.	Judith.blaine@ucdenver.edu		Dylewski, James/0000-0002-8158-8605	Norman Coplon Satellite Healthcare; NIH [R01DK104264]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL132318, R01HL117062, R01HL133545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104264, R01DK096030, T32DK007135] Funding Source: NIH RePORTER	Norman Coplon Satellite Healthcare; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by a Norman Coplon Satellite Healthcare grant (https://www.satellitehealth.com/about-us/satellite-research/coplon-grants-overview/) and NIH R01DK104264 (https://www.niddk.nih.gov/research-funding/current-opportunities/pa-18-484) to JB. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abbate M, 2002, AM J PATHOL, V161, P2179, DOI 10.1016/S0002-9440(10)64495-1; Abbate M, 2006, J AM SOC NEPHROL, V17, P2974, DOI 10.1681/ASN.2006040377; Akilesh S, 2008, P NATL ACAD SCI USA, V105, P967, DOI 10.1073/pnas.0711515105; Andersen JT, 2010, J BIOL CHEM, V285, P4826, DOI 10.1074/jbc.M109.081828; Andersen JT, 2009, DRUG METAB PHARMACOK, V24, P318, DOI 10.2133/dmpk.24.318; Carson JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099771; Castrop H, 2017, ACTA PHYSIOL, V219, P544, DOI 10.1111/apha.12760; Chaudhury C, 2003, J EXP MED, V197, P315, DOI 10.1084/jem.20021829; Cui SY, 1996, AM J PHYSIOL-RENAL, V271, pF900, DOI 10.1152/ajprenal.1996.271.4.F900; Dickinson BL, 2016, CLIN IMMUNOL, V169, P89, DOI 10.1016/j.clim.2016.06.011; Dobrinskikh E, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12510; Dobrinskikh E, 2014, AM J PHYSIOL-RENAL, V306, pF941, DOI 10.1152/ajprenal.00532.2013; Eyre J, 2007, AM J PHYSIOL-RENAL, V292, pF674, DOI 10.1152/ajprenal.00272.2006; FARQUHAR MG, 1960, J BIOPHYS BIOCHEM CY, V7, P297, DOI 10.1083/jcb.7.2.297; Gansevoort RT, 2011, KIDNEY INT, V80, P93, DOI 10.1038/ki.2010.531; Gianesello L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13789-z; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; JAT PS, 1989, MOL CELL BIOL, V9, P1672, DOI 10.1128/MCB.9.4.1672; JOHNSON RJ, 1991, J CLIN INVEST, V87, P847, DOI 10.1172/JCI115089; KERJASCHKI D, 1987, J EXP MED, V166, P109, DOI 10.1084/jem.166.1.109; Kim JH, 2006, AM J PHYSIOL-GASTR L, V290, pG352, DOI 10.1152/ajpgi.00286.2005; Kinugasa S, 2011, KIDNEY INT, V80, P1328, DOI 10.1038/ki.2011.282; Kinugasa S, 2010, MED MOL MORPHOL, V43, P218, DOI 10.1007/s00795-010-0500-9; Kuo TT, 2010, J CLIN IMMUNOL, V30, P777, DOI 10.1007/s10875-010-9468-4; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Masuda M, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88646; Montoyo HP, 2009, P NATL ACAD SCI USA, V106, P2788, DOI 10.1073/pnas.0810796106; Morigi M, 2005, AM J PATHOL, V166, P1309, DOI 10.1016/S0002-9440(10)62350-4; Okamura K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054817; Peti-Peterdi J, 2009, AM J PHYSIOL-RENAL, V296, pF1255, DOI 10.1152/ajprenal.00144.2009; Roopenian DC, 2003, J IMMUNOL, V170, P3528, DOI 10.4049/jimmunol.170.7.3528; Russo LM, 2007, KIDNEY INT, V71, P504, DOI 10.1038/sj.ki.5002041; Sandoval RM, 2012, J AM SOC NEPHROL, V23, P447, DOI 10.1681/ASN.2011070666; Schiessl IM, 2016, J AM SOC NEPHROL, V27, P731, DOI 10.1681/ASN.2014111125; Schiessl IM, 2013, AM J PHYSIOL-RENAL, V305, pF1189, DOI 10.1152/ajprenal.00377.2013; Scott RP, 2015, J CELL BIOL, V209, P199, DOI 10.1083/jcb.201410017; Tenten V, 2013, J AM SOC NEPHROL, V24, P1966, DOI 10.1681/ASN.2013010018; Tojo A, 2008, MED MOL MORPHOL, V41, P92, DOI 10.1007/s00795-008-0397-8; YOSHIKAWA N, 1986, ARCH PATHOL LAB MED, V110, P394	39	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0209732	10.1371/journal.pone.0209732	http://dx.doi.org/10.1371/journal.pone.0209732			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811433	gold, Green Published, Green Submitted			2022-12-27	WOS:000459806400005
J	Frantzis, A; Leaper, R; Alexiadou, P; Prospathopoulos, A; Lekkas, D				Frantzis, Alexandros; Leaper, Russell; Alexiadou, Paraskevi; Prospathopoulos, Aristides; Lekkas, Dimitrios			Shipping routes through core habitat of endangered sperm whales along the Hellenic Trench, Greece: Can we reduce collision risks?	PLOS ONE			English	Article							PHYSETER-MACROCEPHALUS; SEA; ECHOLOCATION	The Mediterranean sperm whale population is listed as 'Endangered". The Hellenic Trench is the core habitat of the eastern Mediterranean sperm whale sub-population that numbers two to three hundred individuals. Major shipping routes running on or very close to the 1000 m depth contour along the Hellenic Trench are causing an unsustainable number of ship-strikes with sperm whales reviewed in this paper. Sperm whale sighting and density data were combined with specific information on the vessel traffic in the area (e.g., types of vessels, traffic patterns, speed and traffic density), in order to estimate the risk of a whale/ship interaction. Routing options to significantly reduce ship strike risk by a small offshore shift in shipping routes were identified. The overall collision risk for sperm whales in the study area would be reduced by around 70%, while a maximum of 11 nautical miles would be added to major routes and only around 5 nautical miles for the majority of ships. No negative impacts were associated with re-routing by shipping away from sperm whale habitat and there would be additional shipping safety and environmental benefits. A significant contribution to the overall conservation status of the marine Natura2000 sites in the area and very important population units of threatened species such as Cuvier's beaked whales, monk seals and loggerhead turtles would be achieved, by the reduction of shipping noise and reduced risk of any oil spills reaching the coasts, which are also important touristic destinations in Greece.	[Frantzis, Alexandros; Alexiadou, Paraskevi] Pelagos Cetacean Res Inst, Vouliagmeni, Greece; [Leaper, Russell] Int Fund Anim Welf, London, England; [Prospathopoulos, Aristides] Inst Oceanog, Hellen Ctr Marine Res, Anavyssos, Greece; [Lekkas, Dimitrios] MarineTraff Operat SA, Athens, Greece	Hellenic Centre for Marine Research	Frantzis, A (corresponding author), Pelagos Cetacean Res Inst, Vouliagmeni, Greece.	afrantzis@otenet.gr	Prospathopoulos, Aristides M./G-9216-2011	Prospathopoulos, Aristides M./0000-0002-3150-6966; Alexiadou, Paraskevi/0000-0003-0275-2540; Frantzis, Alexandros/0000-0001-7117-062X	International Fund for Animal Welfare (IFAW); OceanCare (Switzerland); Green Institute, Greece (Prasino Institouto)	International Fund for Animal Welfare (IFAW); OceanCare (Switzerland); Green Institute, Greece (Prasino Institouto)	Some funders provided support in the form of salaries for authors according to the following lines. No funder had any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section. International Fund for Animal Welfare, https://www.ifaw.org, provided salaries for AF, RL, and running costs for a server collecting AIS data. MarineTraffic Operations SA provided salary for DL. OceanCare, Switzerland, https://www.oceancare.org/en/startpage/, provided running costs and equipment purchase for sperm whale surveys of Pelagos Cetacean Research Institute (sic) (Green Institute), Greece, http://www.greeninstitute.gr/, provided salary for PA and running costs and equipment purchase for sperm whale surveys of Pelagos Cetacean Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We deeply thank the International Fund for Animal Welfare (IFAW) for their support of this study and of our conservation efforts regarding the mitigation of ship strikes. We are grateful to Sigrid Luber, Silvia Frey and OceanCare (Switzerland) for their continuous support of the sperm whale research and conservation efforts of the Pelagos Cetacean Research Institute since 2008 and their support of various phases of this project. We are also grateful to Olga Kikou and the Green Institute, Greece (Prasino Institouto; http://www.greeninstitute.gr) for their support of the initial phases of this project. We wish to thank Dr. Manos N. Anagnostou for clarifications concerning PAL data. MarineTraffic (https://www.marinetraffic.com) have kindly provided all the AIS data used for this study. Logging data during the sperm whale surveys were collected using the software Logger 2000 developed by the IFAW to promote benign and non-invasive research. Bathymetric data for all plots were from the GEBCO_2014 Grid, version 20150318, www.gebco.net.	Agardy T, 2007, SCI WORKSH; Andre M, 2017, SCI REP-UK, V7, DOI 10.1038/srep45517; Anonymous, 2017, Journal of Cetacean Research and Management, V18, P1; [Anonymous], NATL STRATEGY ACTION; Boisseau O, 2017, CETACEAN POPUL UNPUB; Canadas A, 2018, ECOL INDIC, V85, P128, DOI 10.1016/j.ecolind.2017.10.021; Canadas A., 2012, IUCN RED LIST THREAT; Caruso F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144503; Conn PB, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00004.1; Fais A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150660; Frantzis A., 2003, Journal of Cetacean Research and Management, V5, P219; Frantzis A, 1998, NATURE, V392, P29, DOI 10.1038/32068; Frantzis A., 2014, IWC SCI COMM BLED SL; Frantzis A, 2015, IWC SCI COMM SAN DIE; Frantzis A., 2015, FINS, V6, P10; Frantzis A., 2009, CETACEANS GREECE PRE; Frantzis A, 2014, AQUAT CONSERV, V24, P83, DOI 10.1002/aqc.2435; International Maritime Organization, 2017, ROUT MEAS OTH TRAFF; International Maritime Organization, 2009, GUID DOC MIN RISK SH; International Maritime Organization, 2018, FURTH INF REL IMP UN, P1; International Maritime Organization, 2013, EST NEW ROUT MEAS PA; International Maritime Organization, 2016, ID PROT SPEC AR PSSA; International Union for the Conservation of Nature-Marine Mammal Protected Areas Task Force, 2017, 1 IMMA REG WORKH MED; International Whaling Commission, 2016, J CETACEAN RES MAN S, V17, P293; International Whaling Commission, 2016, J CETACEAN RES MAN S, V17, P16; Leaper R, 2011, IWC SCI COMM TROMS N; Lewis T, 2007, J MAR BIOL ASSOC UK, V87, P353, DOI 10.1017/S0025315407054896; Lewis Tim, 2018, Journal of Cetacean Research and Management, V18, P103; Madsen PT, 2002, BEHAV ECOL SOCIOBIOL, V53, P31, DOI 10.1007/s00265-002-0548-1; Margaritoulis D, 2015, 35 ANN S SEA TURTL B, P127; Miller L.A, 2004, ECS NEWSLETTER, V42, P14; Nanayakkara Ranil P., 2017, Journal of Marine Biology, P6235398; Neilson JL, 2012, J MAR SCI, V2012, DOI [10.1155/2012/106282, DOI 10.1155/2012/106282]; Notarbartolo di Sciara G., 2006, STATUS DISTRIBUTION, P45; Nystuen JA, 2015, J ATMOS OCEAN TECH, V32, P334, DOI 10.1175/JTECH-D-13-00264.1; Ozturk A., 2013, J BLACK SEA MEDITERR, V19, p169?177; Panigada S, 2006, MAR POLLUT BULL, V52, P1287, DOI 10.1016/j.marpolbul.2006.03.014; Podesta M, 2016, ADV MAR BIOL, V75, P37; Redfern JV, 2013, CONSERV BIOL, V27, P292, DOI 10.1111/cobi.12029; Rendell L, 2016, ADV MAR BIOL, V75, P37, DOI 10.1016/bs.amb.2016.08.001; Shimada T, 2017, OCEAN COAST MANAGE, V142, P163, DOI 10.1016/j.ocecoaman.2017.03.028; Silber GK, 2012, MAR POLICY, V36, P1221, DOI 10.1016/j.marpol.2012.03.008; Vaes T, 2013, EUR SCI TECHN RES SE; Van Waerebeek Koen, 2007, Latin American Journal of Aquatic Mammals, V6, P43; Whitehead H, 2002, MAR ECOL PROG SER, V242, P295, DOI 10.3354/meps242295; Williams R., 2011, CONSERV LETT, V2011, P1, DOI [DOI 10.1111/J.1755-263X.2010.00151.X, 10.1111/j.1755-263X.2010.00151.x]	46	15	19	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0212016	10.1371/journal.pone.0212016	http://dx.doi.org/10.1371/journal.pone.0212016			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811429	Green Submitted, Green Published, gold			2022-12-27	WOS:000459806400045
J	Goudarzi, M; Boquet-Pujadas, A; Olivo-Marin, JC; Raz, E				Goudarzi, Mohammad; Boquet-Pujadas, Aleix; Olivo-Marin, Jean-Christophe; Raz, Erez			Fluid dynamics during bleb formation in migrating cells in vivo	PLOS ONE			English	Article							MEMBRANE; MOTILITY; PRESSURE; BEHAVIOR; MODES	Blebs are cellular protrusions observed in migrating cells and in cells undergoing spreading, cytokinesis, and apoptosis. Here we investigate the flow of cytoplasm during bleb formation and the concurrent changes in cell volume using zebrafish primordial germ cells (PGCs) as an in vivo model. We show that bleb inflation occurs concomitantly with cytoplasmic inflow into it and that during this process the total cell volume does not change. We thus show that bleb formation in primordial germ cells results primarily from redistribution of material within the cell rather than being driven by flow of water from an external source.	[Goudarzi, Mohammad; Raz, Erez] ZMBE, Inst Cell Biol, Munster, Germany; [Boquet-Pujadas, Aleix; Olivo-Marin, Jean-Christophe] Inst Pasteur, Bioimage Anal Unit, Paris, France; [Boquet-Pujadas, Aleix; Olivo-Marin, Jean-Christophe] CNRS, UMR3691, Paris, France; [Goudarzi, Mohammad] Inst Sci & Technol Austria IST, Campus 1, Klosterneuburg, Austria	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institute of Science & Technology - Austria	Raz, E (corresponding author), ZMBE, Inst Cell Biol, Munster, Germany.	erez.raz@uni-muenster.de			European Research Council (ERC, CellMig); Deutsche Forschungsgemeinschaft (DFG); IZKF Muenster; Cells in Motion cluster of excellence [EXC 1003-CIM]; European Union's Horizon 2020 research and innovation programme under the Marie Skodowska-Curie grant [665807]; Institut Carnot Pasteur Microbes Sante [ANR 16 CARN 0023-01]; ANR [ANR-10-INBS-04-FranceBioImaging, ANR-10-LABX-62-IBEID]	European Research Council (ERC, CellMig); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); IZKF Muenster; Cells in Motion cluster of excellence; European Union's Horizon 2020 research and innovation programme under the Marie Skodowska-Curie grant; Institut Carnot Pasteur Microbes Sante; ANR(French National Research Agency (ANR))	This work was supported by the European Research Council (ERC, CellMig), the Deutsche Forschungsgemeinschaft (DFG), and the IZKF Muenster to E.R., and the Cells in Motion cluster of excellence (EXC 1003-CIM) to E.R. A.B.P. is part of the Pasteur - Paris University (PPU) International PhD Program. This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Skodowska-Curie grant agreement No 665807, and from the Institut Carnot Pasteur Microbes & Sante (ANR 16 CARN 0023-01). A.B.P is also affiliated with Sorbonne Universite (UPMC, Paris 6) and EDITE. The BIA unit is partially funded by the ANR grants ANR-10-INBS-04-FranceBioImaging and ANR-10-LABX-62-IBEID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the European Research Council (ERC, CellMig), the Deutsche Forschungsgemeinschaft (DFG), and the IZKF Muenster to E.R., and the Cells in Motion cluster of excellence (EXC 1003-CIM) to E.R. A.B.P. is part of the Pasteur-Paris University (PPU) International PhD Program. This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Skodowska-Curie grant agreement No 665807, and from the Institut Carnot Pasteur Microbes & Sante (ANR 16 CARN 0023-01).; A.B.P is also affiliated with Sorbonne Universite (UPMC, Paris 6) and EDITE. The BIA unit is partially funded by the ANR grants ANR-10-INBS-04-FranceBioImaging and ANR-10-LABX-62-IBEID.	Aman A, 2010, DEV BIOL, V341, P20, DOI 10.1016/j.ydbio.2009.11.014; Blaser H, 2005, J CELL SCI, V118, P4027, DOI 10.1242/jcs.02522; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Boquet-Pujadas A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09240-y; Charras GT, 2008, J MICROSC-OXFORD, V231, P466, DOI 10.1111/j.1365-2818.2008.02059.x; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Charras GT, 2008, BIOPHYS J, V94, P1836, DOI 10.1529/biophysj.107.113605; Diz-Munoz A, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0294-x; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gebala V, 2016, NAT CELL BIOL, V18, P443, DOI 10.1038/ncb3320; Goudarzi M, 2012, DEV CELL, V23, P210, DOI 10.1016/j.devcel.2012.05.007; Goudarzi M, 2017, DEV CELL, V43, P577, DOI 10.1016/j.devcel.2017.10.030; Koprunner M, 2001, GENE DEV, V15, P2877; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Logue JS, 2015, ELIFE, V4, DOI 10.7554/eLife.08314; Paksa A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11288; Petrie RJ, 2012, J CELL BIOL, V197, P439, DOI 10.1083/jcb.201201124; Reichman-Fried M, 2004, DEV CELL, V6, P589, DOI 10.1016/S1534-5807(04)00074-7; Reig G, 2014, DEVELOPMENT, V141, P1999, DOI 10.1242/dev.101451; Scarpa E, 2016, J CELL BIOL, V212, P143, DOI 10.1083/jcb.201508047; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Stainier DYR, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007000; Taloni A, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.208101; Tarbashevich K, 2015, CURR BIOL, V25, P1096, DOI 10.1016/j.cub.2015.02.071; Tinevez JY, 2009, P NATL ACAD SCI USA, V106, P18581, DOI 10.1073/pnas.0903353106; Yanai M, 1996, CELL MOTIL CYTOSKEL, V33, P22; Zatulovskiy E, 2014, J CELL BIOL, V204, P1027, DOI 10.1083/jcb.201306147; Zhang YY, 2018, CELL RES, V28, P9, DOI 10.1038/cr.2017.133	30	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0212699	10.1371/journal.pone.0212699	http://dx.doi.org/10.1371/journal.pone.0212699			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807602	Green Published, Green Submitted, gold			2022-12-27	WOS:000459712100022
J	Shari, NI; Zainal, NZ; Guan, NC; Sabki, ZA; Yahaya, NA				Shari, Nurul Izzah; Zainal, Nor Zuraida; Guan, Ng Chong; Sabki, Zuraida Ahmad; Yahaya, Nor Aziyan			Psychometric properties of the acceptance and action questionnaire (AAQ II) Malay version in cancer patients	PLOS ONE			English	Article							PSYCHOLOGICAL INFLEXIBILITY; EXPERIENTIAL AVOIDANCE; CONTENT VALIDITY; FLEXIBILITY; DISTRESS	Psychological inflexibility has been found as one of the predictor to psychopathology in cancer patient. Cancer patients tend to experience psychological inflexibility as a reaction to cancer diagnosis, prognosis and treatment. Therefore, there is a need to identify psychological inflexibility due to its impact on quality of life among cancer patients. Objectives Acceptance and action questionnaire (AAQ II) is a scale used to assess psychological inflexibility. The aim of this study is to translate AAQ II into Malay language and evaluate the psychometric properties of AAQ II Malay version. Methods The AAQ II which has been translated into Malay language via back translation procedure was distributed to 101 cancer patients and 100 non-cancer patients. The evaluation of psychometric properties in this study included content validity index, internal consistency, parallel reliability, exploratory factor analysis, concurrent validity, sensitivity and specificity of AAQ II Malay version. Results AAQ II Malay version has established good content validity index, acceptable internal consistency with Cronbach's alpha value of 0.91, excellent parallel reliability and adequate concurrent validity. Exploratory factor analysis (EFA) results demonstrated AAQ II Malay version is a unidimensional factor instrument. The result of sensitivity and specificity of AAQ II Malay version indicated cancer patients who scored more than 17.5 were having significant psychological inflexibility. Conclusion AAQ II Malay version is a reliable and valid instrument to measure psychological inflexibility among cancer patient in Malaysia.	[Shari, Nurul Izzah] Univ Sains Malaysia, Adv Med & Dent Inst, Lifestyle Sci Cluster, Kepala Batas, Malaysia; [Zainal, Nor Zuraida; Guan, Ng Chong; Sabki, Zuraida Ahmad] Univ Malaya, Fac Med, Dept Psychol Med, Kuala Lumpur, Malaysia; [Yahaya, Nor Aziyan] Univ Malaya, Fac Med, Dept Nursing Sci, Kuala Lumpur, Malaysia	Universiti Sains Malaysia; Universiti Malaya; Universiti Malaya	Shari, NI (corresponding author), Univ Sains Malaysia, Adv Med & Dent Inst, Lifestyle Sci Cluster, Kepala Batas, Malaysia.	izza_lesca@yahoo.com	Shari, Nurul Izzah/M-8843-2016; Yahaya, Nor Aziyan/F-3762-2015; shari, Nurul/ABA-5875-2021; ZAINAL, NOR ZURAIDA/B-9329-2010; SABKI, ZURAIDA BINTI AHMAD/AAA-5434-2021	Shari, Nurul Izzah/0000-0003-3343-2793; Yahaya, Nor Aziyan/0000-0002-4225-2148; 				Abdollahpour I., 2011, IRAN J EPIDEMIOL, V6, P66; Aguirre-Camacho A, 2017, PSYCHO-ONCOLOGY, V26, P469, DOI 10.1002/pon.4162; Bond FW, 2011, BEHAV THER, V42, P676, DOI 10.1016/j.beth.2011.03.007; Bond FW, 2003, J APPL PSYCHOL, V88, P1057, DOI 10.1037/0021-9010.88.6.1057; CICCHETTI DV, 1981, AM J MENT DEF, V86, P127; Costa J., 2014, INT J PSYCHOL PSYCHO, V14, P353; Donovan-Kicken E, 2011, J HEALTH PSYCHOL, V16, P596, DOI 10.1177/1359105310383605; Gonzalez-Fernandez S, 2017, EUR J ONCOL NURS, V30, P75, DOI 10.1016/j.ejon.2017.08.006; Hayes S. C, 2011, ACCEPTANCE COMMITMEN; Hayes SC, 2004, PSYCHOL REC, V54, P553, DOI 10.1007/BF03395492; Hayes SC, 2006, BEHAV RES THER, V44, P1, DOI 10.1016/j.brat.2005.06.006; Hayes SC., 2012, ACCEPTANCE COMMITMEN; Hei K. C., 2015, SEARCH J S E ASIA RE, V7, P53, DOI [10.7603/s40931-015-0003-1, DOI 10.7603/S40931-015-0003-1]; Hulbert-Williams NJ, 2015, EUR J CANCER CARE, V24, P15, DOI 10.1111/ecc.12223; Karekla M, 2004, BEHAV THER, V35, P725, DOI 10.1016/S0005-7894(04)80017-0; Karekla M, 2017, J CONTEXT BEHAV SCI, V6, P119, DOI 10.1016/j.jcbs.2016.11.006; Lilly MM, 2015, J TRAUMA STRESS, V28, P262, DOI 10.1002/jts.22004; Lua PL, 2012, MALAYSIAN J PSYCHIAT, V21, P25; LYNN MR, 1986, NURS RES, V35, P382; Montiel CB, 2016, PSICOTHEMA, V28, P266, DOI 10.7334/psicothema2015.271; Mosher CE, 2017, PSYCHO-ONCOLOGY, V26, P1944, DOI 10.1002/pon.4283; Pinto-Gouveia J., 2012, INT J PSYCHOL PSYCHO, V12, P139, DOI DOI 10.1016/J.JAD; Polit DF, 2007, RES NURS HEALTH, V30, P459, DOI 10.1002/nur.20199; Polit DF, 2006, RES NURS HEALTH, V29, P489, DOI 10.1002/nur.20147; Ruiz FJ, 2016, PSYCHOL REC, V66, P429, DOI 10.1007/s40732-016-0183-2; Salber K, 2015, THESIS; Waltz C. F., 2016, MEASUREMENT NURSING, DOI DOI 10.1891/9780826170620; WEGNER DM, 1994, J PERS, V62, P615, DOI 10.1111/j.1467-6494.1994.tb00311.x; Yaghmaie F., 2003, J MED EDUC, V3, P25, DOI DOI 10.22037/JME.V3I1.870; Yavuz F, 2016, KLIN PSIKOFARMAKOL B, V26, P397, DOI 10.5455/bcp.20160223124107; Zhang CQ, 2014, MEAS EVAL COUNS DEV, V47, P256, DOI 10.1177/0748175614538064; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	32	17	18	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0212788	10.1371/journal.pone.0212788	http://dx.doi.org/10.1371/journal.pone.0212788			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8EU	30807594	Green Published, gold, Green Submitted			2022-12-27	WOS:000459712100024
J	Dos Santos, QM; Dzika, E; Avenant-Oldewage, A				Dos Santos, Quinton Marco; Dzika, Ewa; Avenant-Oldewage, Annemarie			Using scanning electron microscopy (SEM) to study morphology and morphometry of the isolated haptoral sclerites of three distinct diplozoid species	PLOS ONE			English	Article							SP MONOGENEA GYRODACTYLIDAE; SEABREAM SPARUS-AURATA; DIGESTION; L.; POPULATIONS; ATTACHMENT	Diplozoidae infects the gills of cyprinid fishes in Africa, Europe, and Asia. Traditionally the hardened internal structures, crucial for identification of diplozoid species, are studied using light microscopy. Recently, the sclerotised haptoral structures of an African diplozoid, Paradiplozoon vaalense, were successfully isolated and visualised using scanning electron microscopy (SEM). In this paper, the haptoral sclerites of three diplozoid species are compared using SEM for the first time. Paradiplozoon ichthyoxanthon and Paradiplozoon vaalense occur on Labeobarbus and Labeo species, respectively, in the Vaal River system, South Africa, while Diplozoon paradoxum is widely-distributed in Europe and Asia, infecting several host species. Diplozoon paradoxum is a well-studied species, as well as being the type species of the family and ideal for inclusion in an exploratory study for comparative purposes. SEM study of D. paradoxum and P. ichthyoxanthon provided valuable information regarding surface morphology of the attachment structures hitherto not observed. Elaborate morphometric study of the haptoral hooks were incorporated, adding 12 point-to-point measurements to current morphometric characteristics. The results were analysed statistically, and significant differences support absolute separation (100.00%) of the three species following discriminant analysis. These point-to-point measurements could also be used for light microscopical study in the future and aid species delimitation within the Diplozoidae.	[Dos Santos, Quinton Marco; Avenant-Oldewage, Annemarie] Univ Johannesburg, Dept Zool, Johannesburg, South Africa; [Dzika, Ewa] Warmia & Mazury Univ, Dept Med Biol, Fac Med Sci, Olsztyn, Poland	University of Johannesburg; University of Warmia & Mazury	Avenant-Oldewage, A (corresponding author), Univ Johannesburg, Dept Zool, Johannesburg, South Africa.	aoldewage@uj.ac.za	Avenant-Oldewage, Annemarie/A-7778-2011; Dos Santos, Quinton/AAL-5636-2021	Avenant-Oldewage, Annemarie/0000-0001-8820-7679; Dos Santos, Quinton/0000-0002-2641-9059	National Research Foundation of South Africa [80789, 84895]; Faculty of Health Sciences, Warmia and Mazury University in Olsztyn, Poland	National Research Foundation of South Africa(National Research Foundation - South Africa); Faculty of Health Sciences, Warmia and Mazury University in Olsztyn, Poland	A.A.-O. received funding (grant 80789) and Q.M.D.S. received a PhD fellowship (grant 84895) from the National Research Foundation of South Africa (http://www.nrf.ac.za/). E.D.was supported by a grant from the Faculty of Health Sciences, Warmia and Mazury University in Olsztyn, Poland.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Avenant-Oldewage A, 2014, J HELMINTHOL, V88, P166, DOI 10.1017/S0022149X12000879; Bachellerie J P, 1993, Methods Mol Biol, V21, P249; BOVET J, 1967, B SOC NEUCHATEL SCI, V90, P64; Dos Santos QM, 2015, J PARASITOL, V101, P94, DOI 10.1645/14-521.1; Dos Santos QM, 2015, J HELMINTHOL, V89, P58, DOI 10.1017/S0022149X1300059X; Fannes W, 2017, SYST PARASITOL, V94, P133, DOI 10.1007/s11230-016-9685-1; Fannes W, 2015, PARASITOL RES, V114, P2031, DOI 10.1007/s00436-015-4446-7; Glaser H. J., 1965, Zeitschrift fuer Parasitenkunde, V25, P485; GLASER HANS-JOACHIM, 1964, Z PARASITENKUND, V25, P164; Goto S., 1891, J COLL SCI IMP U TOK, V4, P151; Hahn C, 2011, PARASITOL INT, V60, P480, DOI 10.1016/j.parint.2011.08.016; Harris PD, 1999, J PARASITOL, V85, P188, DOI 10.2307/3285617; IBM Corporation, 2017, IBM SPSS STAT WINDOW; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Khotenovsky IA, 1985, FAUNA USSR MONOGENEA, P263; King SD, 2009, SYST PARASITOL, V74, P23, DOI 10.1007/s11230-009-9185-7; LYONS KM, 1966, PARASITOLOGY, V56, P63, DOI 10.1017/S0031182000071109; MAILLARD C, 1982, PARASITOLOGY, V84, P63, DOI 10.1017/S0031182000051660; Matejusova I, 2004, J PARASITOL, V90, P817, DOI 10.1645/GE-138R; Matejusova I, 2001, PARASITOLOGY, V123, P465, DOI 10.1017/S0031182001008617; MO TA, 1990, SYST PARASITOL, V17, P103, DOI 10.1007/BF00009797; OWEN IL, 1963, PARASITOLOGY, V53, P463, DOI 10.1017/S0031182000073911; Paladini G, 2011, PARASITOL INT, V60, P410, DOI 10.1016/j.parint.2011.06.022; Paladini G, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-100; Paladini G, 2009, FOLIA PARASIT, V56, P21, DOI 10.14411/fp.2009.004; Pugachev ON, 2010, GUIDE MONOGENEA FRES; Reichenbach-Klinke H. H., 1961, Zeitschrift fuer Parasitenkunde, V20, P541, DOI 10.1007/BF00333237; Reichenbach-Klinke H. H., 1951, Zeitschrift fuer Parasitenkunde, V15, P148; Schelkle B, 2011, ACTA PARASITOL, V56, P360, DOI 10.2478/s11686-011-0081-3; Shinn AP, 2004, FOLIA PARASIT, V51, P239, DOI 10.14411/fp.2004.029; SHINN AP, 1993, SYST PARASITOL, V25, P135, DOI 10.1007/BF00009983; von Nordmann A., 1832, MIKROGRAPHISCHE BEIT, VVolume 2	33	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2019	14	2							e0211794	10.1371/journal.pone.0211794	http://dx.doi.org/10.1371/journal.pone.0211794			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EH	30802264	Green Published, Green Submitted, gold			2022-12-27	WOS:000459710700006
J	Wang, SP; Zhang, Q; Zhang, YL; Sun, J; Chen, JJ; Sun, XQ				Wang, Shangping; Zhang, Qian; Zhang, Yaling; Sun, Jin; Chen, Juanjuan; Sun, Xiaoqing			Improving the proof of "Privacy-preserving attribute-keyword based data publish-subscribe service on cloud platforms"	PLOS ONE			English	Article								Most recently, Kan Yang et al. proposed an attribute-keyword based encryption scheme for data publish-subscribe service(AKPS), which is highly useful for cloud storage scenario. Unfortunately, we discover that there is a flaw in the security proof of indistinguishability of the tag and trapdoor against chosen keyword attack under the Bilinear Diffie-Hellman (BDH) assumption. As the security proof is a key component for a cryptographic scheme, based on the Decisional Diffie-Hellman (DDH) assumption, we improve the security proof method and give a new security proof of the AKPS scheme for indistinguishability of the tag and trapdoor in our proposal, which is more rigorous than the original one. Furthermore, we also demonstrate that the AKPS scheme is secure against data Replayable Chosen Ciphertext Attack (RCCA).	[Wang, Shangping; Zhang, Qian; Sun, Jin; Chen, Juanjuan; Sun, Xiaoqing] Xian Univ Technol, Sch Sci, Xian, Shaanxi, Peoples R China; [Zhang, Yaling] Xian Univ Technol, Sch Comp Sci & Engn, Xian, Shaanxi, Peoples R China	Xi'an University of Technology; Xi'an University of Technology	Zhang, Q (corresponding author), Xian Univ Technol, Sch Sci, Xian, Shaanxi, Peoples R China.	qianz95119@126.com		Zhang, Qian/0000-0001-9557-483X; Wang, Shangping/0000-0002-8964-5328	National Natural Science Foundation of China [61572019]; Key Project of Research Foundation of Natural Science Foundation of Shaanxi Province of China [2016JZ001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Research Foundation of Natural Science Foundation of Shaanxi Province of China	This research is supported by the National Natural Science Foundation of China (No. 61572019 http://www.nsfc.gov.cn), the Key Project of Research Foundation of Natural Science Foundation of Shaanxi Province of China (NO. 2016JZ001. http://www.sninfo.gov.cn/).	Attrapadung N, 2009, DUAL POLICY ATTRIBUT, P168; Canetti R, 2003, RELAXING CHOSEN CIPH, P565; ELGAMAL T, 1985, IEEE T INFORM THEORY, V31, P469, DOI 10.1109/TIT.1985.1057074; Escala A, 2013, ALGEBRAIC FRAMEWORK; Goyal V, 2006, P 13 ACM C COMP COMM, P89, DOI DOI 10.1145/1180405.1180418; Green M., 2011, P 20 USENIX C SEC BE, P34; Hassan MM, 2015, CLUSTER COMPUT, V18, P1539, DOI 10.1007/s10586-015-0476-2; Hindersah H, 2016, 2016 6 INT C SYST EN; Li D, 2017, EFFICIENT CCA2 SECUR; Nabeel M, 2013, PRIVACY PRESERVING C; Nasim R, 2014, 2014 INTERNATIONAL CONFERENCE ON CLOUD AND AUTONOMIC COMPUTING (ICCAC 2014), P187, DOI 10.1109/ICCAC.2014.15; Wang ZW, 2016, SECUR COMMUN NETW, V9, P2387, DOI 10.1002/sec.1507; Waters B., 2011, CIPHERTEXT POLICY AT; Waters B, 2009, DUAL SYSTEM ENCRYPTI, P619; Waters B, 2011, LECT NOTES COMPUT SC, V6571, P53, DOI 10.1007/978-3-642-19379-8_4; Yang K, 2017, INFORM SCIENCES, V387, P116, DOI 10.1016/j.ins.2016.09.020; Zuo C, 2018, FUTURE GENER COMP SY, V78, P730, DOI 10.1016/j.future.2016.10.028	17	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2019	14	2							e0212761	10.1371/journal.pone.0212761	http://dx.doi.org/10.1371/journal.pone.0212761			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EH	30802275	Green Published, gold			2022-12-27	WOS:000459710700020
J	Addad, F; Mahdhaoui, A; Gouider, J; Boughzela, E; Kamoun, S; Boujnah, MR; Haouala, H; Gamra, H; Maatouk, F; Ben Khalfallah, A; Kachboura, S; Baccar, H; Ben Halima, N; Guesmi, A; Sayahi, K; Sdiri, W; Neji, A; Bouakez, A; Milouchi, S; Battikh, K; Jullieres, Y; Danchin, N; Monsuez, JJ; Mulak, G; Hagege, A; Bataille, V; Chettaoui, R; Mourali, MS				Addad, Faouzi; Mahdhaoui, Abdallah; Gouider, Jeridi; Boughzela, Essia; Kamoun, Samir; Boujnah, Mohamed Rachid; Haouala, Habib; Gamra, Habib; Maatouk, Faouzi; Ben Khalfallah, Ali; Kachboura, Salem; Baccar, Hedi; Ben Halima, Nejeh; Guesmi, Ali; Sayahi, Khaled; Sdiri, Wissem; Neji, Ali; Bouakez, Ahmed; Milouchi, Sami; Battikh, Kais; Jullieres, Yves; Danchin, Nicolas; Monsuez, Jean Jacques; Mulak, Genevieve; Hagege, Albert; Bataille, Vincent; Chettaoui, Rafik; Mourali, Mohamed Sami		FAST-MI Tunisia Investigators	Management of patients with acute ST-elevation myocardial infarction: Results of the FAST-MI Tunisia Registry	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; HEART-DISEASE MORTALITY; FRENCH REGISTRY; TRENDS; SURVIVAL; ASSOCIATION; STRATEGY; OUTCOMES	Background The FAST-MI Tunisia registry was set up by the Tunisian Society of Cardiology and Cardiovascular Surgery to assess the demographic and clinical characteristics, management and hospital outcome of patients with ST-elevation myocardial infarction (STEMI). Methods Data for 459 consecutive patients (mean age 60.8 years; 88.5% male) with STEMI, treated in 16 public hospitals (representing 72.2% of public hospitals in Tunisia treating STEMI patients), were collected prospectively. The most common risk factors were smoking (63.6%), hypertension (39.7%), diabetes (32%) and dyslipidaemia (18.2%). Results Among the 459 patients, 61.8% received reperfusion therapy: 30% with primary percutaneous coronary intervention (PPCI) and 31.8% with intravenous fibrinolysis (IF) (28.6% with pre-hospital thrombolysis). The median time from symptom onset to thrombolysis was 185 min and to PPCI was 358 min. In-hospital mortality was 5.3%. Compared with those managed at regional hospitals, patients managed at interventional university hospitals (n = 357) were more likely to receive reperfusion therapy (52.9% vs. 34.1%; p<0.001), with less IF (28.6% vs. 43.1%; p = 0.002) but more PPCI (37.8% vs. 3.9%; p<0.0001). However, in-hospital mortality in the two types of hospitals was similar (5.3% vs. 5.1%; p = 0.866). Conclusions Data from the FAST-MI Tunisia registry show that a pharmaco-invasive strategy of management for STEMI should be promoted in non-interventional regional hospitals.	[Addad, Faouzi; Kachboura, Salem] CHU Abderrahmen Mami, Cardiol Dept, Ariana, Tunisia; [Mahdhaoui, Abdallah; Gouider, Jeridi] CHU Farhat Hached, Sousse, Tunisia; [Boughzela, Essia] CHU Sahloul, Sousse, Tunisia; [Kamoun, Samir] CHU Hedi Chaker, Sfax, Tunisia; [Boujnah, Mohamed Rachid] CHU Mongi Slim, Marsa, Tunisia; [Haouala, Habib] Hop Militaire Principal Instruct Tunis, Tunis, Tunisia; [Gamra, Habib] Cardio A CHU Fattouma Bourguiba, Monastir, Tunisia; [Maatouk, Faouzi] Cardio B CHU Fattouma Bourguiba, Monastir, Tunisia; [Ben Khalfallah, Ali] Hop Menzel Bourguiba, Menzel Bourguiba, Tunisia; [Baccar, Hedi] Hop Charles Nicolles, Tunis, Tunisia; [Ben Halima, Nejeh] Hop Reg Ibn El Jazzar, Kairouan, Tunisia; [Guesmi, Ali] Hop Reg Mohamed Ben Sassi, Gabes, Tunisia; [Sayahi, Khaled] Hop Reg MHamed Bourguiba, Kef, Tunisia; [Sdiri, Wissem] Hop Reg Habib Bougatfa, Bizerte, Tunisia; [Neji, Ali] Hop Reg Ben Guerdene, Medenine, Tunisia; [Bouakez, Ahmed] Hop Reg Jendouba, Jendouba, Tunisia; [Milouchi, Sami] Hop Reg Medenine, Medenine, Tunisia; [Battikh, Kais] Clin Djerba, Djerba, Tunisia; [Jullieres, Yves] CHU Nancy, Dept Cardiol, Nancy, France; [Danchin, Nicolas; Hagege, Albert] Hop Europeen Georges Pompidou, AP HP, Paris, France; [Monsuez, Jean Jacques] Hop Univ Paris Seine St Denis, Hop R Muret, AP HP, Sevran, France; [Mulak, Genevieve] Soc Francaise Cardiol, Paris, France; [Bataille, Vincent] CHU Toulouse 3, Serv Aide Med Urgente, Toulouse, France; [Chettaoui, Rafik] Clin Tunis, Tunis, Tunisia; [Mourali, Mohamed Sami] CHU La Rabta, Tunis, Tunisia	Universite de Tunis-El-Manar; Hopital Abderrahmene Mami; Universite de Sousse; Hopital Farhat Hached; Universite de Sousse; Hopital Sahloul; Universite de Sfax; Hopital Hedi Chaker; Universite de Tunis-El-Manar; Hopital Charles Nicolle; CHU de Nancy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Rene-Muret - APHP; CHU de Toulouse; Universite de Tunis-El-Manar; Hopital La Rabta	Addad, F (corresponding author), CHU Abderrahmen Mami, Cardiol Dept, Ariana, Tunisia.	secretaire.stcccv@gmail.com	Danchin, Nicolas/AAN-8291-2020	Bataille, Vincent/0000-0002-5780-2333				Addad F, 2015, Ann Cardiol Angeiol (Paris), V64, P439, DOI 10.1016/j.ancard.2015.09.064; Addad F, 2010, ANN CARDIOL ANGEIOL, V59, P183, DOI 10.1016/j.ancard.2010.07.006; Armstrong PW, 2013, NEW ENGL J MED, V368, P1379, DOI 10.1056/NEJMoa1301092; Danchin N, 2008, CIRCULATION, V118, P268, DOI 10.1161/CIRCULATIONAHA.107.762765; Danchin N, 2014, REV ESP CARDIOL, V67, P659, DOI 10.1016/j.rec.2014.04.004; Danchin N, 2014, CIRCULATION, V129, P1629, DOI 10.1161/CIRCULATIONAHA.113.005874; Donataccio MP, 2015, INT J CARDIOL, V201, P265, DOI 10.1016/j.ijcard.2015.08.065; Hanssen M, 2012, HEART, V98, P699, DOI 10.1136/heartjnl-2012-301700; Jernberg T, 2011, JAMA-J AM MED ASSOC, V305, P1677, DOI 10.1001/jama.2011.522; Kostis WJ, 2010, CIRC-CARDIOVASC QUAL, V3, P581, DOI 10.1161/CIRCOUTCOMES.110.957803; Loirat M, 2013, ANN CARDIOL ANGEIOL, V62, P287, DOI 10.1016/j.ancard.2013.08.008; Montalescot G, 2001, NEW ENGL J MED, V344, P1895, DOI 10.1056/NEJM200106213442503; Moustaghfir A, 2012, ARCH CARDIOVASC DIS, V105, P566, DOI 10.1016/j.acvd.2012.07.002; Nichols M, 2013, EUR HEART J, V34, P3017, DOI 10.1093/eurheartj/eht159; Puymirat E, 2012, JAMA-J AM MED ASSOC, V308, P998, DOI 10.1001/2012.jama.11348; Rogers WJ, 2008, AM HEART J, V156, P1026, DOI 10.1016/j.ahj.2008.07.030; Rosamond WD, 2012, CIRCULATION, V125, P1848, DOI 10.1161/CIRCULATIONAHA.111.047480; Saidi O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063202; Schmidt Morten, 2012, BMJ, V344, pe356, DOI 10.1136/bmj.e356; Sinnaeve P, 2003, AM HEART J, V146, P27, DOI 10.1016/S0002-8703(03)00117-0; Sinnaeve PR, 2014, CIRCULATION, V130, P1139, DOI 10.1161/CIRCULATIONAHA.114.009570; Sozmen K, 2015, INT J PUBLIC HEALTH, V60, pS3, DOI 10.1007/s00038-014-0610-6; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610	24	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0207979	10.1371/journal.pone.0207979	http://dx.doi.org/10.1371/journal.pone.0207979			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794566	Green Published, Green Submitted, gold			2022-12-27	WOS:000459709100006
J	Hong, YY; Luo, YY; Yi, JL; He, L; Dai, LY; Yi, TY				Hong, Yanyun; Luo, Yongyang; Yi, Jianglan; He, Ling; Dai, Liangying; Yi, Tuyong			Screening nested-PCR primer for 'Candidatus Liberibacter asiaticus' associated with citrus Huanglongbing and application in Hunan, China	PLOS ONE			English	Article							REAL-TIME PCR; DIAPHORINA-CITRI; DIAGNOSTIC SYSTEM; ORANGE TREE; OMP GENE; BACTERIUM; DNA; IDENTIFICATION; DIVERSITY; GUANGDONG	Citrus Huanglongbing (HLB) is one of the most devastating citrus diseases worldwide. Sensitive and accurate assays are vital for efficient prevention of the spread of HLB-associated "Candidatus Liberibacter spp". "Candidatus Liberibacter spp" that infect Citrus includes "Candidatus Liberibacter asiaticus" (Las), "Candidatus Liberibacter africanus" (Laf) and "Candidatus Liberibacter americanus" (Lam). Of them, Las is the most widespread species. In this study, a set of nested PCR primer pairs were screened to diagnose Las, and the nested PCR method greatly enhanced the sensitivity to detect Las up to 10 times and 100 times compared to qPCR and conventional PCR, respectively. Totally, 1112 samples from 5 different citrus cultivars in 39 different counties and cities were assayed by nested PCR. The results show that 384 samples were HLB-infected; the highest positive detection rate was 79.7% from the lopsided fruit samples, and the lowest positive detection rate was 16.3% from the apical dieback samples. The results indicate that the designed nested PCR primer pairs can detect Las from different symptomatic tissues, different citrus cultivars and different geographic regions. The set of nested PCR primers designed in the present study will provide a very useful supplementation to the current approaches for Las detection.	[Hong, Yanyun; Luo, Yongyang; He, Ling; Dai, Liangying; Yi, Tuyong] Hunan Agr Univ, Coll Plant Protect, Hunan Prov Key Lab Biol & Control Plant Pests, Changsha, Hunan, Peoples R China; [Yi, Jianglan] Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing, Peoples R China	Hunan Agricultural University; Beijing University of Chemical Technology	Yi, TY (corresponding author), Hunan Agr Univ, Coll Plant Protect, Hunan Prov Key Lab Biol & Control Plant Pests, Changsha, Hunan, Peoples R China.	yituyong@hotmail.com			National key Research and development project of China "Research and demonstration of prevention and control technology in central China citrus Huanglongbing interdiction belt and low epidemic areas" [2018YFD 0201505]; Hunan province key Research and development project:" Research and application of key technologies for green control of citrus pests and diseases" [2018NK 2012]	National key Research and development project of China "Research and demonstration of prevention and control technology in central China citrus Huanglongbing interdiction belt and low epidemic areas"; Hunan province key Research and development project:" Research and application of key technologies for green control of citrus pests and diseases"	The project was supported by National key Research and development project of China "Research and demonstration of prevention and control technology in central China citrus Huanglongbing interdiction belt and low epidemic areas (2018YFD 0201505) " and Hunan province key Research and development project:" Research and application of key technologies for green control of citrus pests and diseases (2018NK 2012)"Tuyong Yi received the first fund and Yanyun Hong received the second fund.	Aghasadeghi MR, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.7481; Ahmad K, 2009, INT J AGRIC BIOL, V11, P401; Anderson TP, 2003, CLIN MICROBIOL INFEC, V9, P746, DOI 10.1046/j.1469-0691.2003.00601.x; Angel J.E., 2015, AGRON COLOMB, V32, P377; Valdes RA, 2016, CAN J MICROBIOL, V62, P803, DOI 10.1139/cjm-2016-0022; Bassanezi R. B, 2007, PLANT HLTH PROGR, V8, P1, DOI DOI 10.1094/PHP-2007-0906-01-RV; Bassanezi RB, 2009, EUR J PLANT PATHOL, V125, P565, DOI 10.1007/s10658-009-9506-3; Bastianel C, 2005, APPL ENVIRON MICROB, V71, P6473, DOI 10.1128/AEM.71.11.6473-6478.2005; Benyon L, 2008, PHYTOPATHOLOGY, V98, pS21; Bove JM, 2006, J PLANT PATHOL, V88, P7; Chen J, 2010, PHYTOPATHOLOGY, V100, P567, DOI 10.1094/PHYTO-100-6-0567; Coy MR, 2014, J MICROBIOL METH, V102, P15, DOI 10.1016/j.mimet.2014.04.007; da Fonseca AJ, 2016, J MED VIROL, V88, P888, DOI 10.1002/jmv.24413; Deng X, 2008, PLANT DIS, V92, P513, DOI 10.1094/PDIS-92-4-0513; Deng X, 2007, PLANT DIS, V91, P1051, DOI 10.1094/PDIS-91-8-1051C; Ding F, 2017, SCI REP-UK, V7, DOI 10.1038/srep46467; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; GOTTWALD TR, 2008, P INT RES C HUANGL O, P480; Hocquellet A, 1999, MOL CELL PROBE, V13, P373, DOI 10.1006/mcpr.1999.0263; Hong YY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14023-6; Hong YY, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01593; Hu WZ, 2011, J PLANT PATHOL, V93, P211; Kamau E, 2011, J CLIN MICROBIOL, V49, P2946, DOI 10.1128/JCM.00276-11; Kogenaru S, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-39; Kunta M, 2014, HORTSCIENCE, V49, P65, DOI 10.21273/HORTSCI.49.1.65; LAFLECHE D, 1970, CR ACAD SCI D NAT, V270, P1915; Lam WY, 2007, J CLIN MICROBIOL, V45, P3631, DOI 10.1128/JCM.00280-07; Langeroudi A. G., 2013, Iranian Journal of Veterinary Medicine, V7, P207; Li WB, 2006, J MICROBIOL METH, V66, P104, DOI 10.1016/j.mimet.2005.10.018; Lin H, 2010, J MICROBIOL METH, V81, P17, DOI 10.1016/j.mimet.2010.01.014; Lin H, 2008, MOL CELL PROBE, V22, P30, DOI 10.1016/j.mcp.2007.06.006; Lu LM, 2013, PLANT DIS, V97, P1295, DOI 10.1094/PDIS-11-12-1086-RE; Manjunath KL, 2008, PHYTOPATHOLOGY, V98, P387, DOI 10.1094/PHYTO-98-4-0387; Okuda M, 2005, PLANT DIS, V89, P705, DOI 10.1094/PD-89-0705; Okuda M., 2008, Japanese Journal of Phytopathology, V74, P316, DOI 10.3186/jjphytopath.74.316; Rigano LA, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-86; Schneid AD, 2006, BRAZ J MICROBIOL, V37, P350, DOI 10.1590/S1517-83822006000300027; SCHWARZ R. E., 1967, S AFR J AGR SCI, V10, P471; Sechler A, 2009, PHYTOPATHOLOGY, V99, P480, DOI 10.1094/PHYTO-99-5-0480; Song MK, 2009, J MICROBIOL BIOTECHN, V19, P1470, DOI 10.4014/jmb.0905.05012; Tatineni S, 2008, PHYTOPATHOLOGY, V98, P592, DOI 10.1094/PHYTO-98-5-0592; Teixeira DC, 2008, MOL CELL PROBE, V22, P139, DOI 10.1016/j.mcp.2007.12.006; Tomimura K, 2009, PHYTOPATHOLOGY, V99, P1062, DOI 10.1094/PHYTO-99-9-1062; Traversa D, 2008, J CLIN MICROBIOL, V46, P1811, DOI 10.1128/JCM.01612-07; Ukuda-Hosokawa R, 2015, APPL ENVIRON MICROB, V81, P3728, DOI 10.1128/AEM.00707-15; Xie ZhongChen, 2009, Scientia Agricultura Sinica, V42, P3888; [Xu Meirong 许美容], 2014, [植物病理学报, Acta Phytopathologica Sinica], V44, P609; Zhang MQ, 2010, PHYTOPATHOLOGY, V100, P239, DOI 10.1094/PHYTO-100-3-0239; Zhong X, 2018, J INTEGR AGR, V17, P483, DOI 10.1016/S2095-3119(17)61815-X	50	3	4	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212020	10.1371/journal.pone.0212020	http://dx.doi.org/10.1371/journal.pone.0212020			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794562	Green Submitted, gold, Green Published			2022-12-27	WOS:000459709100032
J	Minato, N; Sok, S; Chen, SB; Delaquis, E; Phirun, I; Le, VX; Burra, DD; Newby, JC; Wyckhuys, KAG; de Haan, S				Minato, Nami; Sok, Sophearith; Chen, Songbi; Delaquis, Erik; Phirun, Iv; Vi Xuan Le; Burra, Dharani D.; Newby, Jonathan C.; Wyckhuys, Kris A. G.; de Haan, Stef			Surveillance for Sri Lankan cassava mosaic virus (SLCMV) in Cambodia and Vietnam one year after its initial detection in a single plantation in 2015	PLOS ONE			English	Article							DISEASE; DNA; GEMINIVIRUSES; EPIDEMIOLOGY; SEVERITY; YIELD	Cassava mosaic disease, one of the ten most economically important crop viral diseases in the world, was first reported in Southeast Asia from a single plantation in Cambodia in 2015. To determine the presence and incidence of Sri Lankan cassava mosaic virus (SLCMV) one year after first detection, a total of 6,480 samples from 419 fields were systematically collected from cassava production areas across Cambodia (3,840 samples; 240 fields) and Vietnam (2,640samples; 179 fields) in the 2016 cropping season. Using PCR-based diagnostics, we identified 49 SLCMV-infected plants from nine fields, representing 2% of the total number of fields sampled. Infected fields were geographically restricted to two provinces of Eastern Cambodia, while no infection was detected from any of the other sampled sites in either country. Symptom expression patterns in infected plants suggested that SLCMV may have been transmitted both through infected planting materials, and by Bemisia tabaci, the known whitefly vector of SLCMV. In addition, 14% of virus infected plants did not express typical symptoms of cassava mosaic disease on their leaves, highlighting that molecular-based validation is needed to confirm the presence of SLCMV in the field. None of the owners of the SLCMV-infected fields indicated acquired planting materials from the plantation in Ratanakiri where SLCMV was first reported. The surveillance baseline data generated for both countries is discussed in light of future options to control and manage cassava mosaic disease.	[Minato, Nami; Sok, Sophearith; Delaquis, Erik; Newby, Jonathan C.; de Haan, Stef] CGIAR Res Program Roots Tubers & Bananas, Int Ctr Trop Agr CIAT, Agrobiodivers Res Area, Asia Reg Off, Hanoi, Vietnam; [Chen, Songbi] CATAS, TCGRI, Danzhou, Hainan, Peoples R China; [Phirun, Iv] GDA, Dept Ind Crops, Phnom Penh, Cambodia; [Vi Xuan Le] Vietnam Acad Agr Sci, PPRI, Hanoi, Vietnam; [Burra, Dharani D.] Int Ctr Trop Agr CIAT, Asia Reg Off, Decis & Policy Anal Res Area, Hanoi, Vietnam; [Wyckhuys, Kris A. G.] Int Joint Res Lab Ecol Pest Management, Fuzhou, Fujian, Peoples R China	Alliance; International Center for Tropical Agriculture - CIAT; CGIAR; Chinese Academy of Tropical Agricultural Sciences; Alliance; International Center for Tropical Agriculture - CIAT	de Haan, S (corresponding author), CGIAR Res Program Roots Tubers & Bananas, Int Ctr Trop Agr CIAT, Agrobiodivers Res Area, Asia Reg Off, Hanoi, Vietnam.	s.dehaan@cgiar.org	Delaquis, Erik/AAZ-6071-2021; Wyckhuys, Kris/AAJ-4352-2020	Delaquis, Erik/0000-0002-1427-6572; Wyckhuys, Kris/0000-0003-0922-488X; de Haan, Stef/0000-0001-8690-1886	CGIAR Research Program on Roots, Tubers and Bananas (RTB); Australian Centre for International Agricultural Research (ACIAR) [AGB/2016/032]; JSPS Overseas Research Fellowships	CGIAR Research Program on Roots, Tubers and Bananas (RTB)(CGIAR); Australian Centre for International Agricultural Research (ACIAR)(Australian Ctr Intl Agr Res); JSPS Overseas Research Fellowships	This research was undertaken as part of the CGIAR Research Program on Roots, Tubers and Bananas (RTB). Funding support for this work was provided by Australian Centre for International Agricultural Research (ACIAR) (Project number: AGB/2016/032). NM was supported by JSPS Overseas Research Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham K, 2010, P 8 REG WORKSH HELD, P233; Adhikary N., 2018, INT J CURR MICROBIOL, V7, P2887, DOI [10.20546/ijcmas.2018.701.344, DOI 10.20546/IJCMAS.2018.701.344]; Anitha J., 2011, J ROOT CROPS, V37, P41; Boonham N, 2014, VIRUS RES, V186, P20, DOI 10.1016/j.virusres.2013.12.007; Boykin L., 2018, F1000RESEARCH, V7, DOI [10.12688/f1000research.15507.1, DOI 10.12688/F1000RESEARCH.15507.1]; Carvajal-Yepes M, 2016, SURVEYING CASSAVA MO; Cramb R, 2017, J PEASANT STUD, V44, P813, DOI 10.1080/03066150.2016.1242482; Delaquis E, 2018, FRONT SUSTAIN FOOD S, V2, DOI 10.3389/fsufs.2018.00073; Duraisamy R, 2013, MOL BIOTECHNOL, V53, P150, DOI 10.1007/s12033-012-9503-1; Dutt N, 2005, ARCH VIROL, V150, P2101, DOI 10.1007/s00705-005-0579-9; Fargette D, 2006, ANNU REV PHYTOPATHOL, V44, P235, DOI 10.1146/annurev.phyto.44.120705.104644; FARGETTE D, 1985, ANN APPL BIOL, V106, P285, DOI 10.1111/j.1744-7348.1985.tb03118.x; FARGETTE D, 1994, PHYTOPATHOLOGY, V84, P91, DOI 10.1094/Phyto-84-91; FAUQUET C, 1990, PLANT DIS, V74, P404, DOI 10.1094/PD-74-0404; General statistics office of Vietnam, 2018, PLANT AR CASS PROV 0; Gotz M, 2016, J ASIA-PAC ENTOMOL, V19, P537, DOI 10.1016/j.aspen.2016.04.017; Campo BVH, 2011, FOOD SECUR, V3, P329, DOI 10.1007/s12571-011-0141-4; Herrera Campo BV, 2014, REPLICATION DATA THR, DOI [10.7910/DVN/27490, DOI 10.7910/DVN/27490]; Howeler R., 2014, SUSTAINABLE SOIL CRO, P1; Graziosi I, 2016, PEST MANAG SCI, V72, P1071, DOI 10.1002/ps.4250; International Institute of Tropical Agriculture (IITA), 2010, CASS DIS SURV SURV 2; Jose A., 2008, J ROOT CROPS, V34, P21; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Legg JP, 2015, ADV VIRUS RES, V91, P85, DOI 10.1016/bs.aivir.2014.10.001; Legg James P., 2010, P233; Legg JP, 2004, PLANT MOL BIOL, V56, P585, DOI 10.1007/s11103-004-1651-7; Marx V, 2015, NAT METHODS, V12, P393, DOI 10.1038/nmeth.3369; Masinde E. A., 2016, African Journal of Agricultural Research, V11, P2064; Ministry of Agriculture Forestry and Fisheries, 2017, MAFF C CAMB 2017; Mittal D, 2008, ARCH VIROL, V153, P2149, DOI 10.1007/s00705-008-0238-z; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Owor B, 2004, ANN APPL BIOL, V145, P331, DOI 10.1111/j.1744-7348.2004.tb00390.x; Patil BL, 2005, ARCH VIROL, V150, P389, DOI 10.1007/s00705-004-0399-3; Rybicki EP, 2015, ARCH VIROL, V160, P17, DOI 10.1007/s00705-014-2295-9; Saunders K, 2002, VIROLOGY, V293, P63, DOI 10.1006/viro.2001.1251; Scholthof KBG, 2011, MOL PLANT PATHOL, V12, P938, DOI [10.1111/j.1364-3703.2011.00752.x, 10.1111/J.1364-3703.2011.00752.X]; Snehi SK, 2017, VIROL MYCOL, V6, P547, DOI DOI 10.4172/2161-0517.1000164; Sseruwagi P, 2004, VIRUS RES, V100, P129, DOI 10.1016/j.virusres.2003.12.021; Tembo M, 2017, J PLANT PATHOL, V99, P681; Thresh J. M., 1994, Tropical Science, V34, P26; Thresh JM, 2005, PLANT PATHOL, V54, P587, DOI 10.1111/j.1365-3059.2005.01282.x; Thresh JM, ADV DIS VECTOR RES, V10; Wang G, 2014, VIRUS GENES, V48, P402, DOI 10.1007/s11262-014-1034-3; Wang HL, 2016, PLANT DIS, V100, P1029, DOI 10.1094/PDIS-10-15-1228-PDN	44	24	24	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212780	10.1371/journal.pone.0212780	http://dx.doi.org/10.1371/journal.pone.0212780			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794679	Green Published, gold, Green Submitted			2022-12-27	WOS:000459709100135
J	Walker, S; Wankell, M; Ho, V; White, R; Deo, N; Devine, C; Dewdney, B; Bhathal, P; Govaere, O; Roskams, T; Qiao, L; George, J; Hebbard, L				Walker, Sarah; Wankell, Miriam; Ho, Vikki; White, Rose; Deo, Nikita; Devine, Carol; Dewdney, Brittany; Bhathal, Prithi; Govaere, Olivier; Roskams, Tania; Qiao, Liang; George, Jacob; Hebbard, Lionel			Targeting mTOR and Src restricts hepatocellular carcinoma growth in a novel murine liver cancer model	PLOS ONE			English	Article							COLORECTAL CARCINOGENESIS; INSULIN-RESISTANCE; MAMMALIAN TARGET; TUMOR-FORMATION; ADIPONECTIN; SORAFENIB; RAPAMYCIN; ACTIVATION; EVEROLIMUS; SURVIVAL	Liver cancer is a poor prognosis cancer with limited treatment options. To develop a new therapeutic approach, we derived HCC cells from a known model of murine hepatocellular carcinoma (HCC). We treated adiponectin (APN) knock-out mice with the carcinogen diethylnitrosamine, and the resulting tumors were 7-fold larger than wild-type controls. Tumors were disassociated from both genotypes and their growth characteristics evaluated. A52 cells from APN KO mice had the most robust growth in vitro and in vivo, and presented with pathology similar to the parental tumor. All primary tumors and cell lines exhibited activity of the mammalian target of Rapamycin (mTOR) and Src pathways. Subsequent combinatorial treatment, with the mTOR inhibitor Rapamycin and the Src inhibitor Dasatinib reduced A52 HCC growth 29-fold in vivo. Through protein and histological analyzes we observed activation of these pathways in human HCC, suggesting that targeting both mTOR and Src may be a novel approach for the treatment of HCC.	[Walker, Sarah; Ho, Vikki; White, Rose; Deo, Nikita; Devine, Carol; Qiao, Liang; George, Jacob; Hebbard, Lionel] Westmead Hosp, Westmead Inst Med Res, Storr Liver Ctr, Westmead, NSW, Australia; [Walker, Sarah; Ho, Vikki; White, Rose; Deo, Nikita; Devine, Carol; Qiao, Liang; George, Jacob; Hebbard, Lionel] Univ Sydney, Westmead, NSW, Australia; [Walker, Sarah] Canberra Hosp, Gastroenterol & Hepatol Unit, Woden, ACT, Australia; [Wankell, Miriam; Dewdney, Brittany; Hebbard, Lionel] James Cook Univ, Australian Inst Trop Hlth & Med, Ctr Mol Therapeut, Dept Mol & Cell Biol, Townsville, Qld, Australia; [Bhathal, Prithi] Univ Melbourne, Melbourne, Vic, Australia; [Govaere, Olivier; Roskams, Tania] KULeuven, Dept Imaging & Pathol, Translat Cell & Tissue Res, Leuven, Belgium; [Govaere, Olivier; Roskams, Tania] Univ Hosp Leuven, Leuven, Belgium; [Govaere, Olivier] Newcastle Univ, Med Sch, Inst Cellular Med, Liver Res Grp, Newcastle Upon Tyne, Tyne & Wear, England	University of Sydney; Westmead Institute for Medical Research; University of Sydney; Australian National University; Canberra Hospital; James Cook University; University of Melbourne; KU Leuven; KU Leuven; University Hospital Leuven; Newcastle University - UK	Hebbard, L (corresponding author), Westmead Hosp, Westmead Inst Med Res, Storr Liver Ctr, Westmead, NSW, Australia.; Hebbard, L (corresponding author), Univ Sydney, Westmead, NSW, Australia.; Hebbard, L (corresponding author), James Cook Univ, Australian Inst Trop Hlth & Med, Ctr Mol Therapeut, Dept Mol & Cell Biol, Townsville, Qld, Australia.	lionel.hebbard@jcu.edu.au	Hebbard, Lionel/W-4057-2019; Deo, Nikita/J-7688-2019; Govaere, Olivier/R-9372-2019; Hebbard, Lionel/O-1489-2017; Dewdney, Brittany/ABH-1428-2020; Deo, Nikita/V-4547-2019	Govaere, Olivier/0000-0002-4426-6930; Hebbard, Lionel/0000-0002-7094-9065; Dewdney, Brittany/0000-0002-6362-369X; Roskams, Tania/0000-0002-2816-1530; Deo, Nikita/0000-0002-3810-488X	Robert W. Storr Bequest; University of Sydney; National Health and Medical Research Council of Australia (NHMRC) [APP1053206]; NHMRC [1047417, 1006200, 1087297]; Cancer Council NSW [1070076, 1069733]; Cancer Council Queensland Project Grant [1123436]; Belgian Federal Science Policy Office, Interuniversity Attraction Poles program [P7/83-HEPRO]	Robert W. Storr Bequest; University of Sydney(University of Sydney); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council NSW(Cancer Council New South Wales); Cancer Council Queensland Project Grant(Cancer Council Queensland); Belgian Federal Science Policy Office, Interuniversity Attraction Poles program	This work was supported by the Robert W. Storr Bequest to the Sydney Medical Foundation, University of Sydney, National Health and Medical Research Council of Australia (NHMRC) Program grant APP1053206 (https://nhmrc.gov.au/). NHMRC project grants (1047417, LQ; 1006200, 1087297, JG and LH); Cancer Council NSW Project Grants (1070076, LQ; 1069733 (https://www.cancer.org.au/) to LH); Cancer Council Queensland Project Grant (1123436, LH); and the Belgian Federal Science Policy Office, Interuniversity Attraction Poles program-P7/83-HEPRO (TR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano T, 2009, J GASTROEN HEPATOL, V24, P1669, DOI 10.1111/j.1440-1746.2009.06039.x; Balmer ML, 2010, CLIN SCI, V119, P431, DOI 10.1042/CS20100008; Bertot LC, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050774; Bruix J, 2017, LANCET, V389, P56, DOI 10.1016/S0140-6736(16)32453-9; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Castoria G, 2001, EMBO J, V20, P6050, DOI 10.1093/emboj/20.21.6050; Chen B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129663; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Denzel MS, 2009, CLIN CANCER RES, V15, P3256, DOI 10.1158/1078-0432.CCR-08-2661; Ertle J, 2011, INT J CANCER, V128, P2436, DOI 10.1002/ijc.25797; Estes C, 2018, J HEPATOL, V69, P896, DOI 10.1016/j.jhep.2018.05.036; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fujisawa T, 2008, GUT, V57, P1531, DOI 10.1136/gut.2008.159293; Gibbons James J, 2009, Semin Oncol, V36 Suppl 3, pS3, DOI 10.1053/j.seminoncol.2009.10.011; He GB, 2010, CANCER CELL, V17, P286, DOI 10.1016/j.ccr.2009.12.048; Hebbard L, 2011, ONCOGENE, V30, P301, DOI 10.1038/onc.2010.412; Hebbard L, 2014, BEST PRACT RES CL EN, V28, P59, DOI 10.1016/j.beem.2013.11.005; Hebbard L, 2011, NAT REV GASTRO HEPAT, V8, P34, DOI 10.1038/nrgastro.2010.191; Hebbard LW, 2010, CANCER RES, V70, P8863, DOI 10.1158/0008-5472.CAN-10-1295; Hui JM, 2004, HEPATOLOGY, V40, P46, DOI 10.1002/hep.20280; Ito Y, 2001, J HEPATOL, V35, P68, DOI 10.1016/S0168-8278(01)00077-0; Jiang TY, 2003, J BIOL CHEM, V278, P15789, DOI 10.1074/jbc.M212525200; Kamada Y, 2007, J HEPATOL, V47, P556, DOI 10.1016/j.jhep.2007.03.020; Koeberle D, 2016, ANN ONCOL, V27, P856, DOI 10.1093/annonc/mdw054; Kubrusly MS, 2010, HISTOL HISTOPATHOL, V25, P1123, DOI 10.14670/HH-25.1123; Kwong LN, 2014, ONCOGENE, V33, P1, DOI 10.1038/onc.2013.34; Liu TC, 2014, MODERN PATHOL, V27, P420, DOI 10.1038/modpathol.2013.148; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Matter MS, 2014, J HEPATOL, V60, P855, DOI 10.1016/j.jhep.2013.11.031; Nishihara T, 2008, WORLD J GASTROENTERO, V14, P6473, DOI 10.3748/wjg.14.6473; Paradis V, 2009, HEPATOLOGY, V49, P851, DOI 10.1002/hep.22734; Patel A, 2016, LIFE SCI, V157, P52, DOI 10.1016/j.lfs.2016.05.036; Ramezani-Moghadam M, 2015, J BIOL CHEM, V290, P5533, DOI 10.1074/jbc.M114.598011; Ray K, 2013, NAT REV GASTRO HEPAT, V10, P621, DOI [10.1038/nrgastro.2013.184, 10.1038/nrgastro.2013.197]; Rebholz H, 2006, FEBS J, V273, P2023, DOI 10.1111/j.1742-4658.2006.05219.x; Saxena NK, 2010, GASTROENTEROLOGY, V139, P1762, DOI 10.1053/j.gastro.2010.07.001; Varkaris A, 2014, CANCER METAST REV, V33, P595, DOI 10.1007/s10555-013-9481-1; Villanueva A, 2008, GASTROENTEROLOGY, V135, P1972, DOI 10.1053/j.gastro.2008.08.008; Vojtechova M, 2008, NEOPLASIA, V10, P99, DOI 10.1593/neo.07905; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Yeo W, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1334-6; Yori JL, 2014, CANCER RES, V74, P4762, DOI 10.1158/0008-5472.CAN-13-3627; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017; Zhu AX, 2014, JAMA-J AM MED ASSOC, V312, P57, DOI 10.1001/jama.2014.7189	46	13	15	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212860	10.1371/journal.pone.0212860	http://dx.doi.org/10.1371/journal.pone.0212860			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794695	gold, Green Published, Green Accepted			2022-12-27	WOS:000459709100152
J	Barwick, AL; Hurn, SE; van Netten, JJ; Reed, LF; Lazzarini, PA				Barwick, Alex L.; Hurn, Sheree E.; van Netten, Jaap J.; Reed, Lloyd F.; Lazzarini, Peter A.			Factors associated with wearing inadequate outdoor footwear in populations at risk of foot ulceration: A cross-sectional study	PLOS ONE			English	Article							DIABETIC-PATIENTS; IWGDF GUIDANCE; ULCERS; PREVENTION; AMPUTATION; PEOPLE; CARE; PAIN	Background Few studies have investigated if people at risk of foot ulceration actually wear the footwear recommended by best practice guidelines to prevent foot ulceration. This study aimed to investigate the prevalence of, and factors associated with, wearing inadequate outdoor footwear in those with diabetes or peripheral neuropathy in an inpatient population. Methods This was a secondary analysis of a multi-site cross-sectional study investigating foot conditions in a large representative inpatient population admitted into hospital for any medical reason on one day. A range of explanatory variables were collected from all participants including sociodemographic, medical and foot condition factors. The outcome variable for this study was the self-reported outdoor footwear type worn most by participants outside the house in the year prior to hospitalisation. The self-reported footwear type was then categorised into adequate and inadequate according to footwear features recommended in guidelines for populations at risk of foot ulceration. Logistic regression identified factors independently associated with inadequate footwear in all inpatient participants, and diabetes and neuropathy subgroups. Results Overall, 47% of a total of 726 inpatients wore inadequate outdoor footwear; 49% of the 171 in the diabetes subgroup and 43% of 159 in the neuropathy subgroup. Wearing inadequate outdoor footwear was independently associated (Odds Ratio (95% Confidence Interval)) with being female in the diabetes (2.7 (1.4-5.2)) and neuropathy subgroups (3.7 (1.8-7.9)) and being female (5.1 (3.7-7.1)), having critical peripheral arterial disease (2.5 (1.1-5.9)) and an amputation (0.3 (0.1-0.7)) in all inpatients (all, p<0.05). Conclusions Almost half of all inpatients at risk of foot ulceration reported wearing outdoor footwear most of the time that did not meet recommendations for prevention. We found women were much more likely to wear inadequate footwear. More work needs to be done to increase the uptake of footwear recommendations in these populations to prevent foot ulceration.	[Barwick, Alex L.] Southern Cross Univ, Sch Hlth & Human Sci, Bilinga, Qld, Australia; [Hurn, Sheree E.; van Netten, Jaap J.; Reed, Lloyd F.; Lazzarini, Peter A.] Queensland Univ Technol, Sch Clin Sci, Brisbane, Qld, Australia; [Hurn, Sheree E.; van Netten, Jaap J.; Reed, Lloyd F.; Lazzarini, Peter A.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [van Netten, Jaap J.; Lazzarini, Peter A.] Wound Management Innovat Cooperat Res Ctr, Brisbane, Qld, Australia; [van Netten, Jaap J.] Univ Amsterdam, Amsterdam Movement Sci, Dept Rehabil, Amsterdam, Netherlands; [Reed, Lloyd F.] Footmot Podiatry Brisbane, Brisbane, Qld, Australia; [Lazzarini, Peter A.] Metro North Hosp & Hlth Serv, Allied Hlth Res Collaborat, Brisbane, Qld, Australia	Southern Cross University; Queensland University of Technology (QUT); Queensland University of Technology (QUT); University of Amsterdam; Vrije Universiteit Amsterdam	Lazzarini, PA (corresponding author), Queensland Univ Technol, Sch Clin Sci, Brisbane, Qld, Australia.; Lazzarini, PA (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia.; Lazzarini, PA (corresponding author), Wound Management Innovat Cooperat Res Ctr, Brisbane, Qld, Australia.; Lazzarini, PA (corresponding author), Metro North Hosp & Hlth Serv, Allied Hlth Res Collaborat, Brisbane, Qld, Australia.	Peter.Lazzarini@health.qld.gov.au	Hurn, Sheree E/AAT-6069-2021; Barwick, Alex/AAN-8955-2021	Lazzarini, Peter/0000-0002-8235-7964; van Netten, Jaap J./0000-0002-6420-6046; Hurn, Sheree/0000-0003-4638-6597; Barwick, Alex/0000-0001-8469-0528	Queensland Health (Queensland Government); Wound Management Innovation Cooperative Research Centre (Australian Government's Cooperative Research Centres Program)	Queensland Health (Queensland Government); Wound Management Innovation Cooperative Research Centre (Australian Government's Cooperative Research Centres Program)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This work was supported by grant funding from Queensland Health (Queensland Government) and Wound Management Innovation Cooperative Research Centre (Australian Government's Cooperative Research Centres Program).	[Anonymous], 2011, NATL EVIDENCE BASED; Armstrong DG, 2017, NEW ENGL J MED, V376, P2367, DOI 10.1056/NEJMra1615439; Australian Institute of Health and Welfare, 2013, AUSTR HOSP STAT 2011; Barton CJ, 2009, J FOOT ANKLE RES, V2, DOI 10.1186/1757-1146-2-10; Bergin SM, 2013, J FOOT ANKLE RES, V6, DOI 10.1186/1757-1146-6-6; Boulton AJM, 2012, SEMIN VASC SURG, V25, P61, DOI 10.1053/j.semvascsurg.2012.04.009; Bus SA, 2016, DIABETES-METAB RES, V32, P25, DOI 10.1002/dmrr.2697; Bus SA, 2016, DIABETES-METAB RES, V32, P16, DOI 10.1002/dmrr.2696; Chandalia HB, 2008, INT J DIABETES DEV C, V28, P109, DOI 10.4103/0973-3930.45269; Crawford F, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19570; Dinh T, 2008, WOUNDS, V20, P127; Fan L, 2014, DIABETIC FOOT CANADA, V2, P4; Farndon L, 2016, J FOOT ANKLE RES, V9, DOI 10.1186/s13047-016-0149-2; Fernando ME, 2016, CLIN BIOMECH, V37, P98, DOI 10.1016/j.clinbiomech.2016.06.006; Harrison SJ, 2007, INT J CLIN PRACT, V61, P1900, DOI 10.1111/j.1742-1241.2007.01554.x; Hockey J, 2013, SOCIOL RES ONLINE, V18, DOI 10.5153/sro.2897; Hosmer DW, 2013, WILEY SER PROBAB ST, P89; Isip JDQ, 2016, J ASEAN FEDERATION E, V31, P37, DOI DOI 10.15605/JAFES.031.01.07; Jeffcoate WJ, 2016, LANCET DIABETES ENDO, V4, P781, DOI 10.1016/S2213-8587(16)30012-2; Kaminski MR, 2015, NEPHROL DIAL TRANSPL, V30, P1747, DOI 10.1093/ndt/gfv114; Lazzarini PA, 2016, BURDEN FOOT DIS INPA; Lazzarini PA, 2017, INT WOUND J, V14, P716, DOI 10.1111/iwj.12683; Lazzarini PA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010811; Lazzarini PA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008544; Lazzarini PA, 2014, J FOOT ANKLE RES, V7, DOI 10.1186/1757-1146-7-7; McGill M, 2005, INTERN MED J, V35, P451, DOI 10.1111/j.1445-5994.2005.00880.x; Menz HB, 2016, J GERONTOL A-BIOL, V71, P1682, DOI 10.1093/gerona/glw004; Mills JL, 2014, J VASC SURG, V59, P220, DOI 10.1016/j.jvs.2013.08.003; Reiber GE, 2002, J REHABIL RES DEV, V39, P615; Tabachnick B. G., 2007, USING MULTIVARIATE S, V5th; van Netten JJ, 2016, EUR J VASC ENDOVASC, V51, P248, DOI 10.1016/j.ejvs.2015.10.001; van Netten JJ, 2018, J FOOT ANKLE RES, V11, DOI 10.1186/s13047-017-0244-z; van Netten JJ, 2017, PROSTHET ORTHOT INT, V41, P201, DOI 10.1177/0309364616650080; van Netten JJ, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-92; Willrich A, 2005, FOOT ANKLE INT, V26, P128, DOI 10.1177/107110070502600203	35	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0211140	10.1371/journal.pone.0211140	http://dx.doi.org/10.1371/journal.pone.0211140			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789920	Green Published, Green Submitted, gold			2022-12-27	WOS:000459330800010
J	Gallivan, M; Oppenheim, B; Madhav, NK				Gallivan, Mark; Oppenheim, Ben; Madhav, Nita K.			Using social media to estimate Zika's impact on tourism: #babymoon, 2014-2017	PLOS ONE			English	Article							VIRUS; TRANSMISSION; EPIDEMIOLOGY; KNOWLEDGE; WOMEN	Zika virus infection during pregnancy can cause microcephaly and other birth defects. We hypothesized that the Latin America Zika epidemic resulted in pregnant women and their partners adopting behavioral changes to limit risk, leading them to forego travel to Zika-affected locations. We evaluated this hypothesis by studying travelers' intent and behavior through Twitter data related to babymoon: a holiday taken by parents-to-be before their baby is born. We found the odds of mentioning representative Zika-affected locations in #babymoon tweets dropped significantly (Odds ratio: 0.29, 95% CI: 0.20-0.40) after the Zika-microcephaly association became well-known. This result was further corroborated through a content analysis of #babymoon tweets mentioning Zika-affected locations, which identified if the Twitter user was physically present in the Zika-affected locations. Conversely, we found a small but statistically insignificant increase in the odds of mentioning Zika-free locations from #babymoon tweets (Odds Ratio: 1.11, 95% CI: 0.97-1.27) after the Zika-microcephaly association became well-known.	[Gallivan, Mark; Oppenheim, Ben; Madhav, Nita K.] Metabiota Inc, San Francisco, CA 94104 USA		Gallivan, M (corresponding author), Metabiota Inc, San Francisco, CA 94104 USA.	mgallivan@metabiota.com	Madhav, Nita K/J-1343-2018	Madhav, Nita/0000-0001-8077-330X				Cervellin G, 2017, J EPIDEMIOL GLOB HEA, V7, P185, DOI 10.1016/j.jegh.2017.06.001; comScore, 2015, COMSCORE REL JUL 201; Curry CL, 2018, J OBSTET GYNAECOL RE, V44, P503, DOI 10.1111/jog.13533; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR; Google, 2018, BABYM GOOGL TRENDS; Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082; MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1; McGough SF, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005295; Moorhead SA, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.1933; Nuti SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109583; Pan American Health Organization, 2018, ZIK CAS CONG SYNDR A; R CT, 2017, R LANG ENV STAT COMP; Rabaan AA, 2017, J INFECT PUBLIC HEAL, V10, P141, DOI 10.1016/j.jiph.2016.05.007; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Salathe M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002616; Sloan L, 2013, SOCIOL RES ONLINE, V18, DOI 10.5153/sro.3001; Tataryn J, 2018, Can Commun Dis Rep, V44, P18, DOI 10.14745/ccdr.v44i01a05; U. S. Department of Commerce International Trade Administration National Travel and Tourism Office (NTTO), 2017, MONTHL DEP INT DEST; Walker WL, 2016, MMWR-MORBID MORTAL W, V65, P983, DOI 10.15585/mmwr.mm6536e5; Whittemore K, 2017, EMERG INFECT DIS, V23, P164, DOI 10.3201/eid2301.161614; WHO, WHO MICR BRAZ; Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192	23	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212507	10.1371/journal.pone.0212507	http://dx.doi.org/10.1371/journal.pone.0212507			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789944	Green Published, gold, Green Submitted			2022-12-27	WOS:000459330800032
J	Kim, JJ; Savas, JN; Miller, MT; Hu, XD; Carromeu, C; Lavallee-Adam, M; Freitas, BCG; Muotri, AR; Yates, JR; Ghosh, A				Kim, Jean J.; Savas, Jeffrey N.; Miller, Meghan T.; Hu, Xindao; Carromeu, Cassiano; Lavallee-Adam, Mathieu; Freitas, Beatriz C. G.; Muotri, Alysson R.; Yates, John R., III; Ghosh, Anirvan			Proteomic analyses reveal misregulation of LIN28 expression and delayed timing of glial differentiation in human iPS cells with MECP2 loss-of-function	PLOS ONE			English	Article							SEVERE MENTAL-RETARDATION; RETT-SYNDROME; STEM-CELLS; QUANTITATIVE PROTEOMICS; DNA METHYLATION; AMINO-ACIDS; MOUSE MODEL; DUPLICATION; NEURONS; GENE	Rett syndrome (RTT) is a pervasive developmental disorder caused by mutations in MECP2. Complete loss of MECP2 function in males causes congenital encephalopathy, neurodevelopmental arrest, and early lethality. Induced pluripotent stem cell (iPSC) lines from male patients harboring mutations in MECP2, along with control lines from their unaffected fathers, give us an opportunity to identify some of the earliest cellular and molecular changes associated with MECP2 loss-of-function (LOF). We differentiated iPSC-derived neural progenitor cells (NPCs) using retinoic acid (RA) and found that astrocyte differentiation is perturbed in iPSC lines derived from two different patients. Using highly stringent quantitative proteomic analyses, we found that LIN28, a gene important for cell fate regulation and developmental timing, is upregulated in mutant NPCs compared to WT controls. Overexpression of LIN28 protein in control NPCs suppressed astrocyte differentiation and reduced neuronal synapse density, whereas downregulation of LIN28 expression in mutant NPCs partially rescued this synaptic deficiency. These results indicate that the pathophysiology of RTT may be caused in part by misregulation of developmental timing in neural progenitors, and the subsequent consequences of this disruption on neuronal and glial differentiation.	[Kim, Jean J.; Hu, Xindao; Ghosh, Anirvan] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA; [Kim, Jean J.; Hu, Xindao; Carromeu, Cassiano; Freitas, Beatriz C. G.; Muotri, Alysson R.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Savas, Jeffrey N.; Lavallee-Adam, Mathieu; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Miller, Meghan T.; Ghosh, Anirvan] F Hoffmann La Roche, Roche Innovat Ctr Basel, pRED, Basel, Switzerland; [Kim, Jean J.] Baylor Coll Med, Dept Mol & Cellular Biol, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Savas, Jeffrey N.] Northwestern Univ, Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA; [Ghosh, Anirvan] Biogen, Res & Early Dev, Cambridge, MA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; Roche Holding; Baylor College of Medicine; Northwestern University; Feinberg School of Medicine; Biogen	Kim, JJ (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA.; Kim, JJ (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.; Savas, JN (corresponding author), Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA.; Kim, JJ (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Ctr Cell & Gene Therapy, Houston, TX 77030 USA.; Savas, JN (corresponding author), Northwestern Univ, Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA.	jean.kim@bcm.edu; jeffrey.savas@northwestern.edu	Kim, Jean Jieun/G-5774-2018	Kim, Jean Jieun/0000-0003-4709-262X; Carromeu, Cassiano/0000-0002-7570-2213	California Institute for Regenerative Medicine (CIRM) [TR2-01814, TR4-06747, RB3-05229]; National Institutes of Health (NIH) through NIH Director's New Innovator Award Program [1-DP2-0D006495-01]; NIMH [R01 MH100175-01]; International Rett Syndrome Foundation (IRSF) [2915]; F. Hoffman-La Roche Postdoctoral Fellowship Award [SFP2063]; National Institute on Deafness and Other Communication Disorders [1K99DC013805-01]; Hartwell Foundation; Individual Biomedical Research Award; Fonds de Recherche du Quebec-Nature et Technologies (FRQNT); National Institute of General Medical Sciences [P41 GM103533];  [UOW/R41GM103533];  [MH-2 R01 MH06788011];  [1 R01 MH100175-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100175, R01MH067880] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); National Institutes of Health (NIH) through NIH Director's New Innovator Award Program; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); International Rett Syndrome Foundation (IRSF); F. Hoffman-La Roche Postdoctoral Fellowship Award; National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Hartwell Foundation; Individual Biomedical Research Award; Fonds de Recherche du Quebec-Nature et Technologies (FRQNT); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the California Institute for Regenerative Medicine (CIRM) TR2-01814 and TR4-06747 (to A.R.M), and RB3-05229 (to A.G. and J.J.K.). The Muotri lab is supported by National Institutes of Health (NIH) through the NIH Director's New Innovator Award Program (1-DP2-0D006495-01), an R01 MH100175-01 from NIMH and from the International Rett Syndrome Foundation (IRSF grant #2915). J.N.S. was supported by an F. Hoffman-La Roche Postdoctoral Fellowship Award (SFP2063), 1K99DC013805-01 from National Institute on Deafness and Other Communication Disorders, and The Hartwell Foundation, Individual Biomedical Research Award. M.L.-A. was supported by a postdoctoral fellowship from the Fonds de Recherche du Quebec-Nature et Technologies (FRQNT). The Yates' lab is supported by UOW/R41GM103533, MH-2 R01 MH06788011 and 1 R01 MH100175-01, and National Institute of General Medical Sciences P41 GM103533. The funder (F. Hoffmann-La Roche) provided support in the form of salaries for authors (MTM and AG), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ` author contributions' section.	Andoh-Noda T, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0121-2; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Ballas N, 2009, NAT NEUROSCI, V12, P311, DOI 10.1038/nn.2275; Balzer E, 2010, DEVELOPMENT, V137, P891, DOI 10.1242/dev.042895; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brennand K, 2015, MOL PSYCHIATR, V20, P361, DOI 10.1038/mp.2014.22; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Butko MT, 2013, P NATL ACAD SCI USA, V110, pE726, DOI 10.1073/pnas.1300424110; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Chapleau CA, 2009, NEUROBIOL DIS, V35, P219, DOI 10.1016/j.nbd.2009.05.001; Charrier C, 2012, CELL, V149, P923, DOI 10.1016/j.cell.2012.03.034; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Cimadamore F, 2013, P NATL ACAD SCI USA, V110, pE3017, DOI 10.1073/pnas.1220176110; Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216; del Gaudio D, 2006, GENET MED, V8, P784, DOI 10.1097/01.gim.0000250502.28516.3c; Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907; Faigle R, 2008, J NEUROCHEM, V106, P1681, DOI 10.1111/j.1471-4159.2008.05525.x; Friez MJ, 2006, PEDIATRICS, V118, pE1687, DOI 10.1542/peds.2006-0395; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Kim JE, 2011, P NATL ACAD SCI USA, V108, P3005, DOI 10.1073/pnas.1007753108; Kim KY, 2011, P NATL ACAD SCI USA, V108, P14169, DOI 10.1073/pnas.1018979108; Krey JF, 2013, NAT NEUROSCI, V16, P201, DOI 10.1038/nn.3307; Li Y, 2013, CELL STEM CELL, V13, P446, DOI 10.1016/j.stem.2013.09.001; Liao LJ, 2008, P NATL ACAD SCI USA, V105, P15281, DOI 10.1073/pnas.0804678105; Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214; MacCoss MJ, 2003, ANAL CHEM, V75, P6912, DOI 10.1021/ac034790h; Maezawa I, 2009, J NEUROSCI, V29, P5051, DOI 10.1523/JNEUROSCI.0324-09.2009; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Meins M, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.023804; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Namihira M, 2004, FEBS LETT, V572, P184, DOI 10.1016/j.febslet.2004.07.029; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Park SS, 2012, J PROTEOMICS, V75, P3720, DOI 10.1016/j.jprot.2012.04.035; Patterson M, 2014, STEM CELL REP, V3, P758, DOI 10.1016/j.stemcr.2014.08.015; Patterson M, 2012, CELL RES, V22, P178, DOI 10.1038/cr.2011.133; Pfrieger FW, 1997, SCIENCE, V277, P1684, DOI 10.1126/science.277.5332.1684; Reichow B, 2015, J AUTISM DEV DISORD, V45, P3377, DOI 10.1007/s10803-015-2519-1; Rodrigues DC, 2016, CELL REP, V17, P720, DOI 10.1016/j.celrep.2016.09.049; Savas JN, 2012, SCIENCE, V335, P942, DOI 10.1126/science.1217421; Schule B, 2008, CLIN GENET, V74, P116, DOI 10.1111/j.1399-0004.2008.01005.x; Shahbazian MD, 2002, AM J MED GENET, V111, P164, DOI 10.1002/ajmg.10557; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Sloan SA, 2017, NEURON, V95, P779, DOI 10.1016/j.neuron.2017.07.035; Sloan SA, 2014, CURR OPIN NEUROBIOL, V27, P75, DOI 10.1016/j.conb.2014.03.005; Sztainberg Y, 2015, NATURE, V528, P123, DOI 10.1038/nature16159; Tang X, 2016, P NATL ACAD SCI USA, V113, P751, DOI 10.1073/pnas.1524013113; Ullian EM, 2004, GLIA, V47, P209, DOI 10.1002/glia.20082; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; Vu A., 2009, NUCL CYTOPLASMIC ROL; Wang ITJ, 2013, NEUROBIOL DIS, V58, P3, DOI 10.1016/j.nbd.2013.04.020; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Weaving LS, 2003, AM J MED GENET A, V118A, P103, DOI 10.1002/ajmg.a.10053; Wilbert ML, 2012, MOL CELL, V48, P195, DOI 10.1016/j.molcel.2012.08.004; Yasui DH, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-3; Yazdani M, 2012, STEM CELLS, V30, P2128, DOI 10.1002/stem.1180; Young JI, 2005, P NATL ACAD SCI USA, V102, P17551, DOI 10.1073/pnas.0507856102	61	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212553	10.1371/journal.pone.0212553	http://dx.doi.org/10.1371/journal.pone.0212553			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789962	gold, Green Published, Green Submitted			2022-12-27	WOS:000459330800037
J	Behrens, I; Basit, S; Lykke, JA; Ranthe, MF; Wohlfahrt, J; Bundgaard, H; Melbye, M; Boyd, HA				Behrens, Ida; Basit, Saima; Lykke, Jacob A.; Ranthe, Mattis F.; Wohlfahrt, Jan; Bundgaard, Henning; Melbye, Mads; Boyd, Heather A.			Hypertensive disorders of pregnancy and peripartum cardiomyopathy: A nationwide cohort study	PLOS ONE			English	Article							CARDIOLOGY WORKING GROUP; POSITION STATEMENT; EUROPEAN-SOCIETY; PREECLAMPSIA; DIAGNOSIS; RISK; ASSOCIATION; MANAGEMENT; PREDICTORS	Background Peripartum cardiomyopathy (PPCM) is a serious cardiac disorder occurring late in pregnancy or early in the postpartum period. We examined associations between hypertensive disorders of pregnancy (HDP: preeclampsia and gestational hypertension) and PPCM, accounting for other pregnancy-related risk factors for PPCM. Methods Using nationwide Danish register data, we constructed a cohort of all women with >= 1 live birth or stillbirth in Denmark between 1978 and 2012. Using log-linear binomial regression and generalized estimating equations, we estimated risk ratios (RRs) for PPCM associated with HDP of varying severity. Results In a cohort of 1,088,063 women with 2,078,822 eligible pregnancies, 126 women developed PPCM (39 in connection with an HDP-complicated pregnancy). The risks of PPCM were significantly higher in women with HDP-complicated pregnancies than in women with normotensive pregnancies (severe preeclampsia, RR 21.2, 95% confidence interval [CI] 12.0-37.4; moderate preeclampsia, RR 10.2, 95% CI 6.18-16.9; gestational hypertension, RR 5.16, 95% CI 2.11-12.6). The RRs for moderate preeclampsia and gestational hypertension were not significantly different from one another (p = 0.18); the RR for severe preeclampsia was significantly different from the RR for moderate preeclampsia and gestational hypertension combined (p = 0.02). Conclusions Although 70% of PPCM occurred in women with normotensive pregnancies, HDPs were associated with substantial increases in PPCM risk that depended on HDP severity. The heart's capacity to adapt to a normal pregnancy may be exceeded in some women already susceptible to cardiac insult, contributing to PPCM. HDPs, severe preeclampsia in particular, probably represent an additional cardiac stressor during pregnancy.	[Behrens, Ida; Basit, Saima; Ranthe, Mattis F.; Wohlfahrt, Jan; Melbye, Mads; Boyd, Heather A.] Statens Serum Inst, Dept Epidemiol Res, Copenhagen, Denmark; [Lykke, Jacob A.] Copenhagen Univ Hosp, Dept Obstet, Rigshosp, Copenhagen, Denmark; [Bundgaard, Henning] Copenhagen Univ Hosp, Unit Inherited Cardiac Dis, Rigshosp, Copenhagen, Denmark; [Melbye, Mads] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA	Statens Serum Institut; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Stanford University	Boyd, HA (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Copenhagen, Denmark.	hoy@ssi.dk	Bundgaard, Henning/AAA-4381-2020	Bundgaard, Henning/0000-0002-0563-7049; Lykke, Jacob Alexander/0000-0002-3698-9792; melbye, mads/0000-0001-8264-6785; Boyd, Heather/0000-0001-6849-9985; Ranthe, Mattis Flyvholm/0000-0002-6363-6386	Danish Heart Foundation [R90-A3900]; Danish Council for Independent Research [DFF-4092-00213]	Danish Heart Foundation; Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	This work was supported by the Danish Heart Foundation [grant number R90-A3900 to IB] and the Danish Council for Independent Research [grant number DFF-4092-00213 to HAB]. The funders had no role in study design, data Collection and analysis, decision to publish, or preparation of the manuscript.	Arany Z, 2016, CIRCULATION, V133, P1397, DOI 10.1161/CIRCULATIONAHA.115.020491; Behrens I, 2016, JAMA-J AM MED ASSOC, V315, P1026, DOI 10.1001/jama.2016.1869; Bello N, 2013, J AM COLL CARDIOL, V62, P1715, DOI 10.1016/j.jacc.2013.08.717; Blauwet LA, 2013, HEART, V99, P308, DOI 10.1136/heartjnl-2012-302760; Blauwet LA, 2011, HEART, V97, P1970, DOI 10.1136/heartjnl-2011-300349; Brown MA, 2018, PREGNANCY HYPERTENS, V13, P291, DOI 10.1016/j.preghy.2018.05.004; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Dyhr L, 2007, DAN MED BULL, V54, P226; Elkayam U, 2005, CIRCULATION, V111, P2050, DOI 10.1161/01.CIR.0000162478.36652.7E; Elliott P, 2008, EUR HEART J, V29, P270, DOI 10.1093/eurheartj/ehm342; England L, 2007, FRONT BIOSCI-LANDMRK, V12, P2471, DOI 10.2741/2248; Ersboll AS, 2016, ACTA OBSTET GYN SCAN, V95, P1205, DOI 10.1111/aogs.13005; Goland S, 2009, J CARD FAIL, V15, P645, DOI 10.1016/j.cardfail.2009.03.008; Gunderson EP, 2011, OBSTET GYNECOL, V118, P583, DOI 10.1097/AOG.0b013e318229e6de; Haghikia A, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0366-9; Hansen AR, 2005, REPORT HLTH ETHNIC M, P36; Hilfiker-Kleiner D, 2007, CELL, V128, P589, DOI 10.1016/j.cell.2006.12.036; Hull E, 1938, SOUTH MED J, V31, P265, DOI [10.1097/00007611-193803000-00010, DOI 10.1097/00007611-193803000-00010]; Kao DP, 2013, JACC-HEART FAIL, V1, P409, DOI 10.1016/j.jchf.2013.04.011; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Klemmensen AK, 2007, AM J EPIDEMIOL, V166, P117, DOI 10.1093/aje/kwm139; Knudsen LB, 1998, DAN MED BULL, V45, P320; Kolte D, 2014, J AM HEART ASSOC, V3, P1, DOI DOI 10.1161/JAHA.113.000590; Kumler T, 2008, EUR J HEART FAIL, V10, P658, DOI 10.1016/j.ejheart.2008.05.006; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; McNamara DM, 2015, J AM COLL CARDIOL, V66, P905, DOI 10.1016/j.jacc.2015.06.1309; Melchiorre K, 2016, HYPERTENSION, V67, P754, DOI 10.1161/HYPERTENSIONAHA.115.06667; Melchiorre K, 2014, CIRCULATION, V130, P703, DOI 10.1161/CIRCULATIONAHA.113.003664; Melchiorre K, 2012, HYPERTENS PREGNANCY, V31, P454, DOI 10.3109/10641955.2012.697951; Mielniczuk LM, 2006, AM J CARDIOL, V97, P1765, DOI 10.1016/j.amjcard.2006.01.039; Patten IS, 2012, NATURE, V485, P333, DOI 10.1038/nature11040; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Powe CE, 2011, CIRCULATION, V123, P2856, DOI 10.1161/CIRCULATIONAHA.109.853127; Regitz-Zagrosek V, 2011, EUR HEART J, V32, P3147, DOI 10.1093/eurheartj/ehr218; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Sliwa K, 2011, INT J CARDIOL, V147, P202, DOI 10.1016/j.ijcard.2009.08.022; Sliwa K, 2010, EUR J HEART FAIL, V12, P767, DOI 10.1093/eurjhf/hfq120; Sundboll J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012832; Ware JS, 2016, NEW ENGL J MED, V374, P233, DOI 10.1056/NEJMoa1505517	40	18	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2								10.1371/journal.pone.0211857	http://dx.doi.org/10.1371/journal.pone.0211857			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785920	gold, Green Submitted, Green Published			2022-12-27	WOS:000459307000042
J	Cardonick, E; Broadrup, R; Xu, PN; Doan, MT; Jiang, HL; Snyder, NW				Cardonick, Elyce; Broadrup, Robert; Xu, Peining; Doan, Mary T.; Jiang, Helen; Snyder, Nathaniel W.			Preliminary results of identification and quantification of paclitaxel and its metabolites in human meconium from newborns with gestational chemotherapeutic exposure	PLOS ONE			English	Article							BREAST-CANCER; PREGNANCY; TAXANES; CARBOPLATIN; DOCETAXEL; OUTCOMES; CHILDREN	Objective Cancer diagnosis during pregnancy occurs in 1 out of 1000 pregnancies with common malignancies including breast and hematological cancers. Fetal exposure to currently utilized agents is poorly described. We directly assessed fetal exposure by screening meconium from 23 newborns whose mothers had undergone treatment for cancer during pregnancy. Study design Meconium was collected from newborns whose mothers were diagnosed with cancer during pregnancy and underwent chemotherapy in the second or third trimester as part of the Cancer and Pregnancy Registry. We conducted screening of 23 meconium samples for chemotherapeutics and known metabolites of chemotherapeutics by liquid chromatography-high resolution mass spectrometry (LC-HRMS). Putative identification of paclitaxel and/or its metabolites was made in 8 screened samples. In positively screened samples, we quantified paclitaxel, 3'-p-hydroxypaclitaxel, and 6 alpha-hydroxypaclitaxel by stable isotope dilution-LC-HRMS. Results Mean (standard deviation) levels of paclitaxel in positively screened samples were 399.9 (248.6) pg/mg in meconium samples from newborn born to mothers that underwent chemotherapy during pregnancy. 3'-p-hydroxypaclitaxel and 6a-hydroxypaclitaxel mean levels were 105.2 (54.6) and 113.4 (48.9) pg/mg meconium, respectively. Conclusion Intact paclitaxel, 3'-p-hydroxypaclitaxel, and 6 alpha-hydroxypaclitaxel were detected in meconium, providing unambiguous confirmation of human fetal exposure. Variability in meconium levels between individuals may indicate a potential for reducing fetal exposure based on timing, dosing, and individual characteristics. This preliminary study may provide an approach for examining the effects of cancer diagnosis during pregnancy on other outcomes by providing a measure of direct fetal exposure.	[Cardonick, Elyce] Rowan Univ, Cooper Med Sch, Camden, NJ 08102 USA; [Broadrup, Robert; Xu, Peining; Doan, Mary T.; Jiang, Helen; Snyder, Nathaniel W.] Drexel Univ, AJ Drexel Autism Inst, Philadelphia, PA 19104 USA	Rowan University; Cooper Medical School of Rowan University; Drexel University	Cardonick, E (corresponding author), Rowan Univ, Cooper Med Sch, Camden, NJ 08102 USA.; Snyder, NW (corresponding author), Drexel Univ, AJ Drexel Autism Inst, Philadelphia, PA 19104 USA.	Cardonick-Elyce@CooperHealth.edu; Nws28@drexel.edu		cardonick, elyce/0000-0003-2203-3367; Doan, Mary/0000-0001-6295-4895; Snyder, Nathaniel/0000-0001-5643-8747	National Institute of Health [R21HD087866, K22ES026235, R03CA211820]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD087866] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R03CA211820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K22ES026235] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institute of Health Grants R21HD087866, K22ES026235, and R03CA211820 to NWS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander MS, 2003, J CHROMATOGR B, V785, P253, DOI 10.1016/S1570-0232(02)00913-3; Amant F, 2015, NEW ENGL J MED, V373, P1824, DOI 10.1056/NEJMoa1508913; Aviles A, 2001, CLIN LYMPHOMA, V2, P173, DOI 10.3816/CLM.2001.n.023; Berry DL, 1999, J CLIN ONCOL, V17, P855, DOI 10.1200/JCO.1999.17.3.855; Berveiller P, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.10.007; Cardonick E, 2012, ANN ONCOL, V23, P3016, DOI 10.1093/annonc/mds170; Cardonick E, 2004, LANCET ONCOL, V5, P283, DOI 10.1016/S1470-2045(04)01466-4; Cardonick E, 2010, CANCER J, V16, P76, DOI 10.1097/PPO.0b013e3181ce46f9; Cardonick E, 2010, AM J CLIN ONCOL-CANC, V33, P221, DOI 10.1097/COC.0b013e3181a44ca9; Cardonick EH, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.11.032; Daud ANA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173530; de Graan AJM, 2013, CLIN CANCER RES, V19, P3316, DOI 10.1158/1078-0432.CCR-12-3786; De Santis M, 2000, EUR J CANCER CARE, V9, P235, DOI 10.1046/j.1365-2354.2000.00231.x; Fransson MN, 2011, DRUG METAB DISPOS, V39, P247, DOI 10.1124/dmd.110.035394; Frey AJ, 2017, J STEROID BIOCHEM, V167, P78, DOI 10.1016/j.jsbmb.2016.11.010; Gainford MC, 2006, CLIN ONCOL-UK, V18, P159, DOI 10.1016/j.clon.2005.12.002; Hahn KME, 2006, CANCER, V107, P1219, DOI 10.1002/cncr.22081; Hemauer SJ, 2010, BIOCHEM PHARMACOL, V79, P921, DOI 10.1016/j.bcp.2009.10.026; Himes SK, 2013, ANAL CHEM, V85, P1896, DOI 10.1021/ac303188j; Mendez LE, 2003, OBSTET GYNECOL, V102, P1200, DOI 10.1016/S0029-7844(03)00698-7; Mir O, 2010, ANN ONCOL, V21, P425, DOI 10.1093/annonc/mdp517; MONSARRAT B, 1990, DRUG METAB DISPOS, V18, P895; Monsarrat B, 1998, DRUG METAB DISPOS, V26, P229; Myllynen P, 2007, EXPERT OPIN DRUG MET, V3, P331, DOI 10.1517/17425255.3.3.331; Nieto Y, 2006, CLIN BREAST CANCER, V6, P533, DOI 10.3816/CBC.2006.n.008; Park BY, 2014, ANN EPIDEMIOL, V24, P878, DOI 10.1016/j.annepidem.2014.09.009; Peng SY, 2015, J PROTEOME RES, V14, P1799, DOI 10.1021/pr5011857; Potluri V, 2006, CLIN BREAST CANCER, V7, P167, DOI 10.3816/CBC.2006.n.029; Rouzi AA, 2009, ARCH GYNECOL OBSTET, V280, P823, DOI 10.1007/s00404-009-0992-5; Smit JW, 1999, J CLIN INVEST, V104, P1441, DOI 10.1172/JCI7963; Van Calsteren K, 2010, INT J GYNECOL CANCER, V20, P1456, DOI 10.1111/IGC.0b013e3181fb18c8; Weisz Boaz, 2004, Expert Rev Anticancer Ther, V4, P889, DOI 10.1586/14737140.4.5.889	32	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211821	10.1371/journal.pone.0211821	http://dx.doi.org/10.1371/journal.pone.0211821			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785914	gold, Green Submitted, Green Published			2022-12-27	WOS:000459307000040
J	Shevade, VS; Loboda, TV				Shevade, Varada S.; Loboda, Tatiana V.			Oil palm plantations in Peninsular Malaysia: Determinants and constraints on expansion	PLOS ONE			English	Article							AGRICULTURAL LAND; DEFORESTATION; DRIVEN; BORNEO	Agricultural expansion is one of the leading causes of deforestation in the tropics and in Southeast Asia it is predominantly driven by large-scale production for international trade. Peninsular Malaysia has a long history of plantation agriculture and has been a predominantly resource-based economy where expanding plantations like those of oil palm continue to replace natural forests. Habitat loss from deforestation and expanding plantations threatens Malaysian biodiversity. Expanding industrial plantations have also been responsible for drainage and conversions of peatland forests resulting in release of large amounts of carbon dioxide. The demand for palm oil is expected to increase further and result in greater pressures on tropical forests. Given Malaysia's high biophysical suitability for oil palm cultivation, it is important to understand patterns of oil palm expansion to better predict forest areas that are vulnerable to future expansion. We study natural forest conversion to industrial oil palm in Peninsular Malaysia between 1988 and 2012 to identify determinants of recent oil palm expansion using logistic regression and hierarchical partitioning. Using maps of recent conversions and remaining forests, we characterize agro-environmental suitability and accessibility for the past and future conversions. We find that accessibility to previously existing plantations is the strongest determinant of oil palm expansion and is significant throughout the study period. Almost all (> 99%) of the forest loss between 1988 and 2012 that has been converted to industrial oil palm plantations is within 1 km from oil palm plantations that have been established earlier. Although most forest conversions to industrial oil palm have been in areas of high biophysical suitability, there has been an increase in converted area in regions with low oil palm suitability since 2006. We find that reduced suitability does not necessarily restrict conversions to industrial oil palm in the region; however, lack of access to established plantations does.	[Shevade, Varada S.; Loboda, Tatiana V.] Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Shevade, VS (corresponding author), Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA.	vshevade@terpmail.umd.edu						[Anonymous], 2015, GLOBAL OIL PALM SUIT; Austin K G, 2015, INDONESIA PLOS ONE, V10, DOI [10.1371/journal.pone.0127963, DOI 10.1371/JOURNAL.PONE.0127963]; BROOKFIELD H, 1990, GLOBAL ENVIRON CHANG, V1, P42, DOI 10.1016/0959-3780(90)90006-U; Busch J, 2017, REV ENV ECON POLICY, V11, P3, DOI 10.1093/reep/rew013; Carter C, 2007, EUR J LIPID SCI TECH, V109, P307, DOI 10.1002/ejlt.200600256; Castiblanco C, 2013, ENVIRON SCI POLICY, V27, P172, DOI 10.1016/j.envsci.2013.01.003; Chomitz KM, 2003, AM J AGR ECON, V85, P1016, DOI 10.1111/1467-8276.00504; Clements R, 2010, BIODIVERS CONSERV, V19, P1115, DOI 10.1007/s10531-009-9775-3; Corley RHV, 2009, ENVIRON SCI POLICY, V12, P134, DOI 10.1016/j.envsci.2008.10.011; DeFries RS, 2010, NAT GEOSCI, V3, P178, DOI 10.1038/NGEO756; Department of Statistics Malaysia (DOSM), 2016, SEL AGR IND; Etter A, 2006, AGR ECOSYST ENVIRON, V114, P369, DOI 10.1016/j.agee.2005.11.013; Feintrenie L, 2010, SMALL-SCALE FOR, V9, P379, DOI 10.1007/s11842-010-9122-2; Fick SE, 2016, INT J CLIMATOL; Fitzherbert EB, 2008, TRENDS ECOL EVOL, V23, P538, DOI 10.1016/j.tree.2008.06.012; Gaveau DLA, 2016, SCI REP-UK, V6, DOI 10.1038/srep32017; Gaveau DLA, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/3/034013; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Guillaume T, 2016, AGR ECOSYST ENVIRON, V232, P110, DOI 10.1016/j.agee.2016.07.002; Gunarso P., 2013, OIL PALM LAND USE CH; Hai Teoh Cheng, 2000, LAND USE OIL PALM IN; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Harris N, 2013, REPORTS SCI PANEL 2; Henders S, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/12/125012; Hosonuma N, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/044009; Joppa LN, 2011, P ROY SOC B-BIOL SCI, V278, P1633, DOI 10.1098/rspb.2010.1713; Koh LP, 2008, CONSERV LETT, V1, P60, DOI 10.1111/j.1755-263X.2008.00011.x; Koh LP, 2011, P NATL ACAD SCI USA, V108, P5127, DOI 10.1073/pnas.1018776108; KUMMER DM, 1994, BIOSCIENCE, V44, P323, DOI 10.2307/1312382; Mertens B, 2000, ANN ASSOC AM GEOGR, V90, P467, DOI 10.1111/0004-5608.00205; Meyfroidt P, 2016, GLOBAL ENVIRON CHANG, V37, P1, DOI 10.1016/j.gloenvcha.2016.01.003; Meyfroidt P, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/7/074012; Miettinen J, 2016, GLOB ECOL CONSERV, V6, P67, DOI 10.1016/j.gecco.2016.02.004; Nelson A, 2008, CHRISTIAN TRAVEL PLA; Nelson Andrew, 2011, PLOS ONE, V6, DOI DOI 10.1371/JOURNAL.PONE.0022722; Paterson RRM, 2017, J AGR SCI-CAMBRIDGE, V155, P689, DOI 10.1017/S0021859616000605; Paterson RRM, 2015, SCI REP-UK, V5, DOI 10.1038/srep14457; Peh KSH, 2006, DIVERS DISTRIB, V12, P572, DOI 10.1111/j.1366-9516.2006.00257.x; Petersen R., 2016, MAPPING TREE PLANTAT; Pirker J, 2016, GLOBAL ENVIRON CHANG, V40, P73, DOI 10.1016/j.gloenvcha.2016.06.007; Prishchepov AV, 2013, LAND USE POLICY, V30, P873, DOI 10.1016/j.landusepol.2012.06.011; Raison J, 2015, HIGH CARBON STOCK SC; Ratnayeke S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194217; Rayan DM, 2015, BIOL CONSERV, V184, P18, DOI 10.1016/j.biocon.2014.12.024; Furumo PR, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa5892; Rudel TK, 2009, CONSERV BIOL, V23, P1396, DOI 10.1111/j.1523-1739.2009.01332.x; Sayer J, 2012, GLOB FOOD SECUR-AGR, V1, P114, DOI 10.1016/j.gfs.2012.10.003; Shevade VS, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9070747; Stickler C., 2007, UN FRAM CONV CLIM CH; Sumarga E, 2016, REG ENVIRON CHANGE, V16, P1011, DOI 10.1007/s10113-015-0815-0; The World Database on Protected Areas(WDPA), 2014, NON TRADITIONAL REF; Turner EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001572; Vijay V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159668; Weinhold D, 2008, GLOBAL ENVIRON CHANG, V18, P54, DOI 10.1016/j.gloenvcha.2007.06.004; Wheeler D, 2013, ECOL ECON, V85, P85, DOI 10.1016/j.ecolecon.2012.11.005; Wicke B, 2011, LAND USE POLICY, V28, P193, DOI 10.1016/j.landusepol.2010.06.001; World Resources Institute (WRI), CARB EM PEAT DRAIN P	58	31	32	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0210628	10.1371/journal.pone.0210628	http://dx.doi.org/10.1371/journal.pone.0210628			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM2OT	30785883	Green Published, gold, Green Submitted			2022-12-27	WOS:000459307000013
J	Yang, SF; Nie, KL; Jiang, H; Feng, LW; Fan, W				Yang, Shangfei; Nie, Kailai; Jiang, Hui; Feng, Liwen; Fan, Wei			Surgical management of intraocular lens dislocation: A meta-analysis	PLOS ONE			English	Article							IN-THE-BAG; PARS-PLANA VITRECTOMY; PSEUDOEXFOLIATION; EYES; OUTCOMES; SUBLUXATION; EXCHANGE	Purpose To compare the efficacy and safety of intraocular lens (IOL) repositioning and IOL exchange for the treatment of patients with IOL dislocation. Methods We systematically searched for relevant publications in English or Chinese in MEDLINE, Embase, the Cochrane Central Register of Controlled Trials, WHO International Clinical Trial Registration Platform, Clinical Trial.gov, China Biology Medicine Database, China National Knowledge Infrastructure Database and grey literature sources. Study quality was assessed using the STROBE template for observational studies and the Cochrane template for randomized controlled trials (RCTs). Data were meta-analyzed using RevMan 5.3. Results The review included 14 English-language studies reporting 1 RCT and 13 retrospective case series involving 1,082 eyes. Average follow-up time was 13.7 months. Pooled analysis of 10 studies showed that the two procedures had a similarly effect on best corrected visual acuity (MD -0.00, 95%CI: -0.08 to 0.08, P = 0.99). Pooled analysis of nine studies showed no significant difference in incidence of IOL redislocation (RR 2.12, 95%CI 0.85 to 5.30, P = 0.11); pooled analysis of seven studies showed greater extent of incidence of cystoid macular edema in IOL exchange (RR 0.47, 95%CI 0.21 to 1.30, P = 0.06). Pooled analysis of three studies showed greater extent of incidence of anterior vitrectomy in IOL exchange (RR 0.11, 95%CI 0.04 to 0.33, P<0.0001). Pooled analysis of two studies showed greater postoperative spherical equivalents in IOL repositioning (MD 1.02, 95%CI 0.51 to 1.52, P<0.0001). pooled analysis suggested no significant differences between the two procedures in terms of intraocular pressure, endothelial cell density, surgically induced astigmatism, or incidence of retinal detachment, intraocular hemorrhage or pupillary block. Conclusion IOL repositioning and exchange are safe and effective procedures for treating IOL dislocation. Neither procedure significantly affects best corrected visual acuity and IOL redislocation. IOL exchange was superior to repositioning in terms of postoperative SE, but IOL repositioning was associated with lower incidence of anterior vitrectomy, potentially lower incidence of cystoid macular edema.	[Yang, Shangfei; Nie, Kailai; Jiang, Hui; Feng, Liwen; Fan, Wei] Sichuan Univ, West China Hosp, Dept Ophthalmol, Chengdu, Sichuan, Peoples R China	Sichuan University	Fan, W (corresponding author), Sichuan Univ, West China Hosp, Dept Ophthalmol, Chengdu, Sichuan, Peoples R China.	fanwei55@yahoo.com			National Natural Science Foundation of China [81670869]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (No. 81670869). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, Community Eye Health, V13, P17; Auffarth GU, 1996, ACTA OPHTHALMOL SCAN, V74, P463; Baba T, 2018, J OPHTHALMOL, V2018, DOI 10.1155/2018/7342917; Bading G, 2007, AM J OPHTHALMOL, V144, P371, DOI 10.1016/j.ajo.2007.05.014; Boke W R, 1985, J Am Intraocul Implant Soc, V11, P179; Davis D, 2009, OPHTHALMOLOGY, V116, P664, DOI 10.1016/j.ophtha.2008.11.018; DAVISON JA, 1993, J CATARACT REFR SURG, V19, P582, DOI 10.1016/S0886-3350(13)80004-1; Ganesh SK, 2017, INDIAN J OPHTHALMOL, V65, P148, DOI 10.4103/ijo.IJO_938_16; Gimbel HV, 2005, J CATARACT REFR SURG, V31, P2193, DOI 10.1016/j.jcrs.2005.06.053; Gross JG, 2004, AM J OPHTHALMOL, V137, P630, DOI 10.1016/j.ago.2003.10.037; Gul A, 2015, ARQ BRAS OFTALMOL, V78, P313, DOI 10.5935/0004-2749.20150082; Hayashi K, 2007, OPHTHALMOLOGY, V114, P969, DOI 10.1016/j.ophtha.2006.09.017; Higgins JPT., 2011, COCHRANE HDB SYSTEMA, P187, DOI DOI 10.1249/01.MSS.0000043545.02712.A7; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Khoshnood B, 2010, OPHTHAL PHYSL OPT, V30, P816, DOI 10.1111/j.1475-1313.2010.00766.x; Kim SS, 2008, OPHTHALMOLOGY, V115, P1699, DOI 10.1016/j.ophtha.2008.04.016; Kokame GT, 2018, AM J OPHTHALMOL, V189, P10, DOI 10.1016/j.ajo.2018.01.034; Kratz R P, 1981, J Am Intraocul Implant Soc, V7, P55; Kristianslund O, 2017, INVEST OPHTH VIS SCI, V58, P4747, DOI 10.1167/iovs.17-22723; Kristianslund O, 2017, AM J OPHTHALMOL, V176, P219, DOI 10.1016/j.ajo.2017.01.026; Kristianslund O, 2017, OPHTHALMOLOGY, V124, P151, DOI 10.1016/j.ophtha.2016.10.024; Liu E, 2015, J CATARACT REFR SURG, V41, P929, DOI 10.1016/j.jcrs.2014.08.037; Lorente R, 2010, J CATARACT REFR SURG, V36, P1270, DOI 10.1016/j.jcrs.2010.01.035; Oh SY, 2015, EYE, V29, P757, DOI 10.1038/eye.2015.22; Olsen T, 2007, ACTA OPHTHALMOL SCAN, V85, P472, DOI 10.1111/j.1600-0420.2007.00879.x; Ostern AE, 2014, ACTA OPHTHALMOL, V92, P184, DOI 10.1111/aos.12024; Parekh P, 2007, OPHTHALMOLOGY, V114, P232, DOI 10.1016/j.ophtha.2006.10.037; Sarrafizadeh R, 2001, OPHTHALMOLOGY, V108, P82, DOI 10.1016/S0161-6420(00)00410-3; Schneiderman TE, 1997, AM J OPHTHALMOL, V123, P629, DOI 10.1016/S0002-9394(14)71075-X; Shingleton BJ, 2013, J CATARACT REFR SURG, V39, P984, DOI 10.1016/j.jcrs.2013.01.044; SMIDDY WE, 1995, J CATARACT REFR SURG, V21, P64, DOI 10.1016/S0886-3350(13)80482-8; Smiddy WE, 2005, RETINA-J RET VIT DIS, V25, P576, DOI 10.1097/00006982-200507000-00006; Stark W J Jr, 1983, Trans Am Ophthalmol Soc, V81, P280; STARK WJ, 1983, OPHTHALMOLOGY, V90, P311; Vazquez-Ferreiro P, 2017, ACTA OPHTHALMOL, V95, pE164, DOI 10.1111/aos.13234; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013	36	3	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211489	10.1371/journal.pone.0211489	http://dx.doi.org/10.1371/journal.pone.0211489			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785910	gold, Green Published, Green Submitted			2022-12-27	WOS:000459307000028
J	Niimura, Y; Hasegawa, K				Niimura, Yuki; Hasegawa, Koji			Evaporation of droplet in mid-air: Pure and binary droplets in single-axis acoustic levitator	PLOS ONE			English	Article							LIQUID MARBLE; INTERNAL FLOW; STABILITY	Acoustic levitation method (ALM) is a container-less processing method with applications in various fields, including material processing, biology, and analytical chemistry. Because it is a container-less processing technique, ALM could prevent nucleation and contamination of materials being processed via contact with a container wall. It is well-known that evaporation of a sample is an important process in container-less processing of materials; however, the mechanism of evaporation in multicomponent droplets in a single acoustic levitator is still unclear. Thus, we evaluate and understand the evaporation of an acoustically levitated multicomponent droplet and manipulate the evaporation process of the sample in this study. Specifically, we investigate the evaporation process of pure and multicomponent droplets using container-less processing experimentally. The evaporation processes and temporal evolution of the surface temperature of a multicomponent droplet were evaluated using a high-speed camera and radiation thermometer, respectively. We used water, ethanol, methanol, hexane, acetone, pentane, and binary solutions (solution of 25 wt%, 50 wt%, and 75 wt% ethanol, methanol, and acetone, respectively) as test samples to study the effect of saturated vapor pressure on evaporation. Ethanol, methanol, and acetone droplets evaporate in two different stages. It was observed that the water vapor in the air condensed during the evaporation process of these water-soluble droplets; hence, our experimental data did not agree with the theoretical prediction in accordance with the d(2) law. Nevertheless, the evaporation behavior in the first stage of evaporation was consistent with the theoretical prediction. Furthermore, for binary droplets, as the concentration of the resultant solution increased owing to evaporation, the transition time from the first to the second stage of evaporation also increased. Based on these observations, estimation equations for binary droplets were developed to ensure that the experimental and theoretical values were in good agreement.	[Niimura, Yuki; Hasegawa, Koji] Kogakuin Univ, Dept Mech Engn, Hachioji, Tokyo, Japan	Kogakuin University	Hasegawa, K (corresponding author), Kogakuin Univ, Dept Mech Engn, Hachioji, Tokyo, Japan.	kojihasegawa@cc.kogakuin.ac.jp	Hasegawa, Koji/Q-5074-2018	Hasegawa, Koji/0000-0003-4995-8976	JSPS KAKENHI [15K17977]; JGC-S SCHOLARSHIP FOUNDATION	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JGC-S SCHOLARSHIP FOUNDATION	Funded by K. H., JSPS KAKENHI Grant number 15K17977. K. H., JGC-S SCHOLARSHIP FOUNDATION. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2009, ANN NY ACAD SCI, V1161, P211, DOI 10.1111/j.1749-6632.2009.04086.x; Al Zaitone B, 2018, INT J HEAT MASS TRAN, V126, P164, DOI 10.1016/j.ijheatmasstransfer.2018.06.029; Bansch E, 2018, PHYS FLUIDS, V30, DOI 10.1063/1.5017936; Bouyer C, 2016, ADV MATER, V28, P161, DOI 10.1002/adma.201503916; Brandt EH, 2001, NATURE, V413, P474, DOI 10.1038/35097192; Brenn G, 2007, INT J HEAT MASS TRAN, V50, P5073, DOI 10.1016/j.ijheatmasstransfer.2007.07.036; Chen Z, 2017, LANGMUIR, V33, P6232, DOI 10.1021/acs.langmuir.7b00347; Combe NA, 2017, J PHYS CHEM A, V121, P7197, DOI 10.1021/acs.jpca.7b08050; Di WL, 2018, PHYS REV FLUIDS, V3, DOI 10.1103/PhysRevFluids.3.103606; Foresti D, 2012, J FLUID MECH, V709, P581, DOI 10.1017/jfm.2012.350; Foresti D, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.024301; Foresti D, 2013, P NATL ACAD SCI USA, V110, P12549, DOI 10.1073/pnas.1301860110; Frohn A., 2000, EXP FLUID MECH, DOI 10.1007/978-3-662-04040-9; Hasegawa K, 2016, NPJ MICROGRAVITY, V2, DOI 10.1038/npjmgrav.2016.4; Hong ZY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07477-1; Kobayashi K, 2018, PHYS FLUIDS, V30, DOI 10.1063/1.5037728; Marzo A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9661; Ochiai Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097590; Priego-Capote F, 2006, TRAC-TREND ANAL CHEM, V25, P856, DOI 10.1016/j.trac.2006.05.014; Rednikov AY, 2011, J FLUID MECH, V667, P426, DOI 10.1017/S0022112010004532; Santesson S, 2004, ANAL BIOANAL CHEM, V378, P1704, DOI 10.1007/s00216-003-2403-2; Shitanishi K, 2014, MICROGRAVITY SCI TEC, V26, P305, DOI 10.1007/s12217-014-9401-1; Sundvik M, 2015, SCI REP-UK, V5, DOI 10.1038/srep13596; TRINH EH, 1994, PHYS FLUIDS, V6, P3567, DOI 10.1063/1.868415; Vandaele V, 2005, PRECIS ENG, V29, P491, DOI 10.1016/j.precisioneng.2005.03.003; Vasileiou T, 2016, SCI REP-UK, V6, DOI 10.1038/srep20023; Watanabe A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28451-5; Xie WJ, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2396893; Xie WJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.061601; Yamamoto Y, 2008, MICROGRAVITY SCI TEC, V20, P277, DOI 10.1007/s12217-008-9070-z; Yarin AL, 1999, J FLUID MECH, V399, P151, DOI 10.1017/S0022112099006266; Yarin AL, 2002, INT J HEAT FLUID FL, V23, P471, DOI 10.1016/S0142-727X(02)00142-X; Zang DY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05949-0; Zang DY, 2017, ADV COLLOID INTERFAC, V243, P77, DOI 10.1016/j.cis.2017.03.003; Zang DY, 2015, LANGMUIR, V31, P11502, DOI 10.1021/acs.langmuir.5b02917	35	24	24	6	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0212074	10.1371/journal.pone.0212074	http://dx.doi.org/10.1371/journal.pone.0212074			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811437	gold, Green Submitted, Green Published			2022-12-27	WOS:000459806400051
J	Rahman, A; Akter, F				Rahman, Atiya; Akter, Fahmida			Reasons for formula feeding among rural Bangladeshi mothers: A qualitative exploration	PLOS ONE			English	Article							LOW-INCOME WOMEN; INITIATION; PERCEPTIONS; SATURATION; DECISIONS; ATTITUDES; INFANT; RISK	In Bangladesh the exclusive breastfeeding rate remains low and prelacteal, formula and bottle feeding is increasing. This study aims to explore reasons behind infant formula feeding practices from mothers, caregivers, and health care provider's perspective. This was a qualitative study carried out in four sub-districts of Sylhet and Jessore of rural Bangladesh. Data were collected through focus group discussions (12), in-depth interviews (4) and key informant interviews (12) from January to February 2014. The qualitative data collected and were analyzed using thematic content analysis. This study clearly showed the factor behind formula feeding by Bangladeshi rural women. One of the major findings was that women could not differentiate between formula and other milk. Main differences between formula and powder milk were the type of consumer where formula only was taken by infant and children less than 2 years. Other major reasons include; poor breastfeeding practices, lack of appropriate breastfeeding practices, superficial knowledge on harmful effect on infant formula; perceived insufficient breast milk production, the influence of family and society and authoritarian power of hospital staff. Rural mothers have intension to feed infant formula to their infants due to various factors including individual, social, cultural and institutional. These identified factors can contribute to policy making and develop more specific interventions targeting expected mother and their family members that can contribute to stop formula feeding and increase breastfeeding practices in rural Bangladesh.	[Rahman, Atiya; Akter, Fahmida] BRAC, Res & Evaluat Div RED, Dhaka, Bangladesh	Bangladesh Rural Advancement Committee BRAC; BRAC Research & Evaluation Division (RED)	Rahman, A (corresponding author), BRAC, Res & Evaluat Div RED, Dhaka, Bangladesh.	atiya.r@brac.net	Akter, Fahmida/ABG-3098-2021	Akter, Fahmida/0000-0001-9294-265X	Strategic Partnership Arrangement of BRAC	Strategic Partnership Arrangement of BRAC	This research activity was funded by the Strategic Partnership Arrangement of BRAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari T, 2013, J FOOD SCI TECHNOLOG, V8, P71, DOI [10.3126/jfstn.v8i0.11754, DOI 10.3126/JFSTN.V8I0.11754]; Ahmed A, 2003, C DEV RES LUND U 26, P19; Ahmed S, 1998, 146 ICDDRB; Ahmed SM, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-3; Akter F, ROLE STAKEHOLDERS PR; Amir LH, 2011, INT BREASTFEED J, V6, DOI 10.1186/1746-4358-6-7; Amir Lisa Helen, 2006, Aust Fam Physician, V35, P686; [Anonymous], 2010, INC EXP POV; Atchan Marjorie, 2011, Breastfeed Rev, V19, P9; Bangladesh Bureau of Statistics (BBS) and UNICEF Bangladesh, 2014, BANGL MULT IND CLUST; Begum MUH, 2014, J BANGLADESH COLL PH, V32, P26, DOI [DOI 10.3329/JBCPS.V32I1.21033, 10.3329/jbcps.v32i1.21033]; Bennington LK, 2011, NEWBORN INFANT NURS, V11, P194, DOI 10.1053/j.nainr.2011.09.012; Bonia K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-645; Cai XD, 2012, INT BREASTFEED J, V7, DOI 10.1186/1746-4358-7-12; Chezem J, 2001, J Perinat Educ, V10, P20, DOI 10.1624/105812401X88291; Edmond KM, 2006, PEDIATRICS, V117, pE380, DOI 10.1542/peds.2005-1496; Foss KA, 2006, INT BREASTFEED J, V1, DOI 10.1186/1746-4358-1-10; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hackett KM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2115-5; Haider R, 2010, INT BREASTFEED J, V5, DOI 10.1186/1746-4358-5-21; Hossain M, 2016, DRIVING DEV STORY BR; Joshi PC, 2014, INT BREASTFEED J, V9, DOI 10.1186/1746-4358-9-7; Khoury AJ, 2005, WOMEN HEALTH ISS, V15, P64, DOI 10.1016/j.whi.2004.09.003; Kong SKF, 2004, J ADV NURS, V46, P369, DOI 10.1111/j.1365-2648.2004.03003.x; Li RW, 2008, PEDIATRICS, V122, pS69, DOI 10.1542/peds.2008-1315i; Ludvigsson Jonas F, 2003, BMC Pediatr, V3, P4; Mihrshahi S, 2010, FOOD NUTR BULL, V31, P295, DOI 10.1177/156482651003100220; Millennium Development Goals, 2015, BANGL PROGR REP 2015; Mullany LC, 2008, J NUTR, V138, P599, DOI 10.1093/jn/138.3.599; National Institute of Population Research and Training (NIPORT) Mitra and Associates and ICF International, 2015, 2015 BANGL DEM HLTH; O'Reilly M, 2013, QUAL RES, V13, P190, DOI 10.1177/1468794112446106; Oddy W, 2012, LONG TERM EFFECTS BR; Ogbuanu CA, 2009, WOMEN HEALTH ISS, V19, P268, DOI 10.1016/j.whi.2009.03.005; Prak S, 2014, NUTRIENTS, V6, P2920, DOI 10.3390/nu6072920; Qiu LQ, 2009, INT BREASTFEED J, V4, DOI 10.1186/1746-4358-4-1; Rabiee F, 2004, P NUTR SOC, V63, P655, DOI 10.1079/PNS2004399; Ramachandran P, 2004, INDIAN J MED RES, V119, pXIII; Roy SK, 2002, J HEALTH POPUL NUTR, V20, P264; Sanjeev Davey, 2012, National Journal of Community Medicine, V3, P385; Shenton A. K., 2004, ED INFORM, V22, P63, DOI DOI 10.3233/EFI-2004-22201; Shinwell ES, 2006, BREASTFEED MED, V1, P247, DOI 10.1089/bfm.2006.1.247; Shortt E, 2013, MIDWIFERY, V29, P453, DOI 10.1016/j.midw.2012.03.001; Street DJ, 2013, J PERINAT NEONAT NUR, V27, P43, DOI 10.1097/JPN.0b013e31827e57e7; Susiloretni KA, 2013, AM J HEALTH PROMOT, V28, pE44, DOI 10.4278/ajhp.120425-QUAN-221; Tawiah-Agyemang C, 2008, J PERINATOL, V28, pS46, DOI 10.1038/jp.2008.173; Thomas JS, 2015, MATERN CHILD HLTH J, V19, P49, DOI 10.1007/s10995-014-1494-z; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Victora CG, 2000, LANCET, V355, P451, DOI 10.1016/S0140-6736(00)82011-5; Walker Janiece L, 2012, Can J Cardiovasc Nurs, V22, P37; Word Health Organization, 2018, INF YOUNG CHILD FEED; World Health Organization, 1981, INT COD MARK BREAST; World Health Organization, 2012, BREASTF EARL IN WHO; Zhang K, 2015, INT J ENV RES PUB HE, V12, P4520, DOI 10.3390/ijerph120504520	54	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0211761	10.1371/journal.pone.0211761	http://dx.doi.org/10.1371/journal.pone.0211761			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8EU	30807588	gold, Green Published, Green Submitted			2022-12-27	WOS:000459712100006
J	Swaminathan, S; Das, A; Assefa, T; Knight, JM; Da Silva, AF; Carvalho, JPS; Hartman, GL; Huang, XQ; Leandro, LF; Cianzio, SR; Bhattacharyya, MK				Swaminathan, Sivakumar; Das, Anindya; Assefa, Teshale; Knight, Joshua M.; Da Silva, Amilton Ferreira; Carvalho, Joao P. S.; Hartman, Glen L.; Huang, Xiaoqiu; Leandro, Leonor F.; Cianzio, Silvia R.; Bhattacharyya, Madan K.			Genome wide association study identifies novel single nucleotide polymorphic loci and candidate genes involved in soybean sudden death syndrome resistance	PLOS ONE			English	Article							F-SP GLYCINES; FUSARIUM-SOLANI; FIELD-RESISTANCE; UNDERLIE RESISTANCE; DISEASE RESISTANCE; SYNDROME PATHOGEN; SP. GLYCINES; VIRGULIFORME; PROTEINS; PHYTOTOXICITY	Fusarium virguliforme is a soil borne root pathogen that causes sudden death syndrome (SDS) in soybean [Glycine max (L.) Merrill]. Once the fungus invades the root xylem tissues, the pathogen secretes toxins that cause chlorosis and necrosis in foliar tissues leading to defoliation, flower and pod drop and eventually death of plants. Resistance to F. virguliforme in soybean is partial and governed by over 80 quantitative trait loci (QTL). We have conducted genome-wide association study (GWAS) for a group of 254 plant introductions lines using a panel of approximately 30,000 SNPs and identified 19 single nucleotide polymorphic loci (SNPL) that are associated with 14 genomic regions encoding foliar SDS and eight SNPL associated with seven genomic regions for root rot resistance. Of the identified 27 SNPL, six SNPL for foliar SDS resistance and two SNPL for root rot resistance co-mapped to previously identified QTL for SDS resistance. This study identified 13 SNPL associated with eight novel genomic regions containing foliar SDS resistance genes and six SNPL with five novel regions for root-rot resistance. This study identified five genes carrying nonsynonymous mutations: (i) three of which mapped to previously identified QTL for foliar SDS resistance and (ii) two mapped to two novel regions containing root rot resistance genes. Of the three genes mapped to QTL for foliar SDS resistance genes, two encode LRR-receptors and third one encodes a novel protein with unknown function. Of the two genes governing root rot resistance, Glyma. 01g222900.1 encodes a soybean-specific LEA protein and Glyma. 10g058700.1 encodes a heparan-alpha-glucosaminide N-acetyltransferase. In the LEA protein, a conserved serine residue was substituted with asparagine; and in the heparanalpha-glucosaminide N-acetyltransferase, a conserved histidine residue was substituted with an arginine residue. Such changes are expected to alter functions of these two proteins regulated through phosphorylation. The five genes with nonsynonymous mutations could be considered candidate SDS resistance genes and should be suitable molecular markers for breeding SDS resistance in soybean. The study also reports desirable plant introduction lines and novel genomic regions for enhancing SDS resistance in soybean.	[Swaminathan, Sivakumar; Assefa, Teshale; Knight, Joshua M.; Da Silva, Amilton Ferreira; Carvalho, Joao P. S.; Cianzio, Silvia R.; Bhattacharyya, Madan K.] Iowa State Univ, Dept Agron, Ames, IA 50011 USA; [Das, Anindya; Huang, Xiaoqiu] Iowa State Univ, Dept Comp Sci, Ames, IA USA; [Hartman, Glen L.] Univ Illinois, USDA, Urbana, IL 61801 USA; [Hartman, Glen L.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Leandro, Leonor F.] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA USA; [Da Silva, Amilton Ferreira] Univ Fed Sao Joao del Rei, Dept Agr Sci, Sete Lagoas, MG, Brazil; [Carvalho, Joao P. S.] Univ Fed Lavras, Dept Biol, Lavras, MG, Brazil	Iowa State University; Iowa State University; United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Iowa State University; Universidade Federal de Sao Joao del-Rei; Universidade Federal de Lavras	Cianzio, SR; Bhattacharyya, MK (corresponding author), Iowa State Univ, Dept Agron, Ames, IA 50011 USA.	scianzio@iastate.edu; mbhattac@iastate.edu		Swaminathan, Sivakumar/0000-0003-3931-275X; Ferreira da Silva, Amilton/0000-0001-7122-2688	National Institute of Food and Agriculture (NIFA), United States Department of Agriculture [2013-68004-20374]	National Institute of Food and Agriculture (NIFA), United States Department of Agriculture	National Institute of Food and Agriculture (NIFA), United States Department of Agriculture Grant no. 2013-68004-20374 awarded to Madan K. Bhattacharyya, Xiaoqiu Huang, Leonor F. Leandro and Silvia R. Cianzio.; This work was supported by the National Institute of Food and Agriculture (NIFA), United States Department of Agriculture (Grant no. 2013-68004-20374). We thank USDA-ARS-GRIN National Genetic Resources Program for sending us the seeds of soybean lines. We also thank Alexander Luckew, Peter Lundeen, Gregory Gebhart, Vijitha Silva and Sharon Eggenberger for their assistance during the course of the work.	Abdel Majid K.M., 2012, J PLANT GENOME SCI, V1, P18, DOI DOI 10.5147/JPGS.2012.0053; Abdelmajid KM, 2007, REV BIOL BIOTECH, V6, P2, DOI DOI 10.1023/B:PLSO.0000030189.96115.21; Abeysekara NS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093667; Achenbach LA, 1996, PLANT DIS, V80, P1228, DOI 10.1094/PD-80-1228; Anderson J, 2015, 3 BIOTECH, V5, P203, DOI 10.1007/s13205-014-0211-3; Aoki T, 2012, MYCOSCIENCE, V53, P167, DOI 10.1007/s10267-011-0150-3; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Bradley C, 2014, ESTIMATES SOYBEAN YI; Brar HK, 2011, MOL PLANT MICROBE IN, V24, P1179, DOI 10.1094/MPMI-12-10-0285; Camejo D, 2016, PLANT PHYSIOL BIOCH, V103, P10, DOI 10.1016/j.plaphy.2016.02.035; Chang HX, 2018, THEOR APPL GENET, V131, P757, DOI 10.1007/s00122-018-3063-0; Chang HX, 2016, PHYTOPATHOLOGY, V106, P1139, DOI 10.1094/PHYTO-01-16-0042-FI; Chang SJC, 1996, CROP SCI, V36, P1684, DOI 10.2135/cropsci1996.0011183X003600060044x; Hartman GL, 1997, PLANT DIS, V81, P515, DOI 10.1094/PDIS.1997.81.5.515; Hartman GL, 2004, AUSTRALAS PLANT PATH, V33, P9, DOI 10.1071/AP03072; HARTWIG EE, 1973, CROP SCI, V13, P287, DOI 10.2135/cropsci1973.0011183X001300020047x; Hayden R.W., 2012, J BIOPHARM STAT, V22, P418, DOI [10.1080/10543406.2012.635980, DOI 10.1080/10543406.2012.635980]; Hershman DE, 1990, INFORM B, P37; Hirrel M. C., 1987, P AM SEED TRADE ASS, V16, P95; Hnetkovsky N, 1996, CROP SCI, V36, P393, DOI 10.2135/cropsci1996.0011183X003600020030x; Huang LF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156414; Hughes TJ, 2014, MYCOLOGIA, V106, P686, DOI 10.3852/13-318; Hyten DL, 2007, GENETICS, V175, P1937, DOI 10.1534/genetics.106.069740; Iqbal MJ, 2005, THEOR APPL GENET, V110, P1429, DOI 10.1007/s00122-005-1969-9; Kandel YR, 2015, PLANT DIS, V99, P347, DOI 10.1094/PDIS-06-14-0577-RE; Kassem MA, 2006, THEOR APPL GENET, V113, P1015, DOI 10.1007/s00122-006-0361-8; Kaundal A, 2017, PLANT CELL, V29, P2233, DOI 10.1105/tpc.17.00070; Kazi S, 2007, J PLANT REGIST, V1, P175, DOI 10.3198/jpr2006.07.0481crmp; Kazi S, 2008, THEOR APPL GENET, V116, P967, DOI 10.1007/s00122-008-0728-0; Li B, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.26817; Li S, 1999, PLANT CELL REP, V18, P375, DOI 10.1007/s002990050589; Li S, 2003, PLANT PATHOL, V52, P74, DOI 10.1046/j.1365-3059.2003.00797.x; Li YB, 2016, PLANT PHYSIOL, V170, P2392, DOI 10.1104/pp.15.01930; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Lozovaya VV, 2006, PLANT DIS, V90, P77, DOI 10.1094/PD-90-0077; Luckew AS, 2017, THEOR APPL GENET, V130, P2139, DOI 10.1007/s00122-017-2947-8; Luckew AS, 2012, CROP SCI, V52, P2215, DOI 10.2135/cropsci2011.09.0500; Malvick DK, 2008, CAN J PLANT PATHOL, V30, P467, DOI 10.1080/07060660809507544; Mbofung GYC, 2012, CAN J PLANT PATHOL, V34, P83, DOI 10.1080/07060661.2012.664564; Mueller DS, 2002, PLANT DIS, V86, P741, DOI 10.1094/PDIS.2002.86.7.741; Mueller DS, 2003, PLANT DIS, V87, P827, DOI 10.1094/PDIS.2003.87.7.827; Narasimhan ML, 2001, MOL CELL, V8, P921, DOI 10.1016/S1097-2765(01)00365-3; Navi S.S., 2008, PLANT HLTH PROGR, DOI 10.1094/PHP-2008-0222-01-RS; Neto ALD, 2007, MOL BREEDING, V20, P53, DOI 10.1007/s11032-006-9072-8; Ng A, 2011, AUTOPHAGY, V7, P1082, DOI 10.4161/auto.7.9.16464; Njiti VN, 2006, CAN J PLANT SCI, V86, P83, DOI 10.4141/P05-046; Njiti VN, 2002, THEOR APPL GENET, V104, P294, DOI 10.1007/s001220100682; Njiti VN, 1997, CROP SCI, V37, P132, DOI 10.2135/cropsci1997.0011183X003700010023x; Njiti VN, 2001, CROP SCI, V41, P1726, DOI 10.2135/cropsci2001.1726; O'Donnell K, 2010, PHYTOPATHOLOGY, V100, P58, DOI 10.1094/PHYTO-100-1-0058; Park CJ, 2015, PLANT PATHOLOGY J, V31, P323, DOI 10.5423/PPJ.RW.08.2015.0150; Powell JJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17454-3; Prabhu RR, 1999, CROP SCI, V39, P982, DOI 10.2135/cropsci1999.0011183X003900040005x; Pudake RN, 2013, CURR GENET, V59, P107, DOI 10.1007/s00294-013-0392-z; Robertson A, 2010, INTEGRATED CROP MANA; Roy KW, 1997, PLANT DIS, V81, P1100, DOI 10.1094/PDIS.1997.81.10.1100; Ruan L, 2015, SCI REP-UK, V5, DOI 10.1038/srep10090; RUPE JC, 1993, J PROD AGRIC, V6, P218, DOI 10.2134/jpa1993.0218; Sanogo S, 2000, PHYTOPATHOLOGY, V90, P57, DOI 10.1094/PHYTO.2000.90.1.57; Scherm H, 1998, PLANT DIS, V82, P1152, DOI 10.1094/PDIS.1998.82.10.1152; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Seifi HS, 2013, MOL PLANT MICROBE IN, V26, P475, DOI 10.1094/MPMI-07-12-0176-CR; Sharfman M, 2014, PLANT PHYSIOL, V164, P819, DOI 10.1104/pp.113.230136; Sharma M, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01218; SINGH NK, 2013, PLOS ONE, V0008; Singh S, 2005, PROTEIN SCI, V14, P2601, DOI 10.1110/ps.051579205; Song QJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054985; Srivastava SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081832; STEPHENS PA, 1993, CROP SCI, V33, P929, DOI 10.2135/cropsci1993.0011183X003300050010x; Swaminathan S, 2018, THEOR APPL GENET, V131, P1047, DOI 10.1007/s00122-018-3057-y; Swaminathan S, 2016, THEOR APPL GENET, V129, P495, DOI 10.1007/s00122-015-2643-5; Thoenes P, 2015, COMPETITIVE COMMERCI, P1; Wang HH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-428; Wen ZX, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-809; Yuan JZ, 2012, J PLANT GENOME SCI, V1, P10, DOI DOI 10.5147/pggb.v1i1.147; Zhang JP, 2015, PLANT J, V84, P1124, DOI 10.1111/tpj.13069; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546	77	5	5	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0212071	10.1371/journal.pone.0212071	http://dx.doi.org/10.1371/journal.pone.0212071			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807585	Green Submitted, Green Published, gold			2022-12-27	WOS:000459712100012
J	Gonzalez-Rincon, J; Mendez, M; Gomez, S; Garcia, JF; Martin, P; Bellas, C; Pedrosa, L; Rodriguez-Pinilla, SM; Camacho, FI; Quero, C; Perez-Callejo, D; Rueda, A; Llanos, M; Gomez-Codina, J; Piris, MA; Montes-Moreno, S; Barcena, C; Rodriguez-Abreu, D; Menarguez, J; De la Cruz-Merino, L; Monsalvo, S; Parejo, C; Royuela, A; Kwee, I; Cascione, L; Arribas, A; Bertoni, F; Mollejo, M; Provencio, M; Sanchez-Beato, M				Gonzalez-Rincon, Julia; Mendez, Miriam; Gomez, Sagrario; Garcia, Juan F.; Martin, Paloma; Bellas, Carmen; Pedrosa, Lucia; Rodriguez-Pinilla, Socorro M.; Camacho, Francisca I.; Quero, Cristina; Perez-Callejo, David; Rueda, Antonio; Llanos, Marta; Gomez-Codina, Jose; Piris, Miguel A.; Montes-Moreno, Santiago; Barcena, Carmen; Rodriguez-Abreu, Delvys; Menarguez, Javier; De la Cruz-Merino, Luis; Monsalvo, Silvia; Parejo, Consuelo; Royuela, Ana; Kwee, Ivo; Cascione, Luciano; Arribas, Alberto; Bertoni, Francesco; Mollejo, Manuela; Provencio, Mariano; Sanchez-Beato, Margarita			Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma	PLOS ONE			English	Article							COPY-NUMBER ALTERATION; 1ST-LINE IMMUNOCHEMOTHERAPY; HISTOLOGIC TRANSFORMATION; OCA-B; MUTATIONS; GENES; RISK; HYPERMUTATION; DISCOVERY; PATHWAYS	Follicular lymphoma (FL) is an indolent but largely incurable disease. Some patients suffer histological transformation to a more aggressive subtype with poorer prognosis. This study aimed to improve our understanding of the genetics underlying FL histological transformation, and to identify genetic drivers or promoters of the transformation by elucidating the differences between FL samples from patients who did and did not transform. We conducted targeted massive parallel sequencing of 22 pre-transformed FL/transformed diffuse large B-cell lymphoma pairs and 20 diagnostic samples from non-transformed FL patients. Additionally, 22 matched samples from 11 transformed FL patients (pre-transformed FL and diffuse large B-cell lymphoma) and 9 non-transformed FLs were studied for copy number variation using SNP arrays. We identified recurrently mutated genes that were enriched at transformation, most notably LRP1B, GNA13 and POU2AF1, which have roles in B-cell differentiation, GC architecture and migration. Mutations in POU2AF1 might be associated with lower levels of expression, were more frequent in transformed FLs, and seemed to be specific to transformed-compared with de novo-diffuse large B-cell lymphomas. Pre-transformed FLs carried more mutations per sample and had greater subclonal heterogeneity than non-transformed FLs. Finally, we identified four mutated genes in FL samples that differed between patients who did and did not transform: NOTCH2, DTX1, UBE2A and HIST1H1E. The presence of mutations in these genes was associated with shorter time to transformation when mutated in the FL biopsies. This information might be useful for identifying patients at higher risk of transformation.	[Gonzalez-Rincon, Julia; Mendez, Miriam; Gomez, Sagrario; Pedrosa, Lucia; Perez-Callejo, David; Sanchez-Beato, Margarita] Inst Invest Sanitaria Puerta de Hierro Segovia de, Dept Med Oncol, Lymphoma Res Grp, Madrid, Spain; [Gonzalez-Rincon, Julia; Martin, Paloma; Bellas, Carmen; Rodriguez-Pinilla, Socorro M.; Piris, Miguel A.; Montes-Moreno, Santiago] Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain; [Mendez, Miriam; Perez-Callejo, David; Provencio, Mariano] Hosp Univ Puerta de Hierro, Dept Med Oncol, Madrid, Spain; [Garcia, Juan F.] Hosp MD Anderson Canc Ctr, Dept Pathol, Madrid, Spain; [Martin, Paloma; Bellas, Carmen] Hosp Univ Puerta de Hierro, Dept Pathol, Madrid, Spain; [Rodriguez-Pinilla, Socorro M.; Piris, Miguel A.] Fdn Jimenez Diaz, Dept Pathol, Madrid, Spain; [Camacho, Francisca I.] Hosp Univ Getafe, Dept Pathol, Madrid, Spain; [Quero, Cristina] Hosp Univ Virgen de la Victoria, Dept Med Oncol, Malaga, Spain; [Rueda, Antonio] Hosp Costa Sol, Dept Med Oncol, Malaga, Spain; [Llanos, Marta] Hosp Univ Canarias, Dept Med Oncol, Santa Cruz De Tenerife, Spain; [Gomez-Codina, Jose] Hosp Univ & Politecn La Fe, Dept Med Oncol, Valencia, Spain; [Montes-Moreno, Santiago] Hosp Univ Marques de Valdecilla IDIVAL, Translat Hematol Grp, Dept Pathol, Santander, Spain; [Barcena, Carmen] Hosp Univ 12 Octubre, Dept Pathol, Madrid, Spain; [Rodriguez-Abreu, Delvys] Hosp Univ Insular Gran Canaria, Dept Med Oncol, Las Palmas Gran Canaria, Spain; [Menarguez, Javier] Hosp Gen Univ Gregorio Maranon, Dept Pathol, Madrid, Spain; [De la Cruz-Merino, Luis] Hosp Univ Virgen Macarena, Dept Med Oncol, Seville, Spain; [Monsalvo, Silvia] Fdn Jimenez Diaz, Dept Hematol, Madrid, Spain; [Parejo, Consuelo] Inst Invest Sanitaria Puerta de Hierro Segovia de, Dept Med Oncol, TIC Unit, Madrid, Spain; [Royuela, Ana] Inst Invest Sanitaria Puerta de Hierro Segovia de, Clin Biostat Unit, Madrid, Spain; [Kwee, Ivo; Cascione, Luciano; Arribas, Alberto; Bertoni, Francesco] IOR, Belinzona, Switzerland; [Kwee, Ivo; Cascione, Luciano; Arribas, Alberto; Bertoni, Francesco] USI, Lugano, Switzerland; [Kwee, Ivo] Dalle Molle Inst Artificial Intelligence IDSIA, Belinzona, Switzerland; [Kwee, Ivo; Cascione, Luciano; Arribas, Alberto; Bertoni, Francesco] SIB, Belinzona, Switzerland; [Cascione, Luciano; Arribas, Alberto; Bertoni, Francesco] Oncol Inst Southern Switzerland IOSI, Belinzona, Switzerland; [Mollejo, Manuela] Hosp Virgen de la Salud, Dept Pathol, Toledo, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Hospital Puerta de Hierro-Majadahonda; University of Texas System; UTMD Anderson Cancer Center; Hospital Puerta de Hierro-Majadahonda; Hospital Universitario de Getafe; Hospital Virgen de la Victoria; Universidad de Malaga; Universidad de la Laguna; Hospital Universitari i Politecnic La Fe; Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario 12 de Octubre; General University Gregorio Maranon Hospital; Hospital Universitario Virgen Macarena; Universita della Svizzera Italiana; Universita della Svizzera Italiana; Swiss Institute of Bioinformatics; Institute of Oncology Research (IOR); Complejo Hospitalario de Toledo	Sanchez-Beato, M (corresponding author), Inst Invest Sanitaria Puerta de Hierro Segovia de, Dept Med Oncol, Lymphoma Res Grp, Madrid, Spain.	msbeato@idiphim.org	Camacho, Francisca I./AAB-3789-2019; Sanchez-Beato, Margarita/G-8753-2012; Cascione, Luciano/X-3115-2019; Gonzalez-Rincon, Julia/ABE-6664-2021; Piris, Miguel A/AAP-1445-2020; Provencio, Mariano/ABE-8586-2020; Mendez, Miriam/ABH-4165-2020; Montes-Moreno, Santiago/E-7008-2011; de la Cruz-Merino, Luis/K-8633-2017; Acosta, Paloma Martin/AAF-7998-2021; MENARGUEZ, JAVIER/ABC-7303-2020; Vicente, Ana Royuela/AAC-4284-2021; Pérez, Lucía Pedrosa/AAB-6723-2019; Montes-Moreno, Santiago/AAB-2072-2020; Bertoni, Francesco/G-6922-2014	Camacho, Francisca I./0000-0002-2410-1936; Sanchez-Beato, Margarita/0000-0002-0058-7599; Cascione, Luciano/0000-0002-4606-0637; Piris, Miguel A/0000-0001-5839-3634; Provencio, Mariano/0000-0001-9053-9197; Montes-Moreno, Santiago/0000-0002-3565-8262; de la Cruz-Merino, Luis/0000-0002-5333-0535; Acosta, Paloma Martin/0000-0002-3274-4595; MENARGUEZ, JAVIER/0000-0001-5318-9976; Vicente, Ana Royuela/0000-0003-1665-081X; Pérez, Lucía Pedrosa/0000-0002-7486-515X; Montes-Moreno, Santiago/0000-0002-3565-8262; Provencio Pulla, Mariano/0000-0001-6315-7919; Rodriguez-Abreu, Delvys/0000-0003-0506-1366; Bertoni, Francesco/0000-0001-5637-8983; Gomez de benito, Sagrario/0000-0002-2361-4027; Mollejo, Manuela/0000-0001-5658-0532	Spanish Ministry of Economy and Competence (MINECO) [SAF2013-47416-R]; ISCIII-MINECO AES-FEDER (Plan Estatal de I+D+I 2008-2011) [RD12/0036/0060, RD12/0036/0041, PI14/00221, PIE14/0064, PI16/01294, CIBERONC CB16/12/00291, DTS17/00039, PT13/0010/0007]; ISCIII-MINECO AES-FEDER (Plan Estatal de I+D+I 2013-2016) [RD12/0036/0060, RD12/0036/0041, PI14/00221, PIE14/0064, PI16/01294, CIBERONC CB16/12/00291, DTS17/00039, PT13/0010/0007]; Direccion General de Universidades e Investigacion Consejeria de Educacion e Investigacion de la Comunidad de Madrid [B2017/BMD-3778]; iPFIS predoctoral fellowship [IFI14/00003]; Juan Rodes contract [JR14/0018]; ISCIII-MINECO AES-FEDER (Plan Estatal I+D+I 2013-2016) [CPII16/00024]; Fundacion de Investigacion Biomedica Puerta de Hierro; SEOM-Rio Hortega 2015 contract from Comunidad de Madrid (Madrid I+D+I); Plan de Empleo Juvenil from Comunidad de Madrid (Madrid I+D+I); GELU Foundation; Instituto de Salud Carlos III (ISCIII): Complejo Hospitalario de Toledo; Instituto de Salud Carlos III (ISCIII): Hospital MD Anderson Cancer Center-Madrid; Instituto de Salud Carlos III (ISCIII): Hospital 12 de Octubre; Instituto de Salud Carlos III (ISCIII): Hospital Marques de Valdecilla	Spanish Ministry of Economy and Competence (MINECO); ISCIII-MINECO AES-FEDER (Plan Estatal de I+D+I 2008-2011); ISCIII-MINECO AES-FEDER (Plan Estatal de I+D+I 2013-2016); Direccion General de Universidades e Investigacion Consejeria de Educacion e Investigacion de la Comunidad de Madrid; iPFIS predoctoral fellowship; Juan Rodes contract; ISCIII-MINECO AES-FEDER (Plan Estatal I+D+I 2013-2016); Fundacion de Investigacion Biomedica Puerta de Hierro; SEOM-Rio Hortega 2015 contract from Comunidad de Madrid (Madrid I+D+I); Plan de Empleo Juvenil from Comunidad de Madrid (Madrid I+D+I); GELU Foundation; Instituto de Salud Carlos III (ISCIII): Complejo Hospitalario de Toledo; Instituto de Salud Carlos III (ISCIII): Hospital MD Anderson Cancer Center-Madrid; Instituto de Salud Carlos III (ISCIII): Hospital 12 de Octubre; Instituto de Salud Carlos III (ISCIII): Hospital Marques de Valdecilla	This work was supported by the Spanish Ministry of Economy and Competence (MINECO): SAF2013-47416-R; ISCIII-MINECO AES-FEDER (Plan Estatal de I+D+I 2008-2011 and 2013-2016) (RD12/0036/0060 (MAP), RD12/0036/0041(MP), PI14/00221(MSB), PIE14/0064(MP), PI16/01294 (MAP), CIBERONC CB16/12/00291(MAP), DTS17/00039(MSB)), PT13/0010/0007 (MAP) and by Direccion General de Universidades e Investigacion Consejeria de Educacion e Investigacion de la Comunidad de Madrid (B2017/BMD-3778); JG-R is a recipient of an iPFIS predoctoral fellowship (IFI14/00003), PM is supported by a Juan Rodes contract (JR14/0018) and MSB currently holds a Miguel Servet II contract (CPII16/00024), supported by ISCIII-MINECO AES-FEDER (Plan Estatal I+D+I 2013-2016) and the Fundacion de Investigacion Biomedica Puerta de Hierro; DP-C by a SEOM-Rio Hortega 2015 contract and LP by Plan de Empleo Juvenil from Comunidad de Madrid (Madrid I+D+I); FB by a grant from the GELU Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are indebted to the patients who contributed to this study. We acknowledge the Biobank of the Hospital Puerta de Hierro, and the Spanish Hospital Biobank Network, supported by the Instituto de Salud Carlos III (ISCIII): Complejo Hospitalario de Toledo, Hospital MD Anderson Cancer Center-Madrid, Hospital 12 de Octubre and Hospital Marques de Valdecilla, and the pathology departments of the centers collaborating in the study. We also thank E. Ramil from the Instituto de Investigacion Puerta de Hierro, B. Fernandez from Hospital Universitario Ramon y Cajal, and C. Gonzalez-Rincon for their invaluable help.	Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bordon A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004007; Bouska A, 2014, BLOOD, V123, P1681, DOI 10.1182/blood-2013-05-500595; Brunner C, 2006, NUCLEIC ACIDS RES, V34, P1807, DOI 10.1093/nar/gkl131; Casulo C, 2016, HEMATOL-AM SOC HEMAT, P269, DOI 10.1182/asheducation-2016.1.269; Chapuy B, 2018, NAT MED, V24, P679, DOI 10.1038/s41591-018-0016-8; Chapuy B, 2013, CANCER CELL, V24, P777, DOI 10.1016/j.ccr.2013.11.003; de Miranda NFCC, 2014, BLOOD, V124, P2544, DOI 10.1182/blood-2013-12-546309; Healy JA, 2016, BLOOD, V127, P2723, DOI [10.1182/blood-2015-07659938, 10.1182/blood-2015-07-659938]; Hodson DJ, 2016, P NATL ACAD SCI USA, V113, pE2039, DOI 10.1073/pnas.1600557113; Karube K, 2018, LEUKEMIA, V32, P675, DOI 10.1038/leu.2017.251; Karube K, 2014, J PATHOL, V234, P423, DOI 10.1002/path.4428; Khodabakhshi AH, 2012, ONCOTARGET, V3, P1308; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kridel R, 2017, BLOOD, V130, P258, DOI 10.1182/blood-2017-03-691345; Kridel R, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002197; Krysiak K, 2017, BLOOD, V129, P473, DOI 10.1182/blood-2016-07-729954; Kwee IW, 2016, BIORXIV, DOI [10.1101/056705, DOI 10.1101/056705]; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Loeffler M, 2015, LEUKEMIA, V29, P456, DOI 10.1038/leu.2014.209; Lossos IS, 2011, BEST PRACT RES CL HA, V24, P147, DOI 10.1016/j.beha.2011.02.006; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; Martinez N, 2014, LEUKEMIA, V28, P1334, DOI 10.1038/leu.2013.365; Meriranta L, 2017, HAEMATOLOGICA, V102, pE195, DOI 10.3324/haematol.2016.157495; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Montgomery Nathan D, 2016, Surg Pathol Clin, V9, P79, DOI 10.1016/j.path.2015.09.004; Montoto S, 2007, J CLIN ONCOL, V25, P2426, DOI 10.1200/JCO.2006.09.3260; Muppidi JR, 2014, NATURE, V516, P254, DOI 10.1038/nature13765; Okosun J, 2016, CURR OPIN HEMATOL, V23, P385, DOI 10.1097/MOH.0000000000000255; Okosun J, 2014, NAT GENET, V46, P176, DOI 10.1038/ng.2856; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pasqualucci L, 2014, CELL REP, V6, P130, DOI 10.1016/j.celrep.2013.12.027; Pastore A, 2015, LANCET ONCOL, V16, P1111, DOI 10.1016/S1470-2045(15)00169-2; Prazeres H, 2017, ONCOGENE, V36, P146, DOI 10.1038/onc.2016.143; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rossi D, 2012, J EXP MED, V209, P1537, DOI 10.1084/jem.20120904; Sarkozy C, 2016, J CLIN ONCOL, V34, P2575, DOI 10.1200/JCO.2015.65.7163; Schmitz R, 2018, NEW ENGL J MED, V378, P1396, DOI 10.1056/NEJMoa1801445; Sebastian E, 2016, ANN HEMATOL, V95, P253, DOI 10.1007/s00277-015-2552-3; Siegel R, 2006, CELL, V125, P761, DOI 10.1016/j.cell.2006.03.036; Teitell MA, 2003, TRENDS IMMUNOL, V24, P546, DOI 10.1016/j.it.2003.08.002; Valls E, 2017, CANCER DISCOV, V7, P506, DOI 10.1158/2159-8290.CD-16-1189; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Zhang J, 2013, P NATL ACAD SCI USA, V110, P1398, DOI 10.1073/pnas.1205299110	44	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2019	14	2							e0212813	10.1371/journal.pone.0212813	http://dx.doi.org/10.1371/journal.pone.0212813			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EH	30802265	Green Published, gold, Green Submitted			2022-12-27	WOS:000459710700022
J	Gong, SQ; Wang, KS; Li, Y; Alamian, A				Gong, Shaoqing; Wang, Kesheng; Li, Ying; Alamian, Arsham			The influence of immigrant generation on obesity among Asian Americans in California from 2013 to 2014	PLOS ONE			English	Article							BODY-MASS INDEX; UNITED-STATES; US ADULTS; PREVALENCE; ACCULTURATION; MORTALITY; GENDER; TRENDS; ADOLESCENTS; OVERWEIGHT	Objectives We aimed to examine the association between immigrant generation and obesity among Californian adults and Asian Americans. Methods We pooled weighted data (n = 2,967) on Asian Americans from the 2013-2014 California Health Interview Survey. Overweight and obesity were defined using body mass indices (BMI) of 25 kg/m(2) and 30 kg/m(2), respectively, in non-Asians, compared with BMI of 23 kg/m(2) (for being overweight) and 27.5 kg/m(2) (for being obese) in Asians. First-generation or immigrant Asian Americans were defined as those born outside of the U.S. Second-generation Asian Americans were defined as those born in the U.S. with at least one foreign-born parent. All other Asian participants were classified as third-generation or higher. Multiple logistic regression analyses were used with adjustment for age, sex, family income, smoking status, marital status, education, physical activity, and fast food consumption. Results Overall, 23.3% of the Asian population was obese, and 40.0% was overweight. The percentage of 1st, 2nd, and 3rd generation were 72.7%, 22.6%, and 4.6%, respectively. Overall, 1 st generation of Asians had lower odds of being obese compared to Whites (OR = 0.34, 95% CI = 0.26-0.45). Multiple logistic regression analyses showed that overall, 2 nd generation (OR = 1.69, 95% CI = 1.10-2.60) and 3rd generation (OR = 2.33, 95% CI = 1.29-4.22) Asians had higher odds of being obese compared to 1 st generation Asians. Among Chinese, compared to the 1 st generation, the 3rd generation had increased likelihood of being obese (OR = 6.29, 95% CI = 2.38-16.6). Conclusion Compared to Whites, Hispanics, and Blacks, Asian immigrants are less likely to be obese. Among Asians, 2nd and 3rd generations were more likely to be obese compared to 1st generation. The obesity rate seems to increase the longer Asian immigrants remain in the U.S.	[Gong, Shaoqing] Xi An Jiao Tong Univ, Inst Hlth Adm & Policy, Sch Publ Policy & Adm, Xian, Shaanxi, Peoples R China; [Wang, Kesheng; Alamian, Arsham] East Tennessee State Univ, Dept Biostat & Epidemiol, Coll Publ Hlth, Johnson City, TN 37614 USA; [Li, Ying] East Tennessee State Univ, Dept Environm Hlth, Coll Publ Hlth, Johnson City, TN 37614 USA	Xi'an Jiaotong University; East Tennessee State University; East Tennessee State University	Gong, SQ (corresponding author), Xi An Jiao Tong Univ, Inst Hlth Adm & Policy, Sch Publ Policy & Adm, Xian, Shaanxi, Peoples R China.	gongshaoqing@mail.xjtu.edu.cn		Alamian, Arsham/0000-0002-3355-286X	School of Public Policy and Administration, Xi'an Jiaotong University; College of Public Health of East Tennessee State University	School of Public Policy and Administration, Xi'an Jiaotong University; College of Public Health of East Tennessee State University	We thank the support of School of Public Policy and Administration, Xi'an Jiaotong University and College of Public Health of East Tennessee State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afable-Munsuz A, 2004, AM J PUBLIC HLTH S2, V104, pS234, DOI DOI 10.1111/J.1747-7379.2009.00764.X; Angel RJ, 2010, J AGING HEALTH, V22, P914, DOI 10.1177/0898264310376540; Antecol H, 2006, DEMOGRAPHY, V43, P337, DOI 10.1353/dem.2006.0011; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bates LM, 2008, AM J PUBLIC HEALTH, V98, P70, DOI 10.2105/AJPH.2006.102814; Befort CA, 2012, J RURAL HEALTH, V28, P392, DOI 10.1111/j.1748-0361.2012.00411.x; Cattell V, 2001, SOC SCI MED, V52, P1501, DOI 10.1016/S0277-9536(00)00259-8; Chung TL-N, 2010, HDB ASIAN AM HLTH TA, P575; Corlin L, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-603; De La Cruz G. P., 2012, FOREIGN BORN POPULAT; Desir S, 2015, THESIS; Flegal KM, 2016, JAMA-J AM MED ASSOC, V315, P2284, DOI 10.1001/jama.2016.6458; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Frisbie WP, 2001, AM J EPIDEMIOL, V153, P372, DOI 10.1093/aje/153.4.372; Goel MS, 2004, JAMA-J AM MED ASSOC, V292, P2860, DOI 10.1001/jama.292.23.2860; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Hao LX, 2009, INT MIGR REV, V43, P237, DOI 10.1111/j.1747-7379.2009.00764.x; Hoeffel EM., 2012, ASIAN POPULATION 201; Huang ZJ, 2015, J HEALTH CARE POOR U, V26, P16, DOI 10.1353/hpu.2015.0061; Jackson CL, 2013, J OBES, V2013, DOI 10.1155/2013/140743; Jass G., 2004, IFS WORKING PAPERS; Kaushal N, 2009, HEALTH ECON, V18, P291, DOI 10.1002/hec.1368; Kawachi I., 2000, SOCIAL EPIDEMIOLOGY, P174; Kennedy S, 2015, J INT MIGR INTEGR, V16, P317, DOI 10.1007/s12134-014-0340-x; Mossaad N., 2016, US LAWF PERM RES 201; Palloni A, 2004, DEMOGRAPHY, V41, P385, DOI 10.1353/dem.2004.0024; Pearl J, 2009, CAUSALITY MODELS REA, DOI DOI 10.1017/CBO9780511803161; Pew Research Center, 2008, US POPULATION PROJEC; Pew Research Center, 2012, RIS AS AM; Porta M, 2015, EUR J EPIDEMIOL, V30, P1079, DOI 10.1007/s10654-015-0068-8; Roshania R, 2008, OBESITY, V16, P2669, DOI 10.1038/oby.2008.425; Rubalcava LN, 2008, AM J PUBLIC HEALTH, V98, P78, DOI 10.2105/AJPH.2006.098418; Sanchez-Vaznaugh EV, 2009, AM J EPIDEMIOL, V169, P1102, DOI 10.1093/aje/kwp027; Schaefer SE, 2009, J IMMIGR MINOR HEALT, V11, P188, DOI 10.1007/s10903-008-9150-6; Sheth T, 1999, CAN MED ASSOC J, V161, P132; Singh GK, 2009, J COMMUN HEALTH, V34, P271, DOI 10.1007/s10900-009-9148-6; Tu JV, 2015, CIRCULATION, V132, P1549, DOI 10.1161/CIRCULATIONAHA.115.015345; U.S. Census Bureau, 2015, AM FACTFINDER RES; van Hook J, 2010, J HEALTH SOC BEHAV, V51, P200, DOI 10.1177/0022146510372347; Wang HY, 2008, CAN MED ASSOC J, V179, P1133, DOI 10.1503/cmaj.071797; Westreich D, 2013, AM J EPIDEMIOL, V177, P292, DOI 10.1093/aje/kws412; Wolstein J, 2015, OBESITY CALIFORNIA; Yi SS, 2015, PREV MED, V73, P6, DOI 10.1016/j.ypmed.2015.01.007	44	11	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212740	10.1371/journal.pone.0212740	http://dx.doi.org/10.1371/journal.pone.0212740			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794650	Green Published, gold, Green Submitted			2022-12-27	WOS:000459709100128
J	Lee, SH; Son, HF; Kim, KJ				Lee, Seul Hoo; Son, Hyeoncheol Francis; Kim, Kyung-Jin			Structural insights into the inhibition properties of archaeon citrate synthase from Metallosphaera sedula	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; CARBON FIXATION; COENZYME; COMPLEX; SITE; OXALOACETATE; ADAPTATIONS; REFINEMENT; MECHANISM; ENZYME	Metallosphaera sedula is a thermoacidophilic archaeon and has an incomplete TCA/glyoxylate cycle that is used for production of biosynthetic precursors of essential metabolites. Citrate synthase from M. sedula (MsCS) is an enzyme involved in the first step of the incomplete TCA/glyoxylate cycle by converting oxaloacetate and acetyl-CoA into citrate and coenzyme A. To elucidate the inhibition properties of MsCS, we determined its crystal structure at 1.7 A resolution. Like other Type-I CS, MsCS functions as a dimer and each monomer consists of two distinct domains, a large domain and a small domain. The oxaloacetate binding site locates at the cleft between the two domains, and the active site was more closed upon binding of the oxaloacetate substrate than binding of the citrate product. Interestingly, the inhibition kinetic analysis showed that, unlike other Type-I CSs, MsCS is noncompetitively inhibited by NADH. Finally, amino acids and structural comparison of MsCS with other Type-II CSs, which were reported to be non-competitively inhibited by NADH, revealed that MsCS has quite unique NADH binding mode for non-competitive inhibition.	[Lee, Seul Hoo; Son, Hyeoncheol Francis; Kim, Kyung-Jin] Kyungpook Natl Univ, KNU Inst Microorganisms, KNU Creat BioRes Grp, Sch Life Sci, Daegu, South Korea	Kyungpook National University	Kim, KJ (corresponding author), Kyungpook Natl Univ, KNU Inst Microorganisms, KNU Creat BioRes Grp, Sch Life Sci, Daegu, South Korea.	kkim@knu.ac.kr			National Research Foundation of Korea (NRF) - Ministry of Science and ICT [NRF-2016M3D3A1A01913269]; National Research Foundation of Korea (NRF) [NRF-2014M1A2A2033626]; NRF-2015-Global PhD Fellowship Program of the Korean Government [2015H1A2A1034233]	National Research Foundation of Korea (NRF) - Ministry of Science and ICT; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); NRF-2015-Global PhD Fellowship Program of the Korean Government	This work was supported by the C1 Gas Refinery Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (NRF-2016M3D3A1A01913269), and also supported by a National Research Foundation of Korea (NRF) grant (NRF-2014M1A2A2033626). H-F Son was supported by the NRF2015-Global PhD Fellowship Program of the Korean Government (2015H1A2A1034233). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the C1 Gas Refinery Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (NRF-2016M3D3A1A01913269), and also supported by a National Research Foundation of Korea (NRF) grant (NRF-2014M1A2A2033626). H-F Son was supported by the NRF-2015-Global PhD Fellowship Program of the Korean Government (2015H1A2A1034233).	Aleksandrov A, 2014, J PHYS CHEM B, V118, P4505, DOI 10.1021/jp412346g; ALTER GM, 1990, BIOCHEMISTRY-US, V29, P7557, DOI 10.1021/bi00485a003; Auernik KS, 2008, CURR OPIN BIOTECH, V19, P445, DOI 10.1016/j.copbio.2008.08.001; Auernik KS, 2010, APPL ENVIRON MICROB, V76, P931, DOI 10.1128/AEM.01336-09; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAYER E, 1981, EUR J BIOCHEM, V120, P155, DOI 10.1111/j.1432-1033.1981.tb05683.x; Bell GS, 2002, EUR J BIOCHEM, V269, P6250, DOI 10.1046/j.1432-1033.2002.03344.x; Berg IA, 2010, NAT REV MICROBIOL, V8, P447, DOI 10.1038/nrmicro2365; Boutz DR, 2007, J MOL BIOL, V368, P1332, DOI 10.1016/j.jmb.2007.02.078; Chruszcz M, 2008, PROTEIN SCI, V17, P623, DOI 10.1110/ps.073360508; Chuakrut S, 2003, J BACTERIOL, V185, P938, DOI 10.1128/JB.185.3.938-947.2003; DANSON MJ, 1977, BIOCHIM BIOPHYS ACTA, V485, P452, DOI 10.1016/0005-2744(77)90181-4; Estelmann S, 2011, J BACTERIOL, V193, P1191, DOI 10.1128/JB.01155-10; Evans CT, 1996, BIOCHEMISTRY-US, V35, P10661, DOI 10.1021/bi960336e; Francois JA, 2006, BIOCHEMISTRY-US, V45, P13487, DOI 10.1021/bi061083k; HARFORD S, 1975, BIOCHEM J, V151, P455, DOI 10.1042/bj1510455; Hawkins AB, 2014, APPL ENVIRON MICROB, V80, P2536, DOI 10.1128/AEM.04146-13; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; HOSTALEK Z, 1969, FOLIA MICROBIOL, V14, P121, DOI 10.1007/BF02892880; JANGAARD NO, 1968, BIOCHIM BIOPHYS ACTA, V151, P225, DOI 10.1016/0005-2744(68)90177-0; Kanamori E, 2015, BIOPHYS PHYSICOBIOL, V12, P47, DOI 10.2142/biophysico.12.0_47; KARPUSAS M, 1990, BIOCHEMISTRY-US, V29, P2213, DOI 10.1021/bi00461a002; Krebs H, 1979, Nurs Mirror, V149, P30; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LOHLEINWERHAHN G, 1988, BIOL CHEM H-S, V369, P109, DOI 10.1515/bchm3.1988.369.1.109; Maurus R, 2003, BIOCHEMISTRY-US, V42, P5555, DOI 10.1021/bi020622s; Murphy JR, 2015, ACTA CRYSTALLOGR F, V71, P1292, DOI 10.1107/S2053230X15015939; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nguyen NT, 2001, BIOCHEMISTRY-US, V40, P13177, DOI 10.1021/bi010408o; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; REMINGTON S, 1982, J MOL BIOL, V158, P111, DOI 10.1016/0022-2836(82)90452-1; REMINGTON SJ, 1992, CURR TOP CELL REGUL, V33, P209; Russell RJM, 1997, BIOCHEMISTRY-US, V36, P9983, DOI 10.1021/bi9705321; Russell RJM, 1998, STRUCTURE, V6, P351, DOI 10.1016/S0969-2126(98)00037-9; RUSSELL RJM, 1994, STRUCTURE, V2, P1157, DOI 10.1016/S0969-2126(94)00118-9; Selwood T, 2012, ARCH BIOCHEM BIOPHYS, V519, P131, DOI 10.1016/j.abb.2011.11.020; SMITH CM, 1971, FEBS LETT, V18, P35, DOI 10.1016/0014-5793(71)80400-3; Sussman JL, 1998, SCIENCE, V282, P1993; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; WIEGAND G, 1984, J MOL BIOL, V174, P205, DOI 10.1016/0022-2836(84)90373-5; WIEGAND G, 1986, ANNU REV BIOPHYS BIO, V15, P97	41	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212807	10.1371/journal.pone.0212807	http://dx.doi.org/10.1371/journal.pone.0212807			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794680	Green Published, Green Submitted, gold			2022-12-27	WOS:000459709100142
J	Lopez-Sanmartin, M; Catanese, G; Grau, A; Valencia, JM; Garcia-March, JR; Navas, JI				Lopez-Sanmartin, Monserrat; Catanese, Gaetano; Grau, Amalia; Maria Valencia, Jose; Rafa Garcia-March, Jose; Ignacio Navas, Jose			Real-Time PCR based test for the early diagnosis of Haplosporidium pinnae affecting fan mussel Pinna nobilis	PLOS ONE			English	Article							COEFFICIENT; AGREEMENT	Noble pen shell or fan mussel, Pinna nobilis Linnaeus (1758), protected since 1992, was incorporated into the Spanish Catalogue of Threatened Species (Category: Vulnerable, Royal Decree 139/2011). The status is presently in the process of being catalogued as critically endangered, pending approval by Spanish Government (https://www.mapama.gob.es/es/biodiversidad/participacion-publica/Borrador_OM_situacion_critica. aspx). The International Union for the Conservation of Nature (IUCN) alerted the countries of the Mediterranean basin to the "emergent situation" due to serious mortality events suffered by the fan mussel, putting it in serious risk of extinction. Thus, emergency actions have been implemented by Spanish authorities in which several research institutes from all over the country are involved. The parasite, Haplosporidium pinnae, was recently characterized by histology, TEM, SEM and molecular biology techniques and it was considered responsible for the mass mortality of P. nobilis in the Mediterranean Sea. In this context, the aim of this study has been to develop species-specific quantitative PCR (qPCR) protocol carrying out a fast, specific and effective molecular diagnose of H. pinnae. In this sense, the detection limit for qPCR was equal to 30 copies of SSU rDNA / ng of DNA using plasmid alone and when 100ng DNA of non-infected oyster were added. The qPCR assay revealed that 94% of the 32 analysed mantle tissues of fan mussel were infected by H. pinnae, showing a high sensitivity and specificity for its detection (100% if we don't consider negative and too much degraded samples). This technique will allow us to make quicker follow-ups of the disease, allowing us to get a better understanding of its evolution in order to help in the rescue of P. nobilis populations	[Lopez-Sanmartin, Monserrat; Ignacio Navas, Jose] IFAPA Agua Pino, Cartaya, Huelva, Spain; [Catanese, Gaetano; Grau, Amalia; Maria Valencia, Jose] LIMIA Govern Illes Balears, Port Dandratx, Mallorca, Spain; [Catanese, Gaetano; Grau, Amalia; Maria Valencia, Jose] INAGEA INIA CAIB UIB Ctra, Edifici Guillem Colom Casasnoves, Palma de Mallorca, Illes Balears, Spain; [Rafa Garcia-March, Jose] UCV, IMEDMAR, Calpe, Spain	Universidad Catolica de Valencia San Vicente Martir	Lopez-Sanmartin, M (corresponding author), IFAPA Agua Pino, Cartaya, Huelva, Spain.	monserratls@yahoo.es	Navas, José Ignacio/D-9086-2012; Garcia‑March, Jose R./T-4120-2018; CATANESE, GAETANO/A-7510-2009	Navas, José Ignacio/0000-0002-2774-7978; Garcia‑March, Jose R./0000-0003-1646-5331; CATANESE, GAETANO/0000-0001-6219-4494; Lopez-Sanmartin, Monserrat/0000-0001-9077-7515; Valencia, Jose/0000-0002-1912-1975; Grau, Amalia/0000-0002-6461-6985	project MAPAMA within LIFE IPE INTERMARES [28-5310, LIFE15 IPE ES 012]; PHENOFISH Project; State Plan for Scientific and Technical Research and Innovation 2013-2016, MINECO [PTA2015-14709-I]; Ministerio de Economia, Industria y Competitividad, Gobierno de Espana, INIA CCAA [DOC INIA 8-2013]; Prince Albert II of Monaco Foundation [BF/HEM 15-1662];  [IFAPA-UCV 014/2018]	project MAPAMA within LIFE IPE INTERMARES; PHENOFISH Project; State Plan for Scientific and Technical Research and Innovation 2013-2016, MINECO; Ministerio de Economia, Industria y Competitividad, Gobierno de Espana, INIA CCAA; Prince Albert II of Monaco Foundation; 	This research has been funded by the project MAPAMA ref. 28-5310 within LIFE IPE INTERMARES(LIFE15 IPE ES 012) and the agreement IFAPA-UCV 014/2018 and co-funded by PHENOFISH Project. M. Lopez-Sanmartin contract is co-financed by the State Plan for Scientific and Technical Research and Innovation 2013-2016, MINECO, ref. PTA2015-14709-I. Ministerio de Economia, Industria y Competitividad, Gobierno de Espana, INIA CCAA (DOC INIA 8-2013), Dr Gaetano Catanese. Garcia-March was supported by the project BF/HEM 15-1662 -The study, protection and possible breeding of penshell (Pinna nobilis) in the Boka Kotorska bay (Montenegro) of the Prince Albert II of Monaco Foundation. We thank to M. Vila, R. Leon and I. Giraldez of the Chemistry Department of the University of Huelva (Spain).	Audemard C, 2004, APPL ENVIRON MICROB, V70, P6611, DOI 10.1128/AEM.70.11.6611-6618.2004; Berthe FCJ, 1999, BULL EUR ASSN FISH P, V19, P277; Catanese G, 2018, J INVERTEBR PATHOL, V157, P9, DOI 10.1016/j.jip.2018.07.006; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Darriba S, 2017, J INVERTEBR PATHOL, V148, P14, DOI 10.1016/j.jip.2017.05.006; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kralik P, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00108; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Mauri I, 2011, FISH SHELLFISH IMMUN, V30, P1310, DOI 10.1016/j.fsi.2011.03.013; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramilo A, 2013, DIS AQUAT ORGAN, V104, P149, DOI 10.3354/dao02597; Sanna D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067372; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vazquez-Luis M, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00220; Wilbur AE, 2012, DIS AQUAT ORGAN, V102, P107, DOI 10.3354/dao02540; Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741, DOI 10.1128/AEM.63.10.3741-3751.1997	19	17	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212028	10.1371/journal.pone.0212028	http://dx.doi.org/10.1371/journal.pone.0212028			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794588	Green Submitted, Green Published, gold			2022-12-27	WOS:000459709100033
J	Skoglund, C; Lagging, M; Castedal, M				Skoglund, Catarina; Lagging, Martin; Castedal, Maria			No need to discontinue hepatitis C virus therapy at the time of liver transplantation	PLOS ONE			English	Article							INFECTION; INTERFERON; SOFOSBUVIR; RECURRENCE; RIBAVIRIN; HCV; SURVIVAL	Objectives Direct antiviral agents (DAA) has dramatically improved the therapy outcome of hepatitis C-virus (HCV) infection, both on the waiting-list and post liver transplantation (LT). DAA are generally well-tolerated in patients with mild to moderate liver and kidney failure, but some DAAs are contraindicated in patients with severe dysfunction of these organs. Today there are few studies of peri-LT DAA use and treatment is commonly discontinued at the time of LT. We report here our experience of DAA therapy given continuously in the perioperative LT period in a real-life setting in Sweden. Material In total 10 patients with HCV-cirrhosis, with or without hepatocellular carcinoma, and a median age of 60.5 years (range, 52-65) were treated with DAAs on the waiting list for LT, and continued in the early postoperative period without any interruption, on the basis of not having reached a full treatment course at the time of LT. Sofosbuvir and a NS5A inhibitor with or without ribavirin, or sofosbuvir and ribavirin only, were given. The distribution of genotypes was genotype 1 and 3, in 4 and 6 patients, respectively. Six of the 10 patients had previously been treated with IFN-based therapy. Results There were no adverse events leading to premature DAA discontinuation. All recipients achieved a sustained viral response 12 weeks after end-of-treatment (SVR12). At the time of LT the median MELD-score was 16.5 (range 7-21), CTP-score 9.0 (range 5-10), creatinine 82.5 mu mol/L (range 56-135, reference 60-105), bilirubin 33 mu mol/L (range 16-79, reference 5-25) and PK-INR 1.5 (range 1.1-1.8). The median duration of DAA therapy was 60 days (range 18-132) pre-LT, 54 days post-LT (range 8-111 days) and in total 15.5 weeks (range 12-30 weeks). Conclusion Interferon-free DAA therapy of HCV-infection given in the immediate pre- and post-operative LT period is safe, well-tolerated and yields high SVR rates.	[Skoglund, Catarina; Castedal, Maria] Sahlgrens Univ Hosp, Transplant Inst, Dept Surg, Gothenburg, Sweden; [Skoglund, Catarina; Castedal, Maria] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Gothenburg, Sweden; [Lagging, Martin] Sahlgrens Univ Hosp, Dept Infect Dis Virol, Gothenburg, Sweden; [Lagging, Martin] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Gothenburg, Sweden	Sahlgrenska University Hospital; University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg	Castedal, M (corresponding author), Sahlgrens Univ Hosp, Transplant Inst, Dept Surg, Gothenburg, Sweden.; Castedal, M (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Gothenburg, Sweden.	maria.castedal@vgregion.se	; Lagging, Martin/D-7734-2015	Castedal, Maria/0000-0002-4782-2752; Skoglund, Catarina/0000-0002-0138-2026; Lagging, Martin/0000-0002-7995-3626				Ackefors M, 2015, INFECT DIS-NOR, V47, P209, DOI 10.3109/00365548.2014.984322; Adam R, 2012, J HEPATOL, V57, P675, DOI 10.1016/j.jhep.2012.04.015; Berenguer M, 2008, J HEPATOL, V49, P274, DOI 10.1016/j.jhep.2008.05.002; Bernuth S, 2017, DRUG DES DEV THER, V11, P2131, DOI 10.2147/DDDT.S139837; Charlton M, 2015, GASTROENTEROLOGY, V148, P108, DOI 10.1053/j.gastro.2014.10.001; Chen TY, 2016, CURR OPIN ORGAN TRAN, V21, P111, DOI 10.1097/MOT.0000000000000288; Choudhary NS, 2017, J CLIN EXP HEPATOL, V7, P358, DOI 10.1016/j.jceh.2017.10.003; Crespo G, 2018, J HEPATOL, V69, P11, DOI 10.1016/j.jhep.2018.02.012; Curry MP, 2015, GASTROENTEROLOGY, V148, P100, DOI 10.1053/j.gastro.2014.09.023; Forman LM, 2002, GASTROENTEROLOGY, V122, P889, DOI 10.1053/gast.2002.32418; Hobson EV, 2012, PERITON DIALYSIS INT, V32, P590, DOI 10.3747/pdi.2012.00152; Kwo PY, 2015, CURR OPIN ORGAN TRAN, V20, P235, DOI 10.1097/MOT.0000000000000198; Kwo PY, 2014, NEW ENGL J MED, V371, P2375, DOI 10.1056/NEJMoa1408921; Lagging M, 2016, INFECT DIS-NOR, V48, P251, DOI 10.3109/23744235.2015.1113438; Lionetti R, 2018, CLIN TRANSPLANT, V32, DOI 10.1111/ctr.13165; Maria C, 2017, SCAND J GASTROENTERO, V52, P585, DOI 10.1080/00365521.2017.1283439; Melum E, 2007, J HEPATOL, V47, P777, DOI 10.1016/j.jhep.2007.06.013; Mutimer D, 2017, DIGEST DIS, V35, P347, DOI 10.1159/000456586; Reig M, 2016, J HEPATOL, V65, P719, DOI 10.1016/j.jhep.2016.04.008; Roche B, 2018, LIVER INT, V38, P139, DOI 10.1111/liv.13659; Terrault NA, 2006, LIVER TRANSPLANT, V12, P1192, DOI 10.1002/lt.20865	21	3	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0211437	10.1371/journal.pone.0211437	http://dx.doi.org/10.1371/journal.pone.0211437			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794555	Green Published, gold, Green Submitted			2022-12-27	WOS:000459709100016
J	Vicente, CSL; Nemchinov, LG; Mota, M; Eisenback, JD; Kamo, K; Vieira, P				Vicente, Claudia S. L.; Nemchinov, Lev G.; Mota, Manuel; Eisenback, Jonathan D.; Kamo, Kathryn; Vieira, Paulo			Identification and characterization of the first pectin methylesterase gene discovered in the root lesion nematode Pratylenchus penetrans	PLOS ONE			English	Article							PLANT-CELL WALLS; RICE WEEVIL; EXPRESSION; SEQUENCE; ENZYMES; PARASITISM; ALIGNMENT; ESTERASE; PROTEIN; TOMATO	Similar to other plant-parasitic nematodes, root lesion nematodes possess an array of enzymes that are involved in the degradation of the plant cell wall. Here we report the identification of a gene encoding a cell wall-degrading enzyme, pectin methylesterase PME (EC 3.1.1.11), in the root lesion nematode Pratylenchus penetrans. Both genomic and coding sequences of the gene were cloned for this species, that included the presence of four introns which eliminated a possible contamination from bacteria. Expression of the Pp-pme gene was localized in the esophageal glands of P. penetrans as determined by in situ hybridization. Temporal expression of Pp-pme in planta was validated at early time points of infection. The possible function and activity of the gene were assessed by transient expression of Pp-pme in plants of Nicotiana benthamiana plants via a Potato virus X-based vector. To our knowledge, this is the first report on identification and characterization of a PME gene within the phylum Nematoda.	[Vicente, Claudia S. L.] Univ Evora, Inst Invest & Formacao Avancada, ICAAM, Polo Mitra, Evora, Portugal; [Nemchinov, Lev G.; Vieira, Paulo] ARS, Mol Plant Pathol Lab, USDA, Beltsville, MD 20705 USA; [Mota, Manuel] Univ Evora, Polo Mitra, Dept Biol, Evora, Portugal; [Mota, Manuel] Univ Evora, Polo Mitra, ICAAM, Evora, Portugal; [Eisenback, Jonathan D.; Vieira, Paulo] Virginia Tech, Sch Plant Environm Sci, Blacksburg, VA 24061 USA; [Kamo, Kathryn] USDA, Floral & Nursery Plants Res Unit, US Natl Arboretum, Beltsville, MD 20705 USA	University of Evora; United States Department of Agriculture (USDA); University of Evora; University of Evora; Virginia Polytechnic Institute & State University; United States Department of Agriculture (USDA)	Vieira, P (corresponding author), ARS, Mol Plant Pathol Lab, USDA, Beltsville, MD 20705 USA.; Vieira, P (corresponding author), Virginia Tech, Sch Plant Environm Sci, Blacksburg, VA 24061 USA.	pvieira@vt.edu	Vieira, Paulo/I-7173-2019; Vicente, Cláudia SL/X-5058-2019; Mota, Manuel/G-6031-2019	Vieira, Paulo/0000-0001-5627-2628; Vicente, Cláudia SL/0000-0002-3865-5358; Mota, Manuel/0000-0002-4145-5031	FCT (Foundation for Science and Technology) [SFRH/BPD/116030/2016]; national project [PTDC/AGR-PRO/2589/2014 - PratyTech]; National Funds through FCT [UID/AGR/00115/2013]	FCT (Foundation for Science and Technology)(Portuguese Foundation for Science and Technology); national project; National Funds through FCT(Portuguese Foundation for Science and Technology)	This work was supported by the FCT (Foundation for Science and Technology) postdoctoral fellowship SFRH/BPD/116030/2016 (to CSLV); the national project PTDC/AGR-PRO/2589/2014 - PratyTech (to MM), Biotechnology approaches towards control of the root lesion nematode Pratylenchus penetrans and by National Funds through FCT under the Project UID/AGR/00115/2013 (to CSLV and MM).	Agamennone V, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv128; Antony B, 2017, INSECT MOL BIOL, V26, P469, DOI 10.1111/imb.12314; Barsnes H, 2018, J PROTEOME RES, V17, P2552, DOI 10.1021/acs.jproteome.8b00175; Bellincampi D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00228; Bethke G, 2014, PLANT PHYSIOL, V164, P1093, DOI 10.1104/pp.113.227637; Brown AMV, 2016, SCI REP-UK, V6, DOI 10.1038/srep34955; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Castillo P, 2007, NEMATOL MONOGR PERSP, V6, P1; CHAPMAN S, 1992, PLANT J, V2, P549; Chen MH, 2003, PLANT J, V35, P386, DOI 10.1046/j.1365-313X.2003.01818.x; Church M.J., 2008, MICROB ECOL OCEAN, P335, DOI DOI 10.1002/9780470281840.CH10; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Czarnetzki AB, 2004, FEMS MICROBIOL ECOL, V49, P217, DOI 10.1016/j.femsec.2004.03.007; Danchin EGJ, 2010, P NATL ACAD SCI USA, V107, P17651, DOI 10.1073/pnas.1008486107; de Boer JM, 1998, J NEMATOL, V30, P309; Denver DR, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005713; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elhadyl A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177145; Evangelista DE, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/ieu168; Faddeeva-Vakhrusheva A, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3852-x; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Haegeman A, 2011, MPMI, V8, P879; Haegeman A, 2009, MOL PLANT PATHOL, V10, P389, DOI [10.1111/J.1364-3703.2009.00539.X, 10.1111/j.1364-3703.2009.00539.x]; Jones MGK, 2014, ANN APPL BIOL, V164, P163, DOI 10.1111/aab.12105; Jordan DB, 2012, BIOCHEM J, V442, P241, DOI 10.1042/BJ20111922; Katoh K, 2017, MAFFT ONLINE SERVICE; Keegstra K, 2010, PLANT PHYSIOL, V154, P483, DOI 10.1104/pp.110.161240; Keeling CI, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r27; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kikuchi T, 2017, ANNU REV PHYTOPATHOL, V55, P333, DOI 10.1146/annurev-phyto-080516-035434; Kirsch R, 2016, INSECT BIOCHEM MOLEC, V71, P72, DOI 10.1016/j.ibmb.2016.02.007; L'Enfant M, 2015, INT J BIOL MACROMOL, V81, P681, DOI 10.1016/j.ijbiomac.2015.08.066; Li PQ, 2011, J BASIC MICROB, V51, P61, DOI 10.1002/jobm.201000317; Lionetti V, 2012, J PLANT PHYSIOL, V169, P1623, DOI 10.1016/j.jplph.2012.05.006; Micheli F, 2001, TRENDS PLANT SCI, V6, P414, DOI 10.1016/S1360-1385(01)02045-3; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; Pauchet Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015635; Pelloux J, 2007, TRENDS PLANT SCI, V12, P267, DOI 10.1016/j.tplants.2007.04.001; Perez-Riverol Y, 2016, MOL CELL PROTEOMICS, V15, P305, DOI 10.1074/mcp.O115.050229; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pilling J, 2004, PLANTA, V219, P32, DOI 10.1007/s00425-004-1204-y; Protsenko MA, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1053, DOI 10.1134/S0006297908100015; Quist CW, 2015, ANNU REV PHYTOPATHOL, V53, P289, DOI 10.1146/annurev-phyto-080614-120057; Schulz S, 2013, BIOGEOSCIENCES, V10, P3983, DOI 10.5194/bg-10-3983-2013; Senechal F, 2014, J EXP BOT, V65, P5125, DOI 10.1093/jxb/eru272; Shen ZC, 1999, INSECT BIOCHEM MOLEC, V29, P209, DOI 10.1016/S0965-1748(98)00127-1; Shevchik VE, 1997, MOL MICROBIOL, V24, P1285, DOI 10.1046/j.1365-2958.1997.4331800.x; Sierro N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4833; Sorensen I, 2010, PLANT PHYSIOL, V153, P366, DOI 10.1104/pp.110.154427; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Teller DC, 2014, ACTA CRYSTALLOGR F, V70, P1480, DOI 10.1107/S2053230X14020433; TIEMAN DM, 1994, PLANT PHYSIOL, V106, P429, DOI 10.1104/pp.106.2.429; Valette-Collet O, 2003, MOL PLANT MICROBE IN, V16, P360, DOI 10.1094/MPMI.2003.16.4.360; Vanholme B, 2009, NEMATOLOGY, V11, P739, DOI 10.1163/156854109X404599; Vaudel M, 2015, NAT BIOTECHNOL, V33, P22, DOI 10.1038/nbt.3109; Vieira P, 2017, PLANT PATHOL, V66, P1214, DOI 10.1111/ppa.12664; Vieira P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144674; Vieira P, 2018, MOL PLANT PATHOL, V19, P1887, DOI 10.1111/mpp.12666; Vieira P, 2011, J EXP BOT, V62, P1241, DOI 10.1093/jxb/erq352; Voragen AGJ, 2009, STRUCT CHEM, V20, P263, DOI 10.1007/s11224-009-9442-z; Wen FS, 1999, PLANT CELL, V11, P1129, DOI 10.1105/tpc.11.6.1129; Wietholter N, 2003, MOL PLANT MICROBE IN, V16, P945, DOI 10.1094/MPMI.2003.16.10.945; Wolinska A, 2017, APPL SOIL ECOL, V119, P128, DOI 10.1016/j.apsoil.2017.06.009; Yang JX, 2016, BMC BIOL, V14, DOI 10.1186/s12915-015-0223-4	65	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212540	10.1371/journal.pone.0212540	http://dx.doi.org/10.1371/journal.pone.0212540			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794636	gold, Green Published, Green Submitted			2022-12-27	WOS:000459709100083
J	Castellon, RIA; Vargas, EC; Chavarria, REC; Vargas, GAR				Acevedo Castellon, Roger Ivan; Carranza Vargas, Esteban; Cortes Chavarria, Ritzi Elena; Rodriguez Vargas, Gabriel Andres			Rapid assessment of avoidable blindness and diabetic retinopathy in individuals aged 50 years or older in Costa Rica	PLOS ONE			English	Article							VISUAL IMPAIRMENT	In the present study, we examined the causes and the prevalence of avoidable blindness and visual impairment, as well as the prevalence of diabetic retinopathy in individuals aged >= 50 years in Costa Rica, in order to provide baseline data for the initial planning and monitoring of ongoing blindness intervention programs. The assessment was based on the standardized methodology of the Rapid Assessment of Avoidable Blindness and Diabetic Retinopathy, a population-based survey for blindness and visual impairment. From 3,255 eligible subjects, 76.6% were examined. The adjusted prevalence of bilateral blindness [presenting visual acuity (VA) in the better eye of less than 3/60] was 1.7% (95% confidence interval, 1.2%-2.2%), with avoidable causes (treatable and preventable) accounting for 68.8% of cases. The main causes of blindness were cataract (52.1%), glaucoma (6.3%), and diabetic retinopathy (6.3%); these data were similar to those for other neighboring countries. Cataract surgical coverage (CSC) in the survey area was estimated as 88.9% for individuals with blindness (VA, <3/60), 76.6% for those with a VA of <6/60, and 60.3% for those with a VA of <6/18. The most common barriers against cataract surgery in individuals with a best-corrected VA of <= 6/60 included "need not felt" (48.8%) and "fear" (14.6%). Among individuals with a past history of cataract surgery, only 57.1% showed a "good" or "very good" outcome (VA, >= 6/18). Finally, 23.5% individuals with known or newly diagnosed diabetes showed retinopathy and/or maculopathy, with 6.2% exhibiting sight-threatening diabetic retinopathy (proliferative retinopathy, referable maculopathy, or both). Our findings indicate the need to overcome barriers against surgery for cataract, which is the main cause of avoidable blindness, to increase CSC, and to improve surgical outcomes. Moreover, improved methods for diabetic retinopathy screening can ensure prompt identification of patients with a risk of blindness. Glaucoma screening is also necessary for areas with a high prevalence.	[Acevedo Castellon, Roger Ivan; Carranza Vargas, Esteban; Cortes Chavarria, Ritzi Elena; Rodriguez Vargas, Gabriel Andres] Mexico Hosp, Caja Costarricense Seguro Social, Surg Dept, Ophthalmol Serv, San Jose, Costa Rica		Castellon, RIA (corresponding author), Mexico Hosp, Caja Costarricense Seguro Social, Surg Dept, Ophthalmol Serv, San Jose, Costa Rica.	rogerivanac@gmail.com	Castellón, Róger Iván Acevedo/N-8508-2019; Castellón, Róger Iván Acevedo/N-4003-2017; Rodriguez-Vargas, Gabriel/L-9570-2017	Castellón, Róger Iván Acevedo/0000-0002-6935-0178; Castellón, Róger Iván Acevedo/0000-0002-6935-0178; Rodriguez-Vargas, Gabriel/0000-0002-6282-2742	Caja Costarricense de Seguro Social; Panamerican Health Organization	Caja Costarricense de Seguro Social; Panamerican Health Organization	The authors received funding from Caja Costarricense de Seguro Social (http://www.ccss.sa.cr) and Panamerican Health Organization (http://www.paho.org/cor/).	Alvarado D, 2014, REV PANAM SALUD PUBL, V36, P300; American Diabetes Association, 2002, DIABETES CARE, V25, ps90s93, DOI [10.2337/diacare.25.2007.S90, DOI 10.2337/DIACARE.25.2007.S90]; Barcelo A, 2009, SURVERY DIABETES HYP; Silva JC, 2015, REV PANAM SALUD PUBL, V37, P21; Flaxman SR, 2017, LANCET GLOB HEALTH, V5, pE1221, DOI 10.1016/S2214-109X(17)30393-5; Kuper Hannah, 2006, Community Eye Health, V19, P68; Limburg H, 2013, COMMUNITY EYE HLTH J; Limburg H, 2008, BRIT J OPHTHALMOL, V92, P315, DOI 10.1136/bjo.2007.125906; Lopez M, 2014, REV PANAM SALUD PUBL, V36, P355; Resnikoff S, 2012, BRIT J OPHTHALMOL, V96, P783, DOI 10.1136/bjophthalmol-2011-301378; Vision 20/20, 2015, VISION 20 20 B TRIME; WHO, 2013, PREV BLINDN VIS IMP; Williams GA, 2004, OPHTHALMOLOGY, V111, P1055, DOI 10.1016/j.ophtha.2004.02.004; World Health Organization, 2014, PROGR PREV BLINDN VI; Zachariah Sonia, 2015, Community Eye Health, V28, P72	15	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212660	10.1371/journal.pone.0212660	http://dx.doi.org/10.1371/journal.pone.0212660			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789973	Green Published, gold			2022-12-27	WOS:000459330800048
J	LaPaglia, JA; Chan, JCK				LaPaglia, Jessica A.; Chan, Jason C. K.			Telling a good story: The effects of memory retrieval and context processing on eyewitness suggestibility	PLOS ONE			English	Article							FUZZY-TRACE THEORY; DARK SIDE; MISINFORMATION; RECALL; DISFLUENCY; RETENTION; TESTS; MIND	Witnesses are likely to describe a crime many times before testifying or encountering misinformation about that crime. Research examining the effect of retrieval on later suggestibility has yielded mixed results. LaPaglia and Chan manipulated whether misinformation was presented in a narrative or misleading questions, and they found that retrieval increased suggestibility when misinformation was presented in a narrative, but reduced suggestibility when the same misinformation was presented in questions. In the current study, we aimed to address why these differences occurred. Specifically, we examined whether contextual detail and narrative coherence during misinformation exposure influenced the relation between retrieval and suggestibility. Participants watched a robbery video and some were questioned about the event afterwards. They were then exposed to misinformation presented in a narrative (Experiment 1) or questions (Experiment 2) before taking a final memory test. Testing enhanced suggestibility when the misinformation phase reinstated contextual information of the event, but not when the misinformation phase included few contextual details-regardless of whether the misinformation was in a narrative or questions. In Experiment 3, disrupting narrative coherence by randomizing the order of contextual information eliminated retrieval-enhanced suggestibility. Therefore, context processing during the post-event information phase influences whether retrieval enhances or reduces eyewitness suggestibility.	[LaPaglia, Jessica A.] Morningside Coll, Dept Social Sci, Sioux City, IA USA; [Chan, Jason C. K.] Iowa State Univ, Dept Psychol, Ames, IA 50011 USA	Iowa State University	Chan, JCK (corresponding author), Iowa State Univ, Dept Psychol, Ames, IA 50011 USA.	ckchan@iastate.edu	Chan, Jason C.K. C.K./AAW-8827-2021	Chan, Jason C.K. C.K./0000-0003-4221-2979; LaPaglia, Jessica/0000-0002-8505-5304				Alter AL, 2007, J EXP PSYCHOL GEN, V136, P569, DOI 10.1037/0096-3445.136.4.569; Alter AL, 2013, COGNITION, V128, P252, DOI 10.1016/j.cognition.2013.01.006; [Anonymous], 2005, SCI FALSE MEMORY OXF, DOI DOI 10.1093/ACPROF:OSO/9780195154054.001.0001; BARNES JM, 1959, J EXP PSYCHOL, V58, P97, DOI 10.1037/h0047507; Barry J, 2017, CRIMINAL COURT CITY; Brainerd CJ, 1998, J EXP CHILD PSYCHOL, V71, P81, DOI 10.1006/jecp.1998.2464; Cardwell BA, 2016, MEM COGNITION, V44, P883, DOI 10.3758/s13421-016-0603-1; Carpenter CJ, 2012, WESTERN J COMM, V76, P552, DOI 10.1080/10570314.2012.662307; Carroll M, 1999, MEMORY, V7, P309, DOI 10.1080/096582199387940; Chan JCK, 2007, J EXP PSYCHOL LEARN, V33, P431, DOI 10.1037/0278-7393.33.2.431; Chan JCK, 2018, PSYCHOL BULL, V144, P1111, DOI 10.1037/bul0000166; Chan JCK, 2018, J MEM LANG, V102, P83, DOI 10.1016/j.jml.2018.05.007; Chan JCK, 2017, J APPL RES MEM COGN, V6, P213; Chan JCK, 2012, J MEM LANG, V67, P78, DOI 10.1016/j.jml.2012.02.006; Chan JCK, 2011, J EXP PSYCHOL-APPL, V17, P418, DOI 10.1037/a0025147; Chan JCK, 2011, J EXP PSYCHOL LEARN, V37, P248, DOI 10.1037/a0021204; Chan JCK, 2009, J MEM LANG, V61, P153, DOI 10.1016/j.jml.2009.04.004; Chan JC, 2009, PSYCHOL SCI, V20, P66, DOI 10.1111/j.1467-9280.2008.02245.x; Davis SD, 2017, J APPL RES MEM COGN, V6, P434, DOI 10.1016/j.jarmac.2017.07.002; Davis SD, 2015, J EXP PSYCHOL LEARN, V41, P1741, DOI 10.1037/xlm0000126; Del Vicario M, 2016, P NATL ACAD SCI USA, V113, P554, DOI 10.1073/pnas.1517441113; Fazio LK, 2015, MEMORY, V23, P167, DOI 10.1080/09658211.2013.877146; Gabbert F, 2012, APPL COGNITIVE PSYCH, V26, P568, DOI 10.1002/acp.2828; Gordon LT, 2017, J MEM LANG, V95, P190, DOI 10.1016/j.jml.2017.04.004; Gordon LT, 2015, J MEM LANG, V83, P140, DOI 10.1016/j.jml.2015.03.007; Gordon LT, 2014, MEM COGNITION, V42, P186, DOI 10.3758/s13421-013-0361-2; Hanzlikova D, 2017, RES LANGUAGE, V15, P296, DOI [10.1515/rela-2017-0016, DOI 10.1515/RELA-2017-0016]; Huff MJ, 2016, APPL COGNITIVE PSYCH, V30, P61, DOI 10.1002/acp.3167; Jang Y, 2008, J EXP PSYCHOL LEARN, V34, P112, DOI 10.1037/0278-7393.34.1.112; Kebbell MR, 1998, J SOC PSYCHOL, V138, P323, DOI 10.1080/00224549809600384; LaPaglia JA, 2014, APPL COGNITIVE PSYCH, V28, P1, DOI 10.1002/acp.2950; LaPaglia JA, 2013, BEHAV SCI LAW, V31, P593, DOI 10.1002/bsl.2090; LaPaglia JA, 2012, LAW HUMAN BEHAV, V36, P478, DOI 10.1037/h0093931; Lee HS, 2018, J EDUC PSYCHOL, V110, P203, DOI 10.1037/edu0000211; Lev-Ari S, 2010, J EXP SOC PSYCHOL, V46, P1093, DOI 10.1016/j.jesp.2010.05.025; Lewandowsky S, 2017, J APPL RES MEM COGN, V6, P353, DOI 10.1016/j.jarmac.2017.07.008; Loftus EF, 2005, LEARN MEMORY, V12, P361, DOI 10.1101/lm.94705; MANNES S, 1994, J EDUC PSYCHOL, V86, P577, DOI 10.1037/0022-0663.86.4.577; McCabe DP, 2008, COGNITION, V107, P343, DOI 10.1016/j.cognition.2007.07.017; Otgaar H, 2019, LEGAL CRIMINOL PSYCH, V24, P24, DOI 10.1111/lcrp.12137; Pansky A, 2011, MEMORY, V19, P901, DOI 10.1080/09658211.2011.613845; Pansky A, 2011, MEM COGNITION, V39, P155, DOI 10.3758/s13421-010-0005-8; Pastotter B, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00286; Putnam AL, 2017, PSYCHOL SCI, V28, P36, DOI 10.1177/0956797616672268; Reyna VF, 2016, J APPL RES MEM COGN, V5, P1, DOI 10.1016/j.jarmac.2015.12.003; REYNA VF, 1995, LEARN INDIVID DIFFER, V7, P1, DOI 10.1016/1041-6080(95)90031-4; Rowland CA, 2014, PSYCHOL BULL, V140, P1432, DOI 10.1037/a0037559; Saunders J, 2009, MEM COGNITION, V37, P326, DOI 10.3758/MC.37.3.326; Schweitzer NJ, 2013, COGNITION, V129, P501, DOI 10.1016/j.cognition.2013.08.009; Steblay NK, 2014, PSYCHOL PUBLIC POL L, V20, P1, DOI 10.1037/law0000001; Szpunar KK, 2008, J EXP PSYCHOL LEARN, V34, P1392, DOI 10.1037/a0013082; Szpunar KK, 2017, CURR DIR PSYCHOL SCI, V26, P40, DOI 10.1177/0963721416670320; Szpunar KK, 2013, P NATL ACAD SCI USA, V110, P6313, DOI [10.1073/pnas.1221764110, 10.1073/pnas.122764110]; Thomas AK, 2010, J MEM LANG, V63, P149, DOI 10.1016/j.jml.2010.04.004; THORNDYKE PW, 1977, COGNITIVE PSYCHOL, V9, P77, DOI 10.1016/0010-0285(77)90005-6; TOUSIGNANT JP, 1986, MEM COGNITION, V14, P329, DOI 10.3758/BF03202511; U.S. Department of Justice, 2003, EYEW EV TRAIN MAN LA; Unsworth N, 2005, BEHAV RES METHODS, V37, P498, DOI 10.3758/BF03192720; Vaughn LA, 2010, SOC PERSONAL PSYCHOL, V4, P1181, DOI 10.1111/j.1751-9004.2010.00325.x; Wilford MM, 2014, J EXP PSYCHOL-APPL, V20, P81, DOI 10.1037/xap0000001; Yang CL, 2018, NPJ SCI LEARN, V3, DOI 10.1038/s41539-018-0024-y; ZARAGOZA MS, 1994, J EXP PSYCHOL LEARN, V20, P934, DOI 10.1037/0278-7393.20.4.934	62	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212592	10.1371/journal.pone.0212592	http://dx.doi.org/10.1371/journal.pone.0212592			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM2WC	30789952	Green Published, gold, Green Submitted			2022-12-27	WOS:000459330800045
J	Mahmoud, SS; ElAbrak, ES; Aly, MA; Ali, EM				Mahmoud, Sherif S.; ElAbrak, Eman S.; Aly, Mervat A.; Ali, Eman M.			Oculohypotensive effects of various acetozolamide nanopreparations for topical treatment of animal model-induced glaucoma and their impact on optic nerve	PLOS ONE			English	Article							RAMAN-SPECTROSCOPY; OXIDATIVE STRESS; ANTIBACTERIAL; POMEGRANATE; PROPOLIS; DELIVERY; LIPIDS; PLANTS	Acetozolamide-ACZ, carbonic anhydrase inhibitor-is still the most effective systemic drug for glaucoma treatment. Due to its limited ocular bioavailability, topical formulations are not available yet. This study introduces within the framework of nanotechnology three nanopreparations of acetozolamide for topical application, one of them is liposomal phospholipid vehicle and the other two preparations are propolis and Punica granatum (pomegranate). The hypotensive effect of these different nanopreparations in lowering the increased intraocular pressure that was induced in experimental rabbits is monitored for 130 hrs. Structural characteristics of the optic nerve dissected from all involved groups were studied by Fourier transfrom infrared spectroscopy. The obtained results indicate the impact of the topically applied acetozolamide nanopreparations in lowering the intraocular pressure to its normotensive control value. On the other hand, the optic nerve characteristics were found to be dependent on the way acetozolamide introduced. Glaucoma affects structural components that contain OH group and increases beta-turns of the protein secondary structure while, reducing the content of both alpha-helix and Turns. In the same context, liposomal-acetozolamide and propolis nanopreparations protecting the optic nerve protein secondary structure from these changes associated with glaucoma.	[Mahmoud, Sherif S.; ElAbrak, Eman S.; Aly, Mervat A.; Ali, Eman M.] Res Inst Ophthalmol, Biophys & Laser Sci Unit, Giza, Egypt	Egyptian Knowledge Bank (EKB); General Organization of Teaching Hospitals & Institutes (GOTHI); Research Institute of Ophthalmology (RIO)	Mahmoud, SS (corresponding author), Res Inst Ophthalmol, Biophys & Laser Sci Unit, Giza, Egypt.	sherif.siddick@rio.sci.eg	aly, eman mohamed/AAC-1891-2019; Mahmoud, Sherif Siddick/AAJ-7442-2020	aly, eman mohamed/0000-0003-0815-3063; Mahmoud, Sherif Siddick/0000-0002-6826-6011				Adhami VM, 2007, MOL BIOTECHNOL, V37, P52, DOI 10.1007/s12033-007-0047-8; ALVARADO J, 1981, INVEST OPHTH VIS SCI, V21, P714; Beattie JR, 2004, LIPIDS, V39, P407, DOI 10.1007/s11745-004-1245-z; BORCHMAN D, 1991, INVEST OPHTH VIS SCI, V32, P2404; Borchman D, 1996, EXP EYE RES, V62, P191, DOI 10.1006/exer.1996.0023; DeSouza NJ, 1993, J ETHNOPHARMACOL, V83, P167, DOI [10.1016/0378-8741(93)90013-U, DOI 10.1016/0378-8741(93)90013-U]; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Flammer J, 1999, J GLAUCOMA, V8, P212; Gautam R, 2007, J ETHNOPHARMACOL, V110, P200, DOI 10.1016/j.jep.2006.12.031; GOLDBERG I, 2000, GLAUCOMA 21 CENTURY, P1; Granero GE, 2008, J PHARM SCI-US, V97, P3691, DOI 10.1002/jps.21282; Guillard E, 2011, ANAL BIOANAL CHEM, V399, P1201, DOI 10.1007/s00216-010-4389-x; Hegazi AG, 2001, Z NATURFORSCH C, V56, P82; Iomdina EN, 2015, FRONT BIOSCI-LANDMRK, V20, P892, DOI 10.2741/4343; Izzotti A, 2006, MUTAT RES-REV MUTAT, V612, P105, DOI 10.1016/j.mrrev.2005.11.001; Kujumgiev A, 1999, J ETHNOPHARMACOL, V64, P235, DOI 10.1016/S0378-8741(98)00131-7; Kyei S, 2015, EYE VISION, V2, DOI 10.1186/s40662-015-0027-1; Li HL, 2016, AAPS PHARMSCITECH, V17, P710, DOI 10.1208/s12249-015-0382-1; Mahmoud SS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196827; Melena J, 1997, METHOD FIND EXP CLIN, V19, P553; Melendez PA, 2006, PHYTOMEDICINE, V13, P272, DOI 10.1016/j.phymed.2004.11.009; Natarajan JV, 2012, INT J NANOMED, V7, DOI 10.2147/IJN.S25468; Plumb GW, 2002, REDOX REP, V7, P41, DOI 10.1179/135100002125000172; Rhee DJ, 2001, SURV OPHTHALMOL, V46, P43, DOI 10.1016/S0039-6257(01)00233-8; Souleman AM., 2016, EGYPTIAN PHARM J, V15, P143, DOI 10.4103/1687-4315.197582; Tfayli A, 2012, EUR J DERMATOL, V22, P36, DOI 10.1684/ejd.2011.1507; Tilahun ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027203; Tylkowski B, 2010, J MEMBRANE SCI, V348, P124, DOI 10.1016/j.memsci.2009.10.049; Yano I, 1998, EUR J CLIN PHARMACOL, V54, P63, DOI 10.1007/s002280050422; Yu SH, 2015, INT J PHARMACEUT, V480, P128, DOI 10.1016/j.ijpharm.2015.01.032	30	3	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212588	10.1371/journal.pone.0212588	http://dx.doi.org/10.1371/journal.pone.0212588			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789966	Green Published, Green Submitted, gold			2022-12-27	WOS:000459330800044
J	Kamila, S; Hasanuzzaman, M; Ekbal, A; Bhattacharyya, P				Kamila, Sabyasachi; Hasanuzzaman, Mohammad; Ekbal, Asif; Bhattacharyya, Pushpak			Resolution of grammatical tense into actual time, and its application in Time Perspective study in the tweet space	PLOS ONE			English	Article							TEMPORAL ORIENTATION; FUTURE ORIENTATION; PERSONALITY; INVENTORY; EMOTIONS; SMOKING	Time Perspective (TP) is an important area of research within the 'psychological time' paradigm. TP, or the manner in which individuals conduct themselves as a reflection of their cogitation of the past, the present, and the future, is considered as a basic facet of human functioning. These perceptions of time have an influence on our actions, perceptions, and emotions. Assessment of TP based on human language on Twitter opens up a new avenue for research on subjective view of time at a large scale. In order to assess TP of users' from their tweets, the foremost task is to resolve grammatical tense into the underlying temporal orientation of tweets as for many tweets the tense information, and their temporal orientations are not the same. In this article, we first resolve grammatical tense of users' tweets to identify their underlying temporal orientation: past, present, or future. We develop a minimally supervised classification framework for temporal orientation task that enables incorporating linguistic knowledge into a deep neural network. The temporal orientation model achieves an accuracy of 78.7% when tested on a manually annotated test set. This method performs better when compared to the state-of-the-art technique. Secondly, we apply the classification model to classify the users' tweets in either of the past, present or future categories. Tweets classified this way are then grouped for each user which gives rise to unidimensional TP. The valence (positive, negative, and neutral) is added to the temporal orientation dimension to produce the bidimensional TP. We finally investigate the association between the Twitter users' unidimensional and bidimensional TP and their age, education and six basic emotions in a large-scale empirical manner. Our analysis shows that people tend to think more about the past as well as more positive about the future when they age. We also observe that future-negative people are less joyful, more sad, more disgusted, and more angry while past-negative people have more fear.	[Kamila, Sabyasachi; Ekbal, Asif; Bhattacharyya, Pushpak] Indian Inst Technol Patna, Dept Comp Sci & Engn, Patna, Bihar, India; [Hasanuzzaman, Mohammad] Dublin City Univ, ADAPT Ctr, Sch Comp, Dublin, Ireland	Indian Institute of Technology (IIT) - Patna; Indian Institute of Technology System (IIT System); Dublin City University	Kamila, S (corresponding author), Indian Inst Technol Patna, Dept Comp Sci & Engn, Patna, Bihar, India.; Hasanuzzaman, M (corresponding author), Dublin City Univ, ADAPT Ctr, Sch Comp, Dublin, Ireland.	sabysachi.pcs16@iitp.ac.in; hasanuzzaman.im@gmail.com	Hasanuzzaman, Mohammed/AAT-6303-2020		Visvesvaraya PhD scheme for Electronics and IT, Ministry of Electronics and Information Technology (MeitY), Government of India; SFI Research Centres Programme [13/RC/2106]; European Regional Development Fund	Visvesvaraya PhD scheme for Electronics and IT, Ministry of Electronics and Information Technology (MeitY), Government of India; SFI Research Centres Programme; European Regional Development Fund(European Commission)	Asif Ekbal acknowledges the Young Faculty Research Fellowship (YFRF), supported by Visvesvaraya PhD scheme for Electronics and IT, Ministry of Electronics and Information Technology (MeitY), Government of India, being implemented by Digital India Corporation (formerly Media Lab Asia). Mohammed Hasanuzzaman acknowledges the ADAPT Centre for Digital Content Technology, funded under the SFI Research Centres Programme (Grant 13/RC/2106) and is co-funded under the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2009, BRIT J HEALTH PSYCH, V14, P83, DOI 10.1348/135910708X299664; Boniwell I., PERSPECTIVES ON TIME; Boniwell I, 2010, J POSIT PSYCHOL, V5, P24, DOI 10.1080/17439760903271181; Boyd JN, 2005, UNDERSTANDING BEHAVIOR IN THE CONTEXT OF TIME: THEORY , RESEARCH AND APPLICATION, P85; Boyd RL, 2017, CURR OPIN BEHAV SCI, V18, P63, DOI 10.1016/j.cobeha.2017.07.017; Carelli MG, 2011, EUR J PSYCHOL ASSESS, V27, P220, DOI 10.1027/1015-5759/a000076; Chmiel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022207; Choudhury MD, 2012, INT AAAI C WEBL SOC, P66; De Choudhury M., 2013, P SIGCHI C HUM FACT, P3267, DOI [DOI 10.1145/2470654.2466447, 10.1145/2470654.2466447]; De Choudhury M., 2013, ICWSM, V7, P128, DOI DOI 10.1109/IRI.2012.6302998; De Choudhury M., 2013, P 5 ANN ACM WEB SCI, P47, DOI [10.1145/2464464.2464480, DOI 10.1145/2464464.2464480]; De Houwer J., 2010, COGNITION EMOTION RE; Desmyter F, 2012, PSYCHOL BELG, V52, P19, DOI 10.5334/pb-52-1-19; Dodds PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026752; Drake L, 2008, TIME SOC, V17, P47, DOI 10.1177/0961463X07086304; Dzmitry Bahdanau, 2016, Arxiv, DOI arXiv:1409.0473; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; FLEISS JL, 1971, PSYCHOL BULL, V76, P378, DOI 10.1037/h0031619; Francis-Smythe J, 1996, EXPLORATION TIME PER; FREDRICKSON BL, 2001, AM PSYCHOL, V56, P218, DOI DOI 10.1037/0003-066X.56.3.218; Gao W, 2013, PROCEEDINGS OF THE 22ND ACM INTERNATIONAL CONFERENCE ON INFORMATION & KNOWLEDGE MANAGEMENT (CIKM'13), P1505, DOI 10.1145/2505515.2507830; Gimpel K., 2011, P ACL, P42; Gorman BS, 1977, PERSONAL EXPERIENCE, P215; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Gruebner O, 2017, SOC SCI MED, V189, P167, DOI 10.1016/j.socscimed.2017.07.018; Hasanuzzaman M, 2014, 14 C EUR CHAPT ASS C, P6; Hasanuzzaman M, 2017, PROCEEDINGS OF THE 55TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL 2017), VOL 2, P659, DOI 10.18653/v1/P17-2104; Hornik J., 1993, PSYCHOL MARKETING, V10, P239; Hornik J., 1992, J SOCIO EC, V21, P209; Horstmanshof L, 2007, BRIT J EDUC PSYCHOL, V77, P703, DOI 10.1348/000709906X160778; Jacoby WG, 2000, ELECT STUD, V19, P577, DOI 10.1016/S0261-3794(99)00028-1; Jain LC, 1999, INT SER COMPUTAT INT, P1; KAMMANN R, 1983, AUST J PSYCHOL, V35, P259, DOI 10.1080/00049538308255070; Karniol R, 1996, ANNU REV PSYCHOL, V47, P593, DOI 10.1146/annurev.psych.47.1.593; Kaufman C. F., 1991, J BUS PSYCHOL, V6, P79, DOI DOI 10.1007/BF01013686; Keough KA, 1999, BASIC APPL SOC PSYCH, V21, P149, DOI 10.1207/S15324834BA210207; Kosinski M, 2013, P NATL ACAD SCI USA, V110, P5802, DOI 10.1073/pnas.1218772110; Lasane TP, 1999, J SOC BEHAV PERS, V14, P31; Lennings C.J., 1996, ALCOHOLISM TREATMENT, V14, P71, DOI [https://doi.org/10.1300/J020V14N04_05, DOI 10.1300/J020V14N04_05, 10.1300/j020v14n04_05]; Liu CZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep24892; Manning CD, 2014, PROCEEDINGS OF 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS: SYSTEM DEMONSTRATIONS, P55, DOI 10.3115/v1/p14-5010; Marquardt J., 2014, P CLEF 2014 EVALUATI, V1180, P1129; McGrath J. E., 1988, SOCIAL PSYCHOL TIME; Mohammad Saif, 2013, P 7 INT WORKSH SEM E; Naaman M, 2010, 2010 ACM CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK, P189; Neter J., 1996, APPL LINEAR STAT MOD; Paltoglou G, 2013, IEEE T AFFECT COMPUT, V4, P106, DOI 10.1109/T-AFFC.2012.26; Park G, 2017, J PERS, V85, P270, DOI 10.1111/jopy.12239; Pennington Jeffrey, 2014, PROC 2014 C EMPIRICA, P1532, DOI [DOI 10.3115/V1/D14-1162, 10.3115/v1/D14-1162]; Pentland WE, 1999, TIME USE RESOCIAL; Preotiuc-Pietro D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138717; Richardson M, 2012, PSYCHOL BULL, V138, P353, DOI 10.1037/a0026838; Robinson J.P., 2002, TIME USE RESOCIAL, P47, DOI [DOI 10.1007/0-306-47155-8_3, 10.1007/B107540]; Sap Maarten, 2014, P 2014 C EMP METH NA, P1146, DOI DOI 10.3115/V1/D14-1121; Schuster M, 1997, IEEE T SIGNAL PROCES, V45, P2673, DOI 10.1109/78.650093; Schwartz H. A., 2015, P C N AM CHAPT ASS C, P409; Schwartz HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073791; Seginer R., 2003, ONLINE READINGS PSYC, V6, P1056, DOI [10.9707/2307-0919.1056, DOI 10.9707/2307-0919.1056]; Sircova A, 2008, INT J PSYCHOL, V43, P43; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Stolarski M, 2014, J HAPPINESS STUD, V15, P809, DOI 10.1007/s10902-013-9450-y; Strathman A., 2006, UNDERSTANDING BEHAV, DOI [10.4324/9781410613516, DOI 10.4324/9781410613516]; Sykora M, 2015, P 2 INT WORKSH MIN U, P80; Thelwall M., 2010, 1 MONDAY, V15, DOI [10.5210/fm.v15i4.2897, DOI 10.5210/FM.V15I4.2897]; TROMMSDORFF G, 1983, INT J PSYCHOL, V18, P381, DOI 10.1080/00207598308247489; Waller MJ, 2001, ACAD MANAGE REV, V26, P586, DOI 10.2307/3560243; Webley P, 2006, J ECON PSYCHOL, V27, P140, DOI 10.1016/j.joep.2005.06.016; WESTBROOK RA, 1991, J CONSUM RES, V18, P84, DOI 10.1086/209243; Wills TA, 2001, PSYCHOL ADDICT BEHAV, V15, P118, DOI 10.1037/0893-164X.15.2.118; Worrell FC, 2007, EDUC PSYCHOL MEAS, V67, P487, DOI 10.1177/0013164406296985; Zhou P., 2016, P COLING 2016 26 INT, P3485; Zimbardo PG, 1999, J PERS SOC PSYCHOL, V77, P1271, DOI 10.1037/0022-3514.77.6.1271	72	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211872	10.1371/journal.pone.0211872	http://dx.doi.org/10.1371/journal.pone.0211872			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM2OT	30785900	Green Submitted, Green Published, gold			2022-12-27	WOS:000459307000044
J	Langer, MC; McPhee, BW; Marsola, JCD; Roberto-da-Silva, L; Cabreira, SF				Langer, Max Cardoso; McPhee, Blair Wayne; de Almeida Marsola, Julio Cesar; Roberto-da-Silva, Lucio; Cabreira, Sergio Furtado			Anatomy of the dinosaur Pampadromaeus barberenai (Saurischia-Sauropodomorpha) from the Late Triassic Santa Maria Formation of southern Brazil	PLOS ONE			English	Article							GRANDE-DO-SUL; EARLY EVOLUTION; ECOLOGICAL OPPORTUNITY; PHYLOGENETIC-RELATIONSHIPS; CATURRITA FORMATION; THEROPOD DINOSAUR; BASAL DINOSAUR; ORIGIN; ARGENTINA; SKELETON	Sauropodomorphs are the most abundant and diverse Glade of Triassic dinosaurs, but the taxonomy of their earliest (Carnian) representatives is still poorly understood. One such taxon is Pampadromaeus barberenai, represented by a nearly complete disarticulated skeleton recovered from the upper part of the Santa Maria Formation of Rio Grande do Sul, Brazil. Here, the osteology of Pam. barberenai is fully described for the first time. Detailed comparisons with other Carnian sauropodomorphs reveal a unique anatomy, corroborating its status as a valid species. Potential autapomorphies of Pam. barberenai can be seen in the articulation of the sacral zygapophyses, the length of the pectoral epipodium, the shape of the distal articulation of the femur and the proximal articulation of metatarsal 1. A novel phylogenetic study shows that relationships among the Carnian sauropodomorphs are poorly constrained, possibly because they belong to a "zone of variability", where homoplasy abounds. Yet, there is some evidence that Pam. barberenai may nest within Saturnaliidae, along with Saturnalia tupiniquim and Chromogisaurus novasi, which represents the sister group to the larger sauropodomorphs, i.e. Bagualosauria.	[Langer, Max Cardoso; McPhee, Blair Wayne; de Almeida Marsola, Julio Cesar] Univ Sao Paulo, FFCLRP, Lab Paleontol, Ribeirao Preto, SP, Brazil; [Roberto-da-Silva, Lucio; Cabreira, Sergio Furtado] Univ Luterana Brasil, Museu Ciencias Nat, Canoas, RS, Brazil	Universidade de Sao Paulo; Universidade Luterana do Brasil	Langer, MC (corresponding author), Univ Sao Paulo, FFCLRP, Lab Paleontol, Ribeirao Preto, SP, Brazil.	mclanger@ffclrp.usp.br	de A. Marsola, Júlio C./H-6513-2014; Langer, Max/Y-1753-2019; Langer, Max/F-7483-2012	de A. Marsola, Júlio C./0000-0001-5290-7884; Langer, Max/0000-0003-1009-4605	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2014/03825-3, 2013/23114-1]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by: MCL, 2014/03825-3, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, http://www.fapesp.br/; JCAM, 2013/23114-1, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, http://www.fapesp.br/.	Alcober O, 2010, ZOOKEYS, V63, P1; Apaldetti C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026964; Baron MG, 2017, NATURE, V543, P501, DOI 10.1038/nature21700; Baumel Julian J., 1993, Publications of the Nuttall Ornithological Club, V23, P45; Benson RBJ, 2018, ANNU REV ECOL EVOL S, V49, P379, DOI 10.1146/annurev-ecolsys-110617-062231; Benson RBJ, 2018, PALAEONTOLOGY, V61, P13, DOI 10.1111/pala.12329; Benton MJ, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0569; Bever GS, 2015, NATURE, V525, P239, DOI 10.1038/nature14900; Bever GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023393; Bever GS, 2011, EVOL DEV, V13, P269, DOI 10.1111/j.1525-142X.2011.00478.x; Bittencourt JD, 2009, ZOOTAXA, P1; Bittencourt JS, 2015, J SYST PALAEONTOL, V13, P189, DOI 10.1080/14772019.2013.878758; Bonaparte JF., 1980, MEMOIRES SOC GEOLOGI, V139, P19; Boulenger GA., 1881, B ACAD ROYALE BELGIQ, V3, P600; BREMER K, 1988, EVOLUTION, V42, P795, DOI 10.1111/j.1558-5646.1988.tb02497.x; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; Bristowe Anthea, 2004, Palaeontologia Africana, V40, P31; Bronzati M, PALAEONTOL, V61, P289; Bronzati M, 2017, ZOOL J LINN SOC-LOND, DOI [10.1093/zoolinnean/zlx099, DOI 10.1093/ZOOLINNEAN/ZLX099]; Bronzati M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11737-5; Butler RJ, 2010, ZOOL J LINN SOC-LOND, V160, P648, DOI 10.1111/j.1096-3642.2009.00631.x; Cabreira SF, 2011, NATURWISSENSCHAFTEN, V98, P1035, DOI 10.1007/s00114-011-0858-0; Cabreira SF, 2016, CURR BIOL, V26, P3090, DOI 10.1016/j.cub.2016.09.040; Chapelle KEJ, 2018, PEERJ, V6, pe422; Cooper M. R, 1981, NATURAL SCI, V6, P689; CURRIE PJ, 1993, CAN J EARTH SCI, V30, P2037, DOI 10.1139/e93-179; Eddy DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017932; Ezcurra MD, 2010, J SYST PALAEONTOL, V8, P371, DOI 10.1080/14772019.2010.484650; Fabri M, 2018, PHYLONYMS COMPANION; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Galton PM, 2004, DINOSAURIA, 2ND EDITION, P232; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Griffin CT, 2016, J VERTEBR PALEONTOL, V36, DOI 10.1080/02724634.2016.1111224; Hall B.K., 2015, BONES CARTILAGE DEV; Harris J.D., 1998, B NEW MEXICO MUSEUM, V13, P1; Horn BLD, 2014, J S AM EARTH SCI, V55, P123, DOI 10.1016/j.jsames.2014.07.007; Huene F.von., 1932, MONOGRAPHIEN GEOLOGI, V1, P1; Hughes M, 2013, P NATL ACAD SCI USA, V110, P13875, DOI 10.1073/pnas.1302642110; Irmis RB, 2010, EARTH ENV SCI T R SO, V101, P397, DOI 10.1017/S1755691011020068; Jarman P.J., 1979, SERENGETI DYNAMICS E, P130, DOI DOI 10.1086/284321; Langer MC, 2007, SPEC PAP PALAEONTOL, P113; Langer MC, 2006, J SYST PALAEONTOL, V4, P309, DOI 10.1017/S1477201906001970; Langer MC, 2018, GONDWANA RES, V57, P133, DOI 10.1016/j.gr.2018.01.005; Langer MC, 2017, NATURE, V551, pE1, DOI 10.1038/nature24011; Langer MC, 2014, PALAEONTOLOGY, V57, P469, DOI 10.1111/pala.12108; Langer MC, 2013, GEOL SOC SPEC PUBL, V379, P353, DOI 10.1144/SP379.16; Langer MC, 2010, EARTH ENV SCI T R SO, V101, P301, DOI 10.1017/S175569101102007X; Langer MC, 2010, BIOL REV, V85, P55, DOI 10.1111/j.1469-185X.2009.00094.x; Langer Max C., 2007, Bulletin of the New Mexico Museum of Natural History and Science, V41, P201; Langer MC, 2004, DINOSAURIA, 2ND EDITION, P25; Langer Max Cardoso, 2003, Paleobios, V23, P1; Langer MC, 1999, CR ACAD SCI II A, V329, P511, DOI 10.1016/S1251-8050(00)80025-7; Losos JB, 1997, BIOL J LINN SOC, V61, P459, DOI 10.1006/bijl.1997.0137; Losos JB, 2010, AM NAT, V175, P623, DOI 10.1086/652433; Marsh OC., 1877, AM J SCI, V3, P514, DOI DOI 10.2475/AJS.S3-14.84.514; Martinez RN, 2017, AMEGHINIANA, V54, P488, DOI 10.5710/AMGH.09.04.2017.3065; Martinez RN, 2012, J VERTEBR PALEONTOL, V32, P70, DOI 10.1080/02724634.2013.819009; Martinez RN, 2012, J VERTEBR PALEONTOL, V32, P10, DOI 10.1080/02724634.2013.818546; Martinez RN, 2012, J VERTEBR PALEONTOL, V32, P51, DOI 10.1080/02724634.2013.819361; Martinez RN, 2011, SCIENCE, V331, P206, DOI 10.1126/science.1198467; Martinez RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004397; Maxwell EE, 2011, J MORPHOL, V272, P1170, DOI 10.1002/jmor.10972; McPhee BW, 2015, SCI REP-UK, V5, DOI 10.1038/srep13224; McPhee BW, 2014, ZOOL J LINN SOC-LOND, V171, P151, DOI 10.1111/zoj12127; Meyer H, 1837, N JB MIN GEOL PALAON, V816; Muller RT, 2019, HIST BIOL, V31, P794, DOI 10.1080/08912963.2017.1395421; Muller RT, 2016, HIST BIOL, V28, P656, DOI 10.1080/08912963.2015.1004329; Muller RT, 2018, ZOOL J LINN SOC-LOND, DOI [10.1093/zoolinnean/zlx099, DOI 10.1093/ZOOLINNEAN/ZLX099]; Nesbitt SJ, B AM MUS NAT HIST, V352, P1; Nesbitt SJ, 2009, SCIENCE, V326, P1530, DOI 10.1126/science.1180350; Novas FE, 2010, EARTH ENV SCI T R SO, V101, P333, DOI 10.1017/S1755691011020093; Novas Fernando E., 1993, Journal of Vertebrate Paleontology, V13, P400; O'Connor PM, 2007, J VERTEBR PALEONTOL, V27, P127; Otero A, 2013, J VERTEBR PALEONTOL, V33, P1138, DOI 10.1080/02724634.2013.769444; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Neto VDP, 2016, PALAEOGEOGR PALAEOCL, V453, P30, DOI 10.1016/j.palaeo.2016.03.026; Piechowski R, 2014, J VERTEBR PALEONTOL, V34, P1383, DOI 10.1080/02724634.2014.873045; Pol D, 2009, CLADISTICS, V25, P515, DOI 10.1111/j.1096-0031.2009.00258.x; Porro LB, 2015, PEERJ, V3, DOI 10.7717/peerj.1494; Pretto FA, 2018, ZOOL J LINN SOC-LOND, DOI [10.1093/zoolinnean/zlx099, DOI 10.1093/ZOOLINNEAN/ZLX099]; Pretto FA, 2016, REV BRAS PALEONTOLOG, V19, P407, DOI 10.4072/rbp.2016.3.06; Prieto-Marquez A, 2011, AM MUS NOVIT, P1; RAATH M A, 1969, Arnoldia (Rhodesia), V4, P1; Rauhut OWM, 2003, SPEC PAP PALAEONTOL, P1; Riedl R., 1978, ORDER LIVING ORGANIS; Salgado Leonardo, 1997, Ameghiniana, V34, P3; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Sereno P.C., 2005, TAXONSEARCH DATABASE; Sereno Paul C., 1998, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V210, P41; Sereno PC, 2012, J VERTEBR PALEONTOL, V32, P83, DOI 10.1080/02724634.2013.820113; Sereno Paul C., 1993, Journal of Vertebrate Paleontology, V13, P451; SERENO PC, 1993, NATURE, V361, P64, DOI 10.1038/361064a0; Sereno PC., 1994, J VERTEBR PALEONTOL, V13, P425, DOI DOI 10.1080/02724634.1994.10011524; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; Smith ND, 2007, ACTA PALAEONTOL POL, V52, P657; Stroud JT, 2016, ANNU REV ECOL EVOL S, V47, P507, DOI 10.1146/annurev-ecolsys-121415-032254; Sues HD, 2011, P ROY SOC B-BIOL SCI, V278, P3459, DOI 10.1098/rspb.2011.0410; THULBORN R A, 1970, Palaeontology (Oxford), V13, P414; UPCHURCH P, 1997, ENCY DINOSAURS, P658; Whitlock JA, 2013, INT J ORAL SCI, V5, P66, DOI 10.1038/ijos.2013.36; Wilson JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017114; Witmer LM, 1997, J VERTEBR PALEONTOL, V17, P1, DOI 10.1080/02724634.1997.10011027; Yates Adam M., 2007, Historical Biology, V19, P93, DOI 10.1080/08912960600866953; Yates AM, 2007, SPEC PAP PALAEONTOL, P9; Yates Adam M., 2005, Palaeontologia Africana, V41, P105; Yates AM, 2010, PALAEONTOLOGY, V53, P739, DOI 10.1111/j.1475-4983.2010.00952.x; Yates AM, 2010, P ROY SOC B-BIOL SCI, V277, P787, DOI 10.1098/rspb.2009.1440; Yates AM, 2012, COMPLETE DINOSAUR, P425; Yoder JB, 2010, J EVOLUTION BIOL, V23, P1581, DOI 10.1111/j.1420-9101.2010.02029.x; Zerfass H, 2003, SEDIMENT GEOL, V161, P85, DOI 10.1016/S0037-0738(02)00397-4	114	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212543	10.1371/journal.pone.0212543	http://dx.doi.org/10.1371/journal.pone.0212543			64	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785940	gold, Green Published, Green Submitted			2022-12-27	WOS:000459307000069
J	Pfaehler, E; Zwanenburg, A; de Jong, JR; Boellaard, R				Pfaehler, Elisabeth; Zwanenburg, Alex; de Jong, Johan R.; Boellaard, Ronald			RaCaT: An open source and easy to use radiomics calculator tool	PLOS ONE			English	Article							TEXTURAL FEATURES	Purpose The widely known field 'Radiomics' aims to provide an extensive image based phenotyping of e.g. tumors using a wide variety of feature values extracted from medical images. Therefore, it is of utmost importance that feature values calculated by different institutes follow the same feature definitions. For this purpose, the imaging biomarker standardization initiative (IBSI) provides detailed mathematical feature descriptions, as well as (mathematical) test phantoms and corresponding reference feature values. We present here an easy to use radiomic feature calculator, RaCaT, which provides the calculation of a large number of radiomic features for all kind of medical images which are in compliance with the standard. Methods The calculator is implemented in C++ and comes as a standalone executable. Therefore, it can be easily integrated in any programming language, but can also be called from the command line. No programming skills are required to use the calculator. The software architecture is highly modularized so that it is easily extendible. The user can also download the source code, adapt it if needed and build the calculator from source. The calculated feature values are compliant with the ones provided by the IBSI standard. Source code, example files for the software configuration, and documentation can be found online on GitHub (https://gthub.com/ellipfaehlerUMCG/RaCat). Results The comparison with the standard values shows that all calculated features as well as image preprocessing steps, comply with the IBSI standard. The performance is also demonstrated on clinical examples. Conclusions The authors successfully implemented an easy to use Radiomics calculator that can be called from any programming language or from the command line. Image preprocessing and feature settings and calculations can be adjusted by the user.	[Pfaehler, Elisabeth; de Jong, Johan R.; Boellaard, Ronald] Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, Groningen, Netherlands; [Zwanenburg, Alex] Tech Univ Dresden, Helmholtz Zentrum Dresden Rossendorf, Fac Med, OncoRay Natl Ctr Radiat Res Oncol, Dresden, Germany; [Zwanenburg, Alex] Tech Univ Dresden, Helmholtz Zentrum Dresden Rossendorf, Univ Hosp Carl Gustav Carus, Dresden, Germany; [Zwanenburg, Alex] Germany German Canc Res Ctr DKFZ, Partner Site Dresden, Natl Ctr Tumor Dis NCT, Heidelberg, Germany; [Zwanenburg, Alex] Tech Univ Dresden, Fac Med, Dresden, Germany; [Zwanenburg, Alex] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany; [Zwanenburg, Alex] HZDR, Helmholtz Assoc, Dresden, Germany; [Zwanenburg, Alex] German Canc Consortium DKTK, Partner Site Dresden, Heidelberg, Germany; [Zwanenburg, Alex] German Canc Res Ctr, Heidelberg, Germany; [Boellaard, Ronald] Amsterdam Univ Med Ctr, Locat VUMC, Dept Radiol & Nucl Med, Amsterdam, Netherlands	University of Groningen; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Technische Universitat Dresden; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Technische Universitat Dresden; Carl Gustav Carus University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Pfaehler, E (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, Groningen, Netherlands.	e.a.g.pfaehler@umcg.nl	Zwanenburg, Alex/AAF-6476-2020	Zwanenburg, Alex/0000-0002-0342-9545; Pfaehler, Elisabeth/0000-0002-6160-3011	Netherlands Organisation for Scientific Research (NWO) [14929]; Netherlands Organisation for Health Research and Development [10-10400-98-14002]; Dutch Cancer Society, POINTING project [10034]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); Dutch Cancer Society, POINTING project	EP, JdJ, and RB are part of the research program STRaTeGy with project number 14929, which is (partly) financed by the Netherlands Organisation for Scientific Research (NWO). RB is financially supported by the Netherlands Organisation for Health Research and Development [grant 10-10400-98-14002] and by the Dutch Cancer Society, POINTING project, grant 10034.	AMADASUN M, 1989, IEEE T SYST MAN CYB, V19, P1264, DOI 10.1109/21.44046; Avanzo M, 2017, PHYS MEDICA, V38, P122, DOI 10.1016/j.ejmp.2017.05.071; CHU A, 1990, PATTERN RECOGN LETT, V11, P415, DOI 10.1016/0167-8655(90)90112-F; Coroller TP, 2015, RADIOTHER ONCOL, V114, P345, DOI 10.1016/j.radonc.2015.02.015; Data TA, 2016, RADIOMICS IMAGES ARE, P278; Davatzikos C, 2018, J MED IMAGING, V5, DOI 10.1117/1.JMI.5.1.011018; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hatt M, 2017, EUR J NUCL MED MOL I, V44, P151, DOI 10.1007/s00259-016-3427-0; Johnson, 2015, ITK SOFTWARE GUIDE I; Leijenaar R., 2015, EUR J CANCER, V48, P441, DOI DOI 10.1016/J.EJCA.2011.11.036.RADI0MICS; Nioche C, 2018, CANCER RES, V78, P4786, DOI 10.1158/0008-5472.CAN-18-0125; Parekh V, 2017, EXPERT REV PRECIS ME, V1, P1, DOI [10.1080/23808993.2016, DOI 10.1080/23808993.2016.1164013.RADIOMICS]; Parmar C, 2015, SCI REP-UK, V5, DOI 10.1038/srep11044; SHANMUGAN KS, 1981, IEEE T GEOSCI REMOTE, V19, P153, DOI 10.1109/TGRS.1981.350344; SUN CJ, 1983, COMPUT VISION GRAPH, V23, P341, DOI 10.1016/0734-189X(83)90032-4; Thibault G., 2009, PROC PATTERN RECOGNI, P140; Thibault G, 2014, IEEE T BIO-MED ENG, V61, P630, DOI 10.1109/TBME.2013.2284600; Traverso A, RADIOMICS ONTOLOGY; Vallieres M, 2015, PHYS MED BIOL, V60, P5471, DOI 10.1088/0031-9155/60/14/5471; Zhang Lifei, 2015, Med Phys, V42, P1341, DOI 10.1118/1.4908210; Zwanenburg A, 2017, RADIOTHER ONCOL, V123, pS914, DOI 10.1016/S0167-8140(17)32209-0; Zwanenburg A., 2016, RADIOLOGY, DOI DOI 10.1148/RADIOL.2020191145	22	37	37	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212223	10.1371/journal.pone.0212223	http://dx.doi.org/10.1371/journal.pone.0212223			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785937	Green Published, gold, Green Submitted			2022-12-27	WOS:000459307000052
J	Baio, FHR; Antuniassi, UR; Castilho, BR; Teodoro, PE; da Silva, EE				Rojo Baio, Fabio Henrique; Antuniassi, Ulisses Rocha; Castilho, Bruno Rodeguer; Teodoro, Paulo Eduardo; da Silva, Eder Eujacio			Factors affecting aerial spray drift in the Brazilian Cerrado	PLOS ONE			English	Article								Pesticides aerial application may results in the drift to neighboring areas if some application technology is not well executed. This phenomenon should be minimized to reduce environmental risks and agricultural production costs. This work aimed to investigate the interaction of environmental conditions, surrounding distance, and application conditions influencing spray drift in aerial applications. Sampling data from aerial sprays were collected during three agricultural years (from 2012 to 2014) in fields cultivated with sorghum, millet, soybean, corn, and cotton. The following variables were evaluated: application swath width, application rate, distance from the applied field, wind speed, relative humidity, and temperature. The estimated Pearson's correlations and path analysis identified that application rate and distance from the applied field and application were the variables that most influenced drift. Equations relating spray drift in function of distance from the applied field and application rate were adjusted in function of the variable, and a response surface model was constructed to estimate drift. The major pesticide class sprayed with aircraft in the Brazilian Cerrado was insecticide, followed by fungicide. This scenario shows the potential hazard risk of spray drift over the environment. The concentration of the drift deposits decreased as surrounding distance and application rate were increased. A mathematical equation of drift prediction was established, where the variables that contributed most to drift deposits were surrounding distance and wind speed. Thus, it is very important to monitor and respect the wind speed limits during the aerial spraying, mainly when there is any risk potential associated with pesticide exposure over the downwind direction.	[Rojo Baio, Fabio Henrique; Castilho, Bruno Rodeguer; Teodoro, Paulo Eduardo; da Silva, Eder Eujacio] UFMS Chapadao Do Sul Campus, Chapadao Do Sul, MS, Brazil; [Antuniassi, Ulisses Rocha] Unesp FCA, Botucatu, SP, Brazil	Universidade Estadual Paulista	Baio, FHR (corresponding author), UFMS Chapadao Do Sul Campus, Chapadao Do Sul, MS, Brazil.	fabiobaio@ufms.br	SILVA, EDER EUJACIO/J-6094-2018; Baio, Fábio H.R./A-3432-2017; Baio, Fábio Henrique Rojo/M-6201-2019	Baio, Fábio H.R./0000-0002-9522-0342; Baio, Fábio Henrique Rojo/0000-0002-9522-0342; TEODORO, PAULO/0000-0002-8236-542X	CNPq	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	All authors thanks to CNPq, for the financial support, and the company Teonar Agricola de Chapadao do Sul/MS, for the technical support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; To CNPq, for the financial support, and the company Teonar Agricola de Chapadao do Sul/MS, for the technical support.	Al Heidary M, 2014, CROP PROT, V63, P120, DOI 10.1016/j.cropro.2014.05.006; Alves GS, 2014, PLANTA DANINHA, V32, P861, DOI 10.1590/S0100-83582014000400021; American Society of Agricultural and Biological Engineers (ASABE), 2009, S5721 ASABE, P1; Antuniassi U. R., 2014, Aspects of Applied Biology, P279; Antuniassi UR, 2015, OUTLOOKS PEST MANAGE, V26, P12, DOI [10.1564/v26_feb_04, DOI 10.1564/V26_FEB_04, DOI 10.1564/V26_]; Arvidsson T, 2011, PEST MANAG SCI, V67, P586, DOI 10.1002/ps.2114; Bhering LL, 2017, CROP BREED APPL BIOT, V17, P187, DOI 10.1590/1984-70332017v17n2s29; Bueno MR, 2017, BIOSYST ENG, V154, P35, DOI 10.1016/j.biosystemseng.2016.10.017; Cardoso M.R.D., 2015, ACTA GEOGR FICA, V8, P40, DOI DOI 10.5654/ACTA.V8I16.1384; da Cunha JPAR, 2017, ENG AGR-JABOTICABAL, V37, P493, DOI [10.1590/1809-4430-Eng.Agric.v37n3p493-501/2017, 10.1590/1809-4430-eng.agric.v37n3p493-501/2017]; de Cerqueira DTR, 2012, APPL ENG AGRIC, V28, P825; Donkersley P, 2011, CROP PROT, V30, P931, DOI 10.1016/j.cropro.2011.03.020; Embraer, 2018, AER IP; Ferguson JC, 2015, CROP PROT, V76, P1, DOI 10.1016/j.cropro.2015.06.008; Gil E, 2014, CROP PROT, V56, P58, DOI 10.1016/j.cropro.2013.10.018; Gregorio E, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16040499; Gregorio E, 2014, ATMOS ENVIRON, V82, P83, DOI 10.1016/j.atmosenv.2013.09.028; Hilz E, 2013, CROP PROT, V44, P75, DOI 10.1016/j.cropro.2012.10.020; Jiao LZ, 2016, COMPUT ELECTRON AGR, V121, P135, DOI 10.1016/j.compag.2015.12.006; Kim KH, 2017, SCI TOTAL ENVIRON, V575, P525, DOI 10.1016/j.scitotenv.2016.09.009; Micronair, 2018, MICR AU5000 AT; MONTGOMERY D. C., 2001, INTRO LINEAR REGRESS; Nuyttens D, 2017, BIOSYST ENG, V154, P14, DOI 10.1016/j.biosystemseng.2016.09.013; PCIL, 2018, COR PCILBASE; Baio FHR, 2018, AGRON J, V110, P1254, DOI 10.2134/agronj2017.12.0718; Salcedo R, 2017, BIOSYST ENG, V154, P76, DOI 10.1016/j.biosystemseng.2016.09.001; SALYANI M, 1992, T ASAE, V35, P1113, DOI 10.13031/2013.28708; SatLoc, 2018, LITESTAR; Sigma-Aldrich, 2018, TWEEN 80; Teodoro PE., 2014, J AGRON, V13, P23, DOI [10.3923/ja.2014.23.28, DOI 10.3923/JA.2014.23.28]; Trimble, 2018, PROD COMP MATR; Turner, 2018, TRIL LAB FLUOR; Vieira BC, 2018, APPL ENG AGRIC, V34, P507, DOI 10.13031/aea.12587; YATES WE, 1978, WEED SCI, V26, P597, DOI 10.1017/S0043174500064638; Zhang B, 2018, BIOSYST ENG, V166, P184, DOI 10.1016/j.biosystemseng.2017.11.017	35	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212289	10.1371/journal.pone.0212289	http://dx.doi.org/10.1371/journal.pone.0212289			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779797	Green Submitted, gold, Green Published			2022-12-27	WOS:000459062900039
J	Robello, C; Maldonado, DP; Hevia, A; Hoashi, M; Frattaroli, P; Montacutti, V; Heguy, A; Dolgalev, I; Mojica, M; Iraola, G; Dominguez-Bello, MG				Robello, Carlos; Patricia Maldonado, Doris; Hevia, Anna; Hoashi, Marina; Frattaroli, Paola; Montacutti, Valentina; Heguy, Adriana; Dolgalev, Igor; Mojica, Maricruz; Iraola, Gregorio; Dominguez-Bello, Maria G.			The fecal, oral, and skin microbiota of children with Chagas disease treated with benznidazole	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI; SEQUENCES; MEGACOLON; TRIAL; HEART	Background Chagas disease is still prevalent in rural areas of South America. In endemic areas of Bolivia, school children are screened for the program of Chagas disease eradication of the Ministry of Health, and positive children are treated. Here, we compared the fecal, oral and skin microbiomes of children with or without Chagas disease, and before and after benznidazol treatment of infected children. Methods A total of 543 Bolivian children (5-14 years old) were tested for Chagas disease, and 20 positive children were treated with Benznidazole. Fecal samples and oral and skin swabs were obtained before and after treatment, together with samples from a group of 35 uninfected controls. The 16S rRNA genes were sequenced and analyzed using QIIME to determine Alpha diversity differences and community distances, and linear discriminant analyses to determine marker taxa by infection status or treatment. Results Twenty out of 543 children screened were seropositive for Chagas disease (3.7%) and were included in the study, together with 35 control children that were seronegative for the disease. Fecal samples, oral and skin swabs were taken at the beginning of the study and after the anti-protozoa therapy with Benznidazole to the chagasic children. Infected children had higher fecal Firmicutes (Streptococcus, Roseburia, Butyrivibrio, and Blautia), and lower Bacteroides and also showed some skin -but not oral-microbiota differences. Treatment eliminated the fecal microbiota differences from control children, increasing Dialister (class Clostridia) and members of the Enterobacteriaceae, and decreasing Prevotella and Coprococcus, with minor effects on the oral and skin bacterial diversity. Conclusions The results of this study show differences in the fecal microbiota associated with Chagas disease in children, and also evidence that treatment normalizes fecal microbiota (makes it more similar to that in controls), but is associated with oral and skin microbiota differences from control children. Since microbiota impacts in children, it is important to determine the effect of drugs on the children microbiota, since dysbiosis could lead to physiological effects which might be avoidable with microbiota restoration interventions.	[Robello, Carlos; Iraola, Gregorio] Inst Pasteur Montevideo, Montevideo, Uruguay; [Robello, Carlos] Univ Republica, Fac Med, Montevideo, Uruguay; [Patricia Maldonado, Doris] Univ Andina Simon Bolivar, Sucre, Bolivia; [Hevia, Anna; Hoashi, Marina; Frattaroli, Paola; Montacutti, Valentina; Dominguez-Bello, Maria G.] NYU, Sch Med, Div Translat Med, New York, NY 10003 USA; [Heguy, Adriana; Dolgalev, Igor; Mojica, Maricruz] Univ San Francisco Javier Chuquisaca, Sucre, Bolivia; [Iraola, Gregorio] Univ Mayor, Ctr Integrat Biol, Santiago, Chile; [Dominguez-Bello, Maria G.] NYU, Langone Med Ctr, Genome Technol Ctr, New York, NY 10003 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Universidad de la Republica, Uruguay; New York University; Universidad Mayor; New York University; NYU Langone Medical Center	Robello, C (corresponding author), Inst Pasteur Montevideo, Montevideo, Uruguay.; Robello, C (corresponding author), Univ Republica, Fac Med, Montevideo, Uruguay.; Dominguez-Bello, MG (corresponding author), NYU, Sch Med, Div Translat Med, New York, NY 10003 USA.; Dominguez-Bello, MG (corresponding author), NYU, Langone Med Ctr, Genome Technol Ctr, New York, NY 10003 USA.	robello@pasteur.edu.uy; mg.dominguez-bello@rutgers.edu	Heguy, Adriana/GPP-3907-2022; Dolgalev, Igor/AAY-6406-2020; Iraola, Gregorio/L-6539-2019	Dolgalev, Igor/0000-0003-4451-126X; Iraola, Gregorio/0000-0002-6516-3404; Hoashi, Marina/0000-0003-3643-9632; ROBELLO, CARLOS/0000-0001-6985-6171; Hevia, Anna/0000-0001-9372-8487	C&D Fund for Microbial Anthropology; Emch Fund	C&D Fund for Microbial Anthropology; Emch Fund	We acknowledge the support of the C&D Fund for Microbial Anthropology, and the Emch Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bern C, 2015, NEW ENGL J MED, V373, P1882, DOI [10.1056/NEJMra1410150, 10.1056/NEJMc1510996]; Blaser MJ, 2017, NAT REV IMMUNOL, V17, P461, DOI 10.1038/nri.2017.77; Bonney KM, 2014, PARASITE, V21, DOI 10.1051/parasite/2014012; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Clayton J, 2010, NATURE, V465, pS4, DOI 10.1038/nature09220; Coura JR, 2010, NATURE, V465, pS6, DOI 10.1038/nature09221; deAndrade ALSS, 1996, LANCET, V348, P1407, DOI 10.1016/S0140-6736(96)04128-1; del Puerto R, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000687; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; DETORANZO EGD, 1988, EXPERIENTIA, V44, P880, DOI 10.1007/BF01941187; Devkota S, 2016, SCIENCE, V351, P452, DOI 10.1126/science.aaf1353; Diaz-Viraque F, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00456; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; HOF H, 1989, ANTIMICROB AGENTS CH, V33, P404, DOI 10.1128/AAC.33.3.404; Kay GL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003861; Lewis MD, 2016, TRENDS PARASITOL, V32, P899, DOI 10.1016/j.pt.2016.08.009; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Marin-Neto JA, 2009, MEM I OSWALDO CRUZ, V104, P319, DOI 10.1590/S0074-02762009000900042; Martinez KA, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao1874; da Siveira ABM, 2007, HUM PATHOL, V38, P1256, DOI 10.1016/j.humpath.2007.01.020; Mueller NT, 2016, SCI REP-UK, V6, DOI 10.1038/srep23133; Nobel YR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8486; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Robello C, 2000, GENE, V246, P331, DOI 10.1016/S0378-1119(00)00074-3; Ruiz VE, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00531-6; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Trochine A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002844; Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16; Virreira M, 2006, ACTA TROP, V100, P252, DOI 10.1016/j.actatropica.2006.11.005; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wilkinson SR, 2011, CURR TOP MED CHEM, V11, P2072; Zingales B, 2009, MEM I OSWALDO CRUZ, V104, P1051, DOI 10.1590/S0074-02762009000700021	33	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0212593	10.1371/journal.pone.0212593	http://dx.doi.org/10.1371/journal.pone.0212593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807605	Green Submitted, gold, Green Published			2022-12-27	WOS:000459712100020
J	Alcolea, PJ; Alonso, A; Esteban, A; Peris, P; Cortes, A; Castillo, JA; Larraga, V				Alcolea, Pedro J.; Alonso, Ana; Esteban, Adriana; Peris, Paz; Cortes, Alberto; Castillo, Juan A.; Larraga, Vicente			IL12 p35 and p40 subunit genes administered as pPAL plasmid constructs do not improve protection of pPAL-LACK vaccine against canine leishmaniasis	PLOS ONE			English	Article							IMMUNE-RESPONSE; VISCERAL LEISHMANIASIS; INFANTUM; FOCUS; DOGS; DNA; IMMUNIZATION; COINFECTION; IMMUNOLOGY; PARASITE	Leishmania infantum causes zoonotic visceral leishmaniasis (ZVL) in the Mediterranean basin and South America. The parasite has been shown to co-infect HIV patients and an outbreak in central Spain was reported in the last decade. Therfore, ZVL is a public health problem, dogs being the parasite's reservoir. We have developed a DNA vaccine based on the L. infantum activated protein kinase A receptor (LACK) using different plasmid vectors and vaccinia virus strains as vehicles. Recently, we have generated an antibiotic resistance marker-free plasmid vector called pPAL. Homologous pPAL-LACK prime-boost vaccination protects Beagle dogs as well as a heterologous plasmid-virus regime. For both reasons, pPAL improves safety. IL12 was described to trigger Th1 response through IFN-. production in infected dogs, being a good candidate for cytokine therapy in conventional treatmentunresponsive dogs. Herein, we report a complete protection study in dogs through inoculation of genes encoding for the p35 and p40 subunits which compose canine IL12 in combination with the LACK gene. A homologous plasmid-plasmid regime using independent pPAL constructs for each gene was inoculated in a 15-day interval. The infectious challenge using L. infantum promastigotes was successful. The outcome was pPAL-LACK vaccine protection suppression by IL12 administration. The important implications of this finding are discussed in the manuscript.	[Alcolea, Pedro J.; Alonso, Ana; Larraga, Vicente] CSIC, Ctr Invest Biol, Dept Cellular & Mol Biol, Lab Mol Parasitol, Madrid, Spain; [Esteban, Adriana; Peris, Paz; Cortes, Alberto; Castillo, Juan A.] Univ Zaragoza, Fac Vet, Dept Pathol, Lab Parasitol, Zaragoza, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Zaragoza	Alcolea, PJ (corresponding author), CSIC, Ctr Invest Biol, Dept Cellular & Mol Biol, Lab Mol Parasitol, Madrid, Spain.	pjalcolea@cib.csic.es	Peris, María Paz/AFB-2914-2022; Alcolea Alcolea, Pedro José/O-5654-2016	Alcolea Alcolea, Pedro José/0000-0002-0729-8941; Larraga, Vicente/0000-0003-1260-7400; Peris, Maria Paz/0000-0001-5750-3643; Alonso Ayala, Ana Maria/0000-0002-1228-7331	CZ Veterinaria - Biofabri	CZ Veterinaria - Biofabri	This study was performed with funds received by VL through a contract with CZ Veterinaria - Biofabri (http://www.czveterinaria.com/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge Ricardo Molina and Maribel Jimenez (Centro Nacional de Microbiologia, Virologia e Inmunologia Sanitarias, Instituto de Salud Carlos III) for genotyping and zymodeme determination of the Leishmania infantum isolate used in this study, and Esteban Rodriguez, Eugenia Puentes, and Elena Sotelo (CZ Veterinaria-Biofabri) for their support. This work was funded by a contract with CZ Veterinaria-Biofabri.	ABRANCHES P, 1991, J PARASITOL, V77, P557, DOI 10.2307/3283159; Alcolea PJ, 2016, DOI 10.1016/j.vaccine.2007.11.021, Patent No. [WO2016188973A1 PCT/EP2016/061621;EPO 16725105, 2016188973]; Alcolea PJ, 2018, PLASMID; Alvar J, 1997, CLIN MICROBIOL REV, V10, P298, DOI 10.1128/CMR.10.2.298; Arce A, 2013, EUROSURVEILLANCE, V18, P5, DOI 10.2807/1560-7917.ES2013.18.30.20546; BARRETT TV, 1980, T ROY SOC TROP MED H, V74, P84, DOI 10.1016/0035-9203(80)90016-4; CARVALHO EM, 1995, AM J TROP MED HYG, V53, P273, DOI 10.4269/ajtmh.1995.53.273; Gomes DCD, 2007, VACCINE, V25, P2168, DOI 10.1016/j.vaccine.2006.11.060; Desjeux P, 1996, CLIN DERMATOL, V14, P417, DOI 10.1016/0738-081X(96)00057-0; Desjeux P, 1995, Afr Health, V18, P20; Desjeux P, 2001, Med Trop (Mars), V61, P187; Ferrer L, 1989, Enferm Infecc Microbiol Clin, V7, P293; Francino O, 2006, VET PARASITOL, V137, P214, DOI 10.1016/j.vetpar.2006.01.011; Gonzalez-Aseguinolaza G, 1999, EUR J BIOCHEM, V259, P909, DOI 10.1046/j.1432-1327.1999.00122.x; Gonzalo RM, 2001, MICROBES INFECT, V3, P701, DOI 10.1016/S1286-4579(01)01426-5; GRAMICCIA M, 1982, ANN PARASIT HUM COMP, V57, P527, DOI 10.1051/parasite/1982576527; Gurunathan S, 1998, NAT MED, V4, P1409, DOI 10.1038/4000; Gurunathan S, 1997, J EXP MED, V186, P1137, DOI 10.1084/jem.186.7.1137; HANAHAN D, 1983, METHOD ENZYMOL, V100, P333; Hosein S, 2017, PARASITOLOGY, V144, P95, DOI 10.1017/S003118201600055X; Jimenez M, 1997, AIDS, V11, P569, DOI 10.1097/00002030-199705000-00003; Jimenez M, 2014, VET PARASITOL, V202, P296, DOI 10.1016/j.vetpar.2014.03.027; Jimenez M, 2013, PARASITOL RES, V112, P2453, DOI 10.1007/s00436-013-3406-3; Martin-Martin I, 2014, VET PARASITOL, V202, P207, DOI 10.1016/j.vetpar.2014.02.045; Mauricio IL, 2000, PARASITOL TODAY, V16, P188, DOI 10.1016/S0169-4758(00)01637-9; Mauricio IL, 2004, PARASITOLOGY, V128, P263, DOI 10.1017/S0031182003004578; Molina R, 2012, VET PARASITOL, V190, P268, DOI 10.1016/j.vetpar.2012.05.006; Momo Claudia, 2014, Vet Med Int, V2014, P150582, DOI 10.1155/2014/150582; MOODY SF, 1993, ACTA TROP, V53, P185, DOI 10.1016/0001-706X(93)90029-B; Gonzales EP, 2017, PENSAM MARGEN, P1; Poot J, 2006, VACCINE, V24, P2460, DOI 10.1016/j.vaccine.2005.12.039; Ramiro MJ, 2003, VACCINE, V21, P2474, DOI 10.1016/S0264-410X(03)00032-X; Ramos I, 2008, VACCINE, V26, P333, DOI 10.1016/j.vaccine.2007.11.021; Ramos I, 2009, VACCINE, V27, P6695, DOI 10.1016/j.vaccine.2009.08.091; Ribeiro-de-Jesus A, 1998, BRAZ J MED BIOL RES, V31, P143, DOI 10.1590/S0100-879X1998000100020; Roberts MTM, 2005, BRIT MED BULL, V75-76, P115, DOI 10.1093/bmb/ldl003; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; SEMIAOSANTOS SJ, 1995, PARASITOL RES, V81, P235; Strauss-Ayali D, 2005, INT J PARASITOL, V35, P63, DOI 10.1016/j.ijpara.2004.10.015; Tintaya KWQ, 2004, J INFECT DIS, V189, P1035, DOI 10.1086/382049; Tripathi P, 2007, FEMS IMMUNOL MED MIC, V51, P229, DOI 10.1111/j.1574-695X.2007.00311.x; WHO, 2010, WHO TECH REP SER, V949, P1; Wolday D, 2001, MED MICROBIOL IMMUN, V190, P65, DOI 10.1007/s004300100082	43	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212136	10.1371/journal.pone.0212136	http://dx.doi.org/10.1371/journal.pone.0212136			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794597	Green Published, gold, Green Submitted			2022-12-27	WOS:000459709100040
J	Cortellini, M; Casagrande, A; Fornaciari, G; Del Sette, D; Gargano, G; Di Mauro, MG; Saibene, G; Bruno, E; Villarini, A; Venturelli, E; Berrino, F; Baldassari, I; Oliverio, A; Pasanisi, P				Cortellini, Mauro; Casagrande, Alice; Fornaciari, Giuseppe; Del Sette, Daniela; Gargano, Giuliana; Di Mauro, Maria Gaetana; Saibene, Gabriella; Bruno, Eleonora; Villarini, Anna; Venturelli, Elisabetta; Berrino, Franco; Baldassari, Ivan; Oliverio, Andreina; Pasanisi, Patrizia			A management system for randomized clinical trials: A novel way to supply medication	PLOS ONE			English	Article							MEDITERRANEAN DIET; BREAST-CANCER; METFORMIN; PEOPLE	Background Randomized controlled clinical trials require management effort, involving huge organizational, economic and informatics investments. Information technology offers opportunities to approach clinical trial methodology in new ways. However, there are only a few reports of computerized data and drug management systems. Objective This paper describes a novel software created specifically for the management of a randomized trial of diet and metformin in people with metabolic syndrome (the Me. Me. Me. trial). Methods Me. Me. Me. is an ongoing phase III randomized controlled trial in healthy people with metabolic syndrome to test the hypothesis that comprehensive lifestyle changes and/or metformin can prevent age-related chronic non-communicable diseases. To manage all the phases of the trial, we created a software which is a state pattern machine, user friendly, web-based, able to maintain the correct balance between randomization groups, and structured in various levels of security in order to guarantee the participant's privacy and compliance with the study protocol. The software achieves budget savings: drug management is not based on patients' packs, but on the actual need for drugs according to each participant's "state", with strict guidelines for the handling and supply of medication. Results The trial is ongoing and recruitment will close on August 31, 2018. To date, 11737 bottles of metformin/placebo have been dispensed to 1054 randomized participants, with drug savings of 29.5%. Conclusions A software which takes into account the "state" of participant might be a powerful resource for developing and managing clinical trials, helping avoid poor treatment allocation, and wastage of drugs and money.	[Cortellini, Mauro; Casagrande, Alice; Fornaciari, Giuseppe; Del Sette, Daniela; Gargano, Giuliana; Di Mauro, Maria Gaetana; Bruno, Eleonora; Villarini, Anna; Venturelli, Elisabetta; Berrino, Franco; Baldassari, Ivan; Oliverio, Andreina; Pasanisi, Patrizia] Fdn IRCCS Natl Canc Inst Milan, Dept Prevent & Predict Med, Epidemiol Unit, Milan, Italy; [Cortellini, Mauro] Univ Pavia, Dept Nervous Syst & Behav Sci, Pavia, Italy; [Saibene, Gabriella] Fdn IRCCS Natl Canc Inst Milan, SC Pharm, Milan, Italy; [Bruno, Eleonora] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Pavia; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Milan	Pasanisi, P (corresponding author), Fdn IRCCS Natl Canc Inst Milan, Dept Prevent & Predict Med, Epidemiol Unit, Milan, Italy.	patrizia.pasanisi@istitutotumori.mi.it	Baldassari, Ivan/U-2197-2018; Gargano, Giuliana/Q-4497-2019; Oliverio, Andreina/K-1115-2018; Berrino, Franco/AAC-2364-2020; De Santis, Francesca/Q-3453-2019; Di Mauro, Maria Gaetana/AAB-1869-2021; Pasanisi, Patrizia/F-4908-2017; bruno, eleonora/D-4093-2017; Villarini, Anna/K-2838-2017	Baldassari, Ivan/0000-0002-8537-9691; Gargano, Giuliana/0000-0002-0813-3022; Oliverio, Andreina/0000-0002-8624-9186; Berrino, Franco/0000-0002-4858-1866; De Santis, Francesca/0000-0001-5877-0639; Di Mauro, Maria Gaetana/0000-0002-2200-9060; Pasanisi, Patrizia/0000-0001-6278-3491; bruno, eleonora/0000-0002-9605-9482; Villarini, Anna/0000-0002-5789-6587	European Research Council (ERC) under the European Union [322752]	European Research Council (ERC) under the European Union(European Research Council (ERC))	The Me. Me. Me. study has received funding from the European Research Council (ERC) under the European Union's Seventh Framework programme (FP7/2007-2013) (ERC-AdG-2012 n. 322752). Dr. Franco Berrino is the responsible of the funding and project. https://erc.europa.eu/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2001, BRIT MED J, V323, P446, DOI 10.1136/bmj.323.7310.446; Bromage DI, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0273-5; Campagnoli C, 2012, CLIN BREAST CANCER, V12, P175, DOI 10.1016/j.clbc.2012.03.004; Fegan W, 2008, PLOS MED, V5, P347, DOI 10.1371/journal.pmed.0050006; ITEEN SA, 1992, AM J HOSP PHARM, V49, P2746, DOI 10.1093/ajhp/49.11.2746; Lamanna C, 2011, DIABETES OBES METAB, V13, P221, DOI 10.1111/j.1463-1326.2010.01349.x; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; Macleod MR, 2014, LANCET, V383, P101, DOI 10.1016/S0140-6736(13)62329-6; Muti P, 2009, CELL CYCLE, V8, P2661, DOI 10.4161/cc.8.16.9226; Pasanisi P, 2018, TUMORI J, V104, P137, DOI 10.5301/tj.5000599; Pierotti MA, 2013, ONCOGENE, V32, P1475, DOI 10.1038/onc.2012.181; Rogers A, 2016, CLIN TRIALS, V13, P665, DOI 10.1177/1740774516657048; Schroder H, 2007, J NUTR BIOCHEM, V18, P149, DOI 10.1016/j.jnutbio.2006.05.006; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V274, P1456; Sweet BV, 2008, AM J HEALTH-SYST PH, V65, P969, DOI 10.2146/ajhp070212; Welker JA, 2007, CONTEMP CLIN TRIALS, V28, P329, DOI 10.1016/j.cct.2007.01.001; World Medical Association, 1964, DECL HELS ETH PRINC	17	2	2	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212475	10.1371/journal.pone.0212475	http://dx.doi.org/10.1371/journal.pone.0212475			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794607	Green Published, gold, Green Submitted			2022-12-27	WOS:000459709100074
J	Duchateau, L; Martin-Aguilar, L; Lleixa, C; Cortese, A; Dols-Icardo, O; Cervera-Carles, L; Pascual-Goni, E; Diaz-Manera, J; Calegari, I; Franciotta, D; Rojas-Garcia, R; Illa, I; Clarimon, J; Querol, L				Duchateau, Lena; Martin-Aguilar, Lorena; Lleixa, Cinta; Cortese, Andrea; Dols-Icardo, Oriol; Cervera-Carles, Laura; Pascual-Goni, Elba; Diaz-Manera, Jordi; Calegari, Ilaria; Franciotta, Diego; Rojas-Garcia, Ricard; Illa, Isabel; Clarimon, Jordi; Querol, Luis			Absence of pathogenic mutations in CD59 in chronic inflammatory demyelinating polyradiculoneuropathy	PLOS ONE			English	Article							GUILLAIN-BARRE-SYNDROME; COMPLEMENT; POLYNEUROPATHY; ANTIBODIES	Objective Mutations in CD59 cause CIDP-like polyneuropathy in children with inherited chronic hemolysis. We hypothesized that mutations in CD59 might be found in a subset of sporadic CIDP patients. Methods 35 patients from two centers, fulfilling the EFNS/PNS diagnostic criteria for CIDP were included. CD59 coding region was amplified by PCR and Sanger sequenced. Results One rare variant was detected in a patient which resulted in a synonymous change and predicted to be neutral. Pathogenic variants were absent in our cohort. Interpretation Our pilot study suggests that mutations in CD59 are absent in adult-onset sporadic CIDP.	[Duchateau, Lena; Dols-Icardo, Oriol; Cervera-Carles, Laura; Clarimon, Jordi] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Memory Unit, Barcelona, Spain; [Martin-Aguilar, Lorena; Lleixa, Cinta; Pascual-Goni, Elba; Diaz-Manera, Jordi; Rojas-Garcia, Ricard; Illa, Isabel; Querol, Luis] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Neuromuscular Dis Unit, Barcelona, Spain; [Cortese, Andrea; Calegari, Ilaria; Franciotta, Diego] IRCCS Mondino Fdn, Pavia, Italy; [Dols-Icardo, Oriol; Cervera-Carles, Laura; Clarimon, Jordi] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Diaz-Manera, Jordi; Rojas-Garcia, Ricard; Illa, Isabel; Querol, Luis] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain	Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; IRCCS Fondazione Casimiro Mondino; CIBERNED; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Querol, L (corresponding author), Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Neuromuscular Dis Unit, Barcelona, Spain.; Querol, L (corresponding author), Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain.	lquerol@santpau.cat	ILLA, Isabel/AAD-1816-2019; Franciotta, Diego/K-8262-2016; Cervera-Carles, Laura/AAN-4530-2020; Dols-Icardo, Oriol/AAC-1181-2020; Martín-Aguilar, Lorena/ABC-4295-2020; Franciotta, Diego/ABE-0957-2022	Franciotta, Diego/0000-0002-3014-3913; Cervera-Carles, Laura/0000-0003-2286-200X; Dols-Icardo, Oriol/0000-0003-2656-8748; Martín-Aguilar, Lorena/0000-0002-1553-2224; Franciotta, Diego/0000-0002-3014-3913; Duchateau, Lena/0000-0002-1689-7014	Fondo de Investigaciones Sanitarias (FIS), Instituto de Salud Carlos III, Spain; FEDER [FIS16/00627]; Pla Estrategic de Recerca i Innovacioen Salut (PERIS) 2016-2020 of the Departament de Salut of the Generalitat de Catalunya [SLT006/17/00131]	Fondo de Investigaciones Sanitarias (FIS), Instituto de Salud Carlos III, Spain; FEDER(European Commission); Pla Estrategic de Recerca i Innovacioen Salut (PERIS) 2016-2020 of the Departament de Salut of the Generalitat de Catalunya	This project was supported by Fondo de Investigaciones Sanitarias (FIS), Instituto de Salud Carlos III, Spain and FEDER under grant FIS16/00627, and a personal grant to LQ SLT006/17/00131 of the Pla Estrategic de Recerca i Innovacioen Salut (PERIS) 2016-2020 of the Departament de Salut of the Generalitat de Catalunya, pricipal investigator LQ.	Ardicli D, 2017, NEUROPEDIATRICS, V48, P477, DOI 10.1055/s-0037-1604483; Blum S, 2014, J PERIPHER NERV SYST, V19, P88, DOI 10.1111/jns5.12074; Brodsky RA, 2008, BLOOD, V111, P1840, DOI 10.1182/blood-2007-06-094136; DALAKAS MC, 1980, ARCH NEUROL-CHICAGO, V37, P637, DOI 10.1001/archneur.1980.00500590061010; Eftimov F, 2018, NEUROMUSCULAR DISORD, V28, P178, DOI 10.1016/j.nmd.2017.10.009; Haliloglu G, 2015, NEUROLOGY, V84, P1220, DOI 10.1212/WNL.0000000000001391; Koike H, 2017, J NEUROL NEUROSUR PS, V88, P465, DOI 10.1136/jnnp-2016-314895; KOSKI CL, 1987, J CLIN INVEST, V80, P1492, DOI 10.1172/JCI113231; Martinez-Martinez L, 2017, J NEUROINFLAMM, V14, P1, DOI [10.1186/s12974-016-0779-0, DOI 10.1186/S12974-016-0779-0]; Mathey EK, 2015, J NEUROL NEUROSUR PS, V86, P973, DOI 10.1136/jnnp-2014-309697; Mead RJ, 2004, LAB INVEST, V84, P21, DOI 10.1038/labinvest.3700015; Mevorach D, 2016, ANN NEUROL, V80, P708, DOI 10.1002/ana.24770; Miyaji K, 2014, J NEUROIMMUNOL, V276, P172, DOI 10.1016/j.jneuroim.2014.08.004; Nevo Y, 2013, BLOOD, V121, P129, DOI 10.1182/blood-2012-07-441857; Parker C, 2018, REV TRANSLATIONAL HE, V106, P3699, DOI [10.1182/blood-2005-04-1717.Supported, DOI 10.1182/BLOOD-2005-04-1717]; Querol L, 2017, NAT REV NEUROL, V13, P533, DOI 10.1038/nrneurol.2017.84; Querol L, 2014, NEUROLOGY, V82, P879, DOI 10.1212/WNL.0000000000000205; Querol L, 2013, ANN NEUROL, V73, P370, DOI 10.1002/ana.23794; Vallat JM, 2017, NEUROMUSCULAR DISORD, V27, P290, DOI 10.1016/j.nmd.2016.10.008; Van den Bergh PYK, 2010, EUR J NEUROL, V17, P356, DOI 10.1111/j.1468-1331.2009.02930.x	20	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212647	10.1371/journal.pone.0212647	http://dx.doi.org/10.1371/journal.pone.0212647			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794663	Green Published, gold, Green Submitted			2022-12-27	WOS:000459709100104
J	Kim, HS; Cho, SK; Kim, CS; Park, JS				Kim, Hyung Sun; Cho, Seong Kyung; Kim, Chang Soo; Park, Joon Seong			Big data and analysis of risk factors for gallbladder disease in the young generation of Korea	PLOS ONE			English	Article							GALLSTONE DISEASE; DIETARY PATTERNS; POPULATION; PREVALENCE; SMOKING; OBESITY	Background/Purpose Few studies have examined the risk factors for gallbladder (GB) disease in young adults. This study aimed to evaluate risk factors for GB disease in young adults based on big data in Korea. Methods All participants underwent routine checkup at the Korea Medical Institute from June 2014 to May 2015. After excluding 677 individuals with missing information in records, 724,114 individuals (435,635 men, 288,479 women) were finally included. The definition of abnormal GB finding included stones, sludge, polyps, and adenomyomatosis detected using ultrasonography. All statistical analyses were performed using SAS software version 9.2. Results Overall, 27,130 (17.5%) individuals were diagnosed as having abnormal GB finding in the young age group (N = 154,463, aged 20-39 years). In men, significant differences in low-density lipoprotein (LDL) and cholesterol levels were observed between the abnormal GB finding group and normal GB group (p < 0.05). In women, a significant difference in smoking history was noted between the abnormal GB finding group and normal GB group (p < 0.05). The prevalence rate of GB stones was 1.9% (27,979/154,463) in the young age group. High body mass index (BMI), large thigh circumference, and low high-density lipoprotein (HDL) level in women and low HDL level in men were independent risk factors for the presence of GB stones (p < 0.05). Conclusion In this study, obesity-related factors (BMI, waist size, thigh circumference, and cholesterol, LDL, and HDL levels) correlated with GB disease in the young generation of Korea.	[Kim, Hyung Sun; Park, Joon Seong] Yonsei Univ, Dept Surg, Gangnam Severance Hosp, Pancreatobiliary Canc Clin, Seoul, South Korea; [Cho, Seong Kyung; Kim, Chang Soo] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Park, JS (corresponding author), Yonsei Univ, Dept Surg, Gangnam Severance Hosp, Pancreatobiliary Canc Clin, Seoul, South Korea.	JSPARK330@yuhs.ac		Kim, Hyung Sun/0000-0002-9002-3569; a, gokul/0000-0003-2226-4691; Kim, Changsoo/0000-0002-5940-5649; Park, Joon Seong/0000-0001-8048-9990	Korea Medical Institute (KMI)	Korea Medical Institute (KMI)	This thesis was financially supported by Korea Medical Institute (KMI).	Aune D, 2016, EUR J EPIDEMIOL, V31, P643, DOI 10.1007/s10654-016-0124-z; Aune D, 2015, EUR J EPIDEMIOL, V30, P1009, DOI 10.1007/s10654-015-0081-y; Bae Nam-Kyou, 2009, [Journal of Korea Academia-Industrial cooperation Society, 한국산학기술학회논문지], V10, P1091; Banim PJR, 2011, EUR J GASTROEN HEPAT, V23, P733, DOI 10.1097/MEG.0b013e3283477cc9; Cai JS, 2017, SCAND J GASTROENTERO, V52, P34, DOI 10.1080/00365521.2016.1224382; Chen CH, 2006, J GASTROEN HEPATOL, V21, P1737, DOI 10.1111/j.1440-1746.2006.04381.x; Chen YS, 2015, LAB INVEST, V95, P124, DOI 10.1038/labinvest.2014.140; Chilimuri Sridhar, 2017, J Clin Med Res, V9, P117, DOI 10.14740/jocmr2847w; Constantinescu T, 2012, CHIRURGIA-BUCHAREST, V107, P579; CRAIG WY, 1989, BMJ-BRIT MED J, V298, P784, DOI 10.1136/bmj.298.6676.784; Degirmenci B, 2006, WORLD J GASTROENTERO, V12, P5540, DOI 10.3748/wjg.v12.i34.5540; Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), 2002, 3 REP EXP PAN DET EV; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; James PT, 2004, CLIN DERMATOL, V22, P276, DOI 10.1016/j.clindermatol.2004.01.010; Kim CS, 2014, DIABETES METAB J, V38, P35, DOI 10.4093/dmj.2014.38.1.35; Kim Mi-Ok, 2009, Preventive Nutrition and Food Science, V14, P303; Lammert F, 2016, J HEPATOL, V65, P146, DOI 10.1016/j.jhep.2016.03.005; Lammert F, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.24; Larsson SC, 2017, EUR J CANCER, V70, P42, DOI 10.1016/j.ejca.2016.10.012; Leitzmann MF, 1999, NEW ENGL J MED, V341, P777, DOI 10.1056/NEJM199909093411101; Martinez-Gonzalez MA, 2013, REV ENDOCR METAB DIS, V14, P265, DOI 10.1007/s11154-013-9264-6; McConnell TJ, 2017, EUR J CLIN NUTR, V71, P731, DOI 10.1038/ejcn.2016.252; Molina-Molina Emilio, 2018, Eur J Clin Invest, V48, pe12958, DOI 10.1111/eci.12958; NOMURA H, 1988, AM J EPIDEMIOL, V128, P598, DOI 10.1093/oxfordjournals.aje.a115007; Ogden CL, 2016, JAMA-J AM MED ASSOC, V315, P2292, DOI 10.1001/jama.2016.6361; Park Y, 2017, J HEALTH POPUL NUTR, V36, DOI 10.1186/s41043-017-0116-y; Poobalan AS, 2014, HEALTH PSYCHOL BEHAV, V2, P909, DOI 10.1080/21642850.2014.931232; Portincasa P, 2006, LANCET, V368, P230, DOI 10.1016/S0140-6736(06)69044-2; Portincasa P, 2004, WORLD J GASTROENTERO, V10, P2383; Ramachandran A, 2010, J OBES, V2010, DOI 10.1155/2010/868573; Service NHI, 2015, KON HLTH IND STAT SY; Shaffer Eldon A, 2005, Curr Gastroenterol Rep, V7, P132; Sun H, 2009, WORLD J GASTROENTERO, V15, P1886, DOI 10.3748/wjg.15.1886; Tsai CJ, 2008, ANN SURG, V247, P95, DOI 10.1097/SLA.0b013e31815792c2; Unisa S, 2011, HPB, V13, P117, DOI 10.1111/j.1477-2574.2010.00255.x; Van Erpecum KJ, 2011, CLIN RES HEPATOL GAS, V35, P281, DOI 10.1016/j.clinre.2011.01.009; Weerakoon HTW, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-88; Yun-Jin Chung MD, 2007, KOREAN J MED, V72	38	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0211480	10.1371/journal.pone.0211480	http://dx.doi.org/10.1371/journal.pone.0211480			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794560	gold, Green Published, Green Submitted			2022-12-27	WOS:000459709100018
J	Rajamanikam, A; Hooi, HS; Kudva, M; Samudi, C; Kumar, S				Rajamanikam, Arutchelvan; Hooi, Ho Shiaw; Kudva, Madhav; Samudi, Chandramathi; Kumar, Suresh			A Resistance towards metronidazole in Blastocystis sp.: A pathogenic consequence	PLOS ONE			English	Article							COLORECTAL-CANCER CELLS; CYSTEINE PROTEASES; SUBTYPE 3; HOMINIS; ENTAMOEBA; DIFFERENTIATION; ERADICATION; EXPRESSION; GENOME; FORMS	Blastocsytis sp. is a protozoan parasite that has been linked to common gastrointestinal illnesses. Metronidazole, the first line therapy, was reported to show frequent inefficacy. Previously, Blastocystis sp. isolated from different population showed varying metronidazole resistance. However, the effect of metronidazole treatment on pathogenic potentials of Blastocystis sp. isolated from different populations, which is known to have different gut environment, is unclear. This study investigates the in vitro effect of metronidazole on the pathogenic potentials of Blastocystis sp. isolated from urban and orang asli individuals. Blastocystis sp. ST 3 isolated from symptomatic and asymptomatic individuals were treated with a range of metronidazole concentration. The parasites' growth characteristics, apoptotic rate, specific protease activity and the ability to proliferate cancer cells were analyzed upon treatment with 0.001 mg/l metronidazole. The study demonstrates that Blastocystis sp. isolates showed increase in the parasite numbers especially the amoebic forms (only in urban isolates) after treating with metronidazole at the concentration of 0.001 mg/ml. High number of cells in post-treated isolates coincided with increase of apoptosis. There was a significant increase in cysteine protease of Blastocystis sp. isolates upon treatment despite the initial predominance of serine protease in asymptomatic isolates. Metronidazole resistant Blastocystis sp. also showed significant increase in cancer cell proliferation. Resistance to metronidazole did not show significant different influence on the pathogenicity between Blastocystis sp. isolated from urban and orang asli individual. However, an increase in parasite numbers, higher amoebic forms, cysteine protease and ability to proliferate cancer cells implicates a pathogenic role. The study provides evidence for the first time, the effect of metronidazole towards enhancing pathogenic potentials in Blastocystis sp. when isolated from different gut environment. This necessitates the need for reassessment of metronidazole treatment modalities.	[Rajamanikam, Arutchelvan; Kumar, Suresh] Univ Malaya, Fac Med, Depatment Parasitol, Kuala Lumpur, Malaysia; [Hooi, Ho Shiaw] Univ Malaya, Dept Med, Fac Med, Kuala Lumpur, Malaysia; [Kudva, Madhav] Pantai Hosp, Gastroenterol & Hepatol Specialist Clin, Kuala Lumpur, Malaysia; [Samudi, Chandramathi] Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Kumar, S (corresponding author), Univ Malaya, Fac Med, Depatment Parasitol, Kuala Lumpur, Malaysia.	suresh@um.edu.my	samudi@raju, Chandramathi/AAR-1595-2021; Ho, Shiaw-Hooi/B-1606-2017	Ho, Shiaw-Hooi/0000-0003-4992-7627; Rajamanikam, Arutchelvan/0000-0002-3280-1617	Ministry of Higher Education of Malaysia under Fundamental Research Grant Scheme (FRGS) [FP015-2017A]	Ministry of Higher Education of Malaysia under Fundamental Research Grant Scheme (FRGS)	This study was entirely supported by Ministry of Higher Education of Malaysia under Fundamental Research Grant Scheme (FRGS) (FP015-2017A), received by SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andiran N, 2006, J PEDIATR SURG, V41, P1489, DOI 10.1016/j.jpedsurg.2006.04.037; Chan KH, 2012, PARASITOL RES, V110, P2475, DOI 10.1007/s00436-011-2788-3; Chandramathi S, 2010, PARASITOL RES, V106, P941, DOI 10.1007/s00436-010-1764-7; Coyle CM, 2012, CLIN INFECT DIS, V54, P105, DOI 10.1093/cid/cir810; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Denoeud F, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r29; Dhurga DB, 2012, T ROY SOC TROP MED H, V106, P725, DOI 10.1016/j.trstmh.2012.08.005; Dudley R, 2008, FEMS MICROBIOL LETT, V286, P9, DOI 10.1111/j.1574-6968.2008.01249.x; El Deeb HK, 2012, PARASITOL RES, V110, P2167, DOI 10.1007/s00436-011-2743-3; Girish S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0942-y; Graczyk TK, 2005, PARASITOL RES, V98, P38, DOI 10.1007/s00436-005-0003-0; Haresh K, 1999, TROP MED INT HEALTH, V4, P274, DOI 10.1046/j.1365-3156.1999.00398.x; Katsarou-Katsari A, 2008, ACTA DERM-VENEREOL, V88, P80, DOI 10.2340/00015555-0338; Khademvatan S, 2017, PARASITOL INT, V66, P142, DOI 10.1016/j.parint.2017.01.005; Khan NA, 2000, J CLIN MICROBIOL, V38, P2858, DOI 10.1128/JCM.38.8.2858-2861.2000; Kumarasamy V, 2013, PARASITOL RES, V112, P3551, DOI 10.1007/s00436-013-3538-5; Kurt O, 2016, PARASITOL INT, V65, P797, DOI 10.1016/j.parint.2016.01.010; Leelayoova S, 2002, ANN TROP MED PARASIT, V96, P803, DOI 10.1179/000349802125002275; Makioka A, 2009, PARASITOL RES, V105, P977, DOI 10.1007/s00436-009-1478-x; MCKERROW JH, 1993, ANNU REV MICROBIOL, V47, P821, DOI 10.1146/annurev.mi.47.100193.004133; Mirza H, 2012, CELL MICROBIOL, V14, P1474, DOI 10.1111/j.1462-5822.2012.01814.x; Moschen AR, 2012, GUT LIVER, V6, P411, DOI 10.5009/gnl.2012.6.4.411; Nigro L, 2003, J TRAVEL MED, V10, P128, DOI 10.2310/7060.2003.31714; Pal D, 2009, ANTIMICROB AGENTS CH, V53, P458, DOI 10.1128/AAC.00909-08; Pasqui A L, 2004, Eur Rev Med Pharmacol Sci, V8, P117; Puthia MK, 2008, EUKARYOT CELL, V7, P435, DOI 10.1128/EC.00371-07; Puthia MK, 2005, PARASITOL RES, V97, P386, DOI 10.1007/s00436-005-1461-0; Ragavan ND, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-404; Rajamanikam A, 2018, PARASITOL RES, V117, P2585, DOI 10.1007/s00436-018-5948-x; Rajamanikam A, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-295; Raman K, 2016, PARASITOL RES, V115, P391, DOI 10.1007/s00436-015-4760-0; Roberts T, 2014, GUT PATHOG, V6, DOI 10.1186/1757-4749-6-17; Roberts T, 2014, J MED MICROBIOL, V63, P252, DOI 10.1099/jmm.0.065508-0; Scanlan PD, 2014, FEMS MICROBIOL ECOL, V90, P326, DOI 10.1111/1574-6941.12396; Scanlan PD, 2012, TRENDS PARASITOL, V28, P327, DOI 10.1016/j.pt.2012.05.001; Segata N, 2015, CURR BIOL, V25, pR611, DOI 10.1016/j.cub.2015.05.040; Sekar Uma, 2013, Trop Parasitol, V3, P35, DOI 10.4103/2229-5070.113901; Shah Mitanshu, 2012, Case Rep Gastroenterol, V6, P358, DOI 10.1159/000339205; Sio SWS, 2006, PARASITOL RES, V99, P126, DOI 10.1007/s00436-006-0131-1; Stensvold CR, 2008, ANN TROP MED PARASIT, V102, P271, DOI 10.1179/136485908X278847; Stensvold CR, 2010, J CLIN GASTROENTEROL, V44, P85, DOI 10.1097/MCG.0b013e3181bb86ba; Stensvold CR, 2011, AM J TROP MED HYG, V84, P883, DOI 10.4269/ajtmh.2011.11-0005; Tan TC, 2008, PARASITOL RES, V104, P85, DOI 10.1007/s00436-008-1163-5; Tan TC, 2006, PARASITOL RES, V99, P737, DOI 10.1007/s00436-006-0214-z; Tan TC, 2006, PARASITOL RES, V98, P189, DOI 10.1007/s00436-005-0033-7; Tillack M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-170; Tyakht AV, 2014, GUT MICROBES, V5, P351, DOI 10.4161/gmic.28685; Vassalos CM, 2010, AM J CLIN PATHOL, V133, P251, DOI 10.1309/AJCPDOWQSL6E8DMN; Vogelberg C, 2010, PARASITOL INT, V59, P469, DOI 10.1016/j.parint.2010.03.009; Wawrzyniak I, 2012, PARASITOL INT, V61, P437, DOI 10.1016/j.parint.2012.02.007; Weber C, 2006, EUKARYOT CELL, V5, P871, DOI 10.1128/EC.5.5.871-875.2006; Wu ZN, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002885; ZIERDT CH, 1976, Z PARASITENKD, V50, P277, DOI 10.1007/BF02462972	53	14	16	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212542	10.1371/journal.pone.0212542	http://dx.doi.org/10.1371/journal.pone.0212542			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794628	gold, Green Published			2022-12-27	WOS:000459709100084
J	Rauf, R; von Matthey, F; Croenlein, M; Zyskowski, M; van Griensven, M; Biberthaler, P; Lefering, R; Huber-Wagner, S; Matthes, G; Trentzsch, H; Bieler, D; Flohe, S; Paffrath, T; Wolfl, C				Rauf, Rauend; von Matthey, Francesca; Croenlein, Moritz; Zyskowski, Michael; van Griensven, Martijn; Biberthaler, Peter; Lefering, Rolf; Huber-Wagner, Stefan; Matthes, Gerritt; Trentzsch, Heiko; Bieler, Dan; Flohe, Sascha; Paffrath, Thomas; Wolfl, Christoph		Section NIS DGU	Changes in the temporal distribution of in-hospital mortality in severely injured patients-An analysis of the TraumaRegister DGU	PLOS ONE			English	Article							MULTIPLE-ORGAN FAILURE; TRAUMA DEATHS; TRIMODAL DISTRIBUTION; RISK-FACTORS; EPIDEMIOLOGY; TIME; POPULATION; FATALITIES; PATTERNS; SCORE	Background The temporal distribution of trauma mortality has been classically described as a trimodal pattern with an immediate, early and late peak. In modern health care systems this time distribution has changed. Methods Data from the TraumaRegister DGU was analysed retrospectively. Between 2002 and 2015, all registered in-hospital deaths with an Injury Severity Score (ISS). 16 were evaluated considering time of death, trauma mechanism, injured body area, age distribution, rates of sepsis and multiple organ failure. Pre-hospital and post-discharge trauma deaths were not considered. Results 78 310 severely injured patients were registered, non-survivors constituted 14 816, representing an in-hospital mortality rate of 18.9%. Mean ISS of non-survivors was 36.0 +/- 16.0, 66.7% were male, mean age was 59.5 +/- 23.5. Within the first hour after admission to hospital, 10.8% of deaths occurred, after 6 hours the percentage increased to 25.5%, after 12 hours 40.0%, after 24 hours 53.2% and within the first 48 hours 61.9%. Mortality showed a constant temporal decrease. Severe head injury (defined by Abbreviated Injury Scale, AISHead. 3) was found in 76.4% of non-survivors. Patients with an isolated head injury showed a more distinct decrease in survival rate, which was accentuated in the first days after admission. The correlation of age and time of death showed a proportional increase with age (55-74a). The rate of sepsis and multiple organ failure among non-survivors was 11.5% and 70.1%, respectively. Conclusion In a modern trauma care system, the mortality distribution of severely injured patients has changed its pattern, where especially the third peak is no longer detectable.	[Rauf, Rauend; von Matthey, Francesca; Croenlein, Moritz; Zyskowski, Michael; van Griensven, Martijn; Biberthaler, Peter; Huber-Wagner, Stefan] Tech Univ Munich, Hosp Rechts Isar, Dept Trauma Surg, Munich, Germany; [Lefering, Rolf] Univ Witten Herdecke, Inst Res Operat Med IFOM, Cologne, Germany	Technical University of Munich; Witten Herdecke University	Rauf, R (corresponding author), Tech Univ Munich, Hosp Rechts Isar, Dept Trauma Surg, Munich, Germany.	Rauend.Rauf@artemed.de	van Griensven, Martijn/F-5808-2012; Trentzsch, Heiko/ABF-3979-2020; Trentzsch, Heiko/I-7679-2014	van Griensven, Martijn/0000-0001-5104-9881; Trentzsch, Heiko/0000-0002-6395-6873; Trentzsch, Heiko/0000-0002-6395-6873				BAKER CC, 1980, AM J SURG, V140, P144, DOI 10.1016/0002-9610(80)90431-6; DALY KE, 1992, INJURY, V23, P393, DOI 10.1016/0020-1383(92)90015-K; de Knegt C, 2008, INJURY, V39, P993, DOI 10.1016/j.injury.2008.03.033; Debus F, 2015, DTSCH ARZTEBL INT, V112, P823, DOI 10.3238/arztebl.2015.0823; Demetriades D, 2005, J AM COLL SURGEONS, V201, P343, DOI 10.1016/j.jamcollsurg.2005.05.003; Demetriades D, 2004, J AM COLL SURGEONS, V198, P20, DOI 10.1016/j.jamcollsurg.2003.09.003; *DGU, 2016, NON TRADITIONAL REF; Earl-Royal E, 2016, J SURG RES, V205, P368, DOI 10.1016/j.jss.2016.06.082; ESPOSITO TJ, 1995, J TRAUMA, V39, P955, DOI 10.1097/00005373-199511000-00022; Evans JA, 2010, WORLD J SURG, V34, P158, DOI 10.1007/s00268-009-0266-1; FAIST E, 1983, J TRAUMA, V23, P775, DOI 10.1097/00005373-198309000-00002; Frohlich M, 2014, J TRAUMA ACUTE CARE, V76, P921, DOI 10.1097/TA.0000000000000199; Gunst Mark, 2010, Proc (Bayl Univ Med Cent), V23, P349; Harmsen AMK, 2015, INJURY, V46, P602, DOI 10.1016/j.injury.2015.01.008; Kleber C, 2012, WORLD J SURG, V36, P2125, DOI 10.1007/s00268-012-1650-9; Kuhne CA, 2005, WORLD J SURG, V29, P1476, DOI 10.1007/s00268-005-7796-y; Lefering R, 2012, EUR J TRAUMA EMERG S, V38, P3, DOI 10.1007/s00068-011-0168-4; McGwin G, 2009, J TRAUMA, V66, P526, DOI 10.1097/TA.0b013e3181623321; Meislin H, 1997, J TRAUMA, V43, P433, DOI 10.1097/00005373-199709000-00008; Paffrath T, 2014, INJURY, V45, pS64, DOI 10.1016/j.injury.2014.08.020; Pang JM, 2008, INJURY, V39, P102, DOI 10.1016/j.injury.2007.05.022; Pfeifer R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148844; Pfeifer R, 2009, INJURY, V40, P907, DOI 10.1016/j.injury.2009.05.006; REGEL G, 1995, J TRAUMA, V38, P70, DOI 10.1097/00005373-199501000-00020; Ruchholtz S, 2008, DTSCH ARZTEBL INT, V105, P225, DOI 10.3238/arztebl.2008.0225; Ruchholtz S, 2012, EUR J TRAUMA EMERG S, V38, P11, DOI 10.1007/s00068-011-0166-6; SAHDEV P, 1994, ACCIDENT ANAL PREV, V26, P377, DOI 10.1016/0001-4575(94)90011-6; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; Shen LY, 2006, AM SURGEON, V72, P282; Soreide K, 2007, WORLD J SURG, V31, P2092, DOI 10.1007/s00268-007-9226-9; Stewart RM, 2003, J TRAUMA, V54, P66, DOI 10.1097/00005373-200301000-00009; Trunkey D, 1988, SCI AM, V4, pb22; TRUNKEY DD, 1983, SCI AM, V249, P28, DOI 10.1038/scientificamerican0883-28; Trunkey DD., 1974, J AM COLL EMERG PHYS, V3, P368, DOI 10.1016/S0361-1124(74)80005-5; Valdez C, 2016, J SURG RES, V200, P604, DOI 10.1016/j.jss.2015.08.031; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156	39	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212095	10.1371/journal.pone.0212095	http://dx.doi.org/10.1371/journal.pone.0212095			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794579	gold, Green Published, Green Submitted			2022-12-27	WOS:000459709100036
J	Shimahara, Y; Sugawara, K; Kojo, KH; Kawai, H; Yoshida, Y; Hasezawa, S; Kutsuna, N				Shimahara, Yuki; Sugawara, Ko; Kojo, Kei H.; Kawai, Hiroki; Yoshida, Yuya; Hasezawa, Seiichiro; Kutsuna, Natsumaro			IMACEL: A cloud-based bioimage analysis platform for morphological analysis and image classification	PLOS ONE			English	Article							HEAT-SHOCK GRANULES; CELL	Automated quantitative image analysis is essential for all fields of life science research. Although several software programs and algorithms have been developed for bioimage processing, an advanced knowledge of image processing techniques and high-performance computing resources are required to use them. Hence, we developed a cloud-based image analysis platform called IMACEL, which comprises morphological analysis and machine learning-based image classification. The unique click-based user interface of IMACEL's morphological analysis platform enables researchers with limited resources to evaluate particles rapidly and quantitatively without prior knowledge of image processing. Because all the image processing and machine learning algorithms are performed on high-performance virtual machines, users can access the same analytical environment from anywhere. A validation study of the morphological analysis and image classification of IMACEL was performed. The results indicate that this platform is an accessible and potentially powerful tool for the quantitative evaluation of bioimages that will lower the barriers to life science research.	[Shimahara, Yuki; Yoshida, Yuya; Hasezawa, Seiichiro; Kutsuna, Natsumaro] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan; [Shimahara, Yuki; Sugawara, Ko; Kojo, Kei H.; Kawai, Hiroki; Hasezawa, Seiichiro; Kutsuna, Natsumaro] LPixel Inc, Res & Dev Div, Chiyoda Ku, Tokyo, Japan; [Kojo, Kei H.] Sophia Univ, Grad Sch Sci & Technol, Chiyoda Ku, Tokyo, Japan	University of Tokyo; Sophia University	Kutsuna, N (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan.; Kutsuna, N (corresponding author), LPixel Inc, Res & Dev Div, Chiyoda Ku, Tokyo, Japan.	kutsuna@edu.k.u-tokyo.ac.jp		Kawai, Hiroki/0000-0002-7129-2384	Japan Society for the Promotion of Science KAKENHI [JP16H06280, 70578559, 16J06044]; LPixel Inc.	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); LPixel Inc.	Funded by Japan Society for the Promotion of Science KAKENHI. URL: https://www.jsps.go.jp/english/e-grants/. Grant Numbers: JP16H06280 (S.H.) 70578559 (N. K.) 16J06044 (K.K.). Source: Research and Development Division, LPixel Inc. Role: The funder, LPixel Inc., provided support in the form of salaries for authors Y.S., K.S., H.K., and N.K., but all of the funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are provided in the 'author contributions' section.	Buades A, 2005, PROC CVPR IEEE, P60, DOI 10.1109/cvpr.2005.38; Burr Settles, 2009, ACTIVE LEARNING LIT; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chessel A, 2017, METHODS, V115, P110, DOI 10.1016/j.ymeth.2016.12.014; COLLIER NC, 1986, J CELL BIOL, V103, P1495, DOI 10.1083/jcb.103.4.1495; Danuser G, 2011, CELL, V147, P973, DOI 10.1016/j.cell.2011.11.001; Eulenberg P, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00623-3; Hayashi T, 2007, PLANT CELL PHYSIOL, V48, P1509, DOI 10.1093/pcp/pcm117; Kamatani T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17012-x; Krizhevsky A., P 25 INT C NEUR INF, P1097; Kumagai-Sano F, 2006, NAT PROTOC, V1, P2621, DOI 10.1038/nprot.2006.381; Kutsuna N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2030; NAGATA T, 1992, INT REV CYTOL, V132, P1, DOI 10.1016/S0074-7696(08)62452-3; NOVER L, 1989, MOL CELL BIOL, V9, P1298, DOI 10.1128/MCB.9.3.1298; NOVER L, 1983, MOL CELL BIOL, V3, P1648, DOI 10.1128/MCB.3.9.1648; Peng HC, 2016, ADV ANAT EMBRYOL CEL, V219, P263, DOI 10.1007/978-3-319-28549-8_10; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Sasaki N, 2018, CANCER SCI, V109, P1135, DOI 10.1111/cas.13533; Sommer C, 2013, J CELL SCI, V126, P5529, DOI 10.1242/jcs.123604	19	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212619	10.1371/journal.pone.0212619	http://dx.doi.org/10.1371/journal.pone.0212619			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794647	gold, Green Submitted, Green Published			2022-12-27	WOS:000459709100100
J	Srikulnath, K; Azad, B; Singchat, W; Ezaz, T				Srikulnath, Kornsorn; Azad, Bhumika; Singchat, Worapong; Ezaz, Tariq			Distribution and amplification of interstitial telomeric sequences (ITSs) in Australian dragon lizards support frequent chromosome fusions in Iguania	PLOS ONE			English	Article							CENTRAL BEARDED DRAGON; POGONA-VITTICEPS; (TTAGGG)(N) SEQUENCES; KARYOTYPE EVOLUTION; CYTOGENETIC MAP; SEX-CHROMOSOMES; LOCALIZATION; ORIGIN; BIRDS; SQUAMATA	Telomeric sequences are generally located at the ends of chromosomes; however, they can also be found in non-terminal chromosomal regions when they are known as interstitial telomeric sequences (ITSs). Distribution of ITSs across closely related and divergent species elucidates karyotype evolution and speciation as ITSs provide evolutionary evidence for chromosome fusion. In this study, we performed physical mapping of telomeric repeats by fluorescence in situ hybridisation (FISH) in seven Australian dragon lizards thought to represent derived karyotypes of squamate reptiles and a gecko lizard with considerably different karyotypic feature. Telomeric repeats were present at both ends of all chromosomes in all species, while varying numbers of ITSs were also found on microchromosomes and in pericentromeric or centromeric regions on macrochromosomes in five lizard species examined. This suggests that chromosomal rearrangements from ancestral squamate reptiles to Iguania occurred mainly by fusion between ancestral types of acrocentric chromosomes and/or between microchromosomes, leading to appearance of bi-armed macrochromosomes, and in the reduction of microchromosome numbers. These results support the previously proposed hypothesis of karyotype evolution in squamate reptiles. In addition, we observed the presence of telomeric sequences in the similar regions to heterochromatin of the W microchromosome in Pogona barbata and Doporiphora nobbi, while sex chromosomes for the two species contained part of the nucleolar organiser regions (NORs). This likely implies that these ITSs are a part of the satellite DNA and not relics of chromosome fusions. Amplification of telomeric repeats may have involved heterochromatinisation of sex-specific W chromosomes and play a role in the organisation of the nucleolus.	[Srikulnath, Kornsorn; Azad, Bhumika; Ezaz, Tariq] Univ Canberra, Fac Sci & Technol, Inst Appl Ecol, Bruce, ACT, Australia; [Srikulnath, Kornsorn; Singchat, Worapong] Kasetsart Univ, Fac Sci, Dept Genet, Lab Anim Cytogenet & Comparat Genom ACCG, Bangkok, Thailand; [Azad, Bhumika] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT, Australia; [Azad, Bhumika] Australian Natl Univ, Canberra Hosp, Canberra, ACT, Australia	University of Canberra; Kasetsart University; Australian National University; John Curtin School of Medical Research; Australian National University; Canberra Hospital	Srikulnath, K; Ezaz, T (corresponding author), Univ Canberra, Fac Sci & Technol, Inst Appl Ecol, Bruce, ACT, Australia.; Srikulnath, K (corresponding author), Kasetsart Univ, Fac Sci, Dept Genet, Lab Anim Cytogenet & Comparat Genom ACCG, Bangkok, Thailand.	kornsorn.s@ku.ac.th; Tariq.Ezaz@canberra.edu.au	Srikulnath, Kornsorn/GLU-1326-2022	Srikulnath, Kornsorn/0000-0002-5985-7258; Singchat, Worapong/0000-0002-7083-6159	Australian Research Council Future Fellowship [FT110100733]; Endeavour Research Fellowship [6801_2018]; IAE innovation fund	Australian Research Council Future Fellowship(Australian Research Council); Endeavour Research Fellowship; IAE innovation fund	This work was supported by an Australian Research Council Future Fellowship to TE (FT110100733) and an Endeavour Research Fellowship (6801_2018) to KS and IAE innovation fund to TE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by an Australian Research Council Future Fellowship to TE (FT110100733) and an Endeavour Research Fellowship (6801_2018) to KS. BA was supported by research assistance funded by IAE innovation fund awarded to TE. We would also like to thank Arthur Georges, Denis O'Mealey, Mathew Young and Peter Harlow for help with animal sample and Jacqui Richardson and Alistair Zealey for their care of captive animals	Alfoldi J, 2011, NATURE, V477, P587, DOI 10.1038/nature10390; Augstenova B, 2018, GENES-BASEL, V9, DOI 10.3390/genes9010005; Bertolotto CEV, 2001, CARYOLOGIA, V54, P217, DOI 10.1080/00087114.2001.10589229; Bolzan AD, 2017, MUTAT RES-REV MUTAT, V773, P51, DOI 10.1016/j.mrrev.2017.04.002; Deakin JE, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2774-3; Ezaz T, 2005, CHROMOSOME RES, V13, P763, DOI 10.1007/s10577-005-1010-9; Ezaz T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-899; Ezaz T, 2009, CHROMOSOME RES, V17, P91, DOI 10.1007/s10577-008-9019-5; Harlow Peter S., 1996, Herpetological Review, V27, P71; Holleley CE, 2015, NATURE, V523, P79, DOI 10.1038/nature14574; Liu WS, 1999, CHROMOSOME RES, V7, P235, DOI 10.1023/A:1009255517764; Matsubara K, 2006, P NATL ACAD SCI USA, V103, P18190, DOI 10.1073/pnas.0605274103; Matsubara K, 2015, J HERED, V106, P753, DOI 10.1093/jhered/esv083; Matsubara K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-604; Matsuda Y, 2005, CHROMOSOME RES, V13, P601, DOI 10.1007/s10577-005-0986-5; MEYNE J, 1989, P NATL ACAD SCI USA, V86, P7049, DOI 10.1073/pnas.86.18.7049; MEYNE J, 1990, CHROMOSOMA, V99, P3, DOI 10.1007/BF01737283; O'Meally D, 2009, CYTOGENET GENOME RES, V127, P213, DOI 10.1159/000300099; Olmo E, 2008, INTEGR COMP BIOL, V48, P486, DOI 10.1093/icb/icn049; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93; Quinn AE, 2007, SCIENCE, V316, P411, DOI 10.1126/science.1135925; Rovatsos M, 2017, GENES-BASEL, V8, DOI 10.3390/genes8120382; Rovatsos M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134985; Rovatsos M, 2014, EVOLUTION, V68, P2079, DOI 10.1111/evo.12357; Ruiz-Herrera A, 2008, CYTOGENET GENOME RES, V122, P219, DOI 10.1159/000167807; SCHERTHAN H, 1990, CYTOGENET CELL GENET, V53, P115, DOI 10.1159/000132908; Signorino G., 2005, CHROMOREP REPTILE CH; Singchat W, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5293-6; Srikulnath K, 2009, CYTOGENET GENOME RES, V125, P213, DOI 10.1159/000230005; Srikulnath K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134829; Srikulnath K, 2014, CHROMOSOMA, V123, P563, DOI 10.1007/s00412-014-0467-8; Srikulnath K, 2013, CHROMOSOME RES, V21, P805, DOI 10.1007/s10577-013-9398-0; Srikulnath K, 2011, GENET MOL BIOL, V34, P582, DOI 10.1590/S1415-47572011005000042; Srikulnath K, 2009, CHROMOSOME RES, V17, P975, DOI 10.1007/s10577-009-9101-7; Trifonov VA, 2011, CHROMOSOME RES, V19, P843, DOI 10.1007/s10577-011-9241-4; Uno Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053027; WITTEN GJ, 1983, AUST J ZOOL, V31, P533, DOI 10.1071/ZO9830533; Young MJ, 2013, CHROMOSOME RES, V21, P361, DOI 10.1007/s10577-013-9362-z; Zheng YC, 2016, MOL PHYLOGENET EVOL, V94, P537, DOI 10.1016/j.ympev.2015.10.009	39	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212683	10.1371/journal.pone.0212683	http://dx.doi.org/10.1371/journal.pone.0212683			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794668	Green Published, gold, Green Submitted			2022-12-27	WOS:000459709100112
J	Rosa, E; Minard, G; Lindholm, J; Saastamoinen, M				Rosa, Elena; Minard, Guillaume; Lindholm, Johanna; Saastamoinen, Marjo			Moderate plant water stress improves larval development, and impacts immunity and gut microbiota of a specialist herbivore	PLOS ONE			English	Article							INTERGENIC SPACER ANALYSIS; INSECT; BACTERIAL; DROUGHT; CONSEQUENCES; CHEMISTRY; RESPONSES	While host plant drought is generally viewed as a negative phenomenon, its impact on insect herbivores can vary largely depending on the species involved and on the intensity of the drought. Extreme drought killing host plants can clearly reduce herbivore fitness, but the impact of moderate host plant water stress on insect herbivores can vary, and may even be beneficial. The populations of the Finnish Glanville fritillary butterfly (Melitaea cinxia) have faced reduced precipitation in recent years, with impacts even on population dynamics. Whether the negative effects of low precipitation are solely due to extreme desiccation killing the host plant or whether moderate drought reduces plant quality for the larvae remains unknown. We assessed the performance of larvae fed on moderately water-stressed Plantago lanceolata in terms of growth, survival, and immune response, and additionally were interested to assess whether the gut microbial composition of the larvae changed due to modification of the host plant. We found that larvae fed on water-stressed plants had increased growth, with no impact on survival, up-regulated the expression of one candidate immune gene (pelle), and had a more heterogeneous bacterial community and a shifted fungal community in the gut. Most of the measured traits showed considerable variation due to family structure. Our data suggest that in temperate regions moderate host plant water stress can positively shape resource acquisition of this specialized insect herbivore, potentially by increasing nutrient accessibility or concentration. Potentially, the better larval performance may be mediated by a shift of the microbiota on water-stressed plants, calling for further research especially on the understudied gut fungal community.	[Rosa, Elena; Minard, Guillaume; Lindholm, Johanna; Saastamoinen, Marjo] Univ Helsinki, Organismal & Evolutionary Biol Res Programme, Helsinki, Finland; [Rosa, Elena] Uppsala Univ, Dept Ecol & Genet, Uppsala, Sweden; [Minard, Guillaume] Univ Lyon, Lyon, France; [Minard, Guillaume] Univ Claude Bernard Lyon 1, CNRS UMR 5557, Lab Microbial Ecol, INRA UMR1418, Villeurbanne, France	University of Helsinki; Uppsala University; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup	Rosa, E (corresponding author), Univ Helsinki, Organismal & Evolutionary Biol Res Programme, Helsinki, Finland.; Rosa, E (corresponding author), Uppsala Univ, Dept Ecol & Genet, Uppsala, Sweden.	elena.rosa@ebc.uu.se	; Saastamoinen, Marjo/F-6576-2012	Rosa, Elena/0000-0003-3580-2524; Saastamoinen, Marjo/0000-0001-7009-2527; Minard, Guillaume/0000-0002-2079-8844	European Research Council [637412]	European Research Council(European Research Council (ERC)European Commission)	The study was funded by European Research Council (Independent starting grant no. 637412 'META-STRESS') to MS (https://erc.europa.eu/funding/starting-grants).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankrah NYD, 2018, ENVIRON MICROBIOL, V20, P2002, DOI 10.1111/1462-2920.14097; ASLING B, 1995, INSECT BIOCHEM MOLEC, V25, P511, DOI 10.1016/0965-1748(94)00091-C; Bordenstein SR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002226; Capo F, 2016, DEV COMP IMMUNOL, V64, P11, DOI 10.1016/j.dci.2016.01.001; Cardinale M, 2004, APPL ENVIRON MICROB, V70, P6147, DOI 10.1128/AEM.70.10.6147-6156.2004; Coon KL, 2017, P NATL ACAD SCI USA, V114, pE5362, DOI 10.1073/pnas.1702983114; Crava CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125991; Dray S., 2017, ADE4 ANAL ECOLOGICAL; Duron O, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-27; Freitak D, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-56; Freitak D, 2009, P ROY SOC B-BIOL SCI, V276, P2617, DOI 10.1098/rspb.2009.0323; Gutbrodt B, 2011, OIKOS, V120, P1732, DOI 10.1111/j.1600-0706.2011.19558.x; Hammer TJ, 2017, P NATL ACAD SCI USA, V114, P9641, DOI 10.1073/pnas.1707186114; Harrington TC., 2005, INSECT FUNGAL ASS EC; Huberty AF, 2004, ECOLOGY, V85, P1383, DOI 10.1890/03-0352; Jamieson MA, 2012, PLANT PHYSIOL, V160, P1719, DOI 10.1104/pp.112.206524; Kahilainen A, 2018, GLOBAL CHANGE BIOL, V24, P4316, DOI 10.1111/gcb.14280; Konrad M, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1976; Krasensky J, 2012, J EXP BOT, V63, P1593, DOI 10.1093/jxb/err460; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lampert EC, 2015, J CHEM ECOL, V41, P85, DOI 10.1007/s10886-014-0532-z; Leitao-Goncalves R, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000862; Martemyanov VV, 2012, ARTHROPOD-PLANT INTE, V6, P507, DOI 10.1007/s11829-012-9202-7; MATTSON WJ, 1987, BIOSCIENCE, V37, P110, DOI 10.2307/1310365; Minard G, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00970; Mody K, 2009, ECOL ENTOMOL, V34, P133, DOI 10.1111/j.1365-2311.2008.01053.x; Ojanen SP, 2013, ECOL EVOL, V3, P3713, DOI 10.1002/ece3.733; Oksanen J., 2016, VEGAN COMMUNITY ECOL; Otani S, 2016, FRONT ECOL EVOL, V4, DOI [10.3389/fevo.2016.00115, DOI 10.3389/FEVO.2016.00115]; Paludo CR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19583-9; R Development Core Team, 2009, R LANG ENV STAT COMP; Ramette A, 2009, APPL ENVIRON MICROB, V75, P2495, DOI 10.1128/AEM.02409-08; Ranjard L, 2001, APPL ENVIRON MICROB, V67, P4479, DOI 10.1128/AEM.67.10.4479-4487.2001; Reynolds S., 2009, INSECT INFECT IMMUNI; Ruokolainen L, 2016, OECOLOGIA, V181, P895, DOI 10.1007/s00442-016-3603-8; Salgado AL, 2019, ANIM BEHAV, V150, P27, DOI 10.1016/j.anbehav.2019.01.018; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Shikano I, 2017, J CHEM ECOL, V43, P586, DOI 10.1007/s10886-017-0850-z; Siva-Jothy MT, 2002, PHYSIOL ENTOMOL, V27, P206, DOI 10.1046/j.1365-3032.2002.00286.x; Tack AJM, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0173; Tao LL, 2016, J ANIM ECOL, V85, P1246, DOI 10.1111/1365-2656.12558; Vogelweith F, 2015, J INSECT PHYSIOL, V77, P55, DOI 10.1016/j.jinsphys.2015.04.003; Voirol LRP, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00556; WHITE T C R, 1969, Ecology (Washington D C), V50, P905, DOI 10.2307/1933707; Woestmann L, 2017, J EVOLUTION BIOL, V30, P501, DOI 10.1111/jeb.13007; Yi HY, 2014, APPL MICROBIOL BIOT, V98, P5807, DOI 10.1007/s00253-014-5792-6; Yun JH, 2014, APPL ENVIRON MICROB, V80, P5254, DOI 10.1128/AEM.01226-14	47	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0204292	10.1371/journal.pone.0204292	http://dx.doi.org/10.1371/journal.pone.0204292			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785875	Green Published, gold, Green Submitted			2022-12-27	WOS:000459307000003
J	Dandge, S; Jeemon, P; Reddy, PS				Dandge, Shailendra; Jeemon, Panniyammakal; Reddy, P. S.			Technology enabled non-physician health workers extending telemedicine to rural homes to control hypertension and diabetes (TETRA): A pre-post demonstration project in Telangana, India	PLOS ONE			English	Article							PREVALENCE; COUNTRIES; STATES	Objectives We aimed to determine the feasibility and effectiveness of an intervention anchored on mHealth and task sharing strategy of involving non-physician health workers (NPHW) on population level detection, treatment and control of hypertension and diabetes in India. Methods Non-physician health workers (NPHWs) equipped with tablet computers that were linked with point-of-care devices for blood pressure (BP) and blood sugar measurements visited households, screened adult individuals for hypertension and diabetes from two randomly selected villages in the Medchal district, Telangana, India. Further, they digitally connected those individuals with hypertension and diabetes to a study physician via Skype, and handed over a printed e-prescription. Medication adherence checks, BP and fasting blood sugar measurements were done once a month and doctor consultations once in three months during follow-up. Results Among 2456 eligible individuals, 1751 and 1686 individuals were screened for hypertension and diabetes, respectively. Prevalence of hypertension was 23.6% (95% CI 21.6%-25.6%) and among them 38.9% were newly detected. Prevalence of diabetes was 11.2% (9.7%-12.7%) and 28.6% of them were newly detected. After 24 months of intervention, control of BP and blood sugar was achieved in 54.0% and 34.1% of individuals with hypertension and diabetes, respectively. Blood pressure control rate improved by 12% (7.9%-16.0%) in known hypertensive individuals over the intervention period. Interpretation This research demonstrates the feasibility and local acceptability of a mHealth intervention strategy anchored on NPHWs guided by physicians for detection, treatment and regular follow-up of individuals with hypertension and diabetes in a community setting in India.	[Dandge, Shailendra] MediCiti Inst Med Sci, Dept Pharmacol, Hyderabad, Telangana, India; [Dandge, Shailendra; Reddy, P. S.] India SHARE INDIA, Soc Hlth Allied Res & Educ, Hyderabad, Telangana, India; [Jeemon, Panniyammakal] Sree Chitra Tirunal Inst Med Sci & Technol, Trivandrum, Kerala, India; [Reddy, P. S.] Univ Pittsburgh, Pittsburgh, PA USA	Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Dandge, S (corresponding author), MediCiti Inst Med Sci, Dept Pharmacol, Hyderabad, Telangana, India.; Dandge, S (corresponding author), India SHARE INDIA, Soc Hlth Allied Res & Educ, Hyderabad, Telangana, India.	shailendra962@gmail.com	Dandge, Shailendra/AAZ-1330-2020	Dandge, Shailendra/0000-0002-5037-214X; Jeemon, Panniyammakal/0000-0003-4172-4307	Fogarty non-communicable disease research training program [D43_TW009078]	Fogarty non-communicable disease research training program	This study was supported by an in-country grant as part of the Fogarty non-communicable disease research training program under the grant, D43_TW009078. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Ajay VS, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004343; Anchala R, 2014, J HYPERTENS, V32, P1170, DOI 10.1097/HJH.0000000000000146; Anjana RM, 2017, LANCET DIABETES ENDO, V5, P585, DOI 10.1016/S2213-8587(17)30174-2; [Anonymous], 2013, SUMM SETT RES PRIOR; Dandona L, 2017, LANCET, V390, P2437, DOI 10.1016/S0140-6736(17)32804-0; KANNEL WB, 1979, JAMA-J AM MED ASSOC, V241, P2035, DOI 10.1001/jama.241.19.2035; National Institute of Medical Statistics, 2007, ICMR IDSP NONC DIS R; O'Donnell MJ, 2016, LANCET, V388, P761, DOI 10.1016/S0140-6736(16)30506-2; Prabhakaran D, CIRCULATION; Tatineni A, 2009, Indian J Public Health, V53, P41; Unnikrishnan R, 2014, DIABETES TECHNOL THE, V16, P596, DOI 10.1089/dia.2014.0018; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	12	5	6	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0211551	10.1371/journal.pone.0211551	http://dx.doi.org/10.1371/journal.pone.0211551			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779798	Green Submitted, Green Published, gold			2022-12-27	WOS:000459062900015
J	Lorek, J; Centifanti, LCM; Lyons, M; Thorley, C				Lorek, Joanna; Centifanti, Luna C. M.; Lyons, Minna; Thorley, Craig			The impact of individual differences on jurors' note taking during trials and recall of trial evidence, and the association between the type of evidence recalled and verdicts	PLOS ONE			English	Article							WORKING-MEMORY; DIVIDED ATTENTION; NOTE-TAKING; ECOLOGICAL VALIDITY; PRETRIAL PUBLICITY; JURY DELIBERATION; HANDWRITING SPEED; DECISION-MAKING; NOTETAKING; STRATEGIES	Although note taking during trials is known to enhance jurors' recall of trial evidence, little is known about whether individual differences in note taking underpin this effect. Individual differences in handwriting speed, working memory, and attention may influence juror's note taking. This, in turn, may influence their recall. It may also be the case that if jurors note down and recall more incriminating than non-incriminating evidence (or vice versa), then this may predict their verdict. Three studies examined the associations between the aforementioned individual differences, the amount of critical evidence jurors noted down during a trial, the amount of critical evidence they recalled, and the verdicts they reached. Participants had their handwriting speed, short-term memory, working memory, and attention assessed. They then watched a trial video (some took notes), reached a verdict, and recalled as much trial information as possible. We found that jurors with faster handwriting speed (Study 1), higher short-term memory capacity (Study 2), and higher sustained attention capacity (Study 3) noted down, and later recalled, the most critical trial evidence. However, working memory storage capacity, information processing ability (Study 2) and divided attention (Study 3) were not associated with note taking or recall. Further, the type of critical evidence jurors predominantly recalled predicted their verdicts, such that jurors who recalled more incriminating evidence were more likely to reach a guilty verdict, and jurors who recalled more non-incriminating evidence were less likely to do so. The implications of these findings are discussed.	[Lorek, Joanna; Centifanti, Luna C. M.; Lyons, Minna] Univ Liverpool, Dept Psychol Sci, Liverpool, Merseyside, England; [Thorley, Craig] James Cook Univ, Dept Psychol, Townsville, Qld, Australia	University of Liverpool; James Cook University	Lorek, J (corresponding author), Univ Liverpool, Dept Psychol Sci, Liverpool, Merseyside, England.	Joanna.Lorek@liverpool.ac.uk	Centifanti, Luna C. Munoz/D-4962-2012; Thorley, Craig/AAZ-7907-2020; Centifanti, Luna Munoz/N-7687-2019	Centifanti, Luna C. Munoz/0000-0003-4562-8187; Centifanti, Luna Munoz/0000-0003-4562-8187; Thorley, Craig/0000-0002-3207-435X; Lorek, Joanna/0000-0003-0003-8386				ALWIN DF, 1975, AM SOCIOL REV, V40, P37, DOI 10.2307/2094445; [Anonymous], 1983, CANADIAN PSYCHOL; Atkinson RC., 1968, PSYCHOL LEARNING MOT, V2, P89, DOI [10.1016/S0079-7421(08)60422-3, DOI 10.1016/S0079-7421(08)60422-3]; BADDELEY A, 1984, J EXP PSYCHOL GEN, V113, P518, DOI 10.1037/0096-3445.113.4.518; Baddeley A.D., 1974, PSYCHOL LEARNING MOT; BENTON SL, 1984, J EDUC PSYCHOL, V76, P820, DOI 10.1037/0022-0663.76.5.820; BERNINGER VW, 1991, J SCHOOL PSYCHOL, V29, P57, DOI 10.1016/0022-4405(91)90016-K; Bornstein BH, 1999, LAW HUMAN BEHAV, V23, P75, DOI 10.1023/A:1022326807441; Bornstein BH, 2011, CURR DIR PSYCHOL SCI, V20, P63, DOI 10.1177/0963721410397282; Bui DC, 2014, LEARN INDIVID DIFFER, V33, P12, DOI 10.1016/j.lindif.2014.05.002; Bui DC, 2013, J EDUC PSYCHOL, V105, P299, DOI 10.1037/a0030367; COHN E, 1995, J ECON EDUC, V26, P291, DOI 10.2307/1182993; Costabile KA, 2005, BASIC APPL SOC PSYCH, V27, P47, DOI 10.1207/s15324834basp2701_5; Craik FIM, 1996, J EXP PSYCHOL GEN, V125, P159, DOI 10.1037/0096-3445.125.2.159; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; Dewhurst SA, 2007, MEM COGNITION, V35, P660, DOI 10.3758/BF03193304; DIVESTA FJ, 1972, J EDUC PSYCHOL, V63, P8, DOI 10.1037/h0032243; Engle RW, 1999, J EXP PSYCHOL GEN, V128, P309, DOI 10.1037/0096-3445.128.3.309; Fitzgerald JM, 2000, J GERONTOL B-PSYCHOL, V55, pP323, DOI 10.1093/geronb/55.6.P323; FORSTERLEE L, 1994, LAW HUMAN BEHAV, V18, P567, DOI 10.1007/BF01499175; Forsterlee L, 1997, APPL COGNITIVE PSYCH, V11, P305, DOI 10.1002/(SICI)1099-0720(199708)11:4<305::AID-ACP457>3.0.CO;2-J; Gleason J, 2012, THESIS; Grier RA, 2003, HUM FACTORS, V45, P349, DOI 10.1518/hfes.45.3.349.27253; Hadwin AF, 1999, ALBERTA J EDUC RES, V45, P1; HASHER L, 1979, J EXP PSYCHOL GEN, V108, P356, DOI 10.1037/0096-3445.108.3.356; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hope L, 2014, LEGAL CRIMINOL PSYCH, V19, P316, DOI 10.1111/lcrp.12003; Just MA, 2001, NEUROIMAGE, V14, P417, DOI 10.1006/nimg.2001.0826; KIEWRA KA, 1988, CONTEMP EDUC PSYCHOL, V13, P33, DOI 10.1016/0361-476X(88)90004-5; Kiewra KA, 1985, EDUC PSYCHOL-US, V20, P23, DOI 10.1207/s15326985ep2001_4; Mayer RE, 1996, EDUC PSYCHOL REV, V8, P357, DOI 10.1007/BF01463939; Naveh-Benjamin M, 2014, Q J EXP PSYCHOL, V67, P1682, DOI 10.1080/17470218.2013.867517; Oberauer K, 2009, PSYCHOL LEARN MOTIV, V51, P45, DOI 10.1016/S0079-7421(09)51002-X; Parasuraman R., 1987, REC RES PSY, P11, DOI 10.1007/978-1-4612-4756-2_2; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; PEPER RJ, 1978, J EDUC PSYCHOL, V70, P514, DOI 10.1037/0022-0663.70.4.514; PEPER RJ, 1986, J EDUC PSYCHOL, V78, P34, DOI 10.1037/0022-0663.78.1.34; Peverly ST, 2006, DEV NEUROPSYCHOL, V29, P197, DOI 10.1207/s15326942dn2901_10; Peverly ST, 2007, J EDUC PSYCHOL, V99, P167, DOI 10.1037/0022-0663.99.1.167; Peverly ST, 2014, READ WRIT, V27, P1, DOI 10.1007/s11145-013-9431-x; Peverly ST, 2013, APPL COGNITIVE PSYCH, V27, P115, DOI 10.1002/acp.2881; Piolat A, 2005, APPL COGNITIVE PSYCH, V19, P291, DOI 10.1002/acp.1086; Preacher KJ, 2011, PSYCHOL METHODS, V16, P93, DOI 10.1037/a0022658; Pritchard ME, 1999, J EXP PSYCHOL-APPL, V5, P152, DOI 10.1037/1076-898X.5.2.152; Pritchard ME, 2002, APPL COGNITIVE PSYCH, V16, P589, DOI 10.1002/acp.816; R Core Team, 2018, R LANG ENV STAT COMP; Robertson I H, 1996, J Int Neuropsychol Soc, V2, P525; ROSENHAN DL, 1994, LAW HUMAN BEHAV, V18, P53, DOI 10.1007/BF01499143; Ruva C, 2007, APPL COGNITIVE PSYCH, V21, P45, DOI 10.1002/acp.1254; Ruva CL, 2015, LAW HUMAN BEHAV, V39, P294, DOI 10.1037/lhb0000117; SPELKE E, 1976, COGNITION, V4, P215, DOI 10.1016/0010-0277(76)90018-4; Studebaker CA, 2002, LAW HUMAN BEHAV, V26, P19, DOI 10.1023/A:1013877108082; Thorley C, 2016, APPL COGNITIVE PSYCH, V30, P655, DOI 10.1002/acp.3240; Thorley C, 2016, MEMORY, V24, P560, DOI 10.1080/09658211.2015.1031250; Vekaria PC, 2011, THESIS, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; WITTROCK MC, 1992, EDUC PSYCHOL, V27, P531, DOI 10.1207/s15326985ep2704_8; WITTROCK MC, 1975, J EDUC PSYCHOL, V67, P484, DOI 10.1037/h0077017; WITTROCK MC, 1975, AM J PSYCHOL, V88, P489, DOI 10.2307/1421780	59	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212491	10.1371/journal.pone.0212491	http://dx.doi.org/10.1371/journal.pone.0212491			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL9KY	30779768	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000459062900059
J	Nopparat, J; Nualla-ong, A; Phongdara, A				Nopparat, Jongdee; Nualla-ong, Aekkaraj; Phongdara, Amornrat			Ethanolic extracts of Pluchea indica (L.) leaf pretreatment attenuates cytokine-induced beta-cell apoptosis in multiple low-dose streptozotocin-induced diabetic mice	PLOS ONE			English	Article							ANIMAL-MODELS; TYPE-1; QUERCETIN; RESVERATROL; MECHANISM; INHIBITION; LEAVES; LESS.	Loss of beta-cell mass and function is a fundamental feature of pathogenesis for type 1 and type 2 diabetes. Increasing evidence indicates that apoptosis is one of the main mechanisms of beta-cell death in both types. Ethanolic extracts of Pluchea indica leaf (PILE) have been reported to possess blood glucose lowering actions in vivo. Nevertheless, further study is required to determine the underlying mechanisms. In this report, we have investigated the preventive effects of PILE on multiple low doses of streptozotocin (MLDS)induced beta-cell apoptosis. Mice were pre-treated with PILE at 50 mg/kg (PILE 50) or 100 mg/kg (PILE 100) for 2 weeks before streptozotocin (STZ) stimulation, and the treatment continued for 4 or 8 weeks. Results revealed that PILE 100 mice exhibited improved blood biochemistry, maintained a higher body weight, had decreased hyperglycemia, and restored islet architectures compared to non-treated STZ mice. Significantly, PILE 100 decreased levels of inflammatory response markers interferon-gamma (IFN-gamma), tumor necrosis factor-alpha (TNF alpha), and interlukin1-beta (IL-1 beta), concomitant with the inhibition of caspase-3, caspase-8, capsepase- 9, phosphorylation of signal transducer and activator of transcription 1 (pSTAT1), nuclear factor-kappa B p65 (NF-kappa Bp65), and inducible nitric oxide synthase (iNOS). Additionally, survival and proliferative ability of beta-cells was mediated by up-regulated Bcl-2 and Ki67, respectively. These results provide strong evidence that pretreatment with PILE 100 effectively attenuated STZ-induced diabetes-related symptoms and these effects could be associated with the inhibition of cytokine-induced beta-cell apoptosis.	[Nopparat, Jongdee] Prince Songkla Univ, Fac Sci, Dept Anat, Hat Yai, Songkhla, Thailand; [Nualla-ong, Aekkaraj; Phongdara, Amornrat] Prince Songkla Univ, Fac Sci, Ctr Genom & Bioinformat Res, Hat Yai, Songkhla, Thailand; [Nualla-ong, Aekkaraj] Prince Songkla Univ, Fac Med Technol, Med Technol Serv Ctr, Hat Yai, Songkhla, Thailand; [Phongdara, Amornrat] Prince Songkla Univ, Fac Med Technol, Hat Yai, Songkhla, Thailand	Prince of Songkla University; Prince of Songkla University; Prince of Songkla University; Prince of Songkla University	Nopparat, J (corresponding author), Prince Songkla Univ, Fac Sci, Dept Anat, Hat Yai, Songkhla, Thailand.	Jongdee.n@psu.ac.th	Nualla-ong, Aekkaraj/ABD-6369-2020; Nopparat, Jongdee/AAX-1690-2020	Nopparat, Jongdee/0000-0003-3532-1405; Nualla-ong, Aekkaraj/0000-0003-3480-048X	Thailand Research Fund (TRF) [MRG6080028]; Prince of Songkla University [SCI601252S]; Prince of Songkla University Thailand	Thailand Research Fund (TRF)(Thailand Research Fund (TRF)); Prince of Songkla University; Prince of Songkla University Thailand	This study was supported in part by (1) the Thailand Research Fund (TRF), grant number: MRG6080028, and (2) The budget revenue of Prince of Songkla University, grant number: SCI601252S to JN, and (3) the government budget (or budget revenue) of Prince of Songkla University Thailand to AN and AP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Amirshahrokhi K, 2008, TOXICOL APPL PHARM, V232, P119, DOI 10.1016/j.taap.2008.06.020; Arnhold T, 2002, TOXICOL SCI, V66, P274, DOI 10.1093/toxsci/66.2.274; Arsiningtyas IS, 2014, NAT PROD RES, V28, P1350, DOI 10.1080/14786419.2014.904306; Biswas R, 2007, PHYTOMEDICINE, V14, P534, DOI 10.1016/j.phymed.2006.11.003; Buapool D, 2013, J ETHNOPHARMACOL, V146, P495, DOI 10.1016/j.jep.2013.01.014; Cho JJ, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-265; Citro A, 2015, DIABETES, V64, P1329, DOI 10.2337/db14-0443; Furman Brian L, 2015, Curr Protoc Pharmacol, V70, DOI 10.1002/0471141755.ph0547s70; Jeong SM, 2012, NUTR RES PRACT, V6, P201, DOI 10.4162/nrp.2012.6.3.201; Karabatas LM, 2005, PANCREAS, V30, P318, DOI 10.1097/01.mpa.0000161888.02244.7a; Kesari AN, 2006, J ETHNOPHARMACOL, V107, P374, DOI 10.1016/j.jep.2006.03.042; King AJF, 2012, BRIT J PHARMACOL, V166, P877, DOI 10.1111/j.1476-5381.2012.01911.x; Kongkiatpaiboon S, 2018, REV BRAS FARMACOGN, V28, P145, DOI 10.1016/j.bjp.2018.03.002; Lee JH, 2009, DIABETES, V58, P344, DOI 10.2337/db07-1795; Li YY, 2012, BIO-MED MATER ENG, V22, P97, DOI 10.3233/BME-2012-0694; Meier JJ, 2006, DIABETOLOGIA, V49, P2689, DOI 10.1007/s00125-006-0410-5; Meier JJ, 2006, DIABETES CARE, V29, P1554, DOI 10.2337/dc06-0392; Mohamad S, 2011, J ETHNOPHARMACOL, V133, P1021, DOI 10.1016/j.jep.2010.11.037; Mukhopadhyay P, 2015, RSC ADV, V5, P97547, DOI 10.1039/c5ra18896b; Noridayu A.R., 2011, INT FOOD RES J, V18, P925; Oshaghi EA, 2017, CRIT REV CL LAB SCI, V54, P267, DOI 10.1080/10408363.2017.1343274; Revathy J, 2018, BIOMED PHARMACOTHER, V97, P98, DOI 10.1016/j.biopha.2017.10.102; Roslan J, 2017, BIOMED PHARMACOTHER, V86, P570, DOI 10.1016/j.biopha.2016.12.044; SEN T, 1993, LIFE SCI, V52, P737, DOI 10.1016/0024-3205(93)90236-V; SEN T, 1991, J ETHNOPHARMACOL, V33, P135, DOI 10.1016/0378-8741(91)90172-A; Sen T, 2002, PHYTOTHER RES, V16, P331, DOI 10.1002/ptr.892; Sirichaiwetchakoon K, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/4108787; Sumpter KM, 2011, PEDIATR DIABETES, V12, P656, DOI 10.1111/j.1399-5448.2011.00761.x; Suriyaphan O., 2014, MAHIDOL U J PHARM SC, V41, P1; Szkudelski T, 2011, ANN NY ACAD SCI, V1215, P34, DOI 10.1111/j.1749-6632.2010.05844.x; Thomas HE, 2011, DIABETES-METAB RES, V27, P790, DOI 10.1002/dmrr.1253; Thomas HE, 2009, APOPTOSIS, V14, P1389, DOI 10.1007/s10495-009-0339-5; Tomita T, 2017, BOSNIAN J BASIC MED, V17, P183, DOI 10.17305/bjbms.2017.1961; Tomita T, 2016, BOSNIAN J BASIC MED, V16, P162, DOI 10.17305/bjbms.2016.919; van Asseldonk EJP, 2015, CLIN IMMUNOL, V160, P155, DOI 10.1016/j.clim.2015.06.003; Vongsak B, 2018, FOOD BIOSCI, V25, P68, DOI 10.1016/j.fbio.2018.08.006; Widyawati T, 2015, NUTRIENTS, V7, P7764, DOI 10.3390/nu7095365; Widyawati W, 2015, BIRTH-ISS PERINAT C, V42, P337, DOI 10.1111/birt.12181; Wilcox NS, 2016, J AUTOIMMUN, V71, P51, DOI 10.1016/j.jaut.2016.02.001; Yang DK, 2018, BIOMOL THER, V26, P130, DOI 10.4062/biomolther.2017.254; Yazgan UC, 2015, ARCH PHYSIOL BIOCHEM, V121, P157, DOI 10.3109/13813455.2015.1062898; Yu W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098044; Zhang YH, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3919627	43	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212133	10.1371/journal.pone.0212133	http://dx.doi.org/10.1371/journal.pone.0212133			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779805	Green Published, gold, Green Submitted			2022-12-27	WOS:000459062900029
J	Yang, M; Lu, LL; Zhao, M; Liu, J; Li, QL; Li, Q; Xu, P; Fu, L; Luo, LM; He, JH; Meng, WB; Lei, PG; Yuan, JQ				Yang, Man; Lu, Ling-Li; Zhao, Miao; Liu, Jun; Li, Qiu-Lan; Li, Qin; Xu, Peng; Fu, Lin; Luo, Ling-Min; He, Jun-Hui; Meng, Wen-Bo; Lei, Ping-Guang; Yuan, Jin-Qiu			Associations of anxiety with discomfort and tolerance in Chinese patients undergoing esophagogastroduodenoscopy	PLOS ONE			English	Article							GASTROINTESTINAL ENDOSCOPY; SEDATION	Objectives To evaluate the associations of pre-endoscopy anxiety with discomfort and tolerance in patients undergoing unsedated esophagogastroduodenoscopy (EGD). Methods This is a hospital-based cohort study of 348 patients undergoing routine, non-advanced EGD without sedation. The primary outcomes were discomfort and tolerance. The anxiety before endoscopy was evaluated with a 10-point visual analogue scale (VAS). The associations of pre-endoscopy anxiety with the outcomes were evaluated with logistic regression adjusting for potential confounders like age, sex, and body mass index. Results Seventy patients reported severe discomfort and 56 patients reported poor tolerance after endoscopy. The risk of severe discomfort increased with pre-endoscopy anxiety and reached a platform around 7-10 points. Compared with the participants with low pre-endoscopy anxiety, those with moderate (adjusted odds ratio [OR] 2.70, 95% confidence interval [CI] 1.17 to 6.22) and high level of anxiety (adjusted OR 6.87, 95% CI 2.16 to 21.79) were associated with a gradual increase in the risk of severe discomfort (P-trend < 0.001). The association between pre-endoscopy anxiety and tolerance was linear, with an adjusted OR of 1.67(95% CI 1.33 to 2.08) for a 1-score increase in pre-endoscopy anxiety VAS. The associations were not modified by age, sex, pharyngitis, duration of endoscopy, and diameter of the endoscope. Conclusions Pre-endoscopy anxiety was an independent predictor of severe discomfort and poor tolerance in Chinese patients undergoing unsedated EGD. Our findings suggested the importance of the management of anxiety to reduce adverse endoscopic experience and taking high level of anxiety as an indication for sedation.	[Yang, Man; Lu, Ling-Li; Zhao, Miao; Liu, Jun; Li, Qiu-Lan; Li, Qin; Xu, Peng; Fu, Lin; Luo, Ling-Min; He, Jun-Hui; Lei, Ping-Guang] Second Hosp Grp Baoan, Songgang Peoples Hosp, Dept Gastroenterol, Shenzhen, Peoples R China; [Meng, Wen-Bo] Lanzhou Univ, Hosp 1, Special Minimally Invas Surg, Lanzhou, Gansu, Peoples R China; [Yuan, Jin-Qiu] Sun Yat Sen Univ, Affiliated Hosp 7, Sci Res Ctr, Shenzhen, Guangdong, Peoples R China; [Yuan, Jin-Qiu] Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Div Epidemiol, Hong Kong, Peoples R China	Lanzhou University; Sun Yat Sen University; Chinese University of Hong Kong	Lei, PG (corresponding author), Second Hosp Grp Baoan, Songgang Peoples Hosp, Dept Gastroenterol, Shenzhen, Peoples R China.; Yuan, JQ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 7, Sci Res Ctr, Shenzhen, Guangdong, Peoples R China.; Yuan, JQ (corresponding author), Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Div Epidemiol, Hong Kong, Peoples R China.	18002575273@163.com; yuanjinqiu06@gmail.com						Abraham N, 2002, GASTROINTEST ENDOSC, V56, P180, DOI 10.1067/mge.2002.125825; Campo R, 1995, ENDOSCOPY, V27, P659, DOI 10.1055/s-2007-1005783; Campo R, 1999, EUR J GASTROEN HEPAT, V11, P201, DOI 10.1097/00042737-199902000-00023; Chiu J-P., 2009, J INTERN MED, V20, P359; Early DS, 2012, GASTROINTEST ENDOSC, V75, P1127, DOI 10.1016/j.gie.2012.01.011; Farhadi A, 2001, DIAGN THER ENDOSC, V7, P141, DOI DOI 10.1155/DTE.7.141; Goudra B, 2017, CLIN ENDOSC, V50, P161, DOI 10.5946/ce.2016.019; Hakan U., 2011, ENDOSKOPI DERGISI, V19, P47; Hastie T, 1995, Stat Methods Med Res, V4, P187, DOI 10.1177/096228029500400302; Huang HH, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-12; Hurvich CM, 1998, J ROY STAT SOC B, V60, P271, DOI 10.1111/1467-9868.00125; Ko HH, 2009, GASTROINTEST ENDOSC, V69, P883, DOI 10.1016/j.gie.2008.06.024; Kutluturkan S, 2010, INT J NURS STUD, V47, P1066, DOI 10.1016/j.ijnurstu.2010.01.007; Ladas SD, 2010, DIGESTION, V82, P74, DOI 10.1159/000285248; Marschner IC, 2012, BIOSTATISTICS, V13, P179, DOI 10.1093/biostatistics/kxr030; MOULTON C, 1991, BRIT MED J, V303, P1240, DOI 10.1136/bmj.303.6812.1240; Mui LM, 2005, GASTROINTEST ENDOSC, V61, P195, DOI 10.1016/S0016-5107(04)02590-8; Mulcahy HE, 2001, SCAND J GASTROENTERO, V36, P1352; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; Pena LR, 2005, DIGEST DIS SCI, V50, P1860, DOI 10.1007/s10620-005-2952-7; Pontone S, 2015, SAUDI J GASTROENTERO, V21, P111, DOI 10.4103/1319-3767.153839; SAMSOON GLT, 1987, ANAESTHESIA, V42, P487, DOI 10.1111/j.1365-2044.1987.tb04039.x; Thanvi BR, 2003, POSTGRAD MED J, V79, P650, DOI 10.1136/pmj.79.937.650; Wang MC, 2014, PAIN MED, V15, P1786, DOI 10.1111/pme.12514	24	8	8	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212180	10.1371/journal.pone.0212180	http://dx.doi.org/10.1371/journal.pone.0212180			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779762	gold, Green Submitted, Green Published			2022-12-27	WOS:000459062900030
J	Letnes, PA; Hansen, IM; Aas, LMS; Eide, I; Pettersen, R; Tassara, L; Receveur, J; le Floch, S; Guyomarch, J; Camus, L; Bytingsvik, J				Letnes, Paul Anton; Hansen, Ingrid Myrnes; Aas, Lars Martin Sandvik; Eide, Ingvar; Pettersen, Ragnhild; Tassara, Luca; Receveur, Justine; le Floch, Stephane; Guyomarch, Julien; Camus, Lionel; Bytingsvik, Jenny			Underwater hyperspectral classification of deep sea corals exposed to 2-methylnaphthalene	PLOS ONE			English	Article							LOPHELIA-PERTUSA L; HORIZON OIL-SPILL; WATER; REEFS; BIOLOGY	Coral reefs around the world are under threat due to anthropogenic impacts on the environment. It is therefore important to develop methods to monitor the status of the reefs and detect changes in the health condition of the corals at an early stage before severe damage occur. In this work, we evaluate underwater hyperspectral imaging as a method to detect changes in health status of both orange and white color morphs of the coral species Lophelia pertusa. Differing health status was achieved by exposing 60 coral samples to the toxic compound 2-methylnaphthalene in concentrations of 0 mg L-1 to 3.5 mg L-1. A machine learning model was utilized to classify corals according to lethal concentration (LC) levels LC5 (5% mortality) and LC25 (25% mortality), solely based on their reflectance spectra. All coral samples were classified to correct concentration group. This is a first step towards developing a remote sensing technique able to assess environmental impact on deep-water coral habitats over larger areas.	[Letnes, Paul Anton; Hansen, Ingrid Myrnes; Aas, Lars Martin Sandvik] Ecotone AS, Trondheim, Norway; [Eide, Ingvar] Statoil ASA, Res & Technol, Trondheim, Norway; [Pettersen, Ragnhild; Tassara, Luca; Camus, Lionel; Bytingsvik, Jenny] Akvaplan Niva AS, Tromso, Norway; [Receveur, Justine; le Floch, Stephane; Guyomarch, Julien] Ctr Documentat Rech & Expt Pollut Accid Eaux, Brest, France	Equinor; Akvaplan-niva	Letnes, PA (corresponding author), Ecotone AS, Trondheim, Norway.	paul.anton.letnes@gmail.com			Research Council of Norway (RCN); Statoil; ConocoPhillips Skandinavia; Dea Norge; ENI Norge; Lundin Norway; Total EP Norge; Norwegian Deepwater Programme; Ecotone; Akvaplan-niva (RCN project) [235440/E30]; project "Species Sensitivity Distribution for Deep Sea Species and Toxicity of continuous and spiked exposures to crude oil at 1 atm for deep sea species"; American Petroleum Institute (API)	Research Council of Norway (RCN)(Research Council of Norway); Statoil; ConocoPhillips Skandinavia; Dea Norge; ENI Norge; Lundin Norway; Total EP Norge; Norwegian Deepwater Programme; Ecotone; Akvaplan-niva (RCN project)(Akvaplan-niva); project "Species Sensitivity Distribution for Deep Sea Species and Toxicity of continuous and spiked exposures to crude oil at 1 atm for deep sea species"; American Petroleum Institute (API)	This study is part of the joint industry project "New technology and methods for mapping and monitoring of seabed habitats", financed by the Research Council of Norway (RCN), Statoil, ConocoPhillips Skandinavia, Dea Norge, ENI Norge, Lundin Norway, Total E&P Norge, Norwegian Deepwater Programme, Ecotone, and Akvaplan-niva (RCN project number 235440/E30). The exposure experiment received financial support from the project "Species Sensitivity Distribution for Deep Sea Species and Toxicity of continuous and spiked exposures to crude oil at 1 atm for deep sea species", led by Akvaplan-niva and financed by the American Petroleum Institute (API). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Ecotone AS, Statoil and Akvaplan-niva AS provided support in the form of salaries for authors PAL, IMH, LMSA, IE, RP, LT, LC and JB but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Albright R, 2016, NATURE, V531, P362, DOI 10.1038/nature17155; Barott K, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008043, 10.1371/journal.pone.0010950]; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Beyer J, 2016, MAR POLLUT BULL, V110, P28, DOI 10.1016/j.marpolbul.2016.06.027; Brooke S, 2013, MAR BIOL, V160, P139, DOI 10.1007/s00227-012-2071-x; Butler JD, 2013, SCI TOTAL ENVIRON, V463, P952, DOI 10.1016/j.scitotenv.2013.06.079; Cairns Stephen D., 1994, SMITHSONIAN CONTRIBU, V557, P1, DOI DOI 10.5479/SI.00810282.557.I; Chennu A, 2013, LIMNOL OCEANOGR-METH, V11, P511, DOI 10.4319/lom.2013.11.511; Costello MJ, 2005, ERLANGEN EARTH C SER, P771, DOI 10.1007/3-540-27673-4_41; Eide I, 2017, INTEGR ENVIRON ASSES, V13, P387, DOI 10.1002/ieam.1840; Elde AC, 2012, MAR DRUGS, V10, P1400, DOI 10.3390/md10061400; Fossa JH, 2002, HYDROBIOLOGIA, V471, P1, DOI 10.1023/A:1016504430684; Freiwald A., 1998, THESIS; Gleason ACR, 2007, P OCEANS 2007 29 SEP, P1, DOI [10.1109/OCEANS.2007.4449394, DOI 10.1109/OCEANS.2007.4449394]; Guyomarch J, P 33 AMOP TECHN SEM, V1; Holden H, 1999, INT J REMOTE SENS, V20, P2545, DOI 10.1080/014311699211921; Johnsen G., 2013, SUBSEA OPTICS IMAGIN, p, DOI DOI 10.1533/9780857093523.3.508; Johnsen G, 2016, IFAC PAPERSONLINE, V49, P476, DOI 10.1016/j.ifacol.2016.10.451; Joyce KE, 2003, LIMNOL OCEANOGR, V48, P489, DOI 10.4319/lo.2003.48.1_part_2.0489; Kohavi Ron, 1995, P 14 INT JOINT C ART, V2, DOI DOI 10.1067/MOD.2000.109031; Kutser T, 2006, ESTUAR COAST SHELF S, V70, P449, DOI 10.1016/j.ecss.2006.06.026; Larsson AI, 2013, MAR POLLUT BULL, V70, P176, DOI 10.1016/j.marpolbul.2013.02.033; Liu G., 2006, P 10 INT CORAL REEF, Vvol. 1793, P1783; Lopez M, 2011, LECT NOTES ARTIF INT, V6678, P132, DOI 10.1007/978-3-642-21219-2_18; Maier C, 2009, BIOGEOSCIENCES, V6, P1671, DOI 10.5194/bg-6-1671-2009; MORTENSEN PB, 1995, SARSIA, V80, P145, DOI 10.1080/00364827.1995.10413586; Mumby PJ, 2004, MAR POLLUT BULL, V48, P219, DOI 10.1016/j.marpolbul.2003.10.031; Osterloff J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157329; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pope RM, 1997, APPL OPTICS, V36, P8710, DOI 10.1364/AO.36.008710; Reddy CM, 2012, P NATL ACAD SCI USA, V109, P20229, DOI 10.1073/pnas.1101242108; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; Rogers AD, 1999, INT REV HYDROBIOL, V84, P315; SHELTON GAB, 1980, J MAR BIOL ASSOC UK, V60, P517, DOI 10.1017/S0025315400028538; Stogiannidis E, 2015, REV ENVIRON CONTAM T, V234, P49, DOI 10.1007/978-3-319-10638-0_2; Tollefson J, 2016, NATURE, V537, P123, DOI 10.1038/537123a; Turley CM, 2007, CORAL REEFS, V26, P445, DOI 10.1007/s00338-007-0247-5; UPADHYAY RR, 1970, ACTA CHEM SCAND, V24, P3055, DOI 10.3891/acta.chem.scand.24-3055; White HK, 2012, P NATL ACAD SCI USA, V109, P20303, DOI 10.1073/pnas.1118029109; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Wu TF, 2004, J MACH LEARN RES, V5, P975	41	12	12	8	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0209960	10.1371/journal.pone.0209960	http://dx.doi.org/10.1371/journal.pone.0209960			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811426	Green Submitted, gold, Green Published			2022-12-27	WOS:000459806400006
J	Chiou, YJ; Huang, TL				Chiou, Yu-Jie; Huang, Tiao-Lai			Accuracy of brain-derived neurotrophic factor levels for differentiating between Taiwanese patients with major depressive disorder or schizophrenia and healthy controls	PLOS ONE			English	Article							BDNF LEVELS; SERUM CONCENTRATIONS; PLASMA; ASSOCIATIONS; BIOMARKERS; BIPOLAR	Objectives Brain-derived neurotrophic factor (BDNF) has been associated with the psychopathology of both major depressive disorder (MDD) and schizophrenia (SZ). However, studies focusing on the accuracy of BDNF levels to differentiate between these patients and healthy controls (HCs) have been rare. Methods Over a discrete ten-year period, we investigated serum BDNF levels in patients with MDD or SZ and compared them to HCs. Results We found serum BDNF levels in 224 samples with SZ to be lower than those in 390 HCs samples (p = 0.007), but not lower than those in the 273 samples with MDD. Male MDD patients tended to have lower BDNF levels compared to male HCs (p = 0.083). The receiver operating characteristic curve analysis demonstrated that BDNF levels were moderately accurate in differentiating male MDD patients and female patients with SZ from HCs (AUC = 0.652 and 0.623, respectively). The most adequate cut-off points for BDNF level were 5.11 ng/ml (sensitivity = 81.1%, specificity = 48.5%) and 5.88 ng/ml (sensitivity = 74.1%, specificity = 57.4%), respectively. Conclusions Our results support that BDNF demonstrated moderate accuracy in distinguishing male patients with MDD and female patients with SZ from HCs. In the future, greater samples would be required to further confirm these results.	[Chiou, Yu-Jie; Huang, Tiao-Lai] Kaohsiung Chang Gung Mem Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Chiou, Yu-Jie; Huang, Tiao-Lai] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Huang, TL (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Psychiat, Kaohsiung, Taiwan.	a540520@adm.cgmh.org.tw			 [CMRPG8054];  [CMRPG840521];  [CMRPG860491];  [CMRPG870951];  [CMRPG870952];  [CMRPG8E0351];  [CMRPG8F1061];  [CMRPG8F1461];  [NSC94-2314-B-182A-208];  [NSC96-2314-B-182A-091];  [NSC99-2628-B-182-002];  [MOST103-2314-B182A-012]	; ; ; ; ; ; ; ; ; ; ; 	This work was funded by grant nos. CMRPG8054, CMRPG840521, CMRPG860491, CMRPG870951, CMRPG870952, CMRPG8E0351, CMRPG8F1061, CMRPG8F1461, NSC94-2314-B-182A-208, NSC96-2314-B-182A-091, NSC99-2628-B-182-002 and MOST103-2314-B182A-012 in Taiwan.	BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; Buckley PF, 2007, SCHIZOPHR RES, V91, P1, DOI 10.1016/j.schres.2006.12.026; Bus BAA, 2015, MOL PSYCHIATR, V20, P602, DOI 10.1038/mp.2014.83; Bus BAA, 2011, PSYCHONEUROENDOCRINO, V36, P228, DOI 10.1016/j.psyneuen.2010.07.013; Cain SW, 2017, J BIOL RHYTHM, V32, P75, DOI 10.1177/0748730417693124; Cassiman D, 2001, HEPATOLOGY, V33, P148, DOI 10.1053/jhep.2001.20793; Chen CC, 2011, PSYCHIAT RES, V189, P327, DOI 10.1016/j.psychres.2011.01.011; Chen DC, 2009, PSYCHOPHARMACOLOGY, V207, P375, DOI 10.1007/s00213-009-1665-6; Chiou YJ, 2017, WORLD J BIOL PSYCHIA, V18, P382, DOI 10.1080/15622975.2016.1224925; Chiou YJ, 2017, INT J NEUROPSYCHOPH, V20, P213, DOI 10.1093/ijnp/pyw096; CHONG MY, 1989, PSYCHOL MED, V19, P495, DOI 10.1017/S0033291700012526; Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597; Elfving B, 2012, J PSYCHIATR RES, V46, P1118, DOI 10.1016/j.jpsychires.2012.05.003; Fernandes BS, 2015, MOL PSYCHIATR, V20, P1108, DOI 10.1038/mp.2014.117; Fernandes B S, 2014, Mol Psychiatry, V19, P750, DOI 10.1038/mp.2013.172; Fernandes BS, 2009, J PSYCHIATR RES, V43, P1200, DOI 10.1016/j.jpsychires.2009.04.010; First M. B., 1997, STRUCTURED CLIN INTE; Giese M, 2014, MOL PSYCHIATR, V19, P151, DOI 10.1038/mp.2013.10; Halbreich U, 2006, CNS DRUGS, V20, P523, DOI 10.2165/00023210-200620070-00001; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Heitz U, 2019, WORLD J BIOL PSYCHIA, V20, P545, DOI 10.1080/15622975.2018.1462532; Huang TL, 2008, J PSYCHIATR RES, V42, P521, DOI 10.1016/j.jpsychires.2007.05.007; Huang TL, 2006, J PSYCHIATR RES, V40, P664, DOI 10.1016/j.jpsychires.2005.11.004; Huang TL, 2015, ADV CLIN CHEM, V68, P177, DOI 10.1016/bs.acc.2014.11.003; Karege F, 2002, PSYCHIAT RES, V109, P143, DOI 10.1016/S0165-1781(02)00005-7; KAY SR, 1989, BRITISH JOURNAL OF PSYCHIATRY, VOL 155, SUPP NO. 7, P59, DOI 10.1192/S0007125000291514; Kishi T, 2018, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00308; KUHN TS, 1962, SCIENCE, V136, P760, DOI 10.1126/science.136.3518.760; Lee AH, 2011, J CLIN PSYCHOPHARM, V31, P334, DOI 10.1097/JCP.0b013e31821895c1; LEVIMONTALCINI R, 1951, J EXP ZOOL, V116, P321, DOI 10.1002/jez.1401160206; Li CY, 2018, INT J MED SCI, V15, P900, DOI 10.7150/ijms.24346; Li ZZ, 2014, BRIT J PSYCHIAT, V205, P29, DOI 10.1192/bjp.bp.113.134064; Man LJ, 2018, PSYCHIAT RES, V263, P1, DOI 10.1016/j.psychres.2018.02.034; Molendijk ML, 2014, MOL PSYCHIATR, V19, P791, DOI 10.1038/mp.2013.105; Molendijk ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048046; Nuernberg GL, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.227; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Pillai A, 2010, INT J NEUROPSYCHOPH, V13, P535, DOI 10.1017/S1461145709991015; Post RM, 2007, J PSYCHIATR RES, V41, P979, DOI 10.1016/j.jpsychires.2006.09.009; Rizos EN, 2008, PROG NEURO-PSYCHOPH, V32, P1308, DOI 10.1016/j.pnpbp.2008.04.007; Rush AJ, 2007, J CLIN PSYCHIAT, V68, P4; Sotiropoulou M, 2013, LIFE SCI, V92, P305, DOI 10.1016/j.lfs.2013.01.008; Toyooka K, 2002, PSYCHIAT RES, V110, P249, DOI 10.1016/S0165-1781(02)00127-0; Xiu MH, 2009, PROG NEURO-PSYCHOPH, V33, P1508, DOI 10.1016/j.pnpbp.2009.08.011; Youssef MM, 2018, INT J NEUROPSYCHOPH, V21, P528, DOI 10.1093/ijnp/pyy008; Zhang Y, 2018, PSYCHOPHARMACOLOGY, V235, P1191, DOI 10.1007/s00213-018-4835-6	46	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212373	10.1371/journal.pone.0212373	http://dx.doi.org/10.1371/journal.pone.0212373			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794585	Green Published, Green Submitted, gold			2022-12-27	WOS:000459709100059
J	Hemmatian, Z; Tunuguntla, RH; Noy, A; Rolandi, M				Hemmatian, Zahra; Tunuguntla, Ramya H.; Noy, Aleksandr; Rolandi, Marco			Electronic control of H+ current in a bioprotonic device with carbon nanotube porins	PLOS ONE			English	Article							PROTON; TRANSPORT	Hybrid biotic abiotic devices can be used to interface electronics with biological systems for novel therapies or to increase device functionality beyond silicon. Many strategies exist to merge the electronic and biological worlds, one dominated by electrons and holes as charge carriers, the other by ions. In the biological world, lipid bilayers and ion channels are essential to compartmentalize the cell machinery and regulate ionic fluxes across the cell membrane. Here, we demonstrate a bioelectronic device in which a lipid bilayer supported on H+-conducting Pd/PdHx contacts contains carbon nanotubes porin (CNTP) channels. This bioelectronic device uses CNTPs to control of H+ flow across the lipid bilayer with a voltage applied to the Pd/PdHx contacts. Potential applications of these devices include local pH sensing and control.	[Hemmatian, Zahra; Rolandi, Marco] Univ Calif Santa Cruz, Dept Elect & Comp Engn, Santa Cruz, CA 95064 USA; [Tunuguntla, Ramya H.; Noy, Aleksandr] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA USA; [Noy, Aleksandr] Univ Calif Merced, Sch Nat Sci, Merced, CA USA	University of California System; University of California Santa Cruz; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Merced	Rolandi, M (corresponding author), Univ Calif Santa Cruz, Dept Elect & Comp Engn, Santa Cruz, CA 95064 USA.	mrolandi@ucsc.edu		Noy, Aleksandr/0000-0003-4924-2652	National Science Foundation [DMR-1648815]; Air Force Office of Sponsored Research part of the CyrborgCell program [FA9550-15-1-0273]; U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [SCW0972]; U.S. Department of Energy [DE-AC52-07NA27344]	National Science Foundation(National Science Foundation (NSF)); Air Force Office of Sponsored Research part of the CyrborgCell program(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE))	The device work was funded by the National Science Foundation DMR-1648815 and by the Air Force Office of Sponsored Research under award #FA9550-15-1-0273 part of the CyrborgCell program directed by Dr. Patrick Bradshaw to ZH. CNTP synthesis and characterization was supported by the U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering under award SCW0972. Work at the Lawrence Livermore National Laboratory was performed under the auspices of the U.S. Department of Energy under Contract DE-AC52-07NA27344.	Ajo-Franklin CM, 2015, ADV MAT; Angione MD, 2012, P NATL ACAD SCI USA, V109, P6429, DOI 10.1073/pnas.1200549109; Busath D, 1981, GRAMICIDIN FORMS MUL; DeCoursey TE, 2015, BIOCHEMISTRY; Deng Y, 2013, SCI REPORTS, V3; Geng J, 2014, NATURE, V514, P612, DOI 10.1038/nature13817; GLASSER L, 1975, CHEM REV, V75, P21, DOI 10.1021/cr60293a002; Hemmatian Z, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12981; Huang SCJ, 2010, NANO LETT, V10, P1812, DOI 10.1021/nl100499x; Johnson N, 2015, BIOPHYS J, V108, p485A, DOI 10.1016/j.bpj.2014.11.2653; Jonsson A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500039; Josberger EE, 2014, ADV MATER, V26, P4986, DOI 10.1002/adma.201400320; Kim YJ, 2013, J MATER CHEM B, V1, P3781, DOI 10.1039/c3tb20183j; Lanyi JK, 2004, ANNU REV PHYSIOL, V66, P665, DOI 10.1146/annurev.physiol.66.032102.150049; Malliaras G, 2015, ADV MATER, V27, P7492, DOI 10.1002/adma.201504783; Misra N, 2009, P NATL ACAD SCI USA, V106, P13780, DOI 10.1073/pnas.0904850106; MITCHELL P, 1967, FED PROC, V26, P1370; Mitraka E, 2015, J MATER CHEM C, V3, P7604, DOI 10.1039/c5tc00753d; Miyake T, 2016, J PHYS-CONDENS MAT, V28, DOI 10.1088/0953-8984/28/2/023001; Miyake T, 2015, APL MATER, V3, DOI 10.1063/1.4900886; MOROWITZ HJ, 1978, AM J PHYSIOL, V235, pR99, DOI 10.1152/ajpregu.1978.235.3.R99; Noy A, 2015, BIOPHYS J, V108, p443A, DOI 10.1016/j.bpj.2014.11.2418; Ordinario DD, 2015, APL MATER, V3, DOI 10.1063/1.4901296; Ordinario DD, 2014, NAT CHEM, V6, P597, DOI [10.1038/NCHEM.1960, 10.1038/nchem.1960]; Owens RM, 2010, MRS BULL, V35, P449, DOI 10.1557/mrs2010.583; Pang C, 2015, ADV MATER, V27, P634, DOI 10.1002/adma.201403807; Rolandi M, 2014, NAT CHEM, V6, P563, DOI 10.1038/nchem.1980; Shen YX, 2014, J MEMBRANE SCI, V454, P359, DOI 10.1016/j.memsci.2013.12.019; Smith SME, 2011, P NATL ACAD SCI USA, V108, P18162, DOI 10.1073/pnas.1115405108; Soto-Rodriguez J, 2016, ADV MATER, V28, P6581, DOI 10.1002/adma.201600222; Stavrinidou E, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1501136; Tunuguntla RH, 2016, NAT NANOTECHNOL, V11, P639, DOI [10.1038/nnano.2016.43, 10.1038/NNANO.2016.43]; Tybrandt K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1869; Tybrandt K, 2010, P NATL ACAD SCI USA, V107, P9929, DOI 10.1073/pnas.0913911107; Walz D, 2002, BIOELECTROCHEMISTRY, V55, P89, DOI 10.1016/S1567-5394(01)00162-1; Williamson A, 2015, ADV MATER, V27, P3097; Zhong C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1489	37	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212197	10.1371/journal.pone.0212197	http://dx.doi.org/10.1371/journal.pone.0212197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794578	Green Published, gold, Green Submitted			2022-12-27	WOS:000459709100045
J	Lim, CC; Chee, ML; Cheng, CY; Kwek, JL; Foo, M; Wong, TY; Sabanayagam, C				Lim, Cynthia C.; Chee, Miao Li; Cheng, Ching-Yu; Kwek, Jia Liang; Foo, Majorie; Wong, Tien Yin; Sabanayagam, Charumathi			Simplified end stage renal failure risk prediction model for the low-risk general population with chronic kidney disease	PLOS ONE			English	Article							EYE DISEASES; PREVALENCE; PROGRESSION; ASSOCIATION; METHODOLOGY; VALIDATION; ALBUMIN; PEOPLE; COHORT	Background Chronic kidney disease (CKD) contributes significant morbidity and mortality among Asians; hence interventions should focus on those most at-risk of progression. However, current end stage renal failure (ESRF) risk stratification tools are complex and not validated in multi-ethnic Asians. We hence aimed to develop an ESRF risk prediction model by taking into account ethnic differences within a fairly homogenous socioeconomic setting and using parameters readily accessible to primary care clinicians managing the vast majority of patients with CKD. Methods We performed a prospective cohort study of 1970 adults with CKD estimated glomerular filtration rate <60 ml/min/1.73m(2) or albuminuria >30 mg/g from the population-based Singapore Epidemiology of Eye Diseases study (n = 10,033). Outcome was incident ESRF, ascertained by linkage to the Singapore Renal Registry until 2015. Results Mean follow up was 8.5 +/- 1.8 years and ESRF occurred in 32 individuals (1.6%). ESRF incidence rates were 2.8, 0.8 and 2.6 per 1000 patient years in Malays, Indians and Chinese respectively. The best ESRF prediction model included age, gender, eGFR and albuminuria (calibration chi(2) = 0.45, P = 0.93; C-statistic 0.933, 95% confidence interval (CI) 0.889-0.978, p = 0.01; AIC 356). Addition of ethnicity improved discrimination marginally (C statistic 0.942, 95% CI 0.903-0.981, p = 0.21). Addition of clinical variables such as diabetes and hyperlipidemia did not improve model performance significantly. Conclusion We affirmed the utility of commonly available clinical information (age, gender, eGFR and UACR) in prognosticating ESRF for multi-ethnic Asians with CKD.	[Lim, Cynthia C.; Kwek, Jia Liang; Foo, Majorie] Singapore Gen Hosp, Dept Renal Med, Singapore, Singapore; [Chee, Miao Li; Cheng, Ching-Yu; Wong, Tien Yin; Sabanayagam, Charumathi] Singapore Eye Res Inst, Singapore Natl Eye Ctr, Singapore, Singapore; [Cheng, Ching-Yu; Wong, Tien Yin; Sabanayagam, Charumathi] Duke NUS Med Sch, Ophthalmol & Visual Sci Acad Clin Program, Singapore, Singapore; [Cheng, Ching-Yu; Wong, Tien Yin; Sabanayagam, Charumathi] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore, Singapore	Singapore General Hospital; National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore	Sabanayagam, C (corresponding author), Singapore Eye Res Inst, Singapore Natl Eye Ctr, Singapore, Singapore.; Sabanayagam, C (corresponding author), Duke NUS Med Sch, Ophthalmol & Visual Sci Acad Clin Program, Singapore, Singapore.; Sabanayagam, C (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore, Singapore.	charumathi.sabanayagam@seri.com.sg	Sabanayagam, Charumathi/C-1294-2011; Cheng, Ching-Yu/Y-2229-2019; Wong, Tien Yin/AAC-9724-2020	Sabanayagam, Charumathi/0000-0002-4042-4719; Cheng, Ching-Yu/0000-0003-0655-885X; Wong, Tien Yin/0000-0002-8448-1264	National Medical Research Council [0796/2003, 1149/2008, STaR/0003/2008, NMRC/OFLCG/001/2017]; Biomedical Research Council [08/1/35/19/550]	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical Research Council(Agency for Science Technology & Research (A*STAR))	This study was supported by the National Medical Research Council Grants nos. 0796/2003, 1149/2008, STaR/0003/2008, NMRC/OFLCG/001/2017 and Biomedical Research Council no. 08/1/35/19/550. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Assogba GFA, 2012, DIABETES METAB, V38, P558, DOI 10.1016/j.diabet.2012.08.004; Chia YC, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-173; Choong H, 2010, 7 REPORT SINGAPORE R; D'Agostino RB, 2004, HANDB STAT, V23, P1; Eustace JA, 2004, KIDNEY INT, V65, P1031, DOI 10.1111/j.1523-1755.2004.00481.x; Foong AWP, 2007, OPHTHAL EPIDEMIOL, V14, P25, DOI 10.1080/09286580600878844; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Lavanya R, 2009, OPHTHAL EPIDEMIOL, V16, P325, DOI 10.3109/09286580903144738; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levin A, 2007, KIDNEY INT, V71, P31, DOI 10.1038/sj.ki.5002009; Levin A, 2012, KIDNEY INT S, V2013, P1, DOI DOI 10.1038/kisup.2012.73; Lew QLJ, 2018, NEPHRON, V138, P202, DOI 10.1159/000485110; Lim CC, 2015, EUR J PREV CARDIOL, V22, P1018, DOI 10.1177/2047487314536873; Low S, 2017, DIABETES RES CLIN PR, V123, P49, DOI 10.1016/j.diabres.2016.11.008; Matsushita K, 2010, AM J KIDNEY DIS, V55, P648, DOI 10.1053/j.ajkd.2009.12.016; Mise K, 2015, DIABETES-METAB RES, V31, P572, DOI 10.1002/dmrr.2633; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; Peeters MJ, 2013, NEPHROL DIAL TRANSPL, V28, P1773, DOI 10.1093/ndt/gft063; Peralta CA, 2011, JAMA-J AM MED ASSOC, V305, P1545, DOI 10.1001/jama.2011.468; Prasannakumar M, 2015, Indian J Endocrinol Metab, V19, P520, DOI 10.4103/2230-8210.157857; Rim THT, 2013, J KOREAN MED SCI, V28, P814, DOI 10.3346/jkms.2013.28.6.814; Sabanayagam C, 2010, NEPHROL DIAL TRANSPL, V25, P2564, DOI 10.1093/ndt/gfq084; Stevens LA, 2010, AM J KIDNEY DIS, V56, P486, DOI 10.1053/j.ajkd.2010.03.026; Tangri N, 2016, JAMA-J AM MED ASSOC, V315, P164, DOI 10.1001/jama.2015.18202; Tangri N, 2011, JAMA-J AM MED ASSOC, V305, P1553, DOI 10.1001/jama.2011.451; Teo BW, 2011, AM J KIDNEY DIS, V58, P56, DOI 10.1053/j.ajkd.2011.02.393; Vassalotti JA, 2008, AM J KIDNEY DIS, V51, pS56, DOI 10.1053/j.ajkd.2007.12.018; Wong CW, 2016, EBIOMEDICINE, V5, P193, DOI 10.1016/j.ebiom.2016.01.023; Yamanouchi M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190930	31	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212590	10.1371/journal.pone.0212590	http://dx.doi.org/10.1371/journal.pone.0212590			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794622	Green Submitted, Green Published, gold			2022-12-27	WOS:000459709100094
J	Maixnerova, D; Ling, CY; Hall, S; Reily, C; Brown, R; Neprasova, M; Suchanek, M; Honsova, E; Zima, T; Novak, J; Tesar, V				Maixnerova, Dita; Ling, Chunyan; Hall, Stacy; Reily, Colin; Brown, Rhubell; Neprasova, Michaela; Suchanek, Miloslav; Honsova, Eva; Zima, Tomas; Novak, Jan; Tesar, Vladimir			Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression	PLOS ONE			English	Article								Background IgA nephropathy (IgAN), the most common primary glomerulonephritis worldwide, has serious outcomes with end-stage renal disease developing in 30-50% of patients. The diagnosis requires renal biopsy. Due to its inherent risks, non-invasive approaches are needed. Methods We evaluated 91 Czech patients with biopsy-proven IgAN who were assessed at time of diagnosis for estimated glomerular filtration rate (eGFR), proteinuria, microscopic hematuria, and hypertension, and then followed prospectively. Serum samples collected at diagnosis were analyzed for galactose-deficient IgA1 (Gd-IgA1) using new native-IgA1 and established neuraminidase-treated-IgA1 tests, Gd-IgA1-specific IgG autoantibodies, discriminant analysis and logistic regression model assessed correlations with renal function and Oxford classification (MEST score). Results Serum levels of native (P < 0.005) and neuraminidase-treated (P < 0.005) Gd-IgA1 were associated with the rate of eGFR decline. A higher relative degree of galactose deficiency in native serum IgA1 predicted a faster eGFR decline and poor renal survival (P < 0.005). However, Gd-IgA1 has not differentiated patients with low vs. high baseline eGFR. Furthermore, patients with high baseline eGFR that was maintained during follow-up were characterized by low serum levels of Gd-IgA1-specific IgG autoantibodies (P = 0.003). Conclusions Including levels of native and neuraminidase-treated Gd-IgA1 and Gd-IgA1-specific autoantibodies at diagnosis may aid in the prognostication of disease progression in Czech patients with IgAN. Future tests will assess utility of these biomarkers in larger patients cohorts from geographically distinct areas.	[Maixnerova, Dita; Neprasova, Michaela; Tesar, Vladimir] Charles Univ Prague, Gen Teaching Hosp, Fac Med 1, Dept Nephrol, Prague, Czech Republic; [Ling, Chunyan; Hall, Stacy; Brown, Rhubell; Novak, Jan] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Ling, Chunyan] Shanghai Univ Tradit Med, Longhua Hosp, Shanghai, Peoples R China; [Reily, Colin] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Suchanek, Miloslav] Jan Evangelista Purkyne Univ Usti Nad Labem, Fac Environm, Usti Nad Labem, Czech Republic; [Honsova, Eva] Inst Clin & Expt Med, Dept Pathol, Prague, Czech Republic; [Zima, Tomas] Charles Univ Prague, Inst Med Biochem & Lab Diagnost, Gen Teaching Hosp, Fac Med 1, Prague, Czech Republic	Charles University Prague; General University Hospital Prague; University of Alabama System; University of Alabama Birmingham; Shanghai University of Traditional Chinese Medicine; University of Alabama System; University of Alabama Birmingham; University of Jan Evangelista Purkyne; Institute for Clinical & Experimental Medicine (IKEM); Charles University Prague; General University Hospital Prague	Maixnerova, D (corresponding author), Charles Univ Prague, Gen Teaching Hosp, Fac Med 1, Dept Nephrol, Prague, Czech Republic.	ditama@centrum.cz	Tesar, Vladimir/O-2312-2017; suchanek, miloslav/ABB-7429-2020; Zima, Tomas/F-6760-2017	Tesar, Vladimir/0000-0001-6982-0689; Zima, Tomas/0000-0001-8518-6972; Maixnerova, Dita/0000-0002-6733-2857	National Institutes of Health [DK106341, DK079337, DK078244, DK082753, GM098539]; Ministry of Health of the Czech Republic [LH15168, PROGRES Q25/LF1, DRO VFN 64165]; Czech Health Research Council - Ministry of Health of the Czech Republic [AZV 15-31662A]; Ministry of Education, Youth and Sports of the Czech Republic [LM2015073]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK106341, R01DK078244, R01DK082753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Czech Health Research Council - Ministry of Health of the Czech Republic; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	JN and CR have been supported in part by grants DK106341, DK079337, DK078244, DK082753, GM098539 from the National Institutes of Health and a gift from the IGA Nephropathy Foundation of America. DM, VT and TZ received funding from grants LH15168, PROGRES Q25/LF1 and DRO VFN 64165 from the Ministry of Health of the Czech Republic. The study was supported by grant from Czech Health Research Council AZV 15-31662A awarded by the Ministry of Health of the Czech Republic. MS acknowledges the assistance provided by the Research Infrastructure NanoEnviCz supported by the Ministry of Education, Youth and Sports of the Czech Republic under project no. LM2015073.	Barbour SJ, 2016, KIDNEY INT, V89, P167, DOI 10.1038/ki.2015.322; Berthoux F, 2012, J AM SOC NEPHROL, V23, P1579, DOI 10.1681/ASN.2012010053; Caliskan Y, 2014, ADV CHRONIC KIDNEY D, V21, P205, DOI 10.1053/j.ackd.2013.12.002; Camilla R, 2011, CLIN J AM SOC NEPHRO, V6, P1903, DOI 10.2215/CJN.11571210; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Coppo R, 2010, KIDNEY INT, V77, P417, DOI 10.1038/ki.2009.473; Gale DP, 2017, J AM SOC NEPHROL, V28, P2158, DOI 10.1681/ASN.2016091043; Haas M, 2017, J AM SOC NEPHROL, V28, P691, DOI 10.1681/ASN.2016040433; Hastings Margaret Colleen, 2013, Expert Opin Med Diagn, V7, P615, DOI 10.1517/17530059.2013.856878; Kiryluk K, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006609; Kiryluk K, 2014, NAT GENET, V46, P1187, DOI 10.1038/ng.3118; Kiryluk K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002765; Moldoveanu Z, 2007, KIDNEY INT, V71, P1148, DOI 10.1038/sj.ki.5002185; Reich HN, 2007, J AM SOC NEPHROL, V18, P3177, DOI 10.1681/ASN.2007050526; Shimozato S, 2008, NEPHROL DIAL TRANSPL, V23, P1931, DOI 10.1093/ndt/gfm913; Suzuki H, 2014, J BIOL CHEM, V289, P5330, DOI 10.1074/jbc.M113.512277; Suzuki H, 2011, J AM SOC NEPHROL, V22, P1795, DOI 10.1681/ASN.2011050464; Suzuki H, 2009, J CLIN INVEST, V119, P1668, DOI 10.1172/JCI38468; Takahashi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099026; Vandeginste B.G.M., 1998, DATA HANDLING SCI TE, V20, P57, DOI [10.1016/S0922-3487(98)80040-3, DOI 10.1016/S0922-3487(98)80040-3]; Wyatt RJ, 2013, NEW ENGL J MED, V368, P2402, DOI 10.1056/NEJMra1206793; Zhao N, 2012, KIDNEY INT, V82, P790, DOI 10.1038/ki.2012.197	22	18	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212254	10.1371/journal.pone.0212254	http://dx.doi.org/10.1371/journal.pone.0212254			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794576	gold, Green Published, Green Submitted			2022-12-27	WOS:000459709100049
J	Matthews, SM; Eshelman, MA; Berg, AS; Koltun, WA; Yochum, GS				Matthews, Stephen M.; Eshelman, Melanie A.; Berg, Arthur S.; Koltun, Walter A.; Yochum, Gregory S.			The Crohn's disease associated SNP rs6651252 impacts MYC gene expression in human colonic epithelial cells	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; LONG-RANGE INTERACTION; C-MYC; T-CELL; WNT; TARGET; RISK; PATHOGENESIS; ELEMENT; LOCI	Crohn's disease (CD) is a debilitating inflammatory bowel disease (IBD) that arises from chronic inflammation in the gastrointestinal tract. Genome-wide association studies (GWAS) have identified over 200 single nucleotide polymorphisms (SNPs) that are associated with a predisposition for developing IBD. For the majority, the causal variant and target genes affected are unknown. Here, we investigated the CD-associated SNP rs6651252 that maps to a gene desert region on chromosome 8. We demonstrate that rs6651252 resides within a Wnt responsive DNA enhancer element (WRE) and that the disease associated allele augments binding of the TCF7L2 transcription factor to this region. Using CRISPR/Cas9 directed gene editing and epigenetic modulation, we find that the rs6651252 enhancer regulates expression of the c-MYC proto-oncogene (MYC). Furthermore, we found MYC transcript levels are elevated in patient-derived colonic segments harboring the disease-associated allele in comparison to those containing the ancestral allele. These results suggest that Wnt/MYC signaling contributes to CD pathogenesis and that patients harboring the disease-associated allele may benefit from therapies that target MYC or MYC-regulated genes.	[Matthews, Stephen M.; Eshelman, Melanie A.; Yochum, Gregory S.] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Matthews, Stephen M.; Eshelman, Melanie A.; Koltun, Walter A.; Yochum, Gregory S.] Penn State Univ, Coll Med, Dept Surg, Div Colon & Rectal Surg, Hershey, PA 17033 USA; [Berg, Arthur S.] Penn State Univ, Coll Med, Dept Publ Hlth Sci, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Yochum, GS (corresponding author), Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA.; Yochum, GS (corresponding author), Penn State Univ, Coll Med, Dept Surg, Div Colon & Rectal Surg, Hershey, PA 17033 USA.	gsy3@psu.edu		Matthews, Stephen/0000-0002-8968-225X	Peter and Marshia Carlino fund for Inflammatory Bowel Disease research	Peter and Marshia Carlino fund for Inflammatory Bowel Disease research	This work was supported by the Peter and Marshia Carlino fund for Inflammatory Bowel Disease research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; Bottomly D, 2010, NUCLEIC ACIDS RES, V38, P5735, DOI 10.1093/nar/gkq363; Chia LA, 2010, PROG MOL BIOL TRANSL, V96, P157, DOI 10.1016/S1877-1173(10)96007-9; CICLITIRA PJ, 1987, J PATHOL, V151, P293, DOI 10.1002/path.1711510409; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Ek WE, 2014, ANN GASTROENTEROL, V27, P294; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Frey MR, 2016, DIGEST DIS SCI, V61, P327, DOI 10.1007/s10620-015-3947-7; Grisanzio Chiara, 2010, Genes Cancer, V1, P555, DOI 10.1177/1947601910381380; Hartman DJ, 2018, INFLAMM BOWEL DIS, V24, P1780, DOI 10.1093/ibd/izy057; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Huppi Konrad, 2012, Frontiers in Genetics, V3, P69, DOI 10.3389/fgene.2012.00069; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kaplan GG, 2017, GASTROENTEROLOGY, V152, P313, DOI 10.1053/j.gastro.2016.10.020; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Komor AC, 2017, CELL, V169, P559, DOI 10.1016/j.cell.2017.04.005; Konsavage WM, 2013, DIGEST DIS SCI, V58, P2858, DOI 10.1007/s10620-013-2686-x; Konsavage WM, 2012, MOL CELL BIOL, V32, P3891, DOI 10.1128/MCB.00548-12; Konsavage WM, 2012, J BIOL CHEM, V287, P11730, DOI 10.1074/jbc.M111.327767; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McGovern DPB, 2015, GASTROENTEROLOGY, V149, P1163, DOI 10.1053/j.gastro.2015.08.001; Meddens CA, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1100-3; Mokry M, 2014, GASTROENTEROLOGY, V146, P1040, DOI 10.1053/j.gastro.2013.12.003; Mokry M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165893; Momozawa Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04365-8; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Raup-Konsavage WM, 2016, DIGEST DIS SCI, V61, P410, DOI 10.1007/s10620-015-3852-0; Rennoll Sherri, 2015, World J Biol Chem, V6, P290, DOI 10.4331/wjbc.v6.i4.290; Rennoll SA, 2016, CANCERS, V8, DOI 10.3390/cancers8050052; Robles AI, 2016, GASTROENTEROLOGY, V150, P931, DOI 10.1053/j.gastro.2015.12.036; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schieffer KM, 2017, AM J PHYSIOL-GASTR L, V313, pG277, DOI 10.1152/ajpgi.00136.2017; Sehgal R, 2012, DIS COLON RECTUM, V55, P115, DOI 10.1097/DCR.0b013e31823ccea8; Sipos F, 2016, WORLD J GASTROENTERO, V22, P7938, DOI 10.3748/wjg.v22.i35.7938; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; van Loosdregt J, 2018, J IMMUNOL, V201, P2193, DOI 10.4049/jimmunol.1800633; Wright JB, 2010, MOL CELL BIOL, V30, P1411, DOI 10.1128/MCB.01384-09; Yaeger R, 2016, GASTROENTEROLOGY, V151, P278, DOI 10.1053/j.gastro.2016.04.001; Yamada A, 2016, WORLD J GASTROENTERO, V22, P2195, DOI 10.3748/wjg.v22.i7.2195; Yochum GS, 2007, P NATL ACAD SCI USA, V104, P3324, DOI 10.1073/pnas.0611576104; Yochum GS, 2007, J BIOL CHEM, V282, P871, DOI 10.1074/jbc.M609391200; Yochum GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018966; Yochum GS, 2008, MOL CELL BIOL, V28, P7368, DOI 10.1128/MCB.00744-08	56	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212850	10.1371/journal.pone.0212850	http://dx.doi.org/10.1371/journal.pone.0212850			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794691	gold, Green Published, Green Submitted			2022-12-27	WOS:000459709100148
J	Pedrini, LA; Zawada, AM; Winter, AC; Pham, J; Klein, G; Wolf, M; Feuersenger, A; Ruggiero, P; Feliciani, A; Barbieri, C; Gauly, A; Canaud, B; Stuard, S				Pedrini, Luciano A.; Zawada, Adam M.; Winter, Anke C.; Pham, Jenny; Klein, Gudrun; Wolf, Melanie; Feuersenger, Astrid; Ruggiero, Pio; Feliciani, Annalisa; Barbieri, Carlo; Gauly, Adelheid; Canaud, Bernard; Stuard, Stefano			Effects of high-volume online mixed-hemodiafiltration on anemia management in dialysis patients	PLOS ONE			English	Article							ERYTHROPOIESIS-STIMULATING AGENTS; CHRONIC KIDNEY-DISEASE; LOW-FLUX; HEMOGLOBIN LEVELS; HEMODIALYSIS; RESISTANCE; EFFICIENCY; MORTALITY; INFLAMMATION; DARBEPOETIN	Background Anemia is a major comorbidity of patients with end-stage renal disease and poses an enormous economic burden to health-care systems. High dose erythropoiesis-stimulating agents (ESAs) have been associated with unfavorable clinical outcomes. We explored whether mixed-dilution hemodiafiltration (Mixed-HDF), based on its innovative substitution modality, may improve anemia outcomes compared to the traditional post-dilution hemodiafiltration (Post-HDF). Methods We included 174 adult prevalent dialysis patients (87 on Mixed-HDF, 87 on Post-HDF) treated in 24 NephroCare dialysis centers between January 2010 and August 2016 into this retrospective cohort study. All patients were dialyzed three times per week and had fistula/ graft as vascular access. Patients were matched at baseline and followed over a one-year period. The courses of hemoglobin levels (Hb) and monthly ESA consumption were compared between the two groups with linear mixed models. Results Mean baseline Hb was 11.9 +/- 1.3 and 11.8 +/- 1.1g/dl in patients on Mixed-and Post-HDF, respectively. While Hb remained stable in patients on Mixed-HDF, it decreased slightly in patients on Post-HDF (at month 12:11.8 +/- 1.2 vs 11.1 +/- 1.2g/dl). This tendency was confirmed by our linear mixed model (p = 0.0514 for treatment x time interaction). Baseline median ESA consumption was 6000 [Q1:0;Q3:16000] IU/4 weeks in both groups. Throughout the observation period ESA doses tended to be lower in the Mixed-HDF group (4000 [Q1:0; Q3:16000] vs 8000 [Q1:0; Q3:20000] IU/4 weeks at month 12; p = 0.0791 for treatment x time interaction). Sensitivity analyses, adjusting for differences not covered by matching at baseline, strengthened our results (Hb: p = 0.0124; ESA: p = 0.0687). Conclusions Results of our explorative study suggest that patients on Mixed-HDF may have clinical benefits in terms of anemia management. This may also have a beneficial economic impact. Future studies are needed to confirm our hypothesis-generating results and to provide additional evidence on the potential beneficial effects of Mixed-HDF.	[Pedrini, Luciano A.; Ruggiero, Pio; Feliciani, Annalisa] Bolognini Hosp, NephroCare ASST Bergamo Est, Dept Nephrol & Dialysis, Seriate, Italy; [Zawada, Adam M.; Winter, Anke C.; Pham, Jenny; Klein, Gudrun; Wolf, Melanie; Feuersenger, Astrid; Gauly, Adelheid] Fresenius Med Care, Clin & Epidemiol Res, Bad Homburg, Germany; [Barbieri, Carlo] Fresenius Med Care, Palazzo Pignano, Italy; [Canaud, Bernard] Fresenius Med Care, Med Off EMEA, Bad Homburg, Germany; [Stuard, Stefano] Fresenius Med Care, Clin & Therapeut Governance, Bad Homburg, Germany		Zawada, AM (corresponding author), Fresenius Med Care, Clin & Epidemiol Res, Bad Homburg, Germany.	adam.zawada@fmc-ag.com	Gauly, Adelheid/X-7273-2019	stuard, stefano/0000-0002-9546-4507				Adamson JW, 2009, ADV CHRONIC KIDNEY D, V16, P76, DOI 10.1053/j.ackd.2008.12.009; Agbas A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198320; Babitt JL, 2012, J AM SOC NEPHROL, V23, P1631, DOI 10.1681/ASN.2011111078; Bennett CL, 2009, SEMIN DIALYSIS, V22, P1, DOI 10.1111/j.1525-139X.2008.00524.x; Biggar P, 2017, KIDNEY RES CLIN PRAC, V36, P209, DOI 10.23876/j.krcp.2017.36.3.209; Bowry SK, 2011, BLOOD PURIFICAT, V32, P210, DOI 10.1159/000329573; den Hoedt CH, 2014, KIDNEY INT, V86, P423, DOI 10.1038/ki.2014.9; Kuhlmann U, 2001, NEPHROL DIAL TRANSPL, V16, P1053, DOI 10.1093/ndt/16.5.1053; Lin CL, 2002, BLOOD PURIFICAT, V20, P349, DOI 10.1159/000063103; Locatelli F, 2017, CONTRIB NEPHROL, V189, P184, DOI 10.1159/000450779; Locatelli F, 2012, NEPHROL DIAL TRANSPL, V27, P3594, DOI 10.1093/ndt/gfs117; Maduell F, 1999, NEPHROL DIAL TRANSPL, V14, P1202, DOI 10.1093/ndt/14.5.1202; Maduell F, 2002, AM J KIDNEY DIS, V40, P582, DOI 10.1053/ajkd.2002.34918; Maduell F, 2013, J AM SOC NEPHROL, V24, P487, DOI 10.1681/ASN.2012080875; Marcelli D, 2001, J NEPHROL, V14, pS94; Marcelli D, 2016, KIDNEY INT, V90, P192, DOI 10.1016/j.kint.2016.03.009; McFarlane PA, 2010, KIDNEY INT, V78, P215, DOI 10.1038/ki.2010.108; Meert N, 2009, NEPHROL DIAL TRANSPL, V24, P562, DOI 10.1093/ndt/gfn522; Mostovaya IM, 2014, SEMIN DIALYSIS, V27, P119, DOI 10.1111/sdi.12200; Nemeth E, 2014, HEMATOL ONCOL CLIN N, V28, P671, DOI 10.1016/j.hoc.2014.04.005; Oates T, 2011, AM J NEPHROL, V33, P70, DOI 10.1159/000322834; Panichi V, 2008, NEPHROL DIAL TRANSPL, V23, P2337, DOI 10.1093/ndt/gfm951; Panichi V, 2015, NEPHROL DIAL TRANSPL, V30, P682, DOI 10.1093/ndt/gfu345; Parfrey PS, 2005, J AM SOC NEPHROL, V16, P2180, DOI 10.1681/ASN.2004121039; Pedrini LA, 2000, KIDNEY INT, V58, P2155, DOI 10.1111/j.1523-1755.2000.00389.x; Pedrini LA, 2006, KIDNEY INT, V69, P573, DOI 10.1038/sj.ki.5000110; Pedrini LA, 2011, CONTRIB NEPHROL, V175, P129, DOI 10.1159/000333629; Pedrini LA, 2011, NEPHROL DIAL TRANSPL, V26, P2617, DOI 10.1093/ndt/gfq761; Peters SAE, 2016, NEPHROL DIAL TRANSPL, V31, P978, DOI 10.1093/ndt/gfv349; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Rene E, 2017, NEPHROL DIAL TRANSPL, V32, P1047, DOI 10.1093/ndt/gfw268; Roumelioti ME, 2018, NEPHROL DIAL TRANSPL, V33, P1025, DOI 10.1093/ndt/gfx311; Shirazian S, 2012, HEMODIAL INT, V16, P342, DOI 10.1111/j.1542-4758.2012.00671.x; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Stefansson BV, 2012, NEPHRON EXTRA, V2, P55, DOI 10.1159/000336482; Tattersall JE, 2013, NEPHROL DIAL TRANSPL, V28, P542, DOI 10.1093/ndt/gfs530; van der Weerd NC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094434; Vaslaki L, 2006, BLOOD PURIFICAT, V24, P163, DOI 10.1159/000090117; Vega A, 2014, HIPPOKRATIA, V18, P315; Wiecek A, 2015, NEPHROL DIAL TRANSPL, V30, P523, DOI 10.1093/ndt/gfv029	40	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212795	10.1371/journal.pone.0212795	http://dx.doi.org/10.1371/journal.pone.0212795			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794672	Green Submitted, Green Published, gold			2022-12-27	WOS:000459709100140
J	Siddall, ME; Barkdull, M; Tessler, M; Brugler, MR; Borda, E; Hekkala, E				Siddall, Mark E.; Barkdull, Megan; Tessler, Michael; Brugler, Mercer R.; Borda, Elizabeth; Hekkala, Evon			Ideating iDNA: Lessons and limitations from leeches in legacy collections	PLOS ONE			English	Article							DIGESTIVE-TRACT MICROBIOTA; MEDICINAL LEECH; ENVIRONMENTAL DNA; HIRUDO-ORIENTALIS; CONSERVATION; EVOLUTION; HISTORY; TOOL; TRYPANOSOMES; AMPHIBIANS	Indirect methods for conducting faunal inventories present great promise, and genomic inventories derived from environmental sources (eDNA) are improving. Invertebrate ingested DNA (iDNA) from terrestrial leeches in the family Haemadipsidae has shown potential for surveying vertebrates and biodiversity monitoring in protected areas. Here we present an initial, and critical, evaluation of the limitations and biases of current iDNA protocols for biodiversity monitoring using both standard and NGS barcoding approaches. Key findings include the need for taxon relevant multi-locus markers and reference databases. In particular, the limitations of available reference databases have profound potential to mislead and bias eDNA and iDNA results if not critically interpreted. Nevertheless, there is great potential for recovery of amplifiable DNA from gut contents of invertebrate museum specimens which may reveal both temporal patterns and cryptic diversity in protected areas with increased efficiency. Our analyses of ingested DNA (iDNA) from both freshly stored and previously collected (legacy) samples of terrestrial leeches successfully identified vertebrates from Myanmar, Australia and Madagascar and indicate the potential to characterize microbial communities, pathogen diversity and interactions at low cost.	[Siddall, Mark E.; Tessler, Michael; Brugler, Mercer R.] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA; [Barkdull, Megan] New Coll Florida, Sarasota, FL USA; [Brugler, Mercer R.] CUNY, Biol Sci Dept, NYC Coll Technol, Brooklyn, NY 11210 USA; [Borda, Elizabeth] Texas A&M Univ, Dept Sci & Math, San Antonio, TX USA; [Hekkala, Evon] Fordham Univ, Dept Biol Sci, Bronx, NY 10458 USA	American Museum of Natural History (AMNH); State University System of Florida; New College Florida; City University of New York (CUNY) System; Texas A&M University System; Fordham University	Siddall, ME (corresponding author), Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA.	siddall@amnh.org	Brugler, Mercer R./AAV-3202-2021	Brugler, Mercer R./0000-0003-3676-1226; Hekkala, Evon/0000-0001-9250-3091; Siddall, Mark/0000-0002-3977-7517; Barkdull, Megan/0000-0001-9334-5726; Borda, Elizabeth/0000-0003-1179-163X	National Science Foundation [DBI-1358465]; Gerstner Family Foundation	National Science Foundation(National Science Foundation (NSF)); Gerstner Family Foundation	This research was supported by grant DBI-1358465 from the National Science Foundation. The Gerstner Family Foundation provided partial support to MRB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Arengo, 2017, FUTURE NATURAL HIST, P82; Bista I, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14087; Bohmann K, 2013, MOL ECOL, V22, P909, DOI 10.1111/mec.12221; Borda E, 2004, LAUTERBORNIA, V52, P25; Borda E, 2010, INVERTEBR SYST, V24, P456, DOI 10.1071/IS10013; Burton AC, 2015, J APPL ECOL, V52, P675, DOI 10.1111/1365-2664.12432; Calvignac-Spencer S, 2013, MOL ECOL, V22, P915, DOI 10.1111/mec.12183; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P9502, DOI 10.1073/pnas.1105538108; Cook JA, 2016, BIOSCIENCE, V66, P917, DOI 10.1093/biosci/biw123; Creer S, 2016, METHODS ECOL EVOL, V7, P1008, DOI 10.1111/2041-210X.12574; De Bondi N, 2010, WILDLIFE RES, V37, P456, DOI 10.1071/WR10046; Deiner K, 2017, MOL ECOL, V26, P5872, DOI 10.1111/mec.14350; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; DeSalle R, 2004, NAT REV GENET, V5, P702, DOI 10.1038/nrg1425; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gariepy TD, 2012, MOL ECOL RESOUR, V12, P646, DOI 10.1111/j.1755-0998.2012.03140.x; Glen AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067940; Graf J, 1999, INFECT IMMUN, V67, P1; Graf J, 2006, TRENDS MICROBIOL, V14, P365, DOI 10.1016/j.tim.2006.06.009; Graf J, 2016, ANNU REV MICROBIOL, V70, P375, DOI 10.1146/annurev-micro-091014-104258; Greenblatt RJ, 2004, VIROLOGY, V321, P101, DOI 10.1016/j.virol.2003.12.026; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gustafsson DR, 2017, ZOOTAXA, V4313, P1, DOI 10.11646/zootaxa.4313.1.1; HAFNER MS, 1990, SYST ZOOL, V39, P192, DOI 10.2307/2992181; Hamilton PB, 2011, TRENDS PARASITOL, V27, P99, DOI 10.1016/j.pt.2010.11.009; Hamilton PB, 2005, INT J PARASITOL, V35, P431, DOI 10.1016/j.ijpara.2004.12.005; Holmes I, 2018, PEERJ, V6, DOI 10.7717/peerj.4662; JAFFE CL, 1984, J IMMUNOL, V133, P440; Johnson PTJ, 2003, CONSERV BIOL, V17, P1724, DOI 10.1111/j.1523-1739.2003.00217.x; Keegan HL, 1968, BLOOD SUCKING ASIAN; Kitano T, 2007, INT J LEGAL MED, V121, P423, DOI 10.1007/s00414-006-0113-y; Kocher A, 2017, MOL ECOL, V26, P6478, DOI 10.1111/mec.14362; Kvist S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028192; Lassen SB, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-143; Laufer AS, 2008, APPL ENVIRON MICROB, V74, P6151, DOI 10.1128/AEM.00795-08; Levine SM, 2010, AM J CRIT CARE, V19, P471, DOI 10.4037/ajcc2009110; Litwinowicz A, 2014, SURG INFECT, V15, P757, DOI 10.1089/sur.2014.036; Malele I, 2003, INFECT GENET EVOL, V3, P271, DOI 10.1016/S1567-1348(03)00090-X; MARTIN DS, 1992, J PARASITOL, V78, P317, DOI 10.2307/3283481; Maslov DA, 1996, MOL BIOCHEM PARASIT, V75, P197, DOI 10.1016/0166-6851(95)02526-X; McLean BS, 2016, J MAMMAL, V97, P287, DOI 10.1093/jmammal/gyv178; Moore J. P., 1924, Proceedings of the Academy of Natural Sciences of Philadelphia, V76, P343; Nelson MC, 2012, GUT MICROBES, V3, P322, DOI 10.4161/gmic.20227; Poinar HN, 1998, SCIENCE, V281, P402, DOI 10.1126/science.281.5375.402; Rappole JH, 1985, NOCTURNAL MAMMALS TE; Richardson RL, 1974, MEMOIRS NATL MUSEUM, V35, P97; Schnell IB, 2018, MOL ECOLOGY RESOURCE; Schnell IB, 2015, FRONT ZOOL, V12, DOI 10.1186/s12983-015-0115-z; Schnell IB, 2012, CURR BIOL, V22, pR262, DOI 10.1016/j.cub.2012.02.058; Siddall ME, 2007, APPL ENVIRON MICROB, V73, P655, DOI 10.1128/AEM.01282-06; Siddall ME, 2011, PARASITOLOGY, V138, P1815, DOI 10.1017/S0031182011000539; Siddall ME, 2004, MOL PHYLOGENET EVOL, V30, P178, DOI 10.1016/S1055-7903(03)00184-2; Silveira L, 2003, BIOL CONSERV, V114, P351, DOI 10.1016/S0006-3207(03)00063-6; Silveira L, 2010, ORYX, V44, P104, DOI 10.1017/S0030605309990433; Spellerberg I. F., 2005, MONITORING ECOLOGICA, DOI DOI 10.1017/CBO9780511614699; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Takahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056584; Tessler M, 2018, SYST BIODIVERS, V16, P488, DOI 10.1080/14772000.2018.1433729; Tessler M, 2016, ZOOL SCR, V45, P552, DOI 10.1111/zsc.12165; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Tobler MW, 2008, ANIM CONSERV, V11, P187, DOI 10.1111/j.1469-1795.2008.00181.x; Todd BD, 2010, ECOTOXICOLOGY OF AMPHIBIANS AND REPTILES, SECOND EDITION, P47, DOI 10.1201/EBK1420064162-c3; TUBANGUI MARCOS A., 1932, PHILIPPINE JOUR SCI, V48, P115; Villette P, 2016, J MAMMAL, V97, P32, DOI 10.1093/jmammal/gyv150; Vongsombath C, 2011, ACTA TROP, V119, P178, DOI 10.1016/j.actatropica.2011.05.014; Weiskopf SR, 2018, J APPL ECOL, V55, P2071, DOI 10.1111/1365-2664.13111; Whitaker IS, 2014, PLAST RECONSTR SURG, V133, p408E, DOI 10.1097/01.prs.0000438461.06217.bb; Williams EH, 2006, J VIROL, V80, P4643, DOI 10.1128/JVI.80.9.4643-4644.2006; Wilson JJ, 2016, CONSERV BIOL, V30, P982, DOI 10.1111/cobi.12787; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4	70	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212226	10.1371/journal.pone.0212226	http://dx.doi.org/10.1371/journal.pone.0212226			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794582	gold, Green Published, Green Submitted			2022-12-27	WOS:000459709100047
J	Carballo, D; Rodondi, N; Auer, R; Carballo, S; Nanchen, D; Raber, L; Klingenberg, R; Keller, PF; Heg, D; Juni, P; Muller, O; Matter, CM; Luscher, TF; Windecker, S; Mach, F; Gencer, B				Carballo, David; Rodondi, Nicolas; Auer, Reto; Carballo, Sebastian; Nanchen, David; Raber, Lorenz; Klingenberg, Roland; Keller, Pierre-Frederic; Heg, Dik; Juni, Peter; Muller, Olivier; Matter, Christian M.; Luscher, Thomas F.; Windecker, Stephan; Mach, Francois; Gencer, Baris			Clinical impact of a structured secondary cardiovascular prevention program following acute coronary syndromes: A prospective multicenter healthcare intervention	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CARDIAC REHABILITATION; DISEASE PREVENTION; GUIDELINES; RATES; THERAPIES; MORTALITY	Background Structured secondary cardiovascular prevention programs (SSCP) following acute coronary syndromes (ACS) may reduce major adverse cardiovascular events (MACE) through better adherence to post-ACS recommendations. Methods Through a prospective multicenter cohort study, we compared the outcomes of two sequential post-ACS patient cohorts, the initial one receiving standard care (SC) followed by one receiving additional interventions (SSCP) aimed at improving patient education as well as healthcare provider and hospital systems. The primary endpoint was MACE at one year. Secondary endpoints included adherence to recommended therapies, attendance to cardiac rehabilitation (CR) and successful achievement of cardiovascular risk factor (CVRF) targets. Results In total, 2498 post-ACS patients from 4 Swiss university hospitals were included: 1210 vs 1288 in the SC and SSCP groups, respectively. The SSCP group demonstrated a significant increase in attendance to CR programs (RR 1.08, 95% CI 1.02-1.14, P = 0.006), despite not achieving the primary MACE endpoint (HR 0.97, 95% CI 0.77-1.22, P = 0.79). After age-stratification, significant reductions in cardiac death, MI and stroke events (HR 0.53, 95% CI 0.30-0.93, P for interaction = 0.016) were observed for SSCP patients <= 65 years old. The SSCP group also scored significantly better for the LDL cholesterol target (RR 1.07, 95% CI 1.02-1.13, P = 0.012), systolic blood pressure target (RR 1.06, 95% CI 1.01-1.13, P = 0.029) and physical activity (RR 1.10, 95% CI 1.01-1.20, P = 0.021). Conclusions The implementation of an SSCP post ACS was associated with an improvement in the control of CVRF and attendance to CR programs, and was also associated with significant reductions in cardiac death, MI and stroke at one year for patients <= 65years old.	[Carballo, David; Keller, Pierre-Frederic; Mach, Francois; Gencer, Baris] Geneva Univ Hosp, Div Cardiol, Geneva, Switzerland; [Rodondi, Nicolas] Univ Hosp Bern, Dept Gen Internal Med, Bern, Switzerland; [Rodondi, Nicolas; Auer, Reto] Univ Bern, Inst Primary Hlth Care BIHAM, Bern, Switzerland; [Auer, Reto; Nanchen, David] Univ Lausanne, Dept Ambulatory Care & Community Med, Lausanne, Switzerland; [Carballo, Sebastian] Geneva Univ Hosp, Dept Internal Med, Geneva, Switzerland; [Raber, Lorenz; Windecker, Stephan] Univ Hosp Bern, Dept Cardiol, Bern, Switzerland; [Klingenberg, Roland; Matter, Christian M.; Luscher, Thomas F.] Univ Zurich, Univ Heart Ctr, Dept Cardiol, Zurich, Switzerland; [Heg, Dik] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Heg, Dik] Univ Bern, Dept Clin Res, Clin Trials Unit, Bern, Switzerland; [Juni, Peter] St Michaels Hosp, Appl Hlth Res Ctr, HUB, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Muller, Olivier] Lausanne Univ, Div Cardiol, Lausanne, Switzerland	University of Geneva; University of Bern; University Hospital of Bern; University of Bern; University of Lausanne; University of Geneva; University of Bern; University Hospital of Bern; University of Zurich; University of Bern; University of Bern; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Lausanne	Carballo, D (corresponding author), Geneva Univ Hosp, Div Cardiol, Geneva, Switzerland.	david.carballo@hcuge.ch	Juni, Peter/Q-8700-2016; Nanchen, David/AAQ-1118-2021; Gencer, Baris/AAO-2305-2020	Juni, Peter/0000-0002-5985-0670; Nanchen, David/0000-0002-2493-3505; Auer, Reto/0000-0003-4222-4849; Heg, Dik/0000-0002-8766-7945; Rodondi, Nicolas/0000-0001-9083-6896	Swiss National Science Foundation [SNSF 320030-150025, SPUM 33CM30-124112, SPUM 33CM30-140336]; de Reuter Foundation; Gerbex-Bourget Foundation; Geneva University Hospitals; Swiss Heart Foundation; Schmidheiny Foundation; Roche Diagnostics; Eli Lilly; AstraZeneca; Medtronic; Merck Sharpe and Dome (MSD); Sanofi-Aventis; St. Jude Medical	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); de Reuter Foundation; Gerbex-Bourget Foundation; Geneva University Hospitals; Swiss Heart Foundation; Schmidheiny Foundation; Roche Diagnostics; Eli Lilly(Eli Lilly); AstraZeneca(AstraZeneca); Medtronic(Medtronic); Merck Sharpe and Dome (MSD); Sanofi-Aventis(Sanofi-Aventis); St. Jude Medical(St. Jude Medical)	The work was supported by the Swiss National Science Foundation (SPUM 33CM30-124112 and SPUM 33CM30-140336, Inflammation and acute coronary syndromes (ACS)-Novel strategies for prevention and clinical management), de Reuter Foundation, Gerbex-Bourget Foundation. B.G.'s research is supported by grants from the Geneva University Hospitals, Swiss Heart Foundation, de Reuter Foundation, Gerbex-Bourget Foundation and Schmidheiny Foundation. N.R.'s research is supported by grants from the Swiss National Science Foundation (SNSF 320030-150025). R.A. and N.R.'s research on cardiovascular prevention is supported by grants from the Swiss Heart Foundation. The SPUM consortium was also supported by Roche Diagnostics, Eli Lilly, AstraZeneca, Medtronic, Merck Sharpe and Dome (MSD), Sanofi-Aventis and St. Jude Medical. None of the funding institutions had any role in the design and conduct of the study, collection, management, analysis and interpretation of the data, nor in the preparation, review, or approval of the manuscript.	Auer R, 2008, CIRCULATION, V117, P3109, DOI 10.1161/CIRCULATIONAHA.107.748095; Auer R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093147; Berwanger O, 2012, JAMA-J AM MED ASSOC, V307, P2041, DOI 10.1001/jama.2012.413; Busato A, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-31; Clark AM, 2005, ANN INTERN MED, V143, P659, DOI 10.7326/0003-4819-143-9-200511010-00010; de Vries H, 2015, EUR HEART J, V36, P1519, DOI 10.1093/eurheartj/ehv111; Eagle KA, 2005, J AM COLL CARDIOL, V46, P1242, DOI 10.1016/j.jacc.2004.12.083; Fox KAA, 2007, JAMA-J AM MED ASSOC, V297, P1892, DOI 10.1001/jama.297.17.1892; Gencer B, 2015, ATHEROSCLEROSIS, V239, P118, DOI 10.1016/j.atherosclerosis.2014.12.049; Gencer B, 2015, EUR J INTERN MED, V26, P56, DOI 10.1016/j.ejim.2014.12.014; Glasgow RE, 1999, AM J PUBLIC HEALTH, V89, P1322, DOI 10.2105/AJPH.89.9.1322; Hamm CW, 2011, TURK KARDIYOL DERN A, V39, P73, DOI 10.1093/eurheartj/ehr236; Klingenberg R, 2015, HEART, V101, P854, DOI 10.1136/heartjnl-2014-306925; Kotseva K, 2009, LANCET, V373, P929, DOI 10.1016/S0140-6736(09)60330-5; Lambert-Kerzner A, 2012, CIRC-CARDIOVASC QUAL, V5, P571, DOI 10.1161/CIRCOUTCOMES.111.962290; Lappe JM, 2004, ANN INTERN MED, V141, P446, DOI 10.7326/0003-4819-141-6-200409210-00010; Mehta RH, 2002, JAMA-J AM MED ASSOC, V287, P1269, DOI 10.1001/jama.287.10.1269; Miller NH, 2010, J CARDIOVASC NURS, V25, P247, DOI 10.1097/JCN.0b013e3181cec6e7; Ockene IS, 2002, J AM COLL CARDIOL, V40, P630, DOI 10.1016/S0735-1097(02)02078-8; Pack QR, 2013, CIRCULATION, V127, P349, DOI 10.1161/CIRCULATIONAHA.112.121996; Perk J, 2012, TURK KARDIYOL DERN A, V40, P1, DOI 10.1093/eurheartj/ehs092; Rubak S, 2005, BRIT J GEN PRACT, V55, P305; Steg PG, 2007, JAMA-J AM MED ASSOC, V297, P1197, DOI 10.1001/jama.297.11.1197; Terkelsen CJ, 2005, EUR HEART J, V26, P18, DOI 10.1093/eurheartj/ehi002; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Wood DA, 2008, LANCET, V371, P1999, DOI 10.1016/S0140-6736(08)60868-5; Yinko SSLL, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000901	27	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0211464	10.1371/journal.pone.0211464	http://dx.doi.org/10.1371/journal.pone.0211464			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789921	Green Accepted, gold, Green Published			2022-12-27	WOS:000459330800013
J	Rezende, RM; Peluzio, MDG; Silva, FD; Della Lucia, EM; Favarato, LSC; Martino, HSD; Natali, AJ				Rezende, Rafael Marins; Gouveia Peluzio, Maria do Carmo; Silva, Franciany de Jesus; Della Lucia, Emanuel Mattos; Campos Favarato, Lukiya Silva; Duarte Martino, Hercia Stampini; Natali, Antonio Jose			Does aerobic exercise associated with tryptophan supplementation attenuates hyperalgesia and inflammation in female rats with experimental fibromyalgia?	PLOS ONE			English	Article							ALPHA-LACTALBUMIN INCREASES; NEUTRAL AMINO-ACIDS; SEROTONERGIC STIMULATION; PROLONGED EXERCISE; PLASMA TRYPTOPHAN; PAIN; CORTISOL; PROTEIN; STRESS; WOMEN	The objective of this study was to verify the effects of aerobic exercise associated with tryptophan (TRP) supplementation on hyperalgesia, as well as on cortisol, IL-6 and TNF concentrations in female rats with experimental fibromyalgia (FM). Female Wistar rats (initial body weight: similar to 350 g; age: 12 months) were randomly divided into 5 groups: CON (Control); F (Fibromyalgia induced); FE (Fibromyalgia induced plus exercise); FES (Fibromyalgia induced plus exercise and TRP supplementation) and FS (Fibromyalgia induced plus TRP supplementation). Fibromyalgia was induced with two injections (20 mu L) of acidic saline (pH 4.0) into the right gastrocnemius muscle with a 3-day interval. Control animals received the same doses of neutral saline (pH 7.4). The exercised animals underwent progressive low intensity aerobic exercise (LIAE) on a treadmill (10-12 m/min, 30-45 min/day, 5 days/week) for three weeks. During this period, the supplemented animals received a TRP supplemented diet (210 g/week), while the others received a control diet. Mechanical hyperalgesia was evaluated weekly and serum cortisol and muscle IL-6 and TNF concentrations were assessed after three weeks of interventions. Experimental FM caused bilateral hind paw hyperalgesia and augmented serum cortisol and muscle IL-6 concentrations. After 3 weeks of interventions, LIAE alone reduced hyperalgesia (151%) and reduced serum cortisol concentrations (72%). Tryptophan supplementation itself diminished hyperalgesia (57%) and reduced serum cortisol concentrations (67%). Adding TRP supplementation to LIAE did not further reduce hyperalgesia significantly (11%), which was followed by an important decrease in muscle IL-6 concentrations (68%), though reduction in serum cortisol pulled back to 45%. Muscle TNF concentrations were not affected. In conclusion, the association of TRP supplementation to LIAE does not potentiate significantly the reduction of bilateral mechanical hyperalgesia promoted by LIAE in female rats with experimental FM, however an important decrease in IL-6 is evident.	[Rezende, Rafael Marins; Gouveia Peluzio, Maria do Carmo; Duarte Martino, Hercia Stampini] Univ Fed Vicosa, Dept Nutr & Hlth, Vicosa, MG, Brazil; [Silva, Franciany de Jesus; Della Lucia, Emanuel Mattos; Natali, Antonio Jose] Univ Fed Vicosa, Dept Phys Educ, Vicosa, MG, Brazil; [Campos Favarato, Lukiya Silva] Univ Fed Vicosa, Dept Vet Med, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal de Vicosa	Rezende, RM (corresponding author), Univ Fed Vicosa, Dept Nutr & Hlth, Vicosa, MG, Brazil.	faelfisio@yahoo.com.br	NATALI, ANTONIO JOSE/C-1555-2013	NATALI, ANTONIO JOSE/0000-0002-4927-4024	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [PROEX/683/2018]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brasil (CNPq) [306797/2017-8]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [CDS-APQ-01635-15]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brasil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was finnanced in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) (http://www.capes.gov.br/) - Finance Code: PROEX/683/2018 (AJN, MCGP, HSDM); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brasil (CNPq) (http://www.cnpq.br/) - Grant number: 306797/2017-8 (AJN); and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (http://www.fapemig.br/).Grant number: CDS-APQ-01635-15 (AJN). There was no additional external funding received for this study. All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assis MR, 2006, ARTHRIT RHEUM-ARTHR, V55, P57, DOI 10.1002/art.21693; Bote ME, 2012, NEUROIMMUNOMODULAT, V19, P343, DOI 10.1159/000341664; Brosseau L, 2008, PHYS THER, V88, P857, DOI 10.2522/ptj.20070200; Busch AJ, 2011, CURR PAIN HEADACHE R, V15, P358, DOI 10.1007/s11916-011-0214-2; Catley D, 2000, ARTHRIT CARE RES, V13, P51, DOI 10.1002/1529-0131(200002)13:1<51::AID-ART8>3.0.CO;2-Q; Chinn S, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0556-x; COSTILL DL, 1971, J APPL PHYSIOL, V31, P834, DOI 10.1152/jappl.1971.31.6.834; CURZON G, 1974, BRIT J PHARMACOL, V50, P197, DOI 10.1111/j.1476-5381.1974.tb08562.x; Dadabhoy D, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2443; DAVIS JM, 1995, INT J SPORT NUTR, V5, pS29, DOI 10.1123/ijsn.5.s1.s29; Dina OA, 2008, NEUROSCIENCE, V152, P521, DOI 10.1016/j.neuroscience.2008.01.006; Dina OA, 2011, EUR J PAIN, V15, P796, DOI 10.1016/j.ejpain.2011.02.005; Dina OA, 2010, J PAIN, V11, P369, DOI 10.1016/j.jpain.2009.08.007; Bote ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074524; Firk C, 2009, CLIN NUTR, V28, P266, DOI 10.1016/j.clnu.2009.03.002; Fischer S, 2016, PSYCHONEUROENDOCRINO, V63, P68, DOI 10.1016/j.psyneuen.2015.09.018; Forrest CM, 2004, FREE RADICAL RES, V38, P1167, DOI 10.1080/10715760400011437; Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207; Fries E, 2005, PSYCHONEUROENDOCRINO, V30, P1010, DOI 10.1016/j.psyneuen.2005.04.006; FULLER RW, 1981, NEUROENDOCRINOLOGY, V32, P118, DOI 10.1159/000123142; Gibson EL, 2014, PSYCHOPHARMACOLOGY, V231, P4595, DOI 10.1007/s00213-014-3609-z; Hauser W, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3002; Harbeck B, 2013, CLIN EXP RHEUMATOL, V31, pS16; Khasar SG, 2005, PAIN, V116, P79, DOI 10.1016/j.pain.2005.03.040; Lin CCJ, 2012, P NATL ACAD SCI USA, V109, pE76, DOI 10.1073/pnas.1108903108; Lopes KMDC, 2001, THESIS; Macfarlane GJ, 2017, ANN RHEUM DIS, V76, P318, DOI 10.1136/annrheumdis-2016-209724; Markus CR, 2002, AM J CLIN NUTR, V75, P1051, DOI 10.1093/ajcn/75.6.1051; Markus CR, 2000, AM J CLIN NUTR, V71, P1536; Martinov T., 2013, JOVE-J VIS EXP, V19, P51212; Mease P, 2005, J RHEUMATOL, V32, P6; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Pietrelli A, 2018, NEUROBIOL LEARN MEM, V155, P528, DOI 10.1016/j.nlm.2018.05.007; Primola-Gomes TN, 2009, J APPL PHYSIOL, V107, P593, DOI 10.1152/japplphysiol.91218.2008; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Riva R, 2010, INT J BEHAV MED, V17, P223, DOI 10.1007/s12529-010-9097-6; Ross Rebecca L, 2010, Open Immunol J, V3, P9; Sanudo B, 2011, J REHABIL MED, V43, P521, DOI 10.2340/16501977-0814; Schmitt JAJ, 2005, J PSYCHOPHARMACOL, V19, P375, DOI 10.1177/0269881105053288; SELTZER S, 1983, J PSYCHIAT RES, V17, P181, DOI 10.1016/0022-3956(82)90020-6; SELTZER S, 1982, PAIN, V13, P385, DOI 10.1016/0304-3959(82)90007-0; Sharma NK, 2010, PHYS THER, V90, P714, DOI 10.2522/ptj.20090168; Sluka KA, 2001, MUSCLE NERVE, V24, P37, DOI 10.1002/1097-4598(200101)24:1<37::AID-MUS4>3.0.CO;2-8; Tak LM, 2011, BIOL PSYCHOL, V87, P183, DOI 10.1016/j.biopsycho.2011.02.002; White HD, 2015, INT IMMUNOPHARMACOL, V27, P244, DOI 10.1016/j.intimp.2015.05.020; Wolfe F, 2013, ARTHRIT CARE RES, V65, P777, DOI 10.1002/acr.21931; YUNUS MB, 1992, J RHEUMATOL, V19, P90	47	8	8	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211824	10.1371/journal.pone.0211824	http://dx.doi.org/10.1371/journal.pone.0211824			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785911	gold, Green Submitted, Green Published			2022-12-27	WOS:000459307000041
J	Zhao, YF; Wan, JQ				Zhao, Yifei; Wan, Junqiang			Analysis of development and evolution rules of civil aviation in China based on life cycle theory	PLOS ONE			English	Article								The development of CAAC began in the early days of 1949. From a comparatively less popular means of transport to the world's second largest by volume, this means of transport has undergone major and minor changes in the last 70 years. It is not known whether there are significant laws in the process of development. For this reason, we analyze the statistical indicators of the development of civil aviation transport and select representative indicators, namely, the total turnover of transport, the number of routes, the number of aircraft, the number of transport aircraft, and the number of domestic city connections. At the same time, the life cycle theory is introduced, and the typical growth curve model is used to fit the data. It is found that the evolution life cycle of civil aviation in China can be divided into three stages: the first life cycle stage from 1950 to 1981, the second from 1982 to 2003, and the third from 2004 to 2017. Each life cycle follows the growth characteristics of occurrence, growth and maturity, and each life cycle has a time range of approximately 30 years. At present, China's civil aviation industry is in the period of rapid growth in the third life cycle. This industry is expected to reach maturity in approximately 2026 and then to begin to grow slowly. Relevant departments can adopt corresponding development strategies to guide the smooth development of civil aviation in accordance with the growth law of the development and evolution life cycle of civil aviation in China.	[Zhao, Yifei; Wan, Junqiang] Civil Aviat Univ China, Natl Key Lab ATC Safety Technol, Tianjin, Peoples R China	Civil Aviation University of China	Wan, JQ (corresponding author), Civil Aviat Univ China, Natl Key Lab ATC Safety Technol, Tianjin, Peoples R China.	303666682@qq.com		Wan, Junqiang/0000-0002-0982-9953	State Key Laboratory of Air Traffic Management System and Technology [SKLATM201704]; National Key Research Program of China [2016YFB0502400]; National Natural Science Foundation of China [U1633112, U1533112]	State Key Laboratory of Air Traffic Management System and Technology; National Key Research Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This paper is funded by State Key Laboratory of Air Traffic Management System and Technology, NO: SKLATM201704 (YZ), National Key Research Program of China, NO: 2016YFB0502400 (YZ), and National Natural Science Foundation of China, NO: U1633112, U1533112 (YZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert L, 2007, PLANNING CONTROL MAN; Amidan BG, 2005, AEROSP CONF PROC, P3814, DOI 10.1109/AERO.2005.1559688; CAAC Department of Development Planning, 2013, 2013 STAT DAT CIV AV; CAAC Department of Development Planning, 2017, STAT DAT CIV AV CHIN; CAAC Department of Development Planning, 2016, 2016 STAT DAT CIV AV; CAAC Department of Development Planning, 2015, 2015 STAT DAT CIV AV; CAAC Department of Development Planning, 2014, 2014 STAT DAT CIV AV; CAAC Department of Development Planning, 2012, 2012 STAT DAT CIV AV; Chen W, 2012, RES AIRLINE IND EVOL; Chiu RH, 2015, RES TRANSP BUS MANAG, V14, P14, DOI 10.1016/j.rtbm.2014.11.003; Cistone J, 2004, J AIRCRAFT, V41, P36, DOI 10.2514/1.1847; Civil Aviation Administration of China, 2018, CIV AV IND DEV STAT; Coelho CRV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160397; Cox B, 2018, TRANSPORT RES D-TR E, V58, P1, DOI 10.1016/j.trd.2017.10.017; Cui GQ, 2017, CHINAS AIR TRANSPORT; GILBERT GA, 1973, IEEE T COMMUN, VCO21, P364, DOI 10.1109/TCOM.1973.1091699; Islam H, 2015, ENERG BUILDINGS, V104, P250, DOI 10.1016/j.enbuild.2015.07.017; Kraus TL., 2011, J AIR TRAFFIC CONTRO, V53, P17; Li J, 2011, CHRONICLE CHINAS CIV; Li SG., 2008, DEV RES REFORM CIVIL; Michael JP, 2014, GROWTH CURVE MODELIN; NATCA, 2008, HIST AIR TRAFF CONTR; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; Shen ZD, 2015, CHIN PUBLIC ADM, V10, P105; [王宇 Wang Yu], 2015, [交通运输系统工程与信息, Journal of Transporation Systems Engineering & Information Technology], V15, P23; Zhan M., 2016, STAT INFORM FORUM, V31, P17; Zhang J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180685; Zhou DQ., 2009, STAT DECIS, V2, P17; Zhou HM, 2016, NEUROCOMPUTING, V216, P208, DOI 10.1016/j.neucom.2016.07.036	29	3	3	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212338	10.1371/journal.pone.0212338	http://dx.doi.org/10.1371/journal.pone.0212338			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785922	Green Published, Green Submitted, gold			2022-12-27	WOS:000459307000056
J	Akbib, S; Stichelmans, J; Stange, G; Ling, ZD; Assefa, Z; Hellemans, KH				Akbib, Sarah; Stichelmans, Jordy; Stange, Geert; Ling, Zhidong; Assefa, Zerihun; Hellemans, Karine H.			Glucocorticoids and checkpoint tyrosine kinase inhibitors stimulate rat pancreatic beta cell proliferation differentially	PLOS ONE			English	Article							MOLECULE GLUCOKINASE ACTIVATOR; IN-VITRO; DYRK1A; DEATH; AMELIORATION; INCREASES; EXPANSION; CAPACITY; SURVIVAL; THERAPY	Cell therapy for diabetes could benefit from the identification of small-molecule compounds that increase the number of functional pancreatic beta cells. Using a newly developed screening assay, we previously identified glucocorticoids as potent stimulators of human and rat beta cell proliferation. We now compare the stimulatory action of these steroid hormones to a selection of checkpoint tyrosine kinase inhibitors that were also found to activate the cell cycle-in beta cells and analyzed their respective effects on DNA-synthesis, beta cell numbers and expression of cell cycle regulators. Our data using glucocorticoids in combination with a receptor antagonist, mifepristone, show that 48h exposure is sufficient to allow beta cells to pass the cell cycle restriction point and to become committed to cell division regardless of sustained glucocorticoid-signaling. To reach the end-point of mitosis another 40h is required. Within 14 days glucocorticoids stimulate up to 75% of the cells to undergo mitosis, which indicates that these steroid hormones act as proliferation competence-inducing factors. In contrast, by correlating thymidine-analogue incorporation to changes in absolute cell numbers, we show that the checkpoint kinase inhibitors, as compared to glucocorticoids, stimulate DNA-synthesis only during a short time-window in a minority of cells, insufficient to give a measurable increase of beta cell numbers. Glucocorticoids, but not the kinase inhibitors, were also found to induce changes in the expression of checkpoint regulators. Our data, using checkpoint kinase-specific inhibitors further point to a role for Chk1 and Cdk1 in G1/S transition and progression of beta cells through the cell cycle upon stimulation with glucocorticoids.	[Akbib, Sarah; Stichelmans, Jordy; Stange, Geert; Ling, Zhidong; Assefa, Zerihun; Hellemans, Karine H.] Vrije Univ Brussel, Diabet Res Cluster, Unit Diabet Pathol & Therapy, Brussels, Belgium; [Ling, Zhidong] Univ Hosp Brussels, Beta Cell Bank, Brussels, Belgium; [Hellemans, Karine H.] Ctr Beta Cell Therapy Diabet, Brussels, Belgium	Vrije Universiteit Brussel; University Hospital Brussels	Hellemans, KH (corresponding author), Vrije Univ Brussel, Diabet Res Cluster, Unit Diabet Pathol & Therapy, Brussels, Belgium.; Hellemans, KH (corresponding author), Ctr Beta Cell Therapy Diabet, Brussels, Belgium.	Karine.Hellemans@vub.be	stange, geert m/C-1092-2009; Hellemans, Karine/B-7573-2013; stichelmans, jordy/HGB-7174-2022	stange, geert m/0000-0003-3148-1372; Hellemans, Karine/0000-0001-9306-4369; Stichelmans, Jordy/0000-0001-5884-321X	Research Foundation Flanders [FWO G0420-09]; Agency for Innovation by Science and Technology in Flanders (IWT) [IWT645]; Wetenschappelijk Fonds Willy Gepts -UZ Brussel (WFWG) [BOR16, BOR14]; European Commission [H2020-681070 BetaCellTherapy]; IWT [IWT121694]; IWT Postdoctoral Innovation Mandate [IWT 120717]; FWO; European Commission; Wetenschappelijk fonds Willy Gepts - UZ Brussel	Research Foundation Flanders(FWO); Agency for Innovation by Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Wetenschappelijk Fonds Willy Gepts -UZ Brussel (WFWG); European Commission(European CommissionEuropean Commission Joint Research Centre); IWT(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); IWT Postdoctoral Innovation Mandate; FWO(FWO); European Commission(European CommissionEuropean Commission Joint Research Centre); Wetenschappelijk fonds Willy Gepts - UZ Brussel	This study was supported by the Research Foundation Flanders (FWO G0420-09), the Agency for Innovation by Science and Technology in Flanders (IWT; IWT645), Wetenschappelijk Fonds Willy Gepts -UZ Brussel (WFWG; BOR16, BOR14) and the European Commission, (H2020-681070 BetaCellTherapy). S. A. is a recipient of an IWT PhD fellowship (IWT121694); Z.A. was recipient of an IWT Postdoctoral Innovation Mandate (IWT 120717). FWO http://www.fwo.be; IWT - https://www.vlaio.be; European Commission -https://ec.europa.eu/programmes/horizon2020/; Wetenschappelijk fonds Willy Gepts - UZ Brussel -www.uzbrussel.be. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank our collaborators for preparing quality-controlled rat and human beta cells and performing the immunochemical assays and characterizations and D. Pipeleers as director of the Diabetes Research Center and coordinator of the EC H2020 BetaCellTherapy program for supporting this work.	Aarts M, 2012, CANCER DISCOV, V2, P524, DOI 10.1158/2159-8290.CD-11-0320; Abdolazimi Y, 2018, ENDOCRINOLOGY, V159, P3143, DOI 10.1210/en.2018-00083; Agostino Nicole M, 2011, J Oncol Pharm Pract, V17, P197, DOI 10.1177/1078155210378913; Aguayo-Mazzucato C, 2017, CELL METAB; Annes JP, 2012, P NATL ACAD SCI USA, V109, P3915, DOI 10.1073/pnas.1201149109; Assefa Z, 2016, AM J PHYSIOL-ENDOC M, V311, pE698, DOI 10.1152/ajpendo.00070.2016; Assefa Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085174; Beaudry JL, 2012, DIABETES-METAB RES, V28, P560, DOI 10.1002/dmrr.2310; Benthuysen JR, 2016, J CLIN INVEST, V126, P3651, DOI 10.1172/JCI87439; Booher RN, 1997, J BIOL CHEM, V272, P22300, DOI 10.1074/jbc.272.35.22300; Carrassa L, 2012, CELL CYCLE, V11, P2507, DOI 10.4161/cc.20899; Colvin ES, 2013, ENDOCRINOLOGY, V154, P1039, DOI 10.1210/en.2012-1923; Dadon D, 2012, OBES METAB, V14, P101; Del Nagro CJ, 2014, CELL CYCLE, V13, P303, DOI 10.4161/cc.27055; Dirice E, 2016, DIABETES, V65, P1660, DOI 10.2337/db15-1127; Dumortier O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025576; Fiaschi-Taesch NM, 2013, DIABETES, V62, P2450, DOI 10.2337/db12-0777; Fine NHF, 2018, DIABETES, V67, P278, DOI 10.2337/db16-1356; Fransson L, 2013, J ENDOCRINOL, V219, P231, DOI 10.1530/JOE-13-0189; Gesina E, 2006, DIABETOLOGIA, V49, P2939, DOI 10.1007/s00125-006-0449-3; Ghazalli N, 2018, STEM CELLS DEV, V27, P898, DOI 10.1089/scd.2017.0160; Hagerkvist R, 2007, FASEB J, V21, P618, DOI 10.1096/fj.06-6910com; Hamer PCD, 2011, CLIN CANCER RES, V17, P4200, DOI 10.1158/1078-0432.CCR-10-2537; Han MS, 2009, DIABETES, V58, P329, DOI 10.2337/db08-0080; Hija A, 2014, DIABETES, V63, P578, DOI 10.2337/db12-1035; Karunakaran U, 2015, CELL SIGNAL, V27, P1066, DOI 10.1016/j.cellsig.2015.01.018; King AJF, 2016, UPSALA J MED SCI, V121, P140, DOI 10.3109/03009734.2016.1151090; Kiyosue A, 2013, DIABETES OBES METAB, V15, P923, DOI 10.1111/dom.12100; Kumar K, 2018, EUR J MED CHEM, V157, P1005, DOI 10.1016/j.ejmech.2018.08.007; Lee YC, 2009, MOL CELL ENDOCRINOL, V297, P18, DOI 10.1016/j.mce.2008.08.033; LING ZD, 1994, ENDOCRINOLOGY, V134, P2614, DOI 10.1210/en.134.6.2614; Ling ZD, 1996, J CLIN INVEST, V98, P2805, DOI 10.1172/JCI119108; Louvet C, 2008, P NATL ACAD SCI USA, V105, P18895, DOI 10.1073/pnas.0810246105; Ma X, 2017, ACTA BIOCH BIOPH SIN, V49, P298; Magnussen GI, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1474-8; Malek R, 2016, EXPERT OPIN INV DRUG, V25, P287, DOI 10.1517/13543784.2016.1142531; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Mokhtari D, 2013, DIABETOLOGIA, V56, P1327, DOI 10.1007/s00125-013-2868-2; Nakamura A, 2012, DIABETOLOGIA, V55, P1745, DOI 10.1007/s00125-012-2521-5; Nakamura A, 2009, ENDOCRINOLOGY, V150, P1147, DOI 10.1210/en.2008-1183; Ono K, 2012, INTERNAL MED, V51, P2763, DOI 10.2169/internalmedicine.51.8314; Otto T, 2017, NAT REV CANCER, V17, P93, DOI 10.1038/nrc.2016.138; Owa T, 2001, CURR MED CHEM, V8, P1487, DOI 10.2174/0929867013371996; PIPELEERS DG, 1985, ENDOCRINOLOGY, V117, P806, DOI 10.1210/endo-117-3-806; Pozzilli P, 2015, NAT REV ENDOCRINOL, V11, P289, DOI 10.1038/nrendo.2015.8; Prada PO, 2013, EXPERT OPIN INV DRUG, V22, P751, DOI 10.1517/13543784.2013.802768; Rachdi L, 2014, CELL CYCLE, V13, P2221, DOI 10.4161/cc.29250; Rafacho A, 2010, ACTA PHYSIOL, V200, P223, DOI 10.1111/j.1748-1716.2010.02146.x; Rafacho A, 2009, AM J PHYSIOL-ENDOC M, V296, pE681, DOI 10.1152/ajpendo.90931.2008; Rane SG, 2000, FRONT BIOSCI, V5, pD1, DOI 10.2741/Rane; Ranta F, 2006, DIABETES, V55, P1380, DOI 10.2337/db05-1220; Rieck S, 2012, MOL ENDOCRINOL, V26, P1590, DOI 10.1210/me.2012-1019; Robitaille K, 2016, J BIOL CHEM, V291, P4614, DOI 10.1074/jbc.M115.683912; Rojas J, 2015, J PANCREAS, V16, P11, DOI 10.6092/1590-8577/2893; Saunders D, 2016, J AUTOIMMUN, V71, P59, DOI 10.1016/j.jaut.2016.03.014; Shen WJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9372; Shirakawa J, 2013, DIABETES, V62, P3448, DOI 10.2337/db13-0052; Stange G, 2003, DIABETES MELLIT, V83, P015; Stewart AF, 2015, DIABETES, V64, P1872, DOI 10.2337/db14-1843; Stolovich-Rain M, 2012, J BIOL CHEM, V287, P27407, DOI 10.1074/jbc.M112.350736; Tamura K, 2015, JPN J CLIN ONCOL, V45, P1097, DOI 10.1093/jjco/hyv131; Tiwari S, 2015, DIABETES, V64, P3485, DOI 10.2337/db14-1885; Tornovsky-Babeay S, 2014, CELL METAB, V19, P109, DOI 10.1016/j.cmet.2013.11.007; Tsuji N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104112; Valtat B, 2011, DIABETOLOGIA, V54, P350, DOI 10.1007/s00125-010-1898-2; VANDEWINKEL M, 1983, BIOCHEM BIOPH RES CO, V114, P835, DOI 10.1016/0006-291X(83)90857-4; Wang P, 2018, CELL METAB; Wang P, 2015, NAT MED, V21, P383, DOI 10.1038/nm.3820; Zhao Z, 2014, MOL ENDOCRINOL, V28, P1682, DOI 10.1210/me.2014-1120	69	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212210	10.1371/journal.pone.0212210	http://dx.doi.org/10.1371/journal.pone.0212210			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779812	gold, Green Published, Green Submitted			2022-12-27	WOS:000459062900033
J	Piwetz, S				Piwetz, Sarah			Common bottlenose dolphin (Tursiops truncatus) behavior in an active narrow seaport	PLOS ONE			English	Article							SCALE HABITAT SELECTION; MOVEMENT PATTERNS; DUSKY DOLPHIN; LAGENORHYNCHUS-OBSCURUS; IMPACT ASSESSMENT; DOUBTFUL SOUND; TOUR BOATS; RESPONSES; WHALES; ISLAND	The Galveston Ship Channel (GSC) is a narrow, congested waterway that supports largescale shipping, commercial fishing, dolphin tourism, and recreation. Human activity and common bottlenose dolphins (Tursiops truncatus) converge in the GSC with potentially negative consequences on the dolphins. Elevated land-based tracking and behavioral observation of dolphins and vessels were conducted along the GSC in June-August 2013 using a digital theodolite. Positional information was used to calculate dolphin movement patterns and proximity to vessels. Log-likelihood ratio and Chi-square contingency tests were used to assess behavioral states, and generalized additive models were used to analyze movement patterns (i. e., swimming speed, reorientation rate, and linearity) relative to endogenous and exogenous factors and vessel presence. Dolphins regularly use the GSC to forage (57% of observed behavioral states) and socialize (27%), and it is not a travel corridor for accessing other favorable sites (traveling = 5%). Dolphin behavior varied significantly based on time of day, group size, calf presence, and general boat presence. When boats were present, the proportion of time dolphins spent socializing and foraging was significantly less than expected by chance. Swimming speeds increased significantly in the presence of small recreational boats, dolphin-watching tour boats, shrimp trawlers, and when tour boats and shrimp trawlers were both present. Reorientation rate increased significantly in the presence of tour boats and trawlers. Dolphin behavioral responses to vessel presence may result in decreased energy consumption due to disrupted foraging activity. Without proper management, the observed behavioral changes may be detrimental to individuals within this population in the short term, with potential long-term consequences to health and survivorship.	[Piwetz, Sarah] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA	Texas A&M University System	Piwetz, S (corresponding author), Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA.	sarahpiwetz@hotmail.com			Texas Institute of Oceanography Graduate Research Fellowship Program	Texas Institute of Oceanography Graduate Research Fellowship Program	S. P. received funding support through the Texas Institute of Oceanography Graduate Research Fellowship Program (http://tamug.edu/research/tio/tio.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MC, 2001, MAR ECOL PROG SER, V222, P253, DOI 10.3354/meps222253; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Anderson M, 2011, 19 BIENN C BIOL MAR; [Anonymous], 2009, YARMOUTH MA US PREP; [Anonymous], 2004, ECOL SOC; Arcangeli Antonella, 2009, Journal of Marine Animals and their Ecology, V2, P3; Bailey H, 2006, J ANIM ECOL, V75, P456, DOI 10.1111/j.1365-2656.2006.01066.x; Ban NC, 2012, AQUAT CONSERV, V22, P262, DOI 10.1002/aqc.2224; Beale C. M., 2007, INT J COMP PSYCHOL, V20, P111; Bejder L, 1999, MAR MAMMAL SCI, V15, P738, DOI 10.1111/j.1748-7692.1999.tb00840.x; Bejder L., 2005, LINKING SHORT LONG T; Bejder L, 2006, ANIM BEHAV, V72, P1149, DOI 10.1016/j.anbehav.2006.04.003; Bejder Lars, 2003, P229; Bejder L, 2006, CONSERV BIOL, V20, P1791, DOI 10.1111/j.1523-1739.2006.00540.x; Berger-Tal O, 2011, BEHAV ECOL, V22, P236, DOI 10.1093/beheco/arq224; Bishop YM., 2007, DISCRETE MULTIVARIAT; BRAGER S, 1993, MAR MAMMAL SCI, V9, P434, DOI 10.1111/j.1748-7692.1993.tb00477.x; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Christiansen F., 2014, WHALE WATCHING SUSTA, P177, DOI [10.1017/CBO9781139018166.016, DOI 10.1017/CBO9781139018166.016]; Christiansen Fredrik, 2010, Endangered Species Research, V11, P91, DOI 10.3354/esr00265; CONOVER W. J, 1980, PRACTICAL NONPARAMET; Constantine R, 2004, BIOL CONSERV, V117, P299, DOI 10.1016/j.biocon.2003.12.009; Dans SL, 2008, MAR ECOL PROG SER, V369, P287, DOI 10.3354/meps07629; Dray S, 2010, ECOL RES, V25, P673, DOI 10.1007/s11284-010-0701-7; Fertl D., 1997, Journal of Northwest Atlantic Fishery Science, V22, P219; FERTL D, 1994, TEX J SCI, V46, P299; Fertl D., 1994, THESIS; Foroughirad V, 2013, BIOL CONSERV, V160, P242, DOI 10.1016/j.biocon.2013.01.001; Gailey G, 2007, ENVIRON MONIT ASSESS, V134, P75, DOI 10.1007/s10661-007-9812-1; Gailey Glenn, 2002, Journal of Cetacean Research and Management, V4, P213; Gailey G, 2016, ENDANGER SPECIES RES, V30, P53, DOI 10.3354/esr00713; Gill JA, 2001, BIOL CONSERV, V97, P265, DOI 10.1016/S0006-3207(00)00002-1; GITTLEMAN JL, 1988, AM ZOOL, V28, P863, DOI 10.1093/icb/28.3.863; Gottman J. M., 1990, SEQUENTIAL ANAL GUID; Gowans S, 2008, ADV MAR BIOL, V53, P195, DOI 10.1016/S0065-2881(07)53003-8; Guilherme-Silveira F. R., 2009, Marine Biodiversity Records, V2, pe122, DOI 10.1017/S1755267209000906; Hair F., 1995, MULTIVARIATE DATA AN, V4th; Hastie GD, 2004, MAR BIOL, V144, P397, DOI 10.1007/s00227-003-1195-4; Hastie GD, 2003, MAR MAMMAL SCI, V19, P74, DOI 10.1111/j.1748-7692.2003.tb01093.x; Hastie TJ., 2017, GEN ADDITIVE MODELS; Hegar G., 2015, PORT ENTRY GALVESTON; Henderson EE, 2004, BEHAV ASS PATTERNS H; Henningsen T, 1991, P 5 ANN C EUR CET S; Higham JES, 2011, TOURISM MANAGE, V32, P1290, DOI 10.1016/j.tourman.2010.12.006; Higham JES, 2008, ENVIRON CONSERV, V35, P294, DOI 10.1017/S0376892908005249; Hung SK, 2008, HABITAT USE INDO PAC; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Jefferson TA, 2000, WILDLIFE MONOGR, P1; Jefferson TA, 2009, MAR POLICY, V33, P305, DOI 10.1016/j.marpol.2008.07.011; Latusek JN, 2002, IMPACT BOAT TRAFFIC; Leatherwood A., 2016, HDB TEXAS ONLINE; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lundquist D, 2013, NEW ZEAL J MAR FRESH, V47, P430, DOI 10.1080/00288330.2013.778301; Lundquist D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041969; Lusseau D, 2003, MAR ECOL PROG SER, V257, P267, DOI 10.3354/meps257267; Lusseau D, 2006, MAR MAMMAL SCI, V22, P802, DOI 10.1111/j.1748-7692.2006.00052.x; Mann J, 1999, MAR MAMMAL SCI, V15, P102, DOI 10.1111/j.1748-7692.1999.tb00784.x; Mann J, 2000, BEHAV ECOL, V11, P210, DOI 10.1093/beheco/11.2.210; Mann J, 1999, BEHAVIOUR, V136, P529, DOI 10.1163/156853999501469; Meissner AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116962; Moore JE, 2009, MAR POLICY, V33, P435, DOI 10.1016/j.marpol.2008.09.003; Moreno MPT, 2005, ENV PREDICTORS BOTTL; NOAA, 2017, SE REG MAR MAMM SEA; Noren SR, 2002, J ZOOL, V258, P105, DOI 10.1017/S0952836902001243; Nowacek SM, 2001, MAR MAMMAL SCI, V17, P673, DOI 10.1111/j.1748-7692.2001.tb01292.x; Parra GJ, 2006, J ANIM ECOL, V75, P862, DOI 10.1111/j.1365-2656.2006.01104.x; Parra GJ, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P576; Pearson HC, 2012, NEW ZEAL J MAR FRESH, V46, P567, DOI 10.1080/00288330.2012.712977; Phillips NM, 2014, NMFSSEFSC665; Piwetz S, 2012, AQUAT MAMM, V38, P325, DOI 10.1578/AM.38.3.2012.325; Quinn GP, 2003, EXPT DESIGN DATA ANA; Ribeiro S, 2007, J MAR BIOL ASSOC UK, V87, P119, DOI 10.1017/S0025315407051594; Rohr JJ, 2002, MAR MAMMAL SCI, V18, P1, DOI 10.1111/j.1748-7692.2002.tb01014.x; Sallese CW., 2013, HOUSTON GALVESTON NA; Scott M.D., 1990, P235; Shane S.H., 1990, P245; SMOLKER RA, 1992, BEHAVIOUR, V123, P38, DOI 10.1163/156853992X00101; Srinivasan M, 2010, ECOL MODEL, V221, P2687, DOI 10.1016/j.ecolmodel.2010.07.010; Stensland E, 2007, MAR ECOL PROG SER, V332, P225, DOI 10.3354/meps332225; STEWARTOATEN A, 1986, ECOLOGY, V67, P929, DOI 10.2307/1939815; Stockin KA, 2008, MAR ECOL PROG SER, V355, P287, DOI 10.3354/meps07386; Turvey ST, 2007, BIOL LETTERS, V3, P537, DOI 10.1098/rsbl.2007.0292; Tyack PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017009; USACE, 2014, WAT COMM US 5; USCG, 2009, PORTS WAT SAF ASS WO; Van Waerebeek Koen, 2007, Latin American Journal of Aquatic Mammals, V6, P43; WALTERS CJ, 1978, ANNU REV ECOL SYST, V9, P157, DOI 10.1146/annurev.es.09.110178.001105; Weir CR, 2013, MAMMAL REV, V43, P258, DOI 10.1111/j.1365-2907.2012.00222.x; Williams R, 2007, J ZOOL, V272, P390, DOI 10.1111/j.1469-7998.2006.00280.x; Williams R, 2002, J ZOOL, V256, P255, DOI 10.1017/S0952836902000298; Williams R, 2006, BIOL CONSERV, V133, P301, DOI 10.1016/j.biocon.2006.06.010; Wilson B, 1997, J APPL ECOL, V34, P1365, DOI 10.2307/2405254; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd, DOI 10.1201/9781315370279; Wood SN, 2008, J R STAT SOC B, V70, P495, DOI 10.1111/j.1467-9868.2007.00646.x; Wursig B., 1991, P79; WURSIG B, 1989, SCIENCE, V244, P1550, DOI 10.1126/science.2662403; WURSIG B, 1980, FISH B-NOAA, V77, P871	97	9	10	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0211971	10.1371/journal.pone.0211971	http://dx.doi.org/10.1371/journal.pone.0211971			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL9KY	30779764	gold, Green Published, Green Submitted			2022-12-27	WOS:000459062900023
J	Ivlev, DA; Shirinli, SN; Guria, KG; Uzlova, SG; Guria, GT				Ivlev, Dmitry A.; Shirinli, Shakhla N.; Guria, Konstantin G.; Uzlova, Svetlana G.; Guria, Georgy Th.			Control of fibrinolytic drug injection via real-time ultrasonic monitoring of blood coagulation	PLOS ONE			English	Article							THROMBIN ACTIVATABLE FIBRINOLYSIS; DEEP-VEIN THROMBOSIS; FACTOR-XIII; WHOLE-BLOOD; REPERFUSION STRATEGIES; STROKE THROMBOLYSIS; CLOT STRUCTURE; FLOW-RATE; IN-VIVO; MODEL	In the present study, we investigated the capabilities of a novel ultrasonic approach for real-time control of fibrinolysis under flow conditions. Ultrasonic monitoring was performed in a specially designed experimental in vitro system. Fibrinolytic agents were automatically injected at ultrasonically determined stages of the blood clotting. The following clots dissolution in the system was investigated by means of ultrasonic monitoring. It was shown, that clots resistance to fibrinolysis significantly increases during the first 5 minutes since the formation of primary micro-clots. The efficiency of clot lysis strongly depends on the concentration of the fibrinolytic agent as well as the delay of its injection moment. The ultrasonic method was able to detect the coagulation at early stages, when timely pharmacological intervention can still prevent the formation of macroscopic clots in the experimental system. This result serves as evidence that ultrasonic methods may provide new opportunities for real-time monitoring and the early pharmacological correction of thrombotic complications in clinical practice.	[Ivlev, Dmitry A.; Uzlova, Svetlana G.; Guria, Georgy Th.] Natl Res Ctr Hematol, Moscow, Russia; [Shirinli, Shakhla N.; Guria, Konstantin G.; Guria, Georgy Th.] Moscow Inst Phys & Technol, Dolgoprudnyi, Russia	Russian Academy of Medical Sciences; National Medical Research Center for Hematology; Moscow Institute of Physics & Technology	Guria, GT (corresponding author), Natl Res Ctr Hematol, Moscow, Russia.; Guria, GT (corresponding author), Moscow Inst Phys & Technol, Dolgoprudnyi, Russia.	guria@blood.ru	Ivlev, Dmitriy A/G-6834-2014; Guria, Georgy/L-6873-2013	Guria, Georgy/0000-0002-5579-9820	Russian Foundation of Basic Research [14-04-01193, 16-34-01180]; Federal Program "5top100"	Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR)); Federal Program "5top100"	The present work was partially supported by the Russian Foundation of Basic Research (www.rfbr.ru) grants 14-04-01193 (DAI, SNS, SGU, GTG) & 16-34-01180 (KGG, DAI) and the Federal Program "5top100" (www.5top100.ru) (KGG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghourian MN, 2012, J THROMB HAEMOST, V10, P447, DOI 10.1111/j.1538-7836.2011.04615.x; Bagai A, 2014, CIRC RES, V114, P1918, DOI 10.1161/CIRCRESAHA.114.302744; Bhatt M, 2018, PHYS MED BIOL, V63, DOI 10.1088/1361-6560/aab46a; Bouma BN, 2006, ANN MED, V38, P378, DOI 10.1080/07853890600852898; Budhram GR, 2014, RESUSCITATION, V85, P689, DOI 10.1016/j.resuscitation.2014.01.030; Calor MM, 2006, ULTRASOUND MED BIOL, V32, P1055, DOI 10.1016/j.ultrasmedbio.2006.04.002; Campbell BCV, 2015, STROKE, V46, P2341, DOI 10.1161/STROKEAHA.114.007564; Campbell RA, 2010, THROMB HAEMOSTASIS, V104, P1281, DOI 10.1160/TH10-07-0442; Cannata JM, 2012, J ULTRAS MED, V31, P1795, DOI 10.7863/jum.2012.31.11.1795; CHANDLER AB, 1958, LAB INVEST, V7, P110; CUNNINGHAM GM, 1965, LANCET, V1, P729, DOI 10.1016/S0140-6736(65)92089-1; Fang J, 2015, SCI REP-UK, V5, DOI 10.1038/srep11669; Faxon DP, 2005, NAT CLIN PRACT CARD, V2, P22, DOI 10.1038/ncpcardio0065; Fraser SR, 2011, BLOOD, V117, P6371, DOI 10.1182/blood-2011-02-333203; Fuster V, 2012, CIRCULATION, V126, P1645, DOI 10.1161/CIRCULATIONAHA.112.105908; Gennisson JL, 2006, ULTRASOUND MED BIOL, V32, P1529, DOI 10.1016/j.ultrasmedbio.2006.06.008; Gersh KC, 2010, J THROMB HAEMOST, V8, P2826, DOI 10.1111/j.1538-7836.2010.04118.x; GRYBAUSKAS P, 1978, ULTRASONICS, V16, P33, DOI 10.1016/0041-624X(78)90007-0; Hethershaw EL, 2014, J THROMB HAEMOST, V12, P197, DOI 10.1111/jth.12455; Huang CC, 2005, ULTRASOUND MED BIOL, V31, P1567, DOI 10.1016/j.ultrasmedbio.2005.07.003; Huang CC, 2007, IEEE T BIO-MED ENG, V54, P2223, DOI 10.1109/TBME.2007.908334; Huang CC, 2011, J MED BIOL ENG, V31, P79, DOI 10.5405/jmbe.893; Huisman MV, 2013, J THROMB HAEMOST, V11, P412, DOI 10.1111/jth.12124; Jackson SP, 2011, NAT MED, V17, P1423, DOI 10.1038/nm.2515; Jain A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10176; Key NS, 2017, PRACTICAL HEMOSTASIS, P484; King A, 2009, STROKE, V40, P3711, DOI 10.1161/STROKEAHA.109.563056; Komorowicz E, 1998, CIRC RES, V82, P1102, DOI 10.1161/01.RES.82.10.1102; Levi M, 2015, J THROMB HAEMOST, V13, P1960, DOI 10.1111/jth.13126; Libgot-Calle R, 2008, ULTRASOUND MED BIOL, V34, P252, DOI 10.1016/j.ultrasmedbio.2007.06.018; Lippi G, 2011, NAT REV CARDIOL, V8, P502, DOI 10.1038/nrcardio.2011.91; Marshall RS, 2015, JAMA NEUROL, V72, P928, DOI 10.1001/jamaneurol.2015.0835; Maufus M, 2018, THROMB RES, V161, P78, DOI 10.1016/j.thromres.2017.11.004; Meretoja A, 2014, STROKE, V45, P1053, DOI 10.1161/STROKEAHA.113.002910; Mfoumou E, 2014, THROMB RES, V133, P265, DOI 10.1016/j.thromres.2013.11.001; Mosnier LO, 2006, ARTERIOSCL THROM VAS, V26, P2445, DOI 10.1161/01.ATV.0000244680.14653.9a; Mutch NJ, 2010, J THROMB HAEMOST, V8, P2017, DOI 10.1111/j.1538-7836.2010.03963.x; Nam KH, 2012, ULTRASOUND MED BIOL, V38, P468, DOI 10.1016/j.ultrasmedbio.2011.11.013; Robbie LA, 1997, THROMB HAEMOSTASIS, V77, P510; Robinson BR, 2000, CIRCULATION, V102, P1151, DOI 10.1161/01.CIR.102.10.1151; Romero J, 2014, NAT REV CARDIOL, V11, P470, DOI 10.1038/nrcardio.2014.77; Sakharov DV, 2000, THROMB HAEMOSTASIS, V83, P469; Schmitt C, 2011, J BIOMECH, V44, P622, DOI 10.1016/j.jbiomech.2010.11.015; SHUNG KK, 1984, J CLIN ULTRASOUND, V12, P147; SHUNG KP, 1975, IEEE T BIO-MED ENG, VBM22, P334, DOI 10.1109/TBME.1975.324454; Smith S., 2003, DIGIT SIGNAL PROCESS, P650; Uzlova SG, 2008, B BAKOULEV SCI CTR C, P55; Uzlova SG, 2008, PHILOS T R SOC A, V366, P3649, DOI 10.1098/rsta.2008.0109; Varju I, 2011, J THROMB HAEMOST, V9, P979, DOI 10.1111/j.1538-7836.2011.04203.x; Viola F, 2004, ANN BIOMED ENG, V32, P696, DOI 10.1023/B:ABME.0000030235.72255.df; Voleisis A, 2002, ULTRASONICS, V40, P101, DOI 10.1016/S0041-624X(02)00098-7; Walsh JT, 2006, PUMPING INSULIN, P332; Weisel J. W., 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P161, DOI 10.2174/187152508784871963	53	3	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211646	10.1371/journal.pone.0211646	http://dx.doi.org/10.1371/journal.pone.0211646			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811424	Green Published, gold, Green Submitted			2022-12-27	WOS:000459806400028
J	Jaques, DL; Mills, KL; Selby, BG; Veit, RR; Ziccardi, MH				Jaques, Deborah L.; Mills, Kyra L.; Selby, Barton G.; Veit, Richard R.; Ziccardi, Michael H.			Use of plumage and gular pouch color to evaluate condition of oil spill rehabilitated California brown pelicans (Pelecanus occidentalis californicus) post-release	PLOS ONE			English	Article							PENGUINS EUDYPTULA-MINOR; CAROTENOID-BASED PLUMAGE; IMMUNE ACTIVATION; OXIDATIVE STRESS; COMMON MURRES; SURVIVAL; SEABIRDS; EVOLUTION; MOVEMENT; BEHAVIOR	Sublethal effects of oil spills may dampen seabird rehabilitation success due to lingering negative impacts of contamination and stress on reproduction and long-term survival. These effects can be difficult to measure while birds are in care as well as once birds are released. Expression of sexually selected traits that are sensitive to condition can provide information on physiological status of birds. We evaluated plumage molt and gular pouch skin color of California brown pelicans (Pelecanus occidentalis californicus) following oil contamination and rehabilitation to test for differences between previously oiled and rehabilitated (post-spill) and presumably uncontaminated pelicans. Post-spill pelicans released with either color leg bands alone, or bands plus harness-mounted satellite GPS tags, were relocated and visually assessed in the field at non-breeding communal roosts and compared to surrounding unmarked pelicans in the general population. Non-oiled pelicans bearing GPS tags were also included in the study. Post-spill pelicans lagged the general population in molt of ornamental yellow crown feathers but hind neck transition into white plumage was not significantly different. Both post-spill and non-oiled pelicans wearing GPS tags had lower gular redness scores than the unmarked, non-oiled population. Pre-breeding gular pouch redness of post-spill pelicans was more strongly influenced by wearing of a GPS tag than a history of oil contamination and rehabilitation. Gular pouch redness of post-spill pelicans in the first 18 months after release was positively correlated with long term survivorship. If gular pouch color is a condition-dependent sexual signal and overall health influences plumage molt progression, our results indicate that many post-spill pelicans marked with bands alone were in relatively good condition going into the next breeding season, but those released with electronic tags experienced additional stress due to wearing the equipment, introducing a confounding variable to the post-release study.	[Jaques, Deborah L.] Pacific Eco Log, Astoria, OR 97103 USA; [Mills, Kyra L.; Ziccardi, Michael H.] Univ Calif Davis, Sch Vet Med, Karen C Drayer Wildlife Hlth Ctr, Oiled Wildlife Care Network, Davis, CA 95616 USA; [Selby, Barton G.] EH1, San Carlos, CA USA; [Veit, Richard R.] CUNY Coll Staten Isl, Biol Dept, Staten Isl, NY USA	University of California System; University of California Davis; City University of New York (CUNY) System; College of Staten Island (CUNY)	Jaques, DL (corresponding author), Pacific Eco Log, Astoria, OR 97103 USA.	djaques@pacificecologic.org		Jaques, Deborah/0000-0002-9982-3052; Ziccardi, Michael/0000-0002-5430-2499	California Department of Fish and Wildlife's Oil Spill Prevention and Administration Fund through the Oiled Wildlife Care Network (OWCN) at the Karen C. Drayer Wildlife Health Center, School of Veterinary Medicine, University of California, Davis; OWCN budget	California Department of Fish and Wildlife's Oil Spill Prevention and Administration Fund through the Oiled Wildlife Care Network (OWCN) at the Karen C. Drayer Wildlife Health Center, School of Veterinary Medicine, University of California, Davis; OWCN budget	Funding for this study was provided by the California Department of Fish and Wildlife's Oil Spill Prevention and Administration Fund through the Oiled Wildlife Care Network (OWCN) at the Karen C. Drayer Wildlife Health Center, School of Veterinary Medicine, University of California, Davis. Post-release studies are collaborative efforts between the OWCN and appropriate experts, with funding coming from a reserve within the OWCN budget. M. Ziccardi and K. Mills are staff members at OWCN and had roles in project concept and manuscript editing.	Aldrich JW, 1970, REV PROBLEM BIRDS CO; Alonso-Alvarez C, 2004, AM NAT, V164, P651, DOI 10.1086/424971; Alonso-Alvarez C, 2007, P ROY SOC B-BIOL SCI, V274, P819, DOI 10.1098/rspb.2006.3764; Alonso-Alvarez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019403; Altwegg R, 2008, BIOL CONSERV, V141, P1924, DOI 10.1016/j.biocon.2008.04.030; AMADON D, 1966, CONDOR, V68, P263, DOI 10.2307/1365560; ANDERSON D W, 1976, American Birds, V30, P3; ANDERSON DW, 1988, WILDLIFE SOC B, V16, P339; Anderson DW, 1996, MAR POLLUT BULL, V32, P711, DOI 10.1016/0025-326X(96)00027-6; Anderson DW, 2017, BROWN PELICANS PELEC; [Anonymous], 2004, EFFECTS PETROLEUM EX; Barron DG, 2010, METHODS ECOL EVOL, V1, P180, DOI 10.1111/j.2041-210X.2010.00013.x; Blevin P, 2014, SCI TOTAL ENVIRON, V470, P248, DOI 10.1016/j.scitotenv.2013.09.049; Blount JD, 2003, SCIENCE, V300, P125, DOI 10.1126/science.1082142; Briggs KT, 1997, ICES J MAR SCI, V54, P718, DOI 10.1006/jmsc.1997.0254; BRIGGS KT, 1983, J FIELD ORNITHOL, V54, P353; Brush A.H., 1978, P141; Buchanan KL, 2000, TRENDS ECOL EVOL, V15, P156, DOI 10.1016/S0169-5347(99)01812-1; Chilvers BL, 2015, MAR POLLUT BULL, V100, P128, DOI 10.1016/j.marpolbul.2015.09.019; CROLL DA, 1986, CONDOR, V88, P258, DOI 10.2307/1368929; Dauwe T, 2008, NATURWISSENSCHAFTEN, V95, P969, DOI 10.1007/s00114-008-0400-1; Dawson A, 2008, PHILOS T R SOC B, V363, P1621, DOI 10.1098/rstb.2007.0004; De la Cruz SEW, 2013, MAR POLLUT BULL, V67, P100, DOI 10.1016/j.marpolbul.2012.11.027; Dearborn DC, 2002, J EVOLUTION BIOL, V15, P307, DOI 10.1046/j.1420-9101.2002.00388.x; Dey CJ, 2017, AUK, V134, P317, DOI 10.1642/AUK-16-119.1; DUNSTAN T C, 1972, Inland Bird-Banding News, V44, P4; Eisler R., 1987, POLYCYCLIC AROMATIC; EVANS RM, 1994, BEHAVIOUR, V129, P13, DOI 10.1163/156853994X00334; Faivre B, 2003, SCIENCE, V300, P103, DOI 10.1126/science.1081802; Fallon JA, 2018, ENVIRON TOXICOL CHEM, V37, P451, DOI 10.1002/etc.3983; Fiorello C, 2017, REF OIL SPILL INT OI; Freed LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029834; FRY DM, 1986, ARCH ENVIRON CON TOX, V15, P453, DOI 10.1007/BF01066414; FRY DM, 1985, ARCH ENVIRON CON TOX, V14, P725, DOI 10.1007/BF01055780; Geens A, 2009, COMP BIOCHEM PHYS C, V150, P155, DOI 10.1016/j.cbpc.2009.04.007; Giese M, 2000, WILDLIFE RES, V27, P583, DOI 10.1071/WR99077; Godfrey J.D., 2003, Science for Conservation (Wellington), V214, P83; Goldsworthy SD, 2000, WILDLIFE RES, V27, P573, DOI 10.1071/WR99076; Golightly RT, 2002, WILDLIFE SOC B, V30, P539; Goodwin T, 1980, BIOGEOCHEMISTRY CARO, P346; HAHN TP, 1992, ORNIS SCAND, V23, P314, DOI 10.2307/3676655; Helm RC, 2015, OVERVIEW EFFORTS DOC; Henkel LA, 2017, LIFE DEATH SHOULD WE, V9, P296; Hill G.E., 2006, BIRD COLOURATION FUN; HILL GE, 1995, BIOSCIENCE, V45, P25, DOI 10.2307/1312532; HUMPHREY PHILIP S., 1959, AUK, V76, P1; Johnsen S, 2016, J EXP BIOL, V219, P772, DOI 10.1242/jeb.124008; Juola FA, 2008, COMP BIOCHEM PHYS B, V149, P370, DOI 10.1016/j.cbpb.2007.10.010; Kesler DC, 2014, WILDLIFE SOC B, V38, P557, DOI 10.1002/wsb.437; KHAN RA, 1991, B ENVIRON CONTAM TOX, V46, P216, DOI 10.1007/BF01691940; Lamb JS, 2018, MAR POLLUT BULL, V131, P22, DOI 10.1016/j.marpolbul.2018.03.043; Lamb JS, 2017, J ORNITHOL, V158, P617, DOI 10.1007/s10336-016-1418-3; Leighton Frederick A., 1993, Environmental Reviews, V1, P92; Lumpkin DC, 2014, ECOL EVOL, V4, P3210, DOI 10.1002/ece3.1164; Mazet JAK, 2002, J AVIAN MED SURG, V16, P146, DOI 10.1647/1082-6742(2002)016[0146:AIOBEM]2.0.CO;2; McGraw K. J., 2006, BIRD COLORATION, VI; McGraw KJ, 2000, P ROY SOC B-BIOL SCI, V267, P1525, DOI 10.1098/rspb.2000.1174; McGraw KJ, BIRD COLORATION, P177; MCSWEENEY T, 1988, J ZOO WILDLIFE MED, V19, P116, DOI 10.2307/20094867; Miller EK, 2012, P 11 INT C EFF OIL W; Mills KL, 2016, WATERBIRDS, V39, P175, DOI 10.1675/063.039.0208; Montoya B, 2016, J EXP BIOL, V219, P3915, DOI 10.1242/jeb.141325; Montoya B, 2015, BEHAV ECOL, V26, P425, DOI 10.1093/beheco/aru204; Payne R.B., 1972, P103; Perez C, 2010, OECOLOGIA, V163, P875, DOI 10.1007/s00442-010-1677-2; Perez C, 2010, BIOL LETTERS, V6, P33, DOI 10.1098/rsbl.2009.0567; Pyle P, 2008, IDENTIFICATION GUIDE; Saks L, 2003, OECOLOGIA, V134, P301, DOI 10.1007/s00442-002-1125-z; Schreiber R, 1989, NATURAL HIST MUSEUM; Schreiber R.W., 1977, ORNITHOL MONOGR, V22, pIII; Schull Q, 2016, BEHAV ECOL, V27, P1684, DOI 10.1093/beheco/arw091; Sharp BE, 1996, IBIS, V138, P222, DOI 10.1111/j.1474-919X.1996.tb04332.x; Shields M., 2002, BROWN PELICAN PELECA; Team RC, 2015, R LANG ENV STAT COMP; Troisi G, 2016, INT J HYDROGEN ENERG, V41, P16549, DOI 10.1016/j.ijhydene.2016.04.011; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	76	4	4	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211932	10.1371/journal.pone.0211932	http://dx.doi.org/10.1371/journal.pone.0211932			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811430	Green Published, gold			2022-12-27	WOS:000459806400041
J	Xu, R; Li, CY; Paterson, AH				Xu, Rui; Li, Changying; Paterson, Andrew H.			Multispectral imaging and unmanned aerial systems for cotton plant phenotyping	PLOS ONE			English	Article							CROP SURFACE MODELS; WATER-STRESS; VEGETATION INDEXES; UAV; IMAGERY; BAND; TEMPERATURE; PLATFORM; BIOMASS; HEIGHT	This paper demonstrates the application of aerial multispectral images in cotton plant phenotyping. Four phenotypic traits (plant height, canopy cover, vegetation index, and flower) were measured from multispectral images captured by a multispectral camera on an unmanned aerial system. Data were collected on eight different days from two fields. Orthomosaic and digital elevation models (DEM) were constructed from the raw images using the structure from motion (SfM) algorithm. A data processing pipeline was developed to calculate plant height using the ortho-mosaic and DEM. Six ground calibration targets (GCTs) were used to correct the error of the calculated plant height caused by the georeferencing error of the DEM. Plant heights were measured manually to validate the heights predicted from the imaging method. The error in estimation of the maximum height of each plot ranged from -40.4 to 13.5 cm among six datasets, all of which showed strong linear relationships with the manual measurement (R-2 > 0.89). Plot canopy was separated from the soil based on the DEM and normalized differential vegetation index (NDVI). Canopy cover and mean canopy NDVI were calculated to show canopy growth over time and the correlation between the two indices was investigated. The spectral responses of the ground, leaves, cotton flower, and ground shade were analyzed and detection of cotton flowers was satisfactory using a support vector machine (SVM). This study demonstrated the potential of using aerial multispectral images for high throughput phenotyping of important cotton phenotypic traits in the field.	[Xu, Rui; Li, Changying] Univ Georgia, Coll Engn, Biosensing & Instrumentat Lab, Athens, GA 30602 USA; [Paterson, Andrew H.] Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Li, CY (corresponding author), Univ Georgia, Coll Engn, Biosensing & Instrumentat Lab, Athens, GA 30602 USA.	cyli@uga.edu		Xu, Rui/0000-0002-5899-2503	Agricultural Sensing and Robotics Initiative of the College of Engineering; College of Agricultural and Environmental Sciences of the University of Georgia; National Robotics Initiative grant (NIFA) [2017-67021-25928]	Agricultural Sensing and Robotics Initiative of the College of Engineering; College of Agricultural and Environmental Sciences of the University of Georgia; National Robotics Initiative grant (NIFA)	This study was funded jointly by the Agricultural Sensing and Robotics Initiative of the College of Engineering, and the College of Agricultural and Environmental Sciences of the University of Georgia. The project was also partially supported by the National Robotics Initiative grant (NIFA grant No: 2017-67021-25928 to CL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baluja J, 2012, IRRIGATION SCI, V30, P511, DOI 10.1007/s00271-012-0382-9; Bendig J, 2015, INT J APPL EARTH OBS, V39, P79, DOI 10.1016/j.jag.2015.02.012; Bendig J, 2014, REMOTE SENS-BASEL, V6, P10395, DOI 10.3390/rs61110395; Berni JAJ, 2009, IEEE T GEOSCI REMOTE, V47, P722, DOI 10.1109/TGRS.2008.2010457; Busemeyer L, 2013, SENSORS-BASEL, V13, P2830, DOI 10.3390/s130302830; Cabrera-Bosquet L, 2012, J INTEGR PLANT BIOL, V54, P312, DOI 10.1111/j.1744-7909.2012.01116.x; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chu TX, 2016, J APPL REMOTE SENS, V10, DOI 10.1117/1.JRS.10.036018; Comar A, 2012, FUNCT PLANT BIOL, V39, P914, DOI 10.1071/FP12065; Diaz-Varela RA, 2015, REMOTE SENS-BASEL, V7, P4213, DOI 10.3390/rs70404213; Franks SJ, 2015, AM J BOT, V102, P1401, DOI 10.3732/ajb.1500234; Gago J, 2015, AGR WATER MANAGE, V153, P9, DOI 10.1016/j.agwat.2015.01.020; Garcia-Ruiz F, 2013, COMPUT ELECTRON AGR, V91, P106, DOI 10.1016/j.compag.2012.12.002; Holman FH, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8121031; Huang Y, 2016, T ASABE, V59, P1563, DOI 10.13031/trans.59.11831; JACKSON RD, 1983, AGR WATER MANAGE, V7, P351, DOI 10.1016/0378-3774(83)90095-1; JACKSON RD, 1981, WATER RESOUR RES, V17, P1133, DOI 10.1029/WR017i004p01133; Jiang Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19142-2; Araus JL, 2014, TRENDS PLANT SCI, V19, P52, DOI 10.1016/j.tplants.2013.09.008; Mulla DJ, 2013, BIOSYST ENG, V114, P358, DOI 10.1016/j.biosystemseng.2012.08.009; Patrick A, 2017, IEEE INSTRU MEAS MAG, V20, P4, DOI 10.1109/MIM.2017.7951684; Phillips RL, 2010, CROP SCI, V50, pS99, DOI 10.2135/cropsci2009.09.0525; Sankaran S, 2015, EUR J AGRON, V70, P112, DOI 10.1016/j.eja.2015.07.004; Shi YY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159781; Thompson A, 2015, COMP STUDY GENETIC M; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Torino MS, 2014, AGRON J, V106, P1389, DOI 10.2134/agronj13.0578; Torr PHS, 2000, COMPUT VIS IMAGE UND, V78, P138, DOI 10.1006/cviu.1999.0832; Torres-Sanchez J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130479; Zarco-Tejada PJ, 2014, EUR J AGRON, V55, P89, DOI 10.1016/j.eja.2014.01.004; Zarco-Tejada PJ, 2012, REMOTE SENS ENVIRON, V117, P322, DOI 10.1016/j.rse.2011.10.007; Zhao DH, 2007, ISPRS J PHOTOGRAMM, V62, P25, DOI 10.1016/j.isprsjprs.2007.01.003; Zhao DL, 2007, EUR J AGRON, V26, P335, DOI 10.1016/j.eja.2006.12.001	33	36	38	9	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0205083	10.1371/journal.pone.0205083	http://dx.doi.org/10.1371/journal.pone.0205083			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811435	Green Published, gold, Green Submitted			2022-12-27	WOS:000459806400002
J	Guerra-Maupome, M; Vang, DX; McGill, JL				Guerra-Maupome, Mariana; Vang, Dua X.; McGill, Jodi L.			Aerosol vaccination with Bacille Calmette-Guerin induces a trained innate immune phenotype in calves	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS; BCG VACCINATION; NONSPECIFIC PROTECTION; ACTIVATED MACROPHAGES; RANDOMIZED-TRIAL; NEONATAL CALVES; RESPONSES; MODEL; REINFECTION; EXPRESSION	Mycobacterium bovis Bacillus Calmette-Guerin (BCG) is a live attenuated vaccine for use against tuberculosis (TB); however, it is known to reduce childhood mortality from infections other than TB. The unspecific protection induced by BCG vaccination has been associated with the induction of memory-like traits of the innate immune system identified as 'trained' immunity. In humans and mouse models, in vitro and in vivo BCG training leads to enhanced production of monocyte-derived proinflammatory cytokines in response to secondary unrelated bacterial and fungal pathogens. While BCG has been studied extensively for its ability to induce innate training in humans and mouse models, BCG's nonspecific protective effects have not been defined in agricultural species. Here, we show that in vitro BCG training induces a functional change in bovine monocytes, characterized by increased transcription of proinflammatory cytokines upon restimulation with the toll-like receptor agonists. Importantly, in vivo, aerosol BCG vaccination in young calves also induced a 'trained' phenotype in circulating peripheral blood mononuclear cells (PBMCs), that lead to a significantly enhanced TLR-induced proinflammatory cytokine response and changes in cellular metabolism compared to PBMCs from unvaccinated control calves. Similar to the long-term training effects of BCG reported in humans, our results suggest that in young calves, the effects of BCG induced innate training can last for at least 3 months in circulating immune populations. Interestingly, however, aerosol BCG vaccination did not 'train' the innate immune response at the mucosal level, as alveolar macrophages from aerosol BCG vaccinated calves did not mount an enhanced inflammatory response to secondary stimulation, compared to cells isolated from control calves. Together, our results suggest that, like mice and humans, the innate immune system of calves can be 'trained'; and that BCG vaccination could be used as an immunomodulatory strategy to reduce disease burden in juvenile food animals before the adaptive immune system has fully matured.	[Guerra-Maupome, Mariana; McGill, Jodi L.] Iowa State Univ, Dept Vet Microbiol & Preventat Med, Ames, IA 50011 USA; [Vang, Dua X.] Iowa State Univ, Interdept Microbiol Program, Ames, IA USA	Iowa State University; Iowa State University	McGill, JL (corresponding author), Iowa State Univ, Dept Vet Microbiol & Preventat Med, Ames, IA 50011 USA.	jlmcgill@iastate.edu		McGill, Jodi/0000-0001-7637-1455	National Institutes of Health [Kansas INBRE P20 GM103418, COBRE P20 GM103638]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103418, P20GM103638] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health: Kansas INBRE P20 GM103418 and COBRE P20 GM103638 to JLM. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aaby P, 2014, NAT IMMUNOL, V15, P895, DOI 10.1038/ni.2961; Aaby P, 2011, J INFECT DIS, V204, P245, DOI 10.1093/infdis/jir240; Allard B, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01777; Arts RJW, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00298; Arts RJW, 2015, J LEUKOCYTE BIOL, V98, P995, DOI 10.1189/jlb.4MA0215-059R; Arts RJW, 2015, J LEUKOCYTE BIOL, V98, P129, DOI 10.1189/jlb.6AB0914-416R; Bekkering S, 2016, CLIN VACCINE IMMUNOL, V23, P926, DOI 10.1128/CVI.00349-16; Belyakov IM, 2009, J IMMUNOL, V183, P6883, DOI 10.4049/jimmunol.0901466; Benn CS, 2013, TRENDS IMMUNOL, V34, P431, DOI 10.1016/j.it.2013.04.004; Biering-Sorensen S, 2012, PEDIATR INFECT DIS J, V31, P306, DOI 10.1097/INF.0b013e3182458289; Blok BA, 2015, J LEUKOCYTE BIOL, V98, P347, DOI 10.1189/jlb.5RI0315-096R; Buddle BM, 2003, INFECT IMMUN, V71, P6411, DOI 10.1128/IAI.71.11.6411-6419.2003; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; DILUZIO NR, 1978, INFECT IMMUN, V20, P804, DOI 10.1128/IAI.20.3.804-810.1978; Endsley JJ, 2009, VET IMMUNOL IMMUNOP, V128, P199, DOI 10.1016/j.vetimm.2008.10.312; Fu YH, 2013, VET IMMUNOL IMMUNOP, V151, P20, DOI 10.1016/j.vetimm.2012.09.039; Giudice EL, 2006, ADV DRUG DELIVER REV, V58, P68, DOI 10.1016/j.addr.2005.12.003; Hollm-Delgado MG, 2014, PEDIATRICS, V133, pE73, DOI 10.1542/peds.2013-2218; Hope JC, 2005, CLIN EXP IMMUNOL, V139, P48, DOI 10.1111/j.1365-2249.2005.02668.x; Kaufmann E, 2018, CELL, V172, P176, DOI 10.1016/j.cell.2017.12.031; Kleinnijenhuis J, 2014, CLIN IMMUNOL, V155, P213, DOI 10.1016/j.clim.2014.10.005; Kleinnijenhuis J, 2014, J INNATE IMMUN, V6, P152, DOI 10.1159/000355628; Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109; Kurtz J, 2005, TRENDS IMMUNOL, V26, P186, DOI 10.1016/j.it.2005.02.001; Levy O, 2015, T ROY SOC TROP MED H, V109, P3, DOI 10.1093/trstmh/tru185; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marakalala MJ, 2013, MICROBES INFECT, V15, P511, DOI 10.1016/j.micinf.2013.03.002; McGill JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151083; Mitroulis I, 2018, CELL, V172, P147, DOI 10.1016/j.cell.2017.11.034; Mukherjee S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180143; Munoz N, 2010, INFECT IMMUN, V78, P4226, DOI 10.1128/IAI.00224-10; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Netea MG, 2014, SEMIN IMMUNOL, V26, P512, DOI 10.1016/j.smim.2014.09.006; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; Ota MOC, 2002, J IMMUNOL, V168, P919, DOI 10.4049/jimmunol.168.2.919; Palmer MV, 2002, TUBERCULOSIS, V82, P275, DOI 10.1054/tube.2002.0341; Parra M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066115; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698; Sacco RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033074; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Semple PL, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/438463; Stensballe LG, 2005, VACCINE, V23, P1251, DOI 10.1016/j.vaccine.2004.09.006; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; USDA, 1999, HLTH MAN BIOS FEE 3; USDA, 2007, CHANG US DAIR CATT 3; VANTWOUT JW, 1992, SCAND J IMMUNOL, V36, P713; Waters WR, 2007, VACCINE, V25, P7832, DOI 10.1016/j.vaccine.2007.08.029; Whittaker E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00532	49	26	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212751	10.1371/journal.pone.0212751	http://dx.doi.org/10.1371/journal.pone.0212751			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794653	gold, Green Submitted, Green Published			2022-12-27	WOS:000459709100131
J	Maguire, FB; Morris, CR; Parikh-Patel, A; Cress, RD; Keegan, THM; Li, CS; Lin, PS; Kizer, KW				Maguire, Frances B.; Morris, Cyllene R.; Parikh-Patel, Arti; Cress, Rosemary D.; Keegan, Theresa H. M.; Li, Chin-Shang; Lin, Patrick S.; Kizer, Kenneth W.			A text-mining approach to obtain detailed treatment information from free-text fields in population-based cancer registries: A study of non-small cell lung cancer in California	PLOS ONE			English	Article							LANGUAGE; IDENTIFICATION; PATTERNS; NLP	Background Population-based cancer registries have treatment information for all patients making them an excellent resource for population-level monitoring. However, specific treatment details, such as drug names, are contained in a free-text format that is difficult to process and summarize. We assessed the accuracy and efficiency of a text-mining algorithm to identify systemic treatments for lung cancer from free-text fields in the California Cancer Registry. Methods The algorithm used Perl regular expressions in SAS 9.4 to search for treatments in 24,845 free-text records associated with 17,310 patients in California diagnosed with stage IV non-small cell lung cancer between 2012 and 2014. Our algorithm categorized treatments into six groups that align with National Comprehensive Cancer Network guidelines. We compared results to a manual review (gold standard) of the same records. Results Percent agreement ranged from 91.1% to 99.4%. Ranges for other measures were 0.71-0.92 (Kappa), 74.3%-97.3% (sensitivity), 92.4%-99.8% (specificity), 60.4%-96.4% (positive predictive value), and 92.9%-99.9% (negative predictive value). The text-mining algorithm used one-sixth of the time required for manual review. Conclusion SAS-based text mining of free-text data can accurately detect systemic treatments administered to patients and save considerable time compared to manual review, maximizing the utility of the extant information in population-based cancer registries for comparative effectiveness research.	[Maguire, Frances B.; Morris, Cyllene R.; Parikh-Patel, Arti; Kizer, Kenneth W.] Univ Calif Davis Hlth, Inst Populat Hlth Improvement, Calif Canc Reporting & Epidemiol Surveillance Pro, Sacramento, CA 95817 USA; [Maguire, Frances B.] Univ Calif Davis, Grad Grp Epidemiol, Davis, CA 95616 USA; [Cress, Rosemary D.; Keegan, Theresa H. M.] Univ Calif Davis, Dept Publ Hlth Sci, Davis, CA 95616 USA; [Keegan, Theresa H. M.; Lin, Patrick S.] Univ Calif Davis, Sch Med, COHORT, Sacramento, CA 95817 USA; [Keegan, Theresa H. M.; Lin, Patrick S.] Univ Calif Davis, Sch Med, Div Hematol & Oncol, Sacramento, CA 95817 USA; [Li, Chin-Shang] SUNY Buffalo, Sch Nursing, Buffalo, NY USA; [Kizer, Kenneth W.] Univ Calif Davis, Sch Med, Dept Emergency Med, Sacramento, CA 95817 USA; [Kizer, Kenneth W.] Univ Calif Davis, Betty Irene Moore Sch Nursing, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of California System; University of California Davis; University of California System; University of California Davis	Maguire, FB (corresponding author), Univ Calif Davis Hlth, Inst Populat Hlth Improvement, Calif Canc Reporting & Epidemiol Surveillance Pro, Sacramento, CA 95817 USA.; Maguire, FB (corresponding author), Univ Calif Davis, Grad Grp Epidemiol, Davis, CA 95616 USA.	fbmaguire@ucdavis.edu		Maguire, Frances/0000-0001-8490-6229	California Department of Public Health [103885]; National Cancer Institute's Surveillance, Epidemiology and End Results Program; Public Health Institute; Centers for Disease Control and Prevention's National Program of Cancer Registries; National Cancer Institute	California Department of Public Health; National Cancer Institute's Surveillance, Epidemiology and End Results Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Public Health Institute; Centers for Disease Control and Prevention's National Program of Cancer Registries(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the California Department of Public Health as part of the statewide cancer reporting program mandated by California Health and Safety Code Section 103885; the National Cancer Institute's Surveillance, Epidemiology and End Results Program under contracts awarded to the Cancer Prevention Institute of California, the University of Southern California, and the Public Health Institute; and the Centers for Disease Control and Prevention's National Program of Cancer Registries, under agreement awarded to the California Department of Public Health. The ideas and opinions expressed herein are those of the author(s) and endorsement by the State of California, Department of Public Health, the National Cancer Institute, the Centers for Disease Control and Prevention, or their Contractors and Subcontractors is not intended nor should be inferred.	Abernethy AP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178420; Afzal N, 2018, INT J MED INFORM, V111, P83, DOI 10.1016/j.ijmedinf.2017.12.024; Bittoni MA, 2018, CLIN LUNG CANCER, V19, pE629, DOI 10.1016/j.cllc.2018.04.017; Brute SY, 2016, LUNG CANCER, V97, P15, DOI 10.1016/j.lungcan.2016.04.007; Cai TR, 2016, RADIOGRAPHICS, V36, P176, DOI 10.1148/rg.2016150080; California Department of Public Health, 2018, CANC REP CAL CAL CAN, VI; California Department of Public Health, 2016, PHYS REQ CANC REP CA, VIV; California Department of Public Health, 2018, CANC REP CAL STAND A, VII; California Department of Public Health, 2017, CANC REP CAL DAT STA, VIII; Carrell DS, 2014, AM J EPIDEMIOL, V179, P749, DOI 10.1093/aje/kwt441; Chang HM, 2016, STUD HEALTH TECHNOL, V225, P813, DOI 10.3233/978-1-61499-658-3-813; Chapman WW, 2011, J AM MED INFORM ASSN, V18, P540, DOI 10.1136/amiajnl-2011-000465; Dembe AE, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-252; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Enewold L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156728; Flight L, 2015, PHARM STAT, V14, P74, DOI 10.1002/pst.1659; Harpaz R, 2014, DRUG SAFETY, V37, P777, DOI 10.1007/s40264-014-0218-z; Hazlehurst B, 2005, AM J PREV MED, V29, P434, DOI 10.1016/j.amepre.2005.08.007; Isobe H, 2017, LUNG CANCER-TARGETS, V8, P191, DOI 10.2147/LCTT.S140491; Jones BE, 2018, APPL CLIN INFORM, V9, P122, DOI 10.1055/s-0038-1626725; Nadkarni PM, 2011, J AM MED INFORM ASSN, V18, P544, DOI 10.1136/amiajnl-2011-000464; National Comprehensive Cancer Network, 2017, NCCN CLIN PRACT GUID; Osborne JD, 2016, J AM MED INFORM ASSN, V23, P1077, DOI 10.1093/jamia/ocw006; Raja Uzma, 2008, J Healthc Inf Manag, V22, P52; Ruud KL, 2010, INT J QUAL HEALTH C, V22, P229, DOI 10.1093/intqhc/mzq012; Sacher AG, 2015, CANCER-AM CANCER SOC, V121, P2562, DOI 10.1002/cncr.29386; SAS Institute Inc, 2011, SAS FUNCT CALL ROUT; Savova GK, 2008, J AM MED INFORM ASSN, V15, P25, DOI 10.1197/jamia.M2437; Schulkes KJG, 2016, LUNG, V194, P967, DOI 10.1007/s00408-016-9943-7; Shenoy Premnath, 2015, Perspect Clin Res, V6, P184, DOI 10.4103/2229-3485.167099; Spence MM, 2017, J MANAG CARE SPEC PH, V23, P159, DOI 10.18553/jmcp.2017.23.2.195; Strauss JA, 2013, J AM MED INFORM ASSN, V20, P349, DOI 10.1136/amiajnl-2012-000928; Travis WD, 2015, J THORAC ONCOL, V10, P1243, DOI 10.1097/JTO.0000000000000630; Verleye L, 2018, EUR J CANCER CARE, V27, DOI 10.1111/ecc.12747; Viera AJ, 2005, FAM MED, V37, P360; Weng WH, 2017, BMC MED INFORM DECIS, V17, DOI 10.1186/s12911-017-0556-8; Xie Fagen, 2017, J Pathol Inform, V8, P48, DOI 10.4103/jpi.jpi_55_17; Younis T, 2008, J THORAC ONCOL, V3, P1272, DOI 10.1097/JTO.0b013e318189f562	38	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212454	10.1371/journal.pone.0212454	http://dx.doi.org/10.1371/journal.pone.0212454			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794610	gold, Green Published, Green Submitted			2022-12-27	WOS:000459709100069
J	Vicenzino, B; Lawrenson, P; Khan, A; Stephenson, A; Heales, L; Benson, HAE; Wright, A				Vicenzino, Bill; Lawrenson, Peter; Khan, Asaduzzaman; Stephenson, Aiofe; Heales, Luke; Benson, Heather A. E.; Wright, Anthony			A randomised pilot equivalence trial to evaluate diamagnetically enhanced transdermal delivery of key ground substance components in comparison to an established transdermal non-steroidal anti-inflammatory formulation in males with prior knee injury	PLOS ONE			English	Article							SKIN PERMEATION; HYALURONIC-ACID; CHONDROITIN SULFATE; TOPICAL DELIVERY; OSTEOARTHRITIS; MANAGEMENT; HIP; VISCOSUPPLEMENTATION; RECOMMENDATIONS; THERAPIES	Objective This pilot study assessed the efficacy of a knee guard device, which used magnetophoresis to transdermally deliver Glucosamine, Chondroitin and Hyaluronic Acid in a cohort of individuals with prior knee injury. The aim was to determine if the change in physical function and pain with the knee guard device was equivalent to the change produced by an established topical NSAID formulation containing diclofenac sodium 1%. Methods A randomized, controlled, equivalence trial evaluated outcomes following treatment with the knee guard device or NSAID formulation. The study recruited 114 male participants (aged 40-55 years). Participants were randomly allocated to wear the knee guard device or to use a NSAID gel daily for two weeks. The primary outcomes were the knee injury osteoarthritis function score (KOOS-F) and an aggregated function score (AFS). The lower extremity functional scale (LEFS), pain numerical rating scale (PNRS), global rating of change (GROC) and other KOOS scores were also evaluated. Results Multiple linear regression analyses indicated that there were no significant differences between the interventions for changes in the primary outcomes of AFS and KOOS_F. The 95% confidence interval (-2.89 to 5.15) of the estimated treatment difference for KOOS-F was within the lower (-5.61) and upper (5.61) bounds of the 7% equivalence margin for that measure, The mean value for the AFS was within, but the 95% CI (-3.11 to 7.37) exceeded the 7% equivalence margin (-2.97 to 2.97) for that measure. There was a significant difference in PNRS, which favored the knee guard device. Conclusion The knee guard device demonstrated equivalence for the KOOS-F measure but not the AFS measure of function over the two week trial period when compared to a widely available NSAID gel that has been shown to be superior to placebo. The knee guard produced a greater reduction in pain report (p = 0.002) than the NSAID gel. Users of the knee guard device experienced more skin irritation than participants using the NSAID gel. Further research is required to fully evaluate the therapeutic potential of this innovative treatment approach.	[Vicenzino, Bill; Lawrenson, Peter; Khan, Asaduzzaman; Stephenson, Aiofe; Heales, Luke] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; [Benson, Heather A. E.] Curtin Univ, Sch Pharm & Biomed Sci, Perth, WA, Australia; [Wright, Anthony] Curtin Univ, Sch Physiotherapy & Exercise Sci, Perth, WA, Australia	University of Queensland; Curtin University; Curtin University	Wright, A (corresponding author), Curtin Univ, Sch Physiotherapy & Exercise Sci, Perth, WA, Australia.	T.Wright@curtin.edu.au	Khan, Asad/F-8739-2010; Khan, Asad/N-7481-2019; Vicenzino, Bill/A-8492-2011	Khan, Asad/0000-0003-4188-2065; Khan, Asad/0000-0003-4188-2065; Vicenzino, Bill/0000-0003-0253-5933; Lawrenson, Peter/0000-0002-6479-6840; Wright, Anthony/0000-0002-0289-6141; Stephenson, Aoife/0000-0001-8766-5272	OBJ Ltd	OBJ Ltd	The trial was funded by OBJ Ltd through a contractural arrangement with UNIQuest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebowale A, 2002, BIOPHARM DRUG DISPOS, V23, P217, DOI 10.1002/bdd.315; Arden N, 2006, BEST PRACT RES CL RH, V20, P3, DOI 10.1016/j.berh.2005.09.007; Balazs Endre A, 2004, Surg Technol Int, V12, P278; Baraf HSB, 2011, DRUG AGING, V28, P27, DOI 10.2165/11584880-000000000-00000; Baraf HSB, 2010, PHYSICIAN SPORTSMED, V38, P19, DOI 10.3810/psm.2010.06.1779; Benson HAE, 2013, CHEM METHODS PENETRA; Benson HAE, 2010, J PHARM PHARMACOL, V62, P696, DOI 10.1211/jpp.62.06.0005; Binkley JM, 1999, PHYS THER, V79, P371; Campbell KA, 2015, ARTHROSCOPY, V31, P2036, DOI 10.1016/j.arthro.2015.03.030; Chen M, 2014, J CONTROL RELEASE, V173, P67, DOI 10.1016/j.jconrel.2013.10.007; Creamer P, 2000, RHEUMATOLOGY, V39, P490, DOI 10.1093/rheumatology/39.5.490; DAVIS MA, 1989, AM J EPIDEMIOL, V130, P278, DOI 10.1093/oxfordjournals.aje.a115334; Derry S, 2016, COCHRANE DB SYST REV, V4, DOI [DOI 10.1002/14651858.CD007400.PUB3, 10.1002/14651858.cd007400]; Gelber AC, 2000, ANN INTERN MED, V133, P321, DOI 10.7326/0003-4819-133-5-200009050-00007; Han IH, 2010, ARCH PHARM RES, V33, P293, DOI 10.1007/s12272-010-0215-4; Henrotin Y, 2015, SEMIN ARTHRITIS RHEU, V45, P140, DOI 10.1016/j.semarthrit.2015.04.011; Henrotin Y, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0361-z; Hochberg M, 2013, CURR MED RES OPIN, V29, P259, DOI 10.1185/03007995.2012.753430; Hochberg MC, 2012, ARTHRIT CARE RES, V64, P465, DOI 10.1002/acr.21596; Kanwischer M, 2005, DRUG DEV IND PHARM, V31, P91, DOI 10.1081/DDC-200044181; Krishnan G, 2010, J PHARM SCI-US, V99, P2724, DOI 10.1002/jps.22024; McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003; Murthy SN, 2010, J CONTROL RELEASE, V148, P197, DOI 10.1016/j.jconrel.2010.08.015; Namjoshi S, 2008, BIOPOLYMERS, V90, P655, DOI 10.1002/bip.21033; Roos EM, 2012, OSTEOARTHR CARTILAGE, V20, P1477, DOI 10.1016/j.joca.2012.08.028; Roos EM, 1998, J ORTHOP SPORT PHYS, V28, P88, DOI 10.2519/jospt.1998.28.2.88; Roos Ewa M, 2003, Health Qual Life Outcomes, V1, P64, DOI 10.1186/1477-7525-1-64; Salaffi F, 2004, EUR J PAIN, V8, P283, DOI 10.1016/j.ejpain.2003.09.004; Vazquez-Gonzalez ML, 2015, COLLOID SURFACE B, V134, P31, DOI 10.1016/j.colsurfb.2015.06.029; Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI 10.1016/j.joca.2007.12.013; Zhang YQ, 2010, CLIN GERIATR MED, V26, P355, DOI [10.1016/j.cger.2010.03.001, 10.1016/j.rdc.2012.10.004]	31	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0211999	10.1371/journal.pone.0211999	http://dx.doi.org/10.1371/journal.pone.0211999			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794553	Green Published, Green Submitted, gold			2022-12-27	WOS:000459709100029
J	Ward, BP; Brown-Guedira, G; Kolb, FL; Van Sanford, DA; Tyagi, P; Sneller, CH; Griffey, CA				Ward, Brian P.; Brown-Guedira, Gina; Kolb, Frederic L.; Van Sanford, David A.; Tyagi, Priyanka; Sneller, Clay H.; Griffey, Carl A.			Genome-wide association studies for yield-related traits in soft red winter wheat grown in Virginia	PLOS ONE			English	Article							TRITICUM-AESTIVUM L.; SPRING BREAD WHEAT; GRAIN-YIELD; AGRONOMIC TRAITS; GAMYB GENE; STEM RUST; IDENTIFICATION; EXPRESSION; PROTEIN; RICE	Grain yield is a trait of paramount importance in the breeding of all cereals. In wheat (Triticum aestivum L.), yield has steadily increased since the Green Revolution, though the current rate of increase is not forecasted to keep pace with demand due to growing world population and increasing affluence. While several genome-wide association studies (GWAS) on yield and related component traits have been performed in wheat, the previous lack of a reference genome has made comparisons between studies difficult. In this study, a GWAS for yield and yield-related traits was carried out on a population of 322 soft red winter wheat lines across a total of four rain-fed environments in the state of Virginia using single-nucleotide polymorphism (SNP) marker data generated by a genotyping-by-sequencing (GBS) protocol. Two separate mixed linear models were used to identify significant marker-trait associations (MTAs). The first was a single-locus model utilizing a leave-one-chromosome-out approach to estimating kinship. The second was a sub-setting kinship estimation multi-locus method (FarmCPU). The single-locus model identified nine significant MTAs for various yield-related traits, while the FarmCPU model identified 74 significant MTAs. The availability of the wheat reference genome allowed for the description of MTAs in terms of both genetic and physical positions, and enabled more extensive post-GWAS characterization of significant MTAs. The results indicate a number of promising candidate genes contributing to grain yield, including an ortholog of the rice aberrant panicle organization (APO1) protein and a gibberellin oxidase protein (GA2ox-A1) affecting the trait grains per square meter, an ortholog of the Arabidopsis thaliana mother of flowering time and terminal flowering 1 (MFT) gene affecting the trait seeds per square meter, and a B2 heat stress response protein affecting the trait seeds per head.	[Ward, Brian P.; Griffey, Carl A.] Virginia Tech, Dept Crop & Soil Environm Sci, Blacksburg, VA 24061 USA; [Brown-Guedira, Gina] USDA ARS, Eastern Reg Small Grains Genotyping Lab, Raleigh, NC 27695 USA; [Kolb, Frederic L.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Van Sanford, David A.] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY USA; [Ward, Brian P.; Tyagi, Priyanka] North Carolina State Univ, Dept Crop & Soil Sci, Raleigh, NC 27695 USA; [Sneller, Clay H.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Wooster, OH 44691 USA	Virginia Polytechnic Institute & State University; United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign; University of Kentucky; University of North Carolina; North Carolina State University; University System of Ohio; Ohio State University	Ward, BP (corresponding author), Virginia Tech, Dept Crop & Soil Environm Sci, Blacksburg, VA 24061 USA.; Ward, BP (corresponding author), North Carolina State Univ, Dept Crop & Soil Sci, Raleigh, NC 27695 USA.	bpward2@ncsu.edu		Brown-Guedira, Gina/0000-0002-1958-2827; Ward, Brian/0000-0002-4129-7934	Agriculture and Food Research Initiative Competitive Grants (Tritaceae Coordinated Agricultural Project [TCAP]) from the USDA National Institute of Food and Agriculture [2011-68002-30029]; Agriculture and Food Research Initiative Competitive (Wheat Coordinated Agricultural Project [WheatCAP]) from the USDA National Institute of Food and Agriculture [2017-67007-25939]; Virginia Agricultural Council [617]; Virginia Small Grains Board	Agriculture and Food Research Initiative Competitive Grants (Tritaceae Coordinated Agricultural Project [TCAP]) from the USDA National Institute of Food and Agriculture; Agriculture and Food Research Initiative Competitive (Wheat Coordinated Agricultural Project [WheatCAP]) from the USDA National Institute of Food and Agriculture; Virginia Agricultural Council; Virginia Small Grains Board	CHS and GBG received funding from the Agriculture and Food Research Initiative Competitive Grants 2011-68002-30029 (Tritaceae Coordinated Agricultural Project [TCAP]) from the USDA National Institute of Food and Agriculture: https://www.triticeaecap.org/. GBG received funding from the Agriculture and Food Research Initiative Competitive Grant 2017-67007-25939 (Wheat Coordinated Agricultural Project [WheatCAP]) from the USDA National Institute of Food and Agriculture: https://www.triticeaecap.org/. BPW and CAG received funding from Virginia Agricultural Council Grant 617: http://www.vdacs.virginia.gov/boards-virginia-agricultural-council.shtml, and from the Virginia Small Grains Board (no grant number available): http://www.virginiagrains.com/leadership/va-small-grains-board/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ain QU, 2015, FRONT PLANT SCI, V6, DOI [10.3389/fpls.7015.00743, 10.3389/fpls.2015.00743]; ALLARD RW, 1954, PHYTOPATHOLOGY, V44, P266; Appels R, 2018, SCIENCE, V361, P661, DOI 10.1126/science.aar7191; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Borras L, 2004, FIELD CROP RES, V86, P131, DOI 10.1016/j.fcr.2003.08.002; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Bruinsma J., 2011, Looking ahead in world food and agriculture: perspectives to 2050, P233; Cabrera A, 2015, THEOR APPL GENET, V128, P2227, DOI 10.1007/s00122-015-2580-3; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chauhan H, 2011, PLANT MOL BIOL, V75, P35, DOI 10.1007/s11103-010-9702-8; Chen L, 2001, PLANT CELL ENVIRON, V24, P469, DOI 10.1046/j.1365-3040.2001.00688.x; Chen YH, 2009, THEOR APPL GENET, V118, P881, DOI 10.1007/s00122-008-0946-5; Cheng XX, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11013; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Clevenger JP, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00564; Clevenger JP, 2015, G3-GENES GENOM GENET, V5, P1797, DOI 10.1534/g3.115.019703; COX MC, 1985, CROP SCI, V25, P435, DOI 10.2135/cropsci1985.0011183X002500030003x; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Cullis BR, 2006, J AGR BIOL ENVIR ST, V11, P381, DOI 10.1198/108571106X154443; Diaz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033234; Dodig D, 2012, INT J MOL SCI, V13, P6167, DOI 10.3390/ijms13056167; DONALD CM, 1968, EUPHYTICA, V17, P385, DOI 10.1007/BF00056241; Edae EA, 2014, THEOR APPL GENET, V127, P791, DOI 10.1007/s00122-013-2257-8; Ehdaie B, 2003, CROP SCI, V43, P710, DOI 10.2135/cropsci2003.0710; Eilers PHC, 2003, CHEMOMETR INTELL LAB, V66, P159, DOI 10.1016/S0169-7439(03)00029-7; Freiberg C, 2004, J BIOL CHEM, V279, P26066, DOI 10.1074/jbc.M402989200; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Gocal GFW, 1999, PLANT PHYSIOL, V119, P1271, DOI 10.1104/pp.119.4.1271; Godoy J, 2018, CROP SCI, V58, P1838, DOI 10.2135/cropsci2017.07.0423; Green AJ, 2012, CROP SCI, V52, P2097, DOI 10.2135/cropsci2012.01.0026; Groos C, 2003, THEOR APPL GENET, V106, P1032, DOI 10.1007/s00122-002-1111-1; GUBLER F, 1995, PLANT CELL, V7, P1879, DOI 10.1105/tpc.7.11.1879; Guedira M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154242; Guo J, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1234-4; Habier D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-186; Hallab A, 2017, AUTOMATED ASSIGNMENT; Howells RM, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1433-z; Huang M, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giy154; Ikeda K, 2007, PLANT J, V51, P1030, DOI 10.1111/j.1365-313X.2007.03200.x; Jiang QY, 2011, FUNCT INTEGR GENOMIC, V11, P49, DOI 10.1007/s10142-010-0188-x; KaganZur V, 1995, PLANT MOL BIOL, V29, P1101, DOI 10.1007/BF00020455; Kaneko M, 2004, PLANT CELL, V16, P33, DOI 10.1105/tpc.017327; Kippes N, 2015, P NATL ACAD SCI USA, V112, pE5401, DOI 10.1073/pnas.1514883112; Kusmec A, 2018, PLANT DIRECT, V2, DOI 10.1002/pld3.53; Li GQ, 2013, PLANT J, V76, P742, DOI 10.1111/tpj.12326; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liang Z, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14261; Liu X, 2016, PLOS GENET, V12, DOI DOI 10.1371/JOURNAL.PGEN.1005767; Liu YX, 2017, PLANT J, V91, P861, DOI 10.1111/tpj.13614; Lozada DN, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-017-2005-2; Ma DY, 2012, MOL BREEDING, V29, P43, DOI 10.1007/s11032-010-9524-z; Ma FF, 2018, MOL BREEDING, V38, DOI 10.1007/s11032-018-0837-7; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Mengistu DK, 2016, PLANT BIOTECHNOL J, V14, P1800, DOI 10.1111/pbi.12538; Miao CY, 2019, PLANT BIOTECHNOL J, V17, P893, DOI 10.1111/pbi.13023; Micheli F, 2001, TRENDS PLANT SCI, V6, P414, DOI 10.1016/S1360-1385(01)02045-3; MORENOSEVILLA B, 1995, CROP SCI, V35, P1607, DOI 10.2135/cropsci1995.0011183X003500060015x; Murray K, 2016, J STAT COMPUT SIM, V86, P2946, DOI 10.1080/00949655.2016.1139582; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Nakamura S, 2011, PLANT CELL, V23, P3215, DOI 10.1105/tpc.111.088492; Neumann K, 2011, MOL BREEDING, V27, P37, DOI 10.1007/s11032-010-9411-7; NYQUIST W. E., 1957, AGRON JOUR, V49, P222; Ogbonnaya FC, 2017, THEOR APPL GENET, V130, P1819, DOI 10.1007/s00122-017-2927-z; Panavas T, 1998, PLANT PHYSIOL BIOCH, V36, P379, DOI 10.1016/S0981-9428(98)80079-X; Pearce S, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0520-7; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; R Development Core Team, 2009, R LANG ENV STAT COMP; RADLEY M, 1976, J EXP BOT, V27, P1009, DOI 10.1093/jxb/27.5.1009; Reif JC, 2011, THEOR APPL GENET, V122, P961, DOI 10.1007/s00122-010-1502-7; Reynolds MP, 2005, ANN APPL BIOL, V146, P39, DOI 10.1111/j.1744-7348.2005.03100.x; Sado PE, 2009, FUNCT INTEGR GENOMIC, V9, P43, DOI 10.1007/s10142-008-0100-0; Salvi S, 2015, CURR OPIN BIOTECH, V32, P179, DOI 10.1016/j.copbio.2015.01.001; Schrader S, 1997, J PLANT PHYSIOL, V150, P63, DOI 10.1016/S0176-1617(97)80182-4; Segura V, 2012, NAT GENET, V44, P825, DOI 10.1038/ng.2314; Sehgal D, 2017, SCI REP-UK, V7, DOI 10.1038/srep41578; Shan QW, 2014, NAT PROTOC, V9, P2395, DOI 10.1038/nprot.2014.157; Sharma RC, 2012, CROP SCI, V52, P1522, DOI 10.2135/cropsci2011.12.0634; Silva Simone Alves, 2000, Journal of New Seeds, V2, P55, DOI 10.1300/J153v02n02_05; Singh A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00642; Singh RP, 1998, CROP SCI, V38, P27, DOI 10.2135/cropsci1998.0011183X003800010005x; Slafer G.A., 1996, INCREASING YIELD POT, P101; Slafer GA, 2003, ANN APPL BIOL, V142, P117, DOI 10.1111/j.1744-7348.2003.tb00237.x; Soriano JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178290; Sorrells ME, 2011, GENOME, V54, P875, DOI [10.1139/G11-054, 10.1139/g11-054]; Spindel J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004982; Su ZQ, 2011, THEOR APPL GENET, V122, P211, DOI 10.1007/s00122-010-1437-z; Sukumaran S, 2018, THEOR APPL GENET, V131, P985, DOI 10.1007/s00122-017-3037-7; Sukumaran S, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00081; Sukumaran S, 2015, THEOR APPL GENET, V128, P353, DOI 10.1007/s00122-014-2435-3; Tadesse W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141339; TERMAN GL, 1969, AGRON J, V61, P755, DOI 10.2134/agronj1969.00021962006100050031x; Tsilo TJ, 2008, CROP SCI, V48, P253, DOI 10.2135/cropsci2007.04.0204; Turuspekov Y, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1131-2; Valdar W, 2009, GENETICS, V182, P1263, DOI 10.1534/genetics.109.100727; Wallace JG, 2016, CROP SCI, V56, P2365, DOI 10.2135/cropsci2015.10.0632; Wang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094829; Wang SX, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188662; Ward BP, 2019, CROP SCI; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Widmer C, 2014, SCI REP-UK, V4, DOI 10.1038/srep06874; Wurschum T, 2013, THEOR APPL GENET, V126, P1477, DOI 10.1007/s00122-013-2065-1; Rodriguez-Alvarez MX, 2018, SPAT STAT-NETH, V23, P52, DOI 10.1016/j.spasta.2017.10.003; Yang Jian, 2011, Am J Hum Genet, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zanke C, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00217; Zanke CD, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00644; Zanke CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113287; Zhang JL, 2018, THEOR APPL GENET, V131, P1741, DOI 10.1007/s00122-018-3111-9; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606	116	39	39	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0208217	10.1371/journal.pone.0208217	http://dx.doi.org/10.1371/journal.pone.0208217			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794545	Green Published, Green Submitted, gold			2022-12-27	WOS:000459709100008
J	Li, X; He, L; Wang, J; Wang, MX				Li, Xin; He, Lan; Wang, Jing; Wang, Mingxu			Illness uncertainty, social support, and coping mode in hospitalized patients with systemic lupus erythematosus in a hospital in Shaanxi, China	PLOS ONE			English	Article							QUALITY-OF-LIFE	Objective To analyze the relationships between illness uncertainty, social support, and coping mode in hospitalized patients with systematic lupus erythematosus (SLE). Methods The General Health Questionnaire, Mishel Uncertainty in Illness Scale, Social Support Rating Scale, and Medical Coping Modes Questionnaire were to the hospitalized patients with SLE (N = 200) in a tertiary hospital in Shaanxi. Results The hospitalized patients with SLE showed a moderate level of illness uncertainty. Furthermore, illness uncertainty was negatively correlated with support availability (r = -0.161, P = 0.023) and facing coping mode (r = -0.231, P = 0.001), and was positively correlated with the yielding coping mode (r = 0.249, P < 0.001). Conclusion These findings suggest that support availability and coping modes were associated with moderate level of illness uncertainty, indicating that support availability support should be strengthened in hospitalized patients to actively face their disease. This subsequently improves their treatment compliance and quality of life.	[Li, Xin; He, Lan; Wang, Jing] Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China; [Wang, Mingxu] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Publ Hlth, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Wang, MX (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Publ Hlth, Xian, Shaanxi, Peoples R China.	wangmx601@xjtu.edu.cn						Chen L, 2017, NURSING REHABILITATI, V16, P7, DOI [10.1002/msc.220, DOI 10.1002/MSC.220]; Chen PL, 2013, CHINESE J PRACT NURS, V32, P48; Cleanthous S, 2013, PSYCHOL HEALTH, V28, P171, DOI 10.1080/08870446.2012.701628; Ge JB, 2013, INTERNAL MED, V815, P821; He MZH, 2016, MED SOC, V29, P87; Huang L, 2015, CHINESE J BLOOD PURI, V14, P85; Jiang LJ, 2011, J NURS ADMIN, V11, P457; La Paglia GMC, 2017, CLIN EXP RHEUMATOL, V35, P551; Li YY, 2014, CHINESE NURSING RES, V28, P4264; Maikranz JM, 2007, J PEDIATR PSYCHOL, V32, P571, DOI 10.1093/jpepsy/jsl046; Mattsson M, 2012, MUSCULOSKELET CARE, V10, P1, DOI 10.1002/msc.220; McElhone K, 2010, LUPUS, V19, P1640, DOI 10.1177/0961203310378668; Mishel M H, 1988, Image J Nurs Sch, V20, P225, DOI 10.1111/j.1547-5069.1988.tb00082.x; Mishel M H, 1997, Annu Rev Nurs Res, V15, P57; MISHEL MH, 1981, NURS RES, V30, P258; Parker PA, 2016, BJU INT, V117, P469, DOI 10.1111/bju.13099; Parker PA, 2013, EUR UROL, V63, P1122, DOI 10.1016/j.eururo.2013.01.034; Peralta-Ramirez MI, 2018, CLIN EXP RHEUMATOL, V36, P434; Shen XH, 2000, CHINESE J BEHAV MED, V9, P18; Sun XL, 2009, J NURS SCI SURG, V24; Sutanto B, 2013, ARTHRIT CARE RES, V65, P1752, DOI 10.1002/acr.22032; Tunnicliffe DJ, 2016, ARTHRIT CARE RES, V68, P828, DOI 10.1002/acr.22749; Wan WJ, 2013, CHINESE J MOD NURS, V19, P1303; Wang XD, 1999, CHINESE J MENT HLTH, V12, P256; Wang YH, 2006, CHINESE NURS RES, V20, P1801; [韦荣泉 Wei Rongquan], 2013, [中国护理管理, Chinese Nursing Management], V13, P20; Wu QX, 2017, J QIQIHAR MED U, V38, P1334; Wu YR, 2013, J NURS ADMIN, V13, P15; Xu MX, 2016, CHINESE FOREIGN MED, V14, P66; Zhang HY, 2017, MODERN DIGESTION INT, V22, P393; 张卫红, 2007, [中国行为医学科学, Chinese Journal of Behavioral Medical Science], V16, P623	31	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0211313	10.1371/journal.pone.0211313	http://dx.doi.org/10.1371/journal.pone.0211313			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM2WC	30789919	Green Published, Green Submitted, gold			2022-12-27	WOS:000459330800011
J	Zurcher, C; Tough, H; Fekete, C; Jordan, X; Leger, B; Baumberger, M; Gmunder, HP; Curt, A; Schubert, M; Hund-Georgiadis, M; Hug, K; Troger, T; Joggi, D; Landolt, H; Munzel, N; Brach, M; Stucki, G				Zurcher, Carmen; Tough, Hannah; Fekete, Christine; Jordan, Xavier; Leger, Bertrand; Baumberger, Michael; Gmunder, Hans Peter; Curt, Armin; Schubert, Martin; Hund-Georgiadis, Margret; Hug, Kerstin; Troger, Thomas; Joggi, Daniel; Landolt, Hardy; Munzel, Nadja; Brach, Mirjam; Stucki, Gerold		SwiSCI Study Grp	Mental health in individuals with spinal cord injury: The role of socioeconomic conditions and social relationships	PLOS ONE			English	Article							QUALITY-OF-LIFE; HOSPITAL ANXIETY; PARTICIPATION MEASURES; COPING STRATEGIES; UTRECHT SCALE; DEPRESSION; SUPPORT; DISORDERS; VALIDITY; STRESS	Objectives To evaluate socioeconomic inequalities in social relationships, and to assess whether socioeconomic conditions and social relationships are independently related to mental health problems in individuals with a physical disability due to spinal cord injury (SCI). Methods We analyzed cross-sectional data from 511 individuals with SCI aged over 16 years who participated in the community survey of the Swiss SCI Cohort Study (SwiSCI). Indicators for socioeconomic conditions included years of formal education, household income, and financial strain. Social relationships were operationalized by three structural (partner status; social contact frequency; number of supportive relationships) and four functional aspects (satisfaction with: overall social support; family relationships; contacts to friends; partner relationship). General mental health was assessed by the Mental Health Inventory (MHI-5) of SF-36 and depressive symptoms were measured by the Hospital Anxiety and Depression Scale (depression subscale, HADS-D). Established cut-offs for general mental health problems (MHI-5 <= 56) and depressive symptomatology (HADS-D >= 8) were used to dichotomize outcomes. Associations were assessed using logistic regressions. Results Lower household income was predominantly associated with poor structural social relationships, whereas financial strain was robustly linked to poor functional social relationships. Financial strain was associated with general mental health problems and depressive symptomatology, even after controlling for social relationships. Education and household income were not linked to mental health. Poor structural and functional social relationships were related to general mental health problems and depressive symptomatology. Notably, trends remained stable after accounting for socioeconomic conditions. Conclusion This study provides evidence for socioeconomic inequalities in social relationships as well as for independent associations of financial strain and poor social relationships with mental health problems in individuals with SCI. Further research may develop strategies to improve mental health in SCI by strengthening social relationships. Such interventions may be especially beneficial for individuals with low income and financial strain.	[Zurcher, Carmen] Bern Univ Appl Sci, Dept Hlth Profess, Bern, Switzerland; [Tough, Hannah; Fekete, Christine] Swiss Parapleg Res, Nottwil, Switzerland; [Tough, Hannah; Fekete, Christine] Univ Lucerne, Dept Hlth Sci & Hlth Policy, Luzern, Switzerland; [Jordan, Xavier; Leger, Bertrand] Clin Romande Readaptat, Sion, Switzerland; [Baumberger, Michael; Gmunder, Hans Peter; Brach, Mirjam; Stucki, Gerold] Swiss Parapleg Ctr, Nottwil, Switzerland; [Curt, Armin; Schubert, Martin] Univ Clin Balgrist, Zurich, Switzerland; [Hund-Georgiadis, Margret; Hug, Kerstin; Joggi, Daniel] REHAB Basel, Basel, Switzerland; [Landolt, Hardy] SCI, Glarus, Switzerland; [Munzel, Nadja] Parahelp, Nottwil, Switzerland; [Fekete, Christine] Swiss Parapleg Res, SwiSCI Coordinat Grp, Nottwil, Switzerland	Swiss Paraplegic Research; University of Lucerne; Swiss Paraplegic Research; Swiss Paraplegic Research	Fekete, C (corresponding author), Swiss Parapleg Res, Nottwil, Switzerland.; Fekete, C (corresponding author), Univ Lucerne, Dept Hlth Sci & Hlth Policy, Luzern, Switzerland.; Fekete, C (corresponding author), Swiss Parapleg Res, SwiSCI Coordinat Grp, Nottwil, Switzerland.	christine.fekete@paraplegie.ch	Fekete, Christine/AAE-7057-2020; Léger, Bertrand/AAK-4356-2020; Tough, Hannah/AAG-7827-2020	Wyss-Zurcher, Carmen/0000-0002-2384-8114; Fekete, Christine/0000-0002-3753-3017	Swiss Spinal Cord Injury Cohort Study (SwiSCI) - Swiss Paraplegic Foundation	Swiss Spinal Cord Injury Cohort Study (SwiSCI) - Swiss Paraplegic Foundation	This study has been financed in the framework of the Swiss Spinal Cord Injury Cohort Study (SwiSCI, www.swisci.ch), supported by the Swiss Paraplegic Foundation. The funding agency had no influence on design, analysis, or interpretation of the data.	Aalund C, 2014, INT J EQUITY HEALTH, V13, P1, DOI [10.1186/1475-9276-13-1, DOI 10.1186/1475-9276-13-1]; [Anonymous], 2015, STAT MULT IMP REF MA; Arango-Lasprilla JC, 2011, NEUROREHABILITATION, V29, P9, DOI 10.3233/NRE-2011-0672; Barclay L, 2016, AUST OCCUP THER J, V63, P19, DOI 10.1111/1440-1630.12241; Beedie A, 2002, J CLIN PSYCHOL MED S, V9, P227, DOI 10.1023/A:1016003428370; Berkman LF, 2003, JAMA-J AM MED ASSOC, V289, P3106; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; Brinkhof MWG, 2016, J REHABIL MED, V48, P120, DOI 10.2340/16501977-2050; Butterworth P, 2009, SOC SCI MED, V69, P229, DOI 10.1016/j.socscimed.2009.05.008; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037//0033-2909.98.2.310; Cohen S, 2004, AM PSYCHOL, V59, P676, DOI 10.1037/0003-066X.59.8.676; CONGER RD, 1990, J MARRIAGE FAM, V52, P643, DOI 10.2307/352931; Craig A, 2015, ARCH PHYS MED REHAB, V96, P1426, DOI 10.1016/j.apmr.2015.02.027; DIENER E, 1993, SOC INDIC RES, V28, P195, DOI 10.1007/BF01079018; Dijkstra-Kersten SMA, 2015, J EPIDEMIOL COMMUN H, V69, P660, DOI 10.1136/jech-2014-205088; Elfstrom ML, 2005, J REHABIL MED, V37, P9, DOI 10.1080/16501970410034414; Fann JR, 2011, ARCH PHYS MED REHAB, V92, P352, DOI 10.1016/j.apmr.2010.05.016; Fekete C, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0076-0; Fekete C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090130; Friedman B, 2005, J AM GERIATR SOC, V53, P1978, DOI 10.1111/j.1532-5415.2005.00469.x; Fryers T, 2003, SOC PSYCH PSYCH EPID, V38, P229, DOI 10.1007/s00127-003-0627-2; Geyh S, 2016, J REHABIL MED, V48, P219, DOI 10.2340/16501977-2027; Grimm P., 2010, WILEY INT ENCY MARKE, DOI 10.1002/9781444316568.wiem02057; Guilcher SJT, 2010, SPINAL CORD, V48, P45, DOI 10.1038/sc.2009.78; Gulbenkian Calouste, 2014, SOCIAL DETERMINANTS; Helgeson VS, 2003, QUAL LIFE RES, V12, P25, DOI 10.1023/A:1023509117524; Heritage Z, 2009, Public Health, V123, pe29, DOI 10.1016/j.puhe.2008.10.028; Hoffman JM, 2011, ARCH PHYS MED REHAB, V92, P411, DOI 10.1016/j.apmr.2010.10.036; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Institute for Digital Research and Education (IDRE) University of California Los Angeles (UCLA), 2016, REGR STAT CHAPT 2 RE; Jensen MP, 2014, DISABIL HEALTH J, V7, P164, DOI 10.1016/j.dhjo.2013.11.001; Karademas EC, 2016, STRESS HLTH J INT SO, P1, DOI [10.1002/AMI.2735, DOI 10.1002/AMI.2735]; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; Kennedy P, 2000, ARCH PHYS MED REHAB, V81, P932, DOI 10.1053/apmr.2000.5580; Khazaeipour Zahra, 2015, Top Spinal Cord Inj Rehabil, V21, P149, DOI 10.1310/sci2102-149; Kiely KM, 2015, SOC PSYCH PSYCH EPID, V50, P909, DOI 10.1007/s00127-015-1027-0; Kondo N, 2012, J EPIDEMIOL, V22, P2, DOI 10.2188/jea.JE20110116; Krause JS, 2008, ARCH PHYS MED REHAB, V89, P1474, DOI 10.1016/j.apmr.2007.12.040; Krause JS, 2006, ARCH PHYS MED REHAB, V87, P1318, DOI 10.1016/j.apmr.2006.07.254; Krause JS, 2000, ARCH PHYS MED REHAB, V81, P1099, DOI 10.1053/apmr.2000.7167; KRAUSE N, 1995, GERONTOLOGIST, V35, P498, DOI 10.1093/geront/35.4.498; Lavikainen J., 2006, IMPROVING MENTAL HLT; Le J, 2016, SPINAL CORD, V54, P570, DOI 10.1038/sc.2016.15; Lim SW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169623; Lorant V, 2003, AM J EPIDEMIOL, V157, P98, DOI 10.1093/aje/kwf182; Lynch JW, 2000, BMJ-BRIT MED J, V320, P1200, DOI 10.1136/bmj.320.7243.1200; Mackenbach, 2006, HLTH INEQUALITIES EU; Marti A, 2012, SPINAL CORD, V50, P521, DOI 10.1038/sc.2011.181; McDonald SD, 2018, J SPINAL CORD MED, V41, P691, DOI 10.1080/10790268.2017.1293868; MCEWEN BS, 1993, ARCH INTERN MED, V153, P2093, DOI 10.1001/archinte.153.18.2093; Migliorini CE, 2009, SPINAL CORD, V47, P783, DOI 10.1038/sc.2009.43; Migliorini C, 2008, AUST NZ J PSYCHIAT, V42, P309, DOI 10.1080/00048670801886080; Moak ZB, 2010, J PUBLIC HEALTH-UK, V32, P191, DOI 10.1093/pubmed/fdp093; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Muller R, 2012, SPINAL CORD, V50, P94, DOI 10.1038/sc.2011.116; Muller R, 2015, ARCH PHYS MED REHAB, V96, P447, DOI 10.1016/j.apmr.2014.09.006; Muller R, 2012, REHABIL PSYCHOL, V57, P214, DOI 10.1037/a0029287; Muller R, 2016, SPINAL CORD, P1, DOI [10.1038/sc.2015.229, DOI 10.1038/SC.2015.229]; Muntaner C, 2007, MENTAL HEALTH, SOCIAL MIRROR, P127, DOI 10.1007/978-0-387-36320-2_6; Nooijen CF, 2016, CLIN REHABIL, P1, DOI [10.1177/02692/5516657581, DOI 10.1177/02692/5516657581]; Organisation for Economic Co-operation and Development (OECD), 2013, FRAM INT AN OECD FRA; Pollard C, 2007, BRIT J HEALTH PSYCH, V12, P347, DOI 10.1348/135910707X197046; Post MWM, 2012, SPINAL CORD, V50, P382, DOI 10.1038/sc.2011.182; Post MWM, 2012, DISABIL REHABIL, V34, P478, DOI 10.3109/09638288.2011.608148; Post Marcel W M, 2011, Am J Phys Med Rehabil, V90, pS5, DOI 10.1097/PHM.0b013e318230fd41; Ralchle KA, 2007, J PAIN, V8, P718, DOI 10.1016/j.jpain.2007.05.006; Roach MJ, 2011, ARCH PHYS MED REHAB, V92, P472, DOI 10.1016/j.apmr.2010.09.030; Rodrigues D, 2013, PAIN THER, V2, P113, DOI 10.1007/s40122-013-0017-8; SARASON IG, 1987, J SOC PERS RELAT, V4, P497, DOI 10.1177/0265407587044007; Saunders LL, 2012, SPINAL CORD, V50, P72, DOI 10.1038/sc.2011.83; Seeman T, 2010, ANN NY ACAD SCI, V1186, P223, DOI 10.1111/j.1749-6632.2009.05341.x; SNAITH RP, 1986, BRIT MED J, V292, P344, DOI 10.1136/bmj.292.6516.344; Stansfeld S. A., 2005, SOCIAL DETERMINANTS, V1st, P148; StataCorp, 2015, STAT SOFTW REL 14; Stroud MW, 2006, J PAIN, V7, P91, DOI 10.1016/j.jpain.2005.08.006; Teesson M, 2011, AUST NZ J PSYCHIAT, V45, P939, DOI 10.3109/00048674.2011.614590; Teo AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062396; The Commission of the European Communities The National Research and Development Centre for Welfare and Health (STAKES), 2002, ANN 3 PROP GUID US S; The Commission of the European Communities The National Research and Development Centre for Welfare and Health (STAKES), 2005, MENT HLTH INF DET EU; Thoits PA, 2011, J HEALTH SOC BEHAV, V52, P145, DOI 10.1177/0022146510395592; Tompkins Sara Anne, 2013, Int J MS Care, V15, P27, DOI 10.7224/1537-2073.2012-002; Tough H, 2016, DISABIL HLTH J, P1, DOI [10.1016/j.dhjo.2015.11.001, DOI 10.1016/J.DHJO.2015.11.001]; Tough H, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4308-6; Tramonti F, 2015, SPINAL CORD, V53, P120, DOI 10.1038/sc.2014.229; Trenaman L, 2015, J SPINAL CORD MED, V38, P422, DOI 10.1179/2045772315Y.0000000031; UNESCO, 2012, INT STAND CLASS ED I; van der Zee CH, 2011, J REHABIL MED, V43, P1003, DOI 10.2340/16501977-0879; van der Zee CH, 2010, J REHABIL MED, V42, P752, DOI 10.2340/16501977-0589; van Leeuwen CMC, 2012, SPINAL CORD, V50, P707, DOI 10.1038/sc.2012.33; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Ware JE, 1993, SF36 HLTH SURVEY MAN; Weyers S, 2008, INT J EQUITY HEALTH, V7, DOI 10.1186/1475-9276-7-13; WHELAN CT, 1993, SOCIOL HEALTH ILL, V15, P86, DOI 10.1111/1467-9566.ep11343797; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; WHO, 2013, INTERNATIONAL PERSPECTIVES ON SPINAL CORD INJURY, P1; Wilkinson RG, 2003, SOCIAL DETERMINANTS; Williams R, 2015, ARCH PHYS MED REHAB, V96, P133, DOI 10.1016/j.apmr.2014.08.016; Woolrich Rachel A, 2006, Psychol Health Med, V11, P80, DOI 10.1080/13548500500294211; World Health Organization, 1998, M MIN HLTH PAC ISL C; Yan T, 2010, INT J PUBLIC OPIN R, V22, P535, DOI 10.1093/ijpor/edq037; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	101	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0206069	10.1371/journal.pone.0206069	http://dx.doi.org/10.1371/journal.pone.0206069			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM2OT	30785880	gold, Green Submitted, Green Published			2022-12-27	WOS:000459307000007
J	Martin, EA; Castro, MK; Li, LLY; Urban, EJ; Moore, MM				Martin, Elizabeth A.; Castro, Mayan K.; Li, Lilian Y.; Urban, Emily J.; Moore, Melody M.			Emotional response in schizophrenia to the "36 questions that lead to love": Predicted and experienced emotions regarding a live social interaction	PLOS ONE			English	Article							HIERARCHICAL STRUCTURE; NEGATIVE SYMPTOMS; ANHEDONIA	Evidence suggests that individuals with schizophrenia (SZ) report anticipatory pleasure deficits compared to controls and that these deficits are linked to decreased motivation to engage socially. However, these deficits have been identified via self-report measures of hypothetical pleasant stimuli, leaving it unclear whether they exist in reference to actual social situations. To address this issue, we created a live social interaction that minimized the reliance of higher-order cognitive processes. SZ and control participants were told that they would be playing an "enjoyable sharing game" with another study participant (who was actually a confederate) that involved asking and answering questions (36 interpersonal closeness generation questions; Aron et al., 1997). Participants then reported their current mood and the emotions they anticipated experiencing during the pleasant social interaction. Immediately following the interaction, they reported their experienced emotions. We found that the SZ group anticipated more negative emotion (d = 1.0), but were less accurate in forecasting negative emotion (d = .81), than controls, and these effects were large. There were small, non-significant group differences in anticipation, experience, and accuracy in forecasting of positive emotion (all ds < .29). Also, social anhedonia was positively correlated with anticipated negative affect and negatively associated with experienced positive emotion. At the same time, controls reported finding the interaction to be a more positive emotional experience overall, d = 0.75. This is the first study to show that "anticipatory pleasure deficits" in SZ might actually be heightened anticipated negative emotion and that inaccurate forecasting could be linked to decreased social motivation.	[Martin, Elizabeth A.; Castro, Mayan K.; Li, Lilian Y.; Moore, Melody M.] Univ Calif Irvine, Dept Psychol Sci, Irvine, CA 92697 USA; [Urban, Emily J.] Univ Wisconsin, Ctr Hlth Minds, Madison, WI USA	University of California System; University of California Irvine; University of Wisconsin System; University of Wisconsin Madison	Martin, EA (corresponding author), Univ Calif Irvine, Dept Psychol Sci, Irvine, CA 92697 USA.	emartin8@uci.edu	Li, Lilian Yanqing/AAK-2493-2021; Urban, Emily/M-1318-2019	Li, Lilian Yanqing/0000-0001-7507-3632; Urban-Wojcik, Emily/0000-0002-6562-0732; Martin, Elizabeth/0000-0001-8893-1667	Hellman Fellowship; Hellman Fellows Fund	Hellman Fellowship; Hellman Fellows Fund	This work was supported by Hellman Fellowship (no fund number) given by the Hellman Fellows Fund (http://www.hellmanfellows.org) (EAM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen N. C., 1984, SCALE ASSESSMENT POS; Andreasen NC, 1983, SCALE ASSESSMENT NEG; Aron A, 1997, PERS SOC PSYCHOL B, V23, P363, DOI 10.1177/0146167297234003; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Berry DS, 2000, PERS SOC PSYCHOL B, V26, P278, DOI 10.1177/0146167200265002; Brenner CJ, 2014, PSYCHIATR REHABIL J, V37, P316, DOI 10.1037/prj0000105; Cacioppo J T, 1997, Pers Soc Psychol Rev, V1, P3, DOI 10.1207/s15327957pspr0101_2; CARPENTER WT, 1985, SCHIZOPHRENIA BULL, V11, P440, DOI 10.1093/schbul/11.3.440; Catron ML, 2015, NEW YORK TIMES  0109; Cicero DC, 2019, ASSESSMENT, V26, P1001, DOI 10.1177/1073191117719509; Cohen AS, 2011, CLIN PSYCHOL REV, V31, P440, DOI 10.1016/j.cpr.2010.11.001; Cohen AS, 2010, SCHIZOPHRENIA BULL, V36, P143, DOI 10.1093/schbul/sbn061; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Eckblad M.L., 1982, REVISED SOCIAL UNPUB; First M.B., 2015, STRUCTURED CLIN INTE, DOI DOI 10.1002/9781118625392.WBECP351; Gard DE, 2007, SCHIZOPHR RES, V93, P253, DOI 10.1016/j.schres.2007.03.008; Gooding DC, 2005, J ABNORM PSYCHOL, V114, P170, DOI 10.1037/0021-843X.114.1.170; Grupe DW, 2013, NAT REV NEUROSCI, V14, P488, DOI 10.1038/nrn3524; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; Horan WP, 2008, SCHIZOPHRENIA BULL, V34, P856, DOI 10.1093/schbul/sbn083; Horan WP, 2006, J ABNORM PSYCHOL, V115, P496, DOI 10.1037/0021-843X.115.3.496; Kirkpatrick B, 2006, SCHIZOPHRENIA BULL, V32, P214, DOI 10.1093/schbul/sbj053; Kirschner M, 2017, SCHIZOPHR RES, V186, P29, DOI 10.1016/j.schres.2016.05.003; Kohler Christian G, 2006, Cogn Neuropsychiatry, V11, P250, DOI 10.1080/13546800500188575; Kotov R, 2016, J ABNORM PSYCHOL, V125, P1103, DOI 10.1037/abn0000188; Kring AM, 2008, SCHIZOPHRENIA BULL, V34, P819, DOI 10.1093/schbul/sbn071; Kring AM, 2014, EUR NEUROPSYCHOPHARM, V24, P725, DOI 10.1016/j.euroneuro.2013.06.007; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Kwapil TR, 1998, J ABNORM PSYCHOL, V107, P558, DOI 10.1037/0021-843X.107.4.558; Llerena K, 2012, SCHIZOPHR RES, V142, P65, DOI 10.1016/j.schres.2012.09.005; Loewenstein G. F., 1999, WELL BEING FDN HEDON, P85; Man V, 2017, EMOT REV, V9, P124, DOI 10.1177/1754073916667237; Martin EA, 2019, SCHIZOPHR RES, V204, P111, DOI 10.1016/j.schres.2018.08.008; Martin EA, 2013, J ABNORM PSYCHOL, V122, P733, DOI 10.1037/a0033956; R Development Core Team, 2009, R LANG ENV STAT COMP; Strauss GP, 2013, J PSYCHIATR RES, V47, P783, DOI 10.1016/j.jpsychires.2013.01.015; Strauss GP, 2012, AM J PSYCHIAT, V169, P364, DOI 10.1176/appi.ajp.2011.11030447; Strauss GP, 2011, SCHIZOPHR RES, V128, P117, DOI 10.1016/j.schres.2011.01.010; Strauss GP, 2011, PSYCHIAT RES, V187, P36, DOI 10.1016/j.psychres.2011.01.012; Sweeney S, 2015, FRONT PUBLIC HEALTH, V3, DOI 10.3389/fpubh.2015.00259; Tellegen A, 1999, PSYCHOL SCI, V10, P297, DOI 10.1111/1467-9280.00157; Watson D, 2017, EMOT REV, V9, P99, DOI 10.1177/1754073916639659; Wilson TD, 2003, ADV EXP SOC PSYCHOL, V35, P345, DOI 10.1016/S0065-2601(03)01006-2; Winterstein BP, 2011, PERS INDIV DIFFER, V51, P920, DOI 10.1016/j.paid.2011.07.027; Wolf Daniel H, 2006, Curr Psychiatry Rep, V8, P322, DOI 10.1007/s11920-006-0069-0; Yang Y, 2018, SCHIZOPHR RES, V201, P137, DOI 10.1016/j.schres.2018.05.018	46	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0212069	10.1371/journal.pone.0212069	http://dx.doi.org/10.1371/journal.pone.0212069			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM9LQ	30811436	Green Submitted, Green Published, gold			2022-12-27	WOS:000459806400050
J	Mazumdar, R; Nobauer, K; Hummel, K; Hess, M; Bilic, I				Mazumdar, Rounik; Noebauer, Katharina; Hummel, Karin; Hess, Michael; Bilic, Ivana			Molecular characterization of Histomonas meleagridis exoproteome with emphasis on protease secretion and parasite-bacteria interaction	PLOS ONE			English	Article							ESCHERICHIA-COLI; C-ALPHA; PROTEINS; EXPRESSION; IDENTIFICATION; ADAPTATION; INSIGHTS; PATHOGEN; SURFACE; INDOLE	The exoproteome of parasitic protists constitutes extracellular proteins that play a fundamental role in host-parasite interactions. Lytic factors, especially secreted proteases, are capable of modulating tissue invasion, thereby aggravating host susceptibility. Despite the important role of exoproteins during infection, the exoproteomic data on Histomonas meleagridis are non-existent. The present study employed traditional 1D-in-gel-zymography (1DIGZ) and micro-LC-ESI-MS/MS (shotgun proteomics), to investigate H. meleagridis exoproteomes, obtained from a clonal virulent and an attenuated strain. Both strains were maintained as mono-eukaryotic monoxenic cultures with Escherichia coli. We demonstrated active in vitro secretion kinetics of proteases by both parasite strains, with a widespread proteolytic activity ranging from 17 kDa to 120 kDa. Based on protease inhibitor susceptibility assay, the majority of proteases present in both exoproteomes belonged to the family of cysteine proteases and showed stronger activity in the exoproteome of a virulent H. meleagridis. Shotgun proteomics, aided by customized database search, identified 176 proteins including actin, potential moonlighting glycolytic enzymes, lytic molecules such as poreforming proteins (PFPs) and proteases like cathepsin-L like cysteine protease. To quantify the exoproteomic differences between the virulent and the attenuated H. meleagridis cultures, a sequential window acquisition of all theoretical spectra mass spectrometric (SWATH-MS) approach was applied. Surprisingly, results showed most of the exoproteomic differences to be of bacterial origin, especially targeting metabolism and locomotion. By deciphering such molecular signatures, novel insights into a complex in vitro protozoan-bacteria relationship were elucidated.	[Mazumdar, Rounik; Hess, Michael; Bilic, Ivana] Univ Vet Med Vienna, Dept Farm Anim & Vet Publ Hlth, Clin Poultry & Fish Med, Vienna, Austria; [Noebauer, Katharina; Hummel, Karin] Univ Vet Med Vienna, VetCORE, Facil Res, Vienna, Austria; [Hess, Michael] Univ Vet Med Vienna, Christian Doppler Lab Innovat Poultry Vaccines IP, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Bilic, I (corresponding author), Univ Vet Med Vienna, Dept Farm Anim & Vet Publ Hlth, Clin Poultry & Fish Med, Vienna, Austria.	ivana.bilic@vetmeduni.ac.at		Mazumdar, Rounik/0000-0003-0580-5628; Hess, Michael/0000-0002-6991-0120; Bilic, Ivana/0000-0003-3296-5117	Austrian Science Fund (FWF) [P 25519-B25]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Funded by Austrian Science Fund (FWF), grant number P 25519-B25.	Alvarez-Sanchez ME, 2000, MICROB PATHOGENESIS, V28, P193, DOI 10.1006/mpat.1999.0336; Amin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037417; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Armengaud J, 2012, EXPERT REV PROTEOMIC, V9, P561, DOI [10.1586/epr.12.52, 10.1586/EPR.12.52]; Atkinson HJ, 2009, TRENDS PARASITOL, V25, P573, DOI 10.1016/j.pt.2009.09.006; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; Beynon R, 2000, BIOCHEM EDUC, V18, P359, DOI [10.1016/0307-4412(90)90038-P, DOI 10.1016/0307-4412(90)90038-P]; Bilic I, 2009, PARASITOLOGY, V136, P379, DOI 10.1017/S0031182008005477; Bilic I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092438; Bischofberger M, 2012, CELL HOST MICROBE, V12, P266, DOI 10.1016/j.chom.2012.08.005; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; Chevallet M, 2007, PROTEOMICS, V7, P1757, DOI 10.1002/pmic.200601024; Corbalan-Garcia S, 2014, BBA-BIOMEMBRANES, V1838, P1536, DOI 10.1016/j.bbamem.2014.01.008; Cuervo P, 2008, J PROTEOMICS, V71, P109, DOI 10.1016/j.jprot.2008.01.010; De Jesus JB, 2007, J MASS SPECTROM, V42, P1463, DOI 10.1002/jms.1286; Cardenas-Guerra RE, 2013, MICROBES INFECT, V15, P958, DOI 10.1016/j.micinf.2013.09.002; Erde J, 2014, J PROTEOME RES, V13, P1885, DOI 10.1021/pr4010019; Ferenci T, 1996, FEMS MICROBIOL REV, V18, P301, DOI 10.1016/0168-6445(96)00019-8; Flynn JM, 2004, GENE DEV, V18, P2292, DOI 10.1101/gad.1240104; Ganas P, 2012, INT J PARASITOL, V42, P893, DOI 10.1016/j.ijpara.2012.07.007; Gonzalez-Miguel J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124445; Gruber J, 2018, EXP PARASITOL, V185, P53, DOI 10.1016/j.exppara.2018.01.007; Gruber J, 2017, PARASITOLOGY, V144, P1253, DOI 10.1017/S0031182017000646; Guan YH, 2015, SCI REP-UK, V5, DOI 10.1038/srep13370; Hentze MW, 2018, NAT REV MOL CELL BIO, V19, P327, DOI 10.1038/nrm.2017.130; Hernandez HM, 2014, PARASITE, V21, DOI 10.1051/parasite/2014054; Hernandez-Gutierrez R, 2004, EXP PARASITOL, V107, P125, DOI 10.1016/j.exppara.2004.05.004; Hess M, 2006, PARASITOLOGY, V133, P547, DOI 10.1017/S0031182006000758; Hess M, 2017, BRIT POULTRY SCI, V58, P1, DOI 10.1080/00071668.2016.1245849; Hess M, 2008, VACCINE, V26, P4187, DOI 10.1016/j.vaccine.2008.05.071; Hess M, 2015, VET PARASITOL, V208, P67, DOI 10.1016/j.vetpar.2014.12.018; Hirt RP, 2007, TRENDS PARASITOL, V23, P540, DOI 10.1016/j.pt.2007.08.020; Klemba M, 2002, ANNU REV BIOCHEM, V71, P275, DOI 10.1146/annurev.biochem.71.090501.145453; Klodnicki ME, 2013, J PARASITOL, V99, P264, DOI 10.1645/GE-3256.1; Kohout SC, 2003, BIOCHEMISTRY-US, V42, P1254, DOI 10.1021/bi026596f; Kopitar-Jerala N, 2012, CURR PROTEIN PEPT SC, V13, P767, DOI 10.2174/138920312804871102; Leberl M, 2010, MOL BIOCHEM PARASIT, V169, P101, DOI 10.1016/j.molbiopara.2009.10.007; Lee J, 2010, J APPL MICROBIOL, V108, P2088, DOI 10.1111/j.1365-2672.2009.04611.x; Lee JH, 2010, FEMS MICROBIOL REV, V34, P426, DOI 10.1111/j.1574-6976.2009.00204.x; Liebhart D, 2017, AVIAN PATHOL, V46, P1, DOI 10.1080/03079457.2016.1229458; Rosales-Colunga LM, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-74; Mazet M, 2008, INT J PARASITOL, V38, P177, DOI 10.1016/j.ijpara.2007.06.006; Mazumdar R, 2017, PROTIST, V168, P663, DOI 10.1016/j.protis.2017.09.004; McKerrow JH, 2006, ANNU REV PATHOL-MECH, V1, P497, DOI 10.1146/annurev.pathol.1.110304.100151; Mol O, 1996, FEMS MICROBIOL REV, V19, P25, DOI 10.1016/0168-6445(96)00022-8; MOLLBY R, 1976, J GEN MICROBIOL, V96, P137, DOI 10.1099/00221287-96-1-137; Monoyios A, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00407; Monoyios A, 2018, INT J PARASITOL, V48, P145, DOI 10.1016/j.ijpara.2017.08.017; Mueller RS, 2009, J BACTERIOL, V191, P3504, DOI 10.1128/JB.01240-08; NEWTON WA, 1965, J BIOL CHEM, V240, P1211; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pina-Vazquez Carolina, 2012, Journal of Parasitology Research, P748206, DOI 10.1155/2012/748206; Pirkmajer S, 2011, AM J PHYSIOL-CELL PH, V301, pC272, DOI 10.1152/ajpcell.00091.2011; PLOW EF, 1995, FASEB J, V9, P939, DOI 10.1096/fasebj.9.10.7615163; Ranganathan S, 2009, GENOME MED, V1, DOI 10.1186/gm113; RAWLINGS ND, 1995, METHOD ENZYMOL, V248, P183; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Roditi I, 2016, MOL BIOCHEM PARASIT, V208, P16, DOI 10.1016/j.molbiopara.2016.05.008; Sajid M, 2002, MOL BIOCHEM PARASIT, V120, P1, DOI 10.1016/S0166-6851(01)00438-8; Schwebke JR, 2004, CLIN MICROBIOL REV, V17, P794, DOI 10.1128/CMR.17.4.794-803.2004; Shafqat J, 1999, EUR J BIOCHEM, V263, P305, DOI 10.1046/j.1432-1327.1999.00323.x; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sheetz MP, 2006, ANNU REV BIOPH BIOM, V35, P417, DOI 10.1146/annurev.biophys.35.040405.102017; TITBALL RW, 1993, MICROBIOL REV, V57, P347, DOI 10.1128/MMBR.57.2.347-366.1993; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; Tsatsaronis JA, 2018, TRENDS MICROBIOL, V26, P401, DOI 10.1016/j.tim.2018.02.009; Vanacova S, 2001, MICROBIOL-UK, V147, P53; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Worden CR, 2009, FEMS MICROBIOL LETT, V293, P58, DOI 10.1111/j.1574-6968.2009.01508.x; Zhao K, 2007, NUCLEIC ACIDS RES, V35, P4441, DOI 10.1093/nar/gkm456	70	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0212429	10.1371/journal.pone.0212429	http://dx.doi.org/10.1371/journal.pone.0212429			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807611	gold, Green Published, Green Submitted			2022-12-27	WOS:000459712100015
J	Dunbar, MBN; Finnie, TJR; Sloane, B; Hall, IM				Dunbar, Maria Bekker-Nielsen; Finnie, Thomas J. R.; Sloane, Barney; Hall, Ian M.			Methods for calculating credible intervals for ratios of beta distributions with application to relative risks of death during the second plague pandemic	PLOS ONE			English	Article							SPREAD	Employing historical records we are able to estimate the risk of premature death during the second plague pandemic, and identify the Black Death and pestis secunda epidemics. We show a novel method of calculating Bayesian credible intervals for a ratio of beta distributed random variables and use this to quantify uncertainty of relative risk estimates for these two epidemics which we consider in a 2 x 2 contingency table framework.	[Dunbar, Maria Bekker-Nielsen; Finnie, Thomas J. R.; Hall, Ian M.] Publ Hlth England, Emergency Response Dept, Salisbury, Wilts, England; [Sloane, Barney] Hist England, Swindon, Wilts, England; [Hall, Ian M.] Univ Manchester, Manchester, Lancs, England	Public Health England; English Heritage; University of Manchester	Dunbar, MBN (corresponding author), Publ Hlth England, Emergency Response Dept, Salisbury, Wilts, England.	maria.dunbar@phe.gov.uk	Hall, ian/AAF-9135-2019; Dunbar, Maria Bekker-Nielsen/J-4082-2019	Hall, ian/0000-0002-3033-2335; Dunbar, Maria Bekker-Nielsen/0000-0002-7249-3524; Finnie, Thomas/0000-0001-5962-4211	National Institute for Health Research-Health Protection Research Unit for Modelling Methodology; National Institute for Health Research-Health Protection Research Unit for Modelling Methodology (HPRU MM)	National Institute for Health Research-Health Protection Research Unit for Modelling Methodology; National Institute for Health Research-Health Protection Research Unit for Modelling Methodology (HPRU MM)	MBND, TJRF, IMH were supported by National Institute for Health Research-Health Protection Research Unit for Modelling Methodology (https://www.imperial.ac.uk/hpru-modelling).; The research leading to these results has received grant-in-aid funding. MBND, TJRF, and IMH are funded by the National Institute for Health Research-Health Protection Research Unit for Modelling Methodology (HPRU MM). The funding bodies (UK government and HPRU MM) did not play any role in the formulation of this manuscript. The authors declare no conflict of interest. The views expressed in this publication are those of the authors and not necessarily those of Public Health England or English Heritage. We gratefully acknowledge the help and contributions of Steven Dyke who contributed to the calculation of the posterior distribution.	Agresti A, 2005, BIOMETRICS, V61, P515, DOI 10.1111/j.1541-0420.2005.031228.x; [Anonymous], 2010, J JPN STATIST SOC; Chen MH, 1999, J COMPUT GRAPH STAT, V8, P69, DOI 10.2307/1390921; Creighton C., 1891, HIST EPIDEMICS BRITA, VI; Dean KR, 2018, P NATL ACAD SCI USA, V115, P1304, DOI 10.1073/pnas.1715640115; dIrsay Stephen, 1926, ISIS, V8, P328, DOI [10.1086/358397, DOI 10.1086/358397]; Evans CM, 2018, EMERG INFECT DIS, V24, P952, DOI 10.3201/eid2405.172067; Gage KL, 1999, WHOCDSCSREDC992; Gottfried Robert Steven, 1986, BLACK DEATH NATURAL; GROSS L, 1995, P NATL ACAD SCI USA, V92, P7609, DOI 10.1073/pnas.92.17.7609; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; Karlen A., 1995, PLAGUES PROGR SOCIAL; Kerman J, 2011, ELECTRON J STAT, V5, P1450, DOI 10.1214/11-EJS648; Khan IA, 2004, T ROY SOC TROP MED H, V98, P270, DOI 10.1016/S0035-9203(03)00059-2; LETHEM W. A., 1923, Journal of State Medicine, V31, P508; NURMINEN M, 1987, SCAND J STAT, V14, P67; O'Hagan A., 2004, KENDALLS ADV THEOR B, V2B; Pham-Gia T, 2000, COMMUN STAT-THEOR M, V29, P2693, DOI 10.1080/03610920008832632; Sharpe RR, 1889, CALENDAR WILLS PRO 1, P1258; Sharpe RR, 1889, CALENDAR WILLS PRO 2, P1358; Sherman IW, 2017, THE POWER OF PLAGUES; Sloane Barney, 2011, BLACK DEATH LONDON; Wong B, 2011, NAT METHODS, V8, P441, DOI 10.1038/nmeth.1618; World Health Organization, 2017, PLAG; World Health Organization, 2000, WHO REP GLOB SURV EP; Zietz BP, 2004, INT J HYG ENVIR HEAL, V207, P165, DOI 10.1078/1438-4639-00259	26	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0211633	10.1371/journal.pone.0211633	http://dx.doi.org/10.1371/journal.pone.0211633			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794569	Green Submitted, Green Published, gold			2022-12-27	WOS:000459709100020
J	Hall, C; Rodriguez, M; Garcia, J; Posfai, D; DuMez, R; Wictor, E; Quintero, OA; Hill, MS; Rivera, AS; Hill, AL				Hall, Chelsea; Rodriguez, Melanie; Garcia, Josephine; Posfai, Dora; DuMez, Rachel; Wictor, Erik; Quintero, Omar A.; Hill, Malcolm S.; Rivera, Ajna S.; Hill, April L.			Secreted frizzled related protein is a target of PaxB and plays a role in aquiferous system development in the freshwater sponge, Ephydatia muelleri	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; EVOLUTIONARY ORIGINS; WNT; EXPRESSION; GENE; SPECIFICATION; PERFORMANCE; REGULATORS; FAMILIES; ACCURATE	Canonical and non-canonical Wnt signaling, as well as the Pax/ Six gene network, are involved in patterning the freshwater sponge aquiferous system. Using computational approaches to identify transcription factor binding motifs in a freshwater sponge genome, we located putative PaxB binding sites near a Secreted Frizzled Related Protein (SFRP) gene in Ephydatia muelleri. EmSFRP is expressed throughout development, but with highest levels in juvenile sponges. In situ hybridization and antibody staining show EmSFRP expression throughout the pinacoderm and choanoderm in a subpopulation of amoeboid cells that may be differentiating archeocytes. Knockdown of EmSFRP leads to ectopic oscula formation during development, suggesting that EmSFRP acts as an antagonist of Wnt signaling in E. muelleri. Our findings support a hypothesis that regulation of the Wnt pathway by the Pax/ Six network as well as the role of Wnt signaling in body plan morphogenesis was established before sponges diverged from the rest of the metazoans.	[Hall, Chelsea; Rodriguez, Melanie; Garcia, Josephine; Posfai, Dora; DuMez, Rachel; Quintero, Omar A.; Hill, Malcolm S.; Hill, April L.] Univ Richmond, Dept Biol, Richmond, VA 23173 USA; [Wictor, Erik; Rivera, Ajna S.] Univ Pacific, Dept Biol Sci, Stockton, CA 95211 USA; [Hill, Malcolm S.; Hill, April L.] Bates Coll, Dept Biol, Lewiston, ME 04240 USA	University of Richmond; University of the Pacific	Hill, AL (corresponding author), Univ Richmond, Dept Biol, Richmond, VA 23173 USA.; Hill, AL (corresponding author), Bates Coll, Dept Biol, Lewiston, ME 04240 USA.	ahill5@bates.edu		Quintero-Carmona, Omar/0000-0002-9314-1704	NIGMS NIH HHS [P20 GM103423] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103423] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adamska M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001031; Adamska M, 2016, CURR OPIN GENET DEV, V39, P21, DOI 10.1016/j.gde.2016.05.026; Adamska M, 2010, EVOL DEV, V12, P494, DOI 10.1111/j.1525-142X.2010.00435.x; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Baker NE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058266; Bang AG, 1999, DEV BIOL, V212, P366, DOI 10.1006/dbio.1999.9319; Blake JA, 2014, DEVELOPMENT, V141, P737, DOI 10.1242/dev.091785; Borisenko I, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0700-6; Brate J, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1746; Brophy PD, 2003, J BIOL CHEM, V278, P52401, DOI 10.1074/jbc.M305614200; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cramer JM, 2017, SCI REP-UK, V7, DOI 10.1038/srep40674; Dunn CW, 2015, TRENDS ECOL EVOL, V30, P282, DOI 10.1016/j.tree.2015.03.003; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fernandez-Valverde SL, 2016, SCI REP-UK, V6, DOI 10.1038/srep22496; Feuda R, 2017, CURR BIOL, V27, P3864, DOI 10.1016/j.cub.2017.11.008; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fortunato SAV, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-23; Friedrich M, 2006, ARTHROPOD STRUCT DEV, V35, P357, DOI 10.1016/j.asd.2006.08.010; Funayama N, 2010, DEV GROWTH DIFFER, V52, P1, DOI 10.1111/j.1440-169X.2009.01162.x; Gaiti Federico, 2018, Non-Coding RNA, V4, P6, DOI 10.3390/ncrna4010006; Gaiti F, 2017, ELIFE, V6, DOI 10.7554/eLife.22194; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gupta Ramneek, 2002, Pac Symp Biocomput, P310; Halanych KM, 2016, P NATL ACAD SCI USA, V113, pE946, DOI 10.1073/pnas.1525332113; Harcet M, 2010, MOL BIOL EVOL, V27, P2747, DOI 10.1093/molbev/msq174; Hill A, 2010, DEV BIOL, V343, P106, DOI 10.1016/j.ydbio.2010.03.010; Joyner AL, 1996, TRENDS GENET, V12, P15, DOI 10.1016/0168-9525(96)81383-7; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/nmeth.4285, 10.1038/NMETH.4285]; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kim AS, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-05-j0002.2001; Kumar JP, 2009, CELL MOL LIFE SCI, V66, P565, DOI 10.1007/s00018-008-8335-4; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Lapebie P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005823; Leys SP, 2012, ADV MAR BIOL, V62, P1, DOI 10.1016/B978-0-12-394283-8.00001-1; Loh KM, 2016, DEV CELL, V38, P643, DOI 10.1016/j.devcel.2016.08.011; Lopez-Rios J, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-19; Ludeman DA, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-3; Moroz LL, 2014, NATURE, V510, P109, DOI 10.1038/nature13400; Okamoto K, 2012, MECH DEVELOP, V129, P24, DOI 10.1016/j.mod.2012.03.001; Pisani D, 2016, P NATL ACAD SCI USA, V113, pE948, DOI 10.1073/pnas.1525718113; Pisani D, 2015, P NATL ACAD SCI USA, V112, P15402, DOI 10.1073/pnas.1518127112; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; R Development Core Team, 2009, R LANG ENV STAT COMP; Reid PJW, 2018, BMC EVOL BIOL, V18, DOI 10.1186/s12862-018-1118-0; Riesgo A, 2014, MOL BIOL EVOL, V31, P1102, DOI 10.1093/molbev/msu057; Rivera A, 2013, EVOL DEV, V15, P186, DOI 10.1111/ede.12032; Rivera AS, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-67; Schenkelaars Q, 2016, DEV BIOL, V412, P298, DOI 10.1016/j.ydbio.2016.02.026; Schippers KJ, 2018, MOL BIOL EVOL, V35, P1407, DOI 10.1093/molbev/msy033; STREKAL TA, 1974, BIOL BULL, V146, P267, DOI 10.2307/1540623; Telford MJ, 2016, NATURE, V529, P286, DOI 10.1038/529286a; Telford MJ, 2016, P NATL ACAD SCI USA, V113, pE948, DOI [10.1038/529286a, DOI 10.1038/529286A]; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Whelan NV, 2015, P NATL ACAD SCI USA, V112, P5773, DOI 10.1073/pnas.1503453112; Windsor PJ, 2010, EVOL DEV, V12, P484, DOI 10.1111/j.1525-142X.2010.00434.x; Yan J, 2014, GENE, V533, P229, DOI 10.1016/j.gene.2013.09.083	62	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212005	10.1371/journal.pone.0212005	http://dx.doi.org/10.1371/journal.pone.0212005			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794564	gold, Green Submitted, Green Published			2022-12-27	WOS:000459709100030
J	Kumar, K; Kumar, S; Singh, A; Ram, F; Singh, A				Kumar, Kaushalendra; Kumar, Santosh; Singh, Ashish; Ram, Faujdar; Singh, Abhishek			Heterogeneity in the effect of mid-childhood height and weight gain on human capital at age 14-15 years: Evidence from Ethiopia, India, Peru, and Vietnam	PLOS ONE			English	Article							5 BIRTH COHORTS; EARLY-LIFE; GROWTH-PATTERNS; LINEAR GROWTH; NUTRITION; HEALTH; IMPACT; ASSOCIATIONS; ADIPOSITY; ADULTHOOD	Background Under-nutrition in early childhood has harmful impacts on human capital formation in children, with implications for educational, adult health, and labor market outcomes. We investigate the association of linear growth and weight gain in mid-childhood with years of schooling, the Peabody Picture Vocabulary Test score, and math test score during the adolescent age of 14-15 years. Methods Data were derived from the Young Lives study conducted in four low-and middle-income countries (Ethiopia, India, Peru, and Vietnam). The data had detailed information on the children anthropometry and characteristics of the child, household, and community. Multivariate regression analysis, adjusted for the confounding variables, was used to investigate the association between mid-childhood health, measured by conditional linear growth and relative weight gain, and human capital outcomes in adolescent age. Results After controlling for several confounders, one cm increase in conditional linear growth increased years of schooling by 0.034 years and the Peabody Picture Vocabulary Test score and math test score by 0.474 and 0.083 points respectively. Relative weight gain was negatively associated with years of schooling and math test score. There is no evidence of heterogeneous effects by rural, gender, and household wealth. In the quantile regression analyses, the association between conditional linear growth and outcomes is stronger at the lower level of years of schooling and the Peabody Picture Vocabulary Test score. Conclusion Our study highlights that mid-childhood nutritional intervention targeted for students at the lower level of education distribution can accelerate the rate of human capital accumulation in low- and middle-income countries.	[Kumar, Kaushalendra; Ram, Faujdar; Singh, Abhishek] Int Inst Populat Sci, Dept Publ Hlth & Mortal Studies, Mumbai, Maharashtra, India; [Kumar, Santosh] Sam Houston State Univ, Coll Business Adm, Dept Econ & Int Business, Huntsville, TX 77340 USA; [Singh, Ashish] Indian Inst Technol, Shailesh J Mehta Sch Management, Mumbai, Maharashtra, India	International Institute for Population Sciences; Texas State University System; Sam Houston State University; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Kumar, K (corresponding author), Int Inst Populat Sci, Dept Publ Hlth & Mortal Studies, Mumbai, Maharashtra, India.	kaushal@iips.net	Singh, Abhishek/ABC-7813-2020; Kumar, Kaushalendra/ABC-7943-2020	Singh, Abhishek/0000-0001-6263-4410; Kumar, Kaushalendra/0000-0001-5913-0297; Kumar, Santosh/0000-0002-8663-3006				Adair LS, 2013, LANCET, V382, P525, DOI 10.1016/S0140-6736(13)60103-8; Almond D, 2011, J ECON PERSPECT, V25, P153, DOI 10.1257/jep.25.3.153; Barnett I, 2013, INT J EPIDEMIOL, V42, P701, DOI 10.1093/ije/dys082; Cueto S, 2013, PSYCHOMETRIC CHARACT; Currie J, 2013, ANNU REV ECON, V5, P1, DOI 10.1146/annurev-economics-081412-103704; Demerath EW, 2009, OBESITY, V17, P2060, DOI 10.1038/oby.2009.105; DEOLALIKAR AB, 1988, REV ECON STAT, V70, P406, DOI 10.2307/1926778; Glewwe P, 2001, WORLD BANK ECON REV, V15, P81, DOI 10.1093/wber/15.1.81; Hales CN, 2003, J PHYSIOL-LONDON, V547, P5, DOI 10.1113/jphysiol.2002.024406; Horta BL, 2017, J PEDIATR-US, V182, P85, DOI 10.1016/j.jpeds.2016.12.020; Kumar S, 2016, APPL ECON LETT, V23, P1325, DOI 10.1080/13504851.2016.1156225; Kumar S, 2016, POPUL DEV REV, V42, P53, DOI 10.1111/j.1728-4457.2016.00107.x; Duc LT, 2017, ECON HUM BIOL, V26, P86, DOI 10.1016/j.ehb.2017.02.002; Leunissen RWJ, 2009, CLIN ENDOCRINOL, V70, P245, DOI 10.1111/j.1365-2265.2008.03320.x; Liem ET, 2013, J PEDIATR-US, V162, P287, DOI 10.1016/j.jpeds.2012.07.053; Maluccio JA, 2009, ECON J, V119, P734, DOI 10.1111/j.1468-0297.2009.02220.x; Mani S, 2012, OXFORD B ECON STAT, V74, P691, DOI 10.1111/j.1468-0084.2011.00670.x; Martorell R, 2010, J NUTR, V140, P348, DOI 10.3945/jn.109.112300; Ong Ken K, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P30, DOI 10.1097/MED.0b013e328013da6c; Outes-Leon ID, 2009, SURVEY ATTRITION ATT; Prentice AM, 2013, AM J CLIN NUTR, V97, P911, DOI 10.3945/ajcn.112.052332; Sanchez A, 2017, ECON HUM BIOL, V27, P33, DOI 10.1016/j.ehb.2017.04.001; SCHROEDER DG, 1995, J NUTR, V125, pS1051; Stein AD, 2010, AM J HUM BIOL, V22, P353, DOI 10.1002/ajhb.20998; Stettler N, 2010, CURR OPIN CLIN NUTR, V13, P294, DOI 10.1097/MCO.0b013e328337d7b9; Strauss J, 1998, J ECON LIT, V36, P766; Strauss J, 2008, HBK ECON, V9, P3375, DOI 10.1016/S1573-4471(07)04054-5; Victora CG, 2001, INT J EPIDEMIOL, V30, P1325, DOI 10.1093/ije/30.6.1325; World Health Organization (WHO), 2015, AD DEV MAT NEWB CHIL	29	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212783	10.1371/journal.pone.0212783	http://dx.doi.org/10.1371/journal.pone.0212783			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794669	Green Published, gold, Green Submitted			2022-12-27	WOS:000459709100138
J	Ojo, T; Lester, L; Iwelunmor, J; Gyamfi, J; Obiezu-Umeh, C; Onakomaiya, D; Aifah, A; Nagendra, S; Opeyemi, J; Oluwasanmi, M; Dalton, M; Nwaozuru, U; Vieira, D; Ogedegbe, G; Boden-Albala, B				Ojo, Temitope; Lester, Lynette; Iwelunmor, Juliet; Gyamfi, Joyce; Obiezu-Umeh, Chisom; Onakomaiya, Deborah; Aifah, Angela; Nagendra, Shreya; Opeyemi, Jumoke; Oluwasanmi, Mofetoluwa; Dalton, Milena; Nwaozuru, Ucheoma; Vieira, Dorice; Ogedegbe, Gbenga; Boden-Albala, Bernadette			Feasibility of integrated, multilevel care for cardiovascular diseases (CVD) and HIV in low- and middle-income countries (LMICs): A scoping review	PLOS ONE			English	Review							NONCOMMUNICABLE DISEASES; BLOOD-PRESSURE; HYPERTENSION; AFRICA; INTERVENTIONS; COMMUNITY	Background Integrated cardiovascular disease (CVD) and HIV (CVD-HIV) care interventions are being adopted to tackle the growing burden of noncommunicable diseases (NCDs) in low-and middle-income countries (LMICs) but there is a paucity of studies on the feasibility of these interventions in LMICs. This scoping review aims to present evidence of the feasibility of integrated CVD-HIV care in LMICs, and the alignment of feasibility reporting in LMICs with the existing implementation science methodology. Methods A systematic search of published articles including systematic and narrative reviews that reported on integrated CVD-HIV care was conducted, using multiple search engines including PubMed/Medline, Global Health, and Web of Science. We examined the articles for evidence of feasibility reporting. Adopting the definition of Proctor and colleagues (2011), feasibility was defined as the extent to which an intervention was plausible in a given agency or setting. Evidence from the articles was synthesized by level of integration, the chronic care continuum, and stages of intervention development. Results Twenty studies, reported in 18 articles and 3 conferences abstracts, reported on feasibility of integrated CVD-HIV care interventions. These studies were conducted in Sub-Saharan Africa, Southeast Asia and South America. Four of these studies were conducted as feasibility studies. Eighty percent of the studies reported feasibility, using descriptive sentences that included words synonymous with feasibility terminologies in existing definition recommended by Proctor and colleagues. There was also an overlap in the use of descriptive phrases for feasibility amongst the selected studies. Conclusions Integrating CVD and HIV care is feasible in LMICs, although methodology for reporting feasibility is inconsistent. Assessing feasibility based on settings and integration goals will provide a unique perspective of the implementation landscape in LMICs. There is a need for consistency in measures in order to accurately assess the feasibility of integrated CVD-HIV care in LMICs.	[Ojo, Temitope; Obiezu-Umeh, Chisom; Opeyemi, Jumoke; Vieira, Dorice; Boden-Albala, Bernadette] NYU, Dept Epidemiol, Coll Global Publ Hlth, New York, NY USA; [Lester, Lynette] NYU, Sch Med, New York, NY USA; [Iwelunmor, Juliet; Nagendra, Shreya; Oluwasanmi, Mofetoluwa; Nwaozuru, Ucheoma] St Louis Univ, Coll Publ Hlth & Social Justice, Dept Behav Sci & Hlth Educ, St Louis, MO 63103 USA; [Gyamfi, Joyce; Onakomaiya, Deborah; Aifah, Angela; Dalton, Milena; Vieira, Dorice; Ogedegbe, Gbenga] NYU, Sch Med, Dept Populat Hlth, Sect Global Hlth, New York, NY 10003 USA; [Vieira, Dorice] NYU, Hlth Sci Lib, New York, NY USA; [Boden-Albala, Bernadette] NYU, Coll Dent, Dept Epidemiol, New York, NY USA; [Boden-Albala, Bernadette] NYU, Dept Neurol, Langone Sch Med, New York, NY 10016 USA	New York University; New York University; Saint Louis University; New York University; New York University; New York University; New York University; NYU Langone Medical Center	Ogedegbe, G (corresponding author), NYU, Sch Med, Dept Populat Hlth, Sect Global Hlth, New York, NY 10003 USA.	Olugbenga.Ogedegbe@nyumc.org		Boden-Albala, Bernadette/0000-0002-3752-329X; Vieira, Dorice/0000-0003-4232-9413; Aifah, Angela/0000-0002-2811-8487				Adam T, 2012, HEALTH POLICY PLANN, V27, P1, DOI 10.1093/heapol/czs084; Ameh S, 2017, JAIDS-J ACQ IMM DEF, V75, P472, DOI 10.1097/QAI.0000000000001437; Ameh S, 2017, HEALTH POLICY PLANN, V32, P257, DOI 10.1093/heapol/czw118; Arksey H., 2005, INT J SOC RES METHOD, V8, P19, DOI [10.1080/1364557032000119616, DOI 10.1080/1364557032000119616]; Chalmers I, 2014, LANCET, V383, P156, DOI 10.1016/S0140-6736(13)62229-1; Chang W, 2016, JAIDS-J ACQ IMM DEF, V73, pE39, DOI 10.1097/QAI.0000000000001141; Collaboration TC, 2011, COCHR HDB SYST REV I; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Curry N, 2010, CLIN SERVICE INTEGRA; Davis S, 2013, TROP MED INT HEALTH, V18, P328, DOI 10.1111/tmi.12041; Duffy M, 2017, TROPICAL MED INT HLT; Edwards JK, 2015, T ROY SOC TROP MED H, V109, P440, DOI 10.1093/trstmh/trv038; Fairall LR, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002178; Glasgow RE, 1999, AM J PUBLIC HEALTH, V89, P1322, DOI 10.2105/AJPH.89.9.1322; Govindasamy D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080017; Grant Janet F, 2006, Epidemiol Perspect Innov, V3, P4, DOI 10.1186/1742-5573-3-4; Guariguata L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131737; Gwarzo U, 2012, J INT AIDS SOC, V23, P1202; Haldane V, 2018, AIDS CARE, V30, P103, DOI 10.1080/09540121.2017.1344350; Hoddinott Pat, 2015, Pilot Feasibility Stud, V1, P36; Janssens B, 2007, B WORLD HEALTH ORGAN, V85, P880, DOI 10.2471/BLT.06.036574; Kabami J, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21514; Kachimanga C, 2017, MALAWI MED J, V29, P78, DOI 10.4314/mmj.v29i2.1; Kemp CG, 2018, AIDS, V32, pS93, DOI 10.1097/QAD.0000000000001897; Khabala KB, 2015, TROP MED INT HEALTH, V20, P1265, DOI 10.1111/tmi.12539; Kotwani P, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1151; Leung C, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3661-1; National Cancer Institute UNIoH, GRID EN MEAS GEM DAT; Nielsen WB, 1997, AM J HYPERTENS, V10, P634, DOI 10.1016/S0895-7061(96)00505-5; Nilsen P, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0242-0; Nsagha Dickson Shey, 2015, Open AIDS J, V9, P51, DOI 10.2174/1874613601509010051; Nyabera R, 2011, CARDIOVASCULAR J AFR, V2011, P17; Palma AM, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25099; Pastakia SD, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-21; Permanente K, 2018, FAST FACTS KAISER PE; Pfaff C, 2017, AFR J PRIM HEALTH CA, V9, DOI 10.4102/phcfm.v9i1.1151; Pinotti JA, 2001, REPROD HEALTH MATTER, V9, P69, DOI 10.1016/S0968-8080(01)90093-X; Proctor E, 2011, ADM POLICY MENT HLTH, V38, P65, DOI 10.1007/s10488-010-0319-7; The Joint United Nations Programme on HIV/AIDS (UNAIDS) New York, 2011, CHRON CAR HIV NONC D; Tiam A, 2012, J INT AIDS SOC, V23, P1202; Topp SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011522; Wells BS, 2009, NEWCASTLE OTTAWA SCA; World Health Organization, 2008, INTEGRATED HLTH SERV; World Health Organization W, 2013, TOOLS NAT MULT ACT P; Wroe EB, 2015, HEALTHCARE, V3, P270, DOI 10.1016/j.hjdsi.2015.08.002	45	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212296	10.1371/journal.pone.0212296	http://dx.doi.org/10.1371/journal.pone.0212296			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794591	Green Published, Green Submitted, gold			2022-12-27	WOS:000459709100053
J	Reis-Santos, B; Shete, P; Bertolde, A; Sales, CM; Sanchez, MN; Arakaki-Sanchez, D; Andrade, KB; Gomes, MGM; Boccia, D; Lienhardt, C; Maciel, EL				Reis-Santos, Barbara; Shete, Priya; Bertolde, Adelmo; Sales, Carolina M.; Sanchez, Mauro N.; Arakaki-Sanchez, Denise; Andrade, Kleydson B.; Gomes, M. Gabriela M.; Boccia, Delia; Lienhardt, Christian; Maciel, Ethel L.			Tuberculosis in Brazil and cash transfer programs: A longitudinal database study of the effect of cash transfer on cure rates	PLOS ONE			English	Article							MISSING VALUE IMPUTATION; DETERMINANTS; IMPACT	Introduction Tuberculosis incidence is disproportionately high among people in poverty. Cash transfer programs have become an important strategy in Brazil fight inequalities as part of comprehensive poverty alleviation policies. This study was aimed at assessing the effect of being a beneficiary of a governmental cash transfer program on tuberculosis (TB) treatment cure rates. Methods We conducted a longitudinal database study including people. 18 years old with confirmed incident TB in Brazil in 2015. We treated missing data with multiple imputation. Poisson regression models with robust variance were carried out to assess the effect of TB determinants on cure rates. The average effect of being beneficiary of cash transfer was estimated by propensity-score matching. Results In 2015, 25,084 women and men diagnosed as new tuberculosis case, of whom 1,714 (6.8%) were beneficiaries of a national cash transfer. Among the total population with pulmonary tuberculosis several determinants were associated with cure rates. However, among the cash transfer group, this association was vanished in males, blacks, region of residence, and people not deprived of their freedom and who smoke tobacco. The average treatment effect of cash transfers on TB cure rates, based on propensity score matching, found that being beneficiary of cash transfer improved TB cure rates by 8% [Coefficient 0.08 (95% confidence interval 0.06-0.11) in subjects with pulmonary TB]. Conclusion Our study suggests that, in Brazil, the effect of cash transfer on the outcome of TB treatment may be achieved by the indirect effect of other determinants. Also, these results suggest the direct effect of being beneficiary of cash transfer on improving TB cure rates.	[Reis-Santos, Barbara; Sales, Carolina M.; Maciel, Ethel L.] Univ Fed Espirito Santo, Lab Epidemiol, Vitoria, ES, Brazil; [Shete, Priya] Univ Calif San Francisco, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; [Bertolde, Adelmo] Univ Fed Espirito Santo, Dept Estat, Vitoria, ES, Brazil; [Sanchez, Mauro N.] Univ Brasilia Asa Norte, Dept Saude Colet, Brasilia, DF, Brazil; [Arakaki-Sanchez, Denise; Andrade, Kleydson B.] Minist Saude, Programa Nacl Controle TB, Brasilia, DF, Brazil; [Gomes, M. Gabriela M.] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Gomes, M. Gabriela M.] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, CIBIO InBIO, Vairao, Portugal; [Boccia, Delia] London Sch Hyg & Trop Med Keppel St, London, England; [Lienhardt, Christian] WHO, Global TB Programme, Geneva, Switzerland; [Lienhardt, Christian] Univ Montpellier, Inst Rech Dev, Unite Mixte Int TransVIHMI, INSERM,UMI 233,IRD,U1175, Montpellier, France	Universidade Federal do Espirito Santo; University of California System; University of California San Francisco; Universidade Federal do Espirito Santo; Liverpool School of Tropical Medicine; Universidade do Porto; World Health Organization; Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Reis-Santos, B (corresponding author), Univ Fed Espirito Santo, Lab Epidemiol, Vitoria, ES, Brazil.	reissantos.barbara@gmail.com	Reis-Santos, Barbara/A-3149-2014; Arakaki-Sanchez, Denise/M-4766-2013; Gomes, Gabriela/H-7218-2014; Sanchez, Mauro/AAU-2404-2020; Lienhardt, Christian/AAU-4969-2021; Maciel, Ethel Leonor LN/G-1027-2012	Reis-Santos, Barbara/0000-0001-6952-0352; Gomes, Gabriela/0000-0002-1454-4979; Sanchez, Mauro/0000-0002-0472-1804; Lienhardt, Christian/0000-0003-0233-893X; Maciel, Ethel Leonor LN/0000-0003-4826-3355; Bertolde, Adelmo Inacio/0000-0002-1747-9957	World Health Organization through Brazil Research Investment Case	World Health Organization through Brazil Research Investment Case	The study was supported by World Health Organization through Brazil Research Investment Case. This funding source had no role in the design of this study and will not have any role during its execution, analyses, interpretation of the data, or decision to publish the manuscript.	Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Boccia D, 2011, Int J Tuberc Lung Dis, V15 Suppl 2, P37, DOI 10.5588/ijtld.10.0438; Boccia D, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1529-8; BRASIL, PROGRAMA BOLSA FAMIL; Brasil. Ministerio da Saude, 2017, NON TRADITIONAL REF; Chandola T., 2014, HDB EPIDEMIOLOGY, P1551; de Oliveira GP, 2013, BRAZ J INFECT DIS, V17, P218, DOI 10.1016/j.bjid.2013.01.005; de Souza RA, 2018, INT J TUBERC LUNG D, V22, P1300, DOI 10.5588/ijtld.17.0907; Dehejia RH, 2002, REV ECON STAT, V84, P151, DOI 10.1162/003465302317331982; dos Santos NP, 2013, J BRAS PNEUMOL, V39, P221, DOI 10.1590/S1806-37132013000200014; Ferro AR, 2010, RES LABOR ECON, V31, P193, DOI 10.1108/S0147-9121(2010)0000031010; de Andrade KVF, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311x00153116, 10.1590/0102-311X00153116]; Glewwe P, 2012, J DEV ECON, V97, P505, DOI 10.1016/j.jdeveco.2011.05.008; Hargreaves JR, 2011, AM J PUBLIC HEALTH, V101, P654, DOI 10.2105/AJPH.2010.199505; Hirano K, 2003, ECONOMETRICA, V71, P1161, DOI 10.1111/1468-0262.00442; Liao SG, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0346-6; Little R., 2014, STAT ANAL MISSING DA, V2; Maciel EL, 2015, REV PANAM SALUD PUBL, V38, P28; Medeiros M, 2008, WORKING PAPER; Nery JS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003357; Oliosi JN, 2018, NON TRADITIONAL REF; Rasella D, 2013, LANCET, V382, P57, DOI 10.1016/S0140-6736(13)60715-1; Raviglione M., 2016, INFECT DIS REPORTS, V8; Reis-Santos B, 2015, INT J TUBERC LUNG D, V19, P1188, DOI 10.5588/ijtld.14.0776; Rocha Marli Souza, 2015, Cad. saúde colet., V23, P150, DOI 10.1590/1414-462X201500020092; Rudgard WE, UPTAKE GOVT SOCIAL P; Shah AD, 2014, AM J EPIDEMIOL, V179, P764, DOI 10.1093/aje/kwt312; Stekhoven DJ, 2012, BIOINFORMATICS, V28, P112, DOI 10.1093/bioinformatics/btr597; Torrens AW, 2016, T ROY SOC TROP MED H, V110, P199, DOI 10.1093/trstmh/trw011; Uplekar M, 2015, LANCET, V385, P1799, DOI 10.1016/S0140-6736(15)60570-0; White I, 2001, STAT MED, V20, P3441, DOI 10.1002/sim.908; WHO, 2016, GLOB TUB REP; WHO, 2015, HLTH 2015 MDGS MILL, DOI 10.1007/BF01918387; Wingfield T, 2017, B WORLD HEALTH ORGAN, V95, P270, DOI [10.2471/BLT.16.170167, 10.2471/blt.16.170167]; World Health Organization, 2017, TUB PAT COST SURV HD	36	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212617	10.1371/journal.pone.0212617	http://dx.doi.org/10.1371/journal.pone.0212617			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794615	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000459709100098
J	Subban, K; Subramani, R; Srinivasan, VPM; Johnpaul, M; Chelliah, J				Subban, Kamalraj; Subramani, Ramesh; Srinivasan, Vishnu Priya Madambakkam; Johnpaul, Muthumary; Chelliah, Jayabaskaran			Salicylic acid as an effective elicitor for improved taxol production in endophytic fungus Pestalotiopsis microspora	PLOS ONE			English	Article							CELL-SUSPENSION CULTURES; TAXUS-CHINENSIS; GLUTATHIONE-PEROXIDASE; FUNCTIONAL EXPRESSION; TAXANE PRODUCTION; BIOSYNTHESIS; PATHOGEN; STRESS; DEGRADATION; CLONING	Salicylic acid (SA) is an effective elicitor to increase taxol production in Pestalotiopsis microspora. Addition of SA at the concentration of 300 mu M yielded taxol 625.47 mu g L-1, 45-fold higher than that of the control. Elicitation of the role of SA in the fungal taxol biosynthetic pathway revealed that SA enhanced reactive oxygen species and lipid peroxidation of unsaturated fatty acids of P. microspora mycelia. This oxidative process stimulates isoprene biosynthetic pathway by triggering expression of the geranylgeranyl pyrophosphate synthase gene leading to improved biosynthesis of taxol in P. microspora.	[Subban, Kamalraj; Chelliah, Jayabaskaran] Indian Inst Sci, Dept Biochem, Bangalore, Karnataka, India; [Subban, Kamalraj; Srinivasan, Vishnu Priya Madambakkam; Johnpaul, Muthumary] Univ Madras, Ctr Adv Studies Bot, Guindy Campus, Chennai, Tamil Nadu, India; [Subramani, Ramesh] Univ South Pacific, Sch Biol & Chem Sci, Fac Sci Technol & Environm, Laucala Campus,Private Mail Bag, Suva, Fiji	Indian Institute of Science (IISC) - Bangalore; University of Madras; University of the South Pacific	Chelliah, J (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore, Karnataka, India.	cjb@iisc.ac.in	Subramani, Ramesh/AAM-2316-2020	Subramani, Ramesh/0000-0001-8168-2215; Subban, Kamalraj/0000-0003-2720-0697	Department of Science and Technology, GOI, New Delhi, India [EMR/2015/001071]; IISc-DBT partnership programme; DST-FIST; UGC; Society for Innovation and Development-IISc-Phytobiotech Pvt. Ltd; DST-SERB, Govt. of India (DST) [SERB/LS-412/2013]	Department of Science and Technology, GOI, New Delhi, India(Department of Science & Technology (India)Department of Science & Technology (DOST), Philippines); IISc-DBT partnership programme(Indian Institute of Science (IISC) - Bangalore); DST-FIST(Department of Science & Technology (India)); UGC(University Grants Commission, India); Society for Innovation and Development-IISc-Phytobiotech Pvt. Ltd; DST-SERB, Govt. of India (DST)	This study was supported by the grant EMR/2015/001071 from Department of Science and Technology, GOI, New Delhi, India, IISc-DBT partnership programme, DST-FIST and UGC special assistance programme for financial support. This work also was supported by the Society for Innovation and Development-IISc-Phytobiotech Pvt. Ltd and DST-SERB, Govt. of India (DST No: SERB/LS-412/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H., 1984, METHOD ENZYMOL, P114; Amini SA, 2014, TURK J BIOL, V38, P528, DOI 10.3906/biy-1401-47; Bai ZH, 2003, CRIT REV BIOTECHNOL, V23, P267, DOI 10.1080/07388550390449294; Bian GK, 2017, BIOTECHNOL J, V12, DOI 10.1002/biot.201600697; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033731; Chen J, 2007, J ENVIRON SCI, V19, P44, DOI 10.1016/S1001-0742(07)60007-2; Chen JY, 2006, POSTHARVEST BIOL TEC, V40, P64, DOI 10.1016/j.postharvbio.2005.12.017; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLAIBORNE A, 1979, J BIOL CHEM, V254, P4245; COURCHAINE AJ, 1959, CLIN CHEM, V5, P609; Decker LA., 1977, WORTHINGTON ENZYME M, DOI [10.1002/tox.20212, DOI 10.1002/TOX.20212]; DIDIER E, 1994, TETRAHEDRON LETT, V35, P3063, DOI 10.1016/S0040-4039(00)76828-6; Dieryckx C, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00859; Dong HD, 2001, BIOCHEM ENG J, V8, P145, DOI 10.1016/S1369-703X(01)00096-1; Eraslan F, 2007, SCI HORTIC-AMSTERDAM, V113, P120, DOI 10.1016/j.scienta.2007.03.012; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gangadevi V, 2008, CHIN J CHROMATOGR, V26, P50; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P309, DOI 10.1104/pp.59.2.309; Hefner J, 1998, ARCH BIOCHEM BIOPHYS, V360, P62, DOI 10.1006/abbi.1998.0926; Herrera-Vasquez A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00171; HOLTON RA, 1994, J AM CHEM SOC, V116, P1599, DOI 10.1021/ja00083a067; Hu YM, 2003, ACTA BOT SIN, V45, P373; Isah T, 2015, BRIT J PHARM RES, V6, P214, DOI 10.9734/BJPR/2015/16293; JENKINSON SG, 1982, J NUTR, V112, P197, DOI 10.1093/jn/112.1.197; Jennewein S, 2003, ARCH BIOCHEM BIOPHYS, V413, P262, DOI 10.1016/S0003-9861(03)00090-0; Jennewein S, 2001, P NATL ACAD SCI USA, V98, P13595, DOI 10.1073/pnas.251539398; Khan MIR, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00462; Kim HB, 2010, PLANT PHYSIOL, V152, P192, DOI 10.1104/pp.109.149088; Kusari S, 2014, TRENDS BIOTECHNOL, V32, P304, DOI 10.1016/j.tibtech.2014.03.011; LARSEN TO, 1995, MYCOL RES, V99, P1153, DOI 10.1016/S0953-7562(09)80271-2; Li JY, 1998, MYCOL RES, V102, P461, DOI 10.1017/S0953756297005078; Li JY, 1998, J IND MICROBIOL BIOT, V20, P259, DOI 10.1038/sj.jim.2900521; Liu TL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5686; Loake G, 2007, CURR OPIN PLANT BIOL, V10, P466, DOI 10.1016/j.pbi.2007.08.008; Miao LY, 2018, AMB EXPRESS, V8, DOI 10.1186/s13568-018-0567-6; Mirjalili MH, 2012, FEMS MICROBIOL LETT, V328, P122, DOI 10.1111/j.1574-6968.2011.02488.x; MORON MS, 1979, BIOCHIM BIOPHYS ACTA, V582, P67, DOI 10.1016/0304-4165(79)90289-7; NICOLAOU KC, 1994, NATURE, V367, P630, DOI 10.1038/367630a0; NOHL H, 1979, MECH AGEING DEV, V11, P145, DOI 10.1016/0047-6374(79)90050-2; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Penn CD, 2013, CURR MICROBIOL, V67, P218, DOI 10.1007/s00284-013-0349-y; Qiao WC, 2017, FUNGAL BIOL-UK, V121, P1037, DOI 10.1016/j.funbio.2017.08.011; Rabe F, 2013, MOL MICROBIOL, V89, P179, DOI 10.1111/mmi.12269; Rovenich H, 2014, CURR OPIN PLANT BIOL, V20, P96, DOI 10.1016/j.pbi.2014.05.001; Sambrook J., 2001, MOL CLONING LAB MANU, P2344; Sarmadi M, 2018, PLANT PHYSIOL BIOCH, V132, P271, DOI 10.1016/j.plaphy.2018.09.013; Schoendorf A, 2001, P NATL ACAD SCI USA, V98, P1501, DOI 10.1073/pnas.98.4.1501; SIEGEL MR, 1981, PLANT DIS, V65, P986, DOI 10.1094/PD-65-986; Soliman SSM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00353; Soliman SSM, 2017, APPL MICROBIOL BIOT, V101, P7523, DOI 10.1007/s00253-017-8509-9; Soliman SSM, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00003; Somjaipeng S, 2016, ENZYME MICROB TECH, V90, P69, DOI 10.1016/j.enzmictec.2016.05.002; Strobel GA, 1996, J IND MICROBIOL BIOT, V17, P417, DOI 10.1007/BF01574772; Subban K, 2016, CANADIAN J PURE APPL, V10, P3951; Tabata H, 2004, ADV BIOCHEM ENG BIOT, V87, P1; Wang YD, 2007, CELL BIOL INT, V31, P1179, DOI 10.1016/j.cellbi.2007.03.038; Wu HS, 2008, CHEMOSPHERE, V74, P45, DOI 10.1016/j.chemosphere.2008.09.027; Xiong ZQ, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-71; Xu F, 2006, BIOCHEM ENG J, V31, P67, DOI 10.1016/j.bej.2006.05.024; Yu LJ, 2001, PROCESS BIOCHEM, V37, P477, DOI 10.1016/S0032-9592(01)00243-6; Yuan JS, 2008, TRENDS PLANT SCI, V13, P165, DOI 10.1016/j.tplants.2008.02.003; Yuan YJ, 2001, ENZYME MICROB TECH, V29, P372, DOI 10.1016/S0141-0229(01)00406-9; Zhou XW, 2010, APPL MICROBIOL BIOT, V86, P1707, DOI 10.1007/s00253-010-2546-y	64	19	19	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212736	10.1371/journal.pone.0212736	http://dx.doi.org/10.1371/journal.pone.0212736			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794656	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000459709100126
J	Suzuki, Y; Maekawa, S; Komatsu, N; Sato, M; Tatsumi, A; Miura, M; Matsuda, S; Muraoka, M; Nakakuki, N; Amemiya, F; Takano, S; Fukasawa, M; Nakayama, Y; Yamaguchi, T; Inoue, T; Sato, T; Sakamoto, M; Yamashita, A; Moriishi, K; Enomoto, N				Suzuki, Yuichiro; Maekawa, Shinya; Komatsu, Nobutoshi; Sato, Mitsuaki; Tatsumi, Akihisa; Miura, Mika; Matsuda, Shuya; Muraoka, Masaru; Nakakuki, Natsuko; Amemiya, Fumitake; Takano, Shinichi; Fukasawa, Mitsuharu; Nakayama, Yasuhiro; Yamaguchi, Tatsuya; Inoue, Taisuke; Sato, Tadashi; Sakamoto, Minoru; Yamashita, Atsuya; Moriishi, Kohji; Enomoto, Nobuyuki			HBV preS deletion mapping using deep sequencing demonstrates a unique association with viral markers	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; GROUND GLASS HEPATOCYTES; CORE-RELATED ANTIGEN; CYCLIN-A EXPRESSION; CLOSED CIRCULAR DNA; SURFACE-ANTIGEN; HEPATOCELLULAR-CARCINOMA; ENDOPLASMIC-RETICULUM; S DELETION; MUTATIONS	Aim Deletions are observed frequently in the preS1/S2 region of hepatitis B virus (HBV) genome, in association with liver disease advancement. However, the most significant preS1/S2 region and its influences on viral markers are unclear. Methods The preS1/S2 HBV regions of 90 patients without antiviral therapy were subjected to deep sequencing and deleted regions influencing viral markers were investigated. Results From the deletion frequency analysis in each patient, deletions were observed most frequently in the preS2 codon 132-141 region. When the patients were divided into three groups (0-0.1%: n = 27, 0.1%-10%: n = 34, 10-100%: n = 29), based on the deletion frequency, FIB-4 (p < 0.01), HBV DNA (p < 0.01), HBcrAg (p < 0.01) and preS1/S2 start codon mutations (p < 0.01, both) were significantly associated with the deletion. When clinical and viral markers were investigated by multivariate analysis for their association with the deletion, FIB-4 (p < 0.05), HBcrAg (p < 0.05), and preS1 start codon mutation (p < 0.01) were extracted as independent variables. When the influence of the preS codon 132-141deletions on HBsAg and HBcrAg, relative to HBV DNA, was investigated, the HBsAg/HBV DNA ratio was lower (0-10% vs. 10%-100%, p<0.05), while the HBcrAg/HBV DNA rati o was higher (0-0.1% vs. 10%-100%, p<0.05) in the presence of the preS codon 132-141deletions. Conclusion The preS codon. 132-141 deletions have a significant influence on the clinical characteristics and viral markers, even when present as a minor population. Importantly, the preS codon 132-141 deletions have a clear influence on the viral life cycle and pathogenesis.	[Suzuki, Yuichiro; Maekawa, Shinya; Komatsu, Nobutoshi; Sato, Mitsuaki; Tatsumi, Akihisa; Miura, Mika; Matsuda, Shuya; Muraoka, Masaru; Nakakuki, Natsuko; Amemiya, Fumitake; Takano, Shinichi; Fukasawa, Mitsuharu; Nakayama, Yasuhiro; Yamaguchi, Tatsuya; Inoue, Taisuke; Sato, Tadashi; Sakamoto, Minoru; Enomoto, Nobuyuki] Univ Yamanashi, Fac Med, Dept Internal Med 1, Chuo Ku, Yamanashi, Japan; [Yamashita, Atsuya; Moriishi, Kohji] Univ Yamanashi, Dept Microbiol, Chuo Ku, Yamanashi, Japan	University of Yamanashi; University of Yamanashi	Maekawa, S (corresponding author), Univ Yamanashi, Fac Med, Dept Internal Med 1, Chuo Ku, Yamanashi, Japan.	maekawa@yamanashi.ac.jp	Moriishi, Kohji/I-4173-2019; Maekawa, Shinya/AAF-1349-2019	Moriishi, Kohji/0000-0002-9542-5188; 	Research Program on Hepatitis from Japanese Agency for Medical Research and Development (AMED) Japan [16 fk 0210301h0003, 16fk0210102h0001, 16 fk 0210308h0003]; JSPS KAKENHI [16K09349]; Japanese Agency for Medical Research and Development (AMED) Japan [17fk0310103j0001, 17fk0310113h0001, 17fk0210202h0002]	Research Program on Hepatitis from Japanese Agency for Medical Research and Development (AMED) Japan(Japan Agency for Medical Research and Development (AMED)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japanese Agency for Medical Research and Development (AMED) Japan(Japan Agency for Medical Research and Development (AMED))	This study was partly supported by Research Program on Hepatitis from Japanese Agency for Medical Research and Development (AMED) Japan (Grant Number 16 fk 0210301h0003, 16fk0210102h0001, and 16 fk 0210308h0003 to NE), and partly by JSPS KAKENHI (Grant Number 16K09349). This study was also supported partly from Japanese Agency for Medical Research and Development (AMED) Japan (Grant Number 17fk0310103j0001, 17fk0310113h0001 and 17fk0210202h0002 to NE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai X, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007206; Chan HLY, 2007, CLIN GASTROENTEROL H, V5, P1462, DOI 10.1016/j.cgh.2007.09.005; Chan HLY, 2011, J HEPATOL, V55, P1121, DOI 10.1016/j.jhep.2011.06.006; Chen BF, 2006, GASTROENTEROLOGY, V130, P1153, DOI 10.1053/j.gastro.2006.01.011; Chen CH, 2007, GASTROENTEROLOGY, V133, P1466, DOI 10.1053/j.gastro.2007.09.002; Chua PK, 2005, J VIROL, V79, P13483, DOI 10.1128/JVI.79.21.13483-13496.2005; Fang ZL, 2008, J GEN VIROL, V89, P2882, DOI 10.1099/vir.0.2008/002824-0; Gao ZY, 2007, J GASTROENTEROL, V42, P761, DOI 10.1007/s00535-007-2085-1; Hsieh YH, 2004, CARCINOGENESIS, V25, P2023, DOI 10.1093/carcin/bgh207; Hsieh YH, 2015, J PATHOL, V236, P337, DOI 10.1002/path.4531; Li YW, 2016, WORLD J GASTROENTERO, V22, P1943, DOI 10.3748/wjg.v22.i6.1943; Lin LY, 2010, J MED VIROL, V82, P1494, DOI 10.1002/jmv.21863; Liu SJ, 2009, JNCI-J NATL CANCER I, V101, P1066, DOI 10.1093/jnci/djp180; Maasoumy B, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.02.010; Pollicino T, 2014, J HEPATOL, V61, P408, DOI 10.1016/j.jhep.2014.04.041; Pollicino T, 2012, HEPATOLOGY, V56, P434, DOI 10.1002/hep.25592; Rodriguez-Frias F, 2013, WORLD J GASTROENTERO, V19, P6995, DOI 10.3748/wjg.v19.i41.6995; Rokuhara A, 2003, J VIRAL HEPATITIS, V10, P324, DOI 10.1046/j.1365-2893.2003.00437.x; Sato M, 2015, J VIROL, V89, P6105, DOI 10.1128/JVI.03127-14; Su IJ, 2008, J GASTROEN HEPATOL, V23, P1169, DOI 10.1111/j.1440-1746.2008.05348.x; Su IJ, 2014, J BIOMED SCI, V21, DOI 10.1186/s12929-014-0098-7; Sueki R, 2012, J MED VIROL, V84, P1360, DOI 10.1002/jmv.23314; Sugauchi F, 2003, J MED VIROL, V70, P537, DOI 10.1002/jmv.10428; Suzuki F, 2009, J MED VIROL, V81, P27, DOI 10.1002/jmv.21339; Testoni B, 2018, J HEPATOL; Wang HC, 2005, HEPATOLOGY, V41, P761, DOI 10.1002/hep.20615; Wang HC, 2003, AM J PATHOL, V163, P2441, DOI 10.1016/S0002-9440(10)63599-7; Wang HC, 2006, CANCER SCI, V97, P683, DOI 10.1111/j.1349-7006.2006.00235.x; Wang LHC, 2012, CARCINOGENESIS, V33, P466, DOI 10.1093/carcin/bgr296; World Health Organization, 2017, GLOB HEP REP 2017 EX; Zhang D. B., 2013, YANGTZE RIVER, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0065044; Zhang XN, 2015, LIVER INT, V35, P1087, DOI 10.1111/liv.12642	32	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212559	10.1371/journal.pone.0212559	http://dx.doi.org/10.1371/journal.pone.0212559			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794632	Green Published, gold, Green Submitted			2022-12-27	WOS:000459709100088
J	Turcios, L; Chacon, E; Garcia, C; Eman, P; Cornea, V; Jiang, JY; Spear, B; Liu, CM; Watt, DS; Marti, F; Gedaly, R				Turcios, Lilia; Chacon, Eduardo; Garcia, Catherine; Eman, Pedro; Cornea, Virgilius; Jiang, Jieyun; Spear, Brett; Liu, Chunming; Watt, David S.; Marti, Francesc; Gedaly, Roberto			Autophagic flux modulation by Wnt/beta-catenin pathway inhibition in hepatocellular carcinoma	PLOS ONE			English	Article							BETA-CATENIN; CELL-PROLIFERATION; CANCER-CELLS; SORAFENIB; RAS/RAF/MAPK; ACTIVATION; RESISTANCE; INITIATION; ROLES; FH535	Autophagy targets cellular components for lysosomal-dependent degradation in which the products of degradation may be recycled for protein synthesis and utilized for energy production. Autophagy also plays a critical role in cell homeostasis and the regulation of many physiological and pathological processes and prompts this investigation of new agents to effect abnormal autophagy in hepatocellular carcinoma (HCC). 2,5-Dichloro-N-(2-methyl-4-nitrophenyl) benzenesulfonamide (FH535) is a synthetic inhibitor of the Wnt/beta-catenin pathway that exhibits anti-proliferative and anti-angiogenic effects on different types of cancer cells. The combination of FH535 with sorafenib promotes a synergistic inhibition of HCC and liver cancer stem cell proliferation, mediated in part by the simultaneous disruption of mitochondrial respiration and glycolysis. We demonstrated that FH535 decreased HCC tumor progression in a mouse xenograft model. For the first time, we showed the inhibitory effect of an FH535 derivative, FH535-N, alone and in combination with sorafenib on HCC cell proliferation. Our study revealed the contributing effect of Wnt/beta-catenin pathway inhibition by FH535 and its derivative (FH535-N) through disruption of the autophagic flux in HCC cells.	[Turcios, Lilia; Chacon, Eduardo; Garcia, Catherine; Eman, Pedro; Cornea, Virgilius; Marti, Francesc; Gedaly, Roberto] Univ Kentucky, Coll Med, Dept Surg, Transplant Ctr, Lexington, KY 40506 USA; [Turcios, Lilia; Cornea, Virgilius; Jiang, Jieyun; Spear, Brett; Liu, Chunming; Watt, David S.; Marti, Francesc; Gedaly, Roberto] Univ Kentucky, Lucille Parker Markey Canc Ctr, Lexington, KY 40506 USA; [Jiang, Jieyun; Spear, Brett] Univ Kentucky, Coll Med, Dept Microbiol Immunol & Mol Genet, Lexington, KY USA; [Liu, Chunming; Watt, David S.] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY USA; [Watt, David S.] Univ Kentucky, Coll Pharm, Ctr Pharmaceut Res & Innovat, Lexington, KY USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Gedaly, R (corresponding author), Univ Kentucky, Coll Med, Dept Surg, Transplant Ctr, Lexington, KY 40506 USA.; Gedaly, R (corresponding author), Univ Kentucky, Lucille Parker Markey Canc Ctr, Lexington, KY 40506 USA.	rgeda2@uky.edu		Eman, Pedro/0000-0001-6236-1723	Biospecimen Procurement and Translational Pathology Shared Resource Facility of the University of Kentucky Markey Cancer Center [P30CA177558]; Redox Metabolism Shared Resource Facility of the University of Kentucky Markey Cancer Center [P30CA177558]; Office of the Vice President for Research; Markey Cancer Center; NCI Center Core Support Grant [P30 CA177558]; NATIONAL CANCER INSTITUTE [P30CA177558] Funding Source: NIH RePORTER	Biospecimen Procurement and Translational Pathology Shared Resource Facility of the University of Kentucky Markey Cancer Center; Redox Metabolism Shared Resource Facility of the University of Kentucky Markey Cancer Center; Office of the Vice President for Research; Markey Cancer Center; NCI Center Core Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Biospecimen Procurement and Translational Pathology Shared Resource Facility of the University of Kentucky Markey Cancer Center (P30CA177558). The research was also supported by the Redox Metabolism Shared Resource Facility of the University of Kentucky Markey Cancer Center (P30CA177558). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Biospecimen Procurement and Translational Pathology Shared Resource Facility of the University of Kentucky Markey Cancer Center (P30CA177558). The UK Flow Cytometry & Immune Function core facility is supported in part by the Office of the Vice President for Research, the Markey Cancer Center and an NCI Center Core Support Grant (P30 CA177558) to the University of Kentucky Markey Cancer Center. The research was supported by the Redox Metabolism Shared Resource Facility of the University of Kentucky Markey Cancer Center (P30CA177558).	Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; Cai Z, 2018, CANCER RES, V78, P2536, DOI 10.1158/0008-5472.CAN-17-0028; Chen Y, 2017, J CANC, V8, P3142, DOI [10.7150/jca.19273, DOI 10.7150/JCA.19273]; Chi KH, 2016, ONCOTARGET, V7, P58075, DOI 10.18632/oncotarget.10873; Damsky WE, 2011, CANCER CELL, V20, P741, DOI 10.1016/j.ccr.2011.10.030; Dimitroulis D, 2017, WORLD J GASTROENTERO, V23, P5282, DOI 10.3748/wjg.v23.i29.5282; Fu YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102535; Galuppo R, 2014, ANTICANCER RES, V34, P1709; Gao C, 2010, NAT CELL BIOL, V12, P781, DOI 10.1038/ncb2082; Gao CX, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-13; Gedaly R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099272; Gedaly R, 2010, ANTICANCER RES, V30, P4951; Gekas C, 2016, LEUKEMIA, V30, P2002, DOI 10.1038/leu.2016.106; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Iida J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044418; Inagawa S, 2002, CLIN CANCER RES, V8, P450; Jia ZQ, 2014, CELL SIGNAL, V26, P2299, DOI 10.1016/j.cellsig.2014.07.028; Khramtsov AI, 2010, AM J PATHOL, V176, P2911, DOI 10.2353/ajpath.2010.091125; Kobayashi M, 2000, BRIT J CANCER, V82, P1689; Kril LM, 2015, BIOORG MED CHEM LETT, V25, P3897, DOI 10.1016/j.bmcl.2015.07.040; Kuhn K, 2015, CELL DEATH DISCOV, V1, DOI 10.1038/cddiscovery.2015.31; Lee HC, 2006, FRONT BIOSCI-LANDMRK, V11, P1901, DOI 10.2741/1933; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Lin RK, 2015, CELL PHYSIOL BIOCHEM, V35, P926, DOI 10.1159/000369749; Liu L, 2016, ONCOTARGET, V7, P47145, DOI 10.18632/oncotarget.9975; Mittal S, 2013, J CLIN GASTROENTEROL, V47, pS2, DOI 10.1097/MCG.0b013e3182872f29; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Petherick KJ, 2013, EMBO J, V32, P1903, DOI 10.1038/emboj.2013.123; Poillet-Perez L, 2015, REDOX BIOL, V4, P184, DOI 10.1016/j.redox.2014.12.003; Shang S, 2017, ONCOTARGET, V8, P33972, DOI 10.18632/oncotarget.15687; Shi YH, 2011, AUTOPHAGY, V7, P1159, DOI 10.4161/auto.7.10.16818; Shiah SG, 2016, J DENT RES, V95, P129, DOI 10.1177/0022034515613507; Shimizu S, 2012, INT J CANCER, V131, P548, DOI 10.1002/ijc.26374; Society AC, 2018, NON TRADITIONAL REF; Su HF, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0464-6; Su N, 2016, ONCOL LETT, V12, P4623, DOI 10.3892/ol.2016.5289; Sun T, 2017, CELL PHYSIOL BIOCHEM, V44, P716, DOI 10.1159/000485285; Tao H, 2017, MOL MED REP, V16, P1701, DOI 10.3892/mmr.2017.6828; Turcios L, 2017, DIGEST LIVER DIS, V49, P697, DOI 10.1016/j.dld.2017.01.146; Ullman-Cullere MH, 1999, LAB ANIM SCI, V49, P319; Wands JR, 2014, HEPATOLOGY, V60, P452, DOI 10.1002/hep.27081	42	24	25	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212538	10.1371/journal.pone.0212538	http://dx.doi.org/10.1371/journal.pone.0212538			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794613	Green Published, gold, Green Submitted			2022-12-27	WOS:000459709100082
J	Colitti, B; Coradduzza, E; Puggioni, G; Capucchio, MT; Reina, R; Bertolotti, L; Rosati, S				Colitti, Barbara; Coradduzza, Elisabetta; Puggioni, Giantonella; Capucchio, Maria Teresa; Reina, Ramses; Bertolotti, Luigi; Rosati, Sergio			A new approach for Small Ruminant Lentivirus full genome characterization revealed the circulation of divergent strains	PLOS ONE			English	Article							GENETIC-CHARACTERIZATION; IMMUNODOMINANT EPITOPE; ANTIBODY-RESPONSE; GOAT TRANSMISSION; SHEEP; ANTIGEN; CAPRINE	Small Ruminant Lentiviruses (SRLV) include at least 4 viral highly divergent genotypes. Genotypes A and B are widely distributed and genotypes C and E have been recognized in restricted geographic areas. New phylogroups have been identified targeting conserved regions. However, this approach suffers from the potential risk to misamplify highly divergent strains. Pathogenic strains are easily adapted to fibroblastic cells, but non-pathogenic strains isolation may require a different approach. We developed a fast and effective method for SRLV full genome characterization after cell culture isolation. Spleen samples were collected during regular slaughter from sheep and goats in northwestern Italy. Spleen-derived macrophage cultures were monitored for reverse transcriptase activity and RNA was extracted from the supernatant of positive cultures. Using Illumina MiSeq platform 22 new full genome sequences were obtained. The success of this approach is based on the following features: spleen is one of the main target for SRLV persistence; red pulp is a reserve of resident macrophages, the main target for SRLV replication in vivo; RTA is a sensitive assay for any replicating retrovirus; de novo sequencing do not require genetic knowledge in advance.	[Colitti, Barbara; Capucchio, Maria Teresa; Bertolotti, Luigi; Rosati, Sergio] Univ Turin, Dept Vet Sci, Turin, Italy; [Coradduzza, Elisabetta; Puggioni, Giantonella] Ist Zooprofilatt Sperimentale Sardegna, Sassari, Italy; [Reina, Ramses] Govt Navarra, UPNA, CSIC, Inst Agrobiotechnol, Navarra, Spain	University of Turin; IZS Della Sardegna; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-GN-UPNA - Instituto de Agrobiotecnologia (IDAB); Universidad Publica de Navarra	Bertolotti, L (corresponding author), Univ Turin, Dept Vet Sci, Turin, Italy.	luigi.bertolotti@unito.it	Reina, Ramsés/AAL-3924-2020; Arias, Ramses Reina/E-3247-2012; Capucchio, Maria/AAA-6589-2022; Coradduzza, Elisabetta/GRS-3669-2022; Coradduzza, Elisabetta/AAA-4886-2020; Bertolotti, Luigi/F-9236-2013	Arias, Ramses Reina/0000-0003-1265-9139; Coradduzza, Elisabetta/0000-0001-6942-3296; Coradduzza, Elisabetta/0000-0001-6942-3296; Rosati, Sergio/0000-0002-8315-0316; Bertolotti, Luigi/0000-0001-7931-4528; Puggioni, Giantonella/0000-0001-9013-8203	University of Torino; Ramon y Cajal contract	University of Torino; Ramon y Cajal contract(Spanish Government)	This research was funded by the University of Torino (Ricerca Locale ex60% 2016 grant to SR). RR was supported by Ramon y Cajal contract. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by "Ricerca Locale ex60% 2016" grant provided by the University of Torino. The authors acknowledge all the slaughterhouse owners for the collaboration during the sample collection. RR was supported by Ramon y Cajal contract.	Bertolotti L, 2011, J GEN VIROL, V92, P1923, DOI 10.1099/vir.0.032334-0; BERTONI G, 1994, J VIROL, V68, P7139, DOI 10.1128/JVI.68.11.7139-7147.1994; Cardinaux L, 2013, VET MICROBIOL, V162, P572, DOI 10.1016/j.vetmic.2012.11.017; de Andres X, 2013, VET IMMUNOL IMMUNOP, V152, P277, DOI 10.1016/j.vetimm.2012.12.017; Deubelbeiss M, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-65; Gjerset B, 2009, VET MICROBIOL, V135, P231, DOI 10.1016/j.vetmic.2008.09.069; Grego E, 2002, CLIN DIAGN LAB IMMUN, V9, P828, DOI 10.1128/CDLI.9.4.828-832.2002; Grego E, 2007, J GEN VIROL, V88, P3423, DOI 10.1099/vir.0.83292-0; Juganaru M, 2011, VIROLOGY, V410, P88, DOI 10.1016/j.virol.2010.10.031; Juganaru M, 2010, VET RES COMMUN, V34, pS47, DOI 10.1007/s11259-010-9390-5; Mordasini F, 2006, J CLIN MICROBIOL, V44, P981, DOI 10.1128/JCM.44.3.981-991.2006; Olech M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193892; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; PERRY LL, 1995, J INFECT DIS, V171, P328, DOI 10.1093/infdis/171.2.328; Ramirez H, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-8; Reina R, 2010, VET MICROBIOL, V144, P24, DOI 10.1016/j.vetmic.2009.12.020; Reina R, 2009, VET MICROBIOL, V138, P251, DOI 10.1016/j.vetmic.2009.04.005; Reina R, 2009, J VIROL, V83, P1152, DOI 10.1128/JVI.01627-08; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; ROSATI S, 1995, J VET DIAGN INVEST, V7, P437, DOI 10.1177/104063879500700403; Santry LA, 2013, VIRUS RES, V175, P30, DOI 10.1016/j.virusres.2013.03.019; Shah C, 2004, VIROLOGY, V319, P12, DOI 10.1016/j.virol.2003.09.047; Tolari F, 1991, ATTI SOC ITALIANA SC, P1083	23	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212585	10.1371/journal.pone.0212585	http://dx.doi.org/10.1371/journal.pone.0212585			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789950	Green Submitted, Green Published, gold			2022-12-27	WOS:000459330800043
J	Caro, T; Argueta, Y; Briolat, ES; Bruggink, J; Kasprowsky, M; Lake, J; Mitchell, MJ; Richardson, S; How, M				Caro, Tim; Argueta, Yvette; Briolat, Emmanuelle Sophie; Bruggink, Joren; Kasprowsky, Maurice; Lake, Jai; Mitchell, Matthew J.; Richardson, Sarah; How, Martin			Benefits of zebra stripes: Behaviour of tabanid flies around zebras and horses	PLOS ONE			English	Article							ADVANTAGE; PATTERNS; DIPTERA; TSETSE; TRAPS	Averting attack by biting flies is increasingly regarded as the evolutionary driver of zebra stripes, although the precise mechanism by which stripes ameliorate attack by ectoparasites is unknown. We examined the behaviour of tabanids (horse flies) in the vicinity of captive plains zebras and uniformly coloured domestic horses living on a horse farm in Britain. Observations showed that fewer tabanids landed on zebras than on horses per unit time, although rates of tabanid circling around or briefly touching zebra and horse pelage did not differ. In an experiment in which horses sequentially wore cloth coats of different colours, those wearing a striped pattern suffered far lower rates of tabanid touching and landing on coats than the same horses wearing black or white, yet there were no differences in attack rates to their naked heads. In separate, detailed video analyses, tabanids approached zebras faster and failed to decelerate before contacting zebras, and proportionately more tabanids simply touched rather than landed on zebra pelage in comparison to horses. Taken together, these findings indicate that, up close, striped surfaces prevented flies from making a controlled landing but did not influence tabanid behaviour at a distance. To counteract flies, zebras swished their tails and ran away from fly nuisance whereas horses showed higher rates of skin twitching. As a consequence of zebras' striping, very few tabanids successfully landed on zebras and, as a result of zebras' changeable behaviour, few stayed a long time, or probed for blood.	[Caro, Tim; Argueta, Yvette] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA; [Briolat, Emmanuelle Sophie; Kasprowsky, Maurice; Mitchell, Matthew J.; Richardson, Sarah] Univ Exeter, Ctr Ecol & Conservat Biosci, Coll Life & Environm Sci, Penryn Campus, Penryn, Cornwall, England; [Bruggink, Joren] Aeres Univ Appl Sci, Almere, Netherlands; [Lake, Jai; How, Martin] Univ Bristol, Sch Biol Sci, Bristol, Avon, England	University of California System; University of California Davis; University of Exeter; University of Bristol	Caro, T (corresponding author), Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA.	tmcaro@ucdavis.edu	How, Martin J./G-1925-2010	How, Martin J./0000-0001-5135-8828; Richardson, Sarah/0000-0001-8942-7286; Briolat, Emmanuelle/0000-0001-5695-1065; Mitchell, Matt/0000-0001-7599-8926	University of California, Davis; Royal Society	University of California, Davis(University of California System); Royal Society(Royal Society of London)	TC was funded by the University of California, Davis; MH by the Royal Society.	ALLAN SA, 1986, J MED ENTOMOL, V23, P83, DOI 10.1093/jmedent/23.1.83; Baird E, 2013, P NAT ACAD SCI; BALLARD JWO, 1988, MED VET ENTOMOL, V2, P265, DOI 10.1111/j.1365-2915.1988.tb00194.x; Benesch Annette R., 2003, Zoologische Garten, V73, P74; BRADY J, 1988, B ENTOMOL RES, V78, P301, DOI 10.1017/S0007485300013067; Britten KH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154504; Caro T, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150323; Caro T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4535; Caro Tim, 2016, ZEBRA STRIPES; CENA K, 1973, Journal of Mammalogy, V54, P1003, DOI 10.2307/1379105; Egri A, 2012, J EXP BIOL, V215, P736, DOI 10.1242/jeb.065540; FOIL LD, 1989, PARASITOL TODAY, V5, P88, DOI 10.1016/0169-4758(89)90009-4; GIBSON G, 1992, PHYSIOL ENTOMOL, V17, P141, DOI 10.1111/j.1365-3032.1992.tb01191.x; Harris RHTP, 1940, REPORT BIONOMICS TSE; Hayward MW, 2005, J ZOOL, V267, P309, DOI 10.1017/S0952836905007508; Hogan BG, 2016, BEHAV ECOL, V27, P1547, DOI 10.1093/beheco/arw081; Horvath G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27637-1; Horvath G, 2010, P ROY SOC B-BIOL SCI, V277, P1643, DOI 10.1098/rspb.2009.2202; How MJ, 2014, ZOOLOGY, V117, P163, DOI 10.1016/j.zool.2013.10.004; Krcmar S, 2014, PARASITE, V21, DOI 10.1051/parasite/2014068; Larison B, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140452; Lehane M.J., 2005, BIOL BLOOD SUCKING I, V2nd; Melin AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145679; MORRIS K. R. S., 1963, ACTA TROP, V20, P16; MULLENS BA, 1979, ENVIRON ENTOMOL, V8, P1047, DOI 10.1093/ee/8.6.1047; ROBERTS RH, 1972, MOSQ NEWS, V32, P542; Ruxton GD, 2002, MAMMAL REV, V32, P237, DOI 10.1046/j.1365-2907.2002.00108.x; Santer RD, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0811; Scott-Samuel NE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020233; SIEGFRIED WR, 1990, J MAMMAL, V71, P75, DOI 10.2307/1381320; Srinivasan MV, 2004, ANNU REV NEUROSCI, V27, P679, DOI 10.1146/annurev.neuro.27.070203.144343; WAAGE J K, 1981, Journal of the Entomological Society of Southern Africa, V44, P351	32	19	19	6	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0210831	10.1371/journal.pone.0210831	http://dx.doi.org/10.1371/journal.pone.0210831			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785882	gold, Green Submitted, Green Published			2022-12-27	WOS:000459307000015
J	Finnamore, E; Waugh, C; Solomons, L; Ryan, M; West, C; Scott, A				Finnamore, Evan; Waugh, Charlotte; Solomons, Lyndal; Ryan, Michael; West, Christopher; Scott, Alexander			Transverse tendon stiffness is reduced in people with Achilles tendinopathy: A cross-sectional study	PLOS ONE			English	Article							ELASTOGRAPHY; ALTERS; STRAIN	Objectives The objective of the current cross-sectional study was to examine Achilles tendon transverse stiffness in a group of recreational runners with Achilles tendinopathy, in comparison to an asymptomatic group of runners with similar training history. We also aimed to determine the between-week intra-individual reliability of this measurement technique. Design Cross-sectional cohort study. Methods A hand-held dynamometer was used to assess the transverse stiffness of the Achilles tendon (AT) in twenty-five recreational runners. In ten people with midportion Achilles tendinopathy (5 men, 5 women), measurements were taken directly over the most symptomatic location. In 15 people who were free of AT symptoms (7 men, 8 women), measurements were taken at an equivalent location on the tendon. Participants returned after one week to determine measurement reliability (intra-class correlation coefficient/ICC and minimum detectable change/MDC95). We also collected information about people's tendon loading activities, tendon thickness (ultrasound mesaurement), and symptoms (Victorian Institute of Sports Assessment-Achilles / VISA-A score). Results The AT transverse stiffness was lower in people with Achilles tendinopathy (777 N/m +/- 86) compared to those who were asymptomatic (873 N/m +/- 72) (p < 0.05). AT transverse stiffness was negatively correlated with age and tendon thickness, and positively correlated with VISA-A score and waist circumference. Reliability was good, with ICC of 0.81 in people with tendinopathy and 0.80 in healthy controls, and an MDC95 of 118 and 87N/m in these two respective groups. Conclusions Transverse Achilles tendon stiffness can be reliably measured in people with midportion Achilles tendinopathy, and appears to be lower in people who are older, more symptomatic, and with more extensive tendon thickening. The potential clinical utility of monitoring tendon stiffness in the management of tendon injuries merits further study.	[Finnamore, Evan; Waugh, Charlotte; Solomons, Lyndal; Scott, Alexander] Vancouver Coastal Hlth Res Inst, Ctr Hip Hlth & Mobil, Vancouver, BC, Canada; [Finnamore, Evan; Waugh, Charlotte; Solomons, Lyndal; Scott, Alexander] Univ British Columbia, Dept Phys Therapy, Fac Med, Vancouver, BC, Canada; [Ryan, Michael] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada; [West, Christopher] Univ British Columbia Okanagan, Southern Med Program, Dept Cellular & Physiol Sci, Kelowna, BC, Canada	Vancouver Coastal Health Research Institute; University of British Columbia; Simon Fraser University; University of British Columbia; University of British Columbia Okanagan	Scott, A (corresponding author), Vancouver Coastal Hlth Res Inst, Ctr Hip Hlth & Mobil, Vancouver, BC, Canada.; Scott, A (corresponding author), Univ British Columbia, Dept Phys Therapy, Fac Med, Vancouver, BC, Canada.	ascott@mail.ubc.ca	Waugh, Charlie/J-3687-2015	Waugh, Charlie/0000-0002-3090-046X; Scott, Alex/0000-0003-0366-8404				Arya S, 2010, J APPL PHYSIOL, V108, P670, DOI 10.1152/japplphysiol.00259.2009; Bohm S, 2015, SCAND J MED SCI SPOR, V25, pE124, DOI 10.1111/sms.12242; Bohm S, 2015, SPORTS MED OPEN, V1, P9, DOI [10.1186/s40798-015-0012-1, DOI 10.1186/S40798-015-0012-1]; Coombes BK, 2018, SCAND J MED SCI SPOR, V28, P1201, DOI 10.1111/sms.12986; Couppe C, 2008, J APPL PHYSIOL, V105, P805, DOI 10.1152/japplphysiol.90361.2008; de Sa A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199645; Delabastita T, 2019, J AGING PHYS ACTIV, V27, P116, DOI 10.1123/japa.2017-0359; Docking SI, 2015, J SCI MED SPORT, V18, P383, DOI 10.1016/j.jsams.2014.06.004; Eekhoff JD, 2018, CONNECT TISSUE RES, V59, P410, DOI 10.1080/03008207.2018.1449837; Habets B, 2018, SPORTS MED, V48, P705, DOI 10.1007/s40279-017-0833-9; Haen TX, 2017, J MECH BEHAV BIOMED, V69, P178, DOI 10.1016/j.jmbbm.2017.01.007; Hassler U, 2003, J ROY STAT SOC D-STA, V52, P367, DOI 10.1111/1467-9884.00365; Kongsgaard M, 2010, AM J SPORT MED, V38, P749, DOI 10.1177/0363546509350915; Lai A, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0391; Leung JL, 2008, J CLIN ULTRASOUND, V36, P27, DOI 10.1002/jcu.20388; Martin JA, 2018, NAT COMMUN, V9, P6, DOI [10.1038/s41467-017-02251-3, DOI 10.1038/S41467-017-02251-3]; Ooi CC, 2014, SKELETAL RADIOL, V43, P1, DOI 10.1007/s00256-013-1695-3; Paavola M, 2000, AM J SPORT MED, V28, P634, DOI 10.1177/03635465000280050301; Robinson JM, 2001, BRIT J SPORT MED, V35, P335, DOI 10.1136/bjsm.35.5.335; Schepull T, 2015, KNEE SURG SPORT TR A, V23, P884, DOI 10.1007/s00167-013-2720-8; Schneider S, 2015, MED BIOL ENG COMPUT, V53, P57, DOI 10.1007/s11517-014-1211-5; Scott A, 2015, J ORTHOP SPORT PHYS, V45, P833, DOI 10.2519/jospt.2015.5884; Sohirad S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184463; Sussmilch-Leitch SP, 2012, J FOOT ANKLE RES, V5, DOI 10.1186/1757-1146-5-15; Vandenbroucke JP, 2009, GAC SANIT, V23, P158, DOI 10.1016/j.gaceta.2008.12.001; Videbaek S, 2015, SPORTS MED, V45, P1017, DOI 10.1007/s40279-015-0333-8; Waugh CM, 2018, SCAND J MED SCI SPOR, V28, P436, DOI 10.1111/sms.12930; Wearing SC, 2013, J BODYW MOV THER, V17, P316, DOI 10.1016/j.jbmt.2012.11.004	29	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211863	10.1371/journal.pone.0211863	http://dx.doi.org/10.1371/journal.pone.0211863			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785895	Green Submitted, gold, Green Published			2022-12-27	WOS:000459307000043
J	Frederick, DE; VanderWeele, TJ				Frederick, Donald E.; VanderWeele, Tyler J.			Supported employment: Meta-analysis and review of randomized controlled trials of individual placement and support	PLOS ONE			English	Review							SEVERE MENTAL-ILLNESS; QUALITY-OF-LIFE; COST-EFFECTIVENESS; FIDELITY SCALE; PEOPLE; VETERANS; OUTCOMES; UNEMPLOYMENT; PROGRAM; HEALTH	Supported employment is a treatment whereby those with severe mental illness (or other disabilities) receive aid searching for competitive employment and mental health (or other) treatments concurrently. The most popular implementation of supported employment is individual placement and support (IPS). We conducted meta-analytic analyses of the randomized controlled trials of IPS. We found that subjects in IPS, compared to usual treatment conditions, had better vocational outcomes (obtained any competitive employment: RR = 1.63, 95%CI = [1.46, 1.82]; job tenure: d = 0.55, 95%CI = [0.33, 0.79]; job length: d = 0.46, 95%CI = [0.35, 0.57]; income: d = 0.48, 95%CI = [0.36, 0.59]) Non-vocational outcomes estimates, while favoring IPS, included the null (quality of life: d = 0.30, 95%Cl = [-0.07, 0.67]; global functioning: d = 0.09, 95%CI = [-0.09, 0.27]; mental health: d = 0.03, 95%CI = [-0.15, 0.21]). Analysis of the expected proportion of studies with a true effect on non-vocational outcomes with d>0.2 showed some reason to expect a possible improvement for quality of life for at least some settings (Prop = 0.57, 95%CI = [0.30, 0.84]).	[Frederick, Donald E.; VanderWeele, Tyler J.] Harvard Univ, Inst Quantitat Social Sci, Human Flourishing Program, Cambridge, MA 02138 USA; [VanderWeele, Tyler J.] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard T.H. Chan School of Public Health	Frederick, DE (corresponding author), Harvard Univ, Inst Quantitat Social Sci, Human Flourishing Program, Cambridge, MA 02138 USA.	donald_frederick@harvard.edu		Frederick, Donald/0000-0002-7621-8319				[Anonymous], 2006, IS WORK GOOD YOUR HL; Bakker AB, 2011, CURR DIR PSYCHOL SCI, V20, P265, DOI 10.1177/0963721411414534; Barreira PJ, 2010, PSYCHIAT QUART, V81, P139, DOI 10.1007/s11126-010-9124-4; Bejerholm U, 2017, J AFFECT DISORDERS, V207, P212, DOI 10.1016/j.jad.2016.08.028; Bejerholm U, 2015, NORD J PSYCHIAT, V69, P57, DOI 10.3109/08039488.2014.929739; Bond GR, 2007, J CONSULT CLIN PSYCH, V75, P968, DOI 10.1037/0022-006X.75.6.968; Bond GR, 2007, PSYCHIAT SERV, V58, P1412, DOI 10.1176/appi.ps.58.11.1412; Bond GR, 2015, PSYCHIAT SERV, V66, P1027, DOI 10.1176/appi.ps.201400510; Bond GR, 2014, ADM POLICY MENT HLTH, V41, P69, DOI 10.1007/s10488-012-0444-6; Bond GR, 2012, PSYCHIAT SERV, V63, P758, DOI 10.1176/appi.ps.201100476; Bond GR, 1997, REHABIL COUNS BULL, V40, P265; Bond GR, 2004, PSYCHIATR REHABIL J, V27, P345, DOI 10.2975/27.2004.345.359; Burke-Miller J, 2012, PSYCHIATR REHABIL J, V35, P171, DOI 10.2975/35.3.2012.171.179; Burns T, 2007, LANCET, V370, P1146, DOI 10.1016/S0140-6736(07)61516-5; Burns T, 2009, SCHIZOPHRENIA BULL, V35, P949, DOI 10.1093/schbul/sbn024; Davis LL, 2014, PSYCHIATR REHABIL J, V37, P107, DOI 10.1037/prj0000058; Davis LL, 2012, PSYCHIAT SERV, V63, P464, DOI 10.1176/appi.ps.201100340; Dixon L, 2002, PSYCHIATR SERV, V53, P1118, DOI 10.1176/appi.ps.53.9.1118; Drake RE, 1999, ARCH GEN PSYCHIAT, V56, P627, DOI 10.1001/archpsyc.56.7.627; Drake RE, 1996, J CONSULT CLIN PSYCH, V64, P391, DOI 10.1037/0022-006X.64.2.391; Drake RE, 2013, AM J PSYCHIAT, V170, P1433, DOI 10.1176/appi.ajp.2013.13020214; Ellison ML, 2015, J BEHAV HEALTH SER R, V42, P206, DOI 10.1007/s11414-014-9445-4; Fraser VV, 2008, PSYCHIATR REHABIL J, V31, P332, DOI 10.2975/31.4.2008.332.339; Frederick DE, INCREASED JOB CRAFTI; Frounfelker R, 2011, COMMUNITY MENT HLT J, V47, P737, DOI 10.1007/s10597-010-9345-x; Heslin M, 2011, WORLD PSYCHIATRY, V10, P132; Hoffmann H, 2012, ACTA PSYCHIAT SCAND, V125, P157, DOI 10.1111/j.1600-0447.2011.01780.x; Howard LM, 2010, BRIT J PSYCHIAT, V196, P404, DOI 10.1192/bjp.bp.108.061465; Jackel D, 2017, PSYCHIAT SERV, V68, P603, DOI 10.1176/appi.ps.201600083; Johnson-Kwochka A, 2017, ADM POLICY MENT HLTH, V44, P311, DOI 10.1007/s10488-016-0787-5; Kinoshita Y, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008297.pub2; Kukla M, 2013, J VOCAT REHABIL, V38, P91, DOI 10.3233/JVR-130623; Latimer EA, 2006, BRIT J PSYCHIAT, V189, P65, DOI 10.1192/bjp.bp.105.012641; Lehman AF, 2002, ARCH GEN PSYCHIAT, V59, P165, DOI 10.1001/archpsyc.59.2.165; Li-Tsang CWP, 2008, J OCCUP REHABIL, V18, P299, DOI 10.1007/s10926-008-9138-z; Lones CE, 2017, ADM POLICY MENT HLTH, V44, P359, DOI 10.1007/s10488-017-0793-2; Lucas RE, 2004, PSYCHOL SCI, V15, P8, DOI 10.1111/j.0963-7214.2004.01501002.x; Mathur MB, 2017, ARXIV170709076; McGurk SR, 2005, SCHIZOPHRENIA BULL, V31, P898, DOI 10.1093/schbul/sbi037; McGurk SR, 2007, AM J PSYCHIAT, V164, P437, DOI 10.1176/appi.ajp.164.3.437; McGurk SR, 2015, AM J PSYCHIAT, V172, P852, DOI 10.1176/appi.ajp.2015.14030374; McKee-Ryan FM, 2005, J APPL PSYCHOL, V90, P53, DOI 10.1037/0021-9010.90.1.53; Metcalfe JD, 2018, SCHIZOPHRENIA BULL, V44, P22, DOI 10.1093/schbul/sbx132; Michon H, 2014, PSYCHIATR REHABIL J, V37, P129, DOI 10.1037/prj0000061; Modini M, 2016, AUSTRALASIAN PSYCHIA; Modini M, 2016, BRIT J PSYCHIAT, V209, P14, DOI 10.1192/bjp.bp.115.165092; Mueser KT, 2014, PSYCHIATR REHABIL J, V37, P113, DOI 10.1037/prj0000062; Mueser KT, 2005, PSYCHIAT SERV, V56, P1254, DOI 10.1176/appi.ps.56.10.1254; Mueser KT, 2004, J CONSULT CLIN PSYCH, V72, P479, DOI 10.1037/0022-006X.72.3.479; Nordt C, 2015, LANCET PSYCHIAT, V2, P239, DOI 10.1016/S2215-0366(14)00118-7; Oshima I, 2014, PSYCHIATR REHABIL J, V37, P137, DOI 10.1037/prj0000085; Ottomanelli L, 2014, ARCH PHYS MED REHAB, V95, P784, DOI 10.1016/j.apmr.2013.11.012; Ottomanelli L, 2013, QUAL LIFE RES, V22, P2133, DOI 10.1007/s11136-013-0353-5; Ottomanelli L, 2012, ARCH PHYS MED REHAB, V93, P740, DOI 10.1016/j.apmr.2012.01.002; Paul KI, 2009, J VOCAT BEHAV, V74, P264, DOI 10.1016/j.jvb.2009.01.001; Poremski D, 2017, ADM POLICY MENT HLTH, V44, P217, DOI 10.1007/s10488-015-0713-2; Rueda S, 2012, AM J PUBLIC HEALTH, V102, P541, DOI 10.2105/AJPH.2011.300401; Serafini G, 2014, EUR CHILD ADOLES PSY, V23, P1023, DOI 10.1007/s00787-014-0614-z; Sinnott PL, 2014, ARCH PHYS MED REHAB, V95, P1254, DOI 10.1016/j.apmr.2014.01.010; Terkel Studs, 1974, WORKING PEOPLE TALK; Tims M, 2016, J VOCAT BEHAV, V92, P44, DOI 10.1016/j.jvb.2015.11.007; Tsang HWH, 2009, J BEHAV THER EXP PSY, V40, P292, DOI 10.1016/j.jbtep.2008.12.007; Twamley EW, 2012, SCHIZOPHR RES, V135, P100, DOI 10.1016/j.schres.2011.11.036; van Rijn RM, 2016, OCCUP ENVIRON MED, V73, P275, DOI 10.1136/oemed-2015-103121; VanderWeele TJ, 2017, P NATL ACAD SCI USA, V114, P8148, DOI 10.1073/pnas.1702996114; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Viering S, 2015, FRONT PUBLIC HEALTH, V3, DOI 10.3389/fpubh.2015.00237; Waghorn G, 2014, AUST OCCUP THER J, V61, P424, DOI 10.1111/1440-1630.12148; Wong KK, 2008, PSYCHIAT SERV, V59, P84, DOI 10.1176/ps.2008.59.1.84; Zhang GF, 2017, AM J OCCUP THER, V71, DOI 10.5014/ajot.2017.024802	70	58	58	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212208	10.1371/journal.pone.0212208	http://dx.doi.org/10.1371/journal.pone.0212208			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM2OT	30785954	Green Submitted, Green Published, gold			2022-12-27	WOS:000459307000051
J	Miller, BA; Chapwanya, A; Kilminster, T; Scanlon, T; Milton, J; Osorio, H; Oldham, C; Greeff, J; Bergfelt, DR; Campos, AMO; Almeida, AM				Miller, Blake A.; Chapwanya, Aspinas; Kilminster, Tanya; Scanlon, Tim; Milton, John; Osorio, Hugo; Oldham, Chris; Greeff, Johan; Bergfelt, Don R.; Campos, Alexandre M. O.; Almeida, Andre M.			The ovine hepatic mitochondrial proteome: Understanding seasonal weight loss tolerance in two distinct breeds	PLOS ONE			English	Article							AUSTRALIAN MERINO LAMBS; GENETIC-RESOURCES; ANIMAL PRODUCTION; GUINEA-BISSAU; LIVE WEIGHT; GOAT BREEDS; DAMARA; PARAMETERS; MAJORERA; DORPER	Seasonal weight loss (SWL) is a primary constraint for farmers in the Mediterranean and tropics. One cost-effective solution to SWL is utilizing breeds like the Damara sheep that have adapted to deal with nutritional stress. Previous studies concluded that one of the adaptation mechanisms of SWL is a specialized fatty acid metabolism. Accordingly, hepatic-mitochondrial proteomes were compared across two different breeds (24 sheep total, Merino, n = 12 and Damara, n = 12) and two different diets (restricted vs unrestricted diet, 6 per breed, per diet, 24 total). Mitochondrial-proteins were isolated and relatively quantified using Blue native PAGE/2D-electrophoresis and then analyzed via mass spectrometry. The tool ReviGO summarized the proteomes' gene-ontology terms. A total of 50 proteins were identified with 7 changing significantly in abundance (ANOVA p-value<0.05). Specific abundance patterns of corticosteroid and inflammatory response-associated proteins such as annexin and glutamate dehydrogenase suggests that the Damara has an unusual inflammation response when subjected to SWL in addition to its unique metabolism. All significant proteins warrant further study; Annexin in particular shows promise as a potentially useful biomarker.	[Miller, Blake A.; Chapwanya, Aspinas; Bergfelt, Don R.] Ross Univ Sch Vet Med, Dept Clin Sci, Basseterre, St Kitts & Nevi; [Kilminster, Tanya; Scanlon, Tim; Oldham, Chris; Greeff, Johan] Dept Agr & Food Western Australia, Perth, WA, Australia; [Milton, John] Univ Western Australia, Perth, WA, Australia; [Osorio, Hugo] Univ Porto, Inst Invest & Inovacao Saude, Porto, Portugal; [Osorio, Hugo] Univ Porto, Inst Mol Pathol & Immunol, Porto, Portugal; [Osorio, Hugo] Univ Porto, Dept Pathol, Fac Med, Porto, Portugal; [Campos, Alexandre M. O.] Univ Porto, Interdisciplinary Ctr Marine & Environm Res, Matosinhos, Portugal; [Almeida, Andre M.] Univ Lisbon, Inst Super Agron, Linking Landscape Environm Agr & Food, Lisbon, Portugal	University of Western Australia; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade de Lisboa	Almeida, AM (corresponding author), Univ Lisbon, Inst Super Agron, Linking Landscape Environm Agr & Food, Lisbon, Portugal.	aalmeida@isa.ulisboa.pt	Campos, Alexandre/AGP-3558-2022; Almeida, Andre/I-4369-2013; Osorio, Hugo/A-7847-2012	Campos, Alexandre/0000-0003-4621-885X; Almeida, Andre/0000-0002-7810-3988; Scanlon, Timothy/0000-0001-5706-5487; Osorio, Hugo/0000-0002-6362-8255	Fundacao para a Ciencia e a Tecnologia [ROTEIRO/0028/2013, LISBOA-01-0145-FEDER-022125]; Centre for Integrative Mammalian Research of Ross University School of Veterinary Medicine (St. Kitts and Nevis, West Indies); LEAF [UID/AGR/04129/2013]	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Centre for Integrative Mammalian Research of Ross University School of Veterinary Medicine (St. Kitts and Nevis, West Indies); LEAF	Mass spectrometry work was performed at the Proteomics i3S Scientific Platform that has support from the Fundacao para a Ciencia e a Tecnologia (ROTEIRO/0028/2013; LISBOA-01-0145-FEDER-022125). This work was supported by an Intra-Mural grant (Ovinomics II) from the Centre for Integrative Mammalian Research of Ross University School of Veterinary Medicine (St. Kitts and Nevis, West Indies). Author AM Almeida acknowledges funding from LEAF (UID/AGR/04129/2013).	Almeida AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146367; Almeida AM, 2013, TROP ANIM HEALTH PRO, V45, P1305, DOI 10.1007/s11250-013-0361-z; Almeida AM, 2011, TROP ANIM HEALTH PRO, V43, P1427, DOI 10.1007/s11250-011-9868-3; Alves SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077313; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Ceciliani F, 2018, J PROTEOMICS, V178, P92, DOI 10.1016/j.jprot.2017.10.010; Cugno G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151599; de Almeida AM, 2008, TROP ANIM HEALTH PRO, V40, P529, DOI 10.1007/s11250-008-9130-9; de Almeida AM, 2008, TROP ANIM HEALTH PRO, V40, P537, DOI 10.1007/s11250-008-9131-8; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; Eswaramoorthy S, 2006, P NATL ACAD SCI USA, V103, P9832, DOI 10.1073/pnas.0602398103; Ferreira AM, 2017, J PROTEOMICS, V161, P57, DOI 10.1016/j.jprot.2017.03.020; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Lerias JR, 2015, J DAIRY RES, V82, P416, DOI 10.1017/S0022029915000412; Lerias JR, 2013, TROP ANIM HEALTH PRO, V45, P1731, DOI 10.1007/s11250-013-0423-2; Liu AJ, 2011, CANCER EPIDEMIOL, V35, P490, DOI 10.1016/j.canep.2010.10.004; McKenna MC, 2016, ADV NEUROBIOL, V13, P59, DOI 10.1007/978-3-319-45096-4_4; Miller B, 2018, J PROTEOMICS; Mondov? B., 1982, STRUCTURE FUNCTION R, P141; Palma M, 2016, SCI REP-UK, V6, DOI 10.1038/srep39120; Plaitakis A, 2017, BIOLOGY-BASEL, V6, DOI 10.3390/biology6010011; Scanlon TT, 2013, SMALL RUMINANT RES, V109, P101, DOI 10.1016/j.smallrumres.2012.08.004; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Uhlmann T, 2012, MOL CELL PROTEOMICS, V11, P1489, DOI 10.1074/mcp.M112.020743; Vassilopoulos A, 2014, ANTIOXID REDOX SIGN, V21, P551, DOI 10.1089/ars.2013.5420; WALKER JE, 1984, BIOCHIM BIOPHYS ACTA, V768, P164, DOI 10.1016/0304-4173(84)90003-X; Zane NR, 2018, PEDIATR RES, V83, P527, DOI 10.1038/pr.2017.226	28	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212580	10.1371/journal.pone.0212580	http://dx.doi.org/10.1371/journal.pone.0212580			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785939	Green Published, gold, Green Submitted			2022-12-27	WOS:000459307000073
J	Petruzziello, A; Sabatino, R; Loquercio, G; Guzzo, A; Di Capua, L; Labonia, F; Cozzolino, A; Azzaro, R; Botti, G				Petruzziello, Arnolfo; Sabatino, Rocco; Loquercio, Giovanna; Guzzo, Annunziata; Di Capua, Lucia; Labonia, Francesco; Cozzolino, Anna; Azzaro, Rosa; Botti, Gerardo			Nine-year distribution pattern of hepatitis C virus (HCV) genotypes in Southern Italy	PLOS ONE			English	Article							GENERAL-POPULATION; RISK-FACTORS; MOLECULAR EPIDEMIOLOGY; GLOBAL EPIDEMIOLOGY; METROPOLITAN-AREA; VIRAL LOAD; B-VIRUS; INFECTION; PREVALENCE; SUBTYPES	Introduction It has been greatly described that different hepatitis C virus (HCV) genotypes are strictly correlated to various evolution, prognosis and response to therapy during the chronic liver disease. Aim of this study was to outline the changes in the epidemiology of Hepatitis C genotypes in Southern Italy regions from 2006 to 2014. Material/Methods Prevalence of HCV genotypes was analyzed in 535 HCV-RNA positive patients with chronic Hepatitis C infection, selected during the period 2012-2014, and compared with our previous data, referred to periods 2006-2008 and 2009-2011. Results In all the three periods analyzed, genotype 1 b is predominant (51.8% in 2006-08, 48.3% in 2009-11 and 54.4% in 2012-14) while genotype 2 showed an increase in prevalence (27.9% in 2006-08, 31.7% in 2009-11 and 35.2% in 2012-14) and genotypes 3a and 1a a decrease during the same period (6.8% in 2006-08, 4.7% in 2009-11 and 3.2% in 2012-14 and 7.9% in 2006-08, 4.7% in 2009-11 and 2.6% in 2012-14, respectively). Subtype 1 b seems to be equally distributed between males and females (52.7% vs 56.6%) and the prevalence in the age range 31-40 years is significantly higher in the 2012-14 period than in both previous periods (53.8% vs. 16.6% in 2009-11, p < 0.001 and 13.4% in 2006-08, p < 0.001). Conclusions Genotype 1 b is still the most prevalent, even if shows a significantly increase in the under 40 years old population. Instead, genotype 3a seems to have a moderate increase among young people. Overall, the alarming finding is the "returning" role of the iatrogenic transmission as risk factor for the diffusion of Hepatitis C infection.	[Petruzziello, Arnolfo; Sabatino, Rocco; Loquercio, Giovanna; Guzzo, Annunziata; Di Capua, Lucia; Labonia, Francesco; Cozzolino, Anna; Botti, Gerardo] IRCCS Italia, SSD Virol & Mol Biol, Dept Diagnost Area, Ist Nazl Tumori,Fdn G Pascale, Naples, Italy; [Azzaro, Rosa] IRCCS Italia, Transfus Serv, Dept Hemathol, Ist Nazl Tumori,Fdn G Pascale, Naples, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Fondazione Pascale; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Fondazione Pascale	Petruzziello, A (corresponding author), IRCCS Italia, SSD Virol & Mol Biol, Dept Diagnost Area, Ist Nazl Tumori,Fdn G Pascale, Naples, Italy.	a.petruzziello@istitutotumori.na.it	di capua, lucia/D-8605-2019; Labonia, Francesco/AAA-4083-2021; Guzzo, Annunziata/ABF-2550-2020; PETRUZZIELLO, ARNOLFO/O-1163-2017	Labonia, Francesco/0000-0001-5819-1290; Guzzo, Annunziata/0000-0001-5001-6383; PETRUZZIELLO, ARNOLFO/0000-0003-0353-9151; Botti, Gerardo/0000-0002-6287-733X; Sabatino, Rocco/0000-0003-1113-8665				Aguilera A, 2017, J VIRAL HEPATITIS, V24, P725, DOI 10.1111/jvh.12700; Anderson JC, 2003, J CLIN VIROL, V28, P27, DOI 10.1016/S1386-6532(02)00235-4; [Anonymous], 41 ANN M EUR ASS STU; Ansaldi F, 2005, J MED VIROL, V76, P327, DOI 10.1002/jmv.20376; Antaki N, 2013, J VIRAL HEPATITIS, V20, P59, DOI 10.1111/j.1365-2893.2012.01621.x; Blach S, 2017, LANCET GASTROENTEROL, V2, P161, DOI 10.1016/S2468-1253(16)30181-9; Campello C, 2002, INFECTION, V30, P7, DOI 10.1007/s15010-001-1197-4; Cenci M, 2007, ANTICANCER RES, V27, P1219; Cooke GS, 2013, J VIRAL HEPATITIS, V20, P600, DOI 10.1111/jvh.12123; Coppola RC, 2000, J VIRAL HEPATITIS, V7, P130; Dal Molin G, 2002, J MED VIROL, V68, P352, DOI 10.1002/jmv.10210; De Conto F, 2016, ARCH VIROL, V161, P2727, DOI 10.1007/s00705-016-2975-8; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Grimaldi E, 2017, INTERVIROLOGY, V60, P82, DOI 10.1159/000481821; Guadagnino V, 1997, HEPATOLOGY, V26, P1006, DOI 10.1053/jhep.1997.v26.pm0009328327; Guadagnino V, 2013, DIGEST LIVER DIS, V45, P403, DOI 10.1016/j.dld.2012.10.014; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Haldeda M, 2014, INT J INFECT DIS, V18, P90, DOI 10.1016/j.ijid.2013.08.015; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Karmochkine M, 2006, J VIRAL HEPATITIS, V13, P775, DOI 10.1111/j.1365-2893.2006.00742.x; Magiorkinis G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000198; Maio G, 2000, J HEPATOL, V33, P116, DOI 10.1016/S0168-8278(00)80167-1; Marascio N, 2014, BMC INFECT DIS S5, V14, P52; Marascio N, 2014, INFECT GENET EVOL, V26, P352, DOI 10.1016/j.meegid.2014.06.006; Martin NK, 2013, CLIN INFECT DIS, V57, pS39, DOI 10.1093/cid/cit296; Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259; Negro F, 2014, DIGEST LIVER DIS, V46, pS158, DOI 10.1016/j.dld.2014.09.023; Osella AR, 2001, CLIN INFECT DIS, V33, P70, DOI 10.1086/320887; PAWLOTSKY JM, 1995, J INFECT DIS, V171, P1607, DOI 10.1093/infdis/171.6.1607; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Petruzziello A, 2018, J MED VIROL; Petruzziello Arnolfo, 2018, Open Virol J, V12, P26, DOI 10.2174/1874357901812010026; Petruzziello A, 2017, INFECT AGENTS CANCER, V12, DOI 10.1186/s13027-017-0162-5; Petruzziello A, 2016, INFECT AGENTS CANCER, V11, DOI 10.1186/s13027-016-0099-0; Petruzziello A, 2016, WORLD J GASTROENTERO, V22, P7824, DOI 10.3748/wjg.v22.i34.7824; Petruzziello A, 2014, INTERVIROLOGY, V57, P311, DOI 10.1159/000363386; Petruzziello A, 2013, INTERVIROLOGY, V56, P206, DOI 10.1159/000348506; Pybus Oliver G, 2005, Infect Genet Evol, V5, P131, DOI 10.1016/j.meegid.2004.08.001; Pybus OG, 2009, J VIROL, V83, P1071, DOI 10.1128/JVI.01501-08; Raffaele A, 2001, EUR J EPIDEMIOL, V17, P41, DOI 10.1023/A:1010932832190; Razavi H, 2014, J VIRAL HEPATITIS, V21, P34, DOI 10.1111/jvh.12248; Roffi L, 1998, J HEPATOL, V29, P701, DOI 10.1016/S0168-8278(98)80249-3; Romeo R, 2018, EPIDEMIOL INFECT, V146, P1612, DOI [10.1017/S0950268818001942, 10.1017/s0950268818001942]; SAGNELLI E, 1991, INFECTION, V19, P155, DOI 10.1007/BF01643238; Sereno S, 2009, J CLIN VIROL, V45, P354, DOI 10.1016/j.jcv.2009.04.022; SIMMONDS P, 1994, HEPATOLOGY, V19, P1321, DOI 10.1016/0270-9139(94)90887-7; Simmonds P, 2001, J GEN VIROL, V82, P693, DOI 10.1099/0022-1317-82-4-693; Smith DB, 1997, J GEN VIROL, V78, P321, DOI 10.1099/0022-1317-78-2-321; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Stamouli M, 2012, CLIN LAB, V58, P173; STROFFOLINI T, 1992, HEPATO-GASTROENTEROL, V39, P62; Svirtlih N, 2007, WORLD J GASTROENTERO, V13, P355, DOI 10.3748/wjg.v13.i3.355; Wedemeyer H, 2014, J VIRAL HEPATITIS, V21, P60, DOI 10.1111/jvh.12249; Wyles DL, 2014, J VIRAL HEPATITIS, V21, P229, DOI 10.1111/jvh.12230; Zhang Y, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0710-z	55	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212033	10.1371/journal.pone.0212033	http://dx.doi.org/10.1371/journal.pone.0212033			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785909	gold, Green Published, Green Submitted			2022-12-27	WOS:000459307000047
J	Garcia-Ramos, A; Ulloa-Diaz, D; Barboza-Gonzalez, P; Rodriguez-Perea, A; Martinez-Garcia, D; Quidel-Catrilelbun, M; Guede-Rojas, F; Cuevas-Aburto, J; Janicijevic, D; Weakley, J				Garcia-Ramos, Amador; Ulloa-Diaz, David; Barboza-Gonzalez, Paola; Rodriguez-Perea, Angela; Martinez-Garcia, Dario; Quidel-Catrilelbun, Mauricio; Guede-Rojas, Francisco; Cuevas-Aburto, Jesualdo; Janicijevic, Danica; Weakley, Jonathon			Assessment of the load-velocity profile in the free-weight prone bench pull exercise through different velocity variables and regression models	PLOS ONE			English	Article							MOVEMENT VELOCITY; PERFORMANCE; INTENSITY; STRENGTH; PRESS	This aims of this study were (I) to determine the velocity variable and regression model which best fit the load-velocity relationship during the free-weight prone bench pull exercise, (II) to compare the reliability of the velocity attained at each percentage of the one-repetition maximum (1RM) between different velocity variables and regression models, and (III) to compare the within-and between-subject variability of the velocity attained at each %1RM. Eighteen men (14 rowers and four weightlifters) performed an incremental test during the free-weight prone bench pull exercise in two different sessions. General and individual load-velocity relationships were modelled through three velocity variables (mean velocity [MV], mean propulsive velocity [MPV] and peak velocity [PV]) and two regression models (linear and second-order polynomial). The main findings revealed that (I) the general (Pearson's correlation coefficient [r] range = 0.964-0.973) and individual (median r = 0.986 for MV, 0.989 for MPV, and 0.984 for PV) load-velocity relationships were highly linear, (II) the reliability of the velocity attained at each %1RM did not meaningfully differ between the velocity variables (coefficient of variation [ CV] range = 2.55-7.61% for MV, 2.84-7.72% for MPV and 3.50-6.03% for PV) neither between the regression models (CV range = 2.55-7.72% and 2.73-5.25% for the linear and polynomial regressions, respectively), and (III) the within-subject variability of the velocity attained at each % 1RM was lower than the between-subject variability for the light-moderate loads. No meaningful differences between the within-and between-subject CVs were observed for the MV of the 1RM trial (6.02% vs. 6.60%; CVratio = 1.10), while the within-subject CV was lower for PV (6.36% vs. 7.56%; CVratio = 1.19). These results suggest that the individual load-MV relationship should be determined with a linear regression model to obtain the most accurate prescription of the relative load during the free-weight prone bench pull exercise.	[Garcia-Ramos, Amador; Rodriguez-Perea, Angela; Martinez-Garcia, Dario] Univ Granada, Fac Sport Sci, Dept Phys Educ & Sport, Granada, Spain; [Garcia-Ramos, Amador; Ulloa-Diaz, David; Quidel-Catrilelbun, Mauricio; Cuevas-Aburto, Jesualdo] Catholic Univ Most Holy Concepcion, Dept Sports Sci & Phys Conditioning, Fac Educ, CIEDE, Concepcion, Chile; [Barboza-Gonzalez, Paola] Univ Andres Bello, Fac Educ, Concepcion, Chile; [Guede-Rojas, Francisco] Univ Andres Bello, Fac Rehabil Sci, Concepcion, Chile; [Janicijevic, Danica] Univ Belgrade, Res Ctr, Fac Sport & Phys Educ, Belgrade, Serbia; [Weakley, Jonathon] Leeds Beckett Univ, Inst Sport Phys Act & Leisure, Leeds, W Yorkshire, England	University of Granada; Universidad Catolica de la Santisima Concepcion; Universidad Andres Bello; Universidad Andres Bello; University of Belgrade; Leeds Beckett University	Garcia-Ramos, A (corresponding author), Univ Granada, Fac Sport Sci, Dept Phys Educ & Sport, Granada, Spain.; Garcia-Ramos, A (corresponding author), Catholic Univ Most Holy Concepcion, Dept Sports Sci & Phys Conditioning, Fac Educ, CIEDE, Concepcion, Chile.	amagr@ugr.es	Weakley, Jonathon/AAJ-2182-2020; Guede, Francisco/AAD-3561-2019; Ramos, Amador Garcia/S-6982-2016; Janićijević, Danica/AAA-9861-2020; RODRIGUEZ PEREA, ANGELA/B-6638-2019; Garcia, Dario Martinez/Q-2872-2016; Martínez-García, Darío/O-4742-2019	Weakley, Jonathon/0000-0001-7892-4885; Guede, Francisco/0000-0002-1870-1396; Ramos, Amador Garcia/0000-0003-0608-8755; Janićijević, Danica/0000-0001-9925-7751; RODRIGUEZ PEREA, ANGELA/0000-0001-5155-1337; Martínez-García, Darío/0000-0003-0077-6813; Ulloa-Diaz, David/0000-0003-1288-1397				Banyard HG, 2018, INT J SPORT PHYSIOL, V13, P763, DOI 10.1123/ijspp.2017-0610; Conceicao F, 2016, J SPORT SCI, V34, P1099, DOI 10.1080/02640414.2015.1090010; Cormack SJ, 2008, INTJ SPORT PHYSIOL, V3, P131, DOI 10.1123/ijspp.3.2.131; Dong JG, 2016, EXP THER MED, V11, P1531, DOI 10.3892/etm.2016.3104; Fernandes JFT, 2021, J STRENGTH COND RES, V35, P1760, DOI 10.1519/JSC.0000000000002952; Fulton SK, 2009, J SPORT SCI, V27, P535, DOI 10.1080/02640410802641418; Garcia- Ramos A, 2018, INT J SPORTS SCI COA, DOI [10.1177/1747954118791525b, DOI 10.1177/1747954118791525B]; Garcia-Ramos A, 2018, STRENGTH COND J, V40, P54, DOI 10.1519/SSC.0000000000000359; Garcia-Ramos A, 2018, J STRENGTH COND RES, V32, P1273, DOI 10.1519/JSC.0000000000001998; Garcia-Ramos A, 2018, INT J SPORT PHYSIOL, V13, P326, DOI 10.1123/ijspp.2017-0158; Garcia-Ramos A, 2018, INT J SPORT PHYSIOL, V13, P474, DOI 10.1123/ijspp.2017-0374; Gonzalez-Badillo JJ, 2010, INT J SPORTS MED, V31, P347, DOI 10.1055/s-0030-1248333; Gonzalez-Hernandez JM, 2020, J STRENGTH COND RES, V34, P1581, DOI 10.1519/JSC.0000000000002117; Harris NK, 2010, STRENGTH COND J, V32, P66, DOI 10.1519/SSC.0b013e3181eb341b; Helms ER, 2017, J STRENGTH COND RES, V31, P292, DOI 10.1519/JSC.0000000000001517; Hopkins W., NEW VIEW STAT 2000; Jidovtseff B, 2011, J STRENGTH COND RES, V25, P267, DOI 10.1519/JSC.0b013e3181b62c5f; Jovanovic M., 2014, J AUST STRENGTH COND, V22, P58; Loturco I, 2021, J STRENGTH COND RES, V35, P300, DOI 10.1519/JSC.0000000000002543; Pestana-Melero FL, 2018, J APPL BIOMECH, V34, P184, DOI 10.1123/jab.2017-0266; Mann JB, 2015, STRENGTH COND J, V37, P52, DOI 10.1519/SSC.0000000000000177; Peart DJ, 2019, J STRENGTH COND RES, V33, P1167, DOI 10.1519/JSC.0000000000002344; Perez-Castilla A, 2020, J STRENGTH COND RES, V34, P1024, DOI 10.1519/JSC.0000000000002072; Picerno P, 2016, EUR J APPL PHYSIOL, V116, P2035, DOI 10.1007/s00421-016-3457-0; Randell AD, 2011, J STRENGTH COND RES, V25, P87, DOI 10.1519/JSC.0b013e3181fee634; Sanchez-Medina L, 2014, INT J SPORTS MED, V35, P209, DOI 10.1055/s-0033-1351252; Sanchez-Medina L, 2010, INT J SPORTS MED, V31, P123, DOI 10.1055/s-0029-1242815; Sanchez-Medina L, 2011, MED SCI SPORT EXER, V43, P1725, DOI 10.1249/MSS.0b013e318213f880; Weakley JJS, 2019, J STRENGTH COND RES, V33, P2420, DOI 10.1519/JSC.0000000000002133	29	24	24	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0212085	10.1371/journal.pone.0212085	http://dx.doi.org/10.1371/journal.pone.0212085			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811432	Green Published, gold, Green Accepted			2022-12-27	WOS:000459806400052
J	Simon, M; Bosset, PO; Rouanne, M; Benhamou, S; Radulescu, C; Molinie, V; Neuzillet, Y; Paoletti, X; Lebret, T				Simon, Marie; Bosset, Pierre-Olivier; Rouanne, Mathieu; Benhamou, Simone; Radulescu, Camelia; Molinie, Vincent; Neuzillet, Yann; Paoletti, Xavier; Lebret, Thierry			Multiple recurrences and risk of disease progression in patients with primary low-grade (TaG1) non-muscle-invasive bladder cancer and with low and intermediate EORTC-risk score	PLOS ONE			English	Article							BACILLUS-CALMETTE-GUERIN; FOLLOW-UP; UROTHELIAL CARCINOMA; IMPACT; FGFR3	Aim To assess the prognostic value of multiple recurrences on the risk of progression in a large cohort of TaG1 bladder cancer of low and intermediate risk based on the EORTC score and to evaluate prognostic factors of multiple recurrences. Materials and methods We retrospectively analyzed a French cohort of 470 patients with primary TaG1 bladder cancer diagnosed between 1986 and 2010 and followed until 2012. They were classified at low and intermediate risk using the EORTC risk score. Associations between the number of recurrences and the risk of progression to high grade Ta/T1 bladder cancer and progression to muscle-invasive disease were assessed. The characteristics of recurrences, as occurrence time or localization, and risk of other recurrences were evaluated. Results Out of 470 patients, 251 had recurrence, 34 progressed to high grade Ta/T1 and 17 to muscle-invasive disease, including 4 who had non muscle-invasive progression first. The median follow-up was 7.2 years (interquartile range: 4.2-10.9). In half the progressions, no previous recurrence was observed. No association between the number of recurrences and the risk of progression was detected. Even after 5 years free of event, patients had a 15% risk of recurrence. History of two or more recurrences increased by 4.5 the risk of subsequent recurrence. Time between two recurrences inferior to six months and multifocal localization increased the risk of recurrence. Conclusion Surveillance of patients with TaG1 should be continued beyond 5 years of follow-up. However, cystoscopy exams could be spaced after 5 years. Multiple TaG1 recurrences did not appear to be prognostic for disease progression, but increased significantly the risk of subsequent recurrences. Short time between two recurrences and multifocal localization may serve to adapt monitoring of patients with TaG1 Bladder cancer.	[Simon, Marie; Paoletti, Xavier] Univ Paris Saclay, UVSQ, Inst Gustave Roussy, Serv Biostat & Epidemiol, Villejuif, France; [Simon, Marie; Paoletti, Xavier] Univ Paris Saclay, UVSQ, Inst Gustave Roussy, CESP OncoStat,INSERM, Villejuif, France; [Bosset, Pierre-Olivier; Rouanne, Mathieu; Neuzillet, Yann; Lebret, Thierry] Univ Paris Saclay, UVSQ, Hop Foch, Dept Urol, Suresnes, France; [Benhamou, Simone] INSERM, UMR 946, Genet Variat & Human Dis Unit, Paris, France; [Radulescu, Camelia] Univ Paris Saclay, UVSQ, Hop Foch, Dept Pathol, Suresnes, France; [Molinie, Vincent] Univ Hosp Martinique, Dept Pathol, Fort De France, Martinique, France	UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Hospital Foch; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Hospital Foch; UDICE-French Research Universities; Universite Paris Saclay; CHU Martinique	Paoletti, X (corresponding author), Univ Paris Saclay, UVSQ, Inst Gustave Roussy, Serv Biostat & Epidemiol, Villejuif, France.; Paoletti, X (corresponding author), Univ Paris Saclay, UVSQ, Inst Gustave Roussy, CESP OncoStat,INSERM, Villejuif, France.	xavier.paoletti@gustaveroussy.fr	Rouanne, Mathieu/AAU-9095-2021; Benhamou, Simone/K-6554-2015; Benhamou, Simone/ABD-2590-2020	Rouanne, Mathieu/0000-0003-2970-4821; RADULESCU, Camelia/0000-0002-3704-8679				Aveyard P, 2002, BJU INT, V90, P228, DOI 10.1046/j.1464-410X.2002.02880.x; Babjuk M., 2018, EUROPEAN ASS UROLOGY; Balan D, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010522; Bosset PO, 2015, UROL ONCOL-SEMIN ORI, V33, DOI 10.1016/j.urolonc.2014.09.001; Dafni U, 2011, CIRC-CARDIOVASC QUAL, V4, P363, DOI 10.1161/CIRCOUTCOMES.110.957951; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fernandez-Gomez J, 2008, EUR UROL, V53, P992, DOI 10.1016/j.eururo.2007.10.006; Giobbie-Hurder Anita, CLIN ONCOL, V31, P2963; Golabesk T, 2017, UROLOGY, V100, P145, DOI 10.1016/j.urology.2016.07.063; Gui-shuang Y, STAT ANAL CLUSTERED; Guy L, 2006, EUR UROL, V50, P516, DOI 10.1016/j.eururo.2006.03.022; Hedegaard J, 2016, CANCER CELL, V30, P27, DOI 10.1016/j.ccell.2016.05.004; Hernandez S, 2006, J CLIN ONCOL, V24, P3664, DOI 10.1200/JCO.2005.05.1771; Hong YM, 2008, UROLOGY, V71, P131, DOI 10.1016/j.urology.2007.08.014; Kamat AM, 2016, LANCET, V388, P2796, DOI 10.1016/S0140-6736(16)30512-8; Knowles MA, 2007, WORLD J UROL, V25, P581, DOI 10.1007/s00345-007-0213-4; Le Goux C, 2013, PROG UROL, V23, P399, DOI 10.1016/j.purol.2013.01.025; Lujan S, 2014, ACTAS UROL ESP; Mongiat-Artus P, 2010, PROG UROL, V20, pS54, DOI 10.1016/S1166-7087(10)70043-9; Rieken M, 2014, EUR UROL, V65, P201, DOI 10.1016/j.eururo.2013.08.034; Roupret M, CCAFU FRENCH NATL GU; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; Tian YJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158891; van Rhijn BWG, 2010, EUR UROL, V58, P433, DOI 10.1016/j.eururo.2010.05.043; van Rhijn BWG, 2009, EUR UROL, V56, P430, DOI 10.1016/j.eururo.2009.06.028; VAUPEL JW, 1979, DEMOGRAPHY, V16, P439, DOI 10.2307/2061224; Vollmer RT, 2016, AM J CLIN PATHOL, V146, P215, DOI [10.1093/AJCP/AQW103, 10.1093/ajcp/aqw103]; Zieger K, 2000, BJU INT, V85, P824, DOI 10.1046/j.1464-410x.2000.00547.x	29	10	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211721	10.1371/journal.pone.0211721	http://dx.doi.org/10.1371/journal.pone.0211721			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811419	Green Published, Green Submitted, gold			2022-12-27	WOS:000459806400031
J	Zevallos-Morales, A; Luna-Porta, L; Medina-Salazar, H; Yauri, M; Taype-Rondan, A				Zevallos-Morales, Alejandro; Luna-Porta, Leslie; Medina-Salazar, Henry; Yauri, Maria; Taype-Rondan, Alvaro			Association between migration and physical activity among medical students from a university located in Lima, Peru	PLOS ONE			English	Article							PERCEIVED BARRIERS; RISK-FACTORS; HEALTH; EXERCISE; ACCULTURATION; ATTITUDES; BENEFITS; DISEASE	Objective To evaluate the association between migration and physical activity among medical students from a university located in Lima, Peru. Methods A cross-sectional study was conducted among second-year medical students from a Peruvian university. Data on moderate-to vigorous-intensity physical activity (MVPA) and migration features were obtained through a self-report questionnaire. To assess the associations of interest, prevalence ratios (PR) along with their 95% confidence intervals (95% CI) were calculated using Poisson regression with robust variances. Results We analyzed data from 312 students (54.5% were women, mean age: 19.0 years, standard deviation: 1.4 years), 90 (28.9%) students performed MVPA for >= 150 minutes/week, 118 (37.8%) performed MVPA for <= 30 minutes/week, and 114 (36.7%) were migrants. Being a migrant was not associated with performing MVPA for <= 30 nor >= 150 minutes/week. However, adjusted analysis showed that the frequency of performing MVPA for <= 30 minutes/week was greater among those who migrated less than five years ago (PR: 1.43; 95% CI: 1.05-1.93) and among those who migrated to continue their studies (PR: 1.44; 95% CI: 1.06-1.94), compared to non-migrants. Conclusion In our population, being a migrant was not associated with physical activity. However, low physical activity was more prevalent among recent migrants and among those who had migrated to study, compared to non-migrants.	[Zevallos-Morales, Alejandro; Luna-Porta, Leslie; Medina-Salazar, Henry; Yauri, Maria] Univ San Martin Porres, Fac Med Humana, Lima, Peru; [Taype-Rondan, Alvaro] Univ San Ignacio Loyola, Unidad Invest Generac & Sintesis Evidencias Salud, Lima, Peru	Universidad de San Martin de Porres; Universidad San Ignacio de Loyola	Taype-Rondan, A (corresponding author), Univ San Ignacio Loyola, Unidad Invest Generac & Sintesis Evidencias Salud, Lima, Peru.	alvaro.taype.r@gmail.com	Zevallos-Morales, Alejandro/AAR-3045-2020	Zevallos-Morales, Alejandro/0000-0002-5314-8469; Yauri Santiago, Maria Victoria/0000-0003-0633-0468; Luna, Leslie/0000-0002-7227-3521				Ainsworth B, 2015, PROG CARDIOVASC DIS, V57, P387, DOI 10.1016/j.pcad.2014.10.005; Al-Drees A, 2016, MED TEACH, V38, pS66, DOI 10.3109/0142159X.2016.1142516; Anand T, 2011, KNOWLEDGE ATTITUDE L; Aslam F., 2004, JPMA Journal of the Pakistan Medical Association, V54, P492; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Brown SA, 2005, AM J HEALTH BEHAV, V29, P107, DOI 10.5993/AJHB.29.2.2; Chinn DJ, 1999, J EPIDEMIOL COMMUN H, V53, P191, DOI 10.1136/jech.53.3.191; Coutinho Leticia M S, 2008, Rev. Saúde Pública, V42, P992, DOI 10.1590/S0034-89102008000600003; Creber RMM, 2010, REV PANAM SALUD PUBL, V28, P1, DOI 10.1590/S1020-49892010000700001; Desa U., 2011, WORLD URB PROSP 2011, V505; Dogra Shilpa, 2010, Int J Behav Nutr Phys Act, V7, P75, DOI 10.1186/1479-5868-7-75; Ebrahim S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000268; El Ansari Walid, 2014, Glob J Health Sci, V6, P274, DOI 10.5539/gjhs.v6n5p274; Frank E, 2008, MED SCI SPORT EXER, V40, P413, DOI [10.1249/MSS.0b013e31815ff399, 10.1249/mss.0b013e31815ff399]; Gerber M, 2012, J PUBLIC HEALTH-HEID, V20, P313, DOI 10.1007/s10389-011-0443-1; Gomez-Lopez M, 2010, J SPORT SCI MED, V9, P374; Gyurcsik NC, 2006, J ADOLESCENT HEALTH, V38, P704, DOI 10.1016/j.jadohealth.2005.06.007; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Holtz KA, 2013, CAN FAM PHYSICIAN, V59, pE26; Hui SSC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115098; Informatica INdEe, 2018, LIM ALB 9 MILL 320 M; Kagotho N, 2011, J HUM BEHAV SOC ENVI, V21, P540, DOI 10.1080/10911359.2011.580243; Koya DL, 2007, J GEN INTERN MED, V22, P841, DOI 10.1007/s11606-007-0163-y; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lovell GP, 2010, INT J ENV RES PUB HE, V7, P784, DOI 10.3390/ijerph7030784; Lyngdoh T, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-2; Migration IOf, 2015, WORLD MIGR REP 2015; Nacar Melis, 2015, Asian Pac J Cancer Prev, V16, P7675; Oyebode O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122747; Patel RB, 2009, NEW ENGL J MED, V361, P741, DOI 10.1056/NEJMp0810878; Perez Lilian G., 2016, HEALTH EDUC BEHAV; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Ramirez-Velez R, 2014, PREVALENCIA BARRERAS, V31, P858; Rodriguez F, 2013, NUTR HOSP, V28, P447, DOI 10.3305/nh.2013.28.2.6230; Rodriguez Vignoli J., 2004, MIGRACION INTERNA AM; Salinas EM, 2009, PERU MIGRACIONES INT; Sallis JF, 2000, RES Q EXERCISE SPORT, V71, pS1, DOI 10.1080/02701367.2000.11082780; Schwartz SJ, 2010, AM PSYCHOL, V65, P237, DOI 10.1037/a0019330; Statistics ABo, 2006, MIGR PART SPORT PHYS; Steptoe A, 2002, PREV MED, V35, P97, DOI 10.1006/pmed.2002.1048; Thomas RN, 1971, PUBLICATION SERIES C; Tremblay MS, 2006, CAN J PUBLIC HEALTH, V97, P277, DOI 10.1007/BF03405603; Tremblay MS, 2011, APPL PHYSIOL NUTR ME, V36, P47, DOI 10.1139/H11-010; Wald A, 2014, AM J HEALTH PROMOT, V28, P298, DOI 10.4278/ajhp.120518-QUAN-265; Warburton DER, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-39; WHO, 2017, GLOB HLTH RISKS MORT; WOLF TM, 1984, J MED EDUC, V59, P806	47	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0212009	10.1371/journal.pone.0212009	http://dx.doi.org/10.1371/journal.pone.0212009			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM9LQ	30811427	gold, Green Submitted, Green Published			2022-12-27	WOS:000459806400044
J	Stettz, S; Zaitchik, BF; Ademe, D; Musie, S; Simane, B				Stettz, Stephanie; Zaitchik, Benjamin F.; Ademe, Dereje; Musie, Sintayehu; Simane, Belay			Estimating variability in downwelling surface shortwave radiation in a tropical highland environment	PLOS ONE			English	Article							GLOBAL SOLAR-RADIATION; BUILDING CLIMATE RESILIENCE; BLUE NILE/ABAY HIGHLANDS; PRODUCTS; MODELS; SYSTEM	Surface incoming shortwave (solar) radiation data are an important component of many scientific analyses, but direct measurements are not commonly available. Estimates can be obtained from gridded meteorological analysis or reanalysis systems, such as the Global Data Assimilation Systems (GDAS) and Modern Era Retrospective Reanalysis System (MERRA-2), or calculated using empirical models dependent on meteorological variables such as air temperature. The purpose of this analysis was to compare multiple methods for estimating daily shortwave radiation in a tropical highland environment in Ethiopia. Direct solar radiation outputs of GDAS and MERRA-2, topographically corrected outputs of the two analysis systems, and empirically estimated solar radiation values calculated with the systems' air temperature data were compared to see which produced the most reliable radiation values. GDAS appeared to underestimate the seasonal variability, resulting in low correlation (R-2) with in situ data and large mean bias error (MBE). In comparison, MERRA-2 did not underestimate variability, but produced larger bias than the empirical model estimates. There was an improvement in correlation and reduction in MBE when using the GDAS air temperature predictions in the empirical model, but the opposite was true for MERRA-2. The empirical model using station air temperature data (stationT) produced the highest correlation across all four stations, with best performance at the lower elevation sites. The direct shortwave radiation outputs of MERRA-2 produced comparable correlation values, with larger R-2 at stations at higher elevation. Topography possibly influenced these results, as MERRA-2 performed comparably to stationT at the stations in moderate terrain, but not in steeper terrain. This work can serve as a starting point for analyses in other tropical highland regions, where continuous in situ solar radiation data are rarely available.	[Stettz, Stephanie; Zaitchik, Benjamin F.] Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA; [Ademe, Dereje; Musie, Sintayehu] Debre Markos Univ, Debre Markos, Amhara, Ethiopia; [Simane, Belay] Addis Ababa Univ, Coll Dev Studies, Addis Ababa, Ethiopia	Johns Hopkins University; Addis Ababa University	Zaitchik, BF (corresponding author), Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA.	zaitchik@jhu.edu	Birhan, Dereje/GRO-6552-2022; Zaitchik, Benjamin/AAB-3298-2020	Zaitchik, Benjamin/0000-0002-0698-0658; Mulugeta, Sintayehu Musie/0000-0001-8510-1983	U.S. National Science Foundation, Directorate for Geosciences [GEO-1211235]	U.S. National Science Foundation, Directorate for Geosciences	Funded by U.S. National Science Foundation, Directorate for Geosciences, Grant GEO-1211235 (BFZ).	Allen RG, 56 FAO, P15; Almorox J, 2011, APPL ENERG, V88, P1703, DOI 10.1016/j.apenergy.2010.11.003; Almorox J, 2008, INTERCIENCIA, V33, P280; Almorox J, 2013, RENEW ENERG, V60, P382, DOI 10.1016/j.renene.2013.05.033; Almorox J, 2011, TURK J PHYS, V35, P53, DOI 10.3906/fiz-0912-20; Boilley A, 2015, RENEW ENERG, V75, P135, DOI 10.1016/j.renene.2014.09.042; BRISTOW KL, 1984, AGR FOREST METEOROL, V31, P159, DOI 10.1016/0168-1923(84)90017-0; DERBER JC, 1991, WEATHER FORECAST, V6, P538, DOI 10.1175/1520-0434(1991)006<0538:TNGOAS>2.0.CO;2; Deressa TT, 2009, J AFR ECON, V18, P529, DOI 10.1093/jae/ejp002; Dingman S., 2002, PHYS HYDROLOGY; Dinku T, 2008, INT J REMOTE SENS, V29, P4097, DOI 10.1080/01431160701772526; Donatelli M, 1998, P 5 EUROPEAN SOC AGR, VII, P133; Gelaro R, 2017, J CLIMATE, V30, P5419, DOI 10.1175/JCLI-D-16-0758.1; Goodin DG, 1999, AGRON J, V91, P845, DOI 10.2134/agronj1999.915845x; HARGREAVES GH, 1982, J IRR DRAIN DIV-ASCE, V108, P225; Hassan MA, 2018, RENEW SUST ENERG REV, V82, P1565, DOI 10.1016/j.rser.2017.07.002; Hassan MA, 2017, APPL ENERG, V203, P897, DOI 10.1016/j.apenergy.2017.06.104; Hirpa FA, 2010, J APPL METEOROL CLIM, V49, P1044, DOI 10.1175/2009JAMC2298.1; Hussain S, 2017, APPL ENERG, V208, P540, DOI 10.1016/j.apenergy.2017.09.100; Quej VH, 2017, J ATMOS SOL-TERR PHY, V155, P62, DOI 10.1016/j.jastp.2017.02.002; Quej VH, 2017, J CLEAN PROD, V141, P75, DOI 10.1016/j.jclepro.2016.09.062; Quej VH, 2016, ENERG CONVERS MANAGE, V110, P448, DOI 10.1016/j.enconman.2015.12.050; Rigollier C, 2004, SOL ENERGY, V77, P159, DOI 10.1016/j.solener.2004.04.017; Romilly TG, 2011, HYDROL EARTH SYST SC, V15, P1505, DOI 10.5194/hess-15-1505-2011; Silva V. J. da, 2016, Australian Journal of Crop Science, V10, P926, DOI 10.21475/ajcs.2016.10.07.p7301; Simane B, 2012, INT J ENV RES PUB HE, V9, P610, DOI 10.3390/ijerph9020610; Vancutsem C, 2010, REMOTE SENS ENVIRON, V114, P449, DOI 10.1016/j.rse.2009.10.002; Zaitchik BF, 2012, INT J ENV RES PUB HE, V9, P435, DOI 10.3390/ijerph9020435; Zhang JY, 2017, RENEW SUST ENERG REV, V70, P314, DOI 10.1016/j.rser.2016.11.124	29	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2019	14	2							e0211220	10.1371/journal.pone.0211220	http://dx.doi.org/10.1371/journal.pone.0211220			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EH	30802255	gold, Green Submitted, Green Published			2022-12-27	WOS:000459710700005
J	Babacic, H; Mehta, A; Merkel, O; Schoser, B				Babacic, Haris; Mehta, Aditi; Merkel, Olivia; Schoser, Benedikt			CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion diseases: A systematic review	PLOS ONE			English	Review							CONTROL CELL-LINE; RESTORES DYSTROPHIN EXPRESSION; PLURIPOTENT STEM-CELLS; MUSCULAR-DYSTROPHY; IN-VIVO; MOUSE MODEL; HOMOLOGOUS RECOMBINATION; HUNTINGTONS-DISEASE; PRECISE CORRECTION; GENOME	Introduction The system of clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated proteins (cas) is a new technology that allows easier manipulation of the genome. Its potential to edit genes opened a new door in treatment development for incurable neurological monogenic diseases (NMGDs). The aim of this systematic review was to summarise the findings on the current development of CRISPR-cas for therapeutic purposes in the most frequent NMGDs and provide critical assessment. Methods and data acquisition We searched the MEDLINE and EMBASE databases, looking for original studies on the use of CRISPR-cas to edit pathogenic variants in models of the most frequent NMGDs, until end of 2017. We included all the studies that met the following criteria: 1. Peer-reviewed study report with explicitly described experimental designs; 2. In vitro, ex vivo, or in vivo study using human or other animal biological systems (including cells, tissues, organs, organisms); 3. focusing on CRISPR as the gene-editing method of choice; and 5. featured at least one NMGD. Results We obtained 404 papers from MEDLINE and 513 from EMBASE. After removing the duplicates, we screened 490 papers by title and abstract and assessed them for eligibility. After reading 50 full-text papers, we finally selected 42 for the review. Discussion Here we give a systematic summary on the preclinical development of CRISPR-cas for therapeutic purposes in NMGDs. Furthermore, we address the clinical interpretability of the findings, giving a comprehensive overview of the current state of the art. Duchenne's muscular dystrophy (DMD) paves the way forward, with 26 out of 42 studies reporting different strategies on DMD gene editing in different models of the disease. Most of the strategies aimed for permanent exon skipping by deletion with CRISPR-cas. Successful silencing of the mHTT gene with CRISPR-cas led to successful reversal of the neurotoxic effects in the striatum of mouse models of Huntington's disease. Many other strategies have been explored, including epigenetic regulation of gene expression, in cellular and animal models of: myotonic dystrophy, Fraxile X syndrome, ataxias, and other less frequent dystrophies. Still, before even considering the clinical application of CRISPR-cas, three major bottlenecks need to be addressed: efficacy, safety, and delivery of the systems. This requires a collaborative approach in the research community, while having ethical considerations in mind.	[Babacic, Haris; Schoser, Benedikt] Ludwig Maximilians Univ Munchen, Friedrich Baur Inst, Dept Neurol, Munich, Germany; [Mehta, Aditi; Merkel, Olivia] Ludwig Maximilians Univ Munchen, Fac Pharm, Munich, Germany	University of Munich; University of Munich	Babacic, H; Schoser, B (corresponding author), Ludwig Maximilians Univ Munchen, Friedrich Baur Inst, Dept Neurol, Munich, Germany.	haris.babacic@gmail.com; benedikt.schoser@med.uni-muenchen.de	Schoser, Benedikt/AAH-6286-2020; Babačić, Haris/AAU-9224-2021; Merkel, Olivia M/A-9772-2010	Babačić, Haris/0000-0003-0813-0005; Merkel, Olivia M/0000-0002-4151-3916; Schoser, Benedikt/0000-0002-2757-8131				Aartsma-Rus A, 2006, MUSCLE NERVE, V34, P135, DOI 10.1002/mus.20586; Amoasii L, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8081; Ball P, 2017, DESIGNER BABIES ETHI; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bates GP, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.5; Batra R, 2017, CELL, V170, P899, DOI 10.1016/j.cell.2017.07.010; Bengtsson NE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14454; Benston S, 2017, J MED ETHICS, V43, P819, DOI 10.1136/medethics-2016-103666; Blat Y, 2015, J BIOMOL SCREEN, V20, P1189, DOI 10.1177/1087057115586535; Burk Katrin, 2017, Cerebellum Ataxias, V4, P4, DOI 10.1186/s40673-017-0062-x; Chau A, 2015, DEV DYNAM, V244, P377, DOI 10.1002/dvdy.24240; Chew WL, 2016, NAT METHODS, V13, P868, DOI 10.1038/nmeth.3993; CHOULIKA A, 1995, MOL CELL BIOL, V15, P1968; Chu ML, 2018, NEUROTHERAPEUTICS, DOI 10.1007/s13311.018-0648-x; Collins PJ, 2017, PHARM RES, DOI 10.1016/j.phrs.2017.09.008; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cribbs AP, 2017, YALE J BIOL MED, V90, P625; DANOWSKI BA, 1992, J CELL BIOL, V118, P1411, DOI 10.1083/jcb.118.6.1411; de Die-Smulders CEM, 1998, BRAIN, V121, P1557, DOI 10.1093/brain/121.8.1557; Deenen JCW, 2014, NEUROLOGY, V83, P1056, DOI 10.1212/WNL.0000000000000797; DeMichele G, 1996, NEUROLOGY, V47, P1260, DOI 10.1212/WNL.47.5.1260; Duchene B, 2018, METHODS MOL BIOL, V1687, P267, DOI 10.1007/978-1-4939-7374-3_19; Durbeej M, 2015, CURR TOP MEMBR, V76, P31, DOI 10.1016/bs.ctm.2015.05.002; E JM, 2000, STRUCT FUNCT DYSTR G; Echigoya Y, 2014, NUCLEIC ACID THER, V24, P57, DOI 10.1089/nat.2013.0451; Ehrhardt A, 2002, BLOOD, V99, P3923, DOI 10.1182/blood.V99.11.3923; Ehrke-Schulz E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17180-w; Ehrke-Schulz E, 2016, MOL THER, V24, pS44; El Refaey M, 2017, CIRC RES, V121, P923, DOI 10.1161/CIRCRESAHA.117.310996; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Fardaei M, 2002, HUM MOL GENET, V11, P805, DOI 10.1093/hmg/11.7.805; Fardaei M, 2001, NUCLEIC ACIDS RES, V29, P2766, DOI 10.1093/nar/29.13.2766; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas Giedrius, 2012, Proc Natl Acad Sci U S A, V109, pE2579; Govert F, 2013, CURR OPIN NEUROL, V26, P420, DOI 10.1097/WCO.0b013e3283632d90; Hagerman RJ, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.65; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Harper PS, 2001, MYOTONIC DYSTROPHY; Himeda CL, 2016, MOL THER, V24, P527, DOI 10.1038/mt.2015.200; Ho TH, 2005, J CELL SCI, V118, P2923, DOI 10.1242/jcs.02404; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOFFMAN EP, 1987, NATURE, V330, P754, DOI 10.1038/330754a0; Iyombe-Engembe JP, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2015.58; Jackson MF, 2013, FEBS J, V280, P827, DOI 10.1111/febs.12072; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kemaladewi DU, 2017, NAT MED, V23, P984, DOI 10.1038/nm.4367; Kennedy EM, 2015, VIROLOGY, V479, P213, DOI 10.1016/j.virol.2015.02.024; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; Kolli N, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040754; Kyrychenko V, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.95918; Lattanzi A, 2017, MOL THER-NUCL ACIDS, V7, P11, DOI 10.1016/j.omtn.2017.02.004; Lee K, 2017, NAT BIOMED ENG, V1, P889, DOI 10.1038/s41551-017-0137-2; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Li HL, 2015, STEM CELL REP, V4, P143, DOI 10.1016/j.stemcr.2014.10.013; Liao HK, 2017, CELL, V171, P1495, DOI 10.1016/j.cell.2017.10.025; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Liu C, 2017, J CONTROL RELEASE, V266, P17, DOI 10.1016/j.jconrel.2017.09.012; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Lu QL, 2011, MOL THER, V19, P9, DOI 10.1038/mt.2010.219; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Maggio I, 2016, SCI REP-UK, V6, DOI 10.1038/srep37051; Maggio I, 2016, NUCLEIC ACIDS RES, V44, P1449, DOI 10.1093/nar/gkv1540; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marshall E, 1999, SCIENCE, V286, P2244, DOI 10.1126/science.286.5448.2244; Marthaler AG, 2016, STEM CELL RES, V16, P202, DOI 10.1016/j.scr.2015.12.048; Marthaler AG, 2016, STEM CELL RES, V16, P180, DOI 10.1016/j.scr.2015.12.028; Marthaler AG, 2016, STEM CELL RES, V16, P162, DOI 10.1016/j.scr.2015.12.031; Martin F, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091507; Mast TC, 2010, VACCINE, V28, P950, DOI 10.1016/j.vaccine.2009.10.145; Mathieu J, 2012, NEUROMUSCULAR DISORD, V22, P974, DOI 10.1016/j.nmd.2012.05.017; Maxmen A, 2015, THE GENESIS ENGINE; Mehta A, 2014, COLD SPRING HARBOR P, V6, DOI [10.1101/cshperspecta016428, DOI 10.1101/CSHPERSPECTA016428]; Meola G, 2015, BBA-MOL BASIS DIS, V1852, P594, DOI 10.1016/j.bbadis.2014.05.019; Mila M, 2018, CLIN GENET, V93, P197, DOI 10.1111/cge.13075; Moat SJ, 2013, EUR J HUM GENET, V21, P1049, DOI 10.1038/ejhg.2012.301; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Monteys AM, 2017, MOL THER, V25, P12, DOI 10.1016/j.ymthe.2016.11.010; Morris ED, 2017, YALE J BIOL MED, V90, P661; Mou HW, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1237-8; Mulvihill JJ, 2017, BRIT MED BULL, V122, P17, DOI 10.1093/bmb/ldx002; Muthuswamy S, 2015, NEUROLOGIST, V20, P51, DOI 10.1097/NRL.0000000000000054; Nakamura A, 2017, J HUM GENET, V62, P871, DOI 10.1038/jhg.2017.57; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Nigro V, 2015, BBA-MOL BASIS DIS, V1852, P585, DOI 10.1016/j.bbadis.2014.07.023; Nigro Vincenzo, 2014, Acta Myol, V33, P1; Ouellet DL, 2017, GENE THER, V24, P265, DOI 10.1038/gt.2016.89; Ousterout DG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7244; Park CY, 2015, CELL REP, V13, P234, DOI 10.1016/j.celrep.2015.08.084; Parks RJ, 1996, P NATL ACAD SCI USA, V93, P13565, DOI 10.1073/pnas.93.24.13565; Pavlath GK, 2003, CELL CYCLE, V2, P420, DOI 10.4161/cc.2.5.497; Perrin A, 2017, MOL THER-NUCL ACIDS, V6, P68, DOI 10.1016/j.omtn.2016.11.004; Pinto BS, 2017, MOL CELL, V68, P479, DOI 10.1016/j.molcel.2017.09.033; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064; RUDIN N, 1989, GENETICS, V122, P519; Rybakova IN, 1996, J CELL BIOL, V135, P661, DOI 10.1083/jcb.135.3.661; Rybakova IN, 1997, J BIOL CHEM, V272, P28771, DOI 10.1074/jbc.272.45.28771; Rybakova IN, 2000, J CELL BIOL, V150, P1209, DOI 10.1083/jcb.150.5.1209; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schiedner G, 1998, NAT GENET, V18, P180, DOI 10.1038/ng0298-180; Shin JW, 2016, HUM MOL GENET, V25, P4566, DOI 10.1093/hmg/ddw286; Smith C, 2014, CELL STEM CELL, V15, P13, DOI 10.1016/j.stem.2014.06.011; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Turan S, 2016, MOL THER, V24, P685, DOI 10.1038/mt.2016.40; Turner C, 2010, J NEUROL NEUROSUR PS, V81, P358, DOI 10.1136/jnnp.2008.158261; Ul Ain Q, 2015, J CONTROL RELEASE, V205, P120, DOI 10.1016/j.jconrel.2014.12.036; van Agtmaal EL, 2017, MOL THER, V25, P24, DOI 10.1016/j.ymthe.2016.10.014; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Vestergaard G, 2014, RNA BIOL, V11, P156, DOI 10.4161/rna.27990; Wang HF, 2016, ANNU REV BIOCHEM, V85, P227, DOI 10.1146/annurev-biochem-060815-014607; Wang JZ, 2017, BRAIN DEV-JPN, V39, P547, DOI 10.1016/j.braindev.2017.03.024; Wild EJ, 2017, LANCET NEUROL, V16, P837, DOI 10.1016/S1474-4422(17)30280-6; Wojtal D, 2016, AM J HUM GENET, V98, P90, DOI 10.1016/j.ajhg.2015.11.012; Wright DA, 2014, BIOCHEM J, V462, P15, DOI 10.1042/BJ20140295; Xie N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153845; Xu L, 2016, MOL THER, V24, P564, DOI 10.1038/mt.2015.192; Xu XH, 2017, STEM CELL REP, V8, P619, DOI 10.1016/j.stemcr.2017.01.022; Yang S, 2017, J CLIN INVEST, V127, P2719, DOI 10.1172/JCI92087; Yiu EM, 2015, J PAEDIATR CHILD H, V51, P759, DOI 10.1111/jpc.12868; Young CS, 2016, CELL STEM CELL, V18, P533, DOI 10.1016/j.stem.2016.01.021; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang H, 2016, BRIT J HAEMATOL, V175, P208, DOI 10.1111/bjh.14297; Zhang Y, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602814; Zhu P, 2017, MOL THER-NUCL ACIDS, V7, P31, DOI 10.1016/j.omtn.2017.02.007	130	18	19	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212198	10.1371/journal.pone.0212198	http://dx.doi.org/10.1371/journal.pone.0212198			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794581	Green Published, gold, Green Submitted			2022-12-27	WOS:000459709100046
J	Besselink, NJ; Jacobs, JWG; Westgeest, AAA; van der Meijde, P; Welsing, PMJ; Marijnissen, ACA; Lafeber, FPJG; Van Spil, WE				Besselink, N. J.; Jacobs, J. W. G.; Westgeest, A. A. A.; van der Meijde, P.; Welsing, P. M. J.; Marijnissen, A. C. A.; Lafeber, F. P. J. G.; Van Spil, W. E.			Can optical spectral transmission assess ultrasound-detected synovitis in hand osteoarthritis?	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; MUSCULOSKELETAL ULTRASOUND; INFLAMMATION; JOINTS; ULTRASONOGRAPHY; RELIABILITY; SEVERITY; DAMAGE	Objective To determine whether optical spectral transmission (OST) can be used to assess synovitis in hand and wrist joints of patients with hand osteoarthritis (OA). Design Hand and wrist joints of 47 primary hand OA patients with at least one clinically inflamed hand or wrist joint were assessed for synovitis by OST and ultrasound (US). Associations between standardized OST and US synovitis were studied in linear mixed effects models, across all joint types together and individually for wrist, proximal interphalangeal (PIP), and distal interphalangeal (DIP) joints, and were adjusted for OA features that showed associations with US synovitis. Diagnostic performance was determined using receiver operator characteristic (ROC) curves analysis, with US as reference standard. Results Altogether, 6.7% of joints showed US synovitis. Statistically significant associations between OST scores and US synovitis were found for all joints combined (Delta 0.37SD, p<0.001) and PIP joints (Delta 0.81SD, p<0.001), but not for DIP (Delta 0.14SD, p = 0.484) or wrist joints (Delta 0.37SD, p = 0.178). All associations were independent of other OA features, i.e. osteophytes and dorsal vascularity. Analysis of diagnostic performance of OST, revealed an area under the ROC curve (AUC-ROC) of 0.74 for all joints together (p<0.001), 0.69 for PIP joints (p<0.001), 0.54 for DIP joints (p = 0.486), and 0.61 for wrist joints (p = 0.234). Conclusions OST scores and US synovitis are statistically significantly associated, independent of osteophytes and dorsal vascularity. At this stage, OST performs fair in the assessment of synovitis in PIP joints of hand OA patients.	[Besselink, N. J.; Jacobs, J. W. G.; Welsing, P. M. J.; Marijnissen, A. C. A.; Lafeber, F. P. J. G.; Van Spil, W. E.] Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands; [Westgeest, A. A. A.] Maxima Med Ctr, Dept Rheumatol, Eindhoven, Netherlands; [van der Meijde, P.] Noordwest Ziekenhuisgroep, Dept Rheumatol, Alkmaar, Netherlands	Utrecht University; Utrecht University Medical Center; Maxima Medical Center; Medical Center Of Alkmaar	Besselink, NJ (corresponding author), Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands.	W.E.vanSpil@umcutrecht.nl			Hemics	Hemics	This work was financially supported by Hemics (http://www.hemics.com/), in the form of an unrestricted research grant. Hemics was involved in analysis and interpretation of OST data, but had no role in study design, collection of the data, writing of the manuscript or in the decision to submit the manuscript for publication.	Backhaus M, 2001, ANN RHEUM DIS, V60, P641, DOI 10.1136/ard.60.7.641; Besselink NJ, 2018, RHEUMATOLOGY, V57, P865, DOI 10.1093/rheumatology/kex531; Glimm AM, 2016, ANN RHEUM DIS, V75, P566, DOI 10.1136/annrheumdis-2015-207345; Hall M, 2014, OSTEOARTHR CARTILAGE, V22, P1627, DOI 10.1016/j.joca.2014.05.025; Kortekaas MC, 2013, ANN RHEUM DIS, V72, P930, DOI 10.1136/annrheumdis-2012-201458; Lafeber FPJG, 2016, OXFORD TXB RHEUMATOL, P55; Mancarella L, 2010, OSTEOARTHR CARTILAGE, V18, P1263, DOI 10.1016/j.joca.2010.06.006; Mancarella L, 2017, CURR RHEUMATOL REV, V13, P43, DOI 10.2174/1573397112666160909105903; Mathiessen A, 2016, ANN RHEUM DIS, V75, P825, DOI 10.1136/annrheumdis-2015-207241; Naredo E, 2006, ANN RHEUM DIS, V65, P14, DOI 10.1136/ard.2005.037382; Naredo E, 2013, ANN RHEUM DIS, V72, P1328, DOI 10.1136/annrheumdis-2012-202092; Punzi L, 2010, BEST PRACT RES CL RH, V24, P301, DOI 10.1016/j.berh.2009.12.007; Szkudlarek M, 2003, ARTHRITIS RHEUM, V48, P955, DOI 10.1002/art.10877; Takase-Minegishi K, 2018, RHEUMATOLOGY, V57, P49, DOI 10.1093/rheumatology/kex036; Terslev L, 2017, RMD OPEN, V3, DOI 10.1136/rmdopen-2016-000427; Tugwell P, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-38; Wakefield RJ, 2007, J RHEUMATOL, V34, P848; Wakefield RJ, 2005, J RHEUMATOL, V32, P2485; Witt M, 2013, ARTHRITIS RHEUM-US, V65, P1694, DOI 10.1002/art.37954; Zhang YQ, 2002, AM J EPIDEMIOL, V156, P1021, DOI 10.1093/aje/kwf141	20	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0209761	10.1371/journal.pone.0209761	http://dx.doi.org/10.1371/journal.pone.0209761			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794572	Green Published, gold, Green Submitted			2022-12-27	WOS:000459709100011
J	Danielsen, J; Sandbakk, O; McGhie, D; Ettema, G				Danielsen, Jorgen; Sandbakk, Oyvind; McGhie, David; Ettema, Gertjan			Mechanical energetics and dynamics of uphill double-poling on roller-skis at different incline-speed combinations	PLOS ONE			English	Article							CROSS-COUNTRY SKIERS; UPPER-BODY; POWER; FORCES; ENERGY; LEGS	Objectives The purpose of this study was to investigate the effect of different incline-speed combinations, at equal external power outputs, on the mechanics and energetics of the double-poling (DP) technique in cross-country skiing. Methods Fourteen elite male cross-country skiers performed treadmill DP on roller-skis at low, moderate, and high mean external power outputs (P-mean) up a shallow incline (5%, INC5), at which DP is preferred, and up a steep incline (12%, INC12), at which DP is not preferred. Speed was set to produce equal Pmean at both inclines. From recorded kinematics and dynamics, arm power (P-arm) and trunk+leg power (PT+L) were derived, as were pole propulsion power (P-pole) and body mechanical energy perpendicular to the treadmill surface (E-body perpendicular to). Results Over a locomotion cycle, the arms contributed 63% to P-mean at INC5 but surprisingly only 54% at INC12 (P<0.001), with no effect of Pmean (P = 0.312). Thus, the trunk and legs contributed substantially to Pmean both at INC5 (37%) and INC12 (46%). At both inclines, PT+L generation during the swing phase increased approximately linearly with Pmean, which increased E-body perpendicular to. Within the poling phase, similar to 30-35% of the body energy which was developed during the preceding swing phase was transferred into propulsive pole power on both inclines. At INC5, the amount of negative PT+L during the poling phase was larger than at INC12, and this difference increased with P-mean. Conclusions The considerable larger amount of negative PT+L during poling at INC5 than at INC12 indicate that the legs and trunk generate more power than 'necessary' during the swing phase and thus must absorb more energy during the poling phase. This larger surplus of PT+L at INC5 seems necessary for positioning the body and poles so that high P-arm generation can occur in a short time. At INC12, less P-arm is generated, probably due to less advantageous working conditions for the arms, related to body and pole positioning. These incline differences seem linked to shorter swing and longer poling times during steep uphill DP, which are due to the increased influence of gravity and slower speed at steep inclines.	[Danielsen, Jorgen; Sandbakk, Oyvind; McGhie, David; Ettema, Gertjan] Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, Dept Neuromed & Movement Sci, Ctr Elite Sports Res, Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Danielsen, J (corresponding author), Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, Dept Neuromed & Movement Sci, Ctr Elite Sports Res, Trondheim, Norway.	jorgen.danielsen@ntnu.no	Ettema, Gertjan/C-2104-2018					Bisseling RW, 2006, J BIOMECH, V39, P2438, DOI 10.1016/j.jbiomech.2005.07.021; Bojsen-Moller J, 2010, J APPL PHYSIOL, V109, P1895, DOI 10.1152/japplphysiol.00671.2010; Dahl C, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00094; Danielsen J, 2015, MED SCI SPORT EXER, V47, P2586, DOI 10.1249/MSS.0000000000000723; Danielsen J, 2018, HUM MOVEMENT SCI, V57, P83, DOI 10.1016/j.humov.2017.11.010; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; Donelan J, 2005, J BIOMECH, V35, P117; Elftman H, 1939, AM J PHYSIOL, V125, P339, DOI 10.1152/ajplegacy.1939.125.2.339; Farris DJ, 2012, J R SOC INTERFACE, V9, P110, DOI 10.1098/rsif.2011.0182; Griffin T, 1985, J APPL PHYSIOL, V95, P172; Hegge AM, 2016, EUR J APPL PHYSIOL, V116, P291, DOI 10.1007/s00421-015-3281-y; Holmberg HC, 2006, MED SCI SPORT EXER, V38, P1853, DOI 10.1249/01.mss.0000230121.83641.d1; Holmberg HC, 2005, MED SCI SPORT EXER, V37, P807, DOI 10.1249/01.MSS.0000162615.47763.C8; Lindinger SJ, 2011, EUR J APPL PHYSIOL, V111, P1103, DOI 10.1007/s00421-010-1736-8; Lindinger SJ, 2009, EUR J APPL PHYSIOL, V106, P353, DOI 10.1007/s00421-009-1018-5; Lindinger SJ, 2009, MED SCI SPORT EXER, V41, P210, DOI 10.1249/MSS.0b013e318184f436; Nilsson J, 2013, EUR J APPL PHYSIOL, V113, P1385, DOI 10.1007/s00421-012-2568-5; Pellegrini B, 2013, HUM MOVEMENT SCI, V32, P1415, DOI 10.1016/j.humov.2013.07.010; Prilutsky BI, 2001, J EXP BIOL, V204, P2277; Roberts TJ, 1998, J EXP BIOL, V201, P2745; Rud B, 2014, SCAND J MED SCI SPOR, V24, P913, DOI 10.1111/sms.12133; Sandbakk O, 2014, INT J SPORT PHYSIOL, V9, P117, DOI [10.1123/ijspp.2013-0373, 10.1123/IJSPP.2013-0373]; Sandbakk O, 2010, EUR J APPL PHYSIOL, V109, P473, DOI 10.1007/s00421-010-1372-3; Schache AG, 2015, J EXP BIOL, V218, P2472, DOI 10.1242/jeb.119156; SCHENAU GJV, 1990, J BIOMECH, V23, P865, DOI 10.1016/0021-9290(90)90352-4; Solli GS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207195; Stoggl TL, 2016, MED SCI SPORT EXER, V48, P1580, DOI 10.1249/MSS.0000000000000943; Stoggl T, 2011, SCAND J MED SCI SPOR, V21, pE393, DOI 10.1111/j.1600-0838.2011.01324.x; van den Bogert AJ, 1996, P 9 BIENN CAN SOC BI; Welde B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187111; Winter DA., 2009, BIOMECHANICS MOTOR C, V4, P154; Zelik KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031143; Zoppirolli C, 2017, SCAND J MED SCI SPOR, V27, P1292, DOI 10.1111/sms.12783; Zoppirolli C, 2013, J ELECTROMYOGR KINES, V23, P1512, DOI 10.1016/j.jelekin.2013.08.013	34	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212500	10.1371/journal.pone.0212500	http://dx.doi.org/10.1371/journal.pone.0212500			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794617	Green Published, gold, Green Submitted			2022-12-27	WOS:000459709100079
J	Martin, JE; Sandilands, V; Sparrey, J; Baker, L; Dixon, LM; McKeegan, DEF				Martin, Jessica E.; Sandilands, Victoria; Sparrey, Julian; Baker, Laurence; Dixon, Laura M.; McKeegan, Dorothy E. F.			Welfare assessment of novel on-farm killing methods for poultry	PLOS ONE			English	Article							CERVICAL DISLOCATION; BEHAVIORAL-RESPONSES; BLUNT TRAUMA; CAPTIVE BOLT; BRAIN; EEG; ELECTROENCEPHALOGRAM; INSENSIBILITY; SEVOFLURANE; SLAUGHTER	There is a need for novel mechanical devices for dispatching poultry on farm following the introduction of EU Regulation (EC) no. 1099/2009 On the Protection of Animals at the Time of Killing. We examined three novel mechanical killing devices: Modified Armadillo, Modified Rabbit Zinger, a novel mechanical cervical dislocation device; and traditional manual cervical dislocation. The four killing methods were tested on 230 chickens across four batches. We measured behavioural, electroencephalogram and post-mortem outcomes in anesthetized laying hens and broilers at two life stages (juveniles and adults/slaughter age). Graeco Latin-Square designs systematically randomized killing treatment, bird type, age and kill order. All birds were lightly anaesthetized immediately prior to the killing treatment with inhalation of Sevoflurane. The novel mechanical cervical dislocation method had the highest kill success rate (single application attempt only, with no signs of recovery) of a mechanical method (96%). The Modified Armadillo was the least reliable with 49% kill success. Spectral analysis of electroencephalogram signals at 2 s intervals for successfully killed birds only revealed progressive decreases in median frequency alongside increases in total power. Later, total power decreased as the birds exhibited isoelectric electroencephalogram signal. Latencies to pre-defined spectral ranges associated with unconsciousness showed that birds subjected to manual and novel mechanical cervical dislocation achieved these states sooner than birds subjected to the modified Armadillo. Nevertheless all methods exhibited short latencies (<4 s). The Modified Rabbit Zinger had the shortest duration of reflex persistence for nictitating membrane, pupillary and rhythmic breathing post method application. Of the methods tested, the novel mechanical cervical dislocation device is the most promising mechanical method for killing poultry on-farm based on a range of behavioural, electroencephalogram and anatomical parameters. This device has the potential to fulfil the current need for a mechanical alternative to manual cervical dislocation.	[Martin, Jessica E.] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush Campus, Edinburgh, Midlothian, Scotland; [Martin, Jessica E.] Univ Edinburgh, Roslin Inst, Easter Bush Campus, Edinburgh, Midlothian, Scotland; [Martin, Jessica E.; McKeegan, Dorothy E. F.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Sandilands, Victoria; Baker, Laurence; Dixon, Laura M.] Scotlands Rural Coll SRUC, Anim & Vet Sci Res Grp, Edinburgh, Midlothian, Scotland; [Sparrey, Julian] Livetec Syst Ltd, Bedford, England	University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Glasgow; Scotland's Rural College	Martin, JE (corresponding author), Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush Campus, Edinburgh, Midlothian, Scotland.; Martin, JE (corresponding author), Univ Edinburgh, Roslin Inst, Easter Bush Campus, Edinburgh, Midlothian, Scotland.; Martin, JE (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland.	Jessica.Martin@ed.ac.uk	Martin, Jessica/AGC-5181-2022	Martin, Jessica/0000-0003-0294-8770; Sandilands, Victoria/0000-0003-0806-3535; Dixon, Laura/0000-0002-1781-8795	Humane Slaughter Association (HSA) via their Centenary Research Training Scholarship (RTS); Livetec Systems Ltd.; Humane Slaughter Association (HSA), UK via their Centenary Research Training Scholarship (RTS)	Humane Slaughter Association (HSA) via their Centenary Research Training Scholarship (RTS); Livetec Systems Ltd.; Humane Slaughter Association (HSA), UK via their Centenary Research Training Scholarship (RTS)	This research was funded by the Humane Slaughter Association (HSA, https://www.hsa.org.uk/) via their Centenary Research Training Scholarship (RTS), awarded to JM in 2011. Livetec Systems Ltd. provided support in the form of salary to JS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by the Humane Slaughter Association (HSA), UK via their Centenary Research Training Scholarship (RTS) awarded to Jessica Martin in 2011. We are grateful to all the poultry staff at the Monogastric Science Research Centre, Scotland's Rural College (SRUC) for their help and cooperation. We thank Dr Marien Gerritzen at Wageningen UR, Lelystad, Netherlands for providing the telemetric logging units. We thank Dr Sarah Brockle-hurst at Biomathematics & Statistics Scotland, for support and advice on statistical analysis.	Anil MH, 1999, VET REC, V145, P460, DOI 10.1136/vr.145.16.460; Bader S, 2014, J APPL POULTRY RES, V23, P546, DOI 10.3382/japr.2014-00977; BLACKMAN NL, 1986, RES VET SCI, V40, P252, DOI 10.1016/S0034-5288(18)30522-8; Coenen AML, 2009, POULTRY SCI, V88, P10, DOI 10.3382/ps.2008-00120; Constant I, 2005, PEDIATR ANESTH, V15, P266, DOI 10.1111/j.1460-9592.2004.01538.x; Erasmus MA, 2010, VET REC, V167, P850, DOI 10.1136/vr.c5051; Erasmus MA, 2010, POULTRY SCI, V89, P1345, DOI 10.3382/ps.2009-00445; Gerritzen MA, 2000, POULTRY SCI, V79, P928, DOI 10.1093/ps/79.6.928; Gibson TJ, 2009, NEW ZEAL VET J, V57, P77, DOI 10.1080/00480169.2009.36882; GREGORY NG, 1990, VET REC, V126, P570; Gwin JT, 2010, J NEUROPHYSIOL, V103, P3526, DOI 10.1152/jn.00105.2010; Haberham ZL, 2000, BRAIN RES, V873, P287, DOI 10.1016/S0006-8993(00)02504-X; Heinke W, 2005, CURR OPIN ANESTHESIO, V18, P625, DOI 10.1097/01.aco.0000189879.67092.12; HSA, PRACT SLAUGHT POULTR; Kent JP, 2018, INT J POULT SCI, V17, P205; Knudsen SK, 2005, VET J, V169, P42, DOI 10.1016/j.tvjl.2004.02.007; Lowe JC, 2007, COMPUT ELECTRON AGR, V57, P74, DOI 10.1016/j.compag.2007.02.003; Martin JE, 2017, BRIT POULTRY SCI, V58, P216, DOI 10.1080/00071668.2017.1280724; Martin JE, 2016, ANIM WELFARE, V25, P227, DOI 10.7120/09627286.25.2.227; Martin JE, 2016, PHYSIOL BEHAV, V163, P25, DOI 10.1016/j.physbeh.2016.04.038; Martin P., 2007, MEASURING BEHAV; Martoft L, 2001, LAB ANIM-UK, V35, P353, DOI 10.1258/0023677011911958; McIlhone AE, 2014, VET ANAESTH ANALG, V41, P613, DOI 10.1111/vaa.12154; McKeegan DEF, 2013, POULTRY SCI, V92, P1145, DOI 10.3382/ps.2012-02587; McKeegan DEF, 2011, BRIT POULTRY SCI, V52, P645, DOI 10.1080/00071668.2011.640307; Raj ABM, 2001, BRIT POULTRY SCI, V42, P295, DOI 10.1080/00071660120055232; Sandercock DA, 2014, PHYSIOL BEHAV, V133, P252, DOI 10.1016/j.physbeh.2014.05.030; Shi R, 2002, NEUROSCIENCE, V110, P765, DOI 10.1016/S0306-4522(01)00596-6; Sparrey J, 2014, WORLD POULTRY SCI J, V70, P737, DOI 10.1017/S0043933914000816; TIDSWELL SJ, 1987, NEW ZEAL VET J, V35, P46, DOI 10.1080/00480169.1987.35377; Tonner PH, 2006, BEST PRACT RES-CLIN, V20, P147, DOI 10.1016/j.bpa.2005.08.008; van der Sluis HJ, 2009, POULTRY SCI, V88, P1242, DOI 10.3382/ps.2008-00155; Verhoeven MTW, 2015, ANIMAL, V9, P320, DOI 10.1017/S1751731114002596; Woolcott CR, 2018, ANIMALS, V8, DOI 10.3390/ani8030042	34	9	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212872	10.1371/journal.pone.0212872	http://dx.doi.org/10.1371/journal.pone.0212872			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794690	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000459709100154
J	Masino, AJ; Harris, MC; Forsyth, D; Ostapenko, S; Srinivasan, L; Bonafide, CP; Balamuth, F; Schmatz, M; Grundmeier, RW				Masino, Aaron J.; Harris, Mary Catherine; Forsyth, Daniel; Ostapenko, Svetlana; Srinivasan, Lakshmi; Bonafide, Christopher P.; Balamuth, Fran; Schmatz, Melissa; Grundmeier, Robert W.			Machine learning models for early sepsis recognition in the neonatal intensive care unit using readily available electronic health record data	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; EMPIRICAL ANTIBIOTIC-TREATMENT; CLINICAL-OUTCOMES; VITAL SIGNS; PREDICTION; MORTALITY; BACTEREMIA; DISEASE; CULTURE; BURDEN	Background Rapid antibiotic administration is known to improve sepsis outcomes, however early diagnosis remains challenging due to complex presentation. Our objective was to develop a model using readily available electronic health record (EHR) data capable of recognizing infant sepsis at least 4 hours prior to clinical recognition. Methods and findings We performed a retrospective case control study of infants hospitalized. 48 hours in the Neonatal Intensive Care Unit (NICU) at the Children's Hospital of Philadelphia between September 2014 and November 2017 who received at least one sepsis evaluation before 12 months of age. We considered two evaluation outcomes as cases: culture positive-positive blood culture for a known pathogen (110 evaluations); and clinically positive-negative cultures but antibiotics administered for. 120 hours (265 evaluations). Case data was taken from the 44-hour window ending 4 hours prior to evaluation. We randomly sampled 1,100 44-hour windows of control data from all times. 10 days removed from any evaluation. Model inputs consisted of up to 36 features derived from routine EHR data. Using 10-fold nested cross-validation, 8 machine learning models were trained to classify inputs as sepsis positive or negative. When tasked with discriminating culture positive cases from controls, 6 models achieved a mean area under the receiver operating characteristic (AUC) between 0.80-0.82 with no significant differences between them. Including both culture and clinically positive cases, the same 6 models achieved an AUC between 0.85-0.87, again with no significant differences. Conclusions Machine learning models can identify infants with sepsis in the NICU hours prior to clinical recognition. Learning curves indicate model improvement may be achieved with additional training examples. Additional input features may also improve performance. Further research is warranted to assess potential performance improvements and clinical efficacy in a prospective trial.	[Masino, Aaron J.] Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Masino, Aaron J.; Forsyth, Daniel; Ostapenko, Svetlana; Grundmeier, Robert W.] Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Philadelphia, PA 19104 USA; [Harris, Mary Catherine; Srinivasan, Lakshmi; Bonafide, Christopher P.; Balamuth, Fran; Grundmeier, Robert W.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Harris, Mary Catherine; Srinivasan, Lakshmi; Schmatz, Melissa] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Bonafide, Christopher P.; Balamuth, Fran; Grundmeier, Robert W.] Childrens Hosp Philadelphia, Ctr Pediat Clin Effectiveness, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Masino, AJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA.; Masino, AJ (corresponding author), Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Philadelphia, PA 19104 USA.	masinoa@email.chop.edu		Bonafide, Christopher/0000-0003-2823-5883; Grundmeier, Robert/0000-0002-8290-5588; Harris, Mary Catherine/0000-0001-6287-0026	Institute for Biomedical Informatics at the University of Pennsylvania; Research Institute at Children's Hospital of Philadelphia	Institute for Biomedical Informatics at the University of Pennsylvania; Research Institute at Children's Hospital of Philadelphia	This work was funded by the Institute for Biomedical Informatics at the University of Pennsylvania (http://upibi.org/) and the Research Institute at Children's Hospital of Philadelphia (https://www.research.chop.edu/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balamuth F, 2017, ANN EMERG MED, V70, P759, DOI 10.1016/j.annemergmed.2017.03.019; Barber D., 2012, BAYESIAN REASONING M; Batista GEAPA., 2004, ACM SIGKDD EXPL NEWS, V6, P20, DOI [10.1145/1007730.1007735, DOI 10.1145/1007730.1007735]; Beretta L, 2016, BMC MED INFORM DECIS, V16, DOI 10.1186/s12911-016-0318-z; Bohanon FJ, 2015, AM J SURG, V210, P661, DOI 10.1016/j.amjsurg.2015.06.002; Calvert JS, 2016, COMPUT BIOL MED, V74, P69, DOI 10.1016/j.compbiomed.2016.05.003; Castellanos-Ortega A, 2010, CRIT CARE MED, V38, P1036, DOI 10.1097/CCM.0b013e3181d455b6; Chandrashekar G, 2014, COMPUT ELECTR ENG, V40, P16, DOI 10.1016/j.compeleceng.2013.11.024; Coggins SA, 2016, ARCH DIS CHILD-FETAL, V101, pF329, DOI 10.1136/archdischild-2015-309210; Cohen J, 2015, LANCET INFECT DIS, V15, P581, DOI 10.1016/S1473-3099(15)70112-X; Cohen-Wolkowiez M, 2009, PEDIATR INFECT DIS J, V28, P1052, DOI 10.1097/INF.0b013e3181acf6bd; Connell TG, 2007, PEDIATRICS, V119, P891, DOI 10.1542/peds.2006-0440; Cotten CM, 2009, PEDIATRICS, V123, P58, DOI 10.1542/peds.2007-3423; Desautels T, 2016, JMIR MED INF, V4, P67, DOI 10.2196/medinform.5909; Dong YR, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-222; Fairchild KD, 2017, PEDIATR RES, V81, P315, DOI 10.1038/pr.2016.215; Fairchild KD, 2010, CLIN PERINATOL, V37, P581, DOI 10.1016/j.clp.2010.06.002; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; Gonsalves WI, 2009, J CLIN MICROBIOL, V47, P3482, DOI 10.1128/JCM.02107-08; Gultepe E, 2014, J AM MED INFORM ASSN, V21, P315, DOI 10.1136/amiajnl-2013-001815; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hastie T., 2009, SPRINGER SERIES STAT, DOI 10.1007/978-0-387-84858-7; He HB, 2009, IEEE T KNOWL DATA EN, V21, P1263, DOI 10.1109/TKDE.2008.239; Henry KE, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab3719; Horng S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174708; Kam HJ, 2017, COMPUT BIOL MED, V89, P248, DOI 10.1016/j.compbiomed.2017.08.015; Klingenberg C, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00285; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Kuppala VS, 2011, J PEDIATR-US, V159, P720, DOI 10.1016/j.jpeds.2011.05.033; KURLAT I, 1989, J CLIN MICROBIOL, V27, P1068, DOI 10.1128/JCM.27.5.1068-1071.1989; Lake DE, 2014, J CLIN MONIT COMPUT, V28, P329, DOI 10.1007/s10877-013-9530-x; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Mani S, 2014, J AM MED INFORM ASSN, V21, P326, DOI 10.1136/amiajnl-2013-001854; Mayhew MB, 2017, J BIOMED INFORM; Musil CM, 2002, WESTERN J NURS RES, V24, P815, DOI 10.1177/019394502762477004; Nemati S, 2017, CRIT CARE MED, P1; Odetola FO, 2007, PEDIATRICS, V119, P487, DOI 10.1542/peds.2006-2353; Padula MA, 2014, PEDIATR INFECT DIS J, V33, P1027, DOI 10.1097/INF.0000000000000386; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Qazi SA, 2009, PEDIATR INFECT DIS J, V28, pS1, DOI 10.1097/INF.0b013e31819587a9; ROWLEY AH, 1986, CLIN PEDIATR, V25, P485, DOI 10.1177/000992288602501001; Schelonka RL, 1996, J PEDIATR-US, V129, P275, DOI 10.1016/S0022-3476(96)70254-8; Seymour CW, 2016, JAMA J AM MED ASS; Shashikumar SP, 2017, PHYSIOL MEAS, V38, P2235, DOI 10.1088/1361-6579/aa9772; Shashikumar SP, 2017, J ELECTROCARDIOL, V50, P739, DOI 10.1016/j.jelectrocard.2017.08.013; Squire E, 1980, OBSTET GYNECOL SURV, V35, P448; Stoll BJ, 2011, PEDIATRICS, V127, P817, DOI 10.1542/peds.2010-2217; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357; Taylor RA, 2016, ACAD EMERG MED, V23, P269, DOI 10.1111/acem.12876; Ting JY, 2016, JAMA PEDIATR, V170, P1181, DOI 10.1001/jamapediatrics.2016.2132; Umscheid CA, 2015, J HOSP MED, V10, P26, DOI 10.1002/jhm.2259; Verstraete EH, 2015, PEDIATRICS, V135, pE1002, DOI 10.1542/peds.2014-3226; Wang HD, 2016, LANCET, V388, P1725, DOI 10.1016/S0140-6736(16)31575-6; Wang HE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048307; Weiss SL, 2014, CRIT CARE MED; Wynn JL, 2016, CURR OPIN PEDIATR, V28, P135, DOI 10.1097/MOP.0000000000000315; Yende S, 2014, TRENDS MOL MED, V20, P234, DOI 10.1016/j.molmed.2014.02.005; Zea-Vera A, 2015, J TROP PEDIATRICS, V61, P1, DOI 10.1093/tropej/fmu079; Zhu J, 2009, STAT INTERFACE, V2, P349	60	59	61	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212665	10.1371/journal.pone.0212665	http://dx.doi.org/10.1371/journal.pone.0212665			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794638	Green Published, gold, Green Submitted			2022-12-27	WOS:000459709100108
J	Torvik, PO; von Heimburg, ED; Sende, T; Welde, B				Torvik, Per-Oyvind; von Heimburg, Erna Dianne; Sende, Torkel; Welde, Boye			The effect of pole length on physiological and perceptual responses during G3 roller ski skating on uphill terrain	PLOS ONE			English	Article							COUNTRY; PERFORMANCE; CAPACITY	The benefits of using longer than self-selected poles have been shown in double poling, but these potential benefits have not been examined in the gear 3 ski skating sub-technique (G3), during which the poling movement is very similar to double poling. The aim of this study was to examine the effect of longer than self-selected poles on physiological and perceptual responses in the G3 sub-technique. Ten cross-country skiers and biathletes (VO2max 72.4 +/- 3.0 ml.min(-1).kg(-1), age 20.1 +/- 2.8 years, height 1.81 +/- 0.03 m and weight 73.1 +/- 4.6 kg) completed two tests, each with three different submaximal intensities, during roller skiing using the G3 technique. The first test was carried out at a fixed speed (10 km.h(-1)) and the skiers performed two intervals of 5 min at 7, 9 and 11% inclination on a roller ski treadmill with self-selected poles (SSP) and 7.5 cm longer poles (LP) at each step. The second test had a fixed inclination of 4% and speeds of 14, 17 and 20 km.h(-1), also performed with SSP and LP at each step. At fixed speed, the oxygen uptake was 2.7% lower (P = 0.005) and the gross efficiency (GE) 2.1% higher (P = 0.01) with LP than with SSP at the steepest inclination of 11%. At fixed inclination, the oxygen uptake was 2.1% lower (P = 0.01) and the GE was 4.1% higher (P = 0.03) with LP than with SSP at the highest speed of 20 km.h(-1). At 14 km.h(-1), the oxygen uptake was 3.0% lower (P = 0.05) and GE was 3.8% higher (P = 0.03) with LP than with SSP. Our novel findings show that longer poles in the G3 technique may enhance the efficiency of skiing.	[Torvik, Per-Oyvind; von Heimburg, Erna Dianne; Sende, Torkel] Nord Univ, Dept Sports Sci & Phys Educ, Levanger, Norway; [Welde, Boye] UiT Arctic Univ Norway, Sch Sport Sci, Tromso, Norway	Nord University; UiT The Arctic University of Tromso	Torvik, PO (corresponding author), Nord Univ, Dept Sports Sci & Phys Educ, Levanger, Norway.	per.o.torvik@nord.no	Welde, Boye/AAN-3785-2020	Welde, Boye/0000-0003-3805-1615; Torvik, Per-Oyvind/0000-0002-8120-9222				Andersson E, 2010, EUR J APPL PHYSIOL, V110, P585, DOI 10.1007/s00421-010-1535-2; Bengtsson BE, CROSS COUNTRY SKATIN; Bolger CM, 2015, INT J SPORT PHYSIOL, V10, P873, DOI 10.1123/ijspp.2014-0335; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Carlsen CH, 2018, EUR J APPL PHYSIOL, V118, P271, DOI 10.1007/s00421-017-3767-x; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Froyd C, 2005, UTHOLDENHET TRENING; Hansen EA, 2010, SPORTS ENG, V12, P171, DOI 10.1007/s12283-010-0042-3; Holmberg HC, 2005, MED SCI SPORT EXER, V37, P807, DOI 10.1249/01.MSS.0000162615.47763.C8; Kvamme B, 2005, EUR J APPL PHYSIOL, V95, P205, DOI 10.1007/s00421-005-1332-5; Losnegard T, 2017, INT J SPORT PHYSIOL, V12, P211, DOI 10.1123/ijspp.2015-0754; Midgley AW, 2007, SPORTS MED, V37, P1019, DOI 10.2165/00007256-200737120-00002; Myklebust H, 2014, SCAND J MED SCI SPOR, V24, P882, DOI 10.1111/sms.12106; Nilsson Johnny, 2003, Sports Biomech, V2, P227, DOI 10.1080/14763140308522820; Onasch F, 2017, J APPL BIOMECH, V33, P197, DOI 10.1123/jab.2016-0071; PERONNET F, 1991, CAN J SPORT SCI, V16, P23; Sandbakk O, 2017, INT J SPORT PHYSIOL, V12, P1003, DOI 10.1123/ijspp.2016-0749; Sandbakk O, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00326; Sandbakk O, 2016, MED SCI SPORT EXER, V48, P1091, DOI 10.1249/MSS.0000000000000862; Sandbakk O, 2015, EUR J APPL PHYSIOL, V115, P483, DOI 10.1007/s00421-014-3039-y; Sandbakk O, 2010, EUR J APPL PHYSIOL, V109, P473, DOI 10.1007/s00421-010-1372-3; Stoggl TL, 2016, MED SCI SPORT EXER, V48, P1580, DOI 10.1249/MSS.0000000000000943; Stoggl T, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00033; Vandbakk K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172706	24	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0211550	10.1371/journal.pone.0211550	http://dx.doi.org/10.1371/journal.pone.0211550			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794571	gold, Green Published, Green Submitted			2022-12-27	WOS:000459709100019
J	van Ditzhuijzen, J; Brauer, M; Boeije, H; van Nijnatten, CHCJ				van Ditzhuijzen, Jenneke; Brauer, Marieke; Boeije, Hennie; van Nijnatten, Carolus H. C. J.			Dimensions of decision difficulty in women's decision-making about abortion: A mixed methods longitudinal study	PLOS ONE			English	Article							COMMON MENTAL-DISORDERS; PSYCHIATRIC HISTORY; PARTNER SUPPORT; HEALTH SURVEY; HAD	Relatively little is known about the ease or difficulty with which women decide to have an abortion, and most research uses single-item measurements. We used a mixed methods approach to combine data from the Dutch Abortion and Mental Health Study (DAMHS, n = 325) with data from a qualitative study about the decision process with a small subsample (n = 69) of the DAMHS study. We used the findings from the qualitative study to develop the Dimensions of Abortion Decision Difficulty [DADD] scale, and tested this scale among a larger sample of women who took part in the second wave of the cohort study (n = 264). Qualitative analyses revealed six dimensions of decision difficulty. The DADD scale was based on these six dimensions. Results from the DADD scale at follow-up reduced these to four dimensions: (1) unrealistic fears about the abortion and fantasies about the pregnancy; (2) decision conflict; (3) negative abortion attitudes; and (4) general indecisiveness. Decision conflict was the only dimension related to previous mental disorders. The findings suggest that the concept of decision difficulty seems multidimensional, rather than unidimensional. On a clinical level, it could be important to separate the more general fears, attitudes, and indecisiveness from strong decision conflict, because the latter might involve pressure of others, lack of decision ownership, and might be related to previous mental health.	[van Ditzhuijzen, Jenneke; Brauer, Marieke; van Nijnatten, Carolus H. C. J.] Univ Utrecht, Dept Social & Behav Sci, Interdisciplinary Social Sci, Utrecht, Netherlands; [Boeije, Hennie] Univ Utrecht, Dept Social & Behav Sci, Methods & Stat, Utrecht, Netherlands; [Brauer, Marieke] PsyQ Mental Hlth Serv, Purmerend, Netherlands; [Boeije, Hennie] Netherlands Inst Hlth Serv Res NIVEL, Utrecht, Netherlands	Utrecht University; Utrecht University; Netherlands Institute for Health Services Research	van Ditzhuijzen, J (corresponding author), Univ Utrecht, Dept Social & Behav Sci, Interdisciplinary Social Sci, Utrecht, Netherlands.	j.m.vanditzhuijzen@uu.nl	van Ditzhuijzen, Jenneke/R-5942-2019	van Ditzhuijzen, Jenneke/0000-0003-0560-4949	Dutch Ministry of Health, Welfare and Sport, via the Netherlands Organization for Health Research and Development (ZonMw) [127000003, 127000004]	Dutch Ministry of Health, Welfare and Sport, via the Netherlands Organization for Health Research and Development (ZonMw)	This work was supported by the Dutch Ministry of Health, Welfare and Sport, via the Netherlands Organization for Health Research and Development (ZonMw, www.zonmw.nl, grant number 127000003 for the DAMHS Study, and grant number 127000004 for the qualitative study about abortion decision making). The funding source had no role in study design; the collection, analysis and interpretation of data; in the writing of articles; and in the decision to submit for publication.	Allanson S, 1996, J PSYCHOSOM OBST GYN, V17, P158, DOI 10.3109/01674829609025677; Boeije H., 2009, ANAL QUALITATIVE RES; Broen AN, 2006, ACTA OBSTET GYN SCAN, V85, P317, DOI 10.1080/00016340500438116; de Graaf R, 2010, INT J METH PSYCH RES, V19, P125, DOI 10.1002/mpr.317; Fergusson DM, 2009, BRIT J PSYCHIAT, V195, P420, DOI 10.1192/bjp.bp.109.066068; Fielding SL, 2004, QUAL HEALTH RES, V14, P612, DOI 10.1177/1049732304263677; Finer LB, 2006, CONTRACEPTION, V74, P334, DOI 10.1016/j.contraception.2006.04.010; Foster DG, 2012, PERSPECT SEX REPRO H, V44, P117, DOI 10.1363/4411712; HAMARK B, 1995, ACTA OBSTET GYN SCAN, V74, P302, DOI 10.3109/00016349509024454; Haro JM, 2006, INT J METH PSYCH RES, V15, P167, DOI 10.1002/mpr.196; Kapadia F, 2011, WOMEN HEALTH ISS, V21, pS8, DOI 10.1016/j.whi.2011.02.005; Kero A, 2004, SOC SCI MED, V58, P2559, DOI 10.1016/j.socscimed.2003.09.004; Kero A, 2000, J PSYCHOSOM OBST GYN, V21, P81, DOI 10.3109/01674820009075613; Kessler RC, 2007, WORLD PSYCHIATRY, V6, P168; Kroelinger CD, 2000, BIRTH-ISS PERINAT C, V27, P112, DOI 10.1046/j.1523-536x.2000.00112.x; Levels M, 2012, EUR SOCIOL REV, V28, P301, DOI 10.1093/esr/jcq065; Major B, 2000, ARCH GEN PSYCHIAT, V57, P777, DOI 10.1001/archpsyc.57.8.777; Major B, 2009, AM PSYCHOL, V64, P863, DOI 10.1037/a0017497; Ministerie van Volksgezondheid Welzijn en Sport-Inspectie voor de Gezondheidszorg (IGZ): Dutch Ministry of Public Health, JAARR 2015 WET AFBR; Moore AM, 2011, SOC WORK HEALTH CARE, V50, P424, DOI 10.1080/00981389.2011.575538; Moore AM, 2010, SOC SCI MED, V70, P1737, DOI 10.1016/j.socscimed.2010.02.009; QSR International Pty. Ltd, 2006, NVIVO VERS 9; Small ML, 2011, ANNU REV SOCIOL, V37, P57, DOI 10.1146/annurev.soc.012809.102657; Stronks K, 2009, ETHNIC HEALTH, V14, P255, DOI 10.1080/13557850802509206; Tornbom M, 1999, ACTA OBSTET GYN SCAN, V78, P636, DOI 10.1034/j.1600-0412.1999.780713.x; van Ditzhuijzen J, 2017, PERSPECT SEX REPRO H, V49, P123, DOI 10.1363/psrh.12028; van Ditzhuijzen J, 2017, J PSYCHIATR RES, V84, P200, DOI 10.1016/j.jpsychires.2016.10.006; van Ditzhuijzen J, 2015, CONTRACEPTION, V92, P246, DOI 10.1016/j.contraception.2015.05.003; van Ditzhuijzen J, 2013, J PSYCHIATR RES, V47, P1737, DOI 10.1016/j.jpsychires.2013.07.024; Visser M, EVALUATIE WET AFBREK	30	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212611	10.1371/journal.pone.0212611	http://dx.doi.org/10.1371/journal.pone.0212611			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794621	Green Submitted, Green Published, gold			2022-12-27	WOS:000459709100096
J	Gackler, A; Rohn, H; Lisman, T; Benko, T; Witzke, O; Kribben, A; Saner, FH				Gaeckler, Anja; Rohn, Hana; Lisman, Ton; Benkoe, Tamas; Witzke, Oliver; Kribben, Andreas; Saner, Fuat H.			Evaluation of hemostasis in patients with end stage renal disease	PLOS ONE			English	Article							KIDNEY-DISEASE; PULMONARY-EMBOLISM; RISK; AGGREGOMETRY; ADHESION; FAILURE; POINT	An increased bleeding risk is reported for patients with end-stage renal disease. This study aims to analyze, whether bleeding risk can be assessed by global tests of hemostasis. Standard laboratory tests and an extended evaluation of hemostasis by rotational thromboelastometry, platelet function analyzer (PFA) and multiple electrode aggregometry as well as thrombin generation assays and measurement of fibrinolytic potential were performed in 20 patients on hemodialysis, 10 patients on peritoneal dialysis, 10 patients with chronic kidney disease stage G5 (CKD5) and in 10 healthy controls (HC). Hemoglobin was significantly lower in patients with end-stage renal disease versus HC (each p<0.01). Patients on peritoneal dialysis showed increased fibrinogen levels compared to HC (p<0.01), which were also reflected by FIBTEM results (each p<0.05). 41% of hemodialysis patients and 44% of CKD5 patients presented with prolonged PFA-ADP-test (p<0.05), while no patient on peritoneal dialysis and no HC offered this modification. Thrombin generating potential was significantly lower in patients on hemodialysis, while clot lysis time revealed a hypofibrinolytic state in patients on hemo- and peritoneal dialysis compared to HC (p<0.001). In conclusion, patients with end-stage renal disease have complex hemostatic changes with both hyper- and hypo coagulable features, which are dependent on use and type of dialysis. Hypercoagulable features include elevated fibrinogen levels and a hypofibrinolytic state, whereas hypocoagulable features include decreased thrombin generating capacity and platelet dysfunction. Our results may contribute to a more rational approach to hemostatic management in these patients.	[Gaeckler, Anja; Kribben, Andreas] Univ Duisburg Essen, Univ Hosp Essen, Dept Nephrol, Essen, Germany; [Rohn, Hana; Witzke, Oliver] Univ Duisburg Essen, Univ Hosp Essen, Dept Infect Dis, Essen, Germany; [Lisman, Ton] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Surg Res Lab, Groningen, Netherlands; [Lisman, Ton] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Sect Hepatobiliary Surg & Liver Transplantat, Groningen, Netherlands; [Benkoe, Tamas; Saner, Fuat H.] Univ Duisburg Essen, Univ Hosp Essen, Dept Gen Visceral & Transplant Surg, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Groningen; University of Groningen; University of Duisburg Essen	Gackler, A (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Dept Nephrol, Essen, Germany.	anja.gaeckler@uk-essen.de	Saner, Fuat H/W-8024-2019	Lisman, Ton/0000-0002-3503-7140				Acedillo RR, 2013, ANN SURG, V258, P901, DOI 10.1097/SLA.0000000000000244; Awidi A, 2009, PLATELETS, V20, P297, DOI 10.1080/09537100903006246; Bedreli S, 2017, LIVER INT, V37, P562, DOI 10.1111/liv.13254; Brophy DF, 2014, PERITON DIALYSIS INT, V34, P33, DOI 10.3747/pdi.2013.00036; Cheung KL, 2017, AM J KIDNEY DIS, V70, P182, DOI 10.1053/j.ajkd.2016.10.039; DELASERNA G, 1994, J FAM PRACTICE, V39, P468; Desch S, 2012, CLIN RES CARDIOL, V101, P117, DOI 10.1007/s00392-011-0372-6; GAARDER A., 1961, NATURE, V192, P531, DOI 10.1038/192531a0; Group KAW, 2012, KIDNEY INT, V2, P279, DOI DOI 10.1038/kisup.2012.37; Halimeh S, 2010, KLIN PADIATR, V222, P158, DOI 10.1055/s-0030-1249081; Hemker HC, 2002, PATHOPHYSIOL HAEMO T, V32, P249, DOI 10.1159/000073575; HOROWITZ HI, 1970, ARCH INTERN MED, V126, P823, DOI 10.1001/archinte.126.5.823; Jambor C, 2009, ANESTH ANALG, V109, P25, DOI 10.1213/ane.0b013e3181a27d10; Lisman T, 2017, SEMIN THROMB HEMOST, V43, P178, DOI 10.1055/s-0036-1585081; Lu HY, 2018, BMC NEPHROL, V19, DOI 10.1186/s12882-018-0989-z; Lutz J, 2014, NEPHROL DIAL TRANSPL, V29, P29, DOI 10.1093/ndt/gft209; MARTIN W, 1985, J PHARMACOL EXP THER, V233, P679; Mohapatra A, 2018, INDIAN J NEPHROL, V28, P135, DOI 10.4103/ijn.IJN_104_17; Nieuwenhuijs-Moeke GJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200537; Ocak G, 2013, J THROMB HAEMOST, V11, P627, DOI 10.1111/jth.12141; Ocak G, 2012, J THROMB HAEMOST, V10, P2484, DOI 10.1111/j.1538-7836.2012.04921.x; Pavord S, 2011, BLOOD REV, V25, P271, DOI 10.1016/j.blre.2011.07.001; REMUZZI G, 1978, NEPHRON, V22, P347, DOI 10.1159/000181474; Shlipak MG, 2003, CIRCULATION, V107, P87, DOI 10.1161/01.CIR.0000042700.48769.59; Sibbing D, 2008, THROMB HAEMOSTASIS, V99, P121, DOI 10.1160/TH07-07-0478; Tanhehco YC, 2012, SEMIN DIALYSIS, V25, P539, DOI 10.1111/j.1525-139X.2012.01089.x; Wang IK, 2017, NEPHROL DIAL TRANSPL, V32, P1386, DOI 10.1093/ndt/gfw272; ZWAGINGA JJ, 1991, ARTERIOSCLER THROMB, V11, P733, DOI 10.1161/01.ATV.11.3.733; ZWAGINGA JJ, 1990, BLOOD, V75, P1498	29	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212237	10.1371/journal.pone.0212237	http://dx.doi.org/10.1371/journal.pone.0212237			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785941	Green Submitted, Green Published, gold			2022-12-27	WOS:000459307000053
J	Stroud, JL				Stroud, Jacqueline L.			Soil health pilot study in England: Outcomes from an on-farm earthworm survey	PLOS ONE			English	Article							LUMBRICUS-TERRESTRIS; ORGANIC-MATTER; NO-TILL; COMMUNITIES; POPULATIONS; DIVERSITY; ABUNDANCE	Earthworms are primary candidates for national soil health monitoring as they are ecosystem engineers that benefit both food production and ecosystem services associated with soil security. Supporting farmers to monitor soil health could help to achieve the policy aspiration of sustainable soils by 2030 in England; however, little is known about how to overcome participation barriers, appropriate methodologies (practical, cost-effective, usefulness) or training needs. This paper presents the results from a pilot #60minworms study which mobilised farmers to assess over >1300 ha farmland soils in spring 2018. The results interpretation framework is based on the presence of earthworms from each of the three ecological groups at each observation (20 x 20 cm x 20 cm pit) and spatially across a field (10 soil pits). Results showed that most fields have basic earthworm presence and abundance, but 42% fields may be over-worked as indicated by absence/rarity of epigeic and/or anecic earthworms. Tillage had a negative impact (p < 0.05) on earthworm populations and organic matter management did not mitigate tillage impacts. In terms of farmer participation, Twitter and Farmers Weekly magazine were highly effective channels for recruitment. Direct feedback from participants included excellent scores in trust, value and satisfaction of the protocol (e.g. 100% would do the test again) and 57% would use their worm survey results to change their soil management practices. A key training need in terms of earthworm identification skills was reported. The trade-off between data quality, participation rates and fieldwork costs suggests there is potential to streamline the protocol further to #30minworms (5 pits), incurring farmer fieldwork costs of approximately 1.48 pound ha(-1). At national scales, 14 pound million pounds across 4.7 M ha(-1) in fieldwork costs per survey could be saved by farmer participation.	[Stroud, Jacqueline L.] Rothamsted Res, Sustainable Agr Syst Dept, Harpenden, Herts, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Stroud, JL (corresponding author), Rothamsted Res, Sustainable Agr Syst Dept, Harpenden, Herts, England.	Jacqueline.stroud@rothamsted.ac.uk			Natural Environment Research Council [NE/N019253/1]; BBSRC [BBS/E/C/000J0300] Funding Source: UKRI; NERC [NE/N019253/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funded by NE/N019253/1 Natural Environment Research Council (JLS). https://nerc.ukri.org/ The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andriuzzi WS, 2015, PLANT SOIL, V397, P103, DOI 10.1007/s11104-015-2604-4; Bone J, 2012, ENVIRON SCI TECHNOL, V46, P3687, DOI 10.1021/es203880p; Briones MJI, 2017, GLOBAL CHANGE BIOL, V23, P4396, DOI 10.1111/gcb.13744; Cannon RJC, 1999, ANN APPL BIOL, V135, P597, DOI 10.1111/j.1744-7348.1999.tb00892.x; Chan KY, 2001, SOIL TILL RES, V57, P179, DOI 10.1016/S0167-1987(00)00173-2; DEFRA, 2018, AGR FACTS ENGL REG P; Edwards CA, 1996, EARTHWORM BIOL BIOL, P52; Griffiths B, 2018, SOIL BIOL SOIL HLTH; Gruar D, 2003, IBIS, V145, P637, DOI 10.1046/j.1474-919X.2003.00202.x; Jones DT, 2014, NECR145; Kemper WD, 2011, J SOIL WATER CONSERV, V66, p13A, DOI 10.2489/jswc.66.1.13A; Kibblewhite MG, 2008, PHILOS T R SOC B, V363, P685, DOI 10.1098/rstb.2007.2178; King RA, 2008, MOL ECOL, V17, P4684, DOI 10.1111/j.1365-294X.2008.03931.x; Kladivko EJ, 1997, SOIL BIOL BIOCHEM, V29, P613, DOI 10.1016/S0038-0717(96)00187-3; Knight S., 2012, 502 HGCA; Loveland P, 2003, SOIL TILL RES, V70, P1, DOI 10.1016/S0167-1987(02)00139-3; Martay B, 2018, PEDOBIOLOGIA, V67, P1, DOI 10.1016/j.pedobi.2018.01.002; Ritz K, 2009, ECOL INDIC, V9, P1212, DOI 10.1016/j.ecolind.2009.02.009; Roarty S, 2013, AGR ECOSYST ENVIRON, V170, P45, DOI 10.1016/j.agee.2013.02.011; Rossi JP, 2004, APPL SOIL ECOL, V27, P189, DOI 10.1016/j.apsoil.2004.03.001; Rutgers M, 2016, APPL SOIL ECOL, V97, P98, DOI 10.1016/j.apsoil.2015.08.015; Simonsen J, 2010, APPL SOIL ECOL, V44, P147, DOI 10.1016/j.apsoil.2009.11.005; Singh P, 2015, SCI TOTAL ENVIRON, V518, P337, DOI 10.1016/j.scitotenv.2015.03.027; Six J, 2004, SOIL TILL RES, V79, P7, DOI 10.1016/j.still.2004.03.008; Stroud JL, 2016, APPL SOIL ECOL, V108, P72, DOI 10.1016/j.apsoil.2016.08.002; Stroud JL, 2017, SOIL TILL RES, V165, P11, DOI 10.1016/j.still.2016.07.013; Stroud JL, 2016, APPL SOIL ECOL, V105, P31, DOI 10.1016/j.apsoil.2016.03.019; Targetti S, 2016, J ENVIRON MANAGE, V165, P286, DOI 10.1016/j.jenvman.2015.08.044; Targetti S, 2014, ECOL INDIC, V45, P434, DOI 10.1016/j.ecolind.2014.04.050; Townsend TJ, 2016, SOIL USE MANAGE, V32, P106, DOI 10.1111/sum.12241; van Groenigen JW, 2014, SCI REP-UK, V4, DOI 10.1038/srep06365; Whitmore A.P, 2017, 576 AHDB	32	26	28	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0203909	10.1371/journal.pone.0203909	http://dx.doi.org/10.1371/journal.pone.0203909			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785884	Green Submitted, Green Published, gold			2022-12-27	WOS:000459307000002
J	Chappell, MA; Seiter, JM; West, HM; Durham, BD; Porter, BE; Price, CL				Chappell, Mark A.; Seiter, Jennifer M.; West, Haley M.; Durham, Brian D.; Porter, Beth E.; Price, Cynthia L.			Building geochemically based quantitative analogies from soil classification systems using different compositional datasets	PLOS ONE			English	Article							SOLID-PHASE CONSIDERATIONS; ENVIRONMENTAL FATE; 1,3,5-TRINITRO-1,3,5-TRICYCLOHEXANE RDX; 2,4,6-TRINITROTOLUENE TNT; MULTIVARIATE-ANALYSIS; IDENTIFICATION; SORPTION; TAXA	Soil heterogeneity is a major contributor to the uncertainty in near-surface biogeochemical modeling. We sought to overcome this limitation by exploring the development of a new classification analogy concept for transcribing the largely qualitative criteria in the pedomorphologically based, soil taxonomic classification systems to quantitative physicochemical descriptions. We collected soil horizons classified under the Alfisols taxonomic Order in the U.S. National Resource Conservation Service (NRCS) soil classification system and quantified their properties via physical and chemical characterizations. Using multivariate statistical modeling modified for compositional data analysis (CoDA), we developed quantitative analogies by partitioning the characterization data up into three different compositions: Water-extracted (WE), Mehlich-III extracted (ME), and particle-size distribution (PSD) compositions. Afterwards, statistical tests were performed to determine the level of discrimination at different taxonomic and location-specific designations. The analogies showed different abilities to discriminate among the samples. Overall, analogies made up from the WE composition more accurately classified the samples than the other compositions, particularly at the Great Group and thermal regime designations. This work points to the potential to quantitatively discriminate taxonomically different soil types characterized by varying compositional datasets.	[Chappell, Mark A.; Seiter, Jennifer M.; West, Haley M.; Durham, Brian D.; Porter, Beth E.; Price, Cynthia L.] US Army, Engn Res & Dev Ctr, Environm Lab, Vicksburg, MS 39180 USA	United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC)	Chappell, MA (corresponding author), US Army, Engn Res & Dev Ctr, Environm Lab, Vicksburg, MS 39180 USA.	mark.a.chappell@usace.army.mil			Environmental Quality Technology Program of the US Army Corps of Engineers by the U.S. Army Engineer Research and Development Center (ERDC)	Environmental Quality Technology Program of the US Army Corps of Engineers by the U.S. Army Engineer Research and Development Center (ERDC)	The tests described and the resulting data presented herein, unless otherwise noted, were obtained from research funded under the Environmental Quality Technology Program of the US Army Corps of Engineers by the U.S. Army Engineer Research and Development Center (ERDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The use of trade, product, or firm names in this report is for descriptive purposes only and does not imply endorsement by the U.S. Government. The tests described and the resulting data presented herein, unless otherwise noted, were obtained from research conducted under the Environmental Quality Technology Program of the US Army Corps of Engineers by the U.S. Army Engineer Research and Development Center (ERDC). Permission was granted by the Chief of Engineers to publish this information. The findings of this report are not to be construed as an official Department of the Army position unless so designated by other authorized documents. The authors express gratitude to Dr. Elizabeth Ferguson, Technical Director of the U.S. Army ERDC Environmental Quality Technology Program for support of this research.	Aitchison J, 1999, MATH GEOL, V31, P563, DOI 10.1023/A:1007568008032; Aitchison J, 2002, J R STAT SOC C-APPL, V51, P375, DOI 10.1111/1467-9876.00275; [Anonymous], 2001, MULTIMEDIA ENV MODEL, DOI DOI 10.1201/9781420032543; Ansari AA, 2000, CHEM GEOL, V162, P245, DOI 10.1016/S0009-2541(99)00073-X; Beaudette D., soilDB: soil database interface. R Package Version 2.6.5; Chappell MA, 2014, CHEMOSPHERE, V95, P174, DOI 10.1016/j.chemosphere.2013.08.061; Chappell MA, 2011, ACS SYM SER, V1069, P1; Chappell MA, 2011, MAR POLLUT BULL, V62, P1736, DOI 10.1016/j.marpolbul.2011.05.026; Chappell MA, 2011, APPL GEOCHEM, V26, pS330, DOI 10.1016/j.apgeochem.2011.03.067; Cowan CE, 1995, MULTIMEDIA FATE MODE; DEBAKKER H, 1970, GEODERMA, V4, P195, DOI 10.1016/0016-7061(70)90003-0; Evangelou VP., 1998, ENV SOIL WATER CHEM; Fierer N, 2003, SOIL BIOL BIOCHEM, V35, P167, DOI 10.1016/S0038-0717(02)00251-1; FU JM, 1994, GEOCHIM COSMOCHIM AC, V58, P1591, DOI 10.1016/0016-7037(94)90561-4; Hughes P, 2017, GEODERMA REG, V11, P123, DOI 10.1016/j.geodrs.2017.10.004; Hughes P, 2017, GEODERMA, V307, P198, DOI 10.1016/j.geoderma.2017.08.009; JACKSON DA, 1993, ECOLOGY, V74, P2204, DOI 10.2307/1939574; Ballesta RJ, 2010, CENT EUR J GEOSCI, V2, P441, DOI 10.2478/v10085-010-0028-1; Kahle D, 2013, R J, V5, P144; Katseanes CK, 2017, J ENVIRON MANAGE, V203, P383, DOI 10.1016/j.jenvman.2017.08.005; Katseanes CK, 2016, J ENVIRON MANAGE, V182, P101, DOI 10.1016/j.jenvman.2016.07.043; Katseanes CK, 2014, SOIL FERTILITY STATU; Liu X, 2015, SCI REP-UK, V5, DOI [10.1038/srep14139, 10.1038/srep10007]; Mayo M, 2014, SCI TOTAL ENVIRON, V494, P104, DOI 10.1016/j.scitotenv.2014.06.061; MSS Working Group WRB, 2015, WORLD SOIL RESOURCES; Nachtergaele FO, 2000, GEODERMA, V96, P345, DOI 10.1016/S0016-7061(00)00023-9; NORRIS JM, 1972, J SOIL SCI, V23, P62, DOI 10.1111/j.1365-2389.1972.tb01642.x; Palarea-Albaladejo J, 2015, CHEMOMETR INTELL LAB, V143, P85, DOI 10.1016/j.chemolab.2015.02.019; PawlowskyGlahn V, 2011, COMPOSITIONAL DATA ANALYSIS: THEORY AND APPLICATIONS, P1, DOI 10.1002/9781119976462; Perkey DW, 2017, IDENTIFICATION SEDIM; Ramirez-Guinart O, 2016, GEODERMA, V269, P19, DOI 10.1016/j.geoderma.2016.01.026; Reimann C, 2008, STAT DATA ANAL EXPLA; Singh BK, 2007, APPL SOIL ECOL, V36, P147, DOI 10.1016/j.apsoil.2007.01.004; Sirven JB, 2007, J ANAL ATOM SPECTROM, V22, P1471, DOI 10.1039/b704868h; Suarez MH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111828; Team R. RStudio, 2018, INT DEV R; Team RC., 2013, R LANG ENV STAT COMP; Templ M., 2011, ROBCOMPOSITIONS R PA, DOI 10.1002/9781119976462.ch25; van den Boogaart G, R PACKAGE VERSION 1; Van den Boogaart KG., 2013, ANAL COMPOSITIONAL D; Venables WN., 2002, MODERN APPL STAT S; Wold S., 1977, CHEMOMETRICS THEORY, P243, DOI DOI 10.1021/BK-1977-0052.CH012; ZUMBERGE JE, 1987, GEOCHIM COSMOCHIM AC, V51, P1625, DOI 10.1016/0016-7037(87)90343-7	43	2	2	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212214	10.1371/journal.pone.0212214	http://dx.doi.org/10.1371/journal.pone.0212214			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779791	Green Published, gold, Green Submitted			2022-12-27	WOS:000459062900035
J	Kim, D				Kim, Dongwon			A computational scheme for internal models not requiring precise system parameters	PLOS ONE			English	Article							EQUILIBRIUM-POINT CONTROL; TRAJECTORY FORMATION; REACHING MOVEMENTS; TIME-DELAY; INTERMEDIATE CEREBELLUM; FEEDBACK-CONTROL; PARIETAL CORTEX; ARM MOVEMENTS; MOTOR CONTROL; ADAPTATION	Utilization by humans of a precise and adaptable internal model of the dynamics of the body in generating movements is a well-supported concept. The prevailing opinion is that such an internal model ceaselessly develops through long-term repetition and accumulation in the central nervous system (CNS). However, a long-term learning process would not be absolutely necessary for the formation of internal models. It is possible to estimate the dynamics of the system by using a motor command and its resulting output, instead of constructing a model of the dynamics with precise parameters. In this study, a computational model is proposed that uses a motor command and its corresponding output to estimate the dynamics of the system and it is examined whether the proposed model is capable of describing a series of empirical movements. The proposed model was found to be capable of describing humans' fast movements which require compensation for system dynamics as well as sensory delays. In addition, the proposed model shows equifinality under inertial perturbations as seen in several experimental studies. This satisfactory reproducibility of the proposed computation raises the possibility that humans make a movement by estimating the system dynamics with a copy of motor command and sensory output on a momentary basis, without the need to identify precise system parameters.	[Kim, Dongwon] Univ Maryland, Sch Engn, Dept Biongineering, College Pk, MD 20742 USA; [Kim, Dongwon] Univ Maryland, Sch Med, Dept Phys Therapy & Rehabil Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland Baltimore	Kim, D (corresponding author), Univ Maryland, Sch Engn, Dept Biongineering, College Pk, MD 20742 USA.; Kim, D (corresponding author), Univ Maryland, Sch Med, Dept Phys Therapy & Rehabil Sci, Baltimore, MD 21201 USA.	dwkim@umd.edu		Kim, Dongwon/0000-0003-1051-0031				Baek J, 2016, IEEE T IND ELECTRON, V63, P3628, DOI 10.1109/TIE.2016.2522386; Bard C, 1999, EXP BRAIN RES, V125, P410, DOI 10.1007/s002210050697; Battaglia-Mayer A, 2003, CEREB CORTEX, V13, P1009, DOI 10.1093/cercor/13.10.1009; BIZZI E, 1984, J NEUROSCI, V4, P2738; Burdet E, 2006, BIOL CYBERN, V94, P20, DOI 10.1007/s00422-005-0025-9; Chang PH, 2012, IEEE T ROBOT, V28, P773, DOI 10.1109/TRO.2012.2187397; Cluff T, 2013, J NEUROSCI, V33, P15903, DOI 10.1523/JNEUROSCI.0263-13.2013; Crevecoeur F, 2014, PLOS COMPUT BIOL, V10, DOI [10.1371/journal.pcbi.1003869, 10.1371/journal.pcbi.1003996]; Crevecoeur F, 2018, BIORXIV; de Lussanet MHE, 2002, HUM MOVEMENT SCI, V21, P85, DOI 10.1016/S0167-9457(02)00075-1; de Rugy A, 2012, J NEUROSCI, V32, P7384, DOI 10.1523/JNEUROSCI.5792-11.2012; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; DESMURGET M, 1995, CAN J PHYSIOL PHARM, V73, P262, DOI 10.1139/y95-037; Desmurget M, 1999, NAT NEUROSCI, V2, P563, DOI 10.1038/9219; Diedrichsen J, 2010, TRENDS COGN SCI, V14, P31, DOI 10.1016/j.tics.2009.11.004; Dingwell JB, 2002, J NEUROPHYSIOL, V88, P222, DOI 10.1152/jn.2002.88.1.222; Feldman AG, 2005, EXP BRAIN RES, V161, P91, DOI 10.1007/s00221-004-2049-0; FELDMAN AG, 1986, J MOTOR BEHAV, V18, P17; FELDMAN AG, 1995, BEHAV BRAIN SCI, V18, P723, DOI 10.1017/S0140525X0004070X; Feldman AG, 2009, ADV EXP MED BIOL, V629, P699, DOI 10.1007/978-0-387-77064-2_38; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Fortney K, 2012, NEURAL COMPUT, V24, P611, DOI 10.1162/NECO_a_00237; Friston K, 2011, NEURON, V72, P488, DOI 10.1016/j.neuron.2011.10.018; Gawthrop P, 2011, BIOL CYBERN, V104, P31, DOI 10.1007/s00422-010-0416-4; Gritsenko V, 2009, J NEUROPHYSIOL, V102, P914, DOI 10.1152/jn.91324.2008; Hinder MR, 2003, J PHYSIOL-LONDON, V549, P953, DOI 10.1113/jphysiol.2002.033845; HOFF B, 1993, J MOTOR BEHAV, V25, P175, DOI 10.1080/00222895.1993.9942048; Hsia T. C., 1990, Proceedings 1990 IEEE International Conference on Robotics and Automation (Cat. No.90CH2876-1), P2070, DOI 10.1109/ROBOT.1990.126310; HSIA TCS, 1991, IEEE T IND ELECTRON, V38, P21, DOI 10.1109/41.103479; Hwang EJ, 2006, EXP BRAIN RES, V169, P496, DOI 10.1007/s00221-005-0163-2; Ilic DB, 1996, HUM MOVEMENT SCI, V15, P101, DOI 10.1016/0167-9457(95)00042-9; Jagacinski R. J., 2002, CONTROL THEORY HUMAN; JARIC S, 1994, EXP BRAIN RES, V100, P353; Jaric S, 1999, HUM MOVEMENT SCI, V18, P49, DOI 10.1016/S0167-9457(98)00033-5; Jin M, 2009, IEEE T IND ELECTRON, V56, P3593, DOI 10.1109/TIE.2009.2024097; KALASKA JF, 1990, EXP BRAIN RES, V80, P351; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Kim D., 2013, NONLINEAR DYN, P1; Kim S., 2017, IEEE ASME T MECHATRO; Kistemaker DA, 2006, J NEUROPHYSIOL, V95, P2898, DOI 10.1152/jn.00983.2005; KLEINMAN DL, 1969, IEEE T AUTOMAT CONTR, VAC14, P524, DOI 10.1109/TAC.1969.1099242; KOIKE Y, 1995, BIOL CYBERN, V73, P291, DOI 10.1007/BF00199465; Krakauer JW, 1999, NAT NEUROSCI, V2, P1026, DOI 10.1038/14826; Kurtzer IL, 2008, CURR BIOL, V18, P449, DOI 10.1016/j.cub.2008.02.053; LACKNER JR, 1994, J NEUROPHYSIOL, V72, P299, DOI 10.1152/jn.1994.72.1.299; Latash ML, 2008, J HUM KINET, V19, P3, DOI 10.2478/v10078-008-0001-2; Lee BC, 2016, EXP BRAIN RES, V234, P3523, DOI 10.1007/s00221-016-4750-1; MCINTYRE J, 1993, J MOTOR BEHAV, V25, P193, DOI 10.1080/00222895.1993.9942049; Miall RC, 2006, EXP BRAIN RES, V172, P77, DOI 10.1007/s00221-005-0306-5; MIALL RC, 1993, J MOTOR BEHAV, V25, P203, DOI 10.1080/00222895.1993.9942050; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Mitsuo K, 2003, PROG BRAIN RES, V142, P171; Pinter IJ, 2011, J ELECTROMYOGR KINES, V21, P960, DOI 10.1016/j.jelekin.2011.08.001; Popa LS, 2013, CEREBELLUM, V12, P331, DOI 10.1007/s12311-013-0452-4; Popescu FC, 2000, J NEUROPHYSIOL, V84, P2670, DOI 10.1152/jn.2000.84.5.2670; Popescu FC, 2003, MOTOR CONTROL, V7, P323, DOI 10.1123/mcj.7.4.323; ROTHWELL JC, 1982, BRAIN RES, V248, P33, DOI 10.1016/0006-8993(82)91144-1; Schmid M, 2011, HUM MOVEMENT SCI, V30, P262, DOI 10.1016/j.humov.2011.02.002; Schweighofer N, 1998, EUR J NEUROSCI, V10, P86, DOI 10.1046/j.1460-9568.1998.00006.x; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shadmehr R, 2008, EXP BRAIN RES, V185, P359, DOI 10.1007/s00221-008-1280-5; Shadmehr R, 2017, J NEUROSCI, V37, P1663, DOI 10.1523/JNEUROSCI.1675-16.2016; Smith O. J., 1959, ISA J, V6, P28; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Van Ooteghem K, 2008, EXP BRAIN RES, V187, P603, DOI 10.1007/s00221-008-1329-5; VANKAN PLE, 1993, J NEUROPHYSIOL, V69, P74, DOI 10.1152/jn.1993.69.1.74; VANKAN PLE, 1993, J NEUROPHYSIOL, V69, P57, DOI 10.1152/jn.1993.69.1.57; VANSOEST AJ, 1993, BIOL CYBERN, V69, P195, DOI 10.1007/BF00198959; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2; YOUCEFTOUMI K, 1990, J DYN SYST-T ASME, V112, P133, DOI 10.1115/1.2894130; Zhou T, 2014, EXP BRAIN RES, V232, P3847, DOI 10.1007/s00221-014-4059-x	75	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0210616	10.1371/journal.pone.0210616	http://dx.doi.org/10.1371/journal.pone.0210616			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM9LQ	30811420	Green Published, gold, Green Submitted			2022-12-27	WOS:000459806400008
J	Rittenhouse, KJ; Vwalika, B; Keil, A; Winston, J; Stoner, M; Price, JT; Kapasa, M; Mubambe, M; Banda, V; Muunga, W; Stringer, JSA				Rittenhouse, Katelyn J.; Vwalika, Bellington; Keil, Alexander; Winston, Jennifer; Stoner, Marie; Price, Joan T.; Kapasa, Monica; Mubambe, Mulaya; Banda, Vanilla; Muunga, Whyson; Stringer, Jeffrey S. A.			Improving preterm newborn identification in low-resource settings with machine learning	PLOS ONE			English	Article							LAST MENSTRUAL PERIOD; GESTATIONAL-AGE ESTIMATION; FETAL-GROWTH; INFANTS BORN; ULTRASOUND; MORTALITY; OUTCOMES; TERM; SUPPLEMENTATION; STANDARDS	Background Globally, preterm birth is the leading cause of neonatal death with estimated prevalence and associated mortality highest in low-and middle-income countries (LMICs). Accurate identification of preterm infants is important at the individual level for appropriate clinical intervention as well as at the population level for informed policy decisions and resource allocation. As early prenatal ultrasound is commonly not available in these settings, gestational age (GA) is often estimated using newborn assessment at birth. This approach assumes last menstrual period to be unreliable and birthweight to be unable to distinguish preterm infants from those that are small for gestational age (SGA). We sought to leverage machine learning algorithms incorporating maternal factors associated with SGA to improve accuracy of preterm newborn identification in LMIC settings. Methods and findings This study uses data from an ongoing obstetrical cohort in Lusaka, Zambia that uses early pregnancy ultrasound to estimate GA. Our intent was to identify the best set of parameters commonly available at delivery to correctly categorize births as either preterm (<37 weeks) or term, compared to GA assigned by early ultrasound as the gold standard. Trained midwives conducted a newborn assessment (<72 hours) and collected maternal and neonatal data at the time of delivery or shortly thereafter. New Ballard Score (NBS), last menstrual period (LMP), and birth weight were used individually to assign GA at delivery and categorize each birth as either preterm or term. Additionally, machine learning techniques incorporated combinations of these measures with several maternal and newborn characteristics associated with prematurity and SGA to develop GA at delivery and preterm birth prediction models. The distribution and accuracy of all models were compared to early ultrasound dating. Within our live-born cohort to date (n = 862), the median GA at delivery by early ultrasound was 39.4 weeks (IQR: 38.3-40.3). Among assessed newborns with complete data included in this analysis (n = 468), the median GA by ultrasound was 39.6 weeks (IQR: 38.4-40.3). Using machine learning, we identified a combination of six accessible parameters (LMP, birth weight, twin delivery, maternal height, hypertension in labor, and HIV serostatus) that can be used by machine learning to outperform current GA prediction methods. For preterm birth prediction, this combination of covariates correctly classified >94% of newborns and achieved an area under the curve (AUC) of 0.9796. Conclusions We identified a parsimonious list of variables that can be used by machine learning approaches to improve accuracy of preterm newborn identification. Our best-performing model included LMP, birth weight, twin delivery, HIV serostatus, and maternal factors associated with SGA. These variables are all easily collected at delivery, reducing the skill and time required by the frontline health worker to assess GA.	[Rittenhouse, Katelyn J.; Keil, Alexander; Winston, Jennifer; Stoner, Marie; Price, Joan T.; Stringer, Jeffrey S. A.] Univ N Carolina, Chapel Hill, NC 27515 USA; [Rittenhouse, Katelyn J.; Price, Joan T.] Univ N Carolina, Global Projects Zambia, Lusaka, Zambia; [Vwalika, Bellington; Kapasa, Monica; Mubambe, Mulaya; Banda, Vanilla; Muunga, Whyson] Univ Zambia, Sch Med, Lusaka, Zambia	University of North Carolina; University of North Carolina Chapel Hill; University of Zambia	Rittenhouse, KJ (corresponding author), Univ N Carolina, Chapel Hill, NC 27515 USA.; Rittenhouse, KJ (corresponding author), Univ N Carolina, Global Projects Zambia, Lusaka, Zambia.	katelyn_rittenhouse@med.unc.edu	Stringer, Jeffrey S. A./AAU-2342-2021; Rittenhouse, Katelyn/G-2446-2017	Stringer, Jeffrey/0000-0002-9590-7216; Keil, Alexander/0000-0002-0955-6107; Stoner, Marie/0000-0002-7189-8669; Rittenhouse, Katelyn/0000-0002-5571-0793	Bill and Melinda Gates Foundation [GAPPS 13008/OPP1033514]; US National Institutes of Health through the UNC Center for AIDS Research [P30 AI50410, T32 HD075731, K01 TW010857, D43 TW009340]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924, T32HD075731] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [K01TW010857, D43TW009340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); US National Institutes of Health through the UNC Center for AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Bill and Melinda Gates Foundation grant to the Global Alliance to Prevent Prematurity and Stillbirth (Seattle Children's Hospital/GAPPS 13008/OPP1033514). Additional support was provided by the US National Institutes of Health through the UNC Center for AIDS Research (P30 AI50410) and trainee / mentor support: T32 HD075731 (JTP), K01 TW010857 (JTP), and D43 TW009340 (KR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, ZAMBIA CONSOLIDATION; [Anonymous], 2017, GENMOD PROC SAS STAT; [Anonymous], 2017, GAM PROC SAS STAT 14; BALLARD JL, 1991, J PEDIATR-US, V119, P417, DOI 10.1016/S0022-3476(05)82056-6; BAUMANN C, 1993, Z GEBURTSH PERINATOL, V197, P135; Bembom O, 2007, STAT APPL GENET MOL, V6; Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Castillo Marcela C, 2018, Gates Open Res, V2, P25, DOI 10.12688/gatesopenres.12820.2; Chi BH, 2011, INT J GYNECOL OBSTET, V113, P131, DOI 10.1016/j.ijgo.2010.11.013; CONSTANTINE NA, 1987, J PEDIATR-US, V110, P921, DOI 10.1016/S0022-3476(87)80416-X; Gernand AD, 2016, J HEALTH POPUL NUTR, V35, DOI 10.1186/s41043-016-0072-y; Hoffman CS, 2008, PAEDIATR PERINAT EP, V22, P587, DOI 10.1111/j.1365-3016.2008.00965.x; Huybregts L, 2009, AM J CLIN NUTR, V90, P1593, DOI 10.3945/ajcn.2009.28253; Jehan I, 2010, INT J GYNECOL OBSTET, V110, P231, DOI 10.1016/j.ijgo.2010.03.030; Katz J, 2013, LANCET, V382, P417, DOI 10.1016/S0140-6736(13)60993-9; Keil A., 2018, SUPERLEARNERMACRO; KRAMER MS, 1988, JAMA-J AM MED ASSOC, V260, P3306, DOI 10.1001/jama.260.22.3306; Lawn JE, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S5; Lee A, 2016, PUBLIC HEALTH, V138, P1, DOI 10.1016/j.puhe.2016.07.020; Lee ACC, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-1423; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Lynch CD, 2007, PAEDIATR PERINAT EP, V21, P86, DOI 10.1111/j.1365-3016.2007.00865.x; Malaba LC, 2005, AM J CLIN NUTR, V81, P454, DOI 10.1093/ajcn.81.2.454; Montagu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017155; Mwaniki MK, 2012, LANCET, V379, P445, DOI 10.1016/S0140-6736(11)61577-8; Neufeld LM, 2006, PAEDIATR PERINAT EP, V20, P290, DOI 10.1111/j.1365-3016.2006.00741.x; Papageorghiou AT, 2016, ULTRASOUND OBST GYN, V48, P719, DOI 10.1002/uog.15894; Papageorghiou AT, 2014, ULTRASOUND OBST GYN, V44, P641, DOI 10.1002/uog.13448; Roberfroid D, 2008, AM J CLIN NUTR, V88, P1330, DOI 10.3945/ajcn.2008.26296; Rosenberg RE, 2009, J HEALTH POPUL NUTR, V27, P332; Savitz DA, 2002, AM J OBSTET GYNECOL, V187, P1660, DOI 10.1067/mob.2002.127601; Schmiegelow C, 2012, ACTA OBSTET GYN SCAN, V91, P1061, DOI 10.1111/j.1600-0412.2012.01478.x; Stirnemann J, 2017, ULTRASOUND OBST GYN, V49, P478, DOI 10.1002/uog.17347; Stringer EM, 2011, OBSTET GYNECOL, V117, P1151, DOI 10.1097/AOG.0b013e3182167627; Taylor RAM, 2010, ANN TROP PAEDIATR, V30, P197, DOI 10.1179/146532810X12786388978526; The HPFOREST Procedure, 2016, HPFOREST PROC SAS EN; UNICEF, 2005, STAT WORLDS CHILDR; Villar J, 2018, AM J OBSTET GYNECOL, V218, pS841, DOI 10.1016/j.ajog.2017.11.564; Vwalika B, 2017, INT J GYNECOL OBSTET, V136, P180, DOI 10.1002/ijgo.12036; Wang ML, 2004, PEDIATRICS, V114, P372, DOI 10.1542/peds.114.2.372; Woythaler MA, 2011, PEDIATRICS, V127, pE622, DOI 10.1542/peds.2009-3598; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	43	18	18	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0198919	10.1371/journal.pone.0198919	http://dx.doi.org/10.1371/journal.pone.0198919			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811399	gold, Green Published, Green Submitted			2022-12-27	WOS:000459806400001
J	Motoya, S; Watanabe, K; Ogata, H; Kanai, T; Matsui, T; Suzuki, Y; Shikamura, M; Sugiura, K; Oda, K; Hori, T; Araki, T; Watanabe, M; Hibi, T				Motoya, Satoshi; Watanabe, Kenji; Ogata, Haruhiko; Kanai, Takanori; Matsui, Toshiyuki; Suzuki, Yasuo; Shikamura, Mitsuhiro; Sugiura, Kenkichi; Oda, Kazunori; Hori, Tetsuharu; Araki, Takahiro; Watanabe, Mamoru; Hibi, Toshifumi			Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; QUALITY-OF-LIFE; MAINTENANCE THERAPY; INDUCTION; APHERESIS; EFFICACY	Background Vedolizumab safety and efficacy have been established in many populations all over the world, but have never been studied in Japan. We report results from a Phase 3, randomized, double-blind, placebo-controlled study of vedolizumab in Japanese patients with active ulcerative colitis (UC). Methods Patients with moderate-to-severe UC were enrolled into Cohort 1 (double-blinded) or Cohort 2 (open-label) in the induction phase. Cohort 1 was randomized 2: 1 to receive 300 mg vedolizumab or placebo, while Cohort 2 received vedolizumab 300 mg only, at Weeks 0, 2, and 6. Patients from Cohorts 1 and 2 showing a clinical response to vedolizumab at Week 10 were randomized 1: 1 to receive vedolizumab or placebo (double-blinded) at Week 14 and then every 8 weeks up to Week 54 as the maintenance phase. The primary endpoint was clinical response at Week 10, for the induction phase, and clinical remission at Week 60, for the maintenance phase. Results A total of 292 patients were enrolled into the induction phase (246 in Cohort 1, 46 in Cohort 2); 83 patients achieved response to vedolizumab and were subsequently enrolled into the maintenance phase. Clinical response rates at Week 10 were 39.6% (65/164) and 32.9% (27/82) in the vedolizumab and placebo groups in Cohort 1, respectively (adjusted odds ratio [AOR] = 1.37, 95% CI 0.779-2.399; p = 0.2722). In the maintenance phase, clinical remission rate at Week 60 was significantly higher in the vedolizumab group, at 56.1% (23/41), versus 31.0% (13/42) for placebo (AOR = 2.88, 95% CI 1.168-7.108; p = 0.0210). Most adverse events were mild to moderate in intensity, and no deaths occurred during the study period. Conclusions Vedolizumab showed numerically greater efficacy compared with placebo as induction therapy, but the difference was not statistically significant. Vedolizumab was significantly superior to placebo as maintenance therapy in Japanese patients with UC. Vedolizumab has favourable safety and tolerability in these patients.	[Motoya, Satoshi] Sapporo Kosei Gen Hosp, Hokkaido Prefectural Welf Federat Agr Cooperat, IBD Ctr, Sapporo, Hokkaido, Japan; [Watanabe, Kenji] Hyogo Coll Med, Dept Intestinal Inflammat Res, Nishinomiya, Hyogo, Japan; [Ogata, Haruhiko] Keio Univ, Endoscop Ctr, Sch Med, Tokyo, Japan; [Kanai, Takanori] Keio Univ, Div Gastroenterol & Hepatol, Dept Internal Med, Sch Med, Tokyo, Japan; [Matsui, Toshiyuki] Fukuoka Univ, Dept Gastroenterol, Chikushi Hosp, Fukuoka, Fukuoka, Japan; [Suzuki, Yasuo] Toho Univ, Dept Internal Med, Med Ctr, Sakura Hosp, Chiba, Japan; [Shikamura, Mitsuhiro; Sugiura, Kenkichi; Hori, Tetsuharu; Araki, Takahiro] Takeda Pharmaceut Co, Takeda Dev Ctr Japan, Osaka, Japan; [Oda, Kazunori] Takeda Pharmaceut Co, Regenerat Med Unit, Fujisawa, Kanagawa, Japan; [Watanabe, Mamoru] Tokyo Med & Dent Univ, Dept Gastroenterol & Hepatol, Tokyo, Japan; [Hibi, Toshifumi] Kitasato Univ, Ctr Adv Inflammatory Bowel Dis Res & Treatment, Kitasato Inst Hosp, Tokyo, Japan	Sapporo Kosei General Hospital; Hyogo College of Medicine; Keio University; Keio University; Fukuoka University; Toho University; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd; Tokyo Medical & Dental University (TMDU); Kitasato University	Hibi, T (corresponding author), Kitasato Univ, Ctr Adv Inflammatory Bowel Dis Res & Treatment, Kitasato Inst Hosp, Tokyo, Japan.	thibi@insti.kitasato-u.ac.jp	Watanabe, Mamoru/AHE-0489-2022		Takeda Pharmaceutical Company Limited	Takeda Pharmaceutical Company Limited(Takeda Pharmaceutical Company Ltd)	This study was funded by Takeda Pharmaceutical Company Limited. The sponsor was involved in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.; The authors would like to acknowledge the medical writing support of Luisa Madeira, PhD, of FireKite, an Ashfield company, part of UDG Healthcare plc, during the development of this paper, which was funded by Takeda Pharmaceutical Company Limited in compliance with Good Publication Practice 3 ethical guidelines (Battisti WP, et al. Ann Intern Med 2015; 163: 461-4).	Arimura Y, 2014, J GASTROENTEROL, V49, P1217, DOI 10.1007/s00535-013-0866-2; Asakura K, 2009, J GASTROENTEROL, V44, P659, DOI 10.1007/s00535-009-0057-3; Chang S, 2015, WORLD J GASTROENTERO, V21, P11246, DOI 10.3748/wjg.v21.i40.11246; Colombel JF, 2017, GUT, V66, P839, DOI 10.1136/gutjnl-2015-311079; Faubion WA, 2001, GASTROENTEROLOGY, V121, P255, DOI 10.1053/gast.2001.26279; Feagan BG, 2017, ALIMENT PHARM THER, V45, P264, DOI 10.1111/apt.13852; Feagan BG, 2017, CLIN GASTROENTEROL H, V15, P229, DOI 10.1016/j.cgh.2016.08.044; Feagan BG, 2013, NEW ENGL J MED, V369, P699, DOI 10.1056/NEJMoa1215734; Henriksen M, 2008, GUT, V57, P1518, DOI 10.1136/gut.2007.146357; Hibi T, 2010, IBD RES, V4, P189; Higgins PDR, 2010, DIGEST DIS, V28, P483, DOI 10.1159/000320406; Investigative research group for intractable inflammatory bowel disorders (Watanabe group). Diagnostic criteria for ulcerative colitis, 2012, DIAGN ULC COL 2012 R; Jairath V, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011572.pub2; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Kleinschmidt-DeMasters BK, 2005, NEW ENGL J MED, V353, P369, DOI 10.1056/NEJMoa051782; Kobayashi K, 2019, J CLIN PHARMACOL, V59, P271, DOI 10.1002/jcph.1307; Lewis JD, 2008, INFLAMM BOWEL DIS, V14, P1660, DOI 10.1002/ibd.20520; Martin MD, 2008, ARCH NEUROL-CHICAGO, V65, P1596, DOI 10.1001/archneur.65.12.noc80051; Matsuoka K, 2013, DIGEST DIS, V31, P363, DOI 10.1159/000354696; Ooi CJ, 2010, J GASTROEN HEPATOL, V25, P453, DOI 10.1111/j.1440-1746.2010.06241.x; Ordas I, 2012, LANCET, V380, P1606, DOI 10.1016/S0140-6736(12)60150-0; Paine ER, 2014, GASTROENTEROL REP, V2, P161, DOI 10.1093/gastro/gou028; Roda G, 2016, CLIN TRANSL GASTROEN, V7, DOI 10.1038/ctg.2015.63; Sandborn WJ, 2013, NEW ENGL J MED, V369, P711, DOI 10.1056/NEJMoa1215739; Sands BE, 2008, GASTROENTEROLOGY, V135, P400, DOI 10.1053/j.gastro.2008.04.023; Sands BE, 2014, GASTROENTEROLOGY, V147, P618, DOI 10.1053/j.gastro.2014.05.008; Sarlos Patricia, 2014, World J Gastrointest Pathophysiol, V5, P304, DOI 10.4291/wjgp.v5.i3.304; Sawada K, 2005, AM J GASTROENTEROL, V100, P1362, DOI 10.1111/j.1572-0241.2005.41089.x; Shah SC, 2016, CLIN GASTROENTEROL H, V14, P1245, DOI 10.1016/j.cgh.2016.01.015; Soler D, 2009, J PHARMACOL EXP THER, V330, P864, DOI 10.1124/jpet.109.153973; Suzuki Y, 2014, J GASTROENTEROL, V49, P283, DOI 10.1007/s00535-013-0922-y; Ueno F, 2017, J GASTROENTEROL, V52, P555, DOI 10.1007/s00535-016-1241-x; Villoria A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181435; Waljee AK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158017; Wang Y, 2016, COCHRANE DB SYST REV, V5, DOI DOI 10.1002/14651858; Wang YJ, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000543.pub4	36	44	44	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0212989	10.1371/journal.pone.0212989	http://dx.doi.org/10.1371/journal.pone.0212989			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807613	Green Published, gold, Green Submitted			2022-12-27	WOS:000459712100033
J	Wakasugi, T; Shimizu, I; Yoshida, Y; Hayashi, Y; Ikegami, R; Suda, M; Katsuumi, G; Nakao, M; Hoyano, M; Kashimura, T; Nakamura, K; Ito, H; Nojiri, T; Soga, T; Minamino, T				Wakasugi, Takayuki; Shimizu, Ippei; Yoshida, Yohko; Hayashi, Yuka; Ikegami, Ryutaro; Suda, Masayoshi; Katsuumi, Goro; Nakao, Masaaki; Hoyano, Makoto; Kashimura, Takeshi; Nakamura, Kazufumi; Ito, Hiroshi; Nojiri, Takashi; Soga, Tomoyoshi; Minamino, Tohru			Role of smooth muscle cell p53 in pulmonary arterial hypertension	PLOS ONE			English	Article							CARDIAC DYSFUNCTION; INSULIN-RESISTANCE; SENESCENT CELLS; INFLAMMATION; INHIBITION; PROMOTES; CANCER	Pulmonary arterial hypertension (PAH) is characterized by remodeling and narrowing of the pulmonary arteries, which lead to elevation of right ventricular pressure, heart failure, and death. Proliferation of pulmonary artery smooth muscle cells (PASMCs) is thought to be central to the pathogenesis of PAH, although the underlying mechanisms are still being explored. The protein p53 is involved in cell cycle coordination, DNA repair, apoptosis, and cellular senescence, but its role in pulmonary hypertension (PH) is not fully known. We developed a mouse model of hypoxia-induced pulmonary hypertension (PH) and found significant reduction of p53 expression in the lungs. Our in vitro experiments with metabolomic analyses and the Seahorse XF extracellular flux analyzer indicated that suppression of p53 expression in PASMCs led to upregulation of glycolysis and downregulation of mitochondrial respiration, suggesting a proliferative phenotype resembling that of cancer cells. It was previously shown that systemic genetic depletion of p53 in a murine PH model led to more severe lung manifestations. Lack of information about the role of cell-specific p53 signaling promoted us to investigate it in our mouse PH model with the inducible Cre-loxP system. We generated a mouse model with SMC-specific gain or loss of p53 function by crossing Myh11-Cre/ ERT2 mice with floxed Mdm4 mice or floxed Trp53 mice. After these animals were exposed to hypoxia for 4 weeks, we conducted hemodynamic and echocardiographic studies. Surprisingly, the severity of PH was similar in both groups of mice and there were no differences between the genotypes. Our findings in these mice indicate that activation or suppression of p53 signaling in SMCs has a minor role in the pathogenesis of PH and suggest that p53 signaling in other cells (endothelial cells, immune cells, or fibroblasts) may be involved in the progression of this condition.	[Wakasugi, Takayuki; Shimizu, Ippei; Yoshida, Yohko; Hayashi, Yuka; Ikegami, Ryutaro; Suda, Masayoshi; Katsuumi, Goro; Nakao, Masaaki; Hoyano, Makoto; Kashimura, Takeshi; Minamino, Tohru] Niigata Univ, Grad Sch Med & Dent Sci, Dept Cardiovasc Biol & Med, Niigata, Japan; [Shimizu, Ippei; Yoshida, Yohko] Niigata Univ, Grad Sch Med & Dent Sci, Div Mol Aging & Cell Biol, Niigata, Japan; [Nakamura, Kazufumi; Ito, Hiroshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Med, Okayama, Japan; [Nojiri, Takashi] Natl Cerebral & Cardiovascular Ctr Res Inst, Dept Biochem, Suita, Osaka, Japan; [Soga, Tomoyoshi] Keio Univ, Inst Adv Biosci, Yamagata, Japan	Niigata University; Niigata University; Okayama University; Keio University	Minamino, T (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Cardiovasc Biol & Med, Niigata, Japan.	t_minamino@yahoo.co.jp		Shimizu, Ippei/0000-0003-3333-8131	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [17H04172, 26115008, 18K19536]; Japan Agency for Medical Research and Development (AMED); Takeda Medical Research Foundation; Takeda Science Foundation; SENSHIN Medical Research Foundation; Terumo Foundation; Manpei Suzuki Diabetes Foundation; Naito Foundation; NOVARTIS foundation; Japan Heart Foundation Research Grant; Senri Life Science Foundation; MEXT [16K19531, 18K08098]; Bourbon	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Takeda Medical Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Terumo Foundation; Manpei Suzuki Diabetes Foundation; Naito Foundation(Naito Memorial Foundation); NOVARTIS foundation(Novartis); Japan Heart Foundation Research Grant; Senri Life Science Foundation; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Bourbon	This work was supported by a Grant-in-Aid for Scientific Research (Grant number 17H04172), a Grant-in-Aid for Scientific Research on Innovative Areas (Grant number 26115008), and a Grant-in-Aid for Exploratory Research (Grant number 18K19536) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) and grants from the Japan Agency for Medical Research and Development (AMED), the Takeda Medical Research Foundation, the Takeda Science Foundation, the SENSHIN Medical Research Foundation, the Terumo Foundation, the Manpei Suzuki Diabetes Foundation, the Naito Foundation, and the NOVARTIS foundation (to T.M.), as well as by Japan Heart Foundation Research Grant, The Senri Life Science Foundation, SENSHIN Medical Research Foundation (to I.S.); by a Grant-in-Aid for Encouragement of Young Scientists (B) from MEXT (Grant Number 16K19531) (to Y.Y.); by a Grant-in-Aid for Scientific Research (C) from MEXT (Grant Number 18K08098) (to M.H.); and by a grant from Bourbon (to T.M., I.S. and Y.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer SL, 2010, CIRCULATION, V121, P2045, DOI 10.1161/CIRCULATIONAHA.108.847707; Baar MP, 2017, CELL, V169, P132, DOI 10.1016/j.cell.2017.02.031; Boehme J, 2016, AM J PHYSIOL-HEART C, V311, pH944, DOI 10.1152/ajpheart.00040.2016; Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010; Galie N, 2015, NEW ENGL J MED, V373, P834, DOI 10.1056/NEJMoa1413687; Ghofrani HA, 2013, NEW ENGL J MED, V369, P319, DOI 10.1056/NEJMoa1209657; Grier JD, 2006, MOL CELL BIOL, V26, P192, DOI 10.1128/MCB.26.1.192-198.2006; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Mizuno S, 2011, AM J PHYSIOL-LUNG C, V300, pL753, DOI 10.1152/ajplung.00286.2010; Paulin R, 2014, CIRC RES, V115, P148, DOI 10.1161/CIRCRESAHA.115.301130; Roos CM, 2016, AGING CELL, V15, P973, DOI 10.1111/acel.12458; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Shimizu I, 2014, CELL METAB, V20, P967, DOI 10.1016/j.cmet.2014.10.008; Shimizu I, 2013, CELL METAB, V18, P491, DOI 10.1016/j.cmet.2013.09.001; Shimizu I, 2012, CELL METAB, V15, P51, DOI 10.1016/j.cmet.2011.12.006; Sitbon O, 2014, EUROPEAN RESP J, V44; Sutendra G, 2014, CELL METAB, V19, P558, DOI 10.1016/j.cmet.2014.01.004; Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098; Thenappan T, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.j5492; Xiao YB, 2017, CELL PHYSIOL BIOCHEM, V42, P1603, DOI 10.1159/000479401; Yokoyama M, 2014, CELL REP, V7, P1691, DOI 10.1016/j.celrep.2014.04.046; Yoshida Y, 2015, J MOL CELL CARDIOL, V85, P183, DOI 10.1016/j.yjmcc.2015.06.001	24	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0212889	10.1371/journal.pone.0212889	http://dx.doi.org/10.1371/journal.pone.0212889			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807606	Green Published, gold, Green Submitted			2022-12-27	WOS:000459712100028
J	Assis-Hassid, S; Grosz, BJ; Zimlichman, E; Rozenblum, R; Bates, DW				Assis-Hassid, Shiri; Grosz, Barbara J.; Zimlichman, Eyal; Rozenblum, Ronen; Bates, David W.			Assessing EHR use during hospital morning rounds: A multi-faceted study	PLOS ONE			English	Article							PHYSICIAN ORDER ENTRY; HEALTH RECORD ADOPTION; UNINTENDED CONSEQUENCES; MEDICAL-RECORD; CARE; COMMUNICATION; WORKAROUNDS; QUALITY; KNOWLEDGE; TEAMWORK	Background The majority of U.S hospitals have implemented electronic health records (EHRs). While the benefits of EHRs have been widely touted, little is known about their effects on inpatient care, including how well they meet workflow needs and support care. Objective Assess the extent to which EHRs support care team workflow during hospital morning rounds. Design We applied a mixed-method approach including observations of care teams during morning rounds, semi-structured interviews and an electronic survey of hospital inpatient clinicians. Structured field notes taken during observations were used to identify workflow patterns for analysis. We applied a grounded theory approach to extract emerging themes from interview transcripts and used SPSS Statistics 24 to analyze survey responses. Setting Medical units at a major teaching hospital in New England. Results Data triangulation across the three analyses yielded four main findings: (1) a high degree of variance in the ways care teams use EHRs during morning rounds. (2) Pervasive use of workarounds at critical points of care (3) EHRs are not used for information sharing and frequently impede intra-care team communication. (4) System design and hospital room settings do not adequately support care team workflow. Conclusions Gaps between EHR design and the functionality needed in the complex inpatient environment result in lack of standardized workflows, extensive use of workarounds and team communication issues. These issues pose a threat to patient safety and quality of care. Possible solutions need to include improvements in EHR design, care team training and changes to the hospital room setting.	[Assis-Hassid, Shiri; Grosz, Barbara J.] Harvard John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Assis-Hassid, Shiri; Rozenblum, Ronen; Bates, David W.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Assis-Hassid, Shiri; Rozenblum, Ronen; Bates, David W.] Harvard Med Sch, Boston, MA 02115 USA; [Zimlichman, Eyal] Sheba Med Ctr, Ramat Gan, Israel; [Zimlichman, Eyal] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Bates, David W.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Harvard University; Harvard T.H. Chan School of Public Health	Assis-Hassid, S (corresponding author), Harvard John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA.; Assis-Hassid, S (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.; Assis-Hassid, S (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	hassids@gmail.com	Bates, David/AAE-7283-2019	assis-hassid, shiri/0000-0003-1454-0510	Harvard's Center for Research on Computation and Society (CRCS)	Harvard's Center for Research on Computation and Society (CRCS)	There was no funding of this study other than the first author's post-doc fellowship from Harvard's Center for Research on Computation and Society (CRCS).	Adler-Milstein J, 2015, HEALTH AFFAIR, V34, P2174, DOI 10.1377/hlthaff.2015.0992; Ajami Sima, 2013, Acta Inform Med, V21, P129, DOI 10.5455/aim.2013.21.129-134; Ash JS, 2004, J AM MED INFORM ASSN, V11, P104, DOI 10.1197/jamia.M1471; Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; Bates DW, 2001, J AM MED INFORM ASSN, V8, P299, DOI 10.1136/jamia.2001.0080299; Bates DW, 1999, J AM MED INFORM ASSN, V6, P313, DOI 10.1136/jamia.1999.00660313; Bogardus ST, 1998, J GEN INTERN MED, V13, P675, DOI 10.1046/j.1525-1497.1998.00203.x; Campbell EM, 2006, J AM MED INFORM ASSN, V13, P547, DOI 10.1197/jamia.M2042; Dunn EJ, 2007, JT COMM J QUAL PATIE, V33, P317, DOI 10.1016/S1553-7250(07)33036-5; Embi PJ, 2004, J AM MED INFORM ASSN, V11, P300, DOI 10.1197/jamia.M1525; Falschlunger L, 2016, INFOVIS IMPACT INFOR; Ferneley EH, 2006, EUR J INFORM SYST, V15, P345, DOI 10.1057/palgrave.ejis.3000629; Flanagan ME, 2013, J AM MED INFORM ASSN, V20, pE59, DOI 10.1136/amiajnl-2012-000982; Glasser B.G., 1967, DISCOVERY GROUNDED T; Halbesleben JRB, 2010, HEALTH CARE MANAGE R, V35, P124, DOI 10.1097/HMR.0b013e3181d116c2; Jones SS, 2010, AM J MANAG CARE, V16, pSP64; King HB., 2008, ADV PATIENT SAFETY N; Koppel R, 2008, J AM MED INFORM ASSN, V15, P408, DOI 10.1197/jamia.M2616; Leonard M, 2004, QUAL SAF HEALTH CARE, V13, pI85, DOI 10.1136/qshc.2004.010033; Linder JA, 2007, ARCH INTERN MED, V167, P1400, DOI 10.1001/archinte.167.13.1400; Lisbon D, 2016, AM J MED QUAL, V31, P86, DOI 10.1177/1062860614545123; Makoul G, 2001, J AM MED INFORM ASSN, V8, P610, DOI 10.1136/jamia.2001.0080610; Margalit RS, 2006, PATIENT EDUC COUNS, V61, P134, DOI 10.1016/j.pec.2005.03.004; Martin SA, 2016, LANCET, V388, P2053, DOI 10.1016/S0140-6736(16)00338-X; Menachemi N, 2011, RISK MANAG HEALTHC P, V4, P47, DOI 10.2147/RMHP.S12985; Mueller PA, 2014, PSYCHOL SCI, V25, P1159, DOI 10.1177/0956797614524581; NYGREN E, 1992, COMPUT METH PROG BIO, V39, P1, DOI 10.1016/0169-2607(92)90053-A; Patel VL, 2000, J AM MED INFORM ASSN, V7, P569, DOI 10.1136/jamia.2000.0070569; Patterson ES, 2002, J AM MED INFORM ASSN, V9, P540, DOI 10.1197/jamia.M1061; Plantier M, 2017, INT J MED INFORM, V98, P47, DOI 10.1016/j.ijmedinf.2016.12.002; Poon EG, 2010, MED CARE, V48, P203, DOI 10.1097/MLR.0b013e3181c16203; Ratwani RM, 2015, J AM MED INFORM ASSN, V22, P1179, DOI 10.1093/jamia/ocv050; Saleem JJ, 2011, INT J MED INFORM, V80, P466, DOI 10.1016/j.ijmedinf.2011.03.016; Schiff GD, 2015, BMJ QUAL SAF, V24, P264, DOI 10.1136/bmjqs-2014-003555; Sexton JB, 2000, BMJ-BRIT MED J, V320, P745, DOI 10.1136/bmj.320.7237.745; Singh H, 2013, JAMA INTERN MED, V173, P702, DOI 10.1001/2013.jamainternmed.61; Strauss A., 1998, BASICS QUALITATIVE R; Tawfik DS, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-4134; Unni P, 2016, WHY ARENT THEY HAPPY, P2026	39	14	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2019	14	2							e0212816	10.1371/journal.pone.0212816	http://dx.doi.org/10.1371/journal.pone.0212816			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8EH	30802267	Green Published, gold, Green Submitted			2022-12-27	WOS:000459710700023
J	Isomura, ET; Nakagawa, K; Matsukawa, M; Mitsui, R; Kogo, M				Isomura, Emiko Tanaka; Nakagawa, Kiyoko; Matsukawa, Makoto; Mitsui, Ryou; Kogo, Mikihiko			Evaluation of sites of velopharyngeal structure augmentation in dogs for improvement of velopharyngeal insufficiency	PLOS ONE			English	Article							AUTOLOGOUS FAT TRANSPLANTATION; PHARYNGEAL FLAP SURGERY; LEVATOR VELI PALATINI; SOFT PALATE; CLEFT-PALATE; CONSTRICTOR	Background Velopharyngeal structure augmentation methods are used as alternatives to velopharyngeal plasty. Anatomic sites of implantation/injection vary widely due to a lack of standardized criteria. Here, we experimentally investigated optimal sites of velopharyngeal structure augmentation via saline injection in dogs as they naturally exhibit velopharyngeal insufficiency (VPI). Methods Velopharyngeal structure augmentation was performed on 10 beagles (age range: 20-24 months; weight range: 9-12 kg). Saline containing 1/80,000 epinephrine was injected intraorally in 1-mL increments into the nasal mucosa of the soft palate (n = 4), posterior pharyngeal wall (n = 3), or bilateral pharyngeal walls (n = 3) of each dog. Nasal air leakage was measured under rebreathing until velopharyngeal closure was achieved; the measurement was performed using flow meter sensors on both nasal apertures, and the oral cavity was filled with alginate impression material to prevent oral air leakage. Results Pre-injection, the dogs exhibited an average of 0.455 L/s air leakage from the nasal cavity. The dogs with saline injected into the nasal mucosa of the soft palate achieved steady augmentation, and nasal air leakage disappeared under rebreathing following 6-mL saline injection. Conversely, nasal air leakage remained in the dogs with saline injected in the posterior pharyngeal wall or bilateral pharyngeal walls. Conclusions During VPI treatment in dogs, augmentation was most effective at the nasal mucosa of the soft palate. Improvement in nasal air leakage was highly dependent on the saline injection volume. Although velopharyngeal structures vary between dogs and humans, velopharyngeal closure style is similar. Thus, our results may aid in the treatment of VPI patients.	[Isomura, Emiko Tanaka; Nakagawa, Kiyoko; Matsukawa, Makoto; Mitsui, Ryou; Kogo, Mikihiko] Osaka Univ, Grad Sch Dent, Dept Oral & Maxillofacial Surg 1, Suita, Osaka, Japan; [Isomura, Emiko Tanaka] Osaka Univ Hosp, Unit Dent, Suita, Osaka, Japan	Osaka University; Osaka University	Isomura, ET (corresponding author), Osaka Univ, Grad Sch Dent, Dept Oral & Maxillofacial Surg 1, Suita, Osaka, Japan.; Isomura, ET (corresponding author), Osaka Univ Hosp, Unit Dent, Suita, Osaka, Japan.	tanaemi@dent.osaka-u.ac.jp	Kogo, Mikihiko/ABD-7080-2020; Isomura, Emiko/AAG-7594-2021; Isomura, Emiko Tanaka/GPP-3788-2022	Kogo, Mikihiko/0000-0002-4556-2491; Isomura, Emiko Tanaka/0000-0002-7855-9600				Aboloyoun Ali Ibrahim, 2013, Acta Med Acad, V42, P55, DOI 10.5644/ama2006-124.71; Adachi T, 1997, J DENT RES, V76, P1745, DOI 10.1177/00220345970760110501; Bishop A, 2014, J PLAST RECONSTR AES, V67, P1, DOI 10.1016/j.bjps.2013.09.021; Boneti C, 2015, ANN PLAS SURG, V74, pS190, DOI 10.1097/SAP.0000000000000442; BRAUER RO, 1973, PLAST RECONSTR SURG, V51, P254, DOI 10.1097/00006534-197303000-00003; BROWN AS, 1983, PLAST RECONSTR SURG, V72, P1; Campos LD, 2016, CLEFT PALATE-CRAN J, V53, pE53, DOI 10.1597/14-152; CANADY JW, 1995, CLEFT PALATE-CRAN J, V32, P1, DOI 10.1597/1545-1569(1995)032<0001:AOOTIR>2.3.CO;2; Cantarella G, 2011, OTOLARYNG HEAD NECK, V145, P401, DOI 10.1177/0194599811411655; Dejonckere PH, 2001, ANN OTO RHINOL LARYN, V110, P168, DOI 10.1177/000348940111000213; Filip C, 2014, J PLAST RECONSTR AES, V67, P1155, DOI 10.1016/j.bjps.2014.02.001; Filip C, 2013, J PLAST RECONSTR AES, V66, P337, DOI 10.1016/j.bjps.2012.11.006; Filip C, 2011, CLEFT PALATE-CRAN J, V48, P708, DOI 10.1597/09-161; Klotz DA, 2001, LARYNGOSCOPE, V111, P2157, DOI 10.1097/00005537-200112000-00015; Kodama A., 1983, PRACTICA OTO RHINO L, V76, P2671; Kogo M, 1997, CLEFT PALATE-CRAN J, V34, P338, DOI 10.1597/1545-1569(1997)034<0337:AOSPCA>2.3.CO;2; KOGO M, 1992, CLEFT PALATE-CRAN J, V29, P174, DOI 10.1597/1545-1569(1992)029<0174:RAIRTP>2.3.CO;2; Kogo M, 2017, J CLEFT LIP PALATE C, V4, P189; KOIZUMI H, 1995, J DENT RES, V74, P1235, DOI 10.1177/00220345950740051401; Koizumi H, 1996, CLEFT PALATE-CRAN J, V33, P459, DOI 10.1597/1545-1569(1996)033<0459:CBPALM>2.3.CO;2; Lau D, 2013, CLEFT PALATE-CRAN J, V50, P51, DOI 10.1597/11-038; Leboulanger N, 2011, INT J PEDIATR OTORHI, V75, P1401; Leuchter I, 2010, EUR ARCH OTO-RHINO-L, V267, P977, DOI 10.1007/s00405-009-1157-7; Naran S, 2017, PLAST RECONSTR SURG, V139, p1343E, DOI 10.1097/PRS.0000000000003335; ORR WC, 1987, PLAST RECONSTR SURG, V80, P226, DOI 10.1097/00006534-198708000-00010; REMACLE M, 1990, LARYNGOSCOPE, V100, P269; RODENSTEIN DO, 1986, AM REV RESPIR DIS, V134, P311; RODENSTEIN DO, 1984, J APPL PHYSIOL, V57, P651, DOI 10.1152/jappl.1984.57.3.651; Rogers C, 2016, J CRANIOFAC SURG, V27, P1746, DOI 10.1097/SCS.0000000000003050; RUDING R, 1964, Plast Reconstr Surg, V33, P132, DOI 10.1097/00006534-196402000-00004; VALNICEK SM, 1994, PLAST RECONSTR SURG, V93, P954, DOI 10.1097/00006534-199404001-00009; Woo Albert S, 2012, Semin Plast Surg, V26, P170, DOI 10.1055/s-0033-1333882	32	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2019	14	2							e0212752	10.1371/journal.pone.0212752	http://dx.doi.org/10.1371/journal.pone.0212752			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EH	30802272	Green Published, gold, Green Submitted			2022-12-27	WOS:000459710700018
J	Balyan, R; Crossley, SA; Brown, W; Karter, AJ; McNamara, DS; Liu, JY; Lyles, CR; Schillinger, D				Balyan, Renu; Crossley, Scott A.; Brown, William, III; Karter, Andrew J.; McNamara, Danielle S.; Liu, Jennifer Y.; Lyles, Courtney R.; Schillinger, Dean			Using natural language processing and machine learning to classify health literacy from secure messages: The ECLIPPSE study	PLOS ONE			English	Article							MEDICATION ADHERENCE; DIABETES PATIENTS; TEXT; READABILITY; COMMUNICATION; RECORD; VALIDATION; PHARMACY; VALIDITY; ENGINE	Limited health literacy is a barrier to optimal healthcare delivery and outcomes. Current measures requiring patients to self-report limitations are time-consuming and may be considered intrusive by some. This makes widespread classification of patient health literacy challenging. The objective of this study was to develop and validate "literacy profiles" as automated indicators of patients' health literacy to facilitate a non-intrusive, economic and more comprehensive characterization of health literacy among a health care delivery system's membership. To this end, three literacy profiles were generated based on natural language processing (combining computational linguistics and machine learning) using a sample of 283,216 secure messages sent from 6,941 patients to their primary care physicians. All patients were participants in Kaiser Permanente Northern California's DISTANCE Study. Performance of the three literacy profiles were compared against a gold standard of patient self-reported health literacy. Associations were analyzed between each literacy profile and patient demographics, health outcomes and healthcare utilization. T-tests were used for numeric data such as A1C, Charlson comorbidity index and healthcare utilization rates, and chi-square tests for categorical data such as sex, race, poor adherence and severe hypoglycemia. Literacy profiles varied in their test characteristics, with C-statistics ranging from 0.61-0.74. Relations between literacy profiles and health outcomes revealed patterns consistent with previous health literacy research: patients identified via literacy profiles indicative of limited health literacy: (a) were older and more likely of minority status; (b) had poorer medication adherence and glycemic control; and (c) exhibited higher rates of hypoglycemia, comorbidities and healthcare utilization. This represents the first successful attempt to employ natural language processing to estimate health literacy. Literacy profiles can offer an automated and economical way to identify patients with limited health literacy and greater vulnerability to poor health outcomes.	[Balyan, Renu] Arizona State Univ, Ira A Fulton Sch Engn, Mesa, AZ USA; [Crossley, Scott A.] Georgia State Univ, Coll Arts & Sci, ESL, Dept Appl Linguist, Atlanta, GA 30303 USA; [Brown, William, III; Lyles, Courtney R.; Schillinger, Dean] Univ Calif San Francisco, Dept Med, UCSF Ctr Vulnerable Populat, San Francisco, CA 94143 USA; [Karter, Andrew J.; Liu, Jennifer Y.; Lyles, Courtney R.; Schillinger, Dean] Kaiser Permanente Northern Calif, Div Res, Oakland, CA USA; [McNamara, Danielle S.] Arizona State Univ, Dept Psychol, Tempe, AZ 85287 USA; [Lyles, Courtney R.; Schillinger, Dean] Zuckerberg San Francisco Gen Hosp & Trauma Ctr, San Francisco, CA 94110 USA	Arizona State University; University System of Georgia; Georgia State University; University of California System; University of California San Francisco; Kaiser Permanente; Arizona State University; Arizona State University-Tempe	Schillinger, D (corresponding author), Univ Calif San Francisco, Dept Med, UCSF Ctr Vulnerable Populat, San Francisco, CA 94143 USA.; Schillinger, D (corresponding author), Kaiser Permanente Northern Calif, Div Res, Oakland, CA USA.; Schillinger, D (corresponding author), Zuckerberg San Francisco Gen Hosp & Trauma Ctr, San Francisco, CA 94110 USA.	dean.schillinger@ucsf.edu		, Renu/0000-0003-1393-2416	National Institutes of Health [NLM R01 LM012355]; NIDDK Centers for Diabetes Translational Research [P30 DK092924, R01 DK065664]; NICHD [R01 HD46113]; Institute of Education Sciences, U.S. Department of Education [R305A120707, R305A180261]; KPNC; ALT LLC; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092924] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM012355] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK Centers for Diabetes Translational Research; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Institute of Education Sciences, U.S. Department of Education(US Department of Education); KPNC; ALT LLC; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work has been supported by grants NLM R01 LM012355 from the National Institutes of Health, NIDDK Centers for Diabetes Translational Research (P30 DK092924), R01 DK065664, NICHD R01 HD46113 and Institute of Education Sciences, U.S. Department of Education, through grants R305A120707 and R305A180261. Even though Andrew J. Karter and Jennifer Y. Liu are employed by Kaiser Permanente Northern California and Danielle S. McNamara owns a company (Adaptive Literacy Technologies LLC), none of their work has been funded by KPNC or ALT LLC, not even in the form of salaries. The funders or KPNC or ALT LLC did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2006, P LREC; [Anonymous], 2004, P 20 INT C COMP LING, DOI DOI 10.3115/1220355.1220409; Aronson AR, 2010, J AM MED INFORM ASSN, V17, P229, DOI 10.1136/jamia.2009.002733; Baayen R. H, 1995, CELEX LEXICAL DATABA; Bailey SC, 2014, DIABETES EDUCATOR, V40, P581, DOI 10.1177/0145721714540220; Balyan R, 2017, P 10 INT C ED DAT MI; Bauer AM, 2013, J GEN INTERN MED, V28, P1181, DOI 10.1007/s11606-013-2402-8; BNC Consortium, 2001, BRIT NAT CORP VERS 2; Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061; Carrell DS, 2015, INT J MED INFORM, V84, P1057, DOI 10.1016/j.ijmedinf.2015.09.002; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chew LD, 2008, J GEN INTERN MED, V23, P561, DOI 10.1007/s11606-008-0520-5; COLTHEART M, 1981, Q J EXP PSYCHOL-A, V33, P497, DOI 10.1080/14640748108400805; Crossley S. A., 2016, J ED DATA MINING, V8, P1; Crossley SA., 2014, MULTIDIMENSIONAL ANA, P197, DOI [10.1075/scl.60.07cro, DOI 10.1075/SCL.60.07CRO]; Crossley SA, 2013, FLAIRS C MAY 19; Crossley S, 2017, LECT NOTES ARTIF INT, V10318, P330, DOI 10.1007/978-3-319-59888-8_28; Crossley S, 2016, LAK '16 CONFERENCE PROCEEDINGS: THE SIXTH INTERNATIONAL LEARNING ANALYTICS & KNOWLEDGE CONFERENCE,, P6, DOI 10.1145/2883851.2883931; Crossley SA, 2017, DISCOURSE PROCESS, V54, P340, DOI 10.1080/0163853X.2017.1296264; Crossley SA, 2017, BEHAV RES METHODS, V49, P803, DOI 10.3758/s13428-016-0743-z; Crossley SA, 2016, BEHAV RES METHODS, V48, P1227, DOI 10.3758/s13428-015-0651-7; Cunningham JW, 2018, READ WRIT, V31, P813, DOI 10.1007/s11145-017-9815-4; Demner-Fushman D, 2009, J BIOMED INFORM, V42, P760, DOI 10.1016/j.jbi.2009.08.007; Denny Joshua C, 2003, AMIA Annu Symp Proc, P195; DeWalt DA, 2012, CIRCULATION; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Diviani N, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4018; Doak CC, 1996, TEACHING PATIENTS LO; Doak L G, 1987, Promot Health, V8, P6; Doan S, 2016, ACAD EMERG MED, V23, P628, DOI 10.1111/acem.12925; Flesch R, 1948, J APPL PSYCHOL, V32, P221, DOI 10.1037/h0057532; Francois T., 2012, P 1 WORKSH PRED IMPR, P49; Frantzi K., 2000, INT J DIGITAL LIB, V3, P115, DOI [DOI 10.1007/S007999900023, 10.1007/s007999900023]; Friedman C, 1995, Proc Annu Symp Comput Appl Med Care, P347; Gemoets D, 2004, ST HEAL T, V107, P869; Ginde Adit A, 2008, BMC Endocr Disord, V8, P4, DOI 10.1186/1472-6823-8-4; Grigonyte G., 2014, P 3 WORKSH PRED IMPR, P74; Gunning R., 1952, TECHNIQUE CLEAR WRIT; Han J, 2012, MOR KAUF D, P1; Harris LT, 2013, DIABETES CARE, V36, P2726, DOI 10.2337/dc12-2003; Heintzelman NH, 2013, J AM MED INFORM ASSN, V20, P898, DOI 10.1136/amiajnl-2012-001076; Hewett M, 2002, NUCLEIC ACIDS RES, V30, P163, DOI 10.1093/nar/30.1.163; Joachims T., 1998, Machine Learning: ECML-98. 10th European Conference on Machine Learning. Proceedings, P137, DOI 10.1007/BFb0026683; Johnson SB, 1999, J AM MED INFORM ASSN, V6, P205, DOI 10.1136/jamia.1999.0060205; Kandula Sasikiran, 2008, AMIA Annu Symp Proc, P353; Karter AJ, 2015, HEALTH SERV RES, V50, P537, DOI 10.1111/1475-6773.12223; Kauchak D, 2014, P ANN HICSS, P2616, DOI 10.1109/HICSS.2014.330; Kim H, 2017, PATIENT EDUC COUNS, V100, P1073, DOI 10.1016/j.pec.2017.01.015; Kim Hyeoneui, 2007, AMIA Annu Symp Proc, P418; Kyle K, 2017, BEHAV RES METHODS, P1; Kyle K, MEASURING SYNTACTIC; Kyle K, 2015, TESOL QUART, V49, P757, DOI 10.1002/tesq.194; Lu XF, 2010, INT J CORPUS LINGUIS, V15, P474, DOI 10.1075/ijcl.15.4.02lu; Lyles CR, 2016, J AM MED INFORM ASSN, V23, pE28, DOI 10.1093/jamia/ocv126; Lyles CR, 2013, J AM MED INFORM ASSN, V20, P1128, DOI 10.1136/amiajnl-2012-001567; Machtinger EL, 2007, JT COMM J QUAL PATIE, V33, P625, DOI 10.1016/S1553-7250(07)33072-9; MCLAUGHLIN GH, 1969, J READING, V12, P639; McNamara DS, 2013, BEHAV RES METHODS, V45, P499, DOI 10.3758/s13428-012-0258-1; MILLER GA, 1995, COMMUN ACM, V38, P39, DOI 10.1145/219717.219748; Mitchell, 1997, MACH LEARN, V45, P870; Moffet HH, 2009, INT J EPIDEMIOL, V38, P38, DOI 10.1093/ije/dyn040; Nadkarni PM, 2011, J AM MED INFORM ASSN, V18, P544, DOI 10.1136/amiajnl-2011-000464; Nobata C, 2008, P 31 ANN INT ACM SIG, P787, DOI DOI 10.1145/1390334.1390504; Oda K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S3-S5; Osborne JD, 2016, J AM MED INFORM ASSN, V23, P1077, DOI 10.1093/jamia/ocw006; Raebel MA, 2013, MED CARE, V51, pS11, DOI 10.1097/MLR.0b013e31829b1d2a; Ratanawongsa N, 2013, JAMA INTERN MED, V173, P210, DOI 10.1001/jamainternmed.2013.1216; Reed M, 2013, JAMA-J AM MED ASSOC, V310, P1060, DOI 10.1001/jama.2013.276733; Reed M, 2012, ANN INTERN MED, V157, P482, DOI 10.7326/0003-4819-157-7-201210020-00004; Sarkar U, 2014, MED CARE, V52, P194, DOI 10.1097/MLR.0000000000000069; Sarkar U, 2011, J GEN INTERN MED, V26, P265, DOI 10.1007/s11606-010-1552-1; Sarkar U, 2010, J GEN INTERN MED, V25, P962, DOI 10.1007/s11606-010-1389-7; Sasaki Y, 2008, P 3 INT S SEM MIN BI, V3, P109; Savova GK, 2010, J AM MED INFORM ASSN, V17, P507, DOI 10.1136/jamia.2009.001560; Schillinger D, 2002, JAMA-J AM MED ASSOC, V288, P475, DOI 10.1001/jama.288.4.475; Schillinger D, 2004, PATIENT EDUC COUNS, V52, P315, DOI 10.1016/S0738-3991(03)00107-1; Schillinger D, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/1348242; Scholkopf Bernhard., 2002, LEARNING KERNELS SUP; Semere W, 2018, SOC GEN INT MED ANN; Smith S., 2015, J EPIDEMIOL COMMUNIT; Soysal E, 2017, J AM MED INFORM ASS; STEINER JF, 1988, MED CARE, V26, P814, DOI 10.1097/00005650-198808000-00007; Steiner JF, 1997, J CLIN EPIDEMIOL, V50, P105, DOI 10.1016/S0895-4356(96)00268-5; Strauss JA, 2013, J AM MED INFORM ASSN, V20, P349, DOI 10.1136/amiajnl-2012-000928; Thompson P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144717; Thorn Caroline F, 2013, Methods Mol Biol, V1015, P311, DOI 10.1007/978-1-62703-435-7_20; Tsuruoka Y, 2008, BIOINFORMATICS, V24, P2559, DOI 10.1093/bioinformatics/btn469; Uzuner O, 2008, J AM MED INFORM ASSN, V15, P14, DOI 10.1197/jamia.M2408; Uzuner O, 2007, J AM MED INFORM ASSN, V14, P550, DOI 10.1197/jamia.M2444; Uzuner O, 2010, J AM MED INFORM ASSN, V17, P514, DOI 10.1136/jamia.2010.003947; Uzuner O, 2009, J AM MED INFORM ASSN, V16, P561, DOI 10.1197/jamia.M3115; Van Gurp M, 2006, KR MED; Venturi G, 2015, P 6 INT WORKSH HLTH, P131; Wu DTY, 2013, STUD HEALTH TECHNOL, V192, P647, DOI 10.3233/978-1-61499-289-9-647; Zeng-Treitler Q, 2012, METHOD ESTIMATE READ; Zheng JP, 2018, JMIR MED INF, V6, DOI 10.2196/medinform.8611	97	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212488	10.1371/journal.pone.0212488	http://dx.doi.org/10.1371/journal.pone.0212488			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794616	Green Published, Green Submitted, gold			2022-12-27	WOS:000459709100078
J	Bistoletti, M; Caputi, V; Baranzini, N; Marchesi, N; Filpa, V; Marsilio, I; Cerantola, S; Terova, G; Baj, A; Grimaldi, A; Pascale, A; Frigo, G; Crema, F; Giron, MC; Giaroni, C				Bistoletti, Michela; Caputi, Valentina; Baranzini, Nicolo; Marchesi, Nicoletta; Filpa, Viviana; Marsilio, Ilaria; Cerantola, Silvia; Terova, Genciana; Baj, Andreina; Grimaldi, Annalisa; Pascale, Alessia; Frigo, Gianmario; Crema, Francesca; Giron, Maria Cecilia; Giaroni, Cristina			Antibiotic treatment-induced dysbiosis differently affects BDNF and TrkB expression in the brain and in the gut of juvenile mice	PLOS ONE			English	Article							NEUROTROPHIC FACTOR CONTRIBUTES; ENTERIC NERVOUS-SYSTEM; MYENTERIC PLEXUS; MICROBIOTA; STRESS; AXIS; LOCALIZATION; PLASTICITY; RECEPTORS; ISCHEMIA	Antibiotic use during adolescence may result in dysbiosis-induced neuronal vulnerability both in the enteric nervous system (ENS) and central nervous system (CNS) contributing to the onset of chronic gastrointestinal disorders, such as irritable bowel syndrome (IBS), showing significant psychiatric comorbidity. Intestinal microbiota alterations during adolescence influence the expression of molecular factors involved in neuronal development in both the ENS and CNS. In this study, we have evaluated the expression of brain-derived neurotrophic factor (BDNF) and its high-affinity receptor tropomyosin-related kinase B (TrkB) in juvenile mice ENS and CNS, after a 2-week antibiotic (ABX) treatment. In both mucosa and mucosa-deprived whole-wall small intestine segments of ABX-treated animals, BDNF and TrKB mRNA and protein levels significantly increased. In longitudinal muscle-myenteric plexus preparations of ABX-treated mice the percentage of myenteric neurons staining for BDNF and TrkB was significantly higher than in controls. After ABX treatment, a consistent population of BDNF-and TrkB-immunoreactive neurons costained with SP and CGRP, suggesting up-regulation of BDNF signaling in both motor and sensory myenteric neurons. BDNF and TrkB protein levels were downregulated in the hippocampus and remained unchanged in the prefrontal cortex of ABX-treated animals. Immunostaining for BDNF and TrkB decreased in the hippocampus CA3 and dentate gyrus subregions, respectively, and remained unchanged in the prefrontal cortex. These data suggest that dysbiosis differentially influences the expression of BDNF-TrkB in the juvenile mice ENS and CNS. Such changes may potentially contribute later to the development of functional gut disorders, such as IBS, showing psychiatric comorbidity.	[Bistoletti, Michela; Filpa, Viviana; Baj, Andreina; Giaroni, Cristina] Univ Insubria, Dept Med & Surg, Varese, Italy; [Caputi, Valentina; Marsilio, Ilaria; Cerantola, Silvia; Giron, Maria Cecilia] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy; [Caputi, Valentina] Univ Coll Cork, APC Microbiome Ireland, Cork, Ireland; [Baranzini, Nicolo; Terova, Genciana; Grimaldi, Annalisa] Univ Insubria, Dept Biotechnol & Life Sci, Varese, Italy; [Marchesi, Nicoletta; Pascale, Alessia] Univ Pavia, Dept Drug Sci, Pavia, Italy; [Frigo, Gianmario; Crema, Francesca] Univ Pavia, Sect Pharmacol, Dept Internal Med & Therapeut, Pavia, Italy	University of Insubria; University of Padua; University College Cork; University of Insubria; University of Pavia; University of Pavia	Giaroni, C (corresponding author), Univ Insubria, Dept Med & Surg, Varese, Italy.	cristina.giaroni@uninsubria.it	Terova, Genciana/AAL-6412-2021; Marchesi, Nicoletta/GQZ-7428-2022; Giron, Maria Cecilia/AAL-4438-2021; Baj, Andreina/C-8047-2013; Terova, Genciana/G-1779-2010; Baranzini, Nicoló/AAK-9531-2021; Baranzini, Nicolò/AFW-4561-2022; giaroni, cristina/A-8181-2011	Terova, Genciana/0000-0002-7532-7951; Marchesi, Nicoletta/0000-0001-6271-1420; Giron, Maria Cecilia/0000-0002-0825-7965; Baj, Andreina/0000-0003-0088-2712; Terova, Genciana/0000-0002-7532-7951; GIARONI, CRISTINA/0000-0002-3760-3441; Baranzini, Nicolo/0000-0001-6996-4797	University of Insubria (FAR 2016-2018); University of Pavia (FAR 2016-2018); University of Padova (UNIPD-Assegno di Ricerca 2016, San Camillo Hospital, Treviso (Italy)); University of Padova (UNIPD-ex 60%-2017); University of Padova (UNIPD-PRID 2017)	University of Insubria (FAR 2016-2018); University of Pavia (FAR 2016-2018); University of Padova (UNIPD-Assegno di Ricerca 2016, San Camillo Hospital, Treviso (Italy)); University of Padova (UNIPD-ex 60%-2017); University of Padova (UNIPD-PRID 2017)	This research was supported by the University of Insubria (FAR 2016-2018 to CG, AB, AG), the University of Pavia (FAR 2016-2018 to FC) and the University of Padova (UNIPD-Assegno di Ricerca 2016, San Camillo Hospital, Treviso (Italy), UNIPD-ex 60%-2017, UNIPD-PRID 2017 to MCG).	Aguirre JE, 2017, NEUROGASTROENT MOTIL, V29, DOI 10.1111/nmo.13081; Anitha M, 2012, GASTROENTEROLOGY, V143, P1006, DOI 10.1053/j.gastro.2012.06.034; Autry AE, 2012, PHARMACOL REV, V64, P238, DOI 10.1124/pr.111.005108; Bercik P, 2011, GASTROENTEROLOGY, V141, P599, DOI 10.1053/j.gastro.2011.04.052; Bin A, 2018, PURINERG SIGNAL, V14, P409, DOI 10.1007/s11302-018-9623-6; Boesmans W, 2008, GUT, V57, DOI 10.1136/gut.2007.131839; Borre YE, 2014, TRENDS MOL MED, V20, P509, DOI 10.1016/j.molmed.2014.05.002; Brun P, 2015, MOL CELL NEUROSCI, V68, P24, DOI 10.1016/j.mcn.2015.03.018; Brun P, 2013, GASTROENTEROLOGY, V145, P1323, DOI 10.1053/j.gastro.2013.08.047; Caputi V, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061689; Caputi V, 2017, BRIT J PHARMACOL, V174, P3623, DOI 10.1111/bph.13965; Carpanese E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113613; Ceccotti C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201760; Champagne-Jorgensen K, 2019, BRAIN BEHAV IMMUN, V77, P7, DOI 10.1016/j.bbi.2018.12.014; Chen F, 2014, ACTA PHYSIOL, V212, P226, DOI 10.1111/apha.12374; Chen FX, 2012, REGUL PEPTIDES, V178, P86, DOI 10.1016/j.regpep.2012.07.001; Coulie B, 2000, GASTROENTEROLOGY, V119, P41, DOI 10.1053/gast.2000.8553; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Deltheil T, 2008, NEUROPHARMACOLOGY, V55, P1006, DOI 10.1016/j.neuropharm.2008.08.001; Desbonnet L, 2015, BRAIN BEHAV IMMUN, V48, P165, DOI 10.1016/j.bbi.2015.04.004; Duman RS, 2001, J PHARMACOL EXP THER, V299, P401; Enck P, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.14; Farzaei MH, 2016, J NEUROGASTROENTEROL, V22, P558, DOI 10.5056/jnm16001; Filpa V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18020-7; Filpa V, 2017, AM J PHYSIOL-GASTR L, V312, pG374, DOI 10.1152/ajpgi.00386.2016; Filpa V, 2016, NEUROPHARMACOLOGY, V111, P14, DOI 10.1016/j.neuropharm.2016.08.024; Foster JA, 2017, NEUROBIOL STRESS, V7, P124, DOI 10.1016/j.ynstr.2017.03.001; Giaroni C, 2011, NEUROGASTROENT MOTIL, V23, pe91, DOI 10.1111/j.1365-2982.2010.01644.x; Giaroni C, 2015, AUTON NEUROSCI-BASIC, V191, P67, DOI 10.1016/j.autneu.2015.04.009; Grider JR, 2007, AM J PHYSIOL-GASTR L, V292, pG429, DOI 10.1152/ajpgi.00376.2006; Grider JR, 2006, GASTROENTEROLOGY, V130, P771, DOI 10.1053/j.gastro.2005.12.026; Guida F, 2018, BRAIN BEHAV IMMUN, V67, P230, DOI 10.1016/j.bbi.2017.09.001; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Hoehner JC, 1996, GASTROENTEROLOGY, V110, P756, DOI 10.1053/gast.1996.v110.pm8608885; Hyland NP, 2016, DEV BIOL, V417, P182, DOI 10.1016/j.ydbio.2016.06.027; Kabouridis PS, 2015, J CLIN INVEST, V125, P956, DOI 10.1172/JCI76308; Lai KO, 2012, NAT NEUROSCI, V15, P1506, DOI 10.1038/nn.3237; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Lima Giacobbo B, 2018, MOL NEUROBIOL; Lommatzsch M, 1999, AM J PATHOL, V155, P1183, DOI 10.1016/S0002-9440(10)65221-2; Luo XG, 2001, NEUROSCI RES, V39, P377, DOI 10.1016/S0168-0102(00)00238-8; Maqsood R, 2016, NEUROCHEM RES, V41, P2819, DOI 10.1007/s11064-016-2039-1; Matto J, 2005, FEMS IMMUNOL MED MIC, V43, P213, DOI 10.1016/j.femsim.2004.08.009; Minichiello L, 2002, NEURON, V36, P121, DOI 10.1016/S0896-6273(02)00942-X; Moloney RD, 2014, MAMM GENOME, V25, P49, DOI 10.1007/s00335-013-9488-5; Murphy MC, 2010, J COMP NEUROL, V518, P2934, DOI 10.1002/cne.22372; Olen O, 2018, NEUROGASTROENT MOTIL, V30, DOI 10.1111/nmo.13436; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; Pawlowska K, 2018, J PEDIATR-US, V199, P171, DOI 10.1016/j.jpeds.2018.02.069; Qu ZD, 2008, CELL TISSUE RES, V334, P147, DOI 10.1007/s00441-008-0684-7; Quan XJ, 2015, DIGEST DIS SCI, V60, P2316, DOI 10.1007/s10620-015-3695-8; Reikvam DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017996; Rhee SH, 2009, NAT REV GASTRO HEPAT, V6, P306, DOI 10.1038/nrgastro.2009.35; Salio C, 2007, DEV NEUROBIOL, V67, P326, DOI 10.1002/dneu.20358; Sender R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002533; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; Ubeda C, 2012, TRENDS IMMUNOL, V33, P459, DOI 10.1016/j.it.2012.05.003; von Boyen GBT, 2002, J GASTROENTEROL, V37, P583, DOI 10.1007/s005350200093; Wang P, 2016, SCI REP, V6, P20230, DOI [10.1038/srep20230, DOI 10.1038/SREP20230]; Wellman CL, 2018, PSYCHOPHARMACOLOGY B; Wessels JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094036; Xia CM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-30; Yang J, 2010, EUR J PAIN, V14, P574, DOI 10.1016/j.ejpain.2009.10.007; Yu YB, 2012, GUT, V61, P685, DOI 10.1136/gutjnl-2011-300265	65	37	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212856	10.1371/journal.pone.0212856	http://dx.doi.org/10.1371/journal.pone.0212856			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794676	gold, Green Published, Green Submitted			2022-12-27	WOS:000459709100149
J	Cao, YP; Meng, DD; Chen, TZ; Chen, Y; Zeng, W; Zhang, L; Wang, Q; Hen, W; Abdullah, M; Jin, Q; Lin, Y; Cai, YP				Cao, Yunpeng; Meng, Dandan; Chen, Tianzhe; Chen, Yu; Zeng, Wei; Zhang, Lei; Wang, Qi; Hen, Wei; Abdullah, Muhammad; Jin, Qing; Lin, Yi; Cai, Yongping			Metacaspase gene family in Rosaceae genomes: Comparative genomic analysis and their expression during pear pollen tube and fruit development	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; WIDE IDENTIFICATION; RESPONSIVE EXPRESSION; PYRUS-BRETSCHNEIDERI; PRUNUS-PERSICA; STRESS; SOFTWARE; BARLEY	Metacaspase (MC), which is discovered gene family with distant caspase homologs in plants, fungi, and protozoa, may be involved in programmed cell death (PCD) processes during plant development and respond abiotic and biotic stresses. To reveal the evolutionary relationship of MC gene family in Rosaceae genomes, we identified 8, 7, 8, 12, 12, and 23 MC genes in the genomes of Fragaria vesca, Prunus mume, Prunus persica, Pyrus communis, Pyrus bretschneideri and Malus domestica, respectively. Phylogenetic analysis suggested that the MC genes could be grouped into three clades: Type I*, Type I and Type II, which was supported by gene structure and conserved motif analysis. Microsynteny analysis revealed that MC genes present in the corresponding syntenic blocks of P. communis, P. bretschneideri and M. domestica, and further suggested that large-scale duplication events play an important role in the expansion of MC gene family members in these three genomes than other Rosaceae plants (F. vesca, P. mume and P. persica). RNA-seq data showed the specific expression patterns of PbMC genes in response to drought stress. The expression analysis of MC genes demonstrated that PbMC01 and PbMC03 were able to be detected in all four pear pollen tubes and seven fruit development stages. The current study highlighted the evolutionary relationship and duplication of the MC gene family in these six Rosaceae genomes and provided appropriate candidate genes for further studies in P. bretschneideri.	[Cao, Yunpeng; Meng, Dandan; Chen, Tianzhe; Chen, Yu; Zeng, Wei; Zhang, Lei; Abdullah, Muhammad; Jin, Qing; Lin, Yi; Cai, Yongping] Anhui Agr Univ, Sch Life Sci, Hefei, Anhui, Peoples R China; [Wang, Qi; Hen, Wei] Anhui Agr Univ, Coll Hort, Hefei, Anhui, Peoples R China	Anhui Agricultural University; Anhui Agricultural University	Cai, YP (corresponding author), Anhui Agr Univ, Sch Life Sci, Hefei, Anhui, Peoples R China.	swkx12@ahau.edu.cn	Cao, Yunpeng/E-8960-2019	Cao, Yunpeng/0000-0001-5976-2382; Zeng, wei/0000-0002-5613-867X	National Natural Science Foundation of China [31640068]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by The National Natural Science Foundation of China (grant 31640068; Yongping Can). The Funding bodies were not involved in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.	Bailey TL, 2015, NUCLEIC ACIDS RES, V43, pW39, DOI 10.1093/nar/gkv416; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bollhoner B, 2013, NEW PHYTOL, V200, P498, DOI 10.1111/nph.12387; Bostancioglu SM, 2018, MOL BIOL REP, V45, P211, DOI 10.1007/s11033-018-4154-3; Cai B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-79; Cao Yunpeng, 2018, R Soc Open Sci, V5, P171463, DOI 10.1098/rsos.171463; Cao YP, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7070077; Cao YP, 2018, FUNCT INTEGR GENOMIC, V18, P519, DOI 10.1007/s10142-018-0609-9; Cao YP, 2018, GENES-BASEL, V9, DOI 10.3390/genes9040224; Cao YP, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1105-4; Cao YP, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00078; Cao YP, 2017, PEERJ, V5, DOI 10.7717/peerj.3400; Cao YP, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00577; Chagne D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092644; Chen C., 2020, TBTOOLS TOOLKIT BIOL, V289660, P289660, DOI DOI 10.1101/289660; Choi CJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.21; Coll NS, 2010, SCIENCE, V330, P1393, DOI 10.1126/science.1194980; Daccord N, 2017, NAT GENET, V49, P1099, DOI 10.1038/ng.3886; Duan YF, 2010, NEW PHYTOL, V186, P681, DOI 10.1111/j.1469-8137.2010.03207.x; Fagundes D, 2015, FUNCT INTEGR GENOMIC, V15, P639, DOI 10.1007/s10142-015-0459-7; Hao L, 2007, PLANT CELL REP, V26, P1879, DOI 10.1007/s00299-007-0387-7; He R, 2008, J BIOL CHEM, V283, P774, DOI 10.1074/jbc.M704185200; Huang L, 2015, INT J MOL SCI, V16, P16216, DOI 10.3390/ijms160716216; Huang SL, 2014, PLANT PHYSIOL, V165, P810, DOI 10.1104/pp.114.239335; Jiang L, 2018, PEERJ, V6, DOI 10.7717/peerj.4615; Jiang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141037; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim SM, 2013, MOL PLANT PATHOL, V14, P557, DOI 10.1111/mpp.12027; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kwon SI, 2013, J PLANT BIOL, V56, P391, DOI 10.1007/s12374-013-0290-4; Lam E, 2012, TRENDS PLANT SCI, V17, P487, DOI 10.1016/j.tplants.2012.05.003; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Li Z, 2012, NEW PHYTOL, V195, P85, DOI 10.1111/j.1469-8137.2012.04131.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu H, 2016, BIOCHEM BIOPH RES CO, V479, P523, DOI 10.1016/j.bbrc.2016.09.103; Liu H, 2016, PLANT PHYSIOL BIOCH, V105, P90, DOI 10.1016/j.plaphy.2016.04.011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Minina EA, 2013, J CELL BIOL, V203, P917, DOI 10.1083/jcb.201307082; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263; Muthamilarasan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109920; Olvera-Carrillo Y, 2015, PLANT PHYSIOL, V2015; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Tombuloglu H, 2013, MOL GENET GENOMICS, V288, P141, DOI 10.1007/s00438-013-0740-1; Tombuloglu H, 2012, CHEMOSPHERE, V86, P433, DOI 10.1016/j.chemosphere.2011.09.035; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tsiatsiani L, 2011, CELL DEATH DIFFER, V18, P1279, DOI 10.1038/cdd.2011.66; Vercammen D, 2007, J CELL BIOL, V179, P375, DOI 10.1083/jcb.200705193; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Wang LK, 2014, J GENET, V93, P93, DOI 10.1007/s12041-014-0343-6; Wang XD, 2012, MOL PLANT MICROBE IN, V25, P755, DOI 10.1094/MPMI-11-11-0283-R; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1293, 10.1093/nar/gkr1132]; Watanabe N, 2005, J BIOL CHEM, V280, P14691, DOI 10.1074/jbc.M413527200; Watanabe N, 2011, PLANT J, V66, P969, DOI 10.1111/j.1365-313X.2011.04554.x; Wertman J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-115; Wu J, 2013, GENOME RES, V23, P396, DOI 10.1101/gr.144311.112; Zhang CH, 2013, GENE, V528, P267, DOI 10.1016/j.gene.2013.06.062; Zhang QX, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2290; Zhou HS, 2016, GENE EXPR PATTERNS, V20, P11, DOI 10.1016/j.gep.2015.10.004; Zhou Y, 2018, GENOME, V61, P187, DOI 10.1139/gen-2017-0174	62	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0211635	10.1371/journal.pone.0211635	http://dx.doi.org/10.1371/journal.pone.0211635			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794567	Green Published, Green Submitted, gold			2022-12-27	WOS:000459709100021
J	Fried, HG; Narayanan, S; Fallen, B				Fried, Harrison Gregory; Narayanan, Sruthi; Fallen, Benjamin			Evaluation of soybean [Glycine max (L.) Merr.] genotypes for yield, water use efficiency, and root traits	PLOS ONE			English	Article							THIN WAX-LAYERS; PENETRATION ABILITY; DROUGHT TOLERANCE; MAIZE; WHEAT; RICE; SOIL; REGISTRATION; STRESS; FIELD	Drought stress has been identified as the major environmental factor limiting soybean [Glycine max (L.) Merr.] yield worldwide. Current breeding efforts in soybean largely focus on identifying genotypes with high seed yield and drought tolerance. Water use efficiency (WUE) that results in greater yield per unit rainfall is an important parameter in determining crop yields in many production systems, and is often related with crop drought tolerance. Even though roots are major plant organs that perceive and respond to drought stress, their utility in improving soybean yield and WUE under different environmental and management conditions are largely unclear. The objectives of this research was to evaluate soybean cultivars and breeding and germplasm lines for yield, WUE, root penetrability of hardpan, and root morphology. Field experiments were conducted at two locations in South Carolina (southeastern United States) during the 2017 cropping season to test the genotypes for yield and root morphology under irrigated and non-irrigated conditions. Two independent controlled-environmental experiments were conducted to test the genotypes for WUE and root penetrability of synthetic hardpans. The slow wilting lines NTCPR94-5157 and N09-13890 had equal or greater yield than the checks-cultivar NC-Raleigh and the elite South Carolina breeding line SC07-1518RR, under irrigated and non-irrigated conditions. The high yielding genotypes NTCPR94-5157, N09-13890, and SC07-1518RR exhibited root parsimony (reduced root development). This supported the recent hypothesis in literature that root parsimony would have adaptational advantage to improve yield under high input field conditions. The high yielding genotypes NTCPR94-5157, N09-13890, NC-Raleigh, and SC07-1518RR and a cultivar Boggs (intermediate in yield) possessed high WUE and had increased root penetrability of hardpans. These genotypes offer useful genetic materials for soybean breeding programs for improving yield, drought tolerance, and/or hardpan penetrability.	[Fried, Harrison Gregory; Narayanan, Sruthi] Clemson Univ, Dept Plant & Environm Sci, Clemson, SC 29634 USA; [Fallen, Benjamin] Clemson Univ, Pee Dee Res & Educ Ctr, Florence, SC 29506 USA	Clemson University; Clemson University	Narayanan, S (corresponding author), Clemson Univ, Dept Plant & Environm Sci, Clemson, SC 29634 USA.	skutty@clemson.edu		Fallen, Ben/0000-0001-7185-5493; Narayanan, Sruthi/0000-0002-8844-7880	Clemson University Research Grant Committee Project Initiation Grant [1503168]; National Institute of Food and Agriculture/United States Department of Agriculture (NIFA/USDA) [SC- 1700533]	Clemson University Research Grant Committee Project Initiation Grant; National Institute of Food and Agriculture/United States Department of Agriculture (NIFA/USDA)	This research was funded by Clemson University Research Grant Committee Project Initiation Grant number 1503168 (SN, BF) and National Institute of Food and Agriculture/United States Department of Agriculture (NIFA/USDA) project number SC- 1700533 (SN, BF). The open access publication fee was provided by Clemson University Libraries Open Access Publishing Fund Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna TLB, 2007, PLANT SOIL, V301, P135, DOI 10.1007/s11104-007-9428-9; Acuna TLB, 2005, AUST J AGR RES, V56, P1235, DOI 10.1071/AR05067; Allard RW, 1991, MANAGING GLOBAL GENE; [Anonymous], 1999, P WORLD SOYB RES C C; Battisti R, 2015, EXP AGR, V51, P285, DOI 10.1017/S0014479714000283; Battisti R, 2017, AGRON J, V109, P1612, DOI 10.2134/agronj2017.01.0023; Bellaloui N, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00498; Blum A, 2005, AUST J AGR RES, V56, P1159, DOI 10.1071/AR05069; BOLANOS J, 1993, FIELD CROP RES, V31, P269, DOI 10.1016/0378-4290(93)90066-V; Botta GF, 2010, SOIL TILL RES, V110, P167, DOI 10.1016/j.still.2010.07.001; BOWERS GR, 1990, CROP SCI, V30, P427, DOI 10.2135/cropsci1990.0011183X003000020049x; Bunce J. A., 2016, American Journal of Plant Sciences, V7, P773, DOI 10.4236/ajps.2016.76071; Burridge J, 2016, FIELD CROP RES, V192, P21, DOI 10.1016/j.fcr.2016.04.008; Burton JW, 2006, CROP SCI, V46, P2710, DOI 10.2135/cropsci2005.11.0410; Busscher WJ, 2000, COMMUN SOIL SCI PLAN, V31, P3089, DOI 10.1080/00103620009370652; Chen P, 2007, J PLANT REGIST, V1, P166, DOI 10.3198/jpr2007.01.0046crg; Chimungu JG, 2015, J EXP BOT, V66, P3151, DOI 10.1093/jxb/erv121; Clark LJ, 2008, FUNCT PLANT BIOL, V35, P1163, DOI 10.1071/FP08132; Clark LJ, 2000, PLANT SOIL, V219, P187, DOI 10.1023/A:1004753900945; Clark LJ, 2002, FIELD CROP RES, V76, P189, DOI 10.1016/S0378-4290(02)00039-4; de Moraes MT, 2018, PLANT SOIL, V428, P67, DOI 10.1007/s11104-018-3656-z; Djanaguiraman M, 2013, CROP SCI, V53, P1594, DOI 10.2135/cropsci2012.07.0441; Fenta BA, 2014, AGRONOMY-BASEL, V4, P418, DOI 10.3390/agronomy4030418; FITTER AH, 2002, PLANT ROOTS HIDDEN H, P249; Foyer CH, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.112, 10.1038/nplants.2016.112]; Fried HG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200463; Gao YZ, 2016, J EXP BOT, V67, P4545, DOI 10.1093/jxb/erw243; Gillen AM, 2015, UN SOYB TESTS SO STA; Hufstetler EV, 2007, CROP SCI, V47, P25, DOI 10.2135/cropsci2006.04.0243; King CA, 2009, CROP SCI, V49, P290, DOI 10.2135/cropsci2008.04.0219; Kunert KJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01015; LEE GJ, 2002, AGRONOMY ABSTRACTS; Lynch JP, 2018, J EXP BOT, V69, P3279, DOI 10.1093/jxb/ery048; Lynch JP, 2013, ANN BOT-LONDON, V112, P347, DOI 10.1093/aob/mcs293; Manschadi AM, 2008, PLANT SOIL, V303, P115, DOI 10.1007/s11104-007-9492-1; Mertz-Henning LM, 2018, AGRONOMY-BASEL, V8, DOI 10.3390/agronomy8010003; Mourtzinis S, 2017, AGRON J, V109, P1397, DOI 10.2134/agronj2016.10.0581; Narayanan S, 2014, AGRON J, V106, P1593, DOI 10.2134/agronj14.0015; Narayanan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100317; Narayanan S, 2013, AGRON J, V105, P649, DOI 10.2134/agronj2012.0377; Nelson KA, 2005, AGRON J, V97, P832, DOI 10.2134/agronj2004.0241; Oya T, 2004, PLANT PROD SCI, V7, P129, DOI 10.1626/pps.7.129; Purcell LC, 2004, AGRON MONOGR ASA, V16, P520; Richards RA, 2002, CROP SCI, V42, P111, DOI 10.2135/cropsci2002.0111; Sadok W, 2012, CROP SCI, V52, P1261, DOI 10.2135/cropsci2011.11.0622; Scott W.O., 1970, MODERN SOYBEAN PRODU; Sebastian J, 2016, P NATL ACAD SCI USA, V113, P8861, DOI 10.1073/pnas.1604021113; Sinclair TR, 2007, FIELD CROP RES, V101, P68, DOI 10.1016/j.fcr.2006.09.010; Soy Stats, 2018, 2017 SOYST REF GUID; Soybean Official Variety Trials Clemson University, 2017, SOYB OFF VAR TRIALS; Soybean Official Variety Trials Clemson University, 2014, SOYB OFF VAR TRIALS; Soybean Official Variety Trials Clemson University, 2013, SOYB OFF VAR TRIALS; Soybean Official Variety Trials Clemson University, 2016, SOYB OFF VAR TRIALS; Soybean Official Variety Trials University of Georgia, 2013, SOYB OFF VAR TRIALS; Specht JE, 1999, CROP SCI, V39, P1560, DOI 10.2135/cropsci1999.3961560x; Specht JE, 2001, CROP SCI, V41, P493, DOI 10.2135/cropsci2001.412493x; Trachsel S, 2011, PLANT SOIL, V341, P75, DOI 10.1007/s11104-010-0623-8; van Oosterom EJ, 2016, FUNCT PLANT BIOL, V43, P502, DOI 10.1071/FP15308; Xin Z, 2008, FIELD CROP RES, V107, P180, DOI 10.1016/j.fcr.2008.02.006; Xin ZG, 2009, FIELD CROP RES, V111, P74, DOI 10.1016/j.fcr.2008.10.010; YU LX, 1995, CROP SCI, V35, P684, DOI 10.2135/cropsci1995.0011183X003500030005x; Zheng HG, 2000, GENOME, V43, P53, DOI 10.1139/gen-43-1-53; Zhu JM, 2011, CURR OPIN PLANT BIOL, V14, P310, DOI 10.1016/j.pbi.2011.03.020; Zipper SC, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/9/094021	64	28	30	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212700	10.1371/journal.pone.0212700	http://dx.doi.org/10.1371/journal.pone.0212700			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794664	Green Published, gold, Green Submitted			2022-12-27	WOS:000459709100120
J	He, H; Yang, X; Xu, ZH; Deng, N; Shang, YJ; Liu, G; Ji, MY; Zheng, WH; Zhao, JF; Dong, LY				He, Hu; Yang, Xu; Xu, Zhiheng; Deng, Ning; Shang, Yingjie; Liu, Guo; Ji, Mengyao; Zheng, Wenhao; Zhao, Jinfeng; Dong, Liya			Implementing artificial neural networks through bionic construction	PLOS ONE			English	Article								It is evident through biology research that, biological neural network could be implemented through two means: by congenital heredity, or by posteriority learning. However, traditionally, artificial neural network, especially the Deep learning Neural Networks (DNNs) are implemented only through exhaustive training and learning. Fixed structure is built, and then parameters are trained through huge amount of data. In this way, there are a lot of redundancies in the implemented artificial neural network. This redundancy not only requires more effort to train the network, but also costs more computing resources when used. In this paper, we proposed a bionic way to implement artificial neural network through construction rather than training and learning. The hierarchy of the neural network is designed according to analysis of the required functionality, and then module design is carried out to form each hierarchy. We choose the Drosophila's visual neural network as a test case to verify our method's validation. The results show that the bionic artificial neural network built through our method could work as a bionic compound eye, which can achieve the detection of the object and their movement, and the results are better on some properties, compared with the Drosophila's biological compound eyes.	[He, Hu; Xu, Zhiheng; Deng, Ning; Shang, Yingjie; Dong, Liya] Tsinghua Univ, Inst Microelect, Beijing, Peoples R China; [Yang, Xu; Liu, Guo; Ji, Mengyao; Zheng, Wenhao; Zhao, Jinfeng] Beijing Inst Technol, Sch Comp Sci & Technol, Beijing, Peoples R China	Tsinghua University; Beijing Institute of Technology	Yang, X (corresponding author), Beijing Inst Technol, Sch Comp Sci & Technol, Beijing, Peoples R China.	yangxu@tsinghua.edu.cn		Yang, Xu/0000-0001-7983-6473	National Natural Science Foundation of China [91846303, 61502032]; Core Electronic Devices, High-End General Purpose Processor, and Fundamental System Software of China [2012ZX01034-001-002]; Tsinghua National Laboratory for Information Science and Technology (TNList); Samsung Tsinghua Joint Laboratory	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Core Electronic Devices, High-End General Purpose Processor, and Fundamental System Software of China; Tsinghua National Laboratory for Information Science and Technology (TNList); Samsung Tsinghua Joint Laboratory(Samsung)	This work is supported by the National Natural Science Foundation of China under Grant No. 91846303 (for Xu Yang), the National Natural Science Foundation of China under Grant No. 61502032 (for Xu Yang), the Core Electronic Devices, High-End General Purpose Processor, and Fundamental System Software of China under Grant No. 2012ZX01034-001-002 (for Hu He), Tsinghua National Laboratory for Information Science and Technology (TNList) (for Hu He), and Samsung Tsinghua Joint Laboratory (for Hu He). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmedova S, 2015, ICIMCO 2015 PROCEEDINGS OF THE 12TH INTERNATIONAL CONFERENCE ON INFORMATICS IN CONTROL, AUTOMATION AND ROBOTICS, VOL. 1, P310; Nguyen A, 2015, PROC CVPR IEEE, P427, DOI 10.1109/CVPR.2015.7298640; Arena P, 2011, INSECT BRAIN INSPIRE; Arena P, 2013, INT JOINT C NEUR NET; Chang H M, 2013, 2013 IEEE 2 NETW SCI; Chen L, 2016, ASSEMBLY AUTOM, V36, P172, DOI 10.1108/AA-11-2015-105; Egmont-Petersen M, 2002, PATTERN RECOGN, V35, P2279, DOI 10.1016/S0031-3203(01)00178-9; HEISENBERG M, 1977, J COMP PHYSIOL, V117, P127, DOI 10.1007/BF00612784; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Li Dingyuan, 2015, Journal of Mechanical Engineering, V51, P128, DOI 10.3901/JME.2015.22.128; Lin CY, 2013, IEEE INT C BIOINFORM; Ma  Hailin, 2016, INT C ART NEUR NETW; Ma  Hailin, 2016, 25 ANN COMP NEUR M; Masland RH, 2013, NATURE, V500, P154, DOI 10.1038/500154a; Mauss AS, 2014, J NEUROSCI, V34, P2254, DOI 10.1523/JNEUROSCI.3938-13.2014; Morante J, 2008, CURR BIOL, V18, P553, DOI 10.1016/j.cub.2008.02.075; Rigosi E, 2017, SCI REP-UK, V7, DOI 10.1038/srep45972; Rowley H A, 1996, IEEE T PATTERN ANAL, V20, P203, DOI DOI 10.1109/CVPR.1996.517075; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Zaknich A, 1998, IEEE T SIGNAL PROCES, V46, P1980, DOI 10.1109/78.700969; Zhang J, 2006, WCICA 2006: SIXTH WORLD CONGRESS ON INTELLIGENT CONTROL AND AUTOMATION, VOLS 1-12, CONFERENCE PROCEEDINGS, P2733; Zhu Y, 2013, CELL ADHES MIGR, V7, P333, DOI 10.4161/cam.25521; Zuker C. S, 1996, P NATL ACAD SCI US	23	4	4	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212368	10.1371/journal.pone.0212368	http://dx.doi.org/10.1371/journal.pone.0212368			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794587	Green Submitted, Green Published, gold			2022-12-27	WOS:000459709100057
J	Morris, RJ; Ingvalson, EM; Kaschak, MP; Smith, AN				Morris, Richard J.; Ingvalson, Erin M.; Kaschak, Michael P.; Smith, Alissa N.			The effect of the menstrual cycle on dichotic listening	PLOS ONE			English	Article							RIGHT-EAR ADVANTAGE; COGNITIVE CONTROL; ATTENTION; HORMONES; PERCEPTION; STIMULI; ADULTS	The purpose of this study was to determine the effect of the menstrual cycle on responses to a dichotic listening task. It was hypothesized that participants would exhibit a stronger right ear advantage during the menstrual cycle days when estrogen levels are at their peak. It was also hypothesized that the women not taking oral contraceptives would exhibit greater variations in ear advantage over the course of their menstrual cycle than those taking oral contraceptives. Finally, it was hypothesized that the error response rates would remain similar across different listening conditions and over the menstrual cycle. The participants were 30 women who took oral contraceptives and 15 who did not. They completed nine listening sessions comprised of three dichotic listening tasks: forced-left, forced-right, and open. The data were analyzed using a mixed effects models. The participants exhibited a reduction in right ear responses on the days that corresponded to when the level of estrogen would begin to increase. This response was different from what had been hypothesized. The analysis also indicated no response differences between the two groups of women. In addition, the women exhibited fewer errors over the course of the sessions, implying that they adapted to the task. The results indicate that the women's hormone fluctuation across the menstrual cycle affected their responses to the forced-left, cognitive control, task only.	[Morris, Richard J.; Ingvalson, Erin M.; Smith, Alissa N.] Florida State Univ, Sch Commun Sci & Disorders, Tallahassee, FL 32306 USA; [Kaschak, Michael P.] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA; [Smith, Alissa N.] Lee Mem Hosp, Acute Rehabil, Ft Myers, FL USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University	Morris, RJ (corresponding author), Florida State Univ, Sch Commun Sci & Disorders, Tallahassee, FL 32306 USA.	richard.morris@cci.fsu.edu		Kaschak, Michael/0000-0002-7704-4904; Morris, Richard/0000-0003-4274-7500; Ingvalson, Erin/0000-0002-5498-2543				Al-Mana D, 2008, NEUROSCIENCE, V153, P881, DOI 10.1016/j.neuroscience.2008.02.077; Al-Mana D, 2010, HEARING RES, V268, P114, DOI 10.1016/j.heares.2010.05.007; Alexander GM, 2002, NEUROPSYCHOLOGIA, V40, P1293, DOI 10.1016/S0028-3932(01)00220-2; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Batta Meenal, 2017, Int J Appl Basic Med Res, V7, P44, DOI 10.4103/2229-516X.198522; Carneiro CD, 2019, INT ARCH OTORHINOLAR, V23, P70, DOI 10.1055/s-0038-1626701; Cole LA, 2009, FERTIL STERIL, V91, P522, DOI 10.1016/j.fertnstert.2007.11.073; Cowell P, 2000, DEV NEUROPSYCHOL, V18, P95, DOI 10.1207/S15326942DN1801_6; Cowell PE, 2011, BRAIN COGNITION, V76, P256, DOI 10.1016/j.bandc.2011.03.010; Falkenberg LE, 2011, BRAIN COGNITION, V76, P276, DOI 10.1016/j.bandc.2011.02.006; Guion SG, 2000, J ACOUST SOC AM, V107, P2711, DOI 10.1121/1.428657; Hampson E, 2002, BEHAV ENDOCRINOLOGY, P579; Hausmann M, 2006, CLIN NEUROPHYSIOL, V117, P26, DOI 10.1016/j.clinph.2005.08.022; Hillenbrand JM, 2005, J SPEECH LANG HEAR R, V48, P45, DOI 10.1044/1092-4388(2005/005); Hiscock M, 1999, J CLIN EXP NEUROPSYC, V21, P265, DOI 10.1080/13803395.2019.12054455; Hiscock M, 2011, BRAIN COGNITION, V76, P263, DOI 10.1016/j.bandc.2011.03.016; Hjelmervik H, 2012, PSYCHONEUROENDOCRINO, V37, P1866, DOI 10.1016/j.psyneuen.2012.03.021; Hodgetts S, 2015, HORM BEHAV, V74, P194, DOI 10.1016/j.yhbeh.2015.06.019; Hu XJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187672; Hugdahl K, 1999, NEUROPSYCHOLOGIA, V37, P431, DOI 10.1016/S0028-3932(98)00101-8; Hugdahl K, 2003, ASYMMETRICAL BRAIN, P441; INGLIS J, 1962, CAN J PSYCHOLOGY, V16, P11, DOI 10.1037/h0083232; Kimura D., 1967, CORTEX, V3, P163, DOI DOI 10.1016/S0010-9452(67)80010-8; Markevych V, 2011, BRAIN COGNITION, V76, P332, DOI 10.1016/j.bandc.2011.02.004; McNamara A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111891; R Development Core Team, 2009, R LANG ENV STAT COMP; Stirnemann JJ, 2013, HUM REPROD, V28, P1110, DOI 10.1093/humrep/des449; Wadnerkar MB, 2008, LATERALITY, V13, P297, DOI 10.1080/13576500701821106	28	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212673	10.1371/journal.pone.0212673	http://dx.doi.org/10.1371/journal.pone.0212673			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794649	gold, Green Published, Green Submitted			2022-12-27	WOS:000459709100110
J	Tateyama, Y; Musumari, PM; Techasrivichien, T; Suguimoto, SP; Zulu, R; Dube, C; Feldman, MD; Ono-Kihara, M; Kihara, M				Tateyama, Yukiko; Musumari, Patou Masika; Techasrivichien, Teeranee; Suguimoto, S. Pilar; Zulu, Richard; Dube, Christopher; Feldman, Mitchell D.; Ono-Kihara, Masako; Kihara, Masahiro			Dietary habits, body image, and health service access related to cardiovascular diseases in rural Zambia: A qualitative study	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; NONCOMMUNICABLE DISEASES; SOUTH-AFRICA; OBESITY; HYPERTENSION; ALBUMINURIA; PERCEPTIONS; CHALLENGES; DISTRICT; HIV	Background Cardiovascular diseases are among the leading causes of mortality and morbidity in sub-Saharan Africa, including Zambia, where cardiovascular diseases account for 8% of the mortality rates. Despite an increasing number of cardiovascular disease-related studies in Zambia, qualitative studies exploring how cardiovascular diseases and their risk factors are understood in the socioeconomic and cultural contexts are still few. This study, therefore, aimed to analyze the beliefs, perceptions, and behaviors related to cardiovascular diseases and their risk factors among the local residents of Zambia. Methods This qualitative study was conducted from August to September 2014 among healthy residents aged 40 years and above in a rural community in Mumbwa District. We investigated the beliefs, perceptions, and behaviors related to cardiovascular diseases and their potential risk factors in the sociocultural context of Zambia by conducting in-depth interviews and focus group interviews. Audio-recorded interviews were transcribed and analyzed using thematic analysis with investigator triangulation. Results We conducted 34 in-depth interviews and 6 focus group interviews with 27 males and 40 females. Most participants were aware of the prevalence of cardiovascular diseases around them and correctly identified hypertension, excessive salt, sugar, and cooking oil intakes, poor quality cooking oil, consumption of meat or vegetables contaminated with chemicals, obesity, stress ["thinking too much"], lack of physical exercise, and heredity as potential risk factors of cardiovascular diseases, while smoking and alcohol were mentioned by only a few participants. However, they claimed that many of these risk factors were difficult to avoid due to ingrained taste preferences for high salt and sugar, increasingly busy lives that force them to use cooking oil to reduce preparation time, cultural preference for big body size or fatness, especially for women, stigmatized body image attached to HIV, stressful life or life events related to poverty, and financial barriers to affording quality foods and healthcare services. Limited health screening opportunities and the negative impact of HIV-related stigma on health-seeking behavior also emerged as important risk factors for cardiovascular diseases. Conclusions This study revealed that participants are relatively well aware of cardiovascular diseases and their risk factors. However, they engage in high-risk health behaviors, due to ingrained taste preferences, limited knowledge, and unavoidable socioeconomic and cultural circumstances. Results suggest that prevention interventions addressing cardiovascular diseases in rural Zambia should target gaps in knowledge and socioeconomic and cultural barriers.	[Tateyama, Yukiko; Musumari, Patou Masika; Techasrivichien, Teeranee; Suguimoto, S. Pilar; Ono-Kihara, Masako; Kihara, Masahiro] Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Global Hlth & Socioepidemiol, Kyoto, Japan; [Suguimoto, S. Pilar] Kyoto Univ, Grad Sch Med, Med Educ Ctr, Kyoto, Japan; [Zulu, Richard] Univ Zambia, Inst Econ & Social Res, Lusaka, Zambia; [Dube, Christopher] Ndola Dist Hlth Off, Ndola, Zambia; [Feldman, Mitchell D.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	Kyoto University; Kyoto University; University of Zambia; University of California System; University of California San Francisco	Tateyama, Y (corresponding author), Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Global Hlth & Socioepidemiol, Kyoto, Japan.	tateyama.yukiko.57c@st.kyoto-u.ac.jp	TATEYAMA, Yukiko/HCH-1160-2022	TATEYAMA, Yukiko/0000-0002-4649-8428; Suguimoto, S. Pilar/0000-0002-8447-9172	Fujiwara Memorial Foundation, Japan	Fujiwara Memorial Foundation, Japan	This study was funded by the Fujiwara Memorial Foundation, Japan, for the academic year 2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aantjes CJ, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-295; Abubakari AR, 2008, OBES REV, V9, P297, DOI 10.1111/j.1467-789X.2007.00462.x; Atadzhanov M N, 2012, OPEN GEN INTERNAL ME, V5; Ataklte F, 2015, HYPERTENSION, V65, P291, DOI 10.1161/HYPERTENSIONAHA.114.04394; Awah PK, 2008, HEALTH EDUC RES, V23, P612, DOI 10.1093/her/cym037; Belue R, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-10; Boateng D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189264; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Central Statistical Office (CSO) [Zambia] Ministry of Health (MOH) [Zambia] and ICF International, ZAMB DEM HLTH SURV 2; Central Statistical Office Zambia, 2012, 2010 CENS POP HOUS, V11; Connors J., 2016, DIVERSITY EQUALITY H, V13, P372; Coyne IT, 1997, J ADV NURS, V26, P623, DOI 10.1046/j.1365-2648.1997.t01-25-00999.x; Dalal S, 2011, INT J EPIDEMIOL, V40, P885, DOI 10.1093/ije/dyr050; De Kock HL, 2016, APPETITE, V96, P383, DOI 10.1016/j.appet.2015.09.026; Dugas LR, 2009, EUR J CLIN NUTR, V63, P805, DOI 10.1038/ejcn.2008.75; Ganzel BL, 2010, PSYCHOL REV, V117, P134, DOI 10.1037/a0017773; Goma Fastone M, 2011, Int Arch Med, V4, P34, DOI 10.1186/1755-7682-4-34; Guest G, 2018, FIELD METHOD, V18, P59; Iwelunmor J, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0392-8; Kruger HS, 2005, PUBLIC HEALTH NUTR, V8, P491, DOI 10.1079/PHN2005785; Mapulanga M, 2014, ANN MED HEALTH SCI R, V4, P123, DOI 10.4103/2141-9248.138030; Matoti-Mvalo T, 2011, S AFR J CLIN NUTR, V24, P40; Mensah GA, 2015, CARDIOVASC J AFR, V26, pS6, DOI 10.5830/CVJA-2015-036; Mulenga D, 2013, RURAL REMOTE HEALTH, V13; Musenge EM, 2015, J DIABETES RES, V2016; Muthuri SK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149680; Naghavi M, 2013, LANCET, V381, P95; Narayan KMV, 2014, JAIDS-J ACQ IMM DEF, V67, pS2, DOI 10.1097/QAI.0000000000000267; Nsakashalo-Senkwe Mutale, 2011, Int Arch Med, V4, P2, DOI 10.1186/1755-7682-4-2; Nyirenda MJ, 2016, INT HEALTH, V8, P157, DOI 10.1093/inthealth/ihw021; Oelke Nelly D, 2015, Glob J Health Sci, V8, P248, DOI 10.5539/gjhs.v8n2p248; Okop KJ, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3028-7; Puoane T, 2010, ETHNIC DIS, V20, P29; Rasmussen JB, 2016, J CLIN HYPERTENS, V18, P27, DOI 10.1111/jch.12662; Rasmussen JB, 2016, AM J HUM BIOL, V28, P145, DOI 10.1002/ajhb.22758; Rasmussen JB, 2013, TROP MED INT HEALTH, V18, P1080, DOI 10.1111/tmi.12139; Rudatsikira Emmanuel, 2012, Int Arch Med, V5, P14, DOI 10.1186/1755-7682-5-14; Saldana J., 2015, CODING MANUAL QUALIT, V3rd; Sampson UKA, 2013, PROG CARDIOVASC DIS, V56, P344, DOI 10.1016/j.pcad.2013.10.007; Schatz E, 2012, J AGING STUD, V26, P16, DOI 10.1016/j.jaging.2011.05.003; Scott A, 2013, HEALTH PROMOT INT, V28, P4, DOI 10.1093/heapro/das038; Surka S., 2015, African Journal of Primary Health Care and Family Medicine, V7; Topp SM, 2011, B WORLD HEALTH ORGAN, V89, P328, DOI 10.2471/BLT.10.084442; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2008 2013 ACT PLAN G; World Health Organization, GLOBAL STATUS REPORT; World Health Organization, NONC DIS COUNTR PROF; World Health Organization, 2013, GLOB ACT PLAN PREV C; Yan LD, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2258-4	49	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212739	10.1371/journal.pone.0212739	http://dx.doi.org/10.1371/journal.pone.0212739			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794667	Green Published, Green Submitted, gold			2022-12-27	WOS:000459709100127
J	Adams, SD; Bennet, KE; Tye, SJ; Berk, M; Kouzani, AZ				Adams, Scott D.; Bennet, Kevin E.; Tye, Susannah J.; Berk, Michael; Kouzani, Abbas Z.			Development of a miniature device for emerging deep brain stimulation paradigms	PLOS ONE			English	Article							ELECTRICAL-STIMULATION; WAVE-FORMS; FREQUENCY; DISEASE; DBS	Deep brain stimulation (DBS) is a neuromodulatory approach for treatment of several neurological and psychiatric disorders. A new focus on optimising the waveforms used for stimulation is emerging regarding the mechanism of DBS treatment. Many existing DBS devices offer only a limited set of predefined waveforms, mainly rectangular, and hence are inapt for exploring the emerging paradigm. Advances in clinical DBS are moving towards incorporating new stimulation parameters, yet we remain limited in our capacity to test these in animal models, arguably a critical first step. Accordingly, there is a need for the development of new miniature, low-power devices to enable investigation into the new DBS paradigms in preclinical settings. The ideal device would allow for flexibility in the stimulation waveforms, while remaining suitable for chronic, tetherless, biphasic deep brain stimulation. In this work, we elucidate several key parameters in a DBS system, identify gaps in existing solutions, and propose a new device to support preclinical DBS. The device allows for a high degree of flexibility in the output waveform with easily altered shape, frequency, pulse-width and amplitude. The device is suitable for both traditional and modern stimulation schemes, including those using non-rectangular waveforms, as well as delayed feedback schemes. The device incorporates active charge balancing to ensure safe operation, and allows for simple production of custom biphasic waveforms. This custom waveform output is unique in the field of preclinical DBS devices, and could be advantageous in performing future DBS studies investigating new treatment paradigms. This tetherless device can be easily and comfortably carried by an animal in a back-mountable configuration. The results of in-vitro tests are presented and discussed.	[Adams, Scott D.; Kouzani, Abbas Z.] Deakin Univ, Sch Engn, Geelong, Vic, Australia; [Bennet, Kevin E.] Mayo Clin, Div Engn, Rochester, MN USA; [Tye, Susannah J.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia; [Berk, Michael] Deakin Univ, Sch Med, IMPACT SRC, Barwon Hlth, Geelong, Vic, Australia	Deakin University; Mayo Clinic; University of Queensland; Deakin University	Kouzani, AZ (corresponding author), Deakin Univ, Sch Engn, Geelong, Vic, Australia.	kouzani@deakin.edu.au	Berk, Michael/M-3585-2019; Adams, Scott/AAI-4409-2020; Berk, Michael/M-7891-2013; Tye, Susannah/GQP-2577-2022	Berk, Michael/0000-0002-5554-6946; Adams, Scott/0000-0001-6466-0444; Berk, Michael/0000-0002-5554-6946; Kouzani, Abbas Z./0000-0002-6292-1214; Tye, Susannah/0000-0003-1291-4304	NHMRC Senior Principal Research Fellowship [1059660]	NHMRC Senior Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	MB is supported by a NHMRC Senior Principal Research Fellowship (1059660). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SD, 2018, J NEUROENG REHABIL, V15, P1, DOI [10.1186/s12984-017-0340-0, DOI 10.1186/S12984-017-0340-0]; Atmel Corporation, 2016, 8 16 BIT ATM AVR XME; Badstuebner K., 2017, J ELECT BIOIMPEDANCE, V8, P11, DOI [DOI 10.5617/JEB.4086, 10.5617/jeb.4086]; Baker KB, 2011, EXP NEUROL, V231, P309, DOI 10.1016/j.expneurol.2011.06.012; Belasen A, 2017, J NEUROSURG, V126, P397, DOI 10.3171/2016.2.JNS152231; Birdno MJ, 2007, J NEUROPHYSIOL, V98, P1675, DOI 10.1152/jn.00547.2007; Boex C, 2007, SEIZURE-EUR J EPILEP, V16, P664, DOI 10.1016/j.seizure.2007.05.009; Bronstein JM, 2011, ARCH NEUROL-CHICAGO, V68, P165, DOI 10.1001/archneurol.2010.260; Butson CR, 2007, CLIN NEUROPHYSIOL, V118, P1889, DOI 10.1016/j.clinph.2007.05.061; Cheung T, 2013, BRAIN STIMUL, V6, P746, DOI 10.1016/j.brs.2013.03.010; Daneshzand M, 2017, FRONT COMPUT NEUROSC, V11, DOI 10.3389/fncom.2017.00073; Ewing SG, 2013, J NEUROSCI METH, V219, P324, DOI 10.1016/j.jneumeth.2013.08.003; Ewing SG, 2013, J NEUROSCI METH, V213, P228, DOI 10.1016/j.jneumeth.2012.12.008; Fakhar K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058665; Foutz TJ, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/6/066008; Hamani C, 2010, J PSYCHIATR RES, V44, P683, DOI 10.1016/j.jpsychires.2009.12.010; Hauptmann C, 2005, BIOL CYBERN, V93, P463, DOI 10.1007/s00422-005-0020-1; Hentall Ian D, 2013, Front Neuroeng, V6, P8, DOI 10.3389/fneng.2013.00008; Hofmann L., 2011, FRONTIERS NEUROENGIN, V4, P1, DOI DOI 10.HTTPS://D0I.0RG/10.3389/FNENG.2011.00009; Kale RP, 2016, 2016 38 ANN INT C IE; Kolbl F, 2016, IEEE T BIOMED CIRC S, V10, P72, DOI 10.1109/TBCAS.2014.2368788; Koss AM, 2005, ANN NEUROL, V58, P168, DOI 10.1002/ana.20525; Kouzani AZ, 2013, IEEE J TRANSL ENG HE, V1, DOI 10.1109/JTEHM.2013.2264093; Lubarsky G, 2015, FORGOTTEN CONVERTER; McConnell GC, 2012, J NEUROSCI, V32, P15657, DOI 10.1523/JNEUROSCI.2824-12.2012; McIntyre CC, 2015, BRAIN STIMUL, V8, P21, DOI 10.1016/j.brs.2014.07.039; Medtronic Inc, 2010, ACT SC 37603 MULT NE, P10; Parastarfeizabadi M, 2016, 2016 38 ANN INT C IE; Piallat B, 2009, NEUROSURGERY, V64, P156, DOI 10.1227/01.NEU.0000336331.88559.CF; Pinnell RC, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00231; Popovych OV, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01067-x; Popovych OV, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173363; RANCK JB, 1975, BRAIN RES, V98, P417, DOI 10.1016/0006-8993(75)90364-9; Reich MM, 2015, ANN CLIN TRANSL NEUR, V2, P427, DOI 10.1002/acn3.168; Rizzone M, 2001, J NEUROL NEUROSUR PS, V71, P215, DOI 10.1136/jnnp.71.2.215; Sahin M, 2007, J NEURAL ENG, V4, P227, DOI 10.1088/1741-2560/4/3/008; Schlaepfer T E, 2013, Handb Clin Neurol, V116, P235, DOI 10.1016/B978-0-444-53497-2.00018-8; Sheingold DH, 1964, LIGHTING EMPIRICIST, V12, P8; Sit JJ, 2007, IEEE T BIOMED CIRC S, V1, P172, DOI 10.1109/TBCAS.2007.911631; Steigerwald F, 2018, MOVEMENT DISORD, V33, P165, DOI 10.1002/mds.27238; Volkmann J, 2006, MOVEMENT DISORD, V21, pS284, DOI 10.1002/mds.20961; Wyckhuys T, 2010, EPILEPSY RES, V88, P239, DOI 10.1016/j.eplepsyres.2009.11.014	42	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212554	10.1371/journal.pone.0212554	http://dx.doi.org/10.1371/journal.pone.0212554			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789946	Green Published, gold			2022-12-27	WOS:000459330800038
J	Tassew, AA; Tekle, DY; Belachew, AB; Adhena, BM				Tassew, Aberash Abay; Tekle, Dejen Yemane; Belachew, Abate Bekele; Adhena, Beyene Meressa			Factors affecting feeding 6-23 months age children according to minimum acceptable diet in Ethiopia: A multilevel analysis of the Ethiopian Demographic Health Survey	PLOS ONE			English	Article							SECONDARY DATA-ANALYSIS; YOUNG-CHILDREN; DETERMINANTS	Background Though infant and young children should be fed according to a minimum acceptable diet to ensure appropriate growth and development, only 7% of Ethiopian 6-23 months age children meet the minimum acceptable dietary standards, which is lower than the national target of 11% set for 2016. Therefore, this study aims to assess the individual and community level factors affecting feeding according to minimum acceptable diet among 6-23 months age children in Ethiopia. Methods This study analyzed retrospectively a cross-sectional data on a weighted sample of 2919 children aged 6-23 months nested within 617 clusters after extracting from Ethiopian Demographic and Health Survey 2016 via the link www.measuredhs.com. By employing bi-variate multilevel logistic regression model, variables which were significant at the p-value < 0.25 were included in multivariable multilevel logistic regression analysis. Finally, variables with a p-value < 0.05 were considered as significant predictors of minimum acceptable diet. Results Only 6.1% of 6-23 months age children feed minimum acceptable diet in Ethiopia. Children 18-23 months age (AOR = 3.7, 95% CI 1.9, 7.2), father's with secondary or higher education (AOR = 2.1, 95% CI 1.2, 3.6), Employed mothers (AOR = 1.7, 95% CI 1.2, 2.5), mothers have access to drinking water (AOR = 1.9, 95% CI 1.2, 2.9), mothers with media exposure (AOR = 2.1 95% CI 1.1, 2.7) were positive individual level predictors. Urban mothers (AOR = 4.8, 95% CI 1.7, 13.2)) and agrarian dominant region (AOR = 5.6, 95% CI 2.2, 14.5) were community level factors that significantly associated with a minimum acceptable diet of 6-23 months age children. Conclusion Both individual and community level factors were significantly associated with a minimum acceptable diet of 6-23 months age children in Ethiopia, suggesting that nutritional interventions designed to improve child health should not only be implemented at the individual level but tailored to community context as well.	[Tassew, Aberash Abay; Belachew, Abate Bekele] Mekelle Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Biostat, Mekelle, Tigray, Ethiopia; [Tekle, Dejen Yemane; Adhena, Beyene Meressa] Mekelle Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Environm Hlth & Behav Sci, Mekelle, Tigray, Ethiopia	Mekelle University; Mekelle University	Adhena, BM (corresponding author), Mekelle Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Environm Hlth & Behav Sci, Mekelle, Tigray, Ethiopia.	beyene2006m@gmail.com	Tekle, Dejen/AAR-8865-2021; Meressa, Beyene/W-6568-2019; Belachew, Abate Bekele/I-1758-2019; Meressa, Beyene/ABA-8501-2021	Meressa, Beyene/0000-0002-1864-0765; Belachew, Abate Bekele/0000-0003-2583-9913; 	Mekelle University -Norwegian University of Life Sciences (MU-NMBU project) [PG/CHS/01MSc-HI02/09MU-NMBU/2010]; Mekelle University, College of Health Sciences; MU-NMBU	Mekelle University -Norwegian University of Life Sciences (MU-NMBU project); Mekelle University, College of Health Sciences; MU-NMBU	AAT was supported by Mekelle University -Norwegian University of Life Sciences (MU-NMBU project) Grant number: PG/CHS/01MSc-HI02/09MU-NMBU/2010. http://www.mu.edu.et.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Our sincere and deepest gratitude goes to Mekelle University, College of Health Sciences and MU-NMBU for financial support of this study. We are also very grateful to Measure DHS for making the data freely available and we would like to extend our heartfelt thanks and appreciation to family members of Mrs. Aberash Abay (Haset Beyene, Nobel Beyene, Lidiya Beyene and Beyene Meressa) and friends for their endless support and providing the required courage during the research work.	[Anonymous], 2020, BMC PUBLIC HEALTH; Armenia National Statistical Service, 2015, ARM DEM HLTH SURV; Beyene M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2333-x; Browne WJ, 2005, J ROY STAT SOC A STA, V168, P599, DOI 10.1111/j.1467-985X.2004.00365.x; Central Statistics of Afghanistan, 2015, AFGH DEM HLTH SURV; Department of Community Medicine Faculty of Medicine University of Colombo 25 K, 2012, MATERN CHILD NUTR, V8, P5; Ethiopia Health and Nutrition Research Institute and U Suggested, 2010, IYCF PRACT BEL INFL; Federal Democratic Republic of Ethiopia, 2016, IMPL PLAN 2016 2030; Issaka AI, 2015, PUBLIC HEALTH NUTR, V18, P669, DOI 10.1017/S1368980014000834; Kabir I, 2012, MATERN CHILD NUTR, V8, P11, DOI 10.1111/j.1740-8709.2011.00379.x; Khanal V, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-131; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P443, DOI 10.1136/jech.2004.023473; Mokori A, 2017, S AFR J CLIN NUTR, V30, P7, DOI 10.1080/16070658.2016.1225887; Na M, 2017, MATERN CHILD NUTR, V13, P1; National Institute of Statistics of Rwanda, 2014, RWAND DEM HLTH SURV; National Statistical Office ICF, 2018, MAL DEM HLTH SURV 20; Nepal Ministry of Health, 2016, NEP DEM HLTH SURV; Ng CS, 2012, PUBLIC HLTH NUTR, V15; Pakistan National Institute of Population Studies, 2012, PAK DEM HLTH SURV; Patel A, 2012, MATERN CHILD NUTR, V8, P28, DOI 10.1111/j.1740-8709.2011.00385.x; Senarath U, 2012, MATERN CHILD NUTR, V8, P60, DOI 10.1111/j.1740-8709.2011.00375.x; UNICEF, 2016, C4D COMM DEV C4D CAP; USAID, 2010, NUTR IND REF SHEETS; World Health Organization, 2001, GUID PRINC COMPL FEE; Zimbabwe National Statistics Agency The DHS Program ICF International, 2015, ZIMB DEM HLTH SURV	25	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0203098	10.1371/journal.pone.0203098	http://dx.doi.org/10.1371/journal.pone.0203098			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789922	Green Published, Green Submitted, gold			2022-12-27	WOS:000459330800003
J	Kim, SH; Kim, JK; Park, EY; Joo, J; Lee, KH; Seo, HK; Joung, JY; Chung, J				Kim, Sung Han; Kim, Jung Kwon; Park, Eun Young; Joo, Jungnam; Lee, Kang Hyun; Seo, Ho Kyung; Joung, Jae Young; Chung, Jinsoo			Liver metastasis and Heng risk are prognostic factors in patients with non-nephrectomized synchronous metastatic renal cell carcinoma treated with systemic therapy	PLOS ONE			English	Article							TRANSARTERIAL CHEMOEMBOLIZATION; SURVIVAL; SUNITINIB; VALIDATION; SORAFENIB; CRITERIA; TUMORS; ERA	Objective This study aimed to determine the prognostic factors of progression-free survival (PFS) and overall survival (OS) in non-nephrectomized patients with synchronous metastatic renal cell carcinoma (mRCC) receiving first-line vascular endothelial growth factor (VEGF)-targeted therapy or immunotherapy. Methods Of 70 patients, 57 (81.4%) were treated with targeted therapy, including 5 (7.1%) with previous immunotherapy and 13 (18.6%) with immunotherapy only. The medical records of patients were retrospectively reviewed and analyzed to determine factors of PFS and OS using the Cox proportional hazards model with a statistical significance p-value <0.05. Results The median treatment and follow-up periods were 3.9 and 30.9 months, respectively. Disease progression was reported in 90.0% of patients, with an objective response rate and clinical benefit rate of 26.1% and 76.8%, respectively. The lung (77.1%) was the most common site of metastasis. Multivariable analysis showed that poor Heng risk (hazard ratio [HR]: 2.37) and liver metastasis (HR: 2.34) were significant prognostic factors for PFS, and female sex (HR: 2.13), poor Heng risk (HR: 3.14), and liver metastasis (HR: 2.78) were significant prognostic factors for OS (p < 0.05). A subset analysis of risk factors among patients without previous history of immunotherapy also showed poor Heng risk (HR 2.92 and HR 4.24 for PFS) and liver metastasis (HR 2.87 and HR 4.81 for OS) as significant factors for both PFS and OS (p<0.05). Conclusion Poor Heng risk, sex, and liver metastasis were associated with survival outcomes after first-line systemic therapy in patients with non-nephrectomized synchronous mRCC.	[Kim, Sung Han; Kim, Jung Kwon; Lee, Kang Hyun; Seo, Ho Kyung; Joung, Jae Young; Chung, Jinsoo] Natl Canc Ctr, Dept Urol, Ctr Prostate Canc, Goyang, South Korea; [Park, Eun Young; Joo, Jungnam] Natl Canc Ctr, Res Inst & Hosp, Div Canc Epidemiol & Prevent, Biometr Res Branch, Goyang, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Chung, J (corresponding author), Natl Canc Ctr, Dept Urol, Ctr Prostate Canc, Goyang, South Korea.	cjs5225@ncc.re.kr		KIM, Sung Han/0000-0002-1689-5203	Research and institute of National Cancer Center Grant [1710290-2]	Research and institute of National Cancer Center Grant	This study was supported by the Research and institute of National Cancer Center Grant (No. 1710290-2) to JC.	Aloia Thomas A, 2006, HPB (Oxford), V8, P100, DOI 10.1080/13651820500496266; Alves A, 2003, ANN SURG ONCOL, V10, P705, DOI 10.1245/ASO.2003.07.024; Bianchi M, 2012, ANN ONCOL, V23, P973, DOI 10.1093/annonc/mdr362; Buchler T, 2016, EUR UROL, V70, P469, DOI 10.1016/j.eururo.2015.12.031; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dumitru CA, 2013, SEMIN CANCER BIOL, V23, P141, DOI 10.1016/j.semcancer.2013.02.005; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gills J, 2017, J UROLOGY, V198, P538, DOI 10.1016/j.juro.2017.03.076; Ha Y, 2016, ONCOTARGET, V7, P74303, DOI 10.18632/oncotarget.11030; Hu B, 2012, UROL CLIN N AM, V39, P233, DOI 10.1016/j.ucl.2012.02.002; Iacovelli R, 2014, CANCER TREAT REV, V40, P271, DOI 10.1016/j.ctrv.2013.09.003; Jonasch E, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4797; Kim SH, 2016, CANCER RES TREAT, V48, P1092, DOI 10.4143/crt.2015.316; Kroeger N, 2014, EUR UROL, V65, P1086, DOI 10.1016/j.eururo.2013.07.031; Kwon WA, 2013, ANN SURG ONCOL, V20, P4397, DOI 10.1245/s10434-013-3290-1; Langan RC, 2012, J CANCER, V3, P184, DOI 10.7150/jca.4456; Leon L, 2014, TARGET ONCOL, V9, P9, DOI 10.1007/s11523-013-0304-7; Mckay RR, 2014, EUR UROL, V65, P577, DOI 10.1016/j.eururo.2013.08.012; Mekhail TM, 2005, J CLIN ONCOL, V23, P832, DOI 10.1200/JCO.2005.05.179; Motzer RJ, 2008, CANCER-AM CANCER SOC, V113, P1552, DOI 10.1002/cncr.23776; Motzer Robert J, 2015, J Natl Compr Canc Netw, V13, P151; Motzer RJ, 2011, ONCOLOGIST, V16, P1, DOI 10.1634/theoncologist.2011-S2-01; Negrier S, 2002, ANN ONCOL, V13, P1460, DOI 10.1093/annonc/mdf257; Pecuchet N, 2013, ONCOLOGY-BASEL, V84, P22, DOI 10.1159/000342962; Segarra I, 2016, CLIN DRUG INVEST, V36, P791, DOI 10.1007/s40261-016-0428-5; Stafford HS, 2008, J UROLOGY, V179, P1704, DOI 10.1016/j.juro.2008.01.027; Stewart GD, 2014, EUR UROL, V66, P85, DOI 10.1016/j.eururo.2014.03.004; van der Veldt AAM, 2008, BRIT J CANCER, V99, P259, DOI 10.1038/sj.bjc.6604456; Wang GL, 2016, HEPATOL INT, V10, P501, DOI 10.1007/s12072-015-9700-7	30	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211105	10.1371/journal.pone.0211105	http://dx.doi.org/10.1371/journal.pone.0211105			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785902	Green Published, Green Submitted, gold			2022-12-27	WOS:000459307000018
J	Schepers, E; van Os, J; Lousberg, R				Schepers, E.; van Os, J.; Lousberg, R.			White noise speech illusions in the general population: The association with psychosis expression and risk factors for psychosis	PLOS ONE			English	Article							SCHIZOPHRENIA; HALLUCINATIONS; METAANALYSIS; EXPERIENCES; RELIABILITY; ENVIRONMENT; INSTRUMENT; CAPE	Introduction Positive psychotic experiences are associated with increased rate of white noise speech illusions in patients and their relatives. However, findings have been conflicting to what degree speech illusions are associated with subclinical expression of psychosis in the general population. The aim of this study was to investigate the link between speech illusions and positive psychotic experiences in a general population sample. In addition, the hypothesis that speech illusions are on the pathway from known risk factors for psychosis (childhood adversity and recent life events) to subthreshold expression of psychosis, was examined. Methods In a follow-up design (baseline and 6 months) the association between the number of white noise speech illusions and self-reported psychotic experiences, assessed with the Community Assessment of Psychic Experiences (CAPE), was investigated in a general population sample (n = 112). In addition, associations between speech illusions and childhood adversity and life events, using the Childhood Experiences of Care and Abuse questionnaire and the Social Readjustment Rating Scale, were investigated. Results No association was found between the CAPE positive scale and the number of white noise speech illusions. The CAPE positive scale was significantly associated with childhood adversity between 12 and 16 years (B = 0.980 p = 0.001) and life events (B = 0.488 p = 0.044). The number of speech illusions showed no association with either life events or childhood adversity. Conclusion In the nonclinical population, the pathway from risk factors to expression of subclinical psychotic experiences does not involve white noise speech illusions as an intermediate outcome.	[Schepers, E.; van Os, J.; Lousberg, R.] Maastricht Univ, Med Ctr, Dept Psychiat & Psychol, Maastricht, Netherlands; [van Os, J.] Kings Coll London, Kings Hlth Partners, Dept Psychosis Studies, Inst Psychiat, London, England; [van Os, J.] Utrecht Univ Med Ctr, Dept Psychiat, Brain Ctr Rudolf Magnus, Utrecht, Netherlands	Maastricht University; University of London; King's College London; Utrecht University; Utrecht University Medical Center	Schepers, E (corresponding author), Maastricht Univ, Med Ctr, Dept Psychiat & Psychol, Maastricht, Netherlands.	e.schepers@student.maastrichtuniversity.nl	van Os, Jim/V-8884-2019; van Os, Jim/C-2113-2014; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022	van Os, Jim/0000-0002-7245-1586; 				Aleman A, 2003, SCHIZOPHR RES, V64, P175, DOI 10.1016/S0920-9964(03)00060-4; Beards S, 2013, SCHIZOPHRENIA BULL, V39, P740, DOI 10.1093/schbul/sbt065; Behrendt RP, 1998, COMPR PSYCHIAT, V39, P236, DOI 10.1016/S0010-440X(98)90067-0; Catalan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102520; Collip D, 2008, SCHIZOPHRENIA BULL, V34, P220, DOI 10.1093/schbul/sbm163; Daalman K, 2012, SCHIZOPHR RES, V139, P82, DOI 10.1016/j.schres.2012.06.005; Dominguez MDG, 2010, AM J PSYCHIAT, V167, P1075, DOI 10.1176/appi.ajp.2010.09060883; Eduardo Pedrero Fonseca, 2017, PSICOTHEMA, V29; Galdos M, 2011, SCHIZOPHRENIA BULL, V37, P1179, DOI 10.1093/schbul/sbq029; de Artaza MG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192373; Hoffman RE, 2007, BRIT J PSYCHIAT, V191, P355, DOI 10.1192/bjp.bp.106.031195; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Hugdahl K, 2009, SCAND J PSYCHOL, V50, P553, DOI 10.1111/j.1467-9450.2009.00775.x; Kaymaz N, 2012, PSYCHOL MED, V42, P2239, DOI 10.1017/S0033291711002911; Konings M, 2006, ACTA PSYCHIAT SCAND, V114, P55, DOI 10.1111/j.1600-0447.2005.00741.x; Linscott RJ, 2013, PSYCHOL MED, V43, P1133, DOI 10.1017/S0033291712001626; Martin  Debbane, 2014, SCHIZOPHRENIA B S2, V41, pS396; Mossaheb N, 2012, SCHIZOPHR RES, V141, P210, DOI 10.1016/j.schres.2012.08.008; Pries LK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183695; Read J, 2005, ACTA PSYCHIAT SCAND, V112, P330, DOI 10.1111/j.1600-0447.2005.00634.x; Rimvall MK, 2016, PSYCHOL MED, V46, P2731, DOI 10.1017/S0033291716001112; Smeets F, 2013, ACTA PSYCHIAT SCAND, V127, P34, DOI 10.1111/j.1600-0447.2012.01888.x; van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814; van Os J, 2016, WORLD PSYCHIATRY, V15, P118, DOI 10.1002/wps.20310; van Os J, 2014, SCHIZOPHRENIA BULL, V40, P729, DOI 10.1093/schbul/sbu069; van Rossum I, 2011, SCHIZOPHRENIA BULL, V37, P561, DOI 10.1093/schbul/sbp101; Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050; Vollema MG, 2000, SCHIZOPHRENIA BULL, V26, P619, DOI 10.1093/oxfordjournals.schbul.a033482	28	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211914	10.1371/journal.pone.0211914	http://dx.doi.org/10.1371/journal.pone.0211914			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM2OT	30785901	Green Published, gold, Green Submitted			2022-12-27	WOS:000459307000045
J	Khan, NA; Yogeswaran, S; Wang, QX; Muthumalage, T; Sundar, IK; Rahman, I				Khan, Naushad Ahmad; Yogeswaran, Shaiesh; Wang, Qixin; Muthumalage, Thivanka; Sundar, Isaac K.; Rahman, Irfan			Waterpipe smoke and e-cigarette vapor differentially affect circadian molecular clock gene expression in mouse lungs	PLOS ONE			English	Article							REV-ERB-ALPHA; INFLAMMATION; DISRUPTION; DEFENSE; RHYTHM	The use of emerging tobacco products, such as waterpipe or hookah and electronic cigarettes (e-cigs), has gained significant popularity and are promoted as safer alternatives to conventional cigarettes. Circadian systems are internal biological oscillations that are considered important regulators of immune functions in mammals. Tobacco induced inflammatory lung diseases frequently exhibit time-of-day/night variation in lung function and symptom severity. We investigated the impact of inhaled e-cig vapor and waterpipe smoke (WPS) on pulmonary circadian molecular clock disruption by determining the changes in expression levels and abundance of core clock component genes (BMAL1, CLOCK) and clock-controlled output genes (Rev-erb alpha, Per2, Rev-erb beta, Cry2, Ror alpha) in mouse lungs. We showed that the expression levels of these pulmonary core clock genes and clock-controlled output genes were altered significantly following exposure to WPS (Bmal1, Clock, and Rev-erb alpha). We further showed a significant yet differential effect on expression levels of core clock and clock-controlled genes (Bmal1, Per2) in the lungs of mice exposed to e-cig vapor containing nicotine. Thus, acute exposure to WPS and e-cig vapor containing nicotine contributes to altered expression of circadian molecular clock genes in mouse lungs, which may have repercussions on lung cellular and biological functions.	[Khan, Naushad Ahmad; Yogeswaran, Shaiesh; Wang, Qixin; Muthumalage, Thivanka; Sundar, Isaac K.; Rahman, Irfan] Univ Rochester, Med Ctr, Dept Environm Med, Rochester, NY 14642 USA	University of Rochester	Rahman, I (corresponding author), Univ Rochester, Med Ctr, Dept Environm Med, Rochester, NY 14642 USA.	irfan_rahman@urmc.rochester.edu	Wang, Qixin/W-2259-2019; Sundar, Isaac K/F-8764-2012	Wang, Qixin/0000-0001-9051-8388; Sundar, Isaac K/0000-0001-6742-3460; Yogeswaran, Shaiesh/0000-0002-7736-9346	National Institutes of Health (NIH) [1R01HL135613, NIH 1R01HL085613]; Food and Drug Administration (FDA) Center for Tobacco Products (CTP) NIH-FDA-CTP grant [1R01DA042470]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085613, R01HL135613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA042470] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Food and Drug Administration (FDA) Center for Tobacco Products (CTP) NIH-FDA-CTP grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by a National Institutes of Health (NIH) Grants, 1R01HL135613, NIH 1R01HL085613, and the Food and Drug Administration (FDA) Center for Tobacco Products (CTP) NIH-FDA-CTP grant 1R01DA042470 (all granted to IR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castanon-Cervantes O, 2010, J IMMUNOL, V185, P5796, DOI 10.4049/jimmunol.1001026; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Gaddameedhi S, 2012, CELL CYCLE, V11, P3481, DOI 10.4161/cc.21771; Garcia-Arcos I, 2016, THORAX, V71, P1119, DOI 10.1136/thoraxjnl-2015-208039; Gebel S, 2006, TOXICOL SCI, V93, P422, DOI 10.1093/toxsci/kfl071; Gibbs J, 2014, NAT MED, V20, P919, DOI 10.1038/nm.3599; Hadden H, 2012, J APPL PHYSIOL, V113, P385, DOI 10.1152/japplphysiol.00244.2012; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Hwang JW, 2014, FASEB J, V28, P176, DOI 10.1096/fj.13-232629; Hwang JH, 2016, J MOL MED, V94, P667, DOI 10.1007/s00109-016-1378-3; Javed F, 2017, INHAL TOXICOL, V29, P389, DOI 10.1080/08958378.2017.1384084; Khabour OF, 2012, INHAL TOXICOL, V24, P667, DOI 10.3109/08958378.2012.710918; Khan NA, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13579; Lam MTY, 2013, NATURE, V498, P511, DOI 10.1038/nature12209; Lechasseur A, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13440; Maouche K, 2009, AM J PATHOL, V175, P1868, DOI 10.2353/ajpath.2009.090212; MILLER JD, 1993, AM J PHYSIOL, V264, pR821, DOI 10.1152/ajpregu.1993.264.5.R821; Minegishi S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30425-6; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; O'Hara BF, 1998, PSYCHONEUROENDOCRINO, V23, P161, DOI 10.1016/S0306-4530(97)00077-2; Pariollaud M, 2018, J CLIN INVEST, V128, P2281, DOI 10.1172/JCI93910; Pekovic-Vaughan V, 2014, GENE DEV, V28, P548, DOI 10.1101/gad.237081.113; Polosa R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14043-2; Raad D, 2011, CHEST, V139, P764, DOI 10.1378/chest.10-0991; Robinson I, 2014, FEBS LETT, V588, P2477, DOI 10.1016/j.febslet.2014.06.005; Sancar A, 2010, FEBS LETT, V584, P2618, DOI 10.1016/j.febslet.2010.03.017; Song P., 2017, INT J ENV RES PUBLIC, V14; Spengler CM, 2000, AM J RESP CRIT CARE, V162, P1038, DOI 10.1164/ajrccm.162.3.9911107; Spengler ML, 2012, P NATL ACAD SCI USA, V109, pE2457, DOI 10.1073/pnas.1206274109; Sundar IK, 2018, FREE RADICAL BIO MED, V119, P121, DOI 10.1016/j.freeradbiomed.2017.10.383; Sundar IK, 2017, BIOCHEM BIOPH RES CO, V493, P1390, DOI 10.1016/j.bbrc.2017.09.157; Sundar IK, 2015, AM J PHYSIOL-LUNG C, V309, pL1056, DOI 10.1152/ajplung.00152.2015; Sundar IK, 2015, SCI REP-UK, V5, DOI 10.1038/srep09927; Sundar IK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087999; Tsai CL, 2007, CHRONOBIOL INT, V24, P699, DOI 10.1080/07420520701535753; Vasu VT, 2009, INTEGR CANCER THER, V8, P321, DOI 10.1177/1534735409352027; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Yan J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000193; Yang G, 2014, ANTIOXID REDOX SIGN, V21, P17, DOI 10.1089/ars.2013.5539; Yao HW, 2015, AM J RESP CELL MOL, V53, P782, DOI 10.1165/rcmb.2014-0474OC	40	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211645	10.1371/journal.pone.0211645	http://dx.doi.org/10.1371/journal.pone.0211645			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811401	Green Published, Green Submitted, gold			2022-12-27	WOS:000459806400027
J	Smith, NF; Lepofsky, D; Toniello, G; Holmes, K; Wilson, L; Neudorf, CM; Roberts, C				Smith, Nicole F.; Lepofsky, Dana; Toniello, Ginevra; Holmes, Keith; Wilson, Louie; Neudorf, Christina M.; Roberts, Christine			3500 years of shellfish mariculture on the Northwest Coast of North America	PLOS ONE			English	Article							SEA-LEVEL HISTORY; BRITISH-COLUMBIA; CLAM GARDENS	Ancient systems of mariculture were foundations of social-ecological systems of many coastal Indigenous Peoples. However, since such systems either do not leave tangible remains in the archaeological record, and/or are hard to date, we know little about their development and use. Clam gardens, traditional mariculture features located within the intertidal zone along the Northwest Coast of North America, are composed of a rock wall positioned at the low tide mark and a flattened terrace on the landward side of the wall. Because these features are largely composed of rock and sediment, and have complex formation histories, they can be difficult to age. On northern Quadra Island, British Columbia, we identify three variations in clam garden form, constructed in different geomorphological settings, each of which require different sampling approaches to obtain ages on construction and ongoing use. To age the clam gardens, we consider radiocarbon dating of invertebrates that inhabit beach deposits (both pre-and post-garden construction), and the relationship of the gardens and clam samples to the local sea level history and taphonomic processes. Within our study area, we find clam gardens have been in use for 3500 years, likely corresponding to other social and ecological changes of the time. These data allow us to formulate guidelines on samples most suitable to constrain the age of initial and on-going wall construction and use of clam gardens, which can be extrapolated to dating other ancient mariculture features in other regions. Such dating programs are the foundation for understanding the long-term development of traditional marine management practices and how they are situated in broader social-ecological systems.	[Smith, Nicole F.; Lepofsky, Dana; Toniello, Ginevra; Holmes, Keith; Wilson, Louie; Neudorf, Christina M.; Roberts, Christine] Hakai Inst, Heriot Bay, BC, Canada; [Lepofsky, Dana; Toniello, Ginevra] Simon Fraser Univ, Dept Archaeol, Burnaby, BC, Canada; [Wilson, Louie] We Wai Kai Nation, Quathiaski Cove, BC, Canada; [Neudorf, Christina M.] Univ Fraser Valley, Dept Geog & Environm, Abbotsford, BC, Canada; [Roberts, Christine] Wei Wai Kum First Nation, Campbell River, BC, Canada; [Toniello, Ginevra] Tsleil Waututh Nation, Treaty Lands & Resources, N Vancouver, BC, Canada; [Neudorf, Christina M.] Desert Res Inst, Div Earth & Ecosyst Sci, Reno, NV USA	Hakai Institute; Simon Fraser University; University of Fraser Valley; Nevada System of Higher Education (NSHE); Desert Research Institute NSHE	Lepofsky, D (corresponding author), Hakai Inst, Heriot Bay, BC, Canada.; Lepofsky, D (corresponding author), Simon Fraser Univ, Dept Archaeol, Burnaby, BC, Canada.	dlepofsk@sfu.ca		Neudorf, Christina/0000-0002-4449-2655; Holmes, Keith/0000-0001-8796-8222	Hakai Institute; Hakai Postdoctoral Fellowship; Hakai Masters Student Fellowship; National Geographic Society [8636-09]; Social Sciences and Humanities Research Council of Canada [31639830]; Simon Fraser University Small SSHRC grant; SSHRC [31-639830]; SFU Small SSHRC;  [8710]	Hakai Institute; Hakai Postdoctoral Fellowship; Hakai Masters Student Fellowship; National Geographic Society(National Geographic Society); Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Simon Fraser University Small SSHRC grant; SSHRC(Social Sciences and Humanities Research Council of Canada (SSHRC)); SFU Small SSHRC; 	The Hakai Institute provided financial and logistical support to DL in support of this project (no grant number, https://www.hakai.org/), as well as a Hakai Postdoctoral Fellowship to CMN and a Hakai Masters Student Fellowship to GT (no grant numbers). KH is a full-time employee of the Hakai Institute while NS, LW and CR were hired on contract for parts of this project. The Hakai Institute is a branch of the Tula Foundation, which is run by Eric Peterson and Christina Munck. The work was also supported by grants from Wenner Gren (#8710, http://www.wennergren.org/), National Geographic Society (#8636-09, https://www.nationalgeographic.org/), Social Sciences and Humanities Research Council of Canada (#31639830, http://www.sshrc-crsh.gc.ca/home-accueil-eng.aspx), and a Simon Fraser University Small SSHRC grant (no grant number, http://www.sfu.ca/similar to ors/sshrc-list/msg02110.html), all awarded to DL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the We Wai Kai, We Wai Kum, K'omoks, Xwemalhkwu, and Klahoose Nations for allowing us to conduct this work in their territories, and to Eric Peterson and Christina Munck of the Hakai Institute and Tula Foundation for the logistical and financial support that enabled much of this work. We also gratefully acknowledge grants from Wenner Gren (#8710), National Geographic Society (#8636-09) and SSHRC (#31-639830), and a SFU Small SSHRC, all awarded to Dana Lepofsky. The Department of Archaeology at Simon Fraser University and the Department of Anthropology at the University of Victoria offered much logistical support for the fieldwork. We thank the following for their assistance in the field and/or insightful conversations that have greatly enriched our collective understanding of clam gardens around Quadra Island: Cal Abbott, Skye Augustine, Travis Crowell, Daryl Fedje, Travis Gingerich, Amy Groesbeck, Will Hall, Chris Harley, John Harper, Susan Kidwell, Kate Lansley, Olav Lian, Quentin Mackie, Iain McKechnie, Joanne McSporran, Mary Morris, Misha Puckett, Kirsten Rowell, Anne Salomon, Natasha Salter, Mark Wunsch, and all other members of the Clam Garden Network. Thanks to Louise Williams for her beautiful imagery, Gavia Lertzman-Lepofsky for her assistance with Fig 8, and to John Southon at UC Irvine for radiocarbon determinations.	Anderson EN, 2014, CARING FOR PLACE: ECOLOGY, IDEOLOGY, AND EMOTION IN TRADITIONAL LANDSCAPE MANAGEMENT, P1; Augustine S, 2014, CAN GEOGR-GEOGR CAN, V58, P305, DOI 10.1111/cag.12084; Balee William L., 2013, CULTURAL FORESTS AMA; Baxter RE, 1971, EARTHQUAKE EFFECTS C, P238; Berkes F., 2017, SACRED ECOLOGY; BOSERUP E., 1965, The conditions of agricultural growth. The economics of agrarian change under population pressure.; Carrivick JL, 2016, STRUCTURE MOTION GEO; Chew KK, 1987, US CEGNWRC; Crowell T., 2017, THESIS; Deur D, 2015, HUM ECOL, V43, P201, DOI 10.1007/s10745-015-9743-3; Fedje D, 2018, QUATERNARY SCI REV, V192, P300, DOI 10.1016/j.quascirev.2018.05.018; Fowler CS, 2011, ETHNOBIOLOGY, P287; Groesbeck AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091235; Harper JR, 1995, FINAL REPORT BROUGHT; Hoffmann T, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601282; Holmes K., 2016, HAKAI MEDIA     0829; Jackley J, 2016, ECOL SOC, V21, DOI 10.5751/ES-08747-210420; Kowalewski M, 2017, GEOLOGY, V46, P4; Lepofsky D, 2008, BOTANY, V86, P129, DOI 10.1139/B07-094; Lepofsky D, 2015, AM ANTIQUITY, V80, P236, DOI 10.7183/0002-7316.80.2.236; Lepofsky Dana, 2013, Ecological Processes, V2; Letham B, 2016, QUATERNARY SCI REV, V153, P156, DOI 10.1016/j.quascirev.2016.10.004; McLaren D., 2011, CAN J ARCHAEOL, V35, P86; Moss ML, 2017, ALASKA J ANTHR, V15, P7; Moss ML, 2013, OXFORD HDB WETLAND A, P323; Neudorf CM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171775; Neudorf CM, 2017, GEOL SOC AM ANN C; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Toniello G., 2017, THESIS; Toniello G., 2015, QUADRA ISLAND CLAM G; Toniello G., 2016, 107144 BC MIN ENV; Turner N.J., 2014, ANCIENT PATHWAYS ANC; Williams J., 1997, COMMUNICATION; Williams J., 2006, CLAM GARDENS ABORIGI	35	15	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211194	10.1371/journal.pone.0211194	http://dx.doi.org/10.1371/journal.pone.0211194			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811412	Green Submitted, gold, Green Published			2022-12-27	WOS:000459806400015
J	Ghazal, F; Theobald, H; Rosenqvist, M; Al-Khalili, F				Ghazal, Faris; Theobald, Holger; Rosenqvist, Marten; Al-Khalili, Faris			Assessment of N-terminal pro-B-type natriuretic peptide level in screening for atrial fibrillation in primary health care	PLOS ONE			English	Article							PREDICTING STROKE; RISK; VALIDATION; BIOMARKERS; AGE	Background Atrial fibrillation (AF), an important cause of thromboembolic events, is often silent and intermittent, thus presenting a diagnostic challenge. The aim of this study was to assess whether the plasma level of N-terminal pro-brain natriuretic peptide (NT-proBNP) is related to the presence of AF and thereby might be used to facilitate screening programs for AF in primary care. Methods This was a cross sectional screening study. A population of 70-74-year-old individuals registered at a single primary care center in Stockholm were invited to AF screening. Intermittent ECG recording, 30 seconds twice a day using a hand-held device over 2 weeks, was offered to participants without previously known AF. Of the 324 participating persons, 34 patients had already known AF and 16 new cases of AF were detected by screening. Plasma NT-proBNP was measured in patients with previously known AF, newly detected AF, and 53 control participants without AF. Findings The median NT-proBNP was 697 ng/L in patients with previously known AF, 335 ng/L in new cases of AF, and 146 ng/L in patients without AF. After adjustment for several clinical variables and morbidities, the differences of median NT-proBNP levels were statistically significant between cases of previously known AF and new cases of AF as well as between new cases of AF and those without AF. The area under receiver operating characteristic curve of detection of new AF was 0.68 (95% CI 0.56 to 0.79) yielding a cut-off point of 124 ng/L with 75% sensitivity, 45% specificity, and 86% negative predictive value. Conclusions The NT-proBNP plasma levels among patients with known AF are higher than those with newly detected AF, and the latter have higher levels than those without AF. Therefore NT-proBNP might be a useful screening marker for the detection of AF and its persistence.	[Ghazal, Faris; Rosenqvist, Marten; Al-Khalili, Faris] Danderyd Hosp, Karolinska Inst, Dept Clin Sci, Cardiol Unit, Stockholm, Sweden; [Theobald, Holger] Karolinska Inst, Dept Neurobiol, Care Sci & Soc, Stockholm, Sweden	Danderyds Hospital; Karolinska Institutet; Karolinska Institutet	Ghazal, F (corresponding author), Danderyd Hosp, Karolinska Inst, Dept Clin Sci, Cardiol Unit, Stockholm, Sweden.	faris.ghazal@ki.se		Ghazal, Faris/0000-0001-5529-4243; , Faris/0000-0003-4891-0639				Alonso A, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.000102; Bjork J, 2011, SCAND J CLIN LAB INV, V71, P232, DOI 10.3109/00365513.2011.557086; Ghazal F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198069; Hijazi Z, 2016, EUR HEART J, V37, P1582, DOI 10.1093/eurheartj/ehw054; Hijazi Z, 2013, J AM COLL CARDIOL, V61, P2274, DOI 10.1016/j.jacc.2012.11.082; Hijazi Z, 2012, CIRCULATION, V125, P1605, DOI 10.1161/CIRCULATIONAHA.111.038729; Kirchhof P, 2016, EUROPACE, V18, DOI [10.1016/j.rec.2016.11.033, 10.1093/europace/euw295, 10.5603/KP.2016.0172]; Lee-Lewandrowski E, 2007, CLIN CHIM ACTA, V386, P20, DOI 10.1016/j.cca.2007.07.015; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Llombart V, 2015, STROKE, V46, P1187, DOI 10.1161/STROKEAHA.114.008311; Lowres N, 2013, THROMB HAEMOSTASIS, V110, P213, DOI 10.1160/TH13-02-0165; Patton KK, 2013, HEART, V99, P1832, DOI 10.1136/heartjnl-2013-304724; Prontera C, 2009, CLIN CHIM ACTA, V400, P70, DOI 10.1016/j.cca.2008.10.011; Seegers J, 2015, OPEN HEART, V2, DOI 10.1136/openhrt-2014-000182; Svennberg E, 2017, HEART, V103, P1271, DOI 10.1136/heartjnl-2016-310236; Svennberg E, 2016, INT J CARDIOL, V223, P74, DOI 10.1016/j.ijcard.2016.08.001	16	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0212974	10.1371/journal.pone.0212974	http://dx.doi.org/10.1371/journal.pone.0212974			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807614	Green Submitted, Green Published, gold			2022-12-27	WOS:000459712100031
J	Tenland, E; Pochert, A; Krishnan, N; Rao, KU; Kalsum, S; Braun, K; Glegola-Madejska, I; Lerm, M; Robertson, BD; Linden, M; Godaly, G				Tenland, Erik; Pochert, Alexander; Krishnan, Nitya; Rao, Komal Umashankar; Kalsum, Sadaf; Braun, Katharina; Glegola-Madejska, Izabela; Lerm, Maria; Robertson, Brian D.; Linden, Mika; Godaly, Gabriela			Effective delivery of the anti-mycobacterial peptide NZX in mesoporous silica nanoparticles	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; DRUG-DELIVERY; PHAGOCYTOSIS; PARTICLES; CARRIERS; THERAPY	Background Intracellular delivery of antimicrobial agents by nanoparticles, such as mesoporous silica particles (MSPs), offers an interesting strategy to treat intracellular infections. In tuberculosis (TB), Mycobacterium tuberculosis avoids components of the immune system by residing primarily inside alveolar macrophages, which are the desired target for TB therapy. Methods and findings We have previously identified a peptide, called NZX, capable of inhibiting both clinical and multi-drug resistant strains of M. tuberculosis at therapeutic concentrations. In this study we analysed the potential of MSPs containing NZX for the treatment of tuberculosis. The MSPs released functional NZX gradually into simulated lung fluid and the peptide filled MSPs were easily taken up by primary macrophages. In an intracellular infection model, the peptide containing particles showed increased mycobacterial killing compared to free peptide. The therapeutic potential of peptide containing MSPs was investigated in a murine infection model, showing that MSPs preserved the effect to eliminate M. tuberculosis in vivo. Conclusions In this study we found that loading the antimicrobial peptide NZX into MSPs increased the inhibition of intracellular mycobacteria in primary macrophages and preserved the ability to eliminate M. tuberculosis in vivo in a murine model. Our studies provide evidence for the feasibility of using MSPs for treatment of tuberculosis.	[Tenland, Erik; Rao, Komal Umashankar; Braun, Katharina; Godaly, Gabriela] Lund Univ, Inst Lab Med, Dept Microbiol Immunol & Glycobiol, Lund, Sweden; [Pochert, Alexander; Linden, Mika] Ulm Univ, Inorgan Chem 2, Ulm, Germany; [Krishnan, Nitya; Glegola-Madejska, Izabela; Robertson, Brian D.] Imperial Coll London, Dept Med, MRC Ctr Mol Bacteriol & Infect, London, England; [Kalsum, Sadaf; Lerm, Maria] Fac Med & Hlth Sci, Dept Clin & Expt Med, Linkoping, Sweden	Lund University; Ulm University; Imperial College London	Godaly, G (corresponding author), Lund Univ, Inst Lab Med, Dept Microbiol Immunol & Glycobiol, Lund, Sweden.	gabriela.godaly@med.lu.se	Godaly, Gabriela/AAD-7545-2019; Linden, Mika/GRX-9017-2022; Lerm, Maria/AAA-1780-2020; Lerm, Maria/AAM-8705-2020	Godaly, Gabriela/0000-0002-3467-1350; Lerm, Maria/0000-0002-5092-9892; Robertson, Brian D./0000-0001-5785-5307; Linden, Mika/0000-0003-1736-0638	European Union's Seventh Framework Programme (FP7/2007-2013) [604182]; DFG [SFB 1279]; UK Medical Research Council; Swedish Heart-Lung Foundation [20150733]; Alfred Osterlunds Foundation; Royal Physiographic Society of Lund; MRC [MR/P028225/1] Funding Source: UKRI	European Union's Seventh Framework Programme (FP7/2007-2013); DFG(German Research Foundation (DFG)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Alfred Osterlunds Foundation; Royal Physiographic Society of Lund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	ET, AP and KB were funded by the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 604182, FORMAMP-Innovative Nanoformulation of Antimicrobial Peptides to Treat Bacterial Infectious Diseases (https://cordis.europa.eu/project/rcn/110784/factsheet/en).Furthermore, the support from the DFG funded SFB 1279 project "Nutzung des menschlichen Peptidoms zur Entwicklung neuer antimikrobieller und anti-Krebs Therapeutika"is gratefully acknowledged (ML). Prof. Paul Walther, Central Facility for Electron Microscopy, Ulm University, is gratefully acknowledged for the preparation of the microtomed cell samples for TEM analysis. NK, IGM and BR thank the UK Medical Research Council for support in the MRC Centre for Molecular Bacteriology and Infection, Imperial College London. The research was also funded by the Swedish Heart-Lung Foundation (20150733) to GG, Alfred Osterlunds Foundation to GG and the Royal Physiographic Society of Lund to ET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Ahsan FL, 2002, J CONTROL RELEASE, V79, P29, DOI 10.1016/S0168-3659(01)00549-1; Braun K, 2017, MOL SYST DES ENG, V2, P393, DOI 10.1039/c7me00059f; Braun K, 2016, J COLLOID INTERF SCI, V475, P161, DOI 10.1016/j.jcis.2016.05.002; Castillo RR, 2017, EXPERT OPIN DRUG DEL, V14, P229, DOI 10.1080/17425247.2016.1211637; Chibowski E, 2010, ADSORPTION, V16, P305, DOI 10.1007/s10450-010-9242-1; Gallud A, 2017, BIOMATERIALS, V121, P28, DOI 10.1016/j.biomaterials.2016.12.029; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Heidegger S, 2016, NANOSCALE, V8, P938, DOI 10.1039/c5nr06122a; Hilchie AL, 2013, NAT CHEM BIOL, V9, P761, DOI [10.1038/NCHEMBIO.1393, 10.1038/nchembio.1393]; Kalsum S, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00278; Kumar A, 2017, PHARM RES-DORDR, V34, P2454, DOI 10.1007/s11095-017-2169-4; Li X, 2011, BIOMATERIALS, V32, P9546, DOI 10.1016/j.biomaterials.2011.08.068; Li ZX, 2012, CHEM SOC REV, V41, P2590, DOI 10.1039/c1cs15246g; Mamaeva V, 2016, MOL THER, V24, P926, DOI 10.1038/mt.2016.42; Mamaeva V, 2013, ADV DRUG DELIVER REV, V65, P689, DOI 10.1016/j.addr.2012.07.018; Mamaeva V, 2011, MOL THER, V19, P1538, DOI 10.1038/mt.2011.105; Marques MRC, 2011, DISSOLUT TECHNOL, V18, P15, DOI 10.14227/DT180311P15; Marquina-Castillo B, 2009, IMMUNOLOGY, V128, P123, DOI 10.1111/j.1365-2567.2008.03004.x; Martin CJ, 2012, CELL HOST MICROBE, V12, P289, DOI 10.1016/j.chom.2012.06.010; Monopoli MP, 2012, NAT NANOTECHNOL, V7, P779, DOI [10.1038/NNANO.2012.207, 10.1038/nnano.2012.207]; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/nmat2442, 10.1038/NMAT2442]; Pasqua L, 2016, MINI-REV MED CHEM, V16, P743, DOI 10.2174/1389557516666160321113620; Patel A, 2014, PROTEIN PEPTIDE LETT, V21, P1102, DOI 10.2174/0929866521666140807114240; Raffetseder J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112426; Rosenholm JM, 2009, ACS NANO, V3, P197, DOI 10.1021/nn800781r; Snewin VA, 1999, INFECT IMMUN, V67, P4586, DOI 10.1128/IAI.67.9.4586-4593.1999; Tenland E, 2018, TUBERCULOSIS, V113, P231, DOI 10.1016/j.tube.2018.10.008; Zhang LJ, 2016, CURR BIOL, V26, pR14, DOI 10.1016/j.cub.2015.11.017	29	35	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0212858	10.1371/journal.pone.0212858	http://dx.doi.org/10.1371/journal.pone.0212858			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807612	Green Published, gold, Green Submitted			2022-12-27	WOS:000459712100026
J	Kandel, Y; Vulcan, J; Rodriguez, SD; Moore, E; Chung, HN; Mitra, S; Cordova, JJ; Martinez, KJL; Moon, AS; Kulkarni, A; Ettestad, P; Melman, S; Xu, JN; Buenemann, M; Hanley, KA; Hansen, IA				Kandel, Yashoda; Vulcan, Julia; Rodriguez, Stacy D.; Moore, Emily; Chung, Hae-Na; Mitra, Soumi; Cordova, Joel J.; Martinez, Kalli J. L.; Moon, Alex S.; Kulkarni, Aditi; Ettestad, Paul; Melman, Sandra; Xu, Jiannong; Buenemann, Michaela; Hanley, Kathryn A.; Hansen, Immo A.			Widespread insecticide resistance in Aedes aegypti L. from New Mexico, USA	PLOS ONE			English	Article							SODIUM-CHANNEL GENE; KNOCKDOWN RESISTANCE; ZIKA VIRUS; PYRETHROID INSECTICIDES; POINT MUTATIONS; DIPTERA; CHLORPYRIFOS; MOSQUITOS; F1534C; DDT	Background Aedes aegypti mosquitoes are vectors of a variety of emerging viral pathogens, including yellow fever, dengue, chikungunya, and Zika virus. This species has established endemic populations in all cities across southern New Mexico sampled to date. Presently, control of Aedes-borne viruses relies on deployment of insecticides to suppress mosquito populations, but the evolution of insecticide resistance threatens the success of vector control programs. While insecticide resistance is quite common in Ae. aegypti field populations across much of the U.S., the resistance status of this species in populations from New Mexico has not previously been assessed. Results First, we collected information on pesticide use in cities in southern New Mexico and found that the most commonly used active ingredients were pyrethroids. The use of insecticides with the same mode-of-action over multiple years is likely to promote the evolution of resistance. To determine if there was evidence of resistance in some cities in southern New Mexico, we collected Ae. aegypti from the same cities and established laboratory strains to assess resistance to pyrethroid insecticides and, for a subset of populations, to organophosphate insecticides. F2 or F4 generation mosquitoes were assessed for insecticide resistance using bottle test bioassays. The majority of the populations from New Mexico that we analyzed were resistant to the pyrethroids permethrin and deltamethrin. A notable exception to this trend were mosquitoes from Alamogordo, a city that did not report using pyrethroid insecticides for vector control. We screened individuals from each population for known knock down resistance (kdr) mutations via PCR and found a strong association between the presences of the F1534C kdr mutation in the para gene of Ae. aegypti (homologue to F1534C in Musca domestica L.) and pyrethroid resistance. Conclusion High-level pyrethroid resistance is common in Ae. aegypti from New Mexico and geographic variation in such resistance is likely associated with variation in usage of pyrethroids for vector control. Resistance monitoring and management is recommended in light of the potential for arbovirus outbreaks in this state. Also, alternative approaches to mosquito control that do not involve insecticides should be explored.	[Kandel, Yashoda; Vulcan, Julia; Rodriguez, Stacy D.; Moore, Emily; Chung, Hae-Na; Mitra, Soumi; Cordova, Joel J.; Martinez, Kalli J. L.; Moon, Alex S.; Kulkarni, Aditi; Xu, Jiannong; Hanley, Kathryn A.; Hansen, Immo A.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; [Ettestad, Paul; Melman, Sandra] New Mexico Dept Hlth, Santa Fe, NM USA; [Buenemann, Michaela] New Mexico State Univ, Dept Geog, Las Cruces, NM 88003 USA	New Mexico State University; New Mexico Department of Health; New Mexico State University	Hansen, IA (corresponding author), New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.	immoh@nmsu.edu	Xu, Jiannong/N-1583-2019	Xu, Jiannong/0000-0001-7332-4370; , Soumi/0000-0002-3354-5934	New Mexico Department of Health [17/665.0300.20615]; Regents of New Mexico State University, MOA [17/665.0300.20615]; Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) continuation grant from the Centers of Disease Control and Prevention (CDC) [CK14-1401]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061222] Funding Source: NIH RePORTER	New Mexico Department of Health; Regents of New Mexico State University, MOA; Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) continuation grant from the Centers of Disease Control and Prevention (CDC); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded under a Memorandum of Agreement between the New Mexico Department of Health and the Regents of New Mexico State University, MOA#: 17/665.0300.20615. Funding was procured by an Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) continuation grant (section M1, under CK14-1401) from the Centers of Disease Control and Prevention (CDC) awarded to the New Mexico Department of Health.	Alout H, 2016, HEREDITY, V116, P224, DOI 10.1038/hdy.2015.92; Alvarez LC, 2015, PEST MANAG SCI, V71, P863, DOI 10.1002/ps.3846; [Anonymous], 2016, WORLD HLTH ORG TECHN, DOI [10.1021/jp052915b, DOI 10.1021/JP052915B]; Bariami V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001692; Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25; Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x; Brito LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060878; Brogdon WG, 1998, EMERG INFECT DIS, V4, P605, DOI 10.3201/eid0404.980410; Brogdon WG., 2010, GUIDELINES EVALUATIN, V2; Carrerwe Y, 2018, J MED ENTOMOLOGY; Center SE, 2004, CIT GUID PEST US REG; Chang C, 2009, INSECT BIOCHEM MOLEC, V39, P272, DOI 10.1016/j.ibmb.2009.01.001; Clements AN., 1992, BIOL MOSQUITOES DEV; Deming R, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1346-3; Du YZ, 2016, INSECTS, V7, DOI 10.3390/insects7040060; Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297; Chaves LF, 2015, B INSECTOL, V68, P61; Grossman MK, 2018, BIOL LETTERS, V14, DOI 10.1098/rsbl.2018.0022; Grossman MK, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2865-x; Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400; Haddi K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46549; Hahn MB, 2016, J MED ENTOMOL, V53, P1169, DOI 10.1093/jme/tjw072; Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623; Hayden MH, 2010, ECOHEALTH, V7, P64, DOI 10.1007/s10393-010-0288-z; HEMINGWAY J, 1989, B ENTOMOL RES, V79, P123, DOI 10.1017/S0007485300018630; Hendrichs J., 2009, ENCY INSECTS, V2nd ed., P953, DOI DOI 10.1016/B978-0-12-374144-8.00252-6; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Ishak IH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0797-2; Iturbe-Ormaetxe I, 2011, EMBO REP, V12, P508, DOI 10.1038/embor.2011.84; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kasai S, 2011, JPN J INFECT DIS, V64, P217; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; Kushwah RBS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003332; Landau KI, 2012, J VECTOR ECOL, V37, P407, DOI 10.1111/j.1948-7134.2012.00245.x; Lima JBP, 2003, AM J TROP MED HYG, V68, P329, DOI 10.4269/ajtmh.2003.68.329; Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828; Lopez B, 2014, J MED ENTOMOL, V51, P644, DOI 10.1603/ME13185; Lopez-Monroy B, 2018, PEST MANAGEMENT SCI; Maciel-de-Freitas R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092424; Macoris MD, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006390; MARQUARDT WC, 2004, BIOL DIS VECTORS; Morens DM, 2014, NEW ENGL J MED, V371, P885, DOI 10.1056/NEJMp1408509; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Pasteur N, 1999, J MED ENTOMOL, V36, P794, DOI 10.1093/jmedent/36.6.794; Pittendrigh B, 1997, MOL GEN GENET, V256, P602, DOI 10.1007/s004380050608; Plernsub S, 2013, TROP BIOMED, V30, P621; Plernsub S, 2016, ACTA TROP, V162, P125, DOI 10.1016/j.actatropica.2016.06.019; Pless E, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005718; Powers A.M., 2018, EMERGENCE CHIKUNGUNY, P215, DOI [10.1016/B978-0-12-811865-8.00007%E2%80%936, DOI 10.1016/B978-0-12-811865-8.00007%E2%80%936, DOI 10.1016/B978-0-12-811865-8.00007-6]; Ranson H, 2016, TRENDS PARASITOL, V32, P187, DOI 10.1016/j.pt.2015.11.010; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Rauh VA, 2006, PEDIATRICS, V118, pE1845, DOI 10.1542/peds.2006-0338; Rose RI, 2001, EMERG INFECT DIS, V7, P17, DOI 10.3201/eid0701.010103; Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x; Saavedra-Rodriguez K, 2018, SCI REPORTS; Silver JB., 2007, MOSQUITO ECOLOGY FIE; Smith LB, 2018, PEST MANAG SCI, V74, P737, DOI 10.1002/ps.4771; SOPER FL, 1967, B WORLD HEALTH ORGAN, V36, P536; Srisawat R, 2010, APPL ENTOMOL ZOOL, V45, P275, DOI 10.1303/aez.2010.275; Vargas-Teran M, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P629, DOI 10.1007/1-4020-4051-2_24; Walker KR, 2011, J AM MOSQUITO CONTR, V27, P135, DOI 10.2987/10-6078.1; Weaver SC, 2018, ANTIVIR RES, V156, P80, DOI 10.1016/j.antiviral.2018.06.009; WILLIAMSON MS, 1993, MOL GEN GENET, V240, P17, DOI 10.1007/BF00276878; Williamson MS, 1996, MOL GEN GENET, V252, P51, DOI 10.1007/BF02173204; Wu Y, 2001, Afr J Med Med Sci, V30 Suppl, P52; Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6; Yanola J, 2011, TROP MED INT HEALTH, V16, P501, DOI 10.1111/j.1365-3156.2011.02725.x; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	68	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212693	10.1371/journal.pone.0212693	http://dx.doi.org/10.1371/journal.pone.0212693			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794644	gold, Green Published, Green Submitted			2022-12-27	WOS:000459709100117
J	Kazenid, M; Baumann, N; Twenhofel, JF; Kuhl, J				Kazenid, Miguel; Baumann, Nicola; Twenhoefel, Janne F.; Kuhl, Julius			When do anorexic patients perceive their body as too fat? Aggravating and ameliorating factors	PLOS ONE			English	Article							EATING-DISORDERS; SELF-INFILTRATION; HEMISPHERIC ACTIVATION; INDIVIDUAL-DIFFERENCES; ACTION ORIENTATION; BULIMIA-NERVOSA; IMAGE; STRATEGIES; MOTIVATION; HANDEDNESS	Objective Our study investigated body image representations in female patients with anorexia nervosa and healthy controls using a size estimation with pictures of their own body. We also explored a method to reduce body image distortions through right hemispheric activation. Method Pictures of participants' own bodies were shown on the left or right visual fields for 130 ms after presentation of neutral, positive, or negative word primes, which could be self-relevant or not, with the task of classifying the picture as "thinner than", "equal to", or "fatter than" one's own body. Subsequently, activation of the left- or right hemispheric through right-or left-hand muscle contractions for 3 min., respectively. Finally, participants completed the size estimation task again. Results The distorted "fatter than" body image was found only in patients and only when a picture of their own body appeared on the right visual field (left hemisphere) and was preceded by negative self-relevant words. This distorted perception of the patients' body image was reduced after left-hand muscle contractions (right hemispheric activation). Discussion To reduce body image distortions it is advisable to find methods that help anorexia nervosa patients to increase their self-esteem. The body image distortions were ameliorated after right hemispheric activation. A related method to prevent distorted body-image representations in these patients may be Eye Movement Desensitization and Reprocessing (EMDR) therapy.	[Kazenid, Miguel; Twenhoefel, Janne F.; Kuhl, Julius] Univ Osnabruck, Inst Psychol, Osnabruck, Germany; [Baumann, Nicola] Univ Trier, Dept Psychol, Trier, Germany	University Osnabruck; Universitat Trier	Kazenid, M (corresponding author), Univ Osnabruck, Inst Psychol, Osnabruck, Germany.	mikazen@uos.de	Baumann, Nicola/F-9899-2018; Goldwasser, Dr Norman/F-6854-2019	Baumann, Nicola/0000-0002-4713-6664; Goldwasser, Dr Norman/0000-0002-8051-8330; Kazen, Miguel/0000-0001-5012-5723	Open Access Fund of the University of Trier; German Research Foundation (DFG)	Open Access Fund of the University of Trier; German Research Foundation (DFG)(German Research Foundation (DFG))	The publication was funded by the Open Access Fund of the University of Trier and the German Research Foundation (DFG) within the Open Access Publishing funding program.	Amianto F, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00849; [Anonymous], 2000, INT J EDUC RES, DOI [10.1016/S0883-0355(00)00045-8, DOI 10.1016/S0883-0355(00)00045-8]; Baumann N, 2005, MOTIV EMOTION, V29, P135, DOI 10.1007/s11031-005-9439-x; Baumann N, 2003, PERS SOC PSYCHOL B, V29, P487, DOI 10.1177/0146167202250916; Baumeister RF, 1998, J PERS SOC PSYCHOL, V74, P1252, DOI 10.1037/0022-3514.74.5.1252; Beato-Fernandez L, 2009, PSYCHIAT RES-NEUROIM, V171, P129, DOI 10.1016/j.pscychresns.2008.01.001; Beckmann J, 2004, PSYCHOL REP, V95, P1135, DOI 10.2466/PR0.95.7.1135-1153; Beckmann J, 2013, J EXP PSYCHOL GEN, V142, P679, DOI 10.1037/a0029852; BISIACH E, 1991, NEUROPSYCHOLOGIA, V29, P1029, DOI 10.1016/0028-3932(91)90066-H; Bradley SJ, 1997, J CLIN EXP NEUROPSYC, V19, P20, DOI 10.1080/01688639708403833; Brookmeyer T, 2018, BEHAV RES THER, V104, P69, DOI 10.1016/j.brat.2018.03.003; Cash TF, 1997, INT J EAT DISORDER, V22, P107, DOI 10.1002/(SICI)1098-108X(199709)22:2&lt;107::AID-EAT1&gt;3.0.CO;2-J; Christman SD, 2007, INT J EAT DISORDER, V40, P247, DOI 10.1002/eat.20357; COOPER PJ, 1987, INT J EAT DISORDER, V6, P485, DOI 10.1002/1098-108X(198707)6:4<485::AID-EAT2260060405>3.0.CO;2-O; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Esposito R, 2016, J NEUROPSYCHOL, DOI [10.1111/jnp.12106/full, DOI 10.1111/JNP.12106/FULL]; Fehm L, 2004, COGNITIVE THER RES, V28, P105, DOI 10.1023/B:COTR.0000016933.41653.dc; Gardner RM, 2014, PSYCHIAT RES, V219, P407, DOI 10.1016/j.psychres.2014.06.029; Goldstein A, 2010, PSYCHON B REV, V17, P895, DOI 10.3758/PBR.17.6.895; Grunwald M, 2001, INT J EAT DISORDER, V29, P417, DOI 10.1002/eat.1038; Harmon-Jones E, 2006, PSYCHOPHYSIOLOGY, V43, P598, DOI 10.1111/j.1469-8986.2006.00465.x; Hartmann AS, 2015, BODY IMAGE, V14, P77, DOI 10.1016/j.bodyim.2015.03.013; Herbert BM, 2014, EAT BEHAV, V15, P445, DOI 10.1016/j.eatbeh.2014.06.002; HORNE RL, 1991, AM J PSYCHIAT, V148, P211; Imhoff R, 2014, EUR J PERSONALITY, V28, P413, DOI 10.1002/per.1899; Jones C, 2007, J COGN PSYCHOTHER, V21, P156, DOI 10.1891/088983907780851531; Joos AAB, 2011, PSYCHIAT RES-NEUROIM, V191, P189, DOI 10.1016/j.pscychresns.2010.11.008; Kazen M, 2003, MOTIV EMOTION, V27, P157, DOI 10.1023/A:1025043530799; Kazen M, 2017, THOUGHT CONTRO UNPUB; Kazen M, 2008, J RES PERS, V42, P693, DOI 10.1016/j.jrp.2007.09.005; Kazen M, 2015, PSYCHOL RES-PSYCH FO, V79, P1064, DOI 10.1007/s00426-014-0631-z; Kazun M., 2018, WHY PEOPLE DO THINGS, P15; Koole SL, 2004, J PERS SOC PSYCHOL, V87, P974, DOI 10.1037/0022-3514.87.6.974; KUHL J, 1994, J PERS SOC PSYCHOL, V66, P1103, DOI 10.1037/0022-3514.66.6.1103; Kuhl J, 2001, MOTIVATION PERSONLIC; Kuhl J., 1994, VOLITION PERSONALITY, P47; Kuhl J., 1998, MOTIVATION SELF REGU, P15, DOI [10.1017/C809780511527869.003, DOI 10.1017/CBO9780511527869.003, 10.1017/CBO9780511527869.003]; Kuhl J., 1994, VOLITION PERSONALITY; Kuhl J, 2015, SOC PERSONAL PSYCHOL, V9, P115, DOI 10.1111/spc3.12162; Miyake Y, 2010, NEUROIMAGE, V50, P1333, DOI 10.1016/j.neuroimage.2009.12.095; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Peterson CK, 2008, PSYCHOPHYSIOLOGY, V45, P86, DOI 10.1111/j.1469-8986.2007.00597.x; Pollatos Olga, 2008, Eat Behav, V9, P381, DOI 10.1016/j.eatbeh.2008.02.001; Quirin M, 2018, EUR J SOC PSYCHOL, V48, P4, DOI 10.1002/ejsp.2281; RAMACHANDRAN VS, 1995, CONSCIOUS COGN, V4, P22, DOI 10.1006/ccog.1995.1002; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Schiff BB, 1998, NEUROPSYCHOLOGY, V12, P526, DOI 10.1037/0894-4105.12.4.526; Schneider W., 2002, E PRIME USERS GUIDE; Shapiro F, 2018, EYE MOVEMENT DESENSI; Sheldon KM, 1998, PERS SOC PSYCHOL B, V24, P546, DOI 10.1177/0146167298245010; SLADE PD, 1994, BEHAV RES THER, V32, P497, DOI 10.1016/0005-7967(94)90136-8; Smeets MAM, 2001, INT J EAT DISORDER, V29, P409, DOI 10.1002/eat.1037; Stein KF, 2003, ARCH PSYCHIAT NURS, V17, P57, DOI 10.1053/apnu.2003.50000; Tasca GA, 2014, INT J EAT DISORDER, V47, P710, DOI 10.1002/eat.22302; Vanderlinden J, 2008, EUR EAT DISORD REV, V16, P329, DOI 10.1002/erv.889; Vocks S, 2010, J PSYCHIATR NEUROSCI, V35, P163, DOI 10.1503/jpn.090048; WELLS A, 1994, BEHAV RES THER, V32, P871, DOI 10.1016/0005-7967(94)90168-6; Wojdylo K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169729; Zaccagnino M., 2017, NON TRADITIONAL REF, P193, DOI [10.5772/65695, DOI 10.5772/65695]; Zaccagnino M, 2017, J EMDR PRACT RES, V11, P43, DOI 10.1891/1933-3196.11.1.43	60	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212612	10.1371/journal.pone.0212612	http://dx.doi.org/10.1371/journal.pone.0212612			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794659	gold, Green Published, Green Submitted			2022-12-27	WOS:000459709100097
J	Norowitz, HL; Morello, T; Kupfer, HM; Kohlhoff, SA; Smith-Norowitz, TA				Norowitz, Hadara L.; Morello, Timothy; Kupfer, Hadassah M.; Kohlhoff, Stephan A.; Smith-Norowitz, Tamar A.			Association between otitis media infection and failed hearing screenings in children	PLOS ONE			English	Article							DAY-CARE ATTENDANCE; EAR INFECTIONS; FAMILY-SIZE; ASTHMA; EFFUSION; PREVALENCE; FREQUENCY; OUTCOMES; VIRUSES; RISK	This study aims to assess prospectively whether there is an association between frequencies of upper respiratory tract infections (URTI) or asthma in early childhood and failed otoacoustic emission (OAE) screenings later in life. There are no clear recommendations for hearing testing following acute otitis media (AOM) infection. This is a retrospective, practice based chart review. Participants from a primary care setting were 517 pre-adolescent and adolescent children (49.9% female) (ages 10-21; mean, 15 y/o), who had presented with at least one specific bacterial URTI (AOM, Group A Streptococcus (GAS) tonsillitis, or Influenza) during childhood. Hearing testing was recorded incidentally at all subsequent routine health care maintenance visits (OAE hearing screen). Simple linear regression analyses were performed using R (v3.4.4). We found that number of episodes of AOM infections strongly correlated with number of failed OAE screenings later in life (F = 76.37; P = < 0.001; R-2 = 0.1279), while GAS (F = 1.859; P = 0.1733; R-2 = 0.0016) or Influenza infection (F = 2.624; P = 0.1059; R-2 = 0.0031) were not associated with failed OAE screening. Correlation between number of AOM infections and number of failed OAE screenings was not strengthened by presence of asthma. This study found evidence of an association between childhood history of AOM and failed OAE screenings in adolescence. Since this population may be at a higher risk for developing permanent or fluctuating hearing losses, further studies to clarify indications and timing of standard audiological testing among these children should be considered.	[Norowitz, Hadara L.; Morello, Timothy; Kupfer, Hadassah M.; Kohlhoff, Stephan A.; Smith-Norowitz, Tamar A.] Suny Downstate Med Ctr, Dept Pediat, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Smith-Norowitz, TA (corresponding author), Suny Downstate Med Ctr, Dept Pediat, Brooklyn, NY 11203 USA.	tamar.smith-norowitz@downstate.edu		Morello, Timothy/0000-0001-9035-4862				Aarhus L, 2015, EAR HEARING, V36, P302, DOI 10.1097/AUD.0000000000000118; [Anonymous], PRESCRIBER; BALDWIN RL, 1993, AM J OTOL, V14, P601; Ball TM, 2000, NEW ENGL J MED, V343, P538, DOI 10.1056/NEJM200008243430803; Bennett KE, 2001, ARCH DIS CHILD, V85, P91, DOI 10.1136/adc.85.2.91; Casey JR, 2004, PEDIATR INFECT DIS J, V23, P824, DOI 10.1097/01.inf.0000136871.51792.19; Coyte PC, 1999, INT J PEDIATR OTORHI, V49, P27, DOI 10.1016/S0165-5876(99)00041-5; Cunningham M, 2003, PEDIATRICS, V111, P436, DOI 10.1542/peds.111.2.436; Doyle WJ, 1999, LARYNGOSCOPE, V109, P324, DOI 10.1097/00005537-199902000-00027; Eldeirawi K, 2004, CHEST, V125, P1685, DOI 10.1378/chest.125.5.1685; ELLULMICALLEF R, 1980, BRIT J CLIN PHARMACO, V9, P479, DOI 10.1111/j.1365-2125.1980.tb05843.x; Foust T, 2013, PEDIATRICS, V132, P118, DOI 10.1542/peds.2012-3868; Hall A, 2017, ORTHOD CRANIOFAC RES, V20, P8, DOI 10.1111/ocr.12184; Hall JW, 2017, HEARING J, V6; Halloran DR, 2005, ARCH PEDIAT ADOL MED, V159, P949, DOI 10.1001/archpedi.159.10.949; HARDY AM, 1993, AM J PUBLIC HEALTH, V83, P1321, DOI 10.2105/AJPH.83.9.1321; Heikkinen T, 2003, CLIN MICROBIOL REV, V16, P230, DOI 10.1128/CMR.16.2.230-241.2003; Ibrahim HM, 2011, INT J PEDIATR OTORHI, V75, P39, DOI 10.1016/j.ijporl.2010.10.002; Infante-Rivard C, 2001, AM J EPIDEMIOL, V153, P653, DOI 10.1093/aje/153.7.653; Krakau M, 2017, ACTA OTO-LARYNGOL, V137, P1238, DOI 10.1080/00016489.2017.1362111; Lack G, 2001, J ALLERGY CLIN IMMUN, V108, pS9, DOI 10.1067/mai.2001.115562; Lieberthal AS, 2013, PEDIATRICS, V131, pE964, DOI 10.1542/peds.2012-3488; Lieu JEC, 2002, ARCH PEDIAT ADOL MED, V156, P147, DOI 10.1001/archpedi.156.2.147; Luo H, 2001, Zhonghua Er Bi Yan Hou Ke Za Zhi, V36, P295; Micillo E, 2000, ALLERGY, V55, P42; Qureishi A, 2014, INFECT DRUG RESIST, V7, P15, DOI 10.2147/IDR.S39637; Rovers MM, 2008, VACCINE, V26, pG2, DOI 10.1016/j.vaccine.2008.11.005; RUUSKANEN O, 1991, PEDIATR INFECT DIS J, V10, P425, DOI 10.1097/00006454-199106000-00001; Shirakawa T, 1997, SCIENCE, V275, P77, DOI 10.1126/science.275.5296.77; STOOL SE, 1994, PEDIATRICS, V94, P766; von Mutius E, 1999, EUR RESPIR J, V14, P4, DOI 10.1034/j.1399-3003.1999.14a03.x; Wickens KL, 1999, EPIDEMIOLOGY, V10, P699, DOI 10.1097/00001648-199911000-00009; Zernotti ME, 2017, WORLD ALLERGY ORGAN, V10, DOI 10.1186/s40413-017-0168-x	33	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212777	10.1371/journal.pone.0212777	http://dx.doi.org/10.1371/journal.pone.0212777			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794686	Green Published, gold, Green Submitted			2022-12-27	WOS:000459709100134
J	Wiedemann, A; Lino, AC; Dorner, T				Wiedemann, Annika; Lino, Andreia C.; Doerner, Thomas			B cell subset distribution in human bone marrow is stable and similar in left and right femur: An instructive case	PLOS ONE			English	Article							LIVED PLASMA-CELLS; SURVIVAL; NICHE	The bone marrow (BM) is, in addition to being the site of B cell development, a tissue that harbors long-lived plasma cells (PC), the cells that protect the body against foreign antigens by continuous production of antibodies. Nothing is known about the long-term stability and functionality of both B cells and PC in the BM at the individual donor level since repeated sampling possibilities outside of oncology are scarce. Here, we had the opportunity to obtain BM samples from a patient undergoing bilateral total hip arthroplasty half a year apart. We observed that the frequencies of the analyzed B cell and PC subsets were similar despite a time of six months in between and sampling on left and right side of the body. Additionally, B cell receptor stimulation led to comparable results. Our data suggest that composition and functionality of B cells are stable in the BM of adults at the individual donor level.	[Wiedemann, Annika; Doerner, Thomas] Charite Univ Med Berlin, Dept Med Rheumatol & Clin Immunol, Berlin, Germany; [Wiedemann, Annika; Lino, Andreia C.; Doerner, Thomas] German Rheumatism Res Ctr Berlin DRFZ, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Rheuma-Forschungszentrum (DRFZ)	Wiedemann, A (corresponding author), Charite Univ Med Berlin, Dept Med Rheumatol & Clin Immunol, Berlin, Germany.; Wiedemann, A (corresponding author), German Rheumatism Res Ctr Berlin DRFZ, Berlin, Germany.	annika.wiedemann@charite.de	Lino, Andreia/GOV-5217-2022	Lino, Andreia C/0000-0002-3791-8232	German Research Foundation (DFG); Open Access Publication Fund of Charite - Universitatsmedizin Berlin	German Research Foundation (DFG)(German Research Foundation (DFG)); Open Access Publication Fund of Charite - Universitatsmedizin Berlin	We acknowledge support from the German Research Foundation (DFG) and the Open Access Publication Fund of Charite - Universitatsmedizin Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brynjolfsson SF, 2017, BLOOD ADV, V1, P835, DOI 10.1182/bloodadvances.2017004481; Carrion C, 2019, CYTOM PART B-CLIN CY, V96, P30, DOI 10.1002/cyto.b.21747; Cassese G, 2003, J IMMUNOL, V171, P1684, DOI 10.4049/jimmunol.171.4.1684; Giesecke C, 2014, J IMMUNOL, V192, P3091, DOI 10.4049/jimmunol.1302783; Halliley JL, 2015, IMMUNITY, V43, P132, DOI 10.1016/j.immuni.2015.06.016; Kurosaki T, 1999, ANNU REV IMMUNOL, V17, P555, DOI 10.1146/annurev.immunol.17.1.555; Landsverk OJB, 2017, J EXP MED, V214, P309, DOI 10.1084/jem.20161590; Mei HE, 2015, BLOOD, V125, P1739, DOI 10.1182/blood-2014-02-555169; Pinto D, 2013, BLOOD, V121, P4110, DOI 10.1182/blood-2012-09-459289; Theunissen PMJ, 2017, HAEMATOLOGICA, V102, P1869, DOI 10.3324/haematol.2017.171454; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Tsang JS, 2014, CELL, V157, P499, DOI 10.1016/j.cell.2014.03.031; Van TC, 2011, NAT IMMUNOL, V12, P151, DOI 10.1038/ni.1981; Winter O, 2010, BLOOD, V116, P1867, DOI 10.1182/blood-2009-12-259457; Xu YK, 2005, IMMUNITY, V22, P9, DOI 10.1016/j.immuni.2004.12.004; Zehentmeier S, 2014, EUR J IMMUNOL, V44, P2306, DOI 10.1002/eji.201344313	16	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212525	10.1371/journal.pone.0212525	http://dx.doi.org/10.1371/journal.pone.0212525			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794605	Green Submitted, Green Published, gold			2022-12-27	WOS:000459709100081
J	Pozzobon, D; Ferreira, PH; Dario, AB; Almeida, L; Vesentini, G; Harmer, AR; Ferreira, ML				Pozzobon, Daniel; Ferreira, Paulo H.; Dario, Amabile B.; Almeida, Lisandra; Vesentini, Giovana; Harmer, Alison R.; Ferreira, Manuela L.			Is there an association between diabetes and neck and back pain? A systematic review with meta-analyses	PLOS ONE			English	Review							PHYSICAL-ACTIVITY; OLD-AGE; PREVALENCE; MELLITUS; RISK; OBESITY; INFLAMMATION; NEUROPATHY; SARCOPENIA; ADULTS	Background and objective Approximately half of the population will experience either low back pain or neck pain, at some point in their lives. Previous studies suggest that people with diabetes are more likely to present with chronic somatic pain, including shoulder, knee and spinal pain. This study aimed to systematically review and appraise the literature to explore the magnitude as well as the nature of the association between diabetes and back, neck, or spinal (back and neck) pain. Databases and data treatment A systematic search was performed using the Medline, CINAHL, EMBASE, and Web of Science electronic databases. Studies which assessed the association between diabetes and back or neck pain outcomes, in participants older than 18 years of age were included. Two independent reviewers extracted data on the incidence of pain and reported associations. Results Eight studies were included in the meta-analyses. Meta-analyses showed that people with diabetes are more likely to report low back pain [5 studies; n: 131,431; odds ratio (OR): 1.35; 95% Confidence Interval (CI): 1.20 to 1.52; p<0.001] and neck pain (2 studies; n: 6,560; OR: 1.24; 95% CI: 1.05 to 1.47; p = 0.01) compared to those without diabetes. Results from one longitudinal cohort study suggested that diabetes is not associated with the risk of developing future neck, low back or spinal pain. Conclusions Diabetes is associated with low back and neck individually, and spinal pain. The longitudinal analysis showed no association between the conditions. Our results suggest that diabetes co-exists with back pain; however, a direct causal link between diabetes and back pain was not established.	[Pozzobon, Daniel; Ferreira, Manuela L.] Univ Sydney, Sydney Med Sch, Kolling Inst, Inst Bone & Joint Res, Sydney, NSW, Australia; [Ferreira, Paulo H.; Harmer, Alison R.] Univ Sydney, Musculoskeletal Hlth Res Grp, Fac Hlth Sci, Sydney, NSW, Australia; [Dario, Amabile B.] Univ Sydney, Sch Publ Hlth, Sydney Med Sch, Sydney, NSW, Australia; [Almeida, Lisandra] Univ Fed Bahia, Inst Hlth Sci, Discipline Physiotherapy, Salvador, BA, Brazil; [Vesentini, Giovana] UNESP Paulista State Univ, Botucatu Med Sch, Dept Obstet & Gynaecol, Botucatu, SP, Brazil	University of Sydney; Kolling Institute of Medical Research; University of Sydney; University of Sydney; Universidade Federal da Bahia; Universidade Estadual Paulista	Pozzobon, D (corresponding author), Univ Sydney, Kolling Inst, Inst Bone & Joint Res, Sydney Med Sch, Sydney, NSW, Australia.	dpoz5597@uni.sydney.edu.au	Vesentini, Giovana/B-9668-2013; Ferreira, Manuela/AAQ-5446-2020	Vesentini, Giovana/0000-0002-7116-1667; Ferreira, Manuela/0000-0002-3479-0683; Borges Dario, Amabile/0000-0002-4818-7017; Pozzobon, Daniel/0000-0002-2796-4235				Almurdhi MM, 2016, DIABETES CARE, V39, P441, DOI 10.2337/dc15-0995; Asadian L, 2016, CLIN MED INSIGHTS-EN, V9, DOI 10.4137/CMED.S39035; Aune D, 2015, EUR J EPIDEMIOL, V30, P529, DOI 10.1007/s10654-015-0056-z; Balk EM, 2015, ANN INTERN MED, V163, P437, DOI 10.7326/M15-0452; Cesari M, 2005, AM J CLIN NUTR, V82, P428, DOI 10.1093/ajcn/82.2.428; Clark MG, 2003, AM J PHYSIOL-ENDOC M, V284, pE241, DOI 10.1152/ajpendo.00408.2002; Dario A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174757; Davies M, 2006, DIABETES CARE, V29, P1518, DOI 10.2337/dc05-2228; Duncan BB, 2003, DIABETES, V52, P1799, DOI 10.2337/diabetes.52.7.1799; Eivazi M, 2012, HEALTH PROMOT PERSPE, V2, P80, DOI 10.5681/hpp.2012.010; Fabiane SM, 2016, EUR SPINE J, V25, P2716, DOI 10.1007/s00586-016-4612-3; Fields AJ, 2015, J ORTHOP RES, V33, P738, DOI 10.1002/jor.22807; Groen BBL, 2014, J APPL PHYSIOL, V116, P998, DOI 10.1152/japplphysiol.00919.2013; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Hartvigsen J, 2004, SPINE, V29, P576, DOI 10.1097/01.BRS.0000099394.18994.2F; Hartvigsen J, 2003, EUR SPINE J, V12, P528, DOI 10.1007/s00586-003-0542-y; Hassoon A, 2017, J DIABETES COMPLICAT, V31, P38, DOI 10.1016/j.jdiacomp.2016.10.025; Herzog R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-154; Heuch I, 2013, SPINE, V38, P133, DOI 10.1097/BRS.0b013e3182647af2; Hinyard L. J., 2016, The Open Public Health Journal, V9, P65, DOI 10.2174/1874944501609010065; Kaur J, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/943162; Kearns K, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-143; Kim TN, 2010, DIABETES CARE, V33, P1497, DOI 10.2337/dc09-2310; Krein SL, 2005, DIABETES CARE, V28, P65, DOI 10.2337/diacare.28.1.65; Laiguillon MC, 2015, OSTEOARTHR CARTILAGE, V23, P1513, DOI 10.1016/j.joca.2015.04.026; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; MAKELA M, 1991, AM J EPIDEMIOL, V134, P1356; Martini Christian, 2012, J Pain Res, V5, P51, DOI 10.2147/JPR.S30406; Messier SP, 2005, ARTHRITIS RHEUM, V52, P2026, DOI 10.1002/art.21139; Molsted S, 2012, DIABETES RES CLIN PR, V96, P135, DOI 10.1016/j.diabres.2011.12.022; Narayan KMV, 2007, DIABETES CARE, V30, P1562, DOI 10.2337/dc06-2544; Pai LW, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0819-4; Qiu SH, 2012, DIABETES METAB J, V36, P1, DOI 10.4093/dmj.2012.36.1.1; Ritzwoller DP, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-72; Sakellaridis N, 2006, SURG NEUROL, V66, P152, DOI 10.1016/j.surneu.2006.01.019; Sakellaridis N, 2008, CLIN NEUROL NEUROSUR, V110, P810, DOI 10.1016/j.clineuro.2008.05.007; Searle A, 2015, CLIN REHABIL, V29, P1155, DOI 10.1177/0269215515570379; Slater M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-77; Tangvarasittichai S, 2015, WORLD J DIABETES, V6, P456, DOI 10.4239/wjd.v6.i3.456; Teraguchi M, 2016, PLOS ONE, V11; Vincent HK, 2012, AGEING RES REV, V11, P361, DOI 10.1016/j.arr.2012.03.002; Walker BF, 2004, J MANIP PHYSIOL THER, V27, P238, DOI 10.1016/j.jmpt.2004.02.002; Webb R, 2003, SPINE, V28, P1195, DOI 10.1097/00007632-200306010-00021; Welch AA, 2014, P NUTR SOC, V73, P16, DOI 10.1017/S0029665113003698; Wells G., NEWCASTLE OTTAWA SCA; Wright AR, 2015, MYOPAIN, V23, P34, DOI 10.3109/10582452.2015.1132026; Yamagishi S, 2011, EXP GERONTOL, V46, P217, DOI 10.1016/j.exger.2010.11.007	48	19	19	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212030	10.1371/journal.pone.0212030	http://dx.doi.org/10.1371/journal.pone.0212030			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789940	Green Submitted, gold, Green Published			2022-12-27	WOS:000459330800018
J	Wellek, S; Ziegler, A				Wellek, Stefan; Ziegler, Andreas			Testing for goodness rather than lack of fit of an X-chromosomal SNP to the Hardy-Weinberg model	PLOS ONE			English	Article							GENETIC-MARKERS; EQUILIBRIUM; ASSOCIATION; HYPOTHESIS; TRIALS	The problem of checking the genotype distribution obtained for some diallelic marker for compatibility with the Hardy-Weinberg equilibrium (HWE) condition arises also for loci on the X chromosome. The possible genotypes depend on the sex of the individual in this case: for females, the genotype distribution is trinomial, as in the case of an autosomal locus, whereas a binomial proportion is observed for males. Like in genetic association studies with autosomal SNPs, interest is typically in establishing approximate compatibility of the observed genotype frequencies with HWE. This requires to replace traditional methods tailored for detecting lack of fit to the model with an equivalence testing procedure to be derived by treating approximate compatibility with the model as the alternative hypothesis. The test constructed here is based on an upper confidence bound and a simple to interpret combined measure of distance between true and HWE conforming genotype distributions in female and male subjects. A particular focus of the paper is on the derivation of the asymptotic distribution of the test statistic under null alternatives which is not of the usual Gaussian form. A closed sample size formula is also provided and shown to behave satisfactorily in terms of the approximation error.	[Wellek, Stefan] Heidelberg Univ, Mannheim Med Sch, CIMH Mannheim, Dept Biostat, Mannheim, Germany; [Wellek, Stefan] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med Biostat Epidemiol & Informat, Mainz, Germany; [Ziegler, Andreas] Univ Lubeck, Inst Med Biometry & Stat, Lubeck, Germany; [Ziegler, Andreas] StatSol, Moenring 2, Lubeck, Germany; [Ziegler, Andreas] Univ KwaZulu Natal, Sch Math Stat & Comp Sci, Pietermaritzburg, South Africa	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Johannes Gutenberg University of Mainz; University of Lubeck; University of Kwazulu Natal	Wellek, S (corresponding author), Heidelberg Univ, Mannheim Med Sch, CIMH Mannheim, Dept Biostat, Mannheim, Germany.; Wellek, S (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med Biostat Epidemiol & Informat, Mainz, Germany.	stefan.wellek@zi-mannheim.de	Ziegler, Andreas/G-4246-2012	Ziegler, Andreas/0000-0002-8386-5397; Wellek, Stefan/0000-0001-8369-8122				[Anonymous], 2010, TESTING STAT HYPOTHE, DOI DOI 10.1201/EBK1439808184; BERGER RL, 1982, TECHNOMETRICS, V24, P295, DOI 10.2307/1267823; Bishop YM., 2007, DISCRETE MULTIVARIAT; FARRINGTON CP, 1990, STAT MED, V9, P1447, DOI 10.1002/sim.4780091208; Goddard KAB, 2009, GENET EPIDEMIOL, V33, P569, DOI 10.1002/gepi.20409; Graffelman J, 2016, HEREDITY, V116, P558, DOI 10.1038/hdy.2016.20; Graffelman J, 2018, MOL ECOL RESOUR, V18, P461, DOI 10.1111/1755-0998.12748; Graffelman J, 2015, J STAT SOFTW, V64, P1; Loley C, 2016, SCI REP-UK, V6, DOI 10.1038/srep35278; NHGRI, 2011, GENEVA GEN WID ASS S; Panoutsopoulou K, 2018, METHODS MOL BIOL, V1793, P7, DOI 10.1007/978-1-4939-7868-7_2; Puig X, 2017, HEREDITY, V119, P226, DOI 10.1038/hdy.2017.30; Ryckman K, 2008, CURRENT PROTOCOLS HU; Wang J, METHODS MOL BIOL, V1666; Wang P, 2019, STAT METHODS MED RES, V28, P3260, DOI 10.1177/0962280218799532; Wellek S, 2005, BIOMETRICAL J, V47, P48, DOI 10.1002/bimj.200410090; Wellek S, 2004, BIOMETRICS, V60, P694, DOI 10.1111/j.0006-341X.2004.00219.x; Wellek S, 2010, BIOMETRICAL J, V52, P253, DOI 10.1002/bimj.200900249; WellsLassagne S, 2017, ROUT ADV TELEVIS, P1; WESTLAKE WJ, 1972, J PHARM SCI, V61, P1340, DOI 10.1002/jps.2600610845; You XP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145032; Zheng G, 2007, GENET EPIDEMIOL, V31, P834, DOI 10.1002/gepi.20244; Ziegler A., 2010, STAT APPROACH GENETI; Ziegler A, 2011, BREAST CANCER RES TR, V128, P197, DOI 10.1007/s10549-010-1295-z	25	2	2	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212344	10.1371/journal.pone.0212344	http://dx.doi.org/10.1371/journal.pone.0212344			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789927	gold, Green Published, Green Submitted			2022-12-27	WOS:000459330800025
J	Cannizzo, ZJ; Griffen, BD				Cannizzo, Zachary J.; Griffen, Blaine D.			An artificial habitat facilitates a climate-mediated range expansion into a suboptimal novel ecosystem	PLOS ONE			English	Article							MANGROVE TREE CRAB; RESPONSES; ECOLOGY; BIODIVERSITY; POPULATION; EVOLUTION; PREDATION; COMMUNITY; HISTORY; SHIFTS	As the geographic ranges of tropical species and ecosystems continue to shift poleward with climate change, it is critical to prediction and management to identify factors that facilitate these expansions. This is especially true for range shifts that involve the decoupling of a shifting species from its historic ecosystem and the colonization of an ecosystem that it has not previously inhabited (i.e. is novel to the shifting species). In cases where the colonized ecosystem is suboptimal for the shifting species, stepping stone refuges may play a critical role in facilitating further expansion. Here we document the facilitation of the northward range expansion of the mangrove tree crab (Aratus pisonii) into the previously uninhabited salt marsh ecosystem by artificial boat docks. While the cold tolerance of crabs did not differ between habitats, they were found on docks 36 km and 22 km further north than elsewhere in the salt marsh after the winters of 2016-'17 and '17-'18, respectively. This extended range-edge appears to be a result of docks within the salt marsh acting as a stepping stone refuge by providing this historically tropical species with a relatively warm thermal refuge during the winter that mitigates seasonal population die-backs exhibited elsewhere at the range-edge. Further, population abundances were higher on docks at the range-edge than in the surrounding salt marsh. While artificial habitats often favor the expansion of non-indigenous species, our results demonstrate the facilitation of a native species' range shift into a suboptimal ecosystem which it has not previously inhabited. The potential for analogous and refuge habitats, artificial or otherwise, to increase the rate and success of range shifts could be critical to the fate of many current and future range shifting species.	[Cannizzo, Zachary J.] Univ South Carolina, Marine Sci Program, Sch Earth Ocean & Environm, Columbia, SC 29208 USA; [Griffen, Blaine D.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA	University of South Carolina System; University of South Carolina Columbia; Brigham Young University	Cannizzo, ZJ (corresponding author), Univ South Carolina, Marine Sci Program, Sch Earth Ocean & Environm, Columbia, SC 29208 USA.	cannizzz@email.sc.edu	Griffen, Blaine/AAC-6384-2021					Baum KA, 2004, ECOLOGY, V85, P2671, DOI 10.1890/04-0500; BEEVER JW, 1979, OECOLOGIA, V43, P317, DOI 10.1007/BF00344958; Canning-Clode J, 2017, DIVERS DISTRIB, V23, P463, DOI 10.1111/ddi.12551; Canning-Clode J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029657; Cannizzo ZJ, 2018, HYDROBIOLOGIA, V809, P79, DOI 10.1007/s10750-017-3449-z; Cannizzo ZJ, 2018, ECOL EVOL, V8, P1521, DOI 10.1002/ece3.3739; Cannizzo ZJ, 2016, ANIM BEHAV, V121, P79, DOI 10.1016/j.anbehav.2016.08.025; Chester ET, 2013, BIOL CONSERV, V166, P64, DOI 10.1016/j.biocon.2013.06.016; Chuang A, 2016, GLOBAL CHANGE BIOL, V22, P494, DOI 10.1111/gcb.13107; Crozier L, 2004, ECOLOGY, V85, P231, DOI 10.1890/02-0607; D'Odorico P, 2013, GLOBAL ECOL BIOGEOGR, V22, P364, DOI 10.1111/geb.12000; Davis AY, 2014, BIOL INVASIONS, V16, P415, DOI 10.1007/s10530-013-0530-z; Dayton P.K., 1972, P C CONSERVATION PRO, P81; Burroni NE, 2011, INSECT CONSERV DIVER, V4, P39, DOI 10.1111/j.1752-4598.2010.00100.x; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; Gilchrist A, 2016, LANDSCAPE RES, V41, P26, DOI 10.1080/01426397.2015.1045466; Glasby TM, 2007, MAR BIOL, V151, P887, DOI 10.1007/s00227-006-0552-5; Gledhill DG, 2008, LANDSCAPE ECOL, V23, P1219, DOI 10.1007/s10980-008-9292-x; Grant G., 2006, URBAN HABITATS, V4, P51; Grieg E. I., 2017, P R SOC B, V284, DOI DOI 10.1098/RSPB.2017; Hannah L, 2001, ADV GLOB CHANGE RES, V9, P413; Hewitt CL, 2004, MAR BIOL, V144, P183, DOI 10.1007/s00227-003-1173-x; Holt RD, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P259; Jiang J, 2016, ECOL MODEL, V326, P168, DOI 10.1016/j.ecolmodel.2015.04.013; Johnston CA, 2018, BEHAV ECOL, V29, P1124, DOI 10.1093/beheco/ary075; Jurgens LJ, 2018, ECOL LETT, V21, P190, DOI 10.1111/ele.12881; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Keller SR, 2008, ECOL LETT, V11, P852, DOI 10.1111/j.1461-0248.2008.01188.x; Kramer-Schadt S, 2011, LANDSCAPE ECOL, V26, P501, DOI 10.1007/s10980-011-9576-4; Krosby M, 2010, CONSERV BIOL, V24, P1686, DOI 10.1111/j.1523-1739.2010.01585.x; Lundholm JT, 2010, J APPL ECOL, V47, P966, DOI 10.1111/j.1365-2664.2010.01857.x; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; Rahel FJ, 2002, ANNU REV ECOL SYST, V33, P291, DOI 10.1146/annurev.ecolsys.33.010802.150429; Rathbun M. J., 1918, GRAPSOID CRABS AM, V97; Riley M, 2015, THESIS; Riley ME, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176263; Riley ME, 2014, SOUTHEAST NAT, V13, pN43, DOI 10.1656/058.013.0405; Robillard CM, 2015, CONSERV BIOL, V29, P1586, DOI 10.1111/cobi.12556; Saintilan N, 2014, GLOBAL CHANGE BIOL, V20, P147, DOI 10.1111/gcb.12341; Santoul F, 2009, HYDROBIOLOGIA, V634, P107, DOI 10.1007/s10750-009-9886-6; Schweiger O, 2008, ECOLOGY, V89, P3472, DOI 10.1890/07-1748.1; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Sheehy DJ, 2010, ECOL ENG, V36, P1, DOI 10.1016/j.ecoleng.2009.09.012; Shoo LP, 2011, J APPL ECOL, V48, P487, DOI 10.1111/j.1365-2664.2010.01942.x; Sorte CJB, 2010, GLOBAL ECOL BIOGEOGR, V19, P303, DOI 10.1111/j.1466-8238.2009.00519.x; Souter NJ, 2004, BIOL CONSERV, V116, P403, DOI 10.1016/S0006-3207(03)00232-5; Thomas CD, 2001, NATURE, V411, P577, DOI 10.1038/35079066; Uezu A, 2008, BIODIVERS CONSERV, V17, P1907, DOI 10.1007/s10531-008-9329-0; Walther GR, 2010, PHILOS T R SOC B, V365, P2019, DOI 10.1098/rstb.2010.0021; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WARNER GF, 1967, J ZOOL, V153, P321, DOI 10.1111/j.1469-7998.1967.tb04066.x; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; Webb JK, 2000, BIOL CONSERV, V92, P93, DOI 10.1016/S0006-3207(99)00056-7; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325; WILSON KA, 1989, B MAR SCI, V44, P263	55	6	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211638	10.1371/journal.pone.0211638	http://dx.doi.org/10.1371/journal.pone.0211638			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785918	Green Published, Green Submitted, gold			2022-12-27	WOS:000459307000034
J	Onetti, W; Fernandez-Garcia, JC; Castillo-Rodriguez, A				Onetti, Wanesa; Carlos Fernandez-Garcia, Jose; Castillo-Rodriguez, Alfonso			Transition to middle school: Self-concept changes	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PHYSICAL-ACTIVITY; LONGITUDINAL ASSESSMENT; BODY-COMPOSITION; NATIONAL-HEALTH; RISK-FACTORS; FITNESS; CHILDHOOD; GENDER; ADOLESCENTS	Self-concept influences identity and the way that people behave, and it fluctuates over time. The main purpose of this study was to analyze fluctuations in the dimensions of self-concept as a function of gender, educational level, grade, age, physical activity, and weight. In total, 712 Spanish adolescents who were in the 5th and 8th grades (354 boys and 358 girls) and 10 to 14 years old (M = 11.9; SD = 1.3) participated in this study. The Self-Concept Questionnaire, Form 5 was used to analyze several dimensions of self-concept (academic, social, emotional, family, and physical), using the average scores in each dimension. The data showed strong differences in the dimensions of self-concept during the school transition. Middle-school students, compared to elementary-school students, showed significantly lower levels in almost all dimensions (academic, social, family, and physical). Furthermore, student age was a negative predictor of the social and academic dimensions, explaining 33% and 37% of the variance, respectively. Educational level and grade were smaller factors influencing the academic dimension (explaining 29% and 25% of the variance, respectively). The main findings revealed that the school transition and, specifically, increased age were associated with a lower self-concept. These results help us understand the need to strengthen psychological and educational self-concept at school.	[Onetti, Wanesa] Int Univ La Rioja, UNIR, Fac Educ, Logrono, Spain; [Carlos Fernandez-Garcia, Jose] Univ Malaga, Dept Languages Arts & Sport Didact, Andalucia Tech, IBIMA, Malaga, Spain; [Castillo-Rodriguez, Alfonso] Univ Granada, Dept Phys Educ & Sports, Granada, Spain	Universidad Internacional de La Rioja (UNIR); Universidad de Malaga; University of Granada	Castillo-Rodriguez, A (corresponding author), Univ Granada, Dept Phys Educ & Sports, Granada, Spain.	acastillo@ugr.es	García, José Carlos Fernández/X-3910-2019; CASTILLO-RODRÍGUEZ, ALFONSO/L-3606-2017; García, José Carlos Fernández/B-3723-2013; ONETTI, WANESA ONETTI/R-9848-2019	García, José Carlos Fernández/0000-0003-2308-2865; CASTILLO-RODRÍGUEZ, ALFONSO/0000-0002-2723-8970; García, José Carlos Fernández/0000-0003-2308-2865; ONETTI, WANESA ONETTI/0000-0002-8957-6182				Ahern MM, 2017, THESIS; Akos P, 2015, J EARLY ADOLESCENCE, V35, P170, DOI 10.1177/0272431614529367; Alfermann D, 2000, INT J SPORT PSYCHOL, V31, P47; Algars M, 2010, SEX ROLES, V63, P118, DOI 10.1007/s11199-010-9758-6; Andersen RE, 1998, JAMA-J AM MED ASSOC, V279, P938, DOI 10.1001/jama.279.12.938; [Anonymous], 2010, POP BAS PREV STRAT C; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Bronfenbrenner U., 1992, 6 THEORIES CHILD DEV, P187, DOI DOI 10.1037/10518-046; Castro-Sanchez M, 2016, RICYDE-REV INT CIENC, V12, P262, DOI 10.5232/ricyde2016.04504; Chaddock L, 2012, J SPORT SCI, V30, P421, DOI 10.1080/02640414.2011.647706; Coe R, 2003, REV PSICOL-LIMA, V21, P147, DOI DOI 10.18800/PSICO.200301.006; Coelho VA, 2017, J YOUTH ADOLESCENCE, V46, P558, DOI 10.1007/s10964-016-0510-6; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Contreras L, 2015, J FORENSIC PSYCHI PS, V26, P224, DOI 10.1080/14789949.2015.1004634; Crocker PRE, 2006, J APPL SPORT PSYCHOL, V18, P185, DOI 10.1080/10413200600830257; Cunha F, 2008, J HUM RESOUR, V43, P738; Damiano SR, 2015, J EAT DISORD, V3, DOI 10.1186/s40337-015-0043-5; de Gracia M, 2007, PSICOTHEMA, V19, P646; Eccles J., 2009, HDB ADOLESCENT PSYCH, DOI DOI 10.1002/9780470479193.ADLPSY001013; Paris MEC, 2018, EDUC XX1, V21, P321, DOI 10.5944/educXX1.16510; Fenzel LM, 2000, J EARLY ADOLESCENCE, V20, P93, DOI 10.1177/0272431600020001005; Fox K. R., 2000, PHYS ACTIVITY PSYCHO, P88, DOI DOI 10.4324/9780203468326_; Freedman DS, 2001, PEDIATRICS, V108, P712, DOI 10.1542/peds.108.3.712; Fuentes MC, 2011, PSICOTHEMA, V23, P7; Garaigordobil M, 2008, PSICOTHEMA, V20, P114; Garcia F., 2001, AUTOCONCEPTO FORMA 5; Ghaderi A, 2004, SCAND J PSYCHOL, V45, P319, DOI 10.1111/j.1467-9450.2004.00411.x; Grogan S, 2012, BODY IMAGE UNDERSTAN; Garcia FG, 2011, REV PSICOL DEPORTE, V20, P45; Iruka IU, 2018, J APPL DEV PSYCHOL, V54, P1, DOI 10.1016/j.appdev.2017.11.002; Jacobs JE, 2002, CHILD DEV, V73, P509, DOI 10.1111/1467-8624.00421; Lerner Richard M, 2012, New Dir Youth Dev, V2012, P119, DOI 10.1002/yd.20034; Majem LS, 2003, MED CLIN-BARCELONA, V121, P725, DOI 10.1016/S0025-7753(03)74077-9; Marsh HW, 2007, CHILD DEV, V78, P1640, DOI 10.1111/j.1467-8624.2007.01094.x; Marsh HW, 2003, J EDUC PSYCHOL, V95, P687, DOI 10.1037/0022-0663.95.4.687; Martinez-Gonzalez RA, 2013, INT HDB CULTURES ED, P221; Martins CL, 2010, EUR J SPORT SCI, V10, P121, DOI 10.1080/17461390903307842; Molloy LE, 2011, DEV PSYCHOL, V47, P1589, DOI 10.1037/a0025413; Moreno JA, 2008, INT J CLIN HLTH PSYC, V8, P171; Nolen-Hoeksema S, 2001, CURR DIR PSYCHOL SCI, V10, P173, DOI 10.1111/1467-8721.00142; O'Mara AJ, 2006, EDUC PSYCHOL-US, V41, P181, DOI 10.1207/s15326985ep4103_4; Orenstein P, 1994, SCH YOUNG WOMEN SELF; Pereira Coelho VABM, 2011, INTERAMERICAN J PSYC, V45, P185, DOI DOI 10.30849/RIP/IJP.V45I2.148; Pereira Coelho VABM, 2015, THESIS; Pesu L, 2016, J APPL DEV PSYCHOL, V44, P63, DOI 10.1016/j.appdev.2016.03.001; Pichardo Martinez MC, 2000, ANALES PSICOLOGIA, V16, P207; Reigal-Garrido RE, 2014, AN PSICOL-SPAIN, V30, P1079, DOI 10.6018/analesps.30.3.157201; Rodriguez-Fernandez A, 2016, INT J CLIN HLTH PSYC, V16, P166, DOI 10.1016/j.ijchp.2016.01.003; Rosenblum GD, 2008, BLACKWELL HDB ADOLES, P269; Rudolph KD, 2001, CHILD DEV, V72, P929, DOI 10.1111/1467-8624.00325; Saad CS, 2013, SOC PSYCHOL PERS SCI, V4, P369, DOI 10.1177/1948550612456560; de Ocariz US, 2014, RIE-REV INVESTIG EDU, V32, P309, DOI 10.6018/rie.32.2.183911; Sawyer SM, 2012, LANCET, V379, P1630, DOI 10.1016/S0140-6736(12)60072-5; Schmalz DL, 2007, J ADOLESCENT HEALTH, V41, P559, DOI 10.1016/j.jadohealth.2007.07.001; SHAVELSON RJ, 1976, REV EDUC RES, V46, P407, DOI 10.3102/00346543046003407; Sisson SB, 2009, INT J PEDIATR OBES, V4, P353, DOI 10.3109/17477160902934777; Solís Patricio, 2018, Perfiles educativos, V40, P66; Vedul-Kjelsas V, 2012, CHILD CARE HLTH DEV, V38, P394, DOI 10.1111/j.1365-2214.2011.01275.x; Velez A, 2010, J STRENGTH COND RES, V24, P1065, DOI 10.1519/JSC.0b013e3181cc230a; Ortega FZ, 2016, REV PSICOL DEPORTE, V25, P97	61	13	13	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212640	10.1371/journal.pone.0212640	http://dx.doi.org/10.1371/journal.pone.0212640			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM2OT	30785933	Green Submitted, Green Published, gold			2022-12-27	WOS:000459307000079
J	Schmalzl, R; Hartung, FM; Barth, A; Imhof, MA; Kenter, A; Renner, B; Schupp, HT				Schmaelzl, Ralf; Hartung, Freda-Marie; Barth, Alexander; Imhof, Martin A.; Kenter, Alex; Renner, Britta; Schupp, Harald T.			Visual cues that predict intuitive risk perception in the case of HIV	PLOS ONE			English	Article							PHYSICAL ATTRACTIVENESS; PERSONALITY JUDGMENTS; SOCIAL ATTRIBUTIONS; 1ST IMPRESSIONS; UNITED-STATES; HEALTH; FACES; AIDS; INFERENCES; BEHAVIOR	Field studies indicate that people may form impressions about potential partners' HIV risk, yet lack insight into what underlies such intuitions. The present study examined which cues may give rise to the perception of riskiness. Towards this end, portrait pictures of persons that are representative of the kinds of images found on social media were evaluated by independent raters on two sets of data: First, sixty visible cues deemed relevant to person perception, and second, perceived HIV risk and trustworthiness, health, and attractiveness. Here, we report correlations between cues and perceived HIV risk, exposing cue-criterion associations that may be used to infer intuitively HIV risk. Second, we trained a multiple cue based model to forecast perceived HIV risk through cross-validated predictive modelling. Trained models accurately predicted how 'risky' a person was perceived (r = 0.75) in a novel sample of portraits. Findings are discussed with respect to HIV risk stereotypes and implications regarding how to foster effective protective behaviors.	[Schmaelzl, Ralf] Michigan State Univ, Dept Commun, E Lansing, MI 48824 USA; [Schmaelzl, Ralf; Hartung, Freda-Marie; Barth, Alexander; Imhof, Martin A.; Kenter, Alex; Renner, Britta; Schupp, Harald T.] Univ Konstanz, Dept Psychol, Constance, Baden Wurttembe, Germany; [Hartung, Freda-Marie] Hsch Rhein Waal, Dept Commun & Environm, Kamp Lintfort, Nordrhein Westf, Germany	Michigan State University; University of Konstanz	Schmalzl, R (corresponding author), Michigan State Univ, Dept Commun, E Lansing, MI 48824 USA.; Schmalzl, R (corresponding author), Univ Konstanz, Dept Psychol, Constance, Baden Wurttembe, Germany.	schmaelz@msu.edu	Renner, Britta/AAW-1895-2020	Renner, Britta/0000-0001-8385-2839; Imhof, Martin/0000-0001-7465-2624; Schmalzle, Ralf/0000-0002-0179-1364	Deutsche Forschungsgemeinschaft (DFG) [FOR 2374]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This research was funded by Deutsche Forschungsgemeinschaft (DFG, FOR 2374 to BR and HS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agocha VB, 1999, PERS SOC PSYCHOL B, V25, P746, DOI 10.1177/0146167299025006009; AMBADY N, 1992, PSYCHOL BULL, V111, P256, DOI 10.1037/0033-2909.111.2.256; Ariely D, 2006, J BEHAV DECIS MAKING, DOI [10.1002/bdm.501/full, DOI 10.1002/BDM.501/FULL]; ASCH SE, 1946, J ABNORM SOC PSYCH, V41, P258, DOI 10.1037/h0055756; Bar M, 2006, EMOTION, V6, P269, DOI 10.1037/1528-3542.6.2.269; Barth A, 2015, FRONT PUBLIC HEALTH, V3, DOI 10.3389/fpubh.2015.00223; Barth A, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00166; BISHOP GD, 1991, J APPL SOC PSYCHOL, V21, P1877, DOI 10.1111/j.1559-1816.1991.tb00511.x; Bishop GD, 1991, MENTAL REPRESENTATIO, P32; Blanton H, 1997, HEALTH PSYCHOL, V16, P374, DOI 10.1037/0278-6133.16.4.374; Blanz V, 2003, IEEE T PATTERN ANAL, V25, P1063, DOI 10.1109/TPAMI.2003.1227983; BORKENAU P, 1992, J PERS SOC PSYCHOL, V62, P645, DOI 10.1037/0022-3514.62.4.645; Brooks AW, 2014, P NATL ACAD SCI USA, V111, P4427, DOI 10.1073/pnas.1321202111; BRUNSWIK E, 1955, PSYCHOL REV, V62, P193, DOI 10.1037/h0047470; Crowell T. L., 2001, COMMUNICATION STUDIE, V52, P302; Curtis V, 2011, PHILOS T R SOC B, V366, P389, DOI 10.1098/rstb.2010.0117; Dijkstra P, 2000, J APPL SOC PSYCHOL, V30, P1738, DOI 10.1111/j.1559-1816.2000.tb02465.x; EAGLY AH, 1991, PSYCHOL BULL, V110, P109, DOI 10.1037/0033-2909.110.1.109; Eberhardt JL, 2006, PSYCHOL SCI, V17, P383, DOI 10.1111/j.1467-9280.2006.01716.x; Eleftheriou A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010883; EPSTEIN S, 1994, AM PSYCHOL, V49, P709, DOI 10.1037/0003-066X.49.8.709; Fiske ST, 2007, TRENDS COGN SCI, V11, P77, DOI 10.1016/j.tics.2006.11.005; Frost P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190238; Funder DC, 2000, J PERS, V68, P451, DOI 10.1111/1467-6494.00103; Geron A, 2019, HANDS MACHINE LEARNI; GOLD RS, 1992, AIDS CARE, V4, P305, DOI 10.1080/09540129208253101; Gosling SD, 2002, J PERS SOC PSYCHOL, V82, P379, DOI 10.1037//0022-3514.82.3.379; Hacker FEK, 2015, SOC COGN AFFECT NEUR, V10, P612, DOI 10.1093/scan/nsu093; Hartung FM, 2011, PERS SOC PSYCHOL B, V37, P796, DOI 10.1177/0146167211400618; Hennessy M, 2007, AIDS BEHAV, V11, P479, DOI 10.1007/s10461-006-9156-9; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Herek GM, 2002, AM J PUBLIC HEALTH, V92, P371, DOI 10.2105/AJPH.92.3.371; Hofmann W., 2008, HEALTH PSYCHOL REV, V2, P111, DOI [10.1080/17437190802617668, DOI 10.1080/17437190802617668]; Hogarth RM, 2010, PSYCHOL INQ, V21, P338, DOI 10.1080/1047840X.2010.520260; Jones AL, 2018, VIS COGN, V26, P1, DOI 10.1080/13506285.2017.1369202; Jones AL, 2018, EVOL HUM BEHAV, V39, P19, DOI 10.1016/j.evolhumbehav.2017.09.005; Jones AL, 2016, BODY IMAGE, V17, P57, DOI 10.1016/j.bodyim.2016.02.001; Jones AL, 2012, J EXP PSYCHOL HUMAN, V38, P1353, DOI 10.1037/a0027078; Jones BC, 2001, EVOL HUM BEHAV, V22, P417, DOI 10.1016/S1090-5138(01)00083-6; Kleisner K, 2017, EVOL HUM BEHAV, V38, P744, DOI 10.1016/j.evolhumbehav.2017.07.002; Kleisner K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053285; KLEPINGER DH, 1993, FAM PLANN PERSPECT, V25, P74, DOI 10.2307/2136209; Linke L, 2016, PERS INDIV DIFFER, V99, P22, DOI 10.1016/j.paid.2016.04.076; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Masaro CL, 2008, SEX TRANSM DIS, V35, P566, DOI 10.1097/OLQ.0b013e3181660c43; MATICKATYNDALE E, 1991, J SEX RES, V28, P45, DOI 10.1080/00224499109551594; Mattarozzi K, 2017, SOC SCI MED, V182, P68, DOI 10.1016/j.socscimed.2017.04.011; Naumann LP, 2009, PERS SOC PSYCHOL B, V35, P1661, DOI 10.1177/0146167209346309; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Olivola CY, 2014, TRENDS COGN SCI, V18, P566, DOI 10.1016/j.tics.2014.09.007; PARK B, 1989, J PERS SOC PSYCHOL, V56, P493, DOI 10.1037/0022-3514.56.4.493; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Renner B., 2003, Z GESUNDHEITSPSYCHOL, V11, P112, DOI DOI 10.1026//0943-8149.11.3.112; Renner B, 2004, PSYCHOL HLTH ROUTLED, V19, P7; Renner B, 2008, Z GESUNDHEITSPSYCHOL, V16, P150, DOI 10.1026/0943-8149.16.3.150; Renner B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030460; Rhodes G, 2002, FACIAL ATTRACTIVENES; ROSENBER.S, 1968, J PERS SOC PSYCHOL, V9, P283, DOI 10.1037/h0026086; Russell R, 2016, J EXP PSYCHOL HUMAN, V42, P1354, DOI 10.1037/xhp0000219; Schaller M, 2011, PHILOS T R SOC B, V366, P3418, DOI 10.1098/rstb.2011.0029; Schmalzle R, 2012, SOC COGN AFFECT NEUR, V7, P667, DOI 10.1093/scan/nsr039; Schmalzle R, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00043; Schupp HT, 2006, PROG BRAIN RES, V156, P31, DOI 10.1016/S0079-6123(06)56002-9; Schwartz SL, 2014, AIDS CARE, V26, P1171, DOI 10.1080/09540121.2014.882494; Skelton JA, 2006, BASIC APPL SOC PSYCH, V28, P251, DOI 10.1207/s15324834basp2803_4; Slovic P, 2006, CURR DIR PSYCHOL SCI, V15, P322, DOI 10.1111/j.1467-8721.2006.00461.x; Stephen ID, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086302; Sutherland CAM, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01616; Sutherland CAM, 2013, COGNITION, V127, P105, DOI 10.1016/j.cognition.2012.12.001; Swann WB, 1995, PERS RELATSH, DOI [10.1111/j.1475-6811.1995.tb00084.x/full, DOI 10.1111/J.1475-6811.1995.TB00084.X/FULL]; Tan KW, 2018, EVOL HUM BEHAV, V39, P320, DOI 10.1016/j.evolhumbehav.2018.02.003; Thompson SC, 1996, J APPL SOC PSYCHOL, V26, P189, DOI 10.1111/j.1559-1816.1996.tb01845.x; Thompson SC, 2002, AIDS EDUC PREV, V14, P505, DOI 10.1521/aeap.14.8.505.24115; Thompson SC, 1999, J APPL, DOI [10.1111/j.1559-1816.1999.tb02032.x/full, DOI 10.1111/J.1559-1816.1999.TB02032.X/FULL]; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Todorov A, 2005, SCIENCE, V308, P1623, DOI 10.1126/science.1110589; Todorov A., 2011, SOC NEUROSCI-UK, P54, DOI [DOI 10.1093/ACPROF:OSO/9780195316872.001.0001, 10.1093/acprof:oso/9780195316872.003.0004, DOI 10.1093/ACPROF:OSO/9780195316872.003.0004]; Todorov A, 2008, ANN NY ACAD SCI, V1124, P208, DOI 10.1196/annals.1440.012; Todorov A, 2015, ANNU REV PSYCHOL, V66, P519, DOI 10.1146/annurev-psych-113011-143831; Todorov A, 2014, PSYCHOL SCI, V25, P1404, DOI 10.1177/0956797614532474; Vernon RJW, 2014, P NATL ACAD SCI USA, V111, pE3353, DOI 10.1073/pnas.1409860111; Walker M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193190; Wang Y, 2017, DEEP NEURAL NETWORKS, DOI [10.17605/OSF.IO/HV28A, DOI 10.17605/OSF.IO/HV28A]; Willis J, MAKING YOUR MIND 100; World Health Organization, 2016, REP GLOB SEX TRANSM; ZEBROWITZ LA, 1991, LAW HUMAN BEHAV, V15, P603, DOI 10.1007/BF01065855	86	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211770	10.1371/journal.pone.0211770	http://dx.doi.org/10.1371/journal.pone.0211770			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM2OT	30785898	Green Published, gold, Green Submitted			2022-12-27	WOS:000459307000037
J	Tonin, FS; Borba, HH; Mendes, AM; Wiens, A; Fernandez-Llimos, F; Pontarolo, R				Tonin, Fernanda S.; Borba, Helena H.; Mendes, Antonio M.; Wiens, Astrid; Fernandez-Llimos, Fernando; Pontarolo, Roberto			Description of network meta-analysis geometry: A metrics design study	PLOS ONE			English	Article							SYSTEMATIC REVIEWS; PRISMA EXTENSION; ISSUES; PLOT; CARE	Background The conduction and report of network meta-analysis (NMA), including the presentation of the network-plot, should be transparent. We aimed to propose metrics adapted from graph theory and social network-analysis literature to numerically describe NMA geometry. Methods A previous systematic review of NMAs of pharmacological interventions was performed. Data on the graph's presentation were collected. Network-plots were reproduced using Gephi 0.9.1. Eleven geometric metrics were tested. The Spearman test for non-parametric correlation analyses and the Bland-Altman and Lin's Concordance tests were performed (IBM SPSS Statistics 24.0). Results From the 477 identified NMAs only 167 graphs could be reproduced because they provided enough information on the plot characteristics. The median nodes and edges were 8 (IQR 6-11) and 10 (IQR 6-16), respectively, with 22 included studies (IQR 13-35). Metrics such as density (median 0.39, ranged 0.07-1.00), median thickness (2.0, IQR 1.0-3.0), percentages of common comparators (median 68%), and strong edges (median 53%) were found to contribute to the description of NMA geometry. Mean thickness, average weighted degree and average path length produced similar results than other metrics, but they can lead to misleading conclusions. Conclusions We suggest the incorporation of seven simple metrics to report NMA geometry. Editors and peer-reviews should ensure that guidelines for NMA report are strictly followed before publication.	[Tonin, Fernanda S.; Mendes, Antonio M.] Univ Fed Parana, Pharmaceut Sci Postgrad Programme, Curitiba, Parana, Brazil; [Tonin, Fernanda S.; Fernandez-Llimos, Fernando] Univ Lisbon, Res Inst Med iMed ULisboa, Lisbon, Portugal; [Borba, Helena H.; Wiens, Astrid; Pontarolo, Roberto] Univ Fed Parana, Dept Pharm, Curitiba, Parana, Brazil; [Fernandez-Llimos, Fernando] Univ Lisbon, Dept Social Pharm, Fac Pharm, Lisbon, Portugal	Universidade Federal do Parana; Universidade de Lisboa; Universidade Federal do Parana; Universidade de Lisboa	Fernandez-Llimos, F (corresponding author), Univ Lisbon, Res Inst Med iMed ULisboa, Lisbon, Portugal.; Pontarolo, R (corresponding author), Univ Fed Parana, Dept Pharm, Curitiba, Parana, Brazil.; Fernandez-Llimos, F (corresponding author), Univ Lisbon, Dept Social Pharm, Fac Pharm, Lisbon, Portugal.	f-llimos@ff.ul.pt; pontarolo@ufpr.br	Tonin, Fernanda S./AAE-3435-2022; Tonin, Fernanda S/O-2050-2017; Fernandez-Llimos, Fernando/B-8931-2008; Wiens, Astrid/T-4155-2019	Tonin, Fernanda S./0000-0003-4262-8608; Tonin, Fernanda S/0000-0003-4262-8608; Fernandez-Llimos, Fernando/0000-0002-8529-9595; Matoso Mendes, Antonio Eduardo/0000-0002-5752-349X	Brazilian National Council of Technological and Scientific Development (CNPq); Coordination for the Improvement of Higher Education Personnel (CAPES)	Brazilian National Council of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	FST was supported by the Brazilian National Council of Technological and Scientific Development (CNPq), and the Coordination for the Improvement of Higher Education Personnel (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Wattar Bassel H, 2017, Evid Based Med, V22, P12, DOI 10.1136/ebmed-2016-110599; Anzures-Cabrera J, 2010, RES SYNTH METHODS, V1, P66, DOI 10.1002/jrsm.6; Arif T., 2015, INT J COMPUTER APPL, V4, P889, DOI [10.7753/IJCATR0412.1003, DOI 10.7753/IJCATR0412.1003]; Bafeta A, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1741; Batson S, 2017, J CLIN EPIDEMIOL, V86, P182, DOI 10.1016/j.jclinepi.2017.03.008; Bax L, 2009, AM J EPIDEMIOL, V169, P249, DOI 10.1093/aje/kwn340; Bhatnagar Nidhi, 2014, Perspect Clin Res, V5, P154, DOI 10.4103/2229-3485.140550; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brignardello-Petersen R, 2019, J CLIN EPIDEMIOL, V105, P60, DOI 10.1016/j.jclinepi.2018.08.022; Brown S, 2014, SYST REV, V3, DOI 10.1186/2046-4053-3-110; Carroll K, 2016, PHARM STAT, V15, P135, DOI 10.1002/pst.1733; Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654; Chung HJ, 2008, CLIN TRIALS, V5, P301, DOI 10.1177/1740774508093614; Cipriani A, 2013, ANN INTERN MED, V159, P130, DOI 10.7326/0003-4819-159-2-201307160-00008; Cooper NJ, 2011, VALUE HEALTH, V14, P371, DOI 10.1016/j.jval.2010.09.001; Cornell JE, 2015, ANN INTERN MED, V162, P797, DOI 10.7326/M15-0930; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Dias S, 2013, MED DECIS MAKING, V33, P607, DOI 10.1177/0272989X12458724; Donegan S, 2013, RES SYNTH METHODS, V4, P291, DOI 10.1002/jrsm.1085; Dunn AG, 2011, SOC SCI MED, V72, P1064, DOI 10.1016/j.socscimed.2011.01.029; Franchini AJ, 2012, RES SYNTH METHODS, V3, P142, DOI 10.1002/jrsm.1049; Giavarina D, 2015, BIOCHEM MEDICA, V25, P141, DOI 10.11613/BM.2015.015; Gross J.L., 2013, HDB GRAPH THEORY, V2nd ed.; Higgins J, 2011, COCHRANE COLLAB, V5, P1; Hutton B, 2015, ANN INTERN MED, V162, P777, DOI 10.7326/M14-2385; Hutton B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092508; Jansen JP, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-159; Jia YT, 2008, IEEE T VIS COMPUT GR, V14, P1285, DOI 10.1109/TVCG.2008.151; Kanters S, 2016, B WORLD HEALTH ORGAN, V94, P782, DOI 10.2471/BLT.16.174326; Konig J, 2013, STAT MED, V32, P5414, DOI 10.1002/sim.6001; Krahn U, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-35; Lewis S, 2001, BMJ-BRIT MED J, V322, P1479, DOI 10.1136/bmj.322.7300.1479; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Mavridis D, 2015, EVID-BASED MENT HEAL, V18, P40, DOI 10.1136/eb-2015-102088; Mbuagbaw L, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0473-z; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Neupane B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115065; Nooraie RY, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2067-9; Opsahl T, 2010, SOC NETWORKS, V32, P245, DOI 10.1016/j.socnet.2010.03.006; Otte E, 2002, J INF SCI, V28, P441, DOI 10.1177/016555150202800601; Puhan MA, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5630; Rucker G, 2016, RES SYNTH METHODS, V7, P94, DOI 10.1002/jrsm.1143; Rucker G, 2012, RES SYNTH METHODS, V3, P312, DOI 10.1002/jrsm.1058; Salanti G, 2008, ANN INTERN MED, V148, P544, DOI 10.7326/0003-4819-148-7-200804010-00011; Salanti G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099682; Scott J, 2000, SOCIAL NETWORK ANAL; Senn S, 2013, STAT METHODS MED RES, V22, P169, DOI 10.1177/0962280211432220; Sturtz S, 2012, RES SYNTH METHODS, V3, P300, DOI 10.1002/jrsm.1057; Sullivan SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113277; Tan SH, 2014, J CLIN EPIDEMIOL, V67, P672, DOI 10.1016/j.jclinepi.2013.11.006; Tonin FS, 2019, INT J EPIDEMIOL, V48, P620, DOI 10.1093/ije/dyy197; Tonin FS, 2017, PHARM PRACT-GRANADA, V15, DOI [10.18549/pharmpract.2017.01.943, 10.18549/PharmPract.2017.01.943]; Veroniki AA, 2016, J CLIN EPIDEMIOL, V76, P193, DOI 10.1016/j.jclinepi.2016.02.016; Wang EK, 2014, SCI WORLD J, DOI 10.1155/2014/930314; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Zarin W, 2017, BMC MED, V15, DOI 10.1186/s12916-016-0764-6	56	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212650	10.1371/journal.pone.0212650	http://dx.doi.org/10.1371/journal.pone.0212650			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785955	Green Submitted, gold, Green Published			2022-12-27	WOS:000459307000081
J	Laugesen, K; Petersen, I; Sorensen, HT; Jorgensen, JOL				Laugesen, Kristina; Petersen, Irene; Sorensen, Henrik Toft; Jorgensen, Jens Otto Lunde			Clinical indicators of adrenal insufficiency following discontinuation of oral glucocorticoid therapy: A Danish population-based self-controlled case series analysis	PLOS ONE			English	Article							SHORT-TERM; SUPPRESSION; RECOVERY; BURST	Background Biochemical adrenal insufficiency induced by glucocorticoid treatment is prevalent, but data on the clinical implications are sparse. We investigated clinical consequences of glucocorticoid-induced adrenal insufficiency after oral glucocorticoid cessation. Methods We conducted a Danish population-based self-controlled case series utilizing medical registries. In this design each individual serves as their own control allowing event rates to be compared as a function of time and treatment. Clinical indicators of adrenal insufficiency were defined as diagnoses of gastrointestinal symptoms, hypotension, cardiovascular collapse, syncope, hyponatremia, and hypoglycaemia. We included 286,680 persons who discontinued long-term (>= 3 months) oral glucocorticoid treatment. We defined five risk periods and a reference period (before treatment): period 0 (on treatment), withdrawal period (1 month before and after cessation), followed by three consecutive 2 month-risk periods after withdrawal (periods 2-4). Results Median age at cessation was 69 years and 57% were female. Median treatment duration was 297 days and median cumulative dose was 3000 mg prednisolone equivalents. The incidence rates of hypotension, gastrointestinal symptoms, hypoglycemia and hyponatremia were increased in the withdrawal period compared to before treatment started (reference period). Incidence rate ratios comparing the withdrawal period with the reference period were 2.5 [95% confidence interval (CI): 1.4-4.3] for hypotension, 1.7 (95% CI: 1.6-1.9) for gastrointestinal symptoms, 2.2 (95% CI: 0.7-7.3) for hypoglycemia, and 1.5 (95% CI: 1.1-2.0) for hyponatremia. During 7 months of follow up, the rates of hypotension and gastrointestinal symptoms remained elevated compared to the reference period. Risk factors included use of antibiotics, increasing average daily dose of glucocorticoids, cumulative dose, and age. Conclusion Oral glucocorticoid withdrawal was associated with adverse outcomes attributable to adrenal insufficiency. Our study underscores the need for future research to establish evidence-based clinical guidance on management of patients who discontinue oral glucocorticoids.	[Laugesen, Kristina; Petersen, Irene; Sorensen, Henrik Toft] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark; [Petersen, Irene] UCL, Dept Primary Care & Populat Hlth, London, England; [Jorgensen, Jens Otto Lunde] Aarhus Univ Hosp, Dept Endocrinol & Internal Med, Aarhus, Denmark	Aarhus University; University of London; University College London; Aarhus University	Laugesen, K (corresponding author), Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark.	Kristina.laugesen@clin.au.dk	Sorensen, Henrik Toft/Z-6181-2019; Jorgensen, Jens Otto Lunde/O-8003-2019	Sorensen, Henrik Toft/0000-0003-4299-7040; Laugesen, Kristina/0000-0001-7971-8223	Fonden af 1870; Max og Anna Friedmanns legat til sygdomsbekaempelse; Aarhus University Research Foundation	Fonden af 1870; Max og Anna Friedmanns legat til sygdomsbekaempelse; Aarhus University Research Foundation	KL recieved funding from "Fonden af 1870" and "Max og Anna Friedmanns legat til sygdomsbekaempelse". HTS recieved funding from "Aarhus University Research Foundation". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlt W, 2005, ENDOCRIN METAB CLIN, V34, P293, DOI 10.1016/j.ecl.2005.01.002; Arlt W, 2003, LANCET, V361, P1881, DOI 10.1016/S0140-6736(03)13492-7; Boots JMM, 2002, TRANSPLANT P, V34, P1696, DOI 10.1016/S0041-1345(02)02987-1; Bornstein SR, 2009, NEW ENGL J MED, V360, P2328, DOI 10.1056/NEJMra0804635; Broersen LHA, 2015, J CLIN ENDOCR METAB, V100, P2171, DOI 10.1210/jc.2015-1218; CARELLA MJ, 1993, J CLIN ENDOCR METAB, V76, P1188, DOI 10.1210/jc.76.5.1188; Charmandari E, 2005, ANNU REV PHYSIOL, V67, P259, DOI 10.1146/annurev.physiol.67.040403.120816; Charmandari E, 2014, LANCET, V383, P2152, DOI 10.1016/S0140-6736(13)61684-0; Einaudi S, 2008, PEDIATR BLOOD CANCER, V50, P537, DOI 10.1002/pbc.21339; Endocrine Society, 2018, CLIN PRACT GUD; European Society of Endocrinology, 2018, GUIDELINES; Henzen C, 2000, LANCET, V355, P542, DOI 10.1016/S0140-6736(99)06290-X; Jamilloux Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068713; Joseph RM, 2016, SEMIN ARTHRITIS RHEU, V46, P133, DOI 10.1016/j.semarthrit.2016.03.001; Krasner AS, 1999, JAMA-J AM MED ASSOC, V282, P671, DOI 10.1001/jama.282.7.671; Laugesen K, 2017, CLIN EPIDEMIOL, V9, P591, DOI 10.2147/CLEP.S148671; Laugesen K, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015237; Nguyen KL, 2003, ANN ALLERG ASTHMA IM, V91, P38, DOI 10.1016/S1081-1206(10)62056-X; Petersen I, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4515; Pottegard A, 2017, INT J EPIDEMIOL, V46, P798, DOI 10.1093/ije/dyw213; Rix M, 2005, J PEDIATR-US, V147, P645, DOI 10.1016/j.jpeds.2005.06.006; RODGER RSC, 1986, Q J MED, V61, P1039; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; SPIEGEL RJ, 1979, LANCET, V1, P630; WALJEE AK, 2017, BMJ-BRIT MED J, V357, DOI DOI 10.1136/BMJ.J1415; Wass JAH, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6333; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302; Woods CP, 2015, EUR J ENDOCRINOL, V173, P633, DOI 10.1530/EJE-15-0608	30	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212259	10.1371/journal.pone.0212259	http://dx.doi.org/10.1371/journal.pone.0212259			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779776	Green Published, gold, Green Submitted			2022-12-27	WOS:000459062900037
J	Macaulay, V; Soares, P; Richards, MB				Macaulay, Vincent; Soares, Pedro; Richards, Martin B.			Rectifying long-standing misconceptions about the. statistic for molecular dating	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; MTDNA VARIATION; MUTATION-RATES; Y-CHROMOSOME; EVOLUTION; PERSPECTIVE; EXPANSION; SELECTION; ANCESTRY; TREE	When divided by a given mutation rate, the. (rho) statistic provides a simple estimator of the age of a clade within a phylogenetic tree by averaging the number of mutations from each sample in the clade to its root. However, a long-standing critique of the use of. in genetic dating has been quite often cited. Here we show that the critique is unfounded. We demonstrate by a formal mathematical argument and illustrate with a simulation study that. estimates are unbiased and also that. and maximum likelihood estimates do not differ in any systematic fashion. We also demonstrate that the claim that the associated confidence intervals commonly estimate the uncertainty inappropriately is flawed since it relies on a means of calculating standard errors that is not used by any other researchers, whereas an established expression for the standard error is largely unproblematic. We conclude that. dating, alongside approaches such as maximum likelihood (ML) and Bayesian inference, remains a useful tool for genetic dating.	[Macaulay, Vincent] Univ Glasgow, Sch Math & Stat, Glasgow, Lanark, Scotland; [Soares, Pedro] Univ Minho, Dept Biol, CBMA Ctr Mol & Environm Biol, Campus Gualtar, Braga, Portugal; [Soares, Pedro] Univ Minho, Inst Sci & Innovat Biosustainabil IB S, Campus Gualtar, Braga, Portugal; [Soares, Pedro] Univ Porto IPATIMUP, Inst Patol & Imunol Mol, Porto, Portugal; [Richards, Martin B.] Univ Huddersfield, Sch Appl Sci, Dept Biol Sci, Huddersfield, W Yorkshire, England	University of Glasgow; Universidade do Minho; Universidade do Minho; Universidade do Porto; University of Huddersfield	Soares, P (corresponding author), Univ Minho, Dept Biol, CBMA Ctr Mol & Environm Biol, Campus Gualtar, Braga, Portugal.; Soares, P (corresponding author), Univ Minho, Inst Sci & Innovat Biosustainabil IB S, Campus Gualtar, Braga, Portugal.; Soares, P (corresponding author), Univ Porto IPATIMUP, Inst Patol & Imunol Mol, Porto, Portugal.	pedrosoares@bio.uminho.pt	Soares, Pedro A/G-9422-2011	Soares, Pedro A/0000-0002-2807-690X; RICHARDS, MARTIN/0000-0003-3118-0967	FCT - FEDER funds (COMPETE 2020 project) [PTDC/EPH-ARQ/4164/2014, 016899]; FCT [IF/01641/2013]; European Social Fund, Programa Operacional Potencial Humano; FCT/MEC [PEst-OE/BIA/UI4050/2014]; Leverhulme Doctoral Scholarship programme	FCT - FEDER funds (COMPETE 2020 project); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); European Social Fund, Programa Operacional Potencial Humano; FCT/MEC; Leverhulme Doctoral Scholarship programme	P.S. and M.B.R. acknowledge FCT support through project PTDC/EPH-ARQ/4164/2014 partially funded by FEDER funds (COMPETE 2020 project 016899). P.S. is supported by FCT, European Social Fund, Programa Operacional Potencial Humano and the FCT Investigator Programme (IF/01641/2013) and acknowledges FCT/MEC for support to CBMA through Portuguese funds (PIDDAC)-PEst-OE/BIA/UI4050/2014. M.B.R. received support from a Leverhulme Doctoral Scholarship programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2005, AM J HUM GENET, V76, P883, DOI 10.1086/430073; Achilli A, 2013, P NATL ACAD SCI USA, V110, P14308, DOI 10.1073/pnas.1306290110; [Anonymous], 1938, BIOMETRIC B; Balanovsky O, 2017, HUM GENET, V136, P575, DOI 10.1007/s00439-017-1805-8; Batini C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8152; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Cavadas B, 2015, HUM MUTAT, V36, P1100, DOI 10.1002/humu.22849; Cox MP, 2008, HUM BIOL, V80, P335, DOI 10.3378/1534-6617-80.4.335; D'Atanasio E, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1393-5; de Saint Pierre M, 2017, QUATERN INT, V444, P19; Delser PM, 2017, EUR J HUM GENET, V25, P485, DOI 10.1038/ejhg.2016.207; Endicott P, 2010, J HUM EVOL, V59, P87, DOI 10.1016/j.jhevol.2010.04.005; Fernandes V, 2012, AM J HUM GENET, V90, P347, DOI 10.1016/j.ajhg.2011.12.010; Forster P, 1996, AM J HUM GENET, V59, P935; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; Gomes SM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1201-x; Hallast P, 2015, MOL BIOL EVOL, V32, P661, DOI 10.1093/molbev/msu327; Jobling M, 2014, HUMAN EVOLUTIONARY GENETICS, SECOND EDITION, P1; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kulichova I, 2017, AM J PHYS ANTHROPOL, V164, P424, DOI 10.1002/ajpa.23285; Li YC, 2018, MITOCHONDRION, V38, P23, DOI 10.1016/j.mito.2017.07.010; Macaulay VA, 1997, AM J HUM GENET, V61, P983; Mellars P, 2013, P NATL ACAD SCI USA, V110, P10699, DOI 10.1073/pnas.1306043110; Nagle N, 2017, SCI REP-UK, V7, DOI 10.1038/srep43041; Pala M, 2014, ENCY LIFE SCI ELS; Pala M, 2012, AM J HUM GENET, V90, P915, DOI 10.1016/j.ajhg.2012.04.003; Pereira JB, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.1976; Posth C, 2016, CURR BIOL, V26, P827, DOI 10.1016/j.cub.2016.01.037; Rito T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080031; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Sankararaman S, 2016, CURR BIOL, V26, P1241, DOI 10.1016/j.cub.2016.03.037; Scozzari R, 2014, GENOME RES, V24, P535, DOI 10.1101/gr.160788.113; Silva M, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0936-9; Silva M, 2015, SCI REP-UK, V5, DOI 10.1038/srep12526; Soares P, 2016, VERTEBR PALEOBIOL PA, P383, DOI 10.1007/978-94-017-7520-5_18; Soares P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058993; Soares P, 2012, MOL BIOL EVOL, V29, P915, DOI 10.1093/molbev/msr245; Soares P, 2011, AM J HUM GENET, V88, P239, DOI 10.1016/j.ajhg.2011.01.009; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Soares PA, 2016, HUM GENET, V135, P309, DOI 10.1007/s00439-015-1620-z; Sole-Morata N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07710-x; Stoneking M., 2016, INTRO MOL ANTHR; Stoneking M, 2010, CURR BIOL, V20, pR188, DOI 10.1016/j.cub.2009.11.052; Team R. D. C, 2011, R LANG ENV STAT COMP; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Tian JY, 2015, SCI REP-UK, V5, DOI 10.1038/srep08377; Wei W, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007126; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zhabagin M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03176-z	49	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212311	10.1371/journal.pone.0212311	http://dx.doi.org/10.1371/journal.pone.0212311			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779770	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000459062900045
J	Paries, S; Funcke, S; Kershaw, O; Failing, K; Lierz, M				Paries, S.; Funcke, S.; Kershaw, O.; Failing, K.; Lierz, M.			The role of Virus "X" (Tortoise Picornavirus) in kidney disease and shell weakness syndrome in European tortoise species determined by experimental infection	PLOS ONE			English	Article								Tortoise Picornavirus (ToPV) commonly known as Virus "X" was recently discovered in juvenile European tortoises suffering from soft carapace and plastron as well as kidney disease. Therefore, this virus was a potential candidate to be a causative agent for these disease patterns. Spur thighed tortoises (Testudo graeca) seemed to be more susceptible to establish clinical symptoms than other European species like T. hermanni. Thus this trial investigated the role of ToPV in the described syndrome. Two groups of juvenile European tortoises (T. graeca and T. hermanni) each of 10 animals, were cloacally, oronasally and intracoelomically inoculated with an infectious dose (similar to 2000 TICD) of a ToPV strain isolated from a diseased T. graeca. A control group of two animals of each species received non-infected cell culture supernatant. The tortoises were examined daily and pharyngeal and cloacal swabs for detection of ToPV-RNA by RT-PCR were taken from each animal every six days for a period of 6 months. At the end of the study the remaining animals were euthanised and dissected. Bacteriological and parasitological tests were performed and organ samples of all tortoises were investigated by RT-PCR for the presence of ToPV and histopathology. Animals that were euthanised at the end of the experiment, were examined for presence of specific anti-ToPV antibodies. Several animals in both inoculated groups showed retarded growth and a light shell weakness, in comparison to the control animals. Three animals were euthanised during the trial, showing reduced weight gain, retarded growth, severe shell weakness and apathy, in parallel to clinical observations in naturally infected animals. In all inoculated animals of both species an intermittent virus shedding, starting from 18 days post inoculation (d.p.i.), till 164 d.p.i. was detected, while the control animals remained negative. The virus was successfully reisolated in terrapene heart cell culture in 16 of 20 inoculated animals of both species. Histopathology of most inoculated animals revealed a lack of bone remodeling and vacuolisation in kidney tubuli which supports the described pathogenesis of nephropathy and osteodystrophy. Anti-ToPV antibody titres ranged from 1:2 to > 1:256 in 13 of 20 animals, whereas all control animals were seronegative. The study proofed the Henle Koch's postulates of ToPV as causative agent for shell dystrophy and kidney disease in both testudo species. The proposed species specific sensitivity towards clinical disease was not observed.	[Paries, S.; Funcke, S.; Lierz, M.] Justus Liebig Univ, Fac Vet Med, Clin Birds Reptiles Amphibians & Fish, Giessen, Germany; [Kershaw, O.] Free Univ Berlin, Dept Vet Pathol, Berlin, Germany; [Failing, K.] Justus Liebig Univ, Unit Biomath & Data Proc, Giessen, Germany	Justus Liebig University Giessen; Free University of Berlin; Justus Liebig University Giessen	Paries, S (corresponding author), Justus Liebig Univ, Fac Vet Med, Clin Birds Reptiles Amphibians & Fish, Giessen, Germany.	pariessu@hotmail.com						AMBROSIUS H, 1965, Z IMMUN-UND ALLERG, V128, P81; COE JE, 1972, IMMUNOLOGY, V23, P45; Cooper E. L., 1985, BIOL REPTILIA, V14, P601; Cytel Studio, STATXACT 9 0 0 V 201; Deplazes P, 2013, LEHRBUCH PARASITOLOG, P508; Dixon W. J, 1993, BMDP STAT SOFTWARE M, V1; Dixon W. J., 1993, BMDP STAT SOFTWARE M, V2; Donoghue Susan, 1997, Proceedings of the Annual Conference of the Association of Reptilian & Amphibian Veterinarians, V3, P21; Farkas SL, 2014, ARCH VIROL, P1; Gerlach Justin, 2004, African Journal of Herpetology, V53, P77; Hafeli W, 2000, PRAKT TIERARZT, V81, P129; Heuser W, 2014, TIERAERZTL PRAX K H, V42, P310, DOI 10.1055/s-0038-1623777; Heuser W, 2010, EUROPIC 2010 16 M EU, P147; Heuser W, 2012, THESIS; Kolesnik E, 2017, J VET DIAGN INVEST, V29, P820, DOI 10.1177/1040638717722387; LYKAKIS JJ, 1968, IMMUNOLOGY, V14, P799; Marschang RE, 2007, VET REC, V161, P102, DOI 10.1136/vr.161.3.102; Marschang RE, 2016, J VET DIAGN INVEST, V28, P309, DOI 10.1177/1040638716628584; Marschang RE, 2002, P ASS REPT AMPH VET, P101; Marschang RE, 2000, THESIS; MAUNG ROBERT TUN, 1963, JOUR PATHOL AND BACTERIOL, V85, P51, DOI 10.1002/path.1700850106; Origgi Francesco C., 2007, P131, DOI 10.1201/9781420004038.ch2; Paries S, 2018, TIERARZTL PRAX; Pees M, 2010, VET REC, V166, P422, DOI 10.1136/vr.b4819; Rolle M, 2007, ALLGEMEINE SPEZIELLE, P344; SIDKY YA, 1968, J EXP ZOOL, V167, P187, DOI 10.1002/jez.1401670207; UHLENBROK C, 2010, NACHWEIS RANAVIRUSIN; ZWART P, 1980, P EUR HERP S COTSW W, P75	28	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0210790	10.1371/journal.pone.0210790	http://dx.doi.org/10.1371/journal.pone.0210790			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779796	Green Published, gold, Green Submitted			2022-12-27	WOS:000459062900009
J	Lee, MJ; Cho, S; Cha, J; Kim, S; Kim, ST; Bang, OY; Chung, CS; Lee, KH; Kim, GM				Lee, Mi Ji; Cho, Soohyun; Cha, Jihoon; Kim, Seonwoo; Kim, Sung Tae; Bang, Oh Young; Chung, Chin-Sang; Lee, Kwang Ho; Kim, Gyeong-Moon			Visualization of basilar artery atherosclerotic plaques by conventional T2-weighted magnetic resonance imaging: A case-control study	PLOS ONE			English	Article							INTERNAL CAROTID-ARTERY; HIGH-RESOLUTION MRI; INTRAPLAQUE HEMORRHAGE; OCCLUSIVE DISEASE; ISCHEMIC-STROKE; ANGIOGRAPHY; INFARCTION; STENOSIS	Objective In vivo visualization of intracranial atherosclerotic plaque has been performed only with high-resolution magnetic resonance imaging (HRMR). We investigated whether atherosclerotic plaque of the basilar artery (BA) can be identified in conventional magnetic resonance imaging (MRI). Methods Patients with acute ischemic stroke who had BA stenosis ("symptomatic BAA") were retrospectively recruited using the prospective stroke registry. In the HRMR databank, subjects without BA stenosis were recruited and classified as those with silent plaque ("silent BAA") and without any plaque ("normal controls"). Outer diameter of the BA and T2 plaque sign (an eccentric or complete obscuration of normal flow-void) within the BA were assessed by two blinded raters using conventional T2 MRI. Results Seventy-five patients with symptomatic BAA, 40 with asymptomatic BAA, and 36 normal controls were included in the study. Maximal BA diameter was significantly larger in symptomatic BAA patients with <30%, 30-50%, 50-70%, and >70% stenosis (all p<0.01 in each subgroup) and silent BAA subjects (p=0.018) than controls. T2 plaque signs were present in 46 (61.3%) patients with symptomatic BAA and 6 (14.6%) subjects with asymptomatic BAA, while none in normal controls (p<0.001 and 0.057, respectively). Detection rates were increased with an increase in stenosis degree (25.0% in < 30% stenosis, 57.9% in 30-50% stenosis, 38.5% in 50-70% stenosis, 92.3% in 70-99% stenosis, and 100.0% in occlusion). Conclusions Our data suggest that BA atherosclerosis can be detected by conventional MRI. When the use of HRMR is limited, conventional MR imaging may give additive information to clinicians.	[Lee, Mi Ji; Cho, Soohyun; Bang, Oh Young; Chung, Chin-Sang; Lee, Kwang Ho; Kim, Gyeong-Moon] Sungkyunkwan Univ, Samsung Med Ctr, Dept Neurol, Sch Med, Seoul, South Korea; [Cha, Jihoon; Kim, Sung Tae] Sungkyunkwan Univ, Samsung Med Ctr, Dept Radiol, Sch Med, Seoul, South Korea; [Kim, Seonwoo] Samsung Med Ctr, Samsung Biomed Res Inst, Biostat Team, Seoul, South Korea; [Cha, Jihoon] Yonsei Univ, Severance Hosp, Res Inst Radiol Sci, Coll Med,Dept Radiol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Yonsei University; Yonsei University Health System	Lee, MJ (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Dept Neurol, Sch Med, Seoul, South Korea.	mirony.lee@gmail.com		Lee, Mi Ji/0000-0003-1364-1969	National Research Foundation of Korea (NRF) - Korean government (MSIP) [2017R1A2B2009086, 2017R1A2B4007254]; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI13C1521]	National Research Foundation of Korea (NRF) - Korean government (MSIP); Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by the National Research Foundation of Korea (NRF) grants funded by the Korean government (MSIP) (Nos. 2017R1A2B2009086 to CSC and 2017R1A2B4007254 to MJL) and the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI13C1521 to MJL and OYB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXEL L, 1984, AM J ROENTGENOL, V143, P1157, DOI 10.2214/ajr.143.6.1157; Ay H, 2007, STROKE, V38, P2979, DOI 10.1161/STROKEAHA.107.490896; BILLER J, 1988, STROKE, V19, P297, DOI 10.1161/01.STR.19.3.297; Bitar R, 2008, RADIOLOGY, V249, P259, DOI 10.1148/radiol.2491071517; Bodle JD, 2013, STROKE, V44, P287, DOI 10.1161/STROKEAHA.112.664680; BRADLEY WG, 1988, AM J ROENTGENOL, V150, P983, DOI 10.2214/ajr.150.5.983; Chalela JA, 2007, LANCET, V369, P293, DOI 10.1016/S0140-6736(07)60151-2; Degnan AJ, 2012, AM J NEURORADIOL, V33, P1427, DOI 10.3174/ajnr.A2697; Fayad ZA, 2000, CIRCULATION, V102, P506; GIBBONS GH, 1994, NEW ENGL J MED, V330, P1431; Gorelick PB, 2008, STROKE, V39, P2396, DOI 10.1161/STROKEAHA.107.505776; Kang CK, 2010, J MAGN RESON IMAGING, V32, P544, DOI 10.1002/jmri.22250; Klein IF, 2006, NEUROLOGY, V67, P327, DOI 10.1212/01.wnl.0000225074.47396.71; Lee DK, 2005, STROKE, V36, P2583, DOI 10.1161/01.STR.0000189999.19948.14; Lee WJ, 2015, NEURORADIOLOGY, V57, P1007, DOI 10.1007/s00234-015-1566-9; Li Q, 2015, J STROKE CEREBROVASC, V24, P1591, DOI 10.1016/j.jstrokecerebrovasdis.2015.03.028; Lim SH, 2015, ATHEROSCLEROSIS, V240, P278, DOI 10.1016/j.atherosclerosis.2015.03.029; Ma N, 2010, NEUROLOGY, V75, P253, DOI 10.1212/WNL.0b013e3181e8e714; Mehdiratta M, 2007, ARCH NEUROL-CHICAGO, V64, P1666, DOI 10.1001/archneur.64.11.1666; Momjian-Mayor I, 2005, STROKE, V36, P567, DOI 10.1161/01.STR.0000155727.82242.e1; Pandey S, 2013, RADIOGRAPHICS, V33, pE113, DOI 10.1148/rg.333125148; Ryoo S, 2012, NEUROLOGY; Voetsch B, 2004, ARCH NEUROL-CHICAGO, V61, P496, DOI 10.1001/archneur.61.4.496; Wong KS, 2002, ANN NEUROL, V52, P74, DOI 10.1002/ana.10250; Worthley SG, 2000, CIRCULATION, V101, P586, DOI 10.1161/01.CIR.101.6.586; Xu WH, 2012, ANN NEUROL, V71, P195, DOI 10.1002/ana.22626; Yu JH, 2015, STROKE, V46, P2768, DOI 10.1161/STROKEAHA.115.009412; Yuan C, 2002, J MAGN RESON IMAGING, V15, P62, DOI 10.1002/jmri.10030	28	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0212570	10.1371/journal.pone.0212570	http://dx.doi.org/10.1371/journal.pone.0212570			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807597	Green Published, gold, Green Submitted			2022-12-27	WOS:000459712100019
J	Homsy, J; King, R; Bannink, F; Namukwaya, Z; Vittinghof, E; Amone, A; Ojok, F; Rukundo, G; Amama, S; Etima, J; Matovu, J; Weissglas, F; Ojom, L; Atim, P; Darbes, L; Byamugisha, J; Rutherford, G; Katabira, E; Fowler, MG				Homsy, Jaco; King, Rachel; Bannink, Femke; Namukwaya, Zikulah; Vittinghof, Eric; Amone, Alexander; Ojok, Francis; Rukundo, Gordon; Amama, Sharon; Etima, Juliane; Matovu, Joyce; Weissglas, Fitti; Ojom, Lawrence; Atim, Pamela; Darbes, Lynae; Byamugisha, Josaphat; Rutherford, George; Katabira, Elly; Fowler, Mary Glenn		PRIMAL Study Team	Primary HIV prevention in pregnant and lactating Ugandan women: A randomized trial	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; MISSED OPPORTUNITIES; SEXUAL-BEHAVIOR; MALE PARTNERS; MATERNAL HIV; RISK; SEROCONVERSION; ACCEPTABILITY; INVOLVEMENT; INFECTION	Background The 'Primary HIV Prevention among Pregnant and Lactating Ugandan Women' (PRIMAL) study aimed to assess the effectiveness of an enhanced HIV counseling intervention for preventing HIV acquisition among HIV-uninfected mothers during pregnancy and throughout the breastfeeding period. Methods We conducted an unblinded randomized control trial between 22 February 2013 and 22 April 2016 to assess the effectiveness of an extended repeat HIV testing and enhanced counseling (ERHTEC) intervention aimed at preventing primary HIV infection among HIV-uninfected pregnant and lactating women in Uganda. HIV-uninfected pregnant women aged 15-49 were enrolled 1:1 individually or in couples together with their partner. Enrolled women and couples were randomized 1:1 to an intervention (ERHTEC) or control (extended repeat HIV testing and standard counseling) group and followed up to 24 months postpartum or six weeks past complete cessation of breastfeeding, whichever came first. Both groups were tested for sexually transmitted infections (STIs) and HIV at enrollment, delivery, 3 and 6 months postpartum and every 6 months thereafter until the end of follow-up. The intervention group received enhanced HIV prevention counseling every 3 months throughout follow-up. The control group received standard counseling at the time of HIV retesting. Both intervention and control couples were offered couple HIV testing and counseling at all study visits. Main outcome measures Frequency of condom use and incidence of HIV, syphilis, gonorrhea, chlamydia and trichomoniasis over follow-up. Results Between February 2013 and April 2014, we enrolled 820 HIV-uninfected pregnant women presenting for antenatal care individually (n = 410) or in couples (n = 410 women and 410 partners) in one urban and one rural public Ugandan hospital. Women's median age was 24 years (IQR 20-28 years). At baseline, participants did not differ in any socio-demographic, reproductive health, HIV testing history, sexual behavior, medical history or STI status characteristics; 96% (386/402) of couples were tested and counseled for HIV together with their partners at enrolment, 2.1% (7/329) of whom were found to be HIV-infected. Six hundred twenty-five (76%) women completed follow-up as per protocol (S1 Protocol). Women were followed for an average of 1.76 years and cumulated 1,439 women-years of follow-up or 81% of the maximum 1,779 women-years of follow-up assuming no dropouts. Men were followed for an average of 1.72 years. The frequency of consistent condom use and the proportion of women who used condoms over the last 3 months or at last vaginal sex increased substantially over follow-up in both arms, but there were no statistically significant differences in increases between the intervention and control arms. During follow-up, on average 42% (range 36%-46%) of couple partners were counseled together. Between 3.8% and 7.6% of women tested positive at any follow-up visit for any STI including syphilis, gonorrhea, C. trachomatis or T. vaginalis. Four women (two in each arm) and no enrolled men became infected with HIV, representing an overall HIV incidence rate of 0.186 per 100 person-years. Three of the women seroconverters had enrolled individually, one as a couple. At or before seroconversion, all four women reported their partners had extramarital relationships and/or had not disclosed their suspected HIV-infected status. There were no statistically significant differences between study arms for STI or HIV incidences. Conclusions A sustained enhanced HIV prevention counseling intervention for up to 2 years postpartum among pregnant and breastfeeding women did not have a statistically significant effect on condom use or HIV incidence among these women. However, in both study arms, condom use increased over follow-up while STI and HIV incidence remained very low when compared to similar cohorts in and outside Uganda, suggesting that repeat HIV testing during breastfeeding, whether with enhanced or standard counseling, may have had an unintended HIV preventive effect among pregnant and lactating women in this setting. Further research is needed to verify this hypothesis.	[Homsy, Jaco; King, Rachel; Weissglas, Fitti; Rutherford, George] Univ Calif San Francisco, Inst Global Hlth Sci, San Francisco, CA 94143 USA; [Bannink, Femke; Ojok, Francis; Amama, Sharon; Ojom, Lawrence] AVSI Fdn, Kampala, Uganda; [Namukwaya, Zikulah; Amone, Alexander; Rukundo, Gordon; Etima, Juliane; Matovu, Joyce] Makerere Univ, Johns Hopkins Univ Res Collaborat, Kampala, Uganda; [Vittinghof, Eric] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Atim, Pamela] St Josephs Hosp, Kitgum, Uganda; [Darbes, Lynae] Univ Michigan, Sch Nursing, Dept Hlth Behav & Biol Sci, Ctr Sexual & Hlth Dispar, Ann Arbor, MI 48109 USA; [Byamugisha, Josaphat] Makerere Univ, Sch Med, Dept Obstet & Gynecol, Kampala, Uganda; [Katabira, Elly] Makerere Univ, Sch Med, Dept Med, Kampala, Uganda; [Katabira, Elly] Makerere Univ, Sch Med, Coll Hlth Sci, Kampala, Uganda; [Fowler, Mary Glenn] Johns Hopkins Univ, Dept Med, Baltimore, MD USA	University of California System; University of California San Francisco; Makerere University; University of California System; University of California San Francisco; University of Michigan System; University of Michigan; Makerere University; Makerere University; Makerere University; Johns Hopkins University	Homsy, J (corresponding author), Univ Calif San Francisco, Inst Global Hlth Sci, San Francisco, CA 94143 USA.	jaco.homsy@ucsf.edu	Bannink, Femke/AAE-9715-2020; Byamugisha, Josaphat/AAL-5776-2020	Byamugisha, Josaphat/0000-0002-3438-9662; Homsy, Jaco/0000-0001-5932-4569; Darbes, Lynae/0000-0003-4738-6812; Mwambi, Kenneth/0000-0003-3219-0390; Etima, Juliane/0000-0002-5879-6000	National Institutes of Health/National Institute for Child Health and Human Development [R01HD070767]	National Institutes of Health/National Institute for Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was funded by grant R01HD070767 of the National Institutes of Health/National Institute for Child Health and Human Development awarded to JH at the University of California San Francisco. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; Allen S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-349; Audet CM, 2016, QUAL HEALTH RES, V26, P1721, DOI 10.1177/1049732315580302; Bernasconi D, 2010, J CLIN VIROL, V48, P180, DOI 10.1016/j.jcv.2010.04.010; Bhatia DS, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00188; De Schacht C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115014; Delavande Adeline, 2016, J AIDS Clin Res, V7; Dinh TH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125525; Drake AL, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001608; Fatti G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181691; Garber Gary E, 2005, Can J Infect Dis Med Microbiol, V16, P35; Gill MM, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1587-y; Grabowski MK, 2017, NEW ENGL J MED, V377, P2154, DOI [10.1056/NEJMoa1702150, 10.1056/nejmoa1702150]; Gray RH, 2005, LANCET, V366, P1182, DOI 10.1016/S0140-6736(05)67481-8; Gray RH, 2001, AM J OBSTET GYNECOL, V185, P1209, DOI 10.1067/mob.2001.118158; Green EC, 2006, AIDS BEHAV, V10, P335, DOI 10.1007/s10461-006-9073-y; Heemelaar S, 2015, TROP MED INT HEALTH, V20, P277, DOI 10.1111/tmi.12432; International Conference on Harmonisation (ICH), 1994, ICH HARM TRIP GUID C; Jefferys LF, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0084-x; Johnson LF, 2012, JAIDS-J ACQ IMM DEF, V59, P417, DOI 10.1097/QAI.0b013e3182432f27; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2017, END AIDS PROGR 90 90; Kiene SM, 2015, J HEALTH PSYCHOL, V20, P173, DOI 10.1177/1359105313500685; Kim LH, 2013, JAIDS-J ACQ IMM DEF, V63, P195, DOI 10.1097/QAI.0b013e3182895565; Leli Christian, 2016, Infez Med, V24, P112; Liang K, 2009, J INFECT DIS, V200, P682, DOI 10.1086/605123; Liao C, 2017, AIDS PATIENT CARE ST, V31, P20, DOI 10.1089/apc.2016.0204; Lockman S, 2009, J INFECT DIS, V200, P667, DOI 10.1086/605124; Lu L, 2009, 2008 C RETR OPP INF; Ministry of Health, 2012, INT NAT GUID ANT THE; Ministry of Health Uganda (MOH)., 2016, CONSOLIDATED GUIDELI; Montgomery ET, 2011, AIDS BEHAV, V15, P959, DOI 10.1007/s10461-010-9806-9; Moodley D, 2009, AIDS, V23, P1255, DOI 10.1097/QAD.0b013e32832a5934; Nannozi V, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4043-z; Nel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021528; Nyoyoko NP, 2016, PAN AFR MED J, V25, DOI 10.11604/pamj.2016.25.247.6715; Patterson KB, 2007, AIDS, V21, P2303, DOI 10.1097/QAD.0b013e3282f155da; Ramachandran S, 2016, SEX TRANSM INFECT, V92, P571, DOI 10.1136/sextrans-2015-052354; Rogers AJ, 2017, J INT AIDS SOC, V20, DOI 10.1002/jia2.25036; Rogers AJ, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0936-6; Rosenberg NE, 2017, JAIDS-J ACQ IMM DEF, V75, P417, DOI 10.1097/QAI.0000000000001398; Rosenberg NE, 2015, LANCET HIV, V2, pE483, DOI 10.1016/S2352-3018(15)00182-4; Ruzagira E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024037; Schnack A, 2016, AIDS PATIENT CARE ST, V30, P110, DOI 10.1089/apc.2015.0318; Tabu F NJ, 2013, BRIT J OBSTET GYNAEC; Teasdale CA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197696; Thomson KA, 2018, J INFECT DIS, V218, P16, DOI 10.1093/infdis/jiy113; Uganda Ministry of Health, 2010, UG HIV COUNS TEST PO; Uganda Ministry of Health, 2010, NAT IMPL GUID HIV CO; Uganda Ministry of Health, 2009, GUID MAN SEX TRANSM; UNAIDS, 2015, GLOB PLAN EL NEW HIV; WHO, 2013, CONSOLIDATED GUIDELI; Williams B, 2014, HIV MED, V15, P362, DOI 10.1111/hiv.12110; World Health Organization, 2012, PROGR UPD US ANT DRU; World Health Organization, 2010, PMTCT STRAT VIS 2010; World Health Organization, 2016, WHO GUIDELINES TREAT; World Health Organization., 2010, DEL HIV TEST RES MES; World Health Organization, 2010, GUID HIV INF FEED 20; World Health Organization UNICEF United Nations Population Fund UNAIDS, 2006, HIV INF FEED UPD BAS, Viv	58	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2019	14	2							e0212119	10.1371/journal.pone.0212119	http://dx.doi.org/10.1371/journal.pone.0212119			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8EH	30802277	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000459710700010
J	Moran, Z; Sacks, JA; Frimpong, FK; Frimpong, AB; Ben Amor, Y				Moran, Zelda; Sacks, Jilian A.; Frimpong, Francis Kwabena; Frimpong, Atta Boahen; Ben Amor, Yanis			Performance of the BD-FACS Presto for CD4 count and hemoglobin measurement in a district hospital and rural laboratory in Ghana	PLOS ONE			English	Article								Introduction In Ghana, initiation of Antiretroviral Therapy (ART) is recommended for all patients with an HIV diagnosis, regardless of CD4+ T-cell count. However, measurement of CD4 count remains an important metric for identifying patients with advanced HIV disease, and assessing a person's overall immune status, which informs the decision to offer opportunistic infection screening and prophylaxis. Access to CD4+ T cell count in rural health facilities remains a major challenge in Ghana and other resource-limited settings. This study aimed to validate the accuracy of the BD FACSPresto near-patient device for measurement of CD4 count and hemoglobin concentration against the FACSCount (CD4) and Sysmex (hemoglobin) diagnostic machines when operated in both a district hospital and rural laboratory, serving a network of health posts in Ashanti Region, Ghana. Methodology In the first phase of the study, patients were recruited from a district hospital, and both venous and capillary blood samples were tested using the FACSCount and Sysmex as reference tests and compared to results of the FACSPresto performed in the clinic laboratory at the district hospital. In the second phase, patients were recruited from both the hospital and from rural health clinics, and samples were tested using the FACSPresto at a rural laboratory. Sensitivity and specificity among samples categorized into different clinically relevant CD4 count ranges were calculated, along with correlation between the Presto and the reference measurements, and mean and relative bias with limits of agreement. Results The FACSPresto was successfully operated in both clinical settings. A total of 59 samples in the first phase and 48 samples in the second phase were included. Positive bias was observed when comparing CD4 count measured by BD FACSPresto to FACSCount in the district hospital (bias = 44, LOA -72,160) and in the rural laboratory setting (bias = 74, LOA -96, 244). In addition, capillary blood samples were shown to give higher measures when compared to venous blood samples from the same participant. All results were statistically significant (p<0.05) apart from hemoglobin measurement in venous blood in the rural laboratory. Correlation coefficients were high for CD4 count measures and lower for hemoglobin measures. Conclusion Overall, the Presto gave higher estimates of CD4 count compared to FACSCount, and hemoglobin measurements were higher than from Sysmex. Samples of capillary blood in turn gave higher results for both measurements compared to venous blood, consistent with previous analyses. These findings should be considered when selecting CD4 count machines for use at the point of care, especially in remote areas where capillary blood sampling may be preferable, but are likely balanced by device's ease of use, portability, and ability to expand access to services. These results are some of the first to demonstrate the accuracy of the FACSPresto in West Africa and show that this device can be successfully operated in a very rural lab setting and may therefore assist to provide CD4 count and hemoglobin concentration measurement to populations in need.	[Moran, Zelda; Sacks, Jilian A.; Ben Amor, Yanis] Columbia Univ, Earth Inst, New York, NY 10027 USA; [Frimpong, Francis Kwabena; Frimpong, Atta Boahen] Millennium Promise Alliance, Accra, Ghana; [Sacks, Jilian A.] CHAI, Boston, MA USA; [Frimpong, Atta Boahen] Garden City Univ Coll, Kumasi, Ghana	Columbia University	Ben Amor, Y (corresponding author), Columbia Univ, Earth Inst, New York, NY 10027 USA.	yba2101@columbia.edu		Moran, Zelda/0000-0002-1493-5734	Becton Dickinson and Company [AABJ1959]	Becton Dickinson and Company	YBA received grant number AABJ1959 from Becton Dickinson and Company to support this work. The funder was not involved in any aspect of the study design or implementation, data analysis, or publication.	Angira F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157939; [Anonymous], 2015, ACC EV BD FACS PREST; BD Biosciences, 2014, BD FACSPRESTO NEAR P; Bwana P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145586; Calmy A, 2018, CLIN INFECT DIS, V66, pS103, DOI 10.1093/cid/cix1138; Clinical and Laboratory Standards Institute, 2002, METH COMP BIAS EST U; Coetzee L M, 2016, SAMJ, S. Afr. med. j., V106, P82, DOI [10.7196/SAMJ.2016.V106I1.10081, 10.7196/SAMJ.2016.v106i1.10081]; Coetzee LM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156266; Daneau G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170248; Department of Health and Human Services, 2015, 510 K SUBST EQ DET D; Desai MA, 2017, LANCET HIV, V4, pE393, DOI 10.1016/S2352-3018(17)30091-7; Ford N, 2017, CURR OPIN HIV AIDS, V12, P123, DOI 10.1097/COH.0000000000000348; Gebremicael G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176323; Ghana Statistical Service, 2014, DEM HLTH SURV; Ghana Statistical Service, 2014, DISTR CENS REP; Habiyambere V, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002088; Hakim J, 2017, NEW ENGL J MED, V377, P233, DOI 10.1056/NEJMoa1615822; Hoffman S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162085; Kingwara L, 2017, CLIN MED DIAGNOSTICS, V7, P57; Makadzange AT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157546; Ministry of Health/Ghana Health Service, 2010, GUID ANT THER GHAN; Negedu-Momoh OR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178037; Peeling RW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115019; Pham MD, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1588-y; Thakar Madhuri, 2017, Open AIDS J, V11, P76, DOI 10.2174/1874613601711010076; UNAIDS, 2016, AIDSINFO COUNTR FACT; Venter WDF, 2018, INT J STD AIDS, V29, P1048, DOI 10.1177/0956462418771768; WHO, 2010, ANT THER HIV INF AD; World Health Organization, 2016, PROD BD FACSPRESTO N; World Health Organization (WHO), 2017, GUIDELINES MANAGING	30	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212684	10.1371/journal.pone.0212684	http://dx.doi.org/10.1371/journal.pone.0212684			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794637	Green Published, gold, Green Submitted			2022-12-27	WOS:000459709100113
J	Portella, AK; Paquet, C; Bischoff, AR; Molle, RD; Faber, A; Moore, S; Arora, N; Levitan, R; Silveira, PP; Dube, L				Portella, Andre Krumel; Paquet, Catherine; Bischoff, Adrianne Rahde; Molle, Roberta Dalle; Faber, Aida; Moore, Spencer; Arora, Narendra; Levitan, Robert; Silveira, Patricia Pelufo; Dube, Laurette			Multi-behavioral obesogenic phenotypes among school-aged boys and girls along the birth weight continuum	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; PHYSICAL-ACTIVITY; MUSCLE STRENGTH; EATING BEHAVIOR; SLEEP DURATION; CARDIORESPIRATORY FITNESS; YOUNG-ADULTS; RISK-FACTORS; CARDIOVASCULAR FITNESS; NONLINEAR RELATIONSHIP	Evidence shows that extremes of birth weight (BW) carry a common increased risk for the development of adiposity and related cardiovascular diseases, but little is known about the role of obesogenic behaviors in this process. Moreover, no one has empirically examined whether the relationship between BW, obesogenic behaviors and BMI along the full low-to-high birthweight continuum reflects the U-shape pattern expected from common risk at both BW extremes. Our objective was to characterize physical activity, screen time, and eating behavior and their relationship to BMI as a function of BW among school-aged boys and girls. In this cross-sectional study, 460 children aged 6 to 12 years (50% boys) from Montreal, Canada provided information on sleeping time, screen time, physical activity levels, eating behavior (emotional, external and restrained eating) and anthropometrics (height, weight, BW) through parent reported questionnaires. BMI was normalized using WHO Standards (zBMI), and BW expressed as ratio using Canadian population standards (BW for gestational age and sex). Analyses were conducted using generalized linear models with linear and quadratic terms for BW, stratified by sex and adjusted for age, ethnicity and household income. In boys, physical activity and screen time showed U-shaped associations with BW, while physical activity had an inverted U-shaped in girls. Emotional and restrained eating had positive linear relations with BW in boys and girls. Sleep time and external eating were not associated with BW. A U-shaped relationship between BW and zBMI was found in boys but no association was found in girls. Only sleep (in boys and girls), and emotional eating (girls only) were related to zBMI and mediation of the BW-zBMI relationship was only supported for emotional eating. In conclusion, BW relates to obesogenic behaviors and BMI in both non-linear and linear ways, and these associations differed by sex.	[Portella, Andre Krumel; Faber, Aida; Dube, Laurette] McGill Univ, Desautels Fac Management, McGill Ctr Convergence Hlth & Econ, Montreal, PQ, Canada; [Portella, Andre Krumel] Univ Fed Ciencias Saude Porto Alegre, PostGrad Program Pediat, Porto Alegre, RS, Brazil; [Paquet, Catherine] Univ South Australia, Sch Hlth Sci, Ctr Populat Hlth Res, Adelaide, SA, Australia; [Bischoff, Adrianne Rahde] Univ Toronto, Div Neonatol, Dept Pediat, Toronto, ON, Canada; [Molle, Roberta Dalle] Univ Fed Rio Grande do Sul, Fac Med, Programa Posgrad Saude Crianca & Adolescente, Porto Alegre, RS, Brazil; [Moore, Spencer] Univ South Carolina, Arnold Sch Publ Hlth, Columbia, SC USA; [Arora, Narendra] INCLEN Trust, New Delhi, India; [Levitan, Robert] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Levitan, Robert] CAMH, Toronto, ON, Canada; [Silveira, Patricia Pelufo] McGill Univ, Dept Psychiat, Fac Med, Montreal, PQ, Canada; [Silveira, Patricia Pelufo] McGill Univ, Sackler Inst Epigenet & Psychobiol, Montreal, PQ, Canada; [Silveira, Patricia Pelufo] Douglas Hosp, Ludmer Ctr Neuroinformat & Mental Hlth, Montreal, PQ, Canada	McGill University; Universidade Federal de Ciencias da Saude de Porto Alegre; University of South Australia; University of Toronto; Universidade Federal do Rio Grande do Sul; University of South Carolina System; University of South Carolina Columbia; University of Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; McGill University; McGill University; McGill University	Portella, AK (corresponding author), McGill Univ, Desautels Fac Management, McGill Ctr Convergence Hlth & Econ, Montreal, PQ, Canada.; Portella, AK (corresponding author), Univ Fed Ciencias Saude Porto Alegre, PostGrad Program Pediat, Porto Alegre, RS, Brazil.	andre.portella@mcgill.ca	Portella, Andre Krumel/A-9333-2010; Paquet, Catherine/C-3894-2009; Moore, Spencer/AAJ-5022-2020; Silveira, Patricia/F-4897-2014	Portella, Andre Krumel/0000-0003-3390-0016; Paquet, Catherine/0000-0002-6877-7903; Moore, Spencer/0000-0002-1229-9578; Silveira, Patricia/0000-0001-8626-2519; Bischoff, Adrianne R/0000-0001-9218-1301	Canadian Institutes of Health Research (CIHR); CIHR-India [INC 110726]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR-India	This study was supported by Canadian Institutes of Health Research (CIHR); http://www.cihr-irsc.gc.ca/; CIHR-India grant ref no. INC 110726 (LB, SM and NA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril V, 2013, FOOD NUTR BULL, V34, P388, DOI 10.1177/156482651303400404; Alves MB, 2015, BEHAV BRAIN RES, V287, P73, DOI 10.1016/j.bbr.2015.03.019; Andersen LG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008192; Anderson SE, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-366; Ayres C, 2012, INT J PEDIAT, V2012, DOI 10.1155/2012/657379; Barbieri MA, 2009, PEDIATR RES, V65, P215, DOI 10.1203/PDR.0b013e31818d6850; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Bellinger L, 2005, CLIN SCI, V109, P413, DOI 10.1042/CS20050127; Bellinger L, 2006, INT J OBESITY, V30, P729, DOI 10.1038/sj.ijo.0803205; Bischoff AR, 2018, BRIT J NUTR, V119, P1295, DOI [10.1017/S0007114518000892, 10.1017/s0007114518000892]; Bischoff AR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177344; Boreham CA, 2001, PUBLIC HEALTH, V115, P373; BRUCH H, 1964, PSYCHOSOMATICS, V5, P269; Brutsaert TD, 2011, EARLY HUM DEV, V87, P663, DOI 10.1016/j.earlhumdev.2011.05.006; Cafiero G, 2014, ACTA PAEDIATR, V103, pE219, DOI 10.1111/apa.12571; Cameron AJ, 2011, ANN EPIDEMIOL, V21, P95, DOI 10.1016/j.annepidem.2010.11.001; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Carnell S, 2007, APPETITE, V48, P104, DOI 10.1016/j.appet.2006.07.075; CHARLES MA, 1994, AM J MED, V97, P250, DOI 10.1016/0002-9343(94)90008-6; Cleland VJ, 2008, AM J CLIN NUTR, V87, P1148, DOI 10.1093/ajcn/87.5.1148; Croker H, 2011, APPETITE, V57, P525, DOI 10.1016/j.appet.2011.05.320; Cunha FD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118586; de Beer M, 2015, INT J OBESITY, V39, P586, DOI 10.1038/ijo.2014.200; de Jong E, 2013, INT J OBESITY, V37, P47, DOI 10.1038/ijo.2011.244; Dodds R, 2012, J NUTR HEALTH AGING, V16, P609, DOI 10.1007/s12603-012-0053-9; Dulloo AG, 2006, INT J OBESITY, V30, pS23, DOI 10.1038/sj.ijo.0803516; Eisenmann JC, 2004, OBES RES, V12, P1633, DOI 10.1038/oby.2004.203; Eisenstein SA, 2015, SCI REP-UK, V5, DOI 10.1038/srep11283; Ekstrom S, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3947; Eloranta AM, 2012, INT J OBESITY, V36, P950, DOI 10.1038/ijo.2012.89; Eriksson JG, 2004, PREV MED, V39, P164, DOI 10.1016/j.ypmed.2004.01.035; Escobar RS, 2014, APPETITE, V81, P337, DOI 10.1016/j.appet.2014.06.107; Ester WA, 2019, INT J EPIDEMIOL, V48, P124, DOI 10.1093/ije/dyy256; Fernandes FS, 2010, J DEV ORIG HLTH DIS, V1, P255, DOI 10.1017/S204017441000019X; Forsen T, 2000, ANN INTERN MED, V133, P176, DOI 10.7326/0003-4819-133-3-200008010-00008; Fowden AL, 2004, REPRODUCTION, V127, P515, DOI 10.1530/rep.1.00033; Gadermann A.M., 2012, PRACTICAL ASSESSMENT, V17, P3, DOI DOI 10.7275/N560-J767; Gubbels JS, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-77; Gubbels JS, 2012, PUBLIC HEALTH NUTR, V15, P1402, DOI 10.1017/S1368980011003089; Gubbels JS, 2009, J PEDIATR-US, V155, P194, DOI 10.1016/j.jpeds.2009.02.027; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Hancox RJ, 2012, J EPIDEMIOL COMMUN H, V66, P957, DOI 10.1136/jech-2011-200217; Hare-Bruun H, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-311; Hobbs M, 2018, PERSPECT PUBLIC HEAL, V138, P169, DOI 10.1177/1757913917748353; Inskip HM, 2007, J INTERN MED, V262, P368, DOI 10.1111/j.1365-2796.2007.01812.x; Jones RH, 2009, MOL CELL ENDOCRINOL, V297, P4, DOI 10.1016/j.mce.2008.06.020; Kajantie E, 2010, J PEDIATR-US, V157, P610, DOI 10.1016/j.jpeds.2010.04.002; Kakinami L, 2014, ARCH DIS CHILD, V99, P1020, DOI 10.1136/archdischild-2013-305163; Kaseva N, 2013, J PEDIATR-US, V163, P43, DOI 10.1016/j.jpeds.2012.12.076; Koyama S, 2015, J PEDIATR-US, V166, P309, DOI 10.1016/j.jpeds.2014.10.003; Kramer MS, 1999, PEDIATRICS, V103, P599, DOI 10.1542/peds.103.3.599; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; Kremers SPJ, 2004, PSYCHOL HEALTH, V19, P595, DOI 10.1080/08870440412331279630; Laaksonen DE, 2003, DIABETES CARE, V26, P2156, DOI 10.2337/diacare.26.7.2156; Lanfer A, 2012, INT J OBESITY, V36, P27, DOI 10.1038/ijo.2011.164; Laureano DP, 2016, NEUROSCIENCE, V322, P500, DOI 10.1016/j.neuroscience.2016.02.033; Laureano DP, 2016, J CHILD NEUROL, V31, P398, DOI 10.1177/0883073815592225; Lawlor DA, 2008, EUR J EPIDEMIOL, V23, P411, DOI 10.1007/s10654-008-9259-x; Leatherdale ST, 2009, HEALTH PROMOT PRACT, V10, P254, DOI 10.1177/1524839906298499; Lluch A, 2000, INT J OBESITY, V24, P1493, DOI 10.1038/sj.ijo.0801425; Lussana F, 2008, AM J CLIN NUTR, V88, P1648, DOI 10.3945/ajcn.2008.26140; McDonald L, 2015, INT J OBESITY, V39, P1463, DOI 10.1038/ijo.2015.132; Melkevik O, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-46; Mericq V, 2009, EUR J ENDOCRINOL, V161, P419, DOI 10.1530/EJE-09-0308; Molle RD, 2016, J DEV ORIG HLTH DIS, V7, P222, DOI 10.1017/S2040174415007187; Molle RD, 2015, BRAIN RES, V1618, P41, DOI 10.1016/j.brainres.2015.05.019; Murtaugh MA, 2003, DIABETES CARE, V26, P187, DOI 10.2337/diacare.26.1.187; Must A, 2005, INT J OBESITY, V29, pS84, DOI 10.1038/sj.ijo.0803064; Narayanan NS, 2010, FRONT NEUROENDOCRIN, V31, P104, DOI 10.1016/j.yfrne.2009.10.004; Noschang C, 2014, BRIT J MED MED RES, V4; Ortega FB, 2009, J PEDIATR, V154, P61, DOI 10.1016/j.jpeds.2008.07.041; Owens JA, 2000, SLEEP, V23, P1043; Palmiter RD, 2007, TRENDS NEUROSCI, V30, P375, DOI 10.1016/j.tins.2007.06.004; Paquet C, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0540-9; Perala MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046139; Plagemann A, 2006, HORM RES, V65, P83, DOI 10.1159/000091511; Plagemann A, 2009, J PHYSIOL-LONDON, V587, P4963, DOI 10.1113/jphysiol.2009.176156; Portella AK, 2015, BEHAV BRAIN RES, V278, P66, DOI 10.1016/j.bbr.2014.09.033; Ridgway CL, 2009, MED SCI SPORT EXER, V41, P1212, DOI 10.1249/MSS.0b013e31819794ab; Rogers M, 2005, PEDIATRICS, V116, pE58, DOI 10.1542/peds.2004-1603; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; SALLIS JF, 1993, RES Q EXERCISE SPORT, V64, P25, DOI 10.1080/02701367.1993.10608775; Sallis JF, 1996, J CLIN EPIDEMIOL, V49, P125, DOI 10.1016/0895-4356(95)00514-5; Santos JL, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-108; Schellong K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047776; Schuit AJ, 2002, PREV MED, V35, P219, DOI 10.1006/pmed.2002.1064; Seghers J, 2010, PUBLIC HEALTH NUTR, V13, P1838, DOI 10.1017/S1368980010000418; Shakir RN, 2018, NOT ALL SEDENTARY BE; Sigmund E, 2015, INT J ENV RES PUB HE, V12, P11848, DOI 10.3390/ijerph120911848; Silveira PP, 2012, PEDIATR RES, V71, P293, DOI 10.1038/pr.2011.39; Snoek HM, 2007, SCAND J PSYCHOL, V48, P23, DOI 10.1111/j.1467-9450.2006.00568.x; Sokolovic N, 2013, PEDIATR OBES, V8, pe41, DOI 10.1111/j.2047-6310.2012.00142.x; St-Onge MP, 2013, J CLIN SLEEP MED, V9, P73, DOI 10.5664/jcsm.2348; Stansfield BK, 2016, J PEDIATR-US, V174, P185, DOI 10.1016/j.jpeds.2016.04.012; Tam CHT, 2015, DIABETIC MED, V32, P220, DOI 10.1111/dme.12630; Tehranifar P, 2009, AM J EPIDEMIOL, V170, P910, DOI 10.1093/aje/kwp205; Tikanmaki M, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4237-4; Trost SG, 2002, MED SCI SPORT EXER, V34, P350, DOI 10.1097/00005768-200202000-00025; van Deutekom AW, 2015, INT J OBESITY, V39, P593, DOI 10.1038/ijo.2014.204; van Deutekom AW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168186; van Strien T, 2008, INT J EAT DISORDER, V41, P72, DOI 10.1002/eat.20424; van Strien T, 2013, PSYCHONEUROENDOCRINO, V38, P677, DOI 10.1016/j.psyneuen.2012.08.008; van Strien T, 2012, APPETITE, V59, P782, DOI 10.1016/j.appet.2012.08.009; VANSTRIEN T, 1986, INT J EAT DISORDER, V5, P295, DOI 10.1002/1098-108X(198602)5:2<295::AID-EAT2260050209>3.0.CO;2-T; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Volkow ND, 2003, INT J EAT DISORDER, V33, P136, DOI 10.1002/eat.10118; WARDLE J, 1992, APPETITE, V18, P167, DOI 10.1016/0195-6663(92)90195-C; Webber L, 2009, INT J OBESITY, V33, P21, DOI 10.1038/ijo.2008.219; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; Wicklow BA, 2015, INT J OBESITY, V39, P1070, DOI 10.1038/ijo.2015.55; World Health Organization (WHO), 2011, CHILD GROWTH STAND; Yiallourou SR, 2016, SLEEP MED REV, V26, P64, DOI 10.1016/j.smrv.2015.04.001; Yliharsila H, 2007, INT J OBESITY, V31, P1392, DOI 10.1038/sj.ijo.0803612; Yu ZB, 2011, OBES REV, V12, P525, DOI 10.1111/j.1467-789X.2011.00867.x; Zornoza-Moreno M, 2013, DIABETES-METAB RES, V29, P483, DOI 10.1002/dmrr.2417	115	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212290	10.1371/journal.pone.0212290	http://dx.doi.org/10.1371/journal.pone.0212290			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM2WC	30789933	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000459330800023
J	Yang, B; Pan, CS; Li, Q; Yang, Z; Long, FX; Fan, JY; Wang, CS; Han, JY; Tang, DX				Yang, Bing; Pan, Chun-Shui; Li, Quan; Yang, Zhu; Long, Feng-Xi; Fan, Jing-Yu; Wang, Chuan-She; Han, Jing-Yan; Tang, Dong-Xin			Inhibitory effects of Chanling Gao on the proliferation and liver metastasis of transplanted colorectal cancer in nude mice	PLOS ONE			English	Article							EXPRESSION; HYPOXIA; GROWTH; INJURY; CXCR4	This study aimed to explore the efficacy and mechanism of Chanling Gao (CLG), a compound Chinese medicine, on colorectal cancer (CRC). A model of transplanted CRC was established in nude mice. The mice were treated 7 days after CRC transplantation with either Capecitabine or CLG for 3 weeks. On the 28th day after the operation, CRC growth and liver metastasis were assessed by morphology, the changes in the expression of HIF-1 alpha (hypoxia inducible factor-1 alpha), stromal cell-derived factor-1 alpha (SDF-1 alpha), CXCR4 (C-X-C chemokine receptor type 4), PI3K, and Akt in the transplanted tumor and SDF-1 alpha and CXCR4 in the liver were detected by Western blot and immunohistochemistry. The protein contents of vascular endothelial growth factor (VEGF), matrix metalloproteinase (MMP)-2, and collagen IV in the serum and transplanted tumor and SDF-1 alpha and CXCR4 in liver tissues were detected by enzyme-linked immunosorbent assay. In the Capecitabine and high dose CLG groups, the growth and liver metastasis of CRC were significantly inhibited, the protein levels of HIF-1 alpha, SDF-1 alpha, CXCR4, MMP-2, VEGF, PI3K, Akt, P-PI3K and P-Akt in the transplanted tumor were lower, while the content of collagen IV in the transplanted tumor was higher, than in Model group. A high dose of CLG inhibited the growth of transplanted tumor and liver metastasis of CRC in nude mice, probably by inhibiting the HIF-1 alpha/SDF-1 alpha-CXCR4/PI3K-Akt signaling pathway reducing the synthesis and release of VEGF and degradation of collagen IV.	[Yang, Bing; Yang, Zhu; Long, Feng-Xi; Tang, Dong-Xin] Guizhou Univ Tradit Chinese Med, Guiyang, Guizhou, Peoples R China; [Pan, Chun-Shui; Li, Quan; Fan, Jing-Yu; Wang, Chuan-She; Han, Jing-Yan] Peking Univ, Hlth Sci Ctr, Tasly Microcirculat Res Ctr, Beijing, Peoples R China; [Wang, Chuan-She; Han, Jing-Yan] Peking Univ, Sch Basic Med Sci, Dept Integrat Chinese & Western Med, Beijing, Peoples R China; [Tang, Dong-Xin] Guizhou Univ Tradit Chinese Med, Affiliated Hosp 1, Dept Oncol, Guiyang, Guizhou, Peoples R China	Guizhou University of Traditional Chinese Medicine; Peking University; Peking University; Guizhou University of Traditional Chinese Medicine	Tang, DX (corresponding author), Guizhou Univ Tradit Chinese Med, Guiyang, Guizhou, Peoples R China.; Han, JY (corresponding author), Peking Univ, Hlth Sci Ctr, Tasly Microcirculat Res Ctr, Beijing, Peoples R China.; Han, JY (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Integrat Chinese & Western Med, Beijing, Peoples R China.; Tang, DX (corresponding author), Guizhou Univ Tradit Chinese Med, Affiliated Hosp 1, Dept Oncol, Guiyang, Guizhou, Peoples R China.	hanjingyan@bjmu.edu.cn; tangdongxin@sina.com			National Natural Science Foundation of China [81460697, 81760814, 81860819]; Guizhou Province Traditional Chinese Medicine Modernization Project Foundation [SY-2014-3008-1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guizhou Province Traditional Chinese Medicine Modernization Project Foundation	This work was supported in part by National Natural Science Foundation of China (grant number: 81460697 and 81760814 to DXT and 81860819 to BY) and by Guizhou Province Traditional Chinese Medicine Modernization Project Foundation (SY-2014-3008-1 to DXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balamurugan K, 2016, INT J CANCER, V138, P1058, DOI 10.1002/ijc.29519; Bing Y, 2016, LISHIZHEN MED MAT ME, V27, P1289; Canavese M, 2017, INT J CANCER, V140, P2183, DOI 10.1002/ijc.30567; Chatterjee S, 2014, ADV CANCER RES, V124, P31, DOI 10.1016/B978-0-12-411638-2.00002-1; Chen Q, 2013, ONCOL LETT, V6, P207, DOI 10.3892/ol.2013.1343; Cui YC, 2017, SCI REP-UK, V7, DOI 10.1038/srep44579; De Rosa M, 2016, THER ADV GASTROENTER, V9, P861, DOI 10.1177/1756283X16659790; Dongxin T, 2012, LISHIZHEN MED MAT ME, V23, P2213; Dongxin T, 2012, LISHIZHEN MED MAT ME, V23, P1452; Dongxin T, 2012, J MED REASERCH, V41, P79; Guo X, 2017, ONCOTARGET, V8, P80358, DOI 10.18632/oncotarget.18673; Guzman A, 2017, BIOMATERIALS, V115, P19, DOI 10.1016/j.biomaterials.2016.11.014; Hackl C, 2013, GUT, V62, P259, DOI 10.1136/gutjnl-2011-301585; Huang CY, 2010, J CELLULAR PHYSL, V221, P204; Iwai T, 2016, ONCOL REP, V36, P626, DOI 10.3892/or.2016.4902; Jianqiang C, 2016, CHINESE J PRACTICAL, V36, P858; Jones DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044294; Kjersti F, 2004, EUR J CANCER, V40, P1593, DOI [10.1016/j.ejca.2004.02.023, DOI 10.1016/J.EJCA.2004.02.023]; Liang Z, 2007, BIOCHEM BIOPH RES CO, V359, P716, DOI 10.1016/j.bbrc.2007.05.182; Liao D, 2007, CANCER METAST REV, V26, P281, DOI 10.1007/s10555-007-9066-y; Maddirela DR, 2013, INT J ONCOL, V42, P1279, DOI 10.3892/ijo.2013.1806; Moench R, 2016, ONCOTARGET, V7, P68749, DOI 10.18632/oncotarget.11899; Mu HN, 2015, FREE RADICAL BIO MED, V85, P237, DOI 10.1016/j.freeradbiomed.2015.04.033; Murakami T, 2013, INT J CANCER, V132, P276, DOI 10.1002/ijc.27670; Nogawa M, 2005, CANCER LETT, V217, P243, DOI 10.1016/j.canlet.2004.07.010; Ottaiano A, 2005, CANCER IMMUNOL IMMUN, V54, P781, DOI 10.1007/s00262-004-0636-3; Pan F, 2013, MOL BIOL REP, V40, P4139, DOI 10.1007/s11033-012-2225-4; Prasad S, 2012, CLIN CANCER RES, V18, P4942, DOI 10.1158/1078-0432.CCR-11-2805; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Romain B, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-58; Siegel R. L., 2018, CA-CANCER J CLIN, V60, P277; Stanisavljevic L, 2016, TUMOR BIOL, V37, P7441, DOI 10.1007/s13277-015-4591-8; Trudel D, 2010, HUM PATHOL, V41, P1694, DOI 10.1016/j.humpath.2010.05.001; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Veidal SS, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-22; Wang GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055298; Wang X, 2008, BIOCH BIOPHYSICAL RE; Wenqi H, 2016, CONTINUED MED ED, V30, P137; Yamada S, 2014, J SURG RES, V187, P107, DOI 10.1016/j.jss.2013.10.030	39	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0201504	10.1371/journal.pone.0201504	http://dx.doi.org/10.1371/journal.pone.0201504			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789971	Green Published, Green Submitted, gold			2022-12-27	WOS:000459330800002
J	Agrawal, N; Lehtonen, SI; Uusi-Makela, M; Jain, P; Viitala, S; Maatta, JAE; Kahkonen, N; Azizi, L; Riihimaki, TA; Kulomaa, MS; Johnson, MS; Hytonen, VP; Airenne, TT				Agrawal, Nitin; Lehtonen, Soili I.; Uusi-Makela, Meri; Jain, Purvi; Viitala, Sari; Maatta, Juha A. E.; Kahkonen, Niklas; Azizi, Latifeh; Riihimaki, Tiina A.; Kulomaa, Markku S.; Johnson, Mark S.; Hytonen, Vesa P.; Airenne, Tomi T.			Molecular features of steroid-binding antidins and their use for assaying serum progesterone	PLOS ONE			English	Article							TAG II PEPTIDE; CHICKEN AVIDIN; STREP-TAG; AFFINITY PEPTIDE; EGG-WHITE; PROTEIN; STREPTAVIDIN; BIOTIN; PURIFICATION; DESIGN	Chicken avidin (Avd) and streptavidin from Streptomyces avidinii are extensively used in bionanotechnology due to their extremely tight binding to biotin (K-d similar to 10(-15) M for chicken Avd). We previously reported engineered Avds known as antidins, which have micro- to nanomolar affinities for steroids, non-natural ligands of Avd. Here, we report the 2.8 angstrom X-ray structure of the sbAvd-2 (1117Y) antidin co-crystallized with progesterone. We describe the creation of new synthetic phage display libraries and report the experimental as well as computational binding analysis of progesterone-binding antidins. We introduce a next-generation antidin with 5 nM binding affinity for progesterone, and demonstrate the use of anti dins for measuring progesterone in serum samples. Our data give insights on how to engineer and alter the binding preferences of Avds and to develop better molecular tools for modern bionanotechnological applications.	[Agrawal, Nitin; Johnson, Mark S.; Airenne, Tomi T.] Abo Akad Univ, Fac Sci & Engn, Biochem, Struct Bioinformat Lab, Turku, Finland; [Lehtonen, Soili I.; Uusi-Makela, Meri; Jain, Purvi; Maatta, Juha A. E.; Kahkonen, Niklas; Azizi, Latifeh; Riihimaki, Tiina A.; Kulomaa, Markku S.; Hytonen, Vesa P.] Tampere Univ, BioMediTech Inst, Tampere, Finland; [Lehtonen, Soili I.; Uusi-Makela, Meri; Jain, Purvi; Maatta, Juha A. E.; Kahkonen, Niklas; Azizi, Latifeh; Riihimaki, Tiina A.; Kulomaa, Markku S.; Hytonen, Vesa P.] Tampere Univ, Fac Med & Hlth Technol, Tampere, Finland; [Viitala, Sari] Univ Eastern Finland, Sch Pharm, Kuopio, Finland; [Hytonen, Vesa P.] Fimlab Labs, Tampere, Finland	Abo Akademi University; Tampere University; Tampere University; University of Eastern Finland	Airenne, TT (corresponding author), Abo Akad Univ, Fac Sci & Engn, Biochem, Struct Bioinformat Lab, Turku, Finland.; Hytonen, VP (corresponding author), Tampere Univ, BioMediTech Inst, Tampere, Finland.; Hytonen, VP (corresponding author), Tampere Univ, Fac Med & Hlth Technol, Tampere, Finland.; Hytonen, VP (corresponding author), Fimlab Labs, Tampere, Finland.	vesa.hytonen@tuni.fi; tomi.airenne@abo.fi	Lehtonen, Soili/AAW-7751-2021; Hytonen, Vesa P./E-8855-2013	Lehtonen, Soili/0000-0003-2239-9377; Hytonen, Vesa P./0000-0002-9357-1480; Viitala, Sari/0000-0002-1401-3406; Agrawal, Nitin/0000-0002-9482-3440	Academy of Finland [257814, 272283, 263540, 290506, 261285, 272288]; Sigrid Juselius Foundation; Joe, Pentti and Tor Borg Memorial Fund; Orion Research Foundation sr; Academy of Finland FIRI program [141398]; Abo Akademi Center of Excellence in Cell Stress and Aging; Fimlab Laboratories (Tampere, Finland)	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Joe, Pentti and Tor Borg Memorial Fund; Orion Research Foundation sr; Academy of Finland FIRI program; Abo Akademi Center of Excellence in Cell Stress and Aging; Fimlab Laboratories (Tampere, Finland)	This work was supported by grant funding from the Academy of Finland (257814 (M.S.J.), 272283 (M.S.J.), 263540 (V.P.H), 290506 (V.P.H.), 261285 (M.S.K.), and 272288 (M.S.K.)); Sigrid Juselius Foundation; Joe, Pentti and Tor Borg Memorial Fund; Orion Research Foundation sr; Academy of Finland FIRI program (141398); and Abo Akademi Center of Excellence in Cell Stress and Aging. Fimlab Laboratories (Tampere, Finland) provided support in the form of salaries for author VPH and research materials for the group led by VPH. Fimlab and the other funders had no influence in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Avraham O, 2015, J STRUCT BIOL, V191, P139, DOI 10.1016/j.jsb.2015.06.020; Bailey S, 1993, CCP4 SUITE PROGRAMS; Banta S, 2013, ANNU REV BIOMED ENG, V15, P93, DOI 10.1146/annurev-bioeng-071812-152412; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bernard P, 1996, BIOTECHNIQUES, V21, P320; Concannon PW, 2011, ANIM REPROD SCI, V124, P200, DOI 10.1016/j.anireprosci.2010.08.028; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dundas CM, 2013, APPL MICROBIOL BIOT, V97, P9343, DOI 10.1007/s00253-013-5232-z; Eakin RE, 1941, J BIOL CHEM, V140, P535; ELO HA, 1979, COMP BIOCHEM PHYS B, V62, P237, DOI 10.1016/0305-0491(79)90205-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farid R, 2006, BIOORGAN MED CHEM, V14, P3160, DOI 10.1016/j.bmc.2005.12.032; Fellouse FA, 2005, J MOL BIOL, V348, P1153, DOI 10.1016/j.jmb.2005.03.041; Fellouse FA, 2004, P NATL ACAD SCI USA, V101, P12467, DOI 10.1073/pnas.0401786101; Gaj T, 2007, PROTEIN EXPRES PURIF, V56, P54, DOI 10.1016/j.pep.2007.06.010; Gebauer M, 2013, J MOL BIOL, V425, P780, DOI 10.1016/j.jmb.2012.12.004; Gebauer M, 2012, METHOD ENZYMOL, V503, P157, DOI 10.1016/B978-0-12-396962-0.00007-0; Gyorgy P, 1941, SCIENCE, V94, P261, DOI 10.1126/science.94.2437.261; Hytonen VP, 2005, PROTEINS, V61, P597, DOI 10.1002/prot.20604; Hytonen VP, 2005, J BIOL CHEM, V280, P10228, DOI 10.1074/jbc.M414196200; Hytonen VP, 2004, J BIOL CHEM, V279, P9337, DOI 10.1074/jbc.M310989200; Hytonen VR, 2004, BIOCHEM J, V384, P385, DOI 10.1042/BJ20041114; JOHNSON MS, 1993, J MOL BIOL, V233, P716, DOI 10.1006/jmbi.1993.1548; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Keefe AD, 2001, PROTEIN EXPRES PURIF, V23, P440, DOI 10.1006/prep.2001.1515; Korndorfer IP, 2002, PROTEIN SCI, V11, P883, DOI 10.1110/ps.4150102; Laitinen OH, 2006, CELL MOL LIFE SCI, V63, P2992, DOI 10.1007/s00018-006-6288-z; Laitinen OH, 2007, TRENDS BIOTECHNOL, V25, P269, DOI 10.1016/j.tibtech.2007.04.001; Lamla T, 2004, PROTEIN EXPRES PURIF, V33, P39, DOI 10.1016/j.pep.2003.08.014; Le Trong L, 2006, J MOL BIOL, V356, P738, DOI 10.1016/j.jmb.2005.11.086; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Lehtonen SI, 2016, ACS CHEM BIOL, V11, P211, DOI 10.1021/acschembio.5b00906; Lehtonen SI, 2015, PROTEIN ENG DES SEL, V28, P23, DOI 10.1093/protein/gzu050; Leppiniemi J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035962; Leppiniemi J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016576; LIVNAH O, 1993, P NATL ACAD SCI USA, V90, P5076, DOI 10.1073/pnas.90.11.5076; Maatta JAE, 2008, CHEMBIOCHEM, V9, P1124, DOI 10.1002/cbic.200700671; Maatta JAE, 2011, BIOTECHNOL BIOENG, V108, P481, DOI 10.1002/bit.22962; Marttila AT, 2003, BIOCHEM J, V369, P249, DOI 10.1042/BJ20020886; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meyer SC, 2006, CHEM BIOL DRUG DES, V68, P3, DOI 10.1111/j.1747-0285.2006.00401.x; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Niederhauser B, 2012, J BIOTECHNOL, V157, P38, DOI 10.1016/j.jbiotec.2011.10.014; Nordlund HR, 2005, BIOCHEM J, V392, P485, DOI 10.1042/BJ20051038; Nordlund HR, 2004, J BIOL CHEM, V279, P36715, DOI 10.1074/jbc.M403496200; Okura H, 2013, PROTEIN ENG DESIGN S, V26; Panek A, 2017, J MOL MODEL, V23, DOI 10.1007/s00894-017-3278-z; Perbandt M, 2007, PROTEINS, V67, P1147, DOI 10.1002/prot.21236; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; PUGLIESE L, 1993, J MOL BIOL, V231, P698, DOI 10.1006/jmbi.1993.1321; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Repo S, 2006, CHEM BIOL, V13, P1029, DOI 10.1016/j.chembiol.2006.08.006; Riihimaki TA, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-64; Riihimaki TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020535; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schmidt TGM, 1996, J MOL BIOL, V255, P753, DOI 10.1006/jmbi.1996.0061; Sherman W, 2006, CHEM BIOL DRUG DES, V67, P83, DOI 10.1111/j.1747-0285.2005.00327.x; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Siitari H, 2015, AVIAN BIOL RES, V8, P244, DOI 10.3184/175815515X14460614674603; Sinkkonen A, 2014, SOIL BIOL BIOCHEM, V73, P93, DOI 10.1016/j.soilbio.2014.02.002; Skerra A, 1999, BIOMOL ENG, V16, P79, DOI 10.1016/S1050-3862(99)00033-9; Skerra A, 2000, METHOD ENZYMOL, V326, P271; Skerra A, 2008, FEBS J, V275, P2677, DOI 10.1111/j.1742-4658.2008.06439.x; Stahl S, 2013, J CHEM TECHNOL BIOT, V88, P25, DOI 10.1002/jctb.3929; SWILLENS S, 1995, MOL PHARMACOL, V47, P1197; Taskinen B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092058; Traore SM, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-42; Turunen L, 2009, J BIOMOL SCREEN, V14, P282, DOI 10.1177/1087057108330113; Voss S, 1997, PROTEIN ENG, V10, P975, DOI 10.1093/protein/10.8.975; WEBER PC, 1994, J AM CHEM SOC, V116, P2717, DOI 10.1021/ja00086a004; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	73	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212339	10.1371/journal.pone.0212339	http://dx.doi.org/10.1371/journal.pone.0212339			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785944	Green Published, gold, Green Submitted			2022-12-27	WOS:000459307000057
J	Caldeira, D; Alves, D; Costa, J; Ferreira, JJ; Pinto, FJ				Caldeira, Daniel; Alves, Daniela; Costa, Joao; Ferreira, Joaquim J.; Pinto, Fausto J.			Ibrutinib increases the risk of hypertension and atrial fibrillation: Systematic review and meta-analysis	PLOS ONE			English	Review							ANTAGONIST ORAL ANTICOAGULANTS; RHYTHM CONTROL; THERAPY; FAILURE; STROKE	Introduction Ibrutinib is an oral covalent inhibitor of Bruton's tyrosine kinase approved for the treatment of patients with chronic lymphocytic leukemia (CLL), mantle cell lymphoma and Waldenstrom's macroglobulinemia. Ibrutinib has an increased risk of atrial fibrillation but the mechanism is unknown, and hypertension may play a role in the pathogenesis of this adverse drug reaction. Methods We aimed to review the risk of hypertension and atrial fibrillation as adverse events associated with ibrutinib through a systematic review with meta-analysis of randomized controlled trials (RCTs) retrieved in December 2018 on MEDLINE, EMBASE, CENTRAL and Clinical-Trials.gov. The data were pooled using random-effects meta-analyses using the risk ratio (RR) with the 95% confidence interval (95% CI). The confidence on the pooled estimates was ascertained through the grading of recommendations assessment, development, and evaluation (GRADE) approach. Results There were 8 eligible RCTs (2580 patients), all reporting safety data of interest. Ibrutinib was associated with a significant increase in the risk of hypertension with a RR of 2.82 (95% CI 1.52-5.23) with moderate quality evidence. Ibrutinib increased significantly the risk of atrial fibrillation with a RR of 4.69 (95%CI 2.17-7.64) with high quality evidence. Conclusions Ibrutinib was associated with significantly increased risks of both hypertension and atrial fibrillation.	[Caldeira, Daniel; Pinto, Fausto J.] Univ Lisbon, Fac Med, CCUL, Serv Cardiol,Hosp Univ Santa Maria CHLN,CAML, Ave Prof Egas Moniz, Lisbon, Portugal; [Caldeira, Daniel; Costa, Joao; Ferreira, Joaquim J.] Univ Lisbon, Fac Med, Lab Farmacol Clin & Terapeut, Ave Prof Egas Moniz, Lisbon, Portugal; [Caldeira, Daniel; Costa, Joao; Ferreira, Joaquim J.] Univ Lisbon, Fac Med, Inst Med Mol, Ave Prof Egas Moniz, Lisbon, Portugal; [Alves, Daniela] Univ Lisbon, Santa Maria Univ Hosp CHLN, Fac Med, Dept Hematol, Lisbon, Portugal	Instituto Superior de Ciencias da Saude Egas Moniz; Universidade de Lisboa; Hospital Santa Maria; Instituto Superior de Ciencias da Saude Egas Moniz; Universidade de Lisboa; Instituto Superior de Ciencias da Saude Egas Moniz; Universidade de Lisboa; Universidade de Lisboa	Caldeira, D (corresponding author), Univ Lisbon, Fac Med, CCUL, Serv Cardiol,Hosp Univ Santa Maria CHLN,CAML, Ave Prof Egas Moniz, Lisbon, Portugal.; Caldeira, D (corresponding author), Univ Lisbon, Fac Med, Lab Farmacol Clin & Terapeut, Ave Prof Egas Moniz, Lisbon, Portugal.; Caldeira, D (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol, Ave Prof Egas Moniz, Lisbon, Portugal.	dgcaldeira@hotmail.com	Pinto, Fausto/G-9363-2015; Caldeira, Daniel/AAJ-7974-2020; PINTO, FAUSTO J/GQA-4584-2022; Ferreira, Joaquim/AAA-1837-2020	Pinto, Fausto/0000-0002-8034-4529; Caldeira, Daniel/0000-0002-2520-5673; PINTO, FAUSTO J/0000-0002-8034-4529; 	Fundacao para a Ciencia e a Tecnologia (FCT)/Ministerio da Ciencia, Tecnologia e Ensino Superior (MCTES) through Fundos do Orcamento de Estado [UID/BIM/50005/2019]	Fundacao para a Ciencia e a Tecnologia (FCT)/Ministerio da Ciencia, Tecnologia e Ensino Superior (MCTES) through Fundos do Orcamento de Estado	UID/BIM/50005/2019, project funded by Fundacao para a Ciencia e a Tecnologia (FCT)/Ministerio da Ciencia, Tecnologia e Ensino Superior (MCTES) through Fundos do Orcamento de Estado. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, SUMMARY PRODUCT CHAR; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Borenstein M, 2017, RES SYNTH METHODS, V8, P5, DOI 10.1002/jrsm.1230; Brown JR, 2017, HAEMATOLOGICA, V102, P1796, DOI 10.3324/haematol.2017.171041; Burger JA, 2015, NEW ENGL J MED, V373, P2425, DOI 10.1056/NEJMoa1509388; Byrd JC, 2014, NEW ENGL J MED, V371, P213, DOI 10.1056/NEJMoa1400376; Byrd JC, 2015, BLOOD, V125, P1673, DOI 10.1182/blood-2015-01-621466; Caldeira D, 2014, J THROMB HAEMOST, V12, P650, DOI 10.1111/jth.12544; Caldeira D., 2013, COCHRANE DB SYST REV, V4; Caldeira D, 2018, DRUG SAFETY, V41, P77, DOI 10.1007/s40264-017-0586-2; Caldeira D, 2017, REV PORT CARDIOL, V36, P577, DOI 10.1016/j.repc.2016.12.012; Caldeira D, 2015, AM J CARDIOVASC DRUG, V15, P259, DOI 10.1007/s40256-015-0132-5; Caldeira D, 2015, PHARMACOEPIDEM DR S, V24, P757, DOI 10.1002/pds.3791; Caldeira D, 2015, J NEUROL, V262, P516, DOI 10.1007/s00415-014-7462-0; Caldeira D, 2014, AM J CARDIOVASC DRUG, V14, P303, DOI 10.1007/s40256-014-0071-6; Caldeira D, 2014, HEART, V100, P550, DOI 10.1136/heartjnl-2013-305288; Caldeira D, 2013, ACTA MEDICA PORT, V26, P490; Caldeira D, 2012, ARCH CARDIOVASC DIS, V105, P226, DOI 10.1016/j.acvd.2011.11.005; Caldeira D, 2011, EUR J INTERN MED, V22, P448, DOI 10.1016/j.ejim.2011.05.001; Chanan-Khan A, 2016, LANCET ONCOL, V17, P200, DOI 10.1016/S1470-2045(15)00465-9; Chao TF, 2015, J AM COLL CARDIOL, V65, P635, DOI 10.1016/j.jacc.2014.11.046; Dimopoulos MA, 2018, NEW ENGL J MED, V378, P2399, DOI 10.1056/NEJMoa1802917; Dreyling M, 2016, LANCET, V387, P770, DOI 10.1016/S0140-6736(15)00667-4; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Glanville JM, 2006, J MED LIBR ASSOC, V94, P130; Gouveia M, 2015, REV PORT CARDIOL, V34, P1, DOI 10.1016/j.repc.2014.08.005; Health CTEP-DoCTaDNIo, 2018, COMM TERM CRIT ADV E; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huang XJ, 2018, CANCER MED-US, V7, P1043, DOI 10.1002/cam4.1337; IntHout J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010247; IntHout J, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-25; Kirchhof P, 2016, EUROPACE, V18, DOI [10.1016/j.rec.2016.11.033, 10.1093/europace/euw295, 10.5603/KP.2016.0172]; Leong DP, 2016, BLOOD, V128, P138, DOI 10.1182/blood-2016-05-712828; Lip GYH, 2015, J AM COLL CARDIOL, V65, P1385, DOI 10.1016/j.jacc.2015.01.044; McMullen JR, 2014, BLOOD, V124, P3829, DOI 10.1182/blood-2014-10-604272; Moreno C, 2019, LANCET ONCOL, V20, P43, DOI 10.1016/S1470-2045(18)30788-5; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Rule S, 2018, LEUKEMIA, V32, P1799, DOI 10.1038/s41375-018-0023-2; Schnabel RB, 2015, LANCET, V386, P154, DOI 10.1016/S0140-6736(14)61774-8; Shanafelt TD, 2017, LEUKEMIA LYMPHOMA, V58, P1630, DOI 10.1080/10428194.2016.1257795; Sidik K, 2005, J BIOPHARM STAT, V15, P823, DOI 10.1081/BIP-200067915; Sterne JAC, 2011, COCHRANE HDB SYSTEMA; Thorp BC, 2018, LEUKEMIA LYMPHOMA, V59, P311, DOI 10.1080/10428194.2017.1339874; Veroniki AA, 2019, RES SYNTH METHODS, V10, P23, DOI 10.1002/jrsm.1319; Wong SSL, 2006, J MED LIBR ASSOC, V94, P41; Woyach JA, 2018, IBRUTINIB REGIMENS V, DOI [10.1056/NEJMoa1812836, DOI 10.1056/NEJMOA1812836]; Yun S, 2017, CL LYMPH MYELOM LEUK, V17, P31, DOI 10.1016/j.clml.2016.09.010	48	60	60	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211228	10.1371/journal.pone.0211228	http://dx.doi.org/10.1371/journal.pone.0211228			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785921	Green Submitted, Green Published, gold			2022-12-27	WOS:000459307000019
J	Godwin, EM; Uglialoro, AD; Ali, A; Yearwood, L; Banerji, MA; Kral, JG				Godwin, Ellen M.; Uglialoro, Anthony D.; Ali, Andaleeb; Yearwood, Leah; Banerji, Mary Ann; Kral, John G.			A pilot study of metabolic fitness effects of weight-supported walking in women with obesity	PLOS ONE			English	Article							BODY POSITIVE-PRESSURE; PHYSICAL-ACTIVITY; GLYCEMIC CONTROL; RISK MARKERS; EXERCISE; APPETITE; TRIGLYCERIDES; OVERWEIGHT; RESPONSES; BEHAVIOR	Background This is an exploratory pilot study of novel technology enabling people with mobility disability to walk with minimal effort, in the "sedentary range". The study's premise is that impairment of the leading physical activity of daily living, walking, is a major contributor to a dysmetabolic state driving many prevalent "civilization diseases" associated with insulin resistance. Methods We explore within-subject changes in standard oral glucose tolerance (OGT) tests including metabotropic molecules after 22 twice-weekly, 30-minute bouts of weight-supported light-moderate physical activity in 16 non-diabetic obese, otherwise healthy, reproductive-age, volunteer women walking on an "anti-gravity" lower-body positive pressure (LBPP) treadmill. Results Subjects had reference base-line fasting plasma glucose and triglycerides (TG) but 2-hr OGT insulin levels of 467 +/- 276 pmol . liter(-1) (mean +/- S.D.) indicating nascent insulin resistance, compared to post-study 308 +/- 179 (p = 0.002). Fasting TG decreased from 0.80 +/- 0.30 mmol . liter(-1) to 0.71 0.25 (p = 0.03). Concomitantly plasma total ghrelin decreased from 69.6 +/- 41.6 pmol . liter(-1) to 56.0 +/- 41.3 (p = 0.008). There were no statistically significant changes in body weight or any correlations between weight change and cardiometabolic markers. However, there were robust positive correlations between changes among different classes of peptides including C-reactive protein-Interleukin 6, leptin-adiponectin, beta-endorphin oxytocin and orexin A (r(2) = 0.48-0.88). Conclusion We conclude that brief, low-dose physical activity, walking on an anti-gravity LBPP treadmill may improve cardiometabolic risk, exhibiting favorable changes in neuro-regulatory peptides without weight loss in people with problems walking.	[Godwin, Ellen M.] Long Isl Univ, Dept Phys Therapy, Brooklyn, NY USA; [Godwin, Ellen M.] Suny Downstate Med Ctr, Dept Orthoped Rehabil, Brooklyn, NY 11203 USA; [Uglialoro, Anthony D.; Kral, John G.] Suny Downstate Med Ctr, Dept Surg, Brooklyn, NY 11203 USA; [Ali, Andaleeb; Yearwood, Leah; Banerji, Mary Ann; Kral, John G.] Suny Downstate Med Ctr, Dept Med, Brooklyn, NY 11203 USA; [Ali, Andaleeb] Providence Med Grp, Mobile, AL USA; [Yearwood, Leah] Cape Fear Valley Med Ctr, Fayetteville, NC USA	Long Island University-Brooklyn Campus; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Kral, JG (corresponding author), Suny Downstate Med Ctr, Dept Surg, Brooklyn, NY 11203 USA.; Kral, JG (corresponding author), Suny Downstate Med Ctr, Dept Med, Brooklyn, NY 11203 USA.	jkral@downstate.edu		KRAL, John/0000-0003-0842-664X				Afzal A, 2014, J AM SOC HYPERTENS, V8, P388, DOI 10.1016/j.jash.2014.03.004; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Bailey DP, 2016, APPL PHYSIOL NUTR ME, V41, P324, DOI 10.1139/apnm-2015-0462; Baker PRA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008366.pub3; Batacan RB, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/596367; Beaulieu K, 2018, PHYSIOL BEHAV, V192, P23, DOI 10.1016/j.physbeh.2017.12.032; BJORNTORP P, 1970, METABOLIS, V19, P631, DOI 10.1016/0026-0495(70)90020-X; Blevins JE, 2013, REV ENDOCR METAB DIS, V14, P311, DOI 10.1007/s11154-013-9260-x; Bos I, 2013, MED SCI SPORT EXER, V45, P439, DOI 10.1249/MSS.0b013e31827767fc; Brito JP, 2017, JAMA-J AM MED ASSOC, V317, P635, DOI 10.1001/jama.2016.20563; CarterNolan PL, 1996, J NATL MED ASSOC, V88, P558; Chastin SFM, 2015, OBESITY, V23, P1800, DOI 10.1002/oby.21180; Coplan JD, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/917981; Cutuk A, 2006, J APPL PHYSIOL, V101, P771, DOI 10.1152/japplphysiol.00644.2005; DeBoer LB, 2012, EXPERT REV NEUROTHER, V12, P1011, DOI 10.1586/ERN.12.73; Dohrn IM, 2018, CLIN EPIDEMIOL, V10, P179, DOI 10.2147/CLEP.S151613; Dulloo AG, 2018, EUR J CLIN NUTR, V72, P657, DOI 10.1038/s41430-018-0138-6; Duvivier BMFM, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00353; Eiken O, 1987, Acta Physiol Scand Suppl, V566, P1; Ellingsgaard H, 2011, NAT MED, V17, P1481, DOI 10.1038/nm.2513; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Figueroa MA, 2012, INT J APPL SCI TECHN, V2, P204; Francois ME, 2014, DIABETOLOGIA, V57, P1437, DOI 10.1007/s00125-014-3244-6; Freedhoff Y, 2016, LANCET, V388, P849, DOI 10.1016/S0140-6736(16)31338-1; Herisson FM, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12381; Herman AM, 2016, NATURE, V538, P253, DOI 10.1038/nature19789; Heymsfield SB, 2017, NEW ENGL J MED, V376, P1492, DOI 10.1056/NEJMc1701944; Inoue K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128720; Ito N, 2008, NEUROSCIENCE, V157, P720, DOI 10.1016/j.neuroscience.2008.09.042; Koehl M, 2008, FASEB J, V22, P2253, DOI 10.1096/fj.07-099101; KRAL JG, 1977, METABOLISM, V26, P1025, DOI 10.1016/0026-0495(77)90020-8; Kritchevsky SB, 2017, OBESITY, V25, P1199, DOI 10.1002/oby.21860; Larson-Meyer DE, 2012, J OBES, V2012, DOI 10.1155/2012/730409; Lee KY, 2016, ANN REHABIL MED-ARM, V40, P915, DOI 10.5535/arm.2016.40.5.915; Lin SX, 2011, METAB SYNDR RELAT D, V9, P35, DOI 10.1089/met.2010.0050; MacLean PS, 2015, OBESITY, V23, P7, DOI 10.1002/oby.20967; Malkova D, 2008, HORM METAB RES, V40, P410, DOI 10.1055/s-2008-1058100; MAYER J, 1967, SCIENCE, V156, P328, DOI 10.1126/science.156.3773.328; Mudaliar U, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002095; Nordestgaard BG, 2014, LANCET, V384, P626, DOI 10.1016/S0140-6736(14)61177-6; Pedersen BK, 2015, SCAND J MED SCI SPOR, V25, P1, DOI 10.1111/sms.12581; Perello M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059625; Pontzer H, 2016, CURR BIOL, V26, P410, DOI 10.1016/j.cub.2015.12.046; Poulimeneas D, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8090174; Proudler AJ, 1996, METABOLISM, V45, P328, DOI 10.1016/S0026-0495(96)90286-3; Rasgon NL, 2016, MOL PSYCHIATR, V21, P1648, DOI 10.1038/mp.2016.162; Riebe D., 2014, ACSMS GUIDELINES EXE, P161; Rifkind JM, 2014, NITRIC OXIDE-BIOL CH, V40, P117, DOI 10.1016/j.niox.2014.06.007; Rodriguez D, 2011, INT J GEN MED, V4, P549, DOI 10.2147/IJGM.S23094; Ropelle ER, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000465; Ross R, 2016, CONTEMP CLIN TRIALS, V47, P275, DOI 10.1016/j.cct.2016.02.001; Salciccioli LF, 2017, J STRENGTH COND RES, V31, pE69, DOI 10.1519/JSC.0000000000000562; Schwartz MW, 2017, ENDOCR REV, V38, P267, DOI 10.1210/er.2017-00111; Shook RP, 2015, AM J CLIN NUTR, V102, P1332, DOI 10.3945/ajcn.115.115360; Simonson S, 2011, CLIN KINESIOL, V65, P29; Solomon TPJ, 2013, J CLIN ENDOCR METAB, V98, P4176, DOI 10.1210/jc.2013-2232; Voulgari C, 2013, METABOLISM, V62, P609, DOI 10.1016/j.metabol.2012.09.005; Whybrow S, 2008, BRIT J NUTR, V100, P1109, DOI 10.1017/S0007114508968240; WILDMANN J, 1986, LIFE SCI, V38, P997, DOI 10.1016/0024-3205(86)90233-X; Zschucke E, 2015, PSYCHONEUROENDOCRINO, V51, P414, DOI 10.1016/j.psyneuen.2014.10.019	60	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211529	10.1371/journal.pone.0211529	http://dx.doi.org/10.1371/journal.pone.0211529			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785891	Green Published, Green Submitted, gold			2022-12-27	WOS:000459307000029
J	Page, AP; Tremblay, J; Masson, L; Greer, CW				Page, Antoine P.; Tremblay, Julien; Masson, Luke; Greer, Charles W.			Nitrogen- and phosphorus-starved Triticum aestivum show distinct belowground microbiome profiles	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; PLANT-GROWTH; USE-EFFICIENCY; WINTER-WHEAT; PADDY RICE; ROOT; BACTERIA; SOIL; RHIZOSPHERE; FERTILIZATION	Many plants have natural partnerships with microbes that can boost their nitrogen (N) and/or phosphorus (P) acquisition. To assess whether wheat may have undiscovered associations of these types, we tested if N/P-starved Triticum aestivum show microbiome profiles that are simultaneously different from those of N/P-amended plants and those of their own bulk soils. The bacterial and fungal communities of root, rhizosphere, and bulk soil samples from the Historical Dryland Plots (Lethbridge, Canada), which hold T. aestivum that is grown both under N/P fertilization and in conditions of extreme N/P-starvation, were taxonomically described and compared (bacterial 16S rRNA genes and fungal Internal Transcribed Spacers ITS). As the list may include novel N- and/or P-providing wheat partners, we then identified all the operational taxonomic units (OTUs) that were proportionally enriched in one or more of the nutrient starvation- and plant-specific communities. These analyses revealed: a) distinct N-starvation root and rhizosphere bacterial communities that were proportionally enriched, among others, in OTUs belonging to families Enterobacteriaceae, Chitinophagaceae, Comamonadaceae, Caulobacteraceae, Cytophagaceae, Streptomycetaceae, b) distinct N-starvation root fungal communities that were proportionally enriched in OTUs belonging to taxa Lulworthia, Sordariomycetes, Apodus, Conocybe, Ascomycota, Crocicreas, c) a distinct P-starvation rhizosphere bacterial community that was proportionally enriched in an OTU belonging to genus Agrobacterium, and d) a distinct P-starvation root fungal community that was proportionally enriched in OTUs belonging to genera Parastagonospora and Phaeosphaeriopsis. Our study might have exposed wheat-microbe connections that can form the basis of novel complementary yield-boosting tools.	[Page, Antoine P.] Natl Res Council Canada, Aquat & Crop Resource Dev Res Ctr, Montreal, PQ, Canada; [Tremblay, Julien; Greer, Charles W.] Natl Res Council Canada, Energy Min & Environm Res Ctr, Montreal, PQ, Canada; [Masson, Luke] Natl Res Council Canada, Human Hlth Therapeut Res Ctr, Montreal, PQ, Canada	National Research Council Canada; National Research Council Canada; National Research Council Canada	Page, AP (corresponding author), Natl Res Council Canada, Aquat & Crop Resource Dev Res Ctr, Montreal, PQ, Canada.	antoine.page@nrc-cnrc.gc.ca		Tremblay, Julien/0000-0002-6085-3481	National Research Council Canada	National Research Council Canada	This research was funded by the National Research Council Canada. Resources were awarded to LM and CWG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bretz F., 2016, MULTIPLE COMP USING; CADE-MENUN BJ, 1991, CAN J BOT, V69, P78, DOI 10.1139/b91-011; Calvo P, 2014, PLANT SOIL, V383, P3, DOI [10.1007/s11104-014-2131-8, 10.1109/BigData.2014.7004461]; Carroll B. J., 1990, Molecular biology of symbiotic nitrogen fixation., P159; Carvalho TLG, 2016, PLANT MOL BIOL, V90, P561, DOI 10.1007/s11103-016-0435-1; Castrillo G, 2017, NATURE, V543, P513, DOI 10.1038/nature21417; Chen XP, 2014, NATURE, V514, P486, DOI 10.1038/nature13609; Czarnecki O, 2013, INT J MOL SCI, V14, P7681, DOI 10.3390/ijms14047681; Duan JF, 2015, PLANT PHYSIOL BIOCH, V96, P199, DOI 10.1016/j.plaphy.2015.08.006; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; El-Tarabily KA, 2006, SOIL BIOL BIOCHEM, V38, P1505, DOI 10.1016/j.soilbio.2005.12.017; Fonseca ED, 2018, MICROB ECOL, V75, P183, DOI 10.1007/s00248-017-1014-y; Foo E, 2013, ANN BOT-LONDON, V111, P769, DOI 10.1093/aob/mct041; Franche C., 2009, Plant and Soil, V321, P35, DOI 10.1007/s11104-008-9833-8; Fuentes-Ramirez LE, 1999, FEMS MICROBIOL ECOL, V29, P117, DOI 10.1016/S0168-6496(98)00125-1; Fukuda M, 2012, SOIL FERTILITY; Gao Y, 2015, MOL PLANT MICROBE IN, V28, P615, DOI 10.1094/MPMI-12-14-0396-R; Glick BR, 2007, CRIT REV PLANT SCI, V26, P227, DOI 10.1080/07352680701572966; Golzar H, 2012, AUSTRALAS PLANT DIS, V7, P13, DOI 10.1007/s13314-011-0035-5; Grassini P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3918; Han JI, 2011, J BACTERIOL, V193, P1183, DOI 10.1128/JB.00925-10; Han M, 2015, ANNU REV GENET, V49, P269, DOI 10.1146/annurev-genet-112414-055037; Hartmann M, 2015, ISME J, V9, P1177, DOI 10.1038/ismej.2014.210; Hasegawa S., 2006, ACTINOMYCETOLOGICA, V20, P72, DOI [10.3209/saj.20.72, DOI 10.3209/SAJ.20.72]; Heffer P., 2016, P INT NITR IN C MELB; Heyneke E, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02048; Hodge A, 2015, PLANT SOIL, V386, P1, DOI 10.1007/s11104-014-2162-1; Huws SA, 2007, J MICROBIOL METH, V70, P565, DOI 10.1016/j.mimet.2007.06.013; Ikeda S, 2011, APPL ENV MICROBIOLOG; Ikeda S, 2014, MICROBES ENVIRON, V29, P50, DOI 10.1264/jsme2.ME13110; Ikeda S, 2010, ISME J, V4, P315, DOI 10.1038/ismej.2009.119; JANZEN HH, 1995, CAN J SOIL SCI, V75, P123, DOI 10.4141/cjss95-016; Johri AK, 2015, FRONT MICROBIOL, V6, DOI [10.3389/fmicb.2015.00934, 10.3389/fmicb.2015.00984]; Kabir Z, 1997, PLANT SOIL, V192, P285, DOI 10.1023/A:1004205828485; Kapulnik Y, 2016, J INTEGR PLANT BIOL, V58, P203, DOI 10.1111/jipb.12454; Kavamura VN, 2018, FRONTIERS MICROBIOLO, V9, DOI [10.3389/fmicb.2018.00009, DOI 10.3389/FMICB.2018.00009]; Kolde R., PHEATMAP PRETTY HEAT; Konishi N, 2017, MICROBES ENVIRON, V32, P314, DOI 10.1264/jsme2.ME17031; LEYVAL C, 1989, PLANT SOIL, V117, P103, DOI 10.1007/BF02206262; Leyval C, 1993, PHOSPHORUS SULFUR, V77, P133; Li HY, 2006, NEW PHYTOL, V172, P536, DOI 10.1111/j.1469-8137.2006.01846.x; Liu HW, 2017, SCI REP-UK, V7, DOI 10.1038/srep41766; Liu YJ, 2012, NEW PHYTOL, V194, P523, DOI 10.1111/j.1469-8137.2012.04050.x; Madhaiyan M, 2015, INT J SYST EVOL MICR, V65, P578, DOI 10.1099/ijs.0.069377-0; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Mahoney AK, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00132; Marcon E, 2015, J STAT SOFTW, V67, P1; Martin KJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-28; Minamisawa K, 2016, MICROBES ENVIRON, V31, P4, DOI 10.1264/jsme2.ME15180; Mitter B, 2016, MICROB BIOTECHNOL, V9, P635, DOI 10.1111/1751-7915.12382; Nabti E, 2014, EUR J SOIL BIOL, V61, P20, DOI 10.1016/j.ejsobi.2013.12.008; Nagahashi G, 2004, MYCOL RES, V108, P1079, DOI 10.1017/S0953756204000693; Nishida H, 2018, CURR OPIN PLANT BIOL, V44, P129, DOI 10.1016/j.pbi.2018.04.006; Oksanen J., VEGAN PACKAGE COMMUN; Oldroyd GED, 2011, ANNU REV GENET, V45, P119, DOI 10.1146/annurev-genet-110410-132549; Pantigoso HA, 2018, RHIZOSPHERE-NETH, V7, P1, DOI 10.1016/j.rhisph.2018.06.008; Reay DS, 2012, NAT CLIM CHANGE, V2, P410, DOI 10.1038/NCLIMATE1458; Robertson GP, 2009, ANNU REV ENV RESOUR, V34, P97, DOI 10.1146/annurev.environ.032108.105046; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Robinson RJ, 2016, PLANT SOIL, V405, P381, DOI 10.1007/s11104-015-2495-4; Sagar A., 2018, INT J AGR ENV BIOTEC, V11, P159; Sala S, 2017, J CLEAN PROD, V140, P387, DOI 10.1016/j.jclepro.2016.09.054; Santos KFDN, 2017, PLANT SOIL, V415, P245, DOI 10.1007/s11104-016-3140-6; Sasse J, 2018, TRENDS PLANT SCI, V23, P25, DOI 10.1016/j.tplants.2017.09.003; Schlaeppi K, 2015, MOL PLANT MICROBE IN, V28, P212, DOI 10.1094/MPMI-10-14-0334-FI; SHAFFER JP, 1995, ANNU REV PSYCHOL, V46, P561, DOI 10.1146/annurev.ps.46.020195.003021; Sharpley A, 2016, SCI AGR, V73, P1, DOI 10.1590/0103-9016-2015-0107; Siciliano SD, 1999, FEMS MICROBIOL ECOL, V29, P263, DOI 10.1111/j.1574-6941.1999.tb00617.x; Sommermann L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195345; Steffen W, 2015, SCIENCE, V347, DOI 10.1126/science.1259855; Toju H, 2018, NAT PLANTS, V4, P247, DOI 10.1038/s41477-018-0139-4; Tremblay J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00771; Treseder KK, 2004, NEW PHYTOL, V164, P347, DOI 10.1111/j.1469-8137.2004.01159.x; Van Vuuren DP, 2010, GLOBAL ENVIRON CHANG, V20, P428, DOI 10.1016/j.gloenvcha.2010.04.004; Vicre M, 2005, PLANT PHYSIOL, V138, P998, DOI 10.1104/pp.104.051813; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yoneyama T, 2017, SOIL SCI PLANT NUTR, V63, P578, DOI 10.1080/00380768.2017.1407625; Zgadzaj R, 2016, P NATL ACAD SCI USA, V113, pE7996, DOI 10.1073/pnas.1616564113; Zhang Y, 2017, PLANT PHYSIOL BIOCH, V111, P30, DOI 10.1016/j.plaphy.2016.11.009; Zhu SS, 2016, APPL SOIL ECOL, V107, P324, DOI 10.1016/j.apsoil.2016.07.009	80	15	16	7	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0210538	10.1371/journal.pone.0210538	http://dx.doi.org/10.1371/journal.pone.0210538			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785878	Green Published, Green Submitted, gold			2022-12-27	WOS:000459307000012
J	Cegolon, L; Mastrangelo, G; Campbell, OM; Giangreco, M; Alberico, S; Montasta, L; Ronfani, L; Barbone, F				Cegolon, Luca; Mastrangelo, Giuseppe; Campbell, Oona M.; Giangreco, Manuela; Alberico, Salvatore; Montasta, Lorenzo; Ronfani, Luca; Barbone, Fabio			Length of stay following cesarean sections: A population based study in the Friuli Venezia Giulia region (North-Eastern Italy), 2005-2015	PLOS ONE			English	Article							EARLY HOSPITAL DISCHARGE; ENHANCED RECOVERY; DELIVERY; NEWBORN; COMPLICATIONS; READMISSIONS; MORTALITY; OUTCOMES; RATES; CARE	Background Births by cesarean section (CS) usually require longer recovery time, and as a result women remain hospitalized longer following CS than vaginal delivery (VD). A number of strategies have been proposed to reduce avoidable health care costs associated with childbirth. Among these, the containment of length of hospital stay (LoS) has been identified as an important quality indicator of obstetric care and performance efficiency of maternity centres. Since improvement of obstetric care at hospital level needs quantitative evidence, we compared the maternity services of an Italian region on LoS post CS. Methods We conducted a population-based study in Friuli Venezia Giulia (FVG), a region of North-Eastern Italy, collecting data from all its 12 maternity centres (coded from A to K) during 2005-2015. We fitted a multivariable logistic regression using LoS as a binary outcome, higher/lower than the international early discharge (ED) cutoffs for CS (4 days), controlling for hospitals as well as several factors related to the clinical conditions of the mothers and the newborn, the obstetric history and socio-demographic background. Results were expressed as adjusted odds ratios (aOR) with 95% confidence interval (95% CI). Population attributable risks (PARs) were also calculated as proportional variation of LoS>ED for each hospital in the ideal scenario of having the same performance as centre J (the reference) during calendar year 2015. Results were expressed as PAR with 95% CI. Differences in mean LoS were also investigated with a multivariable linear regression model including the same explanatory factors of the above multiple logistic regression. Results were expressed as adjusted regression coefficients (aRC) with 95% CI. Results Although decreasing over the years (5.0 +/- 1.7 days in 2005 vs. 4.4 +/- 1.7 days in 2015), the pooled mean LoS in the whole FVG during these 11 years was still 4.7 +/- 1.7 days, higher than respective international ED benchmark. The significant decreasing trend of LoS>ED over time in FVG (aOR = 0.89; 95% CI: 0.88; 0.90) was marginal as compared to the variability of LoS>ED observed among the various maternity services. Regardless it was expressed as aRC or aOR, LoS after CS was lowest in hospital C, highest in hospital D and intermediate in centres I, K, G, F, A, H, E, B and J (in descending order). The aOR of LoS being longer than ED ranged from 1.63 (95% CI: 1.46; 1.81) in hospital B up to 32.09 (95% CI: 25.68; 40.10) in facility D. When hospitals were ranked by PAR the same pattern was found, even if restricting the analysis to low risk pregnancies. Conclusions Although significantly decreasing over time, the mean LoS in FVG during 2005-2015 was 4.7 days, higher than the international threshold recommended for CS. There was substantial variability in LoS by facility centre, suggesting that internal organizational processes of single hospitals should be improved by enforcing standardized guidelines and using audits, economic incentives and penalties if need be.	[Cegolon, Luca; Giangreco, Manuela; Alberico, Salvatore; Montasta, Lorenzo; Ronfani, Luca; Barbone, Fabio] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy; [Cegolon, Luca] Publ Hlth Dept, Local Hlth Unit Marca Trevigiana 2, Treviso, Veneto Region, Italy; [Mastrangelo, Giuseppe] Univ Padua, Dept Cardiothorac & Vasc Sci, Padua, Italy; [Campbell, Oona M.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, MARCH Ctr, London, England	IRCCS Burlo Garofolo; University of Padua; University of London; London School of Hygiene & Tropical Medicine	Cegolon, L (corresponding author), IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy.; Cegolon, L (corresponding author), Publ Hlth Dept, Local Hlth Unit Marca Trevigiana 2, Treviso, Veneto Region, Italy.	l.cegolon@gmail.com	Monasta, Lorenzo/B-1388-2012; Barbone, Fabio/K-1755-2014; GIANGRECO, Manuela/R-7555-2016	Monasta, Lorenzo/0000-0001-7774-548X; Barbone, Fabio/0000-0001-8795-9959; GIANGRECO, Manuela/0000-0002-4479-3087; Cegolon, Luca/0000-0002-6285-7355	IRCCS "Burlo Garofolo"	IRCCS "Burlo Garofolo"	This study was funded by special programs5 parts per thousand for health research 2014 of IRCCS "Burlo Garofolo". There was no additional external funding received for this study.	Adams EK, 2002, HEALTH ECON, V11, P193, DOI 10.1002/hec.660; Ahlen KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164126; Bertino E, 2010, J PEDIATR GASTR NUTR, V51, P353, DOI 10.1097/MPG.0b013e3181da213e; Betran AP, 2007, PAEDIATR PERINAT EP, V21, P98, DOI 10.1111/j.1365-3016.2007.00786.x; Betran AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148343; Betran AP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097769; Blumenfeld YJ, 2015, AM J PERINAT, V32, P825, DOI 10.1055/s-0034-1543953; BROOTEN D, 1994, OBSTET GYNECOL, V84, P832; Buie VC, 2010, VITAL HLTH STAT, V168, P1; Campbell O, 2016, PLOS MED, P1; Cattin A, 2017, GYNECOL OBST FERT SE, V45, P202, DOI 10.1016/j.gofs.2017.02.006; Cegolon L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0204919; Centers for Disease Control and Prevention, 2016, PREGN COMPL; Chu SY, 2008, NEW ENGL J MED, V358, P1444, DOI 10.1056/NEJMoa0706786; Clark SL, 2018, AM J OBSTET GYNECOL, V219, P267, DOI 10.1016/j.ajog.2018.04.044; Corso E, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1265-0; Datar A, 2006, PEDIATRICS, V118, P63, DOI 10.1542/peds.2005-3044; Declercq E, 2007, OBSTET GYNECOL, V109, P669, DOI 10.1097/01.AOG.0000255668.20639.40; Eriksen HM, 2009, J NORW MED ASS, V129, P618, DOI [10.4045/tidsskr.09.24093, DOI 10.4045/TIDSSKR.09.24093]; Feng XL, 2012, B WORLD HEALTH ORGAN, V90, P30, DOI 10.2471/BLT.11.090399; Fink AM, 2011, JOGNN-J OBST GYN NEO, V40, P149, DOI 10.1111/j.1552-6909.2011.01225.x; Ford JB, 2012, AUST NZ J PUBL HEAL, V36, P430, DOI 10.1111/j.1753-6405.2012.00882.x; Glied S., 2011, OXFORD HDB HLTH EC; Gruber J, 1999, J HEALTH ECON, V18, P473, DOI 10.1016/S0167-6296(99)00009-0; Grullon KE, 1997, OBSTET GYNECOL, V90, P860, DOI 10.1016/S0029-7844(97)00405-5; Gruskay JA, 2016, CLIN SPINE SURG, V29, pE34, DOI 10.1097/BSD.0000000000000080; Gunnarsdottir J, 2011, LAEKNABLADID, V97, P407, DOI 10.17992/lbl.2011.0708.380; He ZF, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5685261; Karanika S, 2016, ANTIMICROB AGENTS CH, V60, P4840, DOI 10.1128/AAC.00825-16; Kim SJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188612; Kitching AJ, 2009, BJA EDUC, V9, P39, DOI 10.1093/bjaceaccp/mkp006; Lewis R, 2015, IMPROVING LENGTH STA; Li HT, 2015, AM J CLIN NUTR, V101, P523, DOI 10.3945/ajcn.114.092585; Liu SL, 2007, CAN MED ASSOC J, V176, P455, DOI 10.1503/cmaj.060870; Liu S, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1698-0; Mamun AA, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-62; Mathauer I, 2013, B WORLD HEALTH ORGAN, V91, P746, DOI 10.2471/BLT.12.115931; Metcalfe A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012007; Morgan KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094532; Morris MS, 2014, JAMA SURG, V149, P348, DOI 10.1001/jamasurg.2013.4064; Niranjan N, 2010, UPDATE ANAESTH, V26, P18; OECD, 2017, TACKL WAST SPEND HLT; Oliphant SS, 2010, OBSTET GYNECOL, V116, P926, DOI 10.1097/AOG.0b013e3181f38599; Paul IM, 2006, PEDIATRICS, V118, P2349, DOI 10.1542/peds.2006-2043; Petrou S, 2013, APPL HEALTH ECON HEA, V11, P561, DOI 10.1007/s40258-013-0063-8; Raleigh VS, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1702; Luna MS, 2009, AN PEDIATR, V71, P349, DOI 10.1016/j.anpedi.2009.07.012; Torloni MR, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-78; Torloni MR, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d276; Tura AK, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020520; Vendittelli F, 2005, REV EPIDEMIOL SANTE, V53, P373, DOI 10.1016/S0398-7620(05)84619-X; Vendittelli F, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-135; Watt Susan, 2005, BMC Pregnancy Childbirth, V5, P13, DOI 10.1186/1471-2393-5-13; Westert GP, 2002, HEALTH POLICY, V61, P269, DOI 10.1016/S0168-8510(01)00236-6; World Health Organization, 2015, WHO STAT CES SECT RA	55	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0210753	10.1371/journal.pone.0210753	http://dx.doi.org/10.1371/journal.pone.0210753			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM9LQ	30811413	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000459806400010
J	Makondi, PT; Wei, PL; Huang, CY; Chang, YJ				Makondi, Precious Takondwa; Wei, Po-Li; Huang, Chien-Yu; Chang, Yu-Jia			Development of novel predictive miRNA/target gene pathways for colorectal cancer distance metastasis to the liver using a bioinformatic approach	PLOS ONE			English	Article							MICRORNA EXPRESSION PROFILES; EXTRACELLULAR VESICLES; DIAGNOSTIC BIOMARKERS; SURVIVAL; EXOSOMES; INVASION; GROWTH; HSA-MIR-619-5P; PROLIFERATION; STATISTICS	Background Liver metastases are the major cause of colorectal cancer (CRC)-related deaths. However, there is no reliable clinical predictor for CRC progression to liver metastasis. In this study, we investigated possible predictors (miRNAs and biomarkers) for clinical application. Methodology The Gene Expression Omnibus (GEO) datasets GSE49355, GSE41258 and GSE81558 for genes and GSE54088 and GSE56350 for miRNAs were used to identify common differentially expressed genes (DEGs) and miRNAs between primary CRC tissues and liver metastases. The identified miRNAs and their targets from the DEGs were verified in datasets comprising gene, miRNA and miRNA exosome profiles of CRC patients with no distant metastases (M0) and distant metastases (M1); the interaction networks and pathways were also mapped. Results There were 49 upregulated and 13 downregulated DEGs and 16 downregulated and 14 upregulated miRNAs; between the DEGs and miRNA targets, there were five upregulated and four downregulated genes. MiR-20a was strongly correlated with the status of liver metastasis. MiR-20a, miR499a, and miR-576-5p were highly correlated with the metastatic outcomes. MiR-20a was significantly highly expressed in the M1 group. In an analysis of the miRNA target genes, we found that CDH2, KNG1, and MMP2 were correlated with CRC metastasis. We demonstrated a new possible pathway for CRC metastasis: miR-576-5p/F9, miR20a/MMP2, CTSK, MMP3, and miR449a/P2RY14. The regulation of IGF transport and uptake by IGFBPs, extracellular matrix organization, signal transduction and the immune system were the enriched pathways. Conclusion This model can predict CRC to liver metastases and the pathways involved, which can be clinically applicable.	[Makondi, Precious Takondwa; Chang, Yu-Jia] Taipei Med Univ, Int PhD Program Med, Taipei, Taiwan; [Makondi, Precious Takondwa; Chang, Yu-Jia] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Wei, Po-Li] Taipei Med Univ, Taipei Med Univ Hosp, Dept Surg, Div Colorectal Surg, Taipei, Taiwan; [Wei, Po-Li; Huang, Chien-Yu] Taipei Med Univ, Coll Med, Dept Surg, Taipei, Taiwan; [Wei, Po-Li; Chang, Yu-Jia] Taipei Med Univ, Taipei Med Univ Hosp, Canc Res Ctr, Taipei, Taiwan; [Wei, Po-Li; Chang, Yu-Jia] Taipei Med Univ, Taipei Med Univ Hosp, Dept Med Res, Translat Lab, Taipei, Taiwan; [Wei, Po-Li] Taipei Med Univ, Grad Inst Canc Biol & Drug Discovery, Taipei, Taiwan; [Huang, Chien-Yu] Taipei Med Univ, Shuang Ho Hosp, Dept Surg, Div Gen Surg, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital	Chang, YJ (corresponding author), Taipei Med Univ, Int PhD Program Med, Taipei, Taiwan.; Chang, YJ (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan.; Huang, CY (corresponding author), Taipei Med Univ, Coll Med, Dept Surg, Taipei, Taiwan.; Chang, YJ (corresponding author), Taipei Med Univ, Taipei Med Univ Hosp, Canc Res Ctr, Taipei, Taiwan.; Chang, YJ (corresponding author), Taipei Med Univ, Taipei Med Univ Hosp, Dept Med Res, Translat Lab, Taipei, Taiwan.; Huang, CY (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Surg, Div Gen Surg, Taipei, Taiwan.	cyh@tmu.edu.tw; r5424012@tmu.edu.tw						Abba M, 2015, GENOM DATA, V6, P33, DOI 10.1016/j.gdata.2015.08.001; Akgul O, 2014, WORLD J GASTROENTERO, V20, P6113, DOI 10.3748/wjg.v20.i20.6113; Arnold M, 2017, GUT, V66, P683, DOI 10.1136/gutjnl-2015-310912; Bai ZG, 2017, CELL PHYSIOL BIOCHEM, V44, P1882, DOI 10.1159/000485877; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Borner MM, 1999, ANN ONCOL, V10, P623, DOI 10.1023/A:1008353227103; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Buzas EI, 2014, NAT REV RHEUMATOL, V10, P356, DOI 10.1038/nrrheum.2014.19; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Clough E, 2016, METHODS MOL BIOL, V1418, P93, DOI 10.1007/978-1-4939-3578-9_5; de Krijger I, 2011, J PATHOL, V224, P438, DOI 10.1002/path.2922; Del Rio M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074599; Drusco A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096670; Engstrand J, 2018, BMC CANCER, V18, DOI 10.1186/s12885-017-3925-x; Eschrich S, 2005, J CLIN ONCOL, V23, P3526, DOI 10.1200/JCO.2005.00.695; Eslamizadeh S, 2018, CELL J, V20, P220, DOI 10.22074/cellj.2018.5366; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Franz M, 2018, NUCLEIC ACIDS RES, V46, pW60, DOI 10.1093/nar/gky311; Georges RB, 2011, CANCER BIOL THER, V12, P69, DOI 10.4161/cbt.12.1.15719; Giannelli F, 1996, BAILLIERE CLIN HAEM, V9, P211, DOI 10.1016/S0950-3536(96)80059-X; House MG, 2010, J AM COLL SURGEONS, V210, P744, DOI 10.1016/j.jamcollsurg.2009.12.040; Jonsson K, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/568214; Kalluri R, 2016, J CLIN INVEST, V126, P1208, DOI 10.1172/JCI81135; Kim KY, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-283; Kim KY, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-218; Knyazev EN, 2016, B EXP BIOL MED+, V161, P108, DOI 10.1007/s10517-016-3357-7; Lan YT, 2012, INT J COLORECTAL DIS, V27, P657, DOI 10.1007/s00384-011-1366-6; Landreau P, 2015, J GASTROEN HEPATOL, V30, P82, DOI 10.1111/jgh.12685; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li ZY, 2012, ONCOL LETT, V3, P346, DOI 10.3892/ol.2011.497; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Maas SLN, 2017, TRENDS CELL BIOL, V27, P172, DOI 10.1016/j.tcb.2016.11.003; Manfredi S, 2006, ANN SURG, V244, P254, DOI 10.1097/01.sla.0000217629.94941.cf; Sayagues JM, 2016, ONCOTARGET, V7, P72908, DOI 10.18632/oncotarget.12140; Marisa L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001453; Michael MZ, 2003, MOL CANCER RES, V1, P882; Mudduluru G, 2015, CANCER RES, V75, P3010, DOI 10.1158/0008-5472.CAN-15-0997; Muhammad S, 2014, WORLD J GASTROENTERO, V20, P17011, DOI 10.3748/wjg.v20.i45.17011; Nannini M, 2009, CANCER TREAT REV, V35, P201, DOI 10.1016/j.ctrv.2008.10.006; Niki M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10500-0; Ogata-Kawata H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092921; Oshima T, 2008, ONCOL REP, V20, P359, DOI 10.3892/or_00000015; Pawlik TM, 2008, ONCOLOGIST, V13, P51, DOI 10.1634/theoncologist.2007-0142; Pawlik TM, 2007, J GASTROINTEST SURG, V11, P1057, DOI 10.1007/s11605-006-0061-3; Penna C, 2002, SURG CLIN N AM, V82, P1075, DOI 10.1016/S0039-6109(02)00051-8; Pizzini S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-589; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Sempere LF, 2011, EXPERT REV MOL DIAGN, V11, P813, DOI [10.1586/ERM.11.69, 10.1586/erm.11.69]; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sheffer M, 2009, P NATL ACAD SCI USA, V106, P7131, DOI 10.1073/pnas.0902232106; Shkurnikov MY, 2017, B EXP BIOL MED+, V163, P475, DOI 10.1007/s10517-017-3831-x; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Sommer SS, 2001, MUTAT RES-DNA REPAIR, V487, P1, DOI 10.1016/S0921-8777(01)00108-2; STANGL R, 1994, LANCET, V343, P1405, DOI 10.1016/S0140-6736(94)92529-1; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Tokar T, 2018, NUCLEIC ACIDS RES, V46, pD360, DOI 10.1093/nar/gkx1144; Tsalis K, 2018, J BUON, V23, P1640; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Van Cutsem E, 2006, EUR J CANCER, V42, P2212, DOI 10.1016/j.ejca.2006.04.012; Venny O.J.C., INTERACTIVE TOOL COM; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang YN, 2017, EUR J MED RES, V22, DOI 10.1186/s40001-017-0294-5; Weidle UH, 2015, CLIN EXP METASTAS, V32, P623, DOI 10.1007/s10585-015-9732-3; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Wu G., 2014, REACTOMEFIVIZ CYTOSC, V3, P146, DOI DOI 10.12688/F1000RESEARCH.4431.2; Xu T, 2015, EXP THER MED, V10, P683, DOI 10.3892/etm.2015.2538; Yan LK, 2017, BIOMED PHARMACOTHER, V96, P974, DOI 10.1016/j.biopha.2017.11.138; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066; Yang LQ, 2016, CANCER MED-US, V5, P2022, DOI 10.1002/cam4.760; Yao H, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20180441; Zekri ARN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154130; Zhou BG, 2016, MOL CARCINOGEN, V55, P2260, DOI 10.1002/mc.22466; Zvibel I, 2013, CLIN EXP METASTAS, V30, P189, DOI 10.1007/s10585-012-9527-8	77	15	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0211968	10.1371/journal.pone.0211968	http://dx.doi.org/10.1371/journal.pone.0211968			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807603	gold, Green Published, Green Submitted			2022-12-27	WOS:000459712100008
J	Chen, J; He, S				Chen, Jie; He, Shan			Drug-induced sleep endoscopy-directed adenotonsillectomy in pediatric obstructive sleep apnea with small tonsils	PLOS ONE			English	Article							UPPER AIRWAY; TONSILLECTOMY; POLYSOMNOGRAPHY; DIAGNOSIS; SEDATION; PROPOFOL; AWAKE	The study aims to examine drug-induced sleep endoscopy (DISE) in the decision-making process of pediatric obstructive sleep apnea (OSA) patients with small tonsils. This was a retrospective study of children who underwent awake flexible endoscopy, DISE, and adenoidectomy with/without tonsillectomy at the Shanghai Children's Medical Center between 03/ 2015 and 12/2016. Tonsillectomy was performed for tonsillar obstruction found by DISE. Adenoidectomy was performed for all children. Cardio-pulmonary coupling (CPC) and oximetry were observed before/after surgery. The study included 126 children: 56 (44.4%) with grade 2 tonsils and 70 (55.6%) with grade 1. Mean age was 5.7 3.2 (range, 2.8-10.4) years and mean BMI of 15.7 5.5 kg/m2. Unexpectedly, DISE showed tonsillar obstruction in 57 (45.2%) children, including 44 (78.6%) with grade 2 tonsils and 13 (18.6%) with grade 1. Therefore, DISE-directed tonsillectomy was performed for 57 patients. There was an improvement in respiratory disturbance index (RDI) and oxygen saturation nadir in the DISE (P = 0.0007, P = 0.037) and control (P = 0.001, P = 0.023) groups 6 months after surgery, but RDI improvement was better in the DISE group compared with controls 1 year after surgery (P = 0.042). DISE is a good way to determine the necessity of tonsillectomy in pediatric OSA patients with small tonsils.	[Chen, Jie; He, Shan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Otolaryngol, Shanghai, Peoples R China	Shanghai Jiao Tong University	He, S (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Otolaryngol, Shanghai, Peoples R China.	heshan@scmc.com.cn			Shenkang Three-Year Clinical Action Plan-Appropriate Technical Promotion Projects [16CR4008A]; Shanghai Jiao Tong University Medical-Engineering Cross Fund [YG2017QN32]	Shenkang Three-Year Clinical Action Plan-Appropriate Technical Promotion Projects; Shanghai Jiao Tong University Medical-Engineering Cross Fund	This study was supported by the Shenkang Three-Year Clinical Action Plan-Appropriate Technical Promotion Projects (No. 16CR4008A) and Shanghai Jiao Tong University Medical-Engineering Cross Fund (YG2017QN32).	Baugh RF, 2011, OTOLARYNG HEAD NECK, V144, pS1, DOI 10.1177/0194599810389949; BRODSKY L, 1989, PEDIATR CLIN N AM, V36, P1551; Campanini A, 2010, ACTA OTORHINOLARYNGO, V30, P73; Cavaliere M, 2013, LARYNGOSCOPE, V123, P2315, DOI 10.1002/lary.23881; Chan DK, 2014, JAMA OTOLARYNGOL, V140, P595, DOI 10.1001/jamaoto.2014.612; CROFT CB, 1991, CLIN OTOLARYNGOL, V16, P504, DOI 10.1111/j.1365-2273.1991.tb01050.x; Dijemeni E, 2017, SLEEP BREATH, V21, P983, DOI 10.1007/s11325-017-1521-6; Edwards BA, 2011, HEAD NECK-J SCI SPEC, V33, pS37, DOI 10.1002/hed.21841; Ehsan Z, 2016, LARYNGOSCOPE, V126, P270, DOI 10.1002/lary.25399; Eikermann M, 2008, ANESTHESIOLOGY, V108, P897, DOI 10.1097/ALN.0b013e31816c8a60; Esteller E, 2016, ACTA OTORRINOLAR ESP, V67, P212, DOI 10.1016/j.otorri.2015.09.001; Guo D, 2011, SLEEP MED, V12, P384, DOI 10.1016/j.sleep.2010.09.011; Harrington J, 2013, SLEEP BREATH, V17, P1071, DOI 10.1007/s11325-013-0804-9; Huntley C, 2017, ANN OTO RHINOL LARYN, V126, P478, DOI 10.1177/0003489417703408; Koutsourelakis I, 2012, LARYNGOSCOPE, V122, P2587, DOI 10.1002/lary.23462; Krishnaswamy U, 2015, J POSTGRAD MED, V61, P223, DOI 10.4103/0022-3859.166509; Ma XX, 2012, CHINESE MED J-PEKING, V125, P869, DOI 10.3760/cma.j.issn.0366-6999.2012.05.025; Ong AA, 2016, OTOLARYNG HEAD NECK, V154, P970, DOI 10.1177/0194599816636835; Randel A, 2011, AM FAM PHYSICIAN, V84, P566; Ravesloot Madeline J L, 2017, Adv Otorhinolaryngol, V80, P22, DOI 10.1159/000470816; Roland PS, 2011, OTOLARYNG HEAD NECK, V145, pS1, DOI 10.1177/0194599811409837; Sowho M, 2014, CLIN CHEST MED, V35, P469, DOI 10.1016/j.ccm.2014.06.002; Thomas RJ, 2005, SLEEP, V28, P1151, DOI 10.1093/sleep/28.9.1151; Tunkel DE, 2012, OTOLARYNG HEAD NECK, V146, P191, DOI 10.1177/0194599811429236; Victores AJ, 2017, J CLIN SLEEP MED, V13, P169, DOI 10.5664/jcsm.6438; Villa MP, 2015, JAMA OTOLARYNGOL, V141, P990, DOI 10.1001/jamaoto.2015.2354	26	11	12	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212317	10.1371/journal.pone.0212317	http://dx.doi.org/10.1371/journal.pone.0212317			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794596	Green Published, Green Submitted, gold			2022-12-27	WOS:000459709100054
J	Doulla, BE; Squire, SB; MacPherson, E; Ngadaya, ES; Mutayoba, BK; Langley, I				Doulla, Basra Esmail; Squire, Stephen Bertel; MacPherson, Eleanor; Ngadaya, Esther Stanslaus; Mutayoba, Beatrice Kemilembe; Langley, Ivor			Routine surveillance for the identification of drug resistant Tuberculosis in Tanzania: A cross-sectional study of stakeholders' perceptions	PLOS ONE			English	Article								Background Routine surveillance is required to monitor the performance of tuberculosis diagnostic programme and is essential for the rapid detection of drug resistance. The main objective of this study was to explore the effectiveness and stakeholder perception of the current routine surveillance system for previously treated tuberculosis cases in Tanzania with a view to identify interventions to improve and accelerate positive patient outcomes. Methods A study using quantitative and qualitative methods of data collection including in-depth interviews and focus group discussions with health care service providers was conducted in four regions. Quantitative data were extracted from the routine databases to assess performance. Results Quantitative findings from 2011 to 2013 showed 2,750 specimens from previously treated TB cases were received at the reference laboratory. The number increased year on year, but even in the most recent year was only 61% of that expected. The median and interquartile range of turnaround time in days from specimen reception to results reported for smear microscopy, culture and drug susceptibility testing were 1(1, 1), 61(43, 71) and 129(72, 170) respectively. Contaminated specimens were reported in 3.6% of cases. The qualitative analysis showed the system of sending specimens using postal services was seen to be efficient by participants. However, there were many challenges and significant delays in specimens reaching the reference laboratory associated with lack of funds to transfer specimens, weak form completion, inadequate training and poor supervision. These all adversely affected the implementation of the routine surveillance system. Conclusions Many issues limit the effectiveness of the routine surveillance system in Tanzania. Priority areas for strengthening are; specimen transportation, supervision and availability of commodities. A pilot study of a revised routine surveillance system that takes into account the observations from this study alongside improved access to drug susceptibility testing using Xpert MTB/RIF should be considered.	[Doulla, Basra Esmail; Mutayoba, Beatrice Kemilembe] Minist Hlth Community Dev Gender Elderly & Childr, Dar Es Salaam, Tanzania; [Doulla, Basra Esmail; Mutayoba, Beatrice Kemilembe] Natl TB & Leprosy Programme, Dar Es Salaam, Tanzania; [Doulla, Basra Esmail; Squire, Stephen Bertel; MacPherson, Eleanor; Langley, Ivor] Univ Liverpool Liverpool Sch Trop Med, Ctr Appl Hlth Res & Delivery, Liverpool, Merseyside, England; [Ngadaya, Esther Stanslaus] Muhimbili Med Res Ctr, Natl Inst Med Res, Dar Es Salaam, Tanzania	Liverpool School of Tropical Medicine; National Institute of Medical Research	Doulla, BE (corresponding author), Minist Hlth Community Dev Gender Elderly & Childr, Dar Es Salaam, Tanzania.; Doulla, BE (corresponding author), Natl TB & Leprosy Programme, Dar Es Salaam, Tanzania.; Doulla, BE (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Ctr Appl Hlth Res & Delivery, Liverpool, Merseyside, England.	bedoulla@gmail.com		Langley, Ivor/0000-0002-9275-6731; MacPherson, Eleanor/0000-0002-7142-1158; Ngadaya, Esther/0000-0003-4540-5637; Squire, Stephen/0000-0001-7173-9038	Swiss Tropical and Public Health Institute, Basel, Geneva; Ministry of Health through the World Bank in Tanzania	Swiss Tropical and Public Health Institute, Basel, Geneva; Ministry of Health through the World Bank in Tanzania	The study is funded by the Swiss Tropical and Public Health Institute, Basel, Geneva and the Ministry of Health through the World Bank support in Tanzania.	Acosta CD, 2014, INT J TUBERC LUNG D, V2, P1, DOI [10.1136/bmj.h111, DOI 10.1136/BMJ.H111]; [Anonymous], 2016, AMBIENT AIR POLLUTIO; Chonde TM, 2010, INT J TUBERC LUNG D, V14, P967; Davies PDO, 2001, J ROY SOC MED, V94, P261, DOI 10.1177/014107680109400601; GLI, GUID PROV TECHN SUPP; Harries AD, 2004, INT J TUBERC LUNG D, V8, P204; Israel GD, 2015, NON TRADITIONAL REF, P1; Kim SJ, 2005, EUR RESPIR J, V25, P564, DOI 10.1183/09031936.05.00111304; Lewis RJ, 2003, QUALITATIVE RES PRAC; Ministry of Health and Social Services, 2013, MAN PRIS RISK HARM S, P1; Ministry of health and Social welfare, 2012, UN REP TANZ NAT TUB; MoHSW, 2012, TANZ NAT GUID MAN TU; NTLP, 2013, UN REP TANZ MIN HLTH; Park PH, 2012, TROP MED INT HEALTH, V17, P374, DOI 10.1111/j.1365-3156.2011.02933.x; Ritchie J, 2003, NON TRADITIONAL REF, P76; Royce S, 2014, INT J TUBERC LUNG D, V18, P1299, DOI 10.5588/ijtld.14.0116; Snape D., 2003, QUALITATIVE RES PRAC, DOI [10.4135/9781452230108, DOI 10.4135/9781452230108]; Store GISO, 2012, NON TRADITIONAL REF; TAHERDOOST H, 2016, SSRN ELECT J; WHO, 2014, WHO REP, P171, DOI [DOI 10.1155/2014/187842, 10.1155/2014/187842]; WHO, WHO TUB GLOB REP 201; World Health Organization, 2006, GUID PROGR MAN DRUG	22	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212421	10.1371/journal.pone.0212421	http://dx.doi.org/10.1371/journal.pone.0212421			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794620	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000459709100065
J	Hauer, V; Risti, M; Miranda, BLM; da Silva, JS; Cidral, AL; Pozzi, CM; Contieri, FLD; Sadissou, IA; Donadi, EA; Augusto, DG; Bicalho, MD				Hauer, Vanessa; Risti, Matilde; Miranda, Bruna L. M.; da Silva, Jose S.; Cidral, Ana L.; Pozzi, Carolina M.; Contieri, Fabiana L. de C.; Sadissou, Ibrahim A.; Donadi, Eduardo A.; Augusto, Danillo G.; Bicalho, Maria da G.			The association of HLA-G polymorphisms and the synergistic effect of sMICA and sHLA-G with chronic kidney disease and allograft acceptance	PLOS ONE			English	Article							HUMAN-LEUKOCYTE ANTIGEN; 3' UNTRANSLATED REGION; G EXPRESSION; CLASS-I; MICA; GENE; NKG2D; RECEPTOR; HAPLOTYPE; VARIANT	The HLA-G and MICA genes are stimulated under inflammatory conditions and code for soluble (sMICA and sHLA-G) or membrane-bound molecules that exhibit immunomodulatory properties. It is still unclear whether they would have a synergistic or antagonistic effect on the immunomodulation of the inflammatory response, such as in chronic kidney disease (CKD), contributing to a better prognosis after the kidney transplantation. In this study, we went from genetic to plasma analysis, first evaluating the polymorphism of MICA, NKG2D and HLA-G in a cohort from Southern Brazil, subdivided in a control group of individuals (n = 75), patients with CKD (n = 94), and kidney-transplant (KT) patients (n = 64). MICA, NKG2D and HLA-G genotyping was performed by polymerase chain reaction with specific oligonucleotide probes, Taqman and Sanger sequencing, respectively. Levels of soluble forms of MICA and HLA-G were measured in plasma with ELISA. Case-control analysis showed that the individuals with haplotype HLA-G* 01: 01/UTR-4 have a lower susceptibility to develop chronic kidney disease (OR = 0.480; p = 0.032). Concerning the group of kidney-transplant patients, the HLA-G genotypes + 3010 GC (rs1710) and + 3142 GC (rs1063320) were associated with higher risk for allograft rejection (OR = 5.357; p = 0.013 and OR = 5.357, p = 0.013, respectively). Nevertheless, the genotype + 3010 GG (OR = 0.136; p = 0.041) was associated with kidney allograft acceptance, suggesting that it is a protection factor for rejection. In addition, the phenotypic analysis revealed higher levels of sHLA-G (p = 0.003) and sMICA (p < 0.001) in plasma were associated with the development of CKD. For patients who were already under chronic pathological stress and underwent a kidney transplant, a high sMICA (p = 0.001) in pre-transplant proved to favor immunomodulation and allograft acceptance. Even so, the association of genetic factors with differential levels of soluble molecules were not evidenced, we displayed a synergistic effect of sMICA and sHLA-G in response to inflammation. This increase was observed in CKD patients, that when undergo transplantation, had this previous amount of immunoregulatory molecules as a positive factor for the allograft acceptance.	[Hauer, Vanessa; Risti, Matilde; Miranda, Bruna L. M.; da Silva, Jose S.; Cidral, Ana L.; Bicalho, Maria da G.] Univ Fed Parana, Dept Genet, Lab Imunogenet & Histocompatibilidade, Curitiba, Parana, Brazil; [Pozzi, Carolina M.; Contieri, Fabiana L. de C.] Hosp Univ Evangel Curitiba, Setor Transplante Renal, Alameda Augusto Stellfeld, Curitiba, Parana, Brazil; [Sadissou, Ibrahim A.; Donadi, Eduardo A.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Lab Biol Mol, Ribeirao Preto, SP, Brazil; [Augusto, Danillo G.] Univ Fed Parana, Dept Genet, Lab Genet Mol Humana, Curitiba, Parana, Brazil; [Augusto, Danillo G.] Univ Estadual Santa Cruz, Dept Ciencias Biol, Ilheus, BA, Brazil	Universidade Federal do Parana; Universidade de Sao Paulo; Universidade Federal do Parana; Universidade Estadual de Santa Cruz	Bicalho, MD (corresponding author), Univ Fed Parana, Dept Genet, Lab Imunogenet & Histocompatibilidade, Curitiba, Parana, Brazil.	mgbicalho@gmail.com	Augusto, Danillo G/H-8179-2019; Sadissou, IBRAHIM/AAT-2692-2020; donadi, eduardo/H-7080-2013	Augusto, Danillo G/0000-0001-5665-8547; Sadissou, IBRAHIM/0000-0001-7300-3753; donadi, eduardo/0000-0002-9457-9601; Cidral, Ana Luiza/0000-0003-0839-1977; Risti, Matilde/0000-0002-4841-3109	CAPES Foundation/Post-Graduate Program in Genetics of UFPR [BEX 10205/14-4]; Ministry of Education of Brazil, Brasilia, Brazil	CAPES Foundation/Post-Graduate Program in Genetics of UFPR; Ministry of Education of Brazil, Brasilia, Brazil	This work was partly supported by a research Ph.D. scholarship awarded to V.H. (No. BEX 10205/14-4) by the CAPES Foundation/Post-Graduate Program in Genetics of UFPR, Ministry of Education of Brazil, Brasilia - DF 70.040-020, Brazil. There was no additional external funding received for this study.	Almasood A, 2011, HUM IMMUNOL, V72, P1064, DOI 10.1016/j.humimm.2011.08.016; Amodio G, 2016, HUM IMMUNOL, V77, P886, DOI 10.1016/j.humimm.2016.06.020; Barkal AA, 2018, NAT IMMUNOL, V19, P76, DOI 10.1038/s41590-017-0004-z; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Bermingham J, 2000, BIOCHEM SOC T, V28, P215, DOI 10.1042/bst0280215; Brugiere O, 2009, AM J TRANSPLANT, V9, P1427, DOI 10.1111/j.1600-6143.2009.02650.x; Carosella ED, 2008, TRENDS IMMUNOL, V29, P125, DOI 10.1016/j.it.2007.11.005; Carosella ED, 2015, ADV IMMUNOL, V127, P33, DOI 10.1016/bs.ai.2015.04.001; Castelli EC, 2010, GENES IMMUN, V11, P134, DOI 10.1038/gene.2009.74; Castelli EC, 2017, MOL IMMUNOL, V83, P115, DOI 10.1016/j.molimm.2017.01.020; Castelli EC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00476; Alves DCC, 2012, HUM IMMUNOL, V73, P52, DOI 10.1016/j.humimm.2011.10.007; Creput C, 2003, J HEPATOL, V39, P587, DOI 10.1016/S0168-8278(03)00354-4; Dendrou CA, 2018, NAT REV IMMUNOL, V18, P325, DOI 10.1038/nri.2017.143; Dias FC, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00009; Donadi EA, 2011, CELL MOL LIFE SCI, V68, P369, DOI 10.1007/s00018-010-0580-7; Espinoza JL, 2009, HAEMATOL-HEMATOL J, V94, P1427, DOI 10.3324/haematol.2009.008318; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Groh V, 2006, NAT IMMUNOL, V7, P755, DOI 10.1038/ni1350; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Isernhagen A, 2016, IMMUNOGENETICS, V68, P109, DOI 10.1007/s00251-015-0884-8; Katsuyama Y, 1999, TISSUE ANTIGENS, V54, P178, DOI 10.1034/j.1399-0039.1999.540209.x; LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444; LeMaoult J, 2003, TISSUE ANTIGENS, V62, P273, DOI 10.1034/j.1399-0039.2003.00143.x; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li JJ, 2013, CHIN J CANCER, V32, P141, DOI 10.5732/cjc.012.10025; Martel G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059116; Menier C, 2003, HUM IMMUNOL, V64, P315, DOI 10.1016/S0198-8859(02)00821-2; Menier C, 2002, INT J CANCER, V100, P63, DOI 10.1002/ijc.10460; Meuleman T, 2018, J REPROD IMMUNOL, V126, P46, DOI 10.1016/j.jri.2018.02.002; Misra MK, 2014, HUM IMMUNOL, V75, P833, DOI 10.1016/j.humimm.2014.06.005; Mosaad YM, 2015, SCAND J IMMUNOL, V82, P283, DOI 10.1111/sji.12329; Muro Manuel, 2012, Current Immunology Reviews, V8, P307; Naji A, 2014, J IMMUNOL, V192, P1536, DOI 10.4049/jimmunol.1300438; Nardi FD, 2012, AM J REPROD IMMUNOL, V68, P507, DOI 10.1111/aji.12001; Passos-Bueno MR, 2014, MOL GENET GENOM MED, V2, P280, DOI 10.1002/mgg3.95; Qiu J, 2006, AM J TRANSPLANT, V6, P2152, DOI 10.1111/j.1600-6143.2006.01417.x; Raache R, 2012, CLIN VACCINE IMMUNOL, V19, P557, DOI 10.1128/CVI.05473-11; Racca AL, 2009, TRANSPL IMMUNOL, V21, P10, DOI 10.1016/j.trim.2009.01.002; Rajasekaran A, 2016, HUM IMMUNOL, V77, P1166, DOI 10.1016/j.humimm.2016.08.013; Rebmann V, 2005, HUM IMMUNOL, V66, P853, DOI 10.1016/j.humimm.2005.05.003; Risti M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00179; Robinson J, 2015, NUCLEIC ACIDS RES, V43, pD423, DOI 10.1093/nar/gku1161; Romphruk AV, 2001, TISSUE ANTIGENS, V58, P83, DOI 10.1034/j.1399-0039.2001.580203.x; Rousseau P, 2003, HUM IMMUNOL, V64, P1005, DOI 10.1016/j.humimm.2003.08.347; Sheshgiri R, 2008, CIRCULATION, V118, pS58, DOI 10.1161/CIRCULATIONAHA.107.757781; Steinle A, 2001, IMMUNOGENETICS, V53, P279, DOI 10.1007/s002510100325; Tonnerre P, 2016, J INFECT DIS, V214, P807, DOI 10.1093/infdis/jiw168; Tonnerre P, 2013, J AM SOC NEPHROL, V24, P954, DOI 10.1681/ASN.2012080814; Vargas RG, 2011, HUM IMMUNOL, V72, P479, DOI 10.1016/j.humimm.2011.02.011; Veit TD, 2009, TRANSPL IMMUNOL, V20, P229, DOI 10.1016/j.trim.2008.11.001; Zambra FMB, 2016, HLA, V87, P79, DOI 10.1111/tan.12741	54	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212750	10.1371/journal.pone.0212750	http://dx.doi.org/10.1371/journal.pone.0212750			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794652	Green Published, Green Submitted, gold			2022-12-27	WOS:000459709100130
J	Moti, N; Yu, J; Boncompain, G; Perez, F; Virshup, DM				Moti, Naushad; Yu, Jia; Boncompain, Gaelle; Perez, Franck; Virshup, David M.			Wnt traffic from endoplasmic reticulum to filopodia	PLOS ONE			English	Article							SECRETION; PROTEIN; TRANSPORT; CELLS; WINGLESS; REVEALS; SIGNALS	Wnts are a family of secreted palmitoleated glycoproteins that play key roles in cell to cell communication during development and regulate stem cell compartments in adults. Wnt receptors, downstream signaling cascades and target pathways have been extensively studied while less is known about how Wnts are secreted and move from producing cells to receiving cells. We used the synchronization system called Retention Using Selective Hook (RUSH) to study Wnt trafficking from endoplasmic reticulum to Golgi and then to plasma membrane and filopodia in real time. Inhibition of porcupine (PORCN) or knockout of Wntless (WLS) blocked Wnt exit from the ER. Wnt-containing vesicles paused at sub-cortical regions of the plasma membrane before exiting the cell. Wnt-containing vesicles were associated with filopodia extending to adjacent cells. These data visualize and confirm the role of WLS and PORCN in ER exit of Wnts and support the role of filopodia in Wnt signaling.	[Moti, Naushad; Yu, Jia; Virshup, David M.] Duke NUS Med Sch, Program Canc & Stem Cell Biol, Singapore, Singapore; [Boncompain, Gaelle; Perez, Franck] Sorbonne Univ, PSL Res Univ, CNRS, Inst Curie,UMR144 Cell Biol & Canc, Paris, France; [Virshup, David M.] Duke Univ, Dept Pediat, Durham, NC 27706 USA; [Moti, Naushad] Univ New South Wales, Lowy Canc Res Ctr, Kensington Campus, Sydney, NSW, Australia	National University of Singapore; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Duke University; University of New South Wales Sydney	Virshup, DM (corresponding author), Duke NUS Med Sch, Program Canc & Stem Cell Biol, Singapore, Singapore.; Virshup, DM (corresponding author), Duke Univ, Dept Pediat, Durham, NC 27706 USA.	david.virshup@duke-nus.edu.sg	Virshup, David M/C-1449-2009; Boncompain, Gaelle/AAX-8374-2021	Virshup, David M/0000-0001-6976-850X; Boncompain, Gaelle/0000-0003-4274-035X; Yu, Jia/0000-0002-7004-9104; Moti, Naushad/0000-0002-8649-9919	National Medical Research Council of Singapore [NMRC/STAR/0017/2013]	National Medical Research Council of Singapore(National Medical Research Council, Singapore)	DMV was supported by Singapore NMRC/STAR/0017/2013 National Medical Research Council of Singapore, http://www.nmrc.gov.sg.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Augustin I, 2012, EMBO MOL MED, V4, P38, DOI 10.1002/emmm.201100186; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Boncompain G, 2012, NAT METHODS, V9, P493, DOI [10.1038/NMETH.1928, 10.1038/nmeth.1928]; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Coombs GS, 2010, J CELL SCI, V123, P3357, DOI 10.1242/jcs.072132; Cretoiu D, 2017, SEMIN CELL DEV BIOL, V64, P26, DOI 10.1016/j.semcdb.2016.08.023; Doubravska L, 2011, CELL SIGNAL, V23, P837, DOI 10.1016/j.cellsig.2011.01.007; Franch-Marro X, 2005, DEVELOPMENT, V132, P659, DOI 10.1242/dev.01639; Greicius G, 2018, P NATL ACAD SCI USA, V115, pE3173, DOI 10.1073/pnas.1713510115; Gross JC, 2012, NAT CELL BIOL, V14, P1036, DOI 10.1038/ncb2574; Herr P, 2012, DEV BIOL, V361, P392, DOI 10.1016/j.ydbio.2011.11.003; Huang H, 2016, ELIFE, V5, DOI 10.7554/eLife.18979; Jacquemet G, 2017, J CELL BIOL, V216, P3387, DOI 10.1083/jcb.201704045; Jacquemet G, 2015, CURR OPIN CELL BIOL, V36, P23, DOI 10.1016/j.ceb.2015.06.007; Kabiri Z, 2014, DEVELOPMENT, V141, P2206, DOI 10.1242/dev.104976; Koles K, 2012, J BIOL CHEM, V287, P16820, DOI 10.1074/jbc.M112.342667; Komekado H, 2007, GENES CELLS, V12, P521, DOI 10.1111/j.1365-2443.2007.01068.x; Korkut C, 2009, CELL, V139, P393, DOI 10.1016/j.cell.2009.07.051; Kornberg TB, 2017, CURR OPIN GENET DEV, V45, P22, DOI 10.1016/j.gde.2017.02.010; Leemhuis J, 2010, J NEUROSCI, V30, P14759, DOI 10.1523/JNEUROSCI.4036-10.2010; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Madan B, 2016, ONCOGENE, V35, P2197, DOI 10.1038/onc.2015.280; MATLIN KS, 1983, CELL, V34, P233, DOI 10.1016/0092-8674(83)90154-X; Mattes B, 2018, HISTOCHEM CELL BIOL, V150, P431, DOI 10.1007/s00418-018-1732-3; Mattes B, 2018, ELIFE, V7, DOI 10.7554/eLife.36953; Najdi R, 2012, DIFFERENTIATION, V84, P203, DOI 10.1016/j.diff.2012.06.004; Pfeiffer S, 2002, CURR BIOL, V12, P957, DOI 10.1016/S0960-9822(02)00867-9; Sagar, 2015, DEVELOPMENT, V142, P665, DOI 10.1242/dev.115964; Saha S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13096; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; SARASTE J, 1984, CELL, V38, P535, DOI 10.1016/0092-8674(84)90508-7; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shoshkes-Carmel M, 2018, NATURE, V557, P242, DOI 10.1038/s41586-018-0084-4; Stanganello E, 2016, J CELL SCI, V129, P665, DOI 10.1242/jcs.182469; Stanganello E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6846; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Tanaka K, 2000, EUR J BIOCHEM, V267, P4300, DOI 10.1046/j.1432-1033.2000.01478.x; Vannucchi MG, 2013, J CELL MOL MED, V17, P1099, DOI 10.1111/jcmm.12134; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Yamamoto H, 2013, J CELL SCI, V126, P2931, DOI 10.1242/jcs.126052; Yu J, 2014, BIOSCIENCE REP, V34, P593, DOI 10.1042/BSR20140119; Yu J, 2014, DEV CELL, V29, P277, DOI 10.1016/j.devcel.2014.03.016; Zhai L, 2004, J BIOL CHEM, V279, P33220, DOI 10.1074/jbc.M403407200	46	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212711	10.1371/journal.pone.0212711	http://dx.doi.org/10.1371/journal.pone.0212711			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794657	Green Published, Green Submitted, gold			2022-12-27	WOS:000459709100124
J	Turner, KME; Looker, KJ; Syred, J; Zienkiewicz, A; Baraitser, P				Turner, Katy M. E.; Looker, Katharine J.; Syred, Jonathan; Zienkiewicz, Adam; Baraitser, Paula			Online testing for sexually transmitted infections: A whole systems approach to predicting value	PLOS ONE			English	Article							CHLAMYDIA-TRACHOMATIS; HEALTH	Background Online testing for sexually transmitted infections has a lower unit cost than testing in clinical services and economic analysis has focused on the cost per test and cost per diagnosis in clinics and online. However, online services generate new demand for testing and shift activity between services, requiring system-level analysis to effectively predict cost-effectiveness. Methods and findings Routinely collected, anonymised, retrospective data on sexual health service activity from all specialist services (clinic and online) within an inner London sexual health economy were collated and harmonised to generate a complete dataset of individual level clinic attendances. Clinic activity and diagnoses were coded using nationally standardised codes assigned by clinicians. Costs were taken from locally or regionally agreed sexual health tariffs. The introduction of online services changed patterns of testing. In an inner London sexual health economy, online STI testing increased total number of tests, the total cost of testing and total diagnoses while slightly reducing the average cost per diagnosis. Two years after the introduction of online services 37% of tests in the were provided online and total diagnoses increased. The positivity of online services is generally lower than that in clinics but varies between contexts. Where the positivity ratio between clinic and online is less than the cost ratio, online services will reduce cost per diagnosis. In this analysis, areas with different classifications as urban and rural had different clinic/online positivity ratios changing the cost effectiveness between areas. Even after the introduction of online services, simple STI testing activity continues in clinics and providers should consider online-first options where clinically appropriate. Conclusions Online services for STI testing are not 'stand alone'. They change STI testing behaviour with impacts on all elements of the sexual health economy. Planning, development and monitoring of such services should reference the dynamic nature of these systems and the role of online services within them.	[Turner, Katy M. E.; Zienkiewicz, Adam] Univ Bristol, Sch Vet Sci, Bristol, Avon, England; [Looker, Katharine J.] Univ Bristol, Bristol Med Sch, Bristol, Avon, England; [Syred, Jonathan; Baraitser, Paula] Kings Coll London, Sch Populat Hlth & Environm Sci, London, England; [Baraitser, Paula] Kings Coll Hosp NHS Fdn Trust, Dept Sexual Hlth & HIV, London, England	University of Bristol; University of Bristol; University of London; King's College London; King's College Hospital NHS Foundation Trust	Baraitser, P (corresponding author), Kings Coll London, Sch Populat Hlth & Environm Sci, London, England.; Baraitser, P (corresponding author), Kings Coll Hosp NHS Fdn Trust, Dept Sexual Hlth & HIV, London, England.	paula.baraitser@kcl.ac.uk	Turner, Katy/R-3853-2019	Turner, Katy/0000-0002-8152-6017; Baraitser, Paula/0000-0002-3354-6494; Syred, Jonathan/0000-0002-4479-1604	'Guys and St Thomas' Charity	'Guys and St Thomas' Charity	This work was supported by a grant from 'Guys and St Thomas' Charity to PB. A mixed method evaluation of virtual sexual health services for Lambeth and Southwark. Evaluation, PI Paula Baraitser. 611,034 pound. Start date 01/01/2014 Duration 36 months. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baraitser P, 2017, SEX TRANSM INFECT, V93, pA6, DOI 10.1136/sextrans-2017-053232.17; Baraitser P, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1200-x; Barnard S, 2016, BASHH 2016 ANN C; Blake DR, 2015, SEX TRANSM DIS, V42, P13, DOI 10.1097/OLQ.0000000000000221; Department for Environment FRA, 2016, RUR URB CLASS; Emma Wilson CF, 2017, PLOS MED UNPUB   AUG; England N, NHS 5 YEAR FORW VIEW; England PH, 2016, SEX TRANSM INF CHLAM; Estcourt CS, 2017, LANCET PUBLIC HEALTH, V2, pE182, DOI 10.1016/S2468-2667(17)30034-8; Fund TKs, 2015, IMP 2015 SPEND REV H; Fund TKs, 2017, FUT NOW INN TOD POIN; Gaydos CA, 2006, SEX TRANSM DIS, V33, P451, DOI 10.1097/01.olq.0000200497.14326.fb; Gott M, 2004, FAM PRACT, V21, P528, DOI 10.1093/fampra/cmh509; Huang W, 2011, SEX TRANSM DIS, V38, P815, DOI 10.1097/OLQ.0b013e31821b0f50; Levine DK, 2005, SEX TRANSM DIS, V32, P139, DOI 10.1097/01.olq.0000149783.67826.4d; Pai NP, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001414; Prevention ECfD Control, 2013, HLTH INEQ FIN CRIS I; Public Health England (PHE), 2013, GEN MED CLIN ACT DAT; Rietmeijer C. A., 2007, Sexuality Research and Social Policy, V4, P65, DOI 10.1525/srsp.2007.4.2.65; Smith KEI, 2007, INDIGEN PEOPLE POLIT, P1, DOI 10.1155/2007/62467; Voices N, SUPP SELF MAN SUMM E; World Health Organisation, 2021, SEXUALLY TRANSMITTED	22	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212420	10.1371/journal.pone.0212420	http://dx.doi.org/10.1371/journal.pone.0212420			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794589	Green Submitted, Green Published, gold			2022-12-27	WOS:000459709100064
J	Ahlborg, MG; Svedberg, P; Nyholm, M; Morgan, A; Nygren, JM				Ahlborg, Mikael G.; Svedberg, Petra; Nyholm, Maria; Morgan, Antony; Nygren, Jens M.			Into the realm of social capital for adolescents: A latent profile analysis	PLOS ONE			English	Article							MENTAL-HEALTH PROBLEMS; SOCIOECONOMIC INEQUALITIES; SCHOOL; CHILDREN; COUNTRIES; PEOPLE; MODELS; TRENDS; FAMILY; PARENT	Background Recent reports of increasing prevalence of frequent health complaints and mental health problems among adolescents call for directing more attention on determinants of adolescent health. The relationship between health and social capital has gained increased attention since the early 2000's and research at review level confirms the importance of social capital for health outcomes, despite methodological heterogeneity. The aim of this study was to identify distinct profiles of family, school and peer social capital in a nationally representative sample of adolescents and to explore health outcomes in those profiles. Method Cross-sectional data from the Swedish Health Behaviour of School-aged Children 2013/14 was used for this study. The analytical sample consisted of 7,804 adolescents aged 11-, 13- and 15-years. Items representing sense of belonging and emotional support were assessed in three contexts; family, school and among peers. Latent profile analyses (LPA) were run to determine social capital profiles. Health outcomes included frequent health complaints and life satisfaction, while socioeconomic status and genders were included as predictors. Results The results show that five distinct profiles best represent the data for 11- and 15-year olds, while a four-profile model was optimal for 13-year olds. Some profiles were recurrent between age groups but unique profiles were also found. Health outcomes were significantly different between profiles depending on levels of social capital in the different contexts. Conclusions This study provides novel insight into how social capital co-occurs among adolescents within the contexts of family, school and peers and how this translates into differences in health outcomes. The national representativeness of the sample increases the implications of the results and contributes to meaningful insights that help explain the interactions of social capital in multiple contexts, complementing what is previously known about the relationship with adolescent health.	[Ahlborg, Mikael G.; Svedberg, Petra; Nyholm, Maria; Morgan, Antony; Nygren, Jens M.] Halmstad Univ, Sch Hlth & Welf, Halmstad, Sweden; [Morgan, Antony] Glasgow Caledonian Univ London, London, England	Halmstad University	Ahlborg, MG (corresponding author), Halmstad Univ, Sch Hlth & Welf, Halmstad, Sweden.	mikael.ahlborg@hh.se		Nygren, Jens M/0000-0002-3576-2393; Svedberg, Petra/0000-0003-4438-6673	Knowledge Foundation [dnr20160098]	Knowledge Foundation	The study was funded by grants to JN from The Knowledge Foundation dnr20160098, http://www.kks.se/om-oss/in-english/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almgren G, 2009, J ADOLESCENCE, V32, P109, DOI 10.1016/j.adolescence.2007.11.003; [Anonymous], 2018, HDB WELL BEING; Bassani C, 2008, J EDUC ENQ, V8, P51; Bor W, 2014, AUST NZ J PSYCHIAT, V48, P606, DOI 10.1177/0004867414533834; Borges Carolina M, 2010, BMC Res Notes, V3, P338, DOI 10.1186/1756-0500-3-338; Bourdieu P., 1984, DISTINCTION SOCIAL C; Alvarez EC, 2017, GAC SANIT, V31, P57, DOI 10.1016/j.gaceta.2016.09.002; Alvarez EC, 2017, SOCIOL HEALTH ILL, V39, P5, DOI 10.1111/1467-9566.12506; COLEMAN JS, 1988, AM J SOCIOL, V94, pS95, DOI 10.1086/228943; Collins W, 1997, J ADOLESCENT RES, V12, P178, DOI 10.1177/0743554897122003; Collishaw S, 2015, J CHILD PSYCHOL PSYC, V56, P370, DOI 10.1111/jcpp.12372; Currie C., 2014, HLTH BEHAV SCH AGED; Daly M, 2008, THEOR SOC, V37, P537, DOI 10.1007/s11186-008-9062-4; De Silva MJ, 2005, J EPIDEMIOL COMMUN H, V59, P619, DOI 10.1136/jech.2004.029678; Ehsan AM, 2015, J EPIDEMIOL COMMUN H, V69, P1021, DOI 10.1136/jech-2015-205868; Elgar FJ, 2015, LANCET, V385, P2088, DOI 10.1016/S0140-6736(14)61460-4; Eriksson U, 2012, ACTA PAEDIATR, V101, P513, DOI 10.1111/j.1651-2227.2011.02579.x; Ferguson KM, 2006, INT J SOC WELF, V15, P2, DOI 10.1111/j.1468-2397.2006.00575.x; Gilbert KL, 2013, J HEALTH PSYCHOL, V18, P1385, DOI 10.1177/1359105311435983; Giordano GN, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-665; Goodman E, 2003, AM J PUBLIC HEALTH, V93, P1844, DOI 10.2105/AJPH.93.11.1844; Hobza V, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14121540; Inaba Y., 2013, GLOBAL PERSPECTIVES; Hombrados-Mendieta MI, 2012, J COMMUNITY PSYCHOL, V40, P645, DOI 10.1002/jcop.20523; Ivarsson A, 2018, PREDICTION INJURY RI; Kawachi I, 1999, AM J PUBLIC HEALTH, V89, P1187, DOI 10.2105/AJPH.89.8.1187; Kawachi I, 2018, SOC SCI MED, V196, P240, DOI 10.1016/j.socscimed.2017.10.034; Lanza ST, 2013, STRUCT EQU MODELING, V20, P361, DOI 10.1080/10705511.2013.797816; Li CK, 2020, J HEALTH PSYCHOL, V25, P853, DOI 10.1177/1359105317737608; Magson NR, 2016, J YOUTH STUD, V19, P569, DOI 10.1080/13676261.2015.1098776; Marsh HW, 2009, MULTIVAR BEHAV RES, V44, P764, DOI 10.1080/00273170903333665; McPherson Kerri E, 2014, BMC Psychol, V2, P7, DOI 10.1186/2050-7283-2-7; Menna R, 2004, GUIDANCE COUNSELING, V19, P176; Morgan A, 2009, HEALTH PROMOT INT, V24, P363, DOI 10.1093/heapro/dap028; Morrow V, 1999, SOCIOL REV, V47, P744, DOI 10.1111/1467-954X.00194; Morrow V., 2001, INT J SOCIOLOGY SOCI, V21, P37, DOI DOI 10.1108/01443330110789439; Morrow V., 2005, J SOCIAL SCI, V9, P57; Nyqvist F, 2013, AGING MENT HEALTH, V17, P394, DOI 10.1080/13607863.2012.742490; Oberski D, 2016, HUM-COMPUT INT-SPRIN, P275, DOI 10.1007/978-3-319-26633-6_12; Ottova-Jordan V, 2015, EUR J PUBLIC HEALTH, V25, P24, DOI 10.1093/eurpub/ckv015; Parcel TL, 2010, J MARRIAGE FAM, V72, P828, DOI 10.1111/j.1741-3737.2010.00733.x; Patton GC, 2016, LANCET, V387, P2423, DOI 10.1016/S0140-6736(16)00579-1; Pearce N, 2003, AM J PUBLIC HEALTH, V93, P122, DOI 10.2105/AJPH.93.1.122; Paiva PCP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103785; Public Health Agency of Sweden, 2014, SKOLB HALS SVER 2013; PUTNAM RD, 1995, J DEMOCRACY, V0006; Reiss F, 2013, SOC SCI MED, V90, P24, DOI 10.1016/j.socscimed.2013.04.026; Roberts C., 2012, HLTH BEHAV SCH AGED; Rocco L, 2014, HEALTH ECON, V23, P586, DOI 10.1002/hec.2934; Rouxel PL, 2015, COMMUNITY DENT ORAL, V43, P97, DOI 10.1111/cdoe.12141; Smith C., 2013, OECD STAT WORKING PA; Tein JY, 2013, STRUCT EQU MODELING, V20, P640, DOI 10.1080/10705511.2013.824781; Uphoff EP, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-54; Van der Graaff J, 2018, J YOUTH ADOLESCENCE, V47, P1086, DOI 10.1007/s10964-017-0786-1; Van Droogenbroeck F, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1591-4; Villalonga-Olives E, 2017, SOC SCI MED, V194, P105, DOI 10.1016/j.socscimed.2017.10.020; Villalonga-Olives E, 2015, GAC SANIT, V29, P62, DOI 10.1016/j.gaceta.2014.09.006; Vyncke V, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-65; World Health Organization, 1986, OTT CHART GES; Yang H, 2017, ASIA PAC EDUC REV, V18, P373, DOI 10.1007/s12564-017-9492-7	60	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212564	10.1371/journal.pone.0212564	http://dx.doi.org/10.1371/journal.pone.0212564			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM2WC	30789947	Green Submitted, Green Published, gold			2022-12-27	WOS:000459330800040
J	Kelle, D; Kirimtay, K; Selcuk, E; Karabay, A				Kelle, Dolunay; Kirimtay, Koray; Selcuk, Ece; Karabay, Arzu			Elk1 affects katanin and spastin proteins via differential transcriptional and post-transcriptional regulations	PLOS ONE			English	Article							TERNARY COMPLEX FACTORS; ETS-DOMAIN; SIGNAL-TRANSDUCTION; ACTIVATED PROTEIN; MESSENGER-RNA; SUMO; MICROTUBULES; IDENTIFICATION; REGION; TARGETS	Microtubule severing, which is highly critical for the survival of both mitotic and post-mitotic cells, has to be precisely adjusted by regulating the expression levels of severing proteins, katanin and spastin. Even though severing mechanism is relatively well-studied, there are limited studies for the transcriptional regulation of microtubule severing proteins. In this study, we identified the main regulatory region of KATNA1 gene encoding katanin-p60 as 5' UTR, which has a key role for its expression, and showed Elk1 binding to KATNA1. Furthermore, we identified that Elk1 decreased katanin-p60 and spastin protein expressions, while mRNA levels were increased upon Elk1 overexpression. In addition, SUMOylation is a known post-translational modification regulating Elk1 activity. A previous study suggested that K230, K249, K254 amino acids in the R domain are the main SUMOylation sites; however, we identified that these amino acids are neither essential nor substantial for Elk1 SUMOylation. Also, we determined that KATNA1 methylation results in the reduction of Elk1 binding whereas SPG4 methylation does not. Together, our findings emphasizing the impacts of both transcriptional and post-transcriptional regulations of katanin-p60 and spastin suggest that Elk1 has a key role for differential expression patterns of microtubule severing proteins, thereby regulating cellular functions through alterations of microtubule organization.	[Kelle, Dolunay; Kirimtay, Koray; Selcuk, Ece; Karabay, Arzu] Istanbul Tech Univ, Dept Mol Biol & Genet, Istanbul, Turkey	Istanbul Technical University	Karabay, A (corresponding author), Istanbul Tech Univ, Dept Mol Biol & Genet, Istanbul, Turkey.	karabaya@itu.edu.tr	Kırımtay, Koray/AHB-4140-2022; Karabay, Arzu/ABB-3681-2020	Karabay, Arzu/0000-0001-5150-5349	Istanbul Technical University Scientific Research Projects-ITU-BAP [415, 38224]; Istanbul Kalkinma Ajansi [TR10/16/YNY/0130]	Istanbul Technical University Scientific Research Projects-ITU-BAP; Istanbul Kalkinma Ajansi	This study was funded by Istanbul Technical University Scientific Research Projects-ITU-BAP [Project ID: 415 #38224] to AK and Istanbul Kalkinma Ajansi [TR10/16/YNY/0130] to AK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad FJ, 1999, J CELL BIOL, V145, P305, DOI 10.1083/jcb.145.2.305; Baas PW, 2005, TRENDS CELL BIOL, V15, P518, DOI 10.1016/j.tcb.2005.08.004; Baczyk D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178056; Barrett LE, 2006, NAT METHODS, V3, P455, DOI 10.1038/NMETH885; Besnard A, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00035; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Canbaz D, 2011, J NEUROCHEM, V117, P724, DOI 10.1111/j.1471-4159.2011.07243.x; Claudiani P, 2005, EXP CELL RES, V309, P358, DOI 10.1016/j.yexcr.2005.06.009; Connerty P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010031; Costa MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024812; Demir O, 2009, MOL CELL NEUROSCI, V40, P111, DOI 10.1016/j.mcn.2008.10.004; Errico A, 2002, HUM MOL GENET, V11, P153, DOI 10.1093/hmg/11.2.153; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Frickey T, 2004, J STRUCT BIOL, V146, P2, DOI 10.1016/j.jsb.2003.11.020; Gille H, 1996, MOL CELL BIOL, V16, P1094; Hartman JJ, 1998, CELL, V93, P277, DOI 10.1016/S0092-8674(00)81578-0; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Hemberg M, 2011, NUCLEIC ACIDS RES, V39, P7092, DOI 10.1093/nar/gkr404; Hendriks IA, 2016, NAT REV MOL CELL BIO, V17, P581, DOI 10.1038/nrm.2016.81; Henson BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036505; Hu BQ, 2017, NUCLEIC ACIDS RES, V45, pD104, DOI 10.1093/nar/gkw888; Karabay A, 2004, J NEUROSCI, V24, P5778, DOI 10.1523/JNEUROSCI.1382-04.2004; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Khan A, 2018, NUCLEIC ACIDS RES, V46, pD260, DOI 10.1093/nar/gkx1126; Kullmann M, 2002, GENE DEV, V16, P3087, DOI 10.1101/gad.248902; Lacroix B, 2010, J CELL BIOL, V189, P945, DOI 10.1083/jcb.201001024; Lee YS, 2015, NEUROBIOL LEARN MEM, V124, P28, DOI 10.1016/j.nlm.2015.08.004; Lumb JH, 2012, BBA-MOL CELL RES, V1823, P192, DOI 10.1016/j.bbamcr.2011.08.010; Mansfield KD, 2012, NUCLEIC ACIDS RES, V40, P2734, DOI 10.1093/nar/gkr1114; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; Matic I, 2010, MOL CELL, V39, P641, DOI 10.1016/j.molcel.2010.07.026; MCNALLY FJ, 1993, CELL, V75, P419, DOI 10.1016/0092-8674(93)90377-3; McNally KP, 2000, J CELL SCI, V113, P1623; Meng Z, 2005, NUCLEIC ACIDS RES, V33, P2962, DOI 10.1093/nar/gki603; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Park JB, 2007, J NEUROCHEM, V100, P555, DOI 10.1111/j.1471-4159.2006.04263.x; Pastorcic M, 2003, MOL BRAIN RES, V113, P57, DOI 10.1016/S0169-328X(03)00090-1; PRICE MA, 1995, EMBO J, V14, P2589, DOI 10.1002/j.1460-2075.1995.tb07257.x; Qiang L, 2006, J NEUROSCI, V26, P3120, DOI 10.1523/JNEUROSCI.5392-05.2006; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Saether T, 2011, ONCOGENE, V30, P212, DOI 10.1038/onc.2010.397; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Salinas S, 2004, J CELL BIOL, V165, P767, DOI 10.1083/jcb.200310136; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Selcuk E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069423; Sgambato V, 1998, J NEUROSCI, V18, P214; Sharma A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009002; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Shaw PE, 2003, INT J BIOCHEM CELL B, V35, P1210, DOI 10.1016/S1357-2725(03)00031-1; SHORE P, 1994, MOL CELL BIOL, V14, P3283, DOI 10.1128/MCB.14.5.3283; Sokolowski M, 1999, J VIROL, V73, P1080, DOI 10.1128/JVI.73.2.1080-1091.1999; Toyo-Oka K, 2005, HUM MOL GENET, V14, P3113, DOI 10.1093/hmg/ddi339; VALE RD, 1991, CELL, V64, P827, DOI 10.1016/0092-8674(91)90511-V; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; Yang CH, 2007, GENE, V389, P52, DOI 10.1016/j.gene.2006.09.029; Yang SH, 2002, MOL CELL BIOL, V22, P5036, DOI 10.1128/MCB.22.14.5036-5046.2002; Yang SH, 2001, MOL CELL BIOL, V21, P2802, DOI 10.1128/MCB.21.8.2802-2814.2001; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7; Yang SH, 2003, MOL CELL, V12, P63, DOI 10.1016/S1097-2765(03)00265-X; Yang YF, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170167; Yang YCT, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1273-2; Yordy JS, 2000, ONCOGENE, V19, P6503, DOI 10.1038/sj.onc.1204036; Yu WQ, 2008, MOL BIOL CELL, V19, P1485, DOI 10.1091/mbc.E07-09-0878; Yu WQ, 2005, J NEUROSCI, V25, P5573, DOI 10.1523/JNEUROSCI.0834-05.2005	66	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212518	10.1371/journal.pone.0212518	http://dx.doi.org/10.1371/journal.pone.0212518			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789974	Green Published, Green Submitted, gold			2022-12-27	WOS:000459330800034
J	Lampert, A; Bruckner, T; Haefeli, WE; Seidling, HM				Lampert, Anette; Bruckner, Thomas; Haefeli, Walter E.; Seidling, Hanna M.			Improving eye-drop administration skills of patients - A multicenter parallel-group cluster-randomized controlled trial	PLOS ONE			English	Article							GLAUCOMA; ASTHMA; INSTILLATION; INFORMATION; TIMOLOL	Background Eye-drop administration errors occur in the majority of patients and increase the risk for treatment failure or systemic adverse events. While lacking knowledge is the principal error cause, most patients overestimate their skills and are unaware of often substantial knowledge gaps. Therefore, the impact of including motivational patient education on long-term eye-drop administration skills of patients was investigated. Methods This is a cluster-randomized controlled trial in German community pharmacies. Patient education in both groups comprised observation of the patient during eye-drop administration to identify individual errors, pharmaceutical counseling, and teach-back evaluation of the training. In the intervention group, motivational communication techniques were included to increase error awareness and readiness for patient education. In addition, intervention patients were trained on repeated errors until administration was performed correctly. In contrast, patients in the control group only received feedback on erroneous administration steps without another assessment and reinforced training. Results In total, 152 adult patients were eligible to the study and 91 patients (intervention group N = 46) agreed to participate in a 1-month, 6-month, and 12-month follow-up. Patient education significantly increased the proportion of patients correctly administering eye-drops from 6% (7 out of 56 intervention patients, 1 out of 82 control patients) at baseline to 35% (12 out of 30 intervention patients, 12 out of 39 control patients, p <= 0.001) at the 1-month follow-up, and 64% (11 out of 15 intervention patients, 17 out of 29 control patients, p <= 0.001) at the 6-month follow-up irrespective of group allocation. In some patients previously resolved errors recurred during follow-up visits. This emphasizes the need for periodical reevaluation of patient administration skills and the provision of prevention strategies besides education. Conclusion Patient education that included demonstration of administration skills and verbal and written counseling on observed errors improved eye-drop administration skills irrespective of the communication technique applied. Whereof, high drop-out rates limited the power to detect a difference between groups. In particular, periodic demonstration of administration skills seemed important for sustainable improvement of administration skills. However, further error prevention strategies such as additional education materials or support by a caregiver may be necessary in some patients.	[Lampert, Anette; Haefeli, Walter E.; Seidling, Hanna M.] Heidelberg Univ, Dept Clin Pharmacol & Pharmacoepidemiol, Heidelberg, Germany; [Lampert, Anette; Haefeli, Walter E.; Seidling, Hanna M.] Heidelberg Univ, Cooperat Unit Clin Pharm, Heidelberg, Germany; [Bruckner, Thomas] Heidelberg Univ, Inst Med Biometry & Informat, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Seidling, HM (corresponding author), Heidelberg Univ, Dept Clin Pharmacol & Pharmacoepidemiol, Heidelberg, Germany.; Seidling, HM (corresponding author), Heidelberg Univ, Cooperat Unit Clin Pharm, Heidelberg, Germany.	hanna.seidling@med.uni-heidelberg.de	Haefeli, Walter Emil/AAJ-3024-2020	Haefeli, Walter Emil/0000-0003-0672-6876	Dr August and Anni Lesmueller foundation; Dr. August and Dr. Anni Lesmueller foundation	Dr August and Anni Lesmueller foundation; Dr. August and Dr. Anni Lesmueller foundation	AL received a personal scholarship from "Dr August and Anni Lesmueller foundation". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Chamber of Pharmacists Baden-Wuerttemberg for its support and particularly all patients, pharmacists, and pharmacy technicians for participation in our study and their effort. AL received a personal scholarship from the "Dr. August and Dr. Anni Lesmueller foundation".	Buetow S, 2009, ANN FAM MED, V7, P223, DOI 10.1370/afm.941; Busche S, 1997, KLIN MONATSBL AUGENH, V211, P257, DOI 10.1055/s-2008-1035132; Campbell MK, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5661; Carpenter DM, 2016, HEALTH COMMUN, V31, P1036, DOI 10.1080/10410236.2015.1020263; Connor AJ, 2011, EYE, V25, P466, DOI 10.1038/eye.2011.5; Dietlein TS, 2008, ACTA OPHTHALMOL, V86, P856, DOI 10.1111/j.1755-3768.2007.01155.x; Doak C, TEACHING PATIENTS LO; Feng A, 2016, CLIN OPHTHALMOL, V10, P1505, DOI 10.2147/OPTH.S108979; Flach Allan J, 2008, Trans Am Ophthalmol Soc, V106, P138; FRAUNFELDER FT, 1987, J OCUL PHARMACOL, V3, P177, DOI 10.1089/jop.1987.3.177; Friedman AJ, 2011, J CANCER EDUC, V26, P12, DOI 10.1007/s13187-010-0183-x; Gupta R, 2012, J GLAUCOMA, V21, P189, DOI 10.1097/IJG.0b013e31820bd2e1; Johnson A., 2003, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD003716; Lampert A, 2016, INT J QUAL HEALTH C, V28, P634, DOI 10.1093/intqhc/mzw077; Lampert A, 2014, PATIENT EDUC COUNS, V97, P434, DOI 10.1016/j.pec.2014.08.018; LOEWENSTEIN A, 1994, GRAEF ARCH CLIN EXP, V232, P680, DOI 10.1007/BF00171384; Mansour K, 2007, CORNEA, V26, P147, DOI 10.1097/01.ico.0000244877.30997.6a; Morales DR, 2016, BRIT J CLIN PHARMACO, V82, P814, DOI 10.1111/bcp.13006; Muir KW, 2010, SURV OPHTHALMOL, V55, P454, DOI 10.1016/j.survophthal.2010.03.005; NELSON JD, 1987, AM J OPHTHALMOL, V103, P333; Press VG, 2012, J GEN INTERN MED, V27, P1317, DOI 10.1007/s11606-012-2090-9; RIVERS PH, 1992, DRUG AGING, V2, P103, DOI 10.2165/00002512-199202020-00004; Rollnick S., 2008, MOTIVATIONAL INTERVI; Sayner R, 2016, INT J PHARM PRACT, V24, P78, DOI 10.1111/ijpp.12215; SCHEIN OD, 1988, AM J OPHTHALMOL, V105, P361, DOI 10.1016/0002-9394(88)90298-X; Schulz M, 2001, J CLIN PHARMACOL, V41, P668, DOI 10.1177/00912700122010438; Schwartz GF, 2013, CURR MED RES OPIN, V29, P1515, DOI 10.1185/03007995.2013.833898; Solomon A, 2003, OPHTHALMOLOGY, V110, P796, DOI 10.1016/S0161-6420(02)01967-X; Stone JL, 2009, ARCH OPHTHALMOL-CHIC, V127, P732, DOI 10.1001/archophthalmol.2009.96; Tatham AJ, 2013, EYE, V27, P1293, DOI 10.1038/eye.2013.187; TEMPLETON WC, 1982, AM J OPHTHALMOL, V93, P723, DOI 10.1016/0002-9394(82)90467-6; WINFIELD AJ, 1990, BRIT J OPHTHALMOL, V74, P477, DOI 10.1136/bjo.74.8.477; ZIMMERMAN TJ, 1984, ARCH OPHTHALMOL-CHIC, V102, P551; ZIMMERMAN TJ, 1981, ANN OPHTHALMOL, V13, P683	34	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212007	10.1371/journal.pone.0212007	http://dx.doi.org/10.1371/journal.pone.0212007			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM2WC	30789934	Green Published, Green Submitted, gold			2022-12-27	WOS:000459330800017
J	Shimbashi, R; Chang, B; Tanabe, Y; Takeda, H; Watanabe, H; Kubota, T; Kasahara, K; Oshima, K; Nishi, J; Maruyama, T; Kuronuma, K; Fujita, J; Ikuse, T; Kinjo, Y; Suzuki, M; Kerdsin, A; Shimada, T; Fukusumi, M; Tanaka-Taya, K; Matsui, T; Sunagawa, T; Ohnishi, M; Oishi, K; Nakano, M; Ikeda, T; Suzuki, Y; Seto, J; Yahagi, K; Kazama, K; Yamazaki, S; Kumakura, E; Hiraoka, M; Nagai, Y; Naraya, S; Tsujimoto, E; Matsumoto, M; Shigemura, H; Okamoto, F; Sera, N; Gokuden, M; Itokazu, T; Kudaka, J; Yokoyama, A; Takahashi, H; Aoyagi, T; Kaku, M; Abe, S; Tsubata, C; Saitoh, A; Ishida, M; Nakamatsu, M				Shimbashi, Reiko; Chang, Bin; Tanabe, Yoshinari; Takeda, Hiroaki; Watanabe, Hiroshi; Kubota, Tetsuya; Kasahara, Kei; Oshima, Kengo; Nishi, Junichiro; Maruyama, Takaya; Kuronuma, Koji; Fujita, Jiro; Ikuse, Tatsuki; Kinjo, Yuki; Suzuki, Motoi; Kerdsin, Anusak; Shimada, Tomoe; Fukusumi, Munehisa; Tanaka-Taya, Keiko; Matsui, Tamano; Sunagawa, Tomimasa; Ohnishi, Makoto; Oishi, Kazunori; Nakano, Michiharu; Ikeda, Tatsuya; Suzuki, Yu; Seto, Junji; Yahagi, Kazue; Kazama, Kurumi; Yamazaki, Satoru; Kumakura, Emiko; Hiraoka, Minoru; Nagai, Yuhki; Naraya, Sagako; Tsujimoto, Eri; Matsumoto, Michiaki; Shigemura, Hiroaki; Okamoto, Fuyuki; Sera, Nobuyuki; Gokuden, Mutsuyo; Itokazu, Toru; Kudaka, Jun; Yokoyama, Akihito; Takahashi, Hiroki; Aoyagi, Tetsuji; Kaku, Mitsuo; Abe, Shuichi; Tsubata, Chikako; Saitoh, Akihiko; Ishida, Masayuki; Nakamatsu, Masashi		Adult IPD Study Grp	Epidemiological and clinical features of invasive pneumococcal disease caused by serotype 12F in adults, Japan	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; POLYSACCHARIDE VACCINE; CONJUGATE VACCINE; POPULATION; RESISTANCE; CARRIAGE; OUTBREAK; CHILDREN; ENGLAND	Enhanced surveillance of invasive pneumococcal disease (IPD) in adults was conducted during April 2013-March 2018 in 10 of 47 prefectures in Japan, and a total of 1277 IPD patients were enrolled. An emergence of IPD caused by serotype 12F was identified during May 2015-March 2018 through this surveillance. 12F isolates were composed of four related sequence types. In total, 120 patients with 12F IPD were reported during this period. To characterize the clinical features of 12F IPD, the disease characteristics of these patients were compared with those of 1157 patients with non-12F IPD. Compared with the non-12F IPD patients, a significantly lower proportion of 12F IPD patients was aged 65 years or older (55% vs. 70%), vaccinated with 23-valent pneumococcal polysaccharide (4% vs. 14%), had comorbid illness (65% vs. 77%), or were immunocompromised (19% vs. 30%; all P < 0.05). No significant difference in the proportion of case fatalities was found between the two groups. The proportions of those aged 65 years or older (53% vs. 69%) and with bacteremic pneumonia (35% vs. 69%) were significantly lower in 17 patients who died from 12F IPD than in 205 patients who died from non-12F IPD (all P < 0.05). Differences in clinical features were similarly found between 12F IPD patients and patients in low-or intermediate-level invasive potential serogroups. Our data demonstrated that serotype 12F was associated with IPD in younger adults and a lower proportion of comorbid illness, including immuno-compromised conditions, in adult IPD, suggesting the high invasive potential of the serotype 12F. In addition, patients who died from 12F IPD were younger and had proportionately more bacteremia without focus. These findings may provide new insight into the pathogenesis of IPD in adults caused by 12F serotype with a high invasive potential.	[Shimbashi, Reiko] Natl Inst Infect Dis, Field Epidemiol Training Program, Tokyo, Japan; [Shimbashi, Reiko] Tohoku Univ, Grad Sch Med, Div Global Infect Dis, Dept Infect & Epidemiol, Sendai, Miyagi, Japan; [Shimbashi, Reiko; Shimada, Tomoe; Fukusumi, Munehisa; Tanaka-Taya, Keiko; Matsui, Tamano; Sunagawa, Tomimasa; Oishi, Kazunori] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo, Japan; [Chang, Bin; Ohnishi, Makoto] Natl Inst Infect Dis, Dept Bacteriol, Tokyo, Japan; [Tanabe, Yoshinari] Niigata Prefectural Shibata Hosp, Dept Resp Med, Shibata, Japan; [Takeda, Hiroaki] Yamagata Saisei Hosp, Dept Resp Med, Yamagata, Japan; [Watanabe, Hiroshi] Kurume Univ, Sch Med, Dept Infect Control & Prevent, Kurume, Fukuoka, Japan; [Kubota, Tetsuya] Kochi Univ, Kochi Med Sch, Dept Hematol & Resp Med, Kochi, Japan; [Kasahara, Kei] Nara Med Univ, Ctr Infect Dis, Kashihara, Nara, Japan; [Oshima, Kengo] Tohoku Univ, Grad Sch Med, Dept Infect Control & Lab Diagnost, Internal Med, Sendai, Miyagi, Japan; [Nishi, Junichiro] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Microbiol, Kagoshima, Japan; [Maruyama, Takaya] Mie Hosp, Natl Hosp Org, Dept Med, Tsu, Mie, Japan; [Kuronuma, Koji] Sapporo Med Univ, Dept Resp Med & Allergol, Sch Med, Sapporo, Hokkaido, Japan; [Fujita, Jiro] Univ Ryukyus, Grad Sch Med, Dept Infect Resp & Digest Med, Nishihara, Okinawa, Japan; [Ikuse, Tatsuki] Niigata Univ, Grad Sch Med & Dent Sci, Dept Pediat, Niigata, Japan; [Kinjo, Yuki] Natl Inst Infect Dis, Dept Bacteriol, Dept Chemotherapy & Mycoses, Tokyo, Japan; [Kinjo, Yuki] Jikei Univ, Sch Med, Tokyo, Japan; [Suzuki, Motoi] Nagasaki Univ, Inst Trop Med, Dept Clin Med, Nagasaki, Japan; [Kerdsin, Anusak] Kasetsart Univ, Fac Publ Hlth, Chalermphrakiat Sakon Nakhon Prov Campus, Sakon Nakhon, Thailand; [Nakano, Michiharu] Hokkaido Inst Publ Hlth, Sapporo, Hokkaido, Japan; Sendai City Publ Hlth Ctr, Sendai, Miyagi, Japan; [Ikeda, Tatsuya] Yamagata Prefectural Bur Publ Hlth & Welf, Yamagata, Japan; [Suzuki, Yu; Seto, Junji; Yahagi, Kazue] Yamagata Prefectural Inst Publ Hlth, Yamagata, Japan; [Kazama, Kurumi] Welf & Publ Hlth Bur Niigata Prefecture, Niigata, Japan; [Yamazaki, Satoru; Kumakura, Emiko] Hlth & Sanitat Dept Niigata City, Niigata, Japan; [Hiraoka, Minoru] Dept Hlth & Welf, Tsu, Mie, Japan; [Nagai, Yuhki; Naraya, Sagako] Mie Prefecture Hlth & Environm Res Inst, Tsu, Mie, Japan; [Tsujimoto, Eri] Dept Med Policy, Nara, Nara, Japan; [Matsumoto, Michiaki] Publ Hlth Inst Kochi Prefecture, Kochi, Japan; [Shigemura, Hiroaki; Okamoto, Fuyuki; Sera, Nobuyuki] Fukuoka Inst Hlth & Environm Sci, Dazaifu, Japan; [Gokuden, Mutsuyo] Ctr Environm & Hlth, Kagoshima, Kagoshima, Japan; [Itokazu, Toru] Welf & Publ Hlth Bur Okinawa Prefecture, Kagoshima, Japan; [Kudaka, Jun] Okinawa Prefectural Inst Hlth & Environm, Nanjo, Japan; [Yokoyama, Akihito] Kochi Univ, Kochi Med Sch, Kochi, Japan; [Takahashi, Hiroki] Sapporo Med Univ, Sch Med, Sapporo, Hokkaido, Japan; [Aoyagi, Tetsuji; Kaku, Mitsuo] Tohoku Univ, Grad Sch Med, Sendai, Miyagi, Japan; [Abe, Shuichi] Yamagata Prefectural Cent Hosp, Yamagata, Japan; [Tsubata, Chikako; Saitoh, Akihiko] Niigata Univ, Grad Sch Med & Dent Sci, Niigata, Japan; [Ishida, Masayuki] Chikamori Hosp, Kochi, Japan; [Nakamatsu, Masashi] Univ Ryukus, Nishihara, Okinawa, Japan	National Institute of Infectious Diseases (NIID); Tohoku University; National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); Kurume University; Kochi University; Nara Medical University; Tohoku University; Kagoshima University; Sapporo Medical University; University of the Ryukyus; Niigata University; National Institute of Infectious Diseases (NIID); Jikei University; Nagasaki University; Kasetsart University; Kochi University; Sapporo Medical University; Tohoku University; Yamagata Prefectural Central Hospital; Niigata University; University of the Ryukyus	Oishi, K (corresponding author), Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo, Japan.	oishik@nih.go.jp	Shimbashi, Reiko/ABG-6220-2021	Suzuki, Motoi/0000-0002-8340-0880; Ikuse, Tatsuki/0000-0002-0417-6797; Kerdsin, Anusak/0000-0003-1055-3656	Ministry of Health, Labour and Welfare of Japan [H28 Shinko-Gyosei-005]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by the Ministry of Health, Labour and Welfare of Japan (Grant number H28 Shinko-Gyosei-005) to KO.	Andrews NJ, 2012, VACCINE, V30, P6802, DOI 10.1016/j.vaccine.2012.09.019; [Anonymous], [No title captured]; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Brueggemann AB, 2004, J INFECT DIS, V190, P1203, DOI 10.1086/423820; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Chang B, 2015, J CLIN MICROBIOL, V53, P3318, DOI 10.1128/JCM.01222-15; CHERIAN T, 1994, JAMA-J AM MED ASSOC, V271, P695, DOI 10.1001/jama.271.9.695; Chiba N, 2010, EPIDEMIOL INFECT, V138, P61, DOI 10.1017/S0950268809990239; Deng XD, 2016, CLIN INFECT DIS, V62, P1126, DOI 10.1093/cid/ciw050; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Falkenhorst G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169368; Fukusumi M, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2113-y; Geno KA, 2015, CLIN MICROBIOL REV, V28, P871, DOI 10.1128/CMR.00024-15; HOGE CW, 1994, NEW ENGL J MED, V331, P643, DOI 10.1056/NEJM199409083311004; Ikuse T, 2018, EPIDEMIOL INFECT, V146, DOI 10.1017/S0950268818002133; Jansen AGSC, 2009, CLIN INFECT DIS, V49, pE23, DOI 10.1086/600045; Jorgenson G., 2005, Morbidity and Mortality Weekly Report, V54, P72; Kraicer-Melamed H, 2016, VACCINE, V34, P1540, DOI 10.1016/j.vaccine.2016.02.024; Ladhani SN, 2018, LANCET INFECT DIS, V18, P441, DOI 10.1016/S1473-3099(18)30052-5; Rakov AV, 2011, INFECT GENET EVOL, V11, P1929, DOI 10.1016/j.meegid.2011.08.016; Rokney A, 2018, EMERG INFECT DIS, V24, P453, DOI 10.3201/eid2403.170769; Sakiyama H, 2017, J AMBULATORY GEN PED, V20, P271; Sandgren A, 2004, J INFECT DIS, V189, P785, DOI 10.1086/381686; Schillberg E, 2014, CLIN INFECT DIS, V59, P651, DOI 10.1093/cid/ciu366; Singleton RJ, 2007, VACCINE, V25, P2288, DOI 10.1016/j.vaccine.2006.11.065; Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710; Torzillo PJ, 2007, VACCINE, V25, P2375, DOI 10.1016/j.vaccine.2006.09.003; Ubukata K, 2018, EMERG INFECT DIS, V24, P2010, DOI 10.3201/eid2411.180326; Ubukata K, 2015, EMERG INFECT DIS, V21, P1956, DOI 10.3201/eid2111.142029; Zulz T, 2013, J CLIN MICROBIOL, V51, P1402, DOI 10.1128/JCM.02880-12	30	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212418	10.1371/journal.pone.0212418	http://dx.doi.org/10.1371/journal.pone.0212418			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789928	Green Published, gold, Green Submitted			2022-12-27	WOS:000459330800027
J	Bedini, S; Flamini, G; Cosci, F; Ascrizzi, R; Echeverria, MC; Gomez, EV; Guidi, L; Landi, M; Lucchi, A; Conti, B				Bedini, Stefano; Flamini, Guido; Cosci, Francesca; Ascrizzi, Roberta; Echeverria, Maria C.; Gomez, Evelin V.; Guidi, Lucia; Landi, Marco; Lucchi, Andrea; Conti, Barbara			Toxicity and oviposition deterrence of essential oils of Clinopodium nubigenum and Lavandula angustifolia against the myiasis-inducing blowfly Lucilia sericata	PLOS ONE			English	Article							PLANT ESSENTIAL OILS; OREGANO ESSENTIAL OIL; ANTIMICROBIAL ACTIVITY; SALMONELLA-ENTERICA; AEDES-ALBOPICTUS; AROMATIC PLANTS; INSECT PESTS; KUNTH KUNTZE; SHEEP; DISEASE	Cutaneous myiasis is a severe worldwide medical and veterinary issue. In this trial the essential oil (EO) of the Andean medicinal plant species Clinopodium nubigenum (Kunth) Kuntze was evaluated for its bioactivity against the myiasis-inducing blowfly Lucilia sericata (Meigen) (Diptera Calliphoridae) and compared with that of the well-known medicinal plant species Lavandula angustifolia Mill. The EOs were analysed and tested in laboratory for their oviposition deterrence and toxicity against L. sericata adults. The physiology of EO toxicity was evaluated by enzymatic inhibition tests. The antibacterial and antifungal properties of the EOs were tested as well. At 0.8 mu L cm(-2), both EOs completely deterred L. sericata oviposition up to 3 hours. After 24 h, the oviposition deterrence was still 82.7% for L. angustifolia and the 89.5% for C. nubigenum. The two EOs were also toxic to eggs and adults of L. sericata. By contact/fumigation, the EOs, the LC50 values against the eggs were 0.07 and 0.48 mu L cm(-2) while, by topical application on the adults, LD50 values were 0.278 and 0.393 mu L per individual for C. nubigenum and L. angustifolia EOs, respectively. Inhibition of acetylcholine esterase of L. sericata by EOs (IC50 = 67.450 and 79.495 mg L-1 for C. nubigenum and L. angustifolia, respectively) suggested that the neural sites are targets of the EO toxicity. Finally, the observed antibacterial and antifungal properties of C. nubigenum and L. angustifolia EOs suggest that they could also help prevent secondary infections.	[Bedini, Stefano; Cosci, Francesca; Guidi, Lucia; Landi, Marco; Lucchi, Andrea; Conti, Barbara] Univ Pisa, Dept Agr Food & Environm, Pisa, Italy; [Flamini, Guido; Ascrizzi, Roberta] Univ Pisa, Dept Pharm, Pisa, Italy; [Echeverria, Maria C.; Gomez, Evelin V.] Univ Tecn Norte, Fac Ingn Ciencias Agr & Ambientales, Ibarra, Ecuador	University of Pisa; University of Pisa	Conti, B (corresponding author), Univ Pisa, Dept Agr Food & Environm, Pisa, Italy.	barbara.conti@unipi.it	Bedini, Stefano/AAF-4453-2020; Ascrizzi, Roberta/J-5608-2018; Cosci, Francesca/Q-3622-2019; Flamini, Guido/A-7988-2011; Conti, Barbara/H-6373-2019	Bedini, Stefano/0000-0002-3760-9894; Ascrizzi, Roberta/0000-0003-1791-8208; Flamini, Guido/0000-0003-2418-9349; Conti, Barbara/0000-0002-7861-1536; Cosci, Francesca/0000-0003-2330-2557; Landi, Marco/0000-0003-0121-0715; Echeverria, Maria Cristina/0000-0001-8475-5432	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), BIOPIC, 2015 BABFCF	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), BIOPIC, 2015 BABFCF	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), BIOPIC, 2015 BABFCF to Prof. Barbara Conti, http://prin.miur.it/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Adams R.P, 2017, IDENTIFICATION ESSEN, V5th; Andrade JM, 2009, PLANTAS MED SILVESTR; Anstead CA, 2017, ADV PARASIT, V98, P227, DOI 10.1016/bs.apar.2017.03.001; Bajpai VK, 2013, FOOD CONTROL, V32, P582, DOI 10.1016/j.foodcont.2013.01.032; Baker KE, 2014, AUST VET J, V92, P376, DOI 10.1111/avj.12247; Bedini S, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2006-y; Bedini S, 2015, J PEST SCI, V88, P583, DOI 10.1007/s10340-015-0647-1; Benelli G, 2012, CROP PROT, V42, P223, DOI 10.1016/j.cropro.2012.05.024; Bennett R, 2003, FINAL REPORT DEP ENV; Bisdorff B, 2006, VET REC, V158, P749, DOI 10.1136/vr.158.22.749; Bosly B., 2013, J ENTOMOL NEMATOL, V5, P50, DOI DOI 10.5897/JEN2013.0073; Bougherra HH, 2015, IND CROP PROD, V63, P249, DOI 10.1016/j.indcrop.2014.09.048; Burt S, 2004, INT J FOOD MICROBIOL, V94, P223, DOI 10.1016/j.ijfoodmicro.2004.03.022; Callander JT, 2012, VET PARASITOL, V184, P271, DOI 10.1016/j.vetpar.2011.08.017; Campolo O, 2014, PHYTOPARASITICA, V42, P223, DOI 10.1007/s12600-013-0355-4; Carson CF, 2002, ANTIMICROB AGENTS CH, V46, P1914, DOI 10.1128/AAC.46.6.1914-1920.2002; Cavanagh HMA, 2002, PHYTOTHER RES, V16, P301, DOI 10.1002/ptr.1103; Cheah SX, 2013, PARASITOL RES, V112, P3275, DOI 10.1007/s00436-013-3506-0; Chen PeterJohn., 2016, ANIMAL WELFARE AUSTR; Conti B, 2012, PARASITOL RES, V111, P291, DOI 10.1007/s00436-012-2837-6; Conti B, 2010, PARASITOL RES, V107, P1455, DOI 10.1007/s00436-010-2018-4; Cos P, 2006, J ETHNOPHARMACOL, V106, P290, DOI 10.1016/j.jep.2006.04.003; Portillo-Ruiz MC, 2012, J FOOD SCI, V77, pM441, DOI 10.1111/j.1750-3841.2012.02821.x; Daferera DJ, 2003, CROP PROT, V22, P39, DOI 10.1016/S0261-2194(02)00095-9; DAVIES NW, 1990, J CHROMATOGR, V503, P1, DOI 10.1016/S0021-9673(01)81487-4; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Gayatri Nahak, 2011, International Journal of Pharmaceutical and Biological Archives, V2, P1236; Gilardoni G, 2011, REV BRAS FARMACOGN, V21, P850, DOI 10.1590/S0102-695X2011005000139; Graczyk TK, 2001, MICROBES INFECT, V3, P231, DOI 10.1016/S1286-4579(01)01371-5; HALL M, 1995, ADV PARASIT, V35, P257, DOI 10.1016/S0065-308X(08)60073-1; Hall MJR, 2016, ANNU REV ENTOMOL, V61, P159, DOI 10.1146/annurev-ento-010715-023655; Holetz FB, 2002, MEM I OSWALDO CRUZ, V97, P1027, DOI 10.1590/S0074-02762002000700017; Ibrahim L, 2012, J ESSENT OIL RES, V24, P339, DOI 10.1080/10412905.2012.692900; Isman MB, 2000, CROP PROT, V19, P603, DOI 10.1016/S0261-2194(00)00079-X; Isman MB, 2006, ANNU REV ENTOMOL, V51, P45, DOI 10.1146/annurev.ento.51.110104.151146; Junqueira ACM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16353-x; Khosravi Roya, 2013, Journal of King Saud University Science, V25, P349, DOI 10.1016/j.jksus.2013.01.002; Kwon SJ, 2017, FOOD MICROBIOL, V65, P114, DOI 10.1016/j.fm.2017.02.004; Lambert RJW, 2001, J APPL MICROBIOL, V91, P453, DOI 10.1046/j.1365-2672.2001.01428.x; Leitner N, 2016, PARASITOL RES, V115, P4417, DOI 10.1007/s00436-016-5206-z; Levot GW, 2012, AUST VET J, V90, P433, DOI 10.1111/j.1751-0813.2012.00984.x; LITTLEJOHN JW, 1991, J INST WATER ENV MAN, V5, P21; Lv F, 2011, FOOD RES INT, V44, P3057, DOI 10.1016/j.foodres.2011.07.030; Moreira MR, 2005, LWT-FOOD SCI TECHNOL, V38, P565, DOI 10.1016/j.lwt.2004.07.012; Nerio LS, 2009, J STORED PROD RES, V45, P212, DOI 10.1016/j.jspr.2009.01.002; Pascual-Villalobos M.J., 1996, Boletin de Sanidad Vegetal Plagas, V22, P411; Perricone M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00076; Rajkumar S, 2009, PARASITOL RES, V104, P337, DOI 10.1007/s00436-008-1197-8; Regnault-Roger C, 2012, ANNU REV ENTOMOL, V57, P405, DOI 10.1146/annurev-ento-120710-100554; REGNAULTROGER C, 1993, J CHEM ECOL, V19, P1233, DOI 10.1007/BF00987383; Rios M, 2007, PLANTAS UTILES ECUAD; Rose H, 2011, INT J PARASITOL, V41, P739, DOI 10.1016/j.ijpara.2011.01.012; Rothwell J, 2007, AUST VET J, V85, P94, DOI 10.1111/j.1751-0813.2007.00116.x; Ruiz S, 2010, J ESSENT OIL BEAR PL, V13, P676, DOI 10.1080/0972060X.2010.10643879; Sackett D., 2006, ASSESSING EC COST EN, V87; Sandeman RM, 2014, INT J PARASITOL, V44, P879, DOI 10.1016/j.ijpara.2014.08.009; Sartoratto A, 2004, BRAZ J MICROBIOL, V35, P275, DOI 10.1590/S1517-83822004000300001; Savelev S, 2003, PHARMACOL BIOCHEM BE, V75, P661, DOI 10.1016/S0091-3057(03)00125-4; Seo SM, 2015, J AGR FOOD CHEM, V63, P9977, DOI 10.1021/acs.jafc.5b03586; SIKKEMA J, 1995, MICROBIOL REV, V59, P201, DOI 10.1128/MMBR.59.2.201-222.1995; Singh A, 2015, PARASITOL RES, V114, P3183, DOI 10.1007/s00436-015-4620-y; Small AH, 2018, RES VET SCI, V118, P305, DOI 10.1016/j.rvsc.2018.03.006; Sotiraki S, 2012, SMALL RUMINANT RES, V103, P75, DOI 10.1016/j.smallrumres.2011.10.021; STEPHENS R, 1995, LANCET, V345, P1135, DOI 10.1016/S0140-6736(95)90976-1; Tellam RL, 1997, INT J PARASITOL, V27, P261, DOI 10.1016/S0020-7519(96)00174-9; Tolouee M, 2010, INT J FOOD MICROBIOL, V139, P127, DOI 10.1016/j.ijfoodmicro.2010.03.032; V de la Torre L., 2008, ENCICLOPEDIA PLANTAS; Waghorn TS, 2013, NEW ZEAL VET J, V61, P274, DOI 10.1080/00480169.2012.760400; Walker JF, 2016, J FOOD SAFETY, V36, P489, DOI 10.1111/jfs.12266; Wall R, 2012, VET PARASITOL, V189, P44, DOI 10.1016/j.vetpar.2012.03.031; Yadegarinia D, 2006, PHYTOCHEMISTRY, V67, P1249, DOI 10.1016/j.phytochem.2006.04.025; Yaghoubi R., 2005, ACTA MED IRAN, V43, P155; Yazdani E, 2013, PESTIC BIOCHEM PHYS, V107, P250, DOI 10.1016/j.pestbp.2013.08.002; ZUMPT F., 1965	75	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2								10.1371/journal.pone.0212576	http://dx.doi.org/10.1371/journal.pone.0212576			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785945	Green Published, gold, Green Submitted			2022-12-27	WOS:000459307000072
J	Gerdes, Z; Ogonowski, M; Nybom, I; Ek, C; Adolfsson-Erici, M; Barth, A; Gorokhova, E				Gerdes, Zandra; Ogonowski, Martin; Nybom, Inna; Ek, Caroline; Adolfsson-Erici, Margaretha; Barth, Andreas; Gorokhova, Elena			Microplastic-mediated transport of PCBs? A depuration study with Daphnia magna	PLOS ONE			English	Article							HYDROPHOBIC ORGANIC-CHEMICALS; POLYCHLORINATED-BIPHENYLS; MARINE-ENVIRONMENT; POLLUTANTS; IMPACT; CONTAMINANTS; INGESTION; PLASTICS; GROWTH; BIOACCUMULATION	The role of microplastic (MP) as a carrier of persistent organic pollutants (POPs) to aquatic organisms has been a topic of debate. However, the reverse POP transport can occur if relative contaminant concentrations are higher in the organism than in the microplastic. We evaluated the effect of microplastic on the PCB removal in planktonic animals by exposing the cladoceran Daphnia magna with a high body burden of polychlorinated biphenyls (PCB 18, 40, 128 and 209) to a mixture of microplastic and algae; daphnids exposed to only algae served as the control. As the endpoints, we used PCB body burden, growth, fecundity and elemental composition (%C and %N) of the daphnids. In the daphnids fed with microplastic, PCB 209 was removed more efficiently, while there was no difference for any other congeners and Sigma PCBs between the microplastic-exposed and control animals. Also, higher size-specific egg production in the animals carrying PCB and receiving food mixed with micro-plastics was observed. However, the effects of the microplastic exposure on fecundity were of low biological significance, because the PCB body burden and the microplastic exposure concentrations were greatly exceeding environmentally relevant concentrations.	[Gerdes, Zandra; Ogonowski, Martin; Nybom, Inna; Ek, Caroline; Adolfsson-Erici, Margaretha; Gorokhova, Elena] Stockholm Univ, Dept Environm Sci & Analyt Chem, Stockholm, Sweden; [Ogonowski, Martin] Aquabiota Water Res AB, Stockholm, Sweden; [Ogonowski, Martin] Swedish Univ Agr Sci, Inst Freshwater Res, Dept Aquat Resources, Stockholm, Sweden; [Barth, Andreas] Stockholm Univ, Dept Biochem & Biophys, Stockholm, Sweden	Stockholm University; Swedish University of Agricultural Sciences; Stockholm University	Gerdes, Z (corresponding author), Stockholm Univ, Dept Environm Sci & Analyt Chem, Stockholm, Sweden.	zandra.gerdes@aces.su.se	Nybom, Inna/AAH-5314-2020; Barth, Andreas/N-8872-2013	Nybom, Inna/0000-0002-3399-1483; Gorokhova, Elena/0000-0002-4192-6956; Ogonowski, Martin/0000-0002-7082-0990; Gerdes, Zandra/0000-0003-0752-677X; Barth, Andreas/0000-0001-5784-7673	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS) [216-2013-1010, 2015-00932]; Swedish Institute, Isotope Ecology Network in the Baltic Sea region (NSSIA project) [12906/2013]; Joint Programming Initiative Healthy and Productive Seas and Oceans (JPI Oceans, WEATHER-MIC project) [942-2015-1866]; Swedish Innovation Agency VINNOVA; joint Baltic Sea research and development programme (BONUS, Blue Baltic) [2017-00979]	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); Swedish Institute, Isotope Ecology Network in the Baltic Sea region (NSSIA project); Joint Programming Initiative Healthy and Productive Seas and Oceans (JPI Oceans, WEATHER-MIC project); Swedish Innovation Agency VINNOVA(Vinnova); joint Baltic Sea research and development programme (BONUS, Blue Baltic)	This work was supported by Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, http://www.formas.se/en/start-page.html, (FORMAS, grant number: 216-2013-1010) - MO, EG; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, http://www.formas.se/en/start-page.html, (FORMAS, grant number: 2015-00932) - AB, EG, MO; Swedish Institute, https://si.se/en/, Isotope Ecology Network in the Baltic Sea region (NSSIA project, grant number 12906/2013) - EG; The Joint Programming Initiative Healthy and Productive Seas and Oceans, http://jpi-oceans.eu/, (JPI Oceans, WEATHER-MIC project, grant number 942-2015-1866) - EG; The Swedish Innovation Agency VINNOVA, https://www.vinnova.se/en/, and the joint Baltic Sea research and development programme, https://www.bonusportal.org/, (BONUS, Blue Baltic) for MICROPOLL project [grant number 2017-00979] - EG.	Andrady AL, 2011, MAR POLLUT BULL, V62, P1596, DOI 10.1016/j.marpolbul.2011.05.030; Avio CG, 2015, ENVIRON POLLUT, V198, P211, DOI 10.1016/j.envpol.2014.12.021; Bakir A, 2016, ENVIRON POLLUT, V219, P56, DOI 10.1016/j.envpol.2016.09.046; Bejgarn S, 2015, CHEMOSPHERE, V132, P114, DOI 10.1016/j.chemosphere.2015.03.010; Bergman TU, 2011, ENVIRON SCI POLLUT R, V18, P655, DOI 10.1007/s11356-010-0413-0; Besseling E, 2017, ENVIRON SCI TECHNOL, V51, P8795, DOI 10.1021/acs.est.7b02286; Besseling E, 2014, ENVIRON SCI TECHNOL, V48, P12336, DOI 10.1021/es503001d; Boerger CM, 2010, MAR POLLUT BULL, V60, P2275, DOI 10.1016/j.marpolbul.2010.08.007; Brennecke D, 2016, ESTUAR COAST SHELF S, V178, P189, DOI 10.1016/j.ecss.2015.12.003; Browne MA, 2008, ENVIRON SCI TECHNOL, V42, P5026, DOI 10.1021/es800249a; Cedervall T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032254; Chen QQ, 2018, ENVIRON SCI TECHNOL, V52, P446, DOI 10.1021/acs.est.7b04682; Chua EM, 2014, ENVIRON SCI TECHNOL, V48, P8127, DOI 10.1021/es405717z; Cole M, 2015, ENVIRON SCI TECHNOL, V49, P1130, DOI 10.1021/es504525u; Cole M, 2013, ENVIRON SCI TECHNOL, V47, P6646, DOI 10.1021/es400663f; Cole M, 2011, MAR POLLUT BULL, V62, P2588, DOI 10.1016/j.marpolbul.2011.09.025; Demkowicz-Dobrzanski K, 1993, SCI TOTAL ENVIRON, V134, P1151, DOI [10.1016/S0048-9697(05)80119-6, DOI 10.1016/S0048-9697(05)80119-6]; DILLON TM, 1990, ENVIRON TOXICOL CHEM, V9, P1317, DOI 10.1002/etc.5620091013; DUMONT HJ, 1975, OECOLOGIA, V19, P75, DOI 10.1007/BF00377592; Fisk AT, 2001, MAR POLLUT BULL, V43, P93, DOI 10.1016/S0025-326X(01)00038-8; Frouin H, 2013, PROG OCEANOGR, V115, P65, DOI 10.1016/j.pocean.2013.05.023; Furuhagen S, 2014, ENVIRON SCI TECHNOL, V48, P12886, DOI 10.1021/es5044722; Ge J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071521; GLAZIER DS, 1991, LIMNOL OCEANOGR, V36, P354, DOI 10.4319/lo.1991.36.2.0354; Goerke H, 2001, MAR ENVIRON RES, V51, P131, DOI 10.1016/S0141-1136(00)00036-2; Gomes SIL, 2015, INT J ENV RES PUB HE, V12, P6858, DOI 10.3390/ijerph120606858; Grilo TF, 2014, ECOTOX ENVIRON SAFE, V101, P97, DOI 10.1016/j.ecoenv.2013.12.020; Hartmann NB, 2017, INTEGR ENVIRON ASSES, V13, P488, DOI 10.1002/ieam.1904; HAWKER DW, 1988, ENVIRON SCI TECHNOL, V22, P382, DOI 10.1021/es00169a004; Herzke D, 2016, ENVIRON SCI TECHNOL, V50, P1924, DOI 10.1021/acs.est.5b04663; KIRK KL, 1991, FRESHWATER BIOL, V25, P357, DOI 10.1111/j.1365-2427.1991.tb00498.x; Koelmans AA, 2015, MARINE ANTHROPOGENIC LITTER, P309, DOI 10.1007/978-3-319-16510-3_11; Koelmans AA, 2013, ENVIRON SCI TECHNOL, V47, P7812, DOI 10.1021/es401169n; Landrum PF, 2001, J GREAT LAKES RES, V27, P117, DOI 10.1016/S0380-1330(01)70627-2; Lu YF, 2016, ENVIRON SCI TECHNOL, V50, P4054, DOI 10.1021/acs.est.6b00183; MCMANUS GB, 1983, ESTUAR COAST SHELF S, V17, P421, DOI 10.1016/0272-7714(83)90127-0; Nybom I, 2016, ENVIRON SCI TECHNOL, V50, P5252, DOI 10.1021/acs.est.6b00991; OECD, 2004, TEST 202 DAPHN SP AC, DOI 10.1787/9789264069947-en; Ogonowski M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155063; Peltonen H, 2014, CHEMOSPHERE, V114, P172, DOI 10.1016/j.chemosphere.2014.04.026; Phuong NN, 2016, ENVIRON POLLUT, V211, P111, DOI 10.1016/j.envpol.2015.12.035; Rochman CM, 2014, SCI TOTAL ENVIRON, V493, P656, DOI 10.1016/j.scitotenv.2014.06.051; Rochman CM, 2013, SCI REP-UK, V3, DOI 10.1038/srep03263; Rummel CD, 2016, ENVIRON SCI-PROC IMP, V18, P788, DOI [10.1039/c6em00234j, 10.1039/C6EM00234J]; Seidensticker S, 2017, ENVIRON SCI TECHNOL, V51, P12254, DOI 10.1021/acs.est.7b02664; SIBLY RM, 1989, BIOL J LINN SOC, V37, P101, DOI 10.1111/j.1095-8312.1989.tb02007.x; Sperfeld E, 2009, J EXP BIOL, V212, P3051, DOI 10.1242/jeb.031401; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; Syberg K, 2017, J TOXICOL ENV HEAL A, V80, P1369, DOI 10.1080/15287394.2017.1385046; Teuten EL, 2007, ENVIRON SCI TECHNOL, V41, P7759, DOI 10.1021/es071737s; Thompson RC, 2004, SCIENCE, V304, P838, DOI 10.1126/science.1094559; Tiano M, 2014, MAR POLLUT BULL, V89, P331, DOI 10.1016/j.marpolbul.2014.09.040; Velzeboer I, 2014, ENVIRON SCI TECHNOL, V48, P4869, DOI 10.1021/es405721v; Wardrop P, 2016, ENVIRON SCI TECHNOL, V50, P4037, DOI 10.1021/acs.est.5b06280; Wright SL, 2013, CURR BIOL, V23, pR1031, DOI 10.1016/j.cub.2013.10.068; Ziccardi LM, 2016, ENVIRON TOXICOL CHEM, V35, P1667, DOI 10.1002/etc.3461	56	26	28	13	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0205378	10.1371/journal.pone.0205378	http://dx.doi.org/10.1371/journal.pone.0205378			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779782	gold, Green Published, Green Submitted			2022-12-27	WOS:000459062900003
J	Bond, JG; Osorio, AR; Avila, N; Gomez-Simuta, Y; Marina, CF; Fernandez-Salas, I; Liedo, P; Dor, A; Carvalho, DO; Bourtzis, K; Williams, T				Guillermo Bond, J.; Osorio, Adriana R.; Avila, Nancy; Gomez-Simuta, Yeudiel; Marina, Carlos F.; Fernandez-Salas, Ildefonso; Liedo, Pablo; Dor, Ariane; Carvalho, Danilo O.; Bourtzis, Kostas; Williams, Trevor			Optimization of irradiation dose to Aedes aegypti and Ae. albopictus in a sterile insect technique program	PLOS ONE			English	Article							GAMMA RADIATION; DISPERSAL; POPULATION; SURVIVAL; DISEASE; FUTURE	The sterile insect technique (SIT) may offer a means to control the transmission of mosquito borne diseases. SIT involves the release of male insects that have been sterilized by exposure to ionizing radiation. We determined the effects of different doses of radiation on the survival and reproductive capacity of local strains of Aedes aegypti and Ae. albopictus in southern Mexico. The survival of irradiated pupae was invariably greater than 90% and did not differ significantly in either sex for either species. Irradiation had no significant adverse effects on the flight ability (capacity to fly out of a test device) of male mosquitoes, which consistently exceeded 91% in Ae. aegypti and 96% in Ae. albopictus. The average number of eggs laid per female was significantly reduced in Ae. aegypti at doses of 15 and 30 Gy and no eggs were laid by females that had been exposed to 50 Gy. Similarly, in Ae. albopictus, egg production was reduced at doses of 15 and 25 Gy and was eliminated at 35 Gy. In Ae. aegypti, fertility in males was eliminated at 70 Gy and was eliminated at 30 Gy in females, whereas in Ae. albopictus, the fertility of males that mated with untreated females was almost zero (0.1%) in the 50 Gy treatment and female fertility was eliminated at 35 Gy. Irradiation treatments resulted in reduced ovary length and fewer follicles in both species. The adult median survival time of both species was reduced by irradiation in a dose-dependent manner. However, sterilizing doses of 35 Gy and 50 Gy resulted in little reduction in survival times of males of Ae. albopictus and Ae. aegypti, respectively, indicating that these doses should be suitable for future evaluations of SIT-based control of these species. The results of the present study will be applied to studies of male sexual competitiveness and to stepwise evaluations of the sterile insect technique for population suppression of these vectors in Mexico.	[Guillermo Bond, J.; Osorio, Adriana R.; Avila, Nancy; Marina, Carlos F.; Fernandez-Salas, Ildefonso] INSP, CRISP, Tapachula, Chiapas, Mexico; [Gomez-Simuta, Yeudiel] IICA, SAGARPA, Programa Moscas Fruta, Camino Cacaotales S-N, Metapa De Dominguez, Chiapas, Mexico; [Fernandez-Salas, Ildefonso] Univ Autonoma Nuevo Leon, Fac Ciencias Biol, Nuevo Leon, Mexico; [Liedo, Pablo; Dor, Ariane] El Colegio Frontera Sur, Tapachula, Chiapas, Mexico; [Carvalho, Danilo O.; Bourtzis, Kostas] IAEA, Joint FAO IAEA Programme Nucl Tech Food & Agr, Insect Pest Control Lab, Seibersdorf, Austria; [Williams, Trevor] Inst Ecol AC INECOL, Xalapa, Veracruz, Mexico	Universidad Autonoma de Nuevo Leon; El Colegio de la Frontera Sur (ECOSUR); International Atomic Energy Agency; Instituto de Ecologia - Mexico	Williams, T (corresponding author), Inst Ecol AC INECOL, Xalapa, Veracruz, Mexico.	trevor.inecol@gmail.com	Dor, Ariane/A-7975-2013; Liedo, Pablo/E-9313-2010; Williams, Trevor/ABG-3961-2020; Carvalho, Danilo Oliveira/AAL-7270-2020; Williams, Trevor/F-1447-2011; Dor, Ariane/AAQ-7554-2020	Dor, Ariane/0000-0002-3483-9547; Liedo, Pablo/0000-0002-0004-1721; Carvalho, Danilo Oliveira/0000-0001-8168-4050; Williams, Trevor/0000-0003-3414-3440; Marina Fernandez, Carlos Felix/0000-0002-4804-8949	Fondo Institucional del Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico [FOINS-PDCAPN-2014-247673]; International Atomic Energy Agency (IAEA) [MEX5031]; Fondo de Investigacion Cientifica y Desarrollo Tecnologico project "Desarrollo de tecnologia para el manejo integral de mosquitos vectores de dengue, chikungunya y Zika en Guatemala y Mexico" of El Colegio de la Frontera Sur (ECOSUR), Mexico; Catedras CONACYT program [71314]; CONACYT, Mexico	Fondo Institucional del Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico; International Atomic Energy Agency (IAEA)(International Atomic Energy Agency); Fondo de Investigacion Cientifica y Desarrollo Tecnologico project "Desarrollo de tecnologia para el manejo integral de mosquitos vectores de dengue, chikungunya y Zika en Guatemala y Mexico" of El Colegio de la Frontera Sur (ECOSUR), Mexico; Catedras CONACYT program; CONACYT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The study received financial support from the Fondo Institucional del Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico, project FOINS-PDCAPN-2014-247673 and the International Atomic Energy Agency (IAEA) through technical cooperation project MEX5031, both awarded to JGB. ARO was funded by the Fondo de Investigacion Cientifica y Desarrollo Tecnologico project "Desarrollo de tecnologia para el manejo integral de mosquitos vectores de dengue, chikungunya y Zika en Guatemala y Mexico" of El Colegio de la Frontera Sur (ECOSUR), Mexico. AD received funding from the Catedras CONACYT program (no. 71314). NA received a Master's program scholarship from CONACYT, Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1979, BASIC PRINCIPLES INS; Arredondo J., 2016, Proceedings of the 9th International Symposium on Fruit Flies of Economic Importance, 12-16 May 2014, Bangkok, Thailand, P355; Azizyan A, 2003, 11024R1 ARM INT AT E; Bakri A, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P233, DOI 10.1007/1-4020-4051-2_9; Bakri A, 2005, ANN ENTOMOL SOC AM, V98, P1, DOI 10.1603/0013-8746(2005)098[0001:FYORBI]2.0.CO;2; Balestrino F, 2010, J MED ENTOMOL, V47, P581, DOI 10.1603/ME09272; Bellini R., 2007, P505, DOI 10.1007/978-1-4020-6059-5_47; Bhuyan K. B., 2016, J MOSQ RES, V6, P1; Bond JG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187420; Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351; Calkins CO, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P269, DOI 10.1007/1-4020-4051-2_10; Casas-Martinez M, 2013, J VECTOR ECOL, V38, P277, DOI 10.1111/j.1948-7134.2013.12041.x; Catteruccia F, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S7; Culbert NJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34469-6; Dominguez J., 2010, MOSCAS FRUTA FUNDAME; Dyck V.A., 2006, STERILE INSECT TECHN; Enkerlin WR, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P651, DOI 10.1007/1-4020-4051-2_25; Equihua M, 2017, ACTA TROP, V166, P316, DOI 10.1016/j.actatropica.2016.11.014; Ernawan B, 2017, AIP CONF PROC, V1854, DOI 10.1063/1.4985401; Hernandez-Avila JE, 2018, B WORLD HEALTH ORGAN, V96, P306, DOI 10.2471/BLT.17.201004; Fernandez-Salas I, 2015, ANTIVIR RES, V124, P30, DOI 10.1016/j.antiviral.2015.10.015; Gaggl K, 1992, MANAGEMENT INSECT PE, P453; Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302; HALLINAN E, 1973, NATURE, V244, P368, DOI 10.1038/244368a0; Hallman GJ, 2003, J ECON ENTOMOL, V96, P1399, DOI 10.1603/0022-0493-96.5.1399; Helinski MEH, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-41; Helinski MEH, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S6; Hendrichs J, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P563, DOI 10.1007/1-4020-4051-2_22; Huang YJS, 2017, INSECTS, V8, DOI 10.3390/insects8010021; International Atomic Energy Agency, 2004, DOS SYST SIT PROC; International Atomic Energy Agency Dosimetry for Food Irradiation, 2002, 409 INT AT EN AG, V409; Ishak IH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0797-2; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; Kuri-Morales P, 2017, MED VET ENTOMOL, V31, P240, DOI 10.1111/mve.12225; Lacroix R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042771; Lance DR, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P69, DOI 10.1007/1-4020-4051-2_3; Lebon C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202236; Lees RS, 2015, CURR OPIN INSECT SCI, V10, P156, DOI 10.1016/j.cois.2015.05.011; Lopez-Martinez G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088128; Luckey T. D., 2006, Dose-Response, V4, P169, DOI 10.2203/dose-response.06-102.Luckey; Maciel-De-Freitas R, 2007, AM J TROP MED HYG, V76, P659, DOI 10.4269/ajtmh.2007.76.659; Oliva CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049414; Parker A, 2007, FLA ENTOMOL, V90, P88, DOI 10.1653/0015-4040(2007)90[88:SITAMF]2.0.CO;2; Rodriguez SD, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-211; Salwa M. A. B., 2011, Journal of Agricultural Biotechnology and Sustainable Development, V3, P105; SHEPPARD PM, 1969, J ANIM ECOL, V38, P661, DOI 10.2307/3042; Shetty V, 2017, TOXICOL IND HEALTH, V33, P930, DOI 10.1177/0748233717733599; Shetty Vinaya, 2016, Parasite Epidemiol Control, V1, P26, DOI 10.1016/j.parepi.2016.02.007; TERZIAN LA, 1958, BIOL BULL, V115, P536, DOI 10.2307/1539116; TRPIS M, 1986, AM J TROP MED HYG, V35, P1263, DOI 10.4269/ajtmh.1986.35.1263; Vargas-Teran M, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P629, DOI 10.1007/1-4020-4051-2_24; WEIDHAAS D. E., 1963, Mosquito News, V23, P32; Yamada H, 2014, J MED ENTOMOL, V51, P811, DOI 10.1603/ME13223; Yanez-Arenas C, 2018, J MED ENTOMOL, V55, P69, DOI 10.1093/jme/tjx185; Zhang DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135194; Zhang DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121126	58	32	32	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212520	10.1371/journal.pone.0212520	http://dx.doi.org/10.1371/journal.pone.0212520			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779779	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000459062900062
J	Kapumba, BM; King, R				Kapumba, Blessings Msango; King, Rebecca			Perceived HIV-protective benefits of male circumcision: Risk compensatory behaviour among women in Malawi	PLOS ONE			English	Article							PREVENTION; MEN	Background Male circumcision (MC) reduces men's risk of contracting HIV by approximately 60% and has the potential to significantly alter HIV epidemics. However, MC does not significantly reduce the risk of HIV transmission to women from a circumcised man. In Malawi, several researchers has examined the acceptability, accessibility and sexual behaviour change after circumcision in men but behaviour change in women following their partner's circumcision remains uncertain. In order to fully realise the protective benefits of MC against HIV, factors related to risky sexual behaviour is imperative as some studies have shown potentials of increased risky behaviour in men following voluntary medical male circumcision (VMMC). This study aimed to explore the perceptions and opinions of female school teachers and health workers on HIV-protective benefits of MC and its impact on risk compensatory behaviour among women in Malawi. Methods We conducted a cross-sectional survey of women (N = 68) between May and June 2016 in three districts of southern Malawi. Risk compensatory behaviour was measured by number of sexual partners and use of protection during sex among female teachers and health care workers who are involved with educating people on benefits of VMMC. The bivariable analysis was conducted to test for association between HIV-protective benefits and risk compensatory behaviour. Purposive sampling was used to conduct eight qualitative in-depth interviews with women from the selected districts and the qualitative data was analysed thematically. Results The mean age of women who participated in the survey was 30 years. Most women (94.1%) correctly indicated that HIV-positive circumcised men can still infect their partner and approximately, 90% of were knowledgeable of risky sexual behaviour for HIV. However, 55.9% perceived MC can lead women to adopt risky sexual behaviour. On the contrary to this finding, qualitative data indicate women's misconceptions regarding their partners' circumcision and HIV-protective benefits. Most women expressed that risky sexual behaviour such as having multiple sexual partners and inconsistent or non-use of condoms can easily be observed among women if they learn of their partners' partial HIV-protective benefits circumcision. Conclusion Exploring women's sexual behaviour change in the right of HIV-protective benefits of MC fills in a research knowledge important to public health. In-depth studies are therefore required to give more evidence that will guide the development of HIV risk-reduction interventions.	[Kapumba, Blessings Msango] Malawi Liverpool Wellcome Trust, Dept Behav & Hlth, Blantyre, Malawi; [King, Rebecca] Univ Leeds, Leeds Inst Hlth Sci, Nuffield Ctr Int Hlth & Dev, Leeds, W Yorkshire, England	University of Malawi; University of Leeds	Kapumba, BM (corresponding author), Malawi Liverpool Wellcome Trust, Dept Behav & Hlth, Blantyre, Malawi.	mblessingsk012@gmail.com	Kapumba, Blessings/GXF-7996-2022	Kapumba, Blessings Msango/0000-0002-8210-3454				Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bryman A., 2006, QUAL RES, V6, P97, DOI [10.1177/1468794106058877, DOI 10.1177/1468794106058877]; Cassell MM, 2006, BMJ-BRIT MED J, V332, P605, DOI 10.1136/bmj.332.7541.605; Clark V. L. P., 2010, QUALITATIVE INQUIRY; Eaton Lisa A, 2007, Curr HIV/AIDS Rep, V4, P165, DOI 10.1007/s11904-007-0024-7; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Greene J. C., 2007, MIXED METHODS SOCIAL; Haberland NA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149517; Hallett TB, 2011, SEX TRANSM INFECT, V87, P88, DOI 10.1136/sti.2010.043372; Hankins C, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000109; John W.C., 2013, RES DESIGN QUALITATI, V4th; Jung J. H., 2012, Consilience: The Journal of Sustainable Development, P103; Kalichman S, 2007, PLOS MED, V4, P597, DOI 10.1371/journal.pmed.0040138; Lanham M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044825; Layer EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074391; Lurie M. N., 2014, AIDS BEHAV, V18, P1; Marshall MN, 1996, FAM PRACT, V13, P522, DOI 10.1093/fampra/13.6.522; Maughan-Brown B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040753; NAC, 2014, MAL NAT HIV PREV SST; NAC, 2012, COMM DEM CREAT COMM; Osaki H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139009; Pett M.A., 2015, NONPARAMETRIC STAT H; Ritchie J., 2013, QUALITATIVE RES PRAC; Thompson MS, 2013, QUANT METH EDUC BEHA, P163; UNAIDS/WHO, 2007, NEW DAT MAL CIRC HIV; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; WHO,, 2014, WHO PROGR BRIEF VOL; WHO & UNAIDS, 2011, JOINT STRAT ACT FRAM; World Health Organization & World Health Organization, 2009, WHO HDB INDOOR RADON	31	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211015	10.1371/journal.pone.0211015	http://dx.doi.org/10.1371/journal.pone.0211015			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811397	Green Published, gold, Green Submitted			2022-12-27	WOS:000459806400012
J	Zhang, LM; Pfoser, D				Zhang, Liming; Pfoser, Dieter			Using OpenStreetMap point-of-interest data to model urban change-A feasibility study	PLOS ONE			English	Article							NEIGHBORHOOD CRIME RATES; INFORMATION; PATTERNS	User-generated content is a valuable resource for capturing all aspects of our environment and lives, and dedicated Volunteered Geographic Information (VGI) efforts such as OpenStreetMap (OSM) have revolutionized spatial data collection. While OSM data is widely used, considerably little attention has been paid to the quality of its Point-of-interest (POI) component. This work studies the accuracy, coverage, and trend worthiness of POI data. We assess the accuracy and coverage using another VGI source that utilizes editorial control. OSM data is compared to Foursquare data by using a combination of label similarity and positional proximity. Using the example of coffee shop POIs in Manhattan we also assess the trend worthiness of OSM data. A series of spatio-temporal statistical models are tested to compare change in the number of coffee shops to home prices in certain areas. This work overall shows that, although not perfect, OSM POI data and specifically its temporal aspect (changeset) can be used to drive urban science research and to study urban change.	[Zhang, Liming; Pfoser, Dieter] George Mason Univ, Dept Geog & GeoInformat Sci, Fairfax, VA 22030 USA	George Mason University	Zhang, LM (corresponding author), George Mason Univ, Dept Geog & GeoInformat Sci, Fairfax, VA 22030 USA.	lzhang22@gmu.edu	Zhang, Liming/AAW-5277-2021	Zhang, Liming/0000-0002-8451-4206	Department of Defense [HM02101410004]; National Science Foundation [1637541]; George Mason University, Presidential graduate research scholarship	Department of Defense(United States Department of Defense); National Science Foundation(National Science Foundation (NSF)); George Mason University, Presidential graduate research scholarship	This work was supported by Department of Defense grant HM02101410004; the National Science Foundation, Grant No. 1637541; and George Mason University, Presidential graduate research scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agterberg FP, 1984, SPATIAL STAT MODELS, V40, P147, DOI [10.1007/978-94-017-3048-8_8, DOI 10.1007/978-94-017-3048-8_8]; Ahmad M, 2015, MAP CONSTRUCTION ALG; Ahmed M, 2015, GEOINFORMATICA, V19, P601, DOI 10.1007/s10707-014-0222-6; AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; Angel A, 2008, P 16 ACM SIGSPATIAL, P1, DOI DOI 10.1145/1463434.1463460; Anselin L., 2013, SPATIAL ECONOMETRICS, V4; Arsanjani JJ, 2015, LECT NOTES GEOINF CA, P1, DOI 10.1007/978-3-319-14280-7_1; Bader MDM, 2010, AM J EPIDEMIOL, V171, P609, DOI 10.1093/aje/kwp419; Batty M, 2008, SCIENCE, V319, P769, DOI 10.1126/science.1151419; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bourassa S, 2010, J REAL ESTATE RES; Carroll GR, 2011, CITY COMMUNITY, V10, P1, DOI 10.1111/j.1540-6040.2010.01350.x; Case B, 2004, J REAL ESTATE FINANC, V29, P167, DOI 10.1023/B:REAL.0000035309.60607.53; Case K., 1987, PRICES SINGLE FAMILY; Ciepluch B., 2010, P 9 INT S SPAT ACC A, P337; Cormen T., 2009, INTRO ALGORITHMS; Crooks A, 2015, INT J GEOGR INF SCI, V29, P720, DOI 10.1080/13658816.2014.977905; Diewert WE, 2010, 1010 U BRIT DEP EC; Estima J, 2015, LECT NOTES GEOINF CA, P273, DOI 10.1007/978-3-319-14280-7_14; Estima Jacinto, 2013, P 2 ACM SIGSPATIAL I, P39, DOI DOI 10.1145/2534732.2534734; Foursquare, 2019, FOURSQ API DOC; Gayawan E., 2009, AUSTR J BASIC APPL S, V3, P3524; Girres JF, 2010, T GIS, V14, P435, DOI 10.1111/j.1467-9671.2010.01203.x; Goodchild MF, 2007, GEOJOURNAL, V69, P211, DOI 10.1007/s10708-007-9111-y; Grant J, 2011, URBAN STUD, V48, P177, DOI 10.1177/0042098009360232; Griffith D.A., 2013, SPATIAL AUTOCORRELAT; Haklay M, 2010, ENVIRON PLANN B, V37, P682, DOI 10.1068/b35097; Jonietz D, 2016, ISPRS INT J GEO-INF, V5, DOI 10.3390/ijgi5090149; Karagiorgou S., 2012, P 20 INT C ADV GEOGR, P89, DOI DOI 10.1145/2424321.2424334; Karagiorgou S, 2014, LECT NOTES COMPUT SC, V8728, P109, DOI 10.1007/978-3-319-11593-1_8; Kennedy C, 2011, ENVIRON POLLUT, V159, P1965, DOI 10.1016/j.envpol.2010.10.022; Kenton W., 2019, EC CYCLE; Kubrin CE, 2011, CRIMINOL PUBLIC POL, V10, P437, DOI 10.1111/j.1745-9133.2011.00719.x; Kuo CL, 1996, J REAL ESTATE FINANC, V12, P139, DOI 10.1007/BF00132264; Liu XJ, 2016, ENVIRON PLANN B, V43, P341, DOI 10.1177/0265813515604767; MCAVINCHEY ID, 1982, URBAN STUD, V19, P43, DOI 10.1080/00420988220080041; McKenna HP, 2016, ENRICHING URBAN SPAC, P209; Mulliganni C, 2011, LECT NOTES COMPUT SC, V6899, P350, DOI 10.1007/978-3-642-23196-4_19; Oldenburg R., 1999, GREAT GOOD PLACE CAF; Pace RK, 2000, INT J FORECASTING, V16, P229, DOI 10.1016/S0169-2070(99)00047-3; Papachristos AV, 2011, CITY COMMUNITY, V10, P215, DOI 10.1111/j.1540-6040.2011.01371.x; Pearson K., 1895, Proceedings of the Royal Society London, Vlviii, P240; Pfoser Dieter, 2011, Advances in Spatial and Temporal Databases. Proceedings 12th International Symposium (SSTD 2011), P458, DOI 10.1007/978-3-642-22922-0_30; Renthop, 2017, RENT SEAS 2016; Schlesinger J, 2015, LECT NOTES GEOINF CA, P295, DOI 10.1007/978-3-319-14280-7_15; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856; SINGH A, 1989, INT J REMOTE SENS, V10, P989, DOI 10.1080/01431168908903939; Singleton A. D., 2017, URBAN ANAL; Stewart B, 2014, LATENT FACTOR REGRES; Thwaites G, 2003, BANK ENGLAND Q B; Touya G, 2017, ISPRS INT J GEO-INF, V6, DOI 10.3390/ijgi6030080; Touya G, 2015, LECT NOTES GEOINF CA, P81, DOI 10.1007/978-3-319-14280-7_5; Verburg P. H., 2004, GeoJournal, V61, P309, DOI 10.1007/s10708-004-4946-y; Waxman L., 2006, J INTERIOR DES, V31, P35, DOI [10.1111/j.1939-1668.2006.tb00530.x, DOI 10.1111/J.1939-1668.2006.TB00530.X]; Zhou WX, 2008, PHYSICA A, V387, P243, DOI 10.1016/j.physa.2007.08.059; Zielstra D, 2010, P GISCIENCE	57	15	16	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2019	14	2							e0212606	10.1371/journal.pone.0212606	http://dx.doi.org/10.1371/journal.pone.0212606			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8EH	30802251	gold, Green Submitted, Green Published			2022-12-27	WOS:000459710700014
J	Berg, JS; Jezequel, D; Duverger, A; Lamy, D; Laberty-Robert, C; Miot, J				Berg, Jasmine S.; Jezequel, Didier; Duverger, Arnaud; Lamy, Dominique; Laberty-Robert, Christel; Miot, Jennyfer			Microbial diversity involved in iron and cryptic sulfur cycling in the ferruginous, low-sulfate waters of Lake Pavin	PLOS ONE			English	Article							ORGANIC-MATTER; CRATER LAKE; GEN. NOV.; MEROMICTIC LAKE; SULFUROSPIRILLUM-DELEYIANUM; FE(III) REDUCTION; FERRIC IRON; BACTERIA; OCEAN; OXIDATION	Both iron-and sulfur-reducing bacteria strongly impact the mineralogy of iron, but their activity has long been thought to be spatially and temporally segregated based on the higher thermodynamic yields of iron over sulfate reduction. However, recent evidence suggests that sulfur cycling can predominate even under ferruginous conditions. In this study, we investigated the potential for bacterial iron and sulfur metabolisms in the iron-rich (1.2 mM dissolved Fe2+), sulfate-poor (< 20 mu M) Lake Pavin which is expected to host large populations of iron-reducing and iron-oxidizing microorganisms influencing the mineralogy of iron precipitates in its permanently anoxic bottom waters and sediments. 16S rRNA gene amplicon libraries from at and below the oxycline revealed that highly diverse populations of sulfur/sulfate-reducing (SRB) and sulfur/sulfide-oxidizing bacteria represented up to 10% and 5% of the total recovered sequences in situ, respectively, which together was roughly equivalent to the fraction of putative iron cycling bacteria. In enrichment cultures amended with key iron phases identified in situ (ferric iron phosphate, ferrihydrite) or with soluble iron (Fe2+), SRB were the most competitive microorganisms, both in the presence and absence of added sulfate. The large fraction of Sulfurospirillum, which are known to reduce thiosulfate and sulfur but not sulfate, present in all cultures was likely supported by Fe(III)-driven sulfide oxidation. These results support the hypothesis that an active cryptic sulfur cycle interacts with iron cycling in the lake. Analyses of mineral phases showed that ferric phosphate in cultures dominated by SRB was transformed to vivianite with concomitant precipitation of iron sulfides. As colloidal FeS and vivianite have been reported in the monimolimnion, we suggest that SRB along with iron-reducing bacteria strongly influence iron mineralogy in the water column and sediments of Lake Pavin.	[Berg, Jasmine S.; Duverger, Arnaud; Miot, Jennyfer] Sorbonne Univ, CNRS, Inst Mineral Phys Mat00E9riaux & Cosmochim, Museum Natl Hist Nat,UMR 7590, Paris, France; [Jezequel, Didier] Univ Paris Diderot, CNRS, Inst Phys Globe Paris, Lab Geochim Eaux,UMR 7154, Paris, France; [Lamy, Dominique] Univ Antilles, Univ Caen Normandie, Sorbonne Univ,Museum Natl Hist Nat,IRD, Unite Biol Organismes & Ecosyst Aquat BOREA,CNRS, Paris, France; [Laberty-Robert, Christel] Univ Paris 06, Lab Chim Matiere Condensee Paris, Paris, France; [Berg, Jasmine S.] Swiss Fed Inst Technol, Dept Environm Syst Sci, Zurich, Switzerland	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Universite de Caen Normandie; UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; Chimie ParisTech; College de France; Centre National de la Recherche Scientifique (CNRS); Swiss Federal Institutes of Technology Domain; ETH Zurich	Berg, JS (corresponding author), Sorbonne Univ, CNRS, Inst Mineral Phys Mat00E9riaux & Cosmochim, Museum Natl Hist Nat,UMR 7590, Paris, France.; Berg, JS (corresponding author), Swiss Fed Inst Technol, Dept Environm Syst Sci, Zurich, Switzerland.	jasmine.berg@usys.ethz.ch	Berg, Jasmine/ABD-4858-2020; Laberty, Christel/G-8847-2011; Duverger, Arnaud/R-6589-2017; JEZEQUEL, DIDIER/K-8269-2012	Berg, Jasmine/0000-0003-3461-4759; Duverger, Arnaud/0000-0001-5347-1701; 	Labex MATISSE; French state funds; Agence Nationale de la Recherche (ANR) within the Investissements d'Avenir programme [ANR-11-IDEX-0004-02]; ANR [ANR-07-BLAN-0124-01]; Region Ile de France grant SESAME [I-07-593/R]; INSU/CNRS; UPMC-Paris 6; IPGP multidisciplinary program PARI; Paris-IdF region SESAME [12015908]	Labex MATISSE; French state funds; Agence Nationale de la Recherche (ANR) within the Investissements d'Avenir programme; ANR(French National Research Agency (ANR)); Region Ile de France grant SESAME(Region Ile-de-France); INSU/CNRS(Centre National de la Recherche Scientifique (CNRS)); UPMC-Paris 6; IPGP multidisciplinary program PARI; Paris-IdF region SESAME	JSB was funded by Labex MATISSE, supported by French state funds managed by the Agence Nationale de la Recherche (ANR) within the Investissements d'Avenir programme under reference ANR-11-IDEX-0004-02, and more specifically within the framework of the Cluster of Excellence MATISSE led by Sorbonne Universites.; We acknowledge support from the ANR (project SRB - ANR-14-CE33-0003-01, PI: JM). The SEM facility at the IMPMC is funded by Region Ile de France grant SESAME 2006 No I-07-593/R, INSU/CNRS, UPMC-Paris 6, and by the ANR (ANR-07-BLAN-0124-01). Parts of this work were supported by IPGP multidisciplinary program PARI, and by Paris-IdF region SESAME Grant No 12015908. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aeschbach-Hertig W, 2002, HYDROBIOLOGIA, V487, P111, DOI 10.1023/A:1022942226198; Alberic P, 2000, LIMNOL OCEANOGR, V45, P1088, DOI 10.4319/lo.2000.45.5.1088; Berg JS, 2016, ENVIRON MICROBIOL, V18, P5288, DOI 10.1111/1462-2920.13587; Bethke CM, 2008, GEOLOGY, V36, P739, DOI 10.1130/G24859A.1; Bethke CM, 2011, AM J SCI, V311, P183, DOI 10.2475/03.2011.01; Biderre-Petit C, 2011, MICROB ECOL, V61, P313, DOI 10.1007/s00248-010-9769-4; Bonhomme C., 2016, LAKE PAVIN MIXING NE, P177, DOI [10.1007/978-3-319-39961-4_10, DOI 10.1007/978-3-319-39961-4_10]; Bonhomme C, 2011, CR GEOSCI, V343, P749, DOI 10.1016/j.crte.2011.09.006; Borch T, 2007, DEV EARTH ENV SCI, P321, DOI [10.1016/S1571-9197(07)07012-7, DOI 10.1016/S1571-9197(07)07012-7]; Bura-Nakic E, 2009, CHEM GEOL, V266, P311, DOI 10.1016/j.chemgeo.2009.06.020; Busigny V, 2014, GEOCHIM COSMOCHIM AC, V133, P443, DOI 10.1016/j.gca.2014.03.004; Camacho A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00323; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; CANFIELD DE, 1993, GEOCHIM COSMOCHIM AC, V57, P3867, DOI 10.1016/0016-7037(93)90340-3; Canfield DE, 2008, SCIENCE, V321, P949, DOI 10.1126/science.1154499; Cornell R.M., 2004, IRON OXIDES, P525, DOI DOI 10.1002/3527602097.CH20; Cosmidis J., 2016, LAKE PAVIN, P205; Cosmidis J, 2014, GEOCHIM COSMOCHIM AC, V126, P78, DOI 10.1016/j.gca.2013.10.037; Crowe SA, 2014, GEOBIOLOGY, V12, P322, DOI 10.1111/gbi.12089; Crowe SA, 2008, P NATL ACAD SCI USA, V105, P15938, DOI 10.1073/pnas.0805313105; Czaja AD, 2013, EARTH PLANET SC LETT, V363, P192, DOI 10.1016/j.epsl.2012.12.025; EHRENREICH A, 1994, APPL ENVIRON MICROB, V60, P4517, DOI 10.1128/AEM.60.12.4517-4526.1994; EISENMANN E, 1995, ARCH MICROBIOL, V164, P180, DOI 10.1007/BF02529969; Elferink SJWHO, 1999, INT J SYST BACTERIOL, V49, P345, DOI 10.1099/00207713-49-2-345; Emerson D, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00254; Emerson D, 2010, ANNU REV MICROBIOL, V64, P561, DOI 10.1146/annurev.micro.112408.134208; Finneran KT, 2003, INT J SYST EVOL MICR, V53, P669, DOI 10.1099/ijs.0.02298-0; Fuller SJ, 2014, APPL ENVIRON MICROB, V80, P128, DOI 10.1128/AEM.02282-13; Hansel CM, 2003, GEOCHIM COSMOCHIM AC, V67, P2977, DOI 10.1016/S0016-7037(03)00276-X; Hansel CM, 2015, ISME J, V9, P2400, DOI 10.1038/ismej.2015.50; Hubert C, 2007, APPL ENVIRON MICROB, V73, P2644, DOI 10.1128/AEM.02332-06; Humayoun SB, 2003, APPL ENVIRON MICROB, V69, P1030, DOI 10.1128/AEM.69.2.1030-1042.2003; Inoue K, 2011, ENV MICROBIOL REP, V3, P211, DOI 10.1111/j.1758-2229.2010.00210.x; Jakobsen R, 1999, GEOCHIM COSMOCHIM AC, V63, P137, DOI 10.1016/S0016-7037(98)00272-5; Johnson DB, 2009, INT J SYST EVOL MICR, V59, P1082, DOI 10.1099/ijs.0.65409-0; JORGENSEN BB, 1982, NATURE, V296, P643, DOI 10.1038/296643a0; JORGENSEN BB, 1990, SCIENCE, V249, P152, DOI 10.1126/science.249.4965.152; Kappler A, 2005, GEOLOGY, V33, P865, DOI 10.1130/G21658.1; Kasten S., 2000, MARINE GEOCHEMISTRY, P263, DOI [10.1007/978-3-662-04242-7-8, DOI 10.1007/978-3-662-04242-7_8, DOI 10.1007/978-3-662-04242-7-8]; Kojima H, 2011, INT J SYST EVOL MICR, V61, P1651, DOI 10.1099/ijs.0.024968-0; Konhauser KO, 2005, GEOBIOLOGY, V3, P167, DOI 10.1111/j.1472-4669.2005.00055.x; Lehours AC, 2005, APPL ENVIRON MICROB, V71, P7389, DOI 10.1128/AEM.71.11.7389-7400.2005; Lehours AC, 2007, APPL ENVIRON MICROB, V73, P2016, DOI 10.1128/AEM.01490-06; Lehours AC, 2009, GEOMICROBIOL J, V26, P212, DOI 10.1080/01490450902744012; Li WQ, 2013, GEOCHIM COSMOCHIM AC, V120, P65, DOI 10.1016/j.gca.2013.06.033; Lohmayer R, 2014, APPL ENVIRON MICROB, V80, P3141, DOI 10.1128/AEM.04220-13; Lopes F, 2011, APPL GEOCHEM, V26, P1919, DOI 10.1016/j.apgeochem.2011.06.021; Lovley DR, 2011, ADV MICROB PHYSIOL, V59, P1, DOI 10.1016/B978-0-12-387661-4.00004-5; LOVLEY DR, 1991, MICROBIOL REV, V55, P259, DOI 10.1128/MMBR.55.2.259-287.1991; LOVLEY DR, 1987, APPL ENVIRON MICROB, V53, P2636, DOI 10.1128/AEM.53.11.2636-2641.1987; LOVLEY DR, 1986, APPL ENVIRON MICROB, V51, P683, DOI 10.1128/AEM.51.4.683-689.1986; LOVLEY DR, 1993, MAR GEOL, V113, P41, DOI 10.1016/0025-3227(93)90148-O; Lu SP, 2013, APPL ENVIRON MICROB, V79, P4272, DOI 10.1128/AEM.00467-13; Lyons TW, 2014, NATURE, V506, P307, DOI 10.1038/nature13068; Ma SF, 2006, ESTUAR COAST SHELF S, V70, P461, DOI 10.1016/j.ecss.2006.06.033; MICHARD G, 1994, CHEM GEOL, V115, P103, DOI 10.1016/0009-2541(94)90147-3; Miot J, 2016, MINERALS-BASEL, V6, DOI 10.3390/min6020024; Miot J, 2009, GEOCHIM COSMOCHIM AC, V73, P696, DOI 10.1016/j.gca.2008.10.033; Mirvaux B, 2016, J ELECTROCHEM SOC, V163, pA2139, DOI 10.1149/2.0101610jes; Mosher JJ, 2012, APPL ENVIRON MICROB, V78, P2082, DOI 10.1128/AEM.07165-11; Nevin KP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005628; Newman DK, 2000, NATURE, V405, P94, DOI 10.1038/35011098; O'Loughlin EJ, 2010, ENVIRON SCI TECHNOL, V44, P4570, DOI 10.1021/es100294w; OVERMANN J, 1992, LIMNOL OCEANOGR, V37, P150, DOI 10.4319/lo.1992.37.1.0150; PARKIN TB, 1980, ARCH MICROBIOL, V125, P19, DOI 10.1007/BF00403193; Pester M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00072; Planavsky N, 2009, EARTH PLANET SC LETT, V286, P230, DOI 10.1016/j.epsl.2009.06.033; Planavsky NJ, 2011, NATURE, V477, P448, DOI 10.1038/nature10327; Posth NR, 2013, CHEM GEOL, V362, P66, DOI 10.1016/j.chemgeo.2013.05.031; Poulton SW, 2011, ELEMENTS, V7, P107, DOI 10.2113/gselements.7.2.107; Poulton SW, 2003, CHEM GEOL, V202, P79, DOI 10.1016/S0009-2541(03)00237-7; PYZIK AJ, 1981, GEOCHIM COSMOCHIM AC, V45, P687, DOI 10.1016/0016-7037(81)90042-9; Rees GN, 2001, INT J SYST EVOL MICR, V51, P1911, DOI 10.1099/00207713-51-5-1911; Reinhard CT, 2013, P NATL ACAD SCI USA, V110, P5357, DOI 10.1073/pnas.1208622110; Rivas-Lamelo S, 2017, GEOCHEM PERSPECT LET, V5, P35, DOI 10.7185/geochemlet.1743; Shelobolina ES, 2007, INT J SYST EVOL MICR, V57, P126, DOI 10.1099/ijs.0.64221-0; Straub KL, 2004, APPL ENVIRON MICROB, V70, P5744, DOI 10.1128/AEM.70.10.5744-5749.2004; Thamdrup B, 2000, ADV MICROB ECOL, V16, P41; THAMDRUP B, 1994, GEOCHIM COSMOCHIM AC, V58, P5115, DOI 10.1016/0016-7037(94)90298-4; VANDAMME P, 1992, INT J SYST BACTERIOL, V42, P344, DOI 10.1099/00207713-42-3-344; Viollier E, 1997, CHEM GEOL, V142, P225, DOI 10.1016/S0009-2541(97)00093-4; VOORDOUW G, 1995, APPL ENVIRON MICROB, V61, P2813, DOI 10.1128/AEM.61.8.2813-2819.1995; Walter XA, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00713; Widdel F, 1980, ANAEROBER ABBAU FETT; Yao WS, 1996, MAR CHEM, V52, P1, DOI 10.1016/0304-4203(95)00072-0; Zopfi J, 2004, BIOGEOCHEMISTRY SULF	87	24	25	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212787	10.1371/journal.pone.0212787	http://dx.doi.org/10.1371/journal.pone.0212787			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794698	Green Published, gold			2022-12-27	WOS:000459709100139
J	Blumel, B; Diercke, M; Sagebiel, D; Gilsdorf, A				Bluemel, Benjamin; Diercke, Michaela; Sagebiel, Daniel; Gilsdorf, Andreas			Positive predictive value of the German notification system for infectious diseases: Surveillance data from eight local health departments, Berlin, 2012	PLOS ONE			English	Article							TIMELINESS	The German Infection Protection Act requires notifying certain cases of infectious diseases to local health departments (LHD) in Germany. LHDs transmit notifications meeting case definitions to the national health authority, where the proportion of discarded notifications is not known. The proportion of discarded cases at the level of LHDs can be expressed as the positive predictive value (PPV) of the notification system. The PPV can be used to assess the efficiency of the system. We quantified the proportion of discarded notifications to calculate the PPV of the German notification system at the level of LHDs using electronic notification data from Berlin LHDs from 2012. We also analysed reasons for discarding notifications by reviewing notification forms. Data was available from eight LHDs (67%) receiving 10,113 notifications in 2012. Overall PPV was 89% (minimum-maximum = 77-97% across LHDs) and ranging from 30% (Hepatitis B) to 99% (Rotavirus). Of 166 individual investigation forms 84% were on hepatitis B or C cases, most of them discarded because of previously diagnosed chronic disease. LHDs investigate many notifications that do not lead to public health action and useful surveillance data leading to inefficient use of resources. Adaptation of case definitions or the legal framework concerning notifications may increase the efficiency of the notification system and lead to better use of data from notified cases.	[Bluemel, Benjamin] Robert Koch Inst, Dept Infect Dis Epidemiol, German FETP, Postgrad Training Appl Epidemiol PAE, Berlin, Germany; [Bluemel, Benjamin] European Ctr Dis Prevent & Control ECDC, EPIET, Stockholm, Sweden; [Bluemel, Benjamin; Diercke, Michaela; Gilsdorf, Andreas] Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany; [Sagebiel, Daniel] Berlin State Off Hlth & Social Affairs, Berlin, Germany; [Bluemel, Benjamin] Univ Freiburg, Fac Med, Med Ctr, Inst Med Microbiol & Hyg, Freiburg, Germany	Robert Koch Institute; European Centre for Disease Prevention & Control; Robert Koch Institute; University of Freiburg	Blumel, B (corresponding author), Robert Koch Inst, Dept Infect Dis Epidemiol, German FETP, Postgrad Training Appl Epidemiol PAE, Berlin, Germany.; Blumel, B (corresponding author), European Ctr Dis Prevent & Control ECDC, EPIET, Stockholm, Sweden.; Blumel, B (corresponding author), Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany.; Blumel, B (corresponding author), Univ Freiburg, Fac Med, Med Ctr, Inst Med Microbiol & Hyg, Freiburg, Germany.	benjamin.blumel@gmail.com		Gilsdorf, Andreas/0000-0001-8572-2798; Diercke, Michaela/0000-0002-4678-1813				Altmann M, 2011, EMERG INFECT DIS, V17, P1906, DOI 10.3201/eid1710.111027; [Anonymous], 2004, FRAM TOOLS EV HLTH S; Centers for Disease Control (CDC), 1988, MMWR Suppl, V37, P1; Cui FQ, 2013, VACCINE, V31, pJ79, DOI 10.1016/j.vaccine.2013.05.054; Diercke M, 2014, BUNDESGESUNDHEITSBLA, V57, P1107, DOI 10.1007/s00103-014-2023-3; Diercke M., 2017, EPIDEMIOL B, V30, P291, DOI [DOI 10.17886/EPIBULL-2017-039, DOI 10.17886/EPIBULL-2017-03]; European Centre for Disease Prevention and Control (ECDC), 2014, HDB METH APPL; German R R, 2001, MMWR Recomm Rep, V50, P1; Hauri AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017341; Krause G, 2006, Euro Surveill, V11, P3, DOI 10.2807/esm.11.11.00657-en; Krause G, 2003, GESUNDHEITSWESEN S, V65, pS8, DOI [10.1055/s-2003-38113, DOI 10.1055/S-2003-38113]; Krause G, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-129; Krause G, 2007, EMERG INFECT DIS, V13, P1548, DOI 10.3201/eid1310.070253; Mazurek J, 2002, EPIDEMIOL INFECT, V129, P119, DOI 10.1017/S0950268802007124; National Public Health Institute (KTL) of Finland, 2004, PROT EV WID SURV NET; Poethko-Muller C, 2013, BUNDESGESUNDHEITSBLA, V56, P707, DOI 10.1007/s00103-013-1673-x; Robert Koch-Institut, 2007, FALLD ROB KOCH I OD; Schumacher J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187037; WHO, 2006, COMM DIS SURV RESP S; Williams CJ, 2009, EPIDEMIOL INFECT, V137, P597, DOI 10.1017/S095026880800112X	20	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212908	10.1371/journal.pone.0212908	http://dx.doi.org/10.1371/journal.pone.0212908			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794677	Green Published, gold, Green Submitted			2022-12-27	WOS:000459709100157
J	McGrath, RL; Ziegler, ML; Pires-Fernandes, M; Knarr, BA; Higginson, JS; Sergi, F				McGrath, Robert L.; Ziegler, Melissa L.; Pires-Fernandes, Margaret; Knarr, Brian A.; Higginson, Jill S.; Sergi, Fabrizio			The effect of stride length on lower extremity joint kinetics at various gait speeds	PLOS ONE			English	Article							WALKING SPEED; PROPULSIVE FORCE; MECHANISMS; CADENCE	Robot-assisted training is a promising tool under development for improving walking function based on repetitive goal-oriented task practice. The challenges in developing the controllers for gait training devices that promote desired changes in gait is complicated by the limited understanding of the human response to robotic input. A possible method of controller formulation can be based on the principle of bio-inspiration, where a robot is controlled to apply the change in joint moment applied by human subjects when they achieve a gait feature of interest. However, it is currently unclear how lower extremity joint moments are modulated by even basic gait spatio-temporal parameters. In this study, we investigated how sagittal plane joint moments are affected by a factorial modulation of two important gait parameters: gait speed and stride length. We present the findings obtained from 20 healthy control subjects walking at various treadmill-imposed speeds and instructed to modulate stride length utilizing real-time visual feedback. Implementing a continuum analysis of inverse-dynamics derived joint moment profiles, we extracted the effects of gait speed and stride length on joint moment throughout the gait cycle. Moreover, we utilized a torque pulse approximation analysis to determine the timing and amplitude of torque pulses that approximate the difference in joint moment profiles between stride length conditions, at all gait speed conditions. Our results show that gait speed has a significant effect on the moment profiles in all joints considered, while stride length has more localized effects, with the main effect observed on the knee moment during stance, and smaller effects observed for the hip joint moment during swing and ankle moment during the loading response. Moreover, our study demonstrated that trailing limb angle, a parameter of interest in programs targeting propulsion at push-off, was significantly correlated with stride length. As such, our study has generated assistance strategies based on pulses of torque suitable for implementation via a wearable exoskeleton with the objective of modulating stride length, and other correlated variables such as trailing limb angle.	[McGrath, Robert L.; Sergi, Fabrizio] Univ Delaware, Dept Biomed Engn, Newark, DE 19713 USA; [Ziegler, Melissa L.] Univ Delaware, Coll Hlth Sci, Biostat Core, Newark, DE 19713 USA; [Pires-Fernandes, Margaret] Univ Florida, Dept Biomed Engn, Gainesville, FL 32611 USA; [Knarr, Brian A.] Univ Nebraska, Dept Biomech, Omaha, NE 68182 USA; [Higginson, Jill S.; Sergi, Fabrizio] Univ Delaware, Dept Mech Engn, Newark, DE 19713 USA	University of Delaware; University of Delaware; State University System of Florida; University of Florida; University of Nebraska System; University of Delaware	Sergi, F (corresponding author), Univ Delaware, Dept Biomed Engn, Newark, DE 19713 USA.; Sergi, F (corresponding author), Univ Delaware, Dept Mech Engn, Newark, DE 19713 USA.	fabs@udel.edu	Sergi, Fabrizio/L-3072-2019	Sergi, Fabrizio/0000-0003-3019-2958; McGrath, Robert/0000-0001-7319-510X	National Science Foundation [NSF-REU-1460757]; National Institutes of Health [NSF-REU-1460757, NIH-P20GM109090, NSF-NRI-1638007, NIH-GM-103333]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103333, P20GM109090] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research study was funded by National Science Foundation NSF-NRI-1638007 (FS & JSH) (www.nsf.gov). Instrumentation was provided by National Institutes of Health NIH-GM-103333 (JSH) (www.nih.gov). Undergraduate research assistant program REU was funded by National Science Foundation NSF-REU-1460757, and software development was funded by National Institutes of Health NIH-P20GM109090. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Research project funded by NSF-NRI-1638007, Instrumentation provided by NIH-GM-103333, NSF-REU-1460757, and NIH-P20GM109090.	Ahn J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031767; Alexander R, 1984, INT J ROBOTICS RES; Allet L, 2011, GAIT POSTURE, V34, P300, DOI 10.1016/j.gaitpost.2011.05.013; Ardestani MM, 2016, GAIT POSTURE, V46, P118, DOI 10.1016/j.gaitpost.2016.02.005; Awad LN, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai9084; Bowden MG, 2006, STROKE, V37, P872, DOI 10.1161/01.STR.0000204063.75779.8d; Browne MG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201407; Devita P, 2009, ASB 2009; Franklin DW, 2011, NEURON, V72, P425, DOI 10.1016/j.neuron.2011.10.006; HOF AL, 1996, GAIT POSTURE, V4, P222; Holanda LJ, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-017-0338-7; Hsiao HY, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0030-8; Hsiao H, 2015, HUM MOVEMENT SCI, V39, P212, DOI 10.1016/j.humov.2014.11.008; KIRTLEY C, 1985, J BIOMED ENG, V7, P282, DOI 10.1016/0141-5425(85)90055-X; Kramer PA, 2008, GAIT POSTURE, V27, P209, DOI 10.1016/j.gaitpost.2007.03.009; Latt MD, 2008, EXP BRAIN RES, V184, P201, DOI 10.1007/s00221-007-1094-x; Mehrholz J., 2017, COCHRANE DATABASE SY; Middleton A, 2015, J AGING PHYS ACTIV, V23, P314, DOI 10.1123/japa.2013-0236; Monaco V, 2009, CLIN BIOMECH, V24, P493, DOI 10.1016/j.clinbiomech.2009.04.004; Pataky TC, 2016, J BIOMECH, V49, P1468, DOI 10.1016/j.jbiomech.2016.03.032; Pataky TC, 2015, J BIOMECH, V48, P1277, DOI 10.1016/j.jbiomech.2015.02.051; Peterson CL, 2010, GAIT POSTURE, V32, P451, DOI 10.1016/j.gaitpost.2010.06.014; Prochazka A, 1997, J NEUROPHYSIOL, V77, P3237, DOI 10.1152/jn.1997.77.6.3237; Riley PO, 2001, J BIOMECH, V34, P197, DOI 10.1016/S0021-9290(00)00174-3; Schmid A, 2007, STROKE, V38, P2096, DOI 10.1161/STROKEAHA.106.475921; Turner DL, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00184; Zhang JJ, 2017, SCIENCE, V356, P1280, DOI 10.1126/science.aal5054	27	15	15	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0200862	10.1371/journal.pone.0200862	http://dx.doi.org/10.1371/journal.pone.0200862			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794565	Green Submitted, Green Published, gold			2022-12-27	WOS:000459709100001
J	Strenge, B; Vogel, L; Schack, T				Strenge, Benjamin; Vogel, Ludwig; Schack, Thomas			Computational assessment of long-term memory structures from SDA-M related to action sequences	PLOS ONE			English	Article							MENTAL REPRESENTATION; MOTOR; PERCEPTION; BEHAVIOR; LINKS	Assistance systems should be able to adapt to individual task-related skills and knowledge. Structural-dimensional analysis of mental representations (SDA-M) is an established method for retrieving human memory structures related to specific activities. For this purpose, SDA-M involves a semi-automatized survey of users (the "split procedure"), which yields data about users' associations between action representations in long-term memory. Up to now this data about associations has commonly been clustered and visualized by SDA-M software in the form of dendrograms that can be used by human experts as a tool to (manually) assess users' individual expertise and identify potential issues with respect to predefined action sequences. This article presents new algorithmic approaches for automatizing the process of assessing task-related memory structures based on SDA-M data to predict probable errors in action sequences. This automation enables direct integration into technical systems, e.g. user-adaptive assistance systems. An evaluation study has compared the automatized computational assessments to predictions made by human scholars based on visualizations of SDA-M data. The different algorithms' outputs matched human experts' manual assessments in 84% to 86% of the test cases.	[Strenge, Benjamin; Vogel, Ludwig; Schack, Thomas] Bielefeld Univ, CITEC Ctr Excellence Cognit Interact Technol, Bielefeld, Germany; [Strenge, Benjamin; Vogel, Ludwig; Schack, Thomas] Bielefeld Univ, Neurocognit & Act Res Grp, Bielefeld, Germany	University of Bielefeld; University of Bielefeld	Strenge, B (corresponding author), Bielefeld Univ, CITEC Ctr Excellence Cognit Interact Technol, Bielefeld, Germany.; Strenge, B (corresponding author), Bielefeld Univ, Neurocognit & Act Res Grp, Bielefeld, Germany.	benjamin.strenge@uni-bielefeld.de		Strenge, Benjamin/0000-0003-1789-6977; Vogel, Ludwig/0000-0002-7183-6177	Cluster of Excellence Cognitive Interaction Technology 'CITEC' at Bielefeld University [EXC 277]; German Research Foundation (DFG); German Federal Ministry of Education and Research (BMBF); Deutsche Forschungsgemeinschaft; Bielefeld University	Cluster of Excellence Cognitive Interaction Technology 'CITEC' at Bielefeld University; German Research Foundation (DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bielefeld University	This research was supported by the Cluster of Excellence Cognitive Interaction Technology 'CITEC' (EXC 277) at Bielefeld University, which is funded by the German Research Foundation (DFG). It was partially related to project ADAMAAS, which is funded by the German Federal Ministry of Education and Research (BMBF). We acknowledge support for the Article Processing Charge by the Deutsche Forschungsgemeinschaft and the Open Access Publication Fund of Bielefeld University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J.R., 1983, ARCHITECTURE COGNITI; Anderson J.R., 1993, RULES MIND; Anderson J.R., 1998, ATOMIC COMPONENTS TH; Anderson JR, 2004, PSYCHOL REV, V111, P1036, DOI 10.1037/0033-295x.111.4.1036; Anderson JR, 2001, PSYCHON B REV, V8, P629, DOI 10.3758/BF03196200; ANDERSON JR, 1982, PSYCHOL REV, V89, P369, DOI 10.1037/0033-295X.89.4.369; Bernstein N, 1967, COORDINATION REGULAT; Blasing B, 2009, PSYCHOL SPORT EXERC, V10, P350, DOI 10.1016/j.psychsport.2008.10.001; Braun SM, 2007, CLIN REHABIL, V21, P822, DOI 10.1177/0269215507078303; Brodersen Kay H., 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P3121, DOI 10.1109/ICPR.2010.764; CHASE WG, 1973, COGNITIVE PSYCHOL, V4, P55, DOI 10.1016/0010-0285(73)90004-2; d'Avella A, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00126; Essig K., 2016, 9 ACM INT C, P1; Frank C, 2016, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01981; Frank C, 2013, PSYCHOL SPORT EXERC, V14, P353, DOI 10.1016/j.psychsport.2012.12.001; Heinen T., 2002, P 7 ANN C EUR COLL S, P608; Heinen T, 2002, OPTIMIERUNG TRAINING, P67; Heinen T., 2004, LEHREN LERNEN GERATT, P85; Hinton G.E., 2007, SCHOLARPEDIA, V2, P1668, DOI 10.4249/scholarpedia.1668; Hoffmann J, 2003, LECT NOTES ARTIF INT, V2684, P44; Jacksteit R, 2018, CLIN REHABIL, V32, P103, DOI 10.1177/0269215517719312; James W., 1890, PRINCIPLES PSYCHOL, P449, DOI [https://doi.org/10.1037/11059-009, DOI 10.1037/11059-009]; Jeannerod M., 2004, INT J SPORT EXERC PS, V2, P376, DOI [10.1080/1612197X.2004.9671752, DOI 10.1080/1612197X.2004.9671752]; Land WM, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00127; LANDER HJ, 1992, Z PSYCHOL, V200, P181; LANDER HJ, 1991, Z PSYCHOL, V199, P167; LEBIERE C, 1994, PROCEEDINGS OF THE SIXTEENTH ANNUAL CONFERENCE OF THE COGNITIVE SCIENCE SOCIETY, P555; Lex H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118219; Lotze H., 1852, MED PSYCHOL PSYCHOL; Louie AH, 2010, FORESIGHT, V12, P18, DOI 10.1108/14636681011049848; Maycock J, 2010, KUNSTL INTELL, V24, P287, DOI 10.1007/s13218-010-0064-9; Newell K.M., 1986, MOTOR DEV CHILDREN A, VVolume 34, P341, DOI DOI 10.1007/978-94-009-4460-2_19; Nielsen J., 2005, 10 USABILITY HEURIST; Nitsch JR., 2004, Z SPORTPSYCHOL, V11, P10, DOI [DOI 10.1026/1612-5010.11.1.10, 10.1026/1612-5010.11.1.10]; NORMAN DA, 1981, PSYCHOL REV, V88, P1, DOI 10.1037/0033-295X.88.1.1; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; Reason J., 1991, HUMAN ERROR, DOI 10.1017/cbo9781139062367; Rosen R, 2012, IFSR INT SER SYST SC, V1, P1, DOI 10.1007/978-1-4614-1269-4; Rosenbaum DA., 2009, HUMAN MOTOR CONTROL; Rosenbaum DA, 2007, HUM MOVEMENT SCI, V26, P525, DOI 10.1016/j.humov.2007.04.001; Said N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158832; Schack T, 2006, NEUROSCI LETT, V391, P77, DOI 10.1016/j.neulet.2005.10.009; Schack T., 2012, HDB MEASUREMENT SPOR, P203; Schack T., 2007, HDB SPORT PSYCHOL, P332; Schack T., 2007, PSYCHOL SPORT TRAINI, P62; Schack T., 2004, J SPORT EXERCISE PSY, V2, P403, DOI [10.1080/1612197x.2004.9671753, DOI 10.1080/1612197X.2004.9671753, 10.1080/1612197X.2004.9671753]; Schack T, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00328; Schack T, 2013, NEW IDEAS PSYCHOL, V31, P258, DOI 10.1016/j.newideapsych.2013.04.003; Schack T, 2009, PROG BRAIN RES, V174, P231, DOI 10.1016/S0079-6123(09)01319-3; Seegelke C, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00024; SHNEIDERMAN B., 2018, DESIGNING USER INTER, V6; Stockel T, 2012, PSYCHOL RES-PSYCH FO, V76, P768, DOI 10.1007/s00426-011-0387-7; Subrahmanian VS, 2017, SCIENCE, V355, P489, DOI 10.1126/science.aam7032; Tscherepanow M, 2011, LECT NOTES COMPUT SC, V7064, P639, DOI 10.1007/978-3-642-24965-5_72; Vogel L, 2016, J SPORT EXERCISE PSY, V38, pS113; Weigelt M, 2011, PSYCHOL SPORT EXERC, V12, P231, DOI 10.1016/j.psychsport.2010.11.001	56	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212414	10.1371/journal.pone.0212414	http://dx.doi.org/10.1371/journal.pone.0212414			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794606	Green Submitted, Green Published, gold			2022-12-27	WOS:000459709100063
J	Martinez, R; Vera-Chang, MN; Haddad, M; Zon, J; Navarro-Martin, L; Trudeau, VL; Mennigen, JA				Martinez, Ruben; Vera-Chang, Marilyn N.; Haddad, Majd; Zon, Jessica; Navarro-Martin, Laia; Trudeau, Vance L.; Mennigen, Jan A.			Developmental fluoxetine exposure in zebrafish reduces offspring basal cortisol concentration via life stage-dependent maternal transmission	PLOS ONE			English	Article							SEROTONIN REUPTAKE INHIBITOR; ENVIRONMENTAL RISK-ASSESSMENT; PITUITARY-INTERRENAL AXIS; DANIO-RERIO; GENE-EXPRESSION; NEUROENDOCRINE RESPONSES; EMBRYONIC-DEVELOPMENT; ANTIDEPRESSANT USE; STRESS REACTIVITY; SOCIAL-STATUS	Fluoxetine (FLX) is a pharmaceutical used to treat affective disorders in humans, but as environmental contaminant also affects inadvertently exposed fish in urban watersheds. In humans and fish, acute FLX treatment and exposure are linked to endocrine disruption, including effects on the reproductive and stress axes. Using the zebrafish model, we build on the recent finding that developmental FLX exposure reduced cortisol production across generations, to determine possible parental and/or life-stage-dependent (age and/or breeding experience) contributions to this phenotype. Specifically, we combined control and developmentally FLX-exposed animals of both sexes (F-0) into four distinct breeding groups mated at 5 and 9 months, and measured offspring (F-1) basal cortisol at 12 dpf. Basal cortisol was lower in F1 descended from developmentally FLX-exposed F-0 females bred at 5, but not 9 months, revealing a maternal, life-stage dependent effect. To investigate potential molecular contributions to this phenotype, we profiled maternally deposited transcripts involved in endocrine stress axis development and regulation, epigenetic (de novo DNA methyltransferases) and post-transcriptional (miRNA pathway components and specific miRNAs) regulation of gene expression in unfertilized eggs. Maternal FLX exposure resulted in decreased transcript abundance of glucocorticoid receptor, dnmt3 paralogues and miRNA pathway components in eggs collected at 5 months, and increased transcript abundance of miRNA pathway components at 9 months. Specific miRNAs predicted to target stress axis transcripts decreased (miR-740) or increased (miR-26, miR-30d, miR-92a, miR-103) in eggs collected from FLX females at 5 months. Increased abundance of miRNA-30d and miRNA-92a persisted in eggs collected from FLX females at 9 months. Clustering and principal component analyses of egg transcript profiles separated eggs collected from FLX-females at 5 months from other groups, suggesting that oocyte molecular signatures, and miRNAs in particular, may serve as predictive tools for the offspring phenotype of reduced basal cortisol in response to maternal FLX exposure.	[Martinez, Ruben; Navarro-Martin, Laia] CSIC, IDAEA, Dept Environm Chem, Barcelona, Spain; [Martinez, Ruben] UB, Dept Cellular Biol Physiol & Immunol, Barcelona, Spain; [Vera-Chang, Marilyn N.; Haddad, Majd; Zon, Jessica; Trudeau, Vance L.; Mennigen, Jan A.] Univ Ottawa, Dept Biol, Ottawa, ON, Canada	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Diagnostico Ambiental y Estudios del Agua (IDAEA); University of Barcelona; University of Ottawa	Mennigen, JA (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON, Canada.	jan.mennigen@uottawa.ca	Navarro-Martin, Laia/A-3588-2011; Martinez Lopez, Ruben Francisco/R-5986-2018	Navarro-Martin, Laia/0000-0001-6554-8833; Mennigen, Jan/0000-0003-4117-6654; Martinez Lopez, Ruben Francisco/0000-0001-9965-7042; Vera-Chang, Marilyn/0000-0002-5234-9971	FPU predoctoral fellowship [FPU15/03332]; Spanish Ministry of Education, Culture and Sport [EST16/00695, EST17/00830]; Natural Sciences and Engineering Research Council of Canada [2114456-2017]; Canada Foundation of Innovation [148035]; FPU [FPU15/03332]; Natural Sciences and Engineering Research Council of Canada (NSERC) [2114456-2017]; Canada Foundation of Innovation John R. Evans Leaders Fund [148035]	FPU predoctoral fellowship(German Research Foundation (DFG)National Health and Medical Research Council (NHMRC) of Australia); Spanish Ministry of Education, Culture and Sport; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation of Innovation(Canada Foundation for Innovation); FPU(Spanish Government); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation of Innovation John R. Evans Leaders Fund	RM was supported also by a FPU predoctoral fellowship (www.ciencia.gob.es), grant #FPU15/03332, and research mobility grants from the Spanish Ministry of Education, Culture and Sport (www.mecd.gob.es), grant #EST16/00695 and grant #EST17/00830, respectively. This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca) under the Discovery Grant program, grant #2114456-2017, and The Canada Foundation of Innovation (www.innovation.ca), under the John R. Evans Leaders Fund (https://www.innovation.ca) program, grant #148035, awarded to JAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; RM was supported also by a FPU predoctoral fellow (FPU15/03332) and the research stay grants EST16/00695 and EST17/00830 from the Spanish Ministry of Education, Culture and Sport. This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC discovery grant #2114456-2017) and The Canada Foundation of Innovation John R. Evans Leaders Fund (grant #148035) to JAM.	Aanes H, 2011, GENOME RES, V21, P1328, DOI 10.1101/gr.116012.110; Abreu MS, 2017, PEERJ, V5, DOI 10.7717/peerj.3330; Airhart MJ, 2007, NEUROTOXICOL TERATOL, V29, P652, DOI 10.1016/j.ntt.2007.07.005; Airhart MJ, 2012, NEUROTOXICOL TERATOL, V34, P152, DOI 10.1016/j.ntt.2011.08.008; Alboni S, 2017, MOL PSYCHIATR, V22, P552, DOI 10.1038/mp.2015.142; Alderman SL, 2009, GEN COMP ENDOCR, V164, P61, DOI 10.1016/j.ygcen.2009.04.007; Alsop D, 2008, AM J PHYSIOL-REG I, V294, pR711, DOI 10.1152/ajpregu.00671.2007; BALDWIN D, 2011, BMJ-BRIT MED J, V342, DOI DOI 10.1136/BMJ.D1199; Barreiro-Iglesias A, 2015, CELL REP, V13, P924, DOI 10.1016/j.celrep.2015.09.050; Best C, 2018, COMP BIOCHEM PHYS B, V224, P210, DOI 10.1016/j.cbpb.2018.01.006; Binder EB, 2009, PSYCHONEUROENDOCRINO, V34, P99, DOI 10.1016/j.psyneuen.2009.05.021; Brooks B. W., 2005, ENV TOXICOL CHEM; Brooks BW, 2014, AQUAT TOXICOL, V151, P61, DOI 10.1016/j.aquatox.2014.01.007; Byatt N, 2013, ACTA PSYCHIAT SCAND, V127, P94, DOI 10.1111/acps.12042; Crago J, 2018, CHEMOSPHERE, V193, P1226, DOI 10.1016/j.chemosphere.2017.11.043; Craig PM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095351; Cunha V, 2016, AQUAT TOXICOL, V178, P182, DOI 10.1016/j.aquatox.2016.08.003; Currie Janet, 2005, MARKETIZATION DEPRES; Damjanoska KJ, 2003, J PHARMACOL EXP THER, V306, P563, DOI 10.1124/jpet.103.050534; de Abreu MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103232; De Assis H. C.Silva, 2013, ENVIRON SCI TECHNOL, V47, P5372, DOI DOI 10.1021/ES3044888; Despic V, 2018, J CELL SCI, V131, DOI 10.1242/jcs.201996; DeVane CL, 1999, CELL MOL NEUROBIOL, V19, P443, DOI 10.1023/A:1006934807375; Dinan TG, 1996, LIFE SCI, V58, P1683, DOI 10.1016/0024-3205(96)00066-5; Duncan GE, 1998, J PHARMACOL EXP THER, V285, P579; Egan RJ, 2009, BEHAV BRAIN RES, V205, P38, DOI 10.1016/j.bbr.2009.06.022; Etain B, 2001, ENCEPHALE, V27, P280; Ewing G, 2015, CLIN PHARMACOKINET, V54, P359, DOI 10.1007/s40262-014-0233-3; Facchinello N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04535-6; Faught E, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160032; FOLCH J, 1957, J BIOL CHEM, V226, P497; Freimer JW, 2018, CURR BIOL, V28, P296, DOI 10.1016/j.cub.2017.11.067; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Gobinath AR, 2016, NEUROPHARMACOLOGY, V101, P165, DOI 10.1016/j.neuropharm.2015.09.001; Harvey SA, 2013, DEVELOPMENT, V140, P2703, DOI 10.1242/dev.095091; Henry TB, 2008, ARCH ENVIRON CON TOX, V54, P325, DOI 10.1007/s00244-007-9018-0; Herculano AM, 2014, PROG NEURO-PSYCHOPH, V55, P50, DOI 10.1016/j.pnpbp.2014.03.008; Hiemke C, 2000, PHARMACOL THERAPEUT, V85, P11, DOI 10.1016/S0163-7258(99)00048-0; Homberg JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016646; Huang SSY, 2017, AQUAT TOXICOL, V182, P102, DOI 10.1016/j.aquatox.2016.11.016; Jeffrey JD, 2016, J EXP BIOL, V219, P1734, DOI 10.1242/jeb.138826; Jorgensen HS, 2007, DAN MED BULL, V54, P266; Kendrick T, 2015, J AFFECT DISORDERS, V186, P171, DOI 10.1016/j.jad.2015.06.052; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Knaepen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057608; Kostyniuk DJ, 2018, AM J PHYSIOL-REG I, V315, pR241, DOI 10.1152/ajpregu.00402.2017; Kreke N, 2008, CRIT REV TOXICOL, V38, P215, DOI 10.1080/10408440801891057; Kristensen JH, 1999, BRIT J CLIN PHARMACO, V48, P521, DOI 10.1046/j.1365-2125.1999.00040.x; Lee MT, 2014, ANNU REV CELL DEV BI, V30, P581, DOI 10.1146/annurev-cellbio-100913-013027; Li Q, 1996, J PHARMACOL EXP THER, V279, P1035; Li YX, 2012, GENOME RES, V22, P1899, DOI 10.1101/gr.128488.111; Lillesaar C, 2011, J CHEM NEUROANAT, V41, P294, DOI 10.1016/j.jchemneu.2011.05.009; Lim JE, 2013, GEN COMP ENDOCR, V192, P246, DOI 10.1016/j.ygcen.2013.08.008; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lykke-Andersen K, 2008, MOL BIOL CELL, V19, P4383, DOI 10.1091/mbc.E08-02-0219; Marvanova Marketa, 2018, Ment Health Clin, V8, P127, DOI 10.9740/mhc.2018.05.127; Matthews SG, 2012, EXP NEUROL, V233, P95, DOI 10.1016/j.expneurol.2011.01.009; McDonald MD, 2017, COMP BIOCHEM PHYS C, V197, P19, DOI 10.1016/j.cbpc.2017.03.007; Mennigen JA, 2018, BIOMED CTR, V17, P18, DOI DOI 10.1186/S12940-018-0362-5; Mennigen JA, 2017, COMP BIOCHEM PHYS C, V202, P70, DOI 10.1016/j.cbpc.2017.08.003; Mennigen JA, 2011, J TOXICOL ENV HEAL B, V14, P387, DOI 10.1080/10937404.2011.578559; Mennigen JA, 2010, AQUAT TOXICOL, V100, P354, DOI 10.1016/j.aquatox.2010.08.016; Metcalfe CD, 2010, ENVIRON TOXICOL CHEM, V29, P79, DOI 10.1002/etc.27; Mishra P, 2017, CHEMOSPHERE, V188, P157, DOI 10.1016/j.chemosphere.2017.08.149; Nakamura Y, 2008, CHEMOSPHERE, V70, P865, DOI 10.1016/j.chemosphere.2007.06.089; Nesan D, 2016, SCI REP-UK, V6, DOI 10.1038/srep22582; Nesan D, 2013, GEN COMP ENDOCR, V181, P35, DOI 10.1016/j.ygcen.2012.10.006; Oakes Ken D., 2010, Integrated Environmental Assessment and Management, V6, P524, DOI 10.1002/ieam.77; Pan CY, 2018, CHEMOSPHERE, V205, P8, DOI 10.1016/j.chemosphere.2018.04.082; Park JW, 2012, ENVIRON POLLUT, V167, P163, DOI 10.1016/j.envpol.2012.03.039; Pasquier J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2709-z; Paterson G, 2008, CHEMOSPHERE, V74, P125, DOI 10.1016/j.chemosphere.2008.08.022; Pawluski JL, 2012, NEUROSCIENCE, V220, P131, DOI 10.1016/j.neuroscience.2012.06.034; Pelegri F, 2016, METHOD CELL BIOL, V135, P39, DOI 10.1016/bs.mcb.2016.05.006; Pinzon N, 2017, GENOME RES, V27, P234, DOI 10.1101/gr.205146.116; Pratt Laura A, 2017, NCHS Data Brief, P1; Presslauer C, 2017, SCI REP-UK, V7, DOI 10.1038/srep43850; Raap DK, 1999, J PHARMACOL EXP THER, V288, P561; Rand-Weaver M, 2013, ENVIRON SCI TECHNOL, V47, P11384, DOI 10.1021/es402065a; Raz E, 2006, CURR OPIN GENET DEV, V16, P355, DOI 10.1016/j.gde.2006.06.007; Rodgers AB, 2015, P NATL ACAD SCI USA, V112, P13699, DOI 10.1073/pnas.1508347112; Safarinejad MR, 2008, J UROLOGY, V180, P2124, DOI 10.1016/j.juro.2008.07.034; Santos D, 2017, AQUAT TOXICOL, V191, P141, DOI 10.1016/j.aquatox.2017.08.005; Schultz MM, 2010, ENVIRON SCI TECHNOL, V44, P1918, DOI 10.1021/es9022706; Sebire M, 2015, AQUAT TOXICOL, V168, P78, DOI 10.1016/j.aquatox.2015.09.009; Segner H, 2009, COMP BIOCHEM PHYS C, V149, P187, DOI 10.1016/j.cbpc.2008.10.099; Sepede G, 2016, CLIN NEUROPHARMACOL, V39, P241, DOI 10.1097/WNF.0000000000000173; Silva LJG, 2015, ENVIRON POLLUT, V197, P127, DOI 10.1016/j.envpol.2014.12.002; Smith EM, 2012, AQUAT TOXICOL, V109, P259, DOI 10.1016/j.aquatox.2011.08.022; Sopinka NM, 2017, PHYSIOL BIOCHEM ZOOL, V90, P15, DOI 10.1086/689994; Steenbergen PJ, 2011, PROG NEURO-PSYCHOPH, V35, P1432, DOI 10.1016/j.pnpbp.2010.10.010; Szymanska M, 2009, PSYCHONEUROENDOCRINO, V34, P822, DOI 10.1016/j.psyneuen.2008.12.012; The Australian Bureau of Statistics Bureau, 2011, 4329000003 AUSTR BUR; Theodoridi A, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00223; Vera-Chang MN, 2018, P NATL ACAD SCI USA, V115, pE12435, DOI 10.1073/pnas.1811695115; Vilhelmsson Andreas, 2013, Front Public Health, V1, P30, DOI 10.3389/fpubh.2013.00030; Weinberger J, 2014, AQUAT TOXICOL, V151, P77, DOI 10.1016/j.aquatox.2013.10.012; Wilson KS, 2016, J ENDOCRINOL, V230, P125, DOI 10.1530/JOE-15-0376; Wilson KS, 2013, J PHYSIOL-LONDON, V591, P6209, DOI 10.1113/jphysiol.2013.256826; Winberg S, 1997, NEUROSCI LETT, V230, P113, DOI 10.1016/S0304-3940(97)00488-6; Winberg S, 2016, CURR ZOOL, V62, P317, DOI 10.1093/cz/zow037; Wong DT, 2005, NAT REV DRUG DISCOV, V4, P764, DOI 10.1038/nrd1821; Wong RY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-348; Workman JL, 2016, NEUROPHARMACOLOGY, V105, P443, DOI 10.1016/j.neuropharm.2015.11.027; Wu MH, 2017, AQUAT TOXICOL, V192, P274, DOI 10.1016/j.aquatox.2017.09.027; Yonkers KA, 2014, ANNU REV CLIN PSYCHO, V10, P369, DOI 10.1146/annurev-clinpsy-032813-153626; Yoshida K, 1998, BRIT J PSYCHIAT, V172, P175, DOI 10.1192/bjp.172.2.175; Young EA, 2004, PSYCHONEUROENDOCRINO, V29, P1198, DOI 10.1016/j.psyneuen.2004.02.002; Zoega H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144474; Zou C, 2013, NEUROPSYCH DIS TREAT, V9, P1661, DOI 10.2147/NDT.S38899	111	12	13	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212577	10.1371/journal.pone.0212577	http://dx.doi.org/10.1371/journal.pone.0212577			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789953	Green Published, Green Submitted, gold			2022-12-27	WOS:000459330800042
J	Wetterauer, C; Winkel, DJ; Federer-Gsponer, JR; Halla, A; Subotic, S; Deckart, A; Seifert, HH; Boll, DT; Ebbing, J				Wetterauer, C.; Winkel, D. J.; Federer-Gsponer, J. R.; Halla, A.; Subotic, S.; Deckart, A.; Seifert, H. H.; Boll, D. T.; Ebbing, J.			Structured reporting of prostate magnetic resonance imaging has the potential to improve interdisciplinary communication	PLOS ONE			English	Article							MRI; RADIOLOGY; IMPACT	Background Effective interdisciplinary communication of imaging findings is vital for patient care, as referring physicians depend on the contained information for the decision-making and subsequent treatment. Traditional radiology reports contain non-structured free text and potentially tangled information in narrative language, which can hamper the information transfer and diminish the clarity of the report. Therefore, this study investigates whether newly developed structured reports (SRs) of prostate magnetic resonance imaging (MRI) can improve interdisciplinary communication, as compared to non-structured reports (NSRs). Methods 50 NSRs and 50 SRs describing a single prostatic lesion were presented to four urologists with expert level experience in prostate cancer surgery or targeted MRI TRUS fusion biopsy. They were subsequently asked to plot the tumor location in a 2-dimensional prostate diagram and to answer a questionnaire focusing on information on clinically relevant key features as well as the perceived structure of the report. A validated scoring system that distinguishes between "major" and "minor" mistakes was used to evaluate the accuracy of the plotting of the tumor position in the prostate diagram. Results The mean total score for accuracy for SRs was significantly higher than for NSRs (28.46 [range 13.33-30.0] vs. 21.75 [range 0.0-30.0], p < 0.01). The overall rates of major mistakes (54% vs. 10%) and minor mistakes (74% vs. 22%) were significantly higher (p < 0.01) for NSRs than for SRs. The rate of radiologist re-consultations was significantly lower (p < 0.01) for SRs than for NSRs (19% vs. 85%). Furthermore, SRs were rated as significantly superior to NSRs in regard to determining the clinical tumor stage (p < 0.01), the quality of the summary (4.4 vs. 2.5; p < 0.01), and overall satisfaction with the report (4.5 vs. 2.3; p < 0.01), and as more valuable for further clinical decision-making and surgical planning (p < 0.01). Conclusions Structured reporting of prostate MRI has the potential to improve interdisciplinary communication. Through SRs, expert urologists were able to more accurately assess the exact location of single prostate cancer lesions, which can facilitate surgical planning. Furthermore, structured reporting of prostate MRI leads to a higher satisfaction level of the referring physician.	[Wetterauer, C.; Federer-Gsponer, J. R.; Halla, A.; Subotic, S.; Deckart, A.; Seifert, H. H.; Ebbing, J.] Urol Univ Clin Basel Liestal, Univ Basel Hosp, Basel, Switzerland; [Winkel, D. J.; Boll, D. T.] Univ Hosp Basel, Dept Radiol, Basel, Switzerland	University of Basel; University of Basel	Winkel, DJ (corresponding author), Univ Hosp Basel, Dept Radiol, Basel, Switzerland.	davidjean.winkel@usb.ch		Wetterauer, Christian/0000-0003-2947-4245				Ahmed HU, 2017, LANCET, V389, P815, DOI 10.1016/S0140-6736(16)32401-1; Barentsz JO, 2012, EUR RADIOL, V22, P746, DOI 10.1007/s00330-011-2377-y; Brook OR, 2015, RADIOLOGY, V274, P464, DOI 10.1148/radiol.14140206; Ebbing J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199477; Faggioni L, 2017, EUR RADIOL, V27, P1934, DOI 10.1007/s00330-016-4553-6; Franconeri A, 2018, EUR RADIOL, V28, P3009, DOI 10.1007/s00330-017-5161-9; Ganeshan D, 2018, ACAD RADIOL, V25, P66, DOI 10.1016/j.acra.2017.08.005; Gassenmaier S, 2017, EUR RADIOL, V27, P4110, DOI 10.1007/s00330-017-4778-z; Hawkins CM, 2014, J DIGIT IMAGING, V27, P581, DOI 10.1007/s10278-014-9699-7; James JT, 2013, J PATIENT SAF, V9, P122, DOI 10.1097/PTS.0b013e3182948a69; Magnetta MJ, 2018, AM J ROENTGENOL, V210, P108, DOI 10.2214/AJR.17.18260; Norenberg D, 2017, INVEST RADIOL, V52, P232, DOI 10.1097/RLI.0000000000000336; Powell DK, 2015, ACAD RADIOL, V22, P226, DOI 10.1016/j.acra.2014.08.014; Sahni VA, 2015, AM J ROENTGENOL, V205, P584, DOI 10.2214/AJR.14.14053; Schwartz LH, 2011, RADIOLOGY, V260, P174, DOI 10.1148/radiol.11101913; Spilseth B, 2018, AM J ROENTGENOL, V210, P101, DOI 10.2214/AJR.17.18241; Weinreb JC, 2016, EUR UROL, V69, P16, DOI 10.1016/j.eururo.2015.08.052; Zhang L, 2017, EUR RADIOL, V27, P5204, DOI 10.1007/s00330-017-4843-7	18	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212444	10.1371/journal.pone.0212444	http://dx.doi.org/10.1371/journal.pone.0212444			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779810	Green Submitted, Green Published, gold			2022-12-27	WOS:000459062900056
J	Devireddy, LR; Myers, M; Screven, R; Liu, ZM; Boxer, L				Devireddy, Laxminarayana R.; Myers, Michael; Screven, Rudell; Liu, Zhuoming; Boxer, Lynne			A serum-free medium formulation efficiently supports isolation and propagation of canine adipose-derived mesenchymal stem/stromal cells	PLOS ONE			English	Article							STEM-CELLS; STROMAL CELLS; ASCORBIC-ACID; DIFFERENTIATION; CULTURE; GROWTH; HYDROCORTISONE; PROLIFERATION; TISSUE; EQUINE	Medium containing Fetal Bovine Serum (FBS) provides a supportive environment for isolation and expansion of mesenchymal stromal/stem cells (MSCs); however, the inherent variability of FBS may contribute to inconsistencies in cell growth and yield between batches of stem cell products. For this reason, we set out to develop a serum-free medium capable of supporting the in vitro expansion of MSCs. First a naive serum-free medium was formulated by Sato's approach. Once it was established that the naive serum-free medium supported the expansion of canine adipose-derived MSCs (Ad-MSCs), the serum-free medium was optimized by addition of growth factors. Combinations of growth factors were chosen and compared by their effect on cell proliferation and colony formation. Growth characteristics of canine adipose-derived MSCs cultured in the serum-free medium were comparable to those cultured in standard FBS containing medium. In addition, cell surface marker expression and differentiation potential of serum-free and FBS-based cultures were also comparable. However, a commercial serum-free medium developed for human MSC culture did not support growth of canine Ad-MSCs. In summary, canine Ad-MSCs isolated and cultured in serum-free medium retained the basic characteristics of MSCs cultured in FBS containing medium.	[Devireddy, Laxminarayana R.; Myers, Michael; Screven, Rudell; Liu, Zhuoming] US FDA, Div Appl Vet Res, Ctr Vet Med, Laurel, MD 20708 USA; [Boxer, Lynne] US FDA, Off New Anim Drug Evaluat, Ctr Vet Med, Rockville, MD 20857 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Devireddy, LR (corresponding author), US FDA, Div Appl Vet Res, Ctr Vet Med, Laurel, MD 20708 USA.	Laxminarayana.Devireddy@fda.hhs.gov						Arzi B, 2017, STEM CELL TRANSL MED, V6, DOI 10.1002/sctm.17-0035; Baer PC, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/812693; BARNES D, 1980, ANAL BIOCHEM, V102, P255, DOI 10.1016/0003-2697(80)90151-7; Benavente CA, 2003, GROWTH FACTORS, V21, P87, DOI 10.1080/08977190310001613789; Bianco P, 2014, ANNU REV CELL DEV BI, V30, P677, DOI 10.1146/annurev-cellbio-100913-013132; Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028; Chase LG, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt8; Choi KM, 2008, J BIOSCI BIOENG, V105, P586, DOI 10.1263/jbb.105.586; Clark KC, 2016, STEM CELL REV REP, V12, P245, DOI 10.1007/s12015-015-9638-0; Colleoni S, 2009, VET RES COMMUN, V33, P811, DOI 10.1007/s11259-009-9229-0; CROISILLE L, 1994, BLOOD, V84, P4116, DOI 10.1182/blood.V84.12.4116.bloodjournal84124116; Francis GL, 2010, CYTOTECHNOLOGY, V62, P1, DOI 10.1007/s10616-010-9263-3; Fraser John K., 2008, V449, P59, DOI 10.1007/978-1-60327-169-1_4; Gottipamula S, 2013, CELL PROLIFERAT, V46, P608, DOI 10.1111/cpr.12063; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Johnson M., 2013, MAT METHODS, V3, P175, DOI [10.13070/mm.en.2.117, DOI 10.13070/MM.EN.2.117]; Jung S, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/123030; Kyurkchiev DS, 2011, VITAM HORM, V87, P217, DOI 10.1016/B978-0-12-386015-6.00040-8; Le Blanc K, 2012, NAT REV IMMUNOL, V12, P383, DOI 10.1038/nri3209; Liu CH, 2007, BIOCHEM ENG J, V33, P1, DOI 10.1016/j.bej.2006.08.005; Liu ZM, 2018, TISSUE ENG PART C-ME, V24, P399, DOI [10.1089/ten.tec.2017.0409, 10.1089/ten.TEC.2017.0409]; Mather JP, 1998, METHOD CELL BIOL, V57, P19; Mimura S, 2011, INT J DEV BIOL, V55, P181, DOI 10.1387/ijdb.103232sm; Nakano R, 2015, J VET MED SCI, V77, P27, DOI 10.1292/jvms.14-0284; Ng F, 2008, BLOOD, V112, P295, DOI 10.1182/blood-2007-07-103697; Panchalingam KM, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0228-5; Parker AM, 2007, CYTOTHERAPY, V9, P637, DOI 10.1080/14653240701508452; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Russell KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136621; Sakwe AM, 2010, J BIOL CHEM, V285, P41827, DOI 10.1074/jbc.M110.128926; Sato H, 2006, BIOCHEM BIOPH RES CO, V342, P107, DOI 10.1016/j.bbrc.2006.01.116; Savonniere S, 1996, J BIOTECHNOL, V48, P161, DOI 10.1016/0168-1656(96)01392-2; Schwarz C, 2012, RES VET SCI, V93, P457, DOI 10.1016/j.rvsc.2011.08.010; Screven R, 2014, VET IMMUNOL IMMUNOP, V161, P21, DOI 10.1016/j.vetimm.2014.06.002; Shih DTB, 2015, NEW BIOTECHNOL, V32, P199, DOI 10.1016/j.nbt.2014.06.001; Shipunova NN, 2013, B EXP BIOL MED+, V155, P159, DOI 10.1007/s10517-013-2102-8; Sotiropoulou PA, 2006, STEM CELLS, V24, P462, DOI 10.1634/stemcells.2004-0331; Tamama K, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/795385; Trounson A, 2015, CELL STEM CELL, V17, P11, DOI 10.1016/j.stem.2015.06.007; Wodewotzky TI, 2012, BRAZ J MED BIOL RES, V45, P1157, DOI 10.1590/S0100-879X2012007500149; Zeve D, 2009, CELL STEM CELL, V5, P472, DOI 10.1016/j.stem.2009.10.014; Zhang DW, 2012, GENE DEV, V26, P461, DOI 10.1101/gad.182998.111; Zuk PA, 2010, MOL BIOL CELL, V21, P1783, DOI 10.1091/mbc.E09-07-0589	43	22	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0210250	10.1371/journal.pone.0210250	http://dx.doi.org/10.1371/journal.pone.0210250			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811421	Green Submitted, Green Published, gold			2022-12-27	WOS:000459806400115
J	Ibrahim, N; Din, NC; Amit, N; Ghazali, SE; Safien, AM				Ibrahim, Norhayati; Din, Normah Che; Amit, Noh; Ghazali, Shazli Ezzat; Safien, Aisyah Mohd			Development and validation of Yatt Suicide Attitude Scale (YSAS) in Malaysia	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; PSYCHOLOGICAL DISTRESS SCALE; PSYCHOMETRIC PROPERTIES; PERCEIVED STRESS; IDEATION; RISK; PREVALENCE; COMMUNITY; COMPONENT; BIAS	Introduction Despite suicide rate becoming a growing trend in research locally and globally, there is no standard measuring instrument developed in Malaysia. The aim of this study is to establish the first ever Malay version of suicide screening tool that is suitable and fit with multiracial and complex culture of Malaysia. Methods This study comprises of three phases, namely (1) items selection phase, (2) pilot study phase, and (3) scale validation phase. During the first phase, the items were selected from items pools which gathered from previous suicide ideation/attitude scales. Then the pilot study was carried out to examine the items for Yatt Suicide Attitude Scale (YSAS). Lastly, the Yatt Suicide Attitude Scale (YSAS) validation study was conducted with 219 university students. Results Initial version of YSAS comprised 16 items and three components. After factor analysis, the questionnaire was reduced into only two components (Suicide Ideation and Suicide Attempt) with 5 items each. Both of the components obtained high reliability value (.89 and .86 respectively) and the questionnaire accounted for 67.84% of the total variance. Conclusion The analysis showed that YSAS has an acceptable reliability and validity for Malaysian population. Although these findings corroborate literature on development of suicide ideation assessment instrument for specific cultural context, there is a need to further examine its reliability with clinical population and general population of different cultural context in Malaysia.	[Ibrahim, Norhayati; Din, Normah Che; Amit, Noh; Ghazali, Shazli Ezzat; Safien, Aisyah Mohd] Univ Kebangsaan Malaysia, Fac Hlth Sci, Sch Healthcare Sci, Hlth Psychol Programme, Kuala Lumpur, Malaysia	Universiti Kebangsaan Malaysia	Ibrahim, N (corresponding author), Univ Kebangsaan Malaysia, Fac Hlth Sci, Sch Healthcare Sci, Hlth Psychol Programme, Kuala Lumpur, Malaysia.	yatieibra@ukm.edu.my	Ghazali, Shazli Ezzat/AAS-9080-2021		Geran Galakan Penyelidikan Universiti Kebangsaan Malaysia [GGP-2017-059]	Geran Galakan Penyelidikan Universiti Kebangsaan Malaysia	This work was supported by Geran Galakan Penyelidikan Universiti Kebangsaan Malaysia (GGP-2017-059).	Andrews G, 2001, AUST NZ J PUBL HEAL, V25, P494, DOI 10.1111/j.1467-842X.2001.tb00310.x; Armitage CJ, 2015, GEN HOSP PSYCHIAT, V37, P153, DOI 10.1016/j.genhosppsych.2014.12.002; BECK AT, 1979, J CONSULT CLIN PSYCH, V47, P343, DOI 10.1037/0022-006X.47.2.343; BECK AT, 1988, J CLIN PSYCHOL, V44, P499, DOI 10.1002/1097-4679(198807)44:4<499::AID-JCLP2270440404>3.0.CO;2-6; Binet A., 1973, DEV INTELLIGENCE CHI; Brown RT, 1999, SCHOOL PSYCHOL QUART, V14, P208, DOI 10.1037/h0089007; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Chan LF, 2011, CRISIS, V32, P283, DOI 10.1027/0227-5910/a000088; Comrey A.L., 1992, 1 COURSE FACTOR ANAL; CRONBACH LJ, 1955, PSYCHOL BULL, V52, P281, DOI 10.1037/h0040957; Cummings J., 2016, PREVENT SUICIDE RECO; Cummings N. A., 2012, REFOCUSED PSYCHOTHER; Davis MT, 2014, PSYCHOL TRAUMA-US, V6, P610, DOI 10.1037/a0033941; De Vogli R, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4908; De Vogli R, 2013, J EPIDEMIOL COMMUN H, V67, DOI 10.1136/jech-2012-201607; Enos M. M., 2001, THESIS; Finney S. J., 2001, THESIS; GUADAGNOLI E, 1988, PSYCHOL BULL, V103, P265, DOI 10.1037/0033-2909.103.2.265; Harris K. M., 2015, ABCS SUICIDE RISK AS, DOI [10.1371/journal.pone.0127442, DOI 10.1371/JOURNAL.PONE.0127442]; Heisel MJ, 2006, AM J GERIAT PSYCHIAT, V14, P742, DOI 10.1097/01.JGP.0000218699.27899.f9; Hilton A, 2002, CANCER NURS, V25, P1, DOI 10.1097/00002820-200202000-00001; Ibrahim N, 2017, Med J Malaysia, V72, P221; Ibrahim Norhayati, 2014, PLoS One, V9, pe110670, DOI 10.1371/journal.pone.0110670; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Klonsky ED, 2016, ANNU REV CLIN PSYCHO, V12, P307, DOI 10.1146/annurev-clinpsy-021815-093204; Krysinska K, 2010, ARCH SUICIDE RES, V14, P1, DOI 10.1080/13811110903478997; Lamis DA, 2012, PSYCHOL WOMEN QUART, V36, P337, DOI 10.1177/0361684312439186; Lane ME, 2012, AM J PUBLIC HEALTH, V102, P1213, DOI 10.2105/AJPH.2011.300280; Law K. S., 2000, TRANSLATING QUESTION, DOI 10.4135/9781412986373; Linehan M. M., 1981, SUICIDAL BEHAV UNPUB; Macaraeg J. C., 2013, PACIFIC ASIA INQUIRY, V4; Malaysian Psychiatric Association, 2007, SUIC ITS SOS; McCrae RR, 2005, J PERS SOC PSYCHOL, V88, P547, DOI 10.1037/0022-3514.88.3.547; Mitchell AM, 2008, RES NURS HEALTH, V31, P576, DOI 10.1002/nur.20284; Musa R, 2007, ASEAN J PSYCHIATR, V8, P82; Ng KM, 2005, FAM J, V13, P416, DOI 10.1177/1066480705278471; Nintachan P, 2007, J TRANSCULT NURS, V18, P127, DOI 10.1177/1043659606298616; Ninth Malaysian Plan, 2006, KUAL LUMP PERC NAS M; Nunnally J.C., 1978, PSYCHOMETRIC THEORY, DOI DOI 10.1037/018882; Oei TPS, 2013, INT J PSYCHOL, V48, P1018, DOI 10.1080/00207594.2012.755535; Omar Asmah Haji, 1996, POSTIMPERIAL ENGLISH, P513; Ong HC, 2016, PSYCHOL RES BEHAV MA, V9, P211, DOI 10.2147/PRBM.S112129; Posner K, 2011, AM J PSYCHIAT, V168, P1266, DOI 10.1176/appi.ajp.2011.10111704; Rajiah K., 2014, INT J APPL PSYCHOL, V4, P68, DOI [DOI 10.5923/J.IJAP.20140402.04, 10.5923/j.ijap.20140402.04]; Ramachandra S., 2010, NEW STRAITS TIMES; Reynolds C. R., 1998, COMPREHENSIVE CLIN P; Reynolds CR, 2000, PSYCHOL PUBLIC POL L, V6, P144, DOI 10.1037/1076-8971.6.1.144; RUDD MD, 1989, SUICIDE LIFE-THREAT, V19, P173; Scowcrof E., 2016, SUICIDE STAT REPORT; Siau CS, 2017, INQUIRY-J HEALTH CAR, V54, DOI 10.1177/0046958017707295; Sinniah A, 2014, SCI WORLD J, DOI 10.1155/2014/718367; Stern, 1914, PSYCHOL DERFRIIHEN K; Sue D, 2008, COUNSELING CULTURALL; Sue D. W. E., 1996, THEORY MULTICULTURAL; Sunderland M, 2012, J PSYCHOPATHOL BEHAV, V34, P253, DOI 10.1007/s10862-012-9276-7; van Spijker BAJ, 2014, SUICIDE LIFE-THREAT, V44, P408, DOI 10.1111/sltb.12084; WIDAMAN KF, 1985, APPL PSYCH MEAS, V9, P1, DOI 10.1177/014662168500900101; World Health Organization, 2014, PREV SUIC GLOB IMP	58	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0209971	10.1371/journal.pone.0209971	http://dx.doi.org/10.1371/journal.pone.0209971			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM9LQ	30811425	Green Submitted, Green Published, gold			2022-12-27	WOS:000459806400007
J	Suhr, OB; Wixner, J; Anan, I; Lundgren, HE; Wijayatunga, P; Westermark, P; Ihse, E				Suhr, Ole Bernt; Wixner, Jonas; Anan, Intissar; Lundgren, Hans-Erik; Wijayatunga, Priyantha; Westermark, Per; Ihse, Elisabet			Amyloid fibril composition within hereditary Val30Met (p. Val50Met) transthyretin amyloidosis families	PLOS ONE			English	Article							LIVER-TRANSPLANTATION; DEPOSITS; IMPACT; ATTR	Background The amyloid fibril in hereditary transthyretin (TTR) Val30Met (pVal50Met) amyloid (ATTR Val30Met) amyloidosis is composed of either a mixture of full-length and TTR fragments (Type A) or of only full-length TTR (Type B). The type of amyloid fibril exerts an impact on the phenotype of the disease, and on the outcome of diagnostic procedures and therapy. The aim of the present study was to investigate if the type of amyloid fibril remains the same within ATTR Val30Met amyloidosis families. Methods Fifteen families were identified in whom at least two first-degree relatives had their amyloid fibril composition determined. The type of ATTR was determined by Western blot in all but two patients. For these two patients a positive 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy indicated ATTR Type A. Results In 14 of the 15 families, the same amyloid fibril composition was noted irrespective of differences in age at onset. In the one family, different ATTR fibril types was found in two brothers with similar ages at onset. Conclusions Family predisposition appears to have an impact on amyloid fibril composition in members of the family irrespective of their age at onset of disease, but if genetically determined, the gene/genes are likely to be situated at another location than the TTR gene in the genome.	[Suhr, Ole Bernt; Wixner, Jonas; Anan, Intissar; Lundgren, Hans-Erik] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Wijayatunga, Priyantha] Umea Univ, Dept Stat, Umea, Sweden; [Westermark, Per; Ihse, Elisabet] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden	Umea University; Umea University; Uppsala University	Suhr, OB (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden.	Ole.suhr@umu.se	Wijayatunga, Priyantha/AAG-5817-2019; Wijayatunga, Priyantha/P-8098-2017; Wixner, Jonas/AAN-5812-2021	Wijayatunga, Priyantha/0000-0003-1654-9148; Wijayatunga, Priyantha/0000-0003-1654-9148; Wixner, Jonas/0000-0002-1536-1277; Suhr, Ole/0000-0002-1175-2369	Swedish Heart and Lung foundation [20160787]; Selander's foundation; patient organisation FAMY/AMYL, Vaster-and Norrbotten	Swedish Heart and Lung foundation(Swedish Heart-Lung Foundation); Selander's foundation; patient organisation FAMY/AMYL, Vaster-and Norrbotten	This work was supported by: The Swedish Heart and Lung foundation grant no. 20160787, https://www3.hjart-lungfonden.se/(OBS); the patient organisation FAMY/AMYL, Vaster-and Norrbotten, https://www.famy.se/and https://www.famynorrbotten.se/sv-SE (OBS, PW); and Selander's foundation, https://www.stiftelsemedel.se/erik-karin-och-gsta-selandersstiftelse/(PW).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergstrom J, 2005, J PATHOL, V206, P224, DOI 10.1002/path.1759; Coelho T, 2018, NEUROLOGY, V91, pE1999, DOI 10.1212/WNL.0000000000006543; Ericzon BG, 2015, TRANSPLANTATION, V99, P1847, DOI 10.1097/TP.0000000000000574; Gustafsson S, 2012, TRANSPLANTATION, V93, P1017, DOI 10.1097/TP.0b013e31824b3749; GUSTAVSSON A, 1995, LAB INVEST, V73, P703; Hammarstrom P, 2001, BIOCHEMISTRY-US, V40, P11453, DOI 10.1021/bi010673+; Ihse E, 2008, J PATHOL, V216, P253, DOI 10.1002/path.2411; Ihse E, 2013, AMYLOID, V20, P142, DOI 10.3109/13506129.2013.797890; Ihse E, 2011, J MOL MED, V89, P171, DOI 10.1007/s00109-010-0695-1; Ikeda S, 2011, AMYLOID, V18, P211, DOI 10.3109/13506129.2011.623199; Koike H, 2018, J NEUROL SCI, V394, P99, DOI 10.1016/j.jns.2018.09.011; Koike H, 2009, J NEUROL SCI, V287, P178, DOI 10.1016/j.jns.2009.07.028; Mangione PP, 2018, J BIOL CHEM, V293, P14192, DOI 10.1074/jbc.RA118.003990; Marcoux J, 2015, EMBO MOL MED, V7, P1337, DOI 10.15252/emmm.201505357; Oshima T, 2014, J NEUROL NEUROSUR PS, V85, P740, DOI 10.1136/jnnp-2013-305973; Pilebro B, 2016, UPSALA J MED SCI, V121, P17, DOI 10.3109/03009734.2015.1122687; SANDGREN O, 1986, OPHTHALMIC RES, V18, P98, DOI 10.1159/000265422; Suhr OB, 2017, J INTERN MED, V281, P337, DOI 10.1111/joim.12585; Tasaki M, 2018, 16 INT S AM KUM JAP, P80; Westermark P, 2017, AMYLOID, V24, P128, DOI 10.1080/13506129.2017.1294058	20	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211983	10.1371/journal.pone.0211983	http://dx.doi.org/10.1371/journal.pone.0211983			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811423	Green Published, Green Submitted, gold			2022-12-27	WOS:000459806400043
J	Huminiecki, L				Huminiecki, Lukasz			Magic roundabout is an endothelial-specific ohnolog of ROBO1 which neo-functionalized to an essential new role in angiogenesis	PLOS ONE			English	Article							DETECTING POSITIVE SELECTION; GENE-EXPRESSION; EVOLUTIONARY ORIGINS; AXON GUIDANCE; DNA ELEMENTS; CNS MIDLINE; DUPLICATION; CELL; RECEPTOR; PROTEIN	Background Magic roundabout (ROBO4) is an unusual endothelial-specific paralog of the family of neuronally-expressed axon guidance receptors called roundabouts. Endothelial cells (ECs), whose uninterrupted sheet delimits the lumen of all vertebrate blood vessels and which are absent from invertebrate species, are a vertebrate-specific evolutionary novelty. Results Herein, the evolutionary mechanism of the duplication, retention and divergence of ROBO4 was investigated for the first time. Phylogenetic analyses carried out suggested that ROBO4 is a fast-evolving paralog of ROBO1 formed at the base of vertebrates. The ancestral expression pattern was neuronal. ROBO4 dramatically shifted its expression and became exceptionally specific to ECs. The data-mining of FANTOM5 and ENCODE reveals that ROBO4's endothelial expression arises from a single transcription start site (TSS), conserved in mouse, controlled by a proximal promoter with a complex architecture suggestive of regulatory neo-functionalization. (An analysis of promoter probabilities suggested the architecture was not due to a chance arrangement of TFBSes). Further evidence for the neo-functionalization of ROBO4 comes from the analysis of its protein interactions, the rates of protein evolution, and of positively selected sites. Conclusions The neo-functionalization model explains why ROBO4 protein acquired new context-specific biological functions in the control of angiogenesis. This endothelial-specific roundabout receptor is an illustrative example of the emergence of an essential vertebrate molecular novelty and an endothelial-specific signaling sub-network through 2R-WGD. The emergence of novel cell types, such as ECs, might be a neglected evolutionary force contributing to the high rate of retention of duplicates post-2R-WGD. Crucially, expression neo-functionalization to evolutionarily novel sites of expression conceptually extends the classical model of neo-functionalization.	[Huminiecki, Lukasz] Polskiej Akad Nauk, Inst Genet & Hodowli Zwierzat, Jastrzebiec, Magdalenka, Poland	Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences; Polish Academy of Sciences	Huminiecki, L (corresponding author), Polskiej Akad Nauk, Inst Genet & Hodowli Zwierzat, Jastrzebiec, Magdalenka, Poland.	l.huminiecki@ighz.pl		Huminiecki, Lukasz/0000-0003-1943-4450	National Science Center, Poland [2016/21/P/NZ2/03926]; Marie Sklodowska-Curie actions from the European Union's Horizon 2020 research and innovation programme	National Science Center, Poland(National Science Centre, Poland); Marie Sklodowska-Curie actions from the European Union's Horizon 2020 research and innovation programme	LH received a POLONEZ 2 grant from the National Science Center, Poland, with the following agreement: 2016/21/P/NZ2/03926. (Note that the POLONEZ 2 scheme was co-funded by Marie Sklodowska-Curie actions from the European Union's Horizon 2020 research and innovation programme.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal CC, 2001, LECT NOTES COMPUT SC, V1973, P420; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Birchler JA, 2007, PLANT CELL, V19, P395, DOI 10.1105/tpc.106.049338; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Carelli FN, 2016, GENOME RES, V26, P301, DOI 10.1101/gr.198473.115; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; De Val S, 2009, DEV CELL, V16, P180, DOI 10.1016/j.devcel.2009.01.014; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Des Marais DL, 2008, NATURE, V454, P762, DOI 10.1038/nature07092; Dubrac A, 2016, CIRCULATION, V133, P409, DOI 10.1161/CIRCULATIONAHA.115.017537; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emerson JJ, 2004, SCIENCE, V303, P537, DOI 10.1126/science.1090042; ENCODE-Consortium, ENCODE CHIP SEQ EXPT; Fares MA, 2006, MOL BIOL EVOL, V23, P245, DOI 10.1093/molbev/msj027; Finn RD, 2015, NUCLEIC ACIDS RES, V43, pW30, DOI 10.1093/nar/gkv397; Fisher WW, 2012, P NATL ACAD SCI USA, V109, P21330, DOI 10.1073/pnas.1209589110; Force A, 1999, GENETICS, V151, P1531; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Franceschini A, 2016, BIOINFORMATICS, V32, P1085, DOI 10.1093/bioinformatics/btv696; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Ghose A, 2002, BIOESSAYS, V24, P401, DOI 10.1002/bies.10080; Graur D, 2013, GENOME BIOL EVOL, V5, P578, DOI 10.1093/gbe/evt028; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guthrie S, 2001, CURR BIOL, V11, pR300, DOI 10.1016/S0960-9822(01)00169-5; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; Hittinger CT, 2007, NATURE, V449, P677, DOI 10.1038/nature06151; Huelsenbeck JP, 1997, SYST BIOL, V46, P69, DOI 10.2307/2413636; Hughes AL, 2005, P NATL ACAD SCI USA, V102, P8791, DOI 10.1073/pnas.0503922102; Huminiecki L, 2004, GENOME RES, V14, P1870, DOI 10.1101/gr.2705204; Huminiecki L, 2002, GENOMICS, V79, P547, DOI 10.1006/geno.2002.6745; Huminiecki L, 2000, GENOME RES, V10, P1796, DOI 10.1101/gr.150700; Huminiecki L, 2017, TRENDS BIOTECHNOL, V35, P530, DOI 10.1016/j.tibtech.2017.03.007; Huminiecki L, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-146; Huminiecki L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-28; Hurst LD, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002315; Jaccard P., 1912, NEW PHYTOLOGIST, V11; Jin J, 2012, CELL, V151, P384, DOI 10.1016/j.cell.2012.08.037; Jones CA, 2009, NAT CELL BIOL, V11, P1325, DOI 10.1038/ncb1976; Kalil K, 2014, NAT REV NEUROSCI, V15, P7, DOI 10.1038/nrn3650; Kasahara M, 2007, CURR OPIN IMMUNOL, V19, P547, DOI 10.1016/j.coi.2007.07.009; Kellis M, 2014, P NATL ACAD SCI USA, V111, P6131, DOI 10.1073/pnas.1318948111; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; Koch AW, 2011, DEV CELL, V20, P33, DOI 10.1016/j.devcel.2010.12.001; LEE ME, 1991, J BIOL CHEM, V266, P16188; Legg JA, 2008, ANGIOGENESIS, V11, P13, DOI 10.1007/s10456-008-9100-x; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Liao BY, 2010, P NATL ACAD SCI USA, V107, P7353, DOI 10.1073/pnas.0910339107; Likhite VS, 2004, J BIOL CHEM, V279, P16875, DOI 10.1074/jbc.M313155200; Lin ZH, 2018, MOL IMMUNOL, V103, P166, DOI 10.1016/j.molimm.2018.08.021; Littlewood TD, 2012, CELL, V151, P11, DOI 10.1016/j.cell.2012.09.006; Locascio A, 2002, P NATL ACAD SCI USA, V99, P16841, DOI 10.1073/pnas.262525399; Loppin B, 2005, CURR BIOL, V15, P87, DOI 10.1016/j.cub.2004.12.071; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2001, GENETICS, V159, P1789; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Monahan-Earley R, 2013, J THROMB HAEMOST, V11, P46, DOI 10.1111/jth.12253; Morlot C, 2007, P NATL ACAD SCI USA, V104, P14923, DOI 10.1073/pnas.0705310104; Munoz-Chapuli R, 2005, EVOL DEV, V7, P351, DOI 10.1111/j.1525-142X.2005.05040.x; Munoz-Chapuli R, 2011, INT J DEV BIOL, V55, P345, DOI 10.1387/ijdb.103212rm; Nery MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065491; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Nielsen R, 1998, GENETICS, V148, P929; Ohno S., 1970, EVOLUTION GENE DUPLI, Vxv; Okada Y, 2008, BLOOD, V112, P2336, DOI 10.1182/blood-2008-01-135079; Okada Y, 2007, CIRC RES, V100, P1712, DOI 10.1161/01.RES.0000269779.10644.dc; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Park KW, 2003, DEV BIOL, V261, P251, DOI 10.1016/S0012-1606(03)00258-6; Pascual-Anaya J, 2013, DEV BIOL, V375, P182, DOI 10.1016/j.ydbio.2012.11.015; Peterson MW, 2007, SOURCE CODE BIOL MED, V2, DOI 10.1186/1751-0473-2-7; Rama N, 2015, NAT MED, V21, P483, DOI 10.1038/nm.3849; Risau W, 1995, ANNU REV CELL DEV BI, V11, P73, DOI 10.1146/annurev.cb.11.110195.000445; Rodriguez-Trelles F, 2003, P NATL ACAD SCI USA, V100, P13413, DOI 10.1073/pnas.1835646100; Seoighe C, 2004, TRENDS GENET, V20, P461, DOI 10.1016/j.tig.2004.07.008; Severin ML Jessica, 2013, NATURE BIOTECHNOLOGY; Sheldon H, 2009, FASEB J, V23, P513, DOI 10.1096/fj.07-098269; Shibata F, 2009, STEM CELLS, V27, P183, DOI 10.1634/stemcells.2008-0292; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Simpson JH, 2000, NEURON, V28, P753, DOI 10.1016/S0896-6273(00)00151-3; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Suchting S, 2004, FASEB J, V18, P121, DOI 10.1096/fj.04-1991fje; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Telford MJ, 2008, PHILOS T R SOC B, V363, P1529, DOI 10.1098/rstb.2007.2243; Telford MJ, 2004, CURR BIOL, V14, pR274, DOI 10.1016/j.cub.2004.03.022; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Warnefors M, 2013, GENOME BIOL EVOL, V5, P1324, DOI 10.1093/gbe/evt093; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wernersson R, 2003, NUCLEIC ACIDS RES, V31, P3537, DOI 10.1093/nar/gkg609; White MA, 2016, CELL REP, V17, P1247, DOI 10.1016/j.celrep.2016.09.066; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2006, MOL BIOL EVOL, V23, P212, DOI 10.1093/molbev/msj024; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Zelina P, 2014, NEURON, V84, P1258, DOI 10.1016/j.neuron.2014.11.004; Zhang B, 2009, BLOOD, V114, P4300, DOI 10.1182/blood-2008-12-193326; Zhang Fu-hua, 2016, Shanghai Kou Qiang Yi Xue, V25, P11; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhuang XD, 2011, BIOCHEM SOC T, V39, P1571, DOI 10.1042/BST20110746; Zmasek CM, 2001, BIOINFORMATICS, V17, P383, DOI 10.1093/bioinformatics/17.4.383; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	108	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2019	14	2							e0208952	10.1371/journal.pone.0208952	http://dx.doi.org/10.1371/journal.pone.0208952			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EH	30802244	Green Published, gold, Green Submitted			2022-12-27	WOS:000459710700003
J	Imai, Y; Yoshida, O; Watanabe, T; Yukimoto, A; Koizumi, Y; Ikeda, Y; Tokumoto, Y; Hirooka, M; Abe, M; Hiasa, Y				Imai, Yusuke; Yoshida, Osamu; Watanabe, Takao; Yukimoto, Atsushi; Koizumi, Yohei; Ikeda, Yoshio; Tokumoto, Yoshio; Hirooka, Masashi; Abe, Masanori; Hiasa, Yoichi			Stimulated hepatic stellate cell promotes progression of hepatocellular carcinoma due to protein kinase R activation	PLOS ONE			English	Article							NONALCOHOLIC STEATOHEPATITIS; INFLAMMASOME ACTIVATION; LIVER; PKR; LPS; FIBROGENESIS; INHIBITION; FIBROSIS; ACID; NASH	Hepatic stellate cells (HSCs) were reported to promote the progression of hepatocellular carcinoma (HCC), however its mechanism is uncertain. We previously reported that protein kinase R (PKR) in hepatocytes regulated HCC proliferation. In this study, we focused on the role of PKR in HSCs, and clarified the mechanism of its association with HCC progression. We confirmed the activation of PKR in a human HSC cell line (LX-2 cell). IL-1 beta is produced from HSCs stimulated by lipopolysaccharide (LPS) or palmitic acid which are likely activators of PKR in non-alcoholic steatohepatitis (NASH). Production was assessed by real-time PCR and ELISA. C16 and small interfering RNA (siRNA) were used to inhibit PKR in HSCs. The HCC cell line (HepG2 cell) was cultured with HSC conditioning medium to assess HCC progression, which was evaluated by proliferation and scratch assays. Expression of PKR was increased and activated in stimulated HSCs, and IL-1 beta production was also increased molecular. Key molecules of the mitogen-activated protein kinase pathway were also upregulated and activated by LPS. Otherwise, PKR inhibition by C16 and PKR siRNA decreased IL-1 beta production. HCC progression was promoted by HSC-stimulated conditioning medium although it was reduced by the conditioning medium from PKR-inhibited HSCs. Moreover, palmitic acid also upregulated IL-1 beta expression in HSCs, and conditioning medium from palmitic acid-stimulated HSCs promoted HCC proliferation. Stimulated HSCs by activators of PKR in NASH could play a role in promoting HCC progression through the production of IL-1 beta, via a mechanism that seems to be dependent on PKR activation.	[Imai, Yusuke; Yoshida, Osamu; Watanabe, Takao; Yukimoto, Atsushi; Koizumi, Yohei; Ikeda, Yoshio; Tokumoto, Yoshio; Hirooka, Masashi; Abe, Masanori; Hiasa, Yoichi] Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon, Ehime, Japan	Ehime University	Yoshida, O (corresponding author), Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon, Ehime, Japan.	yoshidao@m.ehime-u.ac.jp	Hiasa, Yoichi/ABD-2759-2021	Hiasa, Yoichi/0000-0003-4117-339X	Japan Society for the Promotion of Science (JSPS) [18K08007]; JSPS [15K19336, 17K15952]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grant-in-Aid for Scientific Research (C) (Grant no. 18K08007) from the Japan Society for the Promotion of Science (JSPS) (http://www.jsps.go.jp) to YH and Grant-in-Aid for Young Scientists (B) (Grant no. 15K19336, 17K15952) from JSPS to OY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Achiwa K, 2016, BIOCHEM BIOPH RES CO, V470, P15, DOI 10.1016/j.bbrc.2015.12.012; Balogh J, 2016, J HEPATOCELL CARCINO, V3, P41, DOI 10.2147/JHC.S61146; Blanc JF, 1997, GASTROEN CLIN BIOL, V21, P869; Boriushkin E, 2016, SCI REP-UK, V6, DOI 10.1038/srep25013; Bou-Dargham MJ, 2017, MED RES REV, V37, P180, DOI 10.1002/med.21406; Carloni V, 2014, LIVER INT, V34, P834, DOI 10.1111/liv.12465; Chen YH, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0038-z; Connolly MK, 2009, J CLIN INVEST, V119, P3213, DOI 10.1172/JCI37581; Coulouarn C, 2014, J HEPATOL, V60, P1306, DOI 10.1016/j.jhep.2014.02.003; Csak T, 2011, HEPATOLOGY, V54, P133, DOI 10.1002/hep.24341; Duan NN, 2017, LIFE SCI, V176, P42, DOI 10.1016/j.lfs.2017.03.012; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Gabele E, 2011, J HEPATOL, V55, P1391, DOI 10.1016/j.jhep.2011.02.035; Gandhi CR, 2017, J HEPATOL, V67, P1104, DOI 10.1016/j.jhep.2017.06.001; Gao Q, 2011, CANCER SCI, V102, P1522, DOI 10.1111/j.1349-7006.2011.01981.x; Hernandez-Gea V, 2013, GASTROENTEROLOGY, V144, P512, DOI 10.1053/j.gastro.2013.01.002; Hiasa Y, 2003, AM J GASTROENTEROL, V98, P2528, DOI 10.1016/S0002-9270(03)01696-4; Liang W, 2014, LAB INVEST, V94, P491, DOI 10.1038/labinvest.2014.11; Lotersztajn S, 2005, ANNU REV PHARMACOL, V45, P605, DOI 10.1146/annurev.pharmtox.45.120403.095906; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; Nakamura M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144295; Negash AA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003330; Nicholas DA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176793; Pradere JP, 2010, SEMIN LIVER DIS, V30, P232, DOI 10.1055/s-0030-1255353; Ridker PM, 2017, LANCET, V390, P1833, DOI 10.1016/S0140-6736(17)32247-X; Robert S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153118; Saraswat VA, 2014, J CLIN EXP HEPATOL, V4, pS80, DOI 10.1016/j.jceh.2014.05.004; Siegel AB, 2010, HEPATOLOGY, V52, P360, DOI 10.1002/hep.23633; Su B, 2015, HEPATOLOGY, V61, P585, DOI 10.1002/hep.27551; Tateishi R, 2015, J GASTROENTEROL, V50, P350, DOI 10.1007/s00535-014-0973-8; Tokumoto Y, 2007, J MED VIROL, V79, P1120, DOI 10.1002/jmv.20902; Utsunomiya H, 2017, J GASTROENTEROL, V52, P940, DOI 10.1007/s00535-016-1298-6; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; WAKE K, 1971, AM J ANAT, V132, P429, DOI 10.1002/aja.1001320404; Watanabe T, 2018, CANCER SCI, V109, P919, DOI 10.1111/cas.13551; Watanabe T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067750	38	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212589	10.1371/journal.pone.0212589	http://dx.doi.org/10.1371/journal.pone.0212589			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794626	Green Submitted, Green Published, gold			2022-12-27	WOS:000459709100093
J	Leighton, EA; Holle, D; Biery, DN; Gregor, TP; McDonald-Lynch, MB; Wallace, ML; Reagan, JK; Smith, GK				Leighton, Eldin A.; Holle, Dolores; Biery, Darryl N.; Gregor, Thomas P.; McDonald-Lynch, Mischa B.; Wallace, Mandy L.; Reagan, Jennifer K.; Smith, Gail K.			Genetic improvement of hip-extended scores in 3 breeds of guide dogs using estimated breeding values: Notable progress but more improvement is needed	PLOS ONE			English	Article							DEGENERATIVE JOINT DISEASE; LABRADOR-RETRIEVERS; RADIOGRAPHIC EVIDENCE; DISTRACTION INDEX; DIET RESTRICTION; 2 PALPATION; DYSPLASIA; OSTEOARTHRITIS; LAXITY; ASSOCIATION	Two hip quality phenotypes-a hip-extended score assigned by a board certified radiologist and the PennHIP distraction index-were analyzed to estimate genetic parameters and to calculate estimated breeding values used for selecting replacement breeders. Radiographs obtained at 12-18 months of age were available on 5,201 German Shepherd Dogs, 4,987 Labrador Retrievers and 2,308 Golden Retrievers. Obtained by fitting a two-trait model using Bayesian techniques, estimates of heritability for the hip-extended score were 0.76, 0.72, and 0.41 in German Shepherd Dogs, Labrador Retrievers, and Golden Retrievers, respectively, while estimated heritabilities for distraction index were 0.60, 0.66 and 0.59, respectively. Genetic correlations between the two hip quality measures were -0.28 in German Shepherd Dogs, -0.21 in Labrador Retrievers, and -0.29 in Golden Retrievers. Genetic selection for improved hip quality based upon the hip extended score phenotype began in 1980. Among first generation puppies, 34% of 273 German Shepherd Dogs, 55% of 323 Labrador Retrievers, and 43% of 51 Golden Retrievers had an Excellent hip extended score. After 8 generations of selection, mostly based on estimated breeding values derived from the hip extended score, over 93% of 695 German Shepherd Dogs, 94% of 528 Labrador Retrievers, and 87% of 116 Golden Retrievers received an Excellent hip extended score. With respect to PennHIP distraction index values among these same dogs, median values were at or above 0.30 for all 3 breeds meaning that half or more of dogs possessing the Excellent hip-extended-score phenotype remained susceptible to developing the osteoarthritis of canine hip dysplasia. Genetic improvement of the hip-extended-view phenotype to its desired biological endpoint left a surprising proportion of dogs expressing sufficient joint laxity to place them in an osteoarthritis at-risk state as they age. Only by directly applying selection pressure to reduce distraction index was marked reduction in joint laxity noted.	[Leighton, Eldin A.; Holle, Dolores] Seeing Eye Inc, Morristown, NJ 07960 USA; [Biery, Darryl N.; Gregor, Thomas P.; McDonald-Lynch, Mischa B.; Wallace, Mandy L.; Reagan, Jennifer K.; Smith, Gail K.] Univ Penn, Sch Vet Med, Dept Clin Sci & Adv Med, Philadelphia, PA 19104 USA; [Leighton, Eldin A.] Canine Genet Serv LLC, Great Falls, VA USA; [McDonald-Lynch, Mischa B.] Vet Specialty Hosp Carolinas, Cary, NC USA; [Wallace, Mandy L.] Univ Georgia, Dept Small Anim Med & Surg, Athens, GA 30602 USA; [Reagan, Jennifer K.] Seattle Vet Specialists, Seattle, WA USA	University of Pennsylvania; University System of Georgia; University of Georgia	Leighton, EA (corresponding author), Seeing Eye Inc, Morristown, NJ 07960 USA.; Leighton, EA (corresponding author), Canine Genet Serv LLC, Great Falls, VA USA.	eldin@caninegeneticservices.com		Leighton, Eldin/0000-0003-3032-0315	Seeing Eye, Inc., Morristown, NJ; Morris Animal Foundation [93CA-5]; commonwealth of the state of Pennsylvania	Seeing Eye, Inc., Morristown, NJ; Morris Animal Foundation; commonwealth of the state of Pennsylvania	Drs. Gail K. Smith and Daryl N. Biery acknowledge generous financial support from The Seeing Eye, Inc., Morristown, NJ, for funds obtained from and administered by Morris Animal Foundation under grant 93CA-5. All authors acknowledge generous financial support received from the governor and commonwealth of the state of Pennsylvania.	Adams WM, 2000, VET RADIOL ULTRASOUN, V41, P484, DOI 10.1111/j.1740-8261.2000.tb01875.x; Adams WM, 1998, J AM ANIM HOSP ASSOC, V34, P339, DOI 10.5326/15473317-34-4-339; Australian Veterinary Association and Australia New Zealand Kennel Club, 2000, AVA ANKC HIP ELB SCH; Boldman K.G., 1995, MANUAL USE MTDFREML; Breur GJ, 2001, GENETICS DOG; BRINKS JS, 1961, J ANIM SCI, V20, P903; Cameron N.D., 1997, SELECTION INDICES PR; Cole JR, 2004, J ANIM SCI, V82, P2906; Corley EA, 2000, HEREDITARY BONE JOIN, P284; Falconer D. S., 1989, Introduction to quantitative genetics.; Farese JP, 1998, VET SURG, V27, P393, DOI 10.1111/j.1532-950X.1998.tb00146.x; Fluckiger M, 2000, HEREDITARY BONE JOIN, P289; Henricson B, 1966, J Small Anim Pract, V7, P673, DOI 10.1111/j.1748-5827.1966.tb04393.x; Hollander M., 1973, NONPARAMETRIC STAT M; Hou YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076390; Hou YL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009410; Janss LCM, 2011, NON TRADITIONAL REF; Janutta V, 2008, BERL MUNCH TIERARZTL, V121, P102, DOI 10.2376/0005-9366-121-102; Jessen C D, 1972, P CAN HIP DYSPL S WO, P93; JOHNSON JA, 1994, VET COMP ORTHOPAED, V7, P56; Kealy RD, 2000, J AM VET MED ASSOC, V217, P1678, DOI 10.2460/javma.2000.217.1678; Kealy RD, 2002, J AM VET MED ASSOC, V220, P1315, DOI 10.2460/javma.2002.220.1315; Krag K, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-79; LEIGHTON EA, 1977, AM J VET RES, V38, P241; Leighton EA, 1997, J AM VET MED ASSOC, V210, P1474; Lewis TW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012797; LUST G, 1993, AM J VET RES, V54, P1990; Maki K, 2000, J ANIM SCI, V78, P1141; Mateescu RG, 2008, AM J VET RES, V69, P1294, DOI 10.2460/ajvr.69.10.1294; Morgan JP, 2000, HEREDITARY BONE JOIN; Mrode R.A, 2014, LINEAR MODELS PREDIC; Nicholas F., 1987, VET GENETICS; Nicholas FW, 2003, INTRO VET GENETICS; Oberbauer AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172918; PAATSAMA S, 2000, HEREDITARY BONE JOIN, P263; Paster ER, 2005, JAVMA, V226; POPOVITCH CA, 1995, J AM VET MED ASSOC, V206, P648; Powers MY, 2010, JAVMA-J AM VET MED A, V237, P532, DOI 10.2460/javma.237.5.532; Powers MY, 2004, JAVMA-J AM VET MED A, V225, P233, DOI 10.2460/javma.2004.225.233; QUAAS RL, 1976, BIOMETRICS, V32, P949, DOI 10.2307/2529279; R DEVELOPMENT CORE TEAM, 2011, NON TRADITIONAL REF; Reed AL, 2000, J AM VET MED ASSOC, V217, P675, DOI 10.2460/javma.2000.217.675; RISER WH, 1964, J AM VET MED ASSOC, V144, P709; Runge JJ, 2010, J SMALL ANIM PRACT, V51, P264, DOI 10.1111/j.1748-5827.2010.00937.x; Smith G, 2011, VET SURG SMALL ANI M, V1st, P824; Smith GK, 2006, JAVMA-J AM VET MED A, V229, P690, DOI 10.2460/javma.229.5.690; Smith GK, 2012, VET SURG, V41, P20, DOI 10.1111/j.1532-950X.2011.00935.x; SMITH GK, 1993, AM J VET RES, V54, P1021; SMITH GK, 1990, J AM VET MED ASSOC, V196, P59; Smith GK, 1997, AM J VET RES, V58, P1076; Smith GK, 2001, J AM VET MED ASSOC, V219, P1719, DOI 10.2460/javma.2001.219.1719; Smith GK, 2011, PUREBRED PARADOX HLT; Smith GK, 2018, VET SURG SMALL ANIMA; Smith GK, 2009, P 36 ANN C VET ORTH, P23; Smith GK, 2000, HEREDITARY BONE JOIN, P300; Soo M, 2015, NEW ZEAL VET J, V63, P69, DOI 10.1080/00480169.2014.949893; Soo M, 2015, NEW ZEAL VET J, V63, P79, DOI 10.1080/00480169.2014.961581; Vezzoni A, 2018, VET SURG SMALL ANIMA; Whittington K., 1961, J AM VET MED ASS, V139, P791; Wickham H., 2009, MEDIA, V35, P10, DOI 10.1007/978-0-387-98141-3; Wilson BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077470; Wilson BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039620; Wood JLN, 2002, PREV VET MED, V55, P95, DOI 10.1016/S0167-5877(02)00090-9; Zhang ZW, 2009, AM J VET RES, V70, P483, DOI 10.2460/ajvr.70.4.483; Zhou ZK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013219	65	12	13	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212544	10.1371/journal.pone.0212544	http://dx.doi.org/10.1371/journal.pone.0212544			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794614	gold, Green Submitted, Green Published			2022-12-27	WOS:000459709100085
J	Morozumi, N; Yotsumoto, T; Yamaki, A; Yoshikiyo, K; Yoshida, S; Nakamura, R; Jindo, T; Furuya, M; Maeda, H; Minamitake, Y; Kangawa, K				Morozumi, Naomi; Yotsumoto, Takafumi; Yamaki, Akira; Yoshikiyo, Kazunori; Yoshida, Sayaka; Nakamura, Ryuichi; Jindo, Toshimasa; Furuya, Mayumi; Maeda, Hiroaki; Minamitake, Yoshiharu; Kangawa, Kenji			ASB20123: A novel C-type natriuretic peptide derivative for treatment of growth failure and dwarfism	PLOS ONE			English	Article							RECEPTOR; BRAIN; HYALURONAN; STRATEGY; GHRELIN; MOUSE; PLATE	C-type natriuretic peptide (CNP) and its receptor natriuretic peptide receptor B (NPR-B) are physiological potent positive regulators of endochondral bone growth; therefore, the CNP/NPR-B signaling pathway is one of the most promising therapeutic targets for treating growth failure and dwarfism. In this article, we summarized the pharmacological properties of a novel CNP analog peptide ASB20123 as a therapeutic agent for short stature. ASB20123, one of the CNP/ghrelin chimeric peptides, is composed of CNP(1-22) and human ghrelin(12-28, E17D). Compared to CNP(1-22), ASB20123 showed similar agonist activity for NPR-B and improved biokinetics with a longer plasma half-life in rats. In addition, the distribution of ASB20123 to the cartilage was higher than that of CNP(1-22) after single subcutaneous (sc) injection to mice. These results suggested that the C-terminal part of ghrelin, which has clusters of basic amino acid residues and a BX7B motif, might contribute to the retention of ASB20123 in the extracellular matrix of the growth plate. Multiple sc doses of ASB20123 potently stimulated skeletal growth in rats in a dose-dependent manner, and sc infusion was more effective than bolus injection at the same dose. Our data indicated that high plasma levels of ASB20123 would not necessarily be required for bone growth acceleration. Thus, pharmaceutical formulation approaches for sustained-release dosage forms to allow chronic exposure to ASB20123 might be suitable to ensure drug effectiveness and safety.	[Morozumi, Naomi; Yotsumoto, Takafumi; Yamaki, Akira; Yoshikiyo, Kazunori; Yoshida, Sayaka; Nakamura, Ryuichi; Jindo, Toshimasa; Furuya, Mayumi; Maeda, Hiroaki; Minamitake, Yoshiharu] Asubio Pharma Co Ltd, Kobe, Hyogo, Japan; [Yotsumoto, Takafumi; Yamaki, Akira; Yoshikiyo, Kazunori; Yoshida, Sayaka; Nakamura, Ryuichi; Jindo, Toshimasa; Maeda, Hiroaki] Daiichi Sankyo Co Ltd, Tokyo, Japan; [Kangawa, Kenji] Natl Cerebral & Cardiovasc Ctr, Res Inst, Osaka, Japan	Asubio Pharma Co., Ltd.; Daiichi Sankyo Company Limited; National Cerebral & Cardiovascular Center - Japan	Yotsumoto, T (corresponding author), Asubio Pharma Co Ltd, Kobe, Hyogo, Japan.; Yotsumoto, T (corresponding author), Daiichi Sankyo Co Ltd, Tokyo, Japan.	yotsumoto.takafumi.ur@daiichisankyo.co.jp						Chang CY, 2016, RADIOGRAPHICS, V36, P1871, DOI 10.1148/rg.2016160004; Holmes G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201492; HUNT PJ, 1994, J CLIN ENDOCR METAB, V78, P1428, DOI 10.1210/jc.78.6.1428; Iwaki T, 2017, BIOORGAN MED CHEM, V25, P6680, DOI 10.1016/j.bmc.2017.11.006; Jawetz ST, 2015, SPORTS HEALTH, V7, P142, DOI 10.1177/1941738114559380; Jean L, 2001, EUR J BIOCHEM, V268, P544, DOI 10.1046/j.1432-1327.2001.01890.x; Kake T, 2009, AM J PHYSIOL-ENDOC M, V297, pE1339, DOI 10.1152/ajpendo.00272.2009; KENNY AJ, 1993, BIOCHEM J, V291, P83, DOI 10.1042/bj2910083; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lorget F, 2012, AM J HUM GENET, V91, P1108, DOI 10.1016/j.ajhg.2012.10.014; Makino T, 2005, BIOPOLYMERS, V79, P238, DOI 10.1002/bip.20342; McLennan Danielle N, 2005, Drug Discov Today Technol, V2, P89, DOI 10.1016/j.ddtec.2005.05.006; MINAMINO N, 1991, BIOCHEM BIOPH RES CO, V179, P535, DOI 10.1016/0006-291X(91)91404-Z; MINAMINO N, 1990, BIOCHEM BIOPH RES CO, V170, P973, DOI 10.1016/0006-291X(90)92187-5; Morozumi N, 2017, PEPTIDES, V97, P16, DOI 10.1016/j.peptides.2017.09.008; Morozumi N, 2012, PEPTIDES, V33, P279, DOI 10.1016/j.peptides.2012.01.010; Morozumi N, 2011, PEPTIDES, V32, P1001, DOI 10.1016/j.peptides.2011.01.021; Moyes AJ, 2014, J CLIN INVEST, V124, P4039, DOI 10.1172/JCI74281; Myllyharju J, 2014, CURR OSTEOPOROS REP, V12, P439, DOI 10.1007/s11914-014-0232-1; Nakao K, 2013, BMC PHARM TOXICOL S1, V14, pP48, DOI [10.1186/2050-6511-14-S1-P48, DOI 10.1186/2050-6511-14-S1-P48]; Nakao K, 2015, SCI REP-UK, V5, DOI 10.1038/srep10554; OGAWA Y, 1995, CLIN EXP PHARMACOL P, V22, P49, DOI 10.1111/j.1440-1681.1995.tb01918.x; Ornitz DM, 2017, DEV DYNAM, V246, P291, DOI 10.1002/dvdy.24479; Pagel-Langenickel I, 2018, ADV EXP MED BIOL, V1067, P109, DOI 10.1007/5584_2018_143; Potter Lincoln R., 2009, V191, P341, DOI 10.1007/978-3-540-68964-5_15; Saito Y, 2010, J CARDIOL, V56, P262, DOI 10.1016/j.jjcc.2010.08.001; Serrat MA, 2009, J APPL PHYSIOL, V106, P2016, DOI 10.1152/japplphysiol.00295.2009; Stewart JM, 2012, EXPERT REV CARDIOVAS, V10, P1387, DOI [10.1586/ERC.12.139, 10.1586/erc.12.139]; STINGO AJ, 1992, AM J PHYSIOL, V263, pH1318, DOI 10.1152/ajpheart.1992.263.4.H1318; SUZUKI E, 1993, BIOCHEM BIOPH RES CO, V192, P532, DOI 10.1006/bbrc.1993.1448; Tamura N, 1996, J MOL CELL CARDIOL, V28, P1811, DOI 10.1006/jmcc.1996.0170; Tool BP, 2001, SEMIN CELL DEV BIOL, V12, P79, DOI 10.1006/scdb.2000.0244; Wendt DJ, 2015, J PHARMACOL EXP THER, V353, P132, DOI 10.1124/jpet.114.218560; Yasoda A, 2009, ENDOCRINOLOGY, V150, P3138, DOI 10.1210/en.2008-1676	35	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212680	10.1371/journal.pone.0212680	http://dx.doi.org/10.1371/journal.pone.0212680			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794654	gold, Green Submitted, Green Published			2022-12-27	WOS:000459709100111
J	Le, TM; Morimoto, N; Mitsui, T; Notodihardjo, SC; Munisso, MC; Kakudo, N; Kusumoto, K				Tien Minh Le; Morimoto, Naoki; Mitsui, Toshihito; Notodihardjo, Sharon Claudia; Munisso, Maria Chiara; Kakudo, Natsuko; Kusumoto, Kenji			The sustained release of basic fibroblast growth factor accelerates angiogenesis and the engraftment of the inactivated dermis by high hydrostatic pressure	PLOS ONE			English	Article							COLLAGEN/GELATIN SCAFFOLD; CLINICAL-EFFICACY; BFGF; CELLS; PCR	We developed a novel skin regeneration therapy combining nevus tissue inactivated by high hydrostatic pressure (HHP) in the reconstruction of the dermis with a cultured epidermal autograft (CEA). The issue with this treatment is the unstable survival of CEA on the inactivated dermis. In this study, we applied collagen/gelatin sponge (CGS), which can sustain the release of basic fibroblast growth factor (bFGF), to the inactivated skin in order to accelerate angiogenesis. Murine skin grafts from C57BL6J/Jcl mice (8 mm in diameter) were prepared, inactivated by HHP and cryopreserved. One month later, the grafts were transplanted subcutaneously onto the back of other mice and covered by CGS impregnated with saline or bFGF. Grafts were harvested after one, two and eight weeks, at which point the engraftment was evaluated through the histology and angiogenesis-related gene expressions were determined by real-time polymerase chain reaction. Histological sections showed that the dermal cellular density and newly formed capillaries in the bFGF group were significantly higher than in the control group. The relative expression of FGF-2, PDGFA and VEGF-A genes in the bFGF group was significantly higher than in the control group at Week 1. This study suggested that the angiogenesis into grafts was accelerated, which might improve the engraftment of inactivated dermis in combination with the sustained release of bFGF by CGSs.	[Tien Minh Le; Morimoto, Naoki; Mitsui, Toshihito; Notodihardjo, Sharon Claudia; Munisso, Maria Chiara; Kakudo, Natsuko; Kusumoto, Kenji] Kansai Med Univ, Dept Plast & Reconstruct Surg, Hirakata, Osaka, Japan	Kansai Medical University	Morimoto, N (corresponding author), Kansai Med Univ, Dept Plast & Reconstruct Surg, Hirakata, Osaka, Japan.	morimotn@hirakata.kmu.ac.jp	Munisso, Maria Chiara/GXV-5409-2022	Morimoto, Naoki/0000-0002-0712-3172; Le, Tien Minh/0000-0003-4470-8433; Munisso, Maria Chiara/0000-0003-1616-4934	Practical Research for Innovative Cancer Control grant Agency for Medical Research and Development (AMED) [17ck0106304h0001];  [17H04360]	Practical Research for Innovative Cancer Control grant Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); 	This research was partially supported by Grants-in-Aid for Scientific Research (B) (17H04360) (https://kaken.nii.ac.jp/ja/index/) and partially supported by a Practical Research for Innovative Cancer Control grant (17ck0106304h0001) Agency for Medical Research and Development (AMED; http://www.amed.go.jp/en/); Dr. Naoki Morimoto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Akita S, 2005, BURNS, V31, P855, DOI 10.1016/j.burns.2005.04.008; Ayvazyan A, 2011, J SURG RES, V171, pE247, DOI 10.1016/j.jss.2011.06.059; Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003; Bao P, 2009, J SURG RES, V153, P347, DOI 10.1016/j.jss.2008.04.023; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Funamoto S, 2010, BIOMATERIALS, V31, P3590, DOI 10.1016/j.biomaterials.2010.01.073; GOSPODAROWICZ D, 1987, ENDOCR REV, V8, P95, DOI 10.1210/edrv-8-2-95; GOSPODAROWICZ D, 1974, NATURE, V249, P123, DOI 10.1038/249123a0; GREEN H, 1979, P NATL ACAD SCI USA, V76, P5665, DOI 10.1073/pnas.76.11.5665; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hashimoto Y, 2010, BIOMATERIALS, V31, P3941, DOI 10.1016/j.biomaterials.2010.01.122; HAYEK A, 1987, BIOCHEM BIOPH RES CO, V147, P876, DOI 10.1016/0006-291X(87)91011-4; Hiemer B, 2016, SCI REP-UK, V6, DOI 10.1038/srep33747; Ito R, 2013, TISSUE ENG PT A, V19, P1398, DOI [10.1089/ten.tea.2012.0375, 10.1089/ten.TEA.2012.0375]; Jinno C, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4567146; Jinno C, 2015, TISSUE ENG PART C-ME, V21, P1178, DOI [10.1089/ten.tec.2015.0054, 10.1089/ten.TEC.2015.0054]; Kanda N, 2014, J TISSUE ENG REGEN M, V8, P29, DOI 10.1002/term.1492; Kanda N, 2012, ANN PLAS SURG, V69, P569, DOI 10.1097/SAP.0b013e318222832f; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahara A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/379607; Morimoto N, 2017, J BIOMED MATER RES B, V105, P2653, DOI 10.1002/jbm.b.33807; Morimoto N, 2017, J BIOMED MATER RES B, V105, P1091, DOI 10.1002/jbm.b.33631; Morimoto N, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/1320909; Morimoto N, 2015, CELLS TISSUES ORGANS, V201, P170, DOI 10.1159/000444048; Morimoto N, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/587247; Ogino S, 2018, J SURG RES, V221, P173, DOI 10.1016/j.jss.2017.08.051; Ohura T, 2011, WOUND REPAIR REGEN, V19, P542, DOI 10.1111/j.1524-475X.2011.00726.x; Liem PH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133979; Liem PH, 2013, J ARTIF ORGANS, V16, P332, DOI 10.1007/s10047-013-0708-2; Rivalain N, 2010, BIOTECHNOL ADV, V28, P659, DOI 10.1016/j.biotechadv.2010.04.001; Sakamoto M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186958; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Takemoto S, 2008, TISSUE ENG PT A, V14, P1629, DOI 10.1089/ten.tea.2007.0215; Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x; Turabelidze A, 2010, WOUND REPAIR REGEN, V18, P460, DOI 10.1111/j.1524-475X.2010.00611.x; Uchi H, 2009, EUR J DERMATOL, V19, P461, DOI 10.1684/ejd.2009.0750; Watt AJ, 2004, PLAST RECONSTR SURG, V113, P1968, DOI [10.1097/01.PRS.0000122209.10277.2A, 10.1097/01.prs.0000122209.10277.2a]; Weiss EM, 2010, J IMMUNOTOXICOL, V7, P194, DOI 10.3109/15476911003657414; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wiles K, 2016, TISSUE ENG PART B-RE, V22, P208, DOI [10.1089/ten.TEB.2015.0376, 10.1089/ten.teb.2015.0376]	41	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0208658	10.1371/journal.pone.0208658	http://dx.doi.org/10.1371/journal.pone.0208658			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789932	gold, Green Published, Green Submitted			2022-12-27	WOS:000459330800005
J	Zhou, DL; Yu, LF; Fu, H; Zhang, LL; Wei, L; Li, DP; Zhang, TS; Li, WM				Zhou Daliang; Yu Lifang; Fu Hong; Zhang Lingling; Wei Lin; Li Dapeng; Zhang Tianshu; Li Weimin			Netrin-1 plays a role in the effect of moderate exercise on myocardial fibrosis in rats	PLOS ONE			English	Article							TISSUE INHIBITOR; INFARCTION; ANGIOGENESIS; PATHWAY	Introduction This study aimed to investigate the effect of aerobic exercise on the expression of neitrin-1, DCC receptor and myocardial fibrosis in rats with acute myocardial infarction. Methods Twenty-four rats were randomly divided into three groups: the sham group (n = 8), the acute myocardial infarction (AMI) model group (n = 8), and the aerobic exercise treatment after acute myocardial infarction group (ET) (n = 8). After 10 weeks, the serum levels of netrin-1, tumor necrosis factor alpha a (TNF-alpha), and interleukin 6 (IL-6) were measured. The expression of matrix metalloproteinase 2 and 9 (MMP2, 9), and their inhibitor, tissue inhibitor of metalloproteinase 2 (TIMP2), myocardial netrin-1, and the deleted in colorectal cancer (DCC) receptor were evaluated. Histopathological results were also evaluated. The collagen volume fraction of the myocardial tissues was also calculated. Results Compared with the sham group, in the AMI and ET groups, left ventricular end diastolic pressure (LVEDP) were increased, while left ventricular systolic pressure (LVSP), and left ventricular pressure maximal rate of rise and fall (+/- dp/dtmax) were significantly decreased (P<0.05,). Compared with the AMI group, in the ET group, LVSP, and +/- dp/dtmax were significantly increased while LVEDP was decreased (P<0.05). Compared with the sham group, the AMI group and ET groups showed increased levels of serum TNF-alpha, IL-6 and significantly reduced levels of netrin-1. Levels of TNF-alpha and IL-6 were significantly reduced in the ET group compared with the AMI group, whereas the level of netrin-1 was increased. The expression of myocardial MMP2 and MMP9 was significantly increased in the AMI group compared with the sham group, whereas that of myocardial netrin-1, TIMP2 and the DCC receptor, was significantly reduced. Compared with the AMI group, the ET group showed reduced expression of myocardial MMP2 and MMP9 proteins, whereas expression of myocardial netrin-1, TIMP2 and the DCC receptor, was significantly increased. The collagen volume fraction of the myocardial tissues was significantly increased in the AMI group and the ET group compared with the sham group, with a greater increase in the AMI group. Conclusions Aerobic exercise increased levels of serum netrin-1, myocardial netrin-1, and the DCC receptor and reduced the expression of myocardial MMP2 and MMP9 proteins, to improve the degree of fibrosis following myocardial infarction in rats.	[Zhou Daliang; Fu Hong; Zhang Lingling; Wei Lin; Li Dapeng; Zhang Tianshu; Li Weimin] First Hosp Harbin City, Dept Cardiol, Harbin, Heilongjiang, Peoples R China; [Yu Lifang] Heilongjiang Univ Chinese Med, Affiliated Hosp 1, Clin Pharm, Harbin, Heilongjiang, Peoples R China	Heilongjiang University of Chinese Medicine	Wei, L; Li, WM (corresponding author), First Hosp Harbin City, Dept Cardiol, Harbin, Heilongjiang, Peoples R China.	weilin1964@163.com; zhoudaliang007@163.com	zhang, lingling/HDM-2189-2022; zhang, tian/GZK-6001-2022		Harbin, The First Hospital [2013SYYRCYJ06-3]	Harbin, The First Hospital	This study was funded by a grant fund from Harbin, The First Hospital (grant number 2013SYYRCYJ06-3).	Bonnema DD, 2007, J CARD FAIL, V13, P530, DOI 10.1016/j.cardfail.2007.04.010; Bouvree K, 2008, DEV BIOL, V318, P172, DOI 10.1016/j.ydbio.2008.03.023; Dumont O, 2007, ARTERIOSCL THROM VAS, V27, P317, DOI 10.1161/01.ATV.0000254684.80662.44; Fan D, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-15; Forcet C, 2002, NATURE, V417, P443, DOI 10.1038/nature748; Halade GV, 2013, PHARMACOL THERAPEUT, V139, P32, DOI 10.1016/j.pharmthera.2013.03.009; Hirai DM, 2014, AM J PHYSIOL-HEART C, V306, pH690, DOI 10.1152/ajpheart.00901.2013; Jugdutt BI., 2013, CARDIAC REMODELING M, P525; Ke TY, 2014, HUM GENE THER, V25, P787, DOI 10.1089/hum.2014.021; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kwak HB, 2011, FASEB J, V25, P1106, DOI 10.1096/fj.10-172924; Liu N, 2011, NEUROSCIENCE, V194, P349, DOI 10.1016/j.neuroscience.2011.07.037; Nguyen A, 2006, P NATL ACAD SCI USA, V103, P6530, DOI 10.1073/pnas.0511011103; Puhl SL, 2015, AM J PHYSIOL-HEART C, V309, pH345, DOI 10.1152/ajpheart.00683.2014; Ribeiro LP, 2018, BRAZ J MED BIOL RES, V51, DOI [10.1590/1414-431x20177033, 10.1590/1414-431X20177033]; Richardson WJ, 2015, COMPR PHYSIOL, V5, P1877, DOI 10.1002/cphy.c140067; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Silveira AC, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/1549014; Szabo R, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/6709742; Talman V, 2016, CELL TISSUE RES, V365, P563, DOI 10.1007/s00441-016-2431-9; Valente AJ, 2012, AM J PHYSIOL-HEART C, V303, pH282, DOI 10.1152/ajpheart.00231.2012; Xiao XB, 2016, MOL MED REP, V13, P5093, DOI 10.3892/mmr.2016.5178; Yaghooti Hamid, 2010, Avicenna Journal of Medical Biotechnology, V2, P79; Zhang J, 2010, J MOL CELL CARDIOL, V48, P1060, DOI 10.1016/j.yjmcc.2009.11.020	24	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0199802	10.1371/journal.pone.0199802	http://dx.doi.org/10.1371/journal.pone.0199802			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789913	Green Submitted, Green Published, gold			2022-12-27	WOS:000459330800001
J	Chevrier, A; Bhaijiwala, M; Lipszyc, J; Cheyne, D; Graham, S; Schachar, R				Chevrier, Andre; Bhaijiwala, Mehereen; Lipszyc, Jonathan; Cheyne, Douglas; Graham, Simon; Schachar, Russell			Disrupted reinforcement learning during post-error slowing in ADHD	PLOS ONE			English	Article							ATTENTION-DEFICIT HYPERACTIVITY; HIERARCHICAL PREDICTION ERRORS; MEDIAL-PREFRONTAL CORTEX; FUNCTIONAL CONNECTIVITY; LOCUS-COERULEUS; RESPONSE-INHIBITION; DEFICIT/HYPERACTIVITY DISORDER; ACETYLCHOLINE-RECEPTORS; DOPAMINE RELEASE; NEURAL RESPONSES	ADHD is associated with altered dopamine regulated reinforcement learning on prediction errors. Despite evidence of categorically altered error processing in ADHD, neuroimaging advances have largely investigated models of normal reinforcement learning in greater detail. Further, although reinforcement leaning critically relies on ventral striatum exerting error magnitude related thresholding influences on substantia nigra (SN) and dorsal striatum, these thresholding influences have never been identified with neuroimaging. To identify such thresholding influences, we propose that error magnitude related activities must first be separated from opposite activities in overlapping neural regions during error detection. Here we separate error detection from magnitude related adjustment (post-error slowing) during inhibition errors in the stop signal task in typically developing (TD) and ADHD adolescents using fMRI. In TD, we predicted that: 1) deactivation of dorsal striatum on error detection interrupts ongoing processing, and should be proportional to right frontoparietal response phase activity that has been observed in the SST; 2) deactivation of ventral striatum on post-error slowing exerts thresholding influences on, and should be proportional to activity in dorsal striatum. In ADHD, we predicted that ventral striatum would instead correlate with heightened amygdala responses to errors. We found deactivation of dorsal striatum on error detection correlated with response-phase activity in both groups. In TD, post-error slowing deactivation of ventral striatum correlated with activation of dorsal striatum. In ADHD, ventral striatum correlated with heightened amygdala activity. Further, heightened activities in locus coeruleus (norepinephrine), raphe nucleus (serotonin) and medial septal nuclei (acetylcholine), which all compete for control of DA, and are altered in ADHD, exhibited altered correlations with SN. All correlations in TD were replicated in healthy adults. Results in TD are consistent with dopamine regulated reinforcement learning on post-error slowing. In ADHD, results are consistent with heightened activities in the amygdala and non-dopaminergic neurotransmitter nuclei preventing reinforcement learning.	[Chevrier, Andre; Bhaijiwala, Mehereen; Schachar, Russell] Hosp Sick Children, Dept Psychiat, Toronto, ON, Canada; [Lipszyc, Jonathan] Univ Ottawa, Dept Family Med, Ottawa, ON, Canada; [Cheyne, Douglas] Univ Toronto, Dept Med Imaging, Toronto, ON, Canada; [Graham, Simon] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Ottawa; University of Toronto; University of Toronto	Schachar, R (corresponding author), Hosp Sick Children, Dept Psychiat, Toronto, ON, Canada.	russell.schachar@sickkids.ca		Chevrier, Andre/0000-0002-4298-9529	Canadian Institutes of Health Research [MOP 82796]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was funded by a grant from Canadian Institutes of Health Research (Award Number: MOP 82796) to RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Atallah HE, 2007, NAT NEUROSCI, V10, P126, DOI 10.1038/nn1817; Auclair A, 2004, EUR J NEUROSCI, V20, P3073, DOI 10.1111/j.1460-9568.2004.03805.x; Beane M, 2004, PROG NEUROBIOL, V74, P167, DOI 10.1016/j.pneurobio.2004.09.001; Beissner F, 2015, CLIN NEURORADIOL, V25, P251, DOI 10.1007/s00062-015-0404-0; Beliveau V, 2015, NEUROIMAGE, V116, P187, DOI 10.1016/j.neuroimage.2015.04.065; Bhaijiwala M, 2014, BRAIN BEHAV, V4, P602, DOI 10.1002/brb3.244; Bianciardi M, 2016, MAGN RESON MATER PHY, V29, P451, DOI 10.1007/s10334-016-0546-3; Bidwell LC, 2011, PHARMACOL BIOCHEM BE, V99, P262, DOI 10.1016/j.pbb.2011.05.002; Boureau YL, 2011, NEUROPSYCHOPHARMACOL, V36, P74, DOI 10.1038/npp.2010.151; Brooks JCW, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00623; Butler T, 2014, NEUROIMAGE, V97, P245, DOI 10.1016/j.neuroimage.2014.04.026; Cao M, 2014, MOL NEUROBIOL, V50, P1111, DOI 10.1007/s12035-014-8685-x; Chen W, 1999, FUNCTIONAL MRI, P103, DOI 10.1007/978-1-4419-0345-7; Chevrier A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130992; Chevrier A, 2010, NEUROIMAGE, V53, P664, DOI 10.1016/j.neuroimage.2010.06.056; Chevrier AD, 2007, HUM BRAIN MAPP, V28, P1347, DOI 10.1002/hbm.20355; Chikazoe J, 2009, J NEUROSCI, V29, P15870, DOI 10.1523/JNEUROSCI.3645-09.2009; Choi J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083516; Christakou A, 2013, MOL PSYCHIATR, V18, P236, DOI 10.1038/mp.2011.185; Clewett D, 2014, NEUROBIOL LEARN MEM, V111, P65, DOI 10.1016/j.nlm.2014.03.006; Cohen JY, 2015, ELIFE, V4, DOI 10.7554/eLife.06346; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Danielmeier C, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00233; del Campo N, 2013, BRAIN, V136, P3252, DOI 10.1093/brain/awt263; del Campo N, 2011, BIOL PSYCHIAT, V69, pE145, DOI 10.1016/j.biopsych.2011.02.036; den Ouden HEM, 2009, CEREB CORTEX, V19, P1175, DOI 10.1093/cercor/bhn161; Diaconescu AO, 2017, SOC COGN AFFECT NEUR, V12, P618, DOI 10.1093/scan/nsw171; Dodds CM, 2008, J NEUROSCI, V28, P5976, DOI 10.1523/JNEUROSCI.1153-08.2008; Dupuis A, 2018, CHILD DEV, DOI [10.1111/cdev.13062, DOI 10.1111/CDEV.13062PMID:29603204]; Durston S, 2007, J CHILD PSYCHOL PSYC, V48, P881, DOI 10.1111/j.1469-7610.2007.01754.x; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Fischer AG, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00484; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Fudge JL, 2003, J NEUROPSYCH CLIN N, V15, P306, DOI 10.1176/appi.neuropsych.15.3.306; Furukawa E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089129; Gallistel CR, 2000, PSYCHOL REV, V107, P289, DOI 10.1037/0033-295X.107.2.289; Gu Q, 2002, NEUROSCIENCE, V111, P815, DOI 10.1016/S0306-4522(02)00026-X; Haber SN, 2000, J NEUROSCI, V20, P2369; Hauser TU, 2016, TRENDS NEUROSCI, V39, P63, DOI 10.1016/j.tins.2015.12.009; Hauser TU, 2014, JAMA PSYCHIAT, V71, P1165, DOI 10.1001/jamapsychiatry.2014.1093; Ho SS, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00152; Horvitz JC, 2002, BEHAV BRAIN RES, V137, P65, DOI 10.1016/S0166-4328(02)00285-1; Hutton C, 2011, NEUROIMAGE, V57, P101, DOI 10.1016/j.neuroimage.2011.04.018; Ickowicz A, 2006, CAN J PSYCHIAT, V51, P325, DOI 10.1177/070674370605100508; Iglesias S, 2013, NEURON, V80, P519, DOI 10.1016/j.neuron.2013.09.009; JEZZARD P, 1995, MAGNET RESON MED, V34, P65, DOI 10.1002/mrm.1910340111; Johansson J, 2013, ADHD-ATTEND DEFICIT, V5, P267, DOI 10.1007/s12402-013-0103-0; Kempadoo KA, 2016, P NATL ACAD SCI USA, V113, P14835, DOI 10.1073/pnas.1616515114; Keren NI, 2009, NEUROIMAGE, V47, P1261, DOI 10.1016/j.neuroimage.2009.06.012; Kimura F, 1999, EUR J NEUROSCI, V11, P3597, DOI 10.1046/j.1460-9568.1999.00779.x; Kobayashi M, 2000, EUR J NEUROSCI, V12, P264, DOI 10.1046/j.1460-9568.2000.00917.x; Kranz GS, 2012, P NATL ACAD SCI USA, V109, pE2000, DOI 10.1073/pnas.1206247109; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Levy F, 2004, NEUROPSYCHOPHARMACOL, V29, P1589, DOI 10.1038/sj.npp.1300469; Li JC, 2014, BRIT J PHARMACOL, V171, P332, DOI 10.1111/bph.12415; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Liston C, 2011, BIOL PSYCHIAT, V69, P1168, DOI 10.1016/j.biopsych.2011.03.022; LJUNGBERG T, 1991, BRAIN RES, V567, P337, DOI 10.1016/0006-8993(91)90816-E; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; Logan GD, 1997, PSYCHOL SCI, V8, P60, DOI 10.1111/j.1467-9280.1997.tb00545.x; Ma I, 2016, CORTEX, V82, P225, DOI 10.1016/j.cortex.2016.05.021; Maier SJ, 2014, PSYCHOL MED, V44, P85, DOI 10.1017/S0033291713000469; Mamad O, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00166; McHugh SB, 2014, J NEUROSCI, V34, P9024, DOI 10.1523/JNEUROSCI.4465-13.2014; Menegas W, 2015, ELIFE, V4, DOI 10.7554/eLife.10032; Meyniel F, 2016, ELIFE, V5, DOI 10.7554/eLife.17282; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; Morrison SE, 2017, J NEUROPHYSIOL, V118, P2549, DOI 10.1152/jn.00465.2017; Murias M, 2007, CEREB CORTEX, V17, P1788, DOI 10.1093/cercor/bhl089; Napadow V, 2006, NEUROIMAGE, V32, P1113, DOI 10.1016/j.neuroimage.2006.05.050; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; OLDS J, 1954, J COMP PHYSIOL PSYCH, V47, P419, DOI 10.1037/h0058775; Ollinger JM, 2001, NEUROIMAGE, V13, P218, DOI 10.1006/nimg.2000.0711; Palermo S, 2017, J ADV RES, V8, P713, DOI 10.1016/j.jare.2017.09.004; Partridge JG, 2002, J NEUROSCI, V22, P2541, DOI 10.1523/JNEUROSCI.22-07-02541.2002; Payzan-LeNestour E, 2013, NEURON, V79, P191, DOI 10.1016/j.neuron.2013.04.037; Plichta MM, 2014, NEUROSCI BIOBEHAV R, V38, P125, DOI 10.1016/j.neubiorev.2013.07.012; Power JD, 2015, NEUROIMAGE, V105, P536, DOI 10.1016/j.neuroimage.2014.10.044; SCHACHAR R, 1995, J ABNORM CHILD PSYCH, V23, P411, DOI 10.1007/BF01447206; Schultz W, 2016, NAT REV NEUROSCI, V17, P183, DOI 10.1038/nrn.2015.26; SHAFFER D, 1983, ARCH GEN PSYCHIAT, V40, P1228; Shiflett MW, 2010, EUR J NEUROSCI, V32, P1735, DOI 10.1111/j.1460-9568.2010.07439.x; Shohamy D, 2008, NEUROSCI BIOBEHAV R, V32, P219, DOI 10.1016/j.neubiorev.2007.07.008; Slotnick SD, 2017, COGN NEUROSCI-UK, V8, P150, DOI 10.1080/17588928.2017.1319350; Tharoor H, 2008, AM J MED GENET B, V147B, P527, DOI 10.1002/ajmg.b.30637; Tian LX, 2006, NEUROSCI LETT, V400, P39, DOI 10.1016/j.neulet.2006.02.022; Tomasi D, 2012, BIOL PSYCHIAT, V71, P443, DOI 10.1016/j.biopsych.2011.11.003; Tona KD, 2017, BRAIN STRUCT FUNCT, V222, P4203, DOI 10.1007/s00429-017-1464-5; Ullsperger M, 2014, PHYSIOL REV, V94, P35, DOI 10.1152/physrev.00041.2012; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Wallis D, 2009, ADHD-ATTEND DEFICIT, V1, P19, DOI 10.1007/s12402-009-0003-5; Welvaert M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077089; Wilbertz G, 2012, NEUROIMAGE, V60, P353, DOI 10.1016/j.neuroimage.2011.12.011; Wolraich M, 2011, PEDIATRICS, V128, P1007, DOI 10.1542/peds.2011-2654; Yu A. J., 2003, ADV NEURAL INF PROC, V15, P157	98	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0206780	10.1371/journal.pone.0206780	http://dx.doi.org/10.1371/journal.pone.0206780			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM2OT	30785885	Green Submitted, Green Published, gold			2022-12-27	WOS:000459307000008
J	Gilbert, JA; Corbin, JD				Gilbert, Jessica A.; Corbin, Jeffrey D.			Biological soil crusts inhibit seed germination in a temperate pine barren ecosystem	PLOS ONE			English	Article							XERIC FLORIDA SHRUBLAND; 2 ANNUAL GRASSES; POPULATION-DYNAMICS; PLANT-COMMUNITIES; VASCULAR PLANTS; ESTABLISHMENT; DISTURBANCE; BIOCRUSTS; SURVIVAL; SAVANNA	Biological soil crusts (BSCs) are known to affect plants' germination and seedling establishment in arid ecosystems, but their ecological role in more mesic climates is not so wellknown. We tested the effects of moss-crusted versus uncrusted soils on seed germination dynamics in a temperate pine barren ecosystem. We conducted a 35-day laboratory assay of seed germination on moss-crusted soils versus uncrusted soils from the Albany (NY) Pine Bush Preserve. We compared total seed germination and the number of days to 50% of total germination of two herbaceous perennial forb species in each soil type. Three and five times more seeds germinated on uncrusted soil than on crusted soil for bush clover (Lespedeza capitata) and wild lupine (Lupinus perennis), respectively. Seeds of both species also germinated approximately 10 days earlier on uncrusted soil than on crusted soil. This study, and others in similar habitats, show that BSCs in mesic climates can influence germination and other early life-history stages of plants. We hope that further study of the interactions between BSCs and vascular plants in mesic climates will contribute to our understanding of the ecology of BSCs outside the arid and semiarid climates where they are more extensively studied.	[Gilbert, Jessica A.; Corbin, Jeffrey D.] Union Coll, Dept Biol Sci, Schenectady, NY 12308 USA	Union College	Corbin, JD (corresponding author), Union Coll, Dept Biol Sci, Schenectady, NY 12308 USA.	corbinj@union.edu		Corbin, Jeffrey/0000-0002-3377-5916	Union College Summer Research Fellowship	Union College Summer Research Fellowship	JAG was funded by a Union College Summer Research Fellowship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes J.K., 2003, NATURAL HIST ALBANY; Belnap J, 2003, FRONT ECOL ENVIRON, V1, P181, DOI 10.2307/3868062; Belnap J, 1997, LAND DEGRAD DEV, V8, P355, DOI 10.1002/(SICI)1099-145X(199712)8:4<355::AID-LDR266>3.0.CO;2-H; Belnap J, 2002, BIOL FERT SOILS, V35, P128, DOI 10.1007/s00374-002-0452-x; Belnap J., 2001, BIOL SOIL CRUSTS STR; Bried JT, 2015, J SUSTAIN FOREST, V34, P147, DOI 10.1080/10549811.2014.973610; Bu CF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127394; Budel B, 2014, BIODIVERS CONSERV, V23, P1639, DOI 10.1007/s10531-014-0645-2; Castillo-Monroy AP, 2010, PLANT SOIL, V333, P21, DOI 10.1007/s11104-009-0276-7; Chamizo S, 2016, ECOHYDROLOGY, V9, P1208, DOI 10.1002/eco.1719; CRAWLEY MJ, 1990, PHILOS T R SOC B, V330, P125, DOI 10.1098/rstb.1990.0187; Deines L, 2007, PLANT SOIL, V295, P23, DOI 10.1007/s11104-007-9256-y; Edinger G.J, 2014, ECOLOGICAL COMMUNITI; ERIKSSON O, 1992, OECOLOGIA, V91, P360, DOI 10.1007/BF00317624; Gawler S.C., 2010, NATURAL LANDSCAPES M; Godinez-Alvarez H, 2012, PLANT BIOLOGY, V14, P157, DOI 10.1111/j.1438-8677.2011.00495.x; Harper J. L., 1977, Population biology of plants.; Hawkes CV, 2004, PLANT ECOL, V170, P121, DOI 10.1023/B:VEGE.0000019035.56245.91; Hawkes CV, 2002, MICROBIAL ECOL, V43, P1, DOI 10.1007/s00248-001-1017-5; Hoffmann WA, 1999, ECOLOGY, V80, P1354, DOI 10.1890/0012-9658(1999)080[1354:FAPDOW]2.0.CO;2; Jeschke M, 2008, FLORA, V203, P557, DOI 10.1016/j.flora.2007.09.006; Aguilar AJ, 2009, J ARID ENVIRON, V73, P1158, DOI 10.1016/j.jaridenv.2009.05.009; Langhans TM, 2009, FLORA, V204, P157, DOI 10.1016/j.flora.2008.01.001; Motzkin G, 2002, J BIOGEOGR, V29, P1569, DOI 10.1046/j.1365-2699.2002.00769.x; Neher DA, 2003, J TORREY BOT SOC, V130, P244, DOI 10.2307/3557543; PLATT WJ, 1988, AM NAT, V131, P491, DOI 10.1086/284803; Prevey JS, 2015, OECOLOGIA, V179, P765, DOI 10.1007/s00442-015-3398-z; Rascher KG, 2012, ECOL LETT, V15, P484, DOI 10.1111/j.1461-0248.2012.01761.x; Rice SK, 2004, PLANT ECOL, V174, P97, DOI 10.1023/B:VEGE.0000046049.21900.5a; Sedia EG, 2003, OIKOS, V100, P447, DOI 10.1034/j.1600-0706.2003.12058.x; Serpe MD, 2008, PLANT SOIL, V303, P191, DOI 10.1007/s11104-007-9498-8; Smith SM, 2004, MICROB ECOL, V48, P200, DOI 10.1007/s00248-004-0254-9; Song G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185839; Sperduto D., 2011, NATURE NEW HAMPSHIRE; Thiet RK, 2014, PLANT SOIL, V377, P235, DOI 10.1007/s11104-013-2002-8; Thiet RK, 2005, PLANT SOIL, V278, P235, DOI 10.1007/s11104-005-8550-9; Weber B, 2016, BIOL SOIL CRUSTS ORG; Zaady E, 1997, PLANT SOIL, V190, P247, DOI 10.1023/A:1004269031844; Zhang Y., 2016, BIOL SOIL CRUSTS ORG, V226, DOI [10.1007/978-3-319-30214-0_19, DOI 10.1007/978-3-319-30214-0_19]; Zhang YM, 2015, ECOL RES, V30, P1037, DOI 10.1007/s11284-015-1305-z	40	7	7	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212466	10.1371/journal.pone.0212466	http://dx.doi.org/10.1371/journal.pone.0212466			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785942	Green Published, gold, Green Submitted			2022-12-27	WOS:000459307000063
J	Hill, N				Hill, Nicolette			Description of cranial elements and ontogenetic change within Tropidolaemus wagleri (Serpentes: Crotalinae)	PLOS ONE			English	Article							SKULL MORPHOLOGY; PIT VIPERS; TRIMERESURUS; PHYLOGENY; PITVIPERS; BIOGEOGRAPHY; TAXONOMY	Tropidolaemus wagleri is a species of Asian pitviper with a geographic range including Thailand, Vietnam, Malaysia, Singapore, Bruniei, parts of Indonesia, and the Philippines. Tropidolaemus is a member of the Crotalinae subfamily, within Viperidae. The genus Tropidolaemus includes five species, and was once included within the genus Trimeresurus. While some osteologic characteristics have been noted a comprehensive description of cranial elements has not been produced for T. wagleri. An in-depth description of the cranial skeleton of Tropidolaemus wagleri lays the foundation for future projects to compare and contrast other taxa within Crotalinae and Viperidae. The chosen reference specimen was compared to the presumed younger specimens to note any variation in ontogeny. The study here provides a comprehensive description of isolated cranial elements as well as a description of ontogenetic change within the specimens observed. This study contributes to the knowledge of osteological characters in T. wagleri and provides a foundation for a long term project to identify isolated elements in the fossil record.	[Hill, Nicolette] East Tennessee State Univ, Dept Geosci, Johnson City, TN 37614 USA	East Tennessee State University	Hill, N (corresponding author), East Tennessee State Univ, Dept Geosci, Johnson City, TN 37614 USA.	nicolettelhill@gmail.com						Brattstrom B. H., 1964, Transactions of the San Diego Society for Natural History, V13, P185; Burger W.L., 1971, THESIS; Castoe TA, 2006, MOL PHYLOGENET EVOL, V39, P91, DOI 10.1016/j.ympev.2005.12.014; Cundall David, 2008, Contributions to Herpetology, V23, P349; DULLEMEIJER P., 1956, ARCH NEERLAND ZOOL, V11, P387; Evans Susan E., 2008, Contributions to Herpetology, V23, P1; Gumprecht A., 2004, ASIAN PITVIPERS; Guo P, 2009, J ZOOL SYST EVOL RES, V47, P378, DOI 10.1111/j.1439-0469.2009.00525.x; Guo Peng, 1999, Zoological Research, V20, P415; Guo P, 2006, HERPETOL J, V16, P305; Guo P, 2010, ACTA ZOOL-STOCKHOLM, V91, P402, DOI 10.1111/j.1463-6395.2009.00413.x; Hoser Raymond T., 2013, Australasian Journal of Herpetology, V19, P43; Kuch Ulrich, 2007, Zootaxa, V1446, P1; LOMBARD RE, 1986, BIOL J LINN SOC, V27, P133, DOI 10.1111/j.1095-8312.1986.tb01730.x; Malhotra A, 2004, MOL PHYLOGENET EVOL, V32, P83, DOI 10.1016/j.ympev.2004.02.008; Malhotra A, 2000, MOL PHYLOGENET EVOL, V16, P199, DOI 10.1006/mpev.2000.0779; McDiarmid R. W., 1999, TAXONOMIC GEOAND, V1; Molles BE, 2002, J TOXICOL-TOXIN REV, V21, P273, DOI 10.1081/TXR-120014406; Orlov Nikolai, 2002, P345; Schlegel H, 1827, ISIS OKEN, V20, P281; Seba A, 1735, EX TOTO TERRARUM ORB, V2; Tu MC, 2000, ZOOL SCI, V17, P1147, DOI 10.2108/zsj.17.1147; Vogel G, 2007, ZOOTAXA, P1; Wuster W, 2008, MOL PHYLOGENET EVOL, V49, P445, DOI 10.1016/j.ympev.2008.08.019	25	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0206023	10.1371/journal.pone.0206023	http://dx.doi.org/10.1371/journal.pone.0206023			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785876	Green Submitted, Green Published, gold			2022-12-27	WOS:000459307000006
J	Khan, MI; Yuan, T; Chou, RH; Yu, C				Khan, Md. Imran; Yuan, Tai; Chou, Ruey-Hwang; Yu, Chin			S100A4 inhibits cell proliferation by interfering with the S100A1-RAGE V domain	PLOS ONE			English	Article							END-PRODUCTS RAGE; CA2+-BINDING PROTEIN S100A1; THERAPEUTIC TARGET; BINDING-SITE; IN-VITRO; METASTASIS; EXPRESSION; RECEPTOR; CALMODULIN; MOUSE	The Ca2+-dependent human S100A4 (Mts1) protein is part of the S100 family. Here, we studied the interactions of S100A4 with S100A1 using nuclear magnetic resonance (NMR) spectroscopy. We used the chemical shift perturbed residues from HSQC to model S100A4 and S100A1 complex with HADDOCK software. We observed that S100A1 and the RAGE V domain have an analogous binding area in S100A4. We discovered that S100A4 acts as an antagonist among the RAGE V domain and S100A1, which inhibits tumorigenesis and cell proliferation. We used a WST-1 assay to examine the bioactivity of S100A1 and S100A4. This study could possibly be beneficial for evaluating new proteins for the treatment of diseases.	[Khan, Md. Imran; Yuan, Tai; Yu, Chin] Natl Tsing Hua Univ, Chem Dept, Hsinchu, Taiwan; [Chou, Ruey-Hwang] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan; [Chou, Ruey-Hwang] China Med Univ, Ctr Mol Med, Taichung, Taiwan; [Chou, Ruey-Hwang] Asia Univ, Dept Biotechnol, Taichung, Taiwan	National Tsing Hua University; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan	Yu, C (corresponding author), Natl Tsing Hua Univ, Chem Dept, Hsinchu, Taiwan.	cyu.nthu@gmail.com	Chou, Ruey-Hwang/K-8541-2013	Chou, Ruey-Hwang/0000-0002-2297-2180	Ministry of Science and Technology (MOST) of Taiwan [MOST 104-2113-M-007-019-MY3]; Ministry of Health and Welfare (MOHW) [MOST 105-2320-B-039-059-MY3, MOHW107-TDU-B-212-114025]; Drug Development Center, China Medical University from The Featured Areas Research Center Program by the Ministry of Education (MOE) in Taiwan	Ministry of Science and Technology (MOST) of Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Health and Welfare (MOHW); Drug Development Center, China Medical University from The Featured Areas Research Center Program by the Ministry of Education (MOE) in Taiwan	This work was supported by the Ministry of Science and Technology (MOST) of Taiwan (grant number MOST 104-2113-M-007-019-MY3), MOST 105-2320-B-039-059-MY3 and MOHW107-TDU-B-212-114025 from Ministry of Health and Welfare (MOHW), and the Drug Development Center, China Medical University from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari BB, 2001, FEBS LETT, V497, P95, DOI 10.1016/S0014-5793(01)02444-9; Afanador L, 2014, CELL CALCIUM, V56, P68, DOI 10.1016/j.ceca.2014.05.002; Ambartsumian N, 2005, J DAIRY RES, V72, P27, DOI 10.1017/S0022029905001093; Arumugam T, 2011, AMINO ACIDS, V41, P893, DOI 10.1007/s00726-010-0496-4; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Bresnick AR, 2015, NAT REV CANCER, V15, P96, DOI 10.1038/nrc3893; BURSTEIN EA, 1973, PHOTOCHEM PHOTOBIOL, V18, P263, DOI 10.1111/j.1751-1097.1973.tb06422.x; Chen HY, 2014, AM J CANCER RES, V4, P89; Cho CC, 2015, J BIOMOL NMR, V62, P233, DOI 10.1007/s10858-015-9927-6; Christensen H, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00008; Davey GE, 2001, J BIOL CHEM, V276, P30819, DOI 10.1074/jbc.M103541200; Deloulme JC, 2003, MICROSC RES TECHNIQ, V60, P560, DOI 10.1002/jemt.10298; DeRycke MS, 2009, AM J CLIN PATHOL, V132, P846, DOI 10.1309/AJCPTK87EMMIKPFS; Diaconescu DE, 2014, ROM J MORPHOL EMBRYO, V55, P1371; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; Durussel I, 2000, S100A13 BIOCH CHARAC, V275, P8686; ENGELKAMP D, 1993, P NATL ACAD SCI USA, V90, P6547, DOI 10.1073/pnas.90.14.6547; Fernandez-Fernandez MR, 2005, P NATL ACAD SCI USA, V102, P4735, DOI 10.1073/pnas.0501459102; FORD HL, 1995, ONCOGENE, V10, P1597; Gupta AA, 2012, BIOMOL NMR ASSIGN, V6, P213, DOI 10.1007/s12104-012-9360-7; Holakovska B, 2012, J BIOL CHEM, V287, P16645, DOI 10.1074/jbc.M112.350686; Ismail TM, 2010, J BIOL CHEM, V285, P914, DOI 10.1074/jbc.M109.010892; Khan I., 2018, POLYM BLENDS, P1, DOI [10.1007/978-3-319-95987-0_16, DOI 10.1007/978-3-319-92067-2_16-1]; Kiewitz R, 2003, BIOCHEM BIOPH RES CO, V306, P550, DOI 10.1016/S0006-291X(03)00987-2; Kraus C, 2009, J MOL CELL CARDIOL, V47, P445, DOI 10.1016/j.yjmcc.2009.06.003; Kuniyasu H, 2002, J PATHOL, V196, P163, DOI 10.1002/path.1031; L.L.C. Schrodinger, 2018, PYMOL MOL GRAPH SYST, P2; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Leclerc Estelle, 2013, Methods Mol Biol, V963, P201, DOI 10.1007/978-1-62703-230-8_13; Leclerc Estelle, 2011, Front Biosci (Schol Ed), V3, P1232; Leclerc E, 2009, BBA-MOL CELL RES, V1793, P993, DOI 10.1016/j.bbamcr.2008.11.016; Li G, 2007, HISTOPATHOLOGY, V50, P642, DOI 10.1111/j.1365-2559.2007.02655.x; Liang HS, 2011, CANCER LETT, V313, P91, DOI 10.1016/j.canlet.2011.08.028; Logsdon CD, 2007, CURR MOL MED, V7, P777, DOI 10.2174/156652407783220697; Ma L, 2002, J MOL BIOL, P279, DOI [10.1006/jmbi.2002.5421, DOI 10.1006/JMBI.2002.5421]; Maco B, 2001, PHYSIOL RES, V50, P567; Malashkevich VN, 2008, BIOCHEMISTRY-US, V47, P5111, DOI 10.1021/bi702537s; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Mishra SK, 2012, CANCER METAST REV, V31, P163, DOI 10.1007/s10555-011-9338-4; MOORE BW, 1965, BIOCHEM BIOPH RES CO, V19, P739, DOI 10.1016/0006-291X(65)90320-7; Mori M, 1998, HISTOCHEM CELL BIOL, V110, P579, DOI 10.1007/s004180050320; Most P, 2003, J BIOL CHEM, V278, P33809, DOI 10.1074/jbc.M301788200; Naim R, 2006, ONCOL REP, V16, P671; Penumutchu SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103947; Prosser BL, 2008, J BIOL CHEM, V283, P5046, DOI 10.1074/jbc.M709231200; Remppis A, 1996, BBA-MOL CELL RES, V1313, P253, DOI 10.1016/0167-4889(96)00097-3; Rintala-Dempsey AC, 2006, BIOCHEMISTRY-US, V45, P14695, DOI 10.1021/bi061754e; Rohde D, 2010, J CARDIOVASC TRANSL, V3, P525, DOI 10.1007/s12265-010-9211-9; Salama I, 2008, EJSO-EUR J SURG ONC, V34, P357, DOI 10.1016/j.ejso.2007.04.009; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Sastry M, 1998, STRUCTURE, V6, P223, DOI 10.1016/S0969-2126(98)00023-9; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; Semov A, 2005, J BIOL CHEM, V280, P20833, DOI 10.1074/jbc.M412653200; Shanmugam N, 2008, J BIOL CHEM, V283, P36221, DOI 10.1074/jbc.M806322200; Sherbet GV, 1998, ANTICANCER RES, V18, P2415; Sparvero LJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-17; Streicher WW, 2010, BIOPHYS CHEM, V151, P181, DOI 10.1016/j.bpc.2010.06.003; Tan AS, 2000, J IMMUNOL METHODS, V238, P59, DOI 10.1016/S0022-1759(00)00156-3; Tarabykina S, 2000, FEBS LETT, V475, P187, DOI 10.1016/S0014-5793(00)01652-5; Tian T, 2017, DISCOV MED, V23, P235; Tsoporis JN, 2010, CIRC RES, V106, P93, DOI 10.1161/CIRCRESAHA.109.195834; Tsukatani T, 2008, J MICROBIOL METH, V75, P109, DOI 10.1016/j.mimet.2008.05.016; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; van Zundert GCP, 2014, METHODS MOL BIOL, V1137, P163, DOI 10.1007/978-1-4939-0366-5_12; Wang GZ, 2005, ONCOGENE, V24, P1445, DOI 10.1038/sj.onc.1208291; Wang GZ, 2000, J BIOL CHEM, V275, P11141, DOI 10.1074/jbc.275.15.11141; Wright NT, 2008, J BIOL CHEM, V283, P26676, DOI 10.1074/jbc.M804432200; Xue J, 2014, BIOCHEMISTRY-US, V53, P3327, DOI 10.1021/bi500046t; Yan SF, 2010, BIOCHEM PHARMACOL, V79, P1379, DOI 10.1016/j.bcp.2010.01.013; Yang WS, 2012, J PROTEOME RES, V11, P1078, DOI 10.1021/pr2008187; Yap KL, 1999, PROTEINS, V37, P499, DOI 10.1002/(SICI)1097-0134(19991115)37:3<499::AID-PROT17>3.0.CO;2-Y; Zimmer Danna B, 2010, Cardiovasc Psychiatry Neurol, V2010, DOI 10.1155/2010/728052	75	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212299	10.1371/journal.pone.0212299	http://dx.doi.org/10.1371/journal.pone.0212299			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779808	Green Published, gold, Green Submitted			2022-12-27	WOS:000459062900043
J	Sato, T; Kohzuki, M; Ono, M; Muto, M; Osugi, T; Kawamura, K; Naganuma, W; Sato, M; Shishito, N				Sato, Toshimi; Kohzuki, Masahiro; Ono, Masahiro; Muto, Mitsuru; Osugi, Taku; Kawamura, Keiichi; Naganuma, Wakako; Sato, Masayuki; Shishito, Namiko			Association between physical activity and change in renal function in patients after acute myocardial infarction	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; CHRONIC KIDNEY-DISEASE; PERCUTANEOUS CORONARY INTERVENTION; CARDIAC REHABILITATION; CARDIOVASCULAR OUTCOMES; DYSFUNCTION; MORTALITY; DECLINE; IMPACT; JAPAN	Background Combined renal dysfunction worsens the subsequent prognosis in patients after acute myocardial infarction (AMI). Therefore, establishing a therapeutic modality to maintain or improve renal function in AMI patients is necessary. This study aimed to elucidate the association between physical activity level and change in renal function in such patients. Design Prospective and observational study. Methods We enrolled 41 patients (35 men; average age, 67.5 +/- 12.6 years) after AMI onset. Blood biochemistry, urinalysis, and physical function tests were conducted at discharge and 3 months after discharge. Renal function was evaluated based on cystatin C based-estimated glomerular filtration rate (eGFRcys). The number of steps was recorded for 3 months postdischarge. Generalized estimating equations (GEE) was used to test the association between physical activity level and within-patient changes in eGFRcys. Results Patients were stratified into low (n = 21; number of steps, 2335 +/- 1219 steps/day) and high groups (n = 20; number of steps, 7102 +/- 2365 steps/day). eGFRcys significantly increased from baseline to after 3 months in the high group (76.5 +/- 13.8 to 83.2 +/- 16.0 mL/min/1.73 m(2), q = 0.004), whereas no significant change was observed in the low group (65.1 +/- 15.9 to 62.2 +/- 20.2 mL/min/1.73 m(2), q = 0.125). Result of GEE adjusted for potential confounding variables showed a significant positive association between physical activity level and within-patient changes in eGFRcys (p = 0.003). Changes in eGFRcys was -2.9 mL/min/1.73 m(2) among low group versus + 6.7 mL/min/1.73 m(2) among high group. Conclusions Physical activity level was positively associated with changes in renal function, demonstrating that high physical activity may suppress renal function decline in patients after AMI.	[Sato, Toshimi; Kohzuki, Masahiro] Tohoku Univ, Grad Sch Med, Dept Internal Med & Rehabil Sci, Sendai, Miyagi, Japan; [Sato, Toshimi] Southern Tohoku Gen Hosp, Dept Rehabil, Koriyama, Fukushima, Japan; [Ono, Masahiro; Muto, Mitsuru; Osugi, Taku; Kawamura, Keiichi; Naganuma, Wakako; Shishito, Namiko] Southern Tohoku Gen Hosp, Dept Cardiol, Koriyama, Fukushima, Japan; [Sato, Masayuki] Ohara Gen Hosp, Dept Cardiol, Fukushima, Japan	Tohoku University	Kohzuki, M (corresponding author), Tohoku Univ, Grad Sch Med, Dept Internal Med & Rehabil Sci, Sendai, Miyagi, Japan.	kohzuki@med.tohoku.ac.jp		Sato, Toshimi/0000-0003-0586-9402				Ainsworth B, 2015, PROG CARDIOVASC DIS, V57, P387, DOI 10.1016/j.pcad.2014.10.005; Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; Aoyagi Y, 2009, GERONTOLOGY, V55, P523, DOI 10.1159/000236326; Arakawa T, 2016, CIRC J, V80, P1750, DOI 10.1253/circj.CJ-15-1392; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Eijkelkamp WBA, 2007, AM J CARDIOL, V100, P7, DOI 10.1016/j.amjcard.2007.02.047; Hama T, 2018, IJC HEART VASC, V19, P27, DOI 10.1016/j.ijcha.2018.04.001; Herber-Gast GCM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133864; Horio M, 2013, AM J KIDNEY DIS, V61, P197, DOI 10.1053/j.ajkd.2012.07.007; Imai E, 2008, HYPERTENS RES, V31, P433, DOI 10.1291/hypres.31.433; Iseki K, 2002, HYPERTENS RES, V25, P185, DOI 10.1291/hypres.25.185; Iso Y, 2015, INT J CARDIOL, V187, P283, DOI 10.1016/j.ijcard.2015.03.308; Kamiya K, 2017, AM J CARDIOL, V119, P186, DOI 10.1016/j.amjcard.2016.09.040; Kimura S, 2015, INT HEART J, V56, P105, DOI 10.1536/ihj.14-161; Koganei H, 2008, CIRC J, V72, P179, DOI 10.1253/circj.72.179; Kohzuki M, 2001, J HYPERTENS, V19, P1877, DOI 10.1097/00004872-200110000-00024; Kohzuki M, 2017, CARDIOVASC INNOV APP, V2, P387, DOI 10.15212/CVIA.2017.0006; Kohzuki M, 2016, CIRC J, V80, P1697, DOI 10.1253/circj.CJ-16-0619; Kraal JJ, 2017, EUR J PREV CARDIOL, V24, P1260, DOI 10.1177/2047487317710803; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Millor N, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-86; Muntner P, 2000, KIDNEY INT, V58, P293, DOI 10.1046/j.1523-1755.2000.00165.x; Oliveira J, 2008, J CARDIOPULM REHABIL, V28, P392, DOI 10.1097/HCR.0b013e31818c3b83; Poortmans JR, 2013, BRIT J SPORT MED, V47, P1166, DOI 10.1136/bjsports-2012-090976; Posma RA, 2015, CARDIOVASC DRUG THER, V29, P451, DOI 10.1007/s10557-015-6618-1; Robinson-Cohen C, 2014, J AM SOC NEPHROL, V25, P399, DOI 10.1681/ASN.2013040392; Robinson-Cohen C, 2009, ARCH INTERN MED, V169, P2116, DOI 10.1001/archinternmed.2009.438; Ruggenenti P, 2001, LANCET, V357, P1601, DOI 10.1016/S0140-6736(00)04728-0; Seronie-Vivien S, 2008, CLIN CHEM LAB MED, V46, P1664, DOI 10.1515/CCLM.2008.336; Shepherd J, 2016, AM J CARDIOL, V117, P1199, DOI 10.1016/j.amjcard.2016.01.014; Takaya Y, 2014, CIRC J, V78, P377, DOI 10.1253/circj.CJ-13-0779; Toyama K, 2010, J CARDIOL, V56, P142, DOI 10.1016/j.jjcc.2010.06.007; Yamagata K, 2004, AM J KIDNEY DIS, V43, P433, DOI 10.1053/j.ajkd.2003.11.005; Yamaguchi J, 2007, CIRC J, V71, P1354, DOI 10.1253/circj.71.1354; YESAVAGE JA, 1988, PSYCHOPHARMACOL BULL, V24, P709	36	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212100	10.1371/journal.pone.0212100	http://dx.doi.org/10.1371/journal.pone.0212100			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779806	Green Submitted, Green Published, gold			2022-12-27	WOS:000459062900028
J	Tola, E; Al-Gaadi, KA; Madugundu, R				Tola, ElKamil; Al-Gaadi, Khalid A.; Madugundu, Rangaswamy			Employment of GIS techniques to assess the long-term impact of tillage on the soil organic carbon of agricultural fields under hyper-arid conditions	PLOS ONE			English	Article							MANAGEMENT; MATTER; VEGETATION; NITROGEN; LEVEL; YIELD	A study on six 50 ha agricultural fields was conducted to investigate the effect of conservation tillage practices on the long-term (1990-2016) changes in the soil organic carbon (SOC) content of the topsoil layers (0-10 cm) of agricultural fields. The experimental fields were selected from the 49 fields of the Tawdeehiya Arable Farm (TAF), located 200 kilometers southeast of Riyadh, the capital city of the Kingdom of Saudi Arabia. Data sets from laboratory determined SOC and the corresponding Landsat images generated vegetation indices, namely, the Normalized Difference Vegetation Index (NDVI) and the Bare Soil Index (BSI), were utilized for the prediction of SOC using multivariate regression techniques. Long-term changes in the SOC content of the experimental fields, as a result of different tillage practices, were also studied. The developed SOC prediction models exhibited high accuracy indicated by R-2 values ranging from 0.73 to 0.85, RMSE values of 0.34 to 0.85 g kg(-1) and P-values of less than 0.0001. The cross-validation results (R-2 of 0.61-0.70, RMSE value of 0.34-0.85 g kg(-1) and P-values of less than 0.0001) confirmed the high accuracy of the developed SOC prediction models. Results also revealed that the change in the SOC content was clearly associated with soil tillage practices. On the average, 76% of the all agricultural fields in the experimental farm showed a decrease of up to 24 g kg(-1) in their SOC content after 10 years (1990-2000) of continuous conventional tillage practices. On the other hand, an average increase of up to 37 g kg(-1) in the SOC content was observed in 88% of the studied fields at the end of the study period (2016), where conservation tillage was a continous and consistent practice in the experimental farm.	[Tola, ElKamil; Al-Gaadi, Khalid A.; Madugundu, Rangaswamy] King Saud Univ, Precis Agr Res Chair, Riyadh, Saudi Arabia; [Al-Gaadi, Khalid A.] King Saud Univ, Dept Agr Engn, Coll Food & Agr Sci, Riyadh, Saudi Arabia	King Saud University; King Saud University	Tola, E (corresponding author), King Saud Univ, Precis Agr Res Chair, Riyadh, Saudi Arabia.	etola@ksu.edu.sa	Tola, ElKamil/AAX-8777-2021; Madugundu, Rangaswamy/N-9214-2013; Tola, ElKamil/E-8523-2017	Madugundu, Rangaswamy/0000-0002-5326-4785; Tola, ElKamil/0000-0003-0927-9688	Deanship of Scientific Research, King Saud University; Deanship of Scientific Research, King Saud University, Riyadh	Deanship of Scientific Research, King Saud University(King Saud University); Deanship of Scientific Research, King Saud University, Riyadh	This study was supported by the Deanship of Scientific Research, King Saud University. The authors confirm that the funders provided research funds for field trips, data collection, lab analysis, software programs, publication fees and research allowances. Also the authors confirm that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to the Deanship of Scientific Research, King Saud University, Riyadh for funding this study through the Vice Deanship of Scientific Research Chairs. The unsustained cooperation and support extended by the staff of the Tawdeehia farm during the field campaign are gratefully acknowledged.	Abdullah L., 2015, J SUSTAIN DEV, V8, P66, DOI [10.5539/jsd.v8n2p66, DOI 10.5539/JSD.V8N2P66]; Amare T., 2013, ISRN Soil Science, V2013, P720589; [Anonymous], 2010, P 25 ANN C GRASSL SO; Bhunia GS, 2019, GEOCARTO INT, V34, P215, DOI 10.1080/10106049.2017.1381179; Choudhury SG, 2014, SOIL TILL RES, V136, P76, DOI 10.1016/j.still.2013.10.001; Dikgwatlhe SB, 2014, SOIL USE MANAGE, V30, P496, DOI 10.1111/sum.12143; Garten CT, 1999, J ENVIRON QUAL, V28, P1359, DOI 10.2134/jeq1999.00472425002800040041x; Gholizadeh A, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9101078; Griffin E, 2017, WHAT IS SOIL ORGANIC; Grinand C, 2017, INT J APPL EARTH OBS, V54, P1, DOI 10.1016/j.jag.2016.09.002; Haddaway NR, 2017, ENVIRON EVID, V6, DOI 10.1186/s13750-016-0079-2; Hernanz JL, 2002, SOIL TILL RES, V66, P129, DOI 10.1016/S0167-1987(02)00021-1; Hong YS, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10010028; Jamalabad M., 2004, ISPRS C; Kingra P. K., 2016, Agricultural Research Journal, V53, P295, DOI 10.5958/2395-146X.2016.00058.2; Klemmedson J. O., 1989, Arid Soil Research and Rehabilitation, V3, P99, DOI 10.1080/15324988909381194; Kumar P, 2016, EGYPT J REMOTE SENS, V19, P109, DOI 10.1016/j.ejrs.2015.12.003; Liu X, 2006, PLANT SOIL ENVIRON, V52, P531, DOI 10.17221/3544-PSE; Loveland P, 2003, SOIL TILL RES, V70, P1, DOI 10.1016/S0167-1987(02)00139-3; Martin PD, 2002, CAN J SOIL SCI, V82, P413, DOI 10.4141/S01-054; McBratney A. B., 1999, Precision agriculture '99, Part 1 and Part 2. Papers presented at the 2nd European Conference on Precision Agriculture, Odense, Denmark, 11-15 July 1999, P101; McGranahan DA, 2013, LAND-BASEL, V2, P328, DOI 10.3390/land2030328; Mishra N, 2014, REMOTE SENS-BASEL, V6, P12619, DOI 10.3390/rs61212619; Mondal A, 2017, EGYPT J REMOTE SENS, V20, P61, DOI 10.1016/j.ejrs.2016.06.004; Ofori C.S., 1993, SOIL B, P77; Post WM, 2001, CLIMATIC CHANGE, V51, P73, DOI 10.1023/A:1017514802028; Quintero M., 2013, OPEN J SOIL SCI, V3, P361, DOI [DOI 10.4236/0JSS.2013.38042, 10.4236/ojss.2013.38042, DOI 10.4236/OJSS.2013.38042]; Reda GT, 2016, J ENV EARTH SCI, V6, P72; Rouse Jr J.W., 1974, P 3 EARTH RESOURCES, DOI DOI 10.1002/MRM.26868; Roy DP, 2016, REMOTE SENS ENVIRON, V185, P57, DOI 10.1016/j.rse.2015.12.024; Sapkota T.B., 2012, ORGANIC FERTILISATIO, V9, DOI [10.1007/978-94-007-4113-3_6, DOI 10.1007/978-94-007-4113-3_6]; Seyedmohammadi J, 2018, MODEL EARTH SYST ENV, V4, P777, DOI 10.1007/s40808-018-0450-0; Slepetiene A., 2008, Agronomy Research, V6, P543; Verma BC, 2010, ENVIRON MONIT ASSESS, V171, P579, DOI 10.1007/s10661-009-1301-2; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Ward JK, 2006, ASABE ANN INT M PORT; Whitehead D, 2010, 201236 MPI; Yeboah S, 2016, PLANT SOIL ENVIRON, V62, P279, DOI 10.17221/66/2016-PSE; Zarea MJ, 2010, SUSTAIN AGR REV, V5, P195, DOI 10.1007/978-90-481-9513-8_7; Zheng HB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199523	40	5	5	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212521	10.1371/journal.pone.0212521	http://dx.doi.org/10.1371/journal.pone.0212521			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779819	Green Published, gold, Green Submitted			2022-12-27	WOS:000459062900063
J	Le Goff, M; Cornec, D; Guellec, D; Marhadour, T; Devauchelle-Pensec, V; Jousse-Joulin, S; Herbette, M; Cauvin, JM; Le Guillou, C; Renaudineau, Y; Jamin, C; Pers, JO; Saraux, A				Le Goff, Maelle; Cornec, Divi; Guellec, Dewi; Marhadour, Thierry; Devauchelle-Pensec, Valerie; Jousse-Joulin, Sandrine; Herbette, Marion; Cauvin, Jean Michel; Le Guillou, Clara; Renaudineau, Yves; Jamin, Christophe; Pers, Jacques Olivier; Saraux, Alain			Peripheral-blood b-cell subset disturbances in inflammatory joint diseases induced by Tropheryma whipplei	PLOS ONE			English	Article							SYNOVIAL-FLUID; PATHOGENESIS; PREVALENCE; INFECTION; ARTHRITIS; PROFILE; DNA	Objective To look for abnormalities in circulating B-cell subsets in patients with rheumatic symptoms of Whipple's disease (WD). Method Consecutive patients seen between 2010 and 2016 for suspected inflammatory joint disease were identified retrospectively. Results of standardized immunological and serological tests and of peripheral-blood B-cell and T-cell subset analysis by flow cytometry were collected. Patients with criteria suggesting WD underwent PCR testing for Tropheryma whipplei, and those with diagnosis of WD (cases) were compared to those without diagnosis (controls). We used ROC curve analysis to evaluate the diagnostic value of flow cytometry findings for WD. Results Among 2917 patients seen for suspected inflammatory joint disease, 121 had suspected WD, including 9 (9/121, 7.4%) confirmed WD. Proportions of T cells and NK cells were similar between suspected and confirmed WD, whereas cases had a lower proportion of circulating memory B cells (IgD(-)CD38(low), 18.0%+/- 9.7% vs. 26.0%+/- 14.2%, P = 0.041) and higher ratio of activated B cells over memory B cells (4.4 +/- 2.0 vs. 2.9 +/- 2.2, P = 0.023). Among peripheral-blood B-cells, the proportion of IgD+CD27- naive B cells was higher (66.2%+/- 18.2% vs. 54.6%+/- 18.4%, P = 0.047) and that of IgD-CD27+ switched memory B cells lower (13.3%+/- 5.7% vs. 21.4%+/- 11.9%, P = 0.023), in cases vs. controls. The criterion with the best diagnostic performance was a proportion of IgD+CD27- naive B cells above 70.5%, which had 73% sensitivity and 80% specificity. Conclusion Our study provides data on peripheral-blood B-cell disturbances that may have implications for the diagnosis and pathogenetic understanding of WD.	[Le Goff, Maelle; Cornec, Divi; Guellec, Dewi; Marhadour, Thierry; Devauchelle-Pensec, Valerie; Jousse-Joulin, Sandrine; Herbette, Marion; Saraux, Alain] Brest Teaching Hosp, Victor Hugo Network, Ctr Natl Reference Malad Autoimmunes Rares CERAIN, Rheumatol Unit, Brest, France; [Cornec, Divi; Devauchelle-Pensec, Valerie; Jousse-Joulin, Sandrine; Renaudineau, Yves; Jamin, Christophe; Pers, Jacques Olivier; Saraux, Alain] Brest Univ, Brest Teaching Hosp, INSERM, UMR1227,Lymphocytes B & Autoimmun,LabEx IGO, Brest, France; [Cauvin, Jean Michel; Le Guillou, Clara] La Cavale Blanche Hosp, DIM, Brest, France; [Cauvin, Jean Michel; Le Guillou, Clara] La Cavale Blanche Hosp, CDC, Brest, France	CHU Brest; CHU Brest; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; CHU Brest; CHU Brest	Saraux, A (corresponding author), Brest Teaching Hosp, Victor Hugo Network, Ctr Natl Reference Malad Autoimmunes Rares CERAIN, Rheumatol Unit, Brest, France.; Saraux, A (corresponding author), Brest Univ, Brest Teaching Hosp, INSERM, UMR1227,Lymphocytes B & Autoimmun,LabEx IGO, Brest, France.	alain.saraux@chu-brest.fr	Pers, Jacques-Olivier/AGG-7221-2022; Renaudineau, Yves/K-5191-2013	Renaudineau, Yves/0000-0001-5098-5002				Alegria GC, 2017, CLIN REV ALLERG IMMU, V53, P219, DOI 10.1007/s12016-017-8608-5; Alegria GC, 2017, RHEUMATOLOGY, V56, P1401, DOI 10.1093/rheumatology/kex169; Amsler L, 2003, INFECTION, V31, P81, DOI 10.1007/s15010-002-3083-0; Anolik JH, 2008, J IMMUNOL, V180, P688, DOI 10.4049/jimmunol.180.2.688; Binard A, 2009, ANN RHEUM DIS, V68, P1447, DOI 10.1136/ard.2008.096172; Bonhomme CJ, 2008, EUR J CLIN MICROBIOL, V27, P959, DOI 10.1007/s10096-008-0528-0; Bonhomme CJ, 2009, J INFECT DIS, V199, P1043, DOI 10.1086/597277; Desnues B, 2005, J INFECT DIS, V192, P1642, DOI 10.1086/491745; Edouard S, 2012, J CLIN MICROBIOL, V50, P3917, DOI 10.1128/JCM.01517-12; El-Abassi R, 2017, J NEUROL SCI, V377, P197, DOI 10.1016/j.jns.2017.01.048; Fenollar F, 2001, Expert Rev Mol Diagn, V1, P299, DOI 10.1586/14737159.1.3.299; Fenollar F, 2002, J CLIN MICROBIOL, V40, P1119, DOI 10.1128/JCM.40.3.1119-1120.2002; Fenollar F, 2008, CLIN INFECT DIS, V47, P659, DOI 10.1086/590559; Fenollar F, 2008, J INFECT DIS, V197, P880, DOI 10.1086/528693; Fenollar F, 2014, J INFECTION, V69, P103, DOI 10.1016/j.jinf.2014.05.008; Fenollar F, 2007, NEW ENGL J MED, V356, P55, DOI 10.1056/NEJMra062477; Feurle GE, 2010, ANN INTERN MED, V153, P710, DOI 10.7326/0003-4819-153-11-201012070-00004; Glaesener S, 2014, ARTHRITIS RHEUMATOL, V66, P2590, DOI 10.1002/art.38736; Gunther U, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000714; Guerin Antoine, 2018, Elife, V7, DOI 10.7554/eLife.32340; Herbette M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200645; Kalt A, 2006, INT J COLORECTAL DIS, V21, P114, DOI 10.1007/s00384-005-0778-6; Keita AK, 2013, FUTURE MICROBIOL, V8, P57, DOI [10.2217/FMB.12.124, 10.2217/fmb.12.124]; La Scola B, 2001, INT J SYST EVOL MICR, V51, P1471, DOI 10.1099/00207713-51-4-1471; Lagier JC, 2017, FUTURE MICROBIOL, V12, P247, DOI 10.2217/fmb-2017-0178; Lagier JC, 2014, J ANTIMICROB CHEMOTH, V69, P219, DOI 10.1093/jac/dkt310; Lagier JC, 2010, MEDICINE, V89, P337, DOI 10.1097/MD.0b013e3181f204a8; Marth T, 2015, ALIMENT PHARM THER, V41, P709, DOI 10.1111/apt.13140; Marth T, 2002, GASTROENTEROLOGY, V123, P1468, DOI 10.1053/gast.2002.36583; Marth T, 1997, GASTROENTEROLOGY, V113, P442, DOI 10.1053/gast.1997.v113.pm9247462; Marth T, 2016, ACTA CLIN BELG, V71, P373, DOI 10.1080/17843286.2016.1256586; Marth T, 2016, LANCET INFECT DIS, V16, pE13, DOI 10.1016/S1473-3099(15)00537-X; Martinetti M, 2009, GASTROENTEROLOGY, V136, P2289, DOI 10.1053/j.gastro.2009.01.051; Moos V, 2006, J IMMUNOL, V177, P2015, DOI 10.4049/jimmunol.177.3.2015; Moos V, 2012, EXPERT REV ANTI-INFE, V10, P253, DOI [10.1586/ERI.12.4, 10.1586/eri.12.4]; Moos V, 2010, GASTROENTEROLOGY, V138, P210, DOI 10.1053/j.gastro.2009.07.066; O'Duffy JD, 1999, ARTHRITIS RHEUM, V42, P812, DOI 10.1002/1529-0131(199904)42:4<812::AID-ANR27>3.0.CO;2-S; Puechal X, 2007, ARTHRITIS RHEUM, V56, P1713, DOI 10.1002/art.22596; Qin SL, 2016, AM J RESP CRIT CARE, V194, P243, DOI 10.1164/rccm.201601-0162LE; RELMAN DA, 1992, NEW ENGL J MED, V327, P293, DOI 10.1056/NEJM199207303270501; Sack U, 2016, AUTOIMMUN REV, V15, P883, DOI 10.1016/j.autrev.2016.07.010; Schneider T, 2008, LANCET INFECT DIS, V8, P179, DOI 10.1016/S1473-3099(08)70042-2; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; WILSON KH, 1991, LANCET, V338, P474, DOI 10.1016/0140-6736(91)90545-Z	44	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211536	10.1371/journal.pone.0211536	http://dx.doi.org/10.1371/journal.pone.0211536			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811404	gold, Green Published, Green Submitted			2022-12-27	WOS:000459806400021
J	Tominaga, T; Akiyoshi, T; Yamamoto, N; Taguchi, S; Mori, S; Nagasaki, T; Fukunaga, Y; Ueno, M				Tominaga, Tetsuro; Akiyoshi, Takashi; Yamamoto, Noriko; Taguchi, Senzo; Mori, Seiichi; Nagasaki, Toshiya; Fukunaga, Yosuke; Ueno, Masashi			Clinical significance of soluble programmed cell death-1 and soluble programmed cell death-ligand 1 in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; PD-L1; SURVIVAL; CHEMORADIATION; EXPRESSION; CHEMOTHERAPY; LYMPHOMA; FEATURES; CD274	Background Inhibition of the programmed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) axis in combination with radiotherapy may be a promising approach to treat cancer. In the present study, we aimed to evaluate serum soluble PD-1/PD-L1 levels in patients with advanced rectal cancer treated with neoadjuvant chemoradiotherapy (CRT). Methods Serum soluble PD-L1 and PD-1 levels were measured using an enzyme-linked immunosorbent assay before and after CRT in 117 patients with low rectal cancer. Changes in the levels of sPD-L1/PD-1 after CRT, and the correlation between sPD-L1/PD-1 level and clinicopathological characteristics or disease-free survival (DFS) were evaluated. Results sPD-L1 levels significantly increased after CRT (p < 0.0001), whereas sPD-1 levels did not change significantly (p = 0.1050). High sPD-L1 before CRT was significantly associated with younger age (p = 0.044), and after CRT, with lymphovascular invasion (p = 0.021). High sPD-1 before and after CRT was significantly associated with a longer distance of the tumor from the anal verge (both p < 0.001). There was no correlation between sPD-L1 level and local PD-L1 expression on stromal immune cells. High sPD-L1 level after CRT tended to be associated with worse DFS (p = 0.0752). The multivariate analysis could not demonstrate an independent association for sPD-L1 levels after CRT with DFS. Conclusions Significant increase of sPD-L1 levels after CRT suggests that anti-PD-L1 therapy might be a potential treatment strategy in combination with CRT in advanced rectal cancer.	[Tominaga, Tetsuro; Akiyoshi, Takashi; Nagasaki, Toshiya; Fukunaga, Yosuke; Ueno, Masashi] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Surg, Gastroenterol Ctr,Koto Ku, Tokyo, Japan; [Yamamoto, Noriko] Japanese Fdn Canc Res, Canc Inst, Div Pathol, Tokyo, Japan; [Taguchi, Senzo] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Radiat Oncol, Tokyo, Japan; [Mori, Seiichi] Japanese Fdn Canc Res, Canc Precis Med Ctr, Tokyo, Japan	Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research	Akiyoshi, T (corresponding author), Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Surg, Gastroenterol Ctr,Koto Ku, Tokyo, Japan.	takashi.akiyoshi@jfcr.or.jp	Fukunaga, Yosuke/AAR-8933-2021; nagasaki, toshiya/AAE-6844-2020	Fukunaga, Yosuke/0000-0002-6397-0907; nagasaki, toshiya/0000-0001-5853-314X; Akiyoshi, Takashi/0000-0002-2321-1412	JSPS KAKENHI [15K10156, 18K08664]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI under Grant number 15K10156 (TA) and 18K08664 (TA). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bando H, 2018, ANN ONCOL, V29, DOI [10.1093/annonc/mdy151.227, DOI 10.1093/ANNONC/MDY151.227]; Breugom AJ, 2015, ANN ONCOL, V26, P696, DOI 10.1093/annonc/mdu560; Bujko K, 2016, ANN ONCOL, V27, P834, DOI 10.1093/annonc/mdw062; Chen YJ, 2011, CYTOKINE, V56, P231, DOI 10.1016/j.cyto.2011.06.004; Dworak O, 1997, INT J COLORECTAL DIS, V12, P19, DOI 10.1007/s003840050072; Folkesson J, 2005, J CLIN ONCOL, V23, P5644, DOI 10.1200/JCO.2005.08.144; Frigola X, 2012, IMMUNOL LETT, V142, P78, DOI 10.1016/j.imlet.2011.11.001; Frigola X, 2011, CLIN CANCER RES, V17, P1915, DOI 10.1158/1078-0432.CCR-10-0250; Hecht M, 2016, EUR J CANCER, V65, P52, DOI 10.1016/j.ejca.2016.06.015; Kim HJ, 2018, RADIOTHER ONCOL, V129, P130, DOI 10.1016/j.radonc.2017.11.027; Kruger S, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1310358; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Lee KS, 2017, CANCER IMMUNOL IMMUN, V66, P927, DOI 10.1007/s00262-017-1999-6; Lee LH, 2016, MODERN PATHOL, V29, P1433, DOI 10.1038/modpathol.2016.139; Lim YJ, 2017, INT J RADIAT ONCOL, V99, P1216, DOI 10.1016/j.ijrobp.2017.07.004; Ma WJ, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0277-y; Nilsson PJ, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-279; Ogura A, 2018, EUR J CANCER, V91, P11, DOI 10.1016/j.ejca.2017.12.005; Roh MS, 2009, J CLIN ONCOL, V27, P5124, DOI 10.1200/JCO.2009.22.0467; Rossille D, 2017, LEUKEMIA, V31, P988, DOI 10.1038/leu.2016.385; Rossille D, 2014, LEUKEMIA, V28, P2367, DOI 10.1038/leu.2014.137; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Sorensen SF, 2016, LUNG CANCER, V100, P77, DOI 10.1016/j.lungcan.2016.08.001; Teng FF, 2015, TRANSL RES, V166, P721, DOI 10.1016/j.trsl.2015.06.019; Wei W, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000009617; Yamauchi M, 2012, GUT, V61, P847, DOI 10.1136/gutjnl-2011-300865; Zhu XX, 2017, ONCOTARGET, V8, P97671, DOI 10.18632/oncotarget.18311	27	30	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0212978	10.1371/journal.pone.0212978	http://dx.doi.org/10.1371/journal.pone.0212978			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807610	Green Published, gold, Green Submitted			2022-12-27	WOS:000459712100032
J	Martin-Yebraid, A; Martinez, JP				Martin-Yebraid, Alba; Pablo Martinez, Juan			Automatic diagnosis of strict left bundle branch block using a wavelet-based approach	PLOS ONE			English	Article							CARDIAC-RESYNCHRONIZATION THERAPY; EUROPEAN-SOCIETY; HEART-FAILURE; TASK-FORCE; CARDIOLOGY; GUIDELINES; ESC	Patients with left bundle branch block (LBBB) are known to have a good clinical response to cardiac resynchronization therapy. However, the high number of false positive diagnosis obtained with the conventional LBBB criteria limits the effectiveness of this therapy, which has yielded to the definition of new stricter criteria. They require prolonged QRS duration, a QS or rS pattern in the QRS complexes at leads V1 and V2 and the presence of mid-QRS notch/slurs in 2 leads within V1, V2, V5, V6, I and aVL. The aim of this work was to develop and assess a fully-automatic algorithm for strict LBBB diagnosis based on the wavelet transform. Twelve-lead, high-resolution, 10-second ECGs from 602 patients enrolled in the MADIT-CRT trial were available. Data were labelled for strict LBBB by 2 independent experts and divided into training (n = 300) and validation sets (n = 302) for assessing algorithm performance. After QRS detection, a wavelet-based delineator was used to detect individual QRS waves (Q, R, S), QRS onsets and ends, and to identify the morphological QRS pattern on each standard lead. Then, multilead QRS boundaries were defined in order to compute the global QRS duration. Finally, an automatic algorithm for notch/slur detection within the QRS complex was applied based on the same wavelet approach used for delineation. In the validation set, LBBB was diagnosed with a sensitivity and specificity of Se = 92.9% and Sp = 65.1% (Acc = 79.5%, PPV = 74% and NPV = 89.6%). The results confirmed that diagnosis of strict LBBB can be done based on a fully automatic extraction of temporal and morphological QRS features. However, it became evident that consensus in the definition of QRS duration as well as notch and slurs definitions is necessary in order to guarantee accurate and repeatable diagnosis of complete LBBB.	[Martin-Yebraid, Alba; Pablo Martinez, Juan] Univ Zaragoza, Ctr Invest Biomed Red Bioingn Biomat & Nanomed, Zaragoza, Spain; [Martin-Yebraid, Alba; Pablo Martinez, Juan] Univ Zaragoza, IIS Aragon, Aragon Inst Engn Res, BSICoS Grp, Zaragoza, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; University of Zaragoza; University of Zaragoza	Martinez, JP (corresponding author), Univ Zaragoza, Ctr Invest Biomed Red Bioingn Biomat & Nanomed, Zaragoza, Spain.; Martinez, JP (corresponding author), Univ Zaragoza, IIS Aragon, Aragon Inst Engn Res, BSICoS Grp, Zaragoza, Spain.	jpmart@unizar.es	Martinez, Juan/GXM-4393-2022; Martínez, Juan Pablo/A-2759-2009	Martínez, Juan Pablo/0000-0002-7503-3339; Martin-Yebra, Alba/0000-0003-0226-4950	CIBER in Bioengineering, Biomaterials & Nanomedicne (CIBER-BBN) through Instituto de Salud Carlos III; CIBER in Bioengineering, Biomaterials & Nanomedicne (CIBER-BBN) through FEDER (Spain) - MINECO [DPI2016-75458-R]; FEDER; Gobierno de Aragon through BSICoS Reference Group (T39-17R); European Social Fund (EU) through BSICoS Reference Group (T39-17R)	CIBER in Bioengineering, Biomaterials & Nanomedicne (CIBER-BBN) through Instituto de Salud Carlos III; CIBER in Bioengineering, Biomaterials & Nanomedicne (CIBER-BBN) through FEDER (Spain) - MINECO; FEDER(European Commission); Gobierno de Aragon through BSICoS Reference Group (T39-17R); European Social Fund (EU) through BSICoS Reference Group (T39-17R)	This work was supported by CIBER in Bioengineering, Biomaterials & Nanomedicne (CIBER-BBN) through Instituto de Salud Carlos III and FEDER (Spain), project DPI2016-75458-R funded by MINECO and FEDER, and by Gobierno de Aragon and European Social Fund (EU) through BSICoS Reference Group (T39-17R). The computation was performed by the ICTS NANBIOSIS, specifically by the High Performance Computing Unit of the CIBER-BBN at the University of Zaragoza. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by CIBER in Bioengineering, Biomaterials & Nanomedicne (CIBER-BBN) through Instituto de Salud Carlos III and FEDER (Spain), project DPI2016-75458-R funded by MINECO and FEDER, and by Gobierno de Aragon and European Social Fund (EU) through BSICoS Reference Group (T39-17R). The computation was performed by the ICTS NANBIOSIS, specifically by the High Performance Computing Unit of the CIBER-BBN at the University of Zaragoza.	Auricchio A, 2004, CIRCULATION, DOI [10.1161/01.CIR.0000118502.91105.F6?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed, DOI 10.1161/01.CIR.0000118502.91105.F6?URL_VER=Z39.88-2003&RFR_ID=ORI:RID:CROSSREF.ORG&RFR_DAT=CR_PUB%3DPUBMED]; BayesdeLuna A, 2006, MORPHOLOGY ELECTROCA; Brignole M, 2013, EUR HEART J, V34, P2281, DOI 10.1093/eurheartj/eht150; Caputo ML, 2018, INT J CARDIOL, V269, P165, DOI 10.1016/j.ijcard.2018.07.060; GRANT RP, 1956, AM J MED, V20, P834, DOI 10.1016/0002-9343(56)90204-2; Martinez JP, 2004, IEEE T BIO-MED ENG, V51, P570, DOI 10.1109/TBME.2003.821031; Mascioli G, 2012, PACE, V35, P927, DOI 10.1111/j.1540-8159.2012.03427.x; Moss AJ, 2009, NEW ENGL J MED, V361, P1329, DOI 10.1056/NEJMoa0906431; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Smisek R, 2018, J ELECTROCARDIOL, V51, pS31, DOI 10.1016/j.jelectrocard.2018.06.013; Strauss DG, 2011, AM J CARDIOL, V107, P927, DOI 10.1016/j.amjcard.2010.11.010; Surawicz B, 2009, J AM COLL CARDIOL, V53, P976, DOI 10.1016/j.jacc.2008.12.013; Wagner Galen S, 2014, MARRIOTTS PRACTICAL; Xia XJ, 2017, ANN NONINVAS ELECTRO, V22, DOI 10.1111/anec.12398; Zareba W, 2011, CIRCULATION, DOI [10.1161/CIRCULATIONAHA.110.960898?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed, DOI 10.1161/CIRCULATIONAHA.110.960898?URL_VER=Z39.88-2003&RFR_ID=ORI:RID:CROSSREF.ORG&RFR_DAT=CR_PUB%3DPUBMED]; Zusterzeel R, 2018, J ELECTROCARDIOL, V51, pS25, DOI 10.1016/j.jelectrocard.2018.08.001	16	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2019	14	2							e0212971	10.1371/journal.pone.0212971	http://dx.doi.org/10.1371/journal.pone.0212971			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EH	30802276	Green Submitted, Green Published, gold			2022-12-27	WOS:000459710700027
J	Riederer, I; Si-Mohamed, S; Ehn, S; Bar-Ness, D; Noel, PB; Fingerle, AA; Pfeiffer, F; Rummeny, EJ; Douek, P; Pfeiffer, D				Riederer, Isabelle; Si-Mohamed, Salim; Ehn, Sebastian; Bar-Ness, Daniel; Noel, Peter B.; Fingerle, Alexander A.; Pfeiffer, Franz; Rummeny, Ernst J.; Douek, Philippe; Pfeiffer, Daniela			Differentiation between blood and iodine in a bovine brain-Initial experience with Spectral Photon-Counting Computed Tomography (SPCCT)	PLOS ONE			English	Article							DUAL-ENERGY CT; QUANTIFICATION; CONTRAST; ACCURACY; PERFORMANCE; HEMORRHAGE; IMAGE; HEAD	Objectives To evaluate the accuracy of Spectral Photon-Counting Computed Tomography (SPCCT) in the quantification of iodine concentrations and its potential for the differentiation between blood and iodine. Methods Tubes with blood and a concentration series of iodine were scanned with a preclinical SPCCT system (both in vitro and in an ex vivo bovine brain tissue sample). Iodine density maps (IDM) and virtual non-contrast (VNC) images were generated using the multi-bin spectral information to perform material decomposition. Region-of-interest (ROI) analysis was performed within the tubes to quantitatively determine the absolute content of iodine (mg/ml). Results In conventional CT images, ROI analysis showed similar Hounsfield Unit (HU) values for the tubes with blood and iodine (59.9 +/- 1.8 versus 59.2 +/- 1.5). Iodine density maps enabled clear differentiation between blood and iodine in vitro, as well as in the bovine brain model. Quantitative measurements of the different iodine concentrations matched well with those of actual known concentrations even for very small iodine concentrations with values below 1mg/ml (RMSE = 0.19). Conclusions SPCCT providing iodine maps and virtual non-contrast images allows material decomposition, differentiation between blood and iodine in vitro and ex vivo in a bovine brain model and reliably quantifies the iodine concentration.	[Riederer, Isabelle; Noel, Peter B.; Fingerle, Alexander A.; Pfeiffer, Franz; Rummeny, Ernst J.; Pfeiffer, Daniela] Tech Univ Munich, Dept Diagnost & Intervent Radiol, Munich, Germany; [Riederer, Isabelle] Tech Univ Munich, Dept Diagnost & Intervent Neuroradiol, Munich, Germany; [Si-Mohamed, Salim; Douek, Philippe] Louis Pradel Univ Hosp, Dept Intervent Radiol & Cardiovasc & Thorac Diagn, Bron, France; [Si-Mohamed, Salim; Bar-Ness, Daniel; Douek, Philippe] Univ Claude Bernard Lyon 1, CREATIS, CNRS, INSERM,U1206,INSA Lyon,UMR 5220, Lyon, France; [Ehn, Sebastian; Pfeiffer, Franz] Tech Univ Munich, Chair Biomed Phys, Garching, Germany; [Ehn, Sebastian; Pfeiffer, Franz] Tech Univ Munich, Munich Sch BioEngn, Garching, Germany	Technical University of Munich; Technical University of Munich; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Technical University of Munich; Technical University of Munich	Riederer, I (corresponding author), Tech Univ Munich, Dept Diagnost & Intervent Radiol, Munich, Germany.; Riederer, I (corresponding author), Tech Univ Munich, Dept Diagnost & Intervent Neuroradiol, Munich, Germany.	isabelle.riederer@tum.de	douek, philippe c/C-3993-2019; Si-Mohamed, Salim A/F-9020-2019	Si-Mohamed, Salim A/0000-0003-0314-4010; Pfeiffer, Franz/0000-0001-6665-4363; Noel, Peter/0000-0002-9671-6171				Chandarana H, 2011, AM J ROENTGENOL, V196, pW693, DOI 10.2214/AJR.10.5541; Chang S, 2016, EUR RADIOL, V26, P3162, DOI 10.1007/s00330-015-4140-2; Cormode DP, 2010, RADIOLOGY, V256, P774, DOI 10.1148/radiol.10092473; Ehn S, 2018, J APPL CLIN MED PHYS, V19, P204, DOI 10.1002/acm2.12243; Faby S, 2015, MED PHYS, V42, P4349, DOI 10.1118/1.4922654; Flohr TG, 2006, EUR RADIOL, V16, P256, DOI 10.1007/s00330-005-2919-2; Goodsitt MM, 2011, MED PHYS, V38, P2222, DOI 10.1118/1.3567509; Gupta R, 2010, RADIOLOGY, V257, P205, DOI 10.1148/radiol.10091806; Koh MG, 2000, STROKE, V31, P2062, DOI 10.1161/01.STR.31.9.2062; Leng S, 2017, PHYS MED BIOL, V62, P7216, DOI 10.1088/1361-6560/aa8103; Li JH, 2015, J APPL CLIN MED PHYS, V16, P418, DOI 10.1120/jacmp.v16i5.5519; Lummel N, 2014, AM J NEURORADIOL, V35, P345, DOI 10.3174/ajnr.A3656; McCollough CH, 2015, RADIOLOGY, V276, P637, DOI 10.1148/radiol.2015142631; Mileto A, 2014, RADIOLOGY, V273, P813, DOI 10.1148/radiol.14140171; Mokin M, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.1.FOCUS11352; Muenzel D, 2017, RADIOLOGY, V283, P722, DOI 10.1148/radiol.2016160890; Nakano S, 2001, STROKE, V32, P2042, DOI 10.1161/hs0901.095602; Pelgrim GJ, 2017, EUR RADIOL, V27, P3904, DOI 10.1007/s00330-017-4752-9; Phan CM, 2012, AM J NEURORADIOL, V33, P1088, DOI 10.3174/ajnr.A2909; Pourmorteza A, 2016, RADIOLOGY, V279, P239, DOI 10.1148/radiol.2016152601; Roessl E, 2007, PHYS MED BIOL, V52, P4679, DOI 10.1088/0031-9155/52/15/020; Roessl E, 2011, IEEE T MED IMAGING, V30, P1678, DOI 10.1109/TMI.2011.2142188; Schlomka JP, 2008, PHYS MED BIOL, V53, P4031, DOI 10.1088/0031-9155/53/15/002; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Si-Mohamed S, 2018, INVEST RADIOL, V53, P629, DOI 10.1097/RLI.0000000000000483; Si-Mohamed S, 2017, NUCL INSTRUM METH A, V873, P27, DOI 10.1016/j.nima.2017.04.014; Symons R, 2018, INVEST RADIOL, V53, P135, DOI 10.1097/RLI.0000000000000418; Symons R, 2017, MED PHYS, V44, P5120, DOI 10.1002/mp.12301; Symons R, 2017, INT J CARDIOVAS IMAG, V33, P1253, DOI 10.1007/s10554-017-1104-4; Taguchi K, 2013, MED PHYS, V40, DOI 10.1118/1.4820371; Tijssen MPM, 2014, EUR RADIOL, V24, P834, DOI 10.1007/s00330-013-3073-x; Willemink MJ, 2018, RADIOLOGY, V289, P293, DOI 10.1148/radiol.2018172656	32	13	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2019	14	2							e0212679	10.1371/journal.pone.0212679	http://dx.doi.org/10.1371/journal.pone.0212679			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EH	30802258	Green Submitted, Green Published, gold			2022-12-27	WOS:000459710700017
J	Barrada, JR; Navas, JF; de Lara, CMR; Billieux, J; Devos, G; Perales, JC				Barrada, Juan R.; Navas, Juan F.; Ruiz de Lara, Cristian M.; Billieux, Joel; Devos, Gaetan; Perales, Jose C.			Reconsidering the roots, structure, and implications of gambling motives: An integrative approach	PLOS ONE			English	Article							EMOTION-REGULATION; PATHOLOGICAL GAMBLERS; QUESTIONNAIRE; SENSITIVITY; REWARD; IMPULSIVITY; VALIDATION; PUNISHMENT; COGNITIONS; SAMPLE	Rationale and method Accurately identifying motives to gamble is crucial in the functional analysis of gambling behavior. In this study, a data-driven approach was followed to clarify the factor structure underlying a pool of motives for gambling, selected from the Gambling Motives Questionnaire-Financial (GMQ-F), and the Reasons for Gambling Questionnaire (RGQ), in a sample of regular problem and non-problem gamblers. Additionally, the role of gambling motives in the relationship between root behavioral activation/inhibition systems (BIS/BAS) and gambling severity, frequency, and preferences was explored using structural equation modelling (SEM). Results and conclusions The present study identified Social, Financial, and Fun/thrill-related gambling motives factors, but also a fourth factor in which some positive and negative reinforcement-based motives were grouped into a single and broader Affect regulation factor. This Affect regulation factor shared variance both with BIS and BAS-related measures, and was the only direct predictor of disordered gambling symptoms. The Fun/thrill factor was directly related to frequency of participation in high-arousal, skill-based games, and all factors were related to participation in lower-arousal, chance games (with Social motives negatively predicting both participation in the latter and total severity). In the SEM model, measures of BIS/BAS sensitivity were connected to gambling behavior only through gambling motives. Based on measures of items' specificity, a shortened Spanish scale (the brief Gambling Motives Inventory, bGMI) is proposed to assess gambling motives in accordance with the observed 4-factor structure.	[Barrada, Juan R.] Univ Zaragoza, Dept Psicol & Sociol, Teruel, Spain; [Navas, Juan F.; Ruiz de Lara, Cristian M.; Perales, Jose C.] Univ Granada, Mind Brain & Behav Res Ctr CIMCYC, Granada, Spain; [Billieux, Joel] Univ Luxembourg, Inst Hlth & Behav, Addict & Compuls Behav Lab, Esch Sur Alzette, Luxembourg; [Billieux, Joel] Lausanne Univ Hosp, Ctr Excess Gambling, Lausanne, Switzerland; [Billieux, Joel; Devos, Gaetan] Univ Catholic Louvain, Psychol Sci Res Inst, LEP, Louvain La Neuve, Belgium; [Devos, Gaetan] CH Le Vinatier, SUAL, Bron, France; [Devos, Gaetan] Sci Res & Publicat Cell CRPS, Namur, Belgium	University of Zaragoza; University of Granada; University of Luxembourg; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Navas, JF (corresponding author), Univ Granada, Mind Brain & Behav Res Ctr CIMCYC, Granada, Spain.	jfnavas@ugr.es	Billieux, Joel/HCH-3334-2022; Barrada, Juan Ramón/B-8930-2008; Navas, Juan/AAD-3302-2019	Barrada, Juan Ramón/0000-0001-6887-6277; Perales, Jose C./0000-0001-5163-8811; Navas, Juan. F./0000-0002-9521-6642; Devos, Gaetan/0000-0002-6772-915X; Billieux, Joel/0000-0002-7388-6194	Spanish Government (Ministerio de Economia y Competitividad, Secretaria de Estado de Investigacion, Desarrollo e Innovacion; Convocatoria 2017 de Proyectos I+D de Excelencia, Spain) [PSI2017-85488-P]; Fondo Europeo de Desarrollo Regional, FEDER, European Union	Spanish Government (Ministerio de Economia y Competitividad, Secretaria de Estado de Investigacion, Desarrollo e Innovacion; Convocatoria 2017 de Proyectos I+D de Excelencia, Spain); Fondo Europeo de Desarrollo Regional, FEDER, European Union	This work is supported by a grant from the Spanish Government (Ministerio de Economia y Competitividad, Secretaria de Estado de Investigacion, Desarrollo e Innovacion; Convocatoria 2017 de Proyectos I+D de Excelencia, Spain; co-funded by the Fondo Europeo de Desarrollo Regional, FEDER, European Union), with reference number PSI2017-85488-P. The funding agency is public and played no role in planning or executing this work, nor interfered with the collection and interpretation of data.	Abarbanel BL, 2014, INT GAMBL STUD, V14, P472, DOI 10.1080/14459795.2014.966131; Aluja A, 2011, J PERS ASSESS, V93, P628, DOI 10.1080/00223891.2011.608760; Asparouhov T, 2009, STRUCT EQU MODELING, V16, P397, DOI 10.1080/10705510903008204; Atkinson J, 2012, J GAMBL STUD, V28, P437, DOI 10.1007/s10899-011-9273-x; Back KJ, 2011, J GAMBL STUD, V27, P355, DOI 10.1007/s10899-010-9212-2; Balodis SRS, 2014, PERS INDIV DIFFER, V56, P29, DOI 10.1016/j.paid.2013.08.015; Barrault S, 2019, INT GAMBL STUD, V19, P54, DOI 10.1080/14459795.2018.1501403; Billieux J, 2015, TXB ADDICTION TREATM; Billieux J, 2015, COMPUT HUM BEHAV, V43, P242, DOI 10.1016/j.chb.2014.10.055; Billieux J, 2013, COMPUT HUM BEHAV, V29, P103, DOI 10.1016/j.chb.2012.07.021; Binde P, 2013, INT GAMBL STUD, V13, P81, DOI 10.1080/14459795.2012.712150; Blaszczynski A, 2002, ADDICTION, V97, P487, DOI 10.1046/j.1360-0443.2002.00015.x; Braunstein LM, 2017, SOC COGN AFFECT NEUR, V12, P1545, DOI 10.1093/scan/nsx096; Canale N, 2015, PSYCHOL ADDICT BEHAV, V29, P813, DOI 10.1037/adb0000060; Canale N, 2015, ADDICT BEHAV, V45, P276, DOI 10.1016/j.addbeh.2015.01.035; Cocco N, 1995, J Gambl Stud, V11, P221, DOI 10.1007/BF02107116; Cole DA, 2014, PSYCHOL METHODS, V19, P300, DOI 10.1037/a0033805; Corr PJ, 2016, PERS INDIV DIFFER, V89, P60, DOI 10.1016/j.paid.2015.09.045; Cyders MA, 2008, PSYCHOL BULL, V134, P807, DOI 10.1037/a0013341; Dechant K, 2014, J GAMBL STUD, V30, P949, DOI 10.1007/s10899-013-9386-5; Del Prete F, 2017, J BEHAV ADDICT, V6, P51, DOI 10.1556/2006.6.2017.001; Devos G, 2017, INT GAMBL STUD, V17, P87, DOI 10.1080/14459795.2016.1264080; Dixon MR., 2007, ANAL GAMBLING BEHAV, V1, P44; Echeburua E., 1994, ANALISIS MODIFICACIO, V20, P769; Fang X, 2009, J CONSUM MARK, V26, P121; Finney SJ, 2006, QUANT METH EDUC BEHA, P269; Flack M, 2015, J GAMBL STUD, V31, P1561, DOI 10.1007/s10899-014-9484-z; Flayelle M, 2019, COMPUT HUM BEHAV, V90, P26, DOI 10.1016/j.chb.2018.08.022; Francis KL, 2015, J GAMBL STUD, V31, P807, DOI 10.1007/s10899-014-9458-1; Gaher RM, 2015, ADDICT BEHAV, V42, P180, DOI 10.1016/j.addbeh.2014.11.014; Garrido LE, 2020, ASSESSMENT, V27, P1349, DOI 10.1177/1073191118780461; Gibson B, 2004, PERS SOC PSYCHOL B, V30, P149, DOI 10.1177/0146167203259929; Goldstein AL, 2014, PSYCHOL ADDICT BEHAV, V28, P217, DOI 10.1037/a0033001; Grant JE, 2012, J NERV MENT DIS, V200, P996, DOI 10.1097/NMD.0b013e3182718a4d; GRAY JA, 1994, EMOTIONS: ESSAYS ON EMOTION THEORY, P29; Gray JA, 2000, NEUROPSYCHOLOGY ANXI; Hallquist MN, 2018, STRUCT EQU MODELING, V25, P621, DOI 10.1080/10705511.2017.1402334; Handley IM, 2004, J EXP SOC PSYCHOL, V40, P106, DOI 10.1016/S0022-1031(03)00086-6; Harris N, 2015, J GAMBL STUD, V31, P385, DOI 10.1007/s10899-013-9431-4; Hills AM, 2001, ADDICTION, V96, P1629, DOI 10.1046/j.1360-0443.2001.961116299.x; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jacobs D F, 2000, J Gambl Stud, V16, P119, DOI 10.1023/A:1009476829902; Jacobs DF, 2004, GAMBLING PROBLEMS IN YOUTH: THEORETICAL AND APPLIED PERSPECTIVES, P1; Jauregui P, 2018, ADDICT BEHAV, V85, P77, DOI 10.1016/j.addbeh.2018.05.023; Kim HS, 2019, ADDICT RES THEORY, V27, P95, DOI 10.1080/16066359.2018.1455188; Kim Y, 2013, J BUS RES, V66, P1644, DOI 10.1016/j.jbusres.2012.12.010; Lee HP, 2007, PSYCHIAT RES, V150, P21, DOI 10.1016/j.psychres.2006.04.005; Leeman RF, 2014, J ADOLESCENT HEALTH, V54, P460, DOI 10.1016/j.jadohealth.2013.09.014; LESIEUR HR, 1987, AM J PSYCHIAT, V144, P1184; Lister JJ, 2015, CAN J PSYCHIAT, V60, P369, DOI 10.1177/070674371506000806; Little TD, 2013, PSYCHOL METHODS, V18, P285, DOI 10.1037/a0033266; Lloyd J, 2010, BIOL PSYCHIAT, V68, P733, DOI 10.1016/j.biopsych.2010.03.038; Loxton NJ, 2008, PERS INDIV DIFFER, V45, P167, DOI 10.1016/j.paid.2008.03.017; MacLaren V, 2015, PERS INDIV DIFFER, V73, P24, DOI 10.1016/j.paid.2014.09.019; MacLaren VV, 2012, J GAMBL ISSUES, DOI 10.4309/jgi.2012.27.8; Mathieu S, 2018, J GAMBL STUD, V34, P133, DOI 10.1007/s10899-017-9700-8; McMullan JL, 2012, INT J MENT HEALTH AD, V10, P622, DOI 10.1007/s11469-011-9336-3; Milosevic A, 2010, CLIN PSYCHOL REV, V30, P988, DOI 10.1016/j.cpr.2010.06.013; Moragas L, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0459-0; Muthen L.K., 2017, MPLUS USERS GUIDE, V8th ed.; Myrseth H, 2017, ADDICT BEHAV, V65, P68, DOI 10.1016/j.addbeh.2016.10.002; Navas JF., 2019, HARM REDUCTION PROBL; Navas JF, 2017, ADDICTION, V112, P1086, DOI 10.1111/add.13751; Navas JF, 2017, INT GAMBL STUD, V17, P102, DOI 10.1080/14459795.2016.1275739; Navas JF, 2016, J BEHAV ADDICT, V5, P271, DOI 10.1556/2006.5.2016.040; Navas JF, 2015, J GAMBL STUD, V31, P1545, DOI 10.1007/s10899-014-9482-1; Neighbors Clayton, 2002, J Gambl Stud, V18, P361, DOI 10.1023/A:1021065116500; O'Connor RM, 2009, PERS INDIV DIFFER, V46, P514, DOI 10.1016/j.paid.2008.12.002; Pearl J, 2000, CASUSALITY MODELS RE; R Development Core Team, 2009, R LANG ENV STAT COMP; Raylu N, 2004, ADDICTION, V99, P757, DOI 10.1111/j.1360-0443.2004.00753.x; Reuter J, 2005, NAT NEUROSCI, V8, P147, DOI 10.1038/nn1378; Rodriguez LM, 2015, J GAMBL STUD, V31, P1597, DOI 10.1007/s10899-014-9497-7; Rogier G, 2018, J BEHAV ADDICT, V7, P239, DOI 10.1556/2006.7.2018.52; Savalei V, 2013, BRIT J MATH STAT PSY, V66, P201, DOI 10.1111/j.2044-8317.2012.02049.x; Schellenberg BJI, 2016, INT GAMBL STUD, V16, P1, DOI 10.1080/14459795.2015.1088559; Schlagintweit HE, 2017, J GAMBL STUD, V33, P1067, DOI 10.1007/s10899-017-9674-6; Sescousse G, 2013, BRAIN, V136, P2527, DOI 10.1093/brain/awt126; Shinaprayoon T, 2018, J GAMBL ISSUES, P108, DOI 10.4309/jgi.2018.37.5; Ste-Marie C., 2002, INT GAMBL STUD, V2, P123, DOI [10.1080/14459790208732303, DOI 10.1080/14459790208732303]; Ste-Marie C, 2006, J CHILD ADOLES SUBST, V15, P55, DOI 10.1300/J029v15n04_03; Stewart SH, 2008, ADDICTION, V103, P1110, DOI 10.1111/j.1360-0443.2008.02235.x; Stewart SH, 2008, PSYCHOL ADDICT BEHAV, V22, P257, DOI 10.1037/0893-164X.22.2.257; Stinchfield R, 2004, GAMBLING PROBLEMS IN YOUTH: THEORETICAL AND APPLIED PERSPECTIVES, P27; Stinchfield R, 2016, J GAMBL STUD, V32, P905, DOI 10.1007/s10899-015-9573-7; Sundqvist K, 2016, J GAMBL STUD, V32, P1231, DOI 10.1007/s10899-016-9607-9; Sztainert T, 2014, J GAMBL STUD, V30, P901, DOI 10.1007/s10899-013-9394-5; Torrubia R, 2001, PERS INDIV DIFFER, V31, P837, DOI 10.1016/S0191-8869(00)00183-5; van Holst RJ, 2010, NEUROSCI BIOBEHAV R, V34, P87, DOI 10.1016/j.neubiorev.2009.07.007; Wardell JD, 2015, PSYCHOL ADDICT BEHAV, V29, P1022, DOI 10.1037/adb0000066; Wardle H, 2011, INT GAMBL STUD, V11, P339, DOI 10.1080/14459795.2011.628684; Webb TL, 2012, PSYCHOL BULL, V138, P775, DOI 10.1037/a0027600; Williams AD, 2012, BRIT J CLIN PSYCHOL, V51, P223, DOI 10.1111/j.2044-8260.2011.02022.x; Wohl MJA, 2011, INT GAMBL STUD, V11, P7, DOI 10.1080/14459795.2010.541270; Zakiniaeiz Y, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01510	95	20	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212695	10.1371/journal.pone.0212695	http://dx.doi.org/10.1371/journal.pone.0212695			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794642	Green Published, Green Submitted, gold			2022-12-27	WOS:000459709100119
J	Josa-Prado, F; Luo, J; Rubin, P; Henley, JM; Wilkinson, KA				Josa-Prado, Fernando; Luo, Jia; Rubin, Philip; Henley, Jeremy M.; Wilkinson, Kevin A.			Developmental profiles of SUMOylation pathway proteins in rat cerebrum and cerebellum	PLOS ONE			English	Article							SUMO; CONJUGATION; EXPRESSION; BRAIN; MODIFIER; HYPOTHERMIA; MECHANISMS; COMPONENTS; TARGET	Protein SUMOylation regulates multiple processes involved in the differentiation and maturation of cells and tissues during development. Despite this, relatively little is known about the spatial and temporal regulation of proteins that mediate SUMOylation and deSUMOylation in the CNS. Here we monitor the expression of key SUMO pathway proteins and levels of substrate protein SUMOylation in the forebrain and cerebellum of Wistar rats during development. Overall, the SUMOylation machinery is more highly-expressed at E18 and decreases thereafter, as previously described. All of the proteins investigated are less abundant in adult than in embryonic brain. Furthermore, we show for first time that the profiles differ between cerebellum and cerebrum, indicating differential regional regulation of some of the proteins analysed. These data provide further basic observation that may open a new perspective of research about the role of SUMOylation in the development of different brain regions.	[Josa-Prado, Fernando] Univ Alfonso X Sabio, Madrid, Spain; [Josa-Prado, Fernando; Luo, Jia; Rubin, Philip; Henley, Jeremy M.; Wilkinson, Kevin A.] Univ Bristol, Sch Biochem, Med Sci Bldg, Bristol, Avon, England	Universidad Alfonso X el Sabio (UAX); University of Bristol	Josa-Prado, F (corresponding author), Univ Alfonso X Sabio, Madrid, Spain.; Josa-Prado, F; Wilkinson, KA (corresponding author), Univ Bristol, Sch Biochem, Med Sci Bldg, Bristol, Avon, England.	f.josaprado@gmail.com; kevin.wilkinson@bristol.ac.uk	Wilkinson, Kevin/AAM-2888-2020; Prado, Fernando Josa/G-1334-2016; Prado, Fernando Josa/M-3087-2019	Wilkinson, Kevin/0000-0002-8115-8592; Prado, Fernando Josa/0000-0002-6162-3231; Prado, Fernando Josa/0000-0002-6162-3231; Henley, Jeremy/0000-0003-3589-8335	Project "SyMBaD" Synapses: from molecules to higher brain function and diseases / Marie Curie Action: "Networks for Initial Training" / European Commission [238608/FP7-PEOPLE-ITN-2008]; MSCA ITN "SyMBaD"; European Commission (MSCAs); European Commission (European Research Council); SUMOBRAIN - Mechanisms and consequences of synaptic SUMOylation in health and disease' / European Research Council [232881]; BBSRC [BB/R00787X/1] Funding Source: UKRI	Project "SyMBaD" Synapses: from molecules to higher brain function and diseases / Marie Curie Action: "Networks for Initial Training" / European Commission; MSCA ITN "SyMBaD"; European Commission (MSCAs); European Commission (European Research Council)(European CommissionEuropean Commission Joint Research CentreEuropean Research Council (ERC)); SUMOBRAIN - Mechanisms and consequences of synaptic SUMOylation in health and disease' / European Research Council; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by: to JMH: Project "SyMBaD" Synapses: from molecules to higher brain function and diseases / Project ID 238608/FP7-PEOPLE-ITN-2008 - Marie Curie Action: "Networks for Initial Training" / European Commission/https://cordis.europa.eu/project/rcn/92985_en.html/ Joint award between 14 academic and commercial partners co-ordinated by University of Bordeaux; SUMOBRAIN - Mechanisms and consequences of synaptic SUMOylation in health and disease' / Proposal no 232881 / European Research Council/https://cordis.europa.eu/project/rcn/90355_es.html/ (Sole applicant). FJP and KAW received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Fernando Josa Prado was an ESR fellow funded by the MSCA ITN "SyMBaD". We are grateful to the European Commission (MSCAs and European Research Council) for funding this work.	Anderson DB, 2009, DRUG NEWS PERSPECT, V22, P255, DOI 10.1358/dnp.2009.22.5.1378636; Buckby LE, 2004, DEV BRAIN RES, V150, P1, DOI 10.1016/j.devbrainres.2004.01.006; Chamberlain SEL, 2012, NAT NEUROSCI, V15, P845, DOI 10.1038/nn.3089; Chen L, 2000, MOL BRAIN RES, V78, P196, DOI 10.1016/S0169-328X(00)00076-0; Cimarosti H, 2008, NEUROPHARMACOLOGY, V54, P280, DOI 10.1016/j.neuropharm.2007.09.010; Cimarosti H, 2012, J CEREBR BLOOD F MET, V32, P17, DOI 10.1038/jcbfm.2011.146; Craig TJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17669; Craig TJ, 2012, J BIOL CHEM, V287, P22781, DOI 10.1074/jbc.M112.356337; Cubenas-Potts C, 2013, DEV CELL, V24, P1, DOI 10.1016/j.devcel.2012.11.020; Curras MC, 1998, DEV BRAIN RES, V109, P1, DOI 10.1016/S0165-3806(98)00060-1; Datwyler AL, 2011, J CEREBR BLOOD F MET, V31, P2152, DOI 10.1038/jcbfm.2011.112; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Gong LM, 1999, FEBS LETT, V448, P185, DOI 10.1016/S0014-5793(99)00367-1; GRAY EG, 1962, J ANAT, V96, P79; Guo C, 2013, EMBO J; Guo C, 2017, SCI REP-UK, V7, DOI 10.1038/srep43811; Guo C, 2013, EMBO J, V32, P1514, DOI 10.1038/emboj.2013.65; Hannoun Z, 2010, TOXICOLOGY, V278, P288, DOI 10.1016/j.tox.2010.07.013; Hasegawa Y, 2014, J COMP NEUROL, V522, P3020, DOI 10.1002/cne.23563; Hashiyama K, 2009, GENE EXPR PATTERNS, V9, P50, DOI 10.1016/j.gep.2008.08.001; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hendriks IA, 2016, NAT REV MOL CELL BIO, V17, P581, DOI 10.1038/nrm.2016.81; Henley JM, 2018, TRENDS NEUROSCI, V41, P198, DOI 10.1016/j.tins.2018.02.004; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; Ho CW, 2011, J BIOL CHEM, V286, P21826, DOI 10.1074/jbc.M111.234914; Jaafari N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052345; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Jourdi H, 2003, DEV BIOL, V263, P216, DOI 10.1016/j.ydbio.2003.07.008; Klug H, 2013, MOL CELL, V50, P625, DOI 10.1016/j.molcel.2013.03.027; Knipscheer P, 2008, MOL CELL, V31, P371, DOI 10.1016/j.molcel.2008.05.022; La Salle S, 2008, DEV BIOL, V321, P227, DOI 10.1016/j.ydbio.2008.06.020; Lee Y, 2007, J CEREBR BLOOD F MET, V27, P950, DOI 10.1038/sj.jcbfm.9600395; Lee YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025852; Ling W, 2012, ACTA HISTOCHEM, V114, P285, DOI 10.1016/j.acthis.2011.06.005; Loriol C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033757; Lu H, 2009, BIOCHEM BIOPH RES CO, V390, P872, DOI 10.1016/j.bbrc.2009.10.065; Martin LJ, 1998, NEUROSCIENCE, V83, P917, DOI 10.1016/S0306-4522(97)00411-9; Martin S, 2007, NATURE, V447, P321, DOI 10.1038/nature05736; McManus FP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25150-z; Miyazaki H, 2005, FEBS LETT, V579, P6834, DOI 10.1016/j.febslet.2005.11.022; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Praefcke GJK, 2012, TRENDS BIOCHEM SCI, V37, P23, DOI 10.1016/j.tibs.2011.09.002; Rocca DL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00707-6; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Sarge KD, 2009, TRENDS BIOCHEM SCI, V34, P200, DOI 10.1016/j.tibs.2009.01.004; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Tang LTH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8728; Wilkinson KA, 2010, BRAIN RES REV, V64, P195, DOI 10.1016/j.brainresrev.2010.04.002; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Yang W, 2008, J NEUROCHEM, V106, P989, DOI 10.1111/j.1471-4159.2008.05404.x; Yang W, 2008, J CEREBR BLOOD F MET, V28, P269, DOI 10.1038/sj.jcbfm.9600523; Yang W, 2009, J CEREBR BLOOD F MET, V29, P886, DOI 10.1038/jcbfm.2009.16; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Zhu B, 2018, BIOCHEM BIOPH RES CO, V500, P645, DOI 10.1016/j.bbrc.2018.04.125	54	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212857	10.1371/journal.pone.0212857	http://dx.doi.org/10.1371/journal.pone.0212857			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794696	Green Published, Green Submitted, gold			2022-12-27	WOS:000459709100150
J	Reuschel, E; Jilg, W; Seelbach-Goebel, B; Deml, L				Reuschel, Edith; Jilg, Wolfgang; Seelbach-Goebel, Birgit; Deml, Ludwig			Comparative purification and characterization of hepatitis B virus-like particles produced by recombinant vaccinia viruses in human hepatoma cells and human primary hepatocytes	PLOS ONE			English	Article							LONG-TERM CULTURE; SURFACE-ANTIGEN; METHYLOTROPHIC YEAST; HBSAG PARTICLES; INSECT CELLS; EXPRESSION; IMMUNOGENICITY; GLYCOPROTEIN; PROTEINS; EFFICACY	This study describes the comparative expression and purification of hepatitis B surface antigen (HBsAg) particles produced upon infection of human primary hepatocytes and human hepatoma cell lines (HuH-7 and HepG2) with recombinant vaccinia viruses. The highest levels of HBsAg expression were found in HuH-7 hepatoma cells following infection with recombinant vaccinia viruses, which contain the S gene under control of a 7.5 k-promoter. Four different methods for purification of the HBsAg particles were examined: isopycnic ultracentrifugation, sucrose cushion sedimentation, isocratic column gel filtration, and binding to anti-HBs-coated microparticles. The highest degree of purity of HBsAg particles was reached by the method based on anti-HBs-coated microparticles. The resulting product was > 98% pure. Biochemical analysis and characterization of purified HBsAg particles were performed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), western blotting, and electron microscopy. The HBsAg, purified from human hepatoma cell lines and from human primary hepatocytes, consisted of both the non-glycosylated (p25) and the glycosylated (gp27) form and assembled into typical 22-nm particles, and thus may be of great interest and importance for research, diagnostics, and medical treatments.	[Reuschel, Edith; Seelbach-Goebel, Birgit] Univ Regensburg, Hosp Barmherzige Brueder, Clin St Hedwig, Dept Obstet & Gynecol, Regensburg, Germany; [Reuschel, Edith; Jilg, Wolfgang; Deml, Ludwig] Univ Med Ctr, Inst Med Microbiol, Regensburg, Germany; [Deml, Ludwig] Lophius Biosci GmbH, Regensburg, Germany	University of Regensburg; University of Regensburg	Reuschel, E (corresponding author), Univ Regensburg, Hosp Barmherzige Brueder, Clin St Hedwig, Dept Obstet & Gynecol, Regensburg, Germany.; Reuschel, E (corresponding author), Univ Med Ctr, Inst Med Microbiol, Regensburg, Germany.	edith.reuschel@barmherzige-regensburg.de			University of Regensburg	University of Regensburg	This work was supported by institutional research funds of the University of Regensburg to WJ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGGERBECK LP, 1985, VIROLOGY, V141, P155, DOI 10.1016/0042-6822(85)90192-8; Bardiya N, 2006, ANAEROBE, V12, P194, DOI 10.1016/j.anaerobe.2006.05.002; Bauer T, 2007, LIVER TRANSPLANT, V13, P434, DOI 10.1002/lt.21061; Baz EMK, 2001, TRANSFUSION MED, V11, P355, DOI 10.1046/j.1365-3148.2001.00323.x; BOOTH JR, 1974, VOX SANG, V27, P227, DOI 10.1111/j.1423-0410.1974.tb02412.x; BOURBONNAIS R, 1975, VOX SANG, V29, P269, DOI 10.1111/j.1423-0410.1975.tb00507.x; BURRELL CJ, 1979, NATURE, V279, P43, DOI 10.1038/279043a0; Cao JH, 2019, VIRUS RES, V259, P90, DOI 10.1016/j.virusres.2018.10.015; CRUCEANU A, 1973, MED MICROBIOL IMMUN, V159, P83, DOI 10.1007/BF02122652; DANE DS, 1970, LANCET, V1, P695; DAVIS HL, 1995, HUM GENE THER, V6, P1447, DOI 10.1089/hum.1995.6.11-1447; Diminsky D, 1997, VACCINE, V15, P637, DOI 10.1016/S0264-410X(96)00239-3; DREESMAN GR, 1972, INFECT IMMUN, V5, P213, DOI 10.1128/IAI.5.2.213-221.1972; FRANCIS DP, 1982, ANN INTERN MED, V97, P362, DOI 10.7326/0003-4819-97-3-362; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Gallagher JR, 2017, VIROLOGY, V502, P176, DOI 10.1016/j.virol.2016.12.025; GANEM D, 1987, ANNU REV BIOCHEM, V56, P651, DOI 10.1146/annurev.biochem.56.1.651; GRIGORIEVA IM, 1993, IMMUNOL LETT, V36, P267, DOI 10.1016/0165-2478(93)90099-N; Hadiji-Abbes N, 2015, ARCH VIROL, V160, P2427, DOI 10.1007/s00705-015-2515-y; Hadiji-Abbes N, 2013, J VIROL METHODS, V187, P132, DOI 10.1016/j.jviromet.2012.09.023; HILLEMAN MR, 1983, DEV BIOLOGICALS, V54, P3; HSIUNG N, 1984, Journal of Molecular and Applied Genetics, V2, P497; Huang YD, 2007, PROTEIN EXPRES PURIF, V56, P301, DOI 10.1016/j.pep.2007.08.009; JANOWICZ ZA, 1991, YEAST, V7, P431, DOI 10.1002/yea.320070502; KANG CY, 1987, J GEN VIROL, V68, P2607, DOI 10.1099/0022-1317-68-10-2607; Kuhober A, 1996, J IMMUNOL, V156, P3687; KUTINOVA L, 1990, ARCH VIROL, V112, P181, DOI 10.1007/BF01323163; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANFORD RE, 1989, J VIROL, V63, P1549, DOI 10.1128/JVI.63.4.1549-1557.1989; Li JH, 2006, PROCESS BIOCHEM, V41, P317, DOI 10.1016/j.procbio.2005.08.017; LIU GQ, 1990, SCI CHINA SER B, V33, P188; Liu RS, 2009, APPL BIOCHEM BIOTECH, V158, P432, DOI 10.1007/s12010-009-8527-x; LODISH HF, 1983, NATURE, V304, P80, DOI 10.1038/304080a0; LUZZIO AJ, 1975, J INFECT DIS, V131, P359, DOI 10.1093/infdis/131.4.359; Ma Q, 2012, J MED VIROL, V84, P198, DOI 10.1002/jmv.23183; MACKETT M, 1982, P NATL ACAD SCI-BIOL, V79, P7415, DOI 10.1073/pnas.79.23.7415; MACKETT M, 1984, J VIROL, V49, P857, DOI 10.1128/JVI.49.3.857-864.1984; Manti S, 2017, NUTRITION, V42, P20, DOI 10.1016/j.nut.2017.05.012; MARION PL, 1979, J VIROL, V32, P796, DOI 10.1128/JVI.32.3.796-802.1979; MASON HS, 1992, P NATL ACAD SCI USA, V89, P11745, DOI 10.1073/pnas.89.24.11745; MCAULIFFE VJ, 1980, REV INFECT DIS, V2, P470; MISHIRO S, 1980, J IMMUNOL, V124, P1589; MIYANOHARA A, 1983, P NATL ACAD SCI-BIOL, V80, P1, DOI 10.1073/pnas.80.1.1; Mormile MDR, 2017, MED HYPOTHESES, V104, P45, DOI 10.1016/j.mehy.2017.05.020; MOSS B, 1984, NATURE, V311, P67, DOI 10.1038/311067a0; NAKABAYASHI H, 1984, GANN, V75, P151; OSTERRIEDER N, 1995, VIROLOGY, V208, P500, DOI 10.1006/viro.1995.1181; Ottone S, 2007, PROTEIN EXPRES PURIF, V56, P177, DOI 10.1016/j.pep.2007.07.008; PAOLETTI E, 1984, P NATL ACAD SCI-BIOL, V81, P193, DOI 10.1073/pnas.81.1.193; PERKUS ME, 1986, VIROLOGY, V152, P285, DOI 10.1016/0042-6822(86)90132-7; PETERSON DL, 1981, J BIOL CHEM, V256, P6975; PRICE PM, 1989, P NATL ACAD SCI USA, V86, P1453, DOI 10.1073/pnas.86.5.1453; Probst C, 1998, J VIROL, V72, P8013, DOI 10.1128/JVI.72.10.8013-8020.1998; Raz R, 1996, VACCINE, V14, P207, DOI 10.1016/0264-410X(95)00185-4; RYAN CM, 1993, SURGERY, V113, P48; SAMANTA H, 1989, VACCINE, V7, P69, DOI 10.1016/0264-410X(89)90013-3; SANCHEZ Y, 1980, J GEN VIROL, V48, P273, DOI 10.1099/0022-1317-48-2-273; Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009; SHOUVAL D, 1994, VACCINE, V12, P1453, DOI 10.1016/0264-410X(94)90155-4; SMITH GL, 1983, NATURE, V302, P490, DOI 10.1038/302490a0; Stasi C, 2017, J CLIN TRANSL HEPATO, V5, P272, DOI 10.14218/JCTH.2017.00010; SZMUNESS W, 1982, NEW ENGL J MED, V307, P1481, DOI 10.1056/NEJM198212093072403; SZMUNESS W, 1981, HEPATOLOGY, V1, P377, DOI 10.1002/hep.1840010502; Thasler Wolfgang E., 2003, Cell and Tissue Banking, V4, P49, DOI 10.1023/A:1026392429112; THEILMANN L, 1991, BIOCHEM BIOPH RES CO, V179, P1479, DOI 10.1016/0006-291X(91)91739-Y; VALENZUELA P, 1982, NATURE, V298, P347, DOI 10.1038/298347a0; Weiss TS, 2003, J HEPATOL, V38, P476, DOI 10.1016/S0168-8278(02)00454-3; WERNER BG, 1985, ANN INTERN MED, V103, P201, DOI 10.7326/0003-4819-103-2-201; WHO, 2017, GLOB HEP REP; Zhang MS, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-292	70	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212800	10.1371/journal.pone.0212800	http://dx.doi.org/10.1371/journal.pone.0212800			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794666	Green Published, gold, Green Submitted			2022-12-27	WOS:000459709100141
J	Walker, RE; Walker, CG; Camargo, CA; Bartley, J; Flint, D; Thompson, JMD; Mitchell, EA				Walker, Rebecca E.; Walker, Caroline G.; Camargo, Carlos A., Jr.; Bartley, Jim; Flint, David; Thompson, John M. D.; Mitchell, Edwin A.			Nasal microbial composition and chronic otitis media with effusion: A case-control study	PLOS ONE			English	Article							UPPER RESPIRATORY-TRACT; BACTERIAL INTERFERENCE; INFECTION; COLONIZATION; CHILDREN; PATHOGENS; HEALTH; CAVITY; RISK	Objectives Chronic otitis media with effusion (COME) in children can cause prolonged hearing loss, which is associated with an increased risk of learning delays and behavioural problems. Dispersal of bacterial pathogens from the nasal passages to the middle ear is implicated in COME. We sought to determine whether there is an association between nasal microbial composition and COME in children. Methods A case-control study of children aged 3 and 4 years was conducted. Cases undergoing placement of tympanostomy tubes for COME were compared to healthy controls. Nasal swabs were collected and a questionnaire was administered. The V1-3 region of the 16S rRNA gene was amplified, and sequenced on the Illumina MiSeq. Results 73 children with COME had a lower Shannon diversity index than 105 healthy controls (1.62 [.80] versus 1.88 [.84], respectively; P = .046). The nasal microbiota of cases and controls differed in composition using Bray-Curtis dissimilarity (p = 0.002). Children with COME had a higher abundance of otopathogens and lower abundance of commensals including alpha haemolytic Streptococci and Lactococcus. Cluster analysis revealed 4 distinct nasal microbial profiles. Profiles that were Corynebacterium-dominated (aOR 4.18 [95% CI, 1.6810.39], Streptococcus-dominated (aOR 3.12 [95% CI, 1.08-9.06], or Moraxella-dominated (aOR 4.70 [95% CI, 1.73-12.80] were associated with COME, compared to a more mixed microbial profile when controlling for age, ethnicity, and recent antibiotics use. Conclusions Children with COME have a less diverse nasal microbial composition with a higher abundance of pathogens, compared to healthy children who have a more mixed bacterial profile with a higher abundance of commensals. Further research is required to determine how nasal microbiota may relate to the pathogenesis or maintenance of COME, and whether modification of the nasal microbiota can prevent or treat children at risk of COME.	[Walker, Rebecca E.; Thompson, John M. D.; Mitchell, Edwin A.] Univ Auckland, Dept Paediat Child & Youth Hlth, Auckland, New Zealand; [Walker, Caroline G.] Univ Auckland, Dept Populat Hlth, Ctr Longitudinal Res He Ara Ki Mua, Auckland, New Zealand; [Camargo, Carlos A., Jr.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02115 USA; [Bartley, Jim; Flint, David] Manukau SuperClin, Counties Manukau Dist Hlth Board, Div Otolaryngol Head & Neck Surg, Auckland, New Zealand	University of Auckland; University of Auckland; Harvard University; Harvard Medical School; Massachusetts General Hospital	Walker, RE (corresponding author), Univ Auckland, Dept Paediat Child & Youth Hlth, Auckland, New Zealand.	r.walker@auckland.ac.nz	Camargo, Carlos A./C-2145-2008	Camargo, Carlos A./0000-0002-5071-7654; Walker, Rebecca/0000-0002-7825-1438	REW -The Oticon Foundation [3701863]; REW -CRC Starship Foundation [18071300]; REW -Brian Johns Fellowship Trust [4711]; EAM -Deafness Research Foundation [2013/08]	REW -The Oticon Foundation; REW -CRC Starship Foundation; REW -Brian Johns Fellowship Trust; EAM -Deafness Research Foundation	This work was supported by: REW -The Oticon Foundation (Grant no. 3701863) http://www.oticon.org.nz/; REW -CRC Starship Foundation (Grant No. 18071300) https://www.starship.org.nz/; REW -Brian Johns Fellowship Trust (Grant no. 4711); EAM -Deafness Research Foundation (Grant no. 2013/08) https://www.nfd.org.nz/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett KE, 2001, ARCH DIS CHILD, V85, P91, DOI 10.1136/adc.85.2.91; Bluestone CD, 2002, ANN OTO RHINOL LARYN, V111, P8, DOI 10.1177/00034894021110S304; Brook I, 2005, OTOLARYNG HEAD NECK, V133, P139, DOI 10.1016/j.otohns.2005.03.012; Brook I, 1999, PEDIATR INFECT DIS J, V18, P835, DOI 10.1097/00006454-199909000-00021; Camello TCF, 2009, LETT APPL MICROBIOL, V48, P458, DOI 10.1111/j.1472-765X.2009.02553.x; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Chonmaitree T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180630; Coates H, 2008, OTOLARYNG HEAD NECK, V138, P778, DOI 10.1016/j.otohns.2007.02.009; Depner M, 2017, J ALLERGY CLIN IMMUN, V139, P826, DOI 10.1016/j.jaci.2016.05.050; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Hall-Stoodley L, 2006, JAMA-J AM MED ASSOC, V296, P202, DOI 10.1001/jama.296.2.202; Hao Q, 2011, COCHRANE DATABASE SY, V9; Hasegawa K, 2016, EUR RESP J; Hatakka K, 2007, CLIN NUTR, V26, P314, DOI 10.1016/j.clnu.2007.01.003; Hilty M, 2012, J INFECT DIS, V205, P1048, DOI 10.1093/infdis/jis024; Krishnamurthy A, 2009, MICROBES INFECT, V11, P545, DOI 10.1016/j.micinf.2009.03.001; Lappan R, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-018-1154-3; Laufer AS, 2011, MBIO, V2, DOI 10.1128/mBio.00245-10; Lemon KP, 2010, MBIO, V1, DOI 10.1128/mBio.00129-10; Lina G, 2003, APPL ENVIRON MICROB, V69, P18, DOI 10.1128/AEM.69.1.18-23.2003; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maechler M, 2017, CLUSTER CLUSTER ANAL; Man WH, 2017, NAT REV MICROBIOL, V15, P259, DOI 10.1038/nrmicro.2017.14; Marks LR, 2013, MBIO, V4, DOI 10.1128/mBio.00438-13; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Ngo CC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150949; Oksanen J, 2013, PACKAGE VEGAN COMMUN, P2; Pettigrew MM, 2012, APPL ENVIRON MICROB, V78, P6262, DOI 10.1128/AEM.01051-12; Pittet LA, 2010, AM J RESP CELL MOL, V42, P450, DOI 10.1165/rcmb.2007-0417OC; POST JC, 1995, JAMA-J AM MED ASSOC, V273, P1598, DOI 10.1001/jama.273.20.1598; Sajjan U, 2008, AM J RESP CRIT CARE, V178, P1271, DOI 10.1164/rccm.200801-136OC; Short KR, 2011, J INFECT DIS, V204, P1857, DOI 10.1093/infdis/jir618; Siegel SJ, 2014, CELL HOST MICROBE, V16, P55, DOI 10.1016/j.chom.2014.06.005; Stearns JC, 2015, ISME J, V9; Stol K, 2013, INT J PEDIAT OTORHIN; Teo SM, 2015, CELL HOST MICROBE, V17, P704, DOI 10.1016/j.chom.2015.03.008; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Tonnaer EL, 2005, J CLIN MICROBIOL, V43, P3140, DOI 10.1128/JCM.43.7.3140-3144.2005; Vissing NH, 2013, AM J RESP CRIT CARE, V188, P1246, DOI 10.1164/rccm.201302-0215OC; Walker RE, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-016-0767-7; Wren JT, 2014, INFECT IMMUN, V82, P4802, DOI 10.1128/IAI.01856-14; Xu QF, 2017, J INFECTION, V75, P26, DOI 10.1016/j.jinf.2017.04.003; Yang K, 2018, PNEUMONIA, V10, DOI 10.1186/s41479-018-0054-5	43	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212473	10.1371/journal.pone.0212473	http://dx.doi.org/10.1371/journal.pone.0212473			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794625	Green Submitted, gold, Green Published			2022-12-27	WOS:000459709100073
J	Wilke, ABB; Carvajal, A; Medina, J; Anderson, M; Nieves, VJ; Ramirez, M; Vasquez, C; Petrie, W; Cardenas, G; Beier, JC				Wilke, Andre B. B.; Carvajal, Augusto; Medina, Johana; Anderson, Melissa; Nieves, Veronica J.; Ramirez, Monica; Vasquez, Chalmers; Petrie, William; Cardenas, Gabriel; Beier, John C.			Assessment of the effectiveness of BG-Sentinel traps baited with CO2 and BG-Lure for the surveillance of vector mosquitoes in Miami-Dade County, Florida	PLOS ONE			English	Article							ZIKA VIRUS; AEDES-AEGYPTI; DIPTERA-CULICIDAE; TRANSMISSION; DENGUE; EFFICACY	Vector-borne diseases are an increasing issue to public health, endangering billions of people worldwide. Controlling vector mosquitoes is widely accepted as the most effective way to prevent vector-borne disease outbreaks. Mosquito surveillance is critical for the development of control strategies under the integrated vector management framework. We hypothesize that the effectiveness and reliability of using BG-Sentinel traps for the surveillance strongly depend on the bait used to attract mosquitoes. The objective of this study was to compare the effectiveness of BG-Sentinel traps baited with CO2 and BG-Lure. A total of 72 traps were deployed for 48 hours once a week for four weeks. For the initial 24-hour period, the traps were baited with CO2, and then for an additional 24 hours using the BG-Lure. Collected mosquitoes were analyzed using the Generalized Estimating Equation for repeated measures analysis. Biodiversity was assessed by the Shannon and Simpson indices and by individual rarefaction curves and SHE profiles. A total of 5,154 mosquitoes were collected, from which 3,514 by traps baited with CO2 and 1,640 mosquitoes by traps baited with BG-Lure. Aedes aegypti and Culex quinquefasciatus were the most abundant and dominant species. Results from the Generalized Estimating Equation models indicated that more than twice as many mosquitoes were attracted CO2 than to the BG-Lure. The comparison of attractiveness of CO2 and BG-Lure to Ae. aegypti and Cx. quinquefasciatus was non-significant, suggesting that both species were equally attracted by the baits. The individual rarefaction curves for Ae. aegypti and Cx. quinquefasciatus imply that traps baited with BG-Lure underestimated mosquito species richness compared to those baited with CO2. BG-Lure were less effective in attracting mosquitoes with low abundances and failed to collect Cx. coronator and Cx. nigripalpus, which were consistently collected by traps baited with CO2. According to our results, CO2 significantly (P< 0.05) attracted more mosquitoes (2.67 adjusted odds ratios) than the BG-Lure when adjusted for time and species, being more effective in assessing the relative abundance of vector mosquitoes and yielding more trustworthy results. Traps baited with CO2 collected not only more specimens, but also more species in a more consistent pattern.	[Wilke, Andre B. B.; Cardenas, Gabriel; Beier, John C.] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA; [Carvajal, Augusto; Medina, Johana; Anderson, Melissa; Nieves, Veronica J.; Ramirez, Monica; Vasquez, Chalmers; Petrie, William] Miami Dade Cty Mosquito Control Div, Miami, FL USA	University of Miami	Wilke, ABB (corresponding author), Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.	axb1737@med.miami.edu	Wilke, Andre B B/J-9973-2014	Wilke, Andre B B/0000-0002-6629-7666	CDC: Southeastern Regional Center of Excellence in Vector-Borne Diseases: The Gateway Program [1U01CK000510-01]	CDC: Southeastern Regional Center of Excellence in Vector-Borne Diseases: The Gateway Program	This research was supported by CDC (https://www.cdc.gov/) grant 1U01CK000510-01: Southeastern Regional Center of Excellence in Vector-Borne Diseases: The Gateway Program. CDC had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript. JCB is the recipient of the grant.	Alto BW, 2014, VECTOR-BORNE ZOONOT, V14, P606, DOI 10.1089/vbz.2013.1501; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281; Wilke ABB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185150; Buzas MA, 1998, J FORAMIN RES, V28, P233; Cardoso JD, 2011, J VECTOR ECOL, V36, P175, DOI 10.1111/j.1948-7134.2011.00155.x; Cardoso JD, 2010, EMERG INFECT DIS, V16, P1918, DOI 10.3201/eid1612.100608; Chitolina RF, 2016, ACTA TROP, V164, P290, DOI 10.1016/j.actatropica.2016.07.013; Costa-da-Silva AL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005630; Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3; Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296; Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401; de Azara TMF, 2013, MEM I OSWALDO CRUZ, V108, P229, DOI 10.1590/0074-0276108022013016; Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082; Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2; Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35; Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2; Lednicky J, 2016, EMERG INFECT DIS, V22, P2000, DOI 10.3201/eid2211.161015; Lee B. Y., 2017, PLOS NEGLECT TROP D, V11, DOI DOI 10.1371/JOURNAL.PNTD.0005531; Li YJ, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1724-x; Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1; Lorenz C, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005959; Ludwig GV, 2002, AM J TROP MED HYG, V67, P67, DOI 10.4269/ajtmh.2002.67.67; Maciel-de-Freitas R, 2006, MEM I OSWALDO CRUZ, V101, P321, DOI 10.1590/S0074-02762006000300017; Mcnamara TS, 2014, MICROBIOL SPECTR, V1, P1; Morris C. D, 2000, TECH B FLORIDA MOSQ, V1; Morris EK, 2014, ECOL EVOL, V4, P3514, DOI 10.1002/ece3.1155; Multini LC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162328; Paixao ES, 2018, EMERG INFECT DIS, V24, P1748, DOI 10.3201/eid2409.170361; Poletti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018860; Pombi M, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0580-9; Ramasamy R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001369; Roche B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125600; Roiz D, 2016, J MED ENTOMOL, V53, P460, DOI 10.1093/jme/tjv184; Roiz D, 2012, AM J TROP MED HYG, V86, P642, DOI 10.4269/ajtmh.2012.11-0326; Rosenberg Ronald, 2018, MMWR Morb Mortal Wkly Rep, V67, P496, DOI 10.15585/mmwr.mm6717e1; Samy AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163863; Stoddard PK, 2018, ACTA TROP, V187, P108, DOI 10.1016/j.actatropica.2018.07.031; Turell MJ, 2001, J MED ENTOMOL, V38, P130, DOI 10.1603/0022-2585-38.2.130; Vitek CJ, 2008, J MED ENTOMOL, V45, P483, DOI 10.1603/0022-2585(2008)45[483:ATBCNI]2.0.CO;2; Watts J, 2000, WORLD HLTH, V78, P8; WHO, 2013, OUTLOOKS PEST MANAGE, V24, P142; WHO, 2017, EST MAN CAP HUM VACC, P1; Wilke ABB, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2866-9; Wilke ABB, 2018, TRENDS PARASITOL, V34, P456, DOI 10.1016/j.pt.2018.02.003; Zannoli S, 2018, CHIKUNGUNYA ZIKA VIR, P193, DOI DOI 10.1016/B978-0-12-811865-8.00006-4; Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114; Zinser Margaret, 2004, Journal of Insect Science (Tucson), V4, P1	51	23	24	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212688	10.1371/journal.pone.0212688	http://dx.doi.org/10.1371/journal.pone.0212688			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794670	Green Submitted, Green Published, gold			2022-12-27	WOS:000459709100115
J	Kfoury, R; Marzban, B; Makki, E; Greenfield, ML; Yuan, HY				Kfoury, Ralph; Marzban, Bahador; Makki, Emad; Greenfield, Michael L.; Yuan, Hongyan			Effect of pressure profile of shock waves on lipid membrane deformation	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATION; BILAYERS	Use of shock waves to temporarily increase the permeability of the cell membrane is a promising approach in drug delivery and gene therapy to allow the translocation of macromolecules and small polar molecules into the cytoplasm. Our understanding of how the characteristics of the pressure profile of shock waves, such as peak pressure and pulse duration, influences membrane properties is limited. Here we study the response of lipid bilayer membranes to shock pulses with different pressure profiles using atomistic molecular dynamics simulations. From our simulation results, we find that the transient deformation/disordering of the membrane depends on both the magnitude and the pulse duration of the pressure profile of the shock pulse. For a low pressure impulse, peak pressure has a dominant effect on membrane structural changes, while for the high pressure impulse, we find that there exists an optimal pulse duration at which membrane deformation/disordering is maximized.	[Kfoury, Ralph; Marzban, Bahador; Yuan, Hongyan] Univ Rhode Isl, Dept Mech Ind & Syst Engn, Kingston, RI 02881 USA; [Makki, Emad] Umm Al Qura Univ, Coll Engn & Islamic Architecture, Dept Mech Engn, Mecca, Saudi Arabia; [Greenfield, Michael L.] Univ Rhode Isl, Dept Chem Engn, Kingston, RI 02881 USA	University of Rhode Island; Umm Al Qura University; University of Rhode Island	Yuan, HY (corresponding author), Univ Rhode Isl, Dept Mech Ind & Syst Engn, Kingston, RI 02881 USA.	hongyan_yuan@uri.edu	Yuan, Hongyan/C-3816-2011	Yuan, Hongyan/0000-0001-8225-0211; Marzban, Bahador/0000-0002-0724-7749; Makki, Emad/0000-0002-2089-9776; Greenfield, Michael/0000-0002-4704-1489	Haythornthwaite Research Initiation Grant Award of ASME; US Fulbright Program	Haythornthwaite Research Initiation Grant Award of ASME; US Fulbright Program	H.Y. acknowledges funding support from the Haythornthwaite Research Initiation Grant Award of ASME. M.L.G. acknowledges support from the US Fulbright Program.	BALLHAUS WF, 1974, PHYS FLUIDS, V17, P1068, DOI 10.1063/1.1694845; Ganzenmuller GC, 2011, SOFT MATTER, V7, P4307, DOI 10.1039/c0sm01296c; Guixa-Gonzalez R, 2014, BIOINFORMATICS, V30, P1478, DOI 10.1093/bioinformatics/btu037; Han WB, 2014, MAT SCI ENG C-MATER, V36, P49, DOI 10.1016/j.msec.2013.11.033; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hung WC, 2007, BIOPHYS J, V92, P3960, DOI 10.1529/biophysj.106.099234; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kodama T, 2000, BIOPHYS J, V79, P1821, DOI 10.1016/S0006-3495(00)76432-0; Koshiyama K, 2008, BBA-BIOMEMBRANES, V1778, P1423, DOI 10.1016/j.bbamem.2008.03.010; Koshiyama K, 2006, BIOPHYS J, V91, P2198, DOI 10.1529/biophysj.105.077677; Koshiyama K, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.018105; Kucerka N, 2005, J MEMBRANE BIOL, V208, P193, DOI 10.1007/s00232-005-7006-8; Lauer U, 1997, GENE THER, V4, P710, DOI 10.1038/sj.gt.3300462; Lee J, 2016, J CHEM THEORY COMPUT, V12, P405, DOI 10.1021/acs.jctc.5b00935; Rivera AL, 2014, PHYS LIFE REV, V11, P184, DOI 10.1016/j.plrev.2014.01.007; Rivera AL, 2012, PHYS LIFE REV, V9, P308, DOI 10.1016/j.plrev.2012.06.002; Li Y, 2013, P NATL ACAD SCI; Lu XM, 2017, APPL PHYS LETT, V110, DOI 10.1063/1.4973592; Ohl C. D., 2003, PHYS REV LETT, V90, P4; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Santo KP, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4862987; Sun DD, 2016, J PHYS CHEM C, V120, P18803, DOI 10.1021/acs.jpcc.6b04086; Yuan HY, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011905; Zhang L., 2017, SCI REP, V7, P1, DOI DOI 10.1038/S41598-016-0028-X	25	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212566	10.1371/journal.pone.0212566	http://dx.doi.org/10.1371/journal.pone.0212566			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789948	Green Submitted, Green Published, gold			2022-12-27	WOS:000459330800041
J	Kraen, M; Frantz, S; Nihlen, U; Engstrom, G; Lofdahl, CG; Wollmer, P; Dencker, M				Kraen, M.; Frantz, S.; Nihlen, U.; Engstrom, G.; Lofdahl, C. G.; Wollmer, P.; Dencker, M.			Matrix Metalloproteinases in COPD and atherosclerosis with emphasis on the effects of smoking	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; MACROPHAGES; EXPRESSION; PLAQUES; MICE	Background Matrix metalloproteinases (MMP's) are known biomarkers of atherosclerosis. MMP's are also involved in the pathophysiological processes underlying chronic obstructive pulmonary disease (COPD). Cigarette smoking plays an important role in both disease states and is also known to affect the concentration and activity of MMP's systemically. Unfortunately, the epidemiological data concerning the value of MMP's as biomarkers of COPD and atherosclerosis with special regards to smoking habits are limited. Methods 450 middle-aged subjects with records of smoking habits and tobacco consumption were examined with comprehensive spirometry, carotid ultrasound examination and biomarker analysis of MMP-1, -3, -7, -10 and -12. Due to missing data 33 subjects were excluded. Results The remaining 417 participants were divided into 4 different groups. Group I (n = 157, no plaque and no COPD), group II (n = 136, plaque but no COPD), group III (n = 43, COPD but no plaque) and group IV (n = 81, plaque and COPD). Serum levels of MMP-1,-7,-10-12 were significantly influenced by smoking, and MMP-1, -3, -7 and-12 were elevated in subjects with COPD and carotid plaque. This remained statistically significant for MMP-1 and-12 after adjusting for traditional risk factors. Conclusion COPD and concomitant plaque in the carotid artery were associated with elevated levels of MMP-1 and -MMP-12 even when adjusting for risk factors. Further studies are needed to elucidate if these two MMP's could be useful as biomarkers in a clinical setting. Smoking was associated with increased serum levels of MMP's (except for MMP-3) and should be taken into account when interpreting serum MMP results.	[Kraen, M.; Frantz, S.; Wollmer, P.; Dencker, M.] Lund Univ, Dept Translat Med, Clin Physiol & Nucl Med Unit, Malmo, Sweden; [Nihlen, U.; Lofdahl, C. G.] Lund Univ, Dept Clin Sci, Resp Med & Allergol Unit, Lund, Sweden; [Engstrom, G.] Lund Univ, Dept Clin Sci, Cardiovasc Epidemiol Res Grp, Malmo, Sweden	Lund University; Lund University; Lund University	Kraen, M (corresponding author), Lund Univ, Dept Translat Med, Clin Physiol & Nucl Med Unit, Malmo, Sweden.	morten.kraen@skane.se	Wollmer, Per/S-5895-2019; Nihlén, Ulf/AAO-7145-2020	Frantz, Sophia/0000-0003-2147-2077	Lund University; Skane University Hospital; Region Skane	Lund University; Skane University Hospital; Region Skane	Financial support for this study was received from Lund University, Skane University Hospital and Region Skane. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial support for this study was received from Lund University, Skane University Hospital and Region Skane.	Assarsson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095192; Chaudhuri R, 2012, J ALLERGY CLIN IMMUN, V129, P655, DOI 10.1016/j.jaci.2011.12.996; Churg A, 2012, EUR RESPIR J, V39, P197, DOI 10.1183/09031936.00121611; COTES JE, 1993, EUR RESPIR J, V6, P41, DOI 10.1183/09041950.041s1693; Culpitt SV, 2005, RESP MED, V99, P703, DOI 10.1016/j.rmed.2004.10.022; D'Armiento JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056352; Davey A, 2011, EUR RESPIR J, V38, P959, DOI 10.1183/09031936.00032111; Frantz S, 2012, RESP MED, V106, P1116, DOI 10.1016/j.rmed.2012.04.010; Frantz S, 2012, CLIN PHYSIOL FUNCT I, V32, P120, DOI 10.1111/j.1475-097X.2011.01065.x; Gharib SA, 2018, MATRIX BIOL J INT SO; Goncalves I, 2015, ARTERIOSCL THROM VAS, V35, P1723, DOI 10.1161/ATVBAHA.115.305631; Huang B, 2016, ATHEROSCLEROSIS, V254, P52, DOI 10.1016/j.atherosclerosis.2016.09.014; Ilumets H, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-19; Imai K, 2001, AM J RESP CRIT CARE, V163, P786, DOI 10.1164/ajrccm.163.3.2001073; Johnson JL, 2005, P NATL ACAD SCI USA, V102, P15575, DOI 10.1073/pnas.0506201102; Lemaitre V, 2001, J CLIN INVEST, V107, P1227, DOI 10.1172/JCI9626; Loffek S, 2011, EUR RESPIR J, V38, P191, DOI 10.1183/09031936.00146510; Lundberg M, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr424; Luttun A, 2004, CIRCULATION, V109, P1408, DOI 10.1161/01.CIR.0000121728.14930.DE; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Mercer BA, 2009, AM J RESP CELL MOL, V40, P4, DOI 10.1165/rcmb.2007-0310OC; Morgan AR, 2004, STROKE, V35, P1310, DOI 10.1161/01.STR.0000126822.01756.99; Mullerova H, 2013, CHEST, V144, P1163, DOI 10.1378/chest.12-2847; Myasoedova VA, 2018, J MOL CELLULAR CARDI; Navratilova Z, 2016, ARCH IMMUNOL THER EX, V64, P177, DOI 10.1007/s00005-015-0375-5; Navratilova Z, 2012, RESPIROLOGY, V17, P1006, DOI 10.1111/j.1440-1843.2012.02197.x; Peeters SA, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0539-1; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Ruddy JM, 2016, J VASC RES, V53, P1, DOI 10.1159/000446703; Simpson JL, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/462934; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Wallace AM, 2008, COPD, V5, P13, DOI 10.1080/15412550701817789; Wollmer P, 2017, CLIN PHYSIOL FUNCT I, V37, P263, DOI 10.1111/cpf.12294	33	17	18	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0211987	10.1371/journal.pone.0211987	http://dx.doi.org/10.1371/journal.pone.0211987			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789935	Green Published, Green Submitted, gold			2022-12-27	WOS:000459330800015
J	Lev, S; Rupasinghe, T; Desmarini, D; Kaufman-Francis, K; Sorrell, TC; Roessner, U; Djordjevic, JT				Lev, Sophie; Rupasinghe, Thusitha; Desmarini, Desmarini; Kaufman-Francis, Keren; Sorrell, Tania Christine; Roessner, Ute; Djordjevic, Julianne Teresa			The PHO signaling pathway directs lipid remodeling in Cryptococcus neoformans via DGTS synthase to recycle phosphate during phosphate deficiency	PLOS ONE			English	Article							ACIDIC PHOSPHOLIPIDS; BETAINE LIPIDS; BIOSYNTHESIS; REPLACEMENT; GLYCOLIPIDS; PLANTS; PHOSPHATIDYLCHOLINE; ACCUMULATION; DEPRIVATION; ACQUISITION	The phosphate sensing and acquisition (PHO) pathway of Cryptococcus neoformans is essential for growth in phosphate-limiting conditions and for dissemination of infection in a mouse model. Its key transcription factor, Pho4, regulates expression of genes controlling the acquisition of phosphate from both external and cellular sources. One such gene, BTA1, is highly up-regulated during phosphate starvation. Given that a significant proportion of cellular phosphate is incorporated into phospholipids, and that the Pho4-dependent BTA1 gene encodes an enzyme predicted to catalyse production of a phosphorus-free betaine lipid, we investigated whether phospholipids provide an accessible reservoir of phosphate during phosphate deficiency. By comparing lipid profiles of phosphate-starved WT C. neoformans, PHO4 (pho4 Delta) and BTA1 (bta1 Delta) deletion mutants using thin layer chromatography and liquid chromatography mass spectrometry, we showed that phosphatidylcholine (PC) is substituted by the phosphorus-free betaine lipids diacylglyceryl-N,N,N-trimethylhomoserine (DGTS) and diacylgyceryl hydroxymethyl-N,N,N-trimethyl-beta-alanine (DGTA) in a Pho4- and Bta1-dependent manner, and that BTA1 encodes a functional DGTS synthase. Synthesis of DGTA tightly correlated with that of DGTS, consistent with DGTS being the precursor of DGTA. Similar to pho4 Delta bta1 Delta grew more slowly than WT in cell culture medium (RPMI) and was hypovirulent in a murine model of cryptococcosis. In contrast to pho4 Delta bta1 Delta tolerated alkaline pH and disseminated to the brain. Our results demonstrate that Bta1-dependent substitution of PC by betaine lipids is tightly regulated in C. neoformans by the PHO pathway, to conserve phosphate and preserve membrane integrity and function. This phospholipid remodeling strategy may also contribute to cryptococcal virulence during host infection.	[Lev, Sophie; Desmarini, Desmarini; Kaufman-Francis, Keren; Sorrell, Tania Christine; Djordjevic, Julianne Teresa] Westmead Inst Med Res, Fungal Pathogenesis Grp, Ctr Infect Dis & Microbiol, Westmead, NSW, Australia; [Lev, Sophie; Kaufman-Francis, Keren; Sorrell, Tania Christine; Djordjevic, Julianne Teresa] Univ Sydney, Westmead Hosp, Sydney Med Sch Westmead, Westmead, NSW, Australia; [Lev, Sophie; Kaufman-Francis, Keren; Sorrell, Tania Christine; Djordjevic, Julianne Teresa] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW, Australia; [Rupasinghe, Thusitha; Roessner, Ute] Univ Melbourne, Sch Biosci, Metabol Australia, Melbourne, Vic, Australia	University of Sydney; Westmead Institute for Medical Research; University of Sydney; University of Sydney; University of Melbourne	Djordjevic, JT (corresponding author), Westmead Inst Med Res, Fungal Pathogenesis Grp, Ctr Infect Dis & Microbiol, Westmead, NSW, Australia.; Djordjevic, JT (corresponding author), Univ Sydney, Westmead Hosp, Sydney Med Sch Westmead, Westmead, NSW, Australia.; Djordjevic, JT (corresponding author), Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW, Australia.	julianne.djordjevic@sydney.edu.au	Sorrell, Tania/AAZ-5286-2020	Djordjevic, Julianne/0000-0003-4207-4115; Desmarini, Desmarini/0000-0001-9322-3198	National Health and Medical Research Council of Australia [APP1058779]; National Collaborative Research Infrastructure Strategy; Westmead Institute for Medical research	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Collaborative Research Infrastructure Strategy(Australian GovernmentDepartment of Industry, Innovation and Science); Westmead Institute for Medical research(University of Sydney)	This work was supported by a National Health and Medical Research Council of Australia project grant APP1058779 (JTD, SL, TCS) and a grant from the National Collaborative Research Infrastructure Strategy (JTD). SL is supported by a Career Development Grant from the Westmead Institute for Medical research. TCS is a Payne-Scott Distinguished Professor of the University of Sydney and a Sydney Medical Foundation Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abida H, 2015, PLANT PHYSIOL, V167, P118, DOI 10.1104/pp.114.252395; Arras SDM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122916; Banskota AH, 2013, J APPL PHYCOL, V25, P1513, DOI 10.1007/s10811-012-9967-1; Botte CY, 2013, P NATL ACAD SCI USA, V110, P7506, DOI 10.1073/pnas.1301251110; Dembitsky VM, 1996, PROG LIPID RES, V35, P1, DOI 10.1016/0163-7827(95)00009-7; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; Gaude N, 2008, PLANT J, V56, P28, DOI 10.1111/j.1365-313X.2008.03582.x; Geske T, 2013, GLYCOBIOLOGY, V23, P69, DOI 10.1093/glycob/cws124; Hartel H, 2000, BIOCHEM SOC T, V28, P729, DOI 10.1042/BST0280729; Ikeh MAC, 2016, MOL BIOL CELL, V27, P2784, DOI 10.1091/mbc.E16-05-0266; Kalisch B, 2016, SUBCELL BIOCHEM, V86, P51, DOI 10.1007/978-3-319-25979-6_3; Kennedy EP, 1986, BIOSYNTHESIS PHOSPHO, P171; Klug RM, 2001, P NATL ACAD SCI USA, V98, P5910, DOI 10.1073/pnas.101037998; Kretschmer M, 2014, INFECT IMMUN, V82, P2697, DOI 10.1128/IAI.01607-14; Kunzler K, 1997, PHYTOCHEMISTRY, V46, P883, DOI 10.1016/S0031-9422(97)81274-5; Lev S, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007021; Lev S, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00381-16, 10.1128/msphere.00381-16]; Lev S, 2014, MBIO, V5, DOI 10.1128/mBio.01649-14; Marini NJ, 1996, EMBO J, V15, P3040, DOI 10.1002/j.1460-2075.1996.tb00667.x; MINNIKIN DE, 1974, NATURE, V249, P268, DOI 10.1038/249268a0; MINNIKIN DE, 1974, FEBS LETT, V43, P257, DOI 10.1016/0014-5793(74)80655-1; Rajasingham R, 2017, LANCET INFECT DIS, V17, P873, DOI [10.1016/S1473-3099(17)30243-8, 10.1016/s1473-3099(17)30243-8]; Riekhof WR, 2014, EUKARYOT CELL, V13, P749, DOI 10.1128/EC.00004-14; Riekhof WR, 2005, EUKARYOT CELL, V4, P242, DOI 10.1128/EC.4.2.242-252.2005; Senik SV, 2015, PHYTOCHEMISTRY, V117, P34, DOI 10.1016/j.phytochem.2015.05.021; Singh A, 2017, J LIPID RES, V58, P2017, DOI [10.1194/jlr.M078600, 10.1194/jlr.m078600]; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Toh-e A, 2015, FUNGAL GENET BIOL, V80, P19, DOI 10.1016/j.fgb.2015.04.019; Tomar P, 2014, J BIOSCIENCES, V39, P525, DOI 10.1007/s12038-014-9435-y; VOGEL G, 1992, PLANT CELL PHYSIOL, V33, P427; Zavaleta-Pastor M, 2010, P NATL ACAD SCI USA, V107, P302, DOI 10.1073/pnas.0912930107; Zhang Y, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005485	32	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212651	10.1371/journal.pone.0212651	http://dx.doi.org/10.1371/journal.pone.0212651			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789965	Green Published, Green Submitted, gold			2022-12-27	WOS:000459330800047
J	Oliveira, LND; Itria, A; Lima, EC				da Silva Oliveira, Luana Nice; Itria, Alexander; Lima, Erika Coutinho			Cost of illness and program of dengue: A systematic review	PLOS ONE			English	Review							ECONOMIC COST; BURDEN; HEALTH; COLOMBIA; AMERICA; IMPACT; BRAZIL	Background Studies on dengue related to the cost of illness and cost of the program are factors to describe the economic burden of dengue, a neglected disease that has global importance in public health. These studies are often used by health managers in optimizing financial resources. A systematic review of studies estimating the cost of dengue was carried out, comparing the costs between the studies and examining the cost drivers regarding the methodological choices. Methods This study was done according to the guidelines of the Centre for Reviews and Dissemination (CRD). Several databases were searched: Medline, Virtual Health Library and CRD. Two researchers, working independently, selected the studies and extracted the data. The quality of the methodology of the individual studies was achieved by a checklist of 29 items based on protocols proposed by the British Medical Journal and Consolidated Health Economic Evaluation Reporting Standards. A qualitative and quantitative narrative synthesis was performed. Results A literature search yielded 665 publications. Of these, 22 studies are in accordance with previously established inclusion criteria. The cost estimates were compared amongst the studies, highlighting the study design, included population and comparators used (study methodology). The component costs included in the economic evaluation were based on direct and indirect costs, wherein twelve studies included both costs, twelve studies adopted the societal perspective and ten studies used the perspective of the public health service provider, or of a private budget holder. Conclusion This study showed that the cost of dengue in 18 countries generated approximately US$ 3.3 billion Purchasing Power Parity (PPP) in 2015. This confirms that the burden of dengue has a great economic impact on countries with common socioeconomic characteristics and similarities in health systems, particularly developing countries, indicating a need for further studies in these countries.	[da Silva Oliveira, Luana Nice] Univ Fed Goias, Inst Hlth Technol Assessment, Ctr Econ & Hlth Assessments, Fac Pharm, Goiania, Go, Brazil; [Itria, Alexander] Univ Fed Goias, Dept Collect Hlth, Inst Trop Pathol & Publ Hlth, Goiania, Go, Brazil; [Itria, Alexander] Univ Fed Goias, Inst Hlth Technol Assessment, Ctr Econ & Hlth Assessments, Goiania, Go, Brazil; [Lima, Erika Coutinho] Univ Fed Goias, Fac Pharm, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Goias; Universidade Federal de Goias; Universidade Federal de Goias	Oliveira, LND (corresponding author), Univ Fed Goias, Inst Hlth Technol Assessment, Ctr Econ & Hlth Assessments, Fac Pharm, Goiania, Go, Brazil.	luana_n2@hotmail.com		Nice da Silva Oliveira Merola, Luana/0000-0002-6257-6019	Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG)	Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG)	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG). The FAPEG had no direct say in the project methods or outcome beyond providing funding for materials and personnel, and did not directly contribute to the writing of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriana M, 2012, MEDISAN, V16; ANDERSSON F, 1993, PHARMACOECONOMICS, V4, P247, DOI 10.2165/00019053-199304040-00003; Anez G, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004445; [Anonymous], 2016, WKLY EPIDEMIOL REC; [Anonymous], 1996, BRIT MED J, V313, P275, DOI [10.1136/bmj.313.7052.275, DOI 10.1136/BMJ.313.7052.275]; Armien B, 2008, AM J TROP MED HYG, V79, P364, DOI 10.4269/ajtmh.2008.79.364; Barreto Maurício L., 2008, Estud. av., V22, P53, DOI 10.1590/S0103-40142008000300005; Beaute J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-521; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Brasil, 2015, DIR MET DIR AV EC, P1689; Brasil. Ministerio da Saude. Secretaria de Tecnologia e Insumos Estrategicos. Departamento e Tecnologia, 2012, DIR MET EL SIST MET; Bravo L, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003027; Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6; Rodriguez RC, 2016, AM J TROP MED HYG, V94, P1065, DOI 10.4269/ajtmh.15-0280; d'Ercole M.M., 2012, EUROPEAN MEASURES IN, P27; de Oliveira ML, 2014, REV NUTR, V27, DOI 10.1590/1415-52732014000500007; dos Santos SM, 2015, EPIDEMIOL SERV SAUDE, V24, P661, DOI 10.5123/S1679-49742015000400008; Edillo FE, 2015, AM J TROP MED HYG, V92, P360, DOI 10.4269/ajtmh.14-0139; ELIAS P. E. M., 2004, SAO PAULO PERSPECT, V18, P41, DOI [DOI 10.1590/S0102-88392004000300005, 10.1590/S0102-88392004000300005]; Ernstsson O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159129; Gallassi AD, 2008, REV PSIQ CLIN-BRAZIL, V35, P25, DOI 10.1590/S0101-60832008000700007; Garg P, 2008, T ROY SOC TROP MED H, V102, P570, DOI 10.1016/j.trstmh.2008.02.015; Gerschman Silvia, 2006, Rev. bras. Ci. Soc., V21, P177, DOI 10.1590/S0102-69092006000200010; HODGSON TA, 1982, MILBANK FUND Q, V60, P429, DOI 10.2307/3349801; Husereau D, 2013, CONSOLIDATED HLTH EC, P6; Kesorn K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125049; Levino A, 2011, REV PANAM SALUD PUBL, V30, P490, DOI 10.1590/S1020-49892011001100013; Londono-Renteria B, 2015, BIOMEDICA, V35, P572, DOI 10.7705/biomedica.v35i4.2530; Moraz G, 2015, CIENC SAUDE COLETIVA, V20, P3211, DOI 10.1590/1413-812320152010.00962015; Tam PT, 2012, AM J TROP MED HYG, V87, P554, DOI 10.4269/ajtmh.2012.12-0101; Pereira CAR, 2014, CIENC SAUDE COLETIVA, V19, P3693, DOI 10.1590/1413-81232014199.01682014; Sampaio RF, 2007, REV BRAS FISIOTER, V11, P77, DOI DOI 10.1590/S1413-35552007000100013; Selck FW, 2014, VECTOR-BORNE ZOONOT, V14, P824, DOI 10.1089/vbz.2013.1528; Shepard DS, 2014, AM J TROP MED HYG, V91, P1235, DOI 10.4269/ajtmh.14-0002; Shepard DS, 2012, AM J TROP MED HYG, V87, P796, DOI 10.4269/ajtmh.2012.12-0019; Shepard DS, 2011, AM J TROP MED HYG, V84, P200, DOI 10.4269/ajtmh.2011.10-0503; Souza Ricardo Pires de, 2013, Rev. Bioét., V21, P237; Stahl HC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1048; Suaya JA, 2009, AM J TROP MED HYG, V80, P846, DOI 10.4269/ajtmh.2009.80.846; Taliberti H, 2010, REV PANAM SALUD PUBL, V27; Tarragona S, 2012, SALUD COLECT, V8, P151, DOI 10.1590/S1851-82652012000200004; THACKER SB, 1988, EPIDEMIOL REV, V10, P164, DOI 10.1093/oxfordjournals.epirev.a036021; Thalagala N, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004466; Uhart M, 2016, EUR J HEALTH ECON, V17, P497, DOI 10.1007/s10198-015-0694-9; Undurraga EA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003547; Machado AAV, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003104; Villar L, 2014, NEW ENGL J MED, V372; World Health Organization (WHO), 2000, B WORLD HEALTH ORGAN, V78, P215; Zucchi P, 2000, SAUDE SOC, V9, P127, DOI DOI 10.1590/S0104-12902000000100010	50	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211401	10.1371/journal.pone.0211401	http://dx.doi.org/10.1371/journal.pone.0211401			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785894	Green Published, gold, Green Submitted			2022-12-27	WOS:000459307000023
J	Radoi, A; Poca, MA; Gandara, D; Castro, L; Cevallos, M; Pacios, ME; Sahuquillo, J				Radoi, Andreea; Poca, Maria A.; Gandara, Dario; Castro, Lidia; Cevallos, Mauricio; Pacios, Maria E.; Sahuquillo, Juan			The Sport Concussion Assessment Tool (SCAT2) for evaluating civilian mild traumatic brain injury. A pilot normative study	PLOS ONE			English	Article							WHITE-MATTER HYPERINTENSITIES; HEAD-INJURY; HOSPITAL ANXIETY; HIGH-SCHOOL; SYMPTOMS; QUESTIONNAIRE; PREVALENCE; CONSENSUS; RECOVERY; SAMPLE	Self-report measures, particularly symptom inventories, are critical tools for identifying patients with persistent post-concussion symptoms and their follow-up. Unlike in military or sports-related assessment, in general civilian settings pre-injury levels of concussion-like symptoms are lacking. Normative data are available in adolescent and college populations, but no reference data exist to guide clinical adult explorations. The purpose of this study was to use the second edition of the Sport Concussion Assessment Tool (SCAT2) to profile a cohort of 60 healthy community volunteers who had not sustained a head injury. Participating volunteers underwent MRI scanning and were evaluated with the Hospital Anxiety and Depression Scale (HADS). Participants reported a median of 3 concussion-like symptoms and the 97.5 percentile score was found at 10.5 symptoms, out of a total of 22. The median severity score was 4.9 points, and 28.9 was the upper limit of the reference interval. Only 10 participants (16.7%) did not endorse any symptom. The most frequently endorsed symptom was feeling difficulty in concentrating, with 41.7% of the sample reporting it. Age, sex and general distress, anxiety and depressive symptoms were not associated with concussion-like symptoms. Our data yielded elevated cut-offs scores for both the number of symptoms and the symptom severity. In conclusion, postconcussive-like symptoms are frequent in the general non-concussed adult population and it should be taken into account in any future models developed for screening patients at risk of developing physical, cognitive, and psychological complaints following mild traumatic injury.	[Radoi, Andreea; Poca, Maria A.; Castro, Lidia; Sahuquillo, Juan] Vall dHebron Res Inst VHIR, Neurotraumatol & Neurosurg Res Unit UNINN, Barcelona, Spain; [Radoi, Andreea; Poca, Maria A.; Castro, Lidia; Sahuquillo, Juan] Univ Autonoma Barcelona, Barcelona, Spain; [Poca, Maria A.; Gandara, Dario; Cevallos, Mauricio; Sahuquillo, Juan] Vall dHebron Univ Hosp, Dept Neurosurg, Barcelona, Spain; [Pacios, Maria E.] Vall dHebron Univ Hosp, Neurotraumatol Emergency Unit, Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Hospital Universitari Vall d'Hebron	Radoi, A (corresponding author), Vall dHebron Res Inst VHIR, Neurotraumatol & Neurosurg Res Unit UNINN, Barcelona, Spain.; Radoi, A (corresponding author), Univ Autonoma Barcelona, Barcelona, Spain.	aradoi@neurotrauma.net	Rădoi, Andreea/N-5613-2019; Sahuquillo, Juan/B-3577-2008; Poca, Maria A./B-8475-2008; Sabatini, Darío Fabián Gándara/AAB-6699-2019	Rădoi, Andreea/0000-0002-0677-3544; Sahuquillo, Juan/0000-0003-0713-5875; Poca, Maria A./0000-0002-3831-0536; Sabatini, Darío Fabián Gándara/0000-0003-1303-9847	Generalitat de Catalunya [SGR 2014-844]; Fondo de Investigacion Sanitaria (Instituto de Salud Carlos III) [FIS PI11/00700, FIS PI13/02397]; European Regional Development Fund (ERDF); Fundacio Institut de Recerca VHIR [PRED-VHIR-2012-26]	Generalitat de Catalunya(Generalitat de Catalunya); Fondo de Investigacion Sanitaria (Instituto de Salud Carlos III)(Instituto de Salud Carlos III); European Regional Development Fund (ERDF)(European Commission); Fundacio Institut de Recerca VHIR	UNINN is supported by a Grant from the Generalitat de Catalunya (SGR 2014-844, http://agaur.gencat.cat). This work has been supported in part by the Fondo de Investigacion Sanitaria (Instituto de Salud Carlos III, https://portalfis.isciii.es) with grants FIS PI11/00700 (J.S.) and grant FIS PI13/02397 (M.A.P.), which were co-financed by the European Regional Development Fund (ERDF). A.R. was a recipient of a pre-doctoral grant from the Fundacio Institut de Recerca VHIR (PRED-VHIR-2012-26, http://en.vhir.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00010]; Asken BM, 2017, ARCH CLIN NEUROPSYCH, V32, P963, DOI 10.1093/arclin/acx018; Benjamin DJ, 2018, NAT HUM BEHAV, V2, P6, DOI 10.1038/s41562-017-0189-z; Bigler ED, 2013, CLIN NEUROPSYCHOL, V27, P176, DOI 10.1080/13854046.2012.693950; BJELLAND I, 2002, J PSYCHOSOM RES, V0052; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Edmed SL, 2014, BRAIN INJURY, V28, P1277, DOI 10.3109/02699052.2014.915988; Evans WA, 1942, ARCH NEURO PSYCHIATR, V47, P931, DOI 10.1001/archneurpsyc.1942.02290060069004; FAZEKAS F, 1987, AM J NEURORADIOL, V8, P421; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Hastie T, 2001, ELEMENTS STAT LEARNI, Vxvi; Horn PS, 2001, CLIN CHEM, V47, P2137; Horn PS, 2003, CLIN CHIM ACTA, V334, P5, DOI 10.1016/S0009-8981(03)00133-5; Horn PS, 1998, CLIN CHEM, V44, P622; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Ioannidis JPA, 2018, JAMA-J AM MED ASSOC, V319, P1429, DOI 10.1001/jama.2018.1536; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Korley FK, 2017, J NEUROTRAUM, V34, P1531, DOI 10.1089/neu.2016.4723; Kraus JF, 2014, BRAIN INJURY, V28, P1248, DOI 10.3109/02699052.2014.916420; Lange RT, 2014, J NEUROTRAUM, V31, P198, DOI 10.1089/neu.2013.2866; Luoto TM, 2014, J NEUROTRAUM, V31, P728, DOI 10.1089/neu.2013.3174; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.1016/j.jocn.2009.02.002, 10.4085/1062-6050-44.4.434]; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Rose SC, 2015, BRAIN INJURY, V29, P798, DOI 10.3109/02699052.2015.1004756; Scheid R, 2007, J NEUROTRAUM, V24, P1811, DOI 10.1089/neu.2007.0382; Sharp David J, 2015, Pract Neurol, V15, P172, DOI 10.1136/practneurol-2015-001087; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; Thomas RE., 2016, BMJ OPEN SPORT EXERC, V2, DOI DOI 10.1136/BMJSEM-2015-000095; Vargo MM, 2016, PM&R, V8, P241, DOI 10.1016/j.pmrj.2015.07.006; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; Wen W, 2009, HUM BRAIN MAPP, V30, P1155, DOI 10.1002/hbm.20586; World Health Organization, 2013, COUNTR PROF NUTR PHY; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zimmer A, 2015, APPL NEUROPSYCH-ADUL, V22, P132, DOI 10.1080/23279095.2013.867265	45	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212541	10.1371/journal.pone.0212541	http://dx.doi.org/10.1371/journal.pone.0212541			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM2OT	30785950	gold, Green Submitted, Green Published			2022-12-27	WOS:000459307000068
J	Bouza, C; Martinez-Ales, G; Lopez-Cuadrado, T				Bouza, Carmen; Martinez-Ales, Gonzalo; Lopez-Cuadrado, Teresa			The impact of dementia on hospital outcomes for elderly patients with sepsis: A population-based study	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; ALZHEIMERS-DISEASE; SURVIVING SEPSIS; SEPTIC SHOCK; COMORBIDITIES; MORTALITY; LIFE; MULTICENTER; PREVALENCE; MANAGEMENT	Background Prior studies have suggested that dementia adversely influences clinical outcomes and increases resource utilization in patients hospitalized for acute diseases. However, there is limited population-data information on the impact of dementia among elderly hospitalized patients with sepsis. Methods From the 2009-2011 National Hospital Discharge Database we identified hospitalizations in adults aged >= 65 years. Using ICD9-CM codes, we selected sepsis cases, divided them into two cohorts (with and without dementia) and compared both groups with respect to organ dysfunction, in-hospital mortality and the use of hospital resources. We estimated the impact of dementia on these primary endpoints through multivariate regression models. Results Of the 148 293 episodes of sepsis identified, 16 829 (11.3%) had diagnoses of dementia. Compared to their dementia-free counterparts, they were more predominantly female and older, had a lower burden of comorbidities and were more frequently admitted due to a principal diagnosis of sepsis. The dementia cohort showed a lower risk of organ dysfunction (adjusted OR: 0.84, 95% Confidence Interval [CI]: 0.81, 0.87) but higher in-hospital mortality (adjusted OR: 1.32, 95% [CI]: 1.27, 1.37). The impact of dementia on mortality was higher in the cases of younger age, without comorbidities and without organ dysfunction. The cases with dementia also had a lower length of stay (-3.87 days, 95% [CI]: -4.21, -3.54) and lower mean hospital costs (-3040(sic), 95% [CI]: -3279, -2800). Conclusions This nationwide population-based study shows that dementia is present in a substantial proportion of adults. >= 65s hospitalized with sepsis, and while the condition does seem to come with a lower risk of organ dysfunction, it exerts a negative influence on in-hospital mortality and acts as an independent mortality predictor. Furthermore, it is significantly associated with shorter length of stay and lower hospital costs.	[Bouza, Carmen] Carlos III Hlth Inst, Hlth Technol Assessment Agcy, Madrid, Spain; [Martinez-Ales, Gonzalo] La Paz Univ Hosp, Dept Psychiat, Madrid, Spain; [Martinez-Ales, Gonzalo; Lopez-Cuadrado, Teresa] Autonomous Univ Madrid, Sch Med, Madrid, Spain; [Lopez-Cuadrado, Teresa] Carlos III Hlth Inst, Natl Epidemiol Ctr, Madrid, Spain	Instituto de Salud Carlos III; Agencia de Evaluacion de Tecnologias Sanitarias (AETS); Hospital Universitario La Paz; Autonomous University of Madrid; Instituto de Salud Carlos III; Centro Nacional de Epidemiologia (CNE)	Bouza, C (corresponding author), Carlos III Hlth Inst, Hlth Technol Assessment Agcy, Madrid, Spain.	cbouza@isciii.es	López-Cuadrado, Teresa/F-4518-2016	López-Cuadrado, Teresa/0000-0002-5542-9782; Martinez-Ales, Gonzalo/0000-0002-1902-4067	Instituto de Salud Carlos III [PI09/0597]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by a grant from Instituto de Salud Carlos III (grant number: PI09/0597).	Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; [Anonymous], 2014, LANCET, V383, P2185, DOI 10.1016/S0140-6736(14)61066-7; Bail K, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002770; Bermejo-Pareja F, 2008, J NEUROL SCI, V264, P63, DOI 10.1016/j.jns.2007.07.021; Bouza C, 2016, BRIT J SURG, V103, pE73, DOI 10.1002/bjs.10065; Bynum JPW, 2004, J AM GERIATR SOC, V52, P187, DOI 10.1111/j.1532-5415.2004.52054.x; Chen TB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175475; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Esper AM, 2006, CRIT CARE MED, V34, P2576, DOI 10.1097/01.CCM.0000239114.50519.0E; Esteban A, 2001, INTENS CARE MED, V27, P1744, DOI 10.1007/s00134-001-1111-7; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Fillenbaum G, 2001, NEUROLOGY, V56, P201, DOI 10.1212/WNL.56.2.201; Fillit H, 2002, J AM GERIATR SOC, V50, P1871, DOI 10.1046/j.1532-5415.2002.50519.x; Guijarro R, 2010, NEUROEPIDEMIOLOGY, V35, P101, DOI 10.1159/000311032; Hill JW, 2002, NEUROLOGY, V58, P62, DOI 10.1212/WNL.58.1.62; Jin P, 2004, NEUROLOGY, V63, P739, DOI 10.1212/01.WNL.0000134604.48018.97; Kimata T, 2008, INT HEART J, V49, P533, DOI 10.1536/ihj.49.533; Laditka James N, 2005, Am J Alzheimers Dis Other Demen, V20, P27, DOI 10.1177/153331750502000109; Lagu T, 2016, J AM GERIATR SOC, V64, pE63, DOI 10.1111/jgs.14344; Lagu T, 2014, JAMA INTERN MED, V174, P999, DOI 10.1001/jamainternmed.2014.1179; Lagu T, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.02.004; Lerolle N, 2010, CRIT CARE MED, V38, P59, DOI 10.1097/CCM.0b013e3181b088ec; Levy MM, 2010, CRIT CARE MED, V38, P367, DOI 10.1097/CCM.0b013e3181cb0cdc; Librero J, 1999, J CLIN EPIDEMIOL, V52, P171, DOI 10.1016/S0895-4356(98)00160-7; Lyketsos CG, 2000, AM J PSYCHIAT, V157, P704, DOI 10.1176/appi.ajp.157.5.704; Marengoni A, 2011, INT J GERIATR PSYCH, V26, P930, DOI 10.1002/gps.2627; Martin GS, 2012, EXPERT REV ANTI-INFE, V10, P701, DOI [10.1586/ERI.12.50, 10.1586/eri.12.50]; Martin GS, 2006, CRIT CARE MED, V34, P15, DOI 10.1097/01.CCM.0000194535.82812.BA; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Ministerio de Sanidad Consumo y Bienestar Social, MET AN HOSP SIST NAC; Ministerio de Sanidad Consumo y Bienestar Social, HOSP DISCH REC NAT H; OECD, 2013, HLTH GLANC 2013 OECD, DOI [10.1787/health_glance-2013-49-en, DOI 10.1787/HEALTH_GLANCE-2013-49-EN]; Oltean S, 2012, J CRIT CARE, V27, P370, DOI 10.1016/j.jcrc.2011.08.021; Oud L, 2016, MED SCI MONITOR, V22, P3849, DOI 10.12659/MSM.897760; Phelan EA, 2012, JAMA-J AM MED ASSOC, V307, P165, DOI 10.1001/jama.2011.1964; Pisani MA, 2005, CRIT CARE MED, V33, P1371, DOI 10.1097/01.CCM.0000165558.83676.48; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Quartin AA, 1997, JAMA-J AM MED ASSOC, V277, P1058, DOI 10.1001/jama.277.13.1058; Reinhart K, 2017, NEW ENGL J MED, V377, P414, DOI 10.1056/NEJMp1707170; Richardson SS, 2007, HEALTH SERV RES, V42, P183, DOI 10.1111/j.1475-6773.2006.00608.x; Ruiz MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123987; Sampson EL, 2009, BRIT J PSYCHIAT, V195, P61, DOI 10.1192/bjp.bp.108.055335; Shen HN, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0042751, 10.1371/journal.pone.0050238]; Sprung CL, 2003, JAMA-J AM MED ASSOC, V290, P790, DOI 10.1001/jama.290.6.790; Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003; Torian L, 1992, Int Psychogeriatr, V4, P231, DOI 10.1017/S1041610292001066; Galende AV, 2021, NEUROLOGIA, V36, P39, DOI 10.1016/j.nrl.2017.10.005; WOLFKLEIN GP, 1988, J AM GERIATR SOC, V36, P219, DOI 10.1111/j.1532-5415.1988.tb01804.x; Wysham NG, 2017, CRIT CARE MED, V45, pE372, DOI 10.1097/CCM.0000000000002099	51	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212196	10.1371/journal.pone.0212196	http://dx.doi.org/10.1371/journal.pone.0212196			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL9KY	30779777	Green Submitted, gold, Green Published			2022-12-27	WOS:000459062900032
J	Bouchard, B; Barnagaud, JY; Poupard, M; Glotin, H; Gauffier, P; Ortiz, ST; Lisney, TJ; Campagna, S; Rasmussen, M; Celerier, A				Bouchard, Bertrand; Barnagaud, Jean-Yves; Poupard, Marion; Glotin, Herve; Gauffier, Pauline; Ortiz, Sara Torres; Lisney, Thomas J.; Campagna, Sylvie; Rasmussen, Marianne; Celerier, Aurelie			Behavioural responses of humpback whales to food-related chemical stimuli	PLOS ONE			English	Article							DIMETHYL SULFIDE; MEGAPTERA-NOVAEANGLIAE; BOWHEAD WHALE; CETACEA; SEABIRDS; IDENTIFICATION; PERCEPTION; MYSTICETI; ABUNDANCE; DOLPHINS	Baleen whales face the challenge of finding patchily distributed food in the open ocean. Their relatively well-developed olfactory structures suggest that they could identify the specific odours given off by planktonic prey such as krill aggregations. Like other marine predators, they may also detect dimethyl sulfide (DMS), a chemical released in areas of high marine productivity. However, dedicated behavioural studies still have to be conducted in baleen whales in order to confirm the involvement of chemoreception in their feeding ecology. We implemented 56 behavioural response experiments in humpback whales using two food-related chemical stimuli, krill extract and DMS, as well as their respective controls (orange clay and vegetable oil) in their breeding (Madagascar) and feeding grounds (Iceland and Antarctic Peninsula). The whales approached the stimulus area and stayed longer in the trial zone during krill extract trials compared to control trials, suggesting that they were attracted to the chemical source and spent time exploring its surroundings, probably in search of prey. This response was observed in Iceland, and to a lesser extend in Madagascar, but not in Antarctica. Surface behaviours indicative of sensory exploration, such as diving under the stimulus area and stopping navigation, were also observed more often during krill extract trials than during control trials. Exposure to DMS did not elicit such exploration behaviours in any of the study areas. However, acoustic analyses suggest that DMS and krill extract both modified the whales' acoustic activity in Madagascar. Altogether, these results provide the first behavioural evidence that baleen whales actually perceive prey-derived chemical cues over distances of several hundred metres. Chemoreception, especially olfaction, could thus be used for locating prey aggregations and for navigation at sea, as it has been shown in other marine predators including seabirds.	[Bouchard, Bertrand; Barnagaud, Jean-Yves; Lisney, Thomas J.; Celerier, Aurelie] Univ Paul Valery Montpelllier EPHE, Univ Montpellier, CNRS, Behav Ecol Grp,CEFE,UMR 5175, Montpellier, France; [Bouchard, Bertrand; Lisney, Thomas J.; Celerier, Aurelie] Univ Montpellier, Montpellier, France; [Poupard, Marion; Glotin, Herve] Univ Aix Marseille, Univ Toulon, LIS, DYNI Team,CNRS, Marseille, France; [Gauffier, Pauline] CIRCE, Conservat Informat & Res Cetaceans, Cadiz, Spain; [Ortiz, Sara Torres] Univ Southern Denmark, Dept Biol, Marine Biol Res Ctr, Kerteminde, Denmark; [Campagna, Sylvie] Univ Nimes, Univ, France; [Rasmussen, Marianne] Univ Iceland, Husavik Res Ctr, Husavik, Iceland	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Southern Denmark; Universite de Nimes; University of Iceland	Bouchard, B (corresponding author), Univ Paul Valery Montpelllier EPHE, Univ Montpellier, CNRS, Behav Ecol Grp,CEFE,UMR 5175, Montpellier, France.; Bouchard, B (corresponding author), Univ Montpellier, Montpellier, France.	bertrand.bouchard@gmail.com	Lisney, Thomas/AAA-3288-2021; Gauffier, Pauline/M-3952-2014; Gauffier, Pauline/W-8148-2019	Lisney, Thomas/0000-0001-5149-3720; Gauffier, Pauline/0000-0003-2984-6993; Gauffier, Pauline/0000-0003-2984-6993; Glotin, Herve/0000-0001-7338-8518; Poupard, Marion/0000-0002-8235-5184; Bouchard, Bertrand/0000-0002-8670-0299	Fondation Total [144903]; Ministere de l'Enseignement Superieur et de la Recherche	Fondation Total; Ministere de l'Enseignement Superieur et de la Recherche	This research was funded by the Fondation Total (www.fondation.total.com), grant #144903 to A.C., and the Ministere de l'Enseignement Superieur et de la Recherche (www.enseignementsup-recherche.gouv.fr) to B.B., Bourse doctorale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderwald P, 2011, MAR ECOL PROG SER, V424, P219, DOI 10.3354/meps08947; [Anonymous], R LANG ENV STAT COMP; Barth M, 2015, ROUTL STUD SUSTAIN, P1; Berta A, 2015, ANAT REC, V298, P648, DOI 10.1002/ar.23112; Berta A, 2014, ANAT REC, V297, P2205, DOI 10.1002/ar.23034; Bouchard B, 2016, ANN C EUR CET SOC FU, P92; Bouchard B, 2017, APPL ANIM BEHAV SCI, V194, P120, DOI 10.1016/j.applanim.2017.05.013; Brierley AS, 1997, MAR ECOL PROG SER, V150, P87, DOI 10.3354/meps150087; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; CAVE AJE, 1988, J ZOOL, V214, P307, DOI 10.1111/j.1469-7998.1988.tb04724.x; Cerchio S, 2016, MAR ECOL PROG SER, V562, P193, DOI 10.3354/meps11951; Cerchio Salvatore, 2001, Bioacoustics, V11, P277; Christiansen F, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00277; Clapham PJ, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P582; Clua E, 2001, AQUAT LIVING RESOUR, V14, P11, DOI 10.1016/S0990-7440(00)01097-4; Cronin TW, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0067; DACEY JWH, 1986, SCIENCE, V233, P1314, DOI 10.1126/science.233.4770.1314; Dallas LJ, 2010, J FISH BIOL, V77, P947, DOI 10.1111/j.1095-8649.2010.02738.x; Daly KL, 1996, BIOLOGICAL AND ENVIRONMENTAL CHEMISTRY OF DMSP AND RELATED SULFONIUM COMPOUNDS, P223; DeBose JL, 2008, J CHEM ECOL, V34, P867, DOI 10.1007/s10886-008-9493-4; Derby CD, 2008, J CHEM ECOL, V34, P898, DOI 10.1007/s10886-008-9489-0; Dove ADM, 2015, BIOL BULL-US, V228, P65, DOI 10.1086/BBLv228n1p65; Drake SE, 2015, ANAT REC, V298, P1327, DOI 10.1002/ar.23163; Dulau V, 2017, MOV ECOL, V5, DOI 10.1186/s40462-017-0101-5; Dunlop RA, 2013, J EXP BIOL, V216, P759, DOI 10.1242/jeb.071498; Edinger T, 1955, MON PSYCHIATR NEUROL, V129, P37; Eisenmann P, 2016, ISOTOPIC EVIDENCE WI, P1, DOI [10.1371/journal.pone.0156698, DOI 10.1371/JOURNAL.PONE.0156698]; Endres CS, 2012, J EXP BIOL, V215, P3535, DOI 10.1242/jeb.073221; EVANS PGH, 1982, MAMMAL REV, V12, P187, DOI 10.1111/j.1365-2907.1982.tb00015.x; Fan Y, 2017, INT J FOOD PROP, V20, pS820, DOI 10.1080/10942912.2017.1315589; Felix Fernando, 2004, Latin American Journal of Aquatic Mammals, V3, P25; Feng P, 2014, GENOME BIOL EVOL, V6, P1254, DOI 10.1093/gbe/evu095; FOWLKES EB, 1983, J AM STAT ASSOC, V78, P553, DOI 10.2307/2288117; FRANKEL AS, 1995, CAN J ZOOL, V73, P1134, DOI 10.1139/z95-135; FRIEDL WA, 1990, NATO ADV SCI I A-LIF, V196, P447; Friedlaender AS, 2006, MAR ECOL PROG SER, V317, P297, DOI 10.3354/meps317297; Friedlaender AS, 2009, MAR ECOL PROG SER, V395, P91, DOI 10.3354/meps08003; Friedlaender AS, 2009, MAR MAMMAL SCI, V25, P402, DOI 10.1111/j.1748-7692.2008.00263.x; Fristrup KM, 2003, J ACOUST SOC AM, V113, P3411, DOI 10.1121/1.1573637; Godfrey SJ, 2013, ANAT REC, V296, P257, DOI 10.1002/ar.22637; Goldbogen JA, 2008, J EXP BIOL, V211, P3712, DOI 10.1242/jeb.023366; Hagelin JC, 2012, ASS CHEM SCI ANN M, P13; Hazen EL, 2009, MAR ECOL PROG SER, V395, P75, DOI 10.3354/meps08108; Henningsen A, 2013, CENSREG CENSORED REG, P1; HUTCHISON LV, 1980, CONDOR, V82, P314, DOI 10.2307/1367400; Keller M. D., 1989, BIOL OCEANOGR, V6, P375, DOI DOI 10.1080/01965581.1988.10749540; Kienle SS, 2015, ANAT REC, V298, P660, DOI 10.1002/ar.23107; Kim Min-A, 2014, Fisheries and Aquatic Sciences, V17, P409, DOI 10.5657/FAS.2014.0409; Kishida T, 2015, ZOOL LETT, V1, DOI 10.1186/s40851-014-0002-z; Kowalewsky S, 2006, BIOL LETT-UK, V2, P106, DOI 10.1098/rsbl.2005.0380; KREMERS D, 2016, FRONT ECOL EVOL, V4, P1, DOI DOI 10.3389/FEV0.2016.00050; KUZNETZOV VB, 1990, NATO ADV SCI I A-LIF, V196, P481; Leck C, 1996, TELLUS B, V48, P272, DOI 10.1034/j.1600-0889.48.issue2.1.x; McGowen MR, 2008, SYST BIOL, V57, P574, DOI 10.1080/10635150802304787; Miller PJO, 2000, NATURE, V405, P903, DOI 10.1038/35016148; MuMIn Barton K, 2010, MULTIMODEL INFERENCE; Nevitt G, 1999, MAR ECOL PROG SER, V177, P235, DOI 10.3354/meps177235; NEVITT GA, 1995, NATURE, V376, P680, DOI 10.1038/376680ao; Nevitt GA, 2008, J EXP BIOL, V211, P1706, DOI 10.1242/jeb.015412; Nowacek DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019173; POYSA H, 1992, ORNIS SCAND, V23, P159, DOI 10.2307/3676444; Reilly S, 2004, DEEP-SEA RES PT II, V51, P1397, DOI 10.1016/j/dsr2.2004.06.008; Rinberg D, 2006, SEMIN CELL DEV BIOL, V17, P454, DOI 10.1016/j.semcdb.2006.04.009; Risch D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029741; Safi K, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00175; Sakamoto KQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007322; Savoca MS, 2014, P NATL ACAD SCI USA, V111, P4157, DOI 10.1073/pnas.1317120111; Silva T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187360; Silverman ED, 2004, MAR ECOL PROG SER, V277, P25, DOI 10.3354/meps277025; Simon M, 2012, J EXP BIOL, V215, P3786, DOI 10.1242/jeb.071092; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Stamation KA, 2010, MAR MAMMAL SCI, V26, P98, DOI 10.1111/j.1748-7692.2009.00320.x; Stamation Kasey A., 2007, Aquatic Mammals, V33, P165, DOI 10.1578/AM.33.2.2007.165; Stimpert AK, 2007, BIOL LETTERS, V3, P467, DOI 10.1098/rsbl.2007.0281; Strehl A., 2003, Journal of Machine Learning Research, V3, P583, DOI 10.1162/153244303321897735; Thewissen JGM, 2011, MAR MAMMAL SCI, V27, P282, DOI 10.1111/j.1748-7692.2010.00406.x; THOMPSON PO, 1986, J ACOUST SOC AM, V80, P735, DOI 10.1121/1.393947; Torres LG, 2017, MAR MAMMAL SCI, V33, P1170, DOI 10.1111/mms.12426; Torres LG, 2018, FRONT MAR SCI, V5, DOI [10.3389/fmars.2018.00043, DOI 10.3389/FMARS.2018.00043]; Turner SM, 1996, MAR CHEM, V54, P245, DOI 10.1016/0304-4203(96)00028-X; van der Maaten L, 2012, MACH LEARN, V87, P33, DOI 10.1007/s10994-011-5273-4; Vikingsson G. A., 2015, FRONT ECOL EVOL, V3, P1, DOI DOI 10.3389/FEV0.2015.00006; WHITEHEAD H, 1983, CAN J ZOOL, V61, P1391, DOI 10.1139/z83-186; Wikelski M, 2015, SCI REP-UK, V5, DOI 10.1038/srep17061; Wright KLB, 2011, J EXP BIOL, V214, P2509, DOI 10.1242/jeb.058230	85	13	13	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0212515	10.1371/journal.pone.0212515	http://dx.doi.org/10.1371/journal.pone.0212515			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807595	Green Published, gold, Green Submitted			2022-12-27	WOS:000459712100016
J	Hatchard, JL; Neto, JQF; Vasilakis, C; Evans-Reeves, KA				Hatchard, Jenny L.; Neto, Joao Quariguasi Frota; Vasilakis, Christos; Evans-Reeves, Karen A.			Tweeting about public health policy: Social media response to the UK Government's announcement of a Parliamentary vote on draft standardised packaging regulations	PLOS ONE			English	Article							TWITTER; WARNINGS; IMPLEMENTATION; INFORMATION	Background Standardised tobacco packaging has been, and remains, a contentious policy globally, attracting corporate, public health, political, media and popular attention. In January 2015, the UK Government announced it would vote on draft regulations for the policy before the May 2015 General Election. We explored reactions to the announcement on Twitter, in comparison with an earlier period of little UK Government activity on standardised packaging. Methods We obtained a random sample of 1038 tweets in two 4-week periods, before and after the UK Government's announcement. Content analysis was used to examine the following Tweet characteristics: support for the policy, purpose, Twitter-user's geographical location and affiliation, and evidence citation and quality. Chi-squared analyses were used to compare Tweet characteristics between the two periods. Results Overall, significantly more sampled Tweets were in favour of the policy (49%) in comparison to those opposed (19%). Yet, at Time 2, following the announcement, a greater proportion of sampled tweets opposed standardised packaging compared to the period sampled at Time 1, prior to the announcement (p<0.001). The quality of evidence and research cited in URLs linked at Time 2 was significantly lower than at Time 1 (p<0.001), with peer-reviewed research more likely to be shared in positive Tweets (p<0.001) and in Tweets linking to URLs originating from the health sector (p<0.001). The decline in the proportion of positive Tweets was mirrored by a reduction in Tweets by health sector Twitter-users at Time 2 (p<0.001). Conclusions Microblogging sites can reflect offline policy debates and are used differently by policy proponents and opponents dependent on the policy context. Twitter-users opposed to standardised packaging increased their activity following the Government's announcement, while those in support broadly maintained their rate of Twitter engagement. The findings offer insight into the public health community's options for using Twitter to influence policy and disseminate research. In particular, proliferation of Twitter activity following pro-public health policy announcements could be considered to ensure pro-health messages are not overshadowed by anti-regulation voices.	[Hatchard, Jenny L.; Evans-Reeves, Karen A.] Univ Bath, Dept Hlth, Tobacco Control Res Grp, Bath, Avon, England; [Neto, Joao Quariguasi Frota] Univ Manchester, AMBS, Manchester, Lancs, England; [Vasilakis, Christos] Univ Bath, Sch Management, Ctr Healthcare Innovat & Improvement CHI2, Bath, Avon, England	University of Bath; University of Manchester; University of Bath	Evans-Reeves, KA (corresponding author), Univ Bath, Dept Hlth, Tobacco Control Res Grp, Bath, Avon, England.	K.A.Evans-Reeves@bath.ac.uk		Vasilakis, Christos/0000-0002-0391-0910	Cancer Research UK [C27260/A20488]; UK Centre for Tobacco and Alcohol Studies [MR/K023195/1]	Cancer Research UK(Cancer Research UK); UK Centre for Tobacco and Alcohol Studies	KAER was funded by Cancer Research UK C27260/A20488. JLH was funded by UK Centre for Tobacco and Alcohol Studies MR/K023195/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allem JP, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.6185; Allen HG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068914; Beesley Arthur, 2015, IRISH TIMES; Bollen J, 2011, J COMPUT SCI-NETH, V2, P1, DOI 10.1016/j.jocs.2010.12.007; Campaign for Tobacco Free Kids, PLAIN STAND TOB PACK; Canadian Cancer Society, 2016, PLAIN PACK INT OV; Chantler C., 2014, STANDARDISED PACKAGI; Chapman S, 2014, REMOVING EMPORORS CL; Clark EM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157304; Culotta A, 2013, LANG RESOUR EVAL, V47, P217, DOI 10.1007/s10579-012-9185-0; Department of Health, 2013, CONS STAND PACK TOB; Department of Health, 2014, CONS INTR REG STAND; Department of Health, 2015, GOV BACKS STAND PACK; Durkin S, 2015, TOB CONTROL, V24, pII26, DOI 10.1136/tobaccocontrol-2014-052058; Evans-Reeves KA, 2015, TOB CONTROL, V24, pE168, DOI 10.1136/tobaccocontrol-2014-051930; Field A., 2013, DISCOVERING STAT USI; France 24, FRENCH TOB FUM PLAIN; Freeman B CS, 2010, TOBACCO CONTROL, V19; Gerber MS, 2014, DECIS SUPPORT SYST, V61, P115, DOI 10.1016/j.dss.2014.02.003; Hammond D., 2017, STANDARDIZED PACKAGI; Han SF, 2016, LECT NOTES COMPUT SC, V10047, P307, DOI 10.1007/978-3-319-47874-6_22; Harris JK, 2014, J MED INTERNET RES, V16, DOI [10.2196/jmir.2972, 10.2196/jmir.3622]; Harris JK, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.140402; Harris JK, 2014, AM J PUBLIC HEALTH, V104, pE62, DOI 10.2105/AJPH.2013.301860; Hatchard JL, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012634; Hatchard JL, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003757; Hefler M, 2013, TOB CONTROL, V22, P210, DOI 10.1136/tobaccocontrol-2012-050721; Hogarth L, 2015, ADDICTION, V110, P174, DOI 10.1111/add.12756; Huang JD, 2014, TOB CONTROL, V23, P26, DOI 10.1136/tobaccocontrol-2014-051551; Kavuluru R, 2016, J BIOMED INFORM, V61, P19, DOI 10.1016/j.jbi.2016.03.006; Kim AE, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4466; Krippendorff K., 2013, CONTENT ANAL INTRO I; Laverty AA, 2015, TOB CONTROL, V24, P422, DOI 10.1136/tobaccocontrol-2014-052051; Love B, 2013, AM J INFECT CONTROL, V41, P568, DOI 10.1016/j.ajic.2012.10.016; Lovejoy K, 2012, J COMPUT-MEDIAT COMM, V17, P337, DOI 10.1111/j.1083-6101.2012.01576.x; McNeill A., PLAIN PACKAGING WEIG, DOI [10.1111/(ISSN)1360-0443/homepage/plain_packaging.htm, DOI 10.1111/(ISSN)1360-0443/HOMEPAGE/PLAIN_PACKAGING.HTM]; Moodie C, 2012, PLAIN TOBACCO PACKAG; Pak A, 2011, P INT WORKSH DAT EXP; Powell DA, 2012, INNOV HIGH EDUC, V37, P271, DOI 10.1007/s10755-011-9207-7; Savell E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087389; Saxton GD, 2011, NONPROF VOLUNT SEC Q, V40, P270, DOI 10.1177/0899764009341086; Scollo M, 2015, TOB CONTROL, V24, pII66, DOI 10.1136/tobaccocontrol-2014-052071; Siddique Haroon, 2016, GUARDIAN; Smith KE, 2013, TOB CONTROL, V22, P144, DOI 10.1136/tobaccocontrol-2011-050098; Statista, 2016, NUMB MONTHL ACT TWIT; Su LYF, 2015, J MASS COMMUN Q, V92, P597, DOI 10.1177/1077699015586415; Swift E, 2015, TOB CONTROL, V24, P616, DOI 10.1136/tobaccocontrol-2014-051880; TobaccoTactics, 2014, BAT FUND LOBB PLAIN; TobaccoTactics, 2016, PLAIN PACK UK TCRG R; TobaccoTactics, 2016, PLAIN PACK UK OPP FO; Torjesen I., 2015, BMJ, V350; Tumasjan A, 2011, SOC SCI COMPUT REV, V29, P402, DOI 10.1177/0894439310386557; UK Government, 2015, PUBL HLTH STAND PACK; Ulucanlar S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002125; Ulucanlar S, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001629; van der Tempel J, 2016, INT J PUBLIC HEALTH, V61, P249, DOI 10.1007/s00038-016-0791-2; Waa A.M., 2016, TOBACCO CONTROL; Wakefield M, 2015, TOB CONTROL, V24, pII17, DOI 10.1136/tobaccocontrol-2014-052050; Wakefield MA, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003175; Wang YZ, 2015, ACM T WEB, V9, DOI 10.1145/2746366; Waters R. D., 2007, NONPROFIT MANAGEMENT, V18, P59, DOI [10.1002/nml.171, DOI 10.1002/NML.171]; Young JM, 2014, MED J AUSTRALIA, V200, P29, DOI 10.5694/mja13.11070; Zacher M, 2014, ADDICTION, V109, P653, DOI 10.1111/add.12466	64	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0211758	10.1371/journal.pone.0211758	http://dx.doi.org/10.1371/journal.pone.0211758			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8EU	30807582	Green Submitted, Green Published, gold			2022-12-27	WOS:000459712100005
J	Takakusagi, Y; Kawamura, H; Okamoto, M; Kaminuma, T; Kubo, N; Mizukami, T; Sato, H; Onishi, M; Ohtake, N; Sekihara, T; Nakano, T				Takakusagi, Yosuke; Kawamura, Hidemasa; Okamoto, Masahiko; Kaminuma, Takuya; Kubo, Nobuteru; Mizukami, Tatsuji; Sato, Hiro; Onishi, Masahiro; Ohtake, Nobuaki; Sekihara, Tetsuo; Nakano, Takashi			Long-term outcome of hypofractionated intensity-modulated radiotherapy using TomoTherapy for localized prostate cancer: A retrospective study	PLOS ONE			English	Article							RADIATION-DOSE RESPONSE; HELICAL TOMOTHERAPY; ALPHA/BETA RATIO; 5-YEAR OUTCOMES; NON-INFERIORITY; GY; FRACTIONATION; TOXICITY; THERAPY; RATES	Background Recently, the clinical outcome of prostate cancer treated by hypofractionated radiation therapy has been reported. However, there are few reports from Japan. In Hidaka Hospital, hypofractionated intensity-modulated radiotherapy (HIMRT) for prostate cancer was initiated in 2007. The purpose of this study is to analyze the long-term outcome. Methods Ninety-two patients with localized prostate cancer treated with HIMRT at Hidaka Hospital between 2007 and 2009 were retrospectively analyzed. HIMRT was delivered using TomoTherapy. The prescription dose was 66 Gy at 95% of the PTV in 22 fractions performed 3 days a week over 7 weeks in all patients. The overall survival rate, biochemical relapse-free rate, and acute and late toxicities were evaluated. Results The median follow-up duration was 78 (range 14-100) months. The median age at the start of the HIMRT was 72 (range 46-84) years. The disease characteristics were as follows: stage T1c, 45; T2a, 20; T2b, 5; T2c, 1; T3a, 13; T3b, 6; T4, 2; Gleason score 6, 13; 7, 44; 8, 20; 9, 15; 10, 0; pretreatment PSA <= 10 ng/mL, 42; 10 to <= 20, 27; and >20, 23. According to the D'Amico classification system, 10, 37, and 45 patients were classified as low-risk, intermediate-risk, and high-risk. The overall survival rate, the cause-specific survival rate, and the biochemical relapse-free rate at 5 years was 94.7%, 100% and 98.9%, respectively. Severe acute toxicity (grade 3 or more) was not observed. The late urinary toxicity was 52.2% in grade 0, 28.3% in grade 1, 19.6% in grade 2, and 2.2% in grade 3. The late rectal toxicity was 78.3% in grade 0, 7.6% in grade 1, 9.8% in grade 2, and 4.3% in grade 3. Conclusions The present study demonstrated that HIMRT using TomoTherapy for prostate cancer has a favorable outcome with tolerable toxicity.	[Takakusagi, Yosuke; Kawamura, Hidemasa; Okamoto, Masahiko; Kaminuma, Takuya; Kubo, Nobuteru; Mizukami, Tatsuji; Sato, Hiro; Onishi, Masahiro; Nakano, Takashi] Gunma Univ, Grad Sch Med, Dept Radiat Oncol, Showa Machi, Maebashi, Gunma, Japan; [Takakusagi, Yosuke; Kawamura, Hidemasa] Hidaka Hosp, Oncol Ctr, Nakao Machi, Takasaki, Gunma, Japan; [Ohtake, Nobuaki; Sekihara, Tetsuo] Hidaka Hosp, Dept Urol, Nakao Machi, Takasaki, Gunma, Japan	Gunma University	Kawamura, H (corresponding author), Gunma Univ, Grad Sch Med, Dept Radiat Oncol, Showa Machi, Maebashi, Gunma, Japan.; Kawamura, H (corresponding author), Hidaka Hosp, Oncol Ctr, Nakao Machi, Takasaki, Gunma, Japan.	kawa@gunma-u.ac.jp	Kaminuma, Takuya/ABG-1541-2021; Sato, Hiro/GWU-7659-2022	Kaminuma, Takuya/0000-0003-3527-5525; 				Akimoto T, 2004, INT J RADIAT ONCOL, V60, P1033, DOI 10.1016/j.ijrobp.2004.07.695; Akimoto T, 2004, INT J RADIAT ONCOL, V59, P372, DOI 10.1016/j.ijrobp.2003.10.033; Aluwini S, 2016, LANCET ONCOL, V17, P464, DOI 10.1016/S1470-2045(15)00567-7; Brenner DJ, 2004, INT J RADIAT ONCOL, V60, P1013, DOI 10.1016/j.ijrobp.2004.04.014; Brenner DJ, 2002, INT J RADIAT ONCOL, V52, P6; Brenner DJ, 1999, INT J RADIAT ONCOL, V43, P1095, DOI 10.1016/S0360-3016(98)00438-6; Catton CN, 2017, J CLIN ONCOL, V35, P1884, DOI 10.1200/JCO.2016.71.7397; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; D'Souza WD, 2001, INT J RADIAT ONCOL, V51, P1, DOI 10.1016/S0360-3016(01)01650-9; Dearnaley D, 2016, LANCET ONCOL, V17, P1047, DOI 10.1016/S1470-2045(16)30102-4; Fowler JF, 2005, ACTA ONCOL, V44, P265, DOI 10.1080/02841860410002824; Fowler JF, 2003, INT J RADIAT ONCOL, V56, P1093, DOI 10.1016/S0360-3016(03)00132-9; Hashimoto Y, 2018, INT J CLIN ONCOL, V23, P165, DOI 10.1007/s10147-017-1175-1; Haustermans K, 2000, INT J RADIAT ONCOL, V48, P303, DOI 10.1016/S0360-3016(00)00562-9; King CR, 2001, INT J RADIAT ONCOL, V51, P213, DOI 10.1016/S0360-3016(01)01651-0; Kong M, 2014, ONCOTARGETS THER, V7, P553, DOI 10.2147/OTT.S61465; Kupelian PA, 2000, INT J RADIAT ONCOL, V46, P567, DOI 10.1016/S0360-3016(99)00455-1; Kupelian PA, 2002, INT J RADIAT ONCOL, V53, P904, DOI 10.1016/S0360-3016(02)02836-5; Kupelian PA, 2001, INT J RADIAT ONCOL, V50, P621, DOI 10.1016/S0360-3016(01)01466-3; Lyons JA, 2000, UROLOGY, V55, P85, DOI 10.1016/S0090-4295(99)00380-5; Mackie TR, 2006, PHYS MED BIOL, V51, pR427, DOI 10.1088/0031-9155/51/13/R24; MACKIE TR, 1993, MED PHYS, V20, P1709, DOI 10.1118/1.596958; Pollack A, 2002, INT J RADIAT ONCOL, V53, P1097, DOI 10.1016/S0360-3016(02)02829-8; Sanfilippo NJ, 2014, AM J CLIN EXP UROL, V2, P286; Sanguineti G, 2006, INT J RADIAT ONCOL, V64, P151, DOI 10.1016/j.ijrobp.2005.06.026; Spyropoulou Despina, 2012, ISRN Oncol, V2012, P410892, DOI 10.5402/2012/410892; Takeda K, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-105; Tomita N, 2013, J RADIAT RES, V54, P919, DOI 10.1093/jrr/rrt025; Tucker SL, 2011, INT J RADIAT ONCOL, V81, P600, DOI 10.1016/j.ijrobp.2010.11.080; Zelefsky MJ, 2008, INT J RADIAT ONCOL, V70, P1124, DOI 10.1016/j.ijrobp.2007.11.044	30	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0211370	10.1371/journal.pone.0211370	http://dx.doi.org/10.1371/journal.pone.0211370			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807581	Green Published, Green Submitted, gold			2022-12-27	WOS:000459712100004
J	Huang, Q; Sun, D; Hussain, MZ; Liu, YG; Morozova-Roche, LA; Zhang, C				Huang, Qin; Sun, Dan; Hussain, Muhammad Zubair; Liu, Yonggang; Morozova-Roche, Ludmilla A.; Zhang, Ce			HEWL interacts with dissipated oleic acid micelles, and decreases oleic acid cytotoxicity	PLOS ONE			English	Article							FATTY-ACIDS; TRANSPORT; BRAIN; NEUROTOXICITY; PROTEINS	Senile plaques are well-known hallmarks of Alzheimer's Diseases (AD). However, drugs targeting tangles of the protein tau and plaques of beta-amyloid have no significant effect on disease progression, and the studies on the underlying mechanism of AD remain in high demand. Growing evidence supports the protective role of senile plaques in local inflammation driven by S100A9. We herein demonstrate that oleic acid (OA) micelles interact with hen egg white lysozyme (HEWL) and promote its amyloid formation. Consequently, SH-SY5Y cell line and mouse neural stem cells are rescued from OA toxicity by co-aggregation of OA and HEWL. Using atomic force microscopy in combination with fluorescence microscopy, we revealed that HEWL forms round-shaped aggregates in the presence of OA micelles instead of protofibrils of HEWL alone. These HEWL amyloids act as a sink for toxic OA micelles and their co-aggregate form large clumps, suggesting a protective function in amyloid and OA cytotoxicity.	[Huang, Qin; Liu, Yonggang] Chongqing Med Univ, Lab Stem Cell & Tissue Engn, Chongqing, Peoples R China; [Huang, Qin; Sun, Dan; Zhang, Ce] Northwest Univ, Inst Photon & Photon Technol, State Key Lab Cultivat Base Photoelect Technol &, Xian, Shaanxi, Peoples R China; [Hussain, Muhammad Zubair] Govt Emerson Coll, Dept Zool, Multan, Pakistan; [Hussain, Muhammad Zubair; Liu, Yonggang; Morozova-Roche, Ludmilla A.; Zhang, Ce] Umea Univ, Dept Med Biochem & Biophys, Umea, Sweden	Chongqing Medical University; Northwest University Xi'an; Umea University	Liu, YG (corresponding author), Chongqing Med Univ, Lab Stem Cell & Tissue Engn, Chongqing, Peoples R China.; Zhang, C (corresponding author), Northwest Univ, Inst Photon & Photon Technol, State Key Lab Cultivat Base Photoelect Technol &, Xian, Shaanxi, Peoples R China.; Liu, YG; Morozova-Roche, LA; Zhang, C (corresponding author), Umea Univ, Dept Med Biochem & Biophys, Umea, Sweden.	100418@cqmu.edu.cn; ludmilla.morozova-roche@umu.se; zhangce.univ@gmail.com	Morozova-Roche, Ludmilla A./AAU-9044-2021; Liu, Yong/GWQ-6163-2022	Zhang, Ce/0000-0003-1284-7279	Chongqing Basic and Frontier Research Program [cstc2015jcyjA10034]; Swedish Medical Research Council [2014-3241]; Insamlingsstiftelsen [FS 2.1.12-1605-14]; Biochemical Imaging Platform, Umea University	Chongqing Basic and Frontier Research Program; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Insamlingsstiftelsen; Biochemical Imaging Platform, Umea University	This work was supported by the Chongqing Basic and Frontier Research Program. Project (cstc2015jcyjA10034), Swedish Medical Research Council (2014-3241 to L.A.M.-R.), Insamlingsstiftelsen (FS 2.1.12-1605-14 to L.A.M.-R.), Biochemical Imaging Platform, Umea University (to L.A.M.-R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedini A, 2009, PROTEIN ENG DES SEL, V22, P453, DOI 10.1093/protein/gzp036; Aisen PS, 1997, GERONTOLOGY, V43, P143; Behnan J, 2016, NEUROEPIGENETICS, V7, P6, DOI DOI 10.1016/j.nepig.2016.08.002; Calon F, 2004, NEURON, V43, P633, DOI 10.1016/j.neuron.2004.08.013; Cury-Boaventura MF, 2004, CLIN NUTR, V23, P721, DOI 10.1016/j.clnu.2003.12.004; Di Sabatino A, 2011, MUCOSAL IMMUNOL, V4, P574, DOI 10.1038/mi.2011.18; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Fontana A, 2013, BBA-PROTEINS PROTEOM, V1834, P1125, DOI 10.1016/j.bbapap.2013.02.041; Fraser PE, 2010, J NEUROCHEM, V61, P298; Golde TE, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt233; Grela A, 2016, CLIN CHEM LAB MED, V54, P197, DOI 10.1515/cclm-2015-0394; Grimm MOW, 2012, J NUTR BIOCHEM, V23, P1214, DOI 10.1016/j.jnutbio.2011.06.015; Guardia P, 2007, J MAGN MAGN MATER, V316, pE756, DOI 10.1016/j.jmmm.2007.03.085; Hamazaki K, 2013, PSYCHIAT RES, V210, P346, DOI 10.1016/j.psychres.2013.05.006; Hamilton JA, 1999, PROSTAG LEUKOTR ESS, V60, P291, DOI 10.1016/S0952-3278(99)80002-7; Hamilton LK, 2017, FATE FAT NEUTRAL LIP; Hussain MM, 2013, CLIN LIPIDOL, V8, P481, DOI [10.2217/CLP.13.40, 10.2217/clp.13.40]; Kamijima T, 2008, BIOCHEM BIOPH RES CO, V376, P211, DOI 10.1016/j.bbrc.2008.08.127; Ketones CSC, 2018, EDP SCI; Krajnak K, 2018, BIOORGANIC MED CHEM; LAI JCK, 1991, NEUROCHEM RES, V16, P795, DOI 10.1007/BF00965689; Lim GP, 2005, J NEUROSCIENCE OFFIC, P3032; Liskova K, 2010, J AGR FOOD CHEM, V58, P4421, DOI 10.1021/jf903901j; Liu J, 2016, DRUGS AGING, V33, P1; Liu RZ, 2010, INT J DEV BIOL, V54, P1229, DOI 10.1387/ijdb.092976rl; Ma BL, 2017, INT J BIOL MACROMOL, V98, P717, DOI 10.1016/j.ijbiomac.2017.01.128; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Martins DLT, 2006, CLIN SCI, P307, DOI DOI 10.1016/J.IJBIOMAC.2017.01.128; Mitchell RW, 2011, J NEUROCHEM, V117, P735, DOI 10.1111/j.1471-4159.2011.07245.x; Onur B, 2010, EUROPEAN J NEUROSCIE, V25, P1006; Pan YJ, 2015, MOL PHARMACEUT, V12, P4375, DOI 10.1021/acs.molpharmaceut.5b00580; Passingham RE, 2002, NAT REV NEUROSCI, V3, P606, DOI 10.1038/nrn893; PERLMUTTER LS, 1990, NEUROSCI LETT, V119, P32, DOI 10.1016/0304-3940(90)90748-X; Podtelezhnikov AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029610; Reynolds LM, 2001, NEUROSCI LETT, V309, P193, DOI 10.1016/S0304-3940(01)02071-7; Riek R, 2016, NATURE, V539, P227, DOI 10.1038/nature20416; Schappe MS, 2018, IMMUNITY, V48, P59, DOI 10.1016/j.immuni.2017.11.026; Schneider SA, 2017, CURRENT DRUG; Schweiger M, 2012, J LIPID RES, V53, P2307, DOI 10.1194/jlr.M027409; Sebastien CD, 2010, TARGETED TRANSGENE E, V24, P1535; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Sipe JD, 2012, AMYLOID, V19, P167, DOI 10.3109/13506129.2012.734345; Snowden SG, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002266; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Svensson M, 2000, CONVERSION MIN PROTE, V97, P4375; Sykova Eva, 2013, Laser Ther, V22, P87, DOI 10.3136/islsm.22.87; Tan J, 1999, SCIENCE, V286, P2352, DOI 10.1126/science.286.5448.2352; Tarasoff-Conway JM, 2016, NAT REV NEUROL, V12, P248, DOI 10.1038/nrneurol.2016.36; Tugizov S, 2005, J VIROL, V79, P1099, DOI 10.1128/JVI.79.2.1099-1112.2005; van Dyck CH, 2018, BIOL PSYCHIAT, V83, P311, DOI 10.1016/j.biopsych.2017.08.010; Wilson DM, 1997, AM J PATHOL, V150, P2181; Yadav RS, 2014, MOL NEUROBIOL, V50, P168, DOI 10.1007/s12035-014-8661-5; Young SG, 2013, GENE DEV, V27, P459, DOI 10.1101/gad.209296.112; Zhang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032953	54	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212648	10.1371/journal.pone.0212648	http://dx.doi.org/10.1371/journal.pone.0212648			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794655	gold, Green Published, Green Submitted			2022-12-27	WOS:000459709100105
J	Lage, R; Cebro-Marquez, M; Rodriguez-Manero, M; Gonzalez-Juanatey, JR; Moscoso, I				Lage, Ricardo; Cebro-Marquez, Maria; Rodriguez-Manero, Moises; Ramon Gonzalez-Juanatey, Jose; Moscoso, Isabel			Omentin protects H9c2 cells against docetaxel cardiotoxicity	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; OXIDATIVE STRESS; CARDIOVASCULAR-DISEASE; BREAST-CANCER; RISK-FACTORS; APOPTOSIS; DOXORUBICIN; CHEMOTHERAPY; OBESITY; ANTHRACYCLINES	Background Association between obesity and cardiovascular diseases is well known, however increased susceptibility of obese patients to develop several cancer types is not so commonly known. Current data suggest that poorer overall survival in cancer patients might be associated to non-cancer-related causes such as higher risk of cardiotoxicity in obese patients treated with chemotherapeutic agents. Omentin, a novel adipokine decreased in obesity, is actually in the spotlight due to its favourable effects on inflammation, glucose homeostasis and cardiovascular diseases. Also, recent data showed that in vitro anthracycline-induced cardiomyocyte apoptosis is counteracted by omentin suggesting its cardioprotective role. Objective Our aim was to evaluate omentin effects against docetaxel toxicity. Results Our data indicate that omentin inhibits docetaxel-induced viability loss and that increased viability is associated to decreased caspase-3 expression and cell death. Although omentin reduces NOX4 expression, it failed to reduce docetaxel-induced reactive oxygen species production. Our results indicate that omentin decreases docetaxel-induced endoplasmic reticulum stress, suggesting that cardioprotective role might be associated to ERS inhibition. Conclusion These data suggest that omentin treatment may contribute to decrease susceptibility to DTX-induced cardiotoxicity.	[Lage, Ricardo; Cebro-Marquez, Maria; Ramon Gonzalez-Juanatey, Jose; Moscoso, Isabel] Univ Santiago de Compostela, Ctr Res Mol Med & Chron Dis CIMUS, Cardiol Grp, Santiago De Compostela, Spain; [Lage, Ricardo; Cebro-Marquez, Maria; Ramon Gonzalez-Juanatey, Jose; Moscoso, Isabel] Univ Clin Hosp Santiago De Compostela, Hlth Res Inst, Santiago De Compostela, Spain; [Lage, Ricardo; Rodriguez-Manero, Moises; Ramon Gonzalez-Juanatey, Jose; Moscoso, Isabel] Ctr Invest Biomed Red Enfermedades Cardiovasc CIB, Madrid, Spain; [Rodriguez-Manero, Moises; Ramon Gonzalez-Juanatey, Jose] Univ Clin Hosp Santiago De Compostela, Dept Cardiol, Santiago De Compostela, Spain; [Rodriguez-Manero, Moises; Ramon Gonzalez-Juanatey, Jose] Univ Clin Hosp Santiago De Compostela, Coronary Unit, Santiago De Compostela, Spain	Universidade de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela	Lage, R; Moscoso, I (corresponding author), Univ Santiago de Compostela, Ctr Res Mol Med & Chron Dis CIMUS, Cardiol Grp, Santiago De Compostela, Spain.; Lage, R; Moscoso, I (corresponding author), Univ Clin Hosp Santiago De Compostela, Hlth Res Inst, Santiago De Compostela, Spain.; Lage, R; Moscoso, I (corresponding author), Ctr Invest Biomed Red Enfermedades Cardiovasc CIB, Madrid, Spain.	rlagef@gmail.com; imosgal@gmail.com	Moscoso, Isabel/GXZ-9513-2022; Rodríguez-Mañero, Moisés/R-6110-2019	Moscoso, Isabel/0000-0002-6078-4666; Rodríguez-Mañero, Moisés/0000-0001-7566-9321; Cebro-Marquez, Maria/0000-0001-6427-7955; Lage Fernandez, Ricardo/0000-0002-8779-7723; Gonzalez Juanatey, Jose Ramon/0000-0001-9681-3388	Fundacion Mutua Madrilena 2014; Red de Investigacion Cardiovascular (RIC) an initiative of ISCIII [RD12/0042/0039]; Programa de Consolidacion de Unidades de Investigacion Competitivas do SUG of Xunta de Galicia [GPC 2013-051]; Centro de Investigacion Biomedica en Red de Enfermedades Cardiovasculares (CIBERCV) of Instituto de Salud Carlos III [CB16/11/00226]	Fundacion Mutua Madrilena 2014; Red de Investigacion Cardiovascular (RIC) an initiative of ISCIII; Programa de Consolidacion de Unidades de Investigacion Competitivas do SUG of Xunta de Galicia; Centro de Investigacion Biomedica en Red de Enfermedades Cardiovasculares (CIBERCV) of Instituto de Salud Carlos III	This work was supported by Fundacion Mutua Madrilena 2014 (R.L.), Red de Investigacion Cardiovascular (RIC) (RD12/0042/0039) an initiative of ISCIII (J.R.G-J), Programa de Consolidacion de Unidades de Investigacion Competitivas do SUG (GPC 2013-051) of Xunta de Galicia (J.R.G-J) and Centro de Investigacion Biomedica en Red de Enfermedades Cardiovasculares (CIBERCV) (CB16/11/00226) of Instituto de Salud Carlos III (J.R.G-J). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avril T, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.72; Azfer A, 2006, AM J PHYSIOL-HEART C, V291, pH1411, DOI 10.1152/ajpheart.01378.2005; Batista CMDS, 2007, DIABETES, V56, P1655, DOI 10.2337/db06-1506; Berardi R, 2013, CRIT REV ONCOL HEMAT, V88, P75, DOI 10.1016/j.critrevonc.2013.02.007; Brown SA, 2015, NAT REV CLIN ONCOL, V12, P718, DOI 10.1038/nrclinonc.2015.168; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Chong WC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040771; Cueva JF, 2017, CLIN TRANSL ONCOL, V19, P1067, DOI 10.1007/s12094-017-1648-8; Curigliano G, 2016, CA-CANCER J CLIN, V66, P310, DOI 10.3322/caac.21341; Duarte CW, 2017, JCO CLIN CANCER INFO, V1, DOI 10.1200/CCI.16.00071; Fulbright JM, 2015, CANCER CHEMOTH PHARM, V76, P1297, DOI 10.1007/s00280-015-2879-4; Gu NB, 2017, BRAIN RES BULL, V130, P27, DOI 10.1016/j.brainresbull.2016.12.006; Guenancia C, 2016, J CLIN ONCOL, V34, P3157, DOI 10.1200/JCO.2016.67.4846; Guenancia C, 2016, CANCER CHEMOTH PHARM, V77, P777, DOI 10.1007/s00280-016-2995-9; Gundersen GG, 1999, CURR OPIN CELL BIOL, V11, P81, DOI 10.1016/S0955-0674(99)80010-6; HESCHELER J, 1991, CIRC RES, V69, P1476, DOI 10.1161/01.RES.69.6.1476; Hickson J, 2010, CELL DEATH DIFFER, V17, P1003, DOI 10.1038/cdd.2009.205; Hung CH, 2015, TOXICOL SCI, V145, P59, DOI 10.1093/toxsci/kfv017; Iida S, 2013, IN VIVO, V27, P321; Johnson CB, 2016, CAN J CARDIOL, V32, P900, DOI 10.1016/j.cjca.2016.04.008; Kataoka Y, 2014, J AM COLL CARDIOL, V63, P2722, DOI 10.1016/j.jacc.2014.03.032; Kazama K, 2015, BIOCHEM BIOPH RES CO, V457, P602, DOI 10.1016/j.bbrc.2015.01.032; Kazama K, 2014, AM J PHYSIOL-HEART C, V306, pH1714, DOI 10.1152/ajpheart.00048.2014; Kazama K, 2012, EUR J PHARMACOL, V686, P116, DOI 10.1016/j.ejphar.2012.04.033; Kovesdy CP, 2017, J NEPHROL, V30, P1, DOI 10.1007/s40620-017-0377-y; Kuznetsov AV, 2015, BBA-MOL CELL RES, V1853, P276, DOI 10.1016/j.bbamcr.2014.11.015; Maeda K, 2016, J CANCER, V7, P207, DOI 10.7150/jca.13732; Mahmood SS, 2014, LANCET, V383, P999, DOI 10.1016/S0140-6736(13)61752-3; Maruyama S, 2012, J BIOL CHEM, V287, P408, DOI 10.1074/jbc.M111.261818; Maruyama S, 2011, J BIOL CHEM, V286, P32790, DOI 10.1074/jbc.M111.245985; Mathur A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103109; Mhaidat N, 2008, APOPTOSIS, V13, P1505, DOI 10.1007/s10495-008-0276-8; Mitra MS, 2008, TOXICOL APPL PHARM, V231, P413, DOI 10.1016/j.taap.2008.05.006; Nishitoh H, 2012, J BIOCHEM, V151, P217, DOI 10.1093/jb/mvr143; Ogura T, 2016, INT J ONCOL, V48, P2330, DOI 10.3892/ijo.2016.3482; Olsen SR, 2005, BIOMED PHARMACOTHER, V59, pS306, DOI 10.1016/S0753-3322(05)80052-6; Picon-Ruiz M, 2017, CA-CANCER J CLIN, V67, P379, DOI 10.3322/caac.21405; Qian DZ, 2010, PROSTATE, V70, P433, DOI 10.1002/pros.21077; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Rohena CC, 2014, NAT PROD REP, V31, P335, DOI 10.1039/c3np70092e; Sahin F, 2008, HEMATOLOGY, V13, P215, DOI 10.1179/102453308X315997; Shibata R, 2014, CYTOKINE GROWTH F R, V25, P483, DOI 10.1016/j.cytogfr.2014.07.005; Smekal A, 2017, BIOMED PAP, V161, P31, DOI 10.5507/bp.2017.002; Spallarossa P, 2016, J CARDIOVASC MED, V17, pS84, DOI 10.2459/JCM.0000000000000381; Staren'kii V P, 2003, Radiats Biol Radioecol, V43, P640; Tabaczar S, 2013, GEN PHYSIOL BIOPHYS, V32, P535, DOI 10.4149/gpb_2013048; Tan YL, 2015, CLIN CHIM ACTA, V448, P98, DOI 10.1016/j.cca.2015.05.019; Theccanat T, 2016, CELL SIGNAL, V28, P190, DOI 10.1016/j.cellsig.2015.11.013; Todaro MC, 2013, INT J CARDIOL, V168, P680, DOI 10.1016/j.ijcard.2013.03.133; Tsuru A, 2016, SCI REP-UK, V6, DOI 10.1038/srep24217; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Wu S, 2007, CLIN EXP PHARMACOL P, V34, P81, DOI 10.1111/j.1440-1681.2007.04540.x; Yang ZJ, 2009, J LIPOSOME RES, V19, P122, DOI 10.1080/08982100802632649; Younce CW, 2010, BIOCHEM J, V426, P43, DOI 10.1042/BJ20090976; Zhang ZM, 2017, APOPTOSIS, V22, P647, DOI 10.1007/s10495-017-1351-9	55	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212782	10.1371/journal.pone.0212782	http://dx.doi.org/10.1371/journal.pone.0212782			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794687	gold, Green Published, Green Submitted			2022-12-27	WOS:000459709100137
J	Armas, F; Pacor, S; Ferrari, E; Guida, F; Pertinhez, TA; Romani, AA; Scocchi, M; Benincasa, M				Armas, Federica; Pacor, Sabrina; Ferrari, Elena; Guida, Filomena; Pertinhez, Thelma A.; Romani, Antonello A.; Scocchi, Marco; Benincasa, Monica			Design, antimicrobial activity and mechanism of action of Arg-rich ultra-short cationic lipopeptides	PLOS ONE			English	Article							BACTERIAL OUTER-MEMBRANE; ANTIBACTERIAL ACTIVITY; CYTOPLASMIC MEMBRANE; PLAUSIBLE MODE; SIDE-CHAINS; POLYMYXIN-B; IN-VITRO; PEPTIDES; ANTIFUNGAL; CONJUGATION	The increasing emergence of multidrug-resistant microorganisms represents one of the greatest challenges in the clinical management of infectious diseases, and requires the development of novel antimicrobial agents. To this aim, we de novo designed a library of Arg-rich ultra-short cationic antimicrobial lipopeptides (USCLs), based on the Arg-X-Trp-Arg-NH2 peptide moiety conjugated with a fatty acid, and investigated their antibacterial potential. USCLs exhibited an excellent antimicrobial activity against clinically pathogenic microorganisms, in particular Gram-positive bacteria, including multidrug resistant strains, with MIC values ranging between 1.56 and 6.25 mu g/mL. The capability of the two most active molecules, Lau-RIWR-NH2 and Lau-RRIWRR-NH2, to interact with the bacterial membranes has been predicted by molecular dynamics and verified on liposomes by surface plasmon resonance. Both compounds inhibited the growth of S. aureus even at sub MIC concentrations and induced cell membranes permeabilization by producing visible cell surface alterations leading to a significant decrease in bacterial viability. Interestingly, no cytotoxic effects were evidenced for these lipopeptides up to 50-100 mu g/mL in hemolysis assay, in human epidermal model and HaCaT cells, thus highlighting a good cell selectivity. These results, together with the simple composition of USCLs, make them promising lead compounds as new antimicrobials.	[Armas, Federica; Pacor, Sabrina; Guida, Filomena; Scocchi, Marco; Benincasa, Monica] Univ Trieste, Dept Life Sci, Trieste, Italy; [Armas, Federica] Area Sci Pk, Trieste, Italy; [Ferrari, Elena; Pertinhez, Thelma A.] Univ Parma, Dept Med & Surg, Parma, Italy; [Guida, Filomena] Univ Trieste, Dept Engn & Architecture, Trieste, Italy; [Pertinhez, Thelma A.] AUSL IRCCS Reggio Emilia, Transfus Med Unit, Reggio Emilia, Italy; [Romani, Antonello A.] Arta Peptid Srls, Parma, Italy	University of Trieste; University of Parma; University of Trieste	Benincasa, M (corresponding author), Univ Trieste, Dept Life Sci, Trieste, Italy.	mbenincasa@units.it		Armas, Federica/0000-0001-8034-2972	University of Trieste (FRA 2016); Area Science Park of Trieste	University of Trieste (FRA 2016); Area Science Park of Trieste	This study was carried out with the financial support of the University of Trieste (FRA 2016). F. Armas was supported by the fellowship grant "Made in Trieste" from the Area Science Park of Trieste. I declare that the commercial affiliation Arta Peptidion only provided support in the form of research materials, in particular this company provided us the lipopeptides used in this study. The company did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the "author contributions" section.	Ageitos JM, 2017, BIOCHEM PHARMACOL, V133, P117, DOI 10.1016/j.bcp.2016.09.018; Ahlstrom B, 1997, ANTIMICROB AGENTS CH, V41, P544, DOI 10.1128/AAC.41.3.544; Aoki W, 2013, PHARMACEUTICALS-BASE, V6, P1055, DOI 10.3390/ph6081055; Arias M, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8020019; Avrahami D, 2004, J BIOL CHEM, V279, P12277, DOI 10.1074/jbc.M312260200; Avrahami D, 2003, BIOCHEMISTRY-US, V42, P14946, DOI 10.1021/bi035142v; Avrahami D, 2002, BIOCHEMISTRY-US, V41, P2254, DOI 10.1021/bi011549t; Benincasa M, 2004, PEPTIDES, V25, P2055, DOI 10.1016/j.peptides.2004.08.004; Benincasa M, 2006, J ANTIMICROB CHEMOTH, V58, P950, DOI 10.1093/jac/dkl382; Bin Zaman S, 2017, CUREUS, V9, DOI 10.7759/cureus.1403; BLONDELLE SE, 1995, J APPL BACTERIOL, V78, P39, DOI 10.1111/j.1365-2672.1995.tb01671.x; Brandenburg Klaus, 2010, Anti-Infective Agents in Medicinal Chemistry, V9, P9; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; Cirioni O, 2011, J ANTIMICROB CHEMOTH, V66, P859, DOI 10.1093/jac/dkr001; Clifton LA, 2015, LANGMUIR, V31, P404, DOI 10.1021/la504407v; de Lucca AJ, 1999, ANTIMICROB AGENTS CH, V43, P1, DOI 10.1093/jac/43.1.1; DOLZANI L, 1994, FEMS MICROBIOL LETT, V119, P167, DOI 10.1016/0378-1097(94)90409-X; Dryden MS, 2009, INT J ANTIMICROB AG, V34, pS2, DOI 10.1016/S0924-8579(09)70541-2; ECDC ECfDPaC, 2016, SURV ATL INF DIS; Eckhard LH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162537; Falagas ME, 2006, CRIT CARE, V10, DOI 10.1186/cc3995; Falagas ME, 2010, DRUG RESIST UPDATE, V13, P132, DOI 10.1016/j.drup.2010.05.002; Findlay B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041141; Findlay B, 2012, INT J ANTIMICROB AG, V40, P36, DOI 10.1016/j.ijantimicag.2012.03.013; Gordon YJ, 2005, CURR EYE RES, V30, P505, DOI 10.1080/02713680590968637; Grau-Campistany A, 2016, BBA-BIOMEMBRANES, V1858, P333, DOI 10.1016/j.bbamem.2015.11.011; Ha BY, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051902; HOBDEN C, 1995, MICROBIOL-UK, V141, P1875, DOI 10.1099/13500872-141-8-1875; Horn JN, 2013, BIOCHEMISTRY-US, V52, P5604, DOI 10.1021/bi400773q; Huang E, 2014, APPL ENVIRON MICROB, V80, P2700, DOI 10.1128/AEM.03775-13; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Hurdle JG, 2011, NAT REV MICROBIOL, V9, P62, DOI 10.1038/nrmicro2474; Jerala R, 2007, EXPERT OPIN INV DRUG, V16, P1159, DOI 10.1517/13543784.16.8.1159; Kawashima S, 1999, NUCLEIC ACIDS RES, V27, P368, DOI 10.1093/nar/27.1.368; Lam PL, 2018, CRIT REV MICROBIOL, V44, P40, DOI 10.1080/1040841X.2017.1313811; Laverty G, 2010, CHEM BIOL DRUG DES, V75, P563, DOI 10.1111/j.1747-0285.2010.00973.x; Li LB, 2013, J PHYS CHEM B, V117, P11906, DOI 10.1021/jp405418y; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Makovitzki A, 2008, BIOCHEMISTRY-US, V47, P10630, DOI 10.1021/bi8011675; Makovitzki A, 2006, P NATL ACAD SCI USA, V103, P15997, DOI 10.1073/pnas.0606129103; Malina A, 2005, BIOCHEM J, V390, P695, DOI 10.1042/BJ20050520; Mangoni ML, 2011, CELL MOL LIFE SCI, V68, P2267, DOI 10.1007/s00018-011-0718-2; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; Meir O, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02373-0; Nasompag S, 2015, BBA-BIOMEMBRANES, V1848, P2351, DOI 10.1016/j.bbamem.2015.07.004; Nguyen LT, 2011, BBA-BIOMEMBRANES, V1808, P2297, DOI 10.1016/j.bbamem.2011.05.015; Pacor S, 2018, PEP SCI; Pirtskhalava M, 2016, NUCLEIC ACIDS RES, V44, P6503, DOI 10.1093/nar/gkw243; Podda E, 2006, BBA-GEN SUBJECTS, V1760, P1732, DOI 10.1016/j.bbagen.2006.09.006; Radzishevsky IS, 2005, ANTIMICROB AGENTS CH, V49, P2412, DOI 10.1128/AAC.49.6.2412-2420.2005; Rhodes KA, 2016, DRUG RESIST UPDATE, V28, P82, DOI 10.1016/j.drup.2016.07.003; Roberts KD, 2015, ACS INFECT DIS, V1, P568, DOI 10.1021/acsinfecdis.5b00085; Roch M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02303; Romani AA, 2013, J PEPT SCI, V19, P554, DOI 10.1002/psc.2532; Rotem S, 2008, FASEB J, V22, P2652, DOI 10.1096/fj.07-105015; Sarig H, 2008, ANTIMICROB AGENTS CH, V52, P4308, DOI 10.1128/AAC.00656-08; Serrano GN, 2009, ANTIMICROB AGENTS CH, V53, P2215, DOI 10.1128/AAC.01100-08; Steenbergen JN, 2005, J ANTIMICROB CHEMOTH, V55, P283, DOI 10.1093/jac/dkh546; Straus SK, 2006, BBA-BIOMEMBRANES, V1758, P1215, DOI 10.1016/j.bbamem.2006.02.009; Strom MB, 2003, J MED CHEM, V46, P1567, DOI 10.1021/jm0340039; Tam JP, 2002, EUR J BIOCHEM, V269, P923, DOI 10.1046/j.0014-2956.2001.02728.x; Thomas S, 2010, NUCLEIC ACIDS RES, V38, pD774, DOI 10.1093/nar/gkp1021; Wang GS, 2016, NUCLEIC ACIDS RES, V44, pD1087, DOI 10.1093/nar/gkv1278; Wang WY, 2016, SCI REP-UK, V6, DOI 10.1038/srep24112; WHO, 2017, WHO PUBLISHES LIST B; Xhindoli D, 2015, BIOCHEM J, V465, P443, DOI 10.1042/BJ20141016; Yang X, 2017, MICROBIOL RES, V195, P18, DOI 10.1016/j.micres.2016.11.002	67	25	26	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212447	10.1371/journal.pone.0212447	http://dx.doi.org/10.1371/journal.pone.0212447			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789942	Green Published, Green Submitted, gold			2022-12-27	WOS:000459330800028
J	Chakraborty, N; Gautam, A; Muhie, S; Miller, SA; Moyler, C; Jett, M; Hammamieh, R				Chakraborty, Nabarun; Gautam, Aarti; Muhie, Seid; Miller, Stacy-Ann; Moyler, Candace; Jett, Marti; Hammamieh, Rasha			The responses of lungs and adjacent lymph nodes in responding to Yersinia pestis infection: A transcriptomic study using a non-human primate model	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; PRIMARY PNEUMONIC PLAGUE; HEAT-SHOCK PROTEINS; EPITHELIAL-CELLS; IMMUNE-SYSTEM; HOST RESPONSE; MOUSE MODEL; UBIQUITIN; BINDING; APOPTOSIS	Initiation of treatment during the pre-symptomatic phase of Yersinia pestis (Y. pestis) infection is particularly critical. The rapid proliferation of Y. pestis typically couples with the manifestation of common flu-like early symptoms that often misguides the medical intervention. Our study used African green monkeys (AGM) that did not exhibit clear clinical symptoms for nearly two days after intranasal challenge with Y. pestis and succumbed within a day after showing the first signs of clinical symptoms. The lung, and mediastinal and submandibular lymph nodes (LN) accumulated significant Y. pestis colonization immediately after the intranasal challenge. Hence, organ-specific molecular investigations are deemed to be the key to elucidating mechanisms of the initial host response. Our previous study focused on the whole blood of AGM, and we found early perturbations in the ubiquitin-microtubule-mediated host defense. Altered expression of the genes present in ubiquitin and microtubule networks indicated an early suppression of these networks in the submandibular lymph nodes. In concert, the upstream toll-like receptor signaling and downstream NF kappa B signaling were inhibited at the multi-omics level. The inflammatory response was suppressed in the lungs, submandibular lymph nodes and mediastinal lymph nodes. We posited a causal chain of molecular mechanisms that indicated Y. pestis was probably able to impair host-mediated proteolysis activities and evade autophagosome capture by dysregulating both ubiquitin and microtubule networks in submandibular lymph nodes. Targeting these networks in a submandibular LN-specific and time-resolved fashion could be essential for development of the next generation therapeutics for pneumonic plague.	[Chakraborty, Nabarun; Muhie, Seid] US Army, Geneva Fdn, Ctr Environm Hlth Res, Ft Detrick, MD USA; [Gautam, Aarti; Jett, Marti; Hammamieh, Rasha] US Army, Ctr Environm Hlth Res, Ft Detrick, MD 21702 USA; [Muhie, Seid; Miller, Stacy-Ann; Moyler, Candace] US Army, ORISE, Ctr Environm Hlth Res, Ft Detrick, MD USA	United States Department of Energy (DOE); Oak Ridge Institute for Science & Education	Hammamieh, R (corresponding author), US Army, Ctr Environm Hlth Res, Ft Detrick, MD 21702 USA.	Rasha.Hammamieh1.civ@mail.mil		Hammamieh, Rasha/0000-0001-8643-6232	Defense Threat Reduction Agency [TMTI0029_09_WR_T]	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	The authors would like to acknowledge Defense Threat Reduction Agency (TMTI0029_09_WR_T to M.J.) for funding this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aepfelbacher M, 2005, CURR TOP MICROBIOL, V291, P167; Agar SL, 2008, MICROBIOL-SGM, V154, P1939, DOI 10.1099/mic.0.2008/017335-0; Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Alem F, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00050; Araki N, 2006, FRONT BIOSCI, V11, P1479, DOI 10.2741/1897; Ashida H, 2014, NAT REV MICROBIOL, V12, P399, DOI 10.1038/nrmicro3259; Asrat S, 2015, CELL MICROBIOL, V17, P785, DOI 10.1111/cmi.12445; Banerjee S, 2011, J IMMUNOL, V187, P4686, DOI 10.4049/jimmunol.1101500; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Beyer W, 2009, MOL ASPECTS MED, V30, P481, DOI 10.1016/j.mam.2009.08.004; Byron A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7135; Chitra P, 2011, CLIN CHIM ACTA, V412, P1151, DOI 10.1016/j.cca.2011.01.037; Chitta K, 2015, BRIT J HAEMATOL, V169, P377, DOI 10.1111/bjh.13304; Cho KI, 2014, J BIOL CHEM, V289, P4600, DOI 10.1074/jbc.M113.538215; Choi JA, 2016, COMP IMMUNOL MICROB, V44, P54, DOI 10.1016/j.cimid.2016.01.001; Chung LK, 2016, CURR OPIN MICROBIOL, V29, P56, DOI 10.1016/j.mib.2015.11.001; Chung LK, 2014, MBIO, V5, DOI 10.1128/mBio.01402-14; Collins CA, 2010, TRENDS CELL BIOL, V20, P205, DOI 10.1016/j.tcb.2010.01.002; Cowan C, 2000, INFECT IMMUN, V68, P4523, DOI 10.1128/IAI.68.8.4523-4530.2000; Cui ZM, 2010, J NEUROL SCI, V294, P29, DOI 10.1016/j.jns.2010.04.009; Dehmelt L, 2005, GENOME BIOL, V6; Dufner A, 2015, NAT IMMUNOL, V16, P950, DOI 10.1038/ni.3230; Dumoux M, 2015, J CELL SCI, V128, P3420, DOI 10.1242/jcs.169318; Evans SS, 2015, NAT REV IMMUNOL, V15, P335, DOI 10.1038/nri3843; Fourest-Lieuvin A, 2006, MOL BIOL CELL, V17, P1041, DOI 10.1091/mbc.E05-07-0621; Fullgrabe J, 2010, CELL DEATH DIFFER, V17, P1238, DOI 10.1038/cdd.2010.58; Galindo CL, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/914762; Geoffroy MC, 2009, NAT REV MOL CELL BIO, V10, P564, DOI 10.1038/nrm2707; Glatigny S, 2016, J IMMUNOL, V196, P3542, DOI 10.4049/jimmunol.1502614; Grizenkova J, 2012, P NATL ACAD SCI USA, V109, P13722, DOI 10.1073/pnas.1208917109; GTEx Consortium, 2018, Nature, V553, P530, DOI 10.1038/nature25160; Gusev NB, 2005, BIOCHEMISTRY-MOSCOW+, V70, P629, DOI 10.1007/s10541-005-0162-8; Halpain S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-224; Hamilton DH, 2014, CANCER RES, V74, P2510, DOI 10.1158/0008-5472.CAN-13-1894; Hammamieh R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151788; Haslbeck M, 2015, J MOL BIOL, V427, P1537, DOI 10.1016/j.jmb.2015.02.002; He F, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.56; Holzer M, 2016, SCI REP-UK, V6, DOI 10.1038/srep34589; Huang J, 2014, NAT REV MICROBIOL, V12, P101, DOI 10.1038/nrmicro3160; Ikeda T, 2008, FEBS LETT, V582, P1413, DOI 10.1016/j.febslet.2008.02.081; Jahan AS, 2016, P NATL ACAD SCI USA, V113, pE705, DOI 10.1073/pnas.1521763113; Jamart C, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-166; Kang LH, 2013, NEUROCHEM RES, V38, P311, DOI 10.1007/s11064-012-0922-y; Kawabe J, 2006, BIOCHEM BIOPH RES CO, V342, P164, DOI 10.1016/j.bbrc.2006.01.125; Kim Minsoo, 2014, Cells, V3, P848, DOI 10.3390/cells3030848; Kuo JC, 2013, J CELL MOL MED, V17, P704, DOI 10.1111/jcmm.12054; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Lancini C, 2014, J EXP MED, V211, P1759, DOI 10.1084/jem.20131436; Lanneau D, 2008, J CELL MOL MED, V12, P743, DOI 10.1111/j.1582-4934.2008.00273.x; LaRock CN, 2012, CELL HOST MICROBE, V12, P799, DOI 10.1016/j.chom.2012.10.020; Lathem WW, 2005, P NATL ACAD SCI USA, V102, P17786, DOI 10.1073/pnas.0506840102; Layton RC, 2011, J MED PRIMATOL, V40, P6, DOI 10.1111/j.1600-0684.2010.00443.x; Leduc F, 2008, BIOL REPROD, V78, P324, DOI 10.1095/biolreprod.107.064162; Lee SY, 2014, CELL MOL LIFE SCI, V71, P2747, DOI 10.1007/s00018-013-1526-7; Li CM, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002416; Likhite Neah, 2011, J Biomol Tech, V22, P37; Liu JH, 2014, DIGEST DIS SCI, V59, P1452, DOI 10.1007/s10620-014-3049-y; Liu YC, 2005, NAT REV IMMUNOL, V5, P941, DOI 10.1038/nri1731; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; MacDonald E, 2014, TRAFFIC, V15, P879, DOI 10.1111/tra.12180; Mangahas PM, 2008, J CELL BIOL, V180, P357, DOI 10.1083/jcb.200708130; Merriam EB, 2013, J NEUROSCI, V33, P16471, DOI 10.1523/JNEUROSCI.0661-13.2013; Mizel SB, 2009, CLIN VACCINE IMMUNOL, V16, P21, DOI 10.1128/CVI.00333-08; Mosbech A, 2013, J BIOL CHEM, V288, P16579, DOI 10.1074/jbc.M113.459917; Muhie S, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.91; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Nakamura S, 2010, J COMP PATHOL, V143, P150, DOI 10.1016/j.jcpa.2010.01.017; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Naro C, 2014, NUCLEIC ACIDS RES, V42, P3218, DOI 10.1093/nar/gkt1307; Neely KM, 2011, J NEUROSCI, V31, P2781, DOI 10.1523/JNEUROSCI.5156-10.2010; O'Donnell MA, 2011, NAT CELL BIOL, V13, P1437, DOI 10.1038/ncb2362; O'Hagan RC, 2000, GENE DEV, V14, P2185, DOI 10.1101/gad.827200; Ogrunc M, 2016, CELL REP, V15, P1401, DOI 10.1016/j.celrep.2016.04.033; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Ombrello MJ, 2012, NEW ENGL J MED, V366, P330, DOI 10.1056/NEJMoa1102140; Parker AL, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00153; Pechous RD, 2016, TRENDS MICROBIOL, V24, P190, DOI 10.1016/j.tim.2015.11.008; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Popova A, 2012, IMMUNOBIOLOGY, V217, P321, DOI 10.1016/j.imbio.2011.10.004; Popovic D, 2014, NAT MED, V20, P1242, DOI 10.1038/nm.3739; Pujol U, 2005, CLIN IMMUNOL, V114, P216, DOI 10.1016/j.clim.2004.07.013; Radhakrishnan Girish K, 2012, Biomol Concepts, V3, P571; Ritho J, 2015, CELL REP, V12, P734, DOI 10.1016/j.celrep.2015.07.002; Sandoval D, 2015, J BIOL CHEM, V290, P1106, DOI 10.1074/jbc.M114.615559; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Sevin M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/970242; Singla V, 2010, DEV CELL, V18, P410, DOI 10.1016/j.devcel.2009.12.022; Sivaraman V, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004688; St John AL, 2014, IMMUNITY, V41, P440, DOI 10.1016/j.immuni.2014.07.013; Subramanian R, 2010, CELL, V142, P433, DOI 10.1016/j.cell.2010.07.012; Tang LJ, 2016, GENE, V578, P92, DOI 10.1016/j.gene.2015.12.006; Tao T, 2014, TUMOR BIOL, V35, P9053, DOI 10.1007/s13277-014-1974-1; Tourdjman M, 2012, CLIN INFECT DIS, V55, pE58, DOI 10.1093/cid/cis578; Vanamala J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-238; Verma SK, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00602; Wang WY, 2012, J BIOL CHEM, V287, P15143, DOI 10.1074/jbc.M111.317859; White TE, 2015, FRONTIERS NEUROENGIN; Xie J, 2003, BLOOD, V101, P4005, DOI 10.1182/blood-2002-11-3368; Zaucha GM, 1998, ARCH PATHOL LAB MED, V122, P982; Zdolec N, 2015, FOLIA MICROBIOL, V60, P131, DOI 10.1007/s12223-014-0356-9; Zhang M, 2016, J BIOL CHEM, V291, P10783, DOI 10.1074/jbc.M115.700047; Zhang ZQ, 2015, ARCH VIROL, V160, P1449, DOI 10.1007/s00705-015-2403-5; Zhou HL, 2005, J EXP MED, V202, P1327, DOI 10.1084/jem.20051194; Zhou YZ, 2018, MICROBES INFECT, V20, P166, DOI 10.1016/j.micinf.2017.11.005; Zimbler DL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8487; Zuehlke AD, 2015, GENE, V570, P8, DOI 10.1016/j.gene.2015.06.018	106	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0209592	10.1371/journal.pone.0209592	http://dx.doi.org/10.1371/journal.pone.0209592			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789917	Green Published, Green Submitted, gold			2022-12-27	WOS:000459330800006
J	Hardy, SA; Mabotuwana, NS; Murtha, LA; Coulter, B; Sanchez-Bezanilla, S; Al-Omary, MS; Senanayake, T; Loering, S; Starkey, M; Lee, RJ; Rainer, PP; Hansbro, PM; Boyle, AJ				Hardy, Sean A.; Mabotuwana, Nishani S.; Murtha, Lucy A.; Coulter, Brianna; Sanchez-Bezanilla, Sonia; Al-Omary, Mohammed S.; Senanayake, Tharindu; Loering, Svenja; Starkey, Malcolm; Lee, Randall J.; Rainer, Peter P.; Hansbro, Philip M.; Boyle, Andrew J.			Novel role of extracellular matrix protein 1 (ECM1) in cardiac aging and myocardial infarction	PLOS ONE			English	Article							HEART; INFLAMMATION; EXPRESSION; FIBROSIS; AGE; FIBROBLASTS; LYMPHOCYTES; MACROPHAGES; ACTIVATION; NETWORKS	Introduction The prevalence of heart failure increases in the aging population and following myocardial infarction (MI), yet the extracellular matrix (ECM) remodeling underpinning the development of aging- and MI-associated cardiac fibrosis remains poorly understood. A link between inflammation and fibrosis in the heart has long been appreciated, but has mechanistically remained undefined. We investigated the expression of a novel protein, extracellular matrix protein 1 (ECM1) in the aging and infarcted heart. Methods Young adult (3-month old) and aging (18-month old) C57BL/6 mice were assessed. Young mice were subjected to left anterior descending artery-ligation to induce MI, or transverse aortic constriction (TAC) surgery to induce pressure-overload cardiomyopathy. Left ventricle (LV) tissue was collected early and late post-MI/TAC. Bone marrow cells (BMCs) were isolated from young healthy mice, and subject to flow cytometry. Human cardiac fibroblast (CFb), myocyte, and coronary artery endothelial & smooth muscle cell lines were cultured; human CFbs were treated with recombinant ECM1. Primary mouse CFbs were cultured and treated with recombinant angiotensin-II or TGF-beta 1. Immunoblotting, qPCR and mRNA fluorescent in-situ hybridization (mRNA-FISH) were conducted on LV tissue and cells. Results ECM1 expression was upregulated in the aging LV, and in the infarct zone of the LV early post-MI. No significant differences in ECM1 expression were found late post-MI or at any time-point post-TAC. ECM1 was not expressed in any resident cardiac cells, but ECM1 was highly expressed in BMCs, with high ECM1 expression in granulocytes. Flow cytometry of bone marrow revealed ECM1 expression in large granular leucocytes. mRNA-FISH revealed that ECM1 was indeed expressed by inflammatory cells in the infarct zone at day-3 post-MI. ECM1 stimulation of CFbs induced ERK1/2 and AKT activation and collagen-I expression, suggesting a pro-fibrotic role. Conclusions ECM1 expression is increased in ageing and infarcted hearts but is not expressed by resident cardiac cells. Instead it is expressed by bone marrow-derived granulocytes. ECM1 is sufficient to induce cardiac fibroblast stimulation in vitro. Our findings suggest ECM1 is released from infiltrating inflammatory cells, which leads to cardiac fibroblast stimulation and fibrosis in aging and MI. ECM1 may be a novel intermediary between inflammation and fibrosis.	[Hardy, Sean A.; Mabotuwana, Nishani S.; Murtha, Lucy A.; Coulter, Brianna; Al-Omary, Mohammed S.; Senanayake, Tharindu; Boyle, Andrew J.] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW, Australia; [Hardy, Sean A.; Mabotuwana, Nishani S.; Murtha, Lucy A.; Coulter, Brianna; Al-Omary, Mohammed S.; Loering, Svenja; Starkey, Malcolm; Hansbro, Philip M.; Boyle, Andrew J.] Hunter Med Res Inst, New Lambton Hts, NSW, Australia; [Sanchez-Bezanilla, Sonia; Loering, Svenja; Starkey, Malcolm; Hansbro, Philip M.] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW, Australia; [Sanchez-Bezanilla, Sonia; Loering, Svenja; Starkey, Malcolm; Hansbro, Philip M.] Univ Newcastle, Sch Biomed Sci & Pharm, Prior Res Ctr Hlth Lungs, Callaghan, NSW, Australia; [Sanchez-Bezanilla, Sonia; Loering, Svenja; Starkey, Malcolm; Hansbro, Philip M.] Univ Newcastle, Sch Biomed Sci & Pharm, Prior Res Ctr GrowUpWell, Callaghan, NSW, Australia; [Al-Omary, Mohammed S.; Boyle, Andrew J.] John Hunter Hosp, Dept Cardiovasc Med, New Lambton Hts, NSW, Australia; [Lee, Randall J.] Univ Calif San Francisco, Dept Med, Div Cardiol, San Francisco, CA 94143 USA; [Lee, Randall J.] Univ Calif San Francisco, Edyth & Eli Broad Ctr Regenerat Med & Stem Cell R, San Francisco, CA USA; [Rainer, Peter P.] Med Univ Graz, Div Cardiol, Graz, Austria; [Hansbro, Philip M.] Centenary Inst, Ctr Inflammat, Sydney, NSW, Australia; [Hansbro, Philip M.] Univ Technol, Fac Sci, Ultimo, NSW, Australia	University of Newcastle; Hunter Medical Research Institute; University of Newcastle; University of Newcastle; University of Newcastle; University of Newcastle; John Hunter Hospital; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Medical University of Graz; University of Sydney; Centenary Institute; University of Technology Sydney; University of Technology Sydney	Boyle, AJ (corresponding author), Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW, Australia.; Boyle, AJ (corresponding author), Hunter Med Res Inst, New Lambton Hts, NSW, Australia.; Boyle, AJ (corresponding author), John Hunter Hosp, Dept Cardiovasc Med, New Lambton Hts, NSW, Australia.	Andrew.boyle@newcastle.edu.au	Al-Omary, Mohammed/AAQ-4822-2021; Hansbro, Phil/G-7486-2013	Hansbro, Phil/0000-0002-4741-3035; Starkey, Malcolm/0000-0002-7359-7464; Coulter, Brianna/0000-0002-0492-9234; Sanchez Bezanilla, Sonia/0000-0003-2753-2691; Loering, Svenja/0000-0003-3267-0239; Rainer, Peter P/0000-0002-2840-6454	John Hunter Charitable Trust [G1800510]	John Hunter Charitable Trust	This work was supported by the John Hunter Charitable Trust [grant number G1800510], awarded to S.H. To my knowledge there is no URL for the funding source website. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biernacka A, 2011, AGING DIS, V2, P158; Boyle AJ, 2013, CARDIOVASC THER, V31, pE102, DOI 10.1111/1755-5922.12043; Boyle AJ, 2011, EXP GERONTOL, V46, P549, DOI 10.1016/j.exger.2011.02.010; Burkauskiene A, 2006, ACTA CARDIOL, V61, P513, DOI 10.2143/AC.61.5.2017765; Chan I, 2004, CLIN EXP DERMATOL, V29, P52, DOI 10.1111/j.1365-2230.2004.01440.x; Chen H, 2016, WORLD J SURG ONCOL, V14, DOI 10.1186/s12957-016-0952-z; Chen W, 2013, BBA-MOL CELL RES, V1833, P945, DOI 10.1016/j.bbamcr.2012.08.023; Chen WY, 2015, P NATL ACAD SCI USA, V112, P7249, DOI 10.1073/pnas.1424236112; Cieslik KA, 2014, J MOL CELL CARDIOL, V70, P56, DOI 10.1016/j.yjmcc.2013.10.017; Cieslik KA, 2011, J MOL CELL CARDIOL, V50, P248, DOI 10.1016/j.yjmcc.2010.10.019; Dai DF, 2012, CIRC RES, V110, P1109, DOI 10.1161/CIRCRESAHA.111.246140; Diez C, 2001, CARDIOVASC RES, V49, P731, DOI 10.1016/S0008-6363(00)00296-0; Ertl G, 2005, CARDIOVASC RES, V66, P22, DOI 10.1016/j.cardiores.2005.01.011; Fang L, 2015, J GERIATR CARDIOL, V12, P305, DOI 10.11909/j.issn.1671-5411.2015.03.020; Gagliano N, 2000, J GERONTOL A-BIOL, V55, pB365, DOI 10.1093/gerona/55.8.B365; Gao Y, 2014, J THORAC DIS, V6, P1458, DOI 10.3978/j.issn.2072-1439.2014.08.31; Geng XY, 2017, AM J CARDIOVASC DIS, V7, P72; Han ZQ, 2001, FASEB J, V15, P988, DOI 10.1096/fj.99-0934com; Hofmann U, 2015, CIRC RES, V116, P354, DOI 10.1161/CIRCRESAHA.116.304072; Horckmans M, 2017, EUR HEART J, V38, P187, DOI 10.1093/eurheartj/ehw002; Horn MA, 2016, J MOL CELL CARDIOL, V93, P175, DOI 10.1016/j.yjmcc.2015.11.005; Kim RY, 2017, AM J RESP CRIT CARE, V196, P283, DOI 10.1164/rccm.201609-1830OC; Kong L, 2010, MATRIX BIOL, V29, P276, DOI 10.1016/j.matbio.2010.01.007; Kong P, 2014, CELL MOL LIFE SCI, V71, P549, DOI 10.1007/s00018-013-1349-6; Kwak HB, 2013, J EXERC REHABIL, V9, P212, DOI [10.12965/jer.130049, 10.12965/jer.130002]; Lakatta EG, 2003, CIRCULATION, V107, P490, DOI 10.1161/01.CIR.0000048894.99865.02; Landmesser U, 2009, EUR HEART J, V30, P1310, DOI 10.1093/eurheartj/ehp181; Lee KM, 2015, ONCOGENE, V34, P6055, DOI 10.1038/onc.2015.54; Lee KM, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0479-6; Li L, 2011, CARDIOVASC RES, V91, P80, DOI 10.1093/cvr/cvr067; Li ZH, 2011, NAT IMMUNOL, V12, P178, DOI 10.1038/ni.1983; Liu Xiaoyu, 2015, Bio Protoc, V5; Lu C, 2015, J MOL CELL CARDIOL, V89, P87, DOI 10.1016/j.yjmcc.2015.10.011; Lu L, 2017, CLIN EXP PHARMACOL P, V44, P55, DOI 10.1111/1440-1681.12753; Luo SS, 2017, SCI REP-UK, V7, DOI 10.1038/srep43242; Ma YG, 2017, TRENDS PHARMACOL SCI, V38, P448, DOI 10.1016/j.tips.2017.03.001; Meschiari CA, 2017, GEROSCIENCE, V39, P7, DOI 10.1007/s11357-017-9959-9; Mongiat M, 2003, J BIOL CHEM, V278, P17491, DOI 10.1074/jbc.M210529200; Murtha LA, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00777; Nah Deuk-Young, 2009, Korean Circ J, V39, P393, DOI 10.4070/kcj.2009.39.10.393; Oyama N, 2013, EXTRACELLULAR MATRIX; Oyama N, 2017, TXB AGING SKIN, P91; Prabhu SD, 2016, CIRC RES, V119, P91, DOI 10.1161/CIRCRESAHA.116.303577; Quan TH, 2015, GERONTOLOGY, V61, P427, DOI 10.1159/000371708; Ramirez TA, 2012, HYPERTENS RES, V35, P811, DOI 10.1038/hr.2012.32; Repnik K, 2016, J APPL GENET, V57, P363, DOI 10.1007/s13353-015-0334-1; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Sander CS, 2006, BRIT J DERMATOL, V154, P218, DOI 10.1111/j.1365-2133.2005.07001.x; Sansbury BE, 2014, CIRC-HEART FAIL, V7, P634, DOI 10.1161/CIRCHEARTFAILURE.114.001151; Sercu S, 2009, MATRIX BIOL, V28, P160, DOI 10.1016/j.matbio.2009.02.003; Sercu S, 2009, IMPORTANCE EXTRACELL; Smits P, 1997, GENOMICS, V45, P487, DOI 10.1006/geno.1997.4918; Song YX, 1999, FORENSIC SCI INT, V104, P133, DOI 10.1016/S0379-0738(99)00103-6; Steenman Marja, 2017, Biophys Rev, V9, P131, DOI 10.1007/s12551-017-0255-9; Strait JB, 2012, HEART FAIL CLIN, V8, P143, DOI 10.1016/j.hfc.2011.08.011; Suthahar Navin, 2017, Curr Heart Fail Rep, V14, P235, DOI 10.1007/s11897-017-0343-y; Toor IS, 2017, HEART, V103, pA152, DOI 10.1136/heartjnl-2017-311726.236; Townsend N, 2016, EUR HEART J, V37, P3232, DOI [10.1093/eurheartj/ehw334, 10.1093/eurheartj/ehy342]; Walter W, 2018, CELL REP, V23, P622, DOI 10.1016/j.celrep.2018.03.029; Wei L, 2011, EXP MOL PATHOL, V90, P74, DOI 10.1016/j.yexmp.2010.10.004; Wick G, 2010, TRENDS IMMUNOL, V31, P110, DOI 10.1016/j.it.2009.12.001; Wojakowski W, 2004, CIRCULATION, V110, P3213, DOI 10.1161/01.CIR.0000147609.39780.02; Wu JZ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/615312; Yu QL, 2006, HYPERTENSION, V48, P98, DOI 10.1161/01.HYP.0000227247.27111.B2	64	14	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212230	10.1371/journal.pone.0212230	http://dx.doi.org/10.1371/journal.pone.0212230			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789914	Green Published, Green Submitted, gold			2022-12-27	WOS:000459330800021
J	Lepczyk, CA; Fantle-Lepczyk, JE; Misajon, K; Hu, D; Duffy, DC				Lepczyk, Christopher A.; Fantle-Lepczyk, Jean E.; Misajon, Kathleen; Hu, Darcy; Duffy, David C.			Long-term history of vehicle collisions on the endangered Nene (Branta sandvicensis)	PLOS ONE			English	Article							WARNING SIGNS; MORTALITY; PATTERNS; MAGNITUDE; BEHAVIOR	Millions of birds in the United States die annually due to vehicle collisions on roads. Collisions may be of particular interest for species of conservation concern, such as the endangered Hawaiian goose (Nene), which is endemic to Hawaii. Using a nearly 40-year dataset of Nene road mortality in and around Hawaii Volcanoes National Park, we sought to answer the following research questions: 1) has Nene mortality changed over time? 2) are there times of the year in which mortality is greatest and does it relate to specific events in the species' lifecycle? 3) does age at mortality differ over time, space, or sex? 4) given that existing mortalities appear to occur only in certain locations, do the number of mortality events differ across these locations; 5) does mortality rate show any density dependence? and, 6) are mortality rates related to numbers of visitors or vehicles? Between 1977 and 2014, a total of 92 Nene died from vehicle collisions; while absolute mortality increased over this time, the mortality rate remained the same. Similarly, average age of mortality increased over time, but did not differ by location or sex. Between 1995 and 2014, Nene population size and mortality rates were not correlated. Mortality was greatest in November and December (breeding season) and lowest in June. Most of the mortality occurred along just three stretches of road in and around the park, with the number of mortalities split about evenly inside and outside of the park. Furthermore, Nene mortality was unrelated to the number of visitors or traffic volume in the park. These findings suggest vehicle collisions are a growing concern for Nene, but that management actions to reduce mortality can be targeted at specific road segments and times of the year.	[Lepczyk, Christopher A.; Fantle-Lepczyk, Jean E.] Auburn Univ, Sch Forestry & Wildlife Sci, Auburn, AL 36849 USA; [Fantle-Lepczyk, Jean E.] Univ Hawaii Manoa, Dept Zool, Honolulu, HI 96822 USA; [Misajon, Kathleen; Hu, Darcy] Hawai Volcanoes Natl Pk, US Natl Pk Serv, Hawaii Natl Pk, HI USA; [Duffy, David C.] Univ Hawaii Manoa, Dept Bot, Pacific Cooperat Studies Unit, Honolulu, HI 96822 USA	Auburn University System; Auburn University; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Lepczyk, CA (corresponding author), Auburn Univ, Sch Forestry & Wildlife Sci, Auburn, AL 36849 USA.	lepczyk@auburn.edu		Lepczyk, Christopher/0000-0002-5316-3159; Fantle-Lepczyk, Jean/0000-0001-5388-0871	NPS [P14AC01740]	NPS	Funding for this work was provided by the NPS to the University of Hawai'i through the Hawai' i-Pacific Islands Cooperative Ecosystem Studies Unit, Task Agreement No. P14AC01740 with CAL and DCD. Sponsors collected and analyzed the nene data, assisted in design of project and preparation of the manuscript.	Baldwin Paul H., 1945, CONDOR, V47, P27, DOI 10.2307/1364446; Banko PC, 1999, BIRDS N AM; BENNETT AF, 1991, NAT CONSERV SER, P99; BLACK JM, 1995, IBIS, V137, pS153, DOI 10.1111/j.1474-919X.1995.tb08436.x; Black JM, 1998, AVIAN CONSERVATION: RESEARCH AND MANAGEMENT, P125; Calvert AM, 2013, AVIAN CONSERV ECOL, V8, DOI 10.5751/ACE-00581-080211; Canal D, 2018, ANIM BIODIV CONSERV, V41, P281, DOI 10.32800/abc.2018.41.0281; Cian LC, 2015, J CONSUM RES, V41, P1426, DOI 10.1086/680673; Clevenger AP, 2003, BIOL CONSERV, V109, P15, DOI 10.1016/S0006-3207(02)00127-1; Erritzoe J, 2003, ACTA ORNITHOL, V38, P77, DOI 10.3161/068.038.0204; Fahrig L, 2009, ECOL SOC, V14; Found R, 2011, WILDLIFE SOC B, V35, P291, DOI 10.1002/wsb.12; Gunson KE, 2011, J ENVIRON MANAGE, V92, P1074, DOI 10.1016/j.jenvman.2010.11.027; Huijser M, 2007, REPORT C; Huijser MP, 2008, FHWAHRT08034; Husby A, 2014, BEHAV ECOL, V25, P504, DOI 10.1093/beheco/aru011; Husby M, 2016, ORNIS FENNICA, V93, P212; Jagerbrand AK, 2016, ACCIDENT ANAL PREV, V86, P229, DOI 10.1016/j.aap.2015.11.004; Kociolek AV, 2011, CONSERV BIOL, V25, P241, DOI 10.1111/j.1523-1739.2010.01635.x; Loss Scott R, 2013, Nat Commun, V4, P1396, DOI 10.1038/ncomms2380; Loss SR, 2014, J WILDLIFE MANAGE, V78, P763, DOI 10.1002/jwmg.721; Loss SR, 2012, FRONT ECOL ENVIRON, V10, P357, DOI 10.1890/110251; Nene Recovery Action Group, 2016, STAT WID POP EST NEN; Rave E. H., 2005, Wildfowl, V55, P7; Rytwinski T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166941; Sullivan TL, 2004, WILDLIFE SOC B, V32, P907, DOI 10.2193/0091-7648(2004)032[0907:EOTWSI]2.0.CO;2; Ujvari M, 1998, J WILDLIFE MANAGE, V62, P1094, DOI 10.2307/3802562; van der Ree R, 2011, ECOL SOC, V16; Work TM, 2015, J WILDLIFE DIS, V51, P688, DOI 10.7589/2014-11-256	29	3	3	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0210180	10.1371/journal.pone.0210180	http://dx.doi.org/10.1371/journal.pone.0210180			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785887	Green Published, gold, Green Submitted			2022-12-27	WOS:000459307000010
J	Szocs, I; Bereczki, D; Ajtay, A; Oberfrank, F; Vastagh, I				Szocs, Ildiko; Bereczki, Daniel; Ajtay, Andras; Oberfrank, Ferenc; Vastagh, Ildiko			Socioeconomic gap between neighborhoods of Budapest: Striking impact on stroke and possible explanations	PLOS ONE			English	Article							ISCHEMIC-STROKE; RISK-FACTORS; MORTALITY; ASSOCIATION; EUROPE; HEALTH; FEASIBILITY; PREVALENCE; STANDARD; FATALITY	Introduction Hungary has a single payer health insurance system offering free healthcare for acute cerebrovascular disorders. Within the capital, Budapest, however there are considerable micro regional socioeconomic differences. We hypothesized that socioeconomic deprivation reflects in less favorable stroke characteristics despite universal access to care. Methods From the database of the National Health Insurance Fund, we identified 4779 patients hospitalized between 2002 and 2007 for acute cerebrovascular disease (hereafter ACV, i.e. ischemic stroke, intracerebral hemorrhage, or transient ischemia), among residents of the poorest (District 8, n = 2618) and the wealthiest (District 12, n = 2161) neighborhoods of Budapest. Follow-up was until March 2013. Results Mean age at onset of ACV was 70 12 and 74 12 years for District 8 and 12 (p<0.01). Age-standardized incidence was higher in District 8 than in District 12 (680/100,000/year versus 518/100,000/year for ACV and 486/100,000/year versus 259/100,000/year for ischemic stroke). Age-standardized mortality of ACV overall and of ischemic stroke specifically was 157/100,000/year versus 100/100,000/year and 122/100,000/year versus 75/100,000/year for District 8 and 12. Long-term case fatality (at 1,5, and 10 years) for ACV and for ischemic stroke was higher in younger District 8 residents (41-70 years of age at the index event) compared to D12 residents of the same age. This gap between the districts increased with the length of follow-up. Of the risk diseases the prevalence of hypertension and diabetes was higher in District 8 than in District 12 (75% versus 66%, p<0.001; and 26% versus 16%, p<0.001). Discussion Despite universal healthcare coverage, the disadvantaged district has higher ACV incidence and mortality than the wealthier neighborhood. This difference affects primarily the younger age groups. Long-term follow-up data suggest that inequity in institutional rehabilitation and home-care should be investigated and improved in disadvantaged neighborhoods.	[Szocs, Ildiko; Bereczki, Daniel; Ajtay, Andras; Vastagh, Ildiko] Semmelweis Univ, Dept Neurol, Budapest, Hungary; [Oberfrank, Ferenc] Hungarian Acad Sci, Inst Expt Med, Budapest, Hungary	Semmelweis University; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine	Szocs, I (corresponding author), Semmelweis Univ, Dept Neurol, Budapest, Hungary.	szocsiko@gmail.com	Bereczki, Daniel/AAL-9886-2020	Szocs, Ildiko/0000-0003-0785-8280	National Brain Research Program [KTIA-NAP-13-1-2013-0001]; New National Excellence Program of the Ministry of Human Resources of the Government of Hungary [UNKP-17-3]; Semmelweis University [EFOP-3.6.3-VEKOP-16-2017-00009]; Hungarian Brain Research Program [KTIA-NAP-13-1-2013-0001]; New National Excellence Program [UNKP-17-3]	National Brain Research Program; New National Excellence Program of the Ministry of Human Resources of the Government of Hungary; Semmelweis University; Hungarian Brain Research Program; New National Excellence Program	The work was partly supported by grants from the National Brain Research Program (KTIA-NAP-13-1-2013-0001), the New National Excellence Program (UNKP-17-3) of the Ministry of Human Resources of the Government of Hungary and by Semmelweis University (EFOP-3.6.3-VEKOP-16-2017-00009). DB, AA and FO were supported by the grant no. KTIA-NAP-13-1-2013-0001 from the Hungarian Brain Research Program and by the New National Excellence Program (UNKP-17-3). IS was supported by the grant no. EFOP-3.6.3-VEKOP-16-2017-00009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.agykutatas.com; http://www.kormany.hu/hu/emberi-eroforrasok-miniszteriuma/oktatasert-felelos-allamtitkarsag/hirek/az-uj-nemzeti-kivalosag-program.	Addo J, 2012, STROKE, V43, P1186, DOI 10.1161/STROKEAHA.111.639732; Ajtay A, 2015, ORVOSI HETILAP, V156, P1540, DOI 10.1556/650.2015.30258; Aszalos Z, 1999, Orv Hetil, V140, P1155; Avendano M, 2006, J CLIN EPIDEMIOL, V59, P1285, DOI 10.1016/j.jclinepi.2006.03.010; Avendano M, 2004, STROKE, V35, P432, DOI 10.1161/01.STR.0000109225.11509.EE; Bereczki D, 2009, INT J STROKE, V4, P335, DOI 10.1111/j.1747-4949.2009.00332.x; Brown AF, 2013, NEUROLOGY, V80, P520, DOI 10.1212/WNL.0b013e31828154ae; Central Statistical Bureau of Hungary, CENS 2011; Cesaroni G, 2009, STROKE, V40, P2812, DOI 10.1161/STROKEAHA.108.542944; Cox AM, 2006, LANCET NEUROL, V5, P181, DOI 10.1016/S1474-4422(06)70351-9; Dalstra JAA, 2005, INT J EPIDEMIOL, V34, P316, DOI 10.1093/ije/dyh386; Di Carlo A, 2006, J NEUROL SCI, V244, P143, DOI 10.1016/j.jns.2006.01.016; Folyovich A, 2015, INT J PUBLIC HEALTH, V60, P487, DOI 10.1007/s00038-015-0674-y; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Grube MM, 2012, STROKE, V43, P3325, DOI 10.1161/STROKEAHA.112.669580; Hanley GE, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-79; Ingeman A, 2011, STROKE, V42, P3214, DOI 10.1161/STROKEAHA.110.610881; Kerr GD, 2011, CEREBROVASC DIS, V31, P57, DOI 10.1159/000320855; Kolominsky-Rabas PL, 2001, STROKE, V32, P2735, DOI 10.1161/hs1201.100209; Kondo N, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech-2011-200321; Levi F, 2009, EUR J CARDIOV PREV R, V16, P333, DOI 10.1097/HJR.0b013e328325d67d; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Mahonen M, 2000, EUR J EPIDEMIOL, V16, P815, DOI 10.1023/A:1007697720131; Marrugat J, 2007, REV ESP CARDIOL, V60, P573, DOI 10.1157/13107113; Oberfrank F, 2018, EUR J NEUROL, V25, P984, DOI 10.1111/ene.13645; Orban-Kis K, 2016, IDEGGYOGY SZEMLE, V69, P47, DOI 10.18071/isz.69.0047; Saposnik G, 2008, STROKE, V39, P2318, DOI 10.1161/STROKEAHA.107.510362; Southern DA, 2005, MED CARE, V43, P1116, DOI 10.1097/01.mlr.0000182517.57235.6d; Stegmayr B, 2003, SCAND J PUBLIC HEALT, V31, P60, DOI 10.1080/14034950310001379; Szocs I, 2012, IDEGGYOGY SZEMLE, V65, P107; Tancioni V, 2008, EPIDEMIOL PREV, V32, P38; Truelsen T, 2006, EUR J NEUROL, V13, P581, DOI 10.1111/j.1468-1331.2006.01138.x; Voko Z, 2008, LAM, V18, P31	33	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212519	10.1371/journal.pone.0212519	http://dx.doi.org/10.1371/journal.pone.0212519			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785925	Green Submitted, Green Published, gold			2022-12-27	WOS:000459307000067
J	Arriagada, C; Luchsinger, C; Gonzalez, AE; Schwenke, T; Arriagada, G; Folch, H; Ehrenfeld, P; Burgos, PV; Mardones, GA				Arriagada, Cecilia; Luchsinger, Charlotte; Gonzalez, Alexis E.; Schwenke, Tomas; Arriagada, Gloria; Folch, Hugo; Ehrenfeld, Pamela; Burgos, Patricia V.; Mardones, Gonzalo A.			The knocking down of the oncoprotein Golgi phosphoprotein 3 in T98G cells of glioblastoma multiforme disrupts cell migration by affecting focal adhesion dynamics in a focal adhesion kinase-dependent manner	PLOS ONE			English	Article							POTENTIAL THERAPEUTIC TARGET; POOR-PROGNOSIS; SIGNALING PATHWAY; RAPAMYCIN SENSITIVITY; HIGH EXPRESSION; BREAST-CANCER; LUNG-CANCER; DNA-DAMAGE; GOLPH3; OVEREXPRESSION	Golgi phosphoprotein 3 (GOLPH3) is a conserved protein of the Golgi apparatus that in humans has been implicated in tumorigenesis. However, the precise function of GOLPH3 in malignant transformation is still unknown. Nevertheless, clinicopathological data shows that in more than a dozen kinds of cancer, including gliomas, GOLPH3 could be found overexpressed, which correlates with poor prognosis. Experimental data shows that overexpression of GOLPH3 leads to transformation of primary cells and to tumor growth enhancement. Conversely, the knocking down of GOLPH3 in GOLPH3-overexpressing tumor cells reduces tumorigenic features, such as cell proliferation and cell migration and invasion. The cumulative evidence indicate that GOLPH3 is an oncoprotein that promotes tumorigenicity by a mechanism that impact at different levels in different types of cells, including the sorting of Golgi glycosyltransferases, signaling pathways, and the actin cytoskeleton. How GOLPH3 connects mechanistically these processes has not been determined yet. Further studies are important to have a more complete understanding of the role of GOLPH3 as oncoprotein. Given the genetic diversity in cancer, a still outstanding aspect is how in this inherent heterogeneity GOLPH3 could possibly exert its oncogenic function. We have aimed to evaluate the contribution of GOLPH3 overexpression in the malignant phenotype of different types of tumor cells. Here, we analyzed the effect on cell migration that resulted from stable, RNAi-mediated knocking down of GOLPH3 in T98G cells of glioblastoma multiforme, a human glioma cell line with unique features. We found that the reduction of GOLPH3 levels produced dramatic changes in cell morphology, involving rearrangements of the actin cytoskeleton and reduction in the number and dynamics of focal adhesions. These effects correlated with decreased cell migration and invasion due to affected persistence and directionality of cell motility. Moreover, the knocking down of GOLPH3 also caused a reduction in autoactivation of focal adhesion kinase (FAK), a cytoplasmic tyrosine kinase that regulates focal adhesions. Our data support a model in which GOLPH3 in T98G cells promotes cell migration by stimulating the activity of FAK.	[Arriagada, Cecilia; Luchsinger, Charlotte; Gonzalez, Alexis E.; Burgos, Patricia V.; Mardones, Gonzalo A.] Univ Austral Chile, Sch Med, Dept Physiol, Valdivia, Chile; [Arriagada, Cecilia; Luchsinger, Charlotte; Gonzalez, Alexis E.; Ehrenfeld, Pamela; Mardones, Gonzalo A.] Univ Austral Chile, Ctr Interdisciplinary Studies Nervous Syst CISNe, Valdivia, Chile; [Gonzalez, Alexis E.] Fdn Ciencia & Vida, Santiago, Chile; [Schwenke, Tomas; Arriagada, Gloria] Univ Andres Bello, Fac Ciencias Vida, Dept Ciencias Biol, Vina Del Mar, Chile; [Folch, Hugo] Univ Austral Chile, Sch Med, Dept Immunol, Valdivia, Chile; [Ehrenfeld, Pamela] Univ Austral Chile, Dept Anat Histol & Pathol, Sch Med, Valdivia, Chile; [Burgos, Patricia V.; Mardones, Gonzalo A.] Univ San Sebastian, Ctr Cell Biol & Biomed, Sch Sci & Med, Santiago, Chile; [Burgos, Patricia V.] Pontificia Univ Catolica Chile, Ctr Aging & Regenerat CARE, Fac Ciencias Biol, Santiago, Chile; [Arriagada, Cecilia] Univ Chile, Fac Dent, Inst Res Dent Sci, Santiago, Chile; [Gonzalez, Alexis E.] Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci, Frankfurt, Germany	Universidad Austral de Chile; Universidad Austral de Chile; Universidad Andres Bello; Universidad Austral de Chile; Universidad Austral de Chile; Universidad San Sebastian; Pontificia Universidad Catolica de Chile; Universidad de Chile; Goethe University Frankfurt	Mardones, GA (corresponding author), Univ Austral Chile, Sch Med, Dept Physiol, Valdivia, Chile.; Mardones, GA (corresponding author), Univ Austral Chile, Ctr Interdisciplinary Studies Nervous Syst CISNe, Valdivia, Chile.; Mardones, GA (corresponding author), Univ San Sebastian, Ctr Cell Biol & Biomed, Sch Sci & Med, Santiago, Chile.	gonzalo.mardones@uach.cl	Luchsinger, Charlotte/AAZ-6028-2021; Arriagada, Gloria/AAS-1427-2021	Arriagada, Cecilia/0000-0002-5351-2240; EHRENFELD, INGRID/0000-0002-2519-7570	Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile (FONDECYT) [1130710, 1161252, 1171649]; Fondo de Equipamiento Cientifico y Tecnologico of Chile (FONDEQUIP) [EQM150118]; Iniciativa Cientifica Milenio del Ministerio de Economia, Fomento y Turismo of Chile [NC130011]; Direccion de Investigacion y Desarrollo de la Universidad Austral de Chile (DID-UACh); Comision Nacional de Investigacion Cientifica y Tecnologica of Chile (CONICYT) [21120450, 21130116]	Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fondo de Equipamiento Cientifico y Tecnologico of Chile (FONDEQUIP); Iniciativa Cientifica Milenio del Ministerio de Economia, Fomento y Turismo of Chile; Direccion de Investigacion y Desarrollo de la Universidad Austral de Chile (DID-UACh); Comision Nacional de Investigacion Cientifica y Tecnologica of Chile (CONICYT)	This work was funded by grants 1130710, 1161252 (G.A.M.) and 1171649 (P.V.B.) from Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile (FONDECYT; http://www.conicyt.cl/fondecyt), EQM150118 (P.V.B.) from Fondo de Equipamiento Cientifico y Tecnologico of Chile (FONDEQUIP; http://www.conicyt.cl/fondequip), NC130011 (G.A.) to Nucleo Milenio Biology of Neuropsiquiatric Disorders NuMIND from Iniciativa Cientifica Milenio del Ministerio de Economia, Fomento y Turismo of Chile (http://www.iniciativamilenio.cl), and from Direccion de Investigacion y Desarrollo de la Universidad Austral de Chile (DID-UACh; http://investigacion.uach.cl) (G.A.M. and P.V.B.). C.A. and C.L. were supported by fellowships 21120450 and 21130116, respectively, from Comision Nacional de Investigacion Cientifica y Tecnologica of Chile (CONICYT; http://www.conicyt.cl).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanko J, 2016, TRENDS CELL BIOL, V26, P391, DOI 10.1016/j.tcb.2016.02.001; Ali MF, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.346528; Bays JL, 2017, CELL MOL LIFE SCI, V74, P2999, DOI 10.1007/s00018-017-2511-3; Bear JE, 2014, CURR OPIN CELL BIOL, V30, P74, DOI 10.1016/j.ceb.2014.06.005; Bell AW, 2001, J BIOL CHEM, V276, P5152, DOI 10.1074/jbc.M006143200; Bershadsky A, 1996, CURR BIOL, V6, P1279, DOI 10.1016/S0960-9822(02)70714-8; Bhide GP, 2017, HISTOCHEM CELL BIOL, V147, P149, DOI 10.1007/s00418-016-1520-x; Buschman MD, 2015, CANCER RES, V75, P624, DOI 10.1158/0008-5472.CAN-14-3081; Cai Xue, 2018, Oncotarget, V9, P9540, DOI 10.18632/oncotarget.23476; Cavieres VA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136313; Chen JY, 2011, CANCER RES, V71, P473, DOI 10.1158/0008-5472.CAN-10-1303; Dai T, 2015, J PATHOL, V235, P490, DOI 10.1002/path.4479; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; Donizy P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101619; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Farber-Katz SE, 2014, CELL, V156, P413, DOI 10.1016/j.cell.2013.12.023; Gkretsi V, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00145; Gorelik R, 2014, NAT PROTOC, V9, P1931, DOI 10.1038/nprot.2014.131; Guo YT, 2015, WORLD J GASTROENTERO, V21, P13473, DOI 10.3748/wjg.v21.i48.13473; Hall A, 2012, BIOCHEM SOC T, V40, P1378, DOI 10.1042/BST20120103; Hamadi A, 2005, J CELL SCI, V118, P4415, DOI 10.1242/jcs.02565; Hanks SK, 2003, FRONT BIOSCI-LANDMRK, V8, pD982, DOI 10.2741/1114; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; HOEBEKE J, 1976, BIOCHEM BIOPH RES CO, V69, P319, DOI 10.1016/0006-291X(76)90524-6; Holroyd AK, 2018, IMMUNOL LETT, V196, P74, DOI 10.1016/j.imlet.2018.01.015; Horton ER, 2015, NAT CELL BIOL, V17, P1577, DOI 10.1038/ncb3257; Hu BS, 2013, TUMOR BIOL, V34, P515, DOI 10.1007/s13277-012-0576-z; Hu GS, 2014, TUMOR BIOL, V35, P8625, DOI 10.1007/s13277-014-2105-8; Hu YL, 2014, SCI REP-UK, V4, DOI 10.1038/srep06024; Hua X, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-127; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Isaji T, 2014, J BIOL CHEM, V289, P20694, DOI 10.1074/jbc.M113.542688; Jansen S, 2018, PHARMACOL THERAPEUT, V183, P1, DOI 10.1016/j.pharmthera.2017.09.002; Jiang YQ, 2015, INT J CLIN EXP PATHO, V8, P10615; Kim DH, 2018, J CLIN MED, V7, DOI 10.3390/jcm7010001; Kim ND, 2006, CURR CANCER DRUG TAR, V6, P681; Kleinschmidt EG, 2017, CURR OPIN CELL BIOL, V45, P24, DOI 10.1016/j.ceb.2017.01.003; Labernadie A, 2018, CURR OPIN CELL BIOL, V54, P57, DOI 10.1016/j.ceb.2018.04.008; Li H, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-168; Li Q, 2015, MOL MED REP, V11, P4315, DOI 10.3892/mmr.2015.3267; Li WZ, 2015, INT J CLIN EXP PATHO, V8, P3691; Li XY, 2011, J NEURO-ONCOL, V105, P159, DOI 10.1007/s11060-011-0573-x; Liu L, 2010, J BIOL CHEM, V285, P38362, DOI 10.1074/jbc.M110.141168; Longmate Whitney, 2017, F1000Res, V6, P1612, DOI 10.12688/f1000research.11877.1; Ma YC, 2014, TUMOR BIOL, V35, P11845, DOI 10.1007/s13277-014-2411-1; Maritzen T, 2015, CELL MOL LIFE SCI, V72, P2119, DOI 10.1007/s00018-015-1855-9; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Mendoza P, 2013, J CELL SCI, V126, P3835, DOI 10.1242/jcs.119727; Nakashima-Kamimura N, 2005, J CELL SCI, V118, P5357, DOI 10.1242/jcs.02645; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pereira NA, 2014, J BIOL CHEM, V289, P14762, DOI 10.1074/jbc.M114.548305; Rasband W., 2006, IMAGEJ; Rizzo R, 2017, TISSUE CELL, V49, P170, DOI 10.1016/j.tice.2016.06.008; Rodrigues J, 2018, G3-GENES GENOM GENET, V8, P1807, DOI 10.1534/g3.118.200172; Ross BC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087357; Salem AF, 2012, CELL CYCLE, V11, P2545, DOI 10.4161/cc.20920; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Schmitz KR, 2008, DEV CELL, V14, P523, DOI 10.1016/j.devcel.2008.02.016; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott KL, 2010, CLIN CANCER RES, V16, P2229, DOI 10.1158/1078-0432.CCR-09-1695; Scott KL, 2009, NATURE, V459, P1085, DOI 10.1038/nature08109; Sechi S, 2015, ONCOTARGET, V6, P3493, DOI 10.18632/oncotarget.3051; Sechi S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004305; Snyder CM, 2006, MOL BIOL CELL, V17, P511, DOI 10.1091/mbc.E05-07-0682; Sotgia F, 2012, CELL CYCLE, V11, P4390, DOI 10.4161/cc.22777; Stoyanov George St, 2018, Folia Med (Plovdiv), V60, P48, DOI 10.1515/folmed-2017-0069; Sulzmaier FJ, 2014, NAT REV CANCER, V14, P598, DOI 10.1038/nrc3792; Sun J, 2017, CANCER MED-US, V6, P834, DOI 10.1002/cam4.1040; Sun M, 2017, WIRES SYST BIOL MED, V9, DOI 10.1002/wsbm.1365; Szeliga M, 2015, NEUROCHEM INT, V88, P6, DOI 10.1016/j.neuint.2014.11.004; Teicher BA, 2009, TOXICOL PATHOL, V37, P114, DOI 10.1177/0192623308329473; Tenorio MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154719; Tokuda E, 2014, CANCER RES, V74, P3054, DOI 10.1158/0008-5472.CAN-13-2441; Tripathi BK, 2017, J CELL BIOL, V216, P4255, DOI 10.1083/jcb.201703105; Tu L, 2008, SCIENCE, V321, P404, DOI 10.1126/science.1159411; Valle-Tenney R, 2016, J VIROL, V90, P6896, DOI 10.1128/JVI.00863-16; Wang JH, 2017, MOL MED REP, V16, P7138, DOI 10.3892/mmr.2017.7495; Wang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045622; Wang R, 2015, CELL PHYSIOL BIOCHEM, V35, P969, DOI 10.1159/000369753; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wee P, 2017, CANCERS, V9, DOI 10.3390/cancers9050052; Wood CS, 2009, J CELL BIOL, V187, P967, DOI 10.1083/jcb.200909063; Wu CC, 2000, TRAFFIC, V1, P963, DOI 10.1034/j.1600-0854.2000.011206.x; Wu SS, 2018, J NEURO-ONCOL, V139, P269, DOI 10.1007/s11060-018-2884-7; Wu W, 2017, J CANCER, V8, P2163, DOI 10.7150/jca.19940; Xie ZG, 2018, DEV CELL, V44, P725, DOI 10.1016/j.devcel.2018.02.025; Xing MK, 2016, MOL BIOL CELL, V27, P3828, DOI 10.1091/mbc.E16-01-0005; Xue Y, 2014, BRIT J CANCER, V110, P2250, DOI 10.1038/bjc.2014.124; Zeng ZL, 2012, CLIN CANCER RES, V18, P4059, DOI 10.1158/1078-0432.CCR-11-3156; Zhang JW, 2013, CELL REP, V3, P2008, DOI 10.1016/j.celrep.2013.05.021; Zhang LJ, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-571; Zhang Q, 2015, ONCOTARGET, V6, P32177, DOI 10.18632/oncotarget.4867; Zhang X, 2015, MOL CARCINOGEN, V54, P1252, DOI 10.1002/mc.22197; Zhang Y, 2014, TUMOR BIOL, V35, P10833, DOI 10.1007/s13277-014-2357-3; Zhou JX, 2012, J NEURO-ONCOL, V110, P195, DOI 10.1007/s11060-012-0970-9; Zhou XP, 2017, NEURO-ONCOLOGY, V19, P1628, DOI 10.1093/neuonc/nox104; Zhou XP, 2013, BIOCHEM BIOPH RES CO, V433, P338, DOI 10.1016/j.bbrc.2013.03.003	97	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212321	10.1371/journal.pone.0212321	http://dx.doi.org/10.1371/journal.pone.0212321			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779783	gold, Green Published, Green Submitted			2022-12-27	WOS:000459062900046
J	Ayano, G; Tesfaw, G; Shumet, S				Ayano, Getinet; Tesfaw, Getachew; Shumet, Shegaye			Prevalence and determinants of antenatal depression in Ethiopia: A systematic review and meta-analysis	PLOS ONE			English	Review							RISK-FACTORS; POSTPARTUM-PREVALENCE; PERINATAL DEPRESSION; MATERNAL DEPRESSION; PREGNANT-WOMEN; LOW-INCOME; SYMPTOMS; DISORDERS; CHILDBIRTH; ANXIETY	Background Maternal depression is the most prevalent psychiatric disorder during pregnancy, can alter fetal development and have a lasting impact on the offspring's neurological and behavioral development. However, no review has been conducted to report the consolidated magnitude of antenatal depression (AND) in Ethiopia. Therefore, this review aimed to systematically summarize the existing evidence on the epidemiology of AND in Ethiopia. Methods Using PRISMA guideline, we systematically reviewed and meta-analyzed studies that examined the prevalence and associated factors of AND from three electronic databases (PubMed, EMBASE, and SCOPUS). We used predefined inclusion criteria to screen identified studies. A qualitative and quantitative analysis was employed. Heterogeneity across the studies was evaluated using Q and the I-2 test. Publication bias was assessed by funnel plot and Egger's regression test. Results In this review, a total of 193 studies were initially identified and evaluated. Of these, five eligible articles were included in the final analysis. In our meta-analysis, the pooled prevalence of AND in Ethiopia was 21.28% (95% CI; 15.96-27.78). The prevalence of AND was highest in the third trimester of pregnancy at 32.10% and it was 19.13% in the first trimester and 18.86% in the second trimester of pregnancy. The prevalence of AND was 26.48% and 18.28% as measured by Beck depression inventory (BDI) and the Edinburgh Postnatal Depression Scale (EPDS), respectively. Moreover, the prevalence of AND was 15.50% for the studies conducted in the community setting and it was 25.77% for the studies conducted in the institution-based setting. In our qualitative synthesis, we found that those pregnant women who had a history of stillbirth, complications during pregnancy, previous history of depression, no ANC follow-up, irregular ANC follow-up, not satisfied by ANC follow-up, and monthly income <1500 Ethiopian birr were linked with a greater risk of developing ANC. We also found that those women who experienced partner violence during pregnancy, food insecurity, medium and low social support, and those who were unmarried, age group 2029, house wives and farmers were associated with a higher risk of developing ANC. Conclusion and recommendations Our meta-analysis found that the pooled prevalence of AND in Ethiopia was 21.28%. The prevalence of AND was high in the third trimester of pregnancy as compared to the first and second trimesters of pregnancy. The prevalence of AND was high in studies conducted using BDI than EPDS. Studies on the magnitude of AND as well as the possible determinants in each trimester of pregnancy with representative sample size are recommended. Screening of depression in a pregnant woman in perinatal setting might be considered backed by integration of family planning and mental health services. The use of validated and a standard instrument to assess AND is warranted. Systematic review registration The protocol for this systematic review and meta-analysis was registered at PROSPERO (record ID=CRD42017076521, 06 December 2017)	[Ayano, Getinet; Tesfaw, Getachew] Amanuel Mental Specialized Hosp, Res & Training Dept, Addis Ababa, Ethiopia; [Tesfaw, Getachew; Shumet, Shegaye] Univ Gondar, Dept Psychiat, Gondar, Ethiopia	University of Gondar	Ayano, G (corresponding author), Amanuel Mental Specialized Hosp, Res & Training Dept, Addis Ababa, Ethiopia.	babiget2015@gmail.com	shumet, shegaye/AAH-8322-2020; Ayano, Getinet/ABD-2311-2020; Ayano, Getinet/AAF-1759-2019	Ayano, Getinet/0000-0002-9137-4141; Shumet, Shegaye/0000-0001-7714-7455				Adewuya AO, 2007, DEPRESS ANXIETY, V24, P15, DOI 10.1002/da.20221; Ajinkya Shaunak, 2013, Ind Psychiatry J, V22, P37, DOI 10.4103/0972-6748.123615; Andersson L, 2003, AM J OBSTET GYNECOL, V189, P148, DOI 10.1067/mob.2003.336; Ayele TA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155125; Bennett HA, 2004, OBSTET GYNECOL, V103, P698, DOI 10.1097/01.AOG.0000116689.75396.5f; Biratu A, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0092-x; Bisetegn TA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161108; Black MM, 2007, J CHILD PSYCHOL PSYC, V48, P764, DOI 10.1111/j.1469-7610.2007.01752.x; Borenstein M, 2005, BIOSTAT, V104; Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12; Curzik D, 2012, PSYCHIAT DANUB, V24, P167; Dibaba Y, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-135; DiPietro JA, 2012, J ADOLESCENT HEALTH, V51, pS3, DOI 10.1016/j.jadohealth.2012.04.008; Evans J, 2001, BRIT MED J, V323, P257, DOI 10.1136/bmj.323.7307.257; Faisal-Cury A, 2009, ARCH WOMEN MENT HLTH, V12, P335, DOI 10.1007/s00737-009-0081-6; Felice E, 2004, J AFFECT DISORDERS, V82, P297, DOI 10.1016/j.jad.2003.11.011; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; Gelaye B, 2016, LANCET PSYCHIAT, V3, P973, DOI 10.1016/S2215-0366(16)30284-X; Glasser S, 2012, MATERN CHILD HLTH J, V16, P1197, DOI 10.1007/s10995-011-0845-2; Hartley M, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-9; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jesse DE, 2005, J MIDWIFERY WOM HEAL, V50, P405, DOI 10.1016/j.jmwh.2005.05.001; Johanson R, 2000, J PSYCHOSOM OBST GYN, V21, P93, DOI 10.3109/01674820009075614; Josefsson A, 2001, ACTA OBSTET GYN SCAN, V80, P251; Kaaya S F, 2010, Tanzan J Health Res, V12, P23; Kuhner C, 2016, NERVENARZT, V87, P926, DOI 10.1007/s00115-016-0175-0; Lee AM, 2007, OBSTET GYNECOL, V110, P1102, DOI 10.1097/01.AOG.0000287065.59491.70; Lee DTS, 2004, J AFFECT DISORDERS, V82, P93, DOI 10.1016/j.jad.2003.10.003; Manikkam L, 2012, SAMJ S AFR MED J, V102, P940, DOI [10.7196/SAMJ.6009, 10.7196/samj.6009]; Marcus SM, 2003, J WOMEN HEALTH GEN-B, V12, P373, DOI 10.1089/154099903765448880; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Melville JL, 2010, OBSTET GYNECOL, V116, P1064, DOI 10.1097/AOG.0b013e3181f60b0a; Moher D, 2015, SYST REV-LONDON, V4, DOI [10.1186/2046-4053-4-1, 10.1186/s13643-015-0087-2]; Mossie TB, 2017, ETHIOP J HEALTH SCI, V27, P59, DOI 10.4314/ejhs.v27i1.8; Nasreen HE, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-22; Osborne LM, 2013, PSYCHONEUROENDOCRINO, V38, P1929, DOI 10.1016/j.psyneuen.2013.03.019; PROSPERO IPRoSR, 2021, NAT I HLTH RES; Rahman A, 2004, ARCH GEN PSYCHIAT, V61, P946, DOI 10.1001/archpsyc.61.9.946; Rahman A, 2003, PSYCHOL MED, V33, P1161, DOI 10.1017/S0033291703008286; Rubertsson C, 2005, ARCH WOMEN MENT HLTH, V8, P97, DOI 10.1007/s00737-005-0078-8; Rusner M, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1127-1; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Van den Bergh BRH, 2005, NEUROSCI BIOBEHAV R, V29, P237, DOI 10.1016/j.neubiorev.2004.10.007; Wissart Janice, 2005, BMC Pregnancy Childbirth, V5, P15, DOI 10.1186/1471-2393-5-15	44	24	26	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0211764	10.1371/journal.pone.0211764	http://dx.doi.org/10.1371/journal.pone.0211764			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL9KY	30779765	Green Published, Green Submitted, gold			2022-12-27	WOS:000459062900017
J	Basas, J; Palau, M; Gomis, X; Almirante, B; Gavalda, J				Basas, Jana; Palau, Marta; Gomis, Xavier; Almirante, Benito; Gavalda, Joan			Efficacy of liposomal amphotericin B and anidulafungin using an antifungal lock technique (ALT) for catheter-related Candida albicsan and Candida glabrata infections in an experimental model	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; ALBICANS BIOFILMS; DISEASES SOCIETY; RABBIT MODEL; 2009 UPDATE; CASPOFUNGIN; MICAFUNGIN; MANAGEMENT	Objective The aims of this study were as follows. First, we sought to compare the in vitro susceptibility of liposomal amphotericin B (LAmB) and anidulafungin on Candida albicans and Candida glabrata biofilms growing on silicone discs. Second, we sought to compare the activity of LAmB versus anidulafungin for the treatment of experimental catheter-related C. albicans and C. glabrata infections with the antifungal lock technique in a rabbit model. Methods Two C. albicans and two C. glabrata clinical strains were used. The minimum biofilm eradication concentration for 90% eradication (MBEC90) values were determined after 48h of treatment with LAmB and anidulafungin. Confocal microscopy was used to visualize the morphology and viability of yeasts growing in biofilms. Central venous catheters were inserted into New Zealand rabbits, which were inoculated of each strain of C. albicans and C. glabrata. Then, catheters were treated for 48h with saline or with antifungal lock technique using either LAmB (5mg/mL) or anidulafungin (3.33mg/mL). Results In vitro: anidulafungin showed greater activity than LAmB against C. albicans and C. glabrata strains. For C. albicans: MBEC90 of anidulafungin versus LAmB: CA176, 0.03 vs. 128 mg/L; CA180, 0.5 vs. 64 mg/L. For C. glabrata: MBEC90 of anidulafungin versus LAmB: CG171, 0.5 vs. 64 mg/L; CG334, 2 vs. 32 mg/L. In vivo: for C. albicans species, LAmB and anidulafungin achieved significant reductions relative to growth control of log(10) cfu recovered from the catheter tips (CA176: 3.6 +/- 0.3 log(10) CFU, p <= 0.0001; CA180: 3.8 +/- 0.1 log(10) CFU, p <= 0.01). For C. glabrata, anidulafungin lock therapy achieved significant reductions relative to the other treatments (CG171: 4.8 log(10) CFU, p <= 0.0001; CG334: 5.1 log(10) CFU, p <= 0.0001) Conclusions For the C. albicans strains, both LAmB and anidulafungin may be promising antifungal lock technique for long-term catheter-related infections; however, anidulafungin showed significantly higher activity than LAmB against the C. glabrata strains.	[Basas, Jana; Palau, Marta; Gomis, Xavier; Almirante, Benito; Gavalda, Joan] Hosp Valle De Hebron, Vall Hebron Res Inst VHIR, Infect Dis Dept, Antibiot Resistance Lab, Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR)	Gavalda, J (corresponding author), Hosp Valle De Hebron, Vall Hebron Res Inst VHIR, Infect Dis Dept, Antibiot Resistance Lab, Barcelona, Spain.	joan.gavalda@vhir.org		Almirante, Benito/0000-0002-1189-2361; Gavalda, Joan/0000-0002-9829-3141; Gomis Rodriguez, Javier/0000-0001-6258-3721; Palau Gauthier, Marta/0000-0002-4567-9868	Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III [FIS PI070394]; European Development Regional Fund "A way to achieve Europe" ERDF; Spanish Network for Research in Infectious Diseases [REIPI RD12/0015]; Pfizer, Inc.	Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III(Instituto de Salud Carlos III); European Development Regional Fund "A way to achieve Europe" ERDF; Spanish Network for Research in Infectious Diseases; Pfizer, Inc.(Pfizer)	This study was supported by research grants from the Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III (FIS PI070394) and was co-financed by the European Development Regional Fund "A way to achieve Europe" ERDF, the Spanish Network for Research in Infectious Diseases (REIPI RD12/0015), and partially by Pfizer, Inc. The funder had no involvement in the design and conduct of the study; analysis, interpretation of the data; and preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Basas J, 2016, J ANTIMICROB CHEMOTH, V71, P2895, DOI 10.1093/jac/dkw251; BENOIT JL, 1995, CLIN INFECT DIS, V21, P1286, DOI 10.1093/clinids/21.5.1286; Buckler BS, 2008, PEDIATR INFECT DIS J, V27, P762, DOI 10.1097/INF.0b013e318170b68b; Cateau E, 2008, J ANTIMICROB CHEMOTH, V62, P153, DOI 10.1093/jac/dkn160; Chandra J, 2005, CURR DRUG TARGETS, V6, P887, DOI 10.2174/138945005774912762; Chandra J, 2011, VIRULENCE, V2, P466, DOI 10.4161/viru.2.5.16341; Chandra J, 2008, NAT PROTOC, V3, P1909, DOI 10.1038/nprot.2008.192; EUCAST, 2016, BREAKP TABL INT MICS, P35; Imbert C, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7010006; JOHNSON DC, 1994, PEDIATR INFECT DIS J, V13, P930, DOI 10.1097/00006454-199410000-00015; Kawai A, 2015, J INFECT CHEMOTHER, V21, P647, DOI 10.1016/j.jiac.2015.05.007; Kojic EM, 2004, CLIN MICROBIOL REV, V17, P255, DOI 10.1128/CMR.17.2.255-267.2004; Kucharikova S, 2010, ANTIMICROB AGENTS CH, V54, P4474, DOI 10.1128/AAC.00697-10; Lamoth F, 2018, J ANTIMICROB CHEMOTH, V73, pi4, DOI 10.1093/jac/dkx444; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Oncu S, 2011, J INFECT CHEMOTHER, V17, P634, DOI 10.1007/s10156-011-0224-3; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Puig-Asensio M, 2014, CLIN MICROBIOL INFEC, V20, pO245, DOI 10.1111/1469-0691.12380; Ramage G, 2013, ANTIMICROB AGENTS CH, V57, P2369, DOI 10.1128/AAC.02344-12; Rodriguez D, 2007, CLIN MICROBIOL INFEC, V13, P788, DOI 10.1111/j.1469-0691.2007.01758.x; Salma M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077600; Schinabeck MK, 2004, ANTIMICROB AGENTS CH, V48, P1727, DOI 10.1128/AAC.48.5.1727-1732.2004; Shuford JA, 2006, J INFECT DIS, V194, P710, DOI 10.1086/506452; Viale P, 2001, CLIN INFECT DIS, V33, P1947, DOI 10.1086/323554; Walraven CJ, 2013, ANTIMICROB AGENTS CH, V57, P1, DOI 10.1128/AAC.01351-12	25	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212426	10.1371/journal.pone.0212426	http://dx.doi.org/10.1371/journal.pone.0212426			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779771	Green Submitted, Green Published, gold			2022-12-27	WOS:000459062900054
J	Chen, J; Wang, YL; Guo, Y; Jiang, MY				Chen, Jing; Wang, Yinglong; Guo, Ying; Jiang, Mingyue			A metamorphic testing approach for event sequences	PLOS ONE			English	Article							INTEGRATION; SOFTWARE; MUTATION	Test oracles are commonly used in software testing to determine the correctness of the execution results of test cases. However, the testing of many software systems faces the test oracle problem: a test oracle may not always be available, or it may be available but too expensive to apply. One such software system is a system involving abundant business processes. This paper focuses on the testing of business-process-based software systems and proposes a metamorphic testing approach for event sequences, called MTES, to alleviate the oracle problem. We utilized event sequences to represent business processes and then applied the technique of metamorphic testing to test the system without using test oracles. To apply metamorphic testing, we studied the general rules for identifying metamorphic relations for business processes and further demonstrated specific metamorphic relations for individual case studies. Three case studies were conducted to evaluate the effectiveness of our approach. The experimental results show that our approach is feasible and effective in testing the applications with rich business processes. In addition, this paper summarizes the experimental findings and proposes guidelines for selecting good metamorphic relations for business processes.	[Chen, Jing] Shandong Univ Sci & Technol, Coll Comp Sci & Engn, Qingdao, Shandong, Peoples R China; [Chen, Jing; Wang, Yinglong; Guo, Ying] Qilu Univ Technol, Shandong Acad Sci, Natl Supercomp Ctr Jinan, Shandong Prov Key Lab Comp Networks,Shandong Comp, Jinan, Shandong, Peoples R China; [Jiang, Mingyue] Zhejiang Sci Tech Univ, Sch Informat Sci, Hangzhou, Zhejiang, Peoples R China	Shandong University of Science & Technology; Qilu University of Technology; Zhejiang Sci-Tech University	Wang, YL (corresponding author), Qilu Univ Technol, Shandong Acad Sci, Natl Supercomp Ctr Jinan, Shandong Prov Key Lab Comp Networks,Shandong Comp, Jinan, Shandong, Peoples R China.	yinglongwang65@163.com			Shandong Provincial Natural Science Foundation, China [ZR2016FM41]	Shandong Provincial Natural Science Foundation, China(Natural Science Foundation of Shandong Province)	This work is supported by Shandong Provincial Natural Science Foundation, China (Grant number: ZR2016FM41). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alatawi E, 2015, 2015 24TH AUSTRALASIAN SOFTWARE ENGINEERING CONFERENCE (ASWEC 2015), P38, DOI 10.1109/ASWEC.2015.16; Andrews JH, 2005, PROC INT CONF SOFTW, P402, DOI 10.1145/1062455.1062530; Barr ET, 2015, IEEE T SOFTWARE ENG, V41, P507, DOI 10.1109/TSE.2014.2372785; Belli F, 2006, SOFTW TEST VERIF REL, V16, P3, DOI 10.1002/stvr.335; Belli Fevzi, 2008, 2008 IEEE 32nd International Computer Software and Applications Conference (COMPSAC), P1168, DOI 10.1109/COMPSAC.2008.144; Cao YX, 2013, INT CONF QUAL SOFTW, P153, DOI 10.1109/QSIC.2013.43; Chan F. T., 1998, P IASTED INT C SOFTW, P191; Chan WK, 2007, INT J WEB SERV RES, V4, P61, DOI 10.4018/jwsr.2007040103; Chan WK, 2006, INT J SOFTW ENG KNOW, V16, P677, DOI 10.1142/S0218194006002951; Chan WK, 2005, QSIC 2005: FIFTH INTERNATIONAL CONFERENCE ON QUALITY SOFTWARE, PROCEEDINGS, P241; Chen T. Y., 2004, P 4 IB AM S SOFTW EN, P569; Chen T.Y., 1998, HKUSTCS9801; Chen TY, 2018, ACM COMPUT SURV, V51, DOI 10.1145/3143561; Chen TY, 2016, COMPUTER, V49, P48, DOI 10.1109/MC.2016.176; Chen TY, 2016, J SYST SOFTWARE, V116, P177, DOI 10.1016/j.jss.2015.07.037; Chen TY, 2012, INT CONF QUAL SOFTW, P285, DOI 10.1109/QSIC.2012.21; Chen TY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-24; Chen TY, 2003, INFORM SOFTWARE TECH, V45, P1, DOI 10.1016/S0950-5849(02)00129-5; Davis M. D., 1981, P ACM 81 C, P254, DOI [DOI 10.1145/800175.809889, 10.1145/800175.809889]; Ding JH, 2016, P INT COMP SOFTW APP, P263, DOI 10.1109/COMPSAC.2016.48; DURAN JW, 1984, IEEE T SOFTWARE ENG, V10, P438, DOI 10.1109/TSE.1984.5010257; Endo Andre Takeshi, 2010, Proceedings of the 2010 Fourth IEEE International Conference on Secure Software Integration and Reliability Improvement Companion (SSIRI-C 2010), P62, DOI 10.1109/SSIRI-C.2010.24; Hui ZW, 2016, P INT COMP SOFTW APP, P598, DOI 10.1109/COMPSAC.2016.112; Jiang MY, 2017, J SYST SOFTWARE, V126, P127, DOI 10.1016/j.jss.2016.04.002; Jing Chen, 2014, Journal of Software, V9, P2267, DOI 10.4304/jsw.9.9.2267-2275; Kuhn D. R., 2012, 2012 IEEE Fifth International Conference on Software Testing, Verification and Validation (ICST 2012), P601, DOI 10.1109/ICST.2012.147; Kuo FC, 2011, C LOCAL COMPUT NETW, P291, DOI 10.1109/LCN.2011.6115306; Lindvall M, 2015, 2015 IEEE/ACM 37TH IEEE INTERNATIONAL CONFERENCE ON SOFTWARE ENGINEERING, VOL 2, P129, DOI 10.1109/ICSE.2015.348; Liu H, 2014, IEEE T SOFTWARE ENG, V40, P4, DOI 10.1109/TSE.2013.46; Liu H, 2012, INT CONF QUAL SOFTW, P59, DOI 10.1109/QSIC.2012.10; Lizhi Cai, 2011, 2011 First ACIS/JNU International Conference on Computers, Networks, Systems and Industrial Engineering (CNSI), P178, DOI 10.1109/CNSI.2011.12; Ma YS, 2005, SOFTW TEST VERIF REL, V15, P97, DOI 10.1002/stvr.308; Margalit O, 2013, IEEE ICST WORKSHOP, P281, DOI 10.1109/ICSTW.2013.39; Mayer J, 2006, P INT COMP SOFTW APP, P475; Memon AM, 2007, SOFTW TEST VERIF REL, V17, P137, DOI 10.1002/stvr.364; Murphy C., 2008, 20 INT C SOFTW ENG K, P867, DOI DOI 10.7916/D8XK8PFD; Murphy C, 2009, ISSTA 2009: INTERNATIONAL SYMPOSIUM ON SOFTWARE TESTING AND ANALYSIS, P189; Nunez A, 2015, ANN TELECOMMUN, V70, P127, DOI 10.1007/s12243-014-0442-7; Panko RR, 2004, P EUR SPREAD SHEET R, P145; Poon PL, 2017, J ORGAN END USER COM, V29, P25, DOI 10.4018/JOEUC.2017040102; Regehr J., 2014, FINDING COMPILER BUG; Sabharwal Sangeeta, 2010, 2010 International Conference on Computer and Communication Technology (ICCCT 2010), P551, DOI 10.1109/ICCCT.2010.5640469; Schuler D, 2013, SOFTW TEST VERIF REL, V23, P353, DOI 10.1002/stvr.1473; Segura S, 2016, IEEE T SOFTWARE ENG, V42, P805, DOI 10.1109/TSE.2016.2532875; Singh B., 2013, INT J MODERN ENG RES, V3, P990; Sun CA, 2016, P 1 INT WORKSH MET T, P12; Sun CA, 2012, INT J WEB SERV RES, V9, P51, DOI 10.4018/jwsr.2012010103; Troup M, 2016, 2016 IEEE/ACM 1ST INTERNATIONAL WORKSHOP ON METAMORPHIC TESTING (MET), P33, DOI [10.1145/2896971.2896975, 10.1109/MET.2016.014]; Le V, 2014, ACM SIGPLAN NOTICES, V49, P216, DOI [10.1145/2594291.2594334, 10.1145/2666356.2594334]; Weske M., 2007, BUSINESS PROCESS MAN; WEYUKER EJ, 1982, COMPUT J, V25, P465, DOI 10.1093/comjnl/25.4.465; Xie XY, 2011, J SYST SOFTWARE, V84, P544, DOI 10.1016/j.jss.2010.11.920; Xie XY, 2013, INFORM SOFTWARE TECH, V55, P866, DOI 10.1016/j.infsof.2012.08.008; Zhou ZQ, 2016, IEEE T SOFTWARE ENG, V42, P264, DOI 10.1109/TSE.2015.2478001	54	1	1	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212476	10.1371/journal.pone.0212476	http://dx.doi.org/10.1371/journal.pone.0212476			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779769	Green Published, gold, Green Submitted			2022-12-27	WOS:000459062900058
J	Joglekar, AKB; Wood-Sichra, U; Pardey, PG				Joglekar, Alison K. B.; Wood-Sichra, Ulrike; Pardey, Philip G.			Pixelating crop production: Consequences of methodological choices	PLOS ONE			English	Article							GLOBAL CROPLAND	Worldwide, crop production is intrinsically intertwined with biological, environmental and economic systems, all of which involve complex, inter-related and spatially-sensitive phenomena. Thus knowing the location of agriculture matters much for a host of reasons. There are several widely cited attempts to model the spatial pattern of crop production worldwide, not least by pixilating crop production statistics originally reported on an areal (administrative boundary) basis. However, these modeled measures have had little scrutiny regarding the robustness of their results to alternative data and modeling choices. Our research casts a critical eye over the nature and empirical plausibility of these types of datasets. To do so, we determine the sensitivity of the 2005 variant of the spatial production allocation model data series (SPAM2005) to eight methodological-cum-data choices in nine agriculturally-large and developmentally-variable countries: Brazil, China, Ethiopia, France, India, Indonesia, Nigeria, Turkey and the United States. We compare the original published estimates with those obtained from a series of robustness tests using various aggregations of the pixelized spatial production indicators (specifically, commodity-specific harvested area, production quantity and yield). Spatial similarity is empirically assessed using a pixel-level spatial similarity index (SSI). We find that the SPAM2005 estimates are most dependent on the degree of disaggregation of the underlying national and subnational production statistics. The results are also somewhat sensitive to the use of a simple spatial allocation method based solely on cropland proportions versus a cross-entropy allocation method, as well as the set of crops or crop aggregates being modeled, and are least sensitive to the inclusion of crude economic elements. Finally, we assess the spatial concordance between the SPAM2005 estimates of the area harvested of major crops in the United States and pixelated measures derived from remote-sensed data.	[Joglekar, Alison K. B.; Pardey, Philip G.] Univ Minnesota, Dept Appl Econ, St Paul, MN 55108 USA; [Wood-Sichra, Ulrike] Int Food Policy Res Inst, Washington, DC 20036 USA	University of Minnesota System; University of Minnesota Twin Cities; CGIAR; International Food Policy Research Institute (IFPRI)	Joglekar, AKB (corresponding author), Univ Minnesota, Dept Appl Econ, St Paul, MN 55108 USA.	joglekar@umn.edu		Wood-Sichra, Ulrike/0000-0002-0546-2074	Bill and Melinda Gates Foundation; Minnesota Agricultural Experiment Station [MIN-14-134]; International Science Technology Practice and Policy (InSTePP) center	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Minnesota Agricultural Experiment Station; International Science Technology Practice and Policy (InSTePP) center	This paper was prepared for the HarvestChoice project with support from the Bill and Melinda Gates Foundation, the Minnesota Agricultural Experiment Station (project MIN-14-134) and the International Science Technology Practice and Policy (InSTePP) center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson W, 2015, GLOBAL ECOL BIOGEOGR, V24, P180, DOI 10.1111/geb.12243; [Anonymous], 2015, CROPL DAT LAYER 2005; [Anonymous], 2015, CROPL DAT LAYER 2006; [Anonymous], 2015, CROPL DAT LAYER 2004; Avitabile V, 2011, CARBON BAL MANAGE, V6, P14, DOI [10.1186/1750-0680-6-14, DOI 10.1186/1750-0680-6-14]; Beddow J. M., 2014, ENCY AGR FOOD SYSTEM, P352, DOI [DOI 10.1016/B978-0-444-52512-3.00037-1, 10.1016/B978-0-444-52512-3.00037-1]; Borchers A, 2014, EC INFORM B, V125; Boryan C, 2011, GEOCARTO INT, V26, P341, DOI 10.1080/10106049.2011.562309; ESRI (Environmental Systems Research Insitute), 2016, FOC STAT WORK; Fischer G, 2013, GLOBAL AGROECOLOGICA; Franch B, 2015, REMOTE SENS ENVIRON, V161, P131, DOI 10.1016/j.rse.2015.02.014; Fritz S, 2015, GLOBAL CHANGE BIOL, V21, P1980, DOI 10.1111/gcb.12838; GEO (Group on Earth Observations), 2007, WORKSH DEV STRAT GLO; GEOGLAM (Group on Earth Observations Global Agricultural Monitoring), NAT MON SYST; Hagen-Zanker A, 2005, COMP CONTINUOUS VALU; Hutabarat B, 2012, JURNAL AGROEKONOMI, V30, P23; Joglekar A, 2015, THESIS; Johnson M, 2013, 01301 IFPRI; Pittman K, 2010, REMOTE SENS-BASEL, V2, P1844, DOI 10.3390/rs2071844; Portmann FT, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2008GB003435; Ramankutty N, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002952; Wood-Sichra U., 2016, SPATIAL PRODUCTION A; You L., 2017, SPATIAL PRODUCTION A; You L, 2004, 126 IFPRI EPTD; You LZ, 2006, AGR SYST, V90, P329, DOI 10.1016/j.agsy.2006.01.008; You LZ, 2014, AGR SYST, V127, P53, DOI 10.1016/j.agsy.2014.01.002	26	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212281	10.1371/journal.pone.0212281	http://dx.doi.org/10.1371/journal.pone.0212281			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779813	Green Published, gold, Green Submitted			2022-12-27	WOS:000459062900038
J	Klann, JG; Joss, MAH; Embree, K; Murphy, SN				Klann, Jeffrey G.; Joss, Matthew A. H.; Embree, Kevin; Murphy, Shawn N.			Data model harmonization for the All Of Us Research Program: Transforming i2b2 data into the OMOP common data model	PLOS ONE			English	Article								Background The All Of Us Research Program (AOU) is building a nationwide cohort of one million patients' EHR and genomic data. Data interoperability is paramount to the program's success. AOU is standardizing its EHR data around the Observational Medical Outcomes Partnership (OMOP) data model. OMOP is one of several standard data models presently used in national-scale initiatives. Each model is unique enough to make interoperability difficult. The i2b2 data warehousing and analytics platform is used at over 200 sites worldwide, which uses a flexible ontology-driven approach for data storage. We previously demonstrated this ontology system can drive data reconfiguration, to transform data into new formats without site-specific programming. We previously implemented this on our 12-site Accessible Research Commons for Health (ARCH) network to transform i2b2 into the Patient Centered Outcomes Research Network model. Methods and results Here, we leverage our investment in i2b2 high-performance transformations to support the AOU OMOP data pipeline. Because the ARCH ontology has gained widespread national interest (through the Accrual to Clinical Trials network, other PCORnet networks, and the Nebraska Lexicon), we leveraged sites' existing investments into this standard ontology. We developed an i2b2-to-OMOP transformation, driven by the ARCH-OMOP ontology and the OMOP concept mapping dictionary. We demonstrated and validated our approach in the AOU New England HPO (NEHPO). First, we transformed into OMOP a fake patient dataset in i2b2 and verified through AOU tools that the data was structurally compliant with OMOP. We then transformed a subset of data in the Partners Healthcare data warehouse into OMOP. We developed a checklist of assessments to ensure the transformed data had self-integrity (e.g., the distributions have an expected shape and required fields are populated), using OMOP's visual Achilles data quality tool. This i2b2-to-OMOP transformation is being used to send NEHPO production data to AOU. It is open-source and ready for use by other research projects.	[Klann, Jeffrey G.; Joss, Matthew A. H.; Murphy, Shawn N.] Partners Healthcare, Res Informat Sci & Comp, Boston, MA USA; [Klann, Jeffrey G.; Murphy, Shawn N.] Harvard Med Sch, Boston, MA 02115 USA; [Klann, Jeffrey G.; Murphy, Shawn N.] Massachusetts Gen Hosp, Dept Med, Lab Comp Sci, Boston, MA 02114 USA; [Embree, Kevin] Partners Healthcare, Personalized Med, Boston, MA USA	Partners Healthcare System; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Partners Healthcare System	Klann, JG (corresponding author), Partners Healthcare, Res Informat Sci & Comp, Boston, MA USA.; Klann, JG (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Klann, JG (corresponding author), Massachusetts Gen Hosp, Dept Med, Lab Comp Sci, Boston, MA 02114 USA.	jeff.klann@mgh.harvard.edu			National Institutes of Health [NIH 10T20D026553-01]; Patient-Centered Outcomes Research Institute (PCORI) [CDRN-1306-04608]; National Institutes of Health National Human Genome Research Institute [R01 HG009174, U01 HG008685]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG009174, U01HG008685] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [OT2OD026553] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Patient-Centered Outcomes Research Institute (PCORI)(Patient-Centered Outcomes Research Institute - PCORI); National Institutes of Health National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grant number NIH 10T20D026553-01 (JGK, KE, SNM) -https://www.nih.gov/; The Patient-Centered Outcomes Research Institute (PCORI), award number CDRN-1306-04608 (JGK, MJ, SNM) -https://www.pcori.org/, (PCORI DISCLAIMER -The statements presented in this publication are solely the responsibility of the author(s) and do not necessarily represent the views of the Patient-Centered Outcomes Research Institute (PCORI), its Board of Governors or Methodology Committee or other participants in PCORnet.); National Institutes of Health National Human Genome Research Institute grant number R01 HG009174 (JGK, SNM). -https://www.genome.gov/; National Institutes of Health National Human Genome Research Institute grant number U01 HG008685 (JGK, SNM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campbell W., DEPLOYING ONC NATL S; Hripcsak G, 2015, STUD HEALTH TECHNOL, V216, P574, DOI 10.3233/978-1-61499-564-7-574; Kimball R., 2011, DATA WAREHOUSE TOOLK; Klann JG, 2016, J AM MED INFORM ASSN, V23, P909, DOI 10.1093/jamia/ocv188; Klann JG, 2018, I2O TRANSFORM PCORNE; Klann JG, 2018, ARCH ONTOLOGY ARCH I; McMurry AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055811; Murphy SN, 2010, J AM MED INFORM ASSN, V17, P124, DOI 10.1136/jamia.2009.000893; Natarajan K, 2017, PMI SPRINT REPORTER; National Institutes of Health (NIH), ALL US RES PROGR; PCORnet, 2018, PCORNET COMM DAT MOD; Phillips L., NCBO ONTOLOGY TOOLS; Sankar PL, 2017, GENET MED, V19, P743, DOI 10.1038/gim.2016.183; Visweswaran S, 2018, JAMIA OPEN, V1, P147, DOI 10.1093/jamiaopen/ooy033	14	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212463	10.1371/journal.pone.0212463	http://dx.doi.org/10.1371/journal.pone.0212463			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779778	gold, Green Published, Green Submitted			2022-12-27	WOS:000459062900057
J	Mostafavi, E; Molaeipoor, L; Esmaeili, S; Ghasemi, A; Kamalizad, M; Behzadi, MY; Naserifar, R; Rohani, M; Shahraki, AH				Mostafavi, Ehsan; Molaeipoor, Leila; Esmaeili, Saber; Ghasemi, Ahmad; Kamalizad, Maedeh; Behzadi, Manijeh Yousefi; Naserifar, Razi; Rohani, Mehdi; Shahraki, Abdolrazagh Hashemi			Seroprevalence of Q fever among high-risk occupations in the Ilam province, the west of Iran	PLOS ONE			English	Article							COXIELLA-BURNETII; SEROEPIDEMIOLOGICAL SURVEY; UNITED-STATES; SHEEP; TICKS	Background Q fever is a zoonotic disease of great public health importance in Iran. This disease is presented with high phase I antibody development in chronic and high phase II antibody in the acute form of illness. This study was conducted to evaluate the seroprevalence of Q fever among high-risk occupations in the Ilam province in Western Iran. Methods and findings In this cross-sectional study, 367 sera samples were collected from five groups comprised of animal husbandry workers, farmers, butchers, slaughterhouse workers, and park rangers. The collected sera were tested for IgG antibodies against Coxiella burnetii using ELISA. The seroprevalence of antibodies against C. burnetii in phase I and II was 24.38% and 26.37%, respectively (i.e., 32.42% overall). Low educational level, living in rural areas, keeping sheep/goats, ages older than 50 years, and a history of arthropod bites positively correlated with increased risk of Q fever infection. Animal husbandry workers (45.13%) were at higher risk of contracting Q fever compared with other occupations in the study (17.11%). Conclusions High seroprevalence of C. burnetii among high-risk occupations is a serious challenge in the Ilam province. In addition, the high seroprevalence of endemic Q fever in rural and nomadic areas and a higher concentration of occupations who are directly engaged with livestock demonstrate the critical need for preventive medicine education and training in regards to mitigating risk for disease contraction in susceptible groups.	[Mostafavi, Ehsan; Molaeipoor, Leila; Esmaeili, Saber; Ghasemi, Ahmad; Kamalizad, Maedeh; Behzadi, Manijeh Yousefi; Shahraki, Abdolrazagh Hashemi] Pasteur Inst Iran, Dept Epidemiol & Biostat, Res Ctr Emerging & Reemerging Infect Dis, Tehran, Iran; [Mostafavi, Ehsan; Molaeipoor, Leila; Esmaeili, Saber; Ghasemi, Ahmad; Kamalizad, Maedeh; Behzadi, Manijeh Yousefi; Rohani, Mehdi; Shahraki, Abdolrazagh Hashemi] Pasteur Inst Iran, Res Ctr Emerging & Reemerging Infect Dis, Natl Reference Lab Diag & Res Plague Tularemia &, Kabudar Ahang, Hamadan, Iran; [Esmaeili, Saber; Ghasemi, Ahmad] Tarbiat Modares Univ, Dept Bacteriol, Fac Med Sci, Tehran, Iran; [Naserifar, Razi] Ilam Univ Med Sci, Fac Hlth, Dept Parasitol, Ilam, Iran; [Rohani, Mehdi] Pasteur Inst Iran, Dept Microbiol, Tehran, Iran	Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Tarbiat Modares University; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran	Mostafavi, E (corresponding author), Pasteur Inst Iran, Dept Epidemiol & Biostat, Res Ctr Emerging & Reemerging Infect Dis, Tehran, Iran.; Mostafavi, E (corresponding author), Pasteur Inst Iran, Res Ctr Emerging & Reemerging Infect Dis, Natl Reference Lab Diag & Res Plague Tularemia &, Kabudar Ahang, Hamadan, Iran.	mostafaviehsan@gmail.com	Hashemi Shahraki, Abdolrazagh/AAG-2663-2021; Rohani, Mahdi/ABG-3890-2021; Esmaeili, Saber/F-2620-2017; Mostafavi, Ehsan/A-7627-2011; Molaeipour, Leila/M-1102-2018; naserifar, razi/GNM-8497-2022	Hashemi Shahraki, Abdolrazagh/0000-0003-1852-194X; Rohani, Mahdi/0000-0001-8956-5072; Esmaeili, Saber/0000-0003-1920-1737; Mostafavi, Ehsan/0000-0002-1997-517X; Molaeipour, Leila/0000-0002-1086-0907; naserifar, razi/0000-0001-6946-9083	Pasteur institute of Iran; Iranian Center for Communicable Infection Diseases [810]	Pasteur institute of Iran; Iranian Center for Communicable Infection Diseases	This project was supported by Pasteur institute of Iran and Iranian Center for Communicable Infection Diseases (Grant No. 810). http://en.pasteur.ac.ir/http://behdasht.gov.ir/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalah KH, 2015, J U THI QAR, V10, P1; Almogren A, 2013, ANN SAUDI MED, V33, P464, DOI 10.5144/0256-4947.2013.464; Anderson A, 2013, MMWR RECOMM REP, V62, P1; Anderson AD, 2009, AM J TROP MED HYG, V81, P691, DOI 10.4269/ajtmh.2009.09-0168; Angelakis E, 2010, VET MICROBIOL, V140, P297, DOI 10.1016/j.vetmic.2009.07.016; Bailey MS, 2011, J ROY ARMY MED CORPS, V157, P150, DOI 10.1136/jramc-157-02-05; Berktas M, 2011, TURK KLIN TIP BILIM, V31, P45, DOI 10.5336/medsci.2009-15348; Bielawska-Drozd A, 2013, ANN AGR ENV MED, V20, P222; Centers for Disease Control and Prevention, 2013, Q FEV; Clark D, 2009, 47 ANNM IDS; Dupuis G, 1985, Rev Med Suisse Romande, V105, P949; Duron O, 2015, TRENDS PARASITOL, V31, P536, DOI 10.1016/j.pt.2015.06.014; Esmaeili S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005535; Esmaeili S, 2014, VECTOR-BORNE ZOONOT, V14, P189, DOI 10.1089/vbz.2013.1382; Esmaeili S, 2014, VECTOR-BORNE ZOONOT, V14, P41, DOI 10.1089/vbz.2013.1379; Esmaeili S, 2013, ANN AGR ENV MED, V20, P708; Faix DJ, 2008, CLIN INFECT DIS, V46, pE65, DOI 10.1086/528866; Fard SRN, 2011, IRAN J ARTHROPOD-BOR, V5, P1; Fenga C, 2015, INT J OCCUP MED ENV, V28, P901, DOI 10.13075/ijomeh.1896.00448; Gozalan A, 2010, EUR J CLIN MICROBIOL, V29, P465, DOI 10.1007/s10096-010-0885-3; Honarmand H. Q, 2012, INTERDISCIPLINARY PE, V2012; KAPLAN M M, 1955, Bull World Health Organ, V13, P829; Khalili M, 2010, T ROY SOC TROP MED H, V104, P623, DOI 10.1016/j.trstmh.2010.04.002; Lloyd C, 2010, J ZOO WILDLIFE MED, V41, P83, DOI 10.1638/2009-0005.1; Madariaga MG, 2003, LANCET INFECT DIS, V3, P709, DOI 10.1016/S1473-3099(03)00804-1; McCaughey C, 2008, ZOONOSES PUBLIC HLTH, V55, P189, DOI 10.1111/j.1863-2378.2008.01109.x; Meredith AL, 2015, TRANSBOUND EMERG DIS, V62, P639, DOI 10.1111/tbed.12211; Metanat M, 2014, TURK J MED SCI, V44, P99, DOI 10.3906/sag-1209-102; Mobarez AM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005521; Morroy G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131777; Mostafavi E., 2012, Asian Journal of Epidemiology, V5, P66, DOI 10.3923/aje.2012.66.74; Noden BH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108674; RAFYI A., 1954, BULL SOC PATHOL EXOT, V47, P766; Rousset E, 2009, APPL ENVIRON MICROB, V75, P428, DOI 10.1128/AEM.00690-08; Saadatezadeh H, 1976, SPRINGER GODEWIJCKST, V30; Schimmer B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042364; Scrimgeour EM, 2003, ANN NY ACAD SCI, V990, P221, DOI 10.1111/j.1749-6632.2003.tb07366.x; Straily A, 2017, CLIN INFECT DIS; Sun WW, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/7059196; Van den Brom R, 2009, SMALL RUMINANT RES, V86, P74, DOI 10.1016/j.smallrumres.2009.09.022; Woldehiwet Z, 2004, RES VET SCI, V77, P93, DOI 10.1016/j.rvsc.2003.09.001; Yaghmaie F, 2015, J INFECT PUBLIC HEAL, V8, P498, DOI 10.1016/j.jiph.2014.12.004	43	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0211781	10.1371/journal.pone.0211781	http://dx.doi.org/10.1371/journal.pone.0211781			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779802	Green Submitted, gold, Green Published			2022-12-27	WOS:000459062900018
J	Marcinkowska, UM; Helle, S; Jones, BC; Jasienska, G				Marcinkowska, Urszula M.; Helle, Samuli; Jones, Benedict C.; Jasienska, Grazyna			Does testosterone predict women's preference for facial masculinity?	PLOS ONE			English	Article							MENSTRUAL-CYCLE; SALIVARY TESTOSTERONE; SOCIOSEXUALITY; ATTRACTIVENESS; HORMONES; STRESS; FACES	The influence of sex hormones on women's mate preferences has been an intensively discussed topic for more than a decade. Yet the extent to which levels of sex hormones, and testosterone in particular, influence women's mate preferences is unclear. Thus, the current study used multilevel modelling to investigate putative relationships between salivary testosterone and facial masculinity preferences in a sample of 68 women, while controlling for their age, partnership status, and sociosexuality. We found no significant associations between masculinity preferences and either individual differences or within-woman changes in testosterone. We did find however, that sociosexuality was positively correlated with masculinity preferences. Although it has previously been suggested that testosterone is related to women's facial masculinity preference, our data do not support this proposal.	[Marcinkowska, Urszula M.; Jasienska, Grazyna] Jagiellonian Univ, Coll Med, Fac Hlth Sci, Dept Environm Hlth, Krakow, Poland; [Helle, Samuli] Univ Turku, Sect Ecol, Dept Biol, Turku, Finland; [Jones, Benedict C.] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland	Jagiellonian University; Collegium Medicum Jagiellonian University; University of Turku; University of Glasgow	Marcinkowska, UM (corresponding author), Jagiellonian Univ, Coll Med, Fac Hlth Sci, Dept Environm Hlth, Krakow, Poland.	ummarcinkowska@gmail.com	Marcinkowska, Urszula/R-9738-2019; Jones, Benedict/A-7850-2008	Marcinkowska, Urszula/0000-0002-6851-4513; Jones, Benedict/0000-0001-7777-0220; Jasienska, Grazyna/0000-0001-8716-6342	Polish National Science Center [2014/12/S/NZ8/00722]; Jagiellonian University Medical College [K/DSC/004283]; Kone foundation [088423, 090026]	Polish National Science Center; Jagiellonian University Medical College; Kone foundation	This work was supported to UMM by the Polish National Science Center (grant number 2014/12/S/NZ8/00722) and by the structural funds of Jagiellonian University Medical College (grant number K/DSC/004283) and to SH by Kone foundation (grant numbers 088423 and 090026).	Akihito K, 2010, HDB ADV MULTILEVEL A; Blake KR, 2016, HORM BEHAV, V81, P74, DOI 10.1016/j.yhbeh.2016.03.004; Bloch M, 1998, BIOL PSYCHIAT, V43, P897, DOI 10.1016/S0006-3223(98)00403-X; Bobst C, 2014, PSYCHONEUROENDOCRINO, V41, P142, DOI 10.1016/j.psyneuen.2013.12.012; Boothroyd LG, 2014, ARCH SEX BEHAV, V43, P983, DOI 10.1007/s10508-013-0204-z; DABBS JM, 1991, HORM RES, V35, P182, DOI 10.1159/000181899; Ditzen B, 2017, PSYCHONEUROENDOCRINO, V82, P67, DOI 10.1016/j.psyneuen.2017.05.006; Gangestad SW, 1998, P ROY SOC B-BIOL SCI, V265, P927, DOI 10.1098/rspb.1998.0380; Glassenberg AN, 2010, ARCH SEX BEHAV, V39, P1289, DOI 10.1007/s10508-009-9559-6; Grimm K.J., 2016, GROWTH MODELING STRU; Johnston VS, 2001, EVOL HUM BEHAV, V22, P251, DOI 10.1016/S1090-5138(01)00066-6; Jones B. C., 2017, BIORXIV; Jones BC, 2018, PSYCHOL SCI, V29, P996, DOI 10.1177/0956797618760197; Jones BC, 2018, PSYCHONEUROENDOCRINO, V88, P153, DOI 10.1016/j.psyneuen.2017.12.015; Kinsey A, 1948, SEXUAL BEHAV HUMAN M, DOI 10.1037/t17515-000; Little AC, 2007, BEHAV ECOL SOCIOBIOL, V61, P967, DOI 10.1007/s00265-006-0325-7; Marcinkowska UM, 2018, HORM BEHAV, V102, P114, DOI 10.1016/j.yhbeh.2018.05.013; Marcinkowska UM, 2018, ARCH SEX BEHAV, V47, P1367, DOI 10.1007/s10508-017-1093-3; Marcinkowska UM, 2018, PSYCHONEUROENDOCRINO, V88, P47, DOI 10.1016/j.psyneuen.2017.11.007; Moore FR, 2011, P ROY SOC B-BIOL SCI, V278, P774, DOI 10.1098/rspb.2010.1678; Muthen L. K., 2009, MPLUS VERSION 5; Penke L, 2008, J PERS SOC PSYCHOL, V95, P1113, DOI 10.1037/0022-3514.95.5.1113; Penton-Voak IS, 1999, NATURE, V399, P741, DOI 10.1038/21557; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Pisanski K, 2014, HORM BEHAV, V66, P493, DOI 10.1016/j.yhbeh.2014.07.006; Provost MP, 2006, ARCH SEX BEHAV, V35, P305, DOI 10.1007/s10508-006-9029-3; Puts DA, 2006, HUM NATURE-INT BIOS, V17, P114, DOI 10.1007/s12110-006-1023-x; Roney JR, 2008, HORM BEHAV, V53, P14, DOI 10.1016/j.yhbeh.2007.09.008; Roney JR, 2011, PSYCHONEUROENDOCRINO, V36, P742, DOI 10.1016/j.psyneuen.2010.10.010; Schultheiss OC, 2003, HORM BEHAV, V43, P293, DOI 10.1016/S0018-506X(03)00003-5; Scott IML, 2013, BEHAV ECOL, V24, P579, DOI 10.1093/beheco/ars092; Tiddeman B, 2001, IEEE COMPUT GRAPH, V21, P42, DOI 10.1109/38.946630; Tofighi D., 2007, IDENTIFYING CORRECT; van Anders SM, 2012, ARCH SEX BEHAV, V41, P1471, DOI 10.1007/s10508-012-9946-2; Wang HY, 2014, PSYCHONEUROENDOCRINO, V50, P246, DOI 10.1016/j.psyneuen.2014.08.022; Waynforth D, 2005, EVOL HUM BEHAV, V26, P409, DOI 10.1016/j.evolhumbehav.2005.03.003; Welling LLM, 2007, HORM BEHAV, V52, P156, DOI 10.1016/j.yhbeh.2007.01.010; Wilcox AJ, 2004, HUM REPROD, V19, P1539, DOI 10.1093/humrep/deh305	38	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0210636	10.1371/journal.pone.0210636	http://dx.doi.org/10.1371/journal.pone.0210636			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM9LQ	30811400	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000459806400009
J	Xu, MH; Zhang, SX; Wen, J; Yang, XY				Xu, Manhou; Zhang, Shixiong; Wen, Jing; Yang, Xiaoyan			Multiscale spatial patterns of species diversity and biomass together with their correlations along geographical gradients in subalpine meadows	PLOS ONE			English	Article							ALTITUDINAL GRADIENT; STRUCTURAL DIVERSITY; BIODIVERSITY; PRODUCTIVITY; ECOSYSTEM; SCALE; RICHNESS; ROOT; GRASSLANDS; ALLOCATION	Researchers frequently discuss spatial distribution patterns of species diversity and biomass together with their correlations along geographical gradients. Typical subalpine meadows occur widely on the east of the Loess Plateau, China; here, we selected nine mountains belonging to four mountain systems from north to south on the east of the plateau. We analyzed five latitudinal and longitudinal gradients together with six elevational gradients to study the spatial distribution patterns of species diversity (including alpha, beta, and gamma diversity) and biomass plus with their relationships at various scales. Results showed that (1) for diversity, alpha-Diversity manifested unimodal variation patterns in horizontal spaces, peaking at high latitude and low longitude. However, alpha-diversity was not sensitive to elevation in vertical spaces and tended to decrease with increasing elevation. With increased latitude, longitude, and elevation, beta-Diversity diminished; meanwhile, the rate of species turnover decreased and the similarity of community composition enlarged. gamma-Diversity demonstrated quadratic function changes that were initially incremental and then decreased with increasing longitude, elevation, and latitude from 37.5 degrees to 40 degrees. In general, beta-diversity had positive correlation with gamma-diversity and negative correlation with alpha-diversity, which conformed to the function of beta = gamma/alpha. (2) For biomass, changes of aboveground biomass (AB) were more obvious along latitudinal gradients, whereas variations of belowground biomass (BB) had smaller differences along longitudinal and latitudinal gradients. More biomass was allocated to BB toward the north and east, whereas root-to-shoot ratio (R/S) was more evident at greater latitude than greater longitude. With increased elevation, more biomass was also allocated to BB, and the relationship of biomass to elevation was closer in AB. In short, the relation of biomass allocation tended to belowground plant parts with different geographical scales. (3) Species diversity had the strongest positive influence on AB. The Patrick and Shannon indices had correlations of power functions with AB and R/S, respectively, indicating that an allometric model could be used to model relationships between species diversity and biomass. In conclusion, the unique geomorphological structures with a series of basins between mountain systems on the east of the Loess Plateau, meant that subalpine meadows were mostly distributed along latitudinal directions, so the spatial distribution of species diversity and biomass was more evident along latitudinal gradients, and thus the response of above-ground biomass was more sensitive to variations of spatial gradients and species diversity.	[Xu, Manhou; Zhang, Shixiong; Wen, Jing; Yang, Xiaoyan] Taiyuan Normal Univ, Inst Geog Sci, Jinzhong, Peoples R China	Taiyuan Normal University	Xu, MH (corresponding author), Taiyuan Normal Univ, Inst Geog Sci, Jinzhong, Peoples R China.	xumh@tynu.edu.cn	manhou, xu/AAA-3630-2019	manhou, xu/0000-0001-7558-6227	National Natural Science Foundation of China [41501219]; Applied Basic Research Project of Shanxi Province [2016021136]; Higher School of Science and Technology Innovation Project of Shanxi Province [4]; Higher School of Key Discipline Construction Project of Shanxi Province [4]; 1331 Construction Planning Project of Taiyuan Normal University [34]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Applied Basic Research Project of Shanxi Province; Higher School of Science and Technology Innovation Project of Shanxi Province; Higher School of Key Discipline Construction Project of Shanxi Province; 1331 Construction Planning Project of Taiyuan Normal University	This work was supported by the National Natural Science Foundation of China (Grant No. 41501219), the Applied Basic Research Project of Shanxi Province (Grant No. 2016021136), the Higher School of Science and Technology Innovation Project of Shanxi Province (No. 4 document in 2016), the Higher School of Key Discipline Construction Project of Shanxi Province (No. 4 document in 2016), and the 1331 Construction Planning Project of Taiyuan Normal University (No. 34 document in 2017).	Adler PB, 2011, SCIENCE, V333, P1750, DOI 10.1126/science.1204498; Ali A, 2016, BIOGEOSCIENCES, V13, P4627, DOI 10.5194/bg-13-4627-2016; Bai YF, 2007, J APPL ECOL, V44, P1023, DOI 10.1111/j.1365-2664.2007.01351.x; Benayas JMR, 2002, J VEG SCI, V13, P245, DOI 10.1658/1100-9233(2002)013[0245:PDBAEI]2.0.CO;2; Bracken MES, 2017, ECOLOGY, V98, P1434, DOI [10.1002/ecy.1812, 10.1002/ecy.1812/suppinfo]; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Carnicer J, 2015, J PLANT PHYSIOL, V172, P82, DOI 10.1016/j.jplph.2014.07.022; Chen Chao, 2016, Acta Ecologica Sinica, V36, P661; Chen DM, 2016, J BIOGEOGR, V43, P955, DOI 10.1111/jbi.12683; Coates M, 1998, GLOBAL ECOL BIOGEOGR, V7, P115, DOI 10.2307/2997814; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Declerck S, 2005, ECOLOGY, V86, P1905, DOI 10.1890/04-0373; Dolezal J, 2002, PLANT ECOL, V158, P201, DOI 10.1023/A:1015564303206; Dorji T, 2014, ARCT ANTARCT ALP RES, V46, P308, DOI 10.1657/1938-4246-46.2.308; [段敏杰 Duan Minjie], 2011, [草业科学, Pratacultural Science], V28, P1845; Duncanson LI, 2015, GLOBAL ECOL BIOGEOGR, V24, P1465, DOI 10.1111/geb.12371; Fabbro T, 2004, FLORA, V199, P70, DOI 10.1078/0367-2530-00128; Feng TJ, 2018, EARTH SURF PROC LAND, V43, P1860, DOI 10.1002/esp.4361; Fraser LH, 2015, SCIENCE, V349, P302, DOI 10.1126/science.aab3916; Gao QZ, 2009, CLIMATIC CHANGE, V97, P515, DOI 10.1007/s10584-009-9617-z; [葛颂 Ge Song], 2017, [科学通报, Chinese Science Bulletin], V62, P2033; Godfray HCJ, 2001, TRENDS ECOL EVOL, V16, P400, DOI 10.1016/S0169-5347(01)02150-4; Grace JB, 2016, NATURE, V529, P390, DOI 10.1038/nature16524; GREEN J, 1994, HYDROBIOLOGIA, V272, P13, DOI 10.1007/BF00006509; Grytnes JA, 2002, AM NAT, V159, P294, DOI 10.1086/338542; Harrison S, 2007, AM NAT, V170, pS5, DOI 10.1086/519010; He J.S., 1997, ACTA ECOL SIN, V17, P91; Hector A, 2002, ECOL LETT, V5, P502, DOI 10.1046/j.1461-0248.2002.00337.x; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Holscher D, 2002, FORSTWISS CENTRALBL, V121, P229, DOI 10.1046/j.1439-0337.2002.02031.x; Hooper DU, 2000, BIOSCIENCE, V50, P1049, DOI 10.1641/0006-3568(2000)050[1049:IBAABB]2.0.CO;2; Nguyen H, 2012, FOREST ECOL MANAG, V274, P81, DOI 10.1016/j.foreco.2012.02.022; Huston M A, 2000, Science, V289, P1255; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; Jin ShaoHong, 2017, Acta Prataculturae Sinica, V26, P29; KAUFMAN DM, 1995, J MAMMAL, V76, P322, DOI 10.2307/1382344; Kessler M, 2014, J ECOL, V102, P1623, DOI 10.1111/1365-2745.12299; KORNER C, 1987, OECOLOGIA, V74, P411, DOI 10.1007/BF00378938; Li WenHan, 2017, Acta Prataculturae Sinica, V26, P200; Li Y, 2008, J VEG SCI, V19, P245, DOI 10.3170/2007-8-18365; [林敦梅 Lin Dunmei], 2017, [科学通报, Chinese Science Bulletin], V62, P1861; Liu Jing, 2016, Acta Prataculturae Sinica, V25, P36; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; [卢训令 Lu Xunling], 2010, [生态学报, Acta Ecologica Sinica], V30, P5790; Luo LM, 2014, PRATACULT SCI, V23, P320, DOI DOI 10.11686/CYXB20140638; Luo TX, 2005, FOREST ECOL MANAG, V206, P349, DOI 10.1016/j.foreco.2004.11.016; Ma Li, 2018, Shengtaixue Zazhi, V37, P2244, DOI 10.13292/j.1000-4890.201808.036; Ma WH, 2010, SCI CHINA LIFE SCI, V53, P841, DOI 10.1007/s11427-010-4020-6; Mack MC, 2003, ECOL APPL, V13, P154, DOI 10.1890/1051-0761(2003)013[0154:EGACOS]2.0.CO;2; Martinez-Hernandez C, 2017, HYDROL PROCESS, V31, P3095, DOI 10.1002/hyp.11251; McCarthy MC, 2007, FUNCT ECOL, V21, P713, DOI 10.1111/j.1365-2435.2007.01276.x; Mokany K, 2006, GLOBAL CHANGE BIOL, V12, P84, DOI 10.1111/j.1365-2486.2005.001043.x; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; Odland A, 1999, ECOGRAPHY, V22, P548, DOI 10.1111/j.1600-0587.1999.tb01285.x; Oleksyn J, 1998, FUNCT ECOL, V12, P573, DOI 10.1046/j.1365-2435.1998.00236.x; OLEKSYN J, 1992, NEW PHYTOL, V120, P561, DOI 10.1111/j.1469-8137.1992.tb01806.x; Panagos P, 2014, SCI TOTAL ENVIRON, V479, P189, DOI 10.1016/j.scitotenv.2014.02.010; Pedro MS, 2017, J VEG SCI, V28, P649, DOI 10.1111/jvs.12505; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; Qiong La, 2014, Biodiversity Science, V22, P337, DOI 10.3724/SP.J.1003.2014.13186; Shanafelt DW, 2015, J THEOR BIOL, V380, P426, DOI 10.1016/j.jtbi.2015.06.017; Sklenar Petr, 2001, Diversity and Distributions, V7, P113, DOI 10.1046/j.1472-4642.2001.00101.x; Sun YongXiu, 2017, Acta Prataculturae Sinica, V26, P54; [唐志尧 Tang Zhiyao], 2004, [生物多样性, Chinese Biodiversity], V12, P20; Thiele-Bruhn S, 2005, CHEMOSPHERE, V59, P457, DOI 10.1016/j.chemosphere.2005.01.023; Tilman D, 2000, NATURE, V405, P208, DOI 10.1038/35012217; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; TILMAN D, 1994, NATURE, V367, P363, DOI 10.1038/367363a0; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; [仝莉棉 Tong Limian], 2016, [水土保持研究, Research of Soil and Water Conservation], V23, P194; Wang GH, 2003, PLANT ECOL, V165, P169, DOI 10.1023/A:1022236115186; Wang Yang, 2017, Chinese Journal of Plant Ecology, V41, P105, DOI 10.17521/cjpe.2016.0217; Wardle D.A., 2000, B ECOL SOC AM, V81, P235, DOI DOI 10.2307/20168451; Weiner J, 2004, PERSPECT PLANT ECOL, V6, P207, DOI 10.1078/1433-8319-00083; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; Willis KJ, 2002, SCIENCE, V295, P1245, DOI 10.1126/science.1067335; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; WRIGHT DH, 1983, OIKOS, V41, P496, DOI 10.2307/3544109; [颉洪涛 Xie Hongtao], 2016, [生态学报, Acta Ecologica Sinica], V36, P3621; Xu MH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174231; Yang YH, 2010, GLOBAL ECOL BIOGEOGR, V19, P268, DOI 10.1111/j.1466-8238.2009.00502.x; Yang YH, 2009, J VEG SCI, V20, P177, DOI 10.1111/j.1654-1103.2009.05566.x; Yao Jing, 2017, Acta Prataculturae Sinica, V26, P108; Yuan F, 2015, LANDSCAPE ECOL, V30, P1737, DOI 10.1007/s10980-015-0154-z; Zhang Y, 2015, J ECOL, V103, P1245, DOI 10.1111/1365-2745.12425; Zhao Jie, 2017, Acta Prataculturae Sinica, V26, P54; [赵丽娅 Zhao Liya], 2017, [生态学报, Acta Ecologica Sinica], V37, P4108; [朱丽 Zhu Li], 2017, [生态学报, Acta Ecologica Sinica], V37, P1912	90	6	12	8	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211560	10.1371/journal.pone.0211560	http://dx.doi.org/10.1371/journal.pone.0211560			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811410	Green Submitted, Green Published, gold			2022-12-27	WOS:000459806400022
J	Ban, HY; Ahn, JB; Lee, BW				Ban, Ho-Young; Ahn, Joong-Bae; Lee, Byun-Woo			Assimilating MODIS data-derived minimum input data set and water stress factors into CERES-Maize model improves regional corn yield predictions	PLOS ONE			English	Article							REMOTE-SENSING INFORMATION; ENSEMBLE KALMAN FILTER; CROP GROWTH-MODEL; LEAF-AREA INDEX; DEFICIT STRESS; DROUGHT STRESS; VEGETATION; AGRICULTURE; VARIABILITY; SIMULATION	Crop growth models and remote sensing are useful tools for predicting crop growth and yield, but each tool has inherent drawbacks when predicting crop growth and yield at a regional scale. To improve the accuracy and precision of regional corn yield predictions, a simple approach for assimilating Moderate Resolution Imaging Spectroradiometer (MODIS) products into a crop growth model was developed, and regional yield prediction performance was evaluated in a major corn-producing state, Illinois, USA. Corn growth and yield were simulated for each grid using the Crop Environment Resource Synthesis (CERES)-Maize model with minimum inputs comprising planting date, fertilizer amount, genetic coefficients, soil, and weather data. Planting date was estimated using a phenology model with a leaf area duration (LAD)-logistic function that describes the seasonal evolution of MODIS-derived leaf area index (LAI). Genetic coefficients of the corn cultivar were determined to be the genetic coefficients of the maturity group [included in Decision Support System for Agro-technology Transfer (DSSAT) 4.6], which shows the minimum difference between the maximum LAI derived from the LAD-logistic function and that simulated by the CERES-Maize model. In addition, the daily water stress factors were estimated from the ratio between daily leaf area/weight growth rates estimated from the LAD-logistic function and that simulated by the CERES-Maize model under the rain-fed and auto-irrigation conditions. The additional assimilation of MODIS data-derived water stress factors and LAI under the auto-irrigation condition showed the highest prediction accuracy and precision for the yearly corn yield prediction (R-2 is 0.78 and the root mean square error is 0.75 t ha(-1)). The present strategy for assimilating MODIS data into a crop growth model using minimum inputs was successful for predicting regional yields, and it should be examined for spatial portability to diverse agro-climatic and agro-technology regions.	[Ban, Ho-Young; Lee, Byun-Woo] Seoul Natl Univ, Dept Plant Sci, Coll Agr & Life Sci, Seoul, South Korea; [Ban, Ho-Young; Lee, Byun-Woo] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Ahn, Joong-Bae] Pusan Natl Univ, Dept Earth Environm Syst, Busan, South Korea	Seoul National University (SNU); Seoul National University (SNU); Pusan National University	Lee, BW (corresponding author), Seoul Natl Univ, Dept Plant Sci, Coll Agr & Life Sci, Seoul, South Korea.; Lee, BW (corresponding author), Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea.	leebw@snu.ac.kr		, Byun-Woo/0000-0003-2284-1348; Ban, Ho-Young/0000-0001-9024-9683	Cooperative Research Program for Agriculture Science & Technology Development, Rural Development Administration, Republic of Korea [010115022017]	Cooperative Research Program for Agriculture Science & Technology Development, Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This study was conducted with the support of the Cooperative Research Program for Agriculture Science & Technology Development (Project NO. 010115022017), Rural Development Administration, Republic of Korea (www.rda.go.kr). HB, JA, BL received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JB, 2012, J METEOROL SOC JPN, V90, P493, DOI 10.2151/jmsj.2012-404; Ban HY, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9010016; Boote K.J., 2008, RESPONSE CROPS LTD W, V1, P59; BOUMAN BAM, 1995, NETH J AGR SCI, V43, P143; BOYER JS, 1968, PLANT PHYSIOL, V43, P1056, DOI 10.1104/pp.43.7.1056; Boyer JS, 2004, J EXP BOT, V55, P2385, DOI 10.1093/jxb/erh219; Bridges K, 2016, ISWS PUBLICATIONS SE, V12, P5; Cabrera VE, 2007, AGR ECOSYST ENVIRON, V122, P479, DOI 10.1016/j.agee.2007.03.005; Chisanga C. B., 2015, Journal of Agricultural Science (Toronto), V7, P79; Dadhwal VK, 2003, P TRAIN WORKSH HELD, P263; Davis RF, 2014, J NEMATOL, V46, P108; de Wit AM, 2007, AGR FOREST METEOROL, V146, P38, DOI 10.1016/j.agrformet.2007.05.004; DE WIT C. T., 1965, Agric. Res. Reps Centre agric. Publ. Docum., V663; Delecolle R, 1988, SPECTRAL SIGNATURES, P125; Dorigo WA, 2007, INT J APPL EARTH OBS, V9, P165, DOI 10.1016/j.jag.2006.05.003; DUNCAN WG, 1967, HILGARDIA, V38, P181, DOI 10.3733/hilg.v38n04p181; Evensen G.J.O.d., 2003, OCEAN DYNAM, V53, P343, DOI [DOI 10.1007/S10236-003-0036-9, 10.1007/s10236-003-0036-9]; Faivre R, 2004, AGRONOMIE, V24, P205, DOI 10.1051/agro:2004016; Fang HL, 2011, INT J REMOTE SENS, V32, P1039, DOI 10.1080/01431160903505310; Guo YY, 2015, TURK J BIOL, V39, P532, DOI 10.3906/biy-1412-20; Hadjimitsis DG, 2010, NAT HAZARD EARTH SYS, V10, P89, DOI 10.5194/nhess-10-89-2010; Hansen JW, 2000, AGR SYST, V65, P43, DOI 10.1016/S0308-521X(00)00025-1; Heinemann AB, 2016, AGR FOREST METEOROL, V225, P57, DOI 10.1016/j.agrformet.2016.05.010; Hoogenboom G., 2015, DECIS SUPPORT SYST; Ines AVM, 2013, REMOTE SENS ENVIRON, V138, P149, DOI 10.1016/j.rse.2013.07.018; Jiang Z, 2014, 3 INT C AGR 11 14 AU, DOI [10.1109/agro-geoinformatics.2014.6910599, DOI 10.1109/AGRO-GEOINFORMATICS.2014.6910599]; Jiang ZW, 2014, IEEE J-STARS, V7, P4422, DOI 10.1109/JSTARS.2014.2316012; Jin XL, 2018, EUR J AGRON, V92, P141, DOI 10.1016/j.eja.2017.11.002; Jones C., 1986, SIMULATION MODEL MAI; Jones JW, 2003, EUR J AGRON, V18, P235, DOI 10.1016/S1161-0301(02)00107-7; JORDAN CF, 1969, ECOLOGY, V50, P663, DOI 10.2307/1936256; Kiniry JR, 1991, PREDICTING CROP PHEN, P115; Kryvobok O., 2000, P INT ARCH PHOT R B7, V33, P717; Launay M, 2003, AGRONOMIE, V23, P135, DOI 10.1051/agro:2002078; Lenz-Wiedemann VIS, 2012, PROCEDIA ENVIRON SCI, V13, P1946, DOI 10.1016/j.proenv.2012.01.188; Leon Chris T., 2003, Precision Agriculture, V4, P359, DOI 10.1023/A:1026387830942; Li FL, 2009, AGROFOREST SYST, V77, P193, DOI 10.1007/s10457-008-9199-1; Li Y, 2014, ECOL MODEL, V291, P15, DOI 10.1016/j.ecolmodel.2014.07.013; Lilienthal H, 2007, D GREID S ADV TECHN, P87; Lopez-Cedron FX, 2005, EUR J AGRON, V23, P89, DOI 10.1016/j.eja.2005.01.001; Ma YP, 2008, INT J APPL EARTH OBS, V10, P426, DOI 10.1016/j.jag.2007.09.002; Marra M. C., 2012, AgBioForum, V15, P217; Medeiros David Barbosa, 2012, Braz. J. Plant Physiol., V24, P181, DOI 10.1590/S1677-04202012000300005; Morel J., 2014, European Journal of Agronomy, V61, P60, DOI 10.1016/j.eja.2014.08.004; Moulin S, 1998, INT J REMOTE SENS, V19, P1021, DOI 10.1080/014311698215586; Nafziger E., 2009, ILLINOIS AGRONOMY HD, P13; Nguy-Robertson A, 2012, AGRON J, V104, P1336, DOI 10.2134/agronj2012.0065; Oteng-Darko P, 2013, E3 J AGR RES DEV, V2, P1, DOI DOI 10.1007/s40003-012-0046-2; Ozdogan M, 2010, REMOTE SENS-BASEL, V2, P2274, DOI 10.3390/rs2092274; Perie C, 2008, CAN J SOIL SCI, V88, P315, DOI 10.4141/CJSS06008; Ralph EN, 1987, NATL CORN HDB; Reidsma P, 2008, ECOL SOC, V13; Rouse J.W., 1973, EARTH RES TECHN SAT, P309; Sehgal VK, 2016, REMOTE SENSING CROP, V7, P21; Shao HB, 2009, CRIT REV BIOTECHNOL, V29, P131, DOI 10.1080/07388550902869792; Singh R, 2008, 8 ASABE, DOI [10.13031/2013.24598, DOI 10.13031/2013.24598]; Soler CMT, 2007, EUR J AGRON, V27, P165, DOI 10.1016/j.eja.2007.03.002; Tsvetsinskaya EA, 2001, J CLIMATE, V14, P692, DOI 10.1175/1520-0442(2001)014<0692:ITEOSP>2.0.CO;2; Wang X, 2009, CROP MODELING DECISI, P203, DOI [10.1007/978-3-642-01132-0_21, DOI 10.1007/978-3-642-01132-0_21]; Weerts AH, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004093; Weng QH, 2012, REMOTE SENS ENVIRON, V117, P34, DOI 10.1016/j.rse.2011.02.030; Wu S, 2011, INT C COMP COMP TECH, P410, DOI [10.1007/978-3-642-27275-2_46, DOI 10.1007/978-3-642-27275-2_46]; Xiong D.L., 2014, SENSORS TRANSDUCERS, V169, P174; Yin JF, 2015, GEOPHYS RES LETT, V42, P6710, DOI 10.1002/2015GL063366; Zhao YX, 2013, ECOL MODEL, V270, P30, DOI 10.1016/j.ecolmodel.2013.08.016; Zhu XH, 2013, CHINESE GEOGR SCI, V23, P550, DOI 10.1007/s11769-013-0621-x	66	4	4	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2019	14	2							e0211874	10.1371/journal.pone.0211874	http://dx.doi.org/10.1371/journal.pone.0211874			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EH	30802254	gold, Green Submitted, Green Published			2022-12-27	WOS:000459710700007
J	Limmade, Y; Fransisca, L; Rodriguez-Fernandez, R; Bangs, MJ; Rothe, C				Limmade, Yuriko; Fransisca, Liony; Rodriguez-Fernandez, Rodrigo; Bangs, Michael J.; Rothe, Camilla			HIV treatment outcomes following antiretroviral therapy initiation and monitoring: A workplace program in Papua, Indonesia	PLOS ONE			English	Article							RECOVERY; COUNT; DETERMINANTS; PREDICTORS; COHORT	Background Papua Province, Indonesia is experiencing an on-going epidemic of Human Immunodeficiency Virus (HIV) infection, with an estimated 9-fold greater prevalence than the overall national rate. This study reviewed the treatment outcomes of an HIV-infected cohort on Antiretroviral Therapy (ART) and the predictors in terms of immunological recovery and virological response. Methods ART-naive individuals in a workplace HIV program in southern Papua were retrospectively analyzed. Patients were assessed at 6, 12 and 36 months after ART initiation for treatment outcomes, and risk factors for virological suppression (viral load (VL) <1,000 copies/ml), poor immune response (CD4 <200 cells/mm(3)) and immunological failure (CD4 <100 cells/mm 3) after at least 6 months on ART, using a longitudinal Generalized Estimating Equations multivariate model. Results Assessment of 105 patients were included in the final analysis with a median age of 34 years, 88% male, median baseline CD4 236 cells/mm(3), and VL 179,000 copies/ml. There were 74, 73, and 39 patients at 6, 12, and 36 months follow-up, respectively, with 5 deaths over the entire period. For the three observation periods, 68, 80, and 75% of patents achieved virological suppression, poor immune responders decreased from 15, 16 to 10%, whilst 15, 16, 10% met the immunological failure criteria, respectively. Using multivariate analysis, the independent predictor for viral suppression at 12 and 36 months was >= 1 log decrease in VL at 6 months (OR 19.25, p<0.001). Higher baseline CD4 was significantly correlated with better immunological outcomes, and lower likelihood of experiencing immunological failure (p <0.001). Conclusion Virological response at six months after beginning ART is the strongest predictor of viral suppression at 12 and 36 months, and may help in identifying patients needing additional adherence therapy support. Higher baseline CD4 positively affects the immunological outcomes of patients. The findings indicate HIV control programs should prioritize the availability of VL testing and begin ART regardless of CD4 counts in infected patients.	[Limmade, Yuriko] Charite Univ Med Berlin, Inst Trop Med & Int Hlth, Berlin, Germany; [Fransisca, Liony] Int SOS, PT Freeport Indonesia, Kuala Kencana Clin, Papua, Indonesia; [Rodriguez-Fernandez, Rodrigo] Int SOS, Noncommunicable Dis, London, England; [Rodriguez-Fernandez, Rodrigo] NCD Asia Pacific Alliance, Tokyo, Japan; [Bangs, Michael J.] Int SOS, PT Freeport Indonesia, Publ Hlth & Malaria Control Dept, Papua, Indonesia; [Rothe, Camilla] Ludwig Maximilians Univ Munchen, Univ Hosp, Div Infect Dis & Trop Med, Munich, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Freeport Indonesia; International SOS; Freeport Indonesia; International SOS; University of Munich	Limmade, Y (corresponding author), Charite Univ Med Berlin, Inst Trop Med & Int Hlth, Berlin, Germany.	ylimmade@gmail.com		Limmade, Yuriko/0000-0003-3923-4261	PT Freeport Indonesia, an affiliate of Freeport McMoRan, Inc.; International SOS, Ltd.	PT Freeport Indonesia, an affiliate of Freeport McMoRan, Inc.; International SOS, Ltd.	The publication cost of this study was funded by PT Freeport Indonesia, an affiliate of Freeport McMoRan, Inc., and International SOS, Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, IDF DIABETES ATLAS, V9th; Asfaw A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122583; Autran B, 1999, IMMUNOL LETT, V66, P207, DOI 10.1016/S0165-2478(98)00159-X; Ballinger GA, 2004, ORGAN RES METHODS, V7, P127, DOI 10.1177/1094428104263672; Bonner K, 2013, JAIDS-J ACQ IMM DEF, V64, P74, DOI 10.1097/QAI.0b013e31829f05ac; Butt L, 2002, PAPUAN SEXUALITY PRO; Costenaro P, 2014, J CLIN MICROBIOL, V52, P2665, DOI 10.1128/JCM.00961-14; Ditjen PP, 2017, CASES HIV AIDS INDON; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Ekouevi DK, 2007, AIDS RES HUM RETROV, V23, P1469, DOI 10.1089/aid.2007.0059; Estill J, 2016, LANCET HIV, V3, pE132, DOI 10.1016/S2352-3018(16)00016-3; Ferreyra C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049834; Fielding KL, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-93; Ford N, 2015, LANCET INFECT DIS, V15, P241, DOI 10.1016/S1473-3099(14)70896-5; Gilson R, 2010, HIV MED, V11, P152, DOI 10.1111/j.1468-1293.2009.00755.x; Gray RT, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/891593; Haas AD, 2015, LANCET HIV, V2, pE271, DOI 10.1016/S2352-3018(15)00087-9; Indonesia Ministry of Health, 2014, ISL BANK STAT, P1; Jevtovic D, 2014, BIOMED PHARMACOTHER, V68, P391, DOI 10.1016/j.biopha.2014.01.001; Kaufmann GR, 2003, ARCH INTERN MED, V163, P2187, DOI 10.1001/archinte.163.18.2187; KPAD Mimika, 2015, MIM DISTR HIV AIDS S, V1, p[1, 15, 33]; KPAD Mimika, 2016, LAP SIT HIV AIDS DAN, P1; Kwofie Theophilus B, 2015, BMC Res Notes, V8, P413, DOI 10.1186/s13104-015-1406-3; Lohse N, 2006, CLIN INFECT DIS, V42, P136, DOI 10.1086/498515; McMahon JH, 2013, B WORLD HEALTH ORGAN, V91, P377, DOI 10.2471/BLT.12.112946; Mehari M, 2017, FACTORS AFFECTING TR, V3; MoH Indonesia, 2014, PED PENG ANT, P33; Naftalin CM, 2015, INT J STD AIDS, V26, P803, DOI 10.1177/0956462414553826; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Powderly WG, 1999, AIDS, V13, P1873, DOI 10.1097/00002030-199910010-00009; Reda AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058595; Renaud M, 1999, AIDS, V13, P669, DOI 10.1097/00002030-199904160-00007; Sempa JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073190; Smith CJ, 2004, JAIDS-J ACQ IMM DEF, V37, P1155, DOI 10.1097/01.qai.0000135958.80919.e4; Staszewski S, 1999, AIDS, V13, P951, DOI 10.1097/00002030-199905280-00011; Takuva S, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18651; Teshome W, 2014, PLOS ONE, V9, P1; United Nations Data Retrieval System, 2016, UNDATA COUNTR PROF I; Vanobberghen FM, 2015, TROP MED INT HEALTH, V20, P880, DOI 10.1111/tmi.12507; WHO, 2010, ANT THER HIV INF AD; WHO, 2015, WHO ISS NEW HIV REC; WHO, 2016, GLOB REP EARL WARN I; Wijayanti F, 2016, J VIRUS ERAD, V2, P27; World Health Organization, 2016, CONS GUID US ANT DRU; World Health Organization, 2016, CONGUID UANT DRU, P72; Young W, 2013, AIDS RES THER, V10, P1; Yunifiar MQ, 2017, ACTA MED INDONES, V49, P205; Zhou JL, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-361	49	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2019	14	2							e0212432	10.1371/journal.pone.0212432	http://dx.doi.org/10.1371/journal.pone.0212432			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EH	30802257	gold, Green Published, Green Submitted			2022-12-27	WOS:000459710700012
J	Lind, L; Sundstrom, J; Larsson, A; Lampa, E; Arnlov, J; Ingelsson, E				Lind, Lars; Sundstrom, Johan; Larsson, Anders; Lampa, Erik; Arnlov, Johan; Ingelsson, Erik			Longitudinal effects of aging on plasma proteins levels in older adults - associations with kidney function and hemoglobin levels	PLOS ONE			English	Article							PROTEOMICS	Background A targeted proteomics chip has been shown to be useful to discover novel associations of proteins with cardiovascular disease. We investigated how these proteins change with aging, and whether this change is related to a decline in kidney function, or to a change in hemoglobin levels. Material and methods In the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study, including 1,016 participants from the general population aged 70 at baseline, 84 proteins were measured at ages 70, 75, 80. At these occasions, glomerular filtration rate (eGFR) was estimated and the hemoglobin levels were measured. Results Sixty-one of the 84 evaluated proteins changed significantly during the 10-year follow-up (multiple testing-adjusted alpha = 0.00059), most showing an increase. The change in eGFR was inversely related to changes of protein levels for the vast majority of proteins (74%). The change in hemoglobin was significantly related to the change in 40% of the evaluated proteins, with no obvious preference of the direction of these relationships. Conclusion The majority of evaluated proteins increased with aging in adults. Therefore, normal ranges for proteins might be given in age-strata. The increase in protein levels was associated with the degree of reduction in eGFR for the majority of proteins, while no clear pattern was seen for the relationships between the proteins and the change in hemoglobin levels. Studies on changes in urinary proteins are warranted to understand the association between the reduction in eGFR and increase in plasma protein levels.	[Lind, Lars; Sundstrom, Johan; Larsson, Anders] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Sundstrom, Johan; Lampa, Erik] Uppsala Clin Res Ctr, Uppsala, Sweden; [Arnlov, Johan] Dalarna Univ, Sch Hlth & Social Studies, Falun, Sweden; [Arnlov, Johan] Karolinska Inst, Div Family Med, Dept Neurobiol Care Sci & Soc, Huddinge, Sweden; [Ingelsson, Erik] Uppsala Univ, Dept Med Sci, Mol Epidemiol & Sci Life Lab, Uppsala, Sweden; [Ingelsson, Erik] Stanford Univ, Dept Med, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Ingelsson, Erik] Stanford Univ, Stanford Cardiovasc Inst, Stanford, CA 94305 USA; [Ingelsson, Erik] Stanford Univ, Stanford Diabet Res Ctr, Stanford, CA 94305 USA	Uppsala University; Uppsala University; Dalarna University; Karolinska Institutet; Uppsala University; Stanford University; Stanford University; Stanford University	Lind, L (corresponding author), Uppsala Univ, Dept Med Sci, Uppsala, Sweden.	lars.lind@medsci.uu.se	Ärnlöv, Johan/AAF-2746-2019; Sundstrom, Johan/R-2139-2019; Sundström, Johan/A-6286-2009	Ärnlöv, Johan/0000-0002-6933-4637; Sundstrom, Johan/0000-0003-2247-8454; Sundström, Johan/0000-0003-2247-8454; Ingelsson, Erik/0000-0003-2256-6972	Knut och Alice Wallenberg Foundation [2013.0126]; National Institutes of Health [R01DK106236]; Uppsala University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK106236, P30DK116074] Funding Source: NIH RePORTER	Knut och Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uppsala University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was conducted with support from Knut och Alice Wallenberg Foundation (2013.0126), National Institutes of Health (R01DK106236), and Uppsala University. The funding agencies did not have any influence over design, analysis or interpretation of data in the present study.	Alis R, 2015, SCAND J MED SCI SPOR, V25, pE630, DOI 10.1111/sms.12393; Assarsson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095192; Bjurman C, 2015, CLIN BIOCHEM, V48, P302, DOI 10.1016/j.clinbiochem.2015.01.008; Carlsson AC, 2017, CLIN J AM SOC NEPHRO, V12, P1226, DOI 10.2215/CJN.08780816; Carlsson AC, 2014, J AM SOC NEPHROL, V25, P1313, DOI 10.1681/ASN.2013080860; Christensson A, 2018, PROTEOM CLIN APPL, V12, DOI 10.1002/prca.201700067; Eggers KM, 2016, CLIN CHEM, V62, P485, DOI 10.1373/clinchem.2015.246876; Enroth S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5684; Fitzmaurice G.M., 2012, APPL LONGITUDINAL AN; Ignjatovic V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017213; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Jia LL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005146; KOISO K, 1975, UROL RES, V2, P167; Lietzen N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24019-5; Lind L, 2005, ARTERIOSCL THROM VAS, V25, P2368, DOI 10.1161/01.ATV.0000184769.22061.da; Lind L, 2017, HEART, V103, P379, DOI 10.1136/heartjnl-2016-309764; Lind L, 2015, STROKE, V46, P3340, DOI 10.1161/STROKEAHA.115.010829; Lind L, 2015, ATHEROSCLEROSIS, V242, P205, DOI 10.1016/j.atherosclerosis.2015.07.023; Liu CW, 2017, J PROTEOMICS, V152, P321, DOI 10.1016/j.jprot.2016.11.016; Lu JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039726; Menni C, 2015, J GERONTOL A-BIOL, V70, P809, DOI 10.1093/gerona/glu121; Naseeb U, 2015, JCPSP-J COLL PHYSICI, V25, P606, DOI 08.2015/JCPSP.606609; Schenk S, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-41	23	9	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2019	14	2							e0212060	10.1371/journal.pone.0212060	http://dx.doi.org/10.1371/journal.pone.0212060			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EH	30802263	Green Published, Green Submitted, gold			2022-12-27	WOS:000459710700009
J	Peng, PA; Wang, LG				Peng, Pingan; Wang, Liguan			Targeted location of microseismic events based on a 3D heterogeneous velocity model in underground mining	PLOS ONE			English	Article							FORM CROSS-CORRELATION; EARTHQUAKE LOCATION; GLOBAL OPTIMIZATION; TRAVEL-TIME; ALGORITHM; EFFICIENT; CALIFORNIA; RELOCATION; STACKING	The accurate location of induced seismicity is a problem of major interest in the safety monitoring of underground mines. Complexities in the seismic velocity structure, particularly changes in velocity caused by the progression of mining excavations, can cause systematic event mislocations. To address this problem, we present a novel construction method for an arbitrary 3D velocity model and a targeted hypocenter determination method based on this velocity model in underground mining. The method constructs a velocity model from 3D geological objects that can accurately express the interfaces of geologic units. Based on this model, the block corresponding to the minimum difference between the observed arrival times and the theoretical arrival times computed by the Fast Marching Method is located. Finally, a relocation procedure is carried out within the targeted block by heuristic algorithms to improve the performance. The accuracy and efficiency of the proposed method are demonstrated by the source localization results of both synthetic data and on-site data from Dongguashan Copper Mine. The results show that our proposed method significantly improves the location accuracy compared with the widely used Simplex and Particle Swarm Optimization methods.	[Peng, Pingan; Wang, Liguan] Cent S Univ, Sch Resources & Safety Engn, Changsha, Hunan, Peoples R China	Central South University	Peng, PA (corresponding author), Cent S Univ, Sch Resources & Safety Engn, Changsha, Hunan, Peoples R China.	ping_an@outlook.com	Peng, Pingan/P-2551-2018	Peng, Pingan/0000-0002-4957-4035; Wang, Liguan/0000-0002-3120-7464	National Key R&D Program of China [2017YFC0602905]	National Key R&D Program of China	This work was supported by the National Key R&D Program of China (No. 2017YFC0602905 to LW). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akram J, 2017, J GEOPHYS ENG, V14, P1215, DOI 10.1088/1742-2140/aa71d0; [Anonymous], 2016, 50 US ROCK MECH GEOM; Baker T, 2005, B SEISMOL SOC AM, V95, P699, DOI 10.1785/0120040123; Ballard S, 2009, SEISMOL RES LETT, V80, P989, DOI 10.1785/gssrl.80.6.989; Chen YK, 2017, PHYS EARTH PLANET IN, V264, P35, DOI 10.1016/j.pepi.2016.10.003; Collings D, 2014, 48 US ROCK MECH S; Ding L, 2018, GEOPHYS J INT, V214, P2053, DOI 10.1093/gji/ggy256; Feng GL, 2015, TUNN UNDERGR SP TECH, V45, P73, DOI 10.1016/j.tust.2014.09.007; Gajewski D, 2005, GEOPHYS J INT, V163, P276, DOI 10.1111/j.1365-246X.2005.02732.x; Ge MC, 2005, INT J COAL GEOL, V64, P44, DOI 10.1016/j.coal.2005.03.004; Geiger L., 1912, B ST LOUIS U, V8, P56; Gharti HN, 2010, GEOPHYSICS, V75, pMA27, DOI 10.1190/1.3432784; Grigoli F, 2013, SEISMOL RES LETT, V84, P666, DOI 10.1785/0220120191; Hardebeck JL, 2010, EARTHQUAKE LOCATION; Hauksson E, 2005, B SEISMOL SOC AM, V95, P896, DOI 10.1785/0120040167; Kao H, 2004, GEOPHYS J INT, V157, P589, DOI 10.1111/j.1365-246X.2004.02276.x; Lagos SR, 2018, J APPL GEOPHYS, V149, P18, DOI 10.1016/j.jappgeo.2017.12.004; Li JL, 2013, GEOPHYS J INT, V195, P1917, DOI 10.1093/gji/ggt358; Lin GQ, 2018, SEISMOL RES LETT, V89, P1877, DOI 10.1785/0220180108; Michelini A, 2004, GEOPHYS RES LETT, V31; Nakata N, 2016, GEOPHYSICS, V81, pKS51, DOI 10.1190/GEO2015-0278.1; Peng PA, 2018, SHOCK VIB, V2018, DOI 10.1155/2018/4367201; Rawlinson N, 2008, ADV GEOPHYS, V49, P203, DOI 10.1016/S0065-2687(07)49003-3; SAMBRIDGE M, 1993, B SEISMOL SOC AM, V83, P1467; Sethian JA, 1996, P NATL ACAD SCI USA, V93, P1591, DOI 10.1073/pnas.93.4.1591; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Tan YY, 2018, GEOPHYSICS, V83, pKS49, DOI 10.1190/GEO2017-0308.1; THURBER CH, 1985, B SEISMOL SOC AM, V75, P779; Trugman DT, 2017, SEISMOL RES LETT, V88, P379, DOI 10.1785/0220160188; Waldhauser F, 2000, B SEISMOL SOC AM, V90, P1353, DOI 10.1785/0120000006; Waldhauser F, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005479; Zhou S.-Y., 1999, ACTA SEISMOLOGICA SI, V12, P285; Zhou ZL, 2018, IEEE ACCESS, V6, P25090, DOI 10.1109/ACCESS.2018.2805384	33	14	14	5	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2019	14	2							e0212881	10.1371/journal.pone.0212881	http://dx.doi.org/10.1371/journal.pone.0212881			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EH	30802268	gold, Green Published, Green Submitted			2022-12-27	WOS:000459710700024
J	Alvarez, F; Sanchez, F; Hernandez-Penaloza, G; Jimenez, D; Menendez, JM; Cisneros, G				Alvarez, Federico; Sanchez, Faustino; Hernandez-Penaloza, Gustavo; Jimenez, David; Manuel Menendez, Jose; Cisneros, Guillermo			On the influence of low-level visual features in film classification	PLOS ONE			English	Article							RECOMMENDATION	Background In this paper we present a model of parameters to aesthetically characterize films using a multi-disciplinary approach: by combining film theory, visual low-level video descriptors (modeled in order to supply aesthetic information) and classification techniques using machine and deep learning. Methods Four different tests have been developed, each for a different application, proving the model's usefulness. These applications are: aesthetic style clustering, prediction of production year, genre detection and influence on film popularity. Results The results are compared against high-level information to determine the accuracy of the model to classify films without knowing such information previously. The main difference with other film characterization approaches is that we are able to isolate the influence of high-level descriptors to really understand the relevance of low-level features and, accordingly propose a useful set of low-level visual descriptors for that purpose. This model has been tested with a representative number of films to prove that it can be used for different applications.	[Alvarez, Federico; Sanchez, Faustino; Hernandez-Penaloza, Gustavo; Jimenez, David; Manuel Menendez, Jose; Cisneros, Guillermo] Univ Politecn Madrid Ave Complutense, Escuela Tecn Super Ingenieros Telecomunicacio IPT, Grp Aplicac Telecomunicac Visuales, Madrid, Spain	Universidad Politecnica de Madrid	Alvarez, F (corresponding author), Univ Politecn Madrid Ave Complutense, Escuela Tecn Super Ingenieros Telecomunicacio IPT, Grp Aplicac Telecomunicac Visuales, Madrid, Spain.	fag@gatv.ssr.upm.es	Menéndez, José Manuel/AAS-8430-2020; Alvarez, Federico/AAA-7628-2019; Jimenez, David/AAS-2274-2020; David Jimenez, DL López Jiménez/N-6460-2013; Menendez, Jose-Manuel/L-1159-2014	Jimenez, David/0000-0002-7382-4276; David Jimenez, DL López Jiménez/0000-0002-7013-9556; Menendez, Jose-Manuel/0000-0003-0584-2250	Spanish Ministry of Economy and Competitiveness [IPT-2012-0152-430000, TEC2012-38402-C04-01]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported in part by the Spanish Ministry of Economy and Competitiveness, by means of project "RECOPUBLI" (IPT-2012-0152-430000), and project HORFI (TEC2012-38402-C04-01).	Altman R., 1999, FILM GENRE; Asad KI, 2012, 2012 INTERNATIONAL CONFERENCE ON INFORMATICS, ELECTRONICS & VISION (ICIEV), P747, DOI 10.1109/ICIEV.2012.6317401; Aumont J, 1992, AESTHETICS OF FILMS; Balazs B., 1952, THEORY OF THE FILM; Barrilero M, 2011, IEEE INFOCOM 2011 IN; Benjamin W., 1936, WORK ART AGE MECH RE; Bordwell David, 1987, CLASSICAL HOLLYWOOD; Burch N, 1988, THEORY FILM PRACTICE; Canini L, 2013, IEEE T CIRC SYST VID, V23, P636, DOI 10.1109/TCSVT.2012.2211935; Chang SF, 2001, IEEE T CIRC SYST VID, V11, P688, DOI 10.1109/76.927421; Chapman J., 2003, CINEMAS WORLD FILM S; Chu W.-T., 2017, PROC MUSA2 17, P39; Datta R, 2006, LECT NOTES COMPUT SC, V3953, P288, DOI 10.1007/11744078_23; Deldjoo Y, 2016, J DATA SEMANT, V5, P99, DOI 10.1007/s13740-016-0060-9; Djuric N, 2015, PROCEEDINGS OF THE 24TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW 2015), P248, DOI 10.1145/2736277.2741643; Eisenstein S., 1969, FILM FORM ESSAY FILM; Gombrich Ernst H., 2002, ART ILLUSION STUDY P; GRECHANOVSKY E, 1987, ANN NY ACAD SCI, V491, P197, DOI 10.1111/j.1749-6632.1987.tb30057.x; Harper FM, 2016, ACM T INTERACT INTEL, V5, DOI 10.1145/2827872; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Hong HZ, 2015, LECT NOTES COMPUT SC, V9132, P159, DOI 10.1007/978-3-319-20248-8_14; Itten J., 2002, ART COLOR SUBJECTIVE; Langford B., 2005, FILM GENRE HOLLYWOOD; Latif MH, 2016, INT J COMPUT SCI NET, V16, P127; Martin A., 2008, WHAT IS MODERN CINEM; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Mirshahvalad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053943; Moorthy AK, 2010, LECT NOTES COMPUT SC, V6315, P1, DOI 10.1007/978-3-642-15555-0_1; Rasheed Z, 2005, IEEE T CIRC SYST VID, V15, P52, DOI 10.1109/TCSVT.2004.839993; Redi M., 2012, P 20 ACM INT C MULT, P1363; Redi M., 2013, 3 ACM C INT C MULT R, P337; Sanchez F, 2012, MOBILE NETW APPL, V17, P782, DOI 10.1007/s11036-012-0399-6; Sarndal C.-E., 1992, MODEL ASSISTED SURVE; Simoes GS, 2016, IEEE IJCNN, P259, DOI 10.1109/IJCNN.2016.7727207; Steven D., 2000, COLOR PERCEPTION PHI; Suykens JAK, 1999, NEURAL PROCESS LETT, V9, P293, DOI 10.1023/A:1018628609742; Thanouli Eleftheria, 2009, POSTCLASSICAL CINEMA; von Trier L, 2000, DANISH J FILM ST DEC; Wang HL, 2006, IEEE T CIRC SYST VID, V16, P689, DOI 10.1109/TCSVT.2006.873781; Wehrmann J, 2017, APPL SOFT COMPUT, V61, P973, DOI 10.1016/j.asoc.2017.08.029; Xu M, 2005, MULT EXP 2005 ICME 2; Xu M., 2008, P 16 ACM INT C MULTI, P677, DOI [10.1145/1459359.1459457, DOI 10.1145/1459359.1459457]; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	44	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0211406	10.1371/journal.pone.0211406	http://dx.doi.org/10.1371/journal.pone.0211406			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794549	Green Published, gold, Green Submitted			2022-12-27	WOS:000459709100014
J	Calvo-Lerma, J; Fornes-Ferrer, V; Peinado, I; Heredia, A; Ribes-Koninckx, C; Andres, A				Calvo-Lerma, Joaquim; Fornes-Ferrer, Victoria; Peinado, Irene; Heredia, Ana; Ribes-Koninckx, Carmen; Andres, Ana			A first approach for an evidence-based in vitro digestion method to adjust pancreatic enzyme replacement therapy in cystic fibrosis	PLOS ONE			English	Article							NUTRITIONAL-STATUS; DAIRY MATRICES; PH; LIPOLYSIS; PROFILES; RELEASE; DIGESTIBILITY; INSUFFICIENCY; CHILDREN; OUTCOMES	Background Patients with cystic fibrosis have to take enzymatic supplements to allow for food digestion. However, an evidence-based method to adjust Pancreatic Enzyme Replacement Therapy (PERT) is inexistent, and lipid content of meals is used as a rough criterion. Objective In this study, an in vitro digestion model was set up to determine the theoretical optimal dose (TOD) of enzymatic supplement for a selection of foods, which is the dose that allows for maximum lipolysis extent. Methods A static in vitro digestion model was applied to simulate digestion of eight foods covering a wide range of lipid contents. First, the dose of the enzymatic supplement was fixed at 2000 lipase units per gram of fat (LU/g fat) using intestinal pH and bile salt concentration as variables. Second, intestinal pH and bile salt concentrations were fixed and the variable was the dose of the enzymatic supplement. Lipolysis extent was determined by measuring the free fatty acids released from initial triglycerides content of foods after digestion. Results in terms of percentage of lipolysis extent were fitted into a linear-mixed segmented model and the deducted equations were used to predict the TOD to reach 90% of lipolysis in every food. In addition, the effect of intestinal pH and bile salt concentration were investigated. Results The predictive equations obtained for the assessed foods showed that lipolysis was not only dependent on the dose of the enzyme supplement or the lipid content. Moreover, intestinal pH and bile salt concentration had significant effects on lipolysis. Therefore an evidence-based model can be developed taking into account these variables. Conclusions Depending on food characteristics, a specific TOD should be assigned to achieve an optimal digestion extent. This work represents a first step towards an evidence-based method for PERT dosing, which will be applied in an in vivo setting to validate its efficacy.	[Calvo-Lerma, Joaquim; Peinado, Irene; Heredia, Ana; Andres, Ana] Univ Politecn Valencia, Res Inst Food Engn Dev, Valencia, Spain; [Calvo-Lerma, Joaquim; Fornes-Ferrer, Victoria; Ribes-Koninckx, Carmen] Inst Invest Sanitaria La Fe Valencia, Valencia, Spain	Universitat Politecnica de Valencia	Calvo-Lerma, J (corresponding author), Univ Politecn Valencia, Res Inst Food Engn Dev, Valencia, Spain.; Calvo-Lerma, J (corresponding author), Inst Invest Sanitaria La Fe Valencia, Valencia, Spain.	joaquin_calvo@iislafe.es	Heredia, Ana/C-7107-2016; Ribes-Koninckx, Maria Carmen/ABH-5577-2020; Calvo-Lerma, Joaquim/P-4605-2016; Grau, Ana M Andrés/C-9521-2016; Calvo-Lerma, Joaquim/AAB-2783-2020	Heredia, Ana/0000-0001-6629-9779; Calvo-Lerma, Joaquim/0000-0001-7818-0652; Grau, Ana M Andrés/0000-0002-6132-3167; Calvo-Lerma, Joaquim/0000-0001-7818-0652; Ribes-Koninckx, Carmen/0000-0002-0038-6324	European Union [643806]	European Union(European Commission)	This work was fully funded by the European Union and the Horizon 2020 Research and Innovation Framework Programme (PHC-26-2014 call Self management of health and disease: citizen engagement and mHealth) under grant number 643806.	Aburub A, 2018, INT J PHARMACEUT, V544, P158, DOI 10.1016/j.ijpharm.2018.04.031; Aloulou A, 2008, ALIMENT PHARM THERAP, V27, P283, DOI 10.1111/j.1365-2036.2007.03563.x; Andree M., 1996, NEW ENGL J MED, V289, P1001; BLACKBERG L, 1979, J CLIN INVEST, V64, P1303, DOI 10.1172/JCI109586; Bornhorst GM, 2015, J FOOD SCI, V80, pR924, DOI 10.1111/1750-3841.12846; Borowitz D, 2005, J PEDIATR GASTR NUTR, V41, P273, DOI 10.1097/01.mpg.0000178439.64675.8d; Calvo-Leima J, 2017, J CYST FIBROS, V16, P510, DOI 10.1016/j.jcf.2017.03.005; Calvo-Lerma J, 2018, J FOOD SCI, V83, P2629, DOI 10.1111/1750-3841.14343; Calvo-Lerma J, 2017, REV ESP ENFERM DIG, V109, P684, DOI 10.17235/reed.2017.4951/2017; Calvo-Lerma J, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014931; Carriere F, 2000, GASTROENTEROLOGY, V119, P949, DOI 10.1053/gast.2000.18140; COLOMBO C, 1988, SCAND J GASTROENTERO, V23, P151, DOI 10.3109/00365528809090237; Fang XX, 2016, FOOD RES INT, V88, P276, DOI 10.1016/j.foodres.2016.04.008; Farrell PM, 2008, J CYST FIBROS, V7, P450, DOI 10.1016/j.jcf.2008.03.007; Fieker A, 2011, CLIN EXP GASTROENTER, V4, P55, DOI 10.2147/CEG.S17634; Gelfond D, 2013, DIGEST DIS SCI, V58, P2275, DOI 10.1007/s10620-012-2209-1; Gonzalez- Bacerio J., 2010, REV COLOMBIANA DELEL, V12, P113; Helbig A, 2012, FOOD HYDROCOLLOID, V28, P10, DOI 10.1016/j.foodhyd.2011.11.007; Heneen WK, 2003, STARCH-STARKE, V55, P546, DOI 10.1002/star.200300187; Hu M, 2010, FOOD HYDROCOLLOID, V24, P719, DOI 10.1016/j.foodhyd.2010.03.010; Humbert L, 2018, J LIPID RES, V59, P2202, DOI 10.1194/jlr.M084830; Hunter JE, 2001, LIPIDS, V36, P655, DOI 10.1007/s11745-001-0770-0; Kim EHJ, 2008, FOOD BIOPHYS, V3, P229, DOI 10.1007/s11483-008-9066-7; Lamothe S, 2017, FOOD RES INT, V92, P138, DOI 10.1016/j.foodres.2016.12.026; Lamothe S, 2014, FOOD FUNCT, V5, P2621, DOI [10.1039/c4fo00203b, 10.1039/C4FO00203B]; Layer P, 2003, PANCREAS, V26, P1, DOI 10.1097/00006676-200301000-00001; Lesmes U, 2012, FOOD HYDROCOLLOID, V26, P221, DOI 10.1016/j.foodhyd.2011.05.011; Li Y, 2011, FOOD CHEM, V126, P498, DOI 10.1016/j.foodchem.2010.11.027; Mcclements DJ, 2009, CRIT REV FOOD SCI, V49, P48, DOI 10.1080/10408390701764245; Minekus M, 2014, FOOD FUNCT, V5, P1113, DOI 10.1039/c3fo60702j; Muggeo V.M.R., 2016, SEGMENTED MIXED MODE; Norman A. P., 1979, ARCH DIS CHILD, V54, P19; PRAZERES DMF, 1994, BIOPROCESS ENG, V10, P21, DOI 10.1007/BF00373531; RESMINI P, 1983, FOOD MICROSTRUCT, V2, P1; ROBINSON PJ, 1990, DIGEST DIS SCI, V35, P1299, DOI 10.1007/BF01536423; Rovner AJ, 2014, INFLAMM BOWEL DIS MO, V14, P65; Schall JI, 2006, J PEDIATR GASTR NUTR, V43, P651, DOI 10.1097/01.mpg.0000234082.47884.d9; Sikkens ECM, 2010, BEST PRACT RES CL GA, V24, P337, DOI 10.1016/j.bpg.2010.03.006; Turck D, 2016, CLIN NUTR, V35, P557, DOI 10.1016/j.clnu.2016.03.004; VERGER R, 1976, ANNU REV BIOPHYS BIO, V5, P77, DOI 10.1146/annurev.bb.05.060176.000453; Whitcomb DC, 2010, AM J GASTROENTEROL, V105, P2276, DOI 10.1038/ajg.2010.201; Ye XT, 2016, INT J BIOL MACROMOL, V84, P428, DOI 10.1016/j.ijbiomac.2015.12.054; Yen EH, 2013, J PEDIATR-US, V162, P530, DOI 10.1016/j.jpeds.2012.08.040; YOUNGBERG CA, 1987, DIGEST DIS SCI, V32, P472, DOI 10.1007/BF01296029; Zhu XQ, 2013, FOOD CHEM, V139, P398, DOI 10.1016/j.foodchem.2012.12.060	45	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212459	10.1371/journal.pone.0212459	http://dx.doi.org/10.1371/journal.pone.0212459			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794618	Green Submitted, Green Published, gold			2022-12-27	WOS:000459709100071
J	Samarin, AM; Samarin, AM; Ostbye, TKK; Ruyter, B; Sampels, S; Burkina, V; Blecha, M; Gela, D; Policar, T				Samarin, Azin Mohagheghi; Samarin, Azadeh Mohagheghi; Ostbye, Tone-Kari Knutsdatter; Ruyter, Bente; Sampels, Sabine; Burkina, Viktoriia; Blecha, Miroslav; Gela, David; Policar, Tomas			Alteration of mRNA abundance, oxidation products and antioxidant enzyme activities during oocyte ageing in common carp Cyprinus carpio	PLOS ONE			English	Article							RAINBOW-TROUT; IN-VITRO; EGG QUALITY; CALCIUM OSCILLATIONS; GENE-EXPRESSION; MOUSE OOCYTES; STRESS; APOPTOSIS; ACTIVATION; TIME	Oocyte ageing is the most important factor affecting egg quality of several fish species after ovulation. Oxidative stress has been proposed as the initiator of the oocyte ageing process in other vertebrates. To identify the role of oxidative stress and apoptosis on the progress of oocyte ageing in the common carp Cyprinus carpio, changes in the relative mRNA abundance of selected transcripts were examined. The possible alteration in the oxidation status of the oocytes during ageing was also studied. In addition, the activity of antioxidant enzymes during oocyte ageing was evaluated. Oocytes from 6 females were incubated in vivo for 14 hours post-ovulation (HPO) and in vitro for 10 hours post-stripping (HPS) at 20 degrees C before fertilization. Hatching rates were over 65% up to 4-6 HPO, finally dropping to 1.3% at 12-14 HPO. Hatching rates were over 65% up to 4-6 HPO, finally dropping to 1.3% at 1214 HPO. Hatching rates were more than 70% for the eggs stored in vitro up to 6 HPS and then decreased to 21.3% at 10 HPS. The results demonstrated no significant changes in the relative mRNA levels of oxidative stress-related genes or genes involved in the cell cycle during the progress of oocyte ageing in common carp. Additionally, the amount of TBARS and carbonyls did not change as time elapsed following ovulation. The apoptosis-related genes however, were significantly altered following the prolonged time interval between ovulation and fertilization. The lack of response of both activities of antioxidant enzymes and oxidation products during oocyte ageing strengthens the conclusion that oxidative stress is unlikely to be a main factor determining the progress of oocyte ageing in common carp. However, an increase in the mRNA abundance of apoptosis-related genes demonstrates that apoptotic pathway might be involved in the progress of oocyte ageing.	[Samarin, Azin Mohagheghi; Samarin, Azadeh Mohagheghi; Burkina, Viktoriia; Blecha, Miroslav; Gela, David; Policar, Tomas] Univ South Bohemia Ceske Budejovice, Fac Fisheries & Protect Waters, Res Inst Fish Culture & Hydrobiol, South Bohemian Res Ctr Aquaculture & Biodivers Hy, Vodnany, Czech Republic; [Ostbye, Tone-Kari Knutsdatter; Ruyter, Bente] Nofima Norwegian Inst Food Fisheries & Aquacultur, As, Norway; [Sampels, Sabine] Swedish Univ Agr Sci, Dept Mol Sci, Uppsala, Sweden	University of South Bohemia Ceske Budejovice; Nofima; Swedish University of Agricultural Sciences	Samarin, AM (corresponding author), Univ South Bohemia Ceske Budejovice, Fac Fisheries & Protect Waters, Res Inst Fish Culture & Hydrobiol, South Bohemian Res Ctr Aquaculture & Biodivers Hy, Vodnany, Czech Republic.	mohagheghi@frov.jcu.cz	Policar, Tomas/G-4896-2015; Samarin, Azin Mohagheghi/G-3468-2015	Policar, Tomas/0000-0001-9245-4381; Ostbye, Tone-Kari Knutsdatter/0000-0001-5173-7115	Ministry of Education, Youth and Sports of the Czech Republic [LM2018099]; project Reproductive and Genetic Procedures for Preserving Fish Biodiversity and Aquaculture [CZ.02.1.01/0.0/0.0/16_025/0007370]; Ministry of Agriculture of the Czech Republic: project NAZV [QK1710310];  [NF-CZ07-MOP-3-184-2015];  [NF-CZ07-ICP-3-185-2015]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); project Reproductive and Genetic Procedures for Preserving Fish Biodiversity and Aquaculture; Ministry of Agriculture of the Czech Republic: project NAZV; ; 	The study was financially supported by the Ministry of Education, Youth and Sports of the Czech Republic - project "CENAKVA" (LM2018099), project Reproductive and Genetic Procedures for Preserving Fish Biodiversity and Aquaculture (CZ.02.1.01/0.0/0.0/16_025/0007370), the Ministry of Agriculture of the Czech Republic: project NAZV (QK1710310) and by NF-CZ07-MOP-3-184-2015 and NF-CZ07-ICP-3-185-2015.	Aegerter S, 2005, MOL REPROD DEV, V72, P377, DOI 10.1002/mrd.20361; Aegerter S, 2004, AQUACULTURE, V231, P59, DOI 10.1016/j.aquaculture.2003.08.019; Aegerter S, 2004, MOL REPROD DEV, V67, P127, DOI 10.1002/mrd.10384; Babiak I, 2003, J EXP ZOOL PART A, V300A, P140, DOI 10.1002/jez.a.10319; Bobe J, 2010, GEN COMP ENDOCR, V165, P535, DOI 10.1016/j.ygcen.2009.02.011; BOERJAN ML, 1990, MOL REPROD DEV, V25, P155, DOI 10.1002/mrd.1080250208; Bonnet E, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-55; Bonnet E, 2007, THERIOGENOLOGY, V67, P786, DOI 10.1016/j.theriogenology.2006.10.008; Butt AJ, 1999, IMMUNOL CELL BIOL, V77, P256, DOI 10.1046/j.1440-1711.1999.00822.x; Claiborne A, 1985, CRC HDB METHODS OXYG, P283; CLEARY ML, 1986, CELL, V47, P19, DOI 10.1016/0092-8674(86)90362-4; CRIBB AE, 1989, ANAL BIOCHEM, V183, P195, DOI 10.1016/0003-2697(89)90188-7; DEAN RT, 1993, TRENDS BIOCHEM SCI, V18, P437, DOI 10.1016/0968-0004(93)90145-D; Esponda P, 2006, AGE INDUCED APOPTOSI, p184a; Flajshans M, 2007, J FISH BIOL, V71, P868, DOI 10.1111/j.1095-8649.2007.01557.x; Fujino Y, 1996, HUM REPROD, V11, P1480; Gordo AC, 2002, BIOL REPROD, V66, P1828, DOI 10.1095/biolreprod66.6.1828; Hamatani T, 2004, HUM MOL GENET, V13, P2263, DOI 10.1093/hmg/ddh241; Headlam HA, 2004, FREE RADICAL BIO MED, V36, P1175, DOI 10.1016/j.freeradbiomed.2004.02.017; Horvath L, 1985, COMMON CARP PT 1 MAS; Houseweart MK, 2003, J NEUROBIOL, V56, P315, DOI 10.1002/neu.10253; Huang JC, 2007, BIOL REPROD, V77, P666, DOI 10.1095/biolreprod.107.062703; Kagedal K, 2001, FASEB J, V15, P1592, DOI 10.1096/fj.00-0708fje; Kikuchi Kazuhiro, 2002, Cloning and Stem Cells, V4, P211, DOI 10.1089/15362300260339494; Komrakova M, 2009, AQUACULTURE, V286, P156, DOI 10.1016/j.aquaculture.2008.09.019; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Lahnsteiner F, 2001, AQUACULTURE, V195, P331, DOI 10.1016/S0044-8486(00)00550-0; LAM TJ, 1978, CAN J ZOOL, V56, P2029, DOI 10.1139/z78-273; Li MQ, 2000, MOL CELL BIOL, V20, P5096, DOI 10.1128/MCB.20.14.5096-5106.2000; Li P, 2010, BIOL REPROD, V83, P852, DOI 10.1095/biolreprod.110.085852; Liang XW, 2008, BIOCHEM BIOPH RES CO, V371, P16, DOI 10.1016/j.bbrc.2008.03.105; Liang XW, 2011, MOL HUM REPROD, V17, P562, DOI 10.1093/molehr/gar018; Liu W, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2130-z; Lord T, 2013, REPRODUCTION, V146, pR217, DOI 10.1530/REP-13-0111; Lord T, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.106450; Ma H, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1400-0; Ma W, 2005, BIOL REPROD, V72, P373, DOI 10.1095/biolreprod.104.030999; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; MCEVOY LA, 1984, J FISH BIOL, V24, P437, DOI 10.1111/j.1095-8649.1984.tb04814.x; Minami N, 2007, J REPROD DEVELOP, V53, P707, DOI 10.1262/jrd.19029; MOHANDAS J, 1984, BIOCHEM PHARMACOL, V33, P1801, DOI 10.1016/0006-2952(84)90353-8; Mok HJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148577; Mommens Maren, 2010, BMC Research Notes, V3, DOI 10.1186/1756-0500-3-138; Nikolic A, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/1741072; NISHIKIMI M, 1972, BIOCHEM BIOPH RES CO, V46, P849, DOI 10.1016/S0006-291X(72)80218-3; OLIVER CN, 1987, J BIOL CHEM, V262, P5488; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; Perez GI, 2005, FASEB J, V19, P860, DOI 10.1096/fj.04-2903fje; Raz E., 2000, GENOME BIOL, V1; Rime Helene, 2004, Reprod Biol Endocrinol, V2, P26, DOI 10.1186/1477-7827-2-26; Saffman EE, 1999, CELL MOL LIFE SCI, V55, P1141, DOI 10.1007/s000180050363; Samarin AM, 2017, ANIMAL, V11, P78, DOI 10.1017/S1751731116001361; Samarin AM, 2015, J APPL ICHTHYOL, V31, P51, DOI 10.1111/jai.12855; Samarin AM, 2018, AQUAC RES, V49, P1037, DOI 10.1111/are.13552; Samarin AM, 2016, AQUACULTURE, V450, P431, DOI 10.1016/j.aquaculture.2015.08.017; Samarin AM, 2015, REV FISH SCI AQUAC, V23, P302, DOI 10.1080/23308249.2015.1053560; SCHULTZ GA, 1992, MUTAT RES, V296, P17, DOI 10.1016/0165-1110(92)90029-9; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Takahashi T, 2003, MOL REPROD DEV, V66, P143, DOI 10.1002/mrd.10341; Takahashi T, 2013, J OBSTET GYNAECOL RE, V39, P1431, DOI 10.1111/jog.12111; Tarin JJ, 2002, BIOL REPROD, V66, P495, DOI 10.1095/biolreprod66.2.495; Tarin JJ, 2000, HUM REPROD UPDATE, V6, P532, DOI 10.1093/humupd/6.6.532; Torres-Padilla ME, 2006, INT J DEV BIOL, V50, P455, DOI 10.1387/ijdb.052073mt; TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263; Tzung KW, 2015, STEM CELL REP, V4, P61, DOI 10.1016/j.stemcr.2014.10.011; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Xu Z, 1997, BIOL REPROD, V57, P743, DOI 10.1095/biolreprod57.4.743; Yang HW, 1998, HUM REPROD, V13, P998, DOI 10.1093/humrep/13.4.998; Yoshida N, 2007, DEV BIOL, V301, P464, DOI 10.1016/j.ydbio.2006.08.006; Zuccotti M, 2011, HUM REPROD UPDATE, V17, P525, DOI 10.1093/humupd/dmr009	71	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212694	10.1371/journal.pone.0212694	http://dx.doi.org/10.1371/journal.pone.0212694			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794661	Green Published, gold, Green Submitted			2022-12-27	WOS:000459709100118
J	Venkateswaran, M; Bogale, B; Abu Khader, K; Awwad, T; Friberg, IK; Ghanem, B; Hijaz, T; Morkrid, K; Froen, JF				Venkateswaran, Mahima; Bogale, Binyam; Abu Khader, Khadija; Awwad, Tamara; Friberg, Ingrid K.; Ghanem, Buthaina; Hijaz, Taghreed; Morkrid, Kjersti; Froen, J. Frederik			Effective coverage of essential antenatal care interventions: A cross-sectional study of public primary healthcare clinics in the West Bank	PLOS ONE			English	Article							QUALITY; SERVICES	Background The proportion of women attending four or more antenatal care (ANC) visits is widely used for monitoring, but provides limited information on quality of care. Effective coverage metrics, assessing if ANC interventions are completely delivered, can identify critical gaps in healthcare service delivery. We aimed to measure coverage of at least one screening and effective coverage of ANC interventions in the public health system in the West Bank, Palestine, and to explore associations between infrastructure-related and maternal sociodemographic variables and effective coverage. Methods We used data from paper-based clinical records of 1369 pregnant women attending ANC in 17 primary healthcare clinics. Infrastructure-related variables were derived from a 2014 national inventory assessment of clinics. Sample size calculations were made to detect effective coverage ranging 40-60% with a 2-3% margin of error, clinics were selected by probability sampling. We calculated inverse probability weighted percentages of: effective coverage of appropriate number and timing of screenings of ANC interventions; and coverage of at least one screening. Results Coverage of one screening and effective coverage of ANC interventions were notably different for screening for: hypertension (98% vs. 10%); fetal growth abnormalities (66% vs. 6%); anemia (93% vs. 14%); gestational diabetes (93% vs. 34%), and antenatal ultrasound (74% vs. 24%). Clinics with a laboratory and ultrasound generally performed better in terms of effective coverage, and maternal sociodemographic factors had no associations with effective coverage estimates. Only 13% of the women attended ANC visits according to the recommended national schedule, driving effective coverage down. Conclusion Indicators for ANC monitoring and their definitions can have important consequences for quantifying health system performance and identifying issues with care provision. To achieve more effective coverage in public primary care clinics in the West Bank, efforts should be made to improve care provision according to prescribed guidelines.	[Venkateswaran, Mahima; Bogale, Binyam; Friberg, Ingrid K.; Morkrid, Kjersti; Froen, J. Frederik] Norwegian Inst Publ Hlth, Global Hlth Cluster, Div Hlth Serv, Oslo, Norway; [Venkateswaran, Mahima; Bogale, Binyam; Froen, J. Frederik] Univ Bergen, Ctr Intervent Sci Maternal & Child Hlth CISMAC, Bergen, Norway; [Abu Khader, Khadija; Awwad, Tamara; Ghanem, Buthaina] WHO, Palestinian Natl Inst Publ Hlth, Ramallah, Palestine; [Hijaz, Taghreed] Minist Hlth, Ramallah, Palestine	Norwegian Institute of Public Health (NIPH); University of Bergen; World Health Organization	Froen, JF (corresponding author), Norwegian Inst Publ Hlth, Global Hlth Cluster, Div Hlth Serv, Oslo, Norway.; Froen, JF (corresponding author), Univ Bergen, Ctr Intervent Sci Maternal & Child Hlth CISMAC, Bergen, Norway.	frederik.froen@fhi.no	Bogale, Binyam/AAW-1269-2020	Bogale, Binyam/0000-0003-2893-895X; Venkateswaran, Mahima/0000-0002-1226-5685; Froen Froen, Jahn Frederik/0000-0001-9390-8509	European Research Council [617639]; Research Council of Norway [234376, 223269]	European Research Council(European Research Council (ERC)European Commission); Research Council of Norway(Research Council of Norway)	This study and the eRegistries research project are funded by the European Research Council (https://erc.europa.eu/; grant agreement number: 617639, project title, A New Paradigm for Public Health Surveillance: Unlocking the Potential of Data to Empower Woman and Health Systems; project acronym, HEALTMPOWR), and the Research Council of Norway (https://www.forskningsradet.no/en/Home_page/1177315753906; through grant agreement number: 234376, project title, Harmonized Reproductive Health Registry Communication Strategies: Using Health Data to Empower Women and Health Systems; and through grant agreement number: 223269, project title: Centre for Intervention Science in Maternal and Child health (CISMAC), University of Bergen, Norway). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PAL MULT IND CLUST S; [Anonymous], HARM REPR HLTH EREGI; Arsenault C, 2018, LANCET GLOB HEALTH, V6, pE1186, DOI 10.1016/S2214-109X(18)30389-9; Austin A, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-S2-S1; Baker U, 2015, B WORLD HEALTH ORGAN, V93, P380, DOI 10.2471/BLT.14.141879; Bell BA, 2012, AM J PUBLIC HEALTH, V102, P1399, DOI 10.2105/AJPH.2011.300398; Benova L, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000779; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Bollini P, 2013, J EVAL CLIN PRACT, V19, P1060, DOI 10.1111/jep.12027; Carroli G, 2001, LANCET, V357, P1565, DOI 10.1016/S0140-6736(00)04723-1; Carvajal-Aguirre L, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.020501; Dean AG, OPENEPI OPEN SOURCE; Do M, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.020501; Dowswell T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000934.pub2; Giacaman R, 2009, LANCET, V373, P837, DOI 10.1016/S0140-6736(09)60107-0; Hall MH, 2001, LANCET, V357, P1546, DOI 10.1016/S0140-6736(00)04777-2; Health Information Systems Programme (HISP), DISTR HLTH INF SYST; Henriksson DK, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1327256; Hijazi HH, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0542-3; Hodgins S, 2014, GLOB HEALTH-SCI PRAC, V2, P173, DOI 10.9745/GHSP-D-13-00176; Joshi C, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-94; Kanyangarara M, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.021101; Kujawski SA, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-001002; Kyei NNA, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-151; Leslie HH, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002464; Marchant T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126840; Ministry of Health Palestinian Health Information Center, 2016, HLTH STAT; Ministry of Health PHIC Health Status Palestine, 2016, HLTH STAT; Munos MK, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.010801; Nguhiu PK, 2017, TROP MED INT HEALTH, V22, P442, DOI 10.1111/tmi.12841; Rahim HFA, 2009, LANCET, V373, P967, DOI 10.1016/S0140-6736(09)60108-2; Moron-Duarte LS, 2019, INT J QUAL HEALTH C, V31, P497, DOI 10.1093/intqhc/mzy206; StataCorp, SVY EST EST COMM SUR; TANAHASHI T, 1978, B WORLD HEALTH ORGAN, V56, P295; Turienzo CF, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009044; UNICEF, 2016, STATE WORLDS CHILDRE; Venkateswaran M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207813; Venkateswaran M, 2018, TRIALS, V19, DOI 10.1186/s13063-017-2386-5; Victora CG, 2010, HEALTH POLICY PLANN, V25, P253, DOI 10.1093/heapol/czp065; Villar J, 1997, ACTA OBSTET GYN SCAN, V76, P1, DOI 10.3109/00016349709047778; Villar J, 2001, LANCET, V357, P1551, DOI 10.1016/S0140-6736(00)04722-X; WHO, 2003, ANTENATAL CARE DEV C; WHO, 2016, WHO REC ANT CAR POST; WHO, 2015, GLOB REF LIST 100 CO; WHO, 2012, ESS INT COMM GUID RE; Yakob B, 2019, INT J QUAL HEALTH C, V31, P725, DOI 10.1093/intqhc/mzy251	46	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212635	10.1371/journal.pone.0212635	http://dx.doi.org/10.1371/journal.pone.0212635			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794645	gold, Green Submitted, Green Published			2022-12-27	WOS:000459709100101
J	Ware, HH; Kulkarni, VV; Wang, YX; Garcia, JP; Juarez, ML; Kirkpatrick, CT; Wali, S; Syed, S; Kontoyiannis, AD; Sikkema, WKA; Tour, JM; Evans, SE				Ware, Hayden H.; Kulkarni, Vikram V.; Wang, Yongxing; Garcia, Jezreel Pantaleon; Juarez, Miguel Leiva; Kirkpatrick, Carson T.; Wali, Shradha; Syed, Sarah; Kontoyiannis, Alexander D.; Sikkema, William K. A.; Tour, James M.; Evans, Scott E.			Inducible lung epithelial resistance requires multisource reactive oxygen species generation to protect against bacterial infections	PLOS ONE			English	Article							INDUCED ROS RELEASE; INFLUENZA-A VIRUS; CEREBROVASCULAR DYSFUNCTION; RISK-FACTORS; PNEUMONIA; MITOCHONDRIA; DUOX; EFFECTORS; THERAPY; BIOLOGY	Pneumonia remains a global health threat, in part due to expanding categories of susceptible individuals and increasing prevalence of antibiotic resistant pathogens. However, therapeutic stimulation of the lungs' mucosal defenses by inhaled exposure to a synergistic combination of Toll-like receptor (TLR) agonists known as Pam2-ODN promotes mouse survival of pneumonia caused by a wide array of pathogens. This inducible resistance to pneumonia relies on intact lung epithelial TLR signaling, and inducible protection against viral pathogens has recently been shown to require increased production of epithelial reactive oxygen species (ROS) from multiple epithelial ROS generators. To determine whether similar mechanisms contribute to inducible antibacterial responses, the current work investigates the role of ROS in therapeutically-stimulated protection against Pseudomonas aerugnosa challenges. Inhaled Pam2-ODN treatment one day before infection prevented hemorrhagic lung cytotoxicity and mouse death in a manner that correlated with reduction in bacterial burden. The bacterial killing effect of Pam2-ODN was recapitulated in isolated mouse and human lung epithelial cells, and the protection correlated with inducible epithelial generation of ROS. Scavenging or targeted blockade of ROS production from either dual oxidase or mitochondrial sources resulted in near complete loss of Pam2-ODN-induced bacterial killing, whereas deficiency of induced antimicrobial peptides had little effect. These findings support a central role for multisource epithelial ROS in inducible resistance against a bacterial pathogen and provide mechanistic insights into means to protect vulnerable patients against lethal infections.	[Ware, Hayden H.; Kulkarni, Vikram V.; Wang, Yongxing; Garcia, Jezreel Pantaleon; Juarez, Miguel Leiva; Kirkpatrick, Carson T.; Wali, Shradha; Syed, Sarah; Kontoyiannis, Alexander D.; Evans, Scott E.] Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA; [Kulkarni, Vikram V.; Wali, Shradha; Evans, Scott E.] Univ Texas MD Anderson Canc Ctr, UT Hlth Grad Sch Biomed Sci, Houston, TX 77030 USA; [Sikkema, William K. A.; Tour, James M.] Rice Univ, Smalley Inst Nanoscale Sci & Technol, Houston, TX 77005 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Rice University	Evans, SE (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA.; Evans, SE (corresponding author), Univ Texas MD Anderson Canc Ctr, UT Hlth Grad Sch Biomed Sci, Houston, TX 77030 USA.	seevans@mdanderson.org	Wali, Shradha/GNP-5631-2022	Pantaleon Garcia, Jezreel/0000-0002-9647-2584; Evans, Scott/0000-0003-4503-0644; Wali, Shradha/0000-0002-6077-7618	US National Institutes of Health (NIH) [R01 HL117976, DP2 HL123229, P30 CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117976] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by US National Institutes of Health (NIH) grants R01 HL117976 and DP2 HL123229 to S.E.E. and P30 CA016672 to the MD Anderson Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro VY, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00008; Bitner BR, 2012, ACS NANO, V6, P8007, DOI 10.1021/nn302615f; Blake Francis G., 2000, Yale Journal of Biology and Medicine, V73, P103; Blasi F, 2007, RESP MED, V101, P875, DOI 10.1016/j.rmed.2007.02.016; Cegolon L, 2014, INT J HYG ENVIR HEAL, V217, P17, DOI 10.1016/j.ijheh.2013.03.001; Cleaver JO, 2014, MUCOSAL IMMUNOL, V7, P78, DOI 10.1038/mi.2013.26; Dikalov S, 2011, FREE RADICAL BIO MED, V51, P1289, DOI 10.1016/j.freeradbiomed.2011.06.033; Dryden M, 2018, INT J ANTIMICROB AG, V51, P299, DOI 10.1016/j.ijantimicag.2017.08.029; Duggan JM, 2011, J IMMUNOL, V186, P5916, DOI 10.4049/jimmunol.1002122; Evans SE, 2011, BRIT J PHARMACOL, V163, P195, DOI 10.1111/j.1476-5381.2011.01237.x; Evans SE, 2010, ANNU REV PHYSIOL, V72, P413, DOI 10.1146/annurev-physiol-021909-135909; Fang FC, 2011, MBIO, V2, DOI 10.1128/mBio.00141-11; File TM, 2003, LANCET, V362, P1991, DOI 10.1016/S0140-6736(03)15021-0; Fischer H, 2009, ANTIOXID REDOX SIGN, V11, P2453, DOI [10.1089/ars.2009.2558, 10.1089/ARS.2009.2558]; Forteza R, 2005, AM J RESP CELL MOL, V32, P462, DOI 10.1165/rcmb.2004-0302OC; Fry AM, 2005, JAMA-J AM MED ASSOC, V294, P2712, DOI 10.1001/jama.294.21.2712; Garaude J, 2016, NAT IMMUNOL, V17, P1037, DOI 10.1038/ni.3509; Grandvaux N, 2015, CLIN SCI, V128, P337, DOI 10.1042/CS20140321; Guirao-Abad JP, 2017, INT J MED MICROBIOL, V307, P241, DOI 10.1016/j.ijmm.2017.03.005; James John S, 2004, AIDS Treat News, P7; Jeon YJ, 2018, APPL MICROBIOL BIOT, V102, P4339, DOI 10.1007/s00253-018-8956-y; Joos Ladina, 2005, Proc Am Thorac Soc, V2, P445, DOI 10.1513/pats.200508-097JS; Kim S, 2015, ANTIVIR RES, V119, P78, DOI 10.1016/j.antiviral.2015.04.011; Kim YM, 2017, AM J PHYSIOL-CELL PH, V312, pC749, DOI 10.1152/ajpcell.00346.2016; Kirkpatrick CT, 2018, MBIO, V9, DOI 10.1128/mBio.00696-18; KLEBANOFF SJ, 1966, BIOCHIM BIOPHYS ACTA, V117, P63, DOI 10.1016/0304-4165(66)90152-8; Knust J, 2009, ANAT REC, V292, P113, DOI 10.1002/ar.20747; Leiva-Juarez MM, 2018, MUCOSAL IMMUNOL, V11, P21, DOI 10.1038/mi.2017.71; Leiva-Juarez MM, 2016, BLOOD, V128, P982, DOI 10.1182/blood-2016-03-708511; Marcano DC, 2013, J NEUROTRAUM, V30, P789, DOI 10.1089/neu.2011.2301; Memar MY, 2018, INFECT DRUG RESIST, V11, P567, DOI 10.2147/IDR.S142397; Mizgerd JP, 2006, PLOS MED, V3, P155, DOI 10.1371/journal.pmed.0030076; Munro D, 2017, J EXP BIOL, V220, P1170, DOI 10.1242/jeb.132142; Patton JS, 2010, J AEROSOL MED PULM D, V23, pS71, DOI 10.1089/jamp.2010.0836; Pinegin B, 2018, J CELL PHYSIOL, V233, P3745, DOI 10.1002/jcp.26117; Samuel ELG, 2015, P NATL ACAD SCI USA, V112, P2343, DOI 10.1073/pnas.1417047112; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Shekhova E, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00978-17, 10.1128/aac.00978-17]; SOCIETY FOR, 2012, INFECT CONT HOSP EP, V33, P322, DOI DOI 10.1086/665010; Stocks CJ, 2018, J LEUKOCYTE BIOL, V103, P35, DOI 10.1002/JLB.4RI0917-358R; Strengert M, 2014, ANTIOXID REDOX SIGN, V20, P2695, DOI 10.1089/ars.2013.5353; Thomsen RW, 2006, J INTERN MED, V259, P410, DOI 10.1111/j.1365-2796.2006.01629.x; Torres A, 2013, THORAX, V68, P1057, DOI 10.1136/thoraxjnl-2013-204282; Troeger C, 2017, LANCET INFECT DIS, V17, P1133, DOI 10.1016/S1473-3099(17)30396-1; Trotter CL, 2008, EMERG INFECT DIS, V14, P727, DOI 10.3201/eid1405.071011; van der Vliet A, 2008, FREE RADICAL BIO MED, V44, P938, DOI 10.1016/j.freeradbiomed.2007.11.016; Vatansever F, 2013, FEMS MICROBIOL REV, V37, P955, DOI 10.1111/1574-6976.12026; Vinogradova Y, 2009, BRIT J GEN PRACT, V59, P742, DOI 10.3399/bjgp09X472629; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Wijkstrom-Frei C, 2003, AM J RESP CELL MOL, V29, P206, DOI 10.1165/rcmb.2002-0152OC; Wong JL, 2017, CLIN CHEST MED, V38, P263, DOI 10.1016/j.ccm.2016.12.005; World Health Organization, 2004, WORLD HLTH REP 2004; Zhang X, 2015, FREE RADICAL RES, V49, P374, DOI 10.3109/10715762.2015.1014813; Zinkevich NS, 2011, AM J PHYSIOL-HEART C, V301, pH647, DOI 10.1152/ajpheart.01271.2010; Zou LL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29313-w	55	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0208216	10.1371/journal.pone.0208216	http://dx.doi.org/10.1371/journal.pone.0208216			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794556	Green Published, Green Submitted, gold			2022-12-27	WOS:000459709100007
J	Park, JW; Kim, DK; Jung, JY; Lee, SU; Chang, I; Kwak, YH; Hwang, S				Park, Joong Wan; Kim, Do Kyun; Jung, Jae Yun; Lee, Se Uk; Chang, Ikwan; Kwak, Young Ho; Hwang, Soyun			Dog-bite injuries in Korea and risk factors for significant dog-bite injuries: A 6-year cross-sectional study	PLOS ONE			English	Article							EPIDEMIOLOGY	Introduction An accurate understanding of the current status of dog-bite injuries in Korea is essential for establishing preventive strategies. There have been no national reports about dog-bite injuries in Korea. This study investigated dog-bite injuries in Korea that were registered in the nationwide injury surveillance database and analysed the risk factors for significant dog-bite injury. Methods A multicentre cross-sectional study was conducted using the emergency department (ED)-based Injury In-depth Surveillance (EDIIS) registry in Korea between 2011 and 2016. We defined significant injury as death, admission, surgery, or fracture or amputation. A multivariable logistic regression model was used to obtain the adjusted odds ratios (aORs) for the factors associated with significant dog-bite injuries. Results Among 1,537,617 injured patients, 9,966 (6.5 per 1,000 injured patients) presented to the ED for dog-bite injuries (5.6 in 2011 to 7.6 in 2016, P for trend < 0.001), and 489 (4.9%) were significant injuries. In the age-specific analysis, there were increasing trends only among teenagers (12-18 years) and adults (> 18 years). Being elderly (>= 60 years) (aOR: 2.70, 95% CI: 2.15-3.39), having injuries to multiple anatomic sites (aOR: 4.37, 95% CI: 2.96-6.45), being bitten outdoors (aOR: 2.71, 95% CI: 2.20-3.34), and being bitten by a relative's dog (aOR: 2.37, 95% CI: 1.09-5.17) were strongly associated with significant dog-bite injury. Conclusion Dog-bite injuries are increasing in Korea, especially in teenagers and adults. A relative's or neighbour's dog may be more dangerous than a stranger's dog. Preventive strategies are needed to prevent dog-bite injuries in adults and children.	[Park, Joong Wan; Kim, Do Kyun; Jung, Jae Yun; Lee, Se Uk; Kwak, Young Ho; Hwang, Soyun] Seoul Natl Univ Hosp, Dept Emergency Med, Seoul, South Korea; [Chang, Ikwan] Kangwon Natl Univ, Coll Med, Dept Emergency Med, Chunchon, Gangwon Do, South Korea	Seoul National University (SNU); Seoul National University Hospital; Kangwon National University	Kim, DK (corresponding author), Seoul Natl Univ Hosp, Dept Emergency Med, Seoul, South Korea.	birdbeak@naver.com	Kim, Do Kyun/Q-3070-2018	Kim, Do Kyun/0000-0002-6144-302X; Hwang, Soyun/0000-0002-4290-0213				Abrahamian, 2000, Curr Infect Dis Rep, V2, P446, DOI 10.1007/s11908-000-0075-z; Alberghina D, 2017, VET ITAL, V53, P315, DOI 10.12834/VetIt.1063.5709.2; BROGAN TV, 1995, PEDIATRICS, V96, P947; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P605; Ellis R, 2014, AM FAM PHYSICIAN, V90, P239; Gilchrist J, 2008, INJURY PREV, V14, P296, DOI 10.1136/ip.2007.016220; GOLDSTEIN EJC, 1989, J AM ACAD DERMATOL, V21, P1275, DOI 10.1016/S0190-9622(89)70343-1; Golinko MS, 2017, CLIN PEDIATR, V56, P316, DOI 10.1177/0009922816657153; Kaye AE, 2009, PLAST RECONSTR SURG, V124, P551, DOI 10.1097/PRS.0b013e3181addad9; Medeiros I, 2001, COCHRANE DB SYST REV, V1; Meslin FX, 2005, J TRAVEL MED, V12, pS30, DOI 10.2310/7060.2005.12055; National Emergency Medical Center, 2015, 2014 YB NEDIS STAT; Ostanello F, 2005, EMERG MED J, V22, P260, DOI 10.1136/emj.2004.014886; Overall KL, 2001, J AM VET MED ASSOC, V218, P1923, DOI 10.2460/javma.2001.218.1923; Park GJ, 2018, INJURY, V49, P1097, DOI 10.1016/j.injury.2018.04.001; Peters V, 2004, J PEDIATR-US, V144, P121, DOI 10.1016/j.jpeds.2003.10.024; Rhea S, 2014, ACAD EMERG MED, V21, P196, DOI 10.1111/acem.12312; Rosado B, 2009, VET J, V179, P383, DOI 10.1016/j.tvjl.2008.02.002; Steele MT, 2007, ACAD EMERG MED, V14, P398, DOI 10.1111/j.1553-2712.2007.tb01797.x; Talan DA, 1999, NEW ENGL J MED, V340, P85, DOI 10.1056/NEJM199901143400202; Weiss HB, 1998, JAMA-J AM MED ASSOC, V279, P51, DOI 10.1001/jama.279.1.51; Westgarth C, 2018, J EPIDEMIOL COMMUN H, V72, P331, DOI 10.1136/jech-2017-209330	22	12	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0210541	10.1371/journal.pone.0210541	http://dx.doi.org/10.1371/journal.pone.0210541			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789915	Green Published, gold, Green Submitted			2022-12-27	WOS:000459330800009
J	Striegel, L; Brandl, B; Kopp, M; Sam, L; Skurk, T; Rychlik, M				Striegel, Lisa; Brandl, Beate; Kopp, Markus; Sam, Lukas; Skurk, Thomas; Rychlik, Michael			Quantitation of 5-methyltetraydrofolic acid in plasma for determination of folate status and clinical studies by stable isotope dilution assays	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; 5-METHYLTETRAHYDROFOLIC ACID; SERUM FOLATE; BIOAVAILABILITY; HOMOCYSTEINE; DISEASE; CATABOLITES; MECHANISMS; STRAWBERRY; RETENTION	Folates play a key role in the prevention of neural tube defects in newborns. Thus, it is important to reliably determine the bioavailability of folates from various foods. Accurate analytical methods are essential for quantifying blood-folates, especially in human studies. Here, we present the development and validation of a sensitive method using stable isotope dilution liquid chromatography coupled with mass spectrometry for determining various folates in plasma. Moreover, this study reports the applicability of the developed method to a human pilot study using strawberries as a test food. Validation of the assay revealed the precision, sensitivity, and accuracy of the method in determining the predominant 5-methyltetrahydrofolate in plasma. This method was also applicable for the screening of individual folate status using finger prick blood and for monitoring the post-absorptive plasma-concentration curve. Moreover, the human study revealed a high recovery of strawberry folates with a calculated relative bioavailability of 96.2%. Thus, the developed method enables prospective bioavailability studies. This work also confirmed, via human studies, that strawberries are a rich and natural source of folates that are available for human metabolism.	[Striegel, Lisa; Kopp, Markus; Sam, Lukas; Rychlik, Michael] Tech Univ Munich, Chair Analyt Food Chem, Freising Weihenstephan, Germany; [Brandl, Beate; Skurk, Thomas] Tech Univ Munich, Inst Food & Hlth, ZIEL, Core Facil Human Studies, Freising Weihenstephan, Germany; [Skurk, Thomas] Tech Univ Munich, Else Kroner Fresenius Ctr Nutr Med, Freising Weihenstephan, Germany; [Skurk, Thomas] Tech Univ Munich, Inst Nutr Med, Klinikum Rechts Isar, Munich, Germany; [Rychlik, Michael] Univ Queensland, Ctr Nutr & Food Sci, Brisbane, Qld, Australia	Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich; University of Queensland	Striegel, L (corresponding author), Tech Univ Munich, Chair Analyt Food Chem, Freising Weihenstephan, Germany.	lisa.striegel@tum.de	Rychlik, Michael/G-6064-2015	Rychlik, Michael/0000-0002-5826-6288; Skurk, Thomas/0000-0002-6875-1658; Brandl, Beate/0000-0002-9328-8108				Afrin S, 2016, J AGR FOOD CHEM, V64, P4435, DOI 10.1021/acs.jafc.6b00857; Buttner BE, 2013, INT J VITAM NUTR RES, V83, P112, DOI 10.1024/0300-9831/a000152; Castenmiller JJM, 2000, ANN NUTR METAB, V44, P163, DOI 10.1159/000012840; Caudill M, 2004, J FOOD SCI, V69, pS55, DOI 10.1111/j.1365-2621.2004.tb17887.x; Dang J, 2000, FOOD CHEM, V68, P295, DOI 10.1016/S0308-8146(99)00202-2; de Ambrosis A, 2017, EUR J CLIN NUTR, V71, P103, DOI 10.1038/ejcn.2016.122; Delchier N, 2016, COMPR REV FOOD SCI F, V15, P506, DOI 10.1111/1541-4337.12193; Delchier N, 2014, FOOD CHEM, V165, P85, DOI 10.1016/j.foodchem.2014.05.076; Delchier N, 2014, FOOD CHEM, V157, P439, DOI 10.1016/j.foodchem.2014.02.054; Giampieri F, 2014, J AGR FOOD CHEM, V62, P3867, DOI 10.1021/jf405455n; Gregory JF, 2001, J NUTR, V131, p1376S, DOI 10.1093/jn/131.4.1376S; Hagg Margareta, 1995, Journal of Food Composition and Analysis, V8, P12, DOI 10.1006/jfca.1995.1003; Izmirli M, 2013, MOL BIOL REP, V40, P625, DOI 10.1007/s11033-012-2101-2; Kok RM, 2004, ANAL BIOCHEM, V326, P129, DOI 10.1016/j.ab.2003.12.003; Kopp M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143639; Mangoni AA, 2002, AM J MED, V112, P556, DOI 10.1016/S0002-9343(02)01021-5; McKillop DJ, 2002, BRIT J NUTR, V88, P681, DOI 10.1079/BJN2002733; Melse-Boonstra A, 2002, J AGR FOOD CHEM, V50, P3473, DOI 10.1021/jf0112318; Monch S, 2016, FRONT NUTR, V3, DOI 10.3389/fnut.2016.00009; Monch S, 2015, FOOD FUNCT, V6, P242, DOI 10.1039/c4fo00658e; Monch S, 2010, ANAL BIOCHEM, V398, P150, DOI 10.1016/j.ab.2009.11.007; Pawlosky RJ, 2001, ANAL BIOCHEM, V298, P299, DOI 10.1006/abio.2001.5394; Pawlosky RJ, 2001, J AGR FOOD CHEM, V49, P1282, DOI 10.1021/jf001172i; Pfeiffer CM, 2004, CLIN CHEM, V50, P423, DOI 10.1373/clinchem.2003.026955; PIETRZIK K, 1989, Z ERNAHRUNGSWISS, V28, P130, DOI 10.1007/BF02030128; PRATT RF, 1971, J CLIN INVEST, V50, P455, DOI 10.1172/JCI106513; Robinson K, 2000, HEART, V83, P127, DOI 10.1136/heart.83.2.127; Rychlik Michael, 2009, Umweltwissenschaften und Schadstoff-Forschung, V21, P470, DOI 10.1007/s12302-009-0082-0; SAUBERLICH HE, 1987, AM J CLIN NUTR, V46, P1016, DOI 10.1093/ajcn/46.6.1016; Selhub J, 2002, J Nutr Health Aging, V6, P39; Snowdon DA, 2000, AM J CLIN NUTR, V71, P993; STEINBERG SE, 1979, J CLIN INVEST, V64, P83, DOI 10.1172/JCI109467; STEINBERG SE, 1984, AM J PHYSIOL, V246, pG319, DOI 10.1152/ajpgi.1984.246.4.G319; Stralsjo LM, 2003, J AGR FOOD CHEM, V51, P128, DOI 10.1021/jf020699n; Striegel L, 2018, FRONT CHEM, V6, DOI 10.3389/fchem.2018.00011; van der Put NMJ, 2000, EUR J OBSTET GYN R B, V92, P57, DOI 10.1016/S0301-2115(00)00426-7; Verlinde PHCJ, 2008, EUR J CLIN NUTR, V62, P1224, DOI 10.1038/sj.ejcn.1602840; Verwei M, 2005, TRENDS FOOD SCI TECH, V16, P307, DOI 10.1016/j.tifs.2005.03.015; Vogelgesang J, 1998, ACCREDIT QUAL ASSUR, V3, P242, DOI 10.1007/s007690050234; Winkels RM, 2007, AM J CLIN NUTR, V85, P465, DOI 10.1093/ajcn/85.2.465; Witthoft CM, 2016, SCANDINAVIAN J NUTR, V47, P6; Witthoft CM, 2016, NARINGSFORSKNING, V43, P138; Yang TL, 2005, J NUTR, V135, P1139, DOI 10.1093/jn/135.5.1139	43	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212255	10.1371/journal.pone.0212255	http://dx.doi.org/10.1371/journal.pone.0212255			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789924	Green Published, gold, Green Submitted			2022-12-27	WOS:000459330800022
J	Fan, H; Li, L; Wijlaars, L; Gilbert, RE				Fan, Heng; Li, Leah; Wijlaars, Linda; Gilbert, Ruth E.			Associations between use of macrolide antibiotics during pregnancy and adverse child outcomes: A systematic review and meta-analysis	PLOS ONE			English	Review							PRETERM PREMATURE RUPTURE; BROAD-SPECTRUM ANTIBIOTICS; POPULATION-BASED REGISTER; PLACEBO-CONTROLLED TRIAL; 7-YEAR FOLLOW-UP; ERYTHROMYCIN THERAPY; 1ST TRIMESTER; FETAL SAFETY; MEMBRANES; RISK	Background Evidence on adverse effects of maternal macrolide use during pregnancy is inconsistent. We conducted a systematic review and meta-analysis to investigate the association between macrolide use during pregnancy and adverse fetal and child outcomes. Methods and findings We included observational studies and randomised controlled trials (RCTs) that recorded macrolide use during pregnancy and child outcomes. We prioritized comparisons of macrolides with alternative antibiotics (mainly penicillins or cephalosporins) for comparability of indication and effect. Random effects meta-analysis was used to derive pooled odds ratios (OR) for each outcome. Subgroup analyses were performed according to specific types (generic forms) of macrolide. Of 11,186 citations identified, 19 (10 observational, 9 RCTs) studies were included (21 articles including 228,556 participants). Macrolide prescribing during pregnancy was associated with an increased risk of miscarriage (pooled ORobs 1.82, 95% CI 1.57-2. 11, three studies, I-2 = 0%), cerebral palsy and/or epilepsy (ORobs 1.78, 1.18-2.69; one study), epilepsy alone (ORobs 2.02, 1.30-3.14, one study; ORRCT 1.03, 0.79-1.35, two studies), and gastrointestinal malformations (ORobs 1.56, 1.05-2.32, two studies) compared with alternative antibiotics. We found no evidence of an adverse effect on 12 other malformations, stillbirth, or neonatal death. Results were robust to excluding studies with high risk of bias. Conclusions Consistent evidence of an increased risk of miscarriage in observational studies and uncertain risks of cerebral palsy and epilepsy warrant cautious use of macrolide in pregnancy with warnings in drug safety leaflets and use of alternative antibiotics where appropriate. As macrolides are the third most commonly used class of antibiotics, it is important to confirm these results with high quality studies.	[Fan, Heng; Li, Leah; Wijlaars, Linda; Gilbert, Ruth E.] UCL, Great Ormond St Inst Child Hlth, Populat Policy & Practice Programme, London, England; [Wijlaars, Linda] UCL, Adm Data Res Ctr England, London, England	University of London; University College London; University of London; University College London	Gilbert, RE (corresponding author), UCL, Great Ormond St Inst Child Hlth, Populat Policy & Practice Programme, London, England.	r.gilbert@ucl.ac.uk		Gilbert, Ruth/0000-0001-9347-2709; Wijlaars, Linda/0000-0003-1222-2922; Fan, Heng/0000-0002-4203-2516	China Scholarship Council [201606100058]; Economic and Social Research Council [ES/L007517/1]; Department of Health Policy Research Programme [109/0001]; Medical Research Council [London MR/K006584/10]; Child Health Research CIO (CHR CIO) Trust; ESRC [ES/L007517/1] Funding Source: UKRI	China Scholarship Council(China Scholarship Council); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Department of Health Policy Research Programme; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Child Health Research CIO (CHR CIO) Trust; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was funded by the China Scholarship Council (grant reference number 201606100058 to HF, http://www.csc.edu.cn/); The Economic and Social Research Council (grant reference number ES/L007517/1 to LW, https://esrc.ukri.org/); The Department of Health Policy Research Programme (grant reference number 109/0001 to LW, https://www.nihr.ac.uk/); Medical Research Council (grant reference number: London MR/K006584/10, https://mrc.ukri.org/); and Child Health Research CIO (CHR CIO) Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen AMN, 2000, BRIT MED J, V320, P1708, DOI 10.1136/bmj.320.7251.1708; Andersen JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053327; Briggs GG, 2017, DRUGS PREGNANCY LACT; Britain) JFCG, 2016, BRIT NATL FORMULARY, P307; Cheng YJ, 2015, J AM COLL CARDIOL, V66, P2173, DOI 10.1016/j.jacc.2015.09.029; Cooper WO, 2009, PAEDIATR PERINAT EP, V23, P18, DOI 10.1111/j.1365-3016.2008.00978.x; Crider KS, 2009, ARCH PEDIAT ADOL MED, V163, P978, DOI 10.1001/archpediatrics.2009.188; Danielsson C, 2013, CARDIOVASC RES, V97, P23, DOI 10.1093/cvr/cvs296; Danish Medicines Agency, CLAR 2018; Dinur AB, 2013, ANTIMICROB AGENTS CH, V57, P3307, DOI 10.1128/AAC.01691-12; Einarson A, 1998, AM J PERINAT, V15, P523, DOI 10.1055/s-2007-994053; ESCHENBACH DA, 1991, AM J OBSTET GYNECOL, V164, P734, DOI 10.1016/0002-9378(91)90506-M; FDA U, 2018, FDA REV FINDS ADD DA; FDA U, FDA DRUG SAF COMM AZ; Guardian T, GUARDIAN T; Health Canada, 2017, PROD MON RRAN CLAR 2; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Kallen BAJ, 2005, REPROD TOXICOL, V20, P209, DOI 10.1016/j.reprotox.2005.01.010; Kallen B, 2014, EUR J CLIN PHARMACOL, V70, P355, DOI 10.1007/s00228-013-1624-3; Kenyon S, 2008, LANCET, V372, P1319, DOI 10.1016/S0140-6736(08)61203-9; Kenyon S, 2008, LANCET, V372, P1310, DOI 10.1016/S0140-6736(08)61202-7; Kenyon SL, 2001, LANCET, V357, P989, DOI 10.1016/S0140-6736(00)04234-3; Kenyon SL, 2001, LANCET, V357, P979, DOI 10.1016/S0140-6736(00)04233-1; Kwak HM, 2013, PLACENTA, V34, P346, DOI 10.1016/j.placenta.2013.01.016; Lamont HF, 2014, EXPERT OPIN DRUG SAF, V13, P1569, DOI 10.1517/14740338.2014.939580; Le Nguyen T, 2017, FUND CLIN PHARMACOL, V31, P25; Lin KJ, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.12.023; Lund M, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1908; Martin D H, 1997, Infect Dis Obstet Gynecol, V5, P10, DOI 10.1002/(SICI)1098-0997(1997)5:1<10::AID-IDOG5>3.0.CO;2-I; MCGREGOR JA, 1991, AM J OBSTET GYNECOL, V165, P632, DOI 10.1016/0002-9378(91)90299-7; McKenna S, 2001, Can J Infect Dis, V12, P218; Meeraus WH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122034; MERCER BM, 1992, AM J OBSTET GYNECOL, V166, P794, DOI 10.1016/0002-9378(92)91336-9; Muanda FT, 2017, BRIT J CLIN PHARMACO, V83, P2557, DOI 10.1111/bcp.13364; Muanda FT, 2017, CAN MED ASSOC J, V189, pE625, DOI 10.1503/cmaj.161020; Mullick S, 2005, SEX TRANSM INFECT, V81, P294, DOI 10.1136/sti.2002.004077; National Clinical Programme for Obstetrics and Gynaecology, 2017, MED GUID OBST GYN; Parker SE, 2010, BIRTH DEFECTS RES A, V88, P1008, DOI 10.1002/bdra.20735; Pedersen LH, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3569; Petersen I, 2010, J ANTIMICROB CHEMOTH, V65, P2238, DOI 10.1093/jac/dkq307; Reali A, 2005, J CHEMOTHERAPY, V17, P123, DOI 10.1179/joc.2005.17.2.123; Romoren M, 2012, BRIT J CLIN PHARMACO, V74, P1053, DOI 10.1111/j.1365-2125.2012.04286.x; Sarkar Moumita, 2006, BMC Pregnancy Childbirth, V6, P18, DOI 10.1186/1471-2393-6-18; Sterne JAC, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i4919; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; The National Institute for Health and Care Excellence (NICE, CLAR 2018; The United States Food and Drug Administration, BIAXIN FILMT 2012; Tita ATN, 2016, NEW ENGL J MED, V375, P1231, DOI 10.1056/NEJMoa1602044; UK Teratology Information Service, US CLAR PREGN 2012; UK Teratology Information Service, US AZ PREGN 2012; Webster William S., 2007, Birth Defects Research, V81, P215, DOI 10.1002/bdrc.20102; Winkel P, 1874, CLARITHROMYCIN STABL; Winkler M, 1988, CHUNG HUA LIU HSING, V16, P253; Witt A, 2003, AM J OBSTET GYNECOL, V188, P816, DOI 10.1067/mob.2003.171; Wong AYS, 2017, DRUG SAFETY, V40, P663, DOI 10.1007/s40264-017-0533-2; Wurst KE, 2010, BIRTH DEFECTS RES A, V88, P159, DOI 10.1002/bdra.20627	57	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212212	10.1371/journal.pone.0212212	http://dx.doi.org/10.1371/journal.pone.0212212			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779772	Green Published, gold			2022-12-27	WOS:000459062900034
J	Meyer-Rath, G; van Rensburg, C; Chiu, C; Leuner, R; Jamieson, L; Cohen, S				Meyer-Rath, Gesine; van Rensburg, Craig; Chiu, Calvin; Leuner, Rahma; Jamieson, Lise; Cohen, Steve			The per-patient costs of HIV services in South Africa: Systematic review and application in the South African HIV Investment Case	PLOS ONE			English	Review							ANTIRETROVIRAL THERAPY; CARE; PREVENTION; STRATEGIES; INFECTION; PROVISION; HIV/AIDS; CHILDREN; ACCESS; IMPACT	Background In economic analyses of HIV interventions, South Africa is often used as a case in point, due to the availability of good epidemiological and programme data and the global relevance of its epidemic. Few analyses however use locally relevant cost data. We reviewed available cost data as part of the South African HIV Investment Case, a modelling exercise to inform the optimal use of financial resources for the country's HIV programme. Methods We systematically reviewed publication databases for published cost data covering a large range of HIV interventions and summarised relevant unit costs (cost per person receiving a service) for each. Where no data was found in the literature, we constructed unit costs either based on available information regarding ingredients and relevant public-sector prices, or based on expenditure records. Results Only 42 (5%) of 1,047 records included in our full-text review reported primary cost data on HIV interventions in South Africa, with 71% of included papers covering ART. Other papers detailed the costs of HCT, MMC, palliative and inpatient care; no papers were found on the costs of PrEP, social and behaviour change communication, and PMTCT. The results informed unit costs for 5 of 11 intervention categories included in the Investment Case, with the remainder costed based on ingredients (35%) and expenditure data (10%). Conclusions A large number of modelled economic analyses of HIV interventions in South Africa use as inputs the same, often outdated, cost analyses, without reference to additional literature review. More primary cost analyses of non-ART interventions are needed.	[Meyer-Rath, Gesine; van Rensburg, Craig; Chiu, Calvin; Leuner, Rahma; Jamieson, Lise] Univ Witwatersrand, Fac Hlth Sci, Dept Internal Med, Hlth Econ & Epidemiol Res Off HE2RO, Johannesburg, South Africa; [Meyer-Rath, Gesine] Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA; [Cohen, Steve] Strateg Dev Consultants, Pietermaritzburg, South Africa	University of Witwatersrand; Boston University	Meyer-Rath, G (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Dept Internal Med, Hlth Econ & Epidemiol Res Off HE2RO, Johannesburg, South Africa.; Meyer-Rath, G (corresponding author), Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA.	gesine@bu.edu		Chiu, Calvin/0000-0001-5092-6870; Jamieson, Lise/0000-0003-2354-4580; Leuner, Rahma/0000-0001-7127-4795	United States Agency for International Development [AID 674-A-12-00029]; UNAIDS; South African National AIDS Council (SANAC); United States Agency for International Development (USAID) [AID 674-A-12-00029]; UNAIDS South Africa; South African National AIDS Council; SANAC; Strategic Development Consultants	United States Agency for International Development(United States Agency for International Development (USAID)); UNAIDS; South African National AIDS Council (SANAC); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); UNAIDS South Africa; South African National AIDS Council; SANAC; Strategic Development Consultants	The study was funded by the United States Agency for International Development (grant AID 674-A-12-00029) (G.M.-R.'s, C.v.R.'s, C.C.'s, R.L.'s and L.J.'s time) and UNAIDS (grant awarded to Gesine Meyer-Rath). Steve Cohen's time on this study was funded by the South African National AIDS Council (SANAC). SANAC and Strategic Development Consultants only provided financial support in the form of the author's salary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was made possible by the generous support of the American people through the United States Agency for International Development (USAID) under award number AID 674-A-12-00029 (G.M.-R.'s, C.v.R.'s, C.C.'s, R.L.'s and L.J.'s time) as well as funding from UNAIDS South Africa (GMR's time) and the South African National AIDS Council (SC's time). The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We are grateful for the support of the members of the South African HIV Investment Case Steering Committee and Technical Task Team for their help in sourcing expenditure data and reviewing results.	Akudibillah G, 2017, EPIDEMIOL INFECT, V145, P942, DOI 10.1017/S0950268816002958; [Anonymous], CONS PRIC IND IND NU; Bacaer N, 2010, B MATH BIOL, V72, P2180, DOI 10.1007/s11538-010-9535-2; Bachmann MO, 2006, AIDS CARE, V18, P109, DOI 10.1080/09540120500159334; Bango F, 2016, TROP MED INT HEALTH, V21, P1115, DOI 10.1111/tmi.12736; Barton GR, 2013, TROP MED INT HEALTH, V18, P769, DOI 10.1111/tmi.12093; Bassett IV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085197; Beck EJ, 2012, PHARMACOECONOMICS, V30, P887, DOI 10.2165/11596500-000000000-00000; Beck EJ, 2010, CURR OPIN HIV AIDS, V5, P215, DOI 10.1097/COH.0b013e32833860e9; Bendavid E, 2011, AIDS, V25, P211, DOI 10.1097/QAD.0b013e328340fdf8; Callegari L, 2008, SEX TRANSM DIS, V35, P624, DOI 10.1097/OLQ.0b013e31816b3208; Ciaranello AL, 2011, AIDS, V25, P479, DOI 10.1097/QAD.0b013e3283428cbe; Cleary S.M., 2006, COST EFFECT RESOUR A, V4, P1, DOI DOI 10.1186/; Cobb G, 2013, TROP MED INT HEALTH, V18, P45, DOI 10.1111/tmi.12006; de Cherif TKS, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-205; de Tolly K, 2012, TELEMED E-HEALTH, V18, P18, DOI 10.1089/tmj.2011.0058; Deghaye N, 2006, SAMJ S AFR MED J, V96, P140; Department of Health, 2016, S AFR HIV TB INV CAS; Foster N, 2012, HUM RESOUR HEALTH, V10, DOI 10.1186/1478-4491-10-32; Francke JA, 2016, J INFECT DIS, V214, P1319, DOI 10.1093/infdis/jiw379; Galarraga O, 2011, PHARMACOECONOMICS, V29, P579, DOI 10.2165/11586120-000000000-00000; Gavaza P, 2012, PHARMACOECONOMICS, V30, P925, DOI 10.2165/11589450-000000000-00000; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Harling G, 2007, JAIDS-J ACQ IMM DEF, V45, P348; Hongoro C, 2011, J PAIN SYMPTOM MANAG, V41, P1015, DOI 10.1016/j.jpainsymman.2010.08.014; Hontelez JAC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021919; Kevany S, 2009, SAMJ S AFR MED J, V99, P320; Larson B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035444; Leisegang R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000189; Martinson N, 2009, JAIDS-J ACQ IMM DEF, V50, P327, DOI 10.1097/QAI.0b013e3181958546; Meyer-Rath G, 2013, J ACQUIR IMMUNE DEFI, V62; Meyer-Rath G, 2012, J ACQUIR IMMUNE DEFI, V61; Meyer-Rath G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186557; Meyer-Rath G, 2013, JAIDS-J ACQ IMM DEF, V62, P322, DOI 10.1097/QAI.0b013e31827e8785; Meyer-Rath G, 2013, AIDS, V27, P243, DOI 10.1097/QAD.0b013e32835a5b92; Rosen S, 2007, SAMJ S AFR MED J, V97, P524; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Siapka M, 2014, B WORLD HEALTH ORGAN, V92, P499, DOI 10.2471/BLT.13.127639; Sinha A, 2012, PAEDIATR INT CHILD H, V32, P65, DOI 10.1179/2046905512Y.0000000010; Smith JA, 2015, LANCET HIV, V2, pE159, DOI 10.1016/S2352-3018(15)00016-8; Tabana H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135048; Tagar E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108304; Tchuenche M, 2016, PLOS ONE, V11, P1; Thomas LS, 2007, JAIDS-J ACQ IMM DEF, V46, P410, DOI 10.1097/QAI.0b013e318156ec90; Vijayaraghavan A, 2007, JAIDS-J ACQ IMM DEF, V46, P91; Walensky RP, 2016, J INFECT DIS, V213, P1523, DOI 10.1093/infdis/jiv523; Walensky RP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000382; Zhou Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164207	49	29	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0210497	10.1371/journal.pone.0210497	http://dx.doi.org/10.1371/journal.pone.0210497			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807573	Green Published, gold			2022-12-27	WOS:000459712100002
J	Panca, M; Livingston, G; Barber, J; Cooper, C; La Frenais, F; Marston, L; Cousins, S; Hunter, RM				Panca, Monica; Livingston, Gill; Barber, Julie; Cooper, Claudia; La Frenais, Francesca; Marston, Louise; Cousins, Sian; Hunter, Rachael M.			Healthcare resource utilisation and costs of agitation in people with dementia living in care homes in England - The Managing Agitation and Raising QUality of LifE in Dementia (MARQUE) study	PLOS ONE			English	Article							NEUROPSYCHIATRIC SYMPTOMS; PREVALENCE; INVENTORY; PSYCHOPATHOLOGY; DEMOGRAPHICS; PREDICTORS	Background People with dementia living in care homes often experience clinically significant agitation; however, little is known about its economic impact. Objective To calculate the cost of agitation in people with dementia living in care homes. Methods We used the baseline data from 1,424 residents with dementia living in care homes (part of Managing Agitation and Raising QUality of lifE in dementia (MARQUE) study) that had Cohen-Mansfield Agitation Inventory (CMAI) scores recorded. We investigated the relationship between residents' health and social care costs and severity of agitation based on the CMAI total score. In addition, we assessed resource utilisation and compared costs of residents with and without clinically significant symptoms of agitation using the CMAI over and above the cost of the care home. Results Agitation defined by the CMAI was a significant predictor of costs. On average, a one-point increase in the CMAI will lead to a 0.5 percentage points (cost ratio 1.005, 95% CI 1.001 to 1.010) increase in the annual costs. The excess annual cost associated with agitation per resident with dementia was 1,125.35 pound. This suggests that, on average, agitation accounts for 44% of the annual health and social care costs of dementia in people living in care homes. Conclusion Agitation in people with dementia living in care homes contributes significantly to the overall costs increasing as the level of agitation increases. Residents with the highest level of agitation cost nearly twice as much as those with the lowest levels of agitation, suggesting that effective strategies to reduce agitation are likely to be cost-effective in this setting.	[Panca, Monica; Marston, Louise; Hunter, Rachael M.] UCL, Inst Epidemiol & Hlth Care, Res Dept Primary Care & Populat Hlth, London, England; [Panca, Monica; Marston, Louise; Hunter, Rachael M.] UCL, Inst Epidemiol & Hlth Care, Priment Clin Trials Unit, London, England; [Livingston, Gill; Cooper, Claudia; La Frenais, Francesca; Cousins, Sian] UCL, Div Psychiat, Dept Old Age Psychiat, London, England; [Barber, Julie] UCL, Dept Stat Sci, London, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London	Panca, M (corresponding author), UCL, Inst Epidemiol & Hlth Care, Res Dept Primary Care & Populat Hlth, London, England.; Panca, M (corresponding author), UCL, Inst Epidemiol & Hlth Care, Priment Clin Trials Unit, London, England.	m.panca@ucl.ac.uk	Marston, Louise/A-8535-2012; Hunter, Rachael Maree/H-7846-2019; Cooper, Claudia/C-1556-2008	Marston, Louise/0000-0002-9973-1131; Hunter, Rachael Maree/0000-0002-7447-8934; Cooper, Claudia/0000-0002-2777-7616; Livingston, Gill/0000-0001-6741-5516; Barber, Julie/0000-0001-5762-762X	Economic and Social Research Council; National Institute of Health Research [NIHR/ESCRC ES/L001780/1]; UCLH NIHR Biomedical Research Centre; National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) North Thames at Bart's Health NHS Trust; ESRC [ES/L001780/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute of Health Research(National Institute for Health Research (NIHR)); UCLH NIHR Biomedical Research Centre; National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) North Thames at Bart's Health NHS Trust; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The MARQUE study was funded by a grant from the Economic and Social Research Council (https://esrc.ukri.org/) and the National Institute of Health Research (https://www.nihr.ac.uk/) Grant number NIHR/ESCRC ES/L001780/1. CC and GL are supported by the UCLH NIHR Biomedical Research Centre. GL was supported in part by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) North Thames at Bart's Health NHS Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, ESRC or the Department of Health.	Alzheimer's Disease International, 2016, WORLD ALZHEIMER REPO; Alzheimer's Society, 2014, DEMENTIA UK UPDATE; Barber Julie, 2004, J Health Serv Res Policy, V9, P197, DOI 10.1258/1355819042250249; Beecham J., 2001, MEASURING MENTAL HLT, P200; Cerejeira J, 2012, Front Neurol, V3, P73, DOI 10.3389/fneur.2012.00073; COHENMANSFIELD J, 1989, J GERONTOL, V44, pM77, DOI 10.1093/geronj/44.3.M77; COHENMANSFIELD J, 1986, J AM GERIATR SOC, V34, P711, DOI 10.1111/j.1532-5415.1986.tb04302.x; Costa N, 2018, J AM MED DIR ASSOC, V19, DOI 10.1016/j.jamda.2017.10.013; Cummings JL, 1997, NEUROLOGY, V48, pS10, DOI 10.1212/WNL.48.5_Suppl_6.10S; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Department of Health, 2015, 2014 2015 NHS REF CO; Finkel SI, 2003, CLIN GERIATR MED, V19, P799, DOI 10.1016/S0749-0690(03)00046-6; Gustavsson A, 2011, ALZHEIMERS DEMENT, V7, P318, DOI 10.1016/j.jalz.2010.09.001; Husebo BS, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4065; Kales HC, 2014, J AM GERIATR SOC, V62, P762, DOI 10.1111/jgs.12730; Laing & Buisson, 2016, CAR OLD PEOPL UK MAR; LEVIN E, 1989, FAMILIES SERVICES CO; Livingston G, 2014, HEALTH TECHNOL ASSES, V18, pVII, DOI 10.3310/hta18610; Livingston G, 2017, BJPSYCH OPEN, V3, P171, DOI 10.1192/bjpo.bp.117.005181; Lyketsos CG, 2002, JAMA-J AM MED ASSOC, V288, P1475, DOI 10.1001/jama.288.12.1475; Moriarty J., 2000, PART THEIR LIVES COM; Morris S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007382; National Institute for Health and Care Excellence (NICE), 2013, GUID METH TECHN APPR; Okura T, 2011, J AM GERIATR SOC, V59, P473, DOI 10.1111/j.1532-5415.2011.03314.x; Okura T, 2011, ALZ DIS ASSOC DIS, V25, P116, DOI 10.1097/WAD.0b013e318203f208; Okura T, 2010, J AM GERIATR SOC, V58, P330, DOI 10.1111/j.1532-5415.2009.02680.x; Personal Social Services Research Unit (PSSRU), 2017, UNIT COSTS HLTH SOCI; Shega Joseph W, 2005, J Palliat Med, V8, P567, DOI 10.1089/jpm.2005.8.567; StataCorp, 2014, STAT REL 14 STAT SOF; Sutherland Debbie, 2004, Nurs Times, V100, P32; Vance DE, 2003, J GERONTOL B-PSYCHOL, V58, pP129, DOI 10.1093/geronb/58.2.P129; Wubker A, 2015, EUR J HEALTH ECON, V16, P689, DOI 10.1007/s10198-014-0620-6; Zuidema SU, 2011, INT J GERIATR PSYCH, V26, P127, DOI 10.1002/gps.2499	33	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0211953	10.1371/journal.pone.0211953	http://dx.doi.org/10.1371/journal.pone.0211953			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8EU	30807569	Green Published, Green Submitted, gold			2022-12-27	WOS:000459712100007
J	Gebreegziabher, Y; Girma, E; Tesfaye, M				Gebreegziabher, Yohannes; Girma, Eshetu; Tesfaye, Markos			Help-seeking behavior of Jimma university students with common mental disorders: A cross-sectional study	PLOS ONE			English	Article							MEDICAL-STUDENTS; HEALTH PROBLEMS; YOUNG-PEOPLE; SELF-HARM; PROFESSIONAL HELP; SUICIDAL IDEATION; ADDIS-ABABA; DEPRESSION; PREVALENCE; ANXIETY	Background Globally, the mental health help-seeking behavior of university students is reported to be poor; less than one-third of university students with common mental disorders (CMDs) report having sought help from formal sources. Failure to seek treatment is associated with prolonged disability and poor mental health outcomes, including suicide. In Ethiopia, little is known about the help-seeking behavior of university students for CMDs. Objective This study aimed to assess the prevalence and determinants of help seeking, and sources of help sought by Jimma University undergraduate students with CMDs. Method Seven hundred and sixty students were selected to participate in this cross-sectional study using multi-stage sampling. Sources of help were identified using the Actual Help-Seeking Questionnaire. CMDs were assessed using the 10-item Kessler Psychological Distress Scale. Binary logistic regression analysis was used for both univariate and multivariable analysis. Results Of the sampled students, 58.4% were found to have current CMDs. Of those with current CMDs, 78.4% had sought help for their problems. The majority (83.8%) of participants who sought help did so from informal sources. Compared to students who had 'very good' overall levels of satisfaction with life, those who had 'good', 'fair', and 'poor or very poor' overall level of satisfaction with life were less likely to seek help (p-value = 0.021, 0.014, and 0.011, respectively). Lastly, having no previous history of help-seeking was significantly associated with seeking help for CMDs (p-value<0.001). Conclusion More than half of Jimma University students were found to have a high risk of CMDs and the majority of those with CMDs sought help from informal sources. Future studies are needed to explore the barriers of seeking help from formal resources, and the effects of not receiving help from formal sources for CMDs symptoms.	[Gebreegziabher, Yohannes] Debre Berhan Univ, Dept Nursing, Debre Berhan, Ethiopia; [Girma, Eshetu] Addis Ababa Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Prevent Med, Addis Ababa, Ethiopia; [Tesfaye, Markos] St Pauls Hosp, Millennium Med Coll, Dept Psychiat, Addis Ababa, Ethiopia	Addis Ababa University	Gebreegziabher, Y (corresponding author), Debre Berhan Univ, Dept Nursing, Debre Berhan, Ethiopia.	yohannes36@gmail.com		Haile, Yohannes/0000-0003-3649-9555; Tesfaye, Markos/0000-0002-3351-701X	Jimma University; DELTAS Africa Initiative [DEL-15-01]; African Academy of Sciences (AAS)' s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust [DEL-15-01]; UK government; Jimma University, Department of Psychiatry; African Mental Health Research Initiative (AMARI)	Jimma University; DELTAS Africa Initiative; African Academy of Sciences (AAS)' s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust(Wellcome TrustEuropean Commission); UK government; Jimma University, Department of Psychiatry; African Mental Health Research Initiative (AMARI)	This research is fully funded by Jimma University and the primary investigator was also supported through the DELTAS Africa Initiative [DEL-15-01] during writing up the manuscript. The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)' s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust [DEL-15-01] and the UK government. The views expressed in this publication are those of the author(s) and not necessarily those of AAS, NEPAD Agency, Wellcome Trust or the UK government. The funders had no role in study design, data collection and analysis, decision to publication, or preparation of the manuscript.; We would like to acknowledge Jimma University, Department of Psychiatry for supporting the whole research project. Our special gratitude and appreciation go to Ms Susan Gurzenda, Mr Sisay Mulugeta, and Dr Claire van der Westhuizen for editing our manuscript. Our gratitude is also extended to students who participated in this study, for their time and cooperation. We are also very grateful to the data collectors and supervisors for their efforts.; Finally, we would like to appreciate African Mental Health Research Initiative (AMARI) for supporting the primary investigator financially, as well as through providing various capacity building initiatives including manuscript writing workshop which facilitated the writing of the present manuscript.	Al-Qaisy LM., 2011, INT J PSYCHOL COUNSE, V3, P96, DOI [DOI 10.5897/IJPC.9000056, 10.12691/rpbs-5-1-4, DOI 10.12691/RPBS-5-1-4]; Alem A, 2005, ETHIOPIAN MED J, V43, P159; Alem A, 1999, ACTA PSYCHIAT SCAND, V100, P40, DOI 10.1111/j.1600-0447.1999.tb10693.x; Aluh DO, 2018, INT J MENT HEALTH SY, V12, DOI 10.1186/s13033-018-0186-2; Armando M, 2010, CLIN TER, V161, pE25; Association E, 2005, EPIDATA VERS 3 1; Bedaso A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149429; Bekele YY, 2009, PSYCHOL MED, V39, P475, DOI 10.1017/S0033291708003929; Beusenberg M, 1994, USERS GUIDE SELF REP; Bifftu BB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181310; Bitew T, 2014, ETHIOP J HEALTH SCI, V24, P162, DOI 10.4314/ejhs.v24i2.9; Cavanagh JTO, 2003, PSYCHOL MED, V33, P395, DOI 10.1017/S0033291702006943; Cuttilan AN, 2016, ANN TRANSL MED, V4, DOI 10.3978/j.issn.2305-5839.2016.02.07; Czyz EK, 2013, J AM COLL HEALTH, V61, P398, DOI 10.1080/07448481.2013.820731; Dachew BA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119464; Dahlin M, 2011, BMC MED EDUC, V11, DOI 10.1186/1472-6920-11-92; Dalgard O., 1996, PROMOTION MENTAL HLT, P681; Dalgard OS, 2006, SOC PSYCH PSYCH EPID, V41, P444, DOI 10.1007/s00127-006-0051-5; Dessie Y, 2013, PAN AFR MED J, V15, DOI 10.11604/pamj.2013.15.95.2173; Dyrbye LN, 2015, ACAD MED, V90, P961, DOI 10.1097/ACM.0000000000000655; Dyrbye LN, 2006, ACAD MED, V81, P354, DOI 10.1097/00001888-200604000-00009; Eisenberg D, 2007, AM J ORTHOPSYCHIAT, V77, P534, DOI 10.1037/0002-9432.77.4.534; Eisenberg D, 2007, MED CARE, V45, P594, DOI 10.1097/MLR.0b013e31803bb4c1; Elzubeir MA, 2010, EDUC HEALTH, V23, P355; Fleischmann A, 2005, AM J ORTHOPSYCHIAT, V75, P676, DOI 10.1037/0002-9432.75.4.676; Frojd S, 2007, SOC PSYCH PSYCH EPID, V42, P945, DOI 10.1007/s00127-007-0254-4; Garcia-Williams AG, 2014, ACAD PSYCHIATR, V38, P554, DOI 10.1007/s40596-014-0041-y; Girma E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082116; Girma E, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-138; Gulliver A, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-113; Haile YG, 2017, INT J MENT HEALTH SY, V11, DOI 10.1186/s13033-017-0142-6; Hanlon C, 2015, J AFFECT DISORDERS, V186, P32, DOI 10.1016/j.jad.2015.07.015; Hesketh T, 2002, SOC PSYCH PSYCH EPID, V37, P230, DOI 10.1007/s00127-002-0536-9; Hope V, 2014, MED EDUC, V48, P963, DOI 10.1111/medu.12512; Hysenbegasi A, 2005, J MENT HEALTH POLICY, V8, P145; IBM Corp, 2011, IBM SPSS STAT WIND V; Ibrahim AK, 2013, J PSYCHIATR RES, V47, P391, DOI 10.1016/j.jpsychires.2012.11.015; KESSLER RC, 1995, AM J PSYCHIAT, V152, P1026; Liimatainen M. R., 2000, MENTAL HLTH WORKPLAC; Lubman DI, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4655-3; Mariu KR, 2012, CLIN CHILD PSYCHOL P, V17, P284, DOI 10.1177/1359104511404176; Melese Biniam, 2016, BMC Res Notes, V9, P485; Michelmore L, 2012, SUICIDE LIFE-THREAT, V42, P507, DOI 10.1111/j.1943-278X.2012.00108.x; Mogga S, 2006, BRIT J PSYCHIAT, V189, P241, DOI 10.1192/bjp.bp.105.013417; Negash A, 2005, J AFFECT DISORDERS, V87, P193, DOI 10.1016/j.jad.2005.03.011; Nosikov A., 2003, EUROHIS DEV COMMON I, V57, P35; Ogorchukwu JM, 2016, INDIAN J PSYCHOL MED, V38, P234, DOI 10.4103/0253-7176.183092; Oliver MI, 2005, BRIT J PSYCHIAT, V186, P297, DOI 10.1192/bjp.186.4.297; Puthran R, 2016, MED EDUC, V50, P456, DOI 10.1111/medu.12962; Reavley NJ, 2011, EARLY INTERV PSYCHIA, V5, P335, DOI 10.1111/j.1751-7893.2011.00292.x; Reta Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163103; Rickwood D, 2005, ADV MENT HEALTH, V4, P218, DOI 10.5172/jamh.4.3.218; Roness A, 2005, ACTA PSYCHIAT SCAND, V111, P51, DOI 10.1111/j.1600-0447.2004.00433.x; Rotenstein LS, 2016, JAMA-J AM MED ASSOC, V316, P2214, DOI 10.1001/jama.2016.17324; Rowe SL, 2014, AUST NZ J PSYCHIAT, V48, P1083, DOI 10.1177/0004867414555718; Sarokhani Diana, 2013, Depress Res Treat, V2013, P373857, DOI 10.1155/2013/373857; Sawyer MG, 2012, J ADOLESCENT HEALTH, V50, P236, DOI 10.1016/j.jadohealth.2011.06.009; Tesfaye M, 2010, J AFFECT DISORDERS, V122, P102, DOI 10.1016/j.jad.2009.06.020; TISHBY O, 2001, J ADOLESCENCE, V36, P249; Tung YJ, 2018, NURS EDUC TODAY, V63, P119, DOI 10.1016/j.nedt.2018.01.009; Verger P, 2010, SOC PSYCH PSYCH EPID, V45, P189, DOI 10.1007/s00127-009-0055-z; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; Wang YH, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006476; Watanabe N, 2012, NEUROPSYCH DIS TREAT, V8, P561, DOI 10.2147/NDT.S37543; WHO, 2017, DEPR OTH COMM MENT D; Wilson CJ, 2010, J YOUTH ADOLESCENCE, V39, P291, DOI 10.1007/s10964-009-9487-8; Yohannes H, 2018, HELP SEEKING CMD SAV; Zivin K, 2009, J AFFECT DISORDERS, V117, P180, DOI 10.1016/j.jad.2009.01.001; Zochil ML, 2018, AUST J PSYCHOL, V70, P41, DOI 10.1111/ajpy.12160	69	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212657	10.1371/journal.pone.0212657	http://dx.doi.org/10.1371/journal.pone.0212657			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794639	Green Published, Green Submitted, gold			2022-12-27	WOS:000459709100106
J	Haley, MR				Haley, M. Ryan			An EigenFactor-weighted power mean generalization of the Euclidean Index	PLOS ONE			English	Article							IMPACT FACTOR; H-INDEX; JOURNALS; CITATION; ECONOMICS; METRICS; SCHOLAR; PUBLISH	This paper proposes a weighted generalization of the recently developed Euclidean Index. The weighting mechanism is designed to reflect the reputation of the journal within which an article appears. The weights are constructed using the Eigenfactor Article Influence percentiles scores. The rationale for assigning weights is that citations in more prestigious journals should be adjusted to logically reflect higher costs of production and higher vetting standards, and to partially counter several pragmatic issues surrounding truncated citation counts. Simulated and empirical demonstrations of the proposed approaches are included, which emphasize the flexibility and efficacy of the proposed generalization.	[Haley, M. Ryan] Univ Wisconsin, Dept Econ, Oshkosh, WI 54901 USA	University of Wisconsin System	Haley, MR (corresponding author), Univ Wisconsin, Dept Econ, Oshkosh, WI 54901 USA.	haley@uwosh.edu						Andersen JP, 2017, J INFORMETR, V11, P455, DOI 10.1016/j.joi.2017.02.009; Attema AE, 2014, ECON INQ, V52, P495, DOI 10.1111/ecin.12013; Bornmann L, 2011, J INFORMETR, V5, P346, DOI 10.1016/j.joi.2011.01.006; Egghe L, 2006, SCIENTOMETRICS, V69, P131, DOI 10.1007/s11192-006-0144-7; Haley MR, 2018, J ASSOC INF SCI TECH, V69, P172, DOI 10.1002/asi.23908; Haley MR, 2017, J ASSOC INF SCI TECH, V68, P1590, DOI 10.1002/asi.23663; Haley MR, 2017, APPL ECON LETT, V24, P85, DOI 10.1080/13504851.2016.1164812; Haley MR, 2016, APPL ECON, V48, P1710, DOI 10.1080/00036846.2015.1105927; Haley MR, 2014, J ASSOC INF SCI TECH, V65, P1079, DOI 10.1002/asi.23080; Haley MR, 2013, APPL ECON LETT, V20, P830, DOI 10.1080/13504851.2012.697115; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Jin B., 2007, ISSI NEWSLETTER, V3, P6; Leydesdorff L, 2013, J AM SOC INF SCI TEC, V64, P2299, DOI 10.1002/asi.22911; Leydesdorff L, 2013, J AM SOC INF SCI TEC, V64, P96, DOI 10.1002/asi.22765; Marchant T, 2009, SCIENTOMETRICS, V80, P325, DOI 10.1007/s11192-008-2075-y; Ng YK, 2017, J INFORMETR, V11, P685, DOI 10.1016/j.joi.2017.05.008; Oswald AJ, 2007, ECONOMICA, V74, P21, DOI 10.1111/j.1468-0335.2006.00575.x; Perry M, 2016, AM ECON REV, V106, P2722, DOI 10.1257/aer.20140850; Powdthavee N, 2018, J ECON PSYCHOL, V66, P33, DOI 10.1016/j.joep.2018.04.003; Pudovkin AI, 2004, P ASIST ANNU, V41, P507, DOI 10.1002/meet.1450410159; Radicchi F, 2008, P NATL ACAD SCI USA, V105, P17268, DOI 10.1073/pnas.0806977105; Schreiber M, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/4/040201; Seeber M, 2017, RES POLICY; Seglen PO, 1997, BRIT MED J, V314, P498; Sidiropoulos A, 2007, SCIENTOMETRICS, V72, P253, DOI 10.1007/s11192-007-1722-z; SPENCE M, 1973, Q J ECON, V87, P355, DOI 10.2307/1882010; Wesley-Smith I., 2016, ARXIV160608534; West JD, 2013, J AM SOC INF SCI TEC, V64, P787, DOI 10.1002/asi.22790; West JD, 2010, COLL RES LIBR, V71, P236, DOI 10.5860/0710236; Wilhite AW, 2012, SCIENCE, V335, P542, DOI 10.1126/science.1212540; Woeginger GJ, 2008, MATH SOC SCI, V56, P224, DOI 10.1016/j.mathsocsci.2008.03.001	31	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212760	10.1371/journal.pone.0212760	http://dx.doi.org/10.1371/journal.pone.0212760			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794681	gold, Green Published, Green Submitted			2022-12-27	WOS:000459709100132
J	Hulman, A; Ibsen, DB; Laursen, ASD; Dahm, CC				Hulman, Adam; Ibsen, Daniel B.; Laursen, Anne Sofie D.; Dahm, Christina C.			Body mass index trajectories preceding first report of poor self-rated health: A longitudinal case-control analysis of the English Longitudinal Study of Ageing	PLOS ONE			English	Article							WEIGHT CHANGE; PREDICTORS; ASSOCIATION; MORTALITY; OBESITY; DISEASE; COHORT; IMPACT	Background Studies have consistently found that obesity is associated with poor self-rated health, but how body mass index (BMI) developed in the lead up to poor self-rated health is unknown. Methods We nested a longitudinal case-control study in the English Longitudinal Study of Ageing (1998-2015) to investigate BMI trajectories in the years preceding a first self-report of poor health. Participants rated their health at each data collection; every other collection included a BMI assessment by a nurse. Case status was defined as a first report of poor health during follow-up. Three age-and sex-matched controls were identified per case using density sampling. BMI trajectories were fitted to time backwards prior to first report of poor health using mixed-effects models. Age and sex were potential modifiers. We conducted subgroup analyses of those not reporting certain chronic diseases or smoking. Results We identified 732 cases and 2195 controls. Age, but not sex, modified the association between BMI and self-rated health. Participants reporting poor health at age 60 had a 1.5 kg/m(2) (95% CI: 0.8 to 2.1) higher BMI at the time of reporting than controls, and their BMI had previously increased markedly (1.3 kg/m(2) 95% CI: 0.9 to 1.8 over ten years). After age 75, cases no longer had higher BMI than controls, and their BMI had decreased sharply prior to reporting poor health (e.g. -2.0 kg/m(2) 95% CI: -2.6 to -1.5 per decade on average for those reporting poor health at age 90). Age was also an effect modifier among those without diabetes, however BMI trajectories were more similar among the middle-aged. The subgroup analysis of those without cardiovascular disease, cancer and chronic lung disease showed similar results to the main findings. Conclusion Development of BMI was associated with poor self-rated health; however, the nature of the association depended markedly on age.	[Hulman, Adam; Ibsen, Daniel B.; Laursen, Anne Sofie D.; Dahm, Christina C.] Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark; [Hulman, Adam] Danish Diabet Acad, Odense, Denmark; [Hulman, Adam] Aarhus Univ Hosp, Steno Diabet Ctr Aarhus, Aarhus, Denmark	Aarhus University; Aarhus University	Hulman, A (corresponding author), Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark.; Hulman, A (corresponding author), Danish Diabet Acad, Odense, Denmark.; Hulman, A (corresponding author), Aarhus Univ Hosp, Steno Diabet Ctr Aarhus, Aarhus, Denmark.	adam.hulman@ph.au.dk	Dahm, Christina C/G-9787-2014; Laursen, Anne Sofie Dam/ABF-7784-2020; Hulman, Adam/AAI-5859-2021; Ibsen, Daniel Borch/AAD-1193-2019	Dahm, Christina C/0000-0003-0481-2893; Laursen, Anne Sofie Dam/0000-0003-2827-0582; Hulman, Adam/0000-0002-3969-1000; Ibsen, Daniel Borch/0000-0002-7038-4770	Danish Diabetes Academy; Novo Nordisk Foundation; Steno Diabetes Center Aarhus (SDCA) - Novo Nordisk Foundation	Danish Diabetes Academy; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Steno Diabetes Center Aarhus (SDCA) - Novo Nordisk Foundation(Novo Nordisk Foundation)	AH is supported by the Danish Diabetes Academy. The Danish Diabetes Academy is funded by the Novo Nordisk Foundation. Support was provided by the Steno Diabetes Center Aarhus (SDCA) which is partially funded by an unrestricted donation from the Novo Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman CE, 2016, J HEALTH SOC BEHAV, V57, P39, DOI 10.1177/0022146515626218; Aune D, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2156; Bamia C, 2017, MATURITAS, V103, P37, DOI 10.1016/j.maturitas.2017.06.023; Bombak Andrea E, 2013, Front Public Health, V1, P15, DOI 10.3389/fpubh.2013.00015; Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; de Souza VA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176230; Dennerstein L, 2003, J PSYCHOSOM RES, V54, P147, DOI 10.1016/S0022-3999(02)00415-4; Feng XQ, 2017, BMJ OPEN DIAB RES CA, V5, DOI 10.1136/bmjdrc-2016-000198; Giovannucci E, 2018, JNCI-J NATL CANCER I, V110, P935, DOI 10.1093/jnci/djy091; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Jackson SE, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-926; Mavaddat N, 2011, J EPIDEMIOL COMMUN H, V65, P800, DOI 10.1136/jech.2009.090845; Miller SL, 2008, J NUTR HEALTH AGING, V12, P487, DOI 10.1007/BF02982710; Olivarius ND, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122219; Ruhunuhewa I, 2017, OBESITY, V25, P1254, DOI 10.1002/oby.21853; Shahar DR, 2001, J AGING HEALTH, V13, P186, DOI 10.1177/089826430101300202; Simonsen MK, 2008, BMC WOMENS HEALTH, V8, P13, DOI [10.1186/1472-6874-8-1318691402, DOI 10.1186/1472-6874-8-13]; Sirola J, 2010, MATURITAS, V65, P244, DOI 10.1016/j.maturitas.2009.11.014; Stenholm S, 2017, INT J OBESITY, V41, P769, DOI 10.1038/ijo.2017.29; Steptoe A, 2013, INT J EPIDEMIOL, V42, P1640, DOI 10.1093/ije/dys168; Svedberg P, 2006, EUR J EPIDEMIOL, V21, P767, DOI 10.1007/s10654-006-9064-3; Vanfleteren L, 2013, EUR RESP J S57, V42, pP4652; Wagner DC, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130241; Wang M, 2016, J ENVIRON PUBLIC HEA, V2016, DOI 10.1155/2016/7014857; Wannamethee SG, 2005, J EPIDEMIOL COMMUN H, V59, P134, DOI 10.1136/jech.2003.015651	25	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212862	10.1371/journal.pone.0212862	http://dx.doi.org/10.1371/journal.pone.0212862			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794702	Green Published, gold, Green Submitted			2022-12-27	WOS:000459709100153
J	Kopeika, J; Oyewo, A; Punnialingam, S; Reddy, N; Khalaf, Y; Howard, J; Mononen, S; Oteng-Ntim, E				Kopeika, Julia; Oyewo, Adeola; Punnialingam, Sinthiya; Reddy, Nivedita; Khalaf, Yacoub; Howard, Jo; Mononen, Sofia; Oteng-Ntim, Eugene			Ovarian reserve in women with sickle cell disease	PLOS ONE			English	Article							ANTI-MULLERIAN HORMONE; ANTRAL FOLLICLE COUNT; AGE; CONTRACEPTION; FERTILITY; SURVIVAL; ENGLAND; OBESITY; USERS; FSH	Background It has been proposed that ovarian sickling and/or iron overload in women with sickle cell disease (SCD) could contribute to gonadal dysfunction, but there are very few published studies. We hypothesised that the above phenomena might impair ovarian reserve. Methods A total of 50 SCD patients were case-matched by age, ethnicity, and presence of regular cycles (28 5 days) with 73 patients without a known haemoglobinopathy who required anti-Mullerian hormone (AMH) assessment in a gynaecology clinic. SCD patients had AMH levels taken as part of routine care. The patients were case-controlled and matched with patients who had no haemoglobinopathy in a tertiary centre over a period of one year. Results The mean AMH in the SCD case group was 7.6 pmol/l compared with 13.4 pmol/l in the control group (p<0.001). The AMH distributions were subsequently categorised. This showed that SCD patients had a significantly higher chance of having lower AMH in comparison with the control group (OR 2.6 (CI 1.1-6.5, P = 0.02). The proportion of women with AMH > 20 pmol/l was significantly lower in the SCD group (6%) in comparison with the control group (19%) (P = 0.04). Conclusions This is the first study showing that women of reproductive age with SCD are more likely to have a low ovarian reserve at a younger age in comparison with patients with no haemoglobinopathy.	[Kopeika, Julia; Reddy, Nivedita; Khalaf, Yacoub] Guys & St Thomas NHS Trust, Assisted Concept Unit, Great Maze Pond London, England; [Oyewo, Adeola; Mononen, Sofia; Oteng-Ntim, Eugene] Kings Coll London, Guys & St Thomas NHS Trust, Dept Women & Childrens Hlth, London, England; [Punnialingam, Sinthiya] Kings Coll Hosp London, Haematol Dept, Denmark Hill, London, England; [Howard, Jo] Guys & St Thomas NHS Trust, Haematol Dept, Great Maze Pond London, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital	Kopeika, J (corresponding author), Guys & St Thomas NHS Trust, Assisted Concept Unit, Great Maze Pond London, England.	julia_kop@yahoo.com						ABBASI AA, 1976, ANN INTERN MED, V85, P601, DOI 10.7326/0003-4819-85-5-601; AlJuburi G, 2012, J PUBLIC HEALTH-UK, V34, P570, DOI 10.1093/pubmed/fds035; Anderson RA, 2012, CLIN ENDOCRINOL, V77, P652, DOI 10.1111/j.1365-2265.2012.04451.x; Ashcroft RE, 2004, CLIN RES, V23, P103; Baird DT, 2005, HUM REPROD UPDATE, V11, P261, DOI 10.1093/humupd/dmi006; Breart G, 1997, EUR J OBSTET GYN R B, V75, P71, DOI 10.1016/S0301-2115(97)00190-5; Chang HH, 2011, BJOG-INT J OBSTET GY, V118, P825, DOI 10.1111/j.1471-0528.2011.02927.x; Chase A R, 2009, Menopause Int, V15, P70, DOI 10.1258/mi.2009.009015; DADA OA, 1980, CLIN CHIM ACTA, V105, P269, DOI 10.1016/0009-8981(80)90469-6; Deb S, 2012, ULTRASOUND OBST GYN, V39, P574, DOI 10.1002/uog.10114; Dewailly D, 2014, HUM REPROD UPDATE, V20, P370, DOI 10.1093/humupd/dmt062; Elchuri SV, 2015, BLOOD CELL MOL DIS, V55, P56, DOI 10.1016/j.bcmd.2015.03.012; Fanchin R, 2003, HUM REPROD, V18, P323, DOI 10.1093/humrep/deg042; Farooqui MW, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.4932.4932; Fleming R, 2015, REPROD BIOMED ONLINE, V31, P486, DOI 10.1016/j.rbmo.2015.06.015; Freeman EW, 2007, FERTIL STERIL, V87, P101, DOI 10.1016/j.fertnstert.2006.05.074; Gardner K, 2016, BLOOD, V128, P1436, DOI 10.1182/blood-2016-05-716910; Gavish Z, 2014, HUM REPROD, V29, P989, DOI 10.1093/humrep/deu015; Gleicher N, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-77; Halawaty S, 2010, J OBSTET GYNAECOL CA, V32, P687, DOI 10.1016/S1701-2163(16)34573-X; Heck K E, 1997, Matern Child Health J, V1, P81, DOI 10.1023/A:1026218322723; Hvidman HW, 2016, HUM REPROD, V31, P1034, DOI 10.1093/humrep/dew032; Jamil Z, 2016, DIS MARKERS, V2016, DOI 10.1155/2016/5246217; Jayaprakasan K, 2010, FERTIL STERIL, V93, P855, DOI 10.1016/j.fertnstert.2008.10.042; La Marca A, 2007, HUM REPROD, V22, P766, DOI 10.1093/humrep/del421; Lauritsen MP, 2014, HUM REPROD, V29, P791, DOI 10.1093/humrep/det469; Odetunde OI, 2016, PAK J MED SCI, V32, P341, DOI 10.12669/pjms.322.9046; Ojodu J, 2014, MMWR-MORBID MORTAL W, V63, P1155; Parise LV, 2016, BLOOD, V127, P789, DOI 10.1182/blood-2015-12-674606; Petersen KB, 2015, HUM REPROD, V30, P2364, DOI 10.1093/humrep/dev197; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Schram CA, 2015, J CYST FIBROS, V14, P398, DOI 10.1016/j.jcf.2014.09.008; Seifer DB, 2009, FERTIL STERIL, V92, P1674, DOI 10.1016/j.fertnstert.2008.08.110; Serjeant GR, 2001, ARCH DIS CHILD, V85, P375, DOI 10.1136/adc.85.5.375; Smith-Whitley K, 2014, BLOOD, V124, P3538, DOI 10.1182/blood-2014-07-577619; Somunkiran A, 2007, EUR J OBSTET GYN R B, V134, P196, DOI 10.1016/j.ejogrb.2007.01.012; Steiner AZ, 2010, CONTRACEPTION, V81, P245, DOI 10.1016/j.contraception.2009.10.004; Streetly A, 2010, J CLIN PATHOL, V63, P626, DOI 10.1136/jcp.2010.077560; Tal R, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/818912; van den Berg MH, 2010, HUM REPROD, V25, P1520, DOI 10.1093/humrep/deq071; van Rooij IAJ, 2002, HUM REPROD, V17, P3065, DOI 10.1093/humrep/17.12.3065; Visser JA, 2006, REPRODUCTION, V131, P1, DOI 10.1530/rep.1.00529; Wierenga KJJ, 2001, LANCET, V357, P680, DOI 10.1016/S0140-6736(00)04132-5	43	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0213024	10.1371/journal.pone.0213024	http://dx.doi.org/10.1371/journal.pone.0213024			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794713	gold, Green Published, Green Submitted			2022-12-27	WOS:000459709100171
J	Lanz, J; Wyss, D; Raber, L; Stortecky, S; Hunziker, L; Blochlinger, S; Reineke, D; Englberger, L; Zanchin, T; Valgimigli, M; Heg, D; Windecker, S; Pilgrim, T				Lanz, Jonas; Wyss, Dorte; Raber, Lorenz; Stortecky, Stefan; Hunziker, Lukas; Blochlinger, Stefan; Reineke, David; Englberger, Lars; Zanchin, Thomas; Valgimigli, Marco; Heg, Dik; Windecker, Stephan; Pilgrim, Thomas			Mechanical complications in patients with ST-segment elevation myocardial infarction: A single centre experience	PLOS ONE			English	Article							VENTRICULAR SEPTAL-DEFECT; CARDIAC RUPTURE; FREE-WALL; THROMBOLYTIC THERAPY; CORONARY; ANGIOPLASTY; REGISTRY; RISK; ERA; MORTALITY	Background The study aims to assess characteristics and outcomes of patients suffering a mechanical complication (MC) after ST-segment elevation myocardial infarction (STEMI) in a contemporary cohort of patients in the percutaneous coronary intervention era. Methods and results This retrospective single-center cohort study encompasses 2508 patients admitted with STEMI between March 9, 2009 and June 30, 2014. A total of 26 patients (1.1%) suffered a mechanical complication: ventricular septal rupture (VSR) in 17, ventricular free wall rupture (VFWR) in 2, a combination of VSD and VFWR in 2, and papillary muscle rupture (PMR) in 5 patients. Older age (74.5 +/- 10.4 years versus 63.9 +/- 13.1 years, p < 0.001), female sex (42.3% versus 23.3%, p = 0.034), and a longer latency period between symptom onset and angiography (> 24h: 42.3% versus 16.2%, p = 0.002) were more frequent among patients with MC as compared to patients without MC. The majority of MC patients had multivessel disease (77%) and presented in cardiogenic shock (Killip class IV: 73.1%). Nine patients (7 VSR, 2 VFWR & VSR) were treated conservatively and died. Out of the remaining 10 VSR patients, four underwent surgery, three underwent implantation of an occluder device, and another three patients had surgical repair following occluder device implantation. All patients with isolated VFWR and PMR underwent emergency surgery. At 30 days, mortality for VSR, VFWR, VFWR & VSR and PMR amounted to 71%, 50%, 100% and 0%, respectively. Conclusions Despite advances in the management of STEMI patients, mortality of mechanical complications stays considerable in this contemporary cohort. Older age, female sex, and a prolonged latency period between symptom onset and angiography are associated with the occurrence of these complications.	[Lanz, Jonas; Raber, Lorenz; Stortecky, Stefan; Hunziker, Lukas; Blochlinger, Stefan; Zanchin, Thomas; Valgimigli, Marco; Windecker, Stephan; Pilgrim, Thomas] Univ Hosp Bern, Dept Cardiol, Swiss Cardiovascr Ctr, Bern, Switzerland; [Wyss, Dorte; Reineke, David; Englberger, Lars] Univ Hosp Bern, Dept Cardiovasc Surg, Swiss Cardiovasc Ctr, Bern, Switzerland; [Heg, Dik] Univ Bern, Clin Trials Unit, Bern, Switzerland; [Heg, Dik] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University of Bern	Pilgrim, T (corresponding author), Univ Hosp Bern, Dept Cardiol, Swiss Cardiovascr Ctr, Bern, Switzerland.	thomas.pilgrim@insel.ch	Pilgrim, Thomas/AAS-9120-2021; Stortecky, Stefan/AAS-9140-2021; Valgimigli, Marco/AAE-9103-2019	Pilgrim, Thomas/0000-0001-8721-4068; Valgimigli, Marco/0000-0002-4353-7110; Lanz, Jonas/0000-0002-5035-6625; Stortecky, Stefan/0000-0002-5076-0177; Heg, Dik/0000-0002-8766-7945; Hunziker, Lukas/0000-0003-0081-8518				Bajaj A, 2015, J INVEST MED, V63, P844, DOI 10.1097/JIM.0000000000000232; BATTS KP, 1990, HUM PATHOL, V21, P530, DOI 10.1016/0046-8177(90)90010-3; Becker RC, 1999, J AM COLL CARDIOL, V33, P479, DOI 10.1016/S0735-1097(98)00582-8; Becker RC, 1996, J AM COLL CARDIOL, V27, P1321, DOI 10.1016/0735-1097(96)00008-3; Crenshaw BS, 2000, CIRCULATION, V101, P27, DOI 10.1161/01.CIR.101.1.27; Figueras J, 1998, J AM COLL CARDIOL, V32, P135, DOI 10.1016/S0735-1097(98)00180-6; Figueras J, 1997, AM J CARDIOL, V80, P625, DOI 10.1016/S0002-9149(97)00435-9; Figueras J, 2008, CIRCULATION, V118, P2783, DOI 10.1161/CIRCULATIONAHA.108.776690; French JK, 2010, AM J CARDIOL, V105, P59, DOI 10.1016/j.amjcard.2009.08.653; GERTZ SD, 1990, AM J CARDIOL, V66, P904, DOI 10.1016/0002-9149(90)90923-O; HONAN MB, 1990, J AM COLL CARDIOL, V16, P359, DOI 10.1016/0735-1097(90)90586-E; Jones BM, 2014, EUR HEART J, V35, P2060, DOI 10.1093/eurheartj/ehu248; Liebelt JJ, 2016, AM J CARDIOVASC DIS, V6, P10; Lopez-Sendon J, 2010, EUR HEART J, V31, P1449, DOI 10.1093/eurheartj/ehq061; McLaughlin A, 2016, HEART LUNG CIRC, V25, P1063, DOI 10.1016/j.hlc.2016.02.024; Moreno R, 2002, J AM COLL CARDIOL, V39, P598, DOI 10.1016/S0735-1097(01)01796-X; MORISHIMA I, 1995, AM HEART J, V130, P239, DOI 10.1016/0002-8703(95)90434-4; Nakatani D, 2003, AM J CARDIOL, V92, P785, DOI 10.1016/S0002-9149(03)00883-X; Navarro-Cuartero J, 2016, REV ESP CARDIOL, V69, P874, DOI 10.1016/j.rec.2016.04.032; Patel MR, 2006, AM HEART J, V151, P316, DOI 10.1016/j.ahj.2005.04.014; Puerto E, 2018, J AM COLL CARDIOL, V72, P959, DOI 10.1016/j.jacc.2018.06.031; Qian G, 2017, AM J EMERG MED, V35, P589, DOI 10.1016/j.ajem.2016.12.033; Singh V, 2017, AM J MED, V130, DOI 10.1016/j.amjmed.2016.12.004; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; STEVENSON WG, 1989, AM HEART J, V118, P1182, DOI 10.1016/0002-8703(89)90007-0	25	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0209502	10.1371/journal.pone.0209502	http://dx.doi.org/10.1371/journal.pone.0209502			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794547	Green Submitted, Green Published, gold			2022-12-27	WOS:000459709100009
J	Millet, K; Aydinli, A				Millet, Kobe; Aydinli, Aylin			Cognitive reflection, 2D:4D and social value orientation	PLOS ONE			English	Article							DIGIT RATIO 2D4D; FETAL TESTOSTERONE; PROSOCIAL BEHAVIOR; AGGRESSION; LENGTH; METAANALYSIS; COOPERATION; MEN; ASSOCIATION; HEURISTICS	The current study seeks confirmation for the hypothesis that 2D:4D (positively) predicts pro-sociality when people are more likely to rely on intuition than deliberation. We assess intuition and deliberation using the Cognitive Reflection Test (CRT) and measure prosociality via the validated Social Value Orientation (SVO) slider measure. Although our results do not provide collective evidence for our main proposition, we observe in the data that for low (right) 2D:4D men, the more intuitive they are, the less prosocial they become, whereas for high (right) 2D:4D men the thinking style does not affect their prosociality. Importantly, we find that two alternative measures of cognitive reflection, CRT and CRT-2, differently relate to prosocial decision making such that only CRT-2 (but not the classic CRT) positively predicts prosociality. Given that previous research on the role of cognitive reflection and 2D:4D in prosocial decision making provided inconsistent results, the present study findings are highly valuable to get a better understanding in this domain of study. Furthermore, some of our findings invite further confirmatory tests, thereby opening up multiple avenues for further research.	[Millet, Kobe; Aydinli, Aylin] Vrije Univ Amsterdam, Dept Mkt, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Millet, K (corresponding author), Vrije Univ Amsterdam, Dept Mkt, Amsterdam, Netherlands.	kobe.millet@vu.nl		Millet, Kobe/0000-0003-4365-6109; Aydinli, Aylin/0000-0001-5336-1916				Aiken L.S., 1991, MULTIPLE REGRESSION; Alonso J, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00022; Aspara J, 2014, INT J RES MARK, V31, P117, DOI 10.1016/j.ijresmar.2013.09.001; Auger J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1532; Auyeung B, 2009, PSYCHOL SCI, V20, P144, DOI 10.1111/j.1467-9280.2009.02279.x; Bailey AA, 2005, BIOL PSYCHOL, V68, P215, DOI 10.1016/j.biopsycho.2004.05.001; Bailey AA, 2005, PERS INDIV DIFFER, V39, P829, DOI 10.1016/j.paid.2004.12.017; Bosch-Domenech A, 2014, PSYCHONEUROENDOCRINO, V43, P1, DOI 10.1016/j.psyneuen.2014.01.023; Bouwmeester S, 2017, PERSPECT PSYCHOL SCI, V12, P527, DOI 10.1177/1745691617693624; Branas-Garza P, 2015, COGNITIVE REFLECTION, P15; Branas-Garza P., 2018, DIGIT RATIO 2D 4D PR; Branas-Garza P, 2018, INT ECON REV, V59, P1131, DOI 10.1111/iere.12299; Branas-Garza P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060419; Butovskaya M, 2013, AM J PHYS ANTHROPOL, V152, P130, DOI 10.1002/ajpa.22337; Capraro V, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160605; Capraro V, 2016, SCI REP-UK, V6, DOI 10.1038/srep27219; Capraro V, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0237; Cecchi F, 2018, EUR ECON REV, V101, P35, DOI 10.1016/j.euroecorev.2017.09.015; Csatho A, 2003, BIOL PSYCHOL, V62, P147, DOI 10.1016/S0301-0511(02)00127-8; DeWall CN, 2008, PERS SOC PSYCHOL B, V34, P1653, DOI 10.1177/0146167208323981; Franco A, 2014, SCIENCE, V345, P1502, DOI 10.1126/science.1255484; Frederick S, 2005, J ECON PERSPECT, V19, P25, DOI 10.1257/089533005775196732; Galizzi MM, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00041; Gitau R, 2005, ARCH DIS CHILD-FETAL, V90, P166, DOI 10.1136/adc.2004.049320; Grosch K, 2017, J ECON PSYCHOL, V62, P258, DOI 10.1016/j.joep.2017.07.008; Hayes A. F., 2018, INTRO MEDIATION MODE; Honekopp J, 2011, PERS INDIV DIFFER, V51, P381, DOI 10.1016/j.paid.2010.05.003; Honekopp J, 2010, AM J HUM BIOL, V22, P619, DOI 10.1002/ajhb.21054; Honekopp J, 2010, PERS INDIV DIFFER, V48, P4, DOI 10.1016/j.paid.2009.08.009; Horn L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27468-0; Hoskin AW, 2018, PERS INDIV DIFFER, V134, P293, DOI 10.1016/j.paid.2018.06.027; Kaltwasser L, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00250; Kilduff LP, 2013, EVOL PSYCHOL-US, V11, P953, DOI 10.1177/147470491301100502; Klinesmith J, 2006, PSYCHOL SCI, V17, P568, DOI 10.1111/j.1467-9280.2006.01745.x; Manning JT, 2008, AM J HUM BIOL, V20, P451, DOI 10.1002/ajhb.20767; Manning JT, 1998, HUM REPROD, V13, P3000, DOI 10.1093/humrep/13.11.3000; Manning JT., 2002, DIGIT RATIO POINTER; Millet K, 2006, BIOL PSYCHOL, V71, P111, DOI 10.1016/j.biopsycho.2005.06.001; Millet K, 2018, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00254; Millet K, 2011, PERS INDIV DIFFER, V51, P397, DOI 10.1016/j.paid.2010.04.005; Millet K, 2009, BRIT J PSYCHOL, V100, P151, DOI 10.1348/000712608X324359; Murphy RO, 2014, PERS SOC PSYCHOL REV, V18, P13, DOI 10.1177/1088868313501745; Murphy RO, 2011, JUDGM DECIS MAK, V6, P771; Nave G, 2017, PSYCHOL SCI, V28, P1398, DOI 10.1177/0956797617709592; Nepomuceno MV, 2016, PERS INDIV DIFFER, V91, P27, DOI 10.1016/j.paid.2015.11.017; Espinosa MP, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00088; Rand DG, 2016, PSYCHOL SCI, V27, P1192, DOI 10.1177/0956797616654455; Rand DG, 2016, J EXP PSYCHOL GEN, V145, P389, DOI 10.1037/xge0000154; Rand DG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4677; Rand DG, 2012, NATURE, V489, P427, DOI 10.1038/nature11467; Ryckmans J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143307; Sanchez-Pages S, 2010, PHYSIOL BEHAV, V99, P355, DOI 10.1016/j.physbeh.2009.11.013; Sinayev A, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00532; Spiller SA, 2013, J MARKETING RES, V50, P277, DOI 10.1509/jmr.12.0420; Steinberg L, 2008, DEV PSYCHOL, V44, P1764, DOI 10.1037/a0012955; Talarovicova A, 2009, HORM BEHAV, V55, P235, DOI 10.1016/j.yhbeh.2008.10.010; Tester N, 2007, J PERS, V75, P663, DOI 10.1111/j.1467-6494.2007.00452.x; Thomson KS, 2016, JUDGM DECIS MAK, V11, P99; Van Lange PAM, 1999, J PERS SOC PSYCHOL, V77, P337, DOI 10.1037/0022-3514.77.2.337; Voracek M, 2014, EVOL HUM BEHAV, V35, P430, DOI 10.1016/j.evolhumbehav.2014.05.009; Voracek M, 2009, PSYCHOL REP, V104, P922, DOI 10.2466/PR0.104.3.922-956; Yilmaz O, 2017, JUDGM DECIS MAK, V12, P140; Zaki J, 2013, CURR DIR PSYCHOL SCI, V22, P466, DOI 10.1177/0963721413492764; Zheng ZG, 2011, P NATL ACAD SCI USA, V108, P16289, DOI 10.1073/pnas.1108312108	64	1	1	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212767	10.1371/journal.pone.0212767	http://dx.doi.org/10.1371/journal.pone.0212767			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794683	Green Published, gold, Green Submitted			2022-12-27	WOS:000459709100133
J	Vonk, M; Wikkerink, S; Regan, K; Middleton, LE				Vonk, Matthew; Wikkerink, Spencer; Regan, Kayla; Middleton, Laura Elizabeth			Similar changes in executive function after moderate resistance training and loadless movement	PLOS ONE			English	Article							EXERCISE-INDUCED AROUSAL; MIDDLE-AGED ADULTS; COGNITIVE PERFORMANCE; INTENSITY	Growing evidence suggests that physical exercise may improve cognitive function in the short- and long-term. Aerobic exercise has been studied most extensively. Preliminary work suggests that resistance training also improves cognitive function, particularly executive function. Conversely, most studies found little dose-effect by intensity. Consequently, cognitive benefits may be elicited, at least in part, by the movement rather than the physical exertion of resistance training. The objective here was to examine and compare acute changes in executive function after resistance training and a loadless movement control among young, healthy adults. Twenty-two young healthy adults (mean age 23.4 years [2.4]; 50% female) completed three conditions, a baseline condition and two experimental conditions (moderate intensity resistance training, loadless movement control). Participants completed a computerized modified Stroop task with concurrent electroencephalography (EEG) before and 10, 20, 30, and 40min after each intervention. Outcomes (incongruent and congruent response time, accuracy, EEG P3 amplitude and latency) were analyzed using mixed linear regression models (factors: condition, time, condition* time). There was a main effect of time for Stroop response time (F-4,F-84 = 3.94, p = 0.006 and F-4,F-84 = 10.27, p< 0.0001 respectively) and incongruent and congruent P3 amplitude (F-4,F-76 = 4.40, p = 0.003 and F-4,F-76 = 5.09, p = 0.001 respectively). Post-hoc analyses indicated that both incongruent and congruent P3 amplitude were elevated at time points up to and including 40min after the interventions (compared to pre-intervention, p< 0.05). Both incongruent and congruent response times were faster at 10min post-intervention than pre-intervention (p< 0.04). There was no main effect of condition or interaction between condition and time for either outcome (p >= 0.53). Similar improvements in executive function were observed after loadless movement and resistance training, suggesting that movement is at least partially responsible for the benefits to executive function. Future research should continue to probe the influence of movement versus physical exertion in resistance training by including a movement and nonmovement control.	[Vonk, Matthew; Wikkerink, Spencer; Regan, Kayla; Middleton, Laura Elizabeth] Univ Waterloo, Dept Kinesiol, Waterloo, ON, Canada	University of Waterloo	Middleton, LE (corresponding author), Univ Waterloo, Dept Kinesiol, Waterloo, ON, Canada.	Laura.middleton@uwaterloo.ca	Middleton, Laura/ABG-8940-2021; Middleton, Laura/C-6024-2009	Middleton, Laura/0000-0001-8624-3123	Natural Sciences and Engineering Research Council (Canada) Discovery Award	Natural Sciences and Engineering Research Council (Canada) Discovery Award	LM received funding from a Natural Sciences and Engineering Research Council (Canada) Discovery Award.	Angevaren M, 2008, COCHRANE COLLAB; [Anonymous], 2007, AM COLL SPORT MED; [Anonymous], 2014, GLOB STRAT DIET PHYS; Baechle T, 2000, HUMAN KINETICS; Belanger S, 2010, NEUROPSYCHOLOGIA, V48, P581, DOI 10.1016/j.neuropsychologia.2009.10.021; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Brody H, 2000, J FAM PRACTICE, V49, P649; Byun KH, 2014, NEUROIMAGE, V98, P336, DOI 10.1016/j.neuroimage.2014.04.067; Canadian Society Of Exercise Physiology, 2016, PRESCR PHYS ACT PART; Cassilhas RC, 2007, MED SCI SPORT EXER, V39, P1401, DOI 10.1249/mss.0b013e318060111f; Chang YK, 2012, BRAIN RES, V1453, P87, DOI 10.1016/j.brainres.2012.02.068; Chang YK, 2014, J SCI MED SPORT, V17, P51, DOI 10.1016/j.jsams.2013.02.007; Chang YK, 2012, MED SCI SPORT EXER, V44, P1773, DOI 10.1249/MSS.0b013e3182574e0b; Chang YK, 2011, J SPORT EXERCISE PSY, V33, P866, DOI 10.1123/jsep.33.6.866; Chang YK, 2009, RES Q EXERCISE SPORT, V80, P78; Chang YK, 2009, PSYCHOL SPORT EXERC, V10, P19, DOI 10.1016/j.psychsport.2008.05.004; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Compumedics Neuroscan, 2015, CURR NEUR SUIT 7 0 1; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Dunsky A, 2017, PLOS ONE, V12, P1; Harveson AT, 2016, RES Q EXERCISE SPORT, V1367, P1; Henckens MJAG, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00066; Hillman CH, 2003, INT J PSYCHOPHYSIOL, V48, P307, DOI 10.1016/S0167-8760(03)00080-1; Holroyd CB, 2015, PSYCHOL REV, V122, P54, DOI 10.1037/a0038339; Hommel B, 2002, PSYCHOL RES-PSYCH FO, V66, P215, DOI 10.1007/s00426-002-0096-3; Kamijo K, 2004, EUR J APPL PHYSIOL, V92, P305, DOI 10.1007/s00421-004-1097-2; Kamijo K, 2007, INT J PSYCHOPHYSIOL, V65, P114, DOI 10.1016/j.ijpsycho.2007.04.001; Kamijo K, 2009, J GERONTOL B-PSYCHOL, V64, P356, DOI 10.1093/geronb/gbp030; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Lambourne K, 2010, BRAIN RES, V1341, P12, DOI 10.1016/j.brainres.2010.03.091; Lansbergen MM, 2008, CLIN NEUROPHYSIOL, V119, P2247, DOI 10.1016/j.clinph.2008.07.218; Liu-Ambrose T, 2010, ARCH INTERN MED, V170, P170, DOI 10.1001/archinternmed.2009.494; Luck S.J, 2005, MONOGR SOC RES CHILD, V78, P388; Luis G.Tassinary, 2013, PRINCIPLES COGNITIVE; McMorris T, 2011, PHYSIOL BEHAV, V102, P421, DOI 10.1016/j.physbeh.2010.12.007; Moretti DV, 2003, INT J PSYCHOPHYSIOL, V47, P199, DOI 10.1016/S0167-8760(02)00153-8; Nagamatsu LS, 2012, ARCH INTERN MED, V172, P666, DOI 10.1001/archinternmed.2012.379; Nashed JY, 2014, J NEUROSCI, V34, P1769, DOI 10.1523/JNEUROSCI.3063-13.2014; Nikolov I., 2015, REP SCHEME CALCULATO; Penner IK, 2012, CLIN NEUROPSYCHOL, V26, P1142, DOI 10.1080/13854046.2012.713513; Pontifex MB, 2009, MED SCI SPORT EXER, V41, P927, DOI 10.1249/MSS.0b013e3181907d69; Public Health Agency of Canada, 2014, PHYS ACT BEN, V54, P1; Rockwood K, 2007, ALZHEIMERS DEMENT, V3, pS38, DOI 10.1016/j.jalz.2007.01.003; Alves CRR, 2012, J SPORT EXERCISE PSY, V34, P539, DOI 10.1123/jsep.34.4.539; de Asteasu MLS, 2017, AGEING RES REV, V37, P117, DOI 10.1016/j.arr.2017.05.007; Smith PJ, 2010, PSYCHOSOM MED, V72, P239, DOI 10.1097/PSY.0b013e3181d14633; Tsai CL, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00023; Tsai CL, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00262; Wessinger C., 2009, ENCY NEUROSCIENCE, P1117	50	8	8	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212122	10.1371/journal.pone.0212122	http://dx.doi.org/10.1371/journal.pone.0212122			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794593	Green Submitted, gold, Green Published			2022-12-27	WOS:000459709100038
J	Lopez, MY; Pardon, MC; Baiker, K; Prior, M; Ding, YC; Agostini, A; Bai, L; Auer, DP; Faas, HM				Lopez, Maria Yanez; Pardon, Marie-Christine; Baiker, Kerstin; Prior, Malcolm; Ding Yuchun; Agostini, Alessandra; Bai, Li; Auer, Dorothee P.; Faas, Henryk M.			Myoinositol CEST signal in animals with increased Iba-1 levels in response to an inflammatory challenge-Preliminary findings	PLOS ONE			English	Article							SATURATION-TRANSFER CEST; MAGNETIC-RESONANCE-SPECTROSCOPY; IN-VIVO; ALZHEIMERS-DISEASE; MOUSE MODEL; RAT-BRAIN; EXCHANGE; NEUROINFLAMMATION; ACTIVATION; AGENTS	Neuroinflammation plays an important role in the pathogenesis of a range of brain disorders. Non-invasive imaging of neuroinflammation is critical to help improve our understanding of the underlying disease mechanisms, monitor therapies and guide drug development. Generally, MRI lacks specificity to molecular imaging biomarkers, but molecular MR imaging based on chemical exchange saturation transfer (CEST) can potentially detect changes of myoinositol, a putative glial marker that may index neuroinflammation. In this pilot study we aimed to investigate, through validation with immunohistochemistry and in vivo magnetic resonance spectroscopy (MRS), whether CEST imaging can reflect the microglial response to a mild inflammatory challenge with lipopolysaccharide (LPS), in the APPSwe/PS1 mouse model of Alzheimer's disease and wild type controls. The response to the immune challenge was variable and did not align with genotype. Animals with a strong response to LPS (Iba1+, n = 6) showed an increase in CEST contrast compared with those who did not (Iba1-, n = 6). Changes of myoinositol levels after LPS were not significant. We discuss the difficulties of this mild inflammatory model, the role of myoinositol as a glial biomarker, and the technical challenges of CEST imaging at 0.6ppm.	[Lopez, Maria Yanez; Auer, Dorothee P.; Faas, Henryk M.] Univ Nottingham, Sch Med, Sir Peter Mansfield Imaging Ctr, Nottingham, England; [Pardon, Marie-Christine; Agostini, Alessandra] Univ Nottingham, Sch Life Sci, Nottingham, England; [Baiker, Kerstin] Univ Nottingham, Sch Vet Sci, Nottingham, England; [Prior, Malcolm] Univ Nottingham, Med Imaging Unit, Nottingham, England; [Ding Yuchun; Bai, Li] Univ Nottingham, Sch Comp Sci, Nottingham, England	University of Nottingham; University of Nottingham; University of Nottingham; University of Nottingham; University of Nottingham	Faas, HM (corresponding author), Univ Nottingham, Sch Med, Sir Peter Mansfield Imaging Ctr, Nottingham, England.	henryk.faas@nottingham.ac.uk	Lopez, Maria Yanez/AAB-6740-2019	Lopez, Maria Yanez/0000-0001-5187-2501; Baiker, Kerstin/0000-0003-4855-6879; Auer, Dorothee P./0000-0002-4745-3635; Pardon, Marie-Christine/0000-0003-4737-9479	UNICAS - a University of Nottingham initiative [UNICAS-A2B177]; Medical Research Council [CiC2014029]; BBSRC [BB/N021460/1] Funding Source: UKRI	UNICAS - a University of Nottingham initiative; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We acknowledge support from UNICAS - a University of Nottingham initiative to fund interdisciplinary equipment based research (UNICAS-A2B177), as well as a Medical Research Council Confidence in Concept award (CiC2014029).; We acknowledge support on interpretation of histology from Diana Cash and Camilla Simmons, BRAIN Centre, Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London.	Adamczak JM, 2010, NEUROIMAGE, V51, P704, DOI 10.1016/j.neuroimage.2010.02.083; Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; [Anonymous], 2013, R LANG ENV STAT COMP; Bagga P, 2016, J NEUROCHEM, V139, P432, DOI 10.1111/jnc.13771; Banks WA, 2010, BRAIN BEHAV IMMUN, V24, P102, DOI 10.1016/j.bbi.2009.09.001; Bitsch A, 1999, AM J NEURORADIOL, V20, P1619; BRAND A, 1993, DEV NEUROSCI-BASEL, V15, P289, DOI 10.1159/000111347; Cai KJ, 2015, NMR BIOMED, V28, P1, DOI 10.1002/nbm.3216; Carrillo-de Sauvage MA, 2015, J CEREBR BLOOD F MET, V35, P917, DOI 10.1038/jcbfm.2015.48; Chan KWY, 2016, NMR BIOMED, V29, P806, DOI 10.1002/nbm.3526; Chang LD, 2013, J NEUROIMMUNE PHARM, V8, P576, DOI 10.1007/s11481-013-9460-x; Clark DJ, 2016, MAGN RESON MED, V76, P826, DOI 10.1002/mrm.25987; Cunningham C, 2005, J NEUROSCI, V25, P9275, DOI 10.1523/JNEUROSCI.2614-05.2005; Datta G, 2017, MULT SCLER J, V23, P1469, DOI 10.1177/1352458516681504; DiCarlo G, 2001, NEUROBIOL AGING, V22, P1007, DOI 10.1016/S0197-4580(01)00292-5; Ding YC, 2017, IEEE ACM T COMPUT BI, V14, P1366, DOI 10.1109/TCBB.2016.2591520; Garwood M, 2001, J MAGN RESON, V153, P155, DOI 10.1006/jmre.2001.2340; Go M, 2016, BIOCHEM BIOPH RES CO, V479, P331, DOI 10.1016/j.bbrc.2016.09.073; GRUETTER R, 1993, MAGNET RESON MED, V29, P804, DOI 10.1002/mrm.1910290613; Haris M, 2013, NMR BIOMED, V26, P386, DOI 10.1002/nbm.2875; Haris M, 2011, NEUROIMAGE, V54, P2079, DOI 10.1016/j.neuroimage.2010.10.017; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; HENKELMAN RM, 1993, MAGNET RESON MED, V29, P759, DOI 10.1002/mrm.1910290607; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; Henry CJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-15; Herber DL, 2004, EXP NEUROL, V190, P245, DOI 10.1016/j.expneurol.2004.07.007; Huang W, 1999, AM J PSYCHIAT, V156, P1879; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jin T, 2014, NMR BIOMED, V27, P1313, DOI 10.1002/nbm.3191; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim M, 2009, MAGN RESON MED, V61, P1441, DOI 10.1002/mrm.21873; Kim WG, 2000, J NEUROSCI, V20, P6309, DOI 10.1523/JNEUROSCI.20-16-06309.2000; Kozlowski C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031814; Kreisel T, 2014, MOL PSYCHIATR, V19, P699, DOI 10.1038/mp.2013.155; Lee DH, 2017, MAGN RESON MED, V77, P855, DOI 10.1002/mrm.26131; Lee JS, 2016, CONTRAST MEDIA MOL I, V11, P4, DOI 10.1002/cmmi.1652; Liu GS, 2013, MAGN RESON MED, V70, P1690, DOI 10.1002/mrm.24955; Liu Z, 2015, BRAIN, V138, P1239, DOI 10.1093/brain/awv065; Marjanska M, 2014, NEUROSCIENCE, V259, P94, DOI 10.1016/j.neuroscience.2013.11.052; McAteer MA, 2007, NAT MED, V13, P1253, DOI 10.1038/nm1631; Melah KE, 2016, J ALZHEIMERS DIS, V50, P873, DOI 10.3233/JAD-150897; Michaud JP, 2013, P NATL ACAD SCI USA, V110, P1941, DOI 10.1073/pnas.1215165110; Murray ME, 2014, J NEUROSCI, V34, P16247, DOI 10.1523/JNEUROSCI.2027-14.2014; Pardon MC, 2016, SCI REP-UK, V6, DOI 10.1038/srep19880; Pepin J, 2016, NEUROIMAGE, V139, P53, DOI 10.1016/j.neuroimage.2016.06.023; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Roalf DR, 2017, MOL PSYCHIATR, V22, P1298, DOI 10.1038/mp.2016.258; Robinson KM, 2010, MOL IMAGING BIOL, V12, P240, DOI 10.1007/s11307-009-0272-6; Schneider P, 2012, BRAIN BEHAV IMMUN, V26, P277, DOI 10.1016/j.bbi.2011.09.011; Sled JG, 2001, MAGNET RESON MED, V46, P923, DOI 10.1002/mrm.1278; Song XL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7719; Stefaniak J, 2016, J NEUROL NEUROSUR PS, V87, P21, DOI 10.1136/jnnp-2015-311336; Sulzer D, 2017, NATURE, V546, P656, DOI 10.1038/nature22815; Suridjan I, 2014, NEUROIMAGE, V84, P868, DOI 10.1016/j.neuroimage.2013.09.021; Tkac I, 1999, MAGNET RESON MED, V41, P649, DOI 10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G; Tu TW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-19094-z; Turkheimer FE, 2015, BIOCHEM SOC T, V43, P586, DOI 10.1042/BST20150058; Ward KM, 2000, J MAGN RESON, V143, P79, DOI 10.1006/jmre.1999.1956; Wells JA, 2015, NEUROIMAGE, V111, P369, DOI 10.1016/j.neuroimage.2015.02.023; Woessner DE, 2005, MAGN RESON MED, V53, P790, DOI 10.1002/mrm.20408; Zahr NM, 2014, BRAIN PATHOL, V24, P654, DOI 10.1111/bpa.12197; Zhang XY, 2017, MAGN RESON MED, V78, P881, DOI 10.1002/mrm.26802; Zhang XY, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3716; Zhong J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140238	65	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212002	10.1371/journal.pone.0212002	http://dx.doi.org/10.1371/journal.pone.0212002			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789943	Green Published, Green Submitted, gold			2022-12-27	WOS:000459330800016
J	Adesokan, HK; Streicher, EM; van Helden, PD; Warren, RM; Cadmus, SIB				Adesokan, Hezekiah K.; Streicher, Elizabeth M.; van Helden, Paul D.; Warren, Rob M.; Cadmus, Simeon I. B.			Genetic diversity of Mycobacterium tuberculosis complex strains isolated from livestock workers and cattle in Nigeria	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; PULMONARY TUBERCULOSIS; BOVINE TUBERCULOSIS; AFRICANUM; DIFFERENTIATION; INFECTION; LINEAGE	Molecular typing techniques are useful in understanding tuberculosis epidemiology; yet, they have been under-utilised at the human-animal interface in Nigeria. Sixty-four Mycobacterium tuberculosis complex (MTBC) isolates including 42 M. tuberculosis, 13 M. bovis and nine M. africanum obtained from livestock workers (LW, n = 47) and their cattle (n = 17) in three geographical zones of Nigeria were genotyped to identify and evaluate the genetic diversity of the circulating MTBC using spoligotyping. Distribution into clades of M. tuberculosis revealed; 45.3% Uganda I- [SIT46- cattle: 1; LW: 28], 14.1% Latin American Mediterranean- [SIT61, cattle: 1; LW: 8], and 1.6% T- [SIT53-LW: 1]. The M. bovis strains were 6.3% SB0944 [cattle: 4] and 1.6% each of SB0300, SB1026, SB1027 and SB1439 [cattle: 4]. Seventeen MTBC isolates [cattle: 7; LW: 10] yielded 14 new spoligotype patterns including three M. tuberculosis strains (three isolates), five M. bovis strains (five isolates) and six M. africanum strains (nine isolates), two of which belonged to MAF1. Only few families namely, the not previously described Uganda I-, LAM and SB0944 are predominant among the LW and cattle, with other types in lower prevalences. The strain population structure indicates an intriguing diversity and possible zoonotic linkage with consequences for TB control in the country. The need to employ newer molecular techniques such as Mycobacterial Interspersed Repetitive Unit-Variable Number Tandem Repeats and whole genome sequence to decipher circulating MTBC strains in Nigeria is advocated.	[Adesokan, Hezekiah K.; Cadmus, Simeon I. B.] Univ Ibadan, Dept Vet Publ Hlth & Prevent Med, Ibadan, Nigeria; [Streicher, Elizabeth M.; van Helden, Paul D.; Warren, Rob M.] Stellenbosch Univ, DST NRF Ctr Excellence Biomed TB Res, SAMRC Ctr TB Res, Div Mol Biol & Human Genet,Fac Med & Hlth Sci, Cape Town, South Africa; [Cadmus, Simeon I. B.] Univ Ibadan, Ctr Control & Prevent Zoonoses, Fac Vet Med, Ibadan, Nigeria	University of Ibadan; National Research Foundation - South Africa; Stellenbosch University; University of Ibadan	Adesokan, HK; Cadmus, SIB (corresponding author), Univ Ibadan, Dept Vet Publ Hlth & Prevent Med, Ibadan, Nigeria.; Cadmus, SIB (corresponding author), Univ Ibadan, Ctr Control & Prevent Zoonoses, Fac Vet Med, Ibadan, Nigeria.	greaterglory2008@gmail.com; simeonc5@gmail.com	Adesokan, Hezekiah/R-8488-2019; Streicher, Elizabeth/I-7780-2018	Streicher, Elizabeth/0000-0003-3901-1981; Warren, Robin/0000-0001-5741-7358; Adesokan, Hezekiah/0000-0001-5050-8580	Tertiary Education Trust Fund (TETFund); Tertiary Education Trust Fund (TETFund) of the Federal Republic of Nigeria	Tertiary Education Trust Fund (TETFund); Tertiary Education Trust Fund (TETFund) of the Federal Republic of Nigeria	This work was sponsored by the authors and partly supported by a grant received by HKA from Tertiary Education Trust Fund (TETFund, 2015) under the Staff Training and Development (ST&D) Scheme of the University of Ibadan, Nigeria. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.; The authors appreciate the kind assistance of the Veterinary Officers of the sites where the study was carried out. This work was sponsored by the authors and partly supported by Tertiary Education Trust Fund (TETFund) of the Federal Republic of Nigeria.	Abadia E, 2010, INFECT GENET EVOL, V10, P1066, DOI 10.1016/j.meegid.2010.07.006; Adesokan HK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198810; Affolabi D, 2009, INT J TUBERC LUNG D, V13, P317; Ani A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-189; [Anonymous], 2018, GLOB TUB REP; Asante-Poku A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003370; Assam JPA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-431; Ayele WY, 2004, INT J TUBERC LUNG D, V8, P924; Becton D., 1999, BBLTM MYCOPREPTM SPE, P2; Bonard D, 2000, INT J TUBERC LUNG D, V4, P1176; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Cadmus S, 2006, J CLIN MICROBIOL, V44, P29, DOI 10.1128/JCM.44.1.29-34.2006; Cadmus S, 2011, J CLIN MICROBIOL, V49, P220, DOI 10.1128/JCM.01241-10; Cadmus SIB, 2010, TROP ANIM HEALTH PRO, V42, P1047, DOI 10.1007/s11250-010-9533-2; Coll F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5812; DEKANTOR I, 1979, B ACAD VET FRANCE, V52, P499; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Diguimbaye-Djaibe C, 2006, EMERG INFECT DIS, V12, P769; Fritsche A, 2004, INT J TUBERC LUNG D, V8, P903; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Godreuil S, 2007, J CLIN MICROBIOL, V45, P921, DOI 10.1128/JCM.01918-06; Groenheit R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018601; Hirsh AE, 2004, P NATL ACAD SCI USA, V101, P4871, DOI 10.1073/pnas.0305627101; Jenkins AO, 2011, VET MICROBIOL, V151, P139, DOI 10.1016/j.vetmic.2011.02.037; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kato-Maeda M, 2011, INT J TUBERC LUNG D, V15, P131; Koro FK, 2015, REV SCI TECH OIE, V34, P1001, DOI 10.20506/rst.34.3.2390; Krajewska M, 2012, VET MICROBIOL, V159, P269, DOI 10.1016/j.vetmic.2012.04.001; Lawson L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038409; Mathema B, 2006, CLIN MICROBIOL REV, V19, P658, DOI 10.1128/CMR.00061-05; Mbugi EV, 2015, TUBERCULOSIS, V95, P170, DOI 10.1016/j.tube.2014.11.006; Niobe-Eyangoh SN, 2003, J CLIN MICROBIOL, V41, P2547, DOI 10.1128/JCM.41.6.2547-2553.2003; Njanpop-Lafourcade BM, 2001, J CLIN MICROBIOL, V39, P222, DOI 10.1128/JCM.39.1.222-227.2001; Pang Y, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-354; Shitaye JE, 2007, VET MED-CZECH, V52, P317, DOI 10.17221/1872-VETMED; Smith NH, 2012, INFECT GENET EVOL, V12, P873, DOI 10.1016/j.meegid.2011.08.002; Uzoewulu GN, 2016, INT J MYCOBACT, V5, P74, DOI 10.1016/j.ijmyco.2015.06.008; Warren RM, 2006, INT J TUBERC LUNG D, V10, P818; Weber A, 1998, BERL MUNCH TIERARZTL, V111, P6; WHO/ FAO/ OIE/ IUATLD, 48 UN WORLD C LUNG H; Wilkins MJ, 2008, EMERG INFECT DIS, V14, P657, DOI 10.3201/eid1404.070408; Yeboah-Manu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021906; Zumarraga MJ, 2013, RES VET SCI, V94, P9, DOI 10.1016/j.rvsc.2012.07.012	43	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211637	10.1371/journal.pone.0211637	http://dx.doi.org/10.1371/journal.pone.0211637			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785899	Green Submitted, Green Published, gold			2022-12-27	WOS:000459307000033
J	Gavilan-Carrera, B; da Silva, JG; Vargas-Hitos, JA; Sabio, JM; Morillas-de-Laguno, P; Rios-Fernandez, R; Delgado-Fernandez, M; Soriano-Maldonado, A				Gavilan-Carrera, Blanca; Garcia da Silva, Jaqueline; Vargas-Hitos, Jose A.; Sabio, Jose M.; Morillas-de-Laguno, Pablo; Rios-Fernandez, Raquel; Delgado-Fernandez, Manuel; Soriano-Maldonado, Alberto			Association of physical fitness components and health-related quality of life in women with systemic lupus erythematosus with mild disease activity	PLOS ONE			English	Article							PATIENT-REPORTED OUTCOMES; CARDIORESPIRATORY FITNESS; FUNCTIONAL FITNESS; AEROBIC EXERCISE; ACTIVITY PROGRAM; MUSCLE STRENGTH; SF-36; FIBROMYALGIA; CAPACITY; FATIGUE	Objectives To study the association of different components of physical fitness [flexibility, muscle strength and cardiorespiratory fitness (CRF)] and a clustered fitness score with health related quality of life (HRQoL) in women with systemic lupus erythematosus (SLE) and to analyze whether participants with high fitness level have better HRQoL. Methods This cross-sectional study included 70 women with SLE (aged 42.5; SD 13.9 years). The back-scratch test assessed flexibility, the 30-sec chair stand and handgrip strength tests assessed muscle strength, and the 6-min walk test (n = 49) assessed CRF. HRQoL was assessed through the 36-item Short-Form Health Survey (SF-36). Results Flexibility was positively associated with the physical function dimension and the physical component summary (PCS) (r(partial) between 0.26 and 0.31; p<0.05), and negatively related with social functioning dimension (r(partial) = -0.26; p<0.05). Muscle strength was positively associated with the physical function, physical role, bodily pain dimensions and the PCS (r(partial) between 0.27 and 0.49; all p<0.05). CRF was positively associated with the physical function and bodily pain dimensions, and PCS (r(partial) between 0.39 and 0.65; all p<0.05). The clustered fitness score was associated with the physical function (B = 17.16) and bodily pain (B = 14.35) dimensions, and the PCS (B = 6.02), all p<0.005. Patients with high fitness level had greater scores in the physical function, physical role, and bodily pain dimensions and the PCS, all p <= 0.05. Conclusions Our study suggests that muscle strength and CRF are positively associated with HRQoL, while flexibility showed contradictory results. These findings highlight the importance of maintaining adequate fitness levels in women with SLE.	[Gavilan-Carrera, Blanca; Morillas-de-Laguno, Pablo; Delgado-Fernandez, Manuel] Univ Granada, Fac Sport Sci, Dept Phys Educ & Sport, Granada, Spain; [Garcia da Silva, Jaqueline] Univ Granada, Sch Psychol, Dept Personal Assessment & Psychol Treatment, Granada, Spain; [Vargas-Hitos, Jose A.; Sabio, Jose M.] Virgen de las Nieves Univ Hosp, Dept Internal Med, Syst Autoimmune Dis Unit, Granada, Spain; [Rios-Fernandez, Raquel] San Cecilio Univ Hosp, Dept Internal Med, Syst Autoimmune Dis Unit, Granada, Spain; [Soriano-Maldonado, Alberto] Univ Almeria, Fac Educ Sci, Dept Educ, Almeria, Spain; [Soriano-Maldonado, Alberto] Univ Almeria, CERNEP Res Ctr, SPORT Res Grp CTS 1024, Almeria, Spain	University of Granada; University of Granada; Hospital Universitario Virgen de las Nieves; Hospital Universitario San Cecilio; Universidad de Almeria; Universidad de Almeria	Gavilan-Carrera, B (corresponding author), Univ Granada, Fac Sport Sci, Dept Phys Educ & Sport, Granada, Spain.	bgavilan@ugr.es	Vargas-Hitos, José Antonio/ABG-4532-2020; Delgado-Fernández, Manuel/N-2990-2013; Soriano-Maldonado, Alberto/I-6379-2015; Gavilán-Carrera, Blanca/AAB-5424-2021	Vargas-Hitos, José Antonio/0000-0002-0596-8710; Delgado-Fernández, Manuel/0000-0003-0636-9258; Soriano-Maldonado, Alberto/0000-0002-4626-420X; Garcia Da Silva, Jaqueline/0000-0002-1663-9031; Morillas de Laguno, Pablo/0000-0002-7838-3625; Gavilan Carrera, Blanca/0000-0002-9223-7181; Rios-Fernandez, Raquel/0000-0001-6630-8292	Consejeria de Salud, Junta de Andalucia [PI-0525-2016]; Ilustre Colegio Oficial de Medicos de Granada (Premios de Investigacion); Spanish Ministry of Education [FPU15/00002]	Consejeria de Salud, Junta de Andalucia(Junta de Andalucia); Ilustre Colegio Oficial de Medicos de Granada (Premios de Investigacion); Spanish Ministry of Education(Spanish Government)	This work was supported by the Consejeria de Salud, Junta de Andalucia (grant number: PI-0525-2016) and the Ilustre Colegio Oficial de Medicos de Granada (Premios de Investigacion 2017). BG-C was supported by the Spanish Ministry of Education (FPU15/00002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahao MI, 2016, SCAND J RHEUMATOL, V45, P197, DOI 10.3109/03009742.2015.1094126; Alarcon GS, 2004, ARTHRIT RHEUM-ARTHR, V51, P465, DOI 10.1002/art.20409; ALONSO J, 1995, MED CLIN-BARCELONA, V104, P771; Andrews JS, 2015, ARTHRIT CARE RES, V67, P1070, DOI 10.1002/acr.22560; Andrews JS, 2015, ARTHRIT CARE RES, V67, P120, DOI 10.1002/acr.22399; Annapureddy N, 2016, LUPUS, V25, P1111, DOI 10.1177/0961203316652494; Baba S, 2018, LUPUS, V27, P407, DOI 10.1177/0961203317725586; Balsamo S, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-263; Balsamo S, 2013, REV BRAS REUMATOL, V53, P75, DOI 10.1016/S2255-5021(13)70008-7; Beck AT., 1996, BECK DEPRESSION INVE, pb9; Bogdanovic G, 2015, TOHOKU J EXP MED, V237, P193, DOI 10.1620/tjem.237.193; Bostrom C, 2016, LUPUS, V25, P602, DOI 10.1177/0961203315622817; Chaigne B, 2017, BMC IMMUNOL, V18, DOI 10.1186/s12865-017-0200-5; Chung PK, 2017, ARCH GERONTOL GERIAT, V68, P44, DOI 10.1016/j.archger.2016.08.007; Colangelo KJ, 2009, J RHEUMATOL, V36, P2231, DOI 10.3899/jrheum.090193; de Carvalho MRP, 2005, ARTHRIT RHEUM-ARTHR, V53, P838, DOI 10.1002/art.21605; Di Franco M, 2014, REUMATISMO, V66, P33, DOI 10.4081/reumatismo.2014.762; FANGTHAM M, 2017, ARTHRITIS RHEUMA S10, V69, P91327; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Golder V, 2017, MED J AUSTRALIA, V206, P215, DOI 10.5694/mja16.01229; Gregorio-Arenas E, 2016, MATURITAS, V92, P162, DOI 10.1016/j.maturitas.2016.08.008; Griffiths B, 2005, BEST PRACT RES CL RH, V19, P685, DOI 10.1016/j.berh.2005.03.010; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Houghton KM, 2008, ARTHRIT RHEUM-ARTHR, V59, P537, DOI 10.1002/art.23534; Jolly M, 2005, J RHEUMATOL, V32, P1706; Kasikcioglu E, 2006, MED HYPOTHESES, V66, P950, DOI 10.1016/j.mehy.2005.11.028; Katz DL, 2007, MED HYPOTHESES, V69, P517, DOI 10.1016/j.mehy.2005.10.037; Kell RT, 2001, SPORTS MED, V31, P863, DOI 10.2165/00007256-200131120-00003; Keyser RE, 2003, ARTHRIT RHEUM-ARTHR, V49, P16, DOI 10.1002/art.10926; Khanna S, 2004, RHEUMATOLOGY, V43, P1536, DOI 10.1093/rheumatology/keh376; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Lee WJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160876; McElhone K, 2006, LUPUS, V15, P633, DOI 10.1177/0961203306071710; Metsios GS, 2015, RHEUMATOLOGY, V54, P2215, DOI 10.1093/rheumatology/kev035; Moldovan I, 2011, LUPUS, V20, P1285, DOI 10.1177/0961203311412097; Montalban-Mendez C, 2018, EUR J CLIN INVEST, V48, DOI 10.1111/eci.12885; Montero-Marin J, 2013, ATEN PRIM, V45, P376, DOI 10.1016/j.aprim.2013.03.002; O'Dwyer T, 2017, SEMIN ARTHRITIS RHEU, V47, P204, DOI 10.1016/j.semarthrit.2017.04.003; Perandini LA, 2015, EXERC IMMUNOL REV, V21, P174; Timoteo RP, 2018, LUPUS, V27, P1159, DOI 10.1177/0961203318768880; Pinto AJ, 2016, ARTHRIT CARE RES, V68, P1780, DOI 10.1002/acr.22905; Plantinga L, 2016, LUPUS SCI MED, V3, DOI 10.1136/lupus-2016-000161; Ramsey-Goldman R, 2000, ARTHRIT CARE RES, V13, P262, DOI 10.1002/1529-0131(200010)13:5<262::AID-ANR4>3.0.CO;2-8; Rikli RE, 1999, J AGING PHYS ACTIV, V7, P129, DOI 10.1123/japa.7.2.129; Rikli RE, 2013, GERONTOLOGIST, V53, P255, DOI 10.1093/geront/gns071; Ruiz-Ruiz J, 2002, J HAND SURG-AM, V27A, P897, DOI 10.1053/jhsu.2002.34315; Sedlock DA, 2010, INT J SPORT NUTR EXE, V20, P336, DOI 10.1123/ijsnem.20.4.336; Soriano-maldonado A, 2018, ERYTHEMATOSUS NONRAN, P1, DOI [10.3390/jcm7120477, DOI 10.3390/JCM7120477]; Soriano-Maldonado A, 2015, ARTHRIT CARE RES, V67, P1561, DOI 10.1002/acr.22610; Soriano-Maldonado A, 2015, ARCH PHYS MED REHAB, V96, P1599, DOI 10.1016/j.apmr.2015.03.015; Soriano-Maldonado A, 2015, RHEUMATOL INT, V35, P899, DOI 10.1007/s00296-014-3203-z; Stoll T, 1997, J RHEUMATOL, V24, P1608; Tench C, 2002, J RHEUMATOL, V29, P474; Tench CM, 2003, RHEUMATOLOGY, V42, P1050, DOI 10.1093/rheumatology/keg289; Urowitz M, 2014, ARTHRIT CARE RES, V66, P1374, DOI 10.1002/acr.22299; van Vollenhoven RF, 2014, ANN RHEUM DIS, V73, P958, DOI 10.1136/annrheumdis-2013-205139; Vaquero-Cristobol R, 2015, RETOS NUEVAS TENDENC, V27, P127; Vilagut G, 2008, MED CLIN-BARCELONA, V130, P726, DOI 10.1157/13121076	58	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212436	10.1371/journal.pone.0212436	http://dx.doi.org/10.1371/journal.pone.0212436			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785923	Green Submitted, Green Published, gold			2022-12-27	WOS:000459307000061
J	Junaid, M; Islam, N; Hossain, MK; Ullah, MO; Halim, MA				Junaid, Md.; Islam, Nazrul; Hossain, Md. Kamal; Ullah, M. Obayed; Halim, Mohammad A.			Metal based donepezil analogues designed to inhibit human acetylcholinesterase for Alzheimer's disease	PLOS ONE			English	Article							PERIPHERAL ANIONIC SITE; MOLECULAR-DYNAMICS; DOCKING; COMPLEXES; DERIVATIVES; CHALLENGES; PREDICTION; HARDNESS	Among neurodegenerative disorders, Alzheimer's disease (AD) is one of the most common disorders showing slow progressive cognitive decline. Targeting acetylcholinesterase (AChE) is one of the major strategies for AD therapeutics, as cholinergic pathways in the cerebral cortex and basal forebrain are compromised. Herein, we report the design of some copper and other metal based donepezil derivatives, employing density functional theory (DFT). All designed compounds are optimized at the B3LYP/SDD level of theory. Dipole moments, electronic energie, enthalpies, Gibbs free energies, and HOMO-LUMO gaps of these modified compounds are also investigated in the subsequent analysis. The molecules were then subjected to molecular docking analysis with AChE to study the molecular interactions broadly. Ensemble based docking and molecular dynamics (MD) simulations of the best candidates were also performed. Docking and MD simulation reveal that modified drugs are more potent than unmodified donepezil, where Trp86, Tyr337, Phe330 residues play some important roles in drug-receptor interactions. According to ensemble based docking, D9 shows greater binding affinity compared to the parent in most conformations obtained from protein data bank and MD simulation. In addition, it is observed that the pi-pi stacking with the residues of Trp86, Tyr337, Tyr341, Tyr124 and Trp286 may be required for strong ligand binding. Moreover, ADME/T analysis suggests that modified derivatives are less toxic and have improved pharmacokinetic properties than those of the parent drug. These results further confirm the ability of metal-directed drugs to bind simultaneously to the active sites of AChE and support them as potential candidates for the future treatment of Alzheimer's disease.	[Junaid, Md.; Islam, Nazrul; Ullah, M. Obayed] North South Univ, Dept Pharmaceut Sci, Dhaka, Bangladesh; [Hossain, Md. Kamal] Jahangirnagar Univ, Dept Chem, Dhaka, Bangladesh; [Halim, Mohammad A.] Red Green Res Ctr, Div Comp Aided Drug Design, Dhaka, Bangladesh	North South University (NSU); Jahangirnagar University	Ullah, MO (corresponding author), North South Univ, Dept Pharmaceut Sci, Dhaka, Bangladesh.; Halim, MA (corresponding author), Red Green Res Ctr, Div Comp Aided Drug Design, Dhaka, Bangladesh.	obayed.ullah@northsouth.edu; mahalim@grc-bd.org	Ullah, M Obayed/AAR-7211-2020; Halim, Mohammad A./D-1359-2011; Halim, Mohammad/GZA-9474-2022; Junaid, Md./G-3188-2018	Ullah, M Obayed/0000-0002-1175-3636; Halim, Mohammad A./0000-0002-1698-7044; HOSSAIN, MD KAMAL/0000-0002-8092-1728; Junaid, Md./0000-0003-3588-4937				Anand P, 2012, BIOORGAN MED CHEM, V20, P1175, DOI 10.1016/j.bmc.2011.12.042; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; BERGNER A, 1993, MOL PHYS, V80, P1431, DOI 10.1080/00268979300103121; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bourne Y, 1999, J BIOL CHEM, V274, P30370, DOI 10.1074/jbc.274.43.30370; BOURNE Y, 1995, CELL, V83, P503, DOI 10.1016/0092-8674(95)90128-0; Bourne Y, 2004, P NATL ACAD SCI USA, V101, P1449, DOI 10.1073/pnas.0308206100; Chan KY, 2013, LANCET, V381, P2016, DOI 10.1016/S0140-6736(13)60221-4; Cheung J, 2012, J MED CHEM, V55, P10282, DOI 10.1021/jm300871x; Colombres M, 2004, CURR PHARM DESIGN, V10, P3123, DOI 10.2174/1381612043383359; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dash Raju, 2017, Adv Appl Bioinform Chem, V10, P11, DOI 10.2147/AABC.S115859; Egan WJ, 2000, J MED CHEM, V43, P3867, DOI 10.1021/jm000292e; Faerman C, 1996, FEBS LETT, V386, P65, DOI 10.1016/0014-5793(96)00374-2; Fang JS, 2014, ACTA PHARM SIN B, V4, P430, DOI 10.1016/j.apsb.2014.10.002; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fisher A, 2012, J NEUROCHEM, V120, P22, DOI 10.1111/j.1471-4159.2011.07507.x; Flood DG, 2011, BIOCHEM PHARMACOL, V81, P1422, DOI 10.1016/j.bcp.2011.01.021; Frezza M, 2010, CURR PHARM DESIGN, V16, P1813, DOI 10.2174/138161210791209009; Greig NH, 2001, CURR MED RES OPIN, V17, P159; GRUBIC Z, 1995, BBA-PROTEIN STRUCT M, V1249, P155, DOI 10.1016/0167-4838(95)00036-T; Hartinger CG, 2008, CURR MED CHEM, V15, P2574, DOI 10.2174/092986708785908978; Hoque MM, 2015, J PHYS ORG CHEM, V28, P732, DOI 10.1002/poc.3477; Huang L, 2010, BIOORGAN MED CHEM, V18, P1244, DOI 10.1016/j.bmc.2009.12.035; Huijbregts SCJ, 2003, NEUROPSYCHOLOGY, V17, P369, DOI 10.1037/0894-4105.17.3.369; Johnson G, 2006, CURR PHARM DESIGN, V12, P217, DOI 10.2174/138161206775193127; Khan AM, 2017, J MOL GRAPH MODEL, V77, P386, DOI 10.1016/j.jmgm.2017.09.010; Lahiri DK, 2003, CURR DRUG TARGETS, V4, P97, DOI 10.2174/1389450033346957; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Mjos KD, 2014, CHEM REV, V114, P4540, DOI 10.1021/cr400460s; Ordentlich A, 1998, J BIOL CHEM, V273, P19509, DOI 10.1074/jbc.273.31.19509; Parr R. G., 1989, DENSITY FUNCTIONAL T; PARR RG, 1993, ACCOUNTS CHEM RES, V26, P256, DOI 10.1021/ar00029a005; PEARSON RG, 1986, P NATL ACAD SCI USA, V83, P8440, DOI 10.1073/pnas.83.22.8440; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rahman A, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2996-5; Silman I, 2008, CHEM-BIOL INTERACT, V175, P3, DOI 10.1016/j.cbi.2008.05.035; Somani G, 2015, J PHARM BIOALLIED SC, V7, P32, DOI 10.4103/0975-7406.148775; Susnow RG, 2003, J CHEM INF COMP SCI, V43, P1308, DOI 10.1021/ci030283p; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; Tang Q., 2012, ADMETSAR COMPREHENSI, V134, P16909; Thompson KH, 2006, DALTON T, P761, DOI 10.1039/b513476e; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Ying W, 2008, METAL BASED DRUGS, V2008	47	18	18	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211935	10.1371/journal.pone.0211935	http://dx.doi.org/10.1371/journal.pone.0211935			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785927	Green Submitted, Green Published, gold			2022-12-27	WOS:000459307000046
J	Teruya, T				Teruya, Tadanori			Security analysis of elliptic curves with embedding degree 1 proposed in PLOS ONE 2016	PLOS ONE			English	Article							SCALAR MULTIPLICATION; DISCRETE LOGARITHM; IMPLEMENTATION; ATE	Wang et al. proposed a method for obtaining elliptic curves with embedding degree 1 for securing critical infrastructures, and presented several elliptic curves generated by their method with torsion points of 160 bits and 189 bits orders. They also presented some experimental results and claimed that their implementation of an elliptic curve generated with their method is faster than an implementation for embedded devices presented by Bertoni et al. In this paper, we point out that the security and efficiency claims given by Wang et al. are flawed. Specifically, we show that it is possible to solve finite field discrete logarithm problems defined over their elliptic curves in practice. On the elliptic curves with torsion points of 160 bits orders generated by Wang et al., their instances of finite field discrete logarithm problems are solved in around 4 hours by using a standard desktop PC. On the torsion points of 189 bits orders, their instances are solved in around 10 days by using two standard desktop PCs. The hardness of the finite field discrete logarithm problems is one of the most important bases of security; therefore, their elliptic curves should not be used for cryptographic purposes.	[Teruya, Tadanori] Natl Inst Adv Ind Sci & Technol, Cyber Phys Secur Res Ctr, Koto Ku, Tokyo, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Teruya, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Cyber Phys Secur Res Ctr, Koto Ku, Tokyo, Japan.	tadanori.teruya@aist.go.jp	Teruya, Tadanori/O-1145-2016	Teruya, Tadanori/0000-0003-4362-4887				Adrian D, 2015, CCS'15: PROCEEDINGS OF THE 22ND ACM SIGSAC CONFERENCE ON COMPUTER AND COMMUNICATIONS SECURITY, P5, DOI 10.1145/2810103.2813707; Aranha DF, 2014, LECT NOTES COMPUT SC, V8282, P3, DOI 10.1007/978-3-662-43414-7_1; Aranha DF, 2011, LECT NOTES COMPUT SC, V6632, P48, DOI 10.1007/978-3-642-20465-4_5; Balasubramanian R, 1998, J CRYPTOL, V11, P141, DOI 10.1007/s001459900040; Barbulescu R, 2017, UPDATING KEY SIZE ES; Barbulescu R, 2015, LECT NOTES COMPUT SC, V9056, P129, DOI 10.1007/978-3-662-46800-5_6; Bernstein DJ, 2016, FASTER ELLIPTIC CURV; Bertoni G, 2005, COMPUTING TATE PAIRI; Bertoni GM, 2008, J SYST SOFTWARE, V81, P1240, DOI 10.1016/j.jss.2007.09.022; Beuchat JL, 2010, LECT NOTES COMPUT SC, V6487, P21, DOI 10.1007/978-3-642-17455-1_2; Boneh D, 2004, J CRYPTOL, V17, P297, DOI 10.1007/s00145-004-0314-9; Boneh D, 2003, SIAM J COMPUT, V32, P586, DOI 10.1137/S0097539701398521; Chatterjee S, 2017, IEEE T COMPUT, V66, P1061, DOI 10.1109/TC.2016.2633340; Freeman D, 2010, J CRYPTOL, V23, P224, DOI 10.1007/s00145-009-9048-z; FREY G, 1994, MATH COMPUT, V62, P865, DOI 10.2307/2153546; Fried J, 2017, LECT NOTES COMPUT SC, V10210, P202, DOI 10.1007/978-3-319-56620-7_8; Fujimoto D, 2016, INT SOC DESIGN CONF, P203, DOI 10.1109/ISOCC.2016.7799858; Galbraith SD, 2008, LECT NOTES COMPUT SC, V5209, P211, DOI 10.1007/978-3-540-85538-5_15; Galbraith SD, 2008, DISCRETE APPL MATH, V156, P3113, DOI 10.1016/j.dam.2007.12.010; Ghosh Santosh, 2012, Pairing-Based Cryptography - Pairing 2012. 5th International Conference. Revised Selected Papers, P141, DOI 10.1007/978-3-642-36334-4_9; Gremy L, 2017, DISCRETELOGDB DATABA; Groth J, 2012, SIAM J COMPUT, V41, P1193, DOI 10.1137/080725386; Hayashi T, 2012, LECT NOTES COMPUT SC, V7658, P43, DOI 10.1007/978-3-642-34961-4_5; Hayashi T, 2012, IEICE T FUND ELECTR, VE95A, P204, DOI 10.1587/transfun.E95.A.204; Hess F, 2008, LECT NOTES COMPUT SC, V5209, P18, DOI 10.1007/978-3-540-85538-5_2; Hess F, 2006, IEEE T INFORM THEORY, V52, P4595, DOI 10.1109/TIT.2006.881709; Hoffstein J., 2014, UNDERGRADUATE TEXTS; Joux A, 2004, J CRYPTOL, V17, P263, DOI 10.1007/s00145-004-0312-y; Kanayama N, 2011, IEICE T FUND ELECTR, VE94A, P1285, DOI 10.1587/transfun.E94.A.1285; Kleinjung T, 2017, LECT NOTES COMPUT SC, V10210, P185, DOI 10.1007/978-3-319-56620-7_7; Lenstra AK, 2001, J CRYPTOL, V14, P255, DOI 10.1007/s00145-001-0009-4; Matsuda S, 2009, IEICE T FUND ELECTR, VE92A, P1660, DOI 10.1587/transfun.E92.A.1660; Menezes A., 2016, IACR CRYPTOLOGY EPRI, V2016, P1102; MENEZES AJ, 1993, IEEE T INFORM THEORY, V39, P1639, DOI 10.1109/18.259647; Miller V, 1986, SHORT PROGRAMS FUNCT; Miller VS, 2004, J CRYPTOL, V17, P235, DOI 10.1007/s00145-004-0315-8; Mrabet NE., 2017, GUIDE PAIRING BASED; Ogura N, 2012, IEICE T FUND ELECTR, VE95A, P196, DOI 10.1587/transfun.E95.A.196; Onuki H., 2016, JSIAM LETT, V8, P9, DOI [10.14495/jsiaml.8.9, DOI 10.14495/JSIAML.8.9]; Onuki H, 2016, LECT NOTES COMPUT SC, V9836, P319, DOI 10.1007/978-3-319-44524-3_19; Sakai R., 2000, P S CRYPT INF SEC OK, P36; Sakemi Y, 2008, LECT NOTES COMPUT SC, V5339, P226, DOI 10.1007/978-3-540-89641-8_16; Stange KE, 2007, LECT NOTES COMPUT SC, V4575, P329; Teruya T., 2013, LECT NOTES COMPUTER, P97, DOI [10.1007/978-3-319-04873-4_6, DOI 10.1007/978-3-319-04873-4_6]; The CADO-NFS Development Team, 2017, CADO NFS IMPL NUMB F; Tibouchi M, 2017, DESIGN CODE CRYPTOGR, V82, P161, DOI 10.1007/s10623-016-0288-2; Unterluggauer T, 2014, LECT NOTES COMPUT SC, V8731, P298, DOI 10.1007/978-3-662-44709-3_17; Vercauteren F, 2010, IEEE T INFORM THEORY, V56, P455, DOI 10.1109/TIT.2009.2034881; Wang M, PAIRING FRIENDLY ELL, DOI [10.1371/journal.pone.0161857.s001, DOI 10.1371/JOURNAL.PONE.0161857.S001]; Wang M, PAIRING FRIENDLY ELL, DOI [10.1371/journal.pone.0161857.s002, DOI 10.1371/JOURNAL.PONE.0161857.S002]; Wang M, 2016, PLOS ONE, V11, P1, DOI DOI 10.1155/2015/827987; Yao Gavin Xiaoxu, 2012, Pairing-Based Cryptography - Pairing 2012. 5th International Conference. Revised Selected Papers, P160, DOI 10.1007/978-3-642-36334-4_10; Zavattoni E, 2015, IEEE T COMPUT, V64, P1429, DOI 10.1109/TC.2014.2329681; Zhang X, 2013, LECT NOTES COMPUTER, V8365, P131, DOI [10.1007/978-3-319-04873-4_8, DOI 10.1007/978-3-319-04873-4_8]	54	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212310	10.1371/journal.pone.0212310	http://dx.doi.org/10.1371/journal.pone.0212310			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779766	gold, Green Published, Green Submitted			2022-12-27	WOS:000459062900044
J	Elsayed, M; Torres, R; Sterkers, O; Bernardeschi, D; Nguyen, Y				Elsayed, Mohamed; Torres, Renato; Sterkers, Olivier; Bernardeschi, Daniele; Yann Nguyen			Pig as a large animal model for posterior fossa surgery in oto-neurosurgery: A cadaveric study	PLOS ONE			English	Article							TRAINING MODEL; TEMPORAL BONE; BRAIN; EAR	This study proposes a practical model for a new approach to the posterior fossa in common domestic pigs. Several surgical procedures can be simulated in the nonliving pig model, including soft tissue dissection, drilling of temporal bone, dural incision, access to the cerebellopontine angle, exposure of cranial nerves and drilling of the internal auditory canal. The pig model perfectly simulates standard otological and neurosurgical procedures, and we highlight the feasibility of our approach for further experiments in a living pig model with the possibility of reproducing the model for research on cranial nerves in pigs to study their electrophysiological behavior.	[Elsayed, Mohamed; Torres, Renato; Sterkers, Olivier; Bernardeschi, Daniele; Yann Nguyen] Sorbonne Univ, INSERM, Unite Rehabil Chirurg Miniinvas & Robotisee Audit, Paris, France; [Elsayed, Mohamed; Torres, Renato; Sterkers, Olivier; Bernardeschi, Daniele; Yann Nguyen] GHU Pitie Salpetriere, AP HP, Serv ORL Otol Implants Auditifs & Chirurg Base Cr, Paris, France; [Elsayed, Mohamed] Alexandria Univ, Fac Med, ORL Dept, Alexandria, Egypt	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Egyptian Knowledge Bank (EKB); Alexandria University	Elsayed, M (corresponding author), Sorbonne Univ, INSERM, Unite Rehabil Chirurg Miniinvas & Robotisee Audit, Paris, France.; Elsayed, M (corresponding author), GHU Pitie Salpetriere, AP HP, Serv ORL Otol Implants Auditifs & Chirurg Base Cr, Paris, France.; Elsayed, M (corresponding author), Alexandria Univ, Fac Med, ORL Dept, Alexandria, Egypt.	Mohamed.Elsayed@inserm.fr	Torres, Renato/AAU-5149-2020; ELSAYED, MOHAMED/AAG-6106-2020; Nguyen, Yann/AAX-5740-2020	Torres, Renato/0000-0001-6701-6793; ELSAYED, MOHAMED/0000-0001-8753-5152; Nguyen, Yann/0000-0003-4635-0658	Ministry of higher education, Mission sector, Egypt; Ministry of Scientific Research, Egypt	Ministry of higher education, Mission sector, Egypt(Ministry of Higher Education & Scientific Research (MHESR)); Ministry of Scientific Research, Egypt(Science and Technology Development Fund (STDF)Ministry of Higher Education & Scientific Research (MHESR))	This work was supported by the Ministry of higher education, Mission sector, Egypt (http://www.mohe-casm.edu.eg) and the Ministry of Scientific Research, Egypt to ME. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurich LA, 2014, ACTA CIR BRAS, V29, P405, DOI 10.1590/S0102-86502014000600010; Garcia LD, 2014, ACTA CIR BRAS, V29, P77, DOI 10.1590/S0102-86502014001700014; Gurr A, 2010, LARYNGO RHINO OTOL, V89, P17, DOI 10.1055/s-0029-1224158; Gurr A, 2010, EUR ARCH OTO-RHINO-L, V267, P213, DOI 10.1007/s00405-009-1040-6; Hamamcioglu MK, 2008, BRIT J NEUROSURG, V22, P769, DOI 10.1080/02688690802477573; Hicdonmez T, 2006, TURKISH NEUROSURG, V16, P111; Hoffstetter M, 2011, BIOMED TECH, V56, P159, DOI 10.1515/BMT.2011.011; Jarrahy R, 1999, J INVEST SURG, V12, P335; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; Lovell JM, 2007, J MICROSC-OXFORD, V228, P345, DOI 10.1111/j.1365-2818.2007.01852.x; Oertel J, 2016, NEUROMETHODS, V116, P151, DOI 10.1007/978-1-4939-3730-1_12; Regelsberger J, 2011, CENT EUR NEUROSURG, V72, P192, DOI 10.1055/s-0030-1261906; Regelsberger J, 2015, NEUROSURG REV, V38, P157, DOI 10.1007/s10143-014-0572-4; Sauleau P, 2009, ANIMAL, V3, P1138, DOI 10.1017/S1751731109004649; Singh V, 2017, J ANAT SOC INDIA, V66, P78, DOI 10.1016/j.jasi.2017.05.008; Suslu HT, 2013, BRIT J NEUROSURG, V27, P812, DOI 10.3109/02688697.2013.772095	16	1	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0212855	10.1371/journal.pone.0212855	http://dx.doi.org/10.1371/journal.pone.0212855			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807592	Green Submitted, Green Published, gold			2022-12-27	WOS:000459712100025
J	Tektas, OY; Kapsner, L; Lemmer, M; Bouna-Pyrrou, P; Lewczuk, P; Lenz, B; Kornhuber, J				Tektas, Ozan Yueksel; Kapsner, Lorenz; Lemmer, Miriam; Bouna-Pyrrou, Polyxeni; Lewczuk, Piotr; Lenz, Bernd; Kornhuber, Johannes			Digit ratio (2D:4D) and academic success as measured by achievement in the academic degree "Habilitation"	PLOS ONE			English	Article							FINGER LENGTH RATIO; GENDER-DIFFERENCES; SEX-DIFFERENCES; 2ND; WOMEN; TESTOSTERONE; METAANALYSIS; MATHEMATICS; MEN; PRODUCTIVITY	Introduction Prenatal androgen exposure has important organizing effects on brain development and therefore on future behavior. Previous research has shown, that the ratio between index finger (2D) and ring finger (4D) (2D: 4D) could function as a marker of prenatal androgen effects, with a relatively shorter 2D indicating a higher prenatal androgen exposure. 2D: 4D is associated with status-seeking and competitive behavior but also with altruism. Therefore, 2D: 4D should be related to academic success. Methods We examined the 2D: 4D of both hands, as well as the difference between both variables (Dr-l), of 209 university graduates (74 women) employed at the Medical Faculty of the Friedrich-Alexander-University Erlangen-Nurnberg, Germany, and we assessed the relationship of these variables with academic career performance. Career performance was measured by the number of publications as first or last author, and by achievement of an academic degree used in many European countries, the so-called "Habilitation". Results In a within-sex analysis we found a non-monotonic association between the right hand digit ratio and the probability of having a "Habilitation" in females. Academic success, measured by the number of publications as first or last author and the probability of a "Habilitation", increases with age. In agreement with the literature, we found higher academic success in men. Conclusion We found a non-monotonic relationship between right hand 2D: 4D and academic success in females. However, the significance of this relationship was weak.	[Tektas, Ozan Yueksel; Kapsner, Lorenz; Lemmer, Miriam; Bouna-Pyrrou, Polyxeni; Lewczuk, Piotr; Lenz, Bernd; Kornhuber, Johannes] Friedrich Alexander Univ Erlangen Nurnberg FAU, Dept Psychiat & Psychotherapy, Erlangen, Germany	University of Erlangen Nuremberg	Kornhuber, J (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg FAU, Dept Psychiat & Psychotherapy, Erlangen, Germany.	Johannes.kornhuber@uk-erlangen.de	; Kornhuber, Johannes/B-9613-2014	Kapsner, Lorenz A./0000-0003-1866-860X; Lenz, Bernd/0000-0001-6086-0924; Kornhuber, Johannes/0000-0002-8096-3987	University Hospital of the Friedrich-Alexander-University Erlangen-Nurnberg (FAU)	University Hospital of the Friedrich-Alexander-University Erlangen-Nurnberg (FAU)	Funding for this study was provided by intramural grants from the University Hospital of the Friedrich-Alexander-University Erlangen-Nurnberg (FAU). The funders had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.	ALLISON PD, 1982, AM SOCIOL REV, V47, P615, DOI 10.2307/2095162; [Anonymous], 2017, PSCL CLASSES METHODS; Bailey AA, 2005, BIOL PSYCHOL, V68, P215, DOI 10.1016/j.biopsycho.2004.05.001; Beasley TM, 2009, BEHAV GENET, V39, P580, DOI 10.1007/s10519-009-9281-0; Bian L, 2017, SCIENCE, V355, P389, DOI 10.1126/science.aah6524; Bliss CI, 1967, STAT BIOL; Branas-Garza P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060419; Breda T, 2016, SCIENCE, V353, P474, DOI 10.1126/science.aaf4372; Buser T, 2014, Q J ECON, V129, P1409, DOI 10.1093/qje/qju009; COLE JR, 1987, SCI AM, V256, P119, DOI 10.1038/scientificamerican0287-119; Edmunds LD, 2016, LANCET, V388, P2948, DOI 10.1016/S0140-6736(15)01091-0; Falk A, 2018, SCIENCE, V362, DOI 10.1126/science.aas9899; Falter CM, 2006, BIOL PSYCHOL, V73, P132, DOI 10.1016/j.biopsycho.2006.01.011; Falter CM, 2008, J AUTISM DEV DISORD, V38, P507, DOI 10.1007/s10803-007-0419-8; Fortunato S, 2018, SCIENCE, V359, DOI 10.1126/science.aao0185; Fox J., 2019, R COMPANION APPL REG, V.; Fox MF, 2005, SOC STUD SCI, V35, P131, DOI 10.1177/0306312705046630; Furnham A., 2006, IMAGINATION COGNITIO, V25, P119, DOI DOI 10.2190/530V-3M9U-7UQ8-FMBG; Galizzi MM, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00041; Gedrose B, 2012, DEUT MED WOCHENSCHR, V137, P1242, DOI 10.1055/s-0032-1304872; Gino F, 2015, P NATL ACAD SCI USA, V112, P12354, DOI 10.1073/pnas.1502567112; Grimbos T, 2010, BEHAV NEUROSCI, V124, P278, DOI 10.1037/a0018764; Hachmeister CD, 2012, EINSAM SPITZE UNTERR, P1; Halpern Diane F, 2007, Psychol Sci Public Interest, V8, P1, DOI 10.1111/j.1529-1006.2007.00032.x; Honekopp J, 2007, PSYCHONEUROENDOCRINO, V32, P313, DOI 10.1016/j.psyneuen.2007.01.007; Honekopp J, 2012, AUTISM RES, V5, P221, DOI 10.1002/aur.1230; Honekopp J, 2006, HORM BEHAV, V49, P545, DOI 10.1016/j.yhbeh.2005.11.006; Honekopp J, 2010, AM J HUM BIOL, V22, P619, DOI 10.1002/ajhb.21054; Honekopp J, 2010, PERS INDIV DIFFER, V48, P4, DOI 10.1016/j.paid.2009.08.009; Jagsi R, 2006, NEW ENGL J MED, V355, P281, DOI 10.1056/NEJMsa053910; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kornhuber J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079539; Kornhuber J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019332; KYVIK S, 1990, SOC STUD SCI, V20, P149, DOI 10.1177/030631290020001005; Lenz B, 2017, ACTA PSYCHIAT SCAND, V136, P96, DOI 10.1111/acps.12725; Lenz B, 2018, J NEURAL TRANSM, V125, P239, DOI 10.1007/s00702-017-1815-7; Lenz B, 2016, J NEURAL TRANSM, V123, P1499, DOI 10.1007/s00702-016-1608-4; Lenz B, 2012, PROG NEUROBIOL, V96, P136, DOI 10.1016/j.pneurobio.2011.11.001; Lilley T, 2010, PHYSIOL BEHAV, V99, P433, DOI 10.1016/j.physbeh.2009.11.015; Ludecke D., 2017, SJSTATS STAT FUNCTIO; Ludecke D, 2017, SJPLOT DATE VISUALIZ; Lutchmaya S, 2004, EARLY HUM DEV, V77, P23, DOI 10.1016/j.earlhumdev.2003.12.002; Machin S, 2008, SCIENCE, V322, P1331, DOI 10.1126/science.1162573; Manning JT, 2008, AM J HUM BIOL, V20, P451, DOI 10.1002/ajhb.20767; Manning JT, 2001, EVOL HUM BEHAV, V22, P61, DOI 10.1016/S1090-5138(00)00063-5; Millet K, 2006, BIOL PSYCHOL, V71, P111, DOI 10.1016/j.biopsycho.2005.06.001; Millet K, 2018, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00254; Millet K, 2009, P NATL ACAD SCI USA, V106, pE30, DOI 10.1073/pnas.0900396106; MULLER R, 1994, STAT MED, V13, P2465, DOI 10.1002/sim.4780132310; Nakhaie MR, 2002, CAN REV SOC ANTHROP, V39, P151; Nye JVC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046319; Pell AN, 1996, J ANIM SCI, V74, P2843; Revelle W., 2018, USE PSYCH PACKAGE FA; Sanchez A, 2014, LEARN INDIVID DIFFER, V36, P110, DOI 10.1016/j.lindif.2014.10.001; Schulthesis OC, 2018, MOTIV SCI; Shapiro C.A., 2011, NEW DIRECT I RES, V2011, DOI [DOI 10.1002/IR.404, https://doi.org/10.1002/ir.404]; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sinatra R, 2016, SCIENCE, V354, DOI 10.1126/science.aaf5239; Spelke ES, 2005, AM PSYCHOL, V60, P950, DOI 10.1037/0003-066X.60.9.950; Stack S, 2004, RES HIGH EDUC, V45, P891, DOI 10.1007/s11162-004-5953-z; Statistisches Bundesamt, 2017, FRAUEN STUD ABS PERS; Stoet G, 2018, PSYCHOL SCI, V29, P581, DOI 10.1177/0956797617741719; Su R, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00189; Sugimoto CR, 2013, NATURE, V504, P211, DOI 10.1038/504211a; Torchiano M., 2017, **DATA OBJECT**; van Arensbergen P, 2012, SCIENTOMETRICS, V93, P857, DOI 10.1007/s11192-012-0712-y; Warrington NM, 2018, HUM MOL GENET, V27, P2025, DOI 10.1093/hmg/ddy121; Williams WM, 2015, P NATL ACAD SCI USA, V112, P5360, DOI 10.1073/pnas.1418878112; Xu Y, 2015, AM J HUM BIOL, V27, P304, DOI 10.1002/ajhb.22639; Yeung LA, 2017, J INDIVID DIFFER, V38, P36, DOI 10.1027/1614-0001/a000220; Zeileis A., 2002, P NATL ACAD SCI USA, V2, P7, DOI [DOI 10.HTTPS://CRAN.R-PR0JECT.0RG/D0C/RNEWS/, DOI 10.1073/pnas.2022376118]; Zell E, 2015, AM PSYCHOL, V70, P10, DOI 10.1037/a0038208; Zuckerman H, 2001, WOMEN SCI TECHNOLOGY, P69	73	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2019	14	2							e0212167	10.1371/journal.pone.0212167	http://dx.doi.org/10.1371/journal.pone.0212167			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8EH	30802262	Green Submitted, gold, Green Published			2022-12-27	WOS:000459710700011
J	Dong, ZY				Dong, Zhengyang			Dynamic Advisor-Based Ensemble (dynABE): Case study in stock trend prediction of critical metal companies	PLOS ONE			English	Article							PRICE; RETURNS; MACHINE	Stock trend prediction is a challenging task due to the market's noise, and machine learning techniques have recently been successful in coping with this challenge. In this research, we create a novel framework for stock prediction, Dynamic Advisor-Based Ensemble (dynABE). dynABE explores domain-specific areas based on the companies of interest, diversifies the feature set by creating different "advisors" that each handles a different area, follows an effective model ensemble procedure for each advisor, and combines the advisors together in a second-level ensemble through an online update strategy we developed. dynABE is able to adapt to price pattern changes of the market during the active trading period robustly, without needing to retrain the entire model. We test dynABE on three cobalt-related companies, and it achieves the best-case misclassification error of 31.12% and an annualized absolute return of 359.55% with zero maximum drawdown. dynABE also consistently outperforms the baseline models of support vector machine, neural network, and random forest in all case studies.	[Dong, Zhengyang] Middlesex Sch, Concord, MA 01742 USA		Dong, ZY (corresponding author), Middlesex Sch, Concord, MA 01742 USA.	zdong@mxschool.edu	Chanelian, Serena/ABE-4873-2021	Chanelian, Serena/0000-0001-5727-6137; Dong, Zhengyang/0000-0001-6368-8103				ALLEN H, 1990, ECON J, V100, P49, DOI 10.2307/2234183; [Anonymous], 2018, EL COB SUM MET MIN C; Apodaca LE, 2014, 2014 MINERALS YB; Ballings M, 2015, EXPERT SYST APPL, V42, P7046, DOI 10.1016/j.eswa.2015.05.013; Bergstra J, 2012, J MACH LEARN RES, V13, P281; Berk RA, 2006, SOCIOL METHOD RES, V34, P263, DOI 10.1177/0049124105283119; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Chen YM, 2018, CIKM'18: PROCEEDINGS OF THE 27TH ACM INTERNATIONAL CONFERENCE ON INFORMATION AND KNOWLEDGE MANAGEMENT, P1655, DOI 10.1145/3269206.3269269; Das S., 2018, PROCEDIA COMPUTER SC, V132, P956, DOI [10.1016/j.procs.2018.05.111, DOI 10.1016/J.PROCS.2018.05.111]; Ding X, 2015, P 24 INT JOINT C ART, P7; FAMA EF, 1988, J FINANC ECON, V22, P3, DOI 10.1016/0304-405X(88)90020-7; Flannery MJ, 2002, REV FINANC STUD, V15, P751, DOI 10.1093/rfs/15.3.751; Fu XK, 2019, J IND ECOL, V23, P452, DOI 10.1111/jiec.12757; Golzadeh M, 2018, APPL SOFT COMPUT, V64, P109, DOI 10.1016/j.asoc.2017.12.013; Gunn G, 2014, CRITICAL METALS HDB, DOI [10.1016/S0065-3233(08)60135-7, DOI 10.1016/S0065-3233(08)60135-7]; Hagenau M, 2013, DECIS SUPPORT SYST, V55, P685, DOI 10.1016/j.dss.2013.02.006; Hastie T., 2009, SPRINGER SERIES STAT, DOI 10.1007/978-0-387-84858-7; He ZF, 2019, EMERG MARK FINANC TR, V55, P704, DOI 10.1080/1540496X.2018.1460724; Huang Y, 2017, EUR J OPER RES, V258, P692, DOI 10.1016/j.ejor.2016.08.058; Huang Y, 2014, DECIS SUPPORT SYST, V64, P31, DOI 10.1016/j.dss.2014.04.004; Investing News Network, 2018, INVESTING NEWS NETWO; Kononenko I., 1994, EUR C MACH LEARN, V784, P171, DOI DOI 10.1007/3-540-57868-4_57; Lee MC, 2009, EXPERT SYST APPL, V36, P10896, DOI 10.1016/j.eswa.2009.02.038; Levesque M, 2014, J CLEAN PROD, V84, P233, DOI 10.1016/j.jclepro.2013.12.088; Magdon-Ismail M, 2004, J APPL PROBAB, V41, P147, DOI 10.1239/jap/1077134674; Meyer  David, 2015, HIGH CORR CHIL PES C; Olivetti EA, 2017, JOULE, V1, P229, DOI 10.1016/j.joule.2017.08.019; OU JA, 1989, J ACCOUNT ECON, V11, P295, DOI 10.1016/0165-4101(89)90017-7; Patel J, 2015, EXPERT SYST APPL, V42, P259, DOI 10.1016/j.eswa.2014.07.040; PESARAN MH, 1994, J FORECASTING, V13, P335, DOI 10.1002/for.3980130402; Refinitiv, DAT MACR AN; Rice JA, 2007, NON TRADITIONAL REF; Robnik-Sikonja M., 1997, MACHINE LEARNING P 1, P296, DOI [10.5555/645526.657141, DOI 10.1119/1.880454]; Rodriguez JJ, 2006, IEEE T PATTERN ANAL, V28, P1619, DOI 10.1109/TPAMI.2006.211; Saad EW, 1998, IEEE T NEURAL NETWOR, V9, P1456, DOI 10.1109/72.728395; Schumaker RP, 2009, ACM T INFORM SYST, V27, DOI 10.1145/1462198.1462204; Sharpe W, J BUS, V39, P21; SHARPE WF, 1994, J PORTFOLIO MANAGE, V21, P49, DOI 10.3905/jpm.1994.409501; Spencer E, 2016, COB DEV I C MAY 11 S; Sumitomo Metal Mining Co.  Ltd, 2017, NON TRADITIONAL REF, P164; Sutton R. S., 1988, Machine Learning, V3, P9, DOI 10.1023/A:1022633531479; Tsai CF, 2010, DECIS SUPPORT SYST, V50, P258, DOI 10.1016/j.dss.2010.08.028; Tsang PM, 2007, ENG APPL ARTIF INTEL, V20, P453, DOI 10.1016/j.engappai.2006.10.002; Tufano P, 1998, J FINANC, V53, P1015, DOI 10.1111/0022-1082.00042; Xiao JH, 2018, ENERG ECON, V74, P777, DOI 10.1016/j.eneco.2018.07.026; Zijin Mining Group Co.  Ltd, 2018, COPPER	47	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212487	10.1371/journal.pone.0212487	http://dx.doi.org/10.1371/journal.pone.0212487			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794608	Green Published, gold, Green Submitted			2022-12-27	WOS:000459709100077
J	Lim, JA; Jung, KY; Park, B; Kim, TJ; Jun, JS; Kim, KT; Yang, TW; Lee, ST; Jung, KH; Chu, K; Lee, SK; Park, KI				Lim, Jung-Ah; Jung, Ki-Young; Park, Boram; Kim, Tae-Joon; Jun, Jin-Sun; Kim, Keun Tae; Yang, Tae-Won; Lee, Soon-Tae; Jung, Keun-Hwa; Chu, Kon; Lee, Sang Kun; Park, Kyung-Il			Impact of a selective cyclooxygenase-2 inhibitor, celecoxib, on cortical excitability and electrophysiological properties of the brain in healthy volunteers: A randomized, double-blind, placebo-controlled study	PLOS ONE			English	Article							SILENT PERIOD; RAT MODEL; SLEEP; STIMULATION; SEIZURES; EEG	The inflammatory response is considered a defence mechanism against physical or infectious insults and is prevalent within the central nervous system. Seizures also result in a robust inflammatory cascade, leading to enhanced activation of excitatory synaptic networks. Ample evidence based on animal models of epilepsy has demonstrated that celecoxib, a highly selective inhibitor of cyclooxygenase-2, has anticonvulsant effects. We aimed to evaluate the impact of celecoxib on the cortical excitability and electrophysiological properties of the brain in healthy humans. Electroencephalography (EEG) or transmagnetic stimulation (TMS) was used to measure neurophysiological activity. Forty healthy volunteers were randomized to 4 groups (n = 10 in each group): 1) celecoxib and EEG, 2) placebo and EEG, 3) celecoxib and TMS, and 4) placebo and TMS. For the EEG study, resting EEG was performed at baseline just before administering 400 mg of celecoxib or placebo and repeated 4 hours after administration. The subjects took 200 mg of celecoxib or placebo twice a day for 7 subsequent days, and a third EEG was conducted 4 hours after the final dose. Power spectra were compared at each time point. For the TMS study, the resting motor threshold (RMT), motor evoked potential (MEP) peak-to-peak amplitude, and cortical silent period (CSP) were measured at baseline and after taking 200 mg of celecoxib or placebo twice a day for 7 days. Celecoxib did not significantly change brain activity in the EEG study. However, the sum of power recorded from all electrodes tended to increase in the celecoxib group only at 4 hours after administration (p = 0.06). In detail, one dose of celecoxib (400 mg) transiently and significantly increased the alpha band power recorded in the frontal and parietal areas as well as in the whole brain (p = 0.049, 0.017, and 0.014, respectively) and the beta frequency in the central and parietal regions (p = 0.013 and 0.005, respectively), whereas the placebo did not. This effect was abolished after 7 days of treatment. In the TMS study, we found no statistically significant change in the RMT, MEP peak-to-peak amplitude or CSP. This evidence suggests that celecoxib transiently alters the electrophysiological properties of the brain but does not suppress neuronal excitability in healthy humans.	[Lim, Jung-Ah; Jung, Ki-Young; Kim, Tae-Joon; Jun, Jin-Sun; Lee, Soon-Tae; Jung, Keun-Hwa; Chu, Kon; Lee, Sang Kun; Park, Kyung-Il] Seoul Natl Univ Hosp, Biomed Res Inst, Comprehens Epilepsy Ctr, Dept Neurol,Lab Neurotherapeut, Seoul, South Korea; [Lim, Jung-Ah] Hallym Univ, Coll Med, Gangnam Sacred Heart Hosp, Dept Neurol, Seoul, South Korea; [Park, Boram] Seoul Natl Univ, Dept Publ Hlth Sci, Seoul, South Korea; [Kim, Tae-Joon] Ajou Univ, Sch Med, Dept Neurol, Suwon, South Korea; [Jun, Jin-Sun] Kyungpook Natl Univ, Chilgok Hosp, Sch Med, Dept Neurol, Daegu, South Korea; [Kim, Keun Tae] Keimyung Univ, Dongsan Med Ctr, Dept Neurol, Daegu, South Korea; [Yang, Tae-Won] Gyeongsang Natl Univ, Sch Med, Changwon Hosp, Dept Neurol, Chang Won, South Korea; [Park, Kyung-Il] Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Dept Neurol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Hallym University; Seoul National University (SNU); Ajou University; Kyungpook National University; Keimyung University; Gyeongsang National University; Seoul National University (SNU); Seoul National University Hospital	Jung, KY; Park, KI (corresponding author), Seoul Natl Univ Hosp, Biomed Res Inst, Comprehens Epilepsy Ctr, Dept Neurol,Lab Neurotherapeut, Seoul, South Korea.; Park, KI (corresponding author), Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Dept Neurol, Seoul, South Korea.	jungky10@gmail.com; ideopki@gmail.com		Lee, Soon-Tae/0000-0003-4767-7564; Park, Kyung-Il/0000-0001-8064-6749; Chu, Kon/0000-0001-5863-0302; Jung, Keun-Hwa/0000-0003-1433-8005	Pfizer Inc.	Pfizer Inc.(Pfizer)	This study was supported by Pfizer Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baik EJ, 1999, BRAIN RES, V843, P118, DOI 10.1016/S0006-8993(99)01797-7; Berardelli A, 1999, EXP BRAIN RES, V125, P82, DOI 10.1007/s002210050661; Berardelli A, 1998, EXP BRAIN RES, V122, P79, DOI 10.1007/s002210050493; Berdichevsky Y, 2016, ANN CLIN TRANSL NEUR, V3, P908, DOI 10.1002/acn3.364; Bertagnolli MM, 2006, NEW ENGL J MED, V355, P873, DOI 10.1056/NEJMoa061355; Fischborn SV, 2010, EPILEPSY RES, V91, P57, DOI 10.1016/j.eplepsyres.2010.06.012; Gobbo OL, 2004, NEUROSCIENCE, V125, P317, DOI 10.1016/j.neuroscience.2004.01.045; Gorter JA, 2006, J NEUROSCI, V26, P11083, DOI 10.1523/JNEUROSCI.2766-06.2006; Joo EY, 2008, CLIN NEUROPHYSIOL, V119, P1385, DOI 10.1016/j.clinph.2008.02.008; Jung KH, 2006, NEUROBIOL DIS, V23, P237, DOI 10.1016/j.nbd.2006.02.016; Jung KY, 2011, SLEEP MED, V12, P416, DOI 10.1016/j.sleep.2010.08.018; Krueger JM, 2003, BRAIN BEHAV IMMUN, V17, pS41; Krueger JM, 2001, ANN NY ACAD SCI, V933, P211; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Nguyen MD, 2002, NAT REV NEUROSCI, V3, P216, DOI 10.1038/nrn752; Romeo S, 2000, EXP BRAIN RES, V135, P504, DOI 10.1007/s002210000541; Salinsky MC, 2002, EPILEPSIA, V43, P482, DOI 10.1046/j.1528-1157.2002.22501.x; Salinsky TC, 2003, EPILEPSIA, V44, P1042, DOI 10.1046/j.1528-1157.2003.60602.x; Schlichtiger J, 2010, BRIT J PHARMACOL, V160, P1062, DOI 10.1111/j.1476-5381.2010.00765.x; Takemiya T, 2003, PROSTAG OTH LIPID M, V71, P205, DOI 10.1016/S1098-8823(03)00040-6; Terao A, 1998, J NEUROSCI, V18, P6599; Tergau F, 1999, EXP BRAIN RES, V124, P447, DOI 10.1007/s002210050640; Turrin NP, 2004, NEUROBIOL DIS, V16, P321, DOI 10.1016/j.nbd.2004.03.010; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; Voutsinos-Porche B, 2004, NEUROBIOL DIS, V17, P385, DOI 10.1016/j.nbd.2004.07.023; Zhang BJ, 2017, NEUROSCIENCE, V340, P258, DOI 10.1016/j.neuroscience.2016.09.053	26	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212689	10.1371/journal.pone.0212689	http://dx.doi.org/10.1371/journal.pone.0212689			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794658	Green Published, Green Submitted, gold			2022-12-27	WOS:000459709100116
J	Takasaki, Y; Irisawa, A; Shibukawa, G; Sato, A; Abe, Y; Yamabe, A; Arakawa, N; Maki, T; Yoshida, Y; Igarashi, R; Yamamoto, S; Ikeda, T				Takasaki, Yusuke; Irisawa, Atsushi; Shibukawa, Goro; Sato, Ai; Abe, Yoko; Yamabe, Akane; Arakawa, Noriyuki; Maki, Takumi; Yoshida, Yoshitsugu; Igarashi, Ryo; Yamamoto, Shogo; Ikeda, Tsunehiko			New endoscopic ultrasonography criteria for malignant lymphadenopathy based on inter-rater agreement	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; LYMPH-NODE METASTASIS; ENDOSONOGRAPHIC FEATURES; INTEROBSERVER AGREEMENT; ESOPHAGEAL CANCER; PANCREATIC-CANCER; EUS; ULTRASOUND; BENIGN; DIAGNOSIS	Background and aims Various studies have been previously conducted on the diagnosis of lymphadenopathy as benign or malignant, but the results vary. These studies did not describe the inter-rater agreement on the EUS features of lymphadenopathy. In this study, we evaluate the inter-rater agreement on EUS features and propose EUS diagnostic norms for lymphadenopathy based on inter-rater agreement. Method A total of 68 lymph nodes subjected to EUS-fine needle aspiration (FNA) were reviewed by five endoscopic experts. The EUS features evaluated lymph node size, shape, border, margin, echogenicity, homogeneity, and the hilum of the lymph node. Inter-rater agreement (multi-rater kappa statics) was performed. We established new criteria using results with a high degree of inter-rater agreement from EUS features and compared them with the former criteria. Result There was a moderate agreement on shape, kappa (K) = 0.44 (95% confidence interval [CI]: 0.34-0.54), and fair agreement on echogenicity, homogeneity, border, and hilum of the lymph node, K (95% CI) = 0.33 (0.17-0.38), 0.34 (0.26-0.35), 0.22 (0.21-0.31), and 0.22 (0.11-0.26), respectively. This resulted in the establishment of new EUS diagnostic criteria using shape, long axis > 20 mm and short axis > 10 mm. New criteria were superior to old criteria (area under the curve 0.82 vs 0.52, P < 0.001). Conclusion EUS diagnostic criteria for lymphadenopathy based on inter-rater agreement were more accurate than old criteria. This result will be useful for the diagnosis of lymphadenopathy.	[Takasaki, Yusuke; Irisawa, Atsushi; Shibukawa, Goro; Sato, Ai; Abe, Yoko; Yamabe, Akane; Arakawa, Noriyuki; Maki, Takumi; Yoshida, Yoshitsugu; Igarashi, Ryo; Yamamoto, Shogo; Ikeda, Tsunehiko] Fukushima Med Univ, Aizu Med Ctr, Dept Gastroenterol, Aizu Wakamatsu, Fukushima, Japan; [Takasaki, Yusuke] Juntendo Univ, Dept Gastroenterol, Tokyo, Japan; [Irisawa, Atsushi] Dokkyo Med Univ, Dept Gastroenterol, Mibu, Tochigi, Japan; [Abe, Yoko; Arakawa, Noriyuki] Sendai Kousei Hosp, Dept Gastroenterol, Sendai, Miyagi, Japan	Juntendo University; Dokkyo Medical University; Sendai Kousei Hospital	Irisawa, A (corresponding author), Fukushima Med Univ, Aizu Med Ctr, Dept Gastroenterol, Aizu Wakamatsu, Fukushima, Japan.; Irisawa, A (corresponding author), Dokkyo Med Univ, Dept Gastroenterol, Mibu, Tochigi, Japan.	irisawa@dokkyomed.ac.jp		Takasaki, Yusuke/0000-0002-5036-4545				Bhutani MS, 1997, GASTROINTEST ENDOSC, V45, P474, DOI 10.1016/S0016-5107(97)70176-7; CATALANO MF, 1994, GASTROINTEST ENDOSC, V40, P442, DOI 10.1016/S0016-5107(94)70206-3; Chen VK, 2004, AM J GASTROENTEROL, V99, P628, DOI 10.1111/j.1572-0241.2004.04064.x; Chin YK, 2017, WORLD J GASTROENTERO, V23, P5755, DOI 10.3748/wjg.v23.i31.5755; de Melo SW, 2011, DIGEST DIS SCI, V56, P3204, DOI 10.1007/s10620-011-1725-8; Eloubeidi MA, 2001, GASTROINTEST ENDOSC, V54, P714, DOI 10.1067/mge.2001.119873; Faigel DO, 2001, GASTROINTEST ENDOSC, V53, P593, DOI 10.1067/mge.2001.114060; GIOVANNINI M, 1995, ENDOSCOPY, V27, P171, DOI 10.1055/s-2007-1005657; Hocke M, 2008, J CANCER RES CLIN, V134, P473, DOI 10.1007/s00432-007-0309-7; Irisawa A, 2004, J GASTROEN HEPATOL, V19, P1199, DOI 10.1111/j.1440-1746.2004.03468.x; Kalmin B, 2011, CAN J GASTROENTEROL, V25, P261, DOI 10.1155/2011/302382; Kumon RE, 2012, GASTROINTEST ENDOSC, V75, P1175, DOI 10.1016/j.gie.2012.01.039; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Okasha H, 2017, ARAB J GASTROENTEROL, V18, P74, DOI 10.1016/j.ajg.2017.05.015; Thomas M, 2019, CLIN GASTROENTEROLOG, V17, P148; TOHNOSU N, 1989, J CLIN ULTRASOUND, V17, P101, DOI 10.1002/jcu.1870170206; Topazian M, 2007, GASTROINTEST ENDOSC, V66, P62, DOI 10.1016/j.gie.2006.09.018; Vazquez-Sequeiros E, 2006, GASTROINTEST ENDOSC, V63, P204, DOI 10.1016/j.gie.2005.08.053; Wang L, 2015, ANN THORAC SURG, V100, P1203, DOI 10.1016/j.athoracsur.2015.04.143; Zhang MM, 2010, GASTROINTEST ENDOSC, V72, P978, DOI 10.1016/j.gie.2010.06.042; Zhu ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063820	21	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212427	10.1371/journal.pone.0212427	http://dx.doi.org/10.1371/journal.pone.0212427			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794598	gold, Green Submitted, Green Published			2022-12-27	WOS:000459709100067
J	Trejo, CL; Babic, M; Imler, E; Gonzalez, M; Bibikov, SI; Shepard, PJ; VanSteenhouse, HC; Yeakley, JM; Seligmann, BE				Trejo, Christy L.; Babic, Milos; Imler, Elliot; Gonzalez, Migdalia; Bibikov, Sergei I.; Shepard, Peter J.; VanSteenhouse, Harper C.; Yeakley, Joanne M.; Seligmann, Bruce E.			Extraction-free whole transcriptome gene expression analysis of FFPE sections and histology-directed subareas of tissue	PLOS ONE			English	Article							FIXATION	We describe the use of a ligation-based targeted whole transcriptome expression profiling assay, TempO-Seq, to profile formalin-fixed paraffin-embedded (FFPE) tissue, including H& E stained FFPE tissue, by directly lysing tissue scraped from slides without extracting RNA or converting the RNA to cDNA. The correlation of measured gene expression changes in unfixed and fixed samples using blocks prepared from a pellet of a single cell type was R 2 = 0.97, demonstrating that no significant artifacts were introduced by fixation. Fixed and fresh samples prepared in an equivalent manner produced comparable sequencing depth results (+/-20%), with similar % CV (11.5 and 12.7%, respectively), indicating no significant loss of measurable RNA due to fixation. The sensitivity of the TempO-Seq assay was the same whether the tissue section was fixed or not. The assay performance was equivalent for human, mouse, or rat whole transcriptome. The results from 10 mm 2 and 2 mm 2 areas of tissue obtained from 5 mu m thick sections were equivalent, thus demonstrating high sensitivity and ability to profile focal areas of histology within a section. Replicate reproducibility of separate areas of tissue ranged from R-2 = 0.83 (lung) to 0.96 (liver) depending on the tissue type, with an average correlation of R-2 = 0.90 across nine tissue types. The average % CVs were 16.8% for genes expressed at greater than 200 counts, and 20.3% for genes greater than 50 counts. Tissue specific differences in gene expression were identified and agreed with the literature. There was negligible impact on assay performance using FFPE tissues that had been archived for up to 30 years. Similarly, there was negligible impact of H& E staining, facilitating accurate visualization for scraping and assay of small focal areas of specific histology within a section.	[Trejo, Christy L.; Babic, Milos; Imler, Elliot; Gonzalez, Migdalia; Bibikov, Sergei I.; Shepard, Peter J.; VanSteenhouse, Harper C.; Yeakley, Joanne M.; Seligmann, Bruce E.] BioSpyder Technol Inc, Carlsbad, CA 92008 USA		Seligmann, BE (corresponding author), BioSpyder Technol Inc, Carlsbad, CA 92008 USA.	bruceseligmann@biospyder.com		Babic, Milos/0000-0002-4040-0370; Trejo, Christy/0000-0001-5535-3725; VanSteenhouse, Harper/0000-0002-9401-5929	National Institute of Health National Cancer Institute [5R33CA183688-02]; National Institute of Environmental Health Sciences [1R43ES024107-01, 2R44ES24107-02]; NATIONAL CANCER INSTITUTE [R33CA183688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R44ES024107] Funding Source: NIH RePORTER	National Institute of Health National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding for the development of the FFPE TempO-Seq assay was made possible by National Institute of Health National Cancer Institute grants 5R33CA183688-02 (JMY), and National Institute of Environmental Health Sciences grants 1R43ES024107-01 (JMY) and 2R44ES24107-02 (BES). All authors are employees of BioSpyder Technologies, Inc., which has developed and is commercializing the TempO-Seq technology. The funders provided support in the form of salaries for the authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 2011, ILLUMINA WHITE PAPER; Castiglione F, 2007, APPL IMMUNOHISTO M M, V15, P338, DOI 10.1097/01.pai.0000213119.81343.7b; Chung JY, 2016, BIOTECHNIQUES, V60, P239, DOI 10.2144/000114415; Cronin M, 2004, AM J PATHOL, V164, P35, DOI 10.1016/S0002-9440(10)63093-3; Esteve-Codina A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170632; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Feldman AT, 2014, METHODS MOL BIOL, V1180, P31, DOI 10.1007/978-1-4939-1050-2_3; Grimm FA, 2018, ALTEX-ALTERN ANIM EX, V35, P441, DOI 10.14573/altex.1805301; Grimm FA, 2016, GREEN CHEM, V18, P4407, DOI 10.1039/c6gc01147k; Hedegaard J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098187; House JS, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00168; Itoh T, 2005, BIOCHEM BIOPH RES CO, V330, P832, DOI 10.1016/j.bbrc.2005.03.046; Kashofer K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070714; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Macabeo-Ong M, 2002, MODERN PATHOL, V15, P979, DOI 10.1097/01.MP.0000026054.62220.FC; Ripoli FL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050724; Rooney JP, 2017, TOXICOL SCI, V160, P15, DOI 10.1093/toxsci/kfx153; Su ZQ, 2014, NAT BIOTECHNOL, V32, P903, DOI 10.1038/nbt.2957; von Ahlfen S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001261; Wolff A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197162; Yeakley JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178302	23	14	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212031	10.1371/journal.pone.0212031	http://dx.doi.org/10.1371/journal.pone.0212031			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794557	Green Submitted, Green Published, gold			2022-12-27	WOS:000459709100034
J	Abou-El-Hassan, H; Massaad, E; Soudani, N; Assaf-Casals, A; Shaker, R; Khoury, ML; Ghanem, S; Karam, M; Andary, R; Saito, R; Dbaibo, G; Zaraket, H				Abou-El-Hassan, Hadi; Massaad, Elie; Soudani, Nadia; Assaf-Casals, Aia; Shaker, Rouba; Khoury, Mireille Lteif; Ghanem, Soha; Karam, Maria; Andary, Rabih; Saito, Reiko; Dbaibo, Ghassan; Zaraket, Hassan			Detection of ON1 and novel genotypes of human respiratory syncytial virus and emergence of palivizumab resistance in Lebanon	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; GENETIC-VARIABILITY; MONOCLONAL-ANTIBODY; YOUNG-CHILDREN; F-PROTEIN; FUSION; INFECTIONS; RISK; HOSPITALIZATION; GLYCOSYLATION	Respiratory syncytial virus (RSV) is a common cause of respiratory tract infections in children and immunocompromised individuals. A multi-center surveillance of the epidemiologic and molecular characteristics of RSV circulating in Lebanon was performed. The attachment (G) and fusion (F) glycoproteins were analyzed and compared to those reported regionally and globally. 16% (83/519) of the nasopharyngeal swabs collected during the 2016/17 season tested positive for RSV; 50% (27/54) were RSV-A and 50% (27/54) were RSV-B. Phylogenetic analysis of the G glycoprotein revealed predominance of the RSVA ON1 genotype, in addition to two novel Lebanese genotype variants, hereby named LBA1 and LBA2, which descended from the ON1 and NA2 RSV-A genotypes, respectively. RSV-B strains belonged to BA9 genotype except for one BA10. Deduced amino acid sequences depicted several unique substitutions, alteration of glycosylation patterns and the emergence of palivizumab resistance among the Lebanese viruses. The emergence of ON1 and other novel genotypes that are resistant to palivizumab highlights the importance of monitoring RSV globally.	[Abou-El-Hassan, Hadi; Massaad, Elie; Soudani, Nadia; Zaraket, Hassan] Amer Univ Beirut, Fac Med, Dept Expt Pathol Immunol & Microbiol, Beirut, Lebanon; [Abou-El-Hassan, Hadi; Massaad, Elie; Soudani, Nadia; Assaf-Casals, Aia; Shaker, Rouba; Khoury, Mireille Lteif; Dbaibo, Ghassan; Zaraket, Hassan] Amer Univ Beirut, Ctr Infect Dis Res, Beirut, Lebanon; [Soudani, Nadia] Lebanese Univ, EDST, Fac Sci, Dept Biol, Hadath, Lebanon; [Assaf-Casals, Aia; Shaker, Rouba; Khoury, Mireille Lteif; Dbaibo, Ghassan] Amer Univ Beirut, Med Ctr, Fac Med, Dept Pediat & Adolescent Med, Beirut, Lebanon; [Ghanem, Soha] Makassed Gen Hosp, Dept Pediat, Beirut, Lebanon; [Karam, Maria] Kiserwan Med Ctr, Jounieh, Lebanon; [Andary, Rabih] Al Jabal Hosp, Aley, Lebanon; [Saito, Reiko] Niigata Univ, Grad Sch Med & Dent Sci, Div Int Hlth Publ Hlth, Niigata, Japan; [Dbaibo, Ghassan] Amer Univ Beirut, Fac Med, Dept Biochem & Mol Genet, Beirut, Lebanon	American University of Beirut; American University of Beirut; Lebanese University; American University of Beirut; American University of Beirut; Niigata University; American University of Beirut	Zaraket, H (corresponding author), Amer Univ Beirut, Fac Med, Dept Expt Pathol Immunol & Microbiol, Beirut, Lebanon.; Zaraket, H (corresponding author), Amer Univ Beirut, Ctr Infect Dis Res, Beirut, Lebanon.	hz34@aub.edu.lb	Dbaibo, Ghassan S./X-2978-2019	Massaad, Elie/0000-0003-4883-914X	JSPS Core-to-core Program; Ministry of Education, Culture, Sports, Science and Technology (MEXT); Kakenhi from MEXT [18K10043]; Sanofi Pasteur	JSPS Core-to-core Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kakenhi from MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Sanofi Pasteur	This work was supported by JSPS Core-to-core Program, B. Asia-Africa Science Platforms sourced from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); Kakenhi (Grants-in-Aid for Scientific Research) from MEXT, grant number 18K10043. Collection of specimens was supported by a grant from Sanofi Pasteur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamir UB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074018; Adams O, 2010, CLIN INFECT DIS, V51, P185, DOI 10.1086/653534; Arnott A, 2011, J CLIN MICROBIOL, V49, P3504, DOI 10.1128/JCM.01131-11; Blanco JCG, 2018, HUM VACC IMMUNOTHER, V14, P1734, DOI 10.1080/21645515.2018.1472183; Brady MT, 2014, PEDIATRICS, V134, pE620, DOI [10.1542/peds.2014-1665, 10.1542/peds.2014-1666]; Choi EH, 2000, J INFECT DIS, V181, P1547, DOI 10.1086/315468; COLLINS PL, 1992, J GEN VIROL, V73, P849, DOI 10.1099/0022-1317-73-4-849; Crowe JE, 1998, VIROLOGY, V252, P373, DOI 10.1006/viro.1998.9462; Doms RW, 2000, J CELL BIOL, V151, pF9, DOI 10.1083/jcb.151.2.F9; Eshaghi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032807; Ezzeddine A, 2018, GENOME ANNOUNCEMENTS, V6, DOI 10.1128/genomeA.00316-18; Finianos M, 2016, J MED VIROL, V88, P1874, DOI 10.1002/jmv.24544; GarciaBeato R, 1996, VIROLOGY, V221, P301, DOI 10.1006/viro.1996.0379; Gaymard A, 2018, J CLIN VIROL, V102, P12, DOI 10.1016/j.jcv.2018.02.004; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Griffiths C, 2017, CLIN MICROBIOL REV, V30, P277, DOI 10.1128/CMR.00010-16; Gupta R., 2004, RESEARCHGATE; Haider MSH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193525; Haider MSH, 2018, INFECT GENET EVOL, V60, P140, DOI 10.1016/j.meegid.2018.02.010; Hall A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [citeulike-article-id:691774, DOI 10.1021/BK-1999-0734.CH008]; Hamze M., 2010, Eastern Mediterranean Health Journal, V16, P539; Hashimoto K, 2017, FUKUSHIMA J MED SCI, V63, P127, DOI 10.5387/fms.2017-09; Hibino A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192085; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LAMBERT DM, 1988, VIROLOGY, V164, P458, DOI 10.1016/0042-6822(88)90560-0; Laskowski RA, 2018, PROTEIN SCI, V27, P129, DOI 10.1002/pro.3289; McLellan JS, 2011, J VIROL, V85, P7788, DOI 10.1128/JVI.00555-11; Melero JA, 2017, VACCINE, V35, P461, DOI 10.1016/j.vaccine.2016.09.045; MUFSON MA, 1985, J GEN VIROL, V66, P2111, DOI 10.1099/0022-1317-66-10-2111; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Obando-Pacheco P, 2018, J INFECT DIS, V217, P1356, DOI 10.1093/infdis/jiy056; Okamoto M, 2018, J INFECT DIS, V218, P1045, DOI 10.1093/infdis/jiy256; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; PALOMO C, 1991, J GEN VIROL, V72, P669, DOI 10.1099/0022-1317-72-3-669; Papenburg J, 2012, EMERG INFECT DIS, V18, P120, DOI 10.3201/eid1801.110515; Riikonen R, 2019, ACTA PAEDIATR, V108, P124, DOI 10.1111/apa.14412; Sato M, 2005, J CLIN MICROBIOL, V43, P36, DOI 10.1128/JCM.43.1.36-40.2005; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Shi T, 2017, LANCET, V390, P946, DOI [10.1016/s0140-6736(17)30938-8, 10.1016/S0140-6736(17)30938-8]; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Tan L, 2013, J VIROL, V87, P8213, DOI 10.1128/JVI.03278-12; Trist S, 2018, J PAEDIATR CHILD H, V54, P1353, DOI 10.1111/jpc.14083; Venter M, 2001, J GEN VIROL, V82, P2117, DOI 10.1099/0022-1317-82-9-2117; Wong SK, 2018, EXPERT REV RESP MED, V12, P27, DOI 10.1080/17476348.2018.1401926; Yin HS, 2006, NATURE, V439, P38, DOI 10.1038/nature04322; Zhu Q, 2012, J INFECT DIS, V205, P635, DOI 10.1093/infdis/jir790; Zimmer G, 2001, J VIROL, V75, P4744, DOI 10.1128/JVI.75.10.4744-4751.2001	49	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212687	10.1371/journal.pone.0212687	http://dx.doi.org/10.1371/journal.pone.0212687			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789963	Green Published, Green Submitted, gold			2022-12-27	WOS:000459330800049
J	Choi, JE; Ma, SM; Park, H; Cho, YS; Hong, SH; Moon, IJ				Choi, Ji Eun; Ma, Sun Mi; Park, Heesung; Cho, Yang-Sun; Hong, Sung Hwa; Moon, Il Joon			A comparison between wireless CROS/BiCROS and soft-band BAHA for patients with unilateral hearing loss	PLOS ONE			English	Article							BONE-ANCHORED HEARING; INNER-EAR DEAFNESS; SPEECH-IN-NOISE; AIDS; HANDICAP; REHABILITATION; AMPLIFICATION; LOCALIZATION; RECEPTION; DEVICES	This study directly compared the performance of a contralateral routing of signal (CROS)/bilateral routing of signal (BiCROS) and a soft-band bone-anchored hearing aid (BAHA) in patients with unilateral sensorineural hearing loss (SNHL) and assessed the relationship between hearing aid benefits and personal factors. Participants with unilateral SNHL were prospectively enrolled in the study and were tested under the following three conditions: unaided, with CROS/BiCROS, and with soft-band BAHA. Sound localization, consonant, hearing in noise, and psychoacoustic tests were performed. Pseudobinaural benefits (e.g., squelch, summation, and head shadow effect) were obtained in both the CROS/BiCROS and soft-band BAHA conditions and compared to the unaided condition. Sound localization ability was not improved in either the CROS/BiCROS condition or soft-band BAHA condition. Rather, sound localization ability was significantly decreased in the CROS/BiCROS setting. A CROS/BiCROS hearing aid and a soft-band BAHA provided additional benefit for speech-in-noise perception when target speech was directed to the impaired ear side. The CROS/BiCROS hearing aid was superior to the soft-band BAHA one in decreasing the head shadow effect, but it appeared to have a negative effect when the noise was delivered to the better ear. The positive and negative effects of CROS/BiCROS for localization and speech perception were significantly correlated with personal factors such as age, hearing threshold in the better ear, and unaided psychoacoustic performances. Despite the lack of device acclimatization, we believe that this study provides counseling information for hearing aid clinics to use in the context of patients with unilateral SNHL.	[Choi, Ji Eun] Dankook Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Cheonan, South Korea; [Ma, Sun Mi; Park, Heesung] Samsung Med Ctr, Hearing Res Lab, Seoul, South Korea; [Cho, Yang-Sun; Moon, Il Joon] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Hong, Sung Hwa] Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea	Dankook University; Dankook University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Moon, IJ (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea.	moonij@skku.edu		MOON, IL JOON/0000-0002-3613-0734				Agterberg MJH, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00188; Augustine AM, 2013, INDIAN J OTOLARYNGOL, V65, P120, DOI 10.1007/s12070-012-0586-6; Baguley DM, 2006, CLIN OTOLARYNGOL, V31, P6, DOI 10.1111/j.1749-4486.2006.01137.x; Bosman AJ, 2003, ACTA OTO-LARYNGOL, V123, P258, DOI 10.1080/000164580310001105; Chiossoine-Kerdel JA, 2000, AM J OTOL, V21, P645; Cho S.-J., 2008, AUDIOLOGY SPEECH RES, V4, P28, DOI [10.21848/audiol.2008.4.1.28, DOI 10.21848/AUDIOL.2008.4.1.28]; Choi JE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171635; Finbow J, 2015, OTOL NEUROTOL, V36, P819, DOI 10.1097/MAO.0000000000000762; Flynn MC, 2011, ADV OTO-RHINO-LARYNG, V71, P112, DOI 10.1159/000323592; Hol MKS, 2005, OTOL NEUROTOL, V26, P999, DOI 10.1097/01.mao.0000185065.04834.95; Hol MKS, 2004, AUDIOL NEURO-OTOL, V9, P274, DOI 10.1159/000080227; Killion MC, 2004, J ACOUST SOC AM, V116, P2395, DOI 10.1121/1.1784440; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Lin LM, 2006, OTOL NEUROTOL, V27, P172, DOI 10.1097/01.mao.0000196421.30275.73; McDermott AL, 2002, J LARYNGOL OTOL, V116, P29, DOI 10.1258/0022215021911310; Moon SK, 2008, INT J AUDIOL, V47, P375, DOI 10.1080/14992020701882457; NILSSON M, 1994, J ACOUST SOC AM, V95, P1085, DOI 10.1121/1.408469; Niparko JK, 2003, OTOL NEUROTOL, V24, P73, DOI 10.1097/00129492-200301000-00015; Pedley AJ, 2017, HEARING RES, V353, P104, DOI 10.1016/j.heares.2017.06.007; Peters JPM, 2015, LARYNGOSCOPE, V125, P218, DOI 10.1002/lary.24865; Ryu NG, 2015, EUR ARCH OTO-RHINO-L, V272, P2213, DOI 10.1007/s00405-014-3133-0; Sadeghi AM, 2016, B-ENT, V12, P41; Sargent EW, 2001, OTOL NEUROTOL, V22, P480, DOI 10.1097/00129492-200107000-00012; Silverman CA, 2006, J AM ACAD AUDIOL, V17, P747, DOI 10.3766/jaaa.17.10.6; Snapp HA, 2017, OTOL NEUROTOL, V38, P11, DOI 10.1097/MAO.0000000000001269; Van Wanrooij MM, 2004, J NEUROSCI, V24, P4163, DOI 10.1523/JNEUROSCI.0048-04.2004; van Wieringen A, 2011, CLIN OTOLARYNGOL, V36, P114, DOI 10.1111/j.1749-4486.2011.02302.x; Wazen JJ, 2003, OTOLARYNG HEAD NECK, V129, P248, DOI 10.1016/S0194-5998(03)00527-8; Won JH, 2007, JARO-J ASSOC RES OTO, V8, P384, DOI 10.1007/s10162-007-0085-8; Won JH, 2011, J ACOUST SOC AM, V130, P376, DOI 10.1121/1.3592521	30	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212503	10.1371/journal.pone.0212503	http://dx.doi.org/10.1371/journal.pone.0212503			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789931	Green Published, gold, Green Submitted			2022-12-27	WOS:000459330800031
J	Kamoen, N; van de Pol, J; Krouwel, A; de Vreese, C; Holleman, B				Kamoen, Naomi; van de Pol, Jasper; Krouwel, Andre; de Vreese, Claes; Holleman, Bregje			Issue framing in online voting advice applications: The effect of left-wing and right-wing headers on reported attitudes	PLOS ONE			English	Article							POLITICAL-PARTIES; OPINION; STRATEGIES; QUESTIONS; IMPACT	Voting Advice Applications (VAAs) provide voting recommendations to millions of people. As these voting recommendations are based on users' answers to attitude questions, the framing of these questions can have far-reaching consequences. The current study reports on a field experiment in which the framing of the header above VAA statements (N = 17) was manipulated (condition 1: no header; condition 2: a right-wing header, e.g., finance; condition 3: a left-wing header, e.g., nature and environment). Visitors of a VAA developed for Utrecht, the fourth largest municipality in the Netherlands, were randomly guided to one of the versions of the tool in which the header type was varied. Results (based on N-respondents = 27,404) show that providing a header (left-wing or right-wing) leads to more left-wing answers as compared a condition where there is no header above the attitude statement. This effect, however, is only observed for respondents with lower levels of political sophistication.	[Kamoen, Naomi] Tilburg Univ, Dept Commun & Informat Sci, Tilburg, Netherlands; [van de Pol, Jasper; de Vreese, Claes] Univ Amsterdam, ASCoR, Amsterdam, Netherlands; [Krouwel, Andre] Vrije Univ Amsterdam, Dept Commun, Amsterdam, Netherlands; [Holleman, Bregje] Univ Utrecht, Utrecht Inst Linguist, Utrecht, Netherlands	Tilburg University; University of Amsterdam; Vrije Universiteit Amsterdam; Utrecht University	Kamoen, N (corresponding author), Tilburg Univ, Dept Commun & Informat Sci, Tilburg, Netherlands.	N.Kamoen@uvt.nl	Krouwel, Andre/D-3959-2016	Krouwel, Andre/0000-0003-0952-6028	Netherlands Organization for Scientific Research (NWO) [321-89-003]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	Our research is supported by the Netherlands Organization for Scientific Research (NWO), nwo.nl. Grant 321-89-003 to Bregje Holleman (BH). The funder provided support in the form of salaries for authors NK and JvdP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ` author contributions' section.	Alvarez RM, 2014, PARTY POLIT, V20, P227, DOI 10.1177/1354068813519960; Boix C, 1997, AM J POLIT SCI, V41, P814, DOI 10.2307/2111676; Boix C., 1998, POLITICAL PARTIES GR; Borah P, 2011, J COMMUN, V61, P246, DOI 10.1111/j.1460-2466.2011.01539.x; Cacciatore MA, 2016, MASS COMMUN SOC, V19, P7, DOI 10.1080/15205436.2015.1068811; Cacioppo J. T., 1981, COGNITIVE ASSESSMENT, P309; Cacioppo J.T., 2012, COMMUN PERSUATION; Chong D, 2007, J COMMUN, V57, P99, DOI 10.1111/j.1460-2466.2006.00331.x; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; De Graaf J., 2010, VOTING ADVICE APPL E, P35; de Vreese CH, 2012, AM BEHAV SCI, V56, P365, DOI 10.1177/0002764211426331; de Vreese CH, 2011, COMMUN RES, V38, P179, DOI 10.1177/0093650210384934; De Vries CE, 2013, POLIT SCI RES METH, V1, P223, DOI 10.1017/psrm.2013.4; Druckman JN, 2001, J POLIT, V63, P1041, DOI 10.1111/0022-3816.00100; ENTMAN RM, 1993, J COMMUN, V43, P51, DOI 10.1111/j.1460-2466.1993.tb01304.x; FISKE ST, 1983, J EXP SOC PSYCHOL, V19, P381, DOI 10.1016/0022-1031(83)90029-X; Gamson W., 1987, RES POLITICAL SOCIOL, P137, DOI DOI 10.1111/1468-4446.12003; Garzia D, 2014, MATCHING VOTERS PART, P227; Holleman B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164184; Iversen Torben, 1999, CONTESTED EC I; KAHNEMAN D, 1984, AM PSYCHOL, V39, P341, DOI 10.1037/0003-066X.39.4.341; Kamoen N, 2017, PUBLIC OPIN QUART, V81, P613, DOI 10.1093/poq/nfx010; KINDER DR, 1990, SOC COGNITION, V8, P73, DOI 10.1521/soco.1990.8.1.73; Kleinnijenhuis J, 2019, PARTY POLIT, V25, P291, DOI 10.1177/1354068817713121; KROSNICK JA, 1988, J PERS SOC PSYCHOL, V54, P940, DOI 10.1037/0022-3514.54.6.940; KROSNICK JA, 1991, APPL COGNITIVE PSYCH, V5, P213, DOI 10.1002/acp.2350050305; Krouwel Andre, 2012, International Journal of Electronic Governance, V5, P223; Lachat R, 2008, ELECT STUD, V27, P687, DOI 10.1016/j.electstud.2008.06.002; Lecheler S, 2012, J MASS COMMUN Q, V89, P185, DOI 10.1177/1077699011430064; Lecheler S, 2013, COMMUN RES, V40, P147, DOI 10.1177/0093650212470688; Lecheler S, 2009, COMMUN RES, V36, P400, DOI 10.1177/0093650209333028; Leeper ThomasJ, 2018, CAN CITIZENS BE FRAM; Marks G, 2002, AM J POLIT SCI, V46, P585, DOI 10.2307/3088401; Marschall S, VOTING ADVICE APPL C; Matthes J, 2007, COMMUNICATIONS-GER, V32, P51, DOI 10.1515/COMMUN.2007.003; Narayan S, 1996, PUBLIC OPIN QUART, V60, P58, DOI 10.1086/297739; Nelson TE, 1997, AM POLIT SCI REV, V91, P567, DOI 10.2307/2952075; Petty R. E., 2014, ATTITUDE STRENGTH AN; Petty R.E., 1986, ADV EXP SOC PSYCHOL, DOI DOI 10.1016/S0065-2601(08)60214-2; Quene H, 2004, SPEECH COMMUN, V43, P103, DOI [10.1016/j.specom.2004.02.004, 10.1016/j.specom 2004.02.004]; Quene H, 2008, J MEM LANG, V59, P413, DOI 10.1016/j.jml.2008.02.002; Rabin M, 1998, J ECON LIT, V36, P11; Scheufele D.A., 2012, OXFORD HDB POLITICAL, P1, DOI [10.1093/oxfordhb/9780199793471, DOI 10.1093/OXFORDHB/9780199793471.013.47]; Scheufele DA, 1999, J COMMUN, V49, P103, DOI 10.1111/j.1460-2466.1999.tb02784.x; Scheufele DA, 2017, OXFORD HDB POLITICAL; Schuck ART., 2006, EUROPEAN J COMMUNICA, V55, P795; Schuldt JP, 2011, PUBLIC OPIN QUART, V75, P115, DOI 10.1093/poq/nfq073; Sniderman P.M, 2004, STUDIES PUBLIC OPINI, P133, DOI DOI 10.1515/9780691188386-007; Stroh P., 1990, POLITICAL BEHAV, V12, P41, DOI DOI 10.1007/BF00992331; Thomassen J., 2005, EUROPEAN VOTER COMP, p167?191, DOI [10.1093/0199273219.001.0001, DOI 10.1093/0199273219.001.0001]; Van Camp K., 2014, MATCHING VOTERS PART, P11; Walgrave S, 2012, PUBLIC OPIN QUART, V76, P771, DOI 10.1093/poq/nfs023; Wall M, 2014, PARTY POLIT, V20, P416, DOI 10.1177/1354068811436054; Zaller J. R., 1992, NATURE ORIGINS MASS, DOI DOI 10.1017/CBO9780511818691	54	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212555	10.1371/journal.pone.0212555	http://dx.doi.org/10.1371/journal.pone.0212555			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM2WC	30789949	Green Published, gold, Green Submitted			2022-12-27	WOS:000459330800039
J	Marshall, N; Marshall, P; Curnock, M; Pert, P; Smith, A; Visperas, B				Marshall, Nadine; Marshall, Paul; Curnock, Matt; Pert, Petina; Smith, Adam; Visperas, Bernard			Identifying indicators of aesthetics in the Great Barrier Reef for the purposes of management	PLOS ONE			English	Article							NATURAL-RESOURCE MANAGEMENT; WATER APPEARANCE; HUMAN PERCEPTION; LANDSCAPE; HEALTH; PLACE; COLOR; CONSERVATION; EXPERIENCE; TOURISTS	The aesthetic appreciation of natural places is one of the most fundamental ways in which people relate to their environment. It provides wellbeing, an opportunity for recreation and reflection, a sense of place, and cultural enrichment. It also motivates people to take care of natural places and to conserve them for current and future appreciation. Aesthetically valuable places also support significant economic activity. However, there is little guidance available to assist environmental managers and policy-makers to consider and integrate aesthetic values into decision-making processes. In this study, we present an approach for developing robust and practical indicators of aesthetic value to enable environmental managers to consider, assess and report on aesthetic condition and trend. We demonstrate its utility using the case of the Great Barrier Reef, a region currently undergoing significant social, economic and environmental change and an area formally protected, in part, for its aesthetic values. A qualitative scoping study with 30 key informants identified over 180 potential qualities contributing to reef aesthetics. We tested five for their utility in capturing key aspects of the coral reef aesthetic: (i) coral cover, (ii) coral pattern, (iii) coral topography, (iv) fish abundance, and (v) visibility. We asked 1,417 online Australians to aesthetically rate 50 out of 181 underwater coral reef images that varied in relation to these five attributes. Coral topography, fish abundance, and visibility were significantly correlated with aesthetic ratings, whilst coral cover and coral pattern were not. We also tested for demographic patterns in aesthetic ratings. Our pilot study has demonstrated that readily measurable characteristics of coral reefs can provide useful indicators of aesthetic quality, opening up opportunities for coral reef managers and policymakers to assess and track changes in aesthetics in ways that are relevant to the public. There is considerable scope to further advance capacity for monitoring and managing aesthetic values of coral reefs through additional research that resolves nuances in the meanings associated with aesthetics in coral reef settings.	[Marshall, Nadine; Curnock, Matt; Pert, Petina] CSIRO Land & Water Oceans & Atmosphere, Townsville, Qld, Australia; [Marshall, Paul; Smith, Adam] Ecologic, Townsville, Qld, Australia; [Visperas, Bernard] Pollinate, Sydney, NSW, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Marshall, N (corresponding author), CSIRO Land & Water Oceans & Atmosphere, Townsville, Qld, Australia.	nadine.marshall@csiro.au	Pert, Petina Lesley/F-5211-2010; Curnock, Matthew I/I-2578-2013	Pert, Petina Lesley/0000-0002-7738-7691; Curnock, Matthew I/0000-0002-2365-810X	National Environmental Science Program (Australia)	National Environmental Science Program (Australia)	This research was funded by the National Environmental Science Program (Australia) to NM, PM and AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Please note that one of the authors is employed by a commercial company: Pollinate. Pollinate did not provide any financial support (just collegial).	Arriaza M, 2004, LANDSCAPE URBAN PLAN, V69, P115, DOI 10.1016/j.landurbplan.2003.10.029; Balmford A, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000144; Bauske EM, 2013, ACTA HORTIC, V999, P37, DOI 10.17660/ActaHortic.2013.999.3; Bengston DN, 1999, SOC NATUR RESOUR, V12, P493, DOI 10.1080/089419299279560; Birkoff G, 1933, AESTHETIC MEASURE; Brady E, 2006, ENVIRON VALUE, V15, P277, DOI 10.3197/096327106778226202; Bratman GN, 2015, LANDSCAPE URBAN PLAN, V138, P41, DOI 10.1016/j.landurbplan.2015.02.005; Brown G, 2007, APPL GEOGR, V27, P89, DOI 10.1016/j.apgeog.2006.11.002; Carson Rachel, 1994, SILENT SPRING; Coss RG, 2002, ECOL PSYCHOL, V14, P181, DOI 10.1207/S15326969ECO1404_1; Datta R, 2006, LECT NOTES COMPUT SC, V3953, P288, DOI 10.1007/11744078_23; de Vries S, 2013, SOC SCI MED, V94, P26, DOI 10.1016/j.socscimed.2013.06.030; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Deloitte Access Economics, 2017, WHAT PRIC EC SOC IC; Dinsdale EA, 2006, SOC NATUR RESOUR, V19, P239, DOI 10.1080/08941920500460815; Farr M, 2016, TOURISM ECON, V22, P331, DOI 10.5367/te.2014.0426; FENTON DM, 1989, COAST MANAGE, V17, P295, DOI 10.1080/08920758909362092; Fenton DM, 1998, LEISURE SCI, V20, P177, DOI 10.1080/01490409809512279; Folke C, 2011, AMBIO, V40, P719, DOI 10.1007/s13280-011-0184-y; Fry G, 2009, ECOL INDIC, V9, P933, DOI 10.1016/j.ecolind.2008.11.008; Fuller RA, 2007, BIOLOGY LETT, V3, P390, DOI 10.1098/rsbl.2007.0149; Ghermandi A, 2011, TREATISE ON ESTUARINE AND COASTAL SCIENCE, VOL 12: ECOLOGICAL ECONOMICS OF ESTUARIES AND COASTS, P217; Haas AF, 2015, PEERJ, V3, DOI 10.7717/peerj.1390; HARTIG T, 1991, ENVIRON BEHAV, V23, P3, DOI 10.1177/0013916591231001; Hekkert P, 2003, BRIT J PSYCHOL, V94, P111, DOI 10.1348/000712603762842147; Herzog T. R., 1985, J ENVIRON PSYCHOL, V5, P225, DOI [10.1016/S0272-4944(85)80024-4, DOI 10.1016/S0272-4944(85)80024-4]; Hinds J., 2011, EVOLUTIONARY PSYCHOL, V9, DOI [10.1177/147470491100900314, DOI 10.1177/147470491100900314]; Hughes TP, 2007, TRENDS ECOL EVOL, V22, P1, DOI 10.1016/j.tree.2006.10.009; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jarvis D, 2016, TOURISM MANAGE, V52, P1, DOI 10.1016/j.tourman.2015.06.003; Jones PJ, 2016, LAND USE POLICY, V53, P112, DOI 10.1016/j.landusepol.2015.01.038; Kellert SR, 2016, GREEN EXERCISE: LINKING NATURE, HEALTH AND WELL-BEING, P17; Kirillova K, 2014, TOURISM MANAGE, V42, P282, DOI 10.1016/j.tourman.2013.12.006; Larson S, 2015, AMBIO, V44, P166, DOI 10.1007/s13280-014-0554-3; Larson S, 2013, J ENVIRON MANAGE, V117, P226, DOI 10.1016/j.jenvman.2012.11.035; Lee LH, 2017, WETLANDS, V37, P381, DOI 10.1007/s13157-016-0873-1; Lee LeeHsueh, 2016, Journal of Water Resource and Protection, V8, P787; Lee Z, 2016, REMOTE SENS ENVIRON, V177, P101, DOI 10.1016/j.rse.2016.02.033; Lohr VI, 2006, ENVIRON BEHAV, V38, P667, DOI 10.1177/0013916506287355; Ltd CP, 2013, DEF AESTH VAL GREAT; Marselle MR, 2015, INT J ENV RES PUB HE, V12, P106, DOI 10.3390/ijerph120100106; Marshall NA, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/11/114020; Marshall NA, 2018, FRONT ECOL ENV; Maslow AH, 1943, PSYCHOL REV, V50, P370, DOI 10.1037/h0054346; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Nava H, 2011, REV BIOL TROP, V59, P1487; Palmer SE, 2010, P NATL ACAD SCI USA, V107, P8877, DOI 10.1073/pnas.0906172107; Pfluger Y, 2010, LANDSCAPE URBAN PLAN, V95, P68, DOI 10.1016/j.landurbplan.2009.12.004; Richling A, 1995, EKOL BRATISLAVA, V14, P11; Rosley MSF, 2014, PROCD SOC BEHV, V153, P349, DOI 10.1016/j.sbspro.2014.10.068; Rosley MSF, 2013, PROCD SOC BEHV, V85, P318, DOI 10.1016/j.sbspro.2013.08.362; Roughley A, 2005, J RES PRACT, V1; Seppelt R, 2011, J APPL ECOL, V48, P630, DOI 10.1111/j.1365-2664.2010.01952.x; Seresinhe CI, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170170; Seresinhe CI, 2015, SCI REP-UK, V5, DOI 10.1038/srep16899; SMITH DG, 1995, NEW ZEAL J MAR FRESH, V29, P45, DOI 10.1080/00288330.1995.9516638; SMITH DG, 1995, NEW ZEAL J MAR FRESH, V29, P29, DOI 10.1080/00288330.1995.9516637; Sonntag-Ostrom E, 2011, SCAND J FOREST RES, V26, P245, DOI 10.1080/02827581.2011.558521; Spalding M, 2017, MAR POLICY, V82, P104, DOI 10.1016/j.marpol.2017.05.014; Stamps AE, 2004, J ENVIRON PSYCHOL, V24, P1, DOI 10.1016/S0272-4944(03)00023-9; Tribot AS, 2016, SCI REP-UK, V6, DOI 10.1038/srep34229; Tveit M, 2006, LANDSCAPE RES, V31, P229, DOI 10.1080/01426390600783269; ULRICH RS, 1990, PROCEEDINGS OF THE FOURTH URBAN FORESTRY CONFERENCE, P25; UNESCO, UN C SUST DEV RIO DE; van den Berg AE, 1998, J ENVIRON PSYCHOL, V18, P141, DOI 10.1006/jevp.1998.0080; Volker S, 2013, SOC SCI MED, V78, P113, DOI 10.1016/j.socscimed.2012.09.047; White MP, 2013, HEALTH PLACE, V23, P97, DOI 10.1016/j.healthplace.2013.05.006; Wynveen CJ, 2010, LEISURE SCI, V32, P270, DOI 10.1080/01490401003712705; Yamashita S, 2002, LANDSCAPE URBAN PLAN, V62, P3, DOI 10.1016/S0169-2046(02)00093-2; Zhang JW, 2014, J ENVIRON PSYCHOL, V37, P61, DOI 10.1016/j.jenvp.2013.11.008; Zhang MWB, 2014, JMIR MHEALTH UHEALTH, V2, DOI 10.2196/mhealth.2827	71	12	14	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0210196	10.1371/journal.pone.0210196	http://dx.doi.org/10.1371/journal.pone.0210196			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM2OT	30785877	Green Submitted, Green Published, gold			2022-12-27	WOS:000459307000011
J	Wagnew, F; Dejenu, G; Eshetie, S; Alebel, A; Worku, W; Abajobir, AA				Wagnew, Fasil; Dejenu, Getiye; Eshetie, Setegn; Alebel, Animut; Worku, Wubet; Abajobir, Amanuel Alemu			Treatment cure rate and its predictors among children with severe acute malnutrition in northwest Ethiopia: A retrospective record review	PLOS ONE			English	Review							MANAGEMENT	Background More than 29 million that is an estimated 5%, under-five children suffer from severe acute malnutrition (SAM) globally, with a nine times higher risk of mortality than that of well-nourished children. However, little is known regarding outcomes and predictors of SAM in Ethiopia. Therefore, this study aims to determine treatment cure rate and its predictors among children aged 6-59 months with SAM admitted to a stabilization center. Methodology A retrospective record review was employed in SAM children at the University of Gondar Comprehensive Specialized Hospital (UOGCSH) from 2014 to 2016. SAM defined as weight for height below-3 z scores of the median World Health Organization (WHO) growth standards or presence of bilateral edema or mid upper arm circumference < 115mm for a child >= 6months age. All SAM patients with medical complication(s) or failure to pass appetite test are admitted to the malnutrition treatment center for inpatient follow-up. Data were extracted from a randomly selected records after getting ethical clearance. Data were cleaned, coded and entered to Epi-info version-7, and analyzed using STATA/se version-14. Descriptive statistics and analytic analyses schemes including bivariable and multivariable Cox proportional hazards model were conducted. Result Among a total of 416 records recruited for this study, 288 (69.2%) SAM children were cured at the end of the follow up, with a median cure time of 11 days. Kwash-dermatosis (AHR (Adjusted Hazard Ratio): 1.48(95% CI: 1.01, 2.16)), anemia (AHR: 1.36(95% CI: 1.07, 1.74)), tuberculosis (AHR: 1.6(95% CI: 1.04, 2.43)) and altered body temperature at admission (AHR: 1.58(95% CI: 1.04, 2.4) were independent predictors of time to cure. Conclusion The cure rate in SAM children was low relative to sphere standard guideline. Prognosis of SAM largely depends on the presence of other comorbidities at admission. Available intervention modalities need to address coexisting morbidities to achieve better outcomes in SAM children.	[Wagnew, Fasil; Dejenu, Getiye; Alebel, Animut] Debre Markos Univ, Coll Hlth Sci, Debre Markos, Ethiopia; [Eshetie, Setegn; Worku, Wubet] Univ Gondar, Coll Hlth Sci, Gondar, Ethiopia; [Abajobir, Amanuel Alemu] Univ Queensland, Fac Med, Brisbane, Qld, Australia	University of Gondar; University of Queensland	Wagnew, F (corresponding author), Debre Markos Univ, Coll Hlth Sci, Debre Markos, Ethiopia.	fasilw.n@gmail.com	Alebel, Animut/L-4278-2019; Kibret, Getiye Dejenu/ACX-4494-2022; Ayalew, Animut Alebel/U-6092-2019; Eshetie, Setegn/AAF-5419-2020	Alebel, Animut/0000-0003-2822-2062; Kibret, Getiye Dejenu/0000-0002-1374-5744; Eshetie, Setegn/0000-0001-9130-0882; Wagnew, Fasil/0000-0003-3087-2312				[Anonymous], 2014, FEDERAL MINISTRY HLT; [Anonymous], 2011, SPHERE PROJECT HUMAN; Asres DT, 2018, BMC NUTR, V4, DOI 10.1186/s40795-018-0224-0; Bank UW, 2012, LEV TRENDS CHILD MAL; Chamois S, 2007, ETHIOPIA PROTOCOL MA; Collins S, 2006, LANCET, V368, P1992, DOI 10.1016/S0140-6736(06)69443-9; Collins S, 2006, FOOD NUTR BULL, V27, pS49, DOI 10.1177/15648265060273S304; Demissie S., 2013, SCI J PUBLIC HLTH, V1, P175, DOI [10.11648/j.sjph.20130104.12, DOI 10.11648/J.SJPH.20130104.12]; Deolalikar A., 2008, MALNUTRITION HUNGER; Desta K, 2015, J NUTR DISORDERS THE, V5, P2161; Desta K., 2015, J NUTR DISORD THER, V5, P160, DOI DOI 10.4172/2161-0509.1000160; Desyibelew HD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171020; Firehiwot M, 2016, SURVIVAL STATUS PRED; Fuchs G, 2004, J PEDIATR GASTR NUTR, V39, pS670, DOI 10.1097/00005176-200406002-00014; Gathara D, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0850-8; Gebremichael DY, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2593-5; Girum T, 2017, THER CLIN RISK MANAG, V13, P101, DOI 10.2147/TCRM.S119826; GOLDEN M, 1988, T ROY SOC TROP MED H, V82, P3, DOI 10.1016/0035-9203(88)90245-3; Golden MH GY, 2011, GUIDELINES INTEGRATE; Jarso H, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0398-4; Mekuria Getnet, 2017, BMC Nutr, V3, P42, DOI 10.1186/s40795-017-0161-3; Melaku G, 2014, OPEN ACCESS LIB J, V1, P1, DOI DOI 10.4236/OALIB.1100446; Munthali T, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0072-1; Saaka M, 2015, J NUTR METAB, V2015, DOI 10.1155/2015/641784; Tadele Girum Adal MK, 2016, J BIOL AGR HEALTHCAR, V6; Tadesse E, 2017, SURVIVAL STATUS ITS; Tefera Chane, 2014, Journal of Nutrition and Food Sciences, V4, P329; Teferi E., 2010, ETHIOP J HEALTH DEV, V24, P3; UNICEF, 2017, ESS NUTR TREATM 5 CH; Unicef, 2013, IMPR CHILD NUTR ACH; UNICEF G MOH, 2011, GHAN MULT IND CLUST; UNICEF WaWBG, 2012, LEV TRENDS CHILD MAL; WHO, 2013, GUID UPD MAN SEV AC, P6; WHO, 2013, GUID UPD MAN SEV AC; World Health Organization, 1999, MAN SEV MALN MAN PHY; World Health Organization, 2013, POCK BOOK HOSP CAR C; Yebyo HG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065840	37	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211628	10.1371/journal.pone.0211628	http://dx.doi.org/10.1371/journal.pone.0211628			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785917	Green Submitted, Green Published, gold			2022-12-27	WOS:000459307000032
J	Stavropoulou, C; Somai, M; Ioannidis, JPA				Stavropoulou, Charitini; Somai, Melek; Ioannidis, John P. A.			Most UK scientists who publish extremely highly-cited papers do not secure funding from major public and charity funders: A descriptive analysis	PLOS ONE			English	Article							HEALTH	The UK is one of the largest funders of health research in the world, but little is known about how health funding is spent. Our study explores whether major UK public and charitable health research funders support the research of UK-based scientists producing the most highly-cited research. To address this question, we searched for UK-based authors of peer-reviewed papers that were published between January 2006 and February 2018 and received over 1000 citations in Scopus. We explored whether these authors have held a grant from the National Institute for Health Research (NIHR), the Medical Research Council (MRC) and the Wellcome Trust and compared the results with UK-based researchers who serve currently on the boards of these bodies. From the 1,370 papers relevant to medical, biomedical, life and health sciences with more than 1000 citations in the period examined, we identified 223 individuals from a UK institution at the time of publication who were either first/last or single authors. Of those, 164 are still in UK academic institutions, while 59 are not currently in UK academia (have left the country, are retired, or work in other sectors). Of the 164 individuals, only 59 (36%; 95% CI: 29-43%) currently hold an active grant from one of the three funders. Only 79 (48%; 95% CI: 41-56%) have held an active grant from any of the three funders between 2006-2017. Conversely, 457 of the 664 board members of MRC, Wellcome Trust, and NIHR (69%; 95% CI: 65-72%) have held an active grant in the same period by any of these funders. Only 7 out of 655 board members (1.1%) were first, last or single authors of an extremely highly-cited paper. There are many reasons why the majority of the most influential UK authors do not hold a grant from the country's major public and charitable funding bodies. Nevertheless, the results are worrisome and subscribe to similar patterns shown in the US. We discuss possible implications and suggest ways forward.	[Stavropoulou, Charitini] City Univ London, Sch Hlth Sci, London, England; [Somai, Melek] Imperial Coll London, Sch Publ Hlth, Fac Med, London, England; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Humanities & Sci, Dept Stat, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Meta Res Innovat Ctr Stanford METRICS, Stanford, CA 94305 USA	City University London; Imperial College London; Stanford University; Stanford University; Stanford University; Stanford University	Stavropoulou, C (corresponding author), City Univ London, Sch Hlth Sci, London, England.	C.Stavropoulou@city.ac.uk	Ioannidis, John P. A./G-9836-2011	Stavropoulou, Charitini/0000-0003-4307-1848; Somai, Melek/0000-0002-2692-9681; Ioannidis, John P./0000-0003-3118-6859				Bol T, 2018, P NATL ACAD SCI US; Canadian Institutes of Health Research, 2012, EV OP OP GRANT PROGR; Cooksey D., 2006, REV UK HLTH RES FUND; Costas R, 2007, J INFORMETR, V1, P193, DOI 10.1016/j.joi.2007.02.001; Gresham GK, 2018, CLIN TRIALS, V15, P65, DOI 10.1177/1740774517727742; Guthrie Susan, 2017, F1000Res, V6, P1335, DOI 10.12688/f1000research.11917.2; Herbert DL, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002800; Ioannidis JPA, 2018, CIRC-CARDIOVASC QUAL, V11, DOI 10.1161/CIRCOUTCOMES.118.004889; Ioannidis JPA, 2018, NATURE, V561, P167, DOI 10.1038/d41586-018-06185-8; Ioannidis JPA, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002049; Ioannidis JPA, 2015, J PSYCHOSOM RES, V78, P7, DOI 10.1016/j.jpsychores.2014.11.008; Ioannidis JPA, 2013, NATURE, V493, P26, DOI 10.1038/493026c; Ioannidis JPA, 2012, EUR J CLIN INVEST, V42, P349, DOI 10.1111/j.1365-2362.2011.02617.x; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Moher D, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2004089; Morgan Jones M., 2016, NATL I HLTH RES 10 Y; Nicholson JM, 2012, NATURE, V492, P34, DOI 10.1038/492034a; Patsopoulos NA, 2006, BMJ-BRIT MED J, V332, P1061, DOI 10.1136/bmj.38768.420139.80; Quan W, PUBLISH IMPOVERISH I; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Santangelo G, 2013, NATURE, V493, P26, DOI 10.1038/493026a; Sugimoto CR, 2013, NATURE, V504, P211, DOI 10.1038/504211a; UK Clinical Research Collaboration, UK HLTH RES AN 2014; Viergever RF, 2016, HEALTH RES POLICY SY, V14, DOI 10.1186/s12961-015-0074-z	24	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211460	10.1371/journal.pone.0211460	http://dx.doi.org/10.1371/journal.pone.0211460			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811411	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000459806400018
J	Owonikoko, TK; Zhang, GJ; Lallani, SB; Chen, ZJ; Martinson, DE; Khuri, FR; Lonial, S; Marcus, A; Sun, SY				Owonikoko, Taofeek K.; Zhang, Guojing; Lallani, Shenila B.; Chen, Zhengjia; Martinson, Deborah E.; Khuri, Fadlo R.; Lonial, Sagar; Marcus, Adam; Sun, Shi-Yong			Evaluation of preclinical efficacy of everolimus and pasireotide in thyroid cancer cell lines and xenograft models	PLOS ONE			English	Article							SOMATOSTATIN ANALOGS; MAMMALIAN TARGET; PROLIFERATIVE SIGNALS; IN-VIVO; RECEPTOR; RAPAMYCIN; EXPRESSION; SOM230; KINASE; INHIBITION	Background Signaling through mTOR and somatostatin pathway is implicated in thyroid cancer development. Method We evaluated everolimus, an mTOR inhibitor and pasireotide, a multi receptor somatostatin analogue as potential therapy of thyroid cancer focusing on the in vitro and in vivo efficacy, as well as possible mechanism to explain any observed interaction. Results Both everolimus and pasireotide inhibit the growth of thyroid cancer cell lines in vitro with varied efficacy that correlates with tumor origin and somatostatin receptor (SSTR) expression profile of the cell lines. In vitro activity of everolimus show positive correlation with the expression of SSTR types 1, 4 and 5 (CC: 0.9; 0.85, 0.87) while pasireotide activity show negative correlation with SSTR2 (CC: -0.87). Although there is greater modulation of pS6 when pasireotide is combined with everolimus, there is no significant abrogation of the expected feedback upregulation of AKT induced by everolimus. Also, the combination is not significantly better than each agent alone in short and long term in vitro assays. Continuous administration of everolimus at a low dose as opposed to high intermittent dosing schedule has greater antitumor efficacy against thyroid cancer xenografts in vivo. Pasireotide LAR has modest in vivo efficacy and the combination of everolimus and pasireotide LAR achieve greater tumor growth inhibition than each agent alone in TPC-1 xenograft model of thyroid cancer (p = 0.048). Conclusion Our findings provide support for the clinical evaluation of everolimus and pasireotide in thyroid cancer and other neuroendocrine tumors.	[Owonikoko, Taofeek K.; Zhang, Guojing; Lallani, Shenila B.; Martinson, Deborah E.; Khuri, Fadlo R.; Lonial, Sagar; Marcus, Adam; Sun, Shi-Yong] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Owonikoko, Taofeek K.; Chen, Zhengjia; Khuri, Fadlo R.; Lonial, Sagar; Marcus, Adam] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Chen, Zhengjia] Emory Univ, Dept Biostat & Bioinformat, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Rollins School Public Health	Owonikoko, TK (corresponding author), Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA.; Owonikoko, TK (corresponding author), Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA.	towonik@emory.edu	Khuri, Fadlo R./AAU-4942-2020; Owonikoko, Taofeek/C-3012-2011	Khuri, Fadlo R./0000-0002-8638-7618; Owonikoko, Taofeek/0000-0002-7724-7728	National Cancer Institute at the National Institutes of Health Cancer Center Support Grant [NIH/NCI P30CA13829]; Novartis Pharmaceuticals Corporation [CSOM230XUS25T]; Biostatistics and Bioinformatics Shared resource of Winship Cancer Institute of Emory University	National Cancer Institute at the National Institutes of Health Cancer Center Support Grant; Novartis Pharmaceuticals Corporation(Novartis); Biostatistics and Bioinformatics Shared resource of Winship Cancer Institute of Emory University	This work was supported in part by the National Cancer Institute at the National Institutes of Health Cancer Center Support Grant (NIH/NCI P30CA13829) in support of the Biostatistics and Bioinformatics Shared resource of Winship Cancer Institute of Emory University. Novartis Pharmaceuticals Corporation; CSOM230XUS25T (TKO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by the Biostatistics and Bioinformatics Shared resource of Winship Cancer Institute of Emory University. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bousquet C, 1998, J BIOL CHEM, V273, P7099, DOI 10.1074/jbc.273.12.7099; Brewer C, 2007, CANCER RES, V67, P8002, DOI 10.1158/0008-5472.CAN-07-2471; Bruns C, 2002, EUR J ENDOCRINOL, V146, P707, DOI 10.1530/eje.0.1460707; Cerovac V, 2010, CANCER RES, V70, P666, DOI 10.1158/0008-5472.CAN-09-2951; Chen AY, 2009, CANCER-AM CANCER SOC, V115, P3801, DOI 10.1002/cncr.24416; Faggiano A, 2018, ENDOCRINE, V62, P46, DOI 10.1007/s12020-018-1583-7; Guillermet J, 2003, P NATL ACAD SCI USA, V100, P155, DOI 10.1073/pnas.0136771100; Hanly EK, 2015, ONCOTARGET, V6, P39702, DOI 10.18632/oncotarget.4052; Herac M, 2016, APMIS, V124, P839, DOI 10.1111/apm.12584; Kao YJ, 2011, MOL ENDOCRINOL, V25, P1040, DOI 10.1210/me.2010-0398; Lahlou H, 2003, J BIOL CHEM, V278, P39356, DOI 10.1074/jbc.M304524200; Larkin J, 2014, NEW ENGL J MED, V371, P1867, DOI 10.1056/NEJMoa1408868; Lee JW, 2015, NUCL MED MOLEC IMAG, V49, P127, DOI 10.1007/s13139-015-0324-6; Li M, 2005, J AM COLL SURGEONS, V201, P571, DOI 10.1016/j.jamcollsurg.2005.06.089; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; Meric-Bernstam F, 2009, J CLIN ONCOL, V27, P2278, DOI 10.1200/JCO.2008.20.0766; Moreno A, 2008, ENDOCR-RELAT CANCER, V15, P257, DOI 10.1677/ERC-07-0202; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Owonikoko TK, 2014, CANCER MED-US, V3, P1579, DOI 10.1002/cam4.317; Owonikoko TK, 2010, INT J CANCER, V126, P743, DOI 10.1002/ijc.24759; Pasquali D, 2008, J MOL ENDOCRINOL, V40, P263, DOI 10.1677/JME-08-0012; Patel YC, 1999, FRONT NEUROENDOCRIN, V20, P157, DOI 10.1006/frne.1999.0183; Pisarek H, 2015, EXP CLIN ENDOCR DIAB, V123, P342, DOI 10.1055/s-0035-1548825; Pisarek H, 2009, THYROID RES, V2, DOI 10.1186/1756-6614-2-1; Reubi JC, 2013, TRENDS PHARMACOL SCI, V34, P676, DOI 10.1016/j.tips.2013.10.001; Robert C, 2015, NEW ENGL J MED, V372, P30, DOI 10.1056/NEJMoa1412690; Rodriguez-Alvarez F, 2016, MOL CELL BIOCHEM, V411, P253, DOI 10.1007/s11010-015-2587-8; Ruscica M, 2013, CURR MOL MED, V13, P555; Schmid HA, 2008, MOL CELL ENDOCRINOL, V286, P69, DOI 10.1016/j.mce.2007.09.006; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Shi YJ, 2005, MOL CANCER THER, V4, P1533, DOI 10.1158/1535-7163.MCT-05-0068; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sun SY, 2005, CANCER RES, V65, P7052, DOI 10.1158/0008-5472.CAN-05-0917; Tanaka Chiaki, 2008, J Clin Oncol, V26, P1596, DOI 10.1200/JCO.2007.14.1127; Vitale G, 2017, MOL ONCOL, V11, P1007, DOI 10.1002/1878-0261.12070; Woelfl S, 2014, NUKLEARMED-NUCL MED, V53, P179, DOI 10.3413/Nukmed-0646-14-02; Yeager N, 2008, CANCER RES, V68, P444, DOI 10.1158/0008-5472.CAN-07-3030; Zou Y, 2009, ONCOL REP, V21, P379, DOI 10.3892/or_00000233	38	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0206309	10.1371/journal.pone.0206309	http://dx.doi.org/10.1371/journal.pone.0206309			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807575	Green Published, gold, Green Submitted			2022-12-27	WOS:000459712100001
J	Pillai, MR; Mihi, B; Ishiwata, K; Nakamura, K; Sakuragi, N; Finkelstein, DB; McGargill, MA; Nakayama, T; Ayabe, T; Coleman, ML; Bix, M				Pillai, Meenu R.; Mihi, Belgacem; Ishiwata, Kenji; Nakamura, Kiminori; Sakuragi, Naoya; Finkelstein, David B.; McGargill, Maureen A.; Nakayama, Toshinori; Ayabe, Tokiyoshi; Coleman, Mathew L.; Bix, Mark			Myc-induced nuclear antigen constrains a latent intestinal epithelial cell-intrinsic anthelmintic pathway	PLOS ONE			English	Article							GASTROINTESTINAL NEMATODES; ALPHA-DEFENSINS; PANETH CELLS; RESISTANCE; BETA; REDUCTION; IMMUNITY; MICE; MINA; ZINC	Expulsion of parasitic gastrointestinal nematodes requires diverse effector mechanisms coordinated by a Th2-type response. The evolutionarily conserved JmjC protein; Myc Induced Nuclear Antigen (Mina) has been shown to repress IL4, a key Th2 cytokine, suggesting Mina may negatively regulate nematode expulsion. Here we report that expulsion of the parasitic nematode Trichuris muris was indeed accelerated in Mina deficient mice. Unexpectedly, this was associated not with an elevated Th2-but rather an impaired Th1-type response. Further reciprocal bone marrow chimera and conditional KO experiments demonstrated that retarded parasite expulsion and a normal Th1-type response both required Mina in intestinal epithelial cells (IECs). Transcriptional profiling experiments in IECs revealed anti-microbial alpha-defensin peptides to be the major target of Mina-dependent retention of worms in infected mice. In vitro exposure to recombinant alpha-defensin peptides caused cytotoxic damage to whipworms. These results identify a latent IEC-intrinsic anthelmintic pathway actively constrained by Mina and point to alpha-defensins as important effectors that together with Mina may be attractive therapeutic targets for the control of nematode infection.	[Pillai, Meenu R.; Finkelstein, David B.; McGargill, Maureen A.] St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA; [Mihi, Belgacem; Bix, Mark] Chiba Univ, Grad Sch Med, Dept Innovat Med, Chiba, Japan; [Mihi, Belgacem; Bix, Mark] Chiba Univ, Inst Global Prominent Res, Chiba, Japan; [Ishiwata, Kenji] Jikei Univ, Sch Med, Dept Trop Med, Tokyo, Japan; [Nakamura, Kiminori; Sakuragi, Naoya; Ayabe, Tokiyoshi] Hokkaido Univ, Grad Sch Life Sci, Dept Cell Biol Sci, Sapporo, Hokkaido, Japan; [Nakayama, Toshinori] Chiba Univ, Grad Sch Med, Dept Immunol, Chiba, Japan; [Coleman, Mathew L.] Univ Birmingham, Inst Canc & Genom Sci, Birmingham, W Midlands, England	St Jude Children's Research Hospital; Chiba University; Chiba University; Jikei University; Hokkaido University; Chiba University; University of Birmingham	Pillai, MR (corresponding author), St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA.; Bix, M (corresponding author), Chiba Univ, Grad Sch Med, Dept Innovat Med, Chiba, Japan.; Bix, M (corresponding author), Chiba Univ, Inst Global Prominent Res, Chiba, Japan.	meenu.pillai@stjude.org; mbix@alum.mit.edu	Nakamura, Kiminori/GQQ-5570-2022; Ayabe, Tokiyoshi/F-5264-2011; Coleman, Mathew L/C-1676-2014; McGargill, Maureen/N-8131-2018	Nakamura, Kiminori/0000-0002-2138-1733; Ayabe, Tokiyoshi/0000-0002-8631-5593; Coleman, Mathew L/0000-0001-6020-9023; McGargill, Maureen/0000-0002-0916-0372; Ramanatha Pillai, Meenu/0000-0002-7944-3642	ALSAC; National Institutes of Health [AI048636]; Institute for Global Prominent Research, Chiba University; Ministry of Education, Culture, Sports, Science and Technology, Japan [26221305]; Japan Agency for Medical Research and development; Japan Society for the Promotion of Science; Center of Innovation Program from Japan Science and Technology Agency; American Lebanese Syrian Associated Charities;  [26462831]; MRC [MR/N021053/1] Funding Source: UKRI	ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Global Prominent Research, Chiba University; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and development(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Center of Innovation Program from Japan Science and Technology Agency; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by ALSAC (MB); the National Institutes of Health (MB, AI048636); the Institute for Global Prominent Research, Chiba University (MB); the Ministry of Education, Culture, Sports, Science and Technology, Japan: Grants-in-Aid for Scientific Research (S, #26221305) (TN), the Practical Research Project for Allergic Diseases and Immunology (Research on Allergic Diseases and Immunology) from the Japan Agency for Medical Research and development (TN); a Grant-in-Aid for Scientific Research (C, #26462831) (KN); the Japan Society for the Promotion of Science, the Center of Innovation Program from Japan Science and Technology Agency (KN); the American Lebanese Syrian Associated Charities (MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artis D, 2004, P NATL ACAD SCI USA, V101, P13596, DOI 10.1073/pnas.0404034101; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Chowdhury R, 2014, NATURE, V510, P422, DOI 10.1038/nature13263; de Silva NR, 2003, TRENDS PARASITOL, V19, P547, DOI 10.1016/j.pt.2003.10.002; DINSDALE D, 1984, J HISTOCHEM CYTOCHEM, V32, P139, DOI 10.1177/32.2.6693753; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eilbracht J, 2005, EUR J CELL BIOL, V84, P279, DOI 10.1016/j.ejcb.2004.12.022; ELSE KJ, 1992, PARASITE IMMUNOL, V14, P441, DOI 10.1111/j.1365-3024.1992.tb00018.x; Gasbarre LC, 2015, CAN J VET RES, V79, P296; Ge W, 2012, NAT CHEM BIOL, V8, P960, DOI [10.1038/NCHEMBIO.1093, 10.1038/nchembio.1093]; Geerts S, 2001, TROP MED INT HEALTH, V6, P915, DOI 10.1046/j.1365-3156.2001.00774.x; Geurden T, 2015, INT J PARASITOL-DRUG, V5, P163, DOI 10.1016/j.ijpddr.2015.08.001; Giblin LJ, 2006, J HISTOCHEM CYTOCHEM, V54, P311, DOI 10.1369/jhc.5A6724.2005; Gomez-Escobar N, 2000, INFECT IMMUN, V68, P6402, DOI 10.1128/IAI.68.11.6402-6410.2000; Grainger JR, 2010, J EXP MED, V207, P2331, DOI 10.1084/jem.20101074; Grencis RK, 2015, ANNU REV IMMUNOL, V33, P201, DOI 10.1146/annurev-immunol-032713-120218; Grencis RK, 2014, IMMUNOL REV, V260, P183, DOI 10.1111/imr.12188; Hayes KS, 2010, SCIENCE, V328, P1391, DOI 10.1126/science.1187703; Hepworth MR, 2009, J IMMUNOL, V183, P3906, DOI 10.4049/jimmunol.0900577; Huang MY, 2017, ONCOGENE, V36, P387, DOI 10.1038/onc.2016.208; Ihler CF., 1995, ACTA VET SCAND S1, V52, pS24; Jaeger SU, 2013, MUCOSAL IMMUNOL, V6, P1179, DOI 10.1038/mi.2013.17; Klementowicz JE, 2012, SEMIN IMMUNOPATHOL, V34, P815, DOI 10.1007/s00281-012-0348-2; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2011, BIOPROTOCOL, pe157, DOI [10.21769/BioProtoc.157, DOI 10.21769/BIOPROTOC.157]; Lian SL, 2018, IMMUN INFLAMM DIS, V6, P58, DOI 10.1002/iid3.191; Love S., 2011, P AUSTR SHEEP VET C; Lu YJ, 2009, CELL CYCLE, V8, P2101, DOI 10.4161/cc.8.13.8927; Maemoto A, 2004, J BIOL CHEM, V279, P44188, DOI 10.1074/jbc.M406154200; Mastroianni JR, 2009, J BIOL CHEM, V284, P27848, DOI 10.1074/jbc.M109.050773; Masuda K, 2011, J INNATE IMMUN, V3, P315, DOI 10.1159/000322037; Matthews JB, 2014, INT J PARASITOL-DRUG, V4, P310, DOI 10.1016/j.ijpddr.2014.10.003; Mori T, 2013, CELL STRUCT FUNCT, V38, P155; NobenTrauth N, 1997, P NATL ACAD SCI USA, V94, P10838, DOI 10.1073/pnas.94.20.10838; Okamoto M, 2009, NAT IMMUNOL, V10, P872, DOI 10.1038/ni.1747; OUELLETTE AJ, 1990, J BIOL CHEM, V265, P9831; Ouellette AJ, 2011, CELL MOL LIFE SCI, V68, P2215, DOI 10.1007/s00018-011-0714-6; Playford MC, 2014, AUST VET J, V92, P464, DOI 10.1111/avj.12271; Roeber F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-153; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schroeder BO, 2011, NATURE, V469, P419, DOI 10.1038/nature09674; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Shanahan MT, 2011, INFECT IMMUN, V79, P459, DOI 10.1128/IAI.00996-10; Shirafuji Y, 2003, J BIOL CHEM, V278, P7910, DOI 10.1074/jbc.M210600200; STEVENS TL, 1988, NATURE, V334, P255, DOI 10.1038/334255a0; Vercruysse J, 2011, INT J PARASITOL-DRUG, V1, P14, DOI 10.1016/j.ijpddr.2011.09.002; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; WAKELIN D, 1967, PARASITOLOGY, V57, P515, DOI 10.1017/S0031182000072395; Wang C, 2016, SCI REP-UK, V6, DOI 10.1038/srep22875; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981; Zhang YF, 2013, ACS CHEM BIOL, V8, P1907, DOI 10.1021/cb400340k	54	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0211244	10.1371/journal.pone.0211244	http://dx.doi.org/10.1371/journal.pone.0211244			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807587	Green Submitted, gold, Green Published			2022-12-27	WOS:000459712100003
J	Gomes, F; Watanabe, L; Vianez, J; Nunes, M; Cardoso, J; Lima, C; Schneider, H; Sampaio, I				Gomes, Fatima; Watanabe, Luciana; Vianez, Joao; Nunes, Marcio; Cardoso, Jedson; Lima, Clayton; Schneider, Horacio; Sampaio, Iracilda			Comparative analysis of the transcriptome of the Amazonian fish species Colossoma macropomum (tambaqui) and hybrid tambacu by next generation sequencing	PLOS ONE			English	Article							GENETIC-CHARACTERIZATION; FUNCTIONAL GENOMICS; ANNOTATION; EXPRESSION; SKIN; INTERMEDIATE; BIOLOGY; PROTEIN; STRESS; TOOL	Background The C. macropomum is a characiform fish from the Amazon basin that has been hybridized with other pacu species to produce commercial hybrids, such as the tambacu. However, little is known of the functional genomics of the parental species or these hybrid forms. The transcriptome of C. macropomum and tambacu were sequenced using 454 Roche platform (pyrosequencing) techniques to characterize the domains of Gene Ontology (GO) and to evaluate the levels of gene expression in the two organisms. Results The 8,188,945 reads were assembled into 400,845 contigs. A total of 58,322 contigs were annotated with a predominance of biological processes for both organisms, as determined by Gene Ontology (GO). Similar numbers of metabolic pathways were identified in both the C. macropomum and the tambacu, with the metabolism category presenting the largest number of transcripts. The BUSCO analysis indicated that our assembly was more than 40% complete. We identified 21,986 genes for the two fishes. The P and Log2FC values indicated significant differences in the levels of gene expression, with a total of 600 up-regulated genes. Conclusion In spite of the lack of a reference genome, the functional annotation was successful, and confirmed a considerable difference in the specificity and levels of gene expression between the two organisms. This report provides a comprehensive baseline for the genetic management of these commercially important fishes, in particular for the identification of specific genes that may represent markers involved in the immunity, growth, and fertility of these organisms, with potential practical applications in aquaculture management.	[Gomes, Fatima; Watanabe, Luciana; Schneider, Horacio; Sampaio, Iracilda] Univ Fed Para, Lab Genet & Mol Biol, Inst Coastal Studies, Campus Braganca,Alameda Leandro Ribeiro, Braganca, PA, Brazil; [Vianez, Joao; Nunes, Marcio; Cardoso, Jedson; Lima, Clayton] Minist Hlth, Evandro Chagas Inst, Ctr Technol Innovat, Ananindeua, PA, Brazil; [Cardoso, Jedson] Minist Hlth, Evandro Chagas Inst, Postgrad Program Virol PPGV, Ananindeua, PA, Brazil	Universidade Federal do Para; Instituto Evandro Chagas; Instituto Evandro Chagas	Gomes, F (corresponding author), Univ Fed Para, Lab Genet & Mol Biol, Inst Coastal Studies, Campus Braganca,Alameda Leandro Ribeiro, Braganca, PA, Brazil.	fat_gomes@hotmail.com		Gomes, Fatima/0000-0002-9195-5691	Center of Technological Innovation (CIT); Evandro Chagas Institute (IEC); National Council of Scientific and Technological Development (CNPq) [550939/2010-5]	Center of Technological Innovation (CIT); Evandro Chagas Institute (IEC); National Council of Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The study was funded by the Center of Technological Innovation (CIT), Evandro Chagas Institute (IEC) and National Council of Scientific and Technological Development (CNPq) (Bionorte Project: 550939/2010-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J.U., 2008, NATURE ED, V1, P195; Alvarez M, 2015, MOL ECOL, V24, P710, DOI 10.1111/mec.13055; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Bang ML, 2001, CIRC RES, V89, P1065, DOI 10.1161/hh2301.100981; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; Brown T.A., 2002, GENOMES, V2nd; BUCKBINDER L, 1994, P NATL ACAD SCI USA, V91, P10640, DOI 10.1073/pnas.91.22.10640; Calcagnotto D, 1999, AQUACULTURE, V174, P51, DOI 10.1016/S0044-8486(99)00005-8; Cao D, 2001, ANIM GENET, V32, P169, DOI 10.1046/j.1365-2052.2001.00753.x; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; CONDEELIS J, 1995, TRENDS BIOCHEM SCI, V20, P169, DOI 10.1016/S0968-0004(00)88998-7; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5; Nunes JDD, 2017, SCI REP-UK, V7, DOI 10.1038/srep46112; Datta S, 2014, STATTISTICALL ANAL N; DAVENPORT RC, 1991, BIOCHEMISTRY-US, V30, P5821, DOI 10.1021/bi00238a002; Deng TX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147132; Derham BK, 1999, PROG RETIN EYE RES, V18, P463, DOI 10.1016/S1350-9462(98)00030-5; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; DUBIN RA, 1989, MOL CELL BIOL, V9, P1083, DOI 10.1128/MCB.9.3.1083; Elliott Diane G., 2000, P271, DOI 10.1016/B978-012529650-2/50023-8; Fontao L, 2003, MOL BIOL CELL, V14, P1978, DOI 10.1091/mbc.e02-08-0548; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Gallicano GI, 1998, J CELL BIOL, V143, P2009, DOI 10.1083/jcb.143.7.2009; Gao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058453; Giuseppe M, 1994, MEM SOC CI NAT SALLE, V54, P9; Goetz FW, 2008, FISH FISH, V9, P378, DOI 10.1111/j.1467-2979.2008.00301.x; Gomes F, 2017, GENOMICS, V109, P67, DOI 10.1016/j.ygeno.2017.02.001; Gomes F, 2012, AN ACAD BRAS CIENC, V84, P517, DOI 10.1590/S0001-37652012005000025; Gonzalez I, 2012, BIODATA MIN, V5, DOI 10.1186/1756-0381-5-19; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gu LH, 2007, CURR OPIN CELL BIOL, V19, P13, DOI 10.1016/j.ceb.2006.12.007; Guetg A, 2015, J PHYSIOL-LONDON, V593, P1273, DOI 10.1113/jphysiol.2014.283960; Hall A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [citeulike-article-id:691774, DOI 10.1021/BK-1999-0734.CH008]; Hancock CR, 2006, J PHYSIOL PHARMACOL, V57, P17; Hashimoto DT, 2010, AQUACULTURE, V298, P346, DOI 10.1016/j.aquaculture.2009.11.015; Hirayama Y, 1997, EUR J BIOCHEM, V246, P380, DOI 10.1111/j.1432-1033.1997.t01-2-00380.x; Hu YL, 2016, GENOME, V59, P1, DOI 10.1139/gen-2014-0190; JEANPIERRE C, 1993, MAMM GENOME, V4, P104, DOI 10.1007/BF00290434; Jiang YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108200; Jong WW, 1993, MOL BIOL EVOL, V10, P103, DOI DOI 10.1093/0XF0RDJ0URNALS.M0LBEV.A039992; Jorge PH, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00046; KADLER K, 1995, PROTEIN PROFILE, V2, P491; Kanai Y, 1998, J BIOL CHEM, V273, P23629, DOI 10.1074/jbc.273.37.23629; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kopylova E, 2012, BIOINFORMATICS, V1, P1; Kumar S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-571; Le Guellec D, 2004, INT J DEV BIOL, V48, P217, DOI 10.1387/ijdb.15272388; LIMA CA, 1998, FRUTOS TAMBAQUI ECOL; Magin TM, 2007, EXP CELL RES, V313, P2021, DOI 10.1016/j.yexcr.2007.03.005; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martinez JG, 2017, CONSERV GENET RESOUR, V9, P29, DOI 10.1007/s12686-016-0610-3; Martins M. L., 1999, Revista Brasileira de Biologia, V59, P263, DOI 10.1590/S0034-71081999000200010; Martins ML, 2002, ACTA SCI-BIOL SCI, V24; Mastrochirico VA, 2016, CONSERV GENET RESOUR, V8, P109, DOI 10.1007/s12686-016-0521-3; Melo J.S.C, 1994, B TEC CEPTA PIRASSUN, V7, P59; Meyer B, 2015, MOL ECOL RESOUR, V15, P1460, DOI 10.1111/1755-0998.12408; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Micallef G, 2012, MAR BIOTECHNOL, V14, P559, DOI 10.1007/s10126-012-9447-2; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Ministerio da Pesca e Aquicultura, 2014, B EST PESC AQ 2011; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; MORITZ C, 1987, ANNU REV ECOL SYST, V18, P269, DOI 10.1146/annurev.ecolsys.18.1.269; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Muratori M, 2009, INT J ANDROL, V32, P25, DOI 10.1111/j.1365-2605.2008.00875.x; MURGAS L.D.S., 2009, REV BRASILEIRA REPRO, V6, P70; O'Neil ST, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-310; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Palstra AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053171; Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910; Parker PG, 1998, ECOLOGY, V79, P361, DOI 10.1890/0012-9658(1998)079[0361:WMCTUA]2.0.CO;2; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Pinheiro MHP., 1991, CIENC AGRON, V22, P77; Porter JD, 2003, J EXP BIOL, V206, P3101, DOI 10.1242/jeb.00511; Prado-Lima M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152366; Prak ETL, 2000, NAT REV GENET, V1, P134; Rakers S, 2010, EXP DERMATOL, V19, P313, DOI 10.1111/j.1600-0625.2009.01059.x; Ricard-Blum S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004978; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Salem M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-564; Sambrook J., 2001, MOL CLONING LAB MANU; Sanger JW, 2001, J CELL BIOL, V154, P21, DOI 10.1083/jcb.200106072; Schacke H, 1998, J BIOL CHEM, V273, P25937, DOI 10.1074/jbc.273.40.25937; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shen XY, 2014, MOL ECOL RESOUR, V14, P622, DOI 10.1111/1755-0998.12212; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Sparrow JC, 2003, NEUROMUSCULAR DISORD, V13, P519, DOI 10.1016/S0960-8966(03)00101-9; Stojkovic T, 2009, NEW ENGL J MED, V361, P425, DOI 10.1056/NEJMc0901158; Tavares-Dias M, 2011, ARQ BRAS MED VET ZOO, V63, P988, DOI 10.1590/S0102-09352011000400026; Thevasagayam NM, 2015, J MAR SCI ENG, V3, P382, DOI 10.3390/jmse3020382; Thomas PD, 2007, CURR OPIN CHEM BIOL, V11, P4, DOI 10.1016/j.cbpa.2006.11.039; Venner S, 2009, TRENDS GENET, V25, P317, DOI 10.1016/j.tig.2009.05.003; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Warnes G.R., 2016, GPLOTS VARIOUS R PRO; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Zdobnov EM, 2016, NUCLEIC ACIDS RES, V45, P1, DOI DOI 10.1093/NAR/GKW1119; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	106	6	6	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2019	14	2							e0212755	10.1371/journal.pone.0212755	http://dx.doi.org/10.1371/journal.pone.0212755			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EH	30802266	gold, Green Published, Green Submitted			2022-12-27	WOS:000459710700019
J	Lebreton, L; Guillerm-Erckelboudt, AY; Gazengel, K; Linglin, J; Ourry, M; Glory, P; Sarniguet, A; Daval, S; Manzanares-Dauleux, MJ; Mougel, C				Lebreton, Lionel; Guillerm-Erckelboudt, Anne-Yvonne; Gazengel, Kevin; Linglin, Juliette; Ourry, Morgane; Glory, Pascal; Sarniguet, Alain; Daval, Stephanie; Manzanares-Dauleux, Maria J.; Mougel, Christophe			Temporal dynamics of bacterial and fungal communities during the infection of Brassica rapa roots by the protist Plasmodiophora brassicae	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; RHIZOSPHERE MICROBIOME; JASMONIC ACID; PATHOGEN; CANOLA; CLUBROOT; PACKAGE; LIFE	The temporal dynamics of rhizosphere and root microbiota composition was compared between healthy and infected Chinese cabbage plants by the pathogen Plasmodiophora brassicae. When inoculated with P. brassicae, disease was measured at five sampling dates from early root hair infection to late gall development. The first symptoms of clubroot disease appeared 14 days after inoculation (DAI) and increased drastically between 14 and 35 DAI. The structure of microbial communities associated to rhizosphere soil and root from healthy and inoculated plants was characterized through high-throughput DNA sequencing of bacterial (16S) and fungal (18S) molecular markers and compared at each sampling date. In healthy plants, Proteobacteria and Bacteroidetes bacterial phyla dominated the rhizosphere and root microbiota of Chinese cabbage. Rhizosphere bacterial communities contained higher abundances of Actinobacteria and Firmicutes compared to the roots. Moreover, a drastic shift of fungal communities of healthy plants occurred between the two last sampling dates, especially in plant roots, where most of Ascomycota fungi dominated until they were replaced by a fungus assigned to the Chytridiomycota phylum. Parasitic invasion by P. brassicae disrupted the rhizosphere and root-associated community assembly at a late step during the root secondary cortical infection stage of clubroot disease. At this stage, Flavisolibacter and Streptomyces in the rhizosphere, and Bacillus in the roots, were drastically less abundant upon parasite invasion. Rhizosphere of plants colonized by P. brassicae was significantly more invaded by the Chytridiomycota fungus, which could reflect a mutualistic relationship in this compartment between these two microorganisms.	[Lebreton, Lionel; Guillerm-Erckelboudt, Anne-Yvonne; Gazengel, Kevin; Linglin, Juliette; Ourry, Morgane; Glory, Pascal; Sarniguet, Alain; Daval, Stephanie; Manzanares-Dauleux, Maria J.; Mougel, Christophe] Univ Rennes, INRA, IGEPP, AGROCAMPUS OUEST, Le Rheu, France	INRAE; Institut Agro; Agrocampus Ouest	Lebreton, L (corresponding author), Univ Rennes, INRA, IGEPP, AGROCAMPUS OUEST, Le Rheu, France.	lionel.lebreton@inra.fr	OURRY, Morgane/AAU-7974-2020; OURRY, Morgane/AAO-4369-2021; Mougel, Christophe/D-5118-2017	OURRY, Morgane/0000-0002-8641-9114; OURRY, Morgane/0000-0002-8641-9114; GAZENGEL, Kevin/0000-0001-9054-2281; Mougel, Christophe/0000-0001-8675-3115; Manzanares-Dauleux, Maria J./0000-0002-6452-0393; DAVAL, Stephanie/0000-0001-8848-4190; lebreton, Lionel/0000-0003-1759-5269	Rennes Metropole [300 01003]; French state through the National Agency for Research under the program "Investments for the Future" [ANR-11-INBS-0001]; Regional Council of Bourgogne Franche Comte	Rennes Metropole(Region Bretagne); French state through the National Agency for Research under the program "Investments for the Future"; Regional Council of Bourgogne Franche Comte(Region Bourgogne-Franche-Comte)	This work was supported by a Scientific Installation Aid grant (no 300 01003) to CM from Rennes Metropole (https://metropole.rennes.fr/les-aides-la-recherche?idParent=13&typeParent= taxonomy_term). This work, through the involvement of Bioinformatics service of the GenoSol platform of the infrastructure ANAEE-Services, received a grant from the French state through the National Agency for Research under the program "Investments for the Future" (reference ANR-11-INBS-0001), as well as grants from the Regional Council of Bourgogne Franche Comte. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almario J, 2017, P NATL ACAD SCI USA, V114, pE9403, DOI 10.1073/pnas.1710455114; Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; [Anonymous], 1991, PLANT ROOTS HIDDEN H; Bakker PAHM, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00165; Barret M, 2015, APPL ENVIRON MICROB, V81, P1257, DOI 10.1128/AEM.03722-14; Bates D. M., 2010, LME4 MIXED EFFECTS M; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berendsen RL, 2018, ISME J, V12, P1496, DOI 10.1038/s41396-018-0093-1; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Berg G, 2016, J EXP BOT, V67, P995, DOI 10.1093/jxb/erv466; Bodenhausen N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056329; Borneman J, 2000, APPL ENVIRON MICROB, V66, P4356, DOI 10.1128/AEM.66.10.4356-4360.2000; Bulgarelli D, 2015, CELL HOST MICROBE, V17, P392, DOI 10.1016/j.chom.2015.01.011; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Carvalhais LC, 2015, MOL PLANT MICROBE IN, V28, P1049, DOI 10.1094/MPMI-01-15-0016-R; Chapelle E, 2016, ISME J, V10, P265, DOI 10.1038/ismej.2015.82; Chelius MK, 2001, MICROB ECOL, V41, P252, DOI 10.1007/s002480000087; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; COOK RJ, 1995, P NATL ACAD SCI USA, V92, P4197, DOI 10.1073/pnas.92.10.4197; de Souza RSC, 2016, SCI REP-UK, V6, DOI 10.1038/srep28774; de Campos SB, 2013, MICROB ECOL, V65, P593, DOI 10.1007/s00248-012-0132-9; Dombrowski N, 2017, ISME J, V11, P43, DOI 10.1038/ismej.2016.109; Edwards J, 2015, P NATL ACAD SCI USA, V112, pE911, DOI 10.1073/pnas.1414592112; Erlacher A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00175; Fahling M, 2003, J PHYTOPATHOL, V151, P425, DOI 10.1046/j.1439-0434.2003.00744.x; Gkarmiri K, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/AEM.01938-17, 10.1128/aem.01938-17]; Gransee A, 2000, J PLANT NUTR SOIL SC, V163, P381, DOI 10.1002/1522-2624(200008)163:4<381::AID-JPLN381>3.0.CO;2-7; Hacquard S, 2017, ANNU REV PHYTOPATHOL, V55, P565, DOI 10.1146/annurev-phyto-080516-035623; Hacquard S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11362; Hartmann A, 2008, PLANT SOIL, V312, P7, DOI 10.1007/s11104-007-9514-z; Hartmann A, 2009, PLANT SOIL, V321, P235, DOI 10.1007/s11104-008-9814-y; Hartwright LM, 2010, FUNGAL BIOL-UK, V114, P26, DOI 10.1016/j.mycres.2009.09.008; Hilton S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059859; Hu LF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05122-7; Hwang SF, 2012, MOL PLANT PATHOL, V13, P105, DOI 10.1111/j.1364-3703.2011.00729.x; Kageyama K, 2009, J PLANT GROWTH REGUL, V28, P203, DOI 10.1007/s00344-009-9101-z; Kim B, 2016, J MICROBIOL BIOTECHN, V26, P549, DOI 10.4014/jmb.1511.11058; Kong HG, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01314; Lahlali R, 2013, PHYTOPATHOLOGY, V103, P245, DOI 10.1094/PHYTO-06-12-0123-R; Le Van A, 2017, PEERJ, V5, DOI 10.7717/peerj.3454; Lebeis SL, 2015, SCIENCE, V349, P860, DOI 10.1126/science.aaa8764; Lemarie S, 2015, PLANT CELL PHYSIOL, V56, P2158, DOI 10.1093/pcp/pcv127; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Mahoney AK, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00132; Manzanares-Dauleux MJ, 2000, THEOR APPL GENET, V101, P885, DOI 10.1007/s001220051557; Manzanares-Dauleux MJ, 2000, EUPHYTICA, V113, P211, DOI 10.1023/A:1003997421340; Marilley L, 1999, APPL SOIL ECOL, V13, P127, DOI 10.1016/S0929-1393(99)00028-1; Mendes R, 2013, FEMS MICROBIOL REV, V37, P634, DOI 10.1111/1574-6976.12028; Monreal CM, 2018, RHIZOSPHERE-NETH, V5, P16, DOI 10.1016/j.rhisph.2017.11.004; Mougel C, 2006, NEW PHYTOL, V170, P165, DOI 10.1111/j.1469-8137.2006.01650.x; Niu B, 2017, P NATL ACAD SCI USA, V114, pE2450, DOI 10.1073/pnas.1616148114; Oksanen J., 2019, R PACKAGE VERSION, DOI DOI 10.4135/9781412971874.N145; Ourry M, 2018, FRONT ECOL EVOL, V6, DOI 10.3389/fevo.2018.00091; Plassart P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044279; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; R Core TeamR, LANG ENV STAT COMP; Raaijmakers JM, 2009, PLANT SOIL, V321, P341, DOI 10.1007/s11104-008-9568-6; Ranjard L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2431; Rathore R, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01489; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schiltz S, 2015, J APPL MICROBIOL, V119, P1467, DOI 10.1111/jam.12946; Schlaeppi K, 2014, P NATL ACAD SCI USA, V111, P585, DOI 10.1073/pnas.1321597111; Some A, 1996, PLANT PATHOL, V45, P432, DOI 10.1046/j.1365-3059.1996.d01-155.x; Sorensen J, 2009, PLANT SOIL, V321, P483, DOI 10.1007/s11104-009-9946-8; Terrat S, 2015, HEREDITY, V114, P468, DOI 10.1038/hdy.2014.91; Terrat S, 2012, MICROB BIOTECHNOL, V5, P135, DOI 10.1111/j.1751-7915.2011.00307.x; Tkacz A, 2015, ISME J, V9, P2349, DOI 10.1038/ismej.2015.41; Vacher C, 2016, ANNU REV ECOL EVOL S, V47, P1, DOI 10.1146/annurev-ecolsys-121415-032238; Vandenkoornhuyse P, 2015, NEW PHYTOL, V206, P1196, DOI 10.1111/nph.13312; Vorholt JA, 2012, NAT REV MICROBIOL, V10, P828, DOI 10.1038/nrmicro2910; Wei Z, 2018, SOIL BIOL BIOCHEM, V118, P8, DOI 10.1016/j.soilbio.2017.11.012; Yuan J, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0537-x	78	24	24	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2019	14	2							e0204195	10.1371/journal.pone.0204195	http://dx.doi.org/10.1371/journal.pone.0204195			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EH	30802246	Green Published, Green Submitted, gold			2022-12-27	WOS:000459710700001
J	Abdelrehim, A; Shaltiel, L; Zhang, L; Barenholz, Y; High, S; Harris, LK				Abdelrehim, Abbi; Shaltiel, Lior; Zhang, Ling; Barenholz, Yechezkel; High, Stephen; Harris, Lynda K.			The use of tail-anchored protein chimeras to enhance liposomal cargo delivery	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; DRUG-DELIVERY; CELLULAR UPTAKE; TAT PEPTIDE; TUMOR-CELLS; MEMBRANE; TRANSLOCATION; EFFICIENT; SYSTEMS; SIZE	Background Liposomes are employed as drug delivery vehicles offering a beneficial pharmacokinetic/ distribution mechanism for in vivo therapeutics. Therapeutic liposomes can be designed to target specific cell types through the display of epitope-specific targeting peptides on their surface. The majority of peptides are currently attached by chemical modification of lipid constituents. Here we investigate an alternative and novel method of decorating liposomes with targeting ligand, using remotely and spontaneously inserting chimeric tail-anchored membrane (TA) proteins to drug loaded liposomes. Methods and results An artificial TA protein chimera containing the transmembrane domain from the spontaneously inserting TA protein cytochrome b5 (Cytb5) provided a robust membrane tether for the incorporation of three different targeting moieties into preformed liposomes. The moieties investigated were the transactivator of transcription (TAT) peptide, the EGF-receptor binding sequence GE11 and the placental and tumour homing ligand CCGKRK. In all cases, TA protein insertion neither significantly altered the size of the liposomes nor reduced drug loading. The efficacy of this novel targeted delivery system was investigated using two human cell lines, HeLa M and BeWo. Short term incubation with one ligand-modified TA chimera, incorporating the TAT peptide, significantly enhanced liposomal delivery of the encapsulated carboxyfluorescein reporter. Conclusion The Cytb5 TA was successfully employed as a membrane anchor for the incorporation of the desired peptide ligands into a liposomal drug delivery system, with minimal loss of cargo during insertion. This approach therefore provides a viable alternative to chemical conjugation and its potential to accommodate a wider range of targeting ligands may provide an opportunity for enhancing drug delivery.	[Abdelrehim, Abbi; Zhang, Ling; High, Stephen] Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England; [Shaltiel, Lior; Barenholz, Yechezkel] Lipocure Ltd, Jerusalem, Israel; [Barenholz, Yechezkel] Hebrew Univ Jerusalem, Hadassah Med Sch, Membrane & Liposome Res Lab, Jerusalem, Israel; [Harris, Lynda K.] Univ Manchester, Fac Biol Med & Hlth, Div Pharm & Optometry, Manchester, Lancs, England; [Harris, Lynda K.] Univ Manchester, Inst Human Dev, Maternal & Fetal Hlth Res Ctr, Manchester, Lancs, England; [Harris, Lynda K.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, St Marys Hosp, Manchester, Lancs, England	University of Manchester; Hebrew University of Jerusalem; University of Manchester; University of Manchester; University of Manchester	Harris, LK (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Div Pharm & Optometry, Manchester, Lancs, England.; Harris, LK (corresponding author), Univ Manchester, Inst Human Dev, Maternal & Fetal Hlth Res Ctr, Manchester, Lancs, England.; Harris, LK (corresponding author), Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, St Marys Hosp, Manchester, Lancs, England.	lynda.k.harris@manchester.ac.uk	Harris, Lynda K/I-2628-2019	Harris, Lynda K/0000-0001-7709-5202; High, Stephen/0000-0002-4532-8152	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013 under REA [607072]; Lipocure Ltd.; BBSRC David Phillips Fellowship [BB/H022627/1]; Tommy's the Baby Charity; Action Medical Research Endowment Fund; Manchester NIHR Biomedical Research Centre; NIHR Greater Manchester Comprehensive Local Research Network; BBSRC [BB/H022627/1] Funding Source: UKRI	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013 under REA; Lipocure Ltd.; BBSRC David Phillips Fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Tommy's the Baby Charity; Action Medical Research Endowment Fund; Manchester NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); NIHR Greater Manchester Comprehensive Local Research Network; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013 (https://ec.europa.eu/research/mariecurieactions/) under REA grant 607072 to SH laboratory and Lipocure Ltd. The support was in the form of salaries' payment for the authors AA and LS. The specific role of each of these authors is articulated in the `author contributions' section. The BBSRC David Phillips Fellowship (https://bbsrc.ukri.org) to LKH (BB/H022627/1). The Maternal and Fetal Health Research Centre is supported by funding from Tommy's the Baby Charity (https://www.tommys.org), an Action Medical Research Endowment Fund (https://www.action.org.uk), the Manchester NIHR Biomedical Research Centre (https://www.manchesterbrc.nihr.ac.uk/) and the NIHR Greater Manchester Comprehensive Local Research Network (https://www.nihr.ac.uk/nihr-in-your-area/greater-manchester/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMUS G, 1991, VISION RES, V31, P17, DOI 10.1016/0042-6989(91)90069-H; Agemy L, 2011, P NATL ACAD SCI USA, V108, P17450, DOI 10.1073/pnas.1114518108; Allen TM, 2013, ADV DRUG DELIVER REV, V65, P36, DOI 10.1016/j.addr.2012.09.037; ALLEN TM, 1991, BIOCHIM BIOPHYS ACTA, V1066, P29, DOI 10.1016/0005-2736(91)90246-5; Andar AU, 2014, PHARM RES-DORDR, V31, P401, DOI 10.1007/s11095-013-1171-8; Bajoria R, 1997, J PHARM PHARMACOL, V49, P675, DOI 10.1111/j.2042-7158.1997.tb06091.x; Barenholz Y, 2012, J CONTROL RELEASE, V160, P117, DOI 10.1016/j.jconrel.2012.03.020; Bechara C, 2013, FEBS LETT, V587, P1693, DOI 10.1016/j.febslet.2013.04.031; Borgese N, 2001, MOL BIOL CELL, V12, P2482, DOI 10.1091/mbc.12.8.2482; Brambillasca S, 2005, EMBO J, V24, P2533, DOI 10.1038/sj.emboj.7600730; Brambillasca S, 2006, J CELL BIOL, V175, P767, DOI 10.1083/jcb.200608101; Byrne JD, 2008, ADV DRUG DELIVER REV, V60, P1615, DOI 10.1016/j.addr.2008.08.005; Casson J, 2017, J CELL SCI, V130, P3851, DOI 10.1242/jcs.207829; Cheng L, 2014, INT J NANOMED, V9, P921, DOI 10.2147/IJN.S53310; Cheng ZL, 2012, SCIENCE, V338, P903, DOI 10.1126/science.1226338; Deshpande PP, 2013, NANOMEDICINE-UK, V8, P1509, DOI [10.2217/NNM.13.118, 10.2217/nnm.13.118]; Dinca A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020263; Filla MS, 1997, PLACENTA, V18, P17, DOI 10.1016/S0143-4004(97)90067-9; Forssen E, 1998, ADV DRUG DELIVER REV, V29, P249, DOI 10.1016/S0169-409X(97)00083-5; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Guven A, 2009, J LIPOSOME RES, V19, P148, DOI 10.1080/08982100802674419; HARAN G, 1993, BIOCHIM BIOPHYS ACTA, V1151, P201, DOI 10.1016/0005-2736(93)90105-9; Hoffman JA, 2003, CANCER CELL, V4, P383, DOI 10.1016/S1535-6108(03)00273-3; Hu QY, 2013, BIOMATERIALS, V34, P9496, DOI 10.1016/j.biomaterials.2013.09.001; Jayanna PK, 2009, NANOMED-NANOTECHNOL, V5, P83, DOI 10.1016/j.nano.2008.07.006; Johnson N, 2013, BBA-MOL CELL RES, V1833, P2403, DOI 10.1016/j.bbamcr.2012.12.008; Kedmi R, 2018, NAT NANOTECHNOL, V13, P214, DOI 10.1038/s41565-017-0043-5; Kepp O, 2011, NAT REV DRUG DISCOV, V10, P221, DOI 10.1038/nrd3373; King A, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600349; Leznicki P, 2010, J CELL SCI, V123, P2170, DOI 10.1242/jcs.066738; Li ZH, 2005, FASEB J, V19, P1978, DOI 10.1096/fj.05-4058com; Liguori L, 2009, METHOD ENZYMOL, V465, P209, DOI 10.1016/S0076-6879(09)65011-4; Marques-Gallego P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/129458; Matos P, 2014, MOL HUM REPROD, V20, P745, DOI 10.1093/molehr/gau039; Mickler FM, 2012, NANO LETT, V12, P3417, DOI 10.1021/nl300395q; Nomura F, 2004, P NATL ACAD SCI USA, V101, P3420, DOI 10.1073/pnas.0304660101; Pattni BS, 2015, CHEM REV, V115, P10938, DOI 10.1021/acs.chemrev.5b00046; Rabu C, 2008, J BIOL CHEM, V283, P27504, DOI 10.1074/jbc.M804591200; Rabu C, 2009, J CELL SCI, V122, P3605, DOI 10.1242/jcs.041210; Ren Y, 2012, ACS NANO, V6, P8620, DOI 10.1021/nn301975s; Sakamoto Y, 2012, J BIOSCI BIOENG, V113, P322, DOI 10.1016/j.jbiosc.2011.11.004; Sarko D, 2010, MOL PHARMACEUT, V7, P2224, DOI 10.1021/mp100223d; Sawant RR, 2012, AAPS J, V14, P303, DOI 10.1208/s12248-012-9330-0; Sercombe L, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00286; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Torchilin VP, 2001, P NATL ACAD SCI USA, V98, P8786, DOI 10.1073/pnas.151247498; Tseng YL, 2002, MOL PHARMACOL, V62, P864, DOI 10.1124/mol.62.4.864; van Rooy I, 2011, J CONTROL RELEASE, V150, P30, DOI 10.1016/j.jconrel.2010.11.014; Vives E, 2003, CURR PROTEIN PEPT SC, V4, P125, DOI 10.2174/1389203033487306; Wang T, 2010, NANOMEDICINE-UK, V5, P563, DOI [10.2217/nnm.10.30, 10.2217/NNM.10.30]; Wei XH, 2016, EUR J PHARM BIOPHARM, V104, P260, DOI 10.1016/j.ejpb.2016.04.011; Zhang FN, 2015, ANAL CHEM, V87, P9960, DOI 10.1021/acs.analchem.5b02572; Zylberberg C, 2016, DRUG DELIV, V23, P3319, DOI 10.1080/10717544.2016.1177136	54	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212701	10.1371/journal.pone.0212701	http://dx.doi.org/10.1371/journal.pone.0212701			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794671	Green Submitted, Green Published, gold			2022-12-27	WOS:000459709100121
J	Almeida, VM; Marana, SR				Almeida, Vitor M.; Marana, Sandro R.			Optimum temperature may be a misleading parameter in enzyme characterization and application	PLOS ONE			English	Article							RESIDUES	The optimum temperature is commonly determined in enzyme characterization. A search in the PubMed database for "optimum temperature" and "enzymes" yielded more than 1,700 manuscripts reporting this parameter over the last five years. Here, we show that the optimum temperature is not a constant. The catalytic activity of the mesophylic beta-glucosidase Sf beta gly was determined at different temperatures using different assay times and enzyme concentrations. We observed that the optimum temperature for Sf beta gly changed by 5 degrees C simply by modifying the assay length, and it was inversely correlated with enzyme concentration. These observations rely on the fact that close to the melting temperature, thermal denaturation continuously decreases the active enzyme concentration as the assay progresses. Thus, as the denaturation rate increases with increasing temperature, the bell-shaped curves observed in "activity versus temperature plots" occur only if the enzyme is denatured at and above the optimum temperature, which was confirmed using the thermostable beta-glucosidase bglTm. Thus, the optimum temperature hardly reflects an intrinsic enzyme property and is actually a mere consequence of the assay condition. Thus, adoption of the "optimum temperature" determined under bench conditions for large-scale uses, which differ in assay length and enzyme concentration, may result in lower yields and financial losses.	[Almeida, Vitor M.; Marana, Sandro R.] Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, SP, Brazil	Universidade de Sao Paulo	Marana, SR (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, SP, Brazil.	srmarana@iq.usp.br	Marana, Sandro/D-3867-2012	Marana, Sandro/0000-0002-5117-1921; Almeida, Vitor Medeiros/0000-0003-4972-3341	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [001]; FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [16/22365-9]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was financed by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)-Finance code 001, FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [Grant 16/22365-9] and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida VM, 2018, PLOS ONE, V13, DOI [10.1371/Journal.pone.0191282, 10.1371/journal.pone.0191282]; [Anonymous], 2018, BCC RES MARK RES MAR; Beton D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139673; Fersht A., 1999, STRUCTURE MECH PROTE, P191; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Marana SR, 2002, EUR J BIOCHEM, V269, P3705, DOI 10.1046/j.1432-1033.2002.03061.x; Mehmood MA, 2014, PROTEIN PEPTIDE LETT, V21, P1282; Purich DL, 2010, ENZYME KINETICS: CATALYSIS & CONTROL, P1; Segel IH, 1993, ENZYME KINETICS, P926; Souza VP, 2016, FEBS J, V283, P1124, DOI 10.1111/febs.13659	10	12	12	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212977	10.1371/journal.pone.0212977	http://dx.doi.org/10.1371/journal.pone.0212977			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794710	gold, Green Published, Green Submitted			2022-12-27	WOS:000459709100165
J	Bojorquez, JAZ; Jodoin, PM; Bricq, S; Walker, PM; Brunotte, F; Lalande, A				Bojorquez, Jorge Arturo Zavala; Jodoin, Pierre-Marc; Bricq, Stephanie; Walker, Paul Michael; Brunotte, Francois; Lalande, Alain			Automatic classification of tissues on pelvic MRI based on relaxation times and support vector machine	PLOS ONE			English	Article							QUANTITATIVE MRI; SEGMENTATION; T-1	Tissue segmentation and classification in MRI is a challenging task due to a lack of signal intensity standardization. MRI signal is dependent on the acquisition protocol, the coil profile, the scanner type, etc. While we can compute quantitative physical tissue properties independent of the hardware and the sequence parameters, it is still difficult to leverage these physical properties to segment and classify pelvic tissues. The proposed method integrates quantitative MRI values (T1 and T2 relaxation times and pure synthetic weighted images) and machine learning (Support Vector Machine (SVM)) to segment and classify tissues in the pelvic region, i. e.: fat, muscle, prostate, bone marrow, bladder, and air. Twenty-two men with a mean age of 30 +/- 14 years were included in this prospective study. The images were acquired with a 3 Tesla MRI scanner. An inversion recovery-prepared turbo spin echo sequence was used to obtain T1-weighted images at different inversion times with a TR of 14000 ms. A 32-echo spin echo sequence was used to obtain the T2-weighted images at different echo times with a TR of 5000 ms. T1 and T2 relaxation times, synthetic T1-and T2-weighted images and anatomical probabilistic maps were calculated and used as input features of a SVM for segmenting and classifying tissues within the pelvic region. The mean SVM classification accuracy across subjects was calculated for the different tissues: prostate (94.2%), fat (96.9%), muscle (95.8%), bone marrow (91%) and bladder (82.1%) indicating an excellent classification performance. However, the segmentation and classification for air (within the rectum) may not always be successful (mean SVM accuracy 47.5%) due to the lack of air data in the training and testing sets. Our findings suggest that SVM can reliably segment and classify tissues in the pelvic region.	[Bojorquez, Jorge Arturo Zavala; Bricq, Stephanie; Walker, Paul Michael; Brunotte, Francois; Lalande, Alain] Univ Bourgogne Franche Comte, Le2i, Dijon, France; [Jodoin, Pierre-Marc] Univ Sherbrooke, VITAL, Sherbrooke, PQ, Canada; [Walker, Paul Michael; Brunotte, Francois; Lalande, Alain] CHU Dijon, Dijon, France	Universite de Bourgogne; University of Sherbrooke; CHU Dijon Bourgogne	Lalande, A (corresponding author), Univ Bourgogne Franche Comte, Le2i, Dijon, France.; Lalande, A (corresponding author), CHU Dijon, Dijon, France.	alain.lalande@u-bourgogne.fr	Lalande, Alain/T-1050-2017	zavala bojorquez, jorge arturo/0000-0002-2527-8944	Natural Sciences and Engineering Research Council of Canada (CA) [RGPIN-2018-05401]; National Council of Science and Technology of Mexico [218612-314201]	Natural Sciences and Engineering Research Council of Canada (CA)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Council of Science and Technology of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the Natural Sciences and Engineering Research Council of Canada (CA), Grant number: Discovery grant RGPIN-2018-05401 (http://www.nserc-crsng.gc.ca/index_eng.asp) to PMJ and the National Council of Science and Technology of Mexico, Grant number 218612-314201 (https://www.conacyt.gob.mx/) to JAZB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen AH, 2002, J NEUROSCI METH, V122, P13, DOI 10.1016/S0165-0270(02)00273-X; Bitar R, 2006, RADIOGRAPHICS, V26, P513, DOI 10.1148/rg.262055063; Bojorquez JZ, 2017, MAGN RESON IMAGING, V35, P69, DOI 10.1016/j.mri.2016.08.021; Bojorquez JZ, 2016, MAGN RESON MATER PHY, V29, P777, DOI 10.1007/s10334-016-0562-3; Callaghan MF, 2016, NMR BIOMED, V29, P1729, DOI 10.1002/nbm.3658; Chen PF, 2009, INT CONF ACOUST SPEE, P417, DOI 10.1109/ICASSP.2009.4959609; Cho S, 1997, MAGN RESON IMAGING, V15, P1133, DOI 10.1016/S0730-725X(97)00202-6; Criminisil A, 2011, FOUND TRENDS COMPUT, V7, P81, DOI [10.1501/0000000035, 10.1561/0600000035]; de Bazelaire CMJ, 2004, RADIOLOGY, V230, P652, DOI 10.1148/radiol.2303021331; Demuth H. B., 2014, NEURAL NETWORK DESIG; Dunham M. H., 2002, DATA MINING INTRO AD; Edden RAE, 2010, J MAGN RESON IMAGING, V32, P982, DOI 10.1002/jmri.22306; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Gatidis S, 2015, NMR BIOMED, V28, P914, DOI 10.1002/nbm.3329; Iglesias JE, 2010, LECT NOTES COMPUT SC, V6363, P81; Jager F, 2009, IEEE T MED IMAGING, V28, P137, DOI 10.1109/TMI.2008.2004429; Kapur T, 1996, Med Image Anal, V1, P109, DOI 10.1016/S1361-8415(96)80008-9; Keerthi SS, 2008, P 14 ACM SIGKDD INT, P408, DOI DOI 10.1145/1401890.1401942; Kimpe T, 2007, J DIGIT IMAGING, V20, P422, DOI 10.1007/s10278-006-1052-3; Kumar R, 2012, J MAGN RESON IMAGING, V35, P300, DOI 10.1002/jmri.22831; Litjens G, 2014, MED IMAGE ANAL, V18, P359, DOI 10.1016/j.media.2013.12.002; Maji S, 2008, PROC CVPR IEEE, P2245; Noth U, 2015, NMR BIOMED, V28, P818, DOI 10.1002/nbm.3324; Pai A, 2008, MAGN RESON IMAGING, V26, P1215, DOI 10.1016/j.mri.2008.02.017; Pasquier D, 2007, INT J RADIAT ONCOL, V68, P592, DOI 10.1016/j.ijrobp.2007.02.005; Ramos-Llorden G, 2018, IEEE T MED IMAGING, P1; Ratsch G, 2001, MACH LEARN, V42, P287, DOI 10.1023/A:1007618119488; Schick F, 2016, MAGN RESON MATER PHY, V29, P89, DOI 10.1007/s10334-016-0549-0; Shinohara RT, 2014, NEUROIMAGE-CLIN, V6, P9, DOI 10.1016/j.nicl.2014.08.008; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Tofts P, 2005, QUANTITATIVE MRI BRA; Traynor CR, 2011, NEUROIMAGE, V56, P939, DOI 10.1016/j.neuroimage.2011.01.083; Wang L, 2016, MAGN RESON MATER PHY, V29, P95, DOI 10.1007/s10334-015-0520-5; West J, 2012, EUR RADIOL, V22, P998, DOI 10.1007/s00330-011-2336-7; Yakar D, 2012, J MAGN RESON IMAGING, V35, P20, DOI 10.1002/jmri.22790	36	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0211944	10.1371/journal.pone.0211944	http://dx.doi.org/10.1371/journal.pone.0211944			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794559	gold, Green Published, Green Submitted			2022-12-27	WOS:000459709100027
J	Jeong, JJ; Lee, DW; Song, SY; Park, Y; Kim, JH; Kim, JI; Kim, HG; Nam, KT; Lee, WJ; Nam, KH; Lee, JH				Jeong, Jong Ju; Lee, Dong Won; Song, Seung Yong; Park, Yerin; Kim, Ji Hee; Kim, Jang Il; Kim, Hyung Goo; Nam, Ki Taek; Lee, Won Jai; Nam, Kee-Hyun; Lee, Ju Hee			Development of novel biocompatible thermosensitive anti-adhesive agents using human-derived acellular dermal matrix	PLOS ONE			English	Article							HUMAN PERITONEAL ADHESIONS; POSTOPERATIVE ADHESIONS; THYROIDECTOMY SCARS; IN-VITRO; PREVENTION; BARRIER; MEMBRANE; CHITOSAN; ACID	Postoperative adhesion is a natural phenomenon that occurs in damaged tissue cells. Several anti-adhesion agents are currently used, but there is no leading-edge product with excellent adhesion-preventive effects. The purpose of this study was to develop ideal anti-adhesive agents using human-derived acellular dermal matrix (ADM). We developed 5 new biocompatible thermosensitive anti-adhesion barriers (AABs) using micronized human-derived ADM, hyaluronic acid, and temperature-sensitive and biocompatible synthesized polymers. The biocompatibility, anti-adhesion effect, and biodegradability of these AABs were compared with those of commercial thermosensitive anti-adhesion agents. No cytotoxic effects were observed in vitro and in vivo. Animal testing of adhesion resistance confirmed that the adhesion area, strength, and grade of AAB03 were statistically superior to those of the control group. Factors related to adhesion formation, such as lymphocytes, macrophages, microvessels, and collagen fiber density, were observed using specific staining methods; the results confirmed that AAB03 group exhibited significantly lower macrophage counts, microvessel density, and collagen fiber density than the control groups. Furthermore, AAB03 was completely absorbed by 6 weeks. Thus, AAB03 has the potential to be used as a high-performance anti-adhesion agent.	[Jeong, Jong Ju; Nam, Kee-Hyun] Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea; [Lee, Dong Won; Song, Seung Yong; Lee, Won Jai] Yonsei Univ, Coll Med, Inst Human Tissue Restorat, Dept Plast & Reconstruct Surg, Seoul, South Korea; [Park, Yerin; Kim, Jang Il; Kim, Hyung Goo] L&C BIO Co Ltd, R&D Ctr, Gyeonggi Do, South Korea; [Kim, Ji Hee; Lee, Ju Hee] Yonsei Univ, Coll Med, Dept Dermatol, Seoul, South Korea; [Kim, Ji Hee; Lee, Ju Hee] Yonsei Univ, Coll Med, Cutaneous Biol Res Inst, Seoul, South Korea; [Nam, Ki Taek] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Nam, KH (corresponding author), Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea.; Lee, JH (corresponding author), Yonsei Univ, Coll Med, Dept Dermatol, Seoul, South Korea.; Lee, JH (corresponding author), Yonsei Univ, Coll Med, Cutaneous Biol Res Inst, Seoul, South Korea.	khnam@yuhs.ac; juhee@yuhs.ac		Kim, Jihee/0000-0002-0047-5941; Jeong, Jong Ju/0000-0002-4155-6035; Lee, Dongwon/0000-0003-0046-3139; Nam, Kee-Hyun/0000-0002-6852-1190; Lee, Ju Hee/0000-0002-1739-5956; won jai, lee/0000-0003-3056-0503	Technology Development Program [S2305273]; Ministry of SMEs and Startups (MSS, Korea); LC BIO Co. Ltd	Technology Development Program; Ministry of SMEs and Startups (MSS, Korea); LC BIO Co. Ltd	This work was supported by the Technology Development Program (S2305273), which is funded by the Ministry of SMEs and Startups (MSS, Korea). L&C BIO Co. Ltd provided support for this study in the form of salaries for YP, JIK, and HGK. The specific roles of these authors are articulated in the 'author contributions' section. The MSS also provided support in the form of purchasing animal study materials. The funders had no additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Musawi D, 2001, GYNAECOL ENDOSC, V10, P123, DOI 10.1046/j.1365-2508.2001.00422.x; Archana D, 2015, INT J BIOL MACROMOL, V73, P49, DOI 10.1016/j.ijbiomac.2014.10.055; Attard JAP, 2007, CAN J SURG, V50, P291; Bahadir I, 2007, DIS COLON RECTUM, V50, P2209, DOI 10.1007/s10350-007-9074-6; Binnebosel M, 2008, WORLD J SURG, V32, P296, DOI 10.1007/s00268-007-9330-x; BLAUER KL, 1988, FERTIL STERIL, V49, P144; Cheong YC, 2001, HUM REPROD UPDATE, V7, P556, DOI 10.1093/humupd/7.6.556; Ersoy E, 2008, J SURG RES, V147, P148, DOI 10.1016/j.jss.2007.09.005; Gago LA, 2006, FERTIL STERIL, V86, P1223, DOI 10.1016/j.fertnstert.2006.04.021; Gutt CN, 2004, SURG ENDOSC, V18, P898, DOI 10.1007/s00464-003-9233-3; Habara T, 2002, J BIOMED MATER RES, V61, P628, DOI 10.1002/jbm.10247; Hellebrekers BWJ, 2000, FERTIL STERIL, V74, P203, DOI 10.1016/S0015-0282(00)00656-7; Herrick SE, 2000, J PATHOL, V192, P67; Hooker GD, 1999, SURGERY, V125, P211, DOI 10.1016/S0039-6060(99)70267-9; Kim DY, 2015, DERMATOL SURG, V41, P812, DOI 10.1097/DSS.0000000000000410; Lee JH, 2015, BIOMATERIALS, V44, P195, DOI 10.1016/j.biomaterials.2014.12.004; Lee WJ, 1995, J KOREAN SURG SOC, V49, P192; Liu YC, 2007, FERTIL STERIL, V87, P940, DOI 10.1016/j.fertnstert.2006.07.1532; Luo X, 2017, J BIOMED MATER RES B, V105, P585, DOI 10.1002/jbm.b.33572; Mais V, 2011, Minerva Ginecol, V63, P47; Mirzaei-parsa MJ, 2019, CELL TISSUE RES, V375, P709, DOI 10.1007/s00441-018-2927-6; Ouaissi M, 2012, J VISC SURG, V149, pE104, DOI 10.1016/j.jviscsurg.2011.11.006; REPLOGLE RL, 1966, ANN SURG, V163, P580, DOI 10.1097/00000658-196604000-00011; Rosch R, 2011, SURG ENDOSC, V25, P3605, DOI 10.1007/s00464-011-1766-2; Rout UK, 2003, FERTIL STERIL, V79, P138, DOI 10.1016/S0015-0282(02)04569-7; Shin JU, 2015, J WOUND CARE, V24, P163, DOI 10.12968/jowc.2015.24.4.163; SIEGLER AM, 1980, FERTIL STERIL, V34, P46; STEINLEITNER A, 1991, OBSTET GYNECOL, V77, P48; Tjarnstrom J, 1999, EUR J SURG, V165, P834; URMAN B, 1991, FERTIL STERIL, V56, P563; Vlahos A, 2001, AM SURGEON, V67, P15; Yang HY, 1997, J KOREAN SURG SOC, V52, P335; 오애경, 2013, [Biomaterials Research, 생체재료학회지], V17, P138; 이윤기, 2008, [Annals of Surgical Treatment and Research, 대한외과학회지], V74, P399	34	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212583	10.1371/journal.pone.0212583	http://dx.doi.org/10.1371/journal.pone.0212583			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794612	gold, Green Published, Green Submitted			2022-12-27	WOS:000459709100091
J	Kruesi, LM; Burstein, FV; Tanner, KJ				Kruesi, Lisa M.; Burstein, Frada V.; Tanner, Kerry J.			With open science gaining traction, do we need an Australasia PubMed Central (PMC)? A qualitative investigation	PLOS ONE			English	Article							OPEN-ACCESS; REPOSITORIES	Open biomedical repositories, such as PubMed Central (PMC), are a means to make research discoverable and permanently accessible. Assessing the potential interest of key stakeholders in an Australasia PubMed Central was the objective of this research. The investigation is novel, assisting in the development of open science infrastructure through its systematic analysis of the potential interest in, and viability of a biomedical repository for managing openly accessible research outputs for the Australasia region. The research adopted a qualitative approach based on semi-structured interviews and a focus group. Forty-four stakeholders located throughout Australia and New Zealand participated in the research. Participants expanded upon their experience of PubMed, MEDLINE, PMC and their use of information resources for research and clinical practice. The Evidence Based Healthcare (EBHC) pyramid was the theoretical model adopted to explain open biomedical repository processes. A strengths, weaknesses, opportunities and threats (SWOT) analysis identified support for exploring membership of an international PMC system, in particular Europe PMC. Lessons learnt from PMC US, Europe PMC and PMC Canada (collectively known as PubMed Central International) informed the investigation. A major strength identified was that PubMed Central International has been able to achieve high levels of compliance way beyond that of most institutional repositories. A great threat faced is overcoming the difficulties of working together with other major world bodies and financially sustaining an Australasia PMC. Improving Australasian biomedical knowledge management processes may be possible from adopting a PMC for retrieving and transferring research, linked to the data underlying the research. This in turn could help put regional research under a brighter spotlight, potentially leading to improvements in research quality. There is an opportunity for a potential Australasia PMC to harvest biomedical research from the National Library of Australia's aggregator database, Trove and work closely with Europe PMC to avoid duplication of effort. Overall, establishment of an Australasia permanent biomedical digital open repository is perceived as important, with significant potential flow-on benefits to healthcare, industry and society.	[Kruesi, Lisa M.; Burstein, Frada V.; Tanner, Kerry J.] Monash Univ, Fac Informat Technol, Melbourne, Vic, Australia	Monash University	Kruesi, LM (corresponding author), Monash Univ, Fac Informat Technol, Melbourne, Vic, Australia.	lisa.kruesi1@monash.edu	Kruesi, Lisa/O-6316-2019; Burstein, Frada/AAH-2483-2019	Kruesi, Lisa/0000-0001-6629-9138; Burstein, Frada/0000-0001-8258-0878; Tanner, Kerry/0000-0001-6290-8610				Alper Brian S, 2016, Evid Based Med, V21, P123, DOI 10.1136/ebmed-2016-110447; Australian F.A.I.R. Access Working Group, 2017, FRAM FAIR ACC AUSTR; Australian Institute of Health and Welfare, 2015, ACUTE KIDNEY INJURY, P1; Beagrie Neil, 2016, VALUE IMPACT EUROPEA; Becerra-Fernandez I., 2015, KNOWLEDGE MANAGEMENT; Creswell JW., 2018, QUAL INQ, V4th; Cullen R, 2011, J ACAD LIBR, V37, P460, DOI 10.1016/j.acalib.2011.07.002; ELDEN M, 1993, HUM RELAT, V46, P121, DOI 10.1177/001872679304600201; Elliott JH, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001603; Gou Y, 2015, NUCLEIC ACIDS RES, V43, pD1042, DOI 10.1093/nar/gku1061; Greenberg SJ, 2009, J MED LIBR ASSOC, V97, P108, DOI 10.3163/1536-5050.97.2.007; Hansoti B, 2016, WEST J EMERG MED, V17, P497, DOI 10.5811/westjem.2016.7.30328; Haynes R B, 2001, ACP J Club, V134, pA11; Lariviere V, 2018, NATURE, V562, P483, DOI 10.1038/d41586-018-07101-w; National Health and Medical Research Council (Australia), 2018, OP ACC POL; National Library of Australia, 2018, LEG DEP; National Science Foundation, 2018, SCI ENG IND 2018 AC; Pinfield S, 2014, J ASSOC INF SCI TECH, V65, P2404, DOI 10.1002/asi.23131; Piwowar H, 2018, PEERJ, V6, DOI 10.7717/peerj.4375; Poynder R, 2016, Q A CNIS C LYNCH TIM; Roberts RJ, 2001, P NATL ACAD SCI USA, V98, P381, DOI 10.1073/pnas.98.2.381; Steele C, 2013, INSIGHTS, V26, P282, DOI 10.1629/2048-7754.91; Williamson K., 2013, RES METHODS INFORM S, P188; Xu Qinyi, 2014, F1000Res, V3, P292, DOI 10.12688/f1000research.5775.2	24	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212843	10.1371/journal.pone.0212843	http://dx.doi.org/10.1371/journal.pone.0212843			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794701	gold, Green Published, Green Submitted			2022-12-27	WOS:000459709100147
J	Molenaar, NM; Brouwer, ME; Kamperman, AM; Burger, H; Williams, AD; Hoogendijk, WJG; Bockting, CLH; Lambregtse-van den Berg, MP				Molenaar, Nina M.; Brouwer, Marlies E.; Kamperman, Astrid M.; Burger, Huibert; Williams, Alishia D.; Hoogendijk, Witte J. G.; Bockting, Claudi L. H.; Lambregtse-van den Berg, Mijke P.			Recurrence of depression in the perinatal period: Clinical features and associated vulnerability markers in an observational cohort	PLOS ONE			English	Article							ANTENATAL DEPRESSION; MATERNAL DEPRESSION; MAJOR DEPRESSION; MENTAL-HEALTH; DRUG-USE; PREGNANCY; ANTIDEPRESSANTS; PREVALENCE; WOMEN; RISK	Objective Antidepressant medication is commonly used for the prevention of depression recurrence in the perinatal period, yet it is unknown what vulnerability markers may play a role in recurrence. The objective of the current study was to provide a descriptive overview of the associated characteristics of women who experienced a perinatal recurrence of depression despite ongoing antidepressant use, and further, to identify clinically measurable vulnerability markers associated with recurrence. Methods Eighty-five pregnant women with a history of depression who used antidepressants (e.g. Selective Serotonin Reuptake Inhibitors or Serotonin and Noradrenaline Reuptake Inhibitors) at the start of the study were included. Clinical features, including information on psychiatric history and antidepressant use, were collected throughout the perinatal period (in this study defined as the period between 12 weeks of pregnancy untill three months postpartum). The clinical features of women experiencing recurrence of depression were described in detail. To identify vulnerability markers associated with recurrence of depression, we performed exploratory univariable logistic regression analyses. Results Eight women (9.4%) experienced a recurrence of depression; two during pregnancy and six in the first 12 weeks postpartum. All women with recurrence of depression had first onset of depression during childhood or adolescence and had at least 2 psychiatric co-morbidities. Identification of vulnerability markers associated with recurrence of depression yielded associations with depressive symptoms around 16 weeks of pregnancy (OR 1.28, 95% CI 1.08-1.52), number of psychiatric co-morbidities (OR 1.89, 95% CI 1.16-3.09) and duration of antidepressant use (OR 1.01, 95% CI 1.00-1.02). Conclusion Implementing adequate risk assessment in pregnant women who use antidepressants can help identify predictors for recurrence of depression in future studies and thus ultimately lead to improved care.	[Molenaar, Nina M.; Kamperman, Astrid M.; Hoogendijk, Witte J. G.; Lambregtse-van den Berg, Mijke P.] Erasmus MC, Dept Psychiat, Rotterdam, Netherlands; [Brouwer, Marlies E.; Burger, Huibert; Bockting, Claudi L. H.] Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Psychiat, Iocat AMC, Amsterdam, Netherlands; [Brouwer, Marlies E.] Univ Utrecht, Dept Clin Psychol, Utrecht, Netherlands; [Burger, Huibert] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice & Elderly Care Med, Groningen, Netherlands; [Williams, Alishia D.] Univ New South Wales, Sch Psychol, Fac Sci, Sydney, NSW, Australia; [Lambregtse-van den Berg, Mijke P.] Erasmus MC, Sophia Childrens Hosp, Dept Child & Adolescent Psychiat, Rotterdam, Netherlands; [Molenaar, Nina M.] Mt Sinai Hosp, Icahn Sch Med, Dept Psychiat, New York, NY 10029 USA	Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Utrecht University; University of Groningen; University of New South Wales Sydney; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Icahn School of Medicine at Mount Sinai	Molenaar, NM (corresponding author), Erasmus MC, Dept Psychiat, Rotterdam, Netherlands.; Molenaar, NM (corresponding author), Mt Sinai Hosp, Icahn Sch Med, Dept Psychiat, New York, NY 10029 USA.	n.m.molenaar@erasmusmc.nl	Kamperman, Astrid/J-8046-2015	Kamperman, Astrid/0000-0003-4455-6492; Lambregtse-van den Berg, Mijke/0000-0003-1764-5940; Bockting, Claudi L.H./0000-0002-9220-9244; Brouwer, Marlies/0000-0002-9972-9058; Burger, Huibert/0000-0001-6484-0349	Netherlands Organization for Health Research and Development (ZonMw) [836021011]	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	This work was supported by a grant from the Netherlands Organization for Health Research and Development (ZonMw); grant number 836021011; grant recipients: M.P. Lambregtse-van den Berg, W.J.G. Hoogendijk, C.L.H. Bockting, H. Burger. The funding source was not involved in the design and conduct of the study, management, analysis, and interpretation of the data, preparation, review, and approval of the manuscript; or decision to submit the manuscript for publication.	American Psychiatric Association, 2010, PRACTICE GUIDELINE T, V3rd; Bakker MK, 2008, BRIT J CLIN PHARMACO, V65, P600, DOI 10.1111/j.1365-2125.2007.03048.x; Bergink V, 2011, J PSYCHOSOM RES, V70, P385, DOI 10.1016/j.jpsychores.2010.07.008; Bockting CLH, 2018, LANCET PSYCHIAT, V5, P401, DOI 10.1016/S2215-0366(18)30100-7; Bouwmans C, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-217; Brockington I, 2011, WORLD PSYCHIATRY, V10, P93; Brouwer ME, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1192-6; Bunevicius A, 2009, J PSYCHOSOM OBST GYN, V30, P238, DOI 10.3109/01674820903230708; Burcusa SL, 2007, CLIN PSYCHOL REV, V27, P959, DOI 10.1016/j.cpr.2007.02.005; Charlton RA, 2015, BJOG-INT J OBSTET GY, V122, P1010, DOI 10.1111/1471-0528.13143; Cohen LS, 2006, JAMA-J AM MED ASSOC, V295, P499, DOI 10.1001/jama.295.5.499; Cooper WO, 2007, AM J OBSTET GYNECOL, V196, P544, DOI 10.1016/j.ajog.2007.01.033; Cuijpers P, 2015, EUR CHILD ADOLES PSY, V24, P237, DOI 10.1007/s00787-014-0660-6; Daw JR, 2012, CLIN THER, V34, P239, DOI 10.1016/j.clinthera.2011.11.025; Field T, 2011, INFANT BEHAV DEV, V34, P1, DOI 10.1016/j.infbeh.2010.09.008; First MB, 2002, STRUCTURED CLIN INTE; Goodman SH, 2011, CLIN CHILD FAM PSYCH, V14, P1, DOI 10.1007/s10567-010-0080-1; Grigoriadis S, 2013, J CLIN PSYCHIAT, V74, pE321, DOI 10.4088/JCP.12r07968; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; Hardeveld F, 2010, ACTA PSYCHIAT SCAND, V122, P184, DOI 10.1111/j.1600-0447.2009.01519.x; Hay DF, 2010, CHILD DEV, V81, P149, DOI 10.1111/j.1467-8624.2009.01386.x; Home R, 1997, PSYCHOL HEALTH, V14, P1, DOI [DOI 10.1080/08870449908407311, 10.1080/08870449908407311]; Howard LM, 2014, LANCET, V384, P1775, DOI 10.1016/S0140-6736(14)61276-9; Jarde A, 2016, JAMA PSYCHIAT, V73, P826, DOI 10.1001/jamapsychiatry.2016.0934; Jimenez-Solem E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063034; Kuyken W, 2015, LANCET, V386, P63, DOI 10.1016/S0140-6736(14)62222-4; Molenaar NM, 2018, AUST NZ J PSYCHIAT, V52, P320, DOI 10.1177/0004867418762057; Molenaar NM, 2018, MIDWIFERY, V61, P29, DOI 10.1016/j.midw.2018.02.018; Molenaar NM, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0752-6; Molyneaux E, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004363.pub3; National Institute for Health and Clinical Excellence, 2014, ANT POSTN MENT HLTH; Sim K, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyv076; Swanson SA, 2015, PHARMACOEPIDEM DR S, V24, P934, DOI 10.1002/pds.3798; Talge NM, 2007, J CHILD PSYCHOL PSYC, V48, P245, DOI 10.1111/j.1469-7610.2006.01714.x; Ten Have M, 2018, ACTA PSYCHIAT SCAND; Tronick E, 2009, HARVARD REV PSYCHIAT, V17, P147, DOI 10.1080/10673220902899714; van Ravesteyn LM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173397; Ververs T, 2006, EUR J CLIN PHARMACOL, V62, P863, DOI 10.1007/s00228-006-0177-0; Vesga-Lopez O, 2008, ARCH GEN PSYCHIAT, V65, P805, DOI 10.1001/archpsyc.65.7.805; Vliegen N, 2014, HARVARD REV PSYCHIAT, V22, P1, DOI 10.1097/HRP.0000000000000013; Woody CA, 2017, J AFFECT DISORDERS, V219, P86, DOI 10.1016/j.jad.2017.05.003; Yonkers KA, 2011, EPIDEMIOLOGY, V22, P848, DOI 10.1097/EDE.0b013e3182306847; Zisook S, 2007, ACTA PSYCHIAT SCAND, V115, P196, DOI 10.1111/j.1600-0447.2006.00868.x; Zisook S, 2004, PSYCHIAT RES, V129, P127, DOI 10.1016/j.psychres.2004.07.004	44	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212964	10.1371/journal.pone.0212964	http://dx.doi.org/10.1371/journal.pone.0212964			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794709	Green Published, gold, Green Submitted			2022-12-27	WOS:000459709100164
J	Porobic, J; Fulton, EA; Parada, C; Frusher, S; Ernst, B; Manriquez, P				Porobic, Javier; Fulton, Elizabeth A.; Parada, Carolina; Frusher, Stewart; Ernst, Billy; Manriquez, Pablo			The impact of fishing on a highly vulnerable ecosystem, the case of Juan Fernandez Ridge ecosystem	PLOS ONE			English	Article							LOBSTER JASUS-EDWARDSII; CRAB CHACEON-CHILENSIS; ROBINSON-CRUSOE ISLAND; SEA SEAMOUNT FISHERIES; ROCK LOBSTER; HOPLOSTETHUS-ATLANTICUS; MARINE ECOSYSTEMS; SPINY LOBSTER; ORANGE ROUGHY; ARCHIPELAGO	The Juan Fernandez Ridge (JFRE) is a vulnerable marine ecosystem (VME) located off the coast of central Chile formed by the Juan Fernandez Archipelago and a group of seamounts. This ecosystem has unique biological and oceanographic features, characterized by: small geographical units, high degree of endemism with a high degree of connectivity within the system. Two fleets have historically operated in this system: a long term coastal artisanal fishery associated with the Islands, focused mainly on lobster, and a mainland based industrial demersal finfish fishery operating on the seamounts which is currently considered overexploited. The management of these fisheries has been based on a classical single-species approach to determine output controls (industrial fleet) and a mixed management system with formal and informal components (artisanal fleet). There has been growing interest in increasing the exploitation of fisheries, and modernization of the fishing fleet already operating in the JFRE. Under this scenario of increased levels of fishing exploitation and the high level of interrelation of species it might be necessary to understand the impact of these fisheries from a holistic perspective based on a ecosystem-based modeling approach. To address these challenges we developed an Atlantis end-to-end model was configured for this ecosystem. The implemented model has a high degree of skill in representing the observed trends and fluctuations of the JFRE. The model shows that the industrial fishing has a localized impact and the artisanal fisheries have a relatively low impact on the ecosystem, mainly via the lobster fishery. The model indicates that the depletion of large sized lobster has leads to an increase in the population of sea urchins. Although this increase is not sufficient, as yet, to cause substantial flow-on effects to other groups, caution is advised in case extra pressure leads the ecosystem towards a regime shift.	[Porobic, Javier] Inst Marine & Antarctic Studies, Quantitat Marine Sci Program, Hobart, Tas, Australia; [Porobic, Javier; Fulton, Elizabeth A.] CSIRO Oceans & Atmosphere, Hobart, Tas, Australia; [Porobic, Javier] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Fulton, Elizabeth A.; Frusher, Stewart] Univ Tasmania, Ctr Marine Socioecol, Hobart, Tas, Australia; [Parada, Carolina] Univ Concepcion, Dept Geofis, Concepcion, Chile; [Parada, Carolina] Univ Concepcion, Inst Milenio Oceanog, Concepcion, Chile; [Parada, Carolina; Ernst, Billy] Univ CatoIica Norte, Dept Biol Marina, Millennium Nucleus Ecol & Sustainable Management, Coquimbo, Chile; [Ernst, Billy; Manriquez, Pablo] Univ Concepcion, Dept Oceanog, Concepcion, Chile	University of Tasmania; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Tasmania; University of Tasmania; Universidad de Concepcion; Universidad de Concepcion; Universidad de Concepcion	Porobic, J (corresponding author), CSIRO Oceans & Atmosphere, Hobart, Tas, Australia.; Porobic, J (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	javier.porobicgarate@csiro.au	Fulton, Beth/A-2871-2008; Porobic, Javier/ABE-7495-2021	Fulton, Beth/0000-0002-5904-7917; Porobic, Javier/0000-0001-5642-5372	Commonwealth Scientific and Industrial Research Organization; Institute for Marine and Antarctic Studies, University of Tasmania; University of Tasmania	Commonwealth Scientific and Industrial Research Organization; Institute for Marine and Antarctic Studies, University of Tasmania; University of Tasmania	This work was supported by The Commonwealth Scientific and Industrial Research Organization and the Institute for Marine and Antarctic Studies, University of Tasmania. The author Javier Porobic received a PhD scholarship, part of the Quantitative Marine Science program from the University of Tasmania and The Commonwealth Scientific and Industrial Research Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahumada M, 2009, LAT AM J AQUAT RES, V37, P285, DOI 10.3856/vol37-issue3-fulltext-2; Althaus F, 2009, MAR ECOL PROG SER, V397, P279, DOI 10.3354/meps08248; Anderson OF, 2003, MAR FRESHWATER RES, V54, P643, DOI 10.1071/MF02163; Andrade I, 2014, LAT AM J AQUAT RES, V42, P888, DOI 10.3856/vol42-issue4-fulltext-14; [Anonymous], 2009, ADAPTIVE ENV MANAGEM, DOI DOI 10.1007/978-1-4020-9632-7_13; Arana P, 2012, PROPUESTA INDICACION; Arana P, 1983, ANALISIS PESQUERIAS, P77; Arana P., 2000, INVEST MAR, V28, P39; Arana P.M., 1987, ISLAS OCEANICAS CHIL, P321; Arana PM, 2000, INVEST MAR VALPARAIS, V28, P219, DOI 10.4067/S0717-71782000002800016; Arana PM, 1985, INVEST MAR, P126; Ardron JA, 2014, MAR POLICY, V49, P146, DOI 10.1016/j.marpol.2013.11.017; Audzijonyte A., 2017, ATLANTIS USERS GUI 2; Audzijonyte A., 2017, ATLANTIS USERS GUI 1; Audzijonyte A, 2018, METHODS ECOLOGY EVOL; Auster PJ, 2011, ICES J MAR SCI, V68, P254, DOI 10.1093/icesjms/fsq074; Clark MR, 2012, ENVIRON CONSERV, V39, P204, DOI 10.1017/S0376892912000021; Clark MR, 2010, ANNU REV MAR SCI, V2, P253, DOI 10.1146/annurev-marine-120308-081109; Clark Malcolm R., 2007, Fish and Aquatic Resources Series, V12, P413; Clark MR, 2009, LAT AM J AQUAT RES, V37, P501, DOI 10.3856/vol37-issue3-fulltext-17; Directorate General of Civil Aeronautics of Chile, CLIM YB; Dunn MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026704; Ernst B, 2017, INFORME FINAL; Ernst B., 2016, EVALUACION DIRECTA B; Ernst B, 2014, INFORME FINAL PROGRA; Ernst B., 2010, B MAR SCI, V86, P1; Ernst B, 2015, FINAL REPORT ESTUDIO; Ernst B, 2012, 472849LE11 U CONC; Ernst B, 2013, GLOBAL ENVIRON CHANG, V23, P1381, DOI 10.1016/j.gloenvcha.2013.08.002; Francis J, 1998, MAR MAMMAL SCI, V14, P552, DOI 10.1111/j.1748-7692.1998.tb00742.x; Free Software Foundation Inc, 2016, GNU COMP COLL; Friedlander AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145059; Fulton EA, 2011, FISH FISH, V12, P171, DOI 10.1111/j.1467-2979.2011.00412.x; Fulton EA, 2010, J MARINE SYST, V81, P171, DOI 10.1016/j.jmarsys.2009.12.012; Goes CA, 2009, BRAZ J BIOL, V69, P143, DOI 10.1590/S1519-69842009000100018; Goni R, 1998, OCEAN COAST MANAGE, V40, P37, DOI 10.1016/S0964-5691(98)00037-4; Grabowski JH, 2009, NEW ZEAL J MAR FRESH, V43, P185, DOI 10.1080/00288330909509992; Guerrero A, 2009, LAT AM J AQUAT RES, V37, P347, DOI 10.3856/vol37-issue3-fulltext-6; Guest MA, 2009, MAR ECOL PROG SER, V388, P169, DOI 10.3354/meps08096; Halpern BS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8615; Heino M, 2015, ANNU REV ECOL EVOL S, V46, P461, DOI 10.1146/annurev-ecolsys-112414-054339; Hormazabal S, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001956; Horn PL, 2010, J FISH BIOL, V76, P2382, DOI 10.1111/j.1095-8649.2010.02630.x; Huvenne VAI, 2016, BIOL CONSERV, V200, P60, DOI 10.1016/j.biocon.2016.05.030; Ilustre Municipalidad de Juan Fernandez, 2015, ACT PLAN DES COM 2 1; Institute de Recherche pour le Developpement, 2018, ICHTH SIM ICHTH DYN; Johnson P, 2011, CHILD SOC, V25, P394, DOI 10.1111/j.1099-0860.2009.00288.x; Kaiser MJ, 2002, FISH FISH, V3, P114, DOI 10.1046/j.1467-2979.2002.00079.x; Komoroske LM, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00083; Kramer-Schadt S, 2007, ECOL MODEL, V204, P553, DOI 10.1016/j.ecolmodel.2007.01.018; Kruse G.H., 1993, BIOL PERSPECTIVES CR; Labbe F. Johnny, 2001, Revista de Biologia Marina y Oceanografia, V36, P75; Lett C, 2008, ENVIRON MODELL SOFTW, V23, P1210, DOI 10.1016/j.envsoft.2008.02.005; Levin PS, 2009, PLOS BIOL, V7, P23, DOI 10.1371/journal.pbio.1000014; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; Liakath-Ali K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4540; Ling SD, 2009, P NATL ACAD SCI USA, V106, P22341, DOI 10.1073/pnas.0907529106; Linnane A, 2014, ICES J MAR SCI, V71, P528, DOI 10.1093/icesjms/fst176; Loh TL, 2015, PEERJ, V3, P16; MACE PM, 1990, NEW ZEAL J MAR FRESH, V24, P105, DOI 10.1080/00288330.1990.9516406; Manriquez  Pablo, 2016, CRECIMIENTO SOMATICO; Masumoto Y., 2004, J EARTH SIMULATOR, V1, P35; Mayorga E, 2010, ENVIRON MODELL SOFTW, V25, P837, DOI 10.1016/j.envsoft.2010.01.007; Medel C, 2018, PROG OCEANOGR, V162, P98, DOI 10.1016/j.pocean.2018.02.017; Niklitschek E, 2005, ESTIMACION BIOMASA R; Niklitschek E, 2007, INFORME FINAL EVALUA; Niklitschek EJ, 2010, MAR ECOL-EVOL PERSP, V31, P168, DOI 10.1111/j.1439-0485.2010.00372.x; Norse EA, 2012, MAR POLICY, V36, P307, DOI 10.1016/j.marpol.2011.06.008; Olsen E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146467; Parada C, 2017, ICES J MAR SCI, V74, P2398, DOI 10.1093/icesjms/fsx065; Paya I, 2013, 2 INFORME CONVENIO E; Paya I, 2003, DEEP SEA 2003 C GO 2, V1, P97; Pequeno R. German, 2000, Investigaciones Marinas Universidad Catolica de Valparaiso, V28, P27; Perez-Matus A, 2014, LAT AM J AQUAT RES, V42, P814, DOI 10.3856/vol42-issue4-fulltext-9; Pitcher TJ, 2010, OCEANOGRAPHY, V23, P134, DOI 10.5670/oceanog.2010.66; Plaganyi E.E., 2007, MODELS ECOSYSTEM APP, V477; Plaganyi EE, 2014, FISH FISH, V15, P1, DOI 10.1111/j.1467-2979.2012.00488.x; Porobic J, 2013, ESTUDIO CONECTIVIDAD; Porobic J, 2013, J HERED, V104, P223, DOI 10.1093/jhered/ess141; Porobic J, 2012, LAT AM J AQUAT RES, V40, P613, DOI 10.3856/vol40-issue3-fulltext-11; Preciado I, 2017, DEEP-SEA RES PT II, V137, P56, DOI 10.1016/j.dsr2.2016.07.013; Rivara P, 2013, ESTUDIO BIOL REPROD; Rodrigo C, 2014, LAT AM J AQUAT RES, V42, P907, DOI 10.3856/vol42-issue4-fulltext-15; Rodriguez-Ruiz MC, 2014, LAT AM J AQUAT RES, V42, P918, DOI 10.3856/vol42-issue4-fulltext-16; Sasaki H, 2008, HIGH RESOLUTION NUMERICAL MODELLING OF THE ATMOSPHERE AND OCEAN, P157, DOI 10.1007/978-0-387-49791-4_10; Smith ADM, 2007, ICES J MAR SCI, V64, P633, DOI 10.1093/icesjms/fsm041; Steneck RS, 2006, J CRUSTACEAN BIOL, V26, P628, DOI 10.1651/S-2753.1; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Team RC., 2013, R LANG ENV STAT COMP; Vargas R, 2011, BOSQUE, V32, P155, DOI 10.4067/S0717-92002011000200006; Waddington KI, 2009, FISH RES, V99, P1, DOI 10.1016/j.fishres.2009.04.002; White M, 2007, FISH AQUATIC RESOURC, P65; Wiff R, 2013, 2 INFORME CONVENIO E; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; Yanez E, 2008, BIODIVERSIDAD MONTES; YANEZ E, 1996, INVEST MAR, V24, P131; Yanez E, 2009, LAT AM J AQUAT RES, V37, P555, DOI 10.3856/vol37-issue3-fulltext-20	97	9	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212485	10.1371/journal.pone.0212485	http://dx.doi.org/10.1371/journal.pone.0212485			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794609	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000459709100076
J	Roumani, AM; Madkour, A; Ouzzani, M; McGrew, T; Omran, E; Zhang, X				Roumani, Ali M.; Madkour, Amgad; Ouzzani, Mourad; McGrew, Thomas; Omran, Esraa; Zhang, Xiang			BioNetApp: An interactive visual data analysis platform for molecular expressions	PLOS ONE			English	Article							VISUALIZATION; ENVIRONMENT; TOOL	Motivation Systems biology faces two key challenges when dealing with large amounts of disparate data produced by different experiments: the integration of results across different experiments, and the extraction of meaningful information from the data produced by these experiments. An ongoing challenge is to provide better tools that can mine data patterns that could not have been discovered through simple visualization. Such mining capabilities also need to be coupled with intuitive visualization to portray those findings. We introduce a software toolbox entitled BioNetApp to mine these patterns and visualize them across all experiments. Results BioNetApp is an interactive visual data mining software for analyzing high-volume molecular expression data obtained from multiple 'omics experiments. By integrating visualization, statistical methods, and data mining techniques, BioNetApp can perform interactive correlative and comparative analysis along time-course studies of molecular expression data. Correlation analysis provides several visualization features such as Kamada-Kawai, Fruchterman-Reingold Spring embedding network layouts, in addition to single circle, multiple circle and heatmap layouts, whereas comparative analysis presents expression-data distributions across samples, groups, and time points with boxplot display, outlier detection, and data curve fitting. BioNetApp also provides data clustering based on molecular concentrations using Self Organizing Maps (SOM), K-Means, K-Medoids, and Farthest First algorithms. Conclusion BioNetApp has been utilized in a metabolomics study to investigate the metabolite abundance changes in alcohol induced fatty liver, where pair-wise analyses of metabolome concentration revealed correlation networks and interesting patterns in the metabolomics dataset. This study case demonstrates the effectiveness of the BioNetApp software as an interactive visual analysis tool for molecular expression data in systems biology. The BioNetApp software is freely available under GNU GPL license and can be downloaded (including the case-study data and user-manual) at: https://doi.org/10.5281/zenodo.2563129.	[Roumani, Ali M.; Omran, Esraa] Gulf Univ Sci & Technol, Dept Comp Sci, Mishref, Kuwait; [Roumani, Ali M.; McGrew, Thomas] Purdue Univ, Bindley Biosci Ctr, W Lafayette, IN 47907 USA; [Madkour, Amgad] Purdue Univ, Dept Comp Sci, W Lafayette, IN 47907 USA; [Ouzzani, Mourad] Qatar Fdn, Qatar Comp Res Inst, Doha, Qatar; [Zhang, Xiang] Univ Louisville, Dept Chem, Louisville, KY 40292 USA	Gulf University of Science & Technology; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar; Qatar Computing Research Institute; University of Louisville	Roumani, AM (corresponding author), Gulf Univ Sci & Technol, Dept Comp Sci, Mishref, Kuwait.; Roumani, AM (corresponding author), Purdue Univ, Bindley Biosci Ctr, W Lafayette, IN 47907 USA.	roumani.a@gust.edu.kw		Hussein, Israa/0000-0002-2227-3478; Roumani, Ali/0000-0003-1840-9712	NIH [1RO1GM087735]; Purdue Cyber Center; Purdue Bindley Bioscience Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM113226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA024337] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Purdue Cyber Center; Purdue Bindley Bioscience Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was funded by NIH 1RO1GM087735, Purdue Cyber Center, and Purdue Bindley Bioscience Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamcsek B, 2006, BIOINFORMATICS, V22, P1021, DOI 10.1093/bioinformatics/btl039; Baitaluk M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-55; Baitaluk M, 2006, NUCLEIC ACIDS RES, V34, pW466, DOI 10.1093/nar/gkl308; Chen M, 2001, INFORM SOFTWARE TECH, V43, P487, DOI 10.1016/S0950-5849(01)00159-8; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Hartigan J., 1975, CLUSTERING ALGORITHM; Hood L, 2003, MECH AGEING DEV, V124, P9, DOI 10.1016/S0047-6374(02)00164-1; Huan TX, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S5; Huttenhower C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-417; KAMADA T, 1989, INFORM PROCESS LETT, V31, P7, DOI 10.1016/0020-0190(89)90102-6; Kapoor S, 2008, IEEE ENG MED BIO, P2423, DOI 10.1109/IEMBS.2008.4649688; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Kohonen T., 1988, SELF ORG ASS MEMORY; Kozhenkov S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-7; Liu XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060858; Martin A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-91; Olivon F, 2017, ANAL CHEM, V89, P7836, DOI 10.1021/acs.analchem.7b01563; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Poultney CS, 2007, BIOINFORMATICS, V23, P259, DOI 10.1093/bioinformatics/btl496; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Yeung N, 2014, CURRENT PROTOCOLS BI, V23; Zhang MW, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-23	23	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0211277	10.1371/journal.pone.0211277	http://dx.doi.org/10.1371/journal.pone.0211277			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794548	Green Submitted, Green Published, gold			2022-12-27	WOS:000459709100013
J	Miszczuk, GS; Banales, JM; Zucchetti, AE; Pisani, GB; Boaglio, AC; Saez, E; Medina, JF; Roma, MG; Crocenzi, FA				Miszczuk, Gisel S.; Banales, Jesus M.; Zucchetti, Andres E.; Pisani, Gerardo B.; Boaglio, Andrea C.; Saez, Elena; Medina, Juan F.; Roma, Marcelo G.; Crocenzi, Fernando A.			Adaptive downregulation of Cl-/HCO3- exchange activity in rat hepatocytes under experimental obstructive cholestasis	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE PROTEIN-2; AQUAPORIN-8 WATER CHANNELS; PLASMA-MEMBRANE INSERTION; NITRIC-OXIDE PRODUCTION; SALT EXPORT PUMP; TRANSPORTER EXPRESSION; URSODEOXYCHOLIC ACID; BILE-ACIDS; INTRACELLULAR PH; LIVER	In obstructive cholestasis, there is an integral adaptive response aimed to diminish the bile flow and minimize the injury of bile ducts caused by increased intraluminal pressure and harmful levels of bile salts and bilirrubin. Canalicular bicarbonate secretion, driven by the anion exchanger 2 (AE2), is an influential determinant of the canalicular bile salt-independent bile flow. In this work, we ascertained whether AE2 expression and/or activity is reduced in hepatocytes from rats with common bile duct ligation (BDL), as part of the adaptive response to cholestasis. After 4 days of BDL, we found that neither AE2 mRNA expression (measured by quantitative real-time PCR) nor total levels of AE2 protein (assessed by western blot) were modified in freshly isolated hepatocytes. However, BDL led to a decrease in the expression of AE2 protein in plasma membrane fraction as compared with SHAM control. Additionally, AE2 activity (J(OH)-, mmol/L/min), measured in primary cultured hepatocytes from BDL and SHAM rats, was decreased in the BDL group versus the control group (1.9 +/- 0.3 vs. 3.1 +/- 0.2, p<0.005). cAMP-stimulated AE2 activity, however, was not different between SHAM and BDL groups (3.7 +/- 0.3 vs. 3.5 +/- 0.3), suggesting that cAMP stimulated insertion into the canalicular membrane of AE2-containing intracellular vesicles, that had remained abnormally internalized after BDL. In conclusion, our results point to the existence of a novel adaptive mechanism in cholestasis aimed to reduce biliary pressure, in which AE2 internalization in hepatocytes might result in decreased canalicular HCO3- output and decreased bile flow.	[Miszczuk, Gisel S.; Zucchetti, Andres E.; Boaglio, Andrea C.; Roma, Marcelo G.; Crocenzi, Fernando A.] Univ Nacl Rosario, CONICET, Fac Ciencias Bioquim & Farmaceut, Inst Fisiol Expt IFISE, Rosario, Santa Fe, Argentina; [Banales, Jesus M.; Saez, Elena; Medina, Juan F.; Crocenzi, Fernando A.] Univ Navarra, CIMA, Div Gene Therapy & Hepatol, Pamplona, Spain; [Banales, Jesus M.] Univ Basque Country, Dept Liver & Gastrointestinal Dis, Biodonostia Res Inst, Donostia Univ Hosp,CIBERehd,Ikerbasque, Donostia San Sebastian, Spain; [Pisani, Gerardo B.] Univ Nacl Rosario, Area Morfol, Fac Ciencias Bioquim & Farmaceut, Rosario, Santa Fe, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University Hospital Donostia; University of Basque Country; National University of Rosario	Crocenzi, FA (corresponding author), Univ Nacl Rosario, CONICET, Fac Ciencias Bioquim & Farmaceut, Inst Fisiol Expt IFISE, Rosario, Santa Fe, Argentina.	crocenzi@ifise-conicet.gov.ar	Banales, Jesus M/R-9739-2019; Crocenzi, Fernando/P-7522-2018	Crocenzi, Fernando/0000-0001-6893-916X; Banales, Jesus/0000-0002-5224-2373; Saez De Blas, Elena/0000-0002-6494-9739; Zucchetti, Andres Ernesto/0000-0001-7067-1182	Spanish Carlos III Health Institute (ISCIII) - Fondo Europeo de Desarrollo Regional [FIS PI15/01132, PI18/01075, CON14/00129]; "Instituto de Salud Carlos III" [CIBERehd], Spain; BIOEF (Basque Foundation for Innovation and Health Research: EiTB Maratoia) [2017111010]; Department of Health of the Basque Country [2017111010]; Euskadi RIS3 [2016222001, 2017222014, 2018222029]; "Fundacion Cientifica de la Asociacion Espanola Contra el Cancer" (AECC Scientific Foundation); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina	Spanish Carlos III Health Institute (ISCIII) - Fondo Europeo de Desarrollo Regional; "Instituto de Salud Carlos III" [CIBERehd], Spain(Instituto de Salud Carlos III); BIOEF (Basque Foundation for Innovation and Health Research: EiTB Maratoia); Department of Health of the Basque Country(Basque Government); Euskadi RIS3; "Fundacion Cientifica de la Asociacion Espanola Contra el Cancer" (AECC Scientific Foundation); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by grants from Spanish Carlos III Health Institute (ISCIII) [J. M. Banales (FIS PI15/01132, PI18/01075 and Miguel Servet Program CON14/00129) cofinanced by "Fondo Europeo de Desarrollo Regional" (FEDER); "Instituto de Salud Carlos III" [CIBERehd: J. M. Banales], Spain; BIOEF (Basque Foundation for Innovation and Health Research: EiTB Maratoia BIO15/CA/016/BD to J. M. Banales), Department of Health of the Basque Country (J. M. Banales: 2017111010) and Euskadi RIS3 (J. M. Banales: 2016222001, 2017222014, 2018222029). "Fundacion Cientifica de la Asociacion Espanola Contra el Cancer" (AECC Scientific Foundation, to J. M. Banales). F. A. Crocenzi was recipient of a Young Investigator Scholarship from Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVARO D, 1995, J CLIN INVEST, V96, P665, DOI 10.1172/JCI118109; Arenas F, 2008, J CLIN INVEST, V118, P695, DOI 10.1172/JCI33156; BALLATORI N, 1992, AM J PHYSIOL, V263, pG617, DOI 10.1152/ajpgi.1992.263.5.G617; Banales JM, 2006, WORLD J GASTROENTERO, V12, P3496, DOI 10.3748/wjg.v12.i22.3496; BENEDETTI A, 1994, P NATL ACAD SCI USA, V91, P792, DOI 10.1073/pnas.91.2.792; BENEDETTI A, 1991, AM J PHYSIOL, V261, pG512, DOI 10.1152/ajpgi.1991.261.3.G512; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; BOUSCAREL B, 1995, AM J PHYSIOL-GASTR L, V268, pG300, DOI 10.1152/ajpgi.1995.268.2.G300; Boyer JL, 2007, J HEPATOL, V46, P365, DOI 10.1016/j.jhep.2006.12.001; Boyer JL, 2006, AM J PHYSIOL-GASTR L, V290, pG1124, DOI 10.1152/ajpgi.00539.2005; BOYER JL, 1971, AM J PHYSIOL, V221, P1156, DOI 10.1152/ajplegacy.1971.221.4.1156; Carreras FI, 2003, HEPATOLOGY, V37, P1026, DOI 10.1053/jhep.2003.50170; Carreras FI, 2007, AM J PHYSIOL-GASTR L, V292, pG905, DOI 10.1152/ajpgi.00386.2006; CHAILLET JR, 1986, P NATL ACAD SCI USA, V83, P522, DOI 10.1073/pnas.83.2.522; Crocenzi FA, 2008, HEPATOLOGY, V48, P1885, DOI 10.1002/hep.22532; Desmet V., 1979, PATHOLOGY LIVER, P272; Donner MG, 2007, AM J PHYSIOL-GASTR L, V293, pG1134, DOI 10.1152/ajpgi.00079.2007; Esteller A, 2008, WORLD J GASTROENTERO, V14, P5641, DOI 10.3748/wjg.14.5641; Fernandez-Martinez E, 2006, EXP TOXICOL PATHOL, V58, P49, DOI 10.1016/j.etp.2006.03.002; Fickert P, 2002, GASTROENTEROLOGY, V123, P1238, DOI 10.1053/gast.2002.35948; Garcia F, 2001, J BIOL CHEM, V276, P12147, DOI 10.1074/jbc.M009403200; Geier A, 2007, BBA-MOL CELL RES, V1773, P283, DOI 10.1016/J.BBAMCR.2006.04.014; Gerloff T, 1998, J BIOL CHEM, V273, P10046, DOI 10.1074/jbc.273.16.10046; Gradilone SA, 2003, HEPATOLOGY, V37, P1435, DOI 10.1053/jhep.2003.50241; Gradilone Sergio A, 2005, BMC Physiol, V5, P13, DOI 10.1186/1472-6793-5-13; Hamazaki K, VIVO, V9, P109; Huebert RC, 2002, J BIOL CHEM, V277, P22710, DOI 10.1074/jbc.M202394200; KLOPPEL TM, 1987, AM J PHYSIOL, V253, pG232, DOI 10.1152/ajpgi.1987.253.2.G232; Kubitz R, 1999, GASTROENTEROLOGY, V116, P401, DOI 10.1016/S0016-5085(99)70138-1; Lee JM, 2000, GASTROENTEROLOGY, V118, P163, DOI 10.1016/S0016-5085(00)70425-2; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Matsuzaki Y, 1997, AM J PHYSIOL-GASTR L, V273, pG164, DOI 10.1152/ajpgi.1997.273.1.G164; Meier PJ, 2000, NEWS PHYSIOL SCI, V15, P89; Miszczuk GS, 2018, BBA-MOL BASIS DIS, V1864, P1072, DOI 10.1016/j.bbadis.2018.01.015; NATHANSON MH, 1991, HEPATOLOGY, V14, P551, DOI 10.1002/hep.1840140324; Paulusma CC, 2000, HEPATOLOGY, V31, P684, DOI 10.1002/hep.510310319; Rao YP, 1997, J LIPID RES, V38, P2446; Slitt AL, 2007, BBA-BIOMEMBRANES, V1768, P637, DOI 10.1016/j.bbamem.2006.10.008; Spirli C, 2003, GASTROENTEROLOGY, V124, P737, DOI 10.1053/gast.2003.50100; Storrie Brian, 1996, Bioessays, V18, P895, DOI 10.1002/bies.950181108; Tietz P, 2005, J LIPID RES, V46, P1426, DOI 10.1194/jlr.M400412-JLR200; Trauner M, 2003, PHYSIOL REV, V83, P633, DOI 10.1152/physrev.00027.2002; Tu W, 2002, J SURG RES, V106, P31, DOI 10.1006/jsre.2002.6436; Wagner M, 2003, GASTROENTEROLOGY, V125, P825, DOI 10.1016/S0016-5085(03)01068-0; Zollner G, 2003, J HEPATOL, V38, P717, DOI 10.1016/S0168-8278(03)00096-5; Zollner G, 2006, MOL PHARMACEUT, V3, P231, DOI 10.1021/mp060010s	46	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212215	10.1371/journal.pone.0212215	http://dx.doi.org/10.1371/journal.pone.0212215			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789925	Green Submitted, Green Published, gold			2022-12-27	WOS:000459330800020
J	Hirano, D; Urabe, Y; Tanaka, S; Nakamura, K; Ninomiya, Y; Yuge, R; Hayashi, R; Oka, S; Kitadai, Y; Shimamoto, F; Arihiro, K; Chayama, K				Hirano, Daiki; Urabe, Yuji; Tanaka, Shinji; Nakamura, Koki; Ninomiya, Yuki; Yuge, Ryo; Hayashi, Ryohei; Oka, Shiro; Kitadai, Yasuhiko; Shimamoto, Fumio; Arihiro, Koji; Chayama, Kazuaki			Early-stage serrated adenocarcinomas are divided into several molecularly distinct subtypes	PLOS ONE			English	Article							COLORECTAL-CANCER; MICROSATELLITE INSTABILITY; CHROMOSOMAL INSTABILITY; CDX2 EXPRESSION; POOR-PROGNOSIS; COLON-CANCER; FEATURES; BRAF; ADENOMA; DIFFERENTIATION	Serrated adenocarcinoma (SAC) is considered the end stage of the serrated neoplasia pathway. Although SAC prognosis is not widely recognized, the serrated pathway-associated subtype consistently exhibits unfavorable prognosis in genetic studies. Herein, we classified molecularly distinct subtypes of serrated adenocarcinomas and clarified their associated clinicopathological characteristics and genetic changes. We examined 38 early-stage colorectal SACs. Of these, 24 were classified into three molecularly distinct groups by colon cancer subtyping (CCS). The clinicopathological characteristics, Ki 67 labeling index (LI), and SAC epithelial serration were assessed. The DNA from carcinomas and normal tissue/adenoma was extracted by laser microdissection and sequenced by next-generation sequencing, and mutation numbers and patterns of a 15-oncogene panel were determined. The CCS groups included CCS1 (CDX2+, HTR2B-, FRMD6-, ZEB1-, and microsatellite instable-low [MSI-L]/microsatellite stable [MSS]; 14 cases), CCS2 (microsatellite instable-high [MSI-H], 5 cases), and CCS3 (CDX2-, HTR2B+, FRMD6+, ZEB1+, and MSI-L/MSS; 5 cases). Invasive cancer was significantly more frequent in CCS3 than in CCS1 (5/5 versus 3/14, respectively). Ki67 LI and epithelial serration were higher in CCS3 than in CCS1 (83.0 +/- 5.8 versus 65.4 +/- 4.0 and 5/5 versus 3/14, respectively; p=0.031 and 0.0048). CCS2 showed the highest mutation number, whereas KRAS and BRAF mutation numbers were higher in CCS3 than in CCS1. Early-stage SACs were classified into three molecularly distinct subtypes with different clinicopathological and genetic characteristics.	[Hirano, Daiki; Nakamura, Koki; Oka, Shiro; Chayama, Kazuaki] Hiroshima Univ, Inst Biomed & Hlth Sci, Grad Sch Biomed & Hlth Sci, Dept Gastroenterol & Metab, Hiroshima, Japan; [Urabe, Yuji] Hiroshima Univ Hosp, Dept Regenerat & Med, Med Ctr Translat & Clin Res, Hiroshima, Japan; [Tanaka, Shinji; Ninomiya, Yuki; Yuge, Ryo; Hayashi, Ryohei] Hiroshima Univ Hosp, Dept Endoscopy, Hiroshima, Japan; [Kitadai, Yasuhiko] Prefectural Univ Hiroshima, Dept Fac Human Culture & Sci, Hiroshima, Japan; [Shimamoto, Fumio] Hiroshima Shudo Univ Hiroshima, Fac Humanities & Human Sci, Hiroshima, Japan; [Arihiro, Koji] Hiroshima Univ Hosp, Dept Anat Pathol, Hiroshima, Japan	Hiroshima University; Hiroshima University; Hiroshima University; Hiroshima University	Urabe, Y (corresponding author), Hiroshima Univ Hosp, Dept Regenerat & Med, Med Ctr Translat & Clin Res, Hiroshima, Japan.	beyan13@hiroshima-u.ac.jp	Oka, Shiro/AAZ-8368-2021; Kitadai, Yasuhiko/AAG-4389-2021; 北台, 靖彦/AAH-1678-2021	北台, 靖彦/0000-0002-8743-3815; Chayama, Kazuaki/0000-0002-5530-5341; Urabe, Yuji/0000-0003-0942-1541	JSPS KAKENHI [17K09476]; Tuchiya Memorial Medical Promotion Fund; Program of the Network-Type Joint Usage/Research Center for Radiation Disaster Medical Science of Hiroshima University; Nagasaki University; Fukushima Medical University	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Tuchiya Memorial Medical Promotion Fund; Program of the Network-Type Joint Usage/Research Center for Radiation Disaster Medical Science of Hiroshima University; Nagasaki University; Fukushima Medical University	Y.U. have financial relationships to disclose. Next-generation sequencing was carried out at the Analysis Center of Life Science, Hiroshima University (https://www.hiroshima-u.ac.jp). Reagents for a portion of targeted enrichment and next-generation sequencing were provided by Illumina (https://jp.illumina.com/?gclid=EAIaIQobChMIrsDXhrfp3AIVkLaWCh3UxggfEAAYASAAEgJY-vD_BwE). This work was supported by JSPS KAKENHI (grant no. 17K09476), (https://www.jsps.go.jp/english/e-grants/index.html) and Tuchiya Memorial Medical Promotion Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The MSI analysis was supported by the Program of the Network-Type Joint Usage/Research Center for Radiation Disaster Medical Science of Hiroshima University, Nagasaki University, and Fukushima Medical University. Next-generation sequencing was carried out at the Analysis Center of Life Science, Hiroshima University.	Ali M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15617; Aoki K, 2003, NAT GENET, V35, P323, DOI 10.1038/ng1265; Baba Y, 2009, CLIN CANCER RES, V15, P4665, DOI 10.1158/1078-0432.CCR-09-0401; Bae JM, 2015, WORLD J GASTROENTERO, V21, P1457, DOI 10.3748/wjg.v21.i5.1457; Banerjea A, 2003, ANAL BIOCHEM, V322, P130, DOI 10.1016/j.ab.2003.07.006; Boland CR, 1998, CANCER RES, V58, P5248; Bonhomme C, 2003, GUT, V52, P1465, DOI 10.1136/gut.52.10.1465; Bosman F., 2010, WHO CLASSIFICATION T, V4th; Dalerba P, 2016, NEW ENGL J MED, V374, P211, DOI 10.1056/NEJMoa1506597; De Sousa E Melo F, 2013, NAT MED, V19, P614, DOI 10.1038/nm.3174; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gao N, 2009, DEV CELL, V16, P588, DOI 10.1016/j.devcel.2009.02.010; Garcia-Solano J, 2010, HUM PATHOL, V41, P1359, DOI 10.1016/j.humpath.2010.04.002; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Guo RJ, 2004, CANCER BIOL THER, V3, P593, DOI 10.4161/cbt.3.7.913; Gurzu S, 2012, PATHOL RES PRACT, V208, P163, DOI 10.1016/j.prp.2012.01.003; Hirano D, 2017, BMC GASTROENTEROL, V17, DOI 10.1186/s12876-017-0702-x; JASS JR, 1992, PATHOLOGY, V24, P233, DOI 10.3109/00313029209068874; Kaimaktchiev V, 2004, MODERN PATHOL, V17, P1392, DOI 10.1038/modpathol.3800205; Laiho P, 2007, ONCOGENE, V26, P312, DOI 10.1038/sj.onc.1209778; Lee CT, 2017, ONCOTARGET, V8, P35165, DOI 10.18632/oncotarget.16815; Leggett B, 2010, GASTROENTEROLOGY, V138, P2088, DOI 10.1053/j.gastro.2009.12.066; Lugli A, 2008, MODERN PATHOL, V21, P1403, DOI 10.1038/modpathol.2008.117; MACDONALD PM, 1986, NATURE, V324, P537, DOI 10.1038/324537a0; Makinen MJ, 2001, J PATHOL, V193, P286, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH800>3.0.CO;2-2; Michael-Robinson JM, 2001, GUT, V48, P360, DOI 10.1136/gut.48.3.360; Moran A, 2010, WORLD J GASTRO ONCOL, V2, P151, DOI 10.4251/wjgo.v2.i3.151; O'Brien MJ, 2006, AM J SURG PATHOL, V30, P1491, DOI 10.1097/01.pas.0000213313.36306.85; Oka S, 2004, GASTROINTEST ENDOSC, V59, P213, DOI 10.1016/S0016-5107(03)02693-2; Pilati C, 2017, ANN ONCOL, V28, P1032, DOI 10.1093/annonc/mdx066; Pino MS, 2010, GASTROENTEROLOGY, V138, P2059, DOI 10.1053/j.gastro.2009.12.065; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Shida Y, 2012, PATHOBIOLOGY, V79, P169, DOI 10.1159/000334837; Silberg DG, 2000, GASTROENTEROLOGY, V119, P961, DOI 10.1053/gast.2000.18142; Spring KJ, 2006, GASTROENTEROLOGY, V131, P1400, DOI 10.1053/j.gastro.2006.08.038; Stefanius K, 2011, HISTOPATHOLOGY, V58, P679, DOI 10.1111/j.1365-2559.2011.03821.x; Sugihara K, 2009, JAP CLASS COL CARC, P1; Urabe Y, 2013, J HEPATOL, V58, P875, DOI 10.1016/j.jhep.2012.12.024; Vilar E, 2010, NAT REV CLIN ONCOL, V7, P153, DOI 10.1038/nrclinonc.2009.237; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Yao T, 2000, J PATHOL, V190, P444, DOI 10.1002/(SICI)1096-9896(200003)190:4<444::AID-PATH520>3.0.CO;2-O; Zlobec I, 2010, INT J CANCER, V127, P367, DOI 10.1002/ijc.25042	42	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211477	10.1371/journal.pone.0211477	http://dx.doi.org/10.1371/journal.pone.0211477			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785889	Green Published, Green Submitted, gold			2022-12-27	WOS:000459307000027
J	Ivanovic, DM; Almagia, AF; Arancibia, VC; Ibaceta, CV; Arias, VF; Rojas, TR; Flores, OC; Villagran, FS; Tapia, LU; Acevedo, JA; Morales, GI; Martinez, VPCC; Larrain, CG; Silva, CFA; Valenzuela, RB; Barrera, CR; Billeke, PB; Zamorano, FM; Orellana, YZ				Ivanovic, Daniza M.; Almagia, Atilio F.; Arancibia, Violeta C.; Ibaceta, Camila V.; Arias, Vanessa F.; Rojas, Tatiana R.; Flores, Ofelia C.; Villagran, Francisca S.; Tapia, Liliana U.; Acevedo, Javiera A.; Morales, Gladys I.; Martinez, Vi Prime Ctor C.; Larrain, Cristian G.; Silva, Claudio F. A.; Valenzuela, Rodrigo B.; Barrera, Cynthia R.; Billeke, Pablo B.; Zamorano, Francisco M.; Orellana, Yasna Z.			A multifactorial approach of nutritional, intellectual, brain development, cardiovascular risk, socio-economic, demographic and educational variables affecting the scholastic achievement in Chilean students: An eight-year follow-up study	PLOS ONE			English	Article							SCHOOL-AGE-CHILDREN; ACADEMIC-ACHIEVEMENT; HEAD CIRCUMFERENCE; COGNITIVE FUNCTION; ELEMENTARY-SCHOOL; CHILDHOOD OBESITY; INTELLIGENCE; BIRTH; HEALTH; IMPACT	The aim of this study was to quantitate the relative impact of nutritional, intellectual, brain development, cardiovascular risk, socio-economic, demographic and educational variables on the results of the 2009 Quality Education Measurement System (SIMCE) tests of language and mathematics for scholastic achievement (SA) applying a multifactorial approach, in school-age children of the 2010 5th elementary school grade (5ESG) and of the 1st grade of high school (1HSG). The purposes were: i) to test the hypothesis that intellectual ability, the level of SA of the educational establishments in the 2009 SIMCE tests, sex, parental schooling levels, and head circumference-for-age Z-score are the most relevant parameters associated with 2009 SIMCE outcomes; ii) to determine the predictive ability of the 2009 SIMCE results in determining the 2013 SIMCE outcomes for the 2010 5ESG cohort (when they graduated from elementary school, 8th grade) and for determining the 2013 University Selection Test (PSU) outcomes for the 2010 1HSG group (for university admission, when they graduated from high school, 4th grade); iii) to determine the association between the 2009 SIMCE results with the 2017 PSU outcomes for the 2010 5ESG group (for university admission, when they graduated from high school, 4th grade). A representative, proportional and stratified sample of 33 schools of the Metropolitan Region of Chile was randomly chosen. In these schools, 1,353 school-age children of both sexes, of the 2010 5ESG (n = 682; mean age = 10.8 years, SD = 0.6) and of the 2010 1HSG (n = 671; mean age = 14.8 years, SD = 0.6) participated. In both grades and tests, the findings confirm the hypotheses formulated. 2009 SIMCE outcomes were positively and significantly associated with 2013 SIMCE and with 2017 PSU and, with 2013 PSU outcomes in school-age children from 2010 5ESG and 1HSG, respectively. These findings may be useful for educational and health planning in Chile and countries in a comparable stage of development.	[Ivanovic, Daniza M.; Ibaceta, Camila V.; Arias, Vanessa F.; Rojas, Tatiana R.; Flores, Ofelia C.; Villagran, Francisca S.; Tapia, Liliana U.; Acevedo, Javiera A.; Orellana, Yasna Z.] Univ Chile, Inst Nutr & Food Technol Dr Fernando Monckeberg B, Human Nutr Area, Lab Nutr & Neurol Sci, Santiago, Chile; [Almagia, Atilio F.] Pontifical Catholic Univ Valparaiso, Fac Sci, Inst Biol, Lab Phys Anthropol & Human Anat, Valparaiso, Chile; [Arancibia, Violeta C.] Univ Los Andes, Ctr Res Educ & Learning, Santiago, Chile; [Arias, Vanessa F.] Andres Bello Univ, Fac Med, Sch Nutr & Dietet, Santiago, Chile; [Flores, Ofelia C.] Univ Costa Rica, Fac Med, Sch Nutr, San Jose, Costa Rica; [Morales, Gladys I.] Univ La Frontera, Fac Med, Dept Publ Hlth, Temuco, Chile; [Martinez, Vi Prime Ctor C.] Univ Chile, Fac Econ & Business, Dept Commercial Engn, Santiago, Chile; [Larrain, Cristian G.; Silva, Claudio F. A.] Univ Dev, German Clin Santiago, Fac Med, Dept Radiol, Santiago, Chile; [Valenzuela, Rodrigo B.; Barrera, Cynthia R.] Univ Chile, Fac Med, Dept Nutr, Santiago, Chile; [Billeke, Pablo B.; Zamorano, Francisco M.] Univ Dev, Fac Govt, Div Neurosci, Ctr Res Social Complex NeuroSIS, Santiago, Chile; [Zamorano, Francisco M.] Univ Dev, German Clin Santiago, Image Dept, Adv Quantitat Imaging Unit, Santiago, Chile	Universidad de Chile; Pontificia Universidad Catolica de Valparaiso; Universidad de los Andes - Chile; Universidad Andres Bello; Universidad Costa Rica; Universidad de La Frontera; Universidad de Chile; Clinica Alemana; Universidad de Chile; Clinica Alemana	Ivanovic, DM (corresponding author), Univ Chile, Inst Nutr & Food Technol Dr Fernando Monckeberg B, Human Nutr Area, Lab Nutr & Neurol Sci, Santiago, Chile.	daniza@inta.uchile.cl	Billeke, Pablo/D-5311-2011; Ivanovic, Daniza/P-3857-2014	Billeke, Pablo/0000-0003-4261-0678; Ivanovic, Daniza/0000-0002-1054-3231; Morales, Gladys/0000-0001-7194-8833; Orellana, Yasna/0000-0003-1044-1056; Arancibia, Veronica/0000-0001-7493-0460	National Fund for Scientific and Technologic Development (FONDECYT) [1100431, 1150524]	National Fund for Scientific and Technologic Development (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by Grants 1100431 and 1150524 from the National Fund for Scientific and Technologic Development (FONDECYT) (PI: Daniza Ivanovic). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelalim A, 2011, MED PRIN PRACT, V21, P14, DOI 10.1159/000331792; Al-Mekhlafi HM, 2011, BRIT J NUTR, V106, P1100, DOI 10.1017/S0007114511001449; ALVAREZ MD, 1985, REV MED CHILE, V113, P243; [Anonymous], 2008, 59 WMA GEN ASS; Batouli SAH, 2014, AGEING RES REV, V13, P1, DOI 10.1016/j.arr.2013.10.003; Booth JN, 2014, INT J OBESITY, V38, P1335, DOI 10.1038/ijo.2014.40; Burhan NAS, 2017, PERS INDIV DIFFER, V105, P95, DOI 10.1016/j.paid.2016.09.043; Calvin CM, 2012, BEHAV GENET, V42, P699, DOI 10.1007/s10519-012-9549-7; Carey FR, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/1479-5868-12-S1-S3; Cheng ER, 2014, PEDIATRICS, V134, pE749, DOI 10.1542/peds.2014-0259; Chile. Chile's government, 2010, SIMCE 2009 NAT RES; Chile. Ministry of Education, 2009, ENR CHIL STUD 4 GEOG; Chile. Ministry of Education, 1974, 11934 MIN ED; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Diaz TAT, 1998, ARCH LATINOAM NUTR, V48, P201; Downey DB, 2001, AM PSYCHOL, V56, P497, DOI 10.1037//0003-066X.56.6-7.497; Edwards RD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012157; Eriksen HLF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079200; Fernandez JR, 2004, J PEDIATR-US, V145, P439, DOI 10.1016/j.jpeds.2004.06.044; Flores OC, 2018, OBESITY FACTS, V11, P344, DOI 10.1159/000492004; Forns J, 2012, GAC SANIT, V26, P397, DOI 10.1016/j.gaceta.2011.10.011; Gibson RS, 1990, Q REV BIOL; Gross SJ, 2001, J PEDIATR-US, V138, P169, DOI 10.1067/mpd.2001.111945; Guarino CM, 2015, J RES EDUC EFF, V8, P1, DOI 10.1080/19345747.2015.986943; Guilford J, 1984, FUNDAMENTAL STAT PSY; Hair NL, 2015, JAMA PEDIATR, V169, P822, DOI 10.1001/jamapediatrics.2015.1475; HARDY JB, 1973, NEW ENGL J MED, V289, P973, DOI 10.1056/NEJM197311012891811; Heinonen K, 2015, PEDIATRICS, V135, pE818, DOI 10.1542/peds.2014-3556; Holme A, 2010, CHILD CARE HLTH DEV, V36, P583, DOI 10.1111/j.1365-2214.2009.01068.x; Ibaceta CV, 2013, THESIS; Isaacs EB, 2010, PEDIATR RES, V67, P357, DOI 10.1203/PDR.0b013e3181d026da; Ivanovic D, 2008, EUR J CLIN NUTR, V62, P18, DOI 10.1038/sj.ejcn.1602672; IVANOVIC D, 1995, REV MED CHILE, V123, P587; Ivanovic D, 2011, ACHIEVEMENT TESTS TY, P139; Ivanovic D, 2011, ADV PSYCHOL RES, P53; IVANOVIC D, 2000, EDUCACION OEA, V44, P3; IVANOVIC D, 2001, REV PSICOLOGIA GEN A, V54, P443; Ivanovic DA, 2004, NUTRITION, V20, P878, DOI 10.1016/j.nut.2004.06.009; Ivanovic DM, 2019, NUTRITION, V57, P74, DOI 10.1016/j.nut.2018.05.035; Ivanovic DM, 2014, PEDIATR RES, V75, P464, DOI 10.1038/pr.2013.232; Ivanovic DM, 2009, BRIT J NUTR, V102, P142, DOI 10.1017/S0007114508184665; Ivanovic DM, 1996, NUTRITION, V12, P321, DOI 10.1016/S0899-9007(96)80054-2; Ivanovic DM, 2004, INTELLIGENCE, V32, P461, DOI 10.1016/j.intell.2004.07.001; Ivanovic DM, 2004, NEUROPSYCHOLOGIA, V42, P1118, DOI 10.1016/j.neuropsychologia.2003.11.022; Ivanovic DM, 2002, BRIT J NUTR, V87, P81, DOI 10.1079/BJN2001485; Ivanovic DM, 2000, NUTRITION, V16, P1056, DOI 10.1016/S0899-9007(00)00431-7; IVANOVIC R, 1995, REV EDUC, V224, P40; Ivanovic RM, 2000, ECOL FOOD NUTR, V39, P35, DOI 10.1080/03670244.2000.9991604; Ivanovich Rodolfo, 2000, REV PSICOLOGIA GEN A, V53, P5; Jednorog K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042486; Jelliffe D.B., 1966, ASSESSMENT NUTR STAT; Johansson TS, 2005, ENDOCRIN DEV, V8, P126, DOI 10.1159/000084098; Kamijo K, 2012, OBESITY, V20, P2406, DOI 10.1038/oby.2012.112; Kanazawa S, 2012, PERS SOC PSYCHOL B, V38, P1157, DOI 10.1177/0146167212445911; Lyngdoh T, 2013, J HYPERTENS, V31, P1175, DOI 10.1097/HJH.0b013e3283604176; Miller LC, 2016, PAEDIATR INT CHILD H, V36, P91, DOI 10.1080/20469047.2015.1133517; Morita N, 2016, PHYSIOL BEHAV, V163, P161, DOI 10.1016/j.physbeh.2016.04.055; National Center for Health Statistics, 2000, GROWTH CURV CDC GROW; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; NELLHAUS G, 1968, PEDIATRICS, V41, P106; Pearce A, 2016, SOC SCI MED, V165, P108, DOI 10.1016/j.socscimed.2016.07.016; Pietschnig J, 2015, NEUROSCI BIOBEHAV R, V57, P411, DOI 10.1016/j.neubiorev.2015.09.017; Pokropek A, 2015, SOC SCI RES, V53, P73, DOI 10.1016/j.ssresearch.2015.05.005; POLLITT E, 1994, CHILD DEV, V65, P283; Pollitt E, 1983, PUBLICACION CIENTIFI, V450, P58; Rahu K, 2010, EARLY HUM DEV, V86, P493, DOI 10.1016/j.earlhumdev.2010.06.010; Raven J, 2007, STANDARD PROGR MATRI; Reilly D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039904; ROCHE AF, 1987, PEDIATRICS, V79, P706; Ronfani L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127052; Sajjad A, 2015, J EPIDEMIOL COMMUN H, V69, P775, DOI 10.1136/jech-2014-204486; Sanchez S, 2008, ARCH LATINOAM NUTR, V58, P357; Schiefelbein E, 1982, 8 YEARS THEIR LIVES; Schiefelbein E., 1981, DETERMINANTS SCH ACH; SCIARA FJ, 1975, CHILD STUDY J, V5, P45; Segretin MS, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00205; Shashidhar S, 2009, INDIAN J PEDIATR, V76, P495, DOI 10.1007/s12098-009-0091-4; Silva LM, 2010, INT J EPIDEMIOL, V39, P1250, DOI 10.1093/ije/dyq069; Stoet G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057988; Tanis JC, 2015, J PEDIATR-US, V166, P552, DOI 10.1016/j.jpeds.2014.11.043; TANNER JM, 1984, TXB PEDIAT, P278; Torres DD, 2013, BIODEMOGR SOC BIOL, V59, P157, DOI 10.1080/19485565.2013.833804; Ulvund SE, 2001, TIDSSKR NORSKE LAEGE, V121, P298; University of Chile, 2018, STAT COMP YEAR 2018; University of Chile, 2015, STAT COMP YEAR 2013; Veldwijk J, 2012, OBESITY, V20, P590, DOI 10.1038/oby.2011.327; Victora CG, 2015, LANCET GLOB HEALTH, V3, pE199, DOI 10.1016/S2214-109X(15)70002-1; Voyer D, 2014, PSYCHOL BULL, V140, P1174, DOI 10.1037/a0036620; WEAVER DD, 1980, J PEDIATR-US, V96, P990, DOI 10.1016/S0022-3476(80)80623-8; Whitley E, 2013, EUR PSYCHIAT, V28, P219, DOI 10.1016/j.eurpsy.2012.01.005; Yaqub S., 2002, J INT DEV, V14, P1081, DOI [DOI 10.1002/JID.951, https://doi.org/10.1002/jid.951]	91	4	4	7	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212279	10.1371/journal.pone.0212279	http://dx.doi.org/10.1371/journal.pone.0212279			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM2OT	30785935	Green Submitted, Green Published, gold			2022-12-27	WOS:000459307000054
J	Boulton, ML; Carlson, BF; Wagner, AL; Porth, JM; Gebremeskel, B; Abeje, Y				Boulton, Matthew L.; Carlson, Bradley F.; Wagner, Abram L.; Porth, Julia M.; Gebremeskel, Berhanu; Abeje, Yemesrach			Vaccination timeliness among newborns and infants in Ethiopia	PLOS ONE			English	Article							IMMUNIZATION COVERAGE; DETERMINANTS; CHILDREN; DISTRICT; VACCINES; LEVEL	Background We characterize the risk factors for delayed polio dose 1, diphtheria-tetanus-pertussis (DTP) dose 1, pentavalent dose 1, and measles dose 1 in Ethiopian infants. We also examine the interaction between institutional delivery and demographic factors on the birth doses of the BCG and polio vaccines to better understand factors influencing vaccination. Methods Using the 2011 Ethiopia Demographic and Health Survey, we calculated the distribution of the study population across different demographic and vaccination characteristics. We computed acceleration factors using a multivariable accelerated failure time model with a Weibull distribution to account for left and right censoring. For the birth doses, we further specified an interaction term between institutional delivery and every other a priori specified independent variable to test whether institutional delivery modifies sociodemographic disparities in vaccination timeliness. Results Low wealth status, home delivery, and ethnicity are risk factors for delayed vaccination of polio 1, DPT 1, pentavalent 1, and measles 1. Religion is a risk factor for measles 1 vaccination delay and rural residence are risk factors for delayed DPT1 and polio 1 doses. For birth doses of polio and BCG, institutional delivery attenuated many sociodemographic disparities in vaccination delay, except for urbanicity, which showed rural dwellers with more delay than urban dwellers with an institutional vs home birth. Conclusions Less delayed vaccination among children with institutional deliveries highlights the importance of perinatal care and the potential for promoting healthy behaviors to parents. Persistent disparities between urban and rural residents, even among those with institutional births, can be targeted for future interventions. Timely vaccination is key to prevention of unnecessary childhood mortality.	[Boulton, Matthew L.; Carlson, Bradley F.; Wagner, Abram L.; Porth, Julia M.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Boulton, Matthew L.] Univ Michigan, Dept Internal Med, Div Infect Dis, Med Sch, Ann Arbor, MI 48109 USA; [Gebremeskel, Berhanu] Univ Michigan, Ctr Int Reprod Hlth Training, Ann Arbor, MI 48109 USA; [Abeje, Yemesrach] St Pauls Hosp, Millennium Med Coll, Dept Publ Hlth, Addis Ababa, Ethiopia	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Wagner, AL (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.	awag@umich.edu	Wagner, Abram/X-6379-2019	Wagner, Abram/0000-0003-4691-7802; Boulton, Matthew/0000-0002-0565-9010; Carlson, Bradley/0000-0002-9616-5613; Porth, Julia/0000-0001-6407-5579				Abadura SA, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2315-z; Akmatov MK, 2015, VACCINE, V33, P892, DOI 10.1016/j.vaccine.2014.10.089; [Anonymous], 2008, SUMM STAT REP 2007 P; Babirye JN, 2012, ONE PLOS, V7, DOI [10.1371/journal.pone.0035432, DOI 10.1371/JOURNAL.PONE.0035432]; BART KJ, 1991, JAMA-J AM MED ASSOC, V266, P1547; Curran D, 2013, VALUE HEALTH, V16, pA346, DOI 10.1016/j.jval.2013.08.143; Ebrahim Y, 2015, INT J CURR RES, V7, P20234, DOI DOI 10.13140/RG.2.2.21866.54725; Etana B, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-566; Fadnes LT, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-404; Fadnes LT, 2011, VACCINE, V29, P3564, DOI 10.1016/j.vaccine.2011.02.093; Gibson DG, 2015, VACCINE, V33, P6778, DOI 10.1016/j.vaccine.2015.10.021; Glanz JM, 2013, JAMA PEDIATR, V167, P274, DOI 10.1001/jamapediatrics.2013.502; Gram L, 2014, TROP MED INT HEALTH, V19, P802, DOI 10.1111/tmi.12324; Hussen M, 2013, SCI TECHNOL ARTS RES, V2, P36; Kassahun Melkamu Beyene, 2015, BMC Res Notes, V8, P239, DOI 10.1186/s13104-015-1192-y; Lakew Y, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2078-6; Legesse E, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0345-4; Luman ET, 2005, JAMA-J AM MED ASSOC, V293, P1204, DOI 10.1001/jama.293.10.1204; McCarthy NL, 2013, VACCINE, V31, P5822, DOI 10.1016/j.vaccine.2013.10.011; Miyahara R, 2016, VACCINE, V34, P3335, DOI 10.1016/j.vaccine.2016.05.017; Mohamud AN, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-865; Moyer CA, 2013, INT J GYNECOL OBSTET, V123, P217, DOI 10.1016/j.ijgo.2013.06.030; Odutola A, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1015-9; Pew Research Center, 2015, REL COMP COUNTR 2010; Schoeps A, 2013, VACCINE, V32, P96, DOI 10.1016/j.vaccine.2013.10.063; Shrivastwa N, 2016, PEDIATR INFECT DIS J, V35, P955, DOI 10.1097/INF.0000000000001223; Tadesse H, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-150; Tesfaye F., 2014, INT J PUB HLTH SCI I, V3, P185; TURNBULL BW, 1976, J R STAT SOC B, V38, P290; United Nations, 2016, SUST DEV GOAL 3; United Nations Development Programme, 2015, HUM DEV REP 2015; Winter K, 2011, 45 NAT IMM C; World Bank, 2016, ETHIOPIA; You D, 2014, LEVELS TRENDS CHILD	34	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212408	10.1371/journal.pone.0212408	http://dx.doi.org/10.1371/journal.pone.0212408			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779781	Green Published, gold, Green Submitted			2022-12-27	WOS:000459062900052
J	Shahid, N; Rappon, T; Berta, W				Shahid, Nida; Rappon, Tim; Berta, Whitney			Applications of artificial neural networks in health care organizational decision-making: A scoping review	PLOS ONE			English	Review							LEARNING ALGORITHM; INTELLIGENCE; INFORMATION; PERFORMANCE; PREDICTION; REGRESSION; DIAGNOSIS; BUSINESS; SERVICES; SUPPORT	Health care organizations are leveraging machine-learning techniques, such as artificial neural networks (ANN), to improve delivery of care at a reduced cost. Applications of ANN to diagnosis are well-known; however, ANN are increasingly used to inform health care management decisions. We provide a seminal review of the applications of ANN to health care organizational decision-making. We screened 3,397 articles from six databases with coverage of Health Administration, Computer Science and Business Administration. We extracted study characteristics, aim, methodology and context (including level of analysis) from 80 articles meeting inclusion criteria. Articles were published from 1997-2018 and originated from 24 countries, with a plurality of papers (26 articles) published by authors from the United States. Types of ANN used included ANN (36 articles), feed-forward networks (25 articles), or hybrid models (23 articles); reported accuracy varied from 50% to 100%. The majority of ANN informed decision-making at the micro level (61 articles), between patients and health care providers. Fewer ANN were deployed for intra-organizational (meso- level, 29 articles) and system, policy or inter-organizational (macro- level, 10 articles) decision-making. Our review identifies key characteristics and drivers for market uptake of ANN for health care organizational decision-making to guide further adoption of this technique.	[Shahid, Nida; Rappon, Tim; Berta, Whitney] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Shahid, Nida] Univ Hlth Network, Toronto Hlth Econ & Technol Assessment THETA Coll, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Shahid, N (corresponding author), Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.; Shahid, N (corresponding author), Univ Hlth Network, Toronto Hlth Econ & Technol Assessment THETA Coll, Toronto, ON, Canada.	nida.shahid@utoronto.ca		Shahid, Nida/0000-0002-8627-6483				Abbas A, 2015, COMPUTING, V97, P667, DOI 10.1007/s00607-015-0448-7; Adelano Awowale A., 2017, DECISION MAKING HEAL; Agatonovic-Kustrin S, 2000, J PHARMACEUT BIOMED, V22, P717, DOI 10.1016/S0731-7085(99)00272-1; Aguiar FS, 2016, MED BIOL ENG COMPUT, V54, P1751, DOI 10.1007/s11517-016-1465-1; Ahmed SS, 2017, MED BIOL ENG COMPUT, V55, P101, DOI 10.1007/s11517-016-1508-7; Amazon, 2018, AM MACH LEARN DEV GU; Anderson CL, 2011, INFORM SYST RES, V22, P469, DOI 10.1287/isre.1100.0335; Anderson I, 2007, MOBILE NETW APPL, V12, P185, DOI 10.1007/s11036-007-0011-7; [Anonymous], 2017, NBER C RES ISS ART I; Atoui H, 2008, INT J HEALTHC INF SY, V3, P69, DOI 10.4018/jhisi.2008100105; Bajo J, 2009, EXPERT SYST APPL, V36, P5844, DOI 10.1016/j.eswa.2008.07.029; Bartosch-Harlid A, 2008, BRIT J SURG, V95, P817, DOI 10.1002/bjs.6239; Begg R., 2006, NEURAL NETWORKS HEAL; Belmonte M., 1997, SIGBIO Newsletter, V17, P2, DOI 10.1145/270572.270573; Berardi VL, 1999, DECISION SCI, V30, P659, DOI 10.1111/j.1540-5915.1999.tb00902.x; Bourdes V, 2011, MED BIOL ENG COMPUT, V49, P947, DOI 10.1007/s11517-011-0785-4; Buscema PM, 2017, QUAL QUANT, V51, P459, DOI 10.1007/s11135-016-0315-4; Buttar HS, 2016, 600 M 6 BILLION ARTI; Cheng-Min Chao, 2012, International Journal of Organizational Innovation, V4, P155; Chesney T, 2006, INT J HEALTHC INF SY, V1, P51, DOI 10.4018/jhisi.2006040104; Chong AYL, 2015, INT J PROD ECON, V159, P66, DOI 10.1016/j.ijpe.2014.09.034; Collier M., 2017, ARTIF INTELL; Cybenko G., 1989, Mathematics of Control, Signals, and Systems, V2, P303, DOI 10.1007/BF02551274; Da Silva I.N., 2017, ARTIFICIAL NEURAL NE; Deloitte, 2018, EV SMART HLTH CAR; Durairaj M., 2013, INT J SCI TECHNOLOGY, V2; Emanet N., 2014, DECIS ANAL, V1, P1, DOI [10.1186/2193-8636-1-6, DOI 10.1186/2193-8636-1-6]; Ferguson J., NEURAL NETWORKS HEAL; Fisher JM, 2016, PARKINSONISM RELAT D, V33, P44, DOI 10.1016/j.parkreldis.2016.09.009; Fong S., 2009, APPLYING HYBRID MODE; FORSSTROM JJ, 1995, ANN MED, V27, P509, DOI 10.3109/07853899509002462; French R., 2011, ORG BEHAV; Goodey RD, 2000, BRIT DENT J, V189, P556, DOI 10.1038/sj.bdj.4800828a; Goss Ernest Preston, 2002, Health Care Manag Sci, V5, P221, DOI 10.1023/A:1019760901191; Grand View Research, 2016, GRAND VIEW RES HEALT; Grossi E, 2014, QUAL QUANT, V48, P15, DOI 10.1007/s11135-012-9746-8; Guler S, 2015, INT J DIGESTIVE DIS, V1; Gutierrez PA, 2011, HYBRID ARTIFICIAL NE, P177; Han J, 2012, MOR KAUF D, P1; Hanafizadeh P, 2010, INT J HEALTHC INF SY, V5, P1, DOI 10.4018/jhisi.2010100101; Hersh William, 2008, AMIA Annu Symp Proc, P303; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; HORNIK K, 1991, NEURAL NETWORKS, V4, P251, DOI 10.1016/0893-6080(91)90009-T; Houston AL, 1999, ARTIF INTELL REV, V13, P437, DOI 10.1023/A:1006548623067; Hsu SF, 2008, J RISK INSUR, V75, P617, DOI 10.1111/j.1539-6975.2008.00277.x; IBM Corporation, 2013, DAT DRIV HEALTHC ORG; Ibrahim F, 2010, MED BIOL ENG COMPUT, V48, P1141, DOI 10.1007/s11517-010-0669-z; Itchhaporia D, 1996, J AM COLL CARDIOL, V28, P515, DOI 10.1016/0735-1097(96)00174-X; Jiang F, 2017, STROKE VASC NEUROL, V2, P230, DOI 10.1136/svn-2017-000101; Kaur H., 2006, J COMPUT SCI-NETH, V2, P194, DOI [10.3844/jcssp.2006.194.200, DOI 10.3844/JCSSP.2006.194.200]; Kayri Murat, 2010, Journal of Computer Sciences, V6, P606, DOI 10.3844/jcssp.2010.606.612; Krizhevsky A., 2012, PROC INT C NEURAL IN, P1106; Kudyba S, 2010, HEALTH INFORM J, V16, P235, DOI 10.1177/1460458210380529; Kuziemsky Craig, 2016, Healthc Manage Forum, V29, P4, DOI 10.1177/0840470415614842; Kwong EWY, 2018, HEALTH INFORM J, V24, P227, DOI 10.1177/1460458216663025; Lee CW, 2001, INFORM MANAGE-AMSTER, V38, P231, DOI 10.1016/S0378-7206(00)00068-9; Lin CF, 2014, HEALTH CARE MANAG SC, V17, P270, DOI 10.1007/s10729-013-9252-0; Lisboa PJ, 2006, NEURAL NETWORKS, V19, P408, DOI 10.1016/j.neunet.2005.10.007; Liu NT, 2014, MED BIOL ENG COMPUT, V52, P193, DOI 10.1007/s11517-013-1130-x; Lymberis A, 2003, 4 ANN IEEE C INF TEC; Maimon O, 2010, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, SECOND EDITION, P1, DOI 10.1007/978-0-387-09823-4; Malliaris ME, 2011, INT J MANAG INF SYST, V15, P59; May RJ, 2010, NEURAL NETWORKS, V23, P283, DOI 10.1016/j.neunet.2009.11.009; MCCULLOCH WS, 1990, B MATH BIOL, V52, P99, DOI 10.1016/S0092-8240(05)80006-0; McDaniel RR, 2009, HEALTH CARE MANAGE R, V34, P191, DOI 10.1097/HMR.0b013e31819c8b38; McGarry K., 1999, Neural Computing Surveys, V2; Milenova B, 2005, P 31 VLDB C; Mitchell T. M., 1999, COMMUNICATIONS ACM, V42; Moghimi FH, 2014, ARTIFICIAL NEURAL NE; Murdoch TB, 2013, JAMA-J AM MED ASSOC, V309, P1351, DOI 10.1001/jama.2013.393; Nolting Jeanette, 2006, AMIA Annu Symp Proc, P1049; Olatubosun O, 2015, INT J HLTH EC DEV, V1, P1; Oliva JT, 2017, APPL INTELL, V47, P178, DOI 10.1007/s10489-016-0891-y; Oztekin A., 2012, J CENTRUM CATHEDRA B, V5, P185, DOI DOI 10.7835/JCC-BERJ-2012-0074; Paina L, 2012, HEALTH POLICY PLANN, V27, P365, DOI 10.1093/heapol/czr054; Paliwal M, 2009, EXPERT SYST APPL, V36, P2, DOI 10.1016/j.eswa.2007.10.005; Patel VL, 2009, ARTIF INTELL MED, V46, P5, DOI 10.1016/j.artmed.2008.07.017; Penny W, 1996, MED DECIS MAKING, V16, P386, DOI 10.1177/0272989X9601600409; PICARD RR, 1990, AM STAT, V44, P140, DOI 10.2307/2684155; Plsek PE, 2001, BRIT MED J, V323, P625, DOI 10.1136/bmj.323.7313.625; Purwanto, 2012, ADV ENG SOFTW, V53, P23, DOI 10.1016/j.advengsoft.2012.07.006; Reitermanova Z., 2010, WDS, P31; Reller R., AIS REVOLUTIONARY RO; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Saadat P., 2015, ADV BUSINESS RES, V6, P1; Samanta B., 2008, International Journal of Services Operations and Informatics, V3, P162, DOI 10.1504/IJSOI.2008.019331; Sangi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121569; Sarle WS., 1994, 19 ANN SAS US GROUP, P13; Scarborough D. J., 2008, SOC IND ORG PSYCHOL; Schocken S., 1991, NEURAL NETWORKS DECI; Sharma A., 2013, IOSR J BUSINESS MANA, V12, P32; Sharma SK, 2015, J MODEL MANAG, V10, P325, DOI 10.1108/JM2-12-2013-0069; Sheikhtaheri A, 2014, J MED SYST, V38, DOI 10.1007/s10916-014-0110-5; SINGH JV, 1986, ACAD MANAGE J, V29, P562, DOI 10.2307/256224; Smith R., 2018, STAT; Somers J., 2017, MIT TECHNOLOGY REV; Sordo M., 2002, INTRO NEURAL NETWORK; Stahl F, 2012, WIRES DATA MIN KNOWL, V2, P193, DOI 10.1002/widm.1052; Sut N, 2007, EXPERT SYST, V24, P131, DOI 10.1111/j.1468-0394.2007.00425.x; Tatcher L., 2018, DANGERS COMMODITIZED; Tickle AB, 1998, IEEE T NEURAL NETWOR, V9, P1057, DOI 10.1109/72.728352; Tkac M, 2016, APPL SOFT COMPUT, V38, P788, DOI 10.1016/j.asoc.2015.09.040; Tu JV, 1996, J CLIN EPIDEMIOL, V49, P1225, DOI 10.1016/S0895-4356(96)00002-9; Veredas FJ, 2009, INT J INTELL COMPUT, V2, P327, DOI 10.1108/17563780910959929; Verma B, 2011, APPL INTELL, V34, P258, DOI 10.1007/s10489-009-0194-7; Vivekanandan T, 2017, COMPUT BIOL MED, V90, P125, DOI 10.1016/j.compbiomed.2017.09.011; Wong BK, 1997, DECIS SUPPORT SYST, V19, P301, DOI 10.1016/S0167-9236(96)00070-X; Wong BK, 1998, INFORM MANAGE-AMSTER, V34, P129, DOI 10.1016/S0378-7206(98)00050-0; Xiao C, 2018, J AM MED INFORM ASSN, V25, P1419, DOI 10.1093/jamia/ocy068; Xu M, 2013, DECIS SUPPORT SYST, V54, P1488, DOI 10.1016/j.dss.2012.12.019; Young DW, 2006, INT J HEALTH PLAN M, V21, P173, DOI 10.1002/hpm.844; Zhang SY, 2009, INFORM SYST FRONT, V11, P449, DOI 10.1007/s10796-009-9157-0; Zhang ZH, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.05.32	114	136	139	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212356	10.1371/journal.pone.0212356	http://dx.doi.org/10.1371/journal.pone.0212356			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL9KY	30779785	gold, Green Published, Green Submitted			2022-12-27	WOS:000459062900049
J	Vangelisti, A; Mascagni, F; Giordani, T; Sbrana, C; Turrini, A; Cavallini, A; Giovannetti, M; Natali, L				Vangelisti, Alberto; Mascagni, Flavia; Giordani, Tommaso; Sbrana, Cristiana; Turrini, Alessandra; Cavallini, Andrea; Giovannetti, Manuela; Natali, Lucia			Arbuscular mycorrhizal fungi induce the expression of specific retrotransposons in roots of sunflower (Helianthus annuus L.)	PLOS ONE			English	Article							TOBACCO TNT1 RETROTRANSPOSON; TRANSPOSABLE ELEMENTS; EPIGENETIC REGULATION; REPETITIVE COMPONENT; LTR-RETROTRANSPOSONS; PLANT DOMESTICATION; PROVIDES INSIGHTS; GENE-EXPRESSION; COPY-NUMBER; GENOME SIZE	Retrotransposon expression during arbuscular mycorrhizal (AM) fungal colonisation of sunflower roots (Helianthus annuus) was analysed using Illumina RNA-Seq, in order to verify whether mycorrhizal symbiosis can activate retrotransposable elements. Illumina cDNA libraries were produced from RNAs isolated from the roots of sunflower plants at 4 and 16 days after inoculation with the AM fungus Rhizoglomus irregulare and from their respective control plants. Illumina reads were mapped to a library of reverse transcriptase-encoding sequences, putatively belonging to long terminal repeat retrotransposons of Gypsy and Copia superfamilies. Forty-six different reverse transcriptase sequences were transcribed, although at a low rate, in mycorrhizal or control roots and only four were significantly overexpressed at day 16, compared with control roots. Almost all expressed or over-expressed sequences belonged to low-copy elements, mostly, of the Copia superfamily. A meta-analysis, using publicly available Illumina cDNA libraries obtained from sunflower plants treated with different hormones and chemicals, mimicking stimuli produced by abiotic and biotic stresses, was also conducted. Such analyses indicated that the four reverse transcriptase sequences over-expressed in mycorrhizal roots were explicitly induced only by AM symbiosis, showing the specificity of AM stimuli compared to that of other fungal/plant interactions.	[Vangelisti, Alberto; Mascagni, Flavia; Giordani, Tommaso; Turrini, Alessandra; Cavallini, Andrea; Giovannetti, Manuela; Natali, Lucia] Univ Pisa, Dept Agr Food & Environm, Pisa, Italy; [Sbrana, Cristiana] UOS Pisa, Inst Agr Biol & Biotechnol, CNR, Pisa, Italy	University of Pisa; Consiglio Nazionale delle Ricerche (CNR)	Natali, L (corresponding author), Univ Pisa, Dept Agr Food & Environm, Pisa, Italy.	lucia.natali@unipi.it	SBRANA, CRISTIANA/AAQ-4983-2020; Giordani, Tommaso/AAC-7352-2021; Cavallini, Andrea/AAF-1812-2020; Turrini, Alessandra/AHC-4708-2022	Sbrana, Cristiana/0000-0002-8058-8566; Mascagni, Flavia/0000-0001-9747-8040	University of Pisa, Italy (Plantomics)	University of Pisa, Italy (Plantomics)	This research is supported by a project of University of Pisa, Italy (Plantomics) to LN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anca IA, 2014, J PLANT PHYSIOL, V171, P1533, DOI 10.1016/j.jplph.2014.07.003; Araim G, 2009, J AGR FOOD CHEM, V57, P2255, DOI 10.1021/jf803173x; Avio L, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01089; Badouin H, 2017, NATURE, V546, P148, DOI 10.1038/nature22380; Baggerly KA, 2003, BIOINFORMATICS, V19, P1477, DOI 10.1093/bioinformatics/btg173; Barghini E, 2015, MAR GENOM, V24, P397, DOI 10.1016/j.margen.2015.10.002; Battini F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04959-0; Beguiristain T, 2001, PLANT PHYSIOL, V127, P212, DOI 10.1104/pp.127.1.212; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brechenmacher L, 2004, MYCORRHIZA, V14, P253, DOI 10.1007/s00572-003-0263-4; Buti M, 2009, GENOME, V52, P904, DOI [10.1139/G09-064, 10.1139/g09-064]; Buti M, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy010; Cameron DD, 2013, TRENDS PLANT SCI, V18, P539, DOI 10.1016/j.tplants.2013.06.004; Chen ECH, 2018, NEW PHYTOL, V220, P1161, DOI 10.1111/nph.14989; De Coninck B, 2015, TRENDS PLANT SCI, V20, P91, DOI 10.1016/j.tplants.2014.09.007; Fiorilli V, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00636; Fiorilli V, 2009, NEW PHYTOL, V184, P975, DOI 10.1111/j.1469-8137.2009.03031.x; Gallou A, 2012, FUNCT INTEGR GENOMIC, V12, P183, DOI 10.1007/s10142-011-0241-4; Gaude N, 2012, PLANT SIGNAL BEHAV, V7, P461, DOI 10.4161/psb.19650; Gianinazzi S, 2010, MYCORRHIZA, V20, P519, DOI 10.1007/s00572-010-0333-3; Giordani T, 2014, CURR PLANT BIOL, V1, P45, DOI 10.1016/j.cpb.2014.05.001; Giordani T, 2016, TREE GENET GENOMES, V12, DOI 10.1007/s11295-016-1036-5; GIOVANNETTI M, 1980, NEW PHYTOL, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Gomez SK, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-10; Gorinsek B, 2004, MOL BIOL EVOL, V21, P781, DOI 10.1093/molbev/msh057; Grandbastien M, 2005, CYTOGENET GENOME RES, V110, P229, DOI 10.1159/000084957; Grandbastien MA, 1997, GENETICA, V100, P241, DOI 10.1023/A:1018302216927; Grunwald U, 2004, PLANT MOL BIOL, V55, P553, DOI 10.1007/s11103-004-1303-y; Handa Y, 2015, PLANT CELL PHYSIOL, V56, P1490, DOI 10.1093/pcp/pcv071; Hawkins JS, 2006, GENOME RES, V16, P1252, DOI 10.1101/gr.5282906; Hogekamp C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-306; Hogekamp C, 2011, PLANT PHYSIOL, V157, P2023, DOI 10.1104/pp.111.186635; Huettel B, 2007, BBA-GENE STRUCT EXPR, V1769, P358, DOI 10.1016/j.bbaexp.2007.03.001; Kawakami T, 2011, GENOME BIOL EVOL, V3, P156, DOI 10.1093/gbe/evr005; Kazazian HH, 2000, SCIENCE, V289, P1152, DOI 10.1126/science.289.5482.1152; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Leff JW, 2017, NEW PHYTOL, V214, P412, DOI 10.1111/nph.14323; Lisch D, 2009, ANNU REV PLANT BIOL, V60, P43, DOI 10.1146/annurev.arplant.59.032607.092744; Llorens C, 2011, NUCLEIC ACIDS RES, V39, pD70, DOI 10.1093/nar/gkq1061; LOGEMANN J, 1987, ANAL BIOCHEM, V163, P16, DOI 10.1016/0003-2697(87)90086-8; Lohse S, 2005, PLANT PHYSIOL, V139, P329, DOI 10.1104/pp.105.061457; Mascagni F, 2018, GENES-BASEL, V9, DOI 10.3390/genes9090433; Mascagni F, 2017, GENE, V634, P5, DOI 10.1016/j.gene.2017.08.014; Mascagni F, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4050-6; Mascagni F, 2015, GENOME BIOL EVOL, V7, P3368, DOI 10.1093/gbe/evv230; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Melayah D, 2001, PLANT J, V28, P159, DOI 10.1046/j.1365-313X.2001.01141.x; Mhiri C, 1999, MOL PLANT MICROBE IN, V12, P592, DOI 10.1094/MPMI.1999.12.7.592; Mhiri C, 1997, PLANT MOL BIOL, V33, P257, DOI 10.1023/A:1005727132202; Morgante M, 2005, NAT GENET, V37, P997, DOI 10.1038/ng1615; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Natali L, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0937-z; Natali L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-686; Novak P, 2013, BIOINFORMATICS, V29, P792, DOI 10.1093/bioinformatics/btt054; Pepe Alessandra, 2017, Mycorrhiza, V27, P659, DOI 10.1007/s00572-017-0779-7; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; Piegu B, 2006, GENOME RES, V16, P1262, DOI 10.1101/gr.5290206; POUTEAU S, 1994, PLANT J, V5, P535, DOI 10.1046/j.1365-313X.1994.5040535.x; Ropars J, 2015, NEW PHYTOL, V208, P638, DOI 10.1111/nph.13448; Savary R, 2018, ISME J, V12, P17, DOI 10.1038/ismej.2017.153; Schaarschmidt S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r62; Shu B, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00408; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd; SMITH SE, 1990, AUST J PLANT PHYSIOL, V17, P177, DOI 10.1071/PP9900177; Staton SE, 2012, PLANT J, V72, P142, DOI 10.1111/j.1365-313X.2012.05072.x; Tisserant E, 2013, P NATL ACAD SCI USA, V110, P20117, DOI 10.1073/pnas.1313452110; Turrini A, 2016, BIOL FERT SOILS, V52, P643, DOI 10.1007/s00374-016-1106-8; Usai G, 2017, TREE GENET GENOMES, V13, DOI 10.1007/s11295-017-1181-5; Vangelisti A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18445-0; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; von Sternberg R, 2005, CYTOGENET GENOME RES, V110, P108, DOI 10.1159/000084942; Vukich M, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-150; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wright DA, 2002, GENOME RES, V12, P122, DOI 10.1101/gr.196001; Yamazaki M, 2001, MOL GENET GENOMICS, V265, P336, DOI 10.1007/s004380000421	78	12	12	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212371	10.1371/journal.pone.0212371	http://dx.doi.org/10.1371/journal.pone.0212371			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779767	Green Published, gold, Green Submitted			2022-12-27	WOS:000459062900051
J	Wasir, R; Irawati, S; Makady, A; Postma, M; Goettsch, W; Buskens, E; Feenstra, T				Wasir, Riswandy; Irawati, Sylvi; Makady, Amr; Postma, Maarten; Goettsch, Wim; Buskens, Erik; Feenstra, Talitha			Use of medicine pricing and reimbursement policies for universal health coverage in Indonesia	PLOS ONE			English	Article							QUALITATIVE RESEARCH; PERFORMANCE; FOCUS; CARE; PAY	Objectives This study aimed to define the problems of the current use of the e-Catalogue and the national formulary (NF)-two elements of medicine pricing and reimbursement policies in Indonesia for achieving universal health coverage (UHC)-by examining the knowledge and attitudes of stakeholders. Specifically, to investigate (1) the perceived challenges involved in the further implementation of the e-Catalogue and the NF, (2) reasons of prescribing medicines not listed in the NF, and (3) possible improvements in the acceptance and use of the e-Catalogue and the NF. Methods Semi-structured interviews were conducted with stakeholders (policymakers, healthcare providers, a pharmaceutical industry representative, and experienced patients) to collect the qualitative data. The data was analysed using directed content analysis, following the guidelines of the COnsolidated criteria for REporting Qualitative studies (COREQ) in reporting the findings. Results Interestingly, 20 of 45 participants decided to withdraw from the interview due to their lack of knowledge of the e-Catalogue and the NF. All 25 stakeholders who fully participated in this research were in favor of the e-Catalogue and the NF. However, interviewees identified a range of challenges. A major challenge was the lack of harmonization between the lists of medicines in the e-Catalogue and the NF. Several system and personal reasons for prescribing medicines not listed in the NF were identified. Important reasons were a lack of incentives for physicians as well as a lack of transparent and evidence-based methods of selection for the medicines to be listed in the NF. Conclusions The e-Catalogue and the NF have not been fully utilized for achieving UHC in Indonesia. Some possible improvements suggested were harmonization of medicines listed in the e-Catalogue and the NF, restructuring incentive programs for prescribing NF medicines, and increasing the transparency and evidence-based approach for selection of medicines listed in the e-Catalogue and the NF.	[Wasir, Riswandy; Buskens, Erik; Feenstra, Talitha] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Wasir, Riswandy] Sekolah Tinggi Ilmu Farmasi Makassar, Makassar, Indonesia; [Wasir, Riswandy; Irawati, Sylvi; Postma, Maarten] Univ Groningen, Groningen Res Inst Pharm PharmacoTherapy Epidemio, Groningen, Netherlands; [Irawati, Sylvi] Univ Surabaya, Ctr Med Informat & Pharmaceut Care, Fac Pharm, Surabaya, Indonesia; [Irawati, Sylvi] Univ Surabaya, Dept Clin & Community Pharm, Fac Pharm, Surabaya, Indonesia; [Makady, Amr; Goettsch, Wim] Natl Hlth Care Inst, Diemen, Netherlands; [Makady, Amr; Goettsch, Wim] Univ Utrecht, Dept Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands; [Postma, Maarten] Univ Groningen, Dept Hlth Sci, Groningen, Netherlands; [Postma, Maarten] Univ Groningen, Dept Econ Econometr & Finance, Fac Econ & Business, Groningen, Netherlands; [Postma, Maarten] Univ Airlangga, Dept Pharmacol & Therapy, Fac Med, Surabaya, Indonesia; [Buskens, Erik] Univ Groningen, Fac Econ & Business, Dept Operat, Groningen, Netherlands; [Feenstra, Talitha] Dutch Natl Inst Publ Hlth & Environm, Bilthoven, Netherlands	University of Groningen; University of Groningen; Universitas Surabaya (UBAYA); Universitas Surabaya (UBAYA); Utrecht University; University of Groningen; University of Groningen; Airlangga University; University of Groningen	Wasir, R (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.; Wasir, R (corresponding author), Sekolah Tinggi Ilmu Farmasi Makassar, Makassar, Indonesia.; Wasir, R (corresponding author), Univ Groningen, Groningen Res Inst Pharm PharmacoTherapy Epidemio, Groningen, Netherlands.	r.wasir@umcg.nl	Feenstra, Talitha/AAM-3234-2020; Irawati, Sylvi/GLQ-9438-2022	Feenstra, Talitha/0000-0002-5788-0454; Irawati, Sylvi/0000-0001-6278-9017; buskens, erik/0000-0002-6463-1106; Wasir, Riswandy/0000-0001-6184-925X; Postma, Maarten/0000-0002-6306-3653	DIKTI scholarship from the Ministry of Research, Technology and Higher Education; LPDP scholarship from the Ministry of Finance of the Republic Indonesia	DIKTI scholarship from the Ministry of Research, Technology and Higher Education(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); LPDP scholarship from the Ministry of Finance of the Republic Indonesia	This work was financially supported by DIKTI (to RW) and LPDP (to SI) scholarships from the Ministry of Research, Technology and Higher Education, and the Ministry of Finance of the Republic Indonesia, respectively. The DIKTI and LPDP had no direct role in research design, data collection, analysis and interpretation, or manuscript writing and publication.	Angelis A, 2018, EUR J HEALTH ECON, V19, P123, DOI 10.1007/s10198-017-0871-0; [Anonymous], 2013, MALAYSIA HEAL SYST R, V3, P103; [Anonymous], 2010, WOR HEALT REP; Ariati N., 2017, INTEGRITAS, V3, P231; Babar Z, 2017, PHARM POLICY COUNTRI; Bigdeli M, 2015, MED UNIVERSAL HLTH C; BPJS Kesehatan, 2014, PAND PRAKT PROL PROG; Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; Chalkidou K, 2013, LANCET, V382, pE48, DOI 10.1016/S0140-6736(13)62559-3; Diack A, 2010, ASSESSMENT GOVERNANC; Dirjen Binfar dan Alkes Kemenkes RI, 2015, IMPL FORM NAS DAL PE; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Fahamnuaypol P., 2015, KINGDOM THAILAND HLT; Godman B, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00106; Gustafsson LL, 2011, BASIC CLIN PHARMACOL, V108, P224, DOI 10.1111/j.1742-7843.2011.00682.x; Hawkins L., 2011, WHO HAI PROJECT MED; Hidayat B, 2015, OUT POCKET PAYMENTS; Holloway KA., 2011, MISSION REPORT, P30; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Huskamp HA, 2003, NEW ENGL J MED, V349, P2224, DOI 10.1056/NEJMsa030954; Kemetrian Kesehatan Republik Indonesia, 2015, PED PEN FORM NAS; Kibuule D, 2017, INT J CLIN PRACT, V71, DOI 10.1111/ijcp.12918; Leach M, 2012, BRIT J GEN PRACT, V62, P293, DOI 10.3399/bjgp12X649061; Lembaga Kebijakan Pengadaan Barang dan Jasa Pemerintah (LKPP), 2018, KAT PROD OB 2018; Mashalla Y. J., 2016, Journal of Public Health and Epidemiology, V8, P127; MAYS N, 1995, BRIT MED J, V311, P182, DOI 10.1136/bmj.311.6998.182; Menteri Kesehatan Republik Indonesia, 2014, PER MENT KES REP IND, DOI [10.3389/fphar.2014.00106, DOI 10.3389/FPHAR.2014.00106]; Menteri Kesehatan Republik Indonesia, 2015, PED PEN FORM NAS; Ministry of Health Malaysia, 2012, MAL NAT MED POL; Nguyen TA, 2017, PHARM POLICY COUNTRI, P75; Rickwood S, 2013, IMS I HEALTHCARE INF, P5; Soonman Kwon, 2014, PHARM POLICY FINANCI; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Nguyen TA, 2015, HEALTH POLICY PLANN, V30, P267, DOI 10.1093/heapol/czt105; Wettermark B, 2009, APPL HEALTH ECON HEA, V7, P137, DOI 0.2165/11314810-000000000-00000; WHO, 2016, WORLD HLTH STAT 2016; WHO, GLOB HLTH EXP DAT; Whyte P, 2013, ROLE HLTH TECHNOLOGY; Wirtz VJ, 2017, LANCET, V389, P403, DOI 10.1016/S0140-6736(16)31599-9; World Health Organization, 2015, WHO GUID COUNTR PHAR; World Health Organization, WHO DEF EB 134 30	41	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212328	10.1371/journal.pone.0212328	http://dx.doi.org/10.1371/journal.pone.0212328			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL9KY	30779809	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000459062900047
J	Guerra, GES; Caldeira, AP; de Oliveira, FPSL; Brito, MFSF; Gerra, KDDS; D'Angelis, CEM; dos Santos, LAN; de Pinho, L; Rocha, JSB; Popoff, DAV				Souza Guerra Junior, Geraldo Edson; Caldeira, Antonio Prates; Santos Lima de Oliveira, Fernanda Piana; Santos Figueiredo Brito, Maria Fernanda; de Oliveira Silva Gerra, Kelma Dayana; Mendes D'Angelis, Carlos Eduardo; Nogueira dos Santos, Luis Antonio; de Pinho, Lucineia; Brant Rocha, Josiane Santos; Veloso Popoff, Daniela Araujo			Quality of life in climacteric women assisted by primary health care	PLOS ONE			English	Article							MENOPAUSAL SYMPTOMS; QUESTIONNAIRE; IMPACT; ASSOCIATION; VERSION; SLEEP	This cross-sectional study evaluated the quality of life and associated factors of climacteric women in Brazil using a random and representative sample of women assisted by primary care professionals. We investigated the variables using the Menopause-Specific Quality of Life Questionnaire, MENQOL, whose mean scores were compared using Mann-Whitney and Kruskal-Wallis tests according to the sample characteristics. The variables associated with the outcomes in univariate analyses with a p <= 0.2 were jointly evaluated using multiple linear regression. In this study, 849 women ranging in age from 40 to 65 years were evaluated. The predictors of poor quality of life in the vasomotor domain were women with severe climacteric symptoms (p<0.001), increased Body Mass Index (BMI) (p = 0.006), sleep (p = 0.022), and postmenopausal (p<0.001) alterations. For the psychosocial domain, the associated variables were severe climacteric symptoms (p<0.001) and sleep alterations (p<0.001); for the physical domain, the associated variables were severe climacteric symptoms (p<0.001), increased BMI (p<0.001), sleep (p<0.001), and postmenopausal (p<0.001) alterations. Severe climacteric symptoms, low sleep quality, increased BMI, and postmenopausal status were factors that were more associated with impairments in quality of life. With the increase in life expectancy, we suggest that greater attention should be paid to women's quality of life associated with climacteric symptoms.	[Souza Guerra Junior, Geraldo Edson; Caldeira, Antonio Prates; Santos Figueiredo Brito, Maria Fernanda; de Oliveira Silva Gerra, Kelma Dayana; Mendes D'Angelis, Carlos Eduardo; Nogueira dos Santos, Luis Antonio; de Pinho, Lucineia; Brant Rocha, Josiane Santos; Veloso Popoff, Daniela Araujo] Univ Estadual Montes Claros, Postgrad Program Primary Hlth Care, Montes Claros, MG, Brazil; [Souza Guerra Junior, Geraldo Edson; Caldeira, Antonio Prates; Santos Lima de Oliveira, Fernanda Piana; Brant Rocha, Josiane Santos; Veloso Popoff, Daniela Araujo] Fipmoc Univ Ctr UNIFIPMoc, Montes Claros, MG, Brazil	Universidade Estadual de Montes Claros	de Oliveira, FPSL (corresponding author), Fipmoc Univ Ctr UNIFIPMoc, Montes Claros, MG, Brazil.	fernandapiana@gmail.com	brito, maria/HDO-2541-2022; SANTOS, LUIS ANTONIO NOGUEIRA/ABF-6642-2020	SANTOS, LUIS ANTONIO NOGUEIRA/0000-0002-3778-8124; Guerra, Kelma/0000-0003-0591-1914; Piana Santos Lima de Oliveira, Fernanda/0000-0002-8826-6852; Santos Brant Rocha, Josiane/0000-0002-7317-3880; Souza Guerra Junior, Geraldo Edson/0000-0001-5755-0968				Alwi SARS, 2009, CLIMACTERIC, V12, P548, DOI 10.3109/13697130902919519; Asghari M, 2017, WOMEN HEALTH, V57, P173, DOI 10.1080/03630242.2016.1157128; Bertolazi AN, 2011, SLEEP MED, V12, P70, DOI 10.1016/j.sleep.2010.04.020; Blumel JE, 2011, MENOPAUSE, V18, P778, DOI 10.1097/gme.0b013e318207851d; Ceylan B, 2014, CLIMACTERIC, V17, P705, DOI 10.3109/13697137.2014.929108; Donati S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085121; Fallahzadeh H, 2010, QUAL LIFE RES, V19, P813, DOI 10.1007/s11136-010-9644-2; Freedman RR, 2014, J STEROID BIOCHEM, V142, P115, DOI 10.1016/j.jsbmb.2013.08.010; Freitas ER, 2015, ARQ BRAS PSICOL APL, V67, P112; Ghazanfarpour M, 2013, GYNECOL ENDOCRINOL, V29, P917, DOI 10.3109/09513590.2013.819078; Hilditch JR, 1996, MATURITAS, V24, P161, DOI 10.1016/0378-5122(96)01038-9; Kim MJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192934; Kim MJ, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-122; Lewis JE, 2005, MATURITAS, V50, P209, DOI 10.1016/j.maturitas.2004.06.015; Lorenzi Dino Roberto Soares De, 2009, Rev. Bras. Saude Mater. Infant., V9, P459, DOI 10.1590/S1519-38292009000400011; Macinko J, 2015, NEW ENGL J MED, V372, P2177, DOI 10.1056/NEJMp1501140; Matsudo S., 2012, REV BRASILEIRA ATIVI, V6, P5, DOI DOI 10.12820/RBAFS.V.6N2P5-18; de Morais MSM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184031; Menezes Daianne Vieira, 2016, Fisioter. mov., V29, P219, DOI 10.1590/0103-5150.029.002.AO01; Miranda Gabriella Morais Duarte, 2016, Rev. bras. geriatr. gerontol., V19, P507, DOI 10.1590/1809-98232016019.150140; Mirhaghjou SN, 2016, APPL NURS RES, V30, P252, DOI 10.1016/j.apnr.2015.10.004; Nisar Nusrat, 2009, JPMA Journal of the Pakistan Medical Association, V59, P752; Norozi Ensiyeh, 2013, J Educ Health Promot, V2, P58, DOI 10.4103/2277-9531.120857; Poomalar GK, 2013, J CLIN DIAGN RES, V7, P135, DOI 10.7860/JCDR/2012/4910.2688; Schneider HPG, 2017, CLIMACTERIC, V20, P187, DOI 10.1080/13697137.2017.1279599; Shaver JL, 2015, MENOPAUSE, V22, P899, DOI 10.1097/GME.0000000000000499; Shobeiri Fatemeh, 2016, J Menopausal Med, V22, P31, DOI 10.6118/jmm.2016.22.1.31; Sociedade Brasileira de Climaterio, CONS BRAS MULT ASS M; Som N, 2014, CLIMACTERIC, V17, P713, DOI 10.3109/13697137.2014.913283; Sousa RL, 2000, REV BRAS GINECOL OBS, V22, P481; Sydora BC, 2016, MENOPAUSE, V23, P1038, DOI 10.1097/GME.0000000000000636; Utian W H, 1999, Climacteric, V2, P284, DOI 10.3109/13697139909038088; Verma, 2015, JSAFMS, V3, P20, DOI [10.5005/JP, DOI 10.5005/JP]; Williams RE, 2009, MATURITAS, V62, P153, DOI 10.1016/j.maturitas.2008.12.006; World Health Organization (WHO), 1998, OB PREV MAN GLOB EP, P98; Yanikkerem E, 2012, CLIMACTERIC, V15, P552, DOI 10.3109/13697137.2011.637651; Zollner YF, 2005, QUAL LIFE RES, V14, P309, DOI 10.1007/s11136-004-0688-z	37	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211617	10.1371/journal.pone.0211617	http://dx.doi.org/10.1371/journal.pone.0211617			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM9LQ	30811409	gold, Green Published, Green Submitted			2022-12-27	WOS:000459806400025
J	Sahrmann, AS; Stott, NS; Besier, TF; Fernandez, JW; Handsfield, GG				Sahrmann, Annika S.; Stott, Ngaire Susan; Besier, Thor F.; Fernandez, Justin W.; Handsfield, Geoffrey G.			Soleus muscle weakness in cerebral palsy: Muscle architecture revealed with Diffusion Tensor Imaging	PLOS ONE			English	Article							CROSS-SECTIONAL AREA; GROSS MOTOR FUNCTION; MEDIAL GASTROCNEMIUS; SARCOMERE LENGTHS; FASCICLE LENGTH; CHILDREN; CLASSIFICATION; STRENGTH; MRI; DTI	Cerebral palsy (CP) is associated with movement disorders and reduced muscle size. This latter phenomenon has been observed by computing muscle volumes from conventional MRI, with most studies reporting significantly reduced volumes in leg muscles. This indicates impaired muscle growth, but without knowing muscle fiber orientation, it is not clear whether muscle growth in CP is impaired in the along-fiber direction (indicating shortened muscles and limited range of motion) or the cross-fiber direction (indicating weak muscles and impaired strength). Using Diffusion Tensor Imaging (DTI) we can determine muscle fiber orientation and construct 3D muscle architectures which can be used to examine both along-fiber length and cross-sectional area. Such an approach has not been undertaken in CP. Here, we use advanced DTI sequences with fast imaging times to capture fiber orientations in the soleus muscle of children with CP and age-matched, able-bodied controls. Cross sectional areas perpendicular to the muscle fiber direction were reduced (37 +/- 11%) in children with CP compared to controls, indicating impaired muscle strength. Along-fiber muscle lengths were not different between groups. This study is the first to demonstrate along-fiber and cross-fiber muscle architecture in CP using DTI and implicates impaired cross-sectional muscle growth in children with cerebral palsy.	[Sahrmann, Annika S.; Besier, Thor F.; Fernandez, Justin W.; Handsfield, Geoffrey G.] Univ Auckland, Auckland Bioengn Inst, Auckland, New Zealand; [Stott, Ngaire Susan] Univ Auckland, Dept Orthopaed Surg, Fac Med & Hlth Sci, Auckland, New Zealand; [Besier, Thor F.; Fernandez, Justin W.] Univ Auckland, Dept Engn Sci, Fac Engn, Auckland, New Zealand	University of Auckland; University of Auckland; University of Auckland	Handsfield, GG (corresponding author), Univ Auckland, Auckland Bioengn Inst, Auckland, New Zealand.	g.handsfield@auckland.ac.nz	Besier, Thor F/P-6425-2019	Handsfield, Geoffrey/0000-0001-5661-0631	Wishbone Trust of the NZ Orthopaedic Association [3710689]; Whitaker Foundation; Robertson Foundation Aotearoa Fellowship Program [3715249]	Wishbone Trust of the NZ Orthopaedic Association; Whitaker Foundation; Robertson Foundation Aotearoa Fellowship Program	GGH and TFB received funding from the Wishbone Trust of the NZ Orthopaedic Association to pursue this study. [Award Number 3710689; https://nzoa.org.nz/wishbone-orthopaedic-research-foundation-new-zealand; The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.] GGH received fellowships from the Whitaker Foundation [Award Number N/A; https://www.whitaker.org/] and the Robertson Foundation Aotearoa Fellowship Program [Award Number 3715249; http://robertsonfoundation.org/index.html] during the pursuit of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agur AM, 2003, CLIN ANAT, V16, P285, DOI 10.1002/ca.10112; Alexander R.M., 1975, J HUMAN MOVEMENT STU, V1, P115; Alipour M, 2017, BIOMECH MODEL MECHAN, V16, P1729, DOI 10.1007/s10237-017-0916-4; Arkin AM, 1941, ARCH SURG-CHICAGO, V42, P395, DOI 10.1001/archsurg.1941.01210080195012; Barber L, 2011, J BIOMECH, V44, P2496, DOI 10.1016/j.jbiomech.2011.06.008; Barber L, 2011, DEV MED CHILD NEUROL, V53, P543, DOI 10.1111/j.1469-8749.2011.03913.x; Barrett RS, 2010, DEV MED CHILD NEUROL, V52, P794, DOI 10.1111/j.1469-8749.2010.03686.x; Bax M, 2005, DEV MED CHILD NEUROL, V47, P571, DOI 10.1017/S001216220500112X; Bolsterlee B, 2015, J BIOMECH, V48, P1133, DOI 10.1016/j.jbiomech.2015.01.012; Buck AKW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126953; CAPADAY C, 1986, J NEUROSCI, V6, P1308; Chen XF, 2016, J BIOMECH, V49, P4164, DOI 10.1016/j.jbiomech.2016.11.010; Cromie MJ, 2013, MUSCLE NERVE, V48, P286, DOI 10.1002/mus.23760; Damon BM, 2002, MAGN RESON MED, V48, P97, DOI 10.1002/mrm.10198; Fernandez J, 2017, LECT NOTES COMPUT SC, V10549, P71, DOI 10.1007/978-3-319-67552-7_9; Foran JRH, 2005, DEV MED CHILD NEUROL, V47, P713, DOI 10.1017/S0012162205001465; Fukunaga T, 1997, J APPL PHYSIOL, V82, P354, DOI 10.1152/jappl.1997.82.1.354; Handsfield GG, 2017, BIOMECH MODEL MECHAN, V16, P1845, DOI 10.1007/s10237-017-0923-5; Handsfield GG, 2016, MUSCLE NERVE, V53, P933, DOI 10.1002/mus.24972; Handsfield GG, 2014, J BIOMECH, V47, P631, DOI 10.1016/j.jbiomech.2013.12.002; Heemskerk AM, 2010, NMR BIOMED, V23, P294, DOI 10.1002/nbm.1463; Hodgson JA, 2006, J MORPHOL, V267, P584, DOI 10.1002/jmor.10421; Holzbaur KRS, 2007, J BIOMECH, V40, P742, DOI 10.1016/j.jbiomech.2006.11.011; Hooijmans MT, 2015, NMR BIOMED, V28, P1589, DOI 10.1002/nbm.3427; Jellison BJ, 2004, AM J NEURORADIOL, V25, P356; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Ko IH, 2013, J EXERC REHABIL, V9, P368, DOI 10.12965/jer.130045; Lansdown DA, 2007, J APPL PHYSIOL, V103, P673, DOI 10.1152/japplphysiol.00290.2007; Lieber RL, 2000, MUSCLE NERVE, V23, P1647, DOI 10.1002/1097-4598(200011)23:11<1647::AID-MUS1>3.0.CO;2-M; Llewellyn ME, 2008, NATURE, V454, P784, DOI 10.1038/nature07104; Malaiya R, 2007, J ELECTROMYOGR KINES, V17, P657, DOI 10.1016/j.jelekin.2007.02.009; Mathewson MA, 2015, J ORTHOP RES, V33, P33, DOI 10.1002/jor.22728; Moreau NG, 2010, PHYS THER, V90, P1619, DOI 10.2522/ptj.20090377; Moreau NG, 2009, DEV MED CHILD NEUROL, V51, P800, DOI 10.1111/j.1469-8749.2009.03307.x; Morrell DS, 2002, RADIOGRAPHICS, V22, P257, DOI 10.1148/radiographics.22.2.g02mr19257; Morse CI, 2005, J APPL PHYSIOL, V99, P1050, DOI 10.1152/japplphysiol.01186.2004; NARICI MV, 1992, EUR J APPL PHYSIOL O, V65, P438, DOI 10.1007/BF00243511; Noble JJ, 2017, BMC NEUROL BMC NEURO, V17, P1, DOI [10.1186/s12883-016-0787-9, DOI 10.1186/S12883-016-0787-9]; Noble JJ, 2014, BRAIN DEV-JPN, V36, P294, DOI 10.1016/j.braindev.2013.05.008; Oberhofer K, 2010, CLIN BIOMECH, V25, P88, DOI 10.1016/j.clinbiomech.2009.09.007; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; PRUIM GJ, 1980, J BIOMECH, V13, P755, DOI 10.1016/0021-9290(80)90237-7; Reid SL, 2015, DISABIL REHABIL, V37, P579, DOI 10.3109/09638288.2014.935492; Rodda JM, 2004, J BONE JOINT SURG BR, V86B, P251, DOI 10.1302/0301-620X.86B2.13878; Rosenbaum P, 2007, DEV MED CHILD NEUROL, V49, P8, DOI 10.1111/j.1469-8749.2007.tb12610.x; Schenk P, 2013, J ANAT, V223, P61, DOI 10.1111/joa.12062; Shortland AP, 2002, DEV MED CHILD NEUROL, V44, P158, DOI 10.1017/S0012162201001864; Sinha U, 2011, J APPL PHYSIOL, V110, P807, DOI 10.1152/japplphysiol.00923.2010; Sinkjaer T, 2000, J PHYSIOL-LONDON, V523, P817, DOI 10.1111/j.1469-7793.2000.00817.x; Smith LR, 2011, J PHYSIOL-LONDON, V589, P2625, DOI 10.1113/jphysiol.2010.203364; Van Donkelaar CC, 1999, J ANAT, V194, P79, DOI 10.1046/j.1469-7580.1999.19410079.x; Ward SR, 2009, CLIN ORTHOP RELAT R, V467, P1074, DOI 10.1007/s11999-008-0594-8; Wood E, 2000, DEV MED CHILD NEUROL, V42, P292, DOI 10.1017/S0012162200000529; Yeh FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080713; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	55	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2019	14	2							e0205944	10.1371/journal.pone.0205944	http://dx.doi.org/10.1371/journal.pone.0205944			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EH	30802250	Green Published, Green Submitted, gold			2022-12-27	WOS:000459710700002
J	Chenoweth, L; Stein-Parbury, J; Lapkin, S; Wang, A; Liu, ZX; Williams, A				Chenoweth, Lynette; Stein-Parbury, Jane; Lapkin, Samuel; Wang, Alex; Liu, Zhixin; Williams, Anna			Effects of person-centered care at the organisational-level for people with dementia. A systematic review	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; NURSING-HOME; RESIDENTS; AGITATION; PERCEN	The aim of the systematic review was to determine the effectiveness of organizational-level person-centered care for people living with dementia in relation to their quality of life, mood, neuropsychiatric symptoms and function. ALOIS, the Cochrane Dementia and Cognitive Improvement Group Specialised Register databases, were searched up to June 2018 using the terms dementia OR cognitive impairment OR Alzheimer AND non-pharmacological AND personhood OR person-centered care. Reviewed studies included randomized controlled trials (RCTs), cluster-randomized trials (CRTs) and quasi-experimental studies that compared outcomes of person-centered care and usual (non-person-centered) care, for people with a diagnosis of dementia. The search yielded 12 eligible studies with a total of 2599 people living with dementia in long-term care homes, 600 receiving hospital care and 293 living in extra-care community housing. Random-effects models were used to pool adjusted risk ratios and standard mean differences from all studies; the findings were assessed followed the PRISMA guidelines and GRADE criteria. Statistical heterogeneity was assessed using the I-2 method and Chi(2)P value; studies with low statistical heterogeneity were analyzed using a random-effects model with restricted maximum likelihood estimation in R. Analyses of pre/post data within 12 months identified: a significant effect for quality of life (standardized mean difference (SMD) 0.16 and 95% CI 0.03 to 0.28; studies = 6; I-2 = 22%); non-significant effects for neuropsychiatric symptoms (SMD 0.06, 95% CI -0.08 to 0.19; studies = 4; I-2 = 0%) and well-being (SMD 0.15, 95% CI -0.15 to 0.45; studies = 4; I-2 = 77%); and no effects for agitation (SMD -0.05 (95% CI -0.17 to -0.07; studies 5; I-2 = 0%) and depression (SMD -0.06 and 95% CI -0.27 to 0.15, studies = 5; I-2 = 53%). The evidence from this review recommends implementation of person-centered care at the organizational-level to support the quality of life of people with living with dementia.	[Chenoweth, Lynette] Univ New South Wales Sydney, Fac Med, Ctr Hlth Brain Ageing CHeBA, Sydney, NSW, Australia; [Stein-Parbury, Jane; Wang, Alex] Univ Technol Sydney, Fac Hlth, Sydney, NSW, Australia; [Lapkin, Samuel] Univ Wollongong, Fac Sci Med & Hlth, Sch Nursing, South Western Sydney Campus, Wollongong, NSW, Australia; [Liu, Zhixin] Univ New South Wales Sydney, Stats Cent, Sydney, NSW, Australia; [Williams, Anna] Univ Notre Dame Sydney, Fac Med, Sch Nursing, Sydney, NSW, Australia	University of New South Wales Sydney; University of Technology Sydney; University of Wollongong; University of New South Wales Sydney; University of Notre Dame Australia	Chenoweth, L (corresponding author), Univ New South Wales Sydney, Fac Med, Ctr Hlth Brain Ageing CHeBA, Sydney, NSW, Australia.	l.chenoweth@unsw.edu.au		Lapkin, Samuel/0000-0002-1618-3812; Chenoweth, Lynette/0000-0002-1407-3804; Wang, Alex Yueping/0000-0002-3656-4284; Williams, Anna/0000-0003-0349-4248				ALOIS, 2011, COCHR DEM COGN IMPR; Alzheimer's Association, ALZH FACTS FIG 2013; Alzheimer's Disease International, 2014, DEM AS PAC REG; American Psychiatric Association, 2013, DIAGN STAT MAN DSM 5; Australian Health Ministers Advisory Council (AHMAC), 2015, NAT FRAM ACT DEM 201; Berry Lisa, 2009, Nurs Older People, V21, P3; *BRADF DEM GROUP, 2005, DCM 8 US MAN; Bradford Dementia Group and the Commission for Social Care Inspection in England, 2007, SHORT OBS FRAM INSP; Brooker D., 2016, PERSON CTR DEMENTIA; Brooker D., 2004, WHAT IS PERSONCENTRE, V13, P215, DOI [DOI 10.1017/S095925980400108X, 10.1017/S095925980400108X]; Brooker DJ, 2011, AGING MENT HEALTH, V15, P1008, DOI 10.1080/13607863.2011.583628; Brownie S, 2013, CLIN INTERV AGING, V8, P1, DOI 10.2147/CIA.S38589; Burke C, 2016, CLIN GERONTOLOGIST, V39, P282, DOI 10.1080/07317115.2016.1172532; Chenoweth L, 2015, COCHRANE LIB, DOI [10.1002/14651858.CD011963, DOI 10.1002/14651858.CD011963]; Chenoweth L, 2015, INT PSYCHOGERIATR, V27, P2045, DOI 10.1017/S1041610215001350; Chenoweth L, 2014, INT PSYCHOGERIATR, V26, P1147, DOI 10.1017/S1041610214000398; Chenoweth L, 2009, LANCET NEUROL, V8, P317, DOI 10.1016/S1474-4422(09)70045-6; Cohen-Mansfield J, 1999, J Gerontol Nurs, V25, P42; Cohen-Mansfield J, 2012, J CLIN PSYCHIAT, V73, P478; Dewing J, 2008, INT J OLDER PEOPLE N, V3, P3, DOI 10.1111/j.1748-3743.2007.00103.x; Dichter MN, 2015, INT PSYCHOGERIATR, V27, P1875, DOI 10.1017/S1041610215000927; Doyle PJ, 2014, GERONTOLOGIST, V54, P952, DOI 10.1093/geront/gnt081; Effective Practice and Organisation of Care (EPOC)-Cochrane, 2015, EPOC RES REV AUTH, P1; Eriksen S, 2016, DEMENT GERIATR COGN, V42, P342, DOI 10.1159/000452404; Finnema E, 2005, INT J GERIATR PSYCH, V20, P330, DOI 10.1002/gps.1286; Fossey J, 2006, BMJ-BRIT MED J, V332, P756, DOI 10.1136/bmj.38782.575868.7C; Goldberg SE, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4132; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1055/s-0041-111066, 10.1136/bmj.g1687]; Jeon YH, 2015, J AM MED DIR ASSOC, V16, DOI 10.1016/j.jamda.2015.04.005; Kitson A, 2013, J ADV NURS, V69, P4, DOI 10.1111/j.1365-2648.2012.06064.x; Kitwood TM, 2007, DEMENTIA RECONSIDERE; Kogan AC, 2016, J AM GERIATR SOC, V64, pE1, DOI 10.1111/jgs.13873; Lawton MP, 1988, INT PSYCHOGERIATR, V10, P379; Li JX, 2017, BEHAV SLEEP MED, V15, P97, DOI 10.1080/15402002.2015.1104686; Love K, 2013, GENERATIONS, V37, P23; McCormack B., 2011, PERSON CTR NURSING T; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Moore Lucy, 2017, Scand J Caring Sci, V31, P662, DOI 10.1111/scs.12376; Morgan S, 2012, J HOLIST NURS, V30, P6, DOI 10.1177/0898010111412189; National Voices, 2017, PERS CENT CAR 2017; Olsson LE, 2013, J CLIN NURS, V22, P456, DOI 10.1111/jocn.12039; Peters JL, 2008, J EVAL CLIN PRACT, V14, P941, DOI 10.1111/j.1365-2753.2008.01010.x; Review Manager (RevMan), 2014, NON TRADITIONAL REF; Roen I, 2018, INT PSYCHOGERIATR, V30, P1279, DOI 10.1017/S1041610217002708; Rokstad AMM, 2013, DEMENT GERIATR COGN, V36, P340, DOI 10.1159/000354366; Rosvik J, 2013, REV CLIN GERONTOL, V23, P155, DOI 10.1017/S0959259813000014; Ryan R., 2016, COCHRANE CONSUMERS C, V3; Slater Lynne, 2006, Contemp Nurse, V23, P135; Sloane PD, 2004, J AM GERIATR SOC, V52, P1795, DOI 10.1111/j.1532-5415.2004.52501.x; van de Ven G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067325; World Health Organisation, 2019, INT STAT CLASS DIS R, V11th; World Health Organization, 2018, DEM PLAN WHO GUID	53	33	35	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212686	10.1371/journal.pone.0212686	http://dx.doi.org/10.1371/journal.pone.0212686			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794651	Green Submitted, Green Published, gold			2022-12-27	WOS:000459709100114
J	Graff, TC; Luke, SG; Birmingham, WC				Graff, Tyler C.; Luke, Steven G.; Birmingham, Wendy C.			Supportive hand-holding attenuates pupillary responses to stress in adult couples	PLOS ONE			English	Article							BASE-LINE-THEORY; SOCIAL SUPPORT; CARDIOVASCULAR REACTIVITY; MENTAL STRESS; RELATIONSHIP QUALITY; LOCUS-COERULEUS; HEALTH; STROOP; PRESSURE; DISEASE	Background Social relationships, particularly marriage, have been shown to ameliorate the potentially pathogenic impact of stressful events but prior research has been mostly aimed at downstream effects, with less research on real-time reactivity. Pupillometry is an innovative procedure that allows us to see the effects of acute stress in real time. The muscles that control pupil size are linked to the autonomic nervous system, so that when stressed, the pupils dilate; this occurs within 200ms. This quick response allows us to see the immediate effects of acute stress on the autonomic nervous system (ANS), and the real-time effects of social support in buffering stress. Purpose The purpose of this study is to examine the dampening effects of received social support on the ANS's pupillary response. Methods Eighty individuals (40 couples) were randomly assigned to either a spousal support (i.e., spouse hand-holding) or non-support condition (i.e., alone) and administered a Stroop task while pupil dilation was measured. Results The Stroop task elicited a stress reaction in terms of pupil dilation in response to the incongruent task trials. Participants in the support condition showed accelerated habituation to the stress task (p <.001), and less pupil reactivity (p <.001) providing evidence for buffering effects of social support via spousal presence and hand-holding. Conclusions These results reveal the speed at which stress-buffering occurs, suggesting that pupillometry could be a good method to address the immediate dampening effects of social support.	[Graff, Tyler C.; Luke, Steven G.; Birmingham, Wendy C.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA	Brigham Young University	Birmingham, WC (corresponding author), Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA.	wendy_birmingham@byu.edu		, tyler/0000-0003-0838-0442				Bali A, 2015, REV NEUROSCIENCE, V26, P555, DOI 10.1515/revneuro-2015-0004; Barrera M., 2000, HDB COMMUNITY PSYCHO, P215; Bates D, LME4 LINEAR MIXED EF; Beatty J., 2000, HDB PSYCHOPHYSIOL, V2, P142; Beckes L, 2011, SOC PERSONAL PSYCHOL, V5, P976, DOI 10.1111/j.1751-9004.2011.00400.x; BERKMAN LF, 1995, PSYCHOSOM MED, V57, P245, DOI 10.1097/00006842-199505000-00006; Boudsocq M, 2013, TRENDS PLANT SCI, V18, P30, DOI 10.1016/j.tplants.2012.08.008; Boutcher YN, 2006, BIOL PSYCHOL, V73, P235, DOI 10.1016/j.biopsycho.2006.04.005; BROADHEAD WE, 1983, AM J EPIDEMIOL, V117, P521, DOI 10.1093/oxfordjournals.aje.a113575; Brooks KP, 2011, SOC PERSONAL PSYCHOL, V5, P904, DOI 10.1111/j.1751-9004.2011.00395.x; Brown GG, 1999, J INT NEUROPSYCH SOC, V5, P308, DOI 10.1017/S1355617799544020; Burleson BR, 2003, LEA COMMUN SER, P551; Cacioppo JT, 1998, ANN NY ACAD SCI, V840, P664, DOI 10.1111/j.1749-6632.1998.tb09605.x; Cacioppo S, 2015, PERSPECT PSYCHOL SCI, V10, P238, DOI 10.1177/1745691615570616; Carroll D, 2012, PSYCHOPHYSIOLOGY, V49, P1444, DOI 10.1111/j.1469-8986.2012.01463.x; Coan JA, 2006, PSYCHOL SCI, V17, P1032, DOI 10.1111/j.1467-9280.2006.01832.x; Coan JA, 2015, CURR OPIN PSYCHOL, V1, P87, DOI 10.1016/j.copsyc.2014.12.021; COBB S, 1976, PSYCHOSOM MED, V38, P300, DOI 10.1097/00006842-197609000-00003; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037//0033-2909.98.2.310; Cohen S., 1997, MEASURING STRESS GUI; Cooper C.L., 2017, HDB STRESS HLTH GUID, P349, DOI [10.1002/9781118993811.ch21, https://doi.org/10.1002/9781118993811.ch21, DOI 10.1002/9781118993811.CH21]; Coyne JC, 1999, J FAM PSYCHOL, V13, P629, DOI 10.1037/0893-3200.13.4.629; Cultrona CE., 1990, SOCIAL SUPPORT INTER, P319, DOI DOI 10.1111/J.1083-6101.2007.00367.X; Czernichow S, 2012, J HYPERTENS, V30, P2338, DOI 10.1097/HJH.0b013e3283593010; Dhabhar FS, 2009, NEUROIMMUNOMODULAT, V16, P300, DOI 10.1159/000216188; Ditzen B, 2014, RESTOR NEUROL NEUROS, V32, P149, DOI 10.3233/RNN-139008; Eisenberger NI, 2013, PSYCHOSOM MED, V75, P545, DOI 10.1097/PSY.0b013e31829de2e7; Gadassi R, 2014, J ABNORM PSYCHOL, V123, P613, DOI 10.1037/a0036929; Gazzaniga M. S., 2014, COGNITIVE NEUROSCIEN, V4th; GERIN W, 1995, PSYCHOSOM MED, V57, P390, DOI 10.1097/00006842-199507000-00011; GUERRERO LK, 1994, J NONVERBAL BEHAV, V18, P137, DOI 10.1007/BF02170075; Gunnar MR, 2015, SOC NEUROSCI-UK, V10, P474, DOI 10.1080/17470919.2015.1070198; Hawkley LC, 2005, PSYCHOL SCI, V16, P798, DOI 10.1111/j.1467-9280.2005.01617.x; Hawkley LC, 2008, J GERONTOL B-PSYCHOL, V63, pS375, DOI 10.1093/geronb/63.6.S375; Herman JP, 2018, CELL MOL NEUROBIOL, V38, P25, DOI 10.1007/s10571-017-0543-8; Herman JP, 2016, COMPR PHYSL; HOBFOLL SE, 1989, AM PSYCHOL, V44, P513, DOI 10.1037/0003-066X.44.3.513; Hofle M, 2008, INT J PSYCHOPHYSIOL, V70, P171, DOI 10.1016/j.ijpsycho.2008.06.008; Holt-Lunstad J, 2015, PERSPECT PSYCHOL SCI, V10, P227, DOI 10.1177/1745691614568352; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Hostinar CE, 2015, CURR OPIN PSYCHOL, V5, P90, DOI 10.1016/j.copsyc.2015.05.004; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Jakubiak BK, 2017, PERS SOC PSYCHOL REV, V21, P228, DOI 10.1177/1088868316650307; Jakubiak BK, 2016, J EXP SOC PSYCHOL, V65, P59, DOI 10.1016/j.jesp.2016.04.001; JUST MA, 1993, CAN J EXP PSYCHOL, V47, P310, DOI 10.1037/h0078820; KAHNEMAN D, 1966, SCIENCE, V154, P1583, DOI 10.1126/science.154.3756.1583; KAMARCK TW, 1992, PSYCHOPHYSIOLOGY, V29, P17, DOI 10.1111/j.1469-8986.1992.tb02006.x; Kang MJ, 2009, PSYCHOL SCI, V20, P963, DOI 10.1111/j.1467-9280.2009.02402.x; Kazdin A. E, 2016, RES DESIGN CLIN PSYC, DOI 10.1017/9781108993647; KEINAN G, 1989, J SOC CLIN PSYCHOL, V8, P32, DOI 10.1521/jscp.1989.8.1.32; Kiecolt-Glaser JK, 2010, PSYCHOSOM MED, V72, P113, DOI 10.1097/PSY.0b013e3181cb9377; KiecoltGlaser JK, 1996, P NATL ACAD SCI USA, V93, P3043, DOI 10.1073/pnas.93.7.3043; KISSEL S, 1965, J PERS SOC PSYCHOL, V2, P378, DOI 10.1037/h0022223; Krahe B, 2011, J PERS SOC PSYCHOL, V100, P630, DOI 10.1037/a0021711; Krantz DS, 2000, JAMA-J AM MED ASSOC, V283, P1800, DOI 10.1001/jama.283.14.1800; Kuchinsky SE, 2013, PSYCHOPHYSIOLOGY, V50, P23, DOI 10.1111/j.1469-8986.2012.01477.x; Kuznetsova A., 2015, PACKAGE LMERTEST R P, V2; Laeng B, 2012, PERSPECT PSYCHOL SCI, V7, P18, DOI 10.1177/1745691611427305; Laeng B, 2011, COGN PROCESS, V12, P13, DOI 10.1007/s10339-010-0370-z; Luke SG, 2017, BEHAV RES METHODS, V49, P1494, DOI 10.3758/s13428-016-0809-y; MARTEAU TM, 1992, BRIT J CLIN PSYCHOL, V31, P301, DOI 10.1111/j.2044-8260.1992.tb00997.x; Matthews KA, 2002, ARCH INTERN MED, V162, P309, DOI 10.1001/archinte.162.3.309; Mestanik M, 2015, PHYSIOL RES, V64, pS585, DOI 10.33549/physiolres.933217; Mirman D, 2008, J MEM LANG, V59, P475, DOI 10.1016/j.jml.2007.11.006; Moon JS, 2001, J ADV NURS, V35, P407, DOI 10.1046/j.1365-2648.2001.01855.x; Nyberg C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151457; Pacak K, 1995, ANN NY ACAD SCI, V771, P115, DOI 10.1111/j.1749-6632.1995.tb44675.x; Partala T, 2003, INT J HUM-COMPUT ST, V59, P185, DOI 10.1016/S1071-5819(03)00017-X; Pedrotti M, 2014, INT J HUM-COMPUT INT, V30, P220, DOI 10.1080/10447318.2013.848320; Qin SZ, 2012, J NEUROSCI, V32, P4032, DOI 10.1523/JNEUROSCI.3101-11.2012; Ren P, 2014, ANN BIOMED ENG, V42, P162, DOI 10.1007/s10439-013-0880-9; Renaud P, 1997, INT J PSYCHOPHYSIOL, V27, P87, DOI 10.1016/S0167-8760(97)00049-4; Robles TF, 2003, PHYSIOL BEHAV, V79, P409, DOI 10.1016/S0031-9384(03)00160-4; Robles TF, 2014, PSYCHOL BULL, V140, P140, DOI 10.1037/a0031859; Rook KS, 2015, CURR DIR PSYCHOL SCI, V24, P45, DOI 10.1177/0963721414551364; Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192; RULE BG, 1986, J SOC ISSUES, V42, P29, DOI 10.1111/j.1540-4560.1986.tb00241.x; Salverda AP, 2011, J EXP PSYCHOL HUMAN, V37, P1122, DOI 10.1037/a0023101; Samuels ER, 2008, CURR NEUROPHARMACOL, V6, P235, DOI 10.2174/157015908785777229; Seeman TE, 2000, AM J HEALTH PROMOT, V14, P362, DOI 10.4278/0890-1171-14.6.362; Serido J, 2004, J HEALTH SOC BEHAV, V45, P17, DOI 10.1177/002214650404500102; Sharma BK, 2013, J HEALTH SCI, V3, P303; Sharma D, 2001, BRIT J PSYCHOL, V92, P471, DOI 10.1348/000712601162293; Shihab HM, 2012, BODY MASS INDEX RISK; Siegle GJ, 2004, INT J PSYCHOPHYSIOL, V52, P63, DOI 10.1016/j.ijpsycho.2003.12.010; Sirois S, 2014, WIRES COGN SCI, V5, P679, DOI 10.1002/wcs.1323; Skoluda N, 2015, PSYCHONEUROENDOCRINO, V51, P227, DOI 10.1016/j.psyneuen.2014.10.002; Smith TW, 2012, HEALTH PSYCHOL, V31, P763, DOI 10.1037/a0026947; Smith TW, 2002, J CONSULT CLIN PSYCH, V70, P548, DOI 10.1037//0022-006X.70.3.548; StataCorp, 2021, STATA RELEASE 17 STA; Steinhauer SR, 2004, INT J PSYCHOPHYSIOL, V52, P77, DOI 10.1016/j.ijpsycho.2003.12.005; Stroop J. R., 2004, COGNITIVE PSYCHOL, P193; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sun F., 2012, MOBILE COMPUTING APP, DOI https://doi.org/10.1007/978-3-642-29336-8_12; Team RC., 2013, R LANG ENV STAT COMP; THOITS PA, 1986, J CONSULT CLIN PSYCH, V54, P416, DOI 10.1037/0022-006X.54.4.416; Tomaka J, 1997, J PERS SOC PSYCHOL, V73, P63, DOI 10.1037/0022-3514.73.1.63; TULEN JHM, 1989, PHARMACOL BIOCHEM BE, V32, P9, DOI 10.1016/0091-3057(89)90204-9; Uchino BN, 2009, PERSPECT PSYCHOL SCI, V4, P236, DOI 10.1111/j.1745-6924.2009.01122.x; Uchino BN, 1996, PSYCHOL BULL, V119, P488, DOI 10.1037/0033-2909.119.3.488; Uno D, 2002, INT J BEHAV MED, V9, P243, DOI 10.1207/S15327558IJBM0903_06; Yamanaka K, 2009, INT J OCCUP SAF ERGO, V15, P447, DOI 10.1080/10803548.2009.11076824; Zhai D, 2006, BIOMED SCI INSTRUM, V42, P495	104	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212703	10.1371/journal.pone.0212703	http://dx.doi.org/10.1371/journal.pone.0212703			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794665	Green Published, Green Submitted, gold			2022-12-27	WOS:000459709100122
J	Jeon, SM; Kwon, JW; Choi, SH; Park, HY				Jeon, Soo Min; Kwon, Jin-Won; Choi, Sun Ha; Park, Hae-Young			Economic burden of lung cancer: A retrospective cohort study in South Korea, 2002-2015	PLOS ONE			English	Article							INTERNATIONAL EPIDEMIOLOGY; FOLLOW-UP; OF-LIFE; COSTS; CARE; DIAGNOSIS; POPULATION; DECEDENTS; PATTERNS; MODALITY	We evaluated the survival rates and medical expenditure in patients with lung cancer using a nationwide claims database in South Korea. A retrospective observational cohort study design was used, and 2,919 lung cancer patients and their matched controls were included. Medical expenditures were analyzed with the Kaplan-Meier sample average method, and patients were categorized into 4 groups by operation and primary treatment method (i.e. Patients with operation: OP = surgery, OP+CTx/RTx = surgery with anti-cancer drugs or radiotherapy; Patients without operation: CTx/RTx = anti-cancer drugs or radiotherapy, Supportive treatment). The 5-year medical expenditure per case was highest in the OP+CTx/RTx group ($36,013), followed by the CTx/RTx ($23,134), OP ($22,686), and supportive treatment group ($3,700). Lung cancer-related anti-cancer drug therapy was the major cost driver, with an average 53% share across all patients. Generalized linear regression revealed that monthly medical expenditure in lung cancer patients, after adjustment for follow-up month, was approximately 3.1-4.3 times higher than that in the control group (cost ratio for OP = 3.116, OP+CTx/RTx = 3.566, CTx/RTx = 4.340,supportive treatment = 4.157). The monthly medical expenditure at end of life was estimated at $2,139 for all decedents, and approximately a quarter of patients had received chemotherapy in the last 3 months. In conclusion, this study presented the quantified treatment costs of lung cancer on various aspects compared with matched controls according to the treatment of choice. In this study, patients with operation incurred lower lifetime treatment costs than patients with CTx/RTx or supportive treatment, indicating that the economic burden of lung cancer was affected by treatment method. Further studies including both cancer stage and treatment modality are needed to confirm these results and to provide more information on the economic burden according to disease severity.	[Jeon, Soo Min; Kwon, Jin-Won; Park, Hae-Young] Kyungpook Natl Univ, Coll Pharm, Daegu, South Korea; [Jeon, Soo Min; Kwon, Jin-Won; Park, Hae-Young] Kyungpook Natl Univ, Res Inst Pharmaceut Sci, Daegu, South Korea; [Choi, Sun Ha] Kyungpook Natl Univ, Chilgok Hosp, Lung Canc Ctr, Daegu, South Korea	Kyungpook National University; Kyungpook National University; Kyungpook National University	Park, HY (corresponding author), Kyungpook Natl Univ, Coll Pharm, Daegu, South Korea.; Park, HY (corresponding author), Kyungpook Natl Univ, Res Inst Pharmaceut Sci, Daegu, South Korea.	hypark0303@gmail.com		CHOI, SUNHA/0000-0002-9665-7466; Park, Hae-Young/0000-0001-8348-0887	National Research Foundation of Korea [NRF-2018R1D1A3B07047356]; Korea National Research Foundation [NRF-2018R1D1A3B07047356]; National Health Insurance Service [NHIS-2018-2-101]	National Research Foundation of Korea(National Research Foundation of Korea); Korea National Research Foundation(National Research Foundation of Korea); National Health Insurance Service	HYP received the grant (NRF-2018R1D1A3B07047356) funded by the National Research Foundation of Korea (https://www.nrf.re.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.; We thank the Korea National Research Foundation for supporting this research (NRF-2018R1D1A3B07047356). We also thank the National Health Insurance Service for providing data for this study (NHIS-2018-2-101).	Blakely T, 2015, MED CARE, V53, P302, DOI 10.1097/MLR.0000000000000330; Cancer IAFRO, 2012, GLOBOCAN 2012 EST CA; Cheng TYD, 2016, J THORAC ONCOL, V11, P1653, DOI 10.1016/j.jtho.2016.05.021; Choi Y, 2015, CANCER RES TREAT, V47, P555, DOI 10.4143/crt.2014.200; Cipriano LE, 2011, VALUE HEALTH, V14, P41, DOI 10.1016/j.jval.2010.10.006; Davis KL, 2015, LUNG CANCER, V87, P176, DOI 10.1016/j.lungcan.2014.11.002; Ettinger DS, 2018, J NATL COMPR CANC NE, V16, P807, DOI 10.6004/jnccn.2018.0062; Etzioni R, 1996, J CLIN EPIDEMIOL, V49, P95, DOI 10.1016/0895-4356(96)89259-6; Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI 10.1001/jamaoncol.2016.5688; FLEHINGER BJ, 1992, CHEST, V101, P1013, DOI 10.1378/chest.101.4.1013; Gildea TR, 2017, CLINICOECONOMIC OUTC, V9, P261, DOI 10.2147/CEOR.S132259; Hung YN, 2017, ONCOLOGIST, V22, P460, DOI 10.1634/theoncologist.2016-0283; In KH, 2009, LUNG CANCER, V64, P232, DOI 10.1016/j.lungcan.2008.08.005; Jung KW, 2017, CANCER RES TREAT, V49, P292, DOI 10.4143/crt.2017.118; Kwon S, 2009, HEALTH POLICY PLANN, V24, P63, DOI 10.1093/heapol/czn037; Lang K, 2009, CLIN GASTROENTEROL H, V7, P198, DOI 10.1016/j.cgh.2008.08.034; Langton JM, 2016, BRIT J CANCER, V114, P1293, DOI 10.1038/bjc.2016.75; Lin DY, 1997, BIOMETRICS, V53, P419, DOI 10.2307/2533947; Luengo-Fernandez R, 2013, LANCET ONCOL, V14, P1165, DOI 10.1016/S1470-2045(13)70442-X; Malhotra J, 2017, TRANSL LUNG CANCER R, V6, P196, DOI 10.21037/tlcr.2017.03.01; Manegold C, 2016, ESMO OPEN, V1, DOI 10.1136/esmoopen-2016-000118; McGuire A, 2015, J MED ECON, V18, P525, DOI 10.3111/13696998.2015.1032974; Meng XJ, 2017, CANCER LETT, V405, P29, DOI 10.1016/j.canlet.2017.06.033; Miller DL, 2016, ANN THORAC SURG, V101, P1864, DOI 10.1016/j.athoracsur.2015.11.001; Onukwugha E, 2016, PHARMACOECONOMICS, V34, P43, DOI 10.1007/s40273-015-0325-4; Park YS, 2010, LUNG CANCER, V68, P299, DOI 10.1016/j.lungcan.2009.06.016; Prigerson HG, 2015, JAMA ONCOL, V1, P778, DOI 10.1001/jamaoncol.2015.2378; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rasmussen SR, 2007, SCAND J PUBLIC HEALT, V35, P365, DOI 10.1080/14034940701219642; Schnipper LE, 2012, J CLIN ONCOL, V30, P1715, DOI 10.1200/JCO.2012.42.8375; Schwarzkopf L, 2015, LUNG CANCER, V90, P274, DOI 10.1016/j.lungcan.2015.09.005; Shin JY, 2012, ASIAN PAC J CANCER P, V13, P3767, DOI 10.7314/APJCP.2012.13.8.3767; Torre LA, 2016, ADV EXP MED BIOL, V893, P1, DOI 10.1007/978-3-319-24223-1_1; Tremblay L, 2013, THORAC SURG CLIN, V23, P429, DOI 10.1016/j.thorsurg.2013.05.010; Vansteenkiste J, 2013, ANN ONCOL, V24, P89, DOI 10.1093/annonc/mdt241; Yabroff KR, 2008, JNCI-J NATL CANCER I, V100, P630, DOI 10.1093/jnci/djn103; Youlden DR, 2008, J THORAC ONCOL, V3, P819, DOI 10.1097/JTO.0b013e31818020eb	37	8	10	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212878	10.1371/journal.pone.0212878	http://dx.doi.org/10.1371/journal.pone.0212878			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794674	gold, Green Submitted, Green Published			2022-12-27	WOS:000459709100155
J	Navarrete, E; Arcara, G; Mondini, S; Penolazzi, B				Navarrete, Eduardo; Arcara, Giorgio; Mondini, Sara; Penolazzi, Barbara			Italian norms and naming latencies for 357 high quality color images	PLOS ONE			English	Article							WORD-FREQUENCY; SURFACE DETAIL; NAME AGREEMENT; STANDARDIZED SET; AGE; ACQUISITION; PICTURES; SNODGRASS; FRENCH; TIMES	In the domain of cognitive studies on the lexico-semantic representational system, one of the most important means of ensuring effective experimental designs is using ecological stimulus sets accompanied by normative data on the most relevant variables affecting the processing of their items. In the context of image sets, color photographs are particularly suited to this purpose as they reduce the difficulty of visual decoding processes that may emerge with traditional image sets of line drawings. This is especially so in clinical populations. In this study we provide Italian norms for a set of 357 high quality image-items belonging to 23 semantic subcategories from the Moreno-Martinez and Montoro database. Data from several variables affecting image processing were collected from a sample of 255 Italian-speaking participants: age of acquisition, familiarity, lexical frequency, manipulability, name agreement, typicality and visual complexity. Lexical frequency data were derived from the CoLFIS corpus. Furthermore, we collected data on image oral naming latencies to explore how the variance in these latencies could be explained by these critical variables. Multiple regression analyses on the naming latencies show classical psycholinguistic phenomena, such as the effects of age of acquisition and name agreement. In addition, manipulability was also a significant predictor. The described Italian normative data and naming latencies are available for download as supplementary material.	[Navarrete, Eduardo] Univ Padua, Dept Dev & Social Psychol, Padua, Italy; [Arcara, Giorgio] IRCCS Fdn Osped San Camillo, Venice, Italy; [Mondini, Sara] Univ Padua, Dept Gen Psychol, Padua, Italy; [Mondini, Sara] Human Inspired Technol Res Ctr HIT, Padua, Italy; [Penolazzi, Barbara] Univ Trieste, Dept Life Sci, Trieste, Italy	University of Padua; IRCCS Ospedale San Camillo; University of Padua; University of Trieste	Navarrete, E (corresponding author), Univ Padua, Dept Dev & Social Psychol, Padua, Italy.; Arcara, G (corresponding author), IRCCS Fdn Osped San Camillo, Venice, Italy.	eduardo.navarrete@unipd.it; giorgio.arcara@gmail.com	Navarrete, Eduardo/AEW-8408-2022	Navarrete, Eduardo/0000-0002-7619-8397	MIUR	MIUR(Ministry of Education, Universities and Research (MIUR))	The present work was carried out within the scope of the research program "Dipartimenti di Eccellenza", which is supported by a grant from MIUR to the Department of General Psychology, University of Padua.	Adlington RL, 2009, NEUROPSYCHOLOGIA, V47, P2574, DOI 10.1016/j.neuropsychologia.2009.05.004; Alario FX, 1999, BEHAV RES METH INS C, V31, P531, DOI 10.3758/BF03200732; Alario FX, 2004, BEHAV RES METH INS C, V36, P140, DOI 10.3758/BF03195559; Almeida J, 2007, PSYCHON B REV, V14, P1177, DOI 10.3758/BF03193109; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Barca L, 2002, BEHAV RES METH INS C, V34, P424, DOI 10.3758/BF03195471; Barry C, 1997, Q J EXP PSYCHOL-A, V50, P560, DOI 10.1080/783663595; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bates E, 2001, MEM COGNITION, V29, P986, DOI 10.3758/BF03195761; Bertinetto P. M., 2005, COLFIS CORPUS LESSI; Besken M, 2016, J EXP PSYCHOL LEARN, V42, P1417, DOI 10.1037/xlm0000246; Bonin P, 2002, BRIT J PSYCHOL, V93, P89, DOI 10.1348/000712602162463; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Brodeur MB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010773; BRODIE EE, 1991, AM J PSYCHOL, V104, P517, DOI 10.2307/1422939; Brysbaert M, 2006, VIS COGN, V13, P992, DOI 10.1080/13506280544000165; Chalard M, 2003, EUR J COGN PSYCHOL, V15, P209, DOI 10.1080/09541440244000076; Chao LL, 2000, NEUROIMAGE, V12, P478, DOI 10.1006/nimg.2000.0635; Dell'acqua R, 2000, BEHAV RES METH INS C, V32, P588, DOI 10.3758/BF03200832; Dunabeiti A J. A., 2017, Q J EXPT PSYCHOL, P1; Field A., 2013, DISCOVERING STAT USI; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; Garcea Frank E, 2013, Front Hum Neurosci, V7, P120, DOI 10.3389/fnhum.2013.00120; Gerhand S, 1998, J EXP PSYCHOL LEARN, V24, P267, DOI 10.1037/0278-7393.24.2.267; Gimenes M, 2016, BEHAV RES METHODS, V48, P963, DOI 10.3758/s13428-015-0621-0; Griffin ZM, 1998, J MEM LANG, V38, P313, DOI 10.1006/jmla.1997.2547; Guerard K, 2015, BEHAV RES METHODS, V47, P443, DOI 10.3758/s13428-014-0488-5; Harry A, 2014, CLIN NEUROPSYCHOL, V28, P486, DOI 10.1080/13854046.2014.892155; Moreno-Martinez FJ, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/960725; Moreno-Martinez FJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037527; Moreno-Martinez FJ, 2011, AGING NEUROPSYCHOL C, V18, P293, DOI 10.1080/13825585.2010.540849; JESCHENIAK JD, 1994, J EXP PSYCHOL LEARN, V20, P824, DOI 10.1037/0278-7393.20.4.824; Johnston RA, 2005, MEM COGNITION, V33, P905, DOI 10.3758/BF03193084; Juhasz BJ, 2005, PSYCHOL BULL, V131, P684, DOI 10.1037/0033-2909.131.5.684; Kan IP, 2004, COGN AFFECT BEHAV NE, V4, P43, DOI 10.3758/CABN.4.1.43; Kittredge AK, 2008, COGN NEUROPSYCHOL, V25, P463, DOI 10.1080/02643290701674851; Lorenzoni A, 2018, J COGNITION, V1, DOI [10.5334/joc.28, DOI 10.5334/JOC.28]; MORRISON CM, 1992, MEM COGNITION, V20, P705, DOI 10.3758/BF03202720; Navarrete E, 2015, MEM COGNITION, V43, P1085, DOI 10.3758/s13421-015-0525-3; OLDFIELD RC, 1965, Q J EXP PSYCHOL, V17, P273, DOI 10.1080/17470216508416445; Perret C, 2019, BEHAV RES METHODS, V51, P2533, DOI 10.3758/s13428-018-1100-1; PRICE CJ, 1989, Q J EXP PSYCHOL-A, V41, P797, DOI 10.1080/14640748908402394; Protopapas A, 2007, BEHAV RES METHODS, V39, P859, DOI 10.3758/BF03192979; R Development Core Team, 2009, R LANG ENV STAT COMP; Ralph MAL, 2006, VIS COGN, V13, P928, DOI 10.1080/13506280544000110; Rhodes MG, 2008, J EXP PSYCHOL GEN, V137, P615, DOI 10.1037/a0013684; Rossion B, 2004, PERCEPTION, V33, P217, DOI 10.1068/p5117; Salmon JP, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01187; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shao ZSS, 2016, BEHAV RES METHODS, V48, P577, DOI 10.3758/s13428-015-0613-0; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Snodgrass JG, 1996, BEHAV RES METH INSTR, V28, P516, DOI 10.3758/BF03200540; Undorf M, 2017, J MEM LANG, V92, P293, DOI 10.1016/j.jml.2016.07.003; Venables WN, MODERN APPL STAT S P; Viggiano MP, 2004, CORTEX, V40, P491, DOI 10.1016/S0010-9452(08)70142-4; WURM LH, 1993, J EXP PSYCHOL HUMAN, V19, P899, DOI 10.1037/0096-1523.19.4.899	56	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0209524	10.1371/journal.pone.0209524	http://dx.doi.org/10.1371/journal.pone.0209524			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794543	Green Published, gold, Green Submitted			2022-12-27	WOS:000459709100010
J	Shoji, T; Konno, S; Niida, Y; Ogi, T; Suzuki, M; Shimizu, K; Hida, Y; Kaga, K; Seyama, K; Naka, T; Matsuno, Y; Nishimura, M				Shoji, Tetsuaki; Konno, Satoshi; Niida, Yo; Ogi, Takahiro; Suzuki, Masaru; Shimizu, Kaoruko; Hida, Yasuhiro; Kaga, Kichizo; Seyama, Kuniaki; Naka, Tomoaki; Matsuno, Yoshihiro; Nishimura, Masaharu			Familial multifocal micronodular pneumocyte hyperplasia with a novel splicing mutation in TSC1: Three cases in one family	PLOS ONE			English	Article							TUBEROUS SCLEROSIS COMPLEX; PATHOGENESIS; LYMPHANGIOLEIOMYOMATOSIS; DIFFERENTIATION; RECOMMENDATIONS; HETEROZYGOSITY; MECHANISMS; DISEASE; GENES; BRAIN	Multifocal micronodular pneumocyte hyperplasia (MMPH) is a rare pulmonary disease, generally manifesting as a tuberous sclerosis complex (TSC), characterised by multiple, small ground-glass nodular shadows on chest computed tomography (CT). Histological examination typically reveals multicentric, well-demarcated, nodular type II pneumocystic growth. Herein, we describe three cases of this rare pulmonary disease occurring within one family. Using reverse transcription polymerase chain reaction (RT-PCR) and direct DNA sequencing, we identified a novel germline mutation, a point mutation in TSC1 intron 5, which yielded a splice variant and loss of function of TSC1. Furthermore, immunohistochemical staining indicated the expression of phospho-p70S6K and phospho-4E-BP1, suggesting that TSC1 function was impaired by the novel gene mutation in MMPH cells.	[Shoji, Tetsuaki; Konno, Satoshi; Ogi, Takahiro; Suzuki, Masaru; Shimizu, Kaoruko; Nishimura, Masaharu] Hokkaido Univ, Fac Med, Dept Resp Med, Sapporo, Hokkaido, Japan; [Shoji, Tetsuaki; Konno, Satoshi; Ogi, Takahiro; Suzuki, Masaru; Shimizu, Kaoruko; Hida, Yasuhiro; Kaga, Kichizo; Nishimura, Masaharu] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan; [Niida, Yo] Kanazawa Med Univ Hosp, Ctr Clin Genom, Uchinada, Ishikawa, Japan; [Hida, Yasuhiro; Kaga, Kichizo] Hokkaido Univ, Fac Med, Dept Cardiovasc & Thorac Surg, Sapporo, Hokkaido, Japan; [Seyama, Kuniaki] Juntendo Univ, Fac Med, Div Resp Med, Tokyo, Japan; [Seyama, Kuniaki] Grad Sch Med, Tokyo, Japan; [Naka, Tomoaki] Natl Canc Ctr, Div Pathol, Tokyo, Japan; [Matsuno, Yoshihiro] Hokkaido Univ Hosp, Dept Surg Pathol, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Kanazawa Medical University; Hokkaido University; Juntendo University; National Cancer Center - Japan; Hokkaido University	Konno, S (corresponding author), Hokkaido Univ, Fac Med, Dept Resp Med, Sapporo, Hokkaido, Japan.; Konno, S (corresponding author), Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan.	satkonno@med.hokudai.ac.jp	Suzuki, Masaru/H-2087-2012; Nishimura, Masaharu/A-4062-2012; Hida, Yasuhiro/A-7761-2012	Suzuki, Masaru/0000-0002-2124-6793; Nishimura, Masaharu/0000-0002-6456-4361; Hida, Yasuhiro/0000-0003-1759-4215				Adam MP, 2011, GENEREVIEWS; Dabora SL, 2001, AM J HUM GENET, V68, P64, DOI 10.1086/316951; Gao KP, 2008, NUCLEIC ACIDS RES, V36, P2257, DOI 10.1093/nar/gkn073; Giannikou K, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006242; Hayashi T, 2010, MODERN PATHOL, V23, P1251, DOI 10.1038/modpathol.2010.114; Henske EP, 1996, AM J HUM GENET, V59, P400; Henske EP, 1997, AM J PATHOL, V151, P1639; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Jones AC, 1999, AM J HUM GENET, V64, P1305, DOI 10.1086/302381; Jozwiak J, 2008, LANCET ONCOL, V9, P73, DOI 10.1016/S1470-2045(07)70411-4; Karbowniczek M, 2005, ANN NY ACAD SCI, V1059, P168, DOI 10.1196/annals.1339.045; Kobashi Y, 2008, RESPIROLOGY, V13, P1076, DOI 10.1111/j.1440-1843.2008.01382.x; Kobashi Y, 2008, JPN J CLIN ONCOL, V38, P451, DOI 10.1093/jjco/hyn042; Konno S, 2018, RESPIRATION, V95, P310, DOI 10.1159/000486101; Krueger DA, 2013, PEDIATR NEUROL, V49, P255, DOI 10.1016/j.pediatrneurol.2013.08.002; Martin KR, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15816; Maruyama H, 2001, PATHOL INT, V51, P585, DOI 10.1046/j.1440-1827.2001.01242.x; Maruyama H, 2001, MODERN PATHOL, V14, P609, DOI 10.1038/modpathol.3880359; Muir TE, 1998, AM J SURG PATHOL, V22, P465, DOI 10.1097/00000478-199804000-00012; Napolioni V, 2009, BRAIN DEV-JPN, V31, P104, DOI 10.1016/j.braindev.2008.09.013; NELLIST M, 1993, CELL, V75, P1305; Niida Y, 2001, AM J HUM GENET, V69, P493, DOI 10.1086/321972; Niida Y, 2013, J HUM GENET, V58, P216, DOI 10.1038/jhg.2013.3; Niida Y, 2012, MOL GENET METAB, V107, P580, DOI 10.1016/j.ymgme.2012.09.008; Northrup H, 2013, PEDIATR NEUROL, V49, P243, DOI 10.1016/j.pediatrneurol.2013.08.001; POPPER HH, 1992, HISTOPATHOLOGY, V20, P281, DOI 10.1111/j.1365-2559.1992.tb00979.x; Roach ES, 2004, J CHILD NEUROL, V19, P643, DOI 10.1177/08830738040190090301; Roach ES, 1998, J CHILD NEUROL, V13, P624, DOI 10.1177/088307389801301206; Sepp T, 1996, J MED GENET, V33, P962, DOI 10.1136/jmg.33.11.962; SHEPHERD CW, 1991, MAYO CLIN PROC, V66, P792, DOI 10.1016/S0025-6196(12)61196-3; Taniguchi Natsuko, 2011, Nihon Kokyuki Gakkai Zasshi, V49, P355; Tyburczy ME, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005637; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; von Ranke FM, 2015, LUNG, V193, P619, DOI 10.1007/s00408-015-9750-6; Wataya-Kaneda M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063910; Young JM, 1998, ANN HUM GENET, V62, P203, DOI 10.1046/j.1469-1809.1998.6230203.x	36	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212370	10.1371/journal.pone.0212370	http://dx.doi.org/10.1371/journal.pone.0212370			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794603	Green Published, Green Submitted, gold			2022-12-27	WOS:000459709100058
J	Yao, CH; Chang, TH; Lin, CC; Lai, YC; Chen, CH; Chang, YJ				Yao, Chun-Hsu; Chang, Tung-Hao; Lin, Chia-Chi; Lai, Yuan-Chun; Chen, Chin-Hsing; Chang, Yuan-Jen			Three-dimensional dose comparison of flattening filter (FF) and flattening filter-free (FFF) radiation therapy by using NIPAM gel dosimetry	PLOS ONE			English	Article							MODULATED ARC THERAPY; PHOTON BEAMS; RADIOTHERAPY; VERIFICATION	Intensity-modulated radiotherapy and volumetric modulated arc therapy are modern radiation therapy technologies that can create the desired dose distribution by multileaf collimator movement and dose-rate control. However, the homogeneous dose delivery of small-field irradiation techniques shows disagreement with that of treatment planning system. The removal of the flattening filter by flattening filter free (FFF) beam irradiation increases dose conformity and further reduces treatment delivery time in radiosurgery. This study aims to investigate the dose distribution of FFF and flattened beams for small-field irradiation by using the 3D gel dosimeter. The N-isopropylacrylamide (NIPAM) polymer gel dosimeter was employed to record the 3D dose distribution. In addition, flattened and FFF beams were compared using the gamma evaluation technique. The use of an FFF accelerator resulted in excellent radiation treatments with short delivery times and low doses to normal tissues and organs. Results also showed that the passing rate increased with the decrease of field size (30 x 30, 20 x 20, and 10 x 10 mm(2)) at post-irradiation times of 24, 48, 72, and 96 h. The passing rates for each field size were retained at the same level when gamma criteria, namely, distance-to-agreement (DTA) = 3 mm/dose difference (DD) = 3%, were used. Nevertheless, the passing rates for each field size decreased slowly after 48 h when DTA = 2 mm/DD = 2%. The Wilcoxon signed-rank test was used to determine statistical difference with a significant level of p < 0.05. The passing rates of flattened and FFF beams showed no significant difference. The edge enhancement effect in the flattened beam was more evident than in the FFF beam. The 3D NIPAM gel dosimeter can be used for dose verification of small field for radiation therapy with high dose rate.	[Yao, Chun-Hsu] China Med Univ Hosp, Biomat Translat Res Ctr, Taichung, Taiwan; [Yao, Chun-Hsu; Lin, Chia-Chi] China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan; [Yao, Chun-Hsu] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Yao, Chun-Hsu] Asia Univ, Dept Biomed Informat, Taichung, Taiwan; [Chang, Tung-Hao; Lai, Yuan-Chun] Changhua Christian Hosp, Dept Radiat Oncol, Changhua, Taiwan; [Chen, Chin-Hsing] Cent Taiwan Univ Sci & Technol, Dept Management Informat Syst, Taichung, Taiwan; [Chang, Yuan-Jen] Feng Chia Univ, Dept Aerosp & Syst Engn, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; Changhua Christian Hospital; Central Taiwan University Science & Technology; Feng Chia University	Chen, CH (corresponding author), Cent Taiwan Univ Sci & Technol, Dept Management Informat Syst, Taichung, Taiwan.; Chang, YJ (corresponding author), Feng Chia Univ, Dept Aerosp & Syst Engn, Taichung, Taiwan.	chchen@ctust.edu.tw; yjenchang@fcu.edu.tw		Chang, Yuan-Jen/0000-0002-0369-8833	Ministry of Science and Technology, Executive Yuan, Taipei, Taiwan [MOST 106-2314-B-035-001]; Changhua Christian Hospital [CTU106-CH-006]	Ministry of Science and Technology, Executive Yuan, Taipei, Taiwan; Changhua Christian Hospital	This study was supported by the Ministry of Science and Technology, Executive Yuan, Taipei, Taiwan (grant number: MOST 106-2314-B-035-001, website: https://www.most.gov.tw/? l= en) and Changhua Christian Hospital (grant number: CTU106-CH-006, website: http://www2.cch.org.tw/cch_english/).The funders had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.	[Anonymous], CONCEPTS APPL INFERE; Barbiero S, 2016, MED DOSIM, V41, P334, DOI 10.1016/j.meddos.2016.09.002; Cashmore J, 2008, PHYS MED BIOL, V53, P1933, DOI 10.1088/0031-9155/53/7/009; Chang YJ, 2015, J PHYS CONF SER, V573, DOI 10.1088/1742-6596/573/1/012060; Chang YJ, 2014, J RADIOANAL NUCL CH, V301, P765, DOI 10.1007/s10967-014-3231-x; Chang YJ, 2015, NUCL INSTRUM METH A, V784, P585, DOI 10.1016/j.nima.2014.12.112; Chang YJ, 2011, NUCL INSTRUM METH A, V652, P783, DOI 10.1016/j.nima.2010.09.097; Chen CH, 2014, RADIAT PHYS CHEM, V104, P192, DOI 10.1016/j.radphyschem.2014.02.001; De Deene Y, 2007, PHYS MED BIOL, V52, P2719, DOI 10.1088/0031-9155/52/10/006; Ferrari A., 2005, FLUKA MULTIPARTICLE; Hayashi N, 2014, J RADIAT RES, V55, P541, DOI 10.1093/jrr/rrt139; Hsieh BT, 2011, J RADIOANAL NUCL CH, V290, P141, DOI 10.1007/s10967-011-1161-4; Hsieh BT, 2013, IEEE T NUCL SCI, V60, P560, DOI 10.1109/TNS.2012.2230273; Huang WT, 2015, NUCL INSTRUM METH A, V784, P590, DOI 10.1016/j.nima.2015.01.050; Kumar L, 2017, REP PRACT ONCOL RADI, V22, P10, DOI 10.1016/j.rpor.2016.09.010; Low DA, 2003, MED PHYS, V30, P2455, DOI 10.1118/1.1598711; Low DA, 1998, MED PHYS, V25, P656, DOI 10.1118/1.598248; Massillon-JL G, 2010, APPL RADIAT ISOTOPES, V68, P144, DOI 10.1016/j.apradiso.2009.08.016; McAuley K. B., 2006, Journal of Physics: Conference Series, V56, P35, DOI 10.1088/1742-6596/56/1/004; McErlean CM, 2016, PHYS MED BIOL, V61, P320, DOI 10.1088/0031-9155/61/1/320; Nagata Y, 2005, INT J RADIAT ONCOL, V63, P1427, DOI 10.1016/j.ijrobp.2005.05.034; Navarria P, 2013, RADIOTHER ONCOL, V107, P414, DOI 10.1016/j.radonc.2013.04.016; Olding T, 2015, J PHYS CONF SER, V573, DOI 10.1088/1742-6596/573/1/012019; Peguret N, 2013, RADIOTHER ONCOL, V107, P419, DOI 10.1016/j.radonc.2013.04.019; Sangeetha S, 2017, RADIAT PHYS CHEM, V135, P63, DOI 10.1016/j.radphyschem.2017.02.029; Senden RJ, 2006, PHYS MED BIOL, V51, P3301, DOI 10.1088/0031-9155/51/14/001; Shih TY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151300; Stieler F, 2013, RADIOTHER ONCOL, V109, P448, DOI 10.1016/j.radonc.2013.10.017; Vassiliev ON, 2006, PHYS MED BIOL, V51, P1907, DOI 10.1088/0031-9155/51/7/019; Waldenberg C, 2017, J PHYS CONF SER, V847, DOI 10.1088/1742-6596/847/1/012063; Wiant DB, 2013, J APPL CLIN MED PHYS, V14, P293, DOI 10.1120/jacmp.v14i6.4493; Yao CH, 2017, J RADIOANAL NUCL CH, V311, P1277, DOI 10.1007/s10967-016-5161-2	32	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212546	10.1371/journal.pone.0212546	http://dx.doi.org/10.1371/journal.pone.0212546			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789968	Green Published, Green Submitted, gold			2022-12-27	WOS:000459330800036
J	Limwattananon, C; Waleekhachonloet, O				Limwattananon, Chulaporn; Waleekhachonloet, Onanong			Access to and price trends of antidiabetic, antihypertensive, and antilipidemic drugs in outpatient settings of the Universal Coverage Scheme in Thailand	PLOS ONE			English	Article								Under the Universal Coverage Scheme (UCS) with payment per capita for outpatient (OP) services, hospitals' financial risks will rise if access to essential drugs increases. This study examined trends in access to and price of essential drugs for noncommunicable diseases (NCDs) and an overall purchasing price index (PPI) for an OP drug basket from public hospitals. To examine drug access, OP prescription data from 2010-2012 were obtained from the UCS. Access to thirteen drugs for diabetes, hypertension, and dyslipidemia was examined for trend using a time-series analysis. To calculate the PPI, drugs in the same dataset in 2010 that each contributed at least 0.2% of the total OP drug expenditure (N = 118 items) were selected together with drugs expected for near future growth (N = 48 items). The PPI was constructed from purchasing prices in 16 hospitals using a standard method developed by the International Labour Organization. Based on 166 drug items accounting for 75% of OP drug expenditures, the overall PPI continually declined by 6.8% from 2010 to 2012. Access to the 13 selected NCD drugs, accounting for 22% of the total OP drug expenditure increased from 22 to 30 per 1,000 population for antidiabetics, 27 to 47 for antihypertensive agents, and 32 to 53 for antilipidemics from 2010-2012. Growth in the study drug recipients was relatively higher than that in the population and diagnosed patients. Due to generic market competition, metformin, glipizide, amlodipine, losartan, simvastatin, atorvastatin, and fenofibrate prices decreased by 6-22%. Antiretrovirals and risperidone prices decreased by more than 10% due to price negotiation by the UCS. Access to essential drugs for diabetes, hypertension and dyslipidemia has increased. A decline in the PPI could contain essential drug expenditure when the demand for the drugs increased. Generic market competition and price negotiation by the UCS led to price reduction.	[Limwattananon, Chulaporn] Khon Kaen Univ, Fac Pharmaceut Sci, Div Clin Pharm, Khon Kaen, Thailand; [Waleekhachonloet, Onanong] Mahasarakham Univ, Dept Clin Pharm, Fac Pharm, Maha Sarakham, Thailand	Khon Kaen University; Mahasarakham University	Limwattananon, C (corresponding author), Khon Kaen Univ, Fac Pharmaceut Sci, Div Clin Pharm, Khon Kaen, Thailand.	limw0002@kku.ac.th		Waleekhachonloet, Onanong/0000-0002-3692-6302	Health Systems Research Institute [55-050]; URL	Health Systems Research Institute; URL	This work was supported by Health Systems Research Institute, grant number 55-050, URL https://www.hsri.or.th, Authors who received the funding are CL and OW. Health Insurance System Research Office, URL https://www.hisro.or.th. Author who received the funding is OW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARP, RX PRIC WATCH REP TR; Aekplakorn W, 2014, THAI NATL HLTH EXAMI; Agency for Healthcare Research and Quality, 2004, AHRQ QUAL IND GUID P; [Anonymous], 2017, DIABETES CARE, V40, pS1, DOI 10.2337/dc17-S001; [Anonymous], 2012, THAIL U COV SCHEM AN; [Anonymous], 2014, ACC MED RES PROGR CA; Bigdeli M, 2013, HEALTH POLICY PLANN, V28, P692, DOI 10.1093/heapol/czs108; Bureau of policy and strategy Ministry of Public Health, PUBL HLTH STAT; Garber AJ, 2017, ENDOCR PRACT, V23, P207, DOI 10.4158/EP161682.CS; Hogerzeil HV, 2013, LANCET, V381, P680, DOI 10.1016/S0140-6736(12)62128-X; ILO/ IMF/ OECD/ UNECE/ Eurostat/ The World Bank, 2004, CONS PRIC IND MAN TH; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Judge GeorgeG., 1985, THEORY PRACTICE ECON, V2nd ed.; Patent Medicine Prices Review Board, PRIC TREND ANN RAT C; Prakongsai P., 2009, INNOVATIONS HLTH SYS; Rice N, 2001, MILBANK Q, V79, P81, DOI 10.1111/1468-0009.00197; Sanderson C, 2000, J Health Serv Res Policy, V5, P222; Tangcharoensathien V, 2011, EQUITY IMPACT UNIVER; WHO, 2012, PROMOTING ACCESS TO MEDICAL TECHNOLOGIES AND INNOVATION: INTERSECTIONS BETWEEN PUBLIC HEALTH, INTELLECTUAL PROPERTY AND TRADE, P1; WHO Collaborating Centre for Drug Statistics Methodology, ATC STRUCT PRINC; WHO Health Action International, 2008, MEAS MED PRIC AV AFF, V2nd; Yoongthong W, 2012, VALUE HEALTH, V15, pS126, DOI 10.1016/j.jval.2011.11.003	22	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211759	10.1371/journal.pone.0211759	http://dx.doi.org/10.1371/journal.pone.0211759			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785916	Green Published, Green Submitted, gold			2022-12-27	WOS:000459307000036
J	Liu, XX; Xu, YY; An, MM; Zeng, QB				Liu, Xiuxiu; Xu, Yuyan; An, Miaomiao; Zeng, Qibing			The risk factors for diabetic peripheral neuropathy: A meta-analysis	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; GLYCEMIC VARIABILITY; PREVALENCE; POLYNEUROPATHY; PAIN; EPIDEMIOLOGY; SEVERITY; DISEASE	Diabetic peripheral neuropathy (DPN), the most common chronic complication of diabetes, has become an important public health crisis worldwide. Given that DPN is extremely difficult to treat, determining its risk factors and controlling it at an early stage is critical to preventing its serious consequences and the burden of social disease. Current studies suggest that the risk factors for diabetic peripheral neuropathy are the duration of diabetes, age, glycosylated hemoglobin A1c (HbA1c), diabetic retinopathy (DR), smoking, and body mass Index (BMI). However, most of the aforementioned studies are cross-sectional, and the sample sizes are very limited, so the strength of causal reasoning is relatively low. The current study systematically evaluated DPN's influencing factors in patients with type 2 diabetes using evidence-based medicine. Overall, 16 included studies (14 cross-sectional studies and 2 case-control studies including 12,116 cases) that conformed to the present criteria were included in the final analysis. The results suggested that the duration of diabetes (MD 2.5, 95% CI 1.71 similar to 3.29), age (MD 4.00, 95% CI 3.05 similar to 4.95), HbA1c (MD 0.48, 95% CI 0.33 similar to 0.64), and DR (OR 2.34, 95% CI 1.74 similar to 3.16) are associated with significantly increased risks of DPN among diabetic patients, while BMI, smoking, total triglyceride (TG), and total cholesterol (TC) did not indicate any risks of increasing DPN. The findings provide a scientific basis for a further understanding of the causes of type 2 diabetes complicated with peripheral neuropathy and the improvement of preventive strategies. The next step is to conduct further high-quality prospective cohort studies to validate this paper's findings.	[Liu, Xiuxiu; Xu, Yuyan; An, Miaomiao; Zeng, Qibing] Guizhou Med Univ, Key Lab Environm Pollut Monitoring & Dis Control, Minist Educ, Dept Toxicol,Sch Publ Hlth, Guiyang, Guizhou, Peoples R China	Guizhou Medical University	Zeng, QB (corresponding author), Guizhou Med Univ, Key Lab Environm Pollut Monitoring & Dis Control, Minist Educ, Dept Toxicol,Sch Publ Hlth, Guiyang, Guizhou, Peoples R China.	178945324@qq.com	曾, 奇兵/AAX-5089-2021	Zeng, Qibing/0000-0002-6694-1503	National Key R&D Program of China [2017YFC0907301]; first-class discipline construction project in Guizhou Province - Public Health and Preventive Medicine	National Key R&D Program of China; first-class discipline construction project in Guizhou Province - Public Health and Preventive Medicine	This work was supported by the National Key R&D Program of China (NO. 2017YFC0907301), the first-class discipline construction project in Guizhou Province - Public Health and Preventive Medicine (NO. 2017[85]).	Al-Mahroos F, 2007, ANN SAUDI MED, V27, P25, DOI 10.4103/0256-4947.51536; Argoff CE, 2006, MAYO CLIN PROC, V81, pS3, DOI 10.1016/S0025-6196(11)61474-2; Bansal D, 2014, J DIABETES INVEST, V5, P714, DOI 10.1111/jdi.12223; Barbosa AP, 2001, DIABETES METAB, V27, P496; Cabezas-Cerrato J, 1998, DIABETOLOGIA, V41, P1263, DOI 10.1007/s001250051063; Callaghan BC, 2012, LANCET NEUROL, V11, P521, DOI 10.1016/S1474-4422(12)70065-0; [陈兰英 Chen Lanying], 2014, [中国糖尿病杂志, Chinese Journal of Diabetes], V22, P700; [陈晓文 Chen Xiaowen], 2014, [中国糖尿病杂志, Chinese Journal of Diabetes], V22, P1057; Cho NH, 2018, DIABETES RES CLIN PR, V138, P271, DOI 10.1016/j.diabres.2018.02.023; Ede O, 2018, J BIOSCIENCES MED, V6, P71, DOI [DOI 10.4236/JBM.2018.612007, 10.4236/jbm.2018.612007]; Galer BS, 2000, DIABETES RES CLIN PR, V47, P123, DOI 10.1016/S0168-8227(99)00112-6; Gordois A, 2003, DIABETES CARE, V26, P1790, DOI 10.2337/diacare.26.6.1790; Gore M, 2005, J PAIN SYMPTOM MANAG, V30, P374, DOI 10.1016/j.jpainsymman.2005.04.009; [赫广玉 He Guangyu], 2014, [中国糖尿病杂志, Chinese Journal of Diabetes], V22, P118; Hu F, 2018, CHINESE J GEN PRACTI, V16, P781; Hu YM, 2018, ENDOCRINE, V60, P292, DOI 10.1007/s12020-018-1546-z; Iqbal Z, 2018, CLIN THER, V40, P828, DOI 10.1016/j.clinthera.2018.04.001; Katulanda P, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-21; Kiani J, 2013, ARCH IRAN MED, V16, P17, DOI 013161/AIM.006; Liao Y., 2012, CONT MED, V18, P101, DOI [10.3969/j.issn.1009-4393.2012.24.073, DOI 10.3969/J.ISSN.1009-4393.2012.24.073]; Mao H., 2017, HAINAN MED J, V28, P3379, DOI [10.3969/j.issn.1003-6350.2017.20.035, DOI 10.3969/J.ISSN.1003-6350.2017.20.035]; MASER RE, 1989, DIABETES, V38, P1456, DOI 10.2337/diabetes.38.11.1456; Mehra Maneesha, 2014, J Med Econ, V17, P637, DOI 10.3111/13696998.2014.928639; Morkrid K, 2010, INT J DIABETES DEV C, V30, P11, DOI 10.4103/0973-3930.60004; Naqvi IH, 2018, OPEN J ENDOCRINE MET, P125, DOI [10.4236/ojemd.2018, DOI 10.4236/OJEMD.2018]; Nie Chen, 2012, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V26, P467; Ning G., 2007, CHIN J PRACT INTERN, V7, P487, DOI [10.3969/j.issn.1005-2194.2007.07.003, DOI 10.3969/J.ISSN.1005-2194.2007.07.003]; Papanas Nikolaos, 2015, Rev Diabet Stud, V12, P48, DOI 10.1900/RDS.2015.12.48; Rani Padmaja Kumari, 2010, Indian J Med Sci, V64, P51; Shehab D, 2012, DIABETIC MED, V29, P43, DOI 10.1111/j.1464-5491.2011.03510.x; Shen J, 2016, INT J CLIN EXP PATHO, V9, P9318; Skalli S, 2012, EUR J INTERN MED, V23, pE67, DOI 10.1016/j.ejim.2011.11.008; Su JB, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0693-0; Tesfaye S, 1996, DIABETOLOGIA, V39, P1377, DOI 10.1007/s001250050586; Tesfaye S, 2016, PAIN, V157, pS72, DOI 10.1097/j.pain.0000000000000465; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; [万慧 Wan Hui], 2017, [中国糖尿病杂志, Chinese Journal of Diabetes], V25, P514; Wang H, 2016, ZHEJIANG J PREVENTIV, V28; Won JC, 2016, ENDOCRINOL METAB, V31, P230, DOI 10.3803/EnM.2016.31.2.230; Xu F, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-139; Yang CP, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001783; Ybarra-Munoz J, 2016, EUR J CARDIOVASC NUR, V15, P248, DOI 10.1177/1474515114565215; YOUNG MJ, 1993, DIABETOLOGIA, V36, P150, DOI 10.1007/BF00400697; Zhu D., 2011, J MED POSTGRAD, V24, P1035, DOI [10.3969/j.issn.1008-8199, DOI 10.3969/J.ISSN.1008-8199, 10.3969/j.issn.1008-8199.2011.10.007, DOI 10.3969/J.ISSN.1008-8199.2011.10.007]	44	50	55	6	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212574	10.1371/journal.pone.0212574	http://dx.doi.org/10.1371/journal.pone.0212574			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785930	Green Submitted, Green Published, gold			2022-12-27	WOS:000459307000071
J	Ried, K; Muller, T; Briegel, HJ				Ried, Katja; Mueller, Thomas; Briegel, Hans J.			Modelling collective motion based on the principle of agency: General framework and the case of marching locusts	PLOS ONE			English	Article							SIMULATION; MECHANISM; SWARMS	Collective phenomena are studied in a range of contexts-from controlling locust plagues to efficiently evacuating stadiums-but the central question remains: how can a large number of independent individuals form a seemingly perfectly coordinated whole? Previous attempts to answer this question have reduced the individuals to featureless particles, assumed particular interactions between them and studied the resulting collective dynamics. While this approach has provided useful insights, it cannot guarantee that the assumed individual-level behaviour is accurate, and, moreover, does not address its origin-that is, the question of why individuals would respond in one way or another. We propose a new approach to studying collective behaviour, based on the concept of learning agents: individuals endowed with explicitly modelled sensory capabilities, an internal mechanism for deciding how to respond to the sensory input and rules for modifying these responses based on past experience. This detailed modelling of individuals favours a more natural choice of parameters than in typical swarm models, which minimises the risk of spurious dependences or overfitting. Most notably, learning agents need not be programmed with particular responses, but can instead develop these autonomously, allowing for models with fewer implicit assumptions. We illustrate these points with the example of marching locusts, showing how learning agents can account for the phenomenon of density-dependent alignment. Our results suggest that learning agent-based models are a powerful tool for studying a broader class of problems involving collective behaviour and animal agency in general.	[Ried, Katja; Briegel, Hans J.] Univ Innsbruck, Inst Theoret Phys, Innsbruck, Austria; [Mueller, Thomas; Briegel, Hans J.] Univ Konstanz, Dept Philosophy, Constance, Germany	University of Innsbruck; University of Konstanz	Ried, K (corresponding author), Univ Innsbruck, Inst Theoret Phys, Innsbruck, Austria.	Katja.Ried@uibk.ac.at		Ried, Katja/0000-0002-4696-0141; Muller, Thomas/0000-0003-1225-1483	Austrian Science Fund (FWF) [SFB FoQuS F4012]; Ministerium fur Wissenschaft, Forschung, und Kunst Baden-Wurttemberg [AZ: 33-7533.-30-10/41/1]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Ministerium fur Wissenschaft, Forschung, und Kunst Baden-Wurttemberg	K.R. and H.J.B. were supported by the Austrian Science Fund (FWF) through the SFB FoQuS F4012. T.M. was supported by the Ministerium fur Wissenschaft, Forschung, und Kunst Baden-Wurttemberg (AZ: 33-7533.-30-10/41/1). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOKI I, 1982, B JPN SOC SCI FISH, V48, P1081; Ariel G, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004522; Ariel G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101636; Briegel HJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00400; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Dell AI, 2014, TRENDS ECOL EVOL, V29, P417, DOI 10.1016/j.tree.2014.05.004; Dyson L, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.052708; Edelstein-Keshet L, 1998, J MATH BIOL, V36, P515, DOI 10.1007/s002850050112; Ellis P. E., 1959, Animal Behaviour London, V7, P91, DOI 10.1016/0003-3472(59)90037-5; Garnier J, 2019, DISCRETE CONT DYN-B, V24, P851, DOI 10.3934/dcdsb.2018210; Geva N, 2010, NEUROBIOL LEARN MEM, V93, P175, DOI 10.1016/j.nlm.2009.09.008; Giardina I, 2008, HFSP J, V2, P205, DOI 10.2976/1.2961038; Guttal V, 2012, ECOL LETT, V15, P1158, DOI 10.1111/j.1461-0248.2012.01840.x; Hangl S, 2016, 2016 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS (IROS 2016), P2799, DOI 10.1109/IROS.2016.7759434; HUTH A, 1992, J THEOR BIOL, V156, P365, DOI 10.1016/S0022-5193(05)80681-2; Macal CM, 2010, J SIMUL, V4, P151, DOI 10.1057/jos.2010.3; Mautner J, 2015, NEW GENERAT COMPUT, V33, P69, DOI 10.1007/s00354-015-0102-0; Miller JM, 2012, B MATH BIOL, V74, P536, DOI 10.1007/s11538-011-9676-y; Rankin CH, 2009, NEUROBIOL LEARN MEM, V92, P135, DOI 10.1016/j.nlm.2008.09.012; Reynolds C.W., 1987, ACM SIGGRAPH COMPUTE, V21, P25, DOI DOI 10.1145/37402.37406; Romanczuk P, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.010602; Samiloglu AT, 2006, LECT NOTES COMPUT SC, V4263, P665; Shklarsh A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002177; Simoes P, 2011, J EXP BIOL, V214, P2495, DOI 10.1242/jeb.055806; Simoes PMV, 2013, CURR BIOL, V23, P2407, DOI 10.1016/j.cub.2013.10.016; Simoes PMV, 2012, J EXP BIOL, V215, P1711, DOI 10.1242/jeb.068106; SIMPSON SJ, 1990, ANIM BEHAV, V40, P506, DOI 10.1016/S0003-3472(05)80531-7; Simpson SJ, 1999, BIOL REV, V74, P461, DOI 10.1017/S000632319900540X; Simpson SJ, 2008, CURR BIOL, V18, pR364, DOI 10.1016/j.cub.2008.02.029; Strombom D, 2017, ASYNCHRONY PROMOTES; Taylor R, 1990, PROTEAN BEHAV BIOL U; Topaz CM, 2008, EUR PHYS J-SPEC TOP, V157, P93, DOI 10.1140/epjst/e2008-00633-y; Topaz C.M., 2012, PLOS COMPUTATIONAL B, V8, P1, DOI DOI 10.1371/J0URNAL.PCBI.1002642; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Vicsek T, 2012, PHYS REP, V517, P71, DOI 10.1016/j.physrep.2012.03.004; Yates CA, 2009, P NATL ACAD SCI USA, V106, P5464, DOI 10.1073/pnas.0811195106	37	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212044	10.1371/journal.pone.0212044	http://dx.doi.org/10.1371/journal.pone.0212044			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785947	Green Published, gold, Green Submitted			2022-12-27	WOS:000459307000048
J	Dent, J; Gaspar, N; Njeuhmeli, E; Kripke, K				Dent, Juan; Gaspar, Nuno; Njeuhmeli, Emmanuel; Kripke, Katharine			Age targeting and scale-up of voluntary medical male circumcision in Mozambique	PLOS ONE			English	Article							ADOLESCENTS; PREVENTION; HIV	Background The voluntary medical male circumcision (VMMC) program in Mozambique aimed to increase male circumcision (MC) coverage to 80 percent among males ages 10 to 49 by 2018. Given the difficulty in attracting adult men over age 20 for circumcision, Mozambique became interested in assessing its age-targeting strategy and progress at the provincial level to inform program planning. Methods We examined the impact and cost-effectiveness of circumcising different age groups of men using the Decision Makers' Program Planning Toolkit, Version 2.1 (DMPPT 2). We also applied the model to assess the scale-up efforts through the end of September 2017 and project their impact on HIV incidence through 2030. The DMPPT 2 is a compartmental Excel-based model that analyzes the effects of age at circumcision on program impact and cost-effectiveness. The model tracks changes in age-specific MC coverage due to VMMC program circumcisions. Baseline MC prevalence was based on data from the 2011 Demographic and Health Survey. The DMPPT 2 was populated with HIV incidence projections from Spectrum/Goals under an assumption that Mozambique would reach its national targets for HIV treatment and prevention by 2022. Results We estimate the VMMC program increased MC coverage among males ages 10 to 49 from 27 percent in 2009 to 48 percent by end of September 2017. Coverage increased primarily in males ages 10 to 29. VMMCs conducted in the national program through the end of September 2017 are projected to avert 67,076 HIV infections from 2010 to 2030. Scaling up circumcisions in males ages 20 to 29 will have the most immediate impact on HIV incidence, while the greatest impact over a 15-year period is obtained by circumcising males ages 15 to 24 in the majority of priority provinces. Circumcising 80 percent of males ages 10 to 29 can achieve 77 percent of the impact through 2030 compared with circumcising 80 percent of males ages 10 to 49. Conclusion The VMMC program in Mozambique has made great strides in increasing MC coverage, particularly for males ages 10 to 29. Scaling up and maintaining MC coverage in this age group offers an attainable and cost-effective target for VMMC in Mozambique.	[Dent, Juan] Palladium Grp, Washington, DC USA; [Gaspar, Nuno] USAID Mozambique, Maputo, Mozambique; [Njeuhmeli, Emmanuel] USAID Eswatini, Mbabane, Eswatini, South Africa; [Kripke, Katharine] Avenir Hlth, Washington, DC 20012 USA	United States Agency for International Development (USAID)	Kripke, K (corresponding author), Avenir Hlth, Washington, DC 20012 USA.	KKripke@avenirhealth.org			U.S. President's Emergency Plan for AIDS Relief (PEPFAR); U.S. Agency for International Development (USAID) under the Cooperative Agreement Project SOAR (Supporting Operational AIDS Research) [OAA-A-14-00060]; USAID; PEPFAR	U.S. President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); U.S. Agency for International Development (USAID) under the Cooperative Agreement Project SOAR (Supporting Operational AIDS Research)(United States Agency for International Development (USAID)); USAID(United States Agency for International Development (USAID)); PEPFAR	This manuscript is made possible by the generous support of the American people through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) with the U.S. Agency for International Development (USAID) under the Cooperative Agreement Project SOAR (Supporting Operational AIDS Research), number OAA-A-14-00060. Juan Dent was employed by The Palladium Group at the time of writing. The Palladium Group provided support in the form of salary for author JD but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Katharine Kripke is employed by Avenir Health. Avenir Health provided support in the form of salary for author KK but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The information provided does not necessarily reflect the views of USAID or the United States Government, and the contents of this article are the sole responsibility of Projects SOAR, the Population Council, and the authors.; John Stover of Avenir Health developed the DMPPT 2.0 model at the request of USAID, under the USAID- and PEPFAR-funded Health Policy Project. The authors gratefully acknowledge Jotamo Come, the VMMC Program Director of the Mozambican Ministry of Health, and Nathaniel Lohman of USAID for providing the data for this analysis. We thank Steven Forsythe for helpful comments on the draft. The authors are also grateful to Sherry Hutchinson for her help with editing and formatting the manuscript. Finally, we thank Marcos Canda and the staff of Jhpiego, FHI 360, and Columbia University's ICAP whose tireless efforts to implement VMMC in Mozambique form the basis for this manuscript.	BAUTISTAARREDONDO, 2018, PLOS ONE, V13, DOI DOI 10.1371/JOURNAL.PONE.0203121; Direccao Nacional da Assistencia Medica, 2012, PLAN ESTR EXP CIRC M; Forsythe S, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-S1-S4; Galarraga O, 2018, AIDS RES THER, V15, DOI 10.1186/s12981-018-0207-x; Instituto Nacional de Estatistica, 2013, MO AMBIQUE INQU RITO; Instituto Nacional de Estatsitica [Internet], 1996, MAP MOZ REC GER POP; Instituto Nacional de Saude (INS) Instituto Nacional de Estatistica (INE) e ICF Macro, 2010, NON TRADITIONAL REF; Korenromp EL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142908; Kripke K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164144; Kripke K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158693; Kripke K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156776; Kripke K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157071; Kripke K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156909; Kripke K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153363; Kripke K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156521; Kripke K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158767; Mutabazi V, 2012, JAIDS-J ACQ IMM DEF, V61, P49, DOI 10.1097/QAI.0b013e3182631d69; Njeuhmeli E, 2018, CLIN INFECT DIS, V66, pS166, DOI 10.1093/cid/cix969; Njeuhmeli E, 2014, JAIDS-J ACQ IMM DEF, V66, pS193, DOI 10.1097/QAI.0000000000000179; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Tchuenche M, 2018, VOLUNTARY MED MALE C; Torres-Rueda S, 2018, JAIDS-J ACQ IMM DEF, V78, P291, DOI 10.1097/QAI.0000000000001682; World Health Organization and UNAIDS, 2007, P WHO UNAIDS TECHN C; World Health Organization (WHO), 2017, VOL MED MAL CIRC HIV	24	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0211958	10.1371/journal.pone.0211958	http://dx.doi.org/10.1371/journal.pone.0211958			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794561	Green Published, Green Submitted, gold			2022-12-27	WOS:000459709100028
J	Nguyen, DT; Ryu, S; Qureshi, MNI; Choi, M; Lee, KH; Lee, B				Duc Thanh Nguyen; Ryu, Seungjun; Qureshi, Muhammad Naveed Iqbal; Choi, Min; Lee, Kun Ho; Lee, Boreom			Hybrid multivariate pattern analysis combined with extreme learning machine for Alzheimer's dementia diagnosis using multi-measure rs-fMRI spatial patterns	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; RESTING-STATE FMRI; LOW-FREQUENCY FLUCTUATIONS; FEATURE-SELECTION; FUNCTIONAL CONNECTIVITY; FEATURE-RANKING; GENE SELECTION; CLASSIFICATION; DISEASE; PREDICTION	Background Early diagnosis of Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI) is essential for timely treatment. Machine learning and multivariate pattern analysis (MVPA) for the diagnosis of brain disorders are explicitly attracting attention in the neuroimaging community. In this paper, we propose a voxel-wise discriminative framework applied to multi-measure resting-state fMRI (rs-fMRI) that integrates hybrid MVPA and extreme learning machine (ELM) for the automated discrimination of AD and MCI from the cognitive normal (CN) state. Materials and methods We used two rs-fMRI cohorts: the public Alzheimer's disease Neuroimaging Initiative database (ADNI2) and an in-house Alzheimer's disease cohort from South Korea, both including individuals with AD, MCI, and normal controls. After extracting three-dimensional (3-D) patterns measuring regional coherence and functional connectivity during the resting state, we performed univariate statistical t-tests to generate a 3-D mask that retained only voxels showing significant changes. Given the initial univariate features, to enhance discriminative patterns, we implemented MVPA feature reduction using support vector machine-recursive feature elimination (SVM-RFE), and least absolute shrinkage and selection operator (LASSO), in combination with the univariate t-test. Classifications were performed by an ELM, and its efficiency was compared to linear and nonlinear (radial basis function) SVMs. Results The maximal accuracies achieved by the method in the ADNI2 cohort were 98.86% (p<0.001) and 98.57% (p<0.001) for AD and MCI vs. CN, respectively. In the in-house cohort, the same accuracies were 98.70% (p<0.001) and 94.16% (p<0.001). Conclusion From a clinical perspective, combining extreme learning machine and hybrid MVPA applied on concatenations of multiple rs-fMRI biomarkers can potentially assist the clinicians in AD and MCI diagnosis.	[Duc Thanh Nguyen; Ryu, Seungjun; Choi, Min; Lee, Boreom] GIST, IIT, Dept Biomed Sci & Engn BMSE, Gwangju, South Korea; [Qureshi, Muhammad Naveed Iqbal] McGill Univ, Res Ctr Studies Aging MCSA, Translat Neuroimaging Lab, Montreal, PQ, Canada; [Qureshi, Muhammad Naveed Iqbal] McGill Univ, Douglas Mental Hlth Univ Inst, Alzheimers Dis Res Unit, Montreal, PQ, Canada; [Qureshi, Muhammad Naveed Iqbal] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Qureshi, Muhammad Naveed Iqbal] Montreal Neurol Hosp & Inst, Montreal, PQ, Canada; [Lee, Kun Ho] Chosun Univ, Natl Res Ctr Dementia, Gwangju, South Korea; [Lee, Kun Ho] Chosun Univ, Dept Biomed Sci, Gwangju, South Korea	Gwangju Institute of Science & Technology (GIST); McGill University; McGill University; McGill University; McGill University; Chosun University; Chosun University	Lee, B (corresponding author), GIST, IIT, Dept Biomed Sci & Engn BMSE, Gwangju, South Korea.	leebr@gist.ac.kr	ryu, seungjun/AAD-2474-2021		Bio & Medical Technology Development Program of the NRF - Korean government, MSIT [NRF-2016M3A9E9941946]	Bio & Medical Technology Development Program of the NRF - Korean government, MSIT	This work was supported by the Bio & Medical Technology Development Program of the NRF funded by the Korean government, MSIT (NRF-2016M3A9E9941946). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbabshirani MR, 2017, NEUROIMAGE, V145, P137, DOI 10.1016/j.neuroimage.2016.02.079; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Beheshti I, 2017, COMPUT BIOL MED, V83, P109, DOI 10.1016/j.compbiomed.2017.02.011; Beheshti I, 2016, MAGN RESON IMAGING, V34, P252, DOI 10.1016/j.mri.2015.11.009; Beltrachini L, 2015, CURR ALZHEIMER RES, V12, P592, DOI 10.2174/156720501206150716120332; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Calhoun Vince D, 2016, Biol Psychiatry Cogn Neurosci Neuroimaging, V1, P230; Casanova Ramon, 2011, Front Neuroinform, V5, P22, DOI 10.3389/fninf.2011.00022; Challis E, 2015, NEUROIMAGE, V112, P232, DOI 10.1016/j.neuroimage.2015.02.037; Chaves R, 2009, NEUROSCI LETT, V461, P293, DOI 10.1016/j.neulet.2009.06.052; Chu C, 2012, NEUROIMAGE, V60, P59, DOI 10.1016/j.neuroimage.2011.11.066; Dai D, 2013, MACH VISION APPL, V24, P1445, DOI 10.1007/s00138-012-0462-0; Dai D, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00063; Dai ZJ, 2015, CEREB CORTEX, V25, P3723, DOI 10.1093/cercor/bhu246; De Martino F, 2008, NEUROIMAGE, V43, P44, DOI 10.1016/j.neuroimage.2008.06.037; de Vos F, 2018, NEUROIMAGE, V167, P62, DOI 10.1016/j.neuroimage.2017.11.025; Eavani Harini, 2013, Inf Process Med Imaging, V23, P426, DOI 10.1007/978-3-642-38868-2_36; Falahati F, 2014, J ALZHEIMERS DIS, V41, P685, DOI 10.3233/JAD-131928; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Guo ZW, 2017, CLIN NEUROPHYSIOL, V128, P1344, DOI 10.1016/j.clinph.2017.05.003; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Han Y, 2011, NEUROIMAGE, V55, P287, DOI 10.1016/j.neuroimage.2010.11.059; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Hidalgo-Munoz AR, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00020; Jie B, 2014, IEEE T BIO-MED ENG, V61, P576, DOI 10.1109/TBME.2013.2284195; Kendall M., 1990, CORRELATION METHODS; Khazaee A, 2017, BEHAV BRAIN RES, V322, P339, DOI 10.1016/j.bbr.2016.06.043; Khazaee A, 2015, CLIN NEUROPHYSIOL, V126, P2132, DOI 10.1016/j.clinph.2015.02.060; Kim J, 2018, HUM BRAIN MAPP, V39, P3728, DOI 10.1002/hbm.24207; Leonardi N, 2013, NEUROIMAGE, V83, P937, DOI 10.1016/j.neuroimage.2013.07.019; Li XB, 2012, BIOCHEM BIOPH RES CO, V419, P148, DOI 10.1016/j.bbrc.2012.01.087; Li YX, 2017, J ALZHEIMERS DIS, V58, P1175, DOI 10.3233/JAD-161282; Li YX, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/4680972; Lin Q, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00094; Lopez M, 2011, NEUROCOMPUTING, V74, P1260, DOI 10.1016/j.neucom.2010.06.025; Mahmoudi A, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/961257; Mishra S., 2015, KARBALA INT J MOD SC, V1, P86, DOI DOI 10.1016/J.KIJOMS.2015.10.002; Mwangi B, 2014, NEUROINFORMATICS, V12, P229, DOI 10.1007/s12021-013-9204-3; Mwangi B, 2012, BRAIN, V135, P1508, DOI 10.1093/brain/aws084; Duc NT, 2019, J NEURAL ENG, V16, DOI 10.1088/1741-2552/ab0169; Ota K, 2015, J NEUROSCI METH, V256, P168, DOI 10.1016/j.jneumeth.2015.08.020; Qureshi MNI, 2017, FRONT NEUROINFORM, V11, DOI 10.3389/fninf.2017.00059; Qureshi MNI, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00157; Qureshi MNI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160697; Rathore S, 2017, NEUROIMAGE, V155, P530, DOI 10.1016/j.neuroimage.2017.03.057; Retico A, 2015, J NEUROIMAGING, V25, P552, DOI 10.1111/jon.12163; Salvatore C, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00307; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Suk HI, 2016, NEUROIMAGE, V129, P292, DOI 10.1016/j.neuroimage.2016.01.005; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wee CY, 2014, HUM BRAIN MAPP, V35, P3414, DOI 10.1002/hbm.22411; Wee CY, 2014, BRAIN STRUCT FUNCT, V219, P641, DOI 10.1007/s00429-013-0524-8; Wee CY, 2013, HUM BRAIN MAPP, V34, P3411, DOI 10.1002/hbm.22156; Wee CY, 2012, NEUROIMAGE, V59, P2045, DOI 10.1016/j.neuroimage.2011.10.015; Wu TT, 2009, BIOINFORMATICS, V25, P714, DOI 10.1093/bioinformatics/btp041; Wu X, 2013, IEEE ACM T COMPUT BI, V10, P173, DOI 10.1109/TCBB.2012.141; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yan K, 2015, SENSOR ACTUAT B-CHEM, V212, P353, DOI 10.1016/j.snb.2015.02.025; Yang Z, 2012, NEUROSCI BULL, V28, P399, DOI 10.1007/s12264-012-1253-3; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhan ZW, 2018, CNS NEUROSCI THER, V24, P897, DOI 10.1111/cns.12838; Zhang DQ, 2011, NEUROIMAGE, V55, P856, DOI 10.1016/j.neuroimage.2011.01.008; Zheng WH, 2018, BIOL PSYCHIAT-COGN N, V3, P887, DOI 10.1016/j.bpsc.2018.06.004; Zhou J, 2010, BRAIN, V133, P1352, DOI 10.1093/brain/awq075; Zhou Y, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00200; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269	70	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212582	10.1371/journal.pone.0212582	http://dx.doi.org/10.1371/journal.pone.0212582			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794629	Green Published, gold, Green Submitted			2022-12-27	WOS:000459709100090
J	Garcia, PK; Annamalai, T; Wang, WJ; Bell, RS; Le, D; Pancorbo, PM; Sikandar, S; Seddek, A; Yu, XF; Sun, DQ; Uhlemann, AC; Tiwari, PB; Leng, FF; Tse-Dinh, YC				Garcia, Pamela K.; Annamalai, Thirunavukkarasu; Wang, Wenjie; Bell, Raven S.; Le, Duc; Pancorbo, Paula Martin; Sikandar, Sabah; Seddek, Ahmed; Yu, Xufen; Sun, Dianqing; Uhlemann, Anne-Catrin; Tiwari, Purushottam B.; Leng, Fenfei; Tse-Dinh, Yuk-Ching			Mechanism and resistance for antimycobacterial activity of a fluoroquinophenoxazine compound	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS BCG; DNA TOPOISOMERASE-I; MEMBRANE-PROTEINS; CELL-WALL; TUBERCULOSIS; PORIN; ABSCESSUS; GROWTH; GENE; SUSCEPTIBILITY	We have previously reported the inhibition of bacterial topoisomerase I activity by a fluoroquinophenoxazine compound (FP-11g) with a 6-bipiperidinyl lipophilic side chain that exhibited promising antituberculosis activity (MIC = 2.5 mu M against Mycobacterium tuberculosis, SI = 9.8). Here, we found that the compound is bactericidal towards Mycobacterium smegmatis, resulting in greater than 5 Log(10) reduction in colony-forming units [cfu]/mL following a 10 h incubation at 1.25 mu M (4X MIC) concentration. Growth inhibition (MIC = 50 mu M) and reduction in cfu could also be observed against a clinical isolate of Mycobacterium abscessus. Stepwise isolation of resistant mutants of M. smegmatis was conducted to explore the mechanism of resistance. Mutations in the resistant isolates were identified by direct comparison of whole-genome sequencing data from mutant and wild-type isolates. These include mutations in genes likely to affect the entry and retention of the compound. FP-11g inhibits Mtb topoisomerase I and Mtb gyrase with IC50 of 0.24 and 27 mu M, respectively. Biophysical analysis showed that FP-11g binds DNA as an intercalator but the IC50 for inhibition of Mtb topoisomerase I activity is >10 fold lower than the compound concentrations required for producing negatively supercoiled DNA during ligation of nicked circular DNA. Thus, the DNA-binding property of FP-11g may contribute to its antimycobacterial mechanism, but that alone cannot account for the observed inhibition of Mtb topoisomerase I.	[Garcia, Pamela K.; Annamalai, Thirunavukkarasu; Wang, Wenjie; Pancorbo, Paula Martin; Sikandar, Sabah; Seddek, Ahmed; Leng, Fenfei; Tse-Dinh, Yuk-Ching] Florida Int Univ, Biomol Sci Inst, Miami, FL 33199 USA; [Garcia, Pamela K.] Florida Int Univ, Biochem PhD Program, Miami, FL 33199 USA; [Annamalai, Thirunavukkarasu; Wang, Wenjie; Bell, Raven S.; Le, Duc; Seddek, Ahmed; Leng, Fenfei; Tse-Dinh, Yuk-Ching] Florida Int Univ, Dept Chem & Biochem, Miami, FL 33199 USA; [Yu, Xufen; Sun, Dianqing] Univ Hawaii, Daniel K Inouye Coll Pharm, Dept Pharmaceut Sci, Hilo, HI 96720 USA; [Uhlemann, Anne-Catrin] Columbia Univ, Med Ctr, Div Infect Dis, New York, NY USA; [Tiwari, Purushottam B.] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Dept Oncol,Sch Med, Washington, DC 20007 USA	State University System of Florida; Florida International University; State University System of Florida; Florida International University; State University System of Florida; Florida International University; University of Hawaii System; University Hawaii Hilo; Columbia University; Georgetown University	Tse-Dinh, YC (corresponding author), Florida Int Univ, Biomol Sci Inst, Miami, FL 33199 USA.; Tse-Dinh, YC (corresponding author), Florida Int Univ, Dept Chem & Biochem, Miami, FL 33199 USA.	ytsedinh@fiu.edu	Seddek, Ahmed/ABF-6140-2021; YU, XUFEN/AAB-9838-2020	YU, XUFEN/0000-0001-7794-7890	NIH [P30CA51008, R01 AI069313]; FIU Technology Fee Initiative [16-162]; NSF-REU Site Grant [CHE1560375]; NATIONAL CANCER INSTITUTE [P30CA051008] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FIU Technology Fee Initiative; NSF-REU Site Grant(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by NIH grant R01 AI069313 (to Yuk-Ching Tse-Dinh). Next-Gen sequencing was supported by FIU Technology Fee Initiative, Proposal #16-162. Experimental SPR sensorgrams were measured using Biacore T200 SPR instrument available in Biacore Molecular Interaction Shared Resource (BMISR) facility at Georgetown University. The BMISR is supported by NIH grant P30CA51008. REU participant RB was supported by the NSF-REU Site Grant CHE1560375 to FIU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams R, 2012, EUR J CELL BIOL, V91, P326, DOI 10.1016/j.ejcb.2011.06.003; Ahmed W, 2015, MICROBIOL-SGM, V161, P341, DOI 10.1099/mic.0.000014; Ahmed W, 2014, FEMS MICROBIOL LETT, V353, P116, DOI 10.1111/1574-6968.12412; Akerman KJ, 2014, J AM CHEM SOC, V136, P5670, DOI 10.1021/ja412350f; Annamalai T, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-18; Cao N, 2018, NUCLEIC ACIDS RES, V46, P7296, DOI 10.1093/nar/gky492; Cavalli Z, 2017, J CYST FIBROS, V16, P579, DOI 10.1016/j.jcf.2017.01.017; Corbett KD, 2004, ANNU REV BIOPH BIOM, V33, P95, DOI 10.1146/annurev.biophys.33.110502.140357; Danilchanka O, 2008, ANTIMICROB AGENTS CH, V52, P3127, DOI 10.1128/AAC.00239-08; Delmar JA, 2015, J BIOL CHEM, V290, P28559, DOI 10.1074/jbc.M115.683797; Ding C, 2012, J PROTEOMICS, V77, P321, DOI 10.1016/j.jprot.2012.09.006; Domenech P, 2005, INFECT IMMUN, V73, P3492, DOI 10.1128/IAI.73.6.3492-3501.2005; Falkinham JO, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01613; Forterre P, 2009, NUCLEIC ACIDS RES, V37, P679, DOI 10.1093/nar/gkp032; Fujimoto-Nakamura M, 2005, ANTIMICROB AGENTS CH, V49, P3810, DOI 10.1128/AAC.49.9.3810-3815.2005; Gu M, 2016, SCI REP-UK, V6, DOI 10.1038/srep36006; Hayoz S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185359; He ZG, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-121; HSE National Drug Treatment Centre, 2016, CERV SMEAR GUID; Ishiekwene C, 2017, RESPIR MED CASE REP, V20, P123, DOI 10.1016/j.rmcr.2017.01.011; Kartmann B, 1999, J BACTERIOL, V181, P6543, DOI 10.1128/JB.181.20.6543-6546.1999; Korepanova A, 2005, PROTEIN SCI, V14, P148, DOI 10.1110/ps.041022305; Mailaender C, 2004, MICROBIOL-SGM, V150, P853, DOI 10.1099/mic.0.26902-0; Marais BJ, 2016, ADV DRUG DELIVER REV, V102, P3, DOI 10.1016/j.addr.2016.01.021; Martinez-Garcia B, 2018, METHODS MOL BIOL, V1805, P291, DOI 10.1007/978-1-4939-8556-2_15; Mattenberger Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124309; Nagaraja V, 2017, DRUG DISCOV TODAY, V22, P510, DOI 10.1016/j.drudis.2016.11.006; Nessar R, 2012, J ANTIMICROB CHEMOTH, V67, P810, DOI 10.1093/jac/dkr578; Niederweis M, 1999, MOL MICROBIOL, V33, P933, DOI 10.1046/j.1365-2958.1999.01472.x; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pacheco SA, 2013, J BIOL CHEM, V288, P24213, DOI 10.1074/jbc.M113.473371; Purdy GE, 2009, MOL MICROBIOL, V73, P844, DOI 10.1111/j.1365-2958.2009.06801.x; Ravishankar S, 2015, TUBERCULOSIS, V95, P589, DOI 10.1016/j.tube.2015.05.004; Ren JS, 1999, BIOCHEMISTRY-US, V38, P16067, DOI 10.1021/bi992070s; Sandhu P, 2015, INT J MED MICROBIOL, V305, P413, DOI 10.1016/j.ijmm.2015.03.005; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Sharbati S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-31; Sohn Sungmin, 2017, Korean J Thorac Cardiovasc Surg, V50, P50, DOI 10.5090/kjtcs.2017.50.1.50; Soni I, 2016, J MED MICROBIOL, V65, P1, DOI 10.1099/jmm.0.000198; Stahl C, 2001, MOL MICROBIOL, V40, P451, DOI 10.1046/j.1365-2958.2001.02394.x; Stephan J, 2005, MOL MICROBIOL, V58, P714, DOI 10.1111/j.1365-2958.2005.04878.x; Stephan J, 2004, ANTIMICROB AGENTS CH, V48, P4163, DOI 10.1128/AAC.48.11.4163-4170.2004; Strnad L, 2018, SEMIN RESP CRIT CARE, V39, P362, DOI 10.1055/s-0038-1651494; Svetlikova Z, 2009, ANTIMICROB AGENTS CH, V53, P4015, DOI 10.1128/AAC.00590-09; Taneja NK, 2007, J ANTIMICROB CHEMOTH, V60, P288, DOI 10.1093/jac/dkm207; Walker SS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180965; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Yu XF, 2017, EUR J MED CHEM, V125, P515, DOI 10.1016/j.ejmech.2016.09.053	48	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0207733	10.1371/journal.pone.0207733	http://dx.doi.org/10.1371/journal.pone.0207733			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794538	Green Submitted, Green Published, gold			2022-12-27	WOS:000459709100003
J	Lim, HJ; Park, JH; Jo, C; Yoon, K; Koh, YH				Lim, Hyun Joung; Park, Jung Hyun; Jo, Chulman; Yoon, Keejung; Koh, Young Ho			Cigarette smoke extracts and cadmium induce COX-2 expression through gamma-secretase-mediated p38 MAPK activation in C6 astroglia cells	PLOS ONE			English	Article							SIGNALING PATHWAY; GENE-EXPRESSION; PROTEIN-KINASE; EP2 RECEPTORS; ASTROCYTES; BRAIN; DEATH; CREB; TRANSCRIPTION; APOPTOSIS	Exposure to cigarette smoke has been implicated in the progression of cerebrovascular and neurological disorders like stroke through inflammation and blood-brain barrier disruption. In this study, we investigated the signaling cascade activated by cigarette smoke extracts (CSE) and cadmium (Cd) resulting in the COX-2 induction in C6 rat astroglia cells. CSE or Cd induced Notch1 cleavage and activated p38 MAPK and CREB signaling pathways in C6 astroglia cells. Knockdown of nicastrin using siRNA or gamma-secretase inhibitors, DAPT and L-685,486, reduced Notch1 cleavage and phosphorylation of p38 MAPK and CREB, while phosphorylation of ERK and JNK remained unaffected. Additionally, the blockage of gamma-secretase activity did not show any effect on the phosphorylation of AKT, another upstream activator of CREB, indicating that gamma-secretase-mediated CREB activation occurs via p38 MAPK. gamma-secretase inhibitor also inhibited the CSE and Cd-mediated increase in the expression of COX-2. Furthermore, recombinant overexpression of Notch1 intracellular domain resulted in an increase in the expression of COX-2. Notch signaling induced by CSE and Cd induced apoptosis in C6 cells. Our results demonstrate that CSE exposure activated the p38 MAPK and CREB-mediated induction in COX-2 expression in astrocytes via gamma-secretase-mediated Notch1 signaling. Our data provides novel insights into the potential mechanism of pro-inflammatory response activated by exposure to cigarette smoke.	[Lim, Hyun Joung; Park, Jung Hyun; Jo, Chulman; Koh, Young Ho] Korea Natl Inst Hlth, Ctr Biomed Sci, Div Brain Dis, Cheongju, Chungcheongbuk, South Korea; [Yoon, Keejung] Sungkyunkwan Univ, Coll Biotechnol & Bioengn, Suwon, Gyeonggi Do, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Biomedical Science; Sungkyunkwan University (SKKU)	Koh, YH (corresponding author), Korea Natl Inst Hlth, Ctr Biomed Sci, Div Brain Dis, Cheongju, Chungcheongbuk, South Korea.	kohyoungho122@gmail.com			Research of Korea Centers for Disease Control and Prevention [2017-NI62002-00]	Research of Korea Centers for Disease Control and Prevention	This study was supported by funds (2017-NI62002-00) from Research of Korea Centers for Disease Control and Prevention to Dr. YHK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad AS, 2008, NEUROTOX RES, V14, P343, DOI 10.1007/BF03033858; Barnoya J, 2005, CIRCULATION, V111, P2684, DOI 10.1161/CIRCULATIONAHA.104.492215; Borne Y, 2017, J AM HEART ASS, V6; Cakmak S, 2014, ENVIRON POLLUT, V189, P208, DOI 10.1016/j.envpol.2014.03.004; Cheng YL, 2014, BRAIN RES, V1586, P193, DOI 10.1016/j.brainres.2014.08.054; Cho SJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18042-1; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Ebinu JO, 2002, NEURON, V34, P499, DOI 10.1016/S0896-6273(02)00704-3; Gentle ME, 2012, J IMMUNOL, V189, P1274, DOI 10.4049/jimmunol.1103102; Gordon GRJ, 2007, GLIA, V55, P1214, DOI 10.1002/glia.20543; Gu W, 2015, SCI REP-UK, V5, DOI 10.1038/srep08733; Guo SZ, 2009, STROKE, V40, pS4, DOI 10.1161/STROKEAHA.108.534388; Huang RY, 2011, BBA-REV CANCER, V1815, P158, DOI 10.1016/j.bbcan.2010.11.005; Iadecola C, 2001, CURR OPIN NEUROL, V14, P89, DOI 10.1097/00019052-200102000-00014; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; Kim SD, 2005, BIOCHEM BIOPH RES CO, V328, P326, DOI 10.1016/j.bbrc.2004.11.173; Konishi H, 1997, FEBS LETT, V410, P493, DOI 10.1016/S0014-5793(97)00541-3; Ladecola C, 2001, P NATL ACAD SCI USA, V98, P1294, DOI 10.1073/pnas.98.3.1294; Lee SM, 2002, FREE RADICAL BIO MED, V32, P1185, DOI 10.1016/S0891-5849(02)00815-8; Lenz B, 2010, INT J NEUROPSYCHOPH, V13, P207, DOI 10.1017/S1461145709991052; Liu YP, 2008, J NEUROCHEM, V105, P137, DOI 10.1111/j.1471-4159.2007.05118.x; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; MARLOWE M, 1985, J ABNORM CHILD PSYCH, V13, P185, DOI 10.1007/BF00910641; Meng M, 2017, CELL SIGNAL, V31, P15, DOI 10.1016/j.cellsig.2016.12.006; Miyagishi H, 2013, J PHARMACOL SCI, V121, P347, DOI 10.1254/jphs.12274SC; Miyahara T, 2004, TOXICOLOGY, V200, P159, DOI 10.1016/j.tox.2004.03.014; MOON C, 1985, J LEARN DISABIL, V18, P217, DOI 10.1177/002221948501800407; Murata H, 2003, J BIOL CHEM, V278, P50226, DOI 10.1074/jbc.M310171200; Nogawa S, 1997, J NEUROSCI, V17, P2746; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Park CS, 2008, TOXICOL SCI, V106, P413, DOI 10.1093/toxsci/kfn197; Park SY, 2015, J TOXICOL SCI, V40, P151, DOI 10.2131/jts.40.151; Peters JL, 2010, ENVIRON RES, V110, P199, DOI 10.1016/j.envres.2009.12.004; Piao CS, 2002, MOL BRAIN RES, V107, P137, DOI 10.1016/S0169-328X(02)00456-4; Rockwell P, 2004, CELL SIGNAL, V16, P343, DOI 10.1016/j.cellsig.2003.08.006; Sawe N, 2008, J NEUROSCI RES, V86, P1659, DOI 10.1002/jnr.21604; Takadera T, 2004, NEUROCHEM INT, V45, P713, DOI 10.1016/j.neuint.2004.02.005; Takuma K, 2004, PROG NEUROBIOL, V72, P111, DOI 10.1016/j.pneurobio.2004.02.001; Tang QB, 2001, ONCOGENE, V20, P5164, DOI 10.1038/sj.onc.1204667; Tellez-Plaza M, 2013, EPIDEMIOLOGY, V24, P421, DOI 10.1097/EDE.0b013e31828b0631; World Health Organisation, 2011, WHO REP GLOC TOB EP; Zhao YX, 2010, NEUROTHERAPEUTICS, V7, P439, DOI 10.1016/j.nurt.2010.07.004	44	12	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212749	10.1371/journal.pone.0212749	http://dx.doi.org/10.1371/journal.pone.0212749			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794693	Green Submitted, gold, Green Published			2022-12-27	WOS:000459709100129
J	Nunez-Valdez, ME; Lanois, A; Pages, S; Duvic, B; Gaudriault, S				Nunez-Valdez, Maria Eugenia; Lanois, Anne; Pages, Sylvie; Duvic, Bernard; Gaudriault, Sophie			Inhibition of Spodoptera frugiperda phenoloxidase activity by the products of the Xenorhabdus rhabduscin gene cluster	PLOS ONE			English	Article							SUPPRESSES HOST DEFENSES; PHOTORHABDUS-LUMINESCENS; BACTERIAL SYMBIONT; INSECT; NEMATOPHILA; PROTEIN; METABOLITES; EVOLUTION; VIRULENCE; VECTOR	We evaluated the impact of bacterial rhabduscin synthesis on bacterial virulence and phenoloxidase inhibition in a Spodoptera model. We first showed that the rhabduscin cluster of the entomopathogenic bacterium Xenorhabdus nematophila was not necessary for virulence in the larvae of Spodoptera littoralis and Spodoptera frugiperda. Bacteria with mutations affecting the rhabduscin synthesis cluster (Delta isnAB and Delta GT mutants) were as virulent as the wild-type strain. We then developed an assay for measuring phenoloxidase activity in S. frugiperda and assessed the ability of bacterial culture supernatants to inhibit the insect phenoloxidase. Our findings confirm that the X. nematophila rhabduscin cluster is required for the inhibition of S. frugiperda phenoloxidase activity. The X. nematophila Delta isnAB mutant was unable to inhibit phenoloxidase, whereas Delta GT mutants displayed intermediate levels of phenoloxidase inhibition relative to the wild-type strain. The culture supernatants of Escherichia coli and of two entomopathogenic bacteria, Serratia entomophila and Xenorhabdus poinarii, were unable to inhibit S. frugiperda phenoloxidase activity. Heterologous expression of the X. nematophila rhabduscin cluster in these three strains was sufficient to restore inhibition. Interestingly, we observed pseudogenization of the X. poinarii rhabduscin gene cluster via the insertion of a 120 bp element into the isnA promoter. The inhibition of phenoloxidase activity by X. poinarii culture supernatants was restored by expression of the X. poinarii rhabduscin cluster under the control of an inducible P-tet promoter, consistent with recent pseudogenization. This study paves the way for advances in our understanding of the virulence of several entomopathogenic bacteria in non-model insects, such as the new invasive S. frugiperda species in Africa.	[Nunez-Valdez, Maria Eugenia] Univ Autonoma Estado Morelos, Cuernavaca, Morelos, Mexico; [Lanois, Anne; Pages, Sylvie; Duvic, Bernard; Gaudriault, Sophie] Univ Montpellier, INRA, DGIMI, Montpellier, France	Universidad Autonoma del Estado de Morelos; INRAE; Universite de Montpellier	Nunez-Valdez, ME (corresponding author), Univ Autonoma Estado Morelos, Cuernavaca, Morelos, Mexico.; Gaudriault, S (corresponding author), Univ Montpellier, INRA, DGIMI, Montpellier, France.	eugenia@uaem.mx; sophie.gaudriault@umontpellier.fr	Duvic, Bernard/ABG-5094-2020; , Gaudriault/AAK-9152-2021	, Gaudriault/0000-0003-2789-4959; Duvic, Bernard/0000-0002-7618-7719; Nunez-Valdez, Maria Eugenia/0000-0003-4729-9954	INRA [SPE 2010-1133-01]; CONACYT [CB2014-243027]; INRA	INRA; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); INRA	This study was supported by INRA (grant SPE 2010-1133-01, "Genomique comparative et evolutive de nouveaux facteurs d'adaptation de la bacterie entomopathogene Xenorhadus a ses hotes insectes"). MEN-V was the recipient of a travel grant in the DGIMI laboratory from INRA. The support of CONACYT, project CB2014-243027 is acknowledged.	AKHURST RJ, 1986, SYST APPL MICROBIOL, V8, P142, DOI 10.1016/S0723-2020(86)80162-X; Asgari S, 2003, INSECT BIOCHEM MOLEC, V33, P1017, DOI 10.1016/S0965-1748(03)00116-4; Beck MH, 2007, P NATL ACAD SCI USA, V104, P19267, DOI 10.1073/pnas.0708056104; Bisch G, 2016, GENOME BIOL EVOL, V8, P148, DOI 10.1093/gbe/evv248; Bisch G, 2015, J INVERTEBR PATHOL, V124, P15, DOI 10.1016/j.jip.2014.10.002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brugirard-Ricaud K, 2005, CELL MICROBIOL, V7, P363, DOI 10.1111/j.1462-5822.2004.00466.x; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Cerenius L, 2010, TRENDS BIOCHEM SCI, V35, P575, DOI 10.1016/j.tibs.2010.04.006; Chaston JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027909; Ciche TA, 2003, APPL ENVIRON MICROB, V69, P1890, DOI 10.1128/AEM.69.4.1890-1897.2003; Colinet D, 2009, DEV COMP IMMUNOL, V33, P681, DOI 10.1016/j.dci.2008.11.013; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Crawford JM, 2012, P NATL ACAD SCI USA, V109, P10821, DOI 10.1073/pnas.1201160109; Crawford JM, 2010, CURR BIOL, V20, P69, DOI 10.1016/j.cub.2009.10.059; Dowd PF, 1999, NAT TOXINS, V7, P337, DOI 10.1002/1522-7189(199911/12)7:6<337::AID-NT69>3.0.CO;2-O; Duvic B, 2012, J INSECT PHYSIOL, V58, P881, DOI 10.1016/j.jinsphys.2012.04.001; Eleftherianos I, 2007, P NATL ACAD SCI USA, V104, P2419, DOI 10.1073/pnas.0610525104; Eleftherianos I, 2011, J INNATE IMMUN, V3, P28, DOI 10.1159/000321931; Nunez-Valdez ME, 2008, APPL ENVIRON MICROB, V74, P802, DOI 10.1128/AEM.01074-07; Forst S, 1997, ANNU REV MICROBIOL, V51, P47, DOI 10.1146/annurev.micro.51.1.47; Goergen G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165632; Gonzalez-Santoyo I, 2012, ENTOMOL EXP APPL, V142, P1, DOI 10.1111/j.1570-7458.2011.01187.x; GRIMONT PAD, 1988, INT J SYST BACTERIOL, V38, P1, DOI 10.1099/00207713-38-1-1; Herbert EE, 2007, NAT REV MICROBIOL, V5, P634, DOI 10.1038/nrmicro1706; Jubelin G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003915; Kim IH, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4311-4; Kim Y, 2005, J INVERTEBR PATHOL, V89, P258, DOI 10.1016/j.jip.2005.05.001; Kuo CH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001050; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Li XY, 2009, MOL BIOCHEM PARASIT, V165, P162, DOI 10.1016/j.molbiopara.2009.02.001; Lim FY, 2018, MBIO, V9, DOI [10.1128/mBio.00785-18, 10.1128/mbio.00785-18]; Lu Z, 2008, J BIOL CHEM, V283, P21325, DOI 10.1074/jbc.M801593200; Lu ZQ, 2010, INSECT BIOCHEM MOLEC, V40, P497, DOI 10.1016/j.ibmb.2010.04.009; McMullen JG, 2017, MICROBIOL-SGM, V163, P510, DOI 10.1099/mic.0.000449; Mikonranta L, 2017, J INVERTEBR PATHOL, V144, P88, DOI 10.1016/j.jip.2017.01.012; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Mouammine A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110060; Mulley G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144937; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; Thuan NH, 2013, J IND MICROBIOL BIOT, V40, P1329, DOI 10.1007/s10295-013-1332-0; Nielsen-LeRoux C, 2012, CURR OPIN MICROBIOL, V15, P220, DOI 10.1016/j.mib.2012.04.006; Ogier JC, 2014, GENOME BIOL EVOL, V6, P1495, DOI 10.1093/gbe/evu119; Paulick A, 2009, MOL MICROBIOL, V71, P836, DOI 10.1111/j.1365-2958.2008.06570.x; POINAR GO, 1967, J INVERTEBR PATHOL, V9, P510, DOI 10.1016/0022-2011(67)90131-0; POITOUT S, 1970, Annales de Zoologie Ecologie Animale, V2, P79; Sicard M, 2004, APPL ENVIRON MICROB, V70, P6473, DOI 10.1128/AEM.70.11.6473-6480.2004; Snyder H, 2007, APPL ENVIRON MICROB, V73, P5338, DOI 10.1128/AEM.02947-06; Song CJ, 2011, J MICROBIOL BIOTECHN, V21, P317, DOI 10.4014/jmb.1010.10034; Ullah I, 2015, J MICROBIOL, V53, P127, DOI 10.1007/s12275-015-4632-4; Ullah I, 2014, MOLECULES, V19, P20913, DOI 10.3390/molecules191220913; van Sambeek J, 1999, J INVERTEBR PATHOL, V73, P154, DOI 10.1006/jipa.1998.4823; Vigneux F, 2007, J BIOL CHEM, V282, P9571, DOI 10.1074/jbc.M604301200; Waterfield NR, 2009, ANNU REV MICROBIOL, V63, P557, DOI 10.1146/annurev.micro.091208.073507	54	3	3	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212809	10.1371/journal.pone.0212809	http://dx.doi.org/10.1371/journal.pone.0212809			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794697	Green Submitted, Green Published, gold			2022-12-27	WOS:000459709100144
J	Shin, GT; Lee, HJ; Park, JE				Shin, Gyu-Tae; Lee, Hwa Joung; Park, Ji Eun			Growth arrest and DNA damage 45 gamma is required for caspase-dependent renal tubular cell apoptosis	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; IN-VITRO; GADD45-GAMMA; INVOLVEMENT; ACTIVATION; EXPRESSION; PATHWAYS; STRESS; KINASE; ALPHA	Background Growth Arrest and DNA Damage 45 gamma (GADD45 gamma) is a member of the DNA damage-inducible gene family which responds to environmental stresses. Apoptosis is a critical mode of renal tubular cell death in nephrotoxin-induced acute kidney injury. In this study, we investigated the role of GADD45 gamma in renal tubular cell apoptosis induced by nephrotoxic drugs. Methods Primary human renal tubular epithelial (HRE) cells were used in this study. To derive stable cell lines in which GADD45 gamma expression was silenced, HRE cells were transduced with a plasmid encoding GADD45 gamma-specific shRNA. The recombinant adenovirus containing the GADD45 gamma gene was synthesized to overexpress GADD45 gamma protein. Cell death was induced by cisplatin and cyclosporine A (CsA). To prevent apoptotic cell death, pan-caspase inhibitor ZVAD-FMK was used. To prevent non-apoptotic cell death, necrostatin-1 and ferrostatin-1 were used. The degree of apoptosis and necrosis of cultured cells were evaluated by flow cytometry. Results Expression of the GADD45 gamma gene was significantly upregulated in response to treatment with CsA and cisplatin. Apoptosis and necrosis induced by these drugs were significantly reduced by silencing of GADD45 gamma, and significantly augmented by the overexpression of GADD45 gamma. The activation of caspase-3 and caspase-7 as well as caspase-9 induced by cisplatin or CsA was reduced by silencing of GADD45 gamma, and was augmented by the overexpression of GADD45 gamma, indicating that caspase activation is dependent on the expression of GADD45 gamma. ZVAD-FMK significantly inhibited apoptosis induced by cisplatin or CsA, indicating a role of caspases in mediating apoptotic cell death. ZVAD-FMK was effective to prevent necrosis as well, indicating that the observed necrosis was a secondary event following apoptosis at least in part. Conclusions To our knowledge, this is the first study to show that GADD45 gamma is required for the caspase-dependent apoptosis of renal tubular cells induced by nephrotoxic drugs.	[Shin, Gyu-Tae; Lee, Hwa Joung; Park, Ji Eun] Ajou Univ, Sch Med, Dept Nephrol, Suwon, South Korea	Ajou University	Shin, GT (corresponding author), Ajou Univ, Sch Med, Dept Nephrol, Suwon, South Korea.	gtshin@ajou.ac.kr						Arany I, 2003, SEMIN NEPHROL, V23, P460, DOI 10.1016/S0270-9295(03)00089-5; Burdmann EA, 2003, SEMIN NEPHROL, V23, P465, DOI 10.1016/S0270-9295(03)00090-1; Daemen MARC, 1999, J CLIN INVEST, V104, P541, DOI 10.1172/JCI6974; El Mouedden M, 2000, TOXICOL SCI, V56, P229, DOI 10.1093/toxsci/56.1.229; Havasi A, 2011, KIDNEY INT, V80, P29, DOI 10.1038/ki.2011.120; Hizoh I, 1998, NEPHROL DIAL TRANSPL, V13, P911, DOI 10.1093/ndt/13.4.911; Jiang M, 2006, ONCOGENE, V25, P4056, DOI 10.1038/sj.onc.1209440; Justo P, 2003, J AM SOC NEPHROL, V14, P3072, DOI 10.1097/01.ASN.0000099383.57934.0E; Kelly KJ, 2001, J CLIN INVEST, V108, P1291, DOI 10.1172/JCI13018; KOPP JB, 1990, J AM SOC NEPHROL, V1, P162; Lau AH, 1999, KIDNEY INT, V56, P1295, DOI 10.1046/j.1523-1755.1999.00687.x; Lerolle N, 2010, INTENS CARE MED, V36, P471, DOI 10.1007/s00134-009-1723-x; Lieberthal W, 1996, AM J PHYSIOL-RENAL, V270, pF700, DOI 10.1152/ajprenal.1996.270.4.F700; Lin H, 2007, MOL PHARMACOL, V72, P1238, DOI 10.1124/mol.107.037523; Linkermann A, 2013, P NATL ACAD SCI USA, V110, P12024, DOI 10.1073/pnas.1305538110; Lu BF, 2001, IMMUNITY, V14, P583, DOI 10.1016/S1074-7613(01)00141-8; Lucas A, 2015, CARDIOVASC RES, V108, P254, DOI 10.1093/cvr/cvv219; Ohse T, 2006, KIDNEY INT, V70, P1447, DOI 10.1038/sj.ki.5001704; Ortiz A, 1998, KIDNEY INT, V54, pS25, DOI 10.1046/j.1523-1755.1998.06808.x; Sachet M, 2017, APOPTOSIS, V22, P1189, DOI 10.1007/s10495-017-1413-z; Schelling JR, 1999, KIDNEY INT, V56, P1313, DOI 10.1046/j.1523-1755.1999.00684.x; Seth R, 2005, J BIOL CHEM, V280, P31230, DOI 10.1074/jbc.M503305200; Sheikh-Hamad D, 2001, J AM SOC NEPHROL, V12, P2732, DOI 10.1681/ASN.V12122732; Shihab FS, 1999, KIDNEY INT, V56, P2147, DOI 10.1046/j.1523-1755.1999.00794.x; Shin GT, 2008, KIDNEY INT, V73, P1251, DOI 10.1038/ki.2008.93; SMITH ML, 1994, SCIENCE, V266, P1376, DOI 10.1126/science.7973727; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Thomas SE, 1998, KIDNEY INT, V53, P897, DOI 10.1046/j.1523-1755.1998.00835.x; Tsuruya K, 2008, LIFE SCI, V83, P550, DOI 10.1016/j.lfs.2008.08.002; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Verzola D, 2007, KIDNEY INT, V72, P1262, DOI 10.1038/sj.ki.5002531; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Wei Q, 2007, KIDNEY INT, V72, P53, DOI 10.1038/sj.ki.5002256; Yu F, 2007, AM J PHYSIOL-RENAL, V293, pF52, DOI 10.1152/ajprenal.00119.2007; Yu S, 2009, AM J NEPHROL, V30, P135, DOI 10.1159/000209317; Zerbini LF, 2004, P NATL ACAD SCI USA, V101, P13618, DOI 10.1073/pnas.0402069101	37	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212818	10.1371/journal.pone.0212818	http://dx.doi.org/10.1371/journal.pone.0212818			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794682	Green Published, Green Submitted, gold			2022-12-27	WOS:000459709100146
J	Comstock, JP; Sherpa, SR; Ferguson, R; Bailey, S; Beem-Miller, JP; Lin, F; Lehmann, J; Wolfe, DW				Comstock, Jonathan P.; Sherpa, Sonam R.; Ferguson, Richard; Bailey, Scarlett; Beem-Miller, Jeffrey P.; Lin, Feng; Lehmann, Johannes; Wolfe, David W.			Carbonate determination in soils by mid-IR spectroscopy with regional and continental scale models	PLOS ONE			English	Article							DIFFUSE-REFLECTANCE SPECTROSCOPY; PARTIAL LEAST-SQUARES; ORGANIC-MATTER; PREDICTION; SEQUESTRATION; NIR	A Partial Least Squares (PLS) carbonate (CO3) prediction model was developed for soils throughout the contiguous United States using mid-infrared (MIR) spectroscopy. Excellent performance was achieved over an extensive geographic and chemical diversity of soils. A single model for all soil types performed very well with a root mean square error of prediction (RMSEP) of 12.6 g kg(-1) and was further improved if Histosols were excluded (RMSEP 11.1 g kg(-1)). Exclusion of Histosols was particularly beneficial for accurate prediction of CO3 values when the national model was applied to an independent regional dataset. Little advantage was found in further narrowing the taxonomic breadth of the calibration dataset, but higher precision was obtained by running models for a restricted range of CO3. A model calibrated using only on the independent regional dataset, was unable to accurately predict CO3 content for the more chemically diverse national dataset. Ten absorbance peaks enabling CO3 prediction by mid-infrared (MIR) spectroscopy were identified and evaluated for individual and combined predictive power. A single-band model derived from an absorbance peak centered at 1796 cm(-) yielded the lowest RMSEP of 13.5 g kg(-1) for carbonate prediction compared to other single-band models. This predictive power is attributed to the strength and sharpness of the peak, and an apparent minimal overlap with confounding co-occurring spectral features of other soil components. Drawing from the 10 identified bands, multiple combinations of 3 or 4 peaks were able to predict CO3 content as well as the full-spectrum national models. Soil CO3 is an excellent example of a soil parameter that can be predicted with great effectiveness and generality, and MIR models could replace direct laboratory measurement as a lower cost, high quality alternative.	[Comstock, Jonathan P.; Beem-Miller, Jeffrey P.; Wolfe, David W.] Cornell Univ, Sch Integrat Plant Sci, Hort Sect, Ithaca, NY 14850 USA; [Comstock, Jonathan P.; Sherpa, Sonam R.; Ferguson, Richard; Bailey, Scarlett] Nat Resources Conservat Serv, Kellogg Soil Survey Lab, Lincoln, NE USA; [Sherpa, Sonam R.; Lehmann, Johannes] Cornell Univ, Sch Integrat Plant Sci, Soil & Crop Sci Sect, Ithaca, NY USA; [Lin, Feng] Nanjing Agr Univ, Jiangsu Key Lab Low Carbon Agr & GHGs Mitigat, Nanjing, Jiangsu, Peoples R China; [Lehmann, Johannes; Wolfe, David W.] Cornell Univ, Atkinson Ctr Sustainable Future, Ithaca, NY USA	Cornell University; Cornell University; Nanjing Agricultural University; Cornell University	Comstock, JP (corresponding author), Cornell Univ, Sch Integrat Plant Sci, Hort Sect, Ithaca, NY 14850 USA.; Comstock, JP (corresponding author), Nat Resources Conservat Serv, Kellogg Soil Survey Lab, Lincoln, NE USA.	jpc8@cornell.edu	Lehmann, Johannes/H-2682-2014	Lehmann, Johannes/0000-0002-4701-2936; Beem-Miller, Jeffrey/0000-0003-0955-6622	United States Department of Agriculture, National Institute of Food and Agriculture Agriculture, and Food Research Initiative [2011-67003-3025]	United States Department of Agriculture, National Institute of Food and Agriculture Agriculture, and Food Research Initiative(United States Department of Agriculture (USDA))	Funded by grant#2011-67003-3025 United States Department of Agriculture, National Institute of Food and Agriculture Agriculture, and Food Research Initiative. https://nifa.usda.gov/program/agriculture-and-food-research-initiativeafri. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON LE, 1965, METHODS SOIL ANAL 2, P1346; Bellon-Maurel V, 2011, SOIL BIOL BIOCHEM, V43, P1398, DOI 10.1016/j.soilbio.2011.02.019; Bellon-Maurel V, 2010, TRAC-TREND ANAL CHEM, V29, P1073, DOI 10.1016/j.trac.2010.05.006; BENDOR E, 1990, APPL SPECTROSC, V44, P1064, DOI 10.1366/0003702904086821; Bornemann L, 2010, SOIL SCI SOC AM J, V74, P1147, DOI 10.2136/sssaj2009.0195; Brown DJ, 2006, GEODERMA, V132, P273, DOI 10.1016/j.geoderma.2005.04.025; Bughio MA, 2016, GEODERMA, V262, P12, DOI 10.1016/j.geoderma.2015.08.003; Burt R, 2014, 42 USDA; Calderon FJ, 2011, SOIL SCI SOC AM J, V75, P568, DOI 10.2136/sssaj2009.0375; Chatterjee A, 2009, CRIT REV PLANT SCI, V28, P164, DOI 10.1080/07352680902776556; Gillet P, 1996, GEOCHIM COSMOCHIM AC, V60, P3471, DOI 10.1016/0016-7037(96)00178-0; Grinand C, 2012, EUR J SOIL SCI, V63, P141, DOI 10.1111/j.1365-2389.2012.01429.x; HAALAND DM, 1988, ANAL CHEM, V60, P1193, DOI 10.1021/ac00162a020; Hartemink AE, 2014, PROGR SOIL SCI, P483, DOI 10.1007/978-3-319-04084-4_48; Horvath B, 2005, SOIL SCI SOC AM J, V69, P1066, DOI 10.2136/sssaj2004.0010; JANIK LJ, 1995, AUST J SOIL RES, V33, P621, DOI 10.1071/SR9950621; Lal R., 2000, GLOBAL CLIMATE CHANG; Loeppert R. H., 1996, SSSA BOOK SERIES, V3, P53711, DOI DOI 10.2136/sssabookser5.3.c15; McCarty GW, 2006, SOIL SCI, V171, P94, DOI 10.1097/01.ss.0000187377.84391.54; McCarty GW, 2002, SOIL SCI SOC AM J, V66, P640, DOI 10.2136/sssaj2002.0640; NGUYEN TT, 1991, AUST J SOIL RES, V29, P49, DOI 10.1071/SR9910049; RABENHORST MC, 1988, SOIL SCI SOC AM J, V52, P965, DOI 10.2136/sssaj1988.03615995005200040012x; Reeves JB, 2010, GEODERMA, V158, P3, DOI 10.1016/j.geoderma.2009.04.005; Reeves JB, 2009, APPL GEOCHEM, V24, P1472, DOI 10.1016/j.apgeochem.2009.04.017; Rossel RAV, 2012, EUR J SOIL SCI, V63, P848, DOI 10.1111/j.1365-2389.2012.01495.x; Rossel RAV, 2006, GEODERMA, V131, P59, DOI 10.1016/j.geoderma.2005.03.007; Sanderman J, 2012, AGR ECOSYST ENVIRON, V155, P70, DOI 10.1016/j.agee.2012.04.015; Sherrod LA, 2002, SOIL SCI SOC AM J, V66, P299, DOI 10.2136/sssaj2002.0299; Singh BP, SOIL HLTH CLIMATE CH; Singh K, 2012, SOIL RES, V50, P672, DOI 10.1071/SR12119; Soriano-Disla JM, 2014, APPL SPECTROSC REV, V49, P139, DOI 10.1080/05704928.2013.811081; Stetson SJ, 2015, COMMUN SOIL SCI PLAN, V46, P2162, DOI 10.1080/00103624.2015.1069316; Stumpe B, 2011, EUR J SOIL SCI, V62, P849, DOI 10.1111/j.1365-2389.2011.01401.x; Van der Marel H.W., 1976, ATLAS INFRARED SPECT; White W.B, 1974, INFRARED SPECTRA MIN; Williams P. C., 2001, NEAR INFRARED TECHNO, V2, P145	36	11	11	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0210235	10.1371/journal.pone.0210235	http://dx.doi.org/10.1371/journal.pone.0210235			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789918	Green Published, gold			2022-12-27	WOS:000459330800008
J	Thorsted, A; Bouchene, S; Tano, E; Castegren, M; Lipcsey, M; Sjolin, J; Karlsson, MO; Friberg, LE; Nielsen, EI				Thorsted, Anders; Bouchene, Salim; Tano, Eva; Castegren, Markus; Lipcsey, Miklos; Sjolin, Jan; Karlsson, Mats O.; Friberg, Lena E.; Nielsen, Elisabet I.			A non-linear mixed effect model for innate immune response: In vivo kinetics of endotoxin and its induction of the cytokines tumor necrosis factor alpha and interleukin-6	PLOS ONE			English	Article							ESCHERICHIA-COLI; PHARMACOKINETICS; PATHOGENESIS; INFLAMMATION; TOBRAMYCIN; CEFUROXIME; ACTIVATION; REDUCTION; RELEASE; SEPSIS	Endotoxin, a component of the outer membrane of Gram-negative bacteria, has been extensively studied as a stimulator of the innate immune response. However, the temporal aspects and exposure-response relationship of endotoxin and resulting cytokine induction and tolerance development is less well defined. The aim of this work was to establish an in silico model that simultaneously captures and connects the in vivo time-courses of endotoxin, tumor necrosis factor alpha (TNF-alpha), interleukin-6 (IL-6), and associated tolerance development. Data from six studies of porcine endotoxemia in anesthetized piglets (n = 116) were combined and used in the analysis, with purified endotoxin (Escherichia coli O111: B4) being infused intravenously for 1-30 h in rates of 0.063-16.0 mu g/kg/h across studies. All data were modelled simultaneously by means of importance sampling in the non-linear mixed effects modelling software NONMEM. The infused endotoxin followed one-compartment disposition and non-linear elimination, and stimulated the production of TNF-alpha to describe the rapid increase in plasma concentration. Tolerance development, observed as declining TNF-alpha concentration with continued infusion of endotoxin, was also driven by endotoxin as a concentration-dependent increase in the potency parameter related to TNF-alpha production (EC50). Production of IL-6 was stimulated by both endotoxin and TNF-a, and four consecutive transit compartments described delayed increase in plasma IL-6. A model which simultaneously account for the time-courses of endotoxin and two immune response markers, the cytokines TNF-alpha and IL-6, as well as the development of endotoxin tolerance, was successfully established. This model-based approach is unique in its description of the time-courses and their interrelation and may be applied within research on immune response to bacterial endotoxin, or in pre-clinical pharmaceutical research when dealing with study design or translational aspects.	[Thorsted, Anders; Bouchene, Salim; Karlsson, Mats O.; Friberg, Lena E.; Nielsen, Elisabet I.] Uppsala Univ, Dept Pharmaceut Biosci, Pharmacometr Res Grp, Uppsala, Sweden; [Tano, Eva] Uppsala Univ Hosp, Sect Clin Microbiol & Infect Med, Dept Med Sci, Uppsala, Sweden; [Castegren, Markus; Sjolin, Jan] Uppsala Univ Hosp, Infect Dis Sect, Dept Med Sci, Uppsala, Sweden; [Castegren, Markus] Karolinska Univ Hosp, Div Perioperat Med & Intens Care, Stockholm, Sweden; [Castegren, Markus] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Lipcsey, Miklos] Uppsala Univ Hosp, Dept Surg Sci, Sect Anesthesiol & Intens Care, Hedenstierna Lab, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Uppsala University; Uppsala University Hospital	Thorsted, A (corresponding author), Uppsala Univ, Dept Pharmaceut Biosci, Pharmacometr Res Grp, Uppsala, Sweden.	anders.thorsted@farmbio.uu.se	Friberg, Lena/AAW-5888-2021; Nielsen, Elisabet/X-3368-2019; Nielsen, Elisabet I/GSM-6795-2022; Thorsted, Anders/AAA-6475-2021; Castegren, Markus/AAF-2620-2019; Lipcsey, Miklos/K-4308-2012	Friberg, Lena/0000-0002-2979-679X; Thorsted, Anders/0000-0003-1804-2703; Bouchene, Salim/0000-0003-1078-6708; Lipcsey, Miklos/0000-0002-1976-4129; Castegren, Markus/0000-0002-9292-0298; Nielsen, Elisabet/0000-0003-0725-214X	Swedish Foundation for Strategic Research (SSF)	Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research)	This project was sponsored by the Swedish Foundation for Strategic Research (SSF, https://strategiska.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arefian H, 2017, J INFECTION, V74, P107, DOI 10.1016/j.jinf.2016.11.006; Beal S, 2018, NONMEM 7 4 2 USERS G; Beal SL, 2001, J PHARMACOKINET PHAR, V28, P481, DOI 10.1023/A:1012299115260; Bergstrand M, 2011, AAPS J, V13, P143, DOI 10.1208/s12248-011-9255-z; Biesmans S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/716920; BRAUDE AI, 1955, J CLIN INVEST, V34, P858, DOI 10.1172/JCI103141; Brubaker SW, 2015, ANNU REV IMMUNOL, V33, P257, DOI 10.1146/annurev-immunol-032414-112240; Carlsson M, 2009, CRIT CARE MED, V37, P1031, DOI 10.1097/CCM.0b013e31819b5683; Castegren M, 2012, SHOCK, V37, P501, DOI 10.1097/SHK.0b013e318249bb0d; Deng MH, 2013, J IMMUNOL, V190, P5152, DOI 10.4049/jimmunol.1300496; Diep JK, 2018, CPT-PHARMACOMET SYST, V7, P507, DOI 10.1002/psp4.12312; ELIN RJ, 1976, ANNU REV MED, V27, P127, DOI 10.1146/annurev.me.27.020176.001015; Gardmark M, 1999, CLIN PHARMACOKINET, V36, P145; Gnauck A, 2016, CRIT REV CL LAB SCI, V53, P197, DOI 10.3109/10408363.2015.1123215; Gonzalez D, 2011, CURR PHARM BIOTECHNO, V12, P2030, DOI 10.2174/138920111798808211; Goscinski G, 2007, J ANTIMICROB CHEMOTH, V60, P328, DOI 10.1093/jac/dkm190; Goscinski G, 2004, CRIT CARE, V8, pR35, DOI 10.1186/cc2415; Henderson JC, 2016, ANNU REV MICROBIOL, V70, P255, DOI 10.1146/annurev-micro-102215-095308; Hu XY, 2008, IMMUNOL REV, V226, P41, DOI 10.1111/j.1600-065X.2008.00707.x; Jonsson EN, 1999, COMPUT METH PROG BIO, V58, P51, DOI 10.1016/S0169-2607(98)00067-4; Keizer RJ, 2013, CPT-PHARMACOMET SYST, V2, DOI 10.1038/psp.2013.24; LINDSAY GK, 1989, J CLIN MICROBIOL, V27, P947, DOI 10.1128/JCM.27.5.947-951.1989; Lipcsey M, 2006, J ENDOTOXIN RES, V12, P99, DOI 10.1179/096805106X89053; Lipcsey M, 2008, SHOCK, V29, P173, DOI 10.1097/SHK.0b013e318067dfbc; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; MATHISON JC, 1979, J IMMUNOL, V123, P2133; Matsuno H, 2002, RHEUMATOLOGY, V41, P329, DOI 10.1093/rheumatology/41.3.329; Mould DR, 2012, CPT-PHARMACOMET SYST, V1, DOI 10.1038/psp.2012.4; MULLEN PG, 1995, J SURG RES, V58, P124, DOI 10.1006/jsre.1995.1020; Nielsen EI, 2013, PHARMACOL REV, V65, P1053, DOI 10.1124/pr.111.005769; Nieman G, 2012, CRIT CARE MED, V40, P1052, DOI 10.1097/CCM.0b013e31823e986a; Pasin L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082775; PREMARATNE S, 1995, J SURG RES, V59, P428, DOI 10.1006/jsre.1995.1186; R Core Team, 2018, R LANG ENV STAT COMP; REDL H, 1993, IMMUNOBIOLOGY, V187, P330, DOI 10.1016/S0171-2985(11)80348-7; Roberts JA, 2012, INT J ANTIMICROB AG, V39, P187, DOI 10.1016/j.ijantimicag.2011.11.002; Schirm S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156047; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Sjolin J, 2000, CLIN MICROBIOL INFEC, V6, P74, DOI 10.1046/j.1469-0691.2000.00025.x; Skorup P, 2018, CRIT CARE MED, V46, pE634, DOI 10.1097/CCM.0000000000003139; Skorup P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090441; Smith AM, 2011, J THEOR BIOL, V276, P106, DOI 10.1016/j.jtbi.2011.01.052; Stearns-Kurosawa DJ, 2011, ANNU REV PATHOL-MECH, V6, P19, DOI 10.1146/annurev-pathol-011110-130327; Suffredini AF, 1999, J INFECT DIS, V179, P1278, DOI 10.1086/314717; Taccone Fabio Silvio, 2011, Curr Infect Dis Rep, V13, P406, DOI 10.1007/s11908-011-0203-y; Thakar J, 2007, PLOS COMPUT BIOL, V3, P1022, DOI 10.1371/journal.pcbi.0030109; Ulloa L, 2005, TRENDS MOL MED, V11, P56, DOI 10.1016/j.molmed.2004.12.007; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; von Seth M, 2015, SHOCK, V43, P604, DOI 10.1097/SHK.0000000000000351; Wickham H, 2017, TIDYR EASILY TIDY DA; Wickham H., 2009, MEDIA, V35, P10, DOI 10.1007/978-0-387-98141-3; Zhang LP, 2003, J PHARMACOKINET PHAR, V30, P387, DOI 10.1023/B:JOPA.0000012998.04442.1f	52	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0211981	10.1371/journal.pone.0211981	http://dx.doi.org/10.1371/journal.pone.0211981			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789941	Green Published, gold			2022-12-27	WOS:000459330800014
J	Engeli, KM; Baumann, S; Rolle-Kampczyk, U; Schiller, J; von Bergen, M; Grunewald, S				Engeli, Kathrin M.; Baumann, Sven; Rolle-Kampczyk, Ulrike; Schiller, Juergen; von Bergen, Martin; Grunewald, Sonja			Metabolomic profiling reveals correlations between spermiogram parameters and the metabolites present in human spermatozoa and seminal plasma	PLOS ONE			English	Article							TOF MASS-SPECTROMETRY; ANDROGEN RECEPTOR; CREATINE-KINASE; SPERM MOTILITY; SEMEN QUALITY; L-CARNITINE; MEN; IDENTIFICATION; CHROMATOGRAPHY; SPECTROSCOPY	In 50% of all infertility cases, the male is subfertile or infertile, however, the underlying mechanisms are often unknown. Even when assisted reproductive procedures such as in vitro fertilization and intracytoplasmic sperm injection are performed, the causes of male factor infertility frequently remain elusive. Since the overall activity of cells is closely linked to their metabolic capacity, we analyzed a panel of 180 metabolites in human sperm and seminal plasma and elucidated their associations with spermiogram parameters. Therefore, metabolites from a group of 20 healthy donors were investigated using a targeted LC-MS/MS approach. The correlation analyses of the amino acids, biogenic amines, acylcarnitines, lysophosphatidylcholines, phosphatidylcholines, sphingomyelins and sugars from sperm and seminal plasma with standard spermiogram parameters revealed that metabolites in sperm are closely related to sperm motility, whereas those in seminal plasma are closely related to sperm concentration and morphology. This study provides essential insights into the metabolome of human sperm and seminal plasma and its associations with sperm functions. This metabolomics technique could be a promising screening tool to detect the factors of male infertility in cases where the cause of infertility is unclear.	[Engeli, Kathrin M.; Grunewald, Sonja] Univ Hosp Leipzig, Training Ctr European Acad Androl EAA, Dermatol Venerol & Allergol Clin, Leipzig, Germany; [Engeli, Kathrin M.; Schiller, Juergen] Univ Leipzig, Inst Med Phys & Biophys, Fac Med, Leipzig, Germany; [Baumann, Sven; Rolle-Kampczyk, Ulrike; von Bergen, Martin] UFZ Helmholtz Ctr Environm Res, Dept Mol Syst Biol, Leipzig, Germany; [von Bergen, Martin] Univ Leipzig, Inst Biochem, Fac Life Sci, Leipzig, Germany; [Baumann, Sven] Umweltbundesamt UBA, Dessau Rosslau, Germany	Leipzig University; Leipzig University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leipzig University	Grunewald, S (corresponding author), Univ Hosp Leipzig, Training Ctr European Acad Androl EAA, Dermatol Venerol & Allergol Clin, Leipzig, Germany.	sonja.grunewald@medizin.uni-leipzig.de	Baumann, Sven/M-2177-2013; Rolle-Kampczyk, Ulrike E./D-4786-2015	Baumann, Sven/0000-0002-3453-5308; Rolle-Kampczyk, Ulrike E./0000-0002-7728-6284; Schiller, Jurgen/0000-0002-4328-8652	German Research Council (Deutsche Forschungsgemeinschaft) [DFG GR 2075/7-1, DFG Schi 476/12-2]	German Research Council (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	The study was funded by grants for SG and JS of the German Research Council (Deutsche Forschungsgemeinschaft, http://www.dfg.de/, grant numbers DFG GR 2075/7-1 and DFG Schi 476/12-2). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliabadi E, 2012, IRAN J REPROD MED, V10, P77; Amaral A, 2014, J PROTEOME RES, V13, P5670, DOI 10.1021/pr500652y; Andersen JM, 2016, ANDROLOGY-US, V4, P857, DOI 10.1111/andr.12227; [Anonymous], [No title captured]; Baker MA, 2011, ASIAN J ANDROL, V13, P6, DOI 10.1038/aja.2010.62; Bhattacharjee R, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.124495; Bottrel M, 2018, ANIM REPROD SCI, V189, P128, DOI 10.1016/j.anireprosci.2017.12.021; Breier M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089728; Brosnan JT, 2003, J NUTR, V133, p2068S, DOI 10.1093/jn/133.6.2068S; Busetto GM, 2018, ANDROLOGIA, V50, DOI 10.1111/and.12927; CALDAMONE AA, 1980, J UROLOGY, V123, P683, DOI 10.1016/S0022-5347(17)56091-7; Courant F, 2013, J PROTEOME RES, V12, P2914, DOI 10.1021/pr400204q; Dudiki T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141961; EDWARDS K. D. G., 1959, AUSTRALASIAN ANN MED, V8, P218; Ellerbrock RE, 2018, THERIOGENOLOGY, V117, P1, DOI 10.1016/j.theriogenology.2018.05.010; Engel KM, 2017, LIPIDS, V52, P857, DOI 10.1007/s11745-017-4283-9; Esteves SC, 2011, CLINICS, V66, P691, DOI 10.1590/S1807-59322011000400026; Fuchs B, 2012, MINI-REV MED CHEM, V12, P74, DOI 10.2174/138955712798868931; Glander HJ, 2002, ANDROLOGIA, V34, P360, DOI 10.1046/j.1439-0272.2002.00508.x; GONZALES GF, 1992, ANDROLOGIA, V24, P95; Grunewald S, 2005, ANDROLOGIA, V37, P69, DOI 10.1111/j.1439-0272.2005.00656.x; Grunewald S, 2013, J DTSCH DERMATOL GES, V11, P799, DOI 10.1111/ddg.12177; Guo D, 2017, ONCOTARGET, V8, P48619, DOI 10.18632/oncotarget.14950; Hallak J, 2001, UROLOGY, V58, P446, DOI 10.1016/S0090-4295(01)01224-9; Henriksen JR, 2010, BIOPHYS J, V98, P2199, DOI 10.1016/j.bpj.2010.01.037; Holt Jr LE, 1944, T ASSOC AM PHYSICIAN, V58, P143; Ijiri Takashi W, 2012, J Signal Transduct, V2012, P181560, DOI 10.1155/2012/181560; Johnson GD, 2011, MOL HUM REPROD, V17, P721, DOI 10.1093/molehr/gar054; Kenez A, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1112-8; KOHENGKUL S, 1977, FERTIL STERIL, V28, P1333; Lessig J, 2004, COMP BIOCHEM PHYS B, V137, P265, DOI 10.1016/j.cbpc.2003.12.001; Longo N, 2016, BBA-MOL CELL RES, V1863, P2422, DOI 10.1016/j.bbamcr.2016.01.023; Lu JC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146304; Mahony MC, 1999, BIOL REPROD, V60, P1239, DOI 10.1095/biolreprod60.5.1239; MANN T, 1974, J REPROD FERTIL, V37, P179, DOI 10.1530/jrf.0.0370179; Nimptsch A, 2014, LIPIDS, V49, P287, DOI 10.1007/s11745-013-3870-7; Paiva C, 2015, ANDROLOGY-US, V3, P496, DOI 10.1111/andr.12027; Partyka A, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/7279341; Pearson BL, 2018, EPIGENOMICS-UK, V10, P689, DOI 10.2217/epi-2018-0015; Pereira R, 2017, ASIAN J ANDROL, V19, P5, DOI 10.4103/1008-682X.167716; Pyttel S, 2014, THERIOGENOLOGY, V82, P396, DOI 10.1016/j.theriogenology.2014.04.017; Pyttel S, 2012, CHEM PHYS LIPIDS, V165, P861, DOI 10.1016/j.chemphyslip.2012.11.001; Qiao SL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181115; RUBINSTEIN S, 1991, BIOCHEM J, V278, P25, DOI 10.1042/bj2780025; Schiller J, 2000, CHEM PHYS LIPIDS, V106, P145, DOI 10.1016/S0009-3084(00)00148-1; Schmidt JA, 2016, EUR J CLIN NUTR, V70, P306, DOI 10.1038/ejcn.2015.144; SHETTLES LB, 1960, FERTIL STERIL, V11, P88; Sidhu RS, 1998, INT J FERTIL WOMEN M, V43, P192; SILVESTRONI L, 1979, ARCH ANDROLOGY, V2, P257, DOI 10.3109/01485017908987322; TANIMURA J, 1967, Bulletin of the Osaka Medical School, V13, P84; Tanrikut C, 2010, FERTIL STERIL, V94, P1021, DOI 10.1016/j.fertnstert.2009.04.039; Tanrikut C, 2007, UROLOGY, V69, DOI 10.1016/j.urology.2006.10.034; Teuber K, 2011, ANIM REPROD SCI, V123, P270, DOI 10.1016/j.anireprosci.2011.01.009; Tut TG, 1997, J CLIN ENDOCR METAB, V82, P3777, DOI 10.1210/jc.82.11.3777; Vanella A, 1978, Acta Eur Fertil, V9, P99; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Wu GY, 2009, AMINO ACIDS, V37, P153, DOI 10.1007/s00726-008-0210-y; Zhang XL, 2015, CLIN CHIM ACTA, V450, P254, DOI 10.1016/j.cca.2015.09.001; Zhao K, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8327506; Zitzmann M, 2003, INT J ANDROL, V26, P76, DOI 10.1046/j.1365-2605.2003.00393.x; Zopfgen A, 2000, HUM REPROD, V15, P840, DOI 10.1093/humrep/15.4.840	61	36	36	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211679	10.1371/journal.pone.0211679	http://dx.doi.org/10.1371/journal.pone.0211679			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785892	Green Published, Green Submitted, gold			2022-12-27	WOS:000459307000035
J	Ghazal, S; Sauthier, M; Brossier, D; Bouachir, W; Jouvet, PA; Noumeir, R				Ghazal, Sam; Sauthier, Michael; Brossier, David; Bouachir, Wassim; Jouvet, Philippe A.; Noumeir, Rita			Using machine learning models to predict oxygen saturation following ventilator support adjustment in critically ill children: A single center pilot study	PLOS ONE			English	Article							END-EXPIRATORY PRESSURE; MECHANICAL VENTILATION; EQUILIBRATION	Background In an intensive care units, experts in mechanical ventilation are not continuously at patient's bedside to adjust ventilation settings and to analyze the impact of these adjustments on gas exchange. The development of clinical decision support systems analyzing patients' data in real time offers an opportunity to fill this gap. Objective The objective of this study was to determine whether a machine learning predictive model could be trained on a set of clinical data and used to predict transcutaneous hemoglobin oxygen saturation 5 min ((5min) SpO(2)) after a ventilator setting change. Data sources Data of mechanically ventilated children admitted between May 2015 and April 2017 were included and extracted from a high-resolution research database. More than 776,727 data rows were obtained from 610 patients, discretized into 3 class labels (< 84%, 85% to 91% and c92% to 100%). Performance metrics of predictive models Due to data imbalance, four different data balancing processes were applied. Then, two machine learning models (artificial neural network and Bootstrap aggregation of complex decision trees) were trained and tested on these four different balanced datasets. The best model predicted SpO(2) with area under the curves < 0.75. Conclusion This single center pilot study using machine learning predictive model resulted in an algorithm with poor accuracy. The comparison of machine learning models showed that bagged complex trees was a promising approach. However, there is a need to improve these models before incorporating them into a clinical decision support systems. One potentially solution for improving predictive model, would be to increase the amount of data available to limit over-fitting that is potentially one of the cause for poor classification performances for 2 of the three class labels.	[Ghazal, Sam; Noumeir, Rita] ETS, Dept Hlth Informat Anal, Montreal, PQ, Canada; [Sauthier, Michael; Brossier, David; Jouvet, Philippe A.] St Justine Hosp, Dept Pediat, Montreal, PQ, Canada; [Bouachir, Wassim] TELUQ Univ, LICEF Res Ctr, Montreal, PQ, Canada	University of Quebec; Ecole de Technologie Superieure - Canada; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; University of Quebec; Universite TELUQ	Jouvet, PA (corresponding author), St Justine Hosp, Dept Pediat, Montreal, PQ, Canada.	philippe.jouvet@umontreal.ca	Jouvet, Philippe A/H-3293-2018	Jouvet, Philippe A/0000-0001-5684-3398; brossier, david/0000-0002-2059-9888	Natural Sciences and Engineering Research Council of Canada (NSERC); Institut de Valorisation des Donnees (IVADO); Fonds de Recherche du Quebec Sante (FRQS); Quebec Ministry of Health; Sainte Justine Hospital	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Institut de Valorisation des Donnees (IVADO); Fonds de Recherche du Quebec Sante (FRQS); Quebec Ministry of Health; Sainte Justine Hospital	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) to RN, by the Institut de Valorisation des Donnees (IVADO) to PAJ, by grants from the "Fonds de Recherche du Quebec Sante (FRQS)", the Quebec Ministry of Health and Sainte Justine Hospital to PAJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Mr. Redha Eltaani for his support in all tasks related to data access at Ste-Justine Hospital. This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC), by the Institut de Valorisation des Donnees (IVADO), by grants from the "Fonds de Recherche du Quebec-Sante (FRQS)", the Quebec Ministry of Health and Sainte Justine Hospital.	[Anonymous], 2000, REANIM URGENCES, V9, P407; Breiman Leo, 1994, BAGGING PREDICTORS, P421; Brossier D, 2018, PEDIATR CRIT CARE ME, V19, pE189, DOI 10.1097/PCC.0000000000001460; Cakar N, 2001, INTENS CARE MED, V27, P655, DOI 10.1007/s001340100900; Chandler JR, 2012, J CLIN MONIT COMPUT, V26, P145, DOI 10.1007/s10877-012-9347-z; Chawla N.V., 2004, ACM SIGKDD EXPLORATI, V6, P1, DOI DOI 10.1145/1007730.1007733; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Elhassan T., 2016, GLOBAL J TECHNOL OPT, V1; Fildissis G, 2010, HEART LUNG, V39, P147, DOI 10.1016/j.hrtlng.2009.06.009; Flechelles O, 2013, CRIT CARE RES PRACT, V2013, DOI 10.1155/2013/943281; Fouzas S, 2011, PEDIATRICS, V128, P740, DOI 10.1542/peds.2011-0271; Girardis M, 2016, JAMA-J AM MED ASSOC, V316, P1583, DOI 10.1001/jama.2016.11993; Johnson AEW, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.35; Johnson AEW, 2016, P IEEE, V104, P444, DOI 10.1109/JPROC.2015.2501978; Jouvet P, 2015, PEDIATR CRIT CARE ME, V16, P428, DOI 10.1097/PCC.0000000000000350; Jouvet P, 2012, CRIT CARE, V16, DOI 10.1186/cc11343; Jouvet P, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-51; Pannu SR, 2016, AM J RESP CRIT CARE, V193, P4, DOI 10.1164/rccm.201509-1810ED; Payen V, 2012, PEDIATR CRIT CARE ME, V13, P152, DOI 10.1097/PCC.0b013e3182257a24; Rose L, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0755-6; SAFAVIAN SR, 1991, IEEE T SYST MAN CYB, V21, P660, DOI 10.1109/21.97458; Salyer John W, 2003, Respir Care, V48, P386; Sheela KG, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/425740; Smallwood CD, 2018, CRIT CARE MED, V46, pE375, DOI 10.1097/CCM.0000000000003001; Sokolova M, 2009, INFORM PROCESS MANAG, V45, P427, DOI 10.1016/j.ipm.2009.03.002; Tugrul S, 2005, CRIT CARE MED, V33, P995, DOI 10.1097/01.CCM.0000163402.29767.7B	26	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0198921	10.1371/journal.pone.0198921	http://dx.doi.org/10.1371/journal.pone.0198921			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785881	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000459307000001
J	Oliveira, MM; Aragon, DC; Bomfim, VS; Trevilato, TMB; Alves, LG; Heck, AR; Martinez, FE; Camelo, JS				Oliveira, Mariana M.; Aragon, Davi C.; Bomfim, Vanessa S.; Trevilato, Tania M. B.; Alves, Larissa G.; Heck, Analia R.; Martinez, Francisco E.; Camelo, Jose S., Jr.			Development of a human milk concentrate with human milk lyophilizate for feeding very low birth weight preterm infants: A preclinical experimental study	PLOS ONE			English	Article							RAW HUMAN-MILK; NECROTIZING ENTEROCOLITIS; BREAST-MILK; TARGET FORTIFICATION; PREMATURE-INFANTS; VLBW INFANTS; NUTRITION; PROTEIN; OUTCOMES; ZINC	Breast milk is considered the gold standard nutritional resource for very low birth weight (VLBW) infants in terms of nutrients and protective factors. If mother's milk is not available, the second choice is donated and fortified human milk (HM) from the Human Milk Bank (HMB). This study hypothesized that HM could be lyophilized and used as an additive to increase the levels of macronutrients and micronutrients available to VLBW infants. This study aimed to constitute a lyophilized HM concentrate and determine the osmolality and the concentration of macronutrients and micronutrients in HM samples at "baseline" and in "HM concentrates", analyzed immediately (HMCI), and after 3 (HMC3m) and 6 (HMC6m) months of freezing. Osmolality was verified using the freezing point osmometric method. Macronutrient quantification was performed using the MIRIS Human Milk Analyzer. Micro nutrients were determined by Flame Atomic Absorption Spectrophotometry and by the automated colorimetric method. Bayesian linear mixed effect models were adjusted using OpenBUGS to estimate mean differences and 95% credibility intervals (Crl) of osmolality and of macro- and micronutrients between the types of HM samples. A comparison of dosage values showed a significant increase between HM baseline and HMCI, HMC3m, and HMC6m. Comparing HM baseline and HMCI highlighted the increase in energy content and the concentration of carbohydrates and total lipids. The Ca and P contents increased and the levels of energy, total lipids, and Cu were reduced in HMC3m compared to HMCI. Ca, Mg, K, Zn, and P increased and the levels of energy, total lipids, and Cu were reduced in HMC6m, compared to HMCI. The present study confirms the possibility of formulation and utilization of the immediate concentrate. Partial stability of HM concentrates generated from freeze-drying of donated milk do not recommend storage.	[Oliveira, Mariana M.; Aragon, Davi C.; Bomfim, Vanessa S.] Univ Sao Paulo, Ribeirao Preto Med Sch, Childrens Hosp, Dept Pediat, Ribeirao Preto, SP, Brazil; [Trevilato, Tania M. B.] Univ Sao Paulo, Ribeirao Preto Med Sch, Clin Hosp Ribeirao Preto, Pediat Lab, Ribeirao Preto, SP, Brazil; [Alves, Larissa G.; Heck, Analia R.] Clin Hosp Ribeirao Preto, Human Milk Bank, Ribeirao Preto, SP, Brazil; [Martinez, Francisco E.; Camelo, Jose S., Jr.] Univ Sao Paulo, Ribeirao Preto Med Sch, Childrens Hosp, Dept Pediat,Neonatol, Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Camelo, JS (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Childrens Hosp, Dept Pediat,Neonatol, Ribeirao Preto, SP, Brazil.	jscamelo@fmrp.usp.br	Aragon, Davi C/R-6604-2016; Camelo, José/AAL-4716-2020; Camelo, Jose S/G-3169-2012; Martinez, Francisco E/H-1194-2014	Aragon, Davi C/0000-0003-1019-3654; Martinez, Francisco E/0000-0002-6269-9182; Moraes de Oliveira, Mariana/0000-0001-7260-7299; Trevilato, Tania Maria Beltramini/0000-0003-1078-1237	Bill and Melinda Gates Foundation (Grand Challenges Brazil) [OPP1107597]; CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil [401612/2013-9]; Ministry of Health / Department of Science and Technology, Brazil	Bill and Melinda Gates Foundation (Grand Challenges Brazil); CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministry of Health / Department of Science and Technology, Brazil	The present study was supported by Bill and Melinda Gates Foundation (Grand Challenges Brazil), Grant #OPP1107597 to JSC Jr., CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil, Grant #401612/2013-9 to JSC Jr., and Ministry of Health / Department of Science and Technology, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiramalatha T, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012413.pub2; Abrams SA, 2014, BREASTFEED MED, V9, P281, DOI 10.1089/bfm.2014.0024; Agostoni C, 2010, J PEDIATR GASTR NUTR, V50, P85, DOI 10.1097/MPG.0b013e3181adaee0; Ahrabi AF, 2016, J PEDIATR-US, V177, P140, DOI 10.1016/j.jpeds.2016.06.024; Andreas NJ, 2015, EARLY HUM DEV, V91, P629, DOI 10.1016/j.earlhumdev.2015.08.013; Assad M, 2016, J PERINATOL, V36, P216, DOI 10.1038/jp.2015.168; Bertino E, 2013, EARLY HUM DEV, V89, pS3, DOI 10.1016/j.earlhumdev.2013.07.008; Bhatia J, 2013, J PEDIATR-US, V162, pS48, DOI 10.1016/j.jpeds.2012.11.053; Grazziotin MCB, 2016, J HUM LACT, V32, P446, DOI 10.1177/0890334416647710; Brown JVE, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000343.pub3; Carroll K, 2013, BREASTFEED MED, V8, P286, DOI 10.1089/bfm.2012.0068; Choi A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148941; Colaizy TT, 2016, J PEDIATR-US, V175, P100, DOI 10.1016/j.jpeds.2016.03.040; Colaizy TT, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-124; Cortez J, 2018, J PERINATOL, V38, P71, DOI 10.1038/jp.2017.149; de Halleux V, 2013, AM J CLIN NUTR, V98, p529S, DOI 10.3945/ajcn.112.042689; Denning TW, 2017, SEMIN PERINATOL, V41, P15, DOI 10.1053/j.semperi.2016.09.014; Dritsakou K, 2016, J MATERN-FETAL NEO M, V29, P1131, DOI 10.3109/14767058.2015.1038232; Dutta S, 2015, NUTRIENTS, V7, P423, DOI 10.3390/nu7010423; Einloft PR, 2015, OSTEOPOROSIS INT, V26, P2265, DOI 10.1007/s00198-015-3144-8; Escuder-Vieco D, 2016, J HUM LACT, V32, pNP73, DOI 10.1177/0890334415591338; Fumeaux CJF, 2018, NEONATOLOGY, V113, P131, DOI 10.1159/000480535; Ganapathy V, 2012, BREASTFEED MED, V7, P29, DOI 10.1089/bfm.2011.0002; Gidrewicz DA, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-216; Grance Thayana Regina de Souza, 2015, Rev. paul. pediatr., V33, P28, DOI 10.1016/j.rpped.2014.07.001; Haiden N, 2016, ANN NUTR METAB, V69, P8, DOI 10.1159/000452821; Hair AB, 2016, BREASTFEED MED, V11, P133, DOI 10.1089/bfm.2015.0166; Hair AB, 2016, BREASTFEED MED, V11, P70, DOI 10.1089/bfm.2015.0134; Hair AB, 2014, J PEDIATR-US, V165, P915, DOI 10.1016/j.jpeds.2014.07.005; Harding JE, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003310.pub2; Harding JE, 2017, LANCET, V389, P1660, DOI 10.1016/S0140-6736(17)30552-4; Hiltunen H, 2018, NEONATOLOGY, V113, P100, DOI 10.1159/000480633; Isemann B, 2016, JPEN-PARENTER ENTER, V40, P342, DOI 10.1177/0148607114558303; Kojima C, 2017, PEDIATR INT, V59, P1165, DOI 10.1111/ped.13409; Koletzko B, 2017, CLIN PERINATOL, V44, P85, DOI 10.1016/j.clp.2016.11.002; Koo W, 2018, JPEN-PARENTER ENTER, V42, P813, DOI 10.1177/0148607117713202; Kornmann MN, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121318; Kreissl A, 2013, J PEDIATR GASTR NUTR, V57, P432, DOI 10.1097/MPG.0b013e3182a208c7; Kumar RK, 2017, FRONT NUTR, V4, DOI 10.3389/fnut.2017.00020; Lava SAG, 2015, PEDIATR NEPHROL, V30, P1389, DOI 10.1007/s00467-014-2931-3; Lewis ED, 2017, CLIN PERINATOL, V44, P23, DOI 10.1016/j.clp.2016.11.008; Lonnerdal B, 2017, CLIN PERINATOL, V44, P179, DOI 10.1016/j.clp.2016.11.013; Lozano B, 2014, INT J FOOD SCI NUTR, V65, P703, DOI 10.3109/09637486.2014.917154; Marquardt ML, 2012, PEDIATRICS, V130, pE695, DOI 10.1542/peds.2011-1295; McNelis K, 2017, CLIN PERINATOL, V44, P395, DOI 10.1016/j.clp.2017.01.012; Mohd-Taufek N, 2016, J PERINATOL, V36, P897, DOI 10.1038/jp.2016.88; Morlacchi L, 2018, AM J CLIN NUTR, V107, P195, DOI 10.1093/ajcn/nqx001; Patra K, 2017, NEONATOLOGY, V112, P330, DOI 10.1159/000475834; Peila C, 2017, J PEDIATR GASTR NUTR, V64, P353, DOI 10.1097/MPG.0000000000001435; Peila C, 2016, NUTRIENTS, V8, DOI 10.3390/nu8080477; Perrella SL, 2015, J PEDIATR GASTR NUTR, V60, P264, DOI 10.1097/MPG.0000000000000596; Picaud JC, 2017, CLIN PERINATOL, V44, P95, DOI 10.1016/j.clp.2016.11.003; Raiten DJ, 2016, AM J CLIN NUTR, V103, p599S, DOI 10.3945/ajcn.115.124222; Rigo J, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101125; Rochow N, 2015, NUTRIENTS, V7, P2297, DOI 10.3390/nu7042297; Rochow N, 2013, J PEDIATR-US, V163, P1001, DOI 10.1016/j.jpeds.2013.04.052; Rosas R, 2016, ACTA PAEDIATR, V105, pE555, DOI 10.1111/apa.13522; Sammallahti S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185632; Schneider J, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2169; Senterre T, 2015, J PEDIATR GASTR NUTR, V61, P491, DOI 10.1097/MPG.0000000000000854; Shulhan J, 2017, ADV NUTR, V8, P80, DOI 10.3945/an.116.013193; Sousa SG, 2014, FOOD CHEM, V151, P79, DOI 10.1016/j.foodchem.2013.11.024; Spiegler J, 2016, J PEDIATR-US, V169, P76, DOI 10.1016/j.jpeds.2015.10.080; Stephens BE, 2009, PEDIATRICS, V123, P1337, DOI 10.1542/peds.2008-0211; Sullivan S, 2010, J PEDIATR-US, V156, P562, DOI 10.1016/j.jpeds.2009.10.040; Terrin G, 2015, NUTRIENTS, V7, P10427, DOI 10.3390/nu7125542; Terrin G, 2013, AM J CLIN NUTR, V98, P1468, DOI 10.3945/ajcn.112.054478; Thomaz DMC, 2012, J PEDIAT-BRAZIL, V88, P119, DOI 10.2223/JPED.2166; Tudehope D, 2013, J PEDIATR-US, V162, pS72, DOI 10.1016/j.jpeds.2012.11.056; Cortez MV, 2016, BREASTFEED MED, V11, P551, DOI 10.1089/bfm.2016.0102; Valentine CJ, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030302; Walker A, 2010, J PEDIATR-US, V156, pS3, DOI 10.1016/j.jpeds.2009.11.021; Watson L, 2018, J PAEDIATR CHILD H, V54, P319, DOI 10.1111/jpc.13780; Westin V, 2018, CLIN NUTR ESPEN, V23, P245, DOI 10.1016/j.clnesp.2017.09.004	74	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0210999	10.1371/journal.pone.0210999	http://dx.doi.org/10.1371/journal.pone.0210999			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785913	Green Submitted, gold, Green Published			2022-12-27	WOS:000459307000017
J	van Leeuwen, N; Walgaard, C; van Doorn, PA; Jacobs, BC; Steyerberg, EW; Lingsma, HF				van Leeuwen, Nikki; Walgaard, Christa; van Doorn, Pieter A.; Jacobs, Bart C.; Steyerberg, Ewout W.; Lingsma, Hester F.			Efficient design and analysis of randomized controlled trials in rare neurological diseases: An example in Guillain-Barre syndrome	PLOS ONE			English	Article							COVARIATE ADJUSTMENT; BASE-LINE; LOGISTIC-REGRESSION; STATISTICAL POWER; SUBGROUP ANALYSIS; CLINICAL-TRIALS; OUTCOMES	Background Randomized controlled trials (RCTs) pose specific challenges in rare and heterogeneous neurological diseases due to the small numbers of patients and heterogeneity in disease course. Two analytical approaches have been proposed to optimally handle these issues in RCTs: covariate adjustment and ordinal analysis. We investigated the potential gain in efficiency of these approaches in rare and heterogeneous neurological diseases, using Guillain-Barre syndrome (GBS) as an example. Methods We analyzed two published GBS trials with primary outcome 'at least one grade improvement' on the GBS disability scale. We estimated the treatment effect using logistic regression models with and without adjustment for prognostic factors. The difference between the unadjusted and adjusted estimates was disentangled in imbalance (random differences in baseline covariates between treatment arms) and stratification (change of the estimate due to covariate adjustment). Second, we applied proportional odds regression, which exploits the ordinal nature of the GBS disability score. The standard error of the estimated treatment effect indicated the statistical efficiency. Results Both trials were slightly imbalanced with respect to baseline characteristics, which was corrected in the adjusted analysis. Covariate adjustment increased the estimated treatment effect in the two trials by 8% and 18% respectively. Proportional odds analysis resulted in lower standard errors indicating more statistical power. Conclusion Covariate adjustment and proportional odds analysis most efficiently use the available data and ensure balance between the treatment arms to obtain reliable and valid treatment effect estimates. These approaches merit application in future trials in rare and heterogeneous neurological diseases like GBS.	[van Leeuwen, Nikki; Steyerberg, Ewout W.; Lingsma, Hester F.] Erasmus MC, Dept Publ Hlth, Ctr Med Decis Making, Rotterdam, Netherlands; [Walgaard, Christa; van Doorn, Pieter A.; Jacobs, Bart C.] Erasmus MC, Dept Neurol, Rotterdam, Netherlands; [Jacobs, Bart C.] Erasmus MC, Dept Immunol, Rotterdam, Netherlands; [Steyerberg, Ewout W.] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Leiden, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van Leeuwen, N (corresponding author), Erasmus MC, Dept Publ Hlth, Ctr Med Decis Making, Rotterdam, Netherlands.	n.vanleeuwen.1@erasmusmc.nl	Jacobs, Bart/ABE-2210-2021		Netherlands Organization for Health Research and Development; Prinses Beatrix Spierfonds; GBS-CIDP Foundation International; Grifols; Erasmus MC; Baxalta; CSLBehring; Annexon; Janivo Stichting; Sanquin Plasma Pharmaceuticals	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Prinses Beatrix Spierfonds; GBS-CIDP Foundation International; Grifols; Erasmus MC; Baxalta; CSLBehring; Annexon; Janivo Stichting; Sanquin Plasma Pharmaceuticals	BJ received unrestricted research support from the Netherlands Organization for Health Research and Development, Erasmus MC, Prinses Beatrix Spierfonds, GBS-CIDP Foundation International, Baxalta, CSLBehring, Grifols, and Annexon. PvD received unrestricted research support from the Prinses Beatrix Spierfonds, Janivo Stichting, Baxalta, Grifols, and Sanquin Plasma Pharmaceuticals. No other disclosures were reported.	Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; Bath P, 2009, STROKE, V40, P888, DOI 10.1161/STROKEAHA.108.519207; Bath PMW, 2007, STROKE, V38, P1911, DOI 10.1161/STROKEAHA.106.474080; BLAND JM, 1994, BRIT MED J, V309, P780, DOI 10.1136/bmj.309.6957.780; BLAND JM, 1994, BRIT MED J, V308, P1499, DOI 10.1136/bmj.308.6942.1499; Garssen MPJ, 2007, J NEUROL NEUROSUR PS, V78, P1012, DOI 10.1136/jnnp.2006.102731; HAUCK WW, 1991, J CLIN EPIDEMIOL, V44, P77, DOI 10.1016/0895-4356(91)90203-L; Hernandez AV, 2006, J NEUROTRAUM, V23, P1295, DOI 10.1089/neu.2006.23.1295; Hernandez AV, 2004, J CLIN EPIDEMIOL, V57, P454, DOI 10.1016/j.jclinepi.2003.09.014; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; Hughes RAC, 1997, J INFECT DIS, V176, pS92, DOI 10.1086/513793; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; McHugh GS, 2010, CLIN TRIALS, V7, P44, DOI 10.1177/1740774509356580; Pocock SJ, 2002, STAT MED, V21, P2917, DOI 10.1002/sim.1296; ROBINSON LD, 1991, INT STAT REV, V59, P227, DOI 10.2307/1403444; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; Roozenbeek B, 2009, CRIT CARE MED, V37, P2683, DOI 10.1097/CCM.0b013e3181ab85ec; Saver JL, 2007, STROKE, V38, P3055, DOI 10.1161/STROKEAHA.107.488536; SENN S, 1993, STAT MED, V12, P2147, DOI 10.1002/sim.4780122208; Steyerberg EW, 2000, AM HEART J, V139, P745, DOI 10.1016/S0002-8703(00)90001-2; Thompson DD, 2015, J CLIN EPIDEMIOL, V68, P1068, DOI 10.1016/j.jclinepi.2014.11.001; Turner EL, 2012, J CLIN EPIDEMIOL, V65, P474, DOI 10.1016/j.jclinepi.2011.08.012; Valenta Z, 2006, STAT MED, V25, P4227, DOI 10.1002/sim.2678; van Koningsveld R, 2004, LANCET, V363, P192, DOI 10.1016/S0140-6736(03)15324-X; van Koningsveld R, 2007, LANCET NEUROL, V6, P589, DOI 10.1016/S1474-4422(07)70130-8; VANDERMECHE FGA, 1992, NEW ENGL J MED, V326, P1123, DOI 10.1056/NEJM199204233261705; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; Walgaard C, 2011, NEUROLOGY, V76, P968, DOI 10.1212/WNL.0b013e3182104407	28	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211404	10.1371/journal.pone.0211404	http://dx.doi.org/10.1371/journal.pone.0211404			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785890	Green Published, Green Submitted, gold			2022-12-27	WOS:000459307000024
J	Vitali, M; Sirri, R; Zappaterra, M; Zambonelli, P; Giannini, G; Lo Fiego, DP; Davoli, R				Vitali, Marika; Sirri, Rubina; Zappaterra, Martina; Zambonelli, Paolo; Giannini, Giulia; Lo Fiego, Domenico Pietro; Davoli, Roberta			Functional analysis finds differences on the muscle transcriptome of pigs fed an n-3 PUFA-enriched diet with or without antioxidant supplementations	PLOS ONE			English	Article							LONGISSIMUS-DORSI MUSCLE; RICH PLANT-PRODUCTS; GRAPE SEED EXTRACT; MEAT QUALITY; GENE-EXPRESSION; VITAMIN-E; GROWTH-PERFORMANCE; FATTY-ACIDS; OXIDATIVE STABILITY; RESVERATROL	Supplementing pig diets with n-3 polyunsaturated fatty acids (n-3 PUFA) may produce meat products with an increased n-3 fatty acid content, and the combined antioxidants addition could prevent lipid oxidation in the feed. However, to date, the effects of these bioactive compounds at the molecular level in porcine skeletal muscle are mostly unknown. This study aimed to analyse changes in the Longissimus thoracis transcriptome of 35 pigs fed three diets supplemented with: linseed (L); linseed, vitamin E and Selenium (LES) or linseed and plant-derived polyphenols (LPE). Pigs were reared from 80.8 +/- 5.6 kg to 151.8 +/- 9.9 kg. After slaughter, RNA-Seq was performed and 1182 differentially expressed genes (DEGs) were submitted to functional analysis. The L vs LES comparison did not show differences, while L vs LPE showed 1102 DEGs and LES vs LPE 80 DEGs. LPE compared to the other groups showed the highest number of up-regulated genes involved in preserving muscle metabolism and structure. Results enlighten that the combined supplementation of bioactive lipids (n-3 PUFA from linseed) with plant extracts as a source of polyphenols increases, compared to the only addition of linseed, the expression of genes involved in mRNA metabolic processes and transcriptional regulation, glucose uptake and, finally, in supporting muscle development and physiology. These results improve the knowledge of the biological effect of bioactive compounds in Longissimus thoracis muscle, and sustain the growing interest over their use in pig production.	[Vitali, Marika; Sirri, Rubina; Zambonelli, Paolo; Davoli, Roberta] Univ Bologna, Interdept Ctr Ind Agrifood Res CIRI AGRO, Cesena, Italy; [Zappaterra, Martina; Zambonelli, Paolo; Giannini, Giulia; Davoli, Roberta] Univ Bologna, Dept Agr & Food Sci DISTAL, Bologna, Italy; [Lo Fiego, Domenico Pietro] Univ Modena & Reggio Emilia, Dept Life Sci, Reggio Emilia, Italy; [Lo Fiego, Domenico Pietro] Univ Modena & Reggio Emilia, Interdept Res Ctr Agri Food Biol Resources Improv, Reggio Emilia, Italy	University of Bologna; University of Bologna; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia	Davoli, R (corresponding author), Univ Bologna, Interdept Ctr Ind Agrifood Res CIRI AGRO, Cesena, Italy.; Davoli, R (corresponding author), Univ Bologna, Dept Agr & Food Sci DISTAL, Bologna, Italy.	roberta.davoli@unibo.it	Vitali, Marika/P-5927-2019; Sirri, Rubina/O-3903-2019; Zambonelli, Paolo/N-3084-2014; Lo Fiego, Domenico Pietro/H-4811-2013	Vitali, Marika/0000-0002-8373-0898; Zambonelli, Paolo/0000-0002-2532-5528; Lo Fiego, Domenico Pietro/0000-0002-9154-9888; Sirri, Rubina/0000-0002-8603-8418; Zappaterra, Martina/0000-0001-5085-4811; DAVOLI, ROBERTA/0000-0003-4600-8326	Regione Emilia-Romagna POR-FESR [PG/2015/730542]	Regione Emilia-Romagna POR-FESR(Regione Emilia Romagna)	This research was funded by Regione Emilia-Romagna POR-FESR 2014-2020 (URL: https://fesr.regione.emilia-romagna.it/) "Innovare la filiera suina mediante la valorizzazione di sottoprodotti vegetali e l'impiego di avanzate tecnologie "omiche" e di processo, per la produzione sostenibile di carne e salumi ad impatto positivo sulla salute"- Green Charcuterie grant n. PG/2015/730542. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funding was received by RD.	Ahmetov II, 2015, ADV CLIN CHEM, V70, P247, DOI 10.1016/bs.acc.2015.03.003; Andersen HJ, 2005, MEAT SCI, V70, P543, DOI 10.1016/j.meatsci.2004.07.015; [Anonymous], R LANG ENV STAT COMP; Arndt V, 2010, CURR BIOL, V20, P143, DOI 10.1016/j.cub.2009.11.022; Azorin-Ortuno M, 2012, J NUTR BIOCHEM, V23, P829, DOI 10.1016/j.jnutbio.2011.04.007; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; BUCKLEY DJ, 1995, J ANIM SCI, V73, P3122; Calder PC, 2018, P NUTR SOC, V77, P52, DOI [10.1017/S0029665117003950, 10.1017/s0029665117003950]; Calviello G, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/743171; Chen N, 2009, NUTR RES, V29, P784, DOI 10.1016/j.nutres.2009.10.003; Cimmino R, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1513-1; Collins JF, 2004, PFLUG ARCH EUR J PHY, V447, P647, DOI 10.1007/s00424-003-1088-x; Corino C, 2008, J ANIM SCI, V86, P1850, DOI 10.2527/jas.2007-0155; Daleprane JB, 2012, J NUTR, V142, P441, DOI 10.3945/jn.111.150706; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; De Groote D, 2012, ANN NUTR METAB, V61, P15, DOI 10.1159/000338634; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dugdale HF, 2018, MOL CELL BIOCHEM, V444, P109, DOI 10.1007/s11010-017-3236-1; Duriez C, 2002, GENE, V282, P207, DOI 10.1016/S0378-1119(01)00825-3; El Akoum S., 2014, ENDOCRINOL METAB SYN, V3, P2161, DOI [10.4172/2161-1017.1000126, DOI 10.4172/2161-1017.1000126]; Fiesel A, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0196-5; Fletcher LM, 2000, BIOCHEM J, V352, P267, DOI 10.1042/0264-6021:3520267; Gessner DK, 2017, J ANIM PHYSIOL AN N, V101, pe185, DOI 10.1111/jpn.12586; Guo B, 2017, WOODHEAD PUBL FOOD S, P259, DOI 10.1016/B978-0-08-100593-4.00012-6; Gutierrez-Salmean G, 2014, J NUTR BIOCHEM, V25, P91, DOI 10.1016/j.jnutbio.2013.09.007; Han XZ, 2007, INT J MOL SCI, V8, P950, DOI 10.3390/i8090950; Hanhineva K, 2010, INT J MOL SCI, V11, P1365, DOI 10.3390/ijms11041365; Huang L, 2007, GENESIS, V45, P487, DOI 10.1002/dvg.20319; Huguet A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003043; Hussain T, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/7432797; Jakobek L, 2015, FOOD CHEM, V175, P556, DOI 10.1016/j.foodchem.2014.12.013; Jeromson S, 2015, MAR DRUGS, V13, P6977, DOI 10.3390/md13116977; JIANG H, 2010, DIETARY POLYPHENOLS, P325, DOI DOI 10.1007/978-1-4419-0410-2_16; Juang H-H, 2013, EUR UROL SUPPL, V12, pe148; Kaminski J, 2012, J FOOD DRUG ANAL, V20, P398; Kashani Arash, 2015, Journal of Animal Science and Technology, V57, P8, DOI 10.1186/s40781-015-0047-3; Kawabata S, 2015, FEBS LETT, V589, P3679, DOI 10.1016/j.febslet.2015.10.013; Kawecka M, 2013, ACTA AGR SCAND A-AN, V63, P194, DOI 10.1080/09064702.2014.922607; Kim Y., 2016, NUTRIENTS, P8; Lahucky R, 2005, CZECH J ANIM SCI, V50, P175, DOI 10.17221/4012-CJAS; Lamy S, 2012, EXP CELL RES, V318, P1586, DOI 10.1016/j.yexcr.2012.04.004; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lipinski K, 2017, ANN ANIM SCI, V17, P41, DOI 10.1515/aoas-2016-0042; Liu F, 2016, EXP PHYSIOL, V101, P801, DOI 10.1113/EP085746; Lo Fiego DP, 2010, ITAL J ANIM SCI, V9, P200, DOI 10.4081/ijas.2010.e39; Lu JM, 2009, CARCINOGENESIS, V30, P636, DOI 10.1093/carcin/bgp009; Ma XY, 2016, CRIT REV FOOD SCI, V56, P858, DOI 10.1080/10408398.2013.850059; Mapiye C, 2014, J ANIM SCI BIOTECHNO, V5, DOI 10.1186/2049-1891-5-54; Markus MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028926; Marouli E, 2016, NUTR METAB CARDIOVAS, V26, P201, DOI 10.1016/j.numecd.2015.10.003; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mika D, 2014, J CELL SCI, V127, P1033, DOI 10.1242/jcs.140251; Mo XY, 2011, MOL BIOL REP, V38, P4389, DOI 10.1007/s11033-010-0566-4; Montojo J, 2010, BIOINFORMATICS, V26, P2927, DOI 10.1093/bioinformatics/btq562; Morel PCH, 2013, MEAT SCI, V95, P151, DOI 10.1016/j.meatsci.2013.04.047; Niculita Petru, 2007, Polish Journal of Food and Nutrition Sciences, V57, P125; Oczkowicz M, 2016, ANN ANIM SCI, V16, P1073, DOI 10.1515/aoas-2016-0033; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Park JC, 2012, ASIAN AUSTRAL J ANIM, V25, P1759, DOI 10.5713/ajas.2012.12416; Peoples GE, 2014, BRIT J NUTR, V111, P996, DOI 10.1017/S0007114513003449; Pfaffl M.W., 2004, A Z QUANT PCR, P87; Pieszka M, 2017, MEAT SCI, V126, P1, DOI 10.1016/j.meatsci.2016.11.016; Qiu HF, 2010, MOL BIOL REP, V37, P629, DOI 10.1007/s11033-009-9882-y; Ramayo-Caldas Y, 2018, SCI REP, V8, P1, DOI [10.1038/241598-017-17765-5, DOI 10.1038/S41598-017-17765-5]; Ravi S, 2015, J NUTR, V145, P841, DOI 10.3945/jn.114.203216; Robichon C, 2006, BBA-MOL CELL BIOL L, V1761, P1107, DOI 10.1016/j.bbalip.2006.07.007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rossi R, 2014, FOOD RES INT, V65, P88, DOI 10.1016/j.foodres.2014.03.062; Sang NL, 2003, J BIOL CHEM, V278, P14013, DOI 10.1074/jbc.M209702200; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Sayem AM, 2018, MOLECULES, V23, DOI 10.3390/molecules23020258; Smith GI, 2015, AM J CLIN NUTR, V102, P115, DOI 10.3945/ajcn.114.105833; Stankus T, 2009, J AGRIC FOOD INF, V10, P37, DOI 10.1080/10496500802690544; Supruniuk E, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00923; Surai P.F., 2016, J ANIM RES NUTR, V1, P8, DOI [10.21767/2572-5459.100008, DOI 10.21767/2572-5459.100008]; Szostak A, 2016, GENES NUTR, V11, DOI 10.1186/s12263-016-0517-4; Taipale M, 2014, CELL, V158, P434, DOI 10.1016/j.cell.2014.05.039; Tarazona S, 2015, NUCLEIC ACIDS RES, V43, P1; Treins C, 2002, J BIOL CHEM, V277, P27975, DOI 10.1074/jbc.M204152200; Turnham RE, 2016, GENE, V577, P101, DOI 10.1016/j.gene.2015.11.052; Vlavcheski F, 2017, MOLECULES, V22, DOI 10.3390/molecules22101669; Walsh TG, 2015, PLATELETS, V26, P199, DOI 10.3109/09537104.2014.909022; Wang Y, 2012, FOOD RES INT, V46, P460, DOI 10.1016/j.foodres.2011.08.019; Wood JD, 2004, MEAT SCI, V66, P21, DOI 10.1016/S0309-1740(03)00022-6; Zappaterra M, 2016, MEAT SCI, V121, P27, DOI 10.1016/j.meatsci.2016.05.007; Zhang C, 2015, MEAT SCI, V102, P15, DOI 10.1016/j.meatsci.2014.11.014; 2003, DIET NUTR PREV REP J, V916, P1	88	5	6	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212449	10.1371/journal.pone.0212449	http://dx.doi.org/10.1371/journal.pone.0212449			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785965	Green Published, gold, Green Submitted			2022-12-27	WOS:000459307000062
J	Gasmi, S; Ogden, NH; Ripoche, M; Leighton, PA; Lindsay, RL; Nelder, MP; Rees, E; Bouchard, C; Vrbova, L; Rusk, R; Russell, C; Pelcat, Y; Mechai, S; Kotchi, SO; Koffi, JK				Gasmi, Salima; Ogden, Nicholas H.; Ripoche, Marion; Leighton, Patrick A.; Lindsay, Robbin L.; Nelder, Mark P.; Rees, Erin; Bouchard, Catherine; Vrbova, Linda; Rusk, Richard; Russell, Curtis; Pelcat, Yann; Mechai, Samir; Kotchi, Serge-Olivier; Koffi, Jules K.			Detection of municipalities at-risk of Lyme disease using passive surveillance of Ixodes scapularis as an early signal: A province-specific indicator in Canada	PLOS ONE			English	Article							BORRELIA-BURGDORFERI; GEOGRAPHIC-DISTRIBUTION; TICKS; AGENT; SOUTHEASTERN; ABUNDANCE; DENSITY; HABITAT; NYMPHS; ACARI	Lyme disease, the most commonly reported vector-borne disease in North America, is caused by the spirochete Borrelia burgdorferi sensu stricto, which is transmitted by Ixodes scapularis in eastern Canada and Ixodes pacificus in western Canada. Recently, the northward range expansion of I. scapularis ticks, in south-eastern Canada, has resulted in a dramatic increase in the incidence of human Lyme disease. Detecting emerging areas of Lyme disease risk allows public health to target disease prevention efforts. We analysed passive tick surveillance data from Ontario and Manitoba to i) assess the relationship between the total numbers of I. scapularis submissions in passive surveillance from humans, and the number of human Lyme disease cases, and ii) develop province-specific acarological indicators of risk that can be used to generate surveillance-based risk maps. We also assessed associations between numbers of nymphal I. scapularis tick submissions only and Lyme disease case incidence. Using General Estimating Equation regression, the relationship between I. scapularis submissions (total numbers and numbers of nymphs only) in each census sub-division (CSD) and the number of reported Lyme disease cases was positively correlated and highly significant in the two provinces (P <= 0.001). The numbers of I. scapularis submissions over five years discriminated CSDs with >= 3 Lyme disease cases from those with < 3 cases with high accuracy when using total numbers of tick submission (Receiver Operating Characteristics area under the curve [AUC] = 0.89) and moderate accuracy (AUC = 0.78) when using nymphal tick submissions only. In Ontario the optimal cut-off point was a total 12 tick submissions from a CSD over five years (Sensitivity = 0.82, Specificity = 0.84), while in Manitoba the cut-off point was five ticks (Sensitivity = 0.71, Specificity = 0.79) suggesting regional variability of the risk of acquiring Lyme disease from an I. scapularis bite. The performances of the acarological indicators developed in this study for Ontario and Manitoba support the ability of passive tick surveillance to provide an early signal of the existence Lyme disease risk areas in regions where ticks and the pathogens they transmit are expanding their range.	[Gasmi, Salima; Koffi, Jules K.] Publ Hlth Agcy Canada, Ctr Food Borne Environm & Zoonot Infect Dis, Policy Integrat & Zoonoses Div, St Hyacinthe, PQ, Canada; [Gasmi, Salima; Ogden, Nicholas H.; Ripoche, Marion; Leighton, Patrick A.; Rees, Erin; Bouchard, Catherine; Pelcat, Yann; Mechai, Samir; Kotchi, Serge-Olivier; Koffi, Jules K.] Univ Montreal, Fac Vet Med, Grp Rech Epidemiol Zoonoses & Sante Publ, St Hyacinthe, PQ, Canada; [Ogden, Nicholas H.; Bouchard, Catherine; Pelcat, Yann; Mechai, Samir; Kotchi, Serge-Olivier] Publ Hlth Agcy Canada, Natl Microbiol Lab, Publ Hlth Risk Sci Div, St Hyacinthe, PQ, Canada; [Ripoche, Marion; Leighton, Patrick A.; Rees, Erin] Univ Montreal, Fac Vet Med, Dept Pathol & Microbiol, St Hyacinthe, PQ, Canada; [Lindsay, Robbin L.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Zoonot Dis & Special Pathogens Div, Winnipeg, MB, Canada; [Nelder, Mark P.; Russell, Curtis] Publ Hlth Ontario, Communicable Dis Emergency Preparedness & Respons, Enter Zoonot & Vector Borne Dis, Toronto, ON, Canada; [Vrbova, Linda] Publ Hlth Agcy Canada, Ctr Food Borne Environm & Zoonot Infect Dis, Toronto, ON, Canada; [Rusk, Richard] Manitoba Hlth Seniors & Act Living, Act Living Indigenous Relat Populat & Publ Hlth D, Communicable Dis Control Branch, Winnipeg, MB, Canada	Public Health Agency of Canada; Universite de Montreal; Public Health Agency of Canada; Universite de Montreal; Public Health Agency of Canada; Public Health Agency of Canada	Gasmi, S (corresponding author), Publ Hlth Agcy Canada, Ctr Food Borne Environm & Zoonot Infect Dis, Policy Integrat & Zoonoses Div, St Hyacinthe, PQ, Canada.; Gasmi, S (corresponding author), Univ Montreal, Fac Vet Med, Grp Rech Epidemiol Zoonoses & Sante Publ, St Hyacinthe, PQ, Canada.	salima.gasmi@canada.ca	Kotchi, Serge Olivier/R-2237-2019	Kotchi, Serge Olivier/0000-0002-4931-1489; Mechai, Sam/0000-0001-9979-5525	Public Health Agency of Canada	Public Health Agency of Canada	This study was funded by Public Health Agency of Canada.	Adam-Poupart A, 2016, SURVEILLANCE MALADIE; Aenishaenslin C, 2017, TICKS TICK-BORNE DIS, V8, P112, DOI 10.1016/j.ttbdis.2016.10.006; [Anonymous], 2009, CAS DEF COMM DIS NAT; [Anonymous], 2018, EST RISK AR; [Anonymous], 2018, RISK LYM DIS CAN; Bouchard C, 2011, TICKS TICK-BORNE DIS, V2, P183, DOI 10.1016/j.ttbdis.2011.03.005; Bouchard C, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-195; Brownstein JS, 2005, OECOLOGIA, V146, P469, DOI 10.1007/s00442-005-0251-9; Caraguel CGB, 2011, J VET DIAGN INVEST, V23, P2, DOI 10.1177/104063871102300102; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P590; Clow KM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189393; Cull B, 2018, TICKS TICK-BORNE DIS, V9, P605, DOI 10.1016/j.ttbdis.2018.01.011; Dibernardo A, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-183; Diuk-Wasser MA, 2006, J MED ENTOMOL, V43, P166, DOI 10.1603/0022-2585(2006)043[0166:SPOHIS]2.0.CO;2; Diuk-Wasser MA, 2012, AM J TROP MED HYG, V86, P320, DOI 10.4269/ajtmh.2012.11-0395; Diuk-Wasser MA, 2010, GLOBAL ECOL BIOGEOGR, V19, P504, DOI 10.1111/j.1466-8238.2010.00526.x; Dohoo I., 2009, VET EPIDEMIOLOGIC RE; Ebi KL, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aac4bd; Eisen L, 2016, J MED ENTOMOL, V53, P1050, DOI 10.1093/jme/tjw092; Falco RC, 1996, AM J EPIDEMIOL, V143, P187, DOI 10.1093/oxfordjournals.aje.a008728; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Gabriele-Rivet V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131282; GARDNER W, 1995, PSYCHOL BULL, V118, P392, DOI 10.1037/0033-2909.118.3.392; Gasmi S, 2017, Can Commun Dis Rep, V43, P194, DOI 10.14745/ccdr.v43i10a01; Gasmi S, 2016, TICKS TICK-BORNE DIS, V7, P1075, DOI 10.1016/j.ttbdis.2016.09.006; Hanincova K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073066; Hardin J.W., 2005, ENCY STAT BEHAV SCI, DOI 10.1002/0470013192.bsa250; Institut national de sante publique du Quebec, 2018, RAPPORT SURVEILLANCE; Johnson JL, 2004, VECTOR-BORNE ZOONOT, V4, P137, DOI 10.1089/1530366041210710; Koffi JK, 2012, J MED ENTOMOL, V49, P400, DOI 10.1603/ME11210; Leighton PA, 2012, J APPL ECOL, V49, P457, DOI 10.1111/j.1365-2664.2012.02112.x; Lindsay LR, 1999, J MED ENTOMOL, V36, P243, DOI 10.1093/jmedent/36.3.243; Mather TN, 1996, AM J EPIDEMIOL, V144, P1066, DOI 10.1093/oxfordjournals.aje.a008879; Mechai S, 2015, APPL ENVIRON MICROB, V81, P1309, DOI 10.1128/AEM.03730-14; Naleway AL, 2002, AM J EPIDEMIOL, V155, P1120, DOI 10.1093/aje/155.12.1120; Nelder MP, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1529-y; Nelder MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105358; Ogden NH, 2006, J MED ENTOMOL, V43, P600, DOI 10.1603/0022-2585(2006)43[600:ISTCBP]2.0.CO;2; Ogden N H, 2014, Can Commun Dis Rep, V40, P74; Ogden NH, 2006, J MED ENTOMOL, V43, P403, DOI 10.1603/0022-2585(2006)043[0403:IOGLAR]2.0.CO;2; Ogden NH, 2018, J MED ENTOMOL, V55, P1386, DOI 10.1093/jme/tjy104; Ogden NH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171731; Ogden NH, 2013, J APPL ECOL, V50, P510, DOI [10.1111/1365-2664.12050, 10.1111/]; Ogden NH, 2010, ENVIRON HEALTH PERSP, V118, P909, DOI 10.1289/ehp.0901766; Ontario Agency for Health Protection and Promotion (Public Health Ontario), 2017, VECT BORN DIS 2016 S; Ontario Agency for Health Protection and Promotion (Public Health Ontario), 2015, VECT BORN DIS 2014 S; Pepin KM, 2012, AM J TROP MED HYG, V86, P1062, DOI 10.4269/ajtmh.2012.11-0630; Rand PW, 2007, J MED ENTOMOL, V44, P1118, DOI 10.1603/0022-2585(2007)44[1118:PSIMAA]2.0.CO;2; Reichenheim ME, 2002, STATA J, V2, P351, DOI 10.1177/1536867X0200200402; Ripoche M, 2018, J MED ENTOMOL, V55, P1016, DOI 10.1093/jme/tjy030; Simon JA, 2014, EVOL APPL, V7, P750, DOI 10.1111/eva.12165; Stafford KC, 1998, J CLIN MICROBIOL, V36, P1240, DOI 10.1128/JCM.36.5.1240-1244.1998; STEVENS JP, 1984, PSYCHOL BULL, V95, P334, DOI 10.1037/0033-2909.95.2.334; Tack W, 2011, EXP APPL ACAROL, V54, P285, DOI 10.1007/s10493-011-9444-6; Walker ED, 1998, J MED ENTOMOL, V35, P872, DOI 10.1093/jmedent/35.5.872; Walter KS, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0834; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667; Xu G, 2016, VECTOR-BORNE ZOONOT, V16, P520, DOI 10.1089/vbz.2015.1912	59	17	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212637	10.1371/journal.pone.0212637	http://dx.doi.org/10.1371/journal.pone.0212637			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779789	gold, Green Published, Green Submitted			2022-12-27	WOS:000459062900068
J	Ohwada, T; Sakamoto, T; Kanno, Y; Yokokawa, S; Amami, K; Nakazato, K; Takeishi, Y; Watanabe, K				Ohwada, Takayuki; Sakamoto, Takayuki; Kanno, Yuki; Yokokawa, Sayoko; Amami, Kazuaki; Nakazato, Kazuhiko; Takeishi, Yasuchika; Watanabe, Kenichi			Apolipoprotein B correlates with intra-plaque necrotic core volume in stable coronary artery disease	PLOS ONE			English	Article							C-REACTIVE PROTEIN; MYOCARDIAL-INFARCTION; VIRTUAL HISTOLOGY; INTRAVASCULAR ULTRASOUND; ANGINA-PECTORIS; 52 COUNTRIES; A-I; LIPOPROTEINS; CHOLESTEROL; INTERHEART	Objective To determine the relationship between plaque composition and low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), apolipoprotein B (Apo-B), and Apo-A1 using virtual-histology intravascular ultrasound (VH-IVUS). Methods We assessed plaque composition in patients with stable coronary artery disease (SCD) admitted to our hospital for percutaneous coronary intervention (PCI) between November 1, 2012, and March 10, 2015. Before PCI, fibrous (FI), fibrofatty (FF), necrotic core (NC), and dense calcium (DC) regions were evaluated using VH-IVUS, and the contributions of each to the culprit lesion volume were recorded. Plasma LDL-C, HDL-C, Apo-B, and Apo-A1 levels were assessed before PCI. The relationship between the regions on VH-IVUS and plasma lipid levels was assessed. Patients were categorized into low Apo-B (LAB) and high Apo-B (HAB) groups, based on the overall cohort median Apo-B level. Results We enrolled 115 patients (median Apo-B, 91 mg/dL, male n = 88) with 57 and 58 patients in the LAB (Apo-B <= 90 mg/dL) and HAB (Apo-B >= 91 mg/dL) groups, respectively. Vessel, plaque, and %NC volumes were significantly greater in the HAB group than in the LAB group. The %FI, %FF, and %DC volumes were similar in both groups. In all 115 patients, the %NC volume correlated with LDL-C (r = 0.2353, P = 0.0114) and Apo-B (r = 0.2487, P = 0.0074) but not with HDL-C and Apo A-1. The high-sensitivity C-reactive protein level tended to be higher in the HAB group than in the LAB group. Multiple regression analysis showed that being male, Apo-A1, and Apo-B were significant predictors of %NC volume extent. Conclusions Elevated Apo-B level was related to the %NC in target coronary artery lesions in SCD patients, suggesting a role of Apo-B as a biomarker of unstable plaque in this population.	[Ohwada, Takayuki; Sakamoto, Takayuki; Watanabe, Kenichi] Fukushima Red Cross Hosp, Dept Cardiol, Fukushima, Japan; [Kanno, Yuki; Yokokawa, Sayoko; Amami, Kazuaki; Nakazato, Kazuhiko; Takeishi, Yasuchika] Fukushima Med Univ, Dept Cardiol, Fukushima, Japan	Fukushima Medical University	Ohwada, T (corresponding author), Fukushima Red Cross Hosp, Dept Cardiol, Fukushima, Japan.	ikyoku18@fukushima-med-jrc.jp		Ohwada, Takayuki/0000-0003-1515-6377				Campos CM, 2015, EUR HEART J-CARD IMG, V16, P1112, DOI 10.1093/ehjci/jev039; Cheng JM, 2014, AM J CARDIOL, V114, P1497, DOI 10.1016/j.amjcard.2014.08.013; Contois JH, 2009, CLIN CHEM, V55, P407, DOI 10.1373/clinchem.2008.118356; Fuchs M, 2017, J CARDIOVASC SURG, V58, P55, DOI 10.23736/S0021-9509.16.07655-2; Fujiwara H, 2013, CIRC J, V77, P1590, DOI 10.1253/circj.CJ-66-0065; Garcia-Garcia HM, 2011, INT J CARDIOVAS IMAG, V27, P215, DOI 10.1007/s10554-010-9789-7; Golshahi Jafar, 2014, Adv Biomed Res, V3, P192, DOI 10.4103/2277-9175.140624; Hiruta N, 2013, INT HEART J, V54, P68, DOI 10.1536/ihj.54.68; Ko YG, 2012, YONSEI MED J, V53, P508, DOI 10.3349/ymj.2012.53.3.508; Koskinas KC, 2016, ATHEROSCLEROSIS, V247, P154, DOI 10.1016/j.atherosclerosis.2016.02.015; Kubo T, 2009, CORONARY ARTERY DIS, V20, P531, DOI 10.1097/MCA.0b013e328332a6b0; MCGILL DA, 1993, CORONARY ARTERY DIS, V4, P261, DOI 10.1097/00019501-199303000-00006; McQueen MJ, 2008, LANCET, V372, P224, DOI 10.1016/S0140-6736(08)61076-4; Moss AJ, 1999, CIRCULATION, V99, P2517, DOI 10.1161/01.CIR.99.19.2517; Nair Anuja, 2007, EuroIntervention, V3, P113; Park JP, 2010, CIRC J, V74, P332, DOI 10.1253/circj.CJ-09-0570; Puri R, 2014, EUR HEART J-CARD IMG, V15, P380, DOI 10.1093/ehjci/jet251; Raber L, 2015, EUR HEART J, V36, P490, DOI 10.1093/eurheartj/ehu373; Ramjee V, 2011, J AM COLL CARDIOL, V58, P457, DOI 10.1016/j.jacc.2011.05.009; Romero-Corral A, 2010, EUR HEART J, V31, P737, DOI 10.1093/eurheartj/ehp487; Ruotolo G, 1998, J AM COLL CARDIOL, V32, P1648, DOI 10.1016/S0735-1097(98)00442-2; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Walldius G, 2001, LANCET, V358, P2026, DOI 10.1016/S0140-6736(01)07098-2; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	24	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212539	10.1371/journal.pone.0212539	http://dx.doi.org/10.1371/journal.pone.0212539			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779793	Green Published, Green Submitted, gold			2022-12-27	WOS:000459062900064
J	Rytkonen, S; Ritari, J; Perasaari, J; Saarela, V; Nuutinen, M; Jahnukainen, T				Rytkonen, Sari; Ritari, Jarmo; Perasaari, Juha; Saarela, Ville; Nuutinen, Matti; Jahnukainen, Timo			IL-10 polymorphisms+434T/C,+504G/T, and-2849C/T may predispose to tubulointersititial nephritis and uveitis in pediatric population	PLOS ONE			English	Article							ACUTE INTERSTITIAL NEPHRITIS; TUBULOINTERSTITIAL NEPHRITIS; CYTOKINE PRODUCTION; GENE POLYMORPHISM; HLA-DR; INTERLEUKIN-10; ASSOCIATION; CHILDREN; DISEASE; SUSCEPTIBILITY	Background Tubulointerstitial nephritis (TIN) and uveitis syndrome (TINU) are likely to be autoimmune diseases. Based on previous studies, adults with isolated idiopathic uveitis have polymorphisms in interleukin 10 (IL-10) and tumor necrosis factor a (TNF-alpha) genes. We aimed to evaluate the presence of IL-10 and TNF-alpha polymorphisms in a nationwide cohort of pediatric TIN/TINU patients. Methods Single nucleotide polymorphisms in IL-10 (+434T/C, +504G/T, -1082G/A, -2849C/T) and in TNF alpha (-308G/A, -238G/A, -857C/T) genes were genotyped in 30 well-defined pediatric patients with idiopathic TIN/TINU syndrome. Control group frequencies for these SNPs were obtained from 393 independent Finnish subjects. Results The homozygous minor allele in IL-10 +434T (rs2222202) and IL-10+504G (rs3024490) was found in all patients with TIN or TINU syndrome while the frequency of these minor alleles in the control population was 44% and 23%, respectively (p < 0.001). In IL-10 SNP -2849 (rs6703630) a significant difference was found with genotype TT in all patients (p = 0.004) and in subgroups with TINU syndrome (p = 0.017) and TINU syndrome with chronic uveitis (p = 0.01) compared to reference population. There were no statistical differences in any of the studied TNF-alpha genotypes between TIN/TINU patients and control population. Conclusions A significant difference in the frequency of IL-10+434T and +504G alleles was found between TIN/TINU patients and control population. Genotype -2849TT was more frequently present in patients with TINU syndrome than in the reference subjects. Genetic variation in the inflammatory mediators may predispose to autoimmune nephritis and uveitis.	[Rytkonen, Sari; Nuutinen, Matti] Univ Oulu, PEDEGO Res Unit, Oulu, Finland; [Rytkonen, Sari; Nuutinen, Matti] Univ Oulu, MRC, Oulu, Finland; [Rytkonen, Sari; Nuutinen, Matti] Oulu Univ Hosp, Oulu, Finland; [Ritari, Jarmo; Perasaari, Juha] Finnish Red Cross Blood Serv, Clin Lab, Helsinki, Finland; [Saarela, Ville] Oulu Univ Hosp, Dept Ophthalmol, Oulu, Finland; [Jahnukainen, Timo] Univ Helsinki, Dept Pediat Nephrol & Transplantat, New Childrens Hosp, Helsinki, Finland; [Jahnukainen, Timo] Helsinki Univ Hosp, Helsinki, Finland	University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Jahnukainen, T (corresponding author), Univ Helsinki, Dept Pediat Nephrol & Transplantat, New Childrens Hosp, Helsinki, Finland.; Jahnukainen, T (corresponding author), Helsinki Univ Hosp, Helsinki, Finland.	timo.jahnukainen@hus.fi	Ritari, Jarmo/G-4245-2016; Partanen, Jukka/B-7207-2014	Ritari, Jarmo/0000-0002-3458-9314; Partanen, Jukka/0000-0001-6681-4734; Jahnukainen, Timo/0000-0002-1815-7327; Perasaari, Juha/0000-0002-1142-3792	Foundation for Pediatric Research; Paivikki and Sakari Sohlberg Foundation; Finnish Medical Foundation; Alma and K.A. Snellman Foundation, Oulu, Finland	Foundation for Pediatric Research; Paivikki and Sakari Sohlberg Foundation; Finnish Medical Foundation; Alma and K.A. Snellman Foundation, Oulu, Finland	This study has been supported by the Foundation for Pediatric Research, the Paivikki and Sakari Sohlberg Foundation, Finnish Medical Foundation and the Alma and K.A. Snellman Foundation, Oulu, Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah E, 2016, KIDNEY RES CLIN PRAC, V35, P29, DOI 10.1016/j.krcp.2015.11.002; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Amre DK, 2009, ALIMENT PHARM THER, V29, P1025, DOI 10.1111/j.1365-2036.2009.03953.x; Antoniv TT, 2006, ARTHRITIS RHEUM, V54, P2711, DOI 10.1002/art.22055; Atan D, 2013, MOL VIS, V19, P184; Atan D, 2010, INVEST OPHTH VIS SCI, V51, P4133, DOI 10.1167/iovs.09-4583; BARNES PF, 1993, INFECT IMMUN, V61, P3482, DOI 10.1128/IAI.61.8.3482-3489.1993; Bilolikar H, 2005, EUR RESPIR J, V26, P637, DOI 10.1183/09031936.05.00071104; Clive DM, 2018, AM J KIDNEY DIS, V72, P118, DOI 10.1053/j.ajkd.2017.11.013; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Coutant R, 1999, EUR J PEDIATR, V158, P154, DOI 10.1007/s004310051038; ELLIS D, 1981, PEDIATRICS, V67, P862; Ewald L, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/174062; Fathy MM, 2017, ITAL J PEDIATR, V43, DOI 10.1186/s13052-017-0328-1; Ferguson LR, 2008, WORLD J GASTROENTERO, V14, P4652, DOI 10.3748/wjg.14.4652; GREISING J, 1990, CHILD NEPHROL UROL, V10, P189; Grondal G, 2000, CLIN EXP RHEUMATOL, V18, P565; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Jahnukainen T, 2013, PEDIATR NEPHROL, V28, P1253, DOI 10.1007/s00467-013-2476-x; Jahnukainen T, 2011, PEDIATR NEPHROL, V26, P291, DOI 10.1007/s00467-010-1698-4; Korppi M, 2017, PEDIATR PULM, V52, P14, DOI 10.1002/ppul.23489; Levinson RD, 2003, INVEST OPHTH VIS SCI, V44, P653, DOI 10.1167/iovs.02-0376; Li H, 2015, INVEST OPHTH VIS SCI, V56, P4605, DOI 10.1167/iovs.15-16896; Lindner E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130737; LLORENTE L, 1993, EUR CYTOKINE NETW, V4, P421; Mackensen F, 2011, BRIT J OPHTHALMOL, V95, P971, DOI 10.1136/bjo.2010.187955; Mandeville JTH, 2001, SURV OPHTHALMOL, V46, P195, DOI 10.1016/S0039-6257(01)00261-2; Marquez A, 2017, J MED GENET, V54, P38, DOI 10.1136/jmedgenet-2016-104144; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Oikonomou K, 2011, INFLAMM BOWEL DIS, V17, P1034, DOI 10.1002/ibd.21468; Pagni F, 2016, NEPHROLOGY, V21, P35, DOI 10.1111/nep.12555; Perasaari J, 2013, TISSUE ANTIGENS, V81, P435, DOI 10.1111/tan.12116; Praga M, 2010, KIDNEY INT, V77, P956, DOI 10.1038/ki.2010.89; Raja SC, 1999, OPHTHALMOLOGY, V106, P594, DOI 10.1016/S0161-6420(99)90122-7; Reddy AK, 2014, AM J OPHTHALMOL, V157, P678, DOI 10.1016/j.ajo.2013.12.006; Rees LEN, 2002, CELL MOL LIFE SCI, V59, P560, DOI 10.1007/s00018-002-8448-0; Reuss E, 2002, GENES IMMUN, V3, P407, DOI 10.1038/sj.gene.6363920; Rytkonen SH, 2018, PEDIATR NEPHROL, V33, P287, DOI 10.1007/s00467-017-3796-z; Saarela V, 2013, OPHTHALMOLOGY, V120, P1476, DOI 10.1016/j.ophtha.2012.12.039; Takemura T, 1999, AM J KIDNEY DIS, V34, P1016, DOI 10.1016/S0272-6386(99)70006-5; Tang WM, 1997, AM J OPHTHALMOL, V123, P70, DOI 10.1016/S0002-9394(14)70994-8; vanderPoll T, 1996, J INFECT DIS, V174, P994, DOI 10.1093/infdis/174.5.994; Verbon A, 1999, CLIN EXP IMMUNOL, V115, P110; Westendorp RGJ, 1997, LANCET, V349, P170, DOI 10.1016/S0140-6736(96)06413-6; Zheng XY, 2014, LUNG, V192, P65, DOI 10.1007/s00408-013-9519-8	45	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0211915	10.1371/journal.pone.0211915	http://dx.doi.org/10.1371/journal.pone.0211915			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779760	gold, Green Published			2022-12-27	WOS:000459062900020
J	Takeuchi, F; Ikeda, S; Tsukamoto, Y; Iwasawa, Y; Chen, QH; Otakaki, Y; Ryota, O; Yao, WL; Narita, R; Makoto, H; Watashi, K; Wakita, T; Takeuchi, K; Chayama, K; Kogure, A; Kato, H; Fujita, T				Takeuchi, Fumihiko; Ikeda, Sotaro; Tsukamoto, Yuta; Iwasawa, Yoshikazu; Chen Qihao; Otakaki, Yukie; Ryota, Ouda; Yao, Wan-Ling; Narita, Ryo; Makoto, Hijikata; Watashi, Koichi; Wakita, Takaji; Takeuchi, Koh; Chayama, Kazuaki; Kogure, Amane; Kato, Hiroki; Fujita, Takashi			Screening for inhibitor of episomal DNA identified dicumarol as a hepatitis B virus inhibitor	PLOS ONE			English	Article							CLOSED CIRCULAR DNA; HBV; ANTIGEN; REPLICATION; EXPRESSION; PREVENTION; THERAPY; ANALOGS; CCCDNA; CELLS	Currently, there is no available therapy to eradicate hepatitis B virus (HBV) in chronically infected individuals. This is due to the difficulty in eliminating viral covalently closed circular (ccc) DNA, which is central to the gene expression and replication of HBV. We developed an assay system for nuclear circular DNA using an integration-deficient lentiviral vector. This vector produced non-integrated circular DNA in nuclei of infected cells. We engineered this vector to encode firefly luciferase to monitor the lentiviral episome DNA. We screened 3,840 chemicals by this assay for luciferase-reducing activity and identified dicumarol, which is known to have anticoagulation activity. We confirmed that dicumarol reduced lentiviral episome DNA. Furthermore, dicumarol inhibited HBV replication in cell culture using NTCP-expressing HepG2 and primary human hepatocytes. Dicumarol reduced intracellular HBV RNA, DNA, supernatant HBV antigens and DNA. We also found that dicumarol reduced the cccDNA level in HBV infected cells, but did not affect HBV adsorption/entry. This is a novel assay system for screening inhibitors targeting nuclear cccDNA and is useful for finding new antiviral substances for HBV.	[Takeuchi, Fumihiko; Ikeda, Sotaro; Iwasawa, Yoshikazu; Chen Qihao; Otakaki, Yukie; Yao, Wan-Ling; Makoto, Hijikata; Kato, Hiroki; Fujita, Takashi] Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan; [Takeuchi, Fumihiko; Ikeda, Sotaro; Tsukamoto, Yuta; Iwasawa, Yoshikazu; Chen Qihao; Otakaki, Yukie; Ryota, Ouda; Yao, Wan-Ling; Narita, Ryo; Makoto, Hijikata; Kogure, Amane; Kato, Hiroki; Fujita, Takashi] Kyoto Univ, Inst Frontier Life & Med Sci, Dept Virus Res, Kyoto, Japan; [Tsukamoto, Yuta; Kato, Hiroki] Univ Hosp Bonn, Inst Cardiovasc Immunol, Bonn, Germany; [Ryota, Ouda] Hokkaido Univ, Fac Med, Dept Immunol, Sapporo, Hokkaido, Japan; [Ryota, Ouda] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan; [Narita, Ryo] Aarhus Univ, Dept Mol Biol & Genet, Ctr Struct Biol, Aarhus, Denmark; [Watashi, Koichi; Wakita, Takaji] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan; [Watashi, Koichi] Tokyo Univ Sci, Dept Appl Biol Sci, Noda, Chiba, Japan; [Watashi, Koichi] Japan Sci & Technol Agcy JST, CREST, Saitama, Japan; [Takeuchi, Koh] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery, Tokyo, Japan; [Chayama, Kazuaki] Hiroshima Univ, Liver Res Project Ctr, Hiroshima, Japan	Kyoto University; Kyoto University; University of Bonn; Hokkaido University; Hokkaido University; Aarhus University; National Institute of Infectious Diseases (NIID); Tokyo University of Science; Japan Science & Technology Agency (JST); National Institute of Advanced Industrial Science & Technology (AIST); Hiroshima University	Fujita, T (corresponding author), Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan.; Fujita, T (corresponding author), Kyoto Univ, Inst Frontier Life & Med Sci, Dept Virus Res, Kyoto, Japan.	tfujita@infront.kyoto-u.ac.jp	Ouda, Ryota/P-9681-2019; Takeuchi, Koh/B-4971-2010	Takeuchi, Koh/0000-0002-6227-4627; YAO, WAN-LING/0000-0001-6193-9247; Chayama, Kazuaki/0000-0002-5530-5341; TSUKAMOTO, Yuta/0000-0002-0773-7190	Ministry of Health, Labour and Welfare/Japan Agency for Medical Research and Development (AMED) for Program on the Innovative Development and the Application of New Drugs for Hepatitis B [JP18fk0310107h0002, JP18fk0310109h0002]	Ministry of Health, Labour and Welfare/Japan Agency for Medical Research and Development (AMED) for Program on the Innovative Development and the Application of New Drugs for Hepatitis B(Japan Agency for Medical Research and Development (AMED))	The work was supported by The Ministry of Health, Labour and Welfare/Japan Agency for Medical Research and Development (AMED) for Program on the Innovative Development and the Application of New Drugs for Hepatitis B, Grant number: JP18fk0310107h0002 to TF and JP18fk0310109h0002 to KC and HK (URL: https://www.amed.go.jp/).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baran B, 2015, WORLD J HEPATOL, V7, P1742, DOI 10.4254/wjh.v7.i13.1742; BEASLEY RP, 1983, LANCET, V2, P1099; BROWN PO, 1987, CELL, V49, P347, DOI 10.1016/0092-8674(87)90287-X; BUKRINSKY MI, 1991, SCIENCE, V254, P423, DOI 10.1126/science.1925601; Cai DW, 2012, ANTIMICROB AGENTS CH, V56, P4277, DOI 10.1128/AAC.00473-12; DANE DS, 1970, LANCET, V1, P695; Durantel D, 2016, J HEPATOL, V64, pS117, DOI 10.1016/j.jhep.2016.02.016; Faure-Dupuy S, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9050095; Guo H, 2017, METHODS MOL BIOL, V1540, P1, DOI 10.1007/978-1-4939-6700-1; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Honda M, 2016, J INFECT DIS, V213, P1096, DOI 10.1093/infdis/jiv572; Ishida Y, 2015, AM J PATHOL, V185, P1275, DOI 10.1016/j.ajpath.2015.01.028; Kramvis A, 2008, J MED VIROL, V80, P27, DOI 10.1002/jmv.21049; Kumar R, 2016, LIVER INT, V36, P72, DOI 10.1111/liv.13001; Ladner SK, 1997, ANTIMICROB AGENTS CH, V41, P1715, DOI 10.1128/AAC.41.8.1715; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Levrero M, 2016, CURR OPIN VIROL, V18, P135, DOI 10.1016/j.coviro.2016.06.003; Lucifora J, 2016, J HEPATOL, V64, pS41, DOI 10.1016/j.jhep.2016.02.009; Lucifora J, 2014, SCIENCE, V343, P1221, DOI 10.1126/science.1243462; Madari H, 2003, CANCER RES, V63, P1214; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; Ogura N, 2014, BIOCHEM BIOPH RES CO, V452, P315, DOI 10.1016/j.bbrc.2014.08.029; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Tie JK, 2011, BLOOD, V117, P2967, DOI 10.1182/blood-2010-08-304303; Tsukamoto Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197664; Urban S, 2014, GASTROENTEROLOGY, V147, P48, DOI 10.1053/j.gastro.2014.04.030; Watashi K, 2014, INT J MOL SCI, V15, P2892, DOI 10.3390/ijms15022892; WHO, 2015, HEP B; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049; Yao WL, 2017, INT IMMUNOL, V29, P109, DOI 10.1093/intimm/dxx012; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4; Zhang EJ, 2015, ANTIVIR RES, V123, P193, DOI 10.1016/j.antiviral.2015.10.009; Zhou TL, 2006, ANTIVIR RES, V72, P116, DOI 10.1016/j.antiviral.2006.05.006; Zoulim F, 2004, ANTIVIR RES, V64, P1, DOI [10.1016/j.antiviral.2004.07.003, 10.1016/S0166-3542(04)00162-7]	34	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212233	10.1371/journal.pone.0212233	http://dx.doi.org/10.1371/journal.pone.0212233			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779774	Green Published, Green Submitted, gold			2022-12-27	WOS:000459062900036
J	Kuupiel, D; Tlou, B; Bawontuo, V; Drain, PK; Mashamba-Thompson, TP				Kuupiel, Desmond; Tlou, Boikhutso; Bawontuo, Vitalis; Drain, Paul K.; Mashamba-Thompson, Tivani P.			Poor supply chain management and stock-outs of point-of-care diagnostic tests in Upper East Region's primary healthcare clinics, Ghana	PLOS ONE			English	Article							CHALLENGES; IMPLEMENTATION; QUALITY; HIV	Introduction Several supply chain components are important to sustain point-of-care (POC) testing services in rural settings. To evaluate the availability of POC diagnostic tests in rural Ghana's primary healthcare (PHC) clinics, we conducted an audit of the supply chain management for POC diagnostic services in rural Upper East Region's (UER) PHC clinics, Ghana to determine the reasons/causes of POC tests deficiencies. Material and methods We conducted a review of accessible POC diagnostics in 100 PHC clinics in UER, Ghana from February to March 2018. We used a monitoring audit tool adopted from the World Health Organization and Management Science for Health guidelines for supply chain management of diagnostics for compliance. We determined a clinic's compliance with the stipulated guidelines, and a composite compliant score was defined as a percentage rating of 90 to 100%. We used univariate logistic regression analysis in Stata 14 to determine the level of association between supply chain management and the audit variables. Results Overall, the composite compliant score of supply chain management for existing POC tests was at 81% (95% CI: 79%-82%). The mean compliance with distribution guidelines was at 93.8% (95% CI: 91.9%-95.6%) the highest score, whilst inventory management scored the lowest, at 53.5% (95% CI: 49.5%-57.5%) compliance. Of the 13 districts in the region, the results showed complete stock-out of blood glucose test in all selected PHC clinics in seven (53.8%) districts, haemoglobin and hepatitis B virus test in three (23.1%), and urine protein test in two (15.4%) districts. Based on our univariate logistics regression models, stock-out of tests at the Regional Medical and District Health Directorates stores in the region, high clinic attendance, lack of documentation of expiry date/expired tests, poor documentation of inventory level, poor monitoring of monthly consumption level, and failure to document unexplained losses of the various POC tests were significant predictors of complete test stock-out in most of the clinics in the Upper East Region. Discussion There is poor supply chain management of POC diagnostic tests in UER's PHC clinics. Improvement in inventory management and human resource capacity for POC testing is critical to ensure accessibility and sustainability of POC diagnostic services in resource-limited settings PHC clinics.	[Kuupiel, Desmond; Tlou, Boikhutso; Mashamba-Thompson, Tivani P.] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Dept Publ Hlth Med, Durban, South Africa; [Bawontuo, Vitalis] Catholic Univ Coll Ghana, Fac Hlth & Allied Sci, Fiapre, Sunyani, Ghana; [Drain, Paul K.] Univ Washington, Dept Global Hlth, Int Clin Res Ctr, Seattle, WA 98195 USA; [Drain, Paul K.] Univ Washington, Dept Med, Div Infect Dis, Seattle, WA USA; [Drain, Paul K.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	University of Kwazulu Natal; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kuupiel, D (corresponding author), Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Dept Publ Hlth Med, Durban, South Africa.	desmondkuupiel98@hotmail.com	TLOU, BOIKHUTSO/AEA-3161-2022; Mashamba-Thompson, Tivani/GRO-3709-2022; Kuupiel, Desmond/V-8883-2019	Mashamba-Thompson, Tivani/0000-0002-4193-2416; Kuupiel, Desmond/0000-0001-7780-1955; Bawontuo, Vitalis/0000-0001-8440-0172; Drain, Paul/0000-0002-9569-4097	University of KwaZulu-Natal, College of Health Sciences Research Scholarship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI108293] Funding Source: NIH RePORTER	University of KwaZulu-Natal, College of Health Sciences Research Scholarship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by University of KwaZulu-Natal, College of Health Sciences Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonawitz Rachael E, 2015, Int J Gynaecol Obstet, V130 Suppl 1, pS58, DOI 10.1016/j.ijgo.2015.04.015; Dassah ET, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-2935-y; Drain PK, 2014, LANCET INFECT DIS, V14, P239, DOI 10.1016/S1473-3099(13)70250-0; Embrey MA, 2012, HLTH MSF MDS 3 MANAG; Engel N, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000132; Fonjungo PN, 2016, CLIN INFECT DIS, V62, P369, DOI 10.1093/cid/civ866; Ghana Statistical Service, 2012, MAL POP HOUS CENS 19; Hasselback L, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-295; Hawkes S, 2011, LANCET INFECT DIS, V11, P684, DOI 10.1016/S1473-3099(11)70104-9; Jani IV, 2013, NEW ENGL J MED, V368, P2319, DOI 10.1056/NEJMsb1214197; Jaya Z, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183044; Kuupiel D, 2018, ACCESSIBILITY POINT; Kuupiel D, 2017, DIAGNOSTICS, V7, DOI 10.3390/diagnostics7040058; Kyabayinze DJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-695; Mabey DC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001233; Majors CE, 2017, LAB CHIP, V17, P3351, DOI 10.1039/c7lc00374a; Pai NP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001306; Palamountain KM, 2012, J INFECT DIS, V205, pS181, DOI 10.1093/infdis/jis203; Peeling R, 2015, EXPERT REV MOL DIAGN, V15, P1107, DOI 10.1586/14737159.2015.1081802; Peeling RW, 2006, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro1569; Peeling RW, 2015, INT HEALTH, V7, P384, DOI 10.1093/inthealth/ihv062; Peeling RW, 2009, FUTURE MICROBIOL, V4, P1271, DOI 10.2217/FMB.09.100; Pinna R, 2015, APPL CONT MANAGEMENT; Schito M, 2012, J INFECT DIS, V205, pS169, DOI 10.1093/infdis/jis044; Sharma S, 2016, STRATEGIES OVERCOMIN; Smith Adriana, 2015, Int J Gynaecol Obstet, V130 Suppl 1, pS70, DOI 10.1016/j.ijgo.2015.04.009; Thairu L, 2011, AIDS CARE, V23, P814, DOI 10.1080/09540121.2010.541416; UNAIDS, 2011, COUNTD ZERO GLOB PLA; World Health Organization, 2013, MAN PROC DIAGN REL L; World Health Organssatioas, 2018, WHO MOD LIST ESS IN	30	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211498	10.1371/journal.pone.0211498	http://dx.doi.org/10.1371/journal.pone.0211498			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811407	Green Submitted, Green Published, gold			2022-12-27	WOS:000459806400020
J	Merida-Garcia, R; Liu, GZ; He, S; Gonzalez-Dugo, V; Dorado, G; Galvez, S; Solis, I; Zarco-Tejada, PJ; Reif, JC; Hernandez, P				Merida-Garcia, Rosa; Liu, Guozheng; He, Sang; Gonzalez-Dugo, Victoria; Dorado, Gabriel; Galvez, Sergio; Solis, Ignacio; Zarco-Tejada, Pablo J.; Reif, Jochen C.; Hernandez, Pilar			Genetic dissection of agronomic and quality traits based on association mapping and genomic selection approaches in durum wheat grown in Southern Spain	PLOS ONE			English	Article							GRAIN PROTEIN-CONTENT; QUANTITATIVE TRAITS; WIDE ASSOCIATION; GLUTEN STRENGTH; MEDITERRANEAN CONDITIONS; LINKAGE DISEQUILIBRIUM; BREADMAKING QUALITY; DROUGHT RESISTANCE; YIELD; QTLS	Climatic conditions affect the growth, development and final crop production. As wheat is of paramount importance as a staple crop in the human diet, there is a growing need to study its abiotic stress adaptation through the performance of key breeding traits. New and complementary approaches, such as genome-wide association studies (GWAS) and genomic selection (GS), are used for the dissection of different agronomic traits. The present study focused on the dissection of agronomic and quality traits of interest (initial agronomic score, yield, gluten index, sedimentation index, specific weight, whole grain protein and yellow colour) assessed in a panel of 179 durum wheat lines (Triticum durum Desf.), grown under rainfed conditions in different Mediterranean environments in Southern Spain (Andalusia). The findings show a total of 37 marker-trait associations (MTAs) which affect phenotype expression for three quality traits (specific weight, gluten and sedimentation indexes). MTAs could be mapped on the A and B durum wheat subgenomes (on chromosomes 1A, 1B, 2A, 2B and 3A) through the recently available bread wheat reference assembly (IWGSC RefSeqv1). Two of the MTAs found for quality traits (gluten index and SDS) corresponded to the known Glu-B1 and Glu-A1 loci, for which candidate genes corresponding to high molecular weight glutenin subunits could be located. The GS prediction ability values obtained from the breeding materials analyzed showed promising results for traits as grain protein content, sedimentation and gluten indexes, which can be used in plant breeding programs.	[Merida-Garcia, Rosa; Gonzalez-Dugo, Victoria; Zarco-Tejada, Pablo J.; Hernandez, Pilar] CSIC, IAS, Alameda Obispo S-N, Cordoba, Spain; [Liu, Guozheng; He, Sang; Reif, Jochen C.] Leibniz Inst Plant Genet & Crop Plant Res IPK Gat, Dept Breeding Res, Corrensstr 3, Stadt Seeland, Germany; [Dorado, Gabriel] Univ Cordoba, Dept Bioquim & Biol Mol, Campus Rabanales C6-1-E17, Cordoba, Spain; [Galvez, Sergio] Univ Malaga, Andalucia Tech, ETSI Informat, Campus Teatinos S-N, Malaga, Spain; [Solis, Ignacio] Univ Seville, ETSIA, Ctra Utrera Km1, Seville, Spain; [Liu, Guozheng] BASF Agr Solut Seed GmbH, OT Gatersleben, Schwabeplan 8, Gatersleben, Germany; [He, Sang] Agr Victoria, AgriBio, Ctr AgriBiosci, Bundoora, Vic, Australia	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS); Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Universidad de Cordoba; Universidad de Malaga; University of Sevilla; La Trobe University	Hernandez, P (corresponding author), CSIC, IAS, Alameda Obispo S-N, Cordoba, Spain.	phernandez@ias.csic.es	Zarco-Tejada, Pablo J./A-6874-2012; Hernandez, Pilar/B-5996-2016; Rojas, Sergio Gálvez/K-7733-2014; Mérida-García, Rosa/AAA-5540-2020; Zarco-Tejada, Pablo J./AAZ-3704-2020	Zarco-Tejada, Pablo J./0000-0003-1433-6165; Hernandez, Pilar/0000-0001-5166-4454; Rojas, Sergio Gálvez/0000-0003-4743-2807; Mérida-García, Rosa/0000-0002-3169-2471; Reif, Jochen/0000-0002-6742-265X; He, Sang/0000-0003-0832-3472	Junta de Andalucia (Andalusian Regional Government), Spain - (FEDER) [P12-AGR-0482]; MINECO (Spanish Ministry of Economy, Industry and Competitiveness) [AGL2016-77149-C2-1-P]	Junta de Andalucia (Andalusian Regional Government), Spain - (FEDER); MINECO (Spanish Ministry of Economy, Industry and Competitiveness)	This work was funded by project P12-AGR-0482 to PH from Junta de Andalucia (Andalusian Regional Government), Spain (Co-funded by FEDER). PH is supported by project AGL2016-77149-C2-1-P from MINECO (Spanish Ministry of Economy, Industry and Competitiveness). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Galindo MA, 2015, CROP SCI, V55, P477, DOI 10.2135/cropsci2013.11.0793; [Anonymous], 2001, NEAR INFRARED TECHNO; ANSCOMBE FJ, 1963, TECHNOMETRICS, V5, P141, DOI 10.2307/1266059; Appels R, 2018, SCIENCE, V361, P661, DOI 10.1126/science.aar7191; Araus JL, 1998, AUST J PLANT PHYSIOL, V25, P835, DOI 10.1071/PP98071; Araus JL, 2002, ANN BOT-LONDON, V89, P925, DOI 10.1093/aob/mcf049; Araus JL, 1998, FIELD CROP RES, V55, P209, DOI 10.1016/S0378-4290(97)00079-8; AXFORD DWE, 1978, CEREAL FOOD WORLD, V23, P477; Battenfield SD, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2016.01.0005; Belaid A., 2000, Options Mediterraneennes. Serie A, Seminaires Mediterraneens, P35; Beleggia R, 2011, CEREAL CHEM, V88, P504, DOI 10.1094/CCHEM-02-11-0013; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentley AR, 2014, THEOR APPL GENET, V127, P2619, DOI 10.1007/s00122-014-2403-y; Bernardo R, 2009, CROP SCI, V49, P419, DOI 10.2135/cropsci2008.08.0452; BIDINGER FR, 1987, AUST J AGR RES, V38, P37, DOI 10.1071/AR9870037; Blanco A, 2006, THEOR APPL GENET, V112, P1195, DOI 10.1007/s00122-006-0221-6; Blanco A, 2012, MOL BREEDING, V30, P79, DOI 10.1007/s11032-011-9600-z; Blanco A, 2002, PLANT MOL BIOL, V48, P615, DOI 10.1023/A:1014864230933; BLUM A, 1990, AUST J AGR RES, V41, P799, DOI 10.1071/AR9900799; Borghi B, 1997, EUR J AGRON, V6, P145, DOI 10.1016/S1161-0301(96)02040-0; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Burgueno J, 2012, CROP SCI, V52, P707, DOI 10.2135/cropsci2011.06.0299; CARRILLO JM, 1990, THEOR APPL GENET, V79, P321, DOI 10.1007/BF01186074; Clarke FR, 2010, CAN J PLANT SCI, V90, P1, DOI 10.4141/CJPS09035; Conti V, 2011, J APPL GENET, V52, P287, DOI 10.1007/s13353-011-0045-1; Crossa J, 2014, HEREDITY, V112, P48, DOI 10.1038/hdy.2013.16; Crossa J, 2017, TRENDS PLANT SCI, V22, P961, DOI 10.1016/j.tplants.2017.08.011; Crossa J, 2010, GENETICS, V186, P713, DOI 10.1534/genetics.110.118521; CUBADDA R, 1992, CEREAL FOOD WORLD, V37, P866; D'Ovidio R, 2004, J CEREAL SCI, V39, P321, DOI 10.1016/j.jcs.2003.12.002; de los Campos G, 2009, GENETICS, V182, P375, DOI 10.1534/genetics.109.101501; De Vita P, 2007, EUR J AGRON, V26, P39, DOI 10.1016/j.eja.2006.08.009; Elouafi I., 2000, Options Mediterraneennes. Serie A, Seminaires Mediterraneens, P505; FEILLET P, 1996, PASTA NOODLE TECHNOL, P9511; Fernando RL, 2007, ACTA AGR SCAND A-AN, V57, P192, DOI 10.1080/09064700801959395; Fiedler JD, 2017, PLANT GENOME-US, V10, DOI 10.3835/plantgenome2017.05.0038; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Galvez S, 2019, FUNCT INTEGR GENOMIC, V19, P295, DOI 10.1007/s10142-018-0639-3; Garcia del Moral LF, 2003, AGRON J, V95, P266, DOI 10.2134/agronj2003.0266; Garrido-Lestache E, 2005, EUR J AGRON, V23, P265, DOI 10.1016/j.eja.2004.12.001; Giraldo P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166577; Gonzalez-Ribot G, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01781; Groos C, 2003, THEOR APPL GENET, V106, P1032, DOI 10.1007/s00122-002-1111-1; Haile JK, 2018, MOL BREEDING, V38, DOI 10.1007/s11032-018-0818-x; He S, 2017, THEOR APPL GENET, V130, P635, DOI 10.1007/s00122-016-2840-x; Hentschel V, 2002, J AGR FOOD CHEM, V50, P6663, DOI 10.1021/jf025701p; Huang XQ, 2006, THEOR APPL GENET, V113, P753, DOI 10.1007/s00122-006-0346-7; Kaan F., 1993, Journal of Genetics and Breeding, V47, P151; Kabbaj H, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01277; Kollers S, 2014, MOL BREEDING, V34, P363, DOI 10.1007/s11032-014-0039-x; KRAMER T, 1979, EUPHYTICA, V28, P209, DOI 10.1007/BF00056577; Kristensen PS, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00069; Kumar A, 2013, J CEREAL SCI, V57, P21, DOI 10.1016/j.jcs.2012.09.006; Li YF, 2013, J CEREAL SCI, V57, P398, DOI 10.1016/j.jcs.2013.01.005; Liu ZS, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0511-8; LOSS SP, 1994, ADV AGRON, V52, P229, DOI 10.1016/S0065-2113(08)60625-2; Maccaferri M, 2008, GENETICS, V178, P489, DOI 10.1534/genetics.107.077297; Maccaferri M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-873; Maccaferri M, 2011, J EXP BOT, V62, P409, DOI 10.1093/jxb/erq287; Martinez CS, 2010, INT J FOOD PROP, V15, DOI [10.1080/10942912.2010, DOI 10.1080/10942912.2010]; McCartney CA, 2006, PLANT BREEDING, V125, P565, DOI 10.1111/j.1439-0523.2006.01256.x; Mengistu DK, 2016, PLANT BIOTECHNOL J, V14, P1800, DOI 10.1111/pbi.12538; Meuwissen THE, 2001, GENETICS, V157, P1819; MOONEN JHE, 1982, EUPHYTICA, V31, P677, DOI 10.1007/BF00039206; Neumann K, 2011, MOL BREEDING, V27, P37, DOI 10.1007/s11032-010-9411-7; Pagnotta MA, 2009, GENET RESOUR CROP EV, V56, P299, DOI 10.1007/s10722-008-9364-4; Papadakis J, 1980, PENINSULA IBE RICA E; Patil RM, 2013, EUPHYTICA, V190, P117, DOI 10.1007/s10681-012-0785-y; Patil RM, 2009, J CEREAL SCI, V49, P378, DOI 10.1016/j.jcs.2009.01.001; PENA RJ, 1990, J CEREAL SCI, V12, P105, DOI 10.1016/S0733-5210(09)80092-1; Piepho HP, 2000, HEREDITY, V84, P437, DOI 10.1046/j.1365-2540.2000.00678.x; POGNA NE, 1990, J CEREAL SCI, V11, P15, DOI 10.1016/S0733-5210(09)80178-1; Poland J, 2012, PLANT GENOME-US, V5, P103, DOI 10.3835/plantgenome2012.06.0006; Rajaram S, 1992, WHEAT SPECIAL REPORT, V9, P14; Rapp M, 2018, THEOR APPL GENET, V131, P1315, DOI 10.1007/s00122-018-3080-z; Reif JC, 2005, CROP SCI, V45, P1, DOI 10.2135/cropsci2005.0001; Reynolds MP, 2012, PHYSL BREEDING, pix; Rharrabti Y, 2003, FIELD CROP RES, V80, P133, DOI 10.1016/S0378-4290(02)00177-6; Rharrabti Y, 2001, PLANT BREEDING, V120, P381, DOI 10.1046/j.1439-0523.2001.00628.x; Rosello M, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01512; RUIZ M, 1993, THEOR APPL GENET, V87, P353, DOI 10.1007/BF01184923; Seabourn BW, 2012, CROP SCI, V52, P1306, DOI 10.2135/cropsci2011.04.0210; SIMMONDS NW, 1995, J SCI FOOD AGR, V67, P309, DOI 10.1002/jsfa.2740670306; Steiner B, 2019, THEOR APPL GENET, V132, P969, DOI 10.1007/s00122-018-3253-9; Stich B., 2010, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V5, P1, DOI 10.1079/PAVSNNR20105039; Sukumaran S, 2018, PLANT GENOME-US, V11, DOI 10.3835/plantgenome2017.12.0112; Sukumaran S, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00081; Sun CW, 2017, PLANT BIOTECHNOL J, V15, P953, DOI 10.1111/pbi.12690; Zhang JL, 2018, THEOR APPL GENET, V131, P1741, DOI 10.1007/s00122-018-3111-9; Zhao Y, 2014, HEREDITY, V112, P638, DOI 10.1038/hdy.2014.1; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	91	17	18	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211718	10.1371/journal.pone.0211718	http://dx.doi.org/10.1371/journal.pone.0211718			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811415	Green Published, gold			2022-12-27	WOS:000459806400029
J	Sodre, V; Araujo, JN; Goncalves, TA; Vilela, N; Braz, ASK; Franco, TT; Neto, MD; Damasio, ARD; Garcia, W; Squina, FM				Sodre, Victoria; Araujo, Juscemacia Nascimento; Goncalves, Thiago Augusto; Vilela, Nathalia; Kimus Braz, Antonio Sergio; Franco, Telma Teixeira; Neto, Mario de Oliveira; de Lima Damasio, Andre Ricardo; Garcia, Wanius; Squina, Fabio Marcio			An alkaline active feruloyl-CoA synthetase from soil metagenome as a potential key enzyme for lignin valorization strategies	PLOS ONE			English	Article							PEDIOCOCCUS-ACIDILACTICI BD16; CATABOLIC GENES; TRANSCRIPTIONAL REGULATOR; BIOLOGICAL MACROMOLECULES; SOLUTION SCATTERING; ACID; PROTEIN; VANILLIN; STRAIN; DEGRADATION	Ferulic acid (FA), a low-molecular weight aromatic compound derived from lignin, represents a high-value molecule, used for applications in the cosmetic and pharmaceutical industries. FA can be further enzymatically converted in other commercially interesting molecules, such as vanillin and bioplastics. In several organisms, these transformations often start with a common step of FA activation via CoA-thioesterification, catalyzed by feruloyl-CoA synthetases (Fcs). In this context, these enzymes are of biotechnological interest for conversion of lignin-derived FA into high value chemicals. In this study, we describe the first structural characterization of a prokaryotic Fcs, named FCS1, isolated from a lignin-degrading microbial consortium. The FCS1 optimum pH and temperature were 9 and 37 degrees C, respectively, with Km of 0.12 mM and Vmax of 36.82 U/mg. The circular dichroism spectra indicated a notable secondary structure stability at alkaline pH values and high temperatures. This secondary structure stability corroborates the activity data, which remains high until pH 9. The Small Angle X-Ray Scattering analyses resulted on the tertiary/quaternary structure and the low-resolution envelope in solution of FCS1, which was modeled as a homodimer using the hyperthermophilic nucleoside diphosphate-forming acetyl-CoA synthetase from Candidatus Korachaeum cryptofilum. This study contributes to the field of research by establishing the first biophysical and structural characterization for Fcs, and our data may be used for comparison against novel enzymes of this class that to be studied in the future.	[Sodre, Victoria; Franco, Telma Teixeira; Squina, Fabio Marcio] Univ Campinas UNICAMP, Fac Chem Engn, Campinas, SP, Brazil; [Sodre, Victoria; Goncalves, Thiago Augusto; Vilela, Nathalia; de Lima Damasio, Andre Ricardo] Univ Campinas UNICAMP, Inst Biol, Dept Biochem & Tissue Biol, Campinas, SP, Brazil; [Araujo, Juscemacia Nascimento; Kimus Braz, Antonio Sergio; Garcia, Wanius] Univ Fed ABC UFABC, Ctr Ciencias Nat & Humanas, Santo Andre, SP, Brazil; [Goncalves, Thiago Augusto; Vilela, Nathalia; Squina, Fabio Marcio] Univ Sorocaba UNISO, Programa Proc Tecnol & Ambientais, Sorocaba, SP, Brazil; [Neto, Mario de Oliveira] Univ Estadual Paulista UNESP, Inst Biociencias, Dept Fis & Biofis, Botucatu, SP, Brazil	Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Federal do ABC (UFABC); Universidade de Sorocaba; Universidade Estadual Paulista	Squina, FM (corresponding author), Univ Campinas UNICAMP, Fac Chem Engn, Campinas, SP, Brazil.; Squina, FM (corresponding author), Univ Sorocaba UNISO, Programa Proc Tecnol & Ambientais, Sorocaba, SP, Brazil.	fabio.squina@prof.uniso.br	Silva, Wanius J. G./L-3948-2016; Franco, Telma Teixeira/A-2397-2013; Damasio, André RL/H-1162-2016; Neto, Mario Oliveira/F-2717-2013; Franco, Telma Teixeira/AAP-6842-2021; Araujo, Juscemácia Nascimento/N-2245-2017; Squina, Fabio/J-8130-2012; Araujo, Juscemácia/AAQ-7299-2020	Franco, Telma Teixeira/0000-0002-9611-4541; Damasio, André RL/0000-0001-9304-3998; Franco, Telma Teixeira/0000-0002-9611-4541; Araujo, Juscemácia Nascimento/0000-0001-9034-1463; Squina, Fabio/0000-0002-8154-7459; Araujo, Juscemácia/0000-0001-9034-1463; Goncalves, Thiago Augusto/0000-0001-6526-905X; Vilela, Nathalia/0000-0002-1072-0568; Sodre, Victoria/0000-0002-2240-9128; Garcia, Wanius/0000-0003-3712-3488	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [15/50590-4, 15/50612-8, 17/17275-3, 17/22669-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [305748/2017-3, 305740/2017-2, 304816/2017-5]; CAPES/PROEX; FAPESP [2018/18101-1, 2017/05901-7, 17/16089-1, 2017/16976-8, 17/08166-6]; CAPES	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES/PROEX(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was financially supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; 15/50590-4, 15/50612-8, 17/17275-3 and 17/22669-0) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; 305748/2017-3, 305740/2017-2 and 304816/2017-5). TAG and JNA were supported by FAPESP fellowship (17/16089-1 and 2017/16976-8 respectively). VS was supported by CAPES/PROEXFellowship and FAPESP fellowships (2018/18101-1 and 2017/05901-7). NV was supported by CAPES and FAPESP fellowship (17/08166-6).	Achterholt S, 2000, APPL MICROBIOL BIOT, V54, P799, DOI 10.1007/s002530000431; Alper H, 2009, NAT REV MICROBIOL, V7, P715, DOI 10.1038/nrmicro2186; Balan Venkatesh, 2014, ISRN Biotechnol, V2014, P463074, DOI 10.1155/2014/463074; Banci L, 1999, BIOCHEMISTRY-US, V38, P3205, DOI 10.1021/bi982139g; Barberousse H, 2008, J SCI FOOD AGR, V88, P1494, DOI 10.1002/jsfa.3242; Beckham GT, 2016, CURR OPIN BIOTECH, V42, P40, DOI 10.1016/j.copbio.2016.02.030; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brasen C, 2008, J BIOL CHEM, V283, P15409, DOI 10.1074/jbc.M710218200; Brenelli LB, 2016, IND CROP PROD, V83, P94, DOI 10.1016/j.indcrop.2015.12.013; Bugg TDH, 2011, NAT PROD REP, V28, P1883, DOI 10.1039/c1np00042j; Bugg TDH, 2011, CURR OPIN BIOTECH, V22, P394, DOI 10.1016/j.copbio.2010.10.009; Calisti C, 2008, APPL MICROBIOL BIOT, V80, P475, DOI 10.1007/s00253-008-1557-4; Chakraborty D, 2017, APPL MICROBIOL BIOT, V101, P5615, DOI 10.1007/s00253-017-8283-8; Chakraborty D, 2016, PROTEIN EXPRES PURIF, V128, P123, DOI 10.1016/j.pep.2016.08.015; Cortes-Tolalpa L, 2018, APPL MICROBIOL BIOT, V102, P2913, DOI 10.1007/s00253-017-8714-6; Davis KM, 2016, ENERGIES, V9, DOI 10.3390/en9100808; de Oliveira LC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118225; Dellomonaco C, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-3; Engel C, 1996, CURR OPIN STRUC BIOL, V6, P790, DOI 10.1016/S0959-440X(96)80009-1; Fawaz MV, 2011, BIOORG CHEM, V39, P185, DOI 10.1016/j.bioorg.2011.08.004; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fleige C, 2016, APPL ENVIRON MICROB, V82, P3410, DOI 10.1128/AEM.00802-16; Friedman M, 2000, J AGR FOOD CHEM, V48, P2101, DOI 10.1021/jf990489j; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Ghosh S, 2007, J IND MICROBIOL BIOT, V34, P131, DOI 10.1007/s10295-006-0177-1; Gomez LD, 2008, NEW PHYTOL, V178, P473, DOI 10.1111/j.1469-8137.2008.02422.x; Graf N, 2014, APPL MICROBIOL BIOT, V98, P137, DOI 10.1007/s00253-013-5303-1; GROSS GG, 1966, Z NATURFORSCH PT B, VB 21, P683; Grossman A, 2019, CURR OPIN BIOTECH, V56, P112, DOI 10.1016/j.copbio.2018.10.009; Hammersley A. P., 1997, ESRF97HA02T; HEIJNE GV, 1978, ORIGINS LIFE EVOL B, V9, P27, DOI 10.1007/BF00929711; Hirakawa H, 2012, J BACTERIOL, V194, P1960, DOI 10.1128/JB.06817-11; Huerta-Cepas J, 2016, NUCLEIC ACIDS RES, V44, pD286, DOI 10.1093/nar/gkv1248; Jachimska B, 2008, LANGMUIR, V24, P6866, DOI 10.1021/la800548p; Kasai D, 2012, FEMS MICROBIOL LETT, V332, P68, DOI 10.1111/j.1574-6968.2012.02576.x; Kaur B, 2014, APPL MICROBIOL BIOT, V98, P8539, DOI 10.1007/s00253-014-5950-x; Kaur B, 2013, APPL BIOCHEM BIOTECH, V169, P1353, DOI 10.1007/s12010-012-0066-1; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Klumpp S, 2002, EUR J BIOCHEM, V269, P1067, DOI 10.1046/j.1432-1033.2002.02755.x; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Linger JG, 2014, P NATL ACAD SCI USA, V111, P12013, DOI 10.1073/pnas.1410657111; LOFTY S, 1994, PHYTOCHEMISTRY, V35, P1419, DOI 10.1016/S0031-9422(00)86867-3; Madden TL, 1996, METHOD ENZYMOL, V266, P131; Martinez AT, 2005, INT MICROBIOL, V8, P195; Masai E, 2002, APPL ENVIRON MICROB, V68, P4416, DOI 10.1128/AEM.68.9.4416-4424.2002; Mathew S, 2006, CRIT REV MICROBIOL, V32, P115, DOI 10.1080/10408410600709628; Mitra A, 1999, ARCH BIOCHEM BIOPHYS, V365, P10, DOI 10.1006/abbi.1999.1140; Mohr A, 2013, ENERG POLICY, V63, P114, DOI 10.1016/j.enpol.2013.08.033; Moraes EC, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1073-4; Narbad A, 1998, MICROBIOL-SGM, V144, P1397, DOI 10.1099/00221287-144-5-1397; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Otani H, 2016, NUCLEIC ACIDS RES, V44, P595, DOI 10.1093/nar/gkv955; Otani H, 2014, J BACTERIOL, V196, P4293, DOI 10.1128/JB.02247-14; Overhage J, 1999, APPL ENVIRON MICROB, V65, P4837; Parke D, 2003, APPL ENVIRON MICROB, V69, P5398, DOI 10.1128/AEM.69.9.5398-5409.2003; Plaggenborg R, 2006, APPL MICROBIOL BIOT, V72, P745, DOI 10.1007/s00253-005-0302-5; Ragauskas AJ, 2014, SCIENCE, V344, P709, DOI 10.1126/science.1246843; Rosazza JPN, 1995, J IND MICROBIOL, V15, P457, DOI 10.1007/BF01570016; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; Sainsbury PD, 2013, ACS CHEM BIOL, V8, P2151, DOI 10.1021/cb400505a; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Salvachua D, 2015, GREEN CHEM, V17, P4951, DOI [10.1039/C5GC01165E, 10.1039/c5gc01165e]; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teramoto M, 2010, J BIOSCI BIOENG, V110, P48, DOI 10.1016/j.jbiosc.2009.12.008; Varanasi P, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-14; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Weisse RHJ, 2016, P NATL ACAD SCI USA, V113, pE519, DOI 10.1073/pnas.1518614113; WOLODKO WT, 1994, J BIOL CHEM, V269, P10883; Wu ML, 2017, ENVIRON POLLUT, V223, P657, DOI 10.1016/j.envpol.2017.01.079; Yang WW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067339; ZENK MH, 1980, ANAL BIOCHEM, V101, P182, DOI 10.1016/0003-2697(80)90058-5; ZIMMERMANN W, 1990, J BIOTECHNOL, V13, P119, DOI 10.1016/0168-1656(90)90098-V	78	5	5	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2019	14	2							e0212629	10.1371/journal.pone.0212629	http://dx.doi.org/10.1371/journal.pone.0212629			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EH	30802241	Green Published, Green Submitted, gold			2022-12-27	WOS:000459710700015
J	Gutreuter, S; Igumbor, E; Wabiri, N; Desai, M; Durand, L				Gutreuter, Steve; Igumbor, Ehimario; Wabiri, Njeri; Desai, Mitesh; Durand, Lizette			Improving estimates of district HIV prevalence and burden in South Africa using small area estimation techniques	PLOS ONE			English	Article							POPULATION-BASED SURVEYS; GENERALIZED EPIDEMICS; SURVEILLANCE; PEOPLE; PLACES; CENSUS; TRENDS; LEVEL	Many countries, including South Africa, have implemented population-based household surveys to estimate HIV prevalence and the burden of HIV infection. Most household HIV surveys are designed to provide reliable estimates down to only the first subnational geopolitical level which, in South Africa, is composed of nine provinces. However HIV prevalence estimates are needed down to at least the second subnational level in order to better target the delivery of HIV care, treatment and prevention services. The second subnational level in South Africa is composed of 52 districts. Achieving adequate precision at the second subnational level therefore requires either a substantial increase in survey sample size or use of model-based estimation capable of incorporating other pre-existing data. Our purpose is demonstration of the efficacy of relatively simple small-area estimation of HIV prevalence in the 52 districts of South Africa using data from the South African National HIV Prevalence, Incidence and Behavior Survey, 2012, district-level HIV prevalence estimates obtained from testing of pregnant women who attended antenatal care (ANC) clinics in 2012, and 2012 demographic data. The best-fitting model included only ANC prevalence and dependency ratio as out-of-survey predictors. Our key finding is that ANC prevalence was the superior auxiliary covariate, and provided substantially improved precision in many district-level estimates of HIV prevalence in the general population. Inclusion of a district-level spatial simultaneously autoregressive covariance structure did not result in improved estimation.	[Gutreuter, Steve; Desai, Mitesh; Durand, Lizette] US Ctr Dis Control & Prevent, Div Global HIV & TB, Atlanta, GA 30333 USA; [Igumbor, Ehimario] US Ctr Dis Control & Prevent, Div Global HIV & TB, Pretoria, South Africa; [Igumbor, Ehimario] Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa; [Wabiri, Njeri] Human Sci Res Council, Div Epidemiol & Strateg Informat, Pretoria, South Africa; [Desai, Mitesh] US Ctr Dis Control & Prevent, Div Global HIV & TB, Yangon, Myanmar; [Durand, Lizette] US Dept HHS, Off Global Affairs, Camp Hm Smith, HI USA	Centers for Disease Control & Prevention - USA; University of the Western Cape; Human Sciences Research Council-South Africa	Gutreuter, S (corresponding author), US Ctr Dis Control & Prevent, Div Global HIV & TB, Atlanta, GA 30333 USA.	sgutreuter@cdc.gov	Gutreuter, Steve/ABC-7980-2020; Igumbor, Ehimario U/B-2652-2012	Gutreuter, Steve/0000-0002-0733-2900; Igumbor, Ehimario U/0000-0002-6313-6031	U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC)	U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC)	This work was supported by the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC). The findings and conclusions reported in this manuscript are those of the authors and do not represent the views of the US Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SJ, 2014, LANCET, V384, P249, DOI 10.1016/S0140-6736(14)61053-9; [Anonymous], 2017, UNAIDS DAT 2017; [Anonymous], 2013, 2012 NAT ANT SENT HI; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cochran W.G., 2007, SAMPLING TECHNIQUES; Corsi DJ, 2012, INT J EPIDEMIOL, V41, P1602, DOI 10.1093/ije/dys184; FAY RE, 1979, J AM STAT ASSOC, V74, P269, DOI 10.1080/01621459.1979.10482505; Garcia-Calleja JM, 2004, SEX TRANSM INFECT, V80, DOI 10.1136/sti.2004.010298; Gething PW, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000724; GHOSH M, 1994, STAT SCI, V9, P55, DOI 10.1214/ss/1177010647; Gouws E, 2008, SEX TRANSM INFECT, V84, pI17, DOI 10.1136/sti.2008.030452; Hedt BL, 2011, STAT MED, V30, P560, DOI 10.1002/sim.3920; Johnson FA, 2010, J OFF STAT, V26, P341; Johnson LF, 2017, S AFR J HIV MED, V18, DOI 10.4102/sajhivmed.v18i1.695; Kandala NB, 2011, AIDS, V25, P95, DOI 10.1097/QAD.0b013e328340fe0f; Kleinschmidt I, 2007, AM J TROP MED HYG, V77, P1163, DOI 10.4269/ajtmh.2007.77.1163; Kondlo L, 2012, P 58 WORLD STAT C, P5002; Larmarange J, 2014, AIDS, V28, pS469, DOI 10.1097/QAD.0000000000000480; Mahy M, 2012, SEX TRANSM INFECT, V88, pI65, DOI 10.1136/sextrans-2012-050789; Marhuenda Y, 2013, COMPUT STAT DATA AN, V58, P308, DOI 10.1016/j.csda.2012.09.002; Massyn N., 2014, DURBAN HLTH SYSTEMS; Molina I, 2015, R J, V7, P81; Montana LS, 2008, SEX TRANSM INFECT, V84, pI78, DOI 10.1136/sti.2008.030106; Ngesa O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103299; Niragire F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119944; Office of the US Global AIDS Coordinator, 2014, PEPFAR 3 0 CONTR EP; R Core Team, 2018, R LANG ENV STAT COMP; Rao J., 2015, WILEY SERIES SURVEY; South African National AIDS Council, 2017, LET OUR ACT COUNT S; Stanton MC, 2013, ENVIRONMETRICS, V24, P158, DOI 10.1002/env.2205; Statistics South Africa, 2011, 2011 MUN FACT SHEET; UNAIDS, 2014, END AIDS EP 2030; Working Group on Global HIV/ AIDS UW, 2003, GUID COND HIV SENT S; You Y., 2006, SURV METHODOL, V32, P97	34	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212445	10.1371/journal.pone.0212445	http://dx.doi.org/10.1371/journal.pone.0212445			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794619	Green Published, gold, Green Submitted			2022-12-27	WOS:000459709100068
J	Tavares, AS; Morcatty, TQ; Zuanon, J; Magnusson, WE				Tavares, Aline S.; Morcatty, Thais Queiroz; Zuanon, Jansen; Magnusson, William E.			Influence of body size, topography, food availability and tree-fall gaps on space use by yellow-footed tortoises (Chelonoidis denticulatus) in Central Amazonia	PLOS ONE			English	Article							MESOSCALE DISTRIBUTION PATTERNS; GEOCHELONE-DENTICULATA; DESERT TORTOISES; SEED DISPERSAL; HOME-RANGE; MOVEMENT PATTERNS; GOPHER TORTOISES; SOIL; CARBONARIA; FOREST	Habitat selection and extension of the area used by a given species may vary during different phases of its life and are often determined by the distribution and availability of resources throughout the landscape, such as food, breeding sites, and shelters. In this study, we assessed the influence of body size on the areas used by 21 individuals of the yellow-footed tortoises (Chelonoidis denticulatus) from January to June 2017 in a dense rain forest area in Central Amazonia. We also investigated whether individuals selected different ranges of terrain slope, elevation, areas with high food availability, or areas with treefall gaps that could be used for shelter or thermoregulation. We monitored tortoise movements using thread-bobbins, and sampled terrain characteristics, availability of potential food resources and forest gaps along the routes used by the tortoises. We also measured the same variables in plots distributed systematically throughout the study area to evaluate resource availability. Tortoises used an average area of 1.56 ha (SD = 1.51, min = 0.03, max = 6.44). The size of the area used was positively associated with the individual body size, but did not vary between sexes. Small individuals selected higher and flatter areas where the availability of fallen flowers was higher, whereas the area used by larger individuals did not differ from the natural availability of topographic traits and food in the region. Although tortoises did not select areas according to availability of tree-fall gaps, most larger tortoises were found sheltered under fallen trees (85%). Conversely, small individuals were mainly found hidden under litter (66%). Body size determined the patterns of landscape use by tortoises; larger individuals were mainly generalists, but small individuals occupied high and flat areas. The yellow-footed tortoise is endangered by hunting, illegal collection for the pet trade, habitat destruction and effects of climate change. Size-related differences in habitat selection should be taken into account in species-distribution models for the identification of suitable areas for reintroduction and the development of management plans in protected areas.	[Tavares, Aline S.; Morcatty, Thais Queiroz] Inst Nacl de Pesquisas da Amazonia, Programa Posgrad & Ecol, Manaus, AM, Brazil; [Morcatty, Thais Queiroz] Oxford Brookes Univ, Oxford Wildlife Trade Res Grp, Dept Social Sci, Oxford, England; [Zuanon, Jansen; Magnusson, William E.] Inst Nacl de Pesquisas da Amazonia, Coordenacao Biodiversidade, Manaus, AM, Brazil	Institute Nacional de Pesquisas da Amazonia; Oxford Brookes University; Institute Nacional de Pesquisas da Amazonia	Tavares, AS (corresponding author), Inst Nacl de Pesquisas da Amazonia, Programa Posgrad & Ecol, Manaus, AM, Brazil.	tavaressantos.aline@gmail.com	Morcatty, Thais Queiroz/AAU-7435-2020; Zuanon, Jansen A. S./E-5791-2013	Morcatty, Thais Queiroz/0000-0002-3095-7052; Zuanon, Jansen A. S./0000-0001-8354-2750; Tavares, Aline/0000-0002-5413-9070	Centro de Estudos Integrados da Biodiversidade Amazonica (CENBAM) [573721/2008-4]; National Council for Scientific and Technological Development (CNPq) [313183/2014-7, 300627/2008-4]; National Council for Scientific and Technological Development (CNPq); WCS Graduate Scholarship Program; Wildlife Conservation Society; Christensen Conservation Leaders Scholarship; Wildlife Conservation Network Scholarship Program through the Sidney Byers Scholarship award	Centro de Estudos Integrados da Biodiversidade Amazonica (CENBAM); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); WCS Graduate Scholarship Program; Wildlife Conservation Society; Christensen Conservation Leaders Scholarship; Wildlife Conservation Network Scholarship Program through the Sidney Byers Scholarship award	This study received financial and logistic support from the Centro de Estudos Integrados da Biodiversidade Amazonica (CENBAM; processo: 573721/2008-4). JZ and WEM received productivity grants from National Council for Scientific and Technological Development (CNPq; 313183/2014-7 and 300627/2008-4). ATS thanks the National Council for Scientific and Technological Development (CNPq) for financial support. TQM is supported by the WCS Graduate Scholarship Program, a program of the Wildlife Conservation Society, the Christensen Conservation Leaders Scholarship, and by the Wildlife Conservation Network Scholarship Program through the Sidney Byers Scholarship award.; We thank the logistics teams of CENBAM and the Ducke Reserve for supporting our field activities, Cleide, Jabson, Wallace, Celio and especially Joao and Zelao for participating in the data collection. We also thank Jonas Goncalves, Hani El Bizri and Rafael Rabelo for valuable suggestions and assistance in statistical analyses. This study received financial and logistic support from the Centro de Estudos Integrados da Biodiversidade Amazonica (CENBAM; processo: 573721/2008-4). JZ and WEM received productivity grants from National Council for Scientific and Technological Development (CNPq; 313183/2014-7 and 300627/2008-4). ATS thanks the National Council for Scientific and Technological Development (CNPq) for financial support. T. Q. M. is supported by the WCS Graduate Scholarship Program, a program of the Wildlife Conservation Society, and the Christensen Conservation Leaders Scholarship, and by the Wildlife Conservation Network Scholarship Program through the Sidney Byers Scholarship award.	[Anonymous], 1996, RED LIST THREATENED; Brown GP, 2004, ECOLOGY, V85, P1627, DOI 10.1890/03-0107; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Butler JA, 1996, J HERPETOL, V30, P455, DOI 10.2307/1565195; Capaverde UD, 2018, BIOTROPICA, P1; Castano Mora O.V., 1981, Cespedesia, V10, P55; CHAUVEL A, 1987, EXPERIENTIA, V43, P234, DOI 10.1007/BF01945546; Cintra R, 2012, INT J ECOLOGY, V2012, P25; Costa FRC, 2009, J VEG SCI, V20, P69, DOI 10.1111/j.1654-1103.2009.05314.x; Costa FRC, 2005, J ECOL, V93, P863, DOI 10.1111/j.1365-2745.2005.01020.x; de Castilho CV, 2006, FOREST ECOL MANAG, V234, P85, DOI 10.1016/j.foreco.2006.06.024; De Souza-Mazurek RR, 2000, BIODIVERS CONSERV, V9, P579, DOI 10.1023/A:1008999201747; de Toledo JJ, 2011, FOREST ECOL MANAG, V262, P331, DOI 10.1016/j.foreco.2011.03.039; EMMONS LH, 1989, J HERPETOL, V23, P311, DOI 10.2307/1564460; Epperson DM, 2003, J HERPETOL, V37, P315, DOI 10.1670/0022-1511(2003)037[0315:NAHEOG]2.0.CO;2; Eubanks JO, 2003, HERPETOLOGICA, V59, P311, DOI 10.1655/01-105.1; Ferrara C.R., 2017, QUELONIOS AMAZONICOS, V1st; Ferreira Júnior Paulo Dias, 2009, Acta Amaz., V39, P139, DOI 10.1590/S0044-59672009000100014; Guzman A, 2008, AMPHIBIA-REPTILIA, V29, P463, DOI 10.1163/156853808786230442; Harless ML, 2010, HERPETOL CONSERV BIO, V5, P374; Harless ML, 2009, COPEIA, P378, DOI 10.1643/CE-07-226; Hofmeyr M, 2012, AMPHIBIA-REPTILIA, V33, P185, DOI 10.1163/156853812X634071; ICMBIO - Instituto Chico Mendes de Conservacao da Biodiversidade, 2016, LIVR VERM FAUN BRAS; Jerozolimski A, 2005, THESIS, P1; Jerozolimski A, 2009, OECOLOGIA, V161, P517, DOI 10.1007/s00442-009-1396-8; Jimenez-Munoz JC, 2016, SCI REP-UK, V6, DOI 10.1038/srep33130; Kinupp VF, 2005, J TROP ECOL, V21, P363, DOI 10.1017/S0266467405002440; Lagarde F, 2012, ENVIRON CONSERV, V39, P172, DOI 10.1017/S0376892911000634; Laurance WF, 1999, FOREST ECOL MANAG, V118, P127, DOI 10.1016/S0378-1127(98)00494-0; Legler J. M., 1960, MUS NAT HIST, V11, P527; Lovich JE, 2014, CALIF FISH GAME, V100, P404; Magnusson William E., 2005, Biota Neotrop., V5, P19, DOI 10.1590/S1676-06032005000300002; Marques-Filho AO, 1982, ACTA AMAZON, V11, P759; McIntyre NE, 1999, LANDSCAPE ECOL, V14, P437, DOI 10.1023/A:1008074407036; McMaster MK, 2009, J HERPETOL, V43, P561, DOI 10.1670/07-078.1; MCRAE WA, 1981, AM MIDL NAT, V106, P165, DOI 10.2307/2425146; Menin M, 2007, J TROP ECOL, V23, P539, DOI 10.1017/S0266467407004269; Morcatty TQ, 2015, ECOL SOC, V20, DOI 10.5751/ES-07701-200303; Morcatty TQ, 2015, ORYX, V49, P577, DOI 10.1017/S003060531500071X; Morcatty TQ, 2013, ECOL RES, V28, P935, DOI 10.1007/s11284-013-1076-3; Moskovits D., 1985, BEHAV ECOLOGY 2 AMAZ; Moskovits DK, 1987, FUNCT ECOL, V1, P203, DOI 10.2307/2389422; MOSKOVITS DK, 1990, HERPETOLOGICA, V46, P207; PERES CA, 1994, BIOTROPICA, V26, P98, DOI 10.2307/2389114; Peres CA, 2006, BIODIVERS CONSERV, V15, P2627, DOI 10.1007/s10531-005-5406-9; Riedle JD, 2008, COPEIA, P414, DOI 10.1643/CH-06-010; Rodrigues LF, 2014, J TROP ECOL, V30, P565, DOI 10.1017/S0266467414000431; Rojas-Ahumada DP, 2012, AUSTRAL ECOL, V37, P865, DOI 10.1111/j.1442-9993.2011.02330.x; Rozylowicz L, 2013, EUR J WILDLIFE RES, V59, P47, DOI 10.1007/s10344-012-0646-y; Rueda-Almonacid JV, 2007, SERIE GUIAS TROPICAL, V6; Schietti J, 2014, PLANT ECOL DIVERS, V7, P241, DOI 10.1080/17550874.2013.783642; Sobral-Souza T, 2017, PERSPECT ECOL CONSER, V15, P300, DOI 10.1016/j.pecon.2017.08.005; Stevenson PR, 2007, AMPHIBIA-REPTILIA, V28, P217, DOI 10.1163/156853807780202459; Strong JN, 2006, BIOTROPICA, V38, P683, DOI 10.1111/j.1744-7429.2006.00185.x; Valenzuela N, 2004, COPEIA, P735, DOI 10.1643/CH-03-248R1; van Dijk PP, 2012, CHELON RES MONOGR, V5, DOI [DOI 10.3854/CRM.5.000.CHECKLIST.V7.2014, 10.3854/crm.5.000]; Vasconcelos HL, 2003, STUD NEOTROP FAUNA E, V38, P115, DOI 10.1076/snfe.38.2.115.15923; Wilson DS, 1998, ECOLOGY, V79, P1884, DOI 10.2307/176696	58	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0211869	10.1371/journal.pone.0211869	http://dx.doi.org/10.1371/journal.pone.0211869			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794558	Green Published, gold			2022-12-27	WOS:000459709100025
J	Valero-Garcia, J; Gonzalez-Espinosa, MD; Barrios, M; Carmona-Antonanzas, G; Garcia-Planells, J; Ruiz-Lafora, C; Fuentes-Galvez, A; Jimenez-Velasco, A				Valero-Garcia, Jennifer; del Carmen Gonzalez-Espinosa, Maria; Barrios, Manuel; Carmona-Antonanzas, Greta; Garcia-Planells, Javier; Ruiz-Lafora, Carlos; Fuentes-Galvez, Ainhoa; Jimenez-Velasco, Antonio			Earlier relapse detection after allogeneic haematopoietic stem cell transplantation by chimerism assays: Digital PCR versus quantitative real-time PCR of insertion/deletion polymorphisms	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; POLYMERASE-CHAIN-REACTION; MINIMAL RESIDUAL DISEASE; LEUKEMIA; QUANTIFICATION; AMPLIFICATION	Background The analysis of molecular haematopoietic chimerisms (HC) has become a well-established method to monitor the transplant evolution and to assess the risk of relapse after allogeneic stem cells transplantation (allo-STC). Different techniques and molecular markers are being used for chimerism surveillance after transplantation, including quantitative real-time PCR (qPCR) and the recently developed digital PCR (dPCR). This study aims to compare the sensitivity and accuracy of both methods to quantify HC and predict early relapse. Methodology HC was evaluated using custom PCR systems for the specific detection of the Y-chromosome, null alleles and insertion-deletion polymorphisms. A total of 281 samples from 28 adult patients who underwent an allo-SCT were studied. Increasing mixed chimerism was detected prior to relapse in 100% of patients (18 relapses). Results Compared with conventional qPCR amplification, dPCR predicted relapse with a median anticipation period of 63 days versus 45.5 days by qPCR. Overall, 56% of the relapses were predicted earlier with dPCR whereas 38% of the relapses where detected simultaneously using both techniques and only in 1 case, relapse was predicted earlier with qPCR. Conclusions In conclusion, chimerism determination by dPCR constitutes a suitable technique for the follow-up of patients with haematological pathologies after allo-STC, showing greater sensitivity to predict an early relapse.	[Valero-Garcia, Jennifer; Carmona-Antonanzas, Greta; Garcia-Planells, Javier; Ruiz-Lafora, Carlos] Inst Med Genom Imegen, Valencia, Spain; [del Carmen Gonzalez-Espinosa, Maria; Barrios, Manuel; Fuentes-Galvez, Ainhoa; Jimenez-Velasco, Antonio] Hosp Reg Univ Malaga, Haematol Dept, Inst Invest Biomed Malaga IBIMA, Malaga, Spain	Universidad de Malaga	Valero-Garcia, J (corresponding author), Inst Med Genom Imegen, Valencia, Spain.	jennifer.valero@imegen.es		Garcia-Planells, Javier/0000-0002-3224-2966				Alizadeh M, 2002, BLOOD, V99, P4618, DOI 10.1182/blood.V99.12.4618; Bach C, 2015, TRANSFUS MED HEMOTH, V42, P38, DOI 10.1159/000370255; Barrios M, 2003, HAEMATOLOGICA, V88, P801; Buno I, 2005, HAEMATOLOGICA, V90, P1373; Clark JR, 2015, BRIT J HAEMATOL, V168, P26, DOI 10.1111/bjh.13073; Cruz NM, 2017, INT J LAB HEMATOL, V39, P53, DOI 10.1111/ijlh.12670; Frankel W, 1996, AM J HEMATOL, V52, P281, DOI 10.1002/(SICI)1096-8652(199608)52:4<281::AID-AJH7>3.0.CO;2-O; Hayashibara K, 2014, EUR J CANCER, V50, pS241, DOI 10.1016/S0959-8049(14)50879-9; Hendriks-Balk MC, 2007, BASIC RES CARDIOL, V102, P195, DOI 10.1007/s00395-007-0649-0; Huggett JF, 2015, CLIN CHEM, V61, P79, DOI 10.1373/clinchem.2014.221366; Huggett JF, 2013, CLIN CHEM, V59, P1691, DOI 10.1373/clinchem.2013.214742; Jimenez-Velasco A, 2005, LEUKEMIA, V19, P336, DOI 10.1038/sj.leu.2403622; Kim SY, 2014, J MOL DIAGN, V16, P679, DOI 10.1016/j.jmoldx.2014.06.005; Koldehoff M, 2006, AM J HEMATOL, V81, P735, DOI 10.1002/ajh.20693; Kuypers J, 2017, J CLIN MICROBIOL, V55, P1621, DOI [10.1128/JCM.00211-17, 10.1128/jcm.00211-17]; Lion T, 2012, LEUKEMIA, V26, P1821, DOI 10.1038/leu.2012.66; Majumdar N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09183-4; Matsuda K, 2017, ADV CLIN CHEM, V80, P45, DOI 10.1016/bs.acc.2016.11.002; Okano T, 2018, J CLIN IMMUNOL, V38, P300, DOI 10.1007/s10875-018-0497-8; Rosenow F, 2013, BONE MARROW TRANSPL, V48, P1070, DOI 10.1038/bmt.2013.2; Stahl T, 2015, EXP HEMATOL, V43, P462, DOI 10.1016/j.exphem.2015.02.006; Thiede C, 2001, LEUKEMIA, V15, P293, DOI 10.1038/sj.leu.2401953; Thiede Christian, 2004, Am J Pharmacogenomics, V4, P177, DOI 10.2165/00129785-200404030-00005; Tong Y, 2017, CELL PHYSIOL BIOCHEM, V43, P1718, DOI 10.1159/000484035; VANRHEE F, 1994, BLOOD, V83, P3377; Waterhouse M, 2017, CLIN CHEM LAB MED, V55, P1115, DOI 10.1515/cclm-2016-0900; Zeiser R, 2005, LEUKEMIA, V19, P814, DOI 10.1038/sj.leu.2403719	27	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212708	10.1371/journal.pone.0212708	http://dx.doi.org/10.1371/journal.pone.0212708			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794643	gold, Green Published, Green Submitted			2022-12-27	WOS:000459709100123
J	Nguyen, HL; Duviau, MP; Cocaign-Bousquet, M; Nouaille, S; Girbal, L				Huong Le Nguyen; Duviau, Marie-Pierre; Cocaign-Bousquet, Muriel; Nouaille, Sebastien; Girbal, Laurence			Multiplexing polysome profiling experiments to study translation in Escherichia coli	PLOS ONE			English	Article							MESSENGER-RNA TRANSLATION; GENE-EXPRESSION; LACTOCOCCUS-LACTIS; HIGH SALINITY; REVEALS; STRESS; STABILITY; RESPONSES; TRANSCRIPTION; ADAPTATION	Polysome profiling is a widely used method to monitor the translation status of mRNAs. Although it is theoretically a simple technique, it is labor intensive. Repetitive polysome fractionation rapidly generates a large number of samples to be handled in the downstream processes of protein elimination, RNA extraction and quantification. Here, we propose a multiplex polysome profiling experiment in which distinct cellular extracts are pooled before loading on the sucrose gradient for fractionation. We used the multiplexing method to study translation in E. coli. Multiplexing polysome profiling experiments provided similar mRNA translation status to that obtained with the non-multiplex method with comparable distribution of mRNA copies between the polysome profiling fractions, similar ribosome occupancy and ribosome density. The multiplexing method was used for parallel characterization of gene translational responses to changing mRNA levels. When the mRNA level of two native genes, cysZ and lacZ was increased by transcription induction, their global translational response was similar, with a higher ribosome load leading to increased ribosome occupancy and ribosome densities. However the pattern and the magnitude of the translational response were gene specific. By reducing the number of polysome profiling experiments, the multiplexing method saved time and effort and reduced cost and technical bias. This method would be useful to study the translational effect of mRNA sequence-dependent parameters that often require testing multiple samples and conditions in parallel.	[Huong Le Nguyen; Duviau, Marie-Pierre; Cocaign-Bousquet, Muriel; Nouaille, Sebastien; Girbal, Laurence] Univ Toulouse, LISBP, CNRS, INRA,INSA, Toulouse, France	INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Cocaign-Bousquet, M; Girbal, L (corresponding author), Univ Toulouse, LISBP, CNRS, INRA,INSA, Toulouse, France.	cocaign@insa-toulouse.fr; girbal@insa-toulouse.fr		GIRBAL, Laurence/0000-0002-8773-4829	INRA (french national institute for agricultural research)	INRA (french national institute for agricultural research)	HLN was supported by a pre-doctoral fellowship from INRA (french national institute for agricultural research). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ah-Seng Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003956; Alves LR, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0436-2; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Artieri CG, 2014, GENOME RES, V24, P411, DOI 10.1101/gr.165522.113; Chasse H, 2018, NUCLEIC ACIDS RES, V46, P4607, DOI 10.1093/nar/gky258; Chasse H, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw907; Duval M, 2015, BIOCHIMIE, V114, P18, DOI 10.1016/j.biochi.2015.03.007; Esquerre T, 2014, NUCLEIC ACIDS RES, V42, P2460, DOI 10.1093/nar/gkt1150; Evfratov SA, 2017, NUCLEIC ACIDS RES, V45, P3487, DOI 10.1093/nar/gkw1141; Fisunov GY, 2017, BIOCHIMIE, V132, P66, DOI 10.1016/j.biochi.2016.10.015; Giuliodori AM, 2010, MOL CELL, V37, P21, DOI 10.1016/j.molcel.2009.11.033; Gottesman S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003798; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; King HA, 2016, BRIEF FUNCT GENOMICS, V15, P22, DOI 10.1093/bfgp/elu045; Lange C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-415; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Maligoy M, 2008, APPL ENVIRON MICROB, V74, P485, DOI 10.1128/AEM.01531-07; Matsuura H, 2013, PLANT CELL PHYSIOL, V54, P474, DOI 10.1093/pcp/pcs189; Matsuura H, 2010, PLANT CELL PHYSIOL, V51, P448, DOI 10.1093/pcp/pcq010; Melamed D, 2008, RNA, V14, P1337, DOI 10.1261/rna.864908; Morin M, 2017, MBIO, V8, DOI 10.1128/mBio.01628-17; Nouaille S, 2017, NUCLEIC ACIDS RES, V45, P11711, DOI 10.1093/nar/gkx781; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Picard F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-588; Picard F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-528; Potts AH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01613-1; Presnyak V, 2015, CELL, V160, P1111, DOI 10.1016/j.cell.2015.02.029; Pytharopoulou S, 2011, AQUAT TOXICOL, V105, P157, DOI 10.1016/j.aquatox.2011.06.007; Redon E, 2005, J BIOL CHEM, V280, P36380, DOI 10.1074/jbc.M506006200; SAGLIOCCO FA, 1993, J BIOL CHEM, V268, P26522; Smirnova JB, 2005, MOL CELL BIOL, V25, P9340, DOI 10.1128/MCB.25.21.9340-9349.2005; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wang Z, 2015, GENOME BIOL EVOL, V7, P1155, DOI 10.1093/gbe/evv059; Wu YH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163256; Xiang R, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.00501-18, 10.1128/AAC.02356-17, 10.1128/aac.00501-18]; Yamasaki S, 2015, PLANT CELL PHYSL, V56; Yu CH, 2015, MOL CELL, V59, P744, DOI 10.1016/j.molcel.2015.07.018; Zhang L, 2014, BBA-BIOMEMBRANES, V1838, P1809, DOI 10.1016/j.bbamem.2014.03.003	38	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212297	10.1371/journal.pone.0212297	http://dx.doi.org/10.1371/journal.pone.0212297			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779773	Green Published, gold, Green Submitted			2022-12-27	WOS:000459062900042
J	Zhang, YF; Chen, Y; Cai, YT; Cui, ZY; Zhang, JJ; Wang, XH; Shen, LR				Zhang, Yifan; Chen, Yong; Cai, Yiting; Cui, Zongyan; Zhang, Jinjie; Wang, Xiaohou; Shen, Lirong			Novel polyclonal antibody-based rapid gold sandwich immunochromatographic strip for detecting the major royal jelly protein 1 (MRJP1) in honey	PLOS ONE			English	Article							CARBON-ISOTOPE RATIO; INFRARED SPECTROSCOPY; MONOCLONAL-ANTIBODY; APALBUMIN 1; ADULTERATION; SYRUPS; ELISA; AUTHENTICATION; IDENTIFICATION; STANDARD	Honey adulteration is becoming increasingly alarming incidents in food safety. Monitoring and detecting adulteration face greater challenges. Honey contains the major royal jelly proteins (MRJP) secreted by bee workers. To detect honey adulteration fast and accurately, a rapid gold sandwich immunochromatographic strip (GSIS) was developed based on two specific polyclonal antibodies (PoAbs) against the MRJP1, the most abundant protein of all MRJPs. We determined the best of pH value (pH 8.6) and PoAb SP-1 amount (5 mu g/mL) in conjunction with colloidal. The cut-off value (sensitivity) of GSIS in detecting MRJP1 is 2.0 mu g/mL in solution. Validation analysis with RJ, milk vetch honey, acacia honey and honey adulteration containing rice syrup and corn syrup with different ratios demonstrated that the GSIS could show consistent Test line (T line) when the test samples contain more than 30% pure honey or MRJP1 0.4 mg/g. The validation results by isotope ratio mass spectrometry on the same pure and all adulteration milk vetch honey samples showed the same information of GSIS test. The qualitative assay GSIS provided a valuable new way for honey authenticity and laid the foundation for the future application of GSIS with monoclonal antibodies in honey authentication.	[Zhang, Yifan; Chen, Yong; Cai, Yiting; Wang, Xiaohou; Shen, Lirong] Zhejiang Univ, Dept Food Sci & Nutr, Zhejiang Key Lab Agrofood Proc, Hangzhou, Zhejiang, Peoples R China; [Cui, Zongyan; Zhang, Jinjie] Qinhuangdao Entry Exit Inspect & Quarantine Bur, Qinhuangdao, Hebei, Peoples R China	Zhejiang University	Shen, LR (corresponding author), Zhejiang Univ, Dept Food Sci & Nutr, Zhejiang Key Lab Agrofood Proc, Hangzhou, Zhejiang, Peoples R China.	shenlirong@zju.edu.cn	Chen, Yong/ABH-8664-2020	Chen, Yong/0000-0001-8240-1286; Shen, Lirong/0000-0002-3197-9245; Cui, Zongyan/0000-0003-0786-8323	Science and Technology Project of Zhejiang Province [2017C32033]; National Key Research and Development Program of China [2017YFC1601700]	Science and Technology Project of Zhejiang Province; National Key Research and Development Program of China	This work was supported by the Science and Technology Project of Zhejiang Province (No. 2017C32033) and the National Key Research and Development Program of China (No. 2017YFC1601700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anuracpreeda P, 2014, ACTA TROP, V136, P1, DOI 10.1016/j.actatropica.2014.04.012; *AOAC, 2005, 99812 AOAC, P27; Bertelli D, 2010, J AGR FOOD CHEM, V58, P8495, DOI 10.1021/jf101460t; Bilikova K, 2010, J AGR FOOD CHEM, V58, P8776, DOI 10.1021/jf101583s; Bougrini M, 2016, FOOD ANAL METHOD, V9, P2161, DOI 10.1007/s12161-015-0393-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chua LS, 2015, ANAL LETT, V48, P697, DOI 10.1080/00032719.2014.952374; Dong H, 2016, J AGR FOOD CHEM, V64, P3258, DOI 10.1021/acs.jafc.6b00691; Gui WJ, 2008, ANAL BIOCHEM, V377, P202, DOI 10.1016/j.ab.2008.03.013; Guler A, 2014, FOOD CHEM, V155, P155, DOI 10.1016/j.foodchem.2014.01.033; Guo LL, 2015, BIOMED CHROMATOGR, V29, P1432, DOI 10.1002/bmc.3442; Guo YR, 2009, ANAL BIOCHEM, V389, P32, DOI 10.1016/j.ab.2009.03.020; Hawkins J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134735; Kato Y, 2014, J AGR FOOD CHEM, V62, P10672, DOI 10.1021/jf503464a; Lenhardt L, 2015, FOOD CHEM, V175, P284, DOI [10.1016/j.fo, 10.1016/j.foodchem.2014.11.162]; Li SF, 2012, J FOOD COMPOS ANAL, V28, P69, DOI 10.1016/j.jfca.2012.07.006; LUTIER PM, 1993, REV PALAEOBOT PALYNO, V78, P129, DOI 10.1016/0034-6667(93)90019-Q; Pang GF, 2006, J SCI FOOD AGR, V86, P315, DOI 10.1002/jsfa.2328; Rios-Corripio MA, 2012, CYTA-J FOOD, V10, P119, DOI 10.1080/19476337.2011.596576; Rosi NL, 2005, CHEM REV, V105, P1547, DOI 10.1021/cr030067f; Ruiz-Matute AI, 2007, J AGR FOOD CHEM, V55, P7264, DOI 10.1021/jf070559j; Salazar-Olivo LA, 2005, TOXICOL IN VITRO, V19, P645, DOI 10.1016/j.tiv.2005.03.001; Shen LR, 2015, J ZHEJIANG UNIV-SC B, V16, P155, DOI 10.1631/jzus.B1400223; Shim WB, 2006, J AGR FOOD CHEM, V54, P9728, DOI 10.1021/jf0620057; Sivakesava S, 2001, J FOOD SCI, V66, P787, DOI 10.1111/j.1365-2621.2001.tb15173.x; Soares S, 2017, COMPR REV FOOD SCI F, V16, P1072, DOI 10.1111/1541-4337.12278; Trifkovic J, 2017, J AOAC INT, V100, P827, DOI 10.5740/jaoacint.17-0142; Wang JM, 2014, FOOD ANAL METHOD, V7, P2003, DOI 10.1007/s12161-014-9833-7; Wang SQ, 2015, FOOD CHEM, V172, P669, DOI 10.1016/j.foodchem.2014.09.044; WHITE JW, 1989, J ASSOC OFF ANA CHEM, V72, P907; Won SR, 2008, FOOD RES INT, V41, P952, DOI 10.1016/j.foodres.2008.07.014; Wu XL, 2015, ANAL METHODS-UK, V7, P6190, DOI 10.1039/c5ay01166c; Zhu XR, 2010, J FOOD ENG, V101, P92, DOI 10.1016/j.jfoodeng.2010.06.014	33	2	2	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212335	10.1371/journal.pone.0212335	http://dx.doi.org/10.1371/journal.pone.0212335			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779780	gold, Green Published, Green Submitted			2022-12-27	WOS:000459062900048
J	Hierlihy, C; Waddell, L; Young, I; Greig, J; Corrin, T; Mascarenhas, M				Hierlihy, Catherine; Waddell, Lisa; Young, Ian; Greig, Judy; Corrin, Tricia; Mascarenhas, Mariola			A systematic review of individual and community mitigation measures for prevention and control of chikungunya virus	PLOS ONE			English	Review							MOSQUITO AEDES-ALBOPICTUS; REUNION ISLAND; BLOOD-DONORS; ENVIRONMENTAL-FACTORS; SONGKHLA PROVINCE; BORNE DISEASES; VECTOR CONTROL; 2009 EPIDEMIC; PUERTO-RICO; OUTBREAK	Background Chikungunya is a mosquito-borne virus transmitted by mosquitoes from the Aedes genus. The virus, endemic to parts of Asia and Africa, has recently undergone an emergence in other parts of the world where it was previously not found including Indian Ocean Islands, Europe, the Western Pacific and the Americas. There is no vaccine against chikungunya virus, which means that prevention and mitigation rely on personal protective measures and community level interventions including vector control. Methodology/Principal findings A systematic review (SR) was conducted to summarize the literature on individual and community mitigation and control measures and their effectiveness. From a scoping review of the global literature on chikungunya, there were 91 articles that investigated mitigation or control strategies identified at the individual or community level. Of these, 81 were confirmed as relevant and included in this SR. The majority of the research was published since 2010 (76.5%) and was conducted in Asia (39.5%). Cross sectional studies were the most common study design (36.6%). Mitigation measures were placed into six categories: behavioural protective measures, insecticide use, public education, control of blood and blood products, biological vector control and quarantine of infected individuals. The effectiveness of various mitigation measures was rarely evaluated and outcomes were rarely quantitative, making it difficult to summarize results across studies and between mitigation strategies. Meta-analysis of the proportion of individuals engaging in various mitigation measures indicates habitat removal is the most common measure used, which may demonstrate the effectiveness of public education campaigns aimed at reducing standing water. Conclusions/Significance Further research with appropriate and consistent outcome measurements are required in order to determine which mitigation measures, or combination of mitigation measures, are the most effective at protecting against exposure to chikungunya virus.	[Hierlihy, Catherine; Waddell, Lisa; Greig, Judy; Corrin, Tricia; Mascarenhas, Mariola] Publ Hlth Agcy Canada, Natl Microbiol Lab, Publ Hlth Risk Sci Div, Guelph, ON, Canada; [Hierlihy, Catherine; Corrin, Tricia] Univ Guelph, Dept Populat Med, Guelph, ON, Canada; [Young, Ian] Ryerson Univ, Sch Occupat & Publ Hlth, Toronto, ON, Canada	Public Health Agency of Canada; University of Guelph; Toronto Metropolitan University	Hierlihy, C (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Publ Hlth Risk Sci Div, Guelph, ON, Canada.; Hierlihy, C (corresponding author), Univ Guelph, Dept Populat Med, Guelph, ON, Canada.	khierlihy@gmail.com		Young, Ian/0000-0002-5575-5174; Corrin, Tricia/0000-0001-5514-1589				Ahmed S, 2015, EMERG INFECT DIS, V21, P909, DOI 10.3201/eid2105.141813; Akiner MM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004664; Anand T, 2014, ANN MED HEALTH SCI R, V4, P227, DOI 10.4103/2141-9248.129048; Angelini P., 2008, Parassitologia (Rome), V50, P97; Anish TS, 2011, J GLOB INFECT DIS, V3, P32, DOI 10.4103/0974-777X.77293; Appassakij H, 2016, TRANSFUSION, V56, P2100, DOI 10.1111/trf.13675; Appassakij H, 2014, TRANSFUSION, V54, P1945, DOI 10.1111/trf.12575; Arpit Prajapati, 2012, National Journal of Community Medicine, V3, P178; Aswathy S., 2011, Journal of Communicable Diseases, V43, P209; Atkinson JA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-225; Balasubramaniam Sudharsanam M, 2011, Indian J Community Med, V36, P124, DOI 10.4103/0970-0218.84131; Bartlett-Healy K, 2011, INT J ENV RES PUB HE, V8, P1358, DOI 10.3390/ijerph8051358; Bloch D, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005075; Boyer S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091170; Butterworth MK, 2016, ENV HLTH PERSPECT, V125, P579; Caminade C, 2012, J R SOC INTERFACE, V9, P2708, DOI 10.1098/rsif.2012.0138; Campo Carey A. R., 2014, Informe Quincenal - Epidemiologico Nacional, V19, P342; CDC, 2016, AV MOSQ BIT; Abramides GC, 2013, T ROY SOC TROP MED H, V107, P706, DOI 10.1093/trstmh/trt093; Cherry CC, 2016, TRAVEL MED INFECT DI, V14, P475, DOI 10.1016/j.tmaid.2016.08.011; Chiu CY, 2015, EMERG INFECT DIS, V21, P1409, DOI 10.3201/eid2108.150458; D'Ortenzio E, 2011, EMERG INFECT DIS, V17, P309, DOI 10.3201/eid1702.101056; Delisle E, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES2015.20.17.21108; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Disha Mehta, 2015, Healthline, Journal of Indian Association of Preventive and Social Medicine, V6, P29; Doucoure S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/746509; Dumont Y, 2010, MATH BIOSCI ENG, V7, P313, DOI 10.3934/mbe.2010.7.313; Bedoya-Arias JE, 2015, J INFECT DEV COUNTR, V9, P330, DOI 10.3855/jidc.6445; Faddy HM, 2016, TRANSFUSION, V56, P1548, DOI 10.1111/trf.13519; Fernandez-Garcia MD, 2016, EURO SURVEILL, V21; Flahault A., 2011, Revue Medecine Tropicale, V72, P66; FREEMAN MF, 1950, ANN MATH STAT, V21, P607, DOI 10.1214/aoms/1177729756; Fritzell C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005081; Gabor JJ, 2016, TRAVEL MED INFECT DI, V14, P26, DOI 10.1016/j.tmaid.2016.01.005; Gallian P, 2014, BLOOD, V123, P3679, DOI 10.1182/blood-2014-03-564880; Ganushkina LA, 2016, VECTOR-BORNE ZOONOT, V16, P58, DOI 10.1089/vbz.2014.1761; Gerardin P, 2016, NEUROLOGY, V86, P94, DOI 10.1212/WNL.0000000000002234; Ghosh SK, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-599; Goddard Jerome, 2016, J Miss State Med Assoc, V57, P138; Goorah S, 2013, INTERNET J MED UPDAT, V8, P9; Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x; Gould LH, 2008, T ROY SOC TROP MED H, V102, P1247, DOI 10.1016/j.trstmh.2008.04.014; Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873; Guzzetta G, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005918; Harter KR, 2014, WEST J EMERG MED, V15, P841, DOI 10.5811/westjem.2014.8.23062; Healy K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108504; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ho KW, 2011, J INFECTION, V62, P263, DOI 10.1016/j.jinf.2011.02.001; Impoinvil DE, 2007, HEALTH POLICY, V83, P196, DOI 10.1016/j.healthpol.2007.01.009; Jain R, 2013, ANN TROP MED PUBLIC, V6, P297, DOI 10.4103/1755-6783.120987; Jain SK, 2007, INT J HEALTH SCI-IJH, V1, P303; Josseran L, 2006, EMERG INFECT DIS, V12, P1994; Knope K, 2014, COMMUN DIS INTELL Q, V38, pE122; Kuan G, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004773; Lalani T, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw043; Leo YS, 2009, EMERG INFECT DIS, V15, P836, DOI 10.3201/eid1505.081390; Lieshout-Krikke RW, 2013, VOX SANG, V104, P12, DOI 10.1111/j.1423-0410.2012.01631.x; Liew C, 2012, SINGAP MED J, V53, pE66; Liu XZ, 2015, APPL MATH MODEL, V39, P3194, DOI 10.1016/j.apm.2014.10.035; Liumbruno GM, 2008, BLOOD TRANSFUS-ITALY, V6, P199, DOI 10.2450/2008.0016-08; Lorenzi OD, 2016, MMWR-MORBID MORTAL W, V65, P479, DOI 10.15585/mmwr.mm6518e3; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Majra JP, 2011, ANN TROP MED PUBLIC, V4, P3, DOI 10.4103/1755-6783.80513; Mascarenhas M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207554; Mecoli M, 2013, COMPUT OPER RES, V40, P2219, DOI 10.1016/j.cor.2012.03.007; Millman AJ, 2016, AM J TROP MED HYG, V94, P1336, DOI 10.4269/ajtmh.15-0815; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Moro ML, 2010, AM J TROP MED HYG, V82, P508, DOI 10.4269/ajtmh.2010.09-0322; Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14; Moulay D, 2012, MATH BIOSCI ENG, V9, P369, DOI 10.3934/mbe.2012.9.369; Najera J. A., 2001, Parassitologia (Rome), V43, P1; Ndeffo-Mbah ML, 2016, SCI REP-UK, V6, DOI 10.1038/srep23997; Ndille EE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005109; Nhan TX, 2014, EMERG INFECT DIS, V20, P1773, DOI 10.3201/eid2010.141060; Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/eid1206.051210; Patil SS, 2013, J CLIN DIAGN RES, V7, P1059, DOI 10.7860/JCDR/2013/5330.3061; Peters JL, 2008, J EVAL CLIN PRACT, V14, P941, DOI 10.1111/j.1365-2753.2008.01010.x; Poletti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018860; Powers A, 2011, J GEN VIROL, V88, P2363; Ramful D, 2007, PEDIATR INFECT DIS J, V26, P811, DOI 10.1097/INF.0b013e3180616d4f; Raude J, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-002094; Raude J, 2009, HEALTH PLACE, V15, P689, DOI 10.1016/j.healthplace.2008.10.009; Renault P, 2007, AM J TROP MED HYG, V77, P727; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Salje H, 2016, P NATL ACAD SCI USA, V113, P13420, DOI 10.1073/pnas.1611391113; Schiavo R, 2014, PATHOG GLOB HEALTH, V108, P76, DOI 10.1179/2047773214Y.0000000127; Schilte C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002137; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Selvavinayagam T. S., 2007, Indian Journal of Community Medicine, V32, P286; Setbon M, 2008, POPULATION, V63, P555, DOI 10.3917/popu.803.0555; Seyler T, 2012, J ENVIRON HEALTH, V74, P8; Sorge F., 2011, Bulletin Epidemiologique Hebdomadaire, P54; Soulaphy C, 2013, WEST PAC SURVEILL RE, V4, P46, DOI [10.5365/WPSAR.2012.3.4.017, 10.5365/wpsar.2012.3.4.017]; Staikowsky F, 2008, EPIDEMIOL INFECT, V136, P196, DOI 10.1017/S0950268807008424; Surendran S. N., 2007, Tropical Medicine and Health, V35, P249, DOI 10.2149/tmh.35.249; Tan LK, 2013, ADV INFECT DIS, V3, P1; Tapasvi Puwar, 2010, Dengue Bulletin, V34, P40; Tenglikar P. V., 2016, National Journal of Community Medicine, V7, P223; THAUNG U, 1975, Southeast Asian Journal of Tropical Medicine and Public Health, V6, P580; Therrien C, 2016, CAN J INFECT DIS MED, V2016, DOI 10.1155/2016/2980297; Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009; Thuilliez J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002609; Tsiodras S, 2016, PATHOG GLOB HEALTH, V110, P68, DOI 10.1080/20477724.2016.1176311; Uc-Puc V, 2016, SALUD PUBLICA MEXICO, V58, P472, DOI 10.21149/spm.v58i4.8030; Uthappa CK, 2015, INDIAN J MED RES, V142, P108, DOI 10.4103/0971-5916.176637; Vaidya V, 2013, INDIAN J PUBLIC HLTH, V4, P438; Van Bortel W, 2014, EUROSURVEILLANCE, V19, P17, DOI 10.2807/1560-7917.ES2014.19.13.20759; van den Berg H, 2012, ENVIRON HEALTH PERSP, V120, P577, DOI 10.1289/ehp.1104340; van Genderen FT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004625; Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14; Vega-Rua A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059716; Vijayakumar K, 2010, NATL MED J INDIA, V23, P82; Vilain P, 2012, ACTA TROP, V123, P85, DOI 10.1016/j.actatropica.2012.03.009; Yoosuf AA, 2009, T ROY SOC TROP MED H, V103, P192, DOI 10.1016/j.trstmh.2008.09.006; Yoshikawa M. J., 2010, Tropical Medicine and Health, V38, P39, DOI 10.2149/tmh.2009-18; Zhang QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042830	116	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0212054	10.1371/journal.pone.0212054	http://dx.doi.org/10.1371/journal.pone.0212054			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811438	Green Published, Green Submitted, gold			2022-12-27	WOS:000459806400048
J	Korenromp, EL; Rowley, J; Alonso, M; Mello, MB; Wijesooriya, NS; Mahiane, SG; Ishikawa, N; Le, LV; Newman-Owiredu, M; Nagelkerke, N; Newman, L; Kamb, M; Broutet, N; Taylor, MM				Korenromp, Eline L.; Rowley, Jane; Alonso, Monica; Mello, Maeve B.; Wijesooriya, N. Saman; Mahiane, S. Guy; Ishikawa, Naoko; Linh-Vi Le; Newman-Owiredu, Morkor; Nagelkerke, Nico; Newman, Lori; Kamb, Mary; Broutet, Nathalie; Taylor, Melanie M.			Global burden of maternal and congenital syphilis and associated adverse birth outcomes-Estimates for 2016 and progress since 2012	PLOS ONE			English	Article							BLOOD-DONORS; HIV; SEROPREVALENCE; INFECTIONS; PREVALENCE; SERVICE; HEALTH; HCV	Background In 2007 the World Health Organization (WHO) launched the global initiative to eliminate mother-to-child transmission of syphilis (congenital syphilis, or CS). To assess progress towards the goal of <50 CS cases per 100,000 live births, we generated regional and global estimates of maternal and congenital syphilis for 2016 and updated the 2012 estimates. Methods Maternal syphilis estimates were generated using the Spectrum-STI model, fitted to sentinel surveys and routine testing of pregnant women during antenatal care (ANC) and other representative population data. Global and regional estimates of CS used the same approach as previous WHO estimates. Results The estimated global maternal syphilis prevalence in 2016 was 0.69% (95% confidence interval: 0.57-0.81%) resulting in a global CS rate of 473 (385-561) per 100,000 live births and 661,000 (538,000-784,000) total CS cases, including 355,000 (290,000-419,000) adverse birth outcomes (ABO) and 306,000 (249,000-363,000) non-clinical CS cases (infants without clinical signs born to un-treated mothers). The ABOs included 143,000 early fetal deaths and stillbirths, 61,000 neonatal deaths, 41,000 preterm or low-birth weight births, and 109,000 infants with clinical CS. Of these ABOs-203,000 (57%) occurred in pregnant women attending ANC but not screened for syphilis; 74,000 (21%) in mothers not enrolled in ANC, 55,000 (16%) in mothers screened but not treated, and 23,000 (6%) in mothers enrolled, screened and treated. The revised 2012 estimates were 0.70% (95% CI: 0.63-0.77%) maternal prevalence, and 748,000 CS cases (539 per 100,000 live births) including 397,000 (361,000-432,000) ABOs. The estimated decrease in CS case rates between 2012 and 2016 reflected increased access to ANC and to syphilis screening and treatment. Conclusions Congenital syphilis decreased worldwide between 2012 and 2016, although maternal prevalence was stable. Achieving global CS elimination, however, will require improving access to early syphilis screening and treatment in ANC, clinically monitoring all women diagnosed with syphilis and their infants, improving partner management, and reducing syphilis prevalence in the general population by expanding testing, treatment and partner referral beyond ANC.	[Korenromp, Eline L.] Avenir Hlth, Geneva, Switzerland; [Alonso, Monica; Mello, Maeve B.] Panamer Hlth Org, Dept Communicable Dis & Environm Determinants Hlt, Washington, DC USA; [Mahiane, S. Guy] Avenir Hlth, Glastonbury, CT USA; [Ishikawa, Naoko; Linh-Vi Le] WHO, Reg Off Western Pacific, Manila, Philippines; [Newman-Owiredu, Morkor] WHO, Subsaharan Africa Off, Brazzaville, Rep Congo; [Newman, Lori; Kamb, Mary] Ctr Dis Control & Prevent, Cambodia Country Off, Phnom Penh, Cambodia; [Broutet, Nathalie; Taylor, Melanie M.] USA Ctr Dis Control & Prevent, Div STD Prevent, Atlanta, GA USA; [Taylor, Melanie M.] WHO, Dept Reprod Hlth & Res, Geneva, Switzerland	WHO Western Pacific Regional Office; World Health Organization; World Health Organization; World Health Organization	Korenromp, EL (corresponding author), Avenir Hlth, Geneva, Switzerland.	ekorenromp@avenirhealth.org		Wijesooriya, Nalinka Saman/0000-0003-3447-0222; Ishikawa, Naoko/0000-0002-2701-6892	World Health Organization, Department of Reproductive Health and Research/Human Reproduction Programme; U.S. Centers for Disease Control and Prevention; Department of International Development (DfID) of the United Kingdom	World Health Organization, Department of Reproductive Health and Research/Human Reproduction Programme; U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Department of International Development (DfID) of the United Kingdom	The project was funded by the World Health Organization, Department of Reproductive Health and Research/Human Reproduction Programme. The analysis was furthermore supported by a cooperative agreement from the U.S. Centers for Disease Control and Prevention in support of prevention of mother-to-child transmission of syphilis, and by the Department of International Development (DfID) of the United Kingdom. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the World Health Organization, or the U.S. Centers for Disease Control and Prevention.	Amin TT, 2014, INT PUBLIC HLTH FORU, V1, P6; Ansbro EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127728; Arshad Aisha, 2016, BMC Hematol, V16, P27; Attaullah S, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-20; Avenir Health World Health Organization Reproductive Health and Research department, 2017, GUID COUNTR DAT NEED; Blencowe H, 2016, LANCET GLOB HEALTH, V4, pE98, DOI 10.1016/S2214-109X(15)00275-2; Blencowe H, 2011, BMC PUBLIC HEALTH, V11, DOI [10.1186/1471-2458-11-S3-S9, 10.1186/1471-2458-11-S3-S11]; Changalucha J, 2011, SEX TRANSM INFECT, V87, pA1, DOI 10.1136/sextrans-2011-050102.5; Darville T, 1999, Pediatr Rev, V20, P160, DOI 10.1542/pir.20-5-160; Dayan S, 2013, J INFECT DEV COUNTR, V7, P665, DOI 10.3855/jidc.2835; Demirel Y, 2004, SAUDI MED J, V25, P2037; Enkhbat E, 2017, CONGENITAL SYPHILIS; Ensari T, 2015, J INFECT DEV COUNTR, V9, P1011, DOI 10.3855/jidc.6064; Garcia PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066905; Gomez GB, 2013, B WORLD HEALTH ORGAN, V91, P217, DOI 10.2471/BLT.12.107623; Gottlieb SL, 2008, SEX TRANSM DIS, V35, P507, DOI 10.1097/OLQ.0b013e3181644bae; Ham D Cal, 2015, Int J Gynaecol Obstet, V130 Suppl 1, pS10, DOI 10.1016/j.ijgo.2015.04.012; Hawkes SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056713; Kahn JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087510; Korenromp EL, 2018, PAN AM J PUBLIC HLTH, V42, pe118, DOI DOI 10.26633/RPSP.2018.118; Korenromp EL, 2017, SEX TRANSM INFECT; Korenromp EL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29805-9; Lawn JE, 2016, LANCET, V387, P587, DOI 10.1016/S0140-6736(15)00837-5; Mohammadali F, 2014, ARCH IRAN MED, V17, P613, DOI 0141709/AIM.006; Moller AB, 2017, LANCET GLOB HEALTH, V5, pE977, DOI 10.1016/S2214-109X(17)30325-X; Munkhuu B, 2009, SEX TRANSM DIS, V36, P714, DOI 10.1097/OLQ.0b013e3181bc0960; Nazir S, 2013, ADVAN LIFE SCI, V1, P27; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Newman L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001396; Nurse-Findlay S, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002473; Owusu-Edusei K, 2014, SEX TRANSM DIS, V41, P103, DOI 10.1097/OLQ.0000000000000085; Pan-American Health Organization UNICEF, 2016, ELIM MOTH TO CHILD T; Qadeer MI, 2013, SEX TRANSM INFECT S1, V89; Qin JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102203; Rowley J, 2017, PILOT APPL SPECTRUM; Rowley J., 2017, SPECTRUM STI MODULE; Smolak A., 2017, CLIN INFECT DIS; UNICEF East Asia and Pacific Regional Office World Health Organization Western Pacific regional office UNAIDS, 2016, EL PAR TO CHILD TRAN; Waheed U., 2012, ANN PAK I MED SCI, V8, P236; WHO, 2020, WHO INF NOT US DUAL; WHO Regional Office for the Western Pacific, 2017, TRIPL EL MOTH TO CHI; Wijesooriya NS, 2016, LANCET GLOB HEALTH, V4, pE525, DOI 10.1016/S2214-109X(16)30135-8; World Health Organisation, 2017, 2016 GLOB STAT REP B; World Health Organization, 2016, 1609 WHORHR; World Health Organization, GUID US WHO TOOL EST; World Health Organization, 2014, GLOB GUID CRIT PROC; World Health Organization, 2016, WHO GUIDELINES TREAT; World Health Organization, 2018, WHO VAL EL MOTH TO C; World Health Organization, 2017, GLOB GUID CRIT PROC, V2nd	49	127	137	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211720	10.1371/journal.pone.0211720	http://dx.doi.org/10.1371/journal.pone.0211720			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811406	gold, Green Submitted, Green Published			2022-12-27	WOS:000459806400030
J	Wu, J; Niu, P; Zhao, YQ; Cheng, YY; Chen, WP; Lin, L; Lu, JM; Cheng, X; Xu, ZL				Wu, Juan; Niu, Ping; Zhao, Yueqiang; Cheng, Yanyang; Chen, Weiping; Lin, Lan; Lu, Jingmei; Cheng, Xue; Xu, Zhiliang			Impact of miR-223-3p and miR-2909 on inflammatory factors IL-6, IL-1 beta, and TNF-alpha, and the TLR4/TLR2/NF-kappa B/STAT3 signaling pathway induced by lipopolysaccharide in human adipose stem cells	PLOS ONE			English	Article							STROMAL CELLS; EXPRESSION; MACROPHAGES; RESPONSES; INJURY	MicroRNAs (miRNAs) are small non-coding RNA molecules that play an important role in the regulation of gene expression related to inflammatory responses. Human adipose stem cells are characterized by pluripotent differentiation potential and isolated from adipose tissues. These cells regulate inflammation mainly by interacting with immune cells and affecting the secretion of immune factors; details of this interaction are currently unknown. In the current study, we successfully established an acute inflammation model and a chronic inflammation model involving adipose stem cells. We used high-throughput miRNA microarray analysis to identify miRNAs that were significantly (p < 0.05) differentially expressed during both acute and chronic inflammation. Lipopolysaccharide (LPS) significantly (p < 0.05) reduced the expression of miR-223-3P and miR-2909, while promoting the production of pro-inflammatory cytokines, interleukin (IL) 6, IL-1 beta, and tumor necrosis factor (TNF)-alpha via the Toll-like receptor (TLR) 4/TLR2/nuclear factor (NF)-kappa B/signal transducer and activator of transcription (STAT) 3 signaling pathway in human adipose stem cells. Further, miR-2233P expression was significantly (p < 0.05) reduced in human adipose stem cells during activation by IL-6 stimulation. The inducible down-regulation of miR-223-3P resulted in the activation of STAT3, which was directly targeted by miR-223-3P. STAT3 directly targeted TLR4 and TLR2, promoting the production of the pro-inflammatory cytokine, IL-6, and formed a positive feedback loop to regulate IL-6 levels. Similarly, TNF-alpha significantly (p < 0.05) increased the expression of miR-223-3p, with LPS and TLR4/TLR2/NF-kappa B/STAT3 forming a negative feedback loop to regulate TNF-alpha levels. In addition, miR-2909, which depends on NF-kappa B, targeted Krueppel-like factor (KLF) 4 to regulate the levels of pro-inflammatory cytokines, IL-6, IL-1 beta, and TNF-alpha. We conclude that miR-223-3p and miR-2909 form a complex regulatory network with pro-inflammatory factors and signaling pathways in adipose stem cells stimulated by LPS. These findings will inform the development of therapies against autoimmune and inflammatory diseases.	[Wu, Juan; Niu, Ping; Zhao, Yueqiang; Cheng, Yanyang; Chen, Weiping; Lin, Lan; Lu, Jingmei; Cheng, Xue; Xu, Zhiliang] Wuhan Univ, Ren Min Hosp, Dept Pediat, Wuhan, Hubei, Peoples R China	Wuhan University	Xu, ZL (corresponding author), Wuhan Univ, Ren Min Hosp, Dept Pediat, Wuhan, Hubei, Peoples R China.	zlxu-rm@163.com	Chen, Wei/GZK-7348-2022		Wuhan Applied Basic Research Program [2015061701011643]	Wuhan Applied Basic Research Program	This work was supported by grants from the Wuhan Applied Basic Research Program (2015061701011643), which is a government organisation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora M, 2014, MOL CELL BIOCHEM, V392, P49, DOI 10.1007/s11010-014-2017-3; Baloh RH, 2018, CURR OPIN NEUROL, V31, P655, DOI 10.1097/WCO.0000000000000598; Berenstein R, 2016, MOL CARCINOGEN, V55, P1927, DOI 10.1002/mc.22440; Chavarria-Velazquez CO, 2017, IMMUNOBIOLOGY, V223, P38, DOI 10.1016/j.imbio.2017.10.016; Chen QY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037149, 10.1371/journal.pone.0042971]; Chen T, 2018, CELL MOL LIFE SCI, V75, P4079, DOI 10.1007/s00018-018-2859-z; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Dorhoi A, 2013, J CLIN INVEST, V123, P4836, DOI 10.1172/JCI67604; Engin AB, 2017, ADV EXP MED BIOL, V960, P327, DOI 10.1007/978-3-319-48382-5_14; Garibotto G, 2017, J NEPHROL, V30, P719, DOI 10.1007/s40620-017-0432-8; Ha TZ, 2010, CARDIOVASC RES, V87, P694, DOI 10.1093/cvr/cvq116; Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004; Melief SM, 2013, STEM CELLS, V31, P1980, DOI 10.1002/stem.1432; Moqadam FA, 2014, LEUKEMIA, V28, P1008, DOI 10.1038/leu.2013.308; Moriya N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169702; Niu GC, 2018, BMC GASTROENTEROL, V18, DOI 10.1186/s12876-018-0850-7; Nojehdehi S, 2018, J CELL BIOCHEM, V119, P9433, DOI 10.1002/jcb.27260; Paeng SH, 2015, INT J MOL MED, V36, P808, DOI 10.3892/ijmm.2015.2266; Pan GF, 2017, INT IMMUNOPHARMACOL, V52, P119, DOI 10.1016/j.intimp.2017.08.030; Peng SC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-308; Perlee D, 2018, STEM CELLS, V36, P1778, DOI 10.1002/stem.2891; Poon KS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09709-w; Rahimifard M, 2017, AGEING RES REV, V36, P11, DOI 10.1016/j.arr.2017.02.004; Raicevic G, 2010, HUM IMMUNOL, V71, P235, DOI 10.1016/j.humimm.2009.12.005; Sharma M, 2013, GENE, V522, P60, DOI 10.1016/j.gene.2013.03.058; Slomiany BL, 2017, INFLAMMOPHARMACOLOGY, V25, P415, DOI 10.1007/s10787-017-0360-1; Sun KY, 2017, CYTOKINE, V92, P1, DOI 10.1016/j.cyto.2017.01.003; Ulbrich F, 2016, J NEUROCHEM, V138, P859, DOI 10.1111/jnc.13662; Wang JJ, 2016, AM J TRANSL RES, V8, P615; Wang J, 2015, INT J MOL SCI, V16, P24965, DOI 10.3390/ijms161024965; Wang XH, 2014, BBA-MOL BASIS DIS, V1842, P701, DOI 10.1016/j.bbadis.2014.01.012; Xu LL, 2016, MOL MED REP, V13, P5005, DOI 10.3892/mmr.2016.5168; Yan L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01658; Yoon S, 2010, AUTOPHAGY, V6, P1125, DOI 10.4161/auto.6.8.13547; Zhang M, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15028297; Zhang NJ, 2017, MOL IMMUNOL, V91, P42, DOI 10.1016/j.molimm.2017.08.026; Zhu JP, 2016, PHARM BIOL, V54, P347, DOI 10.3109/13880209.2015.1042981; Zulueta A, 2018, CELL SIGNAL, V51, P110, DOI 10.1016/j.cellsig.2018.07.015	38	44	49	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0212063	10.1371/journal.pone.0212063	http://dx.doi.org/10.1371/journal.pone.0212063			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807577	Green Submitted, gold, Green Published			2022-12-27	WOS:000459712100011
J	Artzner, T; Clere-Jehl, R; Schenck, M; Greget, M; Merdji, H; De Marini, P; Tuzin, N; Helms, J; Meziani, F				Artzner, Thierry; Clere-Jehl, Raphael; Schenck, Malika; Greget, Michel; Merdji, Hamid; De Marini, Pierre; Tuzin, Nicolas; Helms, Julie; Meziani, Ferhat			Spontaneous ilio-psoas hematomas complicating intensive care unit hospitalizations	PLOS ONE			English	Article							DISSEMINATED INTRAVASCULAR COAGULATION; SEPTIC SHOCK; MULTICENTER; PREVALENCE; HEMORRHAGE	Background Ilio-psoas hematoma is a potentially lethal condition that can arise during hospital stay. However, neither the incidence nor the prognosis of patients whose stay in intensive care units (ICU) is complicated by a iatrogenic ilio-psoas hematoma is known. Methods A bicentric retrospective study was conducted to compile the patients who developed an ilio-psoas hematoma while they were hospitalized in ICU between January 2009 and December 2016. Their biometric characteristics, pre-existing conditions, the circumstances in which the hematoma was diagnosed, the treatments they received and their prognosis were recorded. Results Forty patients were diagnosed with an ilio-psoas hematoma during their ICU stay. The incidence of this complication was 3.8 cases for 1000 admissions, taking into account only patients who stayed more than three days in ICU. The median age of patients was 74 years old and the median time between admission and the diagnosis of ilio-psoas hematoma was 12.6 days. A large proportion of them was obese (42.5%) and/or under dialysis (50%) prior to developing their hematoma. Ninety-five percent of the patients had heparin at prophylactic or therapeutic doses. Only 10% of them were above the therapeutic range of anticoagulation. The ICU mortality rate was of 50% following this complication (versus a general mortality rate of 22% for the patients without IPH over the same period of time). Patients with IPH that were complicated by disseminated intravascular coagulopathy had a significantly higher mortality rate than those with IPH and no disseminated intravascular coagulopathy (OR 6.91, 95% CI [1.28; 58.8], p = 0.04). Conclusion Age, anticoagulation, a high body mass index and dialysis seem to be risk factors of developing an ilio-psoas hematoma in ICU. Iatrogenic ilio-psoas hematomas complicated by disseminated intravascular coagulopathies are more at risk of leading to death. It is noteworthy that activated partial thromboplastin time above the therapeutic range was not a good predictor of developing a hematoma for patients who received unfractioned heparin therapy.	[Artzner, Thierry; Clere-Jehl, Raphael; Merdji, Hamid; Helms, Julie; Meziani, Ferhat] Univ Strasbourg UNISTRA, Fac Med, Hop Univ Strasbourg, Serv Reanim Med,Nouvel Hop Civil, Strasbourg, France; [Clere-Jehl, Raphael; Helms, Julie] Univ Strasbourg, ImmunoRhumatol Mol, INSERM,Fac Med,Federat Hosp Univ FHU OMICARE,FMTS, UMR S1109,LabEx TRANSPLANTEX,Ctr Rech Immunol & H, Strasbourg, France; [Schenck, Malika] Hop Univ Strasbourg, Hop Hautepierre, Serv Reanimat Med, Strasbourg, France; [Greget, Michel; De Marini, Pierre] Hop Univ Strasbourg, Serv Imagerie Intervent, Strasbourg, France; [Merdji, Hamid; Meziani, Ferhat] French Natl Inst Hlth & Med Res, INSERM, UMR 1260, Regenerat Nanomed RNM,FMTS, Strasbourg, France; [Tuzin, Nicolas] Hop Univ Strasbourg, Lab Biostat & Informat Med, ICube UMR 7357, Fac Med, Strasbourg, France; [Tuzin, Nicolas] Hop Univ Strasbourg, Grp Methode Rech Clin, Serv Sante Publ, Strasbourg, France	CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Meziani, F (corresponding author), Univ Strasbourg UNISTRA, Fac Med, Hop Univ Strasbourg, Serv Reanim Med,Nouvel Hop Civil, Strasbourg, France.; Meziani, F (corresponding author), French Natl Inst Hlth & Med Res, INSERM, UMR 1260, Regenerat Nanomed RNM,FMTS, Strasbourg, France.	ferhat.meziani@chru-strasbourg.fr	merdji, hamid/GXF-7656-2022; DE MARINI, Pierre/P-5110-2019	merdji, hamid/0000-0002-4670-1596; DE MARINI, Pierre/0000-0002-3760-1526				Bajaj SP, 1999, SEMIN THROMB HEMOST, V25, P407, DOI 10.1055/s-2007-994943; Boccardo P, 2004, SEMIN THROMB HEMOST, V30, P579, DOI 10.1055/s-2004-835678; Chan YC, 2008, INT J CLIN PRACT, V62, P1604, DOI 10.1111/j.1742-1241.2007.01494.x; De Waele JJ, 2003, INTENS CARE MED, V29, P332, DOI 10.1007/s00134-002-1578-x; Delabranche X, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0339-5; Delabranche X, 2016, CRIT CARE MED, V44, pE930, DOI 10.1097/CCM.0000000000001836; Delabranche X, 2013, INTENS CARE MED, V39, P1695, DOI 10.1007/s00134-013-2993-x; Gando S, 2006, CRIT CARE MED, V34, P625, DOI 10.1097/01.CCM.0000202209.42491.38; Goldhill DR, 1998, CRIT CARE MED, V26, P1337, DOI 10.1097/00003246-199808000-00017; Gonzalez C, 2003, MEDICINE, V82, P257, DOI 10.1097/00005792-200307000-00004; Guivarc'h M, 1997, J CHIR-PARIS, V134, P382; Hauguel M, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002161; HEIM M, 1982, ARCH ORTHOP TRAUM SU, V99, P195, DOI 10.1007/BF00379208; Kim HY, 2013, PLATELETS, V24, P213, DOI 10.3109/09537104.2012.684733; Llitjos JF, 2016, ANN INTENSIVE CARE, P6; Pezzini A, 2013, STROKE, V44, P1584, DOI 10.1161/STROKEAHA.111.000069; Rossaint R, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1265-x; Sakr Y, 2015, CRIT CARE MED, V43, P519, DOI 10.1097/CCM.0000000000000754; Sunga Kharmene L, 2012, J Emerg Med, V43, pe157, DOI 10.1016/j.jemermed.2011.06.006; Takemoto CM, 2013, AM J CLIN PATHOL, V139, P450, DOI 10.1309/AJCPS6OW6DYNOGNH	20	21	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0211680	10.1371/journal.pone.0211680	http://dx.doi.org/10.1371/journal.pone.0211680			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794573	Green Submitted, Green Published, gold			2022-12-27	WOS:000459709100022
J	Koudelova, J; Hoffmannova, E; Dupej, J; Veleminska, J				Koudelova, Jana; Hoffmannova, Eva; Dupej, Jan; Veleminska, Jana			Simulation of facial growth based on longitudinal data: Age progression and age regression between 7 and 17 years of age using 3D surface data	PLOS ONE			English	Article							CHILDREN; FACE; ADOLESCENTS; MORPHOLOGY; ADIPOSITY; FEATURES; IMAGES; BMI; TRAJECTORIES; RECOGNITION	Modelling of the development of facial morphology during childhood and adolescence is highly useful in forensic and biomedical practice. However, most studies in this area fail to capture the essence of the face as a three-dimensional structure. The main aims of our present study were (1) to construct ageing trajectories for the female and male face between 7 and 17 years of age and (2) to propose a three-dimensional age progression (age-regression) system focused on real growth-related facial changes. Our approach was based on an assessment of a total of 522 three-dimensional (3D) facial scans of Czech children (39 boys, 48 girls) that were longitudinally studied between the ages of 7 to 12 and 12 to 17 years. Facial surface scans were obtained using a Vectra-3D scanner and evaluated using geometric morphometric methods (CPD-DCA, PCA, Hotelling's T-2 tests). We observed very similar growth rates between 7 and 10 years in both sexes, followed by an increase in growth velocity in both sexes, with maxima between 11 and 12 years in girls and 11 to 13 years in boys, which are connected with the different timing of the onset of puberty. Based on these partly different ageing trajectories for girls and boys, we simulated the effects of age progression (age regression) on facial scans. In girls, the mean error was 1.81 mm at 12 years and 1.7 mm at 17 years. In boys, the prediction system was slightly less successful: 2.0 mm at 12 years and 1.94 mm at 17 years. The areas with the greatest deviations between predicted and real facial morphology were not important for facial recognition. Changes of body mass index percentiles in children throughout the observation period had no significant influence on the accuracy of the age progression models for both sexes.	[Koudelova, Jana; Hoffmannova, Eva; Dupej, Jan; Veleminska, Jana] Charles Univ Prague, Fac Sci, Dept Anthropol & Human Genet, Prague, Czech Republic; [Dupej, Jan] Charles Univ Prague, Fac Math & Phys, Dept Software & Comp Sci, Prague, Czech Republic	Charles University Prague; Charles University Prague	Koudelova, J (corresponding author), Charles Univ Prague, Fac Sci, Dept Anthropol & Human Genet, Prague, Czech Republic.	spackovajana@email.cz	Dupej, Ján/AAC-9716-2020	Dupej, Ján/0000-0002-8808-7977; Veleminska, Jana/0000-0002-5213-951X	Charles University Grand Agency [656216]; Charles University Grant Agency [656216]	Charles University Grand Agency; Charles University Grant Agency	This research was supported by Charles University Grand Agency (https://www.cuni.cz/UK-33.html), grant number 656216.; This research was supported by the Charles University Grant Agency (project No. 656216).	Axelrod V, 2010, NEUROIMAGE, V52, P720, DOI 10.1016/j.neuroimage.2010.04.027; Bergman RT, 2014, ANGLE ORTHOD, V84, P48, DOI 10.2319/041513-291.1; Bulygina E, 2006, AM J PHYS ANTHROPOL, V131, P432, DOI 10.1002/ajpa.20317; Caplova Z, 2017, SCI JUSTICE, V57, P250, DOI 10.1016/j.scijus.2017.03.005; Cardenas-Esguerra M, 2012, INF CLEI 2012 38 C L; Cattaneo C, 2012, INT J LEGAL MED, V126, P139, DOI 10.1007/s00414-011-0564-7; Cattaneo C, 2009, FORENSIC SCI INT, V183, pE21, DOI 10.1016/j.forsciint.2008.09.005; Charman SD, 2012, J APPL RES MEM COGN, V1, P171, DOI 10.1016/j.jarmac.2012.07.008; Duong CN, 2017, IEEE I CONF COMP VIS, P3755, DOI 10.1109/ICCV.2017.403; Coetzee V, 2009, PERCEPTION, V38, P1700, DOI 10.1068/p6423; Cole TJ, 2005, EUR J CLIN NUTR, V59, P419, DOI 10.1038/sj.ejcn.1602090; Cole TJ, 1998, STAT MED, V17, P407, DOI 10.1002/(SICI)1097-0258(19980228)17:4&lt;407::AID-SIM742&gt;3.0.CO;2-L; Cunha E, 2009, FORENSIC SCI INT, V193, P1, DOI 10.1016/j.forsciint.2009.09.008; Djordjevic J, 2013, EUR J ORTHODONT, V35, P143, DOI 10.1093/ejo/cjr006; Dupej J, 2014, EUR S GEOM PROC; Enlow DH, 1996, ESSENTIALS FACIAL GR; Erickson WB, 2017, SCI JUSTICE, V57, P136, DOI 10.1016/j.scijus.2016.11.006; Evison MP, 1999, J FORENSIC SCI, V44; Ferrario VF, 2004, ANGLE ORTHOD, V74, P37; Ferrario VF, 2003, CLIN ANAT, V16, P420, DOI 10.1002/ca.10154; Ferrario VF, 1999, PLAST RECONSTR SURG, V103, P768, DOI 10.1097/00006534-199903000-00002; Freedman DS, 2005, INT J OBESITY, V29, P1, DOI 10.1038/sj.ijo.0802735; Freidline SE, 2015, AM J PHYS ANTHROPOL, V158, P116, DOI 10.1002/ajpa.22759; Fu Y, 2010, IEEE T PATTERN ANAL, V32, P1955, DOI 10.1109/TPAMI.2010.36; Geng X, 2006, LEARNING FACIAL AGIN, P307; Gibson SJ, 2009, FORENSIC SCI MED PAT, V5, P174, DOI 10.1007/s12024-009-9102-z; Green MA, 1999, J FORENSIC SCI, V44; Hodges-Simeon CR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153083; Hutton TJ, 2003, IEEE T MED IMAGING, V22, P747, DOI 10.1109/TMI.2003.814784; Jin H, 2017, COMPUT AIDED GEOM D, V50, P1, DOI 10.1016/j.cagd.2016.11.001; Kau CH, 2008, AM J ORTHOD DENTOFAC, V134, P751, DOI 10.1016/j.ajodo.2007.01.037; Kittler J, 2005, IEEE COMP SOC C COMP; Koudelova J, 2015, FORENSIC SCI INT, V248, P33, DOI 10.1016/j.forsciint.2014.12.005; Lampinen JM, 2015, PSYCHOL CRIME LAW, V21, P952, DOI 10.1080/1068316X.2015.1077245; Lampinen JM, 2012, APPL COGNITIVE PSYCH, V26, P167, DOI 10.1002/acp.1819; Liu JY, 2014, SIGNAL PROCESS, V94, P576, DOI 10.1016/j.sigpro.2013.07.025; Liu S, 2017, P 2017 ACM MULT C 82, P82; Longmore CA, 2015, Q J EXP PSYCHOL, V68, P249, DOI 10.1080/17470218.2014.939666; Mallett XDG, 2010, J FORENSIC SCI, V55, P1025, DOI 10.1111/j.1556-4029.2010.01425.x; Matthews H, 2018, FORENSIC SCI INT, V286, P61, DOI 10.1016/j.forsciint.2018.02.024; Matthews HS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22752-5; Mitteroecker P, 2013, HYSTRIX, V24, P59, DOI 10.4404/hystrix-24.1-6369; Mydlova M, 2015, FORENSIC SCI INT, V257, DOI 10.1016/j.forsciint.2015.09.008; Nute S J, 2000, J Orthod, V27, P31, DOI 10.1093/ortho/27.1.31; Machado CEP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180330; Primozic J, 2017, EUR J ORTHODONT, V39, P52, DOI 10.1093/ejo/cjw008; Ramanathan N., 2006, P IEEE COMP SOC C CO, P387, DOI DOI 10.1109/CVPR.2006.187; Ratnayake M, 2014, INT J LEGAL MED, V128, P803, DOI 10.1007/s00414-013-0875-y; Ritz-Timme S, 2000, INT J LEGAL MED, V113, P129, DOI 10.1007/s004140050283; Scandrett CM, 2006, PATTERN RECOGN LETT, V27, P1776, DOI 10.1016/j.patrec.2006.02.007; Scheffler C, 2013, J CRANIOFAC SURG, V24, P237, DOI 10.1097/SCS.0b013e31826d07a3; Sedlak P, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/823841; Shu XB, 2018, IEEE T PATTERN ANAL, V40, P905, DOI 10.1109/TPAMI.2017.2705122; Suwajanakorn S., 2014, TOTAL MOVING FACE RE; Tome P, 2013, FORENSIC SCI INT, V233, P75, DOI 10.1016/j.forsciint.2013.08.020; Veleminska J, 2012, HOMO, V63, P81, DOI 10.1016/j.jchb.2012.02.002; Vignerova J, 2007, ECON HUM BIOL, V5, P409, DOI 10.1016/j.ehb.2007.07.003; Vignerova J, 2006, PEDIAT PROPRAXI, V7, P171; Windhager S, 2013, AM J HUM BIOL, V25, P847, DOI 10.1002/ajhb.22444; Yang HY, 2016, IEEE T IMAGE PROCESS, V25, P2493, DOI 10.1109/TIP.2016.2547587	60	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212618	10.1371/journal.pone.0212618	http://dx.doi.org/10.1371/journal.pone.0212618			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794623	Green Submitted, Green Published, gold			2022-12-27	WOS:000459709100099
J	Ligita, T; Wicking, K; Francis, K; Harvey, N; Nurjannah, I				Ligita, Titan; Wicking, Kristin; Francis, Karen; Harvey, Nichole; Nurjannah, Intansari			How people living with diabetes in Indonesia learn about their disease: A grounded theory study	PLOS ONE			English	Article							SELF-MANAGEMENT EDUCATION; HEALTH; MELLITUS; CARE; COMMUNICATION; INDIVIDUALS; EMPOWERMENT; EXPERIENCES; PREVALENCE; OUTCOMES	Background Diabetes education has been found to impact positively on self-management by people with diabetes although little is known about the process by which they assimilate information. The aim of this study was to generate a theory explaining the process by which people with diabetes learn about their disease in Indonesia. Methods This study employed a grounded theory methodology influenced by constructivism and symbolic interactionism. A total of twenty-eight face-to-face or telephone interviews with participants from Indonesia that included people with diabetes, healthcare professionals, health service providers and families of people with diabetes were conducted in both Indonesia and Australia. Results This study discloses a core category of Learning, choosing, and acting: self-management of diabetes in Indonesia as the basic social process of how people learn about their diabetes. The process includes five distinctive major categories. People with diabetes acted after they had received recommendations that they considered to be trustworthy. Factors that influenced their choice of recommendations to adopt are also identified. Conclusions Awareness of the complexity involved in their decision making will assist healthcare professionals to engage effectively with people living with diabetes.	[Ligita, Titan; Wicking, Kristin; Francis, Karen; Nurjannah, Intansari] James Cook Univ, Coll Healthcare Sci, Nursing Midwifery & Nutr, Townsville, Qld, Australia; [Ligita, Titan] Univ Tanjungpura, Sch Nursing, Pontianak, Indonesia; [Francis, Karen] Univ Tasmania, Coll Hlth & Med, Sch Hlth Sci, Launceston, Tas, Australia; [Harvey, Nichole] James Cook Univ, Coll Med & Dent, Med, Townsville, Qld, Australia; [Nurjannah, Intansari] Univ Gadjahmada, Sch Nursing, Yogyakarta, Indonesia	James Cook University; Universitas Tanjungpura; University of Tasmania; James Cook University; Gadjah Mada University	Ligita, T (corresponding author), James Cook Univ, Coll Healthcare Sci, Nursing Midwifery & Nutr, Townsville, Qld, Australia.; Ligita, T (corresponding author), Univ Tanjungpura, Sch Nursing, Pontianak, Indonesia.	titan.ligita@my.jcu.edu.au	Nurjannah, Intansari/GNH-2409-2022; Francis, Karen/AAC-6291-2019; Francis, Karen/N-9318-2016	Francis, Karen/0000-0003-3578-2498; Wicking, Kristin/0000-0002-5996-6518	Department of Foreign Affairs and Trade, Australian Government; Australia Awards Scholarship [13/3377]	Department of Foreign Affairs and Trade, Australian Government; Australia Awards Scholarship	Department of Foreign Affairs and Trade, Australian Government provides the Australia Awards Scholarship funding for Titan Ligita's Doctor of Philosophy study at James Cook University. The Australia Awards Scholarship grant number 13/3377. www.australiaawardsindonesia.org/.; This paper is part of a doctoral degree program. The authors acknowledge the Department of Foreign Affairs and Trade, Australian Government, for the funding provided for Titan Ligita's Doctor of Philosophy study at James Cook University, Australia. The authors would like to thank the participants for their contributions to this study and appreciate the access to study settings for participant recruitment.	AlQarni ZA, 2016, J INFECT PUBLIC HEAL, V9, P708, DOI 10.1016/j.jiph.2016.08.015; [Anonymous], 2018, REGIONAL PROVINCE MI; [Anonymous], 2014, NATL STATEMENT HLTH; Arksey H., 2005, INT J SOC RES METHOD, V8, P19, DOI [10.1080/1364557032000119616, DOI 10.1080/1364557032000119616]; Birks M., 2015, GROUNDED THEORY PRAC; Blumer H., 1969, SYMB INTERACT; Bockwoldt D, 2017, J TRANSCULT NURS, V28, P363, DOI 10.1177/1043659616651674; Boels AM, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016180; Brunisholz KD, 2014, J MULTIDISCIP HEALTH, V7, P533, DOI 10.2147/JMDH.S69000; Burt R.S., 2005, BROKERAGE CLOSURE IN; Charmaz Kathy, 2014, INTRO QUALITATIVE ME, V2nd; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Creswell J.W., 2018, QUAL INQ, V4th; Edwards DJ, 2018, J CHILD HEALTH CARE, V22, P382, DOI 10.1177/1367493518760734; Eyuboglu E, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010186; Funnell MM, 2010, DIABETES CARE, V33, pS89, DOI 10.2337/dc10-S089; Glaser B.G., 1965, AWARENESS DYING; Grant MJ, 2009, HEALTH INFO LIBR J, V26, P91, DOI 10.1111/j.1471-1842.2009.00848.x; Greenhalgh T, 2005, BRIT MED J, V330, P628, DOI 10.1136/bmj.330.7492.628; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Hartayu TS, 2012, J PHARM HEALTH SERV, V3, P95, DOI 10.1111/j.1759-8893.2012.00088.x; Hartayu Titien Siwi, 2012, BMC Res Notes, V5, P315, DOI 10.1186/1756-0500-5-315; Herlitz A, 2016, HEALTH COMMUN, V31, P964, DOI 10.1080/10410236.2015.1025332; Hjelm K, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-11; Horigan G, 2017, DIABETIC MED, V34, P14, DOI 10.1111/dme.13120; IDF International Diabetes Federation, 2017, DIABETES ATLAS, V8th; Klein HA, 2013, NURS RES PRACT, V2013, DOI 10.1155/2013/581012; Lee YK, 2015, INT J NURS PRACT, V21, P125, DOI 10.1111/ijn.12355; Ligita T, 2018, INT NURSING REV; Mahdalena M, 2016, KESMAS NATL PUBLIC H, V11; Malini H, 2017, COLLEGIAN, V24, P183, DOI 10.1016/j.colegn.2015.11.002; Mays Nicholas, 2005, J Health Serv Res Policy, V10 Suppl 1, P6, DOI 10.1258/1355819054308576; Mendenhall E, 2016, ANTHROPOL MED, V23, P295, DOI 10.1080/13648470.2016.1184010; Moffatt A., 2012, INDONESIAN CULTURE P; Murray CM, 2016, PRIM CARE DIABETES, V10, P179, DOI 10.1016/j.pcd.2015.10.007; Naccashian Z, 2014, DIABETES EDUCATOR, V40, P638, DOI 10.1177/0145721714535993; National Institute for Health Research and Development, 2013, RIS KES DAS; National Institute for Health Research and Development, 2008, RIS KES DAS; Nutbeam D, 1998, HEALTH PROMOT INT, V13, P349, DOI 10.1093/heapro/13.4.349; Peng W, 2016, TELEMED E-HEALTH, V22, P733, DOI 10.1089/tmj.2015.0180; Pitaloka D, 2015, QUAL HEALTH RES, V25, P1155, DOI 10.1177/1049732315577607; Powers MA, 2017, DIABETES EDUCATOR, V43, P40, DOI 10.1177/0145721716689694; Pramono LA, 2015, MED J INDONES, V24, P67, DOI 10.13181/mji.v24i2.1260; QSR International Pty Ltd, 2016, NVIVO QUAL DAT ANL S; Quandt SA, 2013, J APPL GERONTOL, V32, P783, DOI 10.1177/0733464811435506; Rehackova L, 2017, DIABETIC MED, V34, P1554, DOI 10.1111/dme.13426; Rudijanto A., 2011, J ASEAN FED ENDOCR S, V26, P17; Saldana J, 2013, CODING MANUAL QUALIT; Sja'bani Mohammad, 2005, Acta Med Indones, V37, P199; Soebardi Suharko, 2009, Acta Med Indones, V41, P186; Soegondo S, 2009, MED J INDONES, V18, P124; Soewondo P, 2010, MED J INDONES, V19, P235; Soewondo P, 2013, DIABETES RES CLIN PR, V100, pS47, DOI 10.1016/S0168-8227(13)70010-X; Sutanegara D, 2000, DIABETES RES CLIN PR, V50, pS9, DOI 10.1016/S0168-8227(00)00173-X; Tanto A, 2017, AS AC SOC INT C P KH; Wan CR, 2012, PATIENT EDUC COUNS, V87, P402, DOI 10.1016/j.pec.2011.09.010; Webster E, 2017, AUST NZ J PUBL HEAL, V41, P27, DOI 10.1111/1753-6405.12605; White RO, 2016, J HEALTH COMMUN, V21, P127, DOI 10.1080/10810730.2016.1207116; White RO, 2015, PATIENT EDUC COUNS, V98, P144, DOI 10.1016/j.pec.2014.10.019; World Health Organization, 2016, IND DIAB COUNTR PROF; Youngson A, 2015, BRIT J OCCUP THER, V78, P24, DOI 10.1177/0308022614561240	62	24	24	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212019	10.1371/journal.pone.0212019	http://dx.doi.org/10.1371/journal.pone.0212019			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794570	Green Published, Green Accepted, gold			2022-12-27	WOS:000459709100031
J	Lofstedt, T; Brynolfsson, P; Asklund, T; Nyholm, T; Garpebring, A				Lofstedt, Tommy; Brynolfsson, Patrik; Asklund, Thomas; Nyholm, Tufve; Garpebring, Anders			Gray-level invariant Haralick texture features	PLOS ONE			English	Article							PROSTATE-CANCER; MR-IMAGES; FDG-PET; CLASSIFICATION; RADIOMICS; PREDICTION; MODEL; IDENTIFICATION; INFORMATION; STATISTICS	Haralick texture features are common texture descriptors in image analysis. To compute the Haralick features, the image gray-levels are reduced, a process called quantization. The resulting features depend heavily on the quantization step, so Haralick features are not reproducible unless the same quantization is performed. The aim of this work was to develop Haralick features that are invariant to the number of quantization gray-levels. By redefining the gray-level co-occurrence matrix (GLCM) as a discretized probability density function, it becomes asymptotically invariant to the quantization. The invariant and original features were compared using logistic regression classification to separate two classes based on the texture features. Classifiers trained on the invariant features showed higher accuracies, and had similar performance when training and test images had very different quantizations. In conclusion, using the invariant Haralick features, an image pattern will give the same texture feature values independent of image quantization.	[Lofstedt, Tommy; Brynolfsson, Patrik; Asklund, Thomas; Nyholm, Tufve; Garpebring, Anders] Umea Univ, Dept Radiat Sci, Umea, Sweden	Umea University	Brynolfsson, P (corresponding author), Umea Univ, Dept Radiat Sci, Umea, Sweden.	patrik.brynolfsson@umu.se	Brynolfsson, Patrik/Y-1184-2019; Brynolfsson, Patrik/AAI-3979-2020	Brynolfsson, Patrik/0000-0002-0455-8904; Nyholm, Tufve/0000-0002-8971-9788				Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5644; Ahmed A, 2013, J MAGN RESON IMAGING, V38, P89, DOI 10.1002/jmri.23971; Assefa D, 2010, MED PHYS, V37, P1722, DOI 10.1118/1.3357289; Bhat NN, 2016, MEASUREMENT, V90, P500, DOI 10.1016/j.measurement.2016.05.022; Brynolfsson P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04151-4; Brynolfsson P, 2014, MED PHYS, V41, DOI 10.1118/1.4894812; CHAN HP, 1995, PHYS MED BIOL, V40, P857, DOI 10.1088/0031-9155/40/5/010; Chen W, 2007, MAGN RESON MED, V58, P562, DOI 10.1002/mrm.21347; Cho HH, 2017, IEEE ENG MED BIO, P3081, DOI 10.1109/EMBC.2017.8037508; Clausi DA, 2000, PATTERN RECOGN, V33, P1835, DOI 10.1016/S0031-3203(99)00181-8; Clausi DA, 2002, CAN J REMOTE SENS, V28, P45, DOI 10.5589/m02-004; Fernandez-Lozano C, 2016, SCI REP-UK, V6, DOI 10.1038/srep19256; Fjeldbo CS, 2016, CLIN CANCER RES, V22, P4067, DOI 10.1158/1078-0432.CCR-15-2322; Gomez W, 2012, IEEE T MED IMAGING, V31, P1889, DOI 10.1109/TMI.2012.2206398; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hastie T.J., 2001, ELEMENTS STAT LEARNI; Kumar V, 2012, MAGN RESON IMAGING, V30, P1234, DOI 10.1016/j.mri.2012.06.010; Lambin P, 2012, EUR J CANCER, V48, P441, DOI 10.1016/j.ejca.2011.11.036; Leijenaar RTH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11075; LERSKI R A, 1979, Ultrasound in Medicine and Biology, V5, P341, DOI 10.1016/0301-5629(79)90004-8; Li H, 2012, J DIGIT IMAGING, V25, P591, DOI 10.1007/s10278-012-9452-z; Li QH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14753-7; Livens S., 1997, Sixth International Conference on Image Processing and its Applications (Conf. Publ. No.443), P581, DOI 10.1049/cp:19970958; Lovinfosse P, 2018, EUR J NUCL MED MOL I, V45, P365, DOI 10.1007/s00259-017-3855-5; Mayerhoefer ME, 2010, J MAGN RESON IMAGING, V32, P352, DOI 10.1002/jmri.22268; Mayerhoefer ME, 2009, MED PHYS, V36, P1236, DOI 10.1118/1.3081408; Nie K, 2008, ACAD RADIOL, V15, P1513, DOI 10.1016/j.acra.2008.06.005; Nyholm T, 2015, RADIOTHER ONCOL, V115, pS837; OJALA T, 1994, INT C PATT RECOG, P582, DOI 10.1109/ICPR.1994.576366; Ou X, 2014, INT J PHARMACEUT, V460, P28, DOI 10.1016/j.ijpharm.2013.10.024; Raheja JL, 2013, OPTIK, V124, P6469, DOI 10.1016/j.ijleo.2013.05.004; Ryu YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108335; Schad Lothar R, 2004, Dialogues Clin Neurosci, V6, P235; Shafiq-ul-Hassan M, 2017, MED PHYS, V44, P1050, DOI 10.1002/mp.12123; Sirinukunwattana K, 2017, MED IMAGE ANAL, V35, P489, DOI 10.1016/j.media.2016.08.008; Sirinukunwattana K, 2015, IEEE T MED IMAGING, V34, P2366, DOI 10.1109/TMI.2015.2433900; SKORTON DJ, 1983, CIRCULATION, V68, P834, DOI 10.1161/01.CIR.68.4.834; Soh LK, 1999, IEEE T GEOSCI REMOTE, V37, P780, DOI 10.1109/36.752194; Torheim T, 2014, IEEE T MED IMAGING, V33, P1648, DOI 10.1109/TMI.2014.2321024; ULABY FT, 1986, IEEE T GEOSCI REMOTE, V24, P235, DOI 10.1109/TGRS.1986.289643; Vallieres M, 2015, PHYS MED BIOL, V60, P5471, DOI 10.1088/0031-9155/60/14/5471; Marcos JV, 2015, MICRON, V68, P36, DOI 10.1016/j.micron.2014.09.002; Vignati A, 2015, PHYS MED BIOL, V60, P2685, DOI 10.1088/0031-9155/60/7/2685; VijayaLakshmi B, 2016, COMPUT ELECTRON AGR, V125, P99, DOI 10.1016/j.compag.2016.04.033; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Wibmer A, 2015, EUR RADIOL, V25, P2840, DOI 10.1007/s00330-015-3701-8	46	58	60	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212110	10.1371/journal.pone.0212110	http://dx.doi.org/10.1371/journal.pone.0212110			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794577	Green Published, gold, Green Submitted			2022-12-27	WOS:000459709100037
J	Rodriguez, AE; Bogart, C; Gilbert, CM; McCullers, JA; Smith, AM; Kanneganti, TD; Lupfer, CR				Rodriguez, Angeline E.; Bogart, Christopher; Gilbert, Christopher M.; McCullers, Jonathan A.; Smith, Amber M.; Kanneganti, Thirumala-Devi; Lupfer, Christopher R.			Enhanced IL-1 beta production is mediated by a TLR2-MYD88-NLRP3 signaling axis during coinfection with influenza A virus and Streptococcus pneumoniae	PLOS ONE			English	Article							ALVEOLAR MACROPHAGE PHAGOCYTOSIS; PNEUMOCOCCAL PNEUMONIA; BACTERIAL PNEUMONIA; INFLAMMATORY CASPASES; PANDEMIC INFLUENZA; MOUSE MODEL; GASDERMIN D; ACTIVATION; INFECTIONS; SUSCEPTIBILITY	Viral-bacterial coinfections, such as with influenza A virus and Streptococcus pneumoniae (S.p.), are known to cause severe pneumonia. It is well known that the host response has an important role in disease. Interleukin-1 beta (IL-1 beta) is an important immune signaling cytokine responsible for inflammation and has been previously shown to contribute to disease severity in numerous infections. Other studies in mice indicate that IL-1 beta levels are dramatically elevated during IAV-S.p. coinfection. However, the regulation of IL-1 beta during coinfection is unknown. Here, we report the NLRP3 inflammasome is the major inflammasome regulating IL-1 beta activation during coinfection. Furthermore, elevated IL-1 beta mRNA expression is due to enhanced TLR2-MYD88 signaling, which increases the amount of pro-IL-1 beta substrate for the inflammasome to process. Finally, NLRP3 and high IL-1 beta levels were associated with increased bacterial load in the brain. Our results show the NLRP3 inflammasome is not protective during IAV-S.p. coinfection.	[Rodriguez, Angeline E.; Bogart, Christopher; Lupfer, Christopher R.] Missouri State Univ, Dept Biol, Springfield, MO 65897 USA; [Gilbert, Christopher M.] Cox Med Ctr South, Dept Pathol, Springfield, MO USA; [McCullers, Jonathan A.; Smith, Amber M.] Univ Tennessee, Dept Pediat, Hlth Sci Ctr, Memphis, TN USA; [Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Rodriguez, Angeline E.] Univ Arkansas, Dept Poultry Sci, Fayetteville, AR 72701 USA	Missouri State University; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; University of Arkansas System; University of Arkansas Fayetteville	Lupfer, CR (corresponding author), Missouri State Univ, Dept Biol, Springfield, MO 65897 USA.	ChristopherLupfer@missouristate.edu	Kanneganti, Thirumala-Devi/Y-2503-2019	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Smith, Amber/0000-0002-7092-6904	National Institutes of Health [R56 AI125324, K25 AI00946]; American Lebanese Syrian Associated Charities; Missouri State University Grant [F07314]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K25AI100946, R56AI125324, R01AI139088] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); Missouri State University Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants R56 AI125324 (AMS) and K25 AI00946 (AMS), the American Lebanese Syrian Associated Charities (JAM and TDK) and Missouri State University Grant F07314 (CRL). AMS received salary support from the National Institutes of Health grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The results publish here do not necessarily reflect the views of the funding agencies.	Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Bansal S, 2018, J IMMUNOL, V200, P1425, DOI 10.4049/jimmunol.1700210; Brundage JF, 2008, EMERG INFECT DIS, V14, P1193, DOI 10.3201/eid1408.071313; Califano D, 2018, J IMMUNOL, V201, P134, DOI 10.4049/jimmunol.1701406; Casalino E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182191; Colamussi ML, 1999, BLOOD, V93, P2395, DOI 10.1182/blood.V93.7.2395.407a22_2395_2403; Dawood FS, 2014, J INFECT DIS, V209, P686, DOI 10.1093/infdis/jit473; Engelich G, 2001, J LEUKOCYTE BIOL, V69, P50; Fang RD, 2014, INFECT IMMUN, V82, P2310, DOI 10.1128/IAI.01572-14; Fang RD, 2011, J IMMUNOL, V187, P4890, DOI 10.4049/jimmunol.1100381; Ghoneim HE, 2014, J INFECT DIS, V209, P1459, DOI 10.1093/infdis/jit653; Ghoneim HE, 2013, J IMMUNOL, V191, P1250, DOI 10.4049/jimmunol.1300014; Han K, 2011, CLIN INFECT DIS, V53, P326, DOI 10.1093/cid/cir398; HARTSHORN KL, 1995, J IMMUNOL, V154, P3952; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; JAKAB GJ, 1982, AM REV RESPIR DIS, V126, P778; Karunanithi K, 2017, UNIVERSAL J MED SCI, DOI [10.13189/ujmsj.2015.030401, DOI 10.13189/UJMSJ.2015.030401]; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kudva A, 2011, J IMMUNOL, V186, P1666, DOI 10.4049/jimmunol.1002194; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Lee B, 2015, AM J PHYSIOL-LUNG C, V309, pL158, DOI 10.1152/ajplung.00338.2014; Lupfer C, 2008, ARCH VIROL, V153, P929, DOI 10.1007/s00705-008-0067-0; Lupfer C, 2013, NAT IMMUNOL, V14, P480, DOI 10.1038/ni.2563; Lynnelle A, 2006, INFECT INFECT IMMUNI, V74, P6707, DOI [10.1128/IAI.00789-06, DOI 10.1128/IAI.00789-06]; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; McCullers JA, 2002, J INFECT DIS, V186, P341, DOI 10.1086/341462; McCullers JA, 2014, NAT REV MICROBIOL, V12, P252, DOI 10.1038/nrmicro3231; McGuire LW, 1918, AM J PUBLIC HEALTH, V8, P741, DOI 10.2105/AJPH.8.10.741; Metzger DW, 2013, J IMMUNOL, V191, P2047, DOI 10.4049/jimmunol.1301152; Mina MJ, 2015, J INTERF CYTOK RES, V35, P474, DOI 10.1089/jir.2014.0087; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Nakamura S, 2011, J CLIN INVEST, V121, P3657, DOI 10.1172/JCI57762; Nedel Wagner Luis, 2016, World J Crit Care Med, V5, P89, DOI 10.5492/wjccm.v5.i1.89; O'Brien KL, 2000, CLIN INFECT DIS, V30, P784, DOI 10.1086/313772; Peltola VT, 2004, PEDIATR INFECT DIS J, V23, pS87, DOI 10.1097/01.inf.0000108197.81270.35; Pittet LA, 2010, AM J RESP CELL MOL, V42, P450, DOI 10.1165/rcmb.2007-0417OC; Robinson KM, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97470; Robinson KM, 2015, CURR OPIN IMMUNOL, V34, P59, DOI 10.1016/j.coi.2015.02.002; Robinson KM, 2013, J IMMUNOL, V191, P5153, DOI 10.4049/jimmunol.1301237; Rudd Jennifer M, 2016, J Infect Pulm Dis, V2, DOI 10.16966/2470-3176.114; Rynda-Apple A, 2015, INFECT IMMUN, V83, P3764, DOI 10.1128/IAI.00298-15; Seki M, 2004, EUR RESPIR J, V24, P143, DOI 10.1183/09031936.04.00126103; Seki M, 2007, INTERNAL MED, V46, P953, DOI 10.2169/internalmedicine.46.6364; Shahangian A, 2009, J CLIN INVEST, V119, P1910, DOI 10.1172/JCI35412; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Smith AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep38703; Smith AM, 2014, CURR TOP MICROBIOL, V385, P327, DOI 10.1007/82_2014_394; Smith AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003238; Smith MW, 2007, COMPARATIVE MED, V57, P82; Soper GA, 1918, SCIENCE, V48, P451, DOI 10.1126/science.48.1245.451; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; van der Sluijs KF, 2004, J IMMUNOL, V172, P7603, DOI 10.4049/jimmunol.172.12.7603; van Lieshout MHP, 2018, EUR J IMMUNOL, V48, P66, DOI 10.1002/eji.201646554; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	58	22	25	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212236	10.1371/journal.pone.0212236	http://dx.doi.org/10.1371/journal.pone.0212236			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794604	Green Submitted, Green Published, gold			2022-12-27	WOS:000459709100048
J	Sung, SH; Lee, CW; Wang, PN; Lee, HY; Chen, CH; Chung, CP				Sung, Shih-Hsien; Lee, Ching-Wei; Wang, Pei-Ning; Lee, Hsiang-Ying; Chen, Chen-Huan; Chung, Chih-Ping			Cognitive functions and jugular venous reflux in severe mitral regurgitation: A pilot study	PLOS ONE			English	Article							WHITE-MATTER CHANGES; DEMENTIA; IMPAIRMENT; DISEASE; SYSTEM	Cardiac diseases with elevated central venous pressure have higher frequency of jugular venous reflux (JVR), which is associated with decreased cerebral blood flow and white matter hyperintensities. Whether patients with severe mitral-regurgitation (SMR) have poorer cognitive functions and whether JVR is involved were determined in this pilot study. Patients with SMR and age/sex-matched controls were prospectively recruited. Neuropsychological tests such as global cognitive (Mini-Mental State Examination, MMSE), verbal memory, executive, and visuospatial domains were performed. Cardiac parameters by cardiac catheterisation and echocardiography, and the frequency of JVR by colour-coded duplex ultrasonography were obtained. Forty patients with SMR and 40 controls (71.1 +/- 12.2, 38-89 years; 75% men) were included. Compared with the controls, patients with SMR had lower scores in all neuropsychological tests but only MMSE and visuospatial test scores were statistically significant after adjusting for age, sex, and educational level. We further adjusted for cardiovascular risk factors; the significance remained in the visuospatial test but diminished in MMSE. Multivariate linear regression analyses adjusted for age, sex, and educational level showed that JVR combined with high right-atrial-pressure (RAP > 50th-percentile, 12 mmHg) was significantly associated with poorer performances in both MMSE [right JVR: B coefficient(95% confidence interval, p) = -2.83(-5.46-0.20, 0.036); left JVR: -2.77(-5.52-0.02, 0.048)] and visuospatial test [right JVR: -4.52(-8.89-0.16, 0.043); left JVR: -4.56 (-8.81-0.30, 0.037)], with significances that remained after further adjusting for cardiovascular risk factors. Our pilot results suggest that retrogradely-transmitted venous pressure might be involved in the mechanisms mediating the relationship between cardiac diseases and brain functions.	[Sung, Shih-Hsien; Lee, Ching-Wei; Chen, Chen-Huan] Taipei Vet Gen Hosp, Div Cardiol, Dept Med, Taipei, Taiwan; [Sung, Shih-Hsien; Lee, Ching-Wei; Chen, Chen-Huan] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei, Taiwan; [Sung, Shih-Hsien; Chen, Chen-Huan] Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan; [Sung, Shih-Hsien; Lee, Ching-Wei; Wang, Pei-Ning; Chen, Chen-Huan; Chung, Chih-Ping] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Wang, Pei-Ning; Lee, Hsiang-Ying; Chung, Chih-Ping] Taipei Vet Gen Hosp, Neurol Inst, Dept Neurol, Taipei, Taiwan; [Wang, Pei-Ning] Natl Yang Ming Univ, Brain Res Ctr, Taipei, Taiwan; [Chen, Chen-Huan] Taipei Vet Gen Hosp, Dept Med Educ, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Chung, CP (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Chung, CP (corresponding author), Taipei Vet Gen Hosp, Neurol Inst, Dept Neurol, Taipei, Taiwan.	pin324pin324@gmail.com	Chen, Chen-Huan/AAE-4036-2022	Chung, Chih-Ping/0000-0001-9419-9070	Ministry of Science and Technology; Taipei Veterans General Hospital, Taiwan [VGH V105C-055, MOST 104-2314-B-075-MY3]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Taipei Veterans General Hospital, Taiwan(Taipei Veterans General Hospital)	The authors received grants from Ministry of Science and Technology and Taipei Veterans General Hospital, Taiwan (Chung: VGH V105C-055; MOST 104-2314-B-075-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Asgar AW, 2015, J AM COLL CARDIOL, V65, P1231, DOI 10.1016/j.jacc.2015.02.009; Cannon JA, 2017, J CARD FAIL, V23, P464, DOI 10.1016/j.cardfail.2017.04.007; Chang CC, 2010, J INT NEUROPSYCH SOC, V16, P244, DOI 10.1017/S1355617709991184; Chung CP, 2011, ANN NEUROL, V69, P553, DOI 10.1002/ana.22276; Chung CP, 2010, ULTRASOUND MED BIOL, V36, P1776, DOI 10.1016/j.ultrasmedbio.2010.07.006; Chung CP, 2010, CEREBROVASC DIS, V29, P122, DOI 10.1159/000262307; Chung CP, 2008, J MED ULTRASOUND, V16, P210, DOI 10.1016/S0929-6441(08)60050-8; DRESSER LP, 1987, AM J SURG, V154, P220, DOI 10.1016/0002-9610(87)90185-1; FISHER J, 1982, CIRCULATION, V65, P188, DOI 10.1161/01.CIR.65.1.188; Harb SC, 2017, CURR CARDIOL REP, V19, DOI 10.1007/s11886-017-0883-5; Hester RL, 2004, J INT NEUROPSYCH SOC, V10, P475, DOI 10.1017/S1355617704104037; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Jones DW, 2004, HYPERTENSION, V43, P1, DOI 10.1161/01.HYP.0000110061.06674.ca; Kress BT, 2014, ANN NEUROL, V76, P845, DOI 10.1002/ana.24271; Lee WJ, 2018, JAMA NEUROL, V75, P80, DOI 10.1001/jamaneurol.2017.2853; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; LIU HC, 1995, J AM GERIATR SOC, V43, P144, DOI 10.1111/j.1532-5415.1995.tb06379.x; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Nikendei C, 2016, PSYCHOSOM MED, V78, P432, DOI 10.1097/PSY.0000000000000284; Nishimura RA, 2017, J AM COLL CARDIOL, V70, P252, DOI 10.1016/j.jacc.2017.03.011; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Schaller B, 2004, BRAIN RES REV, V46, P243, DOI 10.1016/j.brainresrev.2004.04.005; Schaller B, 2004, CEREBROVASC DIS, V18, P179, DOI 10.1159/000079939; Waragai M, 2006, EUR J NEUROL, V13, P754, DOI 10.1111/j.1468-1331.2006.01318.x; Wu I-Hui, 2011, Acta Neurol Taiwan, V20, P15; Yamakami I, 2001, J CLIN NEUROSCI, V8, P471, DOI 10.1054/jocn.2000.0796; ZEIDMAN SM, 1995, AM J NEURORADIOL, V16, P1080	28	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0207832	10.1371/journal.pone.0207832	http://dx.doi.org/10.1371/journal.pone.0207832			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794544	Green Published, Green Submitted, gold			2022-12-27	WOS:000459709100004
J	Teletcheaid, S; Santuz, H; Leonard, S; Etchebest, C				Teletcheaid, S.; Santuz, H.; Leonard, S.; Etchebest, C.			Repository of Enriched Structures of Proteins Involved in the Red Blood Cell Environment (RESPIRE)	PLOS ONE			English	Article							STRUCTURE PREDICTION; SECONDARY STRUCTURE; PROTEOMIC ANALYSIS; GENE ONTOLOGY; I-TASSER; MEMBRANE; SEQUENCE; DATABASE; IDENTIFICATION; GENERATION	The Red Blood Cell (RBC) is a metabolically-driven cell vital for processes such a gas transport and homeostasis. RBC possesses at its surface exposing antigens proteins that are critical in blood transfusion. Due to their importance, numerous studies address the cell function as a whole but more and more details of RBC structure and protein content are now studied using massive state-of-the art characterisation techniques. Yet, the resulting information is frequently scattered in many scientific articles, in many databases and specialized web servers. To provide a more compendious view of erythrocytes and of their protein content, we developed a dedicated database called RESPIRE that aims at gathering a comprehensive and coherent ensemble of information and data about proteins in RBC. This cell-driven database lists proteins found in erythrocytes. For a given protein entry, initial data are processed from external portals and enriched by using state-of-the-art bioinformatics methods. As structural information is extremely useful to understand protein function and predict the impact of mutations, a strong effort has been put on the prediction of protein structures with a special treatment for membrane proteins. Browsing the database is available through text search for reference gene names or protein identifiers, through pre-defined queries or via hyperlinks. The RESPIRE database provides valuable information and unique annotations that should be useful to a wide audience of biologists, clinicians and structural biologists.	[Teletcheaid, S.; Santuz, H.; Leonard, S.; Etchebest, C.] Inst Natl Transfus Sanguine, Paris, France; [Teletcheaid, S.; Santuz, H.; Leonard, S.; Etchebest, C.] INSERM, UMR S 1134, Paris, France; [Teletcheaid, S.; Santuz, H.; Leonard, S.; Etchebest, C.] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Teletcheaid, S.; Santuz, H.; Leonard, S.; Etchebest, C.] Lab Excellence GR Ex, Paris, France; [Teletcheaid, S.] Univ Nantes, CNRS, UMR 6286, UFIP, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Nantes Universite	Etchebest, C (corresponding author), Inst Natl Transfus Sanguine, Paris, France.; Etchebest, C (corresponding author), INSERM, UMR S 1134, Paris, France.; Etchebest, C (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Paris, France.; Etchebest, C (corresponding author), Lab Excellence GR Ex, Paris, France.	catherine.etchebest@inserm.fr	etchebest, catherine/O-2485-2019; Téletchéa, Stéphane/N-8897-2019; Téletchéa, Stéphane/B-1082-2009	etchebest, catherine/0000-0002-5871-2372; Téletchéa, Stéphane/0000-0002-2402-028X; Téletchéa, Stéphane/0000-0002-2402-028X; Santuz, Hubert/0000-0001-6149-9480	Institut National de la Sante et la Recherche Medicale; Universite Paris Diderot, Sorbonne Paris Cite; Institut National de la Transfusion Sanguine; Conseil Regional Ile de France (SESAME 2009); French National Research Agency [ANR-11-IDEX-0005-02, ANR-11-LABX-0051]; University La Reunion	Institut National de la Sante et la Recherche Medicale; Universite Paris Diderot, Sorbonne Paris Cite; Institut National de la Transfusion Sanguine; Conseil Regional Ile de France (SESAME 2009); French National Research Agency(French National Research Agency (ANR)); University La Reunion	This work was funded by: Institut National de la Sante et la Recherche Medicale, Recurrent funding; Universite Paris Diderot, Sorbonne Paris Cite, Recurrent funding; Institut National de la Transfusion Sanguine, Recurrent funding; Conseil Regional Ile de France (SESAME 2009); French National Research Agency [ANR-11-IDEX-0005-02], Program "Investissements d'avenir"for the Laboratory of Excellence GR-Ex who granted S. Teletchea [ANR-11-LABX-0051]; and University La Reunion, Recurrent funding.	Almen MS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-50; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; An XL, 2015, CURR OPIN HEMATOL, V22, P206, DOI 10.1097/MOH.0000000000000134; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Arnaud L, 2009, TRANSFUSION, V49, P479, DOI 10.1111/j.1537-2995.2008.02003.x; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bagger FO, 2016, NUCLEIC ACIDS RES, V44, pD917, DOI 10.1093/nar/gkv1101; Bakan A, 2011, BIOINFORMATICS, V27, P1575, DOI 10.1093/bioinformatics/btr168; Ballif BA, 2013, EMBO MOL MED, V5, P751, DOI 10.1002/emmm.201302466; Barneaud-Rocca D, 2013, J BIOL CHEM, V288, P26372, DOI 10.1074/jbc.M113.465989; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bell AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060300; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Bryk AH, 2017, J PROTEOME RES, V16, P2752, DOI 10.1021/acs.jproteome.7b00025; Chaar V, 2010, HAEMATOL-HEMATOL J, V95, P1841, DOI 10.3324/haematol.2010.026294; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Chu TTT, 2018, BRIT J HAEMATOL, V180, P118, DOI 10.1111/bjh.14976; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; D'Alessandro A, 2017, EXPERT REV PROTEOMIC, V14, P243, DOI 10.1080/14789450.2017.1291347; D'Alessandro A, 2010, J PROTEOME RES, V9, P144, DOI 10.1021/pr900831f; Daniels G, 2011, ISBT SCI SERIES, V6, P257, DOI DOI 10.1111/J.1751-2824.2011.01497.X; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; de Brevern AG, 2005, BBA-GEN SUBJECTS, V1724, P288, DOI 10.1016/j.bbagen.2005.05.016; de Brevern Alexandre G., 2009, Infectious Disorders - Drug Targets, V9, P289; De Palma A, 2010, J CHROMATOGR A, V1217, P5328, DOI 10.1016/j.chroma.2010.06.045; Edgar RC, 2004, 2004 IEEE COMPUTATIONAL SYSTEMS BIOINFORMATICS CONFERENCE, PROCEEDINGS, P728; Esque J, 2015, AMINO ACIDS, V47, P2303, DOI 10.1007/s00726-015-2010-5; Gautier EF, 2016, CELL REP, V16, P1470, DOI 10.1016/j.celrep.2016.06.085; Gomez J, 2013, BIOINFORMATICS, V29, P1103, DOI 10.1093/bioinformatics/btt100; Goodman SR, 2013, EXP BIOL MED, V238, P509, DOI 10.1177/1535370213488474; Gray KA, 2013, NUCLEIC ACIDS RES, V41, pD545, DOI 10.1093/nar/gks1066; Hanson RM, 2013, ISR J CHEM, V53, P207, DOI 10.1002/ijch.201300024; Hegedus T, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav056; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kajan L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-85; Kelm S, 2010, BIOINFORMATICS, V26, P2833, DOI 10.1093/bioinformatics/btq554; Khor BY, 2015, THEOR BIOL MED MODEL, V12, DOI 10.1186/s12976-015-0014-1; Lange PF, 2014, J PROTEOME RES, V13, P2028, DOI 10.1021/pr401191w; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Martin Andrew C R, 2014, F1000Res, V3, P249, DOI 10.12688/f1000research.5486.1; McGrath KE, 2017, METHODS, V112, P68, DOI 10.1016/j.ymeth.2016.08.012; Moras M, 2017, FRONT PHYSIOL, V8, DOI [10.3389/FPHYS.2017.01076, 10.3389/fphys.2017.01076]; Mungall CJ, 2011, J BIOMED INFORM, V44, P80, DOI 10.1016/j.jbi.2010.02.002; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Olivella M, 2013, BIOINFORMATICS, V29, P1589, DOI 10.1093/bioinformatics/btt249; Ovchinnikov S, 2017, SCIENCE, V355, P294, DOI 10.1126/science.aah4043; Palis J, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00003; Pallotta V, 2013, J PROTEOME RES, V12, P3529, DOI 10.1021/pr400431b; Pasini EM, 2006, BLOOD, V108, P791, DOI 10.1182/blood-2005-11-007799; Pasini EM, 2010, J PROTEOMICS, V73, P403, DOI 10.1016/j.jprot.2009.06.005; Pasini EM, 2010, J PROTEOMICS, V73, P421, DOI 10.1016/j.jprot.2009.07.004; Patrinos GP, 2004, NUCLEIC ACIDS RES, V32, pD537, DOI 10.1093/nar/gkh006; Postic G, 2015, BIOCHIMIE, V115, P155, DOI 10.1016/j.biochi.2015.05.018; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Roux-Dalvai F, 2008, MOL CELL PROTEOMICS, V7, P2254, DOI 10.1074/mcp.M800037-MCP200; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Slynko V, 2009, J AM CHEM SOC, V131, P1274, DOI 10.1021/ja808682v; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485; van Gestel RA, 2010, J PROTEOMICS, V73, P456, DOI 10.1016/j.jprot.2009.08.010; Wagner FF, 2014, TRANSFUS MED HEMOTH, V41, P357, DOI 10.1159/000366176; Wilson MC, 2016, MOL CELL PROTEOMICS, V15, P1938, DOI 10.1074/mcp.M115.057315; Yang JY, 2016, PROTEINS, V84, P233, DOI 10.1002/prot.24918; Yarov-Yarovoy V, 2006, PROTEINS, V62, P1010, DOI 10.1002/prot.20817; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	72	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0211043	10.1371/journal.pone.0211043	http://dx.doi.org/10.1371/journal.pone.0211043			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794542	Green Submitted, Green Published, gold			2022-12-27	WOS:000459709100012
J	Caillaud, M; Guillard, J; Richard, D; Milin, S; Chassaing, D; Paccalin, M; Page, G; Bilan, AR				Caillaud, Martial; Guillard, Jerome; Richard, Damien; Milin, Serge; Chassaing, Damien; Paccalin, Marc; Page, Guylene; Bilan, Agnes Rioux			Trans epsilon viniferin decreases amyloid deposits and inflammation in a mouse transgenic Alzheimer model	PLOS ONE			English	Article							A-BETA; DISEASE; RESVERATROL; MICE; MEMORY; BRAIN	As Alzheimer's disease (AD) induces several cellular and molecular damages, it could be interesting to use multi-target molecules for therapeutics. We previously published that trans E-viniferin induced the disaggregation of A beta(42) peptide and inhibited the inflammatory response in primary cellular model of AD. Here, effects of this stilbenoid were evaluated in transgenic APPswePS1dE9 mice. We report that trans epsilon-viniferin could go through the blood brain barrier, reduces size and density of amyloid deposits and decreases reactivity of astrocytes and microglia, after a weekly intraperitoneal injection at 10 mg/kg from 3 to 6 months of age.	[Caillaud, Martial; Milin, Serge; Chassaing, Damien; Paccalin, Marc; Page, Guylene; Bilan, Agnes Rioux] Univ Poitiers, Neurovasc Unit, EA3808, Poitiers, France; [Caillaud, Martial; Milin, Serge; Chassaing, Damien; Paccalin, Marc; Page, Guylene; Bilan, Agnes Rioux] Univ Poitiers, Pole Biol Sante, Cognit Disorders, Poitiers, France; [Guillard, Jerome] Univ Poitiers, Inst Chem Poitiers Mat & Nat Resources, UMR CNRS 7285, Poitiers, France; [Richard, Damien] UMR INSERM 1107, Dept Pharmacol & Biol Toxicol, Clermont Ferrand, France; [Milin, Serge] Univ Poitiers Hosp, Dept Pathol, Poitiers, France; [Paccalin, Marc] Univ Poitiers Hosp, Dept Geriatr, Poitiers, France; [Paccalin, Marc] Univ Poitiers Hosp, CMRR, Poitiers, France	Universite de Poitiers; Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Poitiers; Universite de Poitiers; CHU Poitiers; Universite de Poitiers; CHU Poitiers; Universite de Poitiers	Bilan, AR (corresponding author), Univ Poitiers, Neurovasc Unit, EA3808, Poitiers, France.; Bilan, AR (corresponding author), Univ Poitiers, Pole Biol Sante, Cognit Disorders, Poitiers, France.	agnes.rioux-bilan@univ-poitiers.fr	Caillaud, Martial/AAW-5733-2021	Caillaud, Martial/0000-0002-7874-1664	French Ministry of Education and Research and Technology [EA3808]	French Ministry of Education and Research and Technology	This work was not supported by any research grant. Financial support came only from the EA3808 dotation from the French Ministry of Education and Research and Technology.	Allain H, 2003, FUND CLIN PHARMACOL, V17, P419, DOI 10.1046/j.1472-8206.2003.00153.x; Anand R, 2014, NEUROPHARMACOLOGY, V76, P27, DOI 10.1016/j.neuropharm.2013.07.004; Capiralla H, 2012, J NEUROCHEM, V120, P461, DOI 10.1111/j.1471-4159.2011.07594.x; Couturier J, 2012, CURR ALZHEIMER RES, V9, P344, DOI 10.2174/156720512800107582; Cuello AC, 2017, TRENDS PHARMACOL SCI, V38, P956, DOI 10.1016/j.tips.2017.07.005; Damjanac M, 2007, BRAIN RES, V1128, P40, DOI 10.1016/j.brainres.2006.05.050; Francois A, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0139-x; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Houille B, 2014, J NAT PROD, V77, P1658, DOI 10.1021/np5002576; Jankowsky JL, 2004, NEUROBIOL AGING, V25, P885, DOI 10.1016/j.neurobiolaging.2003.09.008; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Ladiwala ARA, 2010, J BIOL CHEM, V285, P24228, DOI 10.1074/jbc.M110.133108; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; Marutle A, 2002, NEUROSCI LETT, V328, P269, DOI 10.1016/S0304-3940(02)00546-3; Pedros I, 2014, BBA-MOL BASIS DIS, V1842, P1556, DOI 10.1016/j.bbadis.2014.05.025; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Richard T, 2013, BBA-GEN SUBJECTS, V1830, P5068, DOI 10.1016/j.bbagen.2013.06.031; Richard T, 2011, BIOORGAN MED CHEM, V19, P3152, DOI 10.1016/j.bmc.2011.04.001; Riviere C, 2010, BIOORG MED CHEM LETT, V20, P3441, DOI 10.1016/j.bmcl.2009.09.074; Ruan LF, 2009, CURR ALZHEIMER RES, V6, P531, DOI 10.2174/156720509790147070; Savonenko A, 2005, NEUROBIOL DIS, V18, P602, DOI 10.1016/j.nbd.2004.10.022; Serriere S, 2015, NEUROBIOL AGING, V36, P1639, DOI 10.1016/j.neurobiolaging.2014.11.023; Turner RS, 2015, NEUROLOGY, V85, P1383, DOI 10.1212/WNL.0000000000002035; Vion E, 2018, MOL CELL NEUROSCI, V88, P1, DOI 10.1016/j.mcn.2017.12.003; Worthley G, 1965, TECHNICAL REPORT; Xu PX, 2014, BEHAV BRAIN RES, V264, P173, DOI 10.1016/j.bbr.2014.02.002; Zhou Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081203	27	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212663	10.1371/journal.pone.0212663	http://dx.doi.org/10.1371/journal.pone.0212663			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785960	Green Published, gold, Green Submitted			2022-12-27	WOS:000459307000082
J	Grant, MKO; Seelig, DM; Sharkey, LC; Choi, WSV; Abdelgawad, IY; Zordoky, BN				Grant, Marianne K. O.; Seelig, Davis M.; Sharkey, Leslie C.; Choi, Wan S. V.; Abdelgawad, Ibrahim Y.; Zordoky, Beshay N.			Sexual dimorphism of acute doxorubicin-induced nephrotoxicity in C5761/6 mice	PLOS ONE			English	Article							SOLUBLE EPOXIDE HYDROLASE; ADRIAMYCIN-INDUCED NEPHROPATHY; INDUCED TESTICULAR TOXICITY; ALTERS CYTOCHROME-P450 EXPRESSION; ARACHIDONIC-ACID METABOLISM; ACUTE-RENAL-FAILURE; OXIDATIVE STRESS; IN-VIVO; KIDNEY; LIVER	Doxorubicin (DOX) is a chemotherapeutic agent that has been reported to cause nephrotoxicity in rodent models and to a lesser degree in cancer patients. Female rodents have been shown to be protected against several features of DOX-induced nephrotoxicity. Nevertheless, the underlying mechanisms of this sexual dimorphism are not fully elucidated. Therefore, in the current study, we investigated the sex and time-dependent changes in pathological lesions as well as apoptotic and fibrotic markers in response to acute DOX-induced nephrotoxicity. We also determined the effect of acute DOX treatment on the renal expression of the sexually dimorphic enzyme, soluble epoxide hydrolase (sEH), since inhibition of sEH has been shown to protect against DOX-induced nephrotoxicity. Acute DOX-induced nephrotoxicity was induced by a single intra-peritoneal injection of 20 mg/kg DOX to male and female adult C57BI/6 mice. The kidneys were isolated 1, 3 and 6 days after DOX administration. Histopathology assessment, gene expression of the apoptotic marker, BAX, protein expression of the fibrotic marker, transforming growth factor-beta (TGF-beta), and gene and protein expression of sEH were assessed. DOX administration caused more severe pathological lesions as well as higher induction of the apoptotic and fibrotic markers in kidneys of male than in female mice. Intriguingly, DOX inhibited sEH protein expression in kidneys of male mice sacrificed at 3 and 6 days following administration, suggesting that induction of sEH is not necessary for acute DOX-induced nephrotoxicity. However, DOX-induced inhibition of renal sEH in male mice may protect the kidney from further DOX-induced injury in a negative feedback mechanism. We also observed lower constitutive expressions of TGF-beta and sEH in the kidney of female mice which may contribute, at least in part, to sexual dimorphism of DOX-induced nephrotoxicity.	[Grant, Marianne K. O.; Choi, Wan S. V.; Abdelgawad, Ibrahim Y.; Zordoky, Beshay N.] Univ Minnesota, Coll Pharm, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA; [Seelig, Davis M.; Sharkey, Leslie C.] Univ Minnesota, Coll Vet Med, Dept Vet Clin Sci, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Zordoky, BN (corresponding author), Univ Minnesota, Coll Pharm, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA.	zordo001@umn.edu	Zordoky, Beshay/AAB-4390-2020; Grant, Marianne/AAL-1396-2020	Zordoky, Beshay/0000-0002-9358-4185; Grant, Marianne/0000-0002-2963-4686	Masonic Cancer Center, a comprehensive cancer center; Rally Foundation [582420]	Masonic Cancer Center, a comprehensive cancer center; Rally Foundation	B.N.Z. is a Masonic Cancer Center Women's Health Scholar, sponsored by the Masonic Cancer Center, a comprehensive cancer center designated by the National Cancer Institute, and administered by the University of Minnesota Women's Health Research Program. B.N.Z. was also supported by Rally Foundation grant 582420. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhamid G, 2015, FREE RADICAL BIO MED, V82, P1, DOI 10.1016/j.freeradbiomed.2015.01.005; Anwar-Mohamed A, 2013, XENOBIOTICA, V43, P719, DOI 10.3109/00498254.2012.754113; Bettaieb A, 2017, BBA-GEN SUBJECTS, V1861, P2758, DOI 10.1016/j.bbagen.2017.07.021; Carlson A, 2017, VET COMP ONCOL, DOI [10.1111/vco.2 PMID: 30157941; PubMed Central PMCID: PMCPMC6114275, DOI 10.1111/VCO.2]; Carron PL, 2014, HEMODIAL INT, V18, P846, DOI 10.1111/hdi.12196; Deng BQ, 2017, P NATL ACAD SCI USA, V114, P12608, DOI 10.1073/pnas.1705615114; Fouad AA, 2015, Z NATURFORSCH C, V70, P175, DOI 10.1515/znc-2015-5031; Grant MKO, 2017, BIOL SEX DIFFER, V8, DOI 10.1186/s13293-016-0124-4; Gupta NC, 2012, ARTERIOSCL THROM VAS, V32, P1936, DOI 10.1161/ATVBAHA.112.251520; Hagiuda J, 2015, J ASSIST REPROD GEN, V32, P917, DOI 10.1007/s10815-015-0472-8; Hashimoto T, 2015, J TOXICOL SCI, V40, P451, DOI 10.2131/jts.40.451; INOUE N, 1993, BIOL PHARM BULL, V16, P1004; Kabel AM, 2018, BIOMED PHARMACOTHER, V97, P439, DOI 10.1016/j.biopha.2017.10.144; Kandhi S, 2015, AM J PHYSIOL-LUNG C, V309, pL1478, DOI 10.1152/ajplung.00208.2015; Kienesberger PC, 2012, MOL CELL BIOL, V32, P740, DOI 10.1128/MCB.06470-11; Kim J, 2015, AM J PHYSIOL-RENAL, V308, pF131, DOI 10.1152/ajprenal.00531.2014; Korashy HM, 2016, BASIC CLIN PHARMACOL, V119, P173, DOI 10.1111/bcpt.12555; Lahoti TS, 2012, CURR NEUROVASC RES, V9, P282; Levi M, 2015, REPRODUCTION, V150, P357, DOI 10.1530/REP-15-0129; Liang YX, 2015, BIOCHEM BIOPH RES CO, V463, P70, DOI 10.1016/j.bbrc.2015.05.020; Liu LL, 2007, TOXICOLOGY, V231, P81, DOI 10.1016/j.tox.2006.11.067; Liu SS, 2013, AM J PHYSIOL-RENAL, V305, pF1533, DOI 10.1152/ajprenal.00656.2012; Meiners B, 2018, BIOL SEX DIFFER, V9, DOI 10.1186/s13293-018-0198-2; Mohamed N, 2013, AM J KIDNEY DIS, V61, P778, DOI 10.1053/j.ajkd.2012.08.048; PINOT F, 1995, BIOCHEM PHARMACOL, V50, P501, DOI 10.1016/0006-2952(95)00167-X; Pokrzywinski KL, 2018, BIOL SEX DIFFER, V9, DOI 10.1186/s13293-018-0183-9; Qin J, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12838; Qin J, 2015, AM J PHYSIOL-HEART C, V309, pH1860, DOI 10.1152/ajpheart.00568.2015; Reddy KP, 2016, FOOD CHEM TOXICOL, V91, P65, DOI 10.1016/j.fct.2016.02.017; Rizk SM, 2014, FOOD CHEM TOXICOL, V67, P176, DOI 10.1016/j.fct.2014.02.031; Sakemi T, 1996, AM J NEPHROL, V16, P540, DOI 10.1159/000169057; Sherif IO, 2014, J BIOCHEM MOL TOXIC, V28, P515, DOI 10.1002/jbt.21593; Si H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004802; Su ZH, 2015, SCI REP-UK, V5, DOI 10.1038/srep18314; Szalay CI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127090; Takahashi H, 2011, J TOXICOL SCI, V36, P559; Takiue K, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-14; Wang Q, 2018, AM J PHYSIOL-RENAL, V315, pF915, DOI 10.1152/ajprenal.00534.2017; Wang Q, 2013, AM J PHYSIOL-RENAL, V304, pF168, DOI 10.1152/ajprenal.00129.2012; Wang Yuan Min, 2015, Curr Protoc Immunol, V108, DOI 10.1002/0471142735.im1528s108; Xiao S, 2017, TOXICOL SCI, V157, P320, DOI 10.1093/toxsci/kfx047; Yang WN, 2012, CYTOKINE, V59, P370, DOI 10.1016/j.cyto.2012.04.014; Yang YM, 2018, P NATL ACAD SCI USA, V115, P613, DOI 10.1073/pnas.1716016115; Yu ZG, 2000, CIRC RES, V87, P992, DOI 10.1161/01.RES.87.11.992; Zhang J, 2014, TOXICOL PATHOL, V42, P361, DOI 10.1177/0192623313482778; Zordoky Beshay N, 2016, Cardiooncology, V2, P4, DOI 10.1186/s40959-016-0013-3; Zordoky BNM, 2011, DRUG METAB DISPOS, V39, P1440, DOI 10.1124/dmd.111.039123	47	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212486	10.1371/journal.pone.0212486	http://dx.doi.org/10.1371/journal.pone.0212486			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785938	gold, Green Submitted, Green Published			2022-12-27	WOS:000459307000065
J	Salehi, M; Mobaderi, T; Mehmandar, M; Dehnad, A				Salehi, Masoud; Mobaderi, Tofigh; Mehmandar, Mohammadreza; Dehnad, Afsaneh			Identifying developmental trajectories of worldwide road traffic accident death rates using a latent growth mixture modeling approach	PLOS ONE			English	Article							INJURIES; NUMBER	Road Traffic Accidents (RTA) are a major worldwide public health problem. The aim of this study was to use the growth mixture model for clustering countries on the basis of the mortality rate patterns of RTAs from 2007 to 2013. We obtained the data on RTA death rates from World Health Organization reports and Human Development Index (HDI) of United Nations Development Programme reports for the years 2007, 2010 and 2013. Simple Latent Growth Models (LGM) in 181 countries were applied to estimate overall RTA mortality rate growth trajectories and the latent growth mixture modeling utilized to cluster them. According to non-linear LGM, the overall mortality rate of RTAs showed a decrease from 2007 to 2010 followed by an increase from 2010 to 2013. The HDI covariate had a significant negative and positive effect on intercept and slope of the LGM, respectively. The extracted mixture model appeared to have seven classes with different trends in RTA mortality rates. The worldwide countries were clustered into seven classes. Further studies on each of the seven classes are suggested to provide recommendations for reducing the mortality rate of the RTAs. Additionally, increasing HDI in some countries could have a significant effect on reducing the RTA death rates.	[Salehi, Masoud; Mobaderi, Tofigh] Iran Univ Med Sci, Dept Biostat, Tehran, Iran; [Mehmandar, Mohammadreza] Amin Police Univ, Tehran Traff Police, Dept Traff Operat, Tehran, Iran; [Dehnad, Afsaneh] Iran Univ Med Sci, Dept Foreign Languages, Tehran, Iran	Iran University of Medical Sciences; Iran University of Medical Sciences	Mobaderi, T (corresponding author), Iran Univ Med Sci, Dept Biostat, Tehran, Iran.	tofigh.state@gmail.com	Dehnad, Afsaneh/M-4125-2018; Dehnad, Afsaneh/AAC-4582-2019	mobaderi, tofigh/0000-0002-2207-1390; Dehnad, Afsaneh/0000-0001-5731-8894; Salehi, Masoud/0000-0001-9485-8371				African Development Bank, 2013, ROAD SAF AFR ASS PRO; Aguero-Valverde J, 2008, TRANSPORT RES REC, P55, DOI 10.3141/2061-07; [Anonymous], 2010, HUM DEV REP 2010 20; [Anonymous], 2010, E MED STAT REP ROAD; [Anonymous], 2009, EUR STAT REP ROAD SA; Aubakirova A, 2013, IRAN J PUBLIC HEALTH, V42, P231; Bunn F, 2003, INJURY PREV, V9, P200, DOI 10.1136/ip.9.3.200; Clark, 2010, THESIS; Enders CK, 2011, PSYCHOL METHODS, V16, P1, DOI 10.1037/a0022640; Garg N, 2006, EUR J PUBLIC HEALTH, V16, P487, DOI 10.1093/eurpub/ckl031; Mansuri FA, 2015, SAUDI MED J, V36, P418, DOI 10.15537/smj.2015.4.10003; MCLACHLAN GJ, 1987, J R STAT SOC C-APPL, V36, P318; Muthen B, 2002, BIOSTATISTICS, V3, P459, DOI 10.1093/biostatistics/3.4.459; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Peden M., 2004, WORLD REPORT ROAD TR; Peng YC, 2011, TRANSPORT RES REC, P102, DOI 10.3141/2236-12; Ram N, 2009, INT J BEHAV DEV, V33, P565, DOI 10.1177/0165025409343765; Salari Maryam, 2017, Oman Med J, V32, P417, DOI 10.5001/omj.2017.78; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Stull DE, 2008, QUAL LIFE RES, V17, P47, DOI 10.1007/s11136-007-9290-5; Stull DE, 2011, CONTEMP CLIN TRIALS, V32, P818, DOI 10.1016/j.cct.2011.06.004; Wang J, 2019, STRUCTURAL EQUATION, DOI [DOI 10.1002/9781118356258, DOI 10.1002/]; World Health Organisation, 2018, NONC DIS COUNTR PROF; World Health Organization, 2013, GLOB STAT REP ROAD S; World Health Organization, 2009, GLOB STAT REP ROAD S; Ye X, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197338; Zou YJ, 2018, J APPL STAT, V45, P1652, DOI 10.1080/02664763.2017.1389863	27	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212402	10.1371/journal.pone.0212402	http://dx.doi.org/10.1371/journal.pone.0212402			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM2OT	30785919	gold, Green Submitted, Green Published			2022-12-27	WOS:000459307000059
J	Simon, V; Hyacinthe, C; Retaux, S				Simon, Victor; Hyacinthe, Carole; Retaux, Sylvie			Breeding behavior in the blind Mexican cavefish and its river-dwelling conspecific	PLOS ONE			English	Article							ASTYANAX-MEXICANUS; MATING PREFERENCES; FISH; EVOLUTION; COURTSHIP; GENETICS; MALES	Fish reproductive patterns are very diverse in terms of breeding frequency, mating system, sexual dimorphisms and selection, mate choice, spawning site choice, courtship patterns, spawning behaviors and parental care. Here we have compared the breeding behavior of the surface-dwelling and cave-dwelling morphs of the characiform A. mexicanus, with the goals of documenting the spawning behavior in this emerging model organism, its possible evolution after cave colonization, and the sensory modalities involved. Using infrared video recordings, we showed that cave and surface Astyanax spawning behavior is identical, occurs in the dark, and can be divided into 5 rapid phases repeated many times, about once per minute, during spawning sessions which last about one hour and involve one female and several males. Such features may constitute "pre-adaptive traits" which have facilitated fish survival after cave colonization, and may also explain how the two morphs can hybridize in the wild and in the laboratory. Accordingly, cross-breeding experiments involving females of one morphotype and males of the other morphotype showed the same behavior including the same five phases. However, breeding between cavefish females and surface fish males was more frequent than the reverse. Finally, cavefish female pheromonal solution was able to trigger strong behavioral responses in cavefish males-but not on surface fish males. Lastly, egg production seemed higher in surface fish females than in cavefish females. These results are discussed with regards to the sensory modalities involved in triggering reproductive behavior in the two morphs, as well as its possible ongoing evolution.	[Simon, Victor; Hyacinthe, Carole; Retaux, Sylvie] Univ Paris Saclay, Univ Paris Sud, CNRS UMR9197, Paris Saclay Inst Neurosci, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay	Retaux, S (corresponding author), Univ Paris Saclay, Univ Paris Sud, CNRS UMR9197, Paris Saclay Inst Neurosci, Gif Sur Yvette, France.	retaux@inaf.cnrs-gif.fr		RETAUX, Sylvie/0000-0003-0981-1478; SIMON, Victor/0000-0003-1723-8472	Equipe FRM grant from Fondation pour le Recherche Medicale [DEQ20150331745RETAUX]; CNRS (Centre Nationale de la Recherche Scientifique)	Equipe FRM grant from Fondation pour le Recherche Medicale; CNRS (Centre Nationale de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS))	Work supported by an Equipe FRM grant DEQ20150331745RETAUX from Fondation pour le Recherche Medicale and CNRS (Centre Nationale de la Recherche Scientifique) to SR; https://www.frm.org/chercheurs; http://www.cnrs.fr/fr/page-daccueil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim MCP, 2010, J EXP BIOL, V213, P2997, DOI 10.1242/jeb.044586; Amorim MCP, 2004, J FISH BIOL, V65, P1358, DOI 10.1111/j.0022-1112.2004.00535.x; Azevedo MA, 2010, IHERINGIA SER ZOOL, V100, P469, DOI 10.1590/S0073-47212010000400020; Bibliowicz J, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-25; Borowsky R, 2008, CSH PROTOCOLS, V2008; Borowsky R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079903; Casane D, 2016, ADV GENET, V95, P117, DOI 10.1016/bs.adgen.2016.03.001; Darrow KO, 2004, ZEBRAFISH, V1, P40, DOI 10.1089/154585404774101662; Elipot Y, 2014, ZEBRAFISH, V11, P291, DOI 10.1089/zeb.2014.1005; Elipot Y, 2013, CURR BIOL, V23, P1, DOI 10.1016/j.cub.2012.10.044; Elliott W. R., 2018, BULLETIN, V26; Espinasa L, 2017, SUBTERR BIOL, V21, P1, DOI DOI 10.3897/subtbiol.21.11046; Espinasa L, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-35; Feng NY, 2016, CURR BIOL, V26, P2681, DOI 10.1016/j.cub.2016.07.079; Fumey J, 2018, BMC EVOL BIOL, V18, DOI 10.1186/s12862-018-1156-7; Gross JB, 2008, P NATL ACAD SCI USA, V105, P20106, DOI 10.1073/pnas.0806238105; Helfman G., 2009, DIVERSITY FISH BIOL; Herman A, 2018, MOL ECOL, V27, P4397, DOI 10.1111/mec.14877; Hinaux H, 2016, DEVELOPMENT, V143, P4521, DOI 10.1242/dev.141291; Hinaux H, 2011, ZEBRAFISH, V8, P155, DOI 10.1089/zeb.2011.0713; Huppop K., 1987, International Journal of Speleology, V16, P59; Huppop KaW, 1991, Z ZOOL SYST EVOLUT, V29, P280; Hutchins M, 2003, GRZIMEKS ANIMAL LIFE, V4- 5; Keene AC., 2016, BIOL EVOLUTION MEXIC; Kihslinger RL, 2002, J COMP PSYCHOL, V116, P210, DOI 10.1037//0735-7036.116.2.210; LILEY NR, 1982, CAN J FISH AQUAT SCI, V39, P22, DOI 10.1139/f82-005; Ma L, 2018, DEV BIOL, V441, P209, DOI 10.1016/j.ydbio.2018.07.014; Manica A, 2002, BIOL REV, V77, P261, DOI 10.1017/S1464793101005905; Maruska KP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037612; MITCHELL RW, 1977, SPEC PUBL MUS TEXAS, V12, P1; Miyagi R, 2013, GENES GENET SYST, V88, P145, DOI 10.1266/ggs.88.145; Niemiller ML, 2010, BIOLOGY OF SUBTERRANEAN FISHES, P169, DOI 10.1201/EBK1578086702-c7; Park Jae-Min, 2014, Dev Reprod, V18, P241, DOI 10.12717/devrep.2014.18.4.241; PARTRIDGE BL, 1976, ANIM BEHAV, V24, P291, DOI 10.1016/S0003-3472(76)80037-1; Plath M, 2006, NATURWISSENSCHAFTEN, V93, P103, DOI 10.1007/s00114-005-0072-z; Plath M, 2006, BEHAVIOUR, V143, P15, DOI 10.1163/156853906775133560; Protas ME, 2006, NAT GENET, V38, P107, DOI 10.1038/ng1700; Protas M, 2008, EVOL DEV, V10, P196, DOI 10.1111/j.1525-142X.2008.00227.x; Riesch R, 2010, ECOLOGY, V91, P1494, DOI 10.1890/09-1008.1; SCHEMMEL C, 1980, Z TIERPSYCHOL, V53, P9; Stacey NE, 2015, FISH PHEROMONES RELA; Stacey Norm, 2002, P375; Torres-Paz J, 2018, EVOLUTION GASTRULATI; WILKENS H, 1988, EVOL BIOL, V23, P271; WILKENS H., 1971, ZOOL ANZ, V188, P1	45	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212591	10.1371/journal.pone.0212591	http://dx.doi.org/10.1371/journal.pone.0212591			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785948	Green Submitted, gold, Green Published			2022-12-27	WOS:000459307000074
J	Mandeng, SE; Awono-Ambene, HP; Bigoga, JD; Ekoko, WE; Binyang, J; Piameu, M; Mbakop, LR; Fesuh, BN; Mvondo, N; Tabue, R; Nwane, P; Mimpfoundi, R; Toto, JC; Kleinschmidt, I; Knox, TB; Mnzava, AP; Donnelly, MJ; Fondjo, E; Etang, J				Mandeng, Stanislas Elysee; Awono-Ambene, Herman Parfait; Bigoga, Jude D.; Ekoko, Wolfgang Eyisap; Binyang, Jerome; Piameu, Michael; Mbakop, Lili Ranaise; Fesuh, Betrand Nono; Mvondo, Narcisse; Tabue, Raymond; Nwane, Philippe; Mimpfoundi, Remy; Toto, Jean Claude; Kleinschmidt, Immo; Knox, Tessa Bellamy; Mnzava, Abraham Peter; Donnelly, Martin James; Fondjo, Etienne; Etang, Josiane			Spatial and temporal development of deltamethrin resistance in malaria vectors of the Anopheles gambiae complex from North Cameroon	PLOS ONE			English	Article							SODIUM-CHANNEL GENE; INSECTICIDE RESISTANCE; MOLECULAR-FORMS; POPULATIONS; S.L.; DDT; IDENTIFICATION; CULICIDAE; MOSQUITOS; FUNESTUS	The effectiveness of insecticide-based malaria vector control interventions in Africa is threatened by the spread and intensification of pyrethroid resistance in targeted mosquito populations. The present study aimed at investigating the temporal and spatial dynamics of deltamethrin resistance in An. gambiae s. l. populations from North Cameroon. Mosquito larvae were collected from 24 settings of the Garoua, Pitoa and Mayo Oulo Health Districts (HDs) from 2011 to 2015. Two to five days old female An. gambiae s. l. emerging from larval collections were tested for deltamethrin resistance using the World Health Organization's (WHO) standard protocol. Sub samples of test mosquitoes were identified to species using PCR-RFLP and genotyped for knockdown resistance alleles (Kdr 1014F and 1014S) using Hot Ligation Oligonucleotide Assay (HOLA). All the tested mosquitoes were identified as belonging to the An. gambiae complex, including 3 sibling species mostly represented by Anopheles arabiensis (67.6%), followed by Anopheles coluzzii (25.4%) and Anopheles gambiae (7%). Deltamethrin resistance frequencies increased significantly between 2011 and 2015, with mosquito mortality rates declining from 70-85% to 49-73% in the three HDs (Jonckheere-Terstra test statistic (JT) = 5638, P< 0.001), although a temporary increase of mortality rates (91-97%) was seen in the Pitoa and Mayo Oulo HDs in 2012. Overall, confirmed resistance emerged in 10 An. gambiae s. l. populations over the 24 field populations monitored during the study period, from 2011 to 2015. Phenotypic resistance was mostly found in urban settings compared with semi-urban and rural settings (JT = 5282, P< 0.0001), with a spatial autocorrelation between neighboring localities. The Kdr 1014F allelic frequencies in study HDs increased from 0-30% in 2011 to 18-61% in 2014-2015 (JT = 620, P < 0.001), especially in An. coluzzii samples. The overall frequency of the Kdr 1014S allele was 0.1%. This study revealed a rapid increase and widespread deltamethrin resistance frequency as well as Kdr 1014F allelic frequencies in An. gambiae s. l. populations over time, emphasizing the urgent need for vector surveillance and insecticide resistance management strategies in Cameroon.	[Mandeng, Stanislas Elysee; Awono-Ambene, Herman Parfait; Ekoko, Wolfgang Eyisap; Piameu, Michael; Mbakop, Lili Ranaise; Nwane, Philippe; Toto, Jean Claude; Etang, Josiane] OCEAC, IRY, Yaounde, Cameroon; [Mandeng, Stanislas Elysee; Binyang, Jerome; Mbakop, Lili Ranaise; Mvondo, Narcisse; Mimpfoundi, Remy] Univ Yaounde I, Lab Gen Biol, Yaounde, Cameroon; [Bigoga, Jude D.; Tabue, Raymond] Nkolbisson Univ Yaounde I, Biotechnol Ctr, Natl Reference Unit Vector Control, Lab Vector Biol & Control, Yaounde, Cameroon; [Ekoko, Wolfgang Eyisap] Univ Douala, Fac Sci, Lab Anim Biol & Physiol, Douala, Cameroon; [Piameu, Michael] Univ Catholique Afrique Cent, Ecole Sci Sante, Yaounde, Cameroon; [Fesuh, Betrand Nono] Univ Yaounde I, Natl Adv Sch Engn, Yaounde, Cameroon; [Tabue, Raymond; Fondjo, Etienne] Natl Malaria Control Programme, Minist Publ Hlth, Yaounde, Cameroon; [Kleinschmidt, Immo] London Sch Trop Med & Hyg, MRC Trop Epidemiol Grp, Dept Infect Dis Epidemiol, London, England; [Kleinschmidt, Immo] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Knox, Tessa Bellamy] WHO, Global Malaria Programme, Geneva, Switzerland; [Mnzava, Abraham Peter] ALMA, Dar Es Salaam, Tanzania; [Donnelly, Martin James] Univ Liverpool Liverpool Sch Trop Med, Dept Vector Biol, Liverpool, Merseyside, England; [Etang, Josiane] Univ Douala, Fac Med & Pharmaceut Sci, Dept Biol Sci, Douala, Cameroon; [Etang, Josiane] Justus Liebig Univ Giessen, Inst Insect Biotechnol, Heinrich Buff Ring, Germany	University of Yaounde I; University of Yaounde I; University of London; London School of Hygiene & Tropical Medicine; University of Witwatersrand; World Health Organization; Liverpool School of Tropical Medicine; Justus Liebig University Giessen	Etang, J (corresponding author), OCEAC, IRY, Yaounde, Cameroon.; Etang, J (corresponding author), Univ Douala, Fac Med & Pharmaceut Sci, Dept Biol Sci, Douala, Cameroon.; Etang, J (corresponding author), Justus Liebig Univ Giessen, Inst Insect Biotechnol, Heinrich Buff Ring, Germany.	josyet2@gmail.com		PIAMEU, Michael/0000-0001-7409-3359; Donnelly, Martin/0000-0001-5218-1497; BINYANG, Jerome Achille/0000-0002-2361-0659; Bigoga, Jude/0000-0001-7206-3308	Bill and Melinda Gates Foundation [484991.01]; MRC [MR/R010161/1] Funding Source: UKRI	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding was provided by the Bill and Melinda Gates Foundation (Grant Number: 484991.01). This research forms part of a multi-country study coordinated by the Global Malaria Programme of the World Health Organization. The funders had no role in study design, data collection, decision to publish, or preparation of the manuscript.	Antonio-Nkondjio C, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2417-9; Antonio-Nkondjio C, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0675-6; Badolo A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-232; Busula AO, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0635-1; Chareonviriyaphap T, 2002, J VECTOR ECOL, V27, P222; Chouaibou M, 2008, TROP MED INT HEALTH, V13, P476, DOI 10.1111/j.1365-3156.2008.02025.x; Chouaibou M, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-77; Cisse MBM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0847-4; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; COLLINS FH, 1987, AM J TROP MED HYG, V37, P37, DOI 10.4269/ajtmh.1987.37.37; Corbel V, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P579, DOI 10.5772/56117; Czeher C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-189; Dabire KR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-188; Diabate A, 2007, J MED ENTOMOL, V44, P60, DOI 10.1603/0022-2585(2007)44[60:ETEOPI]2.0.CO;2; Djegbe I, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-261; Etang J, 2003, J MED ENTOMOL, V40, P491, DOI 10.1603/0022-2585-40.4.491; Etang J, 2007, J VECTOR ECOL, V32, P123, DOI 10.3376/1081-1710(2007)32[123:SOMRTD]2.0.CO;2; Etang J, 2006, AM J TROP MED HYG, V74, P795, DOI 10.4269/ajtmh.2006.74.795; Etang J, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1420-x; Etang J, 2009, MOL ECOL, V18, P3076, DOI 10.1111/j.1365-294X.2009.04256.x; Fanello C, 2003, INSECT MOL BIOL, V12, P241, DOI 10.1046/j.1365-2583.2003.00407.x; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Finney D.J., 1971, PROBIT ANAL; Fossog BT, 2015, EVOL APPL, V8, P326, DOI 10.1111/eva.12242; Fossog BT, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-1; Foster GM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155746; Gillies M, 1987, PUBL S AFRI CAN I ME, V55, P1; Gillies M. T., 1968, PUBL S AFR I MED RES, V54, P343; Gimonneau G, 2010, BEHAV ECOL, V21, P1087, DOI 10.1093/beheco/arq114; Glunt KD, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0807-z; Hargreaves K, 2000, MED VET ENTOMOL, V14, P181, DOI 10.1046/j.1365-2915.2000.00234.x; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Kleinschmidt I, 2018, LANCET INFECT DIS, V18, P640, DOI 10.1016/S1473-3099(18)30172-5; Lynd A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-16; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Mbida Arthur Mbida, 2016, Journal of Entomology and Zoology Studies, V4, P105; Muller P, 2008, MOL ECOL, V17, P1145, DOI 10.1111/j.1365-294X.2007.03617.x; Ndiath MO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031943; Ndjemai HNM, 2009, T ROY SOC TROP MED H, V103, P1127, DOI 10.1016/j.trstmh.2008.11.018; Nwane P, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-41; Nwane Philippe, 2011, BMC Res Notes, V4, P463, DOI 10.1186/1756-0500-4-463; Nwane P, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-163; Organization WH, 2015, WHO GLOB MAL PROGR; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; Ranson H, 2016, TRENDS PARASITOL, V32, P187, DOI 10.1016/j.pt.2015.11.010; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Raymond M, 1998, PHILOS T R SOC B, V353, P1707, DOI 10.1098/rstb.1998.0322; Reimer L, 2008, J MED ENTOMOL, V45, P260, DOI 10.1603/0022-2585(2008)45[260:RBKMAR]2.0.CO;2; Rooker S, 1996, HEREDITY, V77, P555; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Same-Ekobo A, 2005, J CAM ACADSCI, V5, P3; *SERV MW, 1993, MOSQ EC FIELD SAMPL; Simard Frederic, 2009, BMC Ecology, V9, P17, DOI 10.1186/1472-6785-9-17; Strode C, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001619; Tabue RN, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-016-1933-3; Toure Y. T., 1998, Parassitologia (Rome), V40, P477; Weill M, 2002, P ROY SOC B-BIOL SCI, V269, P2007, DOI 10.1098/rspb.2002.2122; WHO, 2012, GLOB PLAN INS RES MA; WHO, 2017, WHO GLOB MAL PROGR; WHO, PREQ VECT CONTR; WHO (World Health Organization), WHO PREQ IND RES SPR; Wondji C, 2005, J MED ENTOMOL, V42, P998, DOI 10.1603/0022-2585(2005)042[0998:SAPOTA]2.0.CO;2; World Health Organization, 2016, TAX SUG DRINKS, P2; Yahouedo GA, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1661-8	64	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212024	10.1371/journal.pone.0212024	http://dx.doi.org/10.1371/journal.pone.0212024			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779799	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000459062900024
J	Meelab, S; Bunupuradah, I; Suttiruang, J; Sakulrojanawong, S; Thongkua, N; Chantawiboonchai, C; Chirabandhu, P; Lertthanaporn, S; Suwanthip, K; Songsaengthum, C; Keattisaksri, B; Trakulsuk, P; Pittapun, A; Nata, N; Rangsin, R; Sakboonyarat, B				Meelab, Suprawee; Bunupuradah, Itsara; Suttiruang, Jitrada; Sakulrojanawong, Salisa; Thongkua, Nisanat; Chantawiboonchai, Chattarin; Chirabandhu, Prim; Lertthanaporn, Sasanpin; Suwanthip, Krissada; Songsaengthum, Chindanai; Keattisaksri, Boonyagorn; Trakulsuk, Peeranut; Pittapun, Apichat; Nata, Naowanit; Rangsin, Ram; Sakboonyarat, Boonsub			Prevalence and associated factors of uncontrolled blood pressure among hypertensive patients in the rural communities in the central areas in Thailand: A cross-sectional study	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; SEDENTARY BEHAVIORS; NECK CIRCUMFERENCE; METABOLIC SYNDROME; PHYSICAL-ACTIVITY; FATTY-ACIDS; RISK; POPULATION; OBESITY; PREDICTORS	Introduction Hypertension is a common cardiovascular disease at present. Uncontrolled blood pressure leads to further complications including heart attack, stroke and chronic kidney disease. In Thailand, most of the information related to this issue is collected by hospitals or hospital-based organizations rather than at the community level. The objectives of this study were to determine the prevalence of uncontrolled hypertension and to assess the relationship between patient characteristics (socio-behavioral and clinical) and uncontrolled blood pressure among hypertensive patients in the rural communities in the central areas in Thailand. Materials and methods This was a cross-sectional study conducted in Na-Yao and Phra-Pleong rural communities of Thailand in 2018 using the total design method. In all, 406 individuals aged >= 18 years were interviewed using structured questionnaires related to demographic information, higher risk behavior, comorbidities and arthrometric measurement. Blood pressure was assessed for all participants. Uncontrolled hypertension was defined as BP >= 140/90 mmHg. Results The prevalence of uncontrolled hypertension was 54.4% (males: 59.8%; females: 52.4%). Uncontrolled blood pressure was associated with neck circumference more than 35.75 cm for males and 32.75 cm. for females (adjusted odds ratio; 1.66, 95% confidence interval; 1.03-2.68), sedentary behavior more than 5 hours a day (adjusted odds ratio; 2.03, 95% confidence interval; 1.28-3.23) and missed doctor appointments (adjusted odds ratio; 3.29, 95% confidence interval; 1.09-9.94). Conclusion Approximately one half of hypertensive patients in these rural communities had uncontrolled blood pressure. The Ministry of Public Health and health care providers should provide further strategies to prevent uncontrolled blood pressure's complications.	[Meelab, Suprawee; Bunupuradah, Itsara; Suttiruang, Jitrada; Sakulrojanawong, Salisa; Thongkua, Nisanat; Chantawiboonchai, Chattarin; Chirabandhu, Prim; Lertthanaporn, Sasanpin; Suwanthip, Krissada; Songsaengthum, Chindanai; Keattisaksri, Boonyagorn; Trakulsuk, Peeranut; Pittapun, Apichat] Phramongkutklao Coll Med, Bangkok, Thailand; [Nata, Naowanit] Phramongkutklao Coll Med, Dept Internal Med, Bangkok, Thailand; [Rangsin, Ram; Sakboonyarat, Boonsub] Phramongkutklao Coll Med, Dept Mil & Community Med, Bangkok, Thailand	Phramongkutklao College of Medicine; Phramongkutklao College of Medicine; Phramongkutklao College of Medicine	Sakboonyarat, B (corresponding author), Phramongkutklao Coll Med, Dept Mil & Community Med, Bangkok, Thailand.	boonsub1991@pcm.ac.th	Rangsin, Ram/AAW-9527-2020; Rangsin, Ram/AAR-9082-2021	Rangsin, Ram/0000-0002-7175-0963; Sakboonyarat, Boonsub/0000-0003-0577-0699	Department of Military and Community Medicine, Phramongkutklao College of Medicine	Department of Military and Community Medicine, Phramongkutklao College of Medicine	The authors express their grateful thanks to all participants of the survey, to the health care providers and officers of Na-Yao and Phra-Pleong Primary Healthcare Units. The authors wish to thank the entire staff members of the Department of Military and Community Medicine, Phramongkutklao College of Medicine, for their support in completing this study. The authors wish to thank Mrs. Kornkanok Supawaropas for proof reading the manuscripts.	Aekplakorn W, 2012, J HYPERTENS, V30, P1734, DOI 10.1097/HJH.0b013e3283568158; Ben-Noun LL, 2004, AM J HYPERTENS, V17, P409, DOI 10.1016/j.amjhyper.2004.02.005; Bertrais S, 2005, OBES RES, V13, P936, DOI 10.1038/oby.2005.108; Beunza JJ, 2007, AM J HYPERTENS, V20, P1156, DOI 10.1016/j.amjhyper.2007.06.007; Cardiovascular risk factor levels in urban and rural Thailand-The International Collaborative Study of Cardiovascular Disease in Asia (InterASIA), 2003, EUROPEAN J CARDIOVAS, V10, P249; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Chomistek AK, 2013, J AM COLL CARDIOL, V61, P2346, DOI 10.1016/j.jacc.2013.03.031; Dave GJ, 2013, J CLIN HYPERTENS, V15, P562, DOI 10.1111/jch.12122; Desa U. N, 2014, WORLD URBANIZATION P; Fan SJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02879-7; Federation ID, 2005, MED PRAKT, P1; Freet CS, 2013, AUTON NEUROSCI-BASIC, V174, P8, DOI 10.1016/j.autneu.2012.12.005; Gerage AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146078; Hall JE, 2000, BRAZ J MED BIOL RES, V33, P605, DOI 10.1590/S0100-879X2000000600001; Hall JE, 2015, CIRC RES, V116, P991, DOI 10.1161/CIRCRESAHA.116.305697; Haynes WG, 1997, J CLIN INVEST, V100, P270, DOI 10.1172/JCI119532; Hsu CY, 2005, ARCH INTERN MED, V165, P923, DOI 10.1001/archinte.165.8.923; Iyer AS, 2010, J AM SOC HYPERTENS, V4, P22, DOI 10.1016/j.jash.2010.02.002; Jafar TH, 2018, AM J HYPERTENS, V31, P1205, DOI 10.1093/ajh/hpy071; Jakes RW, 2003, EUR J CLIN NUTR, V57, P1089, DOI 10.1038/sj.ejcn.1601648; Knight EL, 2001, HYPERTENSION, V38, P809, DOI 10.1161/hy0901.091681; Konecny T, 2014, HYPERTENSION, V63, P203, DOI 10.1161/HYPERTENSIONAHA.113.00613; Kuciene R, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0444-2; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Masuo K, 2000, HYPERTENSION, V35, P1135, DOI 10.1161/01.HYP.35.5.1135; Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912; Onat A, 2009, CLIN NUTR, V28, P46, DOI 10.1016/j.clnu.2008.10.006; Parati G, 2013, EUR RESP SOC; Piro S, 2008, NUTR METAB CARDIOVAS, V18, P96, DOI 10.1016/j.numecd.2007.01.009; Stojiljkovic MP, 2002, J HYPERTENS, V20, P1215, DOI 10.1097/00004872-200206000-00036; Tangjatuporn Warakarn, 2012, J Med Assoc Thai, V95 Suppl 5, pS48; Thrift AG, 1996, STROKE, V27, P2020, DOI 10.1161/01.STR.27.11.2020; Vatcheva K.P, 2016, EPIDEMIOLOGY, V6; Wang Z, 2018, CIRCULATION; WHO, 1988, MEAS OB CLASS DESCR; WHO/IASO/IOTF, 2000, ASIA PACIFIC PERSPEC; Yoon Sung Sug Sarah, 2015, NCHS Data Brief, P1; Zhou JY, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-76	38	14	14	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212572	10.1371/journal.pone.0212572	http://dx.doi.org/10.1371/journal.pone.0212572			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779818	gold, Green Published, Green Submitted			2022-12-27	WOS:000459062900065
J	Chen, SL; Liu, HY; Feng, ZK; Shen, CY; Chen, PP				Chen, Shilin; Liu, Haiyang; Feng, Zhongke; Shen, Chaoyong; Chen, Panpan			Applicability of personal laser scanning in forestry inventory	PLOS ONE			English	Article							SIMULTANEOUS LOCALIZATION; TREE HEIGHT; SLAM; VOLUME; STEM; EXTRACTION; PARAMETERS; BIOMASS; SYSTEM	Light Detection and Ranging (LiDAR) technology has been widely used in forestry surveys in the form of airborne laser scanning (ALS), terrestrial laser scanning (TLS), and mobile laser scanning (MLS). The acquisition of important basic tree parameters (e.g., diameter at breast height and tree position) in forest inventory did not solve the problem of low measurement efficiency or weak GNSS signal under the canopy. A personal laser scanning (PLS) device combined with SLAM technology provides an effective solution for forest inventory under complex conditions with its light weight and flexible mobility. This study proposes a new method for calculating the volume of a cylinder using point cloud data obtained by a PLS device by fitting to a polygonal cylinder to calculate the diameter of the trunk. The point cloud data of tree trunks of different thickness were modeled using different fitting methods. The rate of correct tree trunk detection was 93.3% and the total deviation of the estimations of tree diameter at breast height (DBH) was - 1.26 cm. The root mean square errors (RMSEs) of the estimations of the extracted DBH and the tree position were 1.58 cm and 26 cm, respectively. The survey efficiency of the personal laser scanning (PLS) device was 30m(2)/min for each investigator, compared with 0.91m(2)/min for the field survey. The test demonstrated that the PLS device combined with the SLAM algorithm provides an efficient and convenient solution for forest inventory.	[Chen, Shilin; Liu, Haiyang; Feng, Zhongke; Shen, Chaoyong; Chen, Panpan] Beijing Forestry Univ, Coll Forestry, Precis Forestry Key Lab Beijing, Beijing, Peoples R China	Beijing Forestry University	Feng, ZK (corresponding author), Beijing Forestry Univ, Coll Forestry, Precis Forestry Key Lab Beijing, Beijing, Peoples R China.	fengzhongke@126.com		chaoyong, shen/0000-0002-8293-2746; Chen, Shilin/0000-0001-9239-7655; feng, zhong ke/0000-0002-1444-7976	Fundamental Research Funds for the Central Universities [2015ZCQ-LX-01]; National Natural Science Foundation of China [U1710123]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the Fundamental Research Funds for the Central Universities [2015ZCQ-LX-01] and the National Natural Science Foundation of China grant number [U1710123] to ZF.	Bailey T, 2006, IEEE ROBOT AUTOM MAG, V13, P108, DOI 10.1109/MRA.2006.1678144; Bauwens S, 2016, FORESTS, V7, DOI 10.3390/f7060127; Bienert A, 2012, APPL TERRESTRIAL LAS; Bouraoui L, 2011, IEEE INT VEH SYM, P1086, DOI 10.1109/IVS.2011.5940545; Cabo C, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10040540; Cabo C, 2018, INT J APPL EARTH OBS, V69, P164, DOI 10.1016/j.jag.2018.01.011; Chen C, 2016, ISPRS J PHOTOGRAMM, V119, P90, DOI 10.1016/j.isprsjprs.2016.05.007; Dewez TJB, 2017, PHOTOGRAMMETRIC RECO, V32; Dissanayake MWMG, 2001, IEEE T ROBOTIC AUTOM, V17, P229, DOI 10.1109/70.938381; Farina P, 2006, ENG GEOL, V88, P200, DOI 10.1016/j.enggeo.2006.09.007; Hyyppa J., 2013, UNCONVENTIONAL LIDAR, P205; Hyyppa J, 2018, FORESTS, V9, DOI 10.3390/f9010006; James MR, 2014, EARTH SURF PROC LAND, V39, P138, DOI 10.1002/esp.3489; Kankare V, 2015, ISPRS J PHOTOGRAMM, V108, P161, DOI 10.1016/j.isprsjprs.2015.07.007; Kankare V, 2013, ISPRS J PHOTOGRAMM, V75, P64, DOI 10.1016/j.isprsjprs.2012.10.003; Kilpela inen H, 2011, SAW LOG RECOVERY STE; Korhonen L, 2013, INT J REMOTE SENS, V34, P7236, DOI 10.1080/01431161.2013.817715; Ku kenbrink D, 2016, REMOTE SENS ENVIRON, P194; Kukko A, 2017, ISPRS J PHOTOGRAMM, V132, P199, DOI 10.1016/j.isprsjprs.2017.09.006; Liang XL, 2016, ISPRS J PHOTOGRAMM, V115, P63, DOI 10.1016/j.isprsjprs.2016.01.006; Liang XL, 2014, IEEE GEOSCI REMOTE S, V11, P1504, DOI 10.1109/LGRS.2013.2297418; Liang XL, 2014, SENSORS-BASEL, V14, P1228, DOI 10.3390/s140101228; Liang XL, 2012, IEEE T GEOSCI REMOTE, V50, P661, DOI 10.1109/TGRS.2011.2161613; Liang Xinlian, 2018, ISPRS J PHOTOGRAMMET; Lindberg E, 2012, REMOTE SENS-BASEL, V4, P1004, DOI 10.3390/rs4041004; Liu JB, 2017, INT J APPL EARTH OBS, V56, P13, DOI 10.1016/j.jag.2016.11.003; Lovell JL, 2011, ISPRS J PHOTOGRAMM, V66, P46, DOI 10.1016/j.isprsjprs.2010.08.006; Maas HG, 2008, INT J REMOTE SENS, V29, P1579, DOI 10.1080/01431160701736406; Maltamo M, 2013, FORESTRY APPL AIRBOR, P27; Mehtatalo L, 2015, IEEE J-STARS, V8, P1432, DOI 10.1109/JSTARS.2015.2418675; Norbert P, 2017, TERRESTRIAL LASER SC; Nuchter A, 2004, IEEE INT C ROB AUT 2; Olofsson K, 2014, REMOTE SENS-BASEL, V6, P4323, DOI 10.3390/rs6054323; Qiu ZX, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10071080; Rutzinger M, DETECTION MODELLING; Ryding J, 2015, REMOTE SENS-BASEL, V7, P1095, DOI 10.3390/rs70101095; Sun H, 2015, IEEE GEOSCI REMOTE S, V12, P1993, DOI 10.1109/LGRS.2015.2443553; Thrun S, 2006, INT J ROBOT RES, V25, P403, DOI 10.1177/0278364906065387; Vauhkonen J, 2014, ISPRS J PHOTOGRAMM, V96, P57, DOI 10.1016/j.isprsjprs.2014.07.001; Watt PJ, 2005, INT J REMOTE SENS, V26, P1437, DOI 10.1080/01431160512331337961; Wu B, 2013, REMOTE SENS-BASEL, V5, P584, DOI 10.3390/rs5020584; Yang B, 2017, ISPRS J PHOTOGRAMM, P130; Yang BS, 2017, ISPRS J PHOTOGRAMM, V126, P180, DOI 10.1016/j.isprsjprs.2017.02.014; Yang BS, 2015, ISPRS J PHOTOGRAMM, V99, P45, DOI 10.1016/j.isprsjprs.2014.10.005; Yang BS, 2014, ISPRS J PHOTOGRAMM, V95, P109, DOI 10.1016/j.isprsjprs.2014.05.012; Yang BS, 2013, ISPRS J PHOTOGRAMM, V81, P19, DOI 10.1016/j.isprsjprs.2013.04.002; Yang BS, 2013, ISPRS J PHOTOGRAMM, V79, P80, DOI 10.1016/j.isprsjprs.2013.01.016; Yu XW, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9020108; Yu XW, 2004, REMOTE SENS ENVIRON, V90, P451, DOI 10.1016/j.rse.2004.02.001	49	49	51	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211392	10.1371/journal.pone.0211392	http://dx.doi.org/10.1371/journal.pone.0211392			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811414	Green Published, gold, Green Submitted			2022-12-27	WOS:000459806400017
J	Arias, MF; Mazarico, E; Gonzalez, A; Muniesa, M; Molinet, C; Almeida, L; Roig, MDG				Fernandez Arias, M.; Mazarico, E.; Gonzalez, A.; Muniesa, M.; Molinet, C.; Almeida, L.; Gomez Roig, M. D.			Genetic risk assessment of thrombophilia in patients with adverse obstetric outcomes	PLOS ONE			English	Article							MOLECULAR-WEIGHT HEPARIN; V-LEIDEN MUTATION; INHERITED THROMBOPHILIA; PREGNANCY OUTCOMES; RECURRENCE RATE; WOMEN; PREECLAMPSIA; COMPLICATIONS; DISORDERS	Objectives To investigate the incidence of inherited thrombophilias in patients with adverse obstetric outcomes and to compare detection rates of thrombophilias between standard blood tests and a novel genetic test. Methods This is a case-control prospective study performed in Hospital Sant Joan de Deu in Barcelona, Spain. Cases had a history of intrauterine growth restriction requiring delivery before 34 weeks gestation, placental abruption before 34 weeks gestation, or severe preeclampsia. Controls had at least two normal, spontaneously conceived pregnancies at term, without complications or no underlying medical disease. At least 3 months after delivery, all case and control women underwent blood collection for standard blood tests for thrombophilias and saliva collection for the genetic test, which enables the diagnosis of 12 hereditary thrombophilias by analyzing genetic variants affecting different points of the blood coagulation cascade. Results The study included 33 cases and 41 controls. There were no statistically significant differences between cases and controls in the standard blood tests for thrombophilias in plasma or the TiC test for genetic variables. One clinical-genetic model was generated using variables with the lowest P values: ABO, body mass index, C_rs5985, C_rs6025, and protein S. This model exhibited good prediction capacity, with an area under the curve of almost 0.7 (P <0.05), sensitivity of almost 67%, and specificity of 70%. Conclusion Although some association may exist between hypercoagulability and pregnancy outcomes, no significant direct correlation was observed between adverse obstetric outcomes and inherited thrombophilias when analyzed using either standard blood tests or the genetic test. Future studies with a larger sample size are required to create a clinical-genetic model that better discriminates women with a history of adverse pregnancy outcomes and an increased risk of poor outcomes in subsequent pregnancies.	[Fernandez Arias, M.; Mazarico, E.; Gonzalez, A.; Muniesa, M.; Molinet, C.; Almeida, L.; Gomez Roig, M. D.] Hosp St Joan de Deu, BCNatal Barcelona Ctr Maternal Fetal & Neonatal M, Barcelona, Spain; [Fernandez Arias, M.; Mazarico, E.; Gonzalez, A.; Muniesa, M.; Molinet, C.; Almeida, L.; Gomez Roig, M. D.] Hosp Clin Barcelona, Barcelona, Spain; [Mazarico, E.; Almeida, L.; Gomez Roig, M. D.] ISCIII, Subdirectorate Gen Res Assessment & Promot, Maternal & Child Hlth & Dev Network SAMID 2 2, Madrid, Spain; [Mazarico, E.; Almeida, L.; Gomez Roig, M. D.] ERDF, Madrid, Spain; [Mazarico, E.; Almeida, L.; Gomez Roig, M. D.] IR SJD, Barcelona, Spain	University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; Instituto de Salud Carlos III	Mazarico, E (corresponding author), Hosp St Joan de Deu, BCNatal Barcelona Ctr Maternal Fetal & Neonatal M, Barcelona, Spain.; Mazarico, E (corresponding author), Hosp Clin Barcelona, Barcelona, Spain.; Mazarico, E (corresponding author), ISCIII, Subdirectorate Gen Res Assessment & Promot, Maternal & Child Hlth & Dev Network SAMID 2 2, Madrid, Spain.; Mazarico, E (corresponding author), ERDF, Madrid, Spain.; Mazarico, E (corresponding author), IR SJD, Barcelona, Spain.	emazarico@sjdhospitalbarcelona.org		Molinet Coll, Cristina/0000-0002-1775-4509	PN I+D + I 2008-2011 (Spain); ISCIII-Sub-Directorate General for Research Assessment and Promotion; European Regional Development Fund (ERDF) [RD12/0026]; Fund for Health Research of the Spanish Social Security Service [PI11/02613]	PN I+D + I 2008-2011 (Spain); ISCIII-Sub-Directorate General for Research Assessment and Promotion; European Regional Development Fund (ERDF)(European Commission); Fund for Health Research of the Spanish Social Security Service	We thank the Gynecology and Obstetrics Service at the Sant Joan de Deu University Hospital in Barcelona and the RETICS, funded by the PN I+D + I 2008-2011 (Spain), the ISCIII-Sub-Directorate General for Research Assessment and Promotion, the European Regional Development Fund (ERDF, ref. RD12/0026), and the Fund for Health Research of the Spanish Social Security Service, for financial support of this project (Exp. PI11/02613).	Alfirevic Z, 2002, EUR J OBSTET GYN R B, V101, P6, DOI 10.1016/S0301-2115(01)00496-1; Aracic N, 2015, J MATERN-FETAL NEO M, V28, P306, DOI 10.3109/14767058.2014.916268; ARDUINI D, 1990, J PERINAT MED, V18, P165, DOI 10.1515/jpme.1990.18.3.165; Baschat AA, 2003, ULTRASOUND OBST GYN, V21, P124, DOI 10.1002/uog.20; Bates SM, 2008, CHEST, V133, p844S, DOI 10.1378/chest.08-0761; Bates SM, 2013, EXPERT REV HEMATOL, V6, P287, DOI [10.1586/EHM.13.18, 10.1586/ehm.13.18]; Branch DW, 2010, OBSTET GYNECOL, V115, P2, DOI 10.1097/AOG.0b013e3181c879ca; Brenner B, 2007, CLIN PERINATOL, V34, P527, DOI 10.1016/j.clp.2007.09.002; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Davenport WB, 2014, OBSTET GYN CLIN N AM, V41, P133, DOI 10.1016/j.ogc.2013.10.005; De Vries JIP, 2012, J THROMB HAEMOST, V10, P64, DOI 10.1111/j.1538-7836.2011.04553.x; Dizon-Townson D, 2005, OBSTET GYNECOL, V106, P517, DOI 10.1097/01.AOG.0000173986.32528.ca; DizonTomson DS, 1997, AM J OBSTET GYNECOL, V177, P402, DOI 10.1016/S0002-9378(97)70205-9; Facchinetti F, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.07.032; Grandone E, 2008, BLOOD COAGUL FIBRIN, V19, P226, DOI 10.1097/MBC.0b013e3282f54545; Grandone MD., 2009, SEMINARS THROMBOSIS, V35; Kahn SR, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.09.023; Kalk JJ, 2004, NETH J MED, V62, P83; Kist WJ, 2008, THROMB HAEMOSTASIS, V99, P77, DOI 10.1160/TH07-05-0373; Kosar A, 2011, BLOOD COAGUL FIBRIN, V22, P14, DOI 10.1097/MBC.0b013e32834013f2; Kupferminc MJ, 2011, J MATERN-FETAL NEO M, V24, P1042, DOI 10.3109/14767058.2010.545911; Lykke JA, 2012, J THROMB HAEMOST, V10, P1320, DOI 10.1111/j.1538-7836.2012.04773.x; Mello G, 2005, HYPERTENSION, V45, P86, DOI 10.1161/01.HYP.0000149950.05182.a3; Redline R., 2006, CLIN OBSTET GYNECOLO, V46; Rey E, 2003, LANCET, V361, P901, DOI 10.1016/S0140-6736(03)12771-7; Robertson L, 2006, BRIT J HAEMATOL, V132, P171, DOI 10.1111/j.1365-2141.2005.05847.x; ROBINSON HP, 1975, BRIT J OBSTET GYNAEC, V82, P702, DOI 10.1111/j.1471-0528.1975.tb00710.x; Rodger MA, 2008, OBSTET GYNECOL, V112, P320, DOI 10.1097/AOG.0b013e31817e8acc; Said JM, 2012, ACTA OBSTET GYN SCAN, V91, P250, DOI 10.1111/j.1600-0412.2011.01293.x; Silver RM, 2010, OBSTET GYNECOL, V115, P14, DOI 10.1097/AOG.0b013e3181c88918; The American College of Obstetricians and Gynecologists, 2013, INH THROMB PREGN PRA, V22; Woodham PC, 2011, AM J PERINAT, V28, P495, DOI 10.1055/s-0031-1272964	32	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211114	10.1371/journal.pone.0211114	http://dx.doi.org/10.1371/journal.pone.0211114			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811416	Green Submitted, gold, Green Published			2022-12-27	WOS:000459806400014
J	Midway, SR; Wagner, T; Burgess, GH				Midway, Stephen R.; Wagner, Tyler; Burgess, George H.			Trends in global shark attacks	PLOS ONE			English	Article							ECOLOGICAL ROLE; PELAGIC SHARKS; CONSERVATION; POPULATIONS; COLLAPSE	Shark attacks are a global phenomenon that attracts widespread attention and publicity, often with negative outcomes for shark populations. Despite the widespread perceptions of shark attacks, trends in human water activities and shark populations are both dynamic, resulting in variable rates of shark attacks over space and time. Understanding variable trends in shark attacks may contribute to a better understanding of risk, and a more tempered response in the wake of an attack. We found that global shark attack rates are low, yet variable across global regions and over decades. Countries with low populations were found to have the highest rates of attack, while countries with high populations (U.S.A., Australia, South Africa) tended to have overall low attack rates, but also much more interannual variability. From the 1960s to the present, those countries with the highest populations also tended to be the places where attack rates have increased. Ultimately, shark attack risk is also driven by local conditions (e.g., time of day, species present); however, a global scale understanding of attack rates helps place risk into perspective and may contribute to a more scientifically-grounded discussion of sharks, and their management and conservation.	[Midway, Stephen R.] Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA; [Wagner, Tyler] Penn State Univ, US Geol Survey, Penn Cooperat Fish & Wildlife Res Unit, University Pk, PA 16802 USA; [Burgess, George H.] Univ Florida, Int Shark Attack File, Gainesville, FL USA	Louisiana State University System; Louisiana State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of the Interior; United States Geological Survey; State University System of Florida; University of Florida	Midway, SR (corresponding author), Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA.	smidway@lsu.edu		Midway, Stephen/0000-0003-0162-1995				Baum JK, 2004, ECOL LETT, V7, P135, DOI 10.1111/j.1461-0248.2003.00564.x; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Bethea DM, 2015, ENVIRON BIOL FISH, V98, P1233, DOI 10.1007/s10641-014-0355-3; Burgess GH, 2005, FISHERIES, V30, P19, DOI 10.1577/1548-8446(2005)30[19:ITCOSP]2.0.CO;2; Chapman BK, 2016, OCEAN COAST MANAGE, V133, P72, DOI 10.1016/j.ocecoaman.2016.09.010; Clarke SC, 2006, ECOL LETT, V9, P1115, DOI 10.1111/j.1461-0248.2006.00968.x; Dulvy NK, 2008, AQUAT CONSERV, V18, P459, DOI 10.1002/aqc.975; Ferretti F, 2015, FRONT ECOL ENVIRON, V13, P412, DOI 10.1890/150109; Heupel MR, 2014, MAR ECOL PROG SER, V495, P291, DOI 10.3354/meps10597; ISAF, 2016, INT SHARK ATT FIL; Karl SA, 2011, CONSERV GENET, V12, P371, DOI 10.1007/s10592-010-0145-1; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; McPhee D, 2014, COAST MANAGE, V42, P478, DOI 10.1080/08920753.2014.942046; Muter BA, 2013, CONSERV BIOL, V27, P187, DOI 10.1111/j.1523-1739.2012.01952.x; R Team, 2014, R PROJECT STAT COMPU; Roff G, 2016, TRENDS ECOL EVOL, V31, P395, DOI 10.1016/j.tree.2016.02.014; Simpfendorfer CA, 2017, CURR BIOL, V27, pR97, DOI 10.1016/j.cub.2016.12.017; United States Census Bureau, 2016, POPULATION; WINEMILLER KO, 1992, CAN J FISH AQUAT SCI, V49, P2196, DOI 10.1139/f92-242; World Bank, 2016, WORLD BANK POP DAT	20	30	31	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211049	10.1371/journal.pone.0211049	http://dx.doi.org/10.1371/journal.pone.0211049			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811398	gold, Green Submitted, Green Published			2022-12-27	WOS:000459806400013
J	Raitskin, O; Schudoma, C; West, A; Patron, NJ				Raitskin, Oleg; Schudoma, Christian; West, Anthony; Patron, Nicola J.			Comparison of efficiency and specificity of CRISPR-associated (Cas) nucleases in plants: An expanded toolkit for precision genome engineering	PLOS ONE			English	Article							RNA-GUIDED ENDONUCLEASE; TARGETED MUTAGENESIS; DNA REPLICONS; SYSTEM; ARABIDOPSIS; MULTIPLEX; DETERMINANTS; MECHANISMS; EXPRESSION; DESIGN	Molecular tools adapted from bacterial CRISPR (Clustered Regulatory Interspaced Short Palindromic Repeats) systems for adaptive immunity have become widely used for plant genome engineering, both to investigate gene functions and to engineer desirable traits. A number of different Cas (CRISPR-associated) nucleases are now used but, as most studies performed to date have engineered different targets using a variety of plant species and molecular tools, it has been difficult to draw conclusions about the comparative performance of different nucleases. Due to the time and effort required to regenerate engineered plants, efficiency is critical. In addition, there have been several reports of mutations at sequences with less than perfect identity to the target. While in some plant species it is possible to remove these so-called 'off-targets' by backcrossing to a parental line, the specificity of genome engineering tools is important when targeting specific members of closely-related gene families, especially when recent paralogues are co-located in the genome and unlikely to segregate. Specificity is also important for species that take years to reach sexual maturity or that are clonally propagated. Here, we directly compare the efficiency and specificity of Cas nucleases from different bacterial species together with engineered variants of Cas9. We find that the nucleotide content of the target correlates with efficiency and that Cas9 from Staphylococcus aureus (SaCas9) is comparatively most efficient at inducing mutations. We also demonstrate that 'high-fidelity' variants of Cas9 can reduce off-target mutations in plants. We present these molecular tools as standardised DNA parts to facilitate their re-use.	[Raitskin, Oleg; Schudoma, Christian; West, Anthony; Patron, Nicola J.] Earlham Inst, Norwich Res Pk, Norwich, Norfolk, England; [West, Anthony] Isogenica Ltd, Chesterford Res Pk, Saffron Walden, Saffron Walden, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Earlham Institute; Isogenica Limited	Patron, NJ (corresponding author), Earlham Inst, Norwich Res Pk, Norwich, Norfolk, England.	nicola.patron@earlham.ac.uk	Patron, Nicola J/D-8778-2014	Patron, Nicola J/0000-0002-8389-1851; Schudoma, Christian/0000-0003-1157-1354	UK Biotechnological and Biological Sciences Research Council (BBSRC); Engineering and Physics Research Council (EPSRC) Synthetic Biology for Growth program [BB/L014130/1]; BBSRC National Capability in Genomics at the Earlham Institute [BB/CCG1720/1]; BBSRC [BB/CCG1720/1, BBS/E/T/000PR9816]; BBSRC [BB/L014130/1] Funding Source: UKRI	UK Biotechnological and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physics Research Council (EPSRC) Synthetic Biology for Growth program(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC National Capability in Genomics at the Earlham Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the UK Biotechnological and Biological Sciences Research Council (BBSRC) and Engineering and Physics Research Council (EPSRC) Synthetic Biology for Growth program [OpenPlant Synthetic Biology Research Centre; BB/L014130/1]. Next-generation sequencing and library construction and automated DNA assembly was delivered via the BBSRC National Capability in Genomics at the Earlham Institute [BB/CCG1720/1]. CS was supported by BBSRC strategic funding, Core Capability Grant [BB/CCG1720/1, BBS/E/T/000PR9816]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltes NJ, 2014, PLANT CELL, V26, P151, DOI 10.1105/tpc.113.119792; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Begemann MB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11760-6; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Cermak T, 2017, PLANT CELL, DOI [10.1111/TPJ.13446, DOI 10.1111/TPJ.13446]; Cermak T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0796-9; Char SN, 2017, PLANT BIOTECHNOL J, V15, P257, DOI 10.1111/pbi.12611; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Engler C, 2014, ACS SYNTH BIOL, V3, P839, DOI 10.1021/sb4001504; Friedland AE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0817-8; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Gao CX, 2018, NAT REV MOL CELL BIO, V19, P275, DOI 10.1038/nrm.2018.2; Gil-Humanes J, 2017, PLANT J, V89, P1251, DOI 10.1111/tpj.13446; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.19760; Hu JH, 2018, NATURE, V556, P57, DOI 10.1038/nature26155; Hu ZB, 2016, ANNU REV PLANT BIOL, V67, P439, DOI 10.1146/annurev-arplant-043015-111902; Kaya H, 2016, SCI REP-UK, V6, DOI 10.1038/srep26871; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Koster J, 2012, BIOINFORMATICS, V28, P2520, DOI 10.1093/bioinformatics/bts480; Kohli A, 2006, PLANT SIGNAL BEHAV, V1, P185, DOI 10.4161/psb.1.4.3195; Lawrenson T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0826-7; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Li ZS, 2015, PLANT PHYSIOL, V169, P960, DOI 10.1104/pp.15.00783; Liang Z, 2018, NAT PROTOC, V13, P413, DOI 10.1038/nprot.2017.145; Liu MJ, 2015, GENOME RES, V25, P1182, DOI 10.1101/gr.188680.114; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Moreno-Mateos MA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01836-2; Patron N, 2015, NEW PHYTOL, V208, P13, DOI 10.1111/nph.13532; PHILLIPS RL, 1994, P NATL ACAD SCI USA, V91, P5222, DOI 10.1073/pnas.91.12.5222; Pinello L, 2016, NAT BIOTECHNOL, V34, P695, DOI 10.1038/nbt.3583; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ricroch A, 2017, EMERG TOP LIFE SCI, V1, P168; Schiml S, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0103-0; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Slaymaker IM, 2015, SCIENCE, V10, P1126; Steinert J, 2015, PLANT J, V84, P1295, DOI 10.1111/tpj.13078; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Tang X, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.18; Vazquez-Vilar M, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0101-2; Wang YM, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1445-x; Wang ZP, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0715-0; Werner S, 2012, BIOENGINEERED, V3, P38, DOI [10.4161/bbug.3.1.18223, 10.1371/journal.pone.0016765]; Wu JC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0093806, 10.1371/journal.pone.0090528]; Xie HH, 2018, BIOTECHNOL J, V13, DOI 10.1002/biot.201700561; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Xu H, 2015, GENOME RES, V25, P1147, DOI 10.1101/gr.191452.115; XU P, 2018, FRONT PLANT SCI, V9, P1, DOI DOI 10.3389/fpls.2018.01528; Xu RF, 2017, PLANT BIOTECHNOL J, V15, P713, DOI 10.1111/pbi.12669; Xu RF, 2014, RICE, V7, DOI 10.1186/s12284-014-0005-6; Yamano T, 2017, MOL CELL, V67, P633, DOI 10.1016/j.molcel.2017.06.035; Yan LH, 2015, MOL PLANT, V8, P1820, DOI 10.1016/j.molp.2015.10.004; Yin KQ, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.107; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang D, 2014, PLOS ONE, V9, P5, DOI DOI 10.1371/J0URNAL.P0NE.0096132><PMID:24788396>; Zhang DB, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1325-9; Zhang Q, 2018, PLANT MOL BIOL, V96, P445, DOI 10.1007/s11103-018-0709-x; Zhou JH, 2018, PLANT BIOTECHNOL J, V16, P1868, DOI 10.1111/pbi.12922	68	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211598	10.1371/journal.pone.0211598	http://dx.doi.org/10.1371/journal.pone.0211598			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811422	gold, Green Published, Green Submitted			2022-12-27	WOS:000459806400024
J	Takamido, R; Yokoyama, K; Yamamoto, Y				Takamido, Ryota; Yokoyama, Keiko; Yamamoto, Yuji			Task constraints and stepping movement of fast-pitch softball hitting	PLOS ONE			English	Article							VISUAL ANTICIPATION; CLUSTER-ANALYSIS; PICK-UP; EXPERT; PERFORMANCE; INFORMATION; PERCEPTION; SKILL	This study aims to clarify the relationship between task constraints and the preparatory movement of fast-pitch softball batters in Japan for three different competition categories, namely high school, college, and league. As task constraints, we focused on the temporal and tool constraints and evaluated preparatory movements using initiation time and step duration of the stepping movement in a striking action. First, we confirmed the temporal constraints in each category and then examined the relationship between the temporal constraints and the stepping movements. The results demonstrated that the temporal constraints affected both initiation time and step duration of the stepping movements. Hierarchical cluster analysis was applied to the two variables. Consequently, the stepping movement of the softball players was classified into three types: "late initiation-short duration" (LS), "early initiation-short duration" (ES), and "early initiation-long duration" (EL) corresponding to the task constraints. Finally, the relationship between the task constraints of each category and the stepping movements was examined. The results revealed that high school players exhibited mostly the LS- or EL-type stepping movement; college players exhibited mostly the EL-type stepping movement; and league players exhibited all types. These results depict that the players in each category with each temporal and tool constraint exhibited particular types of stepping movements as a preparatory movement corresponding to each task constraint, thereby arguing that players use a not-to-lose strategy exploiting the redundancy in solutions under various task constraints.	[Takamido, Ryota] Nagoya Univ, Grad Sch Educ & Human Dev, Chikusa Ku, Furo Cho, Nagoya, Aichi, Japan; [Yokoyama, Keiko; Yamamoto, Yuji] Nagoya Univ, Res Ctr Hlth Phys Fitness & Sports, Chikusa Ku, Furo Cho, Nagoya, Aichi, Japan; [Yokoyama, Keiko; Yamamoto, Yuji] Nagoya Univ, Dept Psychol & Human Dev Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi, Japan	Nagoya University; Nagoya University; Nagoya University	Takamido, R (corresponding author), Nagoya Univ, Grad Sch Educ & Human Dev, Chikusa Ku, Furo Cho, Nagoya, Aichi, Japan.	ryota.takamido@gmail.com			MEXT, Japan [17H02152]	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partially supported by Grants-in-Aid for Scientific Research (B) 17H02152 from MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Abernethy B, 2001, PERCEPTION, V30, P233, DOI 10.1068/p2872; Abernethy B, 1990, J SPORT SCI, V8, P17, DOI 10.1080/02640419008732128; Adair K. R., 2002, PHYS BASEBALL; Bernstein N, 1967, COORDINATION REGULAT; Brenner E, 1996, HUM MOVEMENT SCI, V15, P39, DOI 10.1016/0167-9457(95)00036-4; Brenton J, 2016, J APPL SPORT PSYCHOL, V28, P483, DOI 10.1080/10413200.2016.1162225; Breunig MM, 2000, SIGMOD REC, V29, P93, DOI 10.1145/335191.335388; Caljouw SR, 2005, HUM MOVEMENT SCI, V24, P206, DOI 10.1016/j.humov.2005.04.003; Caljouw SR, 2004, EXP BRAIN RES, V155, P135, DOI 10.1007/s00221-003-1705-0; Cross R, 2011, PHYSICS OF BASEBALL & SOFTBALL, P1, DOI 10.1007/978-1-4419-8113-4; Flyger N, 2006, SPORTS MED, V36, P797, DOI 10.2165/00007256-200636090-00006; Jain K.A., 1998, ALGORITHMS CLUSTERIN; Katsumata H, 2007, HUM MOVEMENT SCI, V26, P27, DOI 10.1016/j.humov.2006.09.005; Kijima A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047911; Muller S, 2017, J SPORT SCI, V35, P1682, DOI 10.1080/02640414.2016.1230225; Muller S, 2015, ATTEN PERCEPT PSYCHO, V77, P1726, DOI 10.3758/s13414-015-0876-7; Muller S, 2014, PERCEPT MOTOR SKILL, V119, P347, DOI 10.2466/30.PMS.119c21z9; Muller S, 2012, RES Q EXERCISE SPORT, V83, P175; Muller S, 2009, PSYCHOL SPORT EXERC, V10, P644, DOI 10.1016/j.psychsport.2009.04.002; Okumura M, 2017, ECOL PSYCHOL, V29, P1, DOI 10.1080/10407413.2017.1270147; Okumura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051877; PUNJ G, 1983, J MARKETING RES, V20, P134, DOI 10.2307/3151680; Ranganathan R, 2007, J MOTOR BEHAV, V39, P369, DOI 10.3200/JMBR.39.5.369-380; Saltzman E, 2015, ECOL PSYCHOL, V27, P300, DOI 10.1080/10407413.2015.1086228; van de Kamp C, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00055; Van der Kamp J, 2008, INT J SPORT PSYCHOL, V39, P100; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Williams AM, 2005, HUM MOVEMENT SCI, V24, P283, DOI 10.1016/j.humov.2005.06.002; Yamamoto Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072436; Yokoyama K, 2018, PHYS REV E, V97, DOI 10.1103/PhysRevE.97.022410; Yokoyama K, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002181	32	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0212997	10.1371/journal.pone.0212997	http://dx.doi.org/10.1371/journal.pone.0212997			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8EU	30807596	Green Published, gold, Green Submitted			2022-12-27	WOS:000459712100034
J	Moshynets, OV; Babenko, LM; Rogalsky, SP; Iungin, OS; Foster, J; Kosakivska, IV; Potters, G; Spiers, AJ				Moshynets, Olena V.; Babenko, Lidia M.; Rogalsky, Sergiy P.; Iungin, Olga S.; Foster, Jessica; Kosakivska, Iryna V.; Potters, Geert; Spiers, Andrew J.			Priming winter wheat seeds with the bacterial quorum sensing signal N-hexanoyl-L-homoserine lactone (C6-HSL) shows potential to improve plant growth and seed yield	PLOS ONE			English	Article							ACYL-L-HOMOSERINE; DEFENSE RESPONSES; STRESS; COMMUNICATION; RESISTANCE; FERTILIZER; PATHOGENS; DISEASES; TOMATO; SIZE	Several model plants are known to respond to bacterial quorum sensing molecules with altered root growth and gene expression patterns and induced resistance to plant pathogens. These compounds may represent novel elicitors that could be applied as seed primers to enhance cereal crop resistance to pathogens and abiotic stress and to improve yields. We investigated whether the acyl-homoserine lactone N-hexanoyl-L-homoserine lactone (C6-HSL) impacted winter wheat (Triticum aestivum L.) seed germination, plant development and productivity, using two Ukrainian varieties, Volodarka and Yatran 60, in both in vitro experiments and field trials. In vitro germination experiments indicated that C6-HSL seed priming had a small but significant positive impact on germination levels (1.2x increase, p < 0.0001), coleoptile and radicle development (1.4x increase, p < 0.0001). Field trials over two growing seasons (2015-16 and 2016-17) also demonstrated significant improvements in biomass at the tillering stage (1.4x increase, p < 0.0001), and crop structure and productivity at maturity including grain yield (1.4-1.5x increase, p < 0.0007) and quality (1.3x increase in good grain, p < 0.0001). In some cases variety effects were observed (p <= 0.05) suggesting that the effect of C6-HSL seed priming might depend on plant genetics, and some benefits of priming were also evident in F1 plants grown from seeds collected the previous season (p <= 0.05). These field-scale findings suggest that bacterial acyl-homoserine lactones such as C6-HSL could be used to improve cereal crop growth and yield and reduce reliance on fungicides and fertilisers to combat pathogens and stress.	[Moshynets, Olena V.] Natl Acad Sci Ukraine, Inst Mol Biol & Genet, Kiev, Ukraine; [Babenko, Lidia M.; Kosakivska, Iryna V.] Natl Acad Sci Ukraine, MG Kholodny Inst Bot, Kiev, Ukraine; [Rogalsky, Sergiy P.] Natl Acad Sci Ukraine, VP Kukhar Inst Bioorgan Chem & Petrochem, Kiev, Ukraine; [Iungin, Olga S.] Natl Acad Sci Ukraine, DK Zabolotny Inst Microbiol & Virol, Kiev, Ukraine; [Foster, Jessica; Spiers, Andrew J.] Abertay Univ, Sch Sci Engn & Technol, Dundee, Scotland; [Potters, Geert] Antwerp Maritime Acad, Antwerp, Belgium; [Potters, Geert] Univ Antwerp, Dept Biosci Engn, Antwerp, Belgium	National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU; National Academy of Sciences Ukraine; M.G. Kholodny Institute of Botany, NAS of Ukraine; National Academy of Sciences Ukraine; V. P. Kukhar Institute of Bioorganic Chemistry & Petrochemistry of the National Academy of Sciences of Ukraine; National Academy of Sciences Ukraine; Zabolotny Institute of Microbiology & Virology of NASU; University of Abertay Dundee; University of Antwerp	Moshynets, OV (corresponding author), Natl Acad Sci Ukraine, Inst Mol Biol & Genet, Kiev, Ukraine.; Spiers, AJ (corresponding author), Abertay Univ, Sch Sci Engn & Technol, Dundee, Scotland.	moshynets@gmail.com; a.spiers@abertay.ac.uk	Potters, Geert/HDM-3489-2022; Spiers, Andrew/I-3535-2012; Moshynets, Olena/O-8840-2015; Iungin, Olga/AAZ-8970-2021; Kosakivska, Iryna/AAB-7752-2020; Babenko, Lidia/AAC-6216-2020; Rogalsky, Sergiy/AAG-6119-2020; Moshynets, Olena/N-4256-2019	Potters, Geert/0000-0002-8924-3169; Spiers, Andrew/0000-0003-0463-8629; Moshynets, Olena/0000-0002-2209-8681; Iungin, Olga/0000-0001-8876-6075; Babenko, Lidia/0000-0001-5391-9203; Rogalsky, Sergiy/0000-0002-5200-5247; Moshynets, Olena/0000-0002-2209-8681; Kosakivska, Iryna/0000-0002-2173-8341	National Multidisciplinary NASU Research Program "Molecular and Cellular Biotechnology for Medicine, Industry and Agrarian Sciences" [0115U004178]; IMBG; Abertay University	National Multidisciplinary NASU Research Program "Molecular and Cellular Biotechnology for Medicine, Industry and Agrarian Sciences"; IMBG; Abertay University	The project was partially supported by a grant to L.M. Babenko and O.V. Moshynets (0115U004178; Development of wheat priming biotechnology based on N-Acyl Homoserine Lactones for increasing resistance and productivity, 2015-2019) provided under the National Multidisciplinary NASU Research Program "Molecular and Cellular Biotechnology for Medicine, Industry and Agrarian Sciences". Further internal support to O.V. Moshynets and A.J. Spiers was provided by IMBG and Abertay University. There was no additional external funding received for this study.	[Anonymous], 2016, APPROACHES STRATEGIE; [Anonymous], 1989, TISSUE CULTURE TECHN; Bebber DP, 2014, GLOBAL ECOL BIOGEOGR, V23, P1398, DOI 10.1111/geb.12214; Becker-Reshef I, 2010, REMOTE SENS ENVIRON, V114, P1312, DOI 10.1016/j.rse.2010.01.010; BRODFUHRER U, 1955, PLANTA, V45, P1, DOI 10.1007/BF01937677; Chakraborty S, 2013, GLOBAL CHANGE BIOL, V19, P1985, DOI 10.1111/gcb.12205; Cheng FF, 2018, MOL PLANT PATHOL, V19, P104, DOI 10.1111/mpp.12502; Chhabra SR, 2003, J MED CHEM, V46, P97, DOI 10.1021/jm020909n; DEHORITY BA, 1989, APPL ENVIRON MICROB, V55, P2789, DOI 10.1128/AEM.55.11.2789-2792.1989; Ding LN, 2016, PHYSIOL PLANTARUM, V158, P414, DOI 10.1111/ppl.12476; Egorov NS., 1995, GUIDE PRACTICAL TRAI; Elasri M, 2001, APPL ENVIRON MICROB, V67, P1198, DOI 10.1128/AEM.67.3.1198-1209.2001; Figueroa M, 2018, MOL PLANT PATHOL, V19, P1523, DOI 10.1111/mpp.12618; Floryszak-Wieczorek J, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00844; Guberac V, 1999, BODENKULTUR, V50, P39; Gutzat R, 2012, CURR OPIN PLANT BIOL, V15, P568, DOI 10.1016/j.pbi.2012.08.007; Hawkesford MJ, 2014, J CEREAL SCI, V59, P276, DOI 10.1016/j.jcs.2013.12.001; Jansen MAK, 2017, UV-B RADIATION AND PLANT LIFE: MOLECULAR BIOLOGY TO ECOLOGY, P58, DOI 10.1079/9781780648590.0058; Jin GP, 2012, BIOCHEM BIOPH RES CO, V417, P991, DOI 10.1016/j.bbrc.2011.12.066; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Khalid A, 2004, J APPL MICROBIOL, V96, P473, DOI 10.1046/j.1365-2672.2003.02161.x; Kizilkaya R, 2008, ECOL ENG, V33, P150, DOI 10.1016/j.ecoleng.2008.02.011; Klein I, 2009, PLANT SIGNAL BEHAV, V4, P50, DOI 10.4161/psb.4.1.7300; Kogan F, 2013, INT J APPL EARTH OBS, V23, P192, DOI 10.1016/j.jag.2013.01.002; Kumar S, 2018, EPIGENOMES, V2, DOI 10.3390/epigenomes2010006; Lamke J, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1263-6; Lareen A, 2016, PLANT MOL BIOL, V90, P575, DOI 10.1007/s11103-015-0417-8; Laue RE, 2000, MICROBIOL-UK, V146, P2469, DOI 10.1099/00221287-146-10-2469; Licciardello G, 2007, FEMS MICROBIOL ECOL, V61, P222, DOI 10.1111/j.1574-6941.2007.00338.x; Liu F, 2012, MOL PLANT MICROBE IN, V25, P677, DOI 10.1094/MPMI-10-11-0274; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Macholdt J, 2017, AGRONOMY-BASEL, V7, DOI 10.3390/agronomy7030045; Maksimov I. V., 2014, American Journal of Plant Sciences, V5, P1745, DOI 10.4236/ajps.2014.512189; Mathesius U, 2003, P NATL ACAD SCI USA, V100, P1444, DOI 10.1073/pnas.262672599; Miao CJ, 2012, BIOCHEM BIOPH RES CO, V427, P293, DOI 10.1016/j.bbrc.2012.09.044; Moshynets OV, 2010, B NAT KHARKOV AGRARI, V2, P19; Moshynets OV, 2010, B NAT KHARKOV AGRARI, V3, P6; NATELSON S, 1989, MICROCHEM J, V40, P226, DOI 10.1016/0026-265X(89)90074-X; NAYLOR REL, 1993, ANN APPL BIOL, V123, P379, DOI 10.1111/j.1744-7348.1993.tb04100.x; Ortiz-Castro R, 2008, PLANT CELL ENVIRON, V31, P1497, DOI 10.1111/j.1365-3040.2008.01863.x; Palmer AG, 2014, ACS CHEM BIOL, V9, P1834, DOI 10.1021/cb500191a; Papenfort K, 2016, NAT REV MICROBIOL, V14, P576, DOI 10.1038/nrmicro.2016.89; Paradikovic N, 2013, AGR FOOD SCI, V22, P307, DOI 10.23986/afsci.7354; Pierson EA, 1998, MOL PLANT MICROBE IN, V11, P1078, DOI 10.1094/MPMI.1998.11.11.1078; Potters G, 2007, TRENDS PLANT SCI, V12, P98, DOI 10.1016/j.tplants.2007.01.004; ROSENBLATT JE, 1973, APPL MICROBIOL, V25, P77, DOI 10.1128/AEM.25.1.77-85.1973; Schenk ST, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00784; Schenk ST, 2014, PLANT CELL, V26, P2708, DOI 10.1105/tpc.114.126763; Schikora A, 2016, PLANT MOL BIOL, V90, P605, DOI 10.1007/s11103-016-0457-8; Schuhegger R, 2006, PLANT CELL ENVIRON, V29, P909, DOI 10.1111/j.1365-3040.2005.01471.x; Shaharoona B, 2008, APPL MICROBIOL BIOT, V79, P147, DOI 10.1007/s00253-008-1419-0; Sjofjan O, 2011, WORLDS POULT SCI J, V10, P411, DOI [10.3923/ ijps.2011.411.415, DOI 10.3923/IJPS.2011.411.415]; Stella M., 2010, Journal of Tropical Agriculture and Food Science, V38, P211; Torres K.C., 1989, TISSUE CULTURE TECHN, P26; Tsygankova V, 2016, EUR J BIOTECHNOL BIO, V4, P41; Wegulo SN, 2011, CROP PROT, V30, P685, DOI 10.1016/j.cropro.2011.02.002; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; Whiteley M, 2017, NATURE, V551, P313, DOI 10.1038/nature24624; Wiik L, 2010, CROP PROT, V29, P11, DOI 10.1016/j.cropro.2009.09.008; Woomer P.L., 1994, METHODS SOIL ANAL 2, P59	60	18	19	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2019	14	2							e0209460	10.1371/journal.pone.0209460	http://dx.doi.org/10.1371/journal.pone.0209460			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EH	30802259	Green Published, gold, Green Submitted			2022-12-27	WOS:000459710700004
J	Dabagh, M; Randles, A				Dabagh, Mahsa; Randles, Amanda			Role of deformable cancer cells on wall shear stress-associated-VEGF secretion by endothelium in microvasculature	PLOS ONE			English	Article							FINITE-ELEMENT; GROWTH-FACTOR; TUMOR-CELLS; ADHESION; SELECTIN; MOTION; FLOW; SIMULATIONS; RECEPTOR-2; ACTIVATION	Endothelial surface layer (glycocalyx) is the major physiological regulator of tumor cell adhesion to endothelium. Cancer cells express vascular endothelial growth factor (VEGF) which increases the permeability of a microvessel wall by degrading glycocalyx. Endothelial cells lining large arteries have also been reported, in vitro and in vivo, to mediate VEGF expression significantly under exposure to high wall shear stress (WSS) > 0.6 Pa. The objective of the present study is to explore whether local hemodynamic conditions in the vicinity of a migrating deformable cancer cell can influence the function of endothelial cells to express VEGF within the microvasculature. A three-dimensional model of deformable cancer cells (DCCs) migrating within a capillary is developed by applying a massively parallel hemodynamics application to simulate the fluid-structure interaction between the DCC and fluid surrounding the DCC. We study how dynamic interactions between the DCC and its local microenvironment affect WSS exposed on endothelium, under physiological conditions of capillaries with different diameters and flow conditions. Moreover, we quantify the area of endothelium affected by the DCC. Our results show that the DCC alters local hemodynamics in its vicinity up to an area as large as 40 times the cancer cell lateral surface. In this area, endothelium experiences high WSS values in the range of 0.6-12 Pa. Endothelial cells exposed to this range of WSS have been reported to express VEGF. Furthermore, we demonstrate that stiffer cancer cells expose higher WSS on the endothelium. A strong impact of cell stiffness on its local microenvironment is observed in capillaries with diameters <16 mu m. WSS-induced-VEGF by endothelium represents an important potential mechanism for cancer cell adhesion and metastasis in the microvasculature. This work serves as an important first step in understanding the mechanisms driving VEGF-expression by endothelium and identifying the underlying mechanisms of glycocalyx degradation by endothelium in micro-vasculature. The identification of angiogenesis factors involved in early stages of cancer cell-endothelium interactions and understanding their regulation will help, first to develop anti-angiogenic strategies applied to diagnostic studies and therapeutic interventions, second to predict accurately where different cancer cell types most likely adhere in microvasculature, and third to establish accurate criteria predisposing the cancer metastasis.	[Dabagh, Mahsa; Randles, Amanda] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA	Duke University	Randles, A (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	amanda.randles@duke.edu		Dabagh, Mahsa/0000-0003-1540-7420	NIH [DP5OD091876]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	AR and MD received funding from the NIH DP5OD091876. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artoli AM, 2007, J BIOMECH, V40, P3493, DOI 10.1016/j.jbiomech.2007.05.031; Cai B, 2012, J APPL PHYSIOL, V113, P1141, DOI 10.1152/japplphysiol.00479.2012; Chang KC, 2000, P NATL ACAD SCI USA, V97, P11262, DOI 10.1073/pnas.200240897; Dabagh M, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0185; Dabagh M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0431; Daddi-Moussa-Ider A, 2017, PHYS FLUIDS, V29, DOI 10.1063/1.5002192; Fai TG, 2013, SIAM J SCI COMPUT, V35, pB1132, DOI 10.1137/120903038; Fan J, 2016, ANN BIOMED ENG, V44, P2189, DOI 10.1007/s10439-015-1517-y; Fan J, 2011, ANN BIOMED ENG, V39, P2223, DOI 10.1007/s10439-011-0321-6; GELLER AS, 1986, J FLUID MECH, V169, P27, DOI 10.1017/S0022112086000538; Gounley J., 2017, ELS P COMP SCI, V108; Gounley J, 2015, COMMUN COMPUT PHYS, V17, P1073, DOI 10.4208/cicp.2014.m355; Guo P, 2014, BIOMECH MODEL MECHAN, V13, P537, DOI 10.1007/s10237-013-0515-y; Hong D, 2006, AM J PHYSIOL-HEART C, V290, pH2498, DOI 10.1152/ajpheart.00828.2005; Howard B, 1958, J FLU, V4, P195; Jadhav S, 2005, BIOPHYS J, V88, P96, DOI 10.1529/biophysj.104.051029; Khismatullin DB, 2012, BIOPHYS J, V102, P1757, DOI 10.1016/j.bpj.2012.03.018; Khismatullin DB, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.1862635; Kruger T, 2011, COMPUT MATH APPL, V61, P3485, DOI 10.1016/j.camwa.2010.03.057; Lefebvre Y, 2007, J FLUID MECH, V589, P157, DOI 10.1017/S0022112007007586; Li J, 2005, BIOPHYS J, V88, P3707, DOI 10.1529/biophysj.104.047332; Liang S, 2005, EXP CELL RES, V310, P282, DOI 10.1016/j.yexcr.2005.07.028; Luo ZY, 2016, PHYS FLUIDS, V28, DOI 10.1063/1.4965251; Luo ZY, 2015, J FLUID MECH, V775, P77, DOI 10.1017/jfm.2015.286; Matyka M, 2013, COMPUT FLUIDS, V73, P115, DOI 10.1016/j.compfluid.2012.12.018; Paz NG, 2011, J CELL SCI, V125, P831; Peskin CS, 2002, ACT NUMERIC, V11, P479, DOI 10.1017/S0962492902000077; PRASAD ARS, 1993, CIRC RES, V72, P827, DOI 10.1161/01.RES.72.4.827; Rai S, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0223-9; Randles A, 2015, INT C HIGH PERF COMP; Randles A, 2015, J COMPUT SCI-NETH, V9, P70, DOI 10.1016/j.jocs.2015.04.003; Randles AP, 2013, INT PARALL DISTRIB P, P1063, DOI 10.1109/IPDPS.2013.109; Rinker KD, 2001, BIOPHYS J, V80, P1722, DOI 10.1016/S0006-3495(01)76143-7; Secomb TW, 2001, AM J PHYSIOL-HEART C, V281, pH629, DOI 10.1152/ajpheart.2001.281.2.H629; Shay-Salit A, 2002, P NATL ACAD SCI USA, V99, P9462, DOI 10.1073/pnas.142224299; SHRIVASTAVA S, 1993, J STRAIN ANAL ENG, V28, P31, DOI 10.1243/03093247V281031; Smith MJ, 1999, BIOPHYS J, V77, P3371, DOI 10.1016/S0006-3495(99)77169-9; Stroka KM, 2014, AM J PHYSIOL-CELL PH, V306, pC98, DOI 10.1152/ajpcell.00289.2013; Takeishi N, 2016, AM J PHYSIOL-HEART C, V311, pH395, DOI 10.1152/ajpheart.00241.2016; TOZEREN A, 1992, BIOPHYS J, V63, P700, DOI 10.1016/S0006-3495(92)81660-0; Urbich C, 2003, FEBS LETT, V535, P87, DOI 10.1016/S0014-5793(02)03879-6; Walter J, 2010, INT J NUMER METH ENG, V83, P829, DOI 10.1002/nme.2859; Wang DG, 1999, CANCER RES, V59, P1464; White SJ, 2011, J CELL PHYSIOL, V226, P2841, DOI 10.1002/jcp.22629; Wirtz D, 2011, NAT REV CANCER, V11, P512, DOI 10.1038/nrc3080; Xu WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0022900; Zhang Y, 2002, BIOPHYS J, V83, P1934, DOI 10.1016/S0006-3495(02)73956-8; Zhang Z, 2017, BIOMECH MOD MECHANOB; ZHELEV DV, 1994, BIOPHYS J, V67, P696, DOI 10.1016/S0006-3495(94)80529-6; ZHONGCAN OY, 1989, PHYS REV A, V39, P5280, DOI 10.1103/PhysRevA.39.5280	50	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0211418	10.1371/journal.pone.0211418	http://dx.doi.org/10.1371/journal.pone.0211418			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794550	Green Submitted, Green Published, gold			2022-12-27	WOS:000459709100015
J	Mondragon, R; Sanchez, D; Cabello, R; Llopis, R; Julia, JE				Mondragon, Rosa; Sanchez, Daniel; Cabello, Ramon; Llopis, Rodrigo; Enrique Julia, J.			Flat plate solar collector performance using alumina nanofluids: Experimental characterization and efficiency tests	PLOS ONE			English	Article							HEAT-TRANSFER; THERMAL PERFORMANCE; CONDUCTIVITY; FLOW	Solar energy has become an important renewable energy source for reducing the use of fossil fuels and to mitigate global warming, for which solar collectors constitute a technology that is to be promoted. The use of nanofluids can increase the efficiency of solar into thermal energy conversion in solar collectors. Experimental values for the specific heat, thermal conductivity and viscosity of alumina/water nanofluids are needed to evaluate the influence of the solid content (from 0.25 to 5 v%) and the flow rate on the Reynolds, Nusselt and the heat transfer coefficient. In the laminar flow regime, thermal conductivity enhancement over specific heat decrement is key parameter, and a 2.34% increase in the heat transfer coefficient is theoretically obtained for 1 v% alumina nanofluid. To corroborate the results, experimental tests were run in a flat plate solar collector. A reduction in efficiency from 47% to 41.5% and a decrease in the heat removal factor were obtained using the nanofluid due to the formation of a nanoparticle deposition layer adding an addition thermal resistance to heat transfer. Nanofluids are recommended only if the nanoparticle concentration is high enough to enhance thermal conductivity, but no so high so as to avoid wall deposition.	[Mondragon, Rosa; Sanchez, Daniel; Cabello, Ramon; Llopis, Rodrigo; Enrique Julia, J.] Univ Jaume 1, Dept Ingn Mecan & Construcc, Castellon De La Plana, Spain	Universitat Jaume I	Mondragon, R (corresponding author), Univ Jaume 1, Dept Ingn Mecan & Construcc, Castellon De La Plana, Spain.	mondragn@uji.es	García-Vacas, Daniel Sánchez/L-3764-2014; Llopis, R./H-7184-2019; Cabello-Lopez, Ramon/R-1056-2018	García-Vacas, Daniel Sánchez/0000-0003-4924-1254; Llopis, R./0000-0003-0866-1009; Cabello-Lopez, Ramon/0000-0002-1916-5142; Mondragon, Rosa/0000-0002-9353-0275	Spanish Ministry of Science and Innovation [CTQ2010-21321-C02-01, CTQ2010-21321-C02-02]; Spanish Ministry of Economy and Competitiveness [ENE2014-53760-R, ENE2016-77694-R]; University Jaume I of Castellon [P11B2015-66, UJI-B2016-47]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Economy and Competitiveness(Spanish Government); University Jaume I of Castellon	The authors gratefully acknowledge the financial support from the Spanish Ministry of Science and Innovation (CTQ2010-21321-C02-01 and CTQ2010-21321-C02-02), the Spanish Ministry of Economy and Competitiveness (ENE2014-53760-R and ENE2016-77694-R), and the University Jaume I of Castellon (P11B2015-66 and UJI-B2016-47).	[Anonymous], 2001, PERRYS CHEM ENG HDB; Bazdidi-Tehrani F, 2018, RENEW ENERG, V122, P406, DOI 10.1016/j.renene.2018.01.056; Choi SUS., 1993, ASME INT MECH ENG C; Farajzadeh E, 2018, RENEW ENERG, V118, P122, DOI 10.1016/j.renene.2017.10.102; Ganvir RB, 2017, RENEW SUST ENERG REV, V75, P451, DOI 10.1016/j.rser.2016.11.010; Genc AM, 2018, APPL THERM ENG, V130, P395, DOI 10.1016/j.applthermaleng.2017.10.166; Hawwash AA, 2018, APPL THERM ENG, V130, P363, DOI 10.1016/j.applthermaleng.2017.11.027; Hemmat Esfe M, 2014, J THERM ANAL CALORIM, V117, P675, DOI 10.1007/s10973-014-3771-x; Kaya H, 2018, RENEW ENERG, V122, P329, DOI 10.1016/j.renene.2018.01.115; Kherbeet AS, 2015, EXP THERM FLUID SCI, V65, P13, DOI 10.1016/j.expthermflusci.2015.02.023; Kim H, 2017, ENERGY, V118, P1304, DOI 10.1016/j.energy.2016.11.009; KITANO T, 1981, RHEOL ACTA, V20, P207, DOI 10.1007/BF01513064; Mahbubul IM, 2018, RENEW ENERG, V121, P36, DOI 10.1016/j.renene.2018.01.006; Mahian O, 2013, INT J HEAT MASS TRAN, V57, P582, DOI 10.1016/j.ijheatmasstransfer.2012.10.037; Martinez-Cuenca R, 2016, APPL THERM ENG, V98, P841, DOI 10.1016/j.applthermaleng.2015.11.050; Mehrali M, 2015, J NANOPART RES, V17, DOI 10.1007/s11051-015-3062-x; Mirzaei M, 2018, APPL THERM ENG, V134, P68, DOI 10.1016/j.applthermaleng.2018.01.104; Mondragon R, 2013, POWDER TECHNOL, V249, P516, DOI 10.1016/j.powtec.2013.08.035; Purohit N, 2018, RENEW ENERG, V120, P14, DOI 10.1016/j.renene.2017.12.066; Raj P, 2018, RENEW SUST ENERG REV, V84, P54, DOI 10.1016/j.rser.2017.10.012; Sharafeldin MA, 2018, ENERG CONVERS MANAGE, V155, P32, DOI 10.1016/j.enconman.2017.10.070; Sharafeldin MA, 2017, ENERGY, V141, P2436, DOI 10.1016/j.energy.2017.11.068; Stalin PMJ, 2017, J THERMAL ANAL CALOR, P1; Yin ZQ, 2018, J EXP NANOSCI, V13, P82, DOI 10.1080/17458080.2017.1413599; Yousefi T, 2012, SOL ENERGY, V86, P771, DOI 10.1016/j.solener.2011.12.003; Yousefi T, 2012, EXP THERM FLUID SCI, V39, P207, DOI 10.1016/j.expthermflusci.2012.01.025; Yousefi T, 2012, RENEW ENERG, V39, P293, DOI 10.1016/j.renene.2011.08.056	27	22	22	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212260	10.1371/journal.pone.0212260	http://dx.doi.org/10.1371/journal.pone.0212260			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794583	Green Published, gold, Green Submitted			2022-12-27	WOS:000459709100050
J	Rodelo-Haad, C; Aguera, ML; Carmona, A; Navarro, MD; Carracedo, J; Rodriguez-Benot, A; Aljama, P				Rodelo-Haad, Cristian; Luisa Aguera, Maria; Carmona, Andres; Dolores Navarro, Maria; Carracedo, Julia; Rodriguez-Benot, Alberto; Aljama, Pedro			Pancreatic autoantibodies and CD14(+)CD16(+) monocytes subset are associated with the impairment of beta-cell function after simultaneous pancreas-kidney transplantation	PLOS ONE			English	Article							ISLET AUTOANTIBODIES; T-CELLS; TYPE-1; MACROPHAGES; RECURRENCE; DIAGNOSIS; CHILDREN; INSULIN; DISEASE; MARKERS	Pancreatic autoantibodies (AAb) has been associated with a worse pancreas graft survival after simultaneous pancreas-kidney transplantation (SPK). However, due to the variable time for AAb to become positive and the lack of early biomarkers suggesting such autoimmune activation, the mechanisms leading beta-cell destruction remain uncertain. The present study aimed to evaluate the association between post-transplant AAb and the functional impairment of the pancreatic beta-cell and also the association of such AAb with inflammation after SPK. In a longitudinal study, we analyzed the impact of post-transplant glutamic acid decarboxylase (GAD-65) and the insulinoma-associated autoantigen 2 (IA-2) AAb on pancreas graft function. Serum Hb1Ac and C-peptide (C-pep) were longitudinally compared between a group with positive posttransplant AAb (AAb+; n = 40) and another matched group with negative AAb (AAb-; n = 40) until the fifth year following seroconversion. In the cross-sectional analysis, we further evaluated the systemic signatures of inflammation by measuring pro-inflammatory CD14(+)CD16(+) monocytes by flow-cytometry and interleukin 17-A serum levels in 38 SPK recipients and ten healthy controls. In the longitudinal study, patients with AAb+ showed higher levels of Hb1Ac (p<0.001) and lower C-pep levels (p<0.001) compared to those who remained AAb-throughout the follow-up. In the cross-sectional study, AAb+ patients showed a higher percentage of CD14(+)CD16(+) monocytes compared with those with AAb- and the healthy controls (6.70 +/- 4.19% versus 4.0 +/- 1.84% and 3.44 +/- 0.93%; p = 0.026 and 0.009 respectively). Also, CD14(+)CD16(+) monocytes correlated with Hb1Ac and C-pep serum levels. Multivariate logistic regression showed that posttransplant AAb+ was independently associated with a higher percentage of pro-inflammatory monocytes (adjusted-OR 1.59, 95% CI 1.05-2.40, p = 0.027). The group of patients with positive AAb also showed higher levels of IL17A as compared with the other groups (either healthy control or the negative AAb subjects). In conclusion, pancreatic AAb+ after SPK were not only associated with higher Hb1Ac and lower c-peptide serum levels but also with an increased percentage of CD14(+) CD16(+) monocytes and higher levels of circulating IL17-A.	[Rodelo-Haad, Cristian; Luisa Aguera, Maria; Dolores Navarro, Maria; Rodriguez-Benot, Alberto; Aljama, Pedro] Univ Cordoba, Reina Sofia Univ Hosp, Maimonides Biomed Res Inst Cordoba IMIBIC, Cordoba, Spain; [Rodelo-Haad, Cristian; Luisa Aguera, Maria; Carmona, Andres; Dolores Navarro, Maria; Rodriguez-Benot, Alberto; Aljama, Pedro] Reina Sofia Univ Hosp, Nephrol Unit, Cordoba, Spain; [Rodelo-Haad, Cristian; Luisa Aguera, Maria; Carmona, Andres; Dolores Navarro, Maria; Carracedo, Julia; Rodriguez-Benot, Alberto; Aljama, Pedro] Inst Salud Carlos III, RETICs Red Renal, Madrid, Spain; [Carracedo, Julia] Univ Complutense Madrid, Inst Invest Sanitaria Hosp 12 Octubre imas12, Fac Biol, Dept Genet Fisiol & Microbiol, Madrid, Spain	Universidad de Cordoba; Hospital Universitario Reina Sofia - Cordoba; Instituto de Salud Carlos III; Complutense University of Madrid	Rodelo-Haad, C (corresponding author), Univ Cordoba, Reina Sofia Univ Hosp, Maimonides Biomed Res Inst Cordoba IMIBIC, Cordoba, Spain.; Rodelo-Haad, C (corresponding author), Reina Sofia Univ Hosp, Nephrol Unit, Cordoba, Spain.; Rodelo-Haad, C (corresponding author), Inst Salud Carlos III, RETICs Red Renal, Madrid, Spain.	crisroha@yahoo.com	Carracedo, Julia/ABG-2464-2020; Carracedo, Julia/L-2012-2015	Carracedo, Julia/0000-0002-8422-812X; Carracedo, Julia/0000-0002-8422-812X; Rodriguez Benot, Alberto/0000-0003-1385-4526; Carmona, Andres/0000-0002-1830-2096; Aguera Morales, Maria Luisa/0000-0002-7736-908X; Rodelo-Haad, Cristian/0000-0002-8139-3840	Plan Nacional de I+D+i Proyectos de Investigacion en Salud of Instituto de Salud Carlos III (ISCIII)-Subdireccion General de Evaluacion, Fondos de Desarrollo Regional (FEDER) [PI12/01489]	Plan Nacional de I+D+i Proyectos de Investigacion en Salud of Instituto de Salud Carlos III (ISCIII)-Subdireccion General de Evaluacion, Fondos de Desarrollo Regional (FEDER)	This work was supported by Plan Nacional de I+D+i Proyectos de Investigacion en Salud of Instituto de Salud Carlos III (ISCIII)-Subdireccion General de Evaluacion, Fondos de Desarrollo Regional (FEDER) (PI12/01489). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; [Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Bradshaw EM, 2009, J IMMUNOL, V183, P4432, DOI 10.4049/jimmunol.0900576; Carmona A, 2017, AM J PHYSIOL-RENAL, V312, pF673, DOI 10.1152/ajprenal.00013.2016; Choi JY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186827; Dieterle CD, 2005, TRANSPL INT, V18, P1361, DOI 10.1111/j.1432-2277.2005.00223.x; Emamaullee JA, 2009, DIABETES, V58, P1302, DOI 10.2337/db08-1113; Erbel C, 2014, J IMMUNOL, V193, P4344, DOI 10.4049/jimmunol.1400181; Evans HG, 2007, P NATL ACAD SCI USA, V104, P17034, DOI 10.1073/pnas.0708426104; Ge S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098019; Gruessner RWG, 2013, NAT REV ENDOCRINOL, V9, P555, DOI 10.1038/nrendo.2013.138; Han BY, 2005, J CLIN INVEST, V115, P1879, DOI 10.1172/JCI24219; Helminen O, 2015, DIABETES, V64, P1719, DOI 10.2337/db14-0497; Israni AK, 2014, AM J TRANSPLANT, V14, P45, DOI 10.1111/ajt.12580; Koskinen MK, 2016, EUR J ENDOCRINOL, V174, P251, DOI 10.1530/EJE-15-0674; Marwaha AK, 2010, J IMMUNOL, V185, P3814, DOI 10.4049/jimmunol.1001860; Merino A, 2012, NEPHROL DIAL TRANSPL, V27, P2907, DOI 10.1093/ndt/gfr767; Merino A, 2011, J IMMUNOL, V186, P1809, DOI 10.4049/jimmunol.1001866; Morgan NG, 2017, DIABETIC MED, V34, P879, DOI 10.1111/dme.13365; Orban T, 2009, DIABETES CARE, V32, P2269, DOI 10.2337/dc09-0934; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Qiao YC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176157; Reinert-Hartwall L, 2015, J IMMUNOL, V194, P68, DOI 10.4049/jimmunol.1401653; Rodelo-Haad C, 2015, TRANSPL P, V47, P107, DOI 10.1016/j.transproceed.2014.11.011; Schmidt M, 2001, J IMMUNOL; Schuster C, 2018, EUR J IMMUNOL, V48, P1211, DOI 10.1002/eji.201847498; Steck AK, 2011, DIABETES CARE, V34, P1397, DOI 10.2337/dc10-2088; SUTHERLAND DER, 1989, DIABETES, V38, P85, DOI 10.2337/diab.38.1.S85; Thivolet C, 2000, TRANSPLANTATION, V69, P99, DOI 10.1097/00007890-200001150-00018; Ulrich C, 2008, AM J TRANSPLANT, V8, P103, DOI 10.1111/j.1600-6143.2007.02035.x; Uno S, 2007, DIABETOLOGIA, V50, P596, DOI 10.1007/s00125-006-0569-9; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; Vendrame F, 2016, AM J TRANSPLANT, V16, P235, DOI 10.1111/ajt.13426; Vendrame F, 2010, DIABETES, V59, P947, DOI 10.2337/db09-0498; Waugh K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174840; Yu H, 2018, IMMUNOLOGY, V153, P161, DOI 10.1111/imm.12867; Ziegler AG, 2013, JAMA-J AM MED ASSOC, V309, P2473, DOI 10.1001/jama.2013.6285; Zizzo G, 2013, J IMMUNOL, V190, P5237, DOI 10.4049/jimmunol.1203017	39	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212547	10.1371/journal.pone.0212547	http://dx.doi.org/10.1371/journal.pone.0212547			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794611	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000459709100087
J	Couto, CMV; Cumming, GS; Lacorte, GA; Congrains, C; Izbicki, R; Braga, EM; Rocha, CD; Moralez-Silva, E; Henry, DAW; Manu, SA; Abalaka, J; Regalla, A; da Silva, AS; Diop, MS; Del Lama, SN				Villar Couto, Cynthia M.; Cumming, Graeme S.; Lacorte, Gustavo A.; Congrains, Carlos; Izbicki, Rafael; Braga, Erika Martins; Rocha, Cristiano D.; Moralez-Silva, Emmanuel; Henry, Dominic A. W.; Manu, Shiiwua A.; Abalaka, Jacinta; Regalla, Aissa; da Silva, Alfredo Simao; Diop, Moussa S.; Del Lama, Silvia N.			Avian haemosporidians in the cattle egret (Bubulcus ibis) from central-western and southern Africa: High diversity and prevalence	PLOS ONE			English	Article							MALARIA PARASITES; MOLECULAR CHARACTERIZATION; MOSQUITO ABUNDANCE; BLOOD PARASITES; DYNAMICS; TEMPERATURE; PLASMODIUM; LEUCOCYTOZOON; EXPANSION; NETWORKS	We described the geographic distribution of 82 haemosporidian lineages (Plasmodium, Haemoproteus, and Leucocytozoon) in the cattle egret sampled in five countries in central-western and southern Africa. Seventy-three lineages have not previously been reported. We determined the prevalence of three haemosporidians in the samples. We investigated the influence of the internal environment of the host and environmental variables on the Plasmodium diversity and whether environmental variables may explain spatial variations in the prevalence of Plasmodium. We screened DNA from 509 blood samples from nestlings in 15 African colonies for infection by sequencing the cytochrome b gene of parasites. The molecular phylogenetic analysis was performed using Bayesian methods and including sequences from the MalAvi and GeneBank databases. We found 62 new Plasmodium lineages in a clade with MYCAME02, which is a lineage described in waterbirds and recently identified in birds of prey as Plasmodium paranucleophilum. Two Haemoproteus lineages identified in cattle egret formed a distinct group with Haemoproteus catharti and MYCAMH1 (Haemoproteus spp.). Seven Leucocytozoon lineages found in the cattle egret clustered with Leucocytozoon californicus. We found different Plasmodium diversities among the colonies sampled, demonstrating that the internal environment of the host is not the primary determinant of diversity. A linear mixed-effects multivariate model showed that precipitation was positively associated with Plasmodium diversity when controlling for the effects of temperature, colony composition (mixed and non-mixed species) and country. Moreover, a generalized mixed model showed that temperature was positively associated with the prevalence of Plasmodium when controlling for precipitation, elevation and country. We conclude that the cattle egret is a good model for future haemosporidian studies, as we found a significant number of new lineages in this host, which occupies regions with different climate characteristics where environmental variables exert an influence on the diversity and prevalence of Plasmodium.	[Villar Couto, Cynthia M.; Congrains, Carlos; Rocha, Cristiano D.; Moralez-Silva, Emmanuel; Del Lama, Silvia N.] Univ Fed Sao Carlos, Ctr Ciencias Biol & Saude, Dept Genet & Evolucao, Sao Carlos, SP, Brazil; [Cumming, Graeme S.; Henry, Dominic A. W.] Univ Cape Town, DST NRF Ctr Excellence, Percy FitzPatrick Inst, Cape Town, South Africa; [Lacorte, Gustavo A.] Inst Fed Minas Gerais, Dept Ciencias & Linguagens, Bambui, MG, Brazil; [Izbicki, Rafael] Univ Fed Sao Carlos, Ctr Ciencias Exatas & Tecnol, Dept Estat, Sao Carlos, SP, Brazil; [Braga, Erika Martins] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil; [Manu, Shiiwua A.; Abalaka, Jacinta] AP Leventis Ornithol Res Inst, Jos, Nigeria; [Regalla, Aissa; da Silva, Alfredo Simao] IBAP, Bissau, Guinea Bissau; [Diop, Moussa S.] AfriWet Consultants, Dakar, Thiaroye, Senegal; [Cumming, Graeme S.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia; [da Silva, Alfredo Simao] Programme UICN Guinee Bissau, Bissau, Guinea Bissau	Universidade Federal de Sao Carlos; National Research Foundation - South Africa; University of Cape Town; Instituto Federal de Educacao, Ciencia e Tecnologia de Minas Gerais (IFMG); Universidade Federal de Sao Carlos; Universidade Federal de Minas Gerais; James Cook University	Del Lama, SN (corresponding author), Univ Fed Sao Carlos, Ctr Ciencias Biol & Saude, Dept Genet & Evolucao, Sao Carlos, SP, Brazil.	dsdl@ufscar.br	Braga, Erika Martins/A-6776-2008; Lacorte, Gustavo Augusto/AAS-1968-2021; Congrains, Carlos/E-5709-2017; G.A., Lacorte/T-8904-2017; Cumming, Graeme S./B-6551-2008	Braga, Erika Martins/0000-0001-5550-7157; Lacorte, Gustavo Augusto/0000-0002-6866-348X; Congrains, Carlos/0000-0001-7506-6133; G.A., Lacorte/0000-0002-6866-348X; Cumming, Graeme S./0000-0002-3678-1326; Izbicki, Rafael/0000-0003-0379-9690; Regalla de Barros, Aissa/0000-0003-1522-8211	Brazilian fostering agency Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP [State of Sao Paulo Research Assistance Foundation]) through Research Grants [2010/50406-5, 2016/01673-7, 2017/03363-8]	Brazilian fostering agency Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP [State of Sao Paulo Research Assistance Foundation]) through Research Grants(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was primarily funded by governmental institutions from Brazil. This work was supported by the Brazilian fostering agency Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP [State of Sao Paulo Research Assistance Foundation]) through Research Grants awarded to SN Del Lama (2010/50406-5, 2016/01673-7) and awarded to R Izbicki (2017/03363-8). AfriWet Consultants provided support in the form of salaries for authors MD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beadell JS, 2006, P ROY SOC B-BIOL SCI, V273, P2935, DOI 10.1098/rspb.2006.3671; Bensch S, 2007, J ANIM ECOL, V76, P112, DOI 10.1111/j.1365-2656.2006.01176.x; Bensch S, 2009, MOL ECOL RESOUR, V9, P1353, DOI 10.1111/j.1755-0998.2009.02692.x; BROWDER JA, 1973, BIRD BANDING, V44, P158, DOI 10.2307/4511956; Brown L.H., 1982, BIRDS AFRICA, V1; Illera JC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184587; Chahad-Ehlers S, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2847-z; Congrains C, 2016, J AVIAN BIOL, V47, P846, DOI 10.1111/jav.00972; CROSBY GT, 1972, BIRD BANDING, V43, P205, DOI 10.2307/4511880; Cumming GS, 2013, PARASITOLOGY, V140, P193, DOI 10.1017/S0031182012001461; Dawson A, 2004, TECH ECOL CONSERVAT, P211; del Hoyo J., 1992, P1; Durrant KL, 2006, ORNITHOL MONOGR, P98; Ferraguti M, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-208; Galen SC, 2014, J AVIAN BIOL, V45, P374, DOI 10.1111/jav.00375; GODFREY RD, 1987, J WILDLIFE DIS, V23, P558, DOI 10.7589/0090-3558-23.4.558; Hellgren O, 2004, J PARASITOL, V90, P797, DOI 10.1645/GE-184R1; Hellgren O, 2011, J WILDLIFE DIS, V47, P849, DOI 10.7589/0090-3558-47.4.849; HUDSON JW, 1974, COMP BIOCHEM PHYSIOL, V49, P717, DOI 10.1016/0300-9629(74)90900-1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ishtiaq F, 2017, ECOL EVOL, V7, P8040, DOI 10.1002/ece3.3319; Jones MR, 2013, J PARASITOL, V99, P903, DOI 10.1645/12-147.1; Kim KS, 2010, MOL ECOL, V19, P5545, DOI 10.1111/j.1365-294X.2010.04897.x; Krone O, 2001, ACTA PROTOZOOL, V40, P281; Kushlan J.A., 2005, HERONS; Lacorte GA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057770; LaPointe DA, 2010, J PARASITOL, V96, P318, DOI 10.1645/GE-2290.1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MADDOCK M, 1994, OSTRICH, V65, P191, DOI 10.1080/00306525.1994.9639682; Martin AP, 1997, ATLAS SO AFRICAN BIR, V1; Moens MAJ, 2016, INT J PARASITOL, V46, P41, DOI 10.1016/j.ijpara.2015.08.001; Nylander J.A.A, 2004, MRMODELTEST V2 PROGR; Okanga S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086382; Okanga S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-370; Outlaw DC, 2017, PARASITOLOGY, V144, P394, DOI 10.1017/S0031182016001979; Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107; Padilla DP, 2017, INT J PARASITOL, V47, P225, DOI 10.1016/j.ijpara.2016.11.008; Perez-Rodriguez A, 2013, GLOBAL CHANGE BIOL, V19, P3245, DOI 10.1111/gcb.12226; Perkins SL, 2002, J PARASITOL, V88, P972, DOI 10.1645/0022-3395(2002)088[0972:AMPOMP]2.0.CO;2; R Development Core Team, 2015, R LANG ENV STAT COMP; Ricklefs RE, 2017, J BIOGEOGR, V44, P1113, DOI 10.1111/jbi.12928; Sambrook J., 2001, MOL CLONING LAB MANU, Vthird edition; Samraoui F, 2007, OSTRICH, V78, P481, DOI 10.2989/OSTRICH.2007.78.2.58.172; Sehgal RNM, 2011, P ROY SOC B-BIOL SCI, V278, P1025, DOI 10.1098/rspb.2010.1720; Sehgal RNM, 2015, INT J PARASITOL-PAR, V4, P421, DOI 10.1016/j.ijppaw.2015.09.001; Shurulinkov P, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2179-7; Stroup W.W., 2016, GEN LINEAR MIXED MOD; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Tostes R, 2017, PARASITOL RES, V116, P1887, DOI 10.1007/s00436-017-5465-3; Valki<umacron>nas G, 2005, AVIAN MALARIA PARASI; Valkiunas G, 2014, PARASITOL RES, V113, P2251, DOI 10.1007/s00436-014-3880-2; van Rooyen J, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-139; Villar CM, 2013, J PARASITOL, V99, P522, DOI 10.1645/12-73.1; Walther E, 2016, PARASITOL RES, V115, P1853, DOI 10.1007/s00436-016-4925-5; Yabsley MJ, 2018, MALARIA J, V17, DOI 10.1186/s12936-017-2165-5; Zehtindjiev P, 2008, EXP PARASITOL, V119, P99, DOI 10.1016/j.exppara.2007.12.018	60	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212425	10.1371/journal.pone.0212425	http://dx.doi.org/10.1371/journal.pone.0212425			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794584	Green Published, Green Accepted, gold			2022-12-27	WOS:000459709100066
J	Hasnain, Z; Mason, J; Gill, K; Miranda, G; Gill, IS; Kuhn, P; Newton, PK				Hasnain, Zaki; Mason, Jeremy; Gill, Karanvir; Miranda, Gus; Gill, Inderbir S.; Kuhn, Peter; Newton, Paul K.			Machine learning models for predicting post-cystectomy recurrence and survival in bladder cancer patients	PLOS ONE			English	Article							RADICAL CYSTECTOMY; PROGNOSIS	Currently in patients with bladder cancer, various clinical evaluations (imaging, operative findings at transurethral resection and radical cystectomy, pathology) are collectively used to determine disease status and prognosis, and recommend neoadjuvant, definitive and adjuvant treatments. We analyze the predictive power of these measurements in forecasting two key long-term outcomes following radical cystectomy, i.e., cancer recurrence and survival. Information theory and machine learning algorithms are employed to create predictive models using a large prospective, continuously collected, temporally resolved, primary bladder cancer dataset comprised of 3503 patients (1971-2016). Patient recurrence and survival one, three, and five years after cystectomy can be predicted with greater than 70% sensitivity and specificity. Such predictions may inform patient monitoring schedules and post-cystectomy treatments. The machine learning models provide a benchmark for predicting oncologic outcomes in patients undergoing radical cystectomy and highlight opportunities for improving care using optimal preoperative and operative data collection.	[Hasnain, Zaki; Kuhn, Peter; Newton, Paul K.] Univ Southern Calif, Viterbi Sch Engn, Dept Aerosp & Mech Engn, Univ Pk Campus, Los Angeles, CA 90007 USA; [Mason, Jeremy; Gill, Karanvir; Kuhn, Peter] Univ Southern Calif, Dornsife Coll Letters Arts & Sci, Dept Biol Sci, Univ Pk Campus, Los Angeles, CA 90007 USA; [Miranda, Gus; Gill, Inderbir S.; Kuhn, Peter] Univ Southern Calif, Keck Sch Med, USC Inst Urol, Hlth Sci Campus, Los Angeles, CA 90007 USA; [Kuhn, Peter] Univ Southern Calif, Viterbi Sch Engn, Dept Biomed Engn, Univ Pk Campus, Los Angeles, CA 90007 USA; [Kuhn, Peter; Newton, Paul K.] Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Hlth Sci Campus, Los Angeles, CA 90007 USA; [Newton, Paul K.] Univ Southern Calif, Dept Math, Univ Pk Campus, Los Angeles, CA USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Kuhn, P (corresponding author), Univ Southern Calif, Viterbi Sch Engn, Dept Aerosp & Mech Engn, Univ Pk Campus, Los Angeles, CA 90007 USA.; Kuhn, P (corresponding author), Univ Southern Calif, Dornsife Coll Letters Arts & Sci, Dept Biol Sci, Univ Pk Campus, Los Angeles, CA 90007 USA.; Kuhn, P (corresponding author), Univ Southern Calif, Keck Sch Med, USC Inst Urol, Hlth Sci Campus, Los Angeles, CA 90007 USA.; Kuhn, P (corresponding author), Univ Southern Calif, Viterbi Sch Engn, Dept Biomed Engn, Univ Pk Campus, Los Angeles, CA 90007 USA.; Kuhn, P (corresponding author), Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Hlth Sci Campus, Los Angeles, CA 90007 USA.	pkuhn@usc.edu		Miranda, Gus/0000-0001-6110-9024; Kuhn, Peter/0000-0003-2629-4505	Federal funds from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services [HHSN261201500003B]; Seven Bridges Genomics, Inc.	Federal funds from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services; Seven Bridges Genomics, Inc.	This work was supported by Federal funds from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN261201500003B; Seven Bridges Genomics, Inc.; as well as institutional support from the University of Southern California Institute of Urology and the University of Southern California Michelson Center for Convergent Biosciences.	Akritas AG, 2004, MATH COMPUT SIMULAT, V67, P15, DOI 10.1016/j.matcom.2004.05.005; American Cancer Society, 2018, CANC FACTS FIG 2018; [Anonymous], 2018, AGE STANDARDS SURVIV; Bader P, 2003, J UROLOGY, V169, P849, DOI 10.1097/01.ju.0000049032.38743.c7; Bochner BH, 2006, J CLIN ONCOL, V24, P3967, DOI 10.1200/JCO.2005.05.3884; Butte A J, 2000, Pac Symp Biocomput, P418; Cheng L, 2014, CRIT REV ONCOL HEMAT, V89, P73, DOI 10.1016/j.critrevonc.2013.08.008; Cruz JA, 2006, CANCER INFORM, V2, P59; Dobruch J, 2016, EUR UROL, V69, P300, DOI 10.1016/j.eururo.2015.08.037; Herr HW, 2004, J CLIN ONCOL, V22, P2781, DOI 10.1200/JCO.2004.11.024; Horvath S, 2011, WEIGHTED NETWORK ANALYSIS: APPLICATIONS IN GENOMICS AND SYSTEMS BIOLOGY, P1, DOI 10.1007/978-1-4419-8819-5; Kourou K, 2015, COMPUT STRUCT BIOTEC, V13, P8, DOI 10.1016/j.csbj.2014.11.005; Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671; Moriyama M, 2003, MOL CANCER THER, V2, P199; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Quek ML, 2005, J UROLOGY, V174, P103, DOI 10.1097/01.ju.0000163267.93769.d8; Siegel RL, 2017, CA-CANCER J CLIN, V67, P177, DOI 10.3322/caac.21395; Stein JP, 2001, J CLIN ONCOL, V19, P666, DOI 10.1200/JCO.2001.19.3.666; Stenzl A, 2011, EUR UROL, V59, P1009, DOI 10.1016/j.eururo.2011.03.023; Svatek RS, 2011, BJU INT, V107, P898, DOI 10.1111/j.1464-410X.2010.09628.x; Talukder AK, 2016, SCI REP-UK, V6, DOI 10.1038/srep29647; Vickers AJ, 2009, CANCER-AM CANCER SOC, V115, P5460, DOI 10.1002/cncr.24615	22	29	30	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0210976	10.1371/journal.pone.0210976	http://dx.doi.org/10.1371/journal.pone.0210976			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785915	Green Submitted, Green Published, gold			2022-12-27	WOS:000459307000016
J	Uhlenbusch, N; Lowe, B; Harter, M; Schramm, C; Weiler-Normann, C; Depping, MK				Uhlenbusch, Natalie; Loewe, Bernd; Haerter, Martin; Schramm, Christoph; Weiler-Normann, Christina; Depping, Miriam K.			Depression and anxiety in patients with different rare chronic diseases: A cross-sectional study	PLOS ONE			English	Article							PRIMARY-CARE; RISK-FACTOR; HEALTH; DISORDERS; VALIDITY; PHQ-9; COMORBIDITY; SEVERITY; STANDARDIZATION; PREVALENCE	Objective Empirical evidence on depression and anxiety in patients with rare diseases is scarce but can help improve comprehensive treatment. The objectives of this study were to investigate the frequency of depression and anxiety in this heterogeneous population and to examine aspects associated with increased psychopathology. Methods N = 300 patients with 79 different rare diseases (female:80%, age:M = 44.3(12.8), range:16-74 years) participated in a cross-sectional online study. We determined the percentages of patients reporting elevated depression (PHQ-9) and anxiety (GAD-7) scores. We calculated two linear regressions with depression and anxiety as outcomes. Predictor variables were diagnosis-related aspects (diagnosis assigned to ICD-10 chapter, visibility of symptoms, time since diagnosis, comorbid diseases), perceived somatic-symptom-severity (PHQ-15), illness-perceptions (consequences, control, identity, concern, understanding and treatment control; B-IPQ-R), coping mechanisms (constructive attitudes, active engagement in life) and social support (heiQ). We controlled for gender, age and depression or anxiety depending on the outcome. Results 42% of the patients (95%CI [36.41%,47.59%]) reported depression scores indicating moderately or severely elevated symptom levels. Regarding anxiety, this applies to 23% (95%CI [18.54%,28.06%]). Variables significantly associated with depression were higher perceived somatic-symptom-severity (B = 0.41,p <.001), less control (B =.17,p <.05), lower levels of concern (B =-0.32,p <.01) and less constructive attitudes (B =-1.40,p <.001). No diagnosis-related variables were associated with depression. Variables significantly associated with anxiety were diseases of the circulatory system compared to congenital malformations (B = 1.88,p <.05), less consequences (B =-0.32,p <.05) and more concern (B =-0.32,p <.01). Conclusion The data reveal first insights into depression and anxiety in patients with different rare diseases. High percentages of patients showed clinically relevant symptom burden. No diagnosis-related differences were found in depression while anxiety seems to be particularly frequent in patients with rare diseases of the circulatory system. Besides perceived somatic symptom severity, cognitive appraisal seems to be linked to depression. Supporting patients in coping with their disease may help reduce psychopathology and therefore improve overall health.	[Uhlenbusch, Natalie; Loewe, Bernd; Depping, Miriam K.] Univ Med Ctr Hamburg Eppendorf, Dept Psychosomat Med & Psychotherapy, Hamburg, Germany; [Haerter, Martin] Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany; [Schramm, Christoph; Weiler-Normann, Christina] Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Hamburg, Germany; [Schramm, Christoph; Weiler-Normann, Christina] Univ Med Ctr Hamburg Eppendorf, Martin Zeitz Ctr Rare Dis, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Uhlenbusch, N (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Psychosomat Med & Psychotherapy, Hamburg, Germany.	n.uhlenbusch@uke.de	Löwe, Bernd/AAG-4038-2020	Uhlenbusch, Natalie/0000-0002-4031-9839; Lowe, Bernd/0000-0003-4220-3378	Robert Bosch Stiftung; ACHSE e.V.; Martin Zeitz Center for Rare Diseases	Robert Bosch Stiftung; ACHSE e.V.; Martin Zeitz Center for Rare Diseases	The Robert Bosch Stiftung provided funding for this study in the form of salaries for authors [NU] but did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The foundation only provided financial support in the form of authors' salaries and research materials.; This study is part of the research project 'Patients for Patients: Qualified Peer Counselling and Self-Management for Patients with Rare Chronic Diseases' (PI: Prof. Dr. Bernd Lowe). We would like to thank our partners ACHSE e.V. and the Martin Zeitz Center for Rare Diseases for their cooperation and support. We are grateful to all physicians, centres for rare diseases, patient organizations and self-help groups for supporting us in the recruitment process as well as to all patients who supported us by participating in the study. We would further like to thank our research assistant Anne Marie-Wassmuth for supporting data preparation and Dr. Marco Lehmann for statistical advice.	American Psychiatric Association, 2013, DIAGN STAT MAN MENT; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283; Bloss S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172532; Broadbent E, 2006, J PSYCHOSOM RES, V60, P631, DOI 10.1016/j.jpsychores.2005.10.020; Ciribassi RM, 2016, SOC SCI MED, V148, P131, DOI 10.1016/j.socscimed.2015.11.033; Clarke DM, 2009, MED J AUSTRALIA, V190, pS54; Cohen JS, 2010, AM J MED GENET A, V152A, P1136, DOI 10.1002/ajmg.a.33380; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; El-Gabalawy R, 2011, GEN HOSP PSYCHIAT, V33, P556, DOI 10.1016/j.genhosppsych.2011.07.005; EURORDIS, 2009, VOIC 12000 PAT EXP E; Eurordis, 2017, WHAT IS RAR DIS EUR; Eurordis, 2005, RAR DIS UND THIS PUB; Field A., 2013, DISCOVERING STAT USI; Grafe K, 2004, DIAGNOSTICA, V50, P171, DOI 10.1026/0012-1924.50.4.171; Heath J, 2016, ALLERGY ASTHMA PROC, V37, P409, DOI 10.2500/aap.2016.37.3977; Helgeson VS, 2017, ANNU REV PSYCHOL, V68, P545, DOI 10.1146/annurev-psych-010416-044014; Institut fur Qualitat und Wirtschaftlichkeit im Gesundheitswesen (IQWiG), 2014, BEW AUSW STUD BEI SE; Katon W, 2007, GEN HOSP PSYCHIAT, V29, P147, DOI 10.1016/j.genhosppsych.2006.11.005; Kocalevent RD, 2013, GEN HOSP PSYCHIAT, V35, P551, DOI 10.1016/j.genhosppsych.2013.04.006; Kohlmann S, 2016, J PSYCHOSOM RES, V90, P51, DOI 10.1016/j.jpsychores.2016.09.004; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Lichtman JH, 2014, CIRCULATION, V129, P1350, DOI 10.1161/CIR.0000000000000019; Lowe B, 2008, GEN HOSP PSYCHIAT, V30, P191, DOI 10.1016/j.genhosppsych.2008.01.001; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Lowe B, 2017, BRIT J PSYCHIAT, V210, P132, DOI 10.1192/bjp.bp.116.184168; Lowe B, 2004, PSYCHOTHER PSYCHOSOM, V73, P386, DOI 10.1159/000080393; Lowe B, 2004, J AFFECT DISORDERS, V78, P131, DOI 10.1016/S0165-0327(02)00237-9; Martin A, 2006, GEN HOSP PSYCHIAT, V28, P71, DOI 10.1016/j.genhosppsych.2005.07.003; Moller-Leimkuhler AM, 2002, J AFFECT DISORDERS, V71, P1, DOI 10.1016/S0165-0327(01)00379-2; Olney M.F., 2005, J POSTSECOND EDUC DI, V18, P80; Osborne RH, 2007, PATIENT EDUC COUNS, V66, P192, DOI 10.1016/j.pec.2006.12.002; Petrie KJ, 2007, CURR OPIN PSYCHIATR, V20, P163, DOI 10.1097/YCO.0b013e328014a871; POLISSAR L, 1982, MED CARE, V20, P959, DOI 10.1097/00005650-198209000-00008; Roest AM, 2010, J AM COLL CARDIOL, V56, P38, DOI 10.1016/j.jacc.2010.03.034; Sareen J, 2005, DEPRESS ANXIETY, V21, P193, DOI 10.1002/da.20072; Scott KM, 2007, J AFFECT DISORDERS, V103, P113, DOI 10.1016/j.jad.2007.01.015; Shire Human Genetic Therapies, 2013, RAR DIS IMP REP INS; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stafford L, 2009, J PSYCHOSOM RES, V66, P211, DOI 10.1016/j.jpsychores.2008.09.005; Stanton AL, 2007, ANNU REV PSYCHOL, V58, P565, DOI 10.1146/annurev.psych.58.110405.085615; Stewart DE, 2011, PSYCHOSOMATICS, V52, P199, DOI 10.1016/j.psym.2011.01.036; Sumpton D, 2017, ARTHRIT CARE RES, V69, P1733, DOI 10.1002/acr.23207; Talwar A, 2015, J EXERC REHABIL, V11, P259, DOI 10.12965/jer.150230; Velvin G, 2015, CLIN GENET, V87, P109, DOI 10.1111/cge.12422; von der Lippe C, 2017, MOL GENET GENOM MED, V5, P758, DOI 10.1002/mgg3.315; Watkins LL, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.000068	51	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211343	10.1371/journal.pone.0211343	http://dx.doi.org/10.1371/journal.pone.0211343			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM2OT	30785907	Green Published, Green Submitted, gold			2022-12-27	WOS:000459307000021
J	Marcek, T; Hamow, KA; Vegh, B; Janda, T; Darko, E				Marcek, Tihana; Hamow, Kamiran Aron; Vegh, Balazs; Janda, Tibor; Darko, Eva			Metabolic response to drought in six winter wheat genotypes	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION NETWORK; OSMOTIC-STRESS; WATER-STRESS; TRANSPIRATION RATE; GALACTURONIC ACID; ENZYME-ACTIVITIES; GLYCINE BETAINE; GENE-EXPRESSION; ABIOTIC STRESS; PHOTOSYNTHESIS	Wheat is one of the most important cereals, whose growth and development is strongly limited by drought. This study investigated the physiological and metabolic response of six winter wheat cultivars to drought with the emphasis on the induction of dominant metabolites affected by the treatment and genotypes or both. The plants were exposed to a moderate (non-lethal) drought stress, which was induced by withholding watering for six days under controlled greenhouse conditions. A decline in CO2 assimilation (Pn) and transpiration rate, stomata closure, a decrease in relative water content (RWC) and increase of malondialdehyde content were observed in drought-treated plants of all cultivars. These changes were most pronounced in Ellvis, while Soissons was able to retain the higher RWC and Pn. Among the studied metabolites, sugars (sucrose, glucose, fructose, several disaccharides), organic acids (malic acid, oxalic acids), amino acids (proline, threonine, gamma-aminobutyric acid (GABA), glutamine) and sugar alcohols such as myo-inositol accumulated to higher levels in the plants exposed to drought stress in comparison with the control. The accumulation of several metabolites in response to drought differed between the genotypes. Drought induced the production of sucrose, malic acid and oxalic acid, unknown organic acid 1, unknown disaccharide 1, 2 and 3, GABA, L-threonine, glutamic acid in four (Soissons, Zitarka, Antonija or Toborzo) out of six genotypes. In addition, Soissons, which was the most drought tolerant genotype, accumulated the highest amount of unknown disaccharide 5, galactonic and phosphoric acids. The two most drought sensitive cultivars, Srpanjka and Ellvis, demonstrated different metabolic adjustment in response to the stress treatment. Srpanjka responded to drought by increasing the amount of glucose and fructose originated from hydrolyses of sucrose and accumulating unidentified sugar alcohols 1 and 2. In Ellvis, drought caused inhibition of photosynthetic carbon metabolism, as evidence by the decreased Pn, gs, RWC and accumulation levels of sugar metabolites (sucrose, glucose and fructose). The results revealed the differences in metabolic response to drought among the genotypes, which drew attention on metabolites related with general response and on those metabolites which are part of specific response that may play an important role in drought tolerance.	[Marcek, Tihana] Josip Juraj Strossmayer Univ Osijek, Fac Food Technol, Dept Food & Nutr Res, Osijek, Croatia; [Hamow, Kamiran Aron] Hungarian Acad Sci, Ctr Agr Res, Plant Protect Inst, Dept Zool, Budapest, Hungary; [Hamow, Kamiran Aron; Vegh, Balazs; Janda, Tibor; Darko, Eva] Hungarian Acad Sci, Ctr Agr Res, Agr Inst, Dept Plant Physiol, Martonvasar, Hungary	University of JJ Strossmayer Osijek; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research	Darko, E (corresponding author), Hungarian Acad Sci, Ctr Agr Res, Agr Inst, Dept Plant Physiol, Martonvasar, Hungary.	darko.eva@agrar.mta.hu	Darkó, Éva/AAR-8167-2021; , Tihana/AAE-8603-2019	, Tihana/0000-0002-8617-5009; Hamow, Kamiran Aron/0000-0002-7089-1078	European Regional Development Fund; Hungarian Government [GINOP-2.3.2-15-2016-00029]	European Regional Development Fund(European Commission); Hungarian Government	This work was supported by the European Regional Development Fund and the Hungarian Government (GINOP-2.3.2-15-2016-00029).	Abid M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21441-7; Agius F, 2003, NAT BIOTECHNOL, V21, P177, DOI 10.1038/nbt777; Akram NA, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00613; Allahverdiyev T., 2015, Journal of Stress Physiology & Biochemistry, V11, P29; ARAKAWA T, 1982, BIOCHEMISTRY-US, V21, P6536, DOI 10.1021/bi00268a033; Araujo WL, 2011, PLANT SIGNAL BEHAV, V6, P1305, DOI 10.4161/psb.6.9.16425; Arve LE, 2013, PLANT CELL ENVIRON, V36, P382, DOI 10.1111/j.1365-3040.2012.02580.x; Atkinson RRL, 2012, NEW PHYTOL, V196, P200, DOI 10.1111/j.1469-8137.2012.04274.x; Azevedo RA, 2006, AMINO ACIDS, V30, P143, DOI 10.1007/s00726-005-0245-2; Bajji M, 2001, PLANT SCI, V160, P669, DOI 10.1016/S0168-9452(00)00443-X; Bates GW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049641; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Batish DR, 2006, PLANT PHYSIOL BIOCH, V44, P819, DOI 10.1016/j.plaphy.2006.10.014; Bogdan J, 2006, PLANT PHYSIOL BIOCH, V44, P787, DOI 10.1016/j.plaphy.2006.10.028; Bown AW, 2016, TRENDS PLANT SCI, V21, P811, DOI 10.1016/j.tplants.2016.08.001; Bowne JB, 2012, MOL PLANT, V5, P418, DOI 10.1093/mp/ssr114; Budak H, 2013, SCI WORLD J, DOI 10.1155/2013/548246; Bundy JG, 2009, METABOLOMICS, V5, P3, DOI 10.1007/s11306-008-0152-0; Cevik S, 2014, J PLANT PHYSIOL, V171, P807, DOI 10.1016/j.jplph.2014.01.010; Choluj D, 2008, ACTA PHYSIOL PLANT, V30, P679, DOI 10.1007/s11738-008-0166-2; Darko E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174170; Darko E, 2015, EUPHYTICA, V203, P491, DOI 10.1007/s10681-014-1245-7; Daryanto S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156362; Das A, 2017, PLANTS-BASEL, V6, DOI 10.3390/plants6020021; Dichio B, 2006, TREE PHYSIOL, V26, P179, DOI 10.1093/treephys/26.2.179; Du HM, 2012, J AM SOC HORTIC SCI, V137, P411, DOI 10.21273/JASHS.137.6.411; Ergen NZ, 2009, FUNCT INTEGR GENOMIC, V9, P377, DOI 10.1007/s10142-009-0123-1; Ergen NZ, 2009, PLANT CELL ENVIRON, V32, P220, DOI 10.1111/j.1365-3040.2008.01915.x; Fait A, 2008, TRENDS PLANT SCI, V13, P14, DOI 10.1016/j.tplants.2007.10.005; Fang YJ, 2015, CELL MOL LIFE SCI, V72, P673, DOI 10.1007/s00018-014-1767-0; Fernie AR, 2009, PHYTOCHEMISTRY, V70, P828, DOI 10.1016/j.phytochem.2009.04.023; Flexas J, 2006, PHYSIOL PLANTARUM, V127, P343, DOI 10.1111/j.1399-3054.2006.00621.x; Forde BG, 2007, J EXP BOT, V58, P2339, DOI 10.1093/jxb/erm121; Foyer CH, 2000, NEW PHYTOL, V146, P359, DOI 10.1046/j.1469-8137.2000.00667.x; Gigon A, 2004, ANN BOT-LONDON, V94, P345, DOI 10.1093/aob/mch150; Giri J, 2011, PLANT SIGNAL BEHAV, V6, P1746, DOI 10.4161/psb.6.11.17801; Goggin DE, 2004, FUNCT PLANT BIOL, V31, P11, DOI 10.1071/FP03123; GRIEVE CM, 1983, PLANT SOIL, V70, P303, DOI 10.1007/BF02374789; Gu XG, 2004, PLANT PHYSIOL, V136, P4256, DOI 10.1104/pp.104.052365; Guo R, 2018, AOB PLANTS, V10, DOI 10.1093/aobpla/ply016; Hannah MA, 2006, J EXP BOT, V57, P3801, DOI 10.1093/jxb/erl152; Ho SL, 2001, PLANT PHYSIOL, V125, P877, DOI 10.1104/pp.125.2.877; Hou JF, 2018, J PLANT PHYSIOL, V231, P182, DOI 10.1016/j.jplph.2018.09.017; Jain M, 2010, PLANT SOIL ENVIRON, V56, P263, DOI 10.17221/233/2009-PSE; Jin R, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01123; Juhasz Z, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0363-7; Kim TH, 2010, ANNU REV PLANT BIOL, V61, P561, DOI 10.1146/annurev-arplant-042809-112226; Konno H, 2008, J PLANT PHYSIOL, V165, P745, DOI 10.1016/j.jplph.2007.07.007; Krasensky J, 2012, J EXP BOT, V63, P1593, DOI 10.1093/jxb/err460; Larbi A., 2004, Options Mediterraneennes. Serie A, Seminaires Mediterraneens, P193; Li YP, 2017, CROP J, V5, P231, DOI 10.1016/j.cj.2017.01.001; Liu CW, 2003, SCI TOTAL ENVIRON, V313, P77, DOI 10.1016/S0048-9697(02)00683-6; Liu HS, 2005, PLANT GROWTH REGUL, V46, P233, DOI 10.1007/s10725-005-8806-7; Liu SW, 2018, GENET MOL BIOL, V41, P624, DOI [10.1590/1678-4685-GMB-2017-0229, 10.1590/1678-4685-gmb-2017-0229]; Lopez-Bucio J, 2000, PLANT SCI, V160, P1, DOI 10.1016/S0168-9452(00)00347-2; Maggio A, 2002, PLANT J, V31, P699, DOI 10.1046/j.1365-313X.2002.01389.x; Mechri B, 2015, J CHROMATOGR SCI, V53, P1631, DOI 10.1093/chromsci/bmv066; Merewitz EB, 2012, J EXP BOT, V63, P1315, DOI 10.1093/jxb/err372; Mibei EK, 2018, J SCI FOOD AGR, V98, P205, DOI 10.1002/jsfa.8458; Michaletti A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24012-y; Misra BB, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00334; Moharramnejad S., 2015, Journal of BioScience and Biotechnology, V4, P313; Munnik T, 2010, PLANT CELL ENVIRON, V33, P655, DOI 10.1111/j.1365-3040.2009.02097.x; Obata T, 2015, PLANT PHYSIOL, V169, P2665, DOI 10.1104/pp.15.01164; Outlaw WH, 2001, PLANT PHYSIOL, V126, P1716, DOI 10.1104/pp.126.4.1716; Pena-Bautista RJ, 2017, CEREAL FOOD WORLD, V62, P231, DOI 10.1094/CFW-62-5-0231; Pinheiro C, 2011, J EXP BOT, V62, P869, DOI 10.1093/jxb/erq340; Piro G, 2003, PLANT SCI, V165, P559, DOI 10.1016/S0168-9452(03)00215-2; Raza MAS, 2014, J SOIL SCI PLANT NUT, V14, P346; Reddy AR, 2004, J PLANT PHYSIOL, V161, P1189, DOI 10.1016/j.jplph.2004.01.013; Roberts Lee D, 2012, Curr Protoc Mol Biol, VChapter 30, DOI 10.1002/0471142727.mb3002s98; Rodriguez-Calcerrada J, 2011, FUNCT PLANT BIOL, V38, P1004, DOI 10.1071/FP11135; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Rosa M, 2009, PLANT SIGNAL BEHAV, V4, P388, DOI 10.4161/psb.4.5.8294; Saeidi M, 2017, ARID LAND RES MANAG, V31, P204, DOI 10.1080/15324982.2016.1260073; Saibo NJM, 2009, ANN BOT-LONDON, V103, P609, DOI 10.1093/aob/mcn227; Saxena SN, 2017, ACTA PHYSIOL PLANT, V39, DOI 10.1007/s11738-017-2522-6; Schauer N, 2005, J EXP BOT, V56, P297, DOI 10.1093/jxb/eri057; Signarbieux C, 2012, J PLANT RES, V125, P251, DOI 10.1007/s10265-011-0427-9; Singh M, 2015, REV ENVIRON SCI BIO, V14, P407, DOI 10.1007/s11157-015-9372-8; Szegletes Z, 2000, CEREAL RES COMMUN, V28, P403; Tenhaken R, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00771; Tezara W, 1999, NATURE, V401, P914, DOI 10.1038/44842; Toumi I, 2008, BIOL PLANTARUM, V52, P161, DOI 10.1007/s10535-008-0035-2; Tran LSP, 2007, METHOD ENZYMOL, V428, P109, DOI 10.1016/S0076-6879(07)28006-1; Ullah N, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4321-2; Urano K, 2009, PLANT J, V57, P1065, DOI 10.1111/j.1365-313X.2008.03748.x; Vavasseur A, 2005, NEW PHYTOL, V165, P665, DOI 10.1111/j.1469-8137.2004.01276.x; Wang GP, 2010, PHOTOSYNTHETICA, V48, P117, DOI 10.1007/s11099-010-0016-5; Wardlaw IF, 2000, NEW PHYTOL, V148, P413, DOI 10.1046/j.1469-8137.2000.00777.x; Williamson JD, 2002, J AM SOC HORTIC SCI, V127, P467, DOI 10.21273/JASHS.127.4.467; Wu GQ, 2016, PLANT SOIL ENVIRON, V62, P189, DOI 10.17221/101/2016-PSE; Xu ZZ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00657; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zandalinas SI, 2018, PHYSIOL PLANTARUM, V162, P2, DOI 10.1111/ppl.12540; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	96	59	59	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212411	10.1371/journal.pone.0212411	http://dx.doi.org/10.1371/journal.pone.0212411			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779775	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000459062900053
J	Ngocho, JS; Magoma, B; Olomi, GA; Mahande, MJ; Msuya, SE; de Jonge, MI; Mmbaga, BT				Ngocho, James Samwel; Magoma, Best; Olomi, Gaudencia Alois; Mahande, Michael Johnson; Msuya, Sia Emmanueli; de Jonge, Marien Isaak; Mmbaga, Blandina Theophil			Effectiveness of pneumococcal conjugate vaccines against invasive pneumococcal disease among children under five years of age in Africa: A systematic review	PLOS ONE			English	Review							VACCINATION; IMMUNOGENICITY; SURVEILLANCE; SEROTYPES; CARRIAGE; QUALITY; IMPACT; SAFETY	Background Despite the widespread implementation of the pneumococcal conjugate vaccine, Streptococcus pneumoniae remains the leading cause of severe pneumonia associated with mortality among children less than 5 years of age worldwide, with the highest mortality rates recorded in Africa and Asia. However, information on the effectiveness and prevalence of vaccine serotypes post-roll out remains scarce in most African countries. Hence, this systematic review aimed to describe what is known about the decline of childhood invasive pneumococcal disease post-introduction of the pneumococcal conjugate vaccine in Africa. Methods This systematic review included articles published between 2009 and 2018 on the implementation of the pneumococcal conjugate vaccine in Africa. We searched PubMed, Scopus and African Index Medicus for articles in English. Studies on implementation programmes of pneumococcal conjugate vaccine 10/13, with before and after data from different African countries, were considered eligible. The review followed the procedures published in PROSPERO (ID = CRD42016049192). Results In total, 2,280 studies were identified through electronic database research, and only 8 studies were eligible for inclusion in the final analysis. Approximately half (n = 3) of these studies were from South Africa. The overall decline in invasive pneumococcal disease ranged from 31.7 to 80.1%. Invasive pneumococcal diseases caused by vaccine serotypes declined significantly, the decline ranged from 35.0 to 92.0%. A much higher decline (55.0-89.0%) was found in children below 24 months of age. Of all vaccine serotypes, the relative proportions of serotypes 1, 5 and 19A doubled following vaccine roll out. Interpretation Following the introduction of the pneumococcal conjugate vaccine, a significant decline was observed in invasive pneumococcal disease caused by vaccine serotypes. However, data on the effectiveness in this region remain scarce, meriting continued surveillance to assess the effectiveness of pneumococcal vaccination to improve protection against invasive pneumococcal disease.	[Ngocho, James Samwel; Mahande, Michael Johnson; Msuya, Sia Emmanueli] Kilimanjaro Christian Med Univ Coll, Inst Publ Hlth, Moshi, Tanzania; [Magoma, Best; Olomi, Gaudencia Alois] Kilimanjaro Reg Hlth Management Team, Moshi, Tanzania; [de Jonge, Marien Isaak] Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Sect Pediat Infect Dis, Lab Med Immunol,Med Ctr, Nijmegen, Netherlands; [Mmbaga, Blandina Theophil] Kilimanjaro Clin Res Inst, Moshi, Tanzania	Radboud University Nijmegen	Ngocho, JS (corresponding author), Kilimanjaro Christian Med Univ Coll, Inst Publ Hlth, Moshi, Tanzania.	jamesngocho08@gmail.com	Mahande, Michael Johnson J/I-6359-2015; Mmbaga, Blandina Theophil/AAR-8707-2021; Ngocho, James/Q-4477-2019; de Jonge, Marien I./P-5869-2015	Mahande, Michael Johnson J/0000-0002-7750-7657; Mmbaga, Blandina Theophil/0000-0002-5550-1916; de Jonge, Marien I./0000-0003-2812-5895; Ngocho, James Samwel/0000-0001-6242-9863	Fogarty International Center of the National Institutes of Health [D43TW010138]; German Academic Exchange Service (Deutscher Akademischer Austauschdienst-DAAD); FOGARTY INTERNATIONAL CENTER [D43TW010138] Funding Source: NIH RePORTER	Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); German Academic Exchange Service (Deutscher Akademischer Austauschdienst-DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This research was supported by the Fogarty International Center of the National Institutes of Health under Award Number D43TW010138. Additionally, this work was supported partly by the German Academic Exchange Service (Deutscher Akademischer Austauschdienst-DAAD). James Samwel Ngocho is a medical education partnership junior faculty fellow and DAAD fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegbola RA, 2012, CLIN INFECT DIS, V54, pS89, DOI 10.1093/cid/cir1051; Andrews NJ, 2014, LANCET INFECT DIS, V14, P839, DOI 10.1016/S1473-3099(14)70822-9; [Anonymous], 2012, WKLY EPIDEMIOL REC, V87, P129; Balsells E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177113; Casey RM, 2016, MMWR-MORBID MORTAL W, V65, P1270, DOI 10.15585/mmwr.mm6545a5; Chappuy H, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-357; de Oliveira LH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166736; Diawara I, 2015, INT J INFECT DIS, V40, P95, DOI 10.1016/j.ijid.2015.09.019; Geno KA, 2015, CLIN MICROBIOL REV, V28, P871, DOI 10.1128/CMR.00024-15; HAGAN JL, 1983, ANN SURG, V197, P755, DOI 10.1097/00000658-198306000-00015; Hammitt LL, 2014, LANCET GLOB HEALTH, V2, pE397, DOI 10.1016/S2214-109X(14)70224-4; Hammitt LL, 2018, BIORXIV, P1, DOI [10.1101/369876, DOI 10.1101/369876]; Hausdorff WP, 2016, HUM VACC IMMUNOTHER, V12, P358, DOI 10.1080/21645515.2015.1118593; Johns Hopkins Bloomberg School of Public Health International Vaccine Access Center (IVAC), 2018, VIEW HUB REP GLOB VA; Johnson HL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000348; Kambire D, 2018, J INFECTION, V76, P270, DOI 10.1016/j.jinf.2017.12.002; Kaplan SL, 2013, PEDIATR INFECT DIS J, V32, P203, DOI 10.1097/INF.0b013e318275614b; Mackenzie GA, 2016, LANCET INFECT DIS, V16, P703, DOI 10.1016/S1473-3099(16)00054-2; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Moher D, 2009, PHYS THER, V89, P873, DOI 10.1093/ptj/89.9.873; Moraga-Llop F, 2016, PEDIATR INFECT DIS J, V35, P460, DOI 10.1097/INF.0000000000001041; Munoz-Almagro C, 2008, CLIN INFECT DIS, V46, P174, DOI 10.1086/524660; Mwenda JM, 2015, SURVEILLANCE DIS TAR; National Institutes of Health, 2014, QUAL ASS TOOL BEF AF; Torne AN, 2014, VACCINE, V32, P3644, DOI 10.1016/j.vaccine.2014.04.066; Nhantumbo AA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177746; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Rudan I, 2013, J GLOB HEALTH, V3, DOI [10.7189/jogh.03.010101, 10.7189/jogh.03.010401]; Seehra J, 2016, J CLIN EPIDEMIOL, V69, P179, DOI 10.1016/j.jclinepi.2015.06.023; Skinner JM, 2011, VACCINE, V29, P8870, DOI 10.1016/j.vaccine.2011.09.078; Slotved HC, 2016, VACCINE, V34, P769, DOI 10.1016/j.vaccine.2015.12.056; Sobanjo-ter Meulen A, 2015, PEDIATR INFECT DIS J, V34, P186, DOI 10.1097/INF.0000000000000516; Song JY, 2013, INFECT CHEMOTHER, V45, P351, DOI 10.3947/ic.2013.45.4.351; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Tam PYI, 2017, VACCINE, V35, P1817, DOI 10.1016/j.vaccine.2017.02.045; Tempia S, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1198-z; Tranfield D, 2003, BRIT J MANAGE, V14, P207, DOI 10.1111/1467-8551.00375; von Gottberg A, 2014, NEW ENGL J MED, V371, P1889, DOI 10.1056/NEJMoa1401914; von Mollendorf C, 2016, EMERG INFECT DIS, V22, P261, DOI 10.3201/eid2202.150967; Weinbergera M D, 2012, LANCET, V378, P1962, DOI [10.1016/S0140-6736(10)62225-8.Serotype, DOI 10.1016/S0140-6736(10)62225-8.SEROTYPE]; WHO Publication, 2012, VACCINE, V30, P4717, DOI 10.1016/j.vaccine.2012.04.093; Yeh SH, 2010, PEDIATRICS, V126, pE493, DOI 10.1542/peds.2009-3027	43	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212295	10.1371/journal.pone.0212295	http://dx.doi.org/10.1371/journal.pone.0212295			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779801	Green Published, gold, Green Submitted			2022-12-27	WOS:000459062900041
J	Patrick, S; Connick, P				Patrick, Sarah; Connick, Peter			Psychometric properties of the PHQ-9 depression scale in people with multiple sclerosis: A systematic review	PLOS ONE			English	Review							HEALTH QUESTIONNAIRE PHQ-9; DIAGNOSTIC-ACCURACY; VALIDATION; DISORDER; VERSION	Background Depression affects approximately 25% of people with MS (pwMS) at any given time. It is however under recognised in clinical practice, in part due to a lack of uptake for brief assessment tools and uncertainty about their psychometric properties. The 9-item Patient Health Questionnaire (PHQ-9) is an attractive candidate for this role. Objective To synthesise published findings on the psychometric properties of the 9-item Patient Health Questionnaire (PHQ-9) when applied to people with multiple sclerosis (pwMS). Data sources PubMed, Medline and ISI Web of Science databases, supplemented by hand-searching of references from all eligible sources. Study eligibility criteria Primary literature written in English and published following peer-review with a primary aim to evaluate the performance of the PHQ-9 in pwMS. Outcome measures Psychometric performance with respect to appropriateness, reliability, validity, responsiveness, precision, interpretability, acceptability, and feasibility. Results Seven relevant studies were identified, these were of high quality and included 5080 participants from all MS disease-course groups. Strong evidence was found supporting the validity of the PHQ-9 as a unidimensional measure of depression. Used as a screening tool for major depressive disorder (MDD) with a cut-point of 11, sensitivity was 95% sensitivity and specificity 88.3% (PPV 51.4%, NPV 48.6%). Alternative scoring systems that may address the issue of overlap between somatic features of depression and features of MS per se are being developed, although their utility remains unclear. However data on reliability was limited, and no specific evidence was available on test-retest reliability, responsiveness, acceptability, or feasibility. Conclusions The PHQ-9 represents a suitable tool to screen for MDD in pwMS. However use as a diagnostic tool cannot currently be recommended, and the potential value for monitoring depressive symptoms cannot be established without further evidence on test-retest reliability, responsiveness, acceptability, and feasibility.	[Patrick, Sarah] Univ Edinburgh, Edinburgh Med Sch, Edinburgh, Midlothian, Scotland; [Connick, Peter] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Connick, P (corresponding author), Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland.	pconnick@exseed.ed.ac.uk		Patrick, Sarah/0000-0002-1338-4352; Connick, Peter/0000-0002-3892-8037	Wellcome Trust [106716/Z/14/Z]	Wellcome Trust(Wellcome Trust)	PC was funded by The Wellcome Trust, grant number: 106716/Z/14/Z; https://wellcome.ac.uk.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altura KC, 2016, GEN HOSP PSYCHIAT, V42, P22, DOI 10.1016/j.genhosppsych.2016.06.006; Amtmann D, 2015, J PSYCHOSOM RES, V79, P550, DOI 10.1016/j.jpsychores.2015.08.007; Amtmann D, 2014, REHABIL PSYCHOL, V59, P220, DOI 10.1037/a0035919; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Feinstein A, 2017, MULT SCLER J, V23, P923, DOI 10.1177/1352458517702553; Fernandez-Jimenez E, 2015, MULT SCLER J, V21, P1468, DOI 10.1177/1352458514562439; Fitzpatrick R, 1998, Health Technol Assess, V2, P1; Gunzler DD, 2015, J BEHAV MED, V38, P237, DOI 10.1007/s10865-014-9574-5; Hind D, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0931-5; Hyphantis T, 2011, ARTHRIT CARE RES, V63, P1313, DOI 10.1002/acr.20505; Khamseh ME, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-61; Kim J, 2017, ASSESSMENT, V24, P300, DOI 10.1177/1073191115607042; Marrie RA, 2015, MULT SCLER J, V21, P305, DOI 10.1177/1352458514564487; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1186/2046-4053-4-1, 10.1136/bmj.b2535]; Mohr DC, 2006, MULT SCLER J, V12, P204, DOI 10.1191/135248506ms1265oa; Moriarty AS, 2015, GEN HOSP PSYCHIAT, V37, P567, DOI 10.1016/j.genhosppsych.2015.06.012; Patten S. B., 2015, MULT SCLER, V21, P1; Patten SB, 2017, INT REV PSYCHIATR, V29, P463, DOI 10.1080/09540261.2017.1322555; Sjonnesen K, 2012, POSTGRAD MED, V124, P69, DOI 10.3810/pgm.2012.09.2595; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Thekkumpurath P, 2011, CANCER-AM CANCER SOC, V117, P218, DOI 10.1002/cncr.25514; Turner A, 2012, STROKE, V43, P1000, DOI 10.1161/STROKEAHA.111.643296; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI [10.1016/j.jclinepi.2007.11.008, 10.2471/BLT.07.045120]; World Health Organization (WHO), 2008, ATL MULT SCLER RES W	24	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0197943	10.1371/journal.pone.0197943	http://dx.doi.org/10.1371/journal.pone.0197943			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL9KY	30779803	Green Published, gold, Green Submitted			2022-12-27	WOS:000459062900001
J	Santos, CS; Pie, MR; da Rocha, TC; Navarro-Silva, MA				Santos, Camila Silva; Pie, Marcio Roberto; da Rocha, Tatiana Carneiro; Navarro-Silva, Mario Antonio			Molecular identification of blood meals in mosquitoes (Diptera, Culicidae) in urban and forested habitats in southern Brazil	PLOS ONE			English	Article							RIO-DE-JANEIRO; CHAIN-REACTION PCR; SAO-PAULO STATE; FEEDING PATTERNS; ATLANTIC FOREST; RIBEIRA VALLEY; HUMAN DNA; AMPLIFICATION; PREFERENCES; MALARIA	The study of host associations of mosquitoes (Diptera, Culicidae) provides valuable information to assist in our understanding of a variety of related issues, from their life-history to the entomological surveillance of pathogens. In this study, we identified and characterized mosquito blood meals from both urban and forested areas in the city of Paranagua, state of Parana, Brazil, by analyzing the amplification of host DNA ingested by mosquitoes under different storage conditions and digestion levels. Host DNA preservation was evaluated in fresh blood meals according to storage duration (30 to 180 days) and temperature (-20 degrees C / -80 degrees C) and, in digested blood, according the degree of digestion classified on the Sella scale. Molecular analysis of blood meals was based on DNA extraction and amplification of a fragment of the mitochondrial COI gene. We determined that, up to 180 days of storage, the evaluated temperatures did not influence the preservation of fresh blood meals DNA, whereas the amplification success was increasingly reduced over the course of the digestion process. The species Anopheles cruzii, Aedes fluviatilis, Aedes scapularis, Psorophora ferox, Culex quinquefasciatus, Culex mollis, and Culex intrincatus, together with specimens representing four subgenera and one genus of Culicidae [Ae. (Ochlerotatus), Cx. (Culex), Cx. (Melanoconion), Cx. (Microculex), and Limatus, respectively] had their blood meals identified. Their diverse host use was evidenced by the identification of 19 species of vertebrate host, namely two amphibians, three mammals and 14 birds. Birds were the most commonly identified host in blood meals. These results not only show the diversity of mosquito hosts, but also underscore the challenges involved in monitoring arboviruses of public health importance, given potential combinations of host use for each mosquito species.	[Santos, Camila Silva; Navarro-Silva, Mario Antonio] Univ Fed Parana, Dept Zool, Lab Morfol & Fisiol Culicidae & Chironomidae, Curitiba, Parana, Brazil; [Pie, Marcio Roberto] Univ Fed Parana, Dept Zool, Lab Dinam Evolut & Sistemas Complexos, Curitiba, Parana, Brazil; [da Rocha, Tatiana Carneiro] Univ Fed Parana, Dept Farm, Lab Saude Publ & Ambiental, Curitiba, Parana, Brazil	Universidade Federal do Parana; Universidade Federal do Parana; Universidade Federal do Parana	Santos, CS; Navarro-Silva, MA (corresponding author), Univ Fed Parana, Dept Zool, Lab Morfol & Fisiol Culicidae & Chironomidae, Curitiba, Parana, Brazil.	camilatri@hotmail.com; mnavarro@ufpr.br	Santos, Camila Silva/R-2137-2019; da Silva, Mario Antonio Navarro/C-5287-2013; S. Santos, Camila/F-3380-2018	S. Santos, Camila/0000-0002-8733-2627; Navarro da Silva, Mario Antonio/0000-0002-9762-632X	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [132609/2016-9, 301636/2016-8, 307916/2016-2, 440385/2016-4]; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) [88887.130791/2016.00, 14/2016 Zika]	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) under process numbers 132609/2016-9 (CS Santos); 301636/2016-8 (MR Pie); 307916/2016-2; 440385/2016-4 (MA Navarro-Silva) and by CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) under process number 88887.130791/2016.00 Notice 14/2016 Zika (MA Navarro-Silva). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKANE A, 1994, J FORENSIC SCI, V39, P362; Alcaide M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007092; Alencar J, 2015, J MED ENTOMOL, V52, P783, DOI 10.1093/jme/tjv098; Alencar J, 2012, J MED ENTOMOL, V49, P952, DOI 10.1603/ME11270; Ali Oshaghi M, 2006, EXP PARASITOL, V112, P232, DOI 10.1016/j.exppara.2005.11.008; AlRokayan SAH., 2000, PAKISTAN J BIOL SCI, V3, P392, DOI [DOI 10.3923/PJBS.2000.392.394, 10.3923/pjbs.2000.392.394]; [Anonymous], 1962, WHO MONOGRAPHIES SER; [Anonymous], GRAD EST 2010; [Anonymous], 2002, CULICIDOLOGIA MED; Brasil P, 2017, LANCET GLOB HEALTH, V5, pE1038, DOI 10.1016/S2214-109X(17)30333-9; Brugman VA, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2098-4; Carrano E, 2006, THESIS; Consoli R. A. G. B., 1994, PRINCIPAIS MOSQUITOS; COULSON RMR, 1990, MED VET ENTOMOL, V4, P357, DOI 10.1111/j.1365-2915.1990.tb00452.x; Dalla Bona AC, 2012, ZOOLOGIA-CURITIBA, V29, P540; de Carvalho GC, 2014, J VECTOR ECOL, V39, P146, DOI 10.1111/j.1948-7134.2014.12081.x; dos Santos EB, 2016, EXP APPL ACAROL, V69, P323, DOI 10.1007/s10493-016-0045-2; Faraji A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003037; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FORATTINI OP, 1989, REV SAUDE PUBL, V23, P9, DOI 10.1590/S0034-89101989000100003; FORATTINI OP, 1987, REV SAUDE PUBL, V21, P171, DOI 10.1590/S0034-89101987000300002; Garcia-Rejon JE, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.3201; Gomes AC, 2003, J VECTOR ECOL, V28, P74; Gomes LAM, 2001, MEM I OSWALDO CRUZ, V96, P693, DOI 10.1590/S0074-02762001000500020; Gomez-Diaz E, 2010, TRENDS PARASITOL, V26, P470, DOI 10.1016/j.pt.2010.06.007; Guimaraes Rubio Marcelo Burigo, 2014, Chiroptera Neotropical, V20, P1255; Hall A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [citeulike-article-id:691774, DOI 10.1021/BK-1999-0734.CH008]; HALL T., 2013, BIOEDIT VERSION 7 2; Hamer GL, 2009, AM J TROP MED HYG, V80, P268, DOI 10.4269/ajtmh.2009.80.268; Hara M, 2015, FORENS SCI INT-GEN S, V5, pE39, DOI 10.1016/j.fsigss.2015.09.016; Harbach RE, 2007, ZOOTAXA, P591; Hernandez-Triana LM, 2017, ZOOTAXA, V4250, P67, DOI 10.11646/zootaxa.4250.1.5; Kenney JL, 2014, ADV VIRUS RES, V89, P39, DOI 10.1016/B978-0-12-800172-1.00002-1; Kent RJ, 2009, MOL ECOL RESOUR, V9, P4, DOI 10.1111/j.1755-0998.2008.02469.x; Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575; Kirchgatter K, 2014, REV INST MED TROP SP, V56, P403, DOI 10.1590/S0036-46652014000500006; Lane J., NEOTROPICAL CULICIDA, VII; Lane J., NEOTROPICAL CULICIDA, VI; Laurito M, 2013, MEM I OSWALDO CRUZ, V108, P110, DOI 10.1590/0074-0276130457; Leivas PT., 2014, THESIS; Silva JBL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181678; Lorosa ES, 2010, J AM MOSQUITO CONTR, V26, P18, DOI 10.2987/09-5914.1; Lourenco-de-Oliveira R., 1986, Memorias do Instituto Oswaldo Cruz, V81, P15; Lutz A., 1939, Ann Acad Sci Brasil, V11, P250; Lyimo IN, 2012, J EVOLUTION BIOL, V25, P452, DOI 10.1111/j.1420-9101.2011.02442.x; Mestre LAM, 2007, BRAZ ARCH BIOL TECHN, V50, P75, DOI 10.1590/S1516-89132007000100009; Martinez-de la Puente J, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-109; Moreno M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005337; Mucci LF, 2015, J VENOM ANIM TOXINS, V21, DOI 10.1186/s40409-015-0005-z; Mukabana WR, 2002, B ENTOMOL RES, V92, P233, DOI 10.1079/BER2002164; Mukabana WR, 2002, TRENDS PARASITOL, V18, P505, DOI 10.1016/S1471-4922(02)02364-4; Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15; Neves A, 2013, ACTA TROP, V125, P102, DOI 10.1016/j.actatropica.2012.08.014; Ngo KA, 2003, J MED ENTOMOL, V40, P215, DOI 10.1603/0022-2585-40.2.215; Passos FC, 2007, PRIMATOLOGIA BRASIL, V10, P119; Phasomkusolsil S, 2015, ACTA TROP, V152, P220, DOI 10.1016/j.actatropica.2015.09.021; Reeves LE, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0096-5; Reeves LE, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1791-z; Regis L, 2009, AN ACAD BRAS CIENC, V81, P655, DOI 10.1590/S0001-37652009000400004; Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853; Silva JD, 2012, J VECTOR ECOL, V37, P342, DOI 10.1111/j.1948-7134.2012.00237.x; Sotomayor-Bonilla J, 2017, J WILDLIFE DIS, V53, P657, DOI 10.7589/2016-11-249; Stein M, 2013, MEM I OSWALDO CRUZ, V108, P563, DOI 10.1590/S0074-02762013000500005; Styer LM, 2007, VECTOR-BORNE ZOONOT, V7, P86, DOI 10.1089/vbz.2007.0216; Takken W, 2013, ANNU REV ENTOMOL, V58, P433, DOI 10.1146/annurev-ento-120811-153618; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Team RC., 2013, R LANG ENV STAT COMP; Toma T, 2014, J AM MOSQUITO CONTR, V30, P215, DOI 10.2987/14-6398R.1; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Tuten HC, 2012, MED VET ENTOMOL, V26, P407, DOI 10.1111/j.1365-2915.2012.01012.x; Vanhoni F., 2008, REV BRASILEIRA CLIMA, V3, P49, DOI [10.5380/abclima.v3i0.25423, DOI 10.5380/ABCLIMA.V3I0.25423]; Wang Gang, 2012, PLoS ONE, V7, pe47051, DOI 10.1371/journal.pone.0047051	72	20	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212517	10.1371/journal.pone.0212517	http://dx.doi.org/10.1371/journal.pone.0212517			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779816	Green Published, gold, Green Submitted			2022-12-27	WOS:000459062900061
J	Seo, J; Lee, JW; Kang, Y; Lee, E; Ahn, JM; Kim, DH; Kang, HS				Seo, Jiwoon; Lee, Joon Woo; Kang, Yusuhn; Lee, Eugene; Ahn, Joong Mo; Kim, Dong Hyun; Kang, Heung Sik			Evaluation of the responsiveness of outcome measures after spine injection: A retrospective study	PLOS ONE			English	Article							LOW-BACK-PAIN; EPIDURAL STEROID INJECTION; RATING-SCALE; SCORES; REDUCTION; AGREEMENT	Discrepancies in patients' responses to various outcome measures challenge clinicians' evaluation of treatment outcomes. Therefore, we aimed to 1) evaluate the concordance of outcome measures after spine injection, 2) determine the patient variables that lead to discordant responses, and 3) suggest practical outcome measure for spine injections with good responsiveness. From October 2014 to November 2014, 164 patients with neck or low back pain who visited our outpatient clinics and had spine injections on the previous visit were enrolled. We asked patients to report changes in their symptom in the form of outcome measures: numeric rating scale, Oswestry disability index, neck disability index, residual symptom percentage and global perceived effect. The responses were categorized into three groups according to the degree of change; not improved, minimally improved, and significantly improved. The concordances of these categorized answers were evaluated. When "significantly improved" was considered as true improvement, 46 (28%) of the 164 patients had discordant responses to the four measures. There was no significant patients' variable that affects discordance in the outcome measures. Good agreement was shown between the global perceived effect and residual symptom percentage, while the Oswestry disability index had poor agreement with the other measurements. The calculated numeric rating scale and residual symptom percentage also had low levels of agreement. However, patients with severe pre-treatment pain tended to have better agreement. In conclusion, this result suggest that the residual symptom percentage may be a more practical for clinicians and better represent patients' improvements after spine injection.	[Seo, Jiwoon; Lee, Joon Woo; Kang, Yusuhn; Lee, Eugene; Ahn, Joong Mo; Kang, Heung Sik] Seoul Natl Univ, Bundang Hosp, Dept Radiol, Seongnam Si, Gyeonggi Do, South Korea; [Kim, Dong Hyun] Seoul Natl Univ, Boramae Med Ctr, Dept Radiol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Lee, JW (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Radiol, Seongnam Si, Gyeonggi Do, South Korea.	joonwoo2@gmail.com	Kang, Yusuhn/AAE-3405-2019	Kang, Yusuhn/0000-0003-1838-2564; Kim, Dong Hyun/0000-0002-3871-7002; Lee, Joon Woo/0000-0002-7106-5229	National Research Foundation of Korea [NRF-2016R1A2B4010992]; Seoul National University Bundang Hospital [02-2013-092]; NRF - Korea government (MSIP) [NRF-2016R1A2B4010992]; SNUBH Research Fund [02-2013-092]	National Research Foundation of Korea(National Research Foundation of Korea); Seoul National University Bundang Hospital; NRF - Korea government (MSIP); SNUBH Research Fund	Funded by National Research Foundation of Korea NRF-2016R1A2B4010992. Dr Joonwoo Lee. Seoul National University Bundang Hospital 02-2013-092. Dr Joonwoo Lee.; This work was supported by Mid-career Researcher Program through NRF grant funded by the Korea government (MSIP) (No. NRF-2016R1A2B4010992); the SNUBH Research Fund (grant no. 02-2013-092).	Cepeda MS, 2003, PAIN, V106, P439, DOI 10.1016/j.pain.2003.09.006; Chapman JR, 2011, SPINE, V36, pS54, DOI 10.1097/BRS.0b013e31822ef74d; Childs JD, 2005, SPINE, V30, P1331, DOI 10.1097/01.brs.0000164099.92112.29; Cohen SP, 2015, MAYO CLIN PROC, V90, P284, DOI 10.1016/j.mayocp.2014.09.008; Cormier S, 2016, PAIN, V157, P329, DOI 10.1097/j.pain.0000000000000379; Cushman D, 2015, PAIN MED, V16, P870, DOI 10.1111/pme.12669; Guyatt GH, 2002, J CLIN EPIDEMIOL, V55, P900, DOI 10.1016/S0895-4356(02)00435-3; Hooten WM, 2015, MAYO CLIN PROC, V90, P1699, DOI 10.1016/j.mayocp.2015.10.009; Kamper SJ, 2010, J CLIN EPIDEMIOL, V63, P760, DOI 10.1016/j.jclinepi.2009.09.009; Kim HJ, 2014, PAIN PRACT, V14, P405, DOI 10.1111/papr.12084; Ostelo RWJG, 2008, SPINE, V33, P90, DOI 10.1097/BRS.0b013e31815e3a10; Costa LOP, 2008, SPINE, V33, P2459, DOI 10.1097/BRS.0b013e3181849dbe; Shahgholi L, 2015, AM J NEURORADIOL, V36, P594, DOI 10.3174/ajnr.A4150; Theodore BR, 2012, PAIN MED, V13, P1131, DOI 10.1111/j.1526-4637.2012.01442.x; Tomkins-Lane CC, 2012, ARCH PHYS MED REHAB, V93, P2008, DOI 10.1016/j.apmr.2012.05.014	15	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211763	10.1371/journal.pone.0211763	http://dx.doi.org/10.1371/journal.pone.0211763			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811428	Green Published, Green Submitted, gold			2022-12-27	WOS:000459806400032
J	Costa-Urrutia, P; Vizuet-Gamez, A; Ramirez-Alcantara, M; Guillen-Gonzalez, MA; Medina-Contreras, O; Valdes-Moreno, M; Musalem-Younes, C; Solares-Tlapechco, J; Granados, J; Franco-Trecu, V; Rodriguez-Arellano, ME				Costa-Urrutia, Paula; Vizuet-Gamez, Alejandra; Ramirez-Alcantara, Miryam; Angel Guillen-Gonzalez, Miguel; Medina-Contreras, Oscar; Valdes-Moreno, Mariana; Musalem-Younes, Claudette; Solares-Tlapechco, Jaqueline; Granados, Julio; Franco-Trecu, Valentina; Eunice Rodriguez-Arellano, M.			Obesity measured as percent body fat, relationship with body mass index, and percentile curves for Mexican pediatric population	PLOS ONE			English	Article							CHILDREN; ADOLESCENTS; CUTOFFS; PERFORMANCE; OVERWEIGHT; ADIPOSITY; RISK; AGE	In Mexico, the increase in childhood obesity is alarming. Thus, improving the precision of its diagnosis is expected to impact on disease prevention. We estimated obesity prevalence by bioimpedance-based percent body fat (%BF) and body mass index (BMI) in 1061 girls and 1121 boys, from 3 to 17 years old. Multiple regressions and area under receiver operating curves (AUC) were used to determine the predictive value of BMI on %BF and percentile curves were constructed. Overall obesity prevalence estimated by %BF was 43.7%, and by BMI it was 20.1%; it means that the diagnosis by BMI underestimated around 50%of children diagnosed with obesity by %BF (>= 30% for girls, >= 25% for boys). The fat mass excess is further underestimated in boys than in girls when using the standard BMI classification. The relationship between %BF and BMI was strong in school children and adolescents (all cases R-2>0.70), but not in preschool children (girls R-2 = 0.57, boys R-2 = 0.23). AUCs showed greater discriminative power of BMI to detect %BF obesity in school children and adolescents (all cases AUC. 0.90) than in preschool children (girls AUC = 0.86; boys AUC = 0.70). Growth percentile charts showed that girls aged 9-17 years and boys aged 8-17 years presented fat excess from the 50th percentile and above. We suggested to change the BMI cut-off for them, considering values at the 75th percentile as overweight, and values at the 85 th percentile as obesity, as previously recommended for Mexican children. Improving obesity diagnosis will allow greater efficiency when searching for comorbidities in clinical practice.	[Costa-Urrutia, Paula; Angel Guillen-Gonzalez, Miguel; Medina-Contreras, Oscar; Valdes-Moreno, Mariana; Musalem-Younes, Claudette; Solares-Tlapechco, Jaqueline; Eunice Rodriguez-Arellano, M.] ISSSTE, Adolfo Lopez Mateos, Hosp Reg Lic, Lab Med Genom, Mexico City, DF, Mexico; [Vizuet-Gamez, Alejandra] ISSSTE, Adolfo Lopez Mateos, Hosp Reg Lic, Coordinac Pediat, Mexico City, DF, Mexico; [Ramirez-Alcantara, Miryam] ISSSTE, Adolfo Lopez Mateos, Hosp Reg Lic, Lab Invest Clin, Mexico City, DF, Mexico; [Medina-Contreras, Oscar] Hosp Infantil Mexico Dr Federico Gomez, Lab Inmunol & Prote, Mexico City, DF, Mexico; [Granados, Julio] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Trasplantes, Div Inmunogenet, Mexico City, DF, Mexico; [Franco-Trecu, Valentina] Univ Republica, Fac Ciencias, Dept Ecol & Evoluc, Montevideo, Uruguay	Hospital Infantil de Mexico Federico Gomez; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad de la Republica, Uruguay	Rodriguez-Arellano, ME (corresponding author), ISSSTE, Adolfo Lopez Mateos, Hosp Reg Lic, Lab Med Genom, Mexico City, DF, Mexico.	marthaeunicer@yahoo.com.mx	Medina-Contreras, Oscar/B-1956-2010; ARELLANO, MARTHA EUNICE RODRIGUEZ/G-3974-2017; Franco-Trecu, Valentina/N-5266-2019	Medina-Contreras, Oscar/0000-0002-4432-7780; ARELLANO, MARTHA EUNICE RODRIGUEZ/0000-0002-2135-6175; Costa-Urrutia, Paula/0000-0002-6747-5380	ISSSTE (Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado) [E015]	ISSSTE (Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado)	This project was funded by the ISSSTE (Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado) under the grant number E015. We declare that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpizar M, 2017, CHILDREN-BASEL, V4, DOI 10.3390/children4120112; Ayalon N, 2011, SURV ANESTHESIOL, V55, P296, DOI [10.1097/01.sa.0000407026.86152.a1, DOI 10.1097/01.SA.0000407026.86152.A1, DOI 10.1007/S00405-011-1539-5]; Bibbins-Domingo K, 2007, NEW ENGL J MED, V357, P2371, DOI 10.1056/NEJMsa073166; Cole T. J., 2000, OBESITY WORLDWIDE IN, P1; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Del-Rio-Navarro BE, 2007, EUR J CLIN NUTR, V61, P963, DOI 10.1038/sj.ejcn.1602612; Dulloo AG, 2010, INT J OBESITY, V34, pS4, DOI 10.1038/ijo.2010.234; ENSANUT, 2012, ENS 2012, P200, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Eriksson JG, 2015, J INTERN MED, V278, P219, DOI 10.1111/joim.12354; FOMON SJ, 1982, AM J CLIN NUTR, V35, P1169, DOI 10.1093/ajcn/35.5.1169; Going SB, 2011, AM J PREV MED, V41, pS77, DOI 10.1016/j.amepre.2011.07.006; HernuYndez-Avila, 2016, I NAC SALUD PUBLICA, V2016, P151, DOI DOI 10.21149/8593; Javed A, 2015, PEDIATR OBES, V10, P234, DOI 10.1111/ijpo.242; Khalil SF, 2014, SENSORS-BASEL, V14, P10895, DOI 10.3390/s140610895; Lopez-Alvarenga JC, 2003, ARCH MED RES, V34, P137, DOI 10.1016/S0188-4409(03)00002-X; McCarthy HD, 2006, INT J OBESITY, V30, P598, DOI 10.1038/sj.ijo.0803232; McConnell-Nzunga J, 2018, MEAS PHYS EDUC EXERC, V22, P154, DOI 10.1080/1091367X.2017.1405809; Mitchell EA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196221; Mueller WH, 2004, AM J HUM BIOL, V16, P135, DOI 10.1002/ajhb.20002; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nichols SD, 2009, EUR J CLIN NUTR, V63, P253, DOI 10.1038/sj.ejcn.1602913; Nielsen TRH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190576; Ogden Cynthia L, 2011, NCHS Data Brief, P1; Pandit D, 2009, CLIN MED INSIGHTS-PE, V3, P55; Pavanello C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192751; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Seth A, 2013, INDIAN PEDIATR, V50, P832, DOI 10.1007/s13312-013-0224-8; Styne DM, 2017, J CLIN ENDOCR METAB, V102, P709, DOI 10.1210/jc.2016-2573; Taylor RW, 2003, EUR J CLIN NUTR, V57, P764, DOI 10.1038/sj.ejcn.1601608; Taylor RW, 2002, BODY FAT PERCENTAGES, P1416; Torres-Tamayo M, 2015, BOL MED HOSP INFANT, V72, P1; Vizmanos B, 2000, EUR J CLIN NUTR, V54, P203, DOI 10.1038/sj.ejcn.1600920; Wang G, 2013, ADV GENET, V84, P123, DOI 10.1016/B978-0-12-407703-4.00004-9; Wang Lin, 2015, BMC Public Health, V15, P802, DOI 10.1186/s12889-015-2152-0; Who & Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA, DOI [10.4067/S0370-41062009000400012, DOI 10.4067/S0370-41062009000400012]; WILLIAMS DP, 1992, AM J PUBLIC HEALTH, V82, P358, DOI 10.2105/AJPH.82.3.358	36	24	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2019	14	2							e0212792	10.1371/journal.pone.0212792	http://dx.doi.org/10.1371/journal.pone.0212792			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EH	30802270	Green Published, gold, Green Submitted			2022-12-27	WOS:000459710700021
J	Decorte, R; Polet, C; Boudin, M; Tilquin, F; Matroule, JY; Dieu, M; Charles, C; Carlier, A; Lebecque, F; Deparis, O				Decorte, Ronny; Polet, Caroline; Boudin, Mathieu; Tilquin, Francoise; Matroule, Jean-Yves; Dieu, Marc; Charles, Catherine; Carlier, Aurore; Lebecque, Fiona; Deparis, Olivier			An interdisciplinary study around the reliquary of the late cardinal Jacques de Vitry	PLOS ONE			English	Article							DNA; PRESERVATION; CALIBRATION; POPULATION; SEQUENCE; BONES; LOCI; AGE	The reliquary of Jacques de Vitry, a prominent clergyman and theologian in the early 13th century, has experienced several transfers over the last centuries, which seriously question the attribution of the remains to the late Cardinal. Uncertainty about the year of his birth poses an additional question regarding his age at death in 1240. The reliquary, located in the Saint Marie d'Oigines church, Belgium, was reopened in 2015 for an interdisciplinary study around his relics as well as the Treasure of Oignies, a remarkable cultural heritage notably built from Jacques de Vitry's donation. Anthropological, isotopic and genetic analyses were performed independently on the remains found in the reliquary. Results of the analyses provided evidence that the likelihood that these remains are those of Jacques de Vitry is very high: the remains belong to the same human male individual and the historical tradition about his age is confirmed. In addition, a separate relic (left tibia) was analysed and found to match with the remains of the reliquary (right tibia). The unique Jacques de Vitry's mitre, made of parchment, was sampled non-destructively and the extracted parchment collagen was analysed by a proteomic method in order to determine the animal species. The results showed that, surprisingly, not all parts of the mitre were made from the same species. All together, these findings are expected to fertilize knowledge carried by historical tradition around the relics of Jacques de Vitry and his related cultural heritage.	[Decorte, Ronny] KU Leuven KUL, Dept Imaging & Pathol, Forens Biomed Sci, Leuven, Belgium; [Decorte, Ronny] UZ Leuven UZL, Dept Forens Med, Lab Forens Genet & Mol Archaeol, Leuven, Belgium; [Polet, Caroline] Royal Belgian Inst Nat Sci, Dept Palaeontol, Brussels, Belgium; [Boudin, Mathieu] Royal Inst Cultural Heritage KIK IRPA, Radiocarbon Dating Lab, Brussels, Belgium; [Tilquin, Francoise; Matroule, Jean-Yves] Univ Namur, Narilis Inst, ILEE Inst, Res Unit Microorganisms Biol URBM, Namur, Belgium; [Dieu, Marc] Univ Namur, Mass Spectrometry Facil MaSUN, Namur, Belgium; [Charles, Catherine] Univ Namur, Moretus Plantin Univ Lib, Namur, Belgium; [Carlier, Aurore; Lebecque, Fiona] Archeol Soc Namur SAN, Namur, Belgium; [Deparis, Olivier] Univ Namur, Heritages Transmiss Inheritances PaTHs Inst, Namur, Belgium; [Deparis, Olivier] Univ Namur, Dept Phys, Namur, Belgium	KU Leuven; Royal Belgian Institute of Natural Sciences; University of Namur; University of Namur; University of Namur; University of Namur; University of Namur	Deparis, O (corresponding author), Univ Namur, Heritages Transmiss Inheritances PaTHs Inst, Namur, Belgium.; Deparis, O (corresponding author), Univ Namur, Dept Phys, Namur, Belgium.	olivier.deparis@unamur.be	Decorte, Ronny/AAG-1365-2021	Dieu, Marc/0000-0002-3902-542X; Deparis, Olivier/0000-0002-2161-7208; Decorte, Ronny/0000-0002-0001-386X	Fonds Jean-Jacques Comhaire of the Fondation Roi Baudouin, Belgium; Fonds Jean-Jacques Comhaire of the Fondation Roi Baudouin (FRB), Belgium	Fonds Jean-Jacques Comhaire of the Fondation Roi Baudouin, Belgium; Fonds Jean-Jacques Comhaire of the Fondation Roi Baudouin (FRB), Belgium	The work was funded by a grant from the Fonds Jean-Jacques Comhaire of the Fondation Roi Baudouin (www.kbs-frb.be), Belgium.; The CROMIOSS project (www.lasan.be/la-recherche/projet-cromioss) was funded by a grant from the Fonds Jean-Jacques Comhaire of the Fondation Roi Baudouin (FRB), Belgium. Anne De Breuck (FRB) and Prof. Jean-Jacques Cassiman (KU Leuven, Belgium) are acknowledged for their intellectual support to the project. Jacques de Vitry's mitre (donation from the Soeurs de Notre-Dame de Namur to FRB) belongs to FRB collections and is hold at TreM.a-Musee des Arts anciens, Namur, Belgium.	Actes de la journee d'e tude Hugo d'Oignies, 2012, ACT JOURN ET HUG OIG, P58; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; [Anonymous], 1980, J HUM EVOL, V9, P517; Arismendi JL, 2004, J FORENSIC SCI, V49, P930; Auvray L, 1896, REGISTRES GREGOIRE; Boudin M, 2015, NUCL INSTRUM METH B, V361, P120, DOI 10.1016/j.nimb.2015.04.006; Buisseret F, 1609, HIST VIE MIRACLES TR; Colard T, 2018, INT J LEGAL MED, V132, P1117, DOI 10.1007/s00414-015-1172-8; De Trois-Fontaines A, 1925, CHRONICA, P950; DeCantimpre T, 1867, ACTA SANCOTORUM  JUI, VIII, P257; Decorte R, 2017, TAPHON HUM REMAIN FO, V65-80; DENIRO MJ, 1985, NATURE, V317, P806, DOI 10.1038/317806a0; Dognaux S, 2012, FORENSIC SCI INT-GEN, V6, pE75, DOI 10.1016/j.fsigen.2011.05.003; Donnadieu Jean, 2014, JACQUES VITRY 1175 1; Ervynck A, 2018, RADIOCARBON, V60, P395, DOI 10.1017/RDC.2017.148; Fiddyment S, 2015, P NATL ACAD SCI USA, V112, P15066, DOI 10.1073/pnas.1512264112; Furtwangler A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32083-0; Georges P, 1999, MICROLOGUS, V7, P359; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95; Hansen HB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170940; Higgins D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126935; Huygens RBC, 2012, HIST FUNDATIONIS VEN; Huygens RBC, 2012, DEVITRY J VITA MARIA; Huygens RBC, 2012, DEVITRY J VITA MARIA, P144; Krogman WM., 1986, HUMAN SKELETON FOREN; Kwon SY, 2016, FORENSIC SCI INT-GEN, V25, P132, DOI 10.1016/j.fsigen.2016.08.010; Lanting J.N., 1996, PALAEOHIST, V37, P491; Larmuseau MHD, 2016, FORENSIC SCI INT-GEN, V24, P202, DOI 10.1016/j.fsigen.2016.07.008; Larmuseau MHD, 2011, FORENSIC SCI INT-GEN, V5, P95, DOI 10.1016/j.fsigen.2010.08.020; LOVEJOY CO, 1985, AM J PHYS ANTHROPOL, V68, P47, DOI 10.1002/ajpa.1330680105; Morcillo-Mendez Maria Dolores, 2012, Torture, V22 Suppl 1, P5; Moschus F, 1636, OMNIA CURA LABORE AR, P9; Mundorff A, 2014, FORENSIC SCI INT-GEN, V8, P55, DOI 10.1016/j.fsigen.2013.08.001; OLIVIER G, 1978, J HUM EVOL, V7, P513, DOI 10.1016/S0047-2484(78)80020-7; Ottoni C, 2011, EUR J HUM GENET, V19, P571, DOI 10.1038/ejhg.2010.230; Ottoni C, 2009, NATURWISSENSCHAFTEN, V96, P267, DOI 10.1007/s00114-008-0478-5; Paravicini-Bagliani A, 1992, DEMEMBREMENT INTEGRI, P18; Poncelet E, 1912, ANN SOC ARCHEOLOGIQU, P31; Porta D, 2016, J FORENSIC LEG MED, V38, P50, DOI 10.1016/j.jflm.2015.11.016; Pruvost M, 2007, P NATL ACAD SCI USA, V104, P739, DOI 10.1073/pnas.0610257104; Ramsey CB, 1995, RADIOCARBON, V37, P425, DOI 10.1017/S0033822200030903; Rayssius A, 1636, OMNIA CURA LABORE AR, P48; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Rennick SL, 2005, J FORENSIC SCI, V50, P1016; Rutty GN., 2014, ESSENTIALS AUTOPSY P, P59; Schwarz C, 2009, NUCLEIC ACIDS RES, V37, P3215, DOI 10.1093/nar/gkp159; SULLIVAN KM, 1993, BIOTECHNIQUES, V15, P636; Van Strydoncks M, 1991, B K I KUNSTPATRIM, V23, P228; Wankenne A, 1989, VIE MARIE OIGNIES JA, P169; Weiss-Krejci E., 2005, INTERACTING DEAD PER, P155	50	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0201424	10.1371/journal.pone.0201424	http://dx.doi.org/10.1371/journal.pone.0201424			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794540	Green Published, Green Submitted, gold			2022-12-27	WOS:000459709100002
J	Harichund, C; Kunene, P; Simelane, S; Karim, QA; Moshabela, M				Harichund, Charlene; Kunene, Pinky; Simelane, Sinenhlanhla; Karim, Quarraisha Abdool; Moshabela, Mosa			Repeat HIV testing practices in the era of HIV self-testing among adults in KwaZulu-Natal, South Africa	PLOS ONE			English	Article							ACCEPTABILITY; POPULATION; PREVENTION	Repeat HIV testing is important in high HIV burden communities to enable sustainability of prevention initiatives; however, an understanding of repeat testing practices is limited. Additional HIV testing approaches may be required to increase testing. HIV self-testing is an additional testing approach, but knowledge on its potential for repeat testing is limited. This study explored repeat HIV testing practices and uptake of HIV self-testing among repeat testers, following exposure to HIV self-testing. HIV testing practices were explored at two time points. During Phase 1, eighty in-depth interviews were conducted among 40 consenting adults, and 30 telephonic contacts were completed during Phase 2. Framework analysis was used to analyse the transcripts from the in-depth interviews. The practice of repeat HIV testing is primarily influenced by HIV status awareness and risk exposure. Thirteen regular testers and one HIV na ve tester at baseline had undergone repeat testing through the use of a traditional testing approach such as HIV counselling and testing as reported in Phase 2. HIV self-testing has a role among repeat testers, but affordability and access are barriers.	[Harichund, Charlene; Kunene, Pinky; Simelane, Sinenhlanhla; Karim, Quarraisha Abdool] Ctr AIDS Programme Res South Africa, Durban, South Africa; [Karim, Quarraisha Abdool] Columbia Univ, Dept Epidemiol, New York, NY USA; [Karim, Quarraisha Abdool; Moshabela, Mosa] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Durban, South Africa; [Moshabela, Mosa] Africa Hlth Res Inst, Kwa Zulu, South Africa	Columbia University; University of Kwazulu Natal; Africa Health Research Institute	Harichund, C (corresponding author), Ctr AIDS Programme Res South Africa, Durban, South Africa.	Charlene.Harichund@caprisa.org	Abdool Karim, Quarraisha/GVS-1160-2022; Moshabela, Mosa/AAK-4418-2021	Abdool Karim, Quarraisha/0000-0002-0985-477X; Moshabela, Mosa/0000-0002-9438-7095; Harichund, Charlene/0000-0003-4641-1924	University of KwaZulu-Natal	University of KwaZulu-Natal	The research was supported by a scholarship grant from the University of KwaZulu-Natal. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asante A, 2007, B WORLD HEALTH ORGAN, V85, P644, DOI 10.2471/BLT.06.037671; Brown W, 2016, AIDS BEHAV, V20, P2000, DOI 10.1007/s10461-016-1309-x; Burke VM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183280; Cambiano V, 2014, AIDS BEHAV, V18, pS450, DOI 10.1007/s10461-014-0824-x; Harichund C, 2018, AIDS BEHAV, V22, P560, DOI 10.1007/s10461-017-1848-9; Hensen B, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2259-3; Johnson CC, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21594; Kalichman SC, 2008, J CLIN PSYCHOL MED S, V15, P127, DOI 10.1007/s10880-008-9116-9; Kelvin EA, 2018, AIDS CARE, V30, P47, DOI 10.1080/09540121.2017.1360997; Krause J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-735; MUSHEKE M, 2013, BIOMED CENTRAL PUBLI, V13, DOI DOI 10.1186/1471-2458-13-220; Orne-Gliemann J, 2016, AIDS CARE, V28, P14, DOI 10.1080/09540121.2016.1164805; Pai NP, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001414; Perkins JM, 2018, AIDS BEHAV, V22, P616, DOI 10.1007/s10461-017-1691-z; Rabiee F, 2004, P NUTR SOC, V63, P655, DOI 10.1079/PNS2004399; Ryder K, 2005, AIDS BEHAV, V9, P459, DOI 10.1007/s10461-005-9032-z; Siegler AJ, 2015, AIDS CARE, V27, P229, DOI 10.1080/09540121.2014.947914	17	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212343	10.1371/journal.pone.0212343	http://dx.doi.org/10.1371/journal.pone.0212343			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794580	Green Submitted, gold, Green Published			2022-12-27	WOS:000459709100055
J	Sato, T; Morishita, S; Horie, T; Fukumoto, M; Kida, T; Oku, H; Nakamura, K; Takai, S; Jin, D; Ikeda, T				Sato, Takaki; Morishita, Seita; Horie, Taeko; Fukumoto, Masanori; Kida, Teruyo; Oku, Hidehiro; Nakamura, Kimitoshi; Takai, Shinji; Jin, Denan; Ikeda, Tsunehiko			Involvement of premacular mast cells in the pathogenesis of macular diseases	PLOS ONE			English	Article							PRECORTICAL VITREOUS POCKET; ENDOTHELIAL GROWTH-FACTOR; ANGIOTENSIN-CONVERTING ENZYME; TNF-ALPHA; VITREOMACULAR TRACTION; FACTOR-1 CXCL12; LYMPH-NODES; STEM-CELLS; IN-VIVO; FIBROBLASTS	We previously reported on the elevated intravitreal activities of tryptase and chymase in association with idiopathic epiretinal membrane (ERM) and idiopathic macular hole (MH). In this present study, we investigated the potential intraocular production of these serine proteases, and measured and compared tryptase and chymase activities in the vitreous body and serum in ERM, MH, proliferative diabetic retinopathy (PDR), and rhegmatogenous retinal detachment (RRD) patients. In addition, nuclear staining with hematoxylin and eosin (H&E) and mast-cell staining with toluidine blue were performed on samples of the vitreous core and bursa premacularis (BPM) of MH. We also performed immunostaining on the above two regions of vitreous samples for MH with anti-tryptase antibody, anti-chymase antibody, anti-podoplanin antibody, anti-lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1) antibody, and anti-fibroblast antibody. Moreover, we performed immunostaining with anti-tryptase antibody and anti-chymase antibody on ERMs collected intraoperatively. Tryptase activity in the vitreous body was significantly higher in ERM and MH than in PDR. However, no significant differences were observed in the tryptase activity in the serum among these four diseases. Chymase activity in the vitreous body was significantly higher in MH than in the other three diseases, yet chymase activity in the serum was below detection limit in any of the diseases. Nuclear staining with H&E revealed an abundance of nuclei in the BPM region, but few in the surrounding area. Mast-cell staining with toluidine blue revealed that the BPM showed metachromatic staining. In immunostaining with anti-fibroblasts antibody, anti-tryptase antibody, anti-chymase antibody, anti-podoplanin antibody, and anti-LYVE-1 antibody, the BPM stained more strongly than the vitreous core. Tryptase and chymase-positive cells were also observed in ERM. These findings revealed that the presence of mast cells in the BPM potentially represent the source of these serine proteases. Moreover, the BPM, as a lymphatic tissue, may play an important role in the pathogenesis of macular disease.	[Sato, Takaki; Morishita, Seita; Horie, Taeko; Fukumoto, Masanori; Kida, Teruyo; Oku, Hidehiro; Ikeda, Tsunehiko] Osaka Med Coll, Dept Ophthalmol, Takatsuki, Osaka, Japan; [Nakamura, Kimitoshi] Nakamura Eye Clin, Matsumoto, Nagano, Japan; [Takai, Shinji; Jin, Denan] Osaka Med Coll, Grad Sch Med, Dept Innovat Med, Takatsuki, Osaka, Japan	Osaka Medical College; Osaka Medical College	Ikeda, T (corresponding author), Osaka Med Coll, Dept Ophthalmol, Takatsuki, Osaka, Japan.	tikeda@osaka-med.ac.jp	Oku, Hidehiro/AAD-5029-2019	Oku, Hidehiro/0000-0003-4359-4219; Takai, Shinji/0000-0003-3963-3983				Alam F, 2008, AM J ROENTGENOL, V191, P604, DOI 10.2214/AJR.07.3401; Antila S, 2017, J EXP MED, V214, P3645, DOI 10.1084/jem.20170391; ATKINS FM, 1985, INT ARCH ALLER A IMM, V77, P96, DOI 10.1159/000233760; Au SR, 2007, J CELL BIOCHEM, V100, P1170, DOI 10.1002/jcb.21107; Belot MP, 2007, AM J PHYSIOL-ENDOC M, V292, pE1410, DOI 10.1152/ajpendo.00286.2006; Bhatia B, 2009, EXP EYE RES, V89, P373, DOI 10.1016/j.exer.2009.04.005; Bischoff SC, 1999, INT ARCH ALLERGY IMM, V118, P104, DOI 10.1159/000024041; Butler JM, 2005, J CLIN INVEST, V115, P86, DOI 10.1172/JCI200522869; Chang S, 2006, AM J OPHTHALMOL, V141, P1033, DOI 10.1016/j.ajo.2006.02.014; Duker JS, 2013, OPHTHALMOLOGY, V120, P2611, DOI 10.1016/j.ophtha.2013.07.042; Ebihara N, 2005, CURR EYE RES, V30, P429, DOI 10.1080/02713680590959367; EISNER G, 1975, A GRAEF ARCH KLIN EX, V193, P33, DOI 10.1007/BF00410525; Fine HF, 2006, ARCH OPHTHALMOL-CHIC, V124, P1663, DOI 10.1001/archopht.124.11.1663; Friend DS, 1996, J CELL BIOL, V135, P279, DOI 10.1083/jcb.135.1.279; Fukumoto M, 2008, CURR EYE RES, V33, P885, DOI 10.1080/02713680802389851; FURITSU T, 1989, P NATL ACAD SCI USA, V86, P10039, DOI 10.1073/pnas.86.24.10039; GARTNER J, 1971, AM J OPHTHALMOL, V71, P1317; Gruber BL, 1997, J IMMUNOL, V158, P2310; Hata Y, 2011, BRIT J OPHTHALMOL, V95, P261, DOI 10.1136/bjo.2010.190322; Hitchon C, 2002, ARTHRITIS RHEUM, V46, P2587, DOI 10.1002/art.10520; Hjertson M, 1996, EXP HEMATOL, V24, P748; Iddamalgoda A, 2008, ARCH DERMATOL RES, V300, pS69, DOI 10.1007/s00403-007-0806-1; Ikeda T, 2015, CLIN OPHTHALMOL, V9, P1181, DOI 10.2147/OPTH.S82015; Ishizaki E, 2006, AM J OPHTHALMOL, V141, P129, DOI 10.1016/j.ajo.2005.08.066; JONGEBLOED WL, 1986, DOC OPHTHALMOL, V64, P117, DOI 10.1007/BF00166693; Kakehashi Akihiro, 1995, Nippon Ganka Gakkai Zasshi, V99, P323; Kim KW, 2007, ARTHRITIS RHEUM-US, V56, P1076, DOI 10.1002/art.22439; KISHI S, 1990, ARCH OPHTHALMOL-CHIC, V108, P979, DOI 10.1001/archopht.1990.01070090081044; Kishi S, 2016, JPN J OPHTHALMOL, V60, P239, DOI 10.1007/s10384-016-0447-z; KITAMURA Y, 1993, AM J MED SCI, V306, P185, DOI 10.1097/00000441-199309000-00011; KOCHEVAR IE, 1994, J INVEST DERMATOL, V103, P797, DOI 10.1111/1523-1747.ep12413286; LAZARUS HS, 1994, ARCH OPHTHALMOL-CHIC, V112, P1356, DOI 10.1001/archopht.1994.01090220106031; Leskinen M, 2001, ARTERIOSCL THROM VAS, V21, P516, DOI 10.1161/01.ATV.21.4.516; Li JC, 1996, ANN ANAT, V178, P259, DOI 10.1016/S0940-9602(96)80059-8; Li Liang, 2010, Zhonghua Yan Ke Za Zhi, V46, P317; LINENBERGER ML, 1995, EXP HEMATOL, V23, P1104; Liu JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102950; Lobov GI, 2011, B EXP BIOL MED+, V151, P5, DOI 10.1007/s10517-011-1246-7; Los LI, 2008, EYE, V22, P1223, DOI 10.1038/eye.2008.39; Majji AB, 2006, EYE, V20, P46, DOI 10.1038/sj.eye.6701788; Maruichi M, 2004, CURR EYE RES, V29, P321, DOI 10.1080/02713680490516161; May CA, 1999, HISTOCHEM CELL BIOL, V112, P381, DOI 10.1007/s004180050420; Mekori YA, 2000, HEMATOL ONCOL CLIN N, V14, P569, DOI 10.1016/S0889-8588(05)70297-5; Mughal M A, 1988, J Pak Med Assoc, V38, P78; Nguyen M, 2005, J IMMUNOL, V175, P5701, DOI 10.4049/jimmunol.175.9.5701; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Polak BCP, 2012, ACTA OPHTHALMOL, V90, pe652, DOI 10.1111/j.1755-3768.2012.02539.x; Rossi T, 2018, EXP EYE RES, V175, P159, DOI 10.1016/j.exer.2018.06.022; SAINTEMARIE G, 1990, CELL TISSUE RES, V261, P1, DOI 10.1007/BF00329433; Sandler C, 2007, INFLAMM RES, V56, P230, DOI 10.1007/s00011-007-6135-1; Santiago B, 2011, CYTOKINE, V53, P184, DOI 10.1016/j.cyto.2010.06.006; Sato T, 2013, OPHTHALMOLOGICA, V230, P76, DOI 10.1159/000351655; SEBAG J, 1989, INVEST OPHTH VIS SCI, V30, P1867; Shanas U, 1998, J NEUROIMMUNOL, V90, P207, DOI 10.1016/S0165-5728(98)00137-4; Shim YJ, 2012, BIOCHEM BIOPH RES CO, V422, P200, DOI 10.1016/j.bbrc.2012.04.162; Shimada H, 2009, EUR J OPHTHALMOL, V19, P1102, DOI 10.1177/112067210901900638; Shinohara Harumichi, 2003, Okajimas Folia Anatomica Japonica, V79, P175, DOI 10.2535/ofaj.79.175; Sommer F, 2009, EXP EYE RES, V88, P995, DOI 10.1016/j.exer.2008.11.026; Song KF, 1999, JPN J PHARMACOL, V79, P131, DOI 10.1254/jjp.79.131; Spaide RF, 2003, RETINA-J RET VIT DIS, V23, P481, DOI 10.1097/00006982-200308000-00006; Stalmans P, 2012, NEW ENGL J MED, V367, P606, DOI 10.1056/NEJMoa1110823; Stanga PE, 2014, AM J OPHTHALMOL, V157, P397, DOI 10.1016/j.ajo.2013.10.008; Sugiyama T, 2006, OPHTHALMIC RES, V38, P201, DOI 10.1159/000093072; Takai S, 1999, CIRCULATION, V100, P654, DOI 10.1161/01.CIR.100.6.654; Tokuda N, 2010, HISTOCHEM CELL BIOL, V134, P445, DOI 10.1007/s00418-010-0754-2; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; VANVLIET E, 1986, J HISTOCHEM CYTOCHEM, V34, P883, DOI 10.1177/34.7.3519751; Worst J, 1978, J Am Intraocul Implant Soc, V4, P7; WORST J G F, 1976, P275; Worst JG., 1995, CISTERNAL ANATOMY VI; WORST JGF, 1977, T OPHTHAL SOC UK, V97, P550; WORST JGF, 1992, DOC OPHTHALMOL, V82, P169, DOI 10.1007/BF00157007; Yamaba H, 2016, EXP DERMATOL, V25, P45, DOI 10.1111/exd.13084; Zhang H, 2010, INVEST OPHTH VIS SCI, V51, P6157, DOI 10.1167/iovs.10-5205	74	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0211438	10.1371/journal.pone.0211438	http://dx.doi.org/10.1371/journal.pone.0211438			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794552	Green Published, gold, Green Submitted			2022-12-27	WOS:000459709100017
J	Buma, B; Thompson, T				Buma, Brian; Thompson, Thomas			Long-term exposure to more frequent disturbances increases baseline carbon in some ecosystems: Mapping and quantifying the disturbance frequency-ecosystem C relationship	PLOS ONE			English	Article							TEMPERATE RAIN-FOREST; WINDTHROW DISTURBANCE; YELLOW-CEDAR; DYNAMICS; LANDSLIDES; DECLINE; CLIMATE; DIVERSITY; IMPACTS; BIOMASS	Disturbance regimes have a major influence on the baseline carbon that characterizes any particular ecosystem. Often regimes result in lower average regional baseline C (compared to those same systems if the disturbance processes were lessened/removed). However, in infrequently disturbed systems the role of disturbance as a "background" process that influences broad-scale, baseline C levels is often neglected. Long-term chronosequences suggest disturbances in these systems may serve to increase regional biomass C stocks by maintaining productivity. However, that inference has not been tested spatially. Here, the large forested system of southeast Alaska, USA, is utilized to 1) estimate baseline regional C stocks, 2) test the fundamental disturbance-ecosystem C relationship, 3) estimate the cumulative impact of disturbances on baseline C. Using 1491 ground points with carbon measurements and a novel way of mapping disturbance regimes, the relationship between total biomass C, disturbance exposure, and climate was analyzed statistically. A spatial model was created to determine regional C and compare different disturbance scenarios. In this infrequently disturbed ecosystem, higher disturbance exposure is correlated with higher biomass C, supporting the hypothesis that disturbances maintain productivity at broad scales. The region is estimated to potentially contain a baseline 1.21-1.52 Pg biomass C (when unmanaged). Removal of wind and landslides from the model resulted in lower net C stocks (-2 to -19% reduction), though the effect was heterogeneous on finer scales. There removal of landslides alone had a larger effect then landslide and wind combined removal. The relationship between higher disturbance exposure and higher biomass within the broad ecosystem (which, on average, has a very low disturbance frequency) suggest that disturbances can serve maintain higher levels of productivity in infrequently disturbed but very C dense ecosystems. Carbon research in other systems, especially those where disturbances are infrequent relative to successional processes, should consider the role of disturbances in maintaining baseline ecosystem productivity.	[Buma, Brian] Univ Colorado, Dept Integrat Biol, Denver, CO 80202 USA; [Thompson, Thomas] US Forest Serv, USDA, Resource Monitoring & Assessment Program, PNW Res Stn, Anchorage, AK USA	University of Colorado System; University of Colorado Denver; United States Department of Agriculture (USDA); United States Forest Service	Buma, B (corresponding author), Univ Colorado, Dept Integrat Biol, Denver, CO 80202 USA.	brian.buma@ucdenver.edu			National Science Foundation [1711974, 1557186]	National Science Foundation(National Science Foundation (NSF))	Support was provided through National Science Foundation grants to BB, #1711974 and #1557186. The sponsors played no role in study design, analysis, preparation, or publishing.	ADAMS PW, 1987, FOREST ECOL MANAG, V18, P93, DOI 10.1016/0378-1127(87)90136-8; Ager AA, 2012, FOREST ECOL MANAG, V267, P271, DOI 10.1016/j.foreco.2011.11.021; Amiro BD, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2010JG001390; [Anonymous], 2017, SCENARIOS NETWORK AR; Baichtal JF, 2008, AAA ANN M POST SESS; BINKLEY D, 1995, CAN J FOREST RES, V25, P621, DOI 10.1139/x95-069; Bisbing SM, 2018, CAN J FOREST RES, V48, P180, DOI 10.1139/cjfr-2017-0178; Bisbing SM, 2016, ECOHYDROLOGY, V9, P354, DOI 10.1002/eco.1640; Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x; Boose ER, 2001, ECOL MONOGR, V71, P27, DOI 10.1890/0012-9615(2001)071[0027:LARIOH]2.0.CO;2; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Buma B, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00058.1; Buma B, 2017, ENVIRON MONIT ASSESS, V189, DOI 10.1007/s10661-017-6364-x; Buma B, 2017, GLOBAL CHANGE BIOL, V23, P2903, DOI 10.1111/gcb.13555; Buma B, 2016, CAN J FOREST RES, V46, P844, DOI 10.1139/cjfr-2016-0041; Buma B, 2015, GLOBAL CHANGE BIOL, V21, P3445, DOI 10.1111/gcb.12915; Buma B, 2015, GEOMORPHOLOGY, V228, P504, DOI 10.1016/j.geomorph.2014.10.014; Dantas VD, 2016, ECOL LETT, V19, P12, DOI 10.1111/ele.12537; Diaz-Yanez O, 2017, FOREST ECOL MANAG, P401; Geertsema M, 2007, GEOMORPHOLOGY, V89, P55, DOI 10.1016/j.geomorph.2006.07.019; Hard JS, 1974, PNWGTR013 USDA FOR S; Harris AS, 1999, PNWGTR244 USDA FS, P63; Hennon PE, 2012, BIOSCIENCE, V62, P147, DOI 10.1525/bio.2012.62.2.8; Hobbie SE, 2002, PLANT SOIL, V242, P163, DOI 10.1023/A:1019670731128; Hoffman KM, 2018, FOREST ECOL MANAG, V424, P11, DOI 10.1016/j.foreco.2018.04.020; Houghton JT, 1997, REVISED 1996 INTERGO; Hudiburg T, 2009, ECOL APPL, V19, P163, DOI 10.1890/07-2006.1; Hudiburg TW, 2017, BIOGEOSCIENCES, V14, P3873, DOI 10.5194/bg-14-3873-2017; Keith H, 2009, P NATL ACAD SCI USA, V106, P11635, DOI 10.1073/pnas.0901970106; KLINGER LF, 1990, HOLARCTIC ECOL, V13, P72; Kobayashi Y, 2017, ENVIRON MANAGE, V59, P807, DOI 10.1007/s00267-017-0820-9; Kramer MG, 2004, ECOLOGY, V85, P2230, DOI 10.1890/02-4098; Kramer MG, 2001, ECOLOGY, V82, P2749, DOI 10.1890/0012-9658(2001)082[2749:ACOLTW]2.0.CO;2; Kranabetter JM, 2016, ECOSYSTEMS, V19, P387, DOI 10.1007/s10021-015-9934-1; Leighty WW, 2006, ECOSYSTEMS, V9, P1051, DOI 10.1007/s10021-005-0028-3; Lutz JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082784; MATSON PA, 1984, ECOLOGY, V65, P1511, DOI 10.2307/1939130; Mclauchlan KK, 2014, BIOSCIENCE, V64, P105, DOI 10.1093/biosci/bit017; MCNICOL G, 2019, ENV RES LETT, V0014; MILES DWR, 1984, SOIL SCI SOC AM J, V48, P667, DOI 10.2136/sssaj1984.03615995004800030040x; Moisen GG, 2002, ECOL MODEL, V157, P209, DOI 10.1016/S0304-3800(02)00197-7; Morris JL, 2015, FOR ECOSYST, V2, DOI 10.1186/s40663-015-0057-0; Paine RT, 1998, ECOSYSTEMS, V1, P535, DOI 10.1007/s100219900049; Parfitt RL, 2005, BIOGEOCHEMISTRY, V75, P305, DOI 10.1007/s10533-004-7790-8; Peltzer DA, 2010, ECOL MONOGR, V80, P509, DOI 10.1890/09-1552.1; Perakis SS, 2015, ECOSYSTEMS, V18, P573, DOI 10.1007/s10021-015-9847-z; Perakis SS, 2011, OECOLOGIA, V167, P793, DOI 10.1007/s00442-011-2016-y; PICKETT STA, 1989, OIKOS, V54, P129, DOI 10.2307/3565258; Rejou-Mechain M, 2014, BIOGEOSCIENCES DISCU, V11, P5711, DOI DOI 10.5194/BGD-11-5711-2014; Rhemtulla JM, 2009, P NATL ACAD SCI USA, V106, P6082, DOI 10.1073/pnas.0810076106; Running SW, 2008, SCIENCE, V321, P652, DOI 10.1126/science.1159607; Sexton JO, 2013, INT J DIGIT EARTH, V6, P427, DOI 10.1080/17538947.2013.786146; Simard M, 2007, ECOL APPL, V17, P1619, DOI 10.1890/06-1795.1; Smithwick EAH, 2002, ECOL APPL, V12, P1303, DOI 10.1890/1051-0761(2002)012[1303:PUBOCS]2.0.CO;2; Swanston DN, 1974, PNWGTR017 USDA FOR S, P17; Thom D, 2016, BIOL REV, V91, P760, DOI 10.1111/brv.12193; Turner M.G., 2015, LANDSCAPE ECOLOGY TH, P175, DOI 10.1007/978-1-4939-2794-4_4; UGOLINI FC, 1979, NATURE, V281, P366, DOI 10.1038/281366a0; USFS, 2018, FOR INV AN DAT DAT D; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; Wardle DA, 2004, SCIENCE, V305, P509, DOI 10.1126/science.1098778; White PS, 2001, PROG BOT, V62, P399; Wilcke W, 2003, CATENA, V53, P79, DOI 10.1016/S0341-8162(02)00196-0; Zhang GY, 2012, J APPL STAT, V39, P151, DOI 10.1080/02664763.2011.578621	64	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212526	10.1371/journal.pone.0212526	http://dx.doi.org/10.1371/journal.pone.0212526			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789951	gold, Green Published			2022-12-27	WOS:000459330800035
J	Emmett, ES; Douiri, A; Marshall, IJ; Wolfe, CDA; Rudd, AG; Bhalla, A				Emmett, Eva S.; Douiri, Abdel; Marshall, Iain J.; Wolfe, Charles D. A.; Rudd, Anthony G.; Bhalla, Ajay			A comparison of trends in stroke care and outcomes between in-hospital and community-onset stroke - The South London Stroke Register	PLOS ONE			English	Article							ISCHEMIC-STROKE; CLASSIFICATION; THROMBOLYSIS; INPATIENT; SURVIVAL; PROFILE	Background Stroke care and outcomes have improved significantly over the past decades. It is unclear if patients who had a stroke in hospital (in-hospital stroke, IHS) experienced similar improvements to those who were admitted with stroke (community-onset stroke, COS). Methods Data from the South London Stroke Register were analysed to estimate trends in processes of care and outcomes across three cohorts (1995-2001, 2002-2008, 2009-2015). Kaplan-Meier survival curves were calculated for each cohort. Associations between patient location at stroke onset, processes of care, and outcomes were investigated using multiple logistic regression and Cox proportional hazards models. Results Of 5,119 patients admitted to hospital and registered between 1995 and 2015, 552(10.8%) had IHS. Brain imaging rates increased from 92.4%(COS) and 78.3%(IHS) in 1995-2001 to 100% for COS and IHS in 2009-2015. Rates of stroke unit admission rose but remained lower for IHS (1995-2001: 32.2%(COS) vs. 12.4%(IHS), 2002-2008: 77.1%(COS) vs. 50.0%(IHS), 2009-2015: 86.3%(COS) vs. 65.4%(IHS)). After adjusting for patient characteristics and case-mix, IHS was independently associated with lower rates of stroke unit admission in each cohort (1995-2001: OR 0.49, 95% CI 0.29-0.82, 2002-2008: 0.29, 0.18-0.45, 2009-2015: 0.22, 0.11-0.43). In 2009-2015, thrombolysis rates were lower for ischaemic IHS (17.8%(COS) vs. 13.8%(IHS)). Despite a decline, in-hospital mortality remained significantly higher after IHS in 2009-2015 (13.7%(COS) vs. 26.7%(IHS)). Five-year mortality rates declined for COS from 58.9%(1995-2001) to 35.2%(2009-2015) and for IHS from 80.8%(1995-2001) to 51.1%(2009-2015). In multivariable analysis, IHS was associated with higher mortality over five years post-stroke in each cohort (1995-2001: HR 1.27, 95% CI 1.03-1.57, 2002-2008: 1.24, 0.99-1.55, 2009-2016: 1.39, 0.95-2.04). Conclusions Despite significant improvements for IHS patients similar to those for COS patients, rates of stroke unit admission and thrombolysis remain lower, and short- and long-term outcomes poorer after IHS. Factors preventing IHS patients from entering evidence-based stroke-specific hospital pathways in a timely fashion need further investigation.	[Emmett, Eva S.; Douiri, Abdel; Marshall, Iain J.; Wolfe, Charles D. A.; Rudd, Anthony G.; Bhalla, Ajay] Kings Coll London, Sch Populat Hlth & Environm Sci, London, England; [Douiri, Abdel; Wolfe, Charles D. A.; Rudd, Anthony G.; Bhalla, Ajay] Guys & St Thomas NHS Fdn Trust, NIHR Comprehens Biomed Res Ctr, London, England; [Douiri, Abdel; Wolfe, Charles D. A.; Rudd, Anthony G.; Bhalla, Ajay] Kings Coll London, London, England; [Wolfe, Charles D. A.; Rudd, Anthony G.] Guys & St Thomas NHS Fdn Trust, NIHR Collaborat Leadership Appl Hlth Res & Care, London, England; [Rudd, Anthony G.; Bhalla, Ajay] Guys & St Thomas NHS Fdn Trust, Dept Ageing & Hlth, London, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust	Emmett, ES (corresponding author), Kings Coll London, Sch Populat Hlth & Environm Sci, London, England.	eva.s.emmett@kcl.ac.uk		Douiri, Abdel/0000-0002-4354-4433	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South London at King's College Hospital NHS Foundation Trust [RP-PG-0407-10184]; National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and Kings College London; Northern and Yorkshire National Health Service (NHS) R&D Program in Cardiovascular Disease and Stroke; Guy's and St Thomas' Hospitals Charitable Foundation; Stanley Thomas Johnson Foundation; Stroke Association; Department of Health (DH); MRC [MR/N015185/1] Funding Source: UKRI	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South London at King's College Hospital NHS Foundation Trust; National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and Kings College London; Northern and Yorkshire National Health Service (NHS) R&D Program in Cardiovascular Disease and Stroke; Guy's and St Thomas' Hospitals Charitable Foundation; Stanley Thomas Johnson Foundation; Stroke Association; Department of Health (DH); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The research was funded/supported by the National Institute for Health Research (NIHR) (RP-PG-0407-10184) Collaboration for Leadership in Applied Health Research and Care South London at King's College Hospital NHS Foundation Trust and by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and Kings College London. The South London Stroke Register has also received funding from the Northern and Yorkshire National Health Service (NHS) R&D Program in Cardiovascular Disease and Stroke, the Guy's and St Thomas' Hospitals Charitable Foundation, the Stanley Thomas Johnson Foundation, the Stroke Association, and Department of Health (DH) funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Addo J, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d744; Alvaro LC, 2008, NEUROLOGIA, V23, P4; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Bhalla A, 2016, STROKE, V47, P2269, DOI 10.1161/STROKEAHA.116.014136; Bhalla A, 2010, J STROKE CEREBROVASC, V19, P357, DOI 10.1016/j.jstrokecerebrovasdis.2009.07.005; Bunch ME, 2012, J STROKE CEREBROVASC, V21, P808, DOI 10.1016/j.jstrokecerebrovasdis.2011.04.012; Collin C, 1988, Int Disabil Stud, V10, P61; Cumbler E, 2015, NEUROHOSPITALIST, V5, P173, DOI 10.1177/1941874415588319; Cumbler E, 2014, STROKE, V45, P231, DOI 10.1161/STROKEAHA.113.003617; Davenport RJ, 1996, BRIT MED J, V312, P1503, DOI 10.1136/bmj.312.7045.1503; Dulli D, 2007, NEUROEPIDEMIOLOGY, V28, P86, DOI 10.1159/000098551; Farooq MU, 2008, CEREBROVASC DIS, V25, P12, DOI 10.1159/000111494; Fulop N, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-5; Garcia-Santibanez R, 2015, J STROKE CEREBROVASC, V24, P1948, DOI 10.1016/j.jstrokecerebrovasdis.2015.05.010; Gilligan AK DH, 2006, CEREBROVASC DIS, V21; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541; Kamal N, 2015, CAN J NEUROL SCI, V42, P168, DOI 10.1017/cjn.2015.20; Kimura K, 2006, EUR NEUROL, V55, P155, DOI 10.1159/000093574; Lakshminarayan K, 2014, STROKE, V45, P2575, DOI 10.1161/STROKEAHA.114.005512; Langhorne P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000197.pub3; Lyden P, 1999, STROKE, V30, P2347, DOI 10.1161/01.STR.30.11.2347; Manawadu D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104758; Moradiya Y, 2013, STROKE, V44, P1903, DOI 10.1161/STROKEAHA.113.000945; Royal College of Physicians, 2017, SENT STROK NAT AUD P; Royal College of Physicians, 2016, NAT CLIN GUID STROK; Saltman AP, 2015, JAMA NEUROL, V72, P749, DOI 10.1001/jamaneurol.2015.0284; Schuermann K, 2016, J NEUROL, V263, P550, DOI 10.1007/s00415-015-8010-2; TEASDALE G, 1974, LANCET, V2, P81; Tilling K, 2001, INT J EPIDEMIOL, V30, P1351, DOI 10.1093/ije/30.6.1351; Tilling K, 2001, INT J EPIDEMIOL, V30; Tsivgoulis G, 2017, EUR J NEUROL, V24, P1493, DOI 10.1111/ene.13450; Vera R, 2011, EUR J NEUROL, V18, P170, DOI 10.1111/j.1468-1331.2010.03105.x; Wardlaw JM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub2; WOLFE CDA, 1991, STROKE, V22, P1242, DOI 10.1161/01.STR.22.10.1242	35	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212396	10.1371/journal.pone.0212396	http://dx.doi.org/10.1371/journal.pone.0212396			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789929	gold, Green Submitted, Green Published			2022-12-27	WOS:000459330800026
J	Micic, D; Gaetano, JN; Nigam, N; Peller, M; Rao, VL; Semrad, C; Stein, AC; Kupfer, SS				Micic, Dejan; Gaetano, John N.; Nigam, Neha; Peller, Matthew; Rao, Vijaya L.; Semrad, Carol; Stein, Adam C.; Kupfer, Sonia S.			Risk factors for small bowel bleeding in an overt gastrointestinal bleeding presentation after negative upper and lower endoscopy	PLOS ONE			English	Article							VIDEO CAPSULE ENDOSCOPY; DIAGNOSIS; MANAGEMENT; ICD-9-CM	Introduction A small bowel source is suspected when evaluation of overt gastrointestinal (GI) bleeding with upper and lower endoscopy is negative. Video capsule endoscopy (VCE) is the recommended next diagnostic test for small bowel bleeding sources. However, clinical or endoscopic predictive factors for small bowel bleeding in the setting of an overt bleeding presentation are unknown. We aimed to define predictive factors for positive VCE among individuals presenting with overt bleeding and a suspected small bowel source. Methods We included consecutive inpatient VCE performed between September 1, 2012 to September 1, 2015 for melena or hematochezia at two tertiary centers. All patients had EGD and colonoscopy performed prior to VCE. Patient demographics, medication use, and endoscopic findings were retrospectively recorded. VCE findings were graded based on the PO-P2 grading system. The primary outcome of interest was a positive (P2) VCE. The secondary outcome of interest was the performance of a therapeutic intervention. Data were analyzed with the Fisher exact test for dichotomous variables and logistic regression. Results Two hundred forty-three VCE were reviewed, and 117 were included in the final analysis. A positive VCE (P2) was identified in 35 (29.9%) cases. In univariate analysis, a positive VCE was inversely associated with presence of diverticula on preceding colonoscopy (OR: 0.44, 95% CI: 0.2-0.99), while identification of blood on terminal ileal examination was associated with a positive VCE (OR: 5.18, 95% CI: 1.51-17.76). In multivariate analysis, only blood identified on terminal ileal examination remained a significant risk factor for positive VCE (OR: 6.13, 95% CI: 1.57-23.81). Blood on terminal ileal examination was also predictive of therapeutic intervention in both univariate (OR: 4.46, 95% CI: 1.3-15.2) and multivariate analysis (OR: 5.04, 95% CI: 1.25-20.32). Conclusion Among patients presenting with overt bleeding but negative upper and lower endoscopy, the presence of blood on examination of the terminal ileum is strongly associated with a small bowel bleeding source as well as with small bowel therapeutic intervention. Presence of diverticula on colonoscopy is inversely associated with a positive VCE and therapeutic intervention in univariate analysis.	[Micic, Dejan; Gaetano, John N.; Nigam, Neha; Rao, Vijaya L.; Semrad, Carol; Kupfer, Sonia S.] Univ Chicago Med, Dept Internal Med, Sect Gastroenterol Hepatol & Nutr, Chicago, IL 60637 USA; [Peller, Matthew] Northwestern Med, Dept Internal Med, Chicago, IL USA; [Stein, Adam C.] Northwestern Med, Dept Internal Med, Div Gastroenterol & Hepatol, Chicago, IL USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Micic, D (corresponding author), Univ Chicago Med, Dept Internal Med, Sect Gastroenterol Hepatol & Nutr, Chicago, IL 60637 USA.	dmicic@medicine.bsd.uchicago.edu	Kupfer, Sonia S/ABD-9416-2021					DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Gerson LB, 2015, AM J GASTROENTEROL, V110, P1265, DOI 10.1038/ajg.2015.246; Gerson LB, 2013, CLIN GASTROENTEROL H, V11, P1224, DOI 10.1016/j.cgh.2013.03.010; Jensen DM, 2000, NEW ENGL J MED, V342, P78, DOI 10.1056/NEJM200001133420202; Katsinelos P, 2016, HIPPOKRATIA, V20, P127; Lepileur L, 2012, CLIN GASTROENTEROL H, V10, P1376, DOI 10.1016/j.cgh.2012.05.024; Longstreth GF, 1997, AM J GASTROENTEROL, V92, P419; Pennazio M, 2004, GASTROENTEROLOGY, V126, P643, DOI 10.1053/j.gastro.2003.11.057; Prakash C, 2003, GASTROINTEST ENDOSC, V58, P330, DOI 10.1067/S0016-5107(03)00003-8; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rastogi A, 2004, GASTROINTEST ENDOSC, V60, P959, DOI 10.1016/S0016-5107(04)02226-6; Robinson CA, 2011, GASTROINTEST ENDOSC, V74, P1061, DOI 10.1016/j.gie.2011.07.019; Saurin JC, 2003, ENDOSCOPY, V35, P576; Scaglione G, 2011, DIGEST DIS SCI, V56, P1188, DOI 10.1007/s10620-010-1419-7; Schlag C, 2015, GASTROINTEST ENDOSC, V81, P889, DOI 10.1016/j.gie.2014.09.035; Singh A, 2013, GASTROINTEST ENDOSC, V77, P761, DOI 10.1016/j.gie.2012.11.041; Strate LL, 2016, AM J GASTROENTEROL, V111, P459, DOI 10.1038/ajg.2016.41; Zuckerman GR, 1999, GASTROINTEST ENDOSC, V49, P228, DOI 10.1016/S0016-5107(99)70491-8	18	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212509	10.1371/journal.pone.0212509	http://dx.doi.org/10.1371/journal.pone.0212509			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785946	Green Published, gold, Green Submitted			2022-12-27	WOS:000459307000066
J	Qiu, Y; Wang, SC; Huang, BX; Zhong, HX; Pan, ZH; Zhuang, QY; Peng, C; Hou, GY; Wang, KC				Qiu, Yuan; Wang, Suchun; Huang, Baoxu; Zhong, Huanxiang; Pan, Zihao; Zhuang, Qingye; Peng, Cheng; Hou, Guangyu; Wang, Kaicheng			Viral infection detection using metagenomics technology in six poultry farms of eastern China	PLOS ONE			English	Article							NEWCASTLE-DISEASE VIRUS; UNIVERSAL PRIMER SET; PHYLOGENETIC ANALYSIS; GENOME SEQUENCE; RNA VIRUSES; IDENTIFICATION; CLEAVAGE; AMPLIFICATION; GENOTYPE	With rapidly increasing animal pathogen surveillance requirements, new technologies are needed for a comprehensive understanding of the roles of pathogens in the occurrence and development of animal diseases. We applied metagenomic technology to avian virus surveillance to study the main viruses infecting six poultry farms in two provinces in eastern China. Cloacal/throat double swabs were collected from 60 birds at each farm according to a random sampling method. The results showed that the method could simultaneously detect major viruses infecting farms, including avian influenza virus, infectious bronchitis virus, Newcastle disease virus, rotavirus G, duck hepatitis B virus, and avian leukemia virus subgroup J in several farms. The test results were consistent with the results from traditional polymerase chain reaction (PCR) or reverse transcription-PCR analyses. Five H9N2 and one H3N8 avian influenza viruses were detected at the farms and were identified as low pathogenic avian influenza viruses according to HA cleavage sites analysis. One detected Newcastle disease virus was classified as Class II genotype I and avirulent type according to F0 cleavage sites analysis. Three avian infectious bronchitis viruses were identified as 4/91, CK/CH/LSC/99I and TC07-2 genotypes by phylogenetic analysis of S1 genes. The viral infection surveillance method using metagenomics technology enables the monitoring of multiple viral infections, which allows the detection of main infectious viruses.	[Qiu, Yuan; Wang, Suchun; Huang, Baoxu; Zhuang, Qingye; Peng, Cheng; Hou, Guangyu; Wang, Kaicheng] China Anim Hlth & Epidemiol Ctr, Qingdao, Shandong, Peoples R China; [Qiu, Yuan] Guangdong Inst Appl Biol Resources, Guangzhou, Guangdong, Peoples R China; [Zhong, Huanxiang; Pan, Zihao] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China	China Animal Health & Epidemiology Center; Guangdong Academy of Sciences; Institute of Zoology, Guangdong Academy of Sciences; Nanjing Agricultural University	Wang, KC (corresponding author), China Anim Hlth & Epidemiol Ctr, Qingdao, Shandong, Peoples R China.	wangkaicheng@cahec.cn			National Key Research and Development Program of China [2017YFC120050]; China Animal Health and Epidemiology Center Innovation Fund [2015IF-0004FF]	National Key Research and Development Program of China; China Animal Health and Epidemiology Center Innovation Fund	This research was funded by the National Key Research and Development Program of China (2017YFC120050), China Animal Health and Epidemiology Center Innovation Fund (2015IF-0004FF).	Belongia EA, 2016, LANCET INFECT DIS, V16, P942, DOI 10.1016/S1473-3099(16)00129-8; Chen GQ, 2018, VIRUS GENES, V54, P536, DOI 10.1007/s11262-018-1568-x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gall A, 2008, J CLIN MICROBIOL, V46, P2561, DOI 10.1128/JCM.00466-08; Ge FF, 2009, J CLIN MICROBIOL, V47, P3294, DOI 10.1128/JCM.00355-09; Gong YN, 2017, ARCH VIROL, V162, P2013, DOI 10.1007/s00705-017-3406-1; Guan HZ, 2016, J NEUROVIROL, V22, P240, DOI 10.1007/s13365-015-0390-7; Haas L, 1997, J VET MED B, V44, P257, DOI 10.1111/j.1439-0450.1997.tb00972.x; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Horiba K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22133-y; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jenkins AO, 2011, VET MICROBIOL, V151, P139, DOI 10.1016/j.vetmic.2011.02.037; Jing Chen, 2008, CHINESE J VIROLIGY, V24; Kim SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074022; Li LL, 2010, VET MICROBIOL, V143, P145, DOI 10.1016/j.vetmic.2009.11.022; Lin SY, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102030; Liu HL, 2008, RES VET SCI, V85, P612, DOI 10.1016/j.rvsc.2008.02.013; Luo HB, 2012, VIRUS GENES, V44, P19, DOI 10.1007/s11262-011-0657-x; Masembe C, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-218; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Merriman B, 2012, ELECTROPHORESIS, V33, P3397, DOI 10.1002/elps.201200424; Panda A, 2004, MICROB PATHOGENESIS, V36, P1, DOI 10.1016/j.micpath.2003.07.003; Parson W, 2013, FORENSIC SCI INT-GEN, V7, P543, DOI 10.1016/j.fsigen.2013.06.003; Qingye Zhuang, 2016, CHINA ANIMAL HLTH IN, V33; Qiu Y, 2017, VIRUS RES, V237, P22, DOI 10.1016/j.virusres.2017.05.003; Roossinck MJ, 2015, PHYTOPATHOLOGY, V105, P716, DOI 10.1094/PHYTO-12-14-0356-RVW; Roussan DA, 2012, POL J VET SCI, V15, P337, DOI 10.2478/v10181-012-0052-0; Steinhauer DA, 1999, VIROLOGY, V258, P1, DOI 10.1006/viro.1999.9716; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Umali DV, 2014, VIRUS GENES, V49, P89, DOI 10.1007/s11262-014-1075-7; Wang CYJ, 2002, J CLIN MICROBIOL, V40, P2584, DOI 10.1128/JCM.40.7.2584-2590.2002; Wang JY, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0351-z; Wang KC, 2017, VIRUS RES, V233, P1, DOI 10.1016/j.virusres.2017.03.007; Wang YH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183923; Wu W, 2015, INFECT GENET EVOL, V32, P34, DOI 10.1016/j.meegid.2015.02.016; Xu C, 2018, POULTRY SCI, V97, P3023, DOI 10.3382/ps/pey154; Xu CP, 2007, VET MICROBIOL, V122, P61, DOI 10.1016/j.vetmic.2007.01.006; Xu LW, 2018, INFECT GENET EVOL, V66, P82, DOI 10.1016/j.meegid.2018.09.018; Zelin Wang, 2010, CHINESE J VET SCI, V30; Zeng XW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094980; Zengqi Yang, 2015, ACTA AGR BOREALI OCC, V24; Zhao G, 2013, AVIAN DIS, V57, P155, DOI 10.1637/10293-062812-Case.1; Zhaoqiang Xu, 2011, CHINA ANIMAL HLTH, V8; Zhu J, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0211-2; Zou NL, 2010, VIRUS GENES, V41, P202, DOI 10.1007/s11262-010-0500-9; Zou XH, 2017, SCI CHINA LIFE SCI, V60, P279, DOI 10.1007/s11427-016-0244-8	47	4	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211553	10.1371/journal.pone.0211553	http://dx.doi.org/10.1371/journal.pone.0211553			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785912	Green Published, Green Submitted, gold			2022-12-27	WOS:000459307000031
J	Habermann, E; San Martin, JAB; Contin, DR; Bossan, VP; Barboza, A; Braga, MR; Groppo, M; Martinez, CA				Habermann, Eduardo; Barrera San Martin, Juca Abramo; Contin, Daniele Ribeiro; Bossan, Vitor Potenza; Barboza, Anelize; Braga, Marcia Regina; Groppo, Milton; Martinez, Carlos Alberto			Increasing atmospheric CO2 and canopy temperature induces anatomical and physiological changes in leaves of the C-4 forage species Panicum maximum	PLOS ONE			English	Article							INFRARED HEATER ARRAYS; WATER-USE EFFICIENCY; ELEVATED CO2; STOMATAL CONDUCTANCE; GENETIC MANIPULATION; PLANT-GROWTH; PHOTOSYNTHESIS; EVOLUTION; RESPONSES; CARBON	Changes in leaf anatomy and ultrastructure are associated with physiological performance in the context of plant adaptations to climate change. In this study, we investigated the isolated and combined effects of elevated atmospheric CO2 concentration ([CO2]) up to 600 mu mol mol(-1) (eC) and elevated temperature (eT) to 2 degrees C more than the ambient canopy temperature on the ultrastructure, leaf anatomy, and physiology of Panicum maximum Jacq. grown under field conditions using combined free-air carbon dioxide enrichment (FACE) and temperature free-air controlled enhancement (T-FACE) systems. Plants grown under eC showed reduced stomatal density, stomatal index, stomatal conductance (g(s)), and leaf transpiration rate (E), increased soil-water content (SWC) conservation and adaxial epidermis thickness were also observed. The net photosynthesis rate (A) and intrinsic water-use efficiency (iWUE) were enhanced by 25% and 71%, respectively, with a concomitant increase in the size of starch grains in bundle sheath cells. Under air warming, we observed an increase in the thickness of the adaxial cuticle and a decrease in the leaf thickness, size of vascular bundles and bulliform cells, and starch content. Under eCeT, air warming offset the eC effects on SWC and E, and no interactions between [CO2] and temperature for leaf anatomy were observed. Elevated [CO2] exerted more effects on external characteristics, such as the epidermis anatomy and leaf gas exchange, while air warming affected mainly the leaf structure. We conclude that differential anatomical and physiological adjustments contributed to the acclimation of P. maximum growing under elevated [CO2] and air warming, improving the leaf biomass production under these conditions.	[Habermann, Eduardo; Barrera San Martin, Juca Abramo; Contin, Daniele Ribeiro; Bossan, Vitor Potenza; Barboza, Anelize; Groppo, Milton; Martinez, Carlos Alberto] Univ Sao Paulo, FFCLRP, Dept Biol, Ribeirao Preto, SP, Brazil; [Braga, Marcia Regina] Inst Bot, Dept Plant Physiol & Biochem, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Instituto de Botanica - Sao Paulo	Martinez, CA (corresponding author), Univ Sao Paulo, FFCLRP, Dept Biol, Ribeirao Preto, SP, Brazil.	carlosamh@ffclrp.usp.br	Habermann, Eduardo/E-1222-2016; Groppo, Milton/G-2175-2012; Martinez, Carlos/B-8222-2011	Habermann, Eduardo/0000-0003-3371-7684; Groppo, Milton/0000-0003-2932-7798; Martinez, Carlos/0000-0002-0246-9481; San Martin, Juca/0000-0001-8827-4118	CNPq/ANA/MCTI [446357/2015-4]; Sao Paulo Research Foundation -FAPESP [2008/58075-8]; FAPESP [14/26821-3]	CNPq/ANA/MCTI; Sao Paulo Research Foundation -FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the CNPq/ANA/MCTI (Grant 446357/2015-4) to C.A.M. and the Sao Paulo Research Foundation -FAPESP (Grant 2008/58075-8) to C.A.M., and FAPESP Grant (14/26821-3) to E.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdElgawad H, 2015, PLANT SCI, V231, P1, DOI 10.1016/j.plantsci.2014.11.001; Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Ainsworth EA, 2007, PLANT CELL ENVIRON, V30, P258, DOI 10.1111/j.1365-3040.2007.01641.x; Asner GP, 2004, ANNU REV ENV RESOUR, V29, P261, DOI 10.1146/annurev.energy.29.062403.102142; Bernacchi CJ, 2007, PLANT PHYSIOL, V143, P134, DOI 10.1104/pp.106.089557; BOWES G, 1993, ANNU REV PLANT PHYS, V44, P309, DOI 10.1146/annurev.pp.44.060193.001521; Prado CHBD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149620; Carnevalli RA, 2006, TROP GRASSLANDS, V40, P165; Chandra S, 2004, J AGRON CROP SCI, V190, P13, DOI 10.1046/j.0931-2250.2003.00064.x; Chartzoulakis K, 2002, SCI HORTIC-AMSTERDAM, V95, P39, DOI 10.1016/S0304-4238(02)00016-X; Correa LDA, 2003, MANEJO UTILIZACAO PL; da Silva SC, 2015, AGRICULTURE-BASEL, V5, P598, DOI 10.3390/agriculture5030598; De Souza AP, 2008, PLANT CELL ENVIRON, V31, P1116, DOI 10.1111/j.1365-3040.2008.01822.x; DELUCIA EH, 1984, CAN J BOT, V62, P2423, DOI 10.1139/b84-331; DELUCIA EH, 1985, PHOTOSYNTH RES, V7, P175, DOI 10.1007/BF00037008; Doheny-Adams T, 2012, PHILOS T R SOC B, V367, P547, DOI 10.1098/rstb.2011.0272; Driscoll SP, 2006, J EXP BOT, V57, P381, DOI 10.1093/jxb/erj030; EMBRAPA, 2014, REL AV IMP TECN GER, P1; Engineer CB, 2014, NATURE, V513, P246, DOI 10.1038/nature13452; Flugge UI, 2000, TRENDS PLANT SCI, V5, P135, DOI 10.1016/S1360-1385(00)01578-8; FRANKLIN GL, 1945, NATURE, V155, P51, DOI 10.1038/155051a0; Franks PJ, 2015, NEW PHYTOL, V207, P188, DOI 10.1111/nph.13347; Fu G, 2015, J PLANT GROWTH REGUL, V34, P57, DOI 10.1007/s00344-014-9442-0; GRABBER JH, 1992, GRASS FORAGE SCI, V47, P400, DOI 10.1111/j.1365-2494.1992.tb02286.x; Gray JE, 2000, NATURE, V408, P713, DOI 10.1038/35047071; Guan M, 2016, INT J PHYTOREMEDIAT, V18, P368, DOI 10.1080/15226514.2015.1109591; Han M, 2007, FRONT BIOL BEIJING, V2, P333, DOI DOI 10.1007/; Han X, 2013, J EXP BOT, V64, P4589, DOI 10.1093/jxb/ert262; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; IPCC, 2014, CONTRIBUTION WORKING; Johansen DA, 1941, PLANT MICROTECHNIQUE; KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137; Kim HK, 2014, J EXP BOT, V65, P1895, DOI 10.1093/jxb/eru075; Kimball BA, 2008, GLOBAL CHANGE BIOL, V14, P309, DOI 10.1111/j.1365-2486.2007.01486.x; Kimball BA, 2012, THEOR APPL CLIMATOL, V108, P247, DOI 10.1007/s00704-011-0518-5; Kirkham MB, 2011, ELEVATED CARBON DIOX; Kosma DK, 2009, PLANT PHYSIOL, V151, P1918, DOI 10.1104/pp.109.141911; Leakey ADB, 2009, J EXP BOT, V60, P2859, DOI 10.1093/jxb/erp096; Marin FR, 2013, CLIMATIC CHANGE, V117, P227, DOI 10.1007/s10584-012-0561-y; Martinez CA, 2014, ENVIRON EXP BOT, V102, P58, DOI 10.1016/j.envexpbot.2014.02.001; Masle J, 2000, PLANT PHYSIOL, V122, P1399, DOI 10.1104/pp.122.4.1399; Matesanz S, 2010, ANN NY ACAD SCI, V1206, P35, DOI 10.1111/j.1749-6632.2010.05704.x; Metcalfe CR, 1960, ANATOMY MONOCOTYLEDO; Miglietta F, 1999, ENVIRON MONIT ASSESS, V66, P107; Morgan JA, 2011, NATURE, V476, P202, DOI 10.1038/nature10274; OBRIEN TP, 1964, PROTOPLASMA, V59, P368, DOI 10.1007/BF01248568; OERTLI JJ, 1990, ACTA OECOL, V11, P281; Pezzopane JRM, 2017, GRASS FORAGE SCI, V72, P104, DOI 10.1111/gfs.12229; R Development Core Team, 2009, R LANG ENV STAT COMP; Ranasinghe S, 1996, J EXP BOT, V47, P349, DOI 10.1093/jxb/47.3.349; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Sack L, 2013, NEW PHYTOL, V198, P983, DOI 10.1111/nph.12253; Sage RF, 2007, PLANT CELL ENVIRON, V30, P1086, DOI 10.1111/j.1365-3040.2007.01682.x; Samuels L, 2008, ANNU REV PLANT BIOL, V59, P683, DOI 10.1146/annurev.arplant.59.103006.093219; Smith RA, 2012, FUNCT PLANT BIOL, V39, P285, DOI 10.1071/FP11238; Terashima I, 2011, PLANT PHYSIOL, V155, P108, DOI 10.1104/pp.110.165472; Thalmann M, 2017, NEW PHYTOL, V214, P943, DOI 10.1111/nph.14491; Tipping C, 1999, INT J PLANT SCI, V160, P1063, DOI 10.1086/314201; Amaral Lourdes Isabel Velho do, 2007, Hoehnea, V34, P425; Walz H., 2009, IMAGING PAM M SERIES; Wand SJE, 1999, GLOB CHANGE BIOL, V5, P723, DOI 10.1046/j.1365-2486.1999.00265.x; WATSON ML, 1958, J BIOPHYS BIOCHEM CY, V4, P475, DOI 10.1083/jcb.4.4.475; Webb NP, 2012, CLIMATIC CHANGE, V112, P925, DOI 10.1007/s10584-011-0236-0; Werner, 1997, RECOMENDACOES ADUBAC; Wullschleger SD, 2002, PLANT CELL ENVIRON, V25, P319, DOI 10.1046/j.1365-3040.2002.00796.x; Xu CY, 2012, J EXP BOT, V63, P5829, DOI 10.1093/jxb/ers231; Xu ZZ, 2013, J PLANT GROWTH REGUL, V32, P692, DOI 10.1007/s00344-013-9337-5; Yamane K, 2008, PLANT PROD SCI, V11, P139, DOI 10.1626/pps.11.139; Zeeman SC, 2010, ANNU REV PLANT BIOL, V61, P209, DOI 10.1146/annurev-arplant-042809-112301; Zhang FF, 2012, SCI WORLD J, P1, DOI 10.1100/2012/601263; Zhang JJ, 2015, PLANT BIOLOGY, V17, P437, DOI 10.1111/plb.12255; Zheng YP, 2013, ACTA PHYSIOL PLANT, V35, P2891, DOI 10.1007/s11738-013-1320-z	73	31	32	7	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212506	10.1371/journal.pone.0212506	http://dx.doi.org/10.1371/journal.pone.0212506			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779815	gold, Green Published			2022-12-27	WOS:000459062900060
J	Hewitt, L; Stanley, RM; Cliff, D; Okely, AD				Hewitt, Lyndel; Stanley, Rebecca M.; Cliff, Dylan; Okely, Anthony D.			Objective measurement of tummy time in infants (0-6 months): A validation study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SLEEP	The 2017 Australian and Canadian 24-hour movement guidelines recommend infants receive 30 minutes of tummy time daily. Currently, there are no validated objective measurement tools or devices to assess tummy time. The purpose of this study was to: 1) test the practicality of using devices on infants as an objective measure of tummy time, and 2) test the accuracy of developed algorithms and cut-points for predicting prone posture. Thirty-two healthy infants aged 4 to 25 weeks completed a protocol of 12 positions. Infants were placed in each position for 3 minutes while wearing a MonBaby (chest), GENEActiv (right hip) and two ActiGraphs (right hip and ankle). Direct observation was the criterion measure. The accuracy of the algorithms or cut-points to predict prone on floor, non-prone and prone supported positions were analyzed. Parents also completed a practicality questionnaire. Algorithms and cut-points to classify posture using devices from MonBaby, GENEActiv and ActiGraph (hip and ankle) were 79%, 95%, 90% and 88% accurate at defining tummy time and 100%, 98%, 100% and 96% accurate at defining non-prone positions, respectively. GENEActiv had the smallest mean difference and limits of agreement (-8.4s, limits of agreement [LoA]: -78.2 to 61.3s) for the prone on floor positions and ActiGraph Hip had the smallest mean difference and LoA for the non-prone positions (-0.2s, LoA: -1.2 to 0.9s). The majority of parents agreed all devices were practical and feasible to use with MonBaby being the preferred device. The evaluated algorithms and cut-points for GENEActiv and ActiGraph (hip) are of acceptable accuracy to objectively measure tummy time (time spent prone on floor). Accurate measurement of infant positioning practices will be important in the observation of 24-hour movement guidelines in the early years.	[Hewitt, Lyndel; Stanley, Rebecca M.; Cliff, Dylan; Okely, Anthony D.] Univ Wollongong, Fac Social Sci, Early Start, Northfields Ave, Wollongong, NSW, Australia; [Hewitt, Lyndel; Stanley, Rebecca M.; Cliff, Dylan; Okely, Anthony D.] Univ Wollongong, Illawarra Hlth & Med Res Inst, Northfields Ave, Wollongong, NSW, Australia	University of Wollongong; University of Wollongong	Hewitt, L (corresponding author), Univ Wollongong, Fac Social Sci, Early Start, Northfields Ave, Wollongong, NSW, Australia.	llh966@uowmail.edu.au	Okely, Anthony D/R-1679-2018; Stanley, Rebecca M/P-6720-2016	Okely, Anthony D/0000-0002-1626-8170; Stanley, Rebecca M/0000-0001-7007-3406	Australian Government Research Training Program Scholarship	Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science)	This research has been conducted with the support of the Australian Government Research Training Program Scholarship which was awarded to LH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, AUSTR 24 HOUR MOVEME; Carson V, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4860-0; Clark J.E., 2017, KINESIOLOGY REV, V6, P232, DOI [10.1123/kr.2017-0020, DOI 10.1123/KR.2017-0020]; Cliff DP, 2009, J SCI MED SPORT, V12, P557, DOI 10.1016/j.jsams.2008.10.008; De Bock F, 2017, ARCH DIS CHILD, V102, P535, DOI 10.1136/archdischild-2016-312018; Dudek-Shriber Linda, 2007, Pediatr Phys Ther, V19, P48, DOI 10.1097/01.pep.0000234963.72945.b1; Glasgow TS, 2007, J CRANIOFAC SURG, V18, P85, DOI 10.1097/01.scs.0000244919.69264.bf; Gorber S.C., 2012, HLTH REP, V23, P1; Gross RS, 2017, OBESITY, V25, P920, DOI 10.1002/oby.21779; Habal MB, 2004, J CRANIOFAC SURG, V15, P835, DOI 10.1097/00001665-200409000-00025; Hager ER, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3569-9; Hesketh KD, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4856-9; Hesketh KD, 2015, EARLY CHILD DEV CARE, V185, P883, DOI 10.1080/03004430.2014.963066; Hewitt L, 2018, INFANT BEHAV DEV, V50, P88, DOI 10.1016/j.infbeh.2017.11.008; Hewitt L, 2017, INFANT BEHAV DEV, V49, P310, DOI 10.1016/j.infbeh.2017.10.001; Hutchison BL, 2009, ACTA PAEDIATR, V98, P1494, DOI 10.1111/j.1651-2227.2009.01356.x; Hutchison BL, 2004, PEDIATRICS, V114, P970, DOI 10.1542/peds.2003-0668-F; Janssen X, 2015, MEAS PHYS EDUC EXERC, V19, P116, DOI 10.1080/1091367X.2015.1045908; Majnemer A, 2005, DEV MED CHILD NEUROL, V47, P370, DOI 10.1017/S0012162205000733; Meltzer LJ, 2012, SLEEP MED REV, V16, P463, DOI 10.1016/j.smrv.2011.10.002; Monson Renee M, 2003, Pediatr Phys Ther, V15, P196, DOI 10.1097/01.PEP.0000096380.15342.51; Rogers GF, 2011, J CRANIOFAC SURG, V22, P9, DOI 10.1097/SCS.0b013e3181f6c313; Rowlands AV, 2016, MED SCI SPORT EXER, V48, P748, DOI 10.1249/MSS.0000000000000813; Rowlands AV, 2014, MED SCI SPORT EXER, V46, P2308, DOI 10.1249/MSS.0000000000000365; Russell Dorothy C, 2009, S. Afr. j. occup. ther., V39, P11; Salls JS, 2002, AM J OCCUP THER, V56, P577, DOI 10.5014/ajot.56.5.577; Seca group, MED SCAL MEAS SYST; Tremblay MS, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4859-6; Trost SG, 2012, OBESITY, V20, P2317, DOI 10.1038/oby.2011.364; Cauwenberghe E, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-67; van Vlimmeren LA, 2007, PEDIATRICS, V119, pE408, DOI 10.1542/peds.2006-2012	31	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0210977	10.1371/journal.pone.0210977	http://dx.doi.org/10.1371/journal.pone.0210977			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811395	Green Submitted, Green Published, gold			2022-12-27	WOS:000459806400011
J	Zhao, C; Chronaki, G; Schiessl, I; Wan, MW; Abel, KM				Zhao, Chen; Chronaki, Georgia; Schiessl, Ingo; Wan, Ming Wai; Abel, Kathryn M.			Is infant neural sensitivity to vocal emotion associated with mother-infant relational experience?	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; MATERNAL SENSITIVITY; NONLINGUISTIC VOCALIZATIONS; BRAIN RESPONSES; NEGATIVITY BIAS; VOICE; EXPRESSIONS; DISCRIMINATION; LANGUAGE; PROSODY	An early understanding of others' vocal emotions provides infants with a distinct advantage for eliciting appropriate care from caregivers and for navigating their social world. Consistent with this notion, an emerging literature suggests that a temporal cortical response to the prosody of emotional speech is observable in the first year of life. Furthermore, neural specialisation to vocal emotion in infancy may vary according to early experience. Neural sensitivity to emotional non-speech vocalisations was investigated in 29 six-month-old infants using near-infrared spectroscopy (fNIRS). Both angry and happy vocalisations evoked increased activation in the temporal cortices (relative to neutral and angry vocalisations respectively), and the strength of the angry minus neutral effect was positively associated with the degree of directiveness in the mothers' play interactions with their infant. This first fNIRS study of infant vocal emotion processing implicates bilateral temporal mechanisms similar to those found in adults and suggests that infants who experience more directive caregiving or social play may more strongly or preferentially process vocal anger by six months of age.	[Zhao, Chen; Wan, Ming Wai; Abel, Kathryn M.] Univ Manchester, Ctr Womens Mental Hlth, Fac Biol Med & Hlth, Manchester, Lancs, England; [Chronaki, Georgia] Univ Cent Lancashire, Sch Psychol, DCN Lab, Preston, Lancs, England; [Chronaki, Georgia; Schiessl, Ingo] Univ Manchester, Fac Biol Med & Hlth, Div Neurosci & Expt Psychol, Manchester, Lancs, England; [Chronaki, Georgia] Univ Southampton, Dev Brain Behav Lab, Psychol, Southampton, Hants, England; [Abel, Kathryn M.] Greater Manchester Mental Hlth NHS Fdn Trust, Manchester, Lancs, England	University of Manchester; University of Central Lancashire; University of Manchester; University of Southampton	Zhao, C (corresponding author), Univ Manchester, Ctr Womens Mental Hlth, Fac Biol Med & Hlth, Manchester, Lancs, England.	chenzhao510@gmail.com	Wan, Ming Wai/AAG-4688-2019	Wan, Ming Wai/0000-0002-5353-786X; Zhao, Chen/0000-0001-8228-4139; Schiessl, Ingo/0000-0001-9599-6194	China Scholarship Council [201406990026]; European Research Council Consolidator award	China Scholarship Council(China Scholarship Council); European Research Council Consolidator award(European Research Council (ERC))	Chen Zhao was supported by the program of China Scholarship Council (201406990026) while carrying out the study. Professor Kathryn Abel is an NIHR senior Investigator and is funded by a European Research Council Consolidator award.	Alba-Ferrara L, 2012, BRAIN STIMUL, V5, P347, DOI 10.1016/j.brs.2011.06.004; Alba-Ferrara L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028701; Baumwell L, 1997, INFANT BEHAV DEV, V20, P247, DOI 10.1016/S0163-6383(97)90026-6; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergelson E, 2015, LANG LEARN DEV, V11, P369, DOI 10.1080/15475441.2014.979387; Bergelson E, 2012, P NATL ACAD SCI USA, V109, P3253, DOI 10.1073/pnas.1113380109; Bernier A, 2016, CHILD DEV, V87, P1159, DOI 10.1111/cdev.12518; Blasi A, 2015, CORTEX, V71, P122, DOI 10.1016/j.cortex.2015.06.015; Blasi A, 2011, CURR BIOL, V21, P1220, DOI 10.1016/j.cub.2011.06.009; Boersma P., 2001, GLOT INT, V5:9/10, P341; Bowlby J, 1969, ATTACHMENT LOSS SEPA; Brigadoi S, 2014, NEUROIMAGE, V85, P181, DOI 10.1016/j.neuroimage.2013.04.082; Brooker RJ, 2017, PSYCHOPHYSIOLOGY, V54, P1100, DOI 10.1111/psyp.12866; CARON AJ, 1988, CHILD DEV, V59, P604, DOI 10.1111/j.1467-8624.1988.tb03219.x; Chronaki G, 2015, BRIT J DEV PSYCHOL, V33, P218, DOI 10.1111/bjdp.12075; Chronaki G, 2015, J CHILD PSYCHOL PSYC, V56, P477, DOI 10.1111/jcpp.12312; Chronaki G, 2012, DEV COGN NEUROS-NETH, V2, P268, DOI 10.1016/j.dcn.2011.11.007; Cohen D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061402; COHEN J, 1973, EDUC PSYCHOL MEAS, V33, P107, DOI 10.1177/001316447303300111; Cooper RJ, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00147; Dehaene-Lambertz G, 2002, SCIENCE, V298, P2013, DOI 10.1126/science.1077066; Dykas MJ, 2011, PSYCHOL BULL, V137, P19, DOI 10.1037/a0021367; Elsabbagh M, 2007, PROG BRAIN RES, V164, P355, DOI 10.1016/S0079-6123(07)64020-5; Ethofer T, 2006, NEUROREPORT, V17, P249, DOI 10.1097/01.wnr.0000199466.32036.5d; Ethofer T, 2012, CEREB CORTEX, V22, P191, DOI 10.1093/cercor/bhr113; Everdell NL, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.2038567; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FERNALD A, 1993, CHILD DEV, V64, P657, DOI 10.2307/1131209; Field A., 2012, DISCOVERING STAT USI; Flom R, 2007, DEV PSYCHOL, V43, P238, DOI 10.1037/0012-1649.43.1.238; Fox SE, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00089; Fruehholz S, 2013, NEUROSCI BIOBEHAV R, V37, P2847, DOI 10.1016/j.neubiorev.2013.10.007; Fruhholz S, 2012, CEREB CORTEX, V22, P1107, DOI 10.1093/cercor/bhr184; Fukui Y, 2003, APPL OPTICS, V42, P2881, DOI 10.1364/AO.42.002881; Gervain J, 2011, DEV COGN NEUROS-NETH, V1, P22, DOI 10.1016/j.dcn.2010.07.004; Grandjean D, 2005, NAT NEUROSCI, V8, P145, DOI 10.1038/nn1392; Grossmann T, 2005, NEUROREPORT, V16, P1825, DOI 10.1097/01.wnr.0000185964.34336.b1; Grossmann T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068377; Grossmann T, 2010, NEURON, V65, P852, DOI 10.1016/j.neuron.2010.03.001; Guzell JR, 2004, CHILD DEV, V75, P134, DOI 10.1111/j.1467-8624.2004.00659.x; Huppert TJ, 2009, APPL OPTICS, V48, pD280, DOI 10.1364/AO.48.00D280; Ito TA, 1998, J PERS SOC PSYCHOL, V75, P887, DOI 10.1037/0022-3514.75.4.887; KENNEDY JJ, 1970, EDUC PSYCHOL MEAS, V30, P885, DOI 10.1177/001316447003000409; Kisilevsky BS, 2003, PSYCHOL SCI, V14, P220, DOI 10.1111/1467-9280.02435; Lausen A, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00882; Leigh P, 2011, PERCEPT MOTOR SKILL, V113, P281, DOI 10.2466/10.17.21.28.PMS.113.4.281-299; Lloyd-Fox S, 2012, SOC NEUROSCI-UK, V7, P317, DOI 10.1080/17470919.2011.614696; Lloyd-Fox S, 2010, NEUROSCI BIOBEHAV R, V34, P269, DOI 10.1016/j.neubiorev.2009.07.008; Lloyd-Fox S, 2017, DEV COGN NEUROS NETH; Lohaus A, 2004, INFANT CHILD DEV, V13, P235, DOI 10.1002/icd.351; Lohaus A, 2001, PARENT-SCI PRACT, V1, P267, DOI 10.1207/S15327922PAR0104_1; Maurage P, 2007, NEUROPSYCHOL TRENDS, P63, DOI 10.7358/neur-2007-002-maur; McClure EB, 2000, PSYCHOL BULL, V126, P424, DOI 10.1037/0033-2909.126.3.424; Missana M, 2017, DEV COGN NEUROS-NETH, V26, P39, DOI 10.1016/j.dcn.2017.04.003; Missana M, 2015, DEV PSYCHOL, V51, P151, DOI 10.1037/a0038469; Mumme DL, 1996, CHILD DEV, V67, P3219, DOI 10.1111/j.1467-8624.1996.tb01910.x; Murphy K.R., 2014, STAT POWER ANAL SIMP, V4th ed., DOI 10.4324/9781315773155; Peeters G., 1990, EUROPEAN REV SOCIAL, V1, P33, DOI [10.1080/14792779108401856, DOI 10.1080/14792779108401856]; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Pell MD, 2015, BIOL PSYCHOL, V111, P14, DOI 10.1016/j.biopsycho.2015.08.008; Pena M, 2003, P NATL ACAD SCI USA, V100, P11702, DOI 10.1073/pnas.1934290100; Pinti P., 2018, ANN NEW YORK ACAD SC; Ross ED, 2011, NEUROPSYCHOLOGIA, V49, P866, DOI 10.1016/j.neuropsychologia.2010.12.024; Schirmer A, 2006, TRENDS COGN SCI, V10, P24, DOI 10.1016/j.tics.2005.11.009; Scholkmann F, 2010, PHYSIOL MEAS, V31, P649, DOI 10.1088/0967-3334/31/5/004; Schupp HT, 2004, EMOTION, V4, P189, DOI 10.1037/1528-3542.4.2.189; Singh L, 2002, INFANCY, V3, P365, DOI 10.1207/S15327078IN0303_5; Stein A, 2008, CHILD CARE HLTH DEV, V34, P603, DOI 10.1111/j.1365-2214.2008.00837.x; STIFTER CA, 1987, J NONVERBAL BEHAV, V11, P43, DOI 10.1007/BF00999606; Striano T, 2000, INFANCY, V1, P253, DOI 10.1207/S15327078IN0102_7; Swingler MM, 2017, DEV PSYCHOL, V53, P13, DOI 10.1037/dev0000187; Taga G, 2007, NEUROIMAGE, V36, P1246, DOI 10.1016/j.neuroimage.2007.04.037; Trevarthen C., 2017, FUNCTION EMOTIONS EA, P48; TRONICK EZ, 1989, AM PSYCHOL, V44, P112, DOI 10.1037/0003-066X.44.2.112; Vaish A, 2004, DEVELOPMENTAL SCI, V7, P261, DOI 10.1111/j.1467-7687.2004.00344.x; Vaish A, 2008, PSYCHOL BULL, V134, P383, DOI 10.1037/0033-2909.134.3.383; Villringer A, 1997, TRENDS NEUROSCI, V20, P435, DOI 10.1016/S0166-2236(97)01132-6; Walker-Andrews A S, 1998, Pediatrics, V102, P1268; WALKERANDREWS AS, 1983, INFANT BEHAV DEV, V6, P491, DOI 10.1016/S0163-6383(83)90331-4; Wan MW, 2017, INT J BEHAV DEV, V41, P542, DOI 10.1177/0165025416631835; Wan MW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088436; Wan MW, 2012, RES DEV DISABIL, V33, P924, DOI 10.1016/j.ridd.2011.12.011; Wan MW, 2015, MANCHESTER ASS UNPUB; Witteman J, 2012, NEUROPSYCHOLOGIA, V50, P2752, DOI 10.1016/j.neuropsychologia.2012.07.026; Zhang DD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18683-2; Zhang DD, 2017, NEUROSCI LETT, V658, P62, DOI 10.1016/j.neulet.2017.08.047	87	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0212205	10.1371/journal.pone.0212205	http://dx.doi.org/10.1371/journal.pone.0212205			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM9LQ	30811431	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000459806400059
J	Billong, SC; Nguefack-Tsague, G; Fokam, J; Emmanuel, F; Isac, S; Fodjo, RAT; Ngoufack, MN; Kwedi, S; Moukam, LV; Tchetmi, T; Tapka, VK; Ndjolo, A; Shubber, Z; Cheikh, N; Blanchard, J; Elat, JBN; Mziray, EN				Billong, Serge C.; Nguefack-Tsague, Georges; Fokam, Joseph; Emmanuel, Faran; Isac, Shajy; Fodjo, Raoul A. T.; Ngoufack, Marie Nicole; Kwedi, Sylvie; Moukam, Laure Vartan; Tchetmi, Thomas; Tapka, Vincent K.; Ndjolo, Alexis; Shubber, Zara; Cheikh, Nejma; Blanchard, James; Elat, Jean-Bosco N.; Mziray, Elizabeth N.			Mapping and size estimates of female sex workers in Cameroon: Toward informed policy for design and implementation in the national HIV program	PLOS ONE			English	Article							POPULATIONS; HIDDEN	Background Due to high HIV prevalence among Female Sex Workers (FSWs) in Cameroon (36.5%), this population is especially vulnerable to HIV acquisition and transmission nationwide. Though being prioritized in the national HIV response, it would be relevant to generate statistics on the number of FSWs in order to guide HIV interventions among FSWs. Our objective was to estimate the size of FSWs within hotspots of Cameroon. Methods A cross-sectional study was conducted from September-November 2015 in selected cities in Cameroon: Bafoussam, Bamenda, Bertoua, Buea, Douala, Kribi, Limbe, and Yaounde. A programmatic mapping was used, consisting of interviews with secondary key informants (KI) to identify hotspots of FSWs and their respective estimated numbers. Validation of size estimates was done by interviews with FSW at each hotspot. Size estimations in the councils mapped were extended to others not mapped using a Poisson regression model. Results A total of 2,194 hotspots were identified: Douala (760), Yaounde (622), Bamenda (263), Bafoussam (194), Kribi (154), Bertoua (140), Limbe (35), and Buea (26). The estimated total number (range) of FSWs was 21,124 (16,079-26,170), distributed per city as follows: Douala 7,557 (5,550-9,364), Yaounde ' 6,596 (4,712-8,480), Bafoussam 2,458 (1,994-2,923), Bamenda 1,975 (1,605-2,345), Kribi 1,121 (832-1,408), Bertoua 1,044 (8911,198), Buea 225 (185-266), and Limbe ' 148 (110-148). The variability of estimates among cities was also observed within the councils of each city. The national predicted estimate of FSW population was 112,580 (103,436-121,723), covering all councils of Cameroon. An estimate of 1.91% (112,580/5,881,526; 0.47%-3.36%) adult female population in Cameroon could be sex workers. Conclusion There are considerable numbers of FSW in major cities in Cameroon. There is a need to prioritize interventions for HIV prevention toward this population in order to limit the burden of HIV sexual transmission nationwide.	[Billong, Serge C.; Fodjo, Raoul A. T.; Elat, Jean-Bosco N.] Natl AIDS Control Comm, Cent Tech Grp, Yaounde, Cameroon; [Billong, Serge C.; Nguefack-Tsague, Georges; Fokam, Joseph; Kwedi, Sylvie; Ndjolo, Alexis] Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon; [Billong, Serge C.; Fokam, Joseph; Elat, Jean-Bosco N.] Minist Publ Hlth, Natl HIV Drug Resistance Working Grp, Yaounde, Cameroon; [Billong, Serge C.; Nguefack-Tsague, Georges] Minist Publ Hlth, Natl Key Populat Working Grp, Yaounde, Cameroon; [Fokam, Joseph; Ngoufack, Marie Nicole; Ndjolo, Alexis] Chantal BIYA Int Reference Ctr Res HIV AIDS Preve, Yaounde, Cameroon; [Emmanuel, Faran; Isac, Shajy; Blanchard, James] Univ Manitoba, Winnipeg, MB, Canada; [Ngoufack, Marie Nicole] Univ Yaounde I, Fac Sci, Yaounde, Cameroon; [Moukam, Laure Vartan] Assoc Camerounaise Mkt Social, Yaounde, Cameroon; [Tchetmi, Thomas; Tapka, Vincent K.] Country Off, United Nations Joint Programme HIV AIDS, Yaounde, Cameroon; [Shubber, Zara; Cheikh, Nejma; Mziray, Elizabeth N.] World Bank Grp, Hlth Nutr & Populat, Washington, DC USA	University of Yaounde I; University of Manitoba; University of Yaounde I; The World Bank	Nguefack-Tsague, G (corresponding author), Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon.; Nguefack-Tsague, G (corresponding author), Minist Publ Hlth, Natl Key Populat Working Grp, Yaounde, Cameroon.	nguefacktsague@gmail.com	Nguefack-Tsague, Georges/N-3277-2019	Nguefack-Tsague, Georges/0000-0002-3847-3490; Blanchard, James/0000-0002-4701-590X; Fokam, Joseph/0000-0002-1501-2763	World Bank Group	World Bank Group	This study was conducted through the financial support of the World Bank Group. The founder had no role in designing, implementing, analysing and in the decision for publication.	Abdul-Quader AS, 2014, CURR OPIN HIV AIDS, V9, P107, DOI 10.1097/COH.0000000000000041; [Anonymous], 2017, CAMEROON COUNTRY OPE; [Anonymous], 2018, CAMEROON COUNTRY OPE; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; BUCREP, 2015, PROJ POP 2015; CAMPHIA, 2018, CAM POP BAS HIV IMP; Emmanuel F, 2013, SEX TRANSM INFECT, V89, P29, DOI 10.1136/sextrans-2013-051062; Emmanuel F, 2013, EXPERT REV ANTI-INFE, V11, P451, DOI [10.1586/ERI.13.33, 10.1586/eri.13.33]; Emmanuel F, 2010, AIDS, V24, pS77, DOI 10.1097/01.aids.0000386737.25296.c4; Global Fund, 2010, US PROGR MAPP IMPR P; Handcock MS, 2014, ELECTRON J STAT, V8, P1491, DOI 10.1214/14-EJS923; Ikpeazu A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103619; Jing LW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095601; Johnston LG, 2013, SEX TRANSM DIS, V40, P304, DOI 10.1097/OLQ.0b013e31827fd650; NAAC, 2015, NAT HIV AIDS STRAT P; Odek WO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089180; Papworth E, 2014, EXAMINING RISK FACTO; Pisani E., 2003, ESTIMATING SIZE POPU; Pruss-Ustun A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063476; Royston P, 2005, STATA J, V5, P405; Sabin K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155150; Scheibe A, 2017, HARM REDUCT J, V14, DOI 10.1186/s12954-017-0164-z; Tamoufe U, 2009, SEROEPIDEMIOLOGICAL; UNAIDS/WHO, 2013, UNAIDS REP GLOB AIDS; UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance, 2011, GUID EST SIZ POP MOS; Weir SS, 2002, SEX TRANSM INFECT, V78, pI106, DOI 10.1136/sti.78.suppl_1.i106; World Health Organization, 2013, IMPL COMPR HIV STI P; Yu D, 2014, W PACIFIC SURVEILLAN, V5	28	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0212315	10.1371/journal.pone.0212315	http://dx.doi.org/10.1371/journal.pone.0212315			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807616	Green Published, gold, Green Submitted			2022-12-27	WOS:000459712100014
J	Willow, J; Silva, A; Veromann, E; Smagghe, G				Willow, Jonathan; Silva, Ana; Veromann, Eve; Smagghe, Guy			Acute effect of low-dose thiacloprid exposure synergised by tebuconazole in a parasitoid wasp	PLOS ONE			English	Article							ERETMOCERUS-MUNDUS; BIOLOGICAL-CONTROL; HYMENOPTERA; INSECTICIDES; PESTICIDES; DELTAMETHRIN; LEPIDOPTERA; POPULATIONS; EULOPHIDAE; FUNGICIDES	Agricultural practices often involve tank-mixing and co-application of insecticides with fungicides to control crop pests. However, natural methods relying on biological control agents such as hymenopteran parasitoids have been shown to be highly effective in suppressing crop pest populations. The current body of insecticide risk assessment data accounting for fungicide co-application is very small, the present study being the first to examine this in a parasitoid wasp. Through low-dose exposure to dry residues of the neonicotinoid insecticide thiacloprid, we examined its mortal and knockdown effect on Aphelinus abdominalis when co-applied with increasing doses of the fungicide tebuconazole. Both of these acute effects of thiacloprid were synergised (toxicity increased to a greater-than-additive effect) by tebuconazole, resulting in significant mortality from low-dose co-applications of tebuconazole, and significant knockdown even without co-applied tebuconazole, the effect increasing as tebuconazole concentration increased. We show the highly toxic effect that a low dose of thiacloprid imposes on A. abdominalis populations, and a synergistic toxicity when co-applied with low doses of tebuconazole. Our work suggests a need for updating pesticide risk assessment methods, accounting for pesticide mixtures, in order to make these risk assessments more field relevant.	[Willow, Jonathan; Smagghe, Guy] Univ Ghent, Fac Biosci Engn, Dept Plants & Crops, Lab Agrozool, Ghent, Belgium; [Willow, Jonathan; Veromann, Eve] Estonian Univ Life Sci, Inst Agr & Environm Sci, Chair Plant Hlth, Tartu, Estonia; [Silva, Ana] Cardiff Univ, Sch Psychol, CUBRIC, Cardiff, S Glam, Wales	Ghent University; Estonian University of Life Sciences; Cardiff University	Willow, J (corresponding author), Univ Ghent, Fac Biosci Engn, Dept Plants & Crops, Lab Agrozool, Ghent, Belgium.; Willow, J (corresponding author), Estonian Univ Life Sci, Inst Agr & Environm Sci, Chair Plant Hlth, Tartu, Estonia.	jonathan.willow@student.emu.ee	Veromann, Eve/I-3095-2016; Silva, Ana Isabel/AAG-5265-2019; Smagghe, Guy/AAE-8914-2019; Willow, Jonathan/AAG-5864-2019; Willow, Jonathan/AAE-1337-2020	Veromann, Eve/0000-0002-0977-5270; Silva, Ana Isabel/0000-0002-1184-4909; Smagghe, Guy/0000-0001-8334-3313; Willow, Jonathan/0000-0003-2377-4917	European ERA-NET C-IPM project [33: IPM4Meligethes]; Estonian Research Council [IUT36-2]; Research Foundation-Flanders (FWO-Vlaanderen); European Social Fund; Internalisation Programme DoRa by Archimedes Foundation	European ERA-NET C-IPM project; Estonian Research Council; Research Foundation-Flanders (FWO-Vlaanderen)(FWO); European Social Fund(European Social Fund (ESF)); Internalisation Programme DoRa by Archimedes Foundation	This study was partially funded by European ERA-NET C-IPM project no 33: IPM4Meligethes, the Institutional Research Funding project no IUT36-2 of Estonian Research Council, and Research Foundation-Flanders (FWO-Vlaanderen). JW received a PhD grant from European Social Fund Doctoral Students, as well as the Internalisation Programme DoRa (carried out by Archimedes Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	[Anonymous], 2018, R R PROJECT STAT COM; Barmentlo SH, 2018, SCI TOTAL ENVIRON, V631-632, P341, DOI 10.1016/j.scitotenv.2018.03.021; Biondi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076548; Cook N, 2016, ECOL ENTOMOL, V41, P693, DOI 10.1111/een.12344; Delpuech JM, 2013, SCI TOTAL ENVIRON, V447, P274, DOI 10.1016/j.scitotenv.2012.12.096; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Drobnjakovic T, 2018, BIOCONTROL SCI TECHN, V28, P1, DOI 10.1080/09583157.2017.1409336; Francesena N, 2017, ENVIRON SCI POLLUT R, V24, P17719, DOI 10.1007/s11356-017-9400-z; Garcia-Mari F, 2004, BIOL CONTROL, V29, P215, DOI 10.1016/S1049-9644(03)00155-5; Giorio C, 2021, ENVIRON SCI POLLUT R, V28, P11716, DOI 10.1007/s11356-017-0394-3; Johnson RM, 2006, J ECON ENTOMOL, V99, P1046, DOI 10.1603/0022-0493-99.4.1046; Khan MA, 2017, PEST MANAG SCI, V73, P2465, DOI 10.1002/ps.4639; Kovacs G, 2019, PEST MANAG SCI, V75, P658, DOI 10.1002/ps.5161; Kovacs G, 2017, BIOCONTROL, V62, P29, DOI 10.1007/s10526-016-9765-9; Kruess A, 2000, OECOLOGIA, V122, P129, DOI 10.1007/PL00008829; LASHOMB J, 1987, J ECON ENTOMOL, V80, P65, DOI 10.1093/jee/80.1.65; Noyes JS, 2018, UNIVERSAL CHALCIDOID; Pisa L, 2021, ENVIRON SCI POLLUT R, V28, P11749, DOI 10.1007/s11356-017-0341-3; POLLUMAJANDUSAMET PMAIS Avalik Vaade, 2017, PMAIS AV VAADE; Raimets R, 2018, PEST MANAG SCI, V74, P541, DOI 10.1002/ps.4756; Schneider MI, 2003, J ECON ENTOMOL, V96, P1054, DOI 10.1603/0022-0493-96.4.1054; Schowalter TD, 2018, BASIC APPL ECOL, V26, P1, DOI 10.1016/j.baae.2017.09.011; Sgolastra F, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0887; Sgolastra F, 2017, PEST MANAG SCI, V73, P1236, DOI 10.1002/ps.4449; Simmonds MSJ, 2002, ENTOMOL EXP APPL, V102, P39, DOI 10.1023/A:1015255411612; Sugiyama K, 2011, APPL ENTOMOL ZOOL, V46, P311, DOI 10.1007/s13355-011-0044-z; Tappert L, 2017, SCI REP-UK, V7, DOI 10.1038/srep42756; Teder T, 2019, CHEMOSPHERE, V214, P371, DOI 10.1016/j.chemosphere.2018.09.132; Thies C, 1999, SCIENCE, V285, P893, DOI 10.1126/science.285.5429.893; Thompson H.M., 2012, EFSA SUPPORT PUBL; Thompson HM, 2014, APIDOLOGIE, V45, P545, DOI 10.1007/s13592-014-0273-6; Vandame R, 1998, NEUROSCI LETT, V251, P57, DOI 10.1016/S0304-3940(98)00494-7; vandeVeire M, 1996, ENTOMOPHAGA, V41, P235, DOI 10.1007/BF02764249; Veromann E, 2011, INT J PEST MANAGE, V57, P85, DOI 10.1080/09670874.2010.539714; Wang DS, 2018, J PEST SCI, V91, P65, DOI 10.1007/s10340-017-0864-x; Whitehorn PR, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0389; ZHAO JZ, 1992, GREAT LAKES ENTOMOL, V25, P253; Zhu WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0077547; Zhu YC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176837; Zumoffen L, 2018, APPL ENTOMOL ZOOL, V53, P1, DOI 10.1007/s13355-017-0520-1	40	13	13	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212456	10.1371/journal.pone.0212456	http://dx.doi.org/10.1371/journal.pone.0212456			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794624	gold, Green Submitted, Green Published			2022-12-27	WOS:000459709100070
J	Yang, Y; Yang, JJ; Yu, BY; Li, L; Luo, L; Wu, FF; Wu, BB				Yang, Yi; Yang, Jingjuan; Yu, Biying; Li, Li; Luo, Lin; Wu, Fengfeng; Wu, Binbin			Association between circulating mononuclear cell mitochondrial DNA copy number and in-hospital mortality in septic patients: A prospective observational study based on the Sepsis-3 definition	PLOS ONE			English	Article							INTERNATIONAL CONSENSUS DEFINITIONS; SHOCK; DAMPS	Purpose To explore the association between circulating mononuclear cell mitochondrial DNA copy number and the prognosis of sepsis patients based on the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3 definition). Methods A total of 200 adult patients who had recently devoloped sepsis were prospectively recruited as the study cohort. Demographic and clinical data were recorded along with a 28-day outcome. Mononuclear cell mtDNA copy number was assessed by quantitative PCR. Results The 28-day outcome of sepsis patients was significantly associated with circulating mononuclear cell mtDNA copy number. The median mononuclear cell relative mtDNA copy number of survivors was significantly higher than that of nonsurvivors (406.68, range 196.65-625.35 vs. 320.57, range 175.98-437.33, p = 0.001). The Cox proportional hazard survival model analysis indicated that mononuclear cell relative mtDNA copy number was significantly negative associated with the 28-day outcome. For every additional unit of mononuclear cell mtDNA relative copy number, the risk of death falls by 0.1% (HR = 0.999, 95% CI = 0.998 to 1.000, p = 0.017). Conclusions Our data indicate first that circulating mononuclear cellular mtDNA copy number might be helpful for outcome predictions in sepsis patients, and second that lower mtDNA copy number implied poor prognosis.	[Yang, Yi; Wu, Fengfeng; Wu, Binbin] Zhejiang Univ, Key Lab Kidney Dis Prevent & Control Technol, Kidney Dis Ctr, Coll Med,Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China; [Yang, Yi; Wu, Fengfeng; Wu, Binbin] Adm Tradit Chinese Med, Third Grade Lab Natl State, Hangzhou, Zhejiang, Peoples R China; [Yang, Yi; Yang, Jingjuan; Yu, Biying; Li, Li; Luo, Lin] Zhejiang Univ, Coll Med, Affiliated Hosp 4, Dept Nephrol, Yiwu, Peoples R China	Zhejiang University; Zhejiang University	Yang, Y (corresponding author), Zhejiang Univ, Key Lab Kidney Dis Prevent & Control Technol, Kidney Dis Ctr, Coll Med,Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China.; Yang, Y (corresponding author), Adm Tradit Chinese Med, Third Grade Lab Natl State, Hangzhou, Zhejiang, Peoples R China.; Yang, Y (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 4, Dept Nephrol, Yiwu, Peoples R China.	yangyixk@zju.edu.cn			National Nature Science Foundation of China [81670621]; Nature Science Foundation of Zhejiang Province [LY16H050001]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	The study design and preparation of the manuscript were supported by the grants from the National Nature Science Foundation of China (No. 81670621) and the Nature Science Foundation of Zhejiang Province (No. LY16H050001), which were both received by Dr.Yi Yang.	BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Boyapati RK, 2016, MUCOSAL IMMUNOL, V9, P567, DOI 10.1038/mi.2016.14; D'Souza AD, 2007, MITOCHONDRION, V7, P374, DOI 10.1016/j.mito.2007.08.001; Fink MP, 2002, CRIT CARE, V6, P491, DOI 10.1186/cc1824; Gonzalez AS, 2014, FREE RADICAL RES, V48, P769, DOI 10.3109/10715762.2014.906592; Hinkelbein J, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/8498510; Hu QY, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/8074936; Karlsson M, 2016, SHOCK, V45, P404, DOI 10.1097/SHK.0000000000000525; Levy Mitchell M, 2003, Intensive Care Med, V29, P530; MARGULIS L, 1985, Symbiosis, V1, P101; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Muszynski JA, 2018, AM J RESP CRIT CARE, V198, P361, DOI 10.1164/rccm.201710-2006OC; Nakahira K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001577; Parikh SM, 2015, SEMIN NEPHROL, V35, P108, DOI 10.1016/j.semnephrol.2015.01.011; Puskarich MA, 2012, SHOCK, V38, P337, DOI 10.1097/SHK.0b013e318266a169; Pyle A, 2010, INTENS CARE MED, V36, P956, DOI 10.1007/s00134-010-1823-7; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Shen XD, 2018, J CELL MOL MED, V22, P5257, DOI 10.1111/jcmm.13746; Singer M, 2007, CRIT CARE MED, V35, pS441, DOI 10.1097/01.CCM.0000278049.48333.78; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Suomalainen A, 2018, NAT REV MOL CELL BIO, V19, P77, DOI 10.1038/nrm.2017.66; Timmermans K, 2016, SHOCK, V45, P607, DOI 10.1097/SHK.0000000000000549; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Yao ZY, 2016, AUTOPHAGY, V12, P1971, DOI 10.1080/15548627.2016.1235127; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	25	6	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212808	10.1371/journal.pone.0212808	http://dx.doi.org/10.1371/journal.pone.0212808			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794688	Green Published, gold, Green Submitted			2022-12-27	WOS:000459709100143
J	Chung, DY; Kang, DH; Cho, KS; Jeong, WS; Jung, HD; Kwon, JK; Lee, SH; Lee, JY				Chung, Doo Yong; Kang, Dong Hyuk; Cho, Kang Su; Jeong, Won Sik; Jung, Hae Do; Kwon, Jong Kyou; Lee, Seon Heui; Lee, Joo Yong			Comparison of stone-free rates following shock wave lithotripsy, percutaneous nephrolithotomy, and retrograde intrarenal surgery for treatment of renal stones: A systematic review and network meta-analysis	PLOS ONE			English	Review							LOWER-POLE STONES; PROSPECTIVE RANDOMIZED-TRIAL; SUPINE VALDIVIA POSITION; FLEXIBLE URETEROSCOPY; 2 CM; LASER LITHOTRIPSY; CALICEAL CALCULI; MANAGEMENT; KIDNEY; URETERORENOSCOPY	Objectives To perform a systematic review and network meta-analysis comparing stone-free rates following retrograde intrarenal surgery (RIRS), extracorporeal shock wave lithotripsy (SWL), and percutaneous nephrolithotomy (PCNL) treatments of renal stones. Materials and methods Clinical trials comparing RIRS, SWL, and PCNL for treatment of renal stones were identified from electronic databases. Stone-free rates for the procedures were compared by qualitative and quantitative syntheses (meta-analyses). Outcome variables are shown as risk ratios (ORs) with 95% credible intervals (CIs). Results A total of 35 studies were included in this network meta-analysis of success and stone-free rates following three different treatments of renal stones. Six studies compared PCNL versus SWL, ten studies compared PCNL versus RIRS, fourteen studies compared RIRS versus SWL, and five studies compared PCNL, SWL, and RIRS. The quality scores within subscales were relatively low-risk. Network meta-analyses indicated that stone-free rates of RIRS (OR 0.38; 95% CI 0.22-0.64) and SWL (OR 0.12; 95% CI 0.067-0.19) were lower than that of PCNL. In addition, stone-free rate of SWL was lower than that of RIRS (OR 0.31; 95% CI 0.20-0.47). Stone free rate of PCNL was also superior to RIRS in subgroup analyses including >= 2 cm stone (OR 4.680; 95% CI 2.873-8.106), lower pole stone (OR 1.984; 95% CI 1.043-2.849), and randomized studies (OR 2.219; 95% CI 1.348-4.009). In rank-probability test, PCNL was ranked as No. 1 and SWL was ranked as No. 3. Conclusions PCNL showed the highest success and stone-free rate in the surgical treatment of renal stones. In contrast, SWL had the lowest success and stone-free rate.	[Chung, Doo Yong; Lee, Joo Yong] Yonsei Univ, Coll Med, Dept Urol, Severance Hosp,Urol Sci Inst, Seoul, South Korea; [Kang, Dong Hyuk] Inha Univ, Sch Med, Dept Urol, Incheon, South Korea; [Cho, Kang Su] Yonsei Univ, Coll Med, Urol Sci Inst, Dept Urol,Gangnam Severance Hosp, Seoul, South Korea; [Jeong, Won Sik] Kwangju Christian Hosp, Dept Urol, Gwangju, South Korea; [Jung, Hae Do] Yonsei Univ Hlth Syst, Yongin Severance Hosp, Dept Urol, Yongin, South Korea; [Kwon, Jong Kyou] Yonsei Univ Hlth Syst, Severance Check Up, Dept Urol, Seoul, South Korea; [Lee, Seon Heui] Gachon Univ, Coll Nursing, Dept Nursing Sci, Incheon, South Korea	Yonsei University; Yonsei University Health System; Inha University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Gachon University	Lee, JY (corresponding author), Yonsei Univ, Coll Med, Dept Urol, Severance Hosp,Urol Sci Inst, Seoul, South Korea.	joouro@yuhs.ac	; Lee, Joo Yong/C-3851-2013	Cho, Kang Su/0000-0002-3500-8833; Lee, Joo Yong/0000-0002-3470-1767; Choi, Young Deuk/0000-0002-8545-5797	Yonsei University College of Medicine [6-2016-0119]	Yonsei University College of Medicine(General Electric)	This study was supported by a faculty research grant from the Yonsei University College of Medicine (6-2016-0119) to Dr. Joo Yong Lee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboutaleb H, 2012, UROL INT, V89, P348, DOI 10.1159/000341557; Akman T, 2012, BJU INT, V109, P1384, DOI 10.1111/j.1464-410X.2011.10691.x; Albala DM, 2001, J UROLOGY, V166, P2072, DOI 10.1016/S0022-5347(05)65508-5; Bas O, 2015, UROLITHIASIS, V43, P155, DOI 10.1007/s00240-014-0725-5; Bas O, 2014, UROLITHIASIS, V42, P115, DOI 10.1007/s00240-013-0615-2; Bozkurt OF, 2011, J ENDOUROL, V25, P1131, DOI 10.1089/end.2010.0737; BRANDT B, 1993, SCAND J UROL NEPHROL, V27, P75, DOI 10.3109/00365599309180418; Bryniarski P, 2012, J ENDOUROL, V26, P52, DOI 10.1089/end.2011.0235; Burr J, 2015, CENT EUR J UROL, V68, P183, DOI 10.5173/ceju.2015.509; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; CHAUSSY C, 1984, UROLOGY, V23, P59, DOI 10.1016/0090-4295(84)90243-7; Cho SY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28247-7; Cho SY, 2015, KOREAN J UROL, V56, P680, DOI 10.4111/kju.2015.56.10.680; Cracco CM, 2011, WORLD J UROL, V29, P821, DOI 10.1007/s00345-011-0790-0; Dauw CA, 2015, J ENDOUROL, V29, P1221, DOI 10.1089/end.2015.0260; De S, 2015, EUR UROL, V67, P125, DOI 10.1016/j.eururo.2014.07.003; Do Jung H, 2018, INVESTIG CLIN UROL, V59, P348, DOI 10.4111/icu.2018.59.5.348; Donaldson JF, 2015, EUR UROL, V67, P612, DOI 10.1016/j.eururo.2014.09.054; El-Nahas AR, 2012, BJU INT, V110, P898, DOI 10.1111/j.1464-410X.2012.10961.x; FERNSTROM I, 1976, SCAND J UROL NEPHROL, V10, P257, DOI 10.1080/21681805.1976.11882084; FLEISS JL, 1986, CONTROL CLIN TRIALS, V7, P267, DOI 10.1016/0197-2456(86)90034-6; GALBRAITH RF, 1988, STAT MED, V7, P889, DOI 10.1002/sim.4780070807; Geraghty RM, 2017, J ENDOUROL, V31, P729, DOI 10.1089/end.2017.0123; Ghani KR, 2016, EUR UROL, V70, P382, DOI 10.1016/j.eururo.2016.01.047; Gokce MI, 2016, INT BRAZ J UROL, V42, P96, DOI 10.1590/S1677-5538.IBJU.2015.0023; Hassan M, 2015, ARAB J UROL, V13, P212, DOI 10.1016/j.aju.2015.04.002; Havel D, 1998, EUR UROL, V33, P396, DOI 10.1159/000019623; Helal M, 1997, J ENDOUROL, V11, P171, DOI 10.1089/end.1997.11.171; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hyams ES, 2009, J UROLOGY, V182, P1012, DOI 10.1016/j.juro.2009.05.021; Javanmard B, 2016, UROL J, V13, P2823; Jeong JY, 2018, YONSEI MED J, V59, P303, DOI 10.3349/ymj.2018.59.2.303; Jung GH, 2015, KOREAN J UROL, V56, P525, DOI 10.4111/kju.2015.56.7.525; Kang DH, 2016, INVESTIG CLIN UROL, V57, P408, DOI 10.4111/icu.2016.57.6.408; Kang DH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158661; Karakoyunlu N, 2015, UROLITHIASIS, V43, P283, DOI 10.1007/s00240-015-0768-2; Kim BS, 2015, KOREAN J UROL, V56, P614, DOI 10.4111/kju.2015.56.9.614; Koo V, 2011, BJU INT, V108, P1913, DOI 10.1111/j.1464-410X.2011.10172.x; Koyuncu H, 2015, INT BRAZ J UROL, V41, P245, DOI 10.1590/S1677-5538.IBJU.2015.02.09; Kumar A, 2015, J ENDOUROL, V29, P575, DOI 10.1089/end.2013.0473; Kumar A, 2015, J UROLOGY, V193, P160, DOI 10.1016/j.juro.2014.07.088; Kwon O, 2017, INT J UROL, V24, P377, DOI 10.1111/iju.13313; LABBE KA, 1987, ANN INTERN MED, V107, P224, DOI 10.7326/0003-4819-107-2-224; Lawler AC, 2017, CURR UROL REP, V18, DOI 10.1007/s11934-017-0672-0; Lee JY, 2017, BMC UROL, V17, DOI 10.1186/s12894-017-0239-x; Lee JY, 2014, WORLD J MENS HEALTH, V32, P167, DOI 10.5534/wjmh.2014.32.3.167; Lee YJ, 2016, INVESTIG CLIN UROL, V57, P274, DOI 10.4111/icu.2016.57.4.274; Macfarlane TV, 2001, J DENT, V29, P451, DOI 10.1016/S0300-5712(01)00041-0; Mills EJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2914; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; NETTO NR, 1991, J UROLOGY, V146, P721, DOI 10.1016/S0022-5347(17)37905-3; Nomura K, 2005, PREV MED, V40, P138, DOI 10.1016/j.ypmed.2004.05.011; Okhunov Z, 2013, UROLOGY, V81, P1154, DOI 10.1016/j.urology.2012.10.083; Ozayar E, 2016, J ENDOUROL, V30, P184, DOI 10.1089/end.2015.0517; Ozturk U, 2013, UROL INT, V91, P345, DOI 10.1159/000351136; Pearle MS, 2008, J UROLOGY, V179, pS69, DOI 10.1016/j.juro.2008.03.140; Preminger GM, 2006, UROL RES, V34, P108, DOI 10.1007/s00240-005-0020-6; Resorlu B, 2013, WORLD J UROL, V31, P1581, DOI 10.1007/s00345-012-0991-1; Rucker G, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0060-8; Salem A, 2013, J UROLOGY, V189, pE751, DOI 10.1016/j.juro.2013.02.2192; Schuster TG, 2002, J UROLOGY, V168, P43, DOI 10.1016/S0022-5347(05)64828-8; Scoffone CM, 2008, EUR UROL, V54, P1393, DOI 10.1016/j.eururo.2008.07.073; Sener NC, 2015, UROLOGY, V85, P33, DOI 10.1016/j.urology.2014.08.023; Sener NC, 2014, UROLITHIASIS, V42, P127, DOI 10.1007/s00240-013-0618-z; Singh BP, 2014, UROLOGY, V83, P1016, DOI 10.1016/j.urology.2013.12.026; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; Taguchi K, 2015, INT J UROL, V22, P978, DOI 10.1111/iju.12860; Tauber V, 2015, UROL INT, V95, P324, DOI 10.1159/000439356; Teichman JMH, 2004, NEW ENGL J MED, V350, P684, DOI 10.1056/NEJMcp030813; Trinchieri A, 2017, UROLITHIASIS, V45, P553, DOI 10.1007/s00240-017-0962-5; Turk C, 2016, EUR UROL, V69, P475, DOI 10.1016/j.eururo.2015.07.041; Valdivia Uria J G, 1987, Arch Esp Urol, V40, P177; Vilches RM, 2015, ACTAS UROL ESP, V39, P236, DOI 10.1016/j.acuro.2014.08.003; WICKHAM JEA, 1984, BRIT J UROL, V56, P582, DOI 10.1111/j.1464-410X.1984.tb06121.x; Wong Y, 2016, J ENDOUROL, V30, P246, DOI 10.1089/end.2015.0567; Yuruk E, 2015, J ENDOUROL, V29, P463, DOI 10.1089/end.2014.0613; Yuruk E, 2010, J UROLOGY, V183, P1424, DOI 10.1016/j.juro.2009.12.022; Zengin K, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/914231; Zhang W, 2015, J ENDOUROL, V29, P745, DOI 10.1089/end.2014.0799; Zheng CJ, 2014, UROL INT, V93, P417, DOI 10.1159/000363509	80	37	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0211316	10.1371/journal.pone.0211316	http://dx.doi.org/10.1371/journal.pone.0211316			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789937	Green Published, gold, Green Submitted			2022-12-27	WOS:000459330800012
J	Leppanen, A; Ekblad, S; Tomson, T				Leppanen, Anne; Ekblad, Solvig; Tomson, Tanja			Tobacco Cessation on Prescription as a primary health care intervention targeting a context with socioeconomically disadvantaged groups in Sweden: A qualitative study of perceived implementation barriers and facilitators among providers	PLOS ONE			English	Article							SMOKING-CESSATION; PHYSICAL-ACTIVITY; INTERVIEW; SERVICES	Background A new intervention, Tobacco Cessation on Prescription (TCP), has been developed in the Swedish primary health care (PHC) setting to address inequalities in health caused by tobacco use. It consists of counseling for at least 10 minutes, an individualized prescription of tobacco cessation treatment and follow-up on at least one occasion. TCP is currently being tested in clinical practice for the first time but there is a lack of knowledge about how it is perceived by health care providers. Aim To explore PHC provider's perceived barriers and facilitators of implementing TCP as an intervention targeting a context with socioeconomically disadvantaged groups in Sweden. Methods Directed content analysis of transcripts from eight semi-structured interviews and one focus group interview with PHC providers with personal experience of TCP as informants. Data collection and analysis was guided by The Consolidated Framework for Implementation Research. Results Perceived facilitators of implementing TCP were increased self-efficacy among the informants and involvement in the treatment among patients, which led to more intensive counseling and advice being taken more seriously by patients. Lack of resources, routines, and collaboration to work with tobacco cessation and lack of knowledge, motivation and self-efficacy among colleagues were perceived as barriers. Motivation and self-efficacy to quit was perceived as low among some patients, which was explained by low social support to quit, negative attitude and low adherence to treatment and tobacco being used as a coping strategy for life stress. Access to treatment for patients was limited by cost of treatment, long waiting times and focus on face-to-face counseling. Conclusion TCP was perceived positively by the informants but access to treatment for patients was partly limited by how tobacco cessation services were organized. Lack of structural support, resources and differing attitudes among PHC providers need to be addressed to facilitate its implementation.	[Leppanen, Anne; Ekblad, Solvig; Tomson, Tanja] Karolinska Inst, Dept Learning Informat Management & Eth, Stockholm, Sweden	Karolinska Institutet	Leppanen, A (corresponding author), Karolinska Inst, Dept Learning Informat Management & Eth, Stockholm, Sweden.	anne.leppanen@ki.se		Tomson, Tanja/0000-0002-4577-4304; Leppanen, Anne/0000-0003-4273-4072	Public Health Agency of Sweden [02717-2017-6.2]	Public Health Agency of Sweden	This study was funded by the Public Health Agency of Sweden [02717-2017-6.2] https://www.folkhalsomyndigheten.se/the-public-health-agency-of-sweden/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenijevic J, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-012156; Bandura A., 1997, SELF EFFICACY EXERCI; Birken SA, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-015-0362-6; Blumenthal DS, 2007, J AM BOARD FAM MED, V20, P272, DOI 10.3122/jabfm.2007.03.060115; Bohman DM, 2015, PRIM HEALTH CARE RES, V16, P270, DOI 10.1017/S1463423614000267; Bonevski B, 2011, DRUG ALCOHOL REV, V30, P411, DOI 10.1111/j.1465-3362.2010.00248.x; Campbell NC, 2007, BMJ-BRIT MED J, V334, P455, DOI 10.1136/bmj.39108.379965.BE; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Edwards A. L., 1957, SOCIAL DESIRABILITY; Elo S, 2014, SAGE OPEN, V4, DOI 10.1177/2158244014522633; Folkhalsomyndigheten [Public Health Agency of Sweden], 2016, DAGL TOB; Fowles JR, 2018, APPL PHYSIOL NUTR ME, V43, P535, DOI 10.1139/apnm-2017-0763; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Green J, 2009, QUALITATIVE METHODS; Gustavsson C, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3021-1; Hiscock R, 2012, ANN NY ACAD SCI, V1248, P107, DOI 10.1111/j.1749-6632.2011.06202.x; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Kallings L., 2008, THESIS; Kardakis T, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3023-z; Kommisionen for jamlik halsa [ The Commission for Equity in Health], 2017, NAST STEG VAG MOT ME; Leppanen Anne, 2016, JMIR Res Protoc, V5, pe188, DOI 10.2196/resprot.6180; Leppanen Anne, 2016, BMC Res Notes, V9, P151, DOI 10.1186/s13104-016-1949-y; Malterud K, 2016, QUAL HEALTH RES, V26, P1753, DOI 10.1177/1049732315617444; Murray RL, 2009, J PUBLIC HEALTH-UK, V31, P258, DOI 10.1093/pubmed/fdp008; Persson G, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-128; Proctor E, 2011, ADM POLICY MENT HLTH, V38, P65, DOI 10.1007/s10488-010-0319-7; Professional Associations for Physical activity, 2010, PHYS ACT PREV TREATM; Regeringskansliet [Government Offices of Sweden], 2016, TOB ENDG REG ANDT ST; Rubio-Valera M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089554; Socialdepartementet [Ministry of Health and Social Affairs], 2015, KOMM KOMM JAML HALS; Socialstyrelsen, 2011, NAT RIKTL VUX 2011 S; Socialstyrelsen [National Board of Health and Welfare], 2015, NAT RIKTL UTV 2014 S; Socialstyrelsen [National Board of Health and Welfare], 2014, REG TOB SKAD; Socialstyrrelsen, 2018, NAT MARKT NMD; Statens Folkhalsoinstitut [ Swedish Institute of Public Health], 2011, FAR IND SKRIFTL ORD; Stead LF, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002850.pub2; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Twyman L, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006414; Utredningen Styrning for en mer jamlik vard [The Investigation Management for More Equal Health care], 2018, 201855 SOU; World Health Organization, 2008, WHO REP GLOB TOB EP; World Health Organization, 2014, TOB IN GUID ADDR IN	41	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212641	10.1371/journal.pone.0212641	http://dx.doi.org/10.1371/journal.pone.0212641			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM2WC	30789969	Green Published, gold, Green Submitted			2022-12-27	WOS:000459330800046
J	Nonomura, T; Shibata, H; Takaki, R				Nonomura, Taku; Shibata, Hisaichi; Takaki, Ryoji			Extended-Kalman-filter-based dynamic mode decomposition for simultaneous system identification and denoising	PLOS ONE			English	Article							FLOWS	A new dynamic mode decomposition (DMD) method is introduced for simultaneous system identification and denoising in conjunction with the adoption of an extended Kalman filter algorithm. The present paper explains the extended-Kalman-filter-based DMD (EKFDMD) algorithm which is an online algorithm for dataset for a small number of degree of freedom (DoF). It also illustrates that EKFDMD requires significant numerical resources for many-degree-of-freedom (many-DoF) problems and that the combination with truncated proper orthogonal decomposition (trPOD) helps us to apply the EKFDMD algorithm to many-DoF problems, though it prevents the algorithm from being fully online. The numerical experiments of a noisy dataset with a small number of DoFs illustrate that EKFDMD can estimate eigenvalues better than or as well as the existing algorithms, whereas EKFDMD can also denoise the original dataset online. In particular, EKFDMD performs better than existing algorithms for the case in which system noise is present. The EKFDMD with trPOD, which unfortunately is not fully online, can be successfully applied to many-DoF problems, including a fluid-problem example, and the results reveal the superior performance of system identification and denoising.	[Nonomura, Taku] Tohoku Univ, Grad Sch Engn, Dept Aerosp Engn, Sendai, Miyagi, Japan; [Nonomura, Taku] JST, Presto, Sendai, Miyagi, Japan; [Shibata, Hisaichi; Takaki, Ryoji] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Sagamihara, Kanagawa, Japan	Tohoku University; Japan Science & Technology Agency (JST); Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS)	Nonomura, T (corresponding author), Tohoku Univ, Grad Sch Engn, Dept Aerosp Engn, Sendai, Miyagi, Japan.; Nonomura, T (corresponding author), JST, Presto, Sendai, Miyagi, Japan.	nonomura@aero.mech.tohoku.ac.jp	Shibata, Hisaichi/GPX-7331-2022; Nonomura, Taku/AAC-4303-2019	Nonomura, Taku/0000-0001-7739-7104; Shibata, Hisaichi/0000-0003-3187-8871	PREST, JST [JPMJPR1678]	PREST, JST(Japan Science & Technology Agency (JST))	This work was supported by PREST, JST (JPMJPR1678). URL: https://www.jst.go.jp/kisoken/presto/en/index.html.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askham T, 2018, SIAM J APPL DYN SYST, V17, P380, DOI 10.1137/M1124176; BERKOOZ G, 1993, ANNU REV FLUID MECH, V25, P539, DOI 10.1146/annurev.fl.25.010193.002543; Dawson STM, 2016, EXP FLUIDS, V57, DOI 10.1007/s00348-016-2127-7; Fujii K, 1999, AIAA J, V37, P125, DOI 10.2514/2.676; Fujii K., 1990, HIGH PERFORMANCE COM, P139; Hemati M., 2016, P 54 AIAA AER SCI M; Hemati M. S., 2017, THEORETICAL COMPUTAT, P1, DOI [10.1007/s00162-017-0432-2,1502.03854, DOI 10.1007/S00162-017-0432-2,1502.03854]; Kalman RE., 1960, T ASME J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Kutz JN, 2016, DYNAMIC MODE DECOMPO, V149; LELE SK, 1992, J COMPUT PHYS, V103, P16, DOI 10.1016/0021-9991(92)90324-R; Moarref R, 2014, PHYS FLUIDS, V26, DOI 10.1063/1.4876195; Nishida H, 2009, J COMPUT PHYS, V228, P3182, DOI 10.1016/j.jcp.2009.01.032; Nonomura T, 2018, AIP ADV, V8, DOI 10.1063/1.5031816; Ohmichi Y, 2016, INT J NUMER METH FL, V80, P614, DOI 10.1002/fld.4166; Ohmichi Y, 2017, AIP ADV, V7, DOI 10.1063/1.4996024; Ohnishi N, 2015, PHYS FLUIDS, V27, DOI 10.1063/1.4922086; Priebe S, 2016, J FLUID MECH, V807, P441, DOI 10.1017/jfm.2016.557; Rowley CW, 2004, PHYSICA D, V189, P115, DOI 10.1016/j.physd.2003.03.001; Rowley CW., 2017, LIB TOOLS COMPUTING; Schmid PJ, 2010, J FLUID MECH, V656, P5, DOI 10.1017/S0022112010001217; Shibata H, 2015, PLASMA SOURCES SCI T, V24, DOI 10.1088/0963-0252/24/5/055014; Surana A., 2017, 56 IEEE C DEC CONTR, P94; Surana A, 2016, IFAC PAPERSONLINE, V49, P716, DOI 10.1016/j.ifacol.2016.10.250; Taira K, 2017, AIAA J, V55, P4013, DOI 10.2514/1.J056060; Theofilis V, 2011, ANNU REV FLUID MECH, V43, P319, DOI 10.1146/annurev-fluid-122109-160705; Tu J.H., 2014, J COMPUT DYN, V1, P391, DOI [10.3934/jcd.2014.1.391, DOI 10.3934/JCD.2014.1.391]; Wang L, 2019, ACCIDENT ANAL PREV, V122, P378, DOI 10.1016/j.aap.2017.06.003; Zhang H, 2017, PREPRINT	28	26	26	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0209836	10.1371/journal.pone.0209836	http://dx.doi.org/10.1371/journal.pone.0209836			46	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789916	Green Published, gold, Green Submitted			2022-12-27	WOS:000459330800007
J	Graham, C; Seeley, J; Gina, A; Saman, Y				Graham, Christine; Seeley, Janet; Gina, Ayanda; Saman, Yougan			Mapping the content of mothers' knowledge, attitude and practice towards universal newborn hearing screening for development of a KAP survey tool	PLOS ONE			English	Article							MATERNAL VIEWS; INTERVENTION; DEAFNESS; CHILDREN; ANXIETY; PROGRAM	Understanding mother's knowledge, attitude and practice (KAP) of permanent childhood hearing impairment (PCHI) is essential for the success of universal newborn hearing screening (UNHS) as poor compliance and follow-up remains a global challenge. To determine content area for a questionnaire that measures PCHI-related KAP in rural mothers, we trained moderators who interviewed 145 pregnant women (17 groups) from 5 ante-natal clinics. Interviews were recorded, transcribed, summarised and analysed using thematic framework analysis. Four knowledge themes were identified: 1) PCHI was perceived as the malfunction of hearing leading to disability; 2) a poorly-responsive/communicative child may have PCHI; 3) lifestyle, hereditary and environmental factors are significant causes of PCHI; 4) medical management of PCHI was doubted, with some advocating birth and ancestral rituals. Two themes were identified for attitude: 1) beliefs that PCHI was emotionalised due to the negative lifelong impact on the child and family; 2) UNHS processes were favourable though some preferred other belief systems. Three themes were identified for practice: 1) doctors were the first choice followed by traditional healers; 2) willingness to continue follow-up although challenges exist; 3) minimal family support during consultation. The contextualised KAP of women regarding UNHS processes and PCHI provided content area for the design of a KAP tool.	[Graham, Christine; Saman, Yougan] Univ KwaZulu Natal, Nelson Mandela Sch Clin Med, Durban, South Africa; [Seeley, Janet] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England; [Gina, Ayanda] Univ KwaZulu Natal, Dept Audiol, Durban, South Africa; [Saman, Yougan] Univ Hosp Leicester, Ear Nose & Throat Dept, Leicester, Leics, England	University of Kwazulu Natal; University of London; London School of Hygiene & Tropical Medicine; University of Kwazulu Natal; University Hospitals of Leicester NHS Trust; University of Leicester	Graham, C (corresponding author), Univ KwaZulu Natal, Nelson Mandela Sch Clin Med, Durban, South Africa.	cgtinagrm333@gmail.com		Seeley, Janet/0000-0002-0583-5272				Akilan R, 2014, INT J PEDIATR OTORHI, V78, P2083, DOI 10.1016/j.ijporl.2014.09.009; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P1; Azjen I, 2005, ATTITUDES PERSONALIT; Campbell NC, 2007, BMJ-BRIT MED J, V334, P455, DOI 10.1136/bmj.39108.379965.BE; Creswell JW, 2013, RES DESIGN QUALITATI, V53; Crockett R, 2006, J MED SCREEN, V13, P20, DOI 10.1258/096914106776179854; Daher M, 2017, FORUM QUALITATIVE SO, V18; DeVon HA, 2007, J NURS SCHOLARSHIP, V39, P155, DOI 10.1111/j.1547-5069.2007.00161.x; Engle PL, 2007, LANCET, V369, P229, DOI 10.1016/S0140-6736(07)60112-3; Fitzpatrick E, 2007, INT J AUDIOL, V46, P97, DOI 10.1080/14992020600977770; Fox R, 2008, HEALTH EXPECT, V11, P376, DOI 10.1111/j.1369-7625.2008.00504.x; Hardonk S, 2011, J DEAF STUD DEAF EDU, V16, P305, DOI 10.1093/deafed/enq055; Karaca CT, 2014, CLIN EXP OTORHINOLAR, V7, P260, DOI 10.3342/ceo.2014.7.4.260; Khairi MDM, 2011, INT J PEDIATR OTORHI, V75, P513, DOI 10.1016/j.ijporl.2011.01.009; Korver AMH, 2011, LARYNGOSCOPE, V121, P409, DOI 10.1002/lary.21377; Kral A, 2010, NEW ENGL J MED, V363, P1438, DOI 10.1056/NEJMra0911225; MacNeil JR, 2007, AM J AUDIOL, V16; Maluleke R, 2016, ED SERIES, VIV; Mazlan R, 2014, INT J PEDIATR OTORHI, V78, P348, DOI 10.1016/j.ijporl.2013.12.014; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Muse C, 2013, PEDIATRICS, V131, pE1324, DOI 10.1542/peds.2013-0008; Napier AD, 2014, LANCET, V384, P1607, DOI 10.1016/S0140-6736(14)61603-2; NEDERHOF AJ, 1985, EUR J SOC PSYCHOL, V15, P263, DOI 10.1002/ejsp.2420150303; Olusanya BO, 2006, INT J PEDIATR OTORHI, V70, P619, DOI 10.1016/j.ijporl.2005.08.004; Olusanya BO, 2011, EARLY HUM DEV, V87, P647, DOI 10.1016/j.earlhumdev.2011.05.002; Park AH, 2006, OTOLARYNGOL HEAD NEC, V134; Polit D.F., 2006, ESSENTIALS NURSING R; Rabiee F, 2004, P NUTR SOC, V63, P655, DOI 10.1079/PNS2004399; Raine CH, 2018, SCOTT BROWNS OTORHIN, V2, P75; Rajagopalan R, 2014, INDIAN J OTOL, V20, P20, DOI 10.4103/0971-7749.129803; Ravi R, 2016, INT J AUDIOL, V55, P715, DOI 10.1080/14992027.2016.1215560; Ravi R, 2016, INT J PEDIATR OTORHI, V85, P1, DOI 10.1016/j.ijporl.2016.03.012; Shulman S, 2010, PEDIATRICS, V126, pS19, DOI 10.1542/peds.2010-0354F; Stich-Hennen J, 2008, RESOURCE GUIDE EARLY, P1; Suppiej A, 2013, J MATERN-FETAL NEO M, V26, P932, DOI 10.3109/14767058.2013.766687; Swanepoel D, 2008, INT J AUDIOL, V47, pS44, DOI 10.1080/14992020802252279; WHO, 2001, COMM NEEDS ASS; WHO, 2016, CHILDH HEAR STRAT PR; WHO, 2013, 1 INT C HLTH PROM OT, P3; World Health Organization, 2010, DET HLTH; Young, 2005, J DEAF STUD DEAF ED, V10; Young A, 2007, J DEAF STUD DEAF EDU, V12, P209, DOI 10.1093/deafed/enl033	42	1	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0210764	10.1371/journal.pone.0210764	http://dx.doi.org/10.1371/journal.pone.0210764			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785897	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000459307000014
J	Kwon, AY; Park, HY; Hyeon, J; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Cho, SY; Cho, EY				Kwon, Ah-Young; Park, Ha Young; Hyeon, Jiyeon; Nam, Seok Jin; Kim, Seok Won; Lee, Jeong Eon; Yu, Jong-Han; Lee, Se Kyung; Cho, Soo Youn; Cho, Eun Yoon			Practical approaches to automated digital image analysis of Ki-67 labeling index in 997 breast carcinomas and causes of discordance with visual assessment	PLOS ONE			English	Article							NEUROENDOCRINE TUMORS; PROLIFERATIVE INDEX; KI67 INDEX; CANCER; REPRODUCIBILITY; QUANTIFICATION; METAANALYSIS; PROGNOSIS; SURVIVAL; MARKER	The Ki-67 labeling index (LI) is an important prognostic factor in breast carcinoma. The Ki-67 LI is traditionally calculated via unaided microscopic estimation; however, inter-observer and intra-observer variability and low reproducibility are problems with this visual assessment (VA) method. For more accurate assessment and better reproducibility with Ki-67 LI, digital image analysis was introduced recently. We used both VA and automated digital image analysis (ADIA) (Ventana Virtuoso image management software) to estimate Ki-67 LI for 997 cases of breast carcinoma, and compared VA and ADIA results. VA and ADIA were highly correlated (intraclass correlation coefficient 0.982, and Spearman's correlation coefficient 0.966, p<0.05). We retrospectively analyzed cases with a greater than 5% difference between VA and ADIA results. The cause of these differences was: (1) tumor heterogeneity (98 cases, 56.0%), (2) VA interpretation error (32 cases, 18.3%), (3) misidentification of tumor cells (26 cases, 14.9%), (4) poor immunostaining or slide quality (16 cases, 9.1%), and (5) Estimation of non-tumor cells (3 cases, 1.7%). There were more discrepancies between VA and ADIA results in the group with a VA value of 10-20% compared to groups with <10% and >= 20%. Although ADIA is more accurate than VA, there are some limitations. Therefore, ADIA findings require confirmation by a pathologist.	[Kwon, Ah-Young] CHA Univ, Sch Med, CHA Bundang Med Ctr, Dept Pathol, Seongnam, Gyeonggi Do, South Korea; [Park, Ha Young] Inje Univ, Coll Med, Busan Paik Hosp, Dept Pathol, Busan, South Korea; [Hyeon, Jiyeon] Catholic Univ Korea, Coll Med, Incheon St Marys Hosp, Dept Pathol, Seoul, South Korea; [Nam, Seok Jin; Kim, Seok Won; Lee, Jeong Eon; Yu, Jong-Han; Lee, Se Kyung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea; [Cho, Soo Youn; Cho, Eun Yoon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea	Pochon Cha University; Inje University; Catholic University of Korea; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Cho, SY; Cho, EY (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea.	sooyoun.cho@samsung.com; eunyoon.cho@samsung.com		Hyeon, Jiyeon/0000-0003-3074-4142				Abubakar M, 2016, J PATHOL CLIN RES, V2, P138, DOI 10.1002/cjp2.42; Bigras G, 2017, APPL IMMUNOHISTO M M, V25, P687, DOI 10.1097/PAI.0000000000000371; BOUZUBAR N, 1989, BRIT J CANCER, V59, P943, DOI 10.1038/bjc.1989.200; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Christgen M, 2015, HUM PATHOL, V46, P1341, DOI 10.1016/j.humpath.2015.05.016; Chung YR, 2016, J PATHOL TRANSL MED, V50, P129, DOI 10.4132/jptm.2015.12.24; de Azambuja E, 2007, BRIT J CANCER, V96, P1504, DOI 10.1038/sj.bjc.6603756; Demichelis F, 2002, VIRCHOWS ARCH, V441, P159, DOI 10.1007/s00428-001-0561-1; Desmeules P, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0294-0; Domagala W, 1996, CLIN CANCER RES, V2, P147; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; Fasanella S, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-S1-S7; Fulawka L, 2017, INDIAN J PATHOL MICR, V60, P177, DOI 10.4103/IJPM.IJPM_732_15; Fulawka L, 2016, ANTICANCER RES, V36, P3965; Gnant M, 2011, BREAST CARE, V6, P136, DOI 10.1159/000328054; Goldhirsch A, 2009, ANN ONCOL, V20, P1319, DOI 10.1093/annonc/mdp322; Gudlaugsson E, 2012, HISTOPATHOLOGY, V61, P1134, DOI 10.1111/j.1365-2559.2012.04329.x; Harvey J, 2015, PATHOLOGY, V47, P13, DOI 10.1097/PAT.0000000000000192; Hida AI, 2015, J CLIN PATHOL, V68, P356, DOI 10.1136/jclinpath-2014-202695; Koopman T, 2018, BREAST CANCER RES TR, V169, P33, DOI 10.1007/s10549-018-4669-2; Laurinavicius A, 2016, VIRCHOWS ARCH, V468, P493, DOI 10.1007/s00428-016-1907-z; Laurinavicius A, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3639; Maeda I, 2016, BREAST CANCER-TOKYO, V23, P745, DOI 10.1007/s12282-015-0634-7; Mikami Y, 2013, CANCER SCI, V104, P1539, DOI 10.1111/cas.12245; Mohammed ZMA, 2012, BRIT J CANCER, V106, P383, DOI 10.1038/bjc.2011.569; Plancoulaine B, 2015, VIRCHOWS ARCH, V467, P711, DOI 10.1007/s00428-015-1865-x; Reid MD, 2015, MODERN PATHOL, V28, P686, DOI 10.1038/modpathol.2014.156; Roge R, 2016, BREAST CANCER RES TR, V158, P11, DOI 10.1007/s10549-016-3852-6; Romero Q, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-118; Shui RH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125131; Stuart-Harris R, 2008, BREAST, V17, P323, DOI 10.1016/j.breast.2008.02.002; Tang LH, 2012, AM J SURG PATHOL, V36, P1761, DOI 10.1097/PAS.0b013e318263207c; Voros A, 2014, PATHOL ONCOL RES, V20, P391, DOI 10.1007/s12253-013-9708-z; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1; Zhong FF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150505	35	11	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212309	10.1371/journal.pone.0212309	http://dx.doi.org/10.1371/journal.pone.0212309			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785924	gold, Green Published, Green Submitted			2022-12-27	WOS:000459307000055
J	Chen, YY; Fang, WH; Wang, CC; Kao, TW; Chang, YW; Wu, CJ; Zhou, YC; Sun, YS; Chen, WL				Chen, Yuan-Yuei; Fang, Wen-Hui; Wang, Chung-Ching; Kao, Tung-Wei; Chang, Yaw-Wen; Wu, Chen-Jung; Zhou, Yi-Chao; Sun, Yu-Shan; Chen, Wei-Liang			Helicobacter pylori infection increases risk of incident metabolic syndrome and diabetes: A cohort study	PLOS ONE			English	Article							17-BETA-ESTRADIOL; INTERLEUKIN-8; ASSOCIATION; SECRETION; FOCUS; VACA	Emerging studies have shed light on the association between Helicobacter pylori (HP) infection and cardiometabolic risk. However, there is no evidence to support a causal link for the relationship in the general population. Our aim was to determine whether HP infection is associated with the risks of incident type II diabetes mellitus (DM) in a population-based cohort consisting of adults from the general population. A total of 69235 adults enrolled in the study obtained health examinations at the Tri-Service General Hospital in Taiwan from 2010 to 2016. HP infection detection was performed by rapid urease tests (RUTs), and endoscopic examinations were used to diagnose gastroesophageal reflux disease (GERD), gastric ulcers (GUs) and duodenal ulcers (DUs). Cross-sectional and longitudinal analyses were performed to examine the association between HP infection and cardiometabolic diseases using logistic regression and Cox regression in a large population-based study. HP infection was significantly associated with the presence of metabolic syndrome (MetS) (OR = 1.26, 95%CI: 1.00-1.57) and DM (OR = 1.59, 95%CI: 1.17-2.17) only in male subjects, and abnormal endoscopic findings were also correlated with cardiometabolic diseases. Our findings demonstrated that participants with HP infection had an elevated risk of developing incident DM (HR = 1.54, 95%CI: 1.11-2.13). In addition, endoscopic findings of a DU (HR = 1.63, 95%CI: 1.02-2.63), rather than GERD or a GU, were also predictive of incident DM. In this cohort, HP infection was a statistically significant predictor of incident DM among male population.	[Chen, Yuan-Yuei] Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Songshan Branch, Taipei, Taiwan; [Chen, Yuan-Yuei; Fang, Wen-Hui; Wang, Chung-Ching; Kao, Tung-Wei; Chang, Yaw-Wen; Wu, Chen-Jung; Zhou, Yi-Chao; Sun, Yu-Shan; Chen, Wei-Liang] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Chen, Yuan-Yuei; Fang, Wen-Hui; Wang, Chung-Ching; Kao, Tung-Wei; Chang, Yaw-Wen; Wu, Chen-Jung; Zhou, Yi-Chao; Sun, Yu-Shan; Chen, Wei-Liang] Natl Def Med Ctr, Div Family Med, Dept Family & Community Med, Triserv Gen Hosp, Taipei, Taiwan; [Fang, Wen-Hui; Kao, Tung-Wei; Chang, Yaw-Wen; Wu, Chen-Jung; Sun, Yu-Shan; Chen, Wei-Liang] Natl Def Med Ctr, Div Geriatr Med, Dept Family & Community Med, Triserv Gen Hosp, Taipei, Taiwan; [Fang, Wen-Hui; Kao, Tung-Wei; Chang, Yaw-Wen; Sun, Yu-Shan; Chen, Wei-Liang] Natl Def Med Ctr, Hlth Management Ctr, Dept Family & Community Med, Triserv Gen Hosp, Taipei, Taiwan; [Wu, Chen-Jung] Taoyuan Armed Forces Gen Hosp, Dept Community Med, Div Family Med, Taoyuan, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital	Chen, WL (corresponding author), Natl Def Med Ctr, Sch Med, Taipei, Taiwan.; Chen, WL (corresponding author), Natl Def Med Ctr, Div Family Med, Dept Family & Community Med, Triserv Gen Hosp, Taipei, Taiwan.; Chen, WL (corresponding author), Natl Def Med Ctr, Div Geriatr Med, Dept Family & Community Med, Triserv Gen Hosp, Taipei, Taiwan.; Chen, WL (corresponding author), Natl Def Med Ctr, Hlth Management Ctr, Dept Family & Community Med, Triserv Gen Hosp, Taipei, Taiwan.	weiliang0508@gmail.com	Chang, Yaw-Wen/AAF-2630-2020	Chang, Yaw-Wen/0000-0002-8436-0518				Bagheri N, 2015, MICROB PATHOGENESIS, V81, P33, DOI 10.1016/j.micpath.2015.03.010; Bajaj Sarita, 2014, Indian J Endocrinol Metab, V18, P694, DOI 10.4103/2230-8210.139235; Calvet X, 2009, CLIN INFECT DIS, V48, P1385, DOI 10.1086/598198; Cover TL, 2005, NAT REV MICROBIOL, V3, P320, DOI 10.1038/nrmicro1095; CRABTREE JE, 1995, J CLIN PATHOL, V48, P967, DOI 10.1136/jcp.48.10.967; Eeskandarian R, 2012, CARDIOVASC J AFR, V23, P131, DOI 10.5830/CVJA-2011-016; ELOMAR EM, 1995, GASTROENTEROLOGY, V109, P681, DOI 10.1016/0016-5085(95)90374-7; Gasbarrini A, 1998, EUR J GASTROEN HEPAT, V10, P469, DOI 10.1097/00042737-199806000-00006; Herman WH, 2016, DIABETES CARE, V39, pS3, DOI 10.2337/dc16-S002; Jeffery PL, 2011, WORLD J GASTROENTERO, V17, P1249, DOI 10.3748/wjg.v17.i10.1249; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jeon CY, 2012, DIABETES CARE, V35, P520, DOI 10.2337/dc11-1043; Kato S, 2004, ALIMENT PHARM THERAP, V20, P17, DOI 10.1111/j.1365-2036.2004.01985.x; Kayar Y, 2015, RELATIONSHIP HELICOB, P1; Kohlgruber A, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0670-x; KUIPERS EJ, 1995, ALIMENT PHARM THERAP, V9, P59; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Mishra RR, 2013, INDIAN J GASTROENTER, V32, P232, DOI 10.1007/s12664-013-0321-6; NOMURA A, 1994, ANN INTERN MED, V120, P977, DOI 10.7326/0003-4819-120-12-199406150-00001; Ohtani M, 2007, CARCINOGENESIS, V28, P2597, DOI 10.1093/carcin/bgm150; Ohtani M, 2011, CARCINOGENESIS, V32, P1244, DOI 10.1093/carcin/bgr072; Perna F, 2005, Minerva Gastroenterol Dietol, V51, P247; Qi L, 2008, CURR MOL MED, V8, P519, DOI 10.2174/156652408785747915; SIMON L, 1989, Orvosi Hetilap, V130, P1325; Sundrud MS, 2004, P NATL ACAD SCI USA, V101, P7727, DOI 10.1073/pnas.0401528101; Uotani T, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2014.12.04; Wang YK, 2015, WORLD J GASTROENTERO, V21, P11221, DOI 10.3748/wjg.v21.i40.11221; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; White JR, 2015, J INFLAMM RES, V8, P137, DOI 10.2147/JIR.S64888; Wong WM, 1999, GUT, V44, P890, DOI 10.1136/gut.44.6.890; WOTHERSPOON AC, 1991, LANCET, V338, P1175, DOI 10.1016/0140-6736(91)92035-Z; Zhou MG, 2018, DIABETOLOGIA, V61, P300, DOI 10.1007/s00125-017-4465-2	32	12	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0208913	10.1371/journal.pone.0208913	http://dx.doi.org/10.1371/journal.pone.0208913			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779804	Green Published, Green Submitted, gold			2022-12-27	WOS:000459062900006
J	Orkibi, H; Feniger-Schaal, R				Orkibi, Hod; Feniger-Schaal, Rinat			Integrative systematic review of psychodrama psychotherapy research: Trends and methodological implications	PLOS ONE			English	Review							ARTICLE REPORTING STANDARDS; YOUTH VIOLENCE PREVENTION; CLINICAL-SIGNIFICANCE; MENTAL-HEALTH; APA PUBLICATIONS; OUTCOME RESEARCH; GROUP-THERAPY; PSYCHOLOGY; FIDELITY; MUSIC	Background Psychodrama is an experiential psychotherapy in which guided role-play is used to gain insights and work on personal and interpersonal problems and possible solutions. Despite the wealth of literature describing clinical work, psychodrama intervention research is relatively scarce compared to other psychotherapies and psychological interventions. Objective For this reason we implemented the integrative approach to systematic review that authorizes the combination of publications with diverse methodologies and all types of participants, interventions, comparisons, and outcomes. Our aim was to produce a comprehensive summary of psychodrama intervention research in the last decade that critically evaluates methodological issues to inform future studies. Methods We searched four major electronic databases (PsycINFO, PubMEd, Scopus by Elsevier, and Web of Science) for peer-reviewed articles on psychodrama interventions published in English between 1 January 2007 and 31 December 2017. The quality of qualitative and mixed methods studies was assessed on the basis of pre-established guidelines, and the risk of bias was assessed for all quantitative randomized control studies, consistent with the PRISMA protocol. Findings The database search and a hand search resulted in 31 psychodrama intervention publications. Overall, these studies examined the effects of psychodrama on more than 20 different outcomes and most studies had adult clients. The next largest group was adolescents, whereas only two studies involved children. Thus psychodrama intervention research in the last decade suggests there are promising results in all methodologies, and highlights the need to enhance methodological as well as reporting quality and to theorize and examine modality-specific mechanisms that lead to therapeutic change. Recommendations to improve methodology, transparency, and specificity in reporting future psychodrama and other psychotherapy research are discussed.	[Orkibi, Hod; Feniger-Schaal, Rinat] Univ Haifa, Fac Social Welf & Hlth Sci, Sch Creat Arts Therapies, Haifa, Israel	University of Haifa	Orkibi, H (corresponding author), Univ Haifa, Fac Social Welf & Hlth Sci, Sch Creat Arts Therapies, Haifa, Israel.	horkibi@univ.haifa.ac.il		Orkibi, Hod/0000-0003-1498-7953				Akinsola E. F., 2013, PSYCHOLOGY, V4, P246, DOI [DOI 10.4236/PSYCH.2013.43A037, 10.4236/psych.2013.43A037]; Alby F, 2017, RASSEGNA PSICOLOGIA, V34, P67; Ang KX, 2018, PALLIATIVE MED, V32, P500, DOI 10.1177/0269216317717369; Appelbaum M, 2018, AM PSYCHOL, V73, P3, DOI 10.1037/amp0000191; Aytemur ZA, 2012, TURK KLIN TIP BILIM, V32, P630, DOI 10.5336/medsci.2011-23965; Azoulay B, 2015, ART PSYCHOTHER, V42, P10, DOI 10.1016/j.aip.2014.12.012; Bilge A, 2017, J PSYCHIATR NURS, V8, P59, DOI 10.14744/phd.2017.08760; Biolcati R, 2017, RES PSYCHOTHER-PSYCH, V20, P201, DOI 10.4081/ripppo.2017.272; Buuren S.V., 2012, FLEXIBLE IMPUTATION; Chae SE, 2017, J COLL STUD PSYCH, V31, P59, DOI 10.1080/87568225.2016.1239512; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen L.M., 2011, ENCY CREATIVITY, V2nd ed., P9; Comer J. S., 2013, BERGIN GARFIELDS HDB, Vsixth, P21; Creswell J.W., 2018, RES DESIGN, V5th; Creswell W. C., 2011, DESIGNING CONDUCTING; Dehnavi S, 2016, INT J MED RES HEALTH, V5, P243; Denton WH, 2009, J COUPLE RELATSH THE, V8, P226, DOI 10.1080/15332690903048820; Dogan T, 2010, ART PSYCHOTHER, V37, P112, DOI 10.1016/j.aip.2010.02.001; Elliott R, 2002, PSYCHOTHER RES, V12, P1, DOI 10.1080/713869614; Feniger-Schaal R, 2019, INTEGRATIVE SYSTEMAT; Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808; Fox Jonathan, 1987, ESSENTIAL MORENO WRI; Frazier PA, 2004, J COUNS PSYCHOL, V51, P115, DOI 10.1037/0022-0167.51.1.115; Galvan J.L., 2006, WRITING LIT REV GUID; Gatta M, 2010, ART PSYCHOTHER, V37, P240, DOI 10.1016/j.aip.2010.04.010; Gokcakan Z., 2009, TURKISH JOURNAL OF P, V20, P1; Gonzalez AJ, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01662; Gupta Sandeep K, 2011, Perspect Clin Res, V2, P109, DOI 10.4103/2229-3485.83221; Harkins L, 2011, INT J OFFENDER THER, V55, P546, DOI 10.1177/0306624X10370452; Hawker S, 2002, QUAL HEALTH RES, V12, P1284, DOI 10.1177/1049732302238251; Heppner PP., 2015, RES DESIGN COUNSELIN; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hildebrand MW, 2012, AM J PHYS MED REHAB, V91, P715, DOI 10.1097/PHM.0b013e31824ad462; Hogberg Goran, 2008, Clin Child Psychol Psychiatry, V13, P435; Holmes P, 2005, PSYCHODRAMA MORENO I; Hopia H, 2016, SCAND J CARING SCI, V30, P662, DOI 10.1111/scs.12327; Hug E, 1997, ART PSYCHOTHER, V24, P31, DOI 10.1016/S0197-4556(96)00046-9; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Kahonen K, 2012, SCAND J PSYCHOL, V53, P523, DOI 10.1111/sjop.12020; Karabilgin OS, 2012, EUR J PSYCHOTHER COU, V14, P317, DOI 10.1080/13642537.2012.734529; Karatas Z, 2014, EGIT BILIM, V39, P117; Karatas Z, 2011, KURAM UYGUL EGIT BIL, V11, P609; Karatas Z, 2009, KURAM UYGULAMA EGI, V9, P1441; Kazdin A.E., 2011, SINGLE CASE RES DESI, V2nd; Kazdin A. E., 2014, QUANTITATIVE QUALITA, P87, DOI DOI 10.4324/9780203386071-6; Kazdin AE, 2009, PSYCHOTHER RES, V19, P418, DOI 10.1080/10503300802448899; KELLERMANN PF, 1987, SMALL GROUP BEHAV, V18, P459, DOI 10.1177/104649648701800402; Kellermann PF, 2000, FOCUS PSYCHODRAMA TH; Kipper DA, 2003, GROUP DYN-THEOR RES, V7, P13, DOI 10.1037/1089-2699.7.1.13; Kisbu-Sakarya Y, 2013, EDUC PSYCHOL MEAS, V73, P47, DOI 10.1177/0013164412450574; Konopik DA, 2013, SOC WORK, V58, P9, DOI 10.1093/sw/sws054; Kratochwill T. R., 2010, SINGLE CASE DESIGNS; Laird KT, 2017, CLIN PSYCHOL REV, V51, P142, DOI 10.1016/j.cpr.2016.11.001; Lambert MJ, 2009, PSYCHOTHER RES, V19, P493, DOI 10.1080/10503300902849483; Lee JH, 2016, J MUSIC THER, V53, P430, DOI 10.1093/jmt/thw012; Leung WC, 2001, POSTGRAD MED J, V77, P201, DOI 10.1136/pmj.77.905.201; Levitt HM, 2018, AM PSYCHOL, V73, P26, DOI 10.1037/amp0000151; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lutz W, 2014, QUANTITATIVE QUALITA, DOI [10.1080/10503307.2014.989290, DOI 10.1080/10503307.2014.989290]; McVea CS, 2011, PSYCHOTHER RES, V21, P416, DOI 10.1080/10503307.2011.577823; Menichetti J, 2016, EUR J CANCER CARE, V25, P903, DOI 10.1111/ecc.12412; Methley AM, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0579-0; Moreno JL, 1955, SOCIOMETRY, V18, P105, DOI 10.2307/2785848; Moreno J.L., 1946, PSYCHODRAMA, V1; MORENO JL, 1964, GROUP PSYCHOTHER PSY, V17, P149; Moreno JL, 1978, WHO SHALL SURVIVE FD; Munder T, 2018, PSYCHOTHER RES, V28, P347, DOI 10.1080/10503307.2017.1411628; Munn Z, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-017-0468-4; Oguzhanoglu NK, 2014, TURK PSIKIYATR DERG, V25, P75; Orkibi H, 2019, PSYCHOL AESTHET CREA, V13, P416, DOI 10.1037/aca0000193; Orkibi H, 2018, ART PSYCHOTHER, V59, P101, DOI 10.1016/j.aip.2018.04.004; Orkibi H, 2017, CLIN PSYCHOL PSYCHOT, V24, pO1455, DOI 10.1002/cpp.2103; Orkibi H, 2017, ART PSYCHOTHER, V55, P46, DOI 10.1016/j.aip.2017.04.001; Orkibi H, 2014, ART PSYCHOTHER, V41, P458, DOI 10.1016/j.aip.2014.08.006; Ozbas AA, 2016, PALLIAT SUPPORT CARE, V14, P393, DOI 10.1017/S1478951515001121; Robb SL, 2011, J HEALTH PSYCHOL, V16, P342, DOI 10.1177/1359105310374781; Ronk FR, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0895-5; Smokowski PR, 2009, RES SOCIAL WORK PRAC, V19, P165, DOI 10.1177/1049731508315989; Smokowski PR, 2009, SMALL GR RES, V40, P3, DOI 10.1177/1046496408326771; Sproesser E, 2010, PARKINSONISM RELAT D, V16, P298, DOI 10.1016/j.parkreldis.2009.08.008; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; Tarashoeva G., 2017, INT J PSYCHOTHER, V21, P55; Ten Have TR, 2008, PSYCHIAT ANN, V38, P772, DOI 10.3928/00485713-20081201-10; Terzioglu C, 2018, SEX DISABIL, V36, P87, DOI 10.1007/s11195-017-9514-8; Vural P, 2014, ART PSYCHOTHER, V41, P233, DOI 10.1016/j.aip.2014.02.004; Wampold BE, 2015, WORLD PSYCHIATRY, V14, P270, DOI 10.1002/wps.20238; Whittemore R, 2005, J ADV NURS, V52, P546, DOI 10.1111/j.1365-2648.2005.03621.x; Wieser M., 2007, PSYCHODRAMA ADV THEO, P271; Zhao K, 2016, INT J GERIATR PSYCH, V31, P1188, DOI 10.1002/gps.4494	89	43	48	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212575	10.1371/journal.pone.0212575	http://dx.doi.org/10.1371/journal.pone.0212575			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL9KY	30779787	Green Submitted, Green Published, gold			2022-12-27	WOS:000459062900066
J	Sheehan, K; Lee, J; Chong, J; Zavala, K; Sharma, M; Philipsen, S; Maruyama, T; Xu, ZY; Guan, ZH; Eilers, H; Kawamata, T; Schumacher, M				Sheehan, Kayla; Lee, Jessica; Chong, Jillian; Zavala, Kathryn; Sharma, Manohar; Philipsen, Sjaak; Maruyama, Tomoyuki; Xu, Zheyun; Guan, Zhonghui; Eilers, Helge; Kawamata, Tomoyuki; Schumacher, Mark			Transcription factor Sp4 is required for hyperalgesic state persistence	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; PRIMARY SENSORY NEURONS; CHEMOTHERAPY-INDUCED NEUROPATHY; DORSAL-ROOT; VANILLOID RECEPTOR; PERIPHERAL INFLAMMATION; COLD HYPERSENSITIVITY; PAINFUL NEUROPATHY; TRPV1 EXPRESSION; ANIMAL-MODEL	Understanding how painful hypersensitive states develop and persist beyond the initial hours to days is critically important in the effort to devise strategies to prevent and/or reverse chronic painful states. Changes in nociceptor transcription can alter the abundance of nociceptive signaling elements, resulting in longer-term change in nociceptor phenotype. As a result, sensitized nociceptive signaling can be further amplified and nocifensive behaviors sustained for weeks to months. Building on our previous finding that transcription factor Sp4 positively regulates the expression of the pain transducing channel TRPV1 in Dorsal Root Ganglion (DRG) neurons, we sought to determine if Sp4 serves a broader role in the development and persistence of hypersensitive states in mice. We observed that more than 90% of Sp4 staining DRG neurons were small to medium sized, primarily unmyelinated (NF200 neg) and the majority co-expressed nociceptor markers TRPV1 and/or isolectin B4 (IB4). Genetically modified mice (Sp4+/-) with a 50% reduction of Sp4 showed a reduction in DRG TRPV1 mRNA and neuronal responses to the TRPV1 agonist-capsaicin. Importantly, Sp4 +/- mice failed to develop persistent inflammatory thermal hyperalgesia, showing a reversal to control values after 6 hours. Despite a reversal of inflammatory thermal hyperalgesia, there was no difference in CFA-induced hindpaw swelling between CFA Sp4+/- and CFA wild type mice. Similarly, Sp4+/- mice failed to develop persistent mechanical hypersensitivity to hind-paw injection of NGF. Although Sp4+/- mice developed hypersensitivity to traumatic nerve injury, Sp4+/- mice failed to develop persistent cold or mechanical hypersensitivity to the platinum-based chemotherapeutic agent oxaliplatin, a non-traumatic model of neuropathic pain. Overall, Sp4+/- mice displayed a remarkable ability to reverse the development of multiple models of persistent inflammatory and neuropathic hypersensitivity. This suggests that Sp4 functions as a critical control point for a network of genes that conspire in the persistence of painful hypersensitive states.	[Sheehan, Kayla; Lee, Jessica; Chong, Jillian; Zavala, Kathryn; Sharma, Manohar; Xu, Zheyun; Guan, Zhonghui; Eilers, Helge; Schumacher, Mark] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Philipsen, Sjaak] Erasmus Univ, Med Ctr, Dept Cell Biol, Rotterdam, Netherlands; [Maruyama, Tomoyuki; Kawamata, Tomoyuki] Wakayama Med Univ, Dept Anesthesiol, Wakayama, Japan	University of California System; University of California San Francisco; Erasmus University Rotterdam; Erasmus MC; Wakayama Medical University	Schumacher, M (corresponding author), Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA.	Mark.Schumacher@ucsf.edu	Kawamata, Tomoyuki/AAY-6918-2020	Sheehan, Kayla/0000-0003-3944-1666; Xu, Zheyun/0000-0002-1101-7014	Department of Anesthesia and Perioperative Care; University of California, San Francisco (UCSF); National Institutes of Health (NIH) [NS38737]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS100801] Funding Source: NIH RePORTER	Department of Anesthesia and Perioperative Care; University of California, San Francisco (UCSF)(University of California System); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by: MS: Department of Anesthesia and Perioperative Care. University of California, San Francisco (UCSF), with additional support at the projects inception from the National Institutes of Health (NIH) NS38737. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers JW, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005228.pub3; Alloui A, 2006, EMBO J, V25, P2368, DOI 10.1038/sj.emboj.7601116; Amann R, 1996, PAIN, V64, P323, DOI 10.1016/0304-3959(95)00120-4; Amaya F, 2004, EUR J NEUROSCI, V20, P2303, DOI 10.1111/j.1460-9568.2004.03701.x; Amaya F, 2003, BRAIN RES, V963, P190, DOI 10.1016/S0006-8993(02)03972-0; Anderson EO, 2018, CELL REP, V23, P701, DOI 10.1016/j.celrep.2018.03.094; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Attal N, 2009, PAIN, V144, P245, DOI 10.1016/j.pain.2009.03.024; Baiou D, 2007, J COMP NEUROL, V503, P334, DOI 10.1002/cne.21389; Barabas ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047988; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Blackshaw LA, 2014, BRIT J PHARMACOL, V171, P2528, DOI 10.1111/bph.12641; Bonnington JK, 2003, J PHYSIOL-LONDON, V551, P433, DOI 10.1113/jphysiol.2003.039990; Bouwman P, 2002, MOL CELL ENDOCRINOL, V195, P27, DOI 10.1016/S0303-7207(02)00221-6; Bouwman P, 2000, EMBO J, V19, P655, DOI 10.1093/emboj/19.4.655; Breese NM, 2005, PAIN, V115, P37, DOI 10.1016/j.pain.2005.02.010; Brierley SM, 2011, J PHYSIOL-LONDON, V589, P3575, DOI 10.1113/jphysiol.2011.206789; Brouwers Elke E M, 2008, BMC Clin Pharmacol, V8, P7, DOI 10.1186/1472-6904-8-7; Capsoni S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017321; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cavanaugh DJ, 2011, J NEUROSCI, V31, P5067, DOI 10.1523/JNEUROSCI.6451-10.2011; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; Chang WC, 2005, BIOCHEM BIOPH RES CO, V338, P117, DOI 10.1016/j.bbrc.2005.08.014; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Cheng YR, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0448-y; Chu C, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-44; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Crow M, 2015, FASEB J, V29, P3370, DOI 10.1096/fj.14-264440; Daemen MARC, 1998, NEUROL RES, V20, P41; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; De Felice M, 2011, PAIN, V152, P2701, DOI 10.1016/j.pain.2011.06.008; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Descoeur J, 2011, EMBO MOL MED, V3, P266, DOI 10.1002/emmm.201100134; Diogenes A, 2007, J DENT RES, V86, P550, DOI 10.1177/154405910708600612; Eskander MA, 2015, J NEUROSCI, V35, P8593, DOI 10.1523/JNEUROSCI.3993-14.2015; Gauchan P, 2009, NEUROSCI LETT, V458, P93, DOI 10.1016/j.neulet.2009.04.029; Geber C, 2013, PAIN, V154, P2877, DOI 10.1016/j.pain.2013.08.028; Gereau RW, 2014, J PAIN, V15, P1203, DOI 10.1016/j.jpain.2014.09.004; GOLDSTEIN ME, 1991, J NEUROSCI RES, V30, P92, DOI 10.1002/jnr.490300111; Gollner H, 2001, MECH DEVELOP, V106, P77, DOI 10.1016/S0925-4773(01)00420-8; Gollner H, 2001, GENES CELLS, V6, P689, DOI 10.1046/j.1365-2443.2001.00455.x; GREGG RW, 1992, J CLIN ONCOL, V10, P795, DOI 10.1200/JCO.1992.10.5.795; Gregus AM, 2012, P NATL ACAD SCI USA, V109, P6721, DOI 10.1073/pnas.1110460109; Guan Zhonghui, 2016, F1000Res, V5; Guan ZH, 2016, NAT NEUROSCI, V19, P94, DOI 10.1038/nn.4189; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Heurteaux C, 2004, EMBO J, V23, P2684, DOI 10.1038/sj.emboj.7600234; Hong GS, 2016, NEURON, V91, P708, DOI 10.1016/j.neuron.2016.07.019; Indo Y, 2001, HUM MUTAT, V18, P462, DOI 10.1002/humu.1224; Ji RR, 2002, NEURON, V36, P57, DOI 10.1016/S0896-6273(02)00908-X; Johar K, 2014, EUR J NEUROSCI, V39, P566, DOI 10.1111/ejn.12415; Johar K, 2013, J NEUROCHEM, V127, P496, DOI 10.1111/jnc.12433; Joseph EK, 2008, J PAIN, V9, P463, DOI 10.1016/j.jpain.2008.01.335; Kato Y, 2014, ANTI-CANCER DRUG, V25, P39, DOI 10.1097/CAD.0000000000000022; Kays J, 2018, NEUROSCIENCE, V371, P420, DOI 10.1016/j.neuroscience.2017.12.030; Kehlet H, 2006, LANCET, V367, P1618, DOI 10.1016/S0140-6736(06)68700-X; Kwon HS, 1999, J BIOL CHEM, P274; Lawton SK, 2017, J IMMUNOL, V199, P1465, DOI 10.4049/jimmunol.1602151; Lennertz RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043597; Leonard GD, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-116; Lerner LE, 2002, J BIOL CHEM, V277, P25877, DOI 10.1074/jbc.M201407200; LEWIN GR, 1993, TRENDS NEUROSCI, V16, P353, DOI 10.1016/0166-2236(93)90092-Z; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Liedtke W, 2005, J PHYSIOL-LONDON, V567, P53, DOI 10.1113/jphysiol.2005.088963; Lin T, 2007, J NEUROIMMUNOL, V192, P40, DOI 10.1016/j.jneuroim.2007.09.003; Ling B, 2007, TOXICOLOGY, V234, P176, DOI 10.1016/j.tox.2007.02.013; Ling B, 2007, PAIN, V128, P225, DOI 10.1016/j.pain.2006.09.016; Malik-Hall M, 2005, EUR J NEUROSCI, V21, P3387, DOI 10.1111/j.1460-9568.2005.04173.x; McMahon SB, 1996, PHILOS T R SOC B, V351, P431, DOI 10.1098/rstb.1996.0039; Michael GJ, 1999, J NEUROSCI, V19, P1844; Mills CD, 2013, EUR J PAIN, V17, P469, DOI 10.1002/j.1532-2149.2012.00202.x; Miltenburg NC, 2014, CANCER TREAT REV, V40, P872, DOI 10.1016/j.ctrv.2014.04.004; Mizuno K, 2014, J PHARMACOL SCI, V125, P91, DOI 10.1254/jphs.13244FP; Nair B, 2016, BBA-MOL CELL RES, V1863, P1, DOI 10.1016/j.bbamcr.2015.10.005; Nassini R, 2011, PAIN, V152, P1621, DOI 10.1016/j.pain.2011.02.051; Niiyama Y, 2007, NEUROSCIENCE, V148, P560, DOI 10.1016/j.neuroscience.2007.05.049; Pachman DR, 2014, J CLIN INVEST, V124, P72, DOI 10.1172/JCI73908; Pasetto LM, 2006, CRIT REV ONCOL HEMAT, V59, P159, DOI 10.1016/j.critrevonc.2006.01.001; Petruska JC, 2004, NEUROSCI LETT, V361, P168, DOI 10.1016/j.neulet.2003.12.012; Pinacho R, 2011, BIPOLAR DISORD, V13, P474, DOI 10.1111/j.1399-5618.2011.00941.x; Piomelli D, 2014, NAT NEUROSCI, V17, P164, DOI 10.1038/nn.3612; Priya A, 2014, BBA-MOL CELL RES, V1843, P1196, DOI 10.1016/j.bbamcr.2014.02.008; Qiu ZH, 2006, J BIOL CHEM, V281, P16672, DOI 10.1074/jbc.M511648200; Ramos B, 2007, P NATL ACAD SCI USA, V104, P9882, DOI 10.1073/pnas.0701946104; Ramos B, 2009, MOL CELL NEUROSCI, V42, P152, DOI 10.1016/j.mcn.2009.06.008; Ranade SS, 2014, NATURE, V516, P121, DOI 10.1038/nature13980; Reichling DB, 2013, PAIN, V154, pS2, DOI 10.1016/j.pain.2013.05.037; Reichling DB, 2009, TRENDS NEUROSCI, V32, P611, DOI 10.1016/j.tins.2009.07.007; Reichling DB, 1997, P NATL ACAD SCI USA, V94, P7006, DOI 10.1073/pnas.94.13.7006; Ren Ke, 1999, ILAR J, V40, P111; Rukwied R, 2010, PAIN, V148, P407, DOI 10.1016/j.pain.2009.11.022; Saia G, 2014, J NEUROCHEM, V129, P743, DOI 10.1111/jnc.12657; Sakai K, 2016, PAIN, V157, P2536, DOI 10.1097/j.pain.0000000000000674; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schuhmacher LN, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0279-2; Schumacher MA, 2010, PAIN PRACT, V16, DOI [10.1111/J.1471-4159.2006.04363.X, DOI 10.1111/J.1471-4159.2006.04363.X]; Sexton JE, 2014, HANDB EXP PHARMACOL, V223, P873, DOI 10.1007/978-3-319-05161-1_6; Shi J, 2011, MOL PSYCHIATR, V16, P193, DOI 10.1038/mp.2009.124; Shields SD, 2003, J PAIN, V4, P465, DOI 10.1067/S1526-5900(03)00781-8; Shin J, 2002, P NATL ACAD SCI USA, V99, P10150, DOI 10.1073/pnas.152002699; Shu XQ, 1999, P NATL ACAD SCI USA, V96, P7693, DOI 10.1073/pnas.96.14.7693; Sisignano M, 2014, NAT REV NEUROL, V10, P694, DOI 10.1038/nrneurol.2014.211; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Sugimoto A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18089-0; Sun XX, 2015, DEV NEUROBIOL, V75, P93, DOI 10.1002/dneu.22212; Sung KJ, 2018, J NEUROSCI, V38, P3394, DOI 10.1523/JNEUROSCI.1686-17.2018; Supp DM, 1996, DEV BIOL, V176, P284, DOI 10.1006/dbio.1996.0134; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Ta LE, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-15; Ugarte GD, 2013, J CELL PHYSIOL, V228, P860, DOI 10.1002/jcp.24236; WOOLF CJ, 1994, NEUROSCIENCE, V62, P327, DOI 10.1016/0306-4522(94)90366-2; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Xue Q, 2001, GENOMICS, V76, P14, DOI 10.1006/geno.2001.6582; Xue Q, 2007, J NEUROCHEM, V101, P212, DOI 10.1111/j.1471-4159.2006.04363.x; Yamamoto K, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0072-8; Yan F, 2015, J NEUROCHEM, V135, P1099, DOI 10.1111/jnc.13355; Yu L, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-61; Zappia KJ, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0069-16.2017; Zavala K, 2014, NEUROSCI LETT, V578, P211, DOI 10.1016/j.neulet.2014.01.021; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893; Zhao CT, 2006, BIOCHEM BIOPH RES CO, V342, P214, DOI 10.1016/j.bbrc.2006.01.134; Zhou X, 2007, GENES BRAIN BEHAV, V6, P269, DOI 10.1111/j.1601-183X.2006.00256.x; Zhou X, 2005, MOL PSYCHIATR, V10, P393, DOI 10.1038/sj.mp.4001621; Zhou XJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005196; Zhu WG, 2007, MOL CELL NEUROSCI, V34, P689, DOI 10.1016/j.mcn.2007.01.005; Zhuang ZY, 2004, J NEUROSCI, V24, P8300, DOI 10.1523/JNEUROSCI.2893-04.2004; Zwick M, 2002, J NEUROSCI, V22, P4057, DOI 10.1523/JNEUROSCI.22-10-04057.2002	128	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211349	10.1371/journal.pone.0211349	http://dx.doi.org/10.1371/journal.pone.0211349			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811405	Green Published, gold, Green Submitted			2022-12-27	WOS:000459806400016
J	van Dammen, L; Wekker, V; de Rooij, SR; Mol, BJ; Groen, H; Hoek, A; Roseboom, TJ				van Dammen, Lotte; Wekker, Vincent; de Rooij, Susanne R.; Mol, Ben Willem J.; Groen, Henk; Hoek, Annemieke; Roseboom, Tessa J.			The effects of a pre-conception lifestyle intervention in women with obesity and infertility on perceived stress, mood symptoms, sleep and quality of life	PLOS ONE			English	Article							DEPRESSION SCALE HADS; HEALTH SURVEY SF-36; HOSPITAL ANXIETY; WEIGHT-LOSS; ILL PATIENTS; VERSION; ADULTS; VALIDATION; VALIDITY; OUTCOMES	Background Obesity is an increasing problem worldwide and is associated with serious health risks. Obesity not only reduces physical health, but can also negatively affect levels of perceived stress, mood symptoms, sleep quality and quality of life (QoL), which may lead to further weight gain. We have previously shown that a pre-conception lifestyle intervention reduced weight and improved physical QoL in the short term. In the current study, we assessed the effects of this intervention in women with obesity and infertility on perceived stress, mood symptoms, sleep quality and QoL five years after randomization. Methods and findings We followed women who participated in the LIFEstyle study. This is a multi-center randomized controlled trial comparing a six-month lifestyle intervention to improve diet and increase physical activity followed by infertility treatment, versus prompt infertility treatment. Participants were 577 women with infertility between 18 and 39 years of age with a body mass index (BMI). 29 kg/m(2). For the current study we measured perceived stress, mood symptoms, sleep quality and QoL in 178 women five years after randomization. T-tests and linear regression models were used to assess differences between the intervention and control groups. Five years after randomization, no differences were observed for perceived stress, mood symptoms, sleep quality and QoL between the intervention (n = 84) and control groups (n = 94). There was selective participation: women who did not participate in the follow-up had lower baseline mental QoL, and benefitted more from the intervention in terms of improved physical QoL during the original LIFEstyle intervention. Conclusions We found no evidence that a pre-conception lifestyle intervention improved female wellbeing five years after randomization.	[van Dammen, Lotte; Hoek, Annemieke] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynecol, Groningen, Netherlands; [van Dammen, Lotte; Groen, Henk] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Wekker, Vincent; Roseboom, Tessa J.] Univ Amsterdam, Amsterdam UMC, Dept Obstet & Gynecol, Amsterdam, Netherlands; [Wekker, Vincent; de Rooij, Susanne R.; Roseboom, Tessa J.] Univ Amsterdam, Amsterdam UMC, Dept Clin Epidemiol Biostat & Bioinformat, Amsterdam, Netherlands; [Wekker, Vincent; Roseboom, Tessa J.] Amsterdam UMC, Amsterdam Reprod & Dev Res Inst, Amsterdam, Netherlands; [Wekker, Vincent; Roseboom, Tessa J.] Amsterdam UMC, Amsterdam Publ Hlth Res Inst, Amsterdam, Netherlands; [Mol, Ben Willem J.] Monash Univ, Dept Obstet & Gynecol, Clayton, Vic, Australia	University of Groningen; University of Groningen; University of Amsterdam; University of Amsterdam; University of Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Monash University	van Dammen, L (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynecol, Groningen, Netherlands.; van Dammen, L (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.	l.van.dammen@umcg.nl	Groen, Henk/B-2163-2013	Groen, Henk/0000-0002-6629-318X; Mol, Ben Willem/0000-0001-8337-550X; de Rooij, Susanne Rosalie/0000-0001-7382-5749; Roseboom, Tessa/0000-0003-0564-5994	Netherlands Organization for Health Research and Development [50-50110-96-518]; Dutch Heart Foundation [2013T085]; European Commission (Horizon2020 project 'DynaHealth') [633595]	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Dutch Heart Foundation(Netherlands Heart Foundation); European Commission (Horizon2020 project 'DynaHealth')(European CommissionEuropean Commission Joint Research Centre)	This research was supported by The Netherlands Organization for Health Research and Development (50-50110-96-518), the Dutch Heart Foundation (Grant number: 2013T085), and the European Commission (Horizon2020 project 'DynaHealth', 633595). The department of obstetrics and gynaecology from the UMCG receives an unrestricted educational grant from Ferring Pharmaceutical BV the Netherlands, unrelated to the present study.	Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; Augner C, 2011, CENT EUR J PUBL HEAL, V19, P115, DOI 10.21101/cejph.a3647; Barnes RD, 2015, OBES REV, V16, P304, DOI 10.1111/obr.12264; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Butler AC, 2006, CLIN PSYCHOL REV, V26, P17, DOI 10.1016/j.cpr.2005.07.003; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chair SY, 2017, BMC WOMENS HEALTH, V17, DOI 10.1186/s12905-017-0436-5; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Dag ZO, 2017, GYNECOL ENDOCRINOL, V33, P250, DOI 10.1080/09513590.2016.1254610; Fabricatore AN, 2011, INT J OBESITY, V35, P1363, DOI 10.1038/ijo.2011.2; Ford M Allison, 2017, Int J Health Sci (Qassim), V11, P13; Gadie A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014920; Gaudry S, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0243-z; Hinz A, 2011, J PSYCHOSOM RES, V71, P74, DOI 10.1016/j.jpsychores.2011.01.005; Hopman WM, 2006, QUAL LIFE RES, V15, P527, DOI 10.1007/s11136-005-2096-4; Knufinke M, 2018, J SLEEP RES, V27, P78, DOI 10.1111/jsr.12509; Kolotkin R L, 2001, Obes Rev, V2, P219, DOI 10.1046/j.1467-789X.2001.00040.x; Korten NCM, 2017, INT J GERIATR PSYCH, V32, P439, DOI 10.1002/gps.4486; Lee M, 2009, J NUTR HEALTH AGING, V13, P576, DOI 10.1007/s12603-009-0110-1; Lucas AR, 2017, INTEGR CANCER THER, V16, P263, DOI 10.1177/1534735416668257; Marik PE, 2000, CHEST, V118, P569, DOI 10.1378/chest.118.3.569; Markowitz S, 2008, CLIN PSYCHOL-SCI PR, V15, P1, DOI 10.1111/j.1468-2850.2008.00106.x; Marques A, 2018, EUR J PUBLIC HEALTH, V28, P295, DOI 10.1093/eurpub/ckx143; McBride CM, 2003, HEALTH EDUC RES, V18, P156, DOI 10.1093/her/18.2.156; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Moore CJ, 2012, J ACAD NUTR DIET, V112, P518, DOI 10.1016/j.jand.2011.12.001; Mutsaerts MAQ, 2016, NEW ENGL J MED, V374, P1942, DOI 10.1056/NEJMoa1505297; Mutsaerts MAQ, 2010, BMC WOMENS HEALTH, V10, DOI 10.1186/1472-6874-10-22; Nordin M, 2013, SCAND J PSYCHOL, V54, P502, DOI 10.1111/sjop.12071; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Roberti JW, 2006, J COLL COUNS, V9, P135, DOI 10.1002/j.2161-1882.2006.tb00100.x; Ross KM, 2016, J BEHAV MED, V39, P465, DOI 10.1007/s10865-015-9704-8; Scott KM, 2008, INT J OBESITY, V32, P192, DOI 10.1038/sj.ijo.0803701; Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382; Szentkiralyi Andras, 2009, Expert Rev Pharmacoecon Outcomes Res, V9, P49, DOI 10.1586/14737167.9.1.49; van Dammen L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190662; van de Beek C, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-016579; van der Steeg JW, 2008, HUM REPROD, V23, P324, DOI 10.1093/humrep/dem371; Wadden TA, 2014, DIABETES CARE, V37, P1544, DOI 10.2337/dc13-1928; Wadden TA, 2014, OBESITY, V22, P5, DOI 10.1002/oby.20662; Ware JE, 1996, JAMA-J AM MED ASSOC, V276, P1039, DOI 10.1001/jama.1996.03540130037027; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008; Wu T, 2009, OBES REV, V10, P313, DOI 10.1111/j.1467-789X.2008.00547.x; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	45	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2019	14	2							e0212914	10.1371/journal.pone.0212914	http://dx.doi.org/10.1371/journal.pone.0212914			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8EH	30802271	Green Published, gold, Green Submitted			2022-12-27	WOS:000459710700025
J	Alemkere, G; Tenna, A; Engidawork, E				Alemkere, Getachew; Tenna, Admasu; Engidawork, Ephrem			Antibiotic use practice and predictors of hospital outcome among patients with systemic bacterial infection: Identifying targets for antibiotic and health care resource stewardship	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; EPIDEMIOLOGY; PROGRAM	Background Malpractice and excess use of antimicrobials have been associated with multiple costs, including the development of resistant bacteria, which has become a threat to the human health. The aim of this study, therefore, was to assess the antibiotic use practice and to identify predictors of hospital outcome to uncover targets for stewardship. Methods An Institution-based prospective observational study was performed from 9 April to 7 July 2014 in the internal medicine wards of Tikur Anbessa Specialized Hospital. Patients with suspected systemic bacterial infections during this period were strictly followed and data were abstracted using data abstraction format. Descriptive statistics and binary logistic regression were used for statistical analysis. Results About half of the attended patients had suspected systemic bacterial infections, in which pneumonia is the most common. Cephalosporins were the most widely prescribed class of drugs in all the wards. Initial antibiotics were empiric in almost all of the cases. About 28% of the ward and 59% of the ICU patients died during the in-hospital stay. The mean length of stay(LoS) was 18.5+12.2 in the wards and 8.9+4.9 days in the ICU. Whilst digestive disease (AOR = 6.94, 95% CI: 2.24, 21.49), different signs and symptoms of disease(AOR = 2.43, 95% CI: 1.30, 4.56), sepsis(AOR = 2.59, 95% CI: 1.12, 5.99) and vancomycin use(AOR = 2.60, 95% CI: 1.30, 5.21) were independent positive predictors, antibiotic days(> 10) (AOR = 0.37, 95% CI: 0.20, 0.70) was a negative predictor for mortality. On the other hand, hospital-acquired infection(AOR = 3.01, 95% CI: 1.05, 8.62), beyond the median antibiotic days (> 10) (AOR = 4.05, 95% CI: 1.96, 8.37) and agent days beyond 21 days (AOR = 2.18, 95% CI: 1.01-4.68) were independently associated with prolonged LoS. Conclusion Generally, this observation entails an appropriate infection management and antimicrobial use policy. Any future policy should better start by addressing cases like pneumonia, and sepsis and drugs like cephalosporins.	[Alemkere, Getachew; Engidawork, Ephrem] Addis Ababa Univ, Coll Hlth Sci, Sch Pharm, Dept Pharmacol & Clin Pharm, Addis Ababa, Ethiopia; [Tenna, Admasu] Addis Ababa Univ, Sch Med, Dept Internal Med, Addis Ababa, Ethiopia	Addis Ababa University; Addis Ababa University	Alemkere, G (corresponding author), Addis Ababa Univ, Coll Hlth Sci, Sch Pharm, Dept Pharmacol & Clin Pharm, Addis Ababa, Ethiopia.	getachewalemkere@gmail.com	Engidawork, Ephrem/K-7551-2019; Kolech, Getachew/W-3922-2019	Engidawork, Ephrem/0000-0002-9931-6421; Kolech, Getachew/0000-0002-8728-7600	Addis Ababa University	Addis Ababa University	Addis Ababa University is the source of the funding.	Alemkere Getachew, 2018, BMC Res Notes, V11, P675, DOI 10.1186/s13104-018-3782-y; [Anonymous], ETHIOP J HLTH DEV; Beedemariam G, 2018, PLOS ONE, V13, P1; Biadglegne F, 2010, ETHIOP J HEAL DEV, V23, P1498; Capellier G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041290; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; el Moussaoui R, 2006, BMJ-BRIT MED J, V332, P1355, DOI 10.1136/bmj.332.7554.1355; Endale Getachew, 2013, African Journal of Pharmacy and Pharmacology, V7, P2657; Eshetu S, 2018, ECON MICROBIOL, V14, P119; Fernandez J, 2012, HEPATOLOGY, V55, P1551, DOI 10.1002/hep.25532; Gaieski DF, 2013, CRIT CARE MED; Ghods Ali Asghar, 2014, Glob J Health Sci, V7, P82, DOI 10.5539/gjhs.v7n3p82; Gordon Stephen B, 2003, Malawi Med J, V15, P38; Gottlieb Thomas, 2011, Med J Aust, V194, P281; Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202; Hanberger H, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-513; Hill PC, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-2; Jenkins TC, 2013, INFECTION, V41, P135, DOI 10.1007/s15010-012-0362-2; Lee CR, 2013, INT J ENV RES PUB HE, V10, P4274, DOI 10.3390/ijerph10094274; Lye DC, 2012, CLIN MICROBIOL INFEC, V18, P502, DOI 10.1111/j.1469-0691.2011.03606.x; MacDougall C, 2005, CLIN MICROBIOL REV, V18, P638, DOI 10.1128/CMR.18.4.638-656.2005; Mauldin PD, 2010, ANTIMICROB AGENTS CH, V54, P109, DOI 10.1128/AAC.01041-09; McCabe C, 2009, ARCH INTERN MED, V169, P1525, DOI 10.1001/archinternmed.2009.259; Mettler J, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-21; Michaels K., 2012, HOSP PHARM, V47, P608, DOI [10.1310/hpj4708-608, DOI 10.1310/hpj4708-608]; Minejima E, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-252; Moore CL, 2011, ANTIMICROB AGENTS CH, V55, P4581, DOI 10.1128/AAC.00115-11; Roberts RR, 2009, CLIN INFECT DIS, V49, P1175, DOI 10.1086/605630; Sileshi A, 2016, BMC PHARMACOL TOXICO, V17, DOI 10.1186/s40360-016-0057-x; Suter-Widmer I, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-21; Usman M, 2011, GOMAL J MED SCI, V9, P18; van den Bosch CMA, 2015, CLIN INFECT DIS, V60, P281, DOI 10.1093/cid/ciu747; van Dijk CE, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0510-8; Yu VL, 2003, CLIN INFECT DIS, V37, P230, DOI 10.1086/377534; Zar HJ, 2013, THORAX, V68, P1052, DOI 10.1136/thoraxjnl-2013-204247; Zeleke B, 2015, AM J HEAL RES, V3, P333; Zeruesenay Desta, 2002, Ethiopian Journal of Health Development, V16, P183	38	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212661	10.1371/journal.pone.0212661	http://dx.doi.org/10.1371/journal.pone.0212661			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794660	Green Published, Green Submitted, gold			2022-12-27	WOS:000459709100107
J	Cadenas, O; Megson, GM				Cadenas, Oswaldo; Megson, Graham M.			Preprocessing 2D data for fast convex hull computations	PLOS ONE			English	Article								This paper presents a method to reduce a set of n 2D points to a smaller set of s 2D points with the property that the convex hull on the smaller set is the same as the convex hull of the original bigger set. The paper shows, experimentally, that such reduction accelerates computations; the time it takes to reduce from n down to s points plus the time of computing the convex hull on the s points is less than the time to compute the convex hull on the original set of n points. The method accepts 2D points expressed as real numbers and thus extends our previous method that required points as integers. The method achieves a percentage of reduction of points of over 90% in a collections of four datasets. This amount of reduction provides speedup factors of at least two for various common convex hull algorithms. Theoretically, the reduction method executes in time within O(n) and thus is suitable for preprocessing 2D data before computing the convex hull by any known algorithm.	[Cadenas, Oswaldo] London South Bank Univ, Sch Engn, London, England; [Megson, Graham M.] Univ Westminster, Sch Elect & Comp Sci, London, England	London South Bank University; University of Westminster	Cadenas, O (corresponding author), London South Bank Univ, Sch Engn, London, England.	cadenaso@lsbu.ac.uk		Cadenas, Oswaldo/0000-0003-4152-6458				AKL SG, 1978, INFORM PROCESS LETT, V7, P219, DOI 10.1016/0020-0190(78)90003-0; Brassey CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091691; Cadenas JO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149860; Chan TM, 1996, DISCRETE COMPUT GEOM, V16, P361, DOI 10.1007/BF02712873; Chazelle B., 1986, ALGORITHMICA, V1; Dougherty J., 1995, Machine Learning. Proceedings of the Twelfth International Conference on Machine Learning, P194; Knuth KH, 2013, ARXIVPHYSICS0605197; MELKMAN AA, 1987, INFORM PROCESS LETT, V25, P11, DOI 10.1016/0020-0190(87)90086-X; Nodenskjold R, 2013, NEUROIMAGE, V83, P355, DOI [10.1016/j.neuroimage.2013.06.068, DOI 10.1016/J.NEUROIMAGE.2013.06.068]; Patterson, 2019, COMPUTER ARCHITECTUR; PERL Y, 1978, COMMUN ACM, V21, P550, DOI 10.1145/359545.359557; Sellers WI, 2012, BIOL LETTERS, V8, P842, DOI 10.1098/rsbl.2012.0263; Skiena S. S., 2010, ALGORITHM DESIGN MAN; Zheng W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134835	14	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212189	10.1371/journal.pone.0212189	http://dx.doi.org/10.1371/journal.pone.0212189			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794575	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000459709100044
J	Cherny, SS; Freidin, MB; Williams, FMK; Livshits, G				Cherny, Stacey S.; Freidin, Maxim B.; Williams, Frances M. K.; Livshits, Gregory			The analysis of causal relationships between blood lipid levels and BMD	PLOS ONE			English	Article							BONE-MINERAL DENSITY; CROSS-SECTIONAL MEASURES; STRUCTURAL EQUATION; GENETIC INFLUENCES; CHOLESTEROL; DIRECTION; ASSOCIATION; PROFILE; MASS	Bone mineral density (BMD) and lipid levels are two of the most extensively studied risk factors for common diseases of aging, such as cardiovascular disease (CVD) and osteoporosis (OP). These two risk factors are also correlated with each other, but little is known about the molecular mechanisms behind this correlation. Recent studies revealed that circulating levels of several metabolites involved in the biosynthesis of androsterone correlate significantly with BMD and have the capacity to affect cholesterol and lipids levels. A main aim of the present study was to investigate the hypothesis that androsterone-related metabolites could provide a link between CVD and OP, as a common cause of lipid levels and BMD. The present study employed data from the NIHR BRC TwinsUK BioResource, comprising 1909 and 1994 monozygotic and dizygotic twin pairs, respectively, to address the causal relationships among BMD and lipids, and their associated metabolites, using reciprocal causation twin modelling, as well as Mendelian randomization (MR) using large publicly-available GWAS datasets on lipids and BMD, in conjunction with TwinsUK metabolite data. While results involving the twin modelling and MR analyses with metabolites were unable to establish a causal link between metabolite levels and either lipids or BMD, MR analyses of BMD and lipids suggest that lipid levels have a causal impact on BMD, which is consistent with findings from clinical trials of lipid-lowering drugs, which have also increased BMD.	[Cherny, Stacey S.; Livshits, Gregory] Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, Tel Aviv, Israel; [Cherny, Stacey S.] Tel Aviv Univ, Sackler Fac Med, Dept Epidemiol & Prevent Med, Tel Aviv, Israel; [Freidin, Maxim B.; Williams, Frances M. K.; Livshits, Gregory] Kings Coll London, Sch Life Course Sci, Dept Twin Res & Genet Epidemiol, London, England	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; University of London; King's College London	Livshits, G (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, Tel Aviv, Israel.; Livshits, G (corresponding author), Kings Coll London, Sch Life Course Sci, Dept Twin Res & Genet Epidemiol, London, England.	gregl@tauex.tau.ac.il	Freydin, Maxim/A-5603-2011; Livshits, Gregory/AAG-7051-2019; Cherny, Stacey S/B-3315-2008	Freydin, Maxim/0000-0002-1439-6259; Livshits, Gregory/0000-0003-3766-7493; Cherny, Stacey S/0000-0002-0269-3352; Williams, Frances/0000-0002-2998-2744				Ackert-Bicknell CL, 2012, BONE, V50, P525, DOI 10.1016/j.bone.2011.07.002; Arden NK, 1997, J BONE MINER RES, V12, P2076, DOI 10.1359/jbmr.1997.12.12.2076; Bates TC, 2017, E3354V1 PEERJ INC, DOI DOI 10.7287/PEERJ.PREPRINTS.3354V1; Cartwright N, 2010, PHILOS STUD, V147, P59, DOI 10.1007/s11098-009-9450-2; Davey Smith G, 2014, HUM MOL GENET, V23, pR89, DOI 10.1093/hmg/ddu328; DUFFY DL, 1994, GENET EPIDEMIOL, V11, P483, DOI 10.1002/gepi.1370110606; Ghadiri-Anari A, 2016, INT J REPROD BIOMED, V14, P597; Gillespie NA, 2003, BEHAV GENET, V33, P383, DOI 10.1023/A:1025365325016; Gillespie NA, 2012, J SLEEP RES, V21, P675, DOI 10.1111/j.1365-2869.2012.01026.x; Go Jeong-Ho, 2012, Korean J Fam Med, V33, P166, DOI 10.4082/kjfm.2012.33.3.166; Hartwig FP, 2017, ROBUST INFERENCE 2 S, DOI [10.1101/126102, DOI 10.1101/126102]; HEATH AC, 1993, BEHAV GENET, V23, P29, DOI 10.1007/BF01067552; Hemani G, 2016, BIORXIV, DOI [10.1101/078972, DOI 10.1101/078972]; Hunter MD, 2018, STRUCT EQU MODELING, V25, P307, DOI 10.1080/10705511.2017.1369354; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Jeong TD, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/398397; Jiang XY, 2010, EXP CLIN ENDOCR DIAB, V118, P388, DOI 10.1055/s-0029-1225613; Lin X, 2018, MOL GENET GENOMICS, V293, P711, DOI 10.1007/s00438-017-1414-1; Makovey J, 2009, BONE, V44, P208, DOI 10.1016/j.bone.2008.09.020; Martin-Gonzalez C, 2018, CLIN NUTR, V37, P2137, DOI 10.1016/j.clnu.2017.10.008; de Cordova CMM, 2013, ANN CLIN BIOCHEM, V50, P13, DOI 10.1258/acb.2012.011259; Moayyeri A, 2018, J BONE MINER RES, V33, P643, DOI 10.1002/jbmr.3358; Moayyeri A, 2013, TWIN RES HUM GENET, V16, P144, DOI 10.1017/thg.2012.89; Neale B, 2017, DETAILS CONSIDERATIO; Neale MC, 2016, PSYCHOMETRIKA, V81, P535, DOI 10.1007/s11336-014-9435-8; Pritikin JN, 2015, EDUC PSYCHOL MEAS, V75, P458, DOI 10.1177/0013164414554615; Rosol TJ, 2001, TOXICOL PATHOL, V29, P41, DOI 10.1080/019262301301418847; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Tanko LB, 2005, J BONE MINER RES, V20, P1912, DOI 10.1359/JBMR.050711; Toulopoulou T, 2015, MOL PSYCHIATR, V20, P1386, DOI 10.1038/mp.2014.152; Verhulst B, 2012, J THEOR POLIT, V24, P328, DOI 10.1177/0951629812439348; Wang DQ-H, 2009, CITY PLANNING REV, P26, DOI 10.1016/B978-141605469-6.50007-X; Wang ZZ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003042; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Zahery M, 2017, TWIN RES HUM GENET, V20, P290, DOI 10.1017/thg.2017.28; Zheng J, 2017, BIOINFORMATICS, V33, P272, DOI 10.1093/bioinformatics/btw613	37	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212464	10.1371/journal.pone.0212464	http://dx.doi.org/10.1371/journal.pone.0212464			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794634	gold, Green Published, Green Submitted			2022-12-27	WOS:000459709100072
J	Nassisi, M; Baghdasaryan, E; Borrelli, E; Ip, M; Sadda, SR				Nassisi, Marco; Baghdasaryan, Elmira; Borrelli, Enrico; Ip, Michael; Sadda, Srinivas R.			Choriocapillaris flow impairment surrounding geographic atrophy correlates with disease progression	PLOS ONE			English	Article							COHERENCE TOMOGRAPHY ANGIOGRAPHY; QUANTITATIVE FUNDUS AUTOFLUORESCENCE; AGE-RELATED MACULOPATHY; MACULAR DEGENERATION; MORPHOMETRIC-ANALYSIS; ADAPTIVE OPTICS; GROWTH-RATES; DRUSEN; IMAGE; RPE	Purpose To evaluate the correlation between the choriocapillaris (CC) flow alterations around geographic atrophy (GA) and the GA yearly growth rate (yGR) in patients with dry age-related macular degeneration (AMD). Methods We retrospectively reviewed and analyzed spectral domain optical coherence tomography (SD-OCT) and SD-OCT angiography images of consecutive patients with GA acquired using the Cirrus OCT at the Doheny Eye Centers between 2015 and 2017. All eligible patients had one 6 x 6 mm OCTA scan acquired during the first visit (considered as baseline) and two fovea-centered 512 x 128 macular cubes (6 x 6 mm) acquired at baseline and after a minimum of 12 months. Main outcome measures The fundus images from the OCT volumes were used to manually delineate the GA area and calculate the yGR after square root transformation. The en-face angiogram at the level of the CC was analyzed for the percentage of flow voids (FV) outside the atrophic lesion (FVOUT) and in the para-and peri-atrophy regions (FV500 and FV1000 respectively; two concentric 500 mu m wide rings around the atrophy edge). These values, together with the difference between FV500 and FV1000 (Delta FV), were then correlated with the corresponding yGR. Results Thirty-three eyes of 23 patients were eligible for the analysis. The mean yGR was 0.23 +/- 0.17 mm/years. At baseline, the mean FVOUT was 41.86 +/- 2.71%, while FV500 and FV1000 were 46.4 +/- 4.17% and 42.51 +/- 2.65% respectively. The mean Delta FV was 3.89 +/- 2.6%. While in the univariable analysis, the yGR was significantly associated with FV500 and with Delta FV (both p < 0.001), in multivariable model the association remained significant only with Delta FV (p < 0.001). Conclusions Our study reports a correlation between the CC flow impairment around the atrophic lesions and their yGR in patients with GA. If replicated in future longitudinal studies, the choriocapillaris FV in the para-and peri-atrophy regions may prove to be useful parameters for evaluating the prognosis of these eyes.	[Nassisi, Marco; Baghdasaryan, Elmira; Borrelli, Enrico; Ip, Michael; Sadda, Srinivas R.] Doheny Eye Inst, Doheny Image Reading Ctr, 1355 San Pablo St, Los Angeles, CA 90033 USA; [Nassisi, Marco; Baghdasaryan, Elmira; Borrelli, Enrico; Ip, Michael; Sadda, Srinivas R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90095 USA; [Borrelli, Enrico] Univ G dAnnunzio, Dept Med & Sci Ageing, Ophthalmol Clin, Chieti, Italy	Doheny Eye Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; G d'Annunzio University of Chieti-Pescara	Sadda, SR (corresponding author), Doheny Eye Inst, Doheny Image Reading Ctr, 1355 San Pablo St, Los Angeles, CA 90033 USA.; Sadda, SR (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90095 USA.	SSadda@doheny.org	Nassisi, Marco/P-9939-2019; Borrelli, Enrico/AAR-3693-2020	Nassisi, Marco/0000-0002-9354-9005; Borrelli, Enrico/0000-0003-2815-5031				Armenti ST, 2016, JOVE-J VIS EXP, DOI 10.3791/53577; Bearelly S, 2009, OPHTHALMOLOGY, V116, P1762, DOI 10.1016/j.ophtha.2009.04.015; Biesemeier A, 2014, NEUROBIOL AGING, V35, P2562, DOI 10.1016/j.neurobiolaging.2014.05.003; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Borrelli E, 2017, INVEST OPHTH VIS SCI, V58, P4792, DOI 10.1167/iovs.17-22360; Burke TR, 2014, INVEST OPHTH VIS SCI, V55, P2841, DOI 10.1167/iovs.13-13624; Cabrera AP, 2016, INVEST OPHTH VIS SCI, V57, P5910, DOI 10.1167/iovs.16-19727; Choi W, 2015, OPHTHALMOLOGY, V122, P2532, DOI 10.1016/j.ophtha.2015.08.029; Cicinelli MV, 2017, BRIT J OPHTHALMOL, V101, P1193, DOI 10.1136/bjophthalmol-2016-309481; Curcio CA, 2013, RETINA-J RET VIT DIS, V33, P265, DOI 10.1097/IAE.0b013e31827e25e0; Drexler W, 2003, ARCH OPHTHALMOL-CHIC, V121, P695, DOI 10.1001/archopht.121.5.695; Dysli C, 2017, PROG RETIN EYE RES, V60, P120, DOI 10.1016/j.preteyeres.2017.06.005; Eandi CM, 2017, INVEST OPHTH VIS SCI, V58, P2284, DOI 10.1167/iovs.16-20510; Feuer WJ, 2013, JAMA OPHTHALMOL, V131, P110, DOI 10.1001/jamaophthalmol.2013.572; Fleckenstein M, 2018, OPHTHALMOLOGY, V125, P369, DOI 10.1016/j.ophtha.2017.08.038; FRIEDMAN E, 1963, ARCH OPHTHALMOL-CHIC, V69, P220; Gao SS, 2016, INVEST OPHTH VIS SCI, V57, pOCT27, DOI 10.1167/iovs.15-19043; Gocho K, 2013, INVEST OPHTH VIS SCI, V54, P3673, DOI 10.1167/iovs.12-10672; KORTE GE, 1984, INVEST OPHTH VIS SCI, V25, P1135; Lindner M, 2015, OPHTHALMOLOGY, V122, P1356, DOI 10.1016/j.ophtha.2015.03.027; McLeod DS, 2009, INVEST OPHTH VIS SCI, V50, P4982, DOI 10.1167/iovs.09-3639; Moult EM, 2016, RETINA-J RET VIT DIS, V36, pS2, DOI 10.1097/IAE.0000000000001287; Mullins RE, 2011, INVEST OPHTH VIS SCI, V52, P1606, DOI 10.1167/iovs.10-6476; Nassisi M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207638; Nassisi M, 2019, BRIT J OPHTHALMOL, V103, P911, DOI 10.1136/bjophthalmol-2018-312643; Querques G, 2014, OPHTHALMOLOGY, V121, P611, DOI 10.1016/j.ophtha.2013.10.006; RAMRATTAN RS, 1994, INVEST OPHTH VIS SCI, V35, P2857; Sacconi R, 2018, RETINA-J RET VIT DIS, V38, P2350, DOI 10.1097/IAE.0000000000001873; Sadda SR, 2018, OPHTHALMOLOGY, V125, P537, DOI 10.1016/j.ophtha.2017.09.028; Sarks SH, 1999, BRIT J OPHTHALMOL, V83, P358, DOI 10.1136/bjo.83.3.358; Sauer L, 2018, ACTA OPHTHALMOL, V96, P257, DOI 10.1111/aos.13587; Schaal KB, 2017, AM J OPHTHALMOL, V174, P145, DOI 10.1016/j.ajo.2016.11.002; Schlingemann RO, 2004, GRAEF ARCH CLIN EXP, V242, P91, DOI 10.1007/s00417-003-0828-0; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Spaide RF, 2016, AM J OPHTHALMOL, V170, P58, DOI 10.1016/j.ajo.2016.07.023; Spaide RF, 2011, RETINA-J RET VIT DIS, V31, P1609, DOI 10.1097/IAE.0b013e3182247535; Uji A, 2017, JAMA OPHTHALMOL, V135, P1197, DOI 10.1001/jamaophthalmol.2017.3904; Uji A, 2017, OPHTHALMOLOGY, V124, P944, DOI 10.1016/j.ophtha.2017.02.006; Waheed NK, 2016, DEV OPHTHALMOL, V56, P91, DOI 10.1159/000442784; Yehoshua Z, 2015, OSLI RETINA, V46, P413, DOI 10.3928/23258160-20150422-03; Yehoshua Z, 2013, OSLI RETINA, V44, P127, DOI 10.3928/23258160-20130313-05; Yehoshua Z, 2011, OPHTHALMOLOGY, V118, P679, DOI 10.1016/j.ophtha.2010.08.018; Zhang QQ, 2018, INVEST OPHTH VIS SCI, V59, P203, DOI 10.1167/iovs.17-22953	43	57	57	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212563	10.1371/journal.pone.0212563	http://dx.doi.org/10.1371/journal.pone.0212563			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794627	gold, Green Published, Green Submitted			2022-12-27	WOS:000459709100089
J	Skwiot, M; Sliwinski, G; Milanese, S; Sliwinski, Z				Skwiot, Marlena; Sliwinski, Grzegorz; Milanese, Steve; Sliwinski, Zbigniew			Hypermobility of joints in dancers	PLOS ONE			English	Article							RELIABILITY; BEIGHTON; LAXITY; INJURY; MOTION; RANGE	Objectives The current understanding of hypermobility and its diagnostic criteria is still insufficient to create a complete and systematic clinical presentation of the disorder. The objective of this study was to assess the prevalence of joint hypermobility syndrome (JHS) amongst a cohort of jazz dancers, by analyzing its presence in accordance with a number of diagnostic criteria, and to verify potential risk factors for joint hypermobility in jazz dancers. Methods 77 jazz dancers from the Polish Dance Theater were examined (58 female and 19 male). The prevalence of JHS was assessed using the following diagnostic tools: a structured interview, Beighton score, Grahame & Hakim questionnaire, and Sachse's criteria, in the modified version proposed by Kapandji. Results The prevalence of JHS in this cohort of jazz dancers differed significantly, depending on which criteria were adopted (p = 0.001) with Beighton score, Grahame & Hakim questionnaire, and Sachse's criteria identifying 64.9%, 74% and 59.7% of the sample as JHS respectively. Hypermobility was significantly more prevalent in women than men (p < 0.05). Conclusions This study demonstrated a significant prevalence of joint hypermobility in jazz dancers and corroborates the findings of other researchers, indicating the need for unified diagnostic criteria for JHS in dancers.	[Skwiot, Marlena; Sliwinski, Zbigniew] Jan Kochanowski Univ Humanities & Sci, Fac Med & Hlth Sci, Kielce, Poland; [Sliwinski, Grzegorz] Tech Univ Dresden, Fac Biomed Engn, Dresden, Germany; [Milanese, Steve] Univ South Australia, Sch Hlth Sci, Adelaide, SA, Australia	Jan Kochanowski University; Technische Universitat Dresden; University of South Australia	Skwiot, M (corresponding author), Jan Kochanowski Univ Humanities & Sci, Fac Med & Hlth Sci, Kielce, Poland.	marlena.skwiot@gmail.com	Milanese, Steve/F-3898-2013	Milanese, Steve/0000-0002-6470-3296; Sliwinski, Zbigniew/0000-0001-7402-1793; Skwiot, Marlena/0000-0003-2523-9168				Ambegaonkar JP, 2014, MED PROBL PERFORM AR, V29, P189, DOI 10.21091/mppa.2014.4039; Beighton PH, 2012, ASSESSMENT HYPERMOBI; Berger Marcin, 2016, Pol Merkur Lekarski, V40, P248; Bird H, 2016, SAMJ S AFR MED J, V106, pS42, DOI 10.7196/SAMJ.2016.v106i6.10990; Boyle KL, 2003, J ATHL TRAINING, V38, P281; Briggs J, 2009, RHEUMATOLOGY, V48, P1613, DOI 10.1093/rheumatology/kep175; Day H, 2011, INT J SPORTS MED, V32, P485, DOI 10.1055/s-0031-1273690; dos Santos CM, 2012, REV BRAS MED ESPORTE, V18, P38, DOI 10.1590/S1517-86922012000100008; Drezewaska M, 2013, APPL METHOD KINESIOL; Drezewska M, 2013, PILOT STUDY ORTOP TR, V15, P148; Drezewska Marlena, 2012, Ortop Traumatol Rehabil, V14, P443, DOI 10.5604/15093492.1012503; Foley EC, 2013, CLIN RHEUMATOL, V32, P455, DOI 10.1007/s10067-013-2191-9; Hakim AJ, 2003, INT J CLIN PRACT, V57, P163; Sobrino FJ, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115590114; Lewit K, 2001, DIAGNOSIS DYSFUNCTIO; Lin CF, 2011, AM J SPORT MED, V39, P1324, DOI 10.1177/0363546510393943; McCormack M, 2004, J RHEUMATOL, V31, P173; McCormack M., 2010, IADMS B TEACHERS, V2, P5; Nosouhian Saeid, 2015, J Int Oral Health, V7, P1; Pacey V, 2015, J PAEDIATR CHILD H, V51, P689, DOI 10.1111/jpc.12826; Roussel NA, 2009, MANUAL THER, V14, P630, DOI 10.1016/j.math.2008.12.004; Scheper MC, 2013, RHEUMATOLOGY, V52, P651, DOI 10.1093/rheumatology/kes220; Steinberg N, 2012, INT J SPORTS MED, V33, P561, DOI 10.1055/s-0031-1301330; Steinberg N, 2016, JCR-J CLIN RHEUMATOL, V22, P171, DOI 10.1097/RHU.0000000000000420; Stodolna-Tukendorf J, 2011, SURG MOTOR SYSTEMS P, V76, P138; van der Giessen LJ, 2001, J RHEUMATOL, V28, P2726	26	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212188	10.1371/journal.pone.0212188	http://dx.doi.org/10.1371/journal.pone.0212188			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794600	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000459709100043
J	Xiong, XW; Yu, JH; Fan, R; Zhang, CC; Xu, L; Sun, XP; Huang, YM; Wang, QZ; Ruan, HB; Qian, XL				Xiong, Xiwen; Yu, Jiahui; Fan, Rui; Zhang, Cuicui; Xu, Lin; Sun, Xupeng; Huang, Yanmei; Wang, Qingzhi; Ruan, Hai-Bin; Qian, Xinlai			NAMPT overexpression alleviates alcohol-induced hepatic steatosis in mice	PLOS ONE			English	Article							FATTY LIVER-DISEASE; SIRT1; METABOLISM; PROTECTS; MECHANISMS; INHIBITION; INSIGHTS; DELETION; ETHANOL; HEALTH	Nicotinamide phosphoribosyltransferase (NAMPT) is a rate-limiting enzyme in mammalian nicotinamide adenine dinucleotide (NAD)(+) biosynthesis. Through its NAD(+)-biosynthetic activity, NAMPT influences the activity of NAD(+)-dependent enzymes, such as sirtuins. NAMPT is able to modulate processes involved in the pathogenesis of non-alcohol induced fatty liver disease (NAFLD), but the roles NAMPT plays in development of alcoholic liver disease (ALD) still remain unknown. Here, we show that ethanol treatment suppresses the expression of Nampt in hepatocytes. Consistently, chronic ethanol administration also reduces Nampt expression in the mouse liver. We next demonstrate that hepatocytes infected with Ad-NAMPT adenovirus exhibit significantly elevated intracellular NAD(+) levels and decreased ethanol-induced triglyceride (TG) accumulation. Similarly, adenovirus-mediated overexpression of NAMPT in mice ameliorates ethanol induced hepatic steatosis. Moreover, we demonstrate that SIRT1 is required to mediate the effects of NAMPT on reduction of hepatic TG accumulation and serum ALT, AST levels in ethanol-fed mice. Our results provide important insights in targeting NAMPT for treating alcoholic fatty liver disease.	[Xiong, Xiwen; Yu, Jiahui; Sun, Xupeng; Huang, Yanmei; Wang, Qingzhi; Ruan, Hai-Bin; Qian, Xinlai] Xinxiang Med Univ, Sch Forens Med, Xinxiang, Henan, Peoples R China; [Xiong, Xiwen; Yu, Jiahui; Ruan, Hai-Bin] Xinxiang Med Univ, Xinxiang Key Lab Metab & Integrat Physiol, Xinxiang, Henan, Peoples R China; [Fan, Rui; Zhang, Cuicui] Xinxiang Med Univ, Sch Basic Med Sci, Xinxiang, Henan, Peoples R China; [Xu, Lin] Huazhong Univ Sci & Technol, Sch Basic Med, Tongji Med Coll, Dept Med Genet, Wuhan, Hubei, Peoples R China; [Ruan, Hai-Bin] Univ Minnesota, Sch Med, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA	Xinxiang Medical University; Xinxiang Medical University; Xinxiang Medical University; Huazhong University of Science & Technology; University of Minnesota System; University of Minnesota Twin Cities	Xiong, XW; Qian, XL (corresponding author), Xinxiang Med Univ, Sch Forens Med, Xinxiang, Henan, Peoples R China.; Xiong, XW (corresponding author), Xinxiang Med Univ, Xinxiang Key Lab Metab & Integrat Physiol, Xinxiang, Henan, Peoples R China.	xiongxw@yahoo.com; qxlfssws@163.com	huang, yan/GWM-4747-2022; Xiong, Xiwen/GSN-0686-2022; Ruan, Hai-Bin/AAN-7777-2021	Ruan, Hai-Bin/0000-0002-3858-1272	Key Science and Technology Project of Xinxiang [CXGG17007]; National Natural and Science Foundation of China [81670526]; Key Science and Technology Project of Henan [182102310107]; Key Scientific Research Project of Universities in Henan [19A180005]	Key Science and Technology Project of Xinxiang; National Natural and Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Science and Technology Project of Henan; Key Scientific Research Project of Universities in Henan	The present work was supported by grants from the Key Science and Technology Project of Xinxiang (CXGG17007, to X.X), National Natural and Science Foundation of China (81670526, to X.X), the Key Science and Technology Project of Henan (182102310107, to X.X), and the Key Scientific Research Project of Universities in Henan (19A180005, to X.X). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Bertola A, 2013, NAT PROTOC, V8, P627, DOI 10.1038/nprot.2013.032; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Celli R, 2014, J CLIN TRANSL HEPATO, V2, P103, DOI 10.14218/JCTH.2014.00010; Chang HC, 2014, TRENDS ENDOCRIN MET, V25, P138, DOI 10.1016/j.tem.2013.12.001; Choi SE, 2013, AGING CELL, V12, P1062, DOI 10.1111/acel.12135; Dahl TB, 2010, J CLIN ENDOCR METAB, V95, P3039, DOI 10.1210/jc.2009-2148; Dong X Charlie, 2012, Diabetes Manag (Lond), V2, P243; Elhassan YS, 2017, J ENDOCR SOC, V1, P816, DOI 10.1210/js.2017-00092; Etchegaray JP, 2013, CURR TOP MED CHEM, V13, P2991, DOI 10.2174/15680266113136660213; Fan R, 2018, BIOCHEM BIOPH RES CO, V500, P476, DOI 10.1016/j.bbrc.2018.04.107; Gariani K, 2017, J HEPATOL, V66, P132, DOI 10.1016/j.jhep.2016.08.024; Garten A, 2015, NAT REV ENDOCRINOL, V11, P535, DOI 10.1038/nrendo.2015.117; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Huang SS, 2018, J PHARMACOL EXP THER, V364, P452, DOI 10.1124/jpet.117.243105; Imai S, 2013, DIABETES OBES METAB, V15, P26, DOI 10.1111/dom.12171; Li Q, 2014, ALCOHOL CLIN EXP RES, V38, P1982, DOI 10.1111/acer.12396; Li SB, 2016, SCI REP-UK, V6, DOI 10.1038/srep26746; Lieber CS, 2008, BIOCHEM BIOPH RES CO, V373, P246, DOI 10.1016/j.bbrc.2008.06.006; Liu JY, 2014, WORLD J GASTROENTERO, V20, P14672, DOI 10.3748/wjg.v20.i40.14672; Louvet A, 2015, NAT REV GASTRO HEPAT, V12, P231, DOI 10.1038/nrgastro.2015.35; Mukhopadhyay P, 2017, J HEPATOL, V66, P589, DOI 10.1016/j.jhep.2016.10.023; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Orman ES, 2013, J GASTROEN HEPATOL, V28, P77, DOI 10.1111/jgh.12030; Ponugoti B, 2010, J BIOL CHEM, V285, P33959, DOI 10.1074/jbc.M110.122978; Purohit V, 2009, ALCOHOL CLIN EXP RES, V33, P191, DOI 10.1111/j.1530-0277.2008.00827.x; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Rowell Rachel J, 2015, Clin Med (Lond), V15 Suppl 6, ps77, DOI 10.7861/clinmedicine.15-6-s77; Tao RY, 2011, J BIOL CHEM, V286, P14681, DOI 10.1074/jbc.M110.201061; Travelli C, 2018, PHARMACOL RES, V135, P25, DOI 10.1016/j.phrs.2018.06.022; Wang LF, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0464-z; Wang SF, 2018, REDOX BIOL, V17, P89, DOI 10.1016/j.redox.2018.04.006; Warren KR, 2013, J GASTROEN HEPATOL, V28, P4, DOI 10.1111/jgh.12246; Xiong XW, 2012, J BIOL CHEM, V287, P39107, DOI 10.1074/jbc.M112.412569; Yin HQ, 2014, GASTROENTEROLOGY, V146, P801, DOI 10.1053/j.gastro.2013.11.008; Yoshino J, 2018, CELL METAB, V27, P513, DOI 10.1016/j.cmet.2017.11.002; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; You M, 2015, HEPATOBIL SURG NUTR, V4, P88, DOI 10.3978/j.issn.2304-3881.2014.12.06; Zhang DQ, 2018, HEPATOLOGY, V68, P883, DOI 10.1002/hep.29878; Zhang LQ, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.132; Zhou CC, 2016, BRIT J PHARMACOL, V173, P2352, DOI 10.1111/bph.13513	43	8	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212523	10.1371/journal.pone.0212523	http://dx.doi.org/10.1371/journal.pone.0212523			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794635	gold, Green Published, Green Submitted			2022-12-27	WOS:000459709100080
J	Zacharius, KM; Basinda, N; Marwa, K; Mtui, EH; Kalolo, A; Kapesa, A				Zacharius, Kamonga M.; Basinda, Namanya; Marwa, Karol; Mtui, Emmanuel H.; Kalolo, Albino; Kapesa, Anthony			Low adherence to Option B+ antiretroviral therapy among pregnant women and lactating mothers in eastern Tanzania	PLOS ONE			English	Article							DAR-ES-SALAAM; IMMUNOLOGICAL FAILURE; MITRA PLUS; MALAWI; HIV	Background Adherence to option B+ antiretroviral treatment (ART) is vital to a successful implementation of Prevention of Mother to Child Transmission (PMTCT) program. Further studies show that optimal viral suppression is also crucial for a successful PMTCT program, however barriers to adherence exist and differ among populations and particularly within few years of its adoption in Tanzania. This study therefore aimed at investigating the level and predictors of adherence to ART option B+ among pregnant and lactating women in rural and urban settings of eastern Tanzania. Methodology A cross-sectional study was conducted among 305 pregnant women and lactating mothers on Option B+ regime from six health facilities located in rural and urban settings in Morogoro region in eastern Tanzania. Data were collected using a structured questionnaire. Data analysis was performed using descriptive statistics, as well as bivariate and multivariate logistic regression. Results Good adherence to option B+ PMTCT drugs was 26.3% and 61.1% among respondents residing in urban and rural areas respectively. The rural residents were 4.86 times more likely to adhere compared to their counterparts in an urban area (aOR = 4.86; 95% CI = 2.91-8.13). Similarly, women with male partners' support in PMTCT were 3.51 times more likely to have good adherence than those without (aOR = 3.51, 95% CI = 1.21-10.15). Moreover, there was a significantly lower odds of adherence to option B+ among those who had been on treatment between one to two years as compared to those had less than one year of treatment (aOR = 0.45; 95% CI = 0.22-0.93). Conclusion Adherence to PMTCT option B+ antiretroviral drugs treatment among pregnant women and breastfeeding mothers was low and much lower among urban residents. Adherence was significantly predicted by rural residence, male partner support and short duration on ART. Efforts to improve adherence should focus on increasing male participation on PMTCT, tailored interventions to urban residents and those who have been on ART for a long duration.	[Zacharius, Kamonga M.] Family Hlth Int, Dar Es Salaam, Tanzania; [Basinda, Namanya; Kapesa, Anthony] Catholic Univ Hlth & Allied Sci, Sch Publ Hlth, Mwanza, Tanzania; [Marwa, Karol] Catholic Univ Hlth & Allied Sci, Dept Pharmacol, Mwanza, Tanzania; [Mtui, Emmanuel H.] Kilimanjaro Christian Med Univ, Dept Epidemiol & Biostat, Moshi, Tanzania; [Kalolo, Albino] St Francis Univ Hlth & Allied Sci, Dept Community Med, Ifakara, Tanzania		Kapesa, A (corresponding author), Catholic Univ Hlth & Allied Sci, Sch Publ Hlth, Mwanza, Tanzania.	anthony1kapesa@gmail.com	Basinda, Namanya/AAO-5350-2020	Basinda, Namanya/0000-0003-4262-3508				[Anonymous], 2017, UNAIDS DAT 2017; [Anonymous], 2020, HIGH POSS COST COVID; Chagomerana MB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195033; Decker S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179448; Ebuy H, 2015, INT J INFECT DIS, V33, P123, DOI 10.1016/j.ijid.2014.12.026; Ekama SO, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/851810; Gamell A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181096; Haas AD, 2016, CLIN INFECT DIS, V63, P1227, DOI 10.1093/cid/ciw500; Jefferys LF, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0084-x; Kalua T, 2017, JAIDS-J ACQ IMM DEF, V75, pS43, DOI [10.1097/QAI.0000000000001326, 10.1097/qai.0000000000001326]; Kapesa Anthony, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, pS620; Kim MH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149527; Kish L, 1965, SURVEY SAMPLING; Mwalumuli EO, 2017, COMP LEVEL PREDICTOR; Nachega JB, 2012, AIDS, V26, P2039, DOI 10.1097/QAD.0b013e328359590f; Ngarina M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0914-z; Ngarina M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-450; Noiman A, 2017, CHANGES ADHERENCE PR; Okonji JA, 2012, JAIDS-J ACQ IMM DEF, V61, P249, DOI 10.1097/QAI.0b013e318262514f; Steel G, 2007, RPM PLUS, V6; Tanzania Commission for HIV and AIDS, 2017, TANZ HIV IMP SURV TH; Tsegaye D, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016043; Ujiji OA, 2011, CULT HEALTH SEX, V13, P829, DOI 10.1080/13691058.2011.583682; United Republic of Tanzania, TANZ EL MOTH CHILD T; United Republic of Tanzania, 2013, NAT GUID COMPR CAR S; WHO, 2012, US ANT DRUGS TREAT P; World Health Organization, 2017, GLOB GUID CRIT PROC, V2nd	27	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212587	10.1371/journal.pone.0212587	http://dx.doi.org/10.1371/journal.pone.0212587			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794633	Green Published, Green Submitted, gold			2022-12-27	WOS:000459709100092
J	Blazquez, E; Rodriguez, C; Rodenas, J; Navarro, N; Riquelme, C; Rosell, R; Campbell, J; Crenshaw, J; Segales, J; Pujols, J; Polo, J				Blazquez, Elena; Rodriguez, Carmen; Rodenas, Jesus; Navarro, Nuria; Riquelme, Cristina; Rosell, Rosa; Campbell, Joy; Crenshaw, Joe; Segales, Joaquim; Pujols, Joan; Polo, Javier			Evaluation of the effectiveness of the SurePure Turbulator ultraviolet-C irradiation equipment on inactivation of different enveloped and non-enveloped viruses inoculated in commercially collected liquid animal plasma	PLOS ONE			English	Article							PORCINE CIRCOVIRUS TYPE-2; LABILE BLOOD DERIVATIVES; EPIDEMIC DIARRHEA VIRUS; MICROBIAL INACTIVATION; EXPERIMENTAL-INFECTION; NONTHERMAL TREATMENT; UVC IRRADIATION; WEANLING PIGS; RADIATION; LIGHT	The objective of this study was to evaluate the effectiveness of the SurePure Turbulator ultraviolet-C (UV-C, 254 nm wavelength) irradiation equipment on inactivation of different enveloped and non-enveloped viruses in commercially collected liquid animal plasma. Specifically, Pseudorabies virus (PRV), Porcine reproductive and respiratory syndrome virus (PRRSV), Porcine epidemic diarrhea virus (PEDV), Bovine viral diarrhea virus (BVDV), Classical swine fever virus (CSFV), Swine influenza virus (SIV) as enveloped viruses and Porcine parvovirus (PPV), Swine vesicular disease virus (SVDV), Porcine circovirus type 2 (PCV-2) and Senecavirus A (SVA) as non-enveloped viruses, were inoculated in bovine or porcine plasma and subjected to different UV-C irradiation doses (0, 750, 1500, 3000, 6000 and 9000 J/L) using an UV-C device developed for opaque liquid working under turbulent flow. The enveloped viruses tested were inactivated at < 3000 J/L of UV-C, being the dose needed to inactivate 4 log TCID50 (4D) of 1612 J/L for PRV, 1004 J/L for PRRSV, 1953 J/L for PEDV, 1639 J/L for SIV, 1641 J/L for CSFV and 1943 J/L for BVDV. The non-enveloped viruses tended to have higher 4D values: 2161 J/L for PPV, 3223 J/L for SVA and 3708 J/L for SVDV. Because the initial viral concentration was < 4.0 Log for PCV-2, it was not possible to calculate the 4D value for this virus. In conclusion, these results demonstrated that the SurePure Turbulator UV-C treatment system is capable of inactivating significant levels of swine viruses inoculated in commercially collected porcine or bovine plasma. It was concluded that irradiation with UV-C can provide an additional redundant biosafety feature in the manufacturing process of spray-dried animal plasma.	[Blazquez, Elena; Rodriguez, Carmen; Rodenas, Jesus; Polo, Javier] SLU Pol Ind El Congost, APC EUROPE, Granollers, Spain; [Blazquez, Elena; Navarro, Nuria; Riquelme, Cristina; Segales, Joaquim; Pujols, Joan] UAB, IRTA, CReSA, Campus Univ Autonoma Barcelona, Barcelona, Spain; [Rosell, Rosa] Generalitat Catalunya, Dept Agr Ramaderia Pesca & Alimentacio DARP, Campus Univ Autonoma Barcelona, Barcelona, Spain; [Campbell, Joy; Crenshaw, Joe; Polo, Javier] APC Inc, Ankeny, IA 50021 USA; [Segales, Joaquim] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, Barcelona, Spain	Autonomous University of Barcelona; IRTA; Autonomous University of Barcelona; Autonomous University of Barcelona	Polo, J (corresponding author), SLU Pol Ind El Congost, APC EUROPE, Granollers, Spain.; Polo, J (corresponding author), APC Inc, Ankeny, IA 50021 USA.	Javier.polo@apc-europe.com	Pujols, Joan/AAV-6427-2020; Segalés, Joaquim/A-4933-2011; Segalés, Joaquim/AAB-4815-2020	Pujols, Joan/0000-0002-6940-1529; Segalés, Joaquim/0000-0002-1539-7261; Segalés, Joaquim/0000-0002-1539-7261; Rosell, Rosa/0000-0002-8294-1159; Crenshaw, Joe/0000-0002-6704-9373; Blazquez Salvador, Elena/0000-0001-8115-3225	Secretaria de Universitats i Recerca del Departament d'Economia i Coneixement of the Generalitat de Catalunya; Secretaria de Universitats i Recerca del Departament d'Economia i Coneixement of the Generalitat de Catalunya [2014 DI 066]; APC EUROPE	Secretaria de Universitats i Recerca del Departament d'Economia i Coneixement of the Generalitat de Catalunya; Secretaria de Universitats i Recerca del Departament d'Economia i Coneixement of the Generalitat de Catalunya; APC EUROPE	This study was partly supported by Secretaria de Universitats i Recerca del Departament d'Economia i Coneixement of the Generalitat de Catalunya. Author who received the award: EB. Grant number: 2014 DI 066. Full name of funder: Secretaria de Universitats i Recerca del Departament d'Economia i Coneixement of the Generalitat de Catalunya. URL funder website: universitatsirecerca. gencat. cat/ca/inici. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. APC EUROPE provided support in the form of salaries for authors EB, CR, JR and JPolo retrospectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberini F, 2015, J FOOD ENG, V162, P63, DOI 10.1016/j.jfoodeng.2015.04.009; Albert I, 2005, INT J FOOD MICROBIOL, V100, P197, DOI 10.1016/j.ijfoodmicro.2004.10.016; Baratelli M, 2014, RES VET SCI, V96, P380, DOI 10.1016/j.rvsc.2013.12.006; Blazquez E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175289; Burnouf T, 2003, HAEMOPHILIA, V9, P24, DOI 10.1046/j.1365-2516.2003.00701.x; Campbell JM, 2006, J APPL POULTRY RES, V15, P584, DOI 10.1093/japr/15.4.584; Campbell JM, 2004, J APPL POULTRY RES, V13, P388, DOI 10.1093/japr/13.3.388; CERF O, 1977, J APPL BACTERIOL, V42, P1, DOI 10.1111/j.1365-2672.1977.tb00665.x; Chan HL, 2006, FEBS LETT, V580, P3229, DOI 10.1016/j.febslet.2006.05.002; Cottingim KM, 2017, J ANIM SCI, V95, P3120, DOI 10.2527/jas.2017.1486; Crook JA, 2015, FOODBORNE PATHOG DIS, V12, P506, DOI 10.1089/fpd.2014.1843; Cutler T, 2011, J APPL MICROBIOL, V111, P389, DOI 10.1111/j.1365-2672.2011.05046.x; DEBOUCK P, 1980, AM J VET RES, V41, P219; Dee S, 2011, VET MICROBIOL, V150, P96, DOI 10.1016/j.vetmic.2011.01.014; Diaz I, 2005, J GEN VIROL, V86, P1943, DOI 10.1099/vir.0.80959-0; Donaghy J, 2009, LETT APPL MICROBIOL, V49, P217, DOI 10.1111/j.1472-765X.2009.02644.x; Fort M, 2010, VET IMMUNOL IMMUNOP, V137, P226, DOI 10.1016/j.vetimm.2010.05.013; Fredericks IN, 2011, FOOD MICROBIOL, V28, P510, DOI 10.1016/j.fm.2010.10.018; FREEMAN AG, 1987, MUTAT RES, V184, P187, DOI 10.1016/0167-8817(87)90016-2; Geeraerd AH, 2000, INT J FOOD MICROBIOL, V59, P185, DOI 10.1016/S0168-1605(00)00362-7; Geeraerd AH, 2005, INT J FOOD MICROBIOL, V102, P95, DOI 10.1016/j.ijfoodmicro.2004.11.038; Gerber PF, 2014, VET MICROBIOL, V174, P86, DOI 10.1016/j.vetmic.2014.09.008; Groenewald WH, 2013, J NEW GENER SCI, V11, P19; Guerrero-Beltran JA, 2004, FOOD SCI TECHNOL INT, V10, P137, DOI 10.1177/1082013204044359; Hijnen WAM, 2006, WATER RES, V40, P3, DOI 10.1016/j.watres.2005.10.030; HOROWITZ B, 1985, TRANSFUSION, V25, P516, DOI 10.1046/j.1537-2995.1985.25686071422.x; HOROWITZ B, 1988, VOX SANG, V54, P14, DOI 10.1111/j.1423-0410.1988.tb01606.x; Jagger J., 1967, INTRO RES ULTRAVIOLE; KASZA L, 1972, RES VET SCI, V13, P46; Keil SD, 2015, TRANSFUSION, V55, P1736, DOI 10.1111/trf.13030; Keyser M, 2008, INNOV FOOD SCI EMERG, V9, P348, DOI 10.1016/j.ifset.2007.09.002; Korneyeva M, 2002, BIOLOGICALS, V30, P153, DOI 10.1006/biol.2002.0334; Koutchma T, 2009, FOOD BIOPROCESS TECH, V2, P138, DOI 10.1007/s11947-008-0178-3; Lin CH, 2012, J HAZARD MATER, V209, P348, DOI 10.1016/j.jhazmat.2012.01.029; LUNDBLAD JL, 1991, VOX SANG, V60, P75, DOI 10.1111/j.1423-0410.1991.tb00878.x; LYTLE CD, 1972, INT J RADIAT BIOL RE, V22, P159, DOI 10.1080/716100000; Lytle CD, 2005, J VIROL, V79, P14244, DOI 10.1128/JVI.79.22.14244-14252.2005; Mafart P, 2002, INT J FOOD MICROBIOL, V72, P107, DOI 10.1016/S0168-1605(01)00624-9; MCFERRAN JB, 1979, COMP IMMUNOL MICROB, V2, P327, DOI 10.1016/0147-9571(79)90020-1; Meunier SM, 2017, J IND MICROBIOL BIOT, V44, P893, DOI 10.1007/s10295-017-1917-0; Opriessnig T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104766; Orlowska M, 2015, FOOD CONTROL, V47, P647, DOI 10.1016/j.foodcont.2014.08.004; Perez-Bosque A, 2016, PORCINE HEALTH MANAG, V2, DOI 10.1186/s40813-016-0034-1; Phukan T, 2018, ECOTOX ENVIRON SAFE, V155, P171, DOI 10.1016/j.ecoenv.2018.02.066; Polo J, 2005, J ANIM SCI, V83, P1933; Polo J, 2002, BACTERICIDAL EFFECT, V1; Polo J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133008; Pujols J, 2008, VET REC, V163, P536, DOI 10.1136/vr.163.18.536; Pujols J, 2007, AM ASS SWINE VET, P281; Pujols J, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0232-x; Pujols J, 2014, VET MICROBIOL, V174, P427, DOI 10.1016/j.vetmic.2014.10.021; Pujols Joan, 2011, Vet J, V190, pe16, DOI 10.1016/j.tvjl.2011.02.021; RAUTH AM, 1965, BIOPHYS J, V5, P257, DOI 10.1016/S0006-3495(65)86715-7; Rodriguez-Arrioja GM, 2002, AM J VET RES, V63, P354, DOI 10.2460/ajvr.2002.63.354; Seltsam A, 2011, TRANSFUS MED HEMOTH, V38, P43, DOI 10.1159/000323845; Shen HG, 2011, J ANIM SCI, V89, P1930, DOI 10.2527/jas.2010-3502; Simmons MJH, 2012, INNOV FOOD SCI EMERG, V14, P122, DOI 10.1016/j.ifset.2011.11.006; Srinivasan V, 2001, J VIROL, V75, P1681, DOI 10.1128/JVI.75.4.1681-1688.2001; Torrallardona D, 2010, ASIAN AUSTRAL J ANIM, V23, P131; W.H. Organization, 2004, WHO TECHNICAL REPORT, V924, P150; Wang J, 2004, VOX SANG, V86, P230, DOI 10.1111/j.0042-9007.2004.00485.x	61	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212332	10.1371/journal.pone.0212332	http://dx.doi.org/10.1371/journal.pone.0212332			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789926	Green Published, Green Submitted, gold			2022-12-27	WOS:000459330800024
J	Adel, FW; Bernstein, E; Tcheyan, M; Ali, S; Worabo, H; Farokhi, M; Muck, AE				Adel, Fadi W.; Bernstein, Eden; Tcheyan, Michael; Ali, Shane; Worabo, Heidi; Farokhi, Moshtagh; Muck, Andrew E.			San Antonio refugees: Their demographics, healthcare profiles, and how to better serve them	PLOS ONE			English	Article							ALLERGIC RHINITIS; HELICOBACTER-PYLORI; PREVALENCE; ADULTS; TUBERCULOSIS; ASSOCIATION; DEPRESSION; IMMIGRANT; CHILDREN; DISEASE	Objective The recent refugee crisis has resulted in the largest burden of displacement in history, with the US being the top resettlement country since 1975. Texas welcomed the second most US-bound refugees in 2016, with a large percentage arriving in San Antonio. Yet, the composition of the San Antonio refugees has not been described and their healthcare needs remain ill-defined. Through this study, we aim at elucidating their demographics and healthcare profiles, with the goal of devising recommendations to help guide refugee program development and guide other refugee resettlement programs. Methods Data from 731 charts belonging to 448 patients at the San Antonio Refugee Health Clinic (SARHC) were extracted and analyzed. Data included age, gender, country of origin, first language, interpretation need, health insurance status, medical history, vital signs, diagnoses, and prescribed medications. Results Women constituted the majority of patients (n = 267; 56.4%), and the median age of all patients was 39 (Q1: 26, Q3: 52). Nepali-speaking Bhutanese patients were the most represented group (n = 107, 43.1%), followed by Iraqi (n = 35, 14.1%), Burmese (n = 30, 12.1%), and Iranian (n = 19, 7.7%) refugees. Of those who responded, 200 (86.6%) did not have any form of health insurance. Additionally, 262 (50.9%) had a body-mass index (BMI) in the overweight or obese range. Further, 61.4% (n = 337) had blood pressures in the hypertensive range, while 9.3% (n = 51) had an elevated blood pressure. On average, each patient had 1.9 complaints, with abdominal pain, headaches, and cough being the predominant complaints. Allergic rhinitis, viral upper respiratory infections, and elevated blood pressure were the most common diagnoses. However, the list of common diagnoses differed per country of origin. Conclusion The SARHC demographics were different from those of other Texas refugees. The rate of the uninsured and the burden of non-communicable diseases were high. Furthermore, each refugee subgroup had a different set of common problems. These findings reveal important considerations for refugee healthcare providers and the unique approach that may be required for different communities.	[Adel, Fadi W.] Mayo Clin, Dept Internal Med, Rochester, MN 55905 USA; [Bernstein, Eden] Cleveland Clin, Dept Internal Med, Cleveland, OH 44106 USA; [Tcheyan, Michael; Ali, Shane; Worabo, Heidi; Farokhi, Moshtagh; Muck, Andrew E.] Univ Texas Hlth, San Antonio Refugee Hlth Clin, Fac Collaborat Practices Program, Ctr Med Humanities & Eth,Long Sch Med, San Antonio, TX USA	Mayo Clinic; Cleveland Clinic Foundation; University of Texas System; University of Texas Health San Antonio	Adel, FW (corresponding author), Mayo Clin, Dept Internal Med, Rochester, MN 55905 USA.	Adel.Fadi@Mayo.edu	Farokhi, Moshtagh/S-6985-2018	Farokhi, Moshtagh/0000-0001-7461-6033; Adel, Fadi/0000-0003-2143-6826				Abong JM, 2012, ASIA PAC ALLERGY, V2, P129, DOI 10.5415/apallergy.2012.2.2.129; Amara AH, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-24; [Anonymous], 2018, DIABETES CARE, V41, pS1, DOI [10.2337/dc18-Sint01, 10.2337/dc18-SINT01]; [Anonymous], FIG GLANC; Arfken CL, 2014, J IMMIGR MINOR HEALT, V16, P1303, DOI 10.1007/s10903-013-9960-z; Belz M, 2017, TRANSCULT PSYCHIATRY, V54, P595, DOI 10.1177/1363461517745473; Berchick, 2017, CURRENT POPULATION R, pP60; Bhutanese Refugee Health Profile, 2014, CTR DIS EAS CONTR PR; Blood Sugar Chart, DIAB SELF MAN; Bogic M, 2015, BMC INT HEALTH HUM R, V15, DOI 10.1186/s12914-015-0064-9; Brodine SK, 2009, AM J TROP MED HYG, V80, P425, DOI 10.4269/ajtmh.2009.80.425; Brouwer KC., 2007, ASSESSMENT COMMUNITY; Centers for Disease Control and Prevention, 2016, ALZHEIMER DIS; Health Information Health Statistics Overweight & Obesity Statistics, 2017, NAT I DIAB DIG KIDN; Hunt RH, 2011, J GASTROINTEST LIVER, V20, P299, DOI 10.1097/MCG.0b013e31820fb8f6; Iraqi Refugee Health Profile, 2014, NATL CTR EMERGING ZO; Kennedy M, 2016, TEXAS PULLS OUT FEDE; Kivi M., 2005, EPIDEMIOLOGY INFECT, V133; Kong WJ, 2009, CLIN EXP ALLERGY, V39, P869, DOI 10.1111/j.1365-2222.2009.03206.x; Kumar GS, 2014, J IMMIGR MINOR HEALT, V16, P922, DOI 10.1007/s10903-013-9800-1; Lifson AR, 2002, PUBLIC HEALTH REP, V117, P69, DOI 10.1093/phr/117.1.69; LoBue PA, 2004, CHEST, V126, P1777, DOI 10.1378/chest.126.6.1777; Luger TM, 2014, ADDICT BEHAV, V39, P1418, DOI 10.1016/j.addbeh.2014.05.011; Luitel NP, 2013, ALCOHOL ALCOHOLISM, V48, P349, DOI 10.1093/alcalc/agt009; Lutfy C, 2014, J IMMIGR MINOR HEALT, V16, P1016, DOI 10.1007/s10903-013-9796-6; Montour J., TEXAS REFUGEE HLTH P; Morris MD, 2009, J COMMUN HEALTH, V34, P529, DOI 10.1007/s10900-009-9175-3; Mullins J, 2012, LANCET, V380, P552, DOI 10.1016/S0140-6736(12)61315-4; Nathan RA, 1997, J ALLERGY CLIN IMMUN, V99, pS808, DOI 10.1016/S0091-6749(97)80040-1; Nguyen MLT, 2016, J IMMIGR MINOR HEALT, V18, P1274, DOI 10.1007/s10903-015-0327-5; Pavlish CL, 2010, SOC SCI MED, V71, P353, DOI 10.1016/j.socscimed.2010.04.010; Pfortmueller CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148196; Redditt VJ, 2015, CAN FAM PHYSICIAN, V61, pE310; Rohlof HG, 2014, SOC PSYCH PSYCH EPID, V49, P1793, DOI 10.1007/s00127-014-0877-1; Slewa-Younan S, 2015, INT J MENT HEALTH SY, V9, DOI 10.1186/1752-4458-9-5; Staff LS, 2013, 100 WORST US CIT PEO; Stafford L, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-35; Stoll K, 2008, J IMMIGR MINOR HEALT, V10, P567, DOI 10.1007/s10903-008-9136-4; Tantilipikorn P, 2014, CURR OPIN OTOLARYNGO, V22, P249, DOI 10.1097/MOO.0000000000000049; Texas Refugee Medical Assistance: Frequently Asked Questions, 2017, TEX REF MED ASS FREQ; United Nations High Commissioner for Refugees, US RES FACTS; van Wyk S, 2012, AUST NZ J PSYCHIAT, V46, P995, DOI 10.1177/0004867412443059; WEBB PM, 1994, BRIT MED J, V308, P750, DOI 10.1136/bmj.308.6931.750; Whelton PK, 2018, J AM COLL CARDIOL, V71, P2275, DOI 10.1016/j.jacc.2018.03.016; Yun K, 2012, J COMMUN HEALTH, V37, P1110, DOI 10.1007/s10900-012-9552-1; Zar HJ, 2007, PEDIAT ALLERG IMM-UK, V18, P560, DOI 10.1111/j.1399-3038.2007.00554.x	46	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0211930	10.1371/journal.pone.0211930	http://dx.doi.org/10.1371/journal.pone.0211930			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL9KY	30779759	Green Published, gold, Green Submitted			2022-12-27	WOS:000459062900021
J	Lang, SN; Germerodt, S; Glock, C; Skerka, C; Zipfel, PF; Schuster, S				Lang, Stefan N.; Germerodt, Sebastian; Glock, Christina; Skerka, Christine; Zipfel, Peter F.; Schuster, Stefan			Molecular crypsis by pathogenic fungi using human factor H. A numerical model	PLOS ONE			English	Article							CANDIDA-ALBICANS; COMPLEMENT REGULATORS; BORRELIA-BURGDORFERI; IMMUNE EVASION; MIMICRY; HOST; PARASITE; SYSTEM; CONSEQUENCES; COEVOLUTION	Molecular mimicry is the formation of specific molecules by microbial pathogens to avoid recognition and attack by the immune system of the host. Several pathogenic Ascomycota and Zygomycota show such a behaviour by utilizing human complement factor H to hide in the blood stream. We call this type of mimicry molecular crypsis. Such a crypsis can reach a point where the immune system can no longer clearly distinguish between self and non-self cells. Thus, a trade-off between attacking disguised pathogens and erroneously attacking host cells has to be made. Based on signalling theory and protein-interaction modelling, we here present a mathematical model of molecular crypsis of pathogenic fungi using the example of Candida albicans. We tackle the question whether perfect crypsis is feasible, which would imply that protection of human cells by complement factors would be useless. The model identifies pathogen abundance relative to host cell abundance as the predominant factor influencing successful or unsuccessful molecular crypsis. If pathogen cells gain a (locally) quantitative advantage over host cells, even autoreactivity may occur. Our new model enables insights into the mechanisms of candidiasis-induced sepsis and complement-associated autoimmune diseases.	[Lang, Stefan N.; Germerodt, Sebastian; Glock, Christina; Schuster, Stefan] Friedrich Schiller Univ Jena, Dept Bioinformat, Jena, Germany; [Skerka, Christine; Zipfel, Peter F.] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, Jena, Germany; [Zipfel, Peter F.] Friedrich Schiller Univ Jena, Inst Microbiol, Jena, Germany	Friedrich Schiller University of Jena; Hans Knoll Institute (HKI); Friedrich Schiller University of Jena	Schuster, S (corresponding author), Friedrich Schiller Univ Jena, Dept Bioinformat, Jena, Germany.	stefan.schu@uni-jena.de			German Research Foundation (DFG) within the Jena School for Microbial Communication [DFG-GSC 214/2]; German Research Foundation (DFG) [Transregio 124]	German Research Foundation (DFG) within the Jena School for Microbial Communication; German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG) within the Jena School for Microbial Communication (grant no. DFG-GSC 214/2) and the Transregio 124 (FungiNet, projects B1, C4 and C6).; Financial support by the German Research Foundation (DFG) within the Jena School for Microbial Communication (grant no. DFG-GSC 214/2) and the Transregio 124 (FungiNet, projects B1, C4 and C6) is gratefully acknowledged.	ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; Arnold DV, 2002, IEEE T EVOLUT COMPUT, V6, P30, DOI [10.1109/4235.985690, 10.1023/A:1015059928466]; Becker DJ, 2018, J ANIM ECOL, V87, P511, DOI 10.1111/1365-2656.12765; Blank M, 2007, CLIN REV ALLERG IMMU, V32, P111; Blom AM, 2009, MOL IMMUNOL, V46, P2808, DOI 10.1016/j.molimm.2009.04.025; Brockhurst MA, 2013, TRENDS ECOL EVOL, V28, P367, DOI 10.1016/j.tree.2013.02.009; *CDCP, 2001, NAT HLTH NUTR EX SUR; Cusick MF, 2012, CLIN REV ALLERG IMMU, V42, P102, DOI [10.1007/s12016-011-8293-8, 10.1007/s12016-011-8294-7]; DAMIAN RT, 1989, CURR TOP MICROBIOL, V145, P101; DAMIAN RT, 1964, AM NAT, V98, P129, DOI 10.1086/282313; DITTRICH W, 1993, P ROY SOC B-BIOL SCI, V251, P195, DOI 10.1098/rspb.1993.0029; Duhring S, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0095; Duhring S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00625; Ferreira VP, 2010, MOL IMMUNOL, V47, P2187, DOI 10.1016/j.molimm.2010.05.007; Gropp K, 2009, MOL IMMUNOL, V47, P465, DOI 10.1016/j.molimm.2009.08.019; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haupt K, 2007, J INFECT DIS, V196, P124, DOI 10.1086/518509; Hellwage J, 2001, J BIOL CHEM, V276, P8427, DOI 10.1074/jbc.M007994200; Holen OH, 2006, AM NAT, V167, P377, DOI 10.1086/499567; Holen OH, 2004, AM NAT, V164, P598, DOI 10.1086/424972; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; HUHEEY J E, 1988, American Naturalist, V131, pS22, DOI 10.1086/284765; HUHEEY JE, 1976, EVOLUTION, V30, P86, DOI 10.1111/j.1558-5646.1976.tb00884.x; Hummert S, 2017, PLAYING HIDE AND SEE; Hummert S, 2014, MOL BIOSYST, V10, P3044, DOI 10.1039/c3mb70602h; Jacob A, 2010, J NEUROIMMUNOL, V221, P46, DOI 10.1016/j.jneuroim.2010.02.011; Korotaevskiy AA, 2009, MATH BIOSCI, V222, P127, DOI 10.1016/j.mbs.2009.10.003; Kraiczy P, 2001, EUR J IMMUNOL, V31, P1674, DOI 10.1002/1521-4141(200106)31:6&lt;1674::AID-IMMU1674&gt;3.0.CO;2-2; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Lan CY, 2002, P NATL ACAD SCI USA, V99, P14907, DOI 10.1073/pnas.232566499; Liu B, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001059; Lively CM, 2000, NATURE, V405, P679, DOI 10.1038/35015069; Markiewski MM, 2008, J CELL MOL MED, V12, P2245, DOI 10.1111/j.1582-4934.2008.00504.x; Meri T, 2002, INFECT IMMUN, V70, P5185, DOI 10.1128/IAI.70.9.5185-5192.2002; Oldstone MBA, 1998, FASEB J, V12, P1255, DOI 10.1096/fasebj.12.13.1255; PANGBURN MK, 1984, SPRINGER SEMIN IMMUN, V7, P163, DOI 10.1007/BF01893019; PASTEUR G, 1982, ANNU REV ECOL SYST, V13, P169, DOI 10.1146/annurev.es.13.110182.001125; Perkins SJ, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00126; PRIES AR, 1992, AM J PHYSIOL, V263, pH1770, DOI 10.1152/ajpheart.1992.263.6.H1770; Sasse C, 2013, EUKARYOT CELL, V12, P50, DOI 10.1128/EC.00266-12; Schaller M, 2003, INFECT IMMUN, V71, P3227, DOI 10.1128/IAI.71.6.3227-3234.2003; Sharp JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038407; SIM RB, 1981, BIOCHEM J, V193, P115, DOI 10.1042/bj1930115; SLUTSKY B, 1987, J BACTERIOL, V169, P189, DOI 10.1128/JB.169.1.189-197.1987; Soll DR, 2009, FEMS YEAST RES, V9, P973, DOI 10.1111/j.1567-1364.2009.00562.x; Soloviev DA, 2011, INFECT IMMUN, V79, P1546, DOI 10.1128/IAI.00650-10; Speed MP, 2010, AM NAT, V176, pE1, DOI 10.1086/652990; SPEED MP, 1993, ANIM BEHAV, V45, P571, DOI 10.1006/anbe.1993.1067; Spellberg B, 2005, J INFECT DIS, V192, P336, DOI 10.1086/430952; STONE HH, 1974, ANN SURG, V179, P697, DOI 10.1097/00000658-197405000-00024; Tsonis PA, 2008, BBA-MOL CELL RES, V1783, P177, DOI 10.1016/j.bbamcr.2007.11.001; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; VANEWRIGHT RI, 1976, BIOL J LINN SOC, V8, P25, DOI 10.1111/j.1095-8312.1976.tb00240.x; Wiley R. Haven, 1994, P157; Wooster DG, 2006, IMMUNOLOGY, V117, P482, DOI 10.1111/j.1365-2567.2006.02323.x; Yanes RE, 2017, SEMIN HEMATOL, V54, P33, DOI 10.1053/j.seminhematol.2016.10.003; ZABKA H, 1986, BEHAV PROCESS, V13, P159, DOI 10.1016/0376-6357(86)90023-9; Zewde N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152337; Zipfel PF, 2013, MOL IMMUNOL, V56, P152, DOI 10.1016/j.molimm.2013.05.222; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620; Zipfel PF, 2015, COMPLEMENT ALTERNATI; Zuckmayer C, 1932, CAPTAIN KOPENICK MOD	62	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212187	10.1371/journal.pone.0212187	http://dx.doi.org/10.1371/journal.pone.0212187			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779817	Green Submitted, Green Published, gold			2022-12-27	WOS:000459062900031
J	Brunet, J; Zhao, Y; Clayton, MK				Brunet, Johanne; Zhao, Yang; Clayton, Murray K.			Linking the foraging behavior of three bee species to pollen dispersal and gene flow	PLOS ONE			English	Article							SEED DISPERSAL; ALFALFA; POLLINATION; EASE; CONSEQUENCES	Foraging behaviors that impact gene flow can guide the design of pollinator strategies to mitigate gene flow. Reduced gene flow is expected to minimize the impact of genetically engineered (GE) crops on feral and natural populations and to facilitate the coexistence of different agricultural markets. The goal of this study is to link foraging behavior to gene flow and identify behaviors that can help predict gene flow for different bee species. To reach this goal, we first examined and compared the foraging behaviors of three distinct bee species, the European honey bee, Apis mellifera L., the common eastern bumble bee, Bombus impatiens Cr., and the alfalfa leafcutting bee, Megachile rotundata F., foraging on Medicago sativa flowers. Each foraging behavior investigated differed among bee species. Both social bees exhibited directionality of movement and had similar residence, in contrast to the random movement and shorter residence of the solitary bee. Tripping rate and net distance traveled differed among the three bee species. We ranked each behavior among bee species and used the relative ranking as gene flow predictor before testing the predictions against empirical gene flow data. Tripping rate and net distance traveled, but not residence, predicted relative gene dispersal among bee species. Linking specific behaviors to gene flow provides mechanisms to explain differences in gene flow among bee species and guides the development of management practices to reduce gene flow. Although developed in one system, the approach developed here can be generalized to different plant/pollinator systems.	[Brunet, Johanne] Univ Wisconsin, USDA ARS, VCRU, Dept Entomol, Madison, WI 53706 USA; [Zhao, Yang; Clayton, Murray K.] Univ Wisconsin, Dept Stat, Madison, WI 53706 USA; [Zhao, Yang] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA	United States Department of Agriculture (USDA); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Gilead Sciences	Brunet, J (corresponding author), Univ Wisconsin, USDA ARS, VCRU, Dept Entomol, Madison, WI 53706 USA.	Johanne.Brunet@ars.usda.gov	Brunet, Johanne/ABB-6499-2021	Brunet, Johanne/0000-0003-4555-7411	Biotechnology Risk Assessment Grant Program from the USDA National Institute of Food and Agriculture [2013-33522-20999]; Graduate School at UW Madison Fall competition; United States Department of Agriculture, Agricultural Research Service	Biotechnology Risk Assessment Grant Program from the USDA National Institute of Food and Agriculture; Graduate School at UW Madison Fall competition; United States Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This project was supported by a Biotechnology Risk Assessment Grant Program, competitive grant no. 2013-33522-20999 from the USDA National Institute of Food and Agriculture to J. Brunet and M. K. Clayton, from funds from the Graduate School at UW Madison Fall competition to J. B. and M. K. C. and from funds from the United States Department of Agriculture, Agricultural Research Service to J. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer AA, 2017, AM J BOT, V104, P772, DOI 10.3732/ajb.1600405; BOHART GE, 1957, ANNU REV ENTOMOL, V2, P355, DOI 10.1146/annurev.en.02.010157.002035; Breazeale D, 2008, J CENT EUR AGRIC, V9, P107; Brunet J, 2010, PSYCHE; Brunet J, P 2018 WINT SEED SCH, P63; Brunet J, 2009, MOL ECOL, V18, P3745, DOI 10.1111/j.1365-294X.2009.04304.x; Cane JH, 2002, J ECON ENTOMOL, V95, P22, DOI 10.1603/0022-0493-95.1.22; Cecen S, 2008, ACTA AGR SCAND B-S P, V58, P77, DOI 10.1080/09064710701214627; Collevatti R. G., 2000, Revista Brasileira de Biologia, V60, P29, DOI 10.1590/S0034-71082000000100005; Cresswell JE, 2002, OIKOS, V98, P375, DOI 10.1034/j.1600-0706.2002.980302.x; Cresswell JE, 2004, J APPL ECOL, V41, P539, DOI 10.1111/j.0021-8901.2004.00912.x; Ellstrand NC, 2013, ANNU REV ECOL EVOL S, V44, P325, DOI 10.1146/annurev-ecolsys-110512-135840; Fitzpatrick S, 2008, GENE FLOW ALFALFA BI, V28; Fitzpatrick S., 2003, CENTR ALF IMPR C VIR; FREE J. B., 1955, INSECTES SOCIAUX, V2, P195, DOI 10.1007/BF02224381; Greene SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143296; Harder LD, 1998, ECOLOGY, V79, P2789, DOI 10.1890/0012-9658(1998)079[2789:TCOHTC]2.0.CO;2; HARDER LD, 1990, ECOLOGY, V71, P1110, DOI 10.2307/1937379; Hoyle M, 2007, ECOL APPL, V17, P1234, DOI 10.1890/06-0569; Kershen D., 2005, ADVENTITIOUS PRESENC; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; KNAPP EE, 1993, CROP SCI, V33, P1176, DOI 10.2135/cropsci1993.0011183X003300060014x; KNAPP EE, 1994, CROP SCI, V34, P323, DOI 10.2135/cropsci1994.0011183X003400020001x; Levey DJ, 2005, SCIENCE, V309, P146, DOI 10.1126/science.1111479; Levey DJ, 2008, J ECOL, V96, P599, DOI 10.1111/j.1365-2745.2008.01401.x; LEVIN DA, 1971, EVOLUTION, V25, P113, DOI 10.1111/j.1558-5646.1971.tb01864.x; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Pitts-Singer TL, 2011, ANNU REV ENTOMOL, V56, P221, DOI 10.1146/annurev-ento-120709-144836; Putnam DH, 2004, PUB, V8153; RASMUSSEN IR, 1992, OECOLOGIA, V89, P277, DOI 10.1007/BF00317228; SMITH KF, 2016, AGRONOMY-BASEL, V6, DOI DOI 10.3390/AGRONOMY6040059; TEUBER LR, 1988, CROP SCI, V28, P558, DOI 10.2135/cropsci1988.0011183X002800030027x; Teuber LR, 2004, JOINT M 39 N AM ALF; Upton GJG, SPATIAL DATA ANAL EX, V2; Van Deynze A., 2007, P GEN FLOW S N CENTR; WADDINGTON KD, 1980, OECOLOGIA, V44, P199, DOI 10.1007/BF00572680; WASER NM, 1982, OECOLOGIA, V55, P251, DOI 10.1007/BF00384496; WATSON GS, 1967, J GEOPHYS RES, V72, P5655, DOI 10.1029/JZ072i022p05655	38	19	19	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0212561	10.1371/journal.pone.0212561	http://dx.doi.org/10.1371/journal.pone.0212561			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807591	Green Published, gold, Green Submitted			2022-12-27	WOS:000459712100018
J	Coussement, J; Lebeaux, D; El Bizri, N; Claes, V; Kohnen, M; Steensels, D; Etienne, I; Salord, H; Bergeron, E; Rodriguez-Nava, V				Coussement, Julien; Lebeaux, David; El Bizri, Najla; Claes, Vincent; Kohnen, Michel; Steensels, Deborah; Etienne, Isabelle; Salord, Helene; Bergeron, Emmanuelle; Rodriguez-Nava, Veronica			Nocardia polymerase chain reaction (PCR)-based assay performed on bronchoalveolar lavage fluid after lung transplantation: A prospective pilot study	PLOS ONE			English	Article							SOLID-ORGAN; INFECTIONS; SPP.; IDENTIFICATION; RECIPIENTS	Background Transplant recipients are at risk of pulmonary nocardiosis, a life-threatening opportunistic infection caused by Nocardia species. Given the limitations of conventional diagnostic techniques (i.e., microscopy and culture), a polymerase chain reaction (PCR)-based assay was developed to detect Nocardia spp. on clinical samples. While this test is increasingly being used by transplant physicians, its performance characteristics are not well documented. We evaluated the performance characteristics of this test on bronchoalveolar lavage (BAL) fluid samples from lung transplant recipients (LTRs). Methods We prospectively included all BAL samples from LTRs undergoing bronchoscopy at our institution between December 2016 and June 2017 (either surveillance or clinically-indicated bronchoscopies). Presence of microbial pathogens was assessed using techniques available locally (including microscopy and 10-day culture for Nocardia). BAL samples were also sent to the French Nocardiosis Observatory (Lyon, France) for the Nocardia PCR-based assay. Transplant physicians and patients were blinded to the Nocardia PCR results. Results We included 29 BAL samples from 21 patients (18 surveillance and 11 clinically-indicated bronchoscopies). Nocardiosis was not diagnosed in any of these patients by conventional techniques. However, Nocardia PCR was positive in five BAL samples from five of the patients (24%, 95% confidence interval: 11-45%); four were asymptomatic and undergoing surveillance bronchoscopy, and one was symptomatic and was later diagnosed with influenza virus infection. None of the five PCR-positive patients died or were diagnosed with nocardiosis during the median follow-up of 21 months after the index bronchoscopy (range: 20-23 months). Conclusions In this prospective study, Nocardia PCR was positive on BAL fluid from one fourth of the LTRs. Nocardia PCR-based assays should be used with caution on respiratory samples from LTRs because of the possible detection of airway colonization using this technique. Larger studies are required to determine the usefulness of the Nocardia PCR-based assay in transplant recipients.	[Coussement, Julien] Univ Libre Bruxelles, CUB Hop Erasme, Dept Infect Dis, Brussels, Belgium; [Coussement, Julien; El Bizri, Najla; Claes, Vincent; Kohnen, Michel; Steensels, Deborah] Univ Libre Bruxelles, CUB Hop Erasme, Dept Microbiol, Brussels, Belgium; [Lebeaux, David] Univ Paris 05, Sorbonne Paris Cite, Hop Europeen Georges Pompidou, AP HP,Serv Microbiol,Unite Mobile Microbiol Clin, Paris, France; [Etienne, Isabelle] Univ Libre Bruxelles, CUB Hop Erasme, Lung Transplantat Unit, Brussels, Belgium; [Salord, Helene] Hop Croix Rousse, Lab Bacteriol, Lyon, France; [Bergeron, Emmanuelle; Rodriguez-Nava, Veronica] Univ Lyon 1, Res Grp Bacterial Opportunist Pathogens & Environ, Observatoire Francais Nocardioses,Hosp Civils Lyo, CNRS,UMR 5557,INRA1418 Ecol Microbienne,VetAgro S, Lyon, France	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite Libre de Bruxelles; CHU Lyon; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup	Coussement, J (corresponding author), Univ Libre Bruxelles, CUB Hop Erasme, Dept Infect Dis, Brussels, Belgium.; Coussement, J (corresponding author), Univ Libre Bruxelles, CUB Hop Erasme, Dept Microbiol, Brussels, Belgium.	jcoussem@ulb.ac.be	Lebeaux, David/ABB-2704-2020	Coussement, Julien/0000-0002-4302-6599; Claes, Vincent/0000-0001-6398-4009	"Fonds Erasme pour la Recherche Medicale" (Belgium)	"Fonds Erasme pour la Recherche Medicale" (Belgium)	Julien COUSSEMENT is supported by a research grant from the "Fonds Erasme pour la Recherche Medicale" (Belgium).	Ambrosioni J, 2010, INFECTION, V38, P89, DOI 10.1007/s15010-009-9193-9; Bhaskaran A, 2013, SEMIN RESP CRIT CARE, V34, P371, DOI 10.1055/s-0033-1348475; Brown-Elliott BA, 2006, CLIN MICROBIOL REV, V19, P259, DOI 10.1128/CMR.19.2.259-282.2006; Clark NM, 2013, AM J TRANSPLANT, V13, P83, DOI 10.1111/ajt.12102; Couble A, 2005, J CLIN MICROBIOL, V43, P1921, DOI 10.1128/JCM.43.4.1921-1924.2005; Coussement J, 2017, CURR OPIN INFECT DIS, V30, P545, DOI [10.1097/qco.0000000000000404, 10.1097/QCO.0000000000000404]; Coussement J, 2016, CLIN INFECT DIS, V63, P338, DOI 10.1093/cid/ciw241; Ekrami A, 2014, JUNDISHAPUR J MICROB, V7, DOI 10.5812/jjm.12495; Ferrer A, 2005, ENFERM INFEC MICR CL, V23, P62, DOI 10.1157/13071607; Lumb R, 2002, EUR J CLIN MICROBIOL, V21, P230, DOI 10.1007/s10096-001-0687-8; Martin SI, 2013, AM J TRANSPLANT, V13, P272, DOI 10.1111/ajt.12119; Peleg AY, 2007, CLIN INFECT DIS, V44, P1307, DOI 10.1086/514340; Rodriguez-Nava V, 2006, J CLIN MICROBIOL, V44, P536, DOI 10.1128/JCM.44.2.536-546.2006; Rodriguez-Nava V, 2015, MED MICROBIOL IMMUN, V204, P493, DOI 10.1007/s00430-014-0360-3; Rouzaud C, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.00002-18; Saubolle MA, 2003, J CLIN MICROBIOL, V41, P4497, DOI 10.1128/JCM.41.10.4497-4501.2003; Steensels D, 2015, J CLIN VIROL, V72, P36, DOI 10.1016/j.jcv.2015.08.022; TELENTI A, 1993, J CLIN MICROBIOL, V31, P175, DOI 10.1128/JCM.31.2.175-178.1993; Minero MV, 2009, MEDICINE, V88, P250, DOI 10.1097/MD.0b013e3181afa1c8; vanBurik JA, 1997, CLIN INFECT DIS, V24, P1154, DOI 10.1086/513654; Vetor R, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1651-7	21	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2019	14	2							e0211989	10.1371/journal.pone.0211989	http://dx.doi.org/10.1371/journal.pone.0211989			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EH	30802260	Green Published, gold, Green Submitted			2022-12-27	WOS:000459710700008
J	Baldovin, M; Puglisi, A; Vulpiani, A				Baldovin, Marco; Puglisi, Andrea; Vulpiani, Angelo			Langevin equations from experimental data: The case of rotational diffusion in granular media	PLOS ONE			English	Article							MODEL	A model has two main aims: predicting the behavior of a physical system and understanding its nature, that is how it works, at some desired level of abstraction. A promising recent approach to model building consists in deriving a Langevin-type stochastic equation from a time series of empirical data. Even if the protocol is based upon the introduction of drift and diffusion terms in stochastic differential equations, its implementation involves subtle conceptual problems and, most importantly, requires some prior theoretical knowledge about the system. Here we apply this approach to the data obtained in a rotational granular diffusion experiment, showing the power of this method and the theoretical issues behind its limits. A crucial point emerged in the dense liquid regime, where the data reveal a complex multiscale scenario with at least one fast and one slow variable. Identifying the latter is a major problem within the Langevin derivation procedure and led us to introduce innovative ideas for its solution.	[Baldovin, Marco; Puglisi, Andrea; Vulpiani, Angelo] Sapienza Univ Roma, Dipartimento Fis, Ple A Moro 2, I-00185 Rome, Italy; [Puglisi, Andrea] CNR, ISC, Ple A Moro 2, I-00185 Rome, Italy; [Vulpiani, Angelo] Accademia Lincei, Ctr Linceo Interdisciplinare B Segre, Rome, Italy	Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR)	Baldovin, M (corresponding author), Sapienza Univ Roma, Dipartimento Fis, Ple A Moro 2, I-00185 Rome, Italy.	marco.baldovin@roma1.infn.it	BALDOVIN, MARCO/AAJ-3582-2021; Puglisi, Andrea/C-5566-2008	BALDOVIN, MARCO/0000-0003-3559-4032; Puglisi, Andrea/0000-0002-7229-9457				Andersen KH, 2000, EUR PHYS J B, V18, P447, DOI 10.1007/s100510070032; ANDREOTTI B., 2013, GRANULAR MEDIA FLUID; Baldassarri A, 2015, CR PHYS, V16, P291, DOI 10.1016/j.crhy.2015.03.017; Baldovin M, 2018, ENTROPY-SWITZ, V20, DOI 10.3390/e20100807; Baldovin M, 2018, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/aab687; Cavagna A, 2009, PHYS REP, V476, P51, DOI 10.1016/j.physrep.2009.03.003; Cecconi F, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/12/P12001; Coffey W. T., 1996, LANGEVIN EQUATION AP; D'Anna G, 2003, NATURE, V424, P909, DOI 10.1038/nature01867; Dyre JC, 2006, REV MOD PHYS, V78, P953, DOI 10.1103/RevModPhys.78.953; Fiege A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.098001; Flyvbjerg H, 1998, LECT NOTES PHYS, V501, P88; Friedrich R, 2011, PHYS REP, V506, P87, DOI 10.1016/j.physrep.2011.05.003; Gardiner C. W., 1985, HDB STOCHASTIC METHO, V3; Gnoli A, 2013, EPL-EUROPHYS LETT, V102, DOI 10.1209/0295-5075/102/14002; Heussinger C, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/20005; Jaeger HM, 1996, PHYS TODAY, V49, P32, DOI 10.1063/1.881494; Kantz H., 2004, NONLINEAR TIME SERIE, V7; Khain E, 2018, PHYS REV E, V98, DOI 10.1103/PhysRevE.98.012903; Klafter J., 2012, FRACTIONAL DYNAMICS; Klages R, 2008, ANOMALOUS TRANSPORT; Lasanta A, 2015, J CHEM PHYS, V143, DOI 10.1063/1.4928456; Lechenault F, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/46003; Leibovich N, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.052130; Luding S, 2009, NONLINEARITY, V22, pR101, DOI 10.1088/0951-7715/22/12/R01; Ma S. K., 1985, STAT MECH; Mao XG, 2018, CHAOS, V28, DOI 10.1063/1.5038758; Marty G, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.015701; ONSAGER L, 1953, PHYS REV, V91, P1505, DOI 10.1103/PhysRev.91.1505; Pons A, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.020201; Radjai F, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.064302; RAHMAN A, 1964, PHYS REV, V136, pA405, DOI 10.1103/PhysRev.136.A405; Reis PM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.188301; Risken H., 1989, FOKKER PLANCK EQUATI, DOI DOI 10.1007/978-3-642-61544-3; Rodriguez MA, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.042122; RUBIN RJ, 1960, J MATH PHYS, V1, P309, DOI 10.1063/1.1703664; Sarracino A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/34001; Sarracino A, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/04/P04013; SAUER T, 1991, J STAT PHYS, V65, P579, DOI 10.1007/BF01053745; Scalliet C, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.198001; SEARS VF, 1965, P PHYS SOC LOND, V86, P953, DOI 10.1088/0370-1328/86/5/306; Siegert S, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.041107; Utter B, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.031308; van Kampen NG, 2007, NORTH-HOLL PERS LIBR, P1; VOLLMER HD, 1979, Z PHYS B CON MAT, V33, P103, DOI 10.1007/BF01325818; Vulpiani A., 2014, LARGE DEVIATIONS PHY; Wortel GH, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.012202; Zwanzig R., 2001, NONEQUILIBRIUM STAT	48	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212135	10.1371/journal.pone.0212135	http://dx.doi.org/10.1371/journal.pone.0212135			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794586	Green Published, Green Submitted, gold			2022-12-27	WOS:000459709100039
J	Bracke, MBM; Koene, P				Bracke, Marc B. M.; Koene, Paul			Expert opinion on metal chains and other indestructible objects as proper enrichment for intensively-farmed pigs	PLOS ONE			English	Article							ENVIRONMENTAL ENRICHMENT; TAIL; BEHAVIOR; RICHPIG	EC Directive 2001/93 requires that all pigs have access to proper investigation and manipulation materials. Intensively farmed pigs in Europe are frequently provided with a short metal chain with or without an indestructible object attached to the chain. To date authorities are regarding this as proper enrichment, perhaps with (in) direct reference to the RICHPIG model as a justification. However, it has become increasingly clear that the chains do not provide proper enrichment, and that adding an indestructible object to the end of the chain may even reduce rather than improve pig welfare. To test this hypothesis an expert survey was conducted containing 26 more or less compound questions. On a scale from 0 to 10 experts specified their level of agreement with the hypothesis, the prevalence and welfare scores of nine indestructible enrichment materials. In total 36 experts, mostly pig-welfare scientists, responded (response rate: 39%). Indestructible objects are less prevalent in countries that provide straw (like Sweden and the UK) and outside the EU (US). They are more prevalent in the Netherlands, Belgium, France and Finland, while the prevalence seems to be low in Spain. Balls, wood and pipes were provided most frequently: hard wood especially in the UK (as specified in farm assurance); indestructible balls and pipes in Germany and the Netherlands. The experts' score for agreement with the hypothesis was only 4.6 on average (scale 0-10; n = 25). Enrichment materials, ranked from high to low welfare score, were grouped in 5 significance levels as indicated by different superscripts based on Wilcoxon signed rank tests: Branched chains (5.1(a)), Chain on the floor (4.4(b)), Hard wood (3.7(bc)), Pipe (3.5(c)), Bare chain (3.3(c)), Short chain (3.1(d)), Small ball (2.8(d)), Big ball (2.5(d)), and Chain hanging too high (1.3(e)). Branched chains scored significantly better than all other indestructible materials and its welfare score (5.1 on average) was close to the pre-defined level of acceptability (5.5 on a scale from 0, worst, to 10, best). The welfare benefits of adding balls, pipes or hard wood to the metal chain were marginal, and well below what the experts considered acceptable enrichment. The branched-chains design, by contrast, appears to be the most viable alternative. It involves providing a longer chain, i.e. with the free end reaching to floor level, adding 'branches', i.e. several short chains ending at the nose height of the pigs, and providing more chains per pen (i.e. 1 branched chain per 5 pigs). Branched chains should be implemented widely and in the short term as a first step towards, and benchmark for, providing proper enrichment to intensively-farmed pigs.	[Bracke, Marc B. M.; Koene, Paul] Wageningen Univ & Res, Wageningen Livestock Res, Wageningen, Netherlands	Wageningen University & Research	Bracke, MBM (corresponding author), Wageningen Univ & Res, Wageningen Livestock Res, Wageningen, Netherlands.	marc.bracke@wur.nl						[Anonymous], 1994, VARKENSBESLUIT; [Anonymous], 2007, EFSA J, DOI DOI 10.2903/J.EFSA.2007.564; Bikker P, 2012, INGEKUILD GRAS BIOL; Bleijenberg M., 2003, MINISTERIE LNV HOUDT; Bracke MBM, 2008, ANIM WELFARE, V17, P289; Bracke M. B. M., 2018, Advances in pig welfare: a volume in herd and flock welfare, P167; Bracke MBM, 2007, APPL ANIM BEHAV SCI, V104, P14, DOI 10.1016/j.applanim.2006.05.006; Bracke MBM, 2007, APPL ANIM BEHAV SCI, V104, P1, DOI 10.1016/j.applanim.2006.05.005; Bracke MBM, 2006, APPL ANIM BEHAV SCI, V98, P165, DOI 10.1016/j.applanim.2005.08.021; Bracke MBM, 2010, AFLEIDINGSMATE UNPUB; Broom D. M., 2015, Domestic animal behaviour and welfare, P279, DOI 10.1079/9781780645391.0279; Bulens A, 2015, APPL ANIM BEHAV SCI, V169, P26, DOI 10.1016/j.applanim.2015.04.011; Caille M-E, 2016, APPORT PAILLE AUTRES; CIWF, 2014, LACK COMPL PIGS DIR; Courboulay V., 2006, Journees de la Recherche Porcine en France, V38, P421; Courboulay V., 2008, Journees de la Recherche Porcine en France, V40, P255; Courboulay V., 2011, Journees de la Recherche Porcine en France, V43, P183; Courboulay V, 2014, ENRICHMENT MAT FATTE; EC, 2014, GUID PROV ENR MAT PI; Ettema KC, 2010, THESIS; European Food Safety Authority (EFSA), 2007, EFSA J, V611, P1, DOI DOI 10.2903/J.EFSA.2007.611; FEDDES JJR, 1994, T ASAE, V37, P947, DOI 10.13031/2013.28163; FRASER D, 1975, ANIM PROD, V21, P59, DOI 10.1017/S0003356100030415; FRASER D, 1991, APPL ANIM BEHAV SCI, V30, P307, DOI 10.1016/0168-1591(91)90135-K; Grau A. F. de, 2005, Journal of Animal and Veterinary Advances, V4, P51; Hothersall B, 2016, ANIM WELFARE, V25, P499, DOI 10.7120/09627286.25.4.499; Larsen MLV, 2016, VET J, V209, P50, DOI 10.1016/j.tvjl.2015.12.001; LNV, 2007, GOED AFL UW VARK; Nannoni E, 2016, APPL ANIM BEHAV SCI, V184, P25, DOI 10.1016/j.applanim.2016.08.004; NVWA, 2015, VARK NAL WELZ BIJ VA; NVWA, 2015, MANCP MEERJ NAT CONT; Parmentier L, 2007, SPEELGOED VARKENS; Pol F., 2016, Journees de la Recherche Porcine en France, V48, P241; Spoolder HAM, 2011, SE SCI REPORT UPDATI; Telkanranta H, 2014, APPL ANIM BEHAV SCI, V161, P51, DOI 10.1016/j.applanim.2014.09.007; Van de Perre V, 2011, ANIM WELFARE, V20, P641; Varkensloket, 2014, GESCHIKT OMGEVINGSVE; Verburg G, 2007, KAMERVRAGEN AFLEIDIN; Zonderland JJ, 2007, AFLEIDINGSMATERIAAL; Zonderland JJ, 2008, APPL ANIM BEHAV SCI, V110, P269, DOI 10.1016/j.applanim.2007.04.005; Zonderland JJ, 2016, VET J, V211, P1, DOI 10.1016/j.tvjl.2016.02.008	41	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212610	10.1371/journal.pone.0212610	http://dx.doi.org/10.1371/journal.pone.0212610			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794640	Green Published, Green Submitted, gold			2022-12-27	WOS:000459709100095
J	Chattopadhyay, S; Smyth, EM; Kulkarni, P; Babik, KR; Reid, M; Hittle, LE; Clark, PI; Mongodin, EF; Sapkota, AR				Chattopadhyay, Suhana; Smyth, Eoghan M.; Kulkarni, Prachi; Babik, Kelsey R.; Reid, Molly; Hittle, Lauren E.; Clark, Pamela I.; Mongodin, Emmanuel F.; Sapkota, Amy R.			Little cigars and cigarillos harbor diverse bacterial communities that differ between the tobacco and the wrapper	PLOS ONE			English	Article							STAPHYLOCOCCUS-SCIURI; CIGARETTES; SMOKING; RISK; PRODUCTS; CANCER; PRICE	Despite their potential importance with regard to infectious and chronic diseases among tobacco users, microbial constituents of tobacco products lack characterization. Specifically, to our knowledge, there are no data describing the bacterial diversity of little cigars or cigarillos. To address this knowledge gap, we tested four brands of little cigars and cigarillos. Tobacco and wrapper subsamples (n = 132) were separately subjected to DNA extraction, followed by PCR amplification of the V3V4 hypervariable region of the 16S rRNA gene, and sequencing using Illumina HiSeq. Sequences were analyzed using QIIME and Phyloseq implemented in R. We identified 2,681 operational taxonomic units across all products. Significant differences in alpha and beta diversity were observed between Swisher Sweets and Cheyenne products. Alpha and beta diversity was also significantly different between tobacco and wrapper subsamples within the same product. Beta diversity analyses of only tobacco samples identified no significant differences in the bacterial microbiota of different lots of the same products; however, the microbiota in the wrapper differed significantly across lots for all brands. Overall, Firmicutes were found to dominate in the wrapper, whereas Proteobacteria were most abundant in the tobacco. At the genus level, Bacillus and Lactobacillus dominated in the wrappers, and Staphylococcus and Pseudomonas dominated in the tobacco. Our findings suggest that the bacterial microbiota of little cigars and cigarillos is diverse and differs significantly between the tobacco and the wrapper, and across brands. Future work is necessary to evaluate the potential public health implications of these findings.	[Chattopadhyay, Suhana; Smyth, Eoghan M.; Kulkarni, Prachi; Babik, Kelsey R.; Reid, Molly; Sapkota, Amy R.] Univ Maryland, Sch Publ Hlth, Maryland Inst Appl Environm Hlth, College Pk, MD 20742 USA; [Smyth, Eoghan M.; Hittle, Lauren E.; Mongodin, Emmanuel F.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Smyth, Eoghan M.; Hittle, Lauren E.; Mongodin, Emmanuel F.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Clark, Pamela I.] Univ Maryland, Sch Publ Hlth, Dept Behav & Community Hlth, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland College Park	Sapkota, AR (corresponding author), Univ Maryland, Sch Publ Hlth, Maryland Inst Appl Environm Hlth, College Pk, MD 20742 USA.	ars@umd.edu	Babik, Kelsey/GYU-8346-2022; Mongodin, Emmanuel/AAF-1850-2020; Chattopadhyay, Suhana/HHC-2870-2022	Mongodin, Emmanuel/0000-0003-3833-7437; Babik, Kelsey/0000-0002-8084-6449	National Cancer Institute [P50CA180523]; Food and Drug Administration, Center for Tobacco Products; NATIONAL CANCER INSTITUTE [P50CA180523] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Food and Drug Administration, Center for Tobacco Products; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by grant number P50CA180523 from the National Cancer Institute and the Food and Drug Administration, Center for Tobacco Products awarded to the University of Maryland to authors PIC, EFM, and ARS, https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the Food and Drug Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JG, 2015, ENV HLTH PERSPECT, V124; Baker F, 2000, JAMA-J AM MED ASSOC, V284, P735, DOI 10.1001/jama.284.6.735; Baker RR, 2006, PROG ENERG COMBUST, V32, P373, DOI 10.1016/j.pecs.2006.01.001; Barrington-Trimis JL, 2014, JAMA-J AM MED ASSOC, V312, P2493, DOI 10.1001/jama.2014.14830; Bati A., 1997, CIGAR COMPANION CONN, V3rd; Berendsen EM, 2015, APPL ENVIRON MICROB, V81, P7791, DOI 10.1128/AEM.01993-15; Boffetta P, 1999, JNCI-J NATL CANCER I, V91, P697, DOI 10.1093/jnci/91.8.697; Cantrell J, 2013, AM J PUBLIC HEALTH, V103, P1902, DOI 10.2105/AJPH.2013.301362; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chopyk J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00358; Chopyk J, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0235-0; Cruz AT, 2007, J CLIN MICROBIOL, V45, P1989, DOI 10.1128/JCM.00632-07; Cullen J, 2011, AM J PUBLIC HEALTH, V101, P1955, DOI 10.2105/AJPH.2011.300209; Delnevo CD, 2004, ADDICT BEHAV, V29, P1799, DOI 10.1016/j.addbeh.2004.04.024; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Gammon DG, 2016, TOB CONTROL, V25, P538, DOI 10.1136/tobaccocontrol-2015-052343; Garten S, 2004, PREV MED, V38, P793, DOI 10.1016/j.ypmed.2004.01.019; GILARDI GL, 1972, ANN INTERN MED, V77, P211, DOI 10.7326/0003-4819-77-2-211; Hage JE, 2013, PERITON DIALYSIS INT, V33, P223, DOI 10.3747/pdi.2012.00112; Henningfield J E, 1999, Nicotine Tob Res, V1, P163, DOI 10.1080/14622299050011271; Holt Hanne M., 1997, Clin Microbiol Infect, V3, P329, DOI 10.1111/j.1469-0691.1997.tb00622.x; Horii T, 2001, SCAND J INFECT DIS, V33, P930, DOI 10.1080/00365540110076750; Hsueh PR, 2000, J CLIN MICROBIOL, V38, P2450; Iribarren C, 1999, NEW ENGL J MED, V340, P1773, DOI 10.1056/NEJM199906103402301; Jackson HT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095414; Kappstein I, 2000, J HOSP INFECT, V44, P27, DOI 10.1053/jhin.1999.0648; Kostygina G, 2016, TOB CONTROL, V25, pi75, DOI 10.1136/tobaccocontrol-2016-053094; Kreiss K, 2002, NEW ENGL J MED, V347, P330, DOI 10.1056/NEJMoa020300; Larsson L, 2008, TOB INDUC DIS, V4, DOI [10.1007/s12026-009-8117-6, DOI 10.1007/S12026-009-8117-6]; Love MI, 2014, MODERATED ESTIMATION; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Milam AI, 2012, PROG COMM HLTH PARTN, V6, P205, DOI 10.1353/cpr.2012.0027; Nemec A, 2001, INT J SYST EVOL MICR, V51, P1891, DOI 10.1099/00207713-51-5-1891; O'Connor RJ, 2012, TOB CONTROL, V21, P181, DOI 10.1136/tobaccocontrol-2011-050281; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; Pauly JL, 2010, IMMUNOL RES, V46, P127, DOI 10.1007/s12026-009-8117-6; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Richardson A, 2013, NICOTINE TOB RES, V15, P1729, DOI 10.1093/ntr/ntt053; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Sapkota AR, 2010, ENVIRON HEALTH PERSP, V118, P351, DOI 10.1289/ehp.0901201; Schuster RM, 2013, NICOTINE TOB RES, V15, P925, DOI 10.1093/ntr/nts222; Shannon TR, 2004, BIOPHYS J, V87, P3351, DOI 10.1529/biophysj.104.047449; Shapiro JA, 2000, JNCI-J NATL CANCER I, V92, P333, DOI 10.1093/jnci/92.4.333; Shittu A, 2004, J MED MICROBIOL, V53, P51, DOI 10.1099/jmm.0.05294-0; SIDNEY S, 1995, ARCH INTERN MED, V155, P727, DOI 10.1001/archinte.155.7.727; Smyth EM, 2017, APPL MICROBIOL BIOT, V101, P5391, DOI 10.1007/s00253-017-8282-9; Stepanovic S, 2005, INT J STD AIDS, V16, P452, DOI 10.1258/0956462054093999; Stepanovic S, 2003, J CLIN MICROBIOL, V41, P5262, DOI 10.1128/JCM.41.11.5262-5264.2003; Touey GP, 1957, TOBACCO SCI, V1, P33; Tyx RE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146939; Wang HK, 2017, J MICROBIOL IMMUNOL, V50, P923, DOI 10.1016/j.jmii.2016.06.001; Wang TW, 2018, NICOTINE TOB RES, V20, P1401, DOI 10.1093/ntr/ntx249; Wayne GF, 2004, NICOTINE TOB RES, V6, P927, DOI 10.1080/14622200412331324839; Zupancic ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043052	56	8	8	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0211705	10.1371/journal.pone.0211705	http://dx.doi.org/10.1371/journal.pone.0211705			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794551	Green Published, gold, Green Submitted			2022-12-27	WOS:000459709100023
J	Eschenfeldt, PC; Hur, C				Eschenfeldt, Patrick C.; Hur, Chin			A quantitative exploration of gastrointestinal bleeding in intensive care unit patients	PLOS ONE			English	Article							BLOOD UREA NITROGEN; HYPOVOLEMIC SHOCK; CLASSIFICATION	Background Quantitative assessments of the severity of bleeding in patients with bleeds within the gastrointestinal tract (GIB) are generally limited to blood tests like the hematocrit. The varied and irregular nature of the data collected during such observations makes it difficult in retrospective data analysis to characterize the complete course of bleeding. We intend to quantify the rate of blood loss over the course of an ICU stay, facilitating more precise analysis of retrospective data, and to use this quantification to examine questions about the effects of GIB. Methods and findings A population of 2,445 intensive care admissions across 2,266 patients with a diagnosis of GIB was studied. Using statistical techniques for smoothing data and accepted medical approaches for calculating blood loss, we are able to convert collections of individual laboratory readings that are difficult to understand into a simple, interpretable overview of the patient's bleeding status over time. To demonstrate this method, we compare patients' standard vital signs while bleeding heavily to times when they are not bleeding, finding a 3.0 +/- 0.5% increase in heart rate, a 1.3 +/- 0.4% decrease in systolic blood pressure and a 0.9 +/- 0.5% decrease in diastolic blood pressure. After considering the effect of bleeding on standard vital signs, we demonstrate that patients with upper GIB have significantly elevated blood urea nitrogen levels while bleeding heavily, with a mean increase of 11.7 +/- 7.2%, while patients with lower GIB do not, with a mean increase of 4.2 +/- 6.6%. Conclusions This study introduces a novel method of processing retrospective laboratory data to characterize the course of bleeds within the gastrointestinal tract. This method is used to examine the direct effects of bleeding on a patient and can be deployed in future studies of bleeding using retrospective data.	[Eschenfeldt, Patrick C.] Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA; [Eschenfeldt, Patrick C.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Eschenfeldt, Patrick C.] Harvard Med Sch, Boston, MA 02115 USA; [Hur, Chin] Columbia Univ, Med Ctr, Dept Med, New York, NY 10027 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Columbia University	Hur, C (corresponding author), Columbia Univ, Med Ctr, Dept Med, New York, NY 10027 USA.	Ch447@cumc.columbia.edu						Al-Naamani K, 2008, CAN J GASTROENTEROL, V22, P399, DOI 10.1155/2008/207850; American College of Surgeons Committee on Trauma, 2008, ADV TRAUM LIF SUPP D; BOURKE DL, 1974, ANESTHESIOLOGY, V41, P609, DOI 10.1097/00000542-197412000-00015; Brecher ME, 1997, TRANSFUSION, V37, P1070, DOI 10.1046/j.1537-2995.1997.371098016448.x; DIERCKX P, 1982, SIAM J NUMER ANAL, V19, P1286, DOI 10.1137/0719093; Dierckx P., 1993, CURVE SURFACE FITTIN; Dierckx P., 1975, J COMPUT APPL MATH, V1, P165, DOI [DOI 10.1016/0771-050X(75)90034-0, 10.1016/0771-050X(75)90034-0]; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; GROSS JB, 1983, ANESTHESIOLOGY, V58, P277, DOI 10.1097/00000542-198303000-00016; Hunt BJ, 2015, BRIT J HAEMATOL, V170, P788, DOI 10.1111/bjh.13580; Johnson AEW, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.35; Jones E., 2001, SCIPY OPEN SOURCE SC; Kumar S, 2017, FRONTLINE GASTROENTE, V8, P167, DOI 10.1136/flgastro-2016-100722; Mutschler M, 2014, INJURY, V45, pS35, DOI 10.1016/j.injury.2014.08.015; Mutschler M, 2013, RESUSCITATION, V84, P309, DOI 10.1016/j.resuscitation.2012.07.012; Mutschler M, 2013, CRIT CARE, V17, DOI 10.1186/cc12555; NADLER SB, 1962, SURGERY, V51, P224; Rossum G., 1995, PYTHON REFERENCE MAN; TEASDALE G, 1974, LANCET, V2, P81; Thomas I, 2004, BMJ-BRIT MED J, V328, P451, DOI 10.1136/bmj.328.7437.451; Tomizawa M, 2015, WORLD J GASTROENTERO, V21, P7500, DOI 10.3748/wjg.v21.i24.7500; Tomizawa M, 2014, WORLD J GASTROENTERO, V20, P1311, DOI 10.3748/wjg.v20.i5.1311	22	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212040	10.1371/journal.pone.0212040	http://dx.doi.org/10.1371/journal.pone.0212040			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794554	Green Published, Green Submitted, gold			2022-12-27	WOS:000459709100035
J	Komp-Leukkunen, K				Komp-Leukkunen, Kathrin			Capturing the diversity of working age life courses: A European perspective on cohorts born before 1945	PLOS ONE			English	Article							DE-STANDARDIZATION; SEQUENCE-ANALYSIS; LABOR-MARKET; BABY BOOMERS; RETIREMENT; GENDER; FAMILY; TRAJECTORIES; EMPLOYMENT; WOMEN	Life-courses describe people's activities from the cradle to the grave. Because life-courses are typically complex, models are used to simplify their description. The most commonly used model is tripartite, representing lives in subsequent periods of education, work, and retirement. However, researchers criticize this model as limited in the activities considered, overly simplistic in the activity sequence, and blind to variation between life-courses. This article explores working age life-courses, which typically show high diversity. Multichannel sequence and cluster analyses are conducted on people's activities from age 15 to 65. Data stem from the life-history interviews of the Survey of Health, Ageing and Retirement in Europe, capturing cohorts born before 1945. Findings show that three out of four working age life-courses are in line with the tripartite model. This share is particularly high among men, the cohort born 1935 to 1944, and in Northern and Eastern Europe. In contrast, a considerable share of women spent their working age on homemaking, especially women born before 1935, and those living in Southern Europe. Finally, a smaller number of men spent their working age on paid work, followed by a period of illness or of non-employment. The working age life-course patterns identified are used to develop alternative life-course models. However, for a parsimonious solution, the use of two models suffices. A combination of the tripartite model and the model equating middle age to homemaking captures the lives of more than nine out of ten older Europeans. The prevalence of working age life-course patterns in a population is country-specific, and the country differences align with the welfare regimes. This perspective makes working age life-courses characteristics of a society that can be used to map social inequalities at the macro-level and capture social change over time.	[Komp-Leukkunen, Kathrin] Univ Helsinki, Fac Social Sci, Helsinki, Finland	University of Helsinki	Komp-Leukkunen, K (corresponding author), Univ Helsinki, Fac Social Sci, Helsinki, Finland.	kathrin.komp@helsinki.fi		Komp-Leukkunen, Kathrin/0000-0001-9342-2170	European Union [661580]; European Commission [QLK6-CT-2001-00360, SHARE-I3: RII-CT-2006-062193, COMPARE: CIT5-CT-2005-028857, SHARELIFE: CIT4-CT-2006-028812, 211909, 227822, 261982]; German Ministry of Education and Research; Max Planck Society for the Advancement of Science; U.S. National Institute on Aging [U01_AG09740-13S2, P01_AG005842, P01_AG08291, P30_AG12815, R21_AG025169, Y1-AG-4553-01, IAG_BSR06-11, OGHA_04-064, HHSN271201300071C]; NATIONAL INSTITUTE ON AGING [P01AG005842, U01AG009740, P01AG008291, P30AG012815] Funding Source: NIH RePORTER	European Union(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Max Planck Society for the Advancement of Science(Max Planck SocietyEuropean Commission); U.S. National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Kathrin Komp-Leukkunen has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 661580. https://ec.europa.eu/research/mariecurieactions/.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study uses data from SHARE Wave 3 (SHARELIFE) (DOI: 10.6103/SHARE.w3.600), see Borsch-Supan et al. (2013) for methodological details. The SHARE data collection has been primarily funded by the European Commission through FP5 (QLK6-CT-2001-00360), FP6 (SHARE-I3: RII-CT-2006-062193, COMPARE: CIT5-CT-2005-028857, SHARELIFE: CIT4-CT-2006-028812) and FP7 (SHARE-PREP: No 211909, SHARE-LEAP: No 227822, SHARE M4: No 261982). Additional funding from the German Ministry of Education and Research, the Max Planck Society for the Advancement of Science, the U.S. National Institute on Aging (U01_AG09740-13S2, P01_AG005842, P01_AG08291, P30_AG12815, R21_AG025169, Y1-AG-4553-01, IAG_BSR06-11, OGHA_04-064, HHSN271201300071C) and from various national funding sources is gratefully acknowledged (see www.share-project.org).	Aidukaite J., 2011, COMMUNIST POSTCOMMUN, V42, P23; Aisenbrey S, 2010, SOCIOL METHOD RES, V38, P420, DOI 10.1177/0049124109357532; Alcser KH, 2005, SURVEY HLTH AGING RE; Allison PD, 2002, MISSING DATA; Anttonen Anneli, 1996, J EUR SOC POLICY, V6, P87, DOI [10.1177/095892879600600201, DOI 10.1177/095892879600600201]; Anxo D., 2007, SOCIO-ECON REV, V5, P233, DOI DOI 10.1093/SER/MWL019; Anxo D, 2011, FEM ECON, V17, P159, DOI 10.1080/13545701.2011.582822; Backman O, 2011, EUR SOCIOL REV, V27, P107, DOI 10.1093/esr/jcp064; Bask M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142447; Borsch-Supan A, 2013, INT J EPIDEMIOL, V42, P992, DOI 10.1093/ije/dyt088; Booker CL, 2013, LONGITUD LIFE COURSE, V4, P88; Bruckner H., 2005, STRUCTURE LIFE COURS, V9, P27, DOI [10.1016/S1040-2608(04)09002-1, DOI 10.1016/S1040-2608(04)09002-1]; Bynner J., 2005, J YOUTH STUD, V8, P367, DOI DOI 10.1080/13676260500431628; CALASANTI TM, 1993, J AGING STUD, V7, P133, DOI 10.1016/0890-4065(93)90030-N; Cohen JE, 2003, SCIENCE, V302, P1172, DOI 10.1126/science.1088665; Cooke M, 2009, CAN J SOCIOL, V34, P349; Corna LM, 2013, LONGITUD LIFE COURSE, V4, P33; Crockett LJ, 2012, DEV PSYCHOL, V48, P1727, DOI 10.1037/a0027538; CROWN WH, 1985, GERONTOLOGIST, V25, P166, DOI 10.1093/geront/25.2.166; Dannefer D, 2013, CONTEMP SOCIOL, V42, P793, DOI 10.1177/0094306113506870; Dannefer D, 2012, J GERONTOL B-PSYCHOL, V67, P221, DOI 10.1093/geronb/gbr148; Drobni S., 2004, RES SOCIAL STRATIFIC, V21, P139, DOI DOI 10.1016/S0276-5624(04)21008-3; Ebbinghaus B, 2006, REFORMING EARLY RETI; Elzinga CH, 2007, EUR J POPUL, V23, P225, DOI 10.1007/s10680-007-9133-7; Esping-Andersen G., 1990, 3 WORLDS WELFARE CAP; Fasang AE, 2010, SOCIOL RES ONLINE, V15, DOI 10.5153/sro.2110; Gornick JC, 2004, ADV LIFE COURSE RES, V8, P45, DOI 10.1016/S104-2608(03)08003-1; Hajek A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146967; Han SY, 2017, LONGITUD LIFE COURSE, V8, P319, DOI 10.14301/llcs.v8i4.409; Hoff A., 2011, POPULATION AGEING CE; Kaufman L. R., 2005, FINDING GROUPS DATA; Kohli M, 1987, J Aging Stud, V1, P125, DOI 10.1016/0890-4065(87)90003-X; KOHLI M, 1985, KOLNER Z SOZIOL SOZ, V37, P1; Kohli M, 2000, GESCH ZUKUNFT ARBEIT, P362; Kohli Martin., 2007, RES HUM DEV, V4, DOI DOI 10.1080/15427600701663122; Komp K, 2015, AGEING LIFECOURSE, P1, DOI 10.1332/policypress/9781447310716.001.0001; Komp K., 2013, GLOBAL AGEING 21 CEN, P175; Komp K, 2018, J EUR SOC POLICY, V28, P130, DOI 10.1177/0958928717709174; Lammers M, 2013, EUR ECON REV, V58, P31, DOI 10.1016/j.euroecorev.2012.11.003; Laslett P., 1989, FRESH MAP LIFE EMERG; Lave C., 1993, INTRO MODELS SOCIAL; Leibfried S, 2013, NEW PERSPECTIVES WEL, P120; Loretto W, 2013, HUM RELAT, V66, P65, DOI 10.1177/0018726712455832; Maas I, 1999, EUR SOCIOL REV, V15, P213, DOI 10.1093/oxfordjournals.esr.a018261; Macmillan R., 2005, ADV LIFE COURSE RES, V9, P3, DOI [10.1016/S1040-2608(04)09001-X, DOI 10.1016/S1040-2608(04)09001-X]; Madero-Cabib I, 2016, ADV LIFE COURSE RES, V27, P43, DOI 10.1016/j.alcr.2015.11.003; Madero-Cabib I, 2016, WORK AGING RETIRE, V2, P38, DOI 10.1093/workar/wav023; Mayer K.U., 2005, ANAL INEQUALITY LIFE, P17; Mayer Karl Ulrich, 2004, RES HUM DEV, V1, P161, DOI [10.1207/s15427617rhd0103_3, DOI 10.1207/S15427617RHD0103_3]; McMunn A, 2015, ADV LIFE COURSE RES, V26, P60, DOI 10.1016/j.alcr.2015.06.002; MOEN P, 1994, J GERONTOL, V49, pS176, DOI 10.1093/geronj/49.4.S176; Nonneman W, 1996, Q J ECON, V111, P943, DOI 10.2307/2946677; OECD, 2015, PENS GLANC 2015 OECD, DOI 10.1787/pension_glance-2015-en.https://www.oecd-ilibrary.org/content/publication/pension_glance-2015-en; Organisation for Economic Co-operation and Development, 2013, UN RAT LAB FORC; Organization for Economic Cooperation and Development, 2006, AG EMPL POL LIV LONG; Pailhe A, 2013, LONGITUD LIFE COURSE, V4, P196; Park CB, 2009, PUBLIC HEALTH REP, V124, P579, DOI 10.1177/003335490912400415; Pascall G, 2004, J SOC POLICY, V33, P373, DOI 10.1017/S004727940400772X; Pianese A, 2014, DECIS SUPPORT SYST, V64, P109, DOI 10.1016/j.dss.2014.04.009; Plantenga Janneke, 2002, CRIT SOC POLICY, V22, P53, DOI DOI 10.1177/02610183020220010601; RILEY MW, 1994, GERONTOLOGIST, V34, P110, DOI 10.1093/geront/34.1.110; Roos LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188976; Sainsbury D., 1996, GENDER EQUALITY WELF; SCHOMANN K, 1995, EUR SOCIOL REV, V11, P187, DOI 10.1093/oxfordjournals.esr.a036356; Schroder Mathis, 2011, RETROSPECTIVE DATA C; Seierstad C, 2015, GENDER WORK ORGAN, V22, P390, DOI 10.1111/gwao.12099; Settersten R. A., 2003, INVITATION LIFE COUR, P15; Settersten RA, 1997, ANNU REV SOCIOL, V23, P233, DOI 10.1146/annurev.soc.23.1.233; Settersten RA, 2015, ANNU REV GERONTOL GE, V35, P29, DOI 10.1891/0198-8794.35.29; Simonson J, 2011, ADV LIFE COURSE RES, V16, P65, DOI 10.1016/j.alcr.2011.03.002; Sorensen A, 2004, ADV LIFE COURSE RES, V8, P281, DOI 10.1016/S1040-2608(03)08013-4; Spijker J, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6598; Stattin M, 2005, OCCUP ENVIRON MED, V62, P135, DOI 10.1136/oem.2004.015669; Studer M, 2013, WEIGHTEDCLUSTER LIB, DOI [10.12682/lives.2296-1658.2013.24, DOI 10.12682/LIVES.2296-1658.2013.24]; Tikanmaki, 2015, INT J MICROSIMULATIO, V8, P75; Tophoven S, 2016, ADV LIFE COURSE RES, V30, P90, DOI 10.1016/j.alcr.2016.04.003; Turek K, 2015, AGEING LIFECOURSE, P85; Vanhuysse P, 2006, DIVIDE AND PACIFY: STRATEGIC SOCIAL POLICIES AND POLITICAL PROTESTS IN POST-COMMUNIST DEMOCRACIES, P1; Virtanen P, 2011, ADV LIFE COURSE RES, V16, P55, DOI 10.1016/j.alcr.2011.03.001; Widmer ED, 2009, ADV LIFE COURSE RES, V14, P28, DOI 10.1016/j.alcr.2009.04.001; Wilks D.S, 2011, INT GEOPHYS; Wood N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185798; Worts D, 2016, LONGITUD LIFE COURSE, V7, P347, DOI 10.14301/llcs.v7i4.389	83	7	7	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212400	10.1371/journal.pone.0212400	http://dx.doi.org/10.1371/journal.pone.0212400			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794599	Green Submitted, Green Published, gold			2022-12-27	WOS:000459709100060
J	Krifors, A; Ozenci, V; Ullberg, M; Ackefors, M; Jadersten, M; Stralin, K; Blennow, O				Krifors, Anders; Ozenci, Volkan; Ullberg, Mans; Ackefors, Malin; Jadersten, Martin; Stralin, Kristoffer; Blennow, Ola			PCR with electrospray ionization-mass spectrometry on bronchoalveolar lavage for detection of invasive mold infections in hematological patients	PLOS ONE			English	Article							MOLECULAR-DETECTION; CRITICALLY-ILL; GALACTOMANNAN; DIAGNOSIS; ASPERGILLOSIS; SERUM; SAMPLES	Invasive mold infections are life-threatening complications in patients with hematological malignancies. Conventional microbiological methods for diagnosing invasive pulmonary mold infections have low sensitivity, and molecular methods are being developed. Detection of molds using PCR with a narrow spectrum has been reported, but data with broad-spectrum PCR are lacking. In this study, the diagnostic performance and utility of a broad-spectrum PCR (broad-spectrum PCR with subsequent electrospray ionization-mass spectrometry, PCR/ESI-MS) for detection of molds in bronchoalveolar lavage (BAL) in 27 hematological patients with a new pulmonary infiltrate was analyzed. Using the revised EORTC/MSG criteria, PCR/ESI-MS was the only positive microbiological test in patients with proven invasive mold infection (n = 2) and correctly identified all cases of probable invasive pulmonary aspergillosis (n = 5). In patients with a possible invasive mold infection (n = 5), PCR/ESI-MS was positive in three patients. Mucorales was identified with PCR/ESI-MS in four patients that were all culture negative. The PCR/ESI-MS results had a clinical impact on antifungal therapy in 12 (44%) of the patients: modification of treatment in 6 (22%) patients and discontinuation in 6 (22%) patients. This study provides proof of concept that routine use of a broad-spectrum PCR for molds in bronchoalveolar lavage in immunocompromised patients is sensitive, fast, and has an impact on clinical decision-making	[Krifors, Anders] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Ozenci, Volkan; Ullberg, Mans] Karolinska Univ Hosp, Dept Clin Microbiol, Stockholm, Sweden; [Ozenci, Volkan; Ullberg, Mans] Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden; [Ackefors, Malin; Stralin, Kristoffer; Blennow, Ola] Karolinska Univ Hosp, Dept Infect Dis, Huddinge, Sweden; [Jadersten, Martin] Karolinska Inst, Dept Med Huddinge, Ctr Haematol & Regenerat Med, Stockholm, Sweden; [Stralin, Kristoffer; Blennow, Ola] Karolinska Inst, Dept Med Huddinge, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet	Krifors, A (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden.	anders.krifors@regionvastmanland.se	Blennow, Ola/HHR-9848-2022; Özenci, Volkan/H-3116-2019; Blennow, Ola/AAC-9502-2022	Blennow, Ola/0000-0002-7167-7882; Özenci, Volkan/0000-0002-8069-4027; Blennow, Ola/0000-0002-7167-7882; Krifors, Anders/0000-0003-1230-0492				Bellanger AP, 2018, BONE MARROW TRANSPL, V53, P1180, DOI 10.1038/s41409-018-0194-5; Boch T, 2016, MYCOSES, V59, P80, DOI 10.1111/myc.12434; Chamilos G, 2008, CLIN INFECT DIS, V47, P503, DOI 10.1086/590004; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Desmet S, 2016, J CLIN MICROBIOL, V54, P2513, DOI 10.1128/JCM.01066-16; Eigl S, 2017, MED MYCOL, V55, P528, DOI 10.1093/mmy/myw102; Endimiani A, 2011, CLIN INFECT DIS, V52, pS373, DOI 10.1093/cid/cir054; Farmakiotis D, 2016, INFECT DIS CLIN N AM, V30, P143, DOI 10.1016/j.idc.2015.10.011; Heldta S, 2018, J INFECTION, V77, P235, DOI 10.1016/j.jinf.2018.05.001; Hoenigl M, 2013, MYCOSES, V56, P471, DOI 10.1111/myc.12060; Klingspor L, 2006, CLIN MICROBIOL INFEC, V12, P745, DOI 10.1111/j.1469-0691.2006.01498.x; Lahmer T, 2016, J CRIT CARE, V36, P259, DOI 10.1016/j.jcrc.2016.06.026; Loeffler J, 2015, J CLIN MICROBIOL, V53, P2838, DOI 10.1128/JCM.00906-15; Lung ML, 2012, CURR OPIN CRIT CARE, V18, P487, DOI 10.1097/MCC.0b013e3283577d37; Ozenci V, 2018, CLIN INFECT DIS, V66, P452, DOI 10.1093/cid/cix743; Patterson TF, 2016, CLIN INFECT DIS, V63, pE1, DOI 10.1093/cid/ciw326; Roden MM, 2005, CLIN INFECT DIS, V41, P634, DOI 10.1086/432579; Stralin K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159694; Upton A, 2007, CLIN INFECT DIS, V44, P531, DOI 10.1086/510592; Vincent JL, 2015, CRIT CARE MED, V43, P2283, DOI 10.1097/CCM.0000000000001249; White PL, 2013, J CLIN MICROBIOL, V51, P1510, DOI 10.1128/JCM.03189-12; White PL, 2010, J CLIN MICROBIOL, V48, P1231, DOI 10.1128/JCM.01767-09; Zou MX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043347	23	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212812	10.1371/journal.pone.0212812	http://dx.doi.org/10.1371/journal.pone.0212812			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794675	Green Published, Green Submitted, gold			2022-12-27	WOS:000459709100145
J	Peters, SO; Sinecen, M; Gallagher, GR; Pebworth, LA; Jacob, S; Hatfield, JS; Kizilkaya, K				Peters, Sunday O.; Sinecen, Mahmut; Gallagher, George R.; Pebworth, Lauren A.; Jacob, Suleima; Hatfield, Jason S.; Kizilkaya, Kadir			Comparison of linear model and artificial neural network using antler beam diameter and length of white-tailed deer (Odocoileus virginianus) dataset	PLOS ONE			English	Article							MULTIPLE-REGRESSION MODELS; DENSITY; TRAITS; PREDICTION	Evaluation of harvest data remains one of the most important sources of information in the development of strategies to manage regional populations of white-tailed deer. While descriptive statistics and simple linear models are utilized extensively, the use of artificial neural networks for this type of data analyses is unexplored. Linear model was compared to Artificial Neural Networks (ANN) models with Levenberg-Marquardt (L-M), Bayesian Regularization (BR) and Scaled Conjugate Gradient (SCG) learning algorithms, to evaluate the relative accuracy in predicting antler beam diameter and length using age and dressed body weight in white-tailed deer. Data utilized for this study were obtained from male animals harvested by hunters between 1977-2009 at the Berry College Wildlife Management Area. Metrics for evaluating model performance indicated that linear and ANN models resulted in close match and good agreement between predicted and observed values and thus good performance for all models. However, metrics values of Mean Absolute Error and Root Mean Squared Error for linear model and the ANN-BR model indicated smaller error and lower deviation relative to the mean values of antler beam diameter and length in comparison to other ANN models, demonstrating better agreement of the predicted and observed values of antler beam diameter and length. ANN-SCG model resulted in the highest error within the models. Overall, metrics for evaluating model performance from the ANN model with BR learning algorithm and linear model indicated better agreement of the predicted and observed values of antler beam diameter and length. Results of this study suggest the use of ANN generated results that are comparable to Linear Models of harvest data to aid in the development of strategies to manage white-tailed deer.	[Peters, Sunday O.; Gallagher, George R.; Pebworth, Lauren A.; Jacob, Suleima; Hatfield, Jason S.] Berry Coll, Sch Math & Nat Sci, Dept Anim Sci, Mt Berry, GA 30149 USA; [Peters, Sunday O.] Univ Georgia, Dept Anim & Dairy Sci, Athens, GA 30602 USA; [Sinecen, Mahmut] Adnan Menderes Univ, Dept Comp Engn, Fac Engn, Aydin, Turkey; [Kizilkaya, Kadir] Adnan Menderes Univ, Fac Agr, Dept Anim Sci, Aydin, Turkey	University System of Georgia; University of Georgia; Adnan Menderes University; Adnan Menderes University	Peters, SO (corresponding author), Berry Coll, Sch Math & Nat Sci, Dept Anim Sci, Mt Berry, GA 30149 USA.; Peters, SO (corresponding author), Univ Georgia, Dept Anim & Dairy Sci, Athens, GA 30602 USA.	speters@berry.edu; ggallagher@berry.edu	Sinecen, Mahmut/H-2706-2018; Peters, Sunday/AAE-9683-2021	Sinecen, Mahmut/0000-0001-5497-0035; Jacob-Tomas, Suleima/0000-0002-3900-7360; Peters, Sunday/0000-0002-0216-926X				Ali Z, 2017, ADV METEOROL, V2017, DOI 10.1155/2017/5681308; Arnett Edward B., 2015, International Journal of Environmental Studies, V72, P734, DOI 10.1080/00207233.2015.1033944; Barmpadimos I, 2011, ATMOS CHEM PHYS, V11, P1813, DOI 10.5194/acp-11-1813-2011; Baughman D, 1996, NEURAL NETWORKS BIOP; Beale M., 1993, NEURAL NETWORK TOOLB; Booke D, 2017, COMMUNICATION; Campbell SAB, 2013, NORTHEAST NAT, V20, P469, DOI 10.1656/045.020.0310; Carslaw D, 2011, REPORT DEFRA URBAN M; Chaloulakou A, 2003, J AIR WASTE MANAGE, V53, P1183, DOI 10.1080/10473289.2003.10466276; Chang JC, 2004, METEOROL ATMOS PHYS, V87, P167, DOI 10.1007/s00703-003-0070-7; Christodoulou CG, 2001, APPL NEURAL NETWORKS; Cybenko G., 1989, Mathematics of Control, Signals, and Systems, V2, P303, DOI 10.1007/BF02551274; Dehghanisanij A, 2016, RIVER PUBLISHERS SER; Derwent D, 2010, EVALUATING PERFORMAN; Drake D., 2005, Journal of Extension, V43, p1RIB5; Ehret A, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0097-5; EPA, 2007, GUID US MOD OTH AN D; Fan MY, 2017, MATERIALS, V10, DOI 10.3390/ma10050544; Fidele B, 2009, TRENDS APPL SCI RES, V4, P36, DOI DOI 10.3923/TASR.2009.36.46; Gardner MW, 1998, ATMOS ENVIRON, V32, P2627, DOI 10.1016/S1352-2310(97)00447-0; Ghanbary F, 2012, J ENVIRON SCI, V24, P750, DOI 10.1016/S1001-0742(11)60815-2; Gianola D, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-87; Haykin S, 1999, P842; Hewitt DG, 2014, J WILDLIFE MANAGE, V78, P976, DOI 10.1002/jwmg.741; Hodler T.W., 1986, THE ATLAS OF GEORGIA; HORNIK K, 1989, NEURAL NETWORKS, V2, P359, DOI 10.1016/0893-6080(89)90020-8; Huijser MP, 2008, WILDLIFE VEHICLE COL, P7; Keyser PD, 2006, WILDLIFE SOC B, V34, P1113, DOI 10.2193/0091-7648(2006)34[1113:RDCMAP]2.0.CO;2; Keyser PD, 2005, J WILDLIFE MANAGE, V69, P356, DOI 10.2193/0022-541X(2005)069&lt;0356:PDCRIW&gt;2.0.CO;2; Krose B., 1996, INTRO NEURAL NETWORK, VEighth; Lemaitre JF, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.0869; Lockwood MA, 2007, J WILDLIFE MANAGE, V71, P2732, DOI 10.2193/2005-517; Lukefahr SD, 1998, J WILDLIFE MANAGE, V62, P262, DOI 10.2307/3802287; Martins F., 2009, MODELLING POLLUTANTS, V1, P277; McCullough, 2015, ADV ECOL, V2015, DOI DOI 10.1155/2015/156041; McShea WJ, 2012, ANN NY ACAD SCI, V1249, P45, DOI 10.1111/j.1749-6632.2011.06376.x; Park J, 2015, ASIAN AUSTRAL J ANIM, V28, P1303, DOI 10.5713/ajas.14.0535; Paschalidou AK, 2011, ENVIRON SCI POLLUT R, V18, P316, DOI 10.1007/s11356-010-0375-2; Peixoto HM, 2009, AN 9 C BRAS RED NEUR; Premalatha Neelamegam, 2016, J. appl. res. technol, V14, P206, DOI 10.1016/j.jart.2016.05.001; R Development Core Team, 2009, R LANG ENV STAT COMP; Simard A, 2014, WILDLIFE MONOGR, V187, P1, DOI 10.1002/wmon.1010; Simard MA, 2010, J WILDLIFE MANAGE, V74, P1671, DOI 10.2193/2009-258; Strickland BK, 2013, WILDLIFE SOC B, V37, P458, DOI 10.1002/wsb.278; Strickland BK, 2013, J WILDLIFE MANAGE, V77, P243, DOI 10.1002/jwmg.470; Szymczak S, 2009, GENET EPIDEMIOL, V33, pS51, DOI 10.1002/gepi.20473; WILLMOTT CJ, 1985, J GEOPHYS RES-OCEANS, V90, P8995, DOI 10.1029/JC090iC05p08995; YADAV D, 2011, INT J WATER RESOUR E, V3, P30; Yu SC, 2006, ATMOS SCI LETT, V7, P26, DOI 10.1002/asl.125	49	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212545	10.1371/journal.pone.0212545	http://dx.doi.org/10.1371/journal.pone.0212545			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794631	Green Published, Green Submitted, gold			2022-12-27	WOS:000459709100086
J	Schmitt, R; Tscheuschler, A; Laschinski, P; Uffelmann, X; Discher, P; Fuchs, J; Kreibich, M; Peyronnet, R; Kari, FA				Schmitt, Ramona; Tscheuschler, Anke; Laschinski, Philipp; Uffelmann, Xenia; Discher, Philipp; Fuchs, Jana; Kreibich, Maximilian; Peyronnet, Remi; Kari, Fabian A.			A potential key mechanism in ascending aortic aneurysm development: Detection of a linear relationship between MMP-14/TIMP-2 ratio and active MMP-2	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE 2; TISSUE INHIBITOR; DEPENDENT ACTIVATION; IV COLLAGENASE; EXPRESSION; GUIDELINES; DISSECTION; MANAGEMENT; (TIMP)-2; MT1-MMP	Objectives Elevated matrix metalloproteinase-2 (MMP-2) tissue levels have been associated with ascending thoracic aortic aneurysm (aTAA). As MMP-2 activation is controlled by interactions among matrix metalloproteinase-14 (MMP-14), a tissue inhibitor of metalloproteinases-2 (TIMP-2) and Pro-MMP-2 in cell culture, this activation process might also play a role in aTAA. Methods Via gelatin zymography we analyzed tissue levels of MMP-2 isoforms (Pro-MMP-2, active MMP-2, total MMP-2) and via enzyme-linked immunosorbent assay (ELISA,) MMP-14, TIMP-2 and total MMP-2 tissue levels in N = 42 patients with aTAA. As controls, MMP-14 and TIMP-2 aortic tissue levels in N = 9 patients undergoing coronary artery bypass surgery were measured via ELISA, and levels of MMP-2 isoforms in N = 11 patients via gelatin zymography. Results Active MMP-2 was significantly higher in aTAA than in controls. Patients with aTAA exhibited significantly lower Pro-MMP-2 and TIMP-2 levels. Total MMP-2 and MMP-14 did not differ significantly between groups. Regression analysis revealed a linear relationship between TIMP-2 and the MMP-14/TIMP-2 ratio, as well as active MMP-2 in aTAA. Aneurysmatic tissue can be accurately distinguished from control aortic tissue ( AUC = 1) by analyzing the active MMP-2/Pro-MMP-2 ratio with a cutoff value of 0.11, whereas MMP-14 and TIMP-2 roles are negligible in ROC analysis. Conclusion A larger amount of MMP-2 is activated in aTAA than in control aortic tissue-a factor that seems to be a central process in aneurysm development. When active MMP-2 exceeds 10% compared to Pro-MMP-2, we conclude that it originates from aneurysmatic tissue, which we regard as a starting point for further studies of aTAA biomarkers. The tissue's MMP-14/TIMP-2 ratio may regulate the degree of Pro-MMP-2 activation as a determining factor, while the enzymatic activities of MMP-14 and TIMP-2 do not seem to play a key role in aneurysm development.	[Schmitt, Ramona; Tscheuschler, Anke; Laschinski, Philipp; Uffelmann, Xenia; Discher, Philipp; Fuchs, Jana; Kreibich, Maximilian; Kari, Fabian A.] Univ Freiburg, Univ Heart Ctr Freiburg Bad Krozingen, Dept Cardiovasc Surg, Freiburg, Germany; [Schmitt, Ramona; Tscheuschler, Anke; Laschinski, Philipp; Uffelmann, Xenia; Discher, Philipp; Fuchs, Jana; Kreibich, Maximilian; Peyronnet, Remi; Kari, Fabian A.] Univ Freiburg, Fac Med, Freiburg, Germany; [Peyronnet, Remi] Univ Freiburg, Univ Heart Ctr Freiburg Bad Krozingen, Inst Expt Cardiovasc Med, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Schmitt, R (corresponding author), Univ Freiburg, Univ Heart Ctr Freiburg Bad Krozingen, Dept Cardiovasc Surg, Freiburg, Germany.; Schmitt, R (corresponding author), Univ Freiburg, Fac Med, Freiburg, Germany.	ramona.schmitt@uniklinik-freiburg.de	Kreibich, Maximilian/AAA-7396-2021; Kari, Fabian A/AAE-5604-2021	Kreibich, Maximilian/0000-0003-3099-7254; Laschinski, Philipp/0000-0001-8293-7224	German Heart Research Foundation	German Heart Research Foundation	This work was supported by the German Heart Research Foundation, Dr. Rusche Research (http://www.herzstiftung.de) to FAK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alp E, 2011, GENET TEST MOL BIOMA, V15, P193, DOI 10.1089/gtmb.2010.0113; Barbour JR, 2007, J SURG RES, V139, P292, DOI 10.1016/j.jss.2006.09.020; Borges LF, 2009, HUM PATHOL, V40, P306, DOI 10.1016/j.humpath.2008.08.002; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Butler GS, 1998, J BIOL CHEM, V273, P871, DOI 10.1074/jbc.273.2.871; Eagleton MJ, 2006, J SURG RES, V135, P345, DOI 10.1016/j.jss.2006.03.026; El-Hamamsy I, 2009, NAT REV CARDIOL, V6, P771, DOI 10.1038/nrcardio.2009.191; Erbel R, 2014, EUR HEART J, V35, P2873, DOI 10.1093/eurheartj/ehu281; Hiratzka LF, 2010, J AM COLL CARDIOL, V55, pE27, DOI 10.1016/j.jacc.2010.02.015; Huusko T, 2013, J THORAC CARDIOV SUR, V145, P1117, DOI 10.1016/j.jtcvs.2012.04.008; Ikonomidis JS, 2006, CIRCULATION, V114, pI365, DOI 10.1161/CIRCULATIONAHA.105.000810; Ikonomidis JS, 2017, J THORAC CARDIOV SUR, V153, P537, DOI 10.1016/j.jtcvs.2016.10.065; Itoh Y, 1998, J BIOL CHEM, V273, P24360, DOI 10.1074/jbc.273.38.24360; Jiang AX, 2001, P NATL ACAD SCI USA, V98, P13693, DOI 10.1073/pnas.241293698; Jo Y, 2000, BIOCHEM J, V345, P511, DOI 10.1042/bj3450511; Kang HJ, 2015, BIOCHEM BIOPH RES CO, V460, P596, DOI 10.1016/j.bbrc.2015.03.075; Khanafer K, 2019, CARDIOVASC REVASCULA, V20, P324, DOI 10.1016/j.carrev.2018.07.006; Koullias GJ, 2004, ANN THORAC SURG, V78, P2106, DOI 10.1016/j.athoracsur.2004.05.088; Kuliczkowski W, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9352015; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; McNulty M, 2005, AM J HYPERTENS, V18, P504, DOI 10.1016/j.amjhyper.2004.11.011; Meffert P, 2017, INTERACT CARDIOV TH, V24, P20, DOI 10.1093/icvts/ivw309; Miksztowicz V, 2017, CURR VASC PHARMACOL, V15, P135, DOI 10.2174/1570161114666161024124244; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Pape LA, 2007, CIRCULATION, V116, P1120, DOI 10.1161/CIRCULATIONAHA.107.702720; Rylski B, 2014, J THORAC CARDIOV SUR, V148, P944, DOI 10.1016/j.jtcvs.2014.05.050; Shen MC, 2015, ARTERIOSCL THROM VAS, V35, P888, DOI 10.1161/ATVBAHA.114.305115; Sinha I, 2004, SURGERY, V136, P176, DOI 10.1016/j.surg.2004.04.010; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; STRONGIN AY, 1993, J BIOL CHEM, V268, P14033; Tang PCY, 2005, CIRCULATION, V112, P1098, DOI 10.1161/CIRCULATIONAHA.104.511717; Tscheuschler A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164308; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wagenseil JE, 2009, PHYSIOL REV, V89, P957, DOI 10.1152/physrev.00041.2008; Wang CM, 2015, EXP BIOL MED, V240, P1564, DOI 10.1177/1535370215576312; Zhao HR, 2004, J BIOL CHEM, V279, P8592, DOI 10.1074/jbc.M308708200	38	7	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212859	10.1371/journal.pone.0212859	http://dx.doi.org/10.1371/journal.pone.0212859			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794673	gold, Green Submitted, Green Published			2022-12-27	WOS:000459709100151
J	Yoshitake, N; Omori, M; Sugawara, M; Akishinonomiya, K; Shimada, S				Yoshitake, Naomi; Omori, Mika; Sugawara, Masumi; Akishinonomiya, Kiko; Shimada, Sachiko			Do health beliefs, personality traits, and interpersonal concerns predict TB prevention behavior among Japanese adults?	PLOS ONE			English	Article							SELF-REGULATION; MODEL; RISK	Despite public health measures and health-promotion efforts, the decline in tuberculosis (TB) morbidity in Japan has been slow, with a higher TB incidence rate relative to those observed in most developed countries. Because health behavior depends on multiple factors and is formulated within a social context, a theory-driven model would be necessary to increase TB prevention behavior. Based upon the Health Belief Model, this study examined the effects of health beliefs, personality traits, and social factors on TB prevention behavior among Japanese adults. A cross-sectional survey was carried out with a nationally representative sample (N = 911; 50.9% women; mean age 49.5, SD = 14.1). Path analyses gave empirical support for the hypothesized model, suggesting that TB prevention behaviors are influenced by not only perceived susceptibility to the illness but also social factors such as cues to action and one's concern to benefit others. The findings have implications for research examining health communication tailored to individual differences in personality and interpersonal concern.	[Yoshitake, Naomi] Juntendo Univ, Fac Int Liberal Arts, Tokyo, Japan; [Omori, Mika; Sugawara, Masumi; Akishinonomiya, Kiko; Shimada, Sachiko] Ochanomizu Univ, Dept Psychol, Tokyo, Japan	Juntendo University; Ochanomizu University	Yoshitake, N (corresponding author), Juntendo Univ, Fac Int Liberal Arts, Tokyo, Japan.	n-yoshitake@juntendo.ac.jp			Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was funded by a research grant to K.A. from the Japan Society for the Promotion of Science. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akishinonomiya K., 2013, KEKKAKU, V88, P525; BECKER MH, 1975, MED CARE, V13, P10, DOI 10.1097/00005650-197501000-00002; Champion V, 2005, RES NURS HEALTH, V28, P329, DOI 10.1002/nur.20088; Chang Li-Chun, 2007, J Nurs Res, V15, P78; Cornelis I, 2013, J APPL SOC PSYCHOL, V43, P456, DOI 10.1111/j.1559-1816.2013.01029.x; Costa P.T., 2008, SAGE HDB PERSONALITY, P179, DOI [10.4135/9781849200479.n9, DOI 10.4135/9781849200479.N9, 10.4135/9781849200479.N9]; Hu L T., 1995, STRUCTURAL EQUATION, P76, DOI DOI 10.1080/10705519909540118; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Karasz A, 2005, SOC SCI MED, V60, P1625, DOI 10.1016/j.socscimed.2004.08.011; Legler J, 2002, CANCER EPIDEM BIOMAR, V11, P59; LEVENTHAL H, 1983, HEALTH EDUC QUART, V10, P3, DOI 10.1177/109019818301000101; Li M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159780; Li ZT, 2015, PUBLIC HEALTH, V129, P907, DOI 10.1016/j.puhe.2015.04.008; Mattson M, 1999, COMMUN MONOGR, V66, P240, DOI 10.1080/03637759909376476; Nagafusa Noriyuki, 2012, Shinrigaku Kenkyu, V83, P470; Poss J E, 2001, ANS Adv Nurs Sci, V23, P1; Rimer BK, 2001, HEALTH EDUC BEHAV, V28, P231, DOI 10.1177/109019810102800208; Rodriguez-Reimann Dolores I, 2004, J Immigr Health, V6, P51, DOI 10.1023/B:JOIH.0000019165.09266.71; ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P354, DOI 10.1177/109019817400200405; Saito K., 1999, B AICHI SHUKUTOKU U, V24, P67; Shimonaka Y., 1998, JAPANESE J PERSONAL, V6, P138, DOI [10.2132/jjpjspp.6.2_138, DOI 10.2132/JJPJSPP.6.2_138]; Sirois FM, 2015, PERS INDIV DIFFER, V87, P59, DOI 10.1016/j.paid.2015.07.031; Smith TW, 2006, ANNU REV CLIN PSYCHO, V2, P435, DOI 10.1146/annurev.clinpsy.2.022305.095257; Smith TW, 2006, CURR DIR PSYCHOL SCI, V15, P227, DOI 10.1111/j.1467-8721.2006.00441.x; Triandis H. C., 1990, NEBRASKA S MOTIVATIO, P41; Tuberculosis Surveillance Center, 2016, TUB JAP ANN REP; Weber K, 2015, AGING MENT HEALTH, V19, P151, DOI 10.1080/13607863.2014.920295; Wyss LL, 2007, ONLINE J ISSUES NURS, V12, P7, DOI DOI 10.3912/0JIN.V0L12N01PPT01	28	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0211728	10.1371/journal.pone.0211728	http://dx.doi.org/10.1371/journal.pone.0211728			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794563	Green Published, Green Submitted, gold			2022-12-27	WOS:000459709100024
J	Liao, DQ; Zhu, J; Zhang, MH; Li, XE; Sun, P; Wei, JH; Qi, JJ				Liao, Dengqun; Zhu, Juan; Zhang, Menghuan; Li, Xian'en; Sun, Peng; Wei, Jianhe; Qi, Jianjun			Comparative transcriptomic analysis reveals genes regulating the germination of morphophysiologically dormant Paris polyphylla seeds during a warm stratification	PLOS ONE			English	Article							ABSCISIC-ACID; ARABIDOPSIS; HOMEOSTASIS; BIOSYNTHESIS; ACCUMULATION; GIBBERELLINS; MATURATION; ETHYLENE; MUTANTS; GROWTH	We previously analyzed the expression of genes associated with Paris polyphylla var. yunna-nensis seed maturation and dormancy release; however, we were unable to clarify the relationship between gene expression levels and these processes. To reveal the molecular mechanisms underlying P. polyphylla var. yunnanensis seed dormancy release during a warm stratification, the transcriptomes of dormant and germinating P. polyphylla var. yunna-nensis seeds were separately analyzed by RNA sequencing and were also compared with the transcriptomes of stem-leaf and root tissues harvested during the seed maturation stage. The RNA sequencing of five tissues generated 234,331 unigenes, of which 10,137 (4.33%) were differentially expressed among the analyzed tissues. The 6,619 unigenes whose expression varied among mature dormant, sprouted, and germinated seeds included 95 metabolic and 62 signaling genes related to abscisic acid, gibberellin, auxin, brassinosteroid, cytokinin, ethylene, jasmonic acid and salicylic acid. Additionally, 243 differentially expressed genes were annotated as known seed dormancy/germination-related genes. Among these genes, 109 were regulated by hormones or involved in hormone signal transduction. Finally, 310 transcription factor unigenes, including 71 homologs of known seed dormancy/germination-related genes, were observed to be differentially expressed during a warm stratification. These results confirm that multiple hormones and transcription factors influence P. polyphylla var. yunnanensis seed dormancy release and germination during a warm stratification. This study identified candidate genes (e.g., ABI5) that should be cloned and functionally characterized regarding their effects on the release of P. polyphylla var. yunnanensis seed morphophysiological dormancy.	[Liao, Dengqun; Zhu, Juan; Zhang, Menghuan; Li, Xian'en; Sun, Peng; Wei, Jianhe; Qi, Jianjun] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing, Peoples R China; [Liao, Dengqun; Zhu, Juan; Zhang, Menghuan; Li, Xian'en; Sun, Peng; Wei, Jianhe; Qi, Jianjun] Peking Union Med Coll, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Qi, JJ (corresponding author), Chinese Acad Med Sci, Inst Med Plant Dev, Beijing, Peoples R China.	jjqi@implad.ac.cn			National Natural Science Foundation of China [31471575, 31171623]; CAMS Initiative for Innovative Medicine [2016-I2M-2-003, 2017-I2M-3-013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAMS Initiative for Innovative Medicine	This work was supported by the National Natural Science Foundation of China (31471575, and 31171623 to JQ) and the CAMS Initiative for Innovative Medicine (2016-I2M-2-003 to JQ, 2017-I2M-3-013 to XL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertos P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9669; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Antoni R, 2012, PLANT PHYSIOL, V158, P970, DOI 10.1104/pp.111.188623; Ariizumi T, 2007, PLANT CELL, V19, P791, DOI 10.1105/tpc.106.048009; Barrero JM, 2009, PLANT PHYSIOL, V150, P1006, DOI 10.1104/pp.109.137901; Bi C, 2017, PLANT MOL BIOL, V94, P197, DOI 10.1007/s11103-017-0603-y; Chen ShuYing, 2011, Zhongcaoyao = Chinese Traditional and Herbal Drugs, V42, P793; Chen W, 2011, HUBEI AGR SCI, V50, P972; Chen Wei, 2015, Southwest China Journal of Agricultural Sciences, V28, P783; Chitnis VR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087543; Chung HY, 2010, PLANT CELL REP, V29, P397, DOI 10.1007/s00299-010-0830-z; Corbineau F, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00539; Dong T, 2014, PLANT PHYSIOL, V165, P277, DOI 10.1104/pp.114.239210; Dong XY, 2015, MODERN AGR SCI TECHN, V3, P78; Gao WX, 2006, FOREST INVENTORY PLA, V1, P100; Gillespie LM, 2017, ANN BOT-LONDON, V119, P311, DOI 10.1093/aob/mcw264; Gonzalez-Guzman M, 2012, PLANT CELL, V24, P2483, DOI 10.1105/tpc.112.098574; Gutierrez L, 2009, PLANT CELL, V21, P3119, DOI 10.1105/tpc.108.064758; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Han C, 2015, PROTEOMICS, V15, P1671, DOI 10.1002/pmic.201400375; Hauvermale AL, 2015, PLANT CELL PHYSIOL, V56, P1773, DOI 10.1093/pcp/pcv084; Holdsworth MJ, 2008, NEW PHYTOL, V179, P33, DOI 10.1111/j.1469-8137.2008.02437.x; Huang W, 2008, CHINESE AGR SCI B, V24, P242; Kim HJ, 2016, CURR OPIN PLANT BIOL, V33, P48, DOI 10.1016/j.pbi.2016.06.002; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li Ma, 2015, Journal of Yunnan Agricultural University, V30, P766; Li ShaoPing, 2008, Southwest China Journal of Agricultural Sciences, V21, P956; Li XJ, 2016, PLANT BIOTECHNOL J, V14, P1021, DOI 10.1111/pbi.12474; Li Zhao-ling, 2015, Zhongguo Zhong Yao Za Zhi, V40, P629; Ling LZ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010219; Linkies A, 2012, PLANT CELL REP, V31, P253, DOI 10.1007/s00299-011-1180-1; Liu AH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056536, 10.1371/journal.pone.0057359, 10.1371/journal.pone.0056570, 10.1371/journal.pone.0054001]; Liu ZH, 2015, MOL PLANT, V8, P1751, DOI 10.1016/j.molp.2015.09.002; Nonogaki H, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00233; Oh E, 2009, PLANT CELL, V21, P403, DOI 10.1105/tpc.108.064691; Pu Mei, 2016, Forest Research, V29, P268; Qi JJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-358; Riefler M, 2006, PLANT CELL, V18, P40, DOI 10.1105/tpc.105.037796; Sandhu KS, 2012, G3-GENES GENOM GENET, V2, P1585, DOI 10.1534/g3.112.004580; Shang XL, 2016, J INTEGR PLANT BIOL, V58, P627, DOI 10.1111/jipb.12444; Shim D, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.59; Shu K, 2016, MOL PLANT, V9, P34, DOI 10.1016/j.molp.2015.08.010; Skubacz A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01884; Stotz HU, 2013, J EXP BOT, V64, P963, DOI 10.1093/jxb/ers389; Szostkiewicz I, 2010, PLANT J, V61, P25, DOI 10.1111/j.1365-313X.2009.04025.x; Tang L, 2015, J YUNNAN U TRADITION, V5, P37; To JPC, 2008, TRENDS PLANT SCI, V13, P85, DOI 10.1016/j.tplants.2007.11.005; Varbanova M, 2007, PLANT CELL, V19, P32, DOI 10.1105/tpc.106.044602; Verhoef N, 2013, J EXP BOT, V64, P2435, DOI 10.1093/jxb/ert102; Wang YF, 2012, J YUNNAN U TRADITION, V35, P28; Wu Z, 2017, J NAT MED-TOKYO, V71, P139, DOI 10.1007/s11418-016-1043-8; Xu W, 2013, THESIS; Yang YG, 2017, BIOMED CHROMATOGR, V31, DOI 10.1002/bmc.3913; Yoneyama K, 1998, BIOSCI BIOTECH BIOCH, V62, P1448, DOI 10.1271/bbb.62.1448; [袁理春 Yuan Lichun], 2003, [种子, Seed], V0, P33; Zander M, 2010, PLANT J, V61, P200, DOI 10.1111/j.1365-313X.2009.04044.x; Zeng QY, 2016, CENTRAL S PHARM, V12, P1328; Zhang L, 2013, CHINESE PHARM J, V48, P1917; [张绍山 Zhang Shaoshan], 2017, [中草药, Chinese Traditional and Herbal Drugs], V48, P2111; Zhao J, 2014, J YUNNAN U TRADITION, V37, P28; Zhao TZ., 2014, CHIN WILD PLANT RES, V33, P61, DOI [10.3969/j.issn.1006-9690.2014.05.017, DOI 10.3969/J.ISSN.1006-9690.2014.05.017]	61	5	8	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212514	10.1371/journal.pone.0212514	http://dx.doi.org/10.1371/journal.pone.0212514			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789936	Green Submitted, Green Published, gold			2022-12-27	WOS:000459330800033
J	Zeppelini, D; Queiroz, GC; Lopes, NP; Mendonca, FJB				Zeppelini, Douglas; Queiroz, Gabriel C.; Lopes, Norberto P.; Mendonca-Junior, Francisco J. B.			Chemical analysis of Brasilimeria Stach, 1949 (Hexapoda, Collembola, Neanuridae) hemolymphatic secretion, and description of a new species	PLOS ONE			English	Article							VOLATILE CONSTITUENTS; MASS-SPECTROMETRY; LEAVES	Though Collembola is a widespread hexapod its use of chemical compounds for defense has been reported for only a few European species. Chemical composition analyses of the hemolymphatic secretion of Neotropical Collembola using Gas Chromatography with Mass Spectrometry (GC-MS) has been performed for the first time. The GC-MS analysis revealed 32 constituents, such as aliphatic and aromatic hydrocarbons, esters, alcohols, a phenol, an aldehyde and a ketone. Benzyl benzoate, the main component (at 46.98%), is a compound with known acaricide and insecticide properties. This is the first report on chemical constituents produced by Neotropical Pseudachorutinae, genus Brasilimeria, and will permit future secretion comparisons for Collembola. The taxonomic description of the species producing the secretion analyzed is provided; Brasilimeria assu sp. nov. (Collembola, Neanuridae, Pseudachorutinae) is the third known species of the genus; an updated diagnosis of the genus, an identification key, and further remarks on the species Brasilimeria Stach, 1949 are provided.	[Zeppelini, Douglas] State Univ Paraiba, Dept Biol Sci, Lab Sistemat Colembolla & Conservacao, Joao Pessoa, PB, Brazil; [Queiroz, Gabriel C.] Univ Fed Rio de Janeiro, Nacl Museum, Dept Entomol, Setor Apterygota, Rio De Janeiro, RJ, Brazil; [Lopes, Norberto P.] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Dept Chem & Phys, Nucleo Pesquisa Prod Nat & Sintet, Ribeirao Preto, SP, Brazil; [Mendonca-Junior, Francisco J. B.] State Univ Paraiba, Dept Biol Sci, Lab Sintese & Vetorizacao Mol, Joao Pessoa, PB, Brazil	Universidade Estadual da Paraiba; Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo; Universidade Estadual da Paraiba	Zeppelini, D (corresponding author), State Univ Paraiba, Dept Biol Sci, Lab Sistemat Colembolla & Conservacao, Joao Pessoa, PB, Brazil.	zeppelini@daad-alumni.de	QUEIROZ, GABRIEL COSTA/D-7413-2015; JUNIOR, FRANCISCO JAIME BEZERRA MENDONÇA/J-2926-2015; Lopes, Norberto P/C-7148-2012	QUEIROZ, GABRIEL COSTA/0000-0001-9917-1755; JUNIOR, FRANCISCO JAIME BEZERRA MENDONÇA/0000-0003-3588-833X; Lopes, Norberto P/0000-0002-8159-3658; zeppelini, douglas/0000-0002-9026-1129	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) PQ [302673/2015-6, 308590/2017-1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)-PDJ [150451/2015-6, 451149/2016-5]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) PQ; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)-PDJ; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by: D. Zeppelini, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) PQ #302673/2015-6; Francisco J. B. Mendonca-Junior, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) PQ #308590/2017-1; Gabriel C. Queiroz, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)-PDJ #150451/2015-6 and #451149/2016-5, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) -Finance Code 001.	Aksenov AA, 2017, NAT REV CHEM, V1, DOI 10.1038/s41570-017-0054; [Anonymous], 1981, CHEM DEFENSES ARTHRO; ARLE R., 1939, BOL BIOL [SAO PAULO], V4, P67; Bastos IVGA, 2017, AN ACAD BRAS CIENC, V89, P991, DOI 10.1590/0001-3765201720160586; Bellinger P.F., CHECKLIST COLLEMBOLA; BELLINGER PETER F., 1960, ENT NEWS, V71, P254; Botre F, 2008, EXPERT REV PROTEOMIC, V5, P535, DOI 10.1586/14789450.5.4.535; Brunetti AE, 2018, ACS OMEGA, V3, P5426, DOI 10.1021/acsomega.7b02029; Burns DA, 2010, ROOKS TXB DERMATOLOG, P38; Cassagnau P, 1962, COLLEMBOLES AM SUD P, V1, P139; Cassagnau P, 1989, 3 INT SEM APT SIEN, P171; D'Haese C, 2003, EUROPEAN J ENTOMOLOG, V101, P385, DOI [10.14411/eje.2003.060, DOI 10.14411/EJE.2003.060]; De Lima W, 2015, NAT PROD COMMUN, V10, P1321; Deharveng L, 2004, PEDOBIOLOGIA, V48, P415, DOI 10.1016/j.pedobi.2004.08.001; Dettner K, 1996, J CHEM ECOL, V22, P1051, DOI 10.1007/BF02029954; Essien EE, 2019, NAT PROD RES, V33, P1637, DOI 10.1080/14786419.2018.1425842; Faddeeva A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130600; GOHLKE RS, 1993, J AM SOC MASS SPECTR, V4, P367, DOI 10.1016/1044-0305(93)85001-E; Gurevich A, 2018, NAT MICROBIOL, V3, P319, DOI 10.1038/s41564-017-0094-2; Hayes Jr WJ, 1990, HDB PESTICIDE TOXICO, P1505; Hopkin S.P., 1997, BIOL SPRINGTAILS INS; Jannetto PJ, 2016, CLIN CHEM, V62, P92, DOI 10.1373/clinchem.2015.248146; Kildgaard S, 2014, MAR DRUGS, V12, P3681, DOI 10.3390/md12063681; KULAKKATTOLICKAL AT, 1989, AQUACULTURE, V78, P293, DOI 10.1016/0044-8486(89)90107-5; Laurent P, 2005, TOP CURR CHEM, V240, P167; Martinez LC, 2018, B ENTOMOL RES, V108, P716, DOI 10.1017/S0007485317001262; Massoud Z, BIOL AM AUSTRALE, V3; Messer C, 1999, PEDOBIOLOGIA, V43, P174; Messer C, 2000, PEDOBIOLOGIA, V44, P210, DOI 10.1078/S0031-4056(04)70041-4; Oliveira Elisiana, 1994, Bulletin de la Societe Entomologique de France, V99, P389; Pang GF, 2018, J AOAC INT, V101, P1156, DOI 10.5740/jaoacint.17-0125; Pico Y, 2015, ADV MASS SPECTROMETR, V68; Plata-Rueda A, 2018, ECOTOX ENVIRON SAFE, V156, P263, DOI 10.1016/j.ecoenv.2018.03.033; Queiroz GC, 2017, ZOOL ANZ, V269, P127, DOI 10.1016/j.jcz.2017.08.005; Queiroz Gabriel Costa, 2014, Soil Organisms, V86, P169; Satyal P, 2015, NAT PROD COMMUN, V10, P361; Schulz S, 1997, TETRAHEDRON LETT, V38, P2077, DOI 10.1016/S0040-4039(97)00341-9; Shaikh J., 2005, ENCY TOXICOLOGY, V1, P264; Stach J., 1949, ACTA MONOGRAPHICA MU; Stranska-Zachariasova M, 2016, J CHROMATOGR B, V1015, P22, DOI 10.1016/j.jchromb.2016.01.050; WHO, 2009, MOD FORM 2008, P311; Yang KeDi, 2009, Guangxi Zhiwu / Guihaia, V29, P424; Zhang N, 2016, PHYTOMEDICINE, V23, P1727, DOI 10.1016/j.phymed.2016.10.017	43	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212451	10.1371/journal.pone.0212451	http://dx.doi.org/10.1371/journal.pone.0212451			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789930	Green Submitted, gold, Green Published			2022-12-27	WOS:000459330800029
J	Chatio, S; Welaga, P; Tabong, PTN; Akweongo, P				Chatio, Samuel; Welaga, Paul; Tabong, Philip Teg-Nefaah; Akweongo, Patricia			Factors influencing performance of community-based health volunteers' activities in the Kassena-Nankana Districts of Northern Ghana	PLOS ONE			English	Article							UGANDA LESSONS; SCALING-UP; WORKERS; TEAMS; CARE	Background An increasing demand for health care services and getting health care closer to doorsteps of communities has made health managers to use trained community-based health volunteers to support in providing health services to people in rural communities. Community volunteerism in Ghana has been identified as an effective strategy in the implementation of Primary Health Care activities since 1970s. However, little is known about the performance of these volunteers engaged in health interventions activities at the community level. This study assessed the level of performance and factors that affect the performance of health volunteers' activities in Northern Ghana. Methods This was a cross-sectional study using quantitative method of data collection. Two hundred structured interviews were conducted with health volunteers. Data collectors visited health volunteers at home and conducted the interviews after informed consent was obtained. STATA Version 11.2 was used to analyze the data. Descriptive statistics were used to assess the level of performance of the health volunteers. Multiple logistic regression models were then used to assess factors that influence the performance of health volunteers. Results About 45% of volunteers scored high on performance. In the multivariate analysis, educational status [OR = 4.64 95% CI (1.22-17.45)] and ethnicity [OR = 1.85 95% CI (1.00-3.41)] were the factors that influenced the performance of health volunteers. Other intermediary factors such as incentives and means of transport also affected the performance of health volunteers engaged in health intervention activities at the community level. Conclusion The results suggest that higher educational status of health volunteers is more likely to increase their performance. In addition, providing non-monetary incentives and logistics such as bicycles, raincoats, torch lights and wellington boots will enhance the performance of health volunteers and also motivate them to continue to provide health services to their own people at the community level.	[Chatio, Samuel; Welaga, Paul] Navrongo Hlth Res Ctr, Navrongo, Ghana; [Tabong, Philip Teg-Nefaah; Akweongo, Patricia] Univ Ghana, Sch Publ Hlth, Accra, Ghana	Navrongo Health Research Center; University of Ghana	Chatio, S (corresponding author), Navrongo Hlth Res Ctr, Navrongo, Ghana.	schatio@yahoo.co.uk	Tabong, Philip Teg-Nefaah/AAG-5478-2020	Tabong, Philip/0000-0001-9445-1643; AKWEONGO, PATRICIA/0000-0001-6728-3365; Chatio, Samuel Tamti/0000-0001-9998-748X				Alam K, 2011, PERFORMANCE FEMALE V, pB12; Awoonor-Williams JK, 2013, GLOB HEALTH-SCI PRAC, V1, P117, DOI 10.9745/GHSP-D-12-00012; Barbir F, 2010, INT J MIGR HEALTH SO, V6, P36, DOI 10.5042/ijmhsc.2011.0063; Bhattacharyya K, 2001, COMMUNITY HLTH WORKE; Bigirwa P, 2009, HLTH POLICY DEV, V7, P162; Chatio S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174002; Debpuur C, 2002, STUD FAMILY PLANN, V33, P141, DOI 10.1111/j.1728-4465.2002.00141.x; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Linn NYY, 2018, TROP MED HEALTH, V46, DOI 10.1186/s41182-018-0110-0; MOH, 1998, HLTH J; Musinguzi LK, 2017, HUM RESOUR HEALTH, V15, DOI 10.1186/s12960-016-0177-9; Norris SL, 2006, DIABETIC MED, V23, P544, DOI 10.1111/j.1464-5491.2006.01845.x; Nyonator FK, 2005, HEALTH POLICY PLANN, V20, P25, DOI 10.1093/heapol/czi003; Nyonator FK, 2003, GHANA COMMUNITY BASE; Oduro AR, 2012, INT J EPIDEMIOL, V41, P968, DOI 10.1093/ije/dys111; Pence B, 2001, GLOB C INT UN SCI ST; Sakeah E, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-340; Swider SM, 2002, PUBLIC HEALTH NURS, V19, P11, DOI 10.1046/j.1525-1446.2002.19003.x; Turinawe EB, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0074-7; UNICEF, 2004, WHAT WORKS CHILDR FU; World Health Organization Special Programme for Research and Training in Tropical Diseases, 2009, DENG GUID DIAGN TREA	21	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212166	10.1371/journal.pone.0212166	http://dx.doi.org/10.1371/journal.pone.0212166			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785936	Green Published, gold, Green Submitted			2022-12-27	WOS:000459307000050
J	Kitamura, M; Obata, Y; Ota, Y; Muta, K; Yamashita, H; Harada, T; Mukae, H; Nishino, T				Kitamura, Mineaki; Obata, Yoko; Ota, Yuki; Muta, Kumiko; Yamashita, Hiroshi; Harada, Takashi; Mukae, Hiroshi; Nishino, Tomoya			Significance of subepithelial deposits in patients diagnosed with IgA nephropathy	PLOS ONE			English	Article							DOMINANT POSTINFECTIOUS GLOMERULONEPHRITIS; INFECTION	Subepithelial deposits are observed in rare adult IgA nephropathy (IgAN) cases and are a key diagnostic finding in IgA-dominant infection-related glomerulonephritis (IgA-IRGN). Sometimes, it is difficult to distinguish IgA-IRGN from IgAN without a precise clinical history. We hypothesized that some IgA-IRGN cases might be diagnosed as IgAN with subepithelial deposits (IgAN-SD) and aimed to clarify the significance of subepithelial deposits in patients diagnosed with IgAN. We examined 464 patients diagnosed with IgAN at Nagasaki University Hospital and affiliated hospitals between 1996 and 2013. The differences in clinicopathological findings between IgAN-SD and IgAN with no subepithelial deposits (IgAN-NSD) were investigated. In addition to clinical data and typical IgAN pathological features, we analyzed complement levels, immunoglobulin localization, light chain staining patterns, and intramembranous deposits. There were 214 men and 250 women with a mean age of 38.8 +/- 18.3 years. Subepithelial deposition was observed in 51 patients (11%). Compared to patients with IgAN-NSD, those with IgAN-SD had significantly lower mean serum protein (6.4 g/dL vs. 6.7 g/dL; p = 0.02), albumin (3.7 g/dL vs. 3.9 g/dL; p = 0.02), and complement (C3) (94 mg/dL vs. 103 mg/dL; p = 0.02) levels. Diffuse mesangial hypercellularity (M) (65% vs. 45%; p<0.01), endocapillary hypercellularity: (E) (43% vs. 28%; p = 0.03), and IgA staining in the glomerular capillary wall (22% vs. 8%; p<0.01) were more common in patients with IgAN-SD. The incidence of light chain lambda predominance was lower in patients with IgAN-SD (47% vs. 63%; p = 0.03). Hump-shaped subepithelial deposits and intramembranous deposits were observed in nine and 17 patients with IgAN-SD, respectively. Patients with IgAN-SD tended to have the characteristics of IgA-IRGN rather than IgAN-NSD. Since the therapeutic strategies for IgA-IRGN differ from those for IgAN, we should review the clinical history and pay careful attention to the clinical course in cases with atypical findings, such as subepithelial deposits.	[Kitamura, Mineaki] Nagasaki Univ Hosp, Div Blood Purificat, Nagasaki, Japan; [Kitamura, Mineaki; Obata, Yoko; Ota, Yuki; Muta, Kumiko; Yamashita, Hiroshi; Nishino, Tomoya] Nagasaki Univ Hosp, Dept Nephrol, Nagasaki, Japan; [Harada, Takashi] Nagasaki Renal Ctr, Dept Nephrol, Nagasaki, Japan; [Mukae, Hiroshi] Nagasaki Univ, Dept Resp Med, Unit Basic Med Sci, Grad Sch Biomed Sci, Nagasaki, Japan	Nagasaki University; Nagasaki University; Nagasaki University	Kitamura, M (corresponding author), Nagasaki Univ Hosp, Div Blood Purificat, Nagasaki, Japan.; Kitamura, M (corresponding author), Nagasaki Univ Hosp, Dept Nephrol, Nagasaki, Japan.	minekitamura@nagasaki-u.ac.jp	Kitamura, Mineaki/ABA-1041-2021; Kitamura, Mineaki/ADQ-8686-2022	Kitamura, Mineaki/0000-0002-0003-8645; Kitamura, Mineaki/0000-0002-0003-8645	 [16K19492]		This study was supported by a Grant-in-Aid for Scientific Research (KAKENHI; grant number 16K19492 to MK.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGER J, 1969, TRANSPL P, V1, P939; CHUI SH, 1991, J CLIN IMMUNOL, V11, P219, DOI 10.1007/BF00917428; Donadio JV, 2002, NEW ENGL J MED, V347, P738, DOI 10.1056/NEJMra020109; Fogo AB, 2015, AM J KIDNEY DIS, V66, pE33, DOI 10.1053/j.ajkd.2015.08.001; Haas M, 2003, HUM PATHOL, V34, P3, DOI 10.1053/hupa.2003.53; Haas M, 2008, HUM PATHOL, V39, P1309, DOI 10.1016/j.humpath.2008.02.015; Jennette JC., 2015, HEPTINSTALLS PATHOLO; KOYAMA A, 1995, KIDNEY INT, V47, P207, DOI 10.1038/ki.1995.25; Lafayette RA, 2018, AM J NEPHROL, V47, P43, DOI 10.1159/000481636; LAI KN, 1988, AM J KIDNEY DIS, V11, P425, DOI 10.1016/S0272-6386(88)80056-8; LAI KN, 1986, AM J CLIN PATHOL, V85, P548, DOI 10.1093/ajcp/85.5.548; LEE HS, 1989, KIDNEY INT, V35, P880, DOI 10.1038/ki.1989.68; Nasr SH, 2011, NEPHRON CLIN PRACT, V119, pC18, DOI 10.1159/000324180; Nasr SH, 2011, J AM SOC NEPHROL, V22, P187, DOI 10.1681/ASN.2010060611; Nasr SH, 2003, HUM PATHOL, V34, P1235, DOI 10.1016/S0046-8177(03)00424-6; Satoskar AA, 2006, CLIN J AM SOC NEPHRO, V1, P1179, DOI 10.2215/CJN.01030306; SHIGEMATSU H, 1982, NEPHRON, V30, P1, DOI 10.1159/000182423; Suzuki H, 2018, KIDNEY INT, V93, P753, DOI [10.1016/j.kint.2017.06.026, DOI 10.1016/J.KINT.2017.06.026]; Suzuki H, 2019, CLIN EXP NEPHROL, V23, P26, DOI 10.1007/s10157-018-1582-2; Suzuki H, 2011, J AM SOC NEPHROL, V22, P1795, DOI 10.1681/ASN.2011050464; SUZUKI S, 1990, CLIN NEPHROL, V33, P66; Trimarchi H, 2017, KIDNEY INT, V91, P1014, DOI 10.1016/j.kint.2017.02.003; Wen YK, 2011, RENAL FAILURE, V33, P480, DOI 10.3109/0886022X.2011.573895; Worawichawong S, 2011, HUM PATHOL, V42, P279, DOI 10.1016/j.humpath.2010.07.009; Wyatt RJ, 2013, NEW ENGL J MED, V368, P2402, DOI 10.1056/NEJMra1206793; YOSHIKAWA N, 1986, J PATHOL, V150, P119, DOI 10.1002/path.1711500206; YOSHIMURA M, 1987, AM J KIDNEY DIS, V9, P404, DOI 10.1016/S0272-6386(87)80143-9	27	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211812	10.1371/journal.pone.0211812	http://dx.doi.org/10.1371/journal.pone.0211812			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785896	Green Published, Green Submitted, gold			2022-12-27	WOS:000459307000039
J	Sagami, S; Kobayashi, T; Kikkawa, N; Umeda, S; Nakano, M; Toyonaga, T; Okabayashi, S; Ozaki, R; Hibi, T				Sagami, Shintaro; Kobayashi, Taku; Kikkawa, Nao; Umeda, Satoko; Nakano, Masaru; Toyonaga, Takahiko; Okabayashi, Shinji; Ozaki, Ryo; Hibi, Toshifumi			Combination of colonoscopy and magnetic resonance enterography is more useful for clinical decision making than colonoscopy alone in patients with complicated Crohn's disease	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; EVIDENCE-BASED CONSENSUS; SMALL-INTESTINE; CAPSULE ENDOSCOPY; MANAGEMENT; VALIDATION; BIOMARKERS; DIAGNOSIS; SEVERITY; ACCURACY	Background/aims The small bowel is affected in more than half of patients with Crohn's disease (CD) at the time of diagnosis, and small bowel involvement has a negative impact on the long-term outcome. Many patients reportedly have active lesions in the small intestine even in patients in clinical remission. This study was performed to compare findings of magnetic resonance enterography (MRE) and ileocolonoscopy. Methods A single-center retrospective study was conducted in 50 patients (60 imaging series) with CD, for whom MRE was additionally performed during the bowel preparation for subsequent ileocolonoscopy. Endoscopic remission was defined as a Simple Endoscopic Score for CD (SES-CD) of <5. MRE remission was defined as a Magnetic Resonance Index of Activity (MaRIA) score of <50. The time to treatment escalation was assessed by the log-rank test. Results Importantly, 7 of 29 patients (24.1%) with endoscopic remission had a MaRIA score of >= 50. Both SES-CD and MaRIA correlated with the need for treatment escalation (P = 0.025, P = 0.009, respectively). MRE predicted the need for treatment escalation even in patients with endoscopic remission. Although no correlation was present between SES-CD and MaRIA score in patients with structuring/penetrating disease, or insufficient ileal insertion (<10cm), a high MaRIA score still correlated with the need for treatment escalation in stricturing or penetrating disease (P=0.0306). Conclusions The MaRIA score predicts the need for treatment escalation even in patients with endoscopic remission, indicating that addition of MRE to conventional ileocolonoscopy alone can be a useful, noninvasive tool for monitoring CD especially in stricturing or penetrating disease.	[Sagami, Shintaro; Kobayashi, Taku; Nakano, Masaru; Toyonaga, Takahiko; Okabayashi, Shinji; Ozaki, Ryo; Hibi, Toshifumi] Kitasato Univ, Kitasato Inst Hosp, Ctr Adv IBD Res & Treatment, Minato Ku, Tokyo, Japan; [Kikkawa, Nao] Kitasato Univ, Kitasato Inst Hosp, Dept Radiol, Minato Ku, Tokyo, Japan; [Umeda, Satoko] Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol,Shinjuku Ku, Tokyo, Japan; [Nakano, Masaru; Toyonaga, Takahiko; Ozaki, Ryo] Kitasato Univ, Kitasato Inst Hosp, Dept Gastroenterol & Hepatol, Minato Ku, Tokyo, Japan	Kitasato University; Kitasato University; Keio University; Kitasato University	Kobayashi, T (corresponding author), Kitasato Univ, Kitasato Inst Hosp, Ctr Adv IBD Res & Treatment, Minato Ku, Tokyo, Japan.	kobataku@insti.kitasato-u.ac.jp	Sagami, Shintaro/ABB-4369-2020; Kobayashi, Taku/AAO-6437-2020; Sagami, Shintaro/AAU-4476-2021	Kobayashi, Taku/0000-0002-2073-4234; Sagami, Shintaro/0000-0002-1202-8161; Okabayashi, Shinji/0000-0003-2683-9018				Annese V, 2013, J CROHNS COLITIS, V7, P982, DOI 10.1016/j.crohns.2013.09.016; BEST WR, 1976, GASTROENTEROLOGY, V70, P439; Colombel JF, 2017, LANCET, V390, P2779, DOI 10.1016/S0140-6736(17)32641-7; COREMANS G, 1984, GASTROINTEST ENDOSC, V30, P167, DOI 10.1016/S0016-5107(84)72358-3; Daperno M, 2004, GASTROINTEST ENDOSC, V60, P505, DOI 10.1016/S0016-5107(04)01878-4; De Cruz P, 2013, INFLAMM BOWEL DIS, V19, P429, DOI 10.1002/ibd.22977; Florie J, 2005, CLIN GASTROENTEROL H, V3, P1221, DOI 10.1016/S1542-3565(05)00853-0; Florin THJ, 2006, SCAND J GASTROENTERO, V41, P306, DOI 10.1080/00365520500217118; Garcia-Bosch O, 2016, J CROHNS COLITIS, V10, P663, DOI 10.1093/ecco-jcc/jjw015; Gauss A, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003477; Gomollon F, 2017, J CROHNS COLITIS, V11, P3, DOI 10.1093/ecco-jcc/jjw168; Hanauer SB, 2001, AM J GASTROENTEROL, V96, P635; HARVEY RF, 1980, LANCET, V1, P514; Henriksen M, 2007, SCAND J GASTROENTERO, V42, P602, DOI 10.1080/00365520601076124; Jones J, 2008, CLIN GASTROENTEROL H, V6, P1218, DOI 10.1016/j.cgh.2008.06.010; Khanna R, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010642.pub2; Kopylov U, 2015, INFLAMM BOWEL DIS, V21, P2726, DOI 10.1097/MIB.0000000000000497; Kopylov U, 2015, AM J GASTROENTEROL, V110, P1316, DOI 10.1038/ajg.2015.221; Lakatos PL, 2005, HEPATO-GASTROENTEROL, V52, P817; Louis E, 2001, GUT, V49, P777, DOI 10.1136/gut.49.6.777; Manser CN, 2014, INFLAMM BOWEL DIS, V20, P1548, DOI 10.1097/MIB.0000000000000123; Mendoza JL, 2012, REV ESP ENFERM DIG, V104, P578, DOI 10.4321/S1130-01082012001100005; Naganuma M, 2017, ABDOM RADIOL, V42, P141, DOI 10.1007/s00261-016-0878-5; Ordas I, 2014, GASTROENTEROLOGY, V146, P374, DOI 10.1053/j.gastro.2013.10.055; Ordas I, 2012, CURR DRUG TARGETS, V13, P1252, DOI 10.2174/138945012802429714; Rezvan PH, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0022-1; Rimola J, 2009, GUT, V58, P1113, DOI 10.1136/gut.2008.167957; Rimola J, 2011, INFLAMM BOWEL DIS, V17, P1759, DOI 10.1002/ibd.21551; Sato H, 2015, J GASTROEN HEPATOL, V30, P667, DOI 10.1111/jgh.12851; Steward MJ, 2012, EUR J RADIOL, V81, P2080, DOI 10.1016/j.ejrad.2011.07.013; Takenaka K, 2017, AM J GASTROENTEROLOG; Takenaka K, 2015, INFLAMM BOWEL DIS, V21, P1832, DOI 10.1097/MIB.0000000000000449; Takenaka K, 2014, GASTROENTEROLOGY, V147, P334, DOI 10.1053/j.gastro.2014.04.008; Taylor SA, 2018, LANCET GASTROENTEROL, V3, P548, DOI 10.1016/S2468-1253(18)30161-4; van der Heijden GJMG, 2006, J CLIN EPIDEMIOL, V59, P1102, DOI 10.1016/j.jclinepi.2006.01.015; Yoon HM, 2017, JAMA PEDIATR, V171, P1208, DOI 10.1001/jamapediatrics.2017.3400	36	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212404	10.1371/journal.pone.0212404	http://dx.doi.org/10.1371/journal.pone.0212404			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785943	Green Published, Green Submitted, gold			2022-12-27	WOS:000459307000060
J	Shimshoni, JA; Sperling, R; Massarwa, M; Chen, Y; Bommuraj, V; Borisover, M; Barel, S				Shimshoni, Jakob A.; Sperling, Roy; Massarwa, Muhammad; Chen, Yaira; Bommuraj, Vijayakumar; Borisover, Mikhail; Barel, Shimon			Pesticide distribution and depletion kinetic determination in honey and beeswax: Model for pesticide occurrence and distribution in beehive products	PLOS ONE			English	Article							MULTIRESIDUE METHOD; RESIDUES; POLLEN; DEGRADATION; HIVE; NEONICOTINOIDS; STABILITY; EXPOSURE	Beehive products such as honey, beeswax and recently pollen have been regarded for many years as appropriate sentinels for environmental pesticide pollutions. However, despite yearly application of hundreds of approved pesticides in agricultural fields, only a minor fraction of these organic compounds were actually detected in honey and beeswax samples. This observation has led us to question the general suitability of beehive products as a sentinel for synthetic organic pesticides applied in the field. The aim of the present study was to experimentally determine the distribution (logarithmic ratio of beeswax to honey pesticide concentration, LogD) and depletion kinetics (half-life) of selected pesticides in honey and beeswax as a measure of the latter matrixes to serve as a pesticide sentinel. The obtained parameters were used to extrapolate to pesticide burden in honey and beeswax samples collected from German and Israeli apiaries. In addition, we aimed to establish a mathematical model, enabling us to predict distribution of selected pesticides between honey to beeswax, by utilizing simple substance descriptors, namely, octanol/water partitioning coefficient, molar weight and Henry coefficient. Based on the present results, it appears that pesticides with LogD values > 1 and half-life in beeswax > 1 day, were likely to accumulate and detected in beeswax samples, and less likely to be found in honey. On the other hand, pesticides with negative LogD values were highly likely to be found in honey and less so in beeswax samples. Finally, pesticides with LogD values between 0-1 were expected to be found in both matrixes. The developed model was successfully applied to predict LogD values, thereby identifying octanol/water partitioning and molar weight as the most prominent substance descriptors, which affect pesticide distribution between honey and beeswax.	[Shimshoni, Jakob A.; Chen, Yaira; Bommuraj, Vijayakumar] Agr Res Org, Volcani Ctr, Dept Food Qual & Safety, Inst Postharvest & Food Sci, Rishon Leziyyon, Israel; [Sperling, Roy] Bilacon GMbH, Dept Instrumental Analyt, Berlin, Germany; [Massarwa, Muhammad] Minist Agr, Inst Plant Protect & Inspect Serv, Dept Feed Qual Lab, Rishon Leziyyon, Israel; [Borisover, Mikhail] Agr Res Org, Dept Soil Chem Plant Nutr & Microbiol, Inst Soil Water & Environm Sci, Volcani Ctr, Rishon Leziyyon, Israel; [Barel, Shimon] Kimron Vet Inst, Dept Toxicol, Bet Dagan, Israel	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Kimron Veterinary Institute	Shimshoni, JA (corresponding author), Agr Res Org, Volcani Ctr, Dept Food Qual & Safety, Inst Postharvest & Food Sci, Rishon Leziyyon, Israel.	jakobshimshoni@gmail.com	Borisover, Mikhail/AAE-5577-2020	Bommuraj, Vijayakumar/0000-0003-3947-0117	Bilacon GMbH	Bilacon GMbH	Dr. Jakob Shimshoni is a young PI, who joined the Volcani Institute as a young researcher in May 2017. Every young scientist receives from the Volcani Institute seed money for two years. This latter budget was used for financing the analytical services provided by Bilacon GMbH. Otherwise no additional financial support was provided. Dr. Jakob Shimshoni, whose budget was used for financing the analytical services provided by Bilacon GMbH, receives regardless of the present project, salary from the Volcani Institute, Israel. Bilacon GMbH provided support in the form of salaries for author RS, but did not have any additional role in the study design, data collection and decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Aichholz R, 1999, J CHROMATOGR A, V855, P601, DOI 10.1016/S0021-9673(99)00725-6; Al-Alam J, 2017, ANAL BIOANAL CHEM, V409, P5157, DOI 10.1007/s00216-017-0463-y; Amulen DR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178546; Anastassiades M, 2003, J AOAC INT, V86, P412; Anderson KE, 2014, MOL ECOL, V23, P5904, DOI 10.1111/mec.12966; Arnot JA, 2004, ENVIRON TOXICOL CHEM, V23, P2343, DOI 10.1897/03-438; Boi M, 2016, PEST MANAG SCI, V72, P1366, DOI 10.1002/ps.4161; Calatayud-Vernich P, 2017, SCI TOTAL ENVIRON, V605, P745, DOI 10.1016/j.scitotenv.2017.06.174; Chauzat MP, 2011, ENVIRON TOXICOL CHEM, V30, P103, DOI 10.1002/etc.361; Chiesa LM, 2018, FOOD ADDIT CONTAM A, V35, P1340, DOI 10.1080/19440049.2018.1451660; COATS JR, 1991, ACS SYM SER, V459, P10; da Silva PM, 2016, FOOD CHEM, V196, P309, DOI 10.1016/j.foodchem.2015.09.051; de Oliveira RC, 2016, CHEMOSPHERE, V163, P525, DOI 10.1016/j.chemosphere.2016.08.022; European Commission, 2013, SUMM REP STAND COMM; Farha W, 2016, ENVIRON MONIT ASSESS, V188, DOI 10.1007/s10661-016-5709-1; Finizio A, 1997, CHEMOSPHERE, V34, P131, DOI 10.1016/S0045-6535(96)00355-4; Gibaldi M, 1982, PHARMACOKINETICS; Goss KU, 2001, ENVIRON SCI TECHNOL, V35, P1, DOI 10.1021/es000996d; Iyer M, 2002, PHARMACEUT RES, V19, P1611, DOI 10.1023/A:1020792909928; JAN J, 1993, B ENVIRON CONTAM TOX, V51, P640, DOI 10.1007/BF00201639; Jin XC, 2017, ENVIRON SCI-PROC IMP, V19, P300, DOI 10.1039/c6em00626d; Kah M, 2007, J AGR FOOD CHEM, V55, P4487, DOI 10.1021/jf0635356; Kochansky J, 2001, APIDOLOGIE, V32, P119, DOI 10.1051/apido:2001117; Korta E, 2001, J AGR FOOD CHEM, V49, P5835, DOI 10.1021/jf010787s; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Laidler KJ., 1982, PHYS CHEM, P18; Majewski MS, 1995, PESTICIDES ATMOSPHER, P94; Mitchell EAD, 2017, SCIENCE, V358, P109, DOI 10.1126/science.aan3684; Nazzi F, 2014, TRENDS PARASITOL, V30, P556, DOI 10.1016/j.pt.2014.09.006; Niell S, 2015, J AGR FOOD CHEM, V63, P4484, DOI 10.1021/acs.jafc.5b00795; OECD, 1995, TEST NO 107 PARTITIO, DOI 10.1787/9789264069626-en; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Perugini M, 2018, SCI TOTAL ENVIRON, V625, P470, DOI 10.1016/j.scitotenv.2017.12.321; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Sanchez-Bayo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094482; Sharma AK, 2014, J AGR FOOD CHEM, V62, P6577, DOI 10.1021/jf5017175; Silvina N, 2017, SCI TOTAL ENVIRON, V581, P25, DOI 10.1016/j.scitotenv.2017.01.011; Tosi S, 2018, SCI TOTAL ENVIRON, V615, P208, DOI 10.1016/j.scitotenv.2017.09.226; Tulp HC, 2008, ENVIRON SCI TECHNOL, V42, P2034, DOI 10.1021/es702473f; Valdovinos-Flores C, 2017, J APICULT RES, V56, P667, DOI 10.1080/00218839.2017.1340798; Wilmart O, 2016, J AGR FOOD CHEM, V64, P8425, DOI 10.1021/acs.jafc.6b02813; Wolt JD, 2001, REV ENVIRON CONTAM T, V169, P123	42	26	26	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2								10.1371/journal.pone.0212631	http://dx.doi.org/10.1371/journal.pone.0212631			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785931	Green Published, Green Submitted, gold			2022-12-27	WOS:000459307000076
J	Ventura, M; Belleudi, V; Sciattella, P; Di Domenicantonio, R; Di Martino, M; Agabiti, N; Davoli, M; Fusco, D				Ventura, Martina; Belleudi, Valeria; Sciattella, Paolo; Di Domenicantonio, Riccardo; Di Martino, Mirko; Agabiti, Nera; Davoli, Marina; Fusco, Danilo			High quality process of care increases one-year survival after acute myocardial infarction (AM I): A cohort study in Italy	PLOS ONE			English	Article							ST-SEGMENT ELEVATION; TO-BALLOON TIME; ACUTE CORONARY SYNDROMES; LONG-TERM SURVIVAL; OBSTRUCTIVE PULMONARY-DISEASE; PRIMARY ANGIOPLASTY; MEDICAL THERAPY; SECONDARY PREVENTION; HOSPITAL MORTALITY; TASK-FORCE	Background The relationship between guideline adherence and outcomes in patients with acute myocardial infarction (AMI) has been widely investigated considering the emergency, acute, post acute phases separately, but the effectiveness of the whole care process is not known. Aim The study aim was to evaluate the effect of the multicomponent continuum of care on 1-year survival after AMI. Methods We conducted a cohort study selecting all incident cases of AMI from health information systems during 2011-2014 in the Lazio region. Patients' clinical history was defined by retrieving previous hospitalizations and drugs prescriptions. For each subject the probability to reach the hospital and the conditional probabilities to survive to 30 days from admission and to 31-365 days post discharge were estimated through multivariate logistic models. The 1-year survival probability was calculated as the product of the three probabilities. Quality of care indicators were identified in terms of emergency timeliness (time between residence and the nearest hospital), hospital performance in treatment of acute phase (number/timeliness of PCI on STEMI) and drug therapy in post-acute phase (number of drugs among anti platelet, (beta-blockers, ACE inhibitors/ARBs, statins). The 1-year survival Probability Ratio (PR) and its Bootstrap Confidence Intervals (BCI) between who were exposed to the highest level of quality of care (timeliness<10', hospitalization in high performance hospital, complete drug therapy) and who exposed to the worst (timeliness >= 10', hospitalization in low performance hospital, suboptimal drug therapy) were calculated fora mean-severity patient and varying gender and age. PRs for patients with diabetes and COPD were also evaluated. Results We identified 38,517 incident cases of AMI. The out-of-hospital mortality was 27.6%. Among the people arrived in hospital, 42.9% had a hospitalization for STEMI with 11.1% of mortality in acute phase and 5.4% in post-acute phase. For a mean-severity patient the PR was 1.19 (BCI 1.14-1.24). The ratio did not change by gender, while it moved from 1.06 (BCI 1.05-1.08) for age<65 years to 1.62 (BCI 1.45-1.80) for age >85 years. For patients with diabetes and COPD a slight increase in PRs was also observed. Conclusions The 1-year survival probability post AMI depends strongly on the quality of the whole multi component continuum of care. Improving the performance in the different phases, taking into account the relationship among these, can lead to considerable saving of lives, in particular for the elderly and for subjects with chronic diseases.	[Ventura, Martina; Belleudi, Valeria; Di Domenicantonio, Riccardo; Di Martino, Mirko; Agabiti, Nera; Davoli, Marina; Fusco, Danilo] Lazio Reg Hlth Serv, Dept Epidemiol, Rome, Italy; [Sciattella, Paolo] Sapienza Univ Rome, Dept Stat Sci, Rome, Italy	Sapienza University Rome	Agabiti, N (corresponding author), Lazio Reg Hlth Serv, Dept Epidemiol, Rome, Italy.	n.agabiti@deplazio.it	Di Domenicantonio, Riccardo/HII-5605-2022; Belleudi, Valeria/J-9070-2016; belleudi, valeria/AAR-4553-2021; Fusco, Danilo/AAB-8646-2019; Di Domenicantonio, Riccardo/H-7867-2018; Agabiti, Nera/K-1053-2016	Belleudi, Valeria/0000-0002-8286-443X; belleudi, valeria/0000-0002-8286-443X; Fusco, Danilo/0000-0003-1759-5621; Di Domenicantonio, Riccardo/0000-0002-9726-0786; Agabiti, Nera/0000-0003-3385-1197; SCIATTELLA, PAOLO/0000-0002-8364-1895				Agarwal M, 2017, AM J CARDIOL, V119, P1555, DOI 10.1016/j.amjcard.2017.02.024; Kirchberger I, 2014, AM J CARDIOL, V114, P329, DOI 10.1016/j.amjcard.2014.04.046; Amann U, 2014, CLIN RES CARDIOL, V103, P655, DOI 10.1007/s00392-014-0688-0; [Anonymous], 2017, TECHNICAL REPORT; [Anonymous], 2017, LAZIO REGIONAL OUTCO; Aylin P, 2007, BMJ-BRIT MED J, V334, P1044, DOI 10.1136/bmj.39168.496366.55; Bates ER, 2013, NEW ENGL J MED, V369, P889, DOI 10.1056/NEJMp1308772; Belleudi V, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3019-8; Belleudi V, 2012, EPIDEMIOL PREV, V36, P162; Belleudi V, 2011, PHARMACOEPIDEM DR S, V20, P169, DOI 10.1002/pds.2079; Briffa T, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b36; Cannon CP, 2000, JAMA-J AM MED ASSOC, V283, P2941, DOI 10.1001/jama.283.22.2941; De Luca G, 2004, CIRCULATION, V109, P1223, DOI 10.1161/01.CIR.0000121424.76486.20; De Luca G, 2003, J AM COLL CARDIOL, V42, P991, DOI 10.1016/S0735-1097(03)00919-7; De Luca L, 2017, EUR HEART J SUPPL, V19, pD130, DOI 10.1093/eurheartj/sux013; Denktas AE, 2011, JACC-CARDIOVASC INTE, V4, P599, DOI 10.1016/j.jcin.2011.02.012; Di Domenicantonio R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158336; Di Martino M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010926; Estevez-Loureiro R, 2014, WORLD J CARDIOL, V6, P424, DOI 10.4330/wjc.v6.i6.424; Faustini A, 2012, COPD, V9, P184, DOI 10.3109/15412555.2011.654014; Fusco D, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-25; Gouya G, 2007, EUR J EPIDEMIOL, V22, P145, DOI 10.1007/s10654-006-9087-9; Henriksson C, 2014, OPEN HEART, V1, DOI 10.1136/openhrt-2014-000051; Ibanez B, 2018, KARDIOL POL, V76, P229, DOI 10.5603/KP.2018.0041; Iezzoni LI, 1997, ANN INTERN MED, V127, P666, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00048; Jager B, 2017, EUR HEART J-ACUTE CA, V6, P254, DOI 10.1177/2048872616633882; Juliard JM, 2003, AM J CARDIOL, V91, P1401, DOI 10.1016/S0002-9149(03)00388-6; Kim HL, 2013, J KOREAN MED SCI, V28, P1749, DOI 10.3346/jkms.2013.28.12.1749; Kirchmayer U, 2013, PHARMACOEPIDEM DR S, V22, P649, DOI 10.1002/pds.3430; Koek HL, 2007, EUR J EPIDEMIOL, V22, P883, DOI 10.1007/s10654-007-9191-5; Lawesson SS, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020211; Lee JH, 2010, AM HEART J, V159, P1012, DOI 10.1016/j.ahj.2010.03.009; Lee Min Goo, 2009, Korean Circ J, V39, P243, DOI 10.4070/kcj.2009.39.6.243; Lenzi J, 2015, EUR J CLIN PHARMACOL, V71, P243, DOI 10.1007/s00228-014-1793-8; Lundberg V, 1997, J INTERN MED, V241, P485; Magid DJ, 2005, JAMA-J AM MED ASSOC, V294, P803, DOI 10.1001/jama.294.7.803; Marzolini S, 2015, CIRC-CARDIOVASC QUAL, V8, P608, DOI 10.1161/CIRCOUTCOMES.115.001751; McNamara RL, 2006, J AM COLL CARDIOL, V47, P2180, DOI 10.1016/j.jacc.2005.12.072; Mehta RH, 2002, JAMA-J AM MED ASSOC, V287, P1269, DOI 10.1001/jama.287.10.1269; Milonas C, 2010, AM J CARDIOL, V105, P1229, DOI 10.1016/j.amjcard.2009.12.032; Mukherjee D, 2004, CIRCULATION, V109, P745, DOI 10.1161/01.CIR.0000112577.69066.CB; National Clinical Guideline Centre (UK), 2013, MI SEC PREV SEC PREV; Newby LK, 1996, J AM COLL CARDIOL, V27, P1646; Nguyen HL, 2010, CIRC-CARDIOVASC QUAL, V3, P82, DOI 10.1161/CIRCOUTCOMES.109.884361; O'Gara PT, 2013, J AM COLL CARDIOL, V61, P485, DOI [10.1161/CIR.0b013e3182742c84, 10.1016/j.jacc.2012.11.018]; OECD/EU, 2016, HLTH GLANC EUR 2016, DOI [10.1787/health_glance_eur-2016-41-en, DOI 10.1787/HEALTH_GLANCE_EUR-2016-41-EN]; Piepoli MF, 2016, EUR J PREV CARDIOL, V23, P1994, DOI 10.1177/2047487316663873; Pilgrim T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137047; Rathore SS, 2009, AM J CARDIOL, V104, P1198, DOI 10.1016/j.amjcard.2009.06.034; Renzi C, 2014, INT J QUAL HEALTH C, V26, P223, DOI 10.1093/intqhc/mzu041; Ribas N, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0493-6; Rothnie KJ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007824; Rothnie KJ, 2015, HEART, V101, P1103, DOI 10.1136/heartjnl-2014-307251; Saberi F, 2014, NURS MIDWIFERY STUD, V3, DOI 10.17795/nmsjournal24238; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Sorita A, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7393; SPRAFKA JM, 1991, DIABETES CARE, V14, P537, DOI 10.2337/diacare.14.7.537; Stefan MS, 2012, CHEST, V141, P1441, DOI 10.1378/chest.11-2032; Sullivan AL, 2014, CIRC-CARDIOVASC QUAL, V7, P86, DOI 10.1161/CIRCOUTCOMES.113.000396; Terkelsen CJ, 2010, JAMA-J AM MED ASSOC, V304, P763, DOI 10.1001/jama.2010.1139; Timmer JR, 2004, EUR HEART J, V25, P926, DOI 10.1016/j.ehj.2004.04.001; Wei L, 2008, HEART, V94, P1141, DOI 10.1136/hrt.2007.123612; White HD, 2008, LANCET, V372, P570, DOI 10.1016/S0140-6736(08)61237-4; Yan AT, 2007, AM HEART J, V154, P1108, DOI 10.1016/j.ahj.2007.07.040; Yan AT, 2004, AM J CARDIOL, V94, P25, DOI 10.1016/j.amjcard.2004.03.024; Yudi MB, 2016, INT J CARDIOL, V224, P72, DOI 10.1016/j.ijcard.2016.09.003	66	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212398	10.1371/journal.pone.0212398	http://dx.doi.org/10.1371/journal.pone.0212398			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785928	Green Submitted, Green Published, gold			2022-12-27	WOS:000459307000058
J	Carson, NJ; Mullin, B; Sanchez, MJ; Lu, F; Yang, K; Menezes, M; Le Cook, B				Carson, Nicholas J.; Mullin, Brian; Sanchez, Maria Jose; Lu, Frederick; Yang, Kelly; Menezes, Michelle; Le Cook, Benjamin			Identification of suicidal behavior among psychiatrically hospitalized adolescents using natural language processing and machine learning of electronic health records	PLOS ONE			English	Article							RISK-FACTORS; IDEATION; RESILIENCE; PREDICTION; DIAGNOSES; VALIDITY; SUPPORT; TIME; CARE; AGE	Objective The rapid proliferation of machine learning research using electronic health records to classify healthcare outcomes offers an opportunity to address the pressing public health problem of adolescent suicidal behavior. We describe the development and evaluation of a machine learning algorithm using natural language processing of electronic health records to identify suicidal behavior among psychiatrically hospitalized adolescents. Methods Adolescents hospitalized on a psychiatric inpatient unit in a community health system in the northeastern United States were surveyed for history of suicide attempt in the past 12 months. A total of 73 respondents had electronic health records available prior to the index psychiatric admission. Unstructured clinical notes were downloaded from the year preceding the index inpatient admission. Natural language processing identified phrases from the notes associated with the suicide attempt outcome. We enriched this group of phrases with a clinically focused list of terms representing known risk and protective factors for suicide attempt in adolescents. We then applied the random forest machine learning algorithm to develop a classification model. The model performance was evaluated using sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy. Results The final model had a sensitivity of 0.83, specificity of 0.22, AUC of 0.68, a PPV of 0.42, NPV of 0.67, and an accuracy of 0.47. The terms mostly highly associated with suicide attempt clustered around terms related to suicide, family members, psychiatric disorders, and psychotropic medications. Conclusion This analysis demonstrates modest success of a natural language processing and machine learning approach to identifying suicide attempt among a small sample of hospitalized adolescents in a psychiatric setting.	[Carson, Nicholas J.; Mullin, Brian; Sanchez, Maria Jose; Lu, Frederick; Yang, Kelly; Menezes, Michelle; Le Cook, Benjamin] Cambridge Hlth Alliance, Hlth Equ Res Lab, Cambridge, MA 02139 USA; [Carson, Nicholas J.; Le Cook, Benjamin] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Sanchez, Maria Jose] George Washington Univ, Prevent & Community Hlth Dept, Milken Sch Publ Hlth, Washington, DC USA; [Yang, Kelly] Albert Einstein Coll Med, Dept Psychiat, Bronx, NY USA; [Menezes, Michelle] Univ Virginia, Charlottesville, VA USA	Harvard University; Cambridge Health Alliance; Harvard University; Harvard Medical School; George Washington University; Yeshiva University; Albert Einstein College of Medicine; University of Virginia	Carson, NJ (corresponding author), Cambridge Hlth Alliance, Hlth Equ Res Lab, Cambridge, MA 02139 USA.; Carson, NJ (corresponding author), Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA.	ncarson@cha.harvard.edu	Cook, Benjamin/AAA-3543-2022	Lu, Frederick/0000-0002-9884-8231; Sanchez R., Maria Jose/0000-0001-8551-1368	Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Research Resources, National Institutes of Health) [UL1 TR001102]; Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health) [UL1 TR001102]; Harvard University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER	Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Research Resources, National Institutes of Health); Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health); Harvard University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was conducted with support from Harvard Catalyst vertical bar The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award UL1 TR001102) and financial contributions from Harvard University and its affiliated academic healthcare centers. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic healthcare centers, or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson HD, 2015, J AM BOARD FAM MED, V28, P65, DOI 10.3122/jabfm.2015.01.140181; [Anonymous], 2017, R LANG ENV STAT COMP; [Anonymous], 2016, DULCANS TXB CHILD AD; [Anonymous], 2017, INVENIO; Association AP, TEEN SUIC IS PREV 20; Babeva K, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0738-6; Bae SM, 2015, NEUROPSYCH DIS TREAT, V11, P2367, DOI 10.2147/NDT.S91111; Barak-Corren Y, 2017, AM J PSYCHIAT, V174, P154, DOI 10.1176/appi.ajp.2016.16010077; Beam AL, 2018, JAMA-J AM MED ASSOC, V319, P1317, DOI 10.1001/jama.2017.18391; Becker DF, 2007, CAN J PSYCHIAT, V52, P572, DOI 10.1177/070674370705200905; Borowsky IW, 2001, PEDIATRICS, V107, P485, DOI 10.1542/peds.107.3.485; Brady TM, 2015, CLIN PEDIATR, V54, P667, DOI 10.1177/0009922814559379; Brent DA, 1999, J AM ACAD CHILD PSY, V38, P1497, DOI 10.1097/00004583-199912000-00010; Bridge JA, 2006, J CHILD PSYCHOL PSYC, V47, P372, DOI 10.1111/j.1469-7610.2006.01615.x; Busch KA, 2003, J CLIN PSYCHIAT, V64, P14, DOI 10.4088/JCP.v64n0105; Cabitza F, 2017, JAMA-J AM MED ASSOC, V318, P517, DOI 10.1001/jama.2017.7797; Canty A.J., 2002, R NEWS, V2, P2, DOI DOI 10.1159/000323281; Caruana R, 2015, KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1721, DOI 10.1145/2783258.2788613; Center for Disease and Control Prevention, SUIC RISK PROT FACT; Centers for Disease Control and Prevention, 2018, YOUTH RISK BEH SURV; Centers for Disease Control and Prevention, 2017, MMWR MORBIDITY MORTA, DOI 10.15585/mmwr.mm6609a5; Colpe LJ, 2014, AM J PREV MED, V47, pS130, DOI 10.1016/j.amepre.2014.05.024; Connor JJ, 2006, J FAM PSYCHOL, V20, P143, DOI 10.1037/0893-3200.20.1.143; Cook BL, 2016, COMPUT MATH METHOD M, V2016, DOI 10.1155/2016/8708434; Czyz EK, 2015, J CLIN CHILD ADOLESC, V44, P181, DOI 10.1080/15374416.2013.836454; D'Eramo KS, 2004, CHILD PSYCHIAT HUM D, V35, P21, DOI 10.1023/B:CHUD.0000039318.72868.a2; Dietterich TG, 1998, NEURAL COMPUT, V10, P1895, DOI 10.1162/089976698300017197; Downs Johnny, 2017, AMIA Annu Symp Proc, V2017, P641; Fernandes AC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25773-2; Goldston DB, 2009, J CONSULT CLIN PSYCH, V77, P281, DOI 10.1037/a0014732; Goldston DB, 1999, J AM ACAD CHILD PSY, V38, P660, DOI 10.1097/00004583-199906000-00012; Haerian K, 2012, AMIA Annu Symp Proc, V2012, P1244; Harwich E, 2018, THINKING ITS OWN NHS; Hunt IM, 2009, PSYCHOL MED, V39, P443, DOI 10.1017/S0033291708003644; Huth-Bocks AC, 2007, J AM ACAD CHILD PSY, V46, P387, DOI 10.1097/chi.0b013e31802b9535; Jeste DV, 2013, AM J PSYCHIAT, V170, P188, DOI 10.1176/appi.ajp.2012.12030386; Kaslow N, 2018, TEEN SUICIDES WHAT A; Kessler RC, 2015, JAMA PSYCHIAT, V72, P49, DOI 10.1001/jamapsychiatry.2014.1754; Khalilia M, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-51; King CA, 2006, J CONSULT CLIN PSYCH, V74, P199, DOI 10.1037/0022-006X.74.1.199; King CA, 2014, J ABNORM CHILD PSYCH, V42, P467, DOI 10.1007/s10802-013-9794-0; Lachal J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127359; Lacson R, 2011, J AM COLL RADIOL, V8, P436, DOI 10.1016/j.jacr.2011.04.020; Lindberg C, 1990, J Am Med Rec Assoc, V61, P40; Linehan MM, 2006, PSYCHOL ASSESSMENT, V18, P303, DOI 10.1037/1040-3590.18.3.303; Lipschitz JM, 2012, PSYCHIAT RES, V200, P400, DOI 10.1016/j.psychres.2012.07.051; Longhurst CA, 2014, HEALTH AFFAIR, V33, P1229, DOI 10.1377/hlthaff.2014.0099; Luo W, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5870; Mars B, 2016, ARCH SUICIDE RES, V20, P113, DOI 10.1080/13811118.2015.1033121; Millner AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141606; Monuteaux MC, J AM ACAD CHILD ADOL, V55, P835, DOI [10.1016/j.jaac.2016.07.87084340, DOI 10.1016/J.JAAC.2016.07.87084340]; Ougrin D, 2013, J ADOLESCENCE, V36, P221, DOI 10.1016/j.adolescence.2012.09.006; Passos IC, 2016, J AFFECT DISORDERS, V193, P109, DOI 10.1016/j.jad.2015.12.066; Pons E, 2016, RADIOLOGY, V279, P329, DOI 10.1148/radiol.16142770; Poulin C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085733; Qin P, 2005, ARCH GEN PSYCHIAT, V62, P427, DOI 10.1001/archpsyc.62.4.427; Rodriguez JJ, 2006, IEEE T PATTERN ANAL, V28, P1619, DOI 10.1109/TPAMI.2006.211; Safer D J, 1997, Ann Clin Psychiatry, V9, P263, DOI 10.1023/A:1022364629060; Savova GK, 2010, J AM MED INFORM ASSN, V17, P507, DOI 10.1136/jamia.2009.001560; Stewart Christine, 2017, Psychiatr Serv, V68, P215, DOI 10.1176/appi.ps.201600450; Walsh CG, 2018, J CHILD PSYCHOL PSYC, V59, P1261, DOI 10.1111/jcpp.12916; Walsh CG, 2017, CLIN PSYCHOL SCI, V5, P457, DOI 10.1177/2167702617691560; Wisdom JP, 2006, ADM POLICY MENT HLTH, V33, P133, DOI 10.1007/s10488-006-0036-4; Wolff JC, 2018, J ABNORM CHILD PSYCH, V46, P355, DOI 10.1007/s10802-017-0293-6; Yen S, 2013, PSYCHOL MED, V43, P983, DOI 10.1017/S0033291712001912	65	28	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0211116	10.1371/journal.pone.0211116	http://dx.doi.org/10.1371/journal.pone.0211116			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL9KY	30779800	Green Published, gold, Green Submitted			2022-12-27	WOS:000459062900011
J	Gonzalez-Gonzalez, JG; Dorsey-Trevino, EG; Alvarez-Villalobos, N; Barrera-Flores, FJ; Gonzalez-Colmenero, AD; Quintanilla-Sanchez, C; Montori, VM; Rodriguez-Gutierrez, R				Gerardo Gonzalez-Gonzalez, Jose; Gerardo Dorsey-Trevino, Edgar; Alvarez-Villalobos, Neri; Jesus Barrera-Flores, Francisco; Diaz Gonzalez-Colmenero, Alejandro; Quintanilla-Sanchez, Carolina; Montori, Victor M.; Rodriguez-Gutierrez, Rene			Trustworthiness of randomized trials in endocrinology-A systematic survey	PLOS ONE			English	Article							REPORTING QUALITY; CLINICAL-TRIALS; JOURNALS; CONCEALMENT; CONFIDENCE	Background Trustworthy (i.e. low risk of bias) randomized clinical trials (RCTs) play an important role in evidence-based decision making. We aimed to systematically assess the risk of bias of trials published in high-impact endocrinology journals. Methods We searched the MEDLINE/PubMed database between 2014 and 2016 for phase 2-4 RCTs evaluating endocrine-related therapies. Reviewers working independently and in duplicate used the Cochrane Risk of Bias Tool (CCRBT) to determine the extent to which the methods reported protected the results of each RCT from bias. Results We assessed 292 eligible RCTs, of which 40% (116) were judged to be at low risk, 43% (126) at moderate, and 17% (50) at high risk of bias. Blinding of outcome assessment was the least common domain reported 43% (125), while selective reporting of outcomes was the most common 97% (282). In multivariable analysis, RCTs with a parallel design (OR 2.4; 95% CI; 1.2-4.6) and funded by for-profit sources (OR 2.2; 95% CI; 1.3-3.6) were more likely to be at low risk of bias. Conclusions Trustworthy evidence should ultimately shape care to improve the likelihood of desirable patient outcomes. Six out-of 10 RCTs published in top endocrine journals are at moderate/high-risk of bias. Improving this should be a priority in endocrine research.	[Gerardo Gonzalez-Gonzalez, Jose; Gerardo Dorsey-Trevino, Edgar; Rodriguez-Gutierrez, Rene] Univ Autonoma Nuevo Leon, Endocrinol Div, Dept Internal Med, Univ Hosp Dr Jose E Gonzalez, Monterrey, Mexico; [Gerardo Gonzalez-Gonzalez, Jose; Gerardo Dorsey-Trevino, Edgar; Alvarez-Villalobos, Neri; Jesus Barrera-Flores, Francisco; Diaz Gonzalez-Colmenero, Alejandro; Quintanilla-Sanchez, Carolina; Rodriguez-Gutierrez, Rene] Univ Autonoma Nuevo Leon, Plataforma INVEST Med UANL KER Unit, Mayo Clin, KER Unit Mexico, Monterrey, Mexico; [Gerardo Gonzalez-Gonzalez, Jose; Alvarez-Villalobos, Neri] Univ Autonoma Nuevo Leon, Univ Hosp Dr Jose E Gonzalez, Res Unit, Monterrey, Mexico; [Alvarez-Villalobos, Neri; Montori, Victor M.; Rodriguez-Gutierrez, Rene] Mayo Clin, Knowledge & Evaluat Res Unit Endocrinol, Rochester, MN 55905 USA; [Montori, Victor M.; Rodriguez-Gutierrez, Rene] Mayo Clin, Dept Med, Div Endocrinol Diabet Metab & Nutr, Rochester, MN 55905 USA	Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Universidad Autonoma de Nuevo Leon; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Mayo Clinic; Mayo Clinic	Rodriguez-Gutierrez, R (corresponding author), Univ Autonoma Nuevo Leon, Endocrinol Div, Dept Internal Med, Univ Hosp Dr Jose E Gonzalez, Monterrey, Mexico.; Rodriguez-Gutierrez, R (corresponding author), Univ Autonoma Nuevo Leon, Plataforma INVEST Med UANL KER Unit, Mayo Clin, KER Unit Mexico, Monterrey, Mexico.; Rodriguez-Gutierrez, R (corresponding author), Mayo Clin, Knowledge & Evaluat Res Unit Endocrinol, Rochester, MN 55905 USA.; Rodriguez-Gutierrez, R (corresponding author), Mayo Clin, Dept Med, Div Endocrinol Diabet Metab & Nutr, Rochester, MN 55905 USA.	rodriguezgutierrez.rene@mayo.edu	Barrera, Francisco/AAM-2876-2020; Alvarez-Villalobos, Neri/D-4055-2018	Barrera, Francisco/0000-0003-4210-0299; Dorsey-Trevino, Edgar Gerardo/0000-0001-6082-0631; Gonzalez-Gonzalez, Jose Gerardo/0000-0002-6609-9483; Alvarez-Villalobos, Neri/0000-0001-5208-1429				Alexander PE, 2016, J CLIN EPIDEMIOL, V72, P98, DOI 10.1016/j.jclinepi.2014.10.011; Alexander PE, 2014, J CLIN EPIDEMIOL, V67, P629, DOI 10.1016/j.jclinepi.2013.09.020; [Anonymous], 2018, TRANSP REP TRIALS CO; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Bhandari M, 2004, CAN MED ASSOC J, V170, P477; Bridoux V, 2012, J GASTROINTEST SURG, V16, P1758, DOI 10.1007/s11605-012-1952-0; Brito JP, 2013, J CLIN ENDOCR METAB, V98, P3246, DOI 10.1210/jc.2013-1814; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Chen X, 2014, EUR SPINE J, V23, P1606, DOI 10.1007/s00586-014-3283-1; Chu EK, 2005, AM J RESP CRIT CARE, V171, P1202, DOI 10.1164/rccm.200502-257OE; Clark L, 2013, J EVAL CLIN PRACT, V19, P703, DOI 10.1111/jep.12031; Cohen ND, 2007, INTERN MED J, V37, P383, DOI 10.1111/j.1445-5994.2007.01369.x; Devereaux PJ, 2004, J CLIN EPIDEMIOL, V57, P1232, DOI 10.1016/j.jclinepi.2004.03.017; Fredrickson MJ, 2011, REGION ANESTH PAIN M, V36, P619, DOI 10.1097/AAP.0b013e318230fbc4; Gandhi GY, 2008, JAMA-J AM MED ASSOC, V299, P2543, DOI 10.1001/jama.299.21.2543; Gartlehner G, 2009, INT J TECHNOL ASSESS, V25, P323, DOI 10.1017/S0266462309990122; Grimshaw J M, 1994, Qual Health Care, V3, P45, DOI 10.1136/qshc.3.1.45; Groves T, 2010, ORAL DIS, V16, P313, DOI 10.1111/j.1601-0825.2010.01663.x; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Higgins JPT, 2016, COCHRANE DB SYST REV, V10, P29; Jackson JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022475; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jo JK, 2015, J SEX MED, V12, P350, DOI 10.1111/jsm.12784; Julian P.T.H., 2008, COCHRANE HDB SYSTEMA; Kelly MP, 2004, RELATIVE CONTRIBUTIO; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Lau BD, 2014, BMJ QUAL SAF, V23, P187, DOI 10.1136/bmjqs-2012-001782; Lee JW, 2014, NEUROUROL URODYNAM, V33, P472, DOI 10.1002/nau.22457; Lim SM, 2011, J KOREAN MED ASSOC, V54, P419, DOI 10.5124/jkma.2011.54.4.419; Mahtani Kamal R, 2016, Evid Based Med, V21, P201, DOI 10.1136/ebmed-2016-110570; Mclver B DS, 1996, DIABETOLOGIA, V39; Mills E, 2005, J CLIN EPIDEMIOL, V58, P662, DOI 10.1016/j.jclinepi.2005.01.004; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Montori VM, 2008, JAMA-J AM MED ASSOC, V300, P1814, DOI 10.1001/jama.300.15.1814; Montori VM, 2006, DIABETES CARE, V29, P1833, DOI 10.2337/dc06-0077; Montori Victor M, 2004, Treat Endocrinol, V3, P1, DOI 10.2165/00024677-200403010-00001; Montori VM, 2013, JAMA-J AM MED ASSOC, V310, P2503, DOI 10.1001/jama.2013.281422; Murad M Hassan, 2016, Evid Based Med, V21, P125, DOI 10.1136/ebmed-2016-110401; Plint AC, 2006, MED J AUSTRALIA, V185, P263, DOI 10.5694/j.1326-5377.2006.tb00557.x; Rios LP, 2008, J CLIN ENDOCR METAB, V93, P3810, DOI 10.1210/jc.2008-0817; Scott AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126230; Singh Ospina Naykky, 2015, BMC Med, V13, P187, DOI 10.1186/s12916-015-0435-z; Uetani K, 2009, INTERNAL MED, V48, P307, DOI 10.2169/internalmedicine.48.1358; Zarin DA, 2016, NEW ENGL J MED, V375, P1998, DOI 10.1056/NEJMsr1611785	45	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212360	10.1371/journal.pone.0212360	http://dx.doi.org/10.1371/journal.pone.0212360			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779814	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000459062900050
J	Leyland, LA; Spencer, B; Beale, N; Jones, T; van Reekum, CM				Leyland, Louise-Ann; Spencer, Ben; Beale, Nick; Jones, Tim; van Reekum, Carien M.			The effect of cycling on cognitive function and well-being in older adults	PLOS ONE			English	Article							HEALTH SURVEY SF-36; PHYSICAL-ACTIVITY; MENTAL ROTATION; EXERCISE; FITNESS; PEOPLE; MEMORY	It has been demonstrated that, on their own, both exercise and stimulation from the environment can improve cognitive function and well-being in older adults. The combined effect of exercising in the outdoor environment on psychological function is less well studied. The aim of the current study was to investigate the effect of an outdoor cycling intervention on cognitive function and mental health and well-being in older adults. A total of 100 older adults took part in the study (aged 50-83), 26 of which were non-cycling controls, 36 were conventional pedal cyclists and 38 were participants using an e-bike (a bike fitted with an electric motor to provide assistance with pedaling), as part of a larger project (www.cycleboom.org). Participants took part in the study for an eight-week period, with cycling participants required to cycle at least three times a week for thirty minutes in duration for each cycle ride. Cognitive function and well-being were measured before and after the intervention period. For executive function, namely inhibition (the Stroop task) and updating (Letter Updating Task), both cycling groups improved in accuracy after the intervention compared to non-cycling control participants. E-bike participants also improved in processing speed (reaction times in go trials of the Stop-It task) after the intervention compared to non-cycling control participants. Finally, e-bike participants improved in their mental health score after the intervention compared to non-cycling controls as measured by the SF-36. This suggests that there may be an impact of exercising in the environment on executive function and mental health. Importantly, we showed a similar (sometimes larger) effect for the e-bike group compared to the pedal cyclists. This suggests that it is not just the physical activity component of cycling that is having an influence. Both pedal cycles and e-bikes can enable increased physical activity and engagement with the outdoor environment with e-bikes potentially providing greater benefits.	[Leyland, Louise-Ann; van Reekum, Carien M.] Univ Reading, Sch Psychol & Clin Language Sci, Reading, Berks, England; [Leyland, Louise-Ann] UCL, Inst Neurol, Dementia Res Ctr, London, England; [Spencer, Ben; Jones, Tim] Oxford Brookes Univ, Sch Built Environm, Oxford, England; [Beale, Nick] Oxford Brookes Univ, Ctr Movement Occupat & Rehabil Sci MOReS, Oxford, England	University of Reading; University of London; University College London; Oxford Brookes University; Oxford Brookes University	Leyland, LA; van Reekum, CM (corresponding author), Univ Reading, Sch Psychol & Clin Language Sci, Reading, Berks, England.; Leyland, LA (corresponding author), UCL, Inst Neurol, Dementia Res Ctr, London, England.	l.leyland@ucl.ac.uk; c.vanreekum@reading.ac.uk	Beale, Nicholas/T-7420-2018	Beale, Nicholas/0000-0003-4593-706X; van Reekum, Carien M./0000-0002-1516-1101; Leyland, Louise-Ann/0000-0001-6130-6108; Jones, Tim/0000-0002-5187-5654; Spencer, Ben/0000-0003-4806-8509	Engineering and Physical Sciences Research Council (EPSRC) under the UK Research Councils' Lifelong Health and Wellbeing Programme [EP/K037242/1]; EPSRC [EP/K037242/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council (EPSRC) under the UK Research Councils' Lifelong Health and Wellbeing Programme(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research was part of the 'cycle BOOM' project (www.cycleboom.org), funded by the Engineering and Physical Sciences Research Council (EPSRC; https://www.epsrc.ac.uk/) under the UK Research Councils' Lifelong Health and Wellbeing Programme (Grant Number EP/K037242/1), received by TJ and CvR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham A, 2010, INT J PUBLIC HEALTH, V55, P59, DOI 10.1007/s00038-009-0069-z; Allerhand M, 2014, PSYCHOL AGING, V29, P306, DOI 10.1037/a0036551; CHAMBERLAIN K, 1992, SOC INDIC RES, V26, P101, DOI 10.1007/BF00304394; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Erickson KI, 2009, BRIT J SPORT MED, V43, P22, DOI 10.1136/bjsm.2008.052498; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Guiney H, 2015, NEUROPSYCHOLOGY, V29, P1, DOI 10.1037/neu0000124; Hedge C, 2018, BEHAV RES METHODS, V50, P1166, DOI 10.3758/s13428-017-0935-1; Heil M, 1998, PSYCHOL RES-PSYCH FO, V61, P99, DOI 10.1007/s004260050016; HERTZOG C, 1993, J GERONTOL, V48, pP150, DOI 10.1093/geronj/48.3.P150; Karp A, 2006, DEMENT GERIATR COGN, V21, P65, DOI 10.1159/000089919; Kosslyn SM, 1998, PSYCHOPHYSIOLOGY, V35, P151, DOI 10.1017/S0048577298001516; Kramer AF, 1999, NATURE, V400, P418, DOI 10.1038/22682; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; McDermott LM, 2009, J AFFECT DISORDERS, V119, P1, DOI 10.1016/j.jad.2009.04.022; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; MORRIS N, 1990, BRIT J PSYCHOL, V81, P111, DOI 10.1111/j.2044-8295.1990.tb02349.x; Netz Y, 2005, PSYCHOL AGING, V20, P272, DOI 10.1037/0882-7974.20.2.272; Pretty J, 2007, J ENVIRON PLANN MAN, V50, P211, DOI 10.1080/09640560601156466; ROWE JW, 1987, SCIENCE, V237, P143, DOI 10.1126/science.3299702; RUUSKANEN JM, 1995, AGE AGEING, V24, P292, DOI 10.1093/ageing/24.4.292; RYFF CD, 1995, CURR DIR PSYCHOL SCI, V4, P99, DOI 10.1111/1467-8721.ep10772395; Shallice T., 1996, ATTENTION PERFORM, P395; Shao Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00772; Spencer B, 2018, J ADVENTURE ED OUTDO; Spinney JEL, 2009, TRANSPORT POLICY, V16, P1, DOI 10.1016/j.tranpol.2009.01.002; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Thomas AG, 2016, NEUROIMAGE, V131, P162, DOI 10.1016/j.neuroimage.2015.10.090; Vaynman S, 2006, J NEUROSCI RES, V84, P699, DOI 10.1002/jnr.20979; Verbruggen F, 2008, BEHAV RES METHODS, V40, P479, DOI 10.3758/BRM.40.2.479; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wells NM, 2000, ENVIRON BEHAV, V32, P775, DOI 10.1177/00139160021972793; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272; Wilson RS, 2002, PSYCHOL AGING, V17, P179, DOI 10.1037/0882-7974.17.2.179; World Health Organization, WORLD REP AG HLTH; Yaffe K, 2009, NEUROLOGY, V72, P2029, DOI 10.1212/WNL.0b013e3181a92c36	43	27	28	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211779	10.1371/journal.pone.0211779	http://dx.doi.org/10.1371/journal.pone.0211779			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM2OT	30785893	Green Published, Green Accepted, gold			2022-12-27	WOS:000459307000038
J	Feng, LY; Raza, MA; Chen, YK; Bin Khalid, MH; Meraj, TA; Ahsan, F; Fan, YF; Du, JB; Wu, XL; Song, C; Liu, CY; Bawa, G; Zhang, ZW; Yuan, S; Yang, F; Yang, WY				Feng, Lingyang; Raza, Muhammad Ali; Chen, Yuankai; Bin Khalid, Muhammad Hayder; Meraj, Tehseen Ahmad; Ahsan, Faiza; Fan, Yuanfang; Du, Junbo; Wu, Xiaoling; Song, Chun; Liu, Chuanyan; Bawa, George; Zhang, Zhongwei; Yuan, Shu; Yang, Feng; Yang, Wenyu			Narrow-wide row planting pattern improves the light environment and seed yields of intercrop species in relay intercropping system	PLOS ONE			English	Article							PHOTON FLUX-DENSITY; MAIZE; GROWTH; SHADE; WHEAT; PHOTOSYNTHESIS; FIELD; LEAF; PRODUCTIVITY; COMPETITION	Different planting patterns affect the light interception of intercrops under intercropping conditions. Here we revealed that narrow-wide-row relay-intercropping improves the light interception across maize leaves in wide rows (60cm) and narrow rows (40cm), accelerated the biomass production of intercrop-species and compensated the slight maize yield loss by considerably increasing the soybean yield. In a two-year experiment, maize was planted with soybean in different planting patterns (1M1S, 50: 50cm and 2M2S, 40: 60cm) of relay-intercropping, both planting patterns were compared with sole cropping of maize (M) and soybean (S). As compared to M and 1M1S, 2M2S increased the total light interception of maize leaves in wide rows (WR) by 27% and 23%, 20% and 10%, 16% and 9% which in turn significantly enhanced the photosynthetic rate of WR maize leaves by 7% and 5%, 12% and 9%, and 19% and 4%, at tasseling, grain-filling and maturity stage of maize, respectively. Similarly, the light transmittance at soybean canopy increased by 218%, 160% and 172% at V-2, V-5 and R-1 stage in 2M2S compared with 1M1S. The improved light environment at soy-bean canopy in 2M2S considerably enhanced the mean biomass accumulation, and allocation to stem and leaves of soybean by 168%, and 131% and 207%, respectively, while it decreased the mean biomass accumulation, and distribution to stem, leaves and seed of maize by 4%, and 4%, 6% and 5%, respectively than 1M1S. Compared to 1M1S, 2M2S also increased the CR values of soybean (by 157%) but decreased the CR values of maize (by 61%). Overall, under 2M2S, relay-cropped maize and soybean produced 94% and 69% of the sole cropping yield, and the 2M2S achieved LER of 1.7 with net income of 1387.7 US $ha(-1) in 2016 and 1434.4 US $ha(-1) in 2017. Our findings implied that selection of optimum planting pattern (2M2S) may increase the light interception and influence the light distribution between maize and soybean rows under relay-intercropping conditions which will significantly increase the intercrops productivity. Therefore, more attention should be paid to the light environment when considering the sustainability of maize-soybean relay-intercropping via appropriate planting pattern selection.	[Feng, Lingyang; Raza, Muhammad Ali; Chen, Yuankai; Bin Khalid, Muhammad Hayder; Meraj, Tehseen Ahmad; Fan, Yuanfang; Du, Junbo; Wu, Xiaoling; Song, Chun; Liu, Chuanyan; Bawa, George; Yang, Feng; Yang, Wenyu] Sichuan Agr Univ, Coll Agron, Chengdu, Sichuan, Peoples R China; [Feng, Lingyang; Raza, Muhammad Ali; Chen, Yuankai; Fan, Yuanfang; Du, Junbo; Wu, Xiaoling; Song, Chun; Liu, Chuanyan; Bawa, George; Yang, Feng; Yang, Wenyu] Minist Agr, Key Lab Crop Ecophysiol & Farming Syst Southwest, Chengdu, Sichuan, Peoples R China; [Bin Khalid, Muhammad Hayder] Sichuan Agr Univ, Maize Res Inst, Chengdu, Sichuan, Peoples R China; [Ahsan, Faiza; Zhang, Zhongwei; Yuan, Shu] Sichuan Agr Univ, Coll Resources, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University; Ministry of Agriculture & Rural Affairs; Sichuan Agricultural University; Sichuan Agricultural University	Yang, F; Yang, WY (corresponding author), Sichuan Agr Univ, Coll Agron, Chengdu, Sichuan, Peoples R China.; Yang, F; Yang, WY (corresponding author), Minist Agr, Key Lab Crop Ecophysiol & Farming Syst Southwest, Chengdu, Sichuan, Peoples R China.	f.yang@sicau.edu.cn; mssiyangwy@sicau.edu.cn	feng, lingyang/AGG-7869-2022; Bin Khalid, Muhammad Hayder/ABE-6696-2020; Raza, Muhammad Ali/R-8597-2019; Song, Chun/B-8298-2019; Khalid, Muhammad Hayder Bin Khalid/ABF-3145-2020	Raza, Muhammad Ali/0000-0003-3817-6848; Song, Chun/0000-0001-9927-2599; Khalid, Muhammad Hayder Bin Khalid/0000-0003-0934-2093	National Key Research and Development Program of China [2016YFD0300602, 2016YFD0300209]; National Nature Science Foundation [31571615]; Program on Industrial Technology System of National Soybean [CARS-04-PS19]	National Key Research and Development Program of China; National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Program on Industrial Technology System of National Soybean	This work was funded by the National Key Research and Development Program of China (2016YFD0300602, 2016YFD0300209 to WY), the National Nature Science Foundation (31571615 to WY), and Program on Industrial Technology System of National Soybean (CARS-04-PS19 to WY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banik P, 2000, J AGRON CROP SCI, V185, P9, DOI 10.1046/j.1439-037X.2000.00388.x; Blumenberg M, 2013, BIOGEOSCIENCES, V10, P2725, DOI 10.5194/bg-10-2725-2013; Borras L, 2004, FIELD CROP RES, V86, P131, DOI 10.1016/j.fcr.2003.08.002; Chen P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184503; Chirko CP, 1996, FOREST ECOL MANAG, V83, P171, DOI 10.1016/0378-1127(96)03721-8; Fan YF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198159; Feng LY, 2019, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01952; FRANCIS CA, 1969, CROP SCI, V9, P537, DOI 10.2135/cropsci1969.0011183X000900050005x; Ghosh PK, 2004, FIELD CROP RES, V88, P227, DOI 10.1016/j.fcr.2004.01.015; Gou F, 2016, EUR J AGRON, V76, P17, DOI 10.1016/j.eja.2016.01.005; Iqbal N, 2019, PLANT PROD SCI, V22, P131, DOI 10.1080/1343943X.2018.1541137; Jiang CD, 2011, PLANT PHYSIOL, V155, P1416, DOI 10.1104/pp.111.172213; Ju XT, 2006, ENVIRON POLLUT, V143, P117, DOI 10.1016/j.envpol.2005.11.005; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; Kawamura K, 2005, J FOREST RES-JPN, V10, P247, DOI 10.1007/s10310-004-0141-8; KEATING BA, 1993, FIELD CROP RES, V34, P273, DOI 10.1016/0378-4290(93)90118-7; Kurepin LV, 2007, PLANT CELL ENVIRON, V30, P147, DOI 10.1111/j.1365-3040.2006.01612.x; Li FD, 2008, AGROFOREST SYST, V74, P163, DOI 10.1007/s10457-008-9122-9; Li L, 1999, PLANT SOIL, V212, P105, DOI 10.1023/A:1004656205144; Li Rui, 2014, Acta Prataculturae Sinica, V23, P198; Li T, 2014, J PHOTOCH PHOTOBIO B, V137, P31, DOI 10.1016/j.jphotobiol.2014.04.022; Lithourgidis AS, 2011, EUR J AGRON, V34, P287, DOI 10.1016/j.eja.2011.02.007; Liu J, 2016, FOOD CHEM, V207, P107, DOI 10.1016/j.foodchem.2016.03.059; Liu WG, 2016, FIELD CROP RES, V196, P261, DOI 10.1016/j.fcr.2016.07.008; Liu WG, 2015, PLANT PROD SCI, V18, P69, DOI 10.1626/pps.18.69; Liu X, 2018, FIELD CROP RES, V224, P91, DOI 10.1016/j.fcr.2018.05.010; Liu X, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169218; Liu X, 2017, FIELD CROP RES, V200, P38, DOI 10.1016/j.fcr.2016.10.003; Marchiori PER, 2014, FIELD CROP RES, V155, P30, DOI 10.1016/j.fcr.2013.09.025; MIDMORE DJ, 1988, FIELD CROP RES, V18, P159, DOI 10.1016/0378-4290(88)90006-8; Monzon JP, 2014, FIELD CROP RES, V162, P48, DOI 10.1016/j.fcr.2014.03.012; Morelli G, 2002, TRENDS PLANT SCI, V7, P399, DOI 10.1016/S1360-1385(02)02314-2; Nagasuga K, 2008, PLANT PROD SCI, V11, P352, DOI 10.1626/pps.11.352; Omoto E, 2012, J PLANT PHYSIOL, V169, P469, DOI 10.1016/j.jplph.2011.11.009; Oseni T. O., 2010, Journal of Agricultural Science (Toronto), V2, P229; Porcel R, 2015, J PLANT PHYSIOL, V185, P75, DOI 10.1016/j.jplph.2015.07.006; Raza MA, 2018, AGRONOMY-BASEL, V8, DOI 10.3390/agronomy8080149; Raza MA, 2018, FIELD CROP RES, V218, P51, DOI 10.1016/j.fcr.2017.12.024; Ruberti I, 2012, BIOTECHNOL ADV, V30, P1047, DOI 10.1016/j.biotechadv.2011.08.014; Wang ZK, 2015, AGR FOREST METEOROL, V204, P58, DOI 10.1016/j.agrformet.2015.02.004; WARDLAW IF, 1990, NEW PHYTOL, V116, P341, DOI 10.1111/j.1469-8137.1990.tb00524.x; Wittmann C, 2001, BASIC APPL ECOL, V2, P145, DOI 10.1078/1439-1791-00047; WOLFF XY, 1990, J AM SOC HORTIC SCI, V115, P175, DOI 10.21273/JASHS.115.1.175; Wu YS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10026-5; Xue J, 2017, J INTEGR AGR, V16, P85, DOI [10.1016/S2095-3119(16)61394-1, 10.1016/s2095-3119(16)61394-1]; Yang F, 2017, FIELD CROP RES, V203, P16, DOI 10.1016/j.fcr.2016.12.007; Yang Feng, 2015, Acta Agronomica Sinica, V41, P642; Yang F, 2015, AGRON J, V107, P296, DOI 10.2134/agronj14.0263; Yang F, 2014, FIELD CROP RES, V155, P245, DOI 10.1016/j.fcr.2013.08.011; Zhang FS, 2003, PLANT SOIL, V248, P305, DOI 10.1023/A:1022352229863; Zhang YT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129245; Zhang YY, 2012, J ENVIRON SCI, V24, P160, DOI 10.1016/S1001-0742(10)60594-3	52	40	47	10	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0212885	10.1371/journal.pone.0212885	http://dx.doi.org/10.1371/journal.pone.0212885			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807607	Green Published, gold, Green Submitted			2022-12-27	WOS:000459712100027
J	Saito, K; Koido, S; Odamaki, T; Kajihara, M; Kato, K; Horiuchi, S; Adachi, S; Arakawa, H; Yoshida, S; Akasu, T; Ito, Z; Uchiyama, K; Saruta, M; Xiao, JZ; Sato, N; Ohkusa, T				Saito, Keisuke; Koido, Shigeo; Odamaki, Toshitaka; Kajihara, Mikio; Kato, Kumiko; Horiuchi, Sankichi; Adachi, Sei; Arakawa, Hiroshi; Yoshida, Sayumi; Akasu, Takafumi; Ito, Zensho; Uchiyama, Kan; Saruta, Masayuki; Xiao, Jin-zhong; Sato, Nobuhiro; Ohkusa, Toshifumi			Metagenomic analyses of the gut microbiota associated with colorectal adenoma	PLOS ONE			English	Article							FUSOBACTERIUM-NUCLEATUM; CANCER; CELLS	Recent studies have suggested an association between certain members of the Fusobacterium genus, especially F. nucleatum, and the progression of advanced colorectal carcinoma (CRC). We assessed such an association of the gut microbiota in Japanese patients with colorectal adenoma (CRA) or intramucosal CRC using colonoscopy aspirates. We analyzed samples from 81 Japanese patients, including 47 CRA and 24 intramucosal CRC patients, and 10 healthy subjects. Metagenomic analysis of the V3-V4 region of the 16S ribosomal RNA gene was performed. The linear discriminant analysis (LDA) effect size (LEfSe) method was used to examine microbial dysbiosis, revealing significant differences in bacterial abundances between the healthy controls and CRA or intramucosal CRC patients. In particular, F. varium was statistically more abundant in patients with CRA and intramucosal CRC than in healthy subjects. Here, we present the metagenomic profile of CRA and intramucosal CRC and demonstrate that F. varium is at least partially involved in the pathogenesis of CRA and intramucosal CRC.	[Saito, Keisuke; Koido, Shigeo; Kajihara, Mikio; Horiuchi, Sankichi; Yoshida, Sayumi; Akasu, Takafumi; Ito, Zensho; Uchiyama, Kan; Ohkusa, Toshifumi] Jikei Univ, Kashiwa Hosp, Sch Med, Div Gastroenterol & Hepatol, Chiba, Japan; [Odamaki, Toshitaka; Kato, Kumiko; Xiao, Jin-zhong] Morinaga Milk Ind Co Ltd, Next Generat Sci Inst, Gut Microbiota Dept, Zama, Kanagawa, Japan; [Adachi, Sei; Arakawa, Hiroshi] Jikei Univ, Kashiwa Hosp, Sch Med, Dept Endoscopy, Chiba, Japan; [Saruta, Masayuki] Jikei Univ, Sch Med, Div Gastroenterol & Hepatol, Tokyo, Japan; [Sato, Nobuhiro; Ohkusa, Toshifumi] Juntendo Univ, Grad Sch Med, Dept Microbiota Res, Tokyo, Japan	Jikei University; Morinaga Milk Industry Company, Ltd; Jikei University; Jikei University; Juntendo University	Koido, S (corresponding author), Jikei Univ, Kashiwa Hosp, Sch Med, Div Gastroenterol & Hepatol, Chiba, Japan.	shigeo_koido@jikei.ac.jp	Saruta, Masayuki/ABL-4991-2022; 大草, 敏史/HGD-2376-2022; Xiao, Jinzhong/HIR-9791-2022	Saruta, Masayuki/0000-0001-8172-3240; Koido, Shigeo/0000-0003-0397-4348	Morinaga Milk Industry Co., LTD.; Smoking Research Foundation [6]	Morinaga Milk Industry Co., LTD.; Smoking Research Foundation	Employees of Morinaga Milk Industry Co., LTD., Toshitaka Odamaki, Kumiko Kato, and, Jin-zhong Xiao were received salary from the company. The specific roles of these authors are articulated in the 'author contributions' section. Our work was funded by the Smoking Research Foundation (special study, no. 6). The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300; Allen-Vercoe E, 2011, GUT MICROBES, V2, P294, DOI 10.4161/gmic.2.5.18603; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Barberan A, 2015, P ROY SOC B-BIOL SCI, V282, P212, DOI 10.1098/rspb.2015.1139; Bullman S, 2017, SCIENCE, V358, P1443, DOI 10.1126/science.aal5240; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Chen L, 2016, SCI REP-UK, V6, DOI 10.1038/srep23075; de la Cuesta-Zuluaga J, 2017, DIABETES CARE, V40, P54, DOI 10.2337/dc16-1324; Edge SB., 2010, AJCC CANC STAGING MA, P143; Geva-Zatorsky N, 2017, CELL, V168, P928, DOI 10.1016/j.cell.2017.01.022; Hari DM, 2013, J AM COLL SURGEONS, V217, P181, DOI 10.1016/j.jamcollsurg.2013.04.018; Keku TO, 2015, AM J PHYSIOL-GASTR L, V308, pG351, DOI 10.1152/ajpgi.00360.2012; Keren Nirit, 2012, Biosci Microbiota Food Health, V31, P71, DOI 10.12938/bmfh.31.71; Kim SW, 2013, DNA RES, V20, P241, DOI 10.1093/dnares/dst006; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Kuczynski J, 2012, CURR PROTOC MICROBIO, V27, p1E; Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344; Mima K, 2015, JAMA ONCOL, V1, P653, DOI 10.1001/jamaoncol.2015.1377; Nakatsu G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9727; Odamaki T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18391-x; Oh JK, 2014, ANN GLOB HEALTH, V80, P384, DOI 10.1016/j.aogh.2014.09.013; Ohkusa T, 2009, J MED MICROBIOL, V58, P535, DOI 10.1099/jmm.0.005801-0; Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012; Saito T, 2016, NAT MED, V22, P679, DOI 10.1038/nm.4086; Sears CL, 2014, CELL HOST MICROBE, V15, P317, DOI 10.1016/j.chom.2014.02.007; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sekizuka T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189319; Soler AP, 1999, CARCINOGENESIS, V20, P1425, DOI 10.1093/carcin/20.8.1425; Wang HF, 2016, SCI REP-UK, V6, DOI 10.1038/srep33440; Yamaoka Y, 2018, J GASTROENTEROL, V53, P517, DOI 10.1007/s00535-017-1382-6; Yang YB, 2016, 7TH INTERNATIONAL SYMPOSIUM ON HIGH-TEMPERATURE METALLURGICAL PROCESSING, P11	32	22	23	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212406	10.1371/journal.pone.0212406	http://dx.doi.org/10.1371/journal.pone.0212406			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794590	Green Submitted, Green Published, gold			2022-12-27	WOS:000459709100061
J	Wang, GL; Jing, Y; Zhou, H; Ding, Y; Wang, J; Qiu, J; Hua, HY; Dong, C				Wang, Guangli; Jing, Yang; Zhou, Hui; Ding, Yi; Wang, Jie; Qiu, Jing; Hua, Haiyong; Dong, Chen			Association between previous schistosome infection and incident hyperuricemia: A prospective cohort study in China	PLOS ONE			English	Article							SERUM URIC-ACID; METABOLIC SYNDROME; RISK-FACTORS; INFLAMMATION; ACTIVATION; PLASMA; REDUCE; LEVEL	Background More than 11 million people were estimated to be infected by Schistosoma japonicum in China before the 1950s. However, seldom studies have been conducted to evaluate the longitudinal effects of previous schistosome infection (PSI). We aimed to investigate the association between PSI and hyperuricemia in China. Methods From February 2013 to October 2013, 3,517 Chinese subjects (908 persons with PSI and 2,609 persons without PSI) were recruited from a prospective cohort study of "135". After two years, 113 and 462 participants had developed hyperuricemia in the persons with and without PSI, respectively. Multivariable logistic models were used to estimate Relative Ratios (RR) and 95% confidence intervals (CIs) for hyperuricemia. Results The PSI participants had a decreased risk of hyperuricemia compared with those without PSI [adjusted RR (95% CI): 0.73 (0.55, 0.97)]. Within the PSI group, higher level of fasting plasma glucose was significantly associated with the reduced incidence of hyperuricemia in PSI population (RR: 0.40, 95% CI: 0.26-0.63). For females, hypertension, increased levels of serum creatinine and triglycerides were the risk factors for incident hyperuricemia in the PSI group. Conclusions Our results suggest that PSI is significantly associated with the lower incidence of hyperuricemia. Moreover, elevated fasting plasma glucose might prevent the onset of hyperuricemia in PSI population.	[Wang, Guangli; Jing, Yang; Wang, Jie; Qiu, Jing; Dong, Chen] Soochow Univ, Jiangsu Key Lab & Translat Med Geriatr Dis, Dept Epidemiol & Stat, Sch Publ Hlth,Med Coll, Suzhou, Jiangsu, Peoples R China; [Zhou, Hui; Ding, Yi] Suzhou Ind Pk Ctr Dis Control & Prevent, Suzhou, Jiangsu, Peoples R China; [Hua, Haiyong] Jiangsu Inst Parasit Dis, Wuxi City, Jiangsu, Peoples R China	Soochow University - China	Dong, C (corresponding author), Soochow Univ, Jiangsu Key Lab & Translat Med Geriatr Dis, Dept Epidemiol & Stat, Sch Publ Hlth,Med Coll, Suzhou, Jiangsu, Peoples R China.	cdong@suda.edu.cn			National Natural Science Foundation of China [81502869, 81773507]; Key technologies of prevention and control of major diseases and infectious diseases in Suzhou City [Gwzx201506, Gwzx201605, Gwzx201706]; Jiangsu Provincial Special Program of Medical Science [BL2014020]; 'Prospering the public health with science and education' project for young scientists fund of Suzhou city [KJXW2015063]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key technologies of prevention and control of major diseases and infectious diseases in Suzhou City; Jiangsu Provincial Special Program of Medical Science; 'Prospering the public health with science and education' project for young scientists fund of Suzhou city	This work was supported by the National Natural Science Foundation of China (Grant No. 81502869 and 81773507), Key technologies of prevention and control of major diseases and infectious diseases in Suzhou City (Gwzx201506, Gwzx201605, Gwzx201706), Jiangsu Provincial Special Program of Medical Science (BL2014020), and the 'Prospering the public health with science and education' project for young scientists fund of Suzhou city (KJXW2015063).	Brymora A, 2012, NEPHROL DIAL TRANSPL, V27, P608, DOI 10.1093/ndt/gfr223; Chen LY, 2017, FOOD FUNCT, V8, P1785, DOI [10.1039/C6FO01561A, 10.1039/c6fo01561a]; Chen YH, 2013, J CLIN ENDOCR METAB, V98, pE283, DOI 10.1210/jc.2012-2517; Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003; Dehghan A, 2008, DIABETES CARE, V31, P361, DOI 10.2337/dc07-1276; Golembiewska E, 2005, ARCH MED RES, V36, P32, DOI 10.1016/j.arcmed.2004.09.003; Hahn K, 2017, J ADV RES, V8, P529, DOI 10.1016/j.jare.2016.09.006; HERMAN JB, 1976, DIABETOLOGIA, V12, P47, DOI 10.1007/BF01221964; La Flamme AC, 2001, J IMMUNOL, V166, P1903, DOI 10.4049/jimmunol.166.3.1903; Lertrattananon D, 2017, J DIABETES RES, V2017, P1; McMullan CJ, 2017, CLIN J AM SOC NEPHRO, V12, P807, DOI 10.2215/CJN.10771016; Nan HR, 2007, DIABETES RES CLIN PR, V76, P68, DOI 10.1016/j.diabres.2006.07.022; Puddu P, 2012, J CARDIOL, V59, P235, DOI 10.1016/j.jjcc.2012.01.013; Qian XY, 2018, GENET TEST MOL BIOMA, V22, P90, DOI 10.1089/gtmb.2017.0141; ROUBENOFF R, 1991, JAMA-J AM MED ASSOC, V266, P3004, DOI 10.1001/jama.266.21.3004; Shen SW, 2015, PARASITE IMMUNOL, V37, P333, DOI 10.1111/pim.12187; Shen SW, 2015, INT J PARASITOL, V45, P289, DOI 10.1016/j.ijpara.2015.01.001; Shen SW, 2014, INT J CARDIOL, V177, P566, DOI 10.1016/j.ijcard.2014.08.128; Shen Xue-hui, 2015, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V27, P457; Subramanian M, 2013, J CLIN INVEST, V123, P179, DOI 10.1172/JCI64617; Tsai WC, 2009, HEART VESSELS, V24, P371, DOI 10.1007/s00380-008-1127-9; TUOMILEHTO J, 1988, AM J EPIDEMIOL, V127, P321, DOI 10.1093/oxfordjournals.aje.a114807; van der Vlugt LEPM, 2017, INT J PARASITOL, V47, P545, DOI 10.1016/j.ijpara.2017.02.002; Wang LD, 2009, NEW ENGL J MED, V360, P121, DOI 10.1056/NEJMoa0800135; Wasilewska A, 2012, ACTA PAEDIATR, V101, P497, DOI 10.1111/j.1651-2227.2011.02582.x; Zaccone P, 2003, EUR J IMMUNOL, V33, P1439, DOI 10.1002/eji.200323910	26	1	1	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212702	10.1371/journal.pone.0212702	http://dx.doi.org/10.1371/journal.pone.0212702			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789970	gold, Green Published, Green Submitted			2022-12-27	WOS:000459330800050
J	de Groot, N; Bonsel, GJ; Birnie, E; Valentine, NB				de Groot, Nynke; Bonsel, Gouke J.; Birnie, Erwin; Valentine, Nicole B.			Towards a universal concept of vulnerability: Broadening the evidence from the elderly to perinatal health using a Delphi approach	PLOS ONE			English	Article							CARE; DISPARITIES	Background The concept 'vulnerability' is prevalent in the public domain, health care, social institutions and multidisciplinary research. Conceptual heterogeneity is present, hampering the creation of a common evidence-base of research achievements and successful policies. Recently an international expert group combined a specific literature review with a 2-stage Delphi procedure, arriving at a seemingly universal concept of vulnerability for the elderly with applications for research instruments. We replicated and extended this study, to generalize this result to health in general, and perinatal health in particular. Methods Two independent expert panels (general health, perinatal health) repeated the Delphi-procedure, using an extended and updated literature review to derive statements on the concept and defining pathways of vulnerability. Additional views were collected on research tools. Consensus-by-design was explicitly avoided. Data collection and processing was independent. Results Both panels showed surprising convergence on the pathways of vulnerability to health/ill-health, and their interaction. The agreed conceptual model describes a dynamic relation between health and ill-health and vulnerability. The 2 key pathways that link to vulnerability, are complementary, but not symmetrical as biological processes of maintaining health or obtaining better health are not reciprocal to recovery, so also not in terms of vulnerability impacts. An individual's degree of vulnerability is the net balance of risk effects and protective and healing factors (socially, biologically and in terms of health literacy and health care access). These factors can for measurement purposes (according to the panels: interview for exploration, checklists for population research) be grouped into 'material resources', 'taking responsibility for one's own health', 'risky activities and behaviors', and 'social support'. Supportive and transforming action can thus be undertaken. Conclusion A universal concept of vulnerability in the context of health was successfully derived after careful replication and extension of an international Delphi study on vulnerability among the elderly.	[de Groot, Nynke; Bonsel, Gouke J.] Univ Utrecht, Univ Med Ctr Utrecht, Matern Care Acad Res Grp, Dept Obstet & Gynecol, Utrecht, Netherlands; [de Groot, Nynke; Bonsel, Gouke J.] Erasmus MC, Dept Obstet & Gynecol, Div Obstet & Prenatal Med, Rotterdam, Netherlands; [Bonsel, Gouke J.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Birnie, Erwin] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands; [Valentine, Nicole B.] WHO, Publ Hlth Environm & Social Determinants Hlth Dep, Geneva, Switzerland	Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; World Health Organization	Birnie, E (corresponding author), Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands.	birnie@eshpm.eur.nl	Valentine, Nicole/AAF-7999-2020	Valentine, Nicole/0000-0003-2584-2143; de Groot, Nynke/0000-0002-8625-4145	ZonMw (The Netherlands Organization for Health Care Research and Development) [50-52000-99, 50-50200-98-061]	ZonMw (The Netherlands Organization for Health Care Research and Development)	This study was funded by ZonMw (The Netherlands Organization for Health Care Research and Development (grant 50-52000-99 and RCPSWN grant 50-50200-98-061; https://www.zonmw.nl/en/). Both grants were awarded to GB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAY LA, 1994, ANNU REV PUBL HEALTH, V15, P487, DOI 10.1146/annurev.pu.15.050194.002415; [Anonymous], 2008, FIN REP CLOS GAP GEN; [Anonymous], [No title captured]; Arnett MJ, 2016, J URBAN HEALTH, V93, P456, DOI 10.1007/s11524-016-0054-9; Babenko O, 2015, NEUROSCI BIOBEHAV R, V48, P70, DOI 10.1016/j.neubiorev.2014.11.013; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bonsel GJ, 2010, DUTCH REPORT LIJNEN; de Graaf JP, 2013, CURR OPIN OBSTET GYN, V25, P98, DOI 10.1097/GCO.0b013e32835ec9b0; de Groot N, 2016, MIDWIFERY, V40, P153, DOI 10.1016/j.midw.2016.07.003; Fiscella K, 2005, J AMBUL CARE MANAG, V28, P304, DOI 10.1097/00004479-200510000-00005; Fransen MP, 2015, J DIABETES, V7, P418, DOI 10.1111/1753-0407.12191; Gawande Atul, 2010, CHECKLIST MANIFESTO; Gobbens RJJ, 2010, J NUTR HEALTH AGING, V14, P175, DOI 10.1007/s12603-010-0045-6; Gobbens RJJ, 2010, J AM MED DIR ASSOC, V11, P338, DOI 10.1016/j.jamda.2009.09.015; Grabovschi C, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-94; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Hsu CC, 2007, PARE, V12, P1; Hung GCL, 2015, INT J EPIDEMIOL, V44, P1889, DOI 10.1093/ije/dyv303; Lewandowski AJ, 2015, HYPERTENSION, V65, P607, DOI 10.1161/HYPERTENSIONAHA.114.04662; Mechanic D, 2007, HEALTH AFFAIR, V26, P1220, DOI 10.1377/hlthaff.26.5.1220; Novikov DA, 2016, PHYSICIAN SPORTSMED, V44, P335, DOI 10.1080/00913847.2016.1216239; Nutbeam D, 1998, HEALTH PROMOT INT, V13, P349, DOI 10.1093/heapro/13.4.349; Quispel C, 2014, J PSYCHOSOM OBST GYN, V35, P140, DOI 10.3109/0167482X.2014.952278; Seeleman C, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1159-7; Shi LY, 2008, J PUBLIC HEALTH MAN, pS45, DOI 10.1097/01.PHH.0000338386.59565.dc; Shi LY, 2005, J GEN INTERN MED, V20, P148, DOI 10.1111/j.1525-1497.2005.40136.x; Solar O, 2010, 2 WHO; Sorensen LT, 2012, ARCH SURG-CHICAGO, V147, P373, DOI 10.1001/archsurg.2012.5; Stuurgroep Zwangerschap en Geboorte, 2011, DUTCH REP GOED BEG V; Valentine NB, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.29329; Vos AA, 2015, INT J INTEGR CARE, V15; Westlake Cheryl, 2013, Curr Heart Fail Rep, V10, P232, DOI 10.1007/s11897-013-0147-7; WHO, 2008, PHARMAFORUM 0121; World Health Organization, 2008, EUR STRAT APPR MAK P, P41; 2013, WORLD MAL REP 2013, P1	36	17	18	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2								10.1371/journal.pone.0212633	http://dx.doi.org/10.1371/journal.pone.0212633			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM2OT	30785926	Green Published, Green Submitted, gold			2022-12-27	WOS:000459307000077
J	Brunner, MAT; Rufenacht, S; Bauer, A; Erpel, S; Buchs, N; Braga-Lagache, S; Heller, M; Leeb, T; Jagannathan, V; Wiener, DJ; Welle, MM				Brunner, Magdalena A. T.; Rufenacht, Silvia; Bauer, Anina; Erpel, Susanne; Buchs, Natasha; Braga-Lagache, Sophie; Heller, Manfred; Leeb, Tosso; Jagannathan, Vidhya; Wiener, Dominique J.; Welle, Monika M.			Bald thigh syndrome in sighthounds-Revisiting the cause of a well-known disease	PLOS ONE			English	Article							HAIR FOLLICLE DIFFERENTIATION; ECTODERMAL DYSPLASIAS; CYSTEINE-RICH; STEM-CELLS; MUTATIONS; EXPRESSION; KERATINS; PROTEIN; ALOPECIA; HOXC13	Bald thigh syndrome is a common hair loss disorder in sighthounds. Numerous possible causes, including environmental conditions, trauma, stress, endocrinopathies and genetic components have been proposed, but only endocrinopathies have been ruled out scientifically. The overall goal of our study was to identify the cause of bald thigh syndrome and the pathological changes associated with it. We approached this aim by comparing skin biopsies and hair shafts of affected and control dogs microscopically as well as by applying highthroughput technologies such as genomics, transcriptomics and proteomics. While the histology is rather unspecific in most cases, trichogram analysis and scanning electron microscopy revealed severe structural abnormalities in hair shafts of affected dogs. This finding is supported by the results of the transcriptomic and proteomic profiling where genes and proteins important for differentiation of the inner root sheath and the assembly of a proper hair shaft were downregulated. Transcriptome profiling revealed a downregulation of genes encoding 23 hair shaft keratins and 51 keratin associated proteins, as well as desmosomal cadherins and several actors of the BMP signaling pathway which is important for hair shaft differentiation. The lower expression of keratin 71 and desmocollin 2 on the mRNA level in skin biopsies corresponded with a decreased protein expression in the hair shafts of affected dogs. The genetic analysis revealed a missense variant in the IGFBP5 gene homozygous in all available Greyhounds and other sighthounds. Further research is required to clarify whether the IGFBP5 variant represents a predisposing genetic risk factor. We conclude from our results that structural defects in the hair shafts are the cause for this wellknown disease and these defects are associated with a downregulation of genes and proteins essential for hair shaft formation. Our data add important knowledge to further understand the molecular mechanisms of HF morphogenesis and alopecia in dogs.	[Brunner, Magdalena A. T.; Welle, Monika M.] Univ Bern, Vetsuisse Fac, Inst Anim Pathol, Bern, Switzerland; [Brunner, Magdalena A. T.; Bauer, Anina; Leeb, Tosso; Welle, Monika M.] Univ Bern, DermFocus, Bern, Switzerland; [Rufenacht, Silvia] Tierklin Aarau West, DermaVet, Oberentfelden, Switzerland; [Bauer, Anina; Leeb, Tosso; Jagannathan, Vidhya] Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland; [Erpel, Susanne] Univ Basel, SNI, Nano Imaging Lab, Basel, Switzerland; [Buchs, Natasha; Braga-Lagache, Sophie; Heller, Manfred] Univ Bern, Dept BioMed Res DBMR, Bern, Switzerland; [Wiener, Dominique J.] Texas A&M Univ, Dept Vet Pathobiol, College Stn, TX USA	University of Bern; University of Bern; University of Bern; University of Basel; University of Bern; Texas A&M University System; Texas A&M University College Station	Welle, MM (corresponding author), Univ Bern, Vetsuisse Fac, Inst Anim Pathol, Bern, Switzerland.; Welle, MM (corresponding author), Univ Bern, DermFocus, Bern, Switzerland.	monika.welle@vetsuisse.unibe.ch	Welle, Monika Maria/ABF-6113-2021; Wiener, Dominique Judith/AAN-3313-2021; Jagannathan, Vidhya/P-1055-2019; Leeb, Tosso/G-3187-2014	Jagannathan, Vidhya/0000-0002-8155-0041; Leeb, Tosso/0000-0003-0553-4880; Bauer, Anina/0000-0002-6765-4012; Brunner, Magdalena/0000-0002-0449-0989	Swiss National Science Foundation [CRSII3_ 160738 / 1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by a grant from the Swiss National Science Foundation (CRSII3_ 160738 / 1). The funders provided support in the form of the salary for one author (Magdalena Brunner) and consumables, but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Silvia Rufenacht, one of the coauthors, owns a private dermatological specialty clinic (Dermavet) and generates her income by seeing patients. She was involved in the planning of the study and collected the biopsy and trichogram samples. Furthermore she evaluated the trichogram samples. She did not receive any payment for this work. The specific roles of all authors are articulated in the 'author contributions' section.	Abitbol M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120668; Adhikari K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10815; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; [Anonymous], 2018, HGNC DAT; Aoki N, 2001, J INVEST DERMATOL, V116, P359, DOI 10.1046/j.1523-1747.2001.01226.x; Bai B, 2015, NUCLEIC ACIDS RES, V43, pD777, DOI 10.1093/nar/gku1174; Balmer P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180359; Basmanav FBU, 2016, AM J HUM GENET, V99, P1292, DOI 10.1016/j.ajhg.2016.10.004; Bauer A, 2019, ANIM GENET, V50, P97, DOI 10.1111/age.12743; Bazzi H, 2009, DIFFERENTIATION, V78, P292, DOI 10.1016/j.diff.2009.06.004; Brunner MAT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186469; Cadieu E, 2009, SCIENCE, V326, P150, DOI 10.1126/science.1177808; Cai J, 2009, DEV BIOL, V326, P420, DOI 10.1016/j.ydbio.2008.11.021; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Deb-Choudhury S, 2018, ADV EXP MED BIOL, V1054, P173, DOI 10.1007/978-981-10-8195-8_12; Duverger O, 2014, SEMIN CELL DEV BIOL, V25, P22, DOI 10.1016/j.semcdb.2013.12.006; Faghri S, 2008, J MED GENET, V45, P609, DOI 10.1136/jmg.2008.058743; Farooq M, 2011, BRIT J DERMATOL, V165, P425, DOI 10.1111/j.1365-2133.2011.10373.x; Fraser RDB, 2014, J STRUCT BIOL, V188, P213, DOI 10.1016/j.jsb.2014.10.012; Freire-Maia N, 2001, AM J MED GENET, V104, P84, DOI 10.1002/ajmg.1586; Fujimoto A, 2012, J INVEST DERMATOL, V132, P2342, DOI 10.1038/jid.2012.154; Gandolfi B, 2010, MAMM GENOME, V21, P509, DOI 10.1007/s00335-010-9290-6; GARCIA ML, 1978, J SOC COSMET CHEM, V29, P155; Godwin AR, 1998, GENE DEV, V12, P11, DOI 10.1101/gad.12.1.11; Green KJ, 2000, NAT REV MOL CELL BIO, V1, P208, DOI 10.1038/35043032; Gross TL, 2005, SKIN DISEASES OF THE DOG AND CAT: CLINICAL AND HISTOPATHOLOGIC DIAGNOSIS, 2ND EDITION, P480; Gross TL., 2008, SKIN DIS DOG CAT CLI; Guha U, 2004, AM J PATHOL, V165, P729, DOI 10.1016/S0002-9440(10)63336-6; Harel S, 2012, J INVEST DERMATOL, V132, P2315, DOI 10.1038/jid.2012.291; Harland DP, 2018, ADV EXP MED BIOL, V1054, P109, DOI 10.1007/978-981-10-8195-8_10; Hirano-Ali SA, 2015, PEDIATR DERMATOL, V32, P836, DOI 10.1111/pde.12674; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Hwang J, 2008, DEVELOPMENT, V135, P3149, DOI 10.1242/dev.022202; Itin PH, 2001, J AM ACAD DERMATOL, V44, P891, DOI 10.1067/mjd.2001.114294; Itin PH, 2005, DERMATOLOGY, V211, P63, DOI 10.1159/000085582; Johns SA, 2005, DEV DYNAM, V232, P1062, DOI 10.1002/dvdy.20278; Khan I, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-779; Kizawa K, 2002, BIOCHEM BIOPH RES CO, V299, P857, DOI 10.1016/S0006-291X(02)02744-4; Kljuic A, 2003, CELL, V113, P249, DOI 10.1016/S0092-8674(03)00273-3; Koehn H, 2010, J PROTEOME RES, V9, P2920, DOI 10.1021/pr901106m; Kulessa H, 2000, EMBO J, V19, P6664, DOI 10.1093/emboj/19.24.6664; Kuramoto T, 2010, J VET MED SCI, V72, P909, DOI 10.1292/jvms.09-0554; Langbein L, 2003, J INVEST DERMATOL, V120, P512, DOI 10.1046/j.1523-1747.2003.12087.x; Langbein L, 1999, J BIOL CHEM, V274, P19874, DOI 10.1074/jbc.274.28.19874; Langbein L, 2001, J BIOL CHEM, V276, P35123, DOI 10.1074/jbc.M103305200; Langbein L, 2007, J INVEST DERMATOL, V127, P1532, DOI 10.1038/sj.jid.5700734; Langbein L, 2010, J INVEST DERMATOL, V130, P55, DOI 10.1038/jid.2009.192; Levy-Nissenbaum E, 2003, NAT GENET, V34, P151, DOI 10.1038/ng1163; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Lin ZM, 2012, AM J HUM GENET, V91, P906, DOI 10.1016/j.ajhg.2012.08.029; Lord LK, 2007, J VET INTERN MED, V21, P1243, DOI 10.1892/07-063.1; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma L, 2003, DEVELOPMENT, V130, P379, DOI 10.1242/dev.00201; Mallory SB, 2006, ILLUSTRATED DICT DER; Marsh J., 2015, HLTH HAIR, P45; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Muntener T, 2012, VET DERMATOL, V23, P206, DOI 10.1111/j.1365-3164.2012.01049.x; Muntener T, 2011, VET DERMATOL, V22, P383, DOI 10.1111/j.1365-3164.2011.00963.x; Muller Broek A., 2013, VET DERMATOL, V24, P559, DOI [10.1111/vde.12055, DOI 10.1111/VDE.12055]; Peters T, 2003, J INVEST DERMATOL, V121, P674, DOI 10.1046/j.1523-1747.2003.12491.x; PINHEIRO M, 1994, AM J MED GENET, V53, P153, DOI 10.1002/ajmg.1320530207; Poplin R., 2018, BIORXIV, DOI DOI 10.1101/201178; Rakowska A, 2012, MONILETHRIX PSEUDOMO, P145; Velasco MVR, 2009, BRAZ J PHARM SCI, V45, P153, DOI 10.1590/S1984-82502009000100019; Rogers GE, 2004, INT J DEV BIOL, V48, P163, DOI 10.1387/ijdb.15272381; Rogers MA, 2006, INT REV CYTOL, V251, P209, DOI 10.1016/S0074-7696(06)51006-X; Schlake T, 2005, DEVELOPMENT, V132, P2981, DOI 10.1242/dev.01873; Schlake T, 2005, MECH DEVELOP, V122, P988, DOI 10.1016/j.mod.2005.04.012; Schoning PR, 2000, VET DERMATOL, V11, P49, DOI 10.1046/j.1365-3164.2000.00175.x; Shimomura Y, 2005, J INVEST DERM SYMP P, V10, P230, DOI 10.1111/j.1087-0024.2005.10112.x; Shimomura Y, 2016, J DERMATOL SCI, V84, P232, DOI 10.1016/j.jdermsci.2016.08.006; Shimomura Y, 2010, ANNU REV GENOM HUM G, V11, P109, DOI 10.1146/annurev-genom-021610-131501; Takizawa T, 1999, J HISTOCHEM CYTOCHEM, V47, P525, DOI 10.1177/002215549904700411; Tkatchenko AV, 2001, DEVELOPMENT, V128, P1547; Tosti A., 2005, DIAGNOSIS TREATMENT, V1st ed; Tumilowicz P, 2018, VET DERMATOL, V29, P332, DOI 10.1111/vde.12656; Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]; van Steensel M, 2015, EXP DERMATOL, V24, P222, DOI 10.1111/exd.12624; Wong SY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164993; Yamakoshi T, 2013, BIOCHEM BIOPH RES CO, V432, P66, DOI 10.1016/j.bbrc.2013.01.084; Zhang YV, 2009, CELL STEM CELL, V5, P267, DOI 10.1016/j.stem.2009.06.004	81	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212645	10.1371/journal.pone.0212645	http://dx.doi.org/10.1371/journal.pone.0212645			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794648	Green Published, gold			2022-12-27	WOS:000459709100103
J	Rosenberg, YJ; Lewis, GK; Montefiori, DC; LaBranche, CC; Lewis, MG; Urban, LA; Lees, JP; Mao, LJ; Jiang, XM				Rosenberg, Yvonne J.; Lewis, George K.; Montefiori, David C.; LaBranche, Celia C.; Lewis, Mark G.; Urban, Lori A.; Lees, Jonathan P.; Mao, Lingjun; Jiang, Xiaoming			Introduction of the YTE mutation into the non immunogenic HIV bnAb PGT121 induces anti-drug antibodies in macaques	PLOS ONE			English	Article							BROADLY NEUTRALIZING ANTIBODIES; NEONATAL FC-RECEPTOR; MUCOSAL SHIV CHALLENGE; MONOCLONAL-ANTIBODIES; POTENT NEUTRALIZATION; HALF-LIFE; BINDING; PROTECTION; RECOGNITION; COMBINATION	Recombinant antibodies play increasingly important roles as immunotherapeutic treatments for human cancers as well as inflammatory and infectious diseases and have revolutionized their management. In addition, their therapeutic potential may be enhanced by the introduction of defined mutations in the crystallizable fragment (Fc) domains eg YTE (M252Y/S254T/T256E) and LS (M428UN434S), as a consequence of increased half-lives and prolonged duration of protection. However, the functional properties of any biologic may be compromised by unanticipated immunogenicity in humans, rendering them ineffective. Several potent broadly neutralizing HIV monoclonal antibodies (bnAbs) have been identified that protect against SHIV challenge in macaque models and reduce HIV viremia in HIV-infected individuals. In the present study, the pharmacokinetics and immunogenicity of one or more 5mg/kg subcutaneous (SC) injections in naive macaques of the HIV bnAb PGT121 and its PGT121-YTE mutant, both produced in plants, have been compared towards prolonging efficacy. Induction of anti-drug/anti-idiotypic antibodies (ADA, anti-id) has been monitored using both binding ELISAs and more functional inhibition of virus neutralization (ID50) assays. Timing of the anti-Id responses and their impact on pharmacokinetic profiles (clearance) and efficacy (protection) have also been assessed. The results indicate that ADA induction in naive macaques may result both from injection of the previously non immunogenic PGT121 into pre-primed animals and also by the introduction of the YTE mutation. Binding ADA antibody levels, induced in 7/10 macaques within two weeks of a first or second PGT121-YTE injection, were closely associated with both reduced pharmacokinetic profiles and loss of protection. However no correlation was observed with inhibitory ADA activity. These studies provide insights into both the structural features of bnAb and the immune status of the host which may contribute to the development of ADA in macaques and describe possible YTE-mediated changes in structure/orientation of HIV bnAbs that trigger such responses.	[Rosenberg, Yvonne J.; Urban, Lori A.; Lees, Jonathan P.; Mao, Lingjun; Jiang, Xiaoming] PlantVax Corp, Rockville, MD 20850 USA; [Lewis, George K.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Montefiori, David C.; LaBranche, Celia C.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Lewis, Mark G.] Bioqual Inc, Rockville, MD USA	University System of Maryland; University of Maryland Baltimore; Duke University; BIOQUAL Inc.	Rosenberg, YJ (corresponding author), PlantVax Corp, Rockville, MD 20850 USA.	yjr@plantvax.com			National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID) [R44AI081621]; NIH/NIAID NHP Humoral Immunology Laboratory [HHSN27201100016C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI124912, R44AI081621] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/NIAID NHP Humoral Immunology Laboratory; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	YR received funding from National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID) grant #R44AI081621, which provided support in the form of salaries for authors YR, XJ LU, LM and JL but had no additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. DM and CL were funded in part by NIH/NIAID NHP Humoral Immunology Laboratory Contract #HHSN27201100016C.	Barnes CO, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03632-y; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515; Caskey M, 2017, NAT MED, V23, P185, DOI 10.1038/nm.4268; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Dall'Acqua WF, 2006, J BIOL CHEM, V281, P23514, DOI 10.1074/jbc.M604292200; Datta-Mannan A, 2012, MABS-AUSTIN, V4, P267, DOI 10.4161/mabs.4.2.19364; DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; Domachowske JB, 2018, PEDIATR INFECT DIS J, V37, P886, DOI [10.1097/inf.0000000000001916, 10.1097/INF.0000000000001916]; FDA Guidance for Industry, 2014, FDA GUID IND IMM ASS; Garces F, 2014, CELL, V159, P69, DOI 10.1016/j.cell.2014.09.009; Gautam R, 2018, NAT MED, V24, P610, DOI 10.1038/s41591-018-0001-2; Gristick HB, 2016, NAT STRUCT MOL BIOL, V23, P906, DOI 10.1038/nsmb.3291; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Horwitz JA, 2013, P NATL ACAD SCI USA, V110, P16538, DOI 10.1073/pnas.1315295110; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Ko SY, 2014, NATURE, V514, P642, DOI 10.1038/nature13612; Kuo TT, 2011, MABS-AUSTIN, V3, P422, DOI 10.4161/mabs.3.5.16983; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Majumdar R, 2015, MABS-AUSTIN, V7, P84, DOI 10.4161/19420862.2014.985494; Martinez-Navio JM, 2016, MOL THER, V24, P76, DOI 10.1038/mt.2015.191; Mendoza P, 2018, NATURE, V561, P479, DOI 10.1038/s41586-018-0531-2; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Oganesyan V, 2014, J BIOL CHEM, V289, P7812, DOI 10.1074/jbc.M113.537563; Pejchal R, 2010, P NATL ACAD SCI USA, V107, P11483, DOI 10.1073/pnas.1004600107; Robbie GJ, 2013, ANTIMICROB AGENTS CH, V57, P6147, DOI 10.1128/AAC.01285-13; Rosenberg Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120451; Rosenberg Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058724; Rosenberg YJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152760; ROUX KH, 1990, J IMMUNOL, V144, P1387; Scharf L, 2014, CELL REP, V7, P785, DOI 10.1016/j.celrep.2014.04.001; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Shankar G, 2014, AAPS J, V16, P658, DOI 10.1208/s12248-014-9599-2; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Shytaj IL, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-71; Sok D, 2014, P NATL ACAD SCI USA, V111, P17624, DOI 10.1073/pnas.1415789111; Stoger E, 2014, ANNU REV PLANT BIOL, V65, P743, DOI 10.1146/annurev-arplant-050213-035850; Tan EM, 2016, J EXP MED, V213, P1937, DOI 10.1084/jem.20160792; Team RC., 2013, R LANG ENV STAT COMP; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Walters BT, 2016, J BIOL CHEM, V291, P1817, DOI 10.1074/jbc.M115.691568; Wang XH, 2018, PROTEIN CELL, V9, P63, DOI 10.1007/s13238-017-0473-8; Wang YMC, 2016, AAPS J, V18, P395, DOI 10.1208/s12248-015-9857-y; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yu L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00250; Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601	51	8	8	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212649	10.1371/journal.pone.0212649	http://dx.doi.org/10.1371/journal.pone.0212649			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785963	Green Published, Green Submitted, gold			2022-12-27	WOS:000459307000080
J	Muise, ES; Guan, HP; Liu, JQ; Nawrocki, AR; Yang, XD; Wang, CL; Rodriguez, CG; Zhou, D; Gorski, JN; Kurtz, MM; Feng, DQ; Leavitt, KJ; Wei, L; Wilkening, RR; Apgar, JM; Xu, SY; Lu, K; Feng, W; Li, Y; He, HB; Previs, SF; Shen, XL; van Heek, M; Souza, SC; Rosenbach, MJ; Biftu, T; Erion, MD; Kelley, DE; Kemp, DM; Myers, RW; Sebhat, IK				Muise, Eric S.; Guan, Hong-Ping; Liu, Jinqi; Nawrocki, Andrea R.; Yang, Xiaodong; Wang, Chuanlin; Rodriguez, Carlos G.; Zhou, Dan; Gorski, Judith N.; Kurtz, Marc M.; Feng, Danqing; Leavitt, Kenneth J.; Wei, Lan; Wilkening, Robert R.; Apgar, James M.; Xu, Shiyao; Lu, Ku; Feng, Wen; Li, Ying; He, Huaibing; Previs, Stephen F.; Shen, Xiaolan; van Heek, Margaret; Souza, Sandra C.; Rosenbach, Mark J.; Biftu, Tesfaye; Erion, Mark D.; Kelley, David E.; Kemp, Daniel M.; Myers, Robert W.; Sebhat, Iyassu K.			Pharmacological AMPK activation induces transcriptional responses congruent to exercise in skeletal and cardiac muscle, adipose tissues and liver	PLOS ONE			English	Article							5'-AMP-ACTIVATED PROTEIN-KINASE; PHYSICAL-ACTIVITY; ENDURANCE EXERCISE; SIGNALING PATHWAY; GLUCOSE-UPTAKE; ENERGY SENSOR; MALONYL-COA; WEIGHT-LOSS; HEALTH; METABOLISM	Physical activity promotes metabolic and cardiovascular health benefits that derive in part from the transcriptional responses to exercise that occur within skeletal muscle and other organs. There is interest in discovering a pharmacologic exercise mimetic that could imbue wellness and alleviate disease burden. However, the molecular physiology by which exercise signals the transcriptional response is highly complex, making it challenging to identify a single target for pharmacological mimicry. The current studies evaluated the transcriptome responses in skeletal muscle, heart, liver, and white and brown adipose to novel small molecule activators of AMPK (pan-activators for all AMPK isoforms) compared to that of exercise. A striking level of congruence between exercise and pharmacological AMPK activation was observed across the induced transcriptome of these five tissues. However, differences in acute metabolic response between exercise and pharmacologic AMPK activation were observed, notably for acute glycogen balances and related to the energy expenditure induced by exercise but not pharmacologic AMPK activation. Nevertheless, intervention with repeated daily administration of short-acting activation of AMPK was found to mitigate hyperglycemia and hyperinsulinemia in four rodent models of metabolic disease and without the cardiac glycogen accretion noted with sustained pharmacologic AMPK activation. These findings affirm that activation of AMPK is a key node governing exercise mediated transcription and is an attractive target as an exercise mimetic.	[Muise, Eric S.] MRL, Genet & Pharmacogen Dept, Kenilworth, NJ 07033 USA; [Guan, Hong-Ping; Liu, Jinqi; Yang, Xiaodong; Wang, Chuanlin; Lu, Ku; Feng, Wen; Li, Ying; Previs, Stephen F.; Souza, Sandra C.; Rosenbach, Mark J.; Erion, Mark D.; Kelley, David E.; Kemp, Daniel M.] MRL, Biol Discovery Dept, Kenilworth, NJ USA; [Nawrocki, Andrea R.; Rodriguez, Carlos G.; Zhou, Dan; Gorski, Judith N.; van Heek, Margaret] MRL, Vivo Pharmacol Dept, Kenilworth, NJ USA; [Kurtz, Marc M.; Myers, Robert W.] MRL, Vitro Pharmacol Dept, Kenilworth, NJ USA; [Feng, Danqing; Leavitt, Kenneth J.; Wei, Lan; Wilkening, Robert R.; Apgar, James M.; Biftu, Tesfaye; Sebhat, Iyassu K.] MRL, Med Chem Dept, Kenilworth, NJ 07033 USA; [Xu, Shiyao; He, Huaibing] MRL, PPDM Preclin ADME Dept, Kenilworth, NJ USA; [Shen, Xiaolan] MRL, SALAR Dept, Kenilworth, NJ USA		Muise, ES (corresponding author), MRL, Genet & Pharmacogen Dept, Kenilworth, NJ 07033 USA.; Sebhat, IK (corresponding author), MRL, Med Chem Dept, Kenilworth, NJ 07033 USA.	eric_muise@merck.com; iyassu@gmail.com		Muise, Eric/0000-0002-1238-5118	Merck Co., Inc.; Merck Research Laboratories, Kenilworth, NJ, USA	Merck Co., Inc.(Merck & Company); Merck Research Laboratories, Kenilworth, NJ, USA	This work was fully funded by Merck & Co., Inc., Merck Research Laboratories, Kenilworth, NJ, USA. The strategic goal of Merck & Co., Inc., was to explore the drug development potential of an AMPK activator for the treatment of diabetes mellitus and potentially other metabolic disorders. The studies presented in this manuscript accordingly represent investigations undertaken toward this purpose, to gain preclinical proof of concept that long- and short-acting AMPK activators could influence diabetes mellitus in rodent and murine models of this disorder and further, to gain deeper insight into the mechanisms by which salutary effects were obtained through this mechanism. The investigators listed as authors designed the experiments, carried these out, including analysis and made the decision to prepare and publish the manuscript. Senior leaders within Merck & Co., Inc., specifically within Merck Research Laboratories, did periodically review the progress of the AMPK activator program, and as is customary, assign prioritization to the AMPK program. Additionally, through a standard internal review process, senior leaders within Merck authorized the submission of the manuscript for publication.	Arad M, 2002, J CLIN INVEST, V109, P357, DOI 10.1172/JCI200214571; Bijland S, 2013, CLIN SCI, V124, P491, DOI 10.1042/CS20120536; Booth FW, 2000, J APPL PHYSIOL, V88, P774, DOI 10.1152/jappl.2000.88.2.774; Borghouts LB, 2000, INT J SPORTS MED, V21, P1, DOI 10.1055/s-2000-8847; Cao YH, 2010, CELL RES, V20, P99, DOI 10.1038/cr.2009.141; Chen Y, 2007, J CELL BIOCHEM, V100, P1337, DOI 10.1002/jcb.21194; Cokorinos EC, 2017, CELL METAB, V25, P1147, DOI 10.1016/j.cmet.2017.04.010; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Das Sarma J, 2008, CELL COMMUN ADHES, V15, P65, DOI 10.1080/15419060802014305; Fan WW, 2017, CELL METAB, V25, P242, DOI 10.1016/j.cmet.2016.10.022; Ferrera L, 2010, PHYSIOLOGY, V25, P357, DOI 10.1152/physiol.00030.2010; Frosig C, 2004, AM J PHYSIOL-ENDOC M, V286, pE411, DOI 10.1152/ajpendo.00317.2003; Fujii N, 2000, BIOCHEM BIOPH RES CO, V273, P1150, DOI 10.1006/bbrc.2000.3073; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hoffman NJ, 2015, CELL METAB, V22, P922, DOI 10.1016/j.cmet.2015.09.001; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Hunter RW, 2011, DIABETES, V60, P766, DOI 10.2337/db10-1148; Iriyama T, 2009, EMBO J, V28, P843, DOI 10.1038/emboj.2009.32; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kim AS, 2009, ACTA PHYSIOL, V196, P37, DOI 10.1111/j.1748-1716.2009.01978.x; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Liu Y, 2013, BIOCHEM J, V455, P195, DOI 10.1042/BJ20130644; McGee SL, 2010, CLIN SCI, V118, P507, DOI 10.1042/CS20090533; Menshikova EV, 2005, AM J PHYSIOL-ENDOC M, V288, pE818, DOI 10.1152/ajpendo.00322.2004; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Muise ES, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088908; Muoio DM, 2012, CELL METAB, V15, P764, DOI 10.1016/j.cmet.2012.04.005; Myers RW, 2017, SCIENCE, V357, P507, DOI 10.1126/science.aah5582; Neufer PD, 2015, CELL METAB, V22, P4, DOI 10.1016/j.cmet.2015.05.011; O'Neill HM, 2011, P NATL ACAD SCI USA, V108, P16092, DOI 10.1073/pnas.1105062108; Pei HD, 2009, CANCER CELL, V16, P259, DOI 10.1016/j.ccr.2009.07.016; Plaisier CL, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.21; Rasmussen BB, 1997, J APPL PHYSIOL, V83, P1104, DOI 10.1152/jappl.1997.83.4.1104; Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055; ROMIJN JA, 1993, AM J PHYSIOL, V265, pE380, DOI 10.1152/ajpendo.1993.265.3.E380; Ruderman NB, 2013, J CLIN INVEST, V123, P2764, DOI 10.1172/JCI67227; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Schild M, 2015, J PROTEOMICS, V122, P119, DOI 10.1016/j.jprot.2015.03.028; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Toledo FGS, 2007, DIABETES, V56, P2142, DOI 10.2337/db07-0141; Viollet B, 2009, ACTA PHYSIOL, V196, P81, DOI 10.1111/j.1748-1716.2009.01970.x; Wang L, 2011, J APPL PHYSIOL, V111, P1335, DOI 10.1152/japplphysiol.00086.2011; Wang LW, 2011, CURR OPIN PHARMACOL, V11, P360, DOI 10.1016/j.coph.2011.03.008; Williamson DL, 2006, J PHYSIOL-LONDON, V573, P497, DOI 10.1113/jphysiol.2005.103481; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; Wochnik GM, 2005, J BIOL CHEM, V280, P4609, DOI 10.1074/jbc.M407498200; Wojtaszewski JFP, 2002, J APPL PHYSIOL, V93, P384, DOI 10.1152/japplphysiol.00043.2002; Wojtaszewski JFP, 2000, J PHYSIOL-LONDON, V528, P221, DOI 10.1111/j.1469-7793.2000.t01-1-00221.x; Wolfgang MJ, 2006, J BIOL CHEM, V281, P37265, DOI 10.1074/jbc.R600016200; Yang XD, 2016, J BIOL CHEM, V291, P23428, DOI 10.1074/jbc.M116.738591; Yogi A, 2007, ARTERIOSCL THROM VAS, V27, P1960, DOI 10.1161/ATVBAHA.107.146746; Zhang J, 2017, EXP PHYSIOL, V102, P48, DOI 10.1113/EP086019	55	17	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211568	10.1371/journal.pone.0211568	http://dx.doi.org/10.1371/journal.pone.0211568			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811418	Green Submitted, Green Published, gold			2022-12-27	WOS:000459806400023
J	Shimada, S; Tanigawa, T; Watanabe, T; Nakata, A; Sugimura, N; Itani, S; Higashimori, A; Nadatani, Y; Otani, K; Taira, K; Hosomi, S; Nagami, Y; Tanaka, F; Kamata, N; Yamagami, H; Shiba, M; Fujiwara, Y				Shimada, Sunao; Tanigawa, Tetsuya; Watanabe, Toshio; Nakata, Akinobu; Sugimura, Naoki; Itani, Shigehiro; Higashimori, Akira; Nadatani, Yuji; Otani, Koji; Taira, Koichi; Hosomi, Shuhei; Nagami, Yasuaki; Tanaka, Fumio; Kamata, Noriko; Yamagami, Hirokazu; Shiba, Masatsugu; Fujiwara, Yasuhiro			Involvement of gliadin, a component of wheat gluten, in increased intestinal permeability leading to non-steroidal anti-inflammatory drug-induced small-intestinal damage	PLOS ONE			English	Article							SMALL-BOWEL INJURY; TIGHT JUNCTION PERMEABILITY; BARRIER FUNCTION; CAPSULE ENDOSCOPY; GUT PERMEABILITY; IMMUNE-RESPONSE; HUMAN ZONULIN; INDOMETHACIN; BILE; MECHANISMS	Gliadin, a component of wheat gluten known to be an important factor in the etiology of celiac disease, is related to several other diseases through its enhancing effect on intestinal paracellular permeability. We investigated the significance of gliadin in non-steroidal anti-inflammatory drug (NSAID)-induced small-intestinal damage in mice. 7-week-old C57BL/6 male mice were divided into the following groups: standard diet group, in which mice were fed with wheat-containing standard rodent diet (CE-2); gluten-free diet group, in which mice were fed with gluten-free diet (AIN-76A); and gliadin-administered group, in which mice fed with gluten-free diet were administered with gliadin (similar to 250 mg/kg BW). Each group was sub-divided into negative, healthy control group and NSAID-treated group. To some mice fed with gluten-free diet and administered with gliadin, epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor was administered for clarification of the significance of EGFR in NSAID-induced small intestinal damage and intestinal permeability. In mice fed with a gluten-free diet, indomethacin or diclofenac induced very mild mucosal damage in the small intestine compared with that in mice fed with a wheat-containing standard diet. Gliadin exacerbated the NSAID-induced small-intestinal damage in mice fed with a gluten-free diet. With the administration of indomethacin, MPO activity, a marker of neutrophil infiltration into the mucosa and mRNA expression level of tumor necrosis factor a and interleukin-1 beta in the small intestine were higher in the gliadin-administered mice. Gliadin increased the intestinal paracellular permeability without indomethacin administration (4.3-fold) and further increased the permeability after indomethacin administration (2.1-fold). Gliadin induced phosphorylation of epidermal growth factor receptor (EGFR) in small-intestinal tissues, and erlotinib (an EGFR tyrosine kinase inhibitor) attenuated the indomethacin-induced intestinal damage and permeability exacerbated by gliadin, accompanied by inhibition of EGFR phosphorylation. These results suggest that gliadin plays an important role in the induction and exacerbation of NSAID-induced small-intestinal damage, and that increase in intestinal permeability via the EGFR signalling pathway is involved in its mechanism.	[Shimada, Sunao; Tanigawa, Tetsuya; Watanabe, Toshio; Nakata, Akinobu; Sugimura, Naoki; Itani, Shigehiro; Higashimori, Akira; Nadatani, Yuji; Otani, Koji; Taira, Koichi; Hosomi, Shuhei; Nagami, Yasuaki; Tanaka, Fumio; Kamata, Noriko; Yamagami, Hirokazu; Shiba, Masatsugu; Fujiwara, Yasuhiro] Osaka City Univ, Grad Sch Med, Dept Gastroenterol, Osaka, Japan; [Tanigawa, Tetsuya; Watanabe, Toshio; Higashimori, Akira; Fujiwara, Yasuhiro] Osaka City Univ, Grad Sch Med, SAMURAI GI Res Ctr, Osaka, Japan	Osaka Metropolitan University; Osaka Metropolitan University	Tanigawa, T (corresponding author), Osaka City Univ, Grad Sch Med, Dept Gastroenterol, Osaka, Japan.; Tanigawa, T (corresponding author), Osaka City Univ, Grad Sch Med, SAMURAI GI Res Ctr, Osaka, Japan.	ttanigawa@med.osaka-cu.ac.jp	Tanaka, Fumio/HCI-5442-2022	Tanaka, Fumio/0000-0002-9186-1249; Tanigawa, Tetsuya/0000-0002-9305-1637				Antvorskov JC, 2014, DIABETOLOGIA, V57, P1770, DOI 10.1007/s00125-014-3265-1; Barak S, 2015, CRIT REV FOOD SCI, V55, P357, DOI 10.1080/10408398.2012.654863; BJARNASON I, 1993, GASTROENTEROLOGY, V104, P1832, DOI 10.1016/0016-5085(93)90667-2; Bjarnason I, 2018, GASTROENTEROLOGY, V154, P500, DOI 10.1053/j.gastro.2017.10.049; Bueno L, 2008, NEUROGASTROENT MOTIL, V20, P580, DOI 10.1111/j.1365-2982.2008.01139.x; Camilleri M, 2012, NEUROGASTROENT MOTIL, V24, P503, DOI 10.1111/j.1365-2982.2012.01921.x; de Punder K, 2013, NUTRIENTS, V5, P771, DOI 10.3390/nu5030771; DERITIS G, 1979, PEDIATR RES, V13, P1255; Drago S, 2006, SCAND J GASTROENTERO, V41, P408, DOI 10.1080/00365520500235334; Edogawa S, 2018, FASEB J, V32, P6615, DOI 10.1096/fj.201800560R; Elamin E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107421; Forsyth CB, 2007, J PHARMACOL EXP THER, V321, P84, DOI 10.1124/jpet.106.113019; Goldstein JL, 2005, CLIN GASTROENTEROL H, V3, P133, DOI 10.1016/S1542-3565(04)00619-6; Graham DY, 2005, CLIN GASTROENTEROL H, V3, P55, DOI 10.1016/S1542-3565(04)00603-2; Gujral N, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0104-1; Guo SH, 2015, J IMMUNOL, V195, P4999, DOI 10.4049/jimmunol.1402598; Guo SH, 2013, AM J PATHOL, V182, P375, DOI 10.1016/j.ajpath.2012.10.014; Gupta JaN A. R, 2014, BIOPROTOCOL, V4, DOI [10.21769/BioProtoc.1296, DOI 10.21769/BIOPROTOC.1296]; Higashimori A, 2016, MUCOSAL IMMUNOL, V9, P659, DOI 10.1038/mi.2015.89; Higuchi K, 2009, J GASTROENTEROL, V44, P879, DOI 10.1007/s00535-009-0102-2; Jacob M, 2007, ARCH TOXICOL, V81, P291, DOI 10.1007/s00204-006-0149-2; Koszarny Arkadiusz, 2015, Wiad Lek, V68, P242; Lammers KM, 2008, GASTROENTEROLOGY, V135, P194, DOI 10.1053/j.gastro.2008.03.023; Lammers KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138338; Lammers KM, 2011, IMMUNOLOGY, V132, P432, DOI 10.1111/j.1365-2567.2010.03378.x; Lebwohl B, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4347; Maiden L, 2005, GASTROENTEROLOGY, V128, P1172, DOI 10.1053/j.gastro.2005.03.020; Maiuri L, 2010, GUT, V59, P311, DOI 10.1136/gut.2009.183608; Nadatani Y, 2012, AM J PATHOL, V181, P98, DOI 10.1016/j.ajpath.2012.03.039; Raimondi F, 2008, AM J PHYSIOL-GASTR L, V294, pG906, DOI 10.1152/ajpgi.00043.2007; Reuter BK, 1997, GASTROENTEROLOGY, V112, P109, DOI 10.1016/S0016-5085(97)70225-7; Salim SY, 2011, INFLAMM BOWEL DIS, V17, P362, DOI 10.1002/ibd.21403; Samaroo D, 2010, SCHIZOPHR RES, V118, P248, DOI 10.1016/j.schres.2009.08.009; Sappington PL, 2002, GASTROENTEROLOGY, V123, P790, DOI 10.1053/gast.2002.35391; Sigthorsson G, 1998, GUT, V43, P506, DOI 10.1136/gut.43.4.506; Sugimori S, 2008, DIGESTION, V78, P208, DOI 10.1159/000190403; Tanigawa T, 2013, EUR J PHARMACOL, V704, P64, DOI 10.1016/j.ejphar.2013.02.010; Thomas KE, 2006, J IMMUNOL, V176, P2512, DOI 10.4049/jimmunol.176.4.2512; Thomsen HL, 2019, MULT SCLER RELAT DIS, V27, P156, DOI 10.1016/j.msard.2018.10.019; Tripathi A, 2009, P NATL ACAD SCI USA, V106, P16799, DOI 10.1073/pnas.0906773106; Van Buiten CB, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700879; Vincentini O, 2015, CLIN EXP MED, V15, P447, DOI 10.1007/s10238-014-0325-2; Wang WL, 2000, J CELL SCI, V113, P4435; Watanabe T, 2008, GUT, V57, P181, DOI 10.1136/gut.2007.125963; Watanabe T, 2013, DIGEST LIVER DIS, V45, P390, DOI 10.1016/j.dld.2012.12.005; Watanabe T, 2008, CLIN GASTROENTEROL H, V6, P1279, DOI 10.1016/j.cgh.2008.06.021; WHITTLE BJR, 1977, BRIT J PHARMACOL, V60, P455, DOI 10.1111/j.1476-5381.1977.tb07522.x; Wieser H, 2007, FOOD MICROBIOL, V24, P115, DOI 10.1016/j.fm.2006.07.004; YAMADA T, 1993, INFLAMMATION, V17, P641, DOI 10.1007/BF00920471; Zhou Y, 2010, AM J PHYSIOL-GASTR L, V298, pG722, DOI 10.1152/ajpgi.00387.2009	50	12	12	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211436	10.1371/journal.pone.0211436	http://dx.doi.org/10.1371/journal.pone.0211436			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785904	gold, Green Published			2022-12-27	WOS:000459307000026
J	Ali, F; Yilmaz, A; Nadeem, MA; Habyarimana, E; Subasi, I; Nawaz, MA; Chaudhary, HJ; Shahid, MQ; Ercisli, S; Zia, MA; Chung, G; Baloch, FS				Ali, Fawad; Yilmaz, Abdurrahim; Nadeem, Muhammad Azhar; Habyarimana, Ephrem; Subasi, Ilhan; Nawaz, Muhammad Amjad; Chaudhary, Hassan Javed; Shahid, Muhammad Qasim; Ercisli, Sezai; Zia, Muhammad Abu Bakar; Chung, Gyuhwa; Baloch, Faheem Shehzad			Mobile genomic element diversity in world collection of safflower (Carthamus tinctorius L.) panel using iPBS-retrotransposon markers	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; MICROSATELLITE MARKERS; GERM PLASM; WILD; GERMPLASM; ASTERACEAE; SELECTION; CLUSTERS; CENTERS; TRAITS	Safflower (Carthamus tinctorius L.) is a multipurpose crop of dry land yielding very high quality of edible oil. Present study was aimed to investigate the genetic diversity and population structure of 131 safflower accessions originating from 28 different countries using 13 iPBS-retrotransposon markers. A total of 295 iPBS bands were observed among which 275 (93.22%) were found polymorphic. Mean Polymorphism information content (0.48) and diversity parameters including mean effective number of alleles (1.33), mean Shannon's information index (0.33), overall gene diversity (0.19), Fstatistic (0.21), and inbreeding coefficient (1.00) reflected the presence of sufficient amount of genetic diversity in the studied plant materials. Analysis of molecular variance (AMOVA) showed that more than 40% of genetic variation was derived from populations. Model-based structure, principal coordinate analysis (PCoA) and unweighted pair-group method with arithmetic means (UPGMA) algorithms clustered the 131 safflower accessions into four main populations A, B, C, D and an unclassified population, with no meaningful geographical origin. Most diverse accessions originated from Asian countries including Afghanistan, Pakistan, China, Turkey, and India. Four accessions, Turkey3, Afghanistan4, Afghanistan2, and Pakistan24 were found most genetically distant and might be recommended as a candidate parents for breeding purposes. The findings of this study are most probably supported by the seven similarity centers hypothesis of safflower. This is a first study to explore the genetic diversity and population structure in safflower accessions using the iPBS-retrotransposon markers. The information provided in this work will therefore be helpful for scientists interested in safflower breeding.	[Ali, Fawad; Yilmaz, Abdurrahim; Nadeem, Muhammad Azhar; Baloch, Faheem Shehzad] Abant Izzet Baysal Univ, Fac Agr & Nat Sci, Dept Field Crops, Bolu, Turkey; [Ali, Fawad; Chaudhary, Hassan Javed] Quaid I Azam Univ, Dept Plant Sci, Islamabad, Pakistan; [Habyarimana, Ephrem] Consiglio Ric Agr & Anal Econ Agr, Ctr Ric Cerealicoltura & Colture Ind, Bologna, Italy; [Subasi, Ilhan] Cent Res Inst Field Crops, Ankara, Turkey; [Nawaz, Muhammad Amjad] Far Eastern Fed Univ, Educ Sci Ctr Nanotechnol, Vladivostok, Russia; [Shahid, Muhammad Qasim] South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China; [Ercisli, Sezai] Ataturk Univ, Fac Agr, Dept Hort, Erzurum, Turkey; [Zia, Muhammad Abu Bakar] Muhammad Nawaz Sharif Univ Agr, Dept Plant Breeding & Genet, Multan, Pakistan; [Chung, Gyuhwa] Chonnam Natl Univ, Dept Biotechnol, Chungnam, South Korea	Abant Izzet Baysal University; Quaid I Azam University; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Ministry of Food, Agriculture & Livestock - Turkey; Far Eastern Federal University; South China Agricultural University; Ataturk University; Chonnam National University	Baloch, FS (corresponding author), Abant Izzet Baysal Univ, Fac Agr & Nat Sci, Dept Field Crops, Bolu, Turkey.; Chung, G (corresponding author), Chonnam Natl Univ, Dept Biotechnol, Chungnam, South Korea.	chung@chonnam.ac.kr; balochfaheem13@gmail.com	Zia, Muhammad Abu Bakar/AAC-2532-2022; YILMAZ, Abdurrahim/ABF-8217-2021; Habyarimana, Ephrem/AAK-3957-2020; Baloch, Faheem Shehzad/ABG-8788-2020; Shahid, Muhammad Qasim/K-2304-2019; SUBAŞI, İLHAN/AAT-6201-2020; Nawaz, Muhammad Amjad/L-9934-2018; Azhar Nadeem, Muhammad/AAE-2747-2020	YILMAZ, Abdurrahim/0000-0001-9991-1792; Habyarimana, Ephrem/0000-0003-2731-2744; Baloch, Faheem Shehzad/0000-0002-7470-0080; Shahid, Muhammad Qasim/0000-0002-6767-4355; SUBAŞI, İLHAN/0000-0001-7237-937X; Azhar Nadeem, Muhammad/0000-0002-0637-9619; Amjad Nawaz, Muhammad/0000-0001-9901-7555	TUBITAK (The Scientific and Technological Research Council of Turkey)	TUBITAK (The Scientific and Technological Research Council of Turkey)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	The authors express their gratitude to TUBITAK (The Scientific and Technological Research Council of Turkey) for providing a doctoral fellowship to Fawad Ali under the TUBITAK-2216 fellowship program for international researchers.; The authors express their gratitude to TUBITAK (The Scientific and Technological Research Council of Turkey) for providing a doctoral fellowship to Fawad Ali under the TUBITAK2216 fellowship program for international researchers.	Ambreen H, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00402; Ambreen H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135443; Amini F, 2008, EUPHYTICA, V163, P21, DOI 10.1007/s10681-007-9556-6; Andeden EE, 2013, J PLANT BIOCHEM BIOT, V22, P453, DOI 10.1007/s13562-012-0175-5; ANDERSON JA, 1993, GENOME, V36, P181, DOI 10.1139/g93-024; Arystanbekkyzy M, 2019, INT J AGRIC BIOL, V21, P155, DOI 10.17957/IJAB/15.0876; ASHRI A, 1975, EUPHYTICA, V24, P651, DOI 10.1007/BF00132903; Aydin MF, 2019, LEGUME RES, V42, P18, DOI 10.18805/LR-423; Baloch FS, 2016, TURK J AGRIC FOR, V40, P352, DOI 10.3906/tar-1508-27; Baloch FS, 2015, BIOCHEM SYST ECOL, V61, P244, DOI 10.1016/j.bse.2015.06.017; Baloch FS, 2015, BIOCHEM SYST ECOL, V58, P162, DOI 10.1016/j.bse.2014.12.002; Barati M, 2012, BIOCHEM SYST ECOL, V44, P117, DOI 10.1016/j.bse.2012.04.013; Bouchet S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033470; Casacuberta JM, 1997, GENETICA, V100, P109, DOI 10.1023/A:1018309007841; Chapman MA, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-60; Chapman MA, 2010, AM J BOT, V97, P831, DOI 10.3732/ajb.0900137; Collard BCY, 2005, EUPHYTICA, V142, P169, DOI 10.1007/s10681-005-1681-5; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Derakhshan E, 2014, BIOCHEM SYST ECOL, V54, P130, DOI 10.1016/j.bse.2014.01.003; Doyle JJ., 1987, FOCUS, V19, P11, DOI DOI 10.2307/2419362; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FINNEGAN DJ, 1989, TRENDS GENET, V5, P103, DOI 10.1016/0168-9525(89)90039-5; Garcia-Moreno MJ, 2010, EUPHYTICA, V175, P145, DOI 10.1007/s10681-010-0139-6; Golkar P, 2011, INT J MOL SCI, V12, P2664, DOI 10.3390/ijms12042664; Goudet J, 1996, GENETICS, V144, P1933; Guo DL, 2014, BIOCHEM SYST ECOL, V52, P27, DOI 10.1016/j.bse.2013.10.008; Habyarimana E., 2016, Australian Journal of Crop Science, V10, P127; Hamdan YAS, 2011, PLANT BREEDING, V130, P237, DOI 10.1111/j.1439-0523.2010.01826.x; Houmanat K, 2016, INT J AGRIC BIOL, V18, P1081, DOI 10.17957/IJAB/15.0144; Jaccard P., 1908, B SOC VAUD SCI N, V44, P223; Johnson RC, 2007, CROP SCI, V47, P1728, DOI 10.2135/cropsci2006.12.0757; Kalendar R, 2010, THEOR APPL GENET, V121, P1419, DOI 10.1007/s00122-010-1398-2; Khan MA, 2009, GENET RESOUR CROP EV, V56, P19, DOI 10.1007/s10722-008-9338-6; KNOWLES PF, 1969, ECON BOT, V23, P324, DOI 10.1007/BF02860678; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Kumar S, 2015, PLANT MOL BIOL REP, V33, P1299, DOI 10.1007/s11105-014-0828-8; Kumari S., 2017, J PHARMACOGN PHYTOCH, V6, P2723; Lee GA, 2014, MOL ECOL RESOUR, V14, P69, DOI 10.1111/1755-0998.12146; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Marinova E, 2009, VEG HIST ARCHAEOBOT, V18, P341, DOI 10.1007/s00334-009-0212-z; Mokhtari N, 2018, J GENET, V97, P67, DOI 10.1007/s12041-018-0956-2; Nadeem MA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205363; Nadeem MA, 2018, BIOTECHNOL BIOTEC EQ, V32, P261, DOI 10.1080/13102818.2017.1400401; Newell MA, 2013, ANN APPL STAT, V7, P1898, DOI 10.1214/13-AOAS671; Nimbkar N, 2008, SAFFLOWER UNEXPLOITE; Panahi B, 2013, PHYSIOL MOL BIOL PLA, V19, P239, DOI 10.1007/s12298-012-0155-1; Pearl SA, 2014, AM J BOT, V101, P1640, DOI 10.3732/ajb.1400079; R Development Core Team, 2009, R LANG ENV STAT COMP; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Sehgal D, 2009, GENETICA, V135, P457, DOI 10.1007/s10709-008-9292-4; SungJungsook, 2010, [Journal of Life Science, 생명과학회지], V20, P1764; Varshney Rajeev K., 2007, P207, DOI 10.1007/978-1-4020-6297-1_10; Weiss EA, 2000, SAFFLOWER OIL SEED C; Wodajo B, 2015, INT J SCI RES PUBL, V5, P434; Xu JY, 2018, CHIN J NAT MEDICINES, V16, P1, DOI 10.1016/S1875-5364(18)30024-4; Yang RC, 1998, EVOLUTION, V52, P950, DOI 10.1111/j.1558-5646.1998.tb01824.x; Yang YX, 2007, GENET RESOUR CROP EV, V54, P1043, DOI 10.1007/s10722-006-9192-3; Yeh F., 2000, POPGENE32 MICROSOFT; Yildiz M, 2015, GENET MOL RES, V14, P10588, DOI 10.4238/2015.September.8.20; Zhang ZW, 2000, J AIR FORCE ENG U, V1, P6	60	27	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0211985	10.1371/journal.pone.0211985	http://dx.doi.org/10.1371/journal.pone.0211985			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807571	Green Published, gold, Green Submitted			2022-12-27	WOS:000459712100009
J	Han, SH; Yi, J; Kim, JH; Lee, S; Moon, HW				Han, Sung-Hee; Yi, Joowon; Kim, Ji-Hoon; Lee, SangWon; Moon, Hee-Won			Composition of gut microbiota in patients with toxigenic Clostridioides (Clostridium) difficile: Comparison between subgroups according to clinical criteria and toxin gene load	PLOS ONE			English	Article							INFECTIOUS-DISEASES SOCIETY; HEALTH-CARE EPIDEMIOLOGY; CHILDREN 2017 UPDATE; PRACTICE GUIDELINES; ORAL VANCOMYCIN; AMERICA IDSA; ADULTS; TRANSPLANTATION; DIVERSITY; DYSBIOSIS	Data concerning the human microbiota composition during Clostridioides (Clostridium) difficile infection (CDI) using next-generation sequencing are still limited. We aimed to confirm key features indicating tcdB positive patients and compare the microbiota composition between subgroups based on toxin gene load (tcdB gene) and presence of significant diarrhea. Ninety-nine fecal samples from 79 tcdB positive patients and 20 controls were analyzed using 16S rRNA gene sequencing. Chao1 index for alpha diversity were calculated and principal coordinate analysis was performed for beta diversity using Quantitative Insights into Microbial Ecology (QIIME) pipeline. The mean relative abundance in each group was compared at phylum, family, and genus levels. There were significant alterations in alpha and beta diversity in tcdB positive patients (both colonizer and CDI) compared with those in the control. The mean Chao1 index of tcdB positive patients was significantly lower than the control group (P<0.001), whereas there was no significant difference between tcdB groups and between colonizer and CDI. There were significant differences in microbiota compositions between tcdB positive patients and the control at phylum, family, and genus levels. Several genera such as Phascolarctobacterium, Lachnospira, Butyricimonas, Catenibacterium, Paraprevotella, Odoribacter, and Anaerostipes were not detected in most CDI cases. We identified several changes in the microbiota of CDI that could be further evaluated as predictive markers. Microbiota differences between clinical subgroups of CDI need to be further studied in larger controlled studies.	[Han, Sung-Hee] BioCore Co Ltd, Biotechnol, Yongin, South Korea; [Yi, Joowon; Moon, Hee-Won] Konkuk Univ, Dept Lab Med, Sch Med, Seoul, South Korea; [Kim, Ji-Hoon] BioCore Co Ltd, R&D Ctr, Seoul, South Korea; [Lee, SangWon] Konkuk Univ, Coll Vet Med, Seoul, South Korea	Konkuk University; Konkuk University Medical Center; Konkuk University	Moon, HW (corresponding author), Konkuk Univ, Dept Lab Med, Sch Med, Seoul, South Korea.	hannasis@hanmail.net			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science and ICT [2017R1A2B4005402]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science and ICT	This research (HM) was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (2017R1A2B4005402). SH and JK are employed by and receive salary from BioCore Co Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antharam VC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148824; Antharam VC, 2013, J CLIN MICROBIOL, V51, P2884, DOI 10.1128/JCM.00845-13; Bagdasarian N, 2015, JAMA-J AM MED ASSOC, V313, P398, DOI 10.1001/jama.2014.17103; Bartlett JG, 2008, CLIN INFECT DIS, V46, pS4, DOI 10.1086/521865; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Cammarota G, 2014, J CLIN GASTROENTEROL, V48, P693, DOI 10.1097/MCG.0000000000000046; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Crobach MJT, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01316-17; Dao MC, 2016, GUT, V65, P426, DOI 10.1136/gutjnl-2014-308778; Davies KA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205941; Derrien M, 2017, MICROB PATHOGENESIS, V106, P171, DOI 10.1016/j.micpath.2016.02.005; Goodrich JK, 2014, CELL, V158, P250, DOI 10.1016/j.cell.2014.06.037; Gough E, 2011, CLIN INFECT DIS, V53, P994, DOI 10.1093/cid/cir632; Isaac S, 2017, J ANTIMICROB CHEMOTH, V72, P128, DOI 10.1093/jac/dkw383; Kamboj M, 2018, J INFECTION, V76, P369, DOI 10.1016/j.jinf.2017.12.001; Kim HN, 2018, INFECTION, V46, P113, DOI 10.1007/s15010-017-1108-y; Lee YJ, 2017, J INFECT DIS, V215, P1117, DOI 10.1093/infdis/jix011; Lewis BB, 2015, J INFECT DIS, V212, P1656, DOI 10.1093/infdis/jiv256; Li H, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01169; Louie TJ, 2015, CLIN INFECT DIS, V60, pS91, DOI 10.1093/cid/civ252; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Martin J, 2016, CURR OPIN INFECT DIS, V29, P546, DOI 10.1097/QCO.0000000000000320; Martin JSH, 2016, NAT REV GASTRO HEPAT, V13, P206, DOI 10.1038/nrgastro.2016.25; McDonald LC, 2018, CLIN INFECT DIS, V66, pE1, DOI [10.1093/cid/ciy149, 10.1093/cid/cix1085]; Milani C, 2016, SCI REP-UK, V6, DOI 10.1038/srep25945; Miquel S, 2013, CURR OPIN MICROBIOL, V16, P255, DOI 10.1016/j.mib.2013.06.003; Origuen J, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.01125-18; Planche TD, 2013, LANCET INFECT DIS, V13, P936, DOI 10.1016/S1473-3099(13)70200-7; Reeves AE, 2011, GUT MICROBES, V2, P145, DOI 10.4161/gmic.2.3.16333; Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706; Schubert AM, 2014, MBIO, V5, DOI 10.1128/mBio.01021-14; Schwenk HT, 2020, J PEDIAT INF DIS SOC, V9, P44, DOI 10.1093/jpids/piy117; Seekatz AM, 2014, J CLIN INVEST, V124, P4182, DOI 10.1172/JCI72336; Senchyna F, 2017, J CLIN MICROBIOL, V55, P2651, DOI [10.1128/JCM.00563-17, 10.1128/jcm.00563-17]; Serrano-Silva N, 2018, ENVIRON POLLUT, V235, P20, DOI 10.1016/j.envpol.2017.12.035; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Stecher B, 2013, NAT REV MICROBIOL, V11, P277, DOI 10.1038/nrmicro2989; Theriot CM, 2015, ANNU REV MICROBIOL, V69, P445, DOI 10.1146/annurev-micro-091014-104115; Truong CY, 2017, J CLIN MICROBIOL, V55, P1276, DOI 10.1128/JCM.02319-16; Ventura M, 2009, NAT REV MICROBIOL, V7, P61, DOI 10.1038/nrmicro2047; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhang LH, 2015, ANAEROBE, V34, P1, DOI 10.1016/j.anaerobe.2015.03.008	44	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212626	10.1371/journal.pone.0212626	http://dx.doi.org/10.1371/journal.pone.0212626			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785932	gold, Green Published			2022-12-27	WOS:000459307000075
J	Schreuder, A; Jacobs, C; Gallardo-Estrella, L; Prokop, M; Schaefer-Prokop, CM; van Ginneken, B				Schreuder, Anton; Jacobs, Colin; Gallardo-Estrella, Leticia; Prokop, Mathias; Schaefer-Prokop, Cornelia M.; van Ginneken, Bram			Predicting all-cause and lung cancer mortality using emphysema score progression rate between baseline and follow-up chest CT images: A comparison of risk model performances	PLOS ONE			English	Article							QUANTITATIVE COMPUTED-TOMOGRAPHY; MACROSCOPIC MORPHOMETRY; PULMONARY-EMPHYSEMA; SMOKING-CESSATION; DENSITY; QUANTIFICATION; SMOKERS; TIME	Purpose Normalized emphysema score is a protocol-robust CT biomarker of mortality. We aimed to improve mortality prediction by including the emphysema score progression rate-its change over time-into the models. Method and materials CT scans from 6000 National Lung Screening Trial CT arm participants were included. Of these, 1810 died (445 lung cancer-specific). The remaining 4190 survivors were sampled with replacement up to 24432 to approximate the full cohort. Three overlapping subcohorts were formed which required participants to have images from specific screening rounds. Emphysema scores were obtained after resampling, normalization, and bullae cluster analysis of the original images. Base models contained solely the latest emphysema score. Progression models included emphysema score progression rate. Models were adjusted by including baseline age, sex, BMI, smoking status, smoking intensity, smoking duration, and previous COPD diagnosis. Cox proportional hazard models predicting all-cause and lung cancer mortality were compared by calculating the area under the curve per year follow-up. Results In the subcohort of participants with baseline and first annual follow-up scans, the analysis was performed on 4940 participants (23227 after resampling). Area under the curve for all-cause mortality predictions of the base and progression models 6 years after baseline were 0.564 (0.564 to 0.565) and 0.569 (0.568 to 0.569) when unadjusted, and 0.704 (0.703 to 0.704) to 0.705 (0.704 to 0.705) when adjusted. The respective performances predicting lung cancer mortality were 0.638 (0.637 to 0.639) and 0.643 (0.642 to 0.644) when unadjusted, and 0.724 (0.723 to 0.725) and 0.725 (0.725 to 0.726) when adjusted. Conclusion Including emphysema score progression rate into risk models shows no clinically relevant improvement in mortality risk prediction. This is because scan normalization does not adjust for an overall change in lung density. Adjusting for changes in smoking behavior is likely required to make this a clinically useful measure of emphysema progression.	[Schreuder, Anton; Jacobs, Colin; Gallardo-Estrella, Leticia; Prokop, Mathias; Schaefer-Prokop, Cornelia M.; van Ginneken, Bram] Radboudumc, Dept Radiol & Nucl Med, Diagnost Image Anal Grp, Nijmegen, Netherlands; [Gallardo-Estrella, Leticia] Thirona, Nijmegen, Netherlands; [Schaefer-Prokop, Cornelia M.] Meander Med Ctr, Dept Radiol, Amersfoort, Netherlands; [van Ginneken, Bram] Fraunhofer MEVIS, Bremen, Germany	Radboud University Nijmegen; Meander Medisch Centrum	Schreuder, A (corresponding author), Radboudumc, Dept Radiol & Nucl Med, Diagnost Image Anal Grp, Nijmegen, Netherlands.	antonius.schreuder@gmail.com	Schreuder, Anton/N-6349-2017; Jacobs, Colin/P-6938-2015; van Ginneken, Bram/A-3728-2012; Prokop, W.M./H-8081-2014	Schreuder, Anton/0000-0002-6602-1977; Jacobs, Colin/0000-0003-1180-3805; van Ginneken, Bram/0000-0003-2028-8972; Prokop, Mathias/0000-0001-8157-8055				Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Ashraf H, 2011, THORAX, V66, P55, DOI 10.1136/thx.2009.132688; Bankier AA, 1999, RADIOLOGY, V211, P851, DOI 10.1148/radiology.211.3.r99jn05851; Blechschmidt RA, 2001, IEEE T MED IMAGING, V20, P434, DOI 10.1109/42.925296; Camiciottoli G, 2009, EUR RADIOL, V19, P58, DOI 10.1007/s00330-008-1131-6; Chen H., 2011, MED PHYS, V26, P293; Gallardo-Estrella L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188902; Gallardo-Estrella L, 2016, EUR RADIOL, V26, P478, DOI 10.1007/s00330-015-3824-y; Gevenois PA, 1996, AM J RESP CRIT CARE, V154, P187, DOI 10.1164/ajrccm.154.1.8680679; GEVENOIS PA, 1995, AM J RESP CRIT CARE, V152, P653, DOI 10.1164/ajrccm.152.2.7633722; Grydeland TB, 2009, EUR RESPIR J, V34, P858, DOI 10.1183/09031936.00167908; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Jobst BJ, 2018, EUR RADIOL, V28, P807, DOI 10.1007/s00330-017-5030-6; Mets OM, 2012, LUNG, V190, P133, DOI 10.1007/s00408-011-9353-9; MULLER NL, 1988, CHEST, V94, P782, DOI 10.1378/chest.94.4.782; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Shaker SB, 2011, COPD, V8, P2, DOI 10.3109/15412555.2010.541306; Stolk J, 2011, AM J RESP CRIT CARE, V183, P1578, DOI 10.1164/rccm.201104-0615ED; Tammemagi MC, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju084; Uno H, 2013, STAT MED, V32, P2430, DOI 10.1002/sim.5647; Wang ZM, 2013, EUR RADIOL, V23, P975, DOI 10.1007/s00330-012-2683-z; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Zach JA, 2016, J THORAC IMAG, V31, P29, DOI 10.1097/RTI.0000000000000181	24	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212756	10.1371/journal.pone.0212756	http://dx.doi.org/10.1371/journal.pone.0212756			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789954	gold, Green Published, Green Submitted			2022-12-27	WOS:000459330800051
J	Topiwala, A; Suri, S; Allan, C; Valkanova, V; Filippini, N; Sexton, CE; Heise, V; Zsoldos, E; Mahmood, A; Singh-Manoux, A; Mackay, CE; Kivimaki, M; Ebmeier, KP				Topiwala, Anya; Suri, Sana; Allan, Charlotte; Valkanova, Vyara; Filippini, Nicola; Sexton, Claire E.; Heise, Verena; Zsoldos, Eniko; Mahmood, Abda; Singh-Manoux, Archana; Mackay, Clare E.; Kivimaki, Mika; Ebmeier, Klaus P.			Predicting cognitive resilience from midlife lifestyle and multi-modal MRI: A 30-year prospective cohort study	PLOS ONE			English	Article							WHITE-MATTER INTEGRITY; TEMPORAL-LOBE ATROPHY; ALZHEIMERS-DISEASE; OLDER-ADULTS; DEFAULT MODE; BRAIN; RESERVE; NETWORKS; CONNECTIVITY; DEMENTIA	Background There is significant heterogeneity in the clinical expression of structural brain abnormalities, including Alzheimer's disease biomarkers. Some individuals preserve their memory despite the presence of risk factors or pathological brain changes, indicating resilience. We aimed to test whether resilient individuals could be distinguished from those who develop cognitive impairment, using sociodemographic variables and neuroimaging. Methods We included 550 older adults participating in the Whitehall II study with longitudinal data, cognitive test results, and multi-modal MRI. Hippocampal atrophy was defined as Scheltens Scores >0. Resilient individuals (n = 184) were defined by high cognitive performance despite hippocampal atrophy (HA). Non- resilient participants (n = 133) were defined by low cognitive performance (>= 1.5 standard deviations (S.D.) below the group mean) in the presence of HA. Dynamic and static exposures were evaluated for their ability to predict later resilience status using multivariable logistic regression. In a brain-wide analysis we tested for group differences in the integrity of white matter (structural connectivity) and resting-state networks (functional connectivity). Findings Younger age (OR: 0.87, 95% CI: 0.83 to 0.92, p<0.001), higher premorbid FSIQ (OR: 1.06, 95% CI: 1.03 to 1.10, p<0.0001) and social class (OR 1 vs. 3: 4.99, 95% CI: 1.30 to 19.16, p = 0.02, OR 2 vs. 3: 8.43, 95% CI: 1.80 to 39.45, p = 0.007) were independently associated with resilience. Resilient individuals could be differentiated from non-resilient participants by higher fractional anisotropy (FA), and less association between anterior and posterior resting state networks. Higher FA had a significantly more positive effect on cognitive performance in participants with HA, compared to those without. Conclusions Resilient individuals could be distinguished from those who developed impairments on the basis of sociodemographic characteristics, brain structural and functional connectivity, but not midlife lifestyles. There was a synergistic deleterious effect of hippocampal atrophy and poor white matter integrity on cognitive performance. Exploiting and supporting neural correlates of resilience could offer a fresh approach to postpone or avoid the appearance of clinical symptoms.	[Topiwala, Anya; Suri, Sana; Allan, Charlotte; Valkanova, Vyara; Filippini, Nicola; Sexton, Claire E.; Heise, Verena; Zsoldos, Eniko; Mahmood, Abda; Mackay, Clare E.; Ebmeier, Klaus P.] Univ Oxford, Dept Psychiat, Oxford, England; [Suri, Sana] Wellcome Ctr Integrat Neuroimaging, Oxford, England; [Singh-Manoux, Archana] INSERM, Ctr Res Epidemiol & Populat Hlth, Villejuif, France; [Singh-Manoux, Archana; Kivimaki, Mika] UCL, Dept Epidemiol & Publ Hlth, London, England	University of Oxford; Institut National de la Sante et de la Recherche Medicale (Inserm); University of London; University College London	Topiwala, A (corresponding author), Univ Oxford, Dept Psychiat, Oxford, England.	anya.topiwala@psych.ox.ac.uk	Sexton, Claire/W-3990-2019; Heise, Verena/AAE-2731-2021; Kivimaki, Mika/B-3607-2012; Ebmeier, Klaus Peter/B-4789-2008; Filippini, Nicola/Q-5250-2019; Singh-Manoux, Archana/F-6804-2013	Sexton, Claire/0000-0002-3846-2986; Kivimaki, Mika/0000-0002-4699-5627; Ebmeier, Klaus Peter/0000-0002-5190-7038; Filippini, Nicola/0000-0003-1513-5269; Singh-Manoux, Archana/0000-0002-1244-5037; Topiwala, Anya/0000-0002-8408-0372; Zsoldos, Eniko/0000-0002-0478-6165; Mackay, Clare/0000-0001-6111-8318; Mahmood, Abda/0000-0002-3267-4590; Heise, Verena/0000-0002-5625-4128	UK Medical Research Council [G1001354]; Alzheimer's Research UK; HDH Wills 1965 Charitable Trust; NIH [R01AG013196, R01AG034454]; UK MRC [K013351]; NordForsk; National Institute Health Research at Oxford University Hospitals NHS Trust; University of Oxford; Wellcome Trust [203139/Z/16/Z]; NATIONAL INSTITUTE ON AGING [R01AG056477, RF1AG062553] Funding Source: NIH RePORTER; MRC [MR/K013351/1, MR/R024227/1, MR/S011676/1, G1001354, MR/M024962/1, MR/L023784/1, MC_EX_MR/N50192X/1] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); HDH Wills 1965 Charitable Trust; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NordForsk; National Institute Health Research at Oxford University Hospitals NHS Trust; University of Oxford; Wellcome Trust(Wellcome Trust); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Work on the Whitehall II Imaging Substudy was mainly funded by the UK Medical Research Council: G1001354. Other funding was from Alzheimer's Research UK (AT), HDH Wills 1965 Charitable Trust (SS, NF, EZ, AM), NIH (ASM, R01AG013196, R01AG034454), UK MRC (MK, K013351), NordForsk (MK), National Institute Health Research (CEM, CES) based at Oxford University Hospitals NHS Trust and University of Oxford. The Wellcome Centre for Integrative Neuroimaging is supported by core funding from the Wellcome Trust (203139/Z/16/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J.L.R., 2007, TR07JA2 FMRIB; Andreasen N, 1999, NEUROLOGY, V53, P1488, DOI 10.1212/WNL.53.7.1488; Barulli D, 2013, TRENDS COGN SCI, V17, P502, DOI 10.1016/j.tics.2013.08.012; Bastin C, 2012, NEUROIMAGE, V63, P713, DOI 10.1016/j.neuroimage.2012.06.074; Beckmann C., 2009, NEUROIMAGE, V47, pS148, DOI [10.1016/S1053-8119(09)71511-3, DOI 10.1016/S1053-8119(09)71511-3, 10.1016/s1053-8119(09)71511-3]; Bennett DA, 2018, JAMA-J AM MED ASSOC, V319, P123, DOI 10.1001/jama.2017.19700; BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Chan MY, 2014, P NATL ACAD SCI USA, V111, pE4997, DOI 10.1073/pnas.1415122111; Crain B, 2005, MRI ATLAS HUMAN WHIT; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; Doody RS, 2013, NEW ENGL J MED, V369, P341, DOI 10.1056/NEJMoa1210951; Filippini N, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-159; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Franzmeier N, 2018, BRAIN, V141, P1186, DOI 10.1093/brain/awy008; Geerligs L, 2015, CEREB CORTEX, V25, P1987, DOI 10.1093/cercor/bhu012; GOLOMB J, 1994, LEARN MEMORY, V1, P45; Griffanti L, 2014, NEUROIMAGE, V95, P232, DOI 10.1016/j.neuroimage.2014.03.034; Groot C, 2018, NEUROLOGY, V90, pE149, DOI 10.1212/WNL.0000000000004802; Harper Lorna, 2016, Brain, V139, P1211, DOI 10.1093/brain/aww005; Harrison TM, 2018, NEUROBIOL AGING, V67, P162, DOI 10.1016/j.neurobiolaging.2018.03.024; Head D, 2004, CEREB CORTEX, V14, P410, DOI 10.1093/cercor/bhh003; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jobke B, 2018, PUBLIC LIB SCI; Kaup AR, 2015, JAMA NEUROL, V72, P340, DOI 10.1001/jamaneurol.2014.3978; Korf ESC, 2004, NEUROLOGY, V63, P94, DOI 10.1212/01.WNL.0000133114.92694.93; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; Lyden H, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.21; Maillard P, 2012, LANCET NEUROL, V11, P1039, DOI 10.1016/S1474-4422(12)70241-7; Marstaller L, 2015, NEUROSCIENCE, V290, P369, DOI 10.1016/j.neuroscience.2015.01.049; McDermott KL, 2016, SEX EFFECTS PREDICTO; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mok VC, 2017, NATURE REV NEUROLOGY; Morbelli S, 2013, J NUCL MED, V54, P894, DOI 10.2967/jnumed.112.113928; Murray ME, 2011, LANCET NEUROL, V10, P785, DOI 10.1016/S1474-4422(11)70156-9; Ng KK, 2016, NEUROIMAGE, V133, P321, DOI 10.1016/j.neuroimage.2016.03.029; Okonkwo OC, 2017, BRAIN IMAGING BEHAV, V11, P301, DOI 10.1007/s11682-017-9677-z; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Price JL, 2009, NEUROBIOL AGING, V30, P1026, DOI 10.1016/j.neurobiolaging.2009.04.002; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Raz N, 1998, NEUROPSYCHOLOGY, V12, P95, DOI 10.1037/0894-4105.12.1.95; Rentz DM, 2017, BRAIN IMAGING BEHAV, V11, P383, DOI 10.1007/s11682-016-9640-4; Rusmaully J, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002334; SASS KJ, 1990, NEUROLOGY, V40, P1694, DOI 10.1212/WNL.40.11.1694; SCHELTENS P, 1992, J NEUROL NEUROSUR PS, V55, P967, DOI 10.1136/jnnp.55.10.967; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2013, TRENDS COGN SCI, V17, P666, DOI 10.1016/j.tics.2013.09.016; Smith SM, 2012, NEUROIMAGE, V62, P1257, DOI 10.1016/j.neuroimage.2012.01.022; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; STERN Y, 1994, JAMA-J AM MED ASSOC, V271, P1004, DOI 10.1001/jama.271.13.1004; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Suri Sana, 2017, Neuroimage, V159, P122, DOI 10.1016/j.neuroimage.2017.07.049; Team RC., 2013, R LANG ENV STAT COMP; Topiwala A, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2353; Topiwala A, 2015, BRIT J PSYCHIAT, V207, P435, DOI 10.1192/bjp.bp.114.152363; Umarova RM, 2016, CORTEX; van Loenhoud AC, 2017, HUM BRAIN MAPP, V38, P4703, DOI 10.1002/hbm.23695; Voss MW, 2013, HUM BRAIN MAPP, V34, P2972, DOI 10.1002/hbm.22119; Wahlund LO, 1999, PSYCHIAT RES-NEUROIM, V90, P193, DOI 10.1016/S0925-4927(99)00016-5; Wang HX, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002251; Wechsler D., 2011, TEST PREMORBID FUNCT; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045	68	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0211273	10.1371/journal.pone.0211273	http://dx.doi.org/10.1371/journal.pone.0211273			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL9KY	30779761	Green Published, Green Submitted, gold			2022-12-27	WOS:000459062900014
J	Zhang, LJ; Yang, L; Gu, XX; Chen, PX; Fu, JL; Jiang, HX				Zhang, Li-Juan; Yang, Ling; Gu, Xi-Xi; Chen, Pin-Xian; Fu, Jia-Li; Jiang, Hong-Xia			The first isolation of Clostridium difficile RT078/ST11 from pigs in China	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; TOXIN-A; STRAIN; INFECTION; IDENTIFICATION; CIPROFLOXACIN; EMERGENCE; EPIDEMIC; ANIMALS; HUMANS	We investigated the molecular characteristics and antimicrobial susceptibility of Clostridium difficile isolated from animals in China. We obtained 538 rectal swabs from pigs, chickens and ducks in 5 provinces during 2015 and 2016. C. difficile isolates were characterized by detection of toxin genes, multilocus sequence typing and ribotyping. And antimicrobial susceptibility testing was performed using the agar dilution method. Out of 538 samples, 44 (8.2%) were C. difficile positive with high prevalence in pigs (n = 31). Among these, 39 (88.6%) were toxigenic including 14 (31.8%) that were A(+)B(+)CDT(+) and 13 (29.5%) A(+)B(+). The remaining 12 (27.3%) were A(-)B(+). We identified 7 ST types and 6 PCR ribotypes. The most predominant type was ST11/RT078 with toxin profile A(+)B(+) CDT+ and all were isolated from piglets with diarrhea. ST109 isolates possessed two different toxigenic profiles (A(-)B(-)CDT(-) and A(-)B(+) CDT-) and although it was not the most prevalent sequence type, but it was widely distributed between chickens, ducks and pigs in the 5 provinces. All C. difficile isolates were fully susceptible to vancomycin, metronidazole, fidaxomicin, amoxicillin/clavulanate and meropenem but retained resistance to 4 or 5 of the remaining antibiotics, especially cefotaxime, tetracycline, ciprofloxacin, cefoxitin. The RT078/ST11 isolates were simultaneously resistant to cefotaxime, tetracycline, cefoxitin, ciprofloxacin and imipenem. This is the first report of the molecular epidemiology of C. difficile isolated from food animals in China. We identified the epidemic strain RT078/ST11 as the predominate isolate among the animals we screened in our study.	[Zhang, Li-Juan; Yang, Ling; Gu, Xi-Xi; Chen, Pin-Xian; Fu, Jia-Li; Jiang, Hong-Xia] SCAU, Coll Vet Med, Natl Risk Assessment Lab Antimicrobial Resistance, Guangzhou, Guangdong, Peoples R China; [Zhang, Li-Juan; Yang, Ling; Gu, Xi-Xi; Chen, Pin-Xian; Fu, Jia-Li; Jiang, Hong-Xia] SCAU, Coll Vet Med, Guangdong Prov Key Lab Vet Pharmaceut Dev & Safet, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; South China Agricultural University	Jiang, HX (corresponding author), SCAU, Coll Vet Med, Natl Risk Assessment Lab Antimicrobial Resistance, Guangzhou, Guangdong, Peoples R China.; Jiang, HX (corresponding author), SCAU, Coll Vet Med, Guangdong Prov Key Lab Vet Pharmaceut Dev & Safet, Guangzhou, Guangdong, Peoples R China.	hxjiang@scau.edu.cn		Jiang, Hong-Xia/0000-0002-8349-2877	National Natural Science Foundation of China [31272602]; Graduate Student Oversea Study Program of South China Agriculture University [2017LHPY029]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Graduate Student Oversea Study Program of South China Agriculture University	This work was supported by the National Natural Science Foundation of China (31272602) (H-XJ) and Graduate Student Oversea Study Program of South China Agriculture University (2017LHPY029) (LY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, METH ANT SUSC TEST A; Bauer MP, 2011, LANCET, V377, P63, DOI 10.1016/S0140-6736(10)61266-4; Cheng JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep18834; Collins DA, 2013, ANTIMICROB RESIST IN, V2, DOI 10.1186/2047-2994-2-21; Collins J, 2019, GUT MICROBES, V10, P204, DOI 10.1080/19490976.2018.1491266; Debast SB, 2009, ENVIRON MICROBIOL, V11, P505, DOI 10.1111/j.1462-2920.2008.01790.x; Dridi L, 2002, ANTIMICROB AGENTS CH, V46, P3418, DOI 10.1128/AAC.46.11.3418-3421.2002; Fabrega A, 2009, MICROB BIOTECHNOL, V2, P40, DOI 10.1111/j.1751-7915.2008.00063.x; Gao Qiong, 2015, Yichuan, V37, P458, DOI 10.16288/j.yczz.15-131; Goorhuis A, 2008, CLIN INFECT DIS, V47, P1162, DOI 10.1086/592257; Goorhuis A, 2008, J CLIN MICROBIOL, V46, P1157, DOI 10.1128/JCM.01536-07; Griffiths D, 2010, J CLIN MICROBIOL, V48, P770, DOI 10.1128/JCM.01796-09; He M, 2013, NAT GENET, V45, P109, DOI 10.1038/ng.2478; Huang HH, 2009, INT J ANTIMICROB AG, V33, P339, DOI 10.1016/j.ijantimicag.2008.09.022; Janezic S, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-173; Jin H, 2016, INFECT CONT HOSP EP, V37, P745, DOI 10.1017/ice.2016.58; Kato H, 1998, J CLIN MICROBIOL, V36, P2178, DOI 10.1128/JCM.36.8.2178-2182.1998; Keessen EC, 2013, ANTIMICROB RESIST IN, V2, DOI 10.1186/2047-2994-2-14; Knetsch CW, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01384-17; Knetsch CW, 2014, EUROSURVEILLANCE, V19, P30, DOI 10.2807/1560-7917.ES2014.19.45.20954; Knight DR, 2015, CLIN MICROBIOL REV, V28, P721, DOI 10.1128/CMR.00127-14; Krutova M, 2018, INT J MED MICROBIOL, V308, P770, DOI 10.1016/j.ijmm.2018.05.006; Kuijper J, 2006, EMERGENCE CLOSTRIDIU; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Mastrantonio P, 2018, UPDATES CLOSTRIDIUM; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Moono P, 2016, FOODBORNE PATHOG DIS, V13, P647, DOI 10.1089/fpd.2016.2181; Norman KN, 2009, ANAEROBE, V15, P256, DOI 10.1016/j.anaerobe.2009.09.006; O'Donoghue C, 2011, CURR OPIN GASTROEN, V27, P38, DOI 10.1097/MOG.0b013e3283411634; Pituch H, 2005, J CLIN MICROBIOL, V43, P472, DOI 10.1128/JCM.43.1.472-475.2005; Rodriguez C, 2016, ADV EXP MED BIOL, V932, P65, DOI 10.1007/5584_2016_27; Shen A, 2012, J INNATE IMMUN, V4, P149, DOI 10.1159/000332946; Spigaglia P, 2002, J CLIN MICROBIOL, V40, P3470, DOI 10.1128/JCM.40.9.3470-3475.2002; Spigaglia P, 2008, J MED MICROBIOL, V57, P784, DOI 10.1099/jmm.0.47738-0; Spigaglia P, 2016, THER ADV INFECT DIS, V3, P23, DOI 10.1177/2049936115622891; Spigaglia P, 2015, ANAEROBE, V31, P42, DOI 10.1016/j.anaerobe.2014.10.003; Stein K, 2017, ANAEROBE, V48, P237, DOI 10.1016/j.anaerobe.2017.10.004; Stubbs SLJ, 1999, J CLIN MICROBIOL, V37, P461, DOI 10.1128/JCM.37.2.461-463.1999; Suo JJ, 2017, INFECT CONT HOSP EP, V38, P1383, DOI 10.1017/ice.2017.206; Tang CJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep37865; Wu YC, 2016, INT J MED MICROBIOL, V306, P115, DOI 10.1016/j.ijmm.2016.02.002; Yan Q, 2013, EPIDEMIOL INFECT, V141, P195, DOI 10.1017/S0950268812000453; Zhang WH, 2017, MICROB DRUG RESIST, V23, P687, DOI 10.1089/mdr.2016.0119	43	13	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0212965	10.1371/journal.pone.0212965	http://dx.doi.org/10.1371/journal.pone.0212965			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807599	Green Published, Green Submitted, gold			2022-12-27	WOS:000459712100030
J	Monmai, C; You, S; Park, WJ				Monmai, Chaiwat; You, SangGuan; Park, Woo Jung			Immune-enhancing effects of anionic macromolecules extracted from Codium fragile on cyclophosphamide-treated mice	PLOS ONE			English	Article							NF-KAPPA-B; IMMUNOMODULATORY ACTIVITY; IN-VITRO; INDUCED IMMUNOSUPPRESSION; SULFATED POLYSACCHARIDES; BIOLOGICAL-ACTIVITIES; PROTECTS; ACTIVATION; EXPRESSION; ANTITUMOR	Immune-regulation and homeostasis are critical in cancer therapy and immunomodulatory biomaterials have been used to decrease side effects of immunosuppressant drugs. Anionic macromolecules (CFAMs) were isolated from the seaweed Codium fragile, and its immune-enhancing biological activities were examined in CY-induced immunosuppressed mice. CFAMs improved the splenic lymphocyte proliferation, NK cell activity, and spleen index. The expression of immune-associated genes was highly upregulated in splenic lymphocytes, and gene expression was differently regulated according to mitogens such as T-cell (Con A) and B-cell (LPS) mitogens. Additionally, CFAMs boosted the proliferation, NO production, and phagocytosis of peritoneal macrophages. CFAMs also considerably stimulated immune-associated gene expression in peritoneal macrophages. Moreover, our results showed CFAMs mediated its immune-enhancing effects via the MAPK pathway. These suggested CFAMs can be used as a potent immunomodulatory material under immune-suppressive condition. Furthermore, CFAMs may also be used as a bio-functional and pharmaceutical material for improving human health and immunity.	[Monmai, Chaiwat; You, SangGuan; Park, Woo Jung] Gangneung Wonju Natl Univ, Dept Marine Food Sci & Technol, Kangnung, Gangwon, South Korea	Kangnung Wonju National University	Park, WJ (corresponding author), Gangneung Wonju Natl Univ, Dept Marine Food Sci & Technol, Kangnung, Gangwon, South Korea.	pwj0505@gwnu.ac.kr		Monmai, Chaiwat/0000-0002-9267-3047	Marine Bio-Regional Specialization Leading Technology Development Program - Ministry of Oceans and Fisheries in Korea [D11413914H480000100]; University Emphasis Research Institute Support Program from the National Research Foundation of Korea [2018R1A6A1A03023584]	Marine Bio-Regional Specialization Leading Technology Development Program - Ministry of Oceans and Fisheries in Korea; University Emphasis Research Institute Support Program from the National Research Foundation of Korea(National Research Foundation of Korea)	This study was supported by the Marine Bio-Regional Specialization Leading Technology Development Program (D11413914H480000100) funded by the Ministry of Oceans and Fisheries in Korea. This research project also is supported by the University Emphasis Research Institute Support Program (2018R1A6A1A03023584) from the National Research Foundation of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAR HD, 1986, CANCER RES, V46, P1805; Bhattacharyya S, 2010, BLOOD, V115, P1921, DOI 10.1182/blood-2009-06-224782; Cao RA, 2017, INT J BIOL MACROMOL, V99, P539, DOI 10.1016/j.ijbiomac.2017.03.026; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chen JR, 2010, FITOTERAPIA, V81, P1117, DOI 10.1016/j.fitote.2010.07.009; Chen XM, 2012, CARBOHYD POLYM, V90, P1114, DOI 10.1016/j.carbpol.2012.06.052; Cho CW, 2015, INT J BIOL MACROMOL, V72, P519, DOI 10.1016/j.ijbiomac.2014.09.010; Choi JH, 2013, BIOCHIMIE, V95, P1266, DOI 10.1016/j.biochi.2013.01.023; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Daien CI, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00548; Iida Y, 2017, CANCER SCI, V108, P1974, DOI 10.1111/cas.13337; Jesenak M, 2017, NUTRIENTS, V9, DOI 10.3390/nu9070779; Kang CH, 2012, J MED FOOD, V15, P44, DOI 10.1089/jmf.2010.1540; Kim JK, 2011, INT J BIOL MACROMOL, V49, P1051, DOI 10.1016/j.ijbiomac.2011.08.032; Kim JB, 2007, BIOL PHARM BULL, V30, P2345, DOI 10.1248/bpb.30.2345; Lee EJ, 2004, INT IMMUNOPHARMACOL, V4, P235, DOI 10.1016/j.intimp.2003.12.007; Lee JB, 2010, CARBOHYD RES, V345, P1452, DOI 10.1016/j.carres.2010.02.026; Liu XH, 2017, CURR PHARM BIOTECHNO, V18, P1106, DOI 10.2174/1389201019666180226145427; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lori A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061216; Manosroi A, 2003, J ETHNOPHARMACOL, V89, P155, DOI 10.1016/S0378-8741(03)00278-2; MOSMANN TR, 1989, ADV IMMUNOL, V46, P111, DOI 10.1016/S0065-2776(08)60652-5; Narayanan BA, 2003, CANCER RES, V63, P972; Park HR, 2013, INT J MOL MED, V31, P361, DOI 10.3892/ijmm.2012.1224; Pass GJ, 2005, CANCER RES, V65, P4211, DOI 10.1158/0008-5472.CAN-04-4103; Patel S, 2017, INT J BIOL MACROMOL, V97, P331, DOI 10.1016/j.ijbiomac.2017.01.042; Prendergast GC, 2007, CANCER RES, V67, P3500, DOI 10.1158/0008-5472.CAN-06-4626; Quakyi EK, 1999, J INFECT DIS, V180, P747, DOI 10.1086/314927; Rahat MA, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00144; Raj S, 2015, FOOD CHEM TOXICOL, V81, P151, DOI 10.1016/j.fct.2015.04.026; Ray Avijit, 2010, J Vis Exp, DOI 10.3791/1488; Ren Z, 2014, J ETHNOPHARMACOL, V155, P769, DOI 10.1016/j.jep.2014.06.021; Sarangi I, 2006, INT IMMUNOPHARMACOL, V6, P1287, DOI 10.1016/j.intimp.2006.04.002; Sevag MG, 1938, J BIOL CHEM, V124, P0425; SINGH KP, 1993, IMMUNOPHARM IMMUNOT, V15, P525, DOI 10.3109/08923979309019729; Sun YX, 2011, CARBOHYD POLYM, V85, P490, DOI 10.1016/j.carbpol.2011.03.033; Surayot U, 2017, INT J BIOL MACROMOL, V98, P117, DOI 10.1016/j.ijbiomac.2017.01.108; Tabarsa M, 2015, MAR BIOTECHNOL, V17, P266, DOI 10.1007/s10126-015-9615-2; Tabarsa M, 2013, INT J BIOL MACROMOL, V59, P1, DOI 10.1016/j.ijbiomac.2013.04.022; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tu J, 2008, J ETHNOPHARMACOL, V119, P266, DOI 10.1016/j.jep.2008.07.007; Tzianabos AO, 2000, CLIN MICROBIOL REV, V13, P523, DOI 10.1128/CMR.13.4.523-533.2000; Umesue M, 1996, TRANSPLANTATION, V61, P116, DOI 10.1097/00007890-199601150-00023; Walls J, 2016, SEMIN IMMUNOL, V28, P396, DOI 10.1016/j.smim.2016.09.001; Wang H, 2011, INT IMMUNOPHARMACOL, V11, P1946, DOI 10.1016/j.intimp.2011.06.006; Wang JX, 2012, J ETHNOPHARMACOL, V139, P788, DOI 10.1016/j.jep.2011.12.019; WEEKS BA, 1987, DEV COMP IMMUNOL, V11, P117, DOI 10.1016/0145-305X(87)90013-9; Yu ZD, 2016, CARBOHYD POLYM, V148, P318, DOI 10.1016/j.carbpol.2016.04.068; Zheng Y, 2017, INT J BIOL MACROMOL, V95, P1216, DOI 10.1016/j.ijbiomac.2016.11.013	50	16	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0211570	10.1371/journal.pone.0211570	http://dx.doi.org/10.1371/journal.pone.0211570			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779763	Green Published, gold, Green Submitted			2022-12-27	WOS:000459062900016
J	Kato, S; Takahashi, A; Shindo, M; Yoshida, A; Kawamura, T; Matsumoto, K; Matsuura, B				Kato, Shinichi; Takahashi, Aoi; Shindo, Mai; Yoshida, Ayano; Kawamura, Tomoe; Matsumoto, Kenjiro; Matsuura, Bunzo			Characterization of the gastric motility response to human motilin and erythromycin in human motilin receptor-expressing transgenic mice	PLOS ONE			English	Article							GASTROINTESTINAL CONTRACTILE ACTIVITY; SMOOTH-MUSCLE; MOLECULAR CHARACTERIZATION; SUNCUS-MURINUS; HUMAN STOMACH; MOUSE MODEL; PRECURSOR; AGONIST; GASTROPARESIS; PATHWAYS	Motilin is a gastrointestinal peptide hormone that stimulates gastrointestinal motility. Motilin is produced primarily in the duodenum and jejunum. Motilin receptors (MTLRs) are G protein-coupled receptors that may represent a clinically useful pharmacological target as they can be activated by erythromycin. The functions of motilin are highly species-dependent and remain poorly understood. As a functional motilin system is absent in rodents such as rats and mice, these species are not commonly used for basic studies. In this study, we examine the usefulness of human MTLR-overexpressing transgenic (hMTLR-Tg) mice by identifying the mechanisms of the gastric motor response to human motilin and erythromycin. The distribution of hMTLR was examined immunohistochemically in male wild-type (WT) and hMTLR-Tg mice. The contractile response of gastric strips was measured isometrically in an organ bath, while gastric emptying was determined using phenol red. hMTLR expression was abundant in the gastric smooth muscle layer. Interestingly, higher levels of hMTLR expression were observed in the myenteric plexus of hMTLR-Tg mice but not WT mice. hMTLR was not co-localized with vesicular acetylcholine transporter, a marker of cholinergic neurons in the myenteric plexus. Treatment with human motilin and erythromycin caused concentration-dependent contraction of gastric strips obtained from hMTLR-Tg mice but not from WT mice. The contractile response to human motilin and erythromycin in hMTLR-Tg mice was affected by neither atropine nor tetrodotoxin and was totally absent in Ca2+-free conditions. Furthermore, intraperitoneal injection of erythromycin significantly promoted gastric emptying in hMTLR-Tg mice but not in WT mice. Human motilin and erythromycin stimulate gastric smooth muscle contraction in hMTLR-Tg mice. This action is mediated by direct contraction of smooth muscle via the influx of extracellular Ca2+. Thus, hMTLR-Tg mice may be useful for the evaluation of MTLR agonists as gastric prokinetic agents.	[Kato, Shinichi; Takahashi, Aoi; Shindo, Mai; Yoshida, Ayano; Matsumoto, Kenjiro] Kyoto Pharmaceut Univ, Dept Pharmacol & Expt Therapeut, Div Pathol Sci, Yamashina Ku, Kyoto, Japan; [Kawamura, Tomoe] Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon, Ehime, Japan; [Matsuura, Bunzo] Ehime Univ, Grad Sch Med, Dept Lifestylerelated Med & Endocrinol, Toon, Ehime, Japan	Kyoto Pharmaceutical University; Ehime University; Ehime University	Kato, S (corresponding author), Kyoto Pharmaceut Univ, Dept Pharmacol & Expt Therapeut, Div Pathol Sci, Yamashina Ku, Kyoto, Japan.	skato@mb.kyoto-phu.ac.jp						BANFIELD DK, 1992, BIOCHIM BIOPHYS ACTA, V1131, P341, DOI 10.1016/0167-4781(92)90038-2; Broad J, 2012, BRIT J PHARMACOL, V167, P763, DOI 10.1111/j.1476-5381.2012.02009.x; Broad J, 2013, BRIT J PHARMACOL, V168, P1859, DOI 10.1111/bph.12077; BROWN JC, 1973, CAN J BIOCHEM CELL B, V51, P533, DOI 10.1139/o73-066; Coulie B, 1998, GUT, V43, P395, DOI 10.1136/gut.43.3.395; Dass NB, 2003, BRIT J PHARMACOL, V140, P948, DOI 10.1038/sj.bjp.0705505; Dudani A, 2016, J COMP PHYSIOL B, V186, P665, DOI 10.1007/s00360-016-0985-1; Farrugia G, 1997, AM J PHYSIOL-GASTR L, V273, pG404, DOI 10.1152/ajpgi.1997.273.2.G404; Feighner SD, 1999, SCIENCE, V284, P2184, DOI 10.1126/science.284.5423.2184; Folwaczny C, 2001, EUR J ENDOCRINOL, V144, pR1, DOI 10.1530/eje.0.144R001; He J, 2010, J MOL ENDOCRINOL, V44, P37, DOI 10.1677/JME-09-0095; Huang J, 2005, AM J PHYSIOL-GASTR L, V288, pG23, DOI 10.1152/ajpgi.00305.2004; ITOH Z, 1978, AM J DIG DIS, V23, P929, DOI 10.1007/BF01072469; ITOH Z, 1984, AM J PHYSIOL, V247, pG688, DOI 10.1152/ajpgi.1984.247.6.G688; ITOH Z, 1976, SCAND J GASTROENTERO, V11, P93; James AN, 2004, AM J PHYSIOL-GASTR L, V287, pG612, DOI 10.1152/ajpgi.00431.2003; JANSSENS J, 1983, REGUL PEPTIDES, V6, P363, DOI 10.1016/0167-0115(83)90265-3; Jarvie EM, 2007, BRIT J PHARMACOL, V150, P455, DOI 10.1038/sj.bjp.0707118; KHAN N, 1990, BIOCHEMISTRY-US, V29, P5743, DOI 10.1021/bi00476a015; KITAZAWA T, 1994, BRIT J PHARMACOL, V111, P288, DOI 10.1111/j.1476-5381.1994.tb14058.x; LEE KY, 1983, AM J PHYSIOL, V245, pG547, DOI 10.1152/ajpgi.1983.245.4.G547; LUX G, 1976, SCAND J GASTROENTERO, V11, P75; Matsumoto K, 2011, NEUROSCIENCE, V172, P518, DOI 10.1016/j.neuroscience.2010.10.024; Matsumoto K, 2018, AM J PHYSIOL-GASTR L, V315, pG104, DOI 10.1152/ajpgi.00305.2017; Matsumoto K, 2008, BIOL PHARM BULL, V31, P1917, DOI 10.1248/bpb.31.1917; MATTHIJS G, 1988, REGUL PEPTIDES, V21, P321, DOI 10.1016/0167-0115(88)90015-8; Miller P, 2000, AM J PHYSIOL-GASTR L, V278, pG18, DOI 10.1152/ajpgi.2000.278.1.G18; Mondal A, 2011, NEUROGASTROENT MOTIL, V23, P1123, DOI 10.1111/j.1365-2982.2011.01801.x; Nunoi H, 2012, REGUL PEPTIDES, V176, P28, DOI 10.1016/j.regpep.2012.03.001; Ozaki K, 2009, EUR J PHARMACOL, V615, P185, DOI 10.1016/j.ejphar.2009.04.059; PEETERS T, 1989, AM J PHYSIOL, V257, pG470, DOI 10.1152/ajpgi.1989.257.3.G470; PEETERS TL, 1991, N-S ARCH PHARMACOL, V343, P202, DOI 10.1007/BF00168611; Sanger GJ, 2011, TRENDS PHARMACOL SCI, V32, P402, DOI 10.1016/j.tips.2011.03.009; SATOH M, 1994, J PHARMACOL EXP THER, V271, P574; Takeshita E, 2006, J GASTROENTEROL, V41, P223, DOI 10.1007/s00535-005-1739-0; Tanaka T, 1998, J PHARMACOL EXP THER, V287, P712; ter Beek WP, 2008, INFLAMM BOWEL DIS, V14, P612, DOI 10.1002/ibd.20364; Tsutsui C, 2009, PEPTIDES, V30, P318, DOI 10.1016/j.peptides.2008.10.006; Van Assche G, 2001, NEUROGASTROENT MOTIL, V13, P27, DOI 10.1046/j.1365-2982.2001.00237.x; VanAssche G, 1997, EUR J PHARMACOL, V337, P267, DOI 10.1016/S0014-2999(97)01317-4; Xu L, 2003, PEPTIDES, V24, P1387, DOI 10.1016/j.peptides.2003.09.005; Xu L, 2001, FEBS LETT, V490, P7, DOI 10.1016/S0014-5793(01)02125-1	42	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0205939	10.1371/journal.pone.0205939	http://dx.doi.org/10.1371/journal.pone.0205939			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789939	Green Submitted, gold, Green Published			2022-12-27	WOS:000459330800004
J	Chen, IH; Zhao, QQ; Long, YF; Lu, Q; Huang, CR				Chen, I-Hsuan; Zhao, Qingqing; Long, Yunfei; Lu, Qin; Huang, Chu-Ren			Mandarin Chinese modality exclusivity norms	PLOS ONE			English	Article							LANGUAGE; SYNAESTHESIA; ADJECTIVES; WORDS; TASTE	Modality exclusivity norms have been developed in different languages for research on the relationship between perceptual and conceptual systems. This paper sets up the first modality exclusivity norms for Chinese, a Sino-Tibetan language with semantics as its orthographically relevant level. The norms are collected through two studies based on Chinese sensory words. The experimental designs take into consideration the morpho-lexical and orthographic structures of Chinese. Study 1 provides a set of norms for Mandarin Chinese single-morpheme words in mean ratings of the extent to which a word is experienced through the five sense modalities. The degrees of modality exclusivity are also provided. The collected norms are further analyzed to examine how sub-lexical orthographic representations of sense modalities in Chinese characters affect speakers' interpretation of the sensory words. In particular, we found higher modality exclusivity rating for the sense modality explicitly represented by a semantic radical component, as well as higher auditory dominant modality rating for characters with transparent phonetic symbol components. Study 2 presents the mean ratings and modality exclusivity of coordinate disyllabic compounds involving multiple sense modalities. These studies open new perspectives in the study of modality exclusivity. First, links between modality exclusivity and writing systems have been established which has strengthened previous accounts of the influence of orthography in the processing of visual information in reading. Second, a new set of modality exclusivity norms of compounds is proposed to show the competition of influence on modality exclusivity from different linguistic factors and potentially allow such norms to be linked to studies on synesthesia and semantic transparency.	[Chen, I-Hsuan; Zhao, Qingqing; Huang, Chu-Ren] Hong Kong Polytech Univ, Dept Chinese & Bilingual Studies, Kowloon, Hong Kong, Peoples R China; [Zhao, Qingqing; Lu, Qin] Chinese Acad Social Sci, Inst Linguist, Beijing, Peoples R China; [Long, Yunfei] Hong Kong Polytech Univ, Dept Comp, Kowloon, Hong Kong, Peoples R China; [Long, Yunfei] Univ Nottingham, NIHR Nottingham Biomed Res Ctr Nottingham, Nottingham, England	Hong Kong Polytechnic University; Chinese Academy of Social Sciences; Hong Kong Polytechnic University; University of Nottingham	Chen, IH; Huang, CR (corresponding author), Hong Kong Polytech Univ, Dept Chinese & Bilingual Studies, Kowloon, Hong Kong, Peoples R China.	ihcucb@gmail.com; churen.huang@polyu.edu.hk	LONG, YUNFEI/O-5784-2019; Huang, Chu-Ren/A-8757-2010	LONG, YUNFEI/0000-0002-4407-578X; Huang, Chu-Ren/0000-0002-8526-5520	Hong Kong Polytechnic University [1-YW1V, G-YBGM]; Chiang Ching-kuo Foundation for International Scholarly Exchange project [RG012-D-16]	Hong Kong Polytechnic University(Hong Kong Polytechnic University); Chiang Ching-kuo Foundation for International Scholarly Exchange project	The research was funded by Grant 1-YW1V and G-YBGM from The Hong Kong Polytechnic University and by Chiang Ching-kuo Foundation for International Scholarly Exchange project RG012-D-16. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barros-Loscertales A, 2012, CEREB CORTEX, V22, P2554, DOI 10.1093/cercor/bhr324; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Caselli T, 2012, P COLING 2012, P1239; Chen Keh-Jiann, 1996, P 11 PAC AS C LANG I, P167; Chou Y.-M., 2010, ONTOLOGY LEXICON NAT, P122, DOI [https://doi.org/10.1017/CBO9780511676536, DOI 10.1017/CBO9780511676536.009]; Connell L, 2007, COGNITION, V102, P476, DOI 10.1016/j.cognition.2006.02.009; Duan Y., 2007, COMMENTARY EXPLAININ; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Glenberg AM, 2002, PSYCHON B REV, V9, P558, DOI 10.3758/BF03196313; Goldberg RF, 2006, J NEUROSCI, V26, P4917, DOI 10.1523/JNEUROSCI.5389-05.2006; Huang C.-R., 2015, OXFORD HDB CHINESE L, P290; Huang C.-R., 2002, SENTENCE PROCESSING, P53; Huang Chu-Ren, 2016, REFERENCE GRAMMAR CH; Huang CR, 2009, 17 ANN C INT ASS CHI; Huang S.-Z., 2016, REFERENCE GRAMMAR CH; HUNG DL, 1981, PSYCHOL BULL, V90, P377, DOI 10.1037/0033-2909.90.3.377; Jo C, 2018, P WORKSH LING NEUR C, P38; Karlgren Bernhard, 1957, B MUSEUM FAR E ANTIQ, V29, P1; Kiefer M, 2008, J NEUROSCI, V28, P12224, DOI 10.1523/JNEUROSCI.3579-08.2008; Levinson SC, 2014, MIND LANG, V29, P407, DOI 10.1111/mila.12057; Lievers FS, 2018, LINGUA, V204, P45, DOI 10.1016/j.lingua.2017.11.002; Lievers FS, 2015, FUNCT LANG, V22, P69, DOI 10.1075/fol.22.1.04str; Louwerse M, 2011, COGNITIVE SCI, V35, P381, DOI 10.1111/j.1551-6709.2010.01157.x; Lynott D, 2013, BEHAV RES METHODS, V45, P516, DOI 10.3758/s13428-012-0267-0; Lynott D, 2009, BEHAV RES METHODS, V41, P558, DOI 10.3758/BRM.41.2.558; MANN VA, 1986, COGNITION, V24, P65, DOI 10.1016/0010-0277(86)90005-3; Marques JF, 2006, MEM COGNITION, V34, P60, DOI 10.3758/BF03193386; Newman SD, 2005, COGNITIVE BRAIN RES, V23, P235, DOI 10.1016/j.cogbrainres.2004.10.020; Pecher D., 2005, GROUNDING COGNITION; PERFETTI CA, 1991, J EXP PSYCHOL LEARN, V17, P633, DOI 10.1037/0278-7393.17.4.633; Popova Y, 2005, COGN LINGUIST RES, V29, P395; Saito S, 2008, J MEM LANG, V59, P1, DOI 10.1016/j.jml.2008.01.004; Shen Y, 1997, COGN LINGUIST, V8, P33, DOI 10.1515/cogl.1997.8.1.33; Simmons WK, 2007, NEUROPSYCHOLOGIA, V45, P2802, DOI 10.1016/j.neuropsychologia.2007.05.002; Speed LJ, 2017, BEHAV RES METHODS, V49, P2204, DOI 10.3758/s13428-017-0852-3; Sproat R., 2000, COMPUTATIONAL THEORY; TZENG OJL, 1977, J EXP PSYCHOL-HUM L, V3, P621, DOI 10.1037/0278-7393.3.6.621; TZENG OJL, 1983, AM SCI, V71, P238; van Dantzig S, 2011, BEHAV RES METHODS, V43, P145, DOI 10.3758/s13428-010-0038-8; Wang N., 1996, PRINCIPLE ETYMOLOGIC; Wang S, 2019, LANGUAGE LINGUISTICS, V20; WILLIAMS JM, 1976, LANGUAGE, V52, P461, DOI 10.2307/412571; Winter B, 2016, LANG COGN NEUROSCI, V31, P975, DOI 10.1080/23273798.2016.1193619; Xu S., 1963, EXPLAINING GRAPHS AN; Xu Z, 2010, GREAT COMPENDIUM CHI; Zhao Q., 2018, LANG TEACH LING STUD, V1, P44; Zhao QQ, 2018, LINGUISTICS, V56, P1167, DOI 10.1515/ling-2018-0019	47	23	23	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211336	10.1371/journal.pone.0211336	http://dx.doi.org/10.1371/journal.pone.0211336			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM2OT	30785906	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000459307000020
J	Pons, ED; Moraes, CG; Falavigna, M; Sirtori, LR; da Cruz, F; Webster, G; Dal Pizzol, TD				Pons, Emilia da Silva; Moraes, Cassia Garcia; Falavigna, Maicon; Sirtori, Lisana Reginini; da Cruz, Fernanda; Webster, Guilherme; Dal Pizzol, Tatiane da Silva			Users' preferences and perceptions of the comprehensibility and readability of medication labels	PLOS ONE			English	Article							DESIGN; YOUNGER; OLDER	Objective To evaluate the labeling preferences of medication users and characterize their perceptions of the comprehensibility and readability of medication labels. Methods We conducted a population-based cross-sectional study of medication users aged 18 years or older in 10 Brazilian capital cities. Perceptions of the comprehensibility and readability of medication labels in relation to sociodemographic characteristics were evaluated by Poisson regression models with robust variance. Labeling preferences were assessed through questions addressing possible improvements and through the use of digitally simulated packages. Results Of 6,255 medication users interviewed, more than half found it difficult or very difficult to read (50.8%) and/or understand (52.0%) medication labels. Difficulties were more pronounced for participants aged 40 years or older, with lower levels of education, and nonwhites. Increasing the font size (93.7%), describing the indications for use (95.9%) and contraindications (95.6%) on the label, and highlighting the expiration date (96.3%) were the most widely accepted improvements. In the evaluation of simulated packages, users preferred factors that improved readability, such as increased font size, use of graphic elements and color to highlight the concentration of the active ingredient, and contrast between the font color and background. The new simulated package design, with increased font size, color to highlight the concentration and contrast between the font color and background, was preferred over the standard design by 77.0% of participants. Conclusion Based on users' perceptions, increased font size and use of graphic elements and color to emphasize critical information, such as expiration date and concentration, are factors that contribute to making medication labels clearer to users. Pharmaceutical industries and policy makers should consider these items when developing labels and defining policies on this issue.	[Pons, Emilia da Silva; Moraes, Cassia Garcia; Falavigna, Maicon] HMV, Proadi SUS Res Projects Off, Porto Alegre, RS, Brazil; [Sirtori, Lisana Reginini] Brazilian Hlth Regulatory Agcy ANVISA, GGREG Gen Management Off Regulat & Good Regulator, Brasilia, DF, Brazil; [da Cruz, Fernanda] ANVISA, Gen Management Off Hlth Inspect & Surveillance, Brasilia, DF, Brazil; [Webster, Guilherme] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil; [Dal Pizzol, Tatiane da Silva] Univ Fed Rio Grande do Sul, Sch Pharm, Dept Prod & Control Med, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Pons, ED (corresponding author), HMV, Proadi SUS Res Projects Off, Porto Alegre, RS, Brazil.	emiliapons@yahoo.com.br			Program of Support for the Institutional Development of the Unified Health System (PROADI-SUS); Hospital Moinhos de Vento	Program of Support for the Institutional Development of the Unified Health System (PROADI-SUS); Hospital Moinhos de Vento	This work was supported by the Program of Support for the Institutional Development of the Unified Health System (PROADI-SUS) and Hospital Moinhos de Vento. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, ERR IS HUMAN; [Anonymous], 2017, MED HARM WHOS 3 GLOB; [Anonymous], 2016, SAF CONS PROD DES MI; Australian Government. Department of Health. Therapeutic Goods Administration, 2016, MED LAB GUID TGO 91; Bauer DT, 2011, INT J IND ERGONOM, V41, P394, DOI 10.1016/j.ergon.2011.02.005; Berman Adrienne, 2004, J Med Syst, V28, P9, DOI 10.1023/B:JOMS.0000021518.60670.10; Bohra A. S., 2006, Indian Journal of Pharmaceutical Sciences, V68, P677; Buckle P, 2006, APPL ERGON, V37, P491, DOI 10.1016/j.apergo.2006.04.016; Cho J, 2014, ASME P 26 INT C DES; Endestad T, 2016, HUM FACTORS, V58, P1206, DOI 10.1177/0018720816664824; European Commission, 1998, GUID READ LAB PACK L; Grime J, 2007, HEALTH EXPECT, V10, P286, DOI 10.1111/j.1369-7625.2007.00454.x; Health Canada, 2016, GOOD LAB PACK PRACT; Hellier E, 2006, ERGONOMICS, V49, P617, DOI 10.1080/00140130600568980; Hellier Elizabeth, 2010, J Patient Saf, V6, P158; Institute for Safe Medication Practices Canada (ISPM), 2013, LAB PACK AGGR AN MED; James JT, 2013, J PATIENT SAF, V9, P122, DOI 10.1097/PTS.0b013e3182948a69; Koo MM, 2003, ANN PHARMACOTHER, V37, P259, DOI 10.1177/106002800303700218; Medicines and Healthcare products Regulatory Agency, 2014, BEST PRACT GUID PAT; National Health Service. National Patient Safety Agency, 2008, DES PAT SAF GUID LAB; National Patient Safety Agency and the Helen Hamlyn Research Centre, 2007, DES PAT SAF GUID GRA; Shrank WH, 2007, ARCH INTERN MED, V167, P1760, DOI 10.1001/archinte.167.16.1760; Shrank WH, 2010, CONTEMP CLIN TRIALS, V31, P564, DOI 10.1016/j.cct.2010.07.004; Smither J A, 1994, J Clin Psychol Med Settings, V1, P149, DOI 10.1007/BF01999743; Vigilante W. J., 1997, DRUG INF J, V31, P973; Ward J, 2004, ASME P MED HEALTHCAR, V3, P459; WILKE T, 2011, PHARM MED, V25, P307; Wogalter MS, 2003, ERGONOMICS, V46, P327, DOI 10.1080/0014013021000048006; Wolf MS, 2007, PATIENT EDUC COUNS, V67, P293, DOI 10.1016/j.pec.2007.03.024; World Health Organization, 2016, MED ERR TECHN SER SA	30	2	2	6	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212173	10.1371/journal.pone.0212173	http://dx.doi.org/10.1371/journal.pone.0212173			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794574	Green Published, Green Submitted, gold			2022-12-27	WOS:000459709100042
J	Roure, S; Valerio, L; Soldevila, L; Salvador, F; Fernandez-Rivas, G; Sulleiro, E; Manosa, M; Sopena, N; Mate, JL; Clotet, B				Roure, Silvia; Valerio, Lluis; Soldevila, Laura; Salvador, Fernando; Fernandez-Rivas, Gema; Sulleiro, Elena; Manosa, Miriam; Sopena, Nieves; Luis Mate, Jose; Clotet, Bonaventura			Approach to amoebic colitis: Epidemiological, clinical and diagnostic considerations in a non-endemic context (Barcelona, 2007-2017)	PLOS ONE			English	Article							ENTAMOEBA-HISTOLYTICA; INVASIVE AMEBIASIS; PCR; INFECTION; MEN; SEX	Background Amoebic colitis is the most frequent clinical manifestation of invasive intestinal infection due to Entamoeba histolytica and a common cause of diarrhoea worldwide. Since higher transmission rates are usually related to poor health and exposure to unhygienic conditions, cases reported in Europe usually involve immigrants and international travellers. The goal of this study was to characterise both the clinical and the epidemiological features of a European population diagnosed with amoebic colitis and then to evaluate the diagnostic tools and therapeutic options applied. Methods and results This was a retrospective observational study in which data from all patients diagnosed with amoebic colitis attending at the International Health Units of two tertiary referral hospitals, Germans Trias i Pujol University Hospital (Badalona, North Barcelona Metropolitan Area) and Vall d'Hebron University Hospital (Barcelona city) between 2007 and 2017 were analysed. During the study period 50 patients were diagnosed with amoebic colitis. Thirty-six (72%) were men, and immigrants accounted for 46% of all cases. Antecedents of any international travel were reported for 28 (56%), the most frequent destinations having been the Indian subcontinent, South and Central America and sub-Saharan Africa. Preexisting pathological conditions or any kind of immunosuppression were identified in 29 (58%) patients; of these, 13 (26%) had HIV infection-all of them men who have sex with men- and 5 (10%) had inflammatory bowel disease. Diarrhoea, abdominal pain and dysentery were the most frequently recorded symptoms of invasive amoebae. Diagnosis was made through microbiological study in 45 (90%) and/or histological identification of amoebae in colon biopsies in 10 (20%). After treatment with metronidazole (82%) or tinidazole (8%), all patients had good outcomes. Post-acute intraluminal treatment was indicated in 28 (56%). Conclusions Amoebic colitis should be suspected in patients with diarrhoea and compatible epidemiological risk factors (immigration, travelling abroad or men who have sex with men), especially if some degree of immunosuppression concurs. These risk factors must be taken into account in any diagnostic approach to inflammatory bowel disease (IBD), and active searches for stool parasites should be performed in such cases to rule out misdiagnosis or simultaneous amoebic infection. Treatment should include intraluminal anti-amoebic treatment in order to avoid relapse and prevent further spread of the disease.	[Roure, Silvia; Soldevila, Laura] Univ Autonoma Barcelona, Germans Trias & Pujol Univ Hosp, North Metropolitan Int Hlth Unit PROSICS, Infect Dis Dept, Badalona, Spain; [Roure, Silvia; Valerio, Lluis] Inst Catala Salut, North Metropolitan Int Hlth Unit PROSICS, Barcelona, Spain; [Salvador, Fernando] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, PROSICS Barcelona, Infect Dis Dept, Barcelona, Spain; [Fernandez-Rivas, Gema] Autonomous Univ Barcelona, Germans Trias & Pujol Univ Hosp, Dept Genet & Microbiol, Microbiol Depatment,Clin Lab North Metropolitan A, Badalona, Spain; [Sulleiro, Elena] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, PROSICS Barcelona, Microbiol Dept, Barcelona, Spain; [Manosa, Miriam] Germans Trias & Pujol Univ Hosp, Inflammatory Bowel Dis Unit, Gastroenterol Dept, Badalona, Spain; [Manosa, Miriam] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Badalona, Spain; [Sopena, Nieves] Univ Autonoma Barcelona, Germans Trias & Pujol Univ Hosp, Infect Dis Dept, Badalona, Spain; [Luis Mate, Jose] Germans Trias & Pujol Univ Hosp, Dept Pathol Anat, Badalona, Spain; [Clotet, Bonaventura] Univ Autonoma Barcelona, Germans Trias & Pujol Univ Hosp, AIDS Res Inst IrsiCaixa, Infect Dis Dept, Badalona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Autonomous University of Barcelona; Autonomous University of Barcelona; Institut de Recerca de la Sida - IrsiCaixa	Roure, S (corresponding author), Univ Autonoma Barcelona, Germans Trias & Pujol Univ Hosp, North Metropolitan Int Hlth Unit PROSICS, Infect Dis Dept, Badalona, Spain.; Roure, S (corresponding author), Inst Catala Salut, North Metropolitan Int Hlth Unit PROSICS, Barcelona, Spain.	sroura.mn.ics@gencat.cat	SANZ, JOSE LUIS MATE/O-3158-2019	SANZ, JOSE LUIS MATE/0000-0002-4829-3426; Salvador, Fernando/0000-0002-0546-1354; Roure, Silvia/0000-0002-7982-0890; Sulleiro, Elena/0000-0002-9783-6060				ADAMS EB, 1977, MEDICINE, V56, P315, DOI 10.1097/00005792-197707000-00003; ADAMS EB, 1977, MEDICINE, V56, P325, DOI 10.1097/00005792-197707000-00004; [Anonymous], 2013, DRUGS PARASITIC INFE; Babic E, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3261-7; Beebeejaun K, 2017, EUROSURVEILLANCE, V22, P7, DOI 10.2807/1560-7917.ES.2017.22.5.30454; Bercu Tracy E, 2007, Curr Gastroenterol Rep, V9, P429, DOI 10.1007/s11894-007-0054-8; Evangelopoulos A, 2001, PARASITOL INT, V50, P185, DOI 10.1016/S1383-5769(01)00078-2; Hansen L H, 1998, Ugeskr Laeger, V160, P5514; Haque R, 1998, J CLIN MICROBIOL, V36, P449, DOI 10.1128/JCM.36.2.449-452.1998; Haque R, 2003, NEW ENGL J MED, V348, P1565, DOI 10.1056/NEJMra022710; Hung CC, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000175; Hung CC, 2012, LANCET INFECT DIS, V12, P729, DOI 10.1016/S1473-3099(12)70147-0; Keiser PB, 2004, CLIN MICROBIOL REV, V17, P208, DOI 10.1128/CMR.17.1.208-217.2004; Moran P, 2005, AM J TROP MED HYG, V73, P296, DOI 10.4269/ajtmh.2005.73.296; Petri WA, 2002, ANNU REV MICROBIOL, V56, P39, DOI 10.1146/annurev.micro.56.012302.160959; Petridou Christina, 2017, Infez Med, V25, P281; PRATHAP K, 1970, AM J PATHOL, V60, P229; Pritt BS, 2008, MAYO CLIN PROC, V83, P1154, DOI 10.4065/83.10.1154; Shirley DA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004879; Stanley SL, 2003, LANCET, V361, P1025, DOI 10.1016/S0140-6736(03)12830-9; Stark D, 2008, EMERG INFECT DIS, V14, P1141, DOI 10.3201/eid1407.080017; Toh Yoon Ezekiel Wong, 2016, BMJ Case Rep, V2016, DOI 10.1136/bcr-2016-218570; Uslu H, 2016, EURASIAN J MED, V48, P124, DOI 10.5152/eurasianjmed.2015.0074; Verge L, 2017, EUROSURVEILLANCE, V22, DOI [10.2807/1560-7917.ES.2017.22.3030581, DOI 10.2807/1560-7917.ES.2017.22.3030581]; Weitzel T., 2017, New Microbes and New Infections, V18, P50, DOI 10.1016/j.nmni.2017.05.002	25	15	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212791	10.1371/journal.pone.0212791	http://dx.doi.org/10.1371/journal.pone.0212791			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789955	gold, Green Submitted, Green Published			2022-12-27	WOS:000459330800052
J	Granados-Garcia, V; Flores, YN; Diaz-Trejo, LI; Mendez-Sanchez, L; Liu, S; Salinas-Escudero, G; Toledano-Toledano, F; Salmeron, J				Granados-Garcia, Victor; Flores, Yvonne N.; Diaz-Trejo, Lizbeth I.; Mendez-Sanchez, Lucia; Liu, Stephanie; Salinas-Escudero, Guillermo; Toledano-Toledano, Filiberto; Salmeron, Jorge			Estimating the prevalence of hepatitis C among intravenous drug users in upper middle income countries: A systematic review and meta-analysis	PLOS ONE			English	Review							RIO-DE-JANEIRO; VIRUS-INFECTION; HCV INFECTION; RISK-FACTORS; GLOBAL EPIDEMIOLOGY; INJECT DRUGS; B-VIRUS; HIV; TRANSMISSION; PEOPLE	Aim This systematic review and meta-analysis characterizes the prevalence of hepatitis C virus (HCV) infection among intravenous drug users (IDUs) in upper middle-income countries. Methods Five databases were searched from 1990-2016 for studies that took place in countries with a GDP per capita of $7,000 to $13,000 USD. The data extraction was performed based on information regarding prevalence, sample size, age of participants, duration of intravenous drug use (IDU), recruitment location, dates of data collection, study design, sampling scheme, type of tests used in identifying antibody reactivity to HCV, and the use of confirmatory tests. The synthesis was performed with a random effects model. The Cochrane statistical Q-test was used to evaluate the statistical heterogeneity of the results. Results The 33 studies included in the analysis correspond to a sample of seven countries and 23,342 observations. The point prevalence value estimates and confidence intervals of the random effects model were 0.729 and 0.644-0.800, respectively for all seven countries, and were greatest for China (0.633; 0.522-0.732) as compared to Brazil (0.396; 0.249-0.564). Prevalence for Montenegro (0.416; 0.237-0.621) and Malaysia (0.475; 0.177-0.792) appear to be intermediate. Mexico (0.960) and Mauritania (0.973) had only one study with the largest prevalence. A clear association was not observed between age or duration of IDU and prevalence of HCV, but the data from some groups may indicate a possible relationship. The measures of heterogeneity (Q and I2) suggest a high level of heterogeneity in studies conducted at the country level and by groups of countries. Conclusions In this systematic review and meta-analysis, we found that the pooled prevalence of HCV was high (0.729) among a group of seven upper middle income countries. However, there was significant variation in the prevalence of HCV observed in China (0.633) and Brazil (0.396).	[Granados-Garcia, Victor] IMSS, Ctr Med Nacl Siglo 21, Unidad Invest Epidemiol, Mexico City, DF, Mexico; [Granados-Garcia, Victor] IMSS, Ctr Med Nacl Siglo 21, Serv Salud Area Envejecimiento, Mexico City, DF, Mexico; [Flores, Yvonne N.; Liu, Stephanie] Inst Mexicano Seguro Social, Unidad Invest Epidemiol & Serv Salud, Cuernavaca, Morelos, Mexico; [Flores, Yvonne N.] Univ Calif Los Angeles, Dept Hlth Policy & Management, Fielding Sch Publ Hlth, Los Angeles, CA USA; [Flores, Yvonne N.] Jonsson Comprehens Canc Ctr, Los Angeles, CA 90034 USA; [Diaz-Trejo, Lizbeth I.] Secretaria Salud Mexico, Ctr Nacl Programas Prevent & Control Enfermedades, Mexico City, DF, Mexico; [Mendez-Sanchez, Lucia] Hosp Infantil Mexico Dr Federico Gomez, Inst Nacl Salud, Unidad Epidemiol Clin, Mexico City, DF, Mexico; [Mendez-Sanchez, Lucia] Univ Nacl Autonoma Mexico, Fac Med, Mexico City, DF, Mexico; [Liu, Stephanie] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Salinas-Escudero, Guillermo] Hosp Infantil Mexico Dr Federico Gomez, Ctr Estudios Econ & Soiciales Salud, Mexico City, DF, Mexico; [Toledano-Toledano, Filiberto] Hosp Infantil Mexico Dr Federico Gomez, Unidad Invest Med Basada Evidencias, Inst Nacl Salud, Mexico City, DF, Mexico; [Salmeron, Jorge] Univ Nacl Autonoma Mexico, Fac Med, Ctr Invest Polit Poblac & Salud, Mexico City, DF, Mexico; [Salmeron, Jorge] Inst Nacl Salud Publ, Ctt Invest Salud Poblac, Cuernavaca, Morelos, Mexico	Instituto Mexicano del Seguro Social; Instituto Mexicano del Seguro Social; Instituto Mexicano del Seguro Social; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; Hospital Infantil de Mexico Federico Gomez; Universidad Nacional Autonoma de Mexico; University of Washington; University of Washington Seattle; Hospital Infantil de Mexico Federico Gomez; Hospital Infantil de Mexico Federico Gomez; Universidad Nacional Autonoma de Mexico; Instituto Nacional de Salud Publica	Granados-Garcia, V (corresponding author), IMSS, Ctr Med Nacl Siglo 21, Unidad Invest Epidemiol, Mexico City, DF, Mexico.; Granados-Garcia, V (corresponding author), IMSS, Ctr Med Nacl Siglo 21, Serv Salud Area Envejecimiento, Mexico City, DF, Mexico.	vic.granados@gmail.com	Toledano-Toledano, Filiberto/W-1886-2019; Salinas, Guillermo/AGX-9751-2022; Granados-García, Víctor/AAR-5788-2020	Toledano-Toledano, Filiberto/0000-0002-7126-5351; Salinas, Guillermo/0000-0003-4573-4844; Granados-García, Víctor/0000-0002-9075-576X; Mendez-Sanchez, Lucia/0000-0001-7569-2310	Instituto Mexicano del Seguro Social [FIS/IMSS/PROT/MD15/1507]; NATIONAL CANCER INSTITUTE [K07CA197179] Funding Source: NIH RePORTER	Instituto Mexicano del Seguro Social; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by Instituto Mexicano del Seguro Social (Grant number: FIS/IMSS/PROT/MD15/1507 to VGG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceijas C, 2007, INT J DRUG POLICY, V18, P352, DOI 10.1016/j.drugpo.2007.04.004; Oliveira MDA, 2009, J CLIN VIROL, V44, P200, DOI 10.1016/j.jcv.2008.12.008; Alonso M, 2015, INT J PUBLIC HEALTH, V60, P789, DOI 10.1007/s00038-015-0708-5; Bacak V, 2013, EUR ADDICT RES, V19, P68, DOI 10.1159/000339840; Bao YP, 2012, JAIDS-J ACQ IMM DEF, V60, P438, DOI 10.1097/QAI.0b013e31825694f2; Bao YP, 2012, AM J DRUG ALCOHOL AB, V38, P140, DOI 10.3109/00952990.2011.643984; Baozhang T, 1997, EPIDEMIOL INFECT, V119, P343, DOI 10.1017/S0950268897007784; Pacheco SDB, 2014, REV SOC BRAS MED TRO, V47, P367, DOI 10.1590/0037-8682-0153-2013; Barendregt JJ, 2013, J EPIDEMIOL COMMUN H, V67, P974, DOI 10.1136/jech-2013-203104; Bastos FI, 2000, INT J STD AIDS, V11, P383, DOI 10.1258/0956462001916100; Caiaffa Waleska Teixeira, 2006, Cad. Saúde Pública, V22, P771, DOI 10.1590/S0102-311X2006000400016; Contreras AM, 2012, REV INVEST CLIN, V64, P641; Contreras AM, 2008, TRANSFUSION, V48, P2540, DOI 10.1111/j.1537-2995.2008.01886.x; Crofts N, 1997, J EPIDEMIOL COMMUN H, V51, P692, DOI 10.1136/jech.51.6.692; deCarvalho HB, 1996, J ACQ IMMUN DEF SYND, V12, P84, DOI 10.1097/00042560-199605010-00012; Garten RJ, 2004, INT J EPIDEMIOL, V33, P182, DOI 10.1093/ije/dyh019; Hagan H, 2000, MT SINAI J MED, V67, P423; Hagan H, 1998, SUBST USE MISUSE, V33, P1197, DOI 10.3109/10826089809062214; Hagan H, 2007, INT J DRUG POLICY, V18, P341, DOI 10.1016/j.drugpo.2007.01.016; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Howe CJ, 2005, DRUG ALCOHOL DEPEN, V79, P389, DOI 10.1016/j.drugalcdep.2005.03.004; Hser Y, 2012, J PUBLIC HEALTH-UK, V34, P24, DOI 10.1093/pubmed/fdr098; Johnston L, 2011, INT J DRUG POLICY, V22, P252, DOI 10.1016/j.drugpo.2011.05.007; Judd A, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-14; Lausevic D, 2015, HARM REDUCT J, V12, DOI 10.1186/s12954-015-0039-0; Li Jianrong, 2006, J Huazhong Univ Sci Technolog Med Sci, V26, P221; Li L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106899; Lopes Carmen L R, 2009, Rev. Saúde Pública, V43, P43, DOI 10.1590/S0034-89102009000800008; Malekinejad M, 2015, INT J INFECT DIS, V40, P116, DOI 10.1016/j.ijid.2015.09.022; Mathei C, 2002, J VIRAL HEPATITIS, V9, P157, DOI 10.1046/j.1365-2893.2002.00339.x; Mathei C, 2005, ACTA GASTRO-ENT BELG, V68, P50; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Ng K P, 1995, Med J Malaysia, V50, P302; Oliveira MLA, 2009, EPIDEMIOL INFECT, V137, P970, DOI 10.1017/S0950268808001970; Palmateer NE, 2013, INT J DRUG POLICY, V24, P85, DOI 10.1016/j.drugpo.2012.08.006; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Petruzziello A, 2016, WORLD J GASTROENTERO, V22, P7824, DOI 10.3748/wjg.v22.i34.7824; Ramia S, 2012, INFECTION, V40, P1, DOI 10.1007/s15010-011-0236-z; Razavi H, 2013, HEPATOLOGY, V57, P2164, DOI 10.1002/hep.26218; Rodriguez CM, 2002, AIDS, V16, pS34, DOI 10.1097/00002030-200212003-00006; Roy K, 2002, EPIDEMIOL INFECT, V129, P577, DOI 10.1017/S0950268802007902; Ruan YH, 2004, WORLD J GASTROENTERO, V10, P1589, DOI 10.3748/wjg.v10.i11.1589; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Silva MBS, 2010, MEM I OSWALDO CRUZ, V105, P299, DOI 10.1590/S0074-02762010000300009; Stern RK, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-62; Tan Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003608; Tao YL, 2013, WORLD J GASTROENTERO, V19, P5320, DOI 10.3748/wjg.v19.i32.5320; The Joanna Briggs Institute, 2014, J BRIGGS I SYST REV; The World Bank, 2015, DOES WORLD BANK CLAS; Tortu S, 2001, SUBST USE MISUSE, V36, P523, DOI 10.1081/JA-100102640; Vassilev ZP, 2006, INT J STD AIDS, V17, P621, DOI 10.1258/095646206778113041; Vicknasingam B, 2009, DRUG ALCOHOL REV, V28, P447, DOI 10.1111/j.1465-3362.2009.00087.x; White EF, 2007, SALUD PUBLICA MEXICO, V49, P165, DOI 10.1590/S0036-36342007000300001; Wiessing L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103345; World Health Organization, 2008, GLOB BURD DIS 2004 U; Wu J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-657; Xia X, 2008, PUBLIC HEALTH, V122, P990, DOI 10.1016/j.puhe.2008.01.014; Xu CJ, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1808-0; Zhang L, 2013, HARM REDUCT J, V10, DOI 10.1186/1477-7517-10-8; Zhou YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016349; Zhou YB, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-134; Zhou Yuebin, 2012, Proceedings of the CSEE, V32, P8; Zocratto Keli Bahia Felicíssimo, 2006, Cad. Saúde Pública, V22, P839, DOI 10.1590/S0102-311X2006000400022	63	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0212558	10.1371/journal.pone.0212558	http://dx.doi.org/10.1371/journal.pone.0212558			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8EU	30807590	Green Published, Green Submitted, gold			2022-12-27	WOS:000459712100017
J	Diaz, M; Novo, J; Cutrin, P; Gomez-Ulla, F; Penedo, MG; Ortega, M				Diaz, Macarena; Novo, Jorge; Cutrin, Paula; Gomez-Ulla, Francisco; Penedo, Manuel G.; Ortega, Marcos			Automatic segmentation of the foveal avascular zone in ophthalmological OCT-A images	PLOS ONE			English	Article							WEB-BASED SYSTEM; DIAGNOSIS	Angiography by Optical Coherence Tomography (OCT-A) is a non-invasive retinal imaging modality of recent appearance that allows the visualization of the vascular structure at predefined depths based on the detection of the blood movement through the retinal vasculature. In this way, OCT-A images constitute a suitable scenario to analyze the retinal vascular properties of regions of interest as is the case of the macular area, measuring the characteristics of the foveal vascular and avascular zones. Extracted parameters of this region can be used as prognostic factors that determine if the patient suffers from certain pathologies (such as diabetic retinopathy or retinal vein occlusion, among others), indicating the associated pathological degree. The manual extraction of these biomedical parameters is a long, tedious and subjective process, introducing a significant intra and inter expert variability, which penalizes the utility of the measurements. In addition, the absence of tools that automatically facilitate these calculations encourages the creation of computer -aided diagnosis frameworks that ease the doctor's work, increasing their productivity and making viable the use of this type of vascular biomarkers. In this work we propose a fully automatic system that identifies and precisely segments the region of the foveal avascular zone (FAZ) using a novel ophthalmological image modality as is OCT-A. The system combines different image processing techniques to firstly identify the region where the FAZ is contained and, secondly, proceed with the extraction of its precise contour. The system was validated using a representative set of 213 healthy and diabetic OCT-A images, providing accurate results with the best correlation with the manual measurements of two experts clinician of 0.93 as well as a Jaccard's index of 0.82 of the best experimental case in the experiments with healthy OCT-A images. The method also provided satisfactory results in diabetic OCT-A images, with a best correlation coefficient with the manual labeling of an expert clinician of 0.93 and a Jaccard's index of 0.83. This tool provides an accurate FAZ measurement with the desired objectivity and reproducibility, being very useful for the analysis of relevant vascular diseases through the study of the retinal micro circulation.	[Diaz, Macarena; Novo, Jorge; Penedo, Manuel G.; Ortega, Marcos] Univ A Coruna, Dept Comp Sci, La Coruna, Spain; [Diaz, Macarena; Novo, Jorge; Penedo, Manuel G.; Ortega, Marcos] Univ A Coruna, CITIC Res Ctr Informat & Commun Technol, La Coruna, Spain; [Cutrin, Paula; Gomez-Ulla, Francisco] Complejo Hosp Unversitario Santiago, Santiago De Compostela, Spain; [Gomez-Ulla, Francisco] Inst Oftalmol Gomez Ulla, Santiago De Compostela, Spain	Universidade da Coruna; Universidade da Coruna	Diaz, M (corresponding author), Univ A Coruna, Dept Comp Sci, La Coruna, Spain.; Diaz, M (corresponding author), Univ A Coruna, CITIC Res Ctr Informat & Commun Technol, La Coruna, Spain.	macarena.diaz1@udc.es	Buján, Jorge Novo/N-3366-2014; Hortas, Marcos Ortega/A-5955-2011; Penedo, Manuel F. González/N-7767-2015; Díaz, Macarena/S-1369-2019	Buján, Jorge Novo/0000-0002-0125-3064; Hortas, Marcos Ortega/0000-0002-2798-0788; Penedo, Manuel F. González/0000-0002-6881-0865; Díaz, Macarena/0000-0002-6904-2968	Ministerio de Economia y Competitividad, Government of Spain [DPI2015-69948-R]; European Union (European Regional Development Fund - ERDF); Xunta de Galicia, Centro singular de investigacion de Galicia accreditation 2016-2019 [ED431G/01]; Grupos de Referencia Competitiva [ED431C 2016-047]; Instituto de salud Carlos III [PI-00940]; Fundacion Mutua Madrilena project [2017/365]	Ministerio de Economia y Competitividad, Government of Spain; European Union (European Regional Development Fund - ERDF); Xunta de Galicia, Centro singular de investigacion de Galicia accreditation 2016-2019; Grupos de Referencia Competitiva; Instituto de salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fundacion Mutua Madrilena project	This work is supported by the Ministerio de Economia y Competitividad, Government of Spain through the DPI2015-69948-R research project. Also, this work has received financial support from the European Union (European Regional Development Fund - ERDF) and the Xunta de Galicia, Centro singular de investigacion de Galicia accreditation 2016-2019, Ref. ED431G/01; Grupos de Referencia Competitiva, Ref. ED431C 2016-047 and Instituto de salud Carlos III, Ref. PI-00940. Also, this work has received partial financial support from the Fundacion Mutua Madrilena project, Ref. 2017/365.	Balaratnasingam C., 2016, AM ACAD OPHTHALMOLOG, V123; Bouix S, 2007, NEUROIMAGE, V36, P1207, DOI 10.1016/j.neuroimage.2007.04.031; Carpineto P, 2016, BRIT J OPHTHALMOL, V100, P671, DOI 10.1136/bjophthalmol-2015-307330; CHANG YL, 1994, IEEE T IMAGE PROCESS, V3, P868, DOI 10.1109/83.336259; de Carlo Talisa E, 2015, Int J Retina Vitreous, V1, P5; de Moura J, 2017, MED BIOL ENG COMPUT, V55, P2209, DOI 10.1007/s11517-017-1660-8; Diaz M, 2018, OCTAGON; Ding LJ, 2001, PATTERN RECOGN, V34, P721, DOI 10.1016/S0031-3203(00)00023-6; Goncalves L, 2016, EXPERT SYST APPL, V61, P1, DOI 10.1016/j.eswa.2016.05.024; Hwang TS, 2016, JAMA OPHTHALMOL, V134, P367, DOI 10.1001/jamaophthalmol.2015.5658; Ilea DE, 2011, PATTERN RECOGN, V44, P2479, DOI 10.1016/j.patcog.2011.03.005; Lassen BC, 2015, PHYS MED BIOL, V60, P1307, DOI 10.1088/0031-9155/60/3/1307; Leroy F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027128; Lu YS, 2018, INVEST OPHTH VIS SCI, V59, P2212, DOI 10.1167/iovs.17-23498; Mastropasqua R, 2016, BRIT J OPHTHALMOLOGY, P100; Mastropasqua R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170343; Nishio M, 2018, PLOS ONE, P4; Novo J, 2017, COMPUT METH PROG BIO, V139, P61, DOI 10.1016/j.cmpb.2016.10.019; Novo J, 2017, J MED BIOL ENG, V37, P920, DOI 10.1007/s40846-017-0256-y; Real R, 1996, SYST BIOL, V45, P380, DOI 10.2307/2413572; Silva S, 2011, IEEE ENG MED BIO, P3411, DOI 10.1109/IEMBS.2011.6090923; Spet zer RF, 1990, BNI, V6, P35; Zhu SC, 1996, IEEE T PATTERN ANAL, V18, P884, DOI 10.1109/34.537343	23	33	33	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212364	10.1371/journal.pone.0212364	http://dx.doi.org/10.1371/journal.pone.0212364			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794594	gold, Green Submitted, Green Published			2022-12-27	WOS:000459709100056
J	Martinez, GQ; Gordon, SE				Martinez, Gilbert Q.; Gordon, Sharona E.			Multimerization of Homo sapiens TRPA1 ion channel cytoplasmic domains	PLOS ONE			English	Article							RECEPTOR POTENTIAL A1; TRPV1 STRUCTURES; STRUCTURAL BASIS; T1 DOMAIN; ACTIVATION; COLD; REVEALS; MECHANISM; LIGAND; ITCH	The transient receptor potential Ankyrin-1 (TRPA1) ion channel is modulated by myriad noxious stimuli that interact with multiple regions of the channel, including cysteine-reactive natural extracts from onion and garlic which modify residues in the cytoplasmic domains. The way in which TRPA1 cytoplasmic domain modification is coupled to opening of the ion-conducting pore has yet to be elucidated. The cryo-EM structure of TRPA1 revealed a tetrameric C-terminal coiled-coil surrounded by N-terminal ankyrin repeat domains (ARDs), an architecture shared with the canonical transient receptor potential (TRPC) ion channel family. Similarly, structures of the TRP melastatin (TRPM) ion channel family also showed a C-terminal coiled-coil surrounded by N-terminal cytoplasmic domains. This conserved architecture may indicate a common gating mechanism by which modification of cytoplasmic domains can transduce conformational changes to open the ion-conducting pore. We developed an in vitro system in which N-terminal ARDs and C-terminal coiled-coil domains can be expressed in bacteria and maintain the ability to interact. We tested three gating regulators: temperature; the polyphosphate compound IP6; and the covalent modifier allyl isothiocyanate to determine whether they alter N- and C-terminal interactions. We found that none of the modifiers tested abolished ARD-coiled-coil interactions, though there was a significant reduction at 37 degrees C. We found that coiled-coils tetramerize in a concentration dependent manner, with monomers and trimers observed at lower concentrations. Our system provides a method for examining the mechanism of oligomerization of TRPA1 cytoplasmic domains as well as a system to study the transmission of conformational changes resulting from covalent modification.	[Martinez, Gilbert Q.; Gordon, Sharona E.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Gordon, SE (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.	seg@uw.edu			National Eye Institute of the National Institutes of Health [R01EY017564]; National Institute of General Medical Sciences of the National Institutes of Health [R01GM100718, R01GM125351]; National Institutes of Health [S10RR025429, P30DK017047, P30EY001730]; University of Washington Royalty Research Fund; NATIONAL EYE INSTITUTE [P30EY001730, R01EY017564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM125351] Funding Source: NIH RePORTER	National Eye Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington Royalty Research Fund(University of Washington); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the National Eye Institute of the National Institutes of Health under award numbers R01EY017564 (to SEG), by the National Institute of General Medical Sciences of the National Institutes of Health under award numbers R01GM100718 and R01GM125351 (to SEG), and by the following additional awards from the National Institutes of Health: S10RR025429, P30DK017047, and P30EY001730, and the University of Washington Royalty Research Fund.	Arrigoni C, 2016, CELL, V164, P922, DOI 10.1016/j.cell.2016.02.001; Autzen HE, 2018, SCIENCE, V359, P228, DOI 10.1126/science.aar4510; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2013, ANNU REV PHYSIOL, V75, P181, DOI 10.1146/annurev-physiol-030212-183811; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Cavanaugh EJ, 2008, NEUROSCIENCE, V154, P1467, DOI 10.1016/j.neuroscience.2008.04.048; Clapham DE, 2011, P NATL ACAD SCI USA, V108, P19492, DOI 10.1073/pnas.1117485108; Collauto A, 2017, PHYS CHEM CHEM PHYS, V19, P15324, DOI 10.1039/c7cp01925d; DeBerg HA, 2016, J BIOL CHEM, V291, P371, DOI 10.1074/jbc.M115.696450; Fan C, 2018, ELIFE, V7, DOI 10.7554/eLife.36852; Feng Q, 2014, CURR TOP MEMBR, V74, P19, DOI 10.1016/B978-0-12-800181-3.00002-6; Fujiwara Y, 2008, J MOL BIOL, V383, P854, DOI 10.1016/j.jmb.2008.08.059; Gao Y, 2016, NATURE, V534, P347, DOI 10.1038/nature17964; Geppetti P, 2010, LUNG, V188, pS63, DOI 10.1007/s00408-009-9201-3; Guo JT, 2017, NATURE, V552, P205, DOI 10.1038/nature24997; Gupta R, 2016, SCI REP-UK, V6, DOI 10.1038/srep37460; Hansen SB, 2008, J BIOL CHEM, V283, P36066, DOI 10.1074/jbc.C800194200; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Ji RR, 2015, PULM PHARMACOL THER, V35, P81, DOI 10.1016/j.pupt.2015.09.001; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kim D, 2007, J NEUROSCI, V27, P6500, DOI 10.1523/JNEUROSCI.0623-07.2007; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Laursen Willem J, 2015, Temperature (Austin), V2, P214, DOI 10.1080/23328940.2014.1000702; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Moore C, 2018, NEUROSCI BULL, V34, P120, DOI 10.1007/s12264-017-0200-8; Moran MM, 2018, BRIT J PHARMACOL, V175, P2185, DOI 10.1111/bph.14044; Nilius B, 2012, PFLUG ARCH EUR J PHY, V464, P425, DOI 10.1007/s00424-012-1158-z; Palovcak E, 2015, J GEN PHYSIOL, V146, P37, DOI 10.1085/jgp.201411329; Pau VPT, 2011, P NATL ACAD SCI USA, V108, P17684, DOI 10.1073/pnas.1107229108; Paulsen CE, 2015, NATURE, V520, P511, DOI 10.1038/nature14367; Robinson JM, 2005, NEURON, V45, P223, DOI 10.1016/j.neuron.2004.12.043; Sadofsky LR, 2011, PHARMACOL RES, V63, P30, DOI 10.1016/j.phrs.2010.11.004; Samanta A, 2018, J GEN PHYSIOL, V150, P751, DOI 10.1085/jgp.201711876; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Strang C, 2001, J BIOL CHEM, V276, P28493, DOI 10.1074/jbc.M010540200; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Tang QL, 2018, CELL RES, V28, P746, DOI 10.1038/s41422-018-0038-2; Tsuruda PR, 2006, NEURON, V51, P201, DOI 10.1016/j.neuron.2006.06.023; Vinayagam D, 2018, ELIFE, V7, DOI 10.7554/eLife.36615; Voets T, 2014, HANDB EXP PHARMACOL, V223, P729, DOI 10.1007/978-3-319-05161-1_1; Winkler PA, 2017, NATURE, V552, P200, DOI 10.1038/nature24674; Yin Y, 2018, SCIENCE, V359, P237, DOI 10.1126/science.aan4325; Yusifov T, 2008, P NATL ACAD SCI USA, V105, P376, DOI 10.1073/pnas.0705261105; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhou YY, 2018, P NATL ACAD SCI USA, V115, pE11864, DOI 10.1073/pnas.1813162115; Zimova L, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aan8621	47	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0207835	10.1371/journal.pone.0207835	http://dx.doi.org/10.1371/journal.pone.0207835			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794546	Green Published, Green Submitted, gold			2022-12-27	WOS:000459709100005
J	Black, L; Panayiotou, M; Humphrey, N				Black, Louise; Panayiotou, Margarita; Humphrey, Neil			The dimensionality and latent structure of mental health difficulties and wellbeing in early adolescence	PLOS ONE			English	Article							DUAL-FACTOR MODEL; GENERAL PSYCHOPATHOLOGY FACTOR; DISRUPTIVE BEHAVIOR; BIFACTOR MODEL; P-FACTOR; CHILDHOOD; CHILDREN; COMORBIDITY; PERSONALITY; PREVALENCE	Research with adults and older adolescents suggests a general factor may underlie both mental health difficulties and wellbeing. However, the classical bifactor model commonly used to demonstrate this general trait has recently been criticised when a unidimensional structure is not supported. Furthermore, research is lacking in this area with children and early adolescents. We present confirmatory factor analysis models to explore the structure of psychopathology and wellbeing in early adolescents, using secondary data from a large U. K. sample (N = 1982). A simple correlated factors structure fitted the data well and revealed that wellbeing was just as related to internalising as this was to externalising symptoms. The classical bifactor solution also fitted the data well but was rejected as the general factor explained only 55% of the total common variance. S-1 models were therefore used to explore general covariance in a more robust way, and revealed that a general internalising distress factor could play an important role in all item responses. Gender and income differences in mental health were also explored through invariance testing and correlations. Our findings demonstrate the importance of considering mental health difficulties and wellbeing items together, and suggestions are made for how their correspondence could be controlled for.	[Black, Louise; Panayiotou, Margarita; Humphrey, Neil] Univ Manchester, Manchester Inst Educ, Manchester, Lancs, England	University of Manchester	Black, L (corresponding author), Univ Manchester, Manchester Inst Educ, Manchester, Lancs, England.	louise.black@manchester.ac.uk		Black, Louise/0000-0001-8140-3343; Panayiotou, Margarita/0000-0002-6023-7961	National Lottery Community Fund [R118420]; National Institute for Health Research	National Lottery Community Fund; National Institute for Health Research(National Institute for Health Research (NIHR))	The data used in this study was collected as part of HeadStart learning programme and supported by funding from the National Lottery Community Fund, grant R118420. The funders did not seek to influence any aspect of the secondary analysis reported in this study. The content is solely the responsibility of the authors and it does not reflect the views of the National Lottery Community Fund. Louise Black is funded by the National Institute for Health Research.	ACHENBACH TM, 1984, ANNU REV PSYCHOL, V35, P227, DOI 10.1146/annurev.psych.35.1.227; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Anna Freud Centre, HEADSTART PIL EV; Antaramian SP, 2010, AM J ORTHOPSYCHIAT, V80, P462, DOI 10.1111/j.1939-0025.2010.01049.x; Asparouhov T, 2018, NESTING EQUIVALENCE; Bamber D, 2002, J AM ACAD CHILD PSY, V41, P1246, DOI 10.1097/00004583-200210000-00015; Bohnke JR, 2016, BRIT J PSYCHIAT, V209, P162, DOI 10.1192/bjp.bp.115.165530; Bonifay W, 2017, CLIN PSYCHOL SCI, V5, P184, DOI 10.1177/2167702616657069; Borsboom D, 2013, ANNU REV CLIN PSYCHO, V9, P91, DOI 10.1146/annurev-clinpsy-050212-185608; Bowen NK, 2015, J SOC SOC WORK RES, V6, P229, DOI 10.1086/681607; Bradshaw J, 2017, CHILD YOUTH SERV REV, V80, P3, DOI 10.1016/j.childyouth.2017.06.059; Brown T.A., 2015, CONFIRMATORY FACTOR, DOI DOI 10.19030/AJBE.V6I3.7818; BYRNE BM, 1989, PSYCHOL BULL, V105, P456, DOI 10.1037/0033-2909.105.3.456; Carragher N, 2016, PSYCHOL MED, V46, P981, DOI 10.1017/S0033291715002470; Carragher N, 2015, SOC PSYCH PSYCH EPID, V50, P339, DOI 10.1007/s00127-014-1004-z; Caspi A, 2014, CLIN PSYCHOL SCI, V2, P119, DOI 10.1177/2167702613497473; Castellanos-Ryan N, 2016, J ABNORM PSYCHOL, V125, P1039, DOI 10.1037/abn0000193; Cheung GW, 1999, J MANAGE, V25, P1, DOI 10.1177/014920639902500101; Clarke A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-487; Cramer AOJ, 2012, EUR J PERSONALITY, V26, P451, DOI 10.1002/per.1879; Dahl RE, 2018, NATURE, V554, P441, DOI 10.1038/nature25770; De Los Reyes A, 2015, PSYCHOL BULL, V141, P858, DOI 10.1037/a0038498; de Nijs PFA, 2007, PSYCHOPATHOLOGY, V40, P440, DOI 10.1159/000107428; Deighton J, 2013, J PSYCHOEDUC ASSESS, V31, P247, DOI 10.1177/0734282912465570; Department for Education, 2015, SPEC ED NEEDS ENGL; Department for Education, 2015, SCH PUP THEIR CHAR; Diener E, 2000, AM PSYCHOL, V55, P34, DOI 10.1037/0003-066X.55.1.34; Dinisman T, 2016, SOC INDIC RES, V126, P555, DOI 10.1007/s11205-015-0921-x; Duncan B., 2006, J BRIEF THERAPY, V5, P5; Eid M, 2017, PSYCHOL METHODS, V22, P541, DOI 10.1037/met0000083; Fink E, 2015, J ADOLESCENT HEALTH, V56, P502, DOI 10.1016/j.jadohealth.2015.01.023; Fitzsimons E, 2017, SOC SCI MED, V175, P43, DOI 10.1016/j.socscimed.2016.12.040; Forbes MK, 2016, DEV PSYCHOPATHOL, V28, P971, DOI 10.1017/S0954579416000651; Goodman A, 2010, J ABNORM CHILD PSYCH, V38, P1179, DOI 10.1007/s10802-010-9434-x; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Gorard S., 2016, BRIT J ED SOC BEHAV, V14, P1; Greenspoon PJ, 2001, SOC INDIC RES, V54, P81, DOI 10.1023/A:1007219227883; Gutman L., 2015, CHILDREN NEW CENTURY; Horwood J, 2008, BRIT J PSYCHIAT, V193, P185, DOI 10.1192/bjp.bp.108.051904; Hox JJ, 2010, STAT NEERL, V64, P157, DOI 10.1111/j.1467-9574.2009.00445.x; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Humphrey N, 2016, EMOT BEHAV DIFFIC, V21, P22, DOI 10.1080/13632752.2015.1120051; Ilie S, 2017, BRIT EDUC RES J, V43, P253, DOI 10.1002/berj.3260; Jones P B, 2013, Br J Psychiatry Suppl, V54, ps5, DOI 10.1192/bjp.bp.112.119164; Kenny DA, 2003, STRUCT EQU MODELING, V10, P333, DOI 10.1207/S15328007SEM1003_1; Keyes CLM, 2005, J CONSULT CLIN PSYCH, V73, P539, DOI 10.1037/0022-006X.73.3.539; Kinderman P, 2008, J MENT HEALTH, V17, P93, DOI 10.1080/09638230701530226; Kinderman P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076564; Kline R. B., 2015, PRINCIPLES PRACTICE; Kovess-Masfety V, 2016, SOC PSYCH PSYCH EPID, V51, P1093, DOI 10.1007/s00127-016-1253-0; Krueger RF, WORLD PSYCHIAT; Krueger RE, 2006, ANNU REV CLIN PSYCHO, V2, P111, DOI 10.1146/annurev.clinpsy.2.022305.095213; Li CH, 2016, BEHAV RES METHODS, V48, P936, DOI 10.3758/s13428-015-0619-7; Lilienfeld SO, 2003, J ABNORM CHILD PSYCH, V31, P285, DOI 10.1023/A:1023229529866; Lyons MD, 2012, CAN J SCH PSYCHOL, V27, P183, DOI 10.1177/0829573512443669; Lyons MD, 2013, SOC INDIC RES, V114, P549, DOI 10.1007/s11205-012-0161-2; Marsh JK, 2018, CLIN PSYCHOL SCI, V6, P189, DOI 10.1177/2167702617709812; Millsap RE, 2004, PSYCHOL METHODS, V9, P93, DOI 10.1037/1082-989X.9.1.93; Moilanen KL, 2010, DEV PSYCHOPATHOL, V22, P635, DOI 10.1017/S0954579410000337; Moncrieff J, 2013, ANTHROPOL MED, V20, P59, DOI 10.1080/13648470.2012.747591; Murray AL, 2013, INTELLIGENCE, V41, P407, DOI 10.1016/j.intell.2013.06.004; Mutheen BO, 2015, ESTIMATOR CHOICES CA; Mutheen LK, 2007, NEGATIVE RESIDUAL VA; Mutheen LK, 1998, MPLUS USERS GUIDE; Panayiotou Margarita, 2018, Dev Psychopathol, V30, P523, DOI 10.1017/S095457941700102X; Patalay P., 2017, MENTAL ILL HLTH CHIL; Patalay P, 2018, SOC PSYCH PSYCH EPID, V53, P1311, DOI 10.1007/s00127-018-1604-0; Patalay P, 2016, J AM ACAD CHILD PSY, V55, P771, DOI 10.1016/j.jaac.2016.05.019; Patalay P, 2015, BRIT J PSYCHIAT, V207, P15, DOI 10.1192/bjp.bp.114.149591; Patalay P, 2014, CHILD ADOL PSYCH MEN, V8, DOI 10.1186/1753-2000-8-17; Patton GC, 2016, LANCET, V387, P2423, DOI 10.1016/S0140-6736(16)00579-1; Peng XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079476; RAINE A, 1991, SCHIZOPHRENIA BULL, V17, P555, DOI 10.1093/schbul/17.4.555; Ravens-Sieberer U, 2008, VALUE HEALTH, V11, P645, DOI 10.1111/j.1524-4733.2007.00291.x; Raykov T., 2011, INTRO PSYCHOMETRIC T; Raykov T, 2015, EDUC PSYCHOL MEAS, V75, P634, DOI 10.1177/0013164414548217; Reise SP, 2016, MULTIVAR BEHAV RES, V51, P818, DOI 10.1080/00273171.2016.1243461; Reise SP, 2013, EDUC PSYCHOL MEAS, V73, P5, DOI 10.1177/0013164412449831; Reise SP, 2012, MULTIVAR BEHAV RES, V47, P667, DOI 10.1080/00273171.2012.715555; REYNOLDS CR, 1978, J ABNORM CHILD PSYCH, V6, P271, DOI 10.1007/BF00919131; Rodriguez A, 2016, J PERS ASSESS, V98, P223, DOI 10.1080/00223891.2015.1089249; Ryan RM, 2001, ANNU REV PSYCHOL, V52, P141, DOI 10.1146/annurev.psych.52.1.141; Sass DA, 2011, J PSYCHOEDUC ASSESS, V29, P347, DOI 10.1177/0734282911406661; Sawyer SM, 2018, LANCET CHILD ADOLESC, V2, P223, DOI 10.1016/S2352-4642(18)30022-1; Schaefer JD, 2017, J ABNORM PSYCHOL, V126, P212, DOI 10.1037/abn0000232; Sondeijker FEPL, 2005, SOC PSYCH PSYCH EPID, V40, P931, DOI 10.1007/s00127-005-0970-6; Spinhoven P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139912; St Clair MC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175381; Suldo S, 2011, J POSIT PSYCHOL, V6, P17, DOI 10.1080/17439760.2010.536774; Suldo SM, 2008, SCHOOL PSYCHOL REV, V37, P52; Suldo SM, 2016, SCHOOL PSYCHOL REV, V45, P434, DOI 10.17105/SPR45-4.434-457; Tackett JL, 2013, J ABNORM PSYCHOL, V122, P1142, DOI 10.1037/a0034151; Ten Berge JMF, 2004, PSYCHOMETRIKA, V69, P613, DOI 10.1007/BF02289858; van Bork R, 2017, THEOR PSYCHOL, V27, P759, DOI 10.1177/0959354317737185; van Lier PAC, 2003, J CHILD PSYCHOL PSYC, V44, P377; Vanhoutte B, 2014, J POPUL AGEING, V7, P1, DOI 10.1007/s12062-014-9092-9; Waldman ID, 2016, J ABNORM PSYCHOL, V125, P13; Westerhof GJ, 2010, J ADULT DEV, V17, P110, DOI 10.1007/s10804-009-9082-y	98	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0213018	10.1371/journal.pone.0213018	http://dx.doi.org/10.1371/journal.pone.0213018			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8EU	30807608	Green Published, gold, Green Submitted			2022-12-27	WOS:000459712100035
J	Shu, SN; Bian, Y; Rong, J; Xu, DD				Shu, Shinan; Bian, Yang; Rong, Jian; Xu, Dandan			Determining the exact location of a public bicycle station-The optimal distance between the building entrance/exit and the station	PLOS ONE			English	Article							SYSTEM; INEQUALITIES; SCHEME; DESIGN	As a sustainable mode of transportation, public bicycles significantly improve daily mobility. The location of stations is a key element for the success of a public bicycle system, as a long walking distance will reduce people's willingness to use this mode of transportation. Building forms in China are different from the open type seen abroad. Many residential, office and school areas are enclosed by walls, and pedestrian flow is concentrated at the entrances/exits of these areas. Therefore, the station must be located close to the building entrance/exit. Previous studies on station location located the stations only per zone, without providing the exact locations of the stations in the zones. This paper considers the optimal distance between the building entrance/exit and the station to determine the exact station locations. The results can serve as a reference for the planning and optimization of public bicycle stations. A questionnaire survey was conducted in Beijing to determine users' walking distances to the stations. The results indicated that the walking distance decay laws of stations were different for different land uses. Moreover, a binary logistic model was developed to verify that users with different travel purposes have different walking distances. Based on the above results, we explored the optimal distances and tolerable distances between the building entrance/exit and the station for different land uses. These distances can be used to determine exact station locations to meet users' physiological and psychological needs.	[Shu, Shinan; Bian, Yang; Rong, Jian; Xu, Dandan] Beijing Univ Technol, Beijing Engn Res Ctr Urban Transport Operat Guara, Beijing, Peoples R China	Beijing University of Technology	Bian, Y (corresponding author), Beijing Univ Technol, Beijing Engn Res Ctr Urban Transport Operat Guara, Beijing, Peoples R China.	bianyang@bjut.edu.cn						Alta Bike Share, 2011, MELB BIK SHAR SURV; Aultman-Hall L, 1999, ACCIDENT ANAL PREV, V31, P675, DOI 10.1016/S0001-4575(99)00028-7; Bachand-Marleau J, 2012, TRANSPORT RES REC, P66, DOI 10.3141/2314-09; Bian Y, 2014, CICTP 2014 SAF SMART; Buck D, 2013, TRANSPORT RES REC, P112, DOI 10.3141/2387-13; Garcia-Palomares JC, 2012, APPL GEOGR, V35, P235, DOI 10.1016/j.apgeog.2012.07.002; Castillo-Manzano JI, 2015, TRANSPORT RES D-TR E, V38, P15, DOI 10.1016/j.trd.2015.04.004; Chen Q, 2015, J ADV TRANSPORT, V49, P884, DOI 10.1002/atr.1311; Cohen A., 2016, PLANNING SHARED MOBI, P1, DOI [10.7922/G2NV9GDD, DOI 10.7922/G2NV9GDD]; Daskin MS, 1995, J OPERATIONAL RES SO, V48, P763; Dell'Amico M, 2014, OMEGA-INT J MANAGE S, V45, P7, DOI 10.1016/j.omega.2013.12.001; dell'Olio L, 2011, P I CIVIL ENG-MUNIC, V164, P89, DOI 10.1680/muen.2011.164.2.89; DeMaio P.J., 2009, J PUBLIC TRANSPORT, V12, P41, DOI [5038/2375-0901.12.410.5038/2375-0901.12.4.3, DOI 10.5038/2375-0901.12.4.3]; Fishman E, 2014, J TRANSP GEOGR, V41, P325, DOI 10.1016/j.jtrangeo.2014.08.005; Fishman E, 2014, TRANSPORT RES D-TR E, V31, P13, DOI 10.1016/j.trd.2014.05.013; Fuller D, 2011, AM J PREV MED, V41, P80, DOI 10.1016/j.amepre.2011.03.002; Goodman A, 2014, J TRANSP GEOGR, V41, P272, DOI 10.1016/j.jtrangeo.2014.04.004; He Liu, 2012, Journal of Wuhan University of Technology (Transportation Science & Engineering), V36, P129, DOI 10.3963/j.issn.1006-2823.2012.01.030; Hyndman RJ, 1996, AM STAT, V50, P361, DOI 10.2307/2684934; LDA-Consulting, 2012, CAP BIK 2011 MEMB SU; Li C., 2011, P 3 INT C TRANSP ENG, P247, DOI [10.1061/41184(419)42, DOI 10.1061/41184(419)42]; Lin JR, 2011, TRANSPORT RES E-LOG, V47, P284, DOI 10.1016/j.tre.2010.09.004; Lin L., 2017, ARXIV171204997; Martens K, 2007, TRANSPORT RES A-POL, V41, P326, DOI 10.1016/j.tra.2006.09.010; Martin E., 2016, BIKESHARING BICYCLE; Martinez LM, 2012, PROCD SOC BEHV, V54, P513, DOI 10.1016/j.sbspro.2012.09.769; Meddin R, 2015, BIKE SHARING WORLD M; Ministry of Housing and Urban-Rural Development of the People's Republic of China, 2011, COD CLASS URB LAND U; Murphy H., 2010, DUBLIN BIKES INVESTI; Nair R, 2011, TRANSPORT SCI, V45, P524, DOI 10.1287/trsc.1100.0347; Nelson AC., 1997, TRANSPORTATION RES R, V1578, P79, DOI DOI 10.3141/1578-10; Ogilvie F, 2012, PREV MED, V55, P40, DOI 10.1016/j.ypmed.2012.05.002; Pai CW, 2011, ACCIDENT ANAL PREV, V43, P1228, DOI 10.1016/j.aap.2011.01.004; ReVelle CS, 2005, EUR J OPER RES, V165, P1, DOI 10.1016/j.ejor.2003.11.032; Romero JP, 2012, PROCD SOC BEHV, V54, P646, DOI 10.1016/j.sbspro.2012.09.782; Shaheen S, 2012, PUBLIC BIKESHARING N; Shaheen S., 2011, HANGZHOU PUBLIC BICY; Shaheen S., 2014, MTI REP, P12; Shaheen SA, 2010, TRANSPORT RES REC, P159, DOI 10.3141/2143-20; Shu SN, 2014, TRANSP RES BOARD ANN; Tang Y, 2011, TRANSP RES BOARD M; Transport for London, 2010, TRAVEL LONDON REPORT; Zhou XY, 2015, PLOS ONE, V10, P1, DOI [DOI 10.1063/1.4928081, DOI 10.1371/J0URNAL.P0NE.0137922]	43	4	4	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212478	10.1371/journal.pone.0212478	http://dx.doi.org/10.1371/journal.pone.0212478			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM2OT	30785949	gold, Green Published, Green Submitted			2022-12-27	WOS:000459307000064
J	Yang, BH; Gao, Y; Li, HM; Ye, SB; He, HX; Xie, SR				Yang, Baohua; Gao, Yuan; Li, Hongmin; Ye, Shengbo; He, Hongxia; Xie, Shenru			Rapid prediction of yellow tea free amino acids with hyperspectral images	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; SUCCESSIVE PROJECTIONS ALGORITHM; VARIABLE SELECTION; SPECTROSCOPY; REGRESSION; QUALITY; GREEN; CHEMOMETRICS; COMPONENTS; BLACK	Free amino acids are an important indicator of the freshness of yellow tea. This study investigated a novel procedure for predicting the free amino acid (FAA) concentration of yellow tea. It was developed based on the combined spectral and textural features from hyperspectral images. For the purposes of exploration and comparison, hyperspectral images of yellow tea (150 samples) were captured and analyzed. The raw spectra were preprocessed with Savitzky-Golay (SG) smoothing. To reduce the dimension of spectral data, five feature wavelengths were extracted using the successive projections algorithm (SPA). Five textural features (angular second moment, entropy, contrast, correlation, and homogeneity) were extracted as textural variables from the characteristic grayscale images of the five characteristic wavelengths using the gray-level co-occurrence matrix (GLCM). The FAA content prediction model with different variables was established by a genetic algorithm-support vector regression (GA-SVR) algorithm. The results showed that better prediction results were obtained by combining the feature wavelengths and textural variables. Compared with other data, this prediction result was still very satisfactory in the GA-SVR model, indicating that data fusion was an effective way to enhance hyperspectral imaging ability for the determination of free amino acid values in yellow tea.	[Yang, Baohua; Gao, Yuan; Ye, Shengbo; He, Hongxia; Xie, Shenru] Anhui Agr Univ, Sch Informat & Comp, Hefei, Anhui, Peoples R China; [Yang, Baohua] Minist Agr, Key Lab Agr IoT Technol Integrat & Applicat, Hefei, Anhui, Peoples R China; [Yang, Baohua] Nanjing Agr Univ, Natl Engn & Technol Ctr Informat Agr, Nanjing, Jiangsu, Peoples R China; [Yang, Baohua; Li, Hongmin] Kansas State Univ, Dept Comp Sci, Manhattan, KS 66506 USA	Anhui Agricultural University; Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Kansas State University	Yang, BH (corresponding author), Anhui Agr Univ, Sch Informat & Comp, Hefei, Anhui, Peoples R China.; Yang, BH (corresponding author), Minist Agr, Key Lab Agr IoT Technol Integrat & Applicat, Hefei, Anhui, Peoples R China.; Yang, BH (corresponding author), Nanjing Agr Univ, Natl Engn & Technol Ctr Informat Agr, Nanjing, Jiangsu, Peoples R China.; Yang, BH (corresponding author), Kansas State Univ, Dept Comp Sci, Manhattan, KS 66506 USA.	ybh@ahau.edu.cn	Li, Hongmin/HHZ-6644-2022; Li, Hongmin/AAA-3405-2020	Li, Hongmin/0000-0003-4928-3534; yang, Baohua/0000-0003-4996-492X	Natural Science Foundation of Anhui Province [1808085MF195]; Natural Science Research Project of Anhui Province [KJ2016A837]; Open Fund of the Key Laboratory of Technology Integration and Application in Agricultural Internet of Things, Ministry of Agriculture [2016KL02]; National Key RD Program [2016YFD0300608]	Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province); Natural Science Research Project of Anhui Province; Open Fund of the Key Laboratory of Technology Integration and Application in Agricultural Internet of Things, Ministry of Agriculture; National Key RD Program	Funded by Natural Science Foundation of Anhui Province (1808085MF195 to BY), http://www.ahkjt.gov.cn/; the Natural Science Research Project of Anhui Province (KJ2016A837 to BY), http://www.ahedu.gov.cn/; the Open Fund of the Key Laboratory of Technology Integration and Application in Agricultural Internet of Things, Ministry of Agriculture (2016KL02 to BY), http://www.ahau.edu.cn/; and the National Key R&D Program (2016YFD0300608 to BY), http://www.most.gov.cn/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alasalvar C, 2012, J AGR FOOD CHEM, V60, P6323, DOI 10.1021/jf301498p; Andersen CM, 2010, J CHEMOMETR, V24, P728, DOI 10.1002/cem.1360; Araujo MCU, 2001, CHEMOMETR INTELL LAB, V57, P65, DOI 10.1016/S0169-7439(01)00119-8; Balabin RM, 2011, ANAL CHIM ACTA, V692, P63, DOI 10.1016/j.aca.2011.03.006; Bian M., 2012, REMOTE SENS SPATIAL, V1, P237; Bian M, 2010, PHOTOGRAMM ENG REM S, V76, P1385, DOI 10.14358/PERS.76.12.1385; Bulcock H., 2009, HYDROL EARTH SYST SC, V6, P5783, DOI DOI 10.5194/HESSD-6-5783-2009; Cheng JH, 2015, LWT-FOOD SCI TECHNOL, V62, P1060, DOI 10.1016/j.lwt.2015.01.021; Cheng JH, 2014, TRENDS FOOD SCI TECH, V37, P78, DOI 10.1016/j.tifs.2014.03.006; Dai Q, 2015, J FOOD ENG, V149, P97, DOI 10.1016/j.jfoodeng.2014.10.001; Deng SG, 2015, COMPUT ELECTRON AGR, V118, P38, DOI 10.1016/j.compag.2015.08.014; ElMasry G, 2008, J AGR FOOD CHEM, V56, P7672, DOI 10.1021/jf801074s; Gowen AA, 2007, TRENDS FOOD SCI TECH, V18, P590, DOI 10.1016/j.tifs.2007.06.001; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; He HJ, 2014, J FOOD ENG, V126, P156, DOI 10.1016/j.jfoodeng.2013.11.015; Horie H, 2000, J CHROMATOGR A, V881, P425, DOI 10.1016/S0021-9673(99)01345-X; Hsieh MM, 2007, TALANTA, V73, P326, DOI 10.1016/j.talanta.2007.03.049; Hu MH, 2015, POSTHARVEST BIOL TEC, V106, P1, DOI 10.1016/j.postharvbio.2015.03.014; Gonzalez-Martin MI, 2015, SENSORS-BASEL, V15, P27854, DOI 10.3390/s151127854; Kausar T, 2013, RADIAT PHYS CHEM, V86, P96, DOI 10.1016/j.radphyschem.2012.12.011; Li LQ, 2019, J SCI FOOD AGR, V99, P1787, DOI 10.1002/jsfa.9371; Liu D, 2014, FOOD CHEM, V160, P330, DOI 10.1016/j.foodchem.2014.03.096; Liu F, 2008, ANAL CHIM ACTA, V615, P10, DOI 10.1016/j.aca.2008.03.030; Pierna JAF, 2012, CHEMOMETR INTELL LAB, V117, P233, DOI 10.1016/j.chemolab.2012.02.004; Pourbasheer E, 2009, EUR J MED CHEM, V44, P5023, DOI 10.1016/j.ejmech.2009.09.006; Ramedani Z, 2014, SOL ENERGY, V109, P135, DOI 10.1016/j.solener.2014.08.023; Ribaldo PDB, 2009, J NUTR, V139, P96, DOI 10.3945/jn.108.095018; ROBERTS GR, 1966, J SCI FOOD AGR, V17, P182, DOI 10.1002/jsfa.2740170409; Ryu ChanSeok, 2010, Journal of the Japanese Society of Agricultural Machinery, V72, P46; Siripatrawan U, 2015, INT J FOOD MICROBIOL, V199, P93, DOI 10.1016/j.ijfoodmicro.2015.01.001; Sohara Y., 2010, IFAC PROC VOL, V43, P172, DOI [10.3182/20101206-3-JP-3009-00030, DOI 10.3182/20101206-3-JP-3009-00030, 10.3182/20101206-3-JP-3009.00030, DOI 10.3182/20101206-3-JP-3009.00030]; STENSVOLD I, 1992, PREV MED, V21, P546, DOI 10.1016/0091-7435(92)90062-M; Tan FY, 2011, J AGR FOOD CHEM, V59, P10839, DOI 10.1021/jf2023325; Wang Q, 2013, EXP THER MED, V6, P423, DOI 10.3892/etm.2013.1117; WOLD S, 1993, TECHNOMETRICS, V35, P136, DOI 10.2307/1269657; Xie CQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113422; Yang YC, 2015, COMPUT ELECTRON AGR, V113, P203, DOI 10.1016/j.compag.2015.02.008; Ye SF, 2008, CHEMOMETR INTELL LAB, V91, P194, DOI 10.1016/j.chemolab.2007.11.005; Zhang QX, 2012, SPECTROSC-INT J, V27, P93, DOI 10.1155/2012/276795; Zhao JW, 2011, SPECTROSC SPECT ANAL, V31, P512, DOI 10.3964/j.issn.1000-0593(2011)02-0512-04; Zhao JW, 2009, APPL OPTICS, V48, P3557, DOI 10.1364/AO.48.003557; Zhao M, 2011, J AGR FOOD CHEM, V59, P3641, DOI 10.1021/jf104601v; Zhao YR, 2015, J ANAL METHODS CHEM, V2015, DOI 10.1155/2015/343782	43	8	9	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0210084	10.1371/journal.pone.0210084	http://dx.doi.org/10.1371/journal.pone.0210084			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785888	Green Published, gold, Green Submitted			2022-12-27	WOS:000459307000009
J	Leinonen, T; Solovieva, S; Husgafvel-Pursiainen, K; Laaksonen, M; Viikari-Juntura, E				Leinonen, Taina; Solovieva, Svetlana; Husgafvel-Pursiainen, Kirsti; Laaksonen, Mikko; Viikari-Juntura, Eira			Do individual and work-related factors differentiate work participation trajectories before and after vocational rehabilitation?	PLOS ONE			English	Article							EMPLOYMENT OUTCOMES; SICKNESS ABSENCE; SUPPORTED EMPLOYMENT; GENDER-DIFFERENCES; FOLLOW-UP; RETURN; PEOPLE; DISABILITY; SERVICES; PREDICTORS	Background Understanding diverse labor market trajectories around vocational rehabilitation provides important insight into potential effectiveness of rehabilitation efforts. We examined factors associated with work participation trajectories before and after vocational rehabilitation. Methods Using nationwide Finnish register data of 7180 vocational rehabilitees, we constructed latent trajectory groups of work participation two years before and two years after their rehabilitation episode starting in 2008-2010. We plotted changes in labor market statuses in these groups and examined other associated factors using multinomial logistic regression. Results We identified four trajectories based on work participation levels before and after vocational rehabilitation. The "High-Resumed" group (35.6%) typically returned to full duties. The "High-to-Negligible" group (20.7%) typically transitioned to full disability retirement or unemployment. Among the "Medium-Resumed" (25.5%) and "Longstanding Negligible" (18.3%) groups, work disability and unemployment were common before rehabilitation, but afterwards those assigned to the former group often returned to full or partial duties. Overall, older age, male gender, living in areas with lower employment rates, having lower education, being employed in the private sector, and having mental diagnoses were associated with the other three trajectories than the most favorable "High-Resumed" trajectory. Furthermore, certain industrial sectors, job exposures, and less common diagnoses further separated specific trajectories. Conclusions Work participation trajectories around vocational rehabilitation are diverse, only partly dependent on initial levels of work participation, and determined by various individual and work-related factors. Future nationwide studies should assess the effectiveness of vocational rehabilitation taking into consideration both individual and work-related factors.	[Leinonen, Taina; Solovieva, Svetlana; Husgafvel-Pursiainen, Kirsti; Viikari-Juntura, Eira] Finnish Inst Occupat Hlth, Helsinki, Finland; [Laaksonen, Mikko] Finnish Ctr Pens, Helsinki, Finland	Finnish Institute of Occupational Health	Leinonen, T (corresponding author), Finnish Inst Occupat Hlth, Helsinki, Finland.	taina.leinonen@ttl.fi			Academy of Finland [303534]	Academy of Finland(Academy of Finland)	This study was supported by the Academy of Finland (project number 303534 to Viikari-Juntura). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren Asa, 2007, Work, V28, P343; Bekker MHJ, 2009, PSYCHOL HEALTH MED, V14, P405, DOI 10.1080/13548500903012830; Blackwell TL, 2003, REHABIL COUNS BULL, V46, P108, DOI 10.1177/00343552030460020501; Bolton BF, 2000, REHABIL COUNS BULL, V44, P10, DOI 10.1177/003435520004400103; Burke-Miller JK, 2006, COMMUNITY MENT HLT J, V42, P143, DOI 10.1007/s10597-005-9017-4; Burstrom B, 2011, DISABIL REHABIL, V33, P453, DOI 10.3109/09638288.2010.493596; Card D, 2018, J EUR ECON ASSOC, V16, P894, DOI 10.1093/jeea/jvx028; Chan JY, 2014, REHABIL COUNS BULL, V57, P209, DOI 10.1177/0034355213509855; Cook JA, 2006, J VOCAT REHABIL, V25, P71; Corbiere M, 2017, J NERV MENT DIS, V205, P275, DOI 10.1097/NMD.0000000000000612; Dean D, 2017, J HUM RESOUR, V52, P826, DOI 10.3368/jhr.52.3.0114-6111R1; Dutta A, 2008, J OCCUP REHABIL, V18, P326, DOI 10.1007/s10926-008-9154-z; Finnish Centre for Pensions, BACK WORK REH; Friberg IO, 2016, SCAND J PUBLIC HEALT, V44, P264, DOI 10.1177/1403494815618843; Gran JM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2408-8; Jang Y, 2014, J OCCUP REHABIL, V24, P11, DOI 10.1007/s10926-013-9433-1; Jones BL, 2007, SOCIOL METHOD RES, V35, P542, DOI 10.1177/0049124106292364; Karasek R., 1990, HLTH WORK STRESS PRO; Kausto J, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001752; Kuoppala J, 2008, J REHABIL MED, V40, P796, DOI 10.2340/16501977-0270; Laaksonen M, 2015, J OCCUP REHABIL, V25, P471, DOI 10.1007/s10926-014-9554-1; Leinonen T, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019822; Leinonen T, 2018, ANN WORK EXPOS HEAL, V62, P438, DOI 10.1093/annweh/wxx107; Lindholdt L, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015661; Mann DR, 2017, J VOCAT REHABIL, V46, P159, DOI 10.3233/JVR-160852; Mastekaasa A, 2014, EUR SOCIOL REV, V30, P582, DOI 10.1093/esr/jcu059; Mastekaasa A, 2014, EUR J PUBLIC HEALTH, V24, P656, DOI 10.1093/eurpub/cku075; Michon H, 2005, SOC PSYCH PSYCH EPID, V40, P408, DOI 10.1007/s00127-005-0910-5; Nagin DS, 1999, PSYCHOL METHODS, V4, P139, DOI 10.1037/1082-989X.4.2.139; Organisation for Economic Co-operation and Development, 2008, SICKN DIS WORK BREAK, DOI [10.1787/9789264049826-en, DOI 10.1787/9789264049826-EN]; Oyeflaten I, 2014, J OCCUP REHABIL, V24, P199, DOI 10.1007/s10926-013-9466-5; Pedersen P, 2018, SCAND J PUBLIC HEALT, V46, P383, DOI 10.1177/1403494817722290; Rinaldo U, 2016, WORK, V55, P115, DOI 10.3233/WOR-162387; Saarnio L, 2017, TYOELAKEKUNTOUTUS VU; Solovieva S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108987; Solovieva S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048680; Suijkerbuijk YB, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011867.pub2; The Social Insurance Institution of Finland, VOC REH; Vaidya V, 2012, J WOMENS HEALTH, V21, P140, DOI 10.1089/jwh.2011.2876; van Vilsteren M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006955.pub3; Viikari-Juntura E, 2017, SCAND J WORK ENV HEA, V43, P447, DOI 10.5271/sjweh.3664; Wang YY, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003320; Wasiak R, 2007, J OCCUP REHABIL, V17, P766, DOI 10.1007/s10926-007-9101-4; Young AE, 2005, J OCCUP REHABIL, V15, P543, DOI 10.1007/s10926-005-8033-0; Young AE, 2016, J OCCUP REHABIL, V26, P434, DOI 10.1007/s10926-016-9675-9	45	6	6	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212498	10.1371/journal.pone.0212498	http://dx.doi.org/10.1371/journal.pone.0212498			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM2WC	30789938	gold, Green Published, Green Submitted			2022-12-27	WOS:000459330800030
J	Mottaleb, KA; Singh, PK; Sonder, K; Kruseman, G; Erenstein, O				Mottaleb, Khondoker A.; Singh, Pawan K.; Sonder, Kai; Kruseman, Gideon; Erenstein, Olaf			Averting wheat blast by implementing a 'wheat holiday': In search of alternative crops in West Bengal, India	PLOS ONE			English	Article							PUCCINIA-STRIIFORMIS; 1ST REPORT; ADAPTATION; RUST	The emergence of wheat-blast in Bangladesh in the 2015-16 wheat (Triticum aestivum L.) crop threatens the food security of South Asia. A potential spread of the disease from Bangladesh to India could have devastating impacts on India's overall food security as wheat is its second most important staple food crop. West Bengal state in eastern India shares a 2,217 km-long border with Bangladesh and has a similar agro-ecology, enhancing the prospects of the disease entering India via West Bengal. The present study explores the possibility of a 'wheat holiday' policy in the nine border districts of West Bengal. Under the policy, farmers in these districts would stop wheat cultivation for at least two years. The present scoping study assesses the potential economic feasibility of alternative crops to wheat. Of the ten crops considered, maize, gram (chickpea), urad (black gram), rapeseed and mustard, and potatoes are found to be potentially feasible alternative crops. Any crop substitution would need support to ease the transition including addressing the challenges related to the management of alternative crops, ensuring adequate crop combinations and value chain development. Still, as wheat is a major staple, there is some urgency to support further research on disease epidemiology and forecasting, as well as the development and dissemination of blast-resistant wheat varieties across South Asia.	[Mottaleb, Khondoker A.; Kruseman, Gideon; Erenstein, Olaf] CIMMYT Int Maize & Wheat Improvement Ctr, Socioecon Program, Texcoco, Mexico; [Singh, Pawan K.] CIMMYT, Global Wheat Program, Texcoco, Mexico; [Sonder, Kai] CIMMYT, Geog Informat Syst Unit, Socioecon Program, Texcoco, Mexico	CGIAR; International Maize & Wheat Improvement Center (CIMMYT); CGIAR; International Maize & Wheat Improvement Center (CIMMYT); CGIAR; International Maize & Wheat Improvement Center (CIMMYT)	Mottaleb, KA (corresponding author), CIMMYT Int Maize & Wheat Improvement Ctr, Socioecon Program, Texcoco, Mexico.	k.mottaleb@cgiar.org	Kruseman, Gideon/S-6377-2016	Kruseman, Gideon/0000-0002-3392-4176; Sonder, Kai/0000-0001-9672-5361; Singh, Pawan/0000-0003-4610-3120; Erenstein, Olaf/0000-0002-7491-5786	CGIAR research program on WHEAT agro-food systems; Australian Center for International Agriculture Research (ACIAR) [CIM/2016/170]; CGIAR research program on wheat agri-food systems (CRP WHEAT); Australian Center for International Agriculture Research (ACIAR)	CGIAR research program on WHEAT agro-food systems(CGIAR); Australian Center for International Agriculture Research (ACIAR); CGIAR research program on wheat agri-food systems (CRP WHEAT)(CGIAR); Australian Center for International Agriculture Research (ACIAR)	This paper was supported by the CGIAR research program on WHEAT agro-food systems to GK and Australian Center for International Agriculture Research (ACIAR) CIM/2016/170 to PKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Disclaimer: This study was supported by the CGIAR research program on wheat agri-food systems (CRP WHEAT) and the Australian Center for International Agriculture Research (ACIAR). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript. The views expressed here are those of the authors and do not necessarily reflect the views of the funders or associated institutions. The usual disclaimer applies.	Adhikari B., 2011, STATUS PAPER RICE W; Anjos J R. N. D., 1995, PESQUISA AGROPECUARI, V31, P79; [Anonymous], 2016, BANGL DEM HLTH SURV; Barea G, 1996, CTR INVESTIGACION AG, P76; Bebber DP, 2013, NAT CLIM CHANGE, V3, P985, DOI [10.1038/nclimate1990, 10.1038/NCLIMATE1990]; Bueno-Sancho V, 2017, GENOME BIOL EVOL, V9, P3282, DOI 10.1093/gbe/evx241; Cabrera M.G., 2007, JORNADA ACTUALIZACIO, P60; Callaway E, 2016, NATURE, V532, P421, DOI 10.1038/532421a; Ceresini PC, 2018, ANNU REV PHYTOPATHOL, V56, P427, DOI 10.1146/annurev-phyto-080417-050036; Chowdhury Sachchidananda D., 2005, Journal of Poultry Science, V42, P308, DOI 10.2141/jpsa.42.308; CIMMYT (International Maize and Wheat Improvement Center), 2017, SEM REP 2017; Deaton A., 2009, Economic and Political Weekly, V44, P42; Duveiller E, 2011, PHYTOPATHOLOGY, V101, pS220; Duveiller E., 2016, WORLD WHEAT BOOK, V3, P1107; Erenstein O, 2011, AGR SYST, V104, P42, DOI 10.1016/j.agsy.2010.09.004; Gandhi V. P., 2004, Economic and Political Weekly, V39, P4737; Goergen G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165632; GoI, 2018, COST CULT PROD REL D; GoI (Government of India), 2017, PRER 2017 DAC FW ICA; GoI (Government of India), 2016, AGR STAT YB IND 2016; GoI (Government of India), 1996, 401 GOI NAT SAMPL SU; GoI (Government of India), 2017, FARM HARV PRIC PRINC; GoI (Government of India), 2013, PRIC POL RAB CROPS C; GoI (Government of India), 2014, LEV PATT CONS EXP 20; GoI (Government of India), 2017, AGR STAT GLANC 2016; GOULART A C P, 1990, Fitopatologia Brasileira, V15, P112; Goulart Augusto C. P., 2000, Summa Phytopathologica, V26, P279; Gupta DR, 2019, PHYTOPATHOLOGY, V109, P504, DOI 10.1094/PHYTO-06-18-0199-LE; Hellin J, 2015, INT FOOD AGRIBUS MAN, V18, P151; ICAR-CRIDA (Indian Council of Agriculture Research-Central Research Institute for Dryland Agriculture), 2012, AGR CONT PLAN DISTR; Igarashi s, 1990, P INT C FOZ DO IG BR, P480; Igarashi S., 1986, FITOPATOL BRAS, V11, P351; Indian Council of Agricultural Research (ICAR)-National Bureau of Agricultural Insect Resources, 2018, SPOD FRUG JE SMITH I; Islam MT, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0309-7; Loladze A, 2014, PLANT PATHOL, V63, P572, DOI 10.1111/ppa.12132; Malaker PK, 2016, PLANT DIS, V100, P2330, DOI 10.1094/PDIS-05-16-0666-PDN; MoAFW (Ministry of Agriculture and Farmers Welfare) India, 2018, AR PROD STAT; Mottaleb K. A., 2018, BRIT FOOD J, V20, P392; Mottaleb KA, 2018, EUR J DEV RES, V30, P252, DOI 10.1057/s41287-017-0096-1; Nagarajan S, 2005, CURR SCI INDIA, V89, P1467; Goulart Augusto César Pereira, 2007, Summa phytopathol., V33, P358, DOI 10.1590/S0100-54052007000300011; Perello A, 2015, PLANT DIS, V99, P1177, DOI 10.1094/PDIS-11-14-1182-PDN; Piccinini E. C, 1989, FITOPATOL BRAS, V14, P126; Pingali P, 2007, FOOD POLICY, V32, P281, DOI 10.1016/j.foodpol.2006.08.001; Praduman Kumar, 2007, Economic and Political Weekly, V42, P3567; Ranganathan T., 2015, FARMERS INCOME INDIA; Rao CHH, 2000, ECON POLIT WEEKLY, V35, P201; Reis Erlei Melo, 1995, Summa Phytopathologica, V21, P43; Sazzad S. R., 2018, BANGLADESH EXPERIENC; Singh R.P., 2006, CAB REV PERSPECTIVE, V54, P1, DOI [10.1079/PAVSNNR20061054, DOI 10.1079/PAVSNNR20061054]; Surabhi Mittal, 2007, Economic and Political Weekly, V42, P444; Theisen K., 2009, INDIA INT POTATO CTR; United Nations, 2019, UN COMTR DAT; Urashima A. S., 2005, Czech Journal of Genetics and Plant Breeding, V41, P238; Urashima AS, 2009, ADVANCES IN GENETICS, GENOMICS AND CONTROL OF RICE BLAST DISEASE, P267, DOI 10.1007/978-1-4020-9500-9_27; USDA (United States Department of Agriculture), 2018, FAS HOM MARK TRAD DA; Viedma LQ, 2005, PHYTOPATHOLOGY, V95, pS152; Wangai AW, 2012, PLANT DIS, V96, P1582, DOI 10.1094/PDIS-06-12-0576-PDN; Wellings CR, 2007, AUST J AGR RES, V58, P567, DOI 10.1071/AR07130; World Hunger Education Service, 2018, AS HUNG FACTS WHAT E	60	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211410	10.1371/journal.pone.0211410	http://dx.doi.org/10.1371/journal.pone.0211410			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM2OT	30785905	gold, Green Published, Green Submitted			2022-12-27	WOS:000459307000025
J	Gradin, R; Lindstedt, M; Johansson, H				Gradin, Robin; Lindstedt, Malin; Johansson, Henrik			Batch adjustment by reference alignment (BARA): Improved prediction performance in biological test sets with batch effects	PLOS ONE			English	Article							GENE-EXPRESSION; PROGRESSION; MUTATIONS; TUMORS; AGE	Many biological data acquisition platforms suffer from inadvertent inclusion of biologically irrelevant variance in analyzed data, collectively termed batch effects. Batch effects can lead to difficulties in downstream analysis by lowering the power to detect biologically interesting differences and can in certain instances lead to false discoveries. They are especially troublesome in predictive modelling where samples in training sets and test sets are often completely correlated with batches. In this article, we present BARA, a normalization method for adjusting batch effects in predictive modelling. BARA utilizes a few reference samples to adjust for batch effects in a compressed data space spanned by the training set. We evaluate BARA using a collection of publicly available datasets and three different prediction models, and compare its performance to already existing methods developed for similar purposes. The results show that data normalized with BARA generates high and consistent prediction performances. Further, they suggest that BARA produces reliable performances independent of the examined classifiers. We therefore conclude that BARA has great potential to facilitate the development of predictive assays where test sets and training sets are correlated with batch.	[Gradin, Robin; Johansson, Henrik] SenzaGen AB, Lund, Sweden; [Lindstedt, Malin] Lund Univ, Dept Immunotechnol, Lund, Sweden	Lund University	Gradin, R (corresponding author), SenzaGen AB, Lund, Sweden.	robin.gradin@senzagen.com	Lindstedt, Malin/A-3855-2009	Lindstedt, Malin/0000-0001-9136-1087; Gradin, Robin/0000-0002-3339-1269				Berchtold NC, 2013, NEUROBIOL AGING, V34, P1653, DOI 10.1016/j.neurobiolaging.2012.11.024; Blair LJ, 2013, J CLIN INVEST, V123, P4158, DOI 10.1172/JCI69003; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chen DT, 2012, J GASTROINTEST SURG, V16, P905, DOI 10.1007/s11605-011-1815-0; Corporation M, 2017, DOPARALLEL FOREACH P; David M, 2018, E1071 MISC FUNCTIONS; Dhingra N, 2014, J ALLERGY CLIN IMMUN, V134, P362, DOI 10.1016/j.jaci.2014.03.009; Diamandis EP, 2010, J NATL CANCER I, V102, P1462, DOI 10.1093/jnci/djq306; Goh WWB, 2017, TRENDS BIOTECHNOL, V35, P498, DOI 10.1016/j.tibtech.2017.02.012; Gunther OP, 2014, OMICS, V18, P682, DOI 10.1089/omi.2014.0062; Hadley W, 2018, STRINGR SIMPLE CONSI; Hadley W, 2017, DPLYR GRAMMAR DATA M; Higuchi Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129241; Ho DMT, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0103-3; Hornung R, 2017, BIOINFORMATICS, V33, P397, DOI 10.1093/bioinformatics/btw650; Hornung R, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-015-0870-z; Hou J, 2014, J VIROL, V88, P12254, DOI 10.1128/JVI.00775-14; Huffman KM, 2014, DIABETOLOGIA, V57, P2282, DOI 10.1007/s00125-014-3343-4; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kang HN, 2012, BLOOD, V119, P1872, DOI 10.1182/blood-2011-10-382861; Kirzin S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103159; Kolesnikov N, 2015, NUCLEIC ACIDS RES, V43, pD1113, DOI 10.1093/nar/gku1057; Kool M, 2014, CANCER CELL, V25, P393, DOI 10.1016/j.ccr.2014.02.004; Lambert CG, 2012, BIOSTATISTICS, V13, P195, DOI 10.1093/biostatistics/kxr055; Lambert SR, 2014, BRIT J CANCER, V110, P520, DOI 10.1038/bjc.2013.760; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Lu T, 2014, NATURE, V507, P448, DOI 10.1038/nature13163; Luo J, 2010, PHARMACOGENOMICS J, V10, P278, DOI 10.1038/tpj.2010.57; Matt D, 2017, DATA TABLE EXTENSION; McLerran D, 2008, CLIN CHEM, V54, P53, DOI 10.1373/clinchem.2007.091496; Metzelder SK, 2015, LEUKEMIA, V29, P1470, DOI 10.1038/leu.2015.95; Oytam Y, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1212-5; Pajtler KW, 2015, CANCER CELL, V27, P728, DOI 10.1016/j.ccell.2015.04.002; Parker HS, 2014, PEERJ, V2, DOI 10.7717/peerj.561; Phipson B, 2016, ANN APPL STAT, V10, P946, DOI 10.1214/16-AOAS920; Piccolo SR, 2012, GENOMICS, V100, P337, DOI 10.1016/j.ygeno.2012.08.003; Poschl J, 2014, ACTA NEUROPATHOL, V128, P123, DOI 10.1007/s00401-014-1297-8; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Salas S, 2015, CLIN CANCER RES, V21, P4194, DOI 10.1158/1078-0432.CCR-14-2910; SCHERER A., 2009, BATCH EFFECTS NOISE; Shaykhiev R, 2013, STEM CELLS, V31, P1992, DOI 10.1002/stem.1459; Singh D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107381; Stefan MB, 2014, MAGRITTR FORWARD PIP; Steve W, 2017, FOREACH PROVIDES FOR; Sun YH, 2014, J QIQIHAR U MED, V6, P860; Talhouk A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153844; Team,R.C, 2018, R LANG ENV STAT COMP; Trojani A, 2012, CANCER BIOMARK, V11, P15, DOI 10.3233/CBM-2012-0259; Tsay JCJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118132; Tung PY, 2017, SCI REP-UK, V7, DOI 10.1038/srep39921; Venables WN., 2002, MODERN APPL STAT S; Wang L, 2015, MATER TODAY COMMUN, V4, P22, DOI 10.1016/j.mtcomm.2015.03.001; Wegert J, 2015, CANCER CELL, V27, P298, DOI 10.1016/j.ccell.2015.01.002; Wen J, 2014, ANN ONCOL, V25, P1769, DOI 10.1093/annonc/mdu201; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2007, J STAT SOFTW, V21, P1; Zhang LW, 2014, NAT GENET, V46, P726, DOI 10.1038/ng.2995	58	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212669	10.1371/journal.pone.0212669	http://dx.doi.org/10.1371/journal.pone.0212669			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794641	Green Published, Green Submitted, gold			2022-12-27	WOS:000459709100109
J	Chadha, VK; Anjinappa, SM; Dave, P; Rade, K; Baskaran, D; Narang, P; Kolappan, C; Katoch, K; Sharma, SK; Rao, VG; Aggarwal, AN; Praseeja, P; Jitendra, R; Swaminathan, S				Chadha, V. K.; Anjinappa, Sharda M.; Dave, Paresh; Rade, Kiran; Baskaran, D.; Narang, P.; Kolappan, C.; Katoch, K.; Sharma, S. K.; Rao, V. G.; Aggarwal, A. N.; Praseeja, P.; Jitendra, R.; Swaminathan, S.			Sub-national TB prevalence surveys in India, 2006-2012: Results of uniformly conducted data analysis	PLOS ONE			English	Article							TUBERCULOSIS; DISTRICT; BURDEN	Setting Community based tuberculosis (TB) prevalence surveys in ten sites across India during 2006-2012 Objective To re-analyze data of recent sub-national surveys using uniform statistical methods and obtain a pooled national level estimate of prevalence of TB. Methods Individuals >= 15 years old were screened by interview for symptoms suggestive of Pulmonary TB (PTB) and history of anti-TB treatment; additional screening by chest radiography was undertaken in five sites. Two sputum specimens were examined by smear and culture among Screen-positives. Prevalence in each site was estimated after imputing missing values to correct for bias introduced by incompleteness of data. In five sites, prevalence was corrected for non-screening by radiography. Pooled prevalence of bacteriologically positive PTB was estimated using Random Effects Model after excluding data from one site. Overall prevalence of TB (all ages, all types) was estimated by adjusting for extra-pulmonary TB and Pediatric TB. Results Of 769290 individuals registered, 715989 were screened by interview and 294532 also by radiography. Sputum specimen were examined from 50 852 individuals. Estimated prevalence of smear positive, culture positive and bacteriologically positive PTB varied between 108.4-428.1, 147.9-429.8 and 170.8-528.4 per 100000 populations in different sites. Pooled estimate of prevalence of bacteriologically positive PTB was 350.0 (260.7, 439.0). Overall prevalence of TB was estimated at 300.7 (223.7-377.5) in 2009, the mid-year of surveys. Prevalence was significantly higher in rural compared to urban areas. Conclusion TB burden continues to be high in India suggesting further strengthening of TB control activities.	[Chadha, V. K.; Anjinappa, Sharda M.; Praseeja, P.; Jitendra, R.] Natl TB Inst, Bangalore, Karnataka, India; [Chadha, V. K.] Cent Leprosy Teaching & Res Inst, Chenglepattu, Tamil Nadu, India; [Dave, Paresh] State TB Cell, Ahmadabad, Gujarat, India; [Rade, Kiran] Minist Hlth & Family Welf, Cent TB Div, New Delhi, India; [Rade, Kiran] WHO, Country Off India, New Delhi, India; [Baskaran, D.; Kolappan, C.; Swaminathan, S.] Natl Inst Res TB, Chennai, Tamil Nadu, India; [Narang, P.] Mahatma Gandhi Inst Med Sci, Dept Microbiol, Wardha, Maharashtra, India; [Katoch, K.] Natl JALMA Inst Leprosy & Other Mycobacterial Dis, Agra, Uttar Pradesh, India; [Sharma, S. K.] All India Inst Med Sci, Dept Med, New Delhi, India; [Rao, V. G.] Indian Council Med Res, Reg Med Res Ctr Tribals, Jabalpur, Madhya Pradesh, India; [Aggarwal, A. N.] Postgrad Inst Med Educ & Res, Dept Pulm Med, Chandigarh, India; [Swaminathan, S.] ICMR, New Delhi, India; [Swaminathan, S.] WHO, Geneva, Switzerland	World Health Organization; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Mahatma Gandhi Institute of Medical Sciences, Sevagram; Indian Council of Medical Research (ICMR); ICMR - National JALMA Institute for Leprosy & Other Mycobacterial Diseases, Agra; All India Institute of Medical Sciences (AIIMS) New Delhi; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tribal Health (NIRTH); Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Indian Council of Medical Research (ICMR); World Health Organization	Chadha, VK (corresponding author), Natl TB Inst, Bangalore, Karnataka, India.; Chadha, VK (corresponding author), Cent Leprosy Teaching & Res Inst, Chenglepattu, Tamil Nadu, India.	vineet2.chadha@gmail.com	Rade, Kiran/AAU-9564-2020	Rade, Kiran/0000-0001-7601-0780; Chadha, Vineet/0000-0003-4457-4842	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Aggarwal AN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117363; [Anonymous], 1974, Bull World Health Organ, V51, P473; Central TB Division Directorate General Health Services Ministry of Health and Family Welfare Government of India, TRAIN MAN MYC TUB CU; Central TB Division Directorate General Health Services Ministry of Health and Family Welfare Government of India, REV NAT TB CONTR PRO; Chadha VK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042625; Chadha VK, 2005, INT J TUBERC LUNG D, V9, P1072; Chadha VK., TXB PULMONARY CRITIC, P489; Dhanaraj B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124260; Dodd PJ, 2014, LANCET GLOB HEALTH, V2, pE453, DOI 10.1016/S2214-109X(14)70245-1; GOTHI GD, 1976, INDIAN J MED RES, V64, P1150; India New Delhi Tuberculosis Centre, 1999, Indian Journal of Tuberculosis, V46, P113; Indian Council of Medical Research, 1955, ICMR SPEC REP SER, V34, P1955; Indian Council of Medical Research, 1959, ICMR SPEC REP SER, V34; Katoch K, 2015, J INFECT PULM DIS, V1, P2, DOI DOI 10.16966/JIPD.108; Kolappan C, 2013, Indian J Tuberc, V60, P168; Loh LC, 2013, B WORLD HEALTH ORGAN, V91, P227, DOI 10.2471/BLT.12.110791; LORIAN V, 1969, APPL MICROBIOL, V17, P202, DOI 10.1128/AEM.17.2.202-207.1969; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; Narang P, 2015, J EPIDEMIOL GLOB HEA, V5, pS11, DOI 10.1016/j.jegh.2015.03.002; Nayar S, 1982, 585281ECD1 MAH GANDH; Office of the Registrar General & Census Commissioner India, PROJ TOT POP SEX 1 M; Radhakrishna S, 2001, INT J TUBERC LUNG D, V5, P142; Rao VG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043225; Sharma SK, 2015, INDIAN J MED RES, V141, P228, DOI 10.4103/0971-5916.155593; State TB Cell Department of Health & Family Welfare Government of Gujarat, 2013, REP POP BAS SURV ASS; van't Hoog AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038691; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization,, 2011, TUB PREV SURV HDB, V2nd	28	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212264	10.1371/journal.pone.0212264	http://dx.doi.org/10.1371/journal.pone.0212264			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794595	gold, Green Published, Green Submitted			2022-12-27	WOS:000459709100051
J	Marushka, L; Kenny, TA; Batal, M; Cheung, WWL; Fediuk, K; Golden, CD; Salomon, AK; Sadik, T; Weatherdon, LV; Chan, HM				Marushka, Lesya; Kenny, Tiff-Annie; Batal, Malek; Cheung, William W. L.; Fediuk, Karen; Golden, Christopher D.; Salomon, Anne K.; Sadik, Tonio; Weatherdon, Lauren V.; Chan, Hing Man			Potential impacts of climate-related decline of seafood harvest on nutritional status of coastal First Nations in British Columbia, Canada	PLOS ONE			English	Article							NORTHWEST COAST; FOOD INSECURITY; DIET QUALITY; GLOBAL OCEAN; MARINE; FISHERIES; ADAPTATION; HEALTH; SHELLFISH; INUIT	Background Traditional food systems are under pressure from various stressors, including climate change which is projected to negatively alter the abundance of marine species harvested by coastal First Nations (FNs) in British Columbia (BC). Objective To model the potential impacts of the climate-related declines in seafood production on the nutritional status of coastal BC FNs. In addition, we projected potential changes in nutrient intakes, under different scenarios of substitution where traditional seafood is replaced with alternative non-traditional foods. Methods The study design is a mixed-method approach that combines two datasets: projected scenarios of climate-related change on seafood catch potential for coastal BC FNs and data derived from the cross-sectional First Nations Food, Nutrition, and Environment Study. The consumption of seafood was estimated using a food frequency questionnaire among 356 FNs. The contribution of seafood consumption to protein, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), vitamins (A, B12, D, niacin), and minerals (zinc, selenium and iron) requirements was assessed using Dietary Reference Intakes (DRIs). Results Traditional seafood consumption provided daily recommendations of EPA+DHA (74-184%) and vitamin B12 (84-152%) and substantial levels of niacin (28-55%), selenium (29-55%), vitamin D (15-30%) and protein (14-30%). Projected climate change was estimated to reduce the intakes of essential nutrients by 21% and 31% under 'strong mitigation' (Representative Concentration Pathway, RCP2.6) and 'business-as-usual' (RCP8.5) climate change scenarios, respectively, by the year 2050 relative to 2000. The hypothetical substitution of seafood with selected alternative non-traditional foods does not provide adequate amounts of nutrients. Conclusion Traditionally-harvested seafood remains fundamental to the contemporary diet and health of coastal BC FNs. Potential dietary shifts aggravated by climate-related declines in seafood consumption may have significant nutritional and health implications for BC FN. Strategies to improve access to seafood harvest potential in coastal communities are needed to ensure nutritional health and overall well-being and to promote food security and food sovereignty in coastal FNs.	[Marushka, Lesya; Kenny, Tiff-Annie; Chan, Hing Man] Univ Ottawa, Dept Biol, Ottawa, ON, Canada; [Batal, Malek] Univ Montreal, Fac Med, Dept Nutr, Pavillon Liliane de Stewart, Montreal, PQ, Canada; [Cheung, William W. L.] Univ British Columbia, Changing Ocean Res Unit, Inst Oceans & Fisheries, Vancouver, BC, Canada; [Cheung, William W. L.] Univ British Columbia, Inst Oceans & Fisheries, Nippon Fdn, UBC Nereus Program, Vancouver, BC, Canada; [Golden, Christopher D.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Golden, Christopher D.] Harvard Univ, Ctr Environm, Cambridge, MA 02138 USA; [Salomon, Anne K.] Simon Fraser Univ, Sch Resource & Environm Management, Burnaby, BC, Canada; [Sadik, Tonio] Assembly First Nations, Ottawa, ON, Canada; [Weatherdon, Lauren V.] UN Environm World Conservat Monitoring Ctr, Cambridge, England	University of Ottawa; Universite de Montreal; University of British Columbia; University of British Columbia; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Simon Fraser University	Chan, HM (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON, Canada.	laurie.chan@uottawa.ca		Weatherdon, Lauren V./0000-0002-3989-027X; Marushka, Lesya/0000-0001-8040-1004; Chan, Laurie/0000-0003-4351-7483; Kenny, Tiff-Annie/0000-0001-9688-6149	Health Canada; Canadian Institute of Health Research; Canada Research Chair; Welcome Trust Our Planet, Our Health program [106864MA]; National Socio-Environmental Synthesis Center (SESYNC) from National Science Foundation [DBI-1052875]	Health Canada; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Welcome Trust Our Planet, Our Health program; National Socio-Environmental Synthesis Center (SESYNC) from National Science Foundation(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by: 1. Health Canada, https://www.canada.ca/en/health-canada.html, funding to HMC, MB and TS, Funder has no role on the research; 2. Canadian Institute of Health Research, http://www.cihr-irsc.gc.ca/e/193.html, funding to HMC, Funder has no role in the study; 3. Canada Research Chair, http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx, funding to HMC, Funder has no role in the study; 4. Welcome Trust Our Planet, Our Health program [Grant number: 106864MA], https://wellcome.ac.uk/home, funding to CDG, Funder has no role in the study; 5. the National Socio-Environmental Synthesis Center (SESYNC) under funding received from the National Science Foundation DBI-1052875, https://www.sesync.org/, funding to CDG, Funder has no role in the study.	Academy FTHE, 2014, POS AC NUTR DIET DIE; ADA & Journal of the American Dietetic Association, 2007, J AM DIET ASSOC, V107, P2151; Adelson N, 2005, CAN J PUBLIC HEALTH, V96, pS45, DOI 10.1007/BF03403702; AFN, 2017, ASS 1 NAT; Anderson TJ, 2016, CAN J CARDIOL, V32, P1263, DOI 10.1016/j.cjca.2016.07.510; Austin SE, 2015, INT J ENV RES PUB HE, V12, P623, DOI 10.3390/ijerph120100623; Batal M, 2017, QUANTIFYING ASS DIET, P1; Baum J.K., 2016, CANADAS MARINE FISHE; BC AFN, 2017, BRIT COL ASS 1 NAT; Bene C, 2015, FOOD SECUR, V7, P261, DOI 10.1007/s12571-015-0427-z; Bennett M., 1971, INDIAN FISHING ITS C; Brian Morton, VANCOUVER SUN NEWS; Brown F, 2009, STAYING COURSE STAYI, P1; Butler VL, 2004, J WORLD PREHIST, V18, P327, DOI 10.1007/s10963-004-5622-3; Chan L, 2011, 1 NATIONS FOOD NUTR; Chan LH, 1 NATIONS FOOD NUTR; Charlton KE, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2953-9; Cheung WWL, 2016, SCIENCE, V354, P1591, DOI 10.1126/science.aag2331; Cheung WWL, 2016, ICES J MAR SCI, V73, P1283, DOI 10.1093/icesjms/fsv250; Cheung WWL, 2016, ECOL MODEL, V325, P57, DOI 10.1016/j.ecolmodel.2015.12.018; Cheung WWL, 2013, NAT CLIM CHANGE, V3, P254, DOI 10.1038/NCLIMATE1691; Cheung WWL, 2010, GLOBAL CHANGE BIOL, V16, P24, DOI 10.1111/j.1365-2486.2009.01995.x; CHISHOLM BS, 1983, CURR ANTHROPOL, V24, P396, DOI 10.1086/203018; Cisneros-Montemayor AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166681; Colin G., 2017, DIVERSITY HUNTER GAT; DEUR D, 2005, TRADITIONS PLANT USE; Dunne JP, 2013, J CLIMATE, V26, P2247, DOI 10.1175/JCLI-D-12-00150.1; Egeland GM, 2011, J NUTR, V141, P1746, DOI 10.3945/jn.111.139006; Fang R, 2010, SUMMARY REPORT HLTH, P1; FNIGC, 2012, 1 NAT REG HLTH SURV, P1; Fong LC, SQUAMISH 1 NATION CO; Ford JD, 2014, AM J PUBLIC HEALTH, V104, pE9, DOI 10.2105/AJPH.2013.301724; Ford JD, 2010, GLOBAL ENVIRON CHANG, V20, P668, DOI 10.1016/j.gloenvcha.2010.05.003; Furgal C, 2006, ENVIRON HEALTH PERSP, V114, P1964, DOI 10.1289/ehp.8433; Garibaldi A, 2004, ECOL SOC, V9; Golden C, 2016, NATURE, V534, P317, DOI 10.1038/534317a; Government of Canada, AB FISH STRAT; Groesbeck AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091235; Harris D., 2010, ARCTIC REV LAW POLIT, V1, P82; Health Canada, 2008, STAT PROFL HLTH 1 NA; Health Canada, 2015, CAN NUTR FIL CNF 201; Health Canada, 2014, STAT PROF HLTH 1 NAT; Health Canada, 2012, HOUS FOOD SEC SURV M; HLPE, 2014, REP HIGH LEV PAN EXP; Huet C, 2012, J NUTR, V142, P541, DOI 10.3945/jn.111.149278; Institute of Medicine, 2003, MEDICINE, P237; Jackley J, 2016, ECOL SOC, V21, DOI 10.5751/ES-08747-210420; Johannes M, 2007, PACIFIC SALMON RESOU, P69; Kawarazuka, 2010, 2106 WORLDFISH; Krebs-smith SM, 1989, MEAN PROPORTION POPU, V5; Kuhnlein H., 2013, LLEGACY NUXALK FOOD, P159; Kuhnlein H. V., 2013, Indigenous peoples' food systems and well-being: interventions and policies for healthy communities, P3; Kuhnlein H. V., 2013, Indigenous peoples' food systems and well-being: interventions and policies for healthy communities, P237; Kuhnlein HV, 2007, J NUTR, V137, P1110, DOI 10.1093/jn/137.4.1110; Kuhnlein HV, 1996, ANNU REV NUTR, V16, P417, DOI 10.1146/annurev.nu.16.070196.002221; KUHNLEIN HV, 1989, J CAN DIET ASSOC, V50, P102; Lam VWY, 2016, SCI REP-UK, V6, DOI 10.1038/srep32607; Lawn J, 2004, NUTR FOOD SECURITY F; Lehn Don, 2018, FRASER VALLEY 1 NATI; Lepofsky D, 2015, AM ANTIQUITY, V80, P236, DOI 10.7183/0002-7316.80.2.236; McKechnie I, 2014, P NATL ACAD SCI USA, V111, pE807, DOI 10.1073/pnas.1316072111; Mos L, 2004, J TOXICOL ENV HEAL A, V67, P791, DOI 10.1080/15287390490428224a; MOSS ML, 1993, AM ANTHROPOL, V95, P631, DOI 10.1525/aa.1993.95.3.02a00050; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Nancarrow TL, 2010, RURAL REMOTE HEALTH, V10; Nesbitt HK, 2016, J APPL ECOL, V53, P1489, DOI 10.1111/1365-2664.12717; Nord M., 2010, HOUSEHOLD FOOD SECUR; Office of the Provincial Health Officer, 2015, 1 NAT HLTH WELL BEIN; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Otten Jennifer, 2006, DIETARY DRI REFERENC; Pauly D, 2018, GLOBAL CHANGE BIOL, V24, pE15, DOI 10.1111/gcb.13831; Quinn S. B. C., 2018, 1 NATIONS GET CLARIT; Reading C. L., 2009, HLTH INEQUALITIES SO, P1; Reid MG, 2014, J ETHNOBIOL, V34, P401, DOI 10.2993/0278-0771-34.3.401; Rosol R, 2016, INT J CIRCUMPOL HEAL, V75, DOI 10.3402/ijch.v75.31127; Ross AC, 2011, Dietary Reference Intakes for Calcium and Vitamin D, P1; Sheehy T, 2015, J HUM NUTR DIET, V28, P262, DOI 10.1111/jhn.12243; Socha T., 2012, Journal of Aboriginal Health, V8, P5; State Pharmacopoeia Commission, 2015, POPULATION WELFARE, P1; Statistics Canada, 2009, OV OB AD SELF REP; Statistics Canada, 2010, HOUS FOO INS CAN 200; Statistics Canada, 2010, SMOK 2009; Statistics Canada, 2009, LAB MARK REV 2009; Statistics Canada, 2017, AB PEOPL CAN KEY RES; Sturtevant William C., 1978, HDB N AM INDIANS; Turner NJ, 2009, GLOBAL ENVIRON CHANG, V19, P180, DOI 10.1016/j.gloenvcha.2009.01.005; UN-OCHA, 2017, SUST DEV GOALS REP, P1, DOI DOI 10.18356/3405D09F-EN; Weatherdon L V, 2016, PLOS ONE, V11, P1, DOI DOI 10.1371/J0URNAL.P0NE.0145285; Weatherdon LV, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00048; Whaley SE, 2003, J NUTR, V133, p3965S, DOI 10.1093/jn/133.11.3965S; Williams T, 2013, CLIMATIC CHANGE, V120, P531, DOI 10.1007/s10584-013-0850-0; Willows N, 2011, HEAL REPORTS STAT CA, V22; Willows ND, 2005, CAN J PUBLIC HEALTH, V96, pS32, DOI 10.1007/BF03405199	93	16	16	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211473	10.1371/journal.pone.0211473	http://dx.doi.org/10.1371/journal.pone.0211473			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM9LQ	30811408	gold, Green Published, Green Submitted			2022-12-27	WOS:000459806400019
J	Yabe, T; Sekimoto, Y; Tsubouchi, K; Ikemoto, S				Yabe, Takahiro; Sekimoto, Yoshihide; Tsubouchi, Kota; Ikemoto, Satoshi			Cross-comparative analysis of evacuation behavior after earthquakes using mobile phone data	PLOS ONE			English	Article							SYSTEM; GPS	Despite the importance of predicting evacuation mobility dynamics after large scale disasters for effective first response and disaster relief, our general understanding of evacuation behavior remains limited because of the lack of empirical evidence on the evacuation movement of individuals across multiple disaster instances. Here we investigate the GPS trajectories of a total of more than 1 million anonymized mobile phone users whose positions were tracked for a period of 2 months before and after four of the major earthquakes that occurred in Japan. Through a cross comparative analysis between the four disaster instances, we find that in contrast to the assumed complexity of evacuation decision making mechanisms in crisis situations, an individual's evacuation probability is strongly dependent on the seismic intensity that they experience. In fact, we show that the evacuation probabilities in all earthquakes collapse into a similar pattern, with a critical threshold at around seismic intensity 5.5. This indicates that despite the diversity in the earthquakes profiles and urban characteristics, evacuation behavior is similarly dependent on seismic intensity. Moreover, we found that probability density functions of the distances that individuals evacuate are not dependent on seismic intensities that individuals experience. These insights from empirical analysis on evacuation from multiple earthquake instances using large scale mobility data contributes to a deeper understanding of how people react to earthquakes, and can potentially assist decision makers to simulate and predict the number of evacuees in urban areas with little computational time and cost. This can be achieved by utilizing only the information on population density distribution and seismic intensity distribution, which can be observed instantaneously after the shock.	[Yabe, Takahiro; Sekimoto, Yoshihide] Univ Tokyo, Dept Civil Engn, Tokyo, Japan; [Sekimoto, Yoshihide] Univ Tokyo, Inst Ind Sci, Tokyo, Japan; [Tsubouchi, Kota] Yahoo Japan Corp, Tokyo, Japan; [Ikemoto, Satoshi] Zenrin DataCom Corp, Tokyo, Japan; [Yabe, Takahiro] Purdue Univ, Lyles Sch Civil Engn, W Lafayette, IN 47907 USA	University of Tokyo; University of Tokyo; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Yabe, T (corresponding author), Univ Tokyo, Dept Civil Engn, Tokyo, Japan.; Yabe, T (corresponding author), Purdue Univ, Lyles Sch Civil Engn, W Lafayette, IN 47907 USA.	tyabe@purdue.edu		Yabe, Takahiro/0000-0001-8967-1967	Yahoo Japan Corporation; Zenrin DataCom Corporation;  [17J09460]	Yahoo Japan Corporation; Zenrin DataCom Corporation; 	TY was supported by Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) Research Fellow 17J09460. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders (Yahoo Japan Corporation and Zenrin DataCom Corporation) provided support in the form of salaries for authors KT and SI, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We thank Dr. Naoya Fujiwara of Tohoku University and Dr. Akihito Sudo of Shizuoka University for many fruitful discussions. Takahiro Yabe was supported by Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) Research Fellow 17J09460.	[Anonymous], 2016, MAINICHI NEWSPAPER; Ashbrook D, 2003, PERS UBIQUIT COMPUT, V7, P275, DOI 10.1007/s00779-003-0240-0; Bagrow JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017680; Baker JW, 2015, EARTHQ SPECTRA, V31, P579, DOI 10.1193/021113EQS025M; Bengtsson L, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001083; Chiaro G, 2017, RECONNISSANCE REPORT; de Montjoye YA, 2013, SCI REP-UK, V3, DOI 10.1038/srep01376; Demissie MG, 2013, TRANSPORT RES C-EMER, V32, P76, DOI 10.1016/j.trc.2013.03.010; Deville P, 2014, P NATL ACAD SCI USA, V111, P15888, DOI 10.1073/pnas.1408439111; Gething PW, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001085; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Heath R., 1995, DISASTER PREVENTION, V4, P11, DOI DOI 10.1108/09653569510100965; Hirose F, 2011, EARTH PLANETS SPACE, V63, P513, DOI 10.5047/eps.2011.05.019; Horanont T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081153; Horanont T, 2013, IEEE INTELL SYST, V28, P26, DOI 10.1109/MIS.2013.3; Iqbal MS, 2014, TRANSPORT RES C-EMER, V40, P63, DOI 10.1016/j.trc.2014.01.002; Jiang S, 2016, P NATL ACAD SCI USA, V113, pE5370, DOI 10.1073/pnas.1524261113; Kagawa T, 2017, EARTH PLANETS SPACE, V69, DOI 10.1186/s40623-017-0689-0; Kanasugi H, 2013, INT CONF PERVAS COMP, P267; Koshimura S, 2009, COAST ENG J, V51, P243, DOI 10.1142/S0578563409002004; Kryvasheyeu Y, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500779; Kryvasheyeu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117288; Lin AM, 2015, TECTONOPHYSICS, V656, P142, DOI 10.1016/j.tecto.2015.06.018; Lu X, 2012, P NATL ACAD SCI USA, V109, P11576, DOI 10.1073/pnas.1203882109; Mimura N, 2011, MITIG ADAPT STRAT GL, V16, P803, DOI 10.1007/s11027-011-9297-7; Nishi Kentaro, 2014, P 22 ACM SIGSPATIAL, P281; OpenStreetMap contributors, 2017, PLAN DUMP; Phithakkitnukoon S, 2015, PERVASIVE MOB COMPUT, V18, P18, DOI 10.1016/j.pmcj.2014.07.003; Phithakkitnukoon S, 2010, LECT NOTES COMPUT SC, V6219, P14, DOI 10.1007/978-3-642-14715-9_3; Sekimoto Y, 2011, IEEE PERVAS COMPUT, V10, P27, DOI 10.1109/MPRV.2011.43; Shimosaka M, 2015, PROCEEDINGS OF THE 2015 ACM INTERNATIONAL JOINT CONFERENCE ON PERVASIVE AND UBIQUITOUS COMPUTING (UBICOMP 2015), P535, DOI 10.1145/2750858.2807527; Shirahama Y, 2016, EARTH PLANETS SPACE, V68, DOI 10.1186/s40623-016-0559-1; Song X, 2013, IEEE INTELL SYST, V28, P35, DOI 10.1109/MIS.2013.35; Tokyo Metropolitan Government, 2012, REP DAM EST TOK DUE; Tsubokura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081909; Wang P, 2012, SCI REP-UK, V2, DOI 10.1038/srep01001; Wang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112608; Wang Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154547; Wardrop NA, 2018, P NATL ACAD SCI USA, V115, P3529, DOI 10.1073/pnas.1715305115; Wilson Robin, 2016, PLoS Curr, V8, DOI 10.1371/currents.dis.d073fbece328e4c39087bc086d694b5c; Yabe T, 2016, P 24 ACM SIGSPATIAL; Yabe T., 2016, P 5 INT WORKSH URB C, V81, P1; Yun NY, 2015, EARTHQ SPECTRA, V31, P1237, DOI 10.1193/082013EQS234M	46	26	26	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211375	10.1371/journal.pone.0211375	http://dx.doi.org/10.1371/journal.pone.0211375			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785908	gold, Green Published, Green Submitted			2022-12-27	WOS:000459307000022
J	Rodriguez, JE; Marzo, JC; Piqueras, JA				Rodriguez, Jesus E.; Marzo, Juan C.; Piqueras, Jose A.			Efficacy of Sphincter Control Training (SCT) in the treatment of premature ejaculation, a new cognitive behavioral approach: A parallel-group randomized, controlled trial	PLOS ONE			English	Article								Introduction Current evidence suggests that Cognitive Behavioral therapy (CBT) has a limited role in the contemporary management of premature ejaculation (PE). Aim The aim of this study was to determine the efficacy of a new CBT for the PE called Sphincter Control Training (SCT) in combination with a masturbation aid device. Methods The present study included 35 patients' that met diagnostic criteria for PE including intravaginal ejaculatory latency time (IELT) of <= 2 minutes and had a Premature Ejaculation Diagnostic Tool (PEDT) score >= 11. Participants completed all phases of a randomized controlled clinical study with a parallel group design, which was approved by the Ethical Committee of the Hospital Morales Meseguer of Murcia (Spain). The two treatment groups completed SCT over 7 weeks. The SCT consists of four different exercises and an educational session. Its objective is to provide patients with greater knowledge, awareness, and control of the external urethral sphincter. The only difference between groups was the use of a masturbation aid device called Flip Zero (TFZ-001) from the Japanese company Tenga Co., Ltd. Outcomes The main measure was the "fold increase" (FI) of the IELT, which was calculated using the geometric mean pre-treatment and post-treatment. In addition, Premature Ejaculation Profile PE was used as a secondary measure. Results The geometric mean of the measurements corresponding to the 7 weeks of treatment was calculated, and both groups were compared by means of an ANCOVA test, finding a statistically significant difference (F: 10.51, 1; p=.003) in the increase experienced by subjects in the group with the device (GWD) mean = 166.63, SD = 106.54) compared with that experienced by subjects in the group without device (GWtD) (mean = 86.99, SD = 59.98). Using Student's t-test, the Fold increase (FI) corresponding to both groups were compared. The results showed statistically significant differences (p=.008) between the measurements corresponding to the GWtD (1.38 (0.50)) and those relative to the GWD (2.69 (1.81)) Clinical implications The FI in the GWD at the end of the trial allow us to consider this new CBT as a potential and viable PE treatment alternative. No side effects were observed in either treatment group and it required little therapeutic input and no partner involvement. Strengths & limitations The main limitation of this study is the lack of a 3- to 6-month follow-up of the treatment and placebo control. Conclusions This SCT exercise program combined with the use of a masturbation device shows promise because has numerous advantages in relation to current recommended treatments in patients with PE.	[Rodriguez, Jesus E.] Murcian Inst Sexol, Murcia, Spain; [Marzo, Juan C.; Piqueras, Jose A.] Univ Miguel Hernandez Elche, Dept Hlth Psychol, Elche, Spain	Universidad Miguel Hernandez de Elche	Rodriguez, JE (corresponding author), Murcian Inst Sexol, Murcia, Spain.	jesuseugenio@isemu.es	MARTINEZ, JESUS EUGENIO RODRIGUEZ/AAS-8187-2021; Marzo, Juan C/L-7013-2014; Piqueras, Jose A/C-6011-2011	MARTINEZ, JESUS EUGENIO RODRIGUEZ/0000-0001-8404-1413; Marzo, Juan C/0000-0003-4284-6744; Piqueras, Jose A/0000-0002-3604-5441				Althof S, 2016, TRANSLATIONAL ANDROL, V5; Althof SE, 2016, TRANSL ANDROL UROL, V5, P470, DOI 10.21037/tau.2016.05.04; Althof SE, 2014, J SEX MED, V11, P1392, DOI 10.1111/jsm.12504; [Anonymous], 2015, ASIAN PAC J REPROD; Bar-Or D, 2012, EUR UROL, V61, P736, DOI 10.1016/j.eururo.2011.08.039; Cooper K, 2015, SEX MED-UK, V3, P174, DOI 10.1002/sm2.65; Cruz N, 2012, TRATADO ANDROLOGIA M, P669; Giuliano F, 2008, EUR UROL, V53, P1048, DOI 10.1016/j.eururo.2007.10.015; Jern P, 2014, J SEX MARITAL THER, V40, P358, DOI 10.1080/0092623X.2013.857376; McMahon Chris G, 2015, Sex Med Rev, V3, P183, DOI 10.1002/smrj.49; McMahon CG, 2016, TRANSL ANDROL UROL, V5, P508, DOI 10.21037/tau.2016.03.28; Park HJ, 2017, SEX MED-UK, V5, pE99, DOI 10.1016/j.esxm.2017.02.003; Patrick DL, 2009, BJU INT, V103, P358, DOI 10.1111/j.1464-410X.2008.08041.x; Robert Saitz T, 2016, TRANSLATIONAL ANDROL, V5; Rodriguez J.E., 2016, ASIAN PAC J REPROD, V5, P80, DOI DOI 10.1016/j.apjr.2015.12.015; Rodriguez JE, 2017, REV PSICOLOGIA SALUD, V5, P114; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; SEMANS J H, 1956, South Med J, V49, P353; Symonds T, 2007, INT J IMPOT RES, V19, P521, DOI 10.1038/sj.ijir.3901567; Waldinger MD, 2008, J SEX MED, V5, P492, DOI 10.1111/j.1743-6109.2007.00696.x; Wise MEJ, 2000, SEX RELATSH THER, V15, P345	21	4	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0212274	10.1371/journal.pone.0212274	http://dx.doi.org/10.1371/journal.pone.0212274			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807583	Green Published, Green Submitted, gold			2022-12-27	WOS:000459712100013
J	Dolan, CB; BenYishay, A; Grepin, KA; Tanner, JC; Kimmel, AD; Wheeler, DC; McCord, GC				Dolan, Carrie B.; BenYishay, Ariel; Grepin, Karen A.; Tanner, Jeffery C.; Kimmel, April D.; Wheeler, David C.; McCord, Gordon C.			The impact of an insecticide treated bednet campaign on all-cause child mortality: A geospatial impact evaluation from the Democratic Republic of Congo	PLOS ONE			English	Article							MALARIA CONTROL; INFANT-MORTALITY; PLASMODIUM-FALCIPARUM; AFRICA; ERADICATION; STRATEGIES; EFFICACY; PROGRESS; ECOLOGY; HEALTH	Objective To test the impact of a nationwide Long-Lasting Insecticidal Nets [LLINs] distribution program in the Democratic Republic of Congo [DRC] on all-cause under-five child mortality exploiting subnational variation in malaria endemicity and the timing in the scale-up of the program across provinces. Design Geospatial Impact Evaluation using a difference-in-differences approach. Setting Democratic Republic of the Congo. Participants 52,656 children sampled in the 2007 and 2013/2014 DRC Demographic and Health Surveys. Interventions The analysis provides plausibly causal estimates of both average treatment effects of the LLIN distribution campaign and geospatial heterogeneity in these effects based on malaria endemicity. It compares the under-five, all-cause mortality for children pre- and post-LLIN campaign relative to children in those areas that had not yet been exposed to the campaign using a difference-in-differences model and controlling for year- and province-fixed effects, and province-level trends in mortality. Results We find that the campaign led to a 41% decline [3.7 percentage points, 95% CI 1.3 to 6.0] in under-5 mortality risk among children living in rural areas with malaria ecology above the sample median. Results were robust to controlling for household assets and the presence of other health aid programs. No effect was detected in children living in areas with malaria ecology below the median. Conclusion The findings of this paper make important contributions to the evidence base for the effectiveness of large scale-national LLIN campaigns against malaria. We found that the program was effective in areas of the DRC with the highest underlying risk of malaria. Targeting bed-nets to areas with greatest underlying risk for malaria may help to increase the efficiency of increasingly limited malaria resources but should be balanced against other malaria control concerns.	[Dolan, Carrie B.] William & Mary, Dept Kinesiol & Hlth Sci, Williamsburg, VA 23185 USA; [BenYishay, Ariel] William & Mary, Dept Econ, Williamsburg, VA USA; [Grepin, Karen A.] Wilfrid Laurier Univ, Dept Hlth Sci, Waterloo, ON, Canada; [Tanner, Jeffery C.] World Bank, Independent Evaluat Grp, 1818 H St NW, Washington, DC 20433 USA; [Kimmel, April D.] Virginia Commonwealth Univ, Hlth Behav & Policy, Richmond, VA USA; [Wheeler, David C.] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA USA; [McCord, Gordon C.] Univ Calif San Diego, Sch Global Policy & Strategy, San Diego, CA 92103 USA	Wilfrid Laurier University; The World Bank; Virginia Commonwealth University; Virginia Commonwealth University; University of California System; University of California San Diego	Dolan, CB (corresponding author), William & Mary, Dept Kinesiol & Hlth Sci, Williamsburg, VA 23185 USA.	cbdolan@wm.edu	Grepin, Karen Ann/P-1248-2018	Grepin, Karen Ann/0000-0003-4368-0045; McCord, Gordon/0000-0001-5042-9225; Dolan, Carrie/0000-0002-4445-7075	government of Japan through a Policy and Human Resources Development Grant	government of Japan through a Policy and Human Resources Development Grant	This work was partially funded through a generous grant from the government of Japan through a Policy and Human Resources Development Grant, for which the team is grateful. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai CR, 2003, ECON LETT, V80, P123, DOI 10.1016/S0165-1765(03)00032-6; Akachi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021309; [Anonymous], PLOS ONE; Aregawi MW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-46; BenYishay A, 2015, J HUM RESOUR, V50, P516, DOI 10.3368/jhr.50.2.516; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Bleakley H, 2010, AM ECON J-APPL ECON, V2, P1, DOI 10.1257/app.2.2.1; Coghlan B, 2006, LANCET, V367, P44, DOI 10.1016/S0140-6736(06)67923-3; Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4; Coulibaly D, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-374; Cutler D, 2010, AM ECON J-APPL ECON, V2, P72, DOI 10.1257/app.2.2.72; Demombynes G, 2016, ECON HUM BIOL, V21, P17, DOI 10.1016/j.ehb.2015.11.004; Deuchert E, 2010, EVALUATING NATIONWID; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Flaxman AD, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000328; Gething PW, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-39; Giardina F, 2014, LANCET GLOB HEALTH, V2, pe615; Girond F, 2018, ECLINICALMEDICINE, V1, P62, DOI 10.1016/j.eclinm.2018.07.003; Grepin KA, 2012, HEALTH AFFAIR, V31, P1406, DOI 10.1377/hlthaff.2012.0279; International Diabetes Federation, 2013, DIABETES ATLAS, P13; Ishida K, 2011, POP STUD-J DEMOG, V65, P57, DOI 10.1080/00324728.2010.544323; Jagannathan P, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-435; Jakubowski A, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002319; Kiszewski A, 2004, AM J TROP MED HYG, V70, P486, DOI 10.4269/ajtmh.2004.70.486; Kleinschmidt I, 2009, AM J TROP MED HYG, V80, P882, DOI 10.4269/ajtmh.2009.80.882; Kyu HH, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-14; Landoh ED, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-389; Lengeler C., 2004, INSECTICIDE TREATED; Lewin S, 2009, HEALTH RES POLICY SY, V7, DOI 10.1186/1478-4505-7-S1-S8; Lim SS, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001091; Louis VR, 2015, B WORLD HEALTH ORGAN, V93, P750, DOI 10.2471/BLT.14.147702; Lucas AM, 2010, AM ECON J-APPL ECON, V2, P46, DOI 10.1257/app.2.2.46; Macintyre S, 2002, SOC SCI MED, V55, P125, DOI 10.1016/S0277-9536(01)00214-3; Mayer JD, 2000, SOC SCI MED, V50, P937, DOI 10.1016/S0277-9536(99)00346-9; McCord GC, 2017, AM J TROP MED HYG, V96, P616, DOI 10.4269/ajtmh.16-0602; Mukonka VM, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-153; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; Njau JD, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-245; Noor AM, 2014, LANCET, V383, P1739, DOI 10.1016/S0140-6736(13)62566-0; Noor AM, 2009, LANCET, V373, P58, DOI 10.1016/S0140-6736(08)61596-2; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Okiro EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062214; Okiro Emelda A, 2009, BMC Med, V7, P75, DOI 10.1186/1741-7015-7-75; Pathania V, 2014, ECON DEV CULT CHANGE, V62, P459, DOI 10.1086/675382; Pigott DM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-246; Pongou R, 2013, DEMOGRAPHY, V50, P421, DOI 10.1007/s13524-012-0161-5; President's MI, 2014, MAL OP PLAN FY2014; Rajaratnam JK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000253; Simon C, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-458; Snow RW, 2010, LANCET, V376, P137, DOI 10.1016/S0140-6736(10)60577-6; The WB, 2005, PROJ APPR DOC PROP G; USAID, 2017, GLOB HLTH DEM REP CO; WHO, 2015, WORLD MAL REP 2015; World Health Organization, 2017, DEPRESSION; Zelman B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115714; 2012, WORLD MAL REP 2012, P1	57	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212890	10.1371/journal.pone.0212890	http://dx.doi.org/10.1371/journal.pone.0212890			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794694	Green Published, gold			2022-12-27	WOS:000459709100156
J	Chen, YK; Zhang, B; Li, CH; Lei, CX; Kong, CY; Yang, Y; Gong, M				Chen, Yongkun; Zhang, Bo; Li, Canhui; Lei, Chunxia; Kong, Chunyan; Yang, Yu; Gong, Ming			A comprehensive expression analysis of the expansin gene family in potato (Solanum tuberosum) discloses stress-responsive expansin-like B genes for drought and heat tolerances	PLOS ONE			English	Article							MODULATES LEAF GROWTH; CELL-WALLS; PLANT; ROOT; PROTEINS; IDENTIFICATION; RESISTANCE; INDUCTION; TAEXPB23; RICE	Expansin is a type of cell wall elongation and stress relaxation protein involved in various developmental processes and stress resistances in plant. In this study, we identified 36 potato (Solanum tuberosum L.) genes belonging to the expansin (StEXP) gene family from the genome reference. These genes included 24 alpha-expansins (StEXPAs), five beta-expansins (StEXPBs), one expansin-like A (StEXLA) and six expansin-like B (StEXLBs). The RNA-Seq analysis conducted from a variety of tissue types showed 34 expansins differentially expressed among tissues, some of which only expressed in specific tissues. Most of the StEXPAs and StEXPB2 transcripts were more abundant in young tuber compared with other tissues, suggesting they likely play a role in tuber development. There were 31 genes, especially StEXLB6, showed differential expression under the treatments of ABA, IAA and GA3, as well as under the drought and heat stresses, indicating they were likely involved in potato stress resistance. In addition, the gene co-expression analysis indicated the StEXLBs likely contribute to a wider range of stress resistances compared with other genes. We found the StEXLA and six StEXLBs expressed differently under a range of abiotic stresses (salt, alkaline, heavy metals, drought, heat, and cold stresses), which likely participated in the associated signaling pathways. Comparing with the control group, potato growing under the drought or heat stresses exhibited up-regulation of the all six StEXLB genes in leaves, whereas, the StEXLB3, StEXLB4, StEXLB5 and StEXLB6 showed relatively higher expression levels in roots. This suggested these genes likely played a role in the drought and heat tolerance. Overall, this study has shown the potential role of the StEXP genes in potato growth and stress tolerance, and provided fundamental resources for the future studies in potato breeding.	[Chen, Yongkun; Lei, Chunxia; Kong, Chunyan; Yang, Yu; Gong, Ming] Yunnan Normal Univ, Sch Life Sci, Kunming, Yunnan, Peoples R China; [Zhang, Bo; Li, Canhui] Yunnan Normal Univ, Joint Acad Potato Sci, Kunming, Yunnan, Peoples R China	Yunnan Normal University; Yunnan Normal University	Gong, M (corresponding author), Yunnan Normal Univ, Sch Life Sci, Kunming, Yunnan, Peoples R China.	gongming63@163.com	Loukopoulos, Panayiotis/AAC-4164-2020; Quinn, Jane C/ABC-9968-2020; Weston, Leslie/M-4557-2015	Loukopoulos, Panayiotis/0000-0002-4308-8618; Weston, Leslie/0000-0002-1029-7982; Quinn, Jane/0000-0002-9310-0291	National Natural Science Foundation of China [31460059]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by National Natural Science Foundation of China, grant number 31460059. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qsous S, 2004, PLANTA, V219, P369, DOI 10.1007/s00425-004-1246-1; [柏锡 Bai Xi], 2013, [东北农业大学学报, Journal of Northeast Agricultural University], V44, P139; Bajwa KS, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00838; Barilli E, 2015, PLANTA, V242, P1095, DOI 10.1007/s00425-015-2339-8; Brummell DA, 2002, POSTHARVEST BIOL TEC, V25, P209, DOI 10.1016/S0925-5214(01)00179-X; Callebaut A, 1996, PLANT SCI, V118, P109, DOI 10.1016/0168-9452(96)04428-7; Chen YH, 2018, PLANT PHYSIOL BIOCH, V124, P190, DOI 10.1016/j.plaphy.2018.01.020; Chen YH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153494; Chen Y, 2017, MATER RES FOUND, V12, P94; Cho HT, 2000, P NATL ACAD SCI USA, V97, P9783, DOI 10.1073/pnas.160276997; Cho HT, 2002, PLANT CELL, V14, P3237, DOI 10.1105/tpc.006437; Cho HT, 1997, PLANT CELL, V9, P1661, DOI 10.1105/tpc.9.9.1661; Choi DS, 2003, PLANT CELL, V15, P1386, DOI 10.1105/tpc.011965; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Dai FW, 2012, PLANT PHYSIOL, V160, P2064, DOI 10.1104/pp.112.207720; Dal Santo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062206; Deepthi Vylassery, 2014, Archives of Phytopathology and Plant Protection, V47, P1390, DOI 10.1080/03235408.2013.843332; Ding AM, 2016, MOL GENET GENOMICS, V291, P1891, DOI 10.1007/s00438-016-1226-8; Ding XH, 2008, PLANT CELL, V20, P228, DOI 10.1105/tpc.107.055657; Duan Y, 2015, J ANIM PLANT SCI, V25, P1753; Guimaraes LA, 2017, PLANT MOL BIOL, V94, P79, DOI 10.1007/s11103-017-0594-8; Guo WB, 2011, PLANT J, V66, P541, DOI 10.1111/j.1365-313X.2011.04511.x; Han YY, 2012, PLANT PHYSIOL BIOCH, V54, P49, DOI 10.1016/j.plaphy.2012.02.007; Han YY, 2015, J PLANT PHYSIOL, V173, P62, DOI 10.1016/j.jplph.2014.09.007; Hastilestari BR, 2018, PLANT CELL ENVIRON, V41, P2600, DOI 10.1111/pce.13366; He XY, 2015, J EXP BOT, V66, P7405, DOI 10.1093/jxb/erv436; Hu B, 2014, ACTA PHYSIOL PLANT, V36, P2203, DOI 10.1007/s11738-014-1597-6; Huang SX, 2012, MOL GENET GENOMICS, V287, P495, DOI 10.1007/s00438-012-0696-6; Jiang F, 2008, J EXP BOT, V59, P37, DOI 10.1093/jxb/erm127; Jones DA, 1997, ADV BOT RES, V24, P89; Jung J, 2010, PLANT SCI, V179, P77, DOI 10.1016/j.plantsci.2010.04.007; Keegstra K, 2001, CURR OPIN PLANT BIOL, V4, P219, DOI 10.1016/S1369-5266(00)00164-3; Koh S, 2002, PLANT PHYSIOL, V128, P21, DOI 10.1104/pp.010332; Kruger J, 2002, SCIENCE, V296, P744, DOI 10.1126/science.1069288; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lamport DTA, 2011, PLANT PHYSIOL, V156, P11, DOI 10.1104/pp.110.169011; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Le Gall Hyacinthe, 2015, Plants-Basel, V4, P112, DOI 10.3390/plants4010112; Li AX, 2015, ENVIRON EXP BOT, V110, P73, DOI 10.1016/j.envexpbot.2014.10.002; Li F, 2011, J PLANT PHYSIOL, V168, P960, DOI 10.1016/j.jplph.2010.11.023; Lin C, 2011, MOL CELLS, V31, P393, DOI 10.1007/s10059-011-0046-2; Liu CM, 1998, PLANT PHYSIOL, V116, P91, DOI 10.1104/pp.116.1.91; Liu HB, 2016, PLANT CELL TISS ORG, V126, P353, DOI 10.1007/s11240-016-1003-8; Lu PT, 2013, PLANTA, V237, P1547, DOI 10.1007/s00425-013-1867-3; Lu YG, 2016, MOL GENET GENOMICS, V291, P597, DOI 10.1007/s00438-015-1133-4; Luthje S, 1997, BBA-REV BIOMEMBRANES, V1331, P81, DOI 10.1016/S0304-4157(96)00016-0; Marowa P, 2016, PLANT CELL REP, V35, P949, DOI 10.1007/s00299-016-1948-4; MCQUEENMASON S, 1992, PLANT CELL, V4, P1425, DOI 10.1105/tpc.4.11.1425; MCQUEENMASON SJ, 1995, PLANT PHYSIOL, V107, P87, DOI 10.1104/pp.107.1.87; Mohan S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001786; Nakano K, 2010, CYTOSKELETON, V67, P373, DOI 10.1002/cm.20451; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Park S, 2014, J PLANT PHYSIOL, V171, P1645, DOI 10.1016/j.jplph.2014.08.002; REINHARD K, 1989, ARCH BIOCHEM BIOPHYS, V275, P295, DOI 10.1016/0003-9861(89)90376-7; Ren H, 2015, MOL PLANT, V8, P1153, DOI 10.1016/j.molp.2015.05.003; Ren YQ, 2018, PLANT SCI, V270, P245, DOI 10.1016/j.plantsci.2018.02.022; ROBERTS E, 1988, PLANT MOL BIOL, V11, P15, DOI 10.1007/BF00016010; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sampedro J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-242; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sun P, 2010, MOL BIOL REP, V37, P1069, DOI 10.1007/s11033-009-9834-6; Thirugnanasambantham K, 2015, PLANT MOL BIOL REP, V33, P347, DOI 10.1007/s11105-014-0799-9; Triguero A, 2005, PLANT BIOTECHNOL J, V3, P449, DOI 10.1111/j.1467-7652.2005.00137.x; Xu Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100792; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Yamada K, 2009, J JPN SOC HORTIC SCI, V78, P242, DOI 10.2503/jjshs1.78.242; Yoshida K, 2003, APPL MICROBIOL BIOT, V60, P665, DOI 10.1007/s00253-002-1157-7; Zenoni S, 2004, PLANT CELL, V16, P295, DOI 10.1105/tpc.018705; Zhang H, 2017, PLANT BIOTECHNOL REP, V11, P331, DOI 10.1007/s11816-017-0454-7; Zhu Y, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-93	72	33	34	6	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2019	14	7							e0219837	10.1371/journal.pone.0219837	http://dx.doi.org/10.1371/journal.pone.0219837			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IS7PC	30811417	Green Published, Green Submitted, gold			2022-12-27	WOS:000482340700061
J	Chen, YC; Quinn, JC; Weston, LA; Loukopoulos, P				Chen, Yuchi; Quinn, Jane C.; Weston, Leslie A.; Loukopoulos, Panayiotis			The aetiology, prevalence and morbidity of outbreaks of photosensitisation in livestock: A review	PLOS ONE			English	Review							CRYSTAL-ASSOCIATED CHOLANGIOHEPATOPATHY; CONGENITAL ERYTHROCYTIC PROTOPORPHYRIA; FACIAL ECZEMA OUTBREAK; HEPATOGENOUS PHOTOSENSITIZATION; FROELICHIA-HUMBOLDTIANA; BRACHIARIA-DECUMBENS; DAIRY-CATTLE; ENTEROLOBIUM-CONTORTISILIQUUM; SECONDARY PHOTOSENSITIZATION; PANICUM-DICHOTOMIFLORUM	Background Photosensitisation is a clinical condition occurring in both humans and animals that causes significant injury to affected individuals. In livestock, outbreaks of photosensitisation caused by ingestion of toxic plants are relatively common and can be associated with significant economic loss. Objectives The agents that are most commonly implicated in outbreaks of photosensitisation have not been formally investigated on a global scale. To address this question, a systematic review of the literature was undertaken to determine the most common causative agents implicated in outbreaks of photosensitisation in livestock in Australia and globally, as well as the prevalence and morbidity of such outbreaks. Methods A systematic database search was conducted to identify peer-reviewed case reports of photosensitisation in livestock published worldwide between 1900 and April 2018. Only case reports with a full abstract in English were included. Non peer-reviewed reports from Australia were also investigated. Case reports were then sorted by plant and animal species, type of photosensitisation by diagnosis, location, morbidity and mortality rate and tabulated for further analysis. Results One hundred and sixty-six reports qualified for inclusion in this study. Outbreaks were reported in 20 countries. Australia (20), Brazil (20) and the United States (11) showed the highest number of peer-reviewed photosensitisation case reports from this analysis. Hepatogenous (Type III) photosensitisation was the most frequently reported diagnosis (68.5%) and resulted in higher morbidity. Panicum spp., Brachiaria spp. and Tribulus terrestris were identified as the most common causes of hepatogenous photosensitisation globally. Conclusions Hepatogenous photosensitisation in livestock represents a significant risk to livestock production, particularly in Australia, Brazil, and the United States. Management of toxic pastures and common pasture weeds may reduce the economic impact of photosensitisation both at a national and global level.	[Chen, Yuchi; Quinn, Jane C.; Loukopoulos, Panayiotis] Charles Sturt Univ, Sch Anim & Vet Sci, Wagga Wagga, NSW, Australia; [Chen, Yuchi; Quinn, Jane C.; Weston, Leslie A.; Loukopoulos, Panayiotis] Charles Sturt Univ, Graham Ctr Agr Innovat, Wagga Wagga, NSW, Australia; [Chen, Yuchi; Quinn, Jane C.; Weston, Leslie A.; Loukopoulos, Panayiotis] NSW Dept Primary Ind, Wagga Wagga, NSW, Australia; [Weston, Leslie A.] Charles Sturt Univ, Sch Agr & Wine Sci, Wagga Wagga, NSW, Australia; [Loukopoulos, Panayiotis] Univ Melbourne, Melbourne Vet Sch, Werribee, Vic, Australia	Charles Sturt University; Charles Sturt University; NSW Department of Primary Industries; Charles Sturt University; University of Melbourne	Quinn, JC (corresponding author), Charles Sturt Univ, Sch Anim & Vet Sci, Wagga Wagga, NSW, Australia.; Quinn, JC (corresponding author), Charles Sturt Univ, Graham Ctr Agr Innovat, Wagga Wagga, NSW, Australia.; Quinn, JC (corresponding author), NSW Dept Primary Ind, Wagga Wagga, NSW, Australia.	jquinn@csu.edu.au	Loukopoulos, Panayiotis/AAC-4164-2020; Quinn, Jane C/ABC-9968-2020; Weston, Leslie/M-4557-2015	Loukopoulos, Panayiotis/0000-0002-4308-8618; Weston, Leslie/0000-0002-1029-7982; Quinn, Jane/0000-0002-9310-0291	Graham Centre for Agricultural Innovation; CSU School of Animal and Veterinary Science; School of Animal and Veterinary Science (Charles Sturt University)	Graham Centre for Agricultural Innovation; CSU School of Animal and Veterinary Science; School of Animal and Veterinary Science (Charles Sturt University)	Yuchi Chen is supported by a PhD scholarship funded by Graham Centre for Agricultural Innovation and CSU School of Animal and Veterinary Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge financial support from the Graham Centre for Agricultural Innovation and School of Animal and Veterinary Science (Charles Sturt University). The authors would like to thank Dr. Paul Weston for consultation on the data presentation methods from the statistical perspective. The authors would also like to thank Animal Health Australia (www.animalhealthaustralia.com.au) for providing access to archived reports of Animal Health Surveillance Quarterly.	Abera D., 2014, J ENV ANAL TOXICOL, V04, DOI [https://doi.org/10.4172/2161-0525.1000215, DOI 10.4172/2161-0525.1000215]; Albernaz TT, 2010, PESQUISA VET BRASIL, V30, P741, DOI 10.1590/S0100-736X2010000900006; Amjadi A. R., 1977, Archives de l'Institut Razi, P71; AMOROSO EC, 1957, NATURE, V180, P230, DOI 10.1038/180230a0; Armstrong SC, 2002, VET REC, V150, P608, DOI 10.1136/vr.150.19.608; Aslani MR, 2004, SMALL RUMINANT RES, V51, P261, DOI 10.1016/S0921-4488(03)00195-0; Aslani MR, 2003, VET RES COMMUN, V27, P53, DOI 10.1023/A:1022010707704; BABER R, 1989, TROP ANIM HEALTH PRO, V21, P277, DOI 10.1007/BF02261108; Badiei K, 2009, SMALL RUMINANT RES, V82, P99, DOI 10.1016/j.smallrumres.2009.02.002; Barnes J, 2001, J PHARM PHARMACOL, V53, P583, DOI 10.1211/0022357011775910; Barrington GM., 2010, MERCK VET MANUAL, V10, P665; Black A, 2011, SURV, V38, P11; Bourke CA, 2003, AUST VET J, V81, P361, DOI 10.1111/j.1751-0813.2003.tb11515.x; BRIDGES CH, 1987, VET PATHOL, V24, P525, DOI 10.1177/030098588702400609; Brum KB, 2007, PESQUI VET BRASIL, V27, P39, DOI 10.1590/S0100-736X2007000100007; BUTTON C, 1987, AUST VET J, V64, P176, DOI 10.1111/j.1751-0813.1987.tb09677.x; Cardona-Alvarez J, 2016, REV MVZ CORDOBA, V21, P5366, DOI 10.21897/rmvz.603; CASTEEL SW, 1986, VET HUM TOXICOL, V28, P251; Chabchoub A, 1999, REV MED VET-TOULOUSE, V150, P617; Collett MG, 2014, VET PATHOL, V51, P986, DOI 10.1177/0300985813513042; Collett MG, 2011, NEW ZEAL VET J, V59, P147, DOI 10.1080/00480169.2011.567966; de Araujo VO, 2017, TOXICON, V138, P184, DOI 10.1016/j.toxicon.2017.09.009; De Oliveira CHS, 2013, TOXICON, V73, P121, DOI 10.1016/j.toxicon.2013.07.001; DENT C. H. R., 1967, Australian Veterinary Journal, V43, P71, DOI 10.1111/j.1751-0813.1967.tb15072.x; DIMENNA ME, 1992, VET RES COMMUN, V16, P117, DOI 10.1007/BF01839008; Doyle KA, 2008, MERCK VET MANUAL, P278, DOI [10.1111/j.1751-0813.1993.tb08058.x, DOI 10.1111/J.1751-0813.1993.TB08058.X]; EDWARDS JR, 1981, AUST VET J, V57, P392, DOI 10.1111/j.1751-0813.1981.tb00534.x; Ferrer LM, 2007, VET REC, V161, P312, DOI 10.1136/vr.161.9.312; FLAOYEN A, 1991, VET RES COMMUN, V15, P455; Flaoyen A., 1999, NATURAL SELECTED SYN, P204; Flock M, 2003, TIERAERZTL PRAX G N, V31, P143; Fu PP, 2013, J ENVIRON SCI HEAL C, V31, P213, DOI 10.1080/10590501.2013.824206; GALITZER SJ, 1978, VET SCI COMMUN, V2, P217, DOI 10.1007/BF02291451; Ghamkhar K, 2012, CROP PASTURE SCI, V63, P833, DOI 10.1071/CP12126; Giaretta PR, 2014, PESQUI VET BRASIL, V34, P967, DOI 10.1590/S0100-736X2014001000008; Giaretta PR, 2014, PESQUI VET BRASIL, V34, P427, DOI 10.1590/S0100-736X2014000500007; GLASTONBURY JRW, 1984, AUST VET J, V61, P314, DOI 10.1111/j.1751-0813.1984.tb07135.x; GLASTONBURY JRW, 1985, AUST VET J, V62, P62, DOI 10.1111/j.1751-0813.1985.tb14238.x; Gleen BL, 2016, PATHOL VET, V1, P469; GLENN BL, 1965, PATHOL VET, V2, P49, DOI 10.1177/030098586500200104; Golder HM, 2017, NEW ZEAL VET J, V65, P39, DOI 10.1080/00480169.2016.1232181; Grecco FB, 2002, VET HUM TOXICOL, V44, P160; GREENWOOD PE, 1985, AUST VET J, V62, P65, DOI 10.1111/j.1751-0813.1985.tb14241.x; Griffiths IB, 2000, VET REC, V146, P73, DOI 10.1136/vr.146.3.73; HANSEN DE, 1994, J AM VET MED ASSOC, V204, P1668; Birgel EH, 2007, CAN VET J, V48, P323; Hussain SM, 2018, TROP ANIM HLTH PROD, V36, P1; Huxley JN, 2009, VET REC, V165, P694; Ivens P, 2011, VET REC, V169, P81, DOI 10.1136/vr.d4472; JERRETT IV, 1983, AUST VET J, V60, P183, DOI 10.1111/j.1751-0813.1983.tb05959.x; Jesse FF, 2012, VET WORLD, V5, P764, DOI 10.5455/vetworld.2012.764-766; Johnson AL, 2006, J VET INTERN MED, V20, P1414, DOI 10.1892/0891-6640(2006)20[1414:FPPDHI]2.0.CO;2; Johnson JH, 1998, J ZOO WILDLIFE MED, V29, P203; Kawada H, 1980, J JPN VET MED ASSOC, V33, P372; KELLERMAN TS, 1985, ONDERSTEPOORT J VET, V52, P157; Kessell AE, 2015, AUST VET J, V93, P174, DOI 10.1111/avj.12318; KINGSBURY JM, 1958, J DAIRY SCI, V41, P875, DOI 10.3168/jds.S0022-0302(58)91020-8; Lancaster MJ, 2006, AUST VET J, V84, P98, DOI 10.1111/j.1751-0813.2006.tb12238.x; LANCASTER MJ, 1991, AUST VET J, V68, P281, DOI 10.1111/j.1751-0813.1991.tb03246.x; LAUSTRIAT G, 1986, BIOCHIMIE, V68, P771, DOI 10.1016/S0300-9084(86)80092-X; Lemos R. A. A. de, 1998, Ciencia Rural, V28, P507, DOI 10.1590/S0103-84781998000300026; Lin SC, 1981, TW J VET MED ANI HUS, V30, P159, DOI [10.1155/2017/5276106smallrumres.2009.02.002, DOI 10.1155/2017/5276106SMALLRUMRES.2009.02.002]; Lugton IW, 2014, AUST VET J, V92, P62, DOI 10.1111/avj.12148; MARASAS W F O, 1972, Onderstepoort Journal of Veterinary Research, V39, P107; Mauldin EA, 2016, JUBB KENNEDY PALMERS, P577; Mazni OA, 1985, MARDI RES B, P203; McAloon CG, 2015, IRISH VET J, V68, DOI 10.1186/s13620-015-0044-3; McKenzie R, 2012, AUSTRALIAS POISONOUS, DOI [10.1111/j.1751-0813.2012.01001.x, DOI 10.1111/J.1751-0813.2012.01001.X]; MCKENZIE RA, 1988, AUST VET J, V65, P128, DOI 10.1111/j.1751-0813.1988.tb14432.x; Minervino AHH, 2010, RES VET SCI, V88, P519, DOI 10.1016/j.rvsc.2009.12.005; Morton JM, 1997, AUST VET J, V75, P109, DOI 10.1111/j.1751-0813.1997.tb14169.x; Nazifi S., 2009, Comparative Clinical Pathology, V18, P249, DOI 10.1007/s00580-008-0784-5; Ocal N, 2013, ANKARA UNIV VET FAK, V60, P117, DOI 10.1501/Vetfak_0000002564; Olinda RG, 2015, PESQUI VET BRASIL, V35, P44, DOI 10.1590/S0100-736X2015000100010; OPASINA BA, 1985, TROP GRASSLANDS, V19, P120; Ozmen O, 2008, TROP ANIM HEALTH PRO, V40, P545, DOI 10.1007/s11250-008-9132-7; Pence ME, 2002, J AM VET MED ASSOC, V221, P277, DOI 10.2460/javma.2002.221.277; PETERSON JE, 1992, AUST VET J, V69, P51, DOI 10.1111/j.1751-0813.1992.tb07448.x; Pilsworth RC, 2010, EQUINE VET EDUC, V19, P32, DOI [10.1111/j.2042-3292.2007.tb00549.x, DOI 10.1111/J.2042-3292.2007.TB00549.X]; Pimentel LA, 2007, PESQUI VET BRASIL, V27, P23, DOI 10.1590/S0100-736X2007000100005; Pollock ML, 2015, VET J, V206, P275, DOI 10.1016/j.tvjl.2015.07.022; PUOLI JR, 1992, AGRON J, V84, P1077, DOI 10.2134/agronj1992.00021962008400060033x; Puschner B, 2016, VET J, V211, P32, DOI 10.1016/j.tvjl.2016.03.004; Quinn JC, 2018, BMC VET RES, V14, DOI 10.1186/s12917-017-1318-7; Quinn JC, 2014, INT J MOL SCI, V15, P1441, DOI 10.3390/ijms15011441; Read E, 2017, TOXINS, V9, DOI 10.3390/toxins9010008; REGNAULT TRH, 1990, AUST VET J, V67, P419, DOI 10.1111/j.1751-0813.1990.tb03040.x; Knupp SNR, 2016, SEMIN-CIENC AGRAR, V37, P2009, DOI 10.5433/1679-0359.2016v37n4p2009; Knupp SNR, 2014, PESQUI VET BRASIL, V34, P1191, DOI 10.1590/S0100-736X2014001200008; Riet-Correa F, 2009, PESQUISA VET BRASIL, V29, P94, DOI 10.1590/S0100-736X2009000100015; Riet-Correa F, 2012, J APPL TOXICOL, V32, P245, DOI 10.1002/jat.1754; ROWE LD, 1989, VET CLIN N AM-FOOD A, V5, P301, DOI 10.1016/S0749-0720(15)30978-6; Salam KP, 2010, LIVESTOCK RES RURAL; Sandler IL, 1939, JAMA-J AM MED ASSOC, V112, P2411, DOI 10.1001/jama.1939.62800230002012b; Santos DS, 2017, TOXICON, V125, P65, DOI 10.1016/j.toxicon.2016.11.258; Sargison ND, 2012, VET PARASITOL, V189, P233, DOI 10.1016/j.vetpar.2012.04.018; Saturnino KC, 2010, PESQUI VET BRASIL, V30, P195, DOI 10.1590/S0100-736X2010000300002; SCHELCHER F, 1991, VET REC, V129, P403, DOI 10.1136/vr.129.18.403; Smith BL, 1997, NEW ZEAL VET J, V45, P88, DOI 10.1080/00480169.1997.36001; Souza PEC, 2012, RES VET SCI, V93, P1337, DOI 10.1016/j.rvsc.2012.04.005; STAFFORD KJ, 1995, NEW ZEAL VET J, V43, P114, DOI 10.1080/00480169.1995.35866; Steventon CA, 2018, J WILDLIFE DIS, V54, P491, DOI 10.7589/2017-03-066; Thawait V. K., 2013, Intas Polivet, V14, P228; Towers N.R., 1986, P NZ GRASSL ASS, V47, P121, DOI [10.33584/jnzg.1986.47.1726, DOI 10.33584/JNZG.1986.47.1726]; Medeiros RMT, 2014, CIENC RURAL, V44, P1837, DOI 10.1590/0103-8478cr20131417; Truyers I., 2013, Livestock, V18, P30; vanHalderen A, 1995, J S AFR VET ASSOC, V66, P260; Wisloff H, 2002, VET RES COMMUN, V26, P381, DOI 10.1023/A:1016298929610; WITTE ST, 1993, J VET DIAGN INVEST, V5, P133, DOI 10.1177/104063879300500135; WITZEL DA, 1978, AM J VET RES, V39, P319; Woolford L, 2014, J AGR FOOD CHEM, V62, P7413, DOI 10.1021/jf405811n	111	33	34	6	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211625	10.1371/journal.pone.0211625	http://dx.doi.org/10.1371/journal.pone.0211625			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811417	Green Published, gold, Green Submitted			2022-12-27	WOS:000459806400026
